032097|NCT01725620|Sensory System Agents|sensory system agents|mesh-ancestor
56032098|NCT01725620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032099|NCT01725620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032100|NCT01725620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56032101|NCT01725620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56032102|NCT01725620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56032103|NCT01725620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56032104|NCT01725620|Immunologic Factors|immunologic factors|mesh-ancestor
56032105|NCT01045460|Cyclophosphamide|cyclophosphamide|mesh-list
56032106|NCT01045460|Melphalan|melphalan|mesh-list
56032107|NCT01045460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55876789|NCT01925859|Dexamethasone|dexamethasone|mesh-list
55876790|NCT01925859|Dexamethasone acetate|dexamethasone acetate|mesh-list
55876791|NCT01925859|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55876792|NCT01925859|BB 1101|bb 1101|mesh-list
55876793|NCT01925859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876794|NCT01925859|Antiemetics|antiemetics|mesh-ancestor
55876795|NCT01925859|Autonomic Agents|autonomic agents|mesh-ancestor
55876796|NCT01925859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876797|NCT01925859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876801|NCT01925859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876802|NCT01925859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55876804|NCT01925859|Protease Inhibitors|protease inhibitors|mesh-ancestor
55876805|NCT01925859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876806|NCT01925859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876807|NCT01920945|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55876808|NCT01920945|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56032108|NCT01045460|Immunologic Factors|immunologic factors|mesh-ancestor
56032109|NCT01045460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032110|NCT01045460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56032111|NCT01045460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56032112|NCT01045460|Alkylating Agents|alkylating agents|mesh-ancestor
56032113|NCT01045460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032114|NCT01045460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032115|NCT01045460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56032116|NCT03403790|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56032117|NCT03403790|Antidepressive Agents|antidepressive agents|mesh-ancestor
56032118|NCT03403790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56032119|NCT03403790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56032120|NCT03403790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56032121|NCT03403790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032122|NCT03403790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032123|NCT05014919|Vortioxetine|vortioxetine|mesh-list
56032124|NCT05014919|Antidepressive Agents|antidepressive agents|mesh-ancestor
56032125|NCT05014919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56032126|NCT05014919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56032127|NCT05014919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56032128|NCT05014919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032129|NCT05014919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032130|NCT05014919|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56032131|NCT05014919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56032132|NCT05014919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56032133|NCT05014919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032134|NCT05014919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032136|NCT05014919|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56032137|NCT05014919|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56032138|NCT05014919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55827164|NCT05598905|Narcotics|narcotics|mesh-ancestor
56032139|NCT05014919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56032146|NCT05620862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56032147|NCT05620862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56032148|NCT05620862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032149|NCT05620862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032151|NCT03406286|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56032152|NCT03406286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032153|NCT03406286|Natriuretic Agents|natriuretic agents|mesh-ancestor
56032154|NCT03406286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032155|NCT05672537|Gemcitabine|gemcitabine|mesh-list
56032156|NCT05672537|Durvalumab|durvalumab|mesh-list
56032157|NCT05672537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032158|NCT05672537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56032159|NCT05672537|Antimetabolites|antimetabolites|mesh-ancestor
56032160|NCT05672537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032161|NCT05672537|Antiviral Agents|antiviral agents|mesh-ancestor
56032162|NCT05672537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032163|NCT05672537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032164|NCT05672537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56032165|NCT05672537|Immunologic Factors|immunologic factors|mesh-ancestor
56032166|NCT05672537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032167|NCT05672537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032168|NCT03400592|Irinotecan|irinotecan|mesh-list
56032169|NCT03400592|Nimotuzumab|nimotuzumab|mesh-list
56032170|NCT03400592|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56032171|NCT03400592|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56032172|NCT03400592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032173|NCT03400592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032174|NCT03400592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032191|NCT02222129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032192|NCT03003611|Anesthetics|anesthetics|mesh-list
56032193|NCT03003611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032194|NCT03003611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032195|NCT04840199|Letermovir|letermovir|mesh-list
56032196|NCT04840199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56032197|NCT04840199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032198|NCT04840199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032199|NCT04840199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827234|NCT02252042|Antimetabolites|antimetabolites|mesh-ancestor
56032200|NCT04840199|Antiviral Agents|antiviral agents|mesh-ancestor
56032201|NCT04840199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032202|NCT03401294|Leucovorin|leucovorin|mesh-list
56032203|NCT03401294|Bevacizumab|bevacizumab|mesh-list
56032204|NCT03401294|Oxaliplatin|oxaliplatin|mesh-list
56032205|NCT03401294|Irinotecan|irinotecan|mesh-list
56032206|NCT03401294|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032207|NCT03401294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032208|NCT03401294|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55763754|NCT04062201|Linezolid|linezolid|mesh-list
56032209|NCT03401294|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56032210|NCT03401294|Growth Substances|growth substances|mesh-ancestor
56032211|NCT03401294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032212|NCT03401294|Growth Inhibitors|growth inhibitors|mesh-ancestor
56032213|NCT03401294|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56032214|NCT03401294|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56032216|NCT03401294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032218|NCT03401294|Protective Agents|protective agents|mesh-ancestor
56032219|NCT03401294|Vitamin B Complex|vitamin b complex|mesh-ancestor
56032220|NCT03401294|Vitamins|vitamins|mesh-ancestor
56032221|NCT03401294|Micronutrients|micronutrients|mesh-ancestor
56032222|NCT04763759|Antibodies|antibodies|mesh-list
56032223|NCT04763759|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55876809|NCT01920945|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55876810|NCT01920945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876811|NCT01920945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827264|NCT02197520|Insulin|insulin|mesh-list
55876812|NCT01920945|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55876813|NCT01920945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55876814|NCT01920945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876815|NCT01920945|Cholinergic Agents|cholinergic agents|mesh-ancestor
56032224|NCT04763759|Immunologic Factors|immunologic factors|mesh-ancestor
56032225|NCT04763759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032226|NCT02980991|Pemetrexed|pemetrexed|mesh-list
56032227|NCT02980991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032228|NCT02980991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032229|NCT02980991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032230|NCT02980991|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56032231|NCT02980991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56032232|NCT05671913|Ketamine|ketamine|mesh-list
56032233|NCT05671913|Analgesics|analgesics|mesh-ancestor
56032234|NCT05671913|Sensory System Agents|sensory system agents|mesh-ancestor
56032235|NCT05671913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032236|NCT05671913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032237|NCT05671913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56032238|NCT05671913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56032239|NCT05671913|Anesthetics, General|anesthetics, general|mesh-ancestor
56032240|NCT05671913|Anesthetics|anesthetics|mesh-ancestor
56032241|NCT05671913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032242|NCT05671913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56032243|NCT05671913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56032244|NCT05671913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032245|NCT05671913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032246|NCT05671757|Daratumumab|daratumumab|mesh-list
56032247|NCT05671757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56032248|NCT05671757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032249|NCT05671757|Immunologic Factors|immunologic factors|mesh-ancestor
56032250|NCT05671757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032251|NCT03402698|Cholecalciferol|cholecalciferol|mesh-list
56032252|NCT03402698|Vitamin D|vitamin d|mesh-list
56032253|NCT03402698|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56032254|NCT03402698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032255|NCT03402698|Vitamins|vitamins|mesh-ancestor
56032266|NCT02248181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032268|NCT02248181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56032269|NCT02248181|Dopamine Agonists|dopamine agonists|mesh-ancestor
56032270|NCT02248181|Dopamine Agents|dopamine agents|mesh-ancestor
56032271|NCT02248181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032272|NCT03003143|Vigabatrin|vigabatrin|mesh-list
56032273|NCT03003143|Anticonvulsants|anticonvulsants|mesh-ancestor
56032274|NCT03003143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032275|NCT03003143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032276|NCT03003143|GABA Agents|gaba agents|mesh-ancestor
56032277|NCT03003143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032278|NCT03003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032279|NCT02462928|Ranibizumab|ranibizumab|mesh-list
56032280|NCT02462928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56032281|NCT02462928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56032282|NCT02462928|Growth Substances|growth substances|mesh-ancestor
56032283|NCT02462928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032284|NCT02462928|Growth Inhibitors|growth inhibitors|mesh-ancestor
56032285|NCT02462928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032286|NCT03002831|Tegafur|tegafur|mesh-list
56032287|NCT03002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56032288|NCT03002831|Antimetabolites|antimetabolites|mesh-ancestor
56032289|NCT03002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032290|NCT03002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759495|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032291|NCT02248259|Itraconazole|itraconazole|mesh-list
56032292|NCT02248259|BI 409306|bi 409306|mesh-list
56032293|NCT02248259|Antifungal Agents|antifungal agents|mesh-ancestor
56032294|NCT02248259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032309|NCT04526951|Analgesics|analgesics|mesh-ancestor
56032310|NCT04526951|Sensory System Agents|sensory system agents|mesh-ancestor
56032311|NCT04526951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032312|NCT04526951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032313|NCT04526951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56032314|NCT04526951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56032315|NCT04526951|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56032316|NCT04526951|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56032317|NCT04526951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032318|NCT04526951|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56032319|NCT04526951|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56032320|NCT04526951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032321|NCT04526951|Antipyretics|antipyretics|mesh-ancestor
56032322|NCT04956432|Allopurinol|allopurinol|mesh-list
56032323|NCT04956432|Antimetabolites|antimetabolites|mesh-ancestor
56032324|NCT04956432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032326|NCT04956432|Gout Suppressants|gout suppressants|mesh-ancestor
56032327|NCT04956432|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55763755|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
56032328|NCT04956432|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56032329|NCT04956432|Antioxidants|antioxidants|mesh-ancestor
56032330|NCT04956432|Protective Agents|protective agents|mesh-ancestor
56032331|NCT04956432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032332|NCT02248415|Anesthetics|anesthetics|mesh-list
56032333|NCT02248415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032334|NCT02248415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032335|NCT02248571|Bevacizumab|bevacizumab|mesh-list
56032336|NCT02248571|Capecitabine|capecitabine|mesh-list
56032357|NCT00019604|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56032358|NCT00019604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56032359|NCT00019604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032360|NCT03002675|Exenatide|exenatide|mesh-list
56032361|NCT03002675|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56032362|NCT03002675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032363|NCT03002675|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56032364|NCT03002675|Incretins|incretins|mesh-ancestor
56032365|NCT03002675|Hormones|hormones|mesh-ancestor
56032366|NCT03002675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56032367|NCT02246270|Heparin|heparin|mesh-list
56032368|NCT02246270|Calcium heparin|calcium heparin|mesh-list
56032369|NCT02246270|Anticoagulants|anticoagulants|mesh-ancestor
56032370|NCT02246270|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56032371|NCT02246270|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56032372|NCT02246270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032373|NCT02247557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56032374|NCT02247557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56032375|NCT02247557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56032376|NCT02247557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032377|NCT02247557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032378|NCT02247557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56032379|NCT02247557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56032380|NCT02247557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827410|NCT05382299|Antimetabolites|antimetabolites|mesh-ancestor
56032381|NCT02247557|Cholinergic Agents|cholinergic agents|mesh-ancestor
56032382|NCT02247557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032383|NCT02240498|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56032384|NCT02240498|Methylene Blue|methylene blue|mesh-list
56032385|NCT02240498|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56032386|NCT02240498|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56032390|NCT04374188|Ciprofloxacin|ciprofloxacin|mesh-list
56032399|NCT04374188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032400|NCT04374188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56032401|NCT04374188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56032402|NCT04374188|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56032404|NCT04374032|Enkephalin, Methionine|enkephalin, methionine|mesh-list
56032405|NCT04374032|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032406|NCT04374032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032407|NCT04374032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032408|NCT03401606|Dexmedetomidine|dexmedetomidine|mesh-list
56032409|NCT03401606|Remifentanil|remifentanil|mesh-list
56032410|NCT03401606|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56032411|NCT03401606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032412|NCT03401606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032413|NCT03401606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55827438|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
56032414|NCT03401606|Analgesics|analgesics|mesh-ancestor
56032415|NCT03401606|Sensory System Agents|sensory system agents|mesh-ancestor
56032416|NCT03401606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032417|NCT03401606|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56032418|NCT03401606|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56032419|NCT03401606|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56032420|NCT03401606|Adrenergic Agents|adrenergic agents|mesh-ancestor
56032421|NCT03401606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763756|NCT04062201|Ethambutol|ethambutol|mesh-list
55827640|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56032422|NCT03401606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032423|NCT03401606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56032424|NCT03401606|Narcotics|narcotics|mesh-ancestor
56032425|NCT05633381|Temozolomide|temozolomide|mesh-list
56032426|NCT05633381|Trabectedin|trabectedin|mesh-list
56032427|NCT05633381|Olaparib|olaparib|mesh-list
56032428|NCT05633381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56032429|NCT05633381|Alkylating Agents|alkylating agents|mesh-ancestor
56032434|NCT02516592|Fluticasone|fluticasone|mesh-list
56032440|NCT02516592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032441|NCT02516592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56032442|NCT02516592|Respiratory System Agents|respiratory system agents|mesh-ancestor
56032443|NCT02516592|Dermatologic Agents|dermatologic agents|mesh-ancestor
56032444|NCT02516592|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56032445|NCT02516592|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56032446|NCT02516592|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56032447|NCT02516592|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56032448|NCT02516592|Adrenergic Agents|adrenergic agents|mesh-ancestor
56032449|NCT02516592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032450|NCT02516592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032451|NCT03401372|Doxycycline|doxycycline|mesh-list
56032452|NCT03401372|Dexamethasone|dexamethasone|mesh-list
56032453|NCT03401372|Cyclophosphamide|cyclophosphamide|mesh-list
56032454|NCT03401372|Bortezomib|bortezomib|mesh-list
56032455|NCT03401372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56032456|NCT03401372|Immunologic Factors|immunologic factors|mesh-ancestor
55763757|NCT04062201|Bedaquiline|bedaquiline|mesh-list
56032457|NCT03401372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032458|NCT03401372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56032459|NCT03401372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56032460|NCT03401372|Alkylating Agents|alkylating agents|mesh-ancestor
56032461|NCT03401372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032462|NCT03401372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032463|NCT03401372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56032464|NCT03401372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56032465|NCT03401372|Antiemetics|antiemetics|mesh-ancestor
56032470|NCT03401372|Hormones|hormones|mesh-ancestor
56032489|NCT02219321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032510|NCT04716335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032511|NCT04283669|Crizotinib|crizotinib|mesh-list
56032512|NCT04283669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032516|NCT02221349|Listerine|listerine|mesh-list
56032536|NCT04376528|Cyclosporins|cyclosporins|mesh-list
56032537|NCT04376528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032538|NCT04376528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032539|NCT04376528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56032540|NCT04376528|Immunologic Factors|immunologic factors|mesh-ancestor
56032541|NCT04376528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032542|NCT04376528|Antifungal Agents|antifungal agents|mesh-ancestor
56032543|NCT04376528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032544|NCT04376528|Dermatologic Agents|dermatologic agents|mesh-ancestor
56032546|NCT04376528|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56032547|NCT04376528|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56032548|NCT04376528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032549|NCT04376528|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56032550|NCT04376528|Antitubercular Agents|antitubercular agents|mesh-ancestor
56032551|NCT04376528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56032552|NCT04200443|Temozolomide|temozolomide|mesh-list
56032553|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56032554|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
56032555|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032556|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032557|NCT02461134|Ponesimod|ponesimod|mesh-list
56032558|NCT02461134|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56032559|NCT02461134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032560|NCT02461134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56032561|NCT02461134|Immunologic Factors|immunologic factors|mesh-ancestor
56032562|NCT02461134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032563|NCT04373018|Chlorhexidine|chlorhexidine|mesh-list
56032564|NCT04373018|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56032583|NCT04934748|Respiratory System Agents|respiratory system agents|mesh-ancestor
56032584|NCT04934748|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56032585|NCT04934748|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56032586|NCT04934748|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56032587|NCT04934748|Adrenergic Agents|adrenergic agents|mesh-ancestor
56032588|NCT04934748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032589|NCT04934748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759798|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
56032590|NCT04934748|Protective Agents|protective agents|mesh-ancestor
56032591|NCT04594733|Minocycline|minocycline|mesh-list
56032592|NCT04594733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55887133|NCT01806779|Nicotine|nicotine|mesh-list
56032593|NCT04594733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032594|NCT02223065|Dapagliflozin|dapagliflozin|mesh-list
56032595|NCT02223065|Saxagliptin|saxagliptin|mesh-list
56032597|NCT02223065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032598|NCT02223065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56032599|NCT02223065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032600|NCT02223065|Incretins|incretins|mesh-ancestor
56032601|NCT02223065|Hormones|hormones|mesh-ancestor
56032602|NCT02223065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56032603|NCT02223065|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56032604|NCT02223065|Protease Inhibitors|protease inhibitors|mesh-ancestor
56032605|NCT02223065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032606|NCT04366232|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56032607|NCT04366232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56032608|NCT02241200|Darbepoetin alfa|darbepoetin alfa|mesh-list
56032609|NCT02241200|Hematinics|hematinics|mesh-ancestor
56032610|NCT05557877|Aspirin|aspirin|mesh-list
56032611|NCT05557877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56032612|NCT05557877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56032613|NCT05557877|Analgesics|analgesics|mesh-ancestor
56032614|NCT05557877|Sensory System Agents|sensory system agents|mesh-ancestor
56032615|NCT05557877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032616|NCT05557877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032617|NCT05557877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56032618|NCT05557877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56032619|NCT05557877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56032620|NCT05557877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56032621|NCT05557877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032622|NCT05557877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56032623|NCT05557877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56032624|NCT05557877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032625|NCT05557877|Antipyretics|antipyretics|mesh-ancestor
55827745|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56032626|NCT02241278|Ketamine|ketamine|mesh-list
56032627|NCT02241278|Analgesics|analgesics|mesh-ancestor
56032628|NCT02241278|Sensory System Agents|sensory system agents|mesh-ancestor
56032629|NCT02241278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032630|NCT02241278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032631|NCT02241278|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56032632|NCT02241278|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56032633|NCT02241278|Anesthetics, General|anesthetics, general|mesh-ancestor
56032634|NCT02241278|Anesthetics|anesthetics|mesh-ancestor
56032635|NCT02241278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032636|NCT02241278|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56032637|NCT02241278|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56032640|NCT04347512|Azithromycin|azithromycin|mesh-list
56032660|NCT02460978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032662|NCT04372316|Vitamin B Complex|vitamin b complex|mesh-ancestor
56032663|NCT04372316|Vitamins|vitamins|mesh-ancestor
56032664|NCT04372316|Micronutrients|micronutrients|mesh-ancestor
56032665|NCT04372316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032666|NCT02221739|Ipilimumab|ipilimumab|mesh-list
56032667|NCT02221739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032668|NCT02221739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032669|NCT02221739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56032670|NCT02221739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032671|NCT02241356|Methamphetamine|methamphetamine|mesh-list
56032672|NCT02241356|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56032673|NCT02241356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032674|NCT02241356|Sympathomimetics|sympathomimetics|mesh-ancestor
56032675|NCT02241356|Autonomic Agents|autonomic agents|mesh-ancestor
56032676|NCT02241356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032677|NCT02241356|Dopamine Agents|dopamine agents|mesh-ancestor
56032678|NCT02241356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032679|NCT02241356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032680|NCT02241356|Adrenergic Agents|adrenergic agents|mesh-ancestor
56032681|NCT02241356|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56032682|NCT02241356|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56032683|NCT02241356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56032684|NCT02241356|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56032686|NCT04365686|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56032687|NCT04365686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56032688|NCT04365686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032689|NCT04365686|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56032690|NCT04365686|Anesthetics, General|anesthetics, general|mesh-ancestor
56032691|NCT04365686|Anesthetics|anesthetics|mesh-ancestor
56032692|NCT02241590|Entecavir|entecavir|mesh-list
56032702|NCT04372082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56032703|NCT04372082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032704|NCT04372082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032705|NCT04372082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032706|NCT04372082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56032707|NCT04372082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56032708|NCT04372082|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56032709|NCT04372082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56032710|NCT04372082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56032711|NCT04372082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032712|NCT04372082|Vasodilator Agents|vasodilator agents|mesh-ancestor
56032713|NCT04372082|Anticestodal Agents|anticestodal agents|mesh-ancestor
56032714|NCT04372082|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56032715|NCT04372082|Anthelmintics|anthelmintics|mesh-ancestor
56032716|NCT04372082|Antinematodal Agents|antinematodal agents|mesh-ancestor
56032717|NCT05363111|Daratumumab|daratumumab|mesh-list
56032718|NCT05363111|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56032719|NCT05363111|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56032720|NCT05363111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032721|NCT05363111|Immunologic Factors|immunologic factors|mesh-ancestor
56032722|NCT05363111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032723|NCT05363111|Chelating Agents|chelating agents|mesh-ancestor
56032724|NCT05363111|Sequestering Agents|sequestering agents|mesh-ancestor
56032725|NCT05363111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032726|NCT03983993|Panitumumab|panitumumab|mesh-list
56032727|NCT03983993|Niraparib|niraparib|mesh-list
56032728|NCT03983993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032729|NCT03983993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032730|NCT03983993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56032731|NCT03983993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032732|NCT03983993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032733|NCT02489448|Durvalumab|durvalumab|mesh-list
56032734|NCT02489448|Tremelimumab|tremelimumab|mesh-list
56032735|NCT02489448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55876816|NCT01920945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876817|NCT01926639|Rituximab|rituximab|mesh-list
55876818|NCT01926639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55876819|NCT01926639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032736|NCT02489448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032737|NCT00926588|Analgesics|analgesics|mesh-list
56032738|NCT00926588|Sensory System Agents|sensory system agents|mesh-ancestor
56032739|NCT00926588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032740|NCT00926588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032741|NCT04371926|Hydroxychloroquine|hydroxychloroquine|mesh-list
56032742|NCT04371926|Antimalarials|antimalarials|mesh-ancestor
56032743|NCT04371926|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56032744|NCT04371926|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56032745|NCT04371926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032746|NCT04371926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032747|NCT04371926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032748|NCT04371926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56032749|NCT02248883|Moxifloxacin|moxifloxacin|mesh-list
56032750|NCT02248883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56032751|NCT02248883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032752|NCT02248883|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56032753|NCT02248883|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56032754|NCT02248883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032755|NCT02248883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032756|NCT02248883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032757|NCT04364906|Anesthetics|anesthetics|mesh-list
56032758|NCT04364906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840508|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56032760|NCT04134845|Dantrolene|dantrolene|mesh-list
56032761|NCT04134845|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56032765|NCT02488980|Mefloquine|mefloquine|mesh-list
56032785|NCT04371224|Antidotes|antidotes|mesh-ancestor
56032786|NCT04371224|Protective Agents|protective agents|mesh-ancestor
56032787|NCT04371224|Vitamin B Complex|vitamin b complex|mesh-ancestor
56032788|NCT04371224|Vitamins|vitamins|mesh-ancestor
56032789|NCT04371224|Micronutrients|micronutrients|mesh-ancestor
56032790|NCT02227667|Durvalumab|durvalumab|mesh-list
56032791|NCT02227667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032792|NCT02227667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032793|NCT02242214|Misoprostol|misoprostol|mesh-list
56032794|NCT02242214|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56032795|NCT02242214|Abortifacient Agents|abortifacient agents|mesh-ancestor
56032796|NCT02242214|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56032797|NCT02242214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032798|NCT02242214|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56032799|NCT02242214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56032800|NCT02242214|Oxytocics|oxytocics|mesh-ancestor
56032801|NCT03702725|Dexamethasone|dexamethasone|mesh-list
56032802|NCT03702725|Lenalidomide|lenalidomide|mesh-list
56032803|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56032804|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
56032805|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
56032806|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032807|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032808|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56032809|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
56032810|NCT03702725|Hormones|hormones|mesh-ancestor
56032811|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56032812|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56032813|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032814|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
56032815|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56032816|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56032817|NCT03702725|Growth Substances|growth substances|mesh-ancestor
56032818|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
56032819|NCT02245256|Dexmedetomidine|dexmedetomidine|mesh-list
56032820|NCT02245256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56032823|NCT02245256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56032825|NCT02245256|Sensory System Agents|sensory system agents|mesh-ancestor
56032826|NCT02245256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032827|NCT02245256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56032828|NCT02245256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56032829|NCT02245256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56032830|NCT02245256|Adrenergic Agents|adrenergic agents|mesh-ancestor
56032831|NCT02245256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032832|NCT02245256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032833|NCT05208983|Vaccines|vaccines|mesh-list
56032834|NCT05208983|Immunologic Factors|immunologic factors|mesh-ancestor
56032835|NCT05208983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032836|NCT02242292|Scopolamine|scopolamine|mesh-list
56032837|NCT02242292|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56032838|NCT02242292|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56032839|NCT02242292|Antiemetics|antiemetics|mesh-ancestor
56032840|NCT02242292|Autonomic Agents|autonomic agents|mesh-ancestor
56032841|NCT02242292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032842|NCT02242292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032843|NCT02242292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56032844|NCT02242292|Mydriatics|mydriatics|mesh-ancestor
56032845|NCT02242292|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56032846|NCT02242292|Cholinergic Agents|cholinergic agents|mesh-ancestor
56032847|NCT02242292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032848|NCT02242292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032849|NCT02242292|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56032850|NCT02242292|Parasympatholytics|parasympatholytics|mesh-ancestor
56032851|NCT02242370|Telmisartan|telmisartan|mesh-list
56032852|NCT02242370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55876820|NCT01926639|Immunologic Factors|immunologic factors|mesh-ancestor
55876821|NCT01926639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876822|NCT01926639|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876823|NCT02199496|Ustekinumab|ustekinumab|mesh-list
55876824|NCT02199496|Dermatologic Agents|dermatologic agents|mesh-ancestor
55876825|NCT04395417|Hyaluronic Acid|hyaluronic acid|mesh-list
55876826|NCT04395417|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55876827|NCT04395417|Immunologic Factors|immunologic factors|mesh-ancestor
55876828|NCT04395417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876829|NCT04395417|Viscosupplements|viscosupplements|mesh-ancestor
55876830|NCT04395417|Protective Agents|protective agents|mesh-ancestor
55876831|NCT02199574|Bupivacaine|bupivacaine|mesh-list
55876832|NCT02199574|Anesthetics, Local|anesthetics, local|mesh-ancestor
55876833|NCT02199574|Anesthetics|anesthetics|mesh-ancestor
56032853|NCT02242370|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56032854|NCT02242370|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56032855|NCT02242370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032856|NCT04371146|Methylphenidate|methylphenidate|mesh-list
56032857|NCT04371146|Reboxetine|reboxetine|mesh-list
56032858|NCT04371146|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56032859|NCT04371146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032860|NCT04371146|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56032861|NCT04371146|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56032862|NCT04371146|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56032863|NCT04371146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032864|NCT04371146|Dopamine Agents|dopamine agents|mesh-ancestor
56032865|NCT04371146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032866|NCT04371146|Antidepressive Agents|antidepressive agents|mesh-ancestor
56032867|NCT04371146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56032868|NCT04371146|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56032869|NCT04371146|Adrenergic Agents|adrenergic agents|mesh-ancestor
55827641|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55828163|NCT05577845|Ramosetron|ramosetron|mesh-list
56032870|NCT01623479|Bimatoprost|bimatoprost|mesh-list
56032871|NCT01623479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56032872|NCT03399539|Dexamethasone|dexamethasone|mesh-list
56032873|NCT03399539|Dexamethasone acetate|dexamethasone acetate|mesh-list
56032874|NCT03399539|Venetoclax|venetoclax|mesh-list
56032875|NCT03399539|Ixazomib|ixazomib|mesh-list
56032876|NCT03399539|Ichthammol|ichthammol|mesh-list
56032877|NCT03399539|BB 1101|bb 1101|mesh-list
56032878|NCT03399539|Glycine|glycine|mesh-list
56032879|NCT03399539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56032880|NCT03399539|Antiemetics|antiemetics|mesh-ancestor
56032881|NCT03399539|Autonomic Agents|autonomic agents|mesh-ancestor
56032901|NCT03385655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56032902|NCT03385655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032903|NCT03385655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032904|NCT04347200|Anticoagulants|anticoagulants|mesh-list
56032905|NCT04347200|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56032906|NCT04364516|Vitamin K|vitamin k|mesh-list
56032907|NCT04364516|Anticoagulants|anticoagulants|mesh-list
56032908|NCT04364516|Vitamins|vitamins|mesh-ancestor
56032909|NCT04364516|Micronutrients|micronutrients|mesh-ancestor
56032910|NCT04364516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032911|NCT04364516|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56032912|NCT04364516|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56032913|NCT04364516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032914|NCT04364516|Hemostatics|hemostatics|mesh-ancestor
56032915|NCT04364516|Coagulants|coagulants|mesh-ancestor
56032916|NCT01623869|Trebananib|trebananib|mesh-list
56032917|NCT01623869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56032918|NCT01623869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56032919|NCT01623869|Growth Substances|growth substances|mesh-ancestor
56032920|NCT01623869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032921|NCT01623869|Growth Inhibitors|growth inhibitors|mesh-ancestor
56032922|NCT01623869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56032923|NCT02242838|Telmisartan|telmisartan|mesh-list
56032924|NCT02242838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56032925|NCT02242838|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56032926|NCT02242838|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56032950|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032951|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
56032952|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
56032953|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56032954|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56032955|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56032956|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032957|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032958|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
56032959|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56032960|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56032961|NCT03203525|Antidotes|antidotes|mesh-ancestor
56032962|NCT03203525|Protective Agents|protective agents|mesh-ancestor
56032963|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
56032964|NCT03203525|Vitamins|vitamins|mesh-ancestor
56032965|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
56032966|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56032967|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032968|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
56032969|NCT02249039|Clonidine|clonidine|mesh-list
56032970|NCT02249039|Analgesics|analgesics|mesh-ancestor
56032971|NCT02249039|Sensory System Agents|sensory system agents|mesh-ancestor
56032972|NCT02249039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56032973|NCT02249039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032974|NCT02249039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56032975|NCT02249039|Sympatholytics|sympatholytics|mesh-ancestor
56032976|NCT02249039|Autonomic Agents|autonomic agents|mesh-ancestor
56032977|NCT02249039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56032978|NCT02249039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56032979|NCT02249039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56032980|NCT02249039|Adrenergic Agents|adrenergic agents|mesh-ancestor
56032981|NCT02249039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56032982|NCT02249039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032983|NCT04370288|Acetylcysteine|acetylcysteine|mesh-list
56032984|NCT04370288|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56032985|NCT04370288|Methylene Blue|methylene blue|mesh-list
56032986|NCT04370288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56032988|NCT04370288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56032989|NCT04370288|Protective Agents|protective agents|mesh-ancestor
56032990|NCT04370288|Antiviral Agents|antiviral agents|mesh-ancestor
56032991|NCT04370288|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56032992|NCT04370288|Expectorants|expectorants|mesh-ancestor
56032993|NCT04370288|Respiratory System Agents|respiratory system agents|mesh-ancestor
56032994|NCT04370288|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56032995|NCT04370288|Antidotes|antidotes|mesh-ancestor
56032996|NCT04370288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56032997|NCT02993705|Trabectedin|trabectedin|mesh-list
56032998|NCT02993705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56032999|NCT02993705|Alkylating Agents|alkylating agents|mesh-ancestor
56033000|NCT02993705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033001|NCT02993705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033002|NCT02243618|Rebamipide|rebamipide|mesh-list
56033003|NCT02243618|Polaprezinc|polaprezinc|mesh-list
56033004|NCT02243618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56033005|NCT02243618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56033006|NCT02243618|Antioxidants|antioxidants|mesh-ancestor
56033007|NCT02243618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033008|NCT02243618|Protective Agents|protective agents|mesh-ancestor
56033009|NCT02243618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033010|NCT02243618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033011|NCT02243852|Hormones|hormones|mesh-list
56033012|NCT02243852|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033013|NCT02243852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033014|NCT03150329|Pembrolizumab|pembrolizumab|mesh-list
56033015|NCT03150329|Vorinostat|vorinostat|mesh-list
56033035|NCT02231177|Autonomic Agents|autonomic agents|mesh-ancestor
56033036|NCT02231177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033037|NCT02231177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033038|NCT02231177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56033039|NCT02231177|Respiratory System Agents|respiratory system agents|mesh-ancestor
56033040|NCT02231177|Parasympatholytics|parasympatholytics|mesh-ancestor
56033041|NCT02231177|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56033042|NCT02231177|Cholinergic Agents|cholinergic agents|mesh-ancestor
56033043|NCT02231177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033044|NCT02231177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033046|NCT03283007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033047|NCT03283007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56033048|NCT03283007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033049|NCT03283007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033050|NCT02244086|Bupivacaine|bupivacaine|mesh-list
56033051|NCT02244086|Anesthetics, Local|anesthetics, local|mesh-ancestor
56033052|NCT02244086|Anesthetics|anesthetics|mesh-ancestor
56033053|NCT02244086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033054|NCT02244086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033055|NCT02244086|Sensory System Agents|sensory system agents|mesh-ancestor
56033056|NCT02244086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033057|NCT01630109|Metoclopramide|metoclopramide|mesh-list
56033058|NCT01630109|Antiemetics|antiemetics|mesh-ancestor
56033059|NCT01630109|Autonomic Agents|autonomic agents|mesh-ancestor
56033060|NCT01630109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033061|NCT01630109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033062|NCT01630109|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56033080|NCT01632215|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56033081|NCT01632215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56033082|NCT01632215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56033083|NCT01632215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033084|NCT01632215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033085|NCT01632215|Antimanic Agents|antimanic agents|mesh-ancestor
56033086|NCT02244242|Tamsulosin|tamsulosin|mesh-list
56033087|NCT02244242|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56033088|NCT02244242|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56033089|NCT02244242|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56033090|NCT02244242|Adrenergic Agents|adrenergic agents|mesh-ancestor
56033091|NCT02244242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033092|NCT02244242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033093|NCT02244242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033094|NCT02244242|Urological Agents|urological agents|mesh-ancestor
56033095|NCT03127631|Atorvastatin|atorvastatin|mesh-list
56033096|NCT03127631|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56033097|NCT03127631|Simvastatin|simvastatin|mesh-list
56033098|NCT03127631|Pravastatin|pravastatin|mesh-list
56033099|NCT03127631|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56033100|NCT03127631|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56033101|NCT03127631|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56033102|NCT03127631|Antimetabolites|antimetabolites|mesh-ancestor
56033103|NCT03127631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033104|NCT03127631|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55876834|NCT02199574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876835|NCT02199574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876836|NCT02199574|Sensory System Agents|sensory system agents|mesh-ancestor
55876837|NCT02199574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876838|NCT02199652|Prazosin|prazosin|mesh-list
55876839|NCT02199652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55876840|NCT02199652|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55876841|NCT02199652|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55876842|NCT02199652|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55876843|NCT02199652|Adrenergic Agents|adrenergic agents|mesh-ancestor
55876844|NCT02199652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876845|NCT02199652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876846|NCT02199652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876847|NCT03009916|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
55876848|NCT03009916|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55876849|NCT03009916|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55876850|NCT03009916|Antimetabolites|antimetabolites|mesh-ancestor
55876851|NCT03009916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876852|NCT03009916|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55876853|NCT01927029|Progesterone|progesterone|mesh-list
55876854|NCT01927029|Progestins|progestins|mesh-ancestor
55876855|NCT01927029|Hormones|hormones|mesh-ancestor
56033105|NCT03127631|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56033106|NCT03127631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033107|NCT03127631|Protease Inhibitors|protease inhibitors|mesh-ancestor
56033108|NCT02244320|Tamsulosin|tamsulosin|mesh-list
56033110|NCT02244320|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56033111|NCT02244320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56033112|NCT02244320|Adrenergic Agents|adrenergic agents|mesh-ancestor
56033113|NCT02244320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033114|NCT02244320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033115|NCT02244320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033116|NCT02244320|Urological Agents|urological agents|mesh-ancestor
56033117|NCT02244632|Bevacizumab|bevacizumab|mesh-list
56033118|NCT02244632|Fluorouracil|fluorouracil|mesh-list
56033119|NCT02244632|Oxaliplatin|oxaliplatin|mesh-list
55760329|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
56033120|NCT02244632|Irinotecan|irinotecan|mesh-list
56033121|NCT02244632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56033122|NCT02244632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033123|NCT02244632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56033124|NCT02244632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56033125|NCT02244632|Growth Substances|growth substances|mesh-ancestor
56033126|NCT02244632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033127|NCT02244632|Growth Inhibitors|growth inhibitors|mesh-ancestor
56033128|NCT02244632|Antimetabolites|antimetabolites|mesh-ancestor
56033129|NCT02244632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033152|NCT02244710|Purinergic Agents|purinergic agents|mesh-ancestor
56033153|NCT02244710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033154|NCT02244710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033155|NCT02244710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033156|NCT04362332|Hydroxychloroquine|hydroxychloroquine|mesh-list
56033157|NCT04362332|Chloroquine|chloroquine|mesh-list
56033158|NCT04362332|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56033159|NCT04362332|Antimalarials|antimalarials|mesh-ancestor
56033160|NCT04362332|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56033161|NCT04362332|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56033162|NCT04362332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033163|NCT04362332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033164|NCT04362332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033165|NCT04362332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56033166|NCT04362332|Amebicides|amebicides|mesh-ancestor
56033167|NCT04362332|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56033168|NCT04362332|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56033169|NCT04362332|Analgesics|analgesics|mesh-ancestor
56033170|NCT04362332|Sensory System Agents|sensory system agents|mesh-ancestor
56033171|NCT04362332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033172|NCT04362332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033173|NCT04362332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56033174|NCT04362332|Filaricides|filaricides|mesh-ancestor
56033175|NCT04362332|Antinematodal Agents|antinematodal agents|mesh-ancestor
56033176|NCT04362332|Anthelmintics|anthelmintics|mesh-ancestor
56033177|NCT02308241|Ribavirin|ribavirin|mesh-list
56033178|NCT02308241|Antimetabolites|antimetabolites|mesh-ancestor
56033179|NCT02308241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033180|NCT02308241|Antiviral Agents|antiviral agents|mesh-ancestor
56033181|NCT02308241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033182|NCT00932282|Omalizumab|omalizumab|mesh-list
56033195|NCT02159495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033196|NCT02159495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033197|NCT02159495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56033198|NCT02159495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56033200|NCT01632995|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56033201|NCT01632995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56033202|NCT01632995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56033203|NCT01632995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033204|NCT01632995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033205|NCT01632995|Antiviral Agents|antiviral agents|mesh-ancestor
56033206|NCT01632995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033207|NCT01632995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56033208|NCT01632995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56033209|NCT02245022|Tenofovir|tenofovir|mesh-list
56033210|NCT02245022|Lamivudine|lamivudine|mesh-list
56033211|NCT02245022|Efavirenz|efavirenz|mesh-list
56033212|NCT02245022|Dolutegravir|dolutegravir|mesh-list
56033213|NCT02245022|Antiviral Agents|antiviral agents|mesh-ancestor
56033214|NCT02245022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033215|NCT02245022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56033216|NCT02245022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56033217|NCT02245022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033218|NCT02245022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033219|NCT02245022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56033220|NCT02245022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56033221|NCT02245022|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56033222|NCT02245022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56033223|NCT02245022|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55828501|NCT01578850|Etanercept|etanercept|mesh-list
56033224|NCT02245022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56033225|NCT02245022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56033226|NCT02245022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56033227|NCT02245022|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56033228|NCT02245022|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56033233|NCT02224313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033234|NCT02224313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033235|NCT02224313|Progestins|progestins|mesh-ancestor
56033236|NCT04362410|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56033237|NCT04362410|Immunologic Factors|immunologic factors|mesh-ancestor
56033238|NCT04362410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033239|NCT04361708|Leucovorin|leucovorin|mesh-list
56033240|NCT04361708|Docetaxel|docetaxel|mesh-list
56033241|NCT04361708|Fluorouracil|fluorouracil|mesh-list
56033242|NCT04361708|Oxaliplatin|oxaliplatin|mesh-list
56033243|NCT04361708|Irinotecan|irinotecan|mesh-list
56033244|NCT04361708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033245|NCT04361708|Tubulin Modulators|tubulin modulators|mesh-ancestor
56033246|NCT04361708|Antimitotic Agents|antimitotic agents|mesh-ancestor
56033247|NCT04361708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56033248|NCT04361708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033249|NCT04361708|Antimetabolites|antimetabolites|mesh-ancestor
56033250|NCT04361708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56033251|NCT04361708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033252|NCT04361708|Immunologic Factors|immunologic factors|mesh-ancestor
56033253|NCT04361708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033254|NCT04361708|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56033255|NCT04361708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56033256|NCT04361708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033257|NCT04361708|Antidotes|antidotes|mesh-ancestor
56033258|NCT04361708|Protective Agents|protective agents|mesh-ancestor
56033259|NCT04361708|Vitamin B Complex|vitamin b complex|mesh-ancestor
56033260|NCT04361708|Vitamins|vitamins|mesh-ancestor
56033261|NCT04361708|Micronutrients|micronutrients|mesh-ancestor
56033262|NCT02460198|Pembrolizumab|pembrolizumab|mesh-list
56033263|NCT02460198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56033264|NCT02460198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033265|NCT01633853|Vitamin D|vitamin d|mesh-list
56033266|NCT01633853|Ergocalciferols|ergocalciferols|mesh-list
56033267|NCT01633853|Cholecalciferol|cholecalciferol|mesh-list
56033268|NCT01633853|Vitamins|vitamins|mesh-list
56033269|NCT01633853|Micronutrients|micronutrients|mesh-ancestor
56033270|NCT01633853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033273|NCT04361552|Immunoglobulins|immunoglobulins|mesh-list
56033274|NCT04361552|Immunoglobulin G|immunoglobulin g|mesh-list
56033275|NCT04361552|Immunologic Factors|immunologic factors|mesh-ancestor
56033276|NCT04361552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033277|NCT04376216|Prednisone|prednisone|mesh-list
56033278|NCT04376216|Prednisolone|prednisolone|mesh-list
56033279|NCT04376216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56033280|NCT04376216|Glucocorticoids|glucocorticoids|mesh-ancestor
56033281|NCT04376216|Hormones|hormones|mesh-ancestor
56033282|NCT04376216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033283|NCT04376216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033284|NCT04376216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56033285|NCT04376216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033286|NCT02452320|Acetaminophen|acetaminophen|mesh-list
56033287|NCT02452320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56033288|NCT02452320|Analgesics|analgesics|mesh-ancestor
56033289|NCT02452320|Sensory System Agents|sensory system agents|mesh-ancestor
56033290|NCT02452320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744410|NCT03332329|Vaccines|vaccines|mesh-list
56033291|NCT02452320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033293|NCT02459964|Fentanyl|fentanyl|mesh-list
56033294|NCT02459964|Hydromorphone|hydromorphone|mesh-list
56033295|NCT02459964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56033296|NCT02459964|Narcotics|narcotics|mesh-ancestor
56033297|NCT02459964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033298|NCT02459964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033299|NCT02459964|Analgesics|analgesics|mesh-ancestor
56033300|NCT02459964|Sensory System Agents|sensory system agents|mesh-ancestor
56033301|NCT02459964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033302|NCT02459964|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56033303|NCT02459964|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56033304|NCT02459964|Anesthetics, General|anesthetics, general|mesh-ancestor
56033319|NCT02087111|Antiviral Agents|antiviral agents|mesh-ancestor
56033320|NCT02087111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033321|NCT02087111|Antimetabolites|antimetabolites|mesh-ancestor
56033322|NCT02087111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033323|NCT02087111|Immunologic Factors|immunologic factors|mesh-ancestor
56033324|NCT02087111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033325|NCT00932438|Leucovorin|leucovorin|mesh-list
56033326|NCT00932438|Bevacizumab|bevacizumab|mesh-list
56033327|NCT00932438|Fluorouracil|fluorouracil|mesh-list
56033328|NCT00932438|Oxaliplatin|oxaliplatin|mesh-list
56033329|NCT00932438|Irinotecan|irinotecan|mesh-list
56033330|NCT00932438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56033331|NCT00932438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033332|NCT00932438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56033333|NCT00932438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56033334|NCT00932438|Growth Substances|growth substances|mesh-ancestor
56033335|NCT00932438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033336|NCT00932438|Growth Inhibitors|growth inhibitors|mesh-ancestor
56033337|NCT00932438|Antimetabolites|antimetabolites|mesh-ancestor
56033338|NCT00932438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033339|NCT00932438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56033340|NCT00932438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033341|NCT00932438|Immunologic Factors|immunologic factors|mesh-ancestor
56033342|NCT00932438|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56033343|NCT00932438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56033344|NCT00932438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033345|NCT00932438|Antidotes|antidotes|mesh-ancestor
56033346|NCT00932438|Protective Agents|protective agents|mesh-ancestor
56033347|NCT00932438|Vitamin B Complex|vitamin b complex|mesh-ancestor
56033348|NCT00932438|Vitamins|vitamins|mesh-ancestor
56033349|NCT00932438|Micronutrients|micronutrients|mesh-ancestor
56033350|NCT01869413|Tranexamic Acid|tranexamic acid|mesh-list
56033363|NCT02982512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033364|NCT02982512|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56033365|NCT02982512|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56033366|NCT02982512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56033367|NCT02982512|Adrenergic Agents|adrenergic agents|mesh-ancestor
56033368|NCT02982512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033369|NCT02982512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033371|NCT01555697|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56033372|NCT01555697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56033373|NCT01555697|Dopamine Agents|dopamine agents|mesh-ancestor
56033374|NCT01555697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033375|NCT01555697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033376|NCT01555697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033377|NCT01555697|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56033378|NCT01555697|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56033379|NCT02982434|Botulinum Toxins|botulinum toxins|mesh-list
56033380|NCT02982434|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56033381|NCT02982434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56033382|NCT02982434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033383|NCT02982434|Cholinergic Agents|cholinergic agents|mesh-ancestor
56033384|NCT02982434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033385|NCT02982434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033386|NCT02451930|Pembrolizumab|pembrolizumab|mesh-list
56033387|NCT02451930|Necitumumab|necitumumab|mesh-list
56033388|NCT02451930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56033389|NCT02451930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033390|NCT04358120|Hyaluronic Acid|hyaluronic acid|mesh-list
56033391|NCT04358120|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56033406|NCT01639157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033407|NCT01639157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033409|NCT01639157|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56033410|NCT01639157|Serotonin Agents|serotonin agents|mesh-ancestor
56033411|NCT01639157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033412|NCT01639157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033413|NCT02451696|Everolimus|everolimus|mesh-list
56033414|NCT02451696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033415|NCT02451696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033416|NCT02451696|Immunologic Factors|immunologic factors|mesh-ancestor
56033417|NCT02451696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033418|NCT00928772|Midazolam|midazolam|mesh-list
56033419|NCT00928772|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56033420|NCT00928772|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56033421|NCT00928772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033422|NCT00928772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033423|NCT00928772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56033424|NCT00928772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56033425|NCT00928772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56033426|NCT00928772|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56033427|NCT00928772|Anesthetics, General|anesthetics, general|mesh-ancestor
56033428|NCT00928772|Anesthetics|anesthetics|mesh-ancestor
56033429|NCT00928772|GABA Modulators|gaba modulators|mesh-ancestor
56033430|NCT00928772|GABA Agents|gaba agents|mesh-ancestor
56033431|NCT00928772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033432|NCT00928772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033433|NCT02459418|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56033434|NCT02459418|Hormones|hormones|mesh-ancestor
56033437|NCT04361318|Hydroxychloroquine|hydroxychloroquine|mesh-list
56033451|NCT04925076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033452|NCT04925076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033453|NCT04925076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033454|NCT01598207|Dronabinol|dronabinol|mesh-list
56033455|NCT01598207|Hallucinogens|hallucinogens|mesh-ancestor
56033456|NCT01598207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033457|NCT01598207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56033458|NCT01598207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56033459|NCT01598207|Analgesics|analgesics|mesh-ancestor
56033460|NCT01598207|Sensory System Agents|sensory system agents|mesh-ancestor
56033461|NCT01598207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033462|NCT01598207|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56033463|NCT01598207|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56033464|NCT01598207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033465|NCT01598207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033466|NCT01598207|Hormones|hormones|mesh-ancestor
56033467|NCT01598207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033468|NCT01640171|Ketorolac|ketorolac|mesh-list
56033469|NCT01640171|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56033470|NCT01640171|Lidocaine|lidocaine|mesh-list
56033471|NCT01640171|Proxymetacaine|proxymetacaine|mesh-list
56033472|NCT01640171|Anesthetics|anesthetics|mesh-list
56033473|NCT01640171|Anesthetics, Local|anesthetics, local|mesh-ancestor
56033474|NCT01640171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887134|NCT01806779|Varenicline|varenicline|mesh-list
56033475|NCT01640171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033476|NCT01640171|Sensory System Agents|sensory system agents|mesh-ancestor
56033477|NCT01640171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033478|NCT01640171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56033479|NCT01640171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56033480|NCT01640171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56033493|NCT04361474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033494|NCT04361474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033495|NCT04361474|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56033496|NCT04361474|Respiratory System Agents|respiratory system agents|mesh-ancestor
56033497|NCT04361474|Glucocorticoids|glucocorticoids|mesh-ancestor
56033498|NCT04361474|Hormones|hormones|mesh-ancestor
56033499|NCT04361474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033500|NCT04366622|Riociguat|riociguat|mesh-list
56033501|NCT04366622|Enzyme Activators|enzyme activators|mesh-ancestor
56033502|NCT04366622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033503|NCT02245334|Povidone-Iodine|povidone-iodine|mesh-list
56033504|NCT02245334|Povidone|povidone|mesh-list
55828720|NCT04626791|Cytarabine|cytarabine|mesh-list
56033505|NCT02245334|Plasma Substitutes|plasma substitutes|mesh-ancestor
56033506|NCT02245334|Blood Substitutes|blood substitutes|mesh-ancestor
56033507|NCT02245334|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56033508|NCT02245334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033509|NCT04762160|Rituximab|rituximab|mesh-list
56033510|NCT04762160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56033511|NCT04762160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033512|NCT04762160|Immunologic Factors|immunologic factors|mesh-ancestor
56033513|NCT04762160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033514|NCT04762160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56033515|NCT02487498|Glycopyrrolate|glycopyrrolate|mesh-list
56033516|NCT02487498|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56033517|NCT02487498|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56033518|NCT02487498|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56033519|NCT02487498|Cholinergic Agents|cholinergic agents|mesh-ancestor
56033520|NCT02487498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033521|NCT02487498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033523|NCT04356872|Doxorubicin|doxorubicin|mesh-list
56033537|NCT02487108|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56033538|NCT02487108|Analgesics|analgesics|mesh-ancestor
56033539|NCT02487108|Sensory System Agents|sensory system agents|mesh-ancestor
56033540|NCT02487108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033541|NCT02487108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033542|NCT02487108|Antipyretics|antipyretics|mesh-ancestor
56033543|NCT02487108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56033544|NCT02487108|Narcotics|narcotics|mesh-ancestor
56033545|NCT02487108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033546|NCT02487108|Antitussive Agents|antitussive agents|mesh-ancestor
56033547|NCT02487108|Respiratory System Agents|respiratory system agents|mesh-ancestor
56033548|NCT02487108|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56033549|NCT02487108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56033550|NCT02487108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56033551|NCT02487030|Sofosbuvir|sofosbuvir|mesh-list
56033552|NCT02487030|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56033553|NCT02487030|Ledipasvir|ledipasvir|mesh-list
56033554|NCT02487030|Antiviral Agents|antiviral agents|mesh-ancestor
56033555|NCT02487030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033556|NCT02486952|Prednisone|prednisone|mesh-list
56033557|NCT02486952|Cyclophosphamide|cyclophosphamide|mesh-list
56033558|NCT02486952|Rituximab|rituximab|mesh-list
56033559|NCT02486952|Vincristine|vincristine|mesh-list
56033560|NCT02486952|Doxorubicin|doxorubicin|mesh-list
56033561|NCT02486952|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56033562|NCT02486952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033563|NCT02486952|Immunologic Factors|immunologic factors|mesh-ancestor
56033564|NCT02486952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033565|NCT02486952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56033566|NCT02486952|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56033567|NCT02486952|Alkylating Agents|alkylating agents|mesh-ancestor
56033568|NCT02486952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033569|NCT02486952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033577|NCT02486952|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56033578|NCT02486952|Tubulin Modulators|tubulin modulators|mesh-ancestor
56033579|NCT02486952|Antimitotic Agents|antimitotic agents|mesh-ancestor
56033580|NCT02486952|Mitosis Modulators|mitosis modulators|mesh-ancestor
56033581|NCT02486952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56033582|NCT02486952|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56033583|NCT02486952|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56033584|NCT02486952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033585|NCT02486796|Ubiquinone|ubiquinone|mesh-list
56033586|NCT02486796|Coenzyme Q10|coenzyme q10|mesh-list
56033587|NCT02486796|Melatonin|melatonin|mesh-list
56033588|NCT02486796|Antioxidants|antioxidants|mesh-ancestor
56033589|NCT02486796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033590|NCT02486796|Protective Agents|protective agents|mesh-ancestor
56033591|NCT02486796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033592|NCT02486796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033593|NCT02486796|Micronutrients|micronutrients|mesh-ancestor
56033594|NCT02486796|Vitamins|vitamins|mesh-ancestor
56033595|NCT00620477|Levobupivacaine|levobupivacaine|mesh-list
56033596|NCT00620477|Anesthetics, Local|anesthetics, local|mesh-ancestor
56033597|NCT00620477|Anesthetics|anesthetics|mesh-ancestor
56033598|NCT00620477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033599|NCT00620477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033600|NCT00620477|Sensory System Agents|sensory system agents|mesh-ancestor
56033601|NCT00620477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033602|NCT01641653|Midazolam|midazolam|mesh-list
56033603|NCT01641653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56033604|NCT01641653|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56033607|NCT01641653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56033624|NCT01600703|Protease Inhibitors|protease inhibitors|mesh-ancestor
56033625|NCT01600703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033626|NCT01600703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033627|NCT02450526|Botulinum Toxins|botulinum toxins|mesh-list
56033628|NCT02450526|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56033629|NCT02450526|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56033630|NCT02450526|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56033631|NCT02450526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56033632|NCT02450526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033633|NCT02450526|Cholinergic Agents|cholinergic agents|mesh-ancestor
56033634|NCT02450526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033635|NCT02450526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033636|NCT02450526|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56033637|NCT02450526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033638|NCT01605539|Cannabidiol|cannabidiol|mesh-list
56033639|NCT01605539|Anticonvulsants|anticonvulsants|mesh-ancestor
55828805|NCT01574326|Sevelamer|sevelamer|mesh-list
56033640|NCT02458638|Atezolizumab|atezolizumab|mesh-list
56033641|NCT02458638|Antibodies|antibodies|mesh-list
56033642|NCT02458638|Immunologic Factors|immunologic factors|mesh-ancestor
56033643|NCT02458638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033644|NCT02458638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033645|NCT01607411|Fluorides|fluorides|mesh-list
56033646|NCT01607411|Cariostatic Agents|cariostatic agents|mesh-ancestor
56033647|NCT01607411|Protective Agents|protective agents|mesh-ancestor
56033648|NCT01607411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033649|NCT01691339|Vaccines|vaccines|mesh-list
55828856|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
56033650|NCT01691339|Immunologic Factors|immunologic factors|mesh-ancestor
56033651|NCT01691339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033652|NCT02233751|Methyltestosterone|methyltestosterone|mesh-list
56033653|NCT02233751|Testosterone|testosterone|mesh-list
56033654|NCT02233751|Testosterone undecanoate|testosterone undecanoate|mesh-list
55876856|NCT01927029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876857|NCT01927029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876858|NCT01921647|Amoxicillin|amoxicillin|mesh-list
55876859|NCT01921647|Clarithromycin|clarithromycin|mesh-list
55876860|NCT01921647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55876861|NCT01921647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876862|NCT01921647|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55876863|NCT01921647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876864|NCT01921647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876865|NCT01921647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55876866|NCT01921647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56033655|NCT02233751|Testosterone enanthate|testosterone enanthate|mesh-list
56033656|NCT02233751|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56033658|NCT02233751|Hormones|hormones|mesh-ancestor
56033659|NCT02233751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033660|NCT02233751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033661|NCT02233751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56033662|NCT02233751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033663|NCT02233751|Anabolic Agents|anabolic agents|mesh-ancestor
56033665|NCT01607645|Decitabine|decitabine|mesh-list
56033666|NCT01607645|Azacitidine|azacitidine|mesh-list
56033667|NCT01607645|Idarubicin|idarubicin|mesh-list
56033668|NCT01607645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56033669|NCT01607645|Antimetabolites|antimetabolites|mesh-ancestor
56033670|NCT01607645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033671|NCT01607645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033672|NCT01607645|Antiviral Agents|antiviral agents|mesh-ancestor
56033673|NCT01607645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033674|NCT01607645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033675|NCT01607645|Immunologic Factors|immunologic factors|mesh-ancestor
56033676|NCT01607645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033677|NCT01607645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033678|NCT01607645|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56033679|NCT01607645|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56033680|NCT01607645|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56033681|NCT01647581|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56033682|NCT01647581|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56033683|NCT01647581|beta-Endorphin|beta-endorphin|mesh-list
56033684|NCT01647581|Hormones|hormones|mesh-ancestor
56033685|NCT01647581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033697|NCT01608659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033698|NCT01608659|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56033699|NCT01608659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033700|NCT01649609|Mycophenolic Acid|mycophenolic acid|mesh-list
56033701|NCT01649609|Sirolimus|sirolimus|mesh-list
56033702|NCT01649609|Tacrolimus|tacrolimus|mesh-list
56033703|NCT01649609|Antimetabolites|antimetabolites|mesh-list
56033704|NCT01649609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033705|NCT01649609|Immunologic Factors|immunologic factors|mesh-ancestor
56033706|NCT01649609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033707|NCT01649609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56033708|NCT01649609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033709|NCT01649609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033710|NCT01649609|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56033711|NCT01649609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033712|NCT01649609|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56033713|NCT01649609|Antitubercular Agents|antitubercular agents|mesh-ancestor
56033714|NCT01649609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56033715|NCT01649609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033716|NCT01649609|Antifungal Agents|antifungal agents|mesh-ancestor
56033717|NCT02449902|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56033718|NCT02449902|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56033719|NCT02449902|Estradiol|estradiol|mesh-list
56033720|NCT02449902|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56033721|NCT02449902|Estrogens|estrogens|mesh-ancestor
55760935|NCT04854759|Amantadine|amantadine|mesh-list
56033722|NCT02449902|Hormones|hormones|mesh-ancestor
56033723|NCT02449902|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033724|NCT02449902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033725|NCT02449902|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56033726|NCT02449902|Contraceptive Agents|contraceptive agents|mesh-ancestor
56033727|NCT02449902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56033728|NCT02449902|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56033729|NCT02449044|Tolvaptan|tolvaptan|mesh-list
56033730|NCT02449044|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56033731|NCT02449044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033733|NCT02449044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033734|NCT04942626|Capecitabine|capecitabine|mesh-list
56033735|NCT04942626|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56033736|NCT04942626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56033737|NCT04942626|Antimetabolites|antimetabolites|mesh-ancestor
56033738|NCT04942626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033739|NCT04942626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033740|NCT04942626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56033741|NCT04942470|Propolis|propolis|mesh-list
56033742|NCT04942470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033743|NCT02228681|Tamoxifen|tamoxifen|mesh-list
56033744|NCT02228681|Everolimus|everolimus|mesh-list
56033745|NCT02228681|Letrozole|letrozole|mesh-list
56033746|NCT02228681|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56033747|NCT02228681|Medroxyprogesterone|medroxyprogesterone|mesh-list
56033748|NCT02228681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033749|NCT02228681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033750|NCT02228681|Immunologic Factors|immunologic factors|mesh-ancestor
56033751|NCT02228681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033752|NCT02228681|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56033753|NCT02228681|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56033754|NCT02228681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033755|NCT02228681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033756|NCT02228681|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56033757|NCT02228681|Hormone Antagonists|hormone antagonists|mesh-ancestor
56033758|NCT02228681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033759|NCT02228681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56033760|NCT02228681|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56033761|NCT02228681|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56033762|NCT02228681|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56033763|NCT02228681|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56033764|NCT02228681|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55876869|NCT01339858|Antiviral Agents|antiviral agents|mesh-ancestor
55876870|NCT01339858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876871|NCT01339858|Expectorants|expectorants|mesh-ancestor
55876872|NCT01339858|Respiratory System Agents|respiratory system agents|mesh-ancestor
55876873|NCT01339858|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55876874|NCT01339858|Antioxidants|antioxidants|mesh-ancestor
55876875|NCT01339858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033765|NCT02228681|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56033766|NCT02228681|Contraceptive Agents|contraceptive agents|mesh-ancestor
56033767|NCT02228681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56033768|NCT02228681|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56033769|NCT02228681|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56033770|NCT02228681|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56033772|NCT00942578|Bevacizumab|bevacizumab|mesh-list
56033773|NCT00942578|Lenalidomide|lenalidomide|mesh-list
56033774|NCT00942578|Docetaxel|docetaxel|mesh-list
56033775|NCT00942578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56033776|NCT00942578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033777|NCT00942578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56033778|NCT00942578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56033779|NCT00942578|Growth Substances|growth substances|mesh-ancestor
56033780|NCT00942578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033781|NCT00942578|Growth Inhibitors|growth inhibitors|mesh-ancestor
56033782|NCT00942578|Tubulin Modulators|tubulin modulators|mesh-ancestor
56033783|NCT00942578|Antimitotic Agents|antimitotic agents|mesh-ancestor
56033784|NCT00942578|Mitosis Modulators|mitosis modulators|mesh-ancestor
56033785|NCT00942578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033786|NCT00942578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56033787|NCT00942578|Glucocorticoids|glucocorticoids|mesh-ancestor
56033788|NCT00942578|Hormones|hormones|mesh-ancestor
56033789|NCT00942578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033790|NCT00942578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56033813|NCT02229461|Antipyretics|antipyretics|mesh-ancestor
56033814|NCT02229461|Gout Suppressants|gout suppressants|mesh-ancestor
56033816|NCT04641104|Vitamin B Complex|vitamin b complex|mesh-ancestor
56033817|NCT04641104|Vitamins|vitamins|mesh-ancestor
56033818|NCT04641104|Micronutrients|micronutrients|mesh-ancestor
56033819|NCT04641104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033820|NCT04359680|Nitazoxanide|nitazoxanide|mesh-list
56033821|NCT04359680|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56033822|NCT04359680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033823|NCT02237417|Aripiprazole|aripiprazole|mesh-list
56033824|NCT02237417|Antipsychotic Agents|antipsychotic agents|mesh-list
56033825|NCT02237417|Antidepressive Agents|antidepressive agents|mesh-ancestor
56033826|NCT02237417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56033827|NCT02237417|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56033828|NCT02237417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033829|NCT02237417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033830|NCT02237417|Dopamine Agonists|dopamine agonists|mesh-ancestor
56033831|NCT02237417|Dopamine Agents|dopamine agents|mesh-ancestor
56033832|NCT02237417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033833|NCT02237417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033834|NCT02237417|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56033835|NCT02237417|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56033836|NCT02237417|Serotonin Agents|serotonin agents|mesh-ancestor
56033837|NCT02237417|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56033838|NCT02237417|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56033839|NCT02237417|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56033841|NCT04603898|Ascorbic Acid|ascorbic acid|mesh-list
56033863|NCT02245490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56033864|NCT02245490|Adrenergic Agents|adrenergic agents|mesh-ancestor
56033865|NCT02245490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033866|NCT02245490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033867|NCT02245490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033868|NCT02245490|Urological Agents|urological agents|mesh-ancestor
56033869|NCT04355936|Telmisartan|telmisartan|mesh-list
56033870|NCT04355936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56033871|NCT04355936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56033872|NCT04355936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55886633|NCT03316482|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56033873|NCT04355936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033874|NCT00934934|Anidulafungin|anidulafungin|mesh-list
56033875|NCT00934934|Antifungal Agents|antifungal agents|mesh-ancestor
56033876|NCT00934934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033877|NCT01650545|Cyclosporine|cyclosporine|mesh-list
56033878|NCT01650545|Sirolimus|sirolimus|mesh-list
56033879|NCT01650545|Tacrolimus|tacrolimus|mesh-list
56033880|NCT01650545|Cyclosporins|cyclosporins|mesh-list
56033881|NCT01650545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033882|NCT01650545|Immunologic Factors|immunologic factors|mesh-ancestor
56033883|NCT01650545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033884|NCT01650545|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56033911|NCT01652495|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56033912|NCT01652495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55829072|NCT02156492|Simvastatin|simvastatin|mesh-list
56033913|NCT01652495|Prednisolone phosphate|prednisolone phosphate|mesh-list
56033914|NCT01652495|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56033915|NCT01652495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56033916|NCT01652495|Antiemetics|antiemetics|mesh-ancestor
56033917|NCT01652495|Autonomic Agents|autonomic agents|mesh-ancestor
56033918|NCT01652495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033919|NCT01652495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033920|NCT01652495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56033921|NCT01652495|Glucocorticoids|glucocorticoids|mesh-ancestor
56033922|NCT01652495|Hormones|hormones|mesh-ancestor
56033923|NCT01652495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033924|NCT01652495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56033925|NCT01652495|Protective Agents|protective agents|mesh-ancestor
56033926|NCT01652495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56033927|NCT01652495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033928|NCT01652495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033929|NCT01652495|Immunologic Factors|immunologic factors|mesh-ancestor
56033930|NCT01652495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033931|NCT01652495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033932|NCT00935792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56033933|NCT00935792|Alemtuzumab|alemtuzumab|mesh-list
56033934|NCT00935792|Everolimus|everolimus|mesh-list
56033935|NCT00935792|Antibodies|antibodies|mesh-list
56033936|NCT00935792|Immunoglobulins|immunoglobulins|mesh-list
56033937|NCT00935792|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56033938|NCT00935792|Immunologic Factors|immunologic factors|mesh-ancestor
56033958|NCT04355468|Anesthetics|anesthetics|mesh-list
56033959|NCT04355468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56033960|NCT04355468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033961|NCT04355468|Narcotics|narcotics|mesh-ancestor
56033962|NCT04355468|Analgesics|analgesics|mesh-ancestor
56033963|NCT04355468|Sensory System Agents|sensory system agents|mesh-ancestor
56033964|NCT04355468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033965|NCT01653509|Acyclovir|acyclovir|mesh-list
56033966|NCT01653509|Antiviral Agents|antiviral agents|mesh-ancestor
56033967|NCT01653509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56033968|NCT01614509|Triamcinolone|triamcinolone|mesh-list
56033969|NCT01614509|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56033970|NCT01614509|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56033971|NCT01614509|Bevacizumab|bevacizumab|mesh-list
56033972|NCT01614509|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56033973|NCT01614509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56033974|NCT01614509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56033975|NCT01614509|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56033976|NCT01614509|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56033977|NCT01614509|Growth Substances|growth substances|mesh-ancestor
56033978|NCT01614509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033979|NCT01614509|Growth Inhibitors|growth inhibitors|mesh-ancestor
56033980|NCT01614509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56033981|NCT01614509|Glucocorticoids|glucocorticoids|mesh-ancestor
56033982|NCT01614509|Hormones|hormones|mesh-ancestor
56033983|NCT01614509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56033984|NCT01614509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56033985|NCT01614509|Immunologic Factors|immunologic factors|mesh-ancestor
56033986|NCT01614509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56033987|NCT01614509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033988|NCT01614743|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56033989|NCT01614743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56033990|NCT01614743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56033991|NCT01614743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56033992|NCT01614743|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56033993|NCT01614743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56033994|NCT01614743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56033995|NCT01614743|Cholinergic Agents|cholinergic agents|mesh-ancestor
56033996|NCT01614743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56033997|NCT00943202|Vaccines|vaccines|mesh-list
56033998|NCT00943202|Immunologic Factors|immunologic factors|mesh-ancestor
56033999|NCT00943202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034000|NCT01654445|Tenecteplase|tenecteplase|mesh-list
56034001|NCT01654445|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56034002|NCT01654445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56034003|NCT01654445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034004|NCT01703039|Riluzole|riluzole|mesh-list
56034005|NCT01703039|Sertraline|sertraline|mesh-list
56034006|NCT01703039|Antidepressive Agents|antidepressive agents|mesh-ancestor
56034007|NCT01703039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56034008|NCT01703039|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56034009|NCT01703039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56034010|NCT01703039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56034011|NCT01703039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034012|NCT01703039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034013|NCT01703039|Serotonin Agents|serotonin agents|mesh-ancestor
56034014|NCT01703039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034015|NCT01703039|Anticonvulsants|anticonvulsants|mesh-ancestor
56034016|NCT01703039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56034017|NCT01703039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56034018|NCT01703039|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56034019|NCT01703039|Protective Agents|protective agents|mesh-ancestor
56034021|NCT01656629|Alendronate|alendronate|mesh-list
56034022|NCT01656629|Teriparatide|teriparatide|mesh-list
56034023|NCT01656629|Calcium|calcium|mesh-list
56034048|NCT02158520|Mitosis Modulators|mitosis modulators|mesh-ancestor
56034049|NCT02158520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034050|NCT02158520|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56034051|NCT02158520|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56034052|NCT02158520|Growth Substances|growth substances|mesh-ancestor
56034053|NCT02158520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034054|NCT02158520|Growth Inhibitors|growth inhibitors|mesh-ancestor
56034055|NCT02158520|Immunologic Factors|immunologic factors|mesh-ancestor
56034056|NCT02158520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56034089|NCT01658657|Hydrochlorothiazide, lisinopril drug combination|hydrochlorothiazide, lisinopril drug combination|mesh-list
56034090|NCT01658657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56034091|NCT01658657|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56034092|NCT01658657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56034093|NCT01658657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034094|NCT01658657|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56034095|NCT01658657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034096|NCT01658657|Vasodilator Agents|vasodilator agents|mesh-ancestor
56034098|NCT01658657|Natriuretic Agents|natriuretic agents|mesh-ancestor
56034099|NCT01658657|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56034100|NCT01658657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56034101|NCT01658657|Sympatholytics|sympatholytics|mesh-ancestor
56034102|NCT01658657|Autonomic Agents|autonomic agents|mesh-ancestor
56034103|NCT01658657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034104|NCT01658657|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56034105|NCT01658657|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56034106|NCT01658657|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56034107|NCT01658657|Adrenergic Agents|adrenergic agents|mesh-ancestor
56034108|NCT01658657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829218|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
56034109|NCT01658657|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56034110|NCT01658657|Protease Inhibitors|protease inhibitors|mesh-ancestor
56034111|NCT01658657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034112|NCT01658657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56034113|NCT01658657|Protective Agents|protective agents|mesh-ancestor
56034114|NCT04359212|Heparin|heparin|mesh-list
56034115|NCT04359212|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56034116|NCT04359212|Tinzaparin|tinzaparin|mesh-list
56034117|NCT04359212|Dalteparin|dalteparin|mesh-list
56034118|NCT04359212|PENTA|penta|mesh-list
56034119|NCT04359212|Fondaparinux|fondaparinux|mesh-list
56034133|NCT01620047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034134|NCT01620047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034135|NCT01620047|Sensory System Agents|sensory system agents|mesh-ancestor
56034136|NCT01620047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034137|NCT01620047|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56034138|NCT01620047|Narcotics|narcotics|mesh-ancestor
56034139|NCT01620047|Analgesics|analgesics|mesh-ancestor
56034140|NCT01620047|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56034141|NCT01620047|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56034142|NCT01620047|Anesthetics, General|anesthetics, general|mesh-ancestor
56034143|NCT00944450|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56034144|NCT00944450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56034145|NCT00944450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034146|NCT00944450|Incretins|incretins|mesh-ancestor
56034147|NCT00944450|Hormones|hormones|mesh-ancestor
56034148|NCT00944450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56034149|NCT00944450|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56034150|NCT00944450|Protease Inhibitors|protease inhibitors|mesh-ancestor
56034151|NCT00944450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034152|NCT00944450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034153|NCT03875144|Cisplatin|cisplatin|mesh-list
56034154|NCT03875144|Doxorubicin|doxorubicin|mesh-list
56034155|NCT03875144|Pemetrexed|pemetrexed|mesh-list
56034156|NCT03875144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034157|NCT03875144|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56034158|NCT03875144|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56034159|NCT03875144|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56034160|NCT03875144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034162|NCT03875144|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56034180|NCT01620593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034182|NCT00939536|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56034183|NCT00939536|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56034184|NCT00939536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034185|NCT00939536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034186|NCT00939536|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56034187|NCT00939536|GABA Agonists|gaba agonists|mesh-ancestor
56034188|NCT00939536|GABA Agents|gaba agents|mesh-ancestor
56034189|NCT00939536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034190|NCT00939536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034191|NCT02982122|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56034192|NCT04358354|Fluorouracil|fluorouracil|mesh-list
56034193|NCT04358354|Oxaliplatin|oxaliplatin|mesh-list
56034194|NCT04358354|Irinotecan|irinotecan|mesh-list
56034195|NCT04358354|Antimetabolites|antimetabolites|mesh-ancestor
56034196|NCT04358354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034197|NCT04358354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56034198|NCT04358354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034199|NCT04358354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034200|NCT04358354|Immunologic Factors|immunologic factors|mesh-ancestor
56034201|NCT04358354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034203|NCT04358354|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56034204|NCT04358354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034205|NCT03516968|Cholecalciferol|cholecalciferol|mesh-list
56034206|NCT03516968|Vitamin D|vitamin d|mesh-list
56034207|NCT03516968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56034208|NCT03516968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034209|NCT03516968|Vitamins|vitamins|mesh-ancestor
56034224|NCT03032666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034225|NCT04354376|Telmisartan|telmisartan|mesh-list
56034226|NCT04354376|1,4-dihydropyridine|1,4-dihydropyridine|mesh-list
56034227|NCT04354376|Diuretics|diuretics|mesh-list
56034228|NCT04354376|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56034229|NCT04354376|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
56034230|NCT04354376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56034231|NCT04354376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56034232|NCT04354376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56034233|NCT04354376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034234|NCT04354376|Natriuretic Agents|natriuretic agents|mesh-ancestor
56034235|NCT04354376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034236|NCT04354376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56034237|NCT04354376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55876876|NCT01339858|Protective Agents|protective agents|mesh-ancestor
55876877|NCT01339858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876878|NCT01339858|Antidotes|antidotes|mesh-ancestor
55876879|NCT01339936|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55876880|NCT01339936|Glycerol|glycerol|mesh-list
55876881|NCT01339936|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55876882|NCT01339936|Protective Agents|protective agents|mesh-ancestor
55876883|NCT01339936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876884|NCT01339936|Laxatives|laxatives|mesh-ancestor
55876885|NCT01339936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876886|NCT05246865|Androgens|androgens|mesh-list
55876887|NCT05246865|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
55876888|NCT05246865|Hormones|hormones|mesh-ancestor
55876889|NCT05246865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876890|NCT05246865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876891|NCT05246865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55876892|NCT05246865|Immunologic Factors|immunologic factors|mesh-ancestor
55876893|NCT03111537|Nicotine|nicotine|mesh-list
55876894|NCT03111537|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55876895|NCT03111537|Autonomic Agents|autonomic agents|mesh-ancestor
55876896|NCT03111537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876897|NCT03111537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876898|NCT03111537|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55876899|NCT03111537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55876900|NCT03111537|Cholinergic Agents|cholinergic agents|mesh-ancestor
55876901|NCT03111537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876902|NCT03111537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876903|NCT05244525|Epinephrine|epinephrine|mesh-list
55876904|NCT05244525|Bupivacaine|bupivacaine|mesh-list
55876905|NCT05244525|Anesthetics, Local|anesthetics, local|mesh-ancestor
55876906|NCT05244525|Anesthetics|anesthetics|mesh-ancestor
55876907|NCT05244525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876908|NCT05244525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876909|NCT05244525|Sensory System Agents|sensory system agents|mesh-ancestor
55886634|NCT03316482|Fertility Agents|fertility agents|mesh-ancestor
55829339|NCT01554514|Rituximab|rituximab|mesh-list
55876910|NCT05244525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876911|NCT05244525|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55876912|NCT05244525|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55876913|NCT05244525|Adrenergic Agents|adrenergic agents|mesh-ancestor
55876914|NCT05244525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876915|NCT05244525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876917|NCT05244525|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55876918|NCT05244525|Autonomic Agents|autonomic agents|mesh-ancestor
55876919|NCT05244525|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56034238|NCT04354376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56034239|NCT02777372|Sertraline|sertraline|mesh-list
56034240|NCT02777372|Antidepressive Agents|antidepressive agents|mesh-ancestor
56034241|NCT02777372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56034242|NCT02777372|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56034243|NCT02777372|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56034244|NCT02777372|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56034245|NCT02777372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761444|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
56034246|NCT02777372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034247|NCT02777372|Serotonin Agents|serotonin agents|mesh-ancestor
56034248|NCT02777372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034249|NCT01622543|Leucovorin|leucovorin|mesh-list
56034250|NCT01622543|Bevacizumab|bevacizumab|mesh-list
56034251|NCT01622543|Fluorouracil|fluorouracil|mesh-list
56034252|NCT01622543|Oxaliplatin|oxaliplatin|mesh-list
56034253|NCT01622543|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56034254|NCT01622543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034255|NCT01622543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56034256|NCT01622543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56034257|NCT01622543|Growth Substances|growth substances|mesh-ancestor
56034258|NCT01622543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034259|NCT01622543|Growth Inhibitors|growth inhibitors|mesh-ancestor
56034260|NCT01622543|Antimetabolites|antimetabolites|mesh-ancestor
56034261|NCT01622543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034262|NCT01622543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56034263|NCT01622543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034264|NCT01622543|Immunologic Factors|immunologic factors|mesh-ancestor
56034265|NCT01622543|Antidotes|antidotes|mesh-ancestor
56034266|NCT01622543|Protective Agents|protective agents|mesh-ancestor
56034267|NCT01622543|Vitamin B Complex|vitamin b complex|mesh-ancestor
56034268|NCT01622543|Vitamins|vitamins|mesh-ancestor
55876920|NCT05244525|Respiratory System Agents|respiratory system agents|mesh-ancestor
55876921|NCT05244525|Mydriatics|mydriatics|mesh-ancestor
55876922|NCT05244525|Sympathomimetics|sympathomimetics|mesh-ancestor
55876923|NCT05244525|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55876924|NCT01927263|Infliximab|infliximab|mesh-list
55876925|NCT01927263|Dermatologic Agents|dermatologic agents|mesh-ancestor
55876926|NCT01927263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876927|NCT01927263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876928|NCT01341730|Pioglitazone|pioglitazone|mesh-list
55876929|NCT01341730|Atorvastatin|atorvastatin|mesh-list
55876930|NCT01341730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55876931|NCT01341730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55876932|NCT01341730|Antimetabolites|antimetabolites|mesh-ancestor
56034269|NCT01622543|Micronutrients|micronutrients|mesh-ancestor
56034270|NCT03032042|Azithromycin|azithromycin|mesh-list
56034271|NCT03032042|Albendazole|albendazole|mesh-list
56034272|NCT03032042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56034273|NCT03032042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034274|NCT03032042|Anthelmintics|anthelmintics|mesh-ancestor
56034275|NCT03032042|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56034276|NCT03032042|Anticestodal Agents|anticestodal agents|mesh-ancestor
56034277|NCT03032042|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56034278|NCT03032042|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56034279|NCT03032042|Tubulin Modulators|tubulin modulators|mesh-ancestor
56034280|NCT03032042|Antimitotic Agents|antimitotic agents|mesh-ancestor
56034281|NCT03032042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56034282|NCT03032042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034283|NCT03032042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034284|NCT01623323|Fluticasone|fluticasone|mesh-list
56034285|NCT01623323|Xhance|xhance|mesh-list
56034286|NCT01623323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56034287|NCT01623323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56034288|NCT01623323|Autonomic Agents|autonomic agents|mesh-ancestor
56034289|NCT01623323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034290|NCT01623323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034291|NCT01623323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56034292|NCT01623323|Respiratory System Agents|respiratory system agents|mesh-ancestor
56034293|NCT01623323|Dermatologic Agents|dermatologic agents|mesh-ancestor
56034294|NCT01623323|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56034295|NCT00669734|Metronidazole|metronidazole|mesh-list
56034296|NCT00669734|Tricyclodecane-9-yl-xanthogenate|tricyclodecane-9-yl-xanthogenate|mesh-list
55827642|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56034297|NCT00669734|Vaccines|vaccines|mesh-list
56034298|NCT00669734|Sargramostim|sargramostim|mesh-list
56034299|NCT00669734|Immunologic Factors|immunologic factors|mesh-ancestor
56034300|NCT00669734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034301|NCT00669734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034314|NCT01709747|Hydromorphone|hydromorphone|mesh-list
56034315|NCT01709747|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56034316|NCT01709747|Narcotics|narcotics|mesh-ancestor
56034317|NCT01709747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034318|NCT01709747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034319|NCT01709747|Analgesics|analgesics|mesh-ancestor
56034320|NCT01709747|Sensory System Agents|sensory system agents|mesh-ancestor
55829456|NCT01950819|Tacrolimus|tacrolimus|mesh-list
56034321|NCT01709747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034333|NCT03031808|Lidocaine|lidocaine|mesh-list
56034334|NCT03031808|Rocuronium|rocuronium|mesh-list
56034335|NCT03031808|Anesthetics, Local|anesthetics, local|mesh-ancestor
56034336|NCT03031808|Anesthetics|anesthetics|mesh-ancestor
56034337|NCT03031808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034338|NCT03031808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034339|NCT03031808|Sensory System Agents|sensory system agents|mesh-ancestor
56034340|NCT03031808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034341|NCT03031808|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56034342|NCT03031808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56034343|NCT03031808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55887273|NCT01800838|Dermatologic Agents|dermatologic agents|mesh-ancestor
56034344|NCT03031808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56034345|NCT03031808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034346|NCT03031808|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56034347|NCT03031808|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56034348|NCT03031808|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56034349|NCT01662791|Rifaximin|rifaximin|mesh-list
56034350|NCT01662791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56034351|NCT01662791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034372|NCT03034850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034373|NCT03034850|Immunologic Factors|immunologic factors|mesh-ancestor
56034374|NCT03034850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034375|NCT03034850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56034376|NCT03034850|Alkylating Agents|alkylating agents|mesh-ancestor
56034378|NCT01663259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56034379|NCT01663259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034380|NCT03031184|Mirtazapine|mirtazapine|mesh-list
56034381|NCT03031184|Antidepressive Agents|antidepressive agents|mesh-ancestor
56034382|NCT03031184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56034383|NCT03031184|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56034384|NCT03031184|Histamine Antagonists|histamine antagonists|mesh-ancestor
56034385|NCT03031184|Histamine Agents|histamine agents|mesh-ancestor
56034386|NCT03031184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034387|NCT03031184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034388|NCT03031184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034389|NCT03031184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56034390|NCT03031184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56034391|NCT03031184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034392|NCT03031184|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56034393|NCT03031184|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56034394|NCT03031184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56034395|NCT03031184|Adrenergic Agents|adrenergic agents|mesh-ancestor
56034396|NCT03031184|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56034397|NCT03031184|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56034398|NCT03031184|Serotonin Agents|serotonin agents|mesh-ancestor
56034399|NCT03031184|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56034400|NCT02238977|Bupropion|bupropion|mesh-list
56034401|NCT02238977|Fluoxetine|fluoxetine|mesh-list
56034402|NCT02238977|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56034403|NCT02238977|Antidepressive Agents|antidepressive agents|mesh-ancestor
56034404|NCT02238977|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56034405|NCT02238977|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56034406|NCT02238977|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56034407|NCT02238977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56034408|NCT02238977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034409|NCT02238977|Dopamine Agents|dopamine agents|mesh-ancestor
56034410|NCT02238977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829541|NCT01919229|Letrozole|letrozole|mesh-list
56034411|NCT02238977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034412|NCT02238977|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56034413|NCT02238977|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56034414|NCT02238977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034415|NCT02238977|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56034416|NCT02238977|Serotonin Agents|serotonin agents|mesh-ancestor
56034418|NCT05361395|Etoposide|etoposide|mesh-list
56034419|NCT05361395|Atezolizumab|atezolizumab|mesh-list
56034420|NCT05361395|Durvalumab|durvalumab|mesh-list
56034421|NCT05361395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034422|NCT05361395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56034423|NCT05361395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56034424|NCT05361395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56034425|NCT05361395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034426|NCT05361395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034427|NCT05361395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56034428|NCT03034382|Lidocaine|lidocaine|mesh-list
56034429|NCT03034382|Epinephrine|epinephrine|mesh-list
56034430|NCT03034382|Morphine|morphine|mesh-list
56034431|NCT03034382|Nalbuphine|nalbuphine|mesh-list
56034432|NCT03034382|Bupivacaine|bupivacaine|mesh-list
56034433|NCT03034382|Anesthetics, Local|anesthetics, local|mesh-ancestor
56034434|NCT03034382|Anesthetics|anesthetics|mesh-ancestor
56034435|NCT03034382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034436|NCT03034382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034437|NCT03034382|Sensory System Agents|sensory system agents|mesh-ancestor
56034438|NCT03034382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034439|NCT03034382|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56034440|NCT03034382|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56034441|NCT03034382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56034447|NCT03034382|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56034448|NCT03034382|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56034449|NCT03034382|Adrenergic Agents|adrenergic agents|mesh-ancestor
56034450|NCT03034382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034451|NCT03034382|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56034452|NCT03034382|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56034453|NCT03034382|Autonomic Agents|autonomic agents|mesh-ancestor
56034454|NCT03034382|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56034455|NCT03034382|Respiratory System Agents|respiratory system agents|mesh-ancestor
56034456|NCT03034382|Mydriatics|mydriatics|mesh-ancestor
56034457|NCT03034382|Sympathomimetics|sympathomimetics|mesh-ancestor
56034458|NCT03034382|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56034459|NCT01664741|Nicotine|nicotine|mesh-list
56034460|NCT01664741|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56034461|NCT01664741|Autonomic Agents|autonomic agents|mesh-ancestor
56034462|NCT01664741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034463|NCT01664741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034464|NCT01664741|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56034465|NCT01664741|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56034466|NCT01664741|Cholinergic Agents|cholinergic agents|mesh-ancestor
56034467|NCT01664741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034468|NCT01664741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034469|NCT02062346|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
56034470|NCT02062346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56034471|NCT02062346|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56034472|NCT02062346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034473|NCT03030950|Dexmedetomidine|dexmedetomidine|mesh-list
56034474|NCT03030950|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56034475|NCT03030950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034476|NCT03030950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034477|NCT03030950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56034478|NCT03030950|Analgesics|analgesics|mesh-ancestor
56034479|NCT03030950|Sensory System Agents|sensory system agents|mesh-ancestor
56034480|NCT03030950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034486|NCT03030950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034487|NCT02022644|Irinotecan|irinotecan|mesh-list
56034488|NCT02022644|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56034489|NCT02022644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56034490|NCT02022644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034491|NCT02022644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034492|NCT02022644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034493|NCT01664897|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56034494|NCT01664897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034495|NCT01664897|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56034496|NCT01664897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034497|NCT01664897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034499|NCT03030716|Grape Seed Extract|grape seed extract|mesh-list
56034501|NCT03030716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56034502|NCT03030716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034503|NCT03030716|Antioxidants|antioxidants|mesh-ancestor
56034504|NCT03030716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034505|NCT03030716|Protective Agents|protective agents|mesh-ancestor
56034506|NCT03030716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034507|NCT03030716|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56034508|NCT03030716|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56034509|NCT03030716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034510|NCT04353362|Amoxicillin|amoxicillin|mesh-list
56034511|NCT04353362|Metronidazole|metronidazole|mesh-list
56034512|NCT04353362|Ofloxacin|ofloxacin|mesh-list
56034532|NCT00946478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034534|NCT00946478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56034535|NCT00946478|Dermatologic Agents|dermatologic agents|mesh-ancestor
56034536|NCT00946478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034537|NCT00946478|Immunologic Factors|immunologic factors|mesh-ancestor
56034538|NCT00946478|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56034539|NCT00946478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034540|NCT00946478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034541|NCT02249741|Ibandronic Acid|ibandronic acid|mesh-list
56034542|NCT02249741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56034543|NCT02249741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034544|NCT03033836|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56034545|NCT03033836|Dolutegravir|dolutegravir|mesh-list
56034546|NCT03033836|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56034547|NCT03033836|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56034548|NCT03033836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034549|NCT03033836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034550|NCT03033836|Antiviral Agents|antiviral agents|mesh-ancestor
55829681|NCT01487200|FX006|fx006|mesh-list
56034551|NCT03033836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034552|NCT03033836|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56034553|NCT03033836|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56034554|NCT03033836|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56034555|NCT03033836|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56034556|NCT03030560|Lidocaine|lidocaine|mesh-list
56034578|NCT03031262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56034579|NCT03031262|Antimetabolites|antimetabolites|mesh-ancestor
56034580|NCT03031262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034581|NCT03031262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034582|NCT03031262|Antiviral Agents|antiviral agents|mesh-ancestor
55887274|NCT01782131|Voriconazole|voriconazole|mesh-list
55887275|NCT01782131|Posaconazole|posaconazole|mesh-list
55887276|NCT01782131|Antifungal Agents|antifungal agents|mesh-ancestor
55887277|NCT01782131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887278|NCT01782131|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55887279|NCT01782131|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55887280|NCT01782131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887281|NCT01782131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887282|NCT01782131|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55887283|NCT01782131|Hormone Antagonists|hormone antagonists|mesh-ancestor
55887284|NCT01782131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887285|NCT01782131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887286|NCT01782131|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55887287|NCT01782131|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55887288|NCT01782131|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56034583|NCT03031262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034584|NCT03031262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034585|NCT03031262|Immunologic Factors|immunologic factors|mesh-ancestor
56034586|NCT03031262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034587|NCT03032978|Calcium, Dietary|calcium, dietary|mesh-list
56034588|NCT03032978|Calcium|calcium|mesh-list
56034589|NCT03032978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56034590|NCT03032978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034591|NCT03032978|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56034592|NCT03030248|Vancomycin|vancomycin|mesh-list
56034593|NCT03030248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56034594|NCT03030248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034595|NCT03028532|Clomiphene|clomiphene|mesh-list
56034596|NCT03028532|Enclomiphene|enclomiphene|mesh-list
56034597|NCT03028532|Zuclomiphene|zuclomiphene|mesh-list
56034598|NCT03028532|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56034599|NCT03028532|Hormone Antagonists|hormone antagonists|mesh-ancestor
56034600|NCT03028532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56034601|NCT03028532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034602|NCT03028532|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56034604|NCT03028532|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56034605|NCT03028532|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56034606|NCT03028532|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56034607|NCT03017768|Tryptophan|tryptophan|mesh-list
55886635|NCT03316482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56034608|NCT03017768|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56034622|NCT03017222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034623|NCT03017222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034624|NCT03017222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56034625|NCT03017222|Antipruritics|antipruritics|mesh-ancestor
56034626|NCT03017222|Dermatologic Agents|dermatologic agents|mesh-ancestor
56034627|NCT03017222|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56034628|NCT03017222|Serotonin Agents|serotonin agents|mesh-ancestor
56034629|NCT03017222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034630|NCT03017222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034631|NCT03017222|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56034632|NCT03017222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56034633|NCT03017222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034634|NCT03017222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56034635|NCT03017222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56034636|NCT03025724|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56034637|NCT03025724|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56034638|NCT03025724|Dermatologic Agents|dermatologic agents|mesh-ancestor
56034639|NCT01010282|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56034640|NCT01010282|Lubricant Eye Drops|lubricant eye drops|mesh-list
56034641|NCT01010282|Glycerol|glycerol|mesh-list
56034642|NCT01010282|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56034643|NCT01010282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56034644|NCT01010282|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56034645|NCT01010282|Protective Agents|protective agents|mesh-ancestor
56034646|NCT01010282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034647|NCT01010282|Laxatives|laxatives|mesh-ancestor
56034648|NCT01010282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56034649|NCT03016988|Cytarabine|cytarabine|mesh-list
56034650|NCT03016988|Fludarabine|fludarabine|mesh-list
56034651|NCT03016988|Bortezomib|bortezomib|mesh-list
56034652|NCT03016988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034653|NCT03016988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56034654|NCT03016988|Antimetabolites|antimetabolites|mesh-ancestor
56034663|NCT03017066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034664|NCT03016832|Irbesartan|irbesartan|mesh-list
56034665|NCT03016832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56034666|NCT03016832|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56034667|NCT03016832|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56034668|NCT03016832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034669|NCT00955916|Cytarabine|cytarabine|mesh-list
56034670|NCT00955916|Imatinib Mesylate|imatinib mesylate|mesh-list
56034671|NCT00955916|Cladribine|cladribine|mesh-list
56034672|NCT00955916|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56034673|NCT00955916|Antimetabolites|antimetabolites|mesh-ancestor
56034674|NCT00955916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829758|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
56034675|NCT00955916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034676|NCT00955916|Antiviral Agents|antiviral agents|mesh-ancestor
56034677|NCT00955916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034678|NCT00955916|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034679|NCT00955916|Immunologic Factors|immunologic factors|mesh-ancestor
56034680|NCT00955916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034681|NCT00955916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56034682|NCT00955916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034683|NCT01668017|Niacinamide|niacinamide|mesh-list
56034684|NCT01668017|Vitamin B Complex|vitamin b complex|mesh-ancestor
56034685|NCT01668017|Vitamins|vitamins|mesh-ancestor
56034686|NCT01668017|Micronutrients|micronutrients|mesh-ancestor
56034687|NCT01668017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034688|NCT01010984|Doxorubicin|doxorubicin|mesh-list
56034689|NCT01010984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55829777|NCT01888497|Analgesics|analgesics|mesh-ancestor
56034690|NCT01010984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034691|NCT01010984|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56034692|NCT01010984|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56034693|NCT01010984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034694|NCT01010984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034696|NCT05218733|Morphine|morphine|mesh-list
56034703|NCT05218733|Sensory System Agents|sensory system agents|mesh-ancestor
56034704|NCT05218733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034705|NCT05218733|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56034706|NCT05218733|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56034707|NCT05218733|Anesthetics, General|anesthetics, general|mesh-ancestor
56034708|NCT05214599|Budesonide|budesonide|mesh-list
56034709|NCT05214599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56034710|NCT05214599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56034711|NCT05214599|Autonomic Agents|autonomic agents|mesh-ancestor
56034712|NCT05214599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034713|NCT05214599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034714|NCT05214599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56034715|NCT05214599|Respiratory System Agents|respiratory system agents|mesh-ancestor
56034716|NCT05214599|Glucocorticoids|glucocorticoids|mesh-ancestor
56034717|NCT05214599|Hormones|hormones|mesh-ancestor
56034718|NCT05214599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56034719|NCT01011218|Modafinil|modafinil|mesh-list
56034720|NCT01011218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56034721|NCT01011218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034722|NCT01011218|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56034723|NCT01011218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56034724|NCT01011218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56034725|NCT01011218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034726|NCT05201183|Fludarabine|fludarabine|mesh-list
56034727|NCT05201183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034728|NCT03023306|Antiemetics|antiemetics|mesh-list
56034729|NCT03023306|Autonomic Agents|autonomic agents|mesh-ancestor
56034730|NCT03023306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034731|NCT03023306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034732|NCT03023306|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56034733|NCT05710367|Dapagliflozin|dapagliflozin|mesh-list
55829817|NCT01887717|Sorafenib|sorafenib|mesh-list
56034734|NCT05710367|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56034735|NCT05710367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034736|NCT05710367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56034737|NCT05710367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876933|NCT01341730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034742|NCT05184101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56034743|NCT05184101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034744|NCT00957242|Warfarin|warfarin|mesh-list
56034745|NCT00957242|Anticoagulants|anticoagulants|mesh-ancestor
56034746|NCT01014728|Propofol|propofol|mesh-list
56034747|NCT01014728|Sevoflurane|sevoflurane|mesh-list
56034748|NCT01014728|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56034749|NCT01014728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034750|NCT01014728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034751|NCT01014728|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56034752|NCT01014728|Anesthetics, General|anesthetics, general|mesh-ancestor
56034753|NCT01014728|Anesthetics|anesthetics|mesh-ancestor
56034754|NCT01014728|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56034755|NCT01014728|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56034756|NCT01015586|Lamotrigine|lamotrigine|mesh-list
56034757|NCT01015586|Anticonvulsants|anticonvulsants|mesh-ancestor
56034758|NCT01015586|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56034759|NCT01015586|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56034760|NCT01015586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034761|NCT01015586|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56034762|NCT01015586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034763|NCT01015586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56034764|NCT01015586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56034765|NCT01015586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56034766|NCT01015586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56034767|NCT01015586|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56034771|NCT01680653|Glucagon|glucagon|mesh-list
56034772|NCT01680653|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56034773|NCT01680653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56034779|NCT02448810|Panitumumab|panitumumab|mesh-list
56034780|NCT02448810|Antimetabolites|antimetabolites|mesh-ancestor
56034781|NCT02448810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034782|NCT02448810|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56034783|NCT02448810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034784|NCT02448810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034786|NCT02448810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034787|NCT02448810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56034788|NCT05709509|Aspirin|aspirin|mesh-list
56034789|NCT05709509|Colchicine|colchicine|mesh-list
56034790|NCT05709509|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56034791|NCT05709509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56034792|NCT05709509|Analgesics|analgesics|mesh-ancestor
56034793|NCT05709509|Sensory System Agents|sensory system agents|mesh-ancestor
56034794|NCT05709509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56034795|NCT05709509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034796|NCT05709509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56034797|NCT05709509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56034798|NCT05709509|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56034799|NCT05709509|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56034800|NCT05709509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034801|NCT05709509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56034802|NCT05709509|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56034803|NCT05709509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034804|NCT05709509|Antipyretics|antipyretics|mesh-ancestor
56034825|NCT01016678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56034826|NCT01016678|Gout Suppressants|gout suppressants|mesh-ancestor
56034827|NCT01016678|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56034828|NCT01016678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034829|NCT01016678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034830|NCT02457546|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56034831|NCT02457546|Hemostatics|hemostatics|mesh-ancestor
56034832|NCT02457546|Coagulants|coagulants|mesh-ancestor
56034833|NCT01016834|Sumatriptan|sumatriptan|mesh-list
56034834|NCT01016834|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56034835|NCT01016834|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56034836|NCT01016834|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56034837|NCT01016834|Serotonin Agents|serotonin agents|mesh-ancestor
56034838|NCT01016834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034839|NCT01016834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034840|NCT01016834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034841|NCT04923594|Mazindol|mazindol|mesh-list
56034842|NCT04923594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56034843|NCT04923594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034844|NCT04923594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56034845|NCT04923594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55762046|NCT03195491|Nivolumab|nivolumab|mesh-list
56034846|NCT04923594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56034847|NCT04923594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034848|NCT04923594|Adrenergic Agents|adrenergic agents|mesh-ancestor
56034849|NCT04923594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56034850|NCT04923594|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56034851|NCT04923594|Dopamine Agents|dopamine agents|mesh-ancestor
56034852|NCT00961532|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56034853|NCT00961532|Hemostatics|hemostatics|mesh-ancestor
56034854|NCT00961532|Coagulants|coagulants|mesh-ancestor
56034855|NCT00961532|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56034856|NCT00961532|Natriuretic Agents|natriuretic agents|mesh-ancestor
56034865|NCT03016442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034866|NCT01682135|Ramucirumab|ramucirumab|mesh-list
56034867|NCT01682135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827643|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56034868|NCT02249897|Cholestyramine Resin|cholestyramine resin|mesh-list
56034869|NCT02249897|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56034870|NCT02249897|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56034871|NCT02249897|Antimetabolites|antimetabolites|mesh-ancestor
56034872|NCT02249897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034873|NCT02249897|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56034874|NCT00963872|Cyclophosphamide|cyclophosphamide|mesh-list
56034875|NCT00963872|Fludarabine|fludarabine|mesh-list
56034876|NCT00963872|Fludarabine phosphate|fludarabine phosphate|mesh-list
56034877|NCT00963872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034878|NCT00963872|Immunologic Factors|immunologic factors|mesh-ancestor
56034879|NCT00963872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887289|NCT01782131|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56034881|NCT00963872|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56034882|NCT00963872|Alkylating Agents|alkylating agents|mesh-ancestor
56034883|NCT00963872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034884|NCT00963872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034885|NCT00963872|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56034886|NCT00963872|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56034887|NCT00963872|Antimetabolites|antimetabolites|mesh-ancestor
56034888|NCT00964496|Thalidomide|thalidomide|mesh-list
56034916|NCT01685411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034917|NCT01685411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034918|NCT01685411|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56034919|NCT01685411|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56034920|NCT01685411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034921|NCT01685411|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56034922|NCT01685411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56034923|NCT01685411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56034924|NCT01685411|Antitubercular Agents|antitubercular agents|mesh-ancestor
56034925|NCT01685411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56034926|NCT01685411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034927|NCT01685411|Anticonvulsants|anticonvulsants|mesh-ancestor
56034928|NCT01685411|Nootropic Agents|nootropic agents|mesh-ancestor
56034929|NCT01685411|Antimetabolites|antimetabolites|mesh-ancestor
56034930|NCT01685411|Gout Suppressants|gout suppressants|mesh-ancestor
56034931|NCT01685411|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56034932|NCT01685411|Antioxidants|antioxidants|mesh-ancestor
56034933|NCT01685411|Protective Agents|protective agents|mesh-ancestor
56034934|NCT02243813|Psilocybin|psilocybin|mesh-list
56034935|NCT02243813|Hallucinogens|hallucinogens|mesh-ancestor
56034936|NCT02243813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034937|NCT02243813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56034938|NCT02991209|Testosterone|testosterone|mesh-list
56034939|NCT02991209|Androgens|androgens|mesh-ancestor
56034940|NCT02991209|Hormones|hormones|mesh-ancestor
55886639|NCT01771666|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
55827644|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56034941|NCT02991209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56034942|NCT02991209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034943|NCT03019562|Fentanyl|fentanyl|mesh-list
56034944|NCT03019562|Oxycodone|oxycodone|mesh-list
56034945|NCT03019562|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56034946|NCT03019562|Narcotics|narcotics|mesh-ancestor
56034962|NCT00969878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034963|NCT00969878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56034964|NCT05677919|Venetoclax|venetoclax|mesh-list
56034965|NCT05677919|Pyrazole|pyrazole|mesh-list
56034966|NCT05677919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034967|NCT05677919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829985|NCT01502644|Analgesics|analgesics|mesh-ancestor
56034968|NCT05677919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034969|NCT04802759|Trastuzumab|trastuzumab|mesh-list
56034970|NCT04802759|Pertuzumab|pertuzumab|mesh-list
56034971|NCT04802759|Everolimus|everolimus|mesh-list
56034972|NCT04802759|Atezolizumab|atezolizumab|mesh-list
56034973|NCT04802759|Palbociclib|palbociclib|mesh-list
56034974|NCT04802759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56034975|NCT04802759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56034976|NCT04802759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56034977|NCT04802759|Immunologic Factors|immunologic factors|mesh-ancestor
56034978|NCT04802759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56034979|NCT04802759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56034980|NCT04802759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034981|NCT04802759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034982|NCT00970814|Levetiracetam|levetiracetam|mesh-list
56034983|NCT00970814|Anticonvulsants|anticonvulsants|mesh-ancestor
56034984|NCT00970814|Nootropic Agents|nootropic agents|mesh-ancestor
56034985|NCT02486406|Ritonavir|ritonavir|mesh-list
56034986|NCT02486406|Ribavirin|ribavirin|mesh-list
56034987|NCT02486406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56034988|NCT02486406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56034989|NCT02486406|Protease Inhibitors|protease inhibitors|mesh-ancestor
56034990|NCT02486406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56034991|NCT02486406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56034992|NCT02486406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56034993|NCT02486406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56034994|NCT02486406|Antiviral Agents|antiviral agents|mesh-ancestor
55886640|NCT01771666|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56034995|NCT02486406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56034996|NCT02486406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56035004|NCT01688609|Tubulin Modulators|tubulin modulators|mesh-ancestor
56035005|NCT01688609|Antimitotic Agents|antimitotic agents|mesh-ancestor
56035006|NCT01688609|Mitosis Modulators|mitosis modulators|mesh-ancestor
56035007|NCT01688609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035008|NCT01688609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56035009|NCT01688609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56035010|NCT01688609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035011|NCT02485158|Dronabinol|dronabinol|mesh-list
56035012|NCT02485158|Amphetamine|amphetamine|mesh-list
56035013|NCT02485158|Dextroamphetamine|dextroamphetamine|mesh-list
56035014|NCT02485158|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56035015|NCT02485158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035016|NCT02485158|Sympathomimetics|sympathomimetics|mesh-ancestor
56035017|NCT02485158|Autonomic Agents|autonomic agents|mesh-ancestor
56035018|NCT02485158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035019|NCT02485158|Dopamine Agents|dopamine agents|mesh-ancestor
56035020|NCT02485158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035021|NCT02485158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035022|NCT02485158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56035023|NCT02485158|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56035024|NCT02485158|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56035025|NCT02485158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56035026|NCT02485158|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56035027|NCT02485158|Hallucinogens|hallucinogens|mesh-ancestor
56035051|NCT02455518|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56035052|NCT02455518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035053|NCT02455518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035054|NCT02455518|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56035055|NCT02455518|Narcotics|narcotics|mesh-ancestor
56035056|NCT02455518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56035057|NCT02455518|Antitussive Agents|antitussive agents|mesh-ancestor
55827645|NCT02168816|Renal Agents|renal agents|mesh-ancestor
56035058|NCT02455518|Respiratory System Agents|respiratory system agents|mesh-ancestor
56035059|NCT00972374|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56035060|NCT00972374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56035061|NCT00972374|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56035062|NCT00972374|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56035063|NCT00972374|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56035064|NCT00972374|Adrenergic Agents|adrenergic agents|mesh-ancestor
56035065|NCT00972374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035066|NCT00972374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035067|NCT00972374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035069|NCT03018626|Cyclophosphamide|cyclophosphamide|mesh-list
56035070|NCT03018626|Rituximab|rituximab|mesh-list
56035071|NCT03018626|Doxorubicin|doxorubicin|mesh-list
56035072|NCT03018626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56035073|NCT03018626|Etoposide|etoposide|mesh-list
56035074|NCT03018626|Vincristine|vincristine|mesh-list
56035075|NCT03018626|Bleomycin|bleomycin|mesh-list
56035076|NCT03018626|Vindesine|vindesine|mesh-list
56035078|NCT03018626|Immunologic Factors|immunologic factors|mesh-ancestor
56035099|NCT03018626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56035100|NCT01689779|Vitamin D|vitamin d|mesh-list
56035101|NCT01689779|Cholecalciferol|cholecalciferol|mesh-list
56035102|NCT01689779|Vitamins|vitamins|mesh-ancestor
56035103|NCT01689779|Micronutrients|micronutrients|mesh-ancestor
56035104|NCT01689779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035105|NCT01689779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56035106|NCT01689779|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56035107|NCT05388500|Paclitaxel|paclitaxel|mesh-list
56035108|NCT05388500|Trastuzumab|trastuzumab|mesh-list
56035109|NCT05388500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56035110|NCT05388500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035111|NCT05388500|Tubulin Modulators|tubulin modulators|mesh-ancestor
56035112|NCT05388500|Antimitotic Agents|antimitotic agents|mesh-ancestor
56035113|NCT05388500|Mitosis Modulators|mitosis modulators|mesh-ancestor
56035114|NCT05388500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035115|NCT05388500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55886701|NCT02256358|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886702|NCT02256358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886703|NCT02256358|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55886704|NCT02256358|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55886705|NCT02256358|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55886710|NCT01825408|Azithromycin|azithromycin|mesh-list
55886711|NCT01825408|Doxycycline|doxycycline|mesh-list
55887290|NCT01781975|Imatinib Mesylate|imatinib mesylate|mesh-list
56035116|NCT00974246|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56035117|NCT00974246|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56035118|NCT00974246|Autonomic Agents|autonomic agents|mesh-ancestor
56035119|NCT00974246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035120|NCT00974246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035121|NCT00974246|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56035122|NCT00974246|Respiratory System Agents|respiratory system agents|mesh-ancestor
56035123|NCT00974246|Glucocorticoids|glucocorticoids|mesh-ancestor
56035125|NCT00974246|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035126|NCT00974246|Sympathomimetics|sympathomimetics|mesh-ancestor
56035130|NCT00974480|Tretinoin|tretinoin|mesh-list
56035131|NCT00974480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035132|NCT00974480|Keratolytic Agents|keratolytic agents|mesh-ancestor
56035133|NCT00974480|Dermatologic Agents|dermatologic agents|mesh-ancestor
56035134|NCT00975650|Testosterone|testosterone|mesh-list
56035135|NCT00975650|Androgens|androgens|mesh-ancestor
56035136|NCT00975650|Hormones|hormones|mesh-ancestor
56035137|NCT00975650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035141|NCT00979940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56035142|NCT00979940|Antimetabolites|antimetabolites|mesh-ancestor
56035143|NCT00979940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035144|NCT00979940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56035145|NCT00979940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56035146|NCT00979940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035148|NCT03018236|Acetylcysteine|acetylcysteine|mesh-list
56035149|NCT03018236|Cocaine|cocaine|mesh-list
56035150|NCT03018236|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56035151|NCT03018236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56035152|NCT03018236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035153|NCT03018236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56035154|NCT03018236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035155|NCT03018236|Antiviral Agents|antiviral agents|mesh-ancestor
56035156|NCT03018236|Expectorants|expectorants|mesh-ancestor
56035157|NCT03018236|Respiratory System Agents|respiratory system agents|mesh-ancestor
56035158|NCT03018236|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56035159|NCT03018236|Antioxidants|antioxidants|mesh-ancestor
56035160|NCT03018236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035161|NCT03018236|Protective Agents|protective agents|mesh-ancestor
56035162|NCT03018236|Antidotes|antidotes|mesh-ancestor
56035163|NCT03018236|Anesthetics, Local|anesthetics, local|mesh-ancestor
56035164|NCT03018236|Anesthetics|anesthetics|mesh-ancestor
56035165|NCT03018236|Sensory System Agents|sensory system agents|mesh-ancestor
56035166|NCT03018236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035167|NCT03018236|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56035168|NCT03018236|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56035189|NCT02873195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56035191|NCT02873195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035192|NCT02817659|Glucagon|glucagon|mesh-list
56035193|NCT02817659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56035194|NCT02817659|Hormones|hormones|mesh-ancestor
56035195|NCT02817659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035196|NCT02817659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035197|NCT02659241|Adavosertib|adavosertib|mesh-list
55830048|NCT04094584|Naltrexone|naltrexone|mesh-list
56035198|NCT02659241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035199|NCT02659241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035200|NCT04337177|Temozolomide|temozolomide|mesh-list
56035201|NCT04337177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56035202|NCT04337177|Alkylating Agents|alkylating agents|mesh-ancestor
56035203|NCT04337177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035204|NCT04337177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035205|NCT00982592|Leucovorin|leucovorin|mesh-list
56035206|NCT00982592|Fluorouracil|fluorouracil|mesh-list
56035207|NCT00982592|Oxaliplatin|oxaliplatin|mesh-list
56035208|NCT00982592|Calcium|calcium|mesh-list
56035209|NCT00982592|Levoleucovorin|levoleucovorin|mesh-list
56035210|NCT00982592|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56035211|NCT00982592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035212|NCT00982592|Antimetabolites|antimetabolites|mesh-ancestor
56035217|NCT00982592|Immunologic Factors|immunologic factors|mesh-ancestor
56035239|NCT00983216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035241|NCT00983216|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56035242|NCT01788020|Dexamethasone|dexamethasone|mesh-list
56035243|NCT01788020|Dexamethasone acetate|dexamethasone acetate|mesh-list
56035244|NCT01788020|Cyclophosphamide|cyclophosphamide|mesh-list
56035245|NCT01788020|Rituximab|rituximab|mesh-list
56035246|NCT01788020|Bortezomib|bortezomib|mesh-list
56035247|NCT01788020|BB 1101|bb 1101|mesh-list
56035248|NCT01788020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56035249|NCT01788020|Immunologic Factors|immunologic factors|mesh-ancestor
56035250|NCT01788020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035251|NCT01788020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56035252|NCT01788020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56035253|NCT01788020|Alkylating Agents|alkylating agents|mesh-ancestor
56035254|NCT01788020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035255|NCT01788020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035256|NCT01788020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56035257|NCT01788020|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56035258|NCT01788020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56035259|NCT01788020|Antiemetics|antiemetics|mesh-ancestor
56035260|NCT01788020|Autonomic Agents|autonomic agents|mesh-ancestor
56035261|NCT01788020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035262|NCT01788020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56035263|NCT01788020|Glucocorticoids|glucocorticoids|mesh-ancestor
56035264|NCT01788020|Hormones|hormones|mesh-ancestor
56035267|NCT01788020|Protease Inhibitors|protease inhibitors|mesh-ancestor
56035287|NCT01774487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035288|NCT01774487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035289|NCT01774487|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56035290|NCT01774487|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56035291|NCT01774487|Protective Agents|protective agents|mesh-ancestor
56035292|NCT01774487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035293|NCT01774487|Vasodilator Agents|vasodilator agents|mesh-ancestor
56035294|NCT01774487|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56035295|NCT01774487|Antioxidants|antioxidants|mesh-ancestor
56035296|NCT04409600|Botulinum Toxins|botulinum toxins|mesh-list
56035297|NCT04409600|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56035298|NCT04409600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55739935|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56035299|NCT04409600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762505|NCT05474937|GABA Modulators|gaba modulators|mesh-ancestor
56035301|NCT04409600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035302|NCT04409600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035303|NCT02161484|Bupivacaine|bupivacaine|mesh-list
56035304|NCT02161484|Anesthetics, Local|anesthetics, local|mesh-ancestor
56035305|NCT02161484|Anesthetics|anesthetics|mesh-ancestor
56035306|NCT02161484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56035307|NCT02161484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035308|NCT02161484|Sensory System Agents|sensory system agents|mesh-ancestor
56035309|NCT02161484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035310|NCT00988832|Infliximab|infliximab|mesh-list
56035311|NCT00988832|Dermatologic Agents|dermatologic agents|mesh-ancestor
55830059|NCT04757636|Aflibercept|aflibercept|mesh-list
56035312|NCT00988832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56035313|NCT00988832|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56035314|NCT01023776|Vaccines|vaccines|mesh-list
56035315|NCT01023776|Immunologic Factors|immunologic factors|mesh-ancestor
56035316|NCT01023776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035317|NCT00989768|Botulinum Toxins|botulinum toxins|mesh-list
56035318|NCT00989768|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56035319|NCT00989768|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56035320|NCT00989768|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56035323|NCT00989768|Cholinergic Agents|cholinergic agents|mesh-ancestor
56035324|NCT00989768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035325|NCT00989768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035326|NCT00989768|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56035327|NCT00989768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035328|NCT00990236|Enoxaparin|enoxaparin|mesh-list
56035329|NCT00990236|Enoxaparin sodium|enoxaparin sodium|mesh-list
56035330|NCT00990236|Anticoagulants|anticoagulants|mesh-ancestor
56035331|NCT00990236|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56035332|NCT00990236|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56035333|NCT00990236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035334|NCT01024010|Vidarabine|vidarabine|mesh-list
56035335|NCT01024010|Cyclophosphamide|cyclophosphamide|mesh-list
56035336|NCT01024010|Ofatumumab|ofatumumab|mesh-list
56035337|NCT01024010|Pentostatin|pentostatin|mesh-list
56035338|NCT01024010|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56035339|NCT01024010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56035340|NCT01024010|Immunologic Factors|immunologic factors|mesh-ancestor
56035341|NCT01024010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035342|NCT01024010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56035343|NCT01024010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56035344|NCT01024010|Alkylating Agents|alkylating agents|mesh-ancestor
56035345|NCT01024010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887364|NCT01857232|Ondansetron|ondansetron|mesh-list
56035346|NCT01024010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035347|NCT01024010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56035348|NCT01024010|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
56035349|NCT01024010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035350|NCT01024010|Antimetabolites|antimetabolites|mesh-ancestor
56035351|NCT01024010|Antiviral Agents|antiviral agents|mesh-ancestor
56035352|NCT01024010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035353|NCT02484690|Ranibizumab|ranibizumab|mesh-list
56035354|NCT02484690|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56035355|NCT02484690|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56035365|NCT01654224|Vaccines|vaccines|mesh-list
56035366|NCT01654224|Immunologic Factors|immunologic factors|mesh-ancestor
56035367|NCT01654224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035368|NCT02447328|Fulvestrant|fulvestrant|mesh-list
56035369|NCT02447328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56035370|NCT02447328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035371|NCT02447328|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56035372|NCT02447328|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56035373|NCT02447328|Hormone Antagonists|hormone antagonists|mesh-ancestor
56035374|NCT02447328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035375|NCT02447328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035377|NCT02447250|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56035378|NCT02447250|Autonomic Agents|autonomic agents|mesh-ancestor
56035379|NCT02447250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035380|NCT02447250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035381|NCT02447250|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56035382|NCT02447250|Respiratory System Agents|respiratory system agents|mesh-ancestor
56035383|NCT02447250|Tocolytic Agents|tocolytic agents|mesh-ancestor
56035384|NCT02447250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56035385|NCT02447250|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56035386|NCT02447250|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56035387|NCT02447250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56035388|NCT02447250|Adrenergic Agents|adrenergic agents|mesh-ancestor
56035389|NCT02447250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035390|NCT02447250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035391|NCT00993200|Warfarin|warfarin|mesh-list
56035392|NCT00993200|Anticoagulants|anticoagulants|mesh-ancestor
56035393|NCT00993824|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56035394|NCT00993824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56035395|NCT00993824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56035409|NCT04200066|Maprotiline|maprotiline|mesh-list
56035410|NCT04200066|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56035411|NCT04200066|Alkylating Agents|alkylating agents|mesh-ancestor
56035412|NCT04200066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035413|NCT04200066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035414|NCT04200066|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56035415|NCT04200066|Hormone Antagonists|hormone antagonists|mesh-ancestor
56035416|NCT04200066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035417|NCT04200066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035418|NCT04200066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56035419|NCT04200066|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56035420|NCT04200066|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56035421|NCT04200066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56035422|NCT04200066|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56035423|NCT04200066|Antidepressive Agents|antidepressive agents|mesh-ancestor
56035424|NCT04200066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56035425|NCT04200066|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56035426|NCT04200066|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56035427|NCT04200066|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56035428|NCT04200066|Adrenergic Agents|adrenergic agents|mesh-ancestor
56035429|NCT04200066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035430|NCT02455050|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56035431|NCT02455050|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56035432|NCT02455050|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56035434|NCT02455050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56035435|NCT04005716|Cisplatin|cisplatin|mesh-list
56035436|NCT04005716|Carboplatin|carboplatin|mesh-list
56035437|NCT04005716|Etoposide|etoposide|mesh-list
56035438|NCT04005716|Etoposide phosphate|etoposide phosphate|mesh-list
56035439|NCT04005716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035442|NCT04005716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56035449|NCT00994760|Narcotics|narcotics|mesh-ancestor
56035450|NCT00994760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56035451|NCT00994760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035452|NCT00994760|Analgesics|analgesics|mesh-ancestor
56035453|NCT00994760|Sensory System Agents|sensory system agents|mesh-ancestor
56035454|NCT00994760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035455|NCT00994760|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56035456|NCT00994760|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56035457|NCT00994760|Anesthetics, General|anesthetics, general|mesh-ancestor
56035458|NCT00994760|Anesthetics|anesthetics|mesh-ancestor
56035459|NCT00995072|Metoprolol|metoprolol|mesh-list
56035460|NCT00995072|Nebivolol|nebivolol|mesh-list
56035461|NCT00995072|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56035462|NCT00995072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56035463|NCT00995072|Sympatholytics|sympatholytics|mesh-ancestor
56035464|NCT00995072|Autonomic Agents|autonomic agents|mesh-ancestor
56035465|NCT00995072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035466|NCT00995072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035467|NCT00995072|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56035468|NCT00995072|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56035469|NCT00995072|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56035470|NCT00995072|Adrenergic Agents|adrenergic agents|mesh-ancestor
56035471|NCT00995072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035472|NCT00995072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035473|NCT00995072|Vasodilator Agents|vasodilator agents|mesh-ancestor
56035474|NCT00995072|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56035475|NCT00995072|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56035476|NCT00995072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56035477|NCT01027910|Doxorubicin|doxorubicin|mesh-list
56035478|NCT01027910|Abexinostat|abexinostat|mesh-list
56035479|NCT01027910|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56035480|NCT01027910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035481|NCT01027910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56035482|NCT01027910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55830315|NCT03368729|Niraparib|niraparib|mesh-list
56035483|NCT01027910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035484|NCT01027910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035485|NCT01027910|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56035486|NCT01031420|Doxorubicin|doxorubicin|mesh-list
56035487|NCT01031420|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56035488|NCT01031420|Methotrexate|methotrexate|mesh-list
56035489|NCT01031420|Vinblastine|vinblastine|mesh-list
56035490|NCT01031420|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56035491|NCT01031420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035492|NCT01031420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56035493|NCT01031420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56035494|NCT01031420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035495|NCT01031420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035496|NCT01031420|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56035497|NCT01031420|Abortifacient Agents|abortifacient agents|mesh-ancestor
56035498|NCT01031420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56035499|NCT01031420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035500|NCT01031420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56035501|NCT01031420|Antimetabolites|antimetabolites|mesh-ancestor
56035502|NCT01031420|Dermatologic Agents|dermatologic agents|mesh-ancestor
56035503|NCT01031420|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56035504|NCT01031420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56035505|NCT01031420|Immunologic Factors|immunologic factors|mesh-ancestor
56035506|NCT01031420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56035507|NCT01031420|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56035508|NCT01031420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56035509|NCT01031420|Tubulin Modulators|tubulin modulators|mesh-ancestor
56035510|NCT01031420|Antimitotic Agents|antimitotic agents|mesh-ancestor
56035511|NCT01031420|Mitosis Modulators|mitosis modulators|mesh-ancestor
56035512|NCT01031498|Ondansetron|ondansetron|mesh-list
56035513|NCT01031498|Palonosetron|palonosetron|mesh-list
56035514|NCT01031498|Antiemetics|antiemetics|mesh-ancestor
56035529|NCT01031498|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56035530|NCT01031498|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56035531|NCT01031810|Tranylcypromine|tranylcypromine|mesh-list
56035532|NCT01031810|Antidepressive Agents|antidepressive agents|mesh-ancestor
56035533|NCT01031810|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56035534|NCT01031810|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56035535|NCT01031810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035536|NCT01031810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035537|NCT01031810|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56035538|NCT01031810|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56035539|NCT01031810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827659|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035540|NCT01031810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035542|NCT03425006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56035543|NCT03425006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035544|NCT00998426|Immunoglobulins|immunoglobulins|mesh-list
56035545|NCT00998426|Antibodies|antibodies|mesh-list
56035546|NCT00998426|gamma-Globulins|gamma-globulins|mesh-list
56035547|NCT00998426|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56035548|NCT00998426|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56035549|NCT00998426|Immunoglobulin G|immunoglobulin g|mesh-list
56035550|NCT00998426|Immunologic Factors|immunologic factors|mesh-ancestor
56035551|NCT00998426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035552|NCT00998582|Tenofovir|tenofovir|mesh-list
56035553|NCT00998582|Antiviral Agents|antiviral agents|mesh-ancestor
56035554|NCT00998582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035555|NCT00998582|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56035556|NCT00998582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56035557|NCT00998582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035558|NCT00998582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035559|NCT00998582|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56035560|NCT00998582|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56035561|NCT02168660|Vitamin D|vitamin d|mesh-list
56035562|NCT02168660|Cholecalciferol|cholecalciferol|mesh-list
56035563|NCT02168660|Vitamins|vitamins|mesh-ancestor
56035564|NCT02168660|Micronutrients|micronutrients|mesh-ancestor
56035568|NCT01003106|Ranibizumab|ranibizumab|mesh-list
56035569|NCT01003106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56035570|NCT01003106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56035571|NCT01003106|Growth Substances|growth substances|mesh-ancestor
56035572|NCT01003106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035573|NCT01003106|Growth Inhibitors|growth inhibitors|mesh-ancestor
56035574|NCT01003106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035575|NCT01003418|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56035576|NCT01003418|Immunologic Factors|immunologic factors|mesh-ancestor
56035577|NCT01003418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035578|NCT01004042|Botulinum Toxins|botulinum toxins|mesh-list
56035579|NCT01004042|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56035580|NCT01004042|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56035581|NCT01004042|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56035582|NCT01004042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56035583|NCT01004042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035584|NCT01004042|Cholinergic Agents|cholinergic agents|mesh-ancestor
56035585|NCT01004042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035586|NCT01004042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035587|NCT01004042|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56035588|NCT01004042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035589|NCT01004354|Ergocalciferols|ergocalciferols|mesh-list
56035590|NCT01004354|Vitamin D|vitamin d|mesh-list
56035591|NCT01004354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56035592|NCT01004354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035593|NCT01004354|Vitamins|vitamins|mesh-ancestor
56035594|NCT01004354|Micronutrients|micronutrients|mesh-ancestor
56035595|NCT01004354|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56035596|NCT02641028|Aticaprant|aticaprant|mesh-list
56035597|NCT02641028|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56035598|NCT02641028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035599|NCT02641028|Sensory System Agents|sensory system agents|mesh-ancestor
56035610|NCT02417064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035611|NCT02417064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035612|NCT02417064|Serotonin Agents|serotonin agents|mesh-ancestor
56035613|NCT02417064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035614|NCT02417064|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56035615|NCT02417064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56035616|NCT02417064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035617|NCT02417064|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56035618|NCT02417064|Analgesics|analgesics|mesh-ancestor
56035619|NCT02417064|Sensory System Agents|sensory system agents|mesh-ancestor
56035620|NCT02417064|Dopamine Agents|dopamine agents|mesh-ancestor
56035621|NCT01004744|Anastrozole|anastrozole|mesh-list
56035622|NCT01004744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56035623|NCT01004744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035624|NCT01004744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56035625|NCT01004744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56035626|NCT01004744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830429|NCT04070573|Analgesics|analgesics|mesh-ancestor
56035627|NCT01004744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035628|NCT01004744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56035629|NCT01004744|Hormone Antagonists|hormone antagonists|mesh-ancestor
56035630|NCT01004744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035631|NCT01004744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035632|NCT01005290|Ramipril|ramipril|mesh-list
56035633|NCT01005290|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56035634|NCT01005290|Protease Inhibitors|protease inhibitors|mesh-ancestor
56035635|NCT01005290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035636|NCT01005290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035637|NCT01005290|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56035638|NCT04478474|Ganciclovir|ganciclovir|mesh-list
56035639|NCT04478474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56035640|NCT04478474|Antiviral Agents|antiviral agents|mesh-ancestor
56035641|NCT04478474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035642|NCT04478474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56035643|NCT04478474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035646|NCT05592860|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56035647|NCT05592860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035648|NCT01051778|Aspirin|aspirin|mesh-list
56035649|NCT01051778|Heparin|heparin|mesh-list
56035650|NCT01051778|Enoxaparin|enoxaparin|mesh-list
56035651|NCT01051778|Calcium heparin|calcium heparin|mesh-list
56035652|NCT01051778|Calcium|calcium|mesh-list
56035653|NCT01051778|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56035654|NCT01051778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035655|NCT01051778|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56035656|NCT01051778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56035657|NCT01051778|Analgesics|analgesics|mesh-ancestor
56035658|NCT01051778|Sensory System Agents|sensory system agents|mesh-ancestor
56035659|NCT01051778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035660|NCT01051778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56035661|NCT01051778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56035662|NCT01051778|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56035663|NCT01051778|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56035664|NCT01051778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035665|NCT01051778|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56035667|NCT01051778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035668|NCT01051778|Antipyretics|antipyretics|mesh-ancestor
56035669|NCT01051778|Anticoagulants|anticoagulants|mesh-ancestor
56035670|NCT02169440|Opicapone|opicapone|mesh-list
56035671|NCT02169440|Warfarin|warfarin|mesh-list
56035672|NCT02169440|Anticoagulants|anticoagulants|mesh-ancestor
56035673|NCT02169440|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56035674|NCT02169440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035675|NCT02169440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035676|NCT02169440|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56035677|NCT02169440|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56035679|NCT03015350|Desflurane|desflurane|mesh-list
56035680|NCT03015350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56035681|NCT03015350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56035683|NCT03015350|Anesthetics|anesthetics|mesh-ancestor
56035689|NCT01054742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035690|NCT01054742|Antiviral Agents|antiviral agents|mesh-ancestor
56035691|NCT01054742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035692|NCT04171466|Metronidazole|metronidazole|mesh-list
56035693|NCT04171466|Ciprofloxacin|ciprofloxacin|mesh-list
56035694|NCT04171466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035695|NCT04171466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56035696|NCT04171466|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56035697|NCT04171466|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56035698|NCT04171466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56035699|NCT04171466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56035700|NCT04171466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035701|NCT04171466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035702|NCT04171466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035703|NCT04171466|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56035704|NCT04171466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56035705|NCT02170376|Levodopa|levodopa|mesh-list
56035706|NCT02170376|Carbidopa|carbidopa|mesh-list
56035707|NCT02170376|Opicapone|opicapone|mesh-list
56035708|NCT02170376|Entacapone|entacapone|mesh-list
56035709|NCT02170376|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56035710|NCT02170376|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56035711|NCT02170376|Dopamine Agents|dopamine agents|mesh-ancestor
56035712|NCT02170376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035713|NCT02170376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035714|NCT02170376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035715|NCT02170376|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56035716|NCT02170376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035717|NCT02170376|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56035718|NCT02170532|Albuterol|albuterol|mesh-list
55887365|NCT01857232|Fosaprepitant|fosaprepitant|mesh-list
55830531|NCT02072096|Acarbose|acarbose|mesh-list
56035719|NCT02170532|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56035730|NCT02170532|Adrenergic Agents|adrenergic agents|mesh-ancestor
56035731|NCT02170532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035732|NCT02170532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035733|NCT05536154|Cytarabine|cytarabine|mesh-list
56035734|NCT05536154|Etoposide|etoposide|mesh-list
56035735|NCT05536154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56035736|NCT05536154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035737|NCT05536154|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56035738|NCT05536154|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56035739|NCT05536154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035740|NCT05536154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035741|NCT05536154|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56035742|NCT05536154|Antimetabolites|antimetabolites|mesh-ancestor
56035743|NCT05536154|Antiviral Agents|antiviral agents|mesh-ancestor
56035744|NCT05536154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035745|NCT05536154|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56035746|NCT05536154|Immunologic Factors|immunologic factors|mesh-ancestor
56035747|NCT05536154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035748|NCT04079582|Dialysis Solutions|dialysis solutions|mesh-list
56035749|NCT04079582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56035750|NCT05516654|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56035751|NCT05516654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035752|NCT05509634|Dexamethasone|dexamethasone|mesh-list
56035753|NCT05509634|Dexamethasone acetate|dexamethasone acetate|mesh-list
56035754|NCT05509634|Palonosetron|palonosetron|mesh-list
56035755|NCT05509634|Fosaprepitant|fosaprepitant|mesh-list
56035756|NCT05509634|Aprepitant|aprepitant|mesh-list
56035757|NCT05509634|BB 1101|bb 1101|mesh-list
56035758|NCT05509634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56035759|NCT05509634|Antiemetics|antiemetics|mesh-ancestor
56035760|NCT05509634|Autonomic Agents|autonomic agents|mesh-ancestor
56035761|NCT05509634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035762|NCT05509634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035763|NCT05509634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56035764|NCT05509634|Glucocorticoids|glucocorticoids|mesh-ancestor
56035766|NCT05509634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035767|NCT05509634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56035768|NCT05509634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035769|NCT05509634|Protease Inhibitors|protease inhibitors|mesh-ancestor
56035770|NCT05509634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035771|NCT05509634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035772|NCT05509634|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56035773|NCT05509634|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56035774|NCT05509634|Serotonin Agents|serotonin agents|mesh-ancestor
56035775|NCT05509634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035776|NCT05509634|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56035777|NCT02175212|Ascorbic Acid|ascorbic acid|mesh-list
56035778|NCT02175212|Methyltestosterone|methyltestosterone|mesh-list
56035779|NCT02175212|Androgens|androgens|mesh-list
56035780|NCT02175212|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56035781|NCT02175212|Hormones|hormones|mesh-ancestor
56035782|NCT02175212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56035783|NCT02175212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035784|NCT02175212|Antioxidants|antioxidants|mesh-ancestor
56035785|NCT02175212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035786|NCT02175212|Protective Agents|protective agents|mesh-ancestor
56035787|NCT02175212|Vitamins|vitamins|mesh-ancestor
56035788|NCT02175212|Micronutrients|micronutrients|mesh-ancestor
56035789|NCT02175212|Estrogens|estrogens|mesh-ancestor
56035790|NCT02175212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56035791|NCT02175212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035792|NCT02175212|Anabolic Agents|anabolic agents|mesh-ancestor
56035793|NCT03014882|Acetylcysteine|acetylcysteine|mesh-list
56035794|NCT03014882|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56035795|NCT03014882|Antiviral Agents|antiviral agents|mesh-ancestor
56035796|NCT03014882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035797|NCT03014882|Expectorants|expectorants|mesh-ancestor
56035798|NCT03014882|Respiratory System Agents|respiratory system agents|mesh-ancestor
56035809|NCT02171234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56035810|NCT02171234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035811|NCT01061528|Nicotine|nicotine|mesh-list
56035812|NCT01061528|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56035813|NCT01061528|Autonomic Agents|autonomic agents|mesh-ancestor
56035814|NCT01061528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035815|NCT01061528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035816|NCT01061528|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56035817|NCT01061528|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56035818|NCT01061528|Cholinergic Agents|cholinergic agents|mesh-ancestor
56035819|NCT01061528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035820|NCT01061528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035821|NCT01062230|Bortezomib|bortezomib|mesh-list
56035822|NCT01062230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035823|NCT01064882|Bimatoprost|bimatoprost|mesh-list
56035824|NCT01064882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56035825|NCT01064882|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56035826|NCT01064882|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56035827|NCT01065506|Nicotine|nicotine|mesh-list
56035828|NCT01065506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56035829|NCT01065506|Autonomic Agents|autonomic agents|mesh-ancestor
56035830|NCT01065506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035831|NCT01065506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035832|NCT01065506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56035833|NCT01065506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56035834|NCT01065506|Cholinergic Agents|cholinergic agents|mesh-ancestor
56035835|NCT01065506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035836|NCT01065506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035837|NCT03817736|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56035838|NCT03817736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035839|NCT03817736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876934|NCT01341730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55876935|NCT01341730|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55876936|NCT01341730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876937|NCT01341730|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55876938|NCT01341730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876939|NCT01247272|Fluoxetine|fluoxetine|mesh-list
55876940|NCT01247272|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55876941|NCT01247272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55876942|NCT01247272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55876947|NCT01247272|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56035840|NCT03811886|Natalizumab|natalizumab|mesh-list
56035841|NCT03811886|Immunologic Factors|immunologic factors|mesh-ancestor
56035842|NCT03811886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035843|NCT01066364|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56035844|NCT01066364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56035845|NCT01066364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56035846|NCT01066364|Antimetabolites|antimetabolites|mesh-ancestor
56035847|NCT01066364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035848|NCT01066364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56035849|NCT01066520|Diclofenac|diclofenac|mesh-list
56035850|NCT01066520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56035851|NCT01066520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56035852|NCT01066520|Analgesics|analgesics|mesh-ancestor
56035853|NCT01066520|Sensory System Agents|sensory system agents|mesh-ancestor
56035854|NCT01066520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035855|NCT01066520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035856|NCT01066520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56035857|NCT01066520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56035858|NCT01066520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56035859|NCT01066520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035860|NCT01066520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035861|NCT03014804|Nivolumab|nivolumab|mesh-list
56035862|NCT03014804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56035863|NCT03014804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035864|NCT03014804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56035865|NCT03014804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035866|NCT05224388|Heparin|heparin|mesh-list
56035867|NCT05224388|Enoxaparin|enoxaparin|mesh-list
56035868|NCT05224388|Anticoagulants|anticoagulants|mesh-ancestor
56035869|NCT05224388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56035870|NCT05224388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56035871|NCT05224388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035872|NCT03520790|Gemcitabine|gemcitabine|mesh-list
56035873|NCT03520790|Paclitaxel|paclitaxel|mesh-list
56035875|NCT03520790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035879|NCT03520790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035880|NCT03520790|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56035881|NCT03520790|Antimetabolites|antimetabolites|mesh-ancestor
56035882|NCT03520790|Antiviral Agents|antiviral agents|mesh-ancestor
55830720|NCT02235077|Spironolactone|spironolactone|mesh-list
56035883|NCT03520790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035884|NCT03520790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035885|NCT03520790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56035886|NCT03520790|Immunologic Factors|immunologic factors|mesh-ancestor
56035887|NCT03520790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035889|NCT02416908|Plerixafor|plerixafor|mesh-list
56035891|NCT02416908|Cladribine|cladribine|mesh-list
56035892|NCT02416908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56035893|NCT02416908|Antimetabolites|antimetabolites|mesh-ancestor
56035894|NCT02416908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035895|NCT02416908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035896|NCT02416908|Antiviral Agents|antiviral agents|mesh-ancestor
56035897|NCT02416908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035898|NCT02416908|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56035899|NCT02416908|Immunologic Factors|immunologic factors|mesh-ancestor
56035900|NCT02416908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763167|NCT02105974|Xhance|xhance|mesh-list
56035901|NCT02416908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56035902|NCT02416908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56035903|NCT01070810|Thiamine|thiamine|mesh-list
56035904|NCT01070810|Vitamin B Complex|vitamin b complex|mesh-ancestor
56035905|NCT01070810|Vitamins|vitamins|mesh-ancestor
56035906|NCT01070810|Micronutrients|micronutrients|mesh-ancestor
56035907|NCT01070810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035908|NCT01071044|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56035909|NCT01071044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56035924|NCT05150756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56035925|NCT05150756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56035926|NCT05150756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56035927|NCT05150756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56035928|NCT05150756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56035929|NCT05150756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035930|NCT05150756|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56035931|NCT05150756|Narcotics|narcotics|mesh-ancestor
56035932|NCT05150756|Analgesics|analgesics|mesh-ancestor
56035933|NCT01072136|Azithromycin|azithromycin|mesh-list
56035934|NCT01072136|Cefixime|cefixime|mesh-list
56035935|NCT01072136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56035936|NCT01072136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035937|NCT05135858|Methotrexate|methotrexate|mesh-list
56035938|NCT05135858|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56035939|NCT05135858|Abortifacient Agents|abortifacient agents|mesh-ancestor
56035940|NCT05135858|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56035941|NCT05135858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56035942|NCT05135858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56035943|NCT05135858|Antimetabolites|antimetabolites|mesh-ancestor
56035944|NCT05135858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035945|NCT05135858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035946|NCT05135858|Dermatologic Agents|dermatologic agents|mesh-ancestor
56035947|NCT05135858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035948|NCT05135858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56035949|NCT05135858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56035950|NCT05135858|Immunologic Factors|immunologic factors|mesh-ancestor
56035951|NCT05135858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56035952|NCT05135858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56035953|NCT05070650|Acetaminophen|acetaminophen|mesh-list
56035954|NCT05070650|Acetylcysteine|acetylcysteine|mesh-list
56035955|NCT05070650|Phenylephrine|phenylephrine|mesh-list
56035956|NCT05070650|Oxymetazoline|oxymetazoline|mesh-list
56035957|NCT05070650|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56035958|NCT05070650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56035964|NCT05070650|Antiviral Agents|antiviral agents|mesh-ancestor
56035965|NCT05070650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56035967|NCT05070650|Respiratory System Agents|respiratory system agents|mesh-ancestor
56035968|NCT05070650|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56035969|NCT05070650|Antioxidants|antioxidants|mesh-ancestor
56035970|NCT05070650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035971|NCT05070650|Protective Agents|protective agents|mesh-ancestor
56035972|NCT05070650|Antidotes|antidotes|mesh-ancestor
56035973|NCT05070650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56035974|NCT05070650|Mydriatics|mydriatics|mesh-ancestor
56035975|NCT05070650|Autonomic Agents|autonomic agents|mesh-ancestor
56035976|NCT05070650|Sympathomimetics|sympathomimetics|mesh-ancestor
56035977|NCT05070650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56035978|NCT05070650|Nasal Decongestants|nasal decongestants|mesh-ancestor
56035979|NCT05070650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56035980|NCT05070650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56035981|NCT05070650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56035982|NCT05070650|Adrenergic Agents|adrenergic agents|mesh-ancestor
56035983|NCT05070650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56035984|NCT03012230|Pembrolizumab|pembrolizumab|mesh-list
56035985|NCT03012230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56035986|NCT03012230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56035987|NCT03005444|Enoxaparin|enoxaparin|mesh-list
56035988|NCT03005444|Nadroparin|nadroparin|mesh-list
56035989|NCT03005444|Rivaroxaban|rivaroxaban|mesh-list
56035990|NCT03005444|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56035991|NCT03005444|Antithrombins|antithrombins|mesh-ancestor
56035992|NCT03005444|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56035993|NCT03005444|Protease Inhibitors|protease inhibitors|mesh-ancestor
56035994|NCT03005444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56035995|NCT03005444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56035996|NCT03005444|Anticoagulants|anticoagulants|mesh-ancestor
56035997|NCT03005444|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56036011|NCT01076972|Protease Inhibitors|protease inhibitors|mesh-ancestor
56036012|NCT01076972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036013|NCT01076972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036014|NCT01076972|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56036015|NCT01076972|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56036016|NCT01076972|Antiviral Agents|antiviral agents|mesh-ancestor
56036017|NCT01076972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036018|NCT01076972|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56036019|NCT01076972|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56036021|NCT02174432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56036022|NCT02174432|Narcotics|narcotics|mesh-ancestor
56036023|NCT02174432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036024|NCT02174432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036025|NCT02174432|Analgesics|analgesics|mesh-ancestor
56036026|NCT02174432|Sensory System Agents|sensory system agents|mesh-ancestor
56036027|NCT02174432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036028|NCT02176382|Zoledronic Acid|zoledronic acid|mesh-list
56036030|NCT02176382|Teriparatide|teriparatide|mesh-list
56036031|NCT02176382|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56036032|NCT02176382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036033|NCT02176382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56036034|NCT01077596|Bupropion|bupropion|mesh-list
56036061|NCT02414958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036062|NCT02414958|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56036063|NCT02414958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036064|NCT03016208|Misoprostol|misoprostol|mesh-list
56036065|NCT03016208|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56036066|NCT03016208|Abortifacient Agents|abortifacient agents|mesh-ancestor
56036067|NCT03016208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56036068|NCT03016208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036069|NCT03016208|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56036070|NCT03016208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036071|NCT03016208|Oxytocics|oxytocics|mesh-ancestor
56036073|NCT03013790|Antioxidants|antioxidants|mesh-ancestor
56036074|NCT03013790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036075|NCT03013790|Protective Agents|protective agents|mesh-ancestor
56036076|NCT03013790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036077|NCT03013790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036078|NCT01078376|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56036079|NCT01078376|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56036080|NCT01078376|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56036081|NCT01078376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036082|NCT02485184|Propranolol|propranolol|mesh-list
56036083|NCT02485184|Warfarin|warfarin|mesh-list
56036084|NCT02485184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56036085|NCT02485184|Anticoagulants|anticoagulants|mesh-ancestor
56036086|NCT02485184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56036087|NCT02485184|Adrenergic Agents|adrenergic agents|mesh-ancestor
56036088|NCT02485184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036089|NCT02485184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036090|NCT02485184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036091|NCT02485184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55827661|NCT04481009|Paclitaxel|paclitaxel|mesh-list
55830898|NCT02202161|Metformin|metformin|mesh-list
56036092|NCT02485184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56036093|NCT02485184|Vasodilator Agents|vasodilator agents|mesh-ancestor
56036094|NCT03015818|Calcium|calcium|mesh-list
56036099|NCT03015818|Protective Agents|protective agents|mesh-ancestor
56036100|NCT01080248|Gemcitabine|gemcitabine|mesh-list
56036101|NCT01080248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56036102|NCT01080248|Antimetabolites|antimetabolites|mesh-ancestor
56036103|NCT01080248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036104|NCT01080248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036105|NCT01080248|Antiviral Agents|antiviral agents|mesh-ancestor
56036106|NCT01080248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036107|NCT01080248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036108|NCT01080248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56036109|NCT01080248|Immunologic Factors|immunologic factors|mesh-ancestor
56036110|NCT01080248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036111|NCT04802876|Spartalizumab|spartalizumab|mesh-list
56036112|NCT04802876|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55739947|NCT03395665|Progestins|progestins|mesh-ancestor
56036113|NCT04802876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036114|NCT04802876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036116|NCT02452476|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56036117|NCT02452476|Respiratory System Agents|respiratory system agents|mesh-ancestor
56036118|NCT01082588|Pravastatin|pravastatin|mesh-list
56036119|NCT01082588|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56036120|NCT01082588|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56036121|NCT01082588|Antimetabolites|antimetabolites|mesh-ancestor
56036122|NCT01082588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036123|NCT01082588|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56036124|NCT01082588|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56036125|NCT01082588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036126|NCT02413398|Dapagliflozin|dapagliflozin|mesh-list
56036132|NCT02441946|Loperamide|loperamide|mesh-list
56036142|NCT02441946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036143|NCT02441946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036144|NCT02441946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036146|NCT01083368|Bevacizumab|bevacizumab|mesh-list
56036147|NCT01083368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56036148|NCT01083368|Antibodies|antibodies|mesh-list
56036149|NCT01083368|Immunoglobulins|immunoglobulins|mesh-list
56036150|NCT01083368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56036151|NCT01083368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036152|NCT01083368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56036153|NCT01083368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56036154|NCT01083368|Growth Substances|growth substances|mesh-ancestor
56036155|NCT01083368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036156|NCT01083368|Growth Inhibitors|growth inhibitors|mesh-ancestor
56036157|NCT01083368|Immunologic Factors|immunologic factors|mesh-ancestor
56036158|NCT01083368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036159|NCT01083368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036160|NCT01083368|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56036161|NCT01083368|Antifungal Agents|antifungal agents|mesh-ancestor
56036162|NCT01083368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56036163|NCT02387580|Artefenomel|artefenomel|mesh-list
56036164|NCT02387580|Antimalarials|antimalarials|mesh-ancestor
56036165|NCT02387580|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56036166|NCT02387580|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56036167|NCT02387580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036168|NCT02440854|Afatinib|afatinib|mesh-list
56036192|NCT01085786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56036193|NCT01085786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036194|NCT01085786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036195|NCT01085786|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56036196|NCT01085786|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56036197|NCT01085786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56036198|NCT02170220|Vortioxetine|vortioxetine|mesh-list
56036199|NCT02170220|Antidepressive Agents|antidepressive agents|mesh-ancestor
56036200|NCT02170220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56036201|NCT02170220|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56036202|NCT02170220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56036203|NCT02170220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036204|NCT02170220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036205|NCT02170220|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56036206|NCT02170220|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56036207|NCT02170220|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56036208|NCT02170220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036209|NCT02170220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036210|NCT02170220|Serotonin Agents|serotonin agents|mesh-ancestor
56036211|NCT02170220|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56036212|NCT02170220|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56036213|NCT02170220|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56036214|NCT02170220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56036215|NCT01036802|Warfarin|warfarin|mesh-list
56036216|NCT01036802|Anticoagulants|anticoagulants|mesh-ancestor
56036217|NCT01037192|Vancomycin|vancomycin|mesh-list
56036218|NCT01037192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036219|NCT01037192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036220|NCT02386098|Ritonavir|ritonavir|mesh-list
56036221|NCT02386098|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56036222|NCT02386098|Tenofovir|tenofovir|mesh-list
56036234|NCT02386098|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55887366|NCT01857232|Aprepitant|aprepitant|mesh-list
56036235|NCT02386098|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56036236|NCT02386098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56036237|NCT02386098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56036238|NCT02386098|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56036239|NCT02386098|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56036240|NCT01089062|Dihydroergotamine|dihydroergotamine|mesh-list
56036241|NCT01089062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56036242|NCT01089062|Dopamine Agonists|dopamine agonists|mesh-ancestor
56036243|NCT01089062|Dopamine Agents|dopamine agents|mesh-ancestor
56036244|NCT01089062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036245|NCT01089062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036246|NCT01089062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036247|NCT01089062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56036248|NCT01089062|Analgesics|analgesics|mesh-ancestor
56036249|NCT01089062|Sensory System Agents|sensory system agents|mesh-ancestor
56036250|NCT01089062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036251|NCT02412618|Misoprostol|misoprostol|mesh-list
56036252|NCT02412618|Mifepristone|mifepristone|mesh-list
56036253|NCT02412618|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56036254|NCT02412618|Abortifacient Agents|abortifacient agents|mesh-ancestor
56036255|NCT02412618|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56036256|NCT02412618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036257|NCT02412618|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56036258|NCT02412618|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036259|NCT02412618|Oxytocics|oxytocics|mesh-ancestor
56036260|NCT02412618|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56036261|NCT02412618|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56036262|NCT02412618|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56036263|NCT02412618|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56036264|NCT02412618|Contraceptive Agents|contraceptive agents|mesh-ancestor
56036265|NCT02412618|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56036266|NCT02412618|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56036267|NCT02412618|Hormone Antagonists|hormone antagonists|mesh-ancestor
56036269|NCT02412618|Luteolytic Agents|luteolytic agents|mesh-ancestor
56036270|NCT02412618|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56036271|NCT02412618|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56036272|NCT02179892|Acetaminophen|acetaminophen|mesh-list
56036273|NCT02179892|Dexamethasone|dexamethasone|mesh-list
56036274|NCT02179892|Dexamethasone acetate|dexamethasone acetate|mesh-list
56036275|NCT02179892|Bupivacaine|bupivacaine|mesh-list
56036276|NCT02179892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56036277|NCT02179892|Antiemetics|antiemetics|mesh-ancestor
56036278|NCT02179892|Autonomic Agents|autonomic agents|mesh-ancestor
56036279|NCT02179892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036280|NCT02179892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036281|NCT02179892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036282|NCT02179892|Glucocorticoids|glucocorticoids|mesh-ancestor
56036284|NCT02179892|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036285|NCT02179892|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56036286|NCT02179892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036287|NCT02179892|Anesthetics, Local|anesthetics, local|mesh-ancestor
56036288|NCT02179892|Anesthetics|anesthetics|mesh-ancestor
56036289|NCT02179892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036290|NCT02179892|Sensory System Agents|sensory system agents|mesh-ancestor
56036291|NCT02179892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56036292|NCT02179892|Analgesics|analgesics|mesh-ancestor
56036293|NCT02179892|Antipyretics|antipyretics|mesh-ancestor
56036294|NCT01092338|Vitamin D|vitamin d|mesh-list
56036295|NCT01092338|Cholecalciferol|cholecalciferol|mesh-list
56036296|NCT01092338|Vitamins|vitamins|mesh-ancestor
56036297|NCT01092338|Micronutrients|micronutrients|mesh-ancestor
56036298|NCT01092338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831043|NCT01483144|Eflornithine|eflornithine|mesh-list
56036299|NCT01092338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56036300|NCT01092338|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56036301|NCT01110434|Topiramate|topiramate|mesh-list
56036316|NCT01042496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56036317|NCT01111058|Everolimus|everolimus|mesh-list
56036318|NCT01111058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036319|NCT01111058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56036320|NCT01111058|Immunologic Factors|immunologic factors|mesh-ancestor
56036321|NCT01111058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036322|NCT01094522|Morphine|morphine|mesh-list
56036323|NCT01094522|Methadone|methadone|mesh-list
56036324|NCT01094522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56036325|NCT01094522|Narcotics|narcotics|mesh-ancestor
56036326|NCT01094522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036327|NCT01094522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036328|NCT01094522|Analgesics|analgesics|mesh-ancestor
56036329|NCT01094522|Sensory System Agents|sensory system agents|mesh-ancestor
56036330|NCT01094522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036331|NCT01094522|Antitussive Agents|antitussive agents|mesh-ancestor
56036332|NCT01094522|Respiratory System Agents|respiratory system agents|mesh-ancestor
56036333|NCT02178800|Cabotegravir|cabotegravir|mesh-list
56036334|NCT02178800|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56036335|NCT02178800|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56036336|NCT02178800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036337|NCT02178800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036338|NCT02178800|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56036339|NCT02178800|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56036340|NCT02178800|Antiviral Agents|antiviral agents|mesh-ancestor
56036341|NCT02178800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036343|NCT01044212|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56036344|NCT01044212|Cathartics|cathartics|mesh-ancestor
56036345|NCT01044212|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036364|NCT02174510|Dopamine Agents|dopamine agents|mesh-ancestor
56036366|NCT00585195|Rifampin|rifampin|mesh-list
56036367|NCT00585195|Crizotinib|crizotinib|mesh-list
56036368|NCT00585195|Antifungal Agents|antifungal agents|mesh-ancestor
56036369|NCT00585195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036370|NCT00585195|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56036371|NCT00585195|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56036372|NCT00585195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036373|NCT00585195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036374|NCT00585195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56036375|NCT00585195|Hormone Antagonists|hormone antagonists|mesh-ancestor
56036376|NCT00585195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036377|NCT00585195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036378|NCT00585195|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56036379|NCT00585195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56036380|NCT00585195|Antitubercular Agents|antitubercular agents|mesh-ancestor
56036381|NCT00585195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036382|NCT00585195|Leprostatic Agents|leprostatic agents|mesh-ancestor
56036383|NCT00585195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56036384|NCT00585195|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56036385|NCT00585195|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56036386|NCT00585195|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56036387|NCT00585195|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56036388|NCT00585195|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56036389|NCT00585195|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56036390|NCT00585195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036391|NCT00585195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56036392|NCT01113398|Bevacizumab|bevacizumab|mesh-list
56036393|NCT01113398|Rilotumumab|rilotumumab|mesh-list
56036394|NCT01113398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56036406|NCT03013556|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56036407|NCT03013556|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56036408|NCT03013556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036409|NCT03013556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036410|NCT03013556|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56036411|NCT03013556|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56036412|NCT03013556|Immunologic Factors|immunologic factors|mesh-ancestor
56036413|NCT03013556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036415|NCT01113632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036416|NCT00458835|Ciclesonide|ciclesonide|mesh-list
56036417|NCT00458835|Glucocorticoids|glucocorticoids|mesh-ancestor
56036418|NCT00458835|Hormones|hormones|mesh-ancestor
56036419|NCT00458835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036420|NCT00458835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036421|NCT00458835|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56036422|NCT01044758|Levetiracetam|levetiracetam|mesh-list
56036423|NCT01044758|Anticonvulsants|anticonvulsants|mesh-ancestor
56036424|NCT01044758|Nootropic Agents|nootropic agents|mesh-ancestor
56036425|NCT01115582|Cholic Acids|cholic acids|mesh-list
56036426|NCT01115582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036427|NCT03013400|Ebselen|ebselen|mesh-list
55763633|NCT04991025|Nivolumab|nivolumab|mesh-list
56036428|NCT03013400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56036430|NCT03013400|Analgesics|analgesics|mesh-ancestor
56036431|NCT03013400|Sensory System Agents|sensory system agents|mesh-ancestor
56036432|NCT03013400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036433|NCT03013400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036434|NCT03013400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56036435|NCT03013400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56036436|NCT03013400|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55876948|NCT01247272|Antidepressive Agents|antidepressive agents|mesh-ancestor
55876949|NCT01247272|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55876950|NCT01247272|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55876951|NCT01247272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55876952|NCT01247272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876953|NCT01290484|Sildenafil Citrate|sildenafil citrate|mesh-list
55876954|NCT01290484|Vasodilator Agents|vasodilator agents|mesh-ancestor
55876955|NCT01290484|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55876956|NCT01290484|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55876957|NCT01290484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876958|NCT01290484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036437|NCT03013400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036438|NCT03013400|Antioxidants|antioxidants|mesh-ancestor
56036439|NCT03013400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036440|NCT03013400|Protective Agents|protective agents|mesh-ancestor
56036441|NCT03013400|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56036442|NCT03013400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036443|NCT03013400|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56036444|NCT02439138|Idelalisib|idelalisib|mesh-list
56036445|NCT02439138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036446|NCT02439138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036447|NCT02439138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036448|NCT01097642|Cetuximab|cetuximab|mesh-list
56036502|NCT00363285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036503|NCT00363285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036504|NCT00363285|Androgen Antagonists|androgen antagonists|mesh-ancestor
56036505|NCT00363285|Hormone Antagonists|hormone antagonists|mesh-ancestor
56036506|NCT00363285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036507|NCT00363285|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56036508|NCT00363285|Contraceptive Agents|contraceptive agents|mesh-ancestor
56036509|NCT00363285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56036510|NCT02424357|Povidone-Iodine|povidone-iodine|mesh-list
56036511|NCT02424357|Povidone|povidone|mesh-list
56036512|NCT02424357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56036513|NCT02424357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56036514|NCT02424357|Plasma Substitutes|plasma substitutes|mesh-ancestor
56036515|NCT02424357|Blood Substitutes|blood substitutes|mesh-ancestor
55831220|NCT02229539|Antiemetics|antiemetics|mesh-ancestor
56036516|NCT02424357|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56036517|NCT02424357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036518|NCT02425449|Succinylcholine|succinylcholine|mesh-list
56036519|NCT02425449|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
56036520|NCT02425449|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56036521|NCT02425449|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56036522|NCT02425449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036523|NCT02425449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036524|NCT02455167|Ribavirin|ribavirin|mesh-list
56036525|NCT02455167|Sofosbuvir|sofosbuvir|mesh-list
56036526|NCT02455167|Antimetabolites|antimetabolites|mesh-ancestor
56036527|NCT02455167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036528|NCT02455167|Antiviral Agents|antiviral agents|mesh-ancestor
56036550|NCT02435901|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56036551|NCT02435901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036552|NCT02435901|Antifungal Agents|antifungal agents|mesh-ancestor
56036553|NCT02435901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036554|NCT02435901|Dermatologic Agents|dermatologic agents|mesh-ancestor
56036555|NCT02435901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56036556|NCT02435901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56036557|NCT02435901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56036558|NCT02435901|Antitubercular Agents|antitubercular agents|mesh-ancestor
56036559|NCT02435901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036560|NCT02435901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56036561|NCT02435901|Alkylating Agents|alkylating agents|mesh-ancestor
56036562|NCT02435901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56036563|NCT02435901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56036565|NCT02437383|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56036566|NCT02437383|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56036567|NCT02437383|Adrenergic Agents|adrenergic agents|mesh-ancestor
56036568|NCT02437383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036569|NCT02437383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036570|NCT02437383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036571|NCT02437383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56036572|NCT02437383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56036573|NCT02437383|Vasodilator Agents|vasodilator agents|mesh-ancestor
56036574|NCT02385708|Chlorhexidine|chlorhexidine|mesh-list
56036575|NCT02385708|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56036576|NCT02385708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56036599|NCT01118624|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56036600|NCT01118624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036601|NCT01118624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036602|NCT01118624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036603|NCT02439879|Thioctic Acid|thioctic acid|mesh-list
56036604|NCT02439879|Antioxidants|antioxidants|mesh-ancestor
56036605|NCT02439879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036606|NCT02439879|Protective Agents|protective agents|mesh-ancestor
56036607|NCT02439879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036608|NCT02439879|Vitamin B Complex|vitamin b complex|mesh-ancestor
56036609|NCT02439879|Vitamins|vitamins|mesh-ancestor
56036610|NCT02439879|Micronutrients|micronutrients|mesh-ancestor
56036611|NCT03371108|Insulin Glargine|insulin glargine|mesh-list
56036612|NCT03371108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56036613|NCT03371108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036614|NCT01100606|Pancrelipase|pancrelipase|mesh-list
56036615|NCT01100606|Pancreatin|pancreatin|mesh-list
56036616|NCT01100606|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036617|NCT03013010|Oxaliplatin|oxaliplatin|mesh-list
56036618|NCT03013010|Tegafur|tegafur|mesh-list
56036619|NCT03013010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036620|NCT03013010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56036621|NCT03013010|Antimetabolites|antimetabolites|mesh-ancestor
56036622|NCT03013010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036623|NCT02518191|Goserelin|goserelin|mesh-list
56036624|NCT02518191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56036625|NCT02518191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036626|NCT01119794|Bortezomib|bortezomib|mesh-list
56036627|NCT01119794|Ofatumumab|ofatumumab|mesh-list
56036628|NCT01119794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036629|NCT02926196|Avelumab|avelumab|mesh-list
56036630|NCT02926196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56036631|NCT02926196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036646|NCT02819024|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036647|NCT02819024|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56036648|NCT02819024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036649|NCT02819024|Protease Inhibitors|protease inhibitors|mesh-ancestor
56036650|NCT02819024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036651|NCT02819024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036652|NCT02819024|Dermatologic Agents|dermatologic agents|mesh-ancestor
56036653|NCT02819024|Antiviral Agents|antiviral agents|mesh-ancestor
56036654|NCT02819024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036655|NCT02819024|Antimetabolites|antimetabolites|mesh-ancestor
56036656|NCT02819024|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56036657|NCT02819024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56036659|NCT01103414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56036660|NCT01103414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036661|NCT02180828|Fluconazole|fluconazole|mesh-list
56036662|NCT02180828|Clotrimazole|clotrimazole|mesh-list
56036663|NCT02180828|Miconazole|miconazole|mesh-list
56036664|NCT02180828|Antifungal Agents|antifungal agents|mesh-ancestor
56036665|NCT02180828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036666|NCT02180828|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56036667|NCT02180828|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56036668|NCT02180828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036669|NCT02180828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036670|NCT02180828|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56036671|NCT02180828|Hormone Antagonists|hormone antagonists|mesh-ancestor
56036672|NCT02180828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036673|NCT02180828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036674|NCT02180828|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56036675|NCT02180828|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56036676|NCT02180828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56036677|NCT02180828|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56036678|NCT02525523|Alicaforsen|alicaforsen|mesh-list
56036679|NCT02525523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036683|NCT02528409|Vortioxetine|vortioxetine|mesh-list
56036684|NCT02528409|Antidepressive Agents|antidepressive agents|mesh-ancestor
56036685|NCT02528409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56036686|NCT02528409|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56036687|NCT02528409|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56036688|NCT02528409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036689|NCT02528409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036690|NCT02528409|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56036691|NCT02528409|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56036692|NCT02528409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56036693|NCT02528409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036694|NCT02528409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036695|NCT02528409|Serotonin Agents|serotonin agents|mesh-ancestor
55887437|NCT01860586|Growth Inhibitors|growth inhibitors|mesh-ancestor
55831389|NCT04767113|Heparin|heparin|mesh-list
56036696|NCT02528409|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56036697|NCT02528409|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56036698|NCT02528409|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56036699|NCT02528409|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56036700|NCT02530281|Glycopyrrolate|glycopyrrolate|mesh-list
56036701|NCT02530281|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56036702|NCT02530281|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56036703|NCT02530281|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56036704|NCT02530281|Cholinergic Agents|cholinergic agents|mesh-ancestor
56036735|NCT03013322|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56036736|NCT03013322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036737|NCT03013322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036738|NCT03013322|Cholinergic Agents|cholinergic agents|mesh-ancestor
56036739|NCT03013322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036740|NCT03013322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036742|NCT03013322|Autonomic Agents|autonomic agents|mesh-ancestor
56036743|NCT03013322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036744|NCT02469597|Furosemide|furosemide|mesh-list
56036745|NCT02469597|Diuretics|diuretics|mesh-ancestor
56036746|NCT02469597|Natriuretic Agents|natriuretic agents|mesh-ancestor
56036747|NCT02469597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036748|NCT02469597|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56036749|NCT02469597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56036750|NCT02469597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036751|NCT02183792|Furosemide|furosemide|mesh-list
56036752|NCT02183792|Tolvaptan|tolvaptan|mesh-list
56036753|NCT02183792|Diuretics|diuretics|mesh-ancestor
56036754|NCT02183792|Natriuretic Agents|natriuretic agents|mesh-ancestor
56036755|NCT02183792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036756|NCT02183792|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56036757|NCT02183792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56036758|NCT02183792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036759|NCT02183792|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56036760|NCT00363519|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56036761|NCT00363519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55831433|NCT03026842|Cytarabine|cytarabine|mesh-list
56036777|NCT02542761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036778|NCT02475837|Vorapaxar|vorapaxar|mesh-list
56036779|NCT02475837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56036780|NCT01124786|Gemcitabine|gemcitabine|mesh-list
55739958|NCT03390595|Gemcitabine|gemcitabine|mesh-list
56036781|NCT01124786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56036782|NCT01124786|Antimetabolites|antimetabolites|mesh-ancestor
56036783|NCT01124786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036784|NCT01124786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036785|NCT01124786|Antiviral Agents|antiviral agents|mesh-ancestor
56036786|NCT01124786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036787|NCT01124786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036788|NCT01124786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56036789|NCT01124786|Immunologic Factors|immunologic factors|mesh-ancestor
56036790|NCT01124786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036791|NCT01125098|Amoxicillin|amoxicillin|mesh-list
56036792|NCT01125098|Clavulanic Acid|clavulanic acid|mesh-list
56036793|NCT01125098|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56036794|NCT01125098|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036795|NCT01125098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036796|NCT01125098|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56036797|NCT01125098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036798|NCT01125098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036799|NCT02478489|Naltrexone|naltrexone|mesh-list
56036800|NCT02478489|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56036801|NCT02478489|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56036802|NCT02478489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036803|NCT02478489|Sensory System Agents|sensory system agents|mesh-ancestor
56036804|NCT02478489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036805|NCT02322320|Lenalidomide|lenalidomide|mesh-list
56036806|NCT02322320|Immunologic Factors|immunologic factors|mesh-ancestor
56036807|NCT02322320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036808|NCT02322320|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56036809|NCT02322320|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56036810|NCT02322320|Growth Substances|growth substances|mesh-ancestor
56036815|NCT05308160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036816|NCT05308160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56036817|NCT05308160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036818|NCT03010358|Obinutuzumab|obinutuzumab|mesh-list
56036819|NCT03010358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56036820|NCT03010358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036821|NCT01127438|Fospropofol|fospropofol|mesh-list
56036822|NCT01127438|Propofol|propofol|mesh-list
56036823|NCT01127438|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56036824|NCT01127438|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56036825|NCT01127438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036826|NCT01127438|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56036827|NCT01127438|Anesthetics, General|anesthetics, general|mesh-ancestor
56036828|NCT01127438|Anesthetics|anesthetics|mesh-ancestor
56036829|NCT05307614|Moxifloxacin|moxifloxacin|mesh-list
56036830|NCT05307614|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56036831|NCT05307614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036832|NCT05307614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036833|NCT05307614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56036834|NCT05307614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56036835|NCT05307614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036836|NCT05307614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036837|NCT05307614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036838|NCT05307614|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56036839|NCT05307614|Contraceptive Agents|contraceptive agents|mesh-ancestor
56036840|NCT05307614|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56036841|NCT05307614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036862|NCT02481219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56036863|NCT02481219|Antiemetics|antiemetics|mesh-ancestor
56036864|NCT02481219|Autonomic Agents|autonomic agents|mesh-ancestor
56036865|NCT02481219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036866|NCT02481219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036867|NCT02481219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036868|NCT02481219|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56036869|NCT02481219|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56036870|NCT02481219|Dopamine Agents|dopamine agents|mesh-ancestor
56036871|NCT02481219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036872|NCT02481219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036873|NCT02481219|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036874|NCT02481219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036875|NCT02481219|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56036876|NCT02481219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036877|NCT02481219|Cathartics|cathartics|mesh-ancestor
55764083|NCT05691933|Morphine|morphine|mesh-list
56036878|NCT02481219|Laxatives|laxatives|mesh-ancestor
56036879|NCT02481297|Rituximab|rituximab|mesh-list
56036880|NCT02481297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56036881|NCT02481297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036882|NCT02481297|Immunologic Factors|immunologic factors|mesh-ancestor
56036883|NCT02481297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036884|NCT02481297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56036885|NCT02481375|Iron|iron|mesh-list
56036886|NCT02481375|Trace Elements|trace elements|mesh-list
56036887|NCT02481375|Micronutrients|micronutrients|mesh-list
56036888|NCT02481375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036889|NCT01164098|Rituximab|rituximab|mesh-list
56036890|NCT01164098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56036891|NCT01164098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036892|NCT01164098|Immunologic Factors|immunologic factors|mesh-ancestor
56036893|NCT01164098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036894|NCT01164098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56036903|NCT01165112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56036904|NCT01165112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56036905|NCT01165112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55831557|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56036906|NCT01165112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56036907|NCT01165112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036908|NCT01165112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036909|NCT01165112|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56036910|NCT01165112|Alkylating Agents|alkylating agents|mesh-ancestor
56036911|NCT01129778|Omeprazole|omeprazole|mesh-list
56036912|NCT01129778|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56036913|NCT01129778|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
56036914|NCT01129778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56036915|NCT01129778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036916|NCT01129778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036917|NCT01129778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036918|NCT02556333|Tenofovir|tenofovir|mesh-list
56036919|NCT02556333|Emtricitabine|emtricitabine|mesh-list
56036920|NCT02556333|Antiviral Agents|antiviral agents|mesh-ancestor
56036921|NCT02556333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036922|NCT02556333|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56036923|NCT02556333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56036924|NCT02556333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036925|NCT02556333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036926|NCT02556333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56036927|NCT02556333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55876959|NCT01290484|Urological Agents|urological agents|mesh-ancestor
55876960|NCT04396743|Clotrimazole|clotrimazole|mesh-list
55876961|NCT04396743|Miconazole|miconazole|mesh-list
55876962|NCT04396743|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55876963|NCT04396743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55876964|NCT04396743|Antifungal Agents|antifungal agents|mesh-ancestor
55876965|NCT04396743|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55876966|NCT04396743|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55876967|NCT04396743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876968|NCT04396743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876969|NCT04396743|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55876970|NCT04396743|Hormone Antagonists|hormone antagonists|mesh-ancestor
55876971|NCT04396743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876972|NCT04396743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876973|NCT04396743|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55876974|NCT04396743|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55876975|NCT01928043|Curcumin|curcumin|mesh-list
55876976|NCT01928043|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55876977|NCT01928043|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56036928|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56036930|NCT02411448|Osimertinib|osimertinib|mesh-list
56036931|NCT02411448|Ramucirumab|ramucirumab|mesh-list
56036932|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036933|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56036934|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036935|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036936|NCT01166126|Sirolimus|sirolimus|mesh-list
56036937|NCT01166126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036938|NCT01166126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036939|NCT01166126|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56036940|NCT01166126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036941|NCT01166126|Antifungal Agents|antifungal agents|mesh-ancestor
56036942|NCT01166126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56036943|NCT01166126|Immunologic Factors|immunologic factors|mesh-ancestor
56036944|NCT01166126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036945|NCT05306990|Atorvastatin|atorvastatin|mesh-list
56036946|NCT05306990|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56036947|NCT05306990|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56036948|NCT05306990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56036949|NCT05306990|Antimetabolites|antimetabolites|mesh-ancestor
56036950|NCT05306990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764157|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56036951|NCT05306990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56036952|NCT05306990|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56036953|NCT05306990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876978|NCT01928043|Analgesics|analgesics|mesh-ancestor
55876979|NCT01928043|Sensory System Agents|sensory system agents|mesh-ancestor
55876980|NCT01928043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876981|NCT01928043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876982|NCT01928043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876983|NCT01928043|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876984|NCT01928043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876985|NCT01928043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55876986|NCT01928043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876987|NCT01922193|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55876988|NCT01922193|Hormones|hormones|mesh-ancestor
55876989|NCT01922193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55876990|NCT01922193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876991|NCT02979886|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55876992|NCT02979886|Menotropins|menotropins|mesh-list
55876993|NCT02979886|Luteolytic Agents|luteolytic agents|mesh-ancestor
55876994|NCT02979886|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55876995|NCT02979886|Contraceptive Agents|contraceptive agents|mesh-ancestor
55876996|NCT02979886|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55876997|NCT02979886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036954|NCT02557035|Dexamethasone|dexamethasone|mesh-list
56036955|NCT02557035|Palonosetron|palonosetron|mesh-list
56036956|NCT02557035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56036957|NCT02557035|Antiemetics|antiemetics|mesh-ancestor
56036958|NCT02557035|Autonomic Agents|autonomic agents|mesh-ancestor
56036959|NCT02557035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56036960|NCT02557035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56036961|NCT02557035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56036962|NCT02557035|Glucocorticoids|glucocorticoids|mesh-ancestor
56036964|NCT02557035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56036965|NCT02557035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56036966|NCT02557035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56036967|NCT02557035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56036968|NCT02557035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56036969|NCT02557035|Serotonin Agents|serotonin agents|mesh-ancestor
56036970|NCT02557035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56036971|NCT02557035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036972|NCT04341207|Azithromycin|azithromycin|mesh-list
56036973|NCT04341207|Hydroxychloroquine|hydroxychloroquine|mesh-list
56036974|NCT04341207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56036975|NCT04341207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56036976|NCT04341207|Antimalarials|antimalarials|mesh-ancestor
56036977|NCT04341207|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56036978|NCT04341207|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56036979|NCT04341207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56036980|NCT04341207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56036981|NCT04341207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56036982|NCT02411292|Enoxaparin|enoxaparin|mesh-list
56036983|NCT02411292|Anticoagulants|anticoagulants|mesh-ancestor
56036984|NCT02411292|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56036985|NCT02411292|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56036996|NCT02486211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56036998|NCT02486211|Sensory System Agents|sensory system agents|mesh-ancestor
56036999|NCT02486211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037000|NCT01167452|Trimethoprim|trimethoprim|mesh-list
56037001|NCT01167452|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56037002|NCT01167452|Sulfamethoxazole|sulfamethoxazole|mesh-list
56037003|NCT01167452|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56037004|NCT01167452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037005|NCT01167452|Renal Agents|renal agents|mesh-ancestor
56037006|NCT01167452|Antimalarials|antimalarials|mesh-ancestor
56037007|NCT01167452|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56037008|NCT01167452|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56037009|NCT01167452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56037010|NCT01167452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037011|NCT01167452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037012|NCT01167452|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56037013|NCT01167452|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56037014|NCT01167452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56037015|NCT01167452|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56037016|NCT02487225|Pentoxifylline|pentoxifylline|mesh-list
56037017|NCT02487225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56037018|NCT02487225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037019|NCT02487225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037020|NCT02487225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56037021|NCT02487225|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56037022|NCT02487225|Protective Agents|protective agents|mesh-ancestor
56037023|NCT02487225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037024|NCT02487225|Vasodilator Agents|vasodilator agents|mesh-ancestor
56037025|NCT02487225|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56037026|NCT02487225|Antioxidants|antioxidants|mesh-ancestor
56037027|NCT02384850|Leucovorin|leucovorin|mesh-list
56037028|NCT02384850|Folic Acid|folic acid|mesh-list
56037036|NCT02384850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56037037|NCT02384850|Immunologic Factors|immunologic factors|mesh-ancestor
56037038|NCT02384850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037039|NCT02384850|Antidotes|antidotes|mesh-ancestor
56037040|NCT02384850|Protective Agents|protective agents|mesh-ancestor
56037041|NCT02384850|Vitamin B Complex|vitamin b complex|mesh-ancestor
56037042|NCT02384850|Vitamins|vitamins|mesh-ancestor
56037043|NCT02384850|Micronutrients|micronutrients|mesh-ancestor
56037044|NCT02384850|Hematinics|hematinics|mesh-ancestor
56037045|NCT02558829|Insulin|insulin|mesh-list
56037046|NCT02558829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56037047|NCT02558829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56037048|NCT02558829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037049|NCT02487303|Acetaminophen|acetaminophen|mesh-list
56037050|NCT02487303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56037051|NCT02487303|Analgesics|analgesics|mesh-ancestor
56037052|NCT02487303|Sensory System Agents|sensory system agents|mesh-ancestor
56037053|NCT02487303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037054|NCT02487303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037055|NCT02487303|Antipyretics|antipyretics|mesh-ancestor
56037056|NCT01168934|Crizotinib|crizotinib|mesh-list
56037057|NCT01168934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037058|NCT01168934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56037059|NCT01168934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037090|NCT01171118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037091|NCT01171118|Cholinergic Agents|cholinergic agents|mesh-ancestor
56037092|NCT01171118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037093|NCT01171118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037094|NCT01171118|Miotics|miotics|mesh-ancestor
56037095|NCT01171118|Autonomic Agents|autonomic agents|mesh-ancestor
56037096|NCT01171118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037097|NCT03011918|Vitamin D|vitamin d|mesh-list
56037098|NCT03011918|Vitamins|vitamins|mesh-ancestor
56037099|NCT03011918|Micronutrients|micronutrients|mesh-ancestor
56037100|NCT03011918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037101|NCT03011918|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56037102|NCT05296460|Dapsone|dapsone|mesh-list
56037103|NCT05296460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037104|NCT05296460|Antimalarials|antimalarials|mesh-ancestor
56037105|NCT05296460|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56037106|NCT05296460|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56037107|NCT05296460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56037108|NCT05296460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037109|NCT05296460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037110|NCT05296460|Leprostatic Agents|leprostatic agents|mesh-ancestor
56037111|NCT05296460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56037112|NCT01136798|Exenatide|exenatide|mesh-list
56037113|NCT01136798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56037114|NCT01136798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037115|NCT01136798|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56037116|NCT01136798|Incretins|incretins|mesh-ancestor
56037117|NCT01136798|Hormones|hormones|mesh-ancestor
56037118|NCT01136798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037119|NCT01172522|Fexofenadine|fexofenadine|mesh-list
56037136|NCT01172600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56037137|NCT01172600|Analgesics|analgesics|mesh-ancestor
56037138|NCT01172600|Sensory System Agents|sensory system agents|mesh-ancestor
56037139|NCT01172600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037140|NCT01172600|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56037141|NCT02246816|Opium|opium|mesh-list
56037142|NCT02246816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56037143|NCT02246816|Narcotics|narcotics|mesh-ancestor
56037144|NCT02246816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037145|NCT02246816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037146|NCT02246816|Analgesics|analgesics|mesh-ancestor
56037147|NCT02246816|Sensory System Agents|sensory system agents|mesh-ancestor
56037148|NCT02246816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037149|NCT02246816|Antidiarrheals|antidiarrheals|mesh-ancestor
56037150|NCT02246816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037151|NCT02246816|Antitussive Agents|antitussive agents|mesh-ancestor
56037152|NCT02246816|Respiratory System Agents|respiratory system agents|mesh-ancestor
56037153|NCT01137890|Zonisamide|zonisamide|mesh-list
56037154|NCT01137890|Cocaine|cocaine|mesh-list
56037155|NCT01137890|Anticonvulsants|anticonvulsants|mesh-ancestor
56037156|NCT01137890|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56037157|NCT01137890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56037158|NCT01137890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037159|NCT01137890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56037160|NCT01137890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037186|NCT05269628|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037188|NCT01138124|Analgesics|analgesics|mesh-ancestor
56037189|NCT01138124|Sensory System Agents|sensory system agents|mesh-ancestor
56037190|NCT01138124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037191|NCT01138124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037192|NCT01138124|Anticonvulsants|anticonvulsants|mesh-ancestor
56037193|NCT01138124|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56037194|NCT01138124|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56037195|NCT01138124|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037196|NCT01138124|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56037197|NCT01138124|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56037198|NCT01138124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56037199|NCT01138124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037200|NCT01138124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037201|NCT01138124|Antimanic Agents|antimanic agents|mesh-ancestor
56037202|NCT02560779|Sorafenib|sorafenib|mesh-list
56037203|NCT02560779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037204|NCT02560779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56037205|NCT02560779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037206|NCT02560779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037207|NCT01138514|Clindamycin|clindamycin|mesh-list
56037208|NCT01138514|Clindamycin palmitate|clindamycin palmitate|mesh-list
56037209|NCT01138514|Clindamycin phosphate|clindamycin phosphate|mesh-list
56037236|NCT05254418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037237|NCT01175798|Vitamin D|vitamin d|mesh-list
56037238|NCT01175798|Cholecalciferol|cholecalciferol|mesh-list
56037239|NCT01175798|Vitamins|vitamins|mesh-ancestor
56037240|NCT01175798|Micronutrients|micronutrients|mesh-ancestor
56037241|NCT01175798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887438|NCT00705432|Ribavirin|ribavirin|mesh-list
56037242|NCT01175798|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56037243|NCT01175798|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56037244|NCT02246894|Factor VIII|factor viii|mesh-list
56037245|NCT02246894|Coagulants|coagulants|mesh-ancestor
56037246|NCT05177510|Mifepristone|mifepristone|mesh-list
56037247|NCT05177510|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56037248|NCT05177510|Abortifacient Agents|abortifacient agents|mesh-ancestor
56037249|NCT05177510|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56037250|NCT05177510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037251|NCT05177510|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56037252|NCT05177510|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56037253|NCT05177510|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56037254|NCT05177510|Contraceptive Agents|contraceptive agents|mesh-ancestor
56037255|NCT05177510|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56037256|NCT05177510|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56037257|NCT05177510|Hormone Antagonists|hormone antagonists|mesh-ancestor
56037260|NCT05177510|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56037287|NCT01178528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037288|NCT01178528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56037289|NCT01178528|Antioxidants|antioxidants|mesh-ancestor
56037290|NCT01178528|Protective Agents|protective agents|mesh-ancestor
56037291|NCT01178528|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56037292|NCT01178528|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56037293|NCT01178528|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56037295|NCT01178528|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56037296|NCT01178528|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55827662|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56037297|NCT02980250|Domperidone|domperidone|mesh-list
56037298|NCT02980250|Antiemetics|antiemetics|mesh-ancestor
56037299|NCT02980250|Autonomic Agents|autonomic agents|mesh-ancestor
56037300|NCT02980250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739965|NCT03390595|Antiviral Agents|antiviral agents|mesh-ancestor
56037301|NCT02980250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037302|NCT02980250|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037303|NCT02980250|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56037304|NCT02980250|Dopamine Agents|dopamine agents|mesh-ancestor
56037342|NCT01181258|Rituximab|rituximab|mesh-list
56037343|NCT01181258|Fludarabine|fludarabine|mesh-list
56037344|NCT01181258|Interleukin-2|interleukin-2|mesh-list
56037345|NCT01181258|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56037346|NCT01181258|Immunologic Factors|immunologic factors|mesh-ancestor
56037347|NCT01181258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037348|NCT01181258|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56037349|NCT01181258|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56037350|NCT01181258|Alkylating Agents|alkylating agents|mesh-ancestor
56037351|NCT01181258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037352|NCT01181258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037353|NCT01181258|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56037354|NCT01181258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56037355|NCT01181258|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56037356|NCT01181258|Antiemetics|antiemetics|mesh-ancestor
56037357|NCT01181258|Autonomic Agents|autonomic agents|mesh-ancestor
56037358|NCT01181258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037359|NCT01181258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037360|NCT01181258|Glucocorticoids|glucocorticoids|mesh-ancestor
56037361|NCT01181258|Hormones|hormones|mesh-ancestor
56037362|NCT01181258|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037363|NCT01181258|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56037364|NCT01181258|Protective Agents|protective agents|mesh-ancestor
55831932|NCT02167451|Maraviroc|maraviroc|mesh-list
56037365|NCT01181258|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56037366|NCT01181258|Analgesics|analgesics|mesh-ancestor
56037367|NCT01181258|Sensory System Agents|sensory system agents|mesh-ancestor
56037368|NCT02570139|Protective Agents|protective agents|mesh-list
56037369|NCT02570139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037370|NCT02410200|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56037371|NCT02410200|Dermatologic Agents|dermatologic agents|mesh-ancestor
56037372|NCT02410200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56037373|NCT02410200|Immunologic Factors|immunologic factors|mesh-ancestor
56037375|NCT05042648|Buprenorphine|buprenorphine|mesh-list
56037387|NCT02494713|Ketoconazole|ketoconazole|mesh-list
56037388|NCT02494713|Docetaxel|docetaxel|mesh-list
56037389|NCT02494713|Doxorubicin|doxorubicin|mesh-list
56037390|NCT02494713|Estramustine|estramustine|mesh-list
56037391|NCT02494713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037392|NCT02494713|Tubulin Modulators|tubulin modulators|mesh-ancestor
56037393|NCT02494713|Antimitotic Agents|antimitotic agents|mesh-ancestor
56037394|NCT02494713|Mitosis Modulators|mitosis modulators|mesh-ancestor
56037395|NCT02494713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037396|NCT02494713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56037397|NCT02494713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56037398|NCT02494713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56037399|NCT02494713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037400|NCT02494713|Antifungal Agents|antifungal agents|mesh-ancestor
56037401|NCT02494713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037402|NCT02494713|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56037403|NCT02494713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56037404|NCT02494713|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55764609|NCT02434757|Hormones|hormones|mesh-ancestor
56037405|NCT02494713|Hormone Antagonists|hormone antagonists|mesh-ancestor
56037406|NCT02494713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037407|NCT02494713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037408|NCT02494713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56037409|NCT02494713|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56037410|NCT02494713|Alkylating Agents|alkylating agents|mesh-ancestor
56037411|NCT02494713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56037412|NCT02495103|Metformin|metformin|mesh-list
56037413|NCT02495103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56037414|NCT02495103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037415|NCT02382276|Nalmefene|nalmefene|mesh-list
56037416|NCT02382276|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56037427|NCT02571153|Anesthetics, General|anesthetics, general|mesh-ancestor
56037428|NCT02571153|Anesthetics|anesthetics|mesh-ancestor
56037429|NCT02571153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037430|NCT02571153|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56037431|NCT02571153|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56037432|NCT02571153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037433|NCT02571153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037434|NCT04573322|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
56037435|NCT04573322|Antioxidants|antioxidants|mesh-ancestor
56037436|NCT04573322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037437|NCT04573322|Protective Agents|protective agents|mesh-ancestor
56037438|NCT04573322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037439|NCT04573322|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56037440|NCT04573322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037441|NCT01143818|Methyltestosterone|methyltestosterone|mesh-list
56037442|NCT01143818|Testosterone|testosterone|mesh-list
56037443|NCT01143818|Testosterone undecanoate|testosterone undecanoate|mesh-list
56037444|NCT01143818|Testosterone enanthate|testosterone enanthate|mesh-list
56037445|NCT01143818|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56037446|NCT01143818|Androgens|androgens|mesh-ancestor
56037447|NCT01143818|Hormones|hormones|mesh-ancestor
56037448|NCT01143818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037449|NCT01143818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037450|NCT01143818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56037451|NCT01143818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037452|NCT01143818|Anabolic Agents|anabolic agents|mesh-ancestor
56037454|NCT02573181|Immunologic Factors|immunologic factors|mesh-ancestor
56037472|NCT01650558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037473|NCT01650558|Antimalarials|antimalarials|mesh-ancestor
56037474|NCT01650558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56037475|NCT01650558|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56037476|NCT01650558|Renal Agents|renal agents|mesh-ancestor
56037477|NCT01650558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56037479|NCT02579343|Citalopram|citalopram|mesh-list
56037480|NCT02579343|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56037481|NCT02579343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56037482|NCT02579343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56037483|NCT02579343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037484|NCT02579343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037485|NCT02579343|Serotonin Agents|serotonin agents|mesh-ancestor
56037486|NCT02579343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037487|NCT02579343|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56037488|NCT02579343|Antidepressive Agents|antidepressive agents|mesh-ancestor
56037489|NCT02579343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56037490|NCT02579343|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56037491|NCT02579343|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56037492|NCT02579343|Parasympatholytics|parasympatholytics|mesh-ancestor
56037493|NCT02579343|Autonomic Agents|autonomic agents|mesh-ancestor
56037494|NCT02579343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037495|NCT02579343|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56037496|NCT02579343|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56037497|NCT02579343|Cholinergic Agents|cholinergic agents|mesh-ancestor
56037498|NCT04436601|Lactulose|lactulose|mesh-list
56037499|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037500|NCT01144442|Paclitaxel|paclitaxel|mesh-list
56037501|NCT01144442|Carboplatin|carboplatin|mesh-list
56037502|NCT01144442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56037503|NCT01144442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037504|NCT01144442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56037505|NCT01144442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56037506|NCT01144442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56037508|NCT02499081|Ixazomib|ixazomib|mesh-list
56037514|NCT02380248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56037515|NCT02501265|Nicotine|nicotine|mesh-list
56037516|NCT02501265|Varenicline|varenicline|mesh-list
56037517|NCT02501265|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56037518|NCT02501265|Autonomic Agents|autonomic agents|mesh-ancestor
56037519|NCT02501265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037520|NCT02501265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037521|NCT02501265|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56037522|NCT02501265|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56037523|NCT02501265|Cholinergic Agents|cholinergic agents|mesh-ancestor
55887439|NCT00705432|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56037524|NCT02501265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037525|NCT02501265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037526|NCT02408016|Aldesleukin|aldesleukin|mesh-list
56037527|NCT02408016|Cyclophosphamide|cyclophosphamide|mesh-list
56037528|NCT02408016|Interleukin-2|interleukin-2|mesh-list
56037529|NCT02408016|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56037530|NCT02408016|Immunologic Factors|immunologic factors|mesh-ancestor
56037531|NCT02408016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037532|NCT02408016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56037533|NCT02408016|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56037534|NCT02408016|Alkylating Agents|alkylating agents|mesh-ancestor
56037535|NCT02408016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037536|NCT02408016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037537|NCT02408016|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56037538|NCT02408016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56037539|NCT02408016|Analgesics|analgesics|mesh-ancestor
56037540|NCT02408016|Sensory System Agents|sensory system agents|mesh-ancestor
56037541|NCT02408016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037542|NCT02408016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55876998|NCT02979886|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55876999|NCT02979886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55877000|NCT02979886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877001|NCT02979886|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55877002|NCT02979886|Fertility Agents|fertility agents|mesh-ancestor
55877003|NCT03052608|Crizotinib|crizotinib|mesh-list
55877004|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877005|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55877006|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877007|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877008|NCT01928511|Interferons|interferons|mesh-list
55877012|NCT01928511|Interferon alpha-2|interferon alpha-2|mesh-list
55877014|NCT01928511|Adefovir|adefovir|mesh-list
55877015|NCT01928511|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55877016|NCT01928511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877017|NCT01928511|Antiviral Agents|antiviral agents|mesh-ancestor
56037543|NCT02408016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56037544|NCT02408016|Antiviral Agents|antiviral agents|mesh-ancestor
56037545|NCT02408016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037546|NCT02579421|Progesterone|progesterone|mesh-list
56037547|NCT02579421|Progestins|progestins|mesh-ancestor
56037548|NCT02579421|Hormones|hormones|mesh-ancestor
56037549|NCT02579421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037550|NCT02579421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037551|NCT00422175|Siponimod|siponimod|mesh-list
56037552|NCT00422175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56037553|NCT00422175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037554|NCT00422175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56037555|NCT00422175|Immunologic Factors|immunologic factors|mesh-ancestor
56037556|NCT00422175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037557|NCT01186250|Pioglitazone|pioglitazone|mesh-list
56037558|NCT01186250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56037559|NCT01186250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037560|NCT01186406|Bevacizumab|bevacizumab|mesh-list
56037561|NCT01186406|Temozolomide|temozolomide|mesh-list
56037562|NCT01186406|Carmustine|carmustine|mesh-list
56037563|NCT01186406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56037564|NCT01186406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037565|NCT01186406|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56037566|NCT01186406|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56037567|NCT01186406|Growth Substances|growth substances|mesh-ancestor
56037568|NCT01186406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037569|NCT01186406|Growth Inhibitors|growth inhibitors|mesh-ancestor
56037570|NCT01186406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56037571|NCT01186406|Alkylating Agents|alkylating agents|mesh-ancestor
56037572|NCT01186406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037573|NCT02407704|Lorazepam|lorazepam|mesh-list
56037574|NCT02407704|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56037575|NCT02407704|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56037576|NCT02407704|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56037577|NCT02407704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56037578|NCT02407704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037579|NCT02407704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037580|NCT02407704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037581|NCT02407704|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56037582|NCT02407704|Antidepressive Agents|antidepressive agents|mesh-ancestor
56037583|NCT02407704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56037584|NCT02407704|Anticonvulsants|anticonvulsants|mesh-ancestor
56037585|NCT02407704|Antiemetics|antiemetics|mesh-ancestor
56037586|NCT02407704|Autonomic Agents|autonomic agents|mesh-ancestor
56037587|NCT02407704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037588|NCT02407704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037589|NCT02407704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56037590|NCT02407704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037591|NCT02407704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56037592|NCT02407704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56037593|NCT02407704|GABA Modulators|gaba modulators|mesh-ancestor
56037594|NCT02407704|GABA Agents|gaba agents|mesh-ancestor
56037595|NCT02581839|Dexamethasone|dexamethasone|mesh-list
56037597|NCT02581839|Ondansetron|ondansetron|mesh-list
56037598|NCT02581839|BB 1101|bb 1101|mesh-list
56037599|NCT02581839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56037600|NCT02581839|Antiemetics|antiemetics|mesh-ancestor
56037601|NCT02581839|Autonomic Agents|autonomic agents|mesh-ancestor
56037602|NCT02581839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037603|NCT02581839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037604|NCT02581839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037605|NCT02581839|Glucocorticoids|glucocorticoids|mesh-ancestor
56037626|NCT02504775|Sensory System Agents|sensory system agents|mesh-ancestor
56037627|NCT02504775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037628|NCT02504775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037629|NCT02504775|Antipyretics|antipyretics|mesh-ancestor
56037630|NCT02504931|Sertraline|sertraline|mesh-list
56037631|NCT02504931|Antidepressive Agents|antidepressive agents|mesh-ancestor
56037632|NCT02504931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56037633|NCT02504931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56037634|NCT02504931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56037635|NCT02504931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56037636|NCT02504931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037637|NCT02504931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037638|NCT02504931|Serotonin Agents|serotonin agents|mesh-ancestor
56037639|NCT02504931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037640|NCT02584725|Tranexamic Acid|tranexamic acid|mesh-list
56037641|NCT02584725|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56037642|NCT02584725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56037643|NCT02584725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037644|NCT02584725|Hemostatics|hemostatics|mesh-ancestor
56037645|NCT02584725|Coagulants|coagulants|mesh-ancestor
56037646|NCT04423029|Nivolumab|nivolumab|mesh-list
56037647|NCT04423029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56037648|NCT04423029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037649|NCT04423029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56037650|NCT04423029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037651|NCT01186562|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56037671|NCT01187498|Urological Agents|urological agents|mesh-ancestor
56037672|NCT01148420|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56037673|NCT01148420|Medroxyprogesterone|medroxyprogesterone|mesh-list
56037674|NCT01148420|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56037675|NCT01148420|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56037676|NCT01148420|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56037677|NCT01148420|Contraceptive Agents|contraceptive agents|mesh-ancestor
56037678|NCT01148420|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56037679|NCT01148420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037680|NCT01148420|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56037681|NCT01148420|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56037682|NCT01148420|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56037683|NCT01148420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56037684|NCT01148420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037686|NCT01149434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037687|NCT01149434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56037688|NCT01149434|Immunologic Factors|immunologic factors|mesh-ancestor
56037689|NCT01149434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037690|NCT01150760|Alvimopan|alvimopan|mesh-list
56037691|NCT01150760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037692|NCT01150838|Propofol|propofol|mesh-list
56037693|NCT01150838|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56037694|NCT01150838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037695|NCT01150838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037696|NCT01150838|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56037719|NCT01189760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037720|NCT01189760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037721|NCT01189760|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56037722|NCT01189760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56037723|NCT01189760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037724|NCT01189760|Cholinergic Agents|cholinergic agents|mesh-ancestor
56037725|NCT01189760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037726|NCT03010202|Dexamethasone|dexamethasone|mesh-list
56037727|NCT03010202|Rituximab|rituximab|mesh-list
56037728|NCT03010202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56037729|NCT03010202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037730|NCT03010202|Immunologic Factors|immunologic factors|mesh-ancestor
56037731|NCT03010202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037732|NCT03010202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56037733|NCT03010202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56037734|NCT03010202|Antiemetics|antiemetics|mesh-ancestor
56037735|NCT03010202|Autonomic Agents|autonomic agents|mesh-ancestor
56037736|NCT03010202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037737|NCT03010202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037738|NCT03010202|Glucocorticoids|glucocorticoids|mesh-ancestor
56037739|NCT03010202|Hormones|hormones|mesh-ancestor
56037740|NCT03010202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037741|NCT03010202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56037742|NCT01191320|Enclomiphene|enclomiphene|mesh-list
56037743|NCT01191320|Clomiphene|clomiphene|mesh-list
56037744|NCT01191320|Zuclomiphene|zuclomiphene|mesh-list
56037745|NCT01191320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56037746|NCT01191320|Hormone Antagonists|hormone antagonists|mesh-ancestor
56037747|NCT01191320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037748|NCT01191320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037749|NCT01191320|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56037750|NCT01191320|Fertility Agents|fertility agents|mesh-ancestor
56037751|NCT01191320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56037758|NCT01151852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037759|NCT01191398|Atropine|atropine|mesh-list
56037760|NCT01191398|Glycopyrrolate|glycopyrrolate|mesh-list
56037761|NCT01191398|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56037762|NCT01191398|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56037763|NCT01191398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56037764|NCT01191398|Autonomic Agents|autonomic agents|mesh-ancestor
56037765|NCT01191398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037766|NCT01191398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037767|NCT01191398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56037768|NCT01191398|Respiratory System Agents|respiratory system agents|mesh-ancestor
56037769|NCT01191398|Mydriatics|mydriatics|mesh-ancestor
56037770|NCT01191398|Parasympatholytics|parasympatholytics|mesh-ancestor
56037771|NCT01191398|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56037772|NCT01191398|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56037773|NCT01191398|Cholinergic Agents|cholinergic agents|mesh-ancestor
56037774|NCT01191398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037775|NCT01191398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037776|NCT01191476|Propofol|propofol|mesh-list
56037777|NCT01191476|Sevoflurane|sevoflurane|mesh-list
56037778|NCT01191476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55832303|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
56037779|NCT01191476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037780|NCT01191476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037781|NCT01191476|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56037782|NCT01191476|Anesthetics, General|anesthetics, general|mesh-ancestor
56037784|NCT01191476|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56037785|NCT01191476|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56037786|NCT02508207|Ivacaftor|ivacaftor|mesh-list
56037787|NCT02508207|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56037788|NCT02508207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56037789|NCT02508207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037790|NCT02509065|Pancrelipase|pancrelipase|mesh-list
56037791|NCT02509065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037800|NCT02509767|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56037801|NCT02509767|Contraceptive Agents|contraceptive agents|mesh-ancestor
56037802|NCT02509767|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56037803|NCT02509767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037804|NCT02509767|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56037805|NCT02509767|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56037806|NCT02509767|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56037807|NCT02509767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56037808|NCT02509767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037809|NCT01154192|Dexamethasone|dexamethasone|mesh-list
56037810|NCT01154192|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56037811|NCT01154192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56037812|NCT01154192|Antiemetics|antiemetics|mesh-ancestor
56037813|NCT01154192|Autonomic Agents|autonomic agents|mesh-ancestor
56037814|NCT01154192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037815|NCT01154192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037816|NCT01154192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037817|NCT01154192|Glucocorticoids|glucocorticoids|mesh-ancestor
56037819|NCT01154192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037820|NCT01154192|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56037821|NCT01154192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037822|NCT01154192|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56037823|NCT02511561|Ciprofloxacin|ciprofloxacin|mesh-list
56037824|NCT02511561|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56037825|NCT02511561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037826|NCT02511561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56037827|NCT02511561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56037828|NCT02511561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037843|NCT03809780|Lenalidomide|lenalidomide|mesh-list
56037844|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56037845|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
56037846|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
56037847|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037848|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037849|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037850|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
56037851|NCT03809780|Hormones|hormones|mesh-ancestor
55765052|NCT02432651|Xanthohumol|xanthohumol|mesh-list
56037852|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037853|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56037854|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037855|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
56037856|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56037857|NCT03809780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56037858|NCT03809780|Growth Substances|growth substances|mesh-ancestor
56037859|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
56037861|NCT03713528|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56037862|NCT03713528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037863|NCT02512575|Prednisolone|prednisolone|mesh-list
56037864|NCT02512575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56037865|NCT02512575|Glucocorticoids|glucocorticoids|mesh-ancestor
56037866|NCT02512575|Hormones|hormones|mesh-ancestor
56037867|NCT02512575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037868|NCT02512575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037869|NCT02512575|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56037870|NCT02512575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037871|NCT01199744|Zanamivir|zanamivir|mesh-list
56037872|NCT01199744|Antiviral Agents|antiviral agents|mesh-ancestor
56037873|NCT01199744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037874|NCT01199744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56037875|NCT01199744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037876|NCT03702374|Antioxidants|antioxidants|mesh-list
56037878|NCT03702374|Protective Agents|protective agents|mesh-ancestor
56037882|NCT02512809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56037883|NCT02512809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037884|NCT02512809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037885|NCT02512809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56037886|NCT02512809|Analgesics|analgesics|mesh-ancestor
56037887|NCT02512809|Sensory System Agents|sensory system agents|mesh-ancestor
56037888|NCT02512809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037889|NCT02512809|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56037890|NCT02512809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56037891|NCT02512809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56037892|NCT02512809|Adrenergic Agents|adrenergic agents|mesh-ancestor
56037893|NCT02512809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56037894|NCT02512809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037895|NCT02512809|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56037896|NCT02512809|Anesthetics, General|anesthetics, general|mesh-ancestor
56037897|NCT02512809|Anesthetics|anesthetics|mesh-ancestor
56037898|NCT01201772|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56037899|NCT01201772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56037900|NCT01202162|Sevoflurane|sevoflurane|mesh-list
56037901|NCT01202162|Desflurane|desflurane|mesh-list
56037902|NCT01202162|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56037935|NCT01159262|Narcotics|narcotics|mesh-ancestor
56037936|NCT01159262|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56037937|NCT01159262|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56037938|NCT01159262|Anesthetics, General|anesthetics, general|mesh-ancestor
56037939|NCT01159262|Anesthetics|anesthetics|mesh-ancestor
56037940|NCT01159262|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56037941|NCT01159262|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56037942|NCT01159262|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56037943|NCT01159262|GABA Modulators|gaba modulators|mesh-ancestor
56037944|NCT01159262|GABA Agents|gaba agents|mesh-ancestor
56037945|NCT04378959|Lidocaine|lidocaine|mesh-list
56037946|NCT04378959|Anesthetics, Local|anesthetics, local|mesh-ancestor
56037947|NCT04378959|Anesthetics|anesthetics|mesh-ancestor
56037948|NCT04378959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56037949|NCT04378959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037950|NCT04378959|Sensory System Agents|sensory system agents|mesh-ancestor
56037951|NCT04378959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037952|NCT04378959|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56037953|NCT04378959|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56037954|NCT04378959|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56037955|NCT04378959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56037956|NCT04378959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037957|NCT03011060|Capecitabine|capecitabine|mesh-list
56037958|NCT03011060|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56037959|NCT03011060|Antimetabolites|antimetabolites|mesh-ancestor
56037960|NCT03011060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037961|NCT03011060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037962|NCT03010670|Oxytocin|oxytocin|mesh-list
56037963|NCT03010670|Oxytocics|oxytocics|mesh-ancestor
55739972|NCT00271817|Niacin|niacin|mesh-list
56037964|NCT03010670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56037965|NCT03010670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037966|NCT04377711|Ciclesonide|ciclesonide|mesh-list
56037967|NCT04377711|Glucocorticoids|glucocorticoids|mesh-ancestor
56037968|NCT04377711|Hormones|hormones|mesh-ancestor
55877018|NCT01928511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877020|NCT01928511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55877021|NCT01928511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877022|NCT01928511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877023|NCT01928511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56037969|NCT04377711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56037970|NCT04377711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56037971|NCT04377711|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56037972|NCT04366713|Capecitabine|capecitabine|mesh-list
56037973|NCT04366713|Loperamide|loperamide|mesh-list
56037974|NCT04366713|Antidiarrheals|antidiarrheals|mesh-list
56037975|NCT04366713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56037976|NCT04366713|Antimetabolites|antimetabolites|mesh-ancestor
56037977|NCT04366713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037978|NCT04366713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037979|NCT04366713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56037980|NCT03413384|Ceftriaxone|ceftriaxone|mesh-list
56037981|NCT03413384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56037982|NCT03413384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56037983|NCT02976441|Temozolomide|temozolomide|mesh-list
56037984|NCT02976441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56037985|NCT02976441|Alkylating Agents|alkylating agents|mesh-ancestor
56037986|NCT02976441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56037987|NCT02976441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56037988|NCT00363753|Aspirin|aspirin|mesh-list
56037989|NCT00363753|Clopidogrel|clopidogrel|mesh-list
56037990|NCT00363753|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56037991|NCT00363753|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56037992|NCT00363753|Analgesics|analgesics|mesh-ancestor
56037993|NCT00363753|Sensory System Agents|sensory system agents|mesh-ancestor
56037994|NCT00363753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56037996|NCT00363753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038016|NCT01203644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56038017|NCT01203644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038018|NCT01203644|Sensory System Agents|sensory system agents|mesh-ancestor
56038019|NCT01203644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038020|NCT00363831|Oxaliplatin|oxaliplatin|mesh-list
56038021|NCT00363831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038022|NCT02433834|Glycopyrrolate|glycopyrrolate|mesh-list
56038023|NCT02433834|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56038024|NCT02433834|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56038025|NCT02433834|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56038026|NCT02433834|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56038027|NCT02433834|Cholinergic Agents|cholinergic agents|mesh-ancestor
56038028|NCT02433834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038029|NCT02433834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038030|NCT02433834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038031|NCT02433834|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56038032|NCT02433834|Autonomic Agents|autonomic agents|mesh-ancestor
56038033|NCT02433834|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038034|NCT02433834|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56038035|NCT02433834|Respiratory System Agents|respiratory system agents|mesh-ancestor
56038036|NCT02433834|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56038037|NCT02433834|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56038038|NCT02433834|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56038039|NCT02433834|Adrenergic Agents|adrenergic agents|mesh-ancestor
56038040|NCT02433678|Dapagliflozin|dapagliflozin|mesh-list
56038041|NCT02433678|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56038042|NCT02433678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038043|NCT02433678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56038044|NCT02433678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038046|NCT00363909|Citalopram|citalopram|mesh-list
56038047|NCT00363909|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56038048|NCT00363909|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56038054|NCT00363909|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56038055|NCT00363909|Antidepressive Agents|antidepressive agents|mesh-ancestor
56038056|NCT00363909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56038057|NCT00363909|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56038058|NCT00363909|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56038059|NCT00363909|Parasympatholytics|parasympatholytics|mesh-ancestor
56038060|NCT00363909|Autonomic Agents|autonomic agents|mesh-ancestor
56038061|NCT00363909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038062|NCT00363909|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56038063|NCT00363909|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56038064|NCT00363909|Cholinergic Agents|cholinergic agents|mesh-ancestor
56038065|NCT01205828|Temozolomide|temozolomide|mesh-list
56038066|NCT01205828|Veliparib|veliparib|mesh-list
56038067|NCT01205828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56038068|NCT01205828|Alkylating Agents|alkylating agents|mesh-ancestor
56038069|NCT01205828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038070|NCT01205828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038071|NCT01205828|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56038072|NCT01205828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832726|NCT04754399|Cannabidiol|cannabidiol|mesh-list
56038073|NCT02515305|Clindamycin|clindamycin|mesh-list
56038074|NCT02515305|Clindamycin palmitate|clindamycin palmitate|mesh-list
56038075|NCT02515305|Clindamycin phosphate|clindamycin phosphate|mesh-list
56038076|NCT02515305|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56038077|NCT02515305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56038078|NCT02515305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038079|NCT02515305|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56038080|NCT02515305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038081|NCT02515305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038082|NCT02515305|Dermatologic Agents|dermatologic agents|mesh-ancestor
56038083|NCT01206452|Prednisone|prednisone|mesh-list
56038098|NCT03010436|Benralizumab|benralizumab|mesh-list
56038099|NCT03010436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56038100|NCT03010436|Respiratory System Agents|respiratory system agents|mesh-ancestor
56038101|NCT02432040|Atorvastatin|atorvastatin|mesh-list
56038102|NCT02432040|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56038103|NCT02432040|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56038104|NCT02432040|Antimetabolites|antimetabolites|mesh-ancestor
56038105|NCT02432040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038106|NCT02432040|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56038107|NCT02432040|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56038108|NCT02432040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038109|NCT02517021|Dexamethasone|dexamethasone|mesh-list
56038110|NCT02517021|Palonosetron|palonosetron|mesh-list
56038112|NCT02517021|Antiemetics|antiemetics|mesh-ancestor
56038113|NCT02517021|Autonomic Agents|autonomic agents|mesh-ancestor
56038114|NCT02517021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038115|NCT02517021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038116|NCT02517021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56038117|NCT02517021|Glucocorticoids|glucocorticoids|mesh-ancestor
56038118|NCT02517021|Hormones|hormones|mesh-ancestor
56038119|NCT02517021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56038120|NCT02517021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56038121|NCT02517021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038122|NCT02517021|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56038123|NCT02517021|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56038124|NCT02517021|Serotonin Agents|serotonin agents|mesh-ancestor
56038128|NCT02431806|Fluoxetine|fluoxetine|mesh-list
56038145|NCT02431806|Analgesics|analgesics|mesh-ancestor
56038146|NCT02431806|Sensory System Agents|sensory system agents|mesh-ancestor
56038147|NCT02431806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765356|NCT03185351|GABA Modulators|gaba modulators|mesh-ancestor
56038148|NCT05159193|Cyclophosphamide|cyclophosphamide|mesh-list
56038150|NCT05159193|Docetaxel|docetaxel|mesh-list
56038151|NCT05159193|Doxorubicin|doxorubicin|mesh-list
56038152|NCT05159193|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56038153|NCT05159193|Trastuzumab|trastuzumab|mesh-list
56038154|NCT05159193|Pertuzumab|pertuzumab|mesh-list
56038155|NCT05159193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56038156|NCT05159193|Immunologic Factors|immunologic factors|mesh-ancestor
56038157|NCT05159193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038158|NCT05159193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038159|NCT05159193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56038160|NCT05159193|Alkylating Agents|alkylating agents|mesh-ancestor
56038161|NCT05159193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038162|NCT05159193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038163|NCT05159193|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56038164|NCT05159193|Tubulin Modulators|tubulin modulators|mesh-ancestor
56038165|NCT05159193|Antimitotic Agents|antimitotic agents|mesh-ancestor
56038166|NCT05159193|Mitosis Modulators|mitosis modulators|mesh-ancestor
56038167|NCT05159193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56038168|NCT05159193|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56038169|NCT05159193|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56038170|NCT05159193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038171|NCT05159193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038172|NCT04314375|Budesonide|budesonide|mesh-list
56038174|NCT04314375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56038176|NCT04314375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038181|NCT04314375|Hormones|hormones|mesh-ancestor
56038189|NCT05220813|Sensory System Agents|sensory system agents|mesh-ancestor
56038190|NCT05220813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038191|NCT05220813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56038192|NCT05220813|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56038193|NCT05220813|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56038194|NCT05220813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56038195|NCT05220813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038196|NCT01650246|Lesinurad|lesinurad|mesh-list
56038197|NCT01650246|Gout Suppressants|gout suppressants|mesh-ancestor
56038198|NCT01650246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038199|NCT01650246|Uricosuric Agents|uricosuric agents|mesh-ancestor
56038200|NCT01650246|Renal Agents|renal agents|mesh-ancestor
56038201|NCT04313985|Immunologic Factors|immunologic factors|mesh-list
56038202|NCT04313985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038203|NCT01212302|Clopidogrel|clopidogrel|mesh-list
56038204|NCT01212302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038205|NCT01212302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038206|NCT01212302|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56038207|NCT01212302|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56038208|NCT01212302|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56038209|NCT01212302|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56038210|NCT01212302|Purinergic Agents|purinergic agents|mesh-ancestor
56038211|NCT01212302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038212|NCT01284296|Chrysarobin|chrysarobin|mesh-list
56038213|NCT01284296|Lidocaine|lidocaine|mesh-list
56038214|NCT01284296|Anesthetics, Local|anesthetics, local|mesh-ancestor
56038215|NCT01284296|Anesthetics|anesthetics|mesh-ancestor
56038216|NCT01284296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56038217|NCT01284296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038218|NCT01284296|Sensory System Agents|sensory system agents|mesh-ancestor
56038219|NCT01284296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038220|NCT01284296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55832833|NCT04418089|Simvastatin|simvastatin|mesh-list
56038221|NCT01284296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56038225|NCT01284296|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56038226|NCT01284296|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56038227|NCT01284296|Analgesics|analgesics|mesh-ancestor
56038228|NCT01284296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038229|NCT01284296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038230|NCT00364143|Irinotecan|irinotecan|mesh-list
56038231|NCT00364143|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56038232|NCT00364143|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56038233|NCT00364143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038234|NCT00364143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038235|NCT00364143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038236|NCT01652664|Timolol|timolol|mesh-list
56038237|NCT01652664|Travoprost|travoprost|mesh-list
56038238|NCT01652664|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56038239|NCT01652664|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56038240|NCT01652664|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56038241|NCT01652664|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56038242|NCT01652664|Adrenergic Agents|adrenergic agents|mesh-ancestor
56038243|NCT01652664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038245|NCT01652664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038246|NCT01652664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55877024|NCT01928511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55877025|NCT01928511|Immunologic Factors|immunologic factors|mesh-ancestor
55877026|NCT01928511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877027|NCT05241249|Gemcitabine|gemcitabine|mesh-list
55877028|NCT05241249|Paclitaxel|paclitaxel|mesh-list
55877029|NCT05241249|Bethanechol|bethanechol|mesh-list
55877030|NCT05241249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55877031|NCT05241249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877032|NCT05241249|Tubulin Modulators|tubulin modulators|mesh-ancestor
55877033|NCT05241249|Antimitotic Agents|antimitotic agents|mesh-ancestor
55877034|NCT05241249|Mitosis Modulators|mitosis modulators|mesh-ancestor
55877035|NCT05241249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877036|NCT05241249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55877037|NCT05241249|Antimetabolites|antimetabolites|mesh-ancestor
55877038|NCT05241249|Antiviral Agents|antiviral agents|mesh-ancestor
55877039|NCT05241249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877040|NCT05241249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877041|NCT05241249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55877042|NCT05241249|Immunologic Factors|immunologic factors|mesh-ancestor
55877043|NCT05241249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877044|NCT05241249|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55877045|NCT05241249|Autonomic Agents|autonomic agents|mesh-ancestor
55877046|NCT05241249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877047|NCT05241249|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55877048|NCT05241249|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55877049|NCT05241249|Cholinergic Agents|cholinergic agents|mesh-ancestor
55877050|NCT05241249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877051|NCT01928823|Cycloserine|cycloserine|mesh-list
55877052|NCT01928823|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55877053|NCT01928823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038247|NCT01652664|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56038248|NCT04055649|Paclitaxel|paclitaxel|mesh-list
56038249|NCT04055649|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56038250|NCT04055649|TIC10 compound|tic10 compound|mesh-list
56038251|NCT04055649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56038252|NCT04055649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038253|NCT04055649|Tubulin Modulators|tubulin modulators|mesh-ancestor
56038254|NCT04055649|Antimitotic Agents|antimitotic agents|mesh-ancestor
56038255|NCT04055649|Mitosis Modulators|mitosis modulators|mesh-ancestor
56038256|NCT04055649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038257|NCT04899492|Nicotine|nicotine|mesh-list
56038258|NCT04899492|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56038259|NCT04899492|Autonomic Agents|autonomic agents|mesh-ancestor
56038260|NCT04899492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038261|NCT04899492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038262|NCT04899492|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56038263|NCT04899492|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56038264|NCT04899492|Cholinergic Agents|cholinergic agents|mesh-ancestor
56038265|NCT04899492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038266|NCT04899492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038267|NCT00364221|Rosiglitazone|rosiglitazone|mesh-list
56038268|NCT00364221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56038269|NCT00364221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038275|NCT01286402|Bupropion|bupropion|mesh-list
56038276|NCT01286402|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56038277|NCT01286402|Antidepressive Agents|antidepressive agents|mesh-ancestor
56038278|NCT01286402|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55877054|NCT01928823|Renal Agents|renal agents|mesh-ancestor
55877055|NCT01928823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55877056|NCT01928823|Antitubercular Agents|antitubercular agents|mesh-ancestor
55877057|NCT01928823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55877058|NCT01928823|Antimetabolites|antimetabolites|mesh-ancestor
55877059|NCT01928823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877060|NCT01290874|Formoterol Fumarate|formoterol fumarate|mesh-list
55877062|NCT01290874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55877063|NCT01290874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55877064|NCT01290874|Autonomic Agents|autonomic agents|mesh-ancestor
55750138|NCT03236233|PC-786|pc-786|mesh-list
55877065|NCT01290874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877066|NCT01290874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038279|NCT01286402|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56038280|NCT01286402|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56038281|NCT01286402|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56038282|NCT01286402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038283|NCT01286402|Dopamine Agents|dopamine agents|mesh-ancestor
56038284|NCT01286402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038285|NCT01286402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038286|NCT01286402|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56038287|NCT01286402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56038288|NCT01286402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038289|NCT01222832|Bacitracin|bacitracin|mesh-list
56038290|NCT01222832|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56038291|NCT01222832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038292|NCT01222832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56038293|NCT04298229|Dapagliflozin|dapagliflozin|mesh-list
56038294|NCT04298229|Diuretics|diuretics|mesh-list
55877067|NCT01290874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55877068|NCT01290874|Respiratory System Agents|respiratory system agents|mesh-ancestor
55877069|NCT01290874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55877070|NCT01290874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55877071|NCT01290874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55877072|NCT01290874|Adrenergic Agents|adrenergic agents|mesh-ancestor
55877073|NCT01290874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877074|NCT01290874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877075|NCT01290874|Parasympatholytics|parasympatholytics|mesh-ancestor
55877076|NCT01290874|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55877077|NCT01290874|Cholinergic Agents|cholinergic agents|mesh-ancestor
55877078|NCT02977494|Dexamethasone|dexamethasone|mesh-list
55877079|NCT02977494|Dexamethasone acetate|dexamethasone acetate|mesh-list
55877081|NCT02977494|Daratumumab|daratumumab|mesh-list
55877082|NCT02977494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877083|NCT02977494|Antiemetics|antiemetics|mesh-ancestor
55877085|NCT02977494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877086|NCT02977494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877087|NCT02977494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55877089|NCT02977494|Hormones|hormones|mesh-ancestor
55877090|NCT02977494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877091|NCT02977494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55877092|NCT02977494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877093|NCT01929603|Rifampin|rifampin|mesh-list
55877094|NCT01929603|Olaparib|olaparib|mesh-list
55877095|NCT01929603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55877096|NCT01929603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877097|NCT01929603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877098|NCT01929603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877099|NCT01929603|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55877100|NCT01929603|Antitubercular Agents|antitubercular agents|mesh-ancestor
55877101|NCT01929603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55877103|NCT01929603|Leprostatic Agents|leprostatic agents|mesh-ancestor
55877104|NCT01929603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55877105|NCT01929603|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55877106|NCT01929603|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55877107|NCT01929603|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55887440|NCT00705432|Antimetabolites|antimetabolites|mesh-ancestor
55877108|NCT01929603|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55877109|NCT01929603|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55765498|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56038295|NCT04298229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56038296|NCT04298229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038297|NCT04298229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56038298|NCT04298229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038299|NCT04298229|Natriuretic Agents|natriuretic agents|mesh-ancestor
56038300|NCT04297605|Paclitaxel|paclitaxel|mesh-list
56038301|NCT04297605|Pembrolizumab|pembrolizumab|mesh-list
56038302|NCT04297605|Pemetrexed|pemetrexed|mesh-list
56038303|NCT04297605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56038304|NCT04297605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038305|NCT04297605|Tubulin Modulators|tubulin modulators|mesh-ancestor
56038306|NCT04297605|Antimitotic Agents|antimitotic agents|mesh-ancestor
56038307|NCT04297605|Mitosis Modulators|mitosis modulators|mesh-ancestor
56038308|NCT04297605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038309|NCT04297605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038310|NCT04297605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038311|NCT04297605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56038312|NCT04297605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56038313|NCT02379390|Prednisone|prednisone|mesh-list
56038314|NCT02379390|Abiraterone Acetate|abiraterone acetate|mesh-list
56038315|NCT02379390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038316|NCT02379390|Glucocorticoids|glucocorticoids|mesh-ancestor
56038317|NCT02379390|Hormones|hormones|mesh-ancestor
56038318|NCT02379390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56038319|NCT02379390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038320|NCT02379390|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56038341|NCT03904251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56038342|NCT03904251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56038343|NCT03904251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038344|NCT03904251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038345|NCT04932915|Niclosamide|niclosamide|mesh-list
56038346|NCT04932915|Anticestodal Agents|anticestodal agents|mesh-ancestor
56038347|NCT04932915|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56038348|NCT04932915|Anthelmintics|anthelmintics|mesh-ancestor
56038349|NCT04932915|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56038350|NCT04932915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038351|NCT04932915|Antinematodal Agents|antinematodal agents|mesh-ancestor
56038352|NCT01223378|Latanoprost|latanoprost|mesh-list
56038353|NCT01223378|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56038354|NCT01223378|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56038355|NCT03780075|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
56038356|NCT03780075|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56038357|NCT03780075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038358|NCT01224626|Linezolid|linezolid|mesh-list
55833047|NCT04700839|Metformin|metformin|mesh-list
56038359|NCT01224626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56038360|NCT01224626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038361|NCT01224626|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56038362|NCT01224626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877110|NCT01929603|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55877111|NCT05241093|Cytarabine|cytarabine|mesh-list
55877112|NCT05241093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55877113|NCT05241093|Antimetabolites|antimetabolites|mesh-ancestor
55877114|NCT05241093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877115|NCT05241093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877118|NCT05241093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55877119|NCT05241093|Immunologic Factors|immunologic factors|mesh-ancestor
55877120|NCT05241093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877121|NCT04178460|Niraparib|niraparib|mesh-list
55877122|NCT04178460|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55877123|NCT04178460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877124|NCT04178460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877125|NCT04178460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877126|NCT01928901|Thymol|thymol|mesh-list
55877127|NCT01928901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877128|NCT01928901|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55877129|NCT01928901|Antifungal Agents|antifungal agents|mesh-ancestor
55877130|NCT04395183|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
55877131|NCT04395183|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55877132|NCT04395183|Antidepressive Agents|antidepressive agents|mesh-ancestor
55877133|NCT04395183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55877134|NCT04395105|Dexamethasone|dexamethasone|mesh-list
55877135|NCT04395105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877136|NCT04395105|Antiemetics|antiemetics|mesh-ancestor
55750143|NCT02513693|Rocuronium|rocuronium|mesh-list
56038363|NCT01224626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038364|NCT03708627|Bimatoprost|bimatoprost|mesh-list
56038365|NCT03708627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56038366|NCT01289522|Cetuximab|cetuximab|mesh-list
56038367|NCT01289522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038368|NCT01289522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038369|NCT01226420|Alefacept|alefacept|mesh-list
56038370|NCT01226420|Dermatologic Agents|dermatologic agents|mesh-ancestor
56038371|NCT01226420|Immunologic Factors|immunologic factors|mesh-ancestor
56038372|NCT01226420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038373|NCT04277637|Obinutuzumab|obinutuzumab|mesh-list
56038374|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
56038375|NCT04277637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55887913|NCT03303378|Melatonin|melatonin|mesh-list
56038377|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56038378|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038379|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038380|NCT04743453|Dapagliflozin|dapagliflozin|mesh-list
56038381|NCT04743453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56038382|NCT04743453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038383|NCT04743453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55877137|NCT04395105|Autonomic Agents|autonomic agents|mesh-ancestor
55877138|NCT04395105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877139|NCT04395105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877140|NCT04395105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55877141|NCT04395105|Glucocorticoids|glucocorticoids|mesh-ancestor
55877142|NCT04395105|Hormones|hormones|mesh-ancestor
55877143|NCT04395105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877144|NCT04395105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55877145|NCT04395105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877146|NCT04072770|Caseins|caseins|mesh-list
55877147|NCT04072770|Chelating Agents|chelating agents|mesh-ancestor
55877148|NCT04072770|Sequestering Agents|sequestering agents|mesh-ancestor
55877149|NCT04072770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877150|NCT01291108|Bimatoprost|bimatoprost|mesh-list
55877151|NCT01291108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55877152|NCT01929213|Bosentan|bosentan|mesh-list
55877153|NCT01929213|Udenafil|udenafil|mesh-list
55877154|NCT01929213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55877155|NCT01929213|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55877158|NCT01929213|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55877159|NCT01929213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877161|NCT05607615|Sequestering Agents|sequestering agents|mesh-ancestor
55877162|NCT05607615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877163|NCT03712098|Liraglutide|liraglutide|mesh-list
55877164|NCT03712098|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55877165|NCT03712098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877166|NCT03712098|Incretins|incretins|mesh-ancestor
55877167|NCT03712098|Hormones|hormones|mesh-ancestor
55877168|NCT03712098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877169|NCT03430518|Durvalumab|durvalumab|mesh-list
55877170|NCT03430518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55877171|NCT03430518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877172|NCT05240157|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55877173|NCT05240157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038384|NCT04743453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038385|NCT04274517|Chlorhexidine|chlorhexidine|mesh-list
56038386|NCT04274517|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56038387|NCT04274517|Povidone-Iodine|povidone-iodine|mesh-list
56038388|NCT04274517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56038389|NCT04274517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038390|NCT04274517|Disinfectants|disinfectants|mesh-ancestor
56038391|NCT04274517|Dermatologic Agents|dermatologic agents|mesh-ancestor
56038392|NCT00365001|Methotrexate|methotrexate|mesh-list
56038393|NCT00365001|Simvastatin|simvastatin|mesh-list
55833141|NCT02152163|Ibuprofen|ibuprofen|mesh-list
56038394|NCT00365001|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56038395|NCT00365001|Abortifacient Agents|abortifacient agents|mesh-ancestor
56038396|NCT00365001|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56038397|NCT00365001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038398|NCT00365001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56038399|NCT00365001|Antimetabolites|antimetabolites|mesh-ancestor
56038400|NCT00365001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038401|NCT00365001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038402|NCT00365001|Dermatologic Agents|dermatologic agents|mesh-ancestor
56038403|NCT00365001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038404|NCT00365001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56038405|NCT00365001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56038406|NCT00365001|Immunologic Factors|immunologic factors|mesh-ancestor
56038407|NCT00365001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038408|NCT00365001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56038409|NCT00365001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56038410|NCT00365001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56038411|NCT00365001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56038412|NCT00365001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56038413|NCT01289912|Everolimus|everolimus|mesh-list
56038414|NCT01289912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038415|NCT01289912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56038416|NCT01289912|Immunologic Factors|immunologic factors|mesh-ancestor
56038417|NCT01289912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038425|NCT04246047|Antiemetics|antiemetics|mesh-ancestor
56038426|NCT04246047|Autonomic Agents|autonomic agents|mesh-ancestor
56038427|NCT04246047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038428|NCT04246047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038429|NCT04246047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56038430|NCT04246047|Glucocorticoids|glucocorticoids|mesh-ancestor
56038431|NCT04246047|Hormones|hormones|mesh-ancestor
56038432|NCT04246047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56038433|NCT04246047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56038434|NCT04246047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038436|NCT04250805|Ropivacaine|ropivacaine|mesh-list
56038437|NCT04250805|Anesthetics, Local|anesthetics, local|mesh-ancestor
56038438|NCT04250805|Anesthetics|anesthetics|mesh-ancestor
56038439|NCT04250805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56038440|NCT04250805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877174|NCT01925937|Ubiquinone|ubiquinone|mesh-list
55877175|NCT01925937|Coenzyme Q10|coenzyme q10|mesh-list
55877176|NCT01925937|Atorvastatin|atorvastatin|mesh-list
55877177|NCT01925937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55877178|NCT01925937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55877179|NCT01925937|Antimetabolites|antimetabolites|mesh-ancestor
55877180|NCT01925937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877181|NCT01925937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55877182|NCT01925937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55877183|NCT01925937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877184|NCT01925937|Micronutrients|micronutrients|mesh-ancestor
55877185|NCT01925937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877186|NCT01925937|Vitamins|vitamins|mesh-ancestor
55877187|NCT03430362|Scopolamine|scopolamine|mesh-list
55877188|NCT03430362|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55877189|NCT03430362|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55877190|NCT03430362|Antiemetics|antiemetics|mesh-ancestor
55877191|NCT03430362|Autonomic Agents|autonomic agents|mesh-ancestor
55877192|NCT03430362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877193|NCT03430362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877194|NCT03430362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55877195|NCT03430362|Mydriatics|mydriatics|mesh-ancestor
55877196|NCT03430362|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55877197|NCT03430362|Cholinergic Agents|cholinergic agents|mesh-ancestor
55877198|NCT03430362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877199|NCT03430362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877200|NCT03430362|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55877201|NCT03430362|Parasympatholytics|parasympatholytics|mesh-ancestor
55877202|NCT03055377|Acetylcysteine|acetylcysteine|mesh-list
55877203|NCT03055377|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55877204|NCT03055377|Antiviral Agents|antiviral agents|mesh-ancestor
55877205|NCT03055377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877206|NCT03055377|Expectorants|expectorants|mesh-ancestor
55877207|NCT03055377|Respiratory System Agents|respiratory system agents|mesh-ancestor
55877208|NCT03055377|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55877209|NCT03055377|Antioxidants|antioxidants|mesh-ancestor
55877210|NCT03055377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877211|NCT03055377|Protective Agents|protective agents|mesh-ancestor
55877212|NCT03055377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877213|NCT03055377|Antidotes|antidotes|mesh-ancestor
55877214|NCT03428022|Apatinib|apatinib|mesh-list
55877215|NCT03428022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877216|NCT03428022|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56038441|NCT04250805|Sensory System Agents|sensory system agents|mesh-ancestor
56038442|NCT04250805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038443|NCT04250805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56038444|NCT04250805|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56038445|NCT04250805|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56038446|NCT04250805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56038447|NCT04250805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124667|NCT01405950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038448|NCT03069963|Alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|alginate, aluminium hydroxide, magnesium trisilicate, sodium bicarbonate drug combination|mesh-list
56038450|NCT03069963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038451|NCT03069963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56038452|NCT01227434|Palbociclib|palbociclib|mesh-list
56038453|NCT01227434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038454|NCT01227434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56038455|NCT01227434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038456|NCT01227434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038457|NCT01714739|Nivolumab|nivolumab|mesh-list
56038458|NCT01714739|Ipilimumab|ipilimumab|mesh-list
56038459|NCT01714739|Immunoglobulins|immunoglobulins|mesh-list
56038460|NCT01714739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038461|NCT01714739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038462|NCT01714739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56038463|NCT01714739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038464|NCT01714739|Immunologic Factors|immunologic factors|mesh-ancestor
56038485|NCT02377479|Hormone Antagonists|hormone antagonists|mesh-ancestor
56038486|NCT02377479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56038487|NCT02377479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038488|NCT02377479|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56038489|NCT02377479|Fertility Agents|fertility agents|mesh-ancestor
56038490|NCT02377479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56038491|NCT02377479|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56038492|NCT02377479|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56038493|NCT01291784|Antibodies|antibodies|mesh-list
56038494|NCT01291784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56038495|NCT01291784|Immunologic Factors|immunologic factors|mesh-ancestor
56038496|NCT01291784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038497|NCT04205409|Nivolumab|nivolumab|mesh-list
56038498|NCT04205409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038499|NCT04205409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038500|NCT04205409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56038501|NCT04205409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038502|NCT00609791|Paclitaxel|paclitaxel|mesh-list
56038503|NCT00609791|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56038504|NCT00609791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56038505|NCT00609791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038506|NCT00609791|Tubulin Modulators|tubulin modulators|mesh-ancestor
56038507|NCT00609791|Antimitotic Agents|antimitotic agents|mesh-ancestor
56038508|NCT00609791|Mitosis Modulators|mitosis modulators|mesh-ancestor
56038509|NCT00609791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038510|NCT05457959|Poly I-C|poly i-c|mesh-list
56038511|NCT05457959|Nivolumab|nivolumab|mesh-list
56038512|NCT05457959|Ipilimumab|ipilimumab|mesh-list
56038513|NCT05457959|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56038514|NCT05457959|Vaccines|vaccines|mesh-list
56038515|NCT05457959|Poly ICLC|poly iclc|mesh-list
56038516|NCT05457959|Immunologic Factors|immunologic factors|mesh-ancestor
56038517|NCT05457959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038518|NCT05457959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038519|NCT05457959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038520|NCT05457959|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55877217|NCT03428022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038521|NCT05457959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038522|NCT05457959|Interferon Inducers|interferon inducers|mesh-ancestor
56038523|NCT05457959|Laxatives|laxatives|mesh-ancestor
56038524|NCT05457959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56038525|NCT05457959|Antiviral Agents|antiviral agents|mesh-ancestor
56038526|NCT05457959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038528|NCT05457647|Vitamin B Complex|vitamin b complex|mesh-ancestor
56038529|NCT05457647|Vitamins|vitamins|mesh-ancestor
56038531|NCT05457647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038532|NCT05457647|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56038533|NCT05457647|Dermatologic Agents|dermatologic agents|mesh-ancestor
56038534|NCT05455697|Prednisone|prednisone|mesh-list
56038535|NCT05455697|Cyclophosphamide|cyclophosphamide|mesh-list
56038536|NCT05455697|Rituximab|rituximab|mesh-list
56038537|NCT05455697|Doxorubicin|doxorubicin|mesh-list
56038538|NCT05455697|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56038539|NCT05455697|Vincristine|vincristine|mesh-list
56038540|NCT05455697|Daunorubicin|daunorubicin|mesh-list
56038541|NCT05455697|Immunoglobulins|immunoglobulins|mesh-list
56038542|NCT05455697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56038543|NCT05455697|Immunologic Factors|immunologic factors|mesh-ancestor
56038544|NCT05455697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038545|NCT05455697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038546|NCT05455697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56038547|NCT05455697|Alkylating Agents|alkylating agents|mesh-ancestor
56038548|NCT05455697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038549|NCT05455697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038550|NCT05455697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56038551|NCT05455697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038552|NCT05455697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56038553|NCT05455697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56038554|NCT05455697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56038555|NCT05455697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038556|NCT05455697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877218|NCT03428022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877219|NCT03054831|Oxycodone|oxycodone|mesh-list
55877220|NCT03054831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55877221|NCT03054831|Narcotics|narcotics|mesh-ancestor
56038557|NCT05455697|Glucocorticoids|glucocorticoids|mesh-ancestor
56038558|NCT05455697|Hormones|hormones|mesh-ancestor
56038559|NCT05455697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56038560|NCT05455697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56038561|NCT05455697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56038562|NCT05455697|Tubulin Modulators|tubulin modulators|mesh-ancestor
56038563|NCT05455697|Antimitotic Agents|antimitotic agents|mesh-ancestor
56038564|NCT05455697|Mitosis Modulators|mitosis modulators|mesh-ancestor
56038565|NCT01213316|Raltegravir Potassium|raltegravir potassium|mesh-list
56038566|NCT01213316|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56038567|NCT01213316|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56038568|NCT01213316|Antiviral Agents|antiviral agents|mesh-ancestor
56038569|NCT01213316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038570|NCT01213316|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56038571|NCT01213316|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56038572|NCT01213316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038573|NCT01213316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038574|NCT05439629|Ranibizumab|ranibizumab|mesh-list
56038575|NCT05439629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56038576|NCT05439629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56038577|NCT05439629|Growth Substances|growth substances|mesh-ancestor
56038578|NCT05439629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038579|NCT05439629|Growth Inhibitors|growth inhibitors|mesh-ancestor
56038580|NCT05439629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038581|NCT01229228|Naproxen|naproxen|mesh-list
56038582|NCT01229228|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56038583|NCT01229228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56038584|NCT01229228|Analgesics|analgesics|mesh-ancestor
56038585|NCT01229228|Sensory System Agents|sensory system agents|mesh-ancestor
56038586|NCT01229228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038587|NCT01229228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038601|NCT02192684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038602|NCT02243579|Pembrolizumab|pembrolizumab|mesh-list
56038603|NCT02243579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038605|NCT00003407|Cytarabine|cytarabine|mesh-list
56038606|NCT00003407|Mitoxantrone|mitoxantrone|mesh-list
56038607|NCT00003407|Amifostine|amifostine|mesh-list
56038608|NCT00003407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56038609|NCT00003407|Antimetabolites|antimetabolites|mesh-ancestor
56038610|NCT00003407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038611|NCT00003407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038612|NCT00003407|Antiviral Agents|antiviral agents|mesh-ancestor
56038613|NCT00003407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038614|NCT00003407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56038615|NCT00003407|Immunologic Factors|immunologic factors|mesh-ancestor
56038616|NCT00003407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038617|NCT00003407|Analgesics|analgesics|mesh-ancestor
56038618|NCT00003407|Sensory System Agents|sensory system agents|mesh-ancestor
56038619|NCT00003407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038620|NCT00003407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56038621|NCT00003407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56038622|NCT00003407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038623|NCT00003407|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56038624|NCT00003407|Protective Agents|protective agents|mesh-ancestor
56038625|NCT04838717|Doxycycline|doxycycline|mesh-list
56038626|NCT04838717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56038627|NCT04838717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877222|NCT03054831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55877223|NCT03054831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877224|NCT03054831|Analgesics|analgesics|mesh-ancestor
55877225|NCT03054831|Sensory System Agents|sensory system agents|mesh-ancestor
55877226|NCT03054831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877227|NCT05069298|Silybin|silybin|mesh-list
55877228|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55877230|NCT05069298|Protective Agents|protective agents|mesh-ancestor
55877231|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877232|NCT00989781|Dexamethasone|dexamethasone|mesh-list
55877233|NCT00989781|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55877234|NCT00989781|Hormones|hormones|mesh-list
55877235|NCT00989781|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55877236|NCT00989781|Cosyntropin|cosyntropin|mesh-list
55877237|NCT00989781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55877238|NCT00989781|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55877239|NCT00989781|beta-Endorphin|beta-endorphin|mesh-list
55877240|NCT00989781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877241|NCT00989781|Antiemetics|antiemetics|mesh-ancestor
55877242|NCT00989781|Autonomic Agents|autonomic agents|mesh-ancestor
55877243|NCT00989781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877244|NCT00989781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038628|NCT04838717|Antimalarials|antimalarials|mesh-ancestor
56038629|NCT04838717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56038630|NCT04838717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56038631|NCT01710137|Varenicline|varenicline|mesh-list
56038632|NCT01710137|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56038633|NCT01710137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56038634|NCT01710137|Cholinergic Agents|cholinergic agents|mesh-ancestor
55887914|NCT03303378|Antioxidants|antioxidants|mesh-ancestor
56038635|NCT01710137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038636|NCT01710137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038637|NCT01710137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038638|NCT01710839|Ranibizumab|ranibizumab|mesh-list
56038639|NCT01710839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56038640|NCT01710839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56038641|NCT01710839|Growth Substances|growth substances|mesh-ancestor
56038642|NCT01710839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038643|NCT01710839|Growth Inhibitors|growth inhibitors|mesh-ancestor
56038644|NCT01710839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038645|NCT01215110|Bedaquiline|bedaquiline|mesh-list
56038646|NCT01215110|Antitubercular Agents|antitubercular agents|mesh-ancestor
56038647|NCT01215110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56038648|NCT01215110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038649|NCT02980757|Gliclazide|gliclazide|mesh-list
56038650|NCT02980757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56038651|NCT02980757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038652|NCT01229462|Timolol|timolol|mesh-list
56038653|NCT01229462|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56038654|NCT01229462|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56038655|NCT01229462|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56038656|NCT01229462|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56038657|NCT01229462|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56038658|NCT01229462|Adrenergic Agents|adrenergic agents|mesh-ancestor
56038659|NCT01229462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038662|NCT01229462|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56038671|NCT01292642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038672|NCT01292642|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56038673|NCT01292642|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56038674|NCT01292642|Cholinergic Agents|cholinergic agents|mesh-ancestor
56038675|NCT01292642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038676|NCT01292642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038677|NCT01231334|Clindamycin|clindamycin|mesh-list
56038678|NCT01231334|Clindamycin palmitate|clindamycin palmitate|mesh-list
56038679|NCT01231334|Clindamycin phosphate|clindamycin phosphate|mesh-list
56038680|NCT01231334|Dapsone|dapsone|mesh-list
56038681|NCT01231334|Adapalene|adapalene|mesh-list
56038682|NCT01231334|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56038683|NCT01231334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56038684|NCT01231334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038685|NCT01231334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56038686|NCT01231334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038687|NCT01231334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038688|NCT01231334|Dermatologic Agents|dermatologic agents|mesh-ancestor
56038689|NCT01231334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56038690|NCT01231334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56038691|NCT01231334|Analgesics|analgesics|mesh-ancestor
56038692|NCT01231334|Sensory System Agents|sensory system agents|mesh-ancestor
56038693|NCT01231334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038694|NCT01231334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038695|NCT01231334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038696|NCT01231334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038697|NCT01231334|Antimalarials|antimalarials|mesh-ancestor
56038698|NCT01231334|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56038699|NCT01231334|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56038700|NCT01231334|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56038717|NCT01292798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038718|NCT01292798|Growth Inhibitors|growth inhibitors|mesh-ancestor
56038719|NCT01292798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038720|NCT03009500|Methylprednisolone|methylprednisolone|mesh-list
56038721|NCT03009500|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56038722|NCT03009500|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56038723|NCT03009500|Prednisolone|prednisolone|mesh-list
56038724|NCT03009500|Prednisolone acetate|prednisolone acetate|mesh-list
56038725|NCT03009500|Lidocaine|lidocaine|mesh-list
56038726|NCT03009500|Bupivacaine|bupivacaine|mesh-list
56038727|NCT03009500|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56038728|NCT03009500|Prednisolone phosphate|prednisolone phosphate|mesh-list
56038729|NCT03009500|Anesthetics, Local|anesthetics, local|mesh-ancestor
56038730|NCT03009500|Anesthetics|anesthetics|mesh-ancestor
56038732|NCT03009500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038733|NCT03009500|Sensory System Agents|sensory system agents|mesh-ancestor
56038734|NCT03009500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038735|NCT03009500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56038736|NCT03009500|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56038737|NCT03009500|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56038738|NCT03009500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56038739|NCT03009500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038740|NCT03009500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038742|NCT03009500|Autonomic Agents|autonomic agents|mesh-ancestor
56038743|NCT03009500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56038763|NCT01715207|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56038764|NCT01715207|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56038765|NCT01715207|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56038766|NCT01715207|Adrenergic Agents|adrenergic agents|mesh-ancestor
56038767|NCT01715207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038768|NCT01715207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038769|NCT01716221|Dexetimide|dexetimide|mesh-list
56038770|NCT01716221|Bupropion|bupropion|mesh-list
56038771|NCT01716221|Citalopram|citalopram|mesh-list
56038772|NCT01716221|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56038773|NCT01716221|Antidepressive Agents|antidepressive agents|mesh-ancestor
56038774|NCT01716221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56038775|NCT01716221|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56038776|NCT01716221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56038777|NCT01716221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56038778|NCT01716221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038779|NCT01716221|Dopamine Agents|dopamine agents|mesh-ancestor
56038780|NCT01716221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56038781|NCT01716221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038782|NCT01716221|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56038783|NCT01716221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55877245|NCT00989781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55877246|NCT00989781|Glucocorticoids|glucocorticoids|mesh-ancestor
55877247|NCT00989781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877248|NCT00989781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55877249|NCT00989781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877250|NCT00989781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55877251|NCT00989781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877252|NCT00989781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877253|NCT03427944|Calcium Dobesilate|calcium dobesilate|mesh-list
55877254|NCT03427944|Calcium|calcium|mesh-list
55877255|NCT03427944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55877256|NCT03427944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877257|NCT03427944|Hemostatics|hemostatics|mesh-ancestor
55877258|NCT03427944|Coagulants|coagulants|mesh-ancestor
55877259|NCT03429972|Paclitaxel|paclitaxel|mesh-list
55877260|NCT03429972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55877261|NCT03429972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877262|NCT03429972|Tubulin Modulators|tubulin modulators|mesh-ancestor
55877263|NCT03429972|Antimitotic Agents|antimitotic agents|mesh-ancestor
55877264|NCT03429972|Mitosis Modulators|mitosis modulators|mesh-ancestor
55877265|NCT03429972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877266|NCT05601999|Tenecteplase|tenecteplase|mesh-list
55877267|NCT05601999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55877268|NCT05601999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55877269|NCT05601999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877271|NCT03079167|Hematinics|hematinics|mesh-ancestor
55877272|NCT03079011|Letrozole|letrozole|mesh-list
55877273|NCT03079011|Fulvestrant|fulvestrant|mesh-list
56038785|NCT01716221|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56038786|NCT01716221|Serotonin Agents|serotonin agents|mesh-ancestor
56038787|NCT01716221|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56038788|NCT01716221|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56038789|NCT01716221|Parasympatholytics|parasympatholytics|mesh-ancestor
56038790|NCT01716221|Autonomic Agents|autonomic agents|mesh-ancestor
56038791|NCT01716221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038792|NCT01716221|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56038793|NCT01716221|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56038794|NCT01716221|Cholinergic Agents|cholinergic agents|mesh-ancestor
56038795|NCT01215344|Diphosphonates|diphosphonates|mesh-list
56038796|NCT01215344|Dexamethasone|dexamethasone|mesh-list
56038797|NCT01215344|Dexamethasone acetate|dexamethasone acetate|mesh-list
56038798|NCT01215344|Doxorubicin|doxorubicin|mesh-list
56038799|NCT01215344|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56038800|NCT01215344|Lenalidomide|lenalidomide|mesh-list
56038801|NCT01215344|Bortezomib|bortezomib|mesh-list
56038802|NCT01215344|BB 1101|bb 1101|mesh-list
56038803|NCT01215344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038804|NCT01215344|Antiemetics|antiemetics|mesh-ancestor
56038805|NCT01215344|Autonomic Agents|autonomic agents|mesh-ancestor
56038806|NCT01215344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038807|NCT01215344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038808|NCT01215344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56038809|NCT01215344|Glucocorticoids|glucocorticoids|mesh-ancestor
56038810|NCT01215344|Hormones|hormones|mesh-ancestor
56038811|NCT01215344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56038812|NCT01215344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56038813|NCT01215344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038814|NCT01215344|Protease Inhibitors|protease inhibitors|mesh-ancestor
56038815|NCT01215344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038816|NCT01215344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038817|NCT01215344|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55766019|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038824|NCT01215344|Growth Inhibitors|growth inhibitors|mesh-ancestor
56038825|NCT01215344|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56038826|NCT01231412|Cyclosporine|cyclosporine|mesh-list
56038828|NCT01231412|Mycophenolic Acid|mycophenolic acid|mesh-list
56038829|NCT01231412|Fludarabine|fludarabine|mesh-list
56038830|NCT01231412|Fludarabine phosphate|fludarabine phosphate|mesh-list
56038831|NCT01231412|Cyclosporins|cyclosporins|mesh-list
56038832|NCT01231412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038833|NCT01231412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56038834|NCT01231412|Antimetabolites|antimetabolites|mesh-ancestor
56038835|NCT01231412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038836|NCT01231412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56038837|NCT01231412|Immunologic Factors|immunologic factors|mesh-ancestor
56038838|NCT01231412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038839|NCT01231412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038840|NCT01231412|Antifungal Agents|antifungal agents|mesh-ancestor
56038841|NCT01231412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038842|NCT01231412|Dermatologic Agents|dermatologic agents|mesh-ancestor
56038843|NCT01231412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038844|NCT01231412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56038845|NCT01231412|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56038846|NCT01231412|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56038847|NCT01231412|Antitubercular Agents|antitubercular agents|mesh-ancestor
55877274|NCT03079011|Palbociclib|palbociclib|mesh-list
55877275|NCT03079011|Anastrozole|anastrozole|mesh-list
55877276|NCT03079011|Exemestane|exemestane|mesh-list
55877277|NCT03079011|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55877278|NCT03079011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877279|NCT03079011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55877280|NCT03079011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886793|NCT01780324|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55877281|NCT03079011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877282|NCT03079011|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55877283|NCT03079011|Hormone Antagonists|hormone antagonists|mesh-ancestor
55877284|NCT03079011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877285|NCT03079011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877286|NCT03079011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55877287|NCT03079011|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55877288|NCT03079011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55877289|NCT03427632|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
55877290|NCT03427632|Vasodilator Agents|vasodilator agents|mesh-ancestor
55877291|NCT03427632|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55877292|NCT03427632|Protective Agents|protective agents|mesh-ancestor
55877293|NCT03427632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877294|NCT03427554|Tretinoin|tretinoin|mesh-list
55877295|NCT03427554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877296|NCT03427554|Keratolytic Agents|keratolytic agents|mesh-ancestor
55877297|NCT03427554|Dermatologic Agents|dermatologic agents|mesh-ancestor
55877298|NCT01349920|Infliximab|infliximab|mesh-list
55877299|NCT01349920|Dermatologic Agents|dermatologic agents|mesh-ancestor
55877300|NCT01349920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55877301|NCT01349920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877302|NCT03128346|Aspirin|aspirin|mesh-list
55877303|NCT03128346|Acetaminophen|acetaminophen|mesh-list
56038848|NCT01231412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56038849|NCT01719653|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
56038850|NCT01719653|Laxatives|laxatives|mesh-ancestor
56038851|NCT01719653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56038852|NCT04580771|Cisplatin|cisplatin|mesh-list
56038853|NCT04580771|Vaccines|vaccines|mesh-list
56038854|NCT04580771|Immunologic Factors|immunologic factors|mesh-ancestor
56038855|NCT04580771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038856|NCT04580771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038857|NCT01720277|Vaccines|vaccines|mesh-list
56038858|NCT01720277|Immunologic Factors|immunologic factors|mesh-ancestor
56038859|NCT01720277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038860|NCT04514393|Methotrexate|methotrexate|mesh-list
56038861|NCT04514393|Temozolomide|temozolomide|mesh-list
56038862|NCT04514393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56038863|NCT04514393|Abortifacient Agents|abortifacient agents|mesh-ancestor
56038864|NCT04514393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56038865|NCT04514393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038866|NCT04514393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56038867|NCT04514393|Antimetabolites|antimetabolites|mesh-ancestor
56038868|NCT04514393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038869|NCT04514393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038870|NCT04514393|Dermatologic Agents|dermatologic agents|mesh-ancestor
56038871|NCT04514393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038872|NCT04514393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56038873|NCT04514393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56038874|NCT04514393|Immunologic Factors|immunologic factors|mesh-ancestor
56038875|NCT04514393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038876|NCT04514393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55877304|NCT03128346|Fentanyl|fentanyl|mesh-list
55833867|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
55877305|NCT03128346|Hydromorphone|hydromorphone|mesh-list
55877308|NCT03128346|Analgesics|analgesics|mesh-ancestor
55877309|NCT03128346|Sensory System Agents|sensory system agents|mesh-ancestor
55877310|NCT03128346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877311|NCT03128346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877312|NCT03128346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877313|NCT03128346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877314|NCT03128346|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55877315|NCT03128346|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55877316|NCT03128346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877317|NCT03128346|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55877318|NCT03128346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55877319|NCT03128346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877321|NCT03128346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55877322|NCT03128346|Narcotics|narcotics|mesh-ancestor
55877323|NCT03128346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56038877|NCT04514393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56038878|NCT04514393|Alkylating Agents|alkylating agents|mesh-ancestor
56038879|NCT01232504|Molgramostim|molgramostim|mesh-list
56038880|NCT01232504|Lenograstim|lenograstim|mesh-list
56038881|NCT01232504|Sargramostim|sargramostim|mesh-list
56038882|NCT01232504|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56038883|NCT01232504|Immunologic Factors|immunologic factors|mesh-ancestor
56038884|NCT01232504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038885|NCT01232504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038886|NCT01737593|Acetaminophen|acetaminophen|mesh-list
56038887|NCT01737593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56038888|NCT01737593|Analgesics|analgesics|mesh-ancestor
56038889|NCT01737593|Sensory System Agents|sensory system agents|mesh-ancestor
56038890|NCT01737593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038891|NCT01737593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038892|NCT01737593|Antipyretics|antipyretics|mesh-ancestor
56038893|NCT01217840|Vitamin D|vitamin d|mesh-list
56038894|NCT01217840|Ergocalciferols|ergocalciferols|mesh-list
56038895|NCT01217840|Vitamins|vitamins|mesh-ancestor
56038896|NCT01217840|Micronutrients|micronutrients|mesh-ancestor
56038897|NCT01217840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038898|NCT01217840|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56038899|NCT01217840|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56038901|NCT01721603|Dabrafenib|dabrafenib|mesh-list
56038902|NCT01721603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038903|NCT01721603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56038904|NCT01721603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038905|NCT01721603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038906|NCT01296542|Moxifloxacin|moxifloxacin|mesh-list
56038907|NCT01296542|Besifloxacin|besifloxacin|mesh-list
56038908|NCT01296542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56038909|NCT01296542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56038910|NCT01296542|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56038911|NCT01296542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56038912|NCT01296542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038913|NCT01296542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038914|NCT01296542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038915|NCT01234766|Rituximab|rituximab|mesh-list
56038916|NCT01234766|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56038917|NCT01234766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56038918|NCT01234766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56038919|NCT01234766|Immunologic Factors|immunologic factors|mesh-ancestor
56038920|NCT01234766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038921|NCT01234766|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038922|NCT01234766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56038923|NCT01234766|Alkylating Agents|alkylating agents|mesh-ancestor
56038924|NCT01234766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038925|NCT01234922|Losartan|losartan|mesh-list
56038926|NCT01234922|Ramipril|ramipril|mesh-list
56038927|NCT01234922|Lisinopril|lisinopril|mesh-list
56038928|NCT01234922|Benazepril|benazepril|mesh-list
56038929|NCT01234922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56038930|NCT01234922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56038931|NCT01234922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56038932|NCT01234922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56038933|NCT01234922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038934|NCT01234922|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56038935|NCT01234922|Protease Inhibitors|protease inhibitors|mesh-ancestor
56038936|NCT01234922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038937|NCT01234922|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56038938|NCT01234922|Protective Agents|protective agents|mesh-ancestor
56038939|NCT01234922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038940|NCT01337336|Fluticasone|fluticasone|mesh-list
56038941|NCT01337336|Xhance|xhance|mesh-list
56038942|NCT01337336|Tiotropium Bromide|tiotropium bromide|mesh-list
56038943|NCT01337336|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56038945|NCT01337336|Cholinergic Antagonists|cholinergic antagonists|mesh-list
56038946|NCT01337336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038959|NCT01337336|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56038960|NCT01337336|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56038961|NCT01337336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56038962|NCT01337336|Adrenergic Agents|adrenergic agents|mesh-ancestor
56038963|NCT01239212|Levetiracetam|levetiracetam|mesh-list
56038964|NCT01239212|Anticonvulsants|anticonvulsants|mesh-ancestor
56038965|NCT01239212|Nootropic Agents|nootropic agents|mesh-ancestor
56038966|NCT01242644|Ketorolac|ketorolac|mesh-list
56038967|NCT01242644|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56038968|NCT01242644|Morphine|morphine|mesh-list
56038969|NCT01242644|Ropivacaine|ropivacaine|mesh-list
56038970|NCT01242644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56038971|NCT01242644|Narcotics|narcotics|mesh-ancestor
56038972|NCT01242644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56038973|NCT01242644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038974|NCT01242644|Analgesics|analgesics|mesh-ancestor
56038975|NCT01242644|Sensory System Agents|sensory system agents|mesh-ancestor
56038976|NCT01242644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56038977|NCT01242644|Anesthetics, Local|anesthetics, local|mesh-ancestor
56038978|NCT01242644|Anesthetics|anesthetics|mesh-ancestor
56038979|NCT01242644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56038980|NCT01242644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56038981|NCT01242644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56038982|NCT01242644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56038983|NCT01242644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56038984|NCT01242644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56038985|NCT01242644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038987|NCT01303406|Antioxidants|antioxidants|mesh-ancestor
56038988|NCT01303406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56038989|NCT01303406|Protective Agents|protective agents|mesh-ancestor
56038990|NCT01303406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56038991|NCT03619707|Progesterone|progesterone|mesh-list
56038992|NCT03619707|Progestins|progestins|mesh-ancestor
56038993|NCT03619707|Hormones|hormones|mesh-ancestor
56038994|NCT03619707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56038995|NCT03619707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039000|NCT02597907|Autonomic Agents|autonomic agents|mesh-ancestor
56039001|NCT02597907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039002|NCT02597907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039003|NCT02597907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56039004|NCT02597907|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56039005|NCT02597907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039006|NCT02597907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039007|NCT02597907|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56039008|NCT02597907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56039009|NCT02597907|Serotonin Agents|serotonin agents|mesh-ancestor
56039010|NCT02600325|Grazoprevir|grazoprevir|mesh-list
56039011|NCT02600325|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56039012|NCT02600325|Antiviral Agents|antiviral agents|mesh-ancestor
56039013|NCT02600325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039014|NCT02600715|Morphine|morphine|mesh-list
56039015|NCT02600715|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56039016|NCT02600715|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56039017|NCT02600715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56039018|NCT02600715|Narcotics|narcotics|mesh-ancestor
56039019|NCT02600715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039020|NCT02600715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039021|NCT02600715|Analgesics|analgesics|mesh-ancestor
56039022|NCT02600715|Sensory System Agents|sensory system agents|mesh-ancestor
56039023|NCT02600715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039024|NCT02600715|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56039025|NCT02600715|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56039026|NCT02600715|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55877324|NCT03128346|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55877325|NCT03128346|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55877326|NCT03128346|Anesthetics, General|anesthetics, general|mesh-ancestor
55877327|NCT03128346|Anesthetics|anesthetics|mesh-ancestor
55877328|NCT03423030|Macozinone|macozinone|mesh-list
55877329|NCT03423030|Antitubercular Agents|antitubercular agents|mesh-ancestor
55877330|NCT03423030|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55877331|NCT03423030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877332|NCT03427242|Apatinib|apatinib|mesh-list
55877333|NCT03427242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877334|NCT03427242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55877335|NCT03427242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877336|NCT03427242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877337|NCT01252732|Vancomycin|vancomycin|mesh-list
55877338|NCT01252732|Oritavancin|oritavancin|mesh-list
55877339|NCT01252732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55877340|NCT01252732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877341|NCT00989235|Abatacept|abatacept|mesh-list
55877342|NCT00989235|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55877343|NCT00989235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039027|NCT02600715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039028|NCT02600715|Cholinergic Agents|cholinergic agents|mesh-ancestor
56039029|NCT02600715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039030|NCT04743297|Dinoprostone|dinoprostone|mesh-list
56039031|NCT04743297|Oxytocics|oxytocics|mesh-ancestor
56039032|NCT04743297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56039033|NCT04743297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039034|NCT04180371|Nivolumab|nivolumab|mesh-list
56039035|NCT04180371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56039036|NCT04180371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039037|NCT04180371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56039038|NCT04180371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877344|NCT00989235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877345|NCT00989235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55877346|NCT00989235|Immunologic Factors|immunologic factors|mesh-ancestor
55877347|NCT00989235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877348|NCT00989235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877349|NCT03422874|Nelfinavir|nelfinavir|mesh-list
55877350|NCT03422874|Ixazomib|ixazomib|mesh-list
55877351|NCT03422874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877352|NCT03422874|Protease Inhibitors|protease inhibitors|mesh-ancestor
55877353|NCT03422874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877354|NCT03422874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877355|NCT03422874|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55877356|NCT03422874|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55877357|NCT03422874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55877358|NCT03422874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55877359|NCT03422874|Antiviral Agents|antiviral agents|mesh-ancestor
55877360|NCT03422874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877361|NCT01253824|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55877362|NCT01253824|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55877363|NCT01253824|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55877364|NCT01253824|Norethindrone|norethindrone|mesh-list
55877365|NCT01253824|Norethindrone Acetate|norethindrone acetate|mesh-list
55877366|NCT01253824|Norinyl|norinyl|mesh-list
55877367|NCT01253824|Mestranol|mestranol|mesh-list
55877368|NCT01253824|Estradiol|estradiol|mesh-list
55877369|NCT01253824|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55877370|NCT01253824|Estrogens|estrogens|mesh-ancestor
55877371|NCT01253824|Hormones|hormones|mesh-ancestor
55877372|NCT01253824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877373|NCT01253824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877374|NCT01253824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55877375|NCT01253824|Contraceptive Agents|contraceptive agents|mesh-ancestor
55877376|NCT01253824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55877377|NCT01253824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55877378|NCT01253824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55877379|NCT01253824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55877382|NCT03422796|Cilostazol|cilostazol|mesh-list
55877383|NCT03422796|Sumatriptan|sumatriptan|mesh-list
55877384|NCT03422796|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55877385|NCT03422796|Autonomic Agents|autonomic agents|mesh-ancestor
55877386|NCT03422796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877387|NCT03422796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877388|NCT03422796|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55877389|NCT03422796|Respiratory System Agents|respiratory system agents|mesh-ancestor
55877390|NCT03422796|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55877391|NCT03422796|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55877392|NCT03422796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877393|NCT03422796|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55877394|NCT03422796|Vasodilator Agents|vasodilator agents|mesh-ancestor
55877395|NCT03422796|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56039039|NCT04176783|Analgesics, Opioid|analgesics, opioid|mesh-list
56039040|NCT04176783|Narcotics|narcotics|mesh-ancestor
56039041|NCT04176783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039042|NCT04176783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039043|NCT04176783|Analgesics|analgesics|mesh-ancestor
56039044|NCT04176783|Sensory System Agents|sensory system agents|mesh-ancestor
56039045|NCT04176783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039046|NCT00365313|Celecoxib|celecoxib|mesh-list
56039047|NCT00365313|Esomeprazole|esomeprazole|mesh-list
56039048|NCT00365313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56039049|NCT00365313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56039050|NCT00365313|Analgesics|analgesics|mesh-ancestor
56039051|NCT00365313|Sensory System Agents|sensory system agents|mesh-ancestor
56039052|NCT00365313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039053|NCT00365313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039054|NCT00365313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56039055|NCT00365313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039056|NCT00365313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56039057|NCT00365313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56039058|NCT00365313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039059|NCT00365313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039060|NCT00365313|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56039061|NCT00365313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56039062|NCT00365313|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56039063|NCT03113487|Pembrolizumab|pembrolizumab|mesh-list
56039064|NCT03113487|Vaccines|vaccines|mesh-list
56039065|NCT03113487|Immunologic Factors|immunologic factors|mesh-ancestor
56039066|NCT03113487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039067|NCT03113487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56039068|NCT03113487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039069|NCT02605395|Rabeprazole|rabeprazole|mesh-list
56039070|NCT02605395|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56039071|NCT02605395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56039072|NCT02605395|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56039075|NCT04166721|Atezolizumab|atezolizumab|mesh-list
56039080|NCT04343001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56039081|NCT04343001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56039083|NCT04343001|Sensory System Agents|sensory system agents|mesh-ancestor
56039084|NCT04343001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039085|NCT04343001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039086|NCT04343001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56039087|NCT04343001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039088|NCT04343001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56039089|NCT04343001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56039090|NCT04343001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039091|NCT04343001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56039092|NCT04343001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56039093|NCT04343001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039094|NCT04343001|Antipyretics|antipyretics|mesh-ancestor
56039095|NCT04343001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56039096|NCT04343001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56039097|NCT04343001|Antimetabolites|antimetabolites|mesh-ancestor
56039098|NCT04343001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56039099|NCT04343001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56039100|NCT04343001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56039101|NCT04343001|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56039102|NCT04343001|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56039103|NCT04343001|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55877396|NCT03422796|Protective Agents|protective agents|mesh-ancestor
55750172|NCT03241381|Vitamin D|vitamin d|mesh-list
55877397|NCT03422796|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55877398|NCT03422796|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55877399|NCT03422796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877400|NCT03422796|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55877401|NCT03422796|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55877402|NCT03422796|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55877403|NCT03422796|Serotonin Agents|serotonin agents|mesh-ancestor
55877404|NCT03422796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877406|NCT04396977|Histamine Agonists|histamine agonists|mesh-ancestor
55877407|NCT04396977|Histamine Agents|histamine agents|mesh-ancestor
55877408|NCT04396977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877409|NCT04396977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877410|NCT04396977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877411|NCT03429738|Ibuprofen|ibuprofen|mesh-list
55877412|NCT03429738|Pseudoephedrine|pseudoephedrine|mesh-list
55877413|NCT03429738|Ephedrine|ephedrine|mesh-list
55877414|NCT03429738|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55877415|NCT03429738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56039107|NCT02865135|Vaccines|vaccines|mesh-list
56039108|NCT02865135|Immunologic Factors|immunologic factors|mesh-ancestor
56039109|NCT02865135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039110|NCT04742205|Tranexamic Acid|tranexamic acid|mesh-list
56039111|NCT04742205|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56039112|NCT04742205|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56039113|NCT04742205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039114|NCT04742205|Hemostatics|hemostatics|mesh-ancestor
56039115|NCT04742205|Coagulants|coagulants|mesh-ancestor
56039116|NCT04743063|Losartan|losartan|mesh-list
56039117|NCT04743063|Valsartan|valsartan|mesh-list
56039118|NCT04743063|Telmisartan|telmisartan|mesh-list
56039119|NCT04743063|Candesartan|candesartan|mesh-list
56039120|NCT04743063|Olmesartan|olmesartan|mesh-list
56039121|NCT04743063|Irbesartan|irbesartan|mesh-list
56039122|NCT04743063|Eprosartan|eprosartan|mesh-list
56039123|NCT04743063|Angiotensin II|angiotensin ii|mesh-list
56039124|NCT04743063|Giapreza|giapreza|mesh-list
56039125|NCT04743063|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56039126|NCT04743063|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
56039127|NCT04743063|Angiotensinogen|angiotensinogen|mesh-list
56039128|NCT04743063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56039129|NCT04743063|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56039130|NCT04743063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877416|NCT03429738|Analgesics|analgesics|mesh-ancestor
55877417|NCT03429738|Sensory System Agents|sensory system agents|mesh-ancestor
55877418|NCT03429738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877419|NCT03429738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877420|NCT03429738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877421|NCT03429738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877422|NCT03429738|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55877423|NCT03429738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877424|NCT03429738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877425|NCT03429738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55877426|NCT03429738|Autonomic Agents|autonomic agents|mesh-ancestor
55877427|NCT03429738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55877428|NCT03429738|Respiratory System Agents|respiratory system agents|mesh-ancestor
55877429|NCT03429738|Nasal Decongestants|nasal decongestants|mesh-ancestor
55877430|NCT03429738|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55877431|NCT03429738|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55877432|NCT03429738|Sympathomimetics|sympathomimetics|mesh-ancestor
55877433|NCT03429738|Adrenergic Agents|adrenergic agents|mesh-ancestor
55877434|NCT03429738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877435|NCT01253902|Bimatoprost|bimatoprost|mesh-list
55877436|NCT01253902|Travoprost|travoprost|mesh-list
55877437|NCT01253902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55877438|NCT01253902|Latanoprost|latanoprost|mesh-list
55877439|NCT01253902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55877440|NCT01253902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55877442|NCT01253980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55877443|NCT01253980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039131|NCT04743063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56039132|NCT04743063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56039133|NCT04743063|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56039134|NCT04743063|Protease Inhibitors|protease inhibitors|mesh-ancestor
56039135|NCT04743063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039136|NCT04743063|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
56039137|NCT01739699|Acetaminophen|acetaminophen|mesh-list
56039138|NCT01739699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56039139|NCT01739699|Analgesics|analgesics|mesh-ancestor
56039140|NCT01739699|Sensory System Agents|sensory system agents|mesh-ancestor
56039141|NCT01739699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039142|NCT01739699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039143|NCT01739699|Antipyretics|antipyretics|mesh-ancestor
56039145|NCT04154787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56039146|NCT04154787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039147|NCT04154787|Immunologic Factors|immunologic factors|mesh-ancestor
56039148|NCT04154787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039149|NCT04154787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039150|NCT01740713|Deferiprone|deferiprone|mesh-list
56039151|NCT01740713|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56039152|NCT01740713|Chelating Agents|chelating agents|mesh-ancestor
56039153|NCT01740713|Sequestering Agents|sequestering agents|mesh-ancestor
56039154|NCT01740713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039155|NCT02613117|Fluorides|fluorides|mesh-list
56039156|NCT02613117|Tin Fluorides|tin fluorides|mesh-list
56039157|NCT02613117|Cariostatic Agents|cariostatic agents|mesh-ancestor
56039158|NCT02613117|Protective Agents|protective agents|mesh-ancestor
56039159|NCT02613117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039160|NCT01742117|Clopidogrel|clopidogrel|mesh-list
56039161|NCT01742117|Ticagrelor|ticagrelor|mesh-list
56039162|NCT01742117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55877444|NCT00988533|Ivermectin|ivermectin|mesh-list
55877445|NCT00988533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55877446|NCT00988533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877447|NCT01350388|Febuxostat|febuxostat|mesh-list
55877448|NCT01350388|Gout Suppressants|gout suppressants|mesh-ancestor
55877449|NCT01350388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877450|NCT03154749|Cyclophosphamide|cyclophosphamide|mesh-list
55877451|NCT03154749|Carboplatin|carboplatin|mesh-list
55877452|NCT03154749|Docetaxel|docetaxel|mesh-list
55877453|NCT03154749|Epirubicin|epirubicin|mesh-list
55877456|NCT03154749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750192|NCT02513381|Vitamin D|vitamin d|mesh-list
56039163|NCT01742117|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56039164|NCT01742117|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56039165|NCT01742117|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56039166|NCT01742117|Purinergic Agents|purinergic agents|mesh-ancestor
56039167|NCT01742117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877458|NCT03154749|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55877459|NCT03154749|Alkylating Agents|alkylating agents|mesh-ancestor
55877460|NCT03154749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877461|NCT03154749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877462|NCT03154749|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55877463|NCT03154749|Tubulin Modulators|tubulin modulators|mesh-ancestor
55877464|NCT03154749|Antimitotic Agents|antimitotic agents|mesh-ancestor
55877465|NCT03154749|Mitosis Modulators|mitosis modulators|mesh-ancestor
55877466|NCT03154749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55877467|NCT03154749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55877468|NCT03154749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55877469|NCT03154749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877470|NCT03422640|Apremilast|apremilast|mesh-list
55877471|NCT03422640|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55877472|NCT03422640|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55877473|NCT03422640|Analgesics|analgesics|mesh-ancestor
55877474|NCT03422640|Sensory System Agents|sensory system agents|mesh-ancestor
55877475|NCT03422640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877476|NCT03422640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877477|NCT03422640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877478|NCT03422640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877479|NCT03422640|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55877480|NCT03422640|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55877481|NCT03422640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877482|NCT03422640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877483|NCT01351090|Ketorolac|ketorolac|mesh-list
55877484|NCT01351090|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55877485|NCT01351090|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55877486|NCT01351090|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55877487|NCT01351090|Analgesics|analgesics|mesh-ancestor
55877488|NCT01351090|Sensory System Agents|sensory system agents|mesh-ancestor
55877489|NCT01351090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877490|NCT01351090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877491|NCT01351090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877492|NCT01351090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877493|NCT01351090|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55877494|NCT01351090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877495|NCT01351090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877496|NCT01918644|Capecitabine|capecitabine|mesh-list
55877497|NCT01918644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55877498|NCT01918644|Antimetabolites|antimetabolites|mesh-ancestor
55877499|NCT01918644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877500|NCT01918644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877501|NCT00987831|Methylprednisolone|methylprednisolone|mesh-list
55877502|NCT00987831|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55877503|NCT00987831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877504|NCT00987831|Antiemetics|antiemetics|mesh-ancestor
55877505|NCT00987831|Autonomic Agents|autonomic agents|mesh-ancestor
55877506|NCT00987831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877507|NCT00987831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877509|NCT00987831|Glucocorticoids|glucocorticoids|mesh-ancestor
55877510|NCT00987831|Hormones|hormones|mesh-ancestor
55877511|NCT00987831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877512|NCT00987831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55877513|NCT00987831|Protective Agents|protective agents|mesh-ancestor
55877514|NCT03608358|Metformin|metformin|mesh-list
55877515|NCT03608358|Dapagliflozin|dapagliflozin|mesh-list
55877516|NCT03608358|Saxagliptin|saxagliptin|mesh-list
55877517|NCT03608358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55877518|NCT03608358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877519|NCT03608358|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56039168|NCT01742117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039169|NCT01742117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039170|NCT02613897|Dapagliflozin|dapagliflozin|mesh-list
56039171|NCT02613897|Saxagliptin|saxagliptin|mesh-list
56039172|NCT02613897|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56039173|NCT02613897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039174|NCT02613897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56039175|NCT02613897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039176|NCT02613897|Incretins|incretins|mesh-ancestor
56039177|NCT02613897|Hormones|hormones|mesh-ancestor
56039178|NCT02613897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56039179|NCT02613897|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56039180|NCT02613897|Protease Inhibitors|protease inhibitors|mesh-ancestor
56039181|NCT02613897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039182|NCT02615535|Alprostadil|alprostadil|mesh-list
56039183|NCT02615535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56039184|NCT02615535|Vasodilator Agents|vasodilator agents|mesh-ancestor
56039185|NCT02615535|Urological Agents|urological agents|mesh-ancestor
56039186|NCT05732181|Lidocaine|lidocaine|mesh-list
56039187|NCT05732181|Anesthetics, Local|anesthetics, local|mesh-ancestor
56039188|NCT05732181|Anesthetics|anesthetics|mesh-ancestor
56039189|NCT05732181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039190|NCT05732181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039191|NCT05732181|Sensory System Agents|sensory system agents|mesh-ancestor
56039192|NCT05732181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039193|NCT05732181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56039194|NCT05732181|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56039195|NCT05732181|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56039196|NCT05732181|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56039197|NCT05732181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039198|NCT01342172|Lenalidomide|lenalidomide|mesh-list
56039199|NCT01342172|Immunologic Factors|immunologic factors|mesh-ancestor
56039200|NCT01342172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039201|NCT01342172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56039205|NCT01342172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039206|NCT01243112|Lidocaine|lidocaine|mesh-list
56039207|NCT01243112|Epinephrine|epinephrine|mesh-list
56039208|NCT01243112|Racepinephrine|racepinephrine|mesh-list
56039209|NCT01243112|Bupivacaine|bupivacaine|mesh-list
56039210|NCT01243112|Epinephryl borate|epinephryl borate|mesh-list
56039211|NCT01243112|Anesthetics, Local|anesthetics, local|mesh-ancestor
56039212|NCT01243112|Anesthetics|anesthetics|mesh-ancestor
56039213|NCT01243112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039214|NCT01243112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039215|NCT01243112|Sensory System Agents|sensory system agents|mesh-ancestor
56039216|NCT01243112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039217|NCT01243112|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56039218|NCT01243112|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56039219|NCT01243112|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56039220|NCT01243112|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56039221|NCT01243112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039222|NCT01243112|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56039223|NCT01243112|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56039224|NCT01243112|Adrenergic Agents|adrenergic agents|mesh-ancestor
56039225|NCT01243112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039226|NCT01243112|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56039227|NCT01243112|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56039228|NCT01243112|Autonomic Agents|autonomic agents|mesh-ancestor
56039229|NCT01243112|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56039230|NCT01243112|Respiratory System Agents|respiratory system agents|mesh-ancestor
56039231|NCT01243112|Mydriatics|mydriatics|mesh-ancestor
56039232|NCT01243112|Sympathomimetics|sympathomimetics|mesh-ancestor
56039233|NCT01243112|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56039234|NCT01243580|Moxifloxacin|moxifloxacin|mesh-list
56039235|NCT01243580|Contraceptive Agents|contraceptive agents|mesh-list
56039236|NCT01243580|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56039246|NCT01243580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039247|NCT01243580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039248|NCT01243580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56039249|NCT01243580|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56039250|NCT01743131|Abatacept|abatacept|mesh-list
56039251|NCT01743131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56039252|NCT01743131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039253|NCT01743131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039254|NCT01743131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56039255|NCT01743131|Immunologic Factors|immunologic factors|mesh-ancestor
56039256|NCT01743131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039257|NCT01743131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039258|NCT05372133|Morphine|morphine|mesh-list
55834895|NCT01841697|Metformin|metformin|mesh-list
56039259|NCT05372133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56039260|NCT05372133|Narcotics|narcotics|mesh-ancestor
56039261|NCT05372133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039262|NCT05372133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039263|NCT05372133|Analgesics|analgesics|mesh-ancestor
56039264|NCT05372133|Sensory System Agents|sensory system agents|mesh-ancestor
55877520|NCT03608358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877521|NCT03608358|Incretins|incretins|mesh-ancestor
55877522|NCT03608358|Hormones|hormones|mesh-ancestor
55877523|NCT03608358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877524|NCT03608358|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55877532|NCT01256164|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55877533|NCT01256164|Hemostatics|hemostatics|mesh-ancestor
55877534|NCT01256164|Coagulants|coagulants|mesh-ancestor
55877535|NCT03560934|Dronabinol|dronabinol|mesh-list
55877536|NCT03560934|Hallucinogens|hallucinogens|mesh-ancestor
55877537|NCT03560934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877538|NCT03560934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55877539|NCT03560934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55877540|NCT03560934|Analgesics|analgesics|mesh-ancestor
55877541|NCT03560934|Sensory System Agents|sensory system agents|mesh-ancestor
55877542|NCT03560934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877543|NCT03560934|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55877544|NCT03560934|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55877545|NCT03560934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877546|NCT03560934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877547|NCT03560934|Hormones|hormones|mesh-ancestor
55877548|NCT03560934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877549|NCT03077451|Nelfinavir|nelfinavir|mesh-list
55877550|NCT03077451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55877551|NCT03077451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55877552|NCT03077451|Protease Inhibitors|protease inhibitors|mesh-ancestor
55877553|NCT03077451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877554|NCT03077451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877555|NCT03077451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55877556|NCT03077451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55877557|NCT03077451|Antiviral Agents|antiviral agents|mesh-ancestor
55877558|NCT03077451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877560|NCT03427086|Vitamins|vitamins|mesh-ancestor
55877561|NCT03427086|Micronutrients|micronutrients|mesh-ancestor
55877562|NCT03427086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039266|NCT01743521|Ribavirin|ribavirin|mesh-list
56039267|NCT01743521|Antimetabolites|antimetabolites|mesh-ancestor
56039268|NCT01743521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039269|NCT01743521|Antiviral Agents|antiviral agents|mesh-ancestor
56039270|NCT01743521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039271|NCT00361803|Topotecan|topotecan|mesh-list
56039272|NCT00361803|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56039273|NCT00361803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56039274|NCT00361803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039275|NCT00361803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039276|NCT00361803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039278|NCT00361881|Hydrocortisone|hydrocortisone|mesh-list
56039279|NCT00361881|Antiviral Agents|antiviral agents|mesh-ancestor
56039280|NCT00361881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039281|NCT00361881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56039282|NCT01743677|Moxifloxacin|moxifloxacin|mesh-list
56039283|NCT01743677|Tofacitinib|tofacitinib|mesh-list
56039284|NCT01743677|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56039285|NCT01743677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039286|NCT01743677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56039287|NCT01743677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56039288|NCT01743677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039289|NCT01743677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039290|NCT01743677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039291|NCT01743677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56039292|NCT00365937|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56039293|NCT00365937|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
56039294|NCT00365937|Immunologic Factors|immunologic factors|mesh-ancestor
56039295|NCT00365937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039306|NCT04080531|Vaccines|vaccines|mesh-list
56039312|NCT01307462|Montelukast|montelukast|mesh-list
56039313|NCT01307462|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56039314|NCT01307462|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56039315|NCT01307462|Autonomic Agents|autonomic agents|mesh-ancestor
56039316|NCT01307462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039317|NCT01307462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039318|NCT01307462|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56039319|NCT01307462|Respiratory System Agents|respiratory system agents|mesh-ancestor
56039320|NCT01307462|Dermatologic Agents|dermatologic agents|mesh-ancestor
56039321|NCT01307462|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56039322|NCT01307462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56039323|NCT01307462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039324|NCT01307462|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56039325|NCT01307462|Hormone Antagonists|hormone antagonists|mesh-ancestor
56039326|NCT01307462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56039327|NCT01307462|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56039328|NCT01307462|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56039329|NCT01307462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039330|NCT05731089|Aflibercept|aflibercept|mesh-list
56039331|NCT05731089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56039332|NCT05731089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55877563|NCT03427086|Vitamin B Complex|vitamin b complex|mesh-ancestor
55877564|NCT01887522|Vinblastine|vinblastine|mesh-list
55877565|NCT01887522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55877566|NCT01887522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877567|NCT01887522|Tubulin Modulators|tubulin modulators|mesh-ancestor
55877568|NCT01887522|Antimitotic Agents|antimitotic agents|mesh-ancestor
55877569|NCT01887522|Mitosis Modulators|mitosis modulators|mesh-ancestor
55877570|NCT01887522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877571|NCT03422406|Iodine|iodine|mesh-list
55877572|NCT03422406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55877573|NCT03422406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877574|NCT03422406|Trace Elements|trace elements|mesh-ancestor
55877575|NCT03422406|Micronutrients|micronutrients|mesh-ancestor
55877576|NCT03422406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877577|NCT00986427|Cyclosporine|cyclosporine|mesh-list
55877578|NCT00986427|Cyclosporins|cyclosporins|mesh-list
55877579|NCT00986427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750224|NCT03235609|Analgesics|analgesics|mesh-ancestor
55877580|NCT00986427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877581|NCT00986427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55877582|NCT00986427|Immunologic Factors|immunologic factors|mesh-ancestor
55877583|NCT00986427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877584|NCT00986427|Antifungal Agents|antifungal agents|mesh-ancestor
55877585|NCT00986427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877586|NCT00986427|Dermatologic Agents|dermatologic agents|mesh-ancestor
55877587|NCT00986427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877588|NCT00986427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55877590|NCT03529422|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55877591|NCT03529422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877592|NCT03426462|Propofol|propofol|mesh-list
55877593|NCT03426462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56039333|NCT05731089|Growth Substances|growth substances|mesh-ancestor
56039334|NCT05731089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039335|NCT05731089|Growth Inhibitors|growth inhibitors|mesh-ancestor
56039336|NCT05731089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039337|NCT05653713|Lenograstim|lenograstim|mesh-list
56039338|NCT05653713|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56039339|NCT05653713|Immunologic Factors|immunologic factors|mesh-ancestor
56039340|NCT05653713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039341|NCT01307618|Interleukin-12|interleukin-12|mesh-list
56039342|NCT01307618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56039343|NCT01307618|Immunologic Factors|immunologic factors|mesh-ancestor
56039344|NCT01307618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039345|NCT01307618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56039346|NCT01307618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56039347|NCT01307618|Growth Substances|growth substances|mesh-ancestor
56039348|NCT01307618|Growth Inhibitors|growth inhibitors|mesh-ancestor
56039349|NCT01307618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877594|NCT03426462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55877595|NCT03426462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877597|NCT03426462|Anesthetics, General|anesthetics, general|mesh-ancestor
55877598|NCT03426462|Anesthetics|anesthetics|mesh-ancestor
55877599|NCT03421860|Phenylephrine|phenylephrine|mesh-list
55877600|NCT03421860|Epinephrine|epinephrine|mesh-list
55877601|NCT03421860|Oxymetazoline|oxymetazoline|mesh-list
55877602|NCT03421860|Ephedrine|ephedrine|mesh-list
55877603|NCT03421860|Norepinephrine|norepinephrine|mesh-list
55877604|NCT03421860|Ondansetron|ondansetron|mesh-list
55877605|NCT03421860|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55877606|NCT03421860|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55877607|NCT03421860|Adrenergic Agents|adrenergic agents|mesh-ancestor
55877608|NCT03421860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877609|NCT03421860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877610|NCT03421860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877611|NCT03421860|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55877612|NCT03421860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55877613|NCT03421860|Autonomic Agents|autonomic agents|mesh-ancestor
55877614|NCT03421860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877615|NCT03421860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55877616|NCT03421860|Respiratory System Agents|respiratory system agents|mesh-ancestor
55877617|NCT03421860|Mydriatics|mydriatics|mesh-ancestor
55877618|NCT03421860|Sympathomimetics|sympathomimetics|mesh-ancestor
55877619|NCT03421860|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55877620|NCT03421860|Antiemetics|antiemetics|mesh-ancestor
55877621|NCT03421860|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55877622|NCT03421860|Antipruritics|antipruritics|mesh-ancestor
55877623|NCT03421860|Dermatologic Agents|dermatologic agents|mesh-ancestor
55877624|NCT03421860|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55877625|NCT03421860|Serotonin Agents|serotonin agents|mesh-ancestor
55877626|NCT03421860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55877627|NCT03421860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55877628|NCT03421860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55877629|NCT03421860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55877630|NCT03421860|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55877631|NCT03421860|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55877632|NCT03421860|Nasal Decongestants|nasal decongestants|mesh-ancestor
55750230|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
55877633|NCT03421860|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55877634|NCT03421860|Protective Agents|protective agents|mesh-ancestor
55877635|NCT03421860|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55877636|NCT03421314|Selenium|selenium|mesh-list
56039350|NCT01307930|Anidulafungin|anidulafungin|mesh-list
56039351|NCT01307930|Antifungal Agents|antifungal agents|mesh-ancestor
56039352|NCT01307930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039353|NCT05371197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56039354|NCT05371197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039355|NCT05371197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039356|NCT01746095|Vancomycin|vancomycin|mesh-list
56039357|NCT01746095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56039358|NCT01746095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039359|NCT05730777|Paclitaxel|paclitaxel|mesh-list
56039360|NCT05730777|Carboplatin|carboplatin|mesh-list
56039361|NCT05730777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56039362|NCT05730777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039363|NCT05730777|Tubulin Modulators|tubulin modulators|mesh-ancestor
56039364|NCT05730777|Antimitotic Agents|antimitotic agents|mesh-ancestor
56039365|NCT05730777|Mitosis Modulators|mitosis modulators|mesh-ancestor
56039366|NCT05730777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039367|NCT04425239|Leucovorin|leucovorin|mesh-list
56039368|NCT04425239|Folic Acid|folic acid|mesh-list
56039369|NCT04425239|Fluorouracil|fluorouracil|mesh-list
56039370|NCT04425239|Irinotecan|irinotecan|mesh-list
56039371|NCT04425239|Panitumumab|panitumumab|mesh-list
56039372|NCT04425239|Levoleucovorin|levoleucovorin|mesh-list
56039373|NCT04425239|Antimetabolites|antimetabolites|mesh-ancestor
56039374|NCT04425239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039375|NCT04425239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56039376|NCT04425239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039377|NCT04425239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56039378|NCT04425239|Immunologic Factors|immunologic factors|mesh-ancestor
56039379|NCT04425239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039380|NCT04425239|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56039381|NCT04425239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56039382|NCT04425239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039383|NCT04425239|Antidotes|antidotes|mesh-ancestor
56039384|NCT04425239|Protective Agents|protective agents|mesh-ancestor
56039385|NCT04425239|Vitamin B Complex|vitamin b complex|mesh-ancestor
55877637|NCT03421314|Antioxidants|antioxidants|mesh-ancestor
55877638|NCT03421314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877639|NCT03421314|Protective Agents|protective agents|mesh-ancestor
55877640|NCT03421314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877641|NCT03421314|Trace Elements|trace elements|mesh-ancestor
56039394|NCT01309802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56039395|NCT01309802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039396|NCT01309802|Cholinergic Agents|cholinergic agents|mesh-ancestor
56039397|NCT01309802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039398|NCT01309802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039399|NCT01309802|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56039400|NCT01309802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039401|NCT00366093|Eszopiclone|eszopiclone|mesh-list
56039402|NCT00366093|Zopiclone|zopiclone|mesh-list
56039403|NCT00366093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56039404|NCT00366093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039405|NCT00366093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039406|NCT04379999|Aspirin|aspirin|mesh-list
56039407|NCT04379999|Atorvastatin|atorvastatin|mesh-list
56039408|NCT04379999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56039409|NCT04379999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55877642|NCT03421314|Micronutrients|micronutrients|mesh-ancestor
55877643|NCT03425994|Emtricitabine|emtricitabine|mesh-list
55877644|NCT03425994|Cobicistat|cobicistat|mesh-list
55877645|NCT03425994|Elvitegravir|elvitegravir|mesh-list
55877646|NCT03425994|Antiviral Agents|antiviral agents|mesh-ancestor
55877647|NCT03425994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877648|NCT03425994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55877649|NCT03425994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55877650|NCT03425994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877651|NCT03425994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877652|NCT03425994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55877653|NCT03425994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55877654|NCT03425994|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55877655|NCT03425994|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55877656|NCT03425994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55877657|NCT03421002|Micafungin|micafungin|mesh-list
55877658|NCT03421002|Antifungal Agents|antifungal agents|mesh-ancestor
55877659|NCT03421002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877660|NCT00754260|Caffeine|caffeine|mesh-list
55877661|NCT00754260|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55877662|NCT00754260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877663|NCT00754260|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55877664|NCT00754260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877665|NCT00754260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877666|NCT00754260|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56039410|NCT04379999|Analgesics|analgesics|mesh-ancestor
56039411|NCT04379999|Sensory System Agents|sensory system agents|mesh-ancestor
56039412|NCT04379999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039413|NCT04379999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039414|NCT04379999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56039415|NCT04379999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877667|NCT00754260|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55877668|NCT00754260|Purinergic Agents|purinergic agents|mesh-ancestor
55877669|NCT00754260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877672|NCT02546232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55877673|NCT02546232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877674|NCT02546232|Tubulin Modulators|tubulin modulators|mesh-ancestor
55877675|NCT02546232|Antimitotic Agents|antimitotic agents|mesh-ancestor
55877676|NCT02546232|Mitosis Modulators|mitosis modulators|mesh-ancestor
55877677|NCT02546232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877679|NCT02521038|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55877680|NCT02521038|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55877681|NCT02521038|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55877682|NCT02521038|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55877683|NCT02521038|Purinergic Agents|purinergic agents|mesh-ancestor
55877684|NCT02521038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877685|NCT02521038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877686|NCT02521038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877688|NCT00985959|Bortezomib|bortezomib|mesh-list
55877689|NCT00985959|Melphalan|melphalan|mesh-list
55877690|NCT00985959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877691|NCT00985959|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55877692|NCT00985959|Alkylating Agents|alkylating agents|mesh-ancestor
55877693|NCT00985959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877694|NCT00985959|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55877695|NCT00985959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55877696|NCT00985959|Immunologic Factors|immunologic factors|mesh-ancestor
55877697|NCT00985959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877698|NCT00985959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55877699|NCT00985959|Glucocorticoids|glucocorticoids|mesh-ancestor
55877700|NCT00985959|Hormones|hormones|mesh-ancestor
55877701|NCT00985959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877702|NCT00985959|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55877703|NCT00985725|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55877704|NCT00985725|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55877705|NCT00985725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877706|NCT00985725|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55877707|NCT00985725|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55877708|NCT00985725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55877709|NCT00985725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877710|NCT00985725|Dopamine Agents|dopamine agents|mesh-ancestor
55877711|NCT00985725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877712|NCT01294306|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55877713|NCT01294306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877714|NCT01294306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55877715|NCT01294306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877716|NCT01294306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877717|NCT01351480|Abatacept|abatacept|mesh-list
55877718|NCT01351480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55877719|NCT01351480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877720|NCT01351480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877721|NCT01351480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55877722|NCT01351480|Immunologic Factors|immunologic factors|mesh-ancestor
55877723|NCT01351480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877724|NCT01351480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877725|NCT03393741|Paclitaxel|paclitaxel|mesh-list
55877726|NCT03393741|Vinorelbine|vinorelbine|mesh-list
55877727|NCT03393741|Docetaxel|docetaxel|mesh-list
55877728|NCT03393741|Epothilones|epothilones|mesh-list
55877729|NCT03393741|Vinca Alkaloids|vinca alkaloids|mesh-list
56039416|NCT04379999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56039417|NCT04379999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56124668|NCT01405950|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56039418|NCT04379999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039419|NCT04379999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56039420|NCT04379999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56039421|NCT04379999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039422|NCT04379999|Antipyretics|antipyretics|mesh-ancestor
56039423|NCT04379999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56039424|NCT04379999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56039425|NCT04379999|Antimetabolites|antimetabolites|mesh-ancestor
56039426|NCT04379999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56039427|NCT04379999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56039428|NCT03009422|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56039429|NCT03009422|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56039430|NCT03009422|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56039431|NCT03009422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039432|NCT03009422|Schistosomicides|schistosomicides|mesh-ancestor
56039433|NCT03009422|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56039434|NCT03009422|Anthelmintics|anthelmintics|mesh-ancestor
56039435|NCT05730621|Aspirin|aspirin|mesh-list
56039436|NCT05730621|Sarpogrelate|sarpogrelate|mesh-list
56039437|NCT05730621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56039438|NCT05730621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56039439|NCT05730621|Analgesics|analgesics|mesh-ancestor
56039440|NCT05730621|Sensory System Agents|sensory system agents|mesh-ancestor
55877730|NCT03393741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55877731|NCT03393741|Taxane|taxane|mesh-list
55877732|NCT03393741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55877733|NCT03393741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877734|NCT03393741|Tubulin Modulators|tubulin modulators|mesh-ancestor
55877735|NCT03393741|Antimitotic Agents|antimitotic agents|mesh-ancestor
55877736|NCT03393741|Mitosis Modulators|mitosis modulators|mesh-ancestor
55877737|NCT03393741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877738|NCT01352182|Pioglitazone|pioglitazone|mesh-list
55877739|NCT01352182|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55877740|NCT01352182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877741|NCT00984867|Dapagliflozin|dapagliflozin|mesh-list
55877742|NCT00984867|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55877743|NCT00984867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877744|NCT00984867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55877745|NCT00984867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877746|NCT01294384|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55877747|NCT01294384|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55877748|NCT01294384|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55877749|NCT01294384|Laxatives|laxatives|mesh-ancestor
55877750|NCT01294384|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55877751|NCT01257802|Leuprolide|leuprolide|mesh-list
55877752|NCT01257802|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56039441|NCT05730621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039442|NCT05730621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039443|NCT05730621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56039444|NCT05730621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039445|NCT05730621|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55877753|NCT01257802|Fertility Agents|fertility agents|mesh-ancestor
55877754|NCT01257802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55877755|NCT01257802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877756|NCT01257802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55877757|NCT01257802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877758|NCT05607303|Estrogens|estrogens|mesh-list
55877759|NCT05607303|Hormones|hormones|mesh-ancestor
55877760|NCT05607303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877761|NCT05607303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877762|NCT00984009|Colchicine|colchicine|mesh-list
55877763|NCT00984009|Gout Suppressants|gout suppressants|mesh-ancestor
55877764|NCT00984009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877765|NCT00984009|Tubulin Modulators|tubulin modulators|mesh-ancestor
55877766|NCT00984009|Antimitotic Agents|antimitotic agents|mesh-ancestor
55877767|NCT00984009|Mitosis Modulators|mitosis modulators|mesh-ancestor
55877768|NCT00984009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877769|NCT00984009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877770|NCT05604729|Botulinum Toxins|botulinum toxins|mesh-list
55877771|NCT05604729|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55877772|NCT05604729|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55877773|NCT05604729|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55877774|NCT05604729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55877775|NCT05604729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877776|NCT05604729|Cholinergic Agents|cholinergic agents|mesh-ancestor
55877777|NCT05604729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877778|NCT05604729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877779|NCT05604729|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55877780|NCT05604729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877782|NCT05606913|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55877783|NCT05606913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877784|NCT00983931|Cyclosporine|cyclosporine|mesh-list
55877785|NCT00983931|Colchicine|colchicine|mesh-list
55877786|NCT00983931|Cyclosporins|cyclosporins|mesh-list
55877787|NCT00983931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877788|NCT00983931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877789|NCT00983931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55877790|NCT00983931|Immunologic Factors|immunologic factors|mesh-ancestor
55877791|NCT00983931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877792|NCT00983931|Antifungal Agents|antifungal agents|mesh-ancestor
55877793|NCT00983931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877794|NCT00983931|Dermatologic Agents|dermatologic agents|mesh-ancestor
55877795|NCT00983931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877796|NCT00983931|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55877797|NCT00983931|Gout Suppressants|gout suppressants|mesh-ancestor
55877798|NCT00983931|Tubulin Modulators|tubulin modulators|mesh-ancestor
55877799|NCT00983931|Antimitotic Agents|antimitotic agents|mesh-ancestor
55877800|NCT00983931|Mitosis Modulators|mitosis modulators|mesh-ancestor
55877801|NCT00983931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877802|NCT00983853|Ribavirin|ribavirin|mesh-list
55877803|NCT00983853|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55877804|NCT00983853|Antimetabolites|antimetabolites|mesh-ancestor
55877805|NCT00983853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877806|NCT00983853|Antiviral Agents|antiviral agents|mesh-ancestor
55877807|NCT00983853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877808|NCT05604261|Rabeprazole|rabeprazole|mesh-list
55877809|NCT05604261|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55877810|NCT05604261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55877811|NCT05604261|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55877812|NCT05604261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877813|NCT05604261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877814|NCT03032601|Acetylcysteine|acetylcysteine|mesh-list
55877815|NCT03032601|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55877816|NCT03032601|Antiviral Agents|antiviral agents|mesh-ancestor
55877818|NCT03032601|Expectorants|expectorants|mesh-ancestor
56039446|NCT05730621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56039447|NCT05730621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039448|NCT05730621|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56039449|NCT05730621|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56039450|NCT05730621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039451|NCT05730621|Antipyretics|antipyretics|mesh-ancestor
56039452|NCT05730621|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56039453|NCT05730621|Serotonin Agents|serotonin agents|mesh-ancestor
56039454|NCT05730621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039455|NCT01346072|Tolvaptan|tolvaptan|mesh-list
56039456|NCT01346072|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56039457|NCT01346072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039458|NCT01346072|Natriuretic Agents|natriuretic agents|mesh-ancestor
56039459|NCT01346072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039460|NCT04292483|Nitric Oxide|nitric oxide|mesh-list
56039461|NCT04292483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56039462|NCT04292483|Autonomic Agents|autonomic agents|mesh-ancestor
56039463|NCT04292483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039464|NCT04292483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039465|NCT04292483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56039466|NCT04292483|Respiratory System Agents|respiratory system agents|mesh-ancestor
56039467|NCT04292483|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56039468|NCT04292483|Antioxidants|antioxidants|mesh-ancestor
56039469|NCT04292483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039470|NCT04292483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039471|NCT04292483|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56039472|NCT04292483|Vasodilator Agents|vasodilator agents|mesh-ancestor
56039473|NCT04292483|Gasotransmitters|gasotransmitters|mesh-ancestor
56039474|NCT04292483|Protective Agents|protective agents|mesh-ancestor
55877819|NCT03032601|Respiratory System Agents|respiratory system agents|mesh-ancestor
55877820|NCT03032601|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55877821|NCT03032601|Antioxidants|antioxidants|mesh-ancestor
55877822|NCT03032601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877823|NCT03032601|Protective Agents|protective agents|mesh-ancestor
55877824|NCT03032601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877825|NCT03032601|Antidotes|antidotes|mesh-ancestor
55877826|NCT05603013|Vinorelbine|vinorelbine|mesh-list
55877827|NCT05603013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55877828|NCT05603013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55877829|NCT05603013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877830|NCT05603013|Tubulin Modulators|tubulin modulators|mesh-ancestor
55877831|NCT05603013|Antimitotic Agents|antimitotic agents|mesh-ancestor
56039476|NCT05363007|Irinotecan|irinotecan|mesh-list
56039477|NCT05363007|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56039478|NCT05363007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56039479|NCT05363007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039480|NCT05363007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039481|NCT05363007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039482|NCT05363007|Antidotes|antidotes|mesh-ancestor
56039483|NCT05363007|Protective Agents|protective agents|mesh-ancestor
56039484|NCT05363007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039485|NCT05363007|Vitamin B Complex|vitamin b complex|mesh-ancestor
56039486|NCT05363007|Vitamins|vitamins|mesh-ancestor
56039487|NCT05363007|Micronutrients|micronutrients|mesh-ancestor
56039488|NCT01347008|Sildenafil Citrate|sildenafil citrate|mesh-list
56039489|NCT01347008|Citric Acid|citric acid|mesh-list
56039490|NCT01347008|Sodium Citrate|sodium citrate|mesh-list
56039491|NCT01347008|Anticoagulants|anticoagulants|mesh-ancestor
55877832|NCT05603013|Mitosis Modulators|mitosis modulators|mesh-ancestor
55877833|NCT05603013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877834|NCT00983073|Tapentadol|tapentadol|mesh-list
55877835|NCT00983073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55877836|NCT00983073|Narcotics|narcotics|mesh-ancestor
55877837|NCT00983073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55877838|NCT00983073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877839|NCT00983073|Analgesics|analgesics|mesh-ancestor
55877840|NCT00983073|Sensory System Agents|sensory system agents|mesh-ancestor
55877841|NCT00983073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877842|NCT00983073|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55877843|NCT00983073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55877844|NCT00983073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55877845|NCT00983073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877846|NCT00983073|Adrenergic Agents|adrenergic agents|mesh-ancestor
55835555|NCT01773993|Pregabalin|pregabalin|mesh-list
55877847|NCT00983073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877848|NCT05603715|Bromides|bromides|mesh-list
55877849|NCT05603715|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55877850|NCT05603715|Anticonvulsants|anticonvulsants|mesh-ancestor
55877851|NCT05603715|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55877852|NCT05603715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877853|NCT05603715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877854|NCT05603715|Cholinergic Agents|cholinergic agents|mesh-ancestor
55877855|NCT05603715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877856|NCT05603715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877857|NCT00981747|Losartan|losartan|mesh-list
55877858|NCT00981747|Sildenafil Citrate|sildenafil citrate|mesh-list
55877859|NCT00981747|Vasodilator Agents|vasodilator agents|mesh-ancestor
55877860|NCT00981747|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55877861|NCT00981747|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55877862|NCT00981747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877863|NCT00981747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877864|NCT00981747|Urological Agents|urological agents|mesh-ancestor
55877865|NCT00981747|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55877866|NCT00981747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55877867|NCT00981747|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55877868|NCT00981747|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55877869|NCT03046251|Natalizumab|natalizumab|mesh-list
55877870|NCT03046251|Immunologic Factors|immunologic factors|mesh-ancestor
55877871|NCT03046251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877872|NCT03029169|Amiodarone|amiodarone|mesh-list
55877873|NCT03029169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55877874|NCT03029169|Propafenone|propafenone|mesh-list
55877875|NCT03029169|Vasodilator Agents|vasodilator agents|mesh-ancestor
55877876|NCT03029169|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56039492|NCT01347008|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56039493|NCT01347008|Chelating Agents|chelating agents|mesh-ancestor
56039495|NCT01347008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039496|NCT01347008|Vasodilator Agents|vasodilator agents|mesh-ancestor
56039497|NCT01347008|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56039498|NCT01347008|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56039499|NCT01347008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039500|NCT01347008|Urological Agents|urological agents|mesh-ancestor
56039501|NCT05343429|Aspirin|aspirin|mesh-list
56039502|NCT05343429|Benzydamine|benzydamine|mesh-list
56039503|NCT05343429|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56039504|NCT05343429|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56039505|NCT05343429|Analgesics|analgesics|mesh-ancestor
56039506|NCT05343429|Sensory System Agents|sensory system agents|mesh-ancestor
56039507|NCT05343429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039508|NCT05343429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039509|NCT05343429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56039510|NCT05343429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039511|NCT05343429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56039512|NCT05343429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56039513|NCT05343429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039514|NCT05343429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56039515|NCT05343429|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55877877|NCT03029169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55877878|NCT03029169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877879|NCT03029169|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55877880|NCT03029169|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55877881|NCT03029169|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55877882|NCT03029169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877883|NCT03029169|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55877884|NCT03029169|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55877885|NCT03029169|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55877886|NCT03029169|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55877887|NCT01295710|Immunoglobulins|immunoglobulins|mesh-list
55877888|NCT01295710|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55877892|NCT01353976|Econazole|econazole|mesh-list
55877893|NCT01353976|Antifungal Agents|antifungal agents|mesh-ancestor
55877894|NCT01353976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877895|NCT01353976|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55877896|NCT01353976|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55877897|NCT01353976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877898|NCT01353976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877899|NCT01353976|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55877900|NCT01353976|Hormone Antagonists|hormone antagonists|mesh-ancestor
55750271|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
55877901|NCT01353976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877902|NCT01353976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039516|NCT05343429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039518|NCT05319873|Carboplatin|carboplatin|mesh-list
56039519|NCT05319873|Docetaxel|docetaxel|mesh-list
56039520|NCT05319873|Trastuzumab|trastuzumab|mesh-list
56039521|NCT05319873|Fulvestrant|fulvestrant|mesh-list
56039522|NCT05319873|Pertuzumab|pertuzumab|mesh-list
56039523|NCT05319873|Tucatinib|tucatinib|mesh-list
56039524|NCT05319873|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56039525|NCT05319873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56039526|NCT05319873|Antibodies|antibodies|mesh-list
56039527|NCT05319873|Immunoglobulins|immunoglobulins|mesh-list
56039528|NCT05319873|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56039529|NCT05319873|Immunologic Factors|immunologic factors|mesh-ancestor
56039530|NCT05319873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039531|NCT05319873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039532|NCT05319873|Tubulin Modulators|tubulin modulators|mesh-ancestor
56039533|NCT05319873|Antimitotic Agents|antimitotic agents|mesh-ancestor
56039534|NCT05319873|Mitosis Modulators|mitosis modulators|mesh-ancestor
56039535|NCT05319873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039536|NCT05319873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56039537|NCT05319873|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56039538|NCT05319873|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56039539|NCT05319873|Hormone Antagonists|hormone antagonists|mesh-ancestor
56039540|NCT05319873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877904|NCT01354444|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55877905|NCT01354444|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55877906|NCT01354444|Adrenergic Agents|adrenergic agents|mesh-ancestor
55877907|NCT01354444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877908|NCT01354444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877909|NCT01354444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877910|NCT01354444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55877911|NCT01354444|Antioxidants|antioxidants|mesh-ancestor
55877912|NCT01354444|Protective Agents|protective agents|mesh-ancestor
55877913|NCT01354444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55877914|NCT01354444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55877915|NCT01354444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55877916|NCT01354444|Vasodilator Agents|vasodilator agents|mesh-ancestor
55877917|NCT01354444|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55877918|NCT01354444|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55877919|NCT03009526|Pyrimethamine|pyrimethamine|mesh-list
55877920|NCT03009526|Piperaquine|piperaquine|mesh-list
55877921|NCT03009526|Sulfadoxine|sulfadoxine|mesh-list
55877922|NCT03009526|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55877923|NCT03009526|Artenimol|artenimol|mesh-list
55877924|NCT03009526|Antimalarials|antimalarials|mesh-ancestor
55877925|NCT03009526|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55877926|NCT03009526|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55877927|NCT03009526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877928|NCT03009526|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56039541|NCT05319873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56039542|NCT05319873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039543|NCT01310582|Sevoflurane|sevoflurane|mesh-list
56039544|NCT01310582|Desflurane|desflurane|mesh-list
56039545|NCT01310582|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56039546|NCT01310582|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56039547|NCT01310582|Anesthetics, General|anesthetics, general|mesh-ancestor
56039548|NCT01310582|Anesthetics|anesthetics|mesh-ancestor
56039549|NCT01310582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039550|NCT01310582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039551|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
56039552|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56039553|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039554|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
56039555|NCT05193591|Autoantibodies|autoantibodies|mesh-list
56039556|NCT05193591|Immunologic Factors|immunologic factors|mesh-ancestor
56039557|NCT05193591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039558|NCT05138835|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56039559|NCT05138835|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56039560|NCT05138835|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56039561|NCT05138835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039562|NCT05138835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039563|NCT05138835|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56039564|NCT05138835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56039565|NCT05138835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039566|NCT05138835|Cholinergic Agents|cholinergic agents|mesh-ancestor
56039589|NCT05561751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039590|NCT05561751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039591|NCT05561751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039592|NCT05561751|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56039593|NCT05561751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56039594|NCT05561751|Vasodilator Agents|vasodilator agents|mesh-ancestor
56039596|NCT05556681|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56039597|NCT05556681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039598|NCT05556681|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56039599|NCT05556681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039600|NCT05556681|Antifungal Agents|antifungal agents|mesh-ancestor
56039601|NCT05556681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56039602|NCT05556681|Immunologic Factors|immunologic factors|mesh-ancestor
56039603|NCT05556681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039604|NCT05081193|Methyltestosterone|methyltestosterone|mesh-list
56039605|NCT05081193|Testosterone|testosterone|mesh-list
56039606|NCT05081193|Testosterone undecanoate|testosterone undecanoate|mesh-list
56039607|NCT05081193|Testosterone enanthate|testosterone enanthate|mesh-list
56039608|NCT05081193|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56039609|NCT05081193|Androgens|androgens|mesh-ancestor
56039610|NCT05081193|Hormones|hormones|mesh-ancestor
56039611|NCT05081193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56039612|NCT05081193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039613|NCT05081193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56039614|NCT05081193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039615|NCT05081193|Anabolic Agents|anabolic agents|mesh-ancestor
56039616|NCT01349972|Cytarabine|cytarabine|mesh-list
56039617|NCT01349972|Daunorubicin|daunorubicin|mesh-list
56039618|NCT01349972|Mitoxantrone|mitoxantrone|mesh-list
56039619|NCT01349972|Alvocidib|alvocidib|mesh-list
56039620|NCT01349972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56039621|NCT01349972|Antimetabolites|antimetabolites|mesh-ancestor
56039632|NCT01349972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039633|NCT01349972|Analgesics|analgesics|mesh-ancestor
56039634|NCT01349972|Sensory System Agents|sensory system agents|mesh-ancestor
56039635|NCT01349972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039636|NCT01349972|Growth Inhibitors|growth inhibitors|mesh-ancestor
56039637|NCT01349972|Growth Substances|growth substances|mesh-ancestor
56039638|NCT01349972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56039639|NCT04590963|Cetuximab|cetuximab|mesh-list
56039640|NCT04590963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56039641|NCT04590963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039642|NCT01248104|Tranexamic Acid|tranexamic acid|mesh-list
56039643|NCT01248104|Aminocaproic Acid|aminocaproic acid|mesh-list
56039644|NCT01248104|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56039645|NCT01248104|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56039646|NCT01248104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039647|NCT01248104|Hemostatics|hemostatics|mesh-ancestor
56039648|NCT01248104|Coagulants|coagulants|mesh-ancestor
56039649|NCT01748045|Nitric Oxide|nitric oxide|mesh-list
56039650|NCT01748045|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56039651|NCT01748045|Autonomic Agents|autonomic agents|mesh-ancestor
56039652|NCT01748045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039653|NCT01748045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877929|NCT03009526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877930|NCT03009526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877931|NCT03009526|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55877932|NCT03009526|Renal Agents|renal agents|mesh-ancestor
55877933|NCT01354990|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55877934|NCT01354990|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55877935|NCT01354990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877936|NCT01354990|Incretins|incretins|mesh-ancestor
55877937|NCT01354990|Hormones|hormones|mesh-ancestor
55877938|NCT01354990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877939|NCT01354990|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55877940|NCT01354990|Protease Inhibitors|protease inhibitors|mesh-ancestor
55877941|NCT01354990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877942|NCT01354990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877943|NCT01260454|Capsaicin|capsaicin|mesh-list
55877944|NCT01260454|Antipruritics|antipruritics|mesh-ancestor
55877945|NCT01260454|Dermatologic Agents|dermatologic agents|mesh-ancestor
55877946|NCT01260454|Sensory System Agents|sensory system agents|mesh-ancestor
55877947|NCT01260454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877948|NCT01260454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877949|NCT01296646|Naltrexone|naltrexone|mesh-list
55877950|NCT01296646|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55877951|NCT01296646|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55877952|NCT01296646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877953|NCT01296646|Sensory System Agents|sensory system agents|mesh-ancestor
55877954|NCT01296646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55877955|NCT01297348|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55877956|NCT01297348|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55835908|NCT01625897|Risperidone|risperidone|mesh-list
55877957|NCT01297348|Levonorgestrel|levonorgestrel|mesh-list
56039654|NCT01748045|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56039655|NCT01748045|Respiratory System Agents|respiratory system agents|mesh-ancestor
56039656|NCT01748045|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56039657|NCT01748045|Antioxidants|antioxidants|mesh-ancestor
56039658|NCT01748045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039659|NCT01748045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039660|NCT01748045|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56039661|NCT01748045|Vasodilator Agents|vasodilator agents|mesh-ancestor
56039662|NCT01748045|Gasotransmitters|gasotransmitters|mesh-ancestor
56039663|NCT01748045|Protective Agents|protective agents|mesh-ancestor
56039664|NCT01312766|Menotropins|menotropins|mesh-list
56039665|NCT01312766|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56039666|NCT01312766|Fertility Agents|fertility agents|mesh-ancestor
56039667|NCT01312766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56039668|NCT01312766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039669|NCT01749215|Topiramate|topiramate|mesh-list
56039670|NCT01749215|Anticonvulsants|anticonvulsants|mesh-ancestor
56039671|NCT01749215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56039672|NCT01749215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039673|NCT04522167|Aflibercept|aflibercept|mesh-list
56039674|NCT04522167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56039675|NCT04522167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56039676|NCT04522167|Growth Substances|growth substances|mesh-ancestor
56039677|NCT04522167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039678|NCT04522167|Growth Inhibitors|growth inhibitors|mesh-ancestor
56039679|NCT04522167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039680|NCT01248416|Letrozole|letrozole|mesh-list
56039681|NCT01248416|Anastrozole|anastrozole|mesh-list
56039701|NCT01749293|Alkylating Agents|alkylating agents|mesh-ancestor
56039702|NCT01749293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039703|NCT01749293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039704|NCT01749293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56039705|NCT01250210|Levonorgestrel|levonorgestrel|mesh-list
56039706|NCT01250210|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56039707|NCT01250210|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56039708|NCT01250210|Estradiol|estradiol|mesh-list
56039709|NCT01250210|Estrogens|estrogens|mesh-ancestor
56039710|NCT01250210|Hormones|hormones|mesh-ancestor
56039711|NCT01250210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56039712|NCT01250210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039713|NCT01250210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56039714|NCT01250210|Contraceptive Agents|contraceptive agents|mesh-ancestor
56039715|NCT01250210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56039716|NCT01250210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56039717|NCT01250210|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56039718|NCT01250210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56039719|NCT01250210|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56039720|NCT01250210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56039721|NCT01749605|Ciprofloxacin|ciprofloxacin|mesh-list
56039722|NCT01749605|Nitrofurantoin|nitrofurantoin|mesh-list
56039723|NCT01749605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56039724|NCT01749605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039725|NCT01749605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56039726|NCT01749605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56039727|NCT01749605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888154|NCT03176134|Tedizolid phosphate|tedizolid phosphate|mesh-list
56039728|NCT01749605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039729|NCT01749605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039730|NCT01749605|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56039731|NCT01749605|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56039732|NCT01749605|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55877958|NCT01297348|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55877959|NCT01297348|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
55877962|NCT01297348|Contraceptives, Oral|contraceptives, oral|mesh-list
55877963|NCT01297348|Estradiol|estradiol|mesh-list
55877964|NCT01297348|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56039733|NCT01749605|Renal Agents|renal agents|mesh-ancestor
56039734|NCT01312844|Scopolamine|scopolamine|mesh-list
56039735|NCT01312844|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56039736|NCT01312844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56039737|NCT01312844|Antiemetics|antiemetics|mesh-ancestor
56039738|NCT01312844|Autonomic Agents|autonomic agents|mesh-ancestor
56039739|NCT01312844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039740|NCT01312844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039741|NCT01312844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56039742|NCT01312844|Mydriatics|mydriatics|mesh-ancestor
56039743|NCT01312844|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56039744|NCT01312844|Cholinergic Agents|cholinergic agents|mesh-ancestor
56039745|NCT01312844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039746|NCT01312844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039747|NCT01312844|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56039748|NCT01312844|Parasympatholytics|parasympatholytics|mesh-ancestor
56039749|NCT01750931|Meloxicam|meloxicam|mesh-list
56039750|NCT01750931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56039751|NCT01750931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56039752|NCT01750931|Analgesics|analgesics|mesh-ancestor
56039753|NCT01750931|Sensory System Agents|sensory system agents|mesh-ancestor
56039754|NCT01750931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039755|NCT01750931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039756|NCT01750931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56039757|NCT01750931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039758|NCT01750931|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56039759|NCT01750931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56039760|NCT01750931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039761|NCT01750931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039762|NCT01731041|Ticagrelor|ticagrelor|mesh-list
56039776|NCT01313936|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56039777|NCT01313936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039778|NCT01313936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039779|NCT01313936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039780|NCT01313936|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56039782|NCT01752413|Hematinics|hematinics|mesh-ancestor
56039783|NCT01731119|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56039784|NCT01731119|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56039785|NCT01731119|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56039786|NCT01731119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039787|NCT01731119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039788|NCT01731119|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56039789|NCT01731119|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56039790|NCT01731119|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56039791|NCT01731119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56039792|NCT01731119|Adrenergic Agents|adrenergic agents|mesh-ancestor
56039793|NCT01731119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039794|NCT01731119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039795|NCT01731119|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56039796|NCT01731119|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56039798|NCT01731119|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55767000|NCT05507229|Vaccines|vaccines|mesh-list
56039799|NCT01731119|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56039800|NCT01731119|Dopamine Agents|dopamine agents|mesh-ancestor
56039801|NCT04750707|Hydroxyurea|hydroxyurea|mesh-list
56039802|NCT04750707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039803|NCT04750707|Antisickling Agents|antisickling agents|mesh-ancestor
56039804|NCT04750707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039806|NCT04750707|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56039818|NCT01250834|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56039819|NCT01250834|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56039820|NCT01250834|Antimetabolites|antimetabolites|mesh-ancestor
56039821|NCT01250834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039822|NCT01250834|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56039823|NCT01250834|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56039824|NCT01250834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039825|NCT01250834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56039826|NCT01250834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039827|NCT04387695|Sorafenib|sorafenib|mesh-list
56039828|NCT04387695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039829|NCT04387695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56039830|NCT04387695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039833|NCT01354652|Entecavir|entecavir|mesh-list
56039834|NCT01354652|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56039835|NCT01354652|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56039836|NCT01354652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039837|NCT01354652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039838|NCT01354652|Antiviral Agents|antiviral agents|mesh-ancestor
56039839|NCT01354652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039840|NCT01354652|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56051694|NCT01783574|Testosterone enanthate|testosterone enanthate|mesh-list
56039841|NCT01354652|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56039842|NCT01753739|Bepotastine besilate|bepotastine besilate|mesh-list
56039843|NCT01753739|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56039844|NCT04348383|Defibrotide|defibrotide|mesh-list
56039845|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55877967|NCT01297348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877968|NCT01297348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877969|NCT01297348|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55877970|NCT01297348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55877971|NCT01297348|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55877972|NCT01297348|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55877973|NCT01297348|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55877974|NCT01297348|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55877975|NCT01297348|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
55877976|NCT01856309|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55877977|NCT01856309|Immunologic Factors|immunologic factors|mesh-ancestor
55877978|NCT01856309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877979|NCT01260688|Dasatinib|dasatinib|mesh-list
55877980|NCT01260688|Cediranib|cediranib|mesh-list
55877981|NCT01260688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039846|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56039847|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039848|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56039849|NCT01250990|Niacin|niacin|mesh-list
56039850|NCT01250990|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56039851|NCT01250990|Antimetabolites|antimetabolites|mesh-ancestor
56039852|NCT01250990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039853|NCT01250990|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56039854|NCT01250990|Vasodilator Agents|vasodilator agents|mesh-ancestor
56039855|NCT01250990|Vitamin B Complex|vitamin b complex|mesh-ancestor
56039856|NCT01250990|Vitamins|vitamins|mesh-ancestor
56039857|NCT01250990|Micronutrients|micronutrients|mesh-ancestor
56039858|NCT01250990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039859|NCT02990975|Ketamine|ketamine|mesh-list
56039860|NCT02990975|Analgesics|analgesics|mesh-ancestor
56039861|NCT02990975|Sensory System Agents|sensory system agents|mesh-ancestor
56039862|NCT02990975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56039863|NCT02990975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039864|NCT02990975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56039865|NCT02990975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56039866|NCT02990975|Anesthetics, General|anesthetics, general|mesh-ancestor
56039868|NCT02990975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039869|NCT02990975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56039870|NCT02990975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56039871|NCT02990975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55877982|NCT01260688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55877983|NCT01260688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877984|NCT01260688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877985|NCT01298128|NuvaRing|nuvaring|mesh-list
55877986|NCT01298128|Desogestrel|desogestrel|mesh-list
55877987|NCT01298128|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55877988|NCT01298128|Contraceptive Agents|contraceptive agents|mesh-ancestor
55877989|NCT01298128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55877990|NCT01298128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877991|NCT01298128|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55877992|NCT01298128|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55877993|NCT01298128|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55877994|NCT01298128|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55877995|NCT01298128|Progestins|progestins|mesh-ancestor
55877996|NCT01298128|Hormones|hormones|mesh-ancestor
55877997|NCT01298128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55877998|NCT02199964|Cyclosporine|cyclosporine|mesh-list
55877999|NCT02199964|Lubricant Eye Drops|lubricant eye drops|mesh-list
55878000|NCT02199964|Cyclosporins|cyclosporins|mesh-list
55878001|NCT02199964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878002|NCT02199964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878003|NCT02199964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56039872|NCT02990975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039873|NCT01315574|Travoprost|travoprost|mesh-list
56039874|NCT01315574|Latanoprost|latanoprost|mesh-list
56039875|NCT01315574|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55878004|NCT02199964|Immunologic Factors|immunologic factors|mesh-ancestor
55878005|NCT02199964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878006|NCT02199964|Antifungal Agents|antifungal agents|mesh-ancestor
55878007|NCT02199964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878008|NCT02199964|Dermatologic Agents|dermatologic agents|mesh-ancestor
55878009|NCT02199964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55878010|NCT02199964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55878011|NCT02199964|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55878012|NCT02199964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55878013|NCT02323048|Methamphetamine|methamphetamine|mesh-list
55878014|NCT02323048|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55878015|NCT02323048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878016|NCT02323048|Sympathomimetics|sympathomimetics|mesh-ancestor
55878017|NCT02323048|Autonomic Agents|autonomic agents|mesh-ancestor
55878018|NCT02323048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878019|NCT02323048|Dopamine Agents|dopamine agents|mesh-ancestor
55878020|NCT02323048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878021|NCT02323048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878022|NCT02323048|Adrenergic Agents|adrenergic agents|mesh-ancestor
55878023|NCT02323048|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55878024|NCT02323048|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55878025|NCT02323048|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878026|NCT02323048|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55878027|NCT01265446|Lidocaine|lidocaine|mesh-list
55878028|NCT01265446|Anesthetics, Local|anesthetics, local|mesh-ancestor
55878029|NCT01265446|Anesthetics|anesthetics|mesh-ancestor
55878030|NCT01265446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878031|NCT01265446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878033|NCT01265446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878034|NCT01265446|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55878035|NCT01265446|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55878036|NCT01265446|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55878037|NCT01265446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878038|NCT01265446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878040|NCT04352062|Levofloxacin|levofloxacin|mesh-list
55878043|NCT04352062|Pantoprazole|pantoprazole|mesh-list
55878044|NCT04352062|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55878045|NCT04352062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878046|NCT04352062|Antioxidants|antioxidants|mesh-ancestor
55878047|NCT04352062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878048|NCT04352062|Protective Agents|protective agents|mesh-ancestor
55878049|NCT04352062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878050|NCT04352062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878051|NCT04352062|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55878052|NCT04352062|Renal Agents|renal agents|mesh-ancestor
55878053|NCT04352062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55878054|NCT04352062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55878055|NCT04352062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878056|NCT04352062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878057|NCT04352062|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55878058|NCT04352062|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55878059|NCT04352062|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55878060|NCT04352062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878061|NCT04352062|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55878062|NCT01302808|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55878063|NCT01302808|Romidepsin|romidepsin|mesh-list
55878064|NCT01302808|Antiemetics|antiemetics|mesh-list
55878065|NCT01302808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878066|NCT01302808|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55878067|NCT01302808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878068|NCT01302808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878069|NCT01302808|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55878070|NCT01302808|Autonomic Agents|autonomic agents|mesh-ancestor
55878071|NCT01302808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878072|NCT01302808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039876|NCT01315574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56039877|NCT01315574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56039878|NCT00422331|Lithium Carbonate|lithium carbonate|mesh-list
56039879|NCT00422331|Antidepressive Agents|antidepressive agents|mesh-ancestor
56039880|NCT00422331|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56039881|NCT00422331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039882|NCT00422331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039883|NCT00422331|Antimanic Agents|antimanic agents|mesh-ancestor
56039884|NCT00422331|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56039885|NCT00422331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039886|NCT00422331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039888|NCT01316042|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836176|NCT01977794|Amlodipine|amlodipine|mesh-list
56039889|NCT01316042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039890|NCT01754909|Enalapril|enalapril|mesh-list
56039891|NCT01754909|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55878073|NCT01302808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878074|NCT01267240|Capecitabine|capecitabine|mesh-list
55878075|NCT01267240|Vorinostat|vorinostat|mesh-list
55878076|NCT01267240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55878077|NCT01267240|Antimetabolites|antimetabolites|mesh-ancestor
55878078|NCT01267240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878079|NCT01267240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878080|NCT01267240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55878081|NCT01267240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878082|NCT01855919|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55878083|NCT01855919|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55878084|NCT01855919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55878085|NCT01855919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878086|NCT01855919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878087|NCT01855919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878088|NCT01855919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878089|NCT01855919|Analgesics|analgesics|mesh-ancestor
55878090|NCT01855919|Sensory System Agents|sensory system agents|mesh-ancestor
55878091|NCT01855919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878092|NCT01855919|Antidepressive Agents|antidepressive agents|mesh-ancestor
55878093|NCT01855919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55878094|NCT01855919|Dopamine Agents|dopamine agents|mesh-ancestor
55878095|NCT01871285|Morphine|morphine|mesh-list
55878096|NCT01871285|Oxycodone|oxycodone|mesh-list
55878097|NCT01871285|Buprenorphine|buprenorphine|mesh-list
55878098|NCT01871285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55878099|NCT01871285|Narcotics|narcotics|mesh-ancestor
55878100|NCT01871285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878101|NCT01871285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878102|NCT01871285|Analgesics|analgesics|mesh-ancestor
55878103|NCT01871285|Sensory System Agents|sensory system agents|mesh-ancestor
55878104|NCT01871285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836300|NCT04670666|Hormones|hormones|mesh-ancestor
55878105|NCT01871285|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55878109|NCT01358266|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55878110|NCT01358266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878111|NCT01358266|Antifungal Agents|antifungal agents|mesh-ancestor
55878112|NCT01358266|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55878113|NCT01358266|Immunologic Factors|immunologic factors|mesh-ancestor
55878114|NCT01358266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878116|NCT01870973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55878117|NCT01870973|Analgesics|analgesics|mesh-list
55878118|NCT01870973|Anesthetics|anesthetics|mesh-list
55878119|NCT01870973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039892|NCT01754909|Protease Inhibitors|protease inhibitors|mesh-ancestor
56039893|NCT01754909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039894|NCT01754909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039895|NCT01754909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56039896|NCT04375527|Nivolumab|nivolumab|mesh-list
56039897|NCT04375527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56039898|NCT04375527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039899|NCT04375527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56039900|NCT04375527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039901|NCT04297995|Carboplatin|carboplatin|mesh-list
56039902|NCT04297995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039903|NCT04340349|Hydroxychloroquine|hydroxychloroquine|mesh-list
56039904|NCT04340349|Bromhexine|bromhexine|mesh-list
56039905|NCT04340349|Antimalarials|antimalarials|mesh-ancestor
56039906|NCT04340349|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56039907|NCT04340349|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56039908|NCT04340349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039909|NCT04340349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039910|NCT04340349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039911|NCT04340349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039912|NCT04340349|Expectorants|expectorants|mesh-ancestor
56039913|NCT04340349|Respiratory System Agents|respiratory system agents|mesh-ancestor
56039914|NCT04268771|Rituximab|rituximab|mesh-list
56039915|NCT04268771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56039916|NCT04268771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039917|NCT04268771|Immunologic Factors|immunologic factors|mesh-ancestor
56039918|NCT04268771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039919|NCT04268771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56039920|NCT04267809|Vitamin D|vitamin d|mesh-list
56039921|NCT04267809|Metformin|metformin|mesh-list
56039922|NCT04267809|Calcium|calcium|mesh-list
55878120|NCT01870973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878121|NCT01870973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878122|NCT01870973|Antitubercular Agents|antitubercular agents|mesh-ancestor
55878123|NCT01870973|Sensory System Agents|sensory system agents|mesh-ancestor
55878124|NCT01870973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878125|NCT01267864|Ketorolac|ketorolac|mesh-list
55878126|NCT01267864|Valproic Acid|valproic acid|mesh-list
55878127|NCT01267864|Metoclopramide|metoclopramide|mesh-list
55878128|NCT01267864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55878129|NCT01267864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55836319|NCT04717973|Vitamins|vitamins|mesh-list
55878130|NCT01267864|Analgesics|analgesics|mesh-ancestor
55878131|NCT01267864|Sensory System Agents|sensory system agents|mesh-ancestor
55878132|NCT01267864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878133|NCT01267864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039923|NCT04267809|Vitamins|vitamins|mesh-ancestor
56039924|NCT04267809|Micronutrients|micronutrients|mesh-ancestor
56039925|NCT04267809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039926|NCT04267809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56039927|NCT04267809|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56039928|NCT04267809|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56039929|NCT02242409|Gemcitabine|gemcitabine|mesh-list
56039930|NCT02242409|Paclitaxel|paclitaxel|mesh-list
56039931|NCT02242409|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56039932|NCT02242409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56039933|NCT02242409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56039934|NCT02242409|Tubulin Modulators|tubulin modulators|mesh-ancestor
56039935|NCT02242409|Antimitotic Agents|antimitotic agents|mesh-ancestor
56039936|NCT02242409|Mitosis Modulators|mitosis modulators|mesh-ancestor
55744418|NCT03330223|Ticagrelor|ticagrelor|mesh-list
55878134|NCT01267864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55878135|NCT01267864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55878136|NCT01267864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55878137|NCT01267864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878138|NCT01267864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878139|NCT01267864|Anticonvulsants|anticonvulsants|mesh-ancestor
55878140|NCT01267864|GABA Agents|gaba agents|mesh-ancestor
55878141|NCT01267864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878142|NCT01267864|Antimanic Agents|antimanic agents|mesh-ancestor
55878143|NCT01267864|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55878144|NCT01267864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878145|NCT01267864|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55878146|NCT01267864|Antiemetics|antiemetics|mesh-ancestor
55878147|NCT01267864|Autonomic Agents|autonomic agents|mesh-ancestor
55878148|NCT01267864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878149|NCT01267864|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55878150|NCT01267864|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55878151|NCT01267864|Dopamine Agents|dopamine agents|mesh-ancestor
55878152|NCT01854827|Immunoglobulins|immunoglobulins|mesh-list
55878153|NCT01854827|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55878154|NCT01854827|Antibodies|antibodies|mesh-list
55878155|NCT01854827|gamma-Globulins|gamma-globulins|mesh-list
55878156|NCT01854827|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55878157|NCT01854827|Immunologic Factors|immunologic factors|mesh-ancestor
55878158|NCT01854827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878159|NCT01360450|Clonidine|clonidine|mesh-list
55878160|NCT01360450|Analgesics|analgesics|mesh-ancestor
55878161|NCT01360450|Sensory System Agents|sensory system agents|mesh-ancestor
55878162|NCT01360450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878163|NCT01360450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878164|NCT01360450|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55878165|NCT01360450|Sympatholytics|sympatholytics|mesh-ancestor
55878166|NCT01360450|Autonomic Agents|autonomic agents|mesh-ancestor
55878167|NCT01360450|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55878168|NCT01360450|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55878169|NCT01360450|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55878170|NCT01360450|Adrenergic Agents|adrenergic agents|mesh-ancestor
55878171|NCT01360450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878172|NCT01360450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836429|NCT02035553|Pimavanserin|pimavanserin|mesh-list
55878173|NCT01303744|Flurbiprofen|flurbiprofen|mesh-list
55878174|NCT01303744|Analgesics|analgesics|mesh-ancestor
55878175|NCT01303744|Sensory System Agents|sensory system agents|mesh-ancestor
55878176|NCT01303744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878177|NCT01303744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878178|NCT01303744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55878179|NCT01303744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56039937|NCT02242409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039938|NCT02242409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56039939|NCT02242409|Antimetabolites|antimetabolites|mesh-ancestor
56039940|NCT02242409|Antiviral Agents|antiviral agents|mesh-ancestor
56039941|NCT02242409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039942|NCT02242409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039943|NCT02242409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56039944|NCT02242409|Immunologic Factors|immunologic factors|mesh-ancestor
56039945|NCT02242409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039946|NCT00366873|Calcium|calcium|mesh-list
56039947|NCT00366873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56039948|NCT00366873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767151|NCT04591431|Nivolumab|nivolumab|mesh-list
56039949|NCT05317325|Vaccines|vaccines|mesh-list
56039950|NCT05317325|Immunologic Factors|immunologic factors|mesh-ancestor
56039951|NCT05317325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039952|NCT04182399|Zonisamide|zonisamide|mesh-list
56039953|NCT04182399|Anticonvulsants|anticonvulsants|mesh-ancestor
56039954|NCT04182399|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56039955|NCT04182399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878180|NCT01303744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55878182|NCT01303744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55878183|NCT01303744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878184|NCT01303744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878186|NCT01361620|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55878187|NCT01361620|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55878188|NCT01361620|Analgesics|analgesics|mesh-ancestor
55878189|NCT01361620|Sensory System Agents|sensory system agents|mesh-ancestor
55878190|NCT01361620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878191|NCT01361620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878192|NCT01361620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55878194|NCT01361620|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55878195|NCT01361620|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55878196|NCT01361620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878197|NCT01361620|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55878198|NCT01361620|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55878199|NCT01361620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878201|NCT01305772|Panitumumab|panitumumab|mesh-list
55878202|NCT01305772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55878203|NCT01305772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878204|NCT01271452|Botulinum Toxins|botulinum toxins|mesh-list
55878205|NCT01271452|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55878206|NCT01271452|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55878207|NCT01271452|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55878208|NCT01271452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878209|NCT01271452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878210|NCT01271452|Cholinergic Agents|cholinergic agents|mesh-ancestor
55878211|NCT01271452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878212|NCT01271452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878213|NCT01271452|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56039956|NCT04182399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039957|NCT04182399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56039958|NCT04182399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039959|NCT04246619|Pregabalin|pregabalin|mesh-list
56039960|NCT04246619|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56039961|NCT04246619|Analgesics|analgesics|mesh-ancestor
56039962|NCT04246619|Sensory System Agents|sensory system agents|mesh-ancestor
56039963|NCT04246619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888509|NCT02715804|Mitosis Modulators|mitosis modulators|mesh-ancestor
56039964|NCT04246619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039965|NCT04246619|Anticonvulsants|anticonvulsants|mesh-ancestor
56039966|NCT04246619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56039967|NCT04246619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56039968|NCT04246619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56039969|NCT04246619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56039970|NCT04246619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56039971|NCT04246619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56039972|NCT04246619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039973|NCT04246619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56039974|NCT04246619|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55878214|NCT01271452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878215|NCT01271686|Bimatoprost|bimatoprost|mesh-list
55878216|NCT01271686|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55878217|NCT01854047|Albuterol|albuterol|mesh-list
55878218|NCT01854047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55878219|NCT01854047|Autonomic Agents|autonomic agents|mesh-ancestor
55878220|NCT01854047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878221|NCT01854047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878222|NCT01854047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55878223|NCT01854047|Respiratory System Agents|respiratory system agents|mesh-ancestor
55878224|NCT01854047|Tocolytic Agents|tocolytic agents|mesh-ancestor
55878225|NCT01854047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55878226|NCT01854047|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55878227|NCT01854047|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55878228|NCT01854047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55878229|NCT01854047|Adrenergic Agents|adrenergic agents|mesh-ancestor
55878230|NCT01854047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878231|NCT01854047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878232|NCT04605731|Durvalumab|durvalumab|mesh-list
55878233|NCT04605731|Ipilimumab|ipilimumab|mesh-list
55836562|NCT04066192|Brexpiprazole|brexpiprazole|mesh-list
55878234|NCT04605731|Tremelimumab|tremelimumab|mesh-list
55878235|NCT04605731|Immunoglobulins|immunoglobulins|mesh-list
55878236|NCT04605731|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55878237|NCT04605731|Immunoglobulin G|immunoglobulin g|mesh-list
55878238|NCT04605731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55878239|NCT04605731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878240|NCT04605731|Immunologic Factors|immunologic factors|mesh-ancestor
55878241|NCT04605731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878242|NCT04605731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55878243|NCT04605731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878244|NCT01307956|Calcium, Dietary|calcium, dietary|mesh-list
55878245|NCT01307956|Leucovorin|leucovorin|mesh-list
56039975|NCT04246619|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56039976|NCT04246619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56039977|NCT04246619|Antidepressive Agents|antidepressive agents|mesh-ancestor
56039978|NCT04246619|Dopamine Agents|dopamine agents|mesh-ancestor
55878246|NCT01307956|Folic Acid|folic acid|mesh-list
55878247|NCT01307956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55878248|NCT01307956|Panitumumab|panitumumab|mesh-list
55878249|NCT01307956|Fluorouracil|fluorouracil|mesh-list
55878250|NCT01307956|Oxaliplatin|oxaliplatin|mesh-list
55878251|NCT01307956|Antibodies|antibodies|mesh-list
55878252|NCT01307956|Immunoglobulins|immunoglobulins|mesh-list
55878253|NCT01307956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55878254|NCT01307956|Calcium|calcium|mesh-list
55878255|NCT01307956|Levoleucovorin|levoleucovorin|mesh-list
55878259|NCT01307956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55878260|NCT01307956|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55878261|NCT01307956|Antimetabolites|antimetabolites|mesh-ancestor
55878262|NCT01307956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878263|NCT01307956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55878264|NCT01307956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55878265|NCT01307956|Antidotes|antidotes|mesh-ancestor
55878266|NCT01307956|Protective Agents|protective agents|mesh-ancestor
55878267|NCT01307956|Vitamin B Complex|vitamin b complex|mesh-ancestor
55878268|NCT01307956|Vitamins|vitamins|mesh-ancestor
55878269|NCT01307956|Micronutrients|micronutrients|mesh-ancestor
55878270|NCT01307956|Hematinics|hematinics|mesh-ancestor
55878271|NCT01870739|Amlodipine|amlodipine|mesh-list
55878272|NCT01870739|Valsartan|valsartan|mesh-list
55878273|NCT01870739|Olmesartan|olmesartan|mesh-list
55836584|NCT01959139|Antidotes|antidotes|mesh-ancestor
55878274|NCT01870739|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55878275|NCT01870739|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55878276|NCT01870739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55878277|NCT01870739|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55878278|NCT01870739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878279|NCT01870739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878280|NCT01870739|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55878281|NCT01870739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878282|NCT01870739|Vasodilator Agents|vasodilator agents|mesh-ancestor
55878283|NCT01870739|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55878284|NCT01870739|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55878285|NCT01272388|Tadalafil|tadalafil|mesh-list
55878286|NCT01272388|Vasodilator Agents|vasodilator agents|mesh-ancestor
55878287|NCT01272388|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55878288|NCT01272388|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55878289|NCT01272388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878290|NCT01272388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878291|NCT01272388|Urological Agents|urological agents|mesh-ancestor
55878292|NCT01364584|Exenatide|exenatide|mesh-list
55878293|NCT01364584|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55878294|NCT01364584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878295|NCT01364584|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55878296|NCT01364584|Incretins|incretins|mesh-ancestor
55878297|NCT01364584|Hormones|hormones|mesh-ancestor
55878298|NCT01364584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55878300|NCT01870583|Chlorhexidine|chlorhexidine|mesh-list
55878301|NCT01870583|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55878302|NCT01870583|Cadexomer iodine|cadexomer iodine|mesh-list
55878303|NCT01870583|Povidone|povidone|mesh-list
55878304|NCT01870583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55878305|NCT01870583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878306|NCT01870583|Disinfectants|disinfectants|mesh-ancestor
55878307|NCT01870583|Dermatologic Agents|dermatologic agents|mesh-ancestor
55878308|NCT01870583|Trace Elements|trace elements|mesh-ancestor
55878309|NCT01870583|Micronutrients|micronutrients|mesh-ancestor
55878310|NCT01870583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878311|NCT01870583|Plasma Substitutes|plasma substitutes|mesh-ancestor
55878312|NCT01870583|Blood Substitutes|blood substitutes|mesh-ancestor
55878313|NCT04351594|Menthol|menthol|mesh-list
55878314|NCT04351594|Antipruritics|antipruritics|mesh-ancestor
55878315|NCT04351594|Dermatologic Agents|dermatologic agents|mesh-ancestor
55878316|NCT01308814|Estradiol|estradiol|mesh-list
55878317|NCT01308814|Estrogens|estrogens|mesh-ancestor
55878318|NCT01308814|Hormones|hormones|mesh-ancestor
56039979|NCT01757561|Propofol|propofol|mesh-list
56039980|NCT01757561|Sevoflurane|sevoflurane|mesh-list
56039981|NCT01757561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56039982|NCT01757561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56039983|NCT01757561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56039984|NCT01757561|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56039985|NCT01757561|Anesthetics, General|anesthetics, general|mesh-ancestor
56039986|NCT01757561|Anesthetics|anesthetics|mesh-ancestor
56039987|NCT01757561|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56039988|NCT01757561|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56039989|NCT02618187|Vancomycin|vancomycin|mesh-list
56039990|NCT02618187|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56039991|NCT02618187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039992|NCT05316857|Itraconazole|itraconazole|mesh-list
56039993|NCT05316857|Rifampin|rifampin|mesh-list
56039994|NCT05316857|Antifungal Agents|antifungal agents|mesh-ancestor
56039995|NCT05316857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56039996|NCT05316857|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56039997|NCT05316857|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56039998|NCT05316857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56039999|NCT05316857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040000|NCT05316857|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56040001|NCT05316857|Hormone Antagonists|hormone antagonists|mesh-ancestor
56040002|NCT05316857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040003|NCT05316857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040004|NCT05316857|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56040025|NCT02618343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040026|NCT02618343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040027|NCT02618343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56040028|NCT02618343|Antipruritics|antipruritics|mesh-ancestor
56040029|NCT02618343|Dermatologic Agents|dermatologic agents|mesh-ancestor
56040030|NCT02618343|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56040031|NCT02618343|Serotonin Agents|serotonin agents|mesh-ancestor
56040032|NCT02618343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040033|NCT02618343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040034|NCT02618343|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56040035|NCT02618343|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56040036|NCT02618343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040037|NCT02618343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56040038|NCT02618343|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56040039|NCT02991053|Ketamine|ketamine|mesh-list
56040040|NCT02991053|Analgesics|analgesics|mesh-ancestor
56040041|NCT02991053|Sensory System Agents|sensory system agents|mesh-ancestor
56040042|NCT02991053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040043|NCT02991053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040044|NCT02991053|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56040045|NCT02991053|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56040046|NCT02991053|Anesthetics, General|anesthetics, general|mesh-ancestor
56040047|NCT02991053|Anesthetics|anesthetics|mesh-ancestor
56040048|NCT02991053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040049|NCT02991053|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56040050|NCT02991053|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56040072|NCT01355588|Anesthetics|anesthetics|mesh-ancestor
56040073|NCT01355588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040074|NCT01355588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040075|NCT01355588|Sensory System Agents|sensory system agents|mesh-ancestor
56040076|NCT01355588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040077|NCT01355588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56040078|NCT01355588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56040079|NCT01355588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56040080|NCT01355588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040081|NCT01355588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040082|NCT01355588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56040083|NCT01355588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56040085|NCT01355588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56040086|NCT01355588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56040087|NCT01355588|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56040088|NCT01355588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040089|NCT02621619|Acetaminophen|acetaminophen|mesh-list
56040090|NCT02621619|Hydromorphone|hydromorphone|mesh-list
56040091|NCT02621619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56040092|NCT02621619|Analgesics|analgesics|mesh-ancestor
56040093|NCT02621619|Sensory System Agents|sensory system agents|mesh-ancestor
56040094|NCT02621619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040095|NCT02621619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040096|NCT02621619|Antipyretics|antipyretics|mesh-ancestor
56040097|NCT02621619|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56040100|NCT01253642|Docetaxel|docetaxel|mesh-list
56040121|NCT01357148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040122|NCT02623803|Lidocaine|lidocaine|mesh-list
56040123|NCT02623803|Anesthetics, Local|anesthetics, local|mesh-ancestor
56040124|NCT02623803|Anesthetics|anesthetics|mesh-ancestor
56040125|NCT02623803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040126|NCT02623803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040127|NCT02623803|Sensory System Agents|sensory system agents|mesh-ancestor
56040128|NCT02623803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040129|NCT02623803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56040130|NCT02623803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56040131|NCT02623803|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56040132|NCT02623803|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040133|NCT02623803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040134|NCT02322788|Terbutaline|terbutaline|mesh-list
56040135|NCT02322788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56040136|NCT02322788|Autonomic Agents|autonomic agents|mesh-ancestor
56040137|NCT02322788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040138|NCT02322788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040139|NCT02322788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56040140|NCT02322788|Respiratory System Agents|respiratory system agents|mesh-ancestor
56040141|NCT02322788|Sympathomimetics|sympathomimetics|mesh-ancestor
56040142|NCT02322788|Tocolytic Agents|tocolytic agents|mesh-ancestor
56040143|NCT02322788|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56040144|NCT02322788|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56040145|NCT02322788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56040146|NCT02322788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56040147|NCT02322788|Adrenergic Agents|adrenergic agents|mesh-ancestor
55878319|NCT01308814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55878320|NCT01308814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878322|NCT03009604|Antifoaming Agents|antifoaming agents|mesh-ancestor
55878323|NCT03009604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878324|NCT03009604|Emollients|emollients|mesh-ancestor
55878325|NCT03009604|Dermatologic Agents|dermatologic agents|mesh-ancestor
55878326|NCT01275664|Dexamethasone|dexamethasone|mesh-list
55878327|NCT01275664|Dexamethasone acetate|dexamethasone acetate|mesh-list
55878328|NCT01275664|Cisplatin|cisplatin|mesh-list
55878329|NCT01275664|Carboplatin|carboplatin|mesh-list
55878330|NCT01275664|Aprepitant|aprepitant|mesh-list
55878331|NCT01275664|Granisetron|granisetron|mesh-list
55878334|NCT01275664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55878335|NCT01275664|Antiemetics|antiemetics|mesh-ancestor
55878336|NCT01275664|Autonomic Agents|autonomic agents|mesh-ancestor
55878337|NCT01275664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878338|NCT01275664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040148|NCT02322788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040149|NCT02322788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040151|NCT02625207|Darunavir|darunavir|mesh-list
56040152|NCT02625207|Cobicistat|cobicistat|mesh-list
56040153|NCT02625207|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56040154|NCT02625207|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56040155|NCT02625207|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56040156|NCT02625207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040157|NCT02625207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56040158|NCT02625207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56040159|NCT02625207|Antiviral Agents|antiviral agents|mesh-ancestor
56040160|NCT02625207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040161|NCT02625207|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56040162|NCT02625207|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56040163|NCT02625207|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56040164|NCT02625207|Protease Inhibitors|protease inhibitors|mesh-ancestor
56040165|NCT02625207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040166|NCT02625207|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56040167|NCT02625207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56040168|NCT05315999|Palonosetron|palonosetron|mesh-list
56040169|NCT05315999|Antiemetics|antiemetics|mesh-ancestor
56040170|NCT05315999|Autonomic Agents|autonomic agents|mesh-ancestor
56040171|NCT05315999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040172|NCT05315999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040173|NCT05315999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56040174|NCT05315999|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56040175|NCT05315999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56040176|NCT05315999|Serotonin Agents|serotonin agents|mesh-ancestor
56040177|NCT05315999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040178|NCT05315999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040179|NCT01763645|Paclitaxel|paclitaxel|mesh-list
55878339|NCT01275664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878340|NCT01275664|Glucocorticoids|glucocorticoids|mesh-ancestor
55878341|NCT01275664|Hormones|hormones|mesh-ancestor
55878342|NCT01275664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55878343|NCT01275664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55878344|NCT01275664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878345|NCT01275664|Protease Inhibitors|protease inhibitors|mesh-ancestor
55878346|NCT01275664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040181|NCT01763645|Carboplatin|carboplatin|mesh-list
56040182|NCT01763645|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56040183|NCT01763645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040184|NCT01763645|Tubulin Modulators|tubulin modulators|mesh-ancestor
56040185|NCT01763645|Antimitotic Agents|antimitotic agents|mesh-ancestor
56040186|NCT01763645|Mitosis Modulators|mitosis modulators|mesh-ancestor
56040187|NCT01763645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040188|NCT01763645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56040189|NCT01763645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56040190|NCT01763645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56040191|NCT01763645|Growth Substances|growth substances|mesh-ancestor
56040192|NCT01763645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040193|NCT01763645|Growth Inhibitors|growth inhibitors|mesh-ancestor
56040194|NCT02253173|Estradiol|estradiol|mesh-list
56040195|NCT02253173|Estrogens|estrogens|mesh-ancestor
56040196|NCT02253173|Hormones|hormones|mesh-ancestor
56040197|NCT02253173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040198|NCT02253173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040199|NCT03924791|Dexamethasone|dexamethasone|mesh-list
56040200|NCT03924791|Methylprednisolone|methylprednisolone|mesh-list
56040201|NCT03924791|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56040202|NCT03924791|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56040203|NCT03924791|Prednisolone|prednisolone|mesh-list
56040204|NCT03924791|Prednisolone acetate|prednisolone acetate|mesh-list
56040205|NCT03924791|Lidocaine|lidocaine|mesh-list
56040206|NCT03924791|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56040207|NCT03924791|Prednisolone phosphate|prednisolone phosphate|mesh-list
56040208|NCT03924791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56040209|NCT03924791|Antiemetics|antiemetics|mesh-ancestor
56040210|NCT03924791|Autonomic Agents|autonomic agents|mesh-ancestor
56040211|NCT03924791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040212|NCT03924791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040222|NCT03924791|Sensory System Agents|sensory system agents|mesh-ancestor
56040223|NCT03924791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56040224|NCT03924791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56040225|NCT03924791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56040226|NCT03924791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040227|NCT03924791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040228|NCT03924791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56040229|NCT03924791|Protective Agents|protective agents|mesh-ancestor
56040231|NCT01318694|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56040232|NCT01318694|Antimetabolites|antimetabolites|mesh-ancestor
56040233|NCT01318694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040234|NCT01318694|Antiviral Agents|antiviral agents|mesh-ancestor
56040235|NCT01318694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040236|NCT03009578|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56040237|NCT03009578|Hematinics|hematinics|mesh-ancestor
56040238|NCT01361048|Metronidazole|metronidazole|mesh-list
56040239|NCT01361048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040240|NCT01361048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56040241|NCT01361048|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56040242|NCT01361048|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56040243|NCT01766219|Thioctic Acid|thioctic acid|mesh-list
55878347|NCT01275664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878348|NCT01275664|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55878349|NCT01275664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878350|NCT01275664|Dermatologic Agents|dermatologic agents|mesh-ancestor
55878351|NCT01275664|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55878352|NCT01275664|Serotonin Agents|serotonin agents|mesh-ancestor
55878353|NCT01613027|Rituximab|rituximab|mesh-list
55878354|NCT01613027|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55878355|NCT01613027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878356|NCT01613027|Immunologic Factors|immunologic factors|mesh-ancestor
55878357|NCT01613027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878358|NCT01613027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55878359|NCT04595045|Botulinum Toxins|botulinum toxins|mesh-list
55878360|NCT04595045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55878361|NCT04595045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55878362|NCT04595045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55878363|NCT04595045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878364|NCT04595045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878365|NCT04595045|Cholinergic Agents|cholinergic agents|mesh-ancestor
55878366|NCT04595045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878367|NCT04595045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878368|NCT04595045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55878369|NCT04595045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878370|NCT01369732|Epoetin Alfa|epoetin alfa|mesh-list
55878371|NCT01369732|Hematinics|hematinics|mesh-ancestor
55878372|NCT01869725|Octreotide|octreotide|mesh-list
55878373|NCT01869725|Edotreotide|edotreotide|mesh-list
55878374|NCT01869725|Indium-111-octreotide|indium-111-octreotide|mesh-list
55878375|NCT01869725|Somatostatin|somatostatin|mesh-list
55878376|NCT01869725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878377|NCT01869725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55767458|NCT04740099|Naloxone|naloxone|mesh-list
56040244|NCT01766219|Antioxidants|antioxidants|mesh-ancestor
56040245|NCT01766219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040246|NCT01766219|Protective Agents|protective agents|mesh-ancestor
56040247|NCT01766219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040248|NCT01766219|Vitamin B Complex|vitamin b complex|mesh-ancestor
56040250|NCT01766219|Micronutrients|micronutrients|mesh-ancestor
56040251|NCT01767155|Doxorubicin|doxorubicin|mesh-list
56040252|NCT01767155|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56040254|NCT01767155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040255|NCT01767155|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55750312|NCT00707993|Alogliptin|alogliptin|mesh-list
55878378|NCT01869725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878379|NCT01869725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878380|NCT01869725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878381|NCT01869725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55878382|NCT01869725|Hormones|hormones|mesh-ancestor
55878383|NCT01869725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55878384|NCT01309360|Midazolam|midazolam|mesh-list
55878385|NCT01309360|Prilocaine|prilocaine|mesh-list
55878386|NCT01309360|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55878387|NCT01309360|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55878388|NCT01309360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878389|NCT01309360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878390|NCT01309360|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55878391|NCT01309360|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55878392|NCT01309360|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55878393|NCT01309360|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55878394|NCT01309360|Anesthetics, General|anesthetics, general|mesh-ancestor
55878395|NCT01309360|Anesthetics|anesthetics|mesh-ancestor
55878396|NCT01309360|GABA Modulators|gaba modulators|mesh-ancestor
55878397|NCT01309360|GABA Agents|gaba agents|mesh-ancestor
55878398|NCT01309360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878399|NCT01309360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878400|NCT01309360|Anesthetics, Local|anesthetics, local|mesh-ancestor
55878401|NCT01309360|Sensory System Agents|sensory system agents|mesh-ancestor
55878402|NCT01309360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878403|NCT01851863|Flupenthixol|flupenthixol|mesh-list
55878404|NCT01851863|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
55878405|NCT01851863|Omeprazole|omeprazole|mesh-list
55878406|NCT01851863|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55878407|NCT01851863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878408|NCT01851863|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55878409|NCT01851863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878410|NCT01851863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878411|NCT01851863|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55878412|NCT01851863|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55878413|NCT01851863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878414|NCT01851863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878415|NCT01851863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55878416|NCT01851863|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55878417|NCT01851863|Dopamine Agents|dopamine agents|mesh-ancestor
55878418|NCT01851863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878419|NCT01369888|Cyclophosphamide|cyclophosphamide|mesh-list
55878420|NCT01369888|Fludarabine|fludarabine|mesh-list
55878421|NCT01369888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55878422|NCT01369888|Immunologic Factors|immunologic factors|mesh-ancestor
55878423|NCT01369888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878424|NCT01369888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55878425|NCT01369888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55878426|NCT01369888|Alkylating Agents|alkylating agents|mesh-ancestor
55878427|NCT01369888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878428|NCT01369888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040256|NCT01767155|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56040257|NCT01767155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040258|NCT01767155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040259|NCT01362686|Rivastigmine|rivastigmine|mesh-list
56040260|NCT01362686|Donepezil|donepezil|mesh-list
56040261|NCT01362686|Galantamine|galantamine|mesh-list
56040262|NCT01362686|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56040263|NCT01362686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040264|NCT01362686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040265|NCT01362686|Cholinergic Agents|cholinergic agents|mesh-ancestor
56040266|NCT01362686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040267|NCT01362686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040268|NCT01362686|Nootropic Agents|nootropic agents|mesh-ancestor
56040269|NCT01362686|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56040270|NCT01362686|Autonomic Agents|autonomic agents|mesh-ancestor
56040271|NCT01362686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040272|NCT01362686|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56040273|NCT01362686|Protective Agents|protective agents|mesh-ancestor
56040274|NCT01322048|Propranolol|propranolol|mesh-list
56040275|NCT01322048|Clonidine|clonidine|mesh-list
56040276|NCT01322048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56040277|NCT01322048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56040278|NCT01322048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56040279|NCT01322048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040280|NCT01322048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040281|NCT01322048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878429|NCT01369888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55878431|NCT01850615|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55878432|NCT01850615|Insulin Aspart|insulin aspart|mesh-list
55878433|NCT01850615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55878434|NCT01850615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878435|NCT04602221|Lamotrigine|lamotrigine|mesh-list
55878436|NCT04602221|BI 425809|bi 425809|mesh-list
55878437|NCT04602221|BI 409306|bi 409306|mesh-list
55878438|NCT04602221|Anticonvulsants|anticonvulsants|mesh-ancestor
55878439|NCT04602221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55878440|NCT04602221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878441|NCT04602221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878442|NCT04602221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55878443|NCT04602221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878444|NCT04602221|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55878445|NCT04602221|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55878446|NCT04602221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878447|NCT04602221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55878448|NCT04602221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55878449|NCT04602221|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55878450|NCT04602221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040282|NCT01322048|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56040283|NCT01322048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56040284|NCT01322048|Vasodilator Agents|vasodilator agents|mesh-ancestor
56040285|NCT01322048|Analgesics|analgesics|mesh-ancestor
56040286|NCT01322048|Sensory System Agents|sensory system agents|mesh-ancestor
56040287|NCT01322048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040288|NCT01322048|Sympatholytics|sympatholytics|mesh-ancestor
56040289|NCT01322048|Autonomic Agents|autonomic agents|mesh-ancestor
56040290|NCT01322048|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56040291|NCT01322048|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56040292|NCT01322048|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56040293|NCT01322360|Morphine|morphine|mesh-list
56040294|NCT01322360|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56040295|NCT01322360|Narcotics|narcotics|mesh-ancestor
56040296|NCT01322360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040298|NCT01322360|Analgesics|analgesics|mesh-ancestor
56040299|NCT01322360|Sensory System Agents|sensory system agents|mesh-ancestor
56040300|NCT01322360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040301|NCT04351724|Ritonavir|ritonavir|mesh-list
56040302|NCT04351724|Lopinavir|lopinavir|mesh-list
56040303|NCT04351724|Hydroxychloroquine|hydroxychloroquine|mesh-list
56040304|NCT04351724|Chloroquine|chloroquine|mesh-list
55837064|NCT05119166|Niacin|niacin|mesh-list
56040305|NCT04351724|Remdesivir|remdesivir|mesh-list
56040306|NCT04351724|Candesartan|candesartan|mesh-list
56040307|NCT04351724|Antihypertensive Agents|antihypertensive agents|mesh-list
56040308|NCT04351724|Rivaroxaban|rivaroxaban|mesh-list
56040309|NCT04351724|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56040310|NCT04351724|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56040311|NCT04351724|Protease Inhibitors|protease inhibitors|mesh-ancestor
56040312|NCT04351724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040313|NCT04351724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040314|NCT04351724|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56040330|NCT04351724|Amebicides|amebicides|mesh-ancestor
56040331|NCT04351724|Antimetabolites|antimetabolites|mesh-ancestor
56040332|NCT01767701|Raltegravir Potassium|raltegravir potassium|mesh-list
56040333|NCT01767701|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56040334|NCT01767701|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55878451|NCT04602221|Nootropic Agents|nootropic agents|mesh-ancestor
55878452|NCT01280110|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55878453|NCT01280110|Laxatives|laxatives|mesh-ancestor
55878454|NCT01280110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878455|NCT01374802|Ritonavir|ritonavir|mesh-list
55878456|NCT01374802|Darunavir|darunavir|mesh-list
55878457|NCT01374802|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55878458|NCT01374802|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55750330|NCT02508857|Ketorolac|ketorolac|mesh-list
55878459|NCT01374802|Protease Inhibitors|protease inhibitors|mesh-ancestor
55878460|NCT01374802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878461|NCT01374802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878462|NCT01374802|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55878463|NCT01374802|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55878464|NCT01374802|Antiviral Agents|antiviral agents|mesh-ancestor
55878465|NCT01374802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878466|NCT01374802|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55878467|NCT01374802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55878468|NCT01375660|Vitamin D|vitamin d|mesh-list
55878469|NCT01375660|Ergocalciferols|ergocalciferols|mesh-list
55878470|NCT01375660|Vitamins|vitamins|mesh-ancestor
55878471|NCT01375660|Micronutrients|micronutrients|mesh-ancestor
55878472|NCT01375660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878473|NCT01375660|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55878474|NCT01375660|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55878475|NCT01868477|Epoetin Alfa|epoetin alfa|mesh-list
55878476|NCT01868477|Deferasirox|deferasirox|mesh-list
55878477|NCT01868477|Hematinics|hematinics|mesh-ancestor
55878478|NCT01868477|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55878479|NCT01868477|Chelating Agents|chelating agents|mesh-ancestor
55878480|NCT01868477|Sequestering Agents|sequestering agents|mesh-ancestor
55878483|NCT01849289|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55878484|NCT01849289|Insulin Glargine|insulin glargine|mesh-list
55878485|NCT01849289|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55878486|NCT01849289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878487|NCT01868243|Warfarin|warfarin|mesh-list
55878488|NCT01868243|Dabigatran|dabigatran|mesh-list
55878489|NCT01868243|Anticoagulants|anticoagulants|mesh-ancestor
55878490|NCT01868243|Antithrombins|antithrombins|mesh-ancestor
55878491|NCT01868243|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55878492|NCT01868243|Protease Inhibitors|protease inhibitors|mesh-ancestor
55878493|NCT01868243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878494|NCT01868243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878495|NCT01611935|Vasopressins|vasopressins|mesh-list
55878496|NCT01611935|Arginine Vasopressin|arginine vasopressin|mesh-list
55878497|NCT01611935|Hemostatics|hemostatics|mesh-ancestor
55878498|NCT01611935|Coagulants|coagulants|mesh-ancestor
55878499|NCT01611935|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55878500|NCT01611935|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55878501|NCT01611935|Natriuretic Agents|natriuretic agents|mesh-ancestor
55878502|NCT01611935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878503|NCT02201212|Everolimus|everolimus|mesh-list
55878504|NCT02201212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878505|NCT02201212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55878506|NCT02201212|Immunologic Factors|immunologic factors|mesh-ancestor
55878507|NCT02201212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878508|NCT01376362|Interferons|interferons|mesh-list
55878509|NCT01376362|Interferon-gamma|interferon-gamma|mesh-list
55878510|NCT01376362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878511|NCT01376362|Antiviral Agents|antiviral agents|mesh-ancestor
55878512|NCT01376362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878514|NCT03009292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878515|NCT03009292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55878516|NCT03009292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878517|NCT03009292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040335|NCT01767701|Antiviral Agents|antiviral agents|mesh-ancestor
56040336|NCT01767701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040337|NCT01767701|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56040338|NCT01767701|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56040339|NCT01767701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040340|NCT01767701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040341|NCT04351412|Fluorides|fluorides|mesh-list
56040342|NCT04351412|Fluorides, Topical|fluorides, topical|mesh-list
56040343|NCT04351412|Cariostatic Agents|cariostatic agents|mesh-ancestor
56040344|NCT04351412|Protective Agents|protective agents|mesh-ancestor
56040345|NCT04351412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040346|NCT01364090|Interferons|interferons|mesh-list
56040347|NCT01364090|Ribavirin|ribavirin|mesh-list
56040348|NCT01364090|Interferon-alpha|interferon-alpha|mesh-list
56040349|NCT01364090|Interferon alpha-2|interferon alpha-2|mesh-list
56040350|NCT01364090|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56040351|NCT01364090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040352|NCT01364090|Antiviral Agents|antiviral agents|mesh-ancestor
56040353|NCT01364090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040354|NCT01364090|Antimetabolites|antimetabolites|mesh-ancestor
56040355|NCT01364090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040356|NCT01364090|Immunologic Factors|immunologic factors|mesh-ancestor
56040357|NCT01364090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040358|NCT03684785|Pembrolizumab|pembrolizumab|mesh-list
56040359|NCT03684785|Cemiplimab|cemiplimab|mesh-list
56040360|NCT03684785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55878518|NCT01962792|Dexamethasone|dexamethasone|mesh-list
55878519|NCT01962792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55878520|NCT01962792|Antiemetics|antiemetics|mesh-ancestor
55878521|NCT01962792|Autonomic Agents|autonomic agents|mesh-ancestor
55878522|NCT01962792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878523|NCT01962792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878524|NCT01962792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878525|NCT01962792|Glucocorticoids|glucocorticoids|mesh-ancestor
55878526|NCT01962792|Hormones|hormones|mesh-ancestor
55878527|NCT01962792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55878528|NCT01962792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55878529|NCT01962792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878531|NCT01849055|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55878532|NCT01849055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55878533|NCT01849055|Analgesics|analgesics|mesh-ancestor
56051799|NCT02260622|Clopidogrel|clopidogrel|mesh-list
55878534|NCT01849055|Sensory System Agents|sensory system agents|mesh-ancestor
55878535|NCT01849055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878536|NCT01849055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878537|NCT01849055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55878538|NCT01849055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55878539|NCT01849055|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55878540|NCT01849055|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55878541|NCT01849055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878542|NCT01849055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040361|NCT03684785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040362|NCT01364558|Diazepam|diazepam|mesh-list
56040363|NCT01364558|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56040364|NCT01364558|Anticonvulsants|anticonvulsants|mesh-ancestor
56040365|NCT01364558|Antiemetics|antiemetics|mesh-ancestor
55878543|NCT01404832|Lansoprazole|lansoprazole|mesh-list
55878544|NCT01404832|Dexlansoprazole|dexlansoprazole|mesh-list
55878545|NCT01404832|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55878546|NCT01404832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878547|NCT01404832|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55878548|NCT01404832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878549|NCT01404832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878550|NCT03420534|Iloperidone|iloperidone|mesh-list
55878551|NCT03420534|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55878552|NCT03420534|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55878553|NCT03420534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878554|NCT03420534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878557|NCT01313494|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55878558|NCT01313494|Autonomic Agents|autonomic agents|mesh-ancestor
55878559|NCT01313494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878560|NCT01313494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878561|NCT01313494|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55878562|NCT01313494|Respiratory System Agents|respiratory system agents|mesh-ancestor
55878563|NCT01313494|Tocolytic Agents|tocolytic agents|mesh-ancestor
55878564|NCT01313494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55878565|NCT01313494|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55878566|NCT01313494|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55878567|NCT01313494|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55878568|NCT01313494|Adrenergic Agents|adrenergic agents|mesh-ancestor
55878569|NCT01313494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878570|NCT01313494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878572|NCT01407094|Antidepressive Agents|antidepressive agents|mesh-ancestor
55878573|NCT01407094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55878574|NCT01407094|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55878575|NCT01407094|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55878576|NCT01407094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878577|NCT01407094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878578|NCT01407094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878579|NCT01407094|Serotonin Agents|serotonin agents|mesh-ancestor
55878580|NCT01407094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878581|NCT01867307|Empagliflozin|empagliflozin|mesh-list
55878582|NCT01867307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55878583|NCT01867307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878584|NCT01867307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55878585|NCT01867307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878586|NCT01845077|Metformin|metformin|mesh-list
55837278|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
55878587|NCT01845077|Linagliptin|linagliptin|mesh-list
55878588|NCT01845077|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55878589|NCT01845077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878590|NCT01845077|Incretins|incretins|mesh-ancestor
55878591|NCT01845077|Hormones|hormones|mesh-ancestor
55878592|NCT01845077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55878593|NCT01845077|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55878594|NCT01845077|Protease Inhibitors|protease inhibitors|mesh-ancestor
55878595|NCT01845077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878596|NCT01845077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878597|NCT01866917|Ropivacaine|ropivacaine|mesh-list
55878598|NCT01866917|Anesthetics, Local|anesthetics, local|mesh-ancestor
55878599|NCT01866917|Anesthetics|anesthetics|mesh-ancestor
55878600|NCT01866917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878601|NCT01866917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878602|NCT01866917|Sensory System Agents|sensory system agents|mesh-ancestor
55878603|NCT01866917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878604|NCT01316302|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55878605|NCT01316302|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55878606|NCT01316302|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55889709|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
55837305|NCT02023151|Omalizumab|omalizumab|mesh-list
55878607|NCT01316302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878608|NCT01316302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040366|NCT01364558|Autonomic Agents|autonomic agents|mesh-ancestor
56040367|NCT01364558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040368|NCT01364558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040369|NCT01364558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56040370|NCT01364558|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56040371|NCT01364558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040372|NCT01364558|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56040373|NCT01364558|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56040375|NCT01364558|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56040376|NCT01364558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56040377|NCT01364558|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56040378|NCT01364558|Anesthetics, General|anesthetics, general|mesh-ancestor
56040379|NCT01364558|Anesthetics|anesthetics|mesh-ancestor
56040380|NCT01364558|GABA Modulators|gaba modulators|mesh-ancestor
56040381|NCT01364558|GABA Agents|gaba agents|mesh-ancestor
56040382|NCT01364558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040383|NCT01364558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040385|NCT01323140|Androgens|androgens|mesh-ancestor
56040387|NCT01323140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040388|NCT01323140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040389|NCT03516305|Alprazolam|alprazolam|mesh-list
56040390|NCT03516305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56040391|NCT03516305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040392|NCT03516305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040393|NCT03516305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56040394|NCT03516305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56040395|NCT03516305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56040396|NCT03516305|GABA Modulators|gaba modulators|mesh-ancestor
56040397|NCT03516305|GABA Agents|gaba agents|mesh-ancestor
56040398|NCT03516305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040399|NCT03516305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040400|NCT03823287|Aflibercept|aflibercept|mesh-list
56040401|NCT03823287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56040406|NCT03823287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040407|NCT02244671|Botulinum Toxins|botulinum toxins|mesh-list
56040408|NCT02244671|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56040409|NCT02244671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040410|NCT02244671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040411|NCT02244671|Cholinergic Agents|cholinergic agents|mesh-ancestor
56040412|NCT02244671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040413|NCT02244671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040414|NCT02626611|Omalizumab|omalizumab|mesh-list
56040415|NCT02626611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56040416|NCT02626611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56040417|NCT02626611|Respiratory System Agents|respiratory system agents|mesh-ancestor
56040418|NCT01260662|Ketamine|ketamine|mesh-list
56040419|NCT01260662|Propofol|propofol|mesh-list
56040420|NCT01260662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56040421|NCT01260662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040422|NCT01260662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040423|NCT01260662|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56040424|NCT01260662|Anesthetics, General|anesthetics, general|mesh-ancestor
56040425|NCT01260662|Anesthetics|anesthetics|mesh-ancestor
56040426|NCT01260662|Analgesics|analgesics|mesh-ancestor
56040427|NCT01260662|Sensory System Agents|sensory system agents|mesh-ancestor
56040428|NCT01260662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878609|NCT01316302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878610|NCT01316302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878611|NCT01316302|Antidepressive Agents|antidepressive agents|mesh-ancestor
55878612|NCT01316302|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55878613|NCT01410058|Efavirenz|efavirenz|mesh-list
55878614|NCT01410058|Nevirapine|nevirapine|mesh-list
55878615|NCT01410058|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55878616|NCT01410058|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55878617|NCT01410058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878618|NCT01410058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878619|NCT01410058|Antiviral Agents|antiviral agents|mesh-ancestor
55878620|NCT01410058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878621|NCT01410058|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55878622|NCT01410058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55878623|NCT01410058|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55878625|NCT01410058|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55878626|NCT01410058|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55878627|NCT01410058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55878628|NCT01410058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55878629|NCT01380106|Lenalidomide|lenalidomide|mesh-list
55878630|NCT01380106|Immunologic Factors|immunologic factors|mesh-ancestor
55878631|NCT01380106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878632|NCT01380106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55878633|NCT01380106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55878634|NCT01380106|Growth Substances|growth substances|mesh-ancestor
55878635|NCT01380106|Growth Inhibitors|growth inhibitors|mesh-ancestor
55878636|NCT01380106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040429|NCT01260662|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56040430|NCT01260662|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56040431|NCT01260662|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56040432|NCT01260662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040433|NCT01260662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040434|NCT02327117|Tranexamic Acid|tranexamic acid|mesh-list
56040435|NCT02327117|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56040436|NCT02327117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56040437|NCT02327117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040438|NCT02327117|Hemostatics|hemostatics|mesh-ancestor
56040439|NCT02327117|Coagulants|coagulants|mesh-ancestor
56040440|NCT01365650|Fluticasone|fluticasone|mesh-list
56040441|NCT01365650|Xhance|xhance|mesh-list
56040442|NCT01365650|Ketorolac|ketorolac|mesh-list
56040443|NCT01365650|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56040444|NCT01365650|Phenylephrine|phenylephrine|mesh-list
56040445|NCT01365650|Oxymetazoline|oxymetazoline|mesh-list
56040446|NCT01365650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56040447|NCT01365650|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56040448|NCT01365650|Autonomic Agents|autonomic agents|mesh-ancestor
56040449|NCT01365650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040450|NCT01365650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040451|NCT01365650|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55837403|NCT01934972|Cycloserine|cycloserine|mesh-list
56040452|NCT01365650|Respiratory System Agents|respiratory system agents|mesh-ancestor
56040453|NCT01365650|Dermatologic Agents|dermatologic agents|mesh-ancestor
56040454|NCT01365650|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56040455|NCT01365650|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56040456|NCT01365650|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56040457|NCT01365650|Analgesics|analgesics|mesh-ancestor
56040458|NCT01365650|Sensory System Agents|sensory system agents|mesh-ancestor
56040459|NCT01365650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56040460|NCT01365650|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56040461|NCT01365650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040462|NCT01365650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040470|NCT01365650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56040471|NCT01365650|Mydriatics|mydriatics|mesh-ancestor
56040472|NCT01365650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56040473|NCT01365650|Protective Agents|protective agents|mesh-ancestor
56040474|NCT01324700|Dexetimide|dexetimide|mesh-list
56040475|NCT01324700|Citalopram|citalopram|mesh-list
56040476|NCT01324700|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
56040477|NCT01324700|Serotonin|serotonin|mesh-list
56040478|NCT01324700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56040479|NCT01324700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040480|NCT01324700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040481|NCT01324700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040482|NCT01324700|Serotonin Agents|serotonin agents|mesh-ancestor
56040483|NCT01324700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040484|NCT01324700|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56040485|NCT01324700|Antidepressive Agents|antidepressive agents|mesh-ancestor
56040486|NCT01324700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56040487|NCT01324700|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56040488|NCT01324700|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56040489|NCT01324700|Parasympatholytics|parasympatholytics|mesh-ancestor
56040490|NCT01324700|Autonomic Agents|autonomic agents|mesh-ancestor
56040491|NCT01324700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040492|NCT01324700|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56040493|NCT01324700|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55837447|NCT01951105|Analgesics|analgesics|mesh-ancestor
55878637|NCT01381120|Acetaminophen|acetaminophen|mesh-list
55878638|NCT01381120|Oxycodone|oxycodone|mesh-list
55878639|NCT01381120|Solifenacin Succinate|solifenacin succinate|mesh-list
55878640|NCT01381120|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55878641|NCT01381120|Analgesics|analgesics|mesh-ancestor
55878642|NCT01381120|Sensory System Agents|sensory system agents|mesh-ancestor
55878643|NCT01381120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878644|NCT01381120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878645|NCT01381120|Antipyretics|antipyretics|mesh-ancestor
55878646|NCT01381120|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55878647|NCT01381120|Narcotics|narcotics|mesh-ancestor
55878648|NCT01381120|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878649|NCT01381120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55878650|NCT01381120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55878651|NCT01381120|Cholinergic Agents|cholinergic agents|mesh-ancestor
55878652|NCT01381120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878653|NCT01381120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878654|NCT01381120|Urological Agents|urological agents|mesh-ancestor
55878655|NCT01316770|Dexamethasone|dexamethasone|mesh-list
55878656|NCT01316770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55878657|NCT01316770|Antiemetics|antiemetics|mesh-ancestor
55878658|NCT01316770|Autonomic Agents|autonomic agents|mesh-ancestor
55878659|NCT01316770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878660|NCT01316770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878661|NCT01316770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878662|NCT01316770|Glucocorticoids|glucocorticoids|mesh-ancestor
56040494|NCT01324700|Cholinergic Agents|cholinergic agents|mesh-ancestor
56040495|NCT01324700|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56040497|NCT04769297|Analgesics|analgesics|mesh-ancestor
56040498|NCT04769297|Sensory System Agents|sensory system agents|mesh-ancestor
56040499|NCT04769297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040500|NCT04769297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040501|NCT04769297|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56040502|NCT04769297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56040503|NCT04769297|Anesthetics, General|anesthetics, general|mesh-ancestor
56040504|NCT04769297|Anesthetics|anesthetics|mesh-ancestor
56040505|NCT04769297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040506|NCT04769297|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56040507|NCT04769297|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56040508|NCT04769297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040509|NCT04769297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040510|NCT02631057|Warfarin|warfarin|mesh-list
56040511|NCT02631057|Dabigatran|dabigatran|mesh-list
56040512|NCT02631057|Anticoagulants|anticoagulants|mesh-ancestor
56040513|NCT02631057|Antithrombins|antithrombins|mesh-ancestor
56040514|NCT02631057|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56040515|NCT02631057|Protease Inhibitors|protease inhibitors|mesh-ancestor
56040516|NCT02631057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886794|NCT01780324|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040517|NCT02631057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040518|NCT02631525|Propofol|propofol|mesh-list
56040519|NCT02631525|Desflurane|desflurane|mesh-list
56040520|NCT02631525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56040521|NCT02631525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040522|NCT02631525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040523|NCT02631525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56040539|NCT05190315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040540|NCT05190315|Antiemetics|antiemetics|mesh-ancestor
56040541|NCT05190315|Autonomic Agents|autonomic agents|mesh-ancestor
56040542|NCT05190315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040543|NCT05190315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040544|NCT05190315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56040545|NCT05190315|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56040546|NCT05190315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56040547|NCT05190315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040548|NCT05190315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56040549|NCT05190315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56040550|NCT05190315|Dopamine Agents|dopamine agents|mesh-ancestor
56040551|NCT05190315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040552|NCT05167643|Anastrozole|anastrozole|mesh-list
56040553|NCT05167643|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56040554|NCT05167643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040556|NCT05167643|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56040557|NCT05167643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040558|NCT05167643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040559|NCT05167643|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56040560|NCT05167643|Hormone Antagonists|hormone antagonists|mesh-ancestor
55878663|NCT01316770|Hormones|hormones|mesh-ancestor
55878664|NCT01316770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55878665|NCT01316770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55878666|NCT01316770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878667|NCT01318408|Levetiracetam|levetiracetam|mesh-list
55878668|NCT01318408|Anticonvulsants|anticonvulsants|mesh-ancestor
55878669|NCT01318408|Nootropic Agents|nootropic agents|mesh-ancestor
55878670|NCT01319110|Ubiquinone|ubiquinone|mesh-list
55878671|NCT01319110|Coenzyme Q10|coenzyme q10|mesh-list
55878672|NCT01319110|Micronutrients|micronutrients|mesh-ancestor
55878673|NCT01319110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878674|NCT01319110|Vitamins|vitamins|mesh-ancestor
55878675|NCT03008512|Paclitaxel|paclitaxel|mesh-list
55878676|NCT03008512|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55878677|NCT03008512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878678|NCT03008512|Tubulin Modulators|tubulin modulators|mesh-ancestor
55878679|NCT03008512|Antimitotic Agents|antimitotic agents|mesh-ancestor
55878680|NCT03008512|Mitosis Modulators|mitosis modulators|mesh-ancestor
55878681|NCT03008512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878682|NCT04351516|Hydroxychloroquine|hydroxychloroquine|mesh-list
55878683|NCT04351516|Antimalarials|antimalarials|mesh-ancestor
55878684|NCT04351516|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55878685|NCT04351516|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55878686|NCT04351516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878687|NCT04351516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878688|NCT04351516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878689|NCT04351516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55878690|NCT01411696|Dexamethasone|dexamethasone|mesh-list
55878691|NCT01411696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55878692|NCT01411696|Antiemetics|antiemetics|mesh-ancestor
55878693|NCT01411696|Autonomic Agents|autonomic agents|mesh-ancestor
55878694|NCT01411696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878695|NCT01411696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040561|NCT05167643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040562|NCT05167643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040563|NCT01366196|Pregabalin|pregabalin|mesh-list
56040564|NCT01366196|Analgesics|analgesics|mesh-ancestor
56040565|NCT01366196|Sensory System Agents|sensory system agents|mesh-ancestor
56040566|NCT01366196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040567|NCT01366196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040568|NCT01366196|Anticonvulsants|anticonvulsants|mesh-ancestor
56040569|NCT01366196|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56040570|NCT01366196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040571|NCT01366196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040572|NCT01366196|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56040573|NCT01366196|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56040574|NCT01366196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56040575|NCT01366196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040576|NCT01366196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56040577|NCT01366976|Acetaminophen|acetaminophen|mesh-list
56040578|NCT01366976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56040579|NCT01366976|Analgesics|analgesics|mesh-ancestor
56040580|NCT01366976|Sensory System Agents|sensory system agents|mesh-ancestor
56040581|NCT01366976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040582|NCT01366976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040583|NCT01366976|Antipyretics|antipyretics|mesh-ancestor
56040584|NCT01777217|Solifenacin Succinate|solifenacin succinate|mesh-list
56040585|NCT01777217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56040592|NCT02251379|Fluticasone|fluticasone|mesh-list
56040608|NCT02255357|Oxytocin|oxytocin|mesh-list
56040609|NCT02255357|Oxytocics|oxytocics|mesh-ancestor
56040610|NCT02255357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56040611|NCT02255357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040612|NCT02255513|Methylphenidate|methylphenidate|mesh-list
55889997|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837621|NCT01933334|Analgesics|analgesics|mesh-ancestor
56040613|NCT02255513|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56040614|NCT02255513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040616|NCT02255513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56040617|NCT02255513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040618|NCT02255513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040620|NCT02255513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040621|NCT01778465|Salicylic Acid|salicylic acid|mesh-list
56040622|NCT01778465|Salicylates|salicylates|mesh-list
56040623|NCT01778465|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56040624|NCT01778465|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56040625|NCT01778465|Analgesics|analgesics|mesh-ancestor
56040626|NCT01778465|Sensory System Agents|sensory system agents|mesh-ancestor
56040627|NCT01778465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040628|NCT01778465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040629|NCT01778465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56040630|NCT01778465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56040631|NCT01778465|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56040632|NCT01778465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040633|NCT01778465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040634|NCT01778465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040635|NCT01778465|Antifungal Agents|antifungal agents|mesh-ancestor
56040636|NCT01778465|Keratolytic Agents|keratolytic agents|mesh-ancestor
56040651|NCT01779167|Leprostatic Agents|leprostatic agents|mesh-ancestor
56040652|NCT01779167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56040653|NCT01779167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040654|NCT01780337|Oxytocin|oxytocin|mesh-list
56040655|NCT01780337|Oxytocics|oxytocics|mesh-ancestor
56040656|NCT01780337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56040657|NCT01780337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040658|NCT02251613|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56040659|NCT02251613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56040660|NCT02251613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56040661|NCT02251613|Epinastine|epinastine|mesh-list
56040662|NCT02251613|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56040663|NCT02251613|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56040664|NCT02251613|Analgesics|analgesics|mesh-ancestor
56040665|NCT02251613|Sensory System Agents|sensory system agents|mesh-ancestor
56040666|NCT02251613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040667|NCT02251613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040668|NCT02251613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56040669|NCT02251613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56040670|NCT02251613|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56040671|NCT02251613|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55878696|NCT01411696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878697|NCT01411696|Glucocorticoids|glucocorticoids|mesh-ancestor
55878698|NCT01411696|Hormones|hormones|mesh-ancestor
55878701|NCT01411696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878703|NCT01412164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55878704|NCT01412164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878705|NCT01412164|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55878706|NCT01412164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878707|NCT01412164|Antifungal Agents|antifungal agents|mesh-ancestor
55878708|NCT01412164|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55878709|NCT01412164|Immunologic Factors|immunologic factors|mesh-ancestor
55878710|NCT01412164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878711|NCT01844687|Cannabidiol|cannabidiol|mesh-list
55878712|NCT01844687|Anticonvulsants|anticonvulsants|mesh-ancestor
55878713|NCT01844531|Metformin|metformin|mesh-list
55878714|NCT01844531|Empagliflozin|empagliflozin|mesh-list
55878715|NCT01844531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55878716|NCT01844531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878717|NCT01844531|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55886878|NCT02472054|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55878718|NCT01844531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878719|NCT02367456|Azacitidine|azacitidine|mesh-list
55878720|NCT02367456|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55878721|NCT02367456|Antimetabolites|antimetabolites|mesh-ancestor
55878722|NCT02367456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878723|NCT02367456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878724|NCT02367456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878726|NCT03420378|Vitamins|vitamins|mesh-ancestor
55878727|NCT03420378|Micronutrients|micronutrients|mesh-ancestor
55878728|NCT03420378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878729|NCT03420378|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55878730|NCT03420144|Hormones|hormones|mesh-list
56040672|NCT02251613|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56040673|NCT02251613|Histamine Antagonists|histamine antagonists|mesh-ancestor
56040674|NCT02251613|Histamine Agents|histamine agents|mesh-ancestor
56040675|NCT02251613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040676|NCT02251613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040679|NCT02865473|Autonomic Agents|autonomic agents|mesh-ancestor
56040680|NCT02865473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040681|NCT02865473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040682|NCT02865473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56040683|NCT02865473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56040684|NCT02865473|Cholinergic Agents|cholinergic agents|mesh-ancestor
56040685|NCT02865473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040686|NCT02865473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040687|NCT02850419|Doxorubicin|doxorubicin|mesh-list
56040688|NCT02850419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56040689|NCT02850419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55837702|NCT04630808|Latanoprost|latanoprost|mesh-list
56040690|NCT02850419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040691|NCT02850419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56040692|NCT02850419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56040693|NCT02850419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040694|NCT02850419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040695|NCT02841371|Edetic Acid|edetic acid|mesh-list
56040696|NCT02841371|Pentetic Acid|pentetic acid|mesh-list
56040697|NCT02841371|Antidotes|antidotes|mesh-ancestor
55878731|NCT03420144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55878732|NCT03420144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878733|NCT03425448|Heparin|heparin|mesh-list
55878734|NCT03425448|Anticoagulants|anticoagulants|mesh-ancestor
55878735|NCT03425448|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55878736|NCT03425448|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55878737|NCT03425448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878738|NCT03419910|Cyclosporine|cyclosporine|mesh-list
55878739|NCT03419910|BMS-986165|bms-986165|mesh-list
55878740|NCT03419910|Cyclosporins|cyclosporins|mesh-list
55878741|NCT03419910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878742|NCT03419910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878743|NCT03419910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55878744|NCT03419910|Immunologic Factors|immunologic factors|mesh-ancestor
55878745|NCT03419910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878746|NCT03419910|Antifungal Agents|antifungal agents|mesh-ancestor
55878747|NCT03419910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878748|NCT03419910|Dermatologic Agents|dermatologic agents|mesh-ancestor
55878749|NCT03419910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55878750|NCT03419910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55878751|NCT03419910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55878752|NCT03415386|Anticoagulants|anticoagulants|mesh-list
55878753|NCT03415386|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55878754|NCT01865747|Everolimus|everolimus|mesh-list
55878755|NCT01865747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040698|NCT02841371|Protective Agents|protective agents|mesh-ancestor
56040699|NCT02841371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878756|NCT01865747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55878757|NCT01865747|Immunologic Factors|immunologic factors|mesh-ancestor
55878758|NCT01865747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878760|NCT03424746|Pentetic Acid|pentetic acid|mesh-list
55878761|NCT03424746|Anticoagulants|anticoagulants|mesh-ancestor
55878762|NCT03424746|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55878763|NCT03424746|Chelating Agents|chelating agents|mesh-ancestor
55878764|NCT03424746|Sequestering Agents|sequestering agents|mesh-ancestor
55878766|NCT03424746|Antidotes|antidotes|mesh-ancestor
55878767|NCT03424746|Protective Agents|protective agents|mesh-ancestor
55878768|NCT03424746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878769|NCT03424746|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55878770|NCT03414918|Clarithromycin|clarithromycin|mesh-list
55878771|NCT03414918|Roxithromycin|roxithromycin|mesh-list
55878772|NCT03414918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55878773|NCT03414918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878774|NCT03414918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55878775|NCT03414918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878776|NCT03414918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878777|NCT03414918|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55878778|NCT03414918|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55878779|NCT04448496|Dexamethasone|dexamethasone|mesh-list
55878780|NCT04448496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55878781|NCT04448496|Antiemetics|antiemetics|mesh-ancestor
55878782|NCT04448496|Autonomic Agents|autonomic agents|mesh-ancestor
55878783|NCT04448496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878784|NCT04448496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878785|NCT04448496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878786|NCT04448496|Glucocorticoids|glucocorticoids|mesh-ancestor
55878788|NCT04448496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55878789|NCT04448496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55878790|NCT04448496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878791|NCT01387672|Nitroglycerin|nitroglycerin|mesh-list
55878792|NCT01387672|Vasodilator Agents|vasodilator agents|mesh-ancestor
55878793|NCT03419442|Docetaxel|docetaxel|mesh-list
55878794|NCT03419442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878795|NCT03419442|Tubulin Modulators|tubulin modulators|mesh-ancestor
55878796|NCT03419442|Antimitotic Agents|antimitotic agents|mesh-ancestor
55878797|NCT03419442|Mitosis Modulators|mitosis modulators|mesh-ancestor
55878798|NCT03419442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878800|NCT01412710|Cholecalciferol|cholecalciferol|mesh-list
55878801|NCT01412710|Vitamins|vitamins|mesh-ancestor
55878802|NCT01412710|Micronutrients|micronutrients|mesh-ancestor
55878803|NCT01412710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878804|NCT01412710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55878805|NCT01412710|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55878806|NCT01843205|Methamphetamine|methamphetamine|mesh-list
55878807|NCT01843205|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55878808|NCT01843205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878809|NCT01843205|Sympathomimetics|sympathomimetics|mesh-ancestor
55878810|NCT01843205|Autonomic Agents|autonomic agents|mesh-ancestor
55878811|NCT01843205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878812|NCT01843205|Dopamine Agents|dopamine agents|mesh-ancestor
55878813|NCT01843205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878814|NCT01843205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878815|NCT01843205|Adrenergic Agents|adrenergic agents|mesh-ancestor
55878816|NCT01843205|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55878817|NCT01843205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55878818|NCT01843205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878819|NCT01843205|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55878820|NCT03419130|Pembrolizumab|pembrolizumab|mesh-list
55837779|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
55878821|NCT03419130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55878822|NCT03419130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878823|NCT03414840|Atorvastatin|atorvastatin|mesh-list
55878824|NCT03414840|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55878825|NCT03414840|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55878826|NCT03414840|Antimetabolites|antimetabolites|mesh-ancestor
56040701|NCT02841371|Sequestering Agents|sequestering agents|mesh-ancestor
56040702|NCT02841371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040703|NCT02841371|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56040704|NCT02841371|Anticoagulants|anticoagulants|mesh-ancestor
56040705|NCT02841371|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56040706|NCT01783847|Prednisolone|prednisolone|mesh-list
55878827|NCT03414840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878828|NCT03414840|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55878829|NCT03414840|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55878830|NCT03414840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878832|NCT03418974|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55878833|NCT03418974|Pitavastatin|pitavastatin|mesh-list
55878834|NCT03418974|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55878835|NCT03418974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55878836|NCT03418974|Antimetabolites|antimetabolites|mesh-ancestor
55878837|NCT03418974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878838|NCT03418974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55878839|NCT03418974|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55878840|NCT03418974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878842|NCT03424356|Narcotics|narcotics|mesh-list
55878843|NCT03424356|Analgesics|analgesics|mesh-list
55878844|NCT03424356|Bromides|bromides|mesh-list
55878845|NCT03424356|Propofol|propofol|mesh-list
55878846|NCT03424356|Rocuronium|rocuronium|mesh-list
55878847|NCT03424356|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55878848|NCT03424356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878849|NCT03424356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878850|NCT03424356|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55878851|NCT03424356|Anesthetics, General|anesthetics, general|mesh-ancestor
55878853|NCT03424356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55878854|NCT03424356|Sensory System Agents|sensory system agents|mesh-ancestor
55878855|NCT03424356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878856|NCT03424356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55878857|NCT03424356|Anticonvulsants|anticonvulsants|mesh-ancestor
55878858|NCT03424356|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55878859|NCT03424356|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55878860|NCT03424356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55878861|NCT03414450|Dasatinib|dasatinib|mesh-list
55878862|NCT03414450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878863|NCT03414450|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55878864|NCT03414450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886879|NCT02472054|Prednisolone phosphate|prednisolone phosphate|mesh-list
55878865|NCT03414450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878866|NCT01389076|Methotrexate|methotrexate|mesh-list
55878867|NCT01389076|Tositumomab I-131|tositumomab i-131|mesh-list
55878868|NCT01389076|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55878869|NCT01389076|Abortifacient Agents|abortifacient agents|mesh-ancestor
55878870|NCT01389076|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55878871|NCT01389076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878872|NCT01389076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55878873|NCT01389076|Antimetabolites|antimetabolites|mesh-ancestor
55878874|NCT01389076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878875|NCT01389076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878876|NCT01389076|Dermatologic Agents|dermatologic agents|mesh-ancestor
55878877|NCT01389076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878878|NCT01389076|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55878879|NCT01389076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55878880|NCT01389076|Immunologic Factors|immunologic factors|mesh-ancestor
55878881|NCT01389076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55878882|NCT01389076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55878883|NCT03127800|Morphine|morphine|mesh-list
55878884|NCT03127800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55878885|NCT03127800|Narcotics|narcotics|mesh-ancestor
55878886|NCT03127800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878887|NCT03127800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878888|NCT03127800|Analgesics|analgesics|mesh-ancestor
55878889|NCT03127800|Sensory System Agents|sensory system agents|mesh-ancestor
56040707|NCT01783847|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56040708|NCT01783847|Methylprednisolone|methylprednisolone|mesh-list
56040709|NCT01783847|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56040710|NCT01783847|Prednisolone acetate|prednisolone acetate|mesh-list
56040711|NCT01783847|Epoetin Alfa|epoetin alfa|mesh-list
56040713|NCT01783847|Prednisolone phosphate|prednisolone phosphate|mesh-list
56040714|NCT01783847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56040715|NCT01783847|Glucocorticoids|glucocorticoids|mesh-ancestor
56040716|NCT01783847|Hormones|hormones|mesh-ancestor
56040717|NCT01783847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040718|NCT01783847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040719|NCT01783847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56040720|NCT01783847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040721|NCT01783847|Antiemetics|antiemetics|mesh-ancestor
56040722|NCT01783847|Autonomic Agents|autonomic agents|mesh-ancestor
56040723|NCT01783847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040724|NCT01783847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56040725|NCT01783847|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56040726|NCT01783847|Protective Agents|protective agents|mesh-ancestor
56040727|NCT01783847|Hematinics|hematinics|mesh-ancestor
56040728|NCT02620865|Calcium, Dietary|calcium, dietary|mesh-list
56040729|NCT02620865|Leucovorin|leucovorin|mesh-list
56040730|NCT02620865|Folic Acid|folic acid|mesh-list
56040731|NCT02620865|Gemcitabine|gemcitabine|mesh-list
56040732|NCT02620865|Aldesleukin|aldesleukin|mesh-list
56040733|NCT02620865|Paclitaxel|paclitaxel|mesh-list
56040734|NCT02620865|Camptothecin|camptothecin|mesh-list
56040735|NCT02620865|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56040736|NCT02620865|Fluorouracil|fluorouracil|mesh-list
56040737|NCT02620865|Oxaliplatin|oxaliplatin|mesh-list
56040738|NCT02620865|Irinotecan|irinotecan|mesh-list
56040739|NCT02620865|Interleukin-2|interleukin-2|mesh-list
56040740|NCT02620865|Antibodies|antibodies|mesh-list
56040741|NCT02620865|Immunoglobulins|immunoglobulins|mesh-list
56040742|NCT02620865|Sargramostim|sargramostim|mesh-list
56040743|NCT02620865|Calcium|calcium|mesh-list
56040744|NCT02620865|Levoleucovorin|levoleucovorin|mesh-list
56040745|NCT02620865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55886880|NCT02472054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040746|NCT02620865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040747|NCT02620865|Tubulin Modulators|tubulin modulators|mesh-ancestor
56040748|NCT02620865|Antimitotic Agents|antimitotic agents|mesh-ancestor
56040749|NCT02620865|Mitosis Modulators|mitosis modulators|mesh-ancestor
56040750|NCT02620865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040751|NCT02620865|Immunologic Factors|immunologic factors|mesh-ancestor
56040752|NCT02620865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040753|NCT02620865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56040754|NCT02620865|Antimetabolites|antimetabolites|mesh-ancestor
56040755|NCT02620865|Antiviral Agents|antiviral agents|mesh-ancestor
56040756|NCT02620865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040757|NCT02620865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040758|NCT02620865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56040759|NCT02620865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56040760|NCT02620865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55837925|NCT01464424|Bimatoprost|bimatoprost|mesh-list
56040761|NCT02620865|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56040762|NCT02620865|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56040763|NCT02620865|Antidotes|antidotes|mesh-ancestor
56040764|NCT02620865|Protective Agents|protective agents|mesh-ancestor
56040765|NCT02620865|Vitamin B Complex|vitamin b complex|mesh-ancestor
56040766|NCT02620865|Vitamins|vitamins|mesh-ancestor
56040767|NCT02620865|Micronutrients|micronutrients|mesh-ancestor
56040768|NCT02620865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56040769|NCT02620865|Analgesics|analgesics|mesh-ancestor
56040770|NCT02620865|Sensory System Agents|sensory system agents|mesh-ancestor
56040771|NCT02620865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040772|NCT02620865|Hematinics|hematinics|mesh-ancestor
56040773|NCT02620865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56040774|NCT02620865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56040775|NCT02585375|Latanoprost|latanoprost|mesh-list
56040776|NCT02585375|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56040777|NCT02585375|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56040778|NCT02516813|Peposertib|peposertib|mesh-list
56040779|NCT02516813|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56040792|NCT03362775|Propofol|propofol|mesh-list
56040793|NCT03362775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56040794|NCT03362775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040795|NCT03362775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040796|NCT03362775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56040802|NCT01786967|Cholinergic Agents|cholinergic agents|mesh-ancestor
56040803|NCT01786967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040804|NCT01786967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878890|NCT03127800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878891|NCT01389856|Bosentan|bosentan|mesh-list
55878892|NCT01389856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55878893|NCT01389856|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55878894|NCT01389856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878895|NCT03418896|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55878896|NCT03418896|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55878897|NCT03418896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878898|NCT01323010|Albuterol|albuterol|mesh-list
55878899|NCT01323010|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55878900|NCT01323010|Autonomic Agents|autonomic agents|mesh-ancestor
55878901|NCT01323010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878902|NCT01323010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878903|NCT01323010|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55878904|NCT01323010|Respiratory System Agents|respiratory system agents|mesh-ancestor
55878905|NCT01323010|Tocolytic Agents|tocolytic agents|mesh-ancestor
55878906|NCT01323010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55878907|NCT01323010|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55878908|NCT01323010|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55878909|NCT01323010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55878910|NCT01323010|Adrenergic Agents|adrenergic agents|mesh-ancestor
55878911|NCT01323010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878912|NCT01323010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878913|NCT03423810|Hydralazine|hydralazine|mesh-list
55878914|NCT03423810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55878915|NCT03423810|Vasodilator Agents|vasodilator agents|mesh-ancestor
55878916|NCT01390246|Bupropion|bupropion|mesh-list
55878917|NCT01390246|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55878918|NCT01390246|Antidepressive Agents|antidepressive agents|mesh-ancestor
55878919|NCT01390246|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55878920|NCT01390246|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55878922|NCT01390246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55878923|NCT01390246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878925|NCT01390246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878926|NCT01390246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878927|NCT01390246|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55878928|NCT01390246|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55878929|NCT01390246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878930|NCT01390870|Alfuzosin|alfuzosin|mesh-list
55878931|NCT01390870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878932|NCT01390870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878933|NCT01390870|Urological Agents|urological agents|mesh-ancestor
55878934|NCT01390870|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55878935|NCT01390870|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55878936|NCT01390870|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55790591|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55878937|NCT01390870|Adrenergic Agents|adrenergic agents|mesh-ancestor
56040805|NCT01786967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040807|NCT02392871|Trametinib|trametinib|mesh-list
56040808|NCT02392871|Dabrafenib|dabrafenib|mesh-list
56040809|NCT02392871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040810|NCT02392871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56040811|NCT02392871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040812|NCT02392871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040813|NCT02382575|Rituximab|rituximab|mesh-list
56040814|NCT02382575|Tacrolimus|tacrolimus|mesh-list
56040815|NCT02382575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
55838028|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
56040816|NCT02382575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56040817|NCT02382575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040818|NCT02382575|Immunologic Factors|immunologic factors|mesh-ancestor
56040819|NCT02382575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040820|NCT02382575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56040821|NCT02382575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56040822|NCT02382575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040823|NCT02382575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040824|NCT01642901|Zoledronic Acid|zoledronic acid|mesh-list
56040825|NCT01642901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56040826|NCT01642901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040827|NCT01807871|Nicotine|nicotine|mesh-list
56040828|NCT01807871|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56040829|NCT01807871|Autonomic Agents|autonomic agents|mesh-ancestor
56040854|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56040855|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
56040856|NCT01091831|Hormones|hormones|mesh-ancestor
56040857|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040858|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56040859|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56040860|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56040861|NCT01091831|Growth Substances|growth substances|mesh-ancestor
56040862|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
56040863|NCT01263938|Atorvastatin|atorvastatin|mesh-list
56040864|NCT01263938|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56040865|NCT01263938|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56040866|NCT01263938|Antimetabolites|antimetabolites|mesh-ancestor
56040867|NCT01263938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040868|NCT01263938|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56040869|NCT01263938|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56040870|NCT01263938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040871|NCT02327741|Clopidogrel|clopidogrel|mesh-list
56040872|NCT02327741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56040873|NCT02327741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56040874|NCT02327741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56040875|NCT02327741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56040876|NCT02327741|Purinergic Agents|purinergic agents|mesh-ancestor
56040877|NCT02327741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040878|NCT02327741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040879|NCT02327741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040880|NCT00367185|Thalidomide|thalidomide|mesh-list
56040881|NCT00367185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56040882|NCT00367185|Immunologic Factors|immunologic factors|mesh-ancestor
56040895|NCT02635035|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56040896|NCT02635035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56040897|NCT02635035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040898|NCT02635035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040899|NCT02635035|Dopamine Agents|dopamine agents|mesh-ancestor
56040900|NCT02635035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040902|NCT03283137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56040903|NCT03283137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040904|NCT01267136|Acetaminophen|acetaminophen|mesh-list
56040905|NCT01267136|Tramadol|tramadol|mesh-list
56040906|NCT01267136|Codeine|codeine|mesh-list
56040907|NCT01267136|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56040908|NCT01267136|Analgesics|analgesics|mesh-ancestor
56040909|NCT01267136|Sensory System Agents|sensory system agents|mesh-ancestor
56040910|NCT01267136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040911|NCT01267136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040913|NCT01267136|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56040914|NCT01267136|Narcotics|narcotics|mesh-ancestor
56040915|NCT01267136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040916|NCT01267136|Antitussive Agents|antitussive agents|mesh-ancestor
56040917|NCT01267136|Respiratory System Agents|respiratory system agents|mesh-ancestor
56040918|NCT01370564|Diuretics|diuretics|mesh-list
55878938|NCT01390870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878939|NCT03418506|Lobeline|lobeline|mesh-list
55878940|NCT03418506|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55878941|NCT03418506|Autonomic Agents|autonomic agents|mesh-ancestor
55878942|NCT03418506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878943|NCT03418506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878944|NCT03418506|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55878945|NCT03418506|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55878946|NCT03418506|Cholinergic Agents|cholinergic agents|mesh-ancestor
55878947|NCT03418506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55878948|NCT03418506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878949|NCT03418506|Respiratory System Agents|respiratory system agents|mesh-ancestor
55878950|NCT01842581|Rifaximin|rifaximin|mesh-list
55878951|NCT01842581|Lactulose|lactulose|mesh-list
55878952|NCT01842581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55878953|NCT01842581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878954|NCT01842581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878955|NCT04448028|Esomeprazole|esomeprazole|mesh-list
55878956|NCT04448028|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55878957|NCT04448028|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55878958|NCT04448028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55878959|NCT04448028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55878960|NCT04448028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878961|NCT01833533|Ribavirin|ribavirin|mesh-list
55878962|NCT01833533|Antimetabolites|antimetabolites|mesh-ancestor
55886963|NCT05607420|Alemtuzumab|alemtuzumab|mesh-list
55878963|NCT01833533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878964|NCT01833533|Antiviral Agents|antiviral agents|mesh-ancestor
56040920|NCT01370564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040921|NCT00367263|Ciclesonide|ciclesonide|mesh-list
56040922|NCT00367263|Glucocorticoids|glucocorticoids|mesh-ancestor
56040923|NCT00367263|Hormones|hormones|mesh-ancestor
56040924|NCT00367263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56040925|NCT00367263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040926|NCT00367263|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56040927|NCT01267292|Buspirone|buspirone|mesh-list
56040928|NCT01267292|Methylphenidate|methylphenidate|mesh-list
56040929|NCT01267292|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56040930|NCT01267292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040931|NCT01267292|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56040932|NCT01267292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56040933|NCT01267292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040934|NCT01267292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040935|NCT01267292|Dopamine Agents|dopamine agents|mesh-ancestor
56040936|NCT01267292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56040937|NCT01267292|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56040938|NCT01267292|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56040939|NCT01267292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040940|NCT01267292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56040941|NCT01267292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56040942|NCT01267292|Serotonin Agents|serotonin agents|mesh-ancestor
56040943|NCT02637999|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56040944|NCT02637999|Interferon alpha-2|interferon alpha-2|mesh-list
56040945|NCT02637999|Antiviral Agents|antiviral agents|mesh-ancestor
56040946|NCT02637999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040947|NCT02637999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040948|NCT01371110|Midazolam|midazolam|mesh-list
56040949|NCT01371110|Ketamine|ketamine|mesh-list
56040950|NCT01371110|Analgesics|analgesics|mesh-ancestor
56040951|NCT01371110|Sensory System Agents|sensory system agents|mesh-ancestor
55878965|NCT01833533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878966|NCT03413436|Cisplatin|cisplatin|mesh-list
55878967|NCT03413436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878968|NCT01833455|Flecainide|flecainide|mesh-list
55878969|NCT01833455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55878970|NCT01833455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55878971|NCT01833455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55878972|NCT01833455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56040952|NCT01371110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56040953|NCT01371110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040954|NCT01371110|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56040955|NCT01371110|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56040956|NCT01371110|Anesthetics, General|anesthetics, general|mesh-ancestor
56040957|NCT01371110|Anesthetics|anesthetics|mesh-ancestor
56040958|NCT01371110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56040959|NCT01371110|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56040960|NCT01371110|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56040961|NCT01371110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838149|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
56040962|NCT01371110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040963|NCT01371110|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56040964|NCT01371110|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56040965|NCT01371110|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56040966|NCT01371110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56040967|NCT01371110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56040968|NCT01371110|GABA Modulators|gaba modulators|mesh-ancestor
56040969|NCT01371110|GABA Agents|gaba agents|mesh-ancestor
56040970|NCT01791491|Abatacept|abatacept|mesh-list
56040971|NCT01791491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56040972|NCT01791491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040973|NCT01791491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040974|NCT01791491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56040975|NCT01791491|Immunologic Factors|immunologic factors|mesh-ancestor
56040976|NCT01791491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56040977|NCT01791491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56040979|NCT00367419|Erythromycin Estolate|erythromycin estolate|mesh-list
56040980|NCT00367419|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56040981|NCT00367419|Erythromycin stearate|erythromycin stearate|mesh-list
55878973|NCT01833455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878974|NCT03413358|Carboplatin|carboplatin|mesh-list
55878975|NCT03413358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878976|NCT01833143|Acyclovir|acyclovir|mesh-list
55878977|NCT01833143|Bortezomib|bortezomib|mesh-list
55878978|NCT01833143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878979|NCT01833143|Antiviral Agents|antiviral agents|mesh-ancestor
55878980|NCT01833143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878981|NCT03411096|Ropivacaine|ropivacaine|mesh-list
55878982|NCT03411096|Anesthetics, Local|anesthetics, local|mesh-ancestor
55878983|NCT03411096|Anesthetics|anesthetics|mesh-ancestor
55878984|NCT03411096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55878985|NCT03411096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878986|NCT03411096|Sensory System Agents|sensory system agents|mesh-ancestor
55878987|NCT03411096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55878988|NCT03417648|Vitamin E|vitamin e|mesh-list
56040982|NCT00367419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56040983|NCT00367419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56040984|NCT00367419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56040985|NCT00367419|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56040986|NCT00367419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56040987|NCT00367419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040988|NCT01372202|Paclitaxel|paclitaxel|mesh-list
56040989|NCT01372202|Fluorouracil|fluorouracil|mesh-list
56040990|NCT01372202|Oxaliplatin|oxaliplatin|mesh-list
56040991|NCT01372202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56040992|NCT01372202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56040993|NCT01372202|Tubulin Modulators|tubulin modulators|mesh-ancestor
56040994|NCT01372202|Antimitotic Agents|antimitotic agents|mesh-ancestor
56040995|NCT01372202|Mitosis Modulators|mitosis modulators|mesh-ancestor
56040996|NCT01372202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56040999|NCT01372202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041000|NCT01372202|Immunologic Factors|immunologic factors|mesh-ancestor
56041001|NCT01372202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041002|NCT01811147|Norepinephrine|norepinephrine|mesh-list
56041003|NCT01811147|Serotonin|serotonin|mesh-list
56041004|NCT01811147|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55878989|NCT03417648|Vitamins|vitamins|mesh-ancestor
55878990|NCT03417648|Micronutrients|micronutrients|mesh-ancestor
55878991|NCT03417648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878992|NCT03417648|Antioxidants|antioxidants|mesh-ancestor
55878996|NCT01831817|Listerine|listerine|mesh-list
55878997|NCT01831817|Calcium|calcium|mesh-list
55878998|NCT01831817|Fluorides|fluorides|mesh-list
55878999|NCT01831817|Sodium Fluoride|sodium fluoride|mesh-list
55879000|NCT01831817|Fluorophosphate|fluorophosphate|mesh-list
55879001|NCT01831817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55879002|NCT01831817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879003|NCT01831817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55879004|NCT01831817|Cariostatic Agents|cariostatic agents|mesh-ancestor
55879005|NCT01831817|Protective Agents|protective agents|mesh-ancestor
55879006|NCT01831817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55879007|NCT01831817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55879008|NCT03412500|Vancomycin|vancomycin|mesh-list
55879009|NCT03412500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55879010|NCT03412500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55879011|NCT01840943|Topotecan|topotecan|mesh-list
55879012|NCT01840943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55879013|NCT01840943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55879014|NCT01840943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879015|NCT01840943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879016|NCT01840943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879017|NCT05171400|Insulin|insulin|mesh-list
55879018|NCT05171400|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56041005|NCT01811147|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56041006|NCT01811147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56041007|NCT01811147|Adrenergic Agents|adrenergic agents|mesh-ancestor
56041008|NCT01811147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041009|NCT01811147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041010|NCT01811147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041011|NCT01811147|Sympathomimetics|sympathomimetics|mesh-ancestor
56041012|NCT01811147|Autonomic Agents|autonomic agents|mesh-ancestor
56041013|NCT01811147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041014|NCT01811147|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56041015|NCT01811147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56041016|NCT01811147|Serotonin Agents|serotonin agents|mesh-ancestor
56041017|NCT01811147|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56041018|NCT01811147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56041019|NCT01373450|Liraglutide|liraglutide|mesh-list
56041020|NCT01373450|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56041021|NCT01373450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041022|NCT01373450|Incretins|incretins|mesh-ancestor
56041023|NCT01373450|Hormones|hormones|mesh-ancestor
56041024|NCT01373450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041025|NCT01793285|Etanercept|etanercept|mesh-list
56041026|NCT01793285|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56041027|NCT01793285|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041028|NCT01793285|Analgesics|analgesics|mesh-ancestor
56041029|NCT01793285|Sensory System Agents|sensory system agents|mesh-ancestor
56041052|NCT01811693|Vasodilator Agents|vasodilator agents|mesh-ancestor
56041053|NCT02639637|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56041054|NCT02639637|Valsartan|valsartan|mesh-list
56041055|NCT02639637|Enalaprilat|enalaprilat|mesh-list
56041056|NCT02639637|Enalapril|enalapril|mesh-list
56041057|NCT02639637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56041058|NCT02639637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041059|NCT02639637|Incretins|incretins|mesh-ancestor
56041060|NCT02639637|Hormones|hormones|mesh-ancestor
56041061|NCT02639637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041062|NCT02639637|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56041063|NCT02639637|Protease Inhibitors|protease inhibitors|mesh-ancestor
56041064|NCT02639637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041065|NCT02639637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041066|NCT02639637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56041067|NCT02639637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56041068|NCT02639637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56041069|NCT02639637|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56041070|NCT01332188|Cetirizine|cetirizine|mesh-list
55879019|NCT05171400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879020|NCT02203630|Phenylephrine|phenylephrine|mesh-list
55879021|NCT02203630|Oxymetazoline|oxymetazoline|mesh-list
55879022|NCT02203630|Norepinephrine|norepinephrine|mesh-list
55879023|NCT02203630|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55879024|NCT02203630|Mydriatics|mydriatics|mesh-ancestor
55879025|NCT02203630|Autonomic Agents|autonomic agents|mesh-ancestor
55879026|NCT02203630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879027|NCT02203630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879028|NCT02203630|Sympathomimetics|sympathomimetics|mesh-ancestor
55879029|NCT02203630|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55879030|NCT02203630|Nasal Decongestants|nasal decongestants|mesh-ancestor
55879031|NCT02203630|Respiratory System Agents|respiratory system agents|mesh-ancestor
55879032|NCT02203630|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55879033|NCT02203630|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55879034|NCT02203630|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55879035|NCT02203630|Adrenergic Agents|adrenergic agents|mesh-ancestor
55889998|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55838322|NCT01411774|Cycloserine|cycloserine|mesh-list
55879036|NCT02203630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879037|NCT02203630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879038|NCT02203630|Protective Agents|protective agents|mesh-ancestor
55879039|NCT04593329|Dipyrone|dipyrone|mesh-list
55879040|NCT04593329|Tramadol|tramadol|mesh-list
55879041|NCT04593329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55879042|NCT04593329|Narcotics|narcotics|mesh-ancestor
55879043|NCT04593329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879044|NCT04593329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879045|NCT04593329|Analgesics|analgesics|mesh-ancestor
55879046|NCT04593329|Sensory System Agents|sensory system agents|mesh-ancestor
55879047|NCT04593329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879048|NCT04593329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55879049|NCT04593329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879050|NCT04593329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879051|NCT04593329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879052|NCT04593329|Antipyretics|antipyretics|mesh-ancestor
55879053|NCT03397446|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55879054|NCT03397446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56041071|NCT01332188|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56041072|NCT01332188|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56041073|NCT01332188|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56041074|NCT01332188|Histamine Antagonists|histamine antagonists|mesh-ancestor
56041075|NCT01332188|Histamine Agents|histamine agents|mesh-ancestor
56041076|NCT01332188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041077|NCT01332188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041078|NCT01332188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041079|NCT01794455|Candesartan|candesartan|mesh-list
56041081|NCT01794455|Antidepressive Agents|antidepressive agents|mesh-ancestor
56041082|NCT01794455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56041083|NCT01794455|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56041084|NCT01794455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56041085|NCT01794455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56041086|NCT01794455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041087|NCT01794455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041088|NCT01794455|Serotonin Agents|serotonin agents|mesh-ancestor
56041089|NCT01794455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041090|NCT01794455|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56041091|NCT01794455|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56041092|NCT01794455|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56041094|NCT01332500|Sumatriptan|sumatriptan|mesh-list
56041095|NCT01332500|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56041096|NCT01332500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041097|NCT01332500|Analgesics|analgesics|mesh-ancestor
56041098|NCT01332500|Sensory System Agents|sensory system agents|mesh-ancestor
56041099|NCT01332500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041100|NCT01332500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041101|NCT01332500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041102|NCT01332500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041103|NCT01332500|Gout Suppressants|gout suppressants|mesh-ancestor
56041104|NCT01332500|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56041105|NCT01332500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041107|NCT01332500|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56041108|NCT01332500|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56041109|NCT01332500|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56041110|NCT01332500|Serotonin Agents|serotonin agents|mesh-ancestor
56041111|NCT01332500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041112|NCT01812005|Rituximab|rituximab|mesh-list
56041113|NCT01812005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56041114|NCT01812005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041115|NCT01812005|Immunologic Factors|immunologic factors|mesh-ancestor
56041116|NCT01812005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041117|NCT01812005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041118|NCT01332578|Acetaminophen|acetaminophen|mesh-list
56041119|NCT01332578|Ascorbic Acid|ascorbic acid|mesh-list
56041120|NCT01332578|Phenylephrine|phenylephrine|mesh-list
56041121|NCT01332578|Oxymetazoline|oxymetazoline|mesh-list
56041122|NCT01332578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041123|NCT01332578|Analgesics|analgesics|mesh-ancestor
56041124|NCT01332578|Sensory System Agents|sensory system agents|mesh-ancestor
56041125|NCT01332578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041126|NCT01332578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041127|NCT01332578|Antipyretics|antipyretics|mesh-ancestor
56041128|NCT01332578|Antioxidants|antioxidants|mesh-ancestor
56041129|NCT01332578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041130|NCT01332578|Protective Agents|protective agents|mesh-ancestor
56041132|NCT01332578|Micronutrients|micronutrients|mesh-ancestor
56041133|NCT01332578|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56041134|NCT01332578|Mydriatics|mydriatics|mesh-ancestor
56041135|NCT01332578|Autonomic Agents|autonomic agents|mesh-ancestor
56041136|NCT01332578|Sympathomimetics|sympathomimetics|mesh-ancestor
56041137|NCT01332578|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56041138|NCT01332578|Nasal Decongestants|nasal decongestants|mesh-ancestor
56041139|NCT01332578|Respiratory System Agents|respiratory system agents|mesh-ancestor
56041140|NCT01332578|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56041141|NCT01332578|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56041142|NCT01332578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56041143|NCT01332578|Adrenergic Agents|adrenergic agents|mesh-ancestor
56041144|NCT01332578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041148|NCT01375946|Contraceptive Agents|contraceptive agents|mesh-list
56041149|NCT01375946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56041150|NCT01375946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041151|NCT01734161|Dexamethasone|dexamethasone|mesh-list
56041152|NCT01734161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041153|NCT01734161|Antiemetics|antiemetics|mesh-ancestor
56041154|NCT01734161|Autonomic Agents|autonomic agents|mesh-ancestor
56041155|NCT01734161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041156|NCT01734161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041157|NCT01734161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56041158|NCT01734161|Glucocorticoids|glucocorticoids|mesh-ancestor
56041159|NCT01734161|Hormones|hormones|mesh-ancestor
56041160|NCT01734161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041161|NCT01734161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56041162|NCT01734161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041163|NCT01734239|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56041164|NCT01734239|Immunologic Factors|immunologic factors|mesh-ancestor
56041165|NCT01734239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041166|NCT01797575|Aspirin|aspirin|mesh-list
56041167|NCT01797575|Acetylcysteine|acetylcysteine|mesh-list
56041168|NCT01797575|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56041169|NCT01797575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56041170|NCT01797575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041171|NCT01797575|Analgesics|analgesics|mesh-ancestor
56041172|NCT01797575|Sensory System Agents|sensory system agents|mesh-ancestor
56041173|NCT01797575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041174|NCT01797575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041175|NCT01797575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041176|NCT01797575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041193|NCT02641353|Apremilast|apremilast|mesh-list
56041194|NCT02641353|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56041195|NCT02641353|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041196|NCT02641353|Analgesics|analgesics|mesh-ancestor
56124669|NCT01405950|Sympatholytics|sympatholytics|mesh-ancestor
56041197|NCT02641353|Sensory System Agents|sensory system agents|mesh-ancestor
56041198|NCT02641353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041199|NCT02641353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041200|NCT02641353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041201|NCT02641353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041202|NCT02641353|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56041203|NCT02641353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56041204|NCT02641353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041205|NCT02641353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041206|NCT02641353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041207|NCT02641353|Immunologic Factors|immunologic factors|mesh-ancestor
56041208|NCT02641353|Leprostatic Agents|leprostatic agents|mesh-ancestor
56041209|NCT02641353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56041210|NCT02641353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041211|NCT02641353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56041212|NCT02641353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56041213|NCT02641353|Growth Substances|growth substances|mesh-ancestor
56041214|NCT02641353|Growth Inhibitors|growth inhibitors|mesh-ancestor
56041215|NCT02641353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041216|NCT01378520|Ketoconazole|ketoconazole|mesh-list
56041217|NCT01378520|Antifungal Agents|antifungal agents|mesh-ancestor
56041218|NCT01378520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041219|NCT01378520|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56041220|NCT01378520|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56041221|NCT01378520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041234|NCT01378988|Sensory System Agents|sensory system agents|mesh-ancestor
56041235|NCT01378988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041236|NCT01378988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56041237|NCT01378988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56041238|NCT01378988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56041239|NCT01378988|Adrenergic Agents|adrenergic agents|mesh-ancestor
56041240|NCT01378988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041241|NCT01378988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041243|NCT01335620|Emtricitabine|emtricitabine|mesh-list
56041244|NCT01335620|Raltegravir Potassium|raltegravir potassium|mesh-list
56041245|NCT01335620|Antiviral Agents|antiviral agents|mesh-ancestor
56041246|NCT01335620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041247|NCT01335620|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56041248|NCT01335620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56041249|NCT01335620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041250|NCT01335620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041251|NCT01335620|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56041252|NCT01335620|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56041253|NCT01335620|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56041254|NCT01335620|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56041255|NCT01335932|Ganciclovir|ganciclovir|mesh-list
56041256|NCT01335932|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56041257|NCT01335932|Antiviral Agents|antiviral agents|mesh-ancestor
56041258|NCT01335932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041259|NCT01335932|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56041260|NCT01335932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041262|NCT01273766|Deferasirox|deferasirox|mesh-list
56041280|NCT01403246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041281|NCT01403246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56041282|NCT01403246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56041283|NCT01403246|Growth Substances|growth substances|mesh-ancestor
56041284|NCT01403246|Growth Inhibitors|growth inhibitors|mesh-ancestor
56041285|NCT01403246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041286|NCT01403246|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56041287|NCT01403246|Alkylating Agents|alkylating agents|mesh-ancestor
56041288|NCT01403246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041289|NCT01734551|Clonidine|clonidine|mesh-list
56041290|NCT01734551|Morphine|morphine|mesh-list
56041291|NCT01734551|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56041292|NCT01734551|Narcotics|narcotics|mesh-ancestor
56041293|NCT01734551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041294|NCT01734551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041295|NCT01734551|Analgesics|analgesics|mesh-ancestor
56041296|NCT01734551|Sensory System Agents|sensory system agents|mesh-ancestor
56041297|NCT01734551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041298|NCT01734551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56041299|NCT01734551|Sympatholytics|sympatholytics|mesh-ancestor
56041300|NCT01734551|Autonomic Agents|autonomic agents|mesh-ancestor
56041301|NCT01734551|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56041302|NCT01734551|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56041303|NCT01734551|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56041304|NCT01734551|Adrenergic Agents|adrenergic agents|mesh-ancestor
56041305|NCT01734551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041306|NCT01734551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041309|NCT01404260|Gefitinib|gefitinib|mesh-list
56041310|NCT01404260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041311|NCT01404260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56041312|NCT01404260|Antimetabolites|antimetabolites|mesh-ancestor
56041323|NCT02235909|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56041324|NCT02235909|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56041325|NCT02235909|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56041326|NCT02235909|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56041327|NCT02235909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041328|NCT01404572|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56041329|NCT01404572|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56041330|NCT01404572|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56041331|NCT01404572|Protease Inhibitors|protease inhibitors|mesh-ancestor
56041332|NCT01404572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041333|NCT01404572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041334|NCT01404572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56041335|NCT01404572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56041336|NCT01404572|Antiviral Agents|antiviral agents|mesh-ancestor
56041337|NCT01404572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041338|NCT01381406|Tiotropium Bromide|tiotropium bromide|mesh-list
56041339|NCT01381406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56041340|NCT01381406|Autonomic Agents|autonomic agents|mesh-ancestor
56041341|NCT01381406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041342|NCT01381406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041343|NCT01381406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55838674|NCT01987427|Phentermine|phentermine|mesh-list
56041344|NCT01381406|Respiratory System Agents|respiratory system agents|mesh-ancestor
56041345|NCT01381406|Parasympatholytics|parasympatholytics|mesh-ancestor
56041346|NCT01381406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56041347|NCT01381406|Cholinergic Agents|cholinergic agents|mesh-ancestor
56041348|NCT01381406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041349|NCT01381406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041350|NCT01799213|Meloxicam|meloxicam|mesh-list
56041351|NCT01799213|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56041352|NCT01799213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041353|NCT01799213|Analgesics|analgesics|mesh-ancestor
56041354|NCT01799213|Sensory System Agents|sensory system agents|mesh-ancestor
56041355|NCT01799213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879055|NCT03397446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879056|NCT03397446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55879057|NCT03397446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55879058|NCT03397446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55879059|NCT03397446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041356|NCT01799213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041357|NCT01799213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041358|NCT01799213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041359|NCT01799213|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56041360|NCT01799213|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56041361|NCT01799213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041362|NCT01799213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041364|NCT01383200|Tetracaine|tetracaine|mesh-list
56041365|NCT01383200|Anesthetics, Local|anesthetics, local|mesh-ancestor
56041366|NCT01383200|Anesthetics|anesthetics|mesh-ancestor
56041367|NCT01383200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041368|NCT01383200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041369|NCT01383200|Sensory System Agents|sensory system agents|mesh-ancestor
56041370|NCT01383200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041371|NCT01383200|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56041372|NCT01383200|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56041373|NCT01383200|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56041374|NCT01383200|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56041375|NCT01383200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041376|NCT04868877|Osimertinib|osimertinib|mesh-list
56041377|NCT04868877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041378|NCT04868877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56041379|NCT04868877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041380|NCT04868877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041381|NCT05588037|Dexamethasone|dexamethasone|mesh-list
56041382|NCT05588037|Dexamethasone acetate|dexamethasone acetate|mesh-list
56041401|NCT02194088|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56041402|NCT02194088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041403|NCT02194088|Sensory System Agents|sensory system agents|mesh-ancestor
56041404|NCT02194088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041405|NCT02194088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041406|NCT02194088|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041407|NCT02194088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041408|NCT02194088|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56041409|NCT02194088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041410|NCT02194088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041411|NCT02194088|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56041412|NCT02194088|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56041413|NCT02194088|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56041415|NCT02194088|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56041416|NCT02194088|Respiratory System Agents|respiratory system agents|mesh-ancestor
56041418|NCT02194088|Parasympatholytics|parasympatholytics|mesh-ancestor
56041419|NCT02194088|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56041420|NCT02194088|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55879060|NCT03397446|Dopamine Agents|dopamine agents|mesh-ancestor
55879061|NCT03397446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879062|NCT01393132|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55879063|NCT01393132|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55879065|NCT02520570|Trypsin Inhibitors|trypsin inhibitors|mesh-list
55879066|NCT02520570|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55879067|NCT02520570|Protease Inhibitors|protease inhibitors|mesh-ancestor
55879068|NCT02520570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879069|NCT02520570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879070|NCT03411798|Hydroxychloroquine|hydroxychloroquine|mesh-list
55879071|NCT03411798|Sulfasalazine|sulfasalazine|mesh-list
55879072|NCT03411798|Methotrexate|methotrexate|mesh-list
55879073|NCT03411798|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55879074|NCT03411798|Abortifacient Agents|abortifacient agents|mesh-ancestor
55879075|NCT03411798|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879076|NCT03411798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879077|NCT03411798|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55879078|NCT03411798|Antimetabolites|antimetabolites|mesh-ancestor
55879079|NCT03411798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879080|NCT03411798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879081|NCT03411798|Dermatologic Agents|dermatologic agents|mesh-ancestor
55879082|NCT03411798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879083|NCT03411798|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55879084|NCT03411798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55879085|NCT03411798|Immunologic Factors|immunologic factors|mesh-ancestor
55879086|NCT03411798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879087|NCT03411798|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55879088|NCT03411798|Antimalarials|antimalarials|mesh-ancestor
55879089|NCT03411798|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55879090|NCT03411798|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55879091|NCT03411798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55879092|NCT03411798|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55879093|NCT03411798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879094|NCT03411798|Analgesics|analgesics|mesh-ancestor
55879095|NCT03411798|Sensory System Agents|sensory system agents|mesh-ancestor
56041421|NCT02194088|Cholinergic Agents|cholinergic agents|mesh-ancestor
56041422|NCT02194088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041423|NCT02023593|Leucovorin|leucovorin|mesh-list
56041424|NCT02023593|Fluorouracil|fluorouracil|mesh-list
56041425|NCT02023593|Irinotecan|irinotecan|mesh-list
56041426|NCT02023593|Antimetabolites|antimetabolites|mesh-ancestor
56041427|NCT02023593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041428|NCT02023593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56041429|NCT02023593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041430|NCT02023593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041431|NCT02023593|Immunologic Factors|immunologic factors|mesh-ancestor
56041432|NCT02023593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041433|NCT02023593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56041434|NCT02023593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56041435|NCT02023593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041436|NCT02023593|Antidotes|antidotes|mesh-ancestor
56041437|NCT02023593|Protective Agents|protective agents|mesh-ancestor
56041438|NCT02023593|Vitamin B Complex|vitamin b complex|mesh-ancestor
56041441|NCT01978431|Cocaine|cocaine|mesh-list
56041442|NCT01978431|Methylphenidate|methylphenidate|mesh-list
56041443|NCT01978431|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55879096|NCT03411798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879097|NCT03411798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879098|NCT03411798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55879099|NCT03408756|Methotrexate|methotrexate|mesh-list
55879100|NCT03408756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55879101|NCT03408756|Abortifacient Agents|abortifacient agents|mesh-ancestor
55879102|NCT03408756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879103|NCT03408756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879104|NCT03408756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55879105|NCT03408756|Antimetabolites|antimetabolites|mesh-ancestor
55879106|NCT03408756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879107|NCT03408756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879108|NCT03408756|Dermatologic Agents|dermatologic agents|mesh-ancestor
55879109|NCT03408756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879110|NCT03408756|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55879111|NCT03408756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55879112|NCT03408756|Immunologic Factors|immunologic factors|mesh-ancestor
55879113|NCT03408756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879114|NCT03408756|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55879116|NCT01394614|Immunologic Factors|immunologic factors|mesh-ancestor
55879117|NCT01394614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879118|NCT04588818|Adalimumab|adalimumab|mesh-list
55879119|NCT04588818|Methotrexate|methotrexate|mesh-list
55879120|NCT04588818|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55879121|NCT04588818|Abortifacient Agents|abortifacient agents|mesh-ancestor
55879122|NCT04588818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879123|NCT04588818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879124|NCT04588818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55879125|NCT04588818|Antimetabolites|antimetabolites|mesh-ancestor
55879126|NCT04588818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750601|NCT03342599|Vitamins|vitamins|mesh-ancestor
56041444|NCT01978431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041445|NCT01978431|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56041446|NCT01978431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56041447|NCT01978431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56041448|NCT01978431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041449|NCT01978431|Dopamine Agents|dopamine agents|mesh-ancestor
56041450|NCT01978431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041451|NCT01978431|Anesthetics, Local|anesthetics, local|mesh-ancestor
56041452|NCT01978431|Anesthetics|anesthetics|mesh-ancestor
56041453|NCT01978431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041454|NCT01978431|Sensory System Agents|sensory system agents|mesh-ancestor
56041455|NCT01978431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041456|NCT01978431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56041457|NCT01406444|Risedronic Acid|risedronic acid|mesh-list
56041458|NCT01406444|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56041459|NCT01406444|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56041460|NCT01406444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041461|NCT01406444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56041462|NCT01406444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041463|NCT01406444|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56041464|NCT01749969|Dexamethasone|dexamethasone|mesh-list
56041465|NCT01749969|Lenalidomide|lenalidomide|mesh-list
56041466|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041467|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
56041468|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
56041469|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041473|NCT01749969|Hormones|hormones|mesh-ancestor
56041489|NCT02685267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041490|NCT02685267|Glucocorticoids|glucocorticoids|mesh-ancestor
56041492|NCT02685267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041493|NCT02685267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041494|NCT02685267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56041495|NCT02257541|Imatinib Mesylate|imatinib mesylate|mesh-list
56041496|NCT02257541|Infigratinib|infigratinib|mesh-list
56041497|NCT02257541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041498|NCT02257541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56041499|NCT02257541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041500|NCT02257541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041501|NCT01817855|AZD7624|azd7624|mesh-list
56041502|NCT01817855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56041503|NCT01817855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041504|NCT01817855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041505|NCT00368121|Dexamethasone|dexamethasone|mesh-list
56041506|NCT00368121|Cetuximab|cetuximab|mesh-list
56041507|NCT00368121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041508|NCT00368121|Antiemetics|antiemetics|mesh-ancestor
56041509|NCT00368121|Autonomic Agents|autonomic agents|mesh-ancestor
56041510|NCT00368121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041511|NCT00368121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041512|NCT00368121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56041513|NCT00368121|Glucocorticoids|glucocorticoids|mesh-ancestor
55879127|NCT04588818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879128|NCT04588818|Dermatologic Agents|dermatologic agents|mesh-ancestor
55879129|NCT04588818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879130|NCT04588818|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55879131|NCT04588818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55879132|NCT04588818|Immunologic Factors|immunologic factors|mesh-ancestor
55879133|NCT04588818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879134|NCT04588818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55879135|NCT04588818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879136|NCT01422226|Alprostadil|alprostadil|mesh-list
55879139|NCT01422226|Abortifacient Agents|abortifacient agents|mesh-ancestor
55879140|NCT01422226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879141|NCT01422226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879142|NCT01422226|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55879143|NCT01422226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55879144|NCT01422226|Oxytocics|oxytocics|mesh-ancestor
55879145|NCT01422226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55879146|NCT01422226|Vasodilator Agents|vasodilator agents|mesh-ancestor
55879147|NCT01422226|Urological Agents|urological agents|mesh-ancestor
55879148|NCT01423162|Ascorbic Acid|ascorbic acid|mesh-list
55879149|NCT01423162|Antioxidants|antioxidants|mesh-ancestor
55879150|NCT01423162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879151|NCT01423162|Protective Agents|protective agents|mesh-ancestor
55879152|NCT01423162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879153|NCT01423162|Vitamins|vitamins|mesh-ancestor
55879154|NCT01423162|Micronutrients|micronutrients|mesh-ancestor
56041515|NCT00368121|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041516|NCT00368121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56041517|NCT00368121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041518|NCT00368121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56041519|NCT00367497|Cytarabine|cytarabine|mesh-list
56041520|NCT00367497|Methylprednisolone|methylprednisolone|mesh-list
56041521|NCT00367497|Rituximab|rituximab|mesh-list
56041522|NCT00367497|Etoposide|etoposide|mesh-list
56041523|NCT00367497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56041524|NCT00367497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041525|NCT00367497|Immunologic Factors|immunologic factors|mesh-ancestor
56041526|NCT00367497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768728|NCT05476341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56041527|NCT00367497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041528|NCT00367497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56041529|NCT00367497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56041530|NCT00367497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56041531|NCT00367497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041532|NCT00367497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041533|NCT00367497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56041534|NCT00367497|Antimetabolites|antimetabolites|mesh-ancestor
56041535|NCT00367497|Antiviral Agents|antiviral agents|mesh-ancestor
56041536|NCT00367497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041537|NCT00367497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041562|NCT01387178|Parasympatholytics|parasympatholytics|mesh-ancestor
56041563|NCT01387178|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56041564|NCT01387178|Cholinergic Agents|cholinergic agents|mesh-ancestor
56041565|NCT01387178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052334|NCT03357393|Analgesics|analgesics|mesh-ancestor
56041566|NCT01387178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041567|NCT01387178|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56041569|NCT01387178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56041570|NCT01387178|Adrenergic Agents|adrenergic agents|mesh-ancestor
56041571|NCT01387178|Anticonvulsants|anticonvulsants|mesh-ancestor
56041572|NCT01805297|Aflibercept|aflibercept|mesh-list
56041573|NCT01805297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56041574|NCT01805297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56041575|NCT01805297|Growth Substances|growth substances|mesh-ancestor
56041576|NCT01805297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041577|NCT01805297|Growth Inhibitors|growth inhibitors|mesh-ancestor
56041578|NCT01805297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041579|NCT01389284|Naproxen|naproxen|mesh-list
56041580|NCT01389284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56041581|NCT01389284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041582|NCT01389284|Analgesics|analgesics|mesh-ancestor
56041583|NCT01389284|Sensory System Agents|sensory system agents|mesh-ancestor
56041584|NCT01389284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041585|NCT01389284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041586|NCT01389284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041587|NCT01389284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041588|NCT01389284|Gout Suppressants|gout suppressants|mesh-ancestor
56041589|NCT01389284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56041590|NCT01389284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041591|NCT01389284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041592|NCT01794143|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55879155|NCT01328782|Acetaminophen|acetaminophen|mesh-list
55879156|NCT01328782|Oxycodone|oxycodone|mesh-list
55879157|NCT01328782|Bupivacaine|bupivacaine|mesh-list
55879158|NCT01328782|Ropivacaine|ropivacaine|mesh-list
55879159|NCT01328782|Anesthetics, Local|anesthetics, local|mesh-ancestor
55879160|NCT01328782|Anesthetics|anesthetics|mesh-ancestor
55879161|NCT01328782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879162|NCT01328782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879163|NCT01328782|Sensory System Agents|sensory system agents|mesh-ancestor
55879164|NCT01328782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879165|NCT01328782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879166|NCT01328782|Analgesics|analgesics|mesh-ancestor
55879167|NCT01328782|Antipyretics|antipyretics|mesh-ancestor
55879168|NCT01328782|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55879169|NCT01328782|Narcotics|narcotics|mesh-ancestor
56041593|NCT01794143|Liraglutide|liraglutide|mesh-list
56041594|NCT01794143|Glimepiride|glimepiride|mesh-list
56041595|NCT01794143|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56041596|NCT01794143|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56041597|NCT01794143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041598|NCT01794143|Incretins|incretins|mesh-ancestor
56041600|NCT01794143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041601|NCT01794143|Protease Inhibitors|protease inhibitors|mesh-ancestor
56041602|NCT01794143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768806|NCT05745779|Vitamin D|vitamin d|mesh-list
56041603|NCT01794143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041605|NCT01794143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041606|NCT01794143|Immunologic Factors|immunologic factors|mesh-ancestor
56041607|NCT01547741|Paclitaxel|paclitaxel|mesh-list
56041608|NCT01547741|Docetaxel|docetaxel|mesh-list
55879170|NCT04447326|Endostar protein|endostar protein|mesh-list
55879171|NCT04447326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55879172|NCT04447326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55879173|NCT04447326|Growth Substances|growth substances|mesh-ancestor
55879174|NCT04447326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879175|NCT04447326|Growth Inhibitors|growth inhibitors|mesh-ancestor
55879176|NCT04447326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879179|NCT03411330|Anesthetics, Local|anesthetics, local|mesh-ancestor
55879180|NCT03411330|Anesthetics|anesthetics|mesh-ancestor
55879181|NCT03411330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879182|NCT03411330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879183|NCT03411330|Sensory System Agents|sensory system agents|mesh-ancestor
55879184|NCT03411330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879185|NCT03411330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55879186|NCT03411330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55879187|NCT03411330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55879188|NCT03411330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55879189|NCT03411330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879191|NCT03411252|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55879192|NCT03411252|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55879193|NCT03411252|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55879194|NCT03411252|Adrenergic Agents|adrenergic agents|mesh-ancestor
55879195|NCT03411252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879196|NCT03411252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879197|NCT03411252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879198|NCT03411252|Urological Agents|urological agents|mesh-ancestor
55879199|NCT01831427|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55879200|NCT01831427|Immunologic Factors|immunologic factors|mesh-ancestor
55879201|NCT01831427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879202|NCT01830881|Ibuprofen|ibuprofen|mesh-list
55879203|NCT01830881|Lidocaine|lidocaine|mesh-list
55879204|NCT01830881|Midazolam|midazolam|mesh-list
55879205|NCT01830881|Anesthetics, Local|anesthetics, local|mesh-ancestor
55879206|NCT01830881|Anesthetics|anesthetics|mesh-ancestor
55879207|NCT01830881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879208|NCT01830881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879209|NCT01830881|Sensory System Agents|sensory system agents|mesh-ancestor
55879210|NCT01830881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879211|NCT01830881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55879212|NCT01830881|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55879214|NCT01830881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56041609|NCT01547741|Cyclophosphamide|cyclophosphamide|mesh-list
56041610|NCT01547741|Doxorubicin|doxorubicin|mesh-list
56041611|NCT01547741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56041612|NCT01547741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041613|NCT01547741|Tubulin Modulators|tubulin modulators|mesh-ancestor
56041614|NCT01547741|Antimitotic Agents|antimitotic agents|mesh-ancestor
56041615|NCT01547741|Mitosis Modulators|mitosis modulators|mesh-ancestor
56041616|NCT01547741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041617|NCT01547741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041618|NCT01547741|Immunologic Factors|immunologic factors|mesh-ancestor
56041619|NCT01547741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041620|NCT01547741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041621|NCT01547741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56041622|NCT01547741|Alkylating Agents|alkylating agents|mesh-ancestor
56041623|NCT01547741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56041624|NCT01547741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56041625|NCT01547741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56041626|NCT01547741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56041627|NCT01547741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041628|NCT01390064|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56041629|NCT01390064|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56041630|NCT01390064|Immunologic Factors|immunologic factors|mesh-ancestor
56041631|NCT01390064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041632|NCT01473368|Amoxicillin|amoxicillin|mesh-list
56041633|NCT01473368|Clavulanic Acid|clavulanic acid|mesh-list
56041634|NCT01473368|Clavulanic Acids|clavulanic acids|mesh-list
56041635|NCT01473368|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56041636|NCT01473368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56041637|NCT01473368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041638|NCT01473368|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56041639|NCT01473368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124670|NCT01405560|Ribavirin|ribavirin|mesh-list
56041640|NCT01473368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041642|NCT04351490|Vitamin D|vitamin d|mesh-list
56041643|NCT04351490|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56041647|NCT04351490|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56041648|NCT01391312|Botulinum Toxins|botulinum toxins|mesh-list
56041649|NCT01391312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56041650|NCT01391312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56041651|NCT01391312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56041652|NCT01391312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56041653|NCT01391312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041654|NCT01391312|Cholinergic Agents|cholinergic agents|mesh-ancestor
56041655|NCT01391312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041656|NCT01391312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041657|NCT01391312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56041658|NCT01391312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041660|NCT03008252|Chelating Agents|chelating agents|mesh-ancestor
56041661|NCT03008252|Sequestering Agents|sequestering agents|mesh-ancestor
56041662|NCT03008252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041663|NCT05328635|Candesartan|candesartan|mesh-list
56041664|NCT05328635|Gabapentin|gabapentin|mesh-list
56041665|NCT05328635|Analgesics|analgesics|mesh-ancestor
56041666|NCT05328635|Sensory System Agents|sensory system agents|mesh-ancestor
56041667|NCT05328635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041668|NCT05328635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041669|NCT05328635|Anticonvulsants|anticonvulsants|mesh-ancestor
56041670|NCT05328635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56041671|NCT05328635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56041672|NCT05328635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041673|NCT05328635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56041674|NCT05328635|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56041675|NCT05328635|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56041676|NCT05328635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041677|NCT05328635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041678|NCT05328635|Antimanic Agents|antimanic agents|mesh-ancestor
56041682|NCT01391858|Pregabalin|pregabalin|mesh-list
56041687|NCT01391858|Anticonvulsants|anticonvulsants|mesh-ancestor
56041688|NCT01391858|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56041689|NCT01391858|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56041690|NCT01391858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041691|NCT01391858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56041692|NCT01391858|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56041693|NCT01391858|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56041694|NCT01391858|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041695|NCT01391858|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56041696|NCT05587257|Minoxidil|minoxidil|mesh-list
56041697|NCT05587257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56041698|NCT05587257|Vasodilator Agents|vasodilator agents|mesh-ancestor
56041699|NCT01825655|Cetirizine|cetirizine|mesh-list
56041700|NCT01825655|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56041701|NCT01825655|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56041702|NCT01825655|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56041703|NCT01825655|Histamine Antagonists|histamine antagonists|mesh-ancestor
56041704|NCT01825655|Histamine Agents|histamine agents|mesh-ancestor
56041705|NCT01825655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041706|NCT01825655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041707|NCT01825655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041708|NCT02249663|Fluticasone|fluticasone|mesh-list
56041709|NCT02249663|Xhance|xhance|mesh-list
56041710|NCT02249663|Azelastine|azelastine|mesh-list
56041711|NCT02249663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041712|NCT02249663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56041713|NCT02249663|Autonomic Agents|autonomic agents|mesh-ancestor
56041714|NCT02249663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041715|NCT02249663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041716|NCT02249663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55879215|NCT01830881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879216|NCT01830881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55879217|NCT01830881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55879218|NCT01830881|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55879219|NCT01830881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55879220|NCT01830881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55879221|NCT01830881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55879222|NCT01830881|Anesthetics, General|anesthetics, general|mesh-ancestor
55879224|NCT01830881|GABA Agents|gaba agents|mesh-ancestor
55879225|NCT01830881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879226|NCT01830881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55879227|NCT01830881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879228|NCT01830881|Analgesics|analgesics|mesh-ancestor
56041717|NCT02249663|Respiratory System Agents|respiratory system agents|mesh-ancestor
56041718|NCT02249663|Dermatologic Agents|dermatologic agents|mesh-ancestor
56041719|NCT02249663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56041720|NCT02249663|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56041721|NCT02249663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041722|NCT02249663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041723|NCT02249663|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56041724|NCT02249663|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56041725|NCT02249663|Histamine Antagonists|histamine antagonists|mesh-ancestor
56041726|NCT02249663|Histamine Agents|histamine agents|mesh-ancestor
56041727|NCT02249663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041728|NCT04237623|Sargramostim|sargramostim|mesh-list
56041729|NCT04237623|Immunologic Factors|immunologic factors|mesh-ancestor
56041730|NCT04237623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041731|NCT01825889|Evacetrapib|evacetrapib|mesh-list
56041732|NCT01825889|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56041733|NCT01825889|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56041734|NCT01825889|Antimetabolites|antimetabolites|mesh-ancestor
56041735|NCT01825889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041736|NCT01825889|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56041737|NCT02692755|Letrozole|letrozole|mesh-list
56041738|NCT02692755|Fulvestrant|fulvestrant|mesh-list
56041739|NCT02692755|Palbociclib|palbociclib|mesh-list
56041740|NCT02692755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041741|NCT02692755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56041742|NCT02692755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56041743|NCT02692755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041744|NCT02692755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041745|NCT02692755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56041746|NCT02692755|Hormone Antagonists|hormone antagonists|mesh-ancestor
56041751|NCT02692755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56041760|NCT01829399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56041761|NCT01829399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56041762|NCT01829399|Adrenergic Agents|adrenergic agents|mesh-ancestor
56041763|NCT01829399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041764|NCT01829399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041765|NCT01829399|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56041766|NCT01829399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56041767|NCT01829399|Autonomic Agents|autonomic agents|mesh-ancestor
56041768|NCT01829399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56041769|NCT01829399|Respiratory System Agents|respiratory system agents|mesh-ancestor
56041770|NCT01829399|Mydriatics|mydriatics|mesh-ancestor
56041771|NCT01829399|Sympathomimetics|sympathomimetics|mesh-ancestor
56041772|NCT01829399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56041773|NCT01394510|Acetylcysteine|acetylcysteine|mesh-list
56041774|NCT01394510|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56041775|NCT01394510|Antiviral Agents|antiviral agents|mesh-ancestor
56041776|NCT01394510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041777|NCT01394510|Expectorants|expectorants|mesh-ancestor
56041778|NCT01394510|Respiratory System Agents|respiratory system agents|mesh-ancestor
56041779|NCT01394510|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56041780|NCT01394510|Antioxidants|antioxidants|mesh-ancestor
56041781|NCT01394510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041782|NCT01394510|Protective Agents|protective agents|mesh-ancestor
56041783|NCT01394510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041784|NCT01394510|Antidotes|antidotes|mesh-ancestor
56041785|NCT05580549|Ethanol|ethanol|mesh-list
55879229|NCT01830881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879230|NCT01830881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879231|NCT01830881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55879232|NCT01830881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879234|NCT01396486|Vitamin B Complex|vitamin b complex|mesh-ancestor
55879235|NCT01396486|Vitamins|vitamins|mesh-ancestor
55879236|NCT01396486|Micronutrients|micronutrients|mesh-ancestor
55879237|NCT01396486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879238|NCT01838681|Brexpiprazole|brexpiprazole|mesh-list
55879239|NCT01838681|Serotonin Agents|serotonin agents|mesh-ancestor
55879240|NCT01838681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879241|NCT01838681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879242|NCT01838681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879243|NCT01838681|Dopamine Agonists|dopamine agonists|mesh-ancestor
55879244|NCT01838681|Dopamine Agents|dopamine agents|mesh-ancestor
55879246|NCT03404544|Oxytocin|oxytocin|mesh-list
55879247|NCT03404544|Oxytocics|oxytocics|mesh-ancestor
55879248|NCT03404544|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879249|NCT03404544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879250|NCT01398280|Aminocaproic Acid|aminocaproic acid|mesh-list
55879251|NCT01398280|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55879252|NCT01398280|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56041786|NCT05580549|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56041787|NCT05580549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041788|NCT05580549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041789|NCT05580549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041790|NCT05327777|Oxycodone|oxycodone|mesh-list
56041791|NCT05327777|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56041792|NCT05327777|Narcotics|narcotics|mesh-ancestor
56041793|NCT05327777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041794|NCT05327777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041795|NCT05327777|Analgesics|analgesics|mesh-ancestor
56041796|NCT05327777|Sensory System Agents|sensory system agents|mesh-ancestor
56041797|NCT05327777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041798|NCT05327309|Bleomycin|bleomycin|mesh-list
56041799|NCT05327309|Propranolol|propranolol|mesh-list
56041800|NCT05327309|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56041801|NCT05327309|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56041802|NCT05327309|Adrenergic Agents|adrenergic agents|mesh-ancestor
56041803|NCT05327309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041804|NCT05327309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041805|NCT05327309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041806|NCT05327309|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56041807|NCT05327309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56041808|NCT05327309|Vasodilator Agents|vasodilator agents|mesh-ancestor
56041809|NCT05327309|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56041810|NCT05327309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041811|NCT00367731|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56041812|NCT00367731|Antiviral Agents|antiviral agents|mesh-ancestor
56041813|NCT00367731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041814|NCT05326841|Vitamin D|vitamin d|mesh-list
56041815|NCT05326841|Cholecalciferol|cholecalciferol|mesh-list
56041816|NCT05326841|Vitamins|vitamins|mesh-ancestor
56041817|NCT05326841|Micronutrients|micronutrients|mesh-ancestor
56041818|NCT05326841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041827|NCT01412372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041828|NCT01412372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041829|NCT01412372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041830|NCT01414010|Amoxicillin|amoxicillin|mesh-list
56041831|NCT01414010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56041832|NCT01414010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041834|NCT01415960|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56041835|NCT01415960|Fertility Agents|fertility agents|mesh-ancestor
56041836|NCT01415960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56041837|NCT01415960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041838|NCT01415960|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56041839|NCT01415960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041840|NCT01833845|Ribavirin|ribavirin|mesh-list
56041841|NCT01833845|Hydroxychloroquine|hydroxychloroquine|mesh-list
56041842|NCT01833845|Antimetabolites|antimetabolites|mesh-ancestor
56041843|NCT01833845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041844|NCT01833845|Antiviral Agents|antiviral agents|mesh-ancestor
56041845|NCT01833845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041846|NCT01833845|Antimalarials|antimalarials|mesh-ancestor
56041847|NCT01833845|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56041848|NCT01833845|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56041849|NCT01833845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041850|NCT01833845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041851|NCT01416194|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56041852|NCT01416194|Bazedoxifene|bazedoxifene|mesh-list
56041853|NCT01416194|Diphosphonates|diphosphonates|mesh-list
56041854|NCT01416194|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56041855|NCT01416194|Hormone Antagonists|hormone antagonists|mesh-ancestor
56041856|NCT01416194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56041857|NCT01416194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041858|NCT01416194|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56041859|NCT01416194|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56041860|NCT01416194|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55879253|NCT01398280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879254|NCT01398280|Hemostatics|hemostatics|mesh-ancestor
55879255|NCT01398280|Coagulants|coagulants|mesh-ancestor
55879256|NCT03404310|Zinc Sulfate|zinc sulfate|mesh-list
55879257|NCT03404310|Astringents|astringents|mesh-ancestor
55879258|NCT03404310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879259|NCT03404310|Dermatologic Agents|dermatologic agents|mesh-ancestor
56041862|NCT01416584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56041863|NCT01416584|Narcotics|narcotics|mesh-ancestor
56041864|NCT01416584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041865|NCT01416584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041866|NCT01416584|Analgesics|analgesics|mesh-ancestor
56041867|NCT01416584|Sensory System Agents|sensory system agents|mesh-ancestor
56041868|NCT01416584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041869|NCT01416584|Antitussive Agents|antitussive agents|mesh-ancestor
56041870|NCT01416584|Respiratory System Agents|respiratory system agents|mesh-ancestor
56041872|NCT02698215|Varenicline|varenicline|mesh-list
56041873|NCT02698215|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56041874|NCT02698215|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56041875|NCT02698215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041876|NCT02698215|Sensory System Agents|sensory system agents|mesh-ancestor
56041877|NCT02698215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041878|NCT02698215|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56041879|NCT02698215|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56041880|NCT02698215|Cholinergic Agents|cholinergic agents|mesh-ancestor
56041881|NCT02698215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839793|NCT01383928|Ixazomib|ixazomib|mesh-list
56041882|NCT02698215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041883|NCT04172961|Cyclosporine|cyclosporine|mesh-list
56041884|NCT04172961|Lifitegrast|lifitegrast|mesh-list
56041885|NCT04172961|Cyclosporins|cyclosporins|mesh-list
56041886|NCT04172961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041887|NCT04172961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041888|NCT04172961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56041889|NCT04172961|Immunologic Factors|immunologic factors|mesh-ancestor
56041890|NCT04172961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041891|NCT04172961|Antifungal Agents|antifungal agents|mesh-ancestor
56041892|NCT04172961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56041893|NCT04172961|Dermatologic Agents|dermatologic agents|mesh-ancestor
56041894|NCT04172961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041898|NCT01480232|Nicotine|nicotine|mesh-list
56041904|NCT01480232|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56041905|NCT01480232|Cholinergic Agents|cholinergic agents|mesh-ancestor
56041906|NCT01480232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041907|NCT01480232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041908|NCT04049799|Analgesics, Opioid|analgesics, opioid|mesh-list
56041909|NCT04049799|Narcotics|narcotics|mesh-ancestor
56041910|NCT04049799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041911|NCT04049799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041912|NCT04049799|Analgesics|analgesics|mesh-ancestor
56041913|NCT04049799|Sensory System Agents|sensory system agents|mesh-ancestor
56041914|NCT04049799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041915|NCT01399268|Hydrocortisone|hydrocortisone|mesh-list
56041916|NCT01399268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041917|NCT05437575|Fentanyl|fentanyl|mesh-list
56041918|NCT05437575|Ketamine|ketamine|mesh-list
56041919|NCT05437575|Analgesics|analgesics|mesh-ancestor
56041920|NCT05437575|Sensory System Agents|sensory system agents|mesh-ancestor
56041921|NCT05437575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041922|NCT05437575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041923|NCT05437575|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56041924|NCT05437575|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55879261|NCT03403842|Morphine|morphine|mesh-list
55879262|NCT03403842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55879263|NCT03403842|Narcotics|narcotics|mesh-ancestor
55879264|NCT03403842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879265|NCT03403842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879266|NCT03403842|Analgesics|analgesics|mesh-ancestor
55879267|NCT03403842|Sensory System Agents|sensory system agents|mesh-ancestor
55879268|NCT03403842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879269|NCT03403842|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55879270|NCT03403842|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55879271|NCT03403842|Anesthetics, General|anesthetics, general|mesh-ancestor
55879272|NCT03403842|Anesthetics|anesthetics|mesh-ancestor
55879273|NCT01398982|Bupivacaine|bupivacaine|mesh-list
55879274|NCT01398982|Anesthetics, Local|anesthetics, local|mesh-ancestor
55879275|NCT01398982|Anesthetics|anesthetics|mesh-ancestor
55879276|NCT01398982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879277|NCT01398982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879278|NCT01398982|Sensory System Agents|sensory system agents|mesh-ancestor
55879279|NCT01398982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879280|NCT04447560|Bupivacaine|bupivacaine|mesh-list
55879281|NCT04447560|Anesthetics, Local|anesthetics, local|mesh-ancestor
55879282|NCT04447560|Anesthetics|anesthetics|mesh-ancestor
55879283|NCT04447560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879284|NCT04447560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879285|NCT04447560|Sensory System Agents|sensory system agents|mesh-ancestor
55879286|NCT04447560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879287|NCT03401736|Midazolam|midazolam|mesh-list
55879288|NCT03401736|Dexmedetomidine|dexmedetomidine|mesh-list
55879289|NCT03401736|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55879293|NCT03401736|Analgesics|analgesics|mesh-ancestor
55879294|NCT03401736|Sensory System Agents|sensory system agents|mesh-ancestor
55879295|NCT03401736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041926|NCT05437575|Anesthetics|anesthetics|mesh-ancestor
56041927|NCT05437575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56041928|NCT05437575|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56041929|NCT05437575|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56041930|NCT05437575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56041931|NCT05437575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041932|NCT05437575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56041933|NCT05437575|Narcotics|narcotics|mesh-ancestor
56041934|NCT05437575|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56041935|NCT03008876|Acetaminophen|acetaminophen|mesh-list
56041936|NCT03008876|Ibuprofen|ibuprofen|mesh-list
56041937|NCT03008876|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56041938|NCT03008876|Analgesics|analgesics|mesh-ancestor
56041939|NCT03008876|Sensory System Agents|sensory system agents|mesh-ancestor
56041940|NCT03008876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041941|NCT03008876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041942|NCT03008876|Antipyretics|antipyretics|mesh-ancestor
56041943|NCT03008876|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56041944|NCT03008876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56041945|NCT03008876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56041946|NCT03008876|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56041947|NCT03008876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041948|NCT03008876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041949|NCT05414487|Ofatumumab|ofatumumab|mesh-list
56041950|NCT05414487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041951|NCT02701257|Glucagon|glucagon|mesh-list
56041952|NCT02701257|Pancrelipase|pancrelipase|mesh-list
56041953|NCT02701257|Pancreatin|pancreatin|mesh-list
56041954|NCT02701257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56041955|NCT02701257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56041956|NCT02701257|Hormones|hormones|mesh-ancestor
56041959|NCT02701257|Incretins|incretins|mesh-ancestor
56041970|NCT02703909|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56041971|NCT02703909|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56041973|NCT02703909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56041974|NCT02703909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56041976|NCT01836185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56041977|NCT01836185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56041978|NCT01836185|Antimetabolites|antimetabolites|mesh-ancestor
56041979|NCT01836185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041980|NCT01836185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56041981|NCT02706249|Enoxaparin|enoxaparin|mesh-list
56041982|NCT02706249|Anticoagulants|anticoagulants|mesh-ancestor
56041983|NCT02706249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56041984|NCT02706249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56041985|NCT02706249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041986|NCT04740021|Carboplatin|carboplatin|mesh-list
56041987|NCT04740021|Etoposide|etoposide|mesh-list
56041988|NCT04740021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56041989|NCT04740021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56041990|NCT04740021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56041991|NCT04740021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56041992|NCT04740021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56041993|NCT04740021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56041994|NCT05058287|Methylprednisolone|methylprednisolone|mesh-list
56041995|NCT05058287|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56041996|NCT05058287|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56041997|NCT05058287|Prednisolone|prednisolone|mesh-list
56042015|NCT02708433|Anesthetics, Local|anesthetics, local|mesh-ancestor
56042016|NCT02708433|Anesthetics|anesthetics|mesh-ancestor
56042017|NCT02708433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042018|NCT02708433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042019|NCT02708433|Sensory System Agents|sensory system agents|mesh-ancestor
56042020|NCT02708433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042021|NCT02708433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56042022|NCT02708433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56042023|NCT02708433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56042024|NCT02708433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56042025|NCT02708433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042026|NCT03575013|Docetaxel|docetaxel|mesh-list
56042027|NCT03575013|Avelumab|avelumab|mesh-list
56042028|NCT03575013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042029|NCT03575013|Tubulin Modulators|tubulin modulators|mesh-ancestor
56042030|NCT03575013|Antimitotic Agents|antimitotic agents|mesh-ancestor
56042031|NCT03575013|Mitosis Modulators|mitosis modulators|mesh-ancestor
56042032|NCT03575013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042033|NCT03575013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56042034|NCT00559637|Epoetin Alfa|epoetin alfa|mesh-list
56042035|NCT00559637|Hematinics|hematinics|mesh-ancestor
56042036|NCT03349281|Cytarabine|cytarabine|mesh-list
56042037|NCT03349281|Dexamethasone|dexamethasone|mesh-list
56042038|NCT03349281|Hydrocortisone|hydrocortisone|mesh-list
56042039|NCT03349281|Doxorubicin|doxorubicin|mesh-list
56042040|NCT03349281|Methotrexate|methotrexate|mesh-list
56042041|NCT03349281|Vincristine|vincristine|mesh-list
56042042|NCT03349281|Asparaginase|asparaginase|mesh-list
56042043|NCT03349281|Pegaspargase|pegaspargase|mesh-list
56042044|NCT03349281|Pevonedistat|pevonedistat|mesh-list
56042045|NCT03349281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042046|NCT03349281|Antiemetics|antiemetics|mesh-ancestor
56042047|NCT03349281|Autonomic Agents|autonomic agents|mesh-ancestor
56042048|NCT03349281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042058|NCT03349281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56042059|NCT03349281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042060|NCT03349281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042061|NCT03349281|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56042062|NCT03349281|Abortifacient Agents|abortifacient agents|mesh-ancestor
56042063|NCT03349281|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56042064|NCT03349281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56042065|NCT03349281|Antimetabolites|antimetabolites|mesh-ancestor
56042066|NCT03349281|Dermatologic Agents|dermatologic agents|mesh-ancestor
56042067|NCT03349281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56042068|NCT03349281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56042069|NCT03349281|Immunologic Factors|immunologic factors|mesh-ancestor
56042070|NCT03349281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56042071|NCT03349281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56042072|NCT03349281|Antiviral Agents|antiviral agents|mesh-ancestor
56042073|NCT03349281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042074|NCT03349281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56042075|NCT03349281|Tubulin Modulators|tubulin modulators|mesh-ancestor
56042076|NCT03349281|Antimitotic Agents|antimitotic agents|mesh-ancestor
56042077|NCT03349281|Mitosis Modulators|mitosis modulators|mesh-ancestor
56042078|NCT03206151|Leucovorin|leucovorin|mesh-list
56042079|NCT03206151|Folic Acid|folic acid|mesh-list
56042080|NCT03206151|Fluorouracil|fluorouracil|mesh-list
56042081|NCT03206151|Irinotecan|irinotecan|mesh-list
56042082|NCT03206151|Levoleucovorin|levoleucovorin|mesh-list
56042083|NCT03206151|Antimetabolites|antimetabolites|mesh-ancestor
56042085|NCT03206151|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56042109|NCT02714283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56042110|NCT02714283|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56042111|NCT02714283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042112|NCT02714283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042113|NCT04814927|Copper|copper|mesh-list
56042114|NCT04814927|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56042115|NCT04814927|Levonorgestrel|levonorgestrel|mesh-list
56042116|NCT04814927|Medroxyprogesterone|medroxyprogesterone|mesh-list
56042117|NCT04814927|Etonogestrel|etonogestrel|mesh-list
56042118|NCT04814927|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56042119|NCT04814927|Contraceptive Agents|contraceptive agents|mesh-ancestor
56042120|NCT04814927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56042121|NCT04814927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042122|NCT04814927|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56042123|NCT04814927|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56042124|NCT04814927|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56042125|NCT04814927|Trace Elements|trace elements|mesh-ancestor
56042126|NCT04814927|Micronutrients|micronutrients|mesh-ancestor
56042127|NCT04814927|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56042128|NCT04814927|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56042129|NCT04814927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56042130|NCT04814927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042131|NCT04810949|Vitamin D|vitamin d|mesh-list
56042132|NCT04810949|Cholecalciferol|cholecalciferol|mesh-list
55769335|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56042133|NCT04810949|Vitamins|vitamins|mesh-ancestor
56042134|NCT04810949|Micronutrients|micronutrients|mesh-ancestor
56042138|NCT04795583|Prednisone|prednisone|mesh-list
56042156|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56042158|NCT02722239|Dapagliflozin|dapagliflozin|mesh-list
56042159|NCT02722239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56042160|NCT02722239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042161|NCT02722239|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56042162|NCT02722239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042163|NCT02578641|Gemcitabine|gemcitabine|mesh-list
56042164|NCT02578641|Carboplatin|carboplatin|mesh-list
56042165|NCT02578641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042166|NCT02578641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56042167|NCT02578641|Antimetabolites|antimetabolites|mesh-ancestor
56042168|NCT02578641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042169|NCT02578641|Antiviral Agents|antiviral agents|mesh-ancestor
56042170|NCT02578641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042171|NCT02578641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042172|NCT02578641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56042173|NCT02578641|Immunologic Factors|immunologic factors|mesh-ancestor
56042174|NCT02578641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042175|NCT05084859|Prednisone|prednisone|mesh-list
56042176|NCT05084859|Docetaxel|docetaxel|mesh-list
56042177|NCT05084859|Panitumumab|panitumumab|mesh-list
56042178|NCT05084859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042179|NCT05084859|Tubulin Modulators|tubulin modulators|mesh-ancestor
56042180|NCT05084859|Antimitotic Agents|antimitotic agents|mesh-ancestor
56042181|NCT05084859|Mitosis Modulators|mitosis modulators|mesh-ancestor
56042182|NCT05084859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042204|NCT01848041|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56042205|NCT01848041|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56042206|NCT01848041|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56042207|NCT01848041|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56042208|NCT01848041|Adrenergic Agents|adrenergic agents|mesh-ancestor
56042209|NCT01848041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042210|NCT01848041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042211|NCT01848041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042212|NCT01848041|Sympathomimetics|sympathomimetics|mesh-ancestor
56042213|NCT01848041|Autonomic Agents|autonomic agents|mesh-ancestor
56042214|NCT01848041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042215|NCT01848041|Nasal Decongestants|nasal decongestants|mesh-ancestor
56042216|NCT01848041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56042217|NCT01848041|Respiratory System Agents|respiratory system agents|mesh-ancestor
56042218|NCT01848041|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56042219|NCT01848041|Mydriatics|mydriatics|mesh-ancestor
56042220|NCT01848041|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56042221|NCT01848041|Protective Agents|protective agents|mesh-ancestor
56042222|NCT02724033|Dexamethasone|dexamethasone|mesh-list
56042223|NCT02724033|Ondansetron|ondansetron|mesh-list
56042224|NCT02724033|Antiemetics|antiemetics|mesh-list
56042225|NCT02724033|Bupivacaine|bupivacaine|mesh-list
56042226|NCT02724033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042227|NCT02724033|Autonomic Agents|autonomic agents|mesh-ancestor
56042228|NCT02724033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879296|NCT03401736|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55879297|NCT03401736|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55879298|NCT03401736|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55879299|NCT03401736|Adrenergic Agents|adrenergic agents|mesh-ancestor
55879300|NCT03401736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879301|NCT03401736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879302|NCT03401736|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55879303|NCT03401736|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55879304|NCT03401736|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55879305|NCT03401736|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55879306|NCT03401736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55879307|NCT03401736|Anesthetics, General|anesthetics, general|mesh-ancestor
55879308|NCT03401736|Anesthetics|anesthetics|mesh-ancestor
55879309|NCT03401736|GABA Modulators|gaba modulators|mesh-ancestor
55879310|NCT03401736|GABA Agents|gaba agents|mesh-ancestor
55879311|NCT02203786|Haloperidol|haloperidol|mesh-list
55879312|NCT02203786|Haloperidol decanoate|haloperidol decanoate|mesh-list
55879313|NCT02203786|Fluphenazine|fluphenazine|mesh-list
55879314|NCT02203786|Fluphenazine depot|fluphenazine depot|mesh-list
55879315|NCT02203786|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
55879316|NCT02203786|Amphetamine|amphetamine|mesh-list
55879317|NCT02203786|Dextroamphetamine|dextroamphetamine|mesh-list
55879318|NCT02203786|Antiemetics|antiemetics|mesh-ancestor
55879319|NCT02203786|Autonomic Agents|autonomic agents|mesh-ancestor
55879320|NCT02203786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879321|NCT02203786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879322|NCT02203786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56042229|NCT02724033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042230|NCT02724033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56042231|NCT02724033|Glucocorticoids|glucocorticoids|mesh-ancestor
56042232|NCT02724033|Hormones|hormones|mesh-ancestor
56042233|NCT02724033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56042234|NCT02724033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56042235|NCT02724033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042236|NCT02724033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042237|NCT02724033|Anesthetics, Local|anesthetics, local|mesh-ancestor
56042239|NCT02724033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042241|NCT02724033|Antipruritics|antipruritics|mesh-ancestor
56042242|NCT02724033|Dermatologic Agents|dermatologic agents|mesh-ancestor
56042243|NCT02724033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56042244|NCT02724033|Serotonin Agents|serotonin agents|mesh-ancestor
56042245|NCT02724033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042246|NCT02724033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56042247|NCT02724033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56042248|NCT02724033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56042249|NCT02724033|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56042250|NCT02724423|Diazepam|diazepam|mesh-list
56042251|NCT02724423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56042252|NCT02724423|Anticonvulsants|anticonvulsants|mesh-ancestor
56042253|NCT02724423|Antiemetics|antiemetics|mesh-ancestor
56042254|NCT02724423|Autonomic Agents|autonomic agents|mesh-ancestor
56042255|NCT02724423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879323|NCT02203786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55879324|NCT02203786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55879325|NCT02203786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879326|NCT02203786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55879327|NCT02203786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55879328|NCT02203786|Dopamine Agents|dopamine agents|mesh-ancestor
55879329|NCT02203786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879330|NCT02203786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879331|NCT02203786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55879332|NCT02203786|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55879333|NCT02203786|Sympathomimetics|sympathomimetics|mesh-ancestor
55879334|NCT02203786|Adrenergic Agents|adrenergic agents|mesh-ancestor
55879335|NCT02203786|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55879336|NCT02203786|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55879337|NCT02203786|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55879338|NCT02203786|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55879339|NCT03009058|Leucovorin|leucovorin|mesh-list
55879340|NCT03009058|Folic Acid|folic acid|mesh-list
55879341|NCT03009058|Gemcitabine|gemcitabine|mesh-list
55879342|NCT03009058|Cyclophosphamide|cyclophosphamide|mesh-list
55879343|NCT03009058|Pembrolizumab|pembrolizumab|mesh-list
55879344|NCT03009058|Fluorouracil|fluorouracil|mesh-list
55879345|NCT03009058|Capecitabine|capecitabine|mesh-list
56042256|NCT02724423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042257|NCT02724423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56042258|NCT02724423|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56042259|NCT02724423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042260|NCT02724423|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56042261|NCT02724423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56042262|NCT02724423|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56042263|NCT02724423|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56042265|NCT02724423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56042266|NCT02724423|Anesthetics, General|anesthetics, general|mesh-ancestor
56042267|NCT02724423|Anesthetics|anesthetics|mesh-ancestor
56042268|NCT02724423|GABA Modulators|gaba modulators|mesh-ancestor
56042269|NCT02724423|GABA Agents|gaba agents|mesh-ancestor
56042270|NCT02724423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042271|NCT02724423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042272|NCT02989259|Apatinib|apatinib|mesh-list
56042273|NCT02989259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042274|NCT02989259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56042275|NCT02989259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042276|NCT02989259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042277|NCT04950621|Propofol|propofol|mesh-list
56042278|NCT04950621|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56042308|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
56042309|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042310|NCT01848899|Bivalirudin|bivalirudin|mesh-list
56042311|NCT01848899|Antithrombins|antithrombins|mesh-ancestor
56042312|NCT01848899|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56042313|NCT01848899|Protease Inhibitors|protease inhibitors|mesh-ancestor
56042314|NCT01848899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042315|NCT01848899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042316|NCT01848899|Anticoagulants|anticoagulants|mesh-ancestor
56042317|NCT02731833|Fluorides|fluorides|mesh-list
56042318|NCT02731833|Tin Fluorides|tin fluorides|mesh-list
56042319|NCT02731833|Fluorophosphate|fluorophosphate|mesh-list
56042320|NCT02731833|Cariostatic Agents|cariostatic agents|mesh-ancestor
56042321|NCT02731833|Protective Agents|protective agents|mesh-ancestor
56042322|NCT02731833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042323|NCT01852019|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56042324|NCT01852019|Cangrelor|cangrelor|mesh-list
56042325|NCT01852019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56042326|NCT01852019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56042327|NCT01852019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56042328|NCT01852019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56042329|NCT01852019|Purinergic Agents|purinergic agents|mesh-ancestor
56042330|NCT01852019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042331|NCT01852019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042332|NCT01852019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042333|NCT04457219|Hemostatics|hemostatics|mesh-list
56042334|NCT04457219|Coagulants|coagulants|mesh-ancestor
56042335|NCT02430480|Goserelin|goserelin|mesh-list
56042336|NCT02430480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56042337|NCT02430480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042338|NCT01852175|Ticagrelor|ticagrelor|mesh-list
56042339|NCT01852175|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56042340|NCT01852175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56042341|NCT01852175|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56042342|NCT01852175|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55879346|NCT03009058|Oxaliplatin|oxaliplatin|mesh-list
56042347|NCT01852175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042348|NCT02429934|Abatacept|abatacept|mesh-list
56042349|NCT02429934|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56042350|NCT02429934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042351|NCT02429934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042352|NCT02429934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56042353|NCT02429934|Immunologic Factors|immunologic factors|mesh-ancestor
56042354|NCT02429934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042355|NCT02429934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56042356|NCT01852955|Acetaminophen|acetaminophen|mesh-list
56042357|NCT01852955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56042358|NCT01852955|Analgesics|analgesics|mesh-ancestor
56042359|NCT01852955|Sensory System Agents|sensory system agents|mesh-ancestor
55769556|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042360|NCT01852955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879347|NCT03009058|Nivolumab|nivolumab|mesh-list
55879348|NCT03009058|Irinotecan|irinotecan|mesh-list
55879349|NCT03009058|Cetuximab|cetuximab|mesh-list
55879350|NCT03009058|Ipilimumab|ipilimumab|mesh-list
55879351|NCT03009058|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55879352|NCT03009058|Levoleucovorin|levoleucovorin|mesh-list
55879353|NCT03009058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55879354|NCT03009058|Immunologic Factors|immunologic factors|mesh-ancestor
55879355|NCT03009058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879356|NCT03009058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879357|NCT03009058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55879358|NCT03009058|Alkylating Agents|alkylating agents|mesh-ancestor
55879359|NCT03009058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879360|NCT03009058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879361|NCT03009058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55879362|NCT03009058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55879363|NCT03009058|Antimetabolites|antimetabolites|mesh-ancestor
55879365|NCT03009058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55879366|NCT03009058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879367|NCT03009058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55879368|NCT03009058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55879369|NCT03009058|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55879370|NCT03009058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55879371|NCT03009058|Antidotes|antidotes|mesh-ancestor
55879372|NCT03009058|Protective Agents|protective agents|mesh-ancestor
55879373|NCT03009058|Vitamin B Complex|vitamin b complex|mesh-ancestor
55879374|NCT03009058|Vitamins|vitamins|mesh-ancestor
55879375|NCT03009058|Micronutrients|micronutrients|mesh-ancestor
55879376|NCT03009058|Hematinics|hematinics|mesh-ancestor
55879377|NCT01611857|Leucovorin|leucovorin|mesh-list
55879378|NCT01611857|Fluorouracil|fluorouracil|mesh-list
55879379|NCT01611857|Oxaliplatin|oxaliplatin|mesh-list
55879380|NCT01611857|Levoleucovorin|levoleucovorin|mesh-list
55879381|NCT01611857|Antimetabolites|antimetabolites|mesh-ancestor
55879382|NCT01611857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879383|NCT01611857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55879384|NCT01611857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879385|NCT01611857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55879386|NCT01611857|Immunologic Factors|immunologic factors|mesh-ancestor
55879387|NCT01611857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879388|NCT01611857|Antidotes|antidotes|mesh-ancestor
55879389|NCT01611857|Protective Agents|protective agents|mesh-ancestor
55879390|NCT01611857|Vitamin B Complex|vitamin b complex|mesh-ancestor
55879392|NCT01611857|Micronutrients|micronutrients|mesh-ancestor
55879393|NCT03393858|Antibodies|antibodies|mesh-list
55879394|NCT03393858|Immunologic Factors|immunologic factors|mesh-ancestor
55879395|NCT03393858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042361|NCT01852955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042362|NCT01852955|Antipyretics|antipyretics|mesh-ancestor
56042364|NCT05716763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56042365|NCT05716763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56042366|NCT05716763|Narcotics|narcotics|mesh-ancestor
56042367|NCT05716763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042368|NCT05716763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042369|NCT05716763|Analgesics|analgesics|mesh-ancestor
56042370|NCT05716763|Sensory System Agents|sensory system agents|mesh-ancestor
56042371|NCT05716763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042372|NCT00558467|Pramipexole|pramipexole|mesh-list
56042373|NCT00558467|Antioxidants|antioxidants|mesh-ancestor
56042374|NCT00558467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042375|NCT00558467|Protective Agents|protective agents|mesh-ancestor
56042376|NCT00558467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042377|NCT00558467|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56042378|NCT00558467|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56042379|NCT00558467|Dopamine Agonists|dopamine agonists|mesh-ancestor
56042380|NCT00558467|Dopamine Agents|dopamine agents|mesh-ancestor
56042381|NCT00558467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042382|NCT04226495|Sufentanil|sufentanil|mesh-list
56042384|NCT04226495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56042385|NCT04226495|Narcotics|narcotics|mesh-ancestor
56042386|NCT04226495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042387|NCT04226495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042388|NCT04226495|Analgesics|analgesics|mesh-ancestor
56042389|NCT04226495|Sensory System Agents|sensory system agents|mesh-ancestor
56042390|NCT04226495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042391|NCT04226495|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56042392|NCT04226495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56042393|NCT04226495|Anesthetics, General|anesthetics, general|mesh-ancestor
56042394|NCT04226495|Anesthetics|anesthetics|mesh-ancestor
55879396|NCT03393702|Gabapentin|gabapentin|mesh-list
55879397|NCT03393702|Analgesics|analgesics|mesh-ancestor
55879398|NCT03393702|Sensory System Agents|sensory system agents|mesh-ancestor
55879399|NCT03393702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879400|NCT03393702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879401|NCT03393702|Anticonvulsants|anticonvulsants|mesh-ancestor
55879402|NCT03393702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55879403|NCT03393702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55879404|NCT03393702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879405|NCT03393702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55879406|NCT03393702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56042395|NCT02401230|Tenofovir|tenofovir|mesh-list
56042396|NCT02401230|Emtricitabine|emtricitabine|mesh-list
56042397|NCT02401230|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56042398|NCT02401230|Antiviral Agents|antiviral agents|mesh-ancestor
56042399|NCT02401230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042400|NCT02401230|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56042401|NCT02401230|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56042402|NCT02401230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042403|NCT02401230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042404|NCT02401230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56042405|NCT02401230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56042406|NCT01854359|Idebenone|idebenone|mesh-list
56042407|NCT01854359|Antioxidants|antioxidants|mesh-ancestor
56042408|NCT01854359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042409|NCT01854359|Protective Agents|protective agents|mesh-ancestor
56042410|NCT01854359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042411|NCT01854593|Bevacizumab|bevacizumab|mesh-list
56042412|NCT01854593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56042413|NCT01854593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042414|NCT01854593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56042415|NCT01854593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56042416|NCT01854593|Growth Substances|growth substances|mesh-ancestor
56042417|NCT01854593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042418|NCT01854593|Growth Inhibitors|growth inhibitors|mesh-ancestor
56042419|NCT01855997|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56042420|NCT01855997|Interferon alpha-2|interferon alpha-2|mesh-list
56042421|NCT01855997|Antiviral Agents|antiviral agents|mesh-ancestor
56042422|NCT01855997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042423|NCT01855997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042424|NCT02734953|Nitric Oxide|nitric oxide|mesh-list
56042425|NCT02734953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56042426|NCT02734953|Autonomic Agents|autonomic agents|mesh-ancestor
56042427|NCT02734953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042428|NCT02734953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042429|NCT02734953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55879407|NCT03393702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55879408|NCT03393702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879409|NCT03393702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042431|NCT02734953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56042432|NCT02734953|Antioxidants|antioxidants|mesh-ancestor
56042433|NCT02734953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042434|NCT02734953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042435|NCT02734953|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56042436|NCT02734953|Vasodilator Agents|vasodilator agents|mesh-ancestor
56042437|NCT02734953|Gasotransmitters|gasotransmitters|mesh-ancestor
56042438|NCT02734953|Protective Agents|protective agents|mesh-ancestor
56042439|NCT02428608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56042440|NCT02428608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56042441|NCT02428608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042442|NCT02428608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042443|NCT02428608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56042444|NCT02428608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56042445|NCT02428608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042446|NCT02428608|Cholinergic Agents|cholinergic agents|mesh-ancestor
56042447|NCT02428608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042448|NCT02735187|Vitamin D|vitamin d|mesh-list
56042449|NCT02735187|Vitamins|vitamins|mesh-ancestor
56042450|NCT02735187|Micronutrients|micronutrients|mesh-ancestor
56042451|NCT02735187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042452|NCT02735187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56042453|NCT02428296|Sirolimus|sirolimus|mesh-list
56042454|NCT02428296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56042455|NCT02428296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042456|NCT02428296|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56042457|NCT02428296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042458|NCT02428296|Antifungal Agents|antifungal agents|mesh-ancestor
56042459|NCT02428296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56042460|NCT02428296|Immunologic Factors|immunologic factors|mesh-ancestor
56042461|NCT02428296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042462|NCT02643615|Propofol|propofol|mesh-list
56042463|NCT02643615|Desflurane|desflurane|mesh-list
55879410|NCT03393702|Antimanic Agents|antimanic agents|mesh-ancestor
55879411|NCT01829477|Glimepiride|glimepiride|mesh-list
55879412|NCT01829477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55879413|NCT01829477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55879414|NCT01829477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879415|NCT01829477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56042464|NCT02643615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56042465|NCT02643615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042466|NCT02643615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042467|NCT02643615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56042469|NCT02643615|Anesthetics|anesthetics|mesh-ancestor
56042470|NCT02643615|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56042471|NCT02265341|Ponatinib|ponatinib|mesh-list
56042472|NCT02265341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042473|NCT02265341|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56042474|NCT02265341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042475|NCT02265341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042476|NCT05679479|Meplazumab|meplazumab|mesh-list
56042477|NCT05679479|Antiviral Agents|antiviral agents|mesh-ancestor
56042478|NCT05679479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042479|NCT01421186|Dexamethasone|dexamethasone|mesh-list
56042480|NCT01421186|Lenalidomide|lenalidomide|mesh-list
56042481|NCT01421186|Pomalidomide|pomalidomide|mesh-list
56042482|NCT01421186|Felzartamab|felzartamab|mesh-list
56042483|NCT01421186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042484|NCT01421186|Antiemetics|antiemetics|mesh-ancestor
56042485|NCT01421186|Autonomic Agents|autonomic agents|mesh-ancestor
56042486|NCT01421186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042487|NCT01421186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042488|NCT01421186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56042489|NCT01421186|Glucocorticoids|glucocorticoids|mesh-ancestor
56042490|NCT01421186|Hormones|hormones|mesh-ancestor
56042491|NCT01421186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56042492|NCT01421186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56042493|NCT01421186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042494|NCT01421186|Immunologic Factors|immunologic factors|mesh-ancestor
55841006|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
56042495|NCT01421186|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56042496|NCT01421186|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56042497|NCT01421186|Growth Substances|growth substances|mesh-ancestor
56042525|NCT01860521|Gemeprost|gemeprost|mesh-list
56042526|NCT01860521|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56042527|NCT01860521|Narcotics|narcotics|mesh-ancestor
56042528|NCT01860521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042529|NCT01860521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042530|NCT01860521|Analgesics|analgesics|mesh-ancestor
56042531|NCT01860521|Sensory System Agents|sensory system agents|mesh-ancestor
56042532|NCT01860521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042533|NCT01860521|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56042534|NCT01860521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56042535|NCT01860521|Anesthetics, General|anesthetics, general|mesh-ancestor
56042536|NCT01860521|Anesthetics|anesthetics|mesh-ancestor
56042554|NCT00367653|Mefloquine|mefloquine|mesh-list
56042555|NCT00367653|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56042556|NCT00367653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042557|NCT00367653|Amebicides|amebicides|mesh-ancestor
56042558|NCT00367653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56042559|NCT00367653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56042560|NCT00367653|Antimalarials|antimalarials|mesh-ancestor
56042561|NCT00367653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56042562|NCT01485380|Dexmedetomidine|dexmedetomidine|mesh-list
56042563|NCT01485380|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56042564|NCT01485380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042565|NCT01485380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042566|NCT01485380|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56042567|NCT01485380|Analgesics|analgesics|mesh-ancestor
56042568|NCT01485380|Sensory System Agents|sensory system agents|mesh-ancestor
56042569|NCT01485380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042570|NCT01485380|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56042571|NCT01485380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56042572|NCT01485380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56042573|NCT01485380|Adrenergic Agents|adrenergic agents|mesh-ancestor
56042574|NCT01485380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042575|NCT01485380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042576|NCT05445297|Amiodarone|amiodarone|mesh-list
56042577|NCT05445297|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56042578|NCT05445297|Vasodilator Agents|vasodilator agents|mesh-ancestor
56042579|NCT05445297|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56042580|NCT05445297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56042581|NCT05445297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042582|NCT05445297|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56042598|NCT00556673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56042599|NCT00556673|Respiratory System Agents|respiratory system agents|mesh-ancestor
56042600|NCT00556673|Dermatologic Agents|dermatologic agents|mesh-ancestor
56042601|NCT00556673|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56042602|NCT00556673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56042603|NCT00556673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56042605|NCT00556673|Adrenergic Agents|adrenergic agents|mesh-ancestor
56042606|NCT00556673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042607|NCT00556673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042608|NCT00556673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042610|NCT01422434|Betamethasone|betamethasone|mesh-list
56042611|NCT01422434|Betamethasone Valerate|betamethasone valerate|mesh-list
56042612|NCT01422434|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56042613|NCT01422434|Betamethasone benzoate|betamethasone benzoate|mesh-list
56042614|NCT01422434|Calcipotriene|calcipotriene|mesh-list
56042615|NCT01422434|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56042616|NCT01422434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042617|NCT01422434|Glucocorticoids|glucocorticoids|mesh-ancestor
56042618|NCT01422434|Hormones|hormones|mesh-ancestor
56042619|NCT01422434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56042620|NCT01422434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042621|NCT01422434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55879416|NCT01829477|Immunologic Factors|immunologic factors|mesh-ancestor
55879417|NCT04447092|Leucovorin|leucovorin|mesh-list
55879418|NCT04447092|Gemcitabine|gemcitabine|mesh-list
55879419|NCT04447092|Paclitaxel|paclitaxel|mesh-list
55879420|NCT04447092|Pembrolizumab|pembrolizumab|mesh-list
55879421|NCT04447092|Oxaliplatin|oxaliplatin|mesh-list
55879422|NCT04447092|Irinotecan|irinotecan|mesh-list
55879423|NCT04447092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55879424|NCT04447092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879425|NCT04447092|Tubulin Modulators|tubulin modulators|mesh-ancestor
55879426|NCT04447092|Antimitotic Agents|antimitotic agents|mesh-ancestor
55879427|NCT04447092|Mitosis Modulators|mitosis modulators|mesh-ancestor
55879428|NCT04447092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879429|NCT04447092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55879430|NCT04447092|Antimetabolites|antimetabolites|mesh-ancestor
55879431|NCT04447092|Antiviral Agents|antiviral agents|mesh-ancestor
55879432|NCT04447092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55879433|NCT04447092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879434|NCT04447092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55879435|NCT04447092|Immunologic Factors|immunologic factors|mesh-ancestor
55879436|NCT04447092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879437|NCT04447092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55879438|NCT04447092|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55879439|NCT04447092|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55879440|NCT04447092|Antidotes|antidotes|mesh-ancestor
55879441|NCT04447092|Protective Agents|protective agents|mesh-ancestor
55879444|NCT04447092|Micronutrients|micronutrients|mesh-ancestor
55879445|NCT03126864|Cyclophosphamide|cyclophosphamide|mesh-list
56042622|NCT01422434|Respiratory System Agents|respiratory system agents|mesh-ancestor
56042623|NCT01422434|Dermatologic Agents|dermatologic agents|mesh-ancestor
56042624|NCT01422434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56042625|NCT01422434|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56042626|NCT01422434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56042627|NCT01422434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042628|NCT01422434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56042629|NCT01422434|Vitamins|vitamins|mesh-ancestor
56042630|NCT01422434|Micronutrients|micronutrients|mesh-ancestor
56042631|NCT01422434|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56042632|NCT05434065|Celecoxib|celecoxib|mesh-list
56042633|NCT05434065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56042634|NCT05434065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56042635|NCT05434065|Analgesics|analgesics|mesh-ancestor
56042636|NCT05434065|Sensory System Agents|sensory system agents|mesh-ancestor
56042637|NCT05434065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042638|NCT05434065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042639|NCT05434065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879446|NCT03126864|Fludarabine|fludarabine|mesh-list
55879447|NCT03126864|Fludarabine phosphate|fludarabine phosphate|mesh-list
55879448|NCT03126864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55879449|NCT03126864|Immunologic Factors|immunologic factors|mesh-ancestor
55879450|NCT03126864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879451|NCT03126864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879452|NCT03126864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55879454|NCT03126864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879455|NCT03126864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879456|NCT03126864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55879457|NCT03126864|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55879458|NCT03126864|Antimetabolites|antimetabolites|mesh-ancestor
55879460|NCT03399708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55879461|NCT03399708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879462|NCT03399708|Analgesics|analgesics|mesh-ancestor
55879463|NCT03399708|Sensory System Agents|sensory system agents|mesh-ancestor
55879464|NCT03399708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879465|NCT03399708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879466|NCT03399708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879467|NCT03399708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879468|NCT03399708|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55879469|NCT03399708|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55879470|NCT03399708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890416|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
55879471|NCT03399708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879472|NCT03395730|Oxytocin|oxytocin|mesh-list
55879473|NCT03395730|Oxytocics|oxytocics|mesh-ancestor
55879474|NCT03395730|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879475|NCT03395730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879476|NCT01334086|Aprepitant|aprepitant|mesh-list
55879477|NCT01334086|Antiemetics|antiemetics|mesh-ancestor
55879478|NCT01334086|Autonomic Agents|autonomic agents|mesh-ancestor
55879479|NCT01334086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879480|NCT01334086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879481|NCT01334086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55879482|NCT01334086|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56042640|NCT05434065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56042641|NCT05434065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56042642|NCT05434065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56042643|NCT05434065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042644|NCT05434065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042645|NCT01861457|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56042646|NCT01861457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042647|NCT05662319|Antithrombins|antithrombins|mesh-list
56042648|NCT05662319|Antithrombin III|antithrombin iii|mesh-list
56042649|NCT05662319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56042650|NCT05662319|Protease Inhibitors|protease inhibitors|mesh-ancestor
56042651|NCT05662319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042652|NCT05662319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042653|NCT05662319|Anticoagulants|anticoagulants|mesh-ancestor
56042654|NCT02270255|Lidocaine|lidocaine|mesh-list
56042655|NCT02270255|Ropivacaine|ropivacaine|mesh-list
56042656|NCT02270255|Anesthetics, Local|anesthetics, local|mesh-ancestor
56042657|NCT02270255|Anesthetics|anesthetics|mesh-ancestor
56042658|NCT02270255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042659|NCT02270255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042660|NCT02270255|Sensory System Agents|sensory system agents|mesh-ancestor
56042661|NCT02270255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55769863|NCT02675231|Trastuzumab|trastuzumab|mesh-list
56042662|NCT02270255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56042663|NCT02270255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56042664|NCT02270255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56042665|NCT02270255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56042666|NCT02270255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042667|NCT02651259|Vitamins|vitamins|mesh-list
56042668|NCT02651259|Pyridoxine|pyridoxine|mesh-list
56042669|NCT02651259|Pyridoxal|pyridoxal|mesh-list
56042670|NCT02651259|Vitamin B 6|vitamin b 6|mesh-list
56042671|NCT02651259|Vitamin B Complex|vitamin b complex|mesh-list
56042672|NCT02651259|Isoniazid|isoniazid|mesh-list
56042673|NCT02651259|Rifapentine|rifapentine|mesh-list
56042674|NCT02651259|Rifamycins|rifamycins|mesh-list
56042675|NCT02651259|Hydrazine|hydrazine|mesh-list
56042676|NCT02651259|Micronutrients|micronutrients|mesh-ancestor
56042678|NCT02651259|Antitubercular Agents|antitubercular agents|mesh-ancestor
56042679|NCT02651259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56042680|NCT02651259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042681|NCT02651259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56042682|NCT02651259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56042683|NCT02651259|Antimetabolites|antimetabolites|mesh-ancestor
56042684|NCT02651259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042685|NCT02651259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56042686|NCT02651259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56042687|NCT02651259|Leprostatic Agents|leprostatic agents|mesh-ancestor
56042688|NCT02651259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042690|NCT02271425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56042691|NCT02271425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56042692|NCT02271425|Antimetabolites|antimetabolites|mesh-ancestor
56042693|NCT02271425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042694|NCT02271425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56042695|NCT05442411|Parecoxib|parecoxib|mesh-list
56042696|NCT05442411|Ropivacaine|ropivacaine|mesh-list
56042697|NCT05442411|Anesthetics, Local|anesthetics, local|mesh-ancestor
56042698|NCT05442411|Anesthetics|anesthetics|mesh-ancestor
56042699|NCT05442411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042700|NCT05442411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841385|NCT04026880|Testosterone|testosterone|mesh-list
56042701|NCT05442411|Sensory System Agents|sensory system agents|mesh-ancestor
56042702|NCT05442411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042703|NCT05442411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56042704|NCT05442411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56042705|NCT05442411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042724|NCT02651415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042725|NCT02651415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56042726|NCT00555425|Buprenorphine|buprenorphine|mesh-list
56042727|NCT00555425|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56042728|NCT00555425|Naloxone|naloxone|mesh-list
56042729|NCT00555425|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56042730|NCT00555425|Narcotics|narcotics|mesh-ancestor
56042731|NCT00555425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042732|NCT00555425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042733|NCT00555425|Analgesics|analgesics|mesh-ancestor
56042734|NCT00555425|Sensory System Agents|sensory system agents|mesh-ancestor
56042735|NCT00555425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042736|NCT00555425|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56042737|NCT05444751|Anesthetics|anesthetics|mesh-list
55769936|NCT03158129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042738|NCT05444751|Anesthetics, General|anesthetics, general|mesh-list
56042739|NCT05444751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56042740|NCT05444751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042741|NCT05444673|Cisplatin|cisplatin|mesh-list
56042742|NCT05444673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042743|NCT04338633|Calcium, Dietary|calcium, dietary|mesh-list
56042744|NCT04338633|Calcium|calcium|mesh-list
56042745|NCT04338633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56042746|NCT04338633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042747|NCT04338633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56042748|NCT01488188|Vaccines|vaccines|mesh-list
56042749|NCT01488188|Immunologic Factors|immunologic factors|mesh-ancestor
56042750|NCT01488188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042751|NCT01489670|Bimatoprost|bimatoprost|mesh-list
56042752|NCT01489670|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56042753|NCT01489670|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56042754|NCT01489670|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56042755|NCT01427504|Etravirine|etravirine|mesh-list
56042756|NCT01427504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56042757|NCT01427504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56042758|NCT01427504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042759|NCT01427504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042760|NCT01427504|Antiviral Agents|antiviral agents|mesh-ancestor
56042761|NCT01427504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042762|NCT03169361|Ixazomib|ixazomib|mesh-list
56042763|NCT03169361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042764|NCT03169361|Protease Inhibitors|protease inhibitors|mesh-ancestor
56042765|NCT03169361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042766|NCT03169361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042767|NCT02265965|Nitroglycerin|nitroglycerin|mesh-list
56042768|NCT02265965|Vasodilator Agents|vasodilator agents|mesh-ancestor
56042769|NCT03021083|Fentanyl|fentanyl|mesh-list
56042770|NCT03021083|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56042771|NCT03021083|Narcotics|narcotics|mesh-ancestor
56042772|NCT03021083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790605|NCT04201873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042773|NCT03021083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042775|NCT03021083|Sensory System Agents|sensory system agents|mesh-ancestor
56042776|NCT03021083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042777|NCT03021083|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56042778|NCT03021083|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56042779|NCT03021083|Anesthetics, General|anesthetics, general|mesh-ancestor
56042780|NCT03021083|Anesthetics|anesthetics|mesh-ancestor
56042781|NCT03000257|Venetoclax|venetoclax|mesh-list
56042782|NCT03000257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042783|NCT02945813|Metformin|metformin|mesh-list
56042784|NCT02945813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56042785|NCT02945813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042786|NCT02891447|Cisplatin|cisplatin|mesh-list
56042787|NCT02891447|Mitomycins|mitomycins|mesh-list
56042788|NCT02891447|Mitomycin|mitomycin|mesh-list
56042789|NCT02891447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042790|NCT02891447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56042791|NCT02891447|Alkylating Agents|alkylating agents|mesh-ancestor
56042792|NCT02891447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042793|NCT02891447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56042806|NCT05442801|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56042807|NCT05442801|Cholinergic Agents|cholinergic agents|mesh-ancestor
56042808|NCT05442801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042809|NCT05442801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042810|NCT05442801|Parasympatholytics|parasympatholytics|mesh-ancestor
56042811|NCT05339373|Aceclofenac|aceclofenac|mesh-list
56042812|NCT05339373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56042813|NCT05339373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56042814|NCT05339373|Analgesics|analgesics|mesh-ancestor
56042815|NCT05339373|Sensory System Agents|sensory system agents|mesh-ancestor
56042816|NCT05339373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042817|NCT05339373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042818|NCT05339373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879483|NCT01334086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879484|NCT01334086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879485|NCT03399474|Lidocaine|lidocaine|mesh-list
55879486|NCT03399474|Dexmedetomidine|dexmedetomidine|mesh-list
55879487|NCT03399474|Anesthetics, Local|anesthetics, local|mesh-ancestor
55879488|NCT03399474|Anesthetics|anesthetics|mesh-ancestor
55879489|NCT03399474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879490|NCT03399474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879491|NCT03399474|Sensory System Agents|sensory system agents|mesh-ancestor
55879492|NCT03399474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879493|NCT03399474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55879494|NCT03399474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55879495|NCT03399474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55879496|NCT03399474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55879497|NCT03399474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879498|NCT03399474|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55879499|NCT03399474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879500|NCT03399474|Analgesics|analgesics|mesh-ancestor
55879501|NCT03399474|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55879502|NCT03399474|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55879503|NCT03399474|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55879504|NCT03399474|Adrenergic Agents|adrenergic agents|mesh-ancestor
55879505|NCT03399474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879506|NCT01611155|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55879507|NCT01611155|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55879508|NCT01611155|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55879509|NCT01611155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55879510|NCT01611155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879511|NCT01611155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879512|NCT01611155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879519|NCT01430182|Narcotics|narcotics|mesh-ancestor
55879520|NCT01430182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890498|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
55879521|NCT01430182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879522|NCT01430182|Analgesics|analgesics|mesh-ancestor
55879523|NCT01430182|Sensory System Agents|sensory system agents|mesh-ancestor
55879524|NCT01430182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879525|NCT01430182|Antitussive Agents|antitussive agents|mesh-ancestor
55879526|NCT01430182|Respiratory System Agents|respiratory system agents|mesh-ancestor
55879527|NCT05097768|Dexamethasone|dexamethasone|mesh-list
55879528|NCT05097768|Ibuprofen|ibuprofen|mesh-list
55879529|NCT05097768|Ketorolac|ketorolac|mesh-list
55879530|NCT05097768|Meloxicam|meloxicam|mesh-list
55879531|NCT05097768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879532|NCT05097768|Antiemetics|antiemetics|mesh-ancestor
56042819|NCT05339373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56042820|NCT05439993|Paclitaxel|paclitaxel|mesh-list
56042821|NCT05439993|Tepotinib|tepotinib|mesh-list
56042822|NCT05439993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56042823|NCT05439993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042824|NCT05439993|Tubulin Modulators|tubulin modulators|mesh-ancestor
56042825|NCT05439993|Antimitotic Agents|antimitotic agents|mesh-ancestor
56042826|NCT05439993|Mitosis Modulators|mitosis modulators|mesh-ancestor
56042827|NCT05439993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042828|NCT00554099|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56042829|NCT00554099|Mesalamine|mesalamine|mesh-list
56042830|NCT00554099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042831|NCT00554099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56042832|NCT00554099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56042833|NCT00554099|Analgesics|analgesics|mesh-ancestor
55879533|NCT05097768|Autonomic Agents|autonomic agents|mesh-ancestor
55879534|NCT05097768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879535|NCT05097768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879536|NCT05097768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55879537|NCT05097768|Glucocorticoids|glucocorticoids|mesh-ancestor
55879538|NCT05097768|Hormones|hormones|mesh-ancestor
55879539|NCT05097768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55879540|NCT05097768|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55879541|NCT05097768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879542|NCT05097768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55879543|NCT05097768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879544|NCT05097768|Analgesics|analgesics|mesh-ancestor
55879545|NCT05097768|Sensory System Agents|sensory system agents|mesh-ancestor
55879546|NCT05097768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879547|NCT05097768|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55879548|NCT05097768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879549|NCT05097768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879550|NCT05097768|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55879551|NCT01829243|Milnacipran|milnacipran|mesh-list
55879552|NCT01829243|Levomilnacipran|levomilnacipran|mesh-list
55879553|NCT01829243|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55879554|NCT01829243|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55879555|NCT01829243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55879556|NCT01829243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879557|NCT01829243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879558|NCT01829243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879559|NCT01829243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879560|NCT01829243|Analgesics|analgesics|mesh-ancestor
55879561|NCT01829243|Sensory System Agents|sensory system agents|mesh-ancestor
55879562|NCT01829243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879563|NCT01829243|Antidepressive Agents|antidepressive agents|mesh-ancestor
55879564|NCT01829243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55879565|NCT01838447|Vitamin D|vitamin d|mesh-list
55879566|NCT01838447|Cholecalciferol|cholecalciferol|mesh-list
55879567|NCT01838447|Vitamins|vitamins|mesh-ancestor
55879568|NCT01838447|Micronutrients|micronutrients|mesh-ancestor
55879569|NCT01838447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879570|NCT01838447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55879571|NCT01838447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55879572|NCT03395574|Terlipressin|terlipressin|mesh-list
55879573|NCT03395574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55879574|NCT03395574|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55879575|NCT05040282|Etonogestrel|etonogestrel|mesh-list
56042834|NCT00554099|Sensory System Agents|sensory system agents|mesh-ancestor
56042835|NCT00554099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042836|NCT00554099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042837|NCT00554099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042838|NCT00554099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56042843|NCT04048161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042844|NCT04048161|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56042845|NCT04048161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042846|NCT04048161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042847|NCT04048161|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56042848|NCT04048161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042849|NCT04048161|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56042850|NCT04048161|Antitubercular Agents|antitubercular agents|mesh-ancestor
56042851|NCT04048161|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56042852|NCT04048161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042853|NCT02664909|Tranexamic Acid|tranexamic acid|mesh-list
56042854|NCT02664909|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56042855|NCT02664909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56042856|NCT02664909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042857|NCT02664909|Hemostatics|hemostatics|mesh-ancestor
56042858|NCT02664909|Coagulants|coagulants|mesh-ancestor
56042859|NCT03974217|Talazoparib|talazoparib|mesh-list
56042860|NCT03974217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56042861|NCT03974217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042862|NCT03974217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042863|NCT03974217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042864|NCT00368589|Atorvastatin|atorvastatin|mesh-list
56042865|NCT00368589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56042866|NCT00368589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55879576|NCT05040282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55879577|NCT05040282|Contraceptive Agents|contraceptive agents|mesh-ancestor
55879578|NCT05040282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879579|NCT05040282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879580|NCT05040282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55879581|NCT04982172|Infliximab|infliximab|mesh-list
55879582|NCT04982172|Dermatologic Agents|dermatologic agents|mesh-ancestor
56042867|NCT00368589|Antimetabolites|antimetabolites|mesh-ancestor
56042868|NCT00368589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042869|NCT00368589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56042870|NCT00368589|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56042871|NCT00368589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042875|NCT00553319|Amphetamine|amphetamine|mesh-list
56042876|NCT00553319|Adderall|adderall|mesh-list
56042877|NCT00553319|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56042878|NCT00553319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042879|NCT00553319|Sympathomimetics|sympathomimetics|mesh-ancestor
56042880|NCT00553319|Autonomic Agents|autonomic agents|mesh-ancestor
56042881|NCT00553319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042882|NCT00553319|Dopamine Agents|dopamine agents|mesh-ancestor
56042883|NCT00553319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042884|NCT00553319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042885|NCT00553319|Adrenergic Agents|adrenergic agents|mesh-ancestor
56042886|NCT00553319|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56042887|NCT00553319|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56042888|NCT00553319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55770099|NCT04103489|Eculizumab|eculizumab|mesh-list
56042889|NCT00553319|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56042891|NCT00369291|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56042892|NCT00369291|Immunologic Factors|immunologic factors|mesh-ancestor
56042893|NCT00369291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042894|NCT01868633|Dexamethasone|dexamethasone|mesh-list
56042895|NCT01868633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56042896|NCT01868633|Antiemetics|antiemetics|mesh-ancestor
56042897|NCT01868633|Autonomic Agents|autonomic agents|mesh-ancestor
56042898|NCT01868633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042900|NCT01868633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56042908|NCT04738773|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56042909|NCT04738773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042910|NCT04738773|Sensory System Agents|sensory system agents|mesh-ancestor
56042911|NCT04738773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042912|NCT03637803|Pembrolizumab|pembrolizumab|mesh-list
56042913|NCT03637803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56042914|NCT03637803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042915|NCT03833063|Botulinum Toxins|botulinum toxins|mesh-list
56042916|NCT03833063|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56042917|NCT03833063|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56042918|NCT03833063|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56042919|NCT03833063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56042920|NCT03833063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042921|NCT03833063|Cholinergic Agents|cholinergic agents|mesh-ancestor
56042922|NCT03833063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042923|NCT03833063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042924|NCT03833063|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56042925|NCT03833063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042926|NCT02676375|Bupropion|bupropion|mesh-list
56042927|NCT02676375|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56042928|NCT02676375|Antidepressive Agents|antidepressive agents|mesh-ancestor
56042929|NCT02676375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56042930|NCT02676375|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56042931|NCT02676375|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56042932|NCT02676375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56042933|NCT02676375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042934|NCT02676375|Dopamine Agents|dopamine agents|mesh-ancestor
56042935|NCT02676375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042936|NCT02676375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042937|NCT02676375|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56042938|NCT02676375|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56042939|NCT02676375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879583|NCT04982172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55879584|NCT04982172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879587|NCT01837823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55879588|NCT01837823|Antimetabolites|antimetabolites|mesh-ancestor
55750720|NCT03095469|Analgesics|analgesics|mesh-ancestor
55879589|NCT01837823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042941|NCT01871441|Cyclophosphamide|cyclophosphamide|mesh-list
56042942|NCT01871441|Tacrolimus|tacrolimus|mesh-list
56042943|NCT01871441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56042944|NCT01871441|Immunologic Factors|immunologic factors|mesh-ancestor
56042945|NCT01871441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042946|NCT01871441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56042947|NCT01871441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56042948|NCT01871441|Alkylating Agents|alkylating agents|mesh-ancestor
56042949|NCT01871441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042950|NCT01871441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042951|NCT01871441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56042952|NCT01871441|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56042953|NCT01871441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042954|NCT01871441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56042955|NCT01871441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56042956|NCT01871441|Antitubercular Agents|antitubercular agents|mesh-ancestor
56042957|NCT01871441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56042958|NCT01871441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56042959|NCT04338711|Tofacitinib|tofacitinib|mesh-list
56042960|NCT04338711|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56042961|NCT04338711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042962|NCT04338711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042963|NCT01874951|Naltrexone|naltrexone|mesh-list
56042964|NCT01874951|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56042965|NCT01874951|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56042966|NCT01874951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042967|NCT01874951|Sensory System Agents|sensory system agents|mesh-ancestor
56042968|NCT01874951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042969|NCT04739241|Insulin|insulin|mesh-list
56042970|NCT04739241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55879590|NCT01837823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55879591|NCT01837823|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55879592|NCT01837823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879593|NCT03395262|Caffeine|caffeine|mesh-list
55879594|NCT03395262|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55879595|NCT03395262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879596|NCT03395262|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55879597|NCT03395262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879598|NCT03395262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879599|NCT03395262|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56042971|NCT04739241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56042972|NCT04739241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042973|NCT03024437|Bevacizumab|bevacizumab|mesh-list
56042974|NCT03024437|Atezolizumab|atezolizumab|mesh-list
56042976|NCT03024437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56042977|NCT03024437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56042978|NCT03024437|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56042979|NCT03024437|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56042980|NCT03024437|Growth Substances|growth substances|mesh-ancestor
56042981|NCT03024437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042982|NCT03024437|Growth Inhibitors|growth inhibitors|mesh-ancestor
56042983|NCT03024437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56042984|NCT03024437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56042985|NCT03024437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042986|NCT01489826|HU 211|hu 211|mesh-list
56042987|NCT01489826|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56042988|NCT01489826|Antiemetics|antiemetics|mesh-ancestor
56042989|NCT01489826|Autonomic Agents|autonomic agents|mesh-ancestor
56042990|NCT01489826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56042991|NCT01489826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56042992|NCT01489826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56042993|NCT01489826|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56042994|NCT01489826|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56042995|NCT01489826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56042996|NCT01489826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56042997|NCT01489826|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56042998|NCT01489826|Protective Agents|protective agents|mesh-ancestor
56042999|NCT02677623|Mannitol|mannitol|mesh-list
55879600|NCT03395262|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55879601|NCT03395262|Purinergic Agents|purinergic agents|mesh-ancestor
55879602|NCT03395262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879603|NCT03852888|Methotrexate|methotrexate|mesh-list
55879604|NCT03852888|7-hydroxymethotrexate|7-hydroxymethotrexate|mesh-list
55879605|NCT03852888|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55879606|NCT03852888|Abortifacient Agents|abortifacient agents|mesh-ancestor
55879607|NCT03852888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879608|NCT03852888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879609|NCT03852888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55879610|NCT03852888|Antimetabolites|antimetabolites|mesh-ancestor
55879611|NCT03852888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879612|NCT03852888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879613|NCT03852888|Dermatologic Agents|dermatologic agents|mesh-ancestor
55879614|NCT03852888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879615|NCT03852888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55879616|NCT03852888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043000|NCT02677623|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56043001|NCT02677623|Diuretics|diuretics|mesh-ancestor
56043002|NCT02677623|Natriuretic Agents|natriuretic agents|mesh-ancestor
56043003|NCT02677623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043004|NCT02677701|Azithromycin|azithromycin|mesh-list
56043005|NCT02677701|Tobramycin|tobramycin|mesh-list
56043006|NCT02677701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56043007|NCT02677701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043008|NCT01543178|Rifaximin|rifaximin|mesh-list
56043009|NCT01543178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56043010|NCT01543178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043011|NCT01543178|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043012|NCT05052957|Temozolomide|temozolomide|mesh-list
56043013|NCT05052957|Carmustine|carmustine|mesh-list
55879617|NCT03852888|Immunologic Factors|immunologic factors|mesh-ancestor
55879618|NCT03852888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879619|NCT03852888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55879620|NCT04770012|Aspirin|aspirin|mesh-list
55879621|NCT04770012|Clopidogrel|clopidogrel|mesh-list
55879622|NCT04770012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55879623|NCT04770012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879624|NCT04770012|Analgesics|analgesics|mesh-ancestor
55879625|NCT04770012|Sensory System Agents|sensory system agents|mesh-ancestor
55879626|NCT04770012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879627|NCT04770012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879628|NCT04770012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879629|NCT04770012|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879630|NCT04770012|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55879631|NCT04770012|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55879632|NCT04770012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879633|NCT04770012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55879634|NCT04770012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55879635|NCT04770012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879636|NCT04770012|Antipyretics|antipyretics|mesh-ancestor
55879637|NCT04770012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55879638|NCT04770012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55879639|NCT04770012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55879640|NCT04770012|Purinergic Agents|purinergic agents|mesh-ancestor
55879641|NCT04770012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879642|NCT04755972|Acetylcysteine|acetylcysteine|mesh-list
55879643|NCT04755972|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55879644|NCT04755972|Antiviral Agents|antiviral agents|mesh-ancestor
55879645|NCT04755972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55879646|NCT04755972|Expectorants|expectorants|mesh-ancestor
55879647|NCT04755972|Respiratory System Agents|respiratory system agents|mesh-ancestor
55879648|NCT04755972|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55879649|NCT04755972|Antioxidants|antioxidants|mesh-ancestor
55879650|NCT04755972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879651|NCT04755972|Protective Agents|protective agents|mesh-ancestor
55879652|NCT04755972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879653|NCT04755972|Antidotes|antidotes|mesh-ancestor
55879654|NCT01828073|Raltegravir Potassium|raltegravir potassium|mesh-list
55879655|NCT01828073|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55879661|NCT01828073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879662|NCT01828073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879663|NCT04697693|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55842443|NCT04140058|Ondansetron|ondansetron|mesh-list
55879665|NCT04697693|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55879666|NCT04697693|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55879667|NCT04697693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55879668|NCT04697693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879669|NCT04697693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879670|NCT04697693|Serotonin Agents|serotonin agents|mesh-ancestor
55879671|NCT04697693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043014|NCT05052957|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56043015|NCT05052957|Lenograstim|lenograstim|mesh-list
56043016|NCT05052957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56043017|NCT05052957|Immunologic Factors|immunologic factors|mesh-ancestor
56043018|NCT05052957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043019|NCT05052957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56043020|NCT05052957|Alkylating Agents|alkylating agents|mesh-ancestor
56043021|NCT05052957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043022|NCT05052957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043023|NCT05052957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043024|NCT01649856|Rituximab|rituximab|mesh-list
56043025|NCT01649856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56043026|NCT01649856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043027|NCT01649856|Immunologic Factors|immunologic factors|mesh-ancestor
56043028|NCT01649856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043029|NCT01649856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56043030|NCT01543568|Aflibercept|aflibercept|mesh-list
56043031|NCT01543568|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56043032|NCT01543568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56043033|NCT01543568|Growth Substances|growth substances|mesh-ancestor
56043034|NCT01543568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043035|NCT01543568|Growth Inhibitors|growth inhibitors|mesh-ancestor
56043036|NCT01543568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043037|NCT02681757|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56043038|NCT02681757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043040|NCT02375724|Anticonvulsants|anticonvulsants|mesh-ancestor
56043041|NCT02398188|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56043042|NCT02398188|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56043043|NCT02398188|Autonomic Agents|autonomic agents|mesh-ancestor
56043044|NCT02398188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043045|NCT02398188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043046|NCT02398188|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56043058|NCT02424630|Anesthetics, Local|anesthetics, local|mesh-ancestor
56043059|NCT02424630|Anesthetics|anesthetics|mesh-ancestor
56043060|NCT02424630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043061|NCT02424630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043062|NCT02424630|Sensory System Agents|sensory system agents|mesh-ancestor
56043063|NCT02424630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043064|NCT02397408|Choline|choline|mesh-list
56043065|NCT02397408|Lipotropic Agents|lipotropic agents|mesh-ancestor
56043066|NCT02397408|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56043067|NCT02397408|Antimetabolites|antimetabolites|mesh-ancestor
56043068|NCT02397408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043069|NCT02397408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043070|NCT02397408|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56043071|NCT02397408|Nootropic Agents|nootropic agents|mesh-ancestor
56043072|NCT02397096|Ritonavir|ritonavir|mesh-list
56043073|NCT02397096|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56043074|NCT02397096|Tenofovir|tenofovir|mesh-list
56043075|NCT02397096|Lamivudine|lamivudine|mesh-list
56043076|NCT02397096|Cobicistat|cobicistat|mesh-list
55842588|NCT04027894|Rifamycins|rifamycins|mesh-list
56043077|NCT02397096|Elvitegravir|elvitegravir|mesh-list
56043078|NCT02397096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
56043079|NCT02397096|Protease Inhibitors|protease inhibitors|mesh-list
56043080|NCT02397096|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56043081|NCT02397096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043082|NCT02397096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043083|NCT02397096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56043084|NCT02397096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56043085|NCT02397096|Antiviral Agents|antiviral agents|mesh-ancestor
56043086|NCT02397096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043087|NCT02397096|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56043088|NCT02397096|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56043089|NCT02397096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56043090|NCT02397096|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56043091|NCT02396316|Aflibercept|aflibercept|mesh-list
56043092|NCT02396316|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56043093|NCT02396316|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56043097|NCT02396316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043098|NCT02682381|Teduglutide|teduglutide|mesh-list
56043099|NCT02682381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043100|NCT02682381|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56043101|NCT02682381|Protective Agents|protective agents|mesh-ancestor
56043102|NCT02682381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043103|NCT04915950|APD791|apd791|mesh-list
56043104|NCT04915950|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56043105|NCT04915950|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56043106|NCT04915950|Serotonin Agents|serotonin agents|mesh-ancestor
56043107|NCT04915950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043108|NCT04915950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879672|NCT04697693|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55879673|NCT04697693|Antidepressive Agents|antidepressive agents|mesh-ancestor
55879674|NCT04697693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55879675|NCT04697693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879676|NCT04697693|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55879678|NCT04697693|Sensory System Agents|sensory system agents|mesh-ancestor
55879679|NCT04697693|Dopamine Agents|dopamine agents|mesh-ancestor
55879680|NCT03819114|Levonorgestrel|levonorgestrel|mesh-list
55879681|NCT03819114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55879682|NCT03819114|Contraceptive Agents|contraceptive agents|mesh-ancestor
55879683|NCT03819114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879684|NCT03819114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879685|NCT03819114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55879686|NCT03819114|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55879687|NCT03819114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55879688|NCT01827839|Vaccines|vaccines|mesh-list
55879689|NCT01827839|Immunologic Factors|immunologic factors|mesh-ancestor
55879690|NCT01827839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879691|NCT04709250|Bupivacaine|bupivacaine|mesh-list
55879692|NCT04709250|Anesthetics, Local|anesthetics, local|mesh-ancestor
55879693|NCT04709250|Anesthetics|anesthetics|mesh-ancestor
55879694|NCT04709250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879695|NCT04709250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879696|NCT04709250|Sensory System Agents|sensory system agents|mesh-ancestor
55879697|NCT04709250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879698|NCT05107050|Anti-Infective Agents|anti-infective agents|mesh-list
55879699|NCT05107050|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55879700|NCT01401166|Trastuzumab|trastuzumab|mesh-list
55879701|NCT01401166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55879702|NCT01401166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879703|NCT03395028|Lenograstim|lenograstim|mesh-list
55879704|NCT03395028|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55879705|NCT03395028|Immunologic Factors|immunologic factors|mesh-ancestor
55879706|NCT03395028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879707|NCT03394950|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55879708|NCT03394950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55879709|NCT03394950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55879710|NCT03394950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879711|NCT01334944|Ibuprofen|ibuprofen|mesh-list
55879712|NCT01334944|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55879713|NCT01334944|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879714|NCT01334944|Analgesics|analgesics|mesh-ancestor
55879715|NCT01334944|Sensory System Agents|sensory system agents|mesh-ancestor
55879716|NCT01334944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750760|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55879717|NCT01334944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879718|NCT01334944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879719|NCT01334944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879720|NCT01334944|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56043109|NCT04915950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043110|NCT04976595|Testosterone|testosterone|mesh-list
56043111|NCT04976595|Androgens|androgens|mesh-ancestor
56043112|NCT04976595|Hormones|hormones|mesh-ancestor
56043113|NCT04976595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770316|NCT02084056|Hormones|hormones|mesh-ancestor
56043114|NCT04976595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043116|NCT03033303|Dermatologic Agents|dermatologic agents|mesh-ancestor
56043117|NCT00367965|Eszopiclone|eszopiclone|mesh-list
56043118|NCT00367965|Zopiclone|zopiclone|mesh-list
56043119|NCT00367965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56043120|NCT00367965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043121|NCT00367965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043122|NCT02904291|Amlodipine|amlodipine|mesh-list
56043123|NCT02904291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56124671|NCT01405560|Antimetabolites|antimetabolites|mesh-ancestor
56043124|NCT02904291|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56043125|NCT02904291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56043126|NCT02904291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043127|NCT02904291|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56043128|NCT02904291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043129|NCT02904291|Vasodilator Agents|vasodilator agents|mesh-ancestor
56043130|NCT02683161|Varenicline|varenicline|mesh-list
56043131|NCT02683161|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56043132|NCT02683161|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56043133|NCT02683161|Cholinergic Agents|cholinergic agents|mesh-ancestor
56043134|NCT02683161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043135|NCT02683161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043136|NCT02683161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043153|NCT02683707|Analgesics|analgesics|mesh-ancestor
56043154|NCT02683707|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56043155|NCT02683707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56043156|NCT02683707|Anesthetics, General|anesthetics, general|mesh-ancestor
56043157|NCT02683707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56043158|NCT02683707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56043159|NCT02683707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56043160|NCT02683707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56043161|NCT02683707|GABA Modulators|gaba modulators|mesh-ancestor
56043162|NCT02683707|GABA Agents|gaba agents|mesh-ancestor
56043163|NCT02683707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043164|NCT02371980|Vortioxetine|vortioxetine|mesh-list
56043165|NCT02371980|Antidepressive Agents|antidepressive agents|mesh-ancestor
56043166|NCT02371980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56043167|NCT02371980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56043168|NCT02371980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56043169|NCT02371980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043170|NCT02371980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043171|NCT02371980|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56043172|NCT02371980|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56043173|NCT02371980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56043174|NCT02371980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043175|NCT02371980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043176|NCT02371980|Serotonin Agents|serotonin agents|mesh-ancestor
56043177|NCT02371980|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56043178|NCT02371980|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56043179|NCT02371980|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56043197|NCT02833233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043198|NCT05447949|Levobupivacaine|levobupivacaine|mesh-list
56043199|NCT05447949|Anesthetics, Local|anesthetics, local|mesh-ancestor
56043200|NCT05447949|Anesthetics|anesthetics|mesh-ancestor
56043201|NCT05447949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043202|NCT05447949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043203|NCT05447949|Sensory System Agents|sensory system agents|mesh-ancestor
56043204|NCT05447949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043221|NCT05447871|Bupivacaine|bupivacaine|mesh-list
56043222|NCT05447871|Anesthetics, Local|anesthetics, local|mesh-ancestor
56043223|NCT05447871|Anesthetics|anesthetics|mesh-ancestor
56043224|NCT05447871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043225|NCT05447871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043226|NCT05447871|Sensory System Agents|sensory system agents|mesh-ancestor
56043227|NCT05447871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043228|NCT00369447|Nimotuzumab|nimotuzumab|mesh-list
56043229|NCT00369447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56043230|NCT00369447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043231|NCT00914823|Hormones|hormones|mesh-list
56043232|NCT00914823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043233|NCT00914823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043234|NCT04772235|Osimertinib|osimertinib|mesh-list
56043235|NCT04772235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043236|NCT04772235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56043237|NCT04772235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043238|NCT04772235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043240|NCT04766463|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56043241|NCT04766463|Narcotics|narcotics|mesh-ancestor
56043242|NCT04766463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043243|NCT04766463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043244|NCT04766463|Analgesics|analgesics|mesh-ancestor
56043245|NCT04766463|Sensory System Agents|sensory system agents|mesh-ancestor
56043246|NCT04766463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043247|NCT00823563|Adenosine|adenosine|mesh-list
56043248|NCT00823563|Nitroglycerin|nitroglycerin|mesh-list
56043249|NCT00823563|Vasodilator Agents|vasodilator agents|mesh-ancestor
56043250|NCT00823563|Analgesics|analgesics|mesh-ancestor
56043251|NCT00823563|Sensory System Agents|sensory system agents|mesh-ancestor
56043252|NCT00823563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043253|NCT00823563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043254|NCT00823563|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56043255|NCT00823563|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56043256|NCT00823563|Purinergic Agonists|purinergic agonists|mesh-ancestor
56043257|NCT00823563|Purinergic Agents|purinergic agents|mesh-ancestor
56043258|NCT00823563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043259|NCT00823563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043260|NCT05447169|Antibodies|antibodies|mesh-list
56043261|NCT05447169|Immunologic Factors|immunologic factors|mesh-ancestor
56043262|NCT05447169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043263|NCT04704453|Amitriptyline|amitriptyline|mesh-list
56043264|NCT04704453|Capsaicin|capsaicin|mesh-list
56043265|NCT04704453|Antipruritics|antipruritics|mesh-ancestor
56043266|NCT04704453|Dermatologic Agents|dermatologic agents|mesh-ancestor
56043267|NCT04704453|Sensory System Agents|sensory system agents|mesh-ancestor
56043268|NCT04704453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043269|NCT04704453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043270|NCT04704453|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56043271|NCT04704453|Antidepressive Agents|antidepressive agents|mesh-ancestor
55879721|NCT01334944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043272|NCT04704453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56043273|NCT04704453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56043274|NCT04704453|Analgesics|analgesics|mesh-ancestor
56043275|NCT04704453|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56043276|NCT04704453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56043277|NCT04704453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56043278|NCT04704453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043279|NCT04704453|Adrenergic Agents|adrenergic agents|mesh-ancestor
56043280|NCT04704453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043281|NCT04652193|Anesthetics|anesthetics|mesh-list
56043282|NCT04652193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043283|NCT04652193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043285|NCT05451147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56043286|NCT05451147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043287|NCT04553367|Meropenem|meropenem|mesh-list
56043288|NCT04553367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56043289|NCT04553367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043290|NCT00369837|Clevidipine|clevidipine|mesh-list
56043291|NCT00369837|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56043292|NCT00369837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56043293|NCT00369837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043294|NCT00369837|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56043295|NCT00369837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043296|NCT05449899|Cyclophosphamide|cyclophosphamide|mesh-list
56043297|NCT05449899|Busulfan|busulfan|mesh-list
56043298|NCT05449899|Fludarabine|fludarabine|mesh-list
56043299|NCT05449899|Decitabine|decitabine|mesh-list
56043300|NCT05449899|Lenograstim|lenograstim|mesh-list
56043301|NCT05449899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043302|NCT05449899|Immunologic Factors|immunologic factors|mesh-ancestor
56043303|NCT05449899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043304|NCT05449899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56043305|NCT05449899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56043306|NCT05449899|Alkylating Agents|alkylating agents|mesh-ancestor
56043307|NCT05449899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879722|NCT01334944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879723|NCT04567992|Bupivacaine|bupivacaine|mesh-list
56043308|NCT05449899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043309|NCT05449899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56043310|NCT05449899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56043311|NCT05449899|Antimetabolites|antimetabolites|mesh-ancestor
56043312|NCT05449899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043313|NCT05449899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56043315|NCT05441631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56043316|NCT05441631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56043317|NCT05441631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043318|NCT01546454|Leuprolide|leuprolide|mesh-list
56043319|NCT01546454|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56043320|NCT01546454|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56043321|NCT01546454|Levonorgestrel|levonorgestrel|mesh-list
56043322|NCT01546454|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56043323|NCT01546454|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56043324|NCT01546454|Estradiol|estradiol|mesh-list
56043325|NCT01546454|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56043326|NCT01546454|Progesterone|progesterone|mesh-list
56043327|NCT01546454|Estrogens|estrogens|mesh-ancestor
56043328|NCT01546454|Hormones|hormones|mesh-ancestor
56043329|NCT01546454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043330|NCT01546454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043331|NCT01546454|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56043332|NCT01546454|Contraceptive Agents|contraceptive agents|mesh-ancestor
56043333|NCT01546454|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56043334|NCT01546454|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56043335|NCT01546454|Progestins|progestins|mesh-ancestor
55770543|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
56043336|NCT01546454|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56043337|NCT01546454|Fertility Agents|fertility agents|mesh-ancestor
56043346|NCT05430867|Memantine|memantine|mesh-list
56043352|NCT05430867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043353|NCT05430867|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56043354|NCT05430867|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56043355|NCT05448885|Gemcitabine|gemcitabine|mesh-list
56043356|NCT05448885|Cisplatin|cisplatin|mesh-list
56043357|NCT05448885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043358|NCT05448885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56043359|NCT05448885|Antimetabolites|antimetabolites|mesh-ancestor
56043360|NCT05448885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043361|NCT05448885|Antiviral Agents|antiviral agents|mesh-ancestor
56043362|NCT05448885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043363|NCT05448885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043364|NCT05448885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043365|NCT05448885|Immunologic Factors|immunologic factors|mesh-ancestor
56043366|NCT05448885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043367|NCT01547000|Guanfacine|guanfacine|mesh-list
56043368|NCT01547000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56043369|NCT01547000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56043370|NCT01547000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56043371|NCT01547000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56043372|NCT01547000|Adrenergic Agents|adrenergic agents|mesh-ancestor
56043373|NCT01547000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043374|NCT01547000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043375|NCT01547000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043376|NCT00369603|Donepezil|donepezil|mesh-list
56043401|NCT02980016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56043402|NCT02980016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043403|NCT02980016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56043404|NCT02980016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56043405|NCT02980016|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56043406|NCT02980016|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56043407|NCT02980016|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56043408|NCT02980016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56043409|NCT01493180|Rebamipide|rebamipide|mesh-list
56043410|NCT01493180|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56043411|NCT01493180|Hyaluronic Acid|hyaluronic acid|mesh-list
56043412|NCT01493180|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56043413|NCT01493180|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56043415|NCT01493180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043416|NCT01493180|Viscosupplements|viscosupplements|mesh-ancestor
56043417|NCT01493180|Protective Agents|protective agents|mesh-ancestor
56043418|NCT01493180|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56043419|NCT01493180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043420|NCT01493180|Antioxidants|antioxidants|mesh-ancestor
56043421|NCT01493180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043422|NCT01493180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043423|NCT01431014|Dexamethasone|dexamethasone|mesh-list
56043424|NCT01431014|Dexamethasone acetate|dexamethasone acetate|mesh-list
56043426|NCT01431014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56043427|NCT01431014|Antiemetics|antiemetics|mesh-ancestor
56043428|NCT01431014|Autonomic Agents|autonomic agents|mesh-ancestor
56043429|NCT01431014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043430|NCT01431014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043433|NCT01431014|Hormones|hormones|mesh-ancestor
56043448|NCT04375605|Antimitotic Agents|antimitotic agents|mesh-ancestor
56043449|NCT04375605|Mitosis Modulators|mitosis modulators|mesh-ancestor
56043450|NCT04375605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043451|NCT04375605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56043452|NCT04375605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043453|NCT04375605|Antimetabolites|antimetabolites|mesh-ancestor
56043454|NCT04375605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56043455|NCT04375605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043456|NCT04375605|Immunologic Factors|immunologic factors|mesh-ancestor
56043458|NCT04375605|Protective Agents|protective agents|mesh-ancestor
56043459|NCT04375605|Vitamin B Complex|vitamin b complex|mesh-ancestor
56043460|NCT04375605|Vitamins|vitamins|mesh-ancestor
56043461|NCT04375605|Micronutrients|micronutrients|mesh-ancestor
56043462|NCT01431170|Trimethoprim|trimethoprim|mesh-list
56043463|NCT01431170|Polymyxins|polymyxins|mesh-list
56043464|NCT01431170|Polymyxin B|polymyxin b|mesh-list
56043465|NCT01431170|Besifloxacin|besifloxacin|mesh-list
56043466|NCT01431170|Fluoroquinolones|fluoroquinolones|mesh-list
56043467|NCT01431170|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56043468|NCT01431170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043469|NCT01431170|Renal Agents|renal agents|mesh-ancestor
56043470|NCT01431170|Antimalarials|antimalarials|mesh-ancestor
56043471|NCT01431170|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56043472|NCT01431170|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56043473|NCT01431170|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56043474|NCT01431170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043475|NCT01431170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043476|NCT01431170|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56043477|NCT01431170|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56043478|NCT01431170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56043479|NCT01431170|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56043491|NCT05448183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043492|NCT05448183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043493|NCT05448183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043494|NCT05448183|Immunologic Factors|immunologic factors|mesh-ancestor
56043495|NCT05448183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043496|NCT04732455|Lidocaine|lidocaine|mesh-list
56043497|NCT04732455|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56043498|NCT04732455|Anesthetics, Local|anesthetics, local|mesh-ancestor
56043499|NCT04732455|Anesthetics|anesthetics|mesh-ancestor
56043500|NCT04732455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043501|NCT04732455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043502|NCT04732455|Sensory System Agents|sensory system agents|mesh-ancestor
56052507|NCT01803074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043503|NCT04732455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043504|NCT04732455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56043505|NCT04732455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56043506|NCT04732455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56043507|NCT04732455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56043508|NCT04732455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043509|NCT04732455|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56043510|NCT04732455|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56043511|NCT04732455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043512|NCT04732455|Analgesics|analgesics|mesh-ancestor
56043513|NCT04732455|Antidepressive Agents|antidepressive agents|mesh-ancestor
56043514|NCT04732455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56043515|NCT04732455|Dopamine Agents|dopamine agents|mesh-ancestor
56043517|NCT04306965|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56043518|NCT04306965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56043519|NCT04306965|Analgesics|analgesics|mesh-ancestor
56043520|NCT04306965|Sensory System Agents|sensory system agents|mesh-ancestor
56043523|NCT04306965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56043531|NCT01431794|Gemcitabine|gemcitabine|mesh-list
56043532|NCT01431794|Paclitaxel|paclitaxel|mesh-list
56043533|NCT01431794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56043534|NCT01431794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043535|NCT01431794|Tubulin Modulators|tubulin modulators|mesh-ancestor
56043536|NCT01431794|Antimitotic Agents|antimitotic agents|mesh-ancestor
56043537|NCT01431794|Mitosis Modulators|mitosis modulators|mesh-ancestor
56043538|NCT01431794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043539|NCT01431794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56043540|NCT01431794|Antimetabolites|antimetabolites|mesh-ancestor
56043541|NCT01431794|Antiviral Agents|antiviral agents|mesh-ancestor
56043542|NCT01431794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043543|NCT01431794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043544|NCT01431794|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043545|NCT01431794|Immunologic Factors|immunologic factors|mesh-ancestor
56043546|NCT01431794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043547|NCT01497860|Vinorelbine|vinorelbine|mesh-list
56043548|NCT01497860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56043549|NCT01497860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043550|NCT01497860|Tubulin Modulators|tubulin modulators|mesh-ancestor
56043551|NCT01497860|Antimitotic Agents|antimitotic agents|mesh-ancestor
56043552|NCT01497860|Mitosis Modulators|mitosis modulators|mesh-ancestor
56043553|NCT01497860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043554|NCT02213900|Haloperidol|haloperidol|mesh-list
56043555|NCT02213900|Haloperidol decanoate|haloperidol decanoate|mesh-list
56043556|NCT02213900|Antiemetics|antiemetics|mesh-ancestor
56043557|NCT02213900|Autonomic Agents|autonomic agents|mesh-ancestor
56043558|NCT02213900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043559|NCT02213900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043560|NCT02213900|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043561|NCT02213900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55770770|NCT02375867|Hormones|hormones|mesh-ancestor
56043562|NCT02213900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56043563|NCT02213900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043564|NCT02213900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56043565|NCT02213900|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56043566|NCT02213900|Dopamine Agents|dopamine agents|mesh-ancestor
55886964|NCT05607420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56043568|NCT02213900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043569|NCT02213900|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56043570|NCT05365893|Hydroxychloroquine|hydroxychloroquine|mesh-list
56043571|NCT05365893|Losartan|losartan|mesh-list
56043572|NCT05365893|Antimalarials|antimalarials|mesh-ancestor
56043573|NCT05365893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56043574|NCT05365893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56043575|NCT05365893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043576|NCT05365893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043577|NCT05365893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043578|NCT05365893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56043579|NCT05365893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56043580|NCT05365893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56043581|NCT05365893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56043582|NCT05365893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56043583|NCT02370888|Lenalidomide|lenalidomide|mesh-list
56043584|NCT02370888|Immunologic Factors|immunologic factors|mesh-ancestor
56043585|NCT02370888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043586|NCT02370888|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56043587|NCT02370888|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56043588|NCT02370888|Growth Substances|growth substances|mesh-ancestor
56043589|NCT02370888|Growth Inhibitors|growth inhibitors|mesh-ancestor
56043590|NCT02370888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043591|NCT05358873|Antibodies|antibodies|mesh-list
56043592|NCT05358873|Immunologic Factors|immunologic factors|mesh-ancestor
56043593|NCT05358873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043594|NCT02214290|Caffeine|caffeine|mesh-list
56043595|NCT02214290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56043596|NCT02214290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043597|NCT02214290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56043598|NCT02214290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043602|NCT02214290|Purinergic Agents|purinergic agents|mesh-ancestor
56043610|NCT04678869|Ciprofloxacin|ciprofloxacin|mesh-list
56043611|NCT04678869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043612|NCT04678869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56043613|NCT04678869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56043614|NCT04678869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043615|NCT04678869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043616|NCT04678869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043617|NCT04678869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56043618|NCT04678869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56043619|NCT04635189|Dexamethasone|dexamethasone|mesh-list
56043620|NCT04635189|Lenalidomide|lenalidomide|mesh-list
56043621|NCT04635189|Daratumumab|daratumumab|mesh-list
56043622|NCT04635189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56043623|NCT04635189|Antiemetics|antiemetics|mesh-ancestor
56043624|NCT04635189|Autonomic Agents|autonomic agents|mesh-ancestor
56043625|NCT04635189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043626|NCT04635189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043627|NCT04635189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043628|NCT04635189|Glucocorticoids|glucocorticoids|mesh-ancestor
56043629|NCT04635189|Hormones|hormones|mesh-ancestor
56043630|NCT04635189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043631|NCT04635189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56043632|NCT04635189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043633|NCT04635189|Immunologic Factors|immunologic factors|mesh-ancestor
56043634|NCT04635189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56043643|NCT01551056|Histamine Agents|histamine agents|mesh-ancestor
56043659|NCT01499498|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56043660|NCT01499498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043661|NCT01499498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043662|NCT01499498|Urological Agents|urological agents|mesh-ancestor
56043663|NCT01499654|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
56043664|NCT01499654|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56043665|NCT01499654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043667|NCT02421588|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56043668|NCT02421588|Topotecan|topotecan|mesh-list
56043669|NCT02421588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56043670|NCT02421588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043671|NCT02421588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56043672|NCT02421588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56043673|NCT02421588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043674|NCT02421588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043675|NCT02421588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56043677|NCT02768727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56043678|NCT02768727|Anesthetics, General|anesthetics, general|mesh-ancestor
56043679|NCT02768727|Anesthetics|anesthetics|mesh-ancestor
56043680|NCT02768727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043681|NCT02768727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043682|NCT02688309|Dexamethasone|dexamethasone|mesh-list
56043683|NCT02688309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56043684|NCT02688309|Antiemetics|antiemetics|mesh-ancestor
56043685|NCT02688309|Autonomic Agents|autonomic agents|mesh-ancestor
56043686|NCT02688309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043687|NCT02688309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043688|NCT02688309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56043689|NCT02688309|Glucocorticoids|glucocorticoids|mesh-ancestor
56043690|NCT02688309|Hormones|hormones|mesh-ancestor
56043691|NCT02688309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043692|NCT02688309|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56043693|NCT02688309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043694|NCT00370851|Bevacizumab|bevacizumab|mesh-list
56043697|NCT00370851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56043698|NCT00370851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56043699|NCT00370851|Growth Substances|growth substances|mesh-ancestor
56043700|NCT00370851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043701|NCT00370851|Growth Inhibitors|growth inhibitors|mesh-ancestor
56043702|NCT05124171|Vaccines|vaccines|mesh-list
56043703|NCT05124171|Immunologic Factors|immunologic factors|mesh-ancestor
56043704|NCT05124171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043705|NCT00370305|Rosiglitazone|rosiglitazone|mesh-list
56043706|NCT00370305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56043707|NCT00370305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043708|NCT00371007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56043709|NCT00371007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56043710|NCT00371007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043711|NCT00371007|Incretins|incretins|mesh-ancestor
56043712|NCT00371007|Hormones|hormones|mesh-ancestor
56043713|NCT00371007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043714|NCT00371007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56043715|NCT00371007|Protease Inhibitors|protease inhibitors|mesh-ancestor
56043716|NCT00371007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043717|NCT00371007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043718|NCT02421510|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
56043719|NCT02421510|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56043720|NCT02421510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043721|NCT02421510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56043722|NCT02421510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043723|NCT00552617|Rocuronium|rocuronium|mesh-list
56043724|NCT00552617|Vecuronium Bromide|vecuronium bromide|mesh-list
56043725|NCT00552617|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56043726|NCT00552617|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56043727|NCT00552617|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56043728|NCT00552617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043729|NCT00552617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043733|NCT00552617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043734|NCT00552617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843635|NCT03593590|Ocrelizumab|ocrelizumab|mesh-list
56043735|NCT04387305|Tranexamic Acid|tranexamic acid|mesh-list
56043736|NCT04387305|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56043737|NCT04387305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56043738|NCT04387305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043739|NCT04387305|Hemostatics|hemostatics|mesh-ancestor
56043740|NCT04387305|Coagulants|coagulants|mesh-ancestor
56043741|NCT02421120|Tazobactam|tazobactam|mesh-list
56043742|NCT02421120|Ceftolozane|ceftolozane|mesh-list
56043743|NCT02421120|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
56043744|NCT02421120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56043745|NCT02421120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043746|NCT02421120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56043747|NCT02421120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043748|NCT02421120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043749|NCT02421120|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56043750|NCT02421120|Renal Agents|renal agents|mesh-ancestor
56043751|NCT03022877|Simendan|simendan|mesh-list
56043752|NCT03022877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56043753|NCT03022877|Vasodilator Agents|vasodilator agents|mesh-ancestor
56043754|NCT03022877|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56043755|NCT03022877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56043756|NCT03022877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043757|NCT03022877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043782|NCT02520141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043784|NCT04267887|Prednisone|prednisone|mesh-list
56043785|NCT04267887|Cortisone|cortisone|mesh-list
55770988|NCT02369549|Curcumin|curcumin|mesh-list
56043786|NCT04267887|Methyltestosterone|methyltestosterone|mesh-list
56043787|NCT04267887|Abiraterone Acetate|abiraterone acetate|mesh-list
56043788|NCT04267887|Hormones|hormones|mesh-list
56043789|NCT04267887|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56043790|NCT04267887|Androgens|androgens|mesh-list
56043791|NCT04267887|Androgen Antagonists|androgen antagonists|mesh-list
56043792|NCT04267887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56043793|NCT04267887|Glucocorticoids|glucocorticoids|mesh-ancestor
56043794|NCT04267887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043795|NCT04267887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043796|NCT04267887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56043797|NCT04267887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043798|NCT04267887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56043799|NCT04267887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043800|NCT04267887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043801|NCT04267887|Hormone Antagonists|hormone antagonists|mesh-ancestor
56043802|NCT04267887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56043803|NCT04267887|Antioxidants|antioxidants|mesh-ancestor
56043804|NCT04267887|Protective Agents|protective agents|mesh-ancestor
56043805|NCT04267887|Vitamins|vitamins|mesh-ancestor
56043806|NCT04267887|Micronutrients|micronutrients|mesh-ancestor
56043807|NCT04267887|Estrogens|estrogens|mesh-ancestor
56043808|NCT04267887|Anabolic Agents|anabolic agents|mesh-ancestor
56043809|NCT00369993|Fluticasone|fluticasone|mesh-list
56043810|NCT00369993|Xhance|xhance|mesh-list
56043811|NCT00369993|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56043812|NCT00369993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56043813|NCT00369993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56043814|NCT00369993|Autonomic Agents|autonomic agents|mesh-ancestor
56043815|NCT00369993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043816|NCT00369993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043817|NCT00369993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56043818|NCT00369993|Respiratory System Agents|respiratory system agents|mesh-ancestor
56043819|NCT00369993|Dermatologic Agents|dermatologic agents|mesh-ancestor
56043821|NCT00369993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56043822|NCT00369993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56043823|NCT00369993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56043824|NCT00369993|Adrenergic Agents|adrenergic agents|mesh-ancestor
56043825|NCT00369993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043826|NCT00369993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043827|NCT00552305|Lacosamide|lacosamide|mesh-list
56043828|NCT00552305|Anticonvulsants|anticonvulsants|mesh-ancestor
55890766|NCT01893723|Remifentanil|remifentanil|mesh-list
56043829|NCT00552305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56043830|NCT00552305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56043831|NCT00552305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56043832|NCT00552305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043833|NCT02278887|Cyclophosphamide|cyclophosphamide|mesh-list
56043834|NCT02278887|Fludarabine|fludarabine|mesh-list
56043835|NCT02278887|Ipilimumab|ipilimumab|mesh-list
56043836|NCT02278887|Interleukin-2|interleukin-2|mesh-list
56043837|NCT02278887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043838|NCT02278887|Immunologic Factors|immunologic factors|mesh-ancestor
56043839|NCT02278887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043840|NCT02278887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56043841|NCT02278887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56043842|NCT02278887|Alkylating Agents|alkylating agents|mesh-ancestor
56043843|NCT02278887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043844|NCT02278887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043845|NCT02278887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56043846|NCT02278887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56043847|NCT02278887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56043848|NCT02278887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56043849|NCT02278887|Analgesics|analgesics|mesh-ancestor
55740086|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56043862|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043863|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043864|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56043865|NCT05020821|Analgesics|analgesics|mesh-ancestor
56043866|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
56043867|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043868|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56043869|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56043870|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56043871|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
56043872|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56043873|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043874|NCT04135989|Everolimus|everolimus|mesh-list
56043875|NCT04135989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043876|NCT04135989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043877|NCT04135989|Immunologic Factors|immunologic factors|mesh-ancestor
56043878|NCT04135989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043879|NCT02011971|Vinpocetine|vinpocetine|mesh-list
56043880|NCT02011971|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56043882|NCT02011971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043883|NCT02011971|Vasodilator Agents|vasodilator agents|mesh-ancestor
56043884|NCT02011971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56043885|NCT02011971|Protective Agents|protective agents|mesh-ancestor
56043886|NCT02011971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043887|NCT02011971|Nootropic Agents|nootropic agents|mesh-ancestor
56043888|NCT01854255|Cisplatin|cisplatin|mesh-list
56043889|NCT01854255|Doxorubicin|doxorubicin|mesh-list
56043897|NCT01555281|Nelfinavir|nelfinavir|mesh-list
56043908|NCT01555281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043909|NCT01555281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56043910|NCT01555281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043911|NCT01555281|Immunologic Factors|immunologic factors|mesh-ancestor
56043912|NCT01555281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56043913|NCT01555281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56043914|NCT01555281|Growth Substances|growth substances|mesh-ancestor
56043915|NCT01555281|Growth Inhibitors|growth inhibitors|mesh-ancestor
56043916|NCT01555281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56043917|NCT01555281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56043918|NCT01555281|Protease Inhibitors|protease inhibitors|mesh-ancestor
56043919|NCT01555281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043920|NCT01555281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043921|NCT01555281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56043922|NCT01555281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56043923|NCT01555281|Antiviral Agents|antiviral agents|mesh-ancestor
56043924|NCT01555281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043925|NCT04938765|Magnesium Sulfate|magnesium sulfate|mesh-list
56043926|NCT04938765|Analgesics|analgesics|mesh-ancestor
56043927|NCT04938765|Sensory System Agents|sensory system agents|mesh-ancestor
56043928|NCT04938765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56043929|NCT04938765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043930|NCT04938765|Anesthetics|anesthetics|mesh-ancestor
56043931|NCT04938765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56043932|NCT04938765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56043933|NCT04938765|Anticonvulsants|anticonvulsants|mesh-ancestor
56043934|NCT04938765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56043954|NCT00370539|Glucocorticoids|glucocorticoids|mesh-ancestor
56043955|NCT00370539|Hormones|hormones|mesh-ancestor
56043956|NCT00370539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043957|NCT00370539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56043958|NCT00370539|Immunologic Factors|immunologic factors|mesh-ancestor
56043959|NCT00370539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56043960|NCT00370539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043961|NCT00370539|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56043962|NCT00370539|Dermatologic Agents|dermatologic agents|mesh-ancestor
56043963|NCT03996057|Methenamine|methenamine|mesh-list
56043964|NCT03996057|Methenamine hippurate|methenamine hippurate|mesh-list
56043965|NCT03996057|Methenamine mandelate|methenamine mandelate|mesh-list
56043966|NCT03996057|Estrogens|estrogens|mesh-list
56043967|NCT03996057|Hormones|hormones|mesh-ancestor
56043968|NCT03996057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56043969|NCT03996057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56043970|NCT03996057|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56043971|NCT03996057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56043972|NCT03996057|Renal Agents|renal agents|mesh-ancestor
56043973|NCT03996057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56043974|NCT03150875|Docetaxel|docetaxel|mesh-list
56043975|NCT03150875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56043976|NCT03150875|Tubulin Modulators|tubulin modulators|mesh-ancestor
56043977|NCT03150875|Antimitotic Agents|antimitotic agents|mesh-ancestor
56043978|NCT03150875|Mitosis Modulators|mitosis modulators|mesh-ancestor
56043979|NCT03150875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043980|NCT04900623|Paclitaxel|paclitaxel|mesh-list
56043981|NCT04900623|Cisplatin|cisplatin|mesh-list
56043982|NCT04900623|Carboplatin|carboplatin|mesh-list
56043983|NCT04900623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56043998|NCT00673335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56043999|NCT00673335|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56044000|NCT00673335|Hormone Antagonists|hormone antagonists|mesh-ancestor
56044001|NCT00673335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044002|NCT00673335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044003|NCT00107289|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56044004|NCT00107289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044005|NCT00107289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044006|NCT00107289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044007|NCT00107289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56044008|NCT05523323|Pembrolizumab|pembrolizumab|mesh-list
55843916|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
55843917|NCT04762030|Paclitaxel|paclitaxel|mesh-list
55843918|NCT04762030|Carboplatin|carboplatin|mesh-list
55843919|NCT04762030|Durvalumab|durvalumab|mesh-list
55843920|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55843921|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843922|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
55771212|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56044010|NCT05523323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56044011|NCT05523323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044012|NCT05523323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56044013|NCT05523323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044014|NCT05523323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044015|NCT04880889|Pantothenic Acid|pantothenic acid|mesh-list
56044016|NCT04880889|Thiamine|thiamine|mesh-list
56044017|NCT04880889|Vitamin B Complex|vitamin b complex|mesh-ancestor
56044018|NCT04880889|Vitamins|vitamins|mesh-ancestor
56044019|NCT04880889|Micronutrients|micronutrients|mesh-ancestor
56044020|NCT04880889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044021|NCT03833427|Pembrolizumab|pembrolizumab|mesh-list
56044022|NCT03833427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56044023|NCT03833427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044024|NCT00551759|Docetaxel|docetaxel|mesh-list
56044025|NCT00551759|Fluorouracil|fluorouracil|mesh-list
56044026|NCT00551759|Oxaliplatin|oxaliplatin|mesh-list
56044027|NCT00551759|Cetuximab|cetuximab|mesh-list
56044028|NCT00551759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044041|NCT04849377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044050|NCT03776487|Fluorouracil|fluorouracil|mesh-list
56044051|NCT03776487|Oxaliplatin|oxaliplatin|mesh-list
56044052|NCT03776487|Nivolumab|nivolumab|mesh-list
56044053|NCT03776487|Ipilimumab|ipilimumab|mesh-list
56044054|NCT03776487|Antimetabolites|antimetabolites|mesh-ancestor
56044055|NCT03776487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044056|NCT03776487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56044057|NCT03776487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044058|NCT03776487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56044059|NCT03776487|Immunologic Factors|immunologic factors|mesh-ancestor
56044060|NCT03776487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044061|NCT03776487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56044062|NCT03776487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56044063|NCT05511779|Brincidofovir|brincidofovir|mesh-list
56044064|NCT05511779|Antiviral Agents|antiviral agents|mesh-ancestor
56044065|NCT05511779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044066|NCT00551525|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
56044067|NCT00551525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56044068|NCT00551525|Analgesics|analgesics|mesh-ancestor
56044069|NCT00551525|Sensory System Agents|sensory system agents|mesh-ancestor
56044070|NCT00551525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044071|NCT00551525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044072|NCT03716349|Anesthetics|anesthetics|mesh-list
56044073|NCT03716349|Anesthetics, Local|anesthetics, local|mesh-list
56044074|NCT03716349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044075|NCT03716349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044076|NCT03716349|Sensory System Agents|sensory system agents|mesh-ancestor
56044077|NCT03716349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044078|NCT04802031|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56044079|NCT04802031|Immunologic Factors|immunologic factors|mesh-ancestor
56044080|NCT04802031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044081|NCT05454345|Moxifloxacin|moxifloxacin|mesh-list
56044084|NCT05454345|Pyrazinamide|pyrazinamide|mesh-list
56044085|NCT05454345|Ethambutol|ethambutol|mesh-list
56044086|NCT05454345|Rifapentine|rifapentine|mesh-list
56044087|NCT05454345|Sitafloxacin|sitafloxacin|mesh-list
56044088|NCT05454345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56044089|NCT05454345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044090|NCT05454345|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56044091|NCT05454345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56044092|NCT05454345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843998|NCT01677754|Memantine|memantine|mesh-list
55843999|NCT01677754|Rivastigmine|rivastigmine|mesh-list
56044093|NCT05454345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044094|NCT05454345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044095|NCT05454345|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56044096|NCT05454345|Antitubercular Agents|antitubercular agents|mesh-ancestor
56044097|NCT05454345|Leprostatic Agents|leprostatic agents|mesh-ancestor
56044098|NCT05454345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56044099|NCT05454345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56044100|NCT05454345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56044101|NCT05454345|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56044102|NCT05454345|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56044103|NCT05454345|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56044104|NCT05454345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56044105|NCT05454345|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56044106|NCT05454345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56044107|NCT05454345|Antimetabolites|antimetabolites|mesh-ancestor
56044108|NCT05454345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56044109|NCT03558087|Gemcitabine|gemcitabine|mesh-list
56044110|NCT03558087|Nivolumab|nivolumab|mesh-list
56044111|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044112|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56044129|NCT04459611|Tubulin Modulators|tubulin modulators|mesh-ancestor
56044130|NCT04459611|Antimitotic Agents|antimitotic agents|mesh-ancestor
56044131|NCT04459611|Mitosis Modulators|mitosis modulators|mesh-ancestor
56044132|NCT04459611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044133|NCT04459611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044134|NCT04459611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56044135|NCT04459611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56044136|NCT00370617|Metformin|metformin|mesh-list
56044137|NCT00370617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56044138|NCT00370617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044139|NCT01553708|Sulfadiazine|sulfadiazine|mesh-list
56044140|NCT01553708|Silver Sulfadiazine|silver sulfadiazine|mesh-list
56044141|NCT01553708|Mitogens|mitogens|mesh-list
56044142|NCT01553708|Mitosis Modulators|mitosis modulators|mesh-ancestor
56044143|NCT01553708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044144|NCT01553708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56044145|NCT01553708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044146|NCT01553708|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56044147|NCT01553708|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56044148|NCT01553708|Coccidiostats|coccidiostats|mesh-ancestor
56044149|NCT01553708|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56044150|NCT02370498|Paclitaxel|paclitaxel|mesh-list
56044151|NCT02370498|Pembrolizumab|pembrolizumab|mesh-list
56044152|NCT02370498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56044153|NCT02370498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044154|NCT02370498|Tubulin Modulators|tubulin modulators|mesh-ancestor
56044155|NCT02370498|Antimitotic Agents|antimitotic agents|mesh-ancestor
56044156|NCT02370498|Mitosis Modulators|mitosis modulators|mesh-ancestor
56044157|NCT02370498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044158|NCT02370498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56044159|NCT01554488|Fluticasone|fluticasone|mesh-list
56044161|NCT01554488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56044162|NCT01554488|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56044163|NCT01554488|Autonomic Agents|autonomic agents|mesh-ancestor
55879726|NCT04567992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879727|NCT04567992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879728|NCT04567992|Sensory System Agents|sensory system agents|mesh-ancestor
55879729|NCT04567992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879730|NCT01335724|Diclofenac|diclofenac|mesh-list
55771362|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
56044165|NCT01554488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044166|NCT01554488|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56044167|NCT01554488|Respiratory System Agents|respiratory system agents|mesh-ancestor
56044168|NCT01554488|Dermatologic Agents|dermatologic agents|mesh-ancestor
56044169|NCT01554488|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56044170|NCT04293393|Paclitaxel|paclitaxel|mesh-list
55844198|NCT01688739|Erenumab|erenumab|mesh-list
56044171|NCT04293393|Docetaxel|docetaxel|mesh-list
56044172|NCT04293393|Cyclophosphamide|cyclophosphamide|mesh-list
56044173|NCT04293393|Doxorubicin|doxorubicin|mesh-list
56044174|NCT04293393|Letrozole|letrozole|mesh-list
56044175|NCT04293393|Leuprolide|leuprolide|mesh-list
56044176|NCT04293393|Goserelin|goserelin|mesh-list
56044178|NCT04293393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56044179|NCT04293393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044180|NCT04293393|Tubulin Modulators|tubulin modulators|mesh-ancestor
56044181|NCT04293393|Antimitotic Agents|antimitotic agents|mesh-ancestor
56044182|NCT04293393|Mitosis Modulators|mitosis modulators|mesh-ancestor
56044183|NCT04293393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044184|NCT04293393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56044185|NCT04293393|Immunologic Factors|immunologic factors|mesh-ancestor
56044186|NCT04293393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044187|NCT04293393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56044188|NCT04293393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56044189|NCT04293393|Alkylating Agents|alkylating agents|mesh-ancestor
56044215|NCT02347332|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56044216|NCT02347332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56044217|NCT02347332|Immunologic Factors|immunologic factors|mesh-ancestor
56044218|NCT02347332|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56044219|NCT02347332|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56044221|NCT01502306|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56044222|NCT01502306|Autonomic Agents|autonomic agents|mesh-ancestor
56044223|NCT01502306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044224|NCT01502306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044225|NCT01502306|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56044226|NCT01502306|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56044227|NCT01502306|Cholinergic Agents|cholinergic agents|mesh-ancestor
56044228|NCT01502306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044229|NCT01502306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044230|NCT03325959|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56044231|NCT03325959|Analgesics|analgesics|mesh-ancestor
56044232|NCT03325959|Sensory System Agents|sensory system agents|mesh-ancestor
56044233|NCT03325959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044234|NCT03325959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044235|NCT03325959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044236|NCT03325959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044237|NCT03325959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56044238|NCT03325959|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56044239|NCT03325959|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56044240|NCT03325959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044241|NCT03325959|Antidepressive Agents|antidepressive agents|mesh-ancestor
56044242|NCT03325959|Dopamine Agents|dopamine agents|mesh-ancestor
56044260|NCT05451381|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56044261|NCT05451381|Adrenergic Agents|adrenergic agents|mesh-ancestor
56044262|NCT05451381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044263|NCT05451381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044265|NCT05450913|Anesthetics, Local|anesthetics, local|mesh-list
56044266|NCT05450913|Anesthetics|anesthetics|mesh-list
56044267|NCT05450913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044268|NCT05450913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044269|NCT05450913|Sensory System Agents|sensory system agents|mesh-ancestor
56044270|NCT05450913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044271|NCT05450913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56044272|NCT05450913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56044273|NCT05450913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56044274|NCT05450913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044275|NCT05450913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044276|NCT05446779|Hydrocortisone|hydrocortisone|mesh-list
56044277|NCT05446779|Epinephrine|epinephrine|mesh-list
56044278|NCT05446779|Racepinephrine|racepinephrine|mesh-list
56044279|NCT05446779|Epinephryl borate|epinephryl borate|mesh-list
56044280|NCT05446779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56044281|NCT05446779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56044282|NCT05446779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56044283|NCT05446779|Adrenergic Agents|adrenergic agents|mesh-ancestor
56044285|NCT05446779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044297|NCT02215070|Hormones|hormones|mesh-ancestor
56044306|NCT02347098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
56044307|NCT02347098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56044308|NCT02347098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56044309|NCT02347098|Antimetabolites|antimetabolites|mesh-ancestor
56044310|NCT02347098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044311|NCT02347098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56044312|NCT02347098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044313|NCT03708237|Gabapentin|gabapentin|mesh-list
56044314|NCT03708237|Ropinirole|ropinirole|mesh-list
56044315|NCT03708237|Analgesics|analgesics|mesh-ancestor
56044316|NCT03708237|Sensory System Agents|sensory system agents|mesh-ancestor
56044317|NCT03708237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044318|NCT03708237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044319|NCT03708237|Anticonvulsants|anticonvulsants|mesh-ancestor
56044320|NCT03708237|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56044321|NCT03708237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56044322|NCT03708237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044323|NCT03708237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56044324|NCT03708237|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56044325|NCT03708237|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56044326|NCT03708237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044327|NCT03708237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044328|NCT03708237|Antimanic Agents|antimanic agents|mesh-ancestor
56044329|NCT03708237|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56044330|NCT03708237|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56044331|NCT03708237|Dopamine Agonists|dopamine agonists|mesh-ancestor
56044332|NCT03708237|Dopamine Agents|dopamine agents|mesh-ancestor
56044333|NCT04895592|Dexamethasone|dexamethasone|mesh-list
56044353|NCT01556594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56044354|NCT01556594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044355|NCT01556594|Hormones|hormones|mesh-ancestor
56044356|NCT01556594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044357|NCT01556594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044358|NCT01556594|Incretins|incretins|mesh-ancestor
56044359|NCT00371319|Mycophenolic Acid|mycophenolic acid|mesh-list
56044360|NCT00371319|Tacrolimus|tacrolimus|mesh-list
56044361|NCT00371319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56044362|NCT00371319|Immunologic Factors|immunologic factors|mesh-ancestor
56044363|NCT00371319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044364|NCT00371319|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56044365|NCT00371319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044366|NCT00371319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044368|NCT00371319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044369|NCT00371319|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56044370|NCT00371319|Antitubercular Agents|antitubercular agents|mesh-ancestor
56044371|NCT00371319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56044372|NCT00371319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044373|NCT01439672|Insulin|insulin|mesh-list
56044374|NCT01439672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56044375|NCT01439672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044376|NCT03465111|Hormones|hormones|mesh-list
56044377|NCT03465111|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56044378|NCT03465111|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56044379|NCT03465111|beta-Endorphin|beta-endorphin|mesh-list
56044380|NCT03465111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044381|NCT03465111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044399|NCT02209610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56044400|NCT02209610|Narcotics|narcotics|mesh-ancestor
56044401|NCT02209610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044402|NCT02209610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044404|NCT02209610|Sensory System Agents|sensory system agents|mesh-ancestor
56044405|NCT02209610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044406|NCT02209610|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56044407|NCT02209610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56044408|NCT02209610|Anesthetics, General|anesthetics, general|mesh-ancestor
56044409|NCT02209610|Anesthetics|anesthetics|mesh-ancestor
56044410|NCT01441076|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56044411|NCT01441076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56044412|NCT05244993|Paclitaxel|paclitaxel|mesh-list
56044413|NCT05244993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56044414|NCT05244993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044415|NCT05244993|Tubulin Modulators|tubulin modulators|mesh-ancestor
56044416|NCT05244993|Antimitotic Agents|antimitotic agents|mesh-ancestor
56044417|NCT05244993|Mitosis Modulators|mitosis modulators|mesh-ancestor
56044418|NCT05244993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044419|NCT03289299|Dexamethasone|dexamethasone|mesh-list
56044420|NCT03289299|Lenalidomide|lenalidomide|mesh-list
56044421|NCT03289299|Daratumumab|daratumumab|mesh-list
56044422|NCT03289299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56044423|NCT03289299|Antiemetics|antiemetics|mesh-ancestor
56044424|NCT03289299|Autonomic Agents|autonomic agents|mesh-ancestor
56044425|NCT03289299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044426|NCT03289299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044427|NCT03289299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044428|NCT03289299|Glucocorticoids|glucocorticoids|mesh-ancestor
56044429|NCT03289299|Hormones|hormones|mesh-ancestor
56044430|NCT03289299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044442|NCT01558700|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56044443|NCT01558700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56044444|NCT01558700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044445|NCT01558700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044446|NCT01558700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044447|NCT01558700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044448|NCT01558700|Analgesics|analgesics|mesh-ancestor
56044449|NCT01558700|Sensory System Agents|sensory system agents|mesh-ancestor
56044450|NCT01558700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044451|NCT01558700|Antidepressive Agents|antidepressive agents|mesh-ancestor
56044452|NCT01558700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56044453|NCT01558700|Dopamine Agents|dopamine agents|mesh-ancestor
56044454|NCT02757105|Ondansetron|ondansetron|mesh-list
56044455|NCT02757105|Antiemetics|antiemetics|mesh-ancestor
56044456|NCT02757105|Autonomic Agents|autonomic agents|mesh-ancestor
56044457|NCT02757105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044458|NCT02757105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044459|NCT02757105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044460|NCT02757105|Antipruritics|antipruritics|mesh-ancestor
55771665|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
56044462|NCT02757105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56044463|NCT02757105|Serotonin Agents|serotonin agents|mesh-ancestor
56044464|NCT02757105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044465|NCT02757105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044466|NCT02757105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56044467|NCT02757105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56044489|NCT05071833|Autonomic Agents|autonomic agents|mesh-ancestor
56044490|NCT05071833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044491|NCT05071833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044492|NCT05071833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044493|NCT05071833|Parasympatholytics|parasympatholytics|mesh-ancestor
56044494|NCT02892201|Pembrolizumab|pembrolizumab|mesh-list
56044495|NCT02892201|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56044496|NCT02892201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044497|NCT01507220|Morphine|morphine|mesh-list
56044498|NCT01507220|Bupivacaine|bupivacaine|mesh-list
56044499|NCT01507220|Anesthetics, Local|anesthetics, local|mesh-ancestor
56044500|NCT01507220|Anesthetics|anesthetics|mesh-ancestor
56044501|NCT01507220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044502|NCT01507220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044503|NCT01507220|Sensory System Agents|sensory system agents|mesh-ancestor
56044504|NCT01507220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044505|NCT01507220|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56044506|NCT01507220|Narcotics|narcotics|mesh-ancestor
56044507|NCT01507220|Analgesics|analgesics|mesh-ancestor
56044508|NCT01509404|Valganciclovir|valganciclovir|mesh-list
56044509|NCT01509404|Antiviral Agents|antiviral agents|mesh-ancestor
56044510|NCT01509404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044511|NCT01562132|Fluconazole|fluconazole|mesh-list
56044512|NCT01562132|Flucytosine|flucytosine|mesh-list
56044513|NCT01562132|Antifungal Agents|antifungal agents|mesh-ancestor
56044514|NCT01562132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044515|NCT01562132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56044516|NCT01562132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56044517|NCT01562132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044518|NCT01562132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044519|NCT01562132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56044533|NCT02762799|Lenograstim|lenograstim|mesh-list
56044534|NCT02762799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56044535|NCT02762799|Immunologic Factors|immunologic factors|mesh-ancestor
56044537|NCT01447706|Paclitaxel|paclitaxel|mesh-list
56044538|NCT01447706|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56044539|NCT01447706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044540|NCT01447706|Tubulin Modulators|tubulin modulators|mesh-ancestor
56044541|NCT01447706|Antimitotic Agents|antimitotic agents|mesh-ancestor
56044542|NCT01447706|Mitosis Modulators|mitosis modulators|mesh-ancestor
56044543|NCT01447706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044544|NCT01509638|Bupivacaine|bupivacaine|mesh-list
56044545|NCT01509638|Anesthetics, Local|anesthetics, local|mesh-ancestor
56044546|NCT01509638|Anesthetics|anesthetics|mesh-ancestor
56044547|NCT01509638|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044548|NCT01509638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044549|NCT01509638|Sensory System Agents|sensory system agents|mesh-ancestor
56044550|NCT01509638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044551|NCT04336917|Lidocaine|lidocaine|mesh-list
56044552|NCT04336917|Bupivacaine|bupivacaine|mesh-list
56044553|NCT04336917|Anesthetics, Local|anesthetics, local|mesh-list
56044554|NCT04336917|Anesthetics|anesthetics|mesh-list
56044555|NCT04336917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044556|NCT04336917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044557|NCT04336917|Sensory System Agents|sensory system agents|mesh-ancestor
56044558|NCT04336917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044559|NCT04336917|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56044560|NCT04336917|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56044561|NCT04336917|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56044562|NCT04336917|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044563|NCT04336917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044564|NCT01448486|Raltegravir Potassium|raltegravir potassium|mesh-list
56044565|NCT01448486|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56044577|NCT01562678|Hormones|hormones|mesh-ancestor
56044578|NCT01562678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044579|NCT02767869|Magnesium Oxide|magnesium oxide|mesh-list
56044580|NCT02767869|Antacids|antacids|mesh-ancestor
56044581|NCT02767869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044582|NCT02767869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044583|NCT01449266|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
56044585|NCT01449266|Sequestering Agents|sequestering agents|mesh-ancestor
56044586|NCT01449266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044587|NCT02767947|Luliconazole|luliconazole|mesh-list
56044588|NCT02767947|Antifungal Agents|antifungal agents|mesh-ancestor
56044589|NCT02767947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044590|NCT02770365|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56044591|NCT02770365|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56044592|NCT02770365|Estradiol|estradiol|mesh-list
56044593|NCT02770365|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56044594|NCT02770365|Estrogens|estrogens|mesh-ancestor
56044595|NCT02770365|Hormones|hormones|mesh-ancestor
55844624|NCT01610336|Gefitinib|gefitinib|mesh-list
56044596|NCT02770365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044597|NCT02770365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044598|NCT02770365|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56044602|NCT02770521|Insulin Lispro|insulin lispro|mesh-list
56044626|NCT01511978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044627|NCT02772783|Insulin|insulin|mesh-list
56044628|NCT02772783|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56044629|NCT02772783|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56044630|NCT02772783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044631|NCT02774343|Pioglitazone|pioglitazone|mesh-list
56044632|NCT02774343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56044633|NCT02774343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044634|NCT05349045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
56044635|NCT05349045|Antibodies|antibodies|mesh-list
56044636|NCT05349045|Immunologic Factors|immunologic factors|mesh-ancestor
56044637|NCT05349045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044638|NCT05349045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56044639|NCT05349045|Growth Substances|growth substances|mesh-ancestor
56044640|NCT05349045|Growth Inhibitors|growth inhibitors|mesh-ancestor
56044641|NCT05349045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044642|NCT02392104|Warfarin|warfarin|mesh-list
56044643|NCT02392104|Anticoagulants|anticoagulants|mesh-ancestor
56044644|NCT04336605|Analgesics|analgesics|mesh-list
56044645|NCT04336605|Sensory System Agents|sensory system agents|mesh-ancestor
56044646|NCT04336605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044647|NCT04336605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044648|NCT01450826|Ondansetron|ondansetron|mesh-list
56044649|NCT01450826|Aprepitant|aprepitant|mesh-list
56044650|NCT01450826|Antiemetics|antiemetics|mesh-ancestor
56044651|NCT01450826|Autonomic Agents|autonomic agents|mesh-ancestor
56044652|NCT01450826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044653|NCT01450826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044654|NCT01450826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044655|NCT01450826|Antipruritics|antipruritics|mesh-ancestor
56044656|NCT01450826|Dermatologic Agents|dermatologic agents|mesh-ancestor
56044657|NCT01450826|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56044658|NCT01450826|Serotonin Agents|serotonin agents|mesh-ancestor
56044659|NCT01450826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044661|NCT01450826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56044667|NCT05349903|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56044668|NCT05349903|Antioxidants|antioxidants|mesh-ancestor
56044669|NCT05349903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044670|NCT05349903|Protective Agents|protective agents|mesh-ancestor
56044671|NCT05349903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044672|NCT05349903|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56044673|NCT05349903|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56044674|NCT05349903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044675|NCT05349903|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56044676|NCT05349825|Losartan|losartan|mesh-list
56044677|NCT05349825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56044678|NCT05349825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56044679|NCT05349825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56044680|NCT05349825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56044681|NCT05349825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044682|NCT01451996|Loratadine|loratadine|mesh-list
56044683|NCT01451996|Antipruritics|antipruritics|mesh-ancestor
56044684|NCT01451996|Dermatologic Agents|dermatologic agents|mesh-ancestor
56044685|NCT01451996|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56044686|NCT01451996|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56044687|NCT01451996|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56044688|NCT01451996|Histamine Antagonists|histamine antagonists|mesh-ancestor
56044689|NCT01451996|Histamine Agents|histamine agents|mesh-ancestor
56044690|NCT01451996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886965|NCT05607420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044691|NCT01451996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044692|NCT01451996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044693|NCT01512446|Alendronate|alendronate|mesh-list
56044694|NCT01512446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56044695|NCT01512446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044696|NCT04334967|Ascorbic Acid|ascorbic acid|mesh-list
56044711|NCT04335123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56044712|NCT04335123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56044713|NCT04335123|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56044714|NCT04335123|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56044715|NCT04335123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044716|NCT05453565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56044717|NCT02742987|Clopidogrel|clopidogrel|mesh-list
56044718|NCT02742987|Ticagrelor|ticagrelor|mesh-list
56044719|NCT02742987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56044720|NCT02742987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56044721|NCT02742987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56044722|NCT02742987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56044723|NCT02742987|Purinergic Agents|purinergic agents|mesh-ancestor
56044724|NCT02742987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044725|NCT02742987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044726|NCT02742987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044727|NCT05450055|Lidocaine|lidocaine|mesh-list
56044728|NCT05450055|Analgesics|analgesics|mesh-list
56044729|NCT05450055|Anesthetics, Local|anesthetics, local|mesh-ancestor
56044730|NCT05450055|Anesthetics|anesthetics|mesh-ancestor
56044731|NCT05450055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044732|NCT05450055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044733|NCT05450055|Sensory System Agents|sensory system agents|mesh-ancestor
56044734|NCT05450055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044735|NCT05450055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56044736|NCT05450055|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56044737|NCT05450055|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56044738|NCT05450055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044739|NCT05450055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044740|NCT02743377|Rolipram|rolipram|mesh-list
56044751|NCT05437965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044752|NCT05437965|Immunologic Factors|immunologic factors|mesh-ancestor
56044753|NCT00372099|Calcitonin|calcitonin|mesh-list
56044754|NCT00372099|Salmon calcitonin|salmon calcitonin|mesh-list
56044755|NCT00372099|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56044756|NCT00372099|Katacalcin|katacalcin|mesh-list
56044757|NCT00372099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56044758|NCT00372099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044759|NCT00372099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56044760|NCT00372099|Vasodilator Agents|vasodilator agents|mesh-ancestor
56044761|NCT02748525|Cholecystokinin|cholecystokinin|mesh-list
56044762|NCT02748525|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56044763|NCT02748525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044764|NCT01454414|Permethrin|permethrin|mesh-list
56044765|NCT01454414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56044766|NCT01454414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044767|NCT04335513|Insulin|insulin|mesh-list
56044768|NCT04335513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56044769|NCT04335513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044770|NCT05263557|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56044771|NCT05263557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56044772|NCT05263557|Immunologic Factors|immunologic factors|mesh-ancestor
56044773|NCT05263557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044774|NCT01568528|Oxytocin|oxytocin|mesh-list
56044775|NCT01568528|Oxytocics|oxytocics|mesh-ancestor
56044800|NCT01461824|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56044801|NCT01461824|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56044802|NCT01461824|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56044803|NCT01461824|Contraceptive Agents|contraceptive agents|mesh-ancestor
56044804|NCT01461824|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56044806|NCT01461824|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56044807|NCT01461824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56044808|NCT01461824|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56044809|NCT01461824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56044810|NCT01461824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044812|NCT04080843|Oxaliplatin|oxaliplatin|mesh-list
56044813|NCT04080843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56044814|NCT04080843|Antimetabolites|antimetabolites|mesh-ancestor
56044815|NCT04080843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044816|NCT04080843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044817|NCT04737837|Lacosamide|lacosamide|mesh-list
56044818|NCT04737837|Anticonvulsants|anticonvulsants|mesh-ancestor
56044819|NCT04737837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56044820|NCT04737837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56044821|NCT04737837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044822|NCT04737837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044823|NCT04826133|Calcitriol|calcitriol|mesh-list
56044824|NCT04826133|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56044825|NCT04826133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56044846|NCT02369874|Tremelimumab|tremelimumab|mesh-list
56044847|NCT02369874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56044848|NCT02369874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56044849|NCT02369874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044850|NCT02369874|Immunologic Factors|immunologic factors|mesh-ancestor
56044851|NCT02369874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044852|NCT00372645|Folic Acid|folic acid|mesh-list
56044853|NCT00372645|Hematinics|hematinics|mesh-ancestor
56044854|NCT00372645|Vitamin B Complex|vitamin b complex|mesh-ancestor
56044855|NCT00372645|Vitamins|vitamins|mesh-ancestor
56044856|NCT00372645|Micronutrients|micronutrients|mesh-ancestor
56044857|NCT00372645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044858|NCT00372723|Infliximab|infliximab|mesh-list
56044859|NCT00372723|Dermatologic Agents|dermatologic agents|mesh-ancestor
56044860|NCT00372723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56044861|NCT00372723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56044862|NCT00372801|Ibuprofen|ibuprofen|mesh-list
56044863|NCT00372801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56044864|NCT00372801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56044865|NCT00372801|Analgesics|analgesics|mesh-ancestor
56044866|NCT00372801|Sensory System Agents|sensory system agents|mesh-ancestor
56044867|NCT00372801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044868|NCT00372801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044869|NCT00372801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56044900|NCT00373503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56044901|NCT00373503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56044903|NCT00373503|Sensory System Agents|sensory system agents|mesh-ancestor
56044904|NCT00373503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55772110|NCT02342093|Drospirenone|drospirenone|mesh-list
56044905|NCT00373503|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56044906|NCT00373503|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56044907|NCT00373503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044908|NCT00373503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044909|NCT00373503|Hormones|hormones|mesh-ancestor
56044910|NCT00373503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56044911|NCT00373503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56044912|NCT00373503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56044913|NCT00373503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56044914|NCT00373503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56044915|NCT00373503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56044916|NCT00373503|Adrenergic Agents|adrenergic agents|mesh-ancestor
56044917|NCT02633397|Riociguat|riociguat|mesh-list
56044918|NCT02633397|Enzyme Activators|enzyme activators|mesh-ancestor
56044919|NCT02633397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044920|NCT01515176|Ofatumumab|ofatumumab|mesh-list
56044921|NCT01515176|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56044922|NCT01515176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044923|NCT01515176|Immunologic Factors|immunologic factors|mesh-ancestor
56044924|NCT01515176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044925|NCT02581527|Rifampin|rifampin|mesh-list
56044926|NCT02581527|Isoniazid|isoniazid|mesh-list
56044927|NCT02581527|Pyrazinamide|pyrazinamide|mesh-list
56044928|NCT02581527|Ethambutol|ethambutol|mesh-list
56044929|NCT02581527|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56044930|NCT02581527|Antitubercular Agents|antitubercular agents|mesh-ancestor
56044931|NCT02581527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56044932|NCT02581527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56044933|NCT02581527|Leprostatic Agents|leprostatic agents|mesh-ancestor
56044938|NCT02581527|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56044939|NCT02581527|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56044940|NCT02581527|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56044941|NCT02581527|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56044942|NCT02581527|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56044943|NCT02581527|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56044944|NCT02581527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56044945|NCT02581527|Antimetabolites|antimetabolites|mesh-ancestor
56044946|NCT02581527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56044947|NCT01515410|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56044948|NCT01515410|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56044949|NCT01515410|Immunologic Factors|immunologic factors|mesh-ancestor
56044950|NCT01515410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044951|NCT01515410|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56044952|NCT01515410|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56044953|NCT01515410|Dopamine Agonists|dopamine agonists|mesh-ancestor
56044954|NCT01515410|Dopamine Agents|dopamine agents|mesh-ancestor
56044955|NCT01515410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56044956|NCT01515410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044957|NCT01515566|Fentanyl|fentanyl|mesh-list
56044958|NCT01515566|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56044959|NCT01515566|Narcotics|narcotics|mesh-ancestor
56044960|NCT01515566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044961|NCT01515566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044962|NCT01515566|Analgesics|analgesics|mesh-ancestor
56044963|NCT01515566|Sensory System Agents|sensory system agents|mesh-ancestor
56044964|NCT01515566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044965|NCT01515566|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56044966|NCT01515566|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56044967|NCT01515566|Anesthetics, General|anesthetics, general|mesh-ancestor
56044968|NCT01515566|Anesthetics|anesthetics|mesh-ancestor
56044969|NCT02522715|Prednisone|prednisone|mesh-list
56044970|NCT02522715|Cortisone|cortisone|mesh-list
56044971|NCT02522715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56044972|NCT02522715|Glucocorticoids|glucocorticoids|mesh-ancestor
56044973|NCT02522715|Hormones|hormones|mesh-ancestor
56044976|NCT02522715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56044977|NCT02522715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56044978|NCT02453373|Magnesium Sulfate|magnesium sulfate|mesh-list
55772201|NCT02345993|Hormones|hormones|mesh-ancestor
56044979|NCT02453373|Plasminogen|plasminogen|mesh-list
56044980|NCT02453373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56044981|NCT02453373|Propofol|propofol|mesh-list
56044982|NCT02453373|Etomidate|etomidate|mesh-list
56044983|NCT02453373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56044984|NCT02453373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56044985|NCT02453373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56044986|NCT02453373|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56044987|NCT02453373|Anesthetics, General|anesthetics, general|mesh-ancestor
56044988|NCT02453373|Anesthetics|anesthetics|mesh-ancestor
56044989|NCT02453373|Analgesics|analgesics|mesh-ancestor
56044990|NCT02453373|Sensory System Agents|sensory system agents|mesh-ancestor
56044991|NCT02453373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56044992|NCT02453373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56044993|NCT02453373|Anticonvulsants|anticonvulsants|mesh-ancestor
56044994|NCT02453373|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56044995|NCT02453373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56044996|NCT02453373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56044997|NCT02453373|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56044998|NCT02453373|Tocolytic Agents|tocolytic agents|mesh-ancestor
56044999|NCT02453373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56045000|NCT02453373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56045001|NCT02453373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56045002|NCT00708045|Deoxyglucose|deoxyglucose|mesh-list
56045003|NCT00708045|Antimetabolites|antimetabolites|mesh-ancestor
56045004|NCT00708045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045016|NCT01516268|Sufentanil|sufentanil|mesh-list
56045019|NCT01516268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045020|NCT01516268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045021|NCT01516268|Analgesics|analgesics|mesh-ancestor
56045022|NCT01516268|Sensory System Agents|sensory system agents|mesh-ancestor
56045023|NCT01516268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045024|NCT01516268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56045025|NCT01516268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56045026|NCT01516268|Anesthetics, General|anesthetics, general|mesh-ancestor
56045027|NCT01516268|Anesthetics|anesthetics|mesh-ancestor
56045028|NCT05440968|Chrysarobin|chrysarobin|mesh-list
56045029|NCT05440968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56045030|NCT05440968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56045031|NCT05440968|Analgesics|analgesics|mesh-ancestor
56045032|NCT05440968|Sensory System Agents|sensory system agents|mesh-ancestor
56045033|NCT05440968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045034|NCT05440968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045035|NCT05440968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045036|NCT05440968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045037|NCT01516424|Risperidone|risperidone|mesh-list
56045076|NCT02787057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56045077|NCT02787057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045078|NCT02787057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045079|NCT02787057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045080|NCT01972347|Trametinib|trametinib|mesh-list
56045081|NCT01972347|Dabrafenib|dabrafenib|mesh-list
56045082|NCT01972347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045083|NCT01972347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56045084|NCT01972347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045085|NCT01972347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045086|NCT01468532|Prednisone|prednisone|mesh-list
56045087|NCT01468532|Docetaxel|docetaxel|mesh-list
56045088|NCT01468532|Pasireotide|pasireotide|mesh-list
56045089|NCT01468532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045090|NCT01468532|Tubulin Modulators|tubulin modulators|mesh-ancestor
56045091|NCT01468532|Antimitotic Agents|antimitotic agents|mesh-ancestor
56045092|NCT01468532|Mitosis Modulators|mitosis modulators|mesh-ancestor
56045093|NCT01468532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045095|NCT01468532|Glucocorticoids|glucocorticoids|mesh-ancestor
56045096|NCT01468532|Hormones|hormones|mesh-ancestor
56045097|NCT01468532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56045098|NCT01468532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045099|NCT01468532|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56045100|NCT05062317|Leucovorin|leucovorin|mesh-list
56045101|NCT05062317|Bevacizumab|bevacizumab|mesh-list
56045102|NCT05062317|Fluorouracil|fluorouracil|mesh-list
56045103|NCT05062317|Capecitabine|capecitabine|mesh-list
56045128|NCT01469234|Terfenadine|terfenadine|mesh-list
56045129|NCT01469234|Antipruritics|antipruritics|mesh-ancestor
56045130|NCT01469234|Dermatologic Agents|dermatologic agents|mesh-ancestor
56045131|NCT01469234|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56045132|NCT01469234|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56045133|NCT01469234|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56045134|NCT01469234|Histamine Antagonists|histamine antagonists|mesh-ancestor
56045135|NCT01469234|Histamine Agents|histamine agents|mesh-ancestor
56045136|NCT01469234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045137|NCT01469234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045138|NCT01469234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045139|NCT05045937|Vitamin D|vitamin d|mesh-list
56045140|NCT05045937|Vitamins|vitamins|mesh-list
56045141|NCT05045937|Ivermectin|ivermectin|mesh-list
56045142|NCT05045937|Remdesivir|remdesivir|mesh-list
56045144|NCT05045937|Budesonide|budesonide|mesh-list
56045145|NCT05045937|Melatonin|melatonin|mesh-list
56045146|NCT05045937|Albuterol|albuterol|mesh-list
56045147|NCT05045937|Quercetin|quercetin|mesh-list
56045148|NCT05045937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045149|NCT05045937|Micronutrients|micronutrients|mesh-ancestor
56045150|NCT05045937|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56045151|NCT05045937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56045152|NCT05045937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56045153|NCT05045937|Analgesics|analgesics|mesh-ancestor
56045154|NCT05045937|Sensory System Agents|sensory system agents|mesh-ancestor
56045155|NCT05045937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045156|NCT05045937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045157|NCT05045937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045158|NCT05045937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045159|NCT05045937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56045160|NCT05045937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045161|NCT05045937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56045162|NCT05045937|Autonomic Agents|autonomic agents|mesh-ancestor
56045163|NCT05045937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56045164|NCT05045937|Respiratory System Agents|respiratory system agents|mesh-ancestor
56045165|NCT05045937|Glucocorticoids|glucocorticoids|mesh-ancestor
56045166|NCT05045937|Hormones|hormones|mesh-ancestor
56045167|NCT05045937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56045168|NCT05045937|Antioxidants|antioxidants|mesh-ancestor
56045169|NCT05045937|Protective Agents|protective agents|mesh-ancestor
56045170|NCT05045937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045171|NCT05045937|Tocolytic Agents|tocolytic agents|mesh-ancestor
56045172|NCT05045937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56045173|NCT05045937|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56045174|NCT05045937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56045175|NCT05045937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56045176|NCT05045937|Adrenergic Agents|adrenergic agents|mesh-ancestor
56045177|NCT05045937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045178|NCT05045937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56045179|NCT05045937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045180|NCT05045937|Antimetabolites|antimetabolites|mesh-ancestor
56045181|NCT05045937|Antiviral Agents|antiviral agents|mesh-ancestor
56045183|NCT00373581|Vigabatrin|vigabatrin|mesh-list
56045184|NCT00373581|Anesthetics, Local|anesthetics, local|mesh-ancestor
56045185|NCT00373581|Anesthetics|anesthetics|mesh-ancestor
56045186|NCT00373581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045187|NCT00373581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045188|NCT00373581|Sensory System Agents|sensory system agents|mesh-ancestor
56045189|NCT00373581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045190|NCT00373581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56045191|NCT00373581|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56045192|NCT00373581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56045193|NCT00373581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56045194|NCT00373581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045195|NCT00373581|Dopamine Agents|dopamine agents|mesh-ancestor
56045196|NCT00373581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045197|NCT00373581|Anticonvulsants|anticonvulsants|mesh-ancestor
56045198|NCT00373581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045199|NCT00373581|GABA Agents|gaba agents|mesh-ancestor
56045200|NCT01470170|Alfentanil|alfentanil|mesh-list
56045201|NCT01470170|Propofol|propofol|mesh-list
56045202|NCT01470170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56045203|NCT01470170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045204|NCT01470170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045205|NCT01470170|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56045206|NCT01470170|Anesthetics, General|anesthetics, general|mesh-ancestor
56045207|NCT01470170|Anesthetics|anesthetics|mesh-ancestor
56045208|NCT01470170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56045209|NCT01470170|Narcotics|narcotics|mesh-ancestor
56045210|NCT01470170|Analgesics|analgesics|mesh-ancestor
56045211|NCT01470170|Sensory System Agents|sensory system agents|mesh-ancestor
56045212|NCT01470170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045213|NCT04311567|Methotrexate|methotrexate|mesh-list
56045214|NCT04311567|Tofacitinib|tofacitinib|mesh-list
56045215|NCT04311567|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56045216|NCT04311567|Abortifacient Agents|abortifacient agents|mesh-ancestor
56045217|NCT04311567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56045266|NCT01472432|Vildagliptin|vildagliptin|mesh-list
56045267|NCT01472432|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56045268|NCT01472432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045269|NCT01472432|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56045270|NCT01472432|Protease Inhibitors|protease inhibitors|mesh-ancestor
56045271|NCT01472432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045272|NCT01472432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045273|NCT04251117|Pembrolizumab|pembrolizumab|mesh-list
56045274|NCT04251117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56045275|NCT04251117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045276|NCT01524302|Levofloxacin|levofloxacin|mesh-list
56045278|NCT01524302|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56045279|NCT01524302|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56045280|NCT01524302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045281|NCT01524302|Renal Agents|renal agents|mesh-ancestor
56045282|NCT01524302|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56045283|NCT01524302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56045284|NCT01524302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56045285|NCT01524302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045286|NCT01524302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045287|NCT01524302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045288|NCT01524302|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56045289|NCT01524302|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56045290|NCT04958811|Bevacizumab|bevacizumab|mesh-list
56045291|NCT04958811|Atezolizumab|atezolizumab|mesh-list
56045292|NCT04958811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56045293|NCT04958811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045294|NCT04958811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56045295|NCT04958811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56045296|NCT04958811|Growth Substances|growth substances|mesh-ancestor
56045297|NCT04958811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045306|NCT02802111|Tocolytic Agents|tocolytic agents|mesh-ancestor
56045307|NCT02802111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56045308|NCT02802111|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56045309|NCT02802111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56045310|NCT02802111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56045311|NCT02802111|Adrenergic Agents|adrenergic agents|mesh-ancestor
56045312|NCT02802111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045313|NCT02802111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045314|NCT04164069|Calcium, Dietary|calcium, dietary|mesh-list
56045315|NCT04164069|Leucovorin|leucovorin|mesh-list
56045316|NCT04164069|Folic Acid|folic acid|mesh-list
56045317|NCT04164069|Bevacizumab|bevacizumab|mesh-list
56045318|NCT04164069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56045319|NCT04164069|Fluorouracil|fluorouracil|mesh-list
56045320|NCT04164069|Oxaliplatin|oxaliplatin|mesh-list
56045369|NCT01577966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045370|NCT01577966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045371|NCT01577966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045372|NCT01577966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045373|NCT01577966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56045374|NCT02802501|Primaquine|primaquine|mesh-list
56045375|NCT02802501|Piperaquine|piperaquine|mesh-list
56045376|NCT02802501|Artenimol|artenimol|mesh-list
56045377|NCT02802501|Tafenoquine|tafenoquine|mesh-list
56045378|NCT02802501|Antimalarials|antimalarials|mesh-ancestor
56045379|NCT02802501|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56045380|NCT02802501|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56045381|NCT02802501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045382|NCT01528592|Levodopa|levodopa|mesh-list
56045383|NCT01528592|Carbidopa|carbidopa|mesh-list
56045384|NCT01528592|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56045385|NCT01528592|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56045386|NCT01528592|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56045387|NCT01528592|Dopamine Agents|dopamine agents|mesh-ancestor
56045388|NCT01528592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045389|NCT01528592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045390|NCT01528592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045427|NCT00372879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045428|NCT00372879|Protective Agents|protective agents|mesh-ancestor
56045429|NCT02806869|Ibuprofen|ibuprofen|mesh-list
56045430|NCT02806869|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56045431|NCT02806869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56045432|NCT02806869|Analgesics|analgesics|mesh-ancestor
56045433|NCT02806869|Sensory System Agents|sensory system agents|mesh-ancestor
56045434|NCT02806869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045435|NCT02806869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045436|NCT02806869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045437|NCT02806869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045438|NCT02806869|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56045439|NCT02806869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045440|NCT02806869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045441|NCT03910101|Botulinum Toxins|botulinum toxins|mesh-list
56045442|NCT03910101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56045443|NCT03910101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56045444|NCT03910101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045445|NCT03910101|Cholinergic Agents|cholinergic agents|mesh-ancestor
56045446|NCT03910101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045447|NCT03910101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045448|NCT02813265|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56045449|NCT02813265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56045450|NCT05564858|Antibodies|antibodies|mesh-list
56045474|NCT00373659|Growth Inhibitors|growth inhibitors|mesh-ancestor
56045475|NCT00373659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045476|NCT02885025|Fluticasone|fluticasone|mesh-list
56045477|NCT02885025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045478|NCT02885025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56045479|NCT02885025|Autonomic Agents|autonomic agents|mesh-ancestor
56045480|NCT02885025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045481|NCT02885025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045482|NCT02885025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56045483|NCT02885025|Respiratory System Agents|respiratory system agents|mesh-ancestor
56045484|NCT02885025|Dermatologic Agents|dermatologic agents|mesh-ancestor
56045485|NCT02885025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56045486|NCT01580618|Tenecteplase|tenecteplase|mesh-list
56045487|NCT01580618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56045488|NCT01580618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56045489|NCT01580618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045490|NCT01581710|Montelukast|montelukast|mesh-list
56045491|NCT01581710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56045492|NCT01581710|Respiratory System Agents|respiratory system agents|mesh-ancestor
56045493|NCT01581710|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56045528|NCT02818569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56045529|NCT02818569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56045530|NCT02818569|Adrenergic Agents|adrenergic agents|mesh-ancestor
56045531|NCT02818569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045532|NCT02818569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045533|NCT03581409|Aspirin|aspirin|mesh-list
56045534|NCT03581409|Cilostazol|cilostazol|mesh-list
56045535|NCT03581409|Clopidogrel|clopidogrel|mesh-list
56045536|NCT03581409|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56045537|NCT03581409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56045538|NCT03581409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56045539|NCT03581409|Analgesics|analgesics|mesh-ancestor
56045540|NCT03581409|Sensory System Agents|sensory system agents|mesh-ancestor
56045541|NCT03581409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045542|NCT03581409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045543|NCT03581409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045544|NCT03581409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045545|NCT03581409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56045546|NCT03581409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56045547|NCT03581409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045548|NCT03581409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56045549|NCT03581409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56045550|NCT03581409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045551|NCT03581409|Antipyretics|antipyretics|mesh-ancestor
56045552|NCT03581409|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56045553|NCT03581409|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56045554|NCT03581409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56045555|NCT03581409|Purinergic Agents|purinergic agents|mesh-ancestor
56045556|NCT03581409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045557|NCT03581409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56045558|NCT03581409|Autonomic Agents|autonomic agents|mesh-ancestor
56045559|NCT03581409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56045560|NCT03581409|Respiratory System Agents|respiratory system agents|mesh-ancestor
56045567|NCT03566667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56045568|NCT03566667|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56045569|NCT03566667|Sympatholytics|sympatholytics|mesh-ancestor
56045570|NCT03566667|Autonomic Agents|autonomic agents|mesh-ancestor
56045571|NCT03566667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045572|NCT03566667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045573|NCT03566667|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56045574|NCT03566667|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56045575|NCT03566667|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56045576|NCT03566667|Adrenergic Agents|adrenergic agents|mesh-ancestor
56045577|NCT03566667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045578|NCT03566667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045579|NCT01533116|Levodopa|levodopa|mesh-list
56045580|NCT01533116|Carbidopa|carbidopa|mesh-list
56045581|NCT01533116|Opicapone|opicapone|mesh-list
56045582|NCT01533116|Benserazide|benserazide|mesh-list
56045583|NCT01533116|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56045584|NCT01533116|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56045585|NCT01533116|Dopamine Agents|dopamine agents|mesh-ancestor
56045586|NCT01533116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772775|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045587|NCT01533116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045589|NCT01533116|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56045590|NCT01533116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045591|NCT01533116|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56045592|NCT03510741|Acetylcysteine|acetylcysteine|mesh-list
56045593|NCT03510741|Sodium Benzoate|sodium benzoate|mesh-list
56045594|NCT03510741|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56045595|NCT03510741|Antiviral Agents|antiviral agents|mesh-ancestor
56045596|NCT03510741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045597|NCT03510741|Expectorants|expectorants|mesh-ancestor
56045610|NCT05556044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045611|NCT01584518|Furosemide|furosemide|mesh-list
56045612|NCT01584518|Diuretics|diuretics|mesh-ancestor
56045613|NCT01584518|Natriuretic Agents|natriuretic agents|mesh-ancestor
56045614|NCT01584518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045615|NCT01584518|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56045616|NCT01584518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56045617|NCT01584518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045618|NCT02901249|Lithium Carbonate|lithium carbonate|mesh-list
56045619|NCT02901249|Sertraline|sertraline|mesh-list
56045620|NCT02901249|Nortriptyline|nortriptyline|mesh-list
56045621|NCT02901249|Antidepressive Agents|antidepressive agents|mesh-ancestor
56045622|NCT02901249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56045623|NCT02901249|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56045624|NCT02901249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56045625|NCT02901249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56045626|NCT02901249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045627|NCT02901249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045628|NCT02901249|Serotonin Agents|serotonin agents|mesh-ancestor
56045629|NCT02901249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045630|NCT02901249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045631|NCT02901249|Antimanic Agents|antimanic agents|mesh-ancestor
56045632|NCT02901249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56045633|NCT02901249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045634|NCT02901249|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56045635|NCT02901249|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56045636|NCT02901249|Adrenergic Agents|adrenergic agents|mesh-ancestor
56045637|NCT02212028|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55879731|NCT01335724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55879732|NCT01335724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879733|NCT01335724|Analgesics|analgesics|mesh-ancestor
55879735|NCT01335724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879736|NCT01335724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879737|NCT01335724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879738|NCT01335724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879739|NCT01335724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55879740|NCT01335724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879741|NCT01335724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879742|NCT01476202|Nicotine|nicotine|mesh-list
56045638|NCT02212028|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56045640|NCT00373815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045641|NCT00373815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56045642|NCT00373815|Immunologic Factors|immunologic factors|mesh-ancestor
56045643|NCT00373815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045644|NCT01586312|Hyaluronic Acid|hyaluronic acid|mesh-list
56045645|NCT01586312|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56045646|NCT01586312|Immunologic Factors|immunologic factors|mesh-ancestor
56045647|NCT01586312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045648|NCT01586312|Viscosupplements|viscosupplements|mesh-ancestor
56045649|NCT01586312|Protective Agents|protective agents|mesh-ancestor
56045650|NCT00373893|Lidocaine|lidocaine|mesh-list
56045651|NCT00373893|Anesthetics, Local|anesthetics, local|mesh-ancestor
56045652|NCT00373893|Anesthetics|anesthetics|mesh-ancestor
56045653|NCT00373893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045654|NCT00373893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045655|NCT00373893|Sensory System Agents|sensory system agents|mesh-ancestor
56045693|NCT02903121|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56045694|NCT02903121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045695|NCT02903121|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56045696|NCT02903121|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56045697|NCT02903121|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56045698|NCT02638701|Infliximab|infliximab|mesh-list
56045699|NCT02638701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56045700|NCT02638701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56045701|NCT02638701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045702|NCT02904915|Lidocaine|lidocaine|mesh-list
56045703|NCT02904915|Anesthetics, Local|anesthetics, local|mesh-ancestor
56045704|NCT02904915|Anesthetics|anesthetics|mesh-ancestor
56045705|NCT02904915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045706|NCT02904915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045707|NCT02904915|Sensory System Agents|sensory system agents|mesh-ancestor
56045708|NCT02904915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045709|NCT02904915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56045710|NCT02904915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56045711|NCT02904915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56045712|NCT02904915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56045713|NCT02904915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045714|NCT02907489|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56045715|NCT02907489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56045716|NCT02907489|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045717|NCT02278185|Leuprolide|leuprolide|mesh-list
56045718|NCT02278185|Goserelin|goserelin|mesh-list
56045719|NCT02278185|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56045720|NCT02278185|Tryptophan|tryptophan|mesh-list
56045721|NCT02278185|Androgens|androgens|mesh-list
56045722|NCT02278185|Hormones|hormones|mesh-ancestor
56045723|NCT02278185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56045724|NCT02278185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045725|NCT02278185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56045726|NCT02278185|Fertility Agents|fertility agents|mesh-ancestor
55879743|NCT01476202|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55879744|NCT01476202|Autonomic Agents|autonomic agents|mesh-ancestor
55879745|NCT01476202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879746|NCT01476202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879748|NCT01476202|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56045727|NCT02278185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56045728|NCT02278185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56045729|NCT02278185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045730|NCT02278185|Luteolytic Agents|luteolytic agents|mesh-ancestor
56045731|NCT02278185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56045732|NCT02278185|Contraceptive Agents|contraceptive agents|mesh-ancestor
56045733|NCT02278185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56045734|NCT02278185|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56045735|NCT02278185|Antidepressive Agents|antidepressive agents|mesh-ancestor
56045736|NCT02278185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56045737|NCT01535924|Gemcitabine|gemcitabine|mesh-list
56045738|NCT01535924|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56045751|NCT02909439|Neostigmine|neostigmine|mesh-list
56045788|NCT02060721|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56045789|NCT01588418|Exenatide|exenatide|mesh-list
56045790|NCT01588418|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56045791|NCT01588418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045792|NCT01588418|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56045793|NCT01588418|Incretins|incretins|mesh-ancestor
56045794|NCT01588418|Hormones|hormones|mesh-ancestor
56045795|NCT01588418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56045796|NCT03007160|Potassium Citrate|potassium citrate|mesh-list
56045797|NCT03007160|Diuretics|diuretics|mesh-ancestor
56045798|NCT03007160|Natriuretic Agents|natriuretic agents|mesh-ancestor
56045799|NCT03007160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045800|NCT03007160|Expectorants|expectorants|mesh-ancestor
56045801|NCT03007160|Respiratory System Agents|respiratory system agents|mesh-ancestor
56045802|NCT03007004|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
56045803|NCT03007004|Botulinum Toxins|botulinum toxins|mesh-list
56045804|NCT03007004|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55890767|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55845738|NCT04398004|Clarithromycin|clarithromycin|mesh-list
55772996|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56045805|NCT03007004|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56045806|NCT03007004|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56045807|NCT03007004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56045808|NCT03007004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045809|NCT03007004|Cholinergic Agents|cholinergic agents|mesh-ancestor
56045810|NCT03007004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045811|NCT03007004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045812|NCT03007004|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56045813|NCT03007004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045814|NCT03007004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56045815|NCT02914119|Rocuronium|rocuronium|mesh-list
56045816|NCT02914119|Mivacurium|mivacurium|mesh-list
56045817|NCT02914119|Cisatracurium|cisatracurium|mesh-list
56045818|NCT02914119|Succinylcholine|succinylcholine|mesh-list
56045819|NCT02914119|Neostigmine|neostigmine|mesh-list
56045835|NCT01589510|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56045836|NCT01589510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56045837|NCT02914509|Travoprost|travoprost|mesh-list
56045838|NCT02914509|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56045839|NCT02840097|Tranexamic Acid|tranexamic acid|mesh-list
56045840|NCT02840097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56045841|NCT02840097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56045842|NCT02840097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045843|NCT02840097|Hemostatics|hemostatics|mesh-ancestor
56045844|NCT02840097|Coagulants|coagulants|mesh-ancestor
56045845|NCT02841033|Daratumumab|daratumumab|mesh-list
56045846|NCT02841033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045853|NCT02988089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56045882|NCT02988089|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56045883|NCT02988089|Alkylating Agents|alkylating agents|mesh-ancestor
56045884|NCT02430233|Progesterone|progesterone|mesh-list
56045885|NCT02430233|Progestins|progestins|mesh-ancestor
56045886|NCT02430233|Hormones|hormones|mesh-ancestor
56045887|NCT02430233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56045888|NCT02430233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045889|NCT01589978|Aspirin|aspirin|mesh-list
56045890|NCT01589978|Salicylic Acid|salicylic acid|mesh-list
56045891|NCT01589978|Salicylates|salicylates|mesh-list
56045892|NCT01589978|Ticlopidine|ticlopidine|mesh-list
56045893|NCT01589978|Clopidogrel|clopidogrel|mesh-list
56045894|NCT01589978|Ticagrelor|ticagrelor|mesh-list
56045895|NCT01589978|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56045896|NCT01589978|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56045897|NCT01589978|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56045898|NCT01589978|Analgesics|analgesics|mesh-ancestor
56045899|NCT01589978|Sensory System Agents|sensory system agents|mesh-ancestor
56045900|NCT01589978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045901|NCT01589978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045902|NCT01589978|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045903|NCT01589978|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56045904|NCT01589978|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56045905|NCT01589978|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56045906|NCT01589978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045907|NCT01589978|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56045908|NCT01589978|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56045909|NCT01589978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045911|NCT01589978|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56045912|NCT01589978|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56045913|NCT01589978|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56045914|NCT01589978|Purinergic Agents|purinergic agents|mesh-ancestor
56045915|NCT01589978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56045922|NCT02417285|Obinutuzumab|obinutuzumab|mesh-list
56045924|NCT02417285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045926|NCT01592006|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56045927|NCT01592006|Antimetabolites|antimetabolites|mesh-ancestor
56045928|NCT01592006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045929|NCT01592006|Antiviral Agents|antiviral agents|mesh-ancestor
56045930|NCT01592006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045931|NCT00551291|Mycophenolic Acid|mycophenolic acid|mesh-list
56045932|NCT00551291|Prednisone|prednisone|mesh-list
56045933|NCT00551291|Epoetin Alfa|epoetin alfa|mesh-list
56045934|NCT00551291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045935|NCT00551291|Glucocorticoids|glucocorticoids|mesh-ancestor
56045936|NCT00551291|Hormones|hormones|mesh-ancestor
56045937|NCT00551291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56045938|NCT00551291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045939|NCT00551291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56045940|NCT00551291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56045941|NCT00551291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56045942|NCT00551291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56045943|NCT00551291|Antitubercular Agents|antitubercular agents|mesh-ancestor
56045944|NCT00551291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56045945|NCT00551291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045946|NCT00551291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045947|NCT00551291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045948|NCT00551291|Hematinics|hematinics|mesh-ancestor
56045949|NCT02981264|Lidocaine|lidocaine|mesh-list
56045950|NCT02981264|Anesthetics, Local|anesthetics, local|mesh-ancestor
56045951|NCT02981264|Anesthetics|anesthetics|mesh-ancestor
56045952|NCT02981264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56045953|NCT02981264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045954|NCT02981264|Sensory System Agents|sensory system agents|mesh-ancestor
56045955|NCT02981264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045956|NCT02981264|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56045957|NCT02981264|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56045958|NCT02981264|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55773144|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55879749|NCT01476202|Cholinergic Agents|cholinergic agents|mesh-ancestor
56045960|NCT02981264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045962|NCT05470985|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56045963|NCT05470985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045964|NCT05470985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56045965|NCT05470985|Immunologic Factors|immunologic factors|mesh-ancestor
56045966|NCT05470985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045967|NCT01593722|Ivermectin|ivermectin|mesh-list
56045968|NCT01593722|Diethylcarbamazine|diethylcarbamazine|mesh-list
56045969|NCT01593722|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56045970|NCT01593722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56045971|NCT01593722|Filaricides|filaricides|mesh-ancestor
56045972|NCT01593722|Antinematodal Agents|antinematodal agents|mesh-ancestor
56045973|NCT01593722|Anthelmintics|anthelmintics|mesh-ancestor
56045974|NCT01593722|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56045975|NCT01593722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56045976|NCT01593722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56045977|NCT01594424|Immunoglobulins|immunoglobulins|mesh-list
56045978|NCT01594424|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56045979|NCT01594424|Antibodies|antibodies|mesh-list
56045980|NCT01594424|gamma-Globulins|gamma-globulins|mesh-list
56045981|NCT01594424|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56045982|NCT01594424|Immunologic Factors|immunologic factors|mesh-ancestor
56045983|NCT01594424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045985|NCT01595282|Ketorolac|ketorolac|mesh-list
56045986|NCT01595282|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56045987|NCT01595282|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56045988|NCT01595282|Analgesics|analgesics|mesh-ancestor
56045989|NCT01595282|Sensory System Agents|sensory system agents|mesh-ancestor
56045990|NCT01595282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56045991|NCT01595282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56045992|NCT01595282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56045993|NCT01595282|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56046002|NCT01595516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046003|NCT01595516|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56046004|NCT01595516|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56046005|NCT01595516|Sympatholytics|sympatholytics|mesh-ancestor
56046006|NCT01595516|Autonomic Agents|autonomic agents|mesh-ancestor
56046007|NCT01595516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046008|NCT01595516|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56046009|NCT01595516|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56046010|NCT01595516|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56046011|NCT01595516|Adrenergic Agents|adrenergic agents|mesh-ancestor
56046012|NCT01595516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046013|NCT01595516|Vasodilator Agents|vasodilator agents|mesh-ancestor
56046014|NCT01595516|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56046015|NCT01595516|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56046016|NCT01595516|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56046017|NCT01595516|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56046018|NCT01595516|Protease Inhibitors|protease inhibitors|mesh-ancestor
56046019|NCT01595516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046020|NCT01596842|Cholecalciferol|cholecalciferol|mesh-list
56046021|NCT01596842|Vitamin D|vitamin d|mesh-list
56046022|NCT01596842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56046023|NCT01596842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046024|NCT01596842|Vitamins|vitamins|mesh-ancestor
56046025|NCT01596842|Micronutrients|micronutrients|mesh-ancestor
56046026|NCT01596842|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56046027|NCT02217800|Octreotide|octreotide|mesh-list
56046028|NCT02217800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046029|NCT02217800|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55790613|NCT02996305|Gaboxadol|gaboxadol|mesh-list
56046030|NCT02217800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879750|NCT01476202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879751|NCT01476202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879752|NCT01477762|Dexamethasone|dexamethasone|mesh-list
55879753|NCT01477762|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879754|NCT01477762|Antiemetics|antiemetics|mesh-ancestor
55879755|NCT01477762|Autonomic Agents|autonomic agents|mesh-ancestor
55879756|NCT01477762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879757|NCT01477762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879758|NCT01477762|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55879759|NCT01477762|Glucocorticoids|glucocorticoids|mesh-ancestor
55879760|NCT01477762|Hormones|hormones|mesh-ancestor
55879761|NCT01477762|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55879762|NCT01477762|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55879763|NCT01477762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879764|NCT01434472|Vidarabine|vidarabine|mesh-list
55879765|NCT01434472|Cyclosporine|cyclosporine|mesh-list
56046032|NCT02218190|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046033|NCT03006614|Gemcitabine|gemcitabine|mesh-list
56046034|NCT03006614|Cisplatin|cisplatin|mesh-list
55773220|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
56046035|NCT03006614|Docetaxel|docetaxel|mesh-list
56046036|NCT03006614|Capecitabine|capecitabine|mesh-list
56046037|NCT03006614|Trastuzumab|trastuzumab|mesh-list
56046038|NCT03006614|Vinorelbine|vinorelbine|mesh-list
56046039|NCT03006614|Epirubicin|epirubicin|mesh-list
56046040|NCT03006614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046041|NCT03006614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56046042|NCT03006614|Antimetabolites|antimetabolites|mesh-ancestor
56046043|NCT03006614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046044|NCT03006614|Antiviral Agents|antiviral agents|mesh-ancestor
56046045|NCT03006614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046046|NCT03006614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046047|NCT03006614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56046048|NCT03006614|Immunologic Factors|immunologic factors|mesh-ancestor
56046049|NCT03006614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046050|NCT03006614|Tubulin Modulators|tubulin modulators|mesh-ancestor
56046051|NCT03006614|Antimitotic Agents|antimitotic agents|mesh-ancestor
56046052|NCT03006614|Mitosis Modulators|mitosis modulators|mesh-ancestor
56046053|NCT03006614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56046054|NCT03006614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56046055|NCT03006614|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56046056|NCT03006614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56046057|NCT03006614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56046058|NCT03001466|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56046059|NCT03001466|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56046061|NCT03006380|Oxytocics|oxytocics|mesh-ancestor
56046062|NCT03006380|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56046063|NCT03006380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046064|NCT02981030|Misoprostol|misoprostol|mesh-list
56046065|NCT02981030|Mifepristone|mifepristone|mesh-list
56046066|NCT02981030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56046067|NCT02981030|Abortifacient Agents|abortifacient agents|mesh-ancestor
56046068|NCT02981030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879766|NCT01434472|Mycophenolic Acid|mycophenolic acid|mesh-list
56046070|NCT02981030|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56046071|NCT02981030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046072|NCT02981030|Oxytocics|oxytocics|mesh-ancestor
56046073|NCT02981030|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56046074|NCT02981030|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56046075|NCT02981030|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56046076|NCT02981030|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56046077|NCT02981030|Contraceptive Agents|contraceptive agents|mesh-ancestor
56046078|NCT02981030|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56046079|NCT02981030|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56046080|NCT02981030|Hormone Antagonists|hormone antagonists|mesh-ancestor
56046081|NCT02981030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046082|NCT02981030|Luteolytic Agents|luteolytic agents|mesh-ancestor
56046083|NCT02981030|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56046084|NCT02981030|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56046085|NCT03006146|Molgramostim|molgramostim|mesh-list
56046086|NCT03006146|Sargramostim|sargramostim|mesh-list
56046087|NCT03006146|Immunologic Factors|immunologic factors|mesh-ancestor
56046088|NCT03006146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046089|NCT03006146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046090|NCT00551213|Capecitabine|capecitabine|mesh-list
56046092|NCT00551213|Cetuximab|cetuximab|mesh-list
56046093|NCT00551213|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56046094|NCT00551213|Antimetabolites|antimetabolites|mesh-ancestor
56046095|NCT00551213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046096|NCT00551213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046097|NCT00551213|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56046098|NCT00551213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56046099|NCT00551213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046100|NCT00551213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56046110|NCT01999361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046111|NCT01999361|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56046112|NCT01999361|Antitubercular Agents|antitubercular agents|mesh-ancestor
56046113|NCT01999361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56046114|NCT01999361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046115|NCT01999361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046116|NCT01999361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046118|NCT03006471|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56046119|NCT03006471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046120|NCT03006471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56046121|NCT03006471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046122|NCT01684397|Bevacizumab|bevacizumab|mesh-list
56046123|NCT01684397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56046124|NCT01684397|Endothelial Growth Factors|endothelial growth factors|mesh-list
56046125|NCT01684397|Antibodies|antibodies|mesh-list
56046126|NCT01684397|Immunoglobulins|immunoglobulins|mesh-list
56046127|NCT01684397|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56046128|NCT01684397|Immunoglobulin G|immunoglobulin g|mesh-list
56046129|NCT01684397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046130|NCT01684397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56046131|NCT01684397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56046132|NCT01684397|Growth Substances|growth substances|mesh-ancestor
56046133|NCT01684397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046134|NCT01684397|Growth Inhibitors|growth inhibitors|mesh-ancestor
56046135|NCT01684397|Immunologic Factors|immunologic factors|mesh-ancestor
56046136|NCT03005678|Denosumab|denosumab|mesh-list
56046137|NCT03005678|Alendronate|alendronate|mesh-list
56046138|NCT03005678|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56046139|NCT03005678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046140|NCT03008889|Acetylcysteine|acetylcysteine|mesh-list
56046141|NCT03008889|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56046142|NCT03008889|Antiviral Agents|antiviral agents|mesh-ancestor
56046143|NCT03008889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046144|NCT03008889|Expectorants|expectorants|mesh-ancestor
56046147|NCT03008889|Antioxidants|antioxidants|mesh-ancestor
56046150|NCT03008889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046152|NCT04980482|Interferons|interferons|mesh-list
56046153|NCT04980482|Interferon-alpha|interferon-alpha|mesh-list
56046154|NCT04980482|Interferon alpha-2|interferon alpha-2|mesh-list
56046155|NCT04980482|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56046156|NCT04980482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046157|NCT04980482|Antiviral Agents|antiviral agents|mesh-ancestor
56046158|NCT04980482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046159|NCT04980482|Immunologic Factors|immunologic factors|mesh-ancestor
56046160|NCT04980482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046161|NCT03005210|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56046162|NCT03005210|Antiviral Agents|antiviral agents|mesh-ancestor
56046163|NCT03005210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046164|NCT03000218|Metformin|metformin|mesh-list
56046165|NCT03000218|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56046166|NCT03000218|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56046167|NCT03000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046169|NCT03000218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046170|NCT03010683|Metformin|metformin|mesh-list
56046171|NCT03010683|Liraglutide|liraglutide|mesh-list
56046172|NCT03010683|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56046173|NCT03010683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046174|NCT03010683|Incretins|incretins|mesh-ancestor
56046175|NCT03010683|Hormones|hormones|mesh-ancestor
56046176|NCT03010683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046181|NCT02918097|Sertraline|sertraline|mesh-list
56046200|NCT02918097|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56046201|NCT02918097|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56046202|NCT02918097|Adrenergic Agents|adrenergic agents|mesh-ancestor
56046204|NCT05408585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046205|NCT05408585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046206|NCT02999204|Vitamin D|vitamin d|mesh-list
56046207|NCT02999204|Cholecalciferol|cholecalciferol|mesh-list
56046208|NCT02999204|Vitamins|vitamins|mesh-ancestor
56046209|NCT02999204|Micronutrients|micronutrients|mesh-ancestor
56046210|NCT02999204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046211|NCT02999204|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56046212|NCT02999204|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56046213|NCT03012477|Adavosertib|adavosertib|mesh-list
56046214|NCT03012477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046215|NCT03012477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046216|NCT02919111|Edetic Acid|edetic acid|mesh-list
56046217|NCT02919111|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56046218|NCT02919111|Chelating Agents|chelating agents|mesh-ancestor
56046219|NCT02919111|Sequestering Agents|sequestering agents|mesh-ancestor
56046220|NCT02919111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046221|NCT02919111|Anticoagulants|anticoagulants|mesh-ancestor
56046222|NCT02919111|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56046223|NCT02919111|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56046224|NCT04725188|Docetaxel|docetaxel|mesh-list
56046225|NCT04725188|Pembrolizumab|pembrolizumab|mesh-list
56046226|NCT04725188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046227|NCT04725188|Tubulin Modulators|tubulin modulators|mesh-ancestor
56046228|NCT04725188|Antimitotic Agents|antimitotic agents|mesh-ancestor
56046229|NCT04725188|Mitosis Modulators|mitosis modulators|mesh-ancestor
56046230|NCT04725188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046231|NCT04725188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56046232|NCT02999126|Remifentanil|remifentanil|mesh-list
56046233|NCT02999126|Propofol|propofol|mesh-list
56046234|NCT02999126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56046235|NCT02999126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046236|NCT02999126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046238|NCT02999126|Anesthetics, General|anesthetics, general|mesh-ancestor
56046239|NCT02999126|Anesthetics|anesthetics|mesh-ancestor
56046240|NCT02999126|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56046241|NCT02999126|Narcotics|narcotics|mesh-ancestor
56046242|NCT02999126|Analgesics|analgesics|mesh-ancestor
56046243|NCT02999126|Sensory System Agents|sensory system agents|mesh-ancestor
56046244|NCT02999126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046245|NCT03019887|Methotrimeprazine|methotrimeprazine|mesh-list
56046246|NCT03019887|Haloperidol|haloperidol|mesh-list
56046247|NCT03019887|Olanzapine|olanzapine|mesh-list
56046248|NCT03019887|Risperidone|risperidone|mesh-list
56046249|NCT03019887|Aripiprazole|aripiprazole|mesh-list
56046250|NCT03019887|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56046251|NCT03019887|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56046252|NCT03019887|Haloperidol decanoate|haloperidol decanoate|mesh-list
56046253|NCT03019887|Perphenazine|perphenazine|mesh-list
56046254|NCT03019887|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56046255|NCT03019887|Serotonin Agents|serotonin agents|mesh-ancestor
56046256|NCT03019887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046257|NCT03019887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046258|NCT03019887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046259|NCT03019887|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56046260|NCT03019887|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56046261|NCT03019887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046262|NCT03019887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56046263|NCT03019887|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56046264|NCT03019887|Dopamine Agents|dopamine agents|mesh-ancestor
56046265|NCT03019887|Antiemetics|antiemetics|mesh-ancestor
56046266|NCT03019887|Autonomic Agents|autonomic agents|mesh-ancestor
56046267|NCT03019887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046268|NCT03019887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046269|NCT03019887|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56046270|NCT03019887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56046272|NCT03019887|Antidepressive Agents|antidepressive agents|mesh-ancestor
56046281|NCT03019887|Sensory System Agents|sensory system agents|mesh-ancestor
56046283|NCT02998970|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56046284|NCT02998970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046285|NCT02998970|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56046286|NCT02998970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046287|NCT05406752|Acetaminophen|acetaminophen|mesh-list
56046288|NCT05406752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56046289|NCT05406752|Analgesics|analgesics|mesh-ancestor
56046290|NCT05406752|Sensory System Agents|sensory system agents|mesh-ancestor
56046291|NCT05406752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046292|NCT05406752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046293|NCT05406752|Antipyretics|antipyretics|mesh-ancestor
56046295|NCT02247362|Hemagglutinins|hemagglutinins|mesh-list
56046296|NCT02247362|Immunologic Factors|immunologic factors|mesh-ancestor
56046297|NCT02247362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046298|NCT02247362|Agglutinins|agglutinins|mesh-ancestor
56046299|NCT02920749|Anesthetics|anesthetics|mesh-list
55773524|NCT04593563|Psilocybin|psilocybin|mesh-list
56046340|NCT02921061|Mitoxantrone|mitoxantrone|mesh-list
56046341|NCT02921061|Cladribine|cladribine|mesh-list
56046342|NCT02921061|Lenograstim|lenograstim|mesh-list
56046343|NCT02921061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56046344|NCT02921061|Antimetabolites|antimetabolites|mesh-ancestor
56046345|NCT02921061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046346|NCT02921061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046347|NCT02921061|Antiviral Agents|antiviral agents|mesh-ancestor
56046348|NCT02921061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046349|NCT02921061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56046350|NCT02921061|Immunologic Factors|immunologic factors|mesh-ancestor
56046351|NCT02921061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046352|NCT02921061|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56046353|NCT02921061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046354|NCT02921061|Analgesics|analgesics|mesh-ancestor
56046355|NCT02921061|Sensory System Agents|sensory system agents|mesh-ancestor
56046356|NCT02921061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046357|NCT02921061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56046358|NCT02921061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56046359|NCT05310422|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56046360|NCT05310422|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56046361|NCT03004118|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56046362|NCT03004118|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56046363|NCT03004118|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046364|NCT03004196|Chlorhexidine|chlorhexidine|mesh-list
56046365|NCT03004196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56046366|NCT03004196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046367|NCT03004196|Disinfectants|disinfectants|mesh-ancestor
56046368|NCT02281409|Mogamulizumab|mogamulizumab|mesh-list
56046369|NCT02281409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046370|NCT04523480|Methyltestosterone|methyltestosterone|mesh-list
56046371|NCT04523480|Testosterone|testosterone|mesh-list
55879767|NCT01434472|Rituximab|rituximab|mesh-list
55879768|NCT01434472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55879769|NCT01434472|Fludarabine|fludarabine|mesh-list
55879770|NCT01434472|Fludarabine phosphate|fludarabine phosphate|mesh-list
55879771|NCT01434472|Antibodies|antibodies|mesh-list
55879772|NCT01434472|Immunoglobulins|immunoglobulins|mesh-list
55879773|NCT01434472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55879774|NCT01434472|Cyclosporins|cyclosporins|mesh-list
55879775|NCT01434472|Immunologic Factors|immunologic factors|mesh-ancestor
56046372|NCT04523480|Testosterone undecanoate|testosterone undecanoate|mesh-list
56046373|NCT04523480|Testosterone enanthate|testosterone enanthate|mesh-list
56046374|NCT04523480|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56046375|NCT04523480|Androgens|androgens|mesh-ancestor
56046376|NCT04523480|Hormones|hormones|mesh-ancestor
56046377|NCT04523480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046378|NCT04523480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046379|NCT04523480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56046380|NCT04523480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046382|NCT05200442|Cetuximab|cetuximab|mesh-list
56046383|NCT05200442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56046384|NCT05200442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046385|NCT02859441|Ranibizumab|ranibizumab|mesh-list
56046386|NCT02859441|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56046387|NCT02859441|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56046388|NCT02859441|Growth Substances|growth substances|mesh-ancestor
56046389|NCT02859441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046390|NCT02859441|Growth Inhibitors|growth inhibitors|mesh-ancestor
56046391|NCT02859441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046392|NCT01880099|Galantamine|galantamine|mesh-list
56046393|NCT01880099|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
56046394|NCT01880099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046395|NCT01880099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046396|NCT01880099|Cholinergic Agents|cholinergic agents|mesh-ancestor
56046397|NCT01880099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046398|NCT01880099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046399|NCT01880099|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56046400|NCT01880099|Autonomic Agents|autonomic agents|mesh-ancestor
56046401|NCT01880099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046402|NCT01880099|Nootropic Agents|nootropic agents|mesh-ancestor
56046403|NCT05183204|Metformin|metformin|mesh-list
56046404|NCT05183204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55879776|NCT01434472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879777|NCT01434472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879778|NCT01434472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55879779|NCT01434472|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55879780|NCT01434472|Antimetabolites|antimetabolites|mesh-ancestor
55750787|NCT03120923|Lidocaine|lidocaine|mesh-list
55879781|NCT01434472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879782|NCT01434472|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56046405|NCT05183204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046406|NCT04287803|Methoxyflurane|methoxyflurane|mesh-list
56046407|NCT04287803|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56046408|NCT04287803|Anesthetics, General|anesthetics, general|mesh-ancestor
56046409|NCT04287803|Anesthetics|anesthetics|mesh-ancestor
56046410|NCT04287803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046411|NCT04287803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046412|NCT02860845|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56046413|NCT02860845|Clindamycin|clindamycin|mesh-list
56046414|NCT02860845|Clindamycin palmitate|clindamycin palmitate|mesh-list
55773597|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
56046415|NCT02860845|Clindamycin phosphate|clindamycin phosphate|mesh-list
56046416|NCT02860845|Clotrimazole|clotrimazole|mesh-list
56046418|NCT02860845|Antifungal Agents|antifungal agents|mesh-list
56046419|NCT02860845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046420|NCT02860845|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56046421|NCT02860845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046422|NCT02860845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046423|NCT02860845|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56046424|NCT02860845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56046425|NCT02860845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56046426|NCT02860845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56046427|NCT02860845|Hormone Antagonists|hormone antagonists|mesh-ancestor
56046428|NCT02860845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046429|NCT02860845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046430|NCT02860845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56046452|NCT01880723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046453|NCT01880723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046470|NCT02248454|Insulin Lispro|insulin lispro|mesh-list
56046471|NCT02248454|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56046472|NCT02248454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046473|NCT04466618|Heparin|heparin|mesh-list
56046474|NCT04466618|Calcium heparin|calcium heparin|mesh-list
56046475|NCT04466618|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56046476|NCT04466618|Anticoagulants|anticoagulants|mesh-ancestor
56046477|NCT04466618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56046478|NCT04466618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56046479|NCT04466618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046480|NCT04466618|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56046481|NCT04466618|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56046482|NCT04466618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56046483|NCT01881113|Cetirizine|cetirizine|mesh-list
56046484|NCT01881113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56046485|NCT01881113|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56046486|NCT01881113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56046487|NCT01881113|Histamine Antagonists|histamine antagonists|mesh-ancestor
56046488|NCT01881113|Histamine Agents|histamine agents|mesh-ancestor
55773670|NCT03141593|Vitamin D|vitamin d|mesh-list
56046492|NCT05140694|Empagliflozin|empagliflozin|mesh-list
56046520|NCT03003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046521|NCT03003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046522|NCT03003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56046523|NCT03003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56046524|NCT03003728|Immunologic Factors|immunologic factors|mesh-ancestor
56046525|NCT03003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046526|NCT05672810|Fibrin fragment D|fibrin fragment d|mesh-list
56046527|NCT05672810|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56046528|NCT05672810|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56046529|NCT05672810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046531|NCT05672810|Coagulants|coagulants|mesh-ancestor
56046532|NCT00559247|Asunaprevir|asunaprevir|mesh-list
56046533|NCT00559247|Protease Inhibitors|protease inhibitors|mesh-ancestor
56046534|NCT00559247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046535|NCT00559247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046536|NCT03003416|Dexamethasone|dexamethasone|mesh-list
56046537|NCT03003416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56046538|NCT03003416|Antiemetics|antiemetics|mesh-ancestor
56046539|NCT03003416|Autonomic Agents|autonomic agents|mesh-ancestor
56046540|NCT03003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046541|NCT03003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046542|NCT03003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046543|NCT03003416|Glucocorticoids|glucocorticoids|mesh-ancestor
56046544|NCT03003416|Hormones|hormones|mesh-ancestor
56046545|NCT03003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046546|NCT03003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56046547|NCT03003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046548|NCT02988869|Formoterol Fumarate|formoterol fumarate|mesh-list
56046549|NCT02988869|Tiotropium Bromide|tiotropium bromide|mesh-list
56046550|NCT02988869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56046551|NCT02988869|Autonomic Agents|autonomic agents|mesh-ancestor
56046552|NCT02988869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046553|NCT02988869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046554|NCT02988869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56046555|NCT02988869|Respiratory System Agents|respiratory system agents|mesh-ancestor
56046556|NCT02988869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56046558|NCT02988869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56046559|NCT02988869|Adrenergic Agents|adrenergic agents|mesh-ancestor
56046560|NCT02988869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046561|NCT02988869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046562|NCT02988869|Parasympatholytics|parasympatholytics|mesh-ancestor
56046563|NCT02988869|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56046564|NCT02988869|Cholinergic Agents|cholinergic agents|mesh-ancestor
56046565|NCT03028467|Folic Acid|folic acid|mesh-list
56046566|NCT03028467|Methotrexate|methotrexate|mesh-list
56046567|NCT03028467|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56046568|NCT03028467|Abortifacient Agents|abortifacient agents|mesh-ancestor
56046569|NCT03028467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56046570|NCT03028467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046571|NCT03028467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56046572|NCT03028467|Antimetabolites|antimetabolites|mesh-ancestor
56046573|NCT03028467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046574|NCT03028467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046575|NCT03028467|Dermatologic Agents|dermatologic agents|mesh-ancestor
56046576|NCT03028467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046577|NCT03028467|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55846732|NCT00985504|Citalopram|citalopram|mesh-list
56046578|NCT03028467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56046579|NCT03028467|Immunologic Factors|immunologic factors|mesh-ancestor
56046608|NCT02223338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56046609|NCT02223338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56046610|NCT02223338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046611|NCT02223338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046612|NCT02223338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046613|NCT02223338|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56046614|NCT02223338|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56046615|NCT01887587|Dexamethasone|dexamethasone|mesh-list
56046616|NCT01887587|Doxorubicin|doxorubicin|mesh-list
56046617|NCT01887587|Vincristine|vincristine|mesh-list
56046618|NCT01887587|Ixazomib|ixazomib|mesh-list
56046619|NCT01887587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56046620|NCT01887587|Antiemetics|antiemetics|mesh-ancestor
56046621|NCT01887587|Autonomic Agents|autonomic agents|mesh-ancestor
56046622|NCT01887587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046623|NCT01887587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046624|NCT01887587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046625|NCT01887587|Glucocorticoids|glucocorticoids|mesh-ancestor
56046626|NCT01887587|Hormones|hormones|mesh-ancestor
56046627|NCT01887587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046628|NCT01887587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56046629|NCT01887587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046630|NCT01887587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56046631|NCT01887587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56046632|NCT01887587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56046633|NCT01887587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046634|NCT01887587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046635|NCT01887587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56046636|NCT01887587|Tubulin Modulators|tubulin modulators|mesh-ancestor
56046637|NCT01887587|Antimitotic Agents|antimitotic agents|mesh-ancestor
56046638|NCT01887587|Mitosis Modulators|mitosis modulators|mesh-ancestor
56046639|NCT01887587|Protease Inhibitors|protease inhibitors|mesh-ancestor
56046640|NCT03029091|Losartan|losartan|mesh-list
56046641|NCT03029091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56046642|NCT03029091|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56046645|NCT03029091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046647|NCT02997410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046648|NCT02997410|Antifungal Agents|antifungal agents|mesh-ancestor
56046649|NCT02997410|Keratolytic Agents|keratolytic agents|mesh-ancestor
56046650|NCT02997410|Dermatologic Agents|dermatologic agents|mesh-ancestor
56046651|NCT00374205|Artesunate|artesunate|mesh-list
56046652|NCT00374205|Lumefantrine|lumefantrine|mesh-list
56046653|NCT00374205|Artemether|artemether|mesh-list
56046654|NCT00374205|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56046655|NCT00374205|Amodiaquine|amodiaquine|mesh-list
56046656|NCT00374205|Antimalarials|antimalarials|mesh-ancestor
56046657|NCT00374205|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56046658|NCT00374205|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56046659|NCT00374205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046660|NCT00374205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046661|NCT00374205|Antiviral Agents|antiviral agents|mesh-ancestor
56046662|NCT00374205|Schistosomicides|schistosomicides|mesh-ancestor
56046663|NCT00374205|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56046664|NCT00374205|Anthelmintics|anthelmintics|mesh-ancestor
56046665|NCT02248844|Botulinum Toxins|botulinum toxins|mesh-list
56046666|NCT02248844|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56046667|NCT02248844|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56046668|NCT02248844|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56046669|NCT02248844|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56046670|NCT02248844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046671|NCT02248844|Cholinergic Agents|cholinergic agents|mesh-ancestor
56046672|NCT02248844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046673|NCT02248844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046674|NCT02248844|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56046675|NCT02248844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046676|NCT05672342|Dronabinol|dronabinol|mesh-list
56046677|NCT05672342|Cannabidiol|cannabidiol|mesh-list
55879783|NCT01434472|Antiviral Agents|antiviral agents|mesh-ancestor
55879784|NCT01434472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55879785|NCT01434472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879786|NCT01434472|Antifungal Agents|antifungal agents|mesh-ancestor
55879787|NCT01434472|Dermatologic Agents|dermatologic agents|mesh-ancestor
55879788|NCT01434472|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55879789|NCT01434472|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55879790|NCT01434472|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55879791|NCT01434472|Antitubercular Agents|antitubercular agents|mesh-ancestor
55879792|NCT01434472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55879794|NCT01435174|Dialysis Solutions|dialysis solutions|mesh-list
55879795|NCT01435174|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56046678|NCT05672342|Anticonvulsants|anticonvulsants|mesh-ancestor
56046679|NCT05672342|Hallucinogens|hallucinogens|mesh-ancestor
56046680|NCT05672342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046681|NCT05672342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56046682|NCT05672342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56046683|NCT05672342|Analgesics|analgesics|mesh-ancestor
56046684|NCT05672342|Sensory System Agents|sensory system agents|mesh-ancestor
56046685|NCT05672342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046686|NCT05672342|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56046687|NCT05672342|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56046688|NCT05672342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046689|NCT05672342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046691|NCT05672342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046692|NCT03029715|Dexmedetomidine|dexmedetomidine|mesh-list
56046693|NCT03029715|Remifentanil|remifentanil|mesh-list
56046694|NCT03029715|Propofol|propofol|mesh-list
56046695|NCT03029715|Desflurane|desflurane|mesh-list
56046696|NCT03029715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56046697|NCT03029715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046698|NCT03029715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046699|NCT03029715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56046700|NCT03029715|Anesthetics, General|anesthetics, general|mesh-ancestor
56046701|NCT03029715|Anesthetics|anesthetics|mesh-ancestor
56046702|NCT03029715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56046703|NCT03029715|Analgesics|analgesics|mesh-ancestor
56046704|NCT03029715|Sensory System Agents|sensory system agents|mesh-ancestor
56046705|NCT03029715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046706|NCT03029715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56046707|NCT03029715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56046708|NCT03029715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56046709|NCT03029715|Adrenergic Agents|adrenergic agents|mesh-ancestor
56046710|NCT03029715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046711|NCT03029715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046712|NCT03029715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56046713|NCT03029715|Narcotics|narcotics|mesh-ancestor
56046714|NCT03029715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55773890|NCT04976387|Acetaminophen|acetaminophen|mesh-list
56046715|NCT00555035|Dolutegravir|dolutegravir|mesh-list
56046716|NCT00555035|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56046717|NCT00555035|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56046718|NCT00555035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046719|NCT00555035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046721|NCT00555035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56046722|NCT00555035|Antiviral Agents|antiviral agents|mesh-ancestor
56046723|NCT00555035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046724|NCT04015700|Coal Tar|coal tar|mesh-list
56046725|NCT04015700|Vaccines|vaccines|mesh-list
56046727|NCT04015700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046728|NCT04015700|Keratolytic Agents|keratolytic agents|mesh-ancestor
56046729|NCT04015700|Dermatologic Agents|dermatologic agents|mesh-ancestor
56046730|NCT03035955|Azelaic acid|azelaic acid|mesh-list
56046731|NCT03035955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046732|NCT03035955|Dermatologic Agents|dermatologic agents|mesh-ancestor
56046733|NCT03830060|Hydrocortisone|hydrocortisone|mesh-list
56046734|NCT03830060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56046735|NCT02927223|Atropine|atropine|mesh-list
56046736|NCT02927223|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56046737|NCT02927223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56046738|NCT02927223|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56046739|NCT02927223|Autonomic Agents|autonomic agents|mesh-ancestor
56046740|NCT02927223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046741|NCT02927223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046742|NCT02927223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56046743|NCT02927223|Respiratory System Agents|respiratory system agents|mesh-ancestor
56046744|NCT02927223|Mydriatics|mydriatics|mesh-ancestor
56046745|NCT02927223|Parasympatholytics|parasympatholytics|mesh-ancestor
56046746|NCT02927223|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56046747|NCT02927223|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56046748|NCT02927223|Cholinergic Agents|cholinergic agents|mesh-ancestor
56046749|NCT02927223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046751|NCT03002792|Anesthetics|anesthetics|mesh-list
56046759|NCT05672108|Alkylating Agents|alkylating agents|mesh-ancestor
56046760|NCT05672108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046761|NCT05672108|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56046762|NCT05672108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046763|NCT02927457|GSK2646264|gsk2646264|mesh-list
56046764|NCT02927457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56046765|NCT02927457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046766|NCT02927457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046767|NCT01891331|Fluconazole|fluconazole|mesh-list
56046768|NCT01891331|Antifungal Agents|antifungal agents|mesh-ancestor
56046769|NCT01891331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046770|NCT01891331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56046771|NCT01891331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56046772|NCT01891331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046773|NCT01891331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046774|NCT01891331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56046775|NCT01891331|Hormone Antagonists|hormone antagonists|mesh-ancestor
56046776|NCT01891331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046777|NCT01891331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046778|NCT01891331|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56046779|NCT01891331|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56046780|NCT02247518|Tadalafil|tadalafil|mesh-list
56046781|NCT02247518|Tamsulosin|tamsulosin|mesh-list
56046782|NCT02247518|Vasodilator Agents|vasodilator agents|mesh-ancestor
56046783|NCT02247518|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56046784|NCT02247518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56046785|NCT02247518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046786|NCT02247518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046787|NCT02247518|Urological Agents|urological agents|mesh-ancestor
56046788|NCT02247518|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56046789|NCT02247518|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56046790|NCT02247518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56046791|NCT02247518|Adrenergic Agents|adrenergic agents|mesh-ancestor
56046795|NCT02867163|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56046796|NCT02867163|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55740148|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046797|NCT02867163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046798|NCT02867163|Hemostatics|hemostatics|mesh-ancestor
56046799|NCT02867163|Coagulants|coagulants|mesh-ancestor
56046800|NCT04067609|Dexamethasone|dexamethasone|mesh-list
56046801|NCT04067609|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56046802|NCT04067609|Antiemetics|antiemetics|mesh-ancestor
56046803|NCT04067609|Autonomic Agents|autonomic agents|mesh-ancestor
56046804|NCT04067609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046805|NCT04067609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046806|NCT04067609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046807|NCT04067609|Glucocorticoids|glucocorticoids|mesh-ancestor
56046808|NCT04067609|Hormones|hormones|mesh-ancestor
56046809|NCT04067609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046810|NCT04067609|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56046811|NCT04067609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046812|NCT03022097|Bromides|bromides|mesh-list
56046813|NCT03022097|Formoterol Fumarate|formoterol fumarate|mesh-list
56046814|NCT03022097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56046815|NCT03022097|Autonomic Agents|autonomic agents|mesh-ancestor
56046816|NCT03022097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046817|NCT03022097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046818|NCT03022097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56046819|NCT03022097|Respiratory System Agents|respiratory system agents|mesh-ancestor
56046820|NCT03022097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56046821|NCT03022097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56046822|NCT03022097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56046823|NCT03022097|Adrenergic Agents|adrenergic agents|mesh-ancestor
56046824|NCT03022097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046825|NCT03022097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046826|NCT03022097|Anticonvulsants|anticonvulsants|mesh-ancestor
56046827|NCT03002636|Anesthetics|anesthetics|mesh-list
56046828|NCT03002636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046830|NCT03691610|Vaccines|vaccines|mesh-list
56046832|NCT03691610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046833|NCT03039543|Rocuronium|rocuronium|mesh-list
56046834|NCT03039543|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56046835|NCT03039543|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56046836|NCT03039543|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56046837|NCT03039543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046838|NCT03039543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046839|NCT04047875|Norethindrone|norethindrone|mesh-list
56046840|NCT04047875|Norethindrone Acetate|norethindrone acetate|mesh-list
56046841|NCT04047875|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56046842|NCT04047875|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56046843|NCT04047875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56046844|NCT04047875|Contraceptive Agents|contraceptive agents|mesh-ancestor
56046845|NCT04047875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56046846|NCT04047875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046847|NCT04047875|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56046848|NCT04047875|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56046849|NCT03002090|Iron|iron|mesh-list
56046850|NCT03002090|Trace Elements|trace elements|mesh-ancestor
56046851|NCT03002090|Micronutrients|micronutrients|mesh-ancestor
56046852|NCT03002090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046853|NCT02328755|Methotrexate|methotrexate|mesh-list
56046854|NCT02328755|Tacrolimus|tacrolimus|mesh-list
56046855|NCT02328755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56046856|NCT02328755|Abortifacient Agents|abortifacient agents|mesh-ancestor
56046857|NCT02328755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56046858|NCT02328755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046859|NCT02328755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56046860|NCT02328755|Antimetabolites|antimetabolites|mesh-ancestor
56046862|NCT02328755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046876|NCT02870283|Antimanic Agents|antimanic agents|mesh-ancestor
56046877|NCT02870283|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56046878|NCT02870283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046879|NCT02870283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046880|NCT02870283|Anticonvulsants|anticonvulsants|mesh-ancestor
56046882|NCT02870283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046883|NCT02870283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56046884|NCT02870283|Analgesics|analgesics|mesh-ancestor
56046885|NCT02870283|Sensory System Agents|sensory system agents|mesh-ancestor
56046886|NCT02870283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046887|NCT02870283|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55890768|NCT01893723|Narcotics|narcotics|mesh-ancestor
56046888|NCT02870283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56046889|NCT02870283|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56046890|NCT02870283|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56046891|NCT02931045|Clopidogrel|clopidogrel|mesh-list
56046892|NCT02931045|Ticagrelor|ticagrelor|mesh-list
56046893|NCT02931045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56046894|NCT02931045|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56046895|NCT02931045|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56046896|NCT02931045|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56046897|NCT02931045|Purinergic Agents|purinergic agents|mesh-ancestor
56046898|NCT02931045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046899|NCT02931045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046900|NCT02931045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046901|NCT03040011|Dexamethasone|dexamethasone|mesh-list
56046902|NCT03040011|Bupivacaine|bupivacaine|mesh-list
56046903|NCT03040011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56046904|NCT03040011|Antiemetics|antiemetics|mesh-ancestor
56046905|NCT03040011|Autonomic Agents|autonomic agents|mesh-ancestor
56046906|NCT03040011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879796|NCT01435174|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55879798|NCT01435174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879800|NCT01436266|Misoprostol|misoprostol|mesh-list
55879801|NCT01436266|Vitamins|vitamins|mesh-ancestor
55879802|NCT01436266|Micronutrients|micronutrients|mesh-ancestor
55879803|NCT01436266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879804|NCT01436266|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55879805|NCT01436266|Abortifacient Agents|abortifacient agents|mesh-ancestor
55879806|NCT01436266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55879807|NCT01436266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56046907|NCT03040011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046908|NCT03040011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046909|NCT03040011|Glucocorticoids|glucocorticoids|mesh-ancestor
56046911|NCT03040011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046912|NCT03040011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56046913|NCT03040011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046914|NCT03040011|Anesthetics, Local|anesthetics, local|mesh-ancestor
56046915|NCT03040011|Anesthetics|anesthetics|mesh-ancestor
56046916|NCT03040011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56046917|NCT03040011|Sensory System Agents|sensory system agents|mesh-ancestor
56046918|NCT02225132|Hydroxyurea|hydroxyurea|mesh-list
56046919|NCT02225132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046920|NCT02225132|Antisickling Agents|antisickling agents|mesh-ancestor
56046921|NCT02225132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046922|NCT02225132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046923|NCT02225132|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56046924|NCT03040479|Lasmiditan|lasmiditan|mesh-list
56046925|NCT03040479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56046926|NCT03040479|Serotonin Agents|serotonin agents|mesh-ancestor
56046927|NCT03040479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046928|NCT03040479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046929|NCT03040479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046930|NCT02872857|Galantamine|galantamine|mesh-list
56046931|NCT02872857|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56046932|NCT02872857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052671|NCT01833026|Adrenergic Agents|adrenergic agents|mesh-ancestor
56046933|NCT02872857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046934|NCT02872857|Cholinergic Agents|cholinergic agents|mesh-ancestor
56046935|NCT02872857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56046936|NCT02872857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046937|NCT02872857|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56046938|NCT02872857|Autonomic Agents|autonomic agents|mesh-ancestor
56046939|NCT02872857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56046940|NCT02872857|Nootropic Agents|nootropic agents|mesh-ancestor
56046941|NCT02996318|Sirolimus|sirolimus|mesh-list
56046942|NCT02996318|Paclitaxel|paclitaxel|mesh-list
56046943|NCT02996318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56046944|NCT02996318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56046945|NCT02996318|Tubulin Modulators|tubulin modulators|mesh-ancestor
56046946|NCT02996318|Antimitotic Agents|antimitotic agents|mesh-ancestor
56046947|NCT02996318|Mitosis Modulators|mitosis modulators|mesh-ancestor
56046948|NCT02996318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046949|NCT02996318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56046950|NCT02996318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56046951|NCT02996318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56046952|NCT02996318|Antifungal Agents|antifungal agents|mesh-ancestor
56046953|NCT02996318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56046954|NCT02996318|Immunologic Factors|immunologic factors|mesh-ancestor
56046955|NCT02996318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046956|NCT05197751|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56046957|NCT05197751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56046958|NCT05197751|Immunologic Factors|immunologic factors|mesh-ancestor
56046959|NCT05197751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046960|NCT05197751|Antacids|antacids|mesh-ancestor
56046961|NCT05197751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046962|NCT05197751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56046963|NCT02994602|ST 1435|st 1435|mesh-list
56046964|NCT02994602|Testosterone|testosterone|mesh-list
56046965|NCT02994602|Androgens|androgens|mesh-ancestor
56046966|NCT02994602|Hormones|hormones|mesh-ancestor
56046967|NCT02994602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56046968|NCT02994602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56046969|NCT02994602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56046971|NCT02994602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56046972|NCT02994602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56046973|NCT03297710|Trifluridine|trifluridine|mesh-list
56046987|NCT04350671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56046988|NCT04350671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56046989|NCT04350671|Protease Inhibitors|protease inhibitors|mesh-ancestor
56046990|NCT04350671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56046991|NCT04350671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56046992|NCT04350671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56046993|NCT04350671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56046994|NCT04350671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56046995|NCT04350671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56046996|NCT04350671|Antimalarials|antimalarials|mesh-ancestor
56046997|NCT04350671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56046998|NCT04350671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56046999|NCT04350671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047000|NCT04350671|Immunologic Factors|immunologic factors|mesh-ancestor
56047001|NCT04350671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047047|NCT03045861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047048|NCT03045861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047049|NCT02249078|Quetmolimab|quetmolimab|mesh-list
56047050|NCT02249078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047051|NCT02697344|Acetic Acid|acetic acid|mesh-list
56047052|NCT02697344|Dexamethasone|dexamethasone|mesh-list
56047053|NCT02697344|Dexamethasone acetate|dexamethasone acetate|mesh-list
56047054|NCT02697344|Lenalidomide|lenalidomide|mesh-list
56047055|NCT02697344|Retinol acetate|retinol acetate|mesh-list
56047056|NCT02697344|Gossypol acetic acid|gossypol acetic acid|mesh-list
56047057|NCT02697344|Gossypol|gossypol|mesh-list
56047058|NCT02697344|BB 1101|bb 1101|mesh-list
56047059|NCT02697344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047060|NCT02697344|Antiemetics|antiemetics|mesh-ancestor
56047061|NCT02697344|Autonomic Agents|autonomic agents|mesh-ancestor
56047062|NCT02697344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047063|NCT02697344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047064|NCT02697344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56047065|NCT02697344|Glucocorticoids|glucocorticoids|mesh-ancestor
56047066|NCT02697344|Hormones|hormones|mesh-ancestor
56047067|NCT02697344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56047068|NCT02697344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56047069|NCT02697344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047070|NCT02697344|Immunologic Factors|immunologic factors|mesh-ancestor
56047071|NCT02697344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56047072|NCT02697344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56047073|NCT02697344|Growth Substances|growth substances|mesh-ancestor
56047074|NCT02697344|Growth Inhibitors|growth inhibitors|mesh-ancestor
56047075|NCT02697344|Protease Inhibitors|protease inhibitors|mesh-ancestor
56047076|NCT02697344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047077|NCT02697344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047078|NCT02697344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56047079|NCT02697344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047080|NCT02697344|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56047081|NCT02697344|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56047082|NCT02697344|Protective Agents|protective agents|mesh-ancestor
56047086|NCT02697344|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56047087|NCT02697344|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56047088|NCT02697344|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56047089|NCT02697344|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56047090|NCT01903265|Cyclobenzaprine|cyclobenzaprine|mesh-list
56047091|NCT01903265|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56047092|NCT01903265|Antidepressive Agents|antidepressive agents|mesh-ancestor
56047093|NCT01903265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56047094|NCT01903265|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56047095|NCT01903265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047096|NCT01903265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56047097|NCT01903265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047098|NCT01903265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56047099|NCT01903265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047100|NCT01907321|Capsaicin|capsaicin|mesh-list
56047101|NCT01907321|Antipruritics|antipruritics|mesh-ancestor
56047102|NCT01907321|Dermatologic Agents|dermatologic agents|mesh-ancestor
56047103|NCT01907321|Sensory System Agents|sensory system agents|mesh-ancestor
56047104|NCT01907321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047105|NCT01907321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047106|NCT02219516|Verinurad|verinurad|mesh-list
56047107|NCT02219516|Gout Suppressants|gout suppressants|mesh-ancestor
56047108|NCT02219516|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047109|NCT04976777|Dexamethasone|dexamethasone|mesh-list
56047110|NCT04976777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047111|NCT04976777|Antiemetics|antiemetics|mesh-ancestor
56047112|NCT04976777|Autonomic Agents|autonomic agents|mesh-ancestor
56047113|NCT04976777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047114|NCT04976777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047115|NCT04976777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56047116|NCT04976777|Glucocorticoids|glucocorticoids|mesh-ancestor
56047117|NCT04976777|Hormones|hormones|mesh-ancestor
56047118|NCT04976777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56047119|NCT04976777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56047120|NCT04976777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047125|NCT02247596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047126|NCT02247596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047127|NCT02247596|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56047128|NCT03686657|Metformin|metformin|mesh-list
55847536|NCT01455142|Insulin|insulin|mesh-list
56047129|NCT03686657|Celecoxib|celecoxib|mesh-list
56047130|NCT03686657|Valsartan|valsartan|mesh-list
56047131|NCT03686657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56047132|NCT03686657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047133|NCT03686657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56047134|NCT03686657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56047135|NCT03686657|Analgesics|analgesics|mesh-ancestor
56047136|NCT03686657|Sensory System Agents|sensory system agents|mesh-ancestor
56047137|NCT03686657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047138|NCT03686657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047139|NCT03686657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047140|NCT03686657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56047141|NCT03686657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56047142|NCT03686657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047143|NCT03686657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047144|NCT03686657|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56047145|NCT03686657|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56047146|NCT03686657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56047147|NCT02476058|Diphenhydramine|diphenhydramine|mesh-list
56047148|NCT02476058|Promethazine|promethazine|mesh-list
56047149|NCT02476058|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56047150|NCT02476058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56047151|NCT02476058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047152|NCT02476058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047153|NCT02476058|Anesthetics, Local|anesthetics, local|mesh-ancestor
56047154|NCT02476058|Anesthetics|anesthetics|mesh-ancestor
56047156|NCT02476058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047157|NCT02476058|Antiemetics|antiemetics|mesh-ancestor
56047169|NCT02143466|Osimertinib|osimertinib|mesh-list
56047170|NCT02143466|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56047171|NCT02143466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56047172|NCT02143466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047173|NCT02143466|Immunologic Factors|immunologic factors|mesh-ancestor
56047174|NCT02143466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047175|NCT02143466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56047176|NCT02143466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047177|NCT02143466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047178|NCT03050619|Empagliflozin|empagliflozin|mesh-list
56047179|NCT03050619|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56047180|NCT03050619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047181|NCT03050619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56047182|NCT03050619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047183|NCT02071394|Xenon|xenon|mesh-list
56047184|NCT02071394|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56047185|NCT02071394|Anesthetics, General|anesthetics, general|mesh-ancestor
56047186|NCT02071394|Anesthetics|anesthetics|mesh-ancestor
56047188|NCT02071394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047189|NCT01911065|Vaccines|vaccines|mesh-list
56047190|NCT01911065|Immunologic Factors|immunologic factors|mesh-ancestor
56047191|NCT01911065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047192|NCT02995772|Tamoxifen|tamoxifen|mesh-list
56047193|NCT02995772|Fluorouracil|fluorouracil|mesh-list
56047194|NCT02995772|Letrozole|letrozole|mesh-list
56047195|NCT02995772|Anastrozole|anastrozole|mesh-list
56047196|NCT02995772|Exemestane|exemestane|mesh-list
56047197|NCT02995772|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56047198|NCT02995772|Antimetabolites|antimetabolites|mesh-ancestor
56047199|NCT02995772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047200|NCT02995772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56047201|NCT02995772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847668|NCT01453660|Cisplatin|cisplatin|mesh-list
56047202|NCT02995772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56047203|NCT02995772|Immunologic Factors|immunologic factors|mesh-ancestor
56047204|NCT02995772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047205|NCT02995772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047207|NCT02995772|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56047208|NCT02995772|Hormone Antagonists|hormone antagonists|mesh-ancestor
56047209|NCT02995772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56047210|NCT02995772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56047211|NCT02995772|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56047212|NCT02995772|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56047213|NCT02995772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56047215|NCT02987465|Acetylcholine|acetylcholine|mesh-list
56047216|NCT02987465|Darbepoetin alfa|darbepoetin alfa|mesh-list
56047217|NCT02987465|Hematinics|hematinics|mesh-ancestor
56047218|NCT02987465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56047219|NCT02987465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56047220|NCT02987465|Adrenergic Agents|adrenergic agents|mesh-ancestor
56047221|NCT02987465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047222|NCT02987465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047223|NCT02987465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047224|NCT02987465|Sympathomimetics|sympathomimetics|mesh-ancestor
56047225|NCT02987465|Autonomic Agents|autonomic agents|mesh-ancestor
56047226|NCT02987465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047227|NCT02987465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56047228|NCT02987465|Vasodilator Agents|vasodilator agents|mesh-ancestor
55740170|NCT02732015|Mesna|mesna|mesh-list
56047229|NCT02987465|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56047230|NCT02987465|Cholinergic Agents|cholinergic agents|mesh-ancestor
56047231|NCT04895579|Durvalumab|durvalumab|mesh-list
56047232|NCT04895579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56047233|NCT04895579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047234|NCT02227316|Acetaminophen|acetaminophen|mesh-list
56047235|NCT02227316|Ibuprofen|ibuprofen|mesh-list
56047236|NCT02227316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56047237|NCT02227316|Analgesics|analgesics|mesh-ancestor
56047249|NCT00555971|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56047250|NCT00555971|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56047251|NCT00555971|Respiratory System Agents|respiratory system agents|mesh-ancestor
56047253|NCT02943213|Antiemetics|antiemetics|mesh-ancestor
56047254|NCT02943213|Autonomic Agents|autonomic agents|mesh-ancestor
56047255|NCT02943213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047256|NCT02943213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047257|NCT02943213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56047258|NCT02943213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56047259|NCT02943213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56047260|NCT02943213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047261|NCT02943213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56047262|NCT02943213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56047264|NCT02943213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047265|NCT02943213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047266|NCT01850108|Mycophenolic Acid|mycophenolic acid|mesh-list
56047267|NCT01850108|Sirolimus|sirolimus|mesh-list
56047268|NCT01850108|Cyclophosphamide|cyclophosphamide|mesh-list
56047269|NCT01850108|Fludarabine|fludarabine|mesh-list
56047270|NCT01850108|Thymoglobulin|thymoglobulin|mesh-list
56047271|NCT01850108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56047272|NCT01850108|Immunologic Factors|immunologic factors|mesh-ancestor
56047273|NCT01850108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047274|NCT01850108|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047275|NCT01850108|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56047276|NCT01850108|Alkylating Agents|alkylating agents|mesh-ancestor
56047277|NCT01850108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047278|NCT01850108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047279|NCT01850108|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56047280|NCT01850108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56047281|NCT01850108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56047282|NCT01850108|Antitubercular Agents|antitubercular agents|mesh-ancestor
56047283|NCT01850108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56047289|NCT01822652|Fludarabine|fludarabine|mesh-list
56047290|NCT01822652|Fludarabine phosphate|fludarabine phosphate|mesh-list
56047291|NCT01822652|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56047292|NCT01822652|Immunologic Factors|immunologic factors|mesh-ancestor
56047293|NCT01822652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047294|NCT01822652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047295|NCT01822652|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56047296|NCT01822652|Alkylating Agents|alkylating agents|mesh-ancestor
56047297|NCT01822652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047298|NCT01822652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047299|NCT01822652|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56047300|NCT01822652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56047301|NCT01822652|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56047302|NCT01822652|Antimetabolites|antimetabolites|mesh-ancestor
56047303|NCT02249234|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56047304|NCT02249234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56047305|NCT02249234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047306|NCT02249234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047307|NCT02249234|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56047308|NCT02249234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56047309|NCT02249234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047310|NCT02249234|Cholinergic Agents|cholinergic agents|mesh-ancestor
56047311|NCT02249234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047312|NCT01338740|Adalimumab|adalimumab|mesh-list
56047313|NCT01338740|Infliximab|infliximab|mesh-list
56047314|NCT01338740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047315|NCT01338740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55774496|NCT03140033|Ranitidine|ranitidine|mesh-list
56047316|NCT01338740|Dermatologic Agents|dermatologic agents|mesh-ancestor
56047317|NCT01338740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56047318|NCT02944461|Dapsone|dapsone|mesh-list
56047319|NCT02944461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047330|NCT05376722|Glucocorticoids|glucocorticoids|mesh-ancestor
56047331|NCT05376722|Hormones|hormones|mesh-ancestor
56047332|NCT05376722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56047333|NCT05376722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047334|NCT05376722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56047335|NCT05376722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047336|NCT04737057|Fluorides|fluorides|mesh-list
56047337|NCT04737057|Cariostatic Agents|cariostatic agents|mesh-ancestor
56047338|NCT04737057|Protective Agents|protective agents|mesh-ancestor
56047339|NCT04737057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047340|NCT03111381|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56047341|NCT03111381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56047342|NCT03111381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56047343|NCT03111381|Analgesics|analgesics|mesh-ancestor
56047344|NCT03111381|Sensory System Agents|sensory system agents|mesh-ancestor
56047345|NCT03111381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047346|NCT03111381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047347|NCT03111381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047348|NCT03111381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047349|NCT03111381|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56047350|NCT03111381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047351|NCT03111381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047352|NCT02946489|Ketamine|ketamine|mesh-list
56047353|NCT02946489|Analgesics|analgesics|mesh-ancestor
56047354|NCT02946489|Sensory System Agents|sensory system agents|mesh-ancestor
56047355|NCT02946489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047356|NCT02946489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047357|NCT02946489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56047358|NCT02946489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56047360|NCT02946489|Anesthetics|anesthetics|mesh-ancestor
56047372|NCT02949921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047373|NCT02949921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56047374|NCT02949921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56047375|NCT02949921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55740173|NCT02732015|Autonomic Agents|autonomic agents|mesh-ancestor
56047376|NCT02949921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56047377|NCT02949921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047378|NCT02227706|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56047380|NCT02227706|Coagulants|coagulants|mesh-ancestor
56047381|NCT03112863|Vitamin A|vitamin a|mesh-list
56047382|NCT03112863|Retinol palmitate|retinol palmitate|mesh-list
56047383|NCT03112863|Vitamins|vitamins|mesh-ancestor
56047384|NCT03112863|Micronutrients|micronutrients|mesh-ancestor
56047385|NCT03112863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047386|NCT03112863|Antioxidants|antioxidants|mesh-ancestor
56047387|NCT03112863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047388|NCT03112863|Protective Agents|protective agents|mesh-ancestor
56047389|NCT03112863|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56047390|NCT03112863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047392|NCT05257460|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56047393|NCT05257460|Insulin Lispro|insulin lispro|mesh-list
56047394|NCT05257460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56047395|NCT05257460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047396|NCT02950467|Psilocybin|psilocybin|mesh-list
56047397|NCT02950467|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56047398|NCT02950467|Hallucinogens|hallucinogens|mesh-ancestor
56047399|NCT02950467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047400|NCT02950467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56047401|NCT02950467|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56047402|NCT02950467|Serotonin Agents|serotonin agents|mesh-ancestor
56047403|NCT02950467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047404|NCT02950467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047416|NCT03063255|Mepivacaine|mepivacaine|mesh-list
56047417|NCT03063255|Rocuronium|rocuronium|mesh-list
56047418|NCT03063255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047419|NCT03063255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047420|NCT03063255|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56047421|NCT03063255|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56047422|NCT03063255|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56047423|NCT03063255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047424|NCT03063255|Anesthetics, Local|anesthetics, local|mesh-ancestor
56047425|NCT03063255|Sensory System Agents|sensory system agents|mesh-ancestor
56047426|NCT05249114|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56047427|NCT05249114|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56047428|NCT05249114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047429|NCT05245292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56047430|NCT05245292|Antibodies|antibodies|mesh-list
56047431|NCT05245292|Immunoglobulins|immunoglobulins|mesh-list
56047432|NCT05245292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56047433|NCT05245292|Antibodies, Blocking|antibodies, blocking|mesh-list
56047434|NCT05245292|Immunologic Factors|immunologic factors|mesh-ancestor
56047435|NCT05245292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047436|NCT05245292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047437|NCT03115827|Carbidopa|carbidopa|mesh-list
56047438|NCT03115827|Droxidopa|droxidopa|mesh-list
56047439|NCT03115827|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56047440|NCT03115827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56047441|NCT03115827|Dopamine Agents|dopamine agents|mesh-ancestor
56047442|NCT03115827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047443|NCT03115827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047444|NCT03115827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047446|NCT03115827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047460|NCT01915823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047461|NCT01915823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047462|NCT01915823|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56047463|NCT01915823|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56047464|NCT01915823|Histamine Antagonists|histamine antagonists|mesh-ancestor
56047465|NCT01915823|Histamine Agents|histamine agents|mesh-ancestor
56047466|NCT01915823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047467|NCT05199194|Tenecteplase|tenecteplase|mesh-list
56047468|NCT05199194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56047469|NCT05199194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56047470|NCT05199194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047471|NCT01916681|Misoprostol|misoprostol|mesh-list
55847979|NCT02684032|Letrozole|letrozole|mesh-list
56047472|NCT01916681|Oxytocin|oxytocin|mesh-list
56047473|NCT01916681|Oxytocics|oxytocics|mesh-ancestor
56047474|NCT01916681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56047475|NCT01916681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047476|NCT01916681|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56047477|NCT01916681|Abortifacient Agents|abortifacient agents|mesh-ancestor
56047478|NCT01916681|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56047479|NCT01916681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56047480|NCT05735951|Stiripentol|stiripentol|mesh-list
56047481|NCT05735951|Anticonvulsants|anticonvulsants|mesh-ancestor
56047482|NCT01917773|Octreotide|octreotide|mesh-list
56047483|NCT01917773|Bisacodyl|bisacodyl|mesh-list
56047484|NCT01917773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56047485|NCT01917773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56047486|NCT01917773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047487|NCT01917773|Cathartics|cathartics|mesh-ancestor
56047488|NCT01917773|Laxatives|laxatives|mesh-ancestor
56047489|NCT02283749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
56047505|NCT01935791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047506|NCT01935791|Incretins|incretins|mesh-ancestor
56047507|NCT03074409|Oxytocin|oxytocin|mesh-list
56047508|NCT03074409|Oxytocics|oxytocics|mesh-ancestor
56047509|NCT03074409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56047510|NCT03074409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047511|NCT02955147|Prednisone|prednisone|mesh-list
56047512|NCT02955147|Ustekinumab|ustekinumab|mesh-list
56047513|NCT02955147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047514|NCT02955147|Glucocorticoids|glucocorticoids|mesh-ancestor
56047515|NCT02955147|Hormones|hormones|mesh-ancestor
56047516|NCT02955147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56047517|NCT02955147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047518|NCT02955147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56047519|NCT02955147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047520|NCT02955147|Dermatologic Agents|dermatologic agents|mesh-ancestor
56047521|NCT03119181|Lidocaine|lidocaine|mesh-list
56047522|NCT03119181|Epinephrine|epinephrine|mesh-list
56047523|NCT03119181|Racepinephrine|racepinephrine|mesh-list
56047524|NCT03119181|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56047525|NCT03119181|Epinephryl borate|epinephryl borate|mesh-list
56047526|NCT03119181|Anesthetics, Local|anesthetics, local|mesh-ancestor
56047527|NCT03119181|Anesthetics|anesthetics|mesh-ancestor
56047560|NCT01691690|Nitrous Oxide|nitrous oxide|mesh-list
56047561|NCT01691690|Ondansetron|ondansetron|mesh-list
56047563|NCT01691690|Sevoflurane|sevoflurane|mesh-list
56047564|NCT01691690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047565|NCT01691690|Antiemetics|antiemetics|mesh-ancestor
56047566|NCT01691690|Autonomic Agents|autonomic agents|mesh-ancestor
56047567|NCT01691690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047568|NCT01691690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047569|NCT01691690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56047570|NCT01691690|Glucocorticoids|glucocorticoids|mesh-ancestor
56047571|NCT01691690|Hormones|hormones|mesh-ancestor
56047572|NCT01691690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56047573|NCT01691690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56047574|NCT01691690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047575|NCT01691690|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56047576|NCT01691690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047577|NCT01691690|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56047578|NCT01691690|Anesthetics, General|anesthetics, general|mesh-ancestor
56047579|NCT01691690|Anesthetics|anesthetics|mesh-ancestor
56047580|NCT01691690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56047581|NCT01691690|Narcotics|narcotics|mesh-ancestor
56047582|NCT01691690|Analgesics|analgesics|mesh-ancestor
56047583|NCT01691690|Sensory System Agents|sensory system agents|mesh-ancestor
56047584|NCT01691690|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56047585|NCT01691690|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56047586|NCT01691690|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56047587|NCT01691690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56047588|NCT01691690|GABA Modulators|gaba modulators|mesh-ancestor
56047589|NCT01691690|GABA Agents|gaba agents|mesh-ancestor
56047590|NCT01691690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047591|NCT01691690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047592|NCT01691690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56047593|NCT01691690|Antipyretics|antipyretics|mesh-ancestor
55848059|NCT05604118|Analgesics|analgesics|mesh-ancestor
56047594|NCT01691690|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55879808|NCT01436266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55879809|NCT01436266|Oxytocics|oxytocics|mesh-ancestor
55879810|NCT01436266|Hematinics|hematinics|mesh-ancestor
55879811|NCT01436266|Vitamin B Complex|vitamin b complex|mesh-ancestor
55879812|NCT01542502|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55879813|NCT01542502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047595|NCT01691690|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56047597|NCT01691690|Dermatologic Agents|dermatologic agents|mesh-ancestor
56047598|NCT01691690|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56047599|NCT01691690|Serotonin Agents|serotonin agents|mesh-ancestor
56047600|NCT01691690|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56047601|NCT01694108|BCG Vaccine|bcg vaccine|mesh-list
56047602|NCT01694108|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56047603|NCT01694108|Immunologic Factors|immunologic factors|mesh-ancestor
56047604|NCT01694108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047605|NCT02283827|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56047606|NCT02283827|Phenytoin|phenytoin|mesh-list
56047607|NCT02283827|Anticonvulsants|anticonvulsants|mesh-ancestor
56047608|NCT02283827|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56047609|NCT02283827|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56047610|NCT02283827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56047611|NCT02283827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047612|NCT02283827|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56047613|NCT02283827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56047614|NCT05735717|Rituximab|rituximab|mesh-list
56047615|NCT05735717|Fludarabine|fludarabine|mesh-list
56047616|NCT05735717|Melphalan|melphalan|mesh-list
56047617|NCT05735717|Busulfan|busulfan|mesh-list
56047618|NCT05735717|Levetiracetam|levetiracetam|mesh-list
56047619|NCT05735717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56047620|NCT05735717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047621|NCT05735717|Immunologic Factors|immunologic factors|mesh-ancestor
56047622|NCT05735717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047623|NCT05735717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047624|NCT05735717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047625|NCT05735717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56047626|NCT05735717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56047627|NCT05735717|Alkylating Agents|alkylating agents|mesh-ancestor
56047628|NCT05735717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56047629|NCT05735717|Anticonvulsants|anticonvulsants|mesh-ancestor
56047630|NCT05735717|Nootropic Agents|nootropic agents|mesh-ancestor
56047631|NCT01626092|Cyclosporine|cyclosporine|mesh-list
56047634|NCT01626092|Alemtuzumab|alemtuzumab|mesh-list
56047635|NCT01626092|Clofarabine|clofarabine|mesh-list
56047636|NCT01626092|Cyclosporins|cyclosporins|mesh-list
56047637|NCT01626092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047638|NCT01626092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047639|NCT01626092|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56047640|NCT01626092|Immunologic Factors|immunologic factors|mesh-ancestor
56047641|NCT01626092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047642|NCT01626092|Antifungal Agents|antifungal agents|mesh-ancestor
56047643|NCT01626092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047644|NCT01626092|Dermatologic Agents|dermatologic agents|mesh-ancestor
56047645|NCT01626092|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047646|NCT01626092|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56047647|NCT01626092|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56047648|NCT01626092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047649|NCT01626092|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56047650|NCT01626092|Antitubercular Agents|antitubercular agents|mesh-ancestor
56047651|NCT01626092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56047652|NCT01626092|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56047653|NCT01626092|Alkylating Agents|alkylating agents|mesh-ancestor
56047654|NCT01626092|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56047655|NCT01626092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55848204|NCT04126330|Vitamin D|vitamin d|mesh-list
56047656|NCT01626092|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56047657|NCT01626092|Antimetabolites|antimetabolites|mesh-ancestor
56047658|NCT01694966|Methylene Blue|methylene blue|mesh-list
56047659|NCT01694966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047660|NCT01694966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047661|NCT01937975|Grazoprevir|grazoprevir|mesh-list
56047662|NCT01937975|Antiviral Agents|antiviral agents|mesh-ancestor
56047663|NCT01937975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047664|NCT01628588|Bimatoprost|bimatoprost|mesh-list
56047665|NCT01628588|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56047666|NCT00374985|Docetaxel|docetaxel|mesh-list
56047667|NCT00374985|Oxaliplatin|oxaliplatin|mesh-list
56047668|NCT00374985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047669|NCT00374985|Tubulin Modulators|tubulin modulators|mesh-ancestor
55879814|NCT01439854|Dapagliflozin|dapagliflozin|mesh-list
55879815|NCT01439854|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56047670|NCT00374985|Antimitotic Agents|antimitotic agents|mesh-ancestor
56047671|NCT00374985|Mitosis Modulators|mitosis modulators|mesh-ancestor
56047672|NCT00374985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047673|NCT01695668|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56047674|NCT01695668|Cyclosporine|cyclosporine|mesh-list
56047675|NCT01695668|Cyclosporins|cyclosporins|mesh-list
56047676|NCT01695668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047677|NCT01695668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047678|NCT01695668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56047680|NCT01695668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047681|NCT01695668|Antifungal Agents|antifungal agents|mesh-ancestor
56047682|NCT01695668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047683|NCT01695668|Dermatologic Agents|dermatologic agents|mesh-ancestor
56047684|NCT01695668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047685|NCT01695668|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56047686|NCT01695668|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56047687|NCT03270020|Denosumab|denosumab|mesh-list
56047688|NCT03270020|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56047689|NCT03270020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047690|NCT01921751|Gemcitabine|gemcitabine|mesh-list
56047691|NCT01921751|Paclitaxel|paclitaxel|mesh-list
56047692|NCT01921751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56047693|NCT01921751|Capecitabine|capecitabine|mesh-list
56047694|NCT01921751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56047695|NCT01921751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774872|NCT05737511|Analgesics|analgesics|mesh-ancestor
56047696|NCT01921751|Tubulin Modulators|tubulin modulators|mesh-ancestor
56047697|NCT01921751|Antimitotic Agents|antimitotic agents|mesh-ancestor
56047698|NCT01921751|Mitosis Modulators|mitosis modulators|mesh-ancestor
56047699|NCT01921751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047716|NCT01629134|Protective Agents|protective agents|mesh-ancestor
56047717|NCT01629290|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
56047718|NCT01629290|Cariostatic Agents|cariostatic agents|mesh-ancestor
56047719|NCT01629290|Protective Agents|protective agents|mesh-ancestor
56047720|NCT01629290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047721|NCT01696760|Aspirin|aspirin|mesh-list
56047722|NCT01696760|Enoxaparin|enoxaparin|mesh-list
56047723|NCT01696760|Enoxaparin sodium|enoxaparin sodium|mesh-list
56047724|NCT01696760|Anticoagulants|anticoagulants|mesh-ancestor
56047725|NCT01696760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56047726|NCT01696760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56047727|NCT01696760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047728|NCT01696760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56047729|NCT01696760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56047730|NCT01696760|Analgesics|analgesics|mesh-ancestor
56047731|NCT01696760|Sensory System Agents|sensory system agents|mesh-ancestor
56047732|NCT01696760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047733|NCT01696760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047734|NCT01696760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047735|NCT01696760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047736|NCT01696760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56047737|NCT01696760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56047738|NCT01696760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047739|NCT01696760|Antipyretics|antipyretics|mesh-ancestor
56047740|NCT01924169|Lenalidomide|lenalidomide|mesh-list
56047741|NCT01924169|Vaccines|vaccines|mesh-list
56047742|NCT01924169|Immunologic Factors|immunologic factors|mesh-ancestor
56047743|NCT01924169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047744|NCT01924169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56047745|NCT01924169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56047746|NCT01924169|Growth Substances|growth substances|mesh-ancestor
56047749|NCT02958969|Apixaban|apixaban|mesh-list
56047761|NCT01924871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047762|NCT01924871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047763|NCT01924871|Analgesics|analgesics|mesh-ancestor
56047764|NCT01924871|Sensory System Agents|sensory system agents|mesh-ancestor
56047765|NCT01924871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047766|NCT01924871|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56047767|NCT01924871|Anesthetics, General|anesthetics, general|mesh-ancestor
56047768|NCT01924871|Anesthetics|anesthetics|mesh-ancestor
56047770|NCT01698710|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56047771|NCT01698710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56047772|NCT01698710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047773|NCT01698710|Tubulin Modulators|tubulin modulators|mesh-ancestor
56047774|NCT01698710|Antimitotic Agents|antimitotic agents|mesh-ancestor
56047775|NCT01698710|Mitosis Modulators|mitosis modulators|mesh-ancestor
56047776|NCT01698710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047777|NCT01924949|Sofosbuvir|sofosbuvir|mesh-list
56047778|NCT01924949|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56047779|NCT01924949|Ledipasvir|ledipasvir|mesh-list
56047780|NCT01924949|Antiviral Agents|antiviral agents|mesh-ancestor
56047781|NCT01924949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047782|NCT01938989|Methamphetamine|methamphetamine|mesh-list
56047783|NCT01938989|beta-Endorphin|beta-endorphin|mesh-list
56047784|NCT01938989|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56047785|NCT01938989|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56047786|NCT01938989|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56047787|NCT01938989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047788|NCT01938989|Sympathomimetics|sympathomimetics|mesh-ancestor
56047789|NCT01938989|Autonomic Agents|autonomic agents|mesh-ancestor
56047790|NCT01938989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047791|NCT01938989|Dopamine Agents|dopamine agents|mesh-ancestor
56047792|NCT01938989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047793|NCT01938989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047794|NCT01938989|Adrenergic Agents|adrenergic agents|mesh-ancestor
56047795|NCT01938989|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56047800|NCT01938989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56047802|NCT01939301|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56047803|NCT01939301|Autonomic Agents|autonomic agents|mesh-ancestor
56047804|NCT01939301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047805|NCT01939301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047806|NCT01939301|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56047807|NCT01939301|Respiratory System Agents|respiratory system agents|mesh-ancestor
56047808|NCT01939301|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56047809|NCT01939301|Antioxidants|antioxidants|mesh-ancestor
56047810|NCT01939301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848353|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
56047811|NCT01939301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56047812|NCT01939301|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56047813|NCT01939301|Vasodilator Agents|vasodilator agents|mesh-ancestor
56047814|NCT01939301|Gasotransmitters|gasotransmitters|mesh-ancestor
56047815|NCT01939301|Protective Agents|protective agents|mesh-ancestor
56047816|NCT03078075|Naltrexone|naltrexone|mesh-list
56047817|NCT03078075|Bupropion|bupropion|mesh-list
56047818|NCT03078075|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56047819|NCT03078075|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56047820|NCT03078075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047821|NCT03078075|Sensory System Agents|sensory system agents|mesh-ancestor
56047822|NCT03078075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047823|NCT03078075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56047824|NCT03078075|Antidepressive Agents|antidepressive agents|mesh-ancestor
56047847|NCT01928693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56047848|NCT01928693|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56047849|NCT01928693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56047850|NCT01928693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56047851|NCT01928693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56047852|NCT01928693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56047853|NCT01928693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047854|NCT01928693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047855|NCT01928693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047856|NCT01928693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56047857|NCT01928693|Contraceptive Agents|contraceptive agents|mesh-ancestor
56047858|NCT01928693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56047859|NCT01928693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047860|NCT01928693|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56047861|NCT01928693|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56047862|NCT01928693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56047863|NCT01928849|Valproic Acid|valproic acid|mesh-list
56047903|NCT01944371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047904|NCT02343120|Zanubrutinib|zanubrutinib|mesh-list
56047905|NCT02343120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047906|NCT02343120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56047907|NCT02343120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047908|NCT02343120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047909|NCT01631630|Pioglitazone|pioglitazone|mesh-list
56047910|NCT01631630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56047911|NCT01631630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047912|NCT03837860|Oxycodone|oxycodone|mesh-list
56047913|NCT03837860|Risperidone|risperidone|mesh-list
56047914|NCT03837860|Ziprasidone|ziprasidone|mesh-list
56047915|NCT03837860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56047916|NCT03837860|Narcotics|narcotics|mesh-ancestor
56047917|NCT03837860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56047918|NCT03837860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047919|NCT03837860|Analgesics|analgesics|mesh-ancestor
56047920|NCT03837860|Sensory System Agents|sensory system agents|mesh-ancestor
56047923|NCT03837860|Serotonin Agents|serotonin agents|mesh-ancestor
56047958|NCT03129945|Sensory System Agents|sensory system agents|mesh-ancestor
56047959|NCT03129945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047960|NCT03129945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047961|NCT03129945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047962|NCT03129945|Gout Suppressants|gout suppressants|mesh-ancestor
56047964|NCT03129945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047965|NCT01700036|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56047966|NCT01700036|Protein C Inhibitor|protein c inhibitor|mesh-list
56047967|NCT01700036|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56047968|NCT01700036|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56047969|NCT01700036|Protease Inhibitors|protease inhibitors|mesh-ancestor
56047970|NCT01700036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047971|NCT01700036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047972|NCT02971748|Pembrolizumab|pembrolizumab|mesh-list
55879816|NCT01439854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879817|NCT01439854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55879818|NCT01439854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879819|NCT04409262|Remdesivir|remdesivir|mesh-list
55879820|NCT04409262|Antimetabolites|antimetabolites|mesh-ancestor
55879821|NCT04409262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879822|NCT04409262|Antiviral Agents|antiviral agents|mesh-ancestor
55879823|NCT04409262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55879824|NCT01481740|Phenylephrine|phenylephrine|mesh-list
55879825|NCT01481740|Oxymetazoline|oxymetazoline|mesh-list
55879826|NCT01481740|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55879827|NCT01481740|Mydriatics|mydriatics|mesh-ancestor
55879828|NCT01481740|Autonomic Agents|autonomic agents|mesh-ancestor
55879829|NCT01481740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879830|NCT01481740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879831|NCT01481740|Sympathomimetics|sympathomimetics|mesh-ancestor
55879832|NCT01481740|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55879833|NCT01481740|Nasal Decongestants|nasal decongestants|mesh-ancestor
55750844|NCT03098121|Grazoprevir|grazoprevir|mesh-list
55879834|NCT01481740|Respiratory System Agents|respiratory system agents|mesh-ancestor
55879835|NCT01481740|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55879836|NCT01481740|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55879837|NCT01481740|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55879838|NCT01481740|Adrenergic Agents|adrenergic agents|mesh-ancestor
55879839|NCT01481740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879840|NCT01481740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879841|NCT01481740|Protective Agents|protective agents|mesh-ancestor
55879842|NCT01544062|Acetaminophen|acetaminophen|mesh-list
55879843|NCT01544062|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879844|NCT01544062|Analgesics|analgesics|mesh-ancestor
55879845|NCT01544062|Sensory System Agents|sensory system agents|mesh-ancestor
55879846|NCT01544062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879847|NCT01544062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879848|NCT01544062|Antipyretics|antipyretics|mesh-ancestor
55879849|NCT03126084|Acetaminophen|acetaminophen|mesh-list
55879850|NCT03126084|Tramadol|tramadol|mesh-list
55879851|NCT03126084|Bupivacaine|bupivacaine|mesh-list
55879852|NCT03126084|Anesthetics, Local|anesthetics, local|mesh-ancestor
55879853|NCT03126084|Anesthetics|anesthetics|mesh-ancestor
55879854|NCT03126084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879855|NCT03126084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879856|NCT03126084|Sensory System Agents|sensory system agents|mesh-ancestor
55879857|NCT03126084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879858|NCT03126084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879859|NCT03126084|Analgesics|analgesics|mesh-ancestor
55879860|NCT03126084|Antipyretics|antipyretics|mesh-ancestor
56047973|NCT02971748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56047974|NCT02971748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047975|NCT01950299|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56047976|NCT01950299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047977|NCT03093207|Aspirin|aspirin|mesh-list
56047978|NCT03093207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56047979|NCT03093207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56047980|NCT03093207|Analgesics|analgesics|mesh-ancestor
56047981|NCT03093207|Sensory System Agents|sensory system agents|mesh-ancestor
56047982|NCT03093207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56047983|NCT03093207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56047984|NCT03093207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56047985|NCT03093207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56047986|NCT03093207|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56047987|NCT03093207|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56047988|NCT03093207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047989|NCT03093207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56047990|NCT03093207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56047991|NCT03093207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56047992|NCT03093207|Antipyretics|antipyretics|mesh-ancestor
56047993|NCT02365766|Gemcitabine|gemcitabine|mesh-list
56047994|NCT02365766|Pembrolizumab|pembrolizumab|mesh-list
56047995|NCT02365766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56047996|NCT02365766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56047997|NCT02365766|Antimetabolites|antimetabolites|mesh-ancestor
56047998|NCT02365766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56047999|NCT02365766|Antiviral Agents|antiviral agents|mesh-ancestor
56048000|NCT02365766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048001|NCT02365766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048002|NCT02365766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56048003|NCT02365766|Immunologic Factors|immunologic factors|mesh-ancestor
56048004|NCT02365766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048013|NCT05482451|Dermatologic Agents|dermatologic agents|mesh-ancestor
56048014|NCT02228408|Hydralazine|hydralazine|mesh-list
56048015|NCT02228408|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56048016|NCT02228408|Vasodilator Agents|vasodilator agents|mesh-ancestor
56048017|NCT03134703|Morphine|morphine|mesh-list
56048018|NCT03134703|Methadone|methadone|mesh-list
56048019|NCT03134703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56048020|NCT03134703|Narcotics|narcotics|mesh-ancestor
56048021|NCT03134703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56048022|NCT03134703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048023|NCT03134703|Analgesics|analgesics|mesh-ancestor
56048024|NCT03134703|Sensory System Agents|sensory system agents|mesh-ancestor
56048025|NCT03134703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048026|NCT03134703|Antitussive Agents|antitussive agents|mesh-ancestor
56048027|NCT03134703|Respiratory System Agents|respiratory system agents|mesh-ancestor
56048028|NCT01951391|Benzalkonium Compounds|benzalkonium compounds|mesh-list
56048029|NCT01951391|Triclocarban|triclocarban|mesh-list
56048030|NCT01951391|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56048031|NCT01951391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048032|NCT02342886|Moxifloxacin|moxifloxacin|mesh-list
56048033|NCT02342886|Rifampin|rifampin|mesh-list
56048034|NCT02342886|Isoniazid|isoniazid|mesh-list
56048035|NCT02342886|Pyrazinamide|pyrazinamide|mesh-list
56048036|NCT02342886|Ethambutol|ethambutol|mesh-list
56048037|NCT02342886|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56048038|NCT02342886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048039|NCT02342886|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56048040|NCT02342886|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56048041|NCT02342886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048042|NCT02342886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048043|NCT02342886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048044|NCT02342886|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56048059|NCT04350281|Interferon-beta|interferon-beta|mesh-list
56048060|NCT04350281|Hydroxychloroquine|hydroxychloroquine|mesh-list
56048061|NCT04350281|Interferon beta-1b|interferon beta-1b|mesh-list
56048062|NCT04350281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048063|NCT04350281|Antiviral Agents|antiviral agents|mesh-ancestor
56048064|NCT04350281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048065|NCT04350281|Antimalarials|antimalarials|mesh-ancestor
56048066|NCT04350281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56048067|NCT04350281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56048068|NCT04350281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048069|NCT04350281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048070|NCT04350281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56048121|NCT01635062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048122|NCT01635062|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56048123|NCT01635062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56048124|NCT01635062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048125|NCT01635062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56048126|NCT01635062|Vitamins|vitamins|mesh-ancestor
56048127|NCT01635062|Micronutrients|micronutrients|mesh-ancestor
56048128|NCT01635062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56048129|NCT01637090|Everolimus|everolimus|mesh-list
56048130|NCT01637090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048131|NCT01637090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55879861|NCT03126084|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55879862|NCT03126084|Narcotics|narcotics|mesh-ancestor
55879863|NCT01544998|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55879864|NCT01544998|Tadalafil|tadalafil|mesh-list
55879865|NCT01544998|Vasodilator Agents|vasodilator agents|mesh-ancestor
55879866|NCT01544998|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55879867|NCT01544998|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55879868|NCT01544998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879870|NCT01544998|Urological Agents|urological agents|mesh-ancestor
55879871|NCT01544998|Natriuretic Agents|natriuretic agents|mesh-ancestor
55879872|NCT01544998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879873|NCT03391830|Ascorbic Acid|ascorbic acid|mesh-list
55879874|NCT03391830|Atorvastatin|atorvastatin|mesh-list
55879875|NCT03391830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55879876|NCT03391830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55879877|NCT03391830|Antimetabolites|antimetabolites|mesh-ancestor
55879878|NCT03391830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879879|NCT03391830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55879880|NCT03391830|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55879881|NCT03391830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879882|NCT03391830|Antioxidants|antioxidants|mesh-ancestor
55879883|NCT03391830|Protective Agents|protective agents|mesh-ancestor
55879884|NCT03391830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879885|NCT03391830|Vitamins|vitamins|mesh-ancestor
55879886|NCT03391830|Micronutrients|micronutrients|mesh-ancestor
55879887|NCT01441570|Metoprolol|metoprolol|mesh-list
55879888|NCT01441570|Nebivolol|nebivolol|mesh-list
55879889|NCT01441570|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55879890|NCT01441570|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55879891|NCT01441570|Sympatholytics|sympatholytics|mesh-ancestor
55879892|NCT01441570|Autonomic Agents|autonomic agents|mesh-ancestor
55879893|NCT01441570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879894|NCT01441570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879895|NCT01441570|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55879896|NCT01441570|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55879897|NCT01441570|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55879898|NCT01441570|Adrenergic Agents|adrenergic agents|mesh-ancestor
55879899|NCT01441570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879900|NCT01441570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879901|NCT01441570|Vasodilator Agents|vasodilator agents|mesh-ancestor
55879902|NCT01441570|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55879903|NCT01441570|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55879904|NCT01441570|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55879905|NCT05238012|Atorvastatin|atorvastatin|mesh-list
55879906|NCT05238012|Calcium|calcium|mesh-list
55879907|NCT05238012|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55879908|NCT05238012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879909|NCT05238012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55879910|NCT05238012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55879911|NCT05238012|Antimetabolites|antimetabolites|mesh-ancestor
55879912|NCT05238012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879913|NCT05238012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55879914|NCT05238012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56048133|NCT01637090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048134|NCT02389452|Hylan|hylan|mesh-list
56048135|NCT02389452|Viscosupplements|viscosupplements|mesh-ancestor
56048136|NCT02389452|Protective Agents|protective agents|mesh-ancestor
56048137|NCT02389452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048138|NCT02365584|Lanreotide|lanreotide|mesh-list
56048139|NCT02365584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048140|NCT02342418|Tedizolid|tedizolid|mesh-list
56048141|NCT02342418|Tedizolid phosphate|tedizolid phosphate|mesh-list
56048142|NCT02342418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56048143|NCT02342418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048144|NCT04902378|Insulin|insulin|mesh-list
56048145|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56048146|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048147|NCT05727449|Anesthetics|anesthetics|mesh-list
56048148|NCT05727449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56048149|NCT05727449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048150|NCT03102645|Imipramine|imipramine|mesh-list
56048151|NCT03102645|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56048152|NCT03102645|Antidepressive Agents|antidepressive agents|mesh-ancestor
56048154|NCT03102645|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56048155|NCT03102645|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56048161|NCT01639352|Pasireotide|pasireotide|mesh-list
56048184|NCT02312934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56048185|NCT02312934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56048186|NCT02312934|Cholinergic Agents|cholinergic agents|mesh-ancestor
56048187|NCT02312934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048188|NCT02312934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048189|NCT04707027|Aflibercept|aflibercept|mesh-list
56048190|NCT04707027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56048191|NCT04707027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56048192|NCT04707027|Growth Substances|growth substances|mesh-ancestor
56048193|NCT04707027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048194|NCT04707027|Growth Inhibitors|growth inhibitors|mesh-ancestor
56048195|NCT04707027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048196|NCT01602068|Dexamethasone|dexamethasone|mesh-list
56048197|NCT01602068|Citric Acid|citric acid|mesh-list
56048198|NCT01602068|Sodium Citrate|sodium citrate|mesh-list
56048199|NCT01602068|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56048200|NCT01602068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56048201|NCT01602068|Antiemetics|antiemetics|mesh-ancestor
56048202|NCT01602068|Autonomic Agents|autonomic agents|mesh-ancestor
56048203|NCT01602068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048204|NCT01602068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048205|NCT01602068|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048206|NCT01602068|Glucocorticoids|glucocorticoids|mesh-ancestor
56048207|NCT01602068|Hormones|hormones|mesh-ancestor
56048208|NCT01602068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048209|NCT01602068|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56048210|NCT01602068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048211|NCT01602068|Anticoagulants|anticoagulants|mesh-ancestor
56048212|NCT01602068|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56048213|NCT01602068|Chelating Agents|chelating agents|mesh-ancestor
56048214|NCT01602068|Sequestering Agents|sequestering agents|mesh-ancestor
56048215|NCT01602068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048216|NCT02978157|Amoxicillin|amoxicillin|mesh-list
56048217|NCT02978157|Levofloxacin|levofloxacin|mesh-list
56048218|NCT02978157|Ofloxacin|ofloxacin|mesh-list
56048219|NCT02978157|Tetracycline|tetracycline|mesh-list
56048220|NCT02978157|Esomeprazole|esomeprazole|mesh-list
56048224|NCT02978157|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56048225|NCT02978157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048226|NCT02978157|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56048227|NCT02978157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048228|NCT02978157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048229|NCT02978157|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56048230|NCT02978157|Renal Agents|renal agents|mesh-ancestor
56048231|NCT02978157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56048232|NCT02978157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56048233|NCT02978157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048234|NCT02978157|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56048235|NCT02978157|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56048236|NCT02978157|Antacids|antacids|mesh-ancestor
56048237|NCT02978157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55848923|NCT04841434|Methotrexate|methotrexate|mesh-list
56048238|NCT01705964|Epinephrine|epinephrine|mesh-list
56048239|NCT01705964|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56048240|NCT01705964|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56048241|NCT01705964|Adrenergic Agents|adrenergic agents|mesh-ancestor
56048242|NCT01705964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048243|NCT01705964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048244|NCT01705964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048245|NCT01705964|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56048246|NCT01705964|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56048247|NCT01705964|Autonomic Agents|autonomic agents|mesh-ancestor
55879915|NCT05238012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879916|NCT01441882|Dasatinib|dasatinib|mesh-list
55879917|NCT01441882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879918|NCT01441882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55879919|NCT01441882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879920|NCT01441882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879921|NCT01484626|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55879922|NCT01484626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55879923|NCT01484626|Alkylating Agents|alkylating agents|mesh-ancestor
55879924|NCT01484626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879925|NCT01484626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879926|NCT01545700|Dexamethasone|dexamethasone|mesh-list
55879927|NCT01545700|Dexamethasone acetate|dexamethasone acetate|mesh-list
55879928|NCT01545700|BB 1101|bb 1101|mesh-list
55879929|NCT01545700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879930|NCT01545700|Antiemetics|antiemetics|mesh-ancestor
55879931|NCT01545700|Autonomic Agents|autonomic agents|mesh-ancestor
55879932|NCT01545700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879933|NCT01545700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879934|NCT01545700|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55879935|NCT01545700|Glucocorticoids|glucocorticoids|mesh-ancestor
55879936|NCT01545700|Hormones|hormones|mesh-ancestor
55879937|NCT01545700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55879938|NCT01545700|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55879939|NCT01545700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048248|NCT01705964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048249|NCT01705964|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56048250|NCT01705964|Respiratory System Agents|respiratory system agents|mesh-ancestor
56048252|NCT01705964|Sympathomimetics|sympathomimetics|mesh-ancestor
56048253|NCT01705964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56048254|NCT02341482|Itraconazole|itraconazole|mesh-list
56048256|NCT02341482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048257|NCT02341482|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56048258|NCT02341482|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56048259|NCT02341482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048260|NCT02341482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048261|NCT02341482|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56048262|NCT02341482|Hormone Antagonists|hormone antagonists|mesh-ancestor
56048263|NCT02341482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048264|NCT02341482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879940|NCT01545700|Protease Inhibitors|protease inhibitors|mesh-ancestor
55879941|NCT01545700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879944|NCT01486810|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55879945|NCT01486810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879947|NCT01486810|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55879948|NCT01486810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55879949|NCT01486810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879950|NCT01486810|Dopamine Agents|dopamine agents|mesh-ancestor
55879951|NCT01486810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55879952|NCT01443442|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55879953|NCT01443442|Bepotastine besilate|bepotastine besilate|mesh-list
55879954|NCT01443442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55879955|NCT01444924|Bupivacaine|bupivacaine|mesh-list
55879956|NCT01444924|Anesthetics, Local|anesthetics, local|mesh-ancestor
55879957|NCT01444924|Anesthetics|anesthetics|mesh-ancestor
55879958|NCT01444924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750892|NCT02493959|Incretins|incretins|mesh-ancestor
55879959|NCT01444924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879960|NCT01444924|Sensory System Agents|sensory system agents|mesh-ancestor
55879961|NCT01444924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879962|NCT01546402|Dexamethasone|dexamethasone|mesh-list
55879963|NCT01546402|Dexamethasone acetate|dexamethasone acetate|mesh-list
55879964|NCT01546402|BB 1101|bb 1101|mesh-list
55879965|NCT01546402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55879966|NCT01546402|Antiemetics|antiemetics|mesh-ancestor
55879967|NCT01546402|Autonomic Agents|autonomic agents|mesh-ancestor
55879968|NCT01546402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879969|NCT01546402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879970|NCT01546402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55879971|NCT01546402|Glucocorticoids|glucocorticoids|mesh-ancestor
55879972|NCT01546402|Hormones|hormones|mesh-ancestor
55879973|NCT01546402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55879974|NCT01546402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55879975|NCT01546402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879976|NCT01546402|Protease Inhibitors|protease inhibitors|mesh-ancestor
55879977|NCT01546402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55879978|NCT01546402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048276|NCT00422643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048277|NCT00422643|Viscosupplements|viscosupplements|mesh-ancestor
56048278|NCT00422643|Protective Agents|protective agents|mesh-ancestor
56048279|NCT05405907|Hemostatics|hemostatics|mesh-list
56048280|NCT05405907|Coagulants|coagulants|mesh-ancestor
56048292|NCT01706588|Diclofenac|diclofenac|mesh-list
56048293|NCT01706588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56048294|NCT01706588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56048310|NCT05405439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048311|NCT05405439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56048312|NCT05405439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048313|NCT05405439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56048314|NCT05405439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048315|NCT05405439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048316|NCT05405439|Hormone Antagonists|hormone antagonists|mesh-ancestor
56048317|NCT05405439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56048318|NCT01602692|Lidocaine|lidocaine|mesh-list
55849090|NCT02651662|Cemiplimab|cemiplimab|mesh-list
56048319|NCT01602692|Epinephrine|epinephrine|mesh-list
56048320|NCT01602692|Racepinephrine|racepinephrine|mesh-list
56048321|NCT01602692|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56048322|NCT01602692|Epinephryl borate|epinephryl borate|mesh-list
56048323|NCT01602692|Anesthetics, Local|anesthetics, local|mesh-ancestor
56048324|NCT01602692|Anesthetics|anesthetics|mesh-ancestor
56048325|NCT01602692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56048326|NCT01602692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048327|NCT01602692|Sensory System Agents|sensory system agents|mesh-ancestor
56048328|NCT01602692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048329|NCT01602692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56048330|NCT01602692|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56048331|NCT01602692|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56048332|NCT01602692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56048333|NCT01602692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048334|NCT01602692|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56048335|NCT01602692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56048336|NCT01602692|Adrenergic Agents|adrenergic agents|mesh-ancestor
56048337|NCT01602692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048338|NCT01602692|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56048339|NCT01602692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56048340|NCT01602692|Autonomic Agents|autonomic agents|mesh-ancestor
56048341|NCT01602692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56048342|NCT01602692|Respiratory System Agents|respiratory system agents|mesh-ancestor
56048344|NCT01602692|Sympathomimetics|sympathomimetics|mesh-ancestor
56048349|NCT01603940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56048350|NCT01603940|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56048351|NCT01603940|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56048352|NCT01603940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048353|NCT01603940|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56048354|NCT01603940|Protease Inhibitors|protease inhibitors|mesh-ancestor
56048355|NCT01603940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048356|NCT01605032|Bortezomib|bortezomib|mesh-list
56048357|NCT01605032|Melphalan|melphalan|mesh-list
56048358|NCT01605032|Busulfan|busulfan|mesh-list
56048359|NCT01605032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048360|NCT01605032|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56048361|NCT01605032|Alkylating Agents|alkylating agents|mesh-ancestor
56048362|NCT01605032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048363|NCT01605032|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56048364|NCT01605032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56048365|NCT01605032|Immunologic Factors|immunologic factors|mesh-ancestor
56048366|NCT01605032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048367|NCT01706666|Dexamethasone|dexamethasone|mesh-list
56048368|NCT01706666|Cyclophosphamide|cyclophosphamide|mesh-list
56048369|NCT01706666|Lenalidomide|lenalidomide|mesh-list
56048370|NCT01706666|Bortezomib|bortezomib|mesh-list
56048371|NCT01706666|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56048372|NCT01706666|Immunologic Factors|immunologic factors|mesh-ancestor
56048373|NCT01706666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048374|NCT01706666|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56048375|NCT01706666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56048376|NCT01706666|Alkylating Agents|alkylating agents|mesh-ancestor
56048377|NCT01706666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048378|NCT01706666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048379|NCT01706666|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56048380|NCT01706666|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56048381|NCT01706666|Antiemetics|antiemetics|mesh-ancestor
56048389|NCT01706666|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56048391|NCT01706666|Growth Substances|growth substances|mesh-ancestor
56048392|NCT01706666|Growth Inhibitors|growth inhibitors|mesh-ancestor
56048393|NCT03149991|Ketamine|ketamine|mesh-list
56048394|NCT03149991|Brexpiprazole|brexpiprazole|mesh-list
56048395|NCT03149991|Analgesics|analgesics|mesh-ancestor
56048396|NCT03149991|Sensory System Agents|sensory system agents|mesh-ancestor
56048397|NCT03149991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048398|NCT03149991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048399|NCT03149991|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56048400|NCT03149991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56048401|NCT03149991|Anesthetics, General|anesthetics, general|mesh-ancestor
56048402|NCT03149991|Anesthetics|anesthetics|mesh-ancestor
56048403|NCT03149991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56048404|NCT03149991|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56048405|NCT03149991|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56048406|NCT03149991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048407|NCT03149991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048408|NCT03149991|Serotonin Agents|serotonin agents|mesh-ancestor
56048409|NCT03149991|Dopamine Agonists|dopamine agonists|mesh-ancestor
56048410|NCT03149991|Dopamine Agents|dopamine agents|mesh-ancestor
56048411|NCT05704439|Antihypertensive Agents|antihypertensive agents|mesh-list
56048412|NCT05400993|Cyclophosphamide|cyclophosphamide|mesh-list
56048413|NCT05400993|Docetaxel|docetaxel|mesh-list
56048414|NCT05400993|Epirubicin|epirubicin|mesh-list
56048415|NCT05400993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56048416|NCT05400993|Immunologic Factors|immunologic factors|mesh-ancestor
56048417|NCT05400993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048418|NCT05400993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56048419|NCT05400993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56048421|NCT05400993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048422|NCT05400993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048423|NCT05400993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56048424|NCT05400993|Tubulin Modulators|tubulin modulators|mesh-ancestor
56048425|NCT05400993|Antimitotic Agents|antimitotic agents|mesh-ancestor
55879979|NCT03389490|Insulin|insulin|mesh-list
55879980|NCT03389490|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55879981|NCT03389490|Insulin Glargine|insulin glargine|mesh-list
56048426|NCT05400993|Mitosis Modulators|mitosis modulators|mesh-ancestor
56048427|NCT05400993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56048428|NCT05400993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56048429|NCT05400993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56048430|NCT05400993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048431|NCT01605890|Tenofovir|tenofovir|mesh-list
56048432|NCT01605890|Emtricitabine|emtricitabine|mesh-list
56048433|NCT01605890|Raltegravir Potassium|raltegravir potassium|mesh-list
56048434|NCT01605890|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56048435|NCT01605890|Antiviral Agents|antiviral agents|mesh-ancestor
56048436|NCT01605890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048437|NCT01605890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56048438|NCT01605890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56048439|NCT01605890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048440|NCT01605890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048441|NCT01605890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56048442|NCT01605890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56048443|NCT01605890|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56048444|NCT01605890|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56048445|NCT02288273|Exenatide|exenatide|mesh-list
56048446|NCT02288273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56048447|NCT02288273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048448|NCT02288273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56048451|NCT02288273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048452|NCT01606124|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56048454|NCT01606124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048455|NCT01606124|Protective Agents|protective agents|mesh-ancestor
56048456|NCT01606124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048457|NCT01606124|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56048458|NCT01606124|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55879982|NCT03389490|Insulin, Isophane|insulin, isophane|mesh-list
55879983|NCT03389490|Isophane Insulin, Human|isophane insulin, human|mesh-list
55879984|NCT03389490|Isophane insulin, beef|isophane insulin, beef|mesh-list
55879985|NCT03389490|Protamines|protamines|mesh-list
55879986|NCT03389490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55879987|NCT03389490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879988|NCT03389490|Heparin Antagonists|heparin antagonists|mesh-ancestor
56048459|NCT01606124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048460|NCT01606124|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56048461|NCT01607450|Glucagon|glucagon|mesh-list
56048462|NCT01607450|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56048463|NCT01607450|Incretins|incretins|mesh-ancestor
56048464|NCT01607450|Hormones|hormones|mesh-ancestor
56048465|NCT01607450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048466|NCT01607450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048467|NCT01607450|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048468|NCT05738993|Pertuzumab|pertuzumab|mesh-list
56048469|NCT05738993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56048470|NCT05738993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55879989|NCT03389490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879990|NCT03389490|Coagulants|coagulants|mesh-ancestor
55879991|NCT03994146|Remifentanil|remifentanil|mesh-list
55879992|NCT03994146|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55879993|NCT03994146|Narcotics|narcotics|mesh-ancestor
55879994|NCT03994146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879995|NCT03994146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879996|NCT03994146|Analgesics|analgesics|mesh-ancestor
55879997|NCT03994146|Sensory System Agents|sensory system agents|mesh-ancestor
55879998|NCT03994146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55879999|NCT01547806|Plerixafor|plerixafor|mesh-list
55880000|NCT01547806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55880001|NCT01547806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55880002|NCT01547806|Antiviral Agents|antiviral agents|mesh-ancestor
55880003|NCT01547806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880005|NCT01445626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55880006|NCT01445626|Antiemetics|antiemetics|mesh-ancestor
55880007|NCT01445626|Autonomic Agents|autonomic agents|mesh-ancestor
55880008|NCT01445626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880009|NCT01445626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880010|NCT01445626|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55880011|NCT01445626|Glucocorticoids|glucocorticoids|mesh-ancestor
55880012|NCT01445626|Hormones|hormones|mesh-ancestor
55880014|NCT01445626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55880015|NCT01445626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880016|NCT02744742|Cyclophosphamide|cyclophosphamide|mesh-list
55880018|NCT02744742|Decitabine|decitabine|mesh-list
55880019|NCT02744742|Lenograstim|lenograstim|mesh-list
55880020|NCT02744742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880021|NCT02744742|Immunologic Factors|immunologic factors|mesh-ancestor
55880022|NCT02744742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880023|NCT02744742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880026|NCT02744742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880027|NCT02744742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880028|NCT02744742|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55880029|NCT02744742|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55880030|NCT02744742|Antimetabolites|antimetabolites|mesh-ancestor
55880031|NCT02744742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880032|NCT02744742|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55880033|NCT03389412|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55880034|NCT03389412|Hemostatics|hemostatics|mesh-ancestor
55880035|NCT03389412|Coagulants|coagulants|mesh-ancestor
55880036|NCT03389412|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55880037|NCT03389412|Natriuretic Agents|natriuretic agents|mesh-ancestor
55880038|NCT03389412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880039|NCT03125772|Paclitaxel|paclitaxel|mesh-list
55880040|NCT03125772|Everolimus|everolimus|mesh-list
55880041|NCT03125772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55880042|NCT03125772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048472|NCT01709474|Ergocalciferols|ergocalciferols|mesh-list
56048473|NCT01709474|Cholecalciferol|cholecalciferol|mesh-list
56048474|NCT01709474|Vitamins|vitamins|mesh-list
56048475|NCT01709474|Micronutrients|micronutrients|mesh-ancestor
56048476|NCT01709474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048477|NCT01709474|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56048478|NCT01709474|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56048479|NCT02992808|Menotropins|menotropins|mesh-list
56048480|NCT02992808|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56048481|NCT02992808|Fertility Agents|fertility agents|mesh-ancestor
56048482|NCT02992808|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56048483|NCT02992808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048484|NCT02992886|Raltitrexed|raltitrexed|mesh-list
56048485|NCT02992886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56048486|NCT02992886|Antimetabolites|antimetabolites|mesh-ancestor
56048487|NCT02992886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048488|NCT02992886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048489|NCT02992886|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56048490|NCT02992886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048491|NCT02331095|Warfarin|warfarin|mesh-list
56048492|NCT02331095|Rivaroxaban|rivaroxaban|mesh-list
56048493|NCT02331095|Atorvastatin|atorvastatin|mesh-list
56048494|NCT02331095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56048495|NCT02331095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56048496|NCT02331095|Antimetabolites|antimetabolites|mesh-ancestor
56048497|NCT02331095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048498|NCT02331095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55880043|NCT03125772|Tubulin Modulators|tubulin modulators|mesh-ancestor
55880044|NCT03125772|Antimitotic Agents|antimitotic agents|mesh-ancestor
55880045|NCT03125772|Mitosis Modulators|mitosis modulators|mesh-ancestor
55880046|NCT03125772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880047|NCT03125772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880048|NCT03125772|Immunologic Factors|immunologic factors|mesh-ancestor
55880049|NCT03125772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880050|NCT01447888|Morphine|morphine|mesh-list
55880051|NCT01447888|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55880052|NCT01447888|Narcotics|narcotics|mesh-ancestor
55880053|NCT01447888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880054|NCT01447888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880055|NCT01447888|Analgesics|analgesics|mesh-ancestor
55880056|NCT01447888|Sensory System Agents|sensory system agents|mesh-ancestor
55880057|NCT01447888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880058|NCT03389256|Apatinib|apatinib|mesh-list
55880059|NCT03389256|Gefitinib|gefitinib|mesh-list
55880060|NCT03389256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880061|NCT03389256|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56048499|NCT02331095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56048500|NCT02331095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048502|NCT02331095|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56048503|NCT02331095|Antithrombins|antithrombins|mesh-ancestor
56048504|NCT02331095|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56048505|NCT02331095|Protease Inhibitors|protease inhibitors|mesh-ancestor
56048506|NCT01640834|Glucagon|glucagon|mesh-list
56048507|NCT01640834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048508|NCT01640834|Hormones|hormones|mesh-ancestor
56048509|NCT01640834|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048510|NCT01640834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048511|NCT03029273|Cyclophosphamide|cyclophosphamide|mesh-list
56048512|NCT03029273|Fludarabine|fludarabine|mesh-list
55880062|NCT03389256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880063|NCT03389256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880064|NCT01490788|Amitriptyline|amitriptyline|mesh-list
55880065|NCT01490788|Cyclobenzaprine|cyclobenzaprine|mesh-list
55880066|NCT01490788|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55880067|NCT01490788|Antidepressive Agents|antidepressive agents|mesh-ancestor
55880068|NCT01490788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55880069|NCT01490788|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55880070|NCT01490788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880071|NCT01490788|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55880072|NCT01490788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880073|NCT01490788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55880074|NCT01490788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880075|NCT01490788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55880076|NCT01490788|Analgesics|analgesics|mesh-ancestor
55880077|NCT01490788|Sensory System Agents|sensory system agents|mesh-ancestor
55880078|NCT01490788|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55880079|NCT01490788|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55880080|NCT01490788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55880081|NCT01490788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880082|NCT01490788|Adrenergic Agents|adrenergic agents|mesh-ancestor
55880083|NCT01490788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880085|NCT02520180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880086|NCT02520180|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880092|NCT03391050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880093|NCT03391050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880094|NCT03397992|Dialysis Solutions|dialysis solutions|mesh-list
55880095|NCT03397992|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55880096|NCT03390972|Dexmedetomidine|dexmedetomidine|mesh-list
55880097|NCT03390972|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55880098|NCT03390972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880099|NCT03390972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880100|NCT03390972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55880102|NCT03390972|Sensory System Agents|sensory system agents|mesh-ancestor
55880103|NCT03390972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880104|NCT03390972|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55880105|NCT03390972|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55880106|NCT03390972|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55880107|NCT03390972|Adrenergic Agents|adrenergic agents|mesh-ancestor
55880108|NCT03390972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880109|NCT03390972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880110|NCT01550224|Temozolomide|temozolomide|mesh-list
55880111|NCT01550224|Vorinostat|vorinostat|mesh-list
56048513|NCT03029273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56048514|NCT03029273|Immunologic Factors|immunologic factors|mesh-ancestor
56048515|NCT03029273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048516|NCT03029273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56048517|NCT03029273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56048518|NCT03029273|Alkylating Agents|alkylating agents|mesh-ancestor
56048519|NCT03029273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048520|NCT03029273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048521|NCT03029273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56048523|NCT05316935|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56048524|NCT05316935|Cyproterone|cyproterone|mesh-list
56048525|NCT05316935|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
56048526|NCT05316935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048527|NCT05316935|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56048528|NCT05316935|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56048529|NCT05316935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048530|NCT05316935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048531|NCT05316935|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56048532|NCT05316935|Hormone Antagonists|hormone antagonists|mesh-ancestor
56048533|NCT05316935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880112|NCT01550224|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55880113|NCT01550224|Alkylating Agents|alkylating agents|mesh-ancestor
55880114|NCT01550224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880115|NCT01550224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880116|NCT01550224|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55880117|NCT01550224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880118|NCT04929600|Amlodipine|amlodipine|mesh-list
55880119|NCT04929600|Valsartan|valsartan|mesh-list
55880120|NCT04929600|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55880121|NCT04929600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55880122|NCT04929600|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55880123|NCT04929600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55880124|NCT04929600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880125|NCT04929600|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55880126|NCT04929600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880127|NCT04929600|Vasodilator Agents|vasodilator agents|mesh-ancestor
55880128|NCT04929600|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55880129|NCT04929600|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55880130|NCT01491022|4-Aminopyridine|4-aminopyridine|mesh-list
55880131|NCT01491022|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55880132|NCT01491022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55880133|NCT01491022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880135|NCT00782184|Simvastatin|simvastatin|mesh-list
55880136|NCT00782184|Ezetimibe|ezetimibe|mesh-list
55880137|NCT00782184|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
56048534|NCT05316935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048535|NCT05316935|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56048536|NCT05316935|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56048537|NCT05316935|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56048538|NCT05316935|Contraceptive Agents|contraceptive agents|mesh-ancestor
56048539|NCT05316935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56048540|NCT05316935|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56048541|NCT05316935|Estrogens|estrogens|mesh-ancestor
56048542|NCT05316935|Hormones|hormones|mesh-ancestor
56048543|NCT05316935|Androgen Antagonists|androgen antagonists|mesh-ancestor
56048544|NCT05738759|Anesthetics|anesthetics|mesh-list
56048545|NCT05738759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56048546|NCT05738759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048547|NCT05738681|Acetylcysteine|acetylcysteine|mesh-list
56048548|NCT05738681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56048549|NCT05738681|Antiviral Agents|antiviral agents|mesh-ancestor
56048550|NCT05738681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048551|NCT05738681|Expectorants|expectorants|mesh-ancestor
56048552|NCT05738681|Respiratory System Agents|respiratory system agents|mesh-ancestor
56048553|NCT05738681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56048554|NCT05738681|Antioxidants|antioxidants|mesh-ancestor
55891362|NCT02721537|Vitamins|vitamins|mesh-ancestor
55849735|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
56048555|NCT05738681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048556|NCT05738681|Protective Agents|protective agents|mesh-ancestor
56048557|NCT05738681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048558|NCT05738681|Antidotes|antidotes|mesh-ancestor
56048559|NCT01642082|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56048560|NCT01642082|Immunologic Factors|immunologic factors|mesh-ancestor
56048561|NCT01642082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048562|NCT02288819|Diuretics|diuretics|mesh-list
56048563|NCT02288819|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
56048564|NCT02288819|Natriuretic Agents|natriuretic agents|mesh-ancestor
56048565|NCT02288819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048566|NCT02288819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56048567|NCT02288819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048569|NCT01642238|Hirudins|hirudins|mesh-list
56048570|NCT01642238|Bivalirudin|bivalirudin|mesh-list
56048573|NCT01642238|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56048574|NCT01642238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56048575|NCT01642238|Analgesics|analgesics|mesh-ancestor
56048576|NCT01642238|Sensory System Agents|sensory system agents|mesh-ancestor
56048577|NCT01642238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048578|NCT01642238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048579|NCT01642238|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56048580|NCT01642238|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56048581|NCT01642238|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56048582|NCT01642238|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56048583|NCT01642238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048584|NCT01642238|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56048585|NCT01642238|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56048586|NCT01642238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048587|NCT01642238|Antipyretics|antipyretics|mesh-ancestor
56048588|NCT01642238|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56048589|NCT01642238|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56048590|NCT01642238|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56048591|NCT01642238|Purinergic Agents|purinergic agents|mesh-ancestor
56048592|NCT01642238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048593|NCT01642238|Antithrombins|antithrombins|mesh-ancestor
56048594|NCT01642238|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56048595|NCT01642238|Protease Inhibitors|protease inhibitors|mesh-ancestor
56048596|NCT01642238|Anticoagulants|anticoagulants|mesh-ancestor
56048597|NCT05710874|Fluorides|fluorides|mesh-list
56048598|NCT05710874|Cariostatic Agents|cariostatic agents|mesh-ancestor
56048599|NCT05710874|Protective Agents|protective agents|mesh-ancestor
56048600|NCT05710874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048601|NCT05259995|Oxymetazoline|oxymetazoline|mesh-list
56048602|NCT05259995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56048603|NCT05259995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55880138|NCT00782184|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55880139|NCT00782184|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55880140|NCT00782184|Antimetabolites|antimetabolites|mesh-ancestor
55880141|NCT00782184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880142|NCT00782184|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55880143|NCT00782184|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55880144|NCT00782184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880145|NCT03397914|Colistin|colistin|mesh-list
55880146|NCT03397914|Polymyxins|polymyxins|mesh-list
55880147|NCT03397914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55880148|NCT03397914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880149|NCT01450306|Cycloserine|cycloserine|mesh-list
56048604|NCT05259995|Adrenergic Agents|adrenergic agents|mesh-ancestor
56048605|NCT05259995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048606|NCT05259995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048607|NCT05259995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048608|NCT05259995|Sympathomimetics|sympathomimetics|mesh-ancestor
55849792|NCT01506856|Paclitaxel|paclitaxel|mesh-list
56048609|NCT05259995|Autonomic Agents|autonomic agents|mesh-ancestor
56048610|NCT05259995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048611|NCT05259995|Nasal Decongestants|nasal decongestants|mesh-ancestor
56048612|NCT05259995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56048613|NCT05259995|Respiratory System Agents|respiratory system agents|mesh-ancestor
56048614|NCT05737199|Pembrolizumab|pembrolizumab|mesh-list
56048615|NCT05737199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56048616|NCT05737199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048617|NCT03028883|Buprenorphine|buprenorphine|mesh-list
56048618|NCT03028883|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56048619|NCT03028883|Narcotics|narcotics|mesh-ancestor
56048620|NCT03028883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56048621|NCT03028883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048622|NCT03028883|Analgesics|analgesics|mesh-ancestor
56048623|NCT03028883|Sensory System Agents|sensory system agents|mesh-ancestor
56048624|NCT03028883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048625|NCT03028883|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56048626|NCT05238467|Antibodies|antibodies|mesh-list
56048627|NCT05238467|Immunologic Factors|immunologic factors|mesh-ancestor
56048628|NCT05238467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048629|NCT02290613|Ambrisentan|ambrisentan|mesh-list
56048630|NCT02290613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56048631|NCT05736419|Mycophenolic Acid|mycophenolic acid|mesh-list
56048632|NCT05736419|Dexamethasone|dexamethasone|mesh-list
56048633|NCT05736419|Cyclophosphamide|cyclophosphamide|mesh-list
56048634|NCT05736419|Rituximab|rituximab|mesh-list
56048649|NCT05736419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56048650|NCT05736419|Antiemetics|antiemetics|mesh-ancestor
56048651|NCT05736419|Autonomic Agents|autonomic agents|mesh-ancestor
56048652|NCT05736419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048653|NCT05736419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048654|NCT05736419|Glucocorticoids|glucocorticoids|mesh-ancestor
56048655|NCT05736419|Hormones|hormones|mesh-ancestor
56048656|NCT05736419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048657|NCT05736419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56048658|NCT05736419|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56048660|NCT05736419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56048661|NCT05736419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56048663|NCT05736419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56048664|NCT05736419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048665|NCT02986685|Rabeprazole|rabeprazole|mesh-list
56048708|NCT01611662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56048709|NCT01611662|Antimetabolites|antimetabolites|mesh-ancestor
56048710|NCT01611662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048711|NCT01611662|Antiviral Agents|antiviral agents|mesh-ancestor
56048712|NCT01611662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048713|NCT01611662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048714|NCT01611662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56048715|NCT01611662|Immunologic Factors|immunologic factors|mesh-ancestor
56048716|NCT01611662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048717|NCT05200481|Carboplatin|carboplatin|mesh-list
56048718|NCT05200481|Pemetrexed|pemetrexed|mesh-list
56048719|NCT05200481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048720|NCT05200481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048721|NCT05200481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048722|NCT05200481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55880150|NCT01450306|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55880151|NCT01450306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880152|NCT01450306|Renal Agents|renal agents|mesh-ancestor
55880153|NCT01450306|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55880154|NCT01450306|Antitubercular Agents|antitubercular agents|mesh-ancestor
55880155|NCT01450306|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55880157|NCT01450306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880158|NCT03126708|Paclitaxel|paclitaxel|mesh-list
55880159|NCT03126708|Cetuximab|cetuximab|mesh-list
55880160|NCT03126708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55880161|NCT03126708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880162|NCT03126708|Tubulin Modulators|tubulin modulators|mesh-ancestor
55880163|NCT03126708|Antimitotic Agents|antimitotic agents|mesh-ancestor
55880164|NCT03126708|Mitosis Modulators|mitosis modulators|mesh-ancestor
55880165|NCT03126708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880166|NCT03126708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55880168|NCT03390738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55880169|NCT03390738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880170|NCT03390738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55880171|NCT03390738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880172|NCT03390582|Methimazole|methimazole|mesh-list
55880173|NCT03390582|Antithyroid Agents|antithyroid agents|mesh-ancestor
55880174|NCT03390582|Hormone Antagonists|hormone antagonists|mesh-ancestor
55880175|NCT03390582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880176|NCT03390582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880177|NCT03385356|Vitamin D|vitamin d|mesh-list
55880178|NCT03385356|Vitamins|vitamins|mesh-ancestor
55880179|NCT03385356|Micronutrients|micronutrients|mesh-ancestor
55880180|NCT03385356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880181|NCT03385356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55880182|NCT03388866|Immunologic Factors|immunologic factors|mesh-list
55880183|NCT03388866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880184|NCT01873170|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55880185|NCT01873170|Contraceptive Agents|contraceptive agents|mesh-list
55880186|NCT01873170|Levonorgestrel|levonorgestrel|mesh-list
55880187|NCT01873170|Etonogestrel|etonogestrel|mesh-list
55880188|NCT01873170|Desogestrel|desogestrel|mesh-list
55880189|NCT01873170|Contraceptives, Oral|contraceptives, oral|mesh-list
55880190|NCT01873170|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56048744|NCT01646762|Tubulin Modulators|tubulin modulators|mesh-ancestor
56048745|NCT01646762|Antimitotic Agents|antimitotic agents|mesh-ancestor
56048747|NCT01646762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048748|NCT04997525|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56048749|NCT04997525|Estradiol|estradiol|mesh-list
56048750|NCT04997525|Progesterone|progesterone|mesh-list
56048751|NCT04997525|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56048752|NCT04997525|Estrogens|estrogens|mesh-ancestor
56048753|NCT04997525|Hormones|hormones|mesh-ancestor
56048754|NCT04997525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048755|NCT04997525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048757|NCT04997525|Progestins|progestins|mesh-ancestor
56048764|NCT04408313|Buprenorphine|buprenorphine|mesh-list
56048765|NCT04408313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56048766|NCT04408313|Narcotics|narcotics|mesh-ancestor
56048767|NCT04408313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56048768|NCT04408313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048769|NCT04408313|Analgesics|analgesics|mesh-ancestor
56048770|NCT04408313|Sensory System Agents|sensory system agents|mesh-ancestor
56048771|NCT04408313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048772|NCT04408313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56048773|NCT04408313|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56048774|NCT01619774|Trametinib|trametinib|mesh-list
56048775|NCT01619774|Dabrafenib|dabrafenib|mesh-list
56048776|NCT01619774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048777|NCT01619774|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56048778|NCT01619774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048779|NCT01619774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048780|NCT01651442|Zolpidem|zolpidem|mesh-list
56048781|NCT01651442|Trazodone|trazodone|mesh-list
56048782|NCT01651442|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56048783|NCT01651442|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56048784|NCT01651442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56048785|NCT01651442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048786|NCT01651442|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56048787|NCT01651442|GABA Agonists|gaba agonists|mesh-ancestor
56048788|NCT01651442|GABA Agents|gaba agents|mesh-ancestor
55880191|NCT01873170|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55880192|NCT01873170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880193|NCT01873170|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55880194|NCT01873170|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55891363|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
55880195|NCT01873170|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55880196|NCT01873170|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55880197|NCT01873170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55880198|NCT01873170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880199|NCT01873170|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55880200|NCT01873170|Progestins|progestins|mesh-ancestor
55880201|NCT01873170|Hormones|hormones|mesh-ancestor
55880202|NCT01873170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880203|NCT03125694|Pioglitazone|pioglitazone|mesh-list
55880205|NCT03125694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55880206|NCT03125694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880207|NCT03125694|Incretins|incretins|mesh-ancestor
55880208|NCT03125694|Hormones|hormones|mesh-ancestor
55880209|NCT03125694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880210|NCT03125694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55880211|NCT03125694|Protease Inhibitors|protease inhibitors|mesh-ancestor
55880212|NCT03125694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048789|NCT01651442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048790|NCT01651442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048791|NCT01651442|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56048792|NCT01651442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56048793|NCT01651442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56048794|NCT01651442|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56048795|NCT01651442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56048796|NCT01651442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56048797|NCT01651442|Serotonin Agents|serotonin agents|mesh-ancestor
56048798|NCT01651442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56048799|NCT01651442|Antidepressive Agents|antidepressive agents|mesh-ancestor
56048800|NCT05710406|Cetuximab|cetuximab|mesh-list
56048801|NCT05710406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56048802|NCT05710406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048803|NCT05710328|Deoxyglucose|deoxyglucose|mesh-list
56048804|NCT05710328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56048805|NCT05710328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56048806|NCT05710328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048807|NCT05710328|Antimetabolites|antimetabolites|mesh-ancestor
56048808|NCT05710328|Antiviral Agents|antiviral agents|mesh-ancestor
56048809|NCT05710328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048810|NCT05438420|Pembrolizumab|pembrolizumab|mesh-list
56048811|NCT05438420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56048812|NCT05438420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048813|NCT04901975|Spironolactone|spironolactone|mesh-list
56048814|NCT04901975|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56048815|NCT04901975|Hormone Antagonists|hormone antagonists|mesh-ancestor
56048816|NCT04901975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048831|NCT05421416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048832|NCT05069597|Pancrelipase|pancrelipase|mesh-list
56048833|NCT05069597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048835|NCT04868045|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
56048836|NCT04868045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048837|NCT04868045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048838|NCT04803539|Capecitabine|capecitabine|mesh-list
56048839|NCT04803539|Apatinib|apatinib|mesh-list
56048840|NCT04803539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56048841|NCT04803539|Antimetabolites|antimetabolites|mesh-ancestor
56048842|NCT04803539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048843|NCT04803539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048844|NCT04803539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56048845|NCT04803539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048846|NCT04799015|Dexamethasone|dexamethasone|mesh-list
56048847|NCT04799015|Metoclopramide|metoclopramide|mesh-list
56048848|NCT04799015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56048849|NCT04799015|Antiemetics|antiemetics|mesh-ancestor
56048850|NCT04799015|Autonomic Agents|autonomic agents|mesh-ancestor
56048851|NCT04799015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56048852|NCT04799015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048853|NCT04799015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048854|NCT04799015|Glucocorticoids|glucocorticoids|mesh-ancestor
56048855|NCT04799015|Hormones|hormones|mesh-ancestor
56048856|NCT04799015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048857|NCT04799015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55880214|NCT02731638|Voriconazole|voriconazole|mesh-list
55880215|NCT02731638|Natamycin|natamycin|mesh-list
55880216|NCT02731638|Antifungal Agents|antifungal agents|mesh-ancestor
55880217|NCT02731638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880218|NCT02731638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55880219|NCT02731638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55880220|NCT02731638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880221|NCT02731638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880222|NCT02731638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55880223|NCT02731638|Hormone Antagonists|hormone antagonists|mesh-ancestor
55880224|NCT02731638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880225|NCT02731638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880226|NCT02731638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55880228|NCT02731638|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55880230|NCT01451632|Cetuximab|cetuximab|mesh-list
55880231|NCT01451632|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56048859|NCT04799015|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56048860|NCT04799015|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56048861|NCT04799015|Dopamine Agents|dopamine agents|mesh-ancestor
56048862|NCT04799015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048863|NCT04799015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048864|NCT03141359|Paclitaxel|paclitaxel|mesh-list
56048865|NCT03141359|Etoposide|etoposide|mesh-list
56048866|NCT03141359|Carboplatin|carboplatin|mesh-list
56048867|NCT03141359|Durvalumab|durvalumab|mesh-list
56048868|NCT03141359|Cisplatin|cisplatin|mesh-list
56048869|NCT03141359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56048870|NCT03141359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048871|NCT03141359|Tubulin Modulators|tubulin modulators|mesh-ancestor
56048872|NCT03141359|Antimitotic Agents|antimitotic agents|mesh-ancestor
56048873|NCT03141359|Mitosis Modulators|mitosis modulators|mesh-ancestor
56048874|NCT03141359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048875|NCT03141359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56048876|NCT03141359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56048877|NCT03141359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048878|NCT03141359|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56048879|NCT01658228|Donepezil|donepezil|mesh-list
56048880|NCT01658228|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56048881|NCT01658228|Citalopram|citalopram|mesh-list
56048882|NCT01658228|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56048883|NCT01658228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048884|NCT01658228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048885|NCT01658228|Cholinergic Agents|cholinergic agents|mesh-ancestor
56048886|NCT01658228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048887|NCT01658228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048888|NCT01658228|Nootropic Agents|nootropic agents|mesh-ancestor
56048903|NCT01659866|Ceftriaxone|ceftriaxone|mesh-list
56048904|NCT01659866|Imipenem|imipenem|mesh-list
56048905|NCT01659866|Amikacin|amikacin|mesh-list
56048906|NCT01659866|Cefuroxime|cefuroxime|mesh-list
56048907|NCT01659866|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56048908|NCT01659866|Aztreonam|aztreonam|mesh-list
56048909|NCT01659866|Trimethoprim|trimethoprim|mesh-list
56048910|NCT01659866|Sulfamethoxazole|sulfamethoxazole|mesh-list
56048911|NCT01659866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56048912|NCT01659866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048913|NCT01659866|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56048914|NCT01659866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56048915|NCT01659866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048916|NCT01659866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048917|NCT01659866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880232|NCT01451632|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55880233|NCT01451632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880234|NCT01451632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880235|NCT01451632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880236|NCT01451632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55880237|NCT01491958|Methotrexate|methotrexate|mesh-list
55880238|NCT01491958|Atorvastatin|atorvastatin|mesh-list
55880239|NCT01491958|Tacrolimus|tacrolimus|mesh-list
55880240|NCT01491958|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55880241|NCT01491958|Abortifacient Agents|abortifacient agents|mesh-ancestor
55850258|NCT00472966|Tretinoin|tretinoin|mesh-list
55880242|NCT01491958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55880243|NCT01491958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880244|NCT01491958|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55880245|NCT01491958|Antimetabolites|antimetabolites|mesh-ancestor
55880246|NCT01491958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880247|NCT01491958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880248|NCT01491958|Dermatologic Agents|dermatologic agents|mesh-ancestor
55880249|NCT01491958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880250|NCT01491958|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55880251|NCT01491958|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880252|NCT01491958|Immunologic Factors|immunologic factors|mesh-ancestor
55880253|NCT01491958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880254|NCT01491958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55880255|NCT01491958|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55880256|NCT01491958|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55880257|NCT01491958|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55880258|NCT01491958|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55880259|NCT01491958|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55880260|NCT01492582|Vaccines|vaccines|mesh-list
55880261|NCT01492582|Immunologic Factors|immunologic factors|mesh-ancestor
55880262|NCT01492582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880263|NCT02214628|Becaplermin|becaplermin|mesh-list
55880264|NCT02214628|Anticoagulants|anticoagulants|mesh-ancestor
55880265|NCT02214628|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
55880266|NCT02214628|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55880267|NCT02214628|Growth Substances|growth substances|mesh-ancestor
55880268|NCT02214628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880269|NCT01495858|Naproxen|naproxen|mesh-list
55880270|NCT01495858|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55880271|NCT01495858|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55880272|NCT01495858|Analgesics|analgesics|mesh-ancestor
55880273|NCT01495858|Sensory System Agents|sensory system agents|mesh-ancestor
55880274|NCT01495858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880275|NCT01495858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048918|NCT01659866|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56048919|NCT01659866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56048920|NCT01659866|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56048921|NCT01659866|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56048922|NCT01659866|Renal Agents|renal agents|mesh-ancestor
56048923|NCT01659866|Antimalarials|antimalarials|mesh-ancestor
56048924|NCT01659866|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56048925|NCT01659866|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56048926|NCT01659866|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56048927|NCT01659866|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56048928|NCT01659866|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56048929|NCT02249702|Gemcitabine|gemcitabine|mesh-list
56048930|NCT02249702|Docetaxel|docetaxel|mesh-list
56048931|NCT02249702|Trabectedin|trabectedin|mesh-list
56048932|NCT02249702|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56048933|NCT02249702|Antimetabolites|antimetabolites|mesh-ancestor
56048934|NCT02249702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048935|NCT02249702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048936|NCT02249702|Antiviral Agents|antiviral agents|mesh-ancestor
56048937|NCT02249702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048938|NCT02249702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048939|NCT02249702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56048940|NCT02249702|Immunologic Factors|immunologic factors|mesh-ancestor
56048941|NCT02249702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048942|NCT02249702|Tubulin Modulators|tubulin modulators|mesh-ancestor
56048943|NCT02249702|Antimitotic Agents|antimitotic agents|mesh-ancestor
56048944|NCT02249702|Mitosis Modulators|mitosis modulators|mesh-ancestor
56048945|NCT02249702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56048946|NCT02249702|Alkylating Agents|alkylating agents|mesh-ancestor
56048947|NCT02947529|Tranexamic Acid|tranexamic acid|mesh-list
56048948|NCT02947529|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56048949|NCT02947529|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56048950|NCT02947529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048952|NCT02947529|Coagulants|coagulants|mesh-ancestor
56048953|NCT01660802|Dexamethasone|dexamethasone|mesh-list
56048954|NCT01660802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56048958|NCT01660802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048959|NCT01660802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56048961|NCT01660802|Hormones|hormones|mesh-ancestor
56048962|NCT01660802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048963|NCT01660802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56048964|NCT01660802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048965|NCT02899325|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56048966|NCT02899325|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56048967|NCT02899325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048968|NCT01661114|Gemcitabine|gemcitabine|mesh-list
56048969|NCT01661114|Fluorouracil|fluorouracil|mesh-list
56048970|NCT01661114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048971|NCT01661114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56048972|NCT01661114|Antimetabolites|antimetabolites|mesh-ancestor
56048973|NCT01661114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048974|NCT01661114|Antiviral Agents|antiviral agents|mesh-ancestor
56048975|NCT01661114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56048976|NCT01661114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56048977|NCT01661114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56048978|NCT01661114|Immunologic Factors|immunologic factors|mesh-ancestor
56048979|NCT01661114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048981|NCT02683265|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56048982|NCT02683265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048983|NCT02683265|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56048984|NCT02683265|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56048985|NCT02683265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55880276|NCT01495858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55880277|NCT01495858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880278|NCT01495858|Gout Suppressants|gout suppressants|mesh-ancestor
55880279|NCT01495858|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55880280|NCT01495858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880281|NCT01495858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880282|NCT01497496|Methylprednisolone|methylprednisolone|mesh-list
55880283|NCT01497496|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55880284|NCT01497496|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55880285|NCT01497496|Prednisolone|prednisolone|mesh-list
55880286|NCT01497496|Prednisolone acetate|prednisolone acetate|mesh-list
55880287|NCT01497496|Lenalidomide|lenalidomide|mesh-list
55880288|NCT01497496|Ofatumumab|ofatumumab|mesh-list
55880289|NCT01497496|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55880290|NCT01497496|Prednisolone phosphate|prednisolone phosphate|mesh-list
55880292|NCT01497496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880293|NCT01497496|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56048986|NCT02683265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56048988|NCT02683265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56048989|NCT02987829|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
56048990|NCT02987829|Androgen Antagonists|androgen antagonists|mesh-ancestor
56048991|NCT02987829|Hormone Antagonists|hormone antagonists|mesh-ancestor
56048992|NCT02987829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56048993|NCT02987829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56048994|NCT02988843|Bevacizumab|bevacizumab|mesh-list
56048995|NCT02988843|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56048996|NCT02988843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56048997|NCT02988843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56048998|NCT02988843|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56048999|NCT02988843|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56049000|NCT02988843|Growth Substances|growth substances|mesh-ancestor
56049001|NCT02988843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049002|NCT02988843|Growth Inhibitors|growth inhibitors|mesh-ancestor
56049003|NCT01661270|Aflibercept|aflibercept|mesh-list
56049004|NCT01661270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56049005|NCT01661270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56049006|NCT01661270|Growth Substances|growth substances|mesh-ancestor
56049007|NCT01661270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049008|NCT01661270|Growth Inhibitors|growth inhibitors|mesh-ancestor
56049009|NCT01661270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049011|NCT03000309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55880294|NCT01497496|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55880295|NCT01497496|Growth Substances|growth substances|mesh-ancestor
55880296|NCT01497496|Growth Inhibitors|growth inhibitors|mesh-ancestor
55880297|NCT01497496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880298|NCT01497496|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55880300|NCT01497496|Autonomic Agents|autonomic agents|mesh-ancestor
55880301|NCT01497496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880304|NCT01497496|Hormones|hormones|mesh-ancestor
55880305|NCT01497496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880306|NCT01497496|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55880307|NCT01497496|Protective Agents|protective agents|mesh-ancestor
55880308|NCT01497496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55880309|NCT02208310|Vitamin D|vitamin d|mesh-list
55880310|NCT02208310|Ergocalciferols|ergocalciferols|mesh-list
55880311|NCT02208310|Cholecalciferol|cholecalciferol|mesh-list
55880312|NCT02208310|Vitamins|vitamins|mesh-list
55880313|NCT02208310|Micronutrients|micronutrients|mesh-ancestor
55880314|NCT02208310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880315|NCT02208310|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56049012|NCT03000309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56049014|NCT03000309|Sensory System Agents|sensory system agents|mesh-ancestor
55880316|NCT02208310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55880317|NCT01454362|Nicotine|nicotine|mesh-list
55880318|NCT01454362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55880319|NCT01454362|Autonomic Agents|autonomic agents|mesh-ancestor
55880320|NCT01454362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880321|NCT01454362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880322|NCT01454362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55880323|NCT01454362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55880324|NCT01454362|Cholinergic Agents|cholinergic agents|mesh-ancestor
55880325|NCT01454362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880326|NCT01454362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880327|NCT01497808|Ipilimumab|ipilimumab|mesh-list
55880328|NCT01497808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55880329|NCT01497808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880330|NCT01497808|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55880331|NCT01497808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880332|NCT01498588|Cyclophosphamide|cyclophosphamide|mesh-list
55880333|NCT01498588|Doxorubicin|doxorubicin|mesh-list
55880334|NCT01498588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880335|NCT01498588|Immunologic Factors|immunologic factors|mesh-ancestor
55880336|NCT01498588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880337|NCT01498588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880338|NCT01498588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55880339|NCT01498588|Alkylating Agents|alkylating agents|mesh-ancestor
55880340|NCT01498588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880341|NCT01498588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880342|NCT01498588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55880343|NCT01498588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55880344|NCT01498588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55880345|NCT01498588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55880346|NCT01498588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880347|NCT01498744|Clindamycin|clindamycin|mesh-list
55880348|NCT01498744|Clindamycin palmitate|clindamycin palmitate|mesh-list
55880349|NCT01498744|Clindamycin phosphate|clindamycin phosphate|mesh-list
55880350|NCT01498744|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55880351|NCT01498744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880352|NCT01498744|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55880353|NCT01498744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880354|NCT01498744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880355|NCT01498978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55880356|NCT01498978|Ipilimumab|ipilimumab|mesh-list
55880357|NCT01498978|Antibodies|antibodies|mesh-list
55750942|NCT05052879|Tadalafil|tadalafil|mesh-list
55880359|NCT01498978|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55880360|NCT01498978|Immunologic Factors|immunologic factors|mesh-ancestor
55880361|NCT01498978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880362|NCT01498978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880363|NCT01498978|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55880364|NCT01498978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880365|NCT01458418|Montelukast|montelukast|mesh-list
55880366|NCT01458418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55880367|NCT01458418|Respiratory System Agents|respiratory system agents|mesh-ancestor
55880368|NCT01458418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55880369|NCT01458418|Hormone Antagonists|hormone antagonists|mesh-ancestor
55880370|NCT01458418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880371|NCT01458418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880372|NCT01458418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55880374|NCT01458418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880376|NCT01557322|Methotrexate|methotrexate|mesh-list
55880377|NCT01557322|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55880378|NCT01557322|Abortifacient Agents|abortifacient agents|mesh-ancestor
55880379|NCT01557322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55880380|NCT01557322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880381|NCT01557322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55880382|NCT01557322|Antimetabolites|antimetabolites|mesh-ancestor
55880383|NCT01557322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049015|NCT03000309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049016|NCT03000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049017|NCT03000309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56049018|NCT03000309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049019|NCT03000309|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56049020|NCT03000309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56049021|NCT03000309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886966|NCT02477436|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
56049022|NCT03000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049023|NCT02992028|Vitamins|vitamins|mesh-list
56049024|NCT02992028|Micronutrients|micronutrients|mesh-ancestor
56049025|NCT02992028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049026|NCT03165981|Vaccines|vaccines|mesh-list
56049027|NCT03165981|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56049028|NCT03165981|Immunologic Factors|immunologic factors|mesh-ancestor
56049029|NCT03165981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049030|NCT02249780|Parathyroid Hormone|parathyroid hormone|mesh-list
56049031|NCT02249780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56049032|NCT02249780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049033|NCT03170661|Rocuronium|rocuronium|mesh-list
56049034|NCT03170661|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56049035|NCT03170661|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56049036|NCT03170661|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56049037|NCT03170661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049038|NCT03170661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049039|NCT03175731|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56049040|NCT03175731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049041|NCT03175731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049042|NCT01662908|Heparin|heparin|mesh-list
56049043|NCT01662908|Enoxaparin|enoxaparin|mesh-list
56049044|NCT01662908|Calcium heparin|calcium heparin|mesh-list
56049045|NCT01662908|Warfarin|warfarin|mesh-list
56049046|NCT01662908|Edoxaban|edoxaban|mesh-list
56049047|NCT01662908|Anticoagulants|anticoagulants|mesh-ancestor
56049048|NCT01662908|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56049049|NCT01662908|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55880384|NCT01557322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880385|NCT01557322|Dermatologic Agents|dermatologic agents|mesh-ancestor
56049050|NCT01662908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049051|NCT01662908|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56049052|NCT01662908|Antithrombins|antithrombins|mesh-ancestor
56049053|NCT01662908|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56049054|NCT01662908|Protease Inhibitors|protease inhibitors|mesh-ancestor
56049055|NCT01662908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049056|NCT00375297|Sildenafil Citrate|sildenafil citrate|mesh-list
56049057|NCT00375297|Vasodilator Agents|vasodilator agents|mesh-ancestor
56049058|NCT00375297|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56049059|NCT00375297|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56049060|NCT00375297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049061|NCT00375297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049062|NCT00375297|Urological Agents|urological agents|mesh-ancestor
56049063|NCT02234570|Oxfendazole|oxfendazole|mesh-list
56049064|NCT02234570|Anthelmintics|anthelmintics|mesh-ancestor
56049065|NCT02234570|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56049066|NCT02234570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049067|NCT02234570|Antinematodal Agents|antinematodal agents|mesh-ancestor
56049068|NCT04525599|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56049069|NCT04525599|Immunologic Factors|immunologic factors|mesh-ancestor
56049070|NCT04525599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049071|NCT02240030|Levodopa|levodopa|mesh-list
56049072|NCT02240030|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56049073|NCT02240030|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56049074|NCT02240030|Dopamine Agents|dopamine agents|mesh-ancestor
56049075|NCT02240030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049076|NCT02240030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049077|NCT02240030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049078|NCT05183828|Letrozole|letrozole|mesh-list
56049079|NCT05183828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049080|NCT05183828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56049091|NCT03180489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56049092|NCT03180489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049094|NCT03471663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049095|NCT03471663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56049096|NCT03471663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049097|NCT03471663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049098|NCT01664858|Calcium|calcium|mesh-list
56049099|NCT01664858|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56049100|NCT01664858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049101|NCT04348695|Simvastatin|simvastatin|mesh-list
56049102|NCT04348695|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56049103|NCT04348695|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56049104|NCT04348695|Antimetabolites|antimetabolites|mesh-ancestor
56049105|NCT04348695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049106|NCT04348695|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56049107|NCT04348695|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56049108|NCT04348695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880386|NCT01557322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880387|NCT01557322|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55880388|NCT01557322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880389|NCT01557322|Immunologic Factors|immunologic factors|mesh-ancestor
55880390|NCT01557322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880391|NCT01557322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55880392|NCT01557322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55880393|NCT01557322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55880394|NCT01557322|Analgesics|analgesics|mesh-ancestor
55880395|NCT01557322|Sensory System Agents|sensory system agents|mesh-ancestor
55880396|NCT01557322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880397|NCT01557322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55880398|NCT01557322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55880399|NCT01459588|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55880400|NCT01459588|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55880401|NCT01459588|Lubricant Eye Drops|lubricant eye drops|mesh-list
55880402|NCT01459588|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55880403|NCT01459588|Laxatives|laxatives|mesh-ancestor
55880404|NCT01459588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55880405|NCT01501162|Ethanol|ethanol|mesh-list
55880406|NCT01501162|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55880407|NCT01501162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880408|NCT01501162|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880409|NCT01501162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750958|NCT02493335|Budesonide|budesonide|mesh-list
55880410|NCT01557868|Hyaluronic Acid|hyaluronic acid|mesh-list
55880412|NCT01557868|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55880413|NCT01557868|Immunologic Factors|immunologic factors|mesh-ancestor
55880414|NCT01557868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880415|NCT01557868|Viscosupplements|viscosupplements|mesh-ancestor
55880416|NCT01557868|Protective Agents|protective agents|mesh-ancestor
55880418|NCT02208466|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55880419|NCT02208466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55880420|NCT02208466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55880421|NCT02208466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880422|NCT02208466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880423|NCT02208466|Serotonin Agents|serotonin agents|mesh-ancestor
56049109|NCT04316871|Morphine|morphine|mesh-list
56049110|NCT04316871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56049111|NCT04316871|Narcotics|narcotics|mesh-ancestor
56049112|NCT04316871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049113|NCT04316871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049114|NCT04316871|Analgesics|analgesics|mesh-ancestor
56049115|NCT04316871|Sensory System Agents|sensory system agents|mesh-ancestor
56049116|NCT04316871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049117|NCT05364567|Vitamin D|vitamin d|mesh-list
56049118|NCT05364567|Cholecalciferol|cholecalciferol|mesh-list
56049119|NCT05364567|Vitamins|vitamins|mesh-ancestor
56049120|NCT05364567|Micronutrients|micronutrients|mesh-ancestor
56049121|NCT05364567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049122|NCT05364567|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56049123|NCT05364567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56049124|NCT00375765|Dutasteride|dutasteride|mesh-list
56049125|NCT00375765|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56049126|NCT00375765|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56049127|NCT00375765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049128|NCT00375765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049129|NCT00375765|Hormone Antagonists|hormone antagonists|mesh-ancestor
56049130|NCT00375765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56049131|NCT00375765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049132|NCT03325647|Methyltestosterone|methyltestosterone|mesh-list
56049133|NCT03325647|Testosterone|testosterone|mesh-list
56049134|NCT03325647|Testosterone undecanoate|testosterone undecanoate|mesh-list
56049135|NCT03325647|Testosterone enanthate|testosterone enanthate|mesh-list
56049136|NCT03325647|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56049137|NCT03325647|Androgens|androgens|mesh-ancestor
56049138|NCT03325647|Hormones|hormones|mesh-ancestor
56049140|NCT03325647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049152|NCT01667978|Ritonavir|ritonavir|mesh-list
56049153|NCT01667978|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56049154|NCT01667978|Norethindrone|norethindrone|mesh-list
56049155|NCT01667978|Norethindrone Acetate|norethindrone acetate|mesh-list
56049156|NCT01667978|Protease Inhibitors|protease inhibitors|mesh-list
56049157|NCT01667978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56049158|NCT01667978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56049159|NCT01667978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049160|NCT01667978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049161|NCT01667978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56049162|NCT01667978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56049163|NCT01667978|Antiviral Agents|antiviral agents|mesh-ancestor
56049164|NCT01667978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049165|NCT01667978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56049166|NCT01667978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56049167|NCT01667978|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56049168|NCT01667978|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56049169|NCT01667978|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56049170|NCT01667978|Contraceptive Agents|contraceptive agents|mesh-ancestor
56049171|NCT01667978|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55880424|NCT02208466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880425|NCT02208466|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55880426|NCT02208466|Antidepressive Agents|antidepressive agents|mesh-ancestor
55880427|NCT02208466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55880428|NCT02208466|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55880429|NCT02208466|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55880430|NCT02208466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880431|NCT02209948|Temozolomide|temozolomide|mesh-list
55880432|NCT02209948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55880433|NCT02209948|Alkylating Agents|alkylating agents|mesh-ancestor
55880434|NCT02209948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880435|NCT02209948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880436|NCT02981212|Mycophenolic Acid|mycophenolic acid|mesh-list
55880437|NCT02981212|Prednisolone|prednisolone|mesh-list
55880438|NCT02981212|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55880439|NCT02981212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55880440|NCT02981212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880441|NCT02981212|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55880442|NCT02981212|Antitubercular Agents|antitubercular agents|mesh-ancestor
55880443|NCT02981212|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55880444|NCT02981212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880446|NCT02981212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880447|NCT02981212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55880448|NCT02981212|Glucocorticoids|glucocorticoids|mesh-ancestor
55880450|NCT02981212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880451|NCT02981212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880452|NCT02981212|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55880453|NCT02981212|Protease Inhibitors|protease inhibitors|mesh-ancestor
55880454|NCT01464190|Sevelamer|sevelamer|mesh-list
55880455|NCT01464190|Chelating Agents|chelating agents|mesh-ancestor
55880456|NCT01464190|Sequestering Agents|sequestering agents|mesh-ancestor
55880457|NCT01464190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049172|NCT01667978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049173|NCT01667978|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56049174|NCT01667978|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56049175|NCT03282669|Morphine|morphine|mesh-list
56049176|NCT03282669|Hydromorphone|hydromorphone|mesh-list
56049177|NCT03282669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56049178|NCT03282669|Narcotics|narcotics|mesh-ancestor
56049179|NCT03282669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049180|NCT03282669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049181|NCT03282669|Analgesics|analgesics|mesh-ancestor
56049182|NCT03282669|Sensory System Agents|sensory system agents|mesh-ancestor
56049183|NCT03282669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049184|NCT00375843|Citalopram|citalopram|mesh-list
56049185|NCT00375843|Sertraline|sertraline|mesh-list
56049186|NCT00375843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56049187|NCT00375843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56049188|NCT00375843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56049189|NCT00375843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049190|NCT00375843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049191|NCT00375843|Serotonin Agents|serotonin agents|mesh-ancestor
56049192|NCT00375843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049193|NCT00375843|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55880458|NCT01466764|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55880459|NCT01466764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880460|NCT01563406|Ethanol|ethanol|mesh-list
55880461|NCT01563406|Chlorhexidine|chlorhexidine|mesh-list
55880462|NCT01563406|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55880463|NCT01563406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880464|NCT01563406|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880465|NCT01563406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880466|NCT01563406|Disinfectants|disinfectants|mesh-ancestor
55880467|NCT01468012|Levodopa|levodopa|mesh-list
55880468|NCT01468012|Carbidopa|carbidopa|mesh-list
55880469|NCT01468012|Entacapone|entacapone|mesh-list
55880470|NCT01468012|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55880471|NCT01468012|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55880472|NCT01468012|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55880473|NCT01468012|Dopamine Agents|dopamine agents|mesh-ancestor
55880474|NCT01468012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880475|NCT01468012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880476|NCT01468012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880477|NCT01468012|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55880478|NCT01468012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880479|NCT01468012|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55880480|NCT01468012|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55880481|NCT01468012|Immunologic Factors|immunologic factors|mesh-ancestor
55880482|NCT01468012|Dopamine Agonists|dopamine agonists|mesh-ancestor
55880484|NCT01468558|Antifungal Agents|antifungal agents|mesh-ancestor
55880485|NCT01468558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880486|NCT01468558|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55880487|NCT01468558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56049194|NCT00375843|Antidepressive Agents|antidepressive agents|mesh-ancestor
56049195|NCT00375843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56049196|NCT03247569|Edoxaban|edoxaban|mesh-list
56049197|NCT03247569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56049198|NCT03247569|Antithrombins|antithrombins|mesh-ancestor
56049199|NCT03247569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56049200|NCT03247569|Protease Inhibitors|protease inhibitors|mesh-ancestor
56049201|NCT03247569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049202|NCT03247569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049203|NCT03247569|Anticoagulants|anticoagulants|mesh-ancestor
56049204|NCT01668836|Resveratrol|resveratrol|mesh-list
56049205|NCT01668836|Antioxidants|antioxidants|mesh-ancestor
56049206|NCT01668836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049207|NCT01668836|Protective Agents|protective agents|mesh-ancestor
56049208|NCT01668836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049209|NCT01668836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049210|NCT01668836|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56049211|NCT02849457|Vigabatrin|vigabatrin|mesh-list
56049212|NCT02849457|Anticonvulsants|anticonvulsants|mesh-ancestor
56049213|NCT02849457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049214|NCT02849457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049215|NCT02849457|GABA Agents|gaba agents|mesh-ancestor
56049216|NCT02849457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049217|NCT02849457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049218|NCT03744663|Buprenorphine|buprenorphine|mesh-list
56049245|NCT05667662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56049246|NCT05667662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56049247|NCT05667662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049248|NCT05667662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049249|NCT05667662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56049250|NCT05667662|Hormone Antagonists|hormone antagonists|mesh-ancestor
56049251|NCT05667662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56049252|NCT05667662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049253|NCT05667662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56049254|NCT02751255|Tretinoin|tretinoin|mesh-list
56049255|NCT02751255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049256|NCT02751255|Keratolytic Agents|keratolytic agents|mesh-ancestor
56049257|NCT02751255|Dermatologic Agents|dermatologic agents|mesh-ancestor
56049258|NCT04333095|Bupivacaine|bupivacaine|mesh-list
56049259|NCT04333095|Anesthetics, Local|anesthetics, local|mesh-ancestor
56049260|NCT04333095|Anesthetics|anesthetics|mesh-ancestor
56049261|NCT04333095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049262|NCT04333095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049263|NCT04333095|Sensory System Agents|sensory system agents|mesh-ancestor
56049264|NCT04333095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049265|NCT05045144|Vaccines|vaccines|mesh-list
55880488|NCT01468558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880489|NCT01468558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880490|NCT01468558|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55880491|NCT01468558|Hormone Antagonists|hormone antagonists|mesh-ancestor
55880492|NCT01468558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880493|NCT01468558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880494|NCT01468558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55880495|NCT03730662|Insulin Glargine|insulin glargine|mesh-list
55880496|NCT03730662|Tirzepatide|tirzepatide|mesh-list
55880497|NCT03730662|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55880498|NCT03730662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880499|NCT03730662|Incretins|incretins|mesh-ancestor
55880500|NCT03730662|Hormones|hormones|mesh-ancestor
55880501|NCT03730662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880502|NCT01509586|Lobeline|lobeline|mesh-list
55880503|NCT01509586|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55880504|NCT01509586|Autonomic Agents|autonomic agents|mesh-ancestor
55880505|NCT01509586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880506|NCT01509586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880507|NCT01509586|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55880508|NCT01509586|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55851481|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
55880509|NCT01509586|Cholinergic Agents|cholinergic agents|mesh-ancestor
55880510|NCT01509586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880511|NCT01509586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880512|NCT01509586|Respiratory System Agents|respiratory system agents|mesh-ancestor
55880513|NCT01470118|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55880514|NCT01470118|Dextrans|dextrans|mesh-list
55880515|NCT01470118|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55880516|NCT01470118|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56049266|NCT05045144|Immunologic Factors|immunologic factors|mesh-ancestor
56049267|NCT05045144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049268|NCT05357079|Tranexamic Acid|tranexamic acid|mesh-list
56049269|NCT05357079|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56049270|NCT05357079|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56049271|NCT05357079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049273|NCT05357079|Coagulants|coagulants|mesh-ancestor
56049274|NCT00375687|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55776457|NCT02399137|Gemcitabine|gemcitabine|mesh-list
56049275|NCT00375687|Luteolytic Agents|luteolytic agents|mesh-ancestor
56049276|NCT00375687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56049277|NCT00375687|Contraceptive Agents|contraceptive agents|mesh-ancestor
56049278|NCT00375687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56049279|NCT00375687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049280|NCT00375687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56049281|NCT00375687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56049282|NCT00375687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049284|NCT01658241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049285|NCT01658241|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56049286|NCT01658241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049287|NCT01658241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049288|NCT01455051|Ofatumumab|ofatumumab|mesh-list
56049289|NCT01455051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049290|NCT01673828|Pregnanolone|pregnanolone|mesh-list
55880520|NCT01470118|Plasma Substitutes|plasma substitutes|mesh-ancestor
55880521|NCT01470118|Blood Substitutes|blood substitutes|mesh-ancestor
55880522|NCT01470118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55880523|NCT01470118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55880524|NCT01470118|Analgesics|analgesics|mesh-ancestor
55880525|NCT01470118|Sensory System Agents|sensory system agents|mesh-ancestor
55880526|NCT01470118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880527|NCT01470118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880528|NCT01470118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55880529|NCT01470118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880530|NCT01470118|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55880531|NCT01470118|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55880532|NCT01470118|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55880533|NCT01470118|Histamine Antagonists|histamine antagonists|mesh-ancestor
55880534|NCT01470118|Histamine Agents|histamine agents|mesh-ancestor
55880535|NCT01470118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880536|NCT01470118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880537|NCT03390036|Triamcinolone|triamcinolone|mesh-list
55880538|NCT03390036|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55880539|NCT03390036|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55750975|NCT03337607|Eperisone|eperisone|mesh-list
55880540|NCT03390036|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55880541|NCT03390036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56049291|NCT01673828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56049292|NCT01673828|Anesthetics|anesthetics|mesh-ancestor
56049293|NCT01673828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049294|NCT01673828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049295|NCT05325099|Azacitidine|azacitidine|mesh-list
56049296|NCT05325099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56049297|NCT05325099|Antimetabolites|antimetabolites|mesh-ancestor
56049298|NCT05325099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049299|NCT05325099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049300|NCT05325099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049301|NCT05293509|Cyclosporine|cyclosporine|mesh-list
56049302|NCT05293509|Mycophenolic Acid|mycophenolic acid|mesh-list
56049303|NCT05293509|Dexamethasone|dexamethasone|mesh-list
56049304|NCT05293509|Cyclophosphamide|cyclophosphamide|mesh-list
56049305|NCT05293509|Busulfan|busulfan|mesh-list
56049306|NCT05293509|Rituximab|rituximab|mesh-list
56049307|NCT05293509|Fludarabine|fludarabine|mesh-list
56049308|NCT05293509|Bortezomib|bortezomib|mesh-list
56049309|NCT05293509|Tacrolimus|tacrolimus|mesh-list
56049310|NCT05293509|Cyclosporins|cyclosporins|mesh-list
56049311|NCT05293509|Thymoglobulin|thymoglobulin|mesh-list
56049312|NCT05293509|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56049313|NCT05293509|Immunologic Factors|immunologic factors|mesh-ancestor
56049314|NCT05293509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049315|NCT05293509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049316|NCT05293509|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56049317|NCT05293509|Alkylating Agents|alkylating agents|mesh-ancestor
56049318|NCT05293509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049319|NCT05293509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049320|NCT05293509|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56049322|NCT05293509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56049323|NCT05293509|Antiemetics|antiemetics|mesh-ancestor
56049324|NCT05293509|Autonomic Agents|autonomic agents|mesh-ancestor
56049325|NCT05293509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049326|NCT05293509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56049327|NCT05293509|Glucocorticoids|glucocorticoids|mesh-ancestor
56049328|NCT05293509|Hormones|hormones|mesh-ancestor
55880542|NCT03390036|Glucocorticoids|glucocorticoids|mesh-ancestor
56049330|NCT05293509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56049332|NCT05293509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049333|NCT05293509|Antifungal Agents|antifungal agents|mesh-ancestor
56049334|NCT05293509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049335|NCT05293509|Dermatologic Agents|dermatologic agents|mesh-ancestor
56049336|NCT05293509|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56049337|NCT05293509|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56049338|NCT05293509|Antitubercular Agents|antitubercular agents|mesh-ancestor
56049339|NCT05293509|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56049340|NCT04736433|Valsartan|valsartan|mesh-list
56049341|NCT04736433|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56049342|NCT04736433|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56049343|NCT04736433|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56049344|NCT04736433|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56049345|NCT04736433|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55880543|NCT03390036|Hormones|hormones|mesh-ancestor
55880544|NCT03390036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880545|NCT03390036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880546|NCT03390036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880547|NCT03390036|Immunologic Factors|immunologic factors|mesh-ancestor
55880548|NCT03390036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880549|NCT03390036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880550|NCT01470196|Dexamethasone|dexamethasone|mesh-list
55880551|NCT01470196|Rituximab|rituximab|mesh-list
56052870|NCT02335242|Urological Agents|urological agents|mesh-ancestor
55880552|NCT01470196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55880553|NCT01470196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880554|NCT01470196|Immunologic Factors|immunologic factors|mesh-ancestor
55880555|NCT01470196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880556|NCT01470196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880557|NCT01470196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55880558|NCT01470196|Antiemetics|antiemetics|mesh-ancestor
55880559|NCT01470196|Autonomic Agents|autonomic agents|mesh-ancestor
55880560|NCT01470196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880561|NCT01470196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55880562|NCT01470196|Glucocorticoids|glucocorticoids|mesh-ancestor
55880563|NCT01470196|Hormones|hormones|mesh-ancestor
55880564|NCT01470196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880565|NCT01470196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55880567|NCT03389958|Trace Elements|trace elements|mesh-ancestor
55880568|NCT03389958|Micronutrients|micronutrients|mesh-ancestor
55880569|NCT03389958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880570|NCT04446234|Risperidone|risperidone|mesh-list
55880571|NCT04446234|Aripiprazole|aripiprazole|mesh-list
55880572|NCT04446234|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55880573|NCT04446234|Ziprasidone|ziprasidone|mesh-list
55880574|NCT04446234|Amisulpride|amisulpride|mesh-list
55880575|NCT04446234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55880576|NCT04446234|Serotonin Agents|serotonin agents|mesh-ancestor
55880577|NCT04446234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880578|NCT04446234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880579|NCT04446234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880580|NCT04446234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55880581|NCT04446234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55880582|NCT04446234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880583|NCT04446234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56049346|NCT04736433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049347|NCT04736433|Protease Inhibitors|protease inhibitors|mesh-ancestor
56049348|NCT04736433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049349|NCT02296775|Rituximab|rituximab|mesh-list
56049350|NCT02296775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56049351|NCT02296775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049352|NCT02296775|Immunologic Factors|immunologic factors|mesh-ancestor
56049353|NCT02296775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049354|NCT02296775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049355|NCT01675778|Hydromorphone|hydromorphone|mesh-list
56049356|NCT01675778|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56049357|NCT01675778|Narcotics|narcotics|mesh-ancestor
56049358|NCT01675778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049359|NCT01675778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049360|NCT01675778|Analgesics|analgesics|mesh-ancestor
56049361|NCT01675778|Sensory System Agents|sensory system agents|mesh-ancestor
56049362|NCT01675778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049363|NCT04736589|Sirolimus|sirolimus|mesh-list
56049364|NCT04736589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56049365|NCT04736589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049366|NCT04736589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56049367|NCT04736589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880584|NCT04446234|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55880585|NCT04446234|Dopamine Agents|dopamine agents|mesh-ancestor
55880586|NCT04446234|Antidepressive Agents|antidepressive agents|mesh-ancestor
55880587|NCT04446234|Dopamine Agonists|dopamine agonists|mesh-ancestor
55880588|NCT04446234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55880589|NCT04446234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55880590|NCT04446234|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55880591|NCT04446234|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55880592|NCT04446234|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55880594|NCT01511068|Immunologic Factors|immunologic factors|mesh-ancestor
55880595|NCT01511068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880597|NCT03613506|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55880598|NCT03613506|Protease Inhibitors|protease inhibitors|mesh-ancestor
55880599|NCT03613506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880600|NCT03613506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880601|NCT03613506|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55880602|NCT01565902|Siponimod|siponimod|mesh-list
55880603|NCT01565902|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55750987|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
55880604|NCT01565902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880605|NCT01565902|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880606|NCT01565902|Immunologic Factors|immunologic factors|mesh-ancestor
55880607|NCT01565902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880608|NCT01566448|Ketamine|ketamine|mesh-list
55880609|NCT01566448|Analgesics|analgesics|mesh-ancestor
55880610|NCT01566448|Sensory System Agents|sensory system agents|mesh-ancestor
55880611|NCT01566448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880612|NCT01566448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880613|NCT01566448|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56049368|NCT04736589|Antifungal Agents|antifungal agents|mesh-ancestor
56049369|NCT04736589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56049370|NCT04736589|Immunologic Factors|immunologic factors|mesh-ancestor
56049371|NCT04736589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049372|NCT05201859|Capecitabine|capecitabine|mesh-list
56049373|NCT05201859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56049374|NCT05201859|Antimetabolites|antimetabolites|mesh-ancestor
56049375|NCT05201859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049376|NCT05201859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049377|NCT02594111|Colchicine|colchicine|mesh-list
56049378|NCT02594111|Gout Suppressants|gout suppressants|mesh-ancestor
56049379|NCT02594111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049380|NCT02594111|Tubulin Modulators|tubulin modulators|mesh-ancestor
56049381|NCT02594111|Antimitotic Agents|antimitotic agents|mesh-ancestor
56049382|NCT02594111|Mitosis Modulators|mitosis modulators|mesh-ancestor
56049383|NCT02594111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049384|NCT02594111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049385|NCT03186261|Chlorhexidine|chlorhexidine|mesh-list
56049386|NCT03186261|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56049387|NCT03186261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56049389|NCT03186261|Cariostatic Agents|cariostatic agents|mesh-ancestor
56049390|NCT03186261|Protective Agents|protective agents|mesh-ancestor
56049391|NCT03186261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049392|NCT03186261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56049393|NCT03186261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049394|NCT03186261|Disinfectants|disinfectants|mesh-ancestor
56049395|NCT03186261|Dermatologic Agents|dermatologic agents|mesh-ancestor
56049396|NCT02589353|Acarbose|acarbose|mesh-list
56049397|NCT02589353|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56049398|NCT02589353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049399|NCT02589353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049400|NCT02589353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56049401|NCT02589353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880614|NCT01566448|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55880615|NCT01566448|Anesthetics, General|anesthetics, general|mesh-ancestor
55880616|NCT01566448|Anesthetics|anesthetics|mesh-ancestor
55880617|NCT01566448|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880618|NCT01566448|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56049412|NCT04870112|Carboplatin|carboplatin|mesh-list
56049413|NCT04870112|Etoposide|etoposide|mesh-list
56049414|NCT04870112|Durvalumab|durvalumab|mesh-list
56049415|NCT04870112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049416|NCT04870112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56049417|NCT04870112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56049418|NCT04870112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56049419|NCT04870112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049420|NCT04870112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049421|NCT04870112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56049422|NCT02986607|Parathyroid Hormone|parathyroid hormone|mesh-list
56049423|NCT02986607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56049424|NCT02986607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049425|NCT01678976|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56049426|NCT01678976|Oxcarbazepine|oxcarbazepine|mesh-list
56049427|NCT01678976|Anticonvulsants|anticonvulsants|mesh-ancestor
56049428|NCT01678976|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56052871|NCT04883892|Hyaluronic Acid|hyaluronic acid|mesh-list
55851943|NCT00029536|Progesterone|progesterone|mesh-list
55880619|NCT01566448|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55880620|NCT01566448|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880621|NCT01566448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880622|NCT05565976|Aspirin|aspirin|mesh-list
55880623|NCT05565976|Insulin|insulin|mesh-list
55880624|NCT05565976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55880625|NCT05565976|Insulin Glargine|insulin glargine|mesh-list
55880626|NCT05565976|Dapagliflozin|dapagliflozin|mesh-list
55880627|NCT05565976|Insulin Lispro|insulin lispro|mesh-list
55880628|NCT05565976|Biguanides|biguanides|mesh-list
55880629|NCT05565976|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55880630|NCT05565976|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
55880631|NCT05565976|Meglitinide|meglitinide|mesh-list
55880632|NCT05565976|Clopidogrel|clopidogrel|mesh-list
55880633|NCT05565976|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55880634|NCT05565976|Atorvastatin|atorvastatin|mesh-list
55880635|NCT05565976|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55880636|NCT05565976|Pravastatin|pravastatin|mesh-list
55880637|NCT05565976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880638|NCT05565976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55880639|NCT05565976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55880640|NCT05565976|Antimetabolites|antimetabolites|mesh-ancestor
55880641|NCT05565976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880642|NCT05565976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55880643|NCT05565976|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55880644|NCT05565976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880645|NCT05565976|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55880646|NCT05565976|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55880647|NCT05565976|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55880648|NCT05565976|Purinergic Agents|purinergic agents|mesh-ancestor
55880649|NCT05565976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880650|NCT05565976|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55880651|NCT05565976|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55880652|NCT05565976|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55880653|NCT05565976|Analgesics|analgesics|mesh-ancestor
55880654|NCT05565976|Sensory System Agents|sensory system agents|mesh-ancestor
55880655|NCT05565976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880656|NCT05565976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55880657|NCT05565976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880658|NCT05565976|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56049429|NCT01678976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56049430|NCT01678976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56049431|NCT01678976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049432|NCT01678976|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56049433|NCT01678976|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56049435|NCT04645667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56049436|NCT04645667|Immunologic Factors|immunologic factors|mesh-ancestor
56049437|NCT04645667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049438|NCT04645667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56049439|NCT04645667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049440|NCT04645667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049441|NCT02249936|Omeprazole|omeprazole|mesh-list
56049442|NCT02249936|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56049443|NCT02249936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56049444|NCT02249936|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56049445|NCT02249936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049446|NCT02249936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049447|NCT04100135|Clopidogrel|clopidogrel|mesh-list
56049448|NCT04100135|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56049449|NCT04100135|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56049450|NCT04100135|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56049451|NCT04100135|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56049452|NCT04100135|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56049453|NCT04100135|Purinergic Agents|purinergic agents|mesh-ancestor
56049454|NCT04100135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049455|NCT04100135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049456|NCT04100135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049457|NCT03190005|Clopidogrel|clopidogrel|mesh-list
56049458|NCT03190005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56049459|NCT03190005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56049460|NCT03190005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56049465|NCT03190005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049466|NCT04816214|Carboplatin|carboplatin|mesh-list
56049467|NCT04816214|Pemetrexed|pemetrexed|mesh-list
56049468|NCT04816214|Osimertinib|osimertinib|mesh-list
56049469|NCT04816214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049470|NCT04816214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049471|NCT04816214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049472|NCT04816214|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56049473|NCT04816214|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56049474|NCT04816214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56049475|NCT01461915|Gemcitabine|gemcitabine|mesh-list
56049476|NCT01461915|Paclitaxel|paclitaxel|mesh-list
56049477|NCT01461915|Heparin|heparin|mesh-list
56049478|NCT01461915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56049479|NCT01461915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049480|NCT01461915|Tubulin Modulators|tubulin modulators|mesh-ancestor
56049481|NCT01461915|Antimitotic Agents|antimitotic agents|mesh-ancestor
56049482|NCT01461915|Mitosis Modulators|mitosis modulators|mesh-ancestor
56049483|NCT01461915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049484|NCT01461915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56049485|NCT01461915|Antimetabolites|antimetabolites|mesh-ancestor
56049486|NCT01461915|Antiviral Agents|antiviral agents|mesh-ancestor
56049487|NCT01461915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049488|NCT01461915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049489|NCT01461915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56049490|NCT01461915|Immunologic Factors|immunologic factors|mesh-ancestor
56049491|NCT01461915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049492|NCT01461915|Anticoagulants|anticoagulants|mesh-ancestor
56049493|NCT01461915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56049494|NCT01461915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56049496|NCT01682642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56049497|NCT01682642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049498|NCT01683422|Gemcitabine|gemcitabine|mesh-list
55776689|NCT04481971|Prednisolone|prednisolone|mesh-list
56049499|NCT01683422|Capecitabine|capecitabine|mesh-list
56049505|NCT01683422|Antiviral Agents|antiviral agents|mesh-ancestor
56049506|NCT01683422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049507|NCT01683422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049508|NCT01683422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56049509|NCT01683422|Immunologic Factors|immunologic factors|mesh-ancestor
56049510|NCT01683422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049511|NCT01683422|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56049512|NCT03194373|Carboplatin|carboplatin|mesh-list
56049513|NCT03194373|Palbociclib|palbociclib|mesh-list
56049514|NCT03194373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049515|NCT03194373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56049516|NCT03194373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049517|NCT03194373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049519|NCT05066061|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
56049520|NCT05066061|Sensory System Agents|sensory system agents|mesh-ancestor
56049521|NCT05066061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049522|NCT05066061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049523|NCT05066061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55891646|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
56049524|NCT05066061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049525|NCT05066061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56049526|NCT04781673|Lidocaine|lidocaine|mesh-list
56049527|NCT04781673|Ketamine|ketamine|mesh-list
56049528|NCT04781673|Anesthetics, Local|anesthetics, local|mesh-ancestor
56049529|NCT04781673|Anesthetics|anesthetics|mesh-ancestor
56049530|NCT04781673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049531|NCT04781673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049532|NCT04781673|Sensory System Agents|sensory system agents|mesh-ancestor
56049533|NCT04781673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049534|NCT04781673|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56049535|NCT04781673|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56049536|NCT04781673|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56049537|NCT04781673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56049538|NCT04781673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049539|NCT04781673|Analgesics|analgesics|mesh-ancestor
55880659|NCT05565976|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55880660|NCT05565976|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55880661|NCT05565976|Antipyretics|antipyretics|mesh-ancestor
55880662|NCT01566526|Dexamethasone|dexamethasone|mesh-list
56049540|NCT04781673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56049541|NCT04781673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56049542|NCT04781673|Anesthetics, General|anesthetics, general|mesh-ancestor
56049543|NCT04781673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56049544|NCT04781673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56049545|NCT04781673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049546|NCT03197025|Aldesleukin|aldesleukin|mesh-list
56049547|NCT03197025|Interleukin-2|interleukin-2|mesh-list
56049548|NCT03197025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049549|NCT03197025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56049550|NCT03197025|Analgesics|analgesics|mesh-ancestor
56049551|NCT03197025|Sensory System Agents|sensory system agents|mesh-ancestor
56049552|NCT03197025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049553|NCT03197025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049554|NCT03197025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56049555|NCT03197025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56049556|NCT03197025|Antiviral Agents|antiviral agents|mesh-ancestor
56049557|NCT03197025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049558|NCT02249546|Amoxicillin|amoxicillin|mesh-list
56049559|NCT02249546|Clarithromycin|clarithromycin|mesh-list
56049560|NCT02249546|Acetylcysteine|acetylcysteine|mesh-list
56049561|NCT02249546|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56049562|NCT02249546|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56049563|NCT02249546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049564|NCT02249546|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55880663|NCT01566526|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55880665|NCT01566526|Autonomic Agents|autonomic agents|mesh-ancestor
55880666|NCT01566526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892319|NCT01921335|Trastuzumab|trastuzumab|mesh-list
55892320|NCT01921335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892321|NCT01921335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892322|NCT02427724|Lidocaine|lidocaine|mesh-list
55892323|NCT02427724|Tetracaine|tetracaine|mesh-list
55892324|NCT02427724|Prilocaine|prilocaine|mesh-list
55892325|NCT02427724|Anesthetics, Local|anesthetics, local|mesh-list
55892326|NCT02427724|Anesthetics|anesthetics|mesh-list
55892327|NCT02427724|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892328|NCT02427724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892329|NCT02427724|Sensory System Agents|sensory system agents|mesh-ancestor
55880667|NCT01566526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880668|NCT01566526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55880669|NCT01566526|Glucocorticoids|glucocorticoids|mesh-ancestor
55880671|NCT01566526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880672|NCT01566526|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55880673|NCT01566526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880674|NCT01566838|Bupivacaine|bupivacaine|mesh-list
55880675|NCT01566838|Anesthetics, Local|anesthetics, local|mesh-ancestor
55880676|NCT01566838|Anesthetics|anesthetics|mesh-ancestor
56053476|NCT03886701|Leprostatic Agents|leprostatic agents|mesh-ancestor
55880677|NCT01566838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880678|NCT01566838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880679|NCT01566838|Sensory System Agents|sensory system agents|mesh-ancestor
55880680|NCT01566838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880681|NCT05565664|Magnesium Sulfate|magnesium sulfate|mesh-list
55880683|NCT05565664|Analgesics|analgesics|mesh-ancestor
55880684|NCT05565664|Sensory System Agents|sensory system agents|mesh-ancestor
55880685|NCT05565664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880686|NCT05565664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880687|NCT05565664|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55880688|NCT05565664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55880689|NCT05565664|Anesthetics, General|anesthetics, general|mesh-ancestor
55880690|NCT05565664|Anesthetics|anesthetics|mesh-ancestor
56049566|NCT02249546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049567|NCT02249546|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56049568|NCT02249546|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56049569|NCT02249546|Antiviral Agents|antiviral agents|mesh-ancestor
56049570|NCT02249546|Expectorants|expectorants|mesh-ancestor
56049571|NCT02249546|Respiratory System Agents|respiratory system agents|mesh-ancestor
56049572|NCT02249546|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56049573|NCT02249546|Antioxidants|antioxidants|mesh-ancestor
56049574|NCT02249546|Protective Agents|protective agents|mesh-ancestor
56049575|NCT02249546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049577|NCT02303093|gamma-Globulins|gamma-globulins|mesh-list
56049578|NCT02303093|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56049579|NCT02303093|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56049580|NCT02303093|Immunologic Factors|immunologic factors|mesh-ancestor
56049581|NCT02303093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049582|NCT04960215|Ubiquinone|ubiquinone|mesh-list
56049583|NCT04960215|Coenzyme Q10|coenzyme q10|mesh-list
56049584|NCT04960215|Micronutrients|micronutrients|mesh-ancestor
56049585|NCT04960215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049586|NCT04960215|Vitamins|vitamins|mesh-ancestor
56049587|NCT02333045|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56049588|NCT02333045|Maraviroc|maraviroc|mesh-list
56049589|NCT02333045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56049590|NCT02333045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55880691|NCT05565664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880692|NCT05565664|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55880693|NCT05565664|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55880694|NCT05565664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880695|NCT05565664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880696|NCT05565664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55880697|NCT05565664|Anticonvulsants|anticonvulsants|mesh-ancestor
55880698|NCT05565664|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55880699|NCT05565664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55880700|NCT05565664|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55880701|NCT05565664|Tocolytic Agents|tocolytic agents|mesh-ancestor
55880702|NCT05565664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55880703|NCT03125616|Vaccines|vaccines|mesh-list
55880704|NCT03125616|Immunologic Factors|immunologic factors|mesh-ancestor
55880705|NCT03125616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880707|NCT01568008|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55880708|NCT01568008|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55880709|NCT01568008|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55880710|NCT05658120|Epinephrine|epinephrine|mesh-list
55880711|NCT05658120|Racepinephrine|racepinephrine|mesh-list
55880712|NCT05658120|Norepinephrine|norepinephrine|mesh-list
55880713|NCT05658120|Epinephryl borate|epinephryl borate|mesh-list
55880714|NCT05658120|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56049591|NCT02333045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053477|NCT00552578|Buprenorphine|buprenorphine|mesh-list
56049592|NCT02333045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049593|NCT02333045|Antiviral Agents|antiviral agents|mesh-ancestor
56049594|NCT02333045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049595|NCT02333045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56049596|NCT02333045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56049597|NCT02333045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56049598|NCT02333045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56049599|NCT02333045|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56049601|NCT01684748|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56049602|NCT01684748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56049603|NCT01684748|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56049604|NCT01684748|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56049605|NCT01684748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049606|NCT04028063|Doxorubicin|doxorubicin|mesh-list
56049607|NCT04028063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56049608|NCT04028063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049609|NCT04028063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56049610|NCT04028063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56049611|NCT04028063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049612|NCT04028063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049613|NCT03998735|Lobeline|lobeline|mesh-list
56049614|NCT03998735|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56049615|NCT03998735|Autonomic Agents|autonomic agents|mesh-ancestor
55880715|NCT05658120|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55880716|NCT05658120|Adrenergic Agents|adrenergic agents|mesh-ancestor
55880717|NCT05658120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880718|NCT05658120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880719|NCT05658120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880720|NCT05658120|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55880721|NCT05658120|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55880722|NCT05658120|Autonomic Agents|autonomic agents|mesh-ancestor
55880723|NCT05658120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880724|NCT05658120|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55880725|NCT05658120|Respiratory System Agents|respiratory system agents|mesh-ancestor
55880726|NCT05658120|Mydriatics|mydriatics|mesh-ancestor
55880727|NCT05658120|Sympathomimetics|sympathomimetics|mesh-ancestor
55880728|NCT05658120|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55880729|NCT01514734|Timolol|timolol|mesh-list
55880730|NCT01514734|Brinzolamide|brinzolamide|mesh-list
55880731|NCT01514734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880732|NCT01514734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880733|NCT01514734|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55880734|NCT01514734|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55880735|NCT01514734|Adrenergic Agents|adrenergic agents|mesh-ancestor
55880736|NCT01514734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880738|NCT01514734|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56049616|NCT03998735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049617|NCT03998735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049618|NCT03998735|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56049619|NCT03998735|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56049620|NCT03998735|Cholinergic Agents|cholinergic agents|mesh-ancestor
56049621|NCT03998735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049622|NCT03998735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049623|NCT03998735|Respiratory System Agents|respiratory system agents|mesh-ancestor
56049625|NCT02314169|Ipilimumab|ipilimumab|mesh-list
56049627|NCT02314169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049628|NCT02314169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56049629|NCT02314169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049630|NCT01685684|Oxycodone|oxycodone|mesh-list
56049631|NCT01685684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56049632|NCT01685684|Narcotics|narcotics|mesh-ancestor
56049633|NCT01685684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880739|NCT01514734|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55880740|NCT01514734|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55880741|NCT01515046|Ascorbic Acid|ascorbic acid|mesh-list
55880742|NCT01515046|Gemcitabine|gemcitabine|mesh-list
55880743|NCT01515046|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55880744|NCT01515046|Antimetabolites|antimetabolites|mesh-ancestor
55880745|NCT01515046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880746|NCT01515046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880747|NCT01515046|Antiviral Agents|antiviral agents|mesh-ancestor
55880748|NCT01515046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880749|NCT01515046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880750|NCT01515046|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880751|NCT01515046|Immunologic Factors|immunologic factors|mesh-ancestor
55880752|NCT01515046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880753|NCT01515046|Antioxidants|antioxidants|mesh-ancestor
55880754|NCT01515046|Protective Agents|protective agents|mesh-ancestor
55880755|NCT01515046|Vitamins|vitamins|mesh-ancestor
55880756|NCT01515046|Micronutrients|micronutrients|mesh-ancestor
55880757|NCT01568944|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55880758|NCT01568944|Lansoprazole|lansoprazole|mesh-list
55880759|NCT01568944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880760|NCT01568944|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55880761|NCT01568944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55880762|NCT01568944|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55880763|NCT01568944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880764|NCT01568944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880765|NCT05565274|Pentazocine|pentazocine|mesh-list
55880766|NCT05565274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55880767|NCT05565274|Narcotics|narcotics|mesh-ancestor
55880768|NCT05565274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880769|NCT05565274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880770|NCT05565274|Analgesics|analgesics|mesh-ancestor
55880771|NCT05565274|Sensory System Agents|sensory system agents|mesh-ancestor
55880772|NCT05565274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880773|NCT05565274|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55880774|NCT05565274|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55880775|NCT05173584|Albuterol|albuterol|mesh-list
55880776|NCT05173584|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55880777|NCT05173584|Autonomic Agents|autonomic agents|mesh-ancestor
56049634|NCT01685684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049635|NCT01685684|Analgesics|analgesics|mesh-ancestor
56049636|NCT01685684|Sensory System Agents|sensory system agents|mesh-ancestor
56049637|NCT01685684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049638|NCT03978767|Acetaminophen|acetaminophen|mesh-list
56049639|NCT03978767|Ibuprofen|ibuprofen|mesh-list
56049640|NCT03978767|Ketorolac|ketorolac|mesh-list
56049641|NCT03978767|Oxycodone|oxycodone|mesh-list
56049642|NCT03978767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56049643|NCT03978767|Analgesics|analgesics|mesh-ancestor
56049644|NCT03978767|Sensory System Agents|sensory system agents|mesh-ancestor
56049645|NCT03978767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049646|NCT03978767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049647|NCT03978767|Antipyretics|antipyretics|mesh-ancestor
56049648|NCT03978767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55776834|NCT02682641|Rituximab|rituximab|mesh-list
56049649|NCT03978767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56049650|NCT03978767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049651|NCT03978767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56049652|NCT03978767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049653|NCT03978767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049655|NCT03978767|Narcotics|narcotics|mesh-ancestor
56049656|NCT03978767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049657|NCT04436133|Vaccines|vaccines|mesh-list
55880778|NCT05173584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880779|NCT05173584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880780|NCT05173584|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55880781|NCT05173584|Respiratory System Agents|respiratory system agents|mesh-ancestor
55880782|NCT05173584|Tocolytic Agents|tocolytic agents|mesh-ancestor
55880783|NCT05173584|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55880784|NCT05173584|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55880785|NCT05173584|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55880786|NCT05173584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55880787|NCT05173584|Adrenergic Agents|adrenergic agents|mesh-ancestor
55880788|NCT05173584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880789|NCT05173584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880790|NCT04671030|Glycopyrrolate|glycopyrrolate|mesh-list
55880791|NCT04671030|Neostigmine|neostigmine|mesh-list
55880792|NCT04671030|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55880793|NCT04671030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880794|NCT04671030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880795|NCT04671030|Cholinergic Agents|cholinergic agents|mesh-ancestor
55880796|NCT04671030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880797|NCT04671030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880798|NCT04671030|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55880799|NCT04671030|Autonomic Agents|autonomic agents|mesh-ancestor
55880800|NCT04671030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049658|NCT04436133|Immunologic Factors|immunologic factors|mesh-ancestor
56049659|NCT04436133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049660|NCT01685996|Zonisamide|zonisamide|mesh-list
56049661|NCT01685996|Anticonvulsants|anticonvulsants|mesh-ancestor
56049662|NCT01685996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56049663|NCT01685996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56049664|NCT01685996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886967|NCT02477436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56049665|NCT01685996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56049666|NCT01685996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049667|NCT03207399|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56049668|NCT03207399|Antiviral Agents|antiviral agents|mesh-ancestor
56049669|NCT03207399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049670|NCT04633148|Cyclophosphamide|cyclophosphamide|mesh-list
56049671|NCT04633148|Fludarabine|fludarabine|mesh-list
56049672|NCT04633148|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56049673|NCT04633148|Immunologic Factors|immunologic factors|mesh-ancestor
55880801|NCT04671030|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55880802|NCT04671030|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55880803|NCT04671030|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55880804|NCT04660890|Moxifloxacin|moxifloxacin|mesh-list
55880805|NCT04660890|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55880806|NCT04660890|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55880807|NCT04660890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880808|NCT04660890|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55880809|NCT04660890|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55880812|NCT04660890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880813|NCT04660890|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55880814|NCT04660890|Contraceptive Agents|contraceptive agents|mesh-ancestor
55880815|NCT04660890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55880816|NCT04660890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880817|NCT04660890|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55880818|NCT04660890|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55880819|NCT04660890|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55880821|NCT04632264|Oxytocics|oxytocics|mesh-ancestor
55880822|NCT04632264|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55880823|NCT04632264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880824|NCT04607928|Pirfenidone|pirfenidone|mesh-list
55880825|NCT04607928|Analgesics|analgesics|mesh-ancestor
55880826|NCT04607928|Sensory System Agents|sensory system agents|mesh-ancestor
55880827|NCT04607928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880828|NCT04607928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880829|NCT04607928|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55880830|NCT04607928|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55880831|NCT04607928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55880832|NCT04607928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880833|NCT04607928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880834|NCT03380442|Ketamine|ketamine|mesh-list
55880835|NCT03380442|Psilocybin|psilocybin|mesh-list
55880836|NCT03380442|Analgesics|analgesics|mesh-ancestor
55880837|NCT03380442|Sensory System Agents|sensory system agents|mesh-ancestor
55880838|NCT03380442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886968|NCT02477436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880839|NCT03380442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880840|NCT03380442|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55880841|NCT03380442|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55880842|NCT03380442|Anesthetics, General|anesthetics, general|mesh-ancestor
55880843|NCT03380442|Anesthetics|anesthetics|mesh-ancestor
56049674|NCT04633148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049675|NCT04633148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049676|NCT04633148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56049677|NCT04633148|Alkylating Agents|alkylating agents|mesh-ancestor
56049678|NCT04633148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049679|NCT04633148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049680|NCT04633148|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56049681|NCT04543409|Benralizumab|benralizumab|mesh-list
56049682|NCT04543409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56049683|NCT04543409|Respiratory System Agents|respiratory system agents|mesh-ancestor
56049684|NCT02196155|Cortisone|cortisone|mesh-list
56049685|NCT02196155|Botulinum Toxins|botulinum toxins|mesh-list
56049686|NCT02196155|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56049687|NCT02196155|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56049688|NCT02196155|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56049689|NCT02196155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56049690|NCT02196155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049691|NCT02196155|Cholinergic Agents|cholinergic agents|mesh-ancestor
55880844|NCT03380442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880845|NCT03380442|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55880846|NCT03380442|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55880847|NCT03380442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880848|NCT03380442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880849|NCT03380442|Hallucinogens|hallucinogens|mesh-ancestor
55880850|NCT03380442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55880851|NCT05172570|Gabapentin|gabapentin|mesh-list
55880852|NCT05172570|Analgesics|analgesics|mesh-ancestor
55880853|NCT05172570|Sensory System Agents|sensory system agents|mesh-ancestor
55880854|NCT05172570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880855|NCT05172570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880856|NCT05172570|Anticonvulsants|anticonvulsants|mesh-ancestor
55880857|NCT05172570|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55880858|NCT05172570|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55880859|NCT05172570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880860|NCT05172570|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55880861|NCT05172570|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55880862|NCT05172570|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55880863|NCT05172570|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55880864|NCT05172570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880865|NCT05172570|Antimanic Agents|antimanic agents|mesh-ancestor
55880866|NCT03380130|Nivolumab|nivolumab|mesh-list
55880867|NCT03380130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55880868|NCT03380130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880869|NCT03380130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55751021|NCT05051163|Gentamicins|gentamicins|mesh-list
55880870|NCT03380130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880871|NCT03386838|Carboplatin|carboplatin|mesh-list
55880872|NCT03386838|Fluorouracil|fluorouracil|mesh-list
55880873|NCT03386838|Nivolumab|nivolumab|mesh-list
55880874|NCT03386838|Cetuximab|cetuximab|mesh-list
55880875|NCT03386838|Linrodostat|linrodostat|mesh-list
55880876|NCT03386838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880877|NCT03386838|Antimetabolites|antimetabolites|mesh-ancestor
56049692|NCT02196155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049693|NCT02196155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049694|NCT02196155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56049695|NCT02196155|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56049696|NCT02196155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049698|NCT02175173|Anticonvulsants|anticonvulsants|mesh-ancestor
56049699|NCT02175173|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56049700|NCT02175173|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56049701|NCT02175173|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56049702|NCT02175173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049703|NCT02124941|Acetylcysteine|acetylcysteine|mesh-list
56049704|NCT02124941|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56049705|NCT02124941|Antiviral Agents|antiviral agents|mesh-ancestor
56049706|NCT02124941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049707|NCT02124941|Expectorants|expectorants|mesh-ancestor
56049708|NCT02124941|Respiratory System Agents|respiratory system agents|mesh-ancestor
56049709|NCT02124941|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56049710|NCT02124941|Antioxidants|antioxidants|mesh-ancestor
56049711|NCT02124941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887057|NCT03582774|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55887058|NCT03582774|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55887059|NCT01784614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55887060|NCT02474706|Imipenem|imipenem|mesh-list
55887062|NCT02474706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55887063|NCT02474706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887064|NCT01784770|Azithromycin|azithromycin|mesh-list
56051271|NCT00354653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56051272|NCT00354653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56051274|NCT00354653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051275|NCT00354653|Antiviral Agents|antiviral agents|mesh-ancestor
56051276|NCT00354653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051277|NCT00354653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56051278|NCT00354653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56051279|NCT00354731|Pentoxifylline|pentoxifylline|mesh-list
55880878|NCT03386838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880879|NCT03386838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55880880|NCT03386838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880881|NCT03386838|Immunologic Factors|immunologic factors|mesh-ancestor
55880885|NCT03386838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880886|NCT03379974|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55880887|NCT03379974|Hemostatics|hemostatics|mesh-ancestor
55880888|NCT03379974|Coagulants|coagulants|mesh-ancestor
55880889|NCT03379974|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55880890|NCT03379974|Natriuretic Agents|natriuretic agents|mesh-ancestor
55880891|NCT03379974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880892|NCT01570036|Trastuzumab|trastuzumab|mesh-list
55880893|NCT01570036|Molgramostim|molgramostim|mesh-list
55880894|NCT01570036|Sargramostim|sargramostim|mesh-list
55880895|NCT01570036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55880896|NCT01570036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880897|NCT01570036|Immunologic Factors|immunologic factors|mesh-ancestor
55880898|NCT01570036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880899|NCT01516684|Lidocaine|lidocaine|mesh-list
55880900|NCT01516684|Fentanyl|fentanyl|mesh-list
55880901|NCT01516684|Anesthetics, Local|anesthetics, local|mesh-list
55880902|NCT01516684|Prilocaine|prilocaine|mesh-list
55880903|NCT01516684|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55880904|NCT01516684|Propofol|propofol|mesh-list
55880905|NCT01516684|Anesthetics|anesthetics|mesh-list
55880906|NCT01516684|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55880907|NCT01516684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880908|NCT01516684|Sensory System Agents|sensory system agents|mesh-ancestor
55880909|NCT01516684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55880910|NCT01516684|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55880911|NCT01516684|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55880912|NCT01516684|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55880913|NCT01516684|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56049712|NCT02124941|Protective Agents|protective agents|mesh-ancestor
56049713|NCT02124941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049714|NCT02124941|Antidotes|antidotes|mesh-ancestor
56049716|NCT04121403|Cladribine|cladribine|mesh-list
56049717|NCT04121403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56049718|NCT04121403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049719|NCT04121403|Immunologic Factors|immunologic factors|mesh-ancestor
56049720|NCT04121403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049721|NCT04121403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049722|NCT04121403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56049723|NCT02049515|Ofatumumab|ofatumumab|mesh-list
56049724|NCT02049515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049725|NCT03224403|Acetaminophen|acetaminophen|mesh-list
56049726|NCT03224403|Ibuprofen|ibuprofen|mesh-list
56049727|NCT03224403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56049728|NCT03224403|Analgesics|analgesics|mesh-ancestor
56049729|NCT03224403|Sensory System Agents|sensory system agents|mesh-ancestor
56049730|NCT03224403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049731|NCT03224403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880914|NCT01516684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880915|NCT01516684|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55880916|NCT01516684|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55880917|NCT01516684|Anesthetics, General|anesthetics, general|mesh-ancestor
55880918|NCT01516684|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55880919|NCT01516684|Narcotics|narcotics|mesh-ancestor
55880920|NCT01516684|Analgesics|analgesics|mesh-ancestor
55880921|NCT01516684|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55880922|NCT01516684|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55880923|NCT01517074|Sirolimus|sirolimus|mesh-list
55880924|NCT01517074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55880925|NCT01517074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880926|NCT01517074|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55880927|NCT01517074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880928|NCT01517074|Antifungal Agents|antifungal agents|mesh-ancestor
55880929|NCT01517074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880930|NCT01517074|Immunologic Factors|immunologic factors|mesh-ancestor
55880931|NCT01517074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880932|NCT01570348|Mycophenolic Acid|mycophenolic acid|mesh-list
55880933|NCT01570348|Cyclophosphamide|cyclophosphamide|mesh-list
55880934|NCT01570348|Fludarabine|fludarabine|mesh-list
55880935|NCT01570348|Fludarabine phosphate|fludarabine phosphate|mesh-list
55880936|NCT01570348|Tacrolimus|tacrolimus|mesh-list
55880937|NCT01570348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880938|NCT01570348|Immunologic Factors|immunologic factors|mesh-ancestor
55880939|NCT01570348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880940|NCT01570348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880941|NCT01570348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55880942|NCT01570348|Alkylating Agents|alkylating agents|mesh-ancestor
55880943|NCT01570348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880944|NCT01570348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880945|NCT01570348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55880946|NCT01570348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55880948|NCT01570348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55880949|NCT01570348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880950|NCT01570348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55880951|NCT01570348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56049732|NCT03224403|Antipyretics|antipyretics|mesh-ancestor
56049733|NCT03224403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56049734|NCT03224403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56049735|NCT03224403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049736|NCT03224403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56049737|NCT03224403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049738|NCT03224403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049739|NCT02334059|Ketamine|ketamine|mesh-list
56049740|NCT02334059|Analgesics|analgesics|mesh-ancestor
56049741|NCT02334059|Sensory System Agents|sensory system agents|mesh-ancestor
56049742|NCT02334059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049743|NCT02334059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049744|NCT02334059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56049745|NCT02334059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56049746|NCT02334059|Anesthetics, General|anesthetics, general|mesh-ancestor
56049747|NCT02334059|Anesthetics|anesthetics|mesh-ancestor
56049748|NCT02334059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049749|NCT02334059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56049750|NCT02334059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56049751|NCT02334059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049752|NCT02334059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049753|NCT04501523|Capecitabine|capecitabine|mesh-list
56049754|NCT04501523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56049755|NCT04501523|Antimetabolites|antimetabolites|mesh-ancestor
56049756|NCT04501523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049757|NCT04501523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049758|NCT04499573|Cytarabine|cytarabine|mesh-list
56049759|NCT04499573|Dexamethasone|dexamethasone|mesh-list
56049760|NCT04499573|Cyclophosphamide|cyclophosphamide|mesh-list
56049761|NCT04499573|Fludarabine|fludarabine|mesh-list
56049762|NCT04499573|Etoposide|etoposide|mesh-list
56049763|NCT04499573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56049764|NCT04499573|Immunologic Factors|immunologic factors|mesh-ancestor
56049765|NCT04499573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049766|NCT04499573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049767|NCT04499573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56049769|NCT04499573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049770|NCT04499573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049771|NCT04499573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56049772|NCT04499573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56049773|NCT04499573|Antiemetics|antiemetics|mesh-ancestor
56049774|NCT04499573|Autonomic Agents|autonomic agents|mesh-ancestor
56049775|NCT04499573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049776|NCT04499573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56049777|NCT04499573|Glucocorticoids|glucocorticoids|mesh-ancestor
56049778|NCT04499573|Hormones|hormones|mesh-ancestor
56049779|NCT04499573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56049780|NCT04499573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56049781|NCT04499573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880952|NCT01570348|Antitubercular Agents|antitubercular agents|mesh-ancestor
55880953|NCT01570348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55880954|NCT01570348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55880957|NCT03383406|Etoposide|etoposide|mesh-list
55880958|NCT03383406|Ifosfamide|ifosfamide|mesh-list
55880959|NCT03383406|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55880960|NCT03383406|Abortifacient Agents|abortifacient agents|mesh-ancestor
55880961|NCT03383406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55880962|NCT03383406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880963|NCT03383406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55880964|NCT03383406|Antimetabolites|antimetabolites|mesh-ancestor
55880965|NCT03383406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880966|NCT03383406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880967|NCT03383406|Dermatologic Agents|dermatologic agents|mesh-ancestor
55880968|NCT03383406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880969|NCT03383406|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55880970|NCT03383406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55880971|NCT03383406|Immunologic Factors|immunologic factors|mesh-ancestor
55880972|NCT03383406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55880973|NCT03383406|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55880974|NCT03383406|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55880975|NCT03383406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55880976|NCT03383406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55880977|NCT03383406|Antiviral Agents|antiviral agents|mesh-ancestor
55880978|NCT03383406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893237|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
55880979|NCT03383406|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55880980|NCT03383406|Alkylating Agents|alkylating agents|mesh-ancestor
55880981|NCT04445922|Anastrozole|anastrozole|mesh-list
55880982|NCT04445922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55880983|NCT04445922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880984|NCT04445922|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55880985|NCT04445922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55880986|NCT04445922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893238|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
55880987|NCT04445922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880988|NCT04445922|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55880989|NCT04445922|Hormone Antagonists|hormone antagonists|mesh-ancestor
55880990|NCT04445922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880991|NCT04445922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880992|NCT03383328|Prednisolone|prednisolone|mesh-list
55880993|NCT03383328|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55880994|NCT03383328|Methylprednisolone|methylprednisolone|mesh-list
55880995|NCT03383328|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55880996|NCT03383328|Prednisolone acetate|prednisolone acetate|mesh-list
55880997|NCT03383328|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55880998|NCT03383328|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55880999|NCT03383328|Prednisolone phosphate|prednisolone phosphate|mesh-list
56049782|NCT04499573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56049784|NCT04499573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56049785|NCT04499573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55881000|NCT03383328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881003|NCT03383328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881004|NCT03383328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881005|NCT03383328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55881006|NCT03383328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881007|NCT03383328|Antiemetics|antiemetics|mesh-ancestor
55881008|NCT03383328|Autonomic Agents|autonomic agents|mesh-ancestor
55881009|NCT03383328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881010|NCT03383328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55881011|NCT03383328|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55881012|NCT03383328|Protective Agents|protective agents|mesh-ancestor
55881013|NCT03383328|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55881014|NCT03383328|Analgesics|analgesics|mesh-ancestor
55881015|NCT03383328|Sensory System Agents|sensory system agents|mesh-ancestor
55881016|NCT03383328|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881017|NCT01573702|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55881018|NCT01573702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881019|NCT01573702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55881020|NCT01573702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881021|NCT01573702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881022|NCT03093246|Aspirin|aspirin|mesh-list
55881023|NCT03093246|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55881024|NCT03093246|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55881025|NCT03093246|Analgesics|analgesics|mesh-ancestor
55881026|NCT03093246|Sensory System Agents|sensory system agents|mesh-ancestor
55881027|NCT03093246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881030|NCT03093246|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881031|NCT03093246|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55881032|NCT03093246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55881033|NCT03093246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881034|NCT03093246|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55881035|NCT03093246|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55881036|NCT03093246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881037|NCT03093246|Antipyretics|antipyretics|mesh-ancestor
55881038|NCT02969928|Amoxicillin|amoxicillin|mesh-list
55881039|NCT02969928|Metronidazole|metronidazole|mesh-list
55881040|NCT02969928|Clarithromycin|clarithromycin|mesh-list
55881041|NCT02969928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55881042|NCT02969928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881043|NCT02969928|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55881044|NCT02969928|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55881045|NCT02969928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55881046|NCT02969928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881047|NCT02969928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881048|NCT02969928|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55881049|NCT02969928|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55881050|NCT02968446|Vitamin D|vitamin d|mesh-list
55881051|NCT02968446|Cholecalciferol|cholecalciferol|mesh-list
55881052|NCT02968446|Mechlorethamine|mechlorethamine|mesh-list
55881053|NCT02968446|Vitamins|vitamins|mesh-ancestor
55881054|NCT02968446|Micronutrients|micronutrients|mesh-ancestor
55881055|NCT02968446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881056|NCT02968446|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55881057|NCT02968446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55881058|NCT02968446|Alkylating Agents|alkylating agents|mesh-ancestor
55881059|NCT02968446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881060|NCT02968446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55881061|NCT02968446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881062|NCT03378960|Omeprazole|omeprazole|mesh-list
55881063|NCT03378960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55881064|NCT03378960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55881065|NCT03378960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55881066|NCT03378960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049786|NCT04499573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56049787|NCT04499573|Antiviral Agents|antiviral agents|mesh-ancestor
56049788|NCT04499573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049789|NCT03425097|Fexofenadine|fexofenadine|mesh-list
56049790|NCT03425097|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56049791|NCT03425097|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56049792|NCT03425097|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56049793|NCT03425097|Histamine Antagonists|histamine antagonists|mesh-ancestor
56049794|NCT03425097|Histamine Agents|histamine agents|mesh-ancestor
56049795|NCT03425097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049796|NCT03425097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049797|NCT03425097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049798|NCT01926041|Varenicline|varenicline|mesh-list
56049799|NCT01926041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56049800|NCT01926041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56049801|NCT01926041|Cholinergic Agents|cholinergic agents|mesh-ancestor
56049802|NCT01926041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049803|NCT01926041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049804|NCT01926041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049805|NCT01769027|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56049806|NCT01769027|Azithromycin|azithromycin|mesh-list
55881067|NCT03378960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881068|NCT02907996|Sofosbuvir|sofosbuvir|mesh-list
55881069|NCT02907996|Antiviral Agents|antiviral agents|mesh-ancestor
55881070|NCT02907996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881071|NCT03383094|Pembrolizumab|pembrolizumab|mesh-list
55881072|NCT03383094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881073|NCT03383094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55881074|NCT03378726|Micronutrients|micronutrients|mesh-list
55881075|NCT03378726|Trace Elements|trace elements|mesh-list
55881076|NCT03378726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881077|NCT05137938|Ketamine|ketamine|mesh-list
55881078|NCT05137938|Analgesics|analgesics|mesh-ancestor
55881079|NCT05137938|Sensory System Agents|sensory system agents|mesh-ancestor
55881080|NCT05137938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881081|NCT05137938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881082|NCT05137938|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55881083|NCT05137938|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55881084|NCT05137938|Anesthetics, General|anesthetics, general|mesh-ancestor
55881085|NCT05137938|Anesthetics|anesthetics|mesh-ancestor
55881086|NCT05137938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55881087|NCT05137938|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55881088|NCT05137938|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55881089|NCT05137938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881090|NCT05137938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881091|NCT03378648|Bromides|bromides|mesh-list
55881092|NCT03378648|Anticonvulsants|anticonvulsants|mesh-ancestor
55881093|NCT01519882|Rotigotine|rotigotine|mesh-list
55881094|NCT01519882|Dopamine Agonists|dopamine agonists|mesh-ancestor
55881095|NCT01519882|Dopamine Agents|dopamine agents|mesh-ancestor
55881096|NCT01519882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881097|NCT01519882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881098|NCT01519882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049807|NCT01769027|Penicillins|penicillins|mesh-list
56049809|NCT01769027|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56049810|NCT01769027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881099|NCT01576276|Ketorolac|ketorolac|mesh-list
55881100|NCT01576276|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55881102|NCT01576276|Analgesics|analgesics|mesh-ancestor
55881103|NCT01576276|Sensory System Agents|sensory system agents|mesh-ancestor
55881104|NCT01576276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881105|NCT01576276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881106|NCT01576276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881107|NCT01576276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881108|NCT01576276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55881109|NCT01576276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881110|NCT01576276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881111|NCT01576588|Rituximab|rituximab|mesh-list
55881112|NCT01576588|Glucocorticoids|glucocorticoids|mesh-list
55881113|NCT01576588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55881114|NCT01576588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881115|NCT01576588|Immunologic Factors|immunologic factors|mesh-ancestor
55881116|NCT01576588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881117|NCT01576588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881118|NCT01576588|Hormones|hormones|mesh-ancestor
55881119|NCT01576588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881120|NCT01826981|Sofosbuvir|sofosbuvir|mesh-list
55881121|NCT01826981|Antiviral Agents|antiviral agents|mesh-ancestor
55881122|NCT01826981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881123|NCT02247154|Immunoglobulins|immunoglobulins|mesh-list
55881124|NCT02247154|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55881125|NCT02247154|Antibodies|antibodies|mesh-list
55881126|NCT02247154|Immunologic Factors|immunologic factors|mesh-ancestor
55881127|NCT02247154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881128|NCT02728752|gamma-Globulins|gamma-globulins|mesh-list
55881129|NCT02728752|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55881130|NCT02728752|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55881131|NCT02728752|Immunologic Factors|immunologic factors|mesh-ancestor
55881132|NCT02728752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881133|NCT03007810|Hemay005|hemay005|mesh-list
55881134|NCT03007810|Dermatologic Agents|dermatologic agents|mesh-ancestor
55881135|NCT03007810|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55881136|NCT03007810|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55881137|NCT03007810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881138|NCT03007810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881139|NCT01578772|Telmisartan|telmisartan|mesh-list
55881140|NCT01578772|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55881141|NCT01578772|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55881142|NCT01578772|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55881143|NCT01578772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881144|NCT01804049|Metformin|metformin|mesh-list
55881145|NCT01804049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55881146|NCT01804049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881147|NCT02383992|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55881148|NCT02383992|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55881149|NCT02383992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881150|NCT02346630|Levodopa|levodopa|mesh-list
55881151|NCT02346630|Carbidopa|carbidopa|mesh-list
55881152|NCT02346630|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55881153|NCT02346630|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55881154|NCT02346630|Dopamine Agents|dopamine agents|mesh-ancestor
55881155|NCT02346630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881156|NCT02346630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881157|NCT02346630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881158|NCT02346630|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55881159|NCT02346630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881160|NCT03385668|Pirfenidone|pirfenidone|mesh-list
55881161|NCT03385668|Analgesics|analgesics|mesh-ancestor
55881162|NCT03385668|Sensory System Agents|sensory system agents|mesh-ancestor
55881163|NCT03385668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881164|NCT03385668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881165|NCT03385668|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55881166|NCT03385668|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56049812|NCT01769027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56049813|NCT01769027|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56049814|NCT01769027|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56049815|NCT01769027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56049816|NCT01769027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049817|NCT01769027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049818|NCT01769027|Serotonin Agents|serotonin agents|mesh-ancestor
56049819|NCT01769027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049820|NCT01769027|Immunologic Factors|immunologic factors|mesh-ancestor
56049821|NCT04706637|Dapagliflozin|dapagliflozin|mesh-list
56049822|NCT04706637|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56049823|NCT04706637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049824|NCT04706637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55881167|NCT03385668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881168|NCT03385668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881169|NCT03385668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881170|NCT04947072|Anesthetics|anesthetics|mesh-list
55881171|NCT04947072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55881172|NCT04947072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881173|NCT04942158|Eugenol|eugenol|mesh-list
55881178|NCT04942158|Protective Agents|protective agents|mesh-ancestor
55881179|NCT04942158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881180|NCT04942158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881181|NCT03382470|Anti-Infective Agents|anti-infective agents|mesh-list
55881182|NCT03382470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55881183|NCT03387774|Urinastatin|urinastatin|mesh-list
55881184|NCT03387774|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55881185|NCT03387774|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55881186|NCT03387774|Protease Inhibitors|protease inhibitors|mesh-ancestor
55881187|NCT03387774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881188|NCT03387774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881189|NCT03382314|Cholecalciferol|cholecalciferol|mesh-list
55881190|NCT03382314|Vitamin D|vitamin d|mesh-list
55881191|NCT03382314|Bazedoxifene|bazedoxifene|mesh-list
55881192|NCT03382314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55881193|NCT03382314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881194|NCT03382314|Vitamins|vitamins|mesh-ancestor
55881195|NCT03382314|Micronutrients|micronutrients|mesh-ancestor
55881196|NCT03382314|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55881197|NCT03382314|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55881198|NCT03382314|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55881199|NCT03382314|Hormone Antagonists|hormone antagonists|mesh-ancestor
55881200|NCT03382314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881201|NCT03124524|Dienogest|dienogest|mesh-list
55881202|NCT03124524|Drospirenone|drospirenone|mesh-list
55881203|NCT03124524|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55881204|NCT03124524|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55881205|NCT03124524|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55881206|NCT03124524|Estradiol|estradiol|mesh-list
55881207|NCT03124524|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55881208|NCT03124524|Estrogens|estrogens|mesh-ancestor
55881209|NCT03124524|Hormones|hormones|mesh-ancestor
55881210|NCT03124524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881211|NCT03124524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881212|NCT03124524|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55881213|NCT03124524|Contraceptive Agents|contraceptive agents|mesh-ancestor
56049825|NCT04706637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049827|NCT04706949|Pemetrexed|pemetrexed|mesh-list
56049828|NCT04706949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049829|NCT04706949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049830|NCT04706949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049831|NCT04706949|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56049832|NCT04706949|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56049833|NCT02299349|Epinephrine|epinephrine|mesh-list
56049834|NCT02299349|Racepinephrine|racepinephrine|mesh-list
56049835|NCT02299349|Morphine|morphine|mesh-list
56049836|NCT02299349|Bupivacaine|bupivacaine|mesh-list
56049837|NCT02299349|Epinephryl borate|epinephryl borate|mesh-list
56049838|NCT02299349|Anesthetics, Local|anesthetics, local|mesh-ancestor
56049839|NCT02299349|Anesthetics|anesthetics|mesh-ancestor
55881214|NCT03124524|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55881215|NCT03124524|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55881216|NCT03124524|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55881217|NCT03124524|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55881218|NCT03124524|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55881219|NCT03124524|Hormone Antagonists|hormone antagonists|mesh-ancestor
55881220|NCT03124524|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55881221|NCT03124524|Diuretics|diuretics|mesh-ancestor
55881222|NCT03124524|Natriuretic Agents|natriuretic agents|mesh-ancestor
55881223|NCT03124524|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55881224|NCT03124524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55881225|NCT03124524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881226|NCT03377400|Cisplatin|cisplatin|mesh-list
55881227|NCT03377400|Durvalumab|durvalumab|mesh-list
55881228|NCT03377400|Tremelimumab|tremelimumab|mesh-list
55881229|NCT03377400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881230|NCT03377400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55881231|NCT01803269|Topotecan|topotecan|mesh-list
55881232|NCT01803269|Camptothecin|camptothecin|mesh-list
55881233|NCT01803269|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55881234|NCT01803269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55881235|NCT01803269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881236|NCT01803269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881237|NCT01803269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881238|NCT01803269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55881239|NCT01802879|Panobinostat|panobinostat|mesh-list
55881240|NCT01802879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881241|NCT01802879|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55881242|NCT01802879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881243|NCT01802879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881244|NCT01825577|Methylphenidate|methylphenidate|mesh-list
55881247|NCT01825577|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55881248|NCT01825577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55881249|NCT01825577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55881250|NCT01825577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881251|NCT01825577|Dopamine Agents|dopamine agents|mesh-ancestor
55881252|NCT01825577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881253|NCT03375138|Abatacept|abatacept|mesh-list
55881254|NCT03375138|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55881255|NCT03375138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881256|NCT03375138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881257|NCT03375138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55881258|NCT03375138|Immunologic Factors|immunologic factors|mesh-ancestor
55881259|NCT03375138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881260|NCT03375138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881261|NCT03124680|Analgesics, Opioid|analgesics, opioid|mesh-list
56049840|NCT02299349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049841|NCT02299349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049842|NCT02299349|Sensory System Agents|sensory system agents|mesh-ancestor
56049843|NCT02299349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049844|NCT02299349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56049845|NCT02299349|Narcotics|narcotics|mesh-ancestor
56049846|NCT02299349|Analgesics|analgesics|mesh-ancestor
56049847|NCT02299349|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56049848|NCT02299349|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56049849|NCT02299349|Adrenergic Agents|adrenergic agents|mesh-ancestor
56049850|NCT02299349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049851|NCT02299349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049852|NCT02299349|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56049853|NCT02299349|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56049854|NCT02299349|Autonomic Agents|autonomic agents|mesh-ancestor
56049855|NCT02299349|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56049856|NCT02299349|Respiratory System Agents|respiratory system agents|mesh-ancestor
55881263|NCT03124680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55881264|NCT03124680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881265|NCT03124680|Analgesics|analgesics|mesh-ancestor
55881266|NCT03124680|Sensory System Agents|sensory system agents|mesh-ancestor
55881267|NCT03124680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881268|NCT03374670|Aflibercept|aflibercept|mesh-list
55881269|NCT03374670|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55881270|NCT03374670|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55881271|NCT03374670|Growth Substances|growth substances|mesh-ancestor
55881272|NCT03374670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881273|NCT03374670|Growth Inhibitors|growth inhibitors|mesh-ancestor
55881274|NCT03374670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881275|NCT02963610|Pembrolizumab|pembrolizumab|mesh-list
55881276|NCT02963610|Lenalidomide|lenalidomide|mesh-list
55881277|NCT02963610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55881278|NCT02963610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881279|NCT02963610|Immunologic Factors|immunologic factors|mesh-ancestor
55881280|NCT02963610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881281|NCT02963610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55881282|NCT02963610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55881283|NCT02963610|Growth Substances|growth substances|mesh-ancestor
55881284|NCT02963610|Growth Inhibitors|growth inhibitors|mesh-ancestor
55881285|NCT03376932|Albuterol|albuterol|mesh-list
55881286|NCT03376932|Tiotropium Bromide|tiotropium bromide|mesh-list
55881287|NCT03376932|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55881288|NCT03376932|Autonomic Agents|autonomic agents|mesh-ancestor
55881289|NCT03376932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881290|NCT03376932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881291|NCT03376932|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55881292|NCT03376932|Respiratory System Agents|respiratory system agents|mesh-ancestor
55881293|NCT03376932|Parasympatholytics|parasympatholytics|mesh-ancestor
55881294|NCT03376932|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55881295|NCT03376932|Cholinergic Agents|cholinergic agents|mesh-ancestor
55881296|NCT03376932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881297|NCT03376932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881298|NCT03376932|Tocolytic Agents|tocolytic agents|mesh-ancestor
55881299|NCT03376932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55881300|NCT03376932|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55881301|NCT03376932|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56049858|NCT02299349|Sympathomimetics|sympathomimetics|mesh-ancestor
56049859|NCT02299349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56049860|NCT03296163|Paclitaxel|paclitaxel|mesh-list
56049861|NCT03296163|Bevacizumab|bevacizumab|mesh-list
56049862|NCT03296163|Carboplatin|carboplatin|mesh-list
56049863|NCT03296163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56049864|NCT03296163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049865|NCT03296163|Tubulin Modulators|tubulin modulators|mesh-ancestor
56049866|NCT03296163|Antimitotic Agents|antimitotic agents|mesh-ancestor
56049867|NCT03296163|Mitosis Modulators|mitosis modulators|mesh-ancestor
56049868|NCT03296163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049869|NCT03296163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56049870|NCT03296163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56049871|NCT03296163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56049872|NCT03296163|Growth Substances|growth substances|mesh-ancestor
56049873|NCT03296163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049874|NCT03296163|Growth Inhibitors|growth inhibitors|mesh-ancestor
56049875|NCT00376155|Pyrimethamine|pyrimethamine|mesh-list
56049876|NCT00376155|Sulfadoxine|sulfadoxine|mesh-list
56049877|NCT00376155|Amodiaquine|amodiaquine|mesh-list
56049878|NCT00376155|Antimalarials|antimalarials|mesh-ancestor
56049879|NCT00376155|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56049880|NCT00376155|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56049881|NCT00376155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56049882|NCT00376155|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56049883|NCT00376155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049884|NCT00376155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049885|NCT00376155|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55881302|NCT03376932|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55881303|NCT03376932|Adrenergic Agents|adrenergic agents|mesh-ancestor
55881304|NCT03007342|Amoxicillin|amoxicillin|mesh-list
55881305|NCT03007342|Clavulanic Acid|clavulanic acid|mesh-list
55881306|NCT03007342|Clavulanic Acids|clavulanic acids|mesh-list
55881307|NCT03007342|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55881308|NCT03007342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55881309|NCT03007342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881310|NCT03007342|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55881311|NCT03007342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881312|NCT03007342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881313|NCT03376854|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
55881314|NCT03376854|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55881315|NCT03376854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881316|NCT03376854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881318|NCT01579162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55881319|NCT03007654|Chitosan|chitosan|mesh-list
56049886|NCT00376155|Renal Agents|renal agents|mesh-ancestor
56049887|NCT01989221|Granisetron|granisetron|mesh-list
56049888|NCT01989221|Antiemetics|antiemetics|mesh-ancestor
56049889|NCT01989221|Autonomic Agents|autonomic agents|mesh-ancestor
56049890|NCT01989221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049891|NCT01989221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049892|NCT01989221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56049893|NCT01989221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56049894|NCT01989221|Serotonin Agents|serotonin agents|mesh-ancestor
56049895|NCT01989221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049896|NCT01989221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049898|NCT03226899|Allopurinol|allopurinol|mesh-list
56049899|NCT03226899|Febuxostat|febuxostat|mesh-list
56049900|NCT03226899|Lesinurad|lesinurad|mesh-list
56049901|NCT03226899|Gout Suppressants|gout suppressants|mesh-ancestor
56049902|NCT03226899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56049903|NCT03226899|Tubulin Modulators|tubulin modulators|mesh-ancestor
56049904|NCT03226899|Antimitotic Agents|antimitotic agents|mesh-ancestor
56049905|NCT03226899|Mitosis Modulators|mitosis modulators|mesh-ancestor
56049906|NCT03226899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049907|NCT03226899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049908|NCT03226899|Antimetabolites|antimetabolites|mesh-ancestor
56049909|NCT03226899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049910|NCT03226899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56049911|NCT03226899|Antioxidants|antioxidants|mesh-ancestor
56049912|NCT03226899|Protective Agents|protective agents|mesh-ancestor
56049913|NCT03226899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049914|NCT03226899|Uricosuric Agents|uricosuric agents|mesh-ancestor
56049915|NCT03226899|Renal Agents|renal agents|mesh-ancestor
56049916|NCT01990703|Levonorgestrel|levonorgestrel|mesh-list
56049917|NCT01990703|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56049918|NCT01990703|Contraceptive Agents|contraceptive agents|mesh-ancestor
56049919|NCT01990703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56049931|NCT04332627|Neostigmine|neostigmine|mesh-list
56049932|NCT04332627|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56049933|NCT04332627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049934|NCT04332627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049935|NCT04332627|Cholinergic Agents|cholinergic agents|mesh-ancestor
56049936|NCT04332627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56049937|NCT04332627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049938|NCT04332627|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56049939|NCT04332627|Autonomic Agents|autonomic agents|mesh-ancestor
56049940|NCT04332627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049941|NCT03440229|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56049942|NCT03440229|Laxatives|laxatives|mesh-ancestor
56049943|NCT03440229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56049944|NCT01963091|Oxytocin|oxytocin|mesh-list
56049945|NCT01963091|Oxytocics|oxytocics|mesh-ancestor
56049946|NCT01963091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56049947|NCT01963091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049948|NCT02306759|Ketamine|ketamine|mesh-list
56049949|NCT02306759|Analgesics|analgesics|mesh-ancestor
56049950|NCT02306759|Sensory System Agents|sensory system agents|mesh-ancestor
55777152|NCT04014803|Aspirin|aspirin|mesh-list
56049951|NCT02306759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56049952|NCT02306759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049953|NCT02306759|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56049954|NCT02306759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56049955|NCT02306759|Anesthetics, General|anesthetics, general|mesh-ancestor
56049957|NCT02306759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56049958|NCT02306759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56049962|NCT03298113|Protective Agents|protective agents|mesh-list
56049976|NCT03232749|Protective Agents|protective agents|mesh-ancestor
56049978|NCT03441633|Apixaban|apixaban|mesh-list
56049979|NCT03441633|Dabigatran|dabigatran|mesh-list
56049980|NCT03441633|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56049981|NCT03441633|Antithrombins|antithrombins|mesh-ancestor
56049982|NCT03441633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56049983|NCT03441633|Protease Inhibitors|protease inhibitors|mesh-ancestor
56049984|NCT03441633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049985|NCT03441633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049986|NCT03441633|Anticoagulants|anticoagulants|mesh-ancestor
56049987|NCT01687400|Decitabine|decitabine|mesh-list
56049988|NCT01687400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56049989|NCT01687400|Antimetabolites|antimetabolites|mesh-ancestor
56049990|NCT01687400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56049991|NCT01687400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56049992|NCT01687400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56049993|NCT01688102|Vitamin D|vitamin d|mesh-list
56049994|NCT01688102|Cholecalciferol|cholecalciferol|mesh-list
56049995|NCT01688102|Vitamins|vitamins|mesh-ancestor
56049996|NCT01688102|Micronutrients|micronutrients|mesh-ancestor
56049997|NCT01688102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56049998|NCT01688102|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56049999|NCT01688102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56050000|NCT01994993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56050001|NCT01994993|Metronidazole|metronidazole|mesh-list
56050002|NCT01994993|Clindamycin|clindamycin|mesh-list
56050003|NCT01994993|Clindamycin palmitate|clindamycin palmitate|mesh-list
56050004|NCT01994993|Clindamycin phosphate|clindamycin phosphate|mesh-list
56050005|NCT01994993|Gentamicins|gentamicins|mesh-list
56050006|NCT01994993|Tazobactam|tazobactam|mesh-list
56050007|NCT01994993|Piperacillin|piperacillin|mesh-list
56050008|NCT01994993|Ampicillin|ampicillin|mesh-list
56050009|NCT01994993|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56050010|NCT01994993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050011|NCT01994993|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56050012|NCT01994993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56050013|NCT01994993|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56050014|NCT01994993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050016|NCT01994993|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56050017|NCT01688336|Leucovorin|leucovorin|mesh-list
56050018|NCT01688336|Oxaliplatin|oxaliplatin|mesh-list
56050019|NCT01688336|Irinotecan|irinotecan|mesh-list
55881320|NCT03007654|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55881321|NCT03007654|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55881322|NCT03007654|Antimetabolites|antimetabolites|mesh-ancestor
55881323|NCT03007654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881324|NCT03007654|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55881325|NCT03007654|Chelating Agents|chelating agents|mesh-ancestor
55881326|NCT03007654|Sequestering Agents|sequestering agents|mesh-ancestor
55881327|NCT03007654|Hemostatics|hemostatics|mesh-ancestor
55881328|NCT03007654|Coagulants|coagulants|mesh-ancestor
55881329|NCT03374514|Dexamethasone|dexamethasone|mesh-list
55881330|NCT03374514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881331|NCT03374514|Antiemetics|antiemetics|mesh-ancestor
55881332|NCT03374514|Autonomic Agents|autonomic agents|mesh-ancestor
55881333|NCT03374514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881334|NCT03374514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881335|NCT03374514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55881336|NCT03374514|Glucocorticoids|glucocorticoids|mesh-ancestor
55881337|NCT03374514|Hormones|hormones|mesh-ancestor
55881338|NCT03374514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881339|NCT03374514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55881340|NCT03374514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881341|NCT01526356|Sirolimus|sirolimus|mesh-list
55881342|NCT01526356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55881343|NCT01526356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881344|NCT01526356|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55881345|NCT01526356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881346|NCT01526356|Antifungal Agents|antifungal agents|mesh-ancestor
55881347|NCT01526356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55881348|NCT01526356|Immunologic Factors|immunologic factors|mesh-ancestor
55881349|NCT01526356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881350|NCT02903160|Prednisone|prednisone|mesh-list
55881351|NCT02903160|Carboplatin|carboplatin|mesh-list
55881352|NCT02903160|Abiraterone Acetate|abiraterone acetate|mesh-list
55881353|NCT02903160|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55881354|NCT02903160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881355|NCT02903160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881356|NCT02903160|Glucocorticoids|glucocorticoids|mesh-ancestor
55881357|NCT02903160|Hormones|hormones|mesh-ancestor
55881358|NCT02903160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881359|NCT02903160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881360|NCT02903160|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55881361|NCT02903160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55881362|NCT02903160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881363|NCT02903160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881364|NCT02903160|Hormone Antagonists|hormone antagonists|mesh-ancestor
55881365|NCT02903160|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55881367|NCT03376464|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55881368|NCT03376464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881369|NCT03376464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881370|NCT03376464|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55881371|NCT03376464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55881372|NCT03376464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881373|NCT03376464|Cholinergic Agents|cholinergic agents|mesh-ancestor
55881374|NCT03376464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881377|NCT03374280|Gefitinib|gefitinib|mesh-list
55881378|NCT03374280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881379|NCT03374280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881380|NCT03374280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881381|NCT03374280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55881382|NCT03374280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55881383|NCT03374280|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55881384|NCT03381066|Cisplatin|cisplatin|mesh-list
55881385|NCT03381066|Pemetrexed|pemetrexed|mesh-list
55881386|NCT03381066|Vinorelbine|vinorelbine|mesh-list
55881387|NCT03381066|Gefitinib|gefitinib|mesh-list
55881388|NCT03381066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050021|NCT01688336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050022|NCT01688336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56050023|NCT01688336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56050024|NCT01688336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050025|NCT01688336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050026|NCT01688336|Antidotes|antidotes|mesh-ancestor
55881389|NCT03381066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881390|NCT03381066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881392|NCT03381066|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55881393|NCT03381066|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55881394|NCT03381066|Tubulin Modulators|tubulin modulators|mesh-ancestor
55881395|NCT03381066|Antimitotic Agents|antimitotic agents|mesh-ancestor
55881396|NCT03381066|Mitosis Modulators|mitosis modulators|mesh-ancestor
55881397|NCT03381066|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55881399|NCT03630666|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55881400|NCT03630666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881401|NCT03630666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881402|NCT03375996|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55881403|NCT03375996|Cyclopentolate|cyclopentolate|mesh-list
55881404|NCT03375996|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55881405|NCT03375996|Mydriatics|mydriatics|mesh-ancestor
55881406|NCT03375996|Autonomic Agents|autonomic agents|mesh-ancestor
55881407|NCT03375996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881408|NCT03375996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881410|NCT03375996|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55881411|NCT03375996|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55881412|NCT03375996|Cholinergic Agents|cholinergic agents|mesh-ancestor
55881413|NCT03375996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881414|NCT03375996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881415|NCT01580410|Oxaliplatin|oxaliplatin|mesh-list
55881416|NCT01580410|Mitomycins|mitomycins|mesh-list
55881417|NCT01580410|Mitomycin|mitomycin|mesh-list
55881418|NCT01580410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881419|NCT01580410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55751117|NCT03335423|Analgesics|analgesics|mesh-ancestor
55881420|NCT01580410|Alkylating Agents|alkylating agents|mesh-ancestor
55881421|NCT01580410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881422|NCT01580410|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55881423|NCT01580410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881424|NCT02606136|Mitogens|mitogens|mesh-list
55881425|NCT02606136|Mitosis Modulators|mitosis modulators|mesh-ancestor
55881426|NCT02606136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881427|NCT01581658|Empagliflozin|empagliflozin|mesh-list
55881428|NCT01581658|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55887065|NCT01784770|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55881429|NCT01581658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881430|NCT01581658|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55881431|NCT01581658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881432|NCT01530178|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55881433|NCT01530178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55881434|NCT01530178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881435|NCT01530178|Incretins|incretins|mesh-ancestor
55881436|NCT01530178|Hormones|hormones|mesh-ancestor
55881437|NCT01530178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881438|NCT01530178|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55881439|NCT01530178|Protease Inhibitors|protease inhibitors|mesh-ancestor
55881440|NCT01530178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881441|NCT01530178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881442|NCT03369990|Botulinum Toxins|botulinum toxins|mesh-list
55881443|NCT03369990|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55881444|NCT03369990|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55881445|NCT03369990|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55881446|NCT03369990|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55881447|NCT03369990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050027|NCT01688336|Protective Agents|protective agents|mesh-ancestor
56050028|NCT01688336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050029|NCT01688336|Vitamin B Complex|vitamin b complex|mesh-ancestor
55881448|NCT03369990|Cholinergic Agents|cholinergic agents|mesh-ancestor
55881449|NCT03369990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881450|NCT03369990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881451|NCT03369990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55881452|NCT03369990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881453|NCT03006874|Esomeprazole|esomeprazole|mesh-list
55881454|NCT03006874|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55881455|NCT03006874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55881456|NCT03006874|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55881457|NCT03006874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881458|NCT03006874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881459|NCT01581970|Cyclophosphamide|cyclophosphamide|mesh-list
55881460|NCT01581970|Cetuximab|cetuximab|mesh-list
55881464|NCT01581970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881465|NCT01581970|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55881466|NCT01581970|Alkylating Agents|alkylating agents|mesh-ancestor
55881467|NCT01581970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881468|NCT01581970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881469|NCT01581970|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55881470|NCT01581970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55881472|NCT01583686|Cyclophosphamide|cyclophosphamide|mesh-list
55881473|NCT01583686|Fludarabine|fludarabine|mesh-list
55881474|NCT01583686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55881475|NCT01583686|Immunologic Factors|immunologic factors|mesh-ancestor
55881476|NCT01583686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881477|NCT01583686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881478|NCT01583686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55881479|NCT01583686|Alkylating Agents|alkylating agents|mesh-ancestor
55881480|NCT01583686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881481|NCT01583686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881482|NCT01583686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55881483|NCT01583686|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55881484|NCT01583686|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55881485|NCT01583686|Antiviral Agents|antiviral agents|mesh-ancestor
55881486|NCT01583686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881487|NCT01532128|Opicapone|opicapone|mesh-list
55881488|NCT01532128|Rasagiline|rasagiline|mesh-list
55881489|NCT01532128|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55881490|NCT01532128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881491|NCT01532128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881492|NCT01532128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55881493|NCT01532128|Protective Agents|protective agents|mesh-ancestor
55881494|NCT01532128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881495|NCT01532128|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55881496|NCT01532128|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55881497|NCT01532128|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55881498|NCT01584388|Rituximab|rituximab|mesh-list
55881499|NCT01584388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55881500|NCT01584388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881501|NCT01584388|Immunologic Factors|immunologic factors|mesh-ancestor
55881502|NCT01584388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881503|NCT01584388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881504|NCT01584544|Capecitabine|capecitabine|mesh-list
55881505|NCT01584544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55881506|NCT01584544|Antimetabolites|antimetabolites|mesh-ancestor
55881507|NCT01584544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881508|NCT01584544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881509|NCT03006952|Losartan|losartan|mesh-list
55881510|NCT03006952|Pentoxifylline|pentoxifylline|mesh-list
55881511|NCT03006952|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55881512|NCT03006952|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55881513|NCT03006952|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55881514|NCT03006952|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55893239|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
55881515|NCT03006952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881516|NCT03006952|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55881517|NCT03006952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881518|NCT03006952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56050030|NCT01688336|Vitamins|vitamins|mesh-ancestor
56050031|NCT01688336|Micronutrients|micronutrients|mesh-ancestor
55881519|NCT03006952|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55881520|NCT03006952|Protective Agents|protective agents|mesh-ancestor
55881521|NCT03006952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881522|NCT03006952|Vasodilator Agents|vasodilator agents|mesh-ancestor
55881523|NCT03006952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55881524|NCT03006952|Antioxidants|antioxidants|mesh-ancestor
55881525|NCT01802333|Cytarabine|cytarabine|mesh-list
55881526|NCT01802333|Daunorubicin|daunorubicin|mesh-list
55881527|NCT01802333|Vorinostat|vorinostat|mesh-list
55881528|NCT01802333|Idarubicin|idarubicin|mesh-list
55881529|NCT01802333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55881530|NCT01802333|Antimetabolites|antimetabolites|mesh-ancestor
55881531|NCT01802333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881535|NCT01802333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55881536|NCT01802333|Immunologic Factors|immunologic factors|mesh-ancestor
55881537|NCT01802333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881538|NCT01802333|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55881539|NCT01802333|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55881540|NCT01802333|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55881541|NCT01802333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881542|NCT01802333|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55881543|NCT01585324|Ribavirin|ribavirin|mesh-list
55881544|NCT01585324|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55881545|NCT01585324|Antimetabolites|antimetabolites|mesh-ancestor
55881546|NCT01585324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881547|NCT01585324|Antiviral Agents|antiviral agents|mesh-ancestor
55881548|NCT01585324|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881549|NCT01586962|Acetaminophen|acetaminophen|mesh-list
55881550|NCT01586962|Pseudoephedrine|pseudoephedrine|mesh-list
55881551|NCT01586962|Ephedrine|ephedrine|mesh-list
55881552|NCT01586962|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55881553|NCT01586962|Analgesics|analgesics|mesh-ancestor
55881554|NCT01586962|Sensory System Agents|sensory system agents|mesh-ancestor
55881555|NCT01586962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881556|NCT01586962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881557|NCT01586962|Antipyretics|antipyretics|mesh-ancestor
55881558|NCT01586962|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55881559|NCT01586962|Autonomic Agents|autonomic agents|mesh-ancestor
55881560|NCT01586962|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55881561|NCT01586962|Respiratory System Agents|respiratory system agents|mesh-ancestor
55881562|NCT01586962|Nasal Decongestants|nasal decongestants|mesh-ancestor
55881563|NCT01586962|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55881564|NCT01586962|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55881566|NCT01586962|Adrenergic Agents|adrenergic agents|mesh-ancestor
55881567|NCT01586962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881568|NCT01586962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881569|NCT03006250|Sevoflurane|sevoflurane|mesh-list
55881570|NCT03006250|Desflurane|desflurane|mesh-list
55881571|NCT03006250|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55881572|NCT03006250|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55881573|NCT03006250|Anesthetics, General|anesthetics, general|mesh-ancestor
55881574|NCT03006250|Anesthetics|anesthetics|mesh-ancestor
55881575|NCT03006250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55881576|NCT03006250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881577|NCT01824875|Capecitabine|capecitabine|mesh-list
55881578|NCT01824875|Temozolomide|temozolomide|mesh-list
55881579|NCT01824875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55881580|NCT01824875|Antimetabolites|antimetabolites|mesh-ancestor
55881581|NCT01824875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881582|NCT01824875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881583|NCT01824875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55881584|NCT01824875|Alkylating Agents|alkylating agents|mesh-ancestor
55881585|NCT04129437|Ibuprofen|ibuprofen|mesh-list
55881586|NCT04129437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55881587|NCT04129437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55881588|NCT04129437|Analgesics|analgesics|mesh-ancestor
55881589|NCT04129437|Sensory System Agents|sensory system agents|mesh-ancestor
55881590|NCT04129437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881591|NCT04129437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881592|NCT04129437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881593|NCT04129437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56050032|NCT01963481|Cyclophosphamide|cyclophosphamide|mesh-list
56050033|NCT01963481|Exemestane|exemestane|mesh-list
56050034|NCT01963481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56050035|NCT01963481|Immunologic Factors|immunologic factors|mesh-ancestor
55881594|NCT04129437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55881595|NCT04129437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881596|NCT04129437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881597|NCT04588259|Insulin|insulin|mesh-list
55881598|NCT04588259|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55881599|NCT04588259|Insulin Aspart|insulin aspart|mesh-list
55881600|NCT04588259|Insulin, Long-Acting|insulin, long-acting|mesh-list
55881601|NCT04588259|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55881602|NCT04588259|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55881604|NCT01801475|Ondansetron|ondansetron|mesh-list
55881605|NCT01801475|Antiemetics|antiemetics|mesh-ancestor
55881606|NCT01801475|Autonomic Agents|autonomic agents|mesh-ancestor
55881607|NCT01801475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881608|NCT01801475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881609|NCT01801475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55881610|NCT01801475|Antipruritics|antipruritics|mesh-ancestor
55881611|NCT01801475|Dermatologic Agents|dermatologic agents|mesh-ancestor
55881612|NCT01801475|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55881613|NCT01801475|Serotonin Agents|serotonin agents|mesh-ancestor
55751166|NCT03329651|Metformin|metformin|mesh-list
55881614|NCT01801475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881615|NCT01801475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881616|NCT01801475|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55881617|NCT01801475|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55881618|NCT01801475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55881619|NCT01801475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55881620|NCT01801475|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55881621|NCT03063021|Acetylcysteine|acetylcysteine|mesh-list
55881622|NCT03063021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55881623|NCT03063021|Antiviral Agents|antiviral agents|mesh-ancestor
55881624|NCT03063021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881625|NCT03063021|Expectorants|expectorants|mesh-ancestor
55881626|NCT03063021|Respiratory System Agents|respiratory system agents|mesh-ancestor
55881627|NCT03063021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55881628|NCT03063021|Antioxidants|antioxidants|mesh-ancestor
55881629|NCT03063021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881630|NCT03063021|Protective Agents|protective agents|mesh-ancestor
55881631|NCT03063021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881632|NCT03063021|Antidotes|antidotes|mesh-ancestor
55881633|NCT02337933|Ursolic acid|ursolic acid|mesh-list
55881634|NCT02337933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881635|NCT02337933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881636|NCT02337933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55881637|NCT02337933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881638|NCT02337933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55881639|NCT02337933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881640|NCT02337933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55881641|NCT02337933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55881642|NCT02337933|Analgesics|analgesics|mesh-ancestor
55881643|NCT02337933|Sensory System Agents|sensory system agents|mesh-ancestor
55881644|NCT02337933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881645|NCT02337933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881646|NCT02337933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881647|NCT02337933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881648|NCT03028857|Choline|choline|mesh-list
55881649|NCT03028857|Lipotropic Agents|lipotropic agents|mesh-ancestor
55881650|NCT03028857|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55881651|NCT03028857|Antimetabolites|antimetabolites|mesh-ancestor
55881652|NCT03028857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881653|NCT03028857|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55881654|NCT03028857|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55881655|NCT03028857|Nootropic Agents|nootropic agents|mesh-ancestor
55881656|NCT03062943|Nintedanib|nintedanib|mesh-list
55881657|NCT03062943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881658|NCT03062943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55881659|NCT03062943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050036|NCT01963481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050037|NCT01963481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56050038|NCT01963481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56050039|NCT01963481|Alkylating Agents|alkylating agents|mesh-ancestor
56050040|NCT01963481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050041|NCT01963481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050042|NCT01963481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56050043|NCT01963481|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56050044|NCT01963481|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56050045|NCT01963481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881660|NCT03062943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881661|NCT01536886|Betamethasone|betamethasone|mesh-list
55881662|NCT01536886|Calcipotriene|calcipotriene|mesh-list
55881663|NCT01536886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881664|NCT01536886|Glucocorticoids|glucocorticoids|mesh-ancestor
55881665|NCT01536886|Hormones|hormones|mesh-ancestor
55881666|NCT01536886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881667|NCT01536886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881668|NCT01536886|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55881669|NCT01536886|Respiratory System Agents|respiratory system agents|mesh-ancestor
55881670|NCT01536886|Dermatologic Agents|dermatologic agents|mesh-ancestor
55881671|NCT02247310|Interferons|interferons|mesh-list
55881672|NCT02247310|Interferon-beta|interferon-beta|mesh-list
55881673|NCT02247310|Interferon beta-1b|interferon beta-1b|mesh-list
55881674|NCT02247310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881675|NCT02247310|Antiviral Agents|antiviral agents|mesh-ancestor
55881676|NCT02247310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881679|NCT02247310|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55881681|NCT03061539|Ipilimumab|ipilimumab|mesh-list
55881682|NCT03061539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55881683|NCT03061539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881684|NCT03061539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55881685|NCT03061539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881686|NCT01590550|Dialysis Solutions|dialysis solutions|mesh-list
55881689|NCT05609253|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
55881690|NCT05609253|Antifungal Agents|antifungal agents|mesh-ancestor
55881691|NCT05609253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881692|NCT05609253|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55881693|NCT05609253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55881694|NCT05609253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881695|NCT05609253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881696|NCT05609253|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55881697|NCT05609253|Hormone Antagonists|hormone antagonists|mesh-ancestor
55881698|NCT05609253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881699|NCT05609253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881700|NCT05609253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55881701|NCT01822535|Midodrine|midodrine|mesh-list
55881702|NCT01822535|Sympathomimetics|sympathomimetics|mesh-ancestor
55881703|NCT01822535|Autonomic Agents|autonomic agents|mesh-ancestor
55881704|NCT01822535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881705|NCT01822535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881706|NCT01822535|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55881707|NCT01822535|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55881708|NCT01822535|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55881709|NCT01822535|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55881710|NCT01822535|Adrenergic Agents|adrenergic agents|mesh-ancestor
55881711|NCT01822535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881712|NCT01822535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881713|NCT01537666|Vancomycin|vancomycin|mesh-list
55881714|NCT01537666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56050046|NCT01963481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56050047|NCT01963481|Hormone Antagonists|hormone antagonists|mesh-ancestor
56050048|NCT01963481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050050|NCT04436744|Anastrozole|anastrozole|mesh-list
56050051|NCT04436744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050052|NCT04436744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56050053|NCT04436744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050054|NCT04436744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050055|NCT04436744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56050056|NCT04436744|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56050057|NCT04436744|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56050058|NCT04436744|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56050059|NCT04436744|Hormone Antagonists|hormone antagonists|mesh-ancestor
55881715|NCT01537666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881716|NCT01537900|Grazoprevir|grazoprevir|mesh-list
55881717|NCT01537900|Antiviral Agents|antiviral agents|mesh-ancestor
55881718|NCT01537900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881719|NCT01799993|Amikacin|amikacin|mesh-list
55881720|NCT01799993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55881721|NCT01799993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881722|NCT03005860|Fentanyl|fentanyl|mesh-list
55881723|NCT03005860|Propofol|propofol|mesh-list
55881724|NCT03005860|Sevoflurane|sevoflurane|mesh-list
55881725|NCT03005860|Atracurium|atracurium|mesh-list
55881726|NCT03005860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55881727|NCT03005860|Narcotics|narcotics|mesh-ancestor
55881728|NCT03005860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55881729|NCT03005860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881730|NCT03005860|Analgesics|analgesics|mesh-ancestor
55881731|NCT03005860|Sensory System Agents|sensory system agents|mesh-ancestor
55881732|NCT03005860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881733|NCT03005860|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55881734|NCT03005860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55881735|NCT03005860|Anesthetics, General|anesthetics, general|mesh-ancestor
55881736|NCT03005860|Anesthetics|anesthetics|mesh-ancestor
55881737|NCT03005860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881738|NCT03005860|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55881739|NCT03005860|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55881740|NCT03005860|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55881741|NCT03005860|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55881742|NCT03005860|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55881743|NCT03005860|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55881744|NCT03005860|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55881746|NCT03005860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881747|NCT03005860|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55881749|NCT01593592|Clarithromycin|clarithromycin|mesh-list
55881750|NCT01593592|Omeprazole|omeprazole|mesh-list
55881754|NCT01593592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55881755|NCT01593592|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55881756|NCT01593592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881757|NCT01593592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881758|NCT01593592|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55881759|NCT01593592|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55881760|NCT01593592|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55881761|NCT03001960|Clopidogrel|clopidogrel|mesh-list
55881762|NCT03001960|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55881763|NCT03001960|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56050060|NCT04436744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050061|NCT04436744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050063|NCT01963793|Fosaprepitant|fosaprepitant|mesh-list
56050064|NCT01963793|Antiemetics|antiemetics|mesh-ancestor
56050065|NCT01963793|Autonomic Agents|autonomic agents|mesh-ancestor
56050066|NCT01963793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050067|NCT01963793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050068|NCT01963793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56050069|NCT01963793|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56050070|NCT01963793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050071|NCT01963793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050072|NCT03449433|Insulin|insulin|mesh-list
56050073|NCT03449433|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55881764|NCT03001960|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55881765|NCT03001960|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55881766|NCT03001960|Purinergic Agents|purinergic agents|mesh-ancestor
55881767|NCT03001960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881768|NCT03001960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881769|NCT03001960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881770|NCT01593670|Decitabine|decitabine|mesh-list
55881771|NCT01593670|Interleukin-2|interleukin-2|mesh-list
55881772|NCT01593670|Vorinostat|vorinostat|mesh-list
55881773|NCT01593670|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55881774|NCT01593670|Antimetabolites|antimetabolites|mesh-ancestor
55881775|NCT01593670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881776|NCT01593670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881777|NCT01593670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881778|NCT01593670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55881779|NCT01593670|Analgesics|analgesics|mesh-ancestor
55881780|NCT01593670|Sensory System Agents|sensory system agents|mesh-ancestor
55881781|NCT01593670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881782|NCT01593670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881783|NCT01593670|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55881784|NCT01593748|Gemcitabine|gemcitabine|mesh-list
55881785|NCT01593748|Docetaxel|docetaxel|mesh-list
55881786|NCT01593748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55881787|NCT01593748|Antimetabolites|antimetabolites|mesh-ancestor
55881788|NCT01593748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881789|NCT01593748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881790|NCT01593748|Antiviral Agents|antiviral agents|mesh-ancestor
55881791|NCT01593748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881792|NCT01593748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881793|NCT01593748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55881794|NCT01593748|Immunologic Factors|immunologic factors|mesh-ancestor
55881796|NCT01593748|Tubulin Modulators|tubulin modulators|mesh-ancestor
55881797|NCT01593748|Antimitotic Agents|antimitotic agents|mesh-ancestor
55881798|NCT01593748|Mitosis Modulators|mitosis modulators|mesh-ancestor
55881799|NCT01594294|Contact Lens Solutions|contact lens solutions|mesh-list
55881800|NCT01594294|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55881801|NCT01594294|Disinfectants|disinfectants|mesh-ancestor
55881802|NCT01594294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881803|NCT03005704|Aspirin|aspirin|mesh-list
55881804|NCT03005704|Ticagrelor|ticagrelor|mesh-list
55881805|NCT03005704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55881806|NCT03005704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55881807|NCT03005704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56050074|NCT03449433|Insulin Aspart|insulin aspart|mesh-list
56050075|NCT03449433|Insulin, Long-Acting|insulin, long-acting|mesh-list
56050076|NCT03449433|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56050077|NCT03449433|Insulin Lispro|insulin lispro|mesh-list
56050078|NCT03449433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56050079|NCT03449433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050080|NCT03241485|Morphine|morphine|mesh-list
56050081|NCT03241485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56050082|NCT03241485|Narcotics|narcotics|mesh-ancestor
56050083|NCT03241485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050084|NCT03241485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050085|NCT03241485|Analgesics|analgesics|mesh-ancestor
56050086|NCT03241485|Sensory System Agents|sensory system agents|mesh-ancestor
56050087|NCT03241485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050088|NCT04313504|Niraparib|niraparib|mesh-list
56050089|NCT04313504|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56050090|NCT04313504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050091|NCT04313504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050092|NCT04313504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050093|NCT01996943|Ethanol|ethanol|mesh-list
56050094|NCT01996943|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56050095|NCT01996943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050096|NCT01996943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050097|NCT01996943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050098|NCT04812626|Triamcinolone|triamcinolone|mesh-list
56050099|NCT04812626|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56050100|NCT04812626|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55881808|NCT03005704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55881809|NCT03005704|Purinergic Agents|purinergic agents|mesh-ancestor
55881810|NCT03005704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881811|NCT03005704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881812|NCT03005704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881813|NCT03005704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55881814|NCT03005704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55881816|NCT03005704|Sensory System Agents|sensory system agents|mesh-ancestor
55881817|NCT03005704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881818|NCT03005704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881819|NCT03005704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55881820|NCT03005704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55881821|NCT03005704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55881824|NCT03005704|Antipyretics|antipyretics|mesh-ancestor
55881825|NCT01595386|Hydrocortisone|hydrocortisone|mesh-list
55881826|NCT01595386|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55881827|NCT01595386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881828|NCT01595854|Dabigatran|dabigatran|mesh-list
55881829|NCT01595854|Ticagrelor|ticagrelor|mesh-list
56050101|NCT04812626|Fluorouracil|fluorouracil|mesh-list
56050102|NCT04812626|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56050103|NCT04812626|Antimetabolites|antimetabolites|mesh-ancestor
56050104|NCT04812626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881830|NCT01595854|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55881831|NCT01595854|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55881832|NCT01595854|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55881834|NCT01595854|Purinergic Agents|purinergic agents|mesh-ancestor
55881835|NCT01595854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55881836|NCT01595854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881837|NCT01595854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881838|NCT01595854|Antithrombins|antithrombins|mesh-ancestor
55881839|NCT01595854|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55881840|NCT01595854|Protease Inhibitors|protease inhibitors|mesh-ancestor
55881841|NCT01595854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881842|NCT01595854|Anticoagulants|anticoagulants|mesh-ancestor
55881843|NCT01596088|Dexrazoxane|dexrazoxane|mesh-list
55881844|NCT01596088|Razoxane|razoxane|mesh-list
55881845|NCT01596088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881846|NCT01596088|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55881847|NCT01596088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55881848|NCT01596088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55881849|NCT01596088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881850|NCT01596088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881851|NCT01596088|Protective Agents|protective agents|mesh-ancestor
55881852|NCT01596088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881853|NCT01596088|Antimitotic Agents|antimitotic agents|mesh-ancestor
55881854|NCT01596088|Mitosis Modulators|mitosis modulators|mesh-ancestor
55881855|NCT02216422|Ritonavir|ritonavir|mesh-list
55881856|NCT02216422|Ribavirin|ribavirin|mesh-list
55881857|NCT02216422|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55881858|NCT02216422|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55881859|NCT02216422|Protease Inhibitors|protease inhibitors|mesh-ancestor
55881860|NCT02216422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881861|NCT02216422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881862|NCT02216422|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55881863|NCT02216422|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55881864|NCT02216422|Antiviral Agents|antiviral agents|mesh-ancestor
55881865|NCT02216422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881866|NCT02216422|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55881867|NCT02216422|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55881868|NCT02216422|Antimetabolites|antimetabolites|mesh-ancestor
55881869|NCT03001570|Cetuximab|cetuximab|mesh-list
55881870|NCT03001570|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55881871|NCT03001570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881872|NCT03005548|Morphine|morphine|mesh-list
55881873|NCT03005548|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55881874|NCT03005548|Narcotics|narcotics|mesh-ancestor
55751202|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881875|NCT03005548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55881876|NCT03005548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881878|NCT03005548|Sensory System Agents|sensory system agents|mesh-ancestor
55881879|NCT03005548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881880|NCT03373266|Anesthetics|anesthetics|mesh-list
55881881|NCT03373266|Sevoflurane|sevoflurane|mesh-list
55881882|NCT03373266|Isoflurane|isoflurane|mesh-list
55881883|NCT03373266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55881884|NCT03373266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881885|NCT03373266|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55881886|NCT03373266|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55881887|NCT03373266|Anesthetics, General|anesthetics, general|mesh-ancestor
55881888|NCT02217904|Islatravir|islatravir|mesh-list
55881889|NCT02217904|Antiviral Agents|antiviral agents|mesh-ancestor
55881890|NCT02217904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881891|NCT02217904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881892|NCT02217904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881893|NCT02217904|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55881894|NCT02217904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56050105|NCT04812626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56050106|NCT04812626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050107|NCT04812626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56050108|NCT04812626|Immunologic Factors|immunologic factors|mesh-ancestor
55881895|NCT02217904|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55881899|NCT05566834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881900|NCT05566834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881902|NCT01900002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881903|NCT01900002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55881904|NCT01900002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881905|NCT01900002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881906|NCT03005002|Durvalumab|durvalumab|mesh-list
55881907|NCT03005002|Ipilimumab|ipilimumab|mesh-list
55881908|NCT03005002|Tremelimumab|tremelimumab|mesh-list
55881909|NCT03005002|Immunoglobulins|immunoglobulins|mesh-list
55881910|NCT03005002|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55881911|NCT03005002|Immunoglobulin G|immunoglobulin g|mesh-list
55881912|NCT03005002|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55881913|NCT03005002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881914|NCT03005002|Immunologic Factors|immunologic factors|mesh-ancestor
55881915|NCT03005002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881916|NCT03005002|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55881917|NCT03005002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881918|NCT03001102|Chlorhexidine|chlorhexidine|mesh-list
55881919|NCT03001102|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55881920|NCT03001102|Povidone-Iodine|povidone-iodine|mesh-list
55881921|NCT03001102|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
55881922|NCT03001102|Povidone|povidone|mesh-list
55881923|NCT03001102|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881924|NCT03001102|Disinfectants|disinfectants|mesh-ancestor
55881925|NCT03001102|Dermatologic Agents|dermatologic agents|mesh-ancestor
55881926|NCT03001102|Plasma Substitutes|plasma substitutes|mesh-ancestor
55881927|NCT03001102|Blood Substitutes|blood substitutes|mesh-ancestor
55881928|NCT03000946|Octreotide|octreotide|mesh-list
55881929|NCT03000946|Somatostatin|somatostatin|mesh-list
55881930|NCT03000946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55881931|NCT03000946|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55881932|NCT03000946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881934|NCT03000946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881935|NCT03000946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881936|NCT03004768|BMS-986165|bms-986165|mesh-list
55881937|NCT03004768|Dermatologic Agents|dermatologic agents|mesh-ancestor
55881938|NCT03004768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55881939|NCT03004768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881940|NCT03004768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881941|NCT03005236|Tacrolimus|tacrolimus|mesh-list
55881942|NCT03005236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55881943|NCT03005236|Immunologic Factors|immunologic factors|mesh-ancestor
55881944|NCT03005236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881945|NCT03005236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55881946|NCT03005236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881947|NCT03005236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881948|NCT03363204|Salicylic Acid|salicylic acid|mesh-list
55881949|NCT03363204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881950|NCT03363204|Antifungal Agents|antifungal agents|mesh-ancestor
55881951|NCT03363204|Keratolytic Agents|keratolytic agents|mesh-ancestor
55881952|NCT03363204|Dermatologic Agents|dermatologic agents|mesh-ancestor
55881953|NCT02519010|Amlodipine|amlodipine|mesh-list
55881954|NCT02519010|Valsartan|valsartan|mesh-list
55881955|NCT02519010|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
55881956|NCT02519010|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55881957|NCT02519010|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55881958|NCT02519010|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55751248|NCT05048511|Vitamin D|vitamin d|mesh-list
55751249|NCT05048511|Vitamins|vitamins|mesh-ancestor
55881959|NCT02519010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881960|NCT02519010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55881962|NCT02519010|Vasodilator Agents|vasodilator agents|mesh-ancestor
55881963|NCT02519010|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56050109|NCT04812626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050110|NCT04812626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56050111|NCT04812626|Glucocorticoids|glucocorticoids|mesh-ancestor
56050112|NCT04812626|Hormones|hormones|mesh-ancestor
56050113|NCT04812626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050114|NCT04812626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050115|NCT04197986|Infigratinib|infigratinib|mesh-list
56050116|NCT04197986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050117|NCT01997411|Glucagon|glucagon|mesh-list
56050118|NCT01997411|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56050119|NCT01997411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55881964|NCT02519010|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55881966|NCT03004612|Linagliptin|linagliptin|mesh-list
55881971|NCT03004612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55881972|NCT03004612|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55881973|NCT03004612|Protease Inhibitors|protease inhibitors|mesh-ancestor
55881974|NCT03004612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881975|NCT03004612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881976|NCT04527042|Rivaroxaban|rivaroxaban|mesh-list
55881977|NCT04527042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55881978|NCT04527042|Antithrombins|antithrombins|mesh-ancestor
55881979|NCT04527042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55881980|NCT04527042|Protease Inhibitors|protease inhibitors|mesh-ancestor
55881981|NCT04527042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55881982|NCT04527042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55881983|NCT04527042|Anticoagulants|anticoagulants|mesh-ancestor
55881984|NCT03372486|Bupivacaine|bupivacaine|mesh-list
55881985|NCT03372486|Naloxone|naloxone|mesh-list
55881986|NCT03372486|Anesthetics, Local|anesthetics, local|mesh-ancestor
55881987|NCT03372486|Anesthetics|anesthetics|mesh-ancestor
55881988|NCT03372486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55881989|NCT03372486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881990|NCT03372486|Sensory System Agents|sensory system agents|mesh-ancestor
55881991|NCT03372486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55881992|NCT03372486|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55881993|NCT05035888|Phenylephrine|phenylephrine|mesh-list
55881994|NCT05035888|Oxymetazoline|oxymetazoline|mesh-list
55881995|NCT05035888|Norepinephrine|norepinephrine|mesh-list
55881996|NCT05035888|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55881997|NCT05035888|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55881998|NCT05035888|Mydriatics|mydriatics|mesh-ancestor
55881999|NCT05035888|Autonomic Agents|autonomic agents|mesh-ancestor
55882000|NCT05035888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882001|NCT05035888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882002|NCT05035888|Sympathomimetics|sympathomimetics|mesh-ancestor
55882003|NCT05035888|Nasal Decongestants|nasal decongestants|mesh-ancestor
55882004|NCT05035888|Respiratory System Agents|respiratory system agents|mesh-ancestor
55882005|NCT05035888|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55882006|NCT05035888|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55882007|NCT05035888|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55882008|NCT05035888|Adrenergic Agents|adrenergic agents|mesh-ancestor
55882009|NCT05035888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882010|NCT05035888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882012|NCT03362814|Ritonavir|ritonavir|mesh-list
55882013|NCT03362814|Ribavirin|ribavirin|mesh-list
55882014|NCT03362814|Lactams|lactams|mesh-list
55882015|NCT03362814|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55882016|NCT03362814|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55882017|NCT03362814|Protease Inhibitors|protease inhibitors|mesh-ancestor
55882018|NCT03362814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882019|NCT03362814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882020|NCT03362814|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55882021|NCT03362814|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55882022|NCT03362814|Antiviral Agents|antiviral agents|mesh-ancestor
55882023|NCT03362814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882024|NCT03362814|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55882025|NCT03362814|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55882026|NCT03362814|Antimetabolites|antimetabolites|mesh-ancestor
55882027|NCT03362814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55882028|NCT03004066|Daptomycin|daptomycin|mesh-list
55882029|NCT03004066|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55882030|NCT03004066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882031|NCT03362736|Ustekinumab|ustekinumab|mesh-list
55882032|NCT03362736|Dermatologic Agents|dermatologic agents|mesh-ancestor
55882033|NCT03004222|Bupivacaine|bupivacaine|mesh-list
55882034|NCT03004222|Anesthetics, Local|anesthetics, local|mesh-ancestor
55882035|NCT03004222|Anesthetics|anesthetics|mesh-ancestor
55882036|NCT03004222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882037|NCT03004222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882038|NCT03004222|Sensory System Agents|sensory system agents|mesh-ancestor
55882039|NCT03004222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882048|NCT03000634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882050|NCT03000634|Glucocorticoids|glucocorticoids|mesh-ancestor
55882051|NCT03000634|Hormones|hormones|mesh-ancestor
55882052|NCT03000634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55882053|NCT03000634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55882054|NCT03000634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882055|NCT03000634|Immunologic Factors|immunologic factors|mesh-ancestor
55882056|NCT03000634|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55882057|NCT03000634|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55882058|NCT03000634|Growth Substances|growth substances|mesh-ancestor
55882059|NCT03000634|Growth Inhibitors|growth inhibitors|mesh-ancestor
55882060|NCT02520102|Sargramostim|sargramostim|mesh-list
55882061|NCT02520102|Immunologic Factors|immunologic factors|mesh-ancestor
55882062|NCT02520102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882063|NCT03000556|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55882064|NCT03000556|Hyaluronic Acid|hyaluronic acid|mesh-list
55882065|NCT03000556|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55882066|NCT03000556|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55882067|NCT03000556|Immunologic Factors|immunologic factors|mesh-ancestor
55882068|NCT03000556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882069|NCT03000556|Viscosupplements|viscosupplements|mesh-ancestor
55882070|NCT03000556|Protective Agents|protective agents|mesh-ancestor
55882071|NCT03371862|Liraglutide|liraglutide|mesh-list
55882072|NCT03371862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55882073|NCT03371862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882074|NCT03371862|Incretins|incretins|mesh-ancestor
55882075|NCT03371862|Hormones|hormones|mesh-ancestor
55882076|NCT03371862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55882077|NCT03368430|Melatonin|melatonin|mesh-list
55882078|NCT03368430|Antioxidants|antioxidants|mesh-ancestor
55882080|NCT03368430|Protective Agents|protective agents|mesh-ancestor
55882081|NCT03368430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882082|NCT03368430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882083|NCT03371784|Hydrocortisone|hydrocortisone|mesh-list
55882084|NCT03371784|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882085|NCT03003832|Analgesics, Opioid|analgesics, opioid|mesh-list
55882087|NCT03003832|Narcotics|narcotics|mesh-ancestor
55882088|NCT03003832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882089|NCT03003832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751361|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
55882090|NCT03003832|Sensory System Agents|sensory system agents|mesh-ancestor
55882091|NCT03003832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882092|NCT03368352|Melatonin|melatonin|mesh-list
55882093|NCT03368352|Antioxidants|antioxidants|mesh-ancestor
55882094|NCT03368352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882095|NCT03368352|Protective Agents|protective agents|mesh-ancestor
55882096|NCT03368352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882097|NCT03368352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882098|NCT02248012|Everolimus|everolimus|mesh-list
55882099|NCT02248012|Temozolomide|temozolomide|mesh-list
55882100|NCT02248012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882101|NCT02248012|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55882102|NCT02248012|Immunologic Factors|immunologic factors|mesh-ancestor
55882103|NCT02248012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050121|NCT01997411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050122|NCT01997411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050123|NCT01997411|Incretins|incretins|mesh-ancestor
56050124|NCT03534635|Pembrolizumab|pembrolizumab|mesh-list
56050125|NCT03534635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56050126|NCT03534635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050127|NCT01999517|Nitroglycerin|nitroglycerin|mesh-list
56050128|NCT01999517|Vasodilator Agents|vasodilator agents|mesh-ancestor
56050130|NCT04153760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56050131|NCT04153760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56050132|NCT04153760|Analgesics|analgesics|mesh-ancestor
56050133|NCT04153760|Sensory System Agents|sensory system agents|mesh-ancestor
56050134|NCT04153760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050135|NCT04153760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882104|NCT02248012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55882105|NCT02248012|Alkylating Agents|alkylating agents|mesh-ancestor
55882106|NCT02248012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882107|NCT03362268|Omeprazole|omeprazole|mesh-list
55882108|NCT03362268|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55882116|NCT04523844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55882117|NCT04523844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55882118|NCT04523844|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55882119|NCT04523844|Adrenergic Agents|adrenergic agents|mesh-ancestor
55882120|NCT04523844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882121|NCT04523844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882122|NCT04523844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882123|NCT04523844|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55882124|NCT04523844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882125|NCT03361878|Metformin|metformin|mesh-list
55882126|NCT03361878|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55882127|NCT03361878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882128|NCT03361800|Entinostat|entinostat|mesh-list
55882129|NCT03361800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882130|NCT03361800|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55882132|NCT03361800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882133|NCT02998918|Curcumin|curcumin|mesh-list
55882134|NCT02998918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55882135|NCT02998918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55882136|NCT02998918|Analgesics|analgesics|mesh-ancestor
55882137|NCT02998918|Sensory System Agents|sensory system agents|mesh-ancestor
55882138|NCT02998918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882139|NCT02998918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882140|NCT02998918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882141|NCT02998918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55882142|NCT02998918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882143|NCT02998918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882144|NCT02998918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882145|NCT02995642|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
55882146|NCT02995642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882147|NCT02998606|Naloxegol|naloxegol|mesh-list
55882148|NCT02998606|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55882149|NCT02998606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882150|NCT02998606|Sensory System Agents|sensory system agents|mesh-ancestor
55882151|NCT02998606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050137|NCT04153760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56050138|NCT04153760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56050139|NCT04153760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56050140|NCT04153760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050141|NCT04153760|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56050142|NCT04153760|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56050143|NCT04153760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050144|NCT04153760|Antipyretics|antipyretics|mesh-ancestor
56050145|NCT02657486|Infigratinib|infigratinib|mesh-list
56050146|NCT02657486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050147|NCT02385110|Dexamethasone|dexamethasone|mesh-list
56050148|NCT02385110|Methotrexate|methotrexate|mesh-list
56050149|NCT02385110|Etoposide|etoposide|mesh-list
56050150|NCT02385110|Alemtuzumab|alemtuzumab|mesh-list
56050151|NCT02385110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56050152|NCT02385110|Antiemetics|antiemetics|mesh-ancestor
56050153|NCT02385110|Autonomic Agents|autonomic agents|mesh-ancestor
56050154|NCT02385110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882152|NCT05365438|Atorvastatin|atorvastatin|mesh-list
55882153|NCT05365438|Ezetimibe|ezetimibe|mesh-list
55882154|NCT05365438|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55882155|NCT05365438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55882156|NCT05365438|Antimetabolites|antimetabolites|mesh-ancestor
55882157|NCT05365438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882158|NCT05365438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55882159|NCT05365438|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55882160|NCT05365438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882161|NCT05264506|Estradiol|estradiol|mesh-list
55882162|NCT05264506|Estrogens|estrogens|mesh-ancestor
55882163|NCT05264506|Hormones|hormones|mesh-ancestor
55882164|NCT05264506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55882165|NCT05264506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882166|NCT02248168|Pramipexole|pramipexole|mesh-list
55882167|NCT02248168|Antioxidants|antioxidants|mesh-ancestor
55882168|NCT02248168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882169|NCT02248168|Protective Agents|protective agents|mesh-ancestor
55882170|NCT02248168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882171|NCT02248168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55882172|NCT02248168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55882173|NCT02248168|Dopamine Agonists|dopamine agonists|mesh-ancestor
55882174|NCT02248168|Dopamine Agents|dopamine agents|mesh-ancestor
55882175|NCT02248168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882180|NCT05672680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882181|NCT05672680|Sensory System Agents|sensory system agents|mesh-ancestor
55882182|NCT05672680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882183|NCT05672524|Trastuzumab|trastuzumab|mesh-list
55882185|NCT05672524|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55882186|NCT05672524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882187|NCT05672524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55882188|NCT05672524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882189|NCT05672524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882190|NCT03002428|Teriparatide|teriparatide|mesh-list
55882191|NCT03002428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56050155|NCT02385110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050156|NCT02385110|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56050157|NCT02385110|Glucocorticoids|glucocorticoids|mesh-ancestor
56050158|NCT02385110|Hormones|hormones|mesh-ancestor
56050159|NCT02385110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050160|NCT02385110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56050161|NCT02385110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882192|NCT03002428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882193|NCT03002428|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55882194|NCT04398706|Vaccines|vaccines|mesh-list
55882195|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55882196|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
55882197|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882198|NCT05672134|Geranylgeranylacetone|geranylgeranylacetone|mesh-list
55882199|NCT05672134|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55882200|NCT05672134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55882201|NCT05672134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882202|NCT05671822|Capecitabine|capecitabine|mesh-list
55882203|NCT05671822|Oxaliplatin|oxaliplatin|mesh-list
55882204|NCT05671822|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55882205|NCT05671822|Antimetabolites|antimetabolites|mesh-ancestor
55882206|NCT05671822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882207|NCT05671822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882209|NCT03371550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882210|NCT03371550|Tubulin Modulators|tubulin modulators|mesh-ancestor
55882211|NCT03371550|Antimitotic Agents|antimitotic agents|mesh-ancestor
55882212|NCT03371550|Mitosis Modulators|mitosis modulators|mesh-ancestor
55882213|NCT03371550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882214|NCT05670028|Antihypertensive Agents|antihypertensive agents|mesh-list
55882215|NCT05669872|Ferric Compounds|ferric compounds|mesh-list
55882216|NCT05669872|Hematinics|hematinics|mesh-ancestor
55882217|NCT04861948|Bevacizumab|bevacizumab|mesh-list
55882218|NCT04861948|Carboplatin|carboplatin|mesh-list
55882219|NCT04861948|Pemetrexed|pemetrexed|mesh-list
55882220|NCT04861948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55882221|NCT04861948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882222|NCT04861948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55882223|NCT04861948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55882224|NCT04861948|Growth Substances|growth substances|mesh-ancestor
55882225|NCT04861948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882226|NCT04861948|Growth Inhibitors|growth inhibitors|mesh-ancestor
55882227|NCT04861948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882228|NCT04861948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882229|NCT04861948|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55882230|NCT04861948|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55882231|NCT04526028|Fulvestrant|fulvestrant|mesh-list
55882232|NCT04526028|Palbociclib|palbociclib|mesh-list
55882233|NCT04526028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55882234|NCT04526028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882235|NCT04526028|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55882236|NCT04526028|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55882237|NCT04526028|Hormone Antagonists|hormone antagonists|mesh-ancestor
55882238|NCT04526028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55882239|NCT04526028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882240|NCT04526028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55882241|NCT04526028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882242|NCT04526028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882243|NCT02518698|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55882244|NCT02518698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882245|NCT03368274|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
55882246|NCT03368274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882250|NCT03368274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882252|NCT02247544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56050162|NCT02385110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56050163|NCT02385110|Abortifacient Agents|abortifacient agents|mesh-ancestor
56050164|NCT02385110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56050165|NCT02385110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55882253|NCT02247544|Alkylating Agents|alkylating agents|mesh-ancestor
55882254|NCT02247544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882255|NCT02247544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882256|NCT03370848|Aspirin|aspirin|mesh-list
55882257|NCT03370848|Psyllium|psyllium|mesh-list
55882258|NCT03370848|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55882260|NCT03370848|Analgesics|analgesics|mesh-ancestor
55882261|NCT03370848|Sensory System Agents|sensory system agents|mesh-ancestor
55882262|NCT03370848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882263|NCT03370848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882264|NCT03370848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882265|NCT03370848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55882266|NCT03370848|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55882267|NCT03370848|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55882268|NCT03370848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882269|NCT03370848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55882270|NCT03370848|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55882271|NCT03370848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882272|NCT03370848|Antipyretics|antipyretics|mesh-ancestor
55882273|NCT03370848|Cathartics|cathartics|mesh-ancestor
55882274|NCT03370848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55882275|NCT02248792|Methotrexate|methotrexate|mesh-list
55882276|NCT02248792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55882277|NCT02248792|Abortifacient Agents|abortifacient agents|mesh-ancestor
55882278|NCT02248792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55882279|NCT02248792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882280|NCT02248792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55882281|NCT02248792|Antimetabolites|antimetabolites|mesh-ancestor
55882282|NCT02248792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882283|NCT02248792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882284|NCT02248792|Dermatologic Agents|dermatologic agents|mesh-ancestor
55882285|NCT02248792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882286|NCT02248792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55882287|NCT02248792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55882288|NCT02248792|Immunologic Factors|immunologic factors|mesh-ancestor
55882289|NCT02248792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55882290|NCT02248792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55882291|NCT03367728|Ropivacaine|ropivacaine|mesh-list
55882292|NCT03367728|Anesthetics, Local|anesthetics, local|mesh-ancestor
55882293|NCT03367728|Anesthetics|anesthetics|mesh-ancestor
55882295|NCT03367728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882296|NCT03367728|Sensory System Agents|sensory system agents|mesh-ancestor
55882297|NCT03367728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882298|NCT02248870|Dexamethasone|dexamethasone|mesh-list
55882299|NCT02248870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882300|NCT02248870|Antiemetics|antiemetics|mesh-ancestor
55882301|NCT02248870|Autonomic Agents|autonomic agents|mesh-ancestor
55882302|NCT02248870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882303|NCT02248870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882304|NCT02248870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55882306|NCT02248870|Hormones|hormones|mesh-ancestor
55882307|NCT02248870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55882308|NCT02248870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55882309|NCT02248870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882310|NCT04073056|Bupivacaine|bupivacaine|mesh-list
55882311|NCT04073056|Anesthetics, Local|anesthetics, local|mesh-ancestor
55882312|NCT04073056|Anesthetics|anesthetics|mesh-ancestor
55882313|NCT04073056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882314|NCT04073056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882315|NCT04073056|Sensory System Agents|sensory system agents|mesh-ancestor
55882316|NCT04073056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882317|NCT03361098|Dapagliflozin|dapagliflozin|mesh-list
55882318|NCT03361098|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56050167|NCT02385110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050168|NCT02385110|Dermatologic Agents|dermatologic agents|mesh-ancestor
56050169|NCT02385110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050170|NCT02385110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55882319|NCT03361098|Exenatide|exenatide|mesh-list
55887066|NCT01784770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882320|NCT03361098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882323|NCT03361098|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55882324|NCT03361098|Incretins|incretins|mesh-ancestor
55882325|NCT03361098|Hormones|hormones|mesh-ancestor
55882326|NCT03361098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55882327|NCT03367494|Bromides|bromides|mesh-list
55882328|NCT03367494|Anticonvulsants|anticonvulsants|mesh-ancestor
55882329|NCT05594290|Etoposide|etoposide|mesh-list
55882330|NCT05594290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882331|NCT05594290|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55882332|NCT05594290|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55882333|NCT05594290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55882334|NCT05594290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882335|NCT05594290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882336|NCT03370380|Aflibercept|aflibercept|mesh-list
55882337|NCT03370380|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55882338|NCT03370380|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55882339|NCT03370380|Growth Substances|growth substances|mesh-ancestor
55882340|NCT03370380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882341|NCT03370380|Growth Inhibitors|growth inhibitors|mesh-ancestor
55882342|NCT03370380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882343|NCT04414540|Metformin|metformin|mesh-list
55882344|NCT04414540|Pembrolizumab|pembrolizumab|mesh-list
55882345|NCT04414540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55882346|NCT04414540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882347|NCT04414540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55882348|NCT04414540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882349|NCT05568160|Vasopressins|vasopressins|mesh-list
55882350|NCT05568160|Arginine Vasopressin|arginine vasopressin|mesh-list
55882351|NCT05568160|Norepinephrine|norepinephrine|mesh-list
55882352|NCT05568160|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55882353|NCT05568160|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55882354|NCT05568160|Adrenergic Agents|adrenergic agents|mesh-ancestor
55751427|NCT05464433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882355|NCT05568160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882356|NCT05568160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882357|NCT05568160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882358|NCT05568160|Sympathomimetics|sympathomimetics|mesh-ancestor
55882359|NCT05568160|Autonomic Agents|autonomic agents|mesh-ancestor
55882360|NCT05568160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882361|NCT05568160|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55882362|NCT05568160|Hemostatics|hemostatics|mesh-ancestor
55882363|NCT05568160|Coagulants|coagulants|mesh-ancestor
55882364|NCT05568160|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55882365|NCT05568160|Natriuretic Agents|natriuretic agents|mesh-ancestor
55882366|NCT03889912|Cemiplimab|cemiplimab|mesh-list
55882367|NCT03889912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55882368|NCT03889912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882369|NCT03367182|Paclitaxel|paclitaxel|mesh-list
55882370|NCT03367182|Bevacizumab|bevacizumab|mesh-list
55882371|NCT03367182|Doxorubicin|doxorubicin|mesh-list
55882372|NCT03367182|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55882373|NCT03367182|Topotecan|topotecan|mesh-list
55882374|NCT03367182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55882375|NCT03367182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882376|NCT03367182|Tubulin Modulators|tubulin modulators|mesh-ancestor
55882377|NCT03367182|Antimitotic Agents|antimitotic agents|mesh-ancestor
55882378|NCT03367182|Mitosis Modulators|mitosis modulators|mesh-ancestor
55882379|NCT03367182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882380|NCT03367182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55882381|NCT03367182|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55882382|NCT03367182|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55882383|NCT03367182|Growth Substances|growth substances|mesh-ancestor
55882384|NCT03367182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882385|NCT03367182|Growth Inhibitors|growth inhibitors|mesh-ancestor
56050171|NCT02385110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56050172|NCT02385110|Immunologic Factors|immunologic factors|mesh-ancestor
56050173|NCT02385110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56050174|NCT02385110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56050175|NCT02385110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56050176|NCT02385110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56050177|NCT02385110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55777362|NCT04416334|Analgesics|analgesics|mesh-ancestor
56050178|NCT02385110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56050179|NCT01999985|Dasatinib|dasatinib|mesh-list
56050180|NCT01999985|Afatinib|afatinib|mesh-list
56053594|NCT03852537|Hormones|hormones|mesh-ancestor
56050181|NCT01999985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050182|NCT01999985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56050183|NCT01999985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050184|NCT01999985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050185|NCT01968317|Metformin|metformin|mesh-list
56050186|NCT01968317|Megestrol|megestrol|mesh-list
56050187|NCT01968317|Megestrol Acetate|megestrol acetate|mesh-list
56050188|NCT01968317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56050189|NCT01968317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050190|NCT01968317|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56050191|NCT01968317|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56050192|NCT01968317|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56050193|NCT01968317|Contraceptive Agents|contraceptive agents|mesh-ancestor
56050194|NCT01968317|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56050195|NCT01968317|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56050196|NCT01968317|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56050197|NCT01968317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56050198|NCT01968317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050199|NCT01968317|Appetite Stimulants|appetite stimulants|mesh-ancestor
56050200|NCT01968317|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56050202|NCT01971593|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56050203|NCT01971593|Hormone Antagonists|hormone antagonists|mesh-ancestor
56050204|NCT01971593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050205|NCT01971593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050206|NCT01971593|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56050207|NCT01971593|Diuretics|diuretics|mesh-ancestor
56050208|NCT01971593|Natriuretic Agents|natriuretic agents|mesh-ancestor
56050209|NCT01971593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56050210|NCT02986451|Clarithromycin|clarithromycin|mesh-list
56050211|NCT02986451|Dexamethasone|dexamethasone|mesh-list
56050212|NCT02986451|Lenalidomide|lenalidomide|mesh-list
56050213|NCT02986451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56050214|NCT02986451|Antiemetics|antiemetics|mesh-ancestor
56050215|NCT02986451|Autonomic Agents|autonomic agents|mesh-ancestor
56050216|NCT02986451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050217|NCT02986451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050218|NCT02986451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56050219|NCT02986451|Glucocorticoids|glucocorticoids|mesh-ancestor
56050220|NCT02986451|Hormones|hormones|mesh-ancestor
56050221|NCT02986451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050222|NCT02986451|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56050223|NCT02986451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050224|NCT02986451|Immunologic Factors|immunologic factors|mesh-ancestor
56050225|NCT02986451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56050226|NCT02986451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56050227|NCT02986451|Growth Substances|growth substances|mesh-ancestor
56050228|NCT02986451|Growth Inhibitors|growth inhibitors|mesh-ancestor
56050229|NCT02986451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56050230|NCT02986451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050231|NCT02986451|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56050232|NCT02986451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050233|NCT02986451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050234|NCT02986451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55882386|NCT03367182|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55882387|NCT03367182|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55882388|NCT03367182|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55882389|NCT03367182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882390|NCT03367182|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55882391|NCT05561764|Imipenem|imipenem|mesh-list
55882392|NCT05561764|Relebactam|relebactam|mesh-list
55882393|NCT05561764|Cilastatin|cilastatin|mesh-list
55882394|NCT05561764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55882403|NCT04119180|Sensory System Agents|sensory system agents|mesh-ancestor
55882404|NCT04119180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882405|NCT04119180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882406|NCT04119180|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55882407|NCT04119180|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55882408|NCT04119180|Anesthetics, General|anesthetics, general|mesh-ancestor
56050236|NCT03245463|Hyaluronic Acid|hyaluronic acid|mesh-list
56050237|NCT03245463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56050238|NCT03245463|Immunologic Factors|immunologic factors|mesh-ancestor
56050239|NCT03245463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050240|NCT03245463|Viscosupplements|viscosupplements|mesh-ancestor
56050241|NCT03245463|Protective Agents|protective agents|mesh-ancestor
56050242|NCT01974245|Cholecalciferol|cholecalciferol|mesh-list
56050244|NCT01974245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56050245|NCT01974245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050246|NCT01974245|Vitamins|vitamins|mesh-ancestor
56050247|NCT01974245|Micronutrients|micronutrients|mesh-ancestor
56050248|NCT01974245|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56050249|NCT03307005|Zolpidem|zolpidem|mesh-list
56050250|NCT03307005|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56050251|NCT03307005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56050252|NCT03307005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050253|NCT03307005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050254|NCT03307005|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56050255|NCT03307005|GABA Agonists|gaba agonists|mesh-ancestor
56050256|NCT03307005|GABA Agents|gaba agents|mesh-ancestor
56050257|NCT03307005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050258|NCT03307005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050259|NCT02005601|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55882411|NCT04119180|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55882412|NCT04119180|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55882413|NCT04119180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751474|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882414|NCT04119180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882415|NCT04119180|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55882416|NCT04119180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55882417|NCT04119180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55882418|NCT04119180|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55882419|NCT04119180|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55882420|NCT04119180|GABA Modulators|gaba modulators|mesh-ancestor
56050260|NCT02005601|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56050261|NCT02005601|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56050262|NCT02005601|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56050263|NCT02005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050264|NCT02005601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050265|NCT02005601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050266|NCT02005601|Analgesics|analgesics|mesh-ancestor
56050267|NCT02005601|Sensory System Agents|sensory system agents|mesh-ancestor
56050268|NCT02005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882421|NCT04119180|GABA Agents|gaba agents|mesh-ancestor
55882427|NCT03358212|Denosumab|denosumab|mesh-list
55882428|NCT03358212|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55882429|NCT03358212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882430|NCT04522050|Gemcitabine|gemcitabine|mesh-list
55882431|NCT04522050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882432|NCT04522050|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55882433|NCT04522050|Antimetabolites|antimetabolites|mesh-ancestor
55882434|NCT04522050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882435|NCT04522050|Antiviral Agents|antiviral agents|mesh-ancestor
55882436|NCT04522050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882437|NCT04522050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882438|NCT04522050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55882439|NCT04522050|Immunologic Factors|immunologic factors|mesh-ancestor
55751490|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
55882440|NCT04522050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882441|NCT03109392|Lidocaine|lidocaine|mesh-list
55882442|NCT03109392|Anesthetics, Local|anesthetics, local|mesh-ancestor
55882443|NCT03109392|Anesthetics|anesthetics|mesh-ancestor
55882444|NCT03109392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882445|NCT03109392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882446|NCT03109392|Sensory System Agents|sensory system agents|mesh-ancestor
55882447|NCT03109392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882448|NCT03109392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55882449|NCT03109392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55882450|NCT03109392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55882451|NCT03109392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55882452|NCT03109392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882453|NCT03357900|Remifentanil|remifentanil|mesh-list
55882455|NCT03357900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55882456|NCT03357900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053611|NCT00553202|Methotrexate|methotrexate|mesh-list
55882457|NCT03357900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882458|NCT03357900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55882459|NCT03357900|Anesthetics, General|anesthetics, general|mesh-ancestor
55882460|NCT03357900|Anesthetics|anesthetics|mesh-ancestor
55882461|NCT03357900|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55882462|NCT03357900|Narcotics|narcotics|mesh-ancestor
55882463|NCT03357900|Analgesics|analgesics|mesh-ancestor
55882464|NCT03357900|Sensory System Agents|sensory system agents|mesh-ancestor
55882468|NCT04525326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55882470|NCT04525326|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55882471|NCT04525326|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55882473|NCT04525326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882474|NCT04525326|Growth Inhibitors|growth inhibitors|mesh-ancestor
55882477|NCT03357822|Entecavir|entecavir|mesh-list
55882478|NCT03357822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882479|NCT03357822|Antiviral Agents|antiviral agents|mesh-ancestor
55882480|NCT03357822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882481|NCT03357822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55882482|NCT03357822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55882483|NCT03357822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050269|NCT02005601|Antidepressive Agents|antidepressive agents|mesh-ancestor
56050270|NCT02005601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56050271|NCT02005601|Dopamine Agents|dopamine agents|mesh-ancestor
56050273|NCT02007863|Melphalan|melphalan|mesh-list
56050274|NCT02007863|Busulfan|busulfan|mesh-list
56050275|NCT02007863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050276|NCT02007863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050277|NCT02007863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56050278|NCT02007863|Immunologic Factors|immunologic factors|mesh-ancestor
56050279|NCT02007863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050280|NCT02007863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56050281|NCT02007863|Alkylating Agents|alkylating agents|mesh-ancestor
56050282|NCT02007863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56050283|NCT03460899|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56050284|NCT03460899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050285|NCT02305277|Opicapone|opicapone|mesh-list
55882484|NCT03357822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882485|NCT03357822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55882486|NCT03357822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55882487|NCT03359694|Docetaxel|docetaxel|mesh-list
55882488|NCT03359694|Doxorubicin|doxorubicin|mesh-list
55882489|NCT03359694|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55882490|NCT03359694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882491|NCT03359694|Tubulin Modulators|tubulin modulators|mesh-ancestor
55882492|NCT03359694|Antimitotic Agents|antimitotic agents|mesh-ancestor
55882493|NCT03359694|Mitosis Modulators|mitosis modulators|mesh-ancestor
55882494|NCT03359694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882495|NCT03359694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55882496|NCT03359694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55882497|NCT03359694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55882498|NCT03359694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882499|NCT04113382|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55882500|NCT04113382|Laxatives|laxatives|mesh-ancestor
55882501|NCT04113382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55882502|NCT03404596|Nicotine|nicotine|mesh-list
55882503|NCT03404596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55882504|NCT03404596|Autonomic Agents|autonomic agents|mesh-ancestor
55882505|NCT03404596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882506|NCT03404596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882507|NCT03404596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55882508|NCT03404596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55882509|NCT03404596|Cholinergic Agents|cholinergic agents|mesh-ancestor
55882510|NCT03404596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882511|NCT03404596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882512|NCT03123276|Gemcitabine|gemcitabine|mesh-list
55882513|NCT03123276|Pembrolizumab|pembrolizumab|mesh-list
55882514|NCT03123276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55882515|NCT03123276|Antimetabolites|antimetabolites|mesh-ancestor
55882516|NCT03123276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882517|NCT03123276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882518|NCT03123276|Antiviral Agents|antiviral agents|mesh-ancestor
55882519|NCT03123276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882520|NCT03123276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882521|NCT03123276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55882522|NCT03123276|Immunologic Factors|immunologic factors|mesh-ancestor
55882524|NCT03123276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55882525|NCT02249026|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56050286|NCT02305277|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56050287|NCT02305277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050288|NCT02305277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050289|NCT02305277|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56050290|NCT02305277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56050292|NCT03309657|Ceftolozane|ceftolozane|mesh-list
56050293|NCT03309657|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
56050294|NCT03309657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55882526|NCT02249026|Buprenorphine|buprenorphine|mesh-list
55882527|NCT02249026|Opiate Alkaloids|opiate alkaloids|mesh-list
55882528|NCT02249026|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55882529|NCT02249026|Narcotics|narcotics|mesh-ancestor
55882530|NCT02249026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882531|NCT02249026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882532|NCT02249026|Analgesics|analgesics|mesh-ancestor
55882533|NCT02249026|Sensory System Agents|sensory system agents|mesh-ancestor
55882534|NCT02249026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882535|NCT02249026|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55882536|NCT03359070|Miconazole|miconazole|mesh-list
55882537|NCT03359070|Clotrimazole|clotrimazole|mesh-list
55882538|NCT03359070|Antifungal Agents|antifungal agents|mesh-ancestor
55882541|NCT03359070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55882542|NCT03359070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882543|NCT03359070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882544|NCT03359070|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55882545|NCT03359070|Hormone Antagonists|hormone antagonists|mesh-ancestor
55882546|NCT03359070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55882547|NCT03359070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882548|NCT03359070|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55882549|NCT03359070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55882550|NCT03359070|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55882551|NCT03366246|Lidocaine|lidocaine|mesh-list
55882552|NCT03366246|Prilocaine|prilocaine|mesh-list
55882553|NCT03366246|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55882554|NCT03366246|Anesthetics, Local|anesthetics, local|mesh-ancestor
55882555|NCT03366246|Anesthetics|anesthetics|mesh-ancestor
55882556|NCT03366246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882557|NCT03366246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882558|NCT03366246|Sensory System Agents|sensory system agents|mesh-ancestor
55882559|NCT03366246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882560|NCT03366246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55882561|NCT03366246|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55882562|NCT03366246|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55882563|NCT03366246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55882564|NCT03366246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882565|NCT03366246|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55882566|NCT01623466|Contraceptive Agents|contraceptive agents|mesh-list
55882567|NCT01623466|Levonorgestrel|levonorgestrel|mesh-list
55882568|NCT01623466|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55882569|NCT01623466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751623|NCT05016063|Fludarabine|fludarabine|mesh-list
55882570|NCT01623466|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55882571|NCT01623466|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55882573|NCT01623466|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55882575|NCT03556384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55882576|NCT03556384|Alkylating Agents|alkylating agents|mesh-ancestor
55882577|NCT03556384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882578|NCT03556384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882579|NCT04520646|Empagliflozin|empagliflozin|mesh-list
56050296|NCT03309657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56050297|NCT03309657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050298|NCT03309657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050299|NCT03309657|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56050300|NCT03309657|Renal Agents|renal agents|mesh-ancestor
56050301|NCT03463161|Pembrolizumab|pembrolizumab|mesh-list
55882580|NCT04520646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55882581|NCT04520646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882582|NCT04520646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55882583|NCT04520646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882584|NCT01624948|Mycophenolic Acid|mycophenolic acid|mesh-list
55882585|NCT01624948|Everolimus|everolimus|mesh-list
55882586|NCT01624948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882587|NCT01624948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55882588|NCT01624948|Immunologic Factors|immunologic factors|mesh-ancestor
55882589|NCT01624948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882590|NCT01624948|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55882591|NCT01624948|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55882592|NCT01624948|Antitubercular Agents|antitubercular agents|mesh-ancestor
55882593|NCT01624948|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55882594|NCT01624948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882595|NCT01624948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882596|NCT01624948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882597|NCT04523064|Empagliflozin|empagliflozin|mesh-list
55882598|NCT04523064|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55882599|NCT04523064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882600|NCT04523064|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55882601|NCT04523064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882602|NCT04520880|Antibodies|antibodies|mesh-list
55882603|NCT04520880|Immunoglobulins|immunoglobulins|mesh-list
55882604|NCT04520880|Antibodies, Blocking|antibodies, blocking|mesh-list
55882605|NCT04520880|Immunologic Factors|immunologic factors|mesh-ancestor
55882606|NCT04520880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882607|NCT03365466|Aspirin|aspirin|mesh-list
55882610|NCT03365466|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55882611|NCT03365466|Tinzaparin|tinzaparin|mesh-list
55882612|NCT03365466|Dalteparin|dalteparin|mesh-list
55882613|NCT03365466|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55882614|NCT03365466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55882615|NCT03365466|Analgesics|analgesics|mesh-ancestor
55882616|NCT03365466|Sensory System Agents|sensory system agents|mesh-ancestor
55882617|NCT03365466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882618|NCT03365466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882619|NCT03365466|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882620|NCT03365466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55882621|NCT03365466|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55882622|NCT03365466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55882623|NCT03365466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882624|NCT03365466|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55882625|NCT03365466|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55882626|NCT03365466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882627|NCT03365466|Antipyretics|antipyretics|mesh-ancestor
55882628|NCT03365466|Anticoagulants|anticoagulants|mesh-ancestor
55882629|NCT03356964|Hormones|hormones|mesh-list
55882630|NCT03356964|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55882632|NCT03356964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882633|NCT03346252|Botulinum Toxins|botulinum toxins|mesh-list
55882634|NCT03346252|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55882635|NCT03346252|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55882636|NCT03346252|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55882637|NCT03346252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55882638|NCT03346252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050302|NCT03463161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56050303|NCT03463161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050304|NCT03467685|Anesthetics|anesthetics|mesh-list
56050305|NCT03467685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050306|NCT03467685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050307|NCT03468075|Ascorbic Acid|ascorbic acid|mesh-list
56050308|NCT03468075|Gemcitabine|gemcitabine|mesh-list
56050309|NCT03468075|Vitamins|vitamins|mesh-ancestor
56050310|NCT03468075|Micronutrients|micronutrients|mesh-ancestor
55882639|NCT03346252|Cholinergic Agents|cholinergic agents|mesh-ancestor
55882640|NCT03346252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882641|NCT03346252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882642|NCT03346252|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55882643|NCT03346252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882644|NCT03365388|Hyaluronic Acid|hyaluronic acid|mesh-list
55882645|NCT03365388|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55882646|NCT03365388|Immunologic Factors|immunologic factors|mesh-ancestor
55882647|NCT03365388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882648|NCT03365388|Viscosupplements|viscosupplements|mesh-ancestor
55882649|NCT03365388|Protective Agents|protective agents|mesh-ancestor
55882650|NCT03123744|Palbociclib|palbociclib|mesh-list
55882651|NCT03123744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882652|NCT03123744|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55882653|NCT03123744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882654|NCT03123744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882655|NCT03358524|Vitamins|vitamins|mesh-list
55882656|NCT03358524|Vitamin E|vitamin e|mesh-list
55882657|NCT03358524|Tocopherols|tocopherols|mesh-list
55882658|NCT03358524|Tocotrienols|tocotrienols|mesh-list
55882659|NCT03358524|alpha-Tocopherol|alpha-tocopherol|mesh-list
55882660|NCT03358524|Micronutrients|micronutrients|mesh-ancestor
55882661|NCT03358524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882662|NCT03358524|Antioxidants|antioxidants|mesh-ancestor
55882663|NCT03358524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882664|NCT03358524|Protective Agents|protective agents|mesh-ancestor
55882665|NCT04444986|Favipiravir|favipiravir|mesh-list
55882666|NCT04444986|Antiviral Agents|antiviral agents|mesh-ancestor
55882667|NCT04444986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882668|NCT03356730|Vitamin D|vitamin d|mesh-list
55882669|NCT03356730|Vitamins|vitamins|mesh-ancestor
55882670|NCT03356730|Micronutrients|micronutrients|mesh-ancestor
55882671|NCT03356730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882672|NCT03356730|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55882673|NCT03364998|Factor VIII|factor viii|mesh-list
55882674|NCT03364998|Coagulants|coagulants|mesh-ancestor
55882675|NCT03587142|Buspirone|buspirone|mesh-list
55882676|NCT03587142|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55882677|NCT03587142|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55882678|NCT03587142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882680|NCT03587142|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55882681|NCT03587142|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55882682|NCT03587142|Serotonin Agents|serotonin agents|mesh-ancestor
55882683|NCT03587142|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882684|NCT03587142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882686|NCT04509102|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55882687|NCT04509102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882688|NCT04508946|Thiamine|thiamine|mesh-list
55882689|NCT04508946|Hydrocortisone|hydrocortisone|mesh-list
55882690|NCT04508946|Vitamins|vitamins|mesh-ancestor
55882691|NCT04508946|Micronutrients|micronutrients|mesh-ancestor
55882692|NCT04508946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882693|NCT04508946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882694|NCT04508946|Vitamin B Complex|vitamin b complex|mesh-ancestor
55882695|NCT03364842|Furosemide|furosemide|mesh-list
55882696|NCT03364842|Diuretics|diuretics|mesh-ancestor
55882697|NCT03364842|Natriuretic Agents|natriuretic agents|mesh-ancestor
55882698|NCT03364842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050311|NCT03468075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050312|NCT03468075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56050313|NCT03468075|Antimetabolites|antimetabolites|mesh-ancestor
56050314|NCT03468075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050315|NCT03468075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050316|NCT03468075|Antiviral Agents|antiviral agents|mesh-ancestor
56050317|NCT03468075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050318|NCT03468075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751637|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882699|NCT03364842|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55882700|NCT03364842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55882701|NCT03364842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882703|NCT03364764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55882704|NCT03364764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882705|NCT03364764|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55882706|NCT03364764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882707|NCT03364764|Antifungal Agents|antifungal agents|mesh-ancestor
55882708|NCT03364764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55882709|NCT03364764|Immunologic Factors|immunologic factors|mesh-ancestor
55882710|NCT03364764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882711|NCT02519400|Amitriptyline|amitriptyline|mesh-list
55882712|NCT02519400|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55882713|NCT02519400|Antidepressive Agents|antidepressive agents|mesh-ancestor
55882714|NCT02519400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55882715|NCT02519400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55882716|NCT02519400|Analgesics|analgesics|mesh-ancestor
55882717|NCT02519400|Sensory System Agents|sensory system agents|mesh-ancestor
55882718|NCT02519400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882719|NCT02519400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882720|NCT02519400|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55882721|NCT02519400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55882722|NCT02519400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55882723|NCT02519400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882724|NCT02519400|Adrenergic Agents|adrenergic agents|mesh-ancestor
55882725|NCT02519400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882726|NCT04509258|Acetylcarnitine|acetylcarnitine|mesh-list
55882727|NCT04509258|Acetylcysteine|acetylcysteine|mesh-list
55882728|NCT04509258|Ondansetron|ondansetron|mesh-list
55882730|NCT04509258|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55882731|NCT04509258|Antiemetics|antiemetics|mesh-ancestor
55882732|NCT04509258|Autonomic Agents|autonomic agents|mesh-ancestor
55882733|NCT04509258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882734|NCT04509258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882735|NCT04509258|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55882736|NCT04509258|Antipruritics|antipruritics|mesh-ancestor
55882737|NCT04509258|Dermatologic Agents|dermatologic agents|mesh-ancestor
55882738|NCT04509258|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55882739|NCT04509258|Serotonin Agents|serotonin agents|mesh-ancestor
55882740|NCT04509258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882741|NCT04509258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882742|NCT04509258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55882743|NCT04509258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55882744|NCT04509258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882745|NCT04509258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55882746|NCT04509258|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55882747|NCT04509258|Antiviral Agents|antiviral agents|mesh-ancestor
55882748|NCT04509258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882749|NCT04509258|Expectorants|expectorants|mesh-ancestor
55882750|NCT04509258|Respiratory System Agents|respiratory system agents|mesh-ancestor
55882751|NCT04509258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55882752|NCT04509258|Antioxidants|antioxidants|mesh-ancestor
55882753|NCT04509258|Protective Agents|protective agents|mesh-ancestor
55882755|NCT04509258|Vitamin B Complex|vitamin b complex|mesh-ancestor
56050319|NCT03468075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56050320|NCT03468075|Immunologic Factors|immunologic factors|mesh-ancestor
56050321|NCT03468075|Antioxidants|antioxidants|mesh-ancestor
56050322|NCT03468075|Protective Agents|protective agents|mesh-ancestor
56050323|NCT03468933|Plasminogen|plasminogen|mesh-list
56050324|NCT03468933|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56050325|NCT03468933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56050326|NCT03468933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56050327|NCT03468933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050328|NCT03472287|Diacetylrhein|diacetylrhein|mesh-list
56050329|NCT03472287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56050330|NCT02219984|Anticoagulants|anticoagulants|mesh-list
56050331|NCT02067416|Paclitaxel|paclitaxel|mesh-list
56050332|NCT02067416|Docetaxel|docetaxel|mesh-list
56050333|NCT02067416|Epirubicin|epirubicin|mesh-list
56050334|NCT02067416|Taxane|taxane|mesh-list
56050335|NCT02067416|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55882756|NCT04509258|Vitamins|vitamins|mesh-ancestor
55882757|NCT04509258|Micronutrients|micronutrients|mesh-ancestor
55882758|NCT04509258|Nootropic Agents|nootropic agents|mesh-ancestor
55882759|NCT04509258|Emollients|emollients|mesh-ancestor
55882760|NCT03364530|Gemcitabine|gemcitabine|mesh-list
55882763|NCT03364530|Antimetabolites|antimetabolites|mesh-ancestor
55882764|NCT03364530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882765|NCT03364530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882766|NCT03364530|Antiviral Agents|antiviral agents|mesh-ancestor
55882767|NCT03364530|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882768|NCT03364530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882769|NCT03364530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55882770|NCT03364530|Immunologic Factors|immunologic factors|mesh-ancestor
55882771|NCT03364530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882772|NCT03354624|Mitogens|mitogens|mesh-list
55882773|NCT03354624|Mitosis Modulators|mitosis modulators|mesh-ancestor
55882774|NCT03354624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882775|NCT03364218|Acetylcysteine|acetylcysteine|mesh-list
55882776|NCT03364218|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55882777|NCT03364218|Antiviral Agents|antiviral agents|mesh-ancestor
55882778|NCT03364218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882779|NCT03364218|Expectorants|expectorants|mesh-ancestor
55882780|NCT03364218|Respiratory System Agents|respiratory system agents|mesh-ancestor
55882781|NCT03364218|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55882782|NCT03364218|Antioxidants|antioxidants|mesh-ancestor
55882783|NCT03364218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882784|NCT03364218|Protective Agents|protective agents|mesh-ancestor
55882785|NCT03364218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882786|NCT03364218|Antidotes|antidotes|mesh-ancestor
55882788|NCT04444284|Immunologic Factors|immunologic factors|mesh-ancestor
55882789|NCT04444284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882790|NCT03354312|Lidocaine|lidocaine|mesh-list
55882791|NCT03354312|Epinephrine|epinephrine|mesh-list
55882792|NCT03354312|Racepinephrine|racepinephrine|mesh-list
55882793|NCT03354312|Carticaine|carticaine|mesh-list
55882794|NCT03354312|Epinephryl borate|epinephryl borate|mesh-list
55882795|NCT03354312|Anesthetics, Local|anesthetics, local|mesh-ancestor
55882796|NCT03354312|Anesthetics|anesthetics|mesh-ancestor
55882797|NCT03354312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882798|NCT03354312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882799|NCT03354312|Sensory System Agents|sensory system agents|mesh-ancestor
55882800|NCT03354312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882801|NCT03354312|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55882802|NCT03354312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56050336|NCT02067416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050337|NCT02067416|Tubulin Modulators|tubulin modulators|mesh-ancestor
56050338|NCT02067416|Antimitotic Agents|antimitotic agents|mesh-ancestor
55882803|NCT03354312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55882804|NCT03354312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56051301|NCT04769258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882805|NCT03354312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882806|NCT03354312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55882807|NCT03354312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55882808|NCT03354312|Adrenergic Agents|adrenergic agents|mesh-ancestor
55882809|NCT03354312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882810|NCT03354312|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55882811|NCT03354312|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55882812|NCT03354312|Autonomic Agents|autonomic agents|mesh-ancestor
55882813|NCT03354312|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55882814|NCT03354312|Respiratory System Agents|respiratory system agents|mesh-ancestor
55882815|NCT03354312|Mydriatics|mydriatics|mesh-ancestor
55882816|NCT03354312|Sympathomimetics|sympathomimetics|mesh-ancestor
55751666|NCT05015907|Ropivacaine|ropivacaine|mesh-list
55882817|NCT03354312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55882818|NCT03363984|Midazolam|midazolam|mesh-list
55882819|NCT03363984|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55882820|NCT03363984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55882821|NCT03363984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882822|NCT03363984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882823|NCT03363984|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55882824|NCT03363984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55882825|NCT03363984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55882826|NCT03363984|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55882827|NCT03363984|Anesthetics, General|anesthetics, general|mesh-ancestor
55882828|NCT03363984|Anesthetics|anesthetics|mesh-ancestor
55882829|NCT03363984|GABA Modulators|gaba modulators|mesh-ancestor
55882830|NCT03363984|GABA Agents|gaba agents|mesh-ancestor
55882831|NCT03363984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882832|NCT03363984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882833|NCT03355716|Fentanyl|fentanyl|mesh-list
55882834|NCT03355716|Ketamine|ketamine|mesh-list
55882835|NCT03355716|Morphine|morphine|mesh-list
55882837|NCT03355716|Anesthetics, Local|anesthetics, local|mesh-ancestor
55882838|NCT03355716|Anesthetics|anesthetics|mesh-ancestor
55882839|NCT03355716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882840|NCT03355716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790636|NCT00136435|Leucovorin|leucovorin|mesh-list
55882841|NCT03355716|Sensory System Agents|sensory system agents|mesh-ancestor
55882842|NCT03355716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882844|NCT03355716|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55882845|NCT03355716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55882846|NCT03355716|Anesthetics, General|anesthetics, general|mesh-ancestor
55882847|NCT03355716|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55882848|NCT03355716|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55882849|NCT03355716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882850|NCT03355716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882851|NCT03355716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55882852|NCT03355716|Narcotics|narcotics|mesh-ancestor
55882853|NCT03355716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55882854|NCT04508400|Dexamethasone|dexamethasone|mesh-list
55882855|NCT04508400|Dexamethasone acetate|dexamethasone acetate|mesh-list
55882856|NCT04508400|Ondansetron|ondansetron|mesh-list
55882857|NCT04508400|Fosaprepitant|fosaprepitant|mesh-list
55882858|NCT04508400|Aprepitant|aprepitant|mesh-list
55882859|NCT04508400|BB 1101|bb 1101|mesh-list
55882860|NCT04508400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882861|NCT04508400|Antiemetics|antiemetics|mesh-ancestor
55882862|NCT04508400|Autonomic Agents|autonomic agents|mesh-ancestor
55882863|NCT04508400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882864|NCT04508400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882865|NCT04508400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55882866|NCT04508400|Glucocorticoids|glucocorticoids|mesh-ancestor
55882867|NCT04508400|Hormones|hormones|mesh-ancestor
55882868|NCT04508400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751681|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55882869|NCT04508400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55882870|NCT04508400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882871|NCT04508400|Protease Inhibitors|protease inhibitors|mesh-ancestor
55882872|NCT04508400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050339|NCT02067416|Mitosis Modulators|mitosis modulators|mesh-ancestor
56050340|NCT02067416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050341|NCT02067416|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56050342|NCT02067416|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56050343|NCT02067416|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56050344|NCT02067416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050345|NCT03258645|Dabigatran|dabigatran|mesh-list
56050346|NCT03258645|Antithrombins|antithrombins|mesh-ancestor
56050347|NCT03258645|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56050348|NCT03258645|Protease Inhibitors|protease inhibitors|mesh-ancestor
56050349|NCT03258645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050350|NCT03258645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050351|NCT03258645|Anticoagulants|anticoagulants|mesh-ancestor
55882873|NCT04508400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882874|NCT04508400|Antipruritics|antipruritics|mesh-ancestor
55882875|NCT04508400|Dermatologic Agents|dermatologic agents|mesh-ancestor
55882876|NCT04508400|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55882877|NCT04508400|Serotonin Agents|serotonin agents|mesh-ancestor
55882878|NCT04508400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882879|NCT04508400|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55882880|NCT04508400|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55882881|NCT04508400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882882|NCT04508400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55882883|NCT04508400|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55882884|NCT04508400|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55882885|NCT03355638|Pyranoprofen|pyranoprofen|mesh-list
55882886|NCT03355638|Aflibercept|aflibercept|mesh-list
55882887|NCT03355638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55882888|NCT03355638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55882889|NCT03355638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55882890|NCT03355638|Growth Substances|growth substances|mesh-ancestor
55882891|NCT03355638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882892|NCT03355638|Growth Inhibitors|growth inhibitors|mesh-ancestor
55882893|NCT03355638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882894|NCT03355638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55882895|NCT03355638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55882896|NCT03355638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55882897|NCT03355638|Analgesics|analgesics|mesh-ancestor
55882898|NCT03355638|Sensory System Agents|sensory system agents|mesh-ancestor
55882899|NCT03355638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882900|NCT03355638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882901|NCT03355638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55882902|NCT03355638|Gout Suppressants|gout suppressants|mesh-ancestor
55882903|NCT01626664|Gemcitabine|gemcitabine|mesh-list
55882904|NCT01626664|Oxaliplatin|oxaliplatin|mesh-list
55882905|NCT01626664|Mogamulizumab|mogamulizumab|mesh-list
55882906|NCT01626664|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55882907|NCT01626664|Antimetabolites|antimetabolites|mesh-ancestor
55882908|NCT01626664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882909|NCT01626664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882910|NCT01626664|Antiviral Agents|antiviral agents|mesh-ancestor
55882914|NCT01626664|Immunologic Factors|immunologic factors|mesh-ancestor
55882915|NCT01626664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882916|NCT04515966|Methylprednisolone|methylprednisolone|mesh-list
55882917|NCT04515966|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55882918|NCT04515966|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55882919|NCT04515966|Prednisolone|prednisolone|mesh-list
55882920|NCT04515966|Prednisolone acetate|prednisolone acetate|mesh-list
55882922|NCT04515966|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55882923|NCT04515966|Prednisolone phosphate|prednisolone phosphate|mesh-list
55882924|NCT04515966|Anesthetics, Local|anesthetics, local|mesh-ancestor
55882925|NCT04515966|Anesthetics|anesthetics|mesh-ancestor
56050352|NCT03482583|Nicotine|nicotine|mesh-list
56050353|NCT03482583|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56050354|NCT03482583|Autonomic Agents|autonomic agents|mesh-ancestor
56050355|NCT03482583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050356|NCT03482583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050357|NCT03482583|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56050358|NCT03482583|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56050359|NCT03482583|Cholinergic Agents|cholinergic agents|mesh-ancestor
56050360|NCT03482583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050361|NCT03482583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050362|NCT02010203|BCG Vaccine|bcg vaccine|mesh-list
56050363|NCT02010203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56050364|NCT02010203|Immunologic Factors|immunologic factors|mesh-ancestor
56050365|NCT02010203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050366|NCT03261999|Leuprolide|leuprolide|mesh-list
56051302|NCT01762904|Ethanol|ethanol|mesh-list
55882926|NCT04515966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882927|NCT04515966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882928|NCT04515966|Sensory System Agents|sensory system agents|mesh-ancestor
55882929|NCT04515966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882930|NCT04515966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55882931|NCT04515966|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55882932|NCT04515966|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55882933|NCT04515966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55882934|NCT04515966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882935|NCT04515966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882936|NCT04515966|Antiemetics|antiemetics|mesh-ancestor
55882937|NCT04515966|Autonomic Agents|autonomic agents|mesh-ancestor
55882938|NCT04515966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55882939|NCT04515966|Glucocorticoids|glucocorticoids|mesh-ancestor
55882940|NCT04515966|Hormones|hormones|mesh-ancestor
55882941|NCT04515966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55882942|NCT04515966|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55882943|NCT04515966|Protective Agents|protective agents|mesh-ancestor
55882944|NCT04515966|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55882945|NCT04515966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882946|NCT04504110|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55882947|NCT04504110|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55882948|NCT04504110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882949|NCT03355248|Acetaminophen|acetaminophen|mesh-list
55882950|NCT03355248|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55882951|NCT03355248|Oxycodone|oxycodone|mesh-list
55882952|NCT03355248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55882953|NCT03355248|Analgesics|analgesics|mesh-ancestor
55882954|NCT03355248|Sensory System Agents|sensory system agents|mesh-ancestor
55882955|NCT03355248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882956|NCT03355248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882957|NCT03355248|Antipyretics|antipyretics|mesh-ancestor
55882958|NCT03355248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55882959|NCT03355248|Narcotics|narcotics|mesh-ancestor
55882960|NCT03355248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55882961|NCT03355248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55882962|NCT03355248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882963|NCT03355248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55882964|NCT03350334|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55882965|NCT03350334|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55882966|NCT03350334|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55882967|NCT03350334|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55882968|NCT03350334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050367|NCT03261999|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56050368|NCT03261999|Fertility Agents|fertility agents|mesh-ancestor
56050369|NCT03261999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56050370|NCT03261999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050371|NCT03261999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55882969|NCT03350334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882970|NCT03350334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882971|NCT03350334|Analgesics|analgesics|mesh-ancestor
55882972|NCT03350334|Sensory System Agents|sensory system agents|mesh-ancestor
55882973|NCT03350334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882974|NCT03350334|Antidepressive Agents|antidepressive agents|mesh-ancestor
55882975|NCT03350334|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55882976|NCT03350334|Dopamine Agents|dopamine agents|mesh-ancestor
55882977|NCT02230696|Fluticasone|fluticasone|mesh-list
55882979|NCT02230696|Azelastine|azelastine|mesh-list
55882980|NCT02230696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882981|NCT02230696|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55882982|NCT02230696|Autonomic Agents|autonomic agents|mesh-ancestor
55883008|NCT02231086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883010|NCT02231086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883011|NCT02231086|Antidotes|antidotes|mesh-ancestor
55883012|NCT02231086|Protective Agents|protective agents|mesh-ancestor
55883013|NCT02231086|Vitamin B Complex|vitamin b complex|mesh-ancestor
55883014|NCT02231086|Vitamins|vitamins|mesh-ancestor
55883015|NCT02231086|Micronutrients|micronutrients|mesh-ancestor
55883016|NCT03353298|Allopurinol|allopurinol|mesh-list
55883017|NCT03353298|Antimetabolites|antimetabolites|mesh-ancestor
55883018|NCT03353298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883019|NCT03353298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883020|NCT03353298|Gout Suppressants|gout suppressants|mesh-ancestor
55883021|NCT03353298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55883022|NCT03353298|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55883023|NCT03353298|Antioxidants|antioxidants|mesh-ancestor
55883024|NCT03353298|Protective Agents|protective agents|mesh-ancestor
55883025|NCT03353298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883026|NCT02509546|Adenosine|adenosine|mesh-list
55883027|NCT02509546|Analgesics|analgesics|mesh-ancestor
55883028|NCT02509546|Sensory System Agents|sensory system agents|mesh-ancestor
55883029|NCT02509546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883030|NCT02509546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883031|NCT02509546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55883032|NCT02509546|Vasodilator Agents|vasodilator agents|mesh-ancestor
55883036|NCT02509546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883037|NCT02509546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883038|NCT03187210|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55883039|NCT03187210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55883040|NCT03187210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883041|NCT03146962|Ascorbic Acid|ascorbic acid|mesh-list
55883042|NCT03146962|Vitamins|vitamins|mesh-ancestor
55883043|NCT03146962|Micronutrients|micronutrients|mesh-ancestor
55883044|NCT03146962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883045|NCT03146962|Antioxidants|antioxidants|mesh-ancestor
55883046|NCT03146962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883047|NCT03146962|Protective Agents|protective agents|mesh-ancestor
55883048|NCT03349866|Capecitabine|capecitabine|mesh-list
55883049|NCT03349866|Oxaliplatin|oxaliplatin|mesh-list
55883050|NCT03349866|Apatinib|apatinib|mesh-list
55751732|NCT03239743|Midazolam|midazolam|mesh-list
55883051|NCT03349866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55883053|NCT03349866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883054|NCT03349866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883055|NCT03349866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55883056|NCT03349866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883057|NCT01631110|Vaccines|vaccines|mesh-list
55883058|NCT01631110|Immunologic Factors|immunologic factors|mesh-ancestor
55883059|NCT01631110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883060|NCT01631656|Azelaic acid|azelaic acid|mesh-list
55883061|NCT01631656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883062|NCT01631656|Dermatologic Agents|dermatologic agents|mesh-ancestor
55883063|NCT02989636|Nivolumab|nivolumab|mesh-list
55883064|NCT02989636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55883065|NCT02989636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883066|NCT02989636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56050372|NCT03261999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050373|NCT03482973|Bupivacaine|bupivacaine|mesh-list
56050374|NCT03482973|Anesthetics, Local|anesthetics, local|mesh-ancestor
56050375|NCT03482973|Anesthetics|anesthetics|mesh-ancestor
56050376|NCT03482973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050377|NCT03482973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050378|NCT03482973|Sensory System Agents|sensory system agents|mesh-ancestor
56050379|NCT03482973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050381|NCT01602380|Anastrozole|anastrozole|mesh-list
56050382|NCT01602380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55883067|NCT02989636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883068|NCT02985190|Azacitidine|azacitidine|mesh-list
55883069|NCT02985190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55883070|NCT02985190|Antimetabolites|antimetabolites|mesh-ancestor
55883071|NCT02985190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883072|NCT02985190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883073|NCT02985190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883074|NCT01376310|Gemcitabine|gemcitabine|mesh-list
55883075|NCT01376310|Paclitaxel|paclitaxel|mesh-list
55883076|NCT01376310|Docetaxel|docetaxel|mesh-list
55883077|NCT01376310|Carboplatin|carboplatin|mesh-list
55883078|NCT01376310|Pemetrexed|pemetrexed|mesh-list
55883079|NCT01376310|Everolimus|everolimus|mesh-list
55883080|NCT01376310|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55883081|NCT01376310|Trametinib|trametinib|mesh-list
55883082|NCT01376310|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55883083|NCT01376310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883084|NCT01376310|Tubulin Modulators|tubulin modulators|mesh-ancestor
55883085|NCT01376310|Antimitotic Agents|antimitotic agents|mesh-ancestor
55883086|NCT01376310|Mitosis Modulators|mitosis modulators|mesh-ancestor
55883087|NCT01376310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883088|NCT01376310|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55883089|NCT01376310|Antimetabolites|antimetabolites|mesh-ancestor
55883090|NCT01376310|Antiviral Agents|antiviral agents|mesh-ancestor
55883091|NCT01376310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883092|NCT01376310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883093|NCT01376310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883094|NCT01376310|Immunologic Factors|immunologic factors|mesh-ancestor
55883095|NCT01376310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883096|NCT01376310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55883097|NCT01376310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55883098|NCT01376310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55883099|NCT01585402|Etidronic Acid|etidronic acid|mesh-list
55883100|NCT01585402|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55883101|NCT01585402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883102|NCT01638052|Clonidine|clonidine|mesh-list
55883103|NCT01638052|Bupivacaine|bupivacaine|mesh-list
55883104|NCT01638052|Anesthetics, Local|anesthetics, local|mesh-ancestor
55883105|NCT01638052|Anesthetics|anesthetics|mesh-ancestor
55883106|NCT01638052|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883110|NCT01638052|Analgesics|analgesics|mesh-ancestor
55883111|NCT01638052|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55883112|NCT01638052|Sympatholytics|sympatholytics|mesh-ancestor
55883113|NCT01638052|Autonomic Agents|autonomic agents|mesh-ancestor
55883114|NCT01638052|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55883115|NCT01638052|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55883116|NCT01638052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55883117|NCT01638052|Adrenergic Agents|adrenergic agents|mesh-ancestor
55883118|NCT01638052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883119|NCT01638052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883120|NCT02518152|Alendronate|alendronate|mesh-list
55883121|NCT02518152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55883122|NCT02518152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050383|NCT01602380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050384|NCT01602380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55883123|NCT01229878|Vitamin D|vitamin d|mesh-list
55883124|NCT01229878|Cholecalciferol|cholecalciferol|mesh-list
55883125|NCT01229878|Vitamins|vitamins|mesh-ancestor
55883126|NCT01229878|Micronutrients|micronutrients|mesh-ancestor
55883127|NCT01229878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883128|NCT01229878|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55883129|NCT01229878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55883130|NCT03352674|Insulin|insulin|mesh-list
55883131|NCT03352674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55883132|NCT03352674|Insulin Glargine|insulin glargine|mesh-list
55883133|NCT03352674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55883134|NCT03352674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883135|NCT01639222|Calcium, Dietary|calcium, dietary|mesh-list
55883136|NCT01639222|Vitamin D|vitamin d|mesh-list
55883137|NCT01639222|Cholecalciferol|cholecalciferol|mesh-list
55883138|NCT01639222|Calcium|calcium|mesh-list
55883139|NCT01639222|Vitamins|vitamins|mesh-ancestor
55883140|NCT01639222|Micronutrients|micronutrients|mesh-ancestor
55883141|NCT01639222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883142|NCT01639222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55883143|NCT01639222|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55883144|NCT04443270|Chloroquine|chloroquine|mesh-list
55883145|NCT04443270|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
55883146|NCT04443270|Amebicides|amebicides|mesh-ancestor
55883147|NCT04443270|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55751765|NCT03078465|Ticagrelor|ticagrelor|mesh-list
55883148|NCT04443270|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55883149|NCT04443270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883150|NCT04443270|Antimalarials|antimalarials|mesh-ancestor
55883151|NCT04443270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55883152|NCT04443270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55883153|NCT04443270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55883154|NCT04443270|Analgesics|analgesics|mesh-ancestor
55883155|NCT04443270|Sensory System Agents|sensory system agents|mesh-ancestor
55883156|NCT04443270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883157|NCT04443270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883158|NCT04443270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55883159|NCT04443270|Filaricides|filaricides|mesh-ancestor
55883160|NCT04443270|Antinematodal Agents|antinematodal agents|mesh-ancestor
55883161|NCT04443270|Anthelmintics|anthelmintics|mesh-ancestor
55883162|NCT03349008|Entecavir|entecavir|mesh-list
55883163|NCT03349008|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
55883164|NCT03349008|Antiviral Agents|antiviral agents|mesh-ancestor
55883165|NCT03349008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883166|NCT03349008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55883167|NCT03352362|Acetaminophen|acetaminophen|mesh-list
55883168|NCT03352362|Ibuprofen|ibuprofen|mesh-list
55883169|NCT03352362|Propacetamol|propacetamol|mesh-list
55883170|NCT03352362|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55883171|NCT03352362|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55883172|NCT03352362|Analgesics|analgesics|mesh-ancestor
55883173|NCT03352362|Sensory System Agents|sensory system agents|mesh-ancestor
55883174|NCT03352362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883175|NCT03352362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883176|NCT03352362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55883177|NCT03352362|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55883178|NCT03352362|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55883179|NCT03352362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883180|NCT03352362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883185|NCT01598740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883186|NCT01598740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883187|NCT01598740|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55883188|NCT01598740|Diuretics|diuretics|mesh-ancestor
55883189|NCT01598740|Natriuretic Agents|natriuretic agents|mesh-ancestor
55883190|NCT05419050|Denosumab|denosumab|mesh-list
55883191|NCT05419050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55883192|NCT05419050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883194|NCT00709098|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55883195|NCT00709098|Vasodilator Agents|vasodilator agents|mesh-ancestor
55883196|NCT03348696|Dexamethasone|dexamethasone|mesh-list
55883197|NCT03348696|Dexamethasone acetate|dexamethasone acetate|mesh-list
55883198|NCT03348696|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55883199|NCT03348696|BB 1101|bb 1101|mesh-list
56050385|NCT01602380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56050386|NCT01602380|Hormone Antagonists|hormone antagonists|mesh-ancestor
56050387|NCT01602380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883200|NCT03348696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55883201|NCT03348696|Antiemetics|antiemetics|mesh-ancestor
55883202|NCT03348696|Autonomic Agents|autonomic agents|mesh-ancestor
55883203|NCT03348696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883204|NCT03348696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883205|NCT03348696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55883206|NCT03348696|Glucocorticoids|glucocorticoids|mesh-ancestor
55883207|NCT03348696|Hormones|hormones|mesh-ancestor
55883208|NCT03348696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883209|NCT03348696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55883210|NCT03348696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883211|NCT03348696|Protease Inhibitors|protease inhibitors|mesh-ancestor
55883212|NCT03348696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883213|NCT03348696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883214|NCT04506450|Anesthetics|anesthetics|mesh-list
55883215|NCT04506450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883216|NCT04506450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883217|NCT03352128|Calcium|calcium|mesh-list
55883218|NCT03352128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55883219|NCT03352128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883220|NCT03122730|Epoprostenol|epoprostenol|mesh-list
55883221|NCT03122730|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55883222|NCT03122730|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55883223|NCT04505904|Oxytocin|oxytocin|mesh-list
55883224|NCT04505904|Oxytocics|oxytocics|mesh-ancestor
55883225|NCT04505904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55883226|NCT04505904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883227|NCT03348462|Anthralin|anthralin|mesh-list
55883228|NCT03348462|Dermatologic Agents|dermatologic agents|mesh-ancestor
55883229|NCT04505514|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55883230|NCT04505514|Hematinics|hematinics|mesh-ancestor
55883231|NCT04505202|Chlorhexidine|chlorhexidine|mesh-list
55883232|NCT04505202|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55883233|NCT04505202|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55883234|NCT04505202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883235|NCT04505202|Disinfectants|disinfectants|mesh-ancestor
55883236|NCT04505202|Dermatologic Agents|dermatologic agents|mesh-ancestor
55883237|NCT05585346|Prednisolone|prednisolone|mesh-list
55883238|NCT05585346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55883239|NCT05585346|Methylprednisolone|methylprednisolone|mesh-list
55883240|NCT05585346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55883241|NCT05585346|Prednisolone acetate|prednisolone acetate|mesh-list
55883242|NCT05585346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55883243|NCT05585346|Prednisolone phosphate|prednisolone phosphate|mesh-list
55883244|NCT05585346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55883245|NCT05585346|Glucocorticoids|glucocorticoids|mesh-ancestor
55883247|NCT05585346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883248|NCT05585346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883249|NCT05585346|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55751815|NCT03084783|Hormones|hormones|mesh-ancestor
55883250|NCT05585346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883251|NCT05585346|Antiemetics|antiemetics|mesh-ancestor
55883252|NCT05585346|Autonomic Agents|autonomic agents|mesh-ancestor
55883256|NCT05585346|Protective Agents|protective agents|mesh-ancestor
55883257|NCT05098704|Clopidogrel|clopidogrel|mesh-list
55883258|NCT05098704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55883259|NCT05098704|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55883260|NCT05098704|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55883261|NCT05098704|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55883262|NCT05098704|Purinergic Agents|purinergic agents|mesh-ancestor
55883263|NCT05098704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883264|NCT05098704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883265|NCT05098704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883266|NCT05584956|Sildenafil Citrate|sildenafil citrate|mesh-list
55883267|NCT05584956|Vasodilator Agents|vasodilator agents|mesh-ancestor
55883268|NCT05584956|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55883269|NCT05584956|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55883270|NCT05584956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050388|NCT01602380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050389|NCT01602380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56050390|NCT01602380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56050391|NCT01602380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050392|NCT01602380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050393|NCT03483675|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56050394|NCT03483675|Immunologic Factors|immunologic factors|mesh-ancestor
56050395|NCT03483675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050396|NCT03327051|Omeprazole|omeprazole|mesh-list
56050397|NCT03327051|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56050398|NCT03327051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55883271|NCT05584956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883272|NCT05584956|Urological Agents|urological agents|mesh-ancestor
55883273|NCT01376700|Factor VIII|factor viii|mesh-list
55883274|NCT01376700|Coagulants|coagulants|mesh-ancestor
55883275|NCT01797965|Daclizumab|daclizumab|mesh-list
55883276|NCT01797965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883277|NCT01797965|Immunologic Factors|immunologic factors|mesh-ancestor
55883278|NCT01797965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883279|NCT01601236|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55883280|NCT01601236|Hormones|hormones|mesh-ancestor
55883281|NCT01601236|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883282|NCT01601236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883283|NCT05584878|Chitosan|chitosan|mesh-list
55883284|NCT05584878|Calcium|calcium|mesh-list
55883285|NCT05584878|Caseins|caseins|mesh-list
55883286|NCT05584878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55883287|NCT05584878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883288|NCT05584878|Chelating Agents|chelating agents|mesh-ancestor
55883289|NCT05584878|Sequestering Agents|sequestering agents|mesh-ancestor
55883290|NCT05584878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883291|NCT05584878|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55883292|NCT05584878|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55883293|NCT05584878|Antimetabolites|antimetabolites|mesh-ancestor
55883294|NCT05584878|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55883296|NCT05584878|Coagulants|coagulants|mesh-ancestor
55883297|NCT01643902|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55883299|NCT01643902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55883300|NCT01643902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883301|NCT03347994|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
55883302|NCT03347994|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55883303|NCT03347994|Alkylating Agents|alkylating agents|mesh-ancestor
55883304|NCT03347994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883305|NCT03347994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883306|NCT04966338|Ocrelizumab|ocrelizumab|mesh-list
55883307|NCT04966338|Immunologic Factors|immunologic factors|mesh-ancestor
55883308|NCT04966338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883309|NCT03347916|Gabapentin|gabapentin|mesh-list
55883310|NCT03347916|Analgesics|analgesics|mesh-ancestor
55883311|NCT03347916|Sensory System Agents|sensory system agents|mesh-ancestor
55883312|NCT03347916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883313|NCT03347916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883314|NCT03347916|Anticonvulsants|anticonvulsants|mesh-ancestor
55883315|NCT03347916|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55883316|NCT03347916|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55883317|NCT03347916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883318|NCT03347916|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55883319|NCT03347916|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55883320|NCT03347916|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55883321|NCT03347916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883322|NCT03347916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050399|NCT03327051|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56050400|NCT03327051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050401|NCT03327051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050402|NCT02057939|Leuprolide|leuprolide|mesh-list
56050403|NCT02057939|Androgens|androgens|mesh-list
56050404|NCT02057939|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56050405|NCT02057939|Fertility Agents|fertility agents|mesh-ancestor
56050406|NCT02057939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55740215|NCT03439085|Durvalumab|durvalumab|mesh-list
56050407|NCT02057939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050408|NCT02057939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56050409|NCT02057939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050410|NCT02057939|Hormones|hormones|mesh-ancestor
56050411|NCT02057939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050412|NCT03496467|Nepafenac|nepafenac|mesh-list
56050413|NCT03496467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56050414|NCT03496467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56050415|NCT03496467|Analgesics|analgesics|mesh-ancestor
56050416|NCT03496467|Sensory System Agents|sensory system agents|mesh-ancestor
55883323|NCT03347916|Antimanic Agents|antimanic agents|mesh-ancestor
55883326|NCT05584644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55883327|NCT05584644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883328|NCT05584644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883329|NCT04892706|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
55883330|NCT04892706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55883331|NCT04892706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55883332|NCT04892706|Analgesics|analgesics|mesh-ancestor
55883333|NCT04892706|Sensory System Agents|sensory system agents|mesh-ancestor
55883334|NCT04892706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883335|NCT04892706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883336|NCT04892706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55883337|NCT04892706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55883338|NCT04892706|Dermatologic Agents|dermatologic agents|mesh-ancestor
55883339|NCT01821677|Danazol|danazol|mesh-list
55883342|NCT01821677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883343|NCT01821677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883344|NCT03347760|Octreotide|octreotide|mesh-list
55883345|NCT03347760|Edotreotide|edotreotide|mesh-list
55883346|NCT03347760|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55883347|NCT03347760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883348|NCT03347760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55883349|NCT03347760|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55883350|NCT03347760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883351|NCT03062280|Hydrocortisone|hydrocortisone|mesh-list
55883352|NCT03062280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55883353|NCT00709722|Gusperimus|gusperimus|mesh-list
55883354|NCT00709722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55883355|NCT00709722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883356|NCT00709722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55883357|NCT00709722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883358|NCT00709722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56050417|NCT03496467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050418|NCT03496467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050419|NCT03496467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56050420|NCT03496467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56050421|NCT00482690|Nicotine|nicotine|mesh-list
56050422|NCT00482690|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56050423|NCT00482690|Autonomic Agents|autonomic agents|mesh-ancestor
56050424|NCT00482690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050425|NCT00482690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050426|NCT00482690|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56050427|NCT00482690|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56050428|NCT00482690|Cholinergic Agents|cholinergic agents|mesh-ancestor
56050429|NCT00482690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883359|NCT00709722|Immunologic Factors|immunologic factors|mesh-ancestor
55883360|NCT00709722|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55883361|NCT00709722|Protective Agents|protective agents|mesh-ancestor
55883362|NCT01820585|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55883363|NCT01820585|Anticonvulsants|anticonvulsants|mesh-ancestor
55883364|NCT01820585|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55883365|NCT01820585|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55883366|NCT01820585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55883367|NCT01820585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883368|NCT05030272|Nicotine|nicotine|mesh-list
55883369|NCT05030272|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55883370|NCT05030272|Autonomic Agents|autonomic agents|mesh-ancestor
55883371|NCT05030272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883372|NCT05030272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883373|NCT05030272|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55883374|NCT05030272|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55883375|NCT05030272|Cholinergic Agents|cholinergic agents|mesh-ancestor
55883376|NCT05030272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883377|NCT05030272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883378|NCT02378298|Methylprednisolone|methylprednisolone|mesh-list
55883379|NCT02378298|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55883380|NCT02378298|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55883381|NCT02378298|Prednisolone|prednisolone|mesh-list
55883382|NCT02378298|Prednisolone acetate|prednisolone acetate|mesh-list
55883383|NCT02378298|Rituximab|rituximab|mesh-list
55883384|NCT02378298|Methotrexate|methotrexate|mesh-list
55883385|NCT02378298|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55883386|NCT02378298|Prednisolone phosphate|prednisolone phosphate|mesh-list
55883387|NCT02378298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55883388|NCT02378298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883390|NCT02378298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883391|NCT02378298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55883392|NCT02378298|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55883393|NCT02378298|Abortifacient Agents|abortifacient agents|mesh-ancestor
55883394|NCT02378298|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55883395|NCT02378298|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55883396|NCT02378298|Antimetabolites|antimetabolites|mesh-ancestor
55883399|NCT02378298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883400|NCT02378298|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55883401|NCT02378298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883402|NCT02378298|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55883403|NCT02378298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55883404|NCT02378298|Antiemetics|antiemetics|mesh-ancestor
55883405|NCT02378298|Autonomic Agents|autonomic agents|mesh-ancestor
55883406|NCT02378298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050430|NCT00482690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050431|NCT02058251|Oxytocin|oxytocin|mesh-list
55883407|NCT02378298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55883408|NCT02378298|Glucocorticoids|glucocorticoids|mesh-ancestor
55883410|NCT02378298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883411|NCT02378298|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55883412|NCT02378298|Protective Agents|protective agents|mesh-ancestor
55883413|NCT02378298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55883414|NCT02253108|Everolimus|everolimus|mesh-list
55883415|NCT02253108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883416|NCT02253108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883417|NCT02253108|Immunologic Factors|immunologic factors|mesh-ancestor
55883418|NCT02253108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883419|NCT01603420|Ascorbic Acid|ascorbic acid|mesh-list
55883420|NCT01603420|Docetaxel|docetaxel|mesh-list
55883421|NCT01603420|Methyltestosterone|methyltestosterone|mesh-list
55883422|NCT01603420|Hormones|hormones|mesh-list
55883423|NCT01603420|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55883424|NCT01603420|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55883425|NCT01603420|Androgens|androgens|mesh-list
55883426|NCT01603420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883427|NCT01603420|Tubulin Modulators|tubulin modulators|mesh-ancestor
55883428|NCT01603420|Antimitotic Agents|antimitotic agents|mesh-ancestor
55883429|NCT01603420|Mitosis Modulators|mitosis modulators|mesh-ancestor
55883430|NCT01603420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883431|NCT01603420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883432|NCT01603420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883433|NCT01603420|Antioxidants|antioxidants|mesh-ancestor
55883434|NCT01603420|Protective Agents|protective agents|mesh-ancestor
55883435|NCT01603420|Vitamins|vitamins|mesh-ancestor
55883436|NCT01603420|Micronutrients|micronutrients|mesh-ancestor
55883437|NCT01603420|Estrogens|estrogens|mesh-ancestor
55883438|NCT01603420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55883439|NCT01603420|Anabolic Agents|anabolic agents|mesh-ancestor
55883441|NCT02064036|Goserelin|goserelin|mesh-list
55883442|NCT02064036|Bicalutamide|bicalutamide|mesh-list
55883443|NCT02064036|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55883444|NCT02064036|Fertility Agents|fertility agents|mesh-ancestor
55883445|NCT02064036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55883446|NCT02064036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883447|NCT02064036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55883448|NCT02064036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883449|NCT02064036|Androgen Antagonists|androgen antagonists|mesh-ancestor
55883450|NCT02064036|Hormone Antagonists|hormone antagonists|mesh-ancestor
55883451|NCT02064036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883452|NCT05645484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55883453|NCT05645484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55883454|NCT05645484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883455|NCT04551300|Sevelamer|sevelamer|mesh-list
55883456|NCT04551300|Chelating Agents|chelating agents|mesh-ancestor
55883457|NCT04551300|Sequestering Agents|sequestering agents|mesh-ancestor
55883458|NCT04551300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883459|NCT04974580|Nicotine|nicotine|mesh-list
55883460|NCT04974580|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55883461|NCT04974580|Autonomic Agents|autonomic agents|mesh-ancestor
55883462|NCT04974580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883463|NCT04974580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883464|NCT04974580|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55883465|NCT04974580|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55883466|NCT04974580|Cholinergic Agents|cholinergic agents|mesh-ancestor
55883467|NCT04974580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883468|NCT04974580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883469|NCT01691326|Vaccines|vaccines|mesh-list
55883470|NCT01691326|Immunologic Factors|immunologic factors|mesh-ancestor
55883474|NCT01606852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883475|NCT01606852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883476|NCT01606852|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55883478|NCT01606852|Sensory System Agents|sensory system agents|mesh-ancestor
55883479|NCT01606852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883480|NCT01606852|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55883481|NCT01606852|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55883482|NCT01606852|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55883483|NCT01606852|Adrenergic Agents|adrenergic agents|mesh-ancestor
56050432|NCT02058251|Oxytocics|oxytocics|mesh-ancestor
56050433|NCT02058251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56050434|NCT02058251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050435|NCT03329937|Niraparib|niraparib|mesh-list
55883484|NCT01606852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883485|NCT01606852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883486|NCT01691560|Calcium, Dietary|calcium, dietary|mesh-list
55883487|NCT01691560|Listerine|listerine|mesh-list
55883488|NCT01691560|Calcium|calcium|mesh-list
55883489|NCT01691560|Fluorides|fluorides|mesh-list
55883490|NCT01691560|Sodium Fluoride|sodium fluoride|mesh-list
55883492|NCT01691560|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55883493|NCT01691560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883494|NCT01691560|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55883495|NCT01691560|Cariostatic Agents|cariostatic agents|mesh-ancestor
55883496|NCT01691560|Protective Agents|protective agents|mesh-ancestor
55883497|NCT01691560|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55883498|NCT01691560|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883499|NCT03346200|Tamoxifen|tamoxifen|mesh-list
55883500|NCT03346200|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55883501|NCT03346200|Hormone Antagonists|hormone antagonists|mesh-ancestor
55883502|NCT03346200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883503|NCT03346200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883504|NCT03346200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55883505|NCT03346200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883506|NCT03346200|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55883507|NCT03346200|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55883508|NCT03346200|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55883509|NCT01692340|Lycopene|lycopene|mesh-list
55883511|NCT01692340|Antioxidants|antioxidants|mesh-ancestor
55883512|NCT01692340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883513|NCT01692340|Protective Agents|protective agents|mesh-ancestor
55883514|NCT01692340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883515|NCT01692340|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55883516|NCT01692340|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55883517|NCT01692340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883518|NCT02517372|Pemirolast|pemirolast|mesh-list
55883519|NCT02517372|Histamine Antagonists|histamine antagonists|mesh-ancestor
55883520|NCT02517372|Histamine Agents|histamine agents|mesh-ancestor
55883521|NCT02517372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883522|NCT02517372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883523|NCT02517372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883524|NCT02516826|Olmesartan|olmesartan|mesh-list
55883525|NCT02516826|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55883526|NCT02516826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55883527|NCT02516826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55883528|NCT02516826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55883529|NCT02516826|Antimetabolites|antimetabolites|mesh-ancestor
55883530|NCT02516826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883531|NCT02516826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55883532|NCT02516826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55883533|NCT02516826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883534|NCT02516826|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55883535|NCT02516826|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55883536|NCT02516826|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55883537|NCT01650298|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
55883538|NCT01650298|Thrombin|thrombin|mesh-list
55883539|NCT01650298|Hemostatics|hemostatics|mesh-ancestor
55883540|NCT01650298|Coagulants|coagulants|mesh-ancestor
55883541|NCT01650298|Antithrombins|antithrombins|mesh-ancestor
55883545|NCT01650298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883546|NCT01650298|Anticoagulants|anticoagulants|mesh-ancestor
55883548|NCT05583006|Antiviral Agents|antiviral agents|mesh-ancestor
55883549|NCT05583006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751967|NCT03208309|Diacetylrhein|diacetylrhein|mesh-list
55883550|NCT05583006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55883551|NCT05583006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55883552|NCT05583006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050436|NCT03329937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56050437|NCT03329937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050439|NCT03329937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050440|NCT01710254|Regadenoson|regadenoson|mesh-list
56050441|NCT01710254|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56050442|NCT01710254|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56050443|NCT01710254|Purinergic Agonists|purinergic agonists|mesh-ancestor
56050444|NCT01710254|Purinergic Agents|purinergic agents|mesh-ancestor
56050445|NCT01710254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050446|NCT01710254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050447|NCT01710254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050448|NCT03496545|Acetaminophen|acetaminophen|mesh-list
56050449|NCT03496545|Bromocriptine|bromocriptine|mesh-list
56050450|NCT03496545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56050451|NCT03496545|Analgesics|analgesics|mesh-ancestor
56050452|NCT03496545|Sensory System Agents|sensory system agents|mesh-ancestor
56050453|NCT03496545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050454|NCT03496545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050455|NCT03496545|Antipyretics|antipyretics|mesh-ancestor
56050456|NCT03496545|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56050457|NCT03496545|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56050458|NCT03496545|Hormone Antagonists|hormone antagonists|mesh-ancestor
55883553|NCT05583006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883554|NCT05583006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55883555|NCT05583006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55883556|NCT01795937|Itraconazole|itraconazole|mesh-list
55883557|NCT01795937|Atorvastatin|atorvastatin|mesh-list
55883558|NCT01795937|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55883559|NCT01795937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55883560|NCT01795937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55883561|NCT01795937|Antimetabolites|antimetabolites|mesh-ancestor
55883562|NCT01795937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883563|NCT01795937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55883564|NCT01795937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55883565|NCT01795937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883566|NCT01795937|Antifungal Agents|antifungal agents|mesh-ancestor
55883567|NCT01795937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883568|NCT01795937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55883569|NCT01795937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55883570|NCT01795937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55883571|NCT01795937|Hormone Antagonists|hormone antagonists|mesh-ancestor
55883572|NCT01795937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883573|NCT01795937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883574|NCT01795937|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55883575|NCT04501224|Tenofovir|tenofovir|mesh-list
55883576|NCT04501224|Entecavir|entecavir|mesh-list
55883577|NCT04501224|Antiviral Agents|antiviral agents|mesh-ancestor
56050459|NCT03496545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050460|NCT03496545|Dopamine Agonists|dopamine agonists|mesh-ancestor
56050461|NCT03496545|Dopamine Agents|dopamine agents|mesh-ancestor
56050462|NCT03496545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050463|NCT03496545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050464|NCT01710332|Aflibercept|aflibercept|mesh-list
56050465|NCT01710332|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56050467|NCT01710332|Growth Substances|growth substances|mesh-ancestor
56050468|NCT01710332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883578|NCT04501224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883579|NCT04501224|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55883580|NCT04501224|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55883581|NCT04501224|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883582|NCT04501224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883583|NCT04501224|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55883584|NCT04501224|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55883585|NCT01817777|Metformin|metformin|mesh-list
55883586|NCT01817777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55883587|NCT01817777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883588|NCT01795547|Aripiprazole|aripiprazole|mesh-list
55883589|NCT01795547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55883590|NCT01795547|Antidepressive Agents|antidepressive agents|mesh-ancestor
55883591|NCT01795547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55883592|NCT01795547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55883594|NCT01795547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883595|NCT01795547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883596|NCT01795547|Dopamine Agonists|dopamine agonists|mesh-ancestor
55883597|NCT01795547|Dopamine Agents|dopamine agents|mesh-ancestor
55883598|NCT01795547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883599|NCT01795547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883600|NCT01795547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55883601|NCT01795547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55883602|NCT01795547|Serotonin Agents|serotonin agents|mesh-ancestor
55883603|NCT01795547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55883604|NCT01795547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55883605|NCT01795547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55883606|NCT01795547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55883607|NCT03923556|Neostigmine|neostigmine|mesh-list
55883608|NCT03923556|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55883609|NCT03923556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883610|NCT03923556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883611|NCT03923556|Cholinergic Agents|cholinergic agents|mesh-ancestor
55883615|NCT03923556|Autonomic Agents|autonomic agents|mesh-ancestor
55883616|NCT03923556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883617|NCT03863184|Rituximab|rituximab|mesh-list
55883618|NCT03863184|Lenalidomide|lenalidomide|mesh-list
55883619|NCT03863184|Acalabrutinib|acalabrutinib|mesh-list
55883620|NCT03863184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55883621|NCT03863184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883622|NCT03863184|Immunologic Factors|immunologic factors|mesh-ancestor
55883623|NCT03863184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883624|NCT03863184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55883625|NCT03863184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55883626|NCT03863184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55883627|NCT03863184|Growth Substances|growth substances|mesh-ancestor
55883628|NCT03863184|Growth Inhibitors|growth inhibitors|mesh-ancestor
55883629|NCT02516904|Rezafungin|rezafungin|mesh-list
55883630|NCT02516904|Antifungal Agents|antifungal agents|mesh-ancestor
55883631|NCT02516904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050469|NCT01710332|Growth Inhibitors|growth inhibitors|mesh-ancestor
56050470|NCT01710332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050471|NCT04428866|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56050472|NCT04428866|Glucagon|glucagon|mesh-list
56050473|NCT04428866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56050474|NCT04428866|Hormones|hormones|mesh-ancestor
56050475|NCT04428866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050476|NCT04428866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050478|NCT02311907|Carboplatin|carboplatin|mesh-list
56050479|NCT02311907|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56050480|NCT02311907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56050481|NCT02311907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050482|NCT02311907|Tubulin Modulators|tubulin modulators|mesh-ancestor
56050483|NCT02311907|Antimitotic Agents|antimitotic agents|mesh-ancestor
56050484|NCT02311907|Mitosis Modulators|mitosis modulators|mesh-ancestor
56050485|NCT02311907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050486|NCT02013245|Vaccines|vaccines|mesh-list
56050487|NCT02013245|Immunologic Factors|immunologic factors|mesh-ancestor
56050488|NCT02013245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050489|NCT01980485|Carbon Monoxide|carbon monoxide|mesh-list
56050490|NCT01980485|Antimetabolites|antimetabolites|mesh-ancestor
56050491|NCT01980485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050492|NCT01980485|Gasotransmitters|gasotransmitters|mesh-ancestor
56050493|NCT01980485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050494|NCT01980485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050495|NCT01981967|Vaccines|vaccines|mesh-list
56050496|NCT01981967|Immunologic Factors|immunologic factors|mesh-ancestor
56050497|NCT01981967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883632|NCT01794845|Docetaxel|docetaxel|mesh-list
55883633|NCT01794845|Cetuximab|cetuximab|mesh-list
55883634|NCT01794845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883635|NCT01794845|Tubulin Modulators|tubulin modulators|mesh-ancestor
55883636|NCT01794845|Antimitotic Agents|antimitotic agents|mesh-ancestor
55883637|NCT01794845|Mitosis Modulators|mitosis modulators|mesh-ancestor
55883638|NCT01794845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883639|NCT01794845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55883640|NCT01794689|Morphine|morphine|mesh-list
55883641|NCT01794689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55883642|NCT01794689|Narcotics|narcotics|mesh-ancestor
55883643|NCT01794689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883644|NCT01794689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883645|NCT01794689|Analgesics|analgesics|mesh-ancestor
55883646|NCT01794689|Sensory System Agents|sensory system agents|mesh-ancestor
55883647|NCT01794689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883648|NCT04587089|Anti-Infective Agents|anti-infective agents|mesh-list
55883649|NCT04587089|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55883650|NCT01817075|Chlorhexidine|chlorhexidine|mesh-list
56050498|NCT01982123|Edetic Acid|edetic acid|mesh-list
56050499|NCT01982123|Pentetic Acid|pentetic acid|mesh-list
56050500|NCT01982123|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
56050501|NCT01982123|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
56050502|NCT01982123|Antidotes|antidotes|mesh-ancestor
55883651|NCT01817075|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55883652|NCT01817075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55883653|NCT01817075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883654|NCT01817075|Disinfectants|disinfectants|mesh-ancestor
55883655|NCT01817075|Dermatologic Agents|dermatologic agents|mesh-ancestor
55883656|NCT00708552|Donepezil|donepezil|mesh-list
55883657|NCT00708552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55883659|NCT00708552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883660|NCT00708552|Cholinergic Agents|cholinergic agents|mesh-ancestor
55883661|NCT00708552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883662|NCT00708552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883663|NCT00708552|Nootropic Agents|nootropic agents|mesh-ancestor
55883664|NCT02516436|Buprenorphine|buprenorphine|mesh-list
55883665|NCT02516436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55883666|NCT02516436|Narcotics|narcotics|mesh-ancestor
55883667|NCT02516436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883668|NCT02516436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883669|NCT02516436|Analgesics|analgesics|mesh-ancestor
55883670|NCT02516436|Sensory System Agents|sensory system agents|mesh-ancestor
55883671|NCT02516436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883672|NCT02516436|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55883673|NCT03347526|Vigabatrin|vigabatrin|mesh-list
55883674|NCT03347526|Cosyntropin|cosyntropin|mesh-list
55883675|NCT03347526|Anticonvulsants|anticonvulsants|mesh-ancestor
55883676|NCT03347526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883677|NCT03347526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883678|NCT03347526|GABA Agents|gaba agents|mesh-ancestor
55883679|NCT03347526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883680|NCT03347526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883681|NCT03347526|Hormones|hormones|mesh-ancestor
55883682|NCT03347526|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883683|NCT03347370|Interferons|interferons|mesh-list
55883684|NCT03347370|Interferon-beta|interferon-beta|mesh-list
55883685|NCT03347370|Interferon beta-1a|interferon beta-1a|mesh-list
55883686|NCT03347370|Interferon beta-1b|interferon beta-1b|mesh-list
55883687|NCT03347370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883691|NCT03347370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883692|NCT03347370|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55883693|NCT02515968|Propofol|propofol|mesh-list
55883694|NCT02515968|Desflurane|desflurane|mesh-list
55883695|NCT02515968|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55883696|NCT02515968|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883697|NCT02515968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883698|NCT02515968|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55883699|NCT02515968|Anesthetics, General|anesthetics, general|mesh-ancestor
55883700|NCT02515968|Anesthetics|anesthetics|mesh-ancestor
55883701|NCT02515968|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55883702|NCT03345966|Antibodies|antibodies|mesh-list
55883703|NCT03345966|Immunologic Factors|immunologic factors|mesh-ancestor
55883704|NCT03345966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883705|NCT02507700|Bupivacaine|bupivacaine|mesh-list
55883706|NCT02507700|Sevoflurane|sevoflurane|mesh-list
55883707|NCT02507700|Anesthetics, Local|anesthetics, local|mesh-ancestor
55883708|NCT02507700|Anesthetics|anesthetics|mesh-ancestor
55883709|NCT02507700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883710|NCT02507700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883711|NCT02507700|Sensory System Agents|sensory system agents|mesh-ancestor
55883712|NCT02507700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883713|NCT02507700|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55883714|NCT02507700|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55883715|NCT02507700|Anesthetics, General|anesthetics, general|mesh-ancestor
55883716|NCT02513004|Clopidogrel|clopidogrel|mesh-list
55883717|NCT02513004|Ticagrelor|ticagrelor|mesh-list
55883718|NCT02513004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55883719|NCT02513004|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55883720|NCT02513004|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56050503|NCT01982123|Protective Agents|protective agents|mesh-ancestor
56050504|NCT01982123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050505|NCT01982123|Chelating Agents|chelating agents|mesh-ancestor
56050506|NCT01982123|Sequestering Agents|sequestering agents|mesh-ancestor
56050507|NCT01982123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050508|NCT01982123|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56050509|NCT01982123|Anticoagulants|anticoagulants|mesh-ancestor
56050510|NCT01982123|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56050513|NCT02061683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56050514|NCT01711658|Lapatinib|lapatinib|mesh-list
56050515|NCT01711658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050516|NCT01711658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56050517|NCT01711658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050518|NCT01711658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050519|NCT01712360|Naftifine|naftifine|mesh-list
55883721|NCT02513004|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55883722|NCT02513004|Purinergic Agents|purinergic agents|mesh-ancestor
55883723|NCT02513004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752011|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
55883724|NCT02513004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883725|NCT02513004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883726|NCT04500522|Isoniazid|isoniazid|mesh-list
55883727|NCT04500522|Antitubercular Agents|antitubercular agents|mesh-ancestor
55883728|NCT04500522|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55883729|NCT04500522|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883730|NCT04500522|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55883731|NCT04500522|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55883732|NCT04500522|Antimetabolites|antimetabolites|mesh-ancestor
55883733|NCT04500522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883735|NCT02507232|Temozolomide|temozolomide|mesh-list
55883736|NCT02507232|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55883737|NCT02507232|Alkylating Agents|alkylating agents|mesh-ancestor
55883738|NCT02507232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883739|NCT02507232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883740|NCT02506998|Histamine|histamine|mesh-list
55883741|NCT02506998|Histamine Antagonists|histamine antagonists|mesh-list
55883742|NCT02506998|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55883743|NCT02506998|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
55883744|NCT02506998|Histamine Agonists|histamine agonists|mesh-ancestor
55883745|NCT02506998|Histamine Agents|histamine agents|mesh-ancestor
55883746|NCT02506998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883747|NCT02506998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883748|NCT02506998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883749|NCT02507076|Melphalan|melphalan|mesh-list
55883750|NCT02507076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55883751|NCT02507076|Alkylating Agents|alkylating agents|mesh-ancestor
55883752|NCT02507076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883753|NCT02507076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883754|NCT02507076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55883755|NCT02507076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883756|NCT02507076|Immunologic Factors|immunologic factors|mesh-ancestor
55883757|NCT02507076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050520|NCT01712360|Antifungal Agents|antifungal agents|mesh-ancestor
56050521|NCT01712360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050522|NCT02396147|Relugolix|relugolix|mesh-list
56050523|NCT02396147|Androgen Antagonists|androgen antagonists|mesh-ancestor
56050524|NCT02396147|Hormone Antagonists|hormone antagonists|mesh-ancestor
56050525|NCT02396147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050526|NCT02396147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050527|NCT01713608|Artefenomel|artefenomel|mesh-list
56050528|NCT01713608|Antimalarials|antimalarials|mesh-ancestor
56050529|NCT01713608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56050530|NCT01713608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56050531|NCT01713608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050532|NCT03562832|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56050533|NCT03562832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050534|NCT03562832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050535|NCT03562832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050537|NCT04417166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55883758|NCT01609348|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55883762|NCT01609348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883764|NCT01609348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051303|NCT01762904|Chlorhexidine|chlorhexidine|mesh-list
55883765|NCT01609348|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55883766|NCT01609348|Antidepressive Agents|antidepressive agents|mesh-ancestor
55883767|NCT01609348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55883769|NCT04500678|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55883770|NCT04500678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883771|NCT02507154|Cetuximab|cetuximab|mesh-list
55883772|NCT02507154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55883773|NCT02507154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883774|NCT02515734|Leucovorin|leucovorin|mesh-list
55883775|NCT02515734|Bevacizumab|bevacizumab|mesh-list
55883776|NCT02515734|Cetuximab|cetuximab|mesh-list
55883777|NCT02515734|Fluorouracil|fluorouracil|mesh-list
55883778|NCT02515734|Oxaliplatin|oxaliplatin|mesh-list
55883779|NCT02515734|Irinotecan|irinotecan|mesh-list
55883780|NCT02515734|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55883781|NCT02515734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883782|NCT02515734|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55883783|NCT02515734|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55883784|NCT02515734|Growth Substances|growth substances|mesh-ancestor
55883785|NCT02515734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883786|NCT02515734|Growth Inhibitors|growth inhibitors|mesh-ancestor
55883787|NCT02515734|Antimetabolites|antimetabolites|mesh-ancestor
55883788|NCT02515734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883789|NCT02515734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55883790|NCT02515734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883791|NCT02515734|Immunologic Factors|immunologic factors|mesh-ancestor
55883792|NCT02515734|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55883793|NCT02515734|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55883794|NCT02515734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883795|NCT02515734|Antidotes|antidotes|mesh-ancestor
55883796|NCT02515734|Protective Agents|protective agents|mesh-ancestor
55883797|NCT02515734|Vitamin B Complex|vitamin b complex|mesh-ancestor
55883799|NCT02515734|Micronutrients|micronutrients|mesh-ancestor
55883800|NCT02512536|Botulinum Toxins|botulinum toxins|mesh-list
56050538|NCT04417166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050539|NCT02018627|Glucagon|glucagon|mesh-list
55883801|NCT02512536|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55883802|NCT02512536|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55883803|NCT02512536|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55883804|NCT02512536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55883805|NCT02512536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883806|NCT02512536|Cholinergic Agents|cholinergic agents|mesh-ancestor
55883807|NCT02512536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883808|NCT02512536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883809|NCT02512536|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55883810|NCT02512536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883811|NCT02506842|Leucovorin|leucovorin|mesh-list
55883812|NCT02506842|Folic Acid|folic acid|mesh-list
55883813|NCT02506842|Gemcitabine|gemcitabine|mesh-list
55883814|NCT02506842|Fluorouracil|fluorouracil|mesh-list
55883815|NCT02506842|Oxaliplatin|oxaliplatin|mesh-list
55883816|NCT02506842|Levoleucovorin|levoleucovorin|mesh-list
55883817|NCT02506842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883818|NCT02506842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883819|NCT02506842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55883820|NCT02506842|Antimetabolites|antimetabolites|mesh-ancestor
55883821|NCT02506842|Antiviral Agents|antiviral agents|mesh-ancestor
55883822|NCT02506842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883823|NCT02506842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883824|NCT02506842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883825|NCT02506842|Immunologic Factors|immunologic factors|mesh-ancestor
55883826|NCT02506842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883827|NCT02506842|Antidotes|antidotes|mesh-ancestor
55883828|NCT02506842|Protective Agents|protective agents|mesh-ancestor
55883829|NCT02506842|Vitamin B Complex|vitamin b complex|mesh-ancestor
55883830|NCT02506842|Vitamins|vitamins|mesh-ancestor
55883833|NCT02512614|Anti-Infective Agents|anti-infective agents|mesh-list
55883834|NCT02512614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55883835|NCT03345498|Entecavir|entecavir|mesh-list
55883836|NCT03345498|Antiviral Agents|antiviral agents|mesh-ancestor
55883837|NCT03345498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883838|NCT02506686|Meropenem|meropenem|mesh-list
55883839|NCT02506686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55883840|NCT02506686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883841|NCT04499742|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
55883842|NCT04499742|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55883843|NCT04499742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883844|NCT02512380|Docetaxel|docetaxel|mesh-list
55883845|NCT02512380|Oxaliplatin|oxaliplatin|mesh-list
55883846|NCT02512380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883847|NCT02512380|Tubulin Modulators|tubulin modulators|mesh-ancestor
55883848|NCT02512380|Antimitotic Agents|antimitotic agents|mesh-ancestor
55883849|NCT02512380|Mitosis Modulators|mitosis modulators|mesh-ancestor
55883850|NCT02512380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883852|NCT04497792|Empagliflozin|empagliflozin|mesh-list
55883853|NCT04497792|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55883854|NCT04497792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883855|NCT04497792|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55883856|NCT04497792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883857|NCT03344952|Botulinum Toxins|botulinum toxins|mesh-list
55883858|NCT03344952|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55883859|NCT03344952|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55883860|NCT03344952|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55883861|NCT03344952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55883862|NCT03344952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883863|NCT03344952|Cholinergic Agents|cholinergic agents|mesh-ancestor
55883864|NCT03344952|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883865|NCT03344952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883866|NCT03344952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55883867|NCT03344952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883868|NCT02515422|Ketamine|ketamine|mesh-list
55883869|NCT02515422|Bupivacaine|bupivacaine|mesh-list
55883870|NCT02515422|Anesthetics, Local|anesthetics, local|mesh-ancestor
55883871|NCT02515422|Anesthetics|anesthetics|mesh-ancestor
55883872|NCT02515422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883873|NCT02515422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883874|NCT02515422|Sensory System Agents|sensory system agents|mesh-ancestor
55883875|NCT02515422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050540|NCT02018627|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55883876|NCT02515422|Analgesics|analgesics|mesh-ancestor
55883877|NCT02515422|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55883878|NCT02515422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55883879|NCT02515422|Anesthetics, General|anesthetics, general|mesh-ancestor
55883880|NCT02515422|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55883881|NCT02515422|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55883882|NCT02515422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883883|NCT02515422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883884|NCT02506296|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55883885|NCT02506296|Protease Inhibitors|protease inhibitors|mesh-ancestor
55883886|NCT02506296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883887|NCT02506296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883888|NCT02506296|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55883889|NCT02506296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883892|NCT02506140|Ticagrelor|ticagrelor|mesh-list
55883893|NCT02506140|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55883894|NCT02506140|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55883895|NCT02506140|Analgesics|analgesics|mesh-ancestor
55883896|NCT02506140|Sensory System Agents|sensory system agents|mesh-ancestor
55883897|NCT02506140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883898|NCT02506140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883899|NCT02506140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55883900|NCT02506140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55883901|NCT02506140|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55883902|NCT02506140|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55883903|NCT02506140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883908|NCT02506140|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55883909|NCT02506140|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55883910|NCT02506140|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55883911|NCT02506140|Purinergic Agents|purinergic agents|mesh-ancestor
55883912|NCT02506140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883913|NCT02515188|Acetaminophen|acetaminophen|mesh-list
55883914|NCT02515188|Propacetamol|propacetamol|mesh-list
55883915|NCT02515188|Analgesics|analgesics|mesh-ancestor
55883916|NCT02515188|Sensory System Agents|sensory system agents|mesh-ancestor
55883917|NCT02515188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883918|NCT02515188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883919|NCT02515188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55883920|NCT02515188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55883921|NCT02515188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55883922|NCT02515188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55883923|NCT02515188|Antipyretics|antipyretics|mesh-ancestor
55883924|NCT01696084|Cytarabine|cytarabine|mesh-list
55883925|NCT01696084|Daunorubicin|daunorubicin|mesh-list
55883926|NCT01696084|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55883927|NCT01696084|Antimetabolites|antimetabolites|mesh-ancestor
55883928|NCT01696084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883929|NCT01696084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883930|NCT01696084|Antiviral Agents|antiviral agents|mesh-ancestor
55883931|NCT01696084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883932|NCT01696084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883933|NCT01696084|Immunologic Factors|immunologic factors|mesh-ancestor
55883934|NCT01696084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883935|NCT01696084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55883936|NCT01696084|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55883937|NCT01696084|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55883938|NCT01696084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883939|NCT02228824|Nicotine|nicotine|mesh-list
55883940|NCT02228824|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55883941|NCT02228824|Autonomic Agents|autonomic agents|mesh-ancestor
55883942|NCT02228824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883943|NCT02228824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883944|NCT02228824|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55883945|NCT02228824|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55883946|NCT02228824|Cholinergic Agents|cholinergic agents|mesh-ancestor
55883947|NCT02228824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883948|NCT02228824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883949|NCT02511366|Caseins|caseins|mesh-list
56050541|NCT02018627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56050542|NCT02018627|Hormones|hormones|mesh-ancestor
56050543|NCT02018627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55883950|NCT02511366|Chelating Agents|chelating agents|mesh-ancestor
55883951|NCT02511366|Sequestering Agents|sequestering agents|mesh-ancestor
55883952|NCT02511366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883953|NCT02514954|Insulin Lispro|insulin lispro|mesh-list
55883954|NCT02514954|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55883955|NCT02514954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883956|NCT04443036|Paclitaxel|paclitaxel|mesh-list
55883957|NCT04443036|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55883958|NCT04443036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55883959|NCT04443036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883960|NCT04443036|Tubulin Modulators|tubulin modulators|mesh-ancestor
55883961|NCT04443036|Antimitotic Agents|antimitotic agents|mesh-ancestor
55883962|NCT04443036|Mitosis Modulators|mitosis modulators|mesh-ancestor
55883963|NCT04443036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883964|NCT01653418|Cytarabine|cytarabine|mesh-list
55883965|NCT01653418|Etoposide|etoposide|mesh-list
55883966|NCT01653418|Bortezomib|bortezomib|mesh-list
55883967|NCT01653418|Melphalan|melphalan|mesh-list
55883968|NCT01653418|Carmustine|carmustine|mesh-list
55887130|NCT02989558|Purinergic Agents|purinergic agents|mesh-ancestor
55883969|NCT01653418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55883970|NCT01653418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883971|NCT01653418|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55883972|NCT01653418|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55883973|NCT01653418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883974|NCT01653418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883975|NCT01653418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55883977|NCT01653418|Antiviral Agents|antiviral agents|mesh-ancestor
55883978|NCT01653418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883979|NCT01653418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55883980|NCT01653418|Immunologic Factors|immunologic factors|mesh-ancestor
55883981|NCT01653418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883982|NCT01653418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55883983|NCT01653418|Alkylating Agents|alkylating agents|mesh-ancestor
55883984|NCT01653418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55883986|NCT02514642|Ticagrelor|ticagrelor|mesh-list
55883987|NCT02514642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55883988|NCT02514642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55883989|NCT02514642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55883990|NCT02514642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55883991|NCT02514642|Purinergic Agents|purinergic agents|mesh-ancestor
55883992|NCT02514642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883993|NCT02514642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883994|NCT02514642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883995|NCT02511210|Anesthetics|anesthetics|mesh-list
55883996|NCT02511210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55883997|NCT02511210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883998|NCT02237950|Metronidazole|metronidazole|mesh-list
55883999|NCT02237950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884000|NCT02237950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55884001|NCT02237950|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55884002|NCT02237950|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55884003|NCT02511054|Chloroquine|chloroquine|mesh-list
55884004|NCT02511054|Pyrimethamine|pyrimethamine|mesh-list
55884005|NCT02511054|Amebicides|amebicides|mesh-ancestor
55884006|NCT02511054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55884007|NCT02511054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55884008|NCT02511054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884009|NCT02511054|Antimalarials|antimalarials|mesh-ancestor
55884010|NCT02511054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55884011|NCT02511054|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55884012|NCT02511054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884013|NCT02511054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884015|NCT04499118|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55884016|NCT04499118|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55884017|NCT04499118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884018|NCT04499118|Tubulin Modulators|tubulin modulators|mesh-ancestor
55884019|NCT04499118|Antimitotic Agents|antimitotic agents|mesh-ancestor
56050544|NCT02018627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050546|NCT03476330|Quercetin|quercetin|mesh-list
56050547|NCT03476330|Antioxidants|antioxidants|mesh-ancestor
56050548|NCT03476330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050549|NCT03476330|Protective Agents|protective agents|mesh-ancestor
56050550|NCT03476330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050551|NCT04413344|Bromocriptine|bromocriptine|mesh-list
56050552|NCT04413344|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56050553|NCT04413344|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56050554|NCT04413344|Hormone Antagonists|hormone antagonists|mesh-ancestor
56050555|NCT04413344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884020|NCT04499118|Mitosis Modulators|mitosis modulators|mesh-ancestor
55884021|NCT04499118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884022|NCT01612546|Camptothecin|camptothecin|mesh-list
55884023|NCT01612546|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55884024|NCT01612546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884025|NCT01612546|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55884026|NCT01612546|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55884027|NCT01612546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884028|NCT01612546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884029|NCT04499898|Carvedilol|carvedilol|mesh-list
55884030|NCT04499898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55884031|NCT04499898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55884032|NCT04499898|Adrenergic Agents|adrenergic agents|mesh-ancestor
55884033|NCT04499898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884034|NCT04499898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884035|NCT04499898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884036|NCT04499898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55884037|NCT04499898|Antioxidants|antioxidants|mesh-ancestor
55884038|NCT04499898|Protective Agents|protective agents|mesh-ancestor
55884039|NCT04499898|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55884040|NCT04499898|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55884041|NCT04499898|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55884042|NCT04499898|Vasodilator Agents|vasodilator agents|mesh-ancestor
55884043|NCT04499898|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55884044|NCT04499898|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55884045|NCT02514330|Dihydrotachysterol|dihydrotachysterol|mesh-list
55884046|NCT02514330|Vitamins|vitamins|mesh-ancestor
55884047|NCT02514330|Micronutrients|micronutrients|mesh-ancestor
55884048|NCT02514330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884049|NCT02514330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55884052|NCT02510976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55884053|NCT02510976|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55884054|NCT02510976|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55884055|NCT02510976|Serotonin Agents|serotonin agents|mesh-ancestor
55752055|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
55884056|NCT02510976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884057|NCT02510976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884058|NCT02510976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884059|NCT02505516|Metformin|metformin|mesh-list
55884060|NCT02505516|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55884061|NCT02505516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884062|NCT02505360|Hyaluronic Acid|hyaluronic acid|mesh-list
55884063|NCT02505360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55884064|NCT02505360|Immunologic Factors|immunologic factors|mesh-ancestor
55884065|NCT02505360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884066|NCT02505360|Viscosupplements|viscosupplements|mesh-ancestor
55884067|NCT02505360|Protective Agents|protective agents|mesh-ancestor
55884068|NCT04499586|Irinotecan|irinotecan|mesh-list
55884069|NCT04499586|Raltitrexed|raltitrexed|mesh-list
56050556|NCT04413344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050557|NCT04413344|Dopamine Agonists|dopamine agonists|mesh-ancestor
56050558|NCT04413344|Dopamine Agents|dopamine agents|mesh-ancestor
56050559|NCT04413344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050560|NCT04413344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050561|NCT01717742|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56050562|NCT01717742|Plasminogen|plasminogen|mesh-list
56050563|NCT01717742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56050564|NCT01717742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56050565|NCT01717742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884070|NCT04499586|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55884071|NCT04499586|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55884072|NCT04499586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884073|NCT04499586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884074|NCT04499586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884075|NCT04499586|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55884076|NCT04499586|Antimetabolites|antimetabolites|mesh-ancestor
55884077|NCT04499586|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55884078|NCT02505282|Vitamin K|vitamin k|mesh-list
55884079|NCT02505282|Vitamins|vitamins|mesh-ancestor
55884080|NCT02505282|Micronutrients|micronutrients|mesh-ancestor
55884081|NCT02505282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884082|NCT02505282|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55884083|NCT02505282|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55884084|NCT02505282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884085|NCT02505282|Hemostatics|hemostatics|mesh-ancestor
55884086|NCT02505282|Coagulants|coagulants|mesh-ancestor
55884087|NCT01816295|Methyltestosterone|methyltestosterone|mesh-list
55884088|NCT01816295|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55884089|NCT01816295|Testosterone|testosterone|mesh-list
55884090|NCT01816295|Testosterone undecanoate|testosterone undecanoate|mesh-list
55884091|NCT01816295|Testosterone enanthate|testosterone enanthate|mesh-list
55884092|NCT01816295|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55884093|NCT01816295|Androgens|androgens|mesh-ancestor
55884094|NCT01816295|Hormones|hormones|mesh-ancestor
55884095|NCT01816295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884096|NCT01816295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884097|NCT01816295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55884098|NCT01816295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884099|NCT01816295|Anabolic Agents|anabolic agents|mesh-ancestor
55884100|NCT02514018|Vaccines|vaccines|mesh-list
55884101|NCT02514018|Immunologic Factors|immunologic factors|mesh-ancestor
55884102|NCT02514018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884103|NCT02513862|Heparin|heparin|mesh-list
55884104|NCT02513862|Protamines|protamines|mesh-list
55884105|NCT02513862|Anticoagulants|anticoagulants|mesh-ancestor
55884106|NCT02513862|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55884107|NCT02513862|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55884108|NCT02513862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884109|NCT02513862|Heparin Antagonists|heparin antagonists|mesh-ancestor
55884110|NCT02513862|Coagulants|coagulants|mesh-ancestor
55884111|NCT02510586|Sevoflurane|sevoflurane|mesh-list
55884112|NCT02510586|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55884113|NCT02510586|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55884114|NCT02510586|Anesthetics, General|anesthetics, general|mesh-ancestor
55884115|NCT02510586|Anesthetics|anesthetics|mesh-ancestor
55884116|NCT02510586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884117|NCT02510586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884118|NCT01610297|Deferasirox|deferasirox|mesh-list
55884119|NCT01610297|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55884120|NCT01610297|Chelating Agents|chelating agents|mesh-ancestor
55884121|NCT01610297|Sequestering Agents|sequestering agents|mesh-ancestor
55884122|NCT01610297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884123|NCT01660672|Levetiracetam|levetiracetam|mesh-list
56050567|NCT01717898|Abiraterone Acetate|abiraterone acetate|mesh-list
56050569|NCT01717898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56050571|NCT01717898|Hormones|hormones|mesh-ancestor
55884124|NCT01660672|Anticonvulsants|anticonvulsants|mesh-ancestor
55884131|NCT01793051|Minocycline|minocycline|mesh-list
55884132|NCT01793051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55884133|NCT01793051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884134|NCT01792115|Vitamins|vitamins|mesh-list
55884135|NCT01792115|Vitamin E|vitamin e|mesh-list
55884136|NCT01792115|Tocopherols|tocopherols|mesh-list
55884137|NCT01792115|Tocotrienols|tocotrienols|mesh-list
55884138|NCT01792115|alpha-Tocopherol|alpha-tocopherol|mesh-list
55884139|NCT01792115|Micronutrients|micronutrients|mesh-ancestor
55884140|NCT01792115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884141|NCT01792115|Antioxidants|antioxidants|mesh-ancestor
55884142|NCT01792115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884143|NCT01792115|Protective Agents|protective agents|mesh-ancestor
55884144|NCT01791803|Nicotine|nicotine|mesh-list
55884145|NCT01791803|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55884146|NCT01791803|Autonomic Agents|autonomic agents|mesh-ancestor
55884147|NCT01791803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884148|NCT01791803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884149|NCT01791803|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55884150|NCT01791803|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55884151|NCT01791803|Cholinergic Agents|cholinergic agents|mesh-ancestor
55884152|NCT01791803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884153|NCT01791803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884154|NCT01662856|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55884155|NCT01662856|Hemostatics|hemostatics|mesh-ancestor
55884156|NCT01662856|Coagulants|coagulants|mesh-ancestor
55884157|NCT04499976|Misoprostol|misoprostol|mesh-list
55884158|NCT04499976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55884159|NCT04499976|Abortifacient Agents|abortifacient agents|mesh-ancestor
55884160|NCT04499976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55884161|NCT04499976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884162|NCT04499976|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55884163|NCT04499976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55884164|NCT04499976|Oxytocics|oxytocics|mesh-ancestor
55884165|NCT01791413|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55884166|NCT01791413|Medroxyprogesterone|medroxyprogesterone|mesh-list
55884167|NCT01791413|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55884168|NCT01791413|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55884169|NCT01791413|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55884170|NCT01791413|Contraceptive Agents|contraceptive agents|mesh-ancestor
55884171|NCT01791413|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56053612|NCT00553202|Tacrolimus|tacrolimus|mesh-list
55884172|NCT01791413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884173|NCT01791413|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55884174|NCT01791413|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55884175|NCT01791413|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55884176|NCT01791413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55884177|NCT01791413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884178|NCT02509806|Apatinib|apatinib|mesh-list
55884179|NCT02509806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884180|NCT02509806|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55884181|NCT02509806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884182|NCT02509806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884188|NCT02509728|Choline|choline|mesh-list
55884189|NCT02509728|Lipotropic Agents|lipotropic agents|mesh-ancestor
55884190|NCT02509728|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55884191|NCT02509728|Antimetabolites|antimetabolites|mesh-ancestor
55884192|NCT02509728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884193|NCT02509728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55884194|NCT02509728|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55884195|NCT02509728|Nootropic Agents|nootropic agents|mesh-ancestor
55884196|NCT02501616|Metformin|metformin|mesh-list
55884197|NCT02501616|Dapagliflozin|dapagliflozin|mesh-list
55884201|NCT02501616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884203|NCT01788215|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55884204|NCT01788215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884205|NCT01788215|Antimalarials|antimalarials|mesh-ancestor
55884206|NCT01788215|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56050572|NCT01717898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050573|NCT01717898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050574|NCT01717898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56050575|NCT01717898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884207|NCT01788215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55884208|NCT01812707|Atorvastatin|atorvastatin|mesh-list
55884209|NCT01812707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55884210|NCT01812707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55884211|NCT01812707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55884212|NCT01812707|Antimetabolites|antimetabolites|mesh-ancestor
55884213|NCT01812707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884214|NCT01812707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55884215|NCT01812707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55884216|NCT01812707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884217|NCT01812707|Immunologic Factors|immunologic factors|mesh-ancestor
55884218|NCT01812707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884219|NCT01787279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55884220|NCT01787279|Antiviral Agents|antiviral agents|mesh-ancestor
55884221|NCT01787279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884222|NCT02728206|Sofosbuvir|sofosbuvir|mesh-list
55884223|NCT02728206|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55884224|NCT02728206|Velpatasvir|velpatasvir|mesh-list
55884225|NCT02728206|Antiviral Agents|antiviral agents|mesh-ancestor
55884226|NCT02728206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884227|NCT01811225|Progesterone|progesterone|mesh-list
55884228|NCT01811225|Progestins|progestins|mesh-ancestor
55884229|NCT01811225|Hormones|hormones|mesh-ancestor
55884230|NCT01811225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884231|NCT01811225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884232|NCT01809197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55884233|NCT02508870|Azacitidine|azacitidine|mesh-list
55884234|NCT02508870|Atezolizumab|atezolizumab|mesh-list
55884235|NCT02508870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55884236|NCT02508870|Antimetabolites|antimetabolites|mesh-ancestor
55884237|NCT02508870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884238|NCT02508870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884239|NCT02508870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884240|NCT01786109|Dronabinol|dronabinol|mesh-list
55884241|NCT01786109|Hallucinogens|hallucinogens|mesh-ancestor
55893893|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55884242|NCT01786109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884243|NCT01786109|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55884244|NCT01786109|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55884245|NCT01786109|Analgesics|analgesics|mesh-ancestor
55884246|NCT01786109|Sensory System Agents|sensory system agents|mesh-ancestor
55884247|NCT01786109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884248|NCT01786109|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55884249|NCT01786109|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55884250|NCT01786109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884251|NCT01786109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884252|NCT01786109|Hormones|hormones|mesh-ancestor
55884253|NCT01786109|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884254|NCT02509104|Tamsulosin|tamsulosin|mesh-list
55884255|NCT02509104|Dutasteride|dutasteride|mesh-list
55884256|NCT02509104|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55884257|NCT02509104|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55884258|NCT02509104|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55884259|NCT02509104|Adrenergic Agents|adrenergic agents|mesh-ancestor
55884260|NCT02509104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884261|NCT02509104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884262|NCT02509104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884263|NCT02509104|Urological Agents|urological agents|mesh-ancestor
55884264|NCT02509104|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55884265|NCT02509104|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55884266|NCT02509104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884267|NCT02509104|Hormone Antagonists|hormone antagonists|mesh-ancestor
55884270|NCT02500680|Immunologic Factors|immunologic factors|mesh-ancestor
55752115|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
55884271|NCT02500680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884272|NCT02500446|Dolutegravir|dolutegravir|mesh-list
56050576|NCT01717898|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56050578|NCT01717898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050579|NCT01717898|Hormone Antagonists|hormone antagonists|mesh-ancestor
55884273|NCT02500446|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55884274|NCT02500446|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55884275|NCT02500446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884276|NCT02500446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884277|NCT02500446|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55884278|NCT02500446|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55884279|NCT02500446|Antiviral Agents|antiviral agents|mesh-ancestor
55884280|NCT02500446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884281|NCT02500524|Permethrin|permethrin|mesh-list
55884282|NCT02500524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884283|NCT02500524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884284|NCT02508402|Dexamethasone|dexamethasone|mesh-list
55884285|NCT02508402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55884286|NCT02508402|Antiemetics|antiemetics|mesh-ancestor
55884287|NCT02508402|Autonomic Agents|autonomic agents|mesh-ancestor
55884288|NCT02508402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884289|NCT02508402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884290|NCT02508402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55884291|NCT02508402|Glucocorticoids|glucocorticoids|mesh-ancestor
55884292|NCT02508402|Hormones|hormones|mesh-ancestor
55884293|NCT02508402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884294|NCT02508402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55884295|NCT02508402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884296|NCT02500212|Tacrolimus|tacrolimus|mesh-list
55884297|NCT02500212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55884298|NCT02500212|Immunologic Factors|immunologic factors|mesh-ancestor
55884299|NCT02500212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884300|NCT02500212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55884301|NCT02500212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884302|NCT02500212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884303|NCT02508168|Metformin|metformin|mesh-list
55884304|NCT02508168|Alogliptin|alogliptin|mesh-list
55884305|NCT02508168|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55884306|NCT02508168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884307|NCT02508168|Incretins|incretins|mesh-ancestor
55884308|NCT02508168|Hormones|hormones|mesh-ancestor
55884309|NCT02508168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884310|NCT02508168|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55884311|NCT02508168|Protease Inhibitors|protease inhibitors|mesh-ancestor
55884312|NCT02508168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884313|NCT02508168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884314|NCT02503176|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55884315|NCT02503176|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55884316|NCT02508246|Cisplatin|cisplatin|mesh-list
55884317|NCT02508246|Docetaxel|docetaxel|mesh-list
55884318|NCT02508246|Adavosertib|adavosertib|mesh-list
55884319|NCT02508246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884320|NCT02508246|Tubulin Modulators|tubulin modulators|mesh-ancestor
55884321|NCT02508246|Antimitotic Agents|antimitotic agents|mesh-ancestor
55884322|NCT02508246|Mitosis Modulators|mitosis modulators|mesh-ancestor
55884323|NCT02508246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884324|NCT02508246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884325|NCT01617148|Aflibercept|aflibercept|mesh-list
55884326|NCT01617148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55884327|NCT01617148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55884328|NCT01617148|Growth Substances|growth substances|mesh-ancestor
55884329|NCT01617148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884330|NCT01617148|Growth Inhibitors|growth inhibitors|mesh-ancestor
55884331|NCT01617148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884332|NCT02499978|Dolutegravir|dolutegravir|mesh-list
55884333|NCT02499978|Darunavir|darunavir|mesh-list
55884334|NCT02499978|Cobicistat|cobicistat|mesh-list
55884335|NCT02499978|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
55884336|NCT02499978|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55884337|NCT02499978|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55884338|NCT02499978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884339|NCT02499978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884343|NCT02499978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884344|NCT02499978|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55884345|NCT02499978|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55884346|NCT02499978|Protease Inhibitors|protease inhibitors|mesh-ancestor
55884347|NCT02499978|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55884348|NCT02499978|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55884350|NCT01620190|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55884351|NCT01620190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55884352|NCT01620190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884353|NCT01620190|Tubulin Modulators|tubulin modulators|mesh-ancestor
55884354|NCT01620190|Antimitotic Agents|antimitotic agents|mesh-ancestor
55884355|NCT01620190|Mitosis Modulators|mitosis modulators|mesh-ancestor
55884356|NCT01620190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884357|NCT04498884|Insulin|insulin|mesh-list
55884358|NCT04498884|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55884359|NCT04498884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55884360|NCT04498884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884361|NCT01621672|Lenalidomide|lenalidomide|mesh-list
55884362|NCT01621672|Immunologic Factors|immunologic factors|mesh-ancestor
55884363|NCT01621672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884364|NCT01621672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55884365|NCT01621672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55884366|NCT01621672|Growth Substances|growth substances|mesh-ancestor
55884367|NCT01621672|Growth Inhibitors|growth inhibitors|mesh-ancestor
55884368|NCT01621672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884369|NCT03344328|Bortezomib|bortezomib|mesh-list
55884370|NCT03344328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884371|NCT02499822|Ramipril|ramipril|mesh-list
55884372|NCT02499822|Nifedipine|nifedipine|mesh-list
55884373|NCT02499822|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55884374|NCT02499822|Protease Inhibitors|protease inhibitors|mesh-ancestor
55884375|NCT02499822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884376|NCT02499822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884377|NCT02499822|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55884378|NCT02499822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55884379|NCT02499822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55884380|NCT02499822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55884381|NCT02499822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884382|NCT02499822|Vasodilator Agents|vasodilator agents|mesh-ancestor
55884383|NCT02499822|Tocolytic Agents|tocolytic agents|mesh-ancestor
55884384|NCT02499822|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55884385|NCT01663012|Etirinotecan pegol|etirinotecan pegol|mesh-list
55884386|NCT01663012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884387|NCT01663012|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55884388|NCT01663012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55884389|NCT01663012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884390|NCT01663012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884391|NCT03343548|Magnesium Sulfate|magnesium sulfate|mesh-list
55884393|NCT03343548|Sensory System Agents|sensory system agents|mesh-ancestor
55884394|NCT03343548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884395|NCT03343548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884396|NCT03343548|Anesthetics|anesthetics|mesh-ancestor
55884397|NCT03343548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884398|NCT03343548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55884399|NCT03343548|Anticonvulsants|anticonvulsants|mesh-ancestor
55884400|NCT03343548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55884401|NCT03343548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55884402|NCT03343548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884403|NCT03343548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55884404|NCT03343548|Tocolytic Agents|tocolytic agents|mesh-ancestor
55884405|NCT03343548|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55884406|NCT02507934|Hyaluronic Acid|hyaluronic acid|mesh-list
55884407|NCT02507934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55884408|NCT02507934|Immunologic Factors|immunologic factors|mesh-ancestor
55884409|NCT02507934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884410|NCT02507934|Viscosupplements|viscosupplements|mesh-ancestor
55884411|NCT02507934|Protective Agents|protective agents|mesh-ancestor
55884412|NCT01622296|Lidocaine|lidocaine|mesh-list
55884417|NCT01622296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884418|NCT01622296|Sensory System Agents|sensory system agents|mesh-ancestor
55884419|NCT01622296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884420|NCT01622296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55884421|NCT01622296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55884422|NCT01622296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55884423|NCT01622296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55884424|NCT01622296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884425|NCT01622296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55884426|NCT01622296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55884427|NCT01622296|Adrenergic Agents|adrenergic agents|mesh-ancestor
55884428|NCT01622296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884429|NCT01622296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55884430|NCT01622296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55884431|NCT01622296|Autonomic Agents|autonomic agents|mesh-ancestor
55884432|NCT01622296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55884433|NCT01622296|Respiratory System Agents|respiratory system agents|mesh-ancestor
55884435|NCT01622296|Sympathomimetics|sympathomimetics|mesh-ancestor
55884436|NCT01622296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55884438|NCT02728830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55884439|NCT02728830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884440|NCT01705288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55752183|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
55884441|NCT01705288|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55884442|NCT01705288|Morphine|morphine|mesh-list
55884443|NCT01705288|Narcotics|narcotics|mesh-list
55884444|NCT01705288|Anesthetics|anesthetics|mesh-list
55884445|NCT01705288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884446|NCT01705288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884447|NCT01705288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55884448|NCT01705288|Analgesics|analgesics|mesh-ancestor
55884449|NCT01705288|Sensory System Agents|sensory system agents|mesh-ancestor
55884450|NCT01705288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884451|NCT01705288|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55884452|NCT01705288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55884453|NCT03343002|Fentanyl|fentanyl|mesh-list
55884454|NCT03343002|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55884455|NCT03343002|Narcotics|narcotics|mesh-ancestor
55884456|NCT03343002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884457|NCT03343002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884458|NCT03343002|Analgesics|analgesics|mesh-ancestor
55884459|NCT03343002|Sensory System Agents|sensory system agents|mesh-ancestor
55884460|NCT03343002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884461|NCT03343002|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55884462|NCT03343002|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55884463|NCT03343002|Anesthetics, General|anesthetics, general|mesh-ancestor
55884464|NCT03343002|Anesthetics|anesthetics|mesh-ancestor
55884465|NCT03120936|Tenofovir|tenofovir|mesh-list
55884466|NCT03120936|Emtricitabine|emtricitabine|mesh-list
55884467|NCT03120936|Antiviral Agents|antiviral agents|mesh-ancestor
55884468|NCT03120936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884469|NCT03120936|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55884470|NCT03120936|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55884471|NCT03120936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884472|NCT03120936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884473|NCT03120936|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55884474|NCT03120936|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55884475|NCT02234752|Memantine|memantine|mesh-list
55884476|NCT02234752|Galantamine|galantamine|mesh-list
55884477|NCT02234752|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55884478|NCT02234752|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55884479|NCT02234752|Dopamine Agents|dopamine agents|mesh-ancestor
55884480|NCT02234752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884481|NCT02234752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884483|NCT02234752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55884499|NCT01665508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884500|NCT01665508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884501|NCT01665508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884502|NCT04498260|Triamcinolone|triamcinolone|mesh-list
55884503|NCT04498260|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55884504|NCT04498260|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55884505|NCT04498260|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55884506|NCT04498260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56050580|NCT01717898|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56050581|NCT01737944|Methotrexate|methotrexate|mesh-list
56050582|NCT01737944|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56050583|NCT01737944|Abortifacient Agents|abortifacient agents|mesh-ancestor
56050584|NCT01737944|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56050585|NCT01737944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050586|NCT01737944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56050587|NCT01737944|Antimetabolites|antimetabolites|mesh-ancestor
56050588|NCT01737944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884507|NCT04498260|Glucocorticoids|glucocorticoids|mesh-ancestor
55884508|NCT04498260|Hormones|hormones|mesh-ancestor
55884509|NCT04498260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884510|NCT04498260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884511|NCT04498260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55884512|NCT04498260|Immunologic Factors|immunologic factors|mesh-ancestor
55884513|NCT04498260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884514|NCT04498260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884515|NCT03344094|Interferons|interferons|mesh-list
55884516|NCT03344094|Interferon-beta|interferon-beta|mesh-list
55884517|NCT03344094|Ocrelizumab|ocrelizumab|mesh-list
55884518|NCT03344094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884519|NCT03344094|Antiviral Agents|antiviral agents|mesh-ancestor
55884520|NCT03344094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884521|NCT03344094|Immunologic Factors|immunologic factors|mesh-ancestor
55884522|NCT03344094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884523|NCT02498496|Magnesium Sulfate|magnesium sulfate|mesh-list
55884524|NCT02498496|Analgesics|analgesics|mesh-ancestor
55884525|NCT02498496|Sensory System Agents|sensory system agents|mesh-ancestor
55884526|NCT02498496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884527|NCT02498496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884528|NCT02498496|Anesthetics|anesthetics|mesh-ancestor
55884529|NCT02498496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884530|NCT02498496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55884531|NCT02498496|Anticonvulsants|anticonvulsants|mesh-ancestor
55884532|NCT02498496|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55884533|NCT02498496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55884534|NCT02498496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884535|NCT02498496|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55884536|NCT02498496|Tocolytic Agents|tocolytic agents|mesh-ancestor
55884537|NCT02498496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55884538|NCT02502708|Cyclophosphamide|cyclophosphamide|mesh-list
55884539|NCT02502708|Temozolomide|temozolomide|mesh-list
55884540|NCT02502708|Etoposide|etoposide|mesh-list
55884541|NCT02502708|Tryptophan|tryptophan|mesh-list
55884542|NCT02502708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55884543|NCT02502708|Immunologic Factors|immunologic factors|mesh-ancestor
55884544|NCT02502708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884545|NCT02502708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55884546|NCT02502708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55884557|NCT02502708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55884558|NCT01666210|Dexamethasone|dexamethasone|mesh-list
55884559|NCT01666210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55884560|NCT01666210|Antiemetics|antiemetics|mesh-ancestor
55884561|NCT01666210|Autonomic Agents|autonomic agents|mesh-ancestor
55884562|NCT01666210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884563|NCT01666210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884564|NCT01666210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55884565|NCT01666210|Glucocorticoids|glucocorticoids|mesh-ancestor
55884566|NCT01666210|Hormones|hormones|mesh-ancestor
55884567|NCT01666210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884568|NCT01666210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55884569|NCT01666210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884570|NCT01666912|Contraceptive Agents|contraceptive agents|mesh-list
56050589|NCT01737944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050590|NCT01737944|Dermatologic Agents|dermatologic agents|mesh-ancestor
56050591|NCT01737944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050592|NCT01737944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56050593|NCT01737944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56050594|NCT01737944|Immunologic Factors|immunologic factors|mesh-ancestor
56050595|NCT01737944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56050596|NCT01737944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56050597|NCT01740206|Methylphenidate|methylphenidate|mesh-list
55893894|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
56050599|NCT01740206|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56050600|NCT01740206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050601|NCT01740206|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55884571|NCT01666912|Etonogestrel|etonogestrel|mesh-list
55884572|NCT01666912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55884573|NCT01666912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884574|NCT01666912|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55884575|NCT01666912|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55884576|NCT03341988|Ritonavir|ritonavir|mesh-list
55884577|NCT03341988|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55884578|NCT03341988|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55884579|NCT03341988|Protease Inhibitors|protease inhibitors|mesh-ancestor
55884580|NCT03341988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884581|NCT03341988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884582|NCT03341988|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55884583|NCT03341988|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55884584|NCT03341988|Antiviral Agents|antiviral agents|mesh-ancestor
55884585|NCT03341988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884586|NCT03341988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55884587|NCT03341988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55884588|NCT02501850|Metformin|metformin|mesh-list
55884589|NCT02501850|Liraglutide|liraglutide|mesh-list
55884590|NCT02501850|Exenatide|exenatide|mesh-list
55884591|NCT02501850|Lixisenatide|lixisenatide|mesh-list
55884592|NCT02501850|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55884593|NCT02501850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884594|NCT02501850|Incretins|incretins|mesh-ancestor
55884595|NCT02501850|Hormones|hormones|mesh-ancestor
55884596|NCT02501850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884597|NCT02501850|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55884598|NCT01709032|Deferasirox|deferasirox|mesh-list
55884599|NCT01709032|Deferiprone|deferiprone|mesh-list
55884600|NCT01709032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55884601|NCT01709032|Chelating Agents|chelating agents|mesh-ancestor
55884602|NCT01709032|Sequestering Agents|sequestering agents|mesh-ancestor
55884603|NCT01709032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884604|NCT02496078|Asunaprevir|asunaprevir|mesh-list
55884605|NCT02496078|Protease Inhibitors|protease inhibitors|mesh-ancestor
55884606|NCT02496078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884607|NCT02496078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884608|NCT02495922|Dexamethasone|dexamethasone|mesh-list
55884609|NCT02495922|Lenalidomide|lenalidomide|mesh-list
55884610|NCT02495922|Bortezomib|bortezomib|mesh-list
55884611|NCT02495922|Elotuzumab|elotuzumab|mesh-list
55884612|NCT02495922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55884613|NCT02495922|Antiemetics|antiemetics|mesh-ancestor
55884615|NCT02495922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884616|NCT02495922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884617|NCT02495922|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55884618|NCT02495922|Glucocorticoids|glucocorticoids|mesh-ancestor
55884619|NCT02495922|Hormones|hormones|mesh-ancestor
55884620|NCT02495922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884621|NCT02495922|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56050602|NCT01740206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56050603|NCT01740206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56050604|NCT01740206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050605|NCT01740206|Dopamine Agents|dopamine agents|mesh-ancestor
56050606|NCT01740206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050607|NCT01740206|Sympathomimetics|sympathomimetics|mesh-ancestor
56050608|NCT01740206|Autonomic Agents|autonomic agents|mesh-ancestor
56050609|NCT01740206|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050610|NCT01740206|Adrenergic Agents|adrenergic agents|mesh-ancestor
56050611|NCT01740206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56050612|NCT01740362|Tofacitinib|tofacitinib|mesh-list
56050613|NCT01740362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56050614|NCT01740362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050615|NCT01740362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050616|NCT02068157|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56050618|NCT02068157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050619|NCT02068157|Dermatologic Agents|dermatologic agents|mesh-ancestor
56050620|NCT02068157|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56050621|NCT01741454|Tamsulosin|tamsulosin|mesh-list
56050622|NCT01741454|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56050623|NCT01741454|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56050624|NCT01741454|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56050625|NCT01741454|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56050626|NCT01741454|Adrenergic Agents|adrenergic agents|mesh-ancestor
56050627|NCT01741454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884622|NCT02495922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884623|NCT02495922|Immunologic Factors|immunologic factors|mesh-ancestor
55884624|NCT02495922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55884625|NCT02495922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55884626|NCT02495922|Growth Substances|growth substances|mesh-ancestor
55884627|NCT02495922|Growth Inhibitors|growth inhibitors|mesh-ancestor
55884628|NCT01709422|Midazolam|midazolam|mesh-list
55884629|NCT01709422|Meperidine|meperidine|mesh-list
55884630|NCT01709422|Propofol|propofol|mesh-list
55884631|NCT01709422|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55884632|NCT01709422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884633|NCT01709422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884634|NCT01709422|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55884636|NCT01709422|Anesthetics|anesthetics|mesh-ancestor
55884637|NCT01709422|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55884638|NCT01709422|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55884639|NCT01709422|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55884640|NCT01709422|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55884641|NCT01709422|GABA Modulators|gaba modulators|mesh-ancestor
55884642|NCT01709422|GABA Agents|gaba agents|mesh-ancestor
55884643|NCT01709422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884644|NCT01709422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050628|NCT01741454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050629|NCT01741454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050630|NCT01741454|Urological Agents|urological agents|mesh-ancestor
56050631|NCT01741454|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56050632|NCT01741454|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56050633|NCT01741454|Cholinergic Agents|cholinergic agents|mesh-ancestor
56050634|NCT01720316|Glycine|glycine|mesh-list
56050635|NCT01720316|Glycine Agents|glycine agents|mesh-ancestor
56050636|NCT01720316|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050637|NCT01720316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050638|NCT01720316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050639|NCT02399345|Ritonavir|ritonavir|mesh-list
56050640|NCT02399345|Ribavirin|ribavirin|mesh-list
56050641|NCT02399345|Sofosbuvir|sofosbuvir|mesh-list
56050642|NCT02399345|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56050643|NCT02399345|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56050644|NCT02399345|Protease Inhibitors|protease inhibitors|mesh-ancestor
56050645|NCT02399345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050646|NCT02399345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050647|NCT02399345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56050648|NCT02399345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56050649|NCT02399345|Antiviral Agents|antiviral agents|mesh-ancestor
56050650|NCT02399345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050651|NCT02399345|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56050652|NCT02399345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56050653|NCT02399345|Antimetabolites|antimetabolites|mesh-ancestor
56050654|NCT02400437|Dexamethasone|dexamethasone|mesh-list
56050655|NCT02400437|Rituximab|rituximab|mesh-list
56050656|NCT02400437|Ixazomib|ixazomib|mesh-list
56050657|NCT02400437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56050658|NCT02400437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050659|NCT02400437|Immunologic Factors|immunologic factors|mesh-ancestor
55884645|NCT01709422|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55884647|NCT01709422|Analgesics|analgesics|mesh-ancestor
55884648|NCT01709422|Sensory System Agents|sensory system agents|mesh-ancestor
55884649|NCT01709422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884650|NCT01669642|Ketamine|ketamine|mesh-list
55884651|NCT01669642|Analgesics|analgesics|mesh-ancestor
55884652|NCT01669642|Sensory System Agents|sensory system agents|mesh-ancestor
55884653|NCT01669642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884654|NCT01669642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884655|NCT01669642|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55884656|NCT01669642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55884657|NCT01669642|Anesthetics, General|anesthetics, general|mesh-ancestor
56050660|NCT02400437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050661|NCT02400437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56050662|NCT02400437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56050663|NCT02400437|Antiemetics|antiemetics|mesh-ancestor
56050664|NCT02400437|Autonomic Agents|autonomic agents|mesh-ancestor
56050665|NCT02400437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050666|NCT02400437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56050667|NCT02400437|Glucocorticoids|glucocorticoids|mesh-ancestor
56050668|NCT02400437|Hormones|hormones|mesh-ancestor
56050669|NCT02400437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050670|NCT02400437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56050671|NCT02400437|Protease Inhibitors|protease inhibitors|mesh-ancestor
56050672|NCT02400437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050674|NCT02024477|Saxagliptin|saxagliptin|mesh-list
56050675|NCT02024477|Incretins|incretins|mesh-ancestor
56050676|NCT02024477|Hormones|hormones|mesh-ancestor
56050677|NCT02024477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050678|NCT02024477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050679|NCT02024477|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56050680|NCT02024477|Protease Inhibitors|protease inhibitors|mesh-ancestor
56050681|NCT02024477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050682|NCT02024477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050683|NCT02024477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55884658|NCT01669642|Anesthetics|anesthetics|mesh-ancestor
55884659|NCT01669642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884660|NCT01669642|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55884661|NCT01669642|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55884662|NCT01669642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884663|NCT01669642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884664|NCT01669720|Aflibercept|aflibercept|mesh-list
55884665|NCT01669720|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55884666|NCT01669720|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55884667|NCT01669720|Growth Substances|growth substances|mesh-ancestor
55884668|NCT01669720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884669|NCT01669720|Growth Inhibitors|growth inhibitors|mesh-ancestor
55884670|NCT01669720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884671|NCT01670110|Pasireotide|pasireotide|mesh-list
55884672|NCT01670110|Hormones|hormones|mesh-ancestor
55884673|NCT01670110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884674|NCT01670110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884675|NCT02245516|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55884676|NCT02245516|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55884677|NCT01677286|Doxycycline|doxycycline|mesh-list
55884678|NCT01677286|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55884679|NCT01677286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050685|NCT02024711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56050686|NCT02024711|Immunologic Factors|immunologic factors|mesh-ancestor
56050687|NCT02024711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050688|NCT02024711|Viscosupplements|viscosupplements|mesh-ancestor
56050689|NCT02024711|Protective Agents|protective agents|mesh-ancestor
56050690|NCT02071823|Opicapone|opicapone|mesh-list
56050691|NCT02071823|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55884680|NCT01677286|Antimalarials|antimalarials|mesh-ancestor
55884681|NCT01677286|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55884682|NCT01677286|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55884683|NCT05710666|Trastuzumab|trastuzumab|mesh-list
55884684|NCT05710666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55884685|NCT05710666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884686|NCT01680172|Ketamine|ketamine|mesh-list
55884687|NCT01680172|Analgesics|analgesics|mesh-ancestor
55884688|NCT01680172|Sensory System Agents|sensory system agents|mesh-ancestor
55884689|NCT01680172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884692|NCT01680172|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55884693|NCT01680172|Anesthetics, General|anesthetics, general|mesh-ancestor
55884694|NCT01680172|Anesthetics|anesthetics|mesh-ancestor
55884695|NCT01680172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884696|NCT01680172|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55884697|NCT01680172|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55884698|NCT01680172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893969|NCT03263520|Androgens|androgens|mesh-ancestor
55884699|NCT01680172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884700|NCT02235064|Sertraline|sertraline|mesh-list
55884701|NCT02235064|Antidepressive Agents|antidepressive agents|mesh-ancestor
55884702|NCT02235064|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55884703|NCT02235064|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55884704|NCT02235064|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55884705|NCT02235064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55884706|NCT02235064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884707|NCT02235064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884708|NCT02235064|Serotonin Agents|serotonin agents|mesh-ancestor
55884709|NCT02235064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884710|NCT05118490|Isoniazid|isoniazid|mesh-list
55884711|NCT05118490|Rifapentine|rifapentine|mesh-list
55884712|NCT05118490|Rifampin|rifampin|mesh-list
55884713|NCT05118490|Antitubercular Agents|antitubercular agents|mesh-ancestor
55884714|NCT05118490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55884715|NCT05118490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884716|NCT05118490|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55884717|NCT05118490|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55884718|NCT05118490|Antimetabolites|antimetabolites|mesh-ancestor
55884719|NCT05118490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884720|NCT05118490|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55884721|NCT05118490|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55884722|NCT05118490|Leprostatic Agents|leprostatic agents|mesh-ancestor
55884723|NCT05118490|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55884724|NCT05118490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884725|NCT05118490|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55884726|NCT05118490|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55884727|NCT05118490|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55884728|NCT05118490|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55884729|NCT05118490|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55884730|NCT05118490|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55884731|NCT01681030|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55884732|NCT01681030|Hemostatics|hemostatics|mesh-ancestor
55884733|NCT01681030|Coagulants|coagulants|mesh-ancestor
55884734|NCT02249416|Ritonavir|ritonavir|mesh-list
55884735|NCT02249416|Zidovudine|zidovudine|mesh-list
55884736|NCT02249416|Tipranavir|tipranavir|mesh-list
55884737|NCT02249416|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55884738|NCT02249416|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55884739|NCT02249416|Protease Inhibitors|protease inhibitors|mesh-ancestor
55884740|NCT02249416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050693|NCT02071823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050694|NCT02071823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56050695|NCT02071823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56050696|NCT02029703|Hylan|hylan|mesh-list
56050697|NCT02029703|Viscosupplements|viscosupplements|mesh-ancestor
56050698|NCT02029703|Protective Agents|protective agents|mesh-ancestor
56050699|NCT02029703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050700|NCT02406443|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56050701|NCT02406443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56050702|NCT02406443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050703|NCT02406443|Incretins|incretins|mesh-ancestor
55884741|NCT02249416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884742|NCT02249416|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55884743|NCT02249416|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55884744|NCT02249416|Antiviral Agents|antiviral agents|mesh-ancestor
55884745|NCT02249416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884746|NCT02249416|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55884747|NCT02249416|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55884748|NCT02249416|Antimetabolites|antimetabolites|mesh-ancestor
55884749|NCT02249416|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55884750|NCT02249416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55884751|NCT01685242|Cetirizine|cetirizine|mesh-list
55884752|NCT01685242|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55884753|NCT01685242|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55884754|NCT01685242|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55884755|NCT01685242|Histamine Antagonists|histamine antagonists|mesh-ancestor
55884756|NCT01685242|Histamine Agents|histamine agents|mesh-ancestor
55884757|NCT01685242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884758|NCT01685242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884759|NCT01685242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884760|NCT00708162|Raltegravir Potassium|raltegravir potassium|mesh-list
55884769|NCT00708162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884771|NCT04930042|Dermatologic Agents|dermatologic agents|mesh-ancestor
55884772|NCT04915768|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55884773|NCT04915768|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55884775|NCT04915768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884776|NCT04915768|Antacids|antacids|mesh-ancestor
55884777|NCT04915768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884778|NCT04915768|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55884779|NCT04898920|Dexamethasone|dexamethasone|mesh-list
55884780|NCT04898920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55884781|NCT04898920|Antiemetics|antiemetics|mesh-ancestor
55884782|NCT04898920|Autonomic Agents|autonomic agents|mesh-ancestor
55884783|NCT04898920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884784|NCT04898920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884785|NCT04898920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55884786|NCT04898920|Glucocorticoids|glucocorticoids|mesh-ancestor
55884787|NCT04898920|Hormones|hormones|mesh-ancestor
55884788|NCT04898920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884789|NCT04898920|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55884790|NCT04898920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884791|NCT02249884|Carbamide Peroxide|carbamide peroxide|mesh-list
55884792|NCT02249884|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55884793|NCT02249884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884794|NCT01686646|Acetaminophen|acetaminophen|mesh-list
55884795|NCT01686646|Caffeine|caffeine|mesh-list
55884796|NCT01686646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55884797|NCT01686646|Analgesics|analgesics|mesh-ancestor
55884798|NCT01686646|Sensory System Agents|sensory system agents|mesh-ancestor
55884799|NCT01686646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050705|NCT02406443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050706|NCT02406443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56050707|NCT02406443|Protease Inhibitors|protease inhibitors|mesh-ancestor
56050708|NCT02406443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884800|NCT01686646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884801|NCT01686646|Antipyretics|antipyretics|mesh-ancestor
55884802|NCT01686646|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55884803|NCT01686646|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55884804|NCT01686646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884805|NCT01686646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884806|NCT01686646|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55884807|NCT01686646|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55884808|NCT01686646|Purinergic Agents|purinergic agents|mesh-ancestor
55884809|NCT01686646|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884810|NCT02495688|Anesthetics|anesthetics|mesh-list
55884811|NCT02495688|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884812|NCT02495688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884813|NCT01688596|Bupivacaine|bupivacaine|mesh-list
55884814|NCT01688596|Anesthetics, Local|anesthetics, local|mesh-ancestor
55884815|NCT01688596|Anesthetics|anesthetics|mesh-ancestor
55884816|NCT01688596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884817|NCT01688596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884818|NCT01688596|Sensory System Agents|sensory system agents|mesh-ancestor
55884819|NCT01688596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884820|NCT02495532|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55884821|NCT04869592|Vaccines|vaccines|mesh-list
55884822|NCT04869592|Immunologic Factors|immunologic factors|mesh-ancestor
55884823|NCT04869592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884824|NCT05709652|Ivermectin|ivermectin|mesh-list
55884825|NCT05709652|Selamectin|selamectin|mesh-list
55884826|NCT05709652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55884827|NCT05709652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884828|NCT01690000|Melatonin|melatonin|mesh-list
55884839|NCT02495220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884840|NCT02495220|Sensory System Agents|sensory system agents|mesh-ancestor
55884841|NCT02495220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884842|NCT02495220|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55884843|NCT02495220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55884845|NCT02495220|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55884846|NCT02495220|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55884847|NCT02495220|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55884848|NCT02495220|Adrenergic Agents|adrenergic agents|mesh-ancestor
55884849|NCT02495220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884850|NCT02495220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884852|NCT01690546|Buprenorphine|buprenorphine|mesh-list
55884853|NCT01690546|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55884854|NCT01690546|Naloxone|naloxone|mesh-list
55884855|NCT01690546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55884856|NCT01690546|Narcotics|narcotics|mesh-ancestor
55884857|NCT01690546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884858|NCT01690546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884859|NCT01690546|Analgesics|analgesics|mesh-ancestor
55884860|NCT01690546|Sensory System Agents|sensory system agents|mesh-ancestor
55884861|NCT01690546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884862|NCT01690546|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55884863|NCT01690546|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55884864|NCT03336918|Lithium Carbonate|lithium carbonate|mesh-list
55884865|NCT03336918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884866|NCT03336918|Antidepressive Agents|antidepressive agents|mesh-ancestor
55884867|NCT03336918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55884868|NCT03336918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884869|NCT03336918|Antimanic Agents|antimanic agents|mesh-ancestor
55884870|NCT03336918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55884871|NCT03336918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884872|NCT03336918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884873|NCT02494830|Ketamine|ketamine|mesh-list
55884874|NCT02494830|Analgesics|analgesics|mesh-ancestor
55884875|NCT02494830|Sensory System Agents|sensory system agents|mesh-ancestor
55884876|NCT02494830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050709|NCT02406443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050711|NCT02032433|Buprenorphine|buprenorphine|mesh-list
56050712|NCT02032433|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56050713|NCT02032433|Naloxone|naloxone|mesh-list
55884877|NCT02494830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884878|NCT02494830|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55884879|NCT02494830|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55884880|NCT02494830|Anesthetics, General|anesthetics, general|mesh-ancestor
55884881|NCT02494830|Anesthetics|anesthetics|mesh-ancestor
55884882|NCT02494830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884883|NCT02494830|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55884884|NCT02494830|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55884885|NCT02494830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884886|NCT02494830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884887|NCT03336840|Metformin|metformin|mesh-list
55884888|NCT03336840|Promethazine|promethazine|mesh-list
55884889|NCT03336840|Diphenhydramine|diphenhydramine|mesh-list
55884890|NCT03336840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55884891|NCT03336840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884892|NCT03336840|Antipruritics|antipruritics|mesh-ancestor
55884900|NCT03336840|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55884901|NCT03336840|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55884902|NCT03336840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884903|NCT03336840|Anesthetics, Local|anesthetics, local|mesh-ancestor
55884905|NCT03336840|Sensory System Agents|sensory system agents|mesh-ancestor
55884906|NCT03336840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884907|NCT03336840|Antiemetics|antiemetics|mesh-ancestor
55884908|NCT03336840|Autonomic Agents|autonomic agents|mesh-ancestor
55884909|NCT03336840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55884910|NCT02497638|Metformin|metformin|mesh-list
55884911|NCT02497638|Biguanides|biguanides|mesh-list
55884912|NCT02497638|Atorvastatin|atorvastatin|mesh-list
55884913|NCT02497638|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55884914|NCT02497638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884915|NCT02497638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55884916|NCT02497638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55884917|NCT02497638|Antimetabolites|antimetabolites|mesh-ancestor
55884918|NCT02497638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884919|NCT02497638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55884920|NCT02497638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55884921|NCT02497638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884922|NCT02495064|Mometasone Furoate|mometasone furoate|mesh-list
55884923|NCT02495064|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55884924|NCT02495064|Dermatologic Agents|dermatologic agents|mesh-ancestor
55884925|NCT02495064|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55884929|NCT02493192|Antiemetics|antiemetics|mesh-ancestor
55884930|NCT02493192|Autonomic Agents|autonomic agents|mesh-ancestor
55884931|NCT02493192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884932|NCT02493192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884933|NCT02493192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55884935|NCT02493192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55884936|NCT02493192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884937|NCT02493192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55884938|NCT02493192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55884939|NCT02493192|Dopamine Agents|dopamine agents|mesh-ancestor
55884940|NCT02493192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884941|NCT02493192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884942|NCT02493192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55884943|NCT02493192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55884944|NCT02493192|Narcotics|narcotics|mesh-ancestor
55884945|NCT02493192|Analgesics|analgesics|mesh-ancestor
55884946|NCT02493192|Sensory System Agents|sensory system agents|mesh-ancestor
55884947|NCT02493192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55884948|NCT02497716|Rivaroxaban|rivaroxaban|mesh-list
55884949|NCT02497716|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55884950|NCT02497716|Antithrombins|antithrombins|mesh-ancestor
55884951|NCT02497716|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55884952|NCT02497716|Protease Inhibitors|protease inhibitors|mesh-ancestor
56050714|NCT02032433|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56050715|NCT02032433|Narcotics|narcotics|mesh-ancestor
56050716|NCT02032433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050717|NCT02032433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050718|NCT02032433|Analgesics|analgesics|mesh-ancestor
56050719|NCT02032433|Sensory System Agents|sensory system agents|mesh-ancestor
56050720|NCT02032433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050721|NCT02032433|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56050722|NCT02032433|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56050723|NCT02342015|Atorvastatin|atorvastatin|mesh-list
56050724|NCT02342015|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56050725|NCT02342015|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56050726|NCT02342015|Antimetabolites|antimetabolites|mesh-ancestor
56050727|NCT02342015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050728|NCT02342015|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55884953|NCT02497716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884954|NCT02497716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884955|NCT02497716|Anticoagulants|anticoagulants|mesh-ancestor
55884956|NCT02238808|Estradiol|estradiol|mesh-list
55884957|NCT02238808|Estrogens|estrogens|mesh-list
55884958|NCT02238808|Hormones|hormones|mesh-ancestor
55884959|NCT02238808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884960|NCT02238808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884961|NCT02497326|Heparin|heparin|mesh-list
55884962|NCT02497326|Tramadol|tramadol|mesh-list
55884972|NCT02497326|Sensory System Agents|sensory system agents|mesh-ancestor
55884973|NCT02497326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884974|NCT02245672|Fluticasone|fluticasone|mesh-list
55884975|NCT02245672|Xhance|xhance|mesh-list
55884976|NCT02245672|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55884977|NCT02245672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55884978|NCT02245672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55884979|NCT02245672|Autonomic Agents|autonomic agents|mesh-ancestor
55884980|NCT02245672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884981|NCT02245672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884982|NCT02245672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55884983|NCT02245672|Respiratory System Agents|respiratory system agents|mesh-ancestor
55884984|NCT02245672|Dermatologic Agents|dermatologic agents|mesh-ancestor
55884985|NCT02245672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55884986|NCT02245672|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55884989|NCT02245672|Adrenergic Agents|adrenergic agents|mesh-ancestor
55884990|NCT02245672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884991|NCT02245672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884992|NCT04461418|Glucocorticoids|glucocorticoids|mesh-list
55884993|NCT04461418|Hormones|hormones|mesh-ancestor
55884994|NCT04461418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884995|NCT04461418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884996|NCT04305496|Fulvestrant|fulvestrant|mesh-list
55884997|NCT04305496|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55884998|NCT04305496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884999|NCT04305496|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55885000|NCT04305496|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55885001|NCT04305496|Hormone Antagonists|hormone antagonists|mesh-ancestor
55885002|NCT04305496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55885003|NCT04305496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885004|NCT03335904|Losartan|losartan|mesh-list
56050729|NCT02342015|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56050730|NCT02342015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050732|NCT02342327|Antipruritics|antipruritics|mesh-ancestor
56050733|NCT02342327|Dermatologic Agents|dermatologic agents|mesh-ancestor
56050734|NCT01721564|Bosentan|bosentan|mesh-list
56050735|NCT01721564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56050736|NCT01721564|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56050737|NCT01721564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050738|NCT02342561|Anti-Infective Agents|anti-infective agents|mesh-list
56050739|NCT02342561|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56050740|NCT02343575|Valproic Acid|valproic acid|mesh-list
56050741|NCT02343575|Haloperidol|haloperidol|mesh-list
56050742|NCT02343575|Haloperidol decanoate|haloperidol decanoate|mesh-list
56050743|NCT02343575|Antiemetics|antiemetics|mesh-ancestor
56050744|NCT02343575|Autonomic Agents|autonomic agents|mesh-ancestor
55885005|NCT03335904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55885006|NCT03335904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55885007|NCT03335904|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55885008|NCT03335904|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55885009|NCT03335904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885010|NCT03335826|Anesthetics|anesthetics|mesh-list
55885011|NCT03335826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885012|NCT03335826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885013|NCT03340740|Cetirizine|cetirizine|mesh-list
55885014|NCT03340740|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55885015|NCT03340740|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55885016|NCT03340740|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55885017|NCT03340740|Histamine Antagonists|histamine antagonists|mesh-ancestor
55885018|NCT03340740|Histamine Agents|histamine agents|mesh-ancestor
55885019|NCT03340740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885020|NCT03340740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885021|NCT03340740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885022|NCT03340662|Itraconazole|itraconazole|mesh-list
55885023|NCT03340662|Rifampin|rifampin|mesh-list
55885024|NCT03340662|Fluvoxamine|fluvoxamine|mesh-list
55885025|NCT03340662|Antifungal Agents|antifungal agents|mesh-ancestor
55885026|NCT03340662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885030|NCT03340662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885031|NCT03340662|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55885032|NCT03340662|Hormone Antagonists|hormone antagonists|mesh-ancestor
55885033|NCT03340662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55885034|NCT03340662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885035|NCT03340662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55885036|NCT03340662|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55885037|NCT03340662|Antitubercular Agents|antitubercular agents|mesh-ancestor
55885038|NCT03340662|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55885039|NCT03340662|Leprostatic Agents|leprostatic agents|mesh-ancestor
55885040|NCT03340662|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55885041|NCT03340662|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55885042|NCT03340662|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55885043|NCT03340662|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55885044|NCT03340662|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55885045|NCT03340662|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55885046|NCT03340662|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55885047|NCT03340662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55885048|NCT03340662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56050745|NCT02343575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050746|NCT02343575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050747|NCT02343575|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56050748|NCT02343575|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56050749|NCT02343575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56050750|NCT02343575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050751|NCT02343575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56050752|NCT02343575|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56050753|NCT02343575|Dopamine Agents|dopamine agents|mesh-ancestor
56050754|NCT02343575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050755|NCT02343575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050756|NCT02343575|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55885049|NCT03340662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885050|NCT03340662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55885051|NCT03340662|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55885052|NCT03340662|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55885053|NCT03340662|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55885054|NCT03340662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885055|NCT03340662|Serotonin Agents|serotonin agents|mesh-ancestor
55885056|NCT03340662|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55885057|NCT03340662|Antidepressive Agents|antidepressive agents|mesh-ancestor
55885058|NCT03340662|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55885059|NCT03340662|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55885060|NCT03342300|Doxorubicin|doxorubicin|mesh-list
55885061|NCT03342300|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55885062|NCT03342300|Pirarubicin|pirarubicin|mesh-list
55885063|NCT03342300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55885064|NCT03342300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885065|NCT03342300|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55885066|NCT03342300|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55885067|NCT03342300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885068|NCT03342300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885069|NCT01711918|Domperidone|domperidone|mesh-list
55885070|NCT01711918|Antiemetics|antiemetics|mesh-ancestor
55885071|NCT01711918|Autonomic Agents|autonomic agents|mesh-ancestor
55885072|NCT01711918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885073|NCT01711918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885074|NCT01711918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55885075|NCT01711918|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55885076|NCT01711918|Dopamine Agents|dopamine agents|mesh-ancestor
55885077|NCT01711918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885078|NCT01711918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885080|NCT03120468|Acetylcysteine|acetylcysteine|mesh-list
55885081|NCT03120468|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55885082|NCT03120468|Anticonvulsants|anticonvulsants|mesh-ancestor
55885083|NCT03120468|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55885084|NCT03120468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885085|NCT03120468|Antiviral Agents|antiviral agents|mesh-ancestor
55885086|NCT03120468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885087|NCT03120468|Expectorants|expectorants|mesh-ancestor
55885088|NCT03120468|Respiratory System Agents|respiratory system agents|mesh-ancestor
55885089|NCT03120468|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55885090|NCT03120468|Antioxidants|antioxidants|mesh-ancestor
55885091|NCT03120468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885092|NCT03120468|Protective Agents|protective agents|mesh-ancestor
55885093|NCT03120468|Antidotes|antidotes|mesh-ancestor
55885095|NCT01712230|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55885096|NCT01712230|Fertility Agents|fertility agents|mesh-ancestor
55885105|NCT03335436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885106|NCT03335436|Anticonvulsants|anticonvulsants|mesh-ancestor
55885107|NCT03335436|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56050757|NCT02343575|Anticonvulsants|anticonvulsants|mesh-ancestor
56050758|NCT02343575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050760|NCT02343575|Antimanic Agents|antimanic agents|mesh-ancestor
56050761|NCT01744574|Progesterone|progesterone|mesh-list
56050762|NCT01744574|Progestins|progestins|mesh-ancestor
56050763|NCT01744574|Hormones|hormones|mesh-ancestor
56050764|NCT01744574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050765|NCT01744574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885108|NCT03335436|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55885109|NCT03335436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885110|NCT03335436|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55885111|NCT03335436|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55885112|NCT03335436|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55885113|NCT03335436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885114|NCT03335436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885115|NCT03335436|Antimanic Agents|antimanic agents|mesh-ancestor
55885116|NCT02494284|Aspirin|aspirin|mesh-list
55885117|NCT02494284|Clopidogrel|clopidogrel|mesh-list
55885118|NCT02494284|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55885119|NCT02494284|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55885120|NCT02494284|Analgesics|analgesics|mesh-ancestor
55885121|NCT02494284|Sensory System Agents|sensory system agents|mesh-ancestor
55885122|NCT02494284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885123|NCT02494284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885124|NCT02494284|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885125|NCT02494284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55885126|NCT02494284|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55885127|NCT02494284|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55885128|NCT02494284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885129|NCT02494284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55885130|NCT02494284|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55885131|NCT02494284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885132|NCT02494284|Antipyretics|antipyretics|mesh-ancestor
55885133|NCT02494284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55885134|NCT02494284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55885135|NCT02494284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55885136|NCT02494284|Purinergic Agents|purinergic agents|mesh-ancestor
55885137|NCT02494284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885138|NCT01713400|Sirolimus|sirolimus|mesh-list
55885139|NCT01713400|Ustekinumab|ustekinumab|mesh-list
55885140|NCT01713400|Tacrolimus|tacrolimus|mesh-list
55885141|NCT01713400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55885142|NCT01713400|Immunologic Factors|immunologic factors|mesh-ancestor
55885143|NCT01713400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885144|NCT01713400|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55885145|NCT01713400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885146|NCT01713400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885147|NCT01713400|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55885148|NCT01713400|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885149|NCT01713400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55885150|NCT01713400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885151|NCT01713400|Antifungal Agents|antifungal agents|mesh-ancestor
55885152|NCT01713400|Dermatologic Agents|dermatologic agents|mesh-ancestor
55885153|NCT04494828|Dexmedetomidine|dexmedetomidine|mesh-list
55885154|NCT04494828|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55885155|NCT04494828|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885156|NCT04494828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885157|NCT04494828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55885158|NCT04494828|Analgesics|analgesics|mesh-ancestor
55885159|NCT04494828|Sensory System Agents|sensory system agents|mesh-ancestor
55885160|NCT04494828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885161|NCT04494828|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55885171|NCT01714336|Hemostatics|hemostatics|mesh-ancestor
55885172|NCT01714336|Coagulants|coagulants|mesh-ancestor
56050766|NCT01744730|Clindamycin|clindamycin|mesh-list
56050767|NCT01744730|Clindamycin palmitate|clindamycin palmitate|mesh-list
56050768|NCT01744730|Clindamycin phosphate|clindamycin phosphate|mesh-list
56050769|NCT01744730|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56050770|NCT01744730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050771|NCT01744730|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56050772|NCT01744730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050773|NCT01744730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050774|NCT02033993|Paclitaxel|paclitaxel|mesh-list
55777971|NCT02003014|Pioglitazone|pioglitazone|mesh-list
56050775|NCT02033993|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55885173|NCT05582434|Clindamycin|clindamycin|mesh-list
55885174|NCT05582434|Clindamycin palmitate|clindamycin palmitate|mesh-list
55885175|NCT05582434|Clindamycin phosphate|clindamycin phosphate|mesh-list
55885176|NCT05582434|Adapalene|adapalene|mesh-list
55885177|NCT05582434|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55885178|NCT05582434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55885179|NCT05582434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885180|NCT05582434|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55885181|NCT05582434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885182|NCT05582434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885183|NCT05582434|Dermatologic Agents|dermatologic agents|mesh-ancestor
55885184|NCT05582434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55885185|NCT05582434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55885186|NCT05582434|Analgesics|analgesics|mesh-ancestor
55885187|NCT05582434|Sensory System Agents|sensory system agents|mesh-ancestor
55885188|NCT05582434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885189|NCT05582434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885190|NCT05582434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885191|NCT05582434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55885192|NCT01716208|Ofatumumab|ofatumumab|mesh-list
55885193|NCT01716208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885194|NCT00706992|Aldesleukin|aldesleukin|mesh-list
55885196|NCT00706992|Freund's Adjuvant|freund's adjuvant|mesh-list
55885197|NCT00706992|Immunologic Factors|immunologic factors|mesh-ancestor
55885198|NCT00706992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885199|NCT00706992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885200|NCT00706992|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55885201|NCT00706992|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55885202|NCT00706992|Antiviral Agents|antiviral agents|mesh-ancestor
55885203|NCT00706992|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885204|NCT00706992|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55885205|NCT03335124|Vitamins|vitamins|mesh-list
55885206|NCT03335124|Ascorbic Acid|ascorbic acid|mesh-list
55885207|NCT03335124|Thiamine|thiamine|mesh-list
55885208|NCT03335124|Hydrocortisone|hydrocortisone|mesh-list
55885209|NCT03335124|Micronutrients|micronutrients|mesh-ancestor
55885210|NCT03335124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885211|NCT03335124|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885212|NCT03335124|Antioxidants|antioxidants|mesh-ancestor
55885213|NCT03335124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885214|NCT03335124|Protective Agents|protective agents|mesh-ancestor
55885215|NCT03335124|Vitamin B Complex|vitamin b complex|mesh-ancestor
55885216|NCT03339804|Cyclophosphamide|cyclophosphamide|mesh-list
55885217|NCT03339804|Doxorubicin|doxorubicin|mesh-list
55885218|NCT03339804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55885219|NCT03339804|Immunologic Factors|immunologic factors|mesh-ancestor
55885220|NCT03339804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885221|NCT03339804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55885222|NCT03339804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55885223|NCT03339804|Alkylating Agents|alkylating agents|mesh-ancestor
55885224|NCT03339804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885225|NCT03339804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050789|NCT00354965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050790|NCT00354965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050791|NCT02037425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55885226|NCT03339804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55885227|NCT03339804|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55885228|NCT03339804|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55885242|NCT02491320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885243|NCT02491320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55885244|NCT02491320|Hormone Antagonists|hormone antagonists|mesh-ancestor
56050792|NCT02037425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56050793|NCT02037425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56050794|NCT02037425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050795|NCT02037425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050796|NCT02037425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56050797|NCT02037425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56050798|NCT02037425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050799|NCT02037425|Cholinergic Agents|cholinergic agents|mesh-ancestor
56050800|NCT02037425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050802|NCT00355043|Astringents|astringents|mesh-ancestor
56050803|NCT00355043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050804|NCT00355043|Dermatologic Agents|dermatologic agents|mesh-ancestor
56050806|NCT02037893|Benzocaine|benzocaine|mesh-list
56050807|NCT02037893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56050808|NCT02037893|Anesthetics, Local|anesthetics, local|mesh-ancestor
56050809|NCT02037893|Anesthetics|anesthetics|mesh-ancestor
56050810|NCT02037893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050811|NCT02037893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885245|NCT02491320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55885246|NCT02491320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885248|NCT02491242|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55885249|NCT02491242|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55885250|NCT02491242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885251|NCT02491242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885252|NCT02491242|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55885253|NCT02491242|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55885254|NCT02491242|Antiviral Agents|antiviral agents|mesh-ancestor
55885255|NCT02491242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885256|NCT03330990|Midazolam|midazolam|mesh-list
55885257|NCT03330990|Entrectinib|entrectinib|mesh-list
55885258|NCT03330990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56050812|NCT02037893|Sensory System Agents|sensory system agents|mesh-ancestor
56050813|NCT02037893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050814|NCT02037893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56050815|NCT02037893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56050816|NCT02037893|Analgesics|analgesics|mesh-ancestor
56050817|NCT02037893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56050818|NCT02037893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56050819|NCT02040623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56050820|NCT02040623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56050821|NCT02041325|Lenalidomide|lenalidomide|mesh-list
56050822|NCT02041325|Immunologic Factors|immunologic factors|mesh-ancestor
56050823|NCT02041325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885259|NCT03330990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55885260|NCT03330990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885261|NCT03330990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885262|NCT03330990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55885263|NCT03330990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55885264|NCT03330990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55885265|NCT03330990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55885266|NCT03330990|Anesthetics, General|anesthetics, general|mesh-ancestor
55885267|NCT03330990|Anesthetics|anesthetics|mesh-ancestor
55885268|NCT03330990|GABA Modulators|gaba modulators|mesh-ancestor
55885269|NCT03330990|GABA Agents|gaba agents|mesh-ancestor
55885270|NCT03330990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885271|NCT03330990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885272|NCT03330990|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55885273|NCT03330990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885274|NCT03339024|Oxytocin|oxytocin|mesh-list
55885275|NCT03339024|Oxytocics|oxytocics|mesh-ancestor
55885276|NCT03339024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55885277|NCT03339024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885278|NCT03330132|Vaccines|vaccines|mesh-list
55885279|NCT03330132|Hemagglutinins|hemagglutinins|mesh-list
55885280|NCT03330132|Immunologic Factors|immunologic factors|mesh-ancestor
55885281|NCT03330132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885282|NCT03330132|Agglutinins|agglutinins|mesh-ancestor
55885283|NCT02492412|Cyclosporine|cyclosporine|mesh-list
55885284|NCT02492412|Cyclosporins|cyclosporins|mesh-list
55885285|NCT02492412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885286|NCT02492412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885287|NCT02492412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55885288|NCT02492412|Immunologic Factors|immunologic factors|mesh-ancestor
55885289|NCT02492412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885290|NCT02492412|Antifungal Agents|antifungal agents|mesh-ancestor
55885300|NCT03329898|Estrogens|estrogens|mesh-ancestor
55885301|NCT03329898|Hormones|hormones|mesh-ancestor
55885302|NCT03329898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55885303|NCT03329898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885304|NCT03329898|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55885305|NCT03329898|Contraceptive Agents|contraceptive agents|mesh-ancestor
55885306|NCT03329898|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55885307|NCT03329898|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55885308|NCT03329898|Progestins|progestins|mesh-ancestor
55885309|NCT02492568|Pembrolizumab|pembrolizumab|mesh-list
55885310|NCT02492568|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55885311|NCT02492568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885312|NCT01722292|Carboplatin|carboplatin|mesh-list
55885313|NCT01722292|Etoposide|etoposide|mesh-list
55885314|NCT01722292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885315|NCT01722292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55885316|NCT01722292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55885317|NCT01722292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55885318|NCT01722292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050824|NCT02041325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56050825|NCT02041325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56050827|NCT02041325|Growth Inhibitors|growth inhibitors|mesh-ancestor
56050828|NCT02041325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050829|NCT01723514|Erenumab|erenumab|mesh-list
56050830|NCT01723514|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
56050831|NCT01723514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050832|NCT01723514|Analgesics|analgesics|mesh-ancestor
56050833|NCT01723514|Sensory System Agents|sensory system agents|mesh-ancestor
56050834|NCT01723514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050835|NCT01723514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050836|NCT02044367|Dabigatran|dabigatran|mesh-list
56050837|NCT02044367|Antithrombins|antithrombins|mesh-ancestor
56050838|NCT02044367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55752403|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55885319|NCT01722292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885321|NCT02493894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55885322|NCT02493894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885323|NCT01722604|Brinzolamide|brinzolamide|mesh-list
55885324|NCT01722604|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55885325|NCT01722604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885326|NCT01722604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885327|NCT02493738|Itraconazole|itraconazole|mesh-list
55885328|NCT02493738|Antifungal Agents|antifungal agents|mesh-ancestor
55885329|NCT02493738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885330|NCT02493738|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55885331|NCT02493738|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55885332|NCT02493738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885333|NCT02493738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885334|NCT02493738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55885335|NCT02493738|Hormone Antagonists|hormone antagonists|mesh-ancestor
55885336|NCT02493738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55885337|NCT02493738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885338|NCT02493738|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55885339|NCT03875638|Levetiracetam|levetiracetam|mesh-list
55885340|NCT03875638|Anticonvulsants|anticonvulsants|mesh-ancestor
55885341|NCT03875638|Nootropic Agents|nootropic agents|mesh-ancestor
55885342|NCT03858322|Paclitaxel|paclitaxel|mesh-list
55885343|NCT03858322|Cyclophosphamide|cyclophosphamide|mesh-list
55885344|NCT03858322|Carboplatin|carboplatin|mesh-list
55885345|NCT03858322|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55885346|NCT03858322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885347|NCT03858322|Tubulin Modulators|tubulin modulators|mesh-ancestor
55885348|NCT03858322|Antimitotic Agents|antimitotic agents|mesh-ancestor
55885349|NCT03858322|Mitosis Modulators|mitosis modulators|mesh-ancestor
55885350|NCT03858322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885351|NCT03858322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55885352|NCT03858322|Immunologic Factors|immunologic factors|mesh-ancestor
55885353|NCT03858322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885354|NCT03858322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55885355|NCT03858322|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55885356|NCT03858322|Alkylating Agents|alkylating agents|mesh-ancestor
55885366|NCT05560360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885367|NCT05560360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885368|NCT05560360|Antiviral Agents|antiviral agents|mesh-ancestor
55885369|NCT05560360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050839|NCT02044367|Protease Inhibitors|protease inhibitors|mesh-ancestor
56050840|NCT02044367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050841|NCT02044367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050842|NCT02044367|Anticoagulants|anticoagulants|mesh-ancestor
56050844|NCT01745822|Antiviral Agents|antiviral agents|mesh-ancestor
56050845|NCT01745822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050846|NCT01745822|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56050847|NCT01745822|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56050848|NCT01745822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050849|NCT01745822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778040|NCT03106519|Bupivacaine|bupivacaine|mesh-list
56050850|NCT01745822|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56050851|NCT01745822|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56050852|NCT05718869|Zanubrutinib|zanubrutinib|mesh-list
56050853|NCT05718869|Immunoglobulins|immunoglobulins|mesh-list
56050854|NCT05718869|Immunologic Factors|immunologic factors|mesh-ancestor
56050855|NCT05718869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050856|NCT05718869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050858|NCT05718869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050859|NCT05718869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050860|NCT02354339|Magnesium Oxide|magnesium oxide|mesh-list
55885370|NCT05560360|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55885371|NCT05560360|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55885372|NCT05560360|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55885373|NCT05560360|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55885374|NCT05560360|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55885375|NCT05560360|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55885376|NCT03329118|Simvastatin|simvastatin|mesh-list
55885377|NCT03329118|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55885379|NCT03329118|Antimetabolites|antimetabolites|mesh-ancestor
55885380|NCT03329118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885381|NCT03329118|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55885382|NCT03329118|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55885383|NCT03329118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885384|NCT01723384|Naltrexone|naltrexone|mesh-list
55885385|NCT01723384|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55885386|NCT01723384|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55885387|NCT01723384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885388|NCT01723384|Sensory System Agents|sensory system agents|mesh-ancestor
55885389|NCT01723384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885390|NCT02492490|Basiliximab|basiliximab|mesh-list
55885391|NCT02492490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55885392|NCT02492490|Immunologic Factors|immunologic factors|mesh-ancestor
55885393|NCT02492490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885394|NCT03337932|Doxycycline|doxycycline|mesh-list
55885395|NCT03337932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55885396|NCT03337932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050861|NCT02354339|Antacids|antacids|mesh-ancestor
56050862|NCT02354339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050863|NCT02354339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56050864|NCT01747850|Ethanol|ethanol|mesh-list
56050865|NCT01747850|Nabiximols|nabiximols|mesh-list
56050866|NCT01747850|Dronabinol|dronabinol|mesh-list
56050867|NCT01747850|Cannabidiol|cannabidiol|mesh-list
56050868|NCT01747850|Peppermint oil|peppermint oil|mesh-list
56050869|NCT01747850|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56050870|NCT01747850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56050871|NCT01747850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050872|NCT01747850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885397|NCT03337932|Antimalarials|antimalarials|mesh-ancestor
55885398|NCT03337932|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55885399|NCT03337932|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55885400|NCT02493504|Heparin|heparin|mesh-list
55885401|NCT02493504|Anticoagulants|anticoagulants|mesh-ancestor
55885402|NCT02493504|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55885403|NCT02493504|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55885404|NCT02493504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885405|NCT00706914|Formoterol Fumarate|formoterol fumarate|mesh-list
55885406|NCT00706914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55885407|NCT00706914|Autonomic Agents|autonomic agents|mesh-ancestor
55885408|NCT00706914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885409|NCT00706914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885410|NCT00706914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55885411|NCT00706914|Respiratory System Agents|respiratory system agents|mesh-ancestor
55885412|NCT00706914|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55885413|NCT00706914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55885414|NCT00706914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55885415|NCT00706914|Adrenergic Agents|adrenergic agents|mesh-ancestor
55885416|NCT00706914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885417|NCT00706914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885418|NCT03328728|Hylan|hylan|mesh-list
55885419|NCT03328728|Viscosupplements|viscosupplements|mesh-ancestor
55885420|NCT03328728|Protective Agents|protective agents|mesh-ancestor
55885421|NCT03328728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885432|NCT02491398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885433|NCT02491398|Immunologic Factors|immunologic factors|mesh-ancestor
55885434|NCT02491398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885435|NCT02491398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55885436|NCT02491398|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55885437|NCT02491398|Alkylating Agents|alkylating agents|mesh-ancestor
55885438|NCT02491398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885440|NCT03333018|Formoterol Fumarate|formoterol fumarate|mesh-list
55885441|NCT03333018|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55885442|NCT03333018|Autonomic Agents|autonomic agents|mesh-ancestor
55885443|NCT03333018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885444|NCT03333018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885445|NCT03333018|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55885446|NCT03333018|Respiratory System Agents|respiratory system agents|mesh-ancestor
55885447|NCT03333018|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55885448|NCT03333018|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55885449|NCT03333018|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55885450|NCT03333018|Adrenergic Agents|adrenergic agents|mesh-ancestor
55885451|NCT03333018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885452|NCT03333018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885454|NCT03332940|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
55885455|NCT03332940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55885456|NCT03332940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885457|NCT01723696|Vitamins|vitamins|mesh-list
55885458|NCT01723696|Ascorbic Acid|ascorbic acid|mesh-list
55885459|NCT01723696|Micronutrients|micronutrients|mesh-ancestor
56050873|NCT01747850|Anticonvulsants|anticonvulsants|mesh-ancestor
56050874|NCT01747850|Analgesics|analgesics|mesh-ancestor
56050875|NCT01747850|Sensory System Agents|sensory system agents|mesh-ancestor
56050876|NCT01747850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050877|NCT01747850|Hallucinogens|hallucinogens|mesh-ancestor
56050878|NCT01747850|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56050879|NCT01747850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56050880|NCT01747850|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56050881|NCT01747850|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56050882|NCT01747850|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050883|NCT01747850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050884|NCT01747850|Hormones|hormones|mesh-ancestor
56050885|NCT01747850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050886|NCT01747850|Antiemetics|antiemetics|mesh-ancestor
56050887|NCT01747850|Autonomic Agents|autonomic agents|mesh-ancestor
56050888|NCT01747850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56050889|NCT01747850|Parasympatholytics|parasympatholytics|mesh-ancestor
56050890|NCT01727414|Methylphenidate|methylphenidate|mesh-list
55885460|NCT01723696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885461|NCT01723696|Antioxidants|antioxidants|mesh-ancestor
55885462|NCT01723696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885463|NCT01723696|Protective Agents|protective agents|mesh-ancestor
55885464|NCT03327558|Mesalamine|mesalamine|mesh-list
55885465|NCT03327558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55885466|NCT03327558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55885467|NCT03327558|Analgesics|analgesics|mesh-ancestor
55885468|NCT03327558|Sensory System Agents|sensory system agents|mesh-ancestor
55885469|NCT03327558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885470|NCT03327558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885471|NCT03327558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885472|NCT03327558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55885473|NCT02242630|Methylprednisolone|methylprednisolone|mesh-list
55885474|NCT02242630|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55885475|NCT02242630|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55885476|NCT02242630|Prednisolone|prednisolone|mesh-list
55885477|NCT02242630|Prednisolone acetate|prednisolone acetate|mesh-list
55885478|NCT02242630|Triamcinolone|triamcinolone|mesh-list
55885479|NCT02242630|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55885480|NCT02242630|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55885481|NCT02242630|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55885482|NCT02242630|Prednisolone phosphate|prednisolone phosphate|mesh-list
55885483|NCT02242630|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55885484|NCT02242630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885485|NCT02242630|Antiemetics|antiemetics|mesh-ancestor
55885486|NCT02242630|Autonomic Agents|autonomic agents|mesh-ancestor
55885490|NCT02242630|Glucocorticoids|glucocorticoids|mesh-ancestor
55885491|NCT02242630|Hormones|hormones|mesh-ancestor
55885492|NCT02242630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55885493|NCT02242630|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55885494|NCT02242630|Protective Agents|protective agents|mesh-ancestor
55885495|NCT02242630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55885496|NCT02242630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885497|NCT02242630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55885498|NCT02242630|Immunologic Factors|immunologic factors|mesh-ancestor
55885499|NCT02242630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885500|NCT02242630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885501|NCT03109080|Olaparib|olaparib|mesh-list
55885502|NCT03109080|Adenosine|adenosine|mesh-list
56050891|NCT01727414|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56050892|NCT01727414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050893|NCT01727414|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56050894|NCT01727414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56050895|NCT01727414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887131|NCT02989558|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050896|NCT01727414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050897|NCT01727414|Dopamine Agents|dopamine agents|mesh-ancestor
56050898|NCT01727414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050899|NCT02048891|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55885503|NCT03109080|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55885504|NCT03109080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885505|NCT03109080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885506|NCT03109080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885507|NCT03109080|Analgesics|analgesics|mesh-ancestor
55885508|NCT03109080|Sensory System Agents|sensory system agents|mesh-ancestor
55885509|NCT03109080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885510|NCT03109080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885511|NCT03109080|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55885512|NCT03109080|Vasodilator Agents|vasodilator agents|mesh-ancestor
55885513|NCT03109080|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55885514|NCT03109080|Purinergic Agonists|purinergic agonists|mesh-ancestor
55885515|NCT03109080|Purinergic Agents|purinergic agents|mesh-ancestor
55885516|NCT03109080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885517|NCT03109158|Cetuximab|cetuximab|mesh-list
55885518|NCT03109158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55885519|NCT03109158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885520|NCT03324828|Hydroxyzine|hydroxyzine|mesh-list
55885521|NCT03324828|Antipruritics|antipruritics|mesh-ancestor
55885522|NCT03324828|Dermatologic Agents|dermatologic agents|mesh-ancestor
55885523|NCT03324828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55885524|NCT03324828|Histamine Antagonists|histamine antagonists|mesh-ancestor
55885525|NCT03324828|Histamine Agents|histamine agents|mesh-ancestor
55885526|NCT03324828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885527|NCT03324828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885528|NCT03324828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885529|NCT03332316|Dexamethasone|dexamethasone|mesh-list
55885530|NCT03332316|Dexamethasone acetate|dexamethasone acetate|mesh-list
55885531|NCT03332316|Ropivacaine|ropivacaine|mesh-list
55885532|NCT03332316|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55885533|NCT03332316|BB 1101|bb 1101|mesh-list
55885534|NCT03332316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885535|NCT03332316|Antiemetics|antiemetics|mesh-ancestor
55885536|NCT03332316|Autonomic Agents|autonomic agents|mesh-ancestor
55885537|NCT03332316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885538|NCT03332316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885539|NCT03332316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55885540|NCT03332316|Glucocorticoids|glucocorticoids|mesh-ancestor
55885541|NCT03332316|Hormones|hormones|mesh-ancestor
55885542|NCT03332316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55885543|NCT03332316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55885544|NCT03332316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885545|NCT03332316|Anesthetics, Local|anesthetics, local|mesh-ancestor
55885546|NCT03332316|Anesthetics|anesthetics|mesh-ancestor
55885547|NCT03332316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885548|NCT03332316|Sensory System Agents|sensory system agents|mesh-ancestor
55885549|NCT03332316|Protease Inhibitors|protease inhibitors|mesh-ancestor
55885550|NCT03332316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885551|NCT03332316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885552|NCT03327168|Adenosine|adenosine|mesh-list
55885553|NCT03327168|Analgesics|analgesics|mesh-ancestor
55885554|NCT03327168|Sensory System Agents|sensory system agents|mesh-ancestor
56050900|NCT02048891|Progesterone|progesterone|mesh-list
56050901|NCT02048891|Progestins|progestins|mesh-ancestor
56050902|NCT02048891|Hormones|hormones|mesh-ancestor
56050903|NCT02048891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050904|NCT02048891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050905|NCT02048891|Luteolytic Agents|luteolytic agents|mesh-ancestor
56050906|NCT02048891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56050907|NCT02048891|Contraceptive Agents|contraceptive agents|mesh-ancestor
56050908|NCT02048891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56050909|NCT02048891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56050910|NCT02048891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56050911|NCT02048891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050912|NCT01727726|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56050913|NCT01727726|Brexpiprazole|brexpiprazole|mesh-list
55885555|NCT03327168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885556|NCT03327168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885557|NCT03327168|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55885558|NCT03327168|Vasodilator Agents|vasodilator agents|mesh-ancestor
55885568|NCT01726738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885569|NCT01726738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885571|NCT02492178|Quinine|quinine|mesh-list
55885572|NCT02492178|Antimalarials|antimalarials|mesh-ancestor
55885573|NCT02492178|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55885574|NCT02492178|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55885575|NCT02492178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885576|NCT02492178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885577|NCT02492178|Antiviral Agents|antiviral agents|mesh-ancestor
55885578|NCT02492178|Schistosomicides|schistosomicides|mesh-ancestor
55885579|NCT02492178|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55885580|NCT02492178|Anthelmintics|anthelmintics|mesh-ancestor
55885581|NCT02492178|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55885582|NCT02492178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885583|NCT02492178|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55885584|NCT02492178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885585|NCT02492178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55885586|NCT02492178|Analgesics|analgesics|mesh-ancestor
55885587|NCT02492178|Sensory System Agents|sensory system agents|mesh-ancestor
55885588|NCT03679624|Daratumumab|daratumumab|mesh-list
55885589|NCT03679624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885590|NCT04494126|Tranexamic Acid|tranexamic acid|mesh-list
55885591|NCT04494126|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55885592|NCT04494126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55885593|NCT04494126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885594|NCT04494126|Hemostatics|hemostatics|mesh-ancestor
55885595|NCT04494126|Coagulants|coagulants|mesh-ancestor
55885596|NCT01730872|Prednisolone|prednisolone|mesh-list
55885597|NCT01730872|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55885598|NCT01730872|Methylprednisolone|methylprednisolone|mesh-list
55885599|NCT01730872|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55885600|NCT01730872|Prednisolone acetate|prednisolone acetate|mesh-list
55885601|NCT01730872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55885602|NCT01730872|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55885603|NCT01730872|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55885604|NCT01730872|Prednisolone phosphate|prednisolone phosphate|mesh-list
55885605|NCT01730872|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885606|NCT01730872|Glucocorticoids|glucocorticoids|mesh-ancestor
55885607|NCT01730872|Hormones|hormones|mesh-ancestor
55885608|NCT01730872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55885609|NCT01730872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050914|NCT01727726|Antidepressive Agents|antidepressive agents|mesh-ancestor
56050915|NCT01727726|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56050916|NCT01727726|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56050917|NCT01727726|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56050918|NCT01727726|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050919|NCT01727726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050920|NCT01727726|Serotonin Agents|serotonin agents|mesh-ancestor
56050921|NCT01727726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050922|NCT01727726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050923|NCT01727726|Dopamine Agonists|dopamine agonists|mesh-ancestor
56050924|NCT01727726|Dopamine Agents|dopamine agents|mesh-ancestor
56050925|NCT02355821|Bisoprolol|bisoprolol|mesh-list
56050926|NCT02355821|Moxonidine|moxonidine|mesh-list
56050927|NCT02355821|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56050928|NCT02355821|Sympatholytics|sympatholytics|mesh-ancestor
56050929|NCT02355821|Autonomic Agents|autonomic agents|mesh-ancestor
56050930|NCT02355821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050931|NCT02355821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050932|NCT02355821|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56050933|NCT02355821|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56050934|NCT02355821|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56050935|NCT02355821|Adrenergic Agents|adrenergic agents|mesh-ancestor
56050936|NCT02355821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050937|NCT02355821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050938|NCT05718323|Niraparib|niraparib|mesh-list
56050939|NCT05718323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56050940|NCT05718323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885610|NCT01730872|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55885611|NCT01730872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885612|NCT01730872|Antiemetics|antiemetics|mesh-ancestor
55885613|NCT01730872|Autonomic Agents|autonomic agents|mesh-ancestor
55885614|NCT01730872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885615|NCT01730872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55885616|NCT01730872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55885617|NCT01730872|Protective Agents|protective agents|mesh-ancestor
55885619|NCT02491086|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55885620|NCT02491086|Autonomic Agents|autonomic agents|mesh-ancestor
55885621|NCT02491086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885622|NCT02491086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885623|NCT02491086|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55885624|NCT02491086|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55885625|NCT02491086|Cholinergic Agents|cholinergic agents|mesh-ancestor
55885626|NCT02491086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885627|NCT02491086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885633|NCT03331770|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56050941|NCT05718323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050942|NCT05718323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050943|NCT01748240|Azacitidine|azacitidine|mesh-list
56050944|NCT01748240|Vorinostat|vorinostat|mesh-list
56050945|NCT01748240|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56050946|NCT01748240|Antimetabolites|antimetabolites|mesh-ancestor
56050947|NCT01748240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050948|NCT01748240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050949|NCT01748240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050950|NCT01748240|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56050951|NCT01748942|Dexamethasone|dexamethasone|mesh-list
56050952|NCT01748942|Dexamethasone acetate|dexamethasone acetate|mesh-list
56050953|NCT01748942|Ichthammol|ichthammol|mesh-list
56050954|NCT01748942|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56050955|NCT01748942|BB 1101|bb 1101|mesh-list
56050956|NCT01748942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56050957|NCT01748942|Antiemetics|antiemetics|mesh-ancestor
56050958|NCT01748942|Autonomic Agents|autonomic agents|mesh-ancestor
56050959|NCT01748942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050960|NCT01748942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050961|NCT01748942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56050962|NCT01748942|Glucocorticoids|glucocorticoids|mesh-ancestor
56050963|NCT01748942|Hormones|hormones|mesh-ancestor
56050964|NCT01748942|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56050965|NCT01748942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56050966|NCT01748942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56050967|NCT01748942|Protease Inhibitors|protease inhibitors|mesh-ancestor
56050968|NCT01748942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050969|NCT01748942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050970|NCT01748942|Dermatologic Agents|dermatologic agents|mesh-ancestor
56050971|NCT02355977|Minocycline|minocycline|mesh-list
56050972|NCT02355977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56050981|NCT01749410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050982|NCT01749410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050983|NCT01749410|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56050984|NCT01749410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56050985|NCT01729598|Valproic Acid|valproic acid|mesh-list
56050986|NCT01729598|Anticonvulsants|anticonvulsants|mesh-ancestor
56050987|NCT01729598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56050988|NCT01729598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56050989|NCT01729598|GABA Agents|gaba agents|mesh-ancestor
56050990|NCT01729598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56050991|NCT01729598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56050992|NCT01729598|Antimanic Agents|antimanic agents|mesh-ancestor
56050993|NCT01729598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56050994|NCT01729598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56050995|NCT01729598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56050996|NCT05718011|Dexmedetomidine|dexmedetomidine|mesh-list
56050997|NCT05718011|Ketamine|ketamine|mesh-list
56050998|NCT05718011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56050999|NCT05718011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051000|NCT05718011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051001|NCT05718011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56051002|NCT05718011|Analgesics|analgesics|mesh-ancestor
56051003|NCT05718011|Sensory System Agents|sensory system agents|mesh-ancestor
56051004|NCT05718011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051005|NCT05718011|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55885634|NCT05469412|Midazolam|midazolam|mesh-list
55885635|NCT05469412|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55885636|NCT05469412|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55885637|NCT05469412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885638|NCT05469412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885639|NCT05469412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55885640|NCT05469412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55885641|NCT05469412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55885642|NCT05469412|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55885643|NCT05469412|Anesthetics, General|anesthetics, general|mesh-ancestor
55885644|NCT05469412|Anesthetics|anesthetics|mesh-ancestor
55885645|NCT05469412|GABA Modulators|gaba modulators|mesh-ancestor
55885646|NCT05469412|GABA Agents|gaba agents|mesh-ancestor
55885647|NCT05469412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885648|NCT05469412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885649|NCT03331692|Anesthetics|anesthetics|mesh-list
55885650|NCT03331692|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885651|NCT03331692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885652|NCT04826692|Metformin|metformin|mesh-list
55885653|NCT04826692|Biguanides|biguanides|mesh-list
55885654|NCT04826692|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55885655|NCT04826692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051006|NCT05718011|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56051007|NCT05718011|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56051008|NCT05718011|Adrenergic Agents|adrenergic agents|mesh-ancestor
56051009|NCT05718011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051010|NCT05718011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051011|NCT05718011|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56051012|NCT05718011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56051013|NCT05718011|Anesthetics, General|anesthetics, general|mesh-ancestor
56051014|NCT05718011|Anesthetics|anesthetics|mesh-ancestor
56051015|NCT05718011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56051016|NCT05718011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56051017|NCT05717933|Hormones|hormones|mesh-list
56051018|NCT05717933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56051019|NCT05717933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051020|NCT01730846|Doxazosin|doxazosin|mesh-list
56051021|NCT01730846|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56051022|NCT01730846|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56051023|NCT01730846|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56051024|NCT01730846|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56051025|NCT01730846|Adrenergic Agents|adrenergic agents|mesh-ancestor
56051026|NCT01730846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051027|NCT01730846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051028|NCT01730846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051031|NCT02314403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56051032|NCT02314403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885656|NCT02490930|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55885657|NCT02490930|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55885658|NCT02490930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885659|NCT02490930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55885660|NCT02490930|Immunologic Factors|immunologic factors|mesh-ancestor
55885661|NCT02490930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885663|NCT04825990|Olaparib|olaparib|mesh-list
55885664|NCT04825990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55885665|NCT04825990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885666|NCT04825990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55885667|NCT04825990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885668|NCT04825990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885669|NCT03331302|Xenon|xenon|mesh-list
55885670|NCT03331302|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55885671|NCT03331302|Anesthetics, General|anesthetics, general|mesh-ancestor
55885672|NCT03331302|Anesthetics|anesthetics|mesh-ancestor
55752493|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
56051033|NCT02314403|Immunologic Factors|immunologic factors|mesh-ancestor
56051034|NCT02314403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051035|NCT02314403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56051036|NCT02314403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56051037|NCT02314403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051038|NCT02314403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56051039|NCT02052557|Bupivacaine|bupivacaine|mesh-list
56051040|NCT02052557|Anesthetics, Local|anesthetics, local|mesh-ancestor
56051041|NCT02052557|Anesthetics|anesthetics|mesh-ancestor
55885673|NCT03331302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885674|NCT03331302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885675|NCT01738672|Nitrous Oxide|nitrous oxide|mesh-list
55885676|NCT01738672|Entonox|entonox|mesh-list
55885677|NCT01738672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55885678|NCT01738672|Anesthetics, General|anesthetics, general|mesh-ancestor
55885679|NCT01738672|Anesthetics|anesthetics|mesh-ancestor
55885680|NCT01738672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885681|NCT01738672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885682|NCT01738672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55885683|NCT01738672|Analgesics|analgesics|mesh-ancestor
55885684|NCT01738672|Sensory System Agents|sensory system agents|mesh-ancestor
55885685|NCT01738672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885686|NCT01738672|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55885687|NCT02488512|Edotreotide|edotreotide|mesh-list
55885688|NCT02488512|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55885689|NCT02488512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885690|NCT01808651|Fluoxetine|fluoxetine|mesh-list
55885691|NCT01808651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55885692|NCT01808651|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55885693|NCT01808651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55885694|NCT01808651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885695|NCT01808651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885696|NCT01808651|Serotonin Agents|serotonin agents|mesh-ancestor
55885710|NCT05316376|Paclitaxel|paclitaxel|mesh-list
55885711|NCT05316376|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55885712|NCT05316376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55885713|NCT05316376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885714|NCT05316376|Tubulin Modulators|tubulin modulators|mesh-ancestor
55885715|NCT05316376|Antimitotic Agents|antimitotic agents|mesh-ancestor
55885716|NCT05316376|Mitosis Modulators|mitosis modulators|mesh-ancestor
55885717|NCT05316376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885718|NCT01743976|Donepezil|donepezil|mesh-list
55885719|NCT01743976|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55885720|NCT01743976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885721|NCT01743976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885722|NCT01743976|Cholinergic Agents|cholinergic agents|mesh-ancestor
55885723|NCT01743976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885724|NCT01743976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885725|NCT01743976|Nootropic Agents|nootropic agents|mesh-ancestor
55885726|NCT05315830|Vaccines|vaccines|mesh-list
55885727|NCT05315830|Immunologic Factors|immunologic factors|mesh-ancestor
55885728|NCT05315830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885729|NCT05463822|Botulinum Toxins|botulinum toxins|mesh-list
55885730|NCT05463822|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55885731|NCT05463822|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55885732|NCT05463822|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55885733|NCT05463822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55885734|NCT05463822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885735|NCT05463822|Cholinergic Agents|cholinergic agents|mesh-ancestor
55885736|NCT05463822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885737|NCT05463822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885738|NCT05463822|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56051042|NCT02052557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051043|NCT02052557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051044|NCT02052557|Sensory System Agents|sensory system agents|mesh-ancestor
56051045|NCT02052557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051046|NCT02052635|Clopidogrel|clopidogrel|mesh-list
56051047|NCT02052635|Ticagrelor|ticagrelor|mesh-list
55885739|NCT05463822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885740|NCT04639960|Risperidone|risperidone|mesh-list
55885741|NCT04639960|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55885742|NCT04639960|Serotonin Agents|serotonin agents|mesh-ancestor
55885743|NCT04639960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885744|NCT04639960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885745|NCT04639960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885746|NCT04639960|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55885747|NCT04639960|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55885748|NCT04639960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885749|NCT04639960|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55885750|NCT04639960|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55885751|NCT04639960|Dopamine Agents|dopamine agents|mesh-ancestor
55885752|NCT04579120|Corticosterone|corticosterone|mesh-list
55885753|NCT04579120|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885754|NCT03109314|Donepezil|donepezil|mesh-list
55885755|NCT03109314|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55885758|NCT03109314|Cholinergic Agents|cholinergic agents|mesh-ancestor
55885759|NCT03109314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885760|NCT03109314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885761|NCT03109314|Nootropic Agents|nootropic agents|mesh-ancestor
55885763|NCT04566016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885764|NCT04566016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885765|NCT03320538|Rabeprazole|rabeprazole|mesh-list
55885766|NCT03320538|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55885767|NCT03320538|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55885768|NCT03320538|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55885769|NCT03320538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885770|NCT03320538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885771|NCT03322878|Magnesium Sulfate|magnesium sulfate|mesh-list
55885772|NCT03322878|Analgesics|analgesics|mesh-ancestor
55885773|NCT03322878|Sensory System Agents|sensory system agents|mesh-ancestor
55885774|NCT03322878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885775|NCT03322878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885776|NCT03322878|Anesthetics|anesthetics|mesh-ancestor
55885777|NCT03322878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885778|NCT03322878|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55885779|NCT03322878|Anticonvulsants|anticonvulsants|mesh-ancestor
55885780|NCT03322878|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55885781|NCT03322878|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55885782|NCT03322878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885783|NCT03322878|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55885784|NCT03322878|Tocolytic Agents|tocolytic agents|mesh-ancestor
55885785|NCT03322878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55885786|NCT03322800|Ziresovir|ziresovir|mesh-list
55885787|NCT03322800|Antiviral Agents|antiviral agents|mesh-ancestor
55885788|NCT03322800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885789|NCT03320460|Clobetasol|clobetasol|mesh-list
55885790|NCT03320460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885791|NCT03320460|Glucocorticoids|glucocorticoids|mesh-ancestor
55885792|NCT03320460|Hormones|hormones|mesh-ancestor
55885793|NCT03320460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55885794|NCT03320460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885795|NCT04471714|Baclofen|baclofen|mesh-list
55885796|NCT04471714|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55840509|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55885797|NCT04471714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885799|NCT04471714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885800|NCT04471714|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55885801|NCT04471714|GABA Agonists|gaba agonists|mesh-ancestor
55885802|NCT04471714|GABA Agents|gaba agents|mesh-ancestor
55885803|NCT04471714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051048|NCT02052635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56051049|NCT02052635|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56051050|NCT02052635|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56051051|NCT02052635|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56051053|NCT02052635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051054|NCT02052635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051055|NCT02052635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051056|NCT01732718|Atorvastatin|atorvastatin|mesh-list
56051057|NCT01732718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55885804|NCT04471714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885805|NCT05315206|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55885806|NCT05315206|Nootropic Agents|nootropic agents|mesh-ancestor
55885807|NCT03325686|Vitamin D|vitamin d|mesh-list
55885808|NCT03325686|Vitamins|vitamins|mesh-ancestor
55885809|NCT03325686|Micronutrients|micronutrients|mesh-ancestor
55885810|NCT03325686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885811|NCT03325686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55885812|NCT05315128|Methotrexate|methotrexate|mesh-list
55885813|NCT05315128|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55885814|NCT05315128|Abortifacient Agents|abortifacient agents|mesh-ancestor
55885815|NCT05315128|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55885816|NCT05315128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885817|NCT05315128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55885818|NCT05315128|Antimetabolites|antimetabolites|mesh-ancestor
55885819|NCT05315128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885820|NCT05315128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885821|NCT05315128|Dermatologic Agents|dermatologic agents|mesh-ancestor
55885822|NCT05315128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885823|NCT05315128|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55885824|NCT05315128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55885825|NCT05315128|Immunologic Factors|immunologic factors|mesh-ancestor
55885826|NCT05315128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55885845|NCT01808573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55885846|NCT01808573|Antimetabolites|antimetabolites|mesh-ancestor
55885847|NCT01808573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885848|NCT01808573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885849|NCT01808573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55885850|NCT01808573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885852|NCT01746940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55885853|NCT01746940|Anesthetics, Local|anesthetics, local|mesh-ancestor
55885854|NCT01746940|Anesthetics|anesthetics|mesh-ancestor
55885855|NCT01746940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885856|NCT01746940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885857|NCT01746940|Sensory System Agents|sensory system agents|mesh-ancestor
55885858|NCT01746940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885859|NCT01746940|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55885860|NCT01746940|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55885861|NCT01746940|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55885862|NCT01746940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55885863|NCT01746940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885864|NCT01746940|Dopamine Agents|dopamine agents|mesh-ancestor
55885865|NCT01746940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885866|NCT01747330|Pancreatin|pancreatin|mesh-list
55885867|NCT01747330|Pancrelipase|pancrelipase|mesh-list
55885868|NCT01747330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55885869|NCT02990962|Triamcinolone|triamcinolone|mesh-list
55885870|NCT02990962|Lidocaine|lidocaine|mesh-list
55885871|NCT02990962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56051058|NCT01732718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56051059|NCT01732718|Antimetabolites|antimetabolites|mesh-ancestor
56051060|NCT01732718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051061|NCT01732718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56051062|NCT01732718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56051063|NCT01732718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885873|NCT02990962|Hormones|hormones|mesh-ancestor
55885874|NCT02990962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55885875|NCT02990962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885876|NCT02990962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885877|NCT02990962|Anesthetics, Local|anesthetics, local|mesh-ancestor
55885878|NCT02990962|Anesthetics|anesthetics|mesh-ancestor
55885879|NCT02990962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885880|NCT02990962|Sensory System Agents|sensory system agents|mesh-ancestor
55885881|NCT02990962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885882|NCT02990962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55885883|NCT02990962|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55885887|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55885889|NCT03322098|Atropine|atropine|mesh-list
55885890|NCT03322098|Glycopyrrolate|glycopyrrolate|mesh-list
55885891|NCT03322098|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55885892|NCT03322098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55885893|NCT03322098|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55885894|NCT03322098|Autonomic Agents|autonomic agents|mesh-ancestor
55885895|NCT03322098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885896|NCT03322098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885897|NCT03322098|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55885898|NCT03322098|Respiratory System Agents|respiratory system agents|mesh-ancestor
55885899|NCT03322098|Mydriatics|mydriatics|mesh-ancestor
55885900|NCT03322098|Parasympatholytics|parasympatholytics|mesh-ancestor
55885901|NCT03322098|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55885902|NCT03322098|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55885903|NCT03322098|Cholinergic Agents|cholinergic agents|mesh-ancestor
55885904|NCT03322098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885905|NCT03322098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885906|NCT03319680|Dialysis Solutions|dialysis solutions|mesh-list
55885907|NCT03319680|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55885908|NCT01808339|Fluticasone|fluticasone|mesh-list
55885909|NCT01808339|Xhance|xhance|mesh-list
55885910|NCT01808339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55885911|NCT01808339|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55885912|NCT01808339|Autonomic Agents|autonomic agents|mesh-ancestor
55885913|NCT01808339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885914|NCT01808339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885915|NCT01808339|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55885916|NCT01808339|Respiratory System Agents|respiratory system agents|mesh-ancestor
55885917|NCT01808339|Dermatologic Agents|dermatologic agents|mesh-ancestor
55885918|NCT01808339|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55885919|NCT01749904|Timolol|timolol|mesh-list
55885920|NCT01749904|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55885921|NCT01749904|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55885922|NCT01749904|Adrenergic Agents|adrenergic agents|mesh-ancestor
55885923|NCT01749904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885924|NCT01749904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885925|NCT01749904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885926|NCT01749904|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55885927|NCT01749904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55885928|NCT02484768|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55885929|NCT02484768|Hematinics|hematinics|mesh-ancestor
55885930|NCT03316326|Oxaliplatin|oxaliplatin|mesh-list
55885931|NCT03316326|Irinotecan|irinotecan|mesh-list
55885932|NCT03316326|Tegafur|tegafur|mesh-list
55885933|NCT03316326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885934|NCT03316326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55885935|NCT03316326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55885936|NCT03316326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885937|NCT03316326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051064|NCT02362373|Levonorgestrel|levonorgestrel|mesh-list
56051065|NCT02362373|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56051066|NCT02362373|Contraceptive Agents|contraceptive agents|mesh-ancestor
56051067|NCT02362373|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56051068|NCT02362373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051069|NCT02362373|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55885938|NCT03316326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55885939|NCT03316326|Antimetabolites|antimetabolites|mesh-ancestor
55885940|NCT02487732|Ticagrelor|ticagrelor|mesh-list
55885941|NCT02487732|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55885942|NCT02487732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55885943|NCT02487732|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55885944|NCT02487732|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55885945|NCT02487732|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55885946|NCT02487732|Purinergic Agents|purinergic agents|mesh-ancestor
55885947|NCT02487732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885948|NCT02487732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885949|NCT02487732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885950|NCT03833362|Interferons|interferons|mesh-list
55885951|NCT03833362|Ritonavir|ritonavir|mesh-list
55885952|NCT03833362|Ribavirin|ribavirin|mesh-list
55885953|NCT03833362|Interferon-alpha|interferon-alpha|mesh-list
55885954|NCT03833362|Interferon alpha-2|interferon alpha-2|mesh-list
55885955|NCT03833362|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55885956|NCT03833362|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55885965|NCT03833362|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55885966|NCT03833362|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55885967|NCT03833362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55885968|NCT03833362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55885969|NCT03833362|Antimetabolites|antimetabolites|mesh-ancestor
55885970|NCT03833362|Immunologic Factors|immunologic factors|mesh-ancestor
55885971|NCT03833362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885972|NCT05463588|Methamphetamine|methamphetamine|mesh-list
55885973|NCT05463588|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55885974|NCT05463588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885975|NCT05463588|Sympathomimetics|sympathomimetics|mesh-ancestor
55885976|NCT05463588|Autonomic Agents|autonomic agents|mesh-ancestor
55885977|NCT05463588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885978|NCT05463588|Dopamine Agents|dopamine agents|mesh-ancestor
55885979|NCT05463588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885980|NCT05463588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885981|NCT05463588|Adrenergic Agents|adrenergic agents|mesh-ancestor
55885982|NCT05463588|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55885983|NCT05463588|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55885984|NCT05463588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55885985|NCT05463588|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55885986|NCT02490774|Levonorgestrel|levonorgestrel|mesh-list
55885987|NCT02490774|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55885988|NCT02490774|Contraceptive Agents|contraceptive agents|mesh-ancestor
55885989|NCT02490774|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55885990|NCT02490774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885991|NCT02490774|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55885992|NCT02490774|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55885993|NCT02490774|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55885994|NCT02490540|Sufentanil|sufentanil|mesh-list
55885995|NCT02490540|Dsuvia|dsuvia|mesh-list
55885996|NCT02490540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55885997|NCT02490540|Narcotics|narcotics|mesh-ancestor
55885998|NCT02490540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55885999|NCT02490540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886000|NCT02490540|Analgesics|analgesics|mesh-ancestor
55886001|NCT02490540|Sensory System Agents|sensory system agents|mesh-ancestor
55886002|NCT02490540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886003|NCT02490540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55886004|NCT02490540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55886005|NCT02490540|Anesthetics, General|anesthetics, general|mesh-ancestor
55886006|NCT02490540|Anesthetics|anesthetics|mesh-ancestor
55886007|NCT02484300|Melatonin|melatonin|mesh-list
55886008|NCT02484300|Antioxidants|antioxidants|mesh-ancestor
56051070|NCT02362373|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56051071|NCT02362373|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56051072|NCT02363621|Ranibizumab|ranibizumab|mesh-list
56051073|NCT02363621|Aflibercept|aflibercept|mesh-list
56051074|NCT02363621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56051075|NCT02363621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56051076|NCT02363621|Growth Substances|growth substances|mesh-ancestor
56051077|NCT02363621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886009|NCT02484300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886010|NCT02484300|Protective Agents|protective agents|mesh-ancestor
55886011|NCT02484300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886012|NCT02484300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886013|NCT02727660|Budesonide|budesonide|mesh-list
55886014|NCT02727660|Formoterol Fumarate|formoterol fumarate|mesh-list
55886015|NCT02727660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886016|NCT02727660|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55886017|NCT02727660|Autonomic Agents|autonomic agents|mesh-ancestor
55886018|NCT02727660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886019|NCT02727660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886020|NCT02727660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55886021|NCT02727660|Respiratory System Agents|respiratory system agents|mesh-ancestor
55886022|NCT02727660|Glucocorticoids|glucocorticoids|mesh-ancestor
55886023|NCT02727660|Hormones|hormones|mesh-ancestor
55886035|NCT02490072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55886036|NCT02490072|Analgesics|analgesics|mesh-ancestor
55886037|NCT02490072|Sensory System Agents|sensory system agents|mesh-ancestor
55886038|NCT02490072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886039|NCT02490072|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55886040|NCT02490072|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55886041|NCT02490072|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55886042|NCT02490072|Adrenergic Agents|adrenergic agents|mesh-ancestor
55886043|NCT02490072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886044|NCT02490072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886045|NCT02483598|Buspirone|buspirone|mesh-list
55886046|NCT02483598|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55886047|NCT02483598|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55886048|NCT02483598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886049|NCT02483598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886050|NCT02483598|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55886051|NCT02483598|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55886052|NCT02483598|Serotonin Agents|serotonin agents|mesh-ancestor
55886053|NCT02483598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886054|NCT02483598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886055|NCT03321318|Cholecalciferol|cholecalciferol|mesh-list
55886056|NCT03321318|Vitamin D|vitamin d|mesh-list
55886057|NCT03321318|Bazedoxifene|bazedoxifene|mesh-list
55886058|NCT03321318|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55886059|NCT03321318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886060|NCT03321318|Vitamins|vitamins|mesh-ancestor
55886061|NCT03321318|Micronutrients|micronutrients|mesh-ancestor
55886062|NCT03321318|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55886063|NCT03321318|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55886064|NCT03321318|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55886065|NCT03321318|Hormone Antagonists|hormone antagonists|mesh-ancestor
55886066|NCT03321318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886067|NCT01784861|Everolimus|everolimus|mesh-list
55886068|NCT01784861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886069|NCT01784861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886070|NCT01784861|Immunologic Factors|immunologic factors|mesh-ancestor
55886071|NCT01784861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886072|NCT03318744|Aspirin|aspirin|mesh-list
55886073|NCT03318744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55886074|NCT03318744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55886075|NCT03318744|Analgesics|analgesics|mesh-ancestor
56051078|NCT02363621|Growth Inhibitors|growth inhibitors|mesh-ancestor
56051079|NCT02363621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051081|NCT01749956|Fluorouracil|fluorouracil|mesh-list
56051082|NCT01749956|Oxaliplatin|oxaliplatin|mesh-list
56051083|NCT01749956|Aflibercept|aflibercept|mesh-list
55886076|NCT03318744|Sensory System Agents|sensory system agents|mesh-ancestor
55886077|NCT03318744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886078|NCT03318744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886079|NCT03318744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886080|NCT03318744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55886081|NCT03318744|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55886082|NCT03318744|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55886083|NCT03318744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886085|NCT03318744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55886086|NCT03318744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886087|NCT03318744|Antipyretics|antipyretics|mesh-ancestor
55886088|NCT02489604|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55886089|NCT02489604|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55886090|NCT02489604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886091|NCT01751386|Baclofen|baclofen|mesh-list
55886092|NCT01751386|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55886093|NCT01751386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886094|NCT01751386|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55886095|NCT01751386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886096|NCT01751386|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55886097|NCT01751386|GABA Agonists|gaba agonists|mesh-ancestor
55886098|NCT01751386|GABA Agents|gaba agents|mesh-ancestor
55886099|NCT01751386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886100|NCT01751386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886101|NCT05373264|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55886102|NCT05373264|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55886103|NCT05373264|Diuretics|diuretics|mesh-ancestor
55886104|NCT05373264|Natriuretic Agents|natriuretic agents|mesh-ancestor
55886105|NCT05373264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886106|NCT05373264|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55886107|NCT05373264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55886108|NCT05373264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886109|NCT02489760|Adalimumab|adalimumab|mesh-list
55886110|NCT02489760|Etanercept|etanercept|mesh-list
55886111|NCT02489760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886112|NCT02489760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55886113|NCT02489760|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55886114|NCT02489760|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55886115|NCT02489760|Analgesics|analgesics|mesh-ancestor
55886116|NCT02489760|Sensory System Agents|sensory system agents|mesh-ancestor
55886117|NCT02489760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886118|NCT02489760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886119|NCT02489760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55886120|NCT02489760|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886121|NCT02489760|Immunologic Factors|immunologic factors|mesh-ancestor
55886122|NCT01752712|Oxytocin|oxytocin|mesh-list
55886123|NCT01752712|Oxytocics|oxytocics|mesh-ancestor
55886124|NCT01752712|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55886125|NCT01752712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886126|NCT05127928|Vitamins|vitamins|mesh-list
55886127|NCT05127928|Ascorbic Acid|ascorbic acid|mesh-list
55886128|NCT05127928|Vitamin E|vitamin e|mesh-list
55886129|NCT05127928|Tocopherols|tocopherols|mesh-list
55886130|NCT05127928|Micronutrients|micronutrients|mesh-ancestor
55886131|NCT05127928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886132|NCT05127928|Antioxidants|antioxidants|mesh-ancestor
55886133|NCT05127928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886134|NCT05127928|Protective Agents|protective agents|mesh-ancestor
55886135|NCT02483130|Acetylcysteine|acetylcysteine|mesh-list
55886136|NCT02483130|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55886137|NCT02483130|Antiviral Agents|antiviral agents|mesh-ancestor
55886138|NCT02483130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886139|NCT02483130|Expectorants|expectorants|mesh-ancestor
55886140|NCT02483130|Respiratory System Agents|respiratory system agents|mesh-ancestor
55886141|NCT02483130|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55886142|NCT02483130|Antioxidants|antioxidants|mesh-ancestor
55886143|NCT02483130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051084|NCT01749956|Antimetabolites|antimetabolites|mesh-ancestor
56051085|NCT01749956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051086|NCT01749956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56051087|NCT01749956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051088|NCT01749956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56051089|NCT01749956|Immunologic Factors|immunologic factors|mesh-ancestor
56051090|NCT01749956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051092|NCT01749956|Protective Agents|protective agents|mesh-ancestor
56051093|NCT01749956|Vitamin B Complex|vitamin b complex|mesh-ancestor
56051094|NCT01749956|Vitamins|vitamins|mesh-ancestor
56051095|NCT01749956|Micronutrients|micronutrients|mesh-ancestor
56051096|NCT01749956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56051097|NCT01749956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56051098|NCT01749956|Growth Substances|growth substances|mesh-ancestor
56051099|NCT01749956|Growth Inhibitors|growth inhibitors|mesh-ancestor
56051100|NCT02365961|Clonidine|clonidine|mesh-list
56051101|NCT02365961|Epinephrine|epinephrine|mesh-list
56051102|NCT02365961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56051103|NCT02365961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55886144|NCT02483130|Protective Agents|protective agents|mesh-ancestor
55886145|NCT02483130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886146|NCT02483130|Antidotes|antidotes|mesh-ancestor
55886147|NCT03318354|Olmesartan|olmesartan|mesh-list
55886148|NCT03318354|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55886149|NCT03318354|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55886150|NCT03318354|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55886151|NCT03318354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55886152|NCT03318354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886153|NCT05113186|Lenvatinib|lenvatinib|mesh-list
55886154|NCT05113186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886155|NCT05113186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55886156|NCT05113186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886157|NCT05113186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886158|NCT05093140|Prednisone|prednisone|mesh-list
55886168|NCT05093140|Alkylating Agents|alkylating agents|mesh-ancestor
55886169|NCT05093140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886170|NCT05093140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886171|NCT05093140|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55886172|NCT05093140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886173|NCT05093140|Glucocorticoids|glucocorticoids|mesh-ancestor
55886174|NCT05093140|Hormones|hormones|mesh-ancestor
55886175|NCT05093140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886176|NCT05093140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886177|NCT05093140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55886178|NCT05093140|Tubulin Modulators|tubulin modulators|mesh-ancestor
55886179|NCT05093140|Antimitotic Agents|antimitotic agents|mesh-ancestor
55886180|NCT05093140|Mitosis Modulators|mitosis modulators|mesh-ancestor
55886181|NCT05093140|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55886182|NCT05093140|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55886183|NCT05093140|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55886184|NCT05093140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051104|NCT02365961|Adrenergic Agents|adrenergic agents|mesh-ancestor
56051105|NCT02365961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051106|NCT02365961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051107|NCT02365961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886185|NCT03315312|Fluorides|fluorides|mesh-list
55886186|NCT03315312|Fluorides, Topical|fluorides, topical|mesh-list
55886187|NCT03315312|Cariostatic Agents|cariostatic agents|mesh-ancestor
55886188|NCT03315312|Protective Agents|protective agents|mesh-ancestor
55886189|NCT03315312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886190|NCT00705666|Ribavirin|ribavirin|mesh-list
55886191|NCT00705666|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55886192|NCT00705666|Antimetabolites|antimetabolites|mesh-ancestor
55886193|NCT00705666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886194|NCT00705666|Antiviral Agents|antiviral agents|mesh-ancestor
55886195|NCT00705666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886196|NCT04955236|Fentanyl|fentanyl|mesh-list
55886197|NCT04955236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55886198|NCT04955236|Narcotics|narcotics|mesh-ancestor
55886199|NCT04955236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886200|NCT04955236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886202|NCT04955236|Sensory System Agents|sensory system agents|mesh-ancestor
55886203|NCT04955236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886204|NCT04955236|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55886205|NCT04955236|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55886206|NCT04955236|Anesthetics, General|anesthetics, general|mesh-ancestor
55886207|NCT04955236|Anesthetics|anesthetics|mesh-ancestor
55886208|NCT03957304|Dexmedetomidine|dexmedetomidine|mesh-list
55886209|NCT03957304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55886210|NCT03957304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886211|NCT03957304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886212|NCT03957304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55886213|NCT03957304|Analgesics|analgesics|mesh-ancestor
55886214|NCT03957304|Sensory System Agents|sensory system agents|mesh-ancestor
55886215|NCT03957304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886216|NCT03957304|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55886217|NCT03957304|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55886218|NCT03957304|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55886219|NCT03957304|Adrenergic Agents|adrenergic agents|mesh-ancestor
55886220|NCT03957304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886221|NCT03957304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886222|NCT03320928|Methotrexate|methotrexate|mesh-list
55886223|NCT03320928|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55886224|NCT03320928|Abortifacient Agents|abortifacient agents|mesh-ancestor
55886229|NCT03320928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886230|NCT03320928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886231|NCT03320928|Dermatologic Agents|dermatologic agents|mesh-ancestor
55886232|NCT03320928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886233|NCT03320928|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55886234|NCT03320928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886235|NCT03320928|Immunologic Factors|immunologic factors|mesh-ancestor
55886236|NCT03320928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55886237|NCT03320928|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55886240|NCT02488902|Antimalarials|antimalarials|mesh-ancestor
55886241|NCT02488902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55886242|NCT02488902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55886243|NCT02488902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886244|NCT02253160|Lenograstim|lenograstim|mesh-list
55886245|NCT02253160|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55886246|NCT02253160|Immunologic Factors|immunologic factors|mesh-ancestor
55886247|NCT02253160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886248|NCT02254252|Nicorandil|nicorandil|mesh-list
55886249|NCT02254252|Nitroglycerin|nitroglycerin|mesh-list
55886250|NCT02254252|Vasodilator Agents|vasodilator agents|mesh-ancestor
55886251|NCT02254252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55886252|NCT02254252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55886253|NCT02254252|Vitamin B Complex|vitamin b complex|mesh-ancestor
55886254|NCT02254252|Vitamins|vitamins|mesh-ancestor
55886255|NCT02254252|Micronutrients|micronutrients|mesh-ancestor
55886256|NCT02254252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886257|NCT03315078|Busulfan|busulfan|mesh-list
55886258|NCT03315078|Alkylating Agents|alkylating agents|mesh-ancestor
56051108|NCT02365961|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56051109|NCT02365961|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56051110|NCT02365961|Autonomic Agents|autonomic agents|mesh-ancestor
56051111|NCT02365961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051112|NCT02365961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56051113|NCT02365961|Respiratory System Agents|respiratory system agents|mesh-ancestor
56051114|NCT02365961|Mydriatics|mydriatics|mesh-ancestor
56051115|NCT02365961|Sympathomimetics|sympathomimetics|mesh-ancestor
56051116|NCT02365961|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56051117|NCT02365961|Analgesics|analgesics|mesh-ancestor
55886259|NCT03315078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886260|NCT03315078|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886261|NCT03315078|Immunologic Factors|immunologic factors|mesh-ancestor
55886262|NCT03315078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886263|NCT03315078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55886264|NCT03315078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886265|NCT03315078|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55886266|NCT02255110|Doxorubicin|doxorubicin|mesh-list
55886267|NCT02255110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55886269|NCT02255110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55886270|NCT02255110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55886271|NCT02255110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886272|NCT02255110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886273|NCT03320694|Insulin|insulin|mesh-list
55886274|NCT03320694|Metformin|metformin|mesh-list
55886275|NCT03320694|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55886276|NCT03320694|Isophane Insulin, Human|isophane insulin, human|mesh-list
55886277|NCT03320694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55886278|NCT03320694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886279|NCT02482740|Tamoxifen|tamoxifen|mesh-list
55886280|NCT02482740|Letrozole|letrozole|mesh-list
55886281|NCT02482740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886282|NCT02482740|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55886283|NCT02482740|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55886284|NCT02482740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886285|NCT02482740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886286|NCT02482740|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55886287|NCT02482740|Hormone Antagonists|hormone antagonists|mesh-ancestor
55886288|NCT02482740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887132|NCT01806779|Bupropion|bupropion|mesh-list
55886289|NCT02482740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886290|NCT02482740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886291|NCT02482740|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55886292|NCT02482740|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55886293|NCT02482740|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55886294|NCT03315000|Fluticasone|fluticasone|mesh-list
55886296|NCT03315000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886299|NCT03315000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886300|NCT03315000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886301|NCT03315000|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55886302|NCT03315000|Respiratory System Agents|respiratory system agents|mesh-ancestor
55886303|NCT03315000|Dermatologic Agents|dermatologic agents|mesh-ancestor
55886304|NCT03315000|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55886305|NCT02482818|Pregabalin|pregabalin|mesh-list
55886306|NCT02482818|Analgesics|analgesics|mesh-ancestor
55886307|NCT02482818|Sensory System Agents|sensory system agents|mesh-ancestor
55886308|NCT02482818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886309|NCT02482818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886310|NCT02482818|Anticonvulsants|anticonvulsants|mesh-ancestor
55886311|NCT02482818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55886312|NCT02482818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55886313|NCT02482818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051119|NCT02365961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56051120|NCT02365961|Sympatholytics|sympatholytics|mesh-ancestor
56051121|NCT02365961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56051122|NCT05532059|Gemcitabine|gemcitabine|mesh-list
56051123|NCT05532059|Cisplatin|cisplatin|mesh-list
56051124|NCT05532059|Lenvatinib|lenvatinib|mesh-list
56051125|NCT05532059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886314|NCT02482818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55886315|NCT02482818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55886316|NCT02482818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55886317|NCT02482818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886318|NCT02482818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55886319|NCT02989870|Sorafenib|sorafenib|mesh-list
55886320|NCT02989870|Bavituximab|bavituximab|mesh-list
55886321|NCT02989870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886322|NCT02989870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55886323|NCT02989870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886324|NCT02989870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886325|NCT02989870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55886326|NCT02480088|Palonosetron|palonosetron|mesh-list
55886327|NCT02480088|Ramosetron|ramosetron|mesh-list
55886329|NCT02480088|Autonomic Agents|autonomic agents|mesh-ancestor
55886330|NCT02480088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886331|NCT02480088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886332|NCT02480088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55886333|NCT02480088|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55886334|NCT02480088|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55886335|NCT02480088|Serotonin Agents|serotonin agents|mesh-ancestor
55886336|NCT02480088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886337|NCT02480088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886338|NCT01807624|Phenylephrine|phenylephrine|mesh-list
55886339|NCT01807624|Oxymetazoline|oxymetazoline|mesh-list
55886340|NCT01807624|Tetracaine|tetracaine|mesh-list
55886341|NCT01807624|Anesthetics, Local|anesthetics, local|mesh-ancestor
55886342|NCT01807624|Anesthetics|anesthetics|mesh-ancestor
55886343|NCT01807624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886344|NCT01807624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886345|NCT01807624|Sensory System Agents|sensory system agents|mesh-ancestor
55886346|NCT01807624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886347|NCT01807624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55886348|NCT01807624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55886349|NCT01807624|Adrenergic Agents|adrenergic agents|mesh-ancestor
55886350|NCT01807624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886351|NCT01807624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886352|NCT01807624|Sympathomimetics|sympathomimetics|mesh-ancestor
55886353|NCT01807624|Autonomic Agents|autonomic agents|mesh-ancestor
55886354|NCT01807624|Nasal Decongestants|nasal decongestants|mesh-ancestor
55886355|NCT01807624|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55886356|NCT01807624|Respiratory System Agents|respiratory system agents|mesh-ancestor
55886357|NCT01807624|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55886358|NCT01807624|Mydriatics|mydriatics|mesh-ancestor
55886359|NCT01807624|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55886360|NCT01807624|Protective Agents|protective agents|mesh-ancestor
55886361|NCT02486640|Interferons|interferons|mesh-list
55886362|NCT02486640|Interferon-beta|interferon-beta|mesh-list
55886363|NCT02486640|Interferon beta-1b|interferon beta-1b|mesh-list
55752618|NCT03204877|Melatonin|melatonin|mesh-list
55886364|NCT02486640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886365|NCT02486640|Antiviral Agents|antiviral agents|mesh-ancestor
55886366|NCT02486640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886367|NCT02486640|Immunologic Factors|immunologic factors|mesh-ancestor
55886368|NCT02486640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886369|NCT02486640|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55886378|NCT03317730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886379|NCT03317730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051126|NCT05532059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56051127|NCT05532059|Antimetabolites|antimetabolites|mesh-ancestor
56051128|NCT05532059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051129|NCT05532059|Antiviral Agents|antiviral agents|mesh-ancestor
56051130|NCT05532059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051131|NCT05532059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051132|NCT05532059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56051133|NCT05532059|Immunologic Factors|immunologic factors|mesh-ancestor
56051134|NCT05532059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051135|NCT05532059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56051136|NCT03809234|Ondansetron|ondansetron|mesh-list
56051137|NCT03809234|Antiemetics|antiemetics|mesh-ancestor
56051138|NCT03809234|Autonomic Agents|autonomic agents|mesh-ancestor
56051139|NCT03809234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886380|NCT03317730|Analgesics|analgesics|mesh-ancestor
55886381|NCT03317730|Sensory System Agents|sensory system agents|mesh-ancestor
55886382|NCT03317730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886383|NCT02486484|Aflibercept|aflibercept|mesh-list
55886384|NCT02486484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55886385|NCT02486484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55886386|NCT02486484|Growth Substances|growth substances|mesh-ancestor
55886387|NCT02486484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886388|NCT02486484|Growth Inhibitors|growth inhibitors|mesh-ancestor
55886389|NCT02486484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886390|NCT03317652|Nitroprusside|nitroprusside|mesh-list
55886391|NCT03317652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55886392|NCT03317652|Vasodilator Agents|vasodilator agents|mesh-ancestor
55886393|NCT03317652|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55886394|NCT03317652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886395|NCT02479854|Montelukast|montelukast|mesh-list
55886396|NCT02479854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55886397|NCT02479854|Respiratory System Agents|respiratory system agents|mesh-ancestor
55886398|NCT02479854|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55886399|NCT02479854|Hormone Antagonists|hormone antagonists|mesh-ancestor
55886400|NCT02479854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886401|NCT02479854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886402|NCT02479854|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55886403|NCT02479854|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55886404|NCT02479854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886405|NCT01809106|Fentanyl|fentanyl|mesh-list
55886406|NCT01809106|Morphine|morphine|mesh-list
55886407|NCT01809106|Oxycodone|oxycodone|mesh-list
55886408|NCT01809106|Buprenorphine|buprenorphine|mesh-list
55886409|NCT01809106|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55886410|NCT01809106|Narcotics|narcotics|mesh-ancestor
55886411|NCT01809106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886412|NCT01809106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886413|NCT01809106|Analgesics|analgesics|mesh-ancestor
55752624|NCT03204799|Metformin|metformin|mesh-list
55886414|NCT01809106|Sensory System Agents|sensory system agents|mesh-ancestor
55886415|NCT01809106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886416|NCT01809106|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55886417|NCT01809106|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55886418|NCT01809106|Anesthetics, General|anesthetics, general|mesh-ancestor
55886419|NCT01809106|Anesthetics|anesthetics|mesh-ancestor
55886420|NCT01809106|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55886421|NCT03804580|Osimertinib|osimertinib|mesh-list
55886422|NCT03804580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886423|NCT03804580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55886424|NCT03804580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051140|NCT03809234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051141|NCT03809234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56051142|NCT03809234|Antipruritics|antipruritics|mesh-ancestor
55886425|NCT03804580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886426|NCT03317574|Botulinum Toxins|botulinum toxins|mesh-list
55886427|NCT03317574|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55886428|NCT03317574|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55886429|NCT03317574|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55886430|NCT03317574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55886431|NCT03317574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886432|NCT03317574|Cholinergic Agents|cholinergic agents|mesh-ancestor
55886433|NCT03317574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886434|NCT03317574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886435|NCT03317574|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55886445|NCT02482272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886447|NCT02482272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886448|NCT02482272|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55886449|NCT02482272|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55886450|NCT01766440|Calcitriol|calcitriol|mesh-list
55886451|NCT01766440|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55886452|NCT01766440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886453|NCT01766440|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55886454|NCT01766440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55886455|NCT01766440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886456|NCT01766440|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55886457|NCT01766440|Vitamins|vitamins|mesh-ancestor
55886458|NCT01766440|Micronutrients|micronutrients|mesh-ancestor
55886459|NCT01766440|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55886460|NCT02479620|Dexamethasone|dexamethasone|mesh-list
55886461|NCT02479620|Dexamethasone acetate|dexamethasone acetate|mesh-list
55886462|NCT02479620|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55886463|NCT02479620|BB 1101|bb 1101|mesh-list
55886464|NCT02479620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886465|NCT02479620|Antiemetics|antiemetics|mesh-ancestor
55886466|NCT02479620|Autonomic Agents|autonomic agents|mesh-ancestor
55886467|NCT02479620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886468|NCT02479620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886469|NCT02479620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55886470|NCT02479620|Glucocorticoids|glucocorticoids|mesh-ancestor
55886471|NCT02479620|Hormones|hormones|mesh-ancestor
55886472|NCT02479620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886473|NCT02479620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886474|NCT02479620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886475|NCT02479620|Protease Inhibitors|protease inhibitors|mesh-ancestor
55886476|NCT02479620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886477|NCT02479620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886478|NCT02481960|Irinotecan|irinotecan|mesh-list
55886479|NCT02481960|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55886480|NCT02481960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55886482|NCT02481960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886483|NCT02481960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886484|NCT03494530|Edoxaban|edoxaban|mesh-list
55886485|NCT03494530|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55886486|NCT03494530|Antithrombins|antithrombins|mesh-ancestor
55886487|NCT03494530|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55886488|NCT03494530|Protease Inhibitors|protease inhibitors|mesh-ancestor
55886489|NCT03494530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886490|NCT03494530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886491|NCT03494530|Anticoagulants|anticoagulants|mesh-ancestor
55886492|NCT02725866|Ritonavir|ritonavir|mesh-list
55886493|NCT02725866|Ribavirin|ribavirin|mesh-list
55886494|NCT02725866|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55886495|NCT02725866|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55886496|NCT02725866|Protease Inhibitors|protease inhibitors|mesh-ancestor
55886497|NCT02725866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886498|NCT02725866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886499|NCT02725866|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55886500|NCT02725866|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55886501|NCT02725866|Antiviral Agents|antiviral agents|mesh-ancestor
55886502|NCT02725866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886512|NCT03314298|Testosterone undecanoate|testosterone undecanoate|mesh-list
56051143|NCT03809234|Dermatologic Agents|dermatologic agents|mesh-ancestor
56051144|NCT03809234|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56051145|NCT03809234|Serotonin Agents|serotonin agents|mesh-ancestor
56051146|NCT03809234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778341|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
56051147|NCT03809234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051148|NCT03809234|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56051149|NCT03809234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56051150|NCT03809234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051151|NCT03809234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56051152|NCT03809234|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56051154|NCT03711188|Ipilimumab|ipilimumab|mesh-list
56051155|NCT03711188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56051156|NCT03711188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051157|NCT03711188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56051158|NCT03711188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051159|NCT02366663|Cytarabine|cytarabine|mesh-list
56051160|NCT02366663|Rituximab|rituximab|mesh-list
56051161|NCT02366663|Etoposide|etoposide|mesh-list
56051162|NCT02366663|Melphalan|melphalan|mesh-list
56051163|NCT02366663|Carmustine|carmustine|mesh-list
56051164|NCT02366663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56051165|NCT02366663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051166|NCT02366663|Immunologic Factors|immunologic factors|mesh-ancestor
56051167|NCT02366663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051168|NCT02366663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56051169|NCT02366663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55886513|NCT03314298|Testosterone enanthate|testosterone enanthate|mesh-list
55886514|NCT03314298|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55886516|NCT03314298|Hormones|hormones|mesh-ancestor
55886517|NCT03314298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886518|NCT03314298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886519|NCT03314298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886520|NCT03314298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886521|NCT03314298|Anabolic Agents|anabolic agents|mesh-ancestor
55886522|NCT03314298|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55886523|NCT03314298|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55886524|NCT03314298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886525|NCT03314298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886526|NCT03314298|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55886527|NCT03314298|Hormone Antagonists|hormone antagonists|mesh-ancestor
55886528|NCT02479308|Moxifloxacin|moxifloxacin|mesh-list
55886529|NCT02479308|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55886530|NCT02479308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886531|NCT02479308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55886532|NCT02479308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55886533|NCT02479308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051170|NCT02366663|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56051171|NCT02366663|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56051172|NCT02366663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051173|NCT02366663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051174|NCT02366663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56051175|NCT02366663|Antimetabolites|antimetabolites|mesh-ancestor
56051176|NCT02366663|Antiviral Agents|antiviral agents|mesh-ancestor
56051177|NCT02366663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051178|NCT02366663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56051179|NCT02366663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56051180|NCT02366663|Alkylating Agents|alkylating agents|mesh-ancestor
56051181|NCT02366663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56051182|NCT01754480|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
56051184|NCT01754480|Coagulants|coagulants|mesh-ancestor
56051185|NCT02367599|Vitamin D|vitamin d|mesh-list
56051186|NCT02367599|Vitamins|vitamins|mesh-ancestor
56051187|NCT02367599|Micronutrients|micronutrients|mesh-ancestor
56051188|NCT02367599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886534|NCT02479308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886535|NCT02479308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886536|NCT05461560|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55886542|NCT05713578|Docetaxel|docetaxel|mesh-list
55886543|NCT05713578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886544|NCT05713578|Tubulin Modulators|tubulin modulators|mesh-ancestor
55886545|NCT05713578|Antimitotic Agents|antimitotic agents|mesh-ancestor
55886546|NCT05713578|Mitosis Modulators|mitosis modulators|mesh-ancestor
55886547|NCT05713578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886548|NCT02485548|Fluorouracil|fluorouracil|mesh-list
55886549|NCT02485548|Raltitrexed|raltitrexed|mesh-list
55886550|NCT02485548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886551|NCT02485548|Antimetabolites|antimetabolites|mesh-ancestor
55886552|NCT02485548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886553|NCT02485548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55886554|NCT02485548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886555|NCT02485548|Immunologic Factors|immunologic factors|mesh-ancestor
55886556|NCT02485548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886557|NCT02485548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55886558|NCT02485548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886559|NCT02479074|Prednisolone|prednisolone|mesh-list
55886560|NCT02479074|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55886561|NCT02479074|Methylprednisolone|methylprednisolone|mesh-list
55886562|NCT02479074|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55886563|NCT02479074|Prednisolone acetate|prednisolone acetate|mesh-list
55886564|NCT02479074|Montelukast|montelukast|mesh-list
55886565|NCT02479074|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55886566|NCT02479074|Prednisolone phosphate|prednisolone phosphate|mesh-list
55886567|NCT02479074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886576|NCT02479074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886577|NCT02479074|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55886578|NCT02479074|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55886579|NCT02479074|Protective Agents|protective agents|mesh-ancestor
55886580|NCT02479074|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55886581|NCT02479074|Respiratory System Agents|respiratory system agents|mesh-ancestor
55886582|NCT02479074|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56051189|NCT02367599|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56051190|NCT02368457|Tocopherols|tocopherols|mesh-list
56051191|NCT02368457|Vitamin E|vitamin e|mesh-list
56051192|NCT02368457|Tocotrienols|tocotrienols|mesh-list
56051193|NCT02368457|alpha-Tocopherol|alpha-tocopherol|mesh-list
56051194|NCT02368457|Pentoxifylline|pentoxifylline|mesh-list
56051195|NCT02368457|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56051196|NCT02368457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051197|NCT02368457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051198|NCT02368457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56051199|NCT02368457|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56051200|NCT02368457|Protective Agents|protective agents|mesh-ancestor
56051201|NCT02368457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051202|NCT02368457|Vasodilator Agents|vasodilator agents|mesh-ancestor
56051203|NCT02368457|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56051204|NCT02368457|Antioxidants|antioxidants|mesh-ancestor
56051205|NCT02368457|Vitamins|vitamins|mesh-ancestor
56051206|NCT02368457|Micronutrients|micronutrients|mesh-ancestor
56051207|NCT05503355|Venetoclax|venetoclax|mesh-list
56051208|NCT05503355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051209|NCT03527108|Nivolumab|nivolumab|mesh-list
56051210|NCT03527108|Ramucirumab|ramucirumab|mesh-list
56051211|NCT03527108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56051212|NCT03527108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051213|NCT03527108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56051214|NCT03527108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051215|NCT02371187|Dapagliflozin|dapagliflozin|mesh-list
56051216|NCT02371187|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56051217|NCT02371187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051218|NCT02371187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56051219|NCT02371187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051220|NCT02373137|Ofloxacin|ofloxacin|mesh-list
56051221|NCT02373137|Prednisolone|prednisolone|mesh-list
55886583|NCT02479074|Hormone Antagonists|hormone antagonists|mesh-ancestor
55886584|NCT02479074|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55886585|NCT02479074|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55886586|NCT02479074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886588|NCT02481180|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
55886589|NCT02481180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886590|NCT02481180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55886591|NCT02481180|Immunologic Factors|immunologic factors|mesh-ancestor
55886592|NCT02480946|Methotrexate|methotrexate|mesh-list
56051222|NCT02373137|Phenylephrine|phenylephrine|mesh-list
56051223|NCT02373137|Oxymetazoline|oxymetazoline|mesh-list
56051224|NCT02373137|Tropicamide|tropicamide|mesh-list
56051225|NCT02373137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56051226|NCT02373137|Glucocorticoids|glucocorticoids|mesh-ancestor
56051227|NCT02373137|Hormones|hormones|mesh-ancestor
56051228|NCT02373137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56051229|NCT02373137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886593|NCT02480946|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55886594|NCT02480946|Abortifacient Agents|abortifacient agents|mesh-ancestor
55886595|NCT02480946|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55886596|NCT02480946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886597|NCT02480946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55886598|NCT02480946|Antimetabolites|antimetabolites|mesh-ancestor
55886599|NCT02480946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886600|NCT02480946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886601|NCT02480946|Dermatologic Agents|dermatologic agents|mesh-ancestor
55886602|NCT02480946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886603|NCT02480946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55886604|NCT02480946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886605|NCT02480946|Immunologic Factors|immunologic factors|mesh-ancestor
55886606|NCT02480946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55886607|NCT02480946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55886608|NCT01769170|Cidofovir|cidofovir|mesh-list
55886609|NCT01769170|Brincidofovir|brincidofovir|mesh-list
55886610|NCT01769170|Antiviral Agents|antiviral agents|mesh-ancestor
55886611|NCT01769170|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886612|NCT01769170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886613|NCT01769170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886614|NCT02480634|Zoledronic Acid|zoledronic acid|mesh-list
55886615|NCT02480634|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55886616|NCT02480634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886617|NCT03399292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55886618|NCT03399292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55886619|NCT02726022|Ribavirin|ribavirin|mesh-list
55886620|NCT02726022|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55886621|NCT02726022|Antimetabolites|antimetabolites|mesh-ancestor
55886622|NCT02726022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886623|NCT02726022|Antiviral Agents|antiviral agents|mesh-ancestor
55886624|NCT02726022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827663|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827664|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
55827665|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
55827666|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
55863914|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863915|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55863916|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863917|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
55863918|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55863919|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864007|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864293|NCT01946165|Prednisone|prednisone|mesh-list
55864459|NCT01702987|Vitamins|vitamins|mesh-ancestor
55865427|NCT01935947|Gemcitabine|gemcitabine|mesh-list
55865543|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
55865673|NCT01689649|Topiramate|topiramate|mesh-list
55865794|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866062|NCT01908101|Halichondrin B|halichondrin b|mesh-list
55866427|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
55867018|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867019|NCT03210532|Amlodipine|amlodipine|mesh-list
55868285|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55868995|NCT00929344|Pregabalin|pregabalin|mesh-list
55869290|NCT03685773|Niacin|niacin|mesh-list
55869802|NCT03575403|Dopamine Agents|dopamine agents|mesh-ancestor
55870697|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55871309|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871310|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
55871311|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55871312|NCT03018652|Antibodies|antibodies|mesh-list
55871313|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
55871314|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55871315|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
55871316|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818558|NCT04920695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818559|NCT04920695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818560|NCT04920695|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55818561|NCT04920695|Vasodilator Agents|vasodilator agents|mesh-ancestor
55818562|NCT04920695|Gasotransmitters|gasotransmitters|mesh-ancestor
55818805|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818909|NCT04726618|Xenon|xenon|mesh-list
55819978|NCT01620489|Incretins|incretins|mesh-ancestor
55820852|NCT02310581|Analgesics|analgesics|mesh-ancestor
55820990|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55821269|NCT01782742|Bexarotene|bexarotene|mesh-list
55822428|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55822431|NCT01747447|Vitamin D|vitamin d|mesh-list
55822593|NCT00630565|Etoposide|etoposide|mesh-list
55822868|NCT02254291|Incretins|incretins|mesh-ancestor
55823004|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55824210|NCT04564846|Insulin|insulin|mesh-list
55824722|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55824917|NCT04831736|Analgesics|analgesics|mesh-ancestor
55825068|NCT01363700|Epinastine|epinastine|mesh-list
55825216|NCT04076462|Octreotide|octreotide|mesh-list
55825360|NCT04794842|Phenol|phenol|mesh-list
55825446|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55826590|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826722|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
55826852|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826853|NCT01952145|Incretins|incretins|mesh-ancestor
55826969|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55827124|NCT05544071|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55827270|NCT02230904|Rotigotine|rotigotine|mesh-list
55827358|NCT02141659|Relugolix|relugolix|mesh-list
55827434|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55827439|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828029|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55828150|NCT02696993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55828343|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
55828553|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828676|NCT05168657|Pancrelipase|pancrelipase|mesh-list
55828751|NCT04626791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55828869|NCT01573000|Antibodies|antibodies|mesh-list
55829334|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55829345|NCT01553188|Prednisone|prednisone|mesh-list
55829710|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829878|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55829955|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830207|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
55830440|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830745|NCT01896531|Vitamins|vitamins|mesh-ancestor
55830826|NCT03355469|Metformin|metformin|mesh-list
55830901|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830902|NCT02202161|Incretins|incretins|mesh-ancestor
55830903|NCT02202161|Hormones|hormones|mesh-ancestor
55830904|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830905|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55830906|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
55830907|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830908|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830934|NCT03109847|Metformin|metformin|mesh-list
55830935|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55830936|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830937|NCT01461928|Rituximab|rituximab|mesh-list
55830938|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55830939|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830940|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
55830941|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830942|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55830944|NCT03039413|Trace Elements|trace elements|mesh-ancestor
55830945|NCT03039413|Micronutrients|micronutrients|mesh-ancestor
55830946|NCT03039413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830948|NCT04775381|Vitamins|vitamins|mesh-ancestor
55830949|NCT04775381|Micronutrients|micronutrients|mesh-ancestor
55830952|NCT02623205|Citalopram|citalopram|mesh-list
55831059|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831370|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55831568|NCT02252081|Metformin|metformin|mesh-list
55831658|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55831941|NCT02167139|Adalimumab|adalimumab|mesh-list
55832112|NCT01625845|Protective Agents|protective agents|mesh-ancestor
55832854|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55832942|NCT02178059|Terbutaline|terbutaline|mesh-list
55833226|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833328|NCT02091986|Hormones|hormones|mesh-ancestor
55833419|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833536|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
55835172|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
55835556|NCT01773993|Analgesics|analgesics|mesh-ancestor
55835883|NCT02107703|Fulvestrant|fulvestrant|mesh-list
55836132|NCT01471054|Dexamethasone|dexamethasone|mesh-list
55836621|NCT04069936|Nivolumab|nivolumab|mesh-list
55836695|NCT02003365|FX006|fx006|mesh-list
55836787|NCT01999322|Insulin|insulin|mesh-list
55836879|NCT01953913|Afatinib|afatinib|mesh-list
55837740|NCT01929044|Analgesics|analgesics|mesh-ancestor
55838065|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
55838390|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838493|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838689|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55838690|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55839569|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55840215|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840216|NCT01881230|Gemcitabine|gemcitabine|mesh-list
55840217|NCT01881230|Paclitaxel|paclitaxel|mesh-list
55840218|NCT01881230|Carboplatin|carboplatin|mesh-list
55840219|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55840220|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840226|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
55840262|NCT01614470|Ivacaftor|ivacaftor|mesh-list
55840263|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55840264|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55841013|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
55841181|NCT03970954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842296|NCT03020602|Vitamins|vitamins|mesh-ancestor
55842841|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842989|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55842990|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55843036|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55843038|NCT01566435|Cetuximab|cetuximab|mesh-list
55843039|NCT01566435|Antibodies|antibodies|mesh-list
55843040|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55843041|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55843749|NCT04762810|Hormones|hormones|mesh-ancestor
55844873|NCT01970371|Colistin|colistin|mesh-list
55845389|NCT04691986|Niacin|niacin|mesh-list
55845395|NCT04691986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55845636|NCT04397458|Hormones|hormones|mesh-ancestor
55846071|NCT05245708|Oxytocin|oxytocin|mesh-list
55846187|NCT04106115|Durvalumab|durvalumab|mesh-list
55846809|NCT00984568|Mesalamine|mesalamine|mesh-list
55847298|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55847531|NCT02983084|Copper|copper|mesh-list
55847903|NCT02720068|Antidotes|antidotes|mesh-ancestor
55848616|NCT03822520|Analgesics|analgesics|mesh-ancestor
55848706|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848939|NCT04840342|Amlodipine|amlodipine|mesh-list
55849245|NCT02523976|Methotrexate|methotrexate|mesh-list
55849740|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
55849858|NCT01484691|Budesonide|budesonide|mesh-list
55849950|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55849954|NCT01895764|Adalimumab|adalimumab|mesh-list
55850126|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850321|NCT04755322|Aspirin|aspirin|mesh-list
55850601|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
55851008|NCT04771390|Selitrectinib|selitrectinib|mesh-list
55851097|NCT00060346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851372|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55851944|NCT00029536|Progestins|progestins|mesh-ancestor
55852257|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55852258|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55852259|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
55852260|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55852261|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852262|NCT00050986|Temozolomide|temozolomide|mesh-list
55852263|NCT00050986|Tipifarnib|tipifarnib|mesh-list
55852264|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55852265|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
55886625|NCT02478294|Warfarin|warfarin|mesh-list
55886626|NCT02478294|Anticoagulants|anticoagulants|mesh-list
55886627|NCT01770652|Deferiprone|deferiprone|mesh-list
55886628|NCT01770652|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55886629|NCT01770652|Chelating Agents|chelating agents|mesh-ancestor
55886630|NCT01770652|Sequestering Agents|sequestering agents|mesh-ancestor
55886631|NCT01770652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886632|NCT03316482|Leuprolide|leuprolide|mesh-list
55886652|NCT02485080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886653|NCT02480400|Dexetimide|dexetimide|mesh-list
56051230|NCT02373137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56051231|NCT02373137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051233|NCT02373137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051234|NCT02373137|Protective Agents|protective agents|mesh-ancestor
56051235|NCT02373137|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56051237|NCT02373137|Sympathomimetics|sympathomimetics|mesh-ancestor
56051238|NCT02373137|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56051239|NCT02373137|Nasal Decongestants|nasal decongestants|mesh-ancestor
56051240|NCT02373137|Respiratory System Agents|respiratory system agents|mesh-ancestor
56051241|NCT02373137|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56051242|NCT02373137|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56051243|NCT02373137|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56051244|NCT02373137|Adrenergic Agents|adrenergic agents|mesh-ancestor
56051245|NCT02373137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051246|NCT02373137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886654|NCT02480400|Citalopram|citalopram|mesh-list
55886655|NCT02480400|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55886656|NCT02480400|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55886657|NCT02480400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55886658|NCT02480400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886659|NCT02480400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886660|NCT02480400|Serotonin Agents|serotonin agents|mesh-ancestor
55886661|NCT02480400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886662|NCT02480400|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55886663|NCT02480400|Antidepressive Agents|antidepressive agents|mesh-ancestor
55886664|NCT02480400|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55886665|NCT02480400|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55886666|NCT02480400|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55886667|NCT02480400|Parasympatholytics|parasympatholytics|mesh-ancestor
55886668|NCT02480400|Autonomic Agents|autonomic agents|mesh-ancestor
55886669|NCT02480400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886670|NCT02480400|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55886671|NCT02480400|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55886672|NCT02480400|Cholinergic Agents|cholinergic agents|mesh-ancestor
55886673|NCT02725710|Gabapentin|gabapentin|mesh-list
55886674|NCT02725710|Analgesics|analgesics|mesh-ancestor
55886675|NCT02725710|Sensory System Agents|sensory system agents|mesh-ancestor
55886676|NCT02725710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886677|NCT02725710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886678|NCT02725710|Anticonvulsants|anticonvulsants|mesh-ancestor
55886679|NCT02725710|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55886680|NCT02725710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55886681|NCT02725710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886682|NCT02725710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55886683|NCT02725710|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55886684|NCT02725710|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55886685|NCT02725710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886686|NCT02725710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886687|NCT02725710|Antimanic Agents|antimanic agents|mesh-ancestor
55886688|NCT02256358|Midazolam|midazolam|mesh-list
55886689|NCT02256358|Ketamine|ketamine|mesh-list
55886690|NCT02256358|Analgesics|analgesics|mesh-ancestor
55886691|NCT02256358|Sensory System Agents|sensory system agents|mesh-ancestor
55886692|NCT02256358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886693|NCT02256358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886694|NCT02256358|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55886695|NCT02256358|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56051247|NCT02373137|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56051248|NCT02373137|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56051249|NCT02373137|Cholinergic Agents|cholinergic agents|mesh-ancestor
56051250|NCT02373137|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56051251|NCT02373137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051252|NCT02373137|Renal Agents|renal agents|mesh-ancestor
56051253|NCT02373137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56051254|NCT02373137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56051255|NCT02373137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56051256|NCT02373137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886696|NCT02256358|Anesthetics, General|anesthetics, general|mesh-ancestor
55886697|NCT02256358|Anesthetics|anesthetics|mesh-ancestor
55886698|NCT02256358|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886699|NCT02256358|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55886700|NCT02256358|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55886712|NCT01825408|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55886713|NCT01825408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55886714|NCT01825408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886715|NCT01825408|Antimalarials|antimalarials|mesh-ancestor
55886716|NCT01825408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55886717|NCT01825408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55886718|NCT01825408|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55886719|NCT01825408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886720|NCT01825408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886721|NCT04945824|Dexamethasone|dexamethasone|mesh-list
55886722|NCT04945824|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886723|NCT04945824|Antiemetics|antiemetics|mesh-ancestor
55886724|NCT04945824|Autonomic Agents|autonomic agents|mesh-ancestor
55886725|NCT04945824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886726|NCT04945824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886727|NCT04945824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55886728|NCT04945824|Glucocorticoids|glucocorticoids|mesh-ancestor
55886730|NCT04945824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886731|NCT04945824|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886732|NCT04945824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886733|NCT04937634|Melphalan|melphalan|mesh-list
55886734|NCT04937634|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55886735|NCT04937634|Alkylating Agents|alkylating agents|mesh-ancestor
55886736|NCT04937634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886737|NCT04937634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886738|NCT04937634|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55886739|NCT04937634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886740|NCT04937634|Immunologic Factors|immunologic factors|mesh-ancestor
55886741|NCT04937634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886742|NCT05686044|Phenserine|phenserine|mesh-list
55886743|NCT05686044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55886744|NCT05686044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886745|NCT05686044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886746|NCT05686044|Cholinergic Agents|cholinergic agents|mesh-ancestor
55886747|NCT05686044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886748|NCT05686044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886749|NCT02262130|Omalizumab|omalizumab|mesh-list
55886750|NCT02262130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55886751|NCT02262130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55886752|NCT02262130|Respiratory System Agents|respiratory system agents|mesh-ancestor
55886753|NCT04913610|Ivermectin|ivermectin|mesh-list
56051257|NCT02373137|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56051258|NCT02373137|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56051259|NCT05488067|Atorvastatin|atorvastatin|mesh-list
56051260|NCT05488067|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55886754|NCT04913610|Albendazole|albendazole|mesh-list
55886755|NCT04913610|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55886756|NCT04913610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886757|NCT04913610|Anthelmintics|anthelmintics|mesh-ancestor
55886758|NCT04913610|Anticestodal Agents|anticestodal agents|mesh-ancestor
55886759|NCT04913610|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55886760|NCT04913610|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55886761|NCT04913610|Tubulin Modulators|tubulin modulators|mesh-ancestor
55886762|NCT04913610|Antimitotic Agents|antimitotic agents|mesh-ancestor
55886763|NCT04913610|Mitosis Modulators|mitosis modulators|mesh-ancestor
55886764|NCT04913610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886765|NCT04913610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886766|NCT04887870|Pembrolizumab|pembrolizumab|mesh-list
55886767|NCT04887870|Nivolumab|nivolumab|mesh-list
55886768|NCT04887870|Ipilimumab|ipilimumab|mesh-list
55886769|NCT04887870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55886770|NCT04887870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886771|NCT04887870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55886772|NCT04887870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886773|NCT01827358|Calcium, Dietary|calcium, dietary|mesh-list
55886774|NCT01827358|Mupirocin|mupirocin|mesh-list
55886775|NCT01827358|Calcium|calcium|mesh-list
55886776|NCT01827358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55886777|NCT01827358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886778|NCT01827358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55886789|NCT01780324|Sensory System Agents|sensory system agents|mesh-ancestor
55886790|NCT01780324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886791|NCT01780324|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55886792|NCT01780324|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55886795|NCT01780324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886796|NCT02472600|Colistin|colistin|mesh-list
55886797|NCT02472600|Polymyxins|polymyxins|mesh-list
55886798|NCT02472600|Neomycin|neomycin|mesh-list
55886799|NCT02472600|Omeprazole|omeprazole|mesh-list
55886800|NCT02472600|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55886801|NCT02472600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55886802|NCT02472600|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55886803|NCT02472600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886804|NCT02472600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886805|NCT02472600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55886806|NCT02472600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886807|NCT02472600|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55886808|NCT04858776|Dexamethasone|dexamethasone|mesh-list
55886809|NCT04858776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886812|NCT04858776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752684|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
55886813|NCT04858776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886814|NCT04858776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55886815|NCT04858776|Glucocorticoids|glucocorticoids|mesh-ancestor
55886816|NCT04858776|Hormones|hormones|mesh-ancestor
55886817|NCT04858776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886818|NCT04858776|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886819|NCT04858776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886820|NCT01781806|Tenofovir|tenofovir|mesh-list
55886821|NCT01781806|Emtricitabine|emtricitabine|mesh-list
55886822|NCT01781806|Antiviral Agents|antiviral agents|mesh-ancestor
55886823|NCT01781806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886824|NCT01781806|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55886825|NCT01781806|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55886826|NCT01781806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886827|NCT01781806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886828|NCT01781806|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56051261|NCT05488067|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56051262|NCT05488067|Antimetabolites|antimetabolites|mesh-ancestor
56051263|NCT05488067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051264|NCT05488067|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55886829|NCT01781806|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55886831|NCT02477514|Tedizolid phosphate|tedizolid phosphate|mesh-list
55886832|NCT02477514|Midazolam|midazolam|mesh-list
55886833|NCT02477514|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55886834|NCT02477514|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55886835|NCT02477514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55886836|NCT02477514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886837|NCT02477514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886838|NCT02477514|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55886839|NCT02477514|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55886840|NCT02477514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55886841|NCT02477514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55886842|NCT02477514|Anesthetics, General|anesthetics, general|mesh-ancestor
55886852|NCT02477514|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55886853|NCT02477514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886854|NCT02477514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55886855|NCT02477514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886856|NCT01746238|Bevacizumab|bevacizumab|mesh-list
55886857|NCT01746238|Doxorubicin|doxorubicin|mesh-list
55886858|NCT01746238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55886859|NCT01746238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886860|NCT01746238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55886861|NCT01746238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55886862|NCT01746238|Growth Substances|growth substances|mesh-ancestor
55886863|NCT01746238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886864|NCT01746238|Growth Inhibitors|growth inhibitors|mesh-ancestor
55886865|NCT01746238|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55886866|NCT01746238|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55886867|NCT01746238|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55886868|NCT01746238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886869|NCT01746238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886870|NCT02472054|Cyclosporine|cyclosporine|mesh-list
55886871|NCT02472054|Prednisolone|prednisolone|mesh-list
55886872|NCT02472054|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55886873|NCT02472054|Methylprednisolone|methylprednisolone|mesh-list
55886874|NCT02472054|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55886875|NCT02472054|Prednisolone acetate|prednisolone acetate|mesh-list
55886876|NCT02472054|Alemtuzumab|alemtuzumab|mesh-list
55886877|NCT02472054|Cyclosporins|cyclosporins|mesh-list
55886881|NCT02472054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886882|NCT02472054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886883|NCT02472054|Immunologic Factors|immunologic factors|mesh-ancestor
55752688|NCT03075657|Haloperidol|haloperidol|mesh-list
55886884|NCT02472054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886885|NCT02472054|Antifungal Agents|antifungal agents|mesh-ancestor
55886886|NCT02472054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886887|NCT02472054|Dermatologic Agents|dermatologic agents|mesh-ancestor
55886888|NCT02472054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55886889|NCT02472054|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55886890|NCT02472054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886892|NCT02472054|Hormones|hormones|mesh-ancestor
55886893|NCT02472054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886894|NCT02472054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886895|NCT02472054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886896|NCT02472054|Antiemetics|antiemetics|mesh-ancestor
55886897|NCT02472054|Autonomic Agents|autonomic agents|mesh-ancestor
55886898|NCT02472054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886899|NCT02472054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55886900|NCT02472054|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55886901|NCT02472054|Protective Agents|protective agents|mesh-ancestor
55886902|NCT02472054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55886903|NCT01782898|Esmolol|esmolol|mesh-list
56051265|NCT05488067|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55886904|NCT01782898|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55886905|NCT01782898|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55886906|NCT01782898|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55886914|NCT02475876|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55886916|NCT02475876|Sulfamethoxazole|sulfamethoxazole|mesh-list
55886917|NCT02475876|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55886918|NCT02475876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886919|NCT02475876|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55886920|NCT02475876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886921|NCT02475876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886922|NCT02475876|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55886923|NCT02475876|Renal Agents|renal agents|mesh-ancestor
55886924|NCT02475876|Antimalarials|antimalarials|mesh-ancestor
55886925|NCT02475876|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55886926|NCT02475876|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55886927|NCT02475876|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55886928|NCT02475876|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55886929|NCT02475876|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55886930|NCT02475876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55886931|NCT02472210|Botulinum Toxins|botulinum toxins|mesh-list
55886932|NCT02472210|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55886933|NCT02472210|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55886934|NCT02472210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886935|NCT02472210|Cholinergic Agents|cholinergic agents|mesh-ancestor
55886936|NCT02472210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886937|NCT02472210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886938|NCT01783054|Gemcitabine|gemcitabine|mesh-list
55886939|NCT01783054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55886941|NCT01783054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886942|NCT01783054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886944|NCT01783054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886945|NCT01783054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886946|NCT01783054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886947|NCT01783054|Immunologic Factors|immunologic factors|mesh-ancestor
55886948|NCT01783054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886949|NCT05397600|Bimatoprost|bimatoprost|mesh-list
55886950|NCT05397600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55886951|NCT02725008|Dexamethasone|dexamethasone|mesh-list
55886952|NCT02725008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886953|NCT02725008|Antiemetics|antiemetics|mesh-ancestor
55886954|NCT02725008|Autonomic Agents|autonomic agents|mesh-ancestor
55886955|NCT02725008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886956|NCT02725008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886957|NCT02725008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55886958|NCT02725008|Glucocorticoids|glucocorticoids|mesh-ancestor
55886959|NCT02725008|Hormones|hormones|mesh-ancestor
55886960|NCT02725008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886961|NCT02725008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886962|NCT02725008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886969|NCT02477436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886970|NCT02471820|Dexamethasone|dexamethasone|mesh-list
55886971|NCT02471820|Dexamethasone acetate|dexamethasone acetate|mesh-list
55886972|NCT02471820|Lenalidomide|lenalidomide|mesh-list
55886983|NCT02471820|Hormones|hormones|mesh-ancestor
55886984|NCT02471820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886985|NCT02471820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886986|NCT02471820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886987|NCT02471820|Protease Inhibitors|protease inhibitors|mesh-ancestor
55886988|NCT02471820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886989|NCT02471820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886990|NCT02471820|Immunologic Factors|immunologic factors|mesh-ancestor
56051266|NCT05488067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051267|NCT02373371|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56051268|NCT02373371|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56051269|NCT02373371|Dermatologic Agents|dermatologic agents|mesh-ancestor
56051270|NCT00354653|Lamivudine|lamivudine|mesh-list
55886991|NCT02471820|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55886992|NCT02471820|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55886993|NCT02471820|Growth Substances|growth substances|mesh-ancestor
55886994|NCT02471820|Growth Inhibitors|growth inhibitors|mesh-ancestor
55886995|NCT02471820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55886996|NCT02471820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55886997|NCT02471820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55886998|NCT02477280|Methylphenidate|methylphenidate|mesh-list
55886999|NCT02477280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55887000|NCT02477280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887001|NCT02477280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55887002|NCT02477280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55887003|NCT02477280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887004|NCT02477280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887005|NCT02477280|Dopamine Agents|dopamine agents|mesh-ancestor
55887006|NCT02477280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887007|NCT01833130|Botulinum Toxins|botulinum toxins|mesh-list
55887008|NCT01833130|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55887009|NCT01833130|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55887010|NCT01833130|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55887011|NCT01833130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887012|NCT01833130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887013|NCT01833130|Cholinergic Agents|cholinergic agents|mesh-ancestor
55887014|NCT01833130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887015|NCT01833130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887016|NCT01833130|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55887017|NCT01833130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887018|NCT01783912|Nicotine|nicotine|mesh-list
55887019|NCT01783912|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55887020|NCT01783912|Autonomic Agents|autonomic agents|mesh-ancestor
55887021|NCT01783912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887022|NCT01783912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887023|NCT01783912|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55887024|NCT01783912|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55887025|NCT01783912|Cholinergic Agents|cholinergic agents|mesh-ancestor
55887026|NCT01783912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887027|NCT01783912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887028|NCT05583708|Pembrolizumab|pembrolizumab|mesh-list
55887029|NCT05583708|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55887030|NCT05583708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55887031|NCT05583708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887032|NCT05583708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55887033|NCT05583708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887034|NCT01783990|Hydroxyurea|hydroxyurea|mesh-list
55887035|NCT01783990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887036|NCT01783990|Antisickling Agents|antisickling agents|mesh-ancestor
55887046|NCT05363436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887047|NCT05363436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887049|NCT05363436|Sensory System Agents|sensory system agents|mesh-ancestor
55887050|NCT05363436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887051|NCT03582774|Edetic Acid|edetic acid|mesh-list
55887052|NCT03582774|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55887053|NCT03582774|Chelating Agents|chelating agents|mesh-ancestor
55887054|NCT03582774|Sequestering Agents|sequestering agents|mesh-ancestor
55887055|NCT03582774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887056|NCT03582774|Anticoagulants|anticoagulants|mesh-ancestor
55887067|NCT02471274|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
55887068|NCT02471274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55887069|NCT02471274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887070|NCT02471274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55887071|NCT02471274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887072|NCT04491786|Gabapentin|gabapentin|mesh-list
55887073|NCT04491786|Nefopam|nefopam|mesh-list
55887074|NCT04491786|Analgesics|analgesics|mesh-ancestor
55887075|NCT04491786|Sensory System Agents|sensory system agents|mesh-ancestor
55887076|NCT04491786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887077|NCT04491786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887078|NCT04491786|Anticonvulsants|anticonvulsants|mesh-ancestor
55887079|NCT04491786|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55887080|NCT04491786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55887081|NCT04491786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887082|NCT04491786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55887083|NCT04491786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55887084|NCT04491786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55887085|NCT04491786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887086|NCT04491786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887087|NCT04491786|Antimanic Agents|antimanic agents|mesh-ancestor
55887088|NCT04491786|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55887089|NCT01786252|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55887090|NCT01786252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55887091|NCT01786252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887093|NCT02470026|Mydriatics|mydriatics|mesh-ancestor
55887094|NCT02470026|Autonomic Agents|autonomic agents|mesh-ancestor
55887095|NCT02470026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887096|NCT02470026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887097|NCT02470026|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55887098|NCT02470026|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55887099|NCT02470026|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55887100|NCT02470026|Adrenergic Agents|adrenergic agents|mesh-ancestor
55887101|NCT02470026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887114|NCT02989558|Analgesics|analgesics|mesh-ancestor
55887115|NCT02989558|Sensory System Agents|sensory system agents|mesh-ancestor
55887116|NCT02989558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887117|NCT02989558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887118|NCT02989558|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55887119|NCT02989558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55887120|NCT02989558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55887121|NCT02989558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55887122|NCT02989558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887123|NCT02989558|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55887124|NCT02989558|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55887125|NCT02989558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887126|NCT02989558|Antipyretics|antipyretics|mesh-ancestor
55887127|NCT02989558|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55887128|NCT02989558|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55887129|NCT02989558|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56051280|NCT00354731|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56051281|NCT00354731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051282|NCT00354731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051283|NCT00354731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56051284|NCT00354731|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56051285|NCT00354731|Protective Agents|protective agents|mesh-ancestor
56051286|NCT00354731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051287|NCT00354731|Vasodilator Agents|vasodilator agents|mesh-ancestor
56051288|NCT00354731|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56051289|NCT00354731|Antioxidants|antioxidants|mesh-ancestor
56051290|NCT00354809|Casopitant|casopitant|mesh-list
56051291|NCT00354809|Antiemetics|antiemetics|mesh-ancestor
56051292|NCT00354809|Autonomic Agents|autonomic agents|mesh-ancestor
56051293|NCT00354809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051294|NCT00354809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051295|NCT00354809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56051296|NCT00354809|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56051297|NCT00354809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051298|NCT00354809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051299|NCT04769258|Vaccines|vaccines|mesh-list
55778499|NCT02683525|Hormones|hormones|mesh-ancestor
56051300|NCT04769258|Immunologic Factors|immunologic factors|mesh-ancestor
55887143|NCT01806779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887144|NCT01806779|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55887145|NCT01806779|Antidepressive Agents|antidepressive agents|mesh-ancestor
55887146|NCT01806779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55887147|NCT01806779|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55887148|NCT01806779|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55887149|NCT01806779|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887150|NCT01806779|Dopamine Agents|dopamine agents|mesh-ancestor
55887151|NCT01806779|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55887152|NCT01806779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56051304|NCT01762904|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56051305|NCT01762904|Triclosan|triclosan|mesh-list
56051306|NCT01762904|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
56051307|NCT01762904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051308|NCT01762904|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051309|NCT01762904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051310|NCT01762904|Disinfectants|disinfectants|mesh-ancestor
56051311|NCT01762904|Dermatologic Agents|dermatologic agents|mesh-ancestor
56051312|NCT01762904|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55887153|NCT01806779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887154|NCT01878526|Domperidone|domperidone|mesh-list
55887155|NCT01878526|Antiemetics|antiemetics|mesh-ancestor
55887156|NCT01878526|Autonomic Agents|autonomic agents|mesh-ancestor
55887157|NCT01878526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887158|NCT01878526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887159|NCT01878526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55887160|NCT01878526|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55887161|NCT01878526|Dopamine Agents|dopamine agents|mesh-ancestor
55887162|NCT01878526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887163|NCT01878526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887164|NCT01878604|Hypolipidemic Agents|hypolipidemic agents|mesh-list
55887178|NCT01806623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887180|NCT01806623|Hormone Antagonists|hormone antagonists|mesh-ancestor
55887181|NCT01806623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887182|NCT01806623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887183|NCT01806623|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55887184|NCT01806623|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55887185|NCT01806545|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55887186|NCT01806545|Hemostatics|hemostatics|mesh-ancestor
55887187|NCT01806545|Coagulants|coagulants|mesh-ancestor
55887188|NCT01847014|Macitentan|macitentan|mesh-list
55887189|NCT01847014|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55887190|NCT01847014|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55887191|NCT01847014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887192|NCT01847014|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55887193|NCT01847638|Nepafenac|nepafenac|mesh-list
55887194|NCT01847638|Bromfenac|bromfenac|mesh-list
55887195|NCT01847638|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55887196|NCT01847638|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55887197|NCT01847638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55887198|NCT01847638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55887199|NCT01847638|Analgesics|analgesics|mesh-ancestor
55887200|NCT01847638|Sensory System Agents|sensory system agents|mesh-ancestor
55887201|NCT01847638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887202|NCT01847638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887203|NCT01847638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55887204|NCT01847638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55887205|NCT05329090|Rituximab|rituximab|mesh-list
55887206|NCT05329090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55887207|NCT05329090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887208|NCT05329090|Immunologic Factors|immunologic factors|mesh-ancestor
55887209|NCT05329090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887210|NCT05329090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55887211|NCT02474628|Calcium Carbonate|calcium carbonate|mesh-list
55887212|NCT02474628|Calcium|calcium|mesh-list
55887213|NCT02474628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55887214|NCT02474628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887215|NCT02474628|Antacids|antacids|mesh-ancestor
55887216|NCT02474628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887217|NCT02474628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55887218|NCT05211570|Azacitidine|azacitidine|mesh-list
55887219|NCT05211570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55887220|NCT05211570|Antimetabolites|antimetabolites|mesh-ancestor
55887221|NCT05211570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051313|NCT01762904|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56051314|NCT01762904|Antimetabolites|antimetabolites|mesh-ancestor
56051315|NCT01762904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051316|NCT01762904|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56051317|NCT02376257|Cycloserine|cycloserine|mesh-list
56051318|NCT02376257|Modafinil|modafinil|mesh-list
56051319|NCT02376257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56051320|NCT02376257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051321|NCT02376257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56051322|NCT02376257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56051323|NCT02376257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56051324|NCT02376257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051325|NCT02376257|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55887222|NCT05211570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887223|NCT05211570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887226|NCT03099564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887227|NCT02469948|Botulinum Toxins|botulinum toxins|mesh-list
55887228|NCT02469948|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55887229|NCT02469948|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55887230|NCT02469948|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55887231|NCT02469948|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887232|NCT02469948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887233|NCT02469948|Cholinergic Agents|cholinergic agents|mesh-ancestor
55887234|NCT02469948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887235|NCT02469948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887236|NCT02469948|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55887237|NCT02469948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887238|NCT05328310|Nebivolol|nebivolol|mesh-list
55887239|NCT05328310|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55887240|NCT05328310|Vasodilator Agents|vasodilator agents|mesh-ancestor
55887241|NCT05328310|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55887242|NCT05328310|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55887243|NCT05328310|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55887244|NCT05328310|Adrenergic Agents|adrenergic agents|mesh-ancestor
55887245|NCT05328310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887246|NCT05328310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887247|NCT05328310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887248|NCT01797484|Ranolazine|ranolazine|mesh-list
55887249|NCT01797484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55887250|NCT01797484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887251|NCT01797484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887252|NCT01798264|Exenatide|exenatide|mesh-list
55887253|NCT01798264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55887254|NCT01798264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887255|NCT01798264|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55887256|NCT01798264|Incretins|incretins|mesh-ancestor
55887257|NCT01798264|Hormones|hormones|mesh-ancestor
55887258|NCT01798264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887259|NCT05326984|Metformin|metformin|mesh-list
55887260|NCT05326984|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55887261|NCT05326984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887263|NCT01800838|Silicon phthalocyanine|silicon phthalocyanine|mesh-list
55887264|NCT01800838|Trace Elements|trace elements|mesh-ancestor
55887265|NCT01800838|Micronutrients|micronutrients|mesh-ancestor
55887266|NCT01800838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887267|NCT01800838|Antimalarials|antimalarials|mesh-ancestor
55887268|NCT01800838|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55887269|NCT01800838|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55887270|NCT01800838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051326|NCT02376257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051328|NCT02376257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56051329|NCT02376257|Antitubercular Agents|antitubercular agents|mesh-ancestor
56051330|NCT02376257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56051331|NCT02376257|Antimetabolites|antimetabolites|mesh-ancestor
56051332|NCT01762982|Benzalkonium Compounds|benzalkonium compounds|mesh-list
56051333|NCT01762982|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56051334|NCT01762982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051335|NCT03211286|Tranexamic Acid|tranexamic acid|mesh-list
56051336|NCT03211286|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56051337|NCT03211286|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56051338|NCT03211286|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55887271|NCT01800838|Antiviral Agents|antiviral agents|mesh-ancestor
55887272|NCT01800838|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55887294|NCT01781975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887297|NCT01855360|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55887298|NCT01855360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887299|NCT01855360|Antimalarials|antimalarials|mesh-ancestor
55887300|NCT01855360|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55887301|NCT01855360|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55887302|NCT01855360|Antiviral Agents|antiviral agents|mesh-ancestor
55752768|NCT03223519|Ibuprofen|ibuprofen|mesh-list
55887303|NCT01855360|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55887304|NCT01855360|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55887305|NCT04351126|Fludrocortisone|fludrocortisone|mesh-list
55887306|NCT04351126|Bromocriptine|bromocriptine|mesh-list
55887307|NCT04351126|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55887308|NCT04351126|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55887309|NCT04351126|Hormone Antagonists|hormone antagonists|mesh-ancestor
55887310|NCT04351126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887311|NCT04351126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887312|NCT04351126|Dopamine Agonists|dopamine agonists|mesh-ancestor
55887313|NCT04351126|Dopamine Agents|dopamine agents|mesh-ancestor
55887314|NCT04351126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887315|NCT04351126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887316|NCT04351126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56051339|NCT03211286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051340|NCT03211286|Hemostatics|hemostatics|mesh-ancestor
56051341|NCT03211286|Coagulants|coagulants|mesh-ancestor
56051342|NCT01763606|Aspirin|aspirin|mesh-list
56051343|NCT01763606|Enoxaparin|enoxaparin|mesh-list
56051344|NCT01763606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56051345|NCT01763606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56051346|NCT01763606|Analgesics|analgesics|mesh-ancestor
55887317|NCT01804673|Fentanyl|fentanyl|mesh-list
55887318|NCT01804673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55887319|NCT01804673|Narcotics|narcotics|mesh-ancestor
55887320|NCT01804673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887321|NCT01804673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887322|NCT01804673|Analgesics|analgesics|mesh-ancestor
55887323|NCT01804673|Sensory System Agents|sensory system agents|mesh-ancestor
55887324|NCT01804673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887325|NCT01804673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55887326|NCT01804673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55887327|NCT01804673|Anesthetics, General|anesthetics, general|mesh-ancestor
55887328|NCT01804673|Anesthetics|anesthetics|mesh-ancestor
55887329|NCT01856530|Oxytocin|oxytocin|mesh-list
55887330|NCT01856530|Oxytocics|oxytocics|mesh-ancestor
55887331|NCT01856530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55887332|NCT01856530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887333|NCT05302336|Cyclophosphamide|cyclophosphamide|mesh-list
55887334|NCT05302336|Docetaxel|docetaxel|mesh-list
55887335|NCT05302336|Doxorubicin|doxorubicin|mesh-list
55887336|NCT05302336|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55887337|NCT05302336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55887338|NCT05302336|Immunologic Factors|immunologic factors|mesh-ancestor
55887339|NCT05302336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887340|NCT05302336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55887341|NCT05302336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55887342|NCT05302336|Alkylating Agents|alkylating agents|mesh-ancestor
55887343|NCT05302336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887344|NCT05302336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887345|NCT05302336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55887346|NCT05302336|Tubulin Modulators|tubulin modulators|mesh-ancestor
55887347|NCT05302336|Antimitotic Agents|antimitotic agents|mesh-ancestor
55887348|NCT05302336|Mitosis Modulators|mitosis modulators|mesh-ancestor
55887349|NCT05302336|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55887350|NCT05302336|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55887351|NCT05302336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55887352|NCT05302336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887353|NCT01804036|Zolpidem|zolpidem|mesh-list
55887354|NCT01804036|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55887355|NCT01804036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55887356|NCT01804036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887357|NCT01804036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887358|NCT01804036|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55887359|NCT01804036|GABA Agonists|gaba agonists|mesh-ancestor
55887360|NCT01804036|GABA Agents|gaba agents|mesh-ancestor
55887361|NCT01804036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887362|NCT01804036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887363|NCT01857232|Dexamethasone|dexamethasone|mesh-list
55887375|NCT01857232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887376|NCT01857232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56051347|NCT01763606|Sensory System Agents|sensory system agents|mesh-ancestor
56051348|NCT01763606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051349|NCT01763606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051350|NCT01763606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56051351|NCT01763606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56051352|NCT01763606|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56051353|NCT01763606|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56051354|NCT01763606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051355|NCT01763606|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56051360|NCT05309564|Botulinum Toxins|botulinum toxins|mesh-list
56051361|NCT05309564|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56051362|NCT05309564|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56051363|NCT05309564|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56051364|NCT05309564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56051365|NCT05309564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051366|NCT05309564|Cholinergic Agents|cholinergic agents|mesh-ancestor
55887377|NCT01857232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887378|NCT01857232|Antipruritics|antipruritics|mesh-ancestor
55887379|NCT01857232|Dermatologic Agents|dermatologic agents|mesh-ancestor
55887380|NCT01857232|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55887381|NCT01857232|Serotonin Agents|serotonin agents|mesh-ancestor
55887382|NCT01857232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887383|NCT01857232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887384|NCT01857232|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55887385|NCT01857232|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55887386|NCT01857232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887387|NCT01857232|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55887388|NCT01857232|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55887389|NCT01857232|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55887390|NCT01766128|Zonisamide|zonisamide|mesh-list
55887391|NCT01766128|Anticonvulsants|anticonvulsants|mesh-ancestor
55887392|NCT01766128|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55887393|NCT01766128|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887394|NCT01766128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887395|NCT01766128|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55887396|NCT01766128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887397|NCT02859558|Tenofovir|tenofovir|mesh-list
55887398|NCT02859558|Emtricitabine|emtricitabine|mesh-list
55887399|NCT02859558|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55887400|NCT02859558|Cobicistat|cobicistat|mesh-list
55887401|NCT02859558|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
55887402|NCT02859558|Elvitegravir|elvitegravir|mesh-list
55887403|NCT02859558|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55887404|NCT02859558|Antiviral Agents|antiviral agents|mesh-ancestor
55887405|NCT02859558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887406|NCT02859558|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55887407|NCT02859558|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55887408|NCT02859558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051368|NCT05309564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051369|NCT05309564|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56051370|NCT05309564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051371|NCT03161756|Denosumab|denosumab|mesh-list
56051372|NCT03161756|Nivolumab|nivolumab|mesh-list
56051373|NCT03161756|Ipilimumab|ipilimumab|mesh-list
56051374|NCT03161756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56051375|NCT03161756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051376|NCT03161756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56051377|NCT03161756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887409|NCT02859558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887410|NCT02859558|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55887411|NCT02859558|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55887412|NCT02859558|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55887413|NCT02859558|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55887430|NCT01860586|Bevacizumab|bevacizumab|mesh-list
55887431|NCT01860586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55887432|NCT01860586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887433|NCT01860586|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55887434|NCT01860586|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55887435|NCT01860586|Growth Substances|growth substances|mesh-ancestor
55887436|NCT01860586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887441|NCT00705432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887442|NCT00705432|Antiviral Agents|antiviral agents|mesh-ancestor
55887452|NCT00704964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887453|NCT00704808|Temozolomide|temozolomide|mesh-list
55887454|NCT00704808|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55887455|NCT00704808|Alkylating Agents|alkylating agents|mesh-ancestor
55887456|NCT00704808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887457|NCT00704808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887458|NCT05305794|Insulin|insulin|mesh-list
55752804|NCT02485613|Dexamethasone|dexamethasone|mesh-list
55887459|NCT05305794|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55887460|NCT05305794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55887461|NCT05305794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887462|NCT02474316|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55887463|NCT02474316|Antiviral Agents|antiviral agents|mesh-ancestor
55887464|NCT02474316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887465|NCT01862536|Tadalafil|tadalafil|mesh-list
55887466|NCT01862536|Vasodilator Agents|vasodilator agents|mesh-ancestor
55887467|NCT01862536|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55887468|NCT01862536|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55887469|NCT01862536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887470|NCT01862536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051378|NCT03161756|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56051379|NCT03161756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051380|NCT01766024|Interferons|interferons|mesh-list
56051381|NCT01766024|Interferon-beta|interferon-beta|mesh-list
56051382|NCT01766024|Interferon beta-1a|interferon beta-1a|mesh-list
56051383|NCT01766024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051384|NCT01766024|Antiviral Agents|antiviral agents|mesh-ancestor
56051385|NCT01766024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051386|NCT01766024|Immunologic Factors|immunologic factors|mesh-ancestor
56051387|NCT01766024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051388|NCT01766024|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56051389|NCT01767506|Azithromycin|azithromycin|mesh-list
56051390|NCT01767506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56051391|NCT01767506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051393|NCT02383043|Amphetamine|amphetamine|mesh-list
56051394|NCT02383043|Dextroamphetamine|dextroamphetamine|mesh-list
56051395|NCT02383043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56051396|NCT02383043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051397|NCT02383043|Sympathomimetics|sympathomimetics|mesh-ancestor
56051398|NCT02383043|Autonomic Agents|autonomic agents|mesh-ancestor
56051399|NCT02383043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051400|NCT02383043|Dopamine Agents|dopamine agents|mesh-ancestor
56051401|NCT02383043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887471|NCT01862536|Urological Agents|urological agents|mesh-ancestor
55887473|NCT01862614|Racepinephrine|racepinephrine|mesh-list
55887474|NCT01862614|Carticaine|carticaine|mesh-list
55887475|NCT01862614|Epinephryl borate|epinephryl borate|mesh-list
55887476|NCT01862614|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55887477|NCT01862614|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55887478|NCT01862614|Adrenergic Agents|adrenergic agents|mesh-ancestor
55887479|NCT01862614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887480|NCT01862614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887481|NCT01862614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887482|NCT01862614|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55887483|NCT01862614|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55887484|NCT01862614|Autonomic Agents|autonomic agents|mesh-ancestor
55887485|NCT01862614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887486|NCT01862614|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55887487|NCT01862614|Respiratory System Agents|respiratory system agents|mesh-ancestor
55887488|NCT01862614|Mydriatics|mydriatics|mesh-ancestor
55887489|NCT01862614|Sympathomimetics|sympathomimetics|mesh-ancestor
55887490|NCT01862614|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55887491|NCT01862614|Anesthetics, Local|anesthetics, local|mesh-ancestor
55887492|NCT01862614|Anesthetics|anesthetics|mesh-ancestor
55887493|NCT01862614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887494|NCT01862614|Sensory System Agents|sensory system agents|mesh-ancestor
55887496|NCT05166876|Dipyridamole|dipyridamole|mesh-list
55887497|NCT05166876|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55887498|NCT05166876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887499|NCT05166876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051402|NCT02383043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051403|NCT02383043|Adrenergic Agents|adrenergic agents|mesh-ancestor
56051404|NCT02383043|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55893970|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
56051414|NCT01768520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56051415|NCT01768520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56051416|NCT01768520|Analgesics|analgesics|mesh-ancestor
55887500|NCT05166876|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55887501|NCT05166876|Vasodilator Agents|vasodilator agents|mesh-ancestor
55887502|NCT05166876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887503|NCT05166876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55887504|NCT05166876|Immunologic Factors|immunologic factors|mesh-ancestor
55887505|NCT05166876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887506|NCT02470650|Ritonavir|ritonavir|mesh-list
55887507|NCT02470650|Darunavir|darunavir|mesh-list
55887508|NCT02470650|Tenofovir|tenofovir|mesh-list
55887509|NCT02470650|Lamivudine|lamivudine|mesh-list
55887510|NCT02470650|Emtricitabine|emtricitabine|mesh-list
55887515|NCT02470650|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55887516|NCT02470650|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55887517|NCT02470650|Protease Inhibitors|protease inhibitors|mesh-ancestor
55887518|NCT02470650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887519|NCT02470650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887520|NCT02470650|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55887521|NCT02470650|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55887522|NCT02470650|Antiviral Agents|antiviral agents|mesh-ancestor
55887523|NCT02470650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887524|NCT02470650|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55887525|NCT02470650|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55887526|NCT02470650|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55887527|NCT02470650|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55887528|NCT02470650|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55887529|NCT01866592|Adalimumab|adalimumab|mesh-list
55887530|NCT01866592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55887531|NCT01866592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55887533|NCT01375608|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55887535|NCT01375608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887536|NCT01375608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887537|NCT01375608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887538|NCT01868776|Lidocaine|lidocaine|mesh-list
55887539|NCT01868776|Anesthetics, Local|anesthetics, local|mesh-ancestor
55887540|NCT01868776|Anesthetics|anesthetics|mesh-ancestor
55887541|NCT01868776|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887542|NCT01868776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887543|NCT01868776|Sensory System Agents|sensory system agents|mesh-ancestor
55887544|NCT01868776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887545|NCT01868776|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55887546|NCT01868776|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56051417|NCT01768520|Sensory System Agents|sensory system agents|mesh-ancestor
56051418|NCT01768520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051419|NCT01768520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051420|NCT01768520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56051421|NCT01768520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55887547|NCT01868776|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55887548|NCT01868776|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887549|NCT01868776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887550|NCT00704418|Bromfenac|bromfenac|mesh-list
55887551|NCT00704418|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55887552|NCT00704418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55887553|NCT00704418|Analgesics|analgesics|mesh-ancestor
55887554|NCT00704418|Sensory System Agents|sensory system agents|mesh-ancestor
55887555|NCT00704418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887556|NCT00704418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887557|NCT00704418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55887558|NCT00704418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55887559|NCT01869634|Ritonavir|ritonavir|mesh-list
55887560|NCT01869634|Darunavir|darunavir|mesh-list
55887561|NCT01869634|Emtricitabine|emtricitabine|mesh-list
55887562|NCT01869634|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55887563|NCT01869634|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55887564|NCT01869634|Protease Inhibitors|protease inhibitors|mesh-ancestor
55887565|NCT01869634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887566|NCT01869634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887567|NCT01869634|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55887568|NCT01869634|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55887569|NCT01869634|Antiviral Agents|antiviral agents|mesh-ancestor
55887570|NCT01869634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887571|NCT01869634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55887572|NCT01869634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55887577|NCT02047578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887578|NCT02047578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55887579|NCT02047578|Immunologic Factors|immunologic factors|mesh-ancestor
55887580|NCT02047578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887581|NCT02047578|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55887582|NCT02047578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887592|NCT04807894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887594|NCT01874392|Insulin|insulin|mesh-list
55887595|NCT01874392|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55887596|NCT01874392|Pancrelipase|pancrelipase|mesh-list
55887597|NCT01874392|Pancreatin|pancreatin|mesh-list
55887598|NCT01874392|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55887599|NCT01874392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887600|NCT01874392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55887608|NCT00576654|Irinotecan|irinotecan|mesh-list
55887609|NCT00576654|Camptothecin|camptothecin|mesh-list
55887610|NCT00576654|Veliparib|veliparib|mesh-list
55887611|NCT00576654|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55887612|NCT00576654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55887613|NCT00576654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887614|NCT00576654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887615|NCT00576654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887616|NCT00576654|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55887617|NCT00576654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55887618|NCT05542264|Olanzapine|olanzapine|mesh-list
55887619|NCT05542264|Risperidone|risperidone|mesh-list
55887620|NCT05542264|Aripiprazole|aripiprazole|mesh-list
55887621|NCT05542264|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55887622|NCT05542264|Antipsychotic Agents|antipsychotic agents|mesh-list
55887623|NCT05542264|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55887624|NCT05542264|Serotonin Agents|serotonin agents|mesh-ancestor
55887625|NCT05542264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887626|NCT05542264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887627|NCT05542264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051422|NCT01768520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56051423|NCT01768520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56051424|NCT01768520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051425|NCT01768520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051426|NCT00355589|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55887628|NCT05542264|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55887629|NCT05542264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887630|NCT05542264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55887631|NCT05542264|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55887633|NCT05542264|Antiemetics|antiemetics|mesh-ancestor
55887634|NCT05542264|Autonomic Agents|autonomic agents|mesh-ancestor
55887635|NCT05542264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887636|NCT05542264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55887637|NCT05542264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55887638|NCT05542264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55887639|NCT05542264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887640|NCT05542264|Antidepressive Agents|antidepressive agents|mesh-ancestor
55887641|NCT05542264|Dopamine Agonists|dopamine agonists|mesh-ancestor
55887642|NCT05542264|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55887643|NCT05542264|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55887644|NCT05542264|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55887645|NCT05542264|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55887646|NCT03314064|Dolutegravir|dolutegravir|mesh-list
55887647|NCT03314064|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55887648|NCT03314064|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55887649|NCT03314064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887650|NCT03314064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887651|NCT03314064|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55887652|NCT03314064|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55887653|NCT03314064|Antiviral Agents|antiviral agents|mesh-ancestor
55887654|NCT03314064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887655|NCT00552058|Certolizumab Pegol|certolizumab pegol|mesh-list
55887666|NCT02473302|Protective Agents|protective agents|mesh-ancestor
55887667|NCT02473302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887669|NCT02473302|Micronutrients|micronutrients|mesh-ancestor
55887670|NCT05747326|Capecitabine|capecitabine|mesh-list
55887671|NCT05747326|Vinorelbine|vinorelbine|mesh-list
55887672|NCT05747326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55887673|NCT05747326|Antimetabolites|antimetabolites|mesh-ancestor
55887674|NCT05747326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887687|NCT03108300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887688|NCT03108300|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55887689|NCT03108300|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55887690|NCT03108300|Adrenergic Agents|adrenergic agents|mesh-ancestor
55887691|NCT03108300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887692|NCT03108300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887693|NCT03108300|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55887694|NCT03108300|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55887695|NCT03108300|Vasodilator Agents|vasodilator agents|mesh-ancestor
55887696|NCT03313752|Dapagliflozin|dapagliflozin|mesh-list
55887697|NCT03313752|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55887698|NCT03313752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887699|NCT03313752|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55887700|NCT03313752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887725|NCT02989012|Antiviral Agents|antiviral agents|mesh-ancestor
55887726|NCT02989012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887727|NCT02989012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887728|NCT02989012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887729|NCT03832894|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55887730|NCT03832894|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55887732|NCT03832894|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55887733|NCT03832894|Progesterone|progesterone|mesh-list
55887734|NCT03832894|Estrogens|estrogens|mesh-ancestor
55887735|NCT03832894|Hormones|hormones|mesh-ancestor
55887736|NCT03832894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887737|NCT03832894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887738|NCT03832894|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55887739|NCT03832894|Contraceptive Agents|contraceptive agents|mesh-ancestor
55887740|NCT03832894|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55887741|NCT03832894|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55887742|NCT03832894|Progestins|progestins|mesh-ancestor
55887743|NCT02989324|Misoprostol|misoprostol|mesh-list
55887744|NCT02989324|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55887745|NCT02989324|Abortifacient Agents|abortifacient agents|mesh-ancestor
55887746|NCT02989324|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55887747|NCT02989324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887748|NCT02989324|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55887749|NCT02989324|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55887750|NCT02989324|Oxytocics|oxytocics|mesh-ancestor
55887751|NCT03686124|Nivolumab|nivolumab|mesh-list
55887752|NCT03686124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55887753|NCT03686124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887754|NCT03686124|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55887755|NCT03686124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887756|NCT00550732|Posaconazole|posaconazole|mesh-list
55887757|NCT00550732|Antifungal Agents|antifungal agents|mesh-ancestor
55887758|NCT00550732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887759|NCT00550732|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55887760|NCT00550732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55887761|NCT00550732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56051435|NCT00355589|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56051437|NCT00355589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051438|NCT01769222|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56051439|NCT01769222|Ipilimumab|ipilimumab|mesh-list
56051440|NCT01769222|Antibodies|antibodies|mesh-list
56051441|NCT01769222|Immunoglobulins|immunoglobulins|mesh-list
56051442|NCT01769222|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56051443|NCT01769222|Immunologic Factors|immunologic factors|mesh-ancestor
56051444|NCT01769222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051445|NCT01769222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051446|NCT01769222|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56051447|NCT01769222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051448|NCT02386319|Melatonin|melatonin|mesh-list
56051449|NCT02386319|Antioxidants|antioxidants|mesh-ancestor
56051450|NCT02386319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051451|NCT02386319|Protective Agents|protective agents|mesh-ancestor
56051452|NCT02386319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051453|NCT02386319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051454|NCT02240888|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55887762|NCT00550732|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55887763|NCT00550732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55887764|NCT00550732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887765|NCT00550732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887768|NCT00550732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887769|NCT00550732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887771|NCT05422534|Micronutrients|micronutrients|mesh-ancestor
55887772|NCT05422534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887774|NCT03311022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55887775|NCT03311022|Analgesics|analgesics|mesh-ancestor
55887776|NCT03311022|Sensory System Agents|sensory system agents|mesh-ancestor
55887777|NCT03311022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887778|NCT03311022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887779|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
55887780|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55887781|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887782|NCT00550420|Rosiglitazone|rosiglitazone|mesh-list
55887783|NCT00550420|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55887784|NCT00550420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887785|NCT00559936|Bevacizumab|bevacizumab|mesh-list
55887786|NCT00559936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55887787|NCT00559936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887788|NCT00559936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55887789|NCT00559936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55887790|NCT00559936|Growth Substances|growth substances|mesh-ancestor
55887791|NCT00559936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887792|NCT00559936|Growth Inhibitors|growth inhibitors|mesh-ancestor
55887793|NCT05353192|Hormones|hormones|mesh-list
56051455|NCT02240888|Immunologic Factors|immunologic factors|mesh-ancestor
56051456|NCT02240888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051457|NCT02387801|Ixekizumab|ixekizumab|mesh-list
56051458|NCT02387801|Dermatologic Agents|dermatologic agents|mesh-ancestor
56051459|NCT02259608|BCG Vaccine|bcg vaccine|mesh-list
56051460|NCT02259608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56051461|NCT02259608|Immunologic Factors|immunologic factors|mesh-ancestor
56051462|NCT02259608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051463|NCT02326844|Talazoparib|talazoparib|mesh-list
56051464|NCT02326844|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56051465|NCT02326844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051466|NCT02326844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887807|NCT00557128|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55887808|NCT00557128|Protective Agents|protective agents|mesh-ancestor
55887809|NCT00557128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887810|NCT03312582|Metformin|metformin|mesh-list
55887811|NCT03312582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55887812|NCT03312582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887813|NCT04350580|Immunoglobulins|immunoglobulins|mesh-list
55887814|NCT04350580|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55887815|NCT04350580|Antibodies|antibodies|mesh-list
55887816|NCT04350580|Immunologic Factors|immunologic factors|mesh-ancestor
55887817|NCT04350580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887818|NCT00558064|Amlodipine|amlodipine|mesh-list
55887819|NCT00558064|Telmisartan|telmisartan|mesh-list
55887820|NCT00558064|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
55887821|NCT00558064|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55887822|NCT00558064|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55887823|NCT00558064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887824|NCT00558064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887825|NCT00558064|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55887826|NCT00558064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887827|NCT00558064|Vasodilator Agents|vasodilator agents|mesh-ancestor
55887828|NCT00558064|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55887829|NCT00558064|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55887830|NCT03312426|Linrodostat|linrodostat|mesh-list
55887831|NCT03312426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752882|NCT03316469|Clomiphene|clomiphene|mesh-list
55887832|NCT03312426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887834|NCT03309618|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55887835|NCT03309618|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55887836|NCT03309618|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55887837|NCT03309618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887839|NCT03303924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55887840|NCT03303924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887841|NCT03303924|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55887842|NCT03303924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887843|NCT03303924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887844|NCT00557830|Sorafenib|sorafenib|mesh-list
55887848|NCT00557830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887849|NCT00557440|Fluticasone|fluticasone|mesh-list
55887850|NCT00557440|Xhance|xhance|mesh-list
55887851|NCT00557440|Mometasone Furoate|mometasone furoate|mesh-list
55887852|NCT00557440|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55887856|NCT00557440|Autonomic Agents|autonomic agents|mesh-ancestor
55887857|NCT00557440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887858|NCT00557440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887859|NCT00557440|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56051467|NCT02326844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051468|NCT02239874|Vitamin D|vitamin d|mesh-list
56051469|NCT02239874|Ergocalciferols|ergocalciferols|mesh-list
56051470|NCT02239874|Cholecalciferol|cholecalciferol|mesh-list
56051471|NCT02239874|Vitamins|vitamins|mesh-list
56051472|NCT02239874|Micronutrients|micronutrients|mesh-ancestor
56051473|NCT02239874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051474|NCT02239874|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56051475|NCT02239874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56051476|NCT05274269|Ivacaftor|ivacaftor|mesh-list
56051477|NCT05274269|Elexacaftor|elexacaftor|mesh-list
56051478|NCT05274269|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56051479|NCT05274269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56051480|NCT05274269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887860|NCT00557440|Respiratory System Agents|respiratory system agents|mesh-ancestor
55887861|NCT00557440|Dermatologic Agents|dermatologic agents|mesh-ancestor
55887862|NCT00557440|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55887863|NCT00557440|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55887864|NCT00557440|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55887865|NCT00557440|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55887866|NCT00557440|Adrenergic Agents|adrenergic agents|mesh-ancestor
55887867|NCT00557440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887868|NCT00557440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887869|NCT00557440|Glucocorticoids|glucocorticoids|mesh-ancestor
55887871|NCT00557440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887872|NCT00557440|Sympathomimetics|sympathomimetics|mesh-ancestor
55887874|NCT03311178|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55887875|NCT03311178|Sympathomimetics|sympathomimetics|mesh-ancestor
55887876|NCT03311178|Autonomic Agents|autonomic agents|mesh-ancestor
55887877|NCT03311178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887878|NCT03311178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887879|NCT03311178|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55887880|NCT03311178|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55887881|NCT03311178|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55887882|NCT03311178|Adrenergic Agents|adrenergic agents|mesh-ancestor
55887883|NCT03311178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887884|NCT03311178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887885|NCT03311178|Protective Agents|protective agents|mesh-ancestor
55887886|NCT02469012|Ribavirin|ribavirin|mesh-list
55887887|NCT02469012|Sofosbuvir|sofosbuvir|mesh-list
55887888|NCT02469012|Ledipasvir|ledipasvir|mesh-list
55887889|NCT02469012|Antimetabolites|antimetabolites|mesh-ancestor
55887890|NCT02469012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887891|NCT02469012|Antiviral Agents|antiviral agents|mesh-ancestor
55887892|NCT02469012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887893|NCT02468856|Modafinil|modafinil|mesh-list
55887894|NCT02468856|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55887895|NCT02468856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887896|NCT02468856|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55887897|NCT02468856|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55887898|NCT02468856|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55887899|NCT02468856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887901|NCT05224336|Psilocybin|psilocybin|mesh-list
55887902|NCT05224336|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55887903|NCT05224336|Antimetabolites|antimetabolites|mesh-ancestor
55887904|NCT05224336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887905|NCT05224336|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55887906|NCT05224336|Vasodilator Agents|vasodilator agents|mesh-ancestor
55887907|NCT05224336|Vitamin B Complex|vitamin b complex|mesh-ancestor
55887908|NCT05224336|Vitamins|vitamins|mesh-ancestor
56051482|NCT01771952|Hylan|hylan|mesh-list
56051483|NCT01771952|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56051484|NCT01771952|Immunologic Factors|immunologic factors|mesh-ancestor
55887909|NCT05224336|Micronutrients|micronutrients|mesh-ancestor
55887910|NCT05224336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887911|NCT05224336|Hallucinogens|hallucinogens|mesh-ancestor
55887912|NCT05224336|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55887915|NCT03303378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887916|NCT03303378|Protective Agents|protective agents|mesh-ancestor
55887917|NCT03303378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887918|NCT03303378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887919|NCT04491474|Lidocaine|lidocaine|mesh-list
55887921|NCT04491474|Anesthetics|anesthetics|mesh-ancestor
55887922|NCT04491474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887923|NCT04491474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887924|NCT04491474|Sensory System Agents|sensory system agents|mesh-ancestor
55887925|NCT04491474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887934|NCT03308604|Cisplatin|cisplatin|mesh-list
55887935|NCT03308604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887936|NCT05176288|Palbociclib|palbociclib|mesh-list
55887937|NCT05176288|Avelumab|avelumab|mesh-list
55887938|NCT05176288|Axitinib|axitinib|mesh-list
55887939|NCT05176288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887940|NCT05176288|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55887941|NCT05176288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887942|NCT05176288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887943|NCT05176288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55887944|NCT00553306|Aldesleukin|aldesleukin|mesh-list
55887945|NCT00553306|Cyclophosphamide|cyclophosphamide|mesh-list
55887946|NCT00553306|Interleukin-2|interleukin-2|mesh-list
55887947|NCT00553306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55887948|NCT00553306|Immunologic Factors|immunologic factors|mesh-ancestor
55887949|NCT00553306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887950|NCT00553306|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55887951|NCT00553306|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55887952|NCT00553306|Alkylating Agents|alkylating agents|mesh-ancestor
55887953|NCT00553306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887954|NCT00553306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55887955|NCT00553306|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55887956|NCT00553306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55887957|NCT00553306|Analgesics|analgesics|mesh-ancestor
55887958|NCT00553306|Sensory System Agents|sensory system agents|mesh-ancestor
55887959|NCT00553306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887960|NCT00553306|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55887961|NCT00553306|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55887962|NCT00553306|Antiviral Agents|antiviral agents|mesh-ancestor
55887963|NCT00553306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887964|NCT02722044|Adalimumab|adalimumab|mesh-list
55887965|NCT02722044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55887966|NCT02722044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55887967|NCT05728008|Ustekinumab|ustekinumab|mesh-list
55887968|NCT05728008|Tofacitinib|tofacitinib|mesh-list
55887969|NCT05728008|Dermatologic Agents|dermatologic agents|mesh-ancestor
55887970|NCT05728008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55887971|NCT05728008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887972|NCT05728008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887973|NCT02988700|Bupivacaine|bupivacaine|mesh-list
55887974|NCT02988700|Anesthetics, Local|anesthetics, local|mesh-ancestor
55887975|NCT02988700|Anesthetics|anesthetics|mesh-ancestor
55887976|NCT02988700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55887977|NCT02988700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887978|NCT02988700|Sensory System Agents|sensory system agents|mesh-ancestor
55887979|NCT02988700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887980|NCT03308214|Imipenem|imipenem|mesh-list
55887981|NCT03308214|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55887982|NCT03308214|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887983|NCT03308136|Lidocaine|lidocaine|mesh-list
55887984|NCT03308136|Anesthetics, Local|anesthetics, local|mesh-list
55887985|NCT03308136|Anesthetics|anesthetics|mesh-list
55887986|NCT03308136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051485|NCT01771952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051486|NCT01771952|Viscosupplements|viscosupplements|mesh-ancestor
56051487|NCT01771952|Protective Agents|protective agents|mesh-ancestor
55887987|NCT03308136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887988|NCT03308136|Sensory System Agents|sensory system agents|mesh-ancestor
55887989|NCT03308136|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887990|NCT03308136|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55887991|NCT03308136|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55887996|NCT02466984|Antiemetics|antiemetics|mesh-ancestor
55887997|NCT02466984|Autonomic Agents|autonomic agents|mesh-ancestor
55887998|NCT02466984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887999|NCT02466984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888000|NCT02466984|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55888005|NCT02466984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888006|NCT03302754|Alemtuzumab|alemtuzumab|mesh-list
55888007|NCT03302754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888008|NCT03302754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888009|NCT03307902|Imiquimod|imiquimod|mesh-list
55888010|NCT03307902|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55888011|NCT03307902|Immunologic Factors|immunologic factors|mesh-ancestor
55888012|NCT03307902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888013|NCT03307902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888014|NCT03307902|Interferon Inducers|interferon inducers|mesh-ancestor
55888015|NCT04929808|Emollients|emollients|mesh-list
55888016|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
55888017|NCT03302364|Risperidone|risperidone|mesh-list
55888018|NCT03302364|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55888019|NCT03302364|Serotonin Agents|serotonin agents|mesh-ancestor
55888020|NCT03302364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888021|NCT03302364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888022|NCT03302364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888023|NCT03302364|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55888024|NCT03302364|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55888025|NCT03302364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55888026|NCT03302364|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55888027|NCT03302364|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55888028|NCT03302364|Dopamine Agents|dopamine agents|mesh-ancestor
55888029|NCT02467920|Exenatide|exenatide|mesh-list
55888030|NCT02467920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55888031|NCT02467920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888032|NCT02467920|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55888033|NCT02467920|Incretins|incretins|mesh-ancestor
55888034|NCT02467920|Hormones|hormones|mesh-ancestor
55888035|NCT02467920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888036|NCT04927312|Metronidazole|metronidazole|mesh-list
55888037|NCT04927312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888038|NCT04927312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55888039|NCT04927312|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55888040|NCT04927312|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55888041|NCT03307590|Dexmedetomidine|dexmedetomidine|mesh-list
55888042|NCT03307590|Bupivacaine|bupivacaine|mesh-list
55888043|NCT03307590|Anesthetics, Local|anesthetics, local|mesh-ancestor
55888044|NCT03307590|Anesthetics|anesthetics|mesh-ancestor
55888045|NCT03307590|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55888046|NCT03307590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888047|NCT03307590|Sensory System Agents|sensory system agents|mesh-ancestor
55888048|NCT03307590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888049|NCT03307590|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55888050|NCT03307590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55888051|NCT03307590|Analgesics|analgesics|mesh-ancestor
55888052|NCT03307590|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55888053|NCT03307590|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55888054|NCT03307590|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55888055|NCT03307590|Adrenergic Agents|adrenergic agents|mesh-ancestor
55888056|NCT03307590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752913|NCT03316313|Antibodies|antibodies|mesh-list
55888057|NCT03307590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888059|NCT03302208|Analgesics|analgesics|mesh-ancestor
56051488|NCT02389361|Acetaminophen|acetaminophen|mesh-list
56051489|NCT02389361|Tramadol|tramadol|mesh-list
56051490|NCT02389361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56051491|NCT02389361|Analgesics|analgesics|mesh-ancestor
56051492|NCT02389361|Sensory System Agents|sensory system agents|mesh-ancestor
56051493|NCT02389361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051494|NCT02389361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051495|NCT02389361|Antipyretics|antipyretics|mesh-ancestor
56051496|NCT02389361|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56051497|NCT02389361|Narcotics|narcotics|mesh-ancestor
56051498|NCT02389361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051499|NCT02252354|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56051500|NCT02252354|Relugolix|relugolix|mesh-list
56051501|NCT02252354|Androgen Antagonists|androgen antagonists|mesh-ancestor
56051502|NCT02252354|Hormone Antagonists|hormone antagonists|mesh-ancestor
55888060|NCT03302208|Sensory System Agents|sensory system agents|mesh-ancestor
55888061|NCT03302208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888062|NCT03302208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888063|NCT03302208|Anticonvulsants|anticonvulsants|mesh-ancestor
55888081|NCT02721966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55888082|NCT02721966|Immunologic Factors|immunologic factors|mesh-ancestor
55888083|NCT02721966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888085|NCT00553462|Carboplatin|carboplatin|mesh-list
55888093|NCT00553462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888094|NCT00553462|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55888095|NCT00553462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888096|NCT04874038|Lidocaine|lidocaine|mesh-list
55888097|NCT04874038|Anesthetics, Local|anesthetics, local|mesh-ancestor
55888098|NCT04874038|Anesthetics|anesthetics|mesh-ancestor
55888099|NCT04874038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55888100|NCT04874038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888101|NCT04874038|Sensory System Agents|sensory system agents|mesh-ancestor
55888102|NCT04874038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888103|NCT04874038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55888104|NCT04874038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55888105|NCT04874038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55888106|NCT04874038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888107|NCT04874038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888108|NCT03301974|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55888109|NCT03301974|Hemostatics|hemostatics|mesh-ancestor
55888110|NCT03301974|Coagulants|coagulants|mesh-ancestor
55888111|NCT03306732|Thiamine|thiamine|mesh-list
55888112|NCT03306732|Vitamin B Complex|vitamin b complex|mesh-ancestor
55888113|NCT03306732|Vitamins|vitamins|mesh-ancestor
55888114|NCT03306732|Micronutrients|micronutrients|mesh-ancestor
55888115|NCT03306732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888116|NCT03260322|Pembrolizumab|pembrolizumab|mesh-list
55752922|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
55888117|NCT03260322|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888119|NCT05726916|Eculizumab|eculizumab|mesh-list
55888120|NCT05726916|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55888123|NCT05726916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888125|NCT00553150|Temozolomide|temozolomide|mesh-list
55888126|NCT00553150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888127|NCT00553150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55888128|NCT00553150|Immunologic Factors|immunologic factors|mesh-ancestor
56051503|NCT02252354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56051504|NCT02252354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051505|NCT02393339|Acetaminophen|acetaminophen|mesh-list
56051506|NCT02393339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56051507|NCT02393339|Analgesics|analgesics|mesh-ancestor
56051508|NCT02393339|Sensory System Agents|sensory system agents|mesh-ancestor
56051509|NCT02393339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051510|NCT02393339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051511|NCT02393339|Antipyretics|antipyretics|mesh-ancestor
56051512|NCT05235191|Methadone|methadone|mesh-list
56051513|NCT05235191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56051514|NCT05235191|Narcotics|narcotics|mesh-ancestor
56051515|NCT05235191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051516|NCT05235191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051517|NCT05235191|Analgesics|analgesics|mesh-ancestor
56051518|NCT05235191|Sensory System Agents|sensory system agents|mesh-ancestor
56051519|NCT05235191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051520|NCT05235191|Antitussive Agents|antitussive agents|mesh-ancestor
56051521|NCT05235191|Respiratory System Agents|respiratory system agents|mesh-ancestor
55888129|NCT00553150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888130|NCT00553150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55888131|NCT00553150|Alkylating Agents|alkylating agents|mesh-ancestor
55888132|NCT00553150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888133|NCT02468232|Enalapril|enalapril|mesh-list
55888134|NCT02468232|Enalaprilat|enalaprilat|mesh-list
55888135|NCT02468232|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55888136|NCT02468232|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55888137|NCT02468232|Protease Inhibitors|protease inhibitors|mesh-ancestor
55888138|NCT02468232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888139|NCT02468232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888140|NCT02468232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55888141|NCT02468232|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55888142|NCT02246920|Fluticasone|fluticasone|mesh-list
55888144|NCT02246920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55888145|NCT02246920|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55888146|NCT02246920|Autonomic Agents|autonomic agents|mesh-ancestor
55888148|NCT02246920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888149|NCT02246920|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55888150|NCT02246920|Respiratory System Agents|respiratory system agents|mesh-ancestor
55888151|NCT02246920|Dermatologic Agents|dermatologic agents|mesh-ancestor
55888152|NCT02246920|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55888153|NCT03176134|Tedizolid|tedizolid|mesh-list
55888165|NCT04630834|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55888166|NCT04630834|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56051523|NCT01774604|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56051524|NCT01774604|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56051525|NCT01774604|Analgesics|analgesics|mesh-ancestor
56051526|NCT01774604|Sensory System Agents|sensory system agents|mesh-ancestor
56051527|NCT01774604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051528|NCT01774604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051529|NCT01774604|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56051530|NCT01774604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56051531|NCT01774604|Gout Suppressants|gout suppressants|mesh-ancestor
56051532|NCT01774604|Tocolytic Agents|tocolytic agents|mesh-ancestor
56051533|NCT01774604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56051534|NCT01774604|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56051535|NCT01774604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051536|NCT01774604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051537|NCT05208047|Sunitinib|sunitinib|mesh-list
56051538|NCT05208047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051539|NCT05208047|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56051540|NCT05208047|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56051541|NCT05208047|Growth Substances|growth substances|mesh-ancestor
56051542|NCT05208047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051543|NCT05208047|Growth Inhibitors|growth inhibitors|mesh-ancestor
56051544|NCT05208047|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56051547|NCT01777412|Bevacizumab|bevacizumab|mesh-list
56051571|NCT01780454|Immunologic Factors|immunologic factors|mesh-ancestor
56051572|NCT01780454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051573|NCT01780454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56051574|NCT04869449|Ketoconazole|ketoconazole|mesh-list
56051575|NCT04869449|Antifungal Agents|antifungal agents|mesh-ancestor
56051576|NCT04869449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051577|NCT04869449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56051578|NCT04869449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56051579|NCT04869449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051580|NCT04869449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051581|NCT04869449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56051582|NCT04869449|Hormone Antagonists|hormone antagonists|mesh-ancestor
56051583|NCT04869449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56051584|NCT04869449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051585|NCT04869449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56051587|NCT01420874|Fluorouracil|fluorouracil|mesh-list
56051588|NCT01420874|Oxaliplatin|oxaliplatin|mesh-list
56051589|NCT01420874|Antimetabolites|antimetabolites|mesh-ancestor
56051590|NCT01420874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888167|NCT04630834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55888168|NCT04630834|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55888169|NCT04630834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888170|NCT04630834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888171|NCT03301350|Paclitaxel|paclitaxel|mesh-list
55888172|NCT03301350|Cyclophosphamide|cyclophosphamide|mesh-list
55888173|NCT03301350|Carboplatin|carboplatin|mesh-list
55888174|NCT03301350|Doxorubicin|doxorubicin|mesh-list
55888175|NCT03301350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55888176|NCT03301350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888177|NCT03301350|Tubulin Modulators|tubulin modulators|mesh-ancestor
55888178|NCT03301350|Antimitotic Agents|antimitotic agents|mesh-ancestor
55888179|NCT03301350|Mitosis Modulators|mitosis modulators|mesh-ancestor
55888180|NCT03301350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888181|NCT03301350|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55888182|NCT03301350|Immunologic Factors|immunologic factors|mesh-ancestor
55888183|NCT03301350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888184|NCT03301350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55888185|NCT03301350|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55888186|NCT03301350|Alkylating Agents|alkylating agents|mesh-ancestor
55888187|NCT03301350|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55888188|NCT03301350|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55888189|NCT03301350|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55888190|NCT03301350|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55888191|NCT03301350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888192|NCT05722704|Salicylic Acid|salicylic acid|mesh-list
55888193|NCT05722704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888194|NCT05722704|Antifungal Agents|antifungal agents|mesh-ancestor
55888195|NCT05722704|Keratolytic Agents|keratolytic agents|mesh-ancestor
55888208|NCT02722278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888221|NCT03300960|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888223|NCT02993146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888224|NCT02485444|Oxytocin|oxytocin|mesh-list
55888225|NCT02485444|Oxytocics|oxytocics|mesh-ancestor
55888226|NCT02485444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55888227|NCT02485444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888228|NCT04443010|Temozolomide|temozolomide|mesh-list
55888229|NCT04443010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55888230|NCT04443010|Alkylating Agents|alkylating agents|mesh-ancestor
55888231|NCT04443010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888232|NCT04443010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888233|NCT04490694|Lenvatinib|lenvatinib|mesh-list
55888234|NCT04490694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888235|NCT04490694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55888236|NCT04490694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888237|NCT04490694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888238|NCT04601584|Antibodies|antibodies|mesh-list
55888239|NCT04601584|Immunoglobulins|immunoglobulins|mesh-list
55888240|NCT04601584|Immunologic Factors|immunologic factors|mesh-ancestor
55888241|NCT04601584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888242|NCT02359474|Trabectedin|trabectedin|mesh-list
55888243|NCT02359474|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55752947|NCT03315845|Anesthetics|anesthetics|mesh-list
55888244|NCT02359474|Alkylating Agents|alkylating agents|mesh-ancestor
55888245|NCT02359474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888246|NCT02359474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888247|NCT02467686|Tamoxifen|tamoxifen|mesh-list
55888248|NCT02467686|Exemestane|exemestane|mesh-list
55888249|NCT02467686|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55888250|NCT02467686|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55888251|NCT02467686|Hormone Antagonists|hormone antagonists|mesh-ancestor
55888252|NCT02467686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888253|NCT02467686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888254|NCT02467686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55888255|NCT02467686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888256|NCT02467686|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56051606|NCT04847063|Mitomycin|mitomycin|mesh-list
56051607|NCT04847063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051608|NCT04847063|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56051609|NCT04847063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56051610|NCT04847063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56051611|NCT04847063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051612|NCT04847063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051613|NCT04847063|Antimetabolites|antimetabolites|mesh-ancestor
56051614|NCT04847063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56051615|NCT04847063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56051616|NCT04847063|Immunologic Factors|immunologic factors|mesh-ancestor
55888258|NCT02467686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55888259|NCT02467686|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55888261|NCT02467686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888262|NCT05707962|Magnesium Sulfate|magnesium sulfate|mesh-list
55888263|NCT05707962|Neuroprotective Agents|neuroprotective agents|mesh-list
55888264|NCT05707962|Analgesics|analgesics|mesh-ancestor
55888269|NCT05707962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55888270|NCT05707962|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55888271|NCT05707962|Anticonvulsants|anticonvulsants|mesh-ancestor
55888272|NCT05707962|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55888273|NCT05707962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888274|NCT05707962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888275|NCT05707962|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55888276|NCT05707962|Tocolytic Agents|tocolytic agents|mesh-ancestor
55888277|NCT05707962|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55888278|NCT05707962|Protective Agents|protective agents|mesh-ancestor
55888279|NCT01993810|Paclitaxel|paclitaxel|mesh-list
55888280|NCT01993810|Etoposide|etoposide|mesh-list
55888281|NCT01993810|Podophyllotoxin|podophyllotoxin|mesh-list
55888282|NCT01993810|Cisplatin|cisplatin|mesh-list
55888283|NCT01993810|Carboplatin|carboplatin|mesh-list
55888284|NCT01993810|Pemetrexed|pemetrexed|mesh-list
55888285|NCT01993810|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55888286|NCT01993810|Etoposide phosphate|etoposide phosphate|mesh-list
55888287|NCT01993810|Durvalumab|durvalumab|mesh-list
55888288|NCT01993810|Immunoglobulins|immunoglobulins|mesh-list
55888289|NCT01993810|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55888290|NCT01993810|Immunoglobulin G|immunoglobulin g|mesh-list
55888296|NCT01993810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888297|NCT01993810|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55888298|NCT01993810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55888299|NCT01993810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752957|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
55888300|NCT01993810|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55888301|NCT01993810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55888302|NCT01993810|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888303|NCT01993810|Immunologic Factors|immunologic factors|mesh-ancestor
55888304|NCT01993810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888305|NCT01993810|Keratolytic Agents|keratolytic agents|mesh-ancestor
55888306|NCT01993810|Dermatologic Agents|dermatologic agents|mesh-ancestor
55888307|NCT05698680|Prednisolone|prednisolone|mesh-list
55888308|NCT05698680|Colchicine|colchicine|mesh-list
56051617|NCT04847063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051618|NCT04847063|Alkylating Agents|alkylating agents|mesh-ancestor
56051619|NCT04847063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56051620|NCT04847063|Antidotes|antidotes|mesh-ancestor
56051621|NCT04847063|Protective Agents|protective agents|mesh-ancestor
56051622|NCT04847063|Antioxidants|antioxidants|mesh-ancestor
56051623|NCT04847063|Antitubercular Agents|antitubercular agents|mesh-ancestor
56051624|NCT04847063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56051625|NCT04847063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051626|NCT04847063|Chelating Agents|chelating agents|mesh-ancestor
55888309|NCT05698680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55888310|NCT05698680|Glucocorticoids|glucocorticoids|mesh-ancestor
55888311|NCT05698680|Hormones|hormones|mesh-ancestor
55888312|NCT05698680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888313|NCT05698680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888314|NCT05698680|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55888315|NCT05698680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888316|NCT05698680|Gout Suppressants|gout suppressants|mesh-ancestor
55888317|NCT05698680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55888318|NCT05698680|Tubulin Modulators|tubulin modulators|mesh-ancestor
55888319|NCT05698680|Antimitotic Agents|antimitotic agents|mesh-ancestor
55888320|NCT05698680|Mitosis Modulators|mitosis modulators|mesh-ancestor
55888321|NCT05698680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888322|NCT04060108|Methamphetamine|methamphetamine|mesh-list
55888323|NCT04060108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55888324|NCT04060108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888325|NCT04060108|Sympathomimetics|sympathomimetics|mesh-ancestor
55888326|NCT04060108|Autonomic Agents|autonomic agents|mesh-ancestor
55888327|NCT04060108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888328|NCT04060108|Dopamine Agents|dopamine agents|mesh-ancestor
55888329|NCT04060108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888334|NCT04060108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888335|NCT04060108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55888336|NCT04058470|Prednisone|prednisone|mesh-list
55888337|NCT04058470|Cyclophosphamide|cyclophosphamide|mesh-list
55888338|NCT04058470|Rituximab|rituximab|mesh-list
55888339|NCT04058470|Doxorubicin|doxorubicin|mesh-list
55888340|NCT04058470|Vincristine|vincristine|mesh-list
55888341|NCT04058470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56051627|NCT04847063|Sequestering Agents|sequestering agents|mesh-ancestor
56051628|NCT00355901|Visilizumab|visilizumab|mesh-list
56051629|NCT00355901|Immunologic Factors|immunologic factors|mesh-ancestor
56051630|NCT00355901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051631|NCT00355667|Furosemide|furosemide|mesh-list
56051632|NCT00355667|Azosemide|azosemide|mesh-list
56051633|NCT00355667|Diuretics|diuretics|mesh-ancestor
56051634|NCT00355667|Natriuretic Agents|natriuretic agents|mesh-ancestor
56051635|NCT00355667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051636|NCT00355667|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56051637|NCT00355667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56051638|NCT00355667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051639|NCT02364336|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56051640|NCT02364336|Antiviral Agents|antiviral agents|mesh-ancestor
56051641|NCT02364336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051642|NCT04419948|Ibuprofen|ibuprofen|mesh-list
56051643|NCT04419948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56051644|NCT04419948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56051645|NCT04419948|Analgesics|analgesics|mesh-ancestor
56051646|NCT04419948|Sensory System Agents|sensory system agents|mesh-ancestor
55888342|NCT04058470|Immunologic Factors|immunologic factors|mesh-ancestor
55888343|NCT04058470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888344|NCT04058470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55888347|NCT04058470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888348|NCT04058470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888349|NCT04058470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55888350|NCT04058470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888351|NCT04058470|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55888352|NCT04058470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55888353|NCT04058470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55888354|NCT04058470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888355|NCT04058470|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55888356|NCT04058470|Glucocorticoids|glucocorticoids|mesh-ancestor
55888357|NCT04058470|Hormones|hormones|mesh-ancestor
55888358|NCT04058470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888359|NCT04058470|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55888360|NCT04058470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55888361|NCT04058470|Tubulin Modulators|tubulin modulators|mesh-ancestor
55888362|NCT04058470|Antimitotic Agents|antimitotic agents|mesh-ancestor
55888363|NCT04058470|Mitosis Modulators|mitosis modulators|mesh-ancestor
55888364|NCT04449874|Bevacizumab|bevacizumab|mesh-list
55888365|NCT04449874|Cetuximab|cetuximab|mesh-list
55888366|NCT04449874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55888367|NCT04449874|Atezolizumab|atezolizumab|mesh-list
55888368|NCT04449874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888369|NCT04449874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888370|NCT04449874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55888371|NCT04449874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55888372|NCT04449874|Growth Substances|growth substances|mesh-ancestor
55888373|NCT04449874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888374|NCT04449874|Growth Inhibitors|growth inhibitors|mesh-ancestor
55888375|NCT04449874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55888376|NCT04449874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051647|NCT04419948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051648|NCT04419948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051649|NCT04419948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56051650|NCT04419948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56051651|NCT04419948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56051652|NCT04419948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051653|NCT04419948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051655|NCT01312922|Pipamperone|pipamperone|mesh-list
56051656|NCT01312922|Citalopram|citalopram|mesh-list
56051657|NCT01312922|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56051658|NCT01312922|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56051659|NCT01312922|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56051660|NCT01312922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051661|NCT01312922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051663|NCT01312922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051664|NCT01312922|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56051665|NCT01312922|Antidepressive Agents|antidepressive agents|mesh-ancestor
56051666|NCT01312922|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56051667|NCT01312922|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56051668|NCT01312922|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56051669|NCT01312922|Parasympatholytics|parasympatholytics|mesh-ancestor
56051670|NCT01312922|Autonomic Agents|autonomic agents|mesh-ancestor
56051671|NCT01312922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051672|NCT01312922|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56051673|NCT01312922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56051674|NCT01312922|Cholinergic Agents|cholinergic agents|mesh-ancestor
56051675|NCT01312922|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56051676|NCT01312922|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56051677|NCT01312922|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56051678|NCT01312922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051679|NCT03785405|Valsartan|valsartan|mesh-list
56051680|NCT03785405|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56051681|NCT03785405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56051684|NCT03785405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051685|NCT03763643|Rituximab|rituximab|mesh-list
56051686|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56051687|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051688|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
56051689|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051690|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56051691|NCT01783574|Methyltestosterone|methyltestosterone|mesh-list
56051692|NCT01783574|Testosterone|testosterone|mesh-list
56051693|NCT01783574|Testosterone undecanoate|testosterone undecanoate|mesh-list
56051698|NCT01783574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56051699|NCT01783574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051741|NCT04362293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051742|NCT04362293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56051743|NCT04362293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56051744|NCT04362293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051745|NCT04362293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56051748|NCT04362293|Antisickling Agents|antisickling agents|mesh-ancestor
55778946|NCT05422027|Lenalidomide|lenalidomide|mesh-list
56051750|NCT04362293|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56051751|NCT04362293|Antimetabolites|antimetabolites|mesh-ancestor
56051752|NCT04362293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56051753|NCT04362293|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56051754|NCT04362293|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56051755|NCT04362293|Antiviral Agents|antiviral agents|mesh-ancestor
56051757|NCT04296695|Efavirenz|efavirenz|mesh-list
56051758|NCT04296695|Antiviral Agents|antiviral agents|mesh-ancestor
56051759|NCT04296695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56051760|NCT04296695|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56051761|NCT04296695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56051762|NCT04296695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051763|NCT04296695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051764|NCT04296695|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56051765|NCT04296695|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56051766|NCT04296695|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56051767|NCT04296695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55888377|NCT04449874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888378|NCT05680818|Vitamin D|vitamin d|mesh-list
55888379|NCT05680818|Calcitriol|calcitriol|mesh-list
55888380|NCT05680818|Alfacalcidol|alfacalcidol|mesh-list
55888381|NCT05680818|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55888382|NCT05680818|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3|26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin d3|mesh-list
55888383|NCT05680818|Calcium|calcium|mesh-list
55888384|NCT05680818|Vitamins|vitamins|mesh-ancestor
55888385|NCT05680818|Micronutrients|micronutrients|mesh-ancestor
55888386|NCT05680818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888387|NCT05680818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55888388|NCT05680818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55888389|NCT05680818|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55888390|NCT05680818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888391|NCT05680818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888392|NCT05680818|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55888393|NCT05680818|Dermatologic Agents|dermatologic agents|mesh-ancestor
56051768|NCT04296695|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56051769|NCT04296695|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56051770|NCT04296695|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56051771|NCT04296695|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55888394|NCT05456256|Carboplatin|carboplatin|mesh-list
55888395|NCT05456256|Pemetrexed|pemetrexed|mesh-list
55888396|NCT05456256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888397|NCT05456256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888398|NCT05456256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888406|NCT05660616|Gemcitabine|gemcitabine|mesh-list
55888407|NCT05660616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55888408|NCT05660616|Antimetabolites|antimetabolites|mesh-ancestor
55888409|NCT05660616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888410|NCT05660616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888411|NCT05660616|Antiviral Agents|antiviral agents|mesh-ancestor
55888412|NCT05660616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888413|NCT05660616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888414|NCT05660616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55888415|NCT05660616|Immunologic Factors|immunologic factors|mesh-ancestor
55888416|NCT05660616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888417|NCT05447520|Montelukast|montelukast|mesh-list
55888418|NCT05447520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55888419|NCT05447520|Respiratory System Agents|respiratory system agents|mesh-ancestor
55752983|NCT04999137|Thiamine|thiamine|mesh-list
55888421|NCT05447520|Hormone Antagonists|hormone antagonists|mesh-ancestor
55888422|NCT05447520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888423|NCT05447520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888424|NCT05447520|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55888425|NCT05447520|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56053732|NCT03223610|Obinutuzumab|obinutuzumab|mesh-list
55888426|NCT05447520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888427|NCT05438550|Amoxicillin|amoxicillin|mesh-list
55888428|NCT05438550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55867807|NCT01046110|Hormones|hormones|mesh-ancestor
55888429|NCT05438550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888430|NCT05411484|Doxycycline|doxycycline|mesh-list
55888431|NCT05411484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55888432|NCT05411484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888433|NCT05411484|Antimalarials|antimalarials|mesh-ancestor
55888434|NCT05411484|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55888435|NCT05411484|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55888436|NCT05639946|Brivaracetam|brivaracetam|mesh-list
55888437|NCT05639946|Anticonvulsants|anticonvulsants|mesh-ancestor
55888438|NCT03299712|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
55888439|NCT03299712|Vasodilator Agents|vasodilator agents|mesh-ancestor
55888440|NCT03299712|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55888441|NCT03299712|Protective Agents|protective agents|mesh-ancestor
55888442|NCT03299712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888443|NCT05327556|Epinephrine|epinephrine|mesh-list
55888445|NCT05327556|Epinephryl borate|epinephryl borate|mesh-list
55888446|NCT05327556|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55888447|NCT05327556|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55888448|NCT05327556|Adrenergic Agents|adrenergic agents|mesh-ancestor
55888449|NCT05327556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888450|NCT05327556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888451|NCT05327556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888452|NCT05327556|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55888453|NCT05327556|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55888454|NCT05327556|Autonomic Agents|autonomic agents|mesh-ancestor
55888455|NCT05327556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888456|NCT05327556|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55888457|NCT05327556|Respiratory System Agents|respiratory system agents|mesh-ancestor
55888458|NCT05327556|Mydriatics|mydriatics|mesh-ancestor
55888459|NCT05327556|Sympathomimetics|sympathomimetics|mesh-ancestor
55888460|NCT05327556|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55888461|NCT02466438|Tazobactam|tazobactam|mesh-list
55888462|NCT02466438|Piperacillin|piperacillin|mesh-list
55888463|NCT02466438|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55888464|NCT02466438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55888465|NCT02466438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888466|NCT02466438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55888474|NCT05587062|Growth Inhibitors|growth inhibitors|mesh-ancestor
56051773|NCT03310541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55888475|NCT05587062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888476|NCT05578092|Adagrasib|adagrasib|mesh-list
55888477|NCT05578092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888478|NCT02463006|Methamphetamine|methamphetamine|mesh-list
55888479|NCT02463006|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55888480|NCT02463006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888481|NCT02463006|Sympathomimetics|sympathomimetics|mesh-ancestor
55888482|NCT02463006|Autonomic Agents|autonomic agents|mesh-ancestor
55888483|NCT02463006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888484|NCT02463006|Dopamine Agents|dopamine agents|mesh-ancestor
55888485|NCT02463006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888486|NCT02463006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888488|NCT02463006|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55888489|NCT02463006|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55888490|NCT02463006|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888491|NCT02463006|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55888492|NCT04779216|Alendronate|alendronate|mesh-list
55888493|NCT04779216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55888494|NCT04779216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888495|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
55888496|NCT05216328|Antacids|antacids|mesh-ancestor
55888497|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888498|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55888499|NCT02466204|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55888500|NCT02466204|Hormones|hormones|mesh-ancestor
55888501|NCT02466204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888502|NCT02466204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888503|NCT02715804|Gemcitabine|gemcitabine|mesh-list
55888504|NCT02715804|Paclitaxel|paclitaxel|mesh-list
55888505|NCT02715804|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55888506|NCT02715804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888507|NCT02715804|Tubulin Modulators|tubulin modulators|mesh-ancestor
55888508|NCT02715804|Antimitotic Agents|antimitotic agents|mesh-ancestor
55888510|NCT02715804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888511|NCT02715804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55888512|NCT02715804|Antimetabolites|antimetabolites|mesh-ancestor
55888513|NCT02715804|Antiviral Agents|antiviral agents|mesh-ancestor
55888514|NCT02715804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888515|NCT02715804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888516|NCT02715804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55888517|NCT02715804|Immunologic Factors|immunologic factors|mesh-ancestor
55888518|NCT02715804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888520|NCT04745130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888521|NCT04745130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888522|NCT02462304|Bevacizumab|bevacizumab|mesh-list
55888523|NCT02462304|Ranibizumab|ranibizumab|mesh-list
55888524|NCT02462304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888525|NCT02462304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888526|NCT02462304|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55888527|NCT02462304|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55888528|NCT02462304|Growth Substances|growth substances|mesh-ancestor
55888529|NCT02462304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888530|NCT02462304|Growth Inhibitors|growth inhibitors|mesh-ancestor
55888531|NCT03501576|Vaccines|vaccines|mesh-list
55888532|NCT03501576|Immunologic Factors|immunologic factors|mesh-ancestor
55888533|NCT03501576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888534|NCT02465814|Ulipristal acetate|ulipristal acetate|mesh-list
55888536|NCT02465814|Contraceptive Agents|contraceptive agents|mesh-ancestor
55888537|NCT02465814|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55888538|NCT02465814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888539|NCT02465814|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55888540|NCT04645212|Aflibercept|aflibercept|mesh-list
55888541|NCT04645212|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55888542|NCT04645212|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55888543|NCT04645212|Growth Substances|growth substances|mesh-ancestor
55888544|NCT04645212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888545|NCT04645212|Growth Inhibitors|growth inhibitors|mesh-ancestor
55888546|NCT04645212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752998|NCT03200821|Antiviral Agents|antiviral agents|mesh-ancestor
56051774|NCT03310541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051775|NCT03310541|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56051776|NCT03310541|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56051777|NCT03310541|Hormone Antagonists|hormone antagonists|mesh-ancestor
56051778|NCT03310541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56051779|NCT03310541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051780|NCT04259645|Bupivacaine|bupivacaine|mesh-list
56051781|NCT04259645|Anesthetics, Local|anesthetics, local|mesh-ancestor
56051782|NCT04259645|Anesthetics|anesthetics|mesh-ancestor
56051783|NCT04259645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051784|NCT04259645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888557|NCT04489446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888558|NCT04489446|Urological Agents|urological agents|mesh-ancestor
55888559|NCT02717754|Oseltamivir|oseltamivir|mesh-list
55888560|NCT02717754|Antiviral Agents|antiviral agents|mesh-ancestor
55888561|NCT02717754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888562|NCT02717754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888563|NCT02717754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888564|NCT04497168|Citalopram|citalopram|mesh-list
55888565|NCT04497168|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55888566|NCT04497168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55888567|NCT04497168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888568|NCT04497168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888569|NCT04497168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888570|NCT04497168|Serotonin Agents|serotonin agents|mesh-ancestor
55888571|NCT04497168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888572|NCT04497168|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55888573|NCT04497168|Antidepressive Agents|antidepressive agents|mesh-ancestor
55888574|NCT04497168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55888575|NCT04608474|Evolocumab|evolocumab|mesh-list
55888576|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
55888578|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55888579|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
55888580|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888581|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55888582|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888583|NCT02717130|Aripiprazole|aripiprazole|mesh-list
55888593|NCT02717130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888594|NCT02717130|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55888595|NCT02717130|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55888596|NCT02717130|Serotonin Agents|serotonin agents|mesh-ancestor
55888597|NCT02717130|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55888598|NCT02717130|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55888599|NCT02717130|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55888600|NCT02717130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55888601|NCT02256696|Rifampin|rifampin|mesh-list
55888602|NCT02256696|Rifabutin|rifabutin|mesh-list
55888603|NCT02256696|Isoniazid|isoniazid|mesh-list
55888604|NCT02256696|Pyrazinamide|pyrazinamide|mesh-list
55888605|NCT02256696|Ethambutol|ethambutol|mesh-list
56051785|NCT04259645|Sensory System Agents|sensory system agents|mesh-ancestor
56051786|NCT04259645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051787|NCT01787006|Fluorouracil|fluorouracil|mesh-list
56051788|NCT01787006|Cetuximab|cetuximab|mesh-list
56051789|NCT01787006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051790|NCT01787006|Antimetabolites|antimetabolites|mesh-ancestor
56051791|NCT01787006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051792|NCT01787006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56051793|NCT01787006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56051794|NCT01787006|Immunologic Factors|immunologic factors|mesh-ancestor
56051795|NCT01787006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051796|NCT01787006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888606|NCT02256696|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55888607|NCT02256696|Antitubercular Agents|antitubercular agents|mesh-ancestor
55888608|NCT02256696|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55888609|NCT02256696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888610|NCT02256696|Leprostatic Agents|leprostatic agents|mesh-ancestor
55888611|NCT02256696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55888612|NCT02256696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888613|NCT02256696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888614|NCT02256696|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55888615|NCT02256696|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55888625|NCT04936230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55888626|NCT04936230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888627|NCT04936230|Immunologic Factors|immunologic factors|mesh-ancestor
55888628|NCT04936230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888629|NCT01773473|Insulin|insulin|mesh-list
55888630|NCT01773473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55888631|NCT01773473|Insulin Lispro|insulin lispro|mesh-list
55888632|NCT01773473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55888633|NCT01773473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888634|NCT01779869|Regadenoson|regadenoson|mesh-list
55888635|NCT01779869|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55888636|NCT01779869|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55888637|NCT01779869|Purinergic Agonists|purinergic agonists|mesh-ancestor
55888638|NCT01779869|Purinergic Agents|purinergic agents|mesh-ancestor
55888639|NCT01779869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888640|NCT01779869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888641|NCT01779869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888642|NCT01772537|Propofol|propofol|mesh-list
55888643|NCT01772537|Isoflurane|isoflurane|mesh-list
55888644|NCT01772537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55888645|NCT01772537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55888646|NCT01772537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888647|NCT01772537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55888648|NCT01772537|Anesthetics, General|anesthetics, general|mesh-ancestor
55888649|NCT01772537|Anesthetics|anesthetics|mesh-ancestor
55888650|NCT01772537|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55888651|NCT01772147|Fluticasone|fluticasone|mesh-list
55888653|NCT01772147|Bromides|bromides|mesh-list
55888654|NCT01772147|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55888655|NCT01772147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55888656|NCT01772147|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55888657|NCT01772147|Autonomic Agents|autonomic agents|mesh-ancestor
55888658|NCT01772147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888659|NCT01772147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888660|NCT01772147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55888661|NCT01772147|Respiratory System Agents|respiratory system agents|mesh-ancestor
55888662|NCT01772147|Dermatologic Agents|dermatologic agents|mesh-ancestor
55888663|NCT01772147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55888664|NCT01772147|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56051797|NCT02260622|Aspirin|aspirin|mesh-list
56051798|NCT02260622|Rivaroxaban|rivaroxaban|mesh-list
56051800|NCT02260622|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56051801|NCT02260622|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56051802|NCT02260622|Analgesics|analgesics|mesh-ancestor
56051803|NCT02260622|Sensory System Agents|sensory system agents|mesh-ancestor
56051804|NCT02260622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051805|NCT02260622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051806|NCT02260622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56051807|NCT02260622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56051808|NCT02260622|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56051809|NCT02260622|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56051810|NCT02260622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051811|NCT02260622|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56051812|NCT02260622|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56051813|NCT02260622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051814|NCT02260622|Antipyretics|antipyretics|mesh-ancestor
56051815|NCT02260622|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56051816|NCT02260622|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56051817|NCT02260622|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56051818|NCT02260622|Purinergic Agents|purinergic agents|mesh-ancestor
56051819|NCT02260622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051820|NCT02260622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56051821|NCT02260622|Antithrombins|antithrombins|mesh-ancestor
56051822|NCT02260622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56051823|NCT02260622|Protease Inhibitors|protease inhibitors|mesh-ancestor
55888665|NCT01772147|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55888666|NCT01772147|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55888667|NCT01772147|Adrenergic Agents|adrenergic agents|mesh-ancestor
55888668|NCT01772147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888669|NCT01772147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888671|NCT01606787|Mannitol|mannitol|mesh-list
55888672|NCT01606787|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55888673|NCT01606787|Diuretics|diuretics|mesh-ancestor
55888674|NCT01606787|Natriuretic Agents|natriuretic agents|mesh-ancestor
55888675|NCT01606787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888676|NCT01770743|Vaccines|vaccines|mesh-list
55888677|NCT01770743|Immunologic Factors|immunologic factors|mesh-ancestor
55888678|NCT01770743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888679|NCT01777997|Tenofovir|tenofovir|mesh-list
55888680|NCT01777997|Emtricitabine|emtricitabine|mesh-list
55888681|NCT01777997|Rilpivirine|rilpivirine|mesh-list
55888682|NCT01777997|Antiviral Agents|antiviral agents|mesh-ancestor
55888683|NCT01777997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888684|NCT01777997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55888688|NCT01777997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55888689|NCT01777997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56051824|NCT02260622|Anticoagulants|anticoagulants|mesh-ancestor
56051825|NCT03186209|Benralizumab|benralizumab|mesh-list
56051826|NCT03186209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56051827|NCT03186209|Respiratory System Agents|respiratory system agents|mesh-ancestor
56051828|NCT02261948|Simendan|simendan|mesh-list
56051829|NCT02261948|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56051830|NCT02261948|Vasodilator Agents|vasodilator agents|mesh-ancestor
56051831|NCT02261948|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56051832|NCT02261948|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56051833|NCT02261948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56051834|NCT02261948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051835|NCT02261948|Protective Agents|protective agents|mesh-ancestor
56051836|NCT02261948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051837|NCT01787240|Citalopram|citalopram|mesh-list
56051838|NCT01787240|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56051839|NCT01787240|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56051840|NCT01787240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56051841|NCT01787240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051842|NCT01787240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051843|NCT01787240|Serotonin Agents|serotonin agents|mesh-ancestor
56051844|NCT01787240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051845|NCT01787240|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56051846|NCT01787240|Antidepressive Agents|antidepressive agents|mesh-ancestor
56051847|NCT01787240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56051848|NCT00357149|Cisplatin|cisplatin|mesh-list
56051849|NCT00357149|Docetaxel|docetaxel|mesh-list
56051850|NCT00357149|Fluorouracil|fluorouracil|mesh-list
56051851|NCT00357149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051868|NCT04071821|Cetirizine|cetirizine|mesh-list
56051869|NCT04071821|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56051870|NCT04071821|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56051875|NCT04071821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051876|NCT04071821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051877|NCT03064295|Adenosine|adenosine|mesh-list
56051878|NCT03064295|Regadenoson|regadenoson|mesh-list
56051879|NCT03064295|Analgesics|analgesics|mesh-ancestor
56051880|NCT03064295|Sensory System Agents|sensory system agents|mesh-ancestor
55740238|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051881|NCT03064295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051882|NCT03064295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051883|NCT03064295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56051884|NCT03064295|Vasodilator Agents|vasodilator agents|mesh-ancestor
56051885|NCT03064295|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55888692|NCT01770353|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55888693|NCT01770353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55888694|NCT01777763|Posaconazole|posaconazole|mesh-list
55888695|NCT01777763|Antifungal Agents|antifungal agents|mesh-ancestor
55888696|NCT01777763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888697|NCT01777763|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55888698|NCT01777763|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55888699|NCT01777763|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55888700|NCT01777763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55888701|NCT01777763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55888702|NCT01777763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888703|NCT01777763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888704|NCT01777763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55888705|NCT01777763|Hormone Antagonists|hormone antagonists|mesh-ancestor
55753031|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
55888706|NCT01777763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888707|NCT01777763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888708|NCT01769339|Miconazole|miconazole|mesh-list
55888709|NCT01769339|Hydrocortisone|hydrocortisone|mesh-list
55888710|NCT01769339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55888711|NCT01769339|Antifungal Agents|antifungal agents|mesh-ancestor
55888712|NCT01769339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888713|NCT01769339|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55888714|NCT01769339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55888715|NCT01769339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888716|NCT01769339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888717|NCT01769339|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55888718|NCT01769339|Hormone Antagonists|hormone antagonists|mesh-ancestor
55888719|NCT01769339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888720|NCT01769339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888721|NCT01769339|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55888722|NCT01769339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55888723|NCT01777139|Ezogabine|ezogabine|mesh-list
55888724|NCT01777139|Anticonvulsants|anticonvulsants|mesh-ancestor
55888725|NCT01777139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56051887|NCT03064295|Purinergic Agents|purinergic agents|mesh-ancestor
56051888|NCT03064295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051889|NCT03064295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051890|NCT03064295|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56051891|NCT01789814|Clopidogrel|clopidogrel|mesh-list
56051892|NCT01789814|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56051893|NCT01789814|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56051894|NCT01789814|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56051895|NCT01789814|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56051896|NCT01789814|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55888726|NCT01777139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888727|NCT01768637|Aspirin|aspirin|mesh-list
55888728|NCT01768637|Clopidogrel|clopidogrel|mesh-list
55888729|NCT01768637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55888730|NCT01768637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55888731|NCT01768637|Analgesics|analgesics|mesh-ancestor
55888732|NCT01768637|Sensory System Agents|sensory system agents|mesh-ancestor
55888733|NCT01768637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888734|NCT01768637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888735|NCT01768637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55888736|NCT01768637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55888737|NCT01768637|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55888738|NCT01768637|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55888739|NCT01768637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888761|NCT01886872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888762|NCT01768559|Insulin|insulin|mesh-list
55888763|NCT01768559|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55888764|NCT01768559|Metformin|metformin|mesh-list
55888765|NCT01768559|Insulin Glargine|insulin glargine|mesh-list
55888766|NCT01768559|Insulin glulisine|insulin glulisine|mesh-list
55888767|NCT01768559|Lixisenatide|lixisenatide|mesh-list
55888768|NCT01768559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55888769|NCT01768559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888770|NCT00983619|Rituximab|rituximab|mesh-list
55888771|NCT00983619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888772|NCT00983619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888773|NCT00983619|Immunologic Factors|immunologic factors|mesh-ancestor
55888774|NCT00983619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888775|NCT00983619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55888776|NCT00653068|Calcium, Dietary|calcium, dietary|mesh-list
55888777|NCT00653068|Leucovorin|leucovorin|mesh-list
55888778|NCT00653068|Folic Acid|folic acid|mesh-list
55888779|NCT00653068|Cyclophosphamide|cyclophosphamide|mesh-list
55888780|NCT00653068|Thiotepa|thiotepa|mesh-list
55888781|NCT00653068|Cisplatin|cisplatin|mesh-list
55888782|NCT00653068|Carboplatin|carboplatin|mesh-list
56051897|NCT01789814|Purinergic Agents|purinergic agents|mesh-ancestor
56051898|NCT01789814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56051899|NCT01789814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051900|NCT01789814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051901|NCT00356447|Estradiol|estradiol|mesh-list
56051902|NCT00356447|Estrogens|estrogens|mesh-ancestor
56051903|NCT00356447|Hormones|hormones|mesh-ancestor
56051904|NCT00356447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56051905|NCT00356447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051906|NCT01736852|Oxytocin|oxytocin|mesh-list
56051907|NCT01736852|Oxytocics|oxytocics|mesh-ancestor
56051908|NCT01736852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56051909|NCT01736852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051910|NCT01810952|Insulin|insulin|mesh-list
56051911|NCT01810952|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56051912|NCT01810952|Insulin Glargine|insulin glargine|mesh-list
56051913|NCT01810952|Insulin, Isophane|insulin, isophane|mesh-list
56051914|NCT01810952|Isophane Insulin, Human|isophane insulin, human|mesh-list
56051915|NCT01810952|Isophane insulin, beef|isophane insulin, beef|mesh-list
56051916|NCT01810952|Insulin Lispro|insulin lispro|mesh-list
56051917|NCT01810952|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56051918|NCT01810952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051919|NCT04059887|Atezolizumab|atezolizumab|mesh-list
56051920|NCT04059887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051921|NCT01877642|Lorazepam|lorazepam|mesh-list
56051922|NCT01877642|Loxapine|loxapine|mesh-list
56051923|NCT01877642|Anticonvulsants|anticonvulsants|mesh-ancestor
56051924|NCT01877642|Antiemetics|antiemetics|mesh-ancestor
56051925|NCT01877642|Autonomic Agents|autonomic agents|mesh-ancestor
55888783|NCT00653068|Methotrexate|methotrexate|mesh-list
55888784|NCT00653068|Etoposide|etoposide|mesh-list
55888785|NCT00653068|Vincristine|vincristine|mesh-list
55888786|NCT00653068|Etoposide phosphate|etoposide phosphate|mesh-list
55888787|NCT00653068|Podophyllotoxin|podophyllotoxin|mesh-list
55888788|NCT00653068|Lenograstim|lenograstim|mesh-list
55888789|NCT00653068|Calcium|calcium|mesh-list
55888790|NCT00653068|Levoleucovorin|levoleucovorin|mesh-list
55888791|NCT00653068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55888792|NCT00653068|Immunologic Factors|immunologic factors|mesh-ancestor
55888793|NCT00653068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888794|NCT00653068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55888795|NCT00653068|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55888796|NCT00653068|Alkylating Agents|alkylating agents|mesh-ancestor
55888797|NCT00653068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888798|NCT00653068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888799|NCT00653068|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55888800|NCT00653068|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56051926|NCT01877642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56051927|NCT01877642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051928|NCT01877642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56051929|NCT01877642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56051930|NCT01877642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051931|NCT01877642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56051932|NCT01877642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56051933|NCT01877642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56051934|NCT01877642|GABA Modulators|gaba modulators|mesh-ancestor
56051935|NCT01877642|GABA Agents|gaba agents|mesh-ancestor
56051936|NCT01877642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894085|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
56051937|NCT01877642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051938|NCT01877642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56051939|NCT01877642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56051940|NCT01877642|Dopamine Agents|dopamine agents|mesh-ancestor
56051941|NCT02819843|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56051942|NCT02819843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56051943|NCT02819843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56051944|NCT01878656|Sevoflurane|sevoflurane|mesh-list
56051945|NCT01878656|Desflurane|desflurane|mesh-list
56051946|NCT01878656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56051947|NCT01878656|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56051948|NCT01878656|Anesthetics, General|anesthetics, general|mesh-ancestor
56051949|NCT01878656|Anesthetics|anesthetics|mesh-ancestor
56051950|NCT01878656|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56051951|NCT01878656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051952|NCT01811654|Hyaluronic Acid|hyaluronic acid|mesh-list
56051953|NCT01811654|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56051954|NCT01811654|Immunologic Factors|immunologic factors|mesh-ancestor
56051955|NCT01811654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051956|NCT01811654|Viscosupplements|viscosupplements|mesh-ancestor
56051957|NCT01811654|Protective Agents|protective agents|mesh-ancestor
56051958|NCT02266472|Metformin|metformin|mesh-list
56051959|NCT02266472|Empagliflozin|empagliflozin|mesh-list
56051960|NCT02266472|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56051961|NCT02266472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56051966|NCT03500289|Analgesics|analgesics|mesh-ancestor
56051967|NCT03500289|Sensory System Agents|sensory system agents|mesh-ancestor
56051968|NCT03500289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888801|NCT00653068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55888802|NCT00653068|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55888803|NCT00653068|Abortifacient Agents|abortifacient agents|mesh-ancestor
55888804|NCT00653068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55888805|NCT00653068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55888806|NCT00653068|Antimetabolites|antimetabolites|mesh-ancestor
55888807|NCT00653068|Dermatologic Agents|dermatologic agents|mesh-ancestor
55888808|NCT00653068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888809|NCT00653068|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55888810|NCT00653068|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55888811|NCT00653068|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55888812|NCT00653068|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55888813|NCT00653068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55888814|NCT00653068|Antidotes|antidotes|mesh-ancestor
55888815|NCT00653068|Protective Agents|protective agents|mesh-ancestor
55888816|NCT00653068|Vitamin B Complex|vitamin b complex|mesh-ancestor
55888817|NCT00653068|Vitamins|vitamins|mesh-ancestor
55888818|NCT00653068|Micronutrients|micronutrients|mesh-ancestor
55888819|NCT00653068|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55888820|NCT00653068|Tubulin Modulators|tubulin modulators|mesh-ancestor
55888821|NCT00653068|Antimitotic Agents|antimitotic agents|mesh-ancestor
55888822|NCT00653068|Mitosis Modulators|mitosis modulators|mesh-ancestor
55888823|NCT00653068|Hematinics|hematinics|mesh-ancestor
55888824|NCT00653068|Keratolytic Agents|keratolytic agents|mesh-ancestor
55888825|NCT03028311|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
55888826|NCT03028311|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55888828|NCT05608785|Capecitabine|capecitabine|mesh-list
55888829|NCT05608785|Oxaliplatin|oxaliplatin|mesh-list
55888830|NCT05608785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55888831|NCT05608785|Antimetabolites|antimetabolites|mesh-ancestor
55888832|NCT05608785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888833|NCT05608785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888834|NCT03037437|Hydroxychloroquine|hydroxychloroquine|mesh-list
55888835|NCT03037437|Sorafenib|sorafenib|mesh-list
55888836|NCT03037437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888837|NCT03037437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55888838|NCT03037437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888839|NCT03037437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888840|NCT03037437|Antimalarials|antimalarials|mesh-ancestor
55888841|NCT03037437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55888842|NCT03037437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55888843|NCT03037437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888844|NCT03037437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55888845|NCT01775501|Leucovorin|leucovorin|mesh-list
55888846|NCT01775501|Fluorouracil|fluorouracil|mesh-list
55888847|NCT01775501|Oxaliplatin|oxaliplatin|mesh-list
55888848|NCT01775501|Sorafenib|sorafenib|mesh-list
55888849|NCT01775501|Antimetabolites|antimetabolites|mesh-ancestor
55888850|NCT01775501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053785|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
55888955|NCT03832816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888966|NCT04231084|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55888967|NCT04231084|Respiratory System Agents|respiratory system agents|mesh-ancestor
55888968|NCT04231084|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55888969|NCT04231084|Antioxidants|antioxidants|mesh-ancestor
55888970|NCT04231084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888971|NCT04231084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55888972|NCT04231084|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55888973|NCT04231084|Gasotransmitters|gasotransmitters|mesh-ancestor
55888974|NCT04231084|Protective Agents|protective agents|mesh-ancestor
55888975|NCT04231084|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55888976|NCT04231084|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55888977|NCT01884844|Vitamin D|vitamin d|mesh-list
55888978|NCT01884844|Cholecalciferol|cholecalciferol|mesh-list
55888979|NCT01884844|Vitamins|vitamins|mesh-ancestor
55888980|NCT01884844|Micronutrients|micronutrients|mesh-ancestor
55888981|NCT01884844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888982|NCT01884844|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55888983|NCT01884844|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55888984|NCT04123587|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55888985|NCT04123587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888986|NCT04127721|Methotrexate|methotrexate|mesh-list
55888987|NCT04127721|Fludarabine|fludarabine|mesh-list
55888988|NCT04127721|Busulfan|busulfan|mesh-list
55888989|NCT04127721|Tacrolimus|tacrolimus|mesh-list
55888990|NCT04127721|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55888991|NCT04127721|Abortifacient Agents|abortifacient agents|mesh-ancestor
55888992|NCT04127721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55888993|NCT04127721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888994|NCT04127721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55888995|NCT04127721|Antimetabolites|antimetabolites|mesh-ancestor
56051996|NCT01812044|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56051997|NCT01812044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56051998|NCT01812044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56051999|NCT03974789|Dexamethasone|dexamethasone|mesh-list
56052000|NCT03974789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56052001|NCT03974789|Antiemetics|antiemetics|mesh-ancestor
56052002|NCT03974789|Autonomic Agents|autonomic agents|mesh-ancestor
56052003|NCT03974789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052004|NCT03974789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052005|NCT03974789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56052006|NCT03974789|Glucocorticoids|glucocorticoids|mesh-ancestor
56052007|NCT03974789|Hormones|hormones|mesh-ancestor
56052008|NCT03974789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052009|NCT03974789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56052010|NCT03974789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052011|NCT01812668|Fluorides|fluorides|mesh-list
55888996|NCT04127721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888997|NCT04127721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888998|NCT04127721|Dermatologic Agents|dermatologic agents|mesh-ancestor
55888999|NCT04127721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889000|NCT04127721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55889001|NCT04127721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55889002|NCT04127721|Immunologic Factors|immunologic factors|mesh-ancestor
55889003|NCT04127721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889004|NCT04127721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55889005|NCT04127721|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55889006|NCT04127721|Alkylating Agents|alkylating agents|mesh-ancestor
55889007|NCT04127721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55889008|NCT04127721|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55889009|NCT04123743|Sunscreening Agents|sunscreening agents|mesh-list
55889010|NCT04123743|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55889011|NCT04123743|Protective Agents|protective agents|mesh-ancestor
55889012|NCT04123743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889013|NCT04123743|Dermatologic Agents|dermatologic agents|mesh-ancestor
55889014|NCT02996721|Vitamin D|vitamin d|mesh-list
55889015|NCT02996721|Cholecalciferol|cholecalciferol|mesh-list
55889016|NCT02996721|Vitamins|vitamins|mesh-ancestor
55889017|NCT02996721|Micronutrients|micronutrients|mesh-ancestor
55889018|NCT02996721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889019|NCT02996721|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55889020|NCT02996721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55889032|NCT03945448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889033|NCT03945448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889073|NCT04122105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889074|NCT04122105|Urological Agents|urological agents|mesh-ancestor
55889075|NCT02270632|Methotrexate|methotrexate|mesh-list
55889076|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55889077|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
55889078|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55889079|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889080|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55889081|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
55889086|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55889087|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55889088|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
55889089|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889090|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55889092|NCT04127019|Docetaxel|docetaxel|mesh-list
55889093|NCT04127019|Cyclophosphamide|cyclophosphamide|mesh-list
55889094|NCT04127019|Fluorouracil|fluorouracil|mesh-list
55889095|NCT04127019|Epirubicin|epirubicin|mesh-list
55889096|NCT04127019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55889097|NCT04127019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889098|NCT04127019|Tubulin Modulators|tubulin modulators|mesh-ancestor
55889099|NCT04127019|Antimitotic Agents|antimitotic agents|mesh-ancestor
55889100|NCT04127019|Mitosis Modulators|mitosis modulators|mesh-ancestor
55889101|NCT04127019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889102|NCT04127019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55889103|NCT04127019|Immunologic Factors|immunologic factors|mesh-ancestor
55889104|NCT04127019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889105|NCT04127019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889106|NCT04127019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55889107|NCT04127019|Alkylating Agents|alkylating agents|mesh-ancestor
55889108|NCT04127019|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55889109|NCT04127019|Antimetabolites|antimetabolites|mesh-ancestor
56052020|NCT04344821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052021|NCT04351100|Diacetylrhein|diacetylrhein|mesh-list
56052022|NCT04351100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56052023|NCT05328674|Mitogens|mitogens|mesh-list
56052025|NCT05328674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052026|NCT01798316|Acetaminophen|acetaminophen|mesh-list
56052027|NCT01798316|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56052028|NCT01798316|Analgesics|analgesics|mesh-ancestor
56052029|NCT01798316|Sensory System Agents|sensory system agents|mesh-ancestor
56052030|NCT01798316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740240|NCT01164995|Carboplatin|carboplatin|mesh-list
56052031|NCT01798316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052032|NCT01798316|Antipyretics|antipyretics|mesh-ancestor
56052033|NCT03883763|Bupivacaine|bupivacaine|mesh-list
56052034|NCT03883763|Anesthetics, Local|anesthetics, local|mesh-ancestor
55889110|NCT04127019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55889111|NCT04127019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55889112|NCT04127019|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55889113|NCT04127019|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55889114|NCT04127019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889115|NCT02076646|Interleukin-2|interleukin-2|mesh-list
55889116|NCT02076646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889117|NCT02076646|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55889118|NCT02076646|Analgesics|analgesics|mesh-ancestor
55889119|NCT02076646|Sensory System Agents|sensory system agents|mesh-ancestor
55889120|NCT02076646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889121|NCT02076646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889122|NCT03201939|Lisinopril|lisinopril|mesh-list
55889123|NCT03201939|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55889124|NCT03201939|Protease Inhibitors|protease inhibitors|mesh-ancestor
55889125|NCT03201939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889126|NCT03201939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889127|NCT03201939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55889128|NCT03201939|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55889129|NCT03201939|Protective Agents|protective agents|mesh-ancestor
55889130|NCT03201939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889131|NCT03295227|Pembrolizumab|pembrolizumab|mesh-list
55889132|NCT03295227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55889133|NCT03295227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889134|NCT01919086|Dexamethasone|dexamethasone|mesh-list
55889135|NCT01919086|Lenalidomide|lenalidomide|mesh-list
55889136|NCT01919086|Bortezomib|bortezomib|mesh-list
55889137|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889138|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
55889139|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
55889489|NCT02962401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889490|NCT03828279|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55889491|NCT03828279|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55889492|NCT03828279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55889493|NCT03828279|Immunologic Factors|immunologic factors|mesh-ancestor
55889494|NCT03828279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889495|NCT02987920|Acetaminophen|acetaminophen|mesh-list
55889496|NCT02987920|Celecoxib|celecoxib|mesh-list
55889497|NCT02987920|Ketorolac|ketorolac|mesh-list
55889498|NCT02987920|Oxycodone|oxycodone|mesh-list
55889499|NCT02987920|Gabapentin|gabapentin|mesh-list
55889500|NCT02987920|Hydromorphone|hydromorphone|mesh-list
55889501|NCT02987920|Dextromethorphan|dextromethorphan|mesh-list
55889502|NCT02987920|Pantoprazole|pantoprazole|mesh-list
55889503|NCT02987920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55889504|NCT02987920|Analgesics|analgesics|mesh-ancestor
55889505|NCT02987920|Sensory System Agents|sensory system agents|mesh-ancestor
55889506|NCT02987920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889507|NCT02987920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889508|NCT02987920|Antipyretics|antipyretics|mesh-ancestor
55889509|NCT02987920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55889510|NCT02987920|Narcotics|narcotics|mesh-ancestor
56052157|NCT03279237|Protective Agents|protective agents|mesh-ancestor
56052158|NCT03279237|Vitamin B Complex|vitamin b complex|mesh-ancestor
56052159|NCT03279237|Vitamins|vitamins|mesh-ancestor
56052160|NCT03279237|Micronutrients|micronutrients|mesh-ancestor
56052161|NCT03282591|Serlopitant|serlopitant|mesh-list
56052162|NCT03282591|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56052163|NCT03282591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052164|NCT03282591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052165|NCT03282591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052166|NCT03509883|Apixaban|apixaban|mesh-list
56052167|NCT03509883|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56052168|NCT03509883|Antithrombins|antithrombins|mesh-ancestor
56052169|NCT03509883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56052170|NCT03509883|Protease Inhibitors|protease inhibitors|mesh-ancestor
55889511|NCT02987920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55889512|NCT02987920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55889513|NCT02987920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889514|NCT02987920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889515|NCT02987920|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55889516|NCT02987920|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55889517|NCT02987920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889518|NCT02987920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889519|NCT02987920|Anticonvulsants|anticonvulsants|mesh-ancestor
55889520|NCT02987920|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55889521|NCT02987920|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55889522|NCT02987920|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55889523|NCT02987920|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55889524|NCT02987920|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55889525|NCT02987920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889526|NCT02987920|Antimanic Agents|antimanic agents|mesh-ancestor
55889527|NCT02987920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55889528|NCT02987920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55889529|NCT02987920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55889530|NCT02987920|Antitussive Agents|antitussive agents|mesh-ancestor
55889531|NCT02987920|Respiratory System Agents|respiratory system agents|mesh-ancestor
55889532|NCT02974257|Thiamine|thiamine|mesh-list
55889533|NCT02974257|Vitamins|vitamins|mesh-ancestor
55889534|NCT02974257|Micronutrients|micronutrients|mesh-ancestor
55889535|NCT02974257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889536|NCT02974257|Vitamin B Complex|vitamin b complex|mesh-ancestor
55889537|NCT01736189|Adalimumab|adalimumab|mesh-list
55889538|NCT01736189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889539|NCT01736189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889540|NCT02970981|Nivolumab|nivolumab|mesh-list
55889541|NCT02970981|Ipilimumab|ipilimumab|mesh-list
55889542|NCT02970981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55889543|NCT02970981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889544|NCT02970981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55889545|NCT02970981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889546|NCT03374800|Pantoprazole|pantoprazole|mesh-list
55889547|NCT03374800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55889548|NCT03374800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55753244|NCT03071679|Imiquimod|imiquimod|mesh-list
55889549|NCT03374800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55889550|NCT03374800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889571|NCT01941628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052172|NCT03509883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052173|NCT03509883|Anticoagulants|anticoagulants|mesh-ancestor
56052174|NCT03336645|Midazolam|midazolam|mesh-list
56052175|NCT03336645|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56052176|NCT03336645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56052177|NCT03336645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052178|NCT03336645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052179|NCT03336645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56052180|NCT03336645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56052181|NCT03336645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56052182|NCT03336645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56052183|NCT03336645|Anesthetics, General|anesthetics, general|mesh-ancestor
56052184|NCT03336645|Anesthetics|anesthetics|mesh-ancestor
56052185|NCT03336645|GABA Modulators|gaba modulators|mesh-ancestor
56052186|NCT03336645|GABA Agents|gaba agents|mesh-ancestor
56052187|NCT03336645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052188|NCT03336645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052189|NCT00376311|Calcitonin|calcitonin|mesh-list
56052190|NCT00376311|Salmon calcitonin|salmon calcitonin|mesh-list
56052191|NCT00376311|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56052192|NCT00376311|Katacalcin|katacalcin|mesh-list
56052193|NCT00376311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56052194|NCT00376311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052195|NCT00376311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56052196|NCT00376311|Vasodilator Agents|vasodilator agents|mesh-ancestor
56052197|NCT03511521|Insulin|insulin|mesh-list
55889578|NCT02987218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889579|NCT02987218|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55889580|NCT02987218|Anesthetics, General|anesthetics, general|mesh-ancestor
55889581|NCT02987218|Anesthetics|anesthetics|mesh-ancestor
55889582|NCT02987218|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55889583|NCT01762943|Leuprolide|leuprolide|mesh-list
55889584|NCT01762943|Estradiol|estradiol|mesh-list
55889585|NCT01762943|Progesterone|progesterone|mesh-list
55889586|NCT01762943|Estrogens|estrogens|mesh-ancestor
55889587|NCT01762943|Hormones|hormones|mesh-ancestor
55889588|NCT01762943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889589|NCT01762943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889590|NCT01762943|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55889591|NCT01762943|Progestins|progestins|mesh-ancestor
55889592|NCT01762943|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55889593|NCT01762943|Fertility Agents|fertility agents|mesh-ancestor
55889594|NCT01762943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55889595|NCT01762943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889596|NCT04392063|Melatonin|melatonin|mesh-list
55889597|NCT04392063|Antioxidants|antioxidants|mesh-ancestor
55889598|NCT04392063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889599|NCT04392063|Protective Agents|protective agents|mesh-ancestor
56052199|NCT03511521|Insulin Aspart|insulin aspart|mesh-list
56052200|NCT03511521|Insulin, Isophane|insulin, isophane|mesh-list
56052201|NCT03511521|Isophane Insulin, Human|isophane insulin, human|mesh-list
56052202|NCT03511521|Isophane insulin, beef|isophane insulin, beef|mesh-list
56052203|NCT03511521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56052204|NCT03511521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052205|NCT00376077|Methylprednisolone|methylprednisolone|mesh-list
56052206|NCT00376077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56052207|NCT00376077|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56052208|NCT00376077|gamma-Globulins|gamma-globulins|mesh-list
56052209|NCT00376077|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56052210|NCT00376077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56052211|NCT00376077|Antiemetics|antiemetics|mesh-ancestor
56052212|NCT00376077|Autonomic Agents|autonomic agents|mesh-ancestor
56052213|NCT00376077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052214|NCT00376077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052215|NCT00376077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56052216|NCT00376077|Glucocorticoids|glucocorticoids|mesh-ancestor
55889600|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889601|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55889602|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
55889603|NCT01903798|Prednisolone|prednisolone|mesh-list
55889617|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889618|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55889619|NCT01945138|Insulin|insulin|mesh-list
55889620|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55889621|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55889622|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889623|NCT03798639|Nivolumab|nivolumab|mesh-list
55889624|NCT03798639|Ipilimumab|ipilimumab|mesh-list
55889628|NCT03798639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889629|NCT01734785|Empagliflozin|empagliflozin|mesh-list
55889630|NCT01734785|Linagliptin|linagliptin|mesh-list
55889631|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55889632|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889633|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55889634|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889635|NCT01734785|Incretins|incretins|mesh-ancestor
55889636|NCT01734785|Hormones|hormones|mesh-ancestor
55889637|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889638|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55889639|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
55889640|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889641|NCT03821415|Estradiol|estradiol|mesh-list
55889642|NCT03821415|Estrogens|estrogens|mesh-ancestor
55889643|NCT03821415|Hormones|hormones|mesh-ancestor
55889644|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889645|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889646|NCT01734395|Galantamine|galantamine|mesh-list
55889647|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55889648|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889649|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052218|NCT00376077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052219|NCT00376077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55889650|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
55889651|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889652|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889653|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55889654|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
55889655|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889656|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
55889657|NCT02918721|Lidocaine|lidocaine|mesh-list
55889658|NCT02918721|Hyaluronic Acid|hyaluronic acid|mesh-list
55889659|NCT02918721|Anesthetics, Local|anesthetics, local|mesh-ancestor
55889660|NCT02918721|Anesthetics|anesthetics|mesh-ancestor
55889661|NCT02918721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55889663|NCT02918721|Sensory System Agents|sensory system agents|mesh-ancestor
55889664|NCT02918721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889665|NCT02918721|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55889666|NCT02918721|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55889674|NCT01945294|Interferons|interferons|mesh-list
55889675|NCT01945294|Ribavirin|ribavirin|mesh-list
55889676|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
55889677|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
55889678|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55889679|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889680|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
55889681|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889682|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
55889683|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889684|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
55889685|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889686|NCT04392297|Antibodies|antibodies|mesh-list
55889687|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
55889688|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
55889689|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889690|NCT01947946|Benralizumab|benralizumab|mesh-list
55889691|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55889692|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
55889693|NCT02954055|Paclitaxel|paclitaxel|mesh-list
55889694|NCT02954055|Vinorelbine|vinorelbine|mesh-list
55889695|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55889696|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
55889697|NCT02954055|Capecitabine|capecitabine|mesh-list
55889698|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55889699|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889700|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
55889701|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
55889702|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
55889703|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889704|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55889705|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
55889706|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889707|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889708|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55889717|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889718|NCT03275506|Bevacizumab|bevacizumab|mesh-list
55889719|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
55889720|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55889721|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889722|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55889723|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55889724|NCT03275506|Growth Substances|growth substances|mesh-ancestor
55753290|NCT03201835|Nabiximols|nabiximols|mesh-list
55889725|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052221|NCT00376077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56052222|NCT00376077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052223|NCT00376077|Immunologic Factors|immunologic factors|mesh-ancestor
56052224|NCT03519243|Darbepoetin alfa|darbepoetin alfa|mesh-list
56052225|NCT03519243|Hematinics|hematinics|mesh-ancestor
56052226|NCT03577275|Moxifloxacin|moxifloxacin|mesh-list
55889727|NCT03820245|Lycopene|lycopene|mesh-list
55889728|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889729|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
55889730|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889731|NCT03820245|Protective Agents|protective agents|mesh-ancestor
55889732|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889733|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55889734|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55889735|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889738|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889739|NCT03826485|Pranlukast|pranlukast|mesh-list
55889740|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55889741|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
55889742|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55889743|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
55889744|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889745|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889746|NCT03823989|Mitomycins|mitomycins|mesh-list
55889747|NCT03823989|Mitomycin|mitomycin|mesh-list
55889748|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55889749|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889750|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
55889751|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889752|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55889753|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889754|NCT03826875|Fluoxetine|fluoxetine|mesh-list
55889755|NCT03826875|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55889756|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55889757|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55889758|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889759|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889760|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
55889761|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889762|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55889763|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
55889764|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55889765|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55889766|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55889767|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889768|NCT01951066|Dexamethasone|dexamethasone|mesh-list
55889769|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889770|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
55889771|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
55889772|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889773|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889774|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55889775|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
55889776|NCT01951066|Hormones|hormones|mesh-ancestor
55889777|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790666|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
55889778|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55889780|NCT02916771|Dexamethasone|dexamethasone|mesh-list
55889781|NCT02916771|Lenalidomide|lenalidomide|mesh-list
55889782|NCT02916771|Ixazomib|ixazomib|mesh-list
55889783|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889784|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
55889785|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
55889786|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753295|NCT02478515|Ranibizumab|ranibizumab|mesh-list
56052232|NCT03577275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052233|NCT03577275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052234|NCT03521505|Dexmedetomidine|dexmedetomidine|mesh-list
56052235|NCT03521505|Propofol|propofol|mesh-list
56052236|NCT03521505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56052237|NCT03521505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052238|NCT03521505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052239|NCT03521505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56052240|NCT03521505|Anesthetics, General|anesthetics, general|mesh-ancestor
56052241|NCT03521505|Anesthetics|anesthetics|mesh-ancestor
55889791|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889792|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55889793|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889794|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
55889795|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55889796|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55889797|NCT02916771|Growth Substances|growth substances|mesh-ancestor
55889798|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
55889799|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
55889800|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889801|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889802|NCT05735626|Capsaicin|capsaicin|mesh-list
55889803|NCT05735626|Piperine|piperine|mesh-list
55889804|NCT05735626|Antipruritics|antipruritics|mesh-ancestor
55889805|NCT05735626|Dermatologic Agents|dermatologic agents|mesh-ancestor
55889806|NCT05735626|Sensory System Agents|sensory system agents|mesh-ancestor
55889807|NCT05735626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889808|NCT05735626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889816|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889817|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889818|NCT05735470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55889819|NCT05735470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889820|NCT03825861|Folfirinox|folfirinox|mesh-list
55889821|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889822|NCT01760447|Metformin|metformin|mesh-list
55889823|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55889824|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55889825|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889826|NCT01760447|Incretins|incretins|mesh-ancestor
55889827|NCT01760447|Hormones|hormones|mesh-ancestor
55889828|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889829|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55889830|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
55889831|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889832|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889834|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55889835|NCT01915108|Narcotics|narcotics|mesh-ancestor
55889836|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55889837|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889839|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
55889840|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889841|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
55889842|NCT03825471|Anesthetics|anesthetics|mesh-list
56052242|NCT03521505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56052243|NCT03521505|Analgesics|analgesics|mesh-ancestor
56052244|NCT03521505|Sensory System Agents|sensory system agents|mesh-ancestor
56052245|NCT03521505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052246|NCT03521505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56052247|NCT03521505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56052248|NCT03521505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56052249|NCT03521505|Adrenergic Agents|adrenergic agents|mesh-ancestor
56052250|NCT03521505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052251|NCT03521505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052252|NCT03522441|Clindamycin|clindamycin|mesh-list
56052253|NCT03522441|Clindamycin palmitate|clindamycin palmitate|mesh-list
56052254|NCT03522441|Clindamycin phosphate|clindamycin phosphate|mesh-list
56052255|NCT03522441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56052256|NCT03522441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052257|NCT03522441|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56052258|NCT03522441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052259|NCT03522441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052260|NCT03530631|Adderall|adderall|mesh-list
56052261|NCT03530631|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56052262|NCT03530631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889866|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889867|NCT01917214|Sunitinib|sunitinib|mesh-list
55889868|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889869|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55889870|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55889871|NCT01917214|Growth Substances|growth substances|mesh-ancestor
55889872|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889873|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
55889874|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55889875|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889876|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889880|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889881|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889882|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55889883|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
55889884|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889885|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889886|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55889887|NCT01732913|Rituximab|rituximab|mesh-list
55889888|NCT01732913|Idelalisib|idelalisib|mesh-list
55753336|NCT03198637|Cisatracurium|cisatracurium|mesh-list
55889889|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55889890|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889891|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
55889892|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889893|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889894|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889895|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889896|NCT03824925|Zinc|zinc|mesh-list
55889897|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
55889898|NCT03824925|Trace Elements|trace elements|mesh-ancestor
55889899|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
55889900|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889901|NCT03824925|Astringents|astringents|mesh-ancestor
55889902|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
55889903|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55889904|NCT03825081|Pilocarpine|pilocarpine|mesh-list
55889905|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55889906|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55889907|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55889908|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55889909|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
55889910|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889911|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889912|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889913|NCT03825081|Miotics|miotics|mesh-ancestor
55889914|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
55889915|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889916|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55889917|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55889918|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
55889919|NCT02912715|Paclitaxel|paclitaxel|mesh-list
55889920|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55889921|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889922|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
55889923|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
55889924|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
56052275|NCT03594045|Antithrombins|antithrombins|mesh-ancestor
56052276|NCT03594045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56052277|NCT03594045|Protease Inhibitors|protease inhibitors|mesh-ancestor
56052278|NCT03594045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052279|NCT03594045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052280|NCT03594045|Anticoagulants|anticoagulants|mesh-ancestor
56052281|NCT03595449|Lidocaine|lidocaine|mesh-list
56052282|NCT03595449|Anesthetics, Local|anesthetics, local|mesh-ancestor
56052283|NCT03595449|Anesthetics|anesthetics|mesh-ancestor
56052284|NCT03595449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052285|NCT03595449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052286|NCT03595449|Sensory System Agents|sensory system agents|mesh-ancestor
56052287|NCT03595449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052288|NCT03595449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56052289|NCT03595449|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56052290|NCT03595449|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56052291|NCT03595449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55889996|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56052292|NCT03595449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052293|NCT03597009|Nivolumab|nivolumab|mesh-list
56052294|NCT03597009|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56052295|NCT03597009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56052296|NCT03597009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052297|NCT03597009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56052298|NCT03597009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889925|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889926|NCT01920802|Olanzapine|olanzapine|mesh-list
55889927|NCT01920802|Iloperidone|iloperidone|mesh-list
55889928|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
55889929|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
55889930|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889931|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889932|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55889933|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55889934|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55889935|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55889936|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55889937|NCT01920802|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55889938|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55889939|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55889940|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889941|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889942|NCT01920802|Serotonin Agents|serotonin agents|mesh-ancestor
55889943|NCT01451229|Higenamine|higenamine|mesh-list
55889944|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55889945|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55889946|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
55889947|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052300|NCT03352323|Oxymetazoline|oxymetazoline|mesh-list
56052301|NCT03352323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56052302|NCT03352323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56052303|NCT03352323|Adrenergic Agents|adrenergic agents|mesh-ancestor
56052304|NCT03352323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052305|NCT03352323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052306|NCT03352323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052307|NCT03352323|Sympathomimetics|sympathomimetics|mesh-ancestor
56052308|NCT03352323|Autonomic Agents|autonomic agents|mesh-ancestor
56052309|NCT03352323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052310|NCT03352323|Nasal Decongestants|nasal decongestants|mesh-ancestor
56052311|NCT03352323|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55889948|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889963|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889965|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
55889966|NCT01921894|Vitamins|vitamins|mesh-ancestor
55889967|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
55889968|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889969|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55889970|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55889971|NCT01452009|Travoprost|travoprost|mesh-list
55889972|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55889973|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55889974|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55889975|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55889976|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
55889977|NCT03824379|Cathartics|cathartics|mesh-ancestor
55889978|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55889979|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889980|NCT01957930|Insulin|insulin|mesh-list
55889981|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55889982|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55889983|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889984|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55889985|NCT01732757|Dextrans|dextrans|mesh-list
55889986|NCT01732757|Alcaftadine|alcaftadine|mesh-list
55889987|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
55889988|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
55889989|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
55889990|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55889991|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55889992|NCT01732757|Analgesics|analgesics|mesh-ancestor
55889993|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
55889994|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889995|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889999|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55890000|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55890001|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
55890002|NCT01732757|Histamine Agents|histamine agents|mesh-ancestor
55890003|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890004|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890005|NCT01758731|Cetuximab|cetuximab|mesh-list
55890006|NCT01758731|Olaparib|olaparib|mesh-list
55890007|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55890008|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890009|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56052312|NCT03352323|Respiratory System Agents|respiratory system agents|mesh-ancestor
56052313|NCT03352323|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56052314|NCT03352323|Mydriatics|mydriatics|mesh-ancestor
56052315|NCT03352323|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56052316|NCT03352323|Protective Agents|protective agents|mesh-ancestor
56052317|NCT04734639|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
56052318|NCT04734639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052319|NCT04734639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052320|NCT03357393|Midazolam|midazolam|mesh-list
56052321|NCT03357393|Glycopyrrolate|glycopyrrolate|mesh-list
56052322|NCT03357393|Scopolamine|scopolamine|mesh-list
56052323|NCT03357393|Morphine|morphine|mesh-list
56052324|NCT03357393|Propofol|propofol|mesh-list
56052325|NCT03357393|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56052326|NCT03357393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56052327|NCT03357393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890017|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
55890018|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890019|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890020|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55890021|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890022|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
55890023|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55890024|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890025|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890026|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
55890027|NCT01452633|Bupivacaine|bupivacaine|mesh-list
55890028|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
55890029|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
55890030|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890031|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890032|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
55890033|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890034|NCT01606319|Acetaminophen|acetaminophen|mesh-list
55890036|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55890037|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55890038|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55890039|NCT01606319|Analgesics|analgesics|mesh-ancestor
55890040|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
55890041|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890042|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890043|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
55890044|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890045|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55890046|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890047|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890048|NCT01452711|Lansoprazole|lansoprazole|mesh-list
55890049|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
55890050|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55890051|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55890052|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55890053|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890054|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890055|NCT02630121|Phenylephrine|phenylephrine|mesh-list
55890056|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
55890057|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55890058|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55890059|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
55890060|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052328|NCT03357393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052329|NCT03357393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56052330|NCT03357393|Anesthetics, General|anesthetics, general|mesh-ancestor
56052331|NCT03357393|Anesthetics|anesthetics|mesh-ancestor
56052332|NCT03357393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56052333|NCT03357393|Narcotics|narcotics|mesh-ancestor
56052344|NCT03357393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052345|NCT03357393|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55890061|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753380|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
55890062|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890063|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
55890064|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
55890065|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890066|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
55890067|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55890068|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
55890069|NCT02630121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55890070|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
55890071|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55890072|NCT02630121|Protective Agents|protective agents|mesh-ancestor
55890073|NCT02956785|Dinoprostone|dinoprostone|mesh-list
55890074|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
55890075|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55890076|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890077|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
55890090|NCT02947581|Praziquantel|praziquantel|mesh-list
55890091|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
55890092|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55890093|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890094|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
55890095|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55890096|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55890097|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
55890098|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
55890099|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
55890100|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890101|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890102|NCT02618577|Edoxaban|edoxaban|mesh-list
55890103|NCT02618577|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55890104|NCT02618577|Antithrombins|antithrombins|mesh-ancestor
55890105|NCT02618577|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55753422|NCT05712941|Letrozole|letrozole|mesh-list
55890106|NCT02618577|Protease Inhibitors|protease inhibitors|mesh-ancestor
55890107|NCT02618577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890108|NCT02618577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890109|NCT02618577|Anticoagulants|anticoagulants|mesh-ancestor
55890110|NCT05606757|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55890111|NCT05606757|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56052346|NCT03357393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56052347|NCT03357393|Cholinergic Agents|cholinergic agents|mesh-ancestor
56052348|NCT03357393|Antiemetics|antiemetics|mesh-ancestor
56052349|NCT03357393|Autonomic Agents|autonomic agents|mesh-ancestor
56052350|NCT03357393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56052351|NCT03357393|Mydriatics|mydriatics|mesh-ancestor
56052352|NCT03357393|Parasympatholytics|parasympatholytics|mesh-ancestor
56052353|NCT03541941|Bupivacaine|bupivacaine|mesh-list
56052354|NCT03541941|Anesthetics, Local|anesthetics, local|mesh-ancestor
56052355|NCT03541941|Anesthetics|anesthetics|mesh-ancestor
56052356|NCT03541941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052357|NCT03541941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052361|NCT00376467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052362|NCT00376467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56052363|NCT00376467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052364|NCT00376467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052366|NCT03556761|Diuretics|diuretics|mesh-ancestor
56052367|NCT03556761|Natriuretic Agents|natriuretic agents|mesh-ancestor
56052368|NCT03556761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890112|NCT05606757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55890113|NCT05606757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890114|NCT05606757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890115|NCT05606757|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55890116|NCT05606757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55890117|NCT05606757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890118|NCT05606757|Cholinergic Agents|cholinergic agents|mesh-ancestor
55890119|NCT05606757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890120|NCT01453881|Beclomethasone|beclomethasone|mesh-list
55890121|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
55890122|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55890123|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
55890124|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890125|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890133|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890134|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55890135|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
55890136|NCT01453881|Hormones|hormones|mesh-ancestor
55890137|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052369|NCT03556761|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56052370|NCT03556761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56052371|NCT03556761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052372|NCT03559179|Analgesics, Opioid|analgesics, opioid|mesh-list
56052373|NCT03559179|Narcotics|narcotics|mesh-ancestor
56052374|NCT03559179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052375|NCT03559179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052376|NCT03559179|Analgesics|analgesics|mesh-ancestor
56052377|NCT03559179|Sensory System Agents|sensory system agents|mesh-ancestor
56052378|NCT03559179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052379|NCT03366207|Ciprofloxacin|ciprofloxacin|mesh-list
56052380|NCT03366207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56052381|NCT03366207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052382|NCT03366207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55890138|NCT04391361|Atropine|atropine|mesh-list
55890139|NCT04391361|Scopolamine|scopolamine|mesh-list
55890140|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
55890141|NCT04391361|Edaravone|edaravone|mesh-list
55890152|NCT04391361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55890153|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
55890154|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890155|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890156|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55890157|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55890158|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55890159|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
55890160|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55890161|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
55890162|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
55890163|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
55890164|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55890165|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55890166|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
55890167|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
55753432|NCT03198949|Everolimus|everolimus|mesh-list
55890168|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55890169|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55890170|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
55890171|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55890172|NCT04391361|Protective Agents|protective agents|mesh-ancestor
55890173|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
55890174|NCT03035331|Vaccines|vaccines|mesh-list
55890175|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
55890176|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890177|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55890178|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890179|NCT04273191|Brexanolone|brexanolone|mesh-list
55890180|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
55890181|NCT04273191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890182|NCT04273191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890183|NCT04273191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890184|NCT04273191|GABA Modulators|gaba modulators|mesh-ancestor
55890185|NCT04273191|GABA Agents|gaba agents|mesh-ancestor
55890186|NCT04391985|Sofosbuvir|sofosbuvir|mesh-list
55890187|NCT04391985|Antiviral Agents|antiviral agents|mesh-ancestor
55890188|NCT04391985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890189|NCT01455597|Estradiol|estradiol|mesh-list
55890190|NCT01455597|Estrogens|estrogens|mesh-ancestor
55890191|NCT01455597|Hormones|hormones|mesh-ancestor
55890192|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052383|NCT03366207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56052384|NCT03366207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052385|NCT03366207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052386|NCT03366207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052387|NCT03366207|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56052388|NCT03366207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56052389|NCT03368235|Prednisolone|prednisolone|mesh-list
55890193|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890194|NCT01453101|Fludarabine|fludarabine|mesh-list
55890195|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
55890196|NCT01453101|Bortezomib|bortezomib|mesh-list
55890197|NCT01453101|Melphalan|melphalan|mesh-list
55890201|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890202|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890203|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
55890204|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890205|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55890216|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55890217|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55890218|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
55890219|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890220|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890221|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55890222|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55890223|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
55890224|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
55890225|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
55890226|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890227|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55890228|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55890229|NCT04847193|Xanthohumol|xanthohumol|mesh-list
55890230|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890231|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55890232|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55890233|NCT04847193|Growth Substances|growth substances|mesh-ancestor
55890234|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890235|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
55890236|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
55890237|NCT04848519|Propranolol|propranolol|mesh-list
55890238|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55890239|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890240|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55890241|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55890242|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
55890243|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890244|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890245|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890246|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55890247|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55890248|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
55890250|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55890251|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55890252|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890253|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890254|NCT04273035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55890255|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55890256|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55890257|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55890258|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
55890259|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
56052390|NCT03368235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56052391|NCT03368235|Glucocorticoids|glucocorticoids|mesh-ancestor
56052392|NCT03368235|Hormones|hormones|mesh-ancestor
56052393|NCT03368235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052394|NCT03368235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052395|NCT03368235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56052396|NCT03368235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052397|NCT02310750|PF-06700841|pf-06700841|mesh-list
56052398|NCT02310750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56052399|NCT02310750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052400|NCT02310750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052401|NCT03615807|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55890260|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
55890261|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
55890262|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890263|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890264|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
55890265|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55890266|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
55890267|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890268|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890269|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55890270|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
55890282|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55890283|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053978|NCT02988440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890284|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890286|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
55890287|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55890288|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
55890289|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55890290|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
55890291|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890292|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890293|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
55890294|NCT03859869|Pancrelipase|pancrelipase|mesh-list
55890295|NCT03859869|Pancreatin|pancreatin|mesh-list
55890296|NCT03859869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55890297|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
55890298|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55890299|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
55890300|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890301|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890302|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55890303|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
55890304|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
55890305|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55890306|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
55890307|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890308|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890309|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
55890310|NCT02784171|Pemetrexed|pemetrexed|mesh-list
55890311|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890312|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55890313|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890314|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890315|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55890316|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55890317|NCT01455441|Liraglutide|liraglutide|mesh-list
55890318|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55890319|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890320|NCT01455441|Incretins|incretins|mesh-ancestor
56052402|NCT03615807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052404|NCT02310672|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56052405|NCT02310672|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56052406|NCT02310672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052407|NCT02310672|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
56052408|NCT03626415|Abrocitinib|abrocitinib|mesh-list
56052409|NCT03626415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56052410|NCT03626415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052411|NCT03626415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052412|NCT04373421|Chlorhexidine|chlorhexidine|mesh-list
56052413|NCT04373421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56052414|NCT04373421|Benzydamine|benzydamine|mesh-list
56052415|NCT04373421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56052416|NCT04373421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052417|NCT04373421|Disinfectants|disinfectants|mesh-ancestor
55890321|NCT01455441|Hormones|hormones|mesh-ancestor
55890322|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55890323|NCT01455831|Tinzaparin|tinzaparin|mesh-list
55890324|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55890325|NCT01455831|Dalteparin|dalteparin|mesh-list
55890326|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
55890327|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55890328|NCT01455831|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55890329|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890331|NCT04840641|Floxacillin|floxacillin|mesh-list
55890333|NCT04840641|Metoprolol|metoprolol|mesh-list
55890334|NCT04840641|Midazolam|midazolam|mesh-list
55890335|NCT04840641|Caffeine|caffeine|mesh-list
55890336|NCT04840641|Omeprazole|omeprazole|mesh-list
55890337|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55890347|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
55890348|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
55890349|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890350|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890351|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55890352|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55890353|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55890354|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55890355|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56052425|NCT03632109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052426|NCT02363946|Diphenhydramine|diphenhydramine|mesh-list
56052427|NCT02363946|Promethazine|promethazine|mesh-list
56052428|NCT02363946|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56052429|NCT02363946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56052430|NCT02363946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052431|NCT02363946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052432|NCT02363946|Anesthetics, Local|anesthetics, local|mesh-ancestor
56052433|NCT02363946|Anesthetics|anesthetics|mesh-ancestor
56052434|NCT02363946|Sensory System Agents|sensory system agents|mesh-ancestor
56052435|NCT02363946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052436|NCT02363946|Antiemetics|antiemetics|mesh-ancestor
56052437|NCT02363946|Autonomic Agents|autonomic agents|mesh-ancestor
56052438|NCT02363946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56052439|NCT02363946|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56052440|NCT02363946|Histamine Antagonists|histamine antagonists|mesh-ancestor
56052441|NCT02363946|Histamine Agents|histamine agents|mesh-ancestor
56052442|NCT02363946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052443|NCT02363946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052444|NCT02363946|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56052445|NCT02363946|Antipruritics|antipruritics|mesh-ancestor
55890373|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55890374|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
55890375|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
55890376|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890377|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55890378|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55890379|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55890380|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
55890381|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55890382|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55890384|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55890385|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890386|NCT01455909|Incretins|incretins|mesh-ancestor
55890387|NCT01455909|Hormones|hormones|mesh-ancestor
55890388|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55890389|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55890390|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
56052446|NCT02363946|Dermatologic Agents|dermatologic agents|mesh-ancestor
56052447|NCT02363478|Buspirone|buspirone|mesh-list
56052448|NCT02363478|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56052449|NCT02363478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56052450|NCT02363478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052451|NCT02363478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052452|NCT02363478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56052453|NCT02363478|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56052454|NCT02363478|Serotonin Agents|serotonin agents|mesh-ancestor
56052455|NCT02363478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052456|NCT02363478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052457|NCT02338362|Fluticasone|fluticasone|mesh-list
56052458|NCT02338362|Xhance|xhance|mesh-list
56052459|NCT02338362|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56052460|NCT02338362|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56052461|NCT02338362|Autonomic Agents|autonomic agents|mesh-ancestor
56052462|NCT02338362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052463|NCT02338362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052464|NCT02338362|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56052465|NCT02338362|Respiratory System Agents|respiratory system agents|mesh-ancestor
55890391|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890392|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890393|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55890394|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55890395|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55890396|NCT02415621|Abiraterone Acetate|abiraterone acetate|mesh-list
55890397|NCT02415621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890398|NCT02415621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55890399|NCT02415621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890400|NCT02415621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890409|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55890410|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890411|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890413|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55890414|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55890415|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
55890418|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890419|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890420|NCT01756157|Complement C1s|complement c1s|mesh-list
55890421|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55890422|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
55890423|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
55890424|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890425|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55890426|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890427|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55890428|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
55890429|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
55890430|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890431|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
55890432|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052466|NCT02338362|Dermatologic Agents|dermatologic agents|mesh-ancestor
56052467|NCT02338362|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56052468|NCT05438394|Melphalan|melphalan|mesh-list
56052469|NCT05438394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56052470|NCT05438394|Alkylating Agents|alkylating agents|mesh-ancestor
55890433|NCT01756079|Ribavirin|ribavirin|mesh-list
55890434|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55890435|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
55890436|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890437|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
55890438|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890439|NCT04272645|Atezolizumab|atezolizumab|mesh-list
55890440|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890441|NCT04390815|Insulin|insulin|mesh-list
55890442|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55890443|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55890444|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890445|NCT01456611|Diclofenac|diclofenac|mesh-list
55890446|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55890447|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55890448|NCT01456611|Analgesics|analgesics|mesh-ancestor
55890449|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
55890450|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890451|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890452|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55890453|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890454|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55890455|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890456|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890457|NCT01456689|Midazolam|midazolam|mesh-list
55890458|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55890459|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55890460|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890461|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890462|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55890463|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55890464|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55890465|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55890475|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890476|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55890477|NCT02846883|Plasma-lyte 148|plasma-lyte 148|mesh-list
55890478|NCT02846883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55890479|NCT02846883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55890480|NCT01457469|Nicotine|nicotine|mesh-list
55890481|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55890482|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
55890483|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890484|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890485|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55890486|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55890487|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
55890488|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890489|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753514|NCT03195205|Antibodies|antibodies|mesh-list
55890490|NCT01457547|Edetic Acid|edetic acid|mesh-list
55890491|NCT01457547|Vaccines|vaccines|mesh-list
55890492|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
55890493|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
55890494|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890495|NCT01457547|Antidotes|antidotes|mesh-ancestor
55890496|NCT01457547|Protective Agents|protective agents|mesh-ancestor
55890497|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
55890499|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890500|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55890501|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
55890502|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55890503|NCT01457859|Triclosan|triclosan|mesh-list
55890504|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55890505|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890506|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55890507|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56052471|NCT05438394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052472|NCT05438394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052473|NCT05438394|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56052474|NCT05438394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56052475|NCT05438394|Immunologic Factors|immunologic factors|mesh-ancestor
56052476|NCT05438394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052477|NCT02360280|Midazolam|midazolam|mesh-list
56052478|NCT02360280|Ketamine|ketamine|mesh-list
56052479|NCT02360280|Analgesics|analgesics|mesh-ancestor
56052480|NCT02360280|Sensory System Agents|sensory system agents|mesh-ancestor
56052481|NCT02360280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052482|NCT02360280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052483|NCT02360280|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56052484|NCT02360280|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56052485|NCT02360280|Anesthetics, General|anesthetics, general|mesh-ancestor
56052486|NCT02360280|Anesthetics|anesthetics|mesh-ancestor
56052487|NCT02360280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052488|NCT02360280|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56052489|NCT02360280|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55890508|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
55890509|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890510|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55890511|NCT01890993|Liraglutide|liraglutide|mesh-list
55890512|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55890513|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890514|NCT01890993|Incretins|incretins|mesh-ancestor
55890515|NCT01890993|Hormones|hormones|mesh-ancestor
55890516|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55890517|NCT01457937|Interferons|interferons|mesh-list
55890518|NCT01457937|Ribavirin|ribavirin|mesh-list
55890519|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55890520|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890521|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
55890522|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890523|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
55890524|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890525|NCT05021913|Lidocaine|lidocaine|mesh-list
55890526|NCT05021913|Hyaluronic Acid|hyaluronic acid|mesh-list
55890527|NCT05021913|Anesthetics, Local|anesthetics, local|mesh-ancestor
55890528|NCT05021913|Anesthetics|anesthetics|mesh-ancestor
55890529|NCT05021913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890530|NCT05021913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890531|NCT05021913|Sensory System Agents|sensory system agents|mesh-ancestor
55890532|NCT05021913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890533|NCT05021913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55890544|NCT05025423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890545|NCT05025423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55890547|NCT05025423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890548|NCT04272255|Scopolamine|scopolamine|mesh-list
55890549|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56052490|NCT02360280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052491|NCT02360280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052492|NCT02360280|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56052493|NCT02360280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56052494|NCT02360280|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56052495|NCT02360280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56052496|NCT02360280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56052497|NCT02360280|GABA Modulators|gaba modulators|mesh-ancestor
56052498|NCT02360280|GABA Agents|gaba agents|mesh-ancestor
55779704|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
56052500|NCT01803074|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56052501|NCT01803074|Tenofovir|tenofovir|mesh-list
56052502|NCT01803074|Emtricitabine|emtricitabine|mesh-list
56052503|NCT01803074|BMS-955176|bms-955176|mesh-list
56052504|NCT01803074|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56052505|NCT01803074|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56052506|NCT01803074|Protease Inhibitors|protease inhibitors|mesh-ancestor
56052508|NCT01803074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052509|NCT01803074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56052510|NCT01803074|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56052511|NCT01803074|Antiviral Agents|antiviral agents|mesh-ancestor
56052512|NCT01803074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052513|NCT01803074|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56052514|NCT01803074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56052515|NCT01803074|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56052516|NCT01803074|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56052517|NCT05327894|Blinatumomab|blinatumomab|mesh-list
56052518|NCT05327894|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56052519|NCT05327894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052520|NCT05327894|Immunologic Factors|immunologic factors|mesh-ancestor
56052521|NCT05327894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052522|NCT05327660|Carbon Monoxide|carbon monoxide|mesh-list
56052523|NCT05327660|Antimetabolites|antimetabolites|mesh-ancestor
55890550|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55890551|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
55890552|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
55890553|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890554|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052524|NCT05327660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052525|NCT05327660|Gasotransmitters|gasotransmitters|mesh-ancestor
56052526|NCT05327660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052527|NCT05327660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052528|NCT01822886|Gemcitabine|gemcitabine|mesh-list
56052529|NCT01822886|Romidepsin|romidepsin|mesh-list
56052530|NCT01822886|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56052531|NCT01822886|Antimetabolites|antimetabolites|mesh-ancestor
56052532|NCT01822886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052533|NCT01822886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052534|NCT01822886|Antiviral Agents|antiviral agents|mesh-ancestor
56052535|NCT01822886|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052536|NCT01822886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052537|NCT01822886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56052538|NCT01822886|Immunologic Factors|immunologic factors|mesh-ancestor
56052539|NCT01822886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052540|NCT01822886|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56052541|NCT01823510|Aspirin|aspirin|mesh-list
55890556|NCT04272255|Mydriatics|mydriatics|mesh-ancestor
55890557|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55890558|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
55890559|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890560|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890561|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55890562|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
55890563|NCT01458015|Oxycodone|oxycodone|mesh-list
55890564|NCT01458015|Tapentadol|tapentadol|mesh-list
55890565|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55890566|NCT01458015|Narcotics|narcotics|mesh-ancestor
55890567|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890568|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890569|NCT01458015|Analgesics|analgesics|mesh-ancestor
55890570|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
55890572|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55890573|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55890574|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55890575|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890576|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
55890577|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890578|NCT02893293|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55890579|NCT02893293|Hematinics|hematinics|mesh-ancestor
55890580|NCT02893293|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55890581|NCT02893293|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55890582|NCT05022927|Bevacizumab|bevacizumab|mesh-list
55890583|NCT05022927|Atezolizumab|atezolizumab|mesh-list
55890584|NCT05022927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55890585|NCT05022927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890586|NCT05022927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55890587|NCT05022927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55890588|NCT05022927|Growth Substances|growth substances|mesh-ancestor
55890589|NCT05022927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890590|NCT05022927|Growth Inhibitors|growth inhibitors|mesh-ancestor
55890591|NCT05026125|Remifentanil|remifentanil|mesh-list
55890592|NCT05026125|Anesthetics|anesthetics|mesh-list
56052554|NCT01823510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890594|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890595|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55890596|NCT05026125|Narcotics|narcotics|mesh-ancestor
55890597|NCT05026125|Analgesics|analgesics|mesh-ancestor
55890598|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
55890611|NCT04391439|Prednisolone|prednisolone|mesh-list
55890612|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
55890613|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55890614|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
55890615|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55890616|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
55890617|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
55890618|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890619|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890620|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55890621|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
55890623|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55890624|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55890625|NCT04391439|Protective Agents|protective agents|mesh-ancestor
55890626|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55890627|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890628|NCT02884245|Estrogens|estrogens|mesh-list
55890629|NCT02884245|Hormones|hormones|mesh-ancestor
55890630|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55890631|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890632|NCT01891461|Hemostatics|hemostatics|mesh-list
55890633|NCT01891461|Coagulants|coagulants|mesh-ancestor
55890634|NCT02842749|Everolimus|everolimus|mesh-list
55890635|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890636|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890637|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
55890638|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890640|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55890641|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55890642|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
55890643|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890644|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890645|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890646|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
55890647|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
55890648|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890649|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55890650|NCT01891851|Ritonavir|ritonavir|mesh-list
55890651|NCT01891851|Simeprevir|simeprevir|mesh-list
55890652|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55890653|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55890654|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
56052555|NCT01823510|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56052556|NCT01823510|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56052557|NCT01823510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052558|NCT01823510|Antipyretics|antipyretics|mesh-ancestor
56052559|NCT01823510|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56052560|NCT01823510|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56052561|NCT01823510|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55890655|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890656|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890657|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55890658|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55890670|NCT02498613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890671|NCT02498613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55890672|NCT02498613|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55890673|NCT02498613|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55890674|NCT02498613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890675|NCT01459419|Antibodies|antibodies|mesh-list
55890676|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55890677|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
55890678|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890679|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55890680|NCT01892241|Entecavir|entecavir|mesh-list
55890681|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
55890682|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890683|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
55890684|NCT04391127|Ivermectin|ivermectin|mesh-list
55890685|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
55890686|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55890687|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55890695|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890696|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
55890697|NCT05024253|Coagulants|coagulants|mesh-ancestor
55890698|NCT05026593|Carboplatin|carboplatin|mesh-list
55890699|NCT05026593|Etoposide|etoposide|mesh-list
55890700|NCT05026593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890701|NCT05026593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55890702|NCT05026593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55890703|NCT05026593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55890704|NCT05026593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890705|NCT05026593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890706|NCT01459809|Metformin|metformin|mesh-list
55890707|NCT01459809|Glimepiride|glimepiride|mesh-list
55890708|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55890709|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890710|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55890711|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890712|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
55890713|NCT01459887|Prednisone|prednisone|mesh-list
55890714|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
55890715|NCT01459887|Doxorubicin|doxorubicin|mesh-list
55890716|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55890717|NCT01459887|Vincristine|vincristine|mesh-list
55890718|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890719|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
55890720|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890721|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890722|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55890723|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
55890724|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890734|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55890735|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56052562|NCT01823510|Purinergic Agents|purinergic agents|mesh-ancestor
56052563|NCT01823510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052564|NCT05327582|Paclitaxel|paclitaxel|mesh-list
56052565|NCT05327582|Durvalumab|durvalumab|mesh-list
56052566|NCT05327582|Lenvatinib|lenvatinib|mesh-list
56052567|NCT05327582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56052568|NCT05327582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052569|NCT05327582|Tubulin Modulators|tubulin modulators|mesh-ancestor
56052570|NCT05327582|Antimitotic Agents|antimitotic agents|mesh-ancestor
56052571|NCT05327582|Mitosis Modulators|mitosis modulators|mesh-ancestor
56052572|NCT05327582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052573|NCT05327582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56052574|NCT05327582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55890736|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55890737|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
55890738|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
55890739|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
55890740|NCT02876211|Vitamin D|vitamin d|mesh-list
55890741|NCT02876211|Vitamins|vitamins|mesh-ancestor
55890742|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
55890743|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890744|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55890745|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
55890746|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
55890747|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55890748|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55890749|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890750|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890751|NCT02682147|Urological Agents|urological agents|mesh-ancestor
55890752|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
55890753|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55890754|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55890755|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
55890756|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890757|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890758|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55890759|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
55890760|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55890761|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55890762|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55890763|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
55890764|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890765|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052587|NCT02271698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052588|NCT02271698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56052589|NCT02271698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052590|NCT02271698|Protease Inhibitors|protease inhibitors|mesh-ancestor
56052591|NCT02271698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890784|NCT02675829|Mitosis Modulators|mitosis modulators|mesh-ancestor
55890785|NCT02675829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890786|NCT02669901|Naloxone|naloxone|mesh-list
55890787|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55890788|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890798|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890799|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890800|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890801|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
55890802|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890803|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890804|NCT01893177|Vaccines|vaccines|mesh-list
55890805|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
55890806|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890808|NCT05740150|Heparin|heparin|mesh-list
55890809|NCT05740150|Calcium heparin|calcium heparin|mesh-list
55890810|NCT05740150|Anticoagulants|anticoagulants|mesh-ancestor
55890811|NCT05740150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890812|NCT05740150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55890813|NCT05740150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55890814|NCT05740150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890815|NCT05740150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55890816|NCT05740150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890817|NCT05734612|Colchicine|colchicine|mesh-list
55890818|NCT05734612|Gout Suppressants|gout suppressants|mesh-ancestor
55890819|NCT05734612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890820|NCT05734612|Tubulin Modulators|tubulin modulators|mesh-ancestor
55890821|NCT05734612|Antimitotic Agents|antimitotic agents|mesh-ancestor
55890822|NCT05734612|Mitosis Modulators|mitosis modulators|mesh-ancestor
55890823|NCT05734612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890824|NCT05734612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890825|NCT02349867|Gemcitabine|gemcitabine|mesh-list
55890826|NCT02349867|Sorafenib|sorafenib|mesh-list
55890827|NCT02349867|Vorinostat|vorinostat|mesh-list
55890828|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55890829|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
55890830|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890831|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890832|NCT02349867|Antiviral Agents|antiviral agents|mesh-ancestor
56052592|NCT02271698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052594|NCT02328404|Cholecalciferol|cholecalciferol|mesh-list
56052595|NCT02328404|Vitamins|vitamins|mesh-ancestor
56052596|NCT02328404|Micronutrients|micronutrients|mesh-ancestor
56052597|NCT02328404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052598|NCT02328404|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56052599|NCT02328404|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56052600|NCT05748236|Lamotrigine|lamotrigine|mesh-list
56052601|NCT05748236|Carbamazepine|carbamazepine|mesh-list
56052602|NCT05748236|Anticonvulsants|anticonvulsants|mesh-ancestor
56052603|NCT05748236|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56052604|NCT05748236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56052605|NCT05748236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052606|NCT05748236|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56052607|NCT05748236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052608|NCT05748236|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56052609|NCT05748236|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56052610|NCT05748236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890833|NCT02349867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890834|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890835|NCT02349867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890836|NCT02349867|Immunologic Factors|immunologic factors|mesh-ancestor
55890837|NCT02349867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890838|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55890839|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55890840|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
55890841|NCT02630043|Tolcapone|tolcapone|mesh-list
55890842|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890843|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55890844|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55894877|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
55890845|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55890846|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890847|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890848|NCT02629419|Amphotericin B|amphotericin b|mesh-list
55890849|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55890850|NCT02629419|Amebicides|amebicides|mesh-ancestor
55890851|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55890852|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55890853|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890854|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55890855|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
55890865|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55890866|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55890867|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55890868|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
55890869|NCT02329600|Hormones|hormones|mesh-ancestor
55890870|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55890871|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890872|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890873|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
55890874|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890875|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052611|NCT05748236|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56052612|NCT05748236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56052613|NCT05748236|Antimanic Agents|antimanic agents|mesh-ancestor
56052614|NCT05748236|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56052615|NCT05748236|Analgesics|analgesics|mesh-ancestor
56052616|NCT05748236|Sensory System Agents|sensory system agents|mesh-ancestor
56052617|NCT05748236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052618|NCT05748236|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56052619|NCT05748236|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56052620|NCT01829516|Oxytocin|oxytocin|mesh-list
56052621|NCT01829516|Oxytocics|oxytocics|mesh-ancestor
56052622|NCT01829516|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56052623|NCT01829516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052624|NCT01830140|Bimatoprost|bimatoprost|mesh-list
56052625|NCT01830140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56052626|NCT01830842|Nicotine|nicotine|mesh-list
56052627|NCT01830842|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56052628|NCT01830842|Autonomic Agents|autonomic agents|mesh-ancestor
56052629|NCT01830842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052630|NCT01830842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052631|NCT01830842|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56052632|NCT01830842|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56052633|NCT01830842|Cholinergic Agents|cholinergic agents|mesh-ancestor
56052634|NCT01830842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052635|NCT01830842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052636|NCT01831232|Cytarabine|cytarabine|mesh-list
56052637|NCT01831232|Idarubicin|idarubicin|mesh-list
56052638|NCT01831232|Pravastatin|pravastatin|mesh-list
56052639|NCT01831232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56052640|NCT01831232|Antimetabolites|antimetabolites|mesh-ancestor
56052641|NCT01831232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052642|NCT01831232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052643|NCT01831232|Antiviral Agents|antiviral agents|mesh-ancestor
56052644|NCT01831232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890876|NCT02620761|Fenoldopam|fenoldopam|mesh-list
56052652|NCT01831232|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56052653|NCT01831232|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56052654|NCT01831232|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56052655|NCT01831232|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56052656|NCT01831934|Vaccines|vaccines|mesh-list
56052657|NCT01831934|Immunologic Factors|immunologic factors|mesh-ancestor
56052658|NCT01831934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052659|NCT01833026|Albuterol|albuterol|mesh-list
56052660|NCT01833026|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56052661|NCT01833026|Autonomic Agents|autonomic agents|mesh-ancestor
56052662|NCT01833026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052663|NCT01833026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052664|NCT01833026|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56052665|NCT01833026|Respiratory System Agents|respiratory system agents|mesh-ancestor
56052666|NCT01833026|Tocolytic Agents|tocolytic agents|mesh-ancestor
56052667|NCT01833026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56052668|NCT01833026|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56052669|NCT01833026|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56052670|NCT01833026|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56052673|NCT01833026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052674|NCT03383523|Praziquantel|praziquantel|mesh-list
56052675|NCT03383523|Emodepside|emodepside|mesh-list
56052676|NCT03383523|Toltrazuril|toltrazuril|mesh-list
56052677|NCT03383523|Anthelmintics|anthelmintics|mesh-ancestor
56052678|NCT03383523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56052679|NCT03383523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052680|NCT03383523|Coccidiostats|coccidiostats|mesh-ancestor
56052681|NCT03383523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56052698|NCT01835912|Sequestering Agents|sequestering agents|mesh-ancestor
56052699|NCT01835912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052701|NCT05747768|Dabigatran|dabigatran|mesh-list
56052702|NCT05747768|Atorvastatin|atorvastatin|mesh-list
56052703|NCT05747768|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55890877|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55890878|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
55890879|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
55890880|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
55890881|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890882|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890883|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890884|NCT02615691|Factor VIII|factor viii|mesh-list
55890885|NCT02615691|BAX 855|bax 855|mesh-list
55890886|NCT02615691|Coagulants|coagulants|mesh-ancestor
55890887|NCT04758273|Vaccines|vaccines|mesh-list
55890888|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
55890889|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890890|NCT01729871|Vitamin K|vitamin k|mesh-list
55890891|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
55890892|NCT01729871|Vitamins|vitamins|mesh-ancestor
55890893|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
55890894|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890895|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55890896|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
55890897|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55890898|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
55890899|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890900|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890901|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
55890902|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55890903|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55890904|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
55890905|NCT01729871|Coagulants|coagulants|mesh-ancestor
55890906|NCT02611323|Rituximab|rituximab|mesh-list
55890907|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
55890909|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55890910|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890912|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890913|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55890914|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
55890915|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890916|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55890917|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890918|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890919|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
55890920|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55890921|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890922|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55890923|NCT01729559|Heparin|heparin|mesh-list
55890924|NCT01729559|Enoxaparin|enoxaparin|mesh-list
55890938|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55890939|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55890940|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
55890941|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890942|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890943|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55890944|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55890945|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
55890946|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890947|NCT01927120|Sirolimus|sirolimus|mesh-list
55890948|NCT01927120|Aldesleukin|aldesleukin|mesh-list
55890949|NCT01927120|Tacrolimus|tacrolimus|mesh-list
55890950|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890951|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
55890952|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890953|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55890954|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052704|NCT05747768|Pitavastatin|pitavastatin|mesh-list
56052705|NCT05747768|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55890955|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890956|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55890957|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890958|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55890959|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890960|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
55890961|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55890962|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55890963|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
55890964|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
55890965|NCT02600949|Imiquimod|imiquimod|mesh-list
55890966|NCT02600949|Vaccines|vaccines|mesh-list
55890967|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55890968|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890969|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55890970|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
55890971|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890972|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
55890973|NCT01728623|Lenvatinib|lenvatinib|mesh-list
55890974|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890975|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55890976|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890977|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890981|NCT02573337|Lidocaine|lidocaine|mesh-list
55890982|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
55890983|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
55890984|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890985|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890986|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
55890987|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890988|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55890992|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890994|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
55890995|NCT01606007|Metformin|metformin|mesh-list
55890996|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
55890997|NCT01606007|Saxagliptin|saxagliptin|mesh-list
55890998|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55891000|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55891001|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891002|NCT01606007|Incretins|incretins|mesh-ancestor
55891003|NCT01606007|Hormones|hormones|mesh-ancestor
55891004|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891005|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55891006|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
55891007|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891008|NCT02777385|Pembrolizumab|pembrolizumab|mesh-list
55891009|NCT02777385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891010|NCT02777385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891011|NCT02304783|Acetaminophen|acetaminophen|mesh-list
55891012|NCT02304783|Piroxicam|piroxicam|mesh-list
55891013|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55891014|NCT02304783|Analgesics|analgesics|mesh-ancestor
55891015|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
55891016|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891017|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891018|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
55891019|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55891020|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55891021|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55891022|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55891023|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891024|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891025|NCT02553447|Vitamin D|vitamin d|mesh-list
55891026|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
55891027|NCT02553447|Vitamins|vitamins|mesh-ancestor
56052708|NCT05747768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052709|NCT05747768|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56052710|NCT05747768|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56052711|NCT05747768|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56052712|NCT05747768|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56052713|NCT05747768|Anesthetics, General|anesthetics, general|mesh-ancestor
56052714|NCT05747768|Anesthetics|anesthetics|mesh-ancestor
56052715|NCT05747768|GABA Modulators|gaba modulators|mesh-ancestor
56052716|NCT05747768|GABA Agents|gaba agents|mesh-ancestor
56052717|NCT05747768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052718|NCT05747768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052723|NCT05747768|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56052724|NCT05747768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052725|NCT05747768|Antithrombins|antithrombins|mesh-ancestor
56052726|NCT05747768|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56052727|NCT05747768|Protease Inhibitors|protease inhibitors|mesh-ancestor
55891028|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
55891029|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891030|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55891031|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55891032|NCT01928290|Leucovorin|leucovorin|mesh-list
55891033|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
55891034|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
55891035|NCT01928290|Fluorouracil|fluorouracil|mesh-list
55891036|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
55891037|NCT01928290|Trastuzumab|trastuzumab|mesh-list
55891038|NCT01928290|Irinotecan|irinotecan|mesh-list
55891039|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
55891040|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
55891041|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891042|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55891043|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891044|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55891045|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
55891046|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891047|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891048|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55891049|NCT01928290|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55891050|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891052|NCT01928290|Protective Agents|protective agents|mesh-ancestor
55891053|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
55891054|NCT01928290|Vitamins|vitamins|mesh-ancestor
55891055|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
55891056|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
55891057|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
55891058|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55891059|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55891060|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891074|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
55891075|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
56052728|NCT05747768|Anticoagulants|anticoagulants|mesh-ancestor
56052729|NCT04923776|Carboplatin|carboplatin|mesh-list
56052730|NCT04923776|Etoposide|etoposide|mesh-list
56052731|NCT04923776|Atezolizumab|atezolizumab|mesh-list
56052732|NCT04923776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052733|NCT04923776|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56052734|NCT04923776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55891086|NCT02278965|Metformin|metformin|mesh-list
55891087|NCT02278965|Biguanides|biguanides|mesh-list
55891088|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55891089|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891091|NCT02766465|Methotrexate|methotrexate|mesh-list
55891092|NCT02766465|Fludarabine|fludarabine|mesh-list
55891093|NCT02766465|Melphalan|melphalan|mesh-list
55891094|NCT02766465|Busulfan|busulfan|mesh-list
55891095|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
55891097|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55891098|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
55891099|NCT02766465|Lenograstim|lenograstim|mesh-list
55891100|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55891101|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
55891102|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55891103|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891104|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55891105|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
55891106|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891107|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891108|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
55891109|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891110|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55891111|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55891112|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
55891113|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55891114|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55891115|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55891116|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55891117|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891118|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55891119|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
55891150|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891151|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
55891152|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55891153|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753587|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891154|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891156|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55891157|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891159|NCT05733286|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55891160|NCT05733286|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55891161|NCT05733286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55891162|NCT05733286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891163|NCT05733286|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55891164|NCT05733286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052735|NCT04923776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56052736|NCT04923776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052737|NCT04923776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891165|NCT05733286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891166|NCT02753283|Vitamin D|vitamin d|mesh-list
55891167|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
55891168|NCT02753283|Denosumab|denosumab|mesh-list
55891169|NCT02753283|Calcium|calcium|mesh-list
55891170|NCT02753283|Vitamins|vitamins|mesh-ancestor
55891171|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
55891172|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891173|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55891174|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55891175|NCT02748369|Glucagon|glucagon|mesh-list
55891176|NCT02748369|Hormones|hormones|mesh-list
55891177|NCT02748369|Somatostatin|somatostatin|mesh-list
55891178|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891179|NCT02748369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891180|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55891181|NCT01928680|Capecitabine|capecitabine|mesh-list
55891182|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891183|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55891184|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
55891185|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891187|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55891188|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891189|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55891190|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55891191|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891192|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891193|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891194|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55891195|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55891196|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
55891197|NCT02248701|Finasteride|finasteride|mesh-list
55891198|NCT02248701|Testosterone|testosterone|mesh-list
55891199|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
55891200|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
55891201|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55891202|NCT02248701|Androgens|androgens|mesh-ancestor
55891203|NCT02248701|Hormones|hormones|mesh-ancestor
55891204|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891205|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891206|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55891207|NCT02248701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891208|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
55891209|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55891210|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55891211|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891212|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891213|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
55891214|NCT02248701|Urological Agents|urological agents|mesh-ancestor
55891215|NCT02283814|Topiramate|topiramate|mesh-list
55891216|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55891217|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
55891218|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55891219|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891220|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55891221|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55891222|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55891223|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891224|NCT05739682|Anti-Infective Agents|anti-infective agents|mesh-list
55891225|NCT05739682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55891226|NCT05739682|Epinephrine|epinephrine|mesh-list
55891227|NCT05739682|Anesthetics|anesthetics|mesh-list
55891228|NCT05739682|Carticaine|carticaine|mesh-list
55891229|NCT05739682|Anesthetics, Local|anesthetics, local|mesh-list
55891230|NCT05739682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55891231|NCT05739682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052738|NCT04410159|Povidone-Iodine|povidone-iodine|mesh-list
56052739|NCT04410159|Listerine|listerine|mesh-list
56052740|NCT04410159|Povidone|povidone|mesh-list
56052741|NCT04410159|Plasma Substitutes|plasma substitutes|mesh-ancestor
56052742|NCT04410159|Blood Substitutes|blood substitutes|mesh-ancestor
56052743|NCT04410159|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56052744|NCT04410159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052745|NCT03398421|Itraconazole|itraconazole|mesh-list
56052746|NCT03398421|Nemiralisib|nemiralisib|mesh-list
56052747|NCT03398421|Antifungal Agents|antifungal agents|mesh-ancestor
56052748|NCT03398421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052749|NCT03398421|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56052750|NCT03398421|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56052751|NCT03398421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052752|NCT03398421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052753|NCT03398421|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56052754|NCT03398421|Hormone Antagonists|hormone antagonists|mesh-ancestor
56052755|NCT03398421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052756|NCT03398421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052757|NCT03398421|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56052758|NCT03398421|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56052759|NCT01839110|Ranolazine|ranolazine|mesh-list
56052760|NCT01839110|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56052761|NCT01839110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56052762|NCT01839110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052763|NCT04885712|Metformin|metformin|mesh-list
56052764|NCT04885712|Pioglitazone|pioglitazone|mesh-list
56052765|NCT04885712|Dapagliflozin|dapagliflozin|mesh-list
56052766|NCT04885712|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55891232|NCT05739682|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55891233|NCT05739682|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55891234|NCT05739682|Adrenergic Agents|adrenergic agents|mesh-ancestor
55891235|NCT05739682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55891236|NCT05739682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891237|NCT05739682|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55891238|NCT05739682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55891240|NCT05739682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891241|NCT05739682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55891242|NCT05739682|Respiratory System Agents|respiratory system agents|mesh-ancestor
55891243|NCT05739682|Mydriatics|mydriatics|mesh-ancestor
55891244|NCT05739682|Sympathomimetics|sympathomimetics|mesh-ancestor
55891245|NCT05739682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55891246|NCT05739682|Sensory System Agents|sensory system agents|mesh-ancestor
55891247|NCT02462421|Canagliflozin|canagliflozin|mesh-list
55891248|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56052767|NCT04885712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052768|NCT04885712|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56052769|NCT04885712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052770|NCT00559754|Bevacizumab|bevacizumab|mesh-list
56052771|NCT00559754|Docetaxel|docetaxel|mesh-list
56052772|NCT00559754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56052773|NCT00559754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052774|NCT00559754|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56052775|NCT00559754|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56052776|NCT00559754|Growth Substances|growth substances|mesh-ancestor
56052777|NCT00559754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052778|NCT00559754|Growth Inhibitors|growth inhibitors|mesh-ancestor
56052779|NCT00559754|Tubulin Modulators|tubulin modulators|mesh-ancestor
56052780|NCT00559754|Antimitotic Agents|antimitotic agents|mesh-ancestor
56052781|NCT00559754|Mitosis Modulators|mitosis modulators|mesh-ancestor
56052782|NCT00559754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052784|NCT03402243|Antipruritics|antipruritics|mesh-ancestor
56052785|NCT03402243|Dermatologic Agents|dermatologic agents|mesh-ancestor
56052786|NCT01841606|Ondansetron|ondansetron|mesh-list
56052787|NCT01841606|Antiemetics|antiemetics|mesh-ancestor
55891249|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891251|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891252|NCT02219373|Oxcarbazepine|oxcarbazepine|mesh-list
55891253|NCT02219373|Gabapentin|gabapentin|mesh-list
55891254|NCT02219373|Analgesics|analgesics|mesh-ancestor
55891255|NCT02219373|Sensory System Agents|sensory system agents|mesh-ancestor
55891256|NCT02219373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891257|NCT02219373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891258|NCT02219373|Anticonvulsants|anticonvulsants|mesh-ancestor
55891268|NCT02219373|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55891270|NCT02219373|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55891271|NCT02219373|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55891272|NCT02219373|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55891273|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
55891274|NCT02727387|Temozolomide|temozolomide|mesh-list
55891275|NCT02727387|Melphalan|melphalan|mesh-list
55891276|NCT02727387|Busulfan|busulfan|mesh-list
55891277|NCT02727387|Ifosfamide|ifosfamide|mesh-list
55891278|NCT02727387|Irinotecan|irinotecan|mesh-list
55891279|NCT02727387|Etoposide|etoposide|mesh-list
55891280|NCT02727387|Vincristine|vincristine|mesh-list
55891281|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55891282|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
55891283|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891284|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55891285|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55891286|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
55891287|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891288|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891289|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55891290|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55891291|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56052792|NCT01841606|Antipruritics|antipruritics|mesh-ancestor
56052793|NCT01841606|Dermatologic Agents|dermatologic agents|mesh-ancestor
56052794|NCT01841606|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56052795|NCT01841606|Serotonin Agents|serotonin agents|mesh-ancestor
56052796|NCT01841606|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052797|NCT01841606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052798|NCT01841606|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56052799|NCT01841606|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55891292|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891293|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55891294|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55891295|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
55891296|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
55891297|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
55891298|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
55891299|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55891300|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891301|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55891302|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55891303|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891304|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891305|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891306|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55891307|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55891308|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
55891309|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55891310|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
55891311|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891312|NCT02445651|Expectorants|expectorants|mesh-ancestor
55891313|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
55891314|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55891315|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
55891316|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891317|NCT02445651|Protective Agents|protective agents|mesh-ancestor
55891318|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891319|NCT02445651|Antidotes|antidotes|mesh-ancestor
55891320|NCT05719714|Dapagliflozin|dapagliflozin|mesh-list
55891321|NCT05719714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55891322|NCT05719714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891355|NCT02284516|Lifitegrast|lifitegrast|mesh-list
55891356|NCT02284516|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55891357|NCT02284516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55891360|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
55891361|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
55891364|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891365|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55891366|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
55891367|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052800|NCT01841606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052801|NCT01841606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56052802|NCT01841606|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56052803|NCT04392141|Colchicine|colchicine|mesh-list
56052804|NCT04392141|Gout Suppressants|gout suppressants|mesh-ancestor
56052805|NCT04392141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56052806|NCT04392141|Tubulin Modulators|tubulin modulators|mesh-ancestor
56052807|NCT04392141|Antimitotic Agents|antimitotic agents|mesh-ancestor
56052808|NCT04392141|Mitosis Modulators|mitosis modulators|mesh-ancestor
56052809|NCT04392141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052810|NCT04392141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052811|NCT04838054|Chlorine dioxide|chlorine dioxide|mesh-list
56052812|NCT04838054|Dental Disinfectants|dental disinfectants|mesh-ancestor
56052813|NCT04838054|Disinfectants|disinfectants|mesh-ancestor
56052814|NCT04838054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052815|NCT00559364|Omeprazole|omeprazole|mesh-list
56052816|NCT00559364|Pancrelipase|pancrelipase|mesh-list
56052817|NCT00559364|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56052818|NCT00559364|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56052819|NCT00559364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56052820|NCT00559364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052821|NCT00559364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052822|NCT05746676|Hyaluronic Acid|hyaluronic acid|mesh-list
56052823|NCT05746676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052824|NCT05746676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56052825|NCT05746676|Immunologic Factors|immunologic factors|mesh-ancestor
56052826|NCT05746676|Viscosupplements|viscosupplements|mesh-ancestor
56052827|NCT05746676|Protective Agents|protective agents|mesh-ancestor
56052828|NCT05746598|Cisplatin|cisplatin|mesh-list
56052829|NCT05746598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052830|NCT05745974|Fibrin fragment D|fibrin fragment d|mesh-list
56052831|NCT05745974|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56052832|NCT05745974|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55891368|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55891369|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
55891370|NCT02185209|Amoxicillin|amoxicillin|mesh-list
55891371|NCT02185209|Metronidazole|metronidazole|mesh-list
55891372|NCT02185209|Penicillin V|penicillin v|mesh-list
55891373|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55891374|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891375|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55891376|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55891377|NCT01894035|Iloprost|iloprost|mesh-list
56052833|NCT05745974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052834|NCT05745974|Hemostatics|hemostatics|mesh-ancestor
56052835|NCT05745974|Coagulants|coagulants|mesh-ancestor
56052836|NCT04476212|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56052837|NCT04476212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052839|NCT05745038|Anticonvulsants|anticonvulsants|mesh-ancestor
56052840|NCT05745038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56052841|NCT05745038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052842|NCT05745038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052843|NCT05745038|GABA Modulators|gaba modulators|mesh-ancestor
56052844|NCT05745038|GABA Agents|gaba agents|mesh-ancestor
56052845|NCT05745038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56052846|NCT05745038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052847|NCT02306850|Pembrolizumab|pembrolizumab|mesh-list
56052848|NCT02306850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56052849|NCT02306850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891379|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
55891380|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
55891381|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55891382|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55891383|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55891384|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
55891385|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55891386|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891387|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891388|NCT02716311|Cetuximab|cetuximab|mesh-list
55891389|NCT02716311|Afatinib|afatinib|mesh-list
55891398|NCT05439694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891401|NCT02714439|Proflavine|proflavine|mesh-list
55891402|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55894878|NCT03250494|Hormones|hormones|mesh-ancestor
55891403|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891404|NCT02165007|Sirolimus|sirolimus|mesh-list
55891405|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55891406|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891407|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55891408|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753643|NCT02447185|Hormones|hormones|mesh-ancestor
55891409|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
55891410|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55891411|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
55891412|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891413|NCT02290444|Hormones|hormones|mesh-list
55891414|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55891415|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55891416|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
55891417|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891418|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891419|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55891420|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891421|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55891422|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
56052851|NCT02306694|Coagulants|coagulants|mesh-ancestor
56052852|NCT01648140|Interferons|interferons|mesh-list
56052853|NCT01648140|Ribavirin|ribavirin|mesh-list
56052854|NCT01648140|Interferon-alpha|interferon-alpha|mesh-list
56052855|NCT01648140|Interferon alpha-2|interferon alpha-2|mesh-list
56052856|NCT01648140|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56052857|NCT01648140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052858|NCT01648140|Antiviral Agents|antiviral agents|mesh-ancestor
56052859|NCT01648140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052860|NCT01648140|Antimetabolites|antimetabolites|mesh-ancestor
56052861|NCT01648140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052862|NCT01648140|Immunologic Factors|immunologic factors|mesh-ancestor
56052863|NCT01648140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052864|NCT02335242|Sildenafil Citrate|sildenafil citrate|mesh-list
55891423|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891424|NCT01752023|Gemcitabine|gemcitabine|mesh-list
55891425|NCT01752023|Itraconazole|itraconazole|mesh-list
55891426|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
55891427|NCT01752023|Cisplatin|cisplatin|mesh-list
55891428|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891429|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55891430|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
55891431|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891432|NCT01752023|Antiviral Agents|antiviral agents|mesh-ancestor
55891433|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891434|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891435|NCT01752023|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55891436|NCT01752023|Immunologic Factors|immunologic factors|mesh-ancestor
55891437|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891438|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
55891439|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55891440|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55891441|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55891442|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
55891443|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891444|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55891445|NCT02986906|Triamcinolone|triamcinolone|mesh-list
55891446|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55891447|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
55891449|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891450|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891451|NCT05658562|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
55891452|NCT05658562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891453|NCT05658562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891463|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891464|NCT01605617|Fesoterodine|fesoterodine|mesh-list
55891465|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55891466|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55891467|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
55891468|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55891469|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891470|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891471|NCT01605617|Urological Agents|urological agents|mesh-ancestor
55891472|NCT05646862|Fulvestrant|fulvestrant|mesh-list
55891473|NCT05646862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55891474|NCT05646862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891475|NCT05646862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55891476|NCT05646862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55891477|NCT05646862|Hormone Antagonists|hormone antagonists|mesh-ancestor
55891478|NCT05646862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56052865|NCT02335242|Vasodilator Agents|vasodilator agents|mesh-ancestor
56052866|NCT02335242|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56052867|NCT02335242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56052868|NCT02335242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052869|NCT02335242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891479|NCT05646862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891480|NCT05402020|Tiotropium Bromide|tiotropium bromide|mesh-list
55891481|NCT05402020|Olodaterol|olodaterol|mesh-list
55891482|NCT05402020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55891483|NCT05402020|Autonomic Agents|autonomic agents|mesh-ancestor
55891484|NCT05402020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891485|NCT05402020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891486|NCT05402020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55891487|NCT05402020|Respiratory System Agents|respiratory system agents|mesh-ancestor
55891488|NCT05402020|Parasympatholytics|parasympatholytics|mesh-ancestor
55891489|NCT05402020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55891490|NCT05402020|Cholinergic Agents|cholinergic agents|mesh-ancestor
55891491|NCT05402020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55891492|NCT05402020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891493|NCT05736640|Denosumab|denosumab|mesh-list
55891494|NCT05736640|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55891495|NCT05736640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891496|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55891497|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
55891498|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55891499|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55891500|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55891501|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891502|NCT01751867|Decitabine|decitabine|mesh-list
55891503|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55891504|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
55891505|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891506|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891507|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891508|NCT02418195|Ketamine|ketamine|mesh-list
55891509|NCT02418195|Analgesics|analgesics|mesh-ancestor
55891510|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
55891511|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891512|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891513|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55891514|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55891515|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
55891534|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
55891535|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891536|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55891537|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55891538|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55891539|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55891540|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891541|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55891542|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55891557|NCT05382364|Tucatinib|tucatinib|mesh-list
55891558|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891559|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55891560|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891561|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891562|NCT02712801|Ritonavir|ritonavir|mesh-list
55891570|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891571|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891572|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55891573|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55891574|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
55891575|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891576|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55891577|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55891578|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56052872|NCT04883892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56052873|NCT04883892|Immunologic Factors|immunologic factors|mesh-ancestor
56052874|NCT04883892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052875|NCT04883892|Viscosupplements|viscosupplements|mesh-ancestor
56052876|NCT04883892|Protective Agents|protective agents|mesh-ancestor
56052877|NCT02334384|Anti-Infective Agents|anti-infective agents|mesh-list
56052878|NCT02334384|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56052879|NCT02305758|Bevacizumab|bevacizumab|mesh-list
56052880|NCT02305758|Fluorouracil|fluorouracil|mesh-list
56052881|NCT02305758|Veliparib|veliparib|mesh-list
55891579|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55891580|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
55891581|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55891582|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55891583|NCT02712723|Letrozole|letrozole|mesh-list
55891584|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891585|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55891586|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55891587|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891588|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891589|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55891590|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
55891591|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891602|NCT02156739|Protective Agents|protective agents|mesh-ancestor
55891603|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891604|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
55891605|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
55891606|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891607|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55891608|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
55891609|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55891610|NCT02402439|Pancrelipase|pancrelipase|mesh-list
55891611|NCT02402439|Pancreatin|pancreatin|mesh-list
55891613|NCT01751087|Vitamins|vitamins|mesh-list
55891614|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
55891615|NCT01751087|Misoprostol|misoprostol|mesh-list
55891616|NCT01751087|Mifepristone|mifepristone|mesh-list
55891617|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
55891618|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891619|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55891620|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
55891621|NCT01751087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55891622|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55891623|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55891624|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
55891625|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
55891626|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55891627|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55891628|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55891629|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55891630|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
55891631|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55891632|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55891633|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
55891634|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891635|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
55891636|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55891637|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56052882|NCT02305758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56052883|NCT02305758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052884|NCT02305758|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56052885|NCT02305758|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56052886|NCT02305758|Growth Substances|growth substances|mesh-ancestor
56052887|NCT02305758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052888|NCT02305758|Growth Inhibitors|growth inhibitors|mesh-ancestor
56052889|NCT02305758|Antimetabolites|antimetabolites|mesh-ancestor
56052890|NCT02305758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052891|NCT02305758|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55891639|NCT02143401|Navitoclax|navitoclax|mesh-list
55891640|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891641|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55891642|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891643|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891644|NCT02401503|Venetoclax|venetoclax|mesh-list
55891645|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55891647|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891648|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55891649|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
55891650|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891651|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891652|NCT02395497|Antibodies|antibodies|mesh-list
55891653|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55891654|NCT02395497|Tacrolimus|tacrolimus|mesh-list
55891655|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
55891656|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891657|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55891658|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55891659|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891660|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891661|NCT05319730|Paclitaxel|paclitaxel|mesh-list
55891662|NCT05319730|Pembrolizumab|pembrolizumab|mesh-list
55891663|NCT05319730|Irinotecan|irinotecan|mesh-list
55891664|NCT05319730|Lenvatinib|lenvatinib|mesh-list
55891665|NCT05319730|Immunoglobulins|immunoglobulins|mesh-list
55891666|NCT05319730|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55891667|NCT05319730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891668|NCT05319730|Tubulin Modulators|tubulin modulators|mesh-ancestor
55891669|NCT05319730|Antimitotic Agents|antimitotic agents|mesh-ancestor
55891670|NCT05319730|Mitosis Modulators|mitosis modulators|mesh-ancestor
55891680|NCT02393157|Etoposide|etoposide|mesh-list
55891681|NCT02393157|Ifosfamide|ifosfamide|mesh-list
55891682|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
55891683|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891684|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55891685|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55891686|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55891687|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891688|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891689|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55891690|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
55891691|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891692|NCT01750697|Rituximab|rituximab|mesh-list
55891693|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891694|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891695|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
55891696|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891697|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55891698|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
55891699|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56052892|NCT02305758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56052893|NCT02305758|Immunologic Factors|immunologic factors|mesh-ancestor
56052894|NCT02305758|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56052895|NCT02305758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052896|NCT04365153|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56052897|NCT04365153|Immunologic Factors|immunologic factors|mesh-ancestor
56052898|NCT04365153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052899|NCT03654417|Lidocaine|lidocaine|mesh-list
56052900|NCT03654417|Anesthetics, Local|anesthetics, local|mesh-ancestor
56052901|NCT03654417|Anesthetics|anesthetics|mesh-ancestor
55891700|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
55891701|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891702|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
55891703|NCT02127723|Protective Agents|protective agents|mesh-ancestor
55891704|NCT05586711|Estradiol|estradiol|mesh-list
55891705|NCT05586711|Estrogens|estrogens|mesh-ancestor
55891706|NCT05586711|Hormones|hormones|mesh-ancestor
55753700|NCT04484779|Insulin Lispro|insulin lispro|mesh-list
55891707|NCT05586711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891708|NCT05586711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891709|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
55891710|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891711|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891712|NCT01724489|Hormones|hormones|mesh-list
55891713|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891714|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891715|NCT01996293|Lamotrigine|lamotrigine|mesh-list
55891716|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
55891717|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55891718|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55891719|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891720|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55891721|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891722|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55891723|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55891724|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55891725|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55891726|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55891727|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55891728|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55891729|NCT05304364|Naltrexone|naltrexone|mesh-list
55891730|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55891731|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55891732|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891733|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
55891736|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55891737|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891738|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891739|NCT01724177|Lenalidomide|lenalidomide|mesh-list
55891740|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
55891741|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891742|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55891743|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55891744|NCT01724177|Growth Substances|growth substances|mesh-ancestor
55891745|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
55891746|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891747|NCT01991457|Fludarabine|fludarabine|mesh-list
55891748|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891749|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55891750|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891751|NCT05529784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55891752|NCT05529784|Immunologic Factors|immunologic factors|mesh-ancestor
55891753|NCT05529784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891754|NCT05524246|Pravastatin|pravastatin|mesh-list
56052902|NCT03654417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56052903|NCT03654417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052904|NCT03654417|Sensory System Agents|sensory system agents|mesh-ancestor
56052905|NCT03654417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052906|NCT03654417|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56052907|NCT03654417|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56052908|NCT03654417|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56052909|NCT03654417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55891755|NCT05524246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55891756|NCT05524246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55891757|NCT05524246|Antimetabolites|antimetabolites|mesh-ancestor
55891758|NCT05524246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891760|NCT05524246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55891761|NCT05524246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891765|NCT02685735|Gabapentin|gabapentin|mesh-list
55891766|NCT02685735|Analgesics|analgesics|mesh-ancestor
55891767|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
55891768|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891769|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891770|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
55891771|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55891772|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55891773|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55891774|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55891775|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55891776|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55891777|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55891778|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891779|NCT02685735|Antimanic Agents|antimanic agents|mesh-ancestor
55891780|NCT02074839|Ivosidenib|ivosidenib|mesh-list
55891781|NCT02074839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891782|NCT02074839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891783|NCT02074839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891784|NCT02070705|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55891785|NCT02070705|Hematinics|hematinics|mesh-ancestor
55891786|NCT02070705|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55891787|NCT02070705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55891797|NCT01530009|Amoxicillin|amoxicillin|mesh-list
55891798|NCT01530009|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55891799|NCT01530009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891800|NCT05238142|Insulin|insulin|mesh-list
55891801|NCT05238142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55891802|NCT05238142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891803|NCT04915144|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
55891805|NCT04915144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891806|NCT01724021|Prednisone|prednisone|mesh-list
55891819|NCT01724021|Prednisolone phosphate|prednisolone phosphate|mesh-list
55891820|NCT01724021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55891821|NCT01724021|Immunologic Factors|immunologic factors|mesh-ancestor
55891822|NCT01724021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052910|NCT03654417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052911|NCT00376701|Bevacizumab|bevacizumab|mesh-list
56052912|NCT00376701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891823|NCT01724021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55891824|NCT01724021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55891825|NCT01724021|Alkylating Agents|alkylating agents|mesh-ancestor
55891826|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891827|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891828|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55891829|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891830|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55891831|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
55891832|NCT01724021|Hormones|hormones|mesh-ancestor
55891833|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891834|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55891835|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55891836|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
55891837|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
55891838|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
55891839|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
55891840|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
55891841|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891842|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55891843|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55891844|NCT01724021|Protective Agents|protective agents|mesh-ancestor
55891845|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55891846|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55891847|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55891848|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891849|NCT05197504|Bevacizumab|bevacizumab|mesh-list
55891850|NCT05197504|Atezolizumab|atezolizumab|mesh-list
55891851|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891852|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891853|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55891854|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55891855|NCT05197504|Growth Substances|growth substances|mesh-ancestor
55891856|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891857|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
55891863|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
55891864|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891865|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891866|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55891867|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55891868|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55891869|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
55891870|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55891871|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891872|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
55891873|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
55891874|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55891893|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
55891894|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55891895|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891896|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55891897|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891898|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891899|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55891900|NCT04223752|Renal Agents|renal agents|mesh-ancestor
55891901|NCT04187404|Nivolumab|nivolumab|mesh-list
55891902|NCT04187404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891903|NCT04187404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891904|NCT04187404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55891905|NCT04187404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891906|NCT04155580|Decitabine|decitabine|mesh-list
55891907|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55891908|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
55891909|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052913|NCT00376701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052914|NCT00376701|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56052915|NCT00376701|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56052916|NCT00376701|Growth Substances|growth substances|mesh-ancestor
56052917|NCT00376701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052918|NCT00376701|Growth Inhibitors|growth inhibitors|mesh-ancestor
56052919|NCT04358991|Ceftazidime|ceftazidime|mesh-list
56052920|NCT04358991|Avibactam|avibactam|mesh-list
56052921|NCT04358991|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
56052922|NCT04358991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56052923|NCT04358991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052924|NCT04358991|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56052925|NCT04358991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052926|NCT04358991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052927|NCT04338009|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56052928|NCT04338009|Protease Inhibitors|protease inhibitors|mesh-ancestor
56052929|NCT04338009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891910|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891911|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891912|NCT01721759|Nivolumab|nivolumab|mesh-list
55891913|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891914|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891915|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55891916|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891923|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
55891924|NCT04776850|Dexamethasone|dexamethasone|mesh-list
55891925|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
55891926|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
55891927|NCT04776850|Busulfan|busulfan|mesh-list
55891928|NCT04776850|Rituximab|rituximab|mesh-list
55891929|NCT04776850|Fludarabine|fludarabine|mesh-list
55891930|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
55891931|NCT04776850|Bortezomib|bortezomib|mesh-list
55891932|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55891933|NCT04776850|Tacrolimus|tacrolimus|mesh-list
55891934|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
55891935|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55891936|NCT04776850|Antibodies|antibodies|mesh-list
55891937|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
55891938|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55891939|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
55891940|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55891941|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55891942|NCT04776850|BB 1101|bb 1101|mesh-list
55891955|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891956|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55891957|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
55891958|NCT04776850|Hormones|hormones|mesh-ancestor
55891959|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891960|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55891961|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
55891962|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052930|NCT04338009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052931|NCT02303574|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56052932|NCT02354976|Fenofibrate|fenofibrate|mesh-list
56052933|NCT02354976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56052934|NCT02354976|Antimetabolites|antimetabolites|mesh-ancestor
56052935|NCT02354976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052936|NCT02354976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56052937|NCT02303262|Gemcitabine|gemcitabine|mesh-list
56052938|NCT02303262|Mocetinostat|mocetinostat|mesh-list
56052939|NCT02303262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56052940|NCT02303262|Antimetabolites|antimetabolites|mesh-ancestor
56052941|NCT02303262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052942|NCT02303262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56052943|NCT02303262|Antiviral Agents|antiviral agents|mesh-ancestor
56052944|NCT02303262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052945|NCT02303262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052946|NCT02303262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56052947|NCT02303262|Immunologic Factors|immunologic factors|mesh-ancestor
56052948|NCT02303262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052949|NCT02303262|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56052951|NCT04889664|Analgesics|analgesics|mesh-ancestor
56052952|NCT04889664|Sensory System Agents|sensory system agents|mesh-ancestor
56052953|NCT04889664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56052954|NCT04889664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052978|NCT00558896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56052979|NCT00558896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56052980|NCT00558896|Growth Substances|growth substances|mesh-ancestor
56052981|NCT00558896|Growth Inhibitors|growth inhibitors|mesh-ancestor
56052983|NCT01857362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56052984|NCT01857362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052985|NCT02265224|Acetylcysteine|acetylcysteine|mesh-list
56052986|NCT02265224|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56052987|NCT02265224|Antiviral Agents|antiviral agents|mesh-ancestor
56052988|NCT02265224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56052989|NCT02265224|Expectorants|expectorants|mesh-ancestor
56052990|NCT02265224|Respiratory System Agents|respiratory system agents|mesh-ancestor
56052991|NCT02265224|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56052992|NCT02265224|Antioxidants|antioxidants|mesh-ancestor
56052993|NCT02265224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56052994|NCT02265224|Protective Agents|protective agents|mesh-ancestor
56052995|NCT02265224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56052996|NCT02265224|Antidotes|antidotes|mesh-ancestor
56052997|NCT01859078|Digoxin|digoxin|mesh-list
56052998|NCT01859078|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56052999|NCT01859078|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56053000|NCT01859078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053001|NCT01859078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053002|NCT01859078|Protective Agents|protective agents|mesh-ancestor
56053003|NCT01859078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053004|NCT00558428|Amlodipine|amlodipine|mesh-list
55891963|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55891964|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
55891965|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55891966|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55891967|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55891968|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
55891969|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55891970|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891971|NCT04766086|Vaccines|vaccines|mesh-list
55891972|NCT04766086|Immunologic Factors|immunologic factors|mesh-ancestor
55891973|NCT04766086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891974|NCT05137054|Lenalidomide|lenalidomide|mesh-list
55891975|NCT05137054|Pomalidomide|pomalidomide|mesh-list
55891976|NCT05137054|Bortezomib|bortezomib|mesh-list
55891977|NCT05137054|Daratumumab|daratumumab|mesh-list
55891978|NCT05137054|Immunologic Factors|immunologic factors|mesh-ancestor
55891979|NCT05137054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891980|NCT05137054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55891981|NCT05137054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55891982|NCT05137054|Growth Substances|growth substances|mesh-ancestor
55891983|NCT05137054|Growth Inhibitors|growth inhibitors|mesh-ancestor
56053005|NCT00558428|Telmisartan|telmisartan|mesh-list
56053006|NCT00558428|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
56053007|NCT00558428|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56053008|NCT00558428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56053009|NCT00558428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55891984|NCT05137054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891986|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55891987|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
55891988|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
55891989|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891990|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891991|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55891992|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
55891993|NCT04756726|Hormones|hormones|mesh-ancestor
55891994|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55891995|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55891996|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891997|NCT04132648|Curcumin|curcumin|mesh-list
55891998|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55891999|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55892000|NCT04132648|Analgesics|analgesics|mesh-ancestor
55892001|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
55892002|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892003|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892004|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892005|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55892019|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892020|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892021|NCT04095208|Nivolumab|nivolumab|mesh-list
55892022|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892023|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892024|NCT04095208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55892025|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892026|NCT05117554|Midazolam|midazolam|mesh-list
55892027|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55892028|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55892029|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892030|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892031|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55892032|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55892033|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55892034|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55892035|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
55892036|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
55892037|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
55892038|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
55892039|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892040|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892041|NCT04093570|Decitabine|decitabine|mesh-list
55892042|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55892043|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
55892044|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892045|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892046|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892047|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
55892048|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892049|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892050|NCT04708054|Fludarabine|fludarabine|mesh-list
55892051|NCT04708054|Fludarabine phosphate|fludarabine phosphate|mesh-list
55892052|NCT04708054|Busulfan|busulfan|mesh-list
55892053|NCT04708054|Venetoclax|venetoclax|mesh-list
55892054|NCT04708054|Thiotepa|thiotepa|mesh-list
55892055|NCT04708054|Cladribine|cladribine|mesh-list
55892056|NCT04708054|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
55892057|NCT04708054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892058|NCT04708054|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55892059|NCT04708054|Antimetabolites|antimetabolites|mesh-ancestor
55892060|NCT04708054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892062|NCT04708054|Immunologic Factors|immunologic factors|mesh-ancestor
56053010|NCT00558428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053011|NCT00558428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56053012|NCT00558428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053013|NCT00558428|Vasodilator Agents|vasodilator agents|mesh-ancestor
56053014|NCT00558428|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56053015|NCT00558428|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56053016|NCT05314725|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56053017|NCT05314725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053018|NCT05314725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56053019|NCT05314725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053020|NCT03867500|Niacin|niacin|mesh-list
56053021|NCT03867500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56053022|NCT03867500|Antimetabolites|antimetabolites|mesh-ancestor
56053023|NCT03867500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053024|NCT03867500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56053025|NCT03867500|Vasodilator Agents|vasodilator agents|mesh-ancestor
56053026|NCT03867500|Vitamin B Complex|vitamin b complex|mesh-ancestor
56053027|NCT03867500|Vitamins|vitamins|mesh-ancestor
56053028|NCT03867500|Micronutrients|micronutrients|mesh-ancestor
56053029|NCT03867500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892063|NCT04708054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892064|NCT04708054|Alkylating Agents|alkylating agents|mesh-ancestor
55892065|NCT04708054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55892066|NCT04708054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55892067|NCT02292082|Cefazolin|cefazolin|mesh-list
55892068|NCT02292082|Dexamethasone|dexamethasone|mesh-list
55892073|NCT02292082|Propofol|propofol|mesh-list
55892074|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892075|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
55892076|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
55892077|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892078|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892079|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55892080|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
55892081|NCT02292082|Hormones|hormones|mesh-ancestor
55892082|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892083|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55892084|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892085|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
55892086|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
55892087|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892088|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
55892089|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55892090|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55892091|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
55892092|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55892093|NCT02292082|Narcotics|narcotics|mesh-ancestor
55892094|NCT02292082|Analgesics|analgesics|mesh-ancestor
55892095|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55892096|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55892097|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55892098|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55892099|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
56053030|NCT04310085|Lumefantrine|lumefantrine|mesh-list
56053032|NCT04310085|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56053033|NCT04310085|Antimalarials|antimalarials|mesh-ancestor
56053034|NCT04310085|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56053035|NCT04310085|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56053036|NCT04310085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053037|NCT00558272|Zoledronic Acid|zoledronic acid|mesh-list
56053038|NCT00558272|Saracatinib|saracatinib|mesh-list
56053039|NCT00558272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56053040|NCT00558272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053041|NCT00558272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053042|NCT00558272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053043|NCT00558272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053044|NCT01859312|Hydrocortisone|hydrocortisone|mesh-list
56053045|NCT01859312|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56053046|NCT01859312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053047|NCT03407625|Misoprostol|misoprostol|mesh-list
56053048|NCT03407625|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56053049|NCT03407625|Abortifacient Agents|abortifacient agents|mesh-ancestor
56053050|NCT03407625|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56053051|NCT03407625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053052|NCT03407625|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56053053|NCT03407625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56053054|NCT03407625|Oxytocics|oxytocics|mesh-ancestor
56053055|NCT03666663|Lidocaine|lidocaine|mesh-list
56053056|NCT03666663|Bupivacaine|bupivacaine|mesh-list
56053057|NCT03666663|Ropivacaine|ropivacaine|mesh-list
55892100|NCT02292082|GABA Agents|gaba agents|mesh-ancestor
55892101|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892102|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892103|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55892104|NCT02292082|Protective Agents|protective agents|mesh-ancestor
55892105|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55753779|NCT03196531|Loratadine|loratadine|mesh-list
55892106|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892108|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
55892109|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55892110|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892111|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892112|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55892113|NCT05072704|Analgesics|analgesics|mesh-ancestor
55892114|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
55892115|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892116|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55892117|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55892118|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55892119|NCT05072704|Adrenergic Agents|adrenergic agents|mesh-ancestor
56053058|NCT03666663|Anesthetics, Local|anesthetics, local|mesh-ancestor
56053059|NCT03666663|Anesthetics|anesthetics|mesh-ancestor
56053060|NCT03666663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053061|NCT03666663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053062|NCT03666663|Sensory System Agents|sensory system agents|mesh-ancestor
56053063|NCT03666663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053064|NCT03666663|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56053065|NCT03666663|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56053066|NCT03666663|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56053067|NCT03666663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56053068|NCT03666663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053069|NCT05692154|Fexofenadine|fexofenadine|mesh-list
56053070|NCT05692154|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56053071|NCT05692154|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56053072|NCT05692154|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56053073|NCT05692154|Histamine Antagonists|histamine antagonists|mesh-ancestor
56053075|NCT05692154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053076|NCT05692154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053077|NCT05692154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053078|NCT04290039|Atropine|atropine|mesh-list
56053079|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56053080|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56053081|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56053082|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56053083|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56053084|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
55892120|NCT05072704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892121|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892122|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55892123|NCT05072704|Narcotics|narcotics|mesh-ancestor
55892124|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55892125|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55892126|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
55892127|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
55892128|NCT03969004|Cemiplimab|cemiplimab|mesh-list
55892129|NCT03969004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892130|NCT03969004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892131|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
55892132|NCT04678336|Fludarabine|fludarabine|mesh-list
55892133|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892134|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
55892135|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892136|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55892137|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55892138|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
55892139|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053086|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053087|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56053088|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
56053089|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
56053090|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
56053091|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56053092|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56053093|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
56053094|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053095|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053096|NCT01863134|Eptifibatide|eptifibatide|mesh-list
56053097|NCT01863134|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56053098|NCT03415581|Oxycodone|oxycodone|mesh-list
56053099|NCT03415581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56053100|NCT03415581|Narcotics|narcotics|mesh-ancestor
56053101|NCT03415581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053102|NCT03415581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053103|NCT03415581|Analgesics|analgesics|mesh-ancestor
56053104|NCT03415581|Sensory System Agents|sensory system agents|mesh-ancestor
56053105|NCT03415581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053107|NCT00557492|Bevacizumab|bevacizumab|mesh-list
56053108|NCT00557492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56053109|NCT00557492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053110|NCT00557492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56053111|NCT00557492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56053112|NCT00557492|Growth Substances|growth substances|mesh-ancestor
56053113|NCT00557492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053114|NCT00557492|Growth Inhibitors|growth inhibitors|mesh-ancestor
56053131|NCT04203225|Anesthetics, Local|anesthetics, local|mesh-ancestor
56053132|NCT04203225|Anesthetics|anesthetics|mesh-ancestor
56053133|NCT04203225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053134|NCT04203225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053135|NCT04203225|Sensory System Agents|sensory system agents|mesh-ancestor
56053136|NCT04203225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053137|NCT04203225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56053138|NCT04203225|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56053139|NCT04203225|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56053140|NCT04203225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56053141|NCT04203225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053142|NCT04203225|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56053143|NCT04203225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56053144|NCT04203225|Adrenergic Agents|adrenergic agents|mesh-ancestor
56053145|NCT04203225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053146|NCT04203225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56053147|NCT04203225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56053148|NCT04203225|Autonomic Agents|autonomic agents|mesh-ancestor
56053149|NCT04203225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56053150|NCT04203225|Respiratory System Agents|respiratory system agents|mesh-ancestor
56053152|NCT04203225|Sympathomimetics|sympathomimetics|mesh-ancestor
56053153|NCT04203225|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56053154|NCT05314257|Granisetron|granisetron|mesh-list
56053155|NCT05314257|Antiemetics|antiemetics|mesh-ancestor
56053156|NCT05314257|Autonomic Agents|autonomic agents|mesh-ancestor
56053164|NCT02354586|Niraparib|niraparib|mesh-list
56053176|NCT00377325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053177|NCT00377325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053178|NCT00377325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053179|NCT00377325|Immunologic Factors|immunologic factors|mesh-ancestor
56053180|NCT00377325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053181|NCT00377325|Antifungal Agents|antifungal agents|mesh-ancestor
56053182|NCT00377325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053183|NCT00377325|Dermatologic Agents|dermatologic agents|mesh-ancestor
56053184|NCT00377325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56053185|NCT00377325|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56053186|NCT03440450|Gemcitabine|gemcitabine|mesh-list
56053187|NCT03440450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56053188|NCT03440450|Antimetabolites|antimetabolites|mesh-ancestor
55892140|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892141|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55892142|NCT03195478|Nivolumab|nivolumab|mesh-list
55892143|NCT03195478|Ipilimumab|ipilimumab|mesh-list
55892154|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892155|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55892157|NCT03099382|Irinotecan|irinotecan|mesh-list
55892158|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892159|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
55892160|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
55892161|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
55892162|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892163|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55892164|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55892165|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892166|NCT04590664|Verteporfin|verteporfin|mesh-list
55892167|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55892168|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
55892169|NCT03818776|Durvalumab|durvalumab|mesh-list
55892170|NCT03818776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892171|NCT03818776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892172|NCT04494412|Zanamivir|zanamivir|mesh-list
55892173|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
55892174|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892175|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892176|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892177|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55892178|NCT03583528|Edotreotide|edotreotide|mesh-list
55892179|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55892180|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892181|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
55892182|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892184|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892185|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
55892186|NCT01949337|Hormones|hormones|mesh-ancestor
55892187|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892188|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892189|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55892190|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892191|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
55892192|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55892193|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
55892194|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55892195|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
55892196|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892330|NCT02427724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892197|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892198|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
55892199|NCT04355832|Glucagon|glucagon|mesh-list
56053189|NCT03440450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053190|NCT03440450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053191|NCT03440450|Antiviral Agents|antiviral agents|mesh-ancestor
56053192|NCT03440450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053193|NCT03440450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053194|NCT03440450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053195|NCT03440450|Immunologic Factors|immunologic factors|mesh-ancestor
56053196|NCT03440450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053197|NCT02332824|Candesartan|candesartan|mesh-list
56053198|NCT02332824|Candesartan cilexetil|candesartan cilexetil|mesh-list
56053199|NCT02332824|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
56053200|NCT02332824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56053201|NCT02332824|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56053202|NCT02332824|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56053203|NCT02332824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053204|NCT02332824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053205|NCT03701061|Vaccines|vaccines|mesh-list
56053206|NCT03701061|Immunologic Factors|immunologic factors|mesh-ancestor
56053207|NCT03701061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053208|NCT03420014|Doxorubicin|doxorubicin|mesh-list
56053209|NCT03420014|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56053210|NCT03420014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56053212|NCT03420014|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56053213|NCT03420014|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56053214|NCT03420014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053215|NCT03420014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053216|NCT03705273|Dexamethasone|dexamethasone|mesh-list
55892200|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55892201|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55892202|NCT04355832|Hormones|hormones|mesh-ancestor
55892203|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892204|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892205|NCT04355832|Incretins|incretins|mesh-ancestor
55892206|NCT02518594|Progesterone|progesterone|mesh-list
55892207|NCT02518594|Progestins|progestins|mesh-ancestor
55892208|NCT02518594|Hormones|hormones|mesh-ancestor
55892220|NCT02057133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892221|NCT02057133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892222|NCT02057133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892223|NCT02057133|Immunologic Factors|immunologic factors|mesh-ancestor
55892224|NCT02057133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892225|NCT02057133|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55892226|NCT02057133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56053217|NCT03705273|Dexamethasone acetate|dexamethasone acetate|mesh-list
56053219|NCT03705273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053220|NCT03705273|Antiemetics|antiemetics|mesh-ancestor
56053221|NCT03705273|Autonomic Agents|autonomic agents|mesh-ancestor
56053222|NCT03705273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053223|NCT03705273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053224|NCT03705273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56053225|NCT03705273|Glucocorticoids|glucocorticoids|mesh-ancestor
56053226|NCT03705273|Hormones|hormones|mesh-ancestor
56053227|NCT03705273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053228|NCT03705273|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56053229|NCT03705273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053230|NCT03705273|Protease Inhibitors|protease inhibitors|mesh-ancestor
56053231|NCT03705273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053232|NCT03705273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053233|NCT04184271|Fluorides|fluorides|mesh-list
56053234|NCT04184271|Cariostatic Agents|cariostatic agents|mesh-ancestor
56053235|NCT04184271|Protective Agents|protective agents|mesh-ancestor
56053236|NCT04184271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053237|NCT03936387|Ropivacaine|ropivacaine|mesh-list
56053238|NCT03936387|Anesthetics, Local|anesthetics, local|mesh-ancestor
56053239|NCT03936387|Anesthetics|anesthetics|mesh-ancestor
56053240|NCT03936387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053241|NCT03936387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053242|NCT03936387|Sensory System Agents|sensory system agents|mesh-ancestor
55892227|NCT02057133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892228|NCT02057133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892229|NCT02057133|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55892230|NCT02057133|Hormone Antagonists|hormone antagonists|mesh-ancestor
55892231|NCT02057133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892232|NCT02057133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55892233|NCT02057133|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55892234|NCT02057133|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55892235|NCT02057133|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55892236|NCT02057133|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55892237|NCT02057133|Antidiarrheals|antidiarrheals|mesh-ancestor
55892238|NCT02057133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55892239|NCT01516593|Cytarabine|cytarabine|mesh-list
55892240|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55892241|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
55892242|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892243|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892244|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
55892245|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892246|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892247|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
56053243|NCT03936387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053244|NCT04173429|Nadroparin|nadroparin|mesh-list
56053245|NCT04173429|Warfarin|warfarin|mesh-list
56053246|NCT04173429|Calcium|calcium|mesh-list
56053247|NCT04173429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55892248|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892249|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
55892250|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
55892251|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55892252|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892253|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892254|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
55892255|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55892256|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892257|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892258|NCT02042391|Cytarabine|cytarabine|mesh-list
55892259|NCT02042391|Prednisone|prednisone|mesh-list
55892260|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
55892261|NCT02042391|Rituximab|rituximab|mesh-list
55892262|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
55892263|NCT02042391|Doxorubicin|doxorubicin|mesh-list
55892264|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55892265|NCT02042391|Vincristine|vincristine|mesh-list
55892266|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892267|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
55892268|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892269|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55892270|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55892271|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
55892272|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892273|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892274|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55892292|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
55892293|NCT02461836|Gemcitabine|gemcitabine|mesh-list
55892294|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55892295|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
55892296|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892297|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892298|NCT02461836|Antiviral Agents|antiviral agents|mesh-ancestor
55892299|NCT02461836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892300|NCT02461836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892301|NCT02461836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892302|NCT02461836|Immunologic Factors|immunologic factors|mesh-ancestor
55892303|NCT02461836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892304|NCT02034981|Crizotinib|crizotinib|mesh-list
55892305|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892306|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55892307|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892308|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892309|NCT01986946|Hydromorphone|hydromorphone|mesh-list
55892310|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55892311|NCT01986946|Narcotics|narcotics|mesh-ancestor
55892312|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892313|NCT01986946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892314|NCT01986946|Analgesics|analgesics|mesh-ancestor
55892315|NCT01986946|Sensory System Agents|sensory system agents|mesh-ancestor
55892316|NCT01986946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892317|NCT01504815|Cisplatin|cisplatin|mesh-list
55892318|NCT01504815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892331|NCT02427724|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56053248|NCT04173429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892332|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55892333|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55892350|NCT01908777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892351|NCT01908777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892352|NCT01908777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55892353|NCT01908777|Antimetabolites|antimetabolites|mesh-ancestor
55892354|NCT01908777|Antiviral Agents|antiviral agents|mesh-ancestor
55892355|NCT01908777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892356|NCT01908777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892357|NCT01908777|Immunologic Factors|immunologic factors|mesh-ancestor
55892358|NCT01908777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892359|NCT01908777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55892360|NCT01908777|Alkylating Agents|alkylating agents|mesh-ancestor
55892361|NCT01908777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55892362|NCT01908777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55892363|NCT03437200|Nivolumab|nivolumab|mesh-list
55892364|NCT03437200|Ipilimumab|ipilimumab|mesh-list
55892365|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892366|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892367|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55892368|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892370|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55892371|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892372|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55892373|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892374|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
55892375|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892376|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
55892377|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892378|NCT02715726|Atorvastatin|atorvastatin|mesh-list
55892379|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55892380|NCT02715726|Simvastatin|simvastatin|mesh-list
55892381|NCT02715726|Ezetimibe|ezetimibe|mesh-list
55892382|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55892383|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55892384|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55892385|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
55892386|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892387|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55892388|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55892389|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892390|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
55892391|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892392|NCT01893567|Clobetasol|clobetasol|mesh-list
55892393|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892394|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
55892408|NCT04847466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892410|NCT04249596|Tianeptine|tianeptine|mesh-list
55892411|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55892412|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
55892413|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55892414|NCT01476501|Vitamin D|vitamin d|mesh-list
55892415|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
55892416|NCT01476501|Vitamins|vitamins|mesh-ancestor
55892417|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
55892418|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892419|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55892420|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55892421|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
55892422|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55892423|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892424|NCT02464020|Vancomycin|vancomycin|mesh-list
55892425|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55892426|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892427|NCT04756089|Oxytocin|oxytocin|mesh-list
55892428|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
55892429|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55892430|NCT04756089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892431|NCT03397888|Betrixaban|betrixaban|mesh-list
55892432|NCT03397888|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55892433|NCT03397888|Antithrombins|antithrombins|mesh-ancestor
55892434|NCT03397888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56053250|NCT04173429|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56053251|NCT04173429|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56053252|NCT04173429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053253|NCT03710187|Hydrocortisone|hydrocortisone|mesh-list
56053254|NCT03710187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053255|NCT04167189|Lidocaine|lidocaine|mesh-list
56053256|NCT04167189|Anesthetics, Local|anesthetics, local|mesh-ancestor
56053257|NCT04167189|Anesthetics|anesthetics|mesh-ancestor
56053258|NCT04167189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053259|NCT04167189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053260|NCT04167189|Sensory System Agents|sensory system agents|mesh-ancestor
56053261|NCT04167189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053262|NCT04167189|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56053263|NCT04167189|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56053264|NCT04167189|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56053265|NCT04167189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56053266|NCT04167189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053267|NCT03929367|Oxytocin|oxytocin|mesh-list
56053268|NCT03929367|Oxytocics|oxytocics|mesh-ancestor
56053269|NCT03929367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56053270|NCT03929367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053271|NCT04149405|Diphosphonates|diphosphonates|mesh-list
56053272|NCT04149405|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56053273|NCT04149405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053274|NCT00556712|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56053275|NCT00556712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053276|NCT00556712|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56053277|NCT00556712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892435|NCT03397888|Protease Inhibitors|protease inhibitors|mesh-ancestor
55892436|NCT03397888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892437|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892438|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
55753813|NCT02449369|Oxycodone|oxycodone|mesh-list
55892439|NCT01886859|Lenalidomide|lenalidomide|mesh-list
55892440|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
55892441|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892442|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55892443|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55892444|NCT01886859|Growth Substances|growth substances|mesh-ancestor
55892445|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
55892446|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892448|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
55892449|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56053278|NCT00556712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053279|NCT03717051|Nicotine|nicotine|mesh-list
56053280|NCT03717051|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56053281|NCT03717051|Autonomic Agents|autonomic agents|mesh-ancestor
56053282|NCT03717051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053283|NCT03717051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053284|NCT03717051|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56053285|NCT03717051|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56053286|NCT03717051|Cholinergic Agents|cholinergic agents|mesh-ancestor
56053287|NCT03717051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053288|NCT03717051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053289|NCT04350320|Colchicine|colchicine|mesh-list
56053290|NCT04350320|Gout Suppressants|gout suppressants|mesh-ancestor
56053291|NCT04350320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56053292|NCT04350320|Tubulin Modulators|tubulin modulators|mesh-ancestor
56053293|NCT04350320|Antimitotic Agents|antimitotic agents|mesh-ancestor
56053294|NCT04350320|Mitosis Modulators|mitosis modulators|mesh-ancestor
56053295|NCT04350320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892450|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55892451|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892452|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892453|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
55892454|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892462|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55892463|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55892464|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55892466|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
55892467|NCT02464722|Remifentanil|remifentanil|mesh-list
55892468|NCT02464722|Propofol|propofol|mesh-list
55892469|NCT02464722|Rocuronium|rocuronium|mesh-list
55892470|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55892471|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892472|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053335|NCT03360890|Mitosis Modulators|mitosis modulators|mesh-ancestor
55892473|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55892474|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
55892475|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
55892476|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55892477|NCT02464722|Analgesics|analgesics|mesh-ancestor
55892478|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
55892479|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892480|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55892481|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55892482|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55892483|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
55892484|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892485|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892486|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55892487|NCT02464722|Narcotics|narcotics|mesh-ancestor
55892488|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55892489|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55892490|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
55892491|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55892492|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
55892493|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
56053296|NCT04350320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053298|NCT03920865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56053299|NCT03920865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053300|NCT03920865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053301|NCT00556322|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56053302|NCT00556322|Docetaxel|docetaxel|mesh-list
55892494|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
55892495|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55753839|NCT03192943|Nivolumab|nivolumab|mesh-list
55892496|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55892497|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55892498|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55892499|NCT01991548|Insulin|insulin|mesh-list
55892500|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55892501|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892502|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
55892503|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55892504|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892505|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
55892506|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55892507|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
55892508|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892509|NCT01878669|Expectorants|expectorants|mesh-ancestor
55892510|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
55892511|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55892512|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
55892513|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892514|NCT01878669|Protective Agents|protective agents|mesh-ancestor
55892515|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892517|NCT02461914|Warfarin|warfarin|mesh-list
55892518|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
55892519|NCT01991860|Amisulpride|amisulpride|mesh-list
55892520|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55892521|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55892535|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
55892536|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892537|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892538|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55892539|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55892540|NCT02463552|Naproxen|naproxen|mesh-list
55892541|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55892542|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55892543|NCT02463552|Analgesics|analgesics|mesh-ancestor
55892544|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
55892545|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892546|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892547|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892548|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55892549|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
55892550|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55892551|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892552|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892553|NCT01992016|Ranolazine|ranolazine|mesh-list
55892554|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55892555|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55892556|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892557|NCT01871571|Leucovorin|leucovorin|mesh-list
55892558|NCT01871571|Bevacizumab|bevacizumab|mesh-list
55892559|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55892560|NCT01871571|Fluorouracil|fluorouracil|mesh-list
55892561|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
55892562|NCT01871571|Antibodies|antibodies|mesh-list
55892563|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
55892564|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55892565|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
55892566|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892567|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55892568|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55892569|NCT01871571|Growth Substances|growth substances|mesh-ancestor
55892570|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892571|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
56053303|NCT00556322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053304|NCT00556322|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56053306|NCT00556322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053307|NCT00556322|Tubulin Modulators|tubulin modulators|mesh-ancestor
56053308|NCT00556322|Antimitotic Agents|antimitotic agents|mesh-ancestor
56053309|NCT00556322|Mitosis Modulators|mitosis modulators|mesh-ancestor
56053310|NCT04137627|Melatonin|melatonin|mesh-list
56053311|NCT04137627|Antioxidants|antioxidants|mesh-ancestor
56053312|NCT04137627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053313|NCT04137627|Protective Agents|protective agents|mesh-ancestor
56053314|NCT04137627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053315|NCT04137627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053316|NCT05664386|Propofol|propofol|mesh-list
56053317|NCT05664386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56053318|NCT05664386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053319|NCT05664386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053320|NCT05664386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56053321|NCT05664386|Anesthetics, General|anesthetics, general|mesh-ancestor
56053322|NCT05664386|Anesthetics|anesthetics|mesh-ancestor
56053323|NCT04136145|Belimumab|belimumab|mesh-list
56053324|NCT04136145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892572|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
55892573|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
55892574|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892575|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55892576|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892577|NCT01871571|Antidotes|antidotes|mesh-ancestor
55892578|NCT01871571|Protective Agents|protective agents|mesh-ancestor
55892579|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
55892580|NCT01871571|Vitamins|vitamins|mesh-ancestor
55892581|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
55892582|NCT02461368|Triamcinolone|triamcinolone|mesh-list
55892591|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
55892592|NCT02461368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892593|NCT02461368|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55892594|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55892595|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55892596|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55892597|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892598|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892599|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
55892600|NCT02461368|Hormones|hormones|mesh-ancestor
55892601|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892602|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892603|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
55892604|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892605|NCT01422759|Spironolactone|spironolactone|mesh-list
55892606|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55892607|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
55892608|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053325|NCT04136145|Immunologic Factors|immunologic factors|mesh-ancestor
56053326|NCT04136145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053328|NCT01869686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56053329|NCT01869686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053330|NCT03360890|Docetaxel|docetaxel|mesh-list
56053331|NCT03360890|Pembrolizumab|pembrolizumab|mesh-list
56053332|NCT03360890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053333|NCT03360890|Tubulin Modulators|tubulin modulators|mesh-ancestor
56053334|NCT03360890|Antimitotic Agents|antimitotic agents|mesh-ancestor
55892609|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892610|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55892611|NCT01422759|Diuretics|diuretics|mesh-ancestor
55892612|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
55892613|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
55892614|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55892615|NCT01992172|Protective Agents|protective agents|mesh-ancestor
55892616|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892617|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
55892618|NCT03296982|Enoxaparin|enoxaparin|mesh-list
55892619|NCT03296982|Edoxaban|edoxaban|mesh-list
55892620|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
55892621|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55892622|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55892623|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892624|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55892625|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
55892638|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55892639|NCT01895829|Hematinics|hematinics|mesh-ancestor
55892640|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55892641|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55892642|NCT03298698|Prednisone|prednisone|mesh-list
55892643|NCT03298698|Prednisolone|prednisolone|mesh-list
55892644|NCT03298698|Rituximab|rituximab|mesh-list
55892645|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892646|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892647|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
55892648|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892649|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55892650|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892651|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
55892652|NCT03298698|Hormones|hormones|mesh-ancestor
55892653|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892654|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55892655|NCT03389620|Dexamethasone|dexamethasone|mesh-list
55892656|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892657|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
55892658|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
55892659|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892660|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892661|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55892676|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892677|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
55892678|NCT03298542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892679|NCT03296670|Nitroglycerin|nitroglycerin|mesh-list
55892680|NCT03296670|Alprostadil|alprostadil|mesh-list
55892681|NCT03296670|Vasodilator Agents|vasodilator agents|mesh-ancestor
55892682|NCT03296670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55892683|NCT03296670|Urological Agents|urological agents|mesh-ancestor
55892684|NCT03298464|Pioglitazone|pioglitazone|mesh-list
55892685|NCT03298464|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55892686|NCT03298464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892687|NCT04491084|Antibodies|antibodies|mesh-list
55892688|NCT04491084|Flt3 ligand protein|flt3 ligand protein|mesh-list
56053336|NCT03360890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053337|NCT03360890|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56053338|NCT03862755|Heparin|heparin|mesh-list
56053339|NCT03862755|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56053340|NCT03862755|Tinzaparin|tinzaparin|mesh-list
56053341|NCT03862755|Dalteparin|dalteparin|mesh-list
55892689|NCT04491084|Immunologic Factors|immunologic factors|mesh-ancestor
55892690|NCT04491084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892691|NCT04491084|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55892692|NCT04491084|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55892693|NCT04491084|Protective Agents|protective agents|mesh-ancestor
55892694|NCT01852071|Busulfan|busulfan|mesh-list
55892695|NCT01852071|Alkylating Agents|alkylating agents|mesh-ancestor
55892696|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892697|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892698|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
55892699|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892700|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55892701|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892702|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55892703|NCT04084548|Lidocaine|lidocaine|mesh-list
55892704|NCT04084548|Ketamine|ketamine|mesh-list
55892705|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
55892706|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
55892707|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892708|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892709|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
55892710|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892711|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55892712|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55892713|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55892714|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55892715|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892716|NCT04084548|Analgesics|analgesics|mesh-ancestor
55892717|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55892718|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55892719|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
55892720|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55892721|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55892722|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892723|NCT02059642|Metadoxine|metadoxine|mesh-list
55892744|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55892745|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55892746|NCT00469755|Analgesics|analgesics|mesh-ancestor
55892747|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
55892748|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892749|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892750|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892751|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55892752|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
55892753|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
55892754|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
55892755|NCT00469755|Vitamins|vitamins|mesh-ancestor
55892756|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
55892757|NCT00453531|Acetylcholine|acetylcholine|mesh-list
55892758|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
55892759|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55892760|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
55892761|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892762|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892763|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892764|NCT03295968|Ibuprofen|ibuprofen|mesh-list
55892765|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55892766|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55892767|NCT03295968|Analgesics|analgesics|mesh-ancestor
55892768|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
55892769|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892770|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892771|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053342|NCT03862755|Anticoagulants|anticoagulants|mesh-ancestor
56053343|NCT03862755|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56053344|NCT03862755|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56053345|NCT03862755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053346|NCT02332590|Adalimumab|adalimumab|mesh-list
56053347|NCT02332590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053348|NCT02332590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56053349|NCT04076787|Sunitinib|sunitinib|mesh-list
56053350|NCT04076787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053351|NCT04076787|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56053352|NCT04076787|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56053353|NCT04076787|Growth Substances|growth substances|mesh-ancestor
56053354|NCT04076787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053355|NCT04076787|Growth Inhibitors|growth inhibitors|mesh-ancestor
56053356|NCT04076787|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56053357|NCT04076787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053358|NCT04076787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053359|NCT00554840|Varenicline|varenicline|mesh-list
56053360|NCT00554840|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56053361|NCT00554840|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56053362|NCT00554840|Cholinergic Agents|cholinergic agents|mesh-ancestor
56053363|NCT00554840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053364|NCT00554840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053365|NCT00554840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053366|NCT04069221|Cobicistat|cobicistat|mesh-list
56053367|NCT04069221|Artefenomel|artefenomel|mesh-list
56053368|NCT04069221|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56053369|NCT04069221|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56053370|NCT04069221|Antiviral Agents|antiviral agents|mesh-ancestor
56053371|NCT04069221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053372|NCT04069221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56053373|NCT04069221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56053374|NCT04069221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053375|NCT04069221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053376|NCT04069221|Antimalarials|antimalarials|mesh-ancestor
56053379|NCT03054038|Afatinib|afatinib|mesh-list
56053381|NCT03054038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053382|NCT03054038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56053383|NCT03054038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053384|NCT03054038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053385|NCT03054038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56053386|NCT02302716|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56053387|NCT02302716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053388|NCT03958071|Pirfenidone|pirfenidone|mesh-list
56053390|NCT03958071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053391|NCT03958071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56053392|NCT03958071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053393|NCT03958071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053394|NCT03958071|Analgesics|analgesics|mesh-ancestor
56053395|NCT03958071|Sensory System Agents|sensory system agents|mesh-ancestor
55892772|NCT03295968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55892773|NCT03295968|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55892774|NCT03295968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892775|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892776|NCT03298074|Etoposide|etoposide|mesh-list
55892777|NCT03298074|Apatinib|apatinib|mesh-list
55892778|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55892779|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892788|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
55892789|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892790|NCT04755543|Fluorouracil|fluorouracil|mesh-list
55892791|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892792|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
55892793|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892794|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55892795|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892796|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
55892797|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892798|NCT01993108|Naltrexone|naltrexone|mesh-list
55892799|NCT01993108|Methylphenidate|methylphenidate|mesh-list
55892800|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55892801|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55892802|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892803|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
55892804|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892805|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55892806|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55892807|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55892808|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55892809|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892810|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
55892811|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892812|NCT02307526|Bromides|bromides|mesh-list
55892813|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55892814|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
55892815|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55892816|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892817|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892818|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
55892819|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892820|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892822|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053396|NCT03958071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053397|NCT03958071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053398|NCT03958071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56053399|NCT03958071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56053400|NCT03958071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053401|NCT03958071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56053402|NCT04066647|Dexamethasone|dexamethasone|mesh-list
56053403|NCT04066647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892823|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55892824|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55892825|NCT01371201|Growth Substances|growth substances|mesh-ancestor
55892826|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892827|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
55892828|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55892829|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892830|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892831|NCT00436527|Metronidazole|metronidazole|mesh-list
55892832|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892833|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55892834|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55892835|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55892836|NCT02307916|Mitogens|mitogens|mesh-list
55892837|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
55892838|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892839|NCT00419367|Vorinostat|vorinostat|mesh-list
55892840|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892841|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55892842|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892843|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892844|NCT01994746|Glucagon|glucagon|mesh-list
55892845|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55892846|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55892864|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892865|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
55892866|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55892867|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
55892869|NCT01999348|Bimatoprost|bimatoprost|mesh-list
55892870|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55892871|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55892872|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
55892873|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892874|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892875|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892876|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55892877|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55892878|NCT01787487|Azacitidine|azacitidine|mesh-list
55892879|NCT01787487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55892880|NCT01787487|Antimetabolites|antimetabolites|mesh-ancestor
55892881|NCT01787487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892882|NCT01787487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892883|NCT01787487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892884|NCT00280761|Fluorouracil|fluorouracil|mesh-list
55892885|NCT00280761|Capecitabine|capecitabine|mesh-list
55892886|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
55892887|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892888|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55892889|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892890|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892891|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
55892892|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892893|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55892894|NCT02463318|Melatonin|melatonin|mesh-list
55892895|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
55892896|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892897|NCT02463318|Protective Agents|protective agents|mesh-ancestor
55892898|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053404|NCT04066647|Antiemetics|antiemetics|mesh-ancestor
56053405|NCT04066647|Autonomic Agents|autonomic agents|mesh-ancestor
56053406|NCT04066647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053407|NCT04066647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053408|NCT04066647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55892899|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892900|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55892901|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892916|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
55892917|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892918|NCT02716194|Factor VIII|factor viii|mesh-list
55892919|NCT02716194|Coagulants|coagulants|mesh-ancestor
55892920|NCT02461056|Ibuprofen|ibuprofen|mesh-list
55892921|NCT02461056|Hydromorphone|hydromorphone|mesh-list
55892922|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55892923|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55892924|NCT02461056|Analgesics|analgesics|mesh-ancestor
55892925|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
55892926|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892927|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892928|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892929|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55892930|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55892931|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892932|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892933|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55892934|NCT02461056|Narcotics|narcotics|mesh-ancestor
55892935|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892936|NCT01173172|Boron|boron|mesh-list
55892937|NCT01173172|Trace Elements|trace elements|mesh-ancestor
55892938|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
55892939|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892940|NCT00003270|Cyclosporine|cyclosporine|mesh-list
55892941|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
55892942|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
55892943|NCT00003270|Busulfan|busulfan|mesh-list
55892944|NCT00003270|Cyclosporins|cyclosporins|mesh-list
55892945|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55892946|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55892947|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
55892948|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892949|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55892950|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55892951|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
55892952|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892953|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892954|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55892955|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892956|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
55892957|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892958|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
55892959|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55892960|NCT00003270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892961|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
55892962|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
55892963|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892972|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
55892973|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892974|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892975|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
55892976|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892977|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55892978|NCT02005354|Anesthetics, General|anesthetics, general|mesh-ancestor
55892979|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55892980|NCT02005354|Analgesics|analgesics|mesh-ancestor
55892981|NCT03290820|Aspirin|aspirin|mesh-list
55892982|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55892983|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55892984|NCT03290820|Analgesics|analgesics|mesh-ancestor
55892985|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
55892986|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892987|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053410|NCT04066647|Hormones|hormones|mesh-ancestor
56053411|NCT04066647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053412|NCT04066647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56053413|NCT04066647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053414|NCT04041453|Ivermectin|ivermectin|mesh-list
56053415|NCT04041453|Albendazole|albendazole|mesh-list
56053416|NCT04041453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56053417|NCT04041453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053418|NCT04041453|Anthelmintics|anthelmintics|mesh-ancestor
56053419|NCT04041453|Anticestodal Agents|anticestodal agents|mesh-ancestor
55892988|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892989|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55892990|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55892991|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55892992|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892993|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55892994|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55892995|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892996|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
55892997|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55892998|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
55892999|NCT03773484|Narcotics|narcotics|mesh-ancestor
55893000|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893001|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893003|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
55893004|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893005|NCT03283410|Propofol|propofol|mesh-list
55893006|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55893007|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893008|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893009|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55893010|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
55893011|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
55893012|NCT04318704|Ifenprodil|ifenprodil|mesh-list
55893013|NCT04318704|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55893014|NCT04318704|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55893015|NCT04318704|Adrenergic Agents|adrenergic agents|mesh-ancestor
55893016|NCT04318704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893017|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893018|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893019|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
55893020|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55893021|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55893022|NCT03283176|Folic Acid|folic acid|mesh-list
55893023|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
55893024|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
55893025|NCT03283176|Vitamins|vitamins|mesh-ancestor
55893026|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
55893027|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893028|NCT03283176|Hematinics|hematinics|mesh-ancestor
55893029|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
55893030|NCT03290430|Nicotine|nicotine|mesh-list
55893031|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55893032|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
55893041|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
55893042|NCT03294798|Interferon alpha-2|interferon alpha-2|mesh-list
55893043|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55893044|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893045|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
55893046|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893047|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
55893048|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893049|NCT04488744|Nicotine|nicotine|mesh-list
55893050|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55893051|NCT04488744|Autonomic Agents|autonomic agents|mesh-ancestor
55893052|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053420|NCT04041453|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56053421|NCT04041453|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56053422|NCT04041453|Tubulin Modulators|tubulin modulators|mesh-ancestor
56053423|NCT04041453|Antimitotic Agents|antimitotic agents|mesh-ancestor
56053424|NCT04041453|Mitosis Modulators|mitosis modulators|mesh-ancestor
56053425|NCT04041453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053426|NCT04041453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053427|NCT02354508|Pasireotide|pasireotide|mesh-list
56053428|NCT02354508|Hormones|hormones|mesh-ancestor
56053429|NCT02354508|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893053|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893054|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55893055|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55893056|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
55893057|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893058|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893059|NCT02005666|Clindamycin|clindamycin|mesh-list
55893060|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
55893061|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
55893062|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55893063|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55893064|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893065|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55893066|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893067|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893068|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
55893069|NCT03283020|Naltrexone|naltrexone|mesh-list
55893070|NCT03283020|Remifentanil|remifentanil|mesh-list
55893071|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
55893072|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55893073|NCT03283020|Narcotics|narcotics|mesh-ancestor
55893074|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893075|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893076|NCT03283020|Analgesics|analgesics|mesh-ancestor
55893077|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
55893123|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
55893078|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893079|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55893080|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55893081|NCT00494182|Paclitaxel|paclitaxel|mesh-list
55893082|NCT00494182|Carboplatin|carboplatin|mesh-list
55893083|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55893084|NCT00494182|Sorafenib|sorafenib|mesh-list
55893085|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55893086|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893087|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
55893088|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
55893089|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
55893090|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893091|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55893092|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893093|NCT02006056|Ondansetron|ondansetron|mesh-list
55893094|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
55893095|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
55893096|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893097|NCT02006056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893098|NCT02006056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55893099|NCT02006056|Antipruritics|antipruritics|mesh-ancestor
55893100|NCT02006056|Dermatologic Agents|dermatologic agents|mesh-ancestor
55893101|NCT02006056|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55893103|NCT02006056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893104|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893105|NCT02006056|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55893106|NCT02006056|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55893107|NCT02006056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893108|NCT02006056|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56053431|NCT00554216|Topiramate|topiramate|mesh-list
56053432|NCT00554216|Phentermine|phentermine|mesh-list
56053433|NCT00554216|Anticonvulsants|anticonvulsants|mesh-ancestor
56053434|NCT00554216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56053435|NCT00554216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053436|NCT00554216|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56053437|NCT00554216|Appetite Depressants|appetite depressants|mesh-ancestor
56053438|NCT00554216|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56053439|NCT00554216|Sympathomimetics|sympathomimetics|mesh-ancestor
56053440|NCT00554216|Autonomic Agents|autonomic agents|mesh-ancestor
56053441|NCT00554216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053442|NCT00554216|Adrenergic Agents|adrenergic agents|mesh-ancestor
56053443|NCT00554216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053444|NCT00554216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053445|NCT02353572|Dexamethasone|dexamethasone|mesh-list
56053446|NCT02353572|Bortezomib|bortezomib|mesh-list
56053447|NCT02353572|Melphalan|melphalan|mesh-list
56053448|NCT02353572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053449|NCT02353572|Antiemetics|antiemetics|mesh-ancestor
56053450|NCT02353572|Autonomic Agents|autonomic agents|mesh-ancestor
56053451|NCT02353572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053452|NCT02353572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053453|NCT02353572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56053454|NCT02353572|Glucocorticoids|glucocorticoids|mesh-ancestor
56053455|NCT02353572|Hormones|hormones|mesh-ancestor
56053456|NCT02353572|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053457|NCT02353572|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56053458|NCT02353572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053459|NCT02353572|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56053460|NCT02353572|Alkylating Agents|alkylating agents|mesh-ancestor
55893109|NCT02006056|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55893110|NCT03290196|Bupivacaine|bupivacaine|mesh-list
55893111|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
55893112|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
55893113|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893114|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893115|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
55893116|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893117|NCT02006836|Insulin|insulin|mesh-list
55893118|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55893120|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
55893121|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55893122|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053461|NCT02353572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053462|NCT02353572|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56053463|NCT02353572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053464|NCT02353572|Immunologic Factors|immunologic factors|mesh-ancestor
55893124|NCT02068846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55893125|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893126|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55893127|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55893128|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893129|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893130|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893131|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55893132|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55893134|NCT03289728|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55893135|NCT03289728|Sympathomimetics|sympathomimetics|mesh-ancestor
55893136|NCT03289728|Autonomic Agents|autonomic agents|mesh-ancestor
55893137|NCT03289728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893138|NCT03289728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893139|NCT03289728|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55893140|NCT03289728|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55893141|NCT03289728|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55893142|NCT03289728|Adrenergic Agents|adrenergic agents|mesh-ancestor
55893143|NCT03289728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893144|NCT03289728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893145|NCT03289728|Protective Agents|protective agents|mesh-ancestor
55893146|NCT03294486|Flucytosine|flucytosine|mesh-list
55893147|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
55893148|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893149|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
55893150|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893151|NCT03294252|Leucovorin|leucovorin|mesh-list
55893152|NCT03294252|Folic Acid|folic acid|mesh-list
55893153|NCT03294252|Fluorouracil|fluorouracil|mesh-list
55893154|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
55893155|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
55893156|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
55893157|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893158|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55893159|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893160|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55893161|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
55893162|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893163|NCT03294252|Antidotes|antidotes|mesh-ancestor
55893164|NCT03294252|Protective Agents|protective agents|mesh-ancestor
55893165|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
55893166|NCT03294252|Vitamins|vitamins|mesh-ancestor
55893167|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
55893168|NCT03294252|Hematinics|hematinics|mesh-ancestor
55893169|NCT03294174|Ropivacaine|ropivacaine|mesh-list
55893170|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
55893171|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
55893172|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893173|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893174|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
55893175|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893176|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
55893177|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
55893178|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55893181|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
55893182|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55893183|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
55893184|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55893186|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
55893187|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893188|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893189|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55893190|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
55893191|NCT03289338|Hormones|hormones|mesh-ancestor
55893192|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053465|NCT03886701|Isoniazid|isoniazid|mesh-list
56053466|NCT03886701|Rifapentine|rifapentine|mesh-list
56053467|NCT03886701|Antitubercular Agents|antitubercular agents|mesh-ancestor
56053468|NCT03886701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56053469|NCT03886701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053470|NCT03886701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56053471|NCT03886701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56053472|NCT03886701|Antimetabolites|antimetabolites|mesh-ancestor
56053473|NCT03886701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053474|NCT03886701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56053475|NCT03886701|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56053478|NCT00552578|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56053479|NCT00552578|Naloxone|naloxone|mesh-list
56053480|NCT00552578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55780671|NCT01953328|Evolocumab|evolocumab|mesh-list
56053481|NCT00552578|Narcotics|narcotics|mesh-ancestor
56053482|NCT00552578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053483|NCT00552578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053484|NCT00552578|Analgesics|analgesics|mesh-ancestor
55893193|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55893194|NCT03289338|Protective Agents|protective agents|mesh-ancestor
55893195|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55893196|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893197|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55893199|NCT02069704|Folic Acid|folic acid|mesh-list
55893200|NCT02069704|Bevacizumab|bevacizumab|mesh-list
55893201|NCT02069704|Fluorouracil|fluorouracil|mesh-list
55893202|NCT02069704|Oxaliplatin|oxaliplatin|mesh-list
55893203|NCT02069704|Irinotecan|irinotecan|mesh-list
55893204|NCT02069704|Levoleucovorin|levoleucovorin|mesh-list
55893205|NCT02069704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55893206|NCT02069704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893207|NCT02069704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55893208|NCT02069704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55893209|NCT02069704|Growth Substances|growth substances|mesh-ancestor
55893210|NCT02069704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893211|NCT02069704|Growth Inhibitors|growth inhibitors|mesh-ancestor
55893212|NCT02069704|Antimetabolites|antimetabolites|mesh-ancestor
55893213|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893214|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55893215|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55893216|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
55893217|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55893218|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55893219|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893220|NCT02069704|Antidotes|antidotes|mesh-ancestor
55893221|NCT02069704|Protective Agents|protective agents|mesh-ancestor
55893222|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
55893223|NCT02069704|Vitamins|vitamins|mesh-ancestor
55893224|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
55893225|NCT02069704|Hematinics|hematinics|mesh-ancestor
55893226|NCT02314546|Lidocaine|lidocaine|mesh-list
56053485|NCT00552578|Sensory System Agents|sensory system agents|mesh-ancestor
56053486|NCT00552578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053487|NCT00552578|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56053488|NCT02301936|Sofosbuvir|sofosbuvir|mesh-list
56053489|NCT02301936|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56053490|NCT02301936|Ledipasvir|ledipasvir|mesh-list
56053491|NCT02301936|Antiviral Agents|antiviral agents|mesh-ancestor
56053492|NCT02301936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053493|NCT03881163|Acetylcysteine|acetylcysteine|mesh-list
56053494|NCT03881163|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56053495|NCT03881163|Antiviral Agents|antiviral agents|mesh-ancestor
56053496|NCT03881163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053497|NCT03881163|Expectorants|expectorants|mesh-ancestor
56053498|NCT03881163|Respiratory System Agents|respiratory system agents|mesh-ancestor
56053499|NCT03881163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56053500|NCT03881163|Antioxidants|antioxidants|mesh-ancestor
56053501|NCT03881163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053502|NCT03881163|Protective Agents|protective agents|mesh-ancestor
56053503|NCT03881163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053504|NCT03881163|Antidotes|antidotes|mesh-ancestor
56053505|NCT02352090|Dienogest|dienogest|mesh-list
56053506|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56053507|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56053508|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56053509|NCT02352090|Estradiol|estradiol|mesh-list
56053510|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56053511|NCT02352090|Nandrolone|nandrolone|mesh-list
56053512|NCT02352090|Estrogens|estrogens|mesh-ancestor
56053513|NCT02352090|Hormones|hormones|mesh-ancestor
55893227|NCT02314546|Midazolam|midazolam|mesh-list
55893228|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55893229|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55893230|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893231|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893232|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55893233|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55893234|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55893235|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55893236|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
55893240|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893241|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893242|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
55893243|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
55893244|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893245|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55893246|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55893247|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56053514|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053515|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053516|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56053517|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
56053518|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56053519|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56053520|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56053521|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56053522|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56053523|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
56053524|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56053525|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053526|NCT02352090|Androgens|androgens|mesh-ancestor
56053527|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
56053528|NCT03848871|Betamethasone|betamethasone|mesh-list
56053529|NCT03848871|Betamethasone Valerate|betamethasone valerate|mesh-list
56053530|NCT03848871|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56053531|NCT03848871|Betamethasone benzoate|betamethasone benzoate|mesh-list
56053532|NCT03848871|Calcipotriene|calcipotriene|mesh-list
56053533|NCT03848871|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56053534|NCT03848871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053535|NCT03848871|Glucocorticoids|glucocorticoids|mesh-ancestor
56053536|NCT03848871|Hormones|hormones|mesh-ancestor
56053537|NCT03848871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053538|NCT03848871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053539|NCT03848871|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56053540|NCT03848871|Respiratory System Agents|respiratory system agents|mesh-ancestor
56053541|NCT03848871|Dermatologic Agents|dermatologic agents|mesh-ancestor
56053542|NCT04032327|Bupivacaine|bupivacaine|mesh-list
56053543|NCT04032327|Anesthetics, Local|anesthetics, local|mesh-ancestor
56053544|NCT04032327|Anesthetics|anesthetics|mesh-ancestor
56053545|NCT04032327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053555|NCT04041219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053556|NCT00552344|Certolizumab Pegol|certolizumab pegol|mesh-list
56053557|NCT00552344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053558|NCT00552344|Immunologic Factors|immunologic factors|mesh-ancestor
56053559|NCT00552344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053560|NCT00552344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56053561|NCT02814968|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56053562|NCT02814968|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56053563|NCT02814968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053564|NCT03879603|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56053565|NCT03879603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56053566|NCT03879603|Immunologic Factors|immunologic factors|mesh-ancestor
56053567|NCT03879603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053569|NCT03879603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053570|NCT03879603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56053571|NCT00553514|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56053572|NCT00553514|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56053574|NCT00553514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053575|NCT00553514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053576|NCT00553514|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56053577|NCT02813642|Mitogens|mitogens|mesh-list
56053578|NCT02813642|Mitosis Modulators|mitosis modulators|mesh-ancestor
56053579|NCT02813642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053580|NCT03852537|Methylprednisolone|methylprednisolone|mesh-list
56053581|NCT03852537|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56053582|NCT03852537|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56053583|NCT03852537|Prednisolone|prednisolone|mesh-list
56053584|NCT03852537|Prednisolone acetate|prednisolone acetate|mesh-list
56053585|NCT03852537|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56053586|NCT03852537|Prednisolone phosphate|prednisolone phosphate|mesh-list
56053587|NCT03852537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053588|NCT03852537|Antiemetics|antiemetics|mesh-ancestor
56053589|NCT03852537|Autonomic Agents|autonomic agents|mesh-ancestor
56053595|NCT03852537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053596|NCT03852537|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56053597|NCT03852537|Protective Agents|protective agents|mesh-ancestor
56053598|NCT03852537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56053599|NCT03852537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053600|NCT03875859|Benzoic Acid|benzoic acid|mesh-list
55893248|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55893249|NCT03289260|Imiquimod|imiquimod|mesh-list
55893250|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55893251|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
55893252|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893253|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893254|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
55893256|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55893257|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893258|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
55893259|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893260|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893261|NCT03289026|Aripiprazole|aripiprazole|mesh-list
55893262|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
55893263|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55893264|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55893265|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55893266|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893267|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893268|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
55893269|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
55893270|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893271|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893272|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55893273|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55893274|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
55893275|NCT03289026|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55893276|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55893277|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55893278|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55893280|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55893281|NCT02460510|Diuretics|diuretics|mesh-ancestor
55893282|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
55893283|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893284|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
55893285|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55893286|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55893287|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55893288|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55893289|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893290|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
55893291|NCT02334436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893292|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893293|NCT02334436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55893294|NCT02334436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893295|NCT03288870|Docetaxel|docetaxel|mesh-list
55893296|NCT03288870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893297|NCT03288870|Tubulin Modulators|tubulin modulators|mesh-ancestor
55893298|NCT03288870|Antimitotic Agents|antimitotic agents|mesh-ancestor
55893299|NCT03288870|Mitosis Modulators|mitosis modulators|mesh-ancestor
55893300|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893301|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
55893302|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
55893303|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893304|NCT02460354|Metformin|metformin|mesh-list
55893305|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55893306|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893307|NCT02008942|Aspirin|aspirin|mesh-list
55893308|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55893309|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55893310|NCT02008942|Analgesics|analgesics|mesh-ancestor
56053602|NCT03875859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053603|NCT00553202|Cyclosporine|cyclosporine|mesh-list
56053604|NCT00553202|Methylprednisolone|methylprednisolone|mesh-list
56053605|NCT00553202|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56053606|NCT00553202|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56053607|NCT00553202|Prednisolone|prednisolone|mesh-list
56053608|NCT00553202|Prednisolone acetate|prednisolone acetate|mesh-list
56053609|NCT00553202|Cyclophosphamide|cyclophosphamide|mesh-list
56053610|NCT00553202|Busulfan|busulfan|mesh-list
55893311|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
55893312|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893313|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893314|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55893315|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893316|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55893317|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55893318|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893319|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55893320|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55893321|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893322|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
55893323|NCT03288636|Ritonavir|ritonavir|mesh-list
55893324|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55893325|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55893326|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
55893327|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893328|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893329|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55893332|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893333|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55893334|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55893335|NCT03293472|Bupivacaine|bupivacaine|mesh-list
55893336|NCT03293472|Ropivacaine|ropivacaine|mesh-list
55893337|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
55893338|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
55893339|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893340|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893341|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
55893342|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893343|NCT02071810|Opicapone|opicapone|mesh-list
55893344|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55893345|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754046|NCT03108833|Saruplase|saruplase|mesh-list
55893346|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893347|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55893348|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55893349|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
55893350|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55893351|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893352|NCT01959490|Paclitaxel|paclitaxel|mesh-list
55893353|NCT01959490|Docetaxel|docetaxel|mesh-list
55893354|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
55893355|NCT01959490|Bevacizumab|bevacizumab|mesh-list
55893356|NCT01959490|Carboplatin|carboplatin|mesh-list
55893357|NCT01959490|Doxorubicin|doxorubicin|mesh-list
55893358|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55893359|NCT01959490|Trastuzumab|trastuzumab|mesh-list
55893360|NCT01959490|Pertuzumab|pertuzumab|mesh-list
55893361|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55893362|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893363|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
55893364|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
55893365|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
56053614|NCT00553202|Thymoglobulin|thymoglobulin|mesh-list
56053615|NCT00553202|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56053616|NCT00553202|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56053617|NCT00553202|Prednisolone phosphate|prednisolone phosphate|mesh-list
56053618|NCT00553202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053619|NCT00553202|Immunologic Factors|immunologic factors|mesh-ancestor
56053620|NCT00553202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053621|NCT00553202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893366|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893367|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55893368|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
55893369|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893370|NCT01959490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893371|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55893372|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
55893373|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55893374|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55893375|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55893376|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55893377|NCT01959490|Growth Substances|growth substances|mesh-ancestor
55893378|NCT01959490|Growth Inhibitors|growth inhibitors|mesh-ancestor
55893379|NCT01959490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55893380|NCT01959490|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55893381|NCT01959490|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55893382|NCT01959490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893384|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55893385|NCT03288402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893386|NCT03288402|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55893387|NCT03288402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754048|NCT03108833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55893388|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893389|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55893390|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55893391|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
55893392|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893393|NCT02341144|Ropivacaine|ropivacaine|mesh-list
55893394|NCT02341144|Anesthetics, Local|anesthetics, local|mesh-ancestor
55893395|NCT02341144|Anesthetics|anesthetics|mesh-ancestor
55893396|NCT02341144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893397|NCT02341144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893398|NCT02341144|Sensory System Agents|sensory system agents|mesh-ancestor
55893399|NCT02341144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893400|NCT02011516|Baclofen|baclofen|mesh-list
55893404|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893405|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55893406|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
55893407|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
55893408|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893409|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893410|NCT04349410|Interferons|interferons|mesh-list
55893411|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
55893412|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
55893413|NCT04349410|Remdesivir|remdesivir|mesh-list
55893414|NCT04349410|Azithromycin|azithromycin|mesh-list
55893415|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
55893416|NCT04349410|Doxycycline|doxycycline|mesh-list
55893417|NCT04349410|Clindamycin|clindamycin|mesh-list
55893418|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
55893419|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
55893420|NCT04349410|Primaquine|primaquine|mesh-list
55893421|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
55893423|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893424|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
55893425|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893426|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053622|NCT00553202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56053623|NCT00553202|Alkylating Agents|alkylating agents|mesh-ancestor
56053624|NCT00553202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053625|NCT00553202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893427|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
55893428|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
55893429|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893430|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893431|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55893432|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
55893433|NCT04349410|Hormones|hormones|mesh-ancestor
55893434|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893435|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55893436|NCT04349410|Protective Agents|protective agents|mesh-ancestor
55893437|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
55893438|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55893439|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
55893440|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55893441|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55893442|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893443|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893444|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893445|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55893446|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55893447|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55893448|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55893449|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55893450|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
55893452|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55893453|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55893454|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55893455|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893456|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893457|NCT03293004|Vitamins|vitamins|mesh-list
55893458|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
55893459|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
55893460|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893461|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
55893462|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893463|NCT03293004|Protective Agents|protective agents|mesh-ancestor
55893464|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
55893465|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
55893466|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893467|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893468|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893469|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
55893470|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
55893471|NCT03282162|Oxytocin|oxytocin|mesh-list
55893472|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
55893473|NCT03282162|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55893474|NCT03282162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893475|NCT03287076|Exenatide|exenatide|mesh-list
55893480|NCT03287076|Hormones|hormones|mesh-ancestor
55893481|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893482|NCT02460276|Rituximab|rituximab|mesh-list
55893483|NCT02460276|Lenalidomide|lenalidomide|mesh-list
55893484|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55893485|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893486|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
55893487|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893488|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893489|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55893490|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55893491|NCT02460276|Growth Substances|growth substances|mesh-ancestor
55893492|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
55893493|NCT02460432|Paclitaxel|paclitaxel|mesh-list
55893494|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56053626|NCT00553202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56053627|NCT00553202|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56053629|NCT00553202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55893495|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893496|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
55893497|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
55893498|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
55893499|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893500|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
55893501|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55893502|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893504|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55893505|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
55893506|NCT03281928|Diuretics|diuretics|mesh-ancestor
55893507|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
55893508|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893509|NCT03281928|Expectorants|expectorants|mesh-ancestor
55893510|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
55893511|NCT03286764|Peppermint oil|peppermint oil|mesh-list
55893512|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
55893513|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
55893514|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893515|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893516|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55893517|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
55893518|NCT03281694|Nicotine|nicotine|mesh-list
55893519|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55893520|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
55893521|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893534|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55893535|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
55893536|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893537|NCT04416282|Terlipressin|terlipressin|mesh-list
55893538|NCT04416282|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55893539|NCT04416282|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55893541|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893542|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55893543|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893544|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893545|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55893546|NCT01895205|Hematinics|hematinics|mesh-ancestor
55893547|NCT01748175|Triamcinolone|triamcinolone|mesh-list
55893548|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55893549|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55893550|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55893551|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55893552|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
55893553|NCT01748175|Hormones|hormones|mesh-ancestor
55893554|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893555|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893556|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55893557|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
55893558|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893559|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893573|NCT04755387|Ticagrelor|ticagrelor|mesh-list
55893574|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55893575|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55893576|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55893577|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55893579|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893580|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893581|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893582|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
55893583|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55893584|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55893586|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893587|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56053630|NCT00553202|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56053632|NCT00553202|Dermatologic Agents|dermatologic agents|mesh-ancestor
55780831|NCT00794495|Cetirizine|cetirizine|mesh-list
56053633|NCT00553202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053634|NCT00553202|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56053635|NCT00553202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56053636|NCT00553202|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56053637|NCT00553202|Antifungal Agents|antifungal agents|mesh-ancestor
56053638|NCT00553202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893588|NCT03285360|Fluorides|fluorides|mesh-list
55893589|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
55893590|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
55893591|NCT03285360|Protective Agents|protective agents|mesh-ancestor
55893592|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893593|NCT00160173|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55893594|NCT00160173|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55893595|NCT00160173|Estradiol|estradiol|mesh-list
55893596|NCT00160173|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55893597|NCT00160173|Estrogens|estrogens|mesh-ancestor
55893598|NCT00160173|Hormones|hormones|mesh-ancestor
55893599|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893600|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893601|NCT00160173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55893603|NCT00160173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55893604|NCT00160173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55893605|NCT00136695|Anastrozole|anastrozole|mesh-list
55893606|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55893607|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893608|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55893609|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55893610|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893611|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893612|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55893613|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
55893614|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893615|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893616|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
55893617|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893618|NCT02459574|Amiodarone|amiodarone|mesh-list
55893619|NCT02459574|Sotalol|sotalol|mesh-list
55893620|NCT02459574|Flecainide|flecainide|mesh-list
55893621|NCT02459574|Propafenone|propafenone|mesh-list
55893622|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55893623|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
55893624|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55893625|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893626|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55893627|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55893628|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
55893629|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893630|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893631|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
55893632|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55893633|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55893634|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55893635|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55893636|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55893637|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893638|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55893639|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55893640|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55893641|NCT02459574|Sympatholytics|sympatholytics|mesh-ancestor
56053640|NCT00553202|Antiemetics|antiemetics|mesh-ancestor
56053641|NCT00553202|Autonomic Agents|autonomic agents|mesh-ancestor
56053642|NCT00553202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053643|NCT00553202|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56053644|NCT00553202|Glucocorticoids|glucocorticoids|mesh-ancestor
55893642|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
55893643|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893644|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55893646|NCT04389567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55893647|NCT04389567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55893648|NCT04389567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55893651|NCT04389567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893652|NCT04389567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893653|NCT04389567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893654|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55893655|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893656|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
55893657|NCT03280212|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55893658|NCT03280212|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55893659|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893660|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
55893661|NCT03280212|Coagulants|coagulants|mesh-ancestor
55893662|NCT03536520|Acetazolamide|acetazolamide|mesh-list
55893663|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
55893664|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55893665|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893666|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893667|NCT03536520|Diuretics|diuretics|mesh-ancestor
55893668|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
55893669|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893670|NCT01673217|Doxorubicin|doxorubicin|mesh-list
55893671|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55893672|NCT01673217|Decitabine|decitabine|mesh-list
55893673|NCT01673217|Azacitidine|azacitidine|mesh-list
55893674|NCT01673217|Vaccines|vaccines|mesh-list
55893675|NCT01673217|Sargramostim|sargramostim|mesh-list
55893676|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
55893677|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
55893678|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893679|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55893680|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893681|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55893682|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55893683|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893684|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893685|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55893686|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
55893687|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55893688|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
55893689|NCT03475134|Nivolumab|nivolumab|mesh-list
55893690|NCT03475134|Fludarabine|fludarabine|mesh-list
55893691|NCT03475134|Interleukin-2|interleukin-2|mesh-list
55893692|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55893693|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
55893694|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893695|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893696|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55893697|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
55893698|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893699|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893700|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55894981|NCT04778865|Cholecalciferol|cholecalciferol|mesh-list
55893701|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55893702|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55893703|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55893704|NCT03475134|Analgesics|analgesics|mesh-ancestor
55893705|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
55893706|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893707|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55893708|NCT01668849|Fentanyl|fentanyl|mesh-list
56053646|NCT00553202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053647|NCT00553202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56053648|NCT00553202|Protective Agents|protective agents|mesh-ancestor
56053649|NCT00553202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56053650|NCT00552188|Atreleuton|atreleuton|mesh-list
56053651|NCT00552188|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56053652|NCT00552188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053653|NCT00552188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053654|NCT00377793|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
56053655|NCT00377793|Vasodilator Agents|vasodilator agents|mesh-ancestor
56053656|NCT00377793|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56053657|NCT00377793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56053658|NCT00377793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053659|NCT00377793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053660|NCT00377793|Urological Agents|urological agents|mesh-ancestor
56053661|NCT02281838|Enalapril|enalapril|mesh-list
56053663|NCT02281838|Hydralazine|hydralazine|mesh-list
55893709|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55893710|NCT01668849|Narcotics|narcotics|mesh-ancestor
55893711|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893712|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893713|NCT01668849|Analgesics|analgesics|mesh-ancestor
55893714|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
55893715|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893716|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55893717|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55893718|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
55893719|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
55893720|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55893721|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55893722|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55893727|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893728|NCT03271866|Metformin|metformin|mesh-list
55893729|NCT03271866|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55893730|NCT03271866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893731|NCT01230411|Ibuprofen|ibuprofen|mesh-list
55893732|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55893733|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55893734|NCT01230411|Analgesics|analgesics|mesh-ancestor
55893735|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
55893736|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893737|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893738|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55893739|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893740|NCT01230411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55893741|NCT01230411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893742|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893743|NCT03283800|Copper|copper|mesh-list
55893744|NCT03283800|Trace Elements|trace elements|mesh-ancestor
55893745|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
55893746|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893747|NCT01962688|Diuretics|diuretics|mesh-list
55893748|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
55893749|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893750|NCT03274596|Vitamin E|vitamin e|mesh-list
55893751|NCT03274596|Vitamins|vitamins|mesh-ancestor
56053664|NCT02281838|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56053666|NCT02281838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053667|NCT02281838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053668|NCT02281838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56053669|NCT02281838|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56053670|NCT02281838|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56053671|NCT02281838|Adrenergic Agents|adrenergic agents|mesh-ancestor
56053672|NCT02281838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053673|NCT02281838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053674|NCT02281838|Sympathomimetics|sympathomimetics|mesh-ancestor
56053675|NCT02281838|Autonomic Agents|autonomic agents|mesh-ancestor
56053676|NCT02281838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053677|NCT02281838|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56053678|NCT02281838|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56053679|NCT02281838|Vasodilator Agents|vasodilator agents|mesh-ancestor
56053680|NCT04027803|Eculizumab|eculizumab|mesh-list
56053681|NCT04027803|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55893752|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
55893753|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893754|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
55893755|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893756|NCT03274596|Protective Agents|protective agents|mesh-ancestor
55893757|NCT01963078|Oxytocin|oxytocin|mesh-list
55893758|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
55893759|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55893760|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893761|NCT03269760|Zolpidem|zolpidem|mesh-list
55893762|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55893763|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55893764|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893765|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893766|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55893767|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
55893768|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
55893769|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893770|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893771|NCT03269916|Hormones|hormones|mesh-list
55893772|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55893773|NCT03269916|Estrogens|estrogens|mesh-list
55893774|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893775|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893776|NCT02346916|Capsaicin|capsaicin|mesh-list
55893777|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
55893778|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
55893779|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
55893780|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893781|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893782|NCT02458482|Albuterol|albuterol|mesh-list
55893783|NCT02458482|Ipratropium|ipratropium|mesh-list
55893784|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55893786|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893787|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893788|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56053682|NCT04027803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053683|NCT04027803|Immunologic Factors|immunologic factors|mesh-ancestor
56053684|NCT04027803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053685|NCT00552110|Mometasone Furoate|mometasone furoate|mesh-list
56053687|NCT00552110|Oxymetazoline|oxymetazoline|mesh-list
56053688|NCT00552110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053689|NCT00552110|Dermatologic Agents|dermatologic agents|mesh-ancestor
56053690|NCT00552110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55893789|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
55893790|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
55893791|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55893792|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55893793|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55893794|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55893795|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
55893796|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893799|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
55893800|NCT03273192|Adalimumab|adalimumab|mesh-list
55893801|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55893802|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893803|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55893804|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55893805|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893806|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
55893807|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
55893808|NCT02349178|Etoposide|etoposide|mesh-list
55893809|NCT02349178|Clofarabine|clofarabine|mesh-list
55893810|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55893811|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
55893812|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893813|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893814|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55893815|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
55893816|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893817|NCT02349178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893818|NCT02349178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55893819|NCT02349178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55893820|NCT02349178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55893821|NCT02349178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55893822|NCT02349178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893823|NCT02349178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55893824|NCT02349178|Antimetabolites|antimetabolites|mesh-ancestor
55893825|NCT03970356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55893826|NCT03970356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893827|NCT05075460|Azacitidine|azacitidine|mesh-list
55893828|NCT05075460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55893829|NCT05075460|Antimetabolites|antimetabolites|mesh-ancestor
55893830|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893831|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893832|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893833|NCT01966978|Insulin|insulin|mesh-list
55893834|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55893835|NCT01966978|Metformin|metformin|mesh-list
55893836|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
55893837|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
55893838|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55893839|NCT01966978|Liraglutide|liraglutide|mesh-list
55893840|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
55893841|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55893842|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893843|NCT01966978|Incretins|incretins|mesh-ancestor
55893844|NCT01966978|Hormones|hormones|mesh-ancestor
55893845|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893846|NCT03269214|Phenytoin|phenytoin|mesh-list
55893847|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
56053691|NCT00552110|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56053692|NCT00552110|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56053693|NCT00552110|Adrenergic Agents|adrenergic agents|mesh-ancestor
56053694|NCT00552110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053695|NCT00552110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053696|NCT00552110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053697|NCT00552110|Sympathomimetics|sympathomimetics|mesh-ancestor
55893848|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55893849|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55893850|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55893851|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893852|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55893853|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55893854|NCT03269058|Dapagliflozin|dapagliflozin|mesh-list
55893855|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55893856|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893857|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55893858|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893859|NCT05074602|Fluconazole|fluconazole|mesh-list
55893860|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
55893861|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893862|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55893863|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55893864|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893865|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893866|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55893867|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
55893877|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893878|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55893879|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
55893880|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893881|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893882|NCT03268902|Niacinamide|niacinamide|mesh-list
55893883|NCT03268902|Niacin|niacin|mesh-list
55893884|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
55893885|NCT03268902|Azithromycin|azithromycin|mesh-list
55893886|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
55893887|NCT03268902|Vitamins|vitamins|mesh-ancestor
55893888|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
55893889|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893890|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55893891|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55893892|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
55893895|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893896|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55893897|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
55893898|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55893899|NCT02458716|Leuprolide|leuprolide|mesh-list
55893900|NCT02458716|Bicalutamide|bicalutamide|mesh-list
55893901|NCT02458716|Androgens|androgens|mesh-list
55893902|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
55893903|NCT02458716|Hormones|hormones|mesh-ancestor
55893904|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893905|NCT02458716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893906|NCT02458716|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55893907|NCT02458716|Fertility Agents|fertility agents|mesh-ancestor
55893908|NCT02458716|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55893909|NCT02458716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55893910|NCT02458716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893911|NCT02458716|Androgen Antagonists|androgen antagonists|mesh-ancestor
55893912|NCT02458716|Hormone Antagonists|hormone antagonists|mesh-ancestor
55893913|NCT03268278|Lidocaine|lidocaine|mesh-list
55893914|NCT03268278|Epinephrine|epinephrine|mesh-list
55893915|NCT03268278|Buprenorphine|buprenorphine|mesh-list
56053699|NCT00552110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053700|NCT00552110|Nasal Decongestants|nasal decongestants|mesh-ancestor
56053701|NCT00552110|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56053702|NCT00552110|Respiratory System Agents|respiratory system agents|mesh-ancestor
56053703|NCT00552110|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56053704|NCT00552110|Mydriatics|mydriatics|mesh-ancestor
56053705|NCT00552110|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56053706|NCT00552110|Protective Agents|protective agents|mesh-ancestor
56053707|NCT02301624|Eculizumab|eculizumab|mesh-list
56053708|NCT02301624|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56053709|NCT02301624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053711|NCT02301624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053712|NCT02007122|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
56053713|NCT02007122|Cephalosporins|cephalosporins|mesh-list
55893916|NCT03268278|Anesthetics, Local|anesthetics, local|mesh-list
55893917|NCT03268278|Anesthetics|anesthetics|mesh-list
55893918|NCT03268278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55893919|NCT03268278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893920|NCT03268278|Sensory System Agents|sensory system agents|mesh-ancestor
55893921|NCT03268278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893922|NCT03268278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55893923|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55893924|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55893925|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55893926|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893927|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55893928|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55893929|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
55893930|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893943|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
55893944|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55893945|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
55893946|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893947|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
55893948|NCT05045586|Protective Agents|protective agents|mesh-ancestor
55893949|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
55893950|NCT03263520|Dexamethasone|dexamethasone|mesh-list
55893951|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
55893952|NCT03263520|Nandrolone|nandrolone|mesh-list
55893953|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
55893954|NCT03263520|BB 1101|bb 1101|mesh-list
55893955|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55893956|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
55893957|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
55893958|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893959|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893960|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55893961|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
55893962|NCT03263520|Hormones|hormones|mesh-ancestor
55893963|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893964|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55893965|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893966|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
55893967|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893968|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893971|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56053714|NCT02007122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56053715|NCT02007122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053716|NCT03250520|Titanium dioxide|titanium dioxide|mesh-list
56053717|NCT03250520|Sunscreening Agents|sunscreening agents|mesh-ancestor
56053718|NCT03250520|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56053719|NCT03250520|Protective Agents|protective agents|mesh-ancestor
56053720|NCT03250520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053721|NCT03250520|Dermatologic Agents|dermatologic agents|mesh-ancestor
56053722|NCT03250520|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55893972|NCT02456844|Leucovorin|leucovorin|mesh-list
55893973|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
55893974|NCT02456844|Methotrexate|methotrexate|mesh-list
55893975|NCT02456844|Digoxin|digoxin|mesh-list
55893976|NCT02456844|Midazolam|midazolam|mesh-list
55893977|NCT02456844|Pravastatin|pravastatin|mesh-list
55893978|NCT02456844|Montelukast|montelukast|mesh-list
55893979|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55893980|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
55893981|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55893982|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893983|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55893984|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
55893985|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893986|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893987|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
55893988|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893989|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55893990|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55893991|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
55893992|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893993|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55893994|NCT02456844|Antidotes|antidotes|mesh-ancestor
55893995|NCT02456844|Protective Agents|protective agents|mesh-ancestor
55893996|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
55893997|NCT02456844|Vitamins|vitamins|mesh-ancestor
55893998|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
55894003|NCT02456844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55894004|NCT02456844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55894005|NCT02456844|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55894006|NCT02456844|Anesthetics, General|anesthetics, general|mesh-ancestor
55894007|NCT02456844|Anesthetics|anesthetics|mesh-ancestor
55894008|NCT02456844|GABA Modulators|gaba modulators|mesh-ancestor
55894009|NCT02456844|GABA Agents|gaba agents|mesh-ancestor
55894010|NCT02456844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894011|NCT02456844|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55894012|NCT02456844|Respiratory System Agents|respiratory system agents|mesh-ancestor
55894013|NCT02456844|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55894014|NCT02456844|Hormone Antagonists|hormone antagonists|mesh-ancestor
55894015|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55894016|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55894017|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55894018|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55894019|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55894020|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55894021|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55894022|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55894023|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55894024|NCT02456844|Analgesics|analgesics|mesh-ancestor
55894025|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
55894026|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894027|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55894028|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894029|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894030|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55894031|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
55894032|NCT03263208|Fludarabine|fludarabine|mesh-list
55894033|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55894034|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
56053723|NCT03847389|Clobetasol|clobetasol|mesh-list
56053724|NCT03847389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053725|NCT03847389|Glucocorticoids|glucocorticoids|mesh-ancestor
56053726|NCT03847389|Hormones|hormones|mesh-ancestor
56053727|NCT03847389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053728|NCT03847389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053729|NCT03223610|Prednisone|prednisone|mesh-list
56053730|NCT03223610|Lenalidomide|lenalidomide|mesh-list
56053731|NCT03223610|Venetoclax|venetoclax|mesh-list
56053733|NCT03223610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053734|NCT03223610|Glucocorticoids|glucocorticoids|mesh-ancestor
56053735|NCT03223610|Hormones|hormones|mesh-ancestor
56053736|NCT03223610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053737|NCT03223610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053738|NCT03223610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56053739|NCT03223610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053740|NCT03223610|Immunologic Factors|immunologic factors|mesh-ancestor
56053741|NCT03223610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56053742|NCT03223610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56053743|NCT03223610|Growth Substances|growth substances|mesh-ancestor
56053744|NCT03223610|Growth Inhibitors|growth inhibitors|mesh-ancestor
56053745|NCT03223610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56053746|NCT02351934|Celecoxib|celecoxib|mesh-list
56053747|NCT02351934|Furosemide|furosemide|mesh-list
56053748|NCT02351934|Gabapentin|gabapentin|mesh-list
56053749|NCT02351934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55894035|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894036|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55894037|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55894038|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
55894039|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894040|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894041|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55894042|NCT03970746|Pembrolizumab|pembrolizumab|mesh-list
55894043|NCT03970746|Pemetrexed|pemetrexed|mesh-list
55894044|NCT03970746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55894045|NCT03970746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894046|NCT03970746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894047|NCT03970746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894048|NCT03970746|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55894049|NCT03970746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55894050|NCT04630002|Ritonavir|ritonavir|mesh-list
55894051|NCT04630002|Darunavir|darunavir|mesh-list
55894052|NCT04630002|Etravirine|etravirine|mesh-list
55894053|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55894054|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55894055|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
55894056|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053750|NCT02351934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56053751|NCT02351934|Analgesics|analgesics|mesh-ancestor
56053752|NCT02351934|Sensory System Agents|sensory system agents|mesh-ancestor
56053753|NCT02351934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053754|NCT02351934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053755|NCT02351934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053756|NCT02351934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56053757|NCT02351934|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55894057|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894058|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55894059|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55894060|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
55894061|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894062|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55894063|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55894064|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55894065|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55894066|NCT03259542|Itraconazole|itraconazole|mesh-list
55894067|NCT03259542|Mifepristone|mifepristone|mesh-list
55894068|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
55894071|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55894072|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894073|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894074|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55894075|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
55894076|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55894077|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894078|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55894079|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55894080|NCT03259542|Abortifacient Agents|abortifacient agents|mesh-ancestor
55894081|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55894082|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55894083|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55894084|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55894086|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55894087|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55894088|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
55894089|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55894090|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55894092|NCT03267654|Gefitinib|gefitinib|mesh-list
55894093|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894097|NCT03263052|Tacrolimus|tacrolimus|mesh-list
55894098|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55894099|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
55894100|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894101|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55894102|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894103|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894104|NCT03259152|Denosumab|denosumab|mesh-list
55894105|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55894106|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894107|NCT02456142|Morphine|morphine|mesh-list
55894108|NCT02456142|Bupivacaine|bupivacaine|mesh-list
55894109|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
55894110|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
55894111|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894112|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894113|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
55894114|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894115|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56053758|NCT02351934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56053759|NCT02351934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053760|NCT02351934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053761|NCT02351934|Anticonvulsants|anticonvulsants|mesh-ancestor
56053762|NCT02351934|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56053763|NCT02351934|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56053764|NCT02351934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053765|NCT02351934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56053766|NCT02351934|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56053767|NCT02351934|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56053768|NCT02351934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053769|NCT02351934|Antimanic Agents|antimanic agents|mesh-ancestor
56053770|NCT02351934|Diuretics|diuretics|mesh-ancestor
56053771|NCT02351934|Natriuretic Agents|natriuretic agents|mesh-ancestor
56053772|NCT02351934|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55894116|NCT02456142|Narcotics|narcotics|mesh-ancestor
55894117|NCT02456142|Analgesics|analgesics|mesh-ancestor
55894118|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55894119|NCT03262740|Norethindrone|norethindrone|mesh-list
55894120|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
55754167|NCT03994601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55894121|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
55894122|NCT03262740|Estradiol|estradiol|mesh-list
55894123|NCT03262740|Branebrutinib|branebrutinib|mesh-list
55894124|NCT03262740|Estrogens|estrogens|mesh-ancestor
55894125|NCT03262740|Hormones|hormones|mesh-ancestor
55894126|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55894127|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894128|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55894129|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
55894130|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55894131|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55894132|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55894133|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55894134|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55894135|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55894136|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
55894140|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55894141|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55894142|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894143|NCT03258684|Thiamine|thiamine|mesh-list
55894144|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
55894145|NCT03258684|Vitamins|vitamins|mesh-ancestor
55894146|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
55894147|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894148|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894149|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
55894150|NCT03266250|Anesthetics|anesthetics|mesh-list
55894982|NCT04778865|Vitamins|vitamins|mesh-list
55894151|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894152|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894153|NCT03258372|Rifampin|rifampin|mesh-list
55894154|NCT03258372|Mifepristone|mifepristone|mesh-list
55894155|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55894156|NCT03258372|Antitubercular Agents|antitubercular agents|mesh-ancestor
56053773|NCT02351934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56053775|NCT03193190|Gemcitabine|gemcitabine|mesh-list
56053776|NCT03193190|Paclitaxel|paclitaxel|mesh-list
56053777|NCT03193190|Bevacizumab|bevacizumab|mesh-list
56053778|NCT03193190|Fluorouracil|fluorouracil|mesh-list
56053779|NCT03193190|Oxaliplatin|oxaliplatin|mesh-list
56053780|NCT03193190|Atezolizumab|atezolizumab|mesh-list
56053781|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55894157|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55894158|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894159|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
55894160|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55894161|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894162|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894163|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55894164|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55894165|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55894166|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55894167|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55894168|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55894169|NCT03258372|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55894170|NCT03258372|Abortifacient Agents|abortifacient agents|mesh-ancestor
55894171|NCT03258372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55894172|NCT03258372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894173|NCT03258372|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55894174|NCT03258372|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55894175|NCT03258372|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55894176|NCT03258372|Contraceptive Agents|contraceptive agents|mesh-ancestor
55894177|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55894178|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55894179|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
55894180|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55894181|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
55894182|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55894183|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55894184|NCT02456454|Valproic Acid|valproic acid|mesh-list
55894185|NCT02456454|Risperidone|risperidone|mesh-list
55894186|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55894187|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
55894188|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894189|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894190|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894191|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55894192|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55894193|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894194|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55894195|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55894196|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
55894197|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
55894198|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894199|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
55894200|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
55894201|NCT03258294|Melatonin|melatonin|mesh-list
55894202|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
55894203|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894204|NCT03258294|Protective Agents|protective agents|mesh-ancestor
55894205|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894206|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894208|NCT03265782|Ibuprofen|ibuprofen|mesh-list
55894209|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55894210|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894211|NCT03265782|Analgesics|analgesics|mesh-ancestor
55894212|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
55894213|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894214|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053782|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053783|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
56053784|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
56053786|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053787|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56053788|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56053789|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56053790|NCT03193190|Growth Substances|growth substances|mesh-ancestor
56053791|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053792|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
56053793|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56053795|NCT03193190|Antiviral Agents|antiviral agents|mesh-ancestor
56053796|NCT03193190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053797|NCT03193190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053798|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55894215|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894216|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55894217|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55894218|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894219|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894221|NCT03798054|Insulin|insulin|mesh-list
55894222|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55894223|NCT03798054|Metformin|metformin|mesh-list
55894224|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
55894225|NCT03798054|Lixisenatide|lixisenatide|mesh-list
55894226|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55894227|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55894228|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894229|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894230|NCT03265470|Fentanyl|fentanyl|mesh-list
55894231|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
55894232|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55894233|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894234|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894235|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894236|NCT03265470|Analgesics|analgesics|mesh-ancestor
55894237|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
55894238|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894239|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55894240|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55894241|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55894242|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
55894243|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894244|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894246|NCT03265470|Narcotics|narcotics|mesh-ancestor
55894247|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55894248|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55894249|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
55894250|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
55894251|NCT02019940|Riluzole|riluzole|mesh-list
55894252|NCT02019940|Anticonvulsants|anticonvulsants|mesh-ancestor
55894253|NCT02019940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55894254|NCT02019940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55894255|NCT02019940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053799|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
56053800|NCT03193190|Antidotes|antidotes|mesh-ancestor
56053801|NCT03193190|Protective Agents|protective agents|mesh-ancestor
56053802|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
56053803|NCT03193190|Vitamins|vitamins|mesh-ancestor
56053804|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
56053805|NCT00377481|Darbepoetin alfa|darbepoetin alfa|mesh-list
56053806|NCT00377481|Hematinics|hematinics|mesh-ancestor
56053807|NCT00377559|Docetaxel|docetaxel|mesh-list
56053808|NCT00377559|Doxorubicin|doxorubicin|mesh-list
56053809|NCT00377559|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56053810|NCT00377559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053811|NCT00377559|Tubulin Modulators|tubulin modulators|mesh-ancestor
56053812|NCT00377559|Antimitotic Agents|antimitotic agents|mesh-ancestor
56053813|NCT00377559|Mitosis Modulators|mitosis modulators|mesh-ancestor
56053814|NCT00377559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053815|NCT00377559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56053816|NCT00377559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56053817|NCT00377559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56053818|NCT00377559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053819|NCT02301390|Amiodarone|amiodarone|mesh-list
56053820|NCT02301390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56053821|NCT02301390|Vasodilator Agents|vasodilator agents|mesh-ancestor
56053822|NCT02301390|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56053823|NCT02301390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56053824|NCT02301390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894256|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894257|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894258|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55894259|NCT02019940|Protective Agents|protective agents|mesh-ancestor
55894260|NCT01229943|Bevacizumab|bevacizumab|mesh-list
55894261|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55894262|NCT01229943|Everolimus|everolimus|mesh-list
55894263|NCT01229943|Octreotide|octreotide|mesh-list
55894264|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
55894265|NCT01229943|Antibodies|antibodies|mesh-list
55894266|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
55894267|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55894268|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
55894269|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894270|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55894271|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55894272|NCT01229943|Growth Substances|growth substances|mesh-ancestor
55894273|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894274|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
55894275|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
55894276|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55894277|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55894278|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55894279|NCT02020408|Raclopride|raclopride|mesh-list
55894280|NCT02020408|Amphetamine|amphetamine|mesh-list
55894281|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
56053825|NCT02301390|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56053826|NCT02301390|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56053827|NCT02301390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56053828|NCT02301390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053829|NCT02301390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56053830|NCT02301390|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56053831|NCT02301390|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56053832|NCT03026348|Aluminum phosphate|aluminum phosphate|mesh-list
56053833|NCT03026348|Vaccines|vaccines|mesh-list
56053834|NCT03026348|Immunologic Factors|immunologic factors|mesh-ancestor
56053835|NCT03026348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894282|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55894288|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894289|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894290|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
55894291|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55894292|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55894293|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55894294|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55894295|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55894296|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55894297|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894298|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55894299|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55894300|NCT01219257|Adalimumab|adalimumab|mesh-list
55894302|NCT01219257|Golimumab|golimumab|mesh-list
55894303|NCT01219257|Infliximab|infliximab|mesh-list
55894304|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894305|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55894306|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
55894307|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55894308|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55894309|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894310|NCT01219257|Analgesics|analgesics|mesh-ancestor
55894311|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
55894312|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894313|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894314|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55894315|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
55894316|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55894317|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55894318|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55894319|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894320|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55894321|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55894322|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56053858|NCT00551642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894323|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894324|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
55894325|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894327|NCT04389801|Siderophores|siderophores|mesh-ancestor
55894328|NCT04389801|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55894329|NCT04389801|Chelating Agents|chelating agents|mesh-ancestor
55894330|NCT04389801|Sequestering Agents|sequestering agents|mesh-ancestor
55894331|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894332|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
56053836|NCT03026348|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56053838|NCT03026348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053839|NCT03026348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56053840|NCT04763408|Sorafenib|sorafenib|mesh-list
56053841|NCT04763408|Lenvatinib|lenvatinib|mesh-list
56053842|NCT04763408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053843|NCT04763408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56053844|NCT04763408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053845|NCT04763408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053846|NCT03825939|Tranexamic Acid|tranexamic acid|mesh-list
56053847|NCT03825939|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56053848|NCT03825939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55894333|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55894334|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
55894335|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55894336|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
55894337|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894338|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894339|NCT01606995|Anticoagulants|anticoagulants|mesh-ancestor
55894340|NCT03257670|Lidocaine|lidocaine|mesh-list
55894341|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
55894342|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
55894343|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894344|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894345|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
55894346|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894347|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55894348|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55894349|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55894350|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55894351|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894352|NCT03265002|Psyllium|psyllium|mesh-list
55894357|NCT01542879|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55894358|NCT01542879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55894359|NCT01542879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55894360|NCT01542879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894362|NCT01542879|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55894363|NCT01542879|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55894364|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
55894365|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
55894366|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894367|NCT03257514|Protective Agents|protective agents|mesh-ancestor
55894368|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894369|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
55894371|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
55894372|NCT03261102|Adalimumab|adalimumab|mesh-list
55894373|NCT03261102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894374|NCT03261102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55894375|NCT04781751|Insulin|insulin|mesh-list
55894376|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55894377|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894378|NCT04643379|Carboplatin|carboplatin|mesh-list
55894379|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
55894380|NCT04643379|Olaparib|olaparib|mesh-list
55894381|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894382|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55894383|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56053849|NCT03825939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053850|NCT03825939|Hemostatics|hemostatics|mesh-ancestor
56053851|NCT03825939|Coagulants|coagulants|mesh-ancestor
56053852|NCT03988647|Pembrolizumab|pembrolizumab|mesh-list
56053853|NCT03988647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56053854|NCT03988647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053855|NCT00551642|Nitric Oxide|nitric oxide|mesh-list
56053856|NCT00551642|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56053857|NCT00551642|Autonomic Agents|autonomic agents|mesh-ancestor
56053859|NCT00551642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053860|NCT00551642|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56053861|NCT00551642|Respiratory System Agents|respiratory system agents|mesh-ancestor
56053862|NCT00551642|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56053863|NCT00551642|Antioxidants|antioxidants|mesh-ancestor
56053864|NCT00551642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053865|NCT00551642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053866|NCT00551642|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56053867|NCT00551642|Vasodilator Agents|vasodilator agents|mesh-ancestor
56053868|NCT00551642|Gasotransmitters|gasotransmitters|mesh-ancestor
56053869|NCT00551642|Protective Agents|protective agents|mesh-ancestor
56053870|NCT02799212|Somatostatin|somatostatin|mesh-list
56053871|NCT02799212|Hormones|hormones|mesh-ancestor
56053872|NCT02799212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053873|NCT02799212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053874|NCT04690322|Factor VIII|factor viii|mesh-list
56053875|NCT04690322|BAX 855|bax 855|mesh-list
56053876|NCT04690322|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56053877|NCT04690322|Coagulants|coagulants|mesh-ancestor
56053878|NCT04690322|Immunologic Factors|immunologic factors|mesh-ancestor
56053879|NCT04690322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053880|NCT02648282|Cyclophosphamide|cyclophosphamide|mesh-list
56053881|NCT02648282|Pembrolizumab|pembrolizumab|mesh-list
56053882|NCT02648282|Vaccines|vaccines|mesh-list
56053883|NCT02648282|Immunologic Factors|immunologic factors|mesh-ancestor
56053884|NCT02648282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053885|NCT02648282|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053887|NCT02648282|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56053888|NCT02648282|Alkylating Agents|alkylating agents|mesh-ancestor
56053889|NCT02648282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053890|NCT02648282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053891|NCT02648282|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56053892|NCT02648282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56053895|NCT04004481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56053896|NCT04004481|Narcotics|narcotics|mesh-ancestor
56053897|NCT04004481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053898|NCT04004481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053899|NCT04004481|Analgesics|analgesics|mesh-ancestor
56053900|NCT04004481|Sensory System Agents|sensory system agents|mesh-ancestor
56053901|NCT04004481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053902|NCT03997851|Acetaminophen|acetaminophen|mesh-list
56053903|NCT03997851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56053904|NCT03997851|Analgesics|analgesics|mesh-ancestor
56053905|NCT03997851|Sensory System Agents|sensory system agents|mesh-ancestor
56053906|NCT03997851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894384|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894385|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894386|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55894387|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894388|NCT03261024|Nickel|nickel|mesh-list
55894389|NCT03261024|Trace Elements|trace elements|mesh-ancestor
55894390|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
55894391|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894392|NCT04777383|Atropine|atropine|mesh-list
55894393|NCT04777383|Phenylephrine|phenylephrine|mesh-list
55894394|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
55894395|NCT04777383|Norepinephrine|norepinephrine|mesh-list
55894396|NCT04777383|Acetylcholine|acetylcholine|mesh-list
55894397|NCT04777383|Neostigmine|neostigmine|mesh-list
55894398|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55894399|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
55894400|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
55894401|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894402|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894403|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
55894404|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55894405|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
55894406|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
55894407|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55894408|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55894409|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55894410|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
55894411|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894412|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894413|NCT04777383|Protective Agents|protective agents|mesh-ancestor
55894414|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55894415|NCT04777383|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55894416|NCT04777383|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55894417|NCT04777383|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56053907|NCT03997851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053908|NCT03997851|Antipyretics|antipyretics|mesh-ancestor
56053909|NCT03989427|Listerine|listerine|mesh-list
56053910|NCT03989427|Sodium Fluoride|sodium fluoride|mesh-list
56053911|NCT03989427|Cariostatic Agents|cariostatic agents|mesh-ancestor
56053912|NCT03989427|Protective Agents|protective agents|mesh-ancestor
56053913|NCT03989427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053914|NCT03989427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56053915|NCT03989427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56053916|NCT03007719|Fluorides|fluorides|mesh-list
56053917|NCT03007719|Cariostatic Agents|cariostatic agents|mesh-ancestor
56053918|NCT03007719|Protective Agents|protective agents|mesh-ancestor
56053919|NCT03007719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053920|NCT04629248|Acetaminophen|acetaminophen|mesh-list
56053921|NCT04629248|Diphenhydramine|diphenhydramine|mesh-list
56053922|NCT04629248|Promethazine|promethazine|mesh-list
56053923|NCT04629248|Methylprednisolone|methylprednisolone|mesh-list
56053924|NCT04629248|Obinutuzumab|obinutuzumab|mesh-list
56053925|NCT04629248|Tacrolimus|tacrolimus|mesh-list
56053926|NCT04629248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56053927|NCT04629248|Immunologic Factors|immunologic factors|mesh-ancestor
56053928|NCT04629248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053929|NCT04629248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56053930|NCT04629248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56053931|NCT04629248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053932|NCT04629248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56053933|NCT04629248|Analgesics|analgesics|mesh-ancestor
56053934|NCT04629248|Sensory System Agents|sensory system agents|mesh-ancestor
56053935|NCT04629248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053936|NCT04629248|Antipyretics|antipyretics|mesh-ancestor
56053937|NCT04629248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053938|NCT04629248|Antiemetics|antiemetics|mesh-ancestor
56053940|NCT04629248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56053941|NCT04629248|Glucocorticoids|glucocorticoids|mesh-ancestor
56053942|NCT04629248|Hormones|hormones|mesh-ancestor
55894418|NCT04777383|Parasympatholytics|parasympatholytics|mesh-ancestor
55894419|NCT04777383|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55894420|NCT04777383|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55894421|NCT04777383|Cholinergic Agents|cholinergic agents|mesh-ancestor
55894422|NCT04777383|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55894423|NCT04777383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894424|NCT04777383|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55894425|NCT04777383|Vasodilator Agents|vasodilator agents|mesh-ancestor
55894426|NCT04777383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55894427|NCT03257124|Osimertinib|osimertinib|mesh-list
56053943|NCT04629248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053945|NCT04629248|Protective Agents|protective agents|mesh-ancestor
56053946|NCT04629248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053947|NCT04629248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56053948|NCT04629248|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56053949|NCT04629248|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56053950|NCT04629248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56053951|NCT04629248|Anesthetics, Local|anesthetics, local|mesh-ancestor
56053952|NCT04629248|Anesthetics|anesthetics|mesh-ancestor
55894442|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55894444|NCT04780659|Vaccines|vaccines|mesh-list
55894445|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
55894446|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894447|NCT03260634|Voriconazole|voriconazole|mesh-list
55894448|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
55894449|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894450|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55894451|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55894452|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894453|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894454|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55894455|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
55894456|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55894458|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55894459|NCT04777227|Lidocaine|lidocaine|mesh-list
55894460|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
55894461|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
55894462|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894463|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894464|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
55894465|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894466|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55894467|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55894468|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55894469|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55894470|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894471|NCT03260556|Pirfenidone|pirfenidone|mesh-list
55894472|NCT03260556|Analgesics|analgesics|mesh-ancestor
55894473|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
55894474|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894475|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894476|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55894477|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894478|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894479|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55894480|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894481|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55894482|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55894483|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894485|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55894486|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55894487|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894489|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894490|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55894491|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
55894492|NCT03252366|Coagulants|coagulants|mesh-ancestor
55894494|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56053954|NCT04629248|Histamine Antagonists|histamine antagonists|mesh-ancestor
56053955|NCT04629248|Histamine Agents|histamine agents|mesh-ancestor
56053956|NCT04629248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56053957|NCT04629248|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56053958|NCT04629248|Antipruritics|antipruritics|mesh-ancestor
56053959|NCT04629248|Dermatologic Agents|dermatologic agents|mesh-ancestor
56053960|NCT02985801|Pancrelipase|pancrelipase|mesh-list
56053961|NCT02985801|Pancreatin|pancreatin|mesh-list
56053962|NCT02985801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55894495|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
55894496|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894497|NCT03573960|Lenvatinib|lenvatinib|mesh-list
55894498|NCT03573960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894499|NCT03573960|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55894500|NCT03573960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894501|NCT03573960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894502|NCT04780347|Paclitaxel|paclitaxel|mesh-list
55894503|NCT04780347|Capecitabine|capecitabine|mesh-list
55894504|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55894505|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55894506|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894507|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
55894508|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
55894509|NCT04780347|Mitosis Modulators|mitosis modulators|mesh-ancestor
55894510|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894511|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55894512|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
55894513|NCT02455596|Interferons|interferons|mesh-list
55894514|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894515|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
55894516|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894517|NCT02455440|Propofol|propofol|mesh-list
55894518|NCT02455440|Sevoflurane|sevoflurane|mesh-list
55894519|NCT02455440|Esmolol|esmolol|mesh-list
55894520|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55894521|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894522|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894523|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55894524|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
55894525|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
55894526|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55894527|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55894528|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55894529|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55894530|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55894531|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
55894532|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894607|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894533|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894534|NCT03260166|Niacinamide|niacinamide|mesh-list
55894535|NCT03260166|Niacin|niacin|mesh-list
55894536|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
55894537|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
55894538|NCT03260166|Vitamins|vitamins|mesh-ancestor
55894539|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
55894540|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894541|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55894542|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
55894543|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894544|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55894545|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
55894546|NCT03260010|Fosfomycin|fosfomycin|mesh-list
55894547|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55894548|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894549|NCT00992901|Atropine|atropine|mesh-list
55894550|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55894551|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55894552|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56053964|NCT02988362|Candesartan|candesartan|mesh-list
56053965|NCT02988362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56053966|NCT02988362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56053967|NCT02988362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55894553|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55894554|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
55894555|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894556|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894557|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55894558|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
55894559|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
55894562|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55894563|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
55894564|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894565|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894566|NCT00992901|Incretins|incretins|mesh-ancestor
55894567|NCT00992901|Hormones|hormones|mesh-ancestor
55894568|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55894569|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
55894570|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55894571|NCT03260088|Antibodies|antibodies|mesh-list
55894572|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
55894573|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
55894574|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894575|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
55894576|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55894577|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894578|NCT04776135|Edaravone|edaravone|mesh-list
55894579|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55894580|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
55894581|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894582|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55894583|NCT04776135|Protective Agents|protective agents|mesh-ancestor
55894584|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894585|NCT03474276|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55894586|NCT03474276|Azithromycin|azithromycin|mesh-list
55894587|NCT03474276|Albendazole|albendazole|mesh-list
55894588|NCT03474276|Antiparasitic Agents|antiparasitic agents|mesh-list
55894589|NCT03474276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894590|NCT03474276|Anthelmintics|anthelmintics|mesh-ancestor
55894591|NCT03474276|Anticestodal Agents|anticestodal agents|mesh-ancestor
55894592|NCT03474276|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55894593|NCT03474276|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55894594|NCT03474276|Tubulin Modulators|tubulin modulators|mesh-ancestor
55894595|NCT03474276|Antimitotic Agents|antimitotic agents|mesh-ancestor
55894596|NCT03474276|Mitosis Modulators|mitosis modulators|mesh-ancestor
55754205|NCT03899987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55894597|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894598|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894599|NCT04779255|Acetaminophen|acetaminophen|mesh-list
55894600|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894601|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894602|NCT04779255|Analgesics|analgesics|mesh-ancestor
55894603|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
55894604|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894605|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
55894606|NCT04779567|Acetaminophen|acetaminophen|mesh-list
55894608|NCT04779567|Analgesics|analgesics|mesh-ancestor
55894609|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
55894610|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894611|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894612|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
55894613|NCT02352844|Everolimus|everolimus|mesh-list
55894614|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894615|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55894616|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
55894617|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894618|NCT03255642|Clonazepam|clonazepam|mesh-list
55894619|NCT03255642|Melatonin|melatonin|mesh-list
55894620|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
55894621|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053968|NCT02988362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053969|NCT02988362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56053970|NCT02988362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053971|NCT02988362|Vasodilator Agents|vasodilator agents|mesh-ancestor
56053972|NCT02988362|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56053976|NCT02988440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894622|NCT03255642|Protective Agents|protective agents|mesh-ancestor
55894623|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894624|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894625|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
55894626|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
55894627|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
55894628|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894629|NCT03562377|Vaccines|vaccines|mesh-list
55894630|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
55894631|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894632|NCT02352922|Bupivacaine|bupivacaine|mesh-list
55894633|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
55894634|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
55894637|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
55894638|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894639|NCT03255330|Dipyrone|dipyrone|mesh-list
55894640|NCT03255330|Gabapentin|gabapentin|mesh-list
55894641|NCT03255330|Tramadol|tramadol|mesh-list
55894642|NCT03255330|Analgesics|analgesics|mesh-ancestor
55894643|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
55894644|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894645|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894646|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
55894647|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55894648|NCT03255330|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55894649|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894650|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55894651|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55894652|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55894653|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894654|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894655|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
55894656|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55894657|NCT03255330|Narcotics|narcotics|mesh-ancestor
55894658|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55894659|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894660|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894661|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55894662|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
55894663|NCT02353780|Etanercept|etanercept|mesh-list
55894664|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
55894665|NCT02353780|Abatacept|abatacept|mesh-list
55894666|NCT02353780|Infliximab|infliximab|mesh-list
55894667|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
55894668|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55754219|NCT02723591|Tacrolimus|tacrolimus|mesh-list
55894669|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894670|NCT02353780|Analgesics|analgesics|mesh-ancestor
55894671|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
55894672|NCT02353780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894673|NCT02353780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894674|NCT02353780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894675|NCT02353780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55894676|NCT02353780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55894677|NCT02353780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55894678|NCT02353780|Immunologic Factors|immunologic factors|mesh-ancestor
55894679|NCT02353780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56053977|NCT02988440|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56053979|NCT02988440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56053980|NCT02988440|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56053981|NCT00550550|Fluticasone|fluticasone|mesh-list
56053982|NCT00550550|Mometasone Furoate|mometasone furoate|mesh-list
56053983|NCT00550550|Loratadine|loratadine|mesh-list
56053984|NCT00550550|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56053986|NCT00550550|Albuterol|albuterol|mesh-list
56053987|NCT00550550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56053988|NCT00550550|Glucocorticoids|glucocorticoids|mesh-ancestor
56053989|NCT00550550|Hormones|hormones|mesh-ancestor
56053990|NCT00550550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56053991|NCT00550550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56053992|NCT00550550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56053993|NCT00550550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56053994|NCT00550550|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56053995|NCT00550550|Autonomic Agents|autonomic agents|mesh-ancestor
55894680|NCT02353780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894681|NCT02353780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894682|NCT02353780|Dermatologic Agents|dermatologic agents|mesh-ancestor
55894683|NCT03176472|Ricolinostat|ricolinostat|mesh-list
55894684|NCT03176472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894685|NCT03176472|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55894686|NCT03176472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894687|NCT03176472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894688|NCT03246360|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55894689|NCT03246360|Cloxacillin|cloxacillin|mesh-list
55894690|NCT03246360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894691|NCT02354092|Anesthetics|anesthetics|mesh-list
55894692|NCT02354092|Anesthetics, Local|anesthetics, local|mesh-list
55894693|NCT02354092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894694|NCT02354092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894695|NCT02354092|Sensory System Agents|sensory system agents|mesh-ancestor
55894696|NCT02354092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894697|NCT00907101|Adapalene|adapalene|mesh-list
55894698|NCT00907101|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
55894700|NCT00907101|Dermatologic Agents|dermatologic agents|mesh-ancestor
55894701|NCT00907101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55894702|NCT00907101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894703|NCT00907101|Analgesics|analgesics|mesh-ancestor
55894704|NCT00907101|Sensory System Agents|sensory system agents|mesh-ancestor
55894705|NCT00907101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894706|NCT00907101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894707|NCT00907101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894710|NCT03245970|Labetalol|labetalol|mesh-list
55894711|NCT03245970|Nifedipine|nifedipine|mesh-list
55894712|NCT03245970|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55894713|NCT03245970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55894714|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894715|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56053996|NCT00550550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56053997|NCT00550550|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56053998|NCT00550550|Respiratory System Agents|respiratory system agents|mesh-ancestor
56053999|NCT00550550|Dermatologic Agents|dermatologic agents|mesh-ancestor
56054000|NCT00550550|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56054001|NCT00550550|Tocolytic Agents|tocolytic agents|mesh-ancestor
56054002|NCT00550550|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56054003|NCT00550550|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56054004|NCT00550550|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56054005|NCT00550550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56054006|NCT00550550|Adrenergic Agents|adrenergic agents|mesh-ancestor
56054007|NCT00550550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054008|NCT00550550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054009|NCT00550550|Antipruritics|antipruritics|mesh-ancestor
56054010|NCT00550550|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56054011|NCT00550550|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56054012|NCT00550550|Histamine Antagonists|histamine antagonists|mesh-ancestor
55894716|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894717|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
55894718|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
55894719|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55894720|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55894721|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55894722|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
55894723|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
55894724|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894725|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55894726|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55894727|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55894728|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
55894729|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894730|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
55894731|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55894732|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55894733|NCT02454348|Vasopressins|vasopressins|mesh-list
55894734|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
55894735|NCT02454348|Norepinephrine|norepinephrine|mesh-list
55894736|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55894737|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55894738|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
55894739|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894740|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894741|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894743|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
55894744|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894745|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55894746|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
55894747|NCT02454348|Coagulants|coagulants|mesh-ancestor
55894748|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55894749|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
55894750|NCT02455908|Aldesleukin|aldesleukin|mesh-list
55894751|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894752|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55894753|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55894754|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
55894755|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894756|NCT03245658|Nabiximols|nabiximols|mesh-list
56054013|NCT00550550|Histamine Agents|histamine agents|mesh-ancestor
56054014|NCT00550550|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56054015|NCT00550550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56054016|NCT00550550|Analgesics|analgesics|mesh-ancestor
56054017|NCT00550550|Sensory System Agents|sensory system agents|mesh-ancestor
55894757|NCT03245658|Analgesics|analgesics|mesh-ancestor
55894758|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
55894759|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894760|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894761|NCT03245424|Ivosidenib|ivosidenib|mesh-list
55894762|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894763|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894764|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894765|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55894766|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
55894767|NCT03251040|Coagulants|coagulants|mesh-ancestor
55894768|NCT04754763|Propolis|propolis|mesh-list
55894769|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894783|NCT02454894|Lidocaine|lidocaine|mesh-list
55894784|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
55894785|NCT02454894|Anesthetics|anesthetics|mesh-ancestor
55894786|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894787|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894788|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
55894789|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894790|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55894791|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55894792|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55894793|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55894794|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894796|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55894799|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894800|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894801|NCT03245190|Chiauranib|chiauranib|mesh-list
55894802|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894803|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55894804|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894805|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894806|NCT04774029|Lidocaine|lidocaine|mesh-list
55894807|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
55894808|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
55894809|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894810|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894811|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
55894812|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894814|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55894815|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55894816|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55894817|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894818|NCT03245346|Anesthetics|anesthetics|mesh-list
55894819|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894820|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894821|NCT03244956|Trametinib|trametinib|mesh-list
55894822|NCT03244956|Dabrafenib|dabrafenib|mesh-list
55894823|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894824|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55894825|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894826|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894827|NCT03244488|Mecamylamine|mecamylamine|mesh-list
55894828|NCT03244488|Scopolamine|scopolamine|mesh-list
55894829|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55894830|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55894831|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
55894832|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
55894833|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894834|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894835|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55894836|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
55894837|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56054018|NCT00550550|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56054019|NCT01590680|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56054020|NCT01590680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054021|NCT01590680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054022|NCT01590680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054023|NCT01590680|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56054024|NCT02971839|Ivacaftor|ivacaftor|mesh-list
56054025|NCT02971839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56054026|NCT02971839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054027|NCT02971839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054028|NCT02974803|Trametinib|trametinib|mesh-list
56054029|NCT02974803|Dabrafenib|dabrafenib|mesh-list
56054030|NCT02974803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054031|NCT02974803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55894838|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
55894839|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894840|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894841|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55894842|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
55894843|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55894844|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
55894845|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55894846|NCT01969708|Bevacizumab|bevacizumab|mesh-list
55894847|NCT01969708|Aflibercept|aflibercept|mesh-list
55894848|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55894849|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894850|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55894851|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55894852|NCT01969708|Growth Substances|growth substances|mesh-ancestor
55894853|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894854|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
55894856|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
55894857|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55894858|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894859|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894860|NCT03243864|Ceftazidime|ceftazidime|mesh-list
55894861|NCT03243864|Avibactam|avibactam|mesh-list
55894862|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
55894863|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55894864|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894865|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55894866|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894867|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894868|NCT03250494|Dexamethasone|dexamethasone|mesh-list
55894869|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
55894873|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
55894874|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894875|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894876|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55894879|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55894880|NCT03250494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55894881|NCT03250494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894882|NCT03250494|Protease Inhibitors|protease inhibitors|mesh-ancestor
55894883|NCT03250494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894884|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894885|NCT03254628|Misoprostol|misoprostol|mesh-list
55894886|NCT03254628|Oxytocin|oxytocin|mesh-list
56054036|NCT02281136|Dermatologic Agents|dermatologic agents|mesh-ancestor
56054043|NCT00558038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56054044|NCT01507233|Morphine|morphine|mesh-list
56054045|NCT01507233|Bupivacaine|bupivacaine|mesh-list
56054046|NCT01507233|Anesthetics, Local|anesthetics, local|mesh-ancestor
56054047|NCT01507233|Anesthetics|anesthetics|mesh-ancestor
56054048|NCT01507233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054049|NCT01507233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054050|NCT01507233|Sensory System Agents|sensory system agents|mesh-ancestor
56054051|NCT01507233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054052|NCT01507233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56054053|NCT01507233|Narcotics|narcotics|mesh-ancestor
56054054|NCT01507233|Analgesics|analgesics|mesh-ancestor
56054055|NCT02278562|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56054056|NCT02278562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56054057|NCT00378417|Vaccines|vaccines|mesh-list
56054058|NCT00378417|Immunologic Factors|immunologic factors|mesh-ancestor
56054059|NCT00378417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054060|NCT01487499|Cisplatin|cisplatin|mesh-list
56054061|NCT01487499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054062|NCT01483209|Botulinum Toxins|botulinum toxins|mesh-list
56054063|NCT01483209|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55894887|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
55894888|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55894889|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894890|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55894891|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
55894892|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55894893|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55894894|NCT01970176|Tadalafil|tadalafil|mesh-list
55894895|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
55894896|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55894897|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55894898|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054065|NCT01483209|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56054066|NCT01483209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054067|NCT01483209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054068|NCT01483209|Cholinergic Agents|cholinergic agents|mesh-ancestor
56054069|NCT01483209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054070|NCT01483209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054071|NCT01483209|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56054072|NCT01483209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054073|NCT02281448|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56054074|NCT02281448|Contraceptive Agents|contraceptive agents|mesh-list
56054075|NCT02281448|Contraceptives, Oral|contraceptives, oral|mesh-list
56054076|NCT02281448|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55894899|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894900|NCT01970176|Urological Agents|urological agents|mesh-ancestor
55894901|NCT02024386|Riociguat|riociguat|mesh-list
55894902|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
55894903|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894904|NCT03250338|Cytarabine|cytarabine|mesh-list
55894905|NCT03250338|Fludarabine|fludarabine|mesh-list
55894906|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
55894907|NCT03250338|Idarubicin|idarubicin|mesh-list
55894908|NCT03250338|Crenolanib|crenolanib|mesh-list
55894909|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894910|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55894911|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
55894912|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894913|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55894914|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
55894915|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894916|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
55894917|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894918|NCT03250338|Analgesics|analgesics|mesh-ancestor
55894919|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
55894920|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894921|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55894922|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55894923|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894924|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55894925|NCT01971580|Ambrisentan|ambrisentan|mesh-list
55894926|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55894928|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894929|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
55894930|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
55894931|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
55894932|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894933|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55894934|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894935|NCT00838383|Sitaxsentan|sitaxsentan|mesh-list
55894936|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55894937|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894938|NCT02355886|Gabapentin|gabapentin|mesh-list
55894939|NCT02355886|Analgesics|analgesics|mesh-ancestor
55894940|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
55754247|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
55894941|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894942|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054077|NCT02281448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56054078|NCT02281448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054079|NCT02281448|Anticonvulsants|anticonvulsants|mesh-ancestor
56054080|NCT02281448|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56054081|NCT02281448|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56054082|NCT02281448|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054083|NCT02281448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054084|NCT02281448|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56054086|NCT00378729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56054087|NCT00378729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054088|NCT00378495|Miltefosine|miltefosine|mesh-list
56054089|NCT00378495|Antifungal Agents|antifungal agents|mesh-ancestor
56054090|NCT00378495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054091|NCT00378495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054092|NCT00378495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56054093|NCT00378495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56054094|NCT02281526|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55894943|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
55894945|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55894946|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894947|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55894948|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55894949|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55894950|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55894951|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894952|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
55894953|NCT03247413|Dexamethasone|dexamethasone|mesh-list
55894954|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894955|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
55894956|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
55894957|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894958|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894959|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55894960|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
55894962|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55894963|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55894964|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894965|NCT02356198|Hydromorphone|hydromorphone|mesh-list
55894966|NCT02356198|Bupivacaine|bupivacaine|mesh-list
55894967|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
55894968|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
55894969|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894970|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894971|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
55894972|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894973|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55894974|NCT02356198|Narcotics|narcotics|mesh-ancestor
55894975|NCT02356198|Analgesics|analgesics|mesh-ancestor
55894976|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
55894977|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55894978|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894979|NCT04778865|Vitamin D|vitamin d|mesh-list
55894980|NCT04778865|Ergocalciferols|ergocalciferols|mesh-list
56054096|NCT02281526|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56054097|NCT02281526|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56054098|NCT02281526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054099|NCT02281526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054101|NCT03802227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56054102|NCT03802227|Narcotics|narcotics|mesh-ancestor
56054103|NCT03802227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054104|NCT03802227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054105|NCT03802227|Analgesics|analgesics|mesh-ancestor
56054106|NCT03802227|Sensory System Agents|sensory system agents|mesh-ancestor
56054107|NCT03802227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054108|NCT02749617|Apixaban|apixaban|mesh-list
56054109|NCT02749617|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56054110|NCT02749617|Antithrombins|antithrombins|mesh-ancestor
56054111|NCT02749617|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56054112|NCT02749617|Protease Inhibitors|protease inhibitors|mesh-ancestor
56054113|NCT02749617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054114|NCT02749617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054115|NCT02749617|Anticoagulants|anticoagulants|mesh-ancestor
56054116|NCT02749227|Pasireotide|pasireotide|mesh-list
56054117|NCT02749227|Hormones|hormones|mesh-ancestor
56054118|NCT02749227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054119|NCT02749227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054120|NCT02746263|Acetaminophen|acetaminophen|mesh-list
55894983|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
55894984|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894985|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55894986|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55894987|NCT02025634|Acetaminophen|acetaminophen|mesh-list
55894988|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55894990|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
55894991|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894992|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894993|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
55894994|NCT04773951|Antibodies|antibodies|mesh-list
55894995|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55894996|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
55894997|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894998|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
55894999|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
55895000|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895001|NCT04773717|Protective Agents|protective agents|mesh-ancestor
55895002|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054121|NCT02746263|Morphine|morphine|mesh-list
56054122|NCT02746263|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56054123|NCT02746263|Narcotics|narcotics|mesh-ancestor
56054124|NCT02746263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054125|NCT02746263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054126|NCT02746263|Analgesics|analgesics|mesh-ancestor
55895004|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
55895005|NCT04444167|Lenvatinib|lenvatinib|mesh-list
55895006|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895007|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55895008|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895009|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895010|NCT03243006|Acetaminophen|acetaminophen|mesh-list
55895011|NCT03243006|Tramadol|tramadol|mesh-list
55895012|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55895013|NCT03243006|Analgesics|analgesics|mesh-ancestor
55895014|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
55895015|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754250|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895016|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895017|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
55895018|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55895019|NCT03243006|Narcotics|narcotics|mesh-ancestor
55895028|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895029|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55895030|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
55895031|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55895032|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55895033|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55895034|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55895035|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55895036|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55895040|NCT03242460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55895041|NCT03242460|Immunologic Factors|immunologic factors|mesh-ancestor
55895042|NCT03242460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895043|NCT03242460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55895044|NCT03242460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55895045|NCT03242460|Alkylating Agents|alkylating agents|mesh-ancestor
55895046|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895047|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895048|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55895049|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55895050|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
55895051|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
55895052|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895053|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55895054|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
55895055|NCT03242460|Hormones|hormones|mesh-ancestor
55895056|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895057|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55895058|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55895059|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55895060|NCT03242460|Growth Substances|growth substances|mesh-ancestor
55895061|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
55895062|NCT03242616|Pemetrexed|pemetrexed|mesh-list
55895063|NCT03242616|Vinorelbine|vinorelbine|mesh-list
55895064|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895065|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895066|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895067|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55895068|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55895069|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55895070|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
55895071|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
55895072|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
55895073|NCT01748825|Adavosertib|adavosertib|mesh-list
55895074|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054127|NCT02746263|Sensory System Agents|sensory system agents|mesh-ancestor
56054128|NCT02746263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054129|NCT02746263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56054130|NCT02746263|Antipyretics|antipyretics|mesh-ancestor
56054131|NCT01394211|Anastrozole|anastrozole|mesh-list
56054132|NCT01394211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55895075|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895076|NCT05605587|Leflunomide|leflunomide|mesh-list
55895077|NCT05605587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895078|NCT05605587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754252|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
55895079|NCT05605587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55895080|NCT05605587|Immunologic Factors|immunologic factors|mesh-ancestor
55895081|NCT05605587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895082|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
55895083|NCT03253224|Analgesics|analgesics|mesh-ancestor
55895085|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895086|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895088|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895089|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55895090|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
55895091|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55895092|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55895093|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895094|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55895095|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
55895096|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55895098|NCT00789399|Fondaparinux|fondaparinux|mesh-list
55895099|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55895100|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
55895101|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55895102|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
55895103|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895104|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895105|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
55895106|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55895107|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55895108|NCT01720667|Levetiracetam|levetiracetam|mesh-list
55895109|NCT01720667|Phenobarbital|phenobarbital|mesh-list
55895112|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55895113|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895115|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55895116|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55895117|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895118|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895119|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
55895120|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
55895121|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55895122|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55895123|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55895124|NCT04773093|Lidocaine|lidocaine|mesh-list
55895125|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
55895126|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
55895127|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895128|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895129|NCT04773093|Sensory System Agents|sensory system agents|mesh-ancestor
55895130|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895131|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55895132|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55895133|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55895134|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55895135|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895136|NCT01720043|Bortezomib|bortezomib|mesh-list
55895137|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054133|NCT01394211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054134|NCT01394211|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56054135|NCT01394211|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56054136|NCT01394211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054137|NCT01394211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054138|NCT01394211|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56054139|NCT01394211|Hormone Antagonists|hormone antagonists|mesh-ancestor
56054140|NCT01394211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054141|NCT01394211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054142|NCT02717949|Ribavirin|ribavirin|mesh-list
55895138|NCT02455362|Morphine|morphine|mesh-list
55895139|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55895140|NCT02455362|Narcotics|narcotics|mesh-ancestor
55895141|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895142|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895144|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
55895145|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895146|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
55895147|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55895148|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
55895149|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55895150|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895151|NCT04772781|Ibuprofen|ibuprofen|mesh-list
55895152|NCT04772781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55895153|NCT04772781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55895154|NCT04772781|Analgesics|analgesics|mesh-ancestor
55895155|NCT04772781|Sensory System Agents|sensory system agents|mesh-ancestor
55895156|NCT04772781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895157|NCT04772781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895158|NCT04772781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55895159|NCT04772781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55895160|NCT04772781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55895161|NCT04772781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895162|NCT04772781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895163|NCT02208375|Olaparib|olaparib|mesh-list
55895164|NCT02208375|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55895165|NCT02208375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895166|NCT02208375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895167|NCT02208375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895168|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55895169|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55895170|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895171|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55895172|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55895173|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55895174|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895176|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895178|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
55895179|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
55895180|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55895181|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
55895182|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55895183|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895184|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55895185|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55895186|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55895187|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55895188|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56054144|NCT02717949|Ledipasvir|ledipasvir|mesh-list
56054145|NCT02717949|Antimetabolites|antimetabolites|mesh-ancestor
56054146|NCT02717949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054147|NCT02717949|Antiviral Agents|antiviral agents|mesh-ancestor
56054148|NCT02717949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054149|NCT02300610|Gemcitabine|gemcitabine|mesh-list
56054150|NCT02300610|Cisplatin|cisplatin|mesh-list
56054151|NCT02300610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054152|NCT02300610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56054153|NCT02300610|Antimetabolites|antimetabolites|mesh-ancestor
56054154|NCT02300610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054155|NCT02300610|Antiviral Agents|antiviral agents|mesh-ancestor
56054156|NCT02300610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054157|NCT02300610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054158|NCT02300610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054159|NCT02300610|Immunologic Factors|immunologic factors|mesh-ancestor
55895189|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895190|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
55895191|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55895192|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55895193|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55895194|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55895195|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55895196|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895197|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895198|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895199|NCT03249168|Analgesics|analgesics|mesh-ancestor
55895200|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
55895201|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895202|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
55895203|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55895204|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
55895205|NCT03248856|Triamcinolone|triamcinolone|mesh-list
55895206|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55895207|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55895208|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55895209|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55895210|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
55895211|NCT03248856|Hormones|hormones|mesh-ancestor
55895212|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895213|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895214|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55895215|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
55895216|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895217|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895218|NCT03241602|Lidocaine|lidocaine|mesh-list
55895220|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
55895221|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895222|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895223|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
55895224|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895225|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55895226|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56054160|NCT02300610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054161|NCT01880840|Azelastine|azelastine|mesh-list
55895227|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55895228|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55895229|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895233|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
55895234|NCT00734877|Melphalan|melphalan|mesh-list
55895235|NCT00734877|Cisplatin|cisplatin|mesh-list
55895236|NCT00734877|Etoposide|etoposide|mesh-list
55895242|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55895243|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
55895244|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895245|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55895246|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55895247|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
55895248|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895249|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895250|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55895251|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55895252|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
55895253|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
55895254|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895255|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55895256|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
55895257|NCT00734877|Hormones|hormones|mesh-ancestor
55895258|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895259|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55895260|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
55895261|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895262|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55895263|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55895264|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55895265|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55895266|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
55895267|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55895268|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895269|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55895270|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55895271|NCT00734877|Growth Substances|growth substances|mesh-ancestor
55895272|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
55895273|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
55895274|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55895275|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
55895276|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895279|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55895280|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
55895281|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895282|NCT02357290|Protective Agents|protective agents|mesh-ancestor
55895283|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895284|NCT02357290|Antidotes|antidotes|mesh-ancestor
55895285|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
55895286|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55895287|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
55895288|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55895289|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895290|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55895291|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55895292|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55895293|NCT00687765|Temozolomide|temozolomide|mesh-list
55895294|NCT00687765|Iniparib|iniparib|mesh-list
55895295|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55895296|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
55895297|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895298|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895299|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55895300|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895302|NCT03248544|Cholecalciferol|cholecalciferol|mesh-list
55895303|NCT03248544|Vitamins|vitamins|mesh-ancestor
56054162|NCT01880840|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56054163|NCT01880840|Autonomic Agents|autonomic agents|mesh-ancestor
56054164|NCT01880840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054165|NCT01880840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054166|NCT01880840|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56054167|NCT01880840|Respiratory System Agents|respiratory system agents|mesh-ancestor
56054168|NCT01880840|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
56054169|NCT01880840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054170|NCT01880840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054171|NCT01880840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56054172|NCT01880840|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56054173|NCT01880840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55895304|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
55895305|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895306|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55895307|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55895308|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55895309|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55895311|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55895312|NCT00984399|Estrogens|estrogens|mesh-ancestor
55895313|NCT00984399|Hormones|hormones|mesh-ancestor
55895314|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895315|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895316|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55895317|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
55895318|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55895319|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55895320|NCT00217737|Calcium, Dietary|calcium, dietary|mesh-list
55895321|NCT00217737|Leucovorin|leucovorin|mesh-list
55895322|NCT00217737|Folic Acid|folic acid|mesh-list
55895323|NCT00217737|Bevacizumab|bevacizumab|mesh-list
55895324|NCT00217737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55895325|NCT00217737|Fluorouracil|fluorouracil|mesh-list
55895326|NCT00217737|Oxaliplatin|oxaliplatin|mesh-list
55895327|NCT00217737|Endothelial Growth Factors|endothelial growth factors|mesh-list
55895328|NCT00217737|Antibodies|antibodies|mesh-list
55895329|NCT00217737|Immunoglobulins|immunoglobulins|mesh-list
55895330|NCT00217737|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55895331|NCT00217737|Immunoglobulin G|immunoglobulin g|mesh-list
55895332|NCT00217737|Calcium|calcium|mesh-list
55895333|NCT00217737|Levoleucovorin|levoleucovorin|mesh-list
55895334|NCT00217737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895335|NCT00217737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55895336|NCT00217737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55895337|NCT00217737|Growth Substances|growth substances|mesh-ancestor
55895338|NCT00217737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895339|NCT00217737|Growth Inhibitors|growth inhibitors|mesh-ancestor
55895340|NCT00217737|Immunologic Factors|immunologic factors|mesh-ancestor
55895341|NCT00217737|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55895342|NCT00217737|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55895343|NCT00217737|Antimetabolites|antimetabolites|mesh-ancestor
55895344|NCT00217737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895345|NCT00217737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55895346|NCT00217737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55895347|NCT00217737|Antidotes|antidotes|mesh-ancestor
55895348|NCT00217737|Protective Agents|protective agents|mesh-ancestor
55789046|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
55895349|NCT00217737|Vitamin B Complex|vitamin b complex|mesh-ancestor
55895350|NCT00217737|Vitamins|vitamins|mesh-ancestor
55895351|NCT00217737|Micronutrients|micronutrients|mesh-ancestor
55895352|NCT00217737|Hematinics|hematinics|mesh-ancestor
56054174|NCT01880840|Histamine Antagonists|histamine antagonists|mesh-ancestor
56054175|NCT01880840|Histamine Agents|histamine agents|mesh-ancestor
56054176|NCT01880840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054177|NCT01377441|Ibuprofen|ibuprofen|mesh-list
56054178|NCT01377441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56054179|NCT01377441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56054180|NCT01377441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56054181|NCT01377441|Analgesics|analgesics|mesh-ancestor
56054182|NCT01377441|Sensory System Agents|sensory system agents|mesh-ancestor
56054183|NCT01377441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054184|NCT01377441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054185|NCT01377441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56054186|NCT01377441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56054187|NCT01377441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054188|NCT01377441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054189|NCT01882868|Leucovorin|leucovorin|mesh-list
56054190|NCT01882868|Irinotecan|irinotecan|mesh-list
56054191|NCT01882868|Aflibercept|aflibercept|mesh-list
56054193|NCT01882868|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56054194|NCT01882868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56054195|NCT01882868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895353|NCT03248700|Vitamins|vitamins|mesh-list
55895354|NCT03248700|Vitamin A|vitamin a|mesh-list
55895355|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
55895356|NCT03248700|Retinol acetate|retinol acetate|mesh-list
55895357|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
55895358|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895359|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
55895360|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895361|NCT03248700|Protective Agents|protective agents|mesh-ancestor
55895362|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55895363|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895364|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55895365|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
55895366|NCT03238482|Fluticasone|fluticasone|mesh-list
55895368|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55895369|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55895370|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55895371|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55895372|NCT03238482|Autonomic Agents|autonomic agents|mesh-ancestor
55895373|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895374|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895376|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
55895377|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
55895379|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55895380|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55895381|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55895382|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
55895383|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895384|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054196|NCT01882868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054197|NCT01882868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054198|NCT01882868|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56054199|NCT01882868|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56054200|NCT01882868|Growth Substances|growth substances|mesh-ancestor
56054201|NCT01882868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054202|NCT01882868|Growth Inhibitors|growth inhibitors|mesh-ancestor
55895387|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895388|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
55895389|NCT02454504|Neostigmine|neostigmine|mesh-list
55895390|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55895391|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895392|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895393|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
55895394|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895395|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895396|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55895397|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
55895398|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895399|NCT03240822|Antibodies|antibodies|mesh-list
55895400|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55895401|NCT03240822|Tacrolimus|tacrolimus|mesh-list
55895402|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
55895403|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895404|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55895405|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55895406|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895407|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895408|NCT03238560|Montelukast|montelukast|mesh-list
55895409|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55895410|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
55895411|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55895412|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
55895413|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895414|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895415|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55895416|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55895417|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895418|NCT04486092|Valproic Acid|valproic acid|mesh-list
55895419|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
55895420|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895421|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895422|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
55895423|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895424|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895425|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
55895426|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55895427|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895428|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55895429|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
55895430|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55895431|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895432|NCT00668655|Metronidazole|metronidazole|mesh-list
55895433|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895434|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55895438|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
55895439|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55895440|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55895441|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55895442|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895443|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054209|NCT01383447|Entinostat|entinostat|mesh-list
56054210|NCT01383447|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
56054211|NCT01383447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054212|NCT01383447|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55895445|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55895446|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55895447|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895448|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895450|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55895451|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55895452|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55895453|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55895454|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55895455|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55895459|NCT03238092|Estrogens|estrogens|mesh-ancestor
55895460|NCT03238092|Hormones|hormones|mesh-ancestor
55895461|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895462|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895463|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55895464|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
55895465|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55895466|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55895467|NCT03238092|Androgens|androgens|mesh-ancestor
55895468|NCT03247998|Remifentanil|remifentanil|mesh-list
55895469|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895470|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895471|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55895472|NCT03247998|Narcotics|narcotics|mesh-ancestor
55895473|NCT03247998|Analgesics|analgesics|mesh-ancestor
55895474|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
55895475|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895476|NCT03248076|Fentanyl|fentanyl|mesh-list
55895477|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55895478|NCT03248076|Narcotics|narcotics|mesh-ancestor
55895479|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895480|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895481|NCT03248076|Analgesics|analgesics|mesh-ancestor
55895482|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
55895483|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895484|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55754301|NCT03310073|Vaccines|vaccines|mesh-list
55895485|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55895486|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
55895487|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
55790692|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55895493|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55895494|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
55895495|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895496|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895497|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
55895498|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55895499|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55895500|NCT03237936|Cyclosporine|cyclosporine|mesh-list
55895501|NCT03237936|Cyclosporins|cyclosporins|mesh-list
55895502|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895503|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895504|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054213|NCT01383447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054214|NCT01383447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054215|NCT02300298|Docetaxel|docetaxel|mesh-list
56054216|NCT02300298|Nintedanib|nintedanib|mesh-list
56054217|NCT02300298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054218|NCT02300298|Tubulin Modulators|tubulin modulators|mesh-ancestor
56054219|NCT02300298|Antimitotic Agents|antimitotic agents|mesh-ancestor
56054220|NCT02300298|Mitosis Modulators|mitosis modulators|mesh-ancestor
56054221|NCT02300298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054222|NCT02300298|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56054223|NCT02300298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054224|NCT02300220|Ciprofloxacin|ciprofloxacin|mesh-list
56054225|NCT02300220|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56054226|NCT02300220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054227|NCT02300220|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56054228|NCT02300220|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56054229|NCT02300220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054230|NCT02300220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054231|NCT02300220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054232|NCT02300220|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56054233|NCT02300220|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56054234|NCT01379469|Carbamazepine|carbamazepine|mesh-list
56054235|NCT01379469|Anticonvulsants|anticonvulsants|mesh-ancestor
56054236|NCT01379469|Antimanic Agents|antimanic agents|mesh-ancestor
56054237|NCT01379469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56054238|NCT01379469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054239|NCT01379469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781441|NCT05058755|Lenalidomide|lenalidomide|mesh-list
56054240|NCT01379469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56054254|NCT04889118|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56054255|NCT04889118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054256|NCT04889118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054257|NCT01309581|Ketamine|ketamine|mesh-list
56054258|NCT01309581|Methohexital|methohexital|mesh-list
56054259|NCT01309581|Analgesics|analgesics|mesh-ancestor
56054260|NCT01309581|Sensory System Agents|sensory system agents|mesh-ancestor
56054261|NCT01309581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054262|NCT01309581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054263|NCT01309581|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56054264|NCT01309581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56054265|NCT01309581|Anesthetics, General|anesthetics, general|mesh-ancestor
56054266|NCT01309581|Anesthetics|anesthetics|mesh-ancestor
56054267|NCT01309581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054268|NCT01309581|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56054269|NCT01309581|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55895505|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
55895506|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895507|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
55895509|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
55895510|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55895511|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55895512|NCT02759835|Osimertinib|osimertinib|mesh-list
55895513|NCT02759835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895514|NCT02759835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55895515|NCT02759835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895516|NCT02759835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895517|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55895518|NCT03247920|Amoxicillin|amoxicillin|mesh-list
55895519|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
55895520|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
55895521|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55895522|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895523|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55895524|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895525|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895526|NCT03239964|Dexamethasone|dexamethasone|mesh-list
55895527|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55895528|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
55895529|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
55895531|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895532|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55895533|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
55895534|NCT03239964|Hormones|hormones|mesh-ancestor
55895535|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895536|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55895537|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895538|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
55895539|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895540|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55895541|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895542|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895543|NCT03102723|Cangrelor|cangrelor|mesh-list
56054270|NCT01309581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054271|NCT01309581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054272|NCT05289050|Ketamine|ketamine|mesh-list
56054273|NCT05289050|Esketamine|esketamine|mesh-list
56054274|NCT05289050|Analgesics|analgesics|mesh-ancestor
56054275|NCT05289050|Sensory System Agents|sensory system agents|mesh-ancestor
56054276|NCT05289050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054277|NCT05289050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054278|NCT05289050|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56054279|NCT05289050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56054280|NCT05289050|Anesthetics, General|anesthetics, general|mesh-ancestor
56054281|NCT05289050|Anesthetics|anesthetics|mesh-ancestor
56054282|NCT05289050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054283|NCT05289050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56054284|NCT05289050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56054285|NCT05289050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054286|NCT05289050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054287|NCT05289050|Antidepressive Agents|antidepressive agents|mesh-ancestor
56054288|NCT05289050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56054289|NCT02987738|Dapagliflozin|dapagliflozin|mesh-list
56054290|NCT02987738|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56054291|NCT02987738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054292|NCT02987738|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56054293|NCT02987738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054294|NCT01292265|Certolizumab Pegol|certolizumab pegol|mesh-list
55895544|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55895545|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55895546|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55895547|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55895550|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895551|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895552|NCT03237312|Hormones|hormones|mesh-list
55895553|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895554|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895555|NCT00057681|Valproic Acid|valproic acid|mesh-list
55895556|NCT00057681|Risperidone|risperidone|mesh-list
55895557|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
55895558|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55895559|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
55895560|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895561|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895562|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895563|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55895564|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56054295|NCT01292265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054296|NCT01292265|Immunologic Factors|immunologic factors|mesh-ancestor
56054297|NCT01292265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054298|NCT01292265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56054299|NCT01885910|Doxycycline|doxycycline|mesh-list
56054300|NCT01885910|Dapsone|dapsone|mesh-list
56054301|NCT01885910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56054302|NCT01885910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054303|NCT01885910|Antimalarials|antimalarials|mesh-ancestor
56054304|NCT01885910|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56054305|NCT01885910|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56054306|NCT01885910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56054307|NCT01885910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054308|NCT01885910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895565|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895566|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55895567|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55895568|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
55895569|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
55895570|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895571|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
55895572|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
55895573|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
55895574|NCT03234816|Norepinephrine|norepinephrine|mesh-list
55895575|NCT03234816|Bupivacaine|bupivacaine|mesh-list
55895576|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
55895577|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
55895578|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895579|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895580|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
55895581|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895582|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55895583|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55895584|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
55895585|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895586|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895587|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
55895588|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
55895589|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55895590|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
55895591|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
55895592|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895593|NCT03247452|Protective Agents|protective agents|mesh-ancestor
55895594|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895595|NCT03247452|Vitamins|vitamins|mesh-ancestor
55895596|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
55895597|NCT03247140|Amlodipine|amlodipine|mesh-list
55895598|NCT03247140|Telmisartan|telmisartan|mesh-list
55895599|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
55895600|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55895601|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55895603|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55895604|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895605|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55895606|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895607|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
55895608|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55895609|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55895610|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
56054309|NCT01885910|Leprostatic Agents|leprostatic agents|mesh-ancestor
56054310|NCT02658357|Risperidone|risperidone|mesh-list
56054311|NCT02658357|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56054312|NCT02658357|Serotonin Agents|serotonin agents|mesh-ancestor
56054313|NCT02658357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054314|NCT02658357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054315|NCT02658357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895611|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55895612|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55895613|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895614|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55895615|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55895617|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895618|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895619|NCT03247296|Ribavirin|ribavirin|mesh-list
55895620|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
55895621|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
55895622|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895623|NCT03247296|Antiviral Agents|antiviral agents|mesh-ancestor
55895624|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895625|NCT03247218|Memantine|memantine|mesh-list
55895626|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55895627|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55895628|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
55895629|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895630|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895631|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895632|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55895633|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55895634|NCT03237624|Chitosan|chitosan|mesh-list
55895635|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55895636|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55895637|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
55895638|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895639|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55895640|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
55895641|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
55895642|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
55895643|NCT03237624|Coagulants|coagulants|mesh-ancestor
55895644|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
55895645|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55895646|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895647|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895648|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55895649|NCT03234660|Analgesics|analgesics|mesh-ancestor
55895650|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
55895651|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895652|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55895653|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55895654|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55895656|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895657|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895658|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
55895659|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55895660|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55895661|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55895662|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55895663|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895664|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
55895665|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895666|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895667|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55895668|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895669|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
55895670|NCT00059475|Interleukin-2|interleukin-2|mesh-list
56054316|NCT02658357|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56054317|NCT02658357|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56054318|NCT02658357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054319|NCT02658357|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56054320|NCT02658357|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56054321|NCT02658357|Dopamine Agents|dopamine agents|mesh-ancestor
56054322|NCT05280704|Lidocaine|lidocaine|mesh-list
56054323|NCT05280704|Anesthetics, Local|anesthetics, local|mesh-ancestor
56054324|NCT05280704|Anesthetics|anesthetics|mesh-ancestor
56054325|NCT05280704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054326|NCT05280704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054327|NCT05280704|Sensory System Agents|sensory system agents|mesh-ancestor
56054328|NCT05280704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054329|NCT05280704|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56054330|NCT05280704|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56054331|NCT05280704|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56054332|NCT05280704|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054333|NCT05280704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895671|NCT00059475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55895672|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895673|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55895676|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895677|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895678|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55895680|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55895681|NCT00059475|Antiviral Agents|antiviral agents|mesh-ancestor
55895682|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895683|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
55895684|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55895685|NCT00059475|Protective Agents|protective agents|mesh-ancestor
55895686|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
55895687|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
55895688|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
55895689|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55895690|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55895691|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895692|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
55895693|NCT02453802|Coagulants|coagulants|mesh-ancestor
55895694|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55895695|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
55895696|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55895697|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
55895698|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895699|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
55895700|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
55895701|NCT02453802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55895702|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55895703|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55895704|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55895705|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895706|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895707|NCT02028676|Lamivudine|lamivudine|mesh-list
55895708|NCT02028676|Zidovudine|zidovudine|mesh-list
55895709|NCT02028676|Efavirenz|efavirenz|mesh-list
55895710|NCT02028676|Nevirapine|nevirapine|mesh-list
55895711|NCT02028676|Abacavir|abacavir|mesh-list
55895712|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
55895713|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
55895714|NCT02028676|Trimethoprim|trimethoprim|mesh-list
55895715|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
55895716|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55895717|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55895718|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55895719|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895720|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895721|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
55895722|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895723|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55895724|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55895725|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
55895726|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55895727|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55895728|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55895729|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55895730|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55895731|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55895732|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55895733|NCT02028676|Renal Agents|renal agents|mesh-ancestor
55895734|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
55895735|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55895736|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55895737|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55895738|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55895739|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55895740|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55895741|NCT03233880|Azithromycin|azithromycin|mesh-list
55895742|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55895743|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895744|NCT00061893|Celecoxib|celecoxib|mesh-list
55895745|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
55895746|NCT00061893|Ifosfamide|ifosfamide|mesh-list
55895747|NCT00061893|Doxorubicin|doxorubicin|mesh-list
55895748|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55895753|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
55895754|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895755|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55895756|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55895757|NCT00061893|Alkylating Agents|alkylating agents|mesh-ancestor
55895758|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895759|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895760|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55895761|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55895762|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55895763|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55895764|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895765|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55895766|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
55895767|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
55895768|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
55895769|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55895770|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55895772|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
55895773|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895774|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55895775|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55895776|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55895777|NCT02957019|Rituximab|rituximab|mesh-list
55895778|NCT02957019|Interleukin-2|interleukin-2|mesh-list
55895779|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55895780|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895781|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
55895782|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054343|NCT02988908|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56054344|NCT02988908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054345|NCT02988908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054346|NCT02988908|Cholinergic Agents|cholinergic agents|mesh-ancestor
56054347|NCT02988908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895783|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55895784|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55895785|NCT02957019|Analgesics|analgesics|mesh-ancestor
55895786|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
55895787|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895788|NCT02028754|Levofloxacin|levofloxacin|mesh-list
55895789|NCT02028754|Ofloxacin|ofloxacin|mesh-list
55895790|NCT02028754|Prednisolone|prednisolone|mesh-list
55895791|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
55895792|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55895793|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55895794|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
55895795|NCT02028754|Hormones|hormones|mesh-ancestor
55895796|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895797|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895798|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55895799|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895800|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55895801|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55895802|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895803|NCT02028754|Renal Agents|renal agents|mesh-ancestor
55895804|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55895805|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55895806|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55895807|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895808|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895809|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55895810|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55895811|NCT02028754|Laxatives|laxatives|mesh-ancestor
55895812|NCT02453490|Fluorouracil|fluorouracil|mesh-list
55895813|NCT02453490|Raltitrexed|raltitrexed|mesh-list
55895814|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
55895815|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895816|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55895817|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895818|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55895819|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
55895829|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895830|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895832|NCT03236610|Entecavir|entecavir|mesh-list
55895833|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
55895834|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895835|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55895836|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55895837|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895838|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895839|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55895840|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55895841|NCT05287893|Pyronaridine|pyronaridine|mesh-list
55895842|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
55895843|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55895844|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55895845|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895846|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55895847|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895848|NCT01552434|Sirolimus|sirolimus|mesh-list
55895849|NCT01552434|Bevacizumab|bevacizumab|mesh-list
55895850|NCT01552434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55895851|NCT01552434|Cetuximab|cetuximab|mesh-list
55895852|NCT01552434|Valproic Acid|valproic acid|mesh-list
55895853|NCT01552434|Endothelial Growth Factors|endothelial growth factors|mesh-list
55895854|NCT01552434|Antibodies|antibodies|mesh-list
55895855|NCT01552434|Immunoglobulins|immunoglobulins|mesh-list
56054348|NCT02988908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054349|NCT02988908|Nootropic Agents|nootropic agents|mesh-ancestor
56054350|NCT02326272|Certolizumab Pegol|certolizumab pegol|mesh-list
56054351|NCT02326272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054352|NCT02326272|Immunologic Factors|immunologic factors|mesh-ancestor
56054353|NCT02326272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054354|NCT02326272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56054355|NCT02325414|Zoledronic Acid|zoledronic acid|mesh-list
56054356|NCT02325414|Diphosphonates|diphosphonates|mesh-list
56054357|NCT02325414|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56054358|NCT02325414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054359|NCT02349048|Sofosbuvir|sofosbuvir|mesh-list
56054360|NCT02349048|Simeprevir|simeprevir|mesh-list
56054361|NCT02349048|Antiviral Agents|antiviral agents|mesh-ancestor
56054362|NCT02349048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054363|NCT02349048|Protease Inhibitors|protease inhibitors|mesh-ancestor
56054364|NCT02349048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054365|NCT02349048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054366|NCT01280643|Leucovorin|leucovorin|mesh-list
56054367|NCT01280643|Bevacizumab|bevacizumab|mesh-list
56054368|NCT01280643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56054369|NCT01280643|Cetuximab|cetuximab|mesh-list
56054370|NCT01280643|Fluorouracil|fluorouracil|mesh-list
55895858|NCT01552434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895859|NCT01552434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55895860|NCT01552434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55895861|NCT01552434|Growth Substances|growth substances|mesh-ancestor
55895862|NCT01552434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895863|NCT01552434|Growth Inhibitors|growth inhibitors|mesh-ancestor
55895865|NCT01552434|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55895866|NCT01552434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895867|NCT01552434|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55895868|NCT01552434|Antifungal Agents|antifungal agents|mesh-ancestor
55895869|NCT01552434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55895870|NCT01552434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895871|NCT01552434|Anticonvulsants|anticonvulsants|mesh-ancestor
55895872|NCT01552434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895873|NCT01552434|GABA Agents|gaba agents|mesh-ancestor
55895874|NCT01552434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895875|NCT01552434|Antimanic Agents|antimanic agents|mesh-ancestor
55895876|NCT01552434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55895877|NCT01552434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895878|NCT01552434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55895879|NCT02357836|Itraconazole|itraconazole|mesh-list
56054376|NCT01280643|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56054377|NCT01280643|Levoleucovorin|levoleucovorin|mesh-list
56054378|NCT01280643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895880|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
55895881|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895882|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55895883|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55895884|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895885|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895886|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55895887|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
55895888|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895889|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895890|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55895893|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55895894|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895895|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55895896|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895897|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895898|NCT04485702|Midazolam|midazolam|mesh-list
55895899|NCT04485702|Ketamine|ketamine|mesh-list
55895900|NCT04485702|Analgesics|analgesics|mesh-ancestor
55895901|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
55895902|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895903|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895904|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55895905|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55895906|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
55895907|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
55895908|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895909|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55895910|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55895911|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895912|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895913|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55895914|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55895915|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55895916|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55895917|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55895918|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
55895919|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
55895920|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55895921|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895922|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55895923|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895924|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895925|NCT03233412|Imiquimod|imiquimod|mesh-list
55895926|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55895928|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895929|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895930|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
55895932|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895933|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
55895935|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895936|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55895937|NCT01976572|Candesartan|candesartan|mesh-list
55895938|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55895939|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55895940|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55895941|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895942|NCT01976650|Dexamethasone|dexamethasone|mesh-list
55895943|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55895944|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
55895945|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
55895946|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895947|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895948|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56054379|NCT01280643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56054380|NCT01280643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56054381|NCT01280643|Growth Substances|growth substances|mesh-ancestor
56054382|NCT01280643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054383|NCT01280643|Growth Inhibitors|growth inhibitors|mesh-ancestor
56054384|NCT01280643|Immunologic Factors|immunologic factors|mesh-ancestor
56054385|NCT01280643|Antimetabolites|antimetabolites|mesh-ancestor
56054386|NCT01280643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054387|NCT01280643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56054388|NCT01280643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054389|NCT01280643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56054390|NCT01280643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56054391|NCT01280643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054393|NCT01280643|Protective Agents|protective agents|mesh-ancestor
56054394|NCT01280643|Vitamin B Complex|vitamin b complex|mesh-ancestor
56054395|NCT01280643|Vitamins|vitamins|mesh-ancestor
56054396|NCT01280643|Micronutrients|micronutrients|mesh-ancestor
56054397|NCT01888952|Prednisone|prednisone|mesh-list
56054398|NCT01888952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56054399|NCT01888952|Glucocorticoids|glucocorticoids|mesh-ancestor
56054400|NCT01888952|Hormones|hormones|mesh-ancestor
56054401|NCT01888952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054402|NCT01888952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054403|NCT01888952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55895949|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
55895950|NCT01976650|Hormones|hormones|mesh-ancestor
55895951|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895952|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55895953|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895954|NCT01978600|Timolol|timolol|mesh-list
55895955|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55895956|NCT01978600|Brinzolamide|brinzolamide|mesh-list
55895957|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895959|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55895960|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55895961|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
55895965|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55895966|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55895967|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55895968|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55895969|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55895971|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55895972|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
55895973|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55895974|NCT03236220|Expectorants|expectorants|mesh-ancestor
56054404|NCT01888952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054405|NCT02299206|Zinc Oxide|zinc oxide|mesh-list
56054406|NCT02299206|Dermatologic Agents|dermatologic agents|mesh-ancestor
56054407|NCT02299206|Sunscreening Agents|sunscreening agents|mesh-ancestor
55895975|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
55895976|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55895977|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
55895978|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895979|NCT03236220|Protective Agents|protective agents|mesh-ancestor
55895980|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895981|NCT03236220|Antidotes|antidotes|mesh-ancestor
55895982|NCT03232632|Flutemetamol|flutemetamol|mesh-list
55895983|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55895984|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895985|NCT01747499|Azacitidine|azacitidine|mesh-list
55895986|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55895988|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895989|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55895990|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895991|NCT00071721|Valproic Acid|valproic acid|mesh-list
55895992|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
55895993|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895994|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55895995|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
55895996|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895997|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895998|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
55895999|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55896000|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896001|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55896002|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
55896003|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55896004|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896005|NCT05606055|Tenofovir|tenofovir|mesh-list
55896006|NCT05606055|Emtricitabine|emtricitabine|mesh-list
55896007|NCT05606055|Antiviral Agents|antiviral agents|mesh-ancestor
55896008|NCT05606055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896009|NCT05606055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55896010|NCT05606055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55896011|NCT05606055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896012|NCT05606055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896013|NCT05606055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55896014|NCT05606055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55896015|NCT03232710|Aripiprazole|aripiprazole|mesh-list
55896016|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
55896017|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55896018|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55896019|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55896020|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896021|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896022|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
55896024|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896025|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896026|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55896027|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55896028|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
55896029|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55896030|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55896031|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55896032|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55896033|NCT01896609|Interferons|interferons|mesh-list
55896034|NCT01896609|Ribavirin|ribavirin|mesh-list
55896038|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
55896039|NCT01896609|Complement Factor H|complement factor h|mesh-list
55896040|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896041|NCT01896609|Antiviral Agents|antiviral agents|mesh-ancestor
55896042|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896043|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
55896048|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896049|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55896050|NCT03232554|Iron|iron|mesh-list
55896051|NCT03232554|Trace Elements|trace elements|mesh-ancestor
55896052|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
55896053|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896054|NCT03232398|Warfarin|warfarin|mesh-list
55896055|NCT03232398|Apixaban|apixaban|mesh-list
55896056|NCT03232398|Anticoagulants|anticoagulants|mesh-ancestor
55896057|NCT03232398|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55896058|NCT03232398|Antithrombins|antithrombins|mesh-ancestor
55896059|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55896060|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
55896061|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896062|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896063|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
55896064|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
55896065|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896066|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896067|NCT00158223|Pimozide|pimozide|mesh-list
55896068|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55896069|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55896070|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896071|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896072|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55896075|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896076|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896077|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55896078|NCT03228576|Everolimus|everolimus|mesh-list
55896079|NCT03228576|Tacrolimus|tacrolimus|mesh-list
55896080|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896081|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
55896082|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896083|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55896084|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896085|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896086|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054424|NCT02640573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054425|NCT02640573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054426|NCT02640573|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56054428|NCT02298192|Xultophy|xultophy|mesh-list
56054429|NCT02298192|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56054433|NCT02298192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054434|NCT01893632|Gabapentin|gabapentin|mesh-list
56054435|NCT01893632|Analgesics|analgesics|mesh-ancestor
56054436|NCT01893632|Sensory System Agents|sensory system agents|mesh-ancestor
56054437|NCT01893632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896087|NCT00158379|Paclitaxel|paclitaxel|mesh-list
55754350|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
55896088|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55896089|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896090|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
55896091|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
55896092|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
55896093|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896094|NCT03228498|Choline|choline|mesh-list
55896095|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
55896096|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55896097|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
55896098|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896099|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55896100|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55896101|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
55896102|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55896103|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55896104|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896105|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896106|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55896107|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896111|NCT02364076|Pembrolizumab|pembrolizumab|mesh-list
55896112|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896113|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896114|NCT02453022|Omeprazole|omeprazole|mesh-list
55896115|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55896116|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55896117|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55896118|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896119|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896120|NCT00163293|Ciclesonide|ciclesonide|mesh-list
55896121|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
55896122|NCT00163293|Hormones|hormones|mesh-ancestor
55896123|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55896124|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896125|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55896126|NCT02365870|Rotigotine|rotigotine|mesh-list
55896127|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
55896128|NCT02365870|Dopamine Agents|dopamine agents|mesh-ancestor
55896129|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896130|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896131|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054438|NCT01893632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054439|NCT01893632|Anticonvulsants|anticonvulsants|mesh-ancestor
56054440|NCT01893632|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56054441|NCT01893632|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56054442|NCT01893632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054443|NCT01893632|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55896132|NCT03228108|Amoxicillin|amoxicillin|mesh-list
55896133|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
55896134|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55896138|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55896139|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
55896140|NCT03228108|Trimethoprim|trimethoprim|mesh-list
55896141|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
55896142|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55896143|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896144|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55896145|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55896146|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896147|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896148|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896149|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55896150|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55896151|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55896152|NCT03228108|Renal Agents|renal agents|mesh-ancestor
55896153|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
55896154|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55896155|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55896156|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55896157|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55754372|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
55896158|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55896159|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55896161|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
55896162|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896163|NCT00078897|Protective Agents|protective agents|mesh-ancestor
55896164|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896165|NCT00078897|Trace Elements|trace elements|mesh-ancestor
55896166|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
55896167|NCT03228030|Thiamine|thiamine|mesh-list
55896168|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
55896169|NCT03228030|Vitamins|vitamins|mesh-ancestor
55896170|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
55896171|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896172|NCT01717313|Metformin|metformin|mesh-list
55896173|NCT01717313|Glimepiride|glimepiride|mesh-list
55896174|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55896175|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896176|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55896177|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896178|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
55896179|NCT00081861|Bevacizumab|bevacizumab|mesh-list
55896180|NCT00081861|Rituximab|rituximab|mesh-list
55896182|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896183|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55896184|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55896185|NCT00081861|Growth Substances|growth substances|mesh-ancestor
55896186|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896187|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
55896188|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
55896189|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55896190|NCT03120234|Fentanyl|fentanyl|mesh-list
55896191|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
55896192|NCT03120234|Ketamine|ketamine|mesh-list
55896193|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55896194|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896195|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054444|NCT01893632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56054445|NCT01893632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56054446|NCT01893632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054447|NCT01893632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054449|NCT01272141|Everolimus|everolimus|mesh-list
56054450|NCT01272141|Lapatinib|lapatinib|mesh-list
56054451|NCT01272141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054452|NCT01272141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054453|NCT01272141|Immunologic Factors|immunologic factors|mesh-ancestor
56054454|NCT01272141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054455|NCT01272141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56054456|NCT01272141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054457|NCT01272141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054463|NCT01895036|Naltrexone|naltrexone|mesh-list
56054464|NCT01895036|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56054465|NCT01895036|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56054466|NCT01895036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054467|NCT01895036|Sensory System Agents|sensory system agents|mesh-ancestor
56054468|NCT01895036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054471|NCT03781479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054472|NCT03781479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054473|NCT03781479|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55896196|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55896197|NCT03120234|Analgesics|analgesics|mesh-ancestor
55896198|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
55896199|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896200|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55896201|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55896202|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55896203|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
55896204|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896205|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896206|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55896207|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55896208|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
55896209|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
55896210|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55896211|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55896212|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55896213|NCT03120234|Narcotics|narcotics|mesh-ancestor
55896214|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55896215|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
55896216|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55896217|NCT03227484|Empagliflozin|empagliflozin|mesh-list
55896218|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56054474|NCT03781479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054475|NCT03781479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054476|NCT01223001|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56054477|NCT01223001|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56054478|NCT01223001|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56054479|NCT01223001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054480|NCT01223001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054481|NCT01223001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054482|NCT01223001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054483|NCT01223001|Analgesics|analgesics|mesh-ancestor
56054484|NCT01223001|Sensory System Agents|sensory system agents|mesh-ancestor
56054485|NCT01223001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054486|NCT01223001|Antidepressive Agents|antidepressive agents|mesh-ancestor
56054487|NCT01223001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56054489|NCT02608905|Dapagliflozin|dapagliflozin|mesh-list
56054490|NCT02608905|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56054491|NCT02608905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054492|NCT02608905|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56054493|NCT02608905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054494|NCT01213329|Alemtuzumab|alemtuzumab|mesh-list
56054495|NCT01213329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56054496|NCT01213329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054498|NCT03964532|Talazoparib|talazoparib|mesh-list
56054499|NCT03964532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56054500|NCT03964532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054501|NCT03964532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56054502|NCT03964532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054514|NCT02515851|Anesthetics|anesthetics|mesh-ancestor
56054515|NCT02515851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054516|NCT02515851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054517|NCT02515851|Sensory System Agents|sensory system agents|mesh-ancestor
56054518|NCT02515851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054519|NCT02492295|Propofol|propofol|mesh-list
56054520|NCT02492295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56054521|NCT02492295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054522|NCT02492295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054523|NCT02492295|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56054524|NCT02492295|Anesthetics, General|anesthetics, general|mesh-ancestor
56054525|NCT02492295|Anesthetics|anesthetics|mesh-ancestor
56054526|NCT02468583|Triamcinolone|triamcinolone|mesh-list
56054527|NCT02468583|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56054528|NCT02468583|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56054529|NCT02468583|FX006|fx006|mesh-list
56054530|NCT02468583|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56054531|NCT02468583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56054532|NCT02468583|Glucocorticoids|glucocorticoids|mesh-ancestor
56054533|NCT02468583|Hormones|hormones|mesh-ancestor
56054534|NCT02468583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054535|NCT02468583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054536|NCT02468583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054537|NCT02468583|Immunologic Factors|immunologic factors|mesh-ancestor
56054538|NCT02468583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896219|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754377|NCT03308201|Letrozole|letrozole|mesh-list
55896220|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55896221|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896222|NCT04555577|Temozolomide|temozolomide|mesh-list
55896224|NCT04555577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55896225|NCT04555577|Alkylating Agents|alkylating agents|mesh-ancestor
55896226|NCT04555577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896227|NCT04555577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054539|NCT02468583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054540|NCT03763929|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
56054541|NCT03763929|Antioxidants|antioxidants|mesh-ancestor
56054542|NCT03763929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054543|NCT03763929|Protective Agents|protective agents|mesh-ancestor
56054544|NCT03763929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054545|NCT03763929|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56054546|NCT03763929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896228|NCT04555577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55896229|NCT04555577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896230|NCT02038894|Propofol|propofol|mesh-list
55896231|NCT02038894|Sevoflurane|sevoflurane|mesh-list
55896232|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55896233|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896234|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896235|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55896236|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
55896237|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
55896238|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55896239|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55896240|NCT01375374|Lacosamide|lacosamide|mesh-list
55896241|NCT01375374|Levetiracetam|levetiracetam|mesh-list
55896242|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
55896243|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
55896244|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55896245|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55896246|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896247|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896248|NCT04348786|Amoxicillin|amoxicillin|mesh-list
55896249|NCT04348786|Doxycycline|doxycycline|mesh-list
55896250|NCT04348786|Levofloxacin|levofloxacin|mesh-list
55896251|NCT04348786|Ofloxacin|ofloxacin|mesh-list
55896252|NCT04348786|Esomeprazole|esomeprazole|mesh-list
55896253|NCT04348786|Bismuth|bismuth|mesh-list
55896254|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
55896255|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55896257|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55896258|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55896259|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55896260|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896261|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896262|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
55896263|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55896264|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55896265|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55896266|NCT04348786|Renal Agents|renal agents|mesh-ancestor
55896267|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55896268|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55896269|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896270|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55896271|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55896272|NCT04348786|Antacids|antacids|mesh-ancestor
55896273|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
55896274|NCT02369068|Triamcinolone|triamcinolone|mesh-list
55896275|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55896276|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55896277|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55754391|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
55896278|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55896280|NCT02369068|Hormones|hormones|mesh-ancestor
55896281|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55896282|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896283|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896284|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
56054548|NCT01118013|Methotrexate|methotrexate|mesh-list
56054549|NCT01118013|Fludarabine phosphate|fludarabine phosphate|mesh-list
56054550|NCT01118013|Fludarabine|fludarabine|mesh-list
56054551|NCT01118013|Busulfan|busulfan|mesh-list
56054552|NCT01118013|Tacrolimus|tacrolimus|mesh-list
56054553|NCT01118013|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56054554|NCT01118013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56054555|NCT01118013|Abortifacient Agents|abortifacient agents|mesh-ancestor
55896285|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896286|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55896287|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896288|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55896289|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896290|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
55896291|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896292|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
55896293|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55896294|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896295|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55896296|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896297|NCT02371252|Alendronate|alendronate|mesh-list
55896298|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55896299|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896300|NCT03221946|Diclofenac|diclofenac|mesh-list
55896301|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55896302|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55896303|NCT03221946|Analgesics|analgesics|mesh-ancestor
55896304|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
55896305|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896306|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896307|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55896308|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55896309|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55896310|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896311|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896312|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
55896313|NCT03229746|Vincristine|vincristine|mesh-list
55896314|NCT03229746|Azathioprine|azathioprine|mesh-list
55896315|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55896316|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896317|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
55896318|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
55896319|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
55896320|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896321|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
55896322|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55896323|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55896324|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896325|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896326|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55896327|NCT03229746|Antimetabolites|antimetabolites|mesh-ancestor
55896328|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55896330|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
55896331|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896332|NCT02040298|Clemastine|clemastine|mesh-list
55896333|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
55896334|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
55896335|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55896336|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
55896337|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
55754405|NCT02722967|Aripiprazole|aripiprazole|mesh-list
55896338|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896339|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896340|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896341|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55896342|NCT03229668|Pregabalin|pregabalin|mesh-list
55896343|NCT03229668|Analgesics|analgesics|mesh-ancestor
56054556|NCT01118013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56054557|NCT01118013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054558|NCT01118013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56054559|NCT01118013|Antimetabolites|antimetabolites|mesh-ancestor
56054560|NCT01118013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054561|NCT01118013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054562|NCT01118013|Dermatologic Agents|dermatologic agents|mesh-ancestor
56054563|NCT01118013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054564|NCT01118013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56054565|NCT01118013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054566|NCT01118013|Immunologic Factors|immunologic factors|mesh-ancestor
56054567|NCT01118013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55896344|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
55896345|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896346|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896347|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
55896348|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55896349|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896350|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896351|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55896353|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55896354|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896355|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55896356|NCT03230058|Voriconazole|voriconazole|mesh-list
55896357|NCT03230058|Natamycin|natamycin|mesh-list
55896358|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55896359|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55896360|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
55896361|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896362|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55896363|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55896364|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896365|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896366|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55896367|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
55896368|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55896369|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896370|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55896371|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55896372|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55896373|NCT03230136|Anesthetics|anesthetics|mesh-list
55896374|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896375|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896376|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
55896377|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896378|NCT00081939|Thalidomide|thalidomide|mesh-list
55896379|NCT00081939|Bortezomib|bortezomib|mesh-list
55896380|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896381|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896382|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
55896383|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896384|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
55896385|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55896386|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896387|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55896388|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55896389|NCT00081939|Growth Substances|growth substances|mesh-ancestor
55896390|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
55896391|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
56054569|NCT01118013|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56054570|NCT01118013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56054571|NCT01118013|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56054572|NCT01118013|Antitubercular Agents|antitubercular agents|mesh-ancestor
56054573|NCT01118013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56054574|NCT01118013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054575|NCT01118013|Alkylating Agents|alkylating agents|mesh-ancestor
56054576|NCT01118013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56054577|NCT01118013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56054579|NCT00378027|Fondaparinux|fondaparinux|mesh-list
55896392|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
55896393|NCT02373124|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55896394|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896395|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754418|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
55896396|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896397|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
55896398|NCT03221634|Daratumumab|daratumumab|mesh-list
55896399|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896405|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896406|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55896407|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55896408|NCT02374060|Dexamethasone|dexamethasone|mesh-list
55896409|NCT02374060|Triamcinolone|triamcinolone|mesh-list
55896410|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55896411|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55896412|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55896413|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55896414|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
55896415|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
55896416|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896417|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896418|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55896419|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
55896420|NCT02374060|Hormones|hormones|mesh-ancestor
55896421|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55896422|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55896423|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896424|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896425|NCT02374060|Immunologic Factors|immunologic factors|mesh-ancestor
55896426|NCT02374060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896427|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896428|NCT03221166|Thalidomide|thalidomide|mesh-list
55896429|NCT03221166|Infliximab|infliximab|mesh-list
55896430|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
55896431|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55896432|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55896433|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896434|NCT03221166|Immunologic Factors|immunologic factors|mesh-ancestor
55896435|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896436|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
55896437|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55896438|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896439|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55896443|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896444|NCT03220932|Bevacizumab|bevacizumab|mesh-list
56054580|NCT00378027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56054581|NCT00378027|Antithrombins|antithrombins|mesh-ancestor
56054582|NCT00378027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56054583|NCT00378027|Protease Inhibitors|protease inhibitors|mesh-ancestor
56054584|NCT00378027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054585|NCT00378027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054586|NCT00378027|Anticoagulants|anticoagulants|mesh-ancestor
56054587|NCT00378027|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56054588|NCT00378027|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56054589|NCT00552032|Mometasone Furoate|mometasone furoate|mesh-list
56054590|NCT00552032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56054591|NCT00552032|Dermatologic Agents|dermatologic agents|mesh-ancestor
56054592|NCT00552032|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56054593|NCT02429583|Vaccines|vaccines|mesh-list
56054594|NCT02429583|Immunologic Factors|immunologic factors|mesh-ancestor
55896445|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896446|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896447|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55896448|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55896449|NCT03220932|Growth Substances|growth substances|mesh-ancestor
55896450|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896451|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
55896452|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
55896453|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55896454|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896455|NCT04484688|Bisoprolol|bisoprolol|mesh-list
55896456|NCT04484688|Perindopril|perindopril|mesh-list
55896457|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55896458|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
55896459|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
55896460|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896461|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896462|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55896463|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55896464|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55896465|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
55896466|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896467|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896468|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55896469|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
55896470|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896473|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55896474|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896475|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896476|NCT00082329|Plerixafor|plerixafor|mesh-list
55896477|NCT00082329|Lenograstim|lenograstim|mesh-list
55896478|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55896480|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896481|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55896482|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55896483|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
55896484|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896485|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
55896486|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56054595|NCT02429583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054596|NCT02413047|Methotrexate|methotrexate|mesh-list
56054597|NCT02413047|Mercaptopurine|mercaptopurine|mesh-list
56054598|NCT02413047|Azathioprine|azathioprine|mesh-list
56054599|NCT02413047|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56054600|NCT02413047|Abortifacient Agents|abortifacient agents|mesh-ancestor
56054601|NCT02413047|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56054602|NCT02413047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054603|NCT02413047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56054604|NCT02413047|Antimetabolites|antimetabolites|mesh-ancestor
56054605|NCT02413047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054606|NCT02413047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054607|NCT02413047|Dermatologic Agents|dermatologic agents|mesh-ancestor
56054608|NCT02413047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054609|NCT02413047|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56054610|NCT02413047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054611|NCT02413047|Immunologic Factors|immunologic factors|mesh-ancestor
56054612|NCT02413047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56054613|NCT02413047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56054614|NCT02277548|Pregabalin|pregabalin|mesh-list
56054615|NCT02277548|Analgesics|analgesics|mesh-ancestor
56054616|NCT02277548|Sensory System Agents|sensory system agents|mesh-ancestor
56054617|NCT02277548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054618|NCT02277548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054619|NCT02277548|Anticonvulsants|anticonvulsants|mesh-ancestor
56054620|NCT02277548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55896487|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896488|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55896489|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
55896491|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896492|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55896493|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
55896494|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55896495|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55896496|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55896497|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896498|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896499|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
55896500|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896501|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896502|NCT03220542|Amoxicillin|amoxicillin|mesh-list
55896503|NCT03220542|Clarithromycin|clarithromycin|mesh-list
55896504|NCT03220542|Sulforaphane|sulforaphane|mesh-list
55896505|NCT03220542|Esomeprazole|esomeprazole|mesh-list
55896506|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55896507|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896508|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55896509|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56054621|NCT02277548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054622|NCT02277548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054623|NCT02277548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56054624|NCT02277548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56054625|NCT02277548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56054626|NCT02277548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054627|NCT02277548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56054628|NCT02411643|Calcipotriene|calcipotriene|mesh-list
56054629|NCT02411643|Dermatologic Agents|dermatologic agents|mesh-ancestor
56054630|NCT03029390|Metformin|metformin|mesh-list
56054631|NCT03029390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56054632|NCT03029390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896510|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55896511|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896512|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896513|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55896514|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55896515|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55896516|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55896517|NCT03220542|Protective Agents|protective agents|mesh-ancestor
55896518|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896519|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896520|NCT03220152|Tenofovir|tenofovir|mesh-list
55896521|NCT03220152|Emtricitabine|emtricitabine|mesh-list
55896522|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
55896523|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896524|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55896525|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55896526|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896527|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896528|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55896529|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55896530|NCT03220464|Interferons|interferons|mesh-list
55896531|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
55896532|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896533|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
55896534|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896535|NCT03206658|Spironolactone|spironolactone|mesh-list
55896536|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55896537|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
55896538|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55896539|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896540|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55896542|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
55896543|NCT00170157|Ipilimumab|ipilimumab|mesh-list
55896544|NCT00170157|Leuprolide|leuprolide|mesh-list
55896545|NCT00170157|Goserelin|goserelin|mesh-list
55896548|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896549|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896550|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55896551|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896552|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55896553|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
55896554|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55896555|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896556|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55896557|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
55896558|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
55896559|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054634|NCT01085643|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56054635|NCT01085643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56054636|NCT01085643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896560|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
55896561|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
55896562|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896563|NCT00170625|Topotecan|topotecan|mesh-list
55896564|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55896565|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55896566|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896567|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896569|NCT02043652|Chloroquine|chloroquine|mesh-list
55896570|NCT02043652|Primaquine|primaquine|mesh-list
55896571|NCT02043652|Amebicides|amebicides|mesh-ancestor
55896572|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55896573|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55896574|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896575|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
55896576|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55896577|NCT01898169|Nicotine|nicotine|mesh-list
55896578|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55896579|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
55896580|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896581|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896582|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55896583|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55896584|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
55896585|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896586|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896587|NCT03227016|Topotecan|topotecan|mesh-list
55896588|NCT03227016|Veliparib|veliparib|mesh-list
55896589|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55896590|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55896591|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55896592|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896593|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896594|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896595|NCT04748991|Amiodarone|amiodarone|mesh-list
55896596|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55896597|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
55896598|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55896599|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896600|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896601|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55896602|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55896603|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55896604|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896605|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55896606|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55896607|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55896608|NCT00176865|Cyclosporine|cyclosporine|mesh-list
55896609|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
55896610|NCT00176865|Fludarabine|fludarabine|mesh-list
55896612|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
55754482|NCT03311321|Vitamin K|vitamin k|mesh-list
55896613|NCT00176865|Cyclosporins|cyclosporins|mesh-list
55896614|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55896615|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
55896616|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55896617|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
55896618|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55896619|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896621|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896622|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
55896623|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896624|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896625|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
55896626|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896627|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
55896628|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56054637|NCT03028766|Adavosertib|adavosertib|mesh-list
56054638|NCT03028766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054639|NCT03028766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054640|NCT03020030|Leucovorin|leucovorin|mesh-list
56054641|NCT03020030|Cytarabine|cytarabine|mesh-list
56054642|NCT03020030|Dexamethasone|dexamethasone|mesh-list
56054643|NCT03020030|Hydrocortisone|hydrocortisone|mesh-list
56054644|NCT03020030|Cyclophosphamide|cyclophosphamide|mesh-list
56054645|NCT03020030|Doxorubicin|doxorubicin|mesh-list
56054646|NCT03020030|Methotrexate|methotrexate|mesh-list
56054647|NCT03020030|Etoposide|etoposide|mesh-list
56054648|NCT03020030|Vincristine|vincristine|mesh-list
55896629|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55896630|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55896631|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55896632|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
55896633|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55896634|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55896635|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
55896636|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55896637|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896639|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
55896640|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
55896641|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896642|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55896643|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55896644|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
55896645|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896646|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896647|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55896648|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55896649|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55896650|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55896651|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896652|NCT02450994|Dexamethasone|dexamethasone|mesh-list
55896653|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55896654|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
55896655|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
55896656|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896658|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55896659|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
55896661|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55896662|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55896663|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896664|NCT00177255|Docetaxel|docetaxel|mesh-list
55896665|NCT00177255|Capecitabine|capecitabine|mesh-list
55896666|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896667|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
55896668|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
55896669|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
55896670|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896671|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55896672|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
55896673|NCT02401048|Durvalumab|durvalumab|mesh-list
55896674|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896675|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896676|NCT02046382|Acetaminophen|acetaminophen|mesh-list
55896677|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55896678|NCT02046382|Analgesics|analgesics|mesh-ancestor
55896679|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
55896680|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896681|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896682|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
55896683|NCT03205176|Olaparib|olaparib|mesh-list
55896684|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56054649|NCT03020030|Asparaginase|asparaginase|mesh-list
56054650|NCT03020030|Dasatinib|dasatinib|mesh-list
56054651|NCT03020030|Mercaptopurine|mercaptopurine|mesh-list
56054652|NCT03020030|Pegaspargase|pegaspargase|mesh-list
56054653|NCT03020030|Dexrazoxane|dexrazoxane|mesh-list
56054654|NCT03020030|Razoxane|razoxane|mesh-list
56054655|NCT03020030|Levoleucovorin|levoleucovorin|mesh-list
56054656|NCT03020030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054657|NCT03020030|Immunologic Factors|immunologic factors|mesh-ancestor
56054658|NCT03020030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054659|NCT03020030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56054660|NCT03020030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56054661|NCT03020030|Alkylating Agents|alkylating agents|mesh-ancestor
56054662|NCT03020030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054663|NCT03020030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054664|NCT03020030|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56054665|NCT03020030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56054666|NCT03020030|Antiemetics|antiemetics|mesh-ancestor
56054667|NCT03020030|Autonomic Agents|autonomic agents|mesh-ancestor
56054668|NCT03020030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054669|NCT03020030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56054670|NCT03020030|Glucocorticoids|glucocorticoids|mesh-ancestor
56054671|NCT03020030|Hormones|hormones|mesh-ancestor
56054672|NCT03020030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054673|NCT03020030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56054674|NCT03020030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56054675|NCT03020030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56054676|NCT03020030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56054677|NCT03020030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896685|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896686|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896687|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896688|NCT02046772|Morphine|morphine|mesh-list
55896689|NCT02046772|Bupivacaine|bupivacaine|mesh-list
55896690|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
55896691|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
55896692|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896693|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896695|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896696|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55896697|NCT02046772|Narcotics|narcotics|mesh-ancestor
55896698|NCT02046772|Analgesics|analgesics|mesh-ancestor
55896699|NCT00178503|Methylphenidate|methylphenidate|mesh-list
55896700|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56054678|NCT03020030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56054680|NCT03020030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56054681|NCT03020030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56054682|NCT03020030|Antimetabolites|antimetabolites|mesh-ancestor
56054683|NCT03020030|Dermatologic Agents|dermatologic agents|mesh-ancestor
56054684|NCT03020030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56054685|NCT03020030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56054686|NCT03020030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56054687|NCT03020030|Antiviral Agents|antiviral agents|mesh-ancestor
56054688|NCT03020030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054690|NCT03020030|Protective Agents|protective agents|mesh-ancestor
56054691|NCT03020030|Vitamin B Complex|vitamin b complex|mesh-ancestor
55781894|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054692|NCT03020030|Vitamins|vitamins|mesh-ancestor
56054693|NCT03020030|Micronutrients|micronutrients|mesh-ancestor
56054694|NCT03020030|Tubulin Modulators|tubulin modulators|mesh-ancestor
56054695|NCT03020030|Antimitotic Agents|antimitotic agents|mesh-ancestor
56054696|NCT03020030|Mitosis Modulators|mitosis modulators|mesh-ancestor
56054697|NCT03020030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56054698|NCT03020030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56054699|NCT01071993|Atorvastatin|atorvastatin|mesh-list
56054700|NCT01071993|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56054701|NCT01071993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56054702|NCT01071993|Antimetabolites|antimetabolites|mesh-ancestor
56054703|NCT01071993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054704|NCT01071993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55896701|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896702|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55896703|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55896704|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896705|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896706|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
55896707|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896709|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
55896710|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
55896711|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55896712|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
55896713|NCT02376010|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55896714|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
55896715|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896716|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896717|NCT00085293|Decitabine|decitabine|mesh-list
55896718|NCT00085293|Azacitidine|azacitidine|mesh-list
55896719|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55896720|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55896721|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
56054705|NCT01071993|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56054706|NCT01071993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054707|NCT02379585|Paclitaxel|paclitaxel|mesh-list
56054708|NCT02379585|Docetaxel|docetaxel|mesh-list
56054709|NCT02379585|Cyclophosphamide|cyclophosphamide|mesh-list
56054710|NCT02379585|Doxorubicin|doxorubicin|mesh-list
56054711|NCT02379585|Trastuzumab|trastuzumab|mesh-list
56054712|NCT02379585|Pertuzumab|pertuzumab|mesh-list
56054713|NCT02379585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56054714|NCT02379585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054715|NCT02379585|Tubulin Modulators|tubulin modulators|mesh-ancestor
56054716|NCT02379585|Antimitotic Agents|antimitotic agents|mesh-ancestor
56054717|NCT02379585|Mitosis Modulators|mitosis modulators|mesh-ancestor
56054718|NCT02379585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054719|NCT02379585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054720|NCT02379585|Immunologic Factors|immunologic factors|mesh-ancestor
56054721|NCT02379585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054722|NCT02379585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56054723|NCT02379585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56054724|NCT02379585|Alkylating Agents|alkylating agents|mesh-ancestor
56054725|NCT02379585|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56054726|NCT02379585|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56054727|NCT02379585|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56054758|NCT01048125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054759|NCT01048125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054760|NCT01048125|Protective Agents|protective agents|mesh-ancestor
56054761|NCT01048125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56054762|NCT01048125|Vasodilator Agents|vasodilator agents|mesh-ancestor
56054763|NCT01048125|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56054764|NCT01901588|Dexmedetomidine|dexmedetomidine|mesh-list
56054765|NCT01901588|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56054766|NCT01901588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054767|NCT01901588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054768|NCT01901588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56054769|NCT01901588|Analgesics|analgesics|mesh-ancestor
56054770|NCT01901588|Sensory System Agents|sensory system agents|mesh-ancestor
55896722|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896723|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896724|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896725|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55896726|NCT02402062|Sunitinib|sunitinib|mesh-list
55896727|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896728|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55896729|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55896730|NCT02402062|Growth Substances|growth substances|mesh-ancestor
55896731|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896732|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
55896733|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55896734|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896735|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896736|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55896737|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55896738|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
55896739|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896740|NCT02450838|Antacids|antacids|mesh-ancestor
55896741|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896742|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55896743|NCT03214302|Tenofovir|tenofovir|mesh-list
55896744|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
55896745|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896746|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55896747|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55896748|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896749|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896750|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55896751|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55896752|NCT00085839|Paclitaxel|paclitaxel|mesh-list
55896753|NCT00085839|Carboplatin|carboplatin|mesh-list
55896754|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55896755|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55896756|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896757|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
55896758|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
55896759|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
55896760|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896761|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55896762|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896763|NCT03204474|Lacosamide|lacosamide|mesh-list
55896764|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
55896765|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55896766|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55896768|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054771|NCT01901588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054772|NCT01901588|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56054773|NCT01901588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56054774|NCT01901588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56054775|NCT01901588|Adrenergic Agents|adrenergic agents|mesh-ancestor
56054776|NCT01901588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054777|NCT01901588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054778|NCT03673124|Letrozole|letrozole|mesh-list
56054779|NCT03673124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054780|NCT03673124|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56054781|NCT03673124|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56054782|NCT03673124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054783|NCT03673124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054785|NCT03673124|Hormone Antagonists|hormone antagonists|mesh-ancestor
56054786|NCT03673124|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054787|NCT03673124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054788|NCT03539744|Dexamethasone|dexamethasone|mesh-list
55896770|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55896771|NCT03204318|Norethindrone|norethindrone|mesh-list
55896772|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
55896773|NCT03204318|Estradiol|estradiol|mesh-list
55896774|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55896775|NCT03204318|Relugolix|relugolix|mesh-list
55896778|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55896779|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896780|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55896781|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
55896782|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55896783|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55896784|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55896785|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55896786|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55896787|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
55896788|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
55896789|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
55896790|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55896791|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896792|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896793|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55896794|NCT03204006|Analgesics|analgesics|mesh-ancestor
55896795|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
55896796|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896797|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55896798|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55896799|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55896800|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
55896801|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896802|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896803|NCT03226080|Rocuronium|rocuronium|mesh-list
55896804|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55896805|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55896806|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55896807|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054790|NCT03539744|Pomalidomide|pomalidomide|mesh-list
56054791|NCT03539744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56054792|NCT03539744|Antiemetics|antiemetics|mesh-ancestor
56054793|NCT03539744|Autonomic Agents|autonomic agents|mesh-ancestor
56054794|NCT03539744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054795|NCT03539744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054796|NCT03539744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56054797|NCT03539744|Glucocorticoids|glucocorticoids|mesh-ancestor
55896809|NCT03225924|Prednisone|prednisone|mesh-list
55896810|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
55896811|NCT03225924|Rituximab|rituximab|mesh-list
55896812|NCT03225924|Doxorubicin|doxorubicin|mesh-list
55896813|NCT03225924|Vincristine|vincristine|mesh-list
55896814|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896815|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
55896816|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896817|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55896818|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55896819|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
55896820|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896821|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896822|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55896823|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896824|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55896825|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55896826|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55896827|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896828|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55896829|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
55896830|NCT03225924|Hormones|hormones|mesh-ancestor
55896831|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55896832|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55896833|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55896834|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
55896835|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
55896836|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
55896837|NCT03119532|Metronidazole|metronidazole|mesh-list
55896838|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054804|NCT03539744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56054805|NCT03539744|Growth Substances|growth substances|mesh-ancestor
56054806|NCT03539744|Growth Inhibitors|growth inhibitors|mesh-ancestor
56054807|NCT01025271|Daptomycin|daptomycin|mesh-list
56054808|NCT01025271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56054809|NCT01025271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054812|NCT01902758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56054813|NCT01902758|Autonomic Agents|autonomic agents|mesh-ancestor
56054814|NCT01902758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054815|NCT01902758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054816|NCT01902758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56054817|NCT01902758|Respiratory System Agents|respiratory system agents|mesh-ancestor
56054818|NCT01902758|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55896856|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
55896857|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896858|NCT02051452|Methylphenidate|methylphenidate|mesh-list
55896859|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55896860|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896861|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55896862|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55896863|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896864|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896866|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896867|NCT00180687|Bupivacaine|bupivacaine|mesh-list
55896868|NCT00180687|Coal Tar|coal tar|mesh-list
55896869|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
55896870|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
55896871|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896872|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896873|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
55896874|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896875|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
55896876|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
55896877|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55896878|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
55896879|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896880|NCT02384044|Listerine|listerine|mesh-list
55896881|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
55896882|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
55896883|NCT02384044|Protective Agents|protective agents|mesh-ancestor
55896884|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896885|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55896886|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896887|NCT02384200|Vancomycin|vancomycin|mesh-list
55896888|NCT02384200|Gentamicins|gentamicins|mesh-list
55896889|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
55896890|NCT02384200|Ampicillin|ampicillin|mesh-list
55896891|NCT02384200|Nitrofurantoin|nitrofurantoin|mesh-list
55896892|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55896893|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896894|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55896895|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896896|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896897|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55896902|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896904|NCT02051686|Coagulants|coagulants|mesh-ancestor
56054820|NCT01902758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054821|NCT01902758|Vasodilator Agents|vasodilator agents|mesh-ancestor
55896905|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
55896906|NCT00182793|Melphalan|melphalan|mesh-list
55896907|NCT00182793|Thiotepa|thiotepa|mesh-list
55896908|NCT00182793|Carboplatin|carboplatin|mesh-list
55896909|NCT00182793|Trastuzumab|trastuzumab|mesh-list
55896910|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896911|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
55896912|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896913|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55896914|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55896915|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
55896916|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896917|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896918|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55896919|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896920|NCT00183339|Fluoxetine|fluoxetine|mesh-list
55896921|NCT00183339|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55896922|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55896923|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896925|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896927|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896928|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55896929|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
55896930|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55896931|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55896932|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55896933|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896934|NCT00183729|Memantine|memantine|mesh-list
55896935|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55896936|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55896937|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
55896938|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896939|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896940|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896941|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55896942|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55896943|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
55896945|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
55896946|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896947|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896948|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
55896949|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896950|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55896951|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
55896952|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55896953|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896954|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896955|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55896956|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
55896957|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55896958|NCT01742897|Fentanyl|fentanyl|mesh-list
55896959|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55896960|NCT01742897|Narcotics|narcotics|mesh-ancestor
55896961|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896962|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896963|NCT01742897|Analgesics|analgesics|mesh-ancestor
55896964|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
55896965|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55896966|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55896967|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55896977|NCT01741259|Analgesics|analgesics|mesh-ancestor
55896978|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
55896979|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054822|NCT01902758|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56054823|NCT01902758|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56054824|NCT01902758|Purinergic Agents|purinergic agents|mesh-ancestor
56054825|NCT01902758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054826|NCT01902758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56054828|NCT01020903|Antiemetics|antiemetics|mesh-ancestor
56054829|NCT01020903|Autonomic Agents|autonomic agents|mesh-ancestor
56054830|NCT01020903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054831|NCT01020903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054832|NCT01020903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56054833|NCT01020903|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56054834|NCT01020903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054835|NCT01020903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054836|NCT02318901|Pembrolizumab|pembrolizumab|mesh-list
56054837|NCT02318901|Trastuzumab|trastuzumab|mesh-list
56054838|NCT02318901|Cetuximab|cetuximab|mesh-list
56054839|NCT02318901|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56054840|NCT02318901|Maytansine|maytansine|mesh-list
56054842|NCT02318901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054843|NCT02318901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56054844|NCT02318901|Tubulin Modulators|tubulin modulators|mesh-ancestor
56054845|NCT02318901|Antimitotic Agents|antimitotic agents|mesh-ancestor
56054846|NCT02318901|Mitosis Modulators|mitosis modulators|mesh-ancestor
55896980|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55896981|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55896982|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
55896983|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55896984|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
55896985|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55896986|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896987|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55896988|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55896989|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896993|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55896994|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55896995|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896996|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896997|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55896998|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896999|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
55897000|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55897001|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56054847|NCT02318901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054848|NCT01904864|Iron|iron|mesh-list
56054849|NCT01904864|Micronutrients|micronutrients|mesh-ancestor
56054850|NCT01904864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054851|NCT01904864|Trace Elements|trace elements|mesh-ancestor
56054852|NCT01016847|Montelukast|montelukast|mesh-list
56054853|NCT01016847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56054854|NCT01016847|Respiratory System Agents|respiratory system agents|mesh-ancestor
56054855|NCT01016847|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56054856|NCT01016847|Hormone Antagonists|hormone antagonists|mesh-ancestor
56054857|NCT01016847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054858|NCT01016847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054859|NCT01016847|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56054860|NCT01016847|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56054861|NCT01016847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054862|NCT00989937|Oxytocin|oxytocin|mesh-list
56054863|NCT00989937|Oxytocics|oxytocics|mesh-ancestor
56054864|NCT00989937|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56054865|NCT00989937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897002|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55897005|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55897006|NCT02387710|Tiagabine|tiagabine|mesh-list
55897007|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
55897008|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
55897009|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55897010|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55897011|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897012|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
55897013|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897014|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897015|NCT01740791|Velpatasvir|velpatasvir|mesh-list
55897016|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
55897017|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897018|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
55897019|NCT01740401|Ipilimumab|ipilimumab|mesh-list
55897020|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55897021|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
55897022|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897023|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897024|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55897025|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
55897026|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897027|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897029|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897030|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55897031|NCT01740323|Curcumin|curcumin|mesh-list
55897032|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55897033|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55897034|NCT01740323|Analgesics|analgesics|mesh-ancestor
56054866|NCT00982995|Palonosetron|palonosetron|mesh-list
56054867|NCT00982995|Antiemetics|antiemetics|mesh-ancestor
56054868|NCT00982995|Autonomic Agents|autonomic agents|mesh-ancestor
56054869|NCT00982995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054870|NCT00982995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054871|NCT00982995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56054872|NCT00982995|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56054873|NCT00982995|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56054874|NCT00982995|Serotonin Agents|serotonin agents|mesh-ancestor
56054875|NCT00982995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897035|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
55897039|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897040|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897041|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897093|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55897042|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897043|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
55897044|NCT00090051|Rituximab|rituximab|mesh-list
55897045|NCT00090051|Fludarabine|fludarabine|mesh-list
55897046|NCT00090051|Fludarabine phosphate|fludarabine phosphate|mesh-list
55897047|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55897048|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
55897049|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897050|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897051|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55897052|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
55897053|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897054|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897055|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55897056|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897057|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55897058|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
55897062|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897063|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
55897064|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897065|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
55897066|NCT01739933|Propofol|propofol|mesh-list
55897067|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55897068|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55897069|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897070|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55897071|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
55897072|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
55897073|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55897074|NCT01739933|Analgesics|analgesics|mesh-ancestor
55897075|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
55897076|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897077|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55897078|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55897079|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55897080|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
55897081|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897082|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897083|NCT00094497|Doxorubicin|doxorubicin|mesh-list
55897084|NCT00094497|Etoposide|etoposide|mesh-list
55897085|NCT00094497|Mitotane|mitotane|mesh-list
55897086|NCT00094497|Streptozocin|streptozocin|mesh-list
55897087|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897088|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55897089|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55897090|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55897091|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054876|NCT00982995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054877|NCT00965055|Atorvastatin|atorvastatin|mesh-list
56054878|NCT00965055|Ezetimibe|ezetimibe|mesh-list
56054879|NCT00965055|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56054880|NCT00965055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56054881|NCT00965055|Antimetabolites|antimetabolites|mesh-ancestor
56054882|NCT00965055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054883|NCT00965055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56054884|NCT00965055|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56054885|NCT00965055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054886|NCT02266797|Dexamethasone|dexamethasone|mesh-list
56054887|NCT02266797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56054888|NCT02266797|Antiemetics|antiemetics|mesh-ancestor
56054889|NCT02266797|Autonomic Agents|autonomic agents|mesh-ancestor
56054890|NCT02266797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054891|NCT02266797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054892|NCT02266797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56054893|NCT02266797|Glucocorticoids|glucocorticoids|mesh-ancestor
56054894|NCT02266797|Hormones|hormones|mesh-ancestor
56054895|NCT02266797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054896|NCT02266797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56054897|NCT02266797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054898|NCT00378183|Risperidone|risperidone|mesh-list
56054899|NCT00378183|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56054900|NCT00378183|Serotonin Agents|serotonin agents|mesh-ancestor
56054901|NCT00378183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054902|NCT00378183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897152|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
55897094|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55897096|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55897097|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
55897098|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897099|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754541|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
55897100|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55897101|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
55897102|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55897104|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897105|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56054903|NCT00378183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054904|NCT00378183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56054905|NCT00378183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56054906|NCT00378183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054907|NCT00378183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56054908|NCT00378183|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56054909|NCT00378183|Dopamine Agents|dopamine agents|mesh-ancestor
56054910|NCT01906658|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56054911|NCT01906658|Hormones|hormones|mesh-ancestor
56054912|NCT01906658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054913|NCT01906658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054914|NCT01908062|Naltrexone|naltrexone|mesh-list
56054915|NCT01908062|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56054916|NCT01908062|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56054917|NCT01908062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054918|NCT01908062|Sensory System Agents|sensory system agents|mesh-ancestor
56054919|NCT01908062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054920|NCT00924807|Sorafenib|sorafenib|mesh-list
56054921|NCT00924807|Leuprolide|leuprolide|mesh-list
56054922|NCT00924807|Bicalutamide|bicalutamide|mesh-list
56054923|NCT00924807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054924|NCT00924807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56054925|NCT00924807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897106|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55897117|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897118|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897120|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897121|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55897122|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
55897123|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897124|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55897126|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
55897127|NCT02096679|Osimertinib|osimertinib|mesh-list
55897128|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897129|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55897130|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897131|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897132|NCT00099021|Pioglitazone|pioglitazone|mesh-list
55897133|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55897134|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897135|NCT00195039|Antibodies|antibodies|mesh-list
55897136|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55897137|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
55897138|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897139|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
55897140|NCT04645719|Analgesics|analgesics|mesh-ancestor
55897141|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
56054926|NCT00924807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054927|NCT00924807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56054928|NCT00924807|Fertility Agents|fertility agents|mesh-ancestor
56054929|NCT00924807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56054930|NCT00924807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897142|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897143|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897144|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
55897145|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55897146|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55897147|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
55897148|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55897149|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55897150|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897151|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55897153|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55897154|NCT02054338|Gemcitabine|gemcitabine|mesh-list
55897155|NCT02054338|Paclitaxel|paclitaxel|mesh-list
55897156|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55897157|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897158|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
55897159|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
55897160|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
55897161|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897162|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55897163|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
55897164|NCT02054338|Antiviral Agents|antiviral agents|mesh-ancestor
55897165|NCT02054338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897166|NCT02054338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897167|NCT02054338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55897168|NCT02054338|Immunologic Factors|immunologic factors|mesh-ancestor
55897169|NCT02054338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897170|NCT00198081|Celecoxib|celecoxib|mesh-list
55897171|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
55897172|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55897175|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
55897176|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897177|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897178|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897179|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897182|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897183|NCT00100659|Interferons|interferons|mesh-list
55897184|NCT00100659|Ribavirin|ribavirin|mesh-list
55897185|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897186|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
55897187|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897188|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
55897189|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897190|NCT00101361|Oxandrolone|oxandrolone|mesh-list
55897191|NCT00101361|Androgens|androgens|mesh-ancestor
55897192|NCT00101361|Hormones|hormones|mesh-ancestor
55897193|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897194|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897195|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
55897196|NCT03225690|Morphine|morphine|mesh-list
55897197|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55897198|NCT03225690|Narcotics|narcotics|mesh-ancestor
55897199|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55897200|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897201|NCT03225690|Analgesics|analgesics|mesh-ancestor
55897202|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
55897203|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897204|NCT02389738|Temozolomide|temozolomide|mesh-list
55897205|NCT02389738|Regadenoson|regadenoson|mesh-list
56054931|NCT00924807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56054932|NCT00924807|Androgen Antagonists|androgen antagonists|mesh-ancestor
56054933|NCT00924807|Hormone Antagonists|hormone antagonists|mesh-ancestor
56054934|NCT00924807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56054935|NCT00896025|Acetylcysteine|acetylcysteine|mesh-list
56054936|NCT00896025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56054937|NCT00896025|Antiviral Agents|antiviral agents|mesh-ancestor
56054938|NCT00896025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054939|NCT00896025|Expectorants|expectorants|mesh-ancestor
56054940|NCT00896025|Respiratory System Agents|respiratory system agents|mesh-ancestor
55897206|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55897207|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
55897208|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897209|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897210|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55897211|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55897212|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
55897213|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
55897214|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897215|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897216|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55897217|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55897218|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55897219|NCT00201123|Interferons|interferons|mesh-list
55897220|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
55897221|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897223|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897224|NCT01712009|Loratadine|loratadine|mesh-list
55897225|NCT01712009|Naproxen|naproxen|mesh-list
55897226|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55897227|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55897228|NCT01712009|Analgesics|analgesics|mesh-ancestor
55897229|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
55897230|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897231|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897232|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897233|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897234|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
55897236|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897237|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897238|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
55897239|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
55897240|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55897241|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55897242|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55897243|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
55897244|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
55897245|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897249|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
55897250|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55897251|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897252|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55897253|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55897254|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
55897255|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55897256|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55897257|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55897258|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55897259|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
56054941|NCT00896025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56054942|NCT00896025|Antioxidants|antioxidants|mesh-ancestor
56054943|NCT00896025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054944|NCT00896025|Protective Agents|protective agents|mesh-ancestor
56054945|NCT00896025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054946|NCT00896025|Antidotes|antidotes|mesh-ancestor
56054947|NCT02162979|Sildenafil Citrate|sildenafil citrate|mesh-list
56054948|NCT02162979|Vasodilator Agents|vasodilator agents|mesh-ancestor
56054949|NCT02162979|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56054950|NCT02162979|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56054951|NCT02162979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054952|NCT02162979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897260|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55897261|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55897262|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
55897263|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897264|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
55897265|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55897266|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55897267|NCT00201825|Docetaxel|docetaxel|mesh-list
55897268|NCT00201825|Capecitabine|capecitabine|mesh-list
55897269|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897270|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
55897271|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
55897272|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
55897273|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897274|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55897275|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
55897276|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
55897277|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55897278|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897279|NCT01711853|Dabigatran|dabigatran|mesh-list
55897280|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
55897281|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55897282|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
55897283|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897284|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897285|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
55897286|NCT00202449|Prazosin|prazosin|mesh-list
55897287|NCT00202449|Paroxetine|paroxetine|mesh-list
55897288|NCT00202449|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55897289|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55897290|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55897292|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897293|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
55897294|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897295|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55897296|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
55897297|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55897298|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55897299|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55897300|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897301|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55897302|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55897303|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55897304|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55897305|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
55897306|NCT03203304|Nivolumab|nivolumab|mesh-list
56054953|NCT02162979|Urological Agents|urological agents|mesh-ancestor
56054954|NCT03734601|Mycophenolic Acid|mycophenolic acid|mesh-list
56054956|NCT03734601|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56054957|NCT03734601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054958|NCT03734601|Immunologic Factors|immunologic factors|mesh-ancestor
56054959|NCT03734601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054960|NCT03734601|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56054961|NCT03734601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054962|NCT03734601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054963|NCT03734601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56054964|NCT03734601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054965|NCT03734601|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56054966|NCT03734601|Antitubercular Agents|antitubercular agents|mesh-ancestor
56054967|NCT03734601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56054968|NCT03734601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054969|NCT01908842|Buprenorphine|buprenorphine|mesh-list
56054970|NCT01908842|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56054971|NCT01908842|Narcotics|narcotics|mesh-ancestor
56054972|NCT01908842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56054973|NCT01908842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054974|NCT01908842|Analgesics|analgesics|mesh-ancestor
56054975|NCT01908842|Sensory System Agents|sensory system agents|mesh-ancestor
56054976|NCT01908842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56054977|NCT01908842|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56054978|NCT00833859|Gemcitabine|gemcitabine|mesh-list
56054979|NCT00833859|Capecitabine|capecitabine|mesh-list
56054980|NCT00833859|Docetaxel|docetaxel|mesh-list
55897307|NCT03203304|Ipilimumab|ipilimumab|mesh-list
55897308|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897309|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897310|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55897311|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897312|NCT03225456|Oxytocin|oxytocin|mesh-list
55897313|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
55897314|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55897315|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897316|NCT05545072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55897319|NCT00203229|Lamotrigine|lamotrigine|mesh-list
55897320|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
55897321|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55897322|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55897323|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897324|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55897325|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897326|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55897327|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56054981|NCT00833859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56054982|NCT00833859|Antimetabolites|antimetabolites|mesh-ancestor
56054984|NCT00833859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56054985|NCT00833859|Antiviral Agents|antiviral agents|mesh-ancestor
56054986|NCT00833859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56054987|NCT00833859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56054988|NCT00833859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56054989|NCT00833859|Immunologic Factors|immunologic factors|mesh-ancestor
56054990|NCT00833859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56054991|NCT00833859|Tubulin Modulators|tubulin modulators|mesh-ancestor
56054992|NCT00833859|Antimitotic Agents|antimitotic agents|mesh-ancestor
56054993|NCT00833859|Mitosis Modulators|mitosis modulators|mesh-ancestor
56054994|NCT00832299|Leucovorin|leucovorin|mesh-list
56054998|NCT00832299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56054999|NCT00832299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56055000|NCT00832299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897328|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55897329|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55897330|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55897331|NCT00203931|Pemetrexed|pemetrexed|mesh-list
55897332|NCT00203931|Cetuximab|cetuximab|mesh-list
55897333|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897334|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897335|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897336|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55897337|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55897338|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897339|NCT02412982|Enoxaparin|enoxaparin|mesh-list
55897340|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
55897341|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
55897342|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55897343|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55897344|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897345|NCT03203616|Trastuzumab|trastuzumab|mesh-list
55897346|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55897347|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897349|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
55897350|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
55897351|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
55897352|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897353|NCT02450214|Ketamine|ketamine|mesh-list
55897354|NCT02450214|Analgesics|analgesics|mesh-ancestor
55897355|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
55897356|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897357|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897358|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55897359|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55897360|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
55897361|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
56055002|NCT00832299|Immunologic Factors|immunologic factors|mesh-ancestor
56055003|NCT00832299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055004|NCT00832299|Antidotes|antidotes|mesh-ancestor
56055005|NCT00832299|Protective Agents|protective agents|mesh-ancestor
56055006|NCT00832299|Vitamin B Complex|vitamin b complex|mesh-ancestor
56055008|NCT00832299|Micronutrients|micronutrients|mesh-ancestor
56055010|NCT03723447|Epinephrine|epinephrine|mesh-list
56055011|NCT03723447|Bupivacaine|bupivacaine|mesh-list
56055012|NCT03723447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897362|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55897363|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55897364|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55897365|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897366|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897367|NCT02450682|Warfarin|warfarin|mesh-list
55897368|NCT02450682|Apixaban|apixaban|mesh-list
55897369|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
55897370|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55897371|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
55897372|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55897373|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
55897374|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897375|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897376|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
55897377|NCT03202836|Progesterone|progesterone|mesh-list
55897378|NCT03202836|Progestins|progestins|mesh-ancestor
55897379|NCT03202836|Hormones|hormones|mesh-ancestor
55897380|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897381|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897382|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55897383|NCT03203070|Dipyrone|dipyrone|mesh-list
55897384|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55897385|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55897386|NCT03203070|Analgesics|analgesics|mesh-ancestor
55897387|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
55897388|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897389|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897399|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55897400|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55897401|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55897402|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897403|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55897405|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55897406|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55897407|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55897408|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897409|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55897410|NCT03209622|Nicotine|nicotine|mesh-list
55897411|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55897412|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
55897413|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897414|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897415|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55897416|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55897417|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
55897418|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897419|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754595|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
55897420|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55897421|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55897423|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897424|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055013|NCT03723447|Antiemetics|antiemetics|mesh-ancestor
56055014|NCT03723447|Autonomic Agents|autonomic agents|mesh-ancestor
56055015|NCT03723447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055016|NCT03723447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055017|NCT03723447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56055018|NCT03723447|Glucocorticoids|glucocorticoids|mesh-ancestor
56055019|NCT03723447|Hormones|hormones|mesh-ancestor
56055020|NCT03723447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055021|NCT03723447|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56055022|NCT03723447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055023|NCT03723447|Anesthetics, Local|anesthetics, local|mesh-ancestor
56055024|NCT03723447|Anesthetics|anesthetics|mesh-ancestor
56055025|NCT03723447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055026|NCT03723447|Sensory System Agents|sensory system agents|mesh-ancestor
55897425|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55897426|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
55897427|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55897428|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55897429|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55897430|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
55897431|NCT00354874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897432|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897433|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
55897434|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55897435|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55897436|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897437|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
55897438|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
55897439|NCT03834688|Rituximab|rituximab|mesh-list
55897440|NCT03834688|Venetoclax|venetoclax|mesh-list
55897441|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55897442|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897443|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897444|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
55897445|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897446|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897447|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55897448|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
55897449|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897450|NCT01710527|Metformin|metformin|mesh-list
55897451|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55897452|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897453|NCT00354952|Azithromycin|azithromycin|mesh-list
55897454|NCT00354952|Clarithromycin|clarithromycin|mesh-list
55897455|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55897463|NCT04943848|Vaccines|vaccines|mesh-list
55897464|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
55897465|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897466|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55897467|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897468|NCT04943848|Trace Elements|trace elements|mesh-ancestor
55897469|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
55897471|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897472|NCT04938232|Nivolumab|nivolumab|mesh-list
55897474|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897475|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897476|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55897477|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897478|NCT03209232|Infliximab|infliximab|mesh-list
55897479|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
56055027|NCT03723447|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56055028|NCT03723447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56055029|NCT03723447|Adrenergic Agents|adrenergic agents|mesh-ancestor
56055030|NCT03723447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055031|NCT03723447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055032|NCT03723447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55897480|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55897481|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897482|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
55897483|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55897484|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897485|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
55897486|NCT01709903|Fluticasone|fluticasone|mesh-list
55897488|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
55897489|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55897490|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55897491|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897493|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
55897494|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897495|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897496|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55897497|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
55897498|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
55897499|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55897500|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55897501|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55897502|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55897503|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
55897504|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897505|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897506|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
55897507|NCT01709903|Hormones|hormones|mesh-ancestor
55897508|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897509|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
55897510|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55897511|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55897512|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55897513|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
55897514|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
55897515|NCT03202446|Chitosan|chitosan|mesh-list
55897516|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55897517|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
55897518|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897519|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897520|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55897521|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
55897522|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897523|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897524|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55897527|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
55897528|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55897529|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
55897530|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
55897531|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
55897532|NCT03202446|Coagulants|coagulants|mesh-ancestor
55897533|NCT05718934|Glycopyrrolate|glycopyrrolate|mesh-list
55897534|NCT05718934|Neostigmine|neostigmine|mesh-list
55897536|NCT05718934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897537|NCT05718934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897538|NCT05718934|Cholinergic Agents|cholinergic agents|mesh-ancestor
55897539|NCT05718934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897540|NCT05718934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897541|NCT05718934|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55897542|NCT05718934|Autonomic Agents|autonomic agents|mesh-ancestor
55897543|NCT05718934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897544|NCT05718934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55897545|NCT05718934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56055033|NCT03723447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56055034|NCT03723447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56055035|NCT03723447|Respiratory System Agents|respiratory system agents|mesh-ancestor
56055037|NCT03723447|Sympathomimetics|sympathomimetics|mesh-ancestor
56055038|NCT03723447|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56055039|NCT00836355|Minocycline|minocycline|mesh-list
56055040|NCT00836355|Enoxaparin|enoxaparin|mesh-list
56055041|NCT00836355|Anticoagulants|anticoagulants|mesh-ancestor
56055042|NCT00836355|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56055043|NCT00836355|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56055044|NCT00836355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055045|NCT00836355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56055046|NCT00836355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055047|NCT00816777|Irinotecan|irinotecan|mesh-list
56055048|NCT00816777|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56055049|NCT00816777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56055050|NCT00816777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055051|NCT00816777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055052|NCT00816777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897546|NCT05718934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55897547|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
55897548|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55897549|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
55897550|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897551|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897552|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55897553|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
55897554|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55897555|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
55897556|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897557|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897558|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55897559|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
55897560|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
55897561|NCT03208764|Protective Agents|protective agents|mesh-ancestor
55897562|NCT05718856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55897563|NCT05718856|Antibodies|antibodies|mesh-list
55897564|NCT05718856|Immunoglobulins|immunoglobulins|mesh-list
55897565|NCT05718856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55897566|NCT05718856|Immunologic Factors|immunologic factors|mesh-ancestor
55897567|NCT05718856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897568|NCT05718856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897569|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55897570|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
55897571|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897573|NCT05718466|Carboplatin|carboplatin|mesh-list
55897574|NCT05718466|Irinotecan|irinotecan|mesh-list
55897575|NCT05718466|Etoposide|etoposide|mesh-list
55897576|NCT05718466|Temozolomide|temozolomide|mesh-list
55897577|NCT05718466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897578|NCT05718466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897579|NCT05718466|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55897580|NCT05718466|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55897581|NCT05718466|Growth Substances|growth substances|mesh-ancestor
55897582|NCT05718466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055054|NCT00823095|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56055055|NCT00823095|Autonomic Agents|autonomic agents|mesh-ancestor
56055056|NCT00823095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055057|NCT00823095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055058|NCT00823095|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56055059|NCT00823095|Respiratory System Agents|respiratory system agents|mesh-ancestor
56055060|NCT00823095|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56055062|NCT00823095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055063|NCT00823095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055064|NCT00823095|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56055065|NCT00823095|Vasodilator Agents|vasodilator agents|mesh-ancestor
56055066|NCT00823095|Gasotransmitters|gasotransmitters|mesh-ancestor
56055067|NCT00823095|Protective Agents|protective agents|mesh-ancestor
55897583|NCT05718466|Growth Inhibitors|growth inhibitors|mesh-ancestor
55897584|NCT05718466|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55897585|NCT05718466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55897586|NCT05718466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897587|NCT05718466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897588|NCT05718466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55897589|NCT05718466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55897590|NCT05718466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55897594|NCT04835506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55897595|NCT04835506|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897596|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
55897597|NCT03208452|Analgesics|analgesics|mesh-ancestor
55897598|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
55897599|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897600|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897610|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55897611|NCT05718310|Nitroglycerin|nitroglycerin|mesh-list
55897612|NCT05718310|Vasodilator Agents|vasodilator agents|mesh-ancestor
55897613|NCT03224208|Vemurafenib|vemurafenib|mesh-list
55897614|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897615|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55897616|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897617|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897618|NCT05718232|Lenvatinib|lenvatinib|mesh-list
55897619|NCT05718232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897620|NCT05718232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55897621|NCT05718232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897622|NCT05718232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897623|NCT00355966|Misoprostol|misoprostol|mesh-list
55897624|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55897625|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
55897626|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55897627|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897628|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55897629|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55897630|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
55897631|NCT03208218|Lenalidomide|lenalidomide|mesh-list
55897632|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
55897633|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897634|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55897635|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56055069|NCT00803283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55782271|NCT03149653|SMOFlipid|smoflipid|mesh-list
56055070|NCT00803283|Narcotics|narcotics|mesh-ancestor
56055071|NCT00803283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055072|NCT00803283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055073|NCT00803283|Analgesics|analgesics|mesh-ancestor
56055074|NCT00803283|Sensory System Agents|sensory system agents|mesh-ancestor
56055077|NCT03701295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56055078|NCT03701295|Antimetabolites|antimetabolites|mesh-ancestor
56055079|NCT03701295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055080|NCT03701295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055081|NCT03701295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055082|NCT00799773|Rituximab|rituximab|mesh-list
56055083|NCT00799773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055084|NCT00799773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055085|NCT00799773|Immunologic Factors|immunologic factors|mesh-ancestor
56055086|NCT00799773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055087|NCT00799773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055088|NCT00765765|Hydroxychloroquine|hydroxychloroquine|mesh-list
56055089|NCT00765765|Antimalarials|antimalarials|mesh-ancestor
56055090|NCT00765765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55897636|NCT03208218|Growth Substances|growth substances|mesh-ancestor
55897637|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
55897638|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897639|NCT05372380|Atorvastatin|atorvastatin|mesh-list
55897640|NCT05372380|Ezetimibe|ezetimibe|mesh-list
55897641|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55897642|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55897643|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
55897644|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897645|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55897646|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55897647|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897648|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
55897649|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55897650|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897651|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897652|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55897653|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55897654|NCT02451774|Protective Agents|protective agents|mesh-ancestor
55897655|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897656|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
56055114|NCT01941615|Contraceptive Agents|contraceptive agents|mesh-ancestor
55897657|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55897658|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
55897659|NCT04789096|Pembrolizumab|pembrolizumab|mesh-list
55897660|NCT04789096|Trastuzumab|trastuzumab|mesh-list
55897661|NCT04789096|Capecitabine|capecitabine|mesh-list
55897662|NCT04789096|Tucatinib|tucatinib|mesh-list
55897663|NCT04789096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897664|NCT04789096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055091|NCT00765765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56055092|NCT00765765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055093|NCT00765765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055094|NCT00765765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055095|NCT00765765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055096|NCT00760461|Domperidone|domperidone|mesh-list
56055097|NCT00760461|Antiemetics|antiemetics|mesh-ancestor
56055098|NCT00760461|Autonomic Agents|autonomic agents|mesh-ancestor
56055099|NCT00760461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055100|NCT00760461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055101|NCT00760461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56055102|NCT00760461|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56055103|NCT00760461|Dopamine Agents|dopamine agents|mesh-ancestor
56055104|NCT00760461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055105|NCT00760461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897665|NCT04789096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55897667|NCT04789096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897668|NCT04789096|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55897669|NCT04789096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897670|NCT00355576|Minocycline|minocycline|mesh-list
55897671|NCT00355576|Celecoxib|celecoxib|mesh-list
55897672|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55897673|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55897674|NCT00355576|Analgesics|analgesics|mesh-ancestor
55897675|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
55897676|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897677|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897678|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897679|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897680|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55897681|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55897682|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897683|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897684|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55897685|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897686|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
55897687|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55897688|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55897689|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897690|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
55897691|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
55897692|NCT02448264|Berotralstat|berotralstat|mesh-list
55897693|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897694|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897695|NCT05333458|Atezolizumab|atezolizumab|mesh-list
55897696|NCT05333458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55897697|NCT05333458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897698|NCT05333458|Immunologic Factors|immunologic factors|mesh-ancestor
55897699|NCT05333458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897700|NCT02451852|Osimertinib|osimertinib|mesh-list
55897701|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897702|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55897703|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897704|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897705|NCT00421642|Adalimumab|adalimumab|mesh-list
55897707|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897708|NCT03200964|Anesthetics|anesthetics|mesh-list
55897709|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055106|NCT00750555|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56055107|NCT00750555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055108|NCT00750555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56055109|NCT00750555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055110|NCT00750555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055111|NCT01941615|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56055112|NCT01941615|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56055113|NCT01941615|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56055115|NCT01941615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56055116|NCT01941615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055117|NCT01941615|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56055118|NCT01941615|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56055120|NCT01941615|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56055121|NCT01941615|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56055122|NCT01941615|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56055124|NCT01941615|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56055125|NCT01901679|Celecoxib|celecoxib|mesh-list
56055126|NCT01901679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56055127|NCT01901679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56055128|NCT01901679|Analgesics|analgesics|mesh-ancestor
56055129|NCT01901679|Sensory System Agents|sensory system agents|mesh-ancestor
56055130|NCT01901679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055132|NCT01901679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56055149|NCT00684255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055150|NCT00684255|Immunologic Factors|immunologic factors|mesh-ancestor
56055151|NCT00684255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055152|NCT00684255|Alkylating Agents|alkylating agents|mesh-ancestor
56055153|NCT00684255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56055154|NCT00684255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56055155|NCT00684255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055156|NCT00668265|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56055157|NCT00668265|Antidepressive Agents|antidepressive agents|mesh-ancestor
56055158|NCT00668265|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56055159|NCT00668265|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56055160|NCT00668265|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56055161|NCT00668265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055162|NCT00668265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055163|NCT01856361|Ramipril|ramipril|mesh-list
56055164|NCT01856361|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56055165|NCT01856361|Protease Inhibitors|protease inhibitors|mesh-ancestor
56055166|NCT01856361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055167|NCT01856361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055168|NCT01856361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56055169|NCT00642603|Bevacizumab|bevacizumab|mesh-list
56055170|NCT00642603|Capecitabine|capecitabine|mesh-list
56055171|NCT00642603|Oxaliplatin|oxaliplatin|mesh-list
56055172|NCT00642603|Irinotecan|irinotecan|mesh-list
56055173|NCT00642603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055174|NCT00642603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055175|NCT00642603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56055176|NCT00642603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56055177|NCT00642603|Growth Substances|growth substances|mesh-ancestor
55897712|NCT04484844|Fluorides|fluorides|mesh-list
55897713|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
55897714|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
55897715|NCT04484844|Protective Agents|protective agents|mesh-ancestor
55897716|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897717|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55897718|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897719|NCT03119454|Betamethasone|betamethasone|mesh-list
55897720|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
55897721|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897722|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
55897723|NCT03119454|Hormones|hormones|mesh-ancestor
56055178|NCT00642603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055179|NCT00642603|Growth Inhibitors|growth inhibitors|mesh-ancestor
56055180|NCT00642603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56055181|NCT00642603|Antimetabolites|antimetabolites|mesh-ancestor
55897724|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897725|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897726|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55897727|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
55897728|NCT04485156|Rifampin|rifampin|mesh-list
55897729|NCT04485156|Isoniazid|isoniazid|mesh-list
55897730|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
55897731|NCT04485156|Ethambutol|ethambutol|mesh-list
55897732|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55897733|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
55897734|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55897735|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897736|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
55897737|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55897739|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897740|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55897743|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55897744|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55897745|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55897746|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55897747|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55897748|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
55897749|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55897750|NCT04637620|Sertraline|sertraline|mesh-list
55897751|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
55897752|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55897753|NCT04637620|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55897754|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55897755|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55897756|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897757|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897758|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
55897759|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897760|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
55897761|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55897762|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55897763|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897764|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
55897765|NCT00355108|Coagulants|coagulants|mesh-ancestor
55897766|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55897767|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897768|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897769|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55897770|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55897771|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897773|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55897774|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55897775|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55897776|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897777|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
55897778|NCT03200886|Hormones|hormones|mesh-ancestor
55897779|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897780|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897781|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55897782|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
55897783|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897784|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897785|NCT05717764|Capecitabine|capecitabine|mesh-list
55897786|NCT05717764|Mitoxantrone|mitoxantrone|mesh-list
55897787|NCT05717764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55897788|NCT05717764|Antimetabolites|antimetabolites|mesh-ancestor
56055182|NCT00642603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055184|NCT00642603|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56055185|NCT00642603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055186|NCT01841931|Buprenorphine|buprenorphine|mesh-list
56055187|NCT01841931|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56055188|NCT01841931|Naloxone|naloxone|mesh-list
56055189|NCT01841931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56055190|NCT01841931|Narcotics|narcotics|mesh-ancestor
56055191|NCT01841931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055192|NCT01841931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055193|NCT01841931|Analgesics|analgesics|mesh-ancestor
56055194|NCT01841931|Sensory System Agents|sensory system agents|mesh-ancestor
56055195|NCT01841931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055196|NCT01841931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56055197|NCT00633087|Deoxyglucose|deoxyglucose|mesh-list
56055198|NCT00633087|Antimetabolites|antimetabolites|mesh-ancestor
56055199|NCT00633087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055200|NCT00633087|Antiviral Agents|antiviral agents|mesh-ancestor
56055201|NCT00633087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055202|NCT04713891|Atezolizumab|atezolizumab|mesh-list
56055203|NCT04713891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56055204|NCT04713891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897789|NCT05717764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897790|NCT05717764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897791|NCT05717764|Analgesics|analgesics|mesh-ancestor
55897792|NCT05717764|Sensory System Agents|sensory system agents|mesh-ancestor
55897793|NCT05717764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897794|NCT05717764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897795|NCT05717764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55897796|NCT05717764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55897797|NCT05717764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897798|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55897799|NCT03118830|Cetrorelix|cetrorelix|mesh-list
55897800|NCT03118830|Hormones|hormones|mesh-list
55897801|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55897802|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897803|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897804|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
55897805|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55897806|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
55897807|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55897808|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55897809|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55897812|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
55897813|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
55897814|NCT03223506|Acetaminophen|acetaminophen|mesh-list
55897815|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55897817|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
56055205|NCT04713891|Immunologic Factors|immunologic factors|mesh-ancestor
56055206|NCT04713891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055207|NCT00379509|Lapatinib|lapatinib|mesh-list
56055208|NCT00379509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055209|NCT00379509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56055210|NCT00379509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055211|NCT00379509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055212|NCT04706247|Anesthetics|anesthetics|mesh-list
56055213|NCT04706247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055214|NCT04706247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055215|NCT00597909|Sodium Benzoate|sodium benzoate|mesh-list
55897818|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897819|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897820|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
55897821|NCT04535362|Nicotine|nicotine|mesh-list
55897822|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55897823|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
55897824|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897825|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897826|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55897827|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55897828|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
55897829|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897830|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897831|NCT03223896|Naloxone|naloxone|mesh-list
55897832|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55897833|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897834|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
55897835|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897836|NCT05716516|Estradiol|estradiol|mesh-list
55897837|NCT05716516|Estrogens|estrogens|mesh-ancestor
55897838|NCT05716516|Hormones|hormones|mesh-ancestor
55897839|NCT05716516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897840|NCT05716516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897841|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
55897842|NCT02447796|Propofol|propofol|mesh-list
55897843|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55897844|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55897845|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897846|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55897847|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
55897848|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
55897849|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55897850|NCT02447796|Analgesics|analgesics|mesh-ancestor
55897851|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
55897852|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897853|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55897854|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55897855|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55897856|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
55897857|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897858|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055324|NCT02101853|Vincristine|vincristine|mesh-list
55897860|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897861|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55897862|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897863|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897865|NCT03838042|Entinostat|entinostat|mesh-list
55897866|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897867|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897868|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55897869|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055216|NCT00597909|Phenylacetic acid|phenylacetic acid|mesh-list
56055217|NCT00597909|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56055219|NCT00597909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055220|NCT00597909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055221|NCT00597909|Antifungal Agents|antifungal agents|mesh-ancestor
56055222|NCT00597909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055223|NCT00422955|Rosiglitazone|rosiglitazone|mesh-list
56055224|NCT00422955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56055225|NCT00422955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055226|NCT00588471|Simvastatin|simvastatin|mesh-list
56055227|NCT00588471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56055228|NCT00588471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56055229|NCT00588471|Antimetabolites|antimetabolites|mesh-ancestor
56055230|NCT00588471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055231|NCT00588471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56055232|NCT00588471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56055233|NCT00588471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055234|NCT05600673|Bimatoprost|bimatoprost|mesh-list
56055235|NCT05600673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56055236|NCT01784991|Morphine|morphine|mesh-list
56055237|NCT01784991|Hydromorphone|hydromorphone|mesh-list
55897870|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55897871|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897872|NCT03195270|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55897873|NCT03195270|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55897874|NCT03195270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897875|NCT05204836|Zoledronic Acid|zoledronic acid|mesh-list
55897876|NCT05204836|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55897877|NCT05204836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897878|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
55897879|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
55897880|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897881|NCT03222960|Propolis|propolis|mesh-list
55897882|NCT03222960|Fluorides|fluorides|mesh-list
55897883|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
55897897|NCT05681260|Vincristine|vincristine|mesh-list
55897898|NCT05681260|Bortezomib|bortezomib|mesh-list
55897899|NCT05681260|Daunorubicin|daunorubicin|mesh-list
55897900|NCT05681260|Asparaginase|asparaginase|mesh-list
55897901|NCT05681260|Mercaptopurine|mercaptopurine|mesh-list
55897902|NCT05681260|Vindesine|vindesine|mesh-list
55897903|NCT05681260|Pegaspargase|pegaspargase|mesh-list
55897904|NCT05681260|BB 1101|bb 1101|mesh-list
55897905|NCT05681260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55897906|NCT05681260|Immunologic Factors|immunologic factors|mesh-ancestor
55897907|NCT05681260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897908|NCT05681260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897909|NCT05681260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55897910|NCT05681260|Alkylating Agents|alkylating agents|mesh-ancestor
55897911|NCT05681260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897912|NCT05681260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897913|NCT05681260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55897914|NCT05681260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897915|NCT05681260|Antiemetics|antiemetics|mesh-ancestor
55897916|NCT05681260|Autonomic Agents|autonomic agents|mesh-ancestor
56055238|NCT01784991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56055240|NCT01784991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055241|NCT01784991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055242|NCT01784991|Analgesics|analgesics|mesh-ancestor
56055243|NCT01784991|Sensory System Agents|sensory system agents|mesh-ancestor
56055244|NCT01784991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055245|NCT01760889|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
56055246|NCT01760889|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55897917|NCT05681260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897918|NCT05681260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55897919|NCT05681260|Glucocorticoids|glucocorticoids|mesh-ancestor
55897921|NCT05681260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55897922|NCT05681260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55897923|NCT05681260|Protease Inhibitors|protease inhibitors|mesh-ancestor
55897924|NCT05681260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897925|NCT05681260|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55897926|NCT05681260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55897927|NCT05681260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55897928|NCT05681260|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55897929|NCT05681260|Abortifacient Agents|abortifacient agents|mesh-ancestor
55897930|NCT05681260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55897931|NCT05681260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55897932|NCT05681260|Antimetabolites|antimetabolites|mesh-ancestor
55897933|NCT05681260|Dermatologic Agents|dermatologic agents|mesh-ancestor
55897934|NCT05681260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55897935|NCT05681260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55897936|NCT05681260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55897937|NCT05681260|Antiviral Agents|antiviral agents|mesh-ancestor
55897938|NCT05681260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897939|NCT05681260|Tubulin Modulators|tubulin modulators|mesh-ancestor
55897940|NCT05681260|Antimitotic Agents|antimitotic agents|mesh-ancestor
55897941|NCT05681260|Mitosis Modulators|mitosis modulators|mesh-ancestor
55897942|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
55897943|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897944|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897945|NCT03199950|Haloperidol|haloperidol|mesh-list
55897946|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
55897947|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
55897948|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
55897949|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897950|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897951|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55897952|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55897955|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55897956|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55897957|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
55897958|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55897959|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897960|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55897961|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55897962|NCT05156632|Vaccines|vaccines|mesh-list
55897963|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
55897964|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897967|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897968|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55897969|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
55897970|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55897971|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55897972|NCT02447016|Tenofovir|tenofovir|mesh-list
55897973|NCT02447016|Emtricitabine|emtricitabine|mesh-list
55897974|NCT02447016|Efavirenz|efavirenz|mesh-list
55897975|NCT02447016|Rilpivirine|rilpivirine|mesh-list
56055247|NCT01760889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055248|NCT01760889|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56055249|NCT01760889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56055250|NCT01760889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56055251|NCT01760889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055252|NCT01760889|Dopamine Agents|dopamine agents|mesh-ancestor
56055253|NCT01760889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055255|NCT05600517|Cariostatic Agents|cariostatic agents|mesh-ancestor
56055256|NCT05600517|Protective Agents|protective agents|mesh-ancestor
56055257|NCT05600517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055258|NCT01745913|Fludarabine|fludarabine|mesh-list
56055259|NCT01745913|Melphalan|melphalan|mesh-list
56055260|NCT01745913|Thymoglobulin|thymoglobulin|mesh-list
56055261|NCT01745913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055262|NCT01745913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055263|NCT01745913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055264|NCT01745913|Immunologic Factors|immunologic factors|mesh-ancestor
56055265|NCT01745913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897976|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
55897977|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897978|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55897979|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55897980|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897981|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897982|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55897983|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55897984|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55897985|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55897986|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55897987|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55897988|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55897989|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55897990|NCT02447094|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55897991|NCT02447094|Plasminogen|plasminogen|mesh-list
55897992|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55897993|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55897994|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897995|NCT02446860|Nivolumab|nivolumab|mesh-list
55897996|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55897997|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897998|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55897999|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898000|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
55898001|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55898002|NCT02449746|Antibodies|antibodies|mesh-list
55898003|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
55898004|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55898005|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
56055266|NCT01745913|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56055267|NCT01745913|Alkylating Agents|alkylating agents|mesh-ancestor
56055268|NCT01745913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56055269|NCT05600127|Avelumab|avelumab|mesh-list
56055270|NCT05600127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055271|NCT05600127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055272|NCT01691079|Bromides|bromides|mesh-list
56055273|NCT01691079|Ipratropium|ipratropium|mesh-list
56055274|NCT01691079|Anticonvulsants|anticonvulsants|mesh-ancestor
56055275|NCT01691079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56055276|NCT01691079|Autonomic Agents|autonomic agents|mesh-ancestor
56055277|NCT01691079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055278|NCT01691079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055279|NCT01691079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56055280|NCT01691079|Respiratory System Agents|respiratory system agents|mesh-ancestor
56055281|NCT01691079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56055282|NCT01691079|Cholinergic Agents|cholinergic agents|mesh-ancestor
56055283|NCT01691079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055284|NCT01691079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055285|NCT01673061|Lidocaine|lidocaine|mesh-list
56055286|NCT01673061|Epinephrine|epinephrine|mesh-list
56055287|NCT01673061|Norflurane|norflurane|mesh-list
56055288|NCT01673061|Anesthetics, Local|anesthetics, local|mesh-ancestor
56055289|NCT01673061|Anesthetics|anesthetics|mesh-ancestor
56055290|NCT01673061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055291|NCT01673061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055292|NCT01673061|Sensory System Agents|sensory system agents|mesh-ancestor
56055293|NCT01673061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055294|NCT01673061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56055295|NCT01673061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56055296|NCT01673061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56055297|NCT01673061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56055298|NCT01673061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055299|NCT01673061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56055300|NCT01673061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56055305|NCT01673061|Autonomic Agents|autonomic agents|mesh-ancestor
56055306|NCT01673061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56055307|NCT01673061|Respiratory System Agents|respiratory system agents|mesh-ancestor
56055308|NCT01673061|Mydriatics|mydriatics|mesh-ancestor
56055309|NCT01673061|Sympathomimetics|sympathomimetics|mesh-ancestor
56055310|NCT01673061|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56055311|NCT02101853|Calcium, Dietary|calcium, dietary|mesh-list
56055313|NCT02101853|Folic Acid|folic acid|mesh-list
56055314|NCT02101853|Cytarabine|cytarabine|mesh-list
56055315|NCT02101853|Dexamethasone|dexamethasone|mesh-list
56055316|NCT02101853|Dexamethasone acetate|dexamethasone acetate|mesh-list
56055317|NCT02101853|Hydrocortisone|hydrocortisone|mesh-list
56055318|NCT02101853|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56055319|NCT02101853|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56055320|NCT02101853|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56055321|NCT02101853|Cyclophosphamide|cyclophosphamide|mesh-list
56055322|NCT02101853|Methotrexate|methotrexate|mesh-list
56055323|NCT02101853|Etoposide|etoposide|mesh-list
56055333|NCT02101853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56055334|NCT02101853|Muromonab-CD3|muromonab-cd3|mesh-list
56055335|NCT02101853|Antibodies|antibodies|mesh-list
56055336|NCT02101853|Immunoglobulins|immunoglobulins|mesh-list
56055337|NCT02101853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56055338|NCT02101853|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56055339|NCT02101853|BB 1101|bb 1101|mesh-list
56055340|NCT02101853|Calcium|calcium|mesh-list
56055341|NCT02101853|2-Aminopurine|2-aminopurine|mesh-list
56055342|NCT02101853|Levoleucovorin|levoleucovorin|mesh-list
56055351|NCT02101853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56055352|NCT02101853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56055353|NCT02101853|Antiemetics|antiemetics|mesh-ancestor
56055354|NCT02101853|Autonomic Agents|autonomic agents|mesh-ancestor
56055355|NCT02101853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055356|NCT02101853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56055357|NCT02101853|Glucocorticoids|glucocorticoids|mesh-ancestor
56055358|NCT02101853|Hormones|hormones|mesh-ancestor
56055359|NCT02101853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055360|NCT02101853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56055361|NCT02101853|Protease Inhibitors|protease inhibitors|mesh-ancestor
56055362|NCT02101853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055363|NCT02101853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56055364|NCT02101853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56055365|NCT02101853|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56055366|NCT02101853|Abortifacient Agents|abortifacient agents|mesh-ancestor
56055367|NCT02101853|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55898006|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898007|NCT02446782|Clindamycin|clindamycin|mesh-list
55898008|NCT02446782|Cefazolin|cefazolin|mesh-list
55898009|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55898010|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898011|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55898012|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898013|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898014|NCT04745260|Fentanyl|fentanyl|mesh-list
55898015|NCT04745260|Midazolam|midazolam|mesh-list
55898016|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55898017|NCT04745260|Narcotics|narcotics|mesh-ancestor
55898018|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55898019|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898020|NCT04745260|Analgesics|analgesics|mesh-ancestor
55898021|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
55898022|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898023|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55898024|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55898025|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
55898029|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55898030|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55898031|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
55898032|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
55898033|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898034|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898035|NCT03199482|Dexamethasone|dexamethasone|mesh-list
55898036|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898037|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
55898038|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
55898039|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898040|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898041|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55898042|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
55898043|NCT03199482|Hormones|hormones|mesh-ancestor
55898044|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898045|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55898046|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898047|NCT02446704|Temozolomide|temozolomide|mesh-list
55898048|NCT02446704|Olaparib|olaparib|mesh-list
56055368|NCT02101853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56055369|NCT02101853|Antimetabolites|antimetabolites|mesh-ancestor
56055370|NCT02101853|Dermatologic Agents|dermatologic agents|mesh-ancestor
56055371|NCT02101853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56055372|NCT02101853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56055373|NCT02101853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55898049|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55898050|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
55898051|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898052|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898053|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55898054|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898055|NCT01605227|Prednisone|prednisone|mesh-list
55898056|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898057|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
55898058|NCT01605227|Hormones|hormones|mesh-ancestor
55898059|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898060|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898063|NCT02446548|Losartan|losartan|mesh-list
55898064|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55898065|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55898066|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55898067|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55898068|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898069|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55898070|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55898071|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898072|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
55898073|NCT04271332|Baclofen|baclofen|mesh-list
55898074|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55898075|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898076|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55898077|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898078|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55898079|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
55898080|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
55898081|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898082|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898083|NCT03199170|Morphine|morphine|mesh-list
55898084|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55898085|NCT03199170|Narcotics|narcotics|mesh-ancestor
55898086|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55898087|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898088|NCT03199170|Analgesics|analgesics|mesh-ancestor
55898089|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
55898090|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898091|NCT03118128|Metformin|metformin|mesh-list
55898092|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55898093|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898094|NCT05100472|Androgens|androgens|mesh-list
55898095|NCT05100472|Hormones|hormones|mesh-ancestor
55898096|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898097|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898101|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55898102|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55898103|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55898104|NCT05087914|Analgesics|analgesics|mesh-ancestor
55898105|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
55898106|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898107|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898108|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898109|NCT05087914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898110|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
55898111|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55898112|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055374|NCT02101853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56055375|NCT02101853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56055376|NCT02101853|Antiviral Agents|antiviral agents|mesh-ancestor
56055377|NCT02101853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055378|NCT02101853|Antidotes|antidotes|mesh-ancestor
56055379|NCT02101853|Protective Agents|protective agents|mesh-ancestor
56055380|NCT02101853|Vitamin B Complex|vitamin b complex|mesh-ancestor
56055381|NCT02101853|Vitamins|vitamins|mesh-ancestor
56055382|NCT02101853|Micronutrients|micronutrients|mesh-ancestor
56055383|NCT02101853|Tubulin Modulators|tubulin modulators|mesh-ancestor
55898113|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898114|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55898115|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55898116|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
55898117|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898118|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55898119|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55898120|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
55898121|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
55898125|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898126|NCT05637970|Hemostatics|hemostatics|mesh-list
55898127|NCT05637970|Coagulants|coagulants|mesh-ancestor
55898128|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
55898129|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55898130|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55898131|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55898132|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55898133|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898134|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
55898135|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898136|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898137|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55898138|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898139|NCT01709513|Atorvastatin|atorvastatin|mesh-list
55898140|NCT01709513|Ezetimibe|ezetimibe|mesh-list
55898141|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55898143|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
55898144|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898145|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55898146|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55898147|NCT01709513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898148|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
55898149|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55898150|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55898151|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898152|NCT02446158|Disinfectants|disinfectants|mesh-ancestor
55898153|NCT02446158|Dermatologic Agents|dermatologic agents|mesh-ancestor
55898154|NCT05631886|Cyclophosphamide|cyclophosphamide|mesh-list
55898155|NCT05631886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55898156|NCT05631886|Paclitaxel|paclitaxel|mesh-list
55898157|NCT05631886|Antibodies|antibodies|mesh-list
55898158|NCT05631886|Immunoglobulins|immunoglobulins|mesh-list
55898159|NCT05631886|Antibodies, Blocking|antibodies, blocking|mesh-list
55898160|NCT05631886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55898161|NCT05631886|Immunologic Factors|immunologic factors|mesh-ancestor
55898162|NCT05631886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898163|NCT05631886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898164|NCT05631886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55898165|NCT05631886|Alkylating Agents|alkylating agents|mesh-ancestor
55898166|NCT05631886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898167|NCT05631886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898168|NCT05631886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55898169|NCT05631886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56055384|NCT02101853|Antimitotic Agents|antimitotic agents|mesh-ancestor
56055385|NCT02101853|Mitosis Modulators|mitosis modulators|mesh-ancestor
56055386|NCT02101853|Hematinics|hematinics|mesh-ancestor
56055387|NCT02101853|Analgesics|analgesics|mesh-ancestor
56055388|NCT02101853|Sensory System Agents|sensory system agents|mesh-ancestor
56055389|NCT02101853|Keratolytic Agents|keratolytic agents|mesh-ancestor
56055390|NCT05599347|Azithromycin|azithromycin|mesh-list
56055391|NCT05599347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56055392|NCT05599347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055393|NCT01621737|Oxytocin|oxytocin|mesh-list
56055394|NCT01621737|Oxytocics|oxytocics|mesh-ancestor
56055395|NCT01621737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56055396|NCT01621737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055397|NCT00379665|Cisplatin|cisplatin|mesh-list
55898170|NCT05631886|Tubulin Modulators|tubulin modulators|mesh-ancestor
55898171|NCT05631886|Antimitotic Agents|antimitotic agents|mesh-ancestor
55898172|NCT05631886|Mitosis Modulators|mitosis modulators|mesh-ancestor
55898187|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898188|NCT02446002|Analgesics|analgesics|mesh-ancestor
55898189|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
55898190|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
55898191|NCT01605071|Estradiol|estradiol|mesh-list
55898192|NCT01605071|Estrogens|estrogens|mesh-ancestor
55898193|NCT01605071|Hormones|hormones|mesh-ancestor
55898194|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898195|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898196|NCT04345198|Epinephrine|epinephrine|mesh-list
55898197|NCT04345198|Racepinephrine|racepinephrine|mesh-list
55898198|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
55898199|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55898200|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55898201|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
55898202|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055432|NCT05550519|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55898203|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898204|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898205|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55898206|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55898207|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
55898208|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898209|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55898210|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
55898211|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
55898212|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
55898213|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55898214|NCT03192618|Leucovorin|leucovorin|mesh-list
55898215|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
55898216|NCT03192618|Calcium|calcium|mesh-list
55898217|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
55898218|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55898219|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898220|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898222|NCT03192618|Protective Agents|protective agents|mesh-ancestor
55898223|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
55898224|NCT03192618|Vitamins|vitamins|mesh-ancestor
55898225|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
55898226|NCT04113226|Rituximab|rituximab|mesh-list
55898227|NCT04113226|Lenalidomide|lenalidomide|mesh-list
55898228|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55898229|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898230|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
55898231|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898232|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898233|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55898234|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55898235|NCT04113226|Growth Substances|growth substances|mesh-ancestor
56055398|NCT00379665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055399|NCT00357383|Azithromycin|azithromycin|mesh-list
56055400|NCT00357383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56055401|NCT00357383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055402|NCT01598025|Fludarabine|fludarabine|mesh-list
56055403|NCT01598025|Fludarabine phosphate|fludarabine phosphate|mesh-list
56055404|NCT01598025|Melphalan|melphalan|mesh-list
56055405|NCT01598025|Thiotepa|thiotepa|mesh-list
56055406|NCT01598025|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56055407|NCT01598025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055408|NCT01598025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56055409|NCT01598025|Antimetabolites|antimetabolites|mesh-ancestor
56055410|NCT01598025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055411|NCT01598025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055412|NCT01598025|Immunologic Factors|immunologic factors|mesh-ancestor
56055413|NCT01598025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055414|NCT01598025|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56055415|NCT01598025|Alkylating Agents|alkylating agents|mesh-ancestor
56055416|NCT01598025|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56055417|NCT01587963|Ascorbic Acid|ascorbic acid|mesh-list
56055418|NCT01587963|Antioxidants|antioxidants|mesh-ancestor
56055419|NCT01587963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055420|NCT01587963|Protective Agents|protective agents|mesh-ancestor
56055421|NCT01587963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055422|NCT01587963|Vitamins|vitamins|mesh-ancestor
56055423|NCT01587963|Micronutrients|micronutrients|mesh-ancestor
56055424|NCT01648751|Estrogens|estrogens|mesh-list
56055425|NCT01648751|Hormones|hormones|mesh-ancestor
56055426|NCT01648751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055427|NCT01648751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055428|NCT05550519|Tenofovir|tenofovir|mesh-list
56055429|NCT05550519|Entecavir|entecavir|mesh-list
56055430|NCT05550519|Antiviral Agents|antiviral agents|mesh-ancestor
55898236|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
55898243|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55898244|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898246|NCT02444364|Hormones|hormones|mesh-ancestor
55898247|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898248|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55898249|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
55898250|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898251|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898252|NCT05039476|Vitamin A|vitamin a|mesh-list
55898253|NCT05039476|Vitamins|vitamins|mesh-ancestor
56055431|NCT05550519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898493|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56055433|NCT05550519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56055434|NCT05550519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055436|NCT05550519|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56055437|NCT05550519|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56055438|NCT01203371|Naftopidil|naftopidil|mesh-list
56055439|NCT01203371|Tamsulosin|tamsulosin|mesh-list
56055440|NCT01203371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56055441|NCT01203371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55898254|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
55898255|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898256|NCT00356356|Etanercept|etanercept|mesh-list
55898257|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55898258|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55898259|NCT00356356|Analgesics|analgesics|mesh-ancestor
55898260|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
55898261|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898262|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898263|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898264|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898265|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55898266|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55898267|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
55898268|NCT02443818|Sirolimus|sirolimus|mesh-list
55754690|NCT05727371|Protective Agents|protective agents|mesh-ancestor
55898269|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55898270|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898271|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55898272|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898273|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
55898274|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55898275|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
55898276|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898278|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
55898279|NCT01705691|Doxorubicin|doxorubicin|mesh-list
55898280|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55898281|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898282|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
55898283|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
55898284|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
55898285|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898286|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55898287|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
55898288|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898289|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898290|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55898291|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
55898292|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55898293|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55898294|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55898295|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55898296|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898297|NCT05169060|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55898298|NCT05169060|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55898299|NCT05169060|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55898300|NCT05169060|Analgesics|analgesics|mesh-ancestor
55898301|NCT05169060|Sensory System Agents|sensory system agents|mesh-ancestor
55898302|NCT05169060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898303|NCT05169060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898304|NCT05169060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898305|NCT05169060|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055442|NCT01203371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56055443|NCT01203371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56055444|NCT01203371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055445|NCT01203371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055446|NCT01203371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055448|NCT01203371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55898316|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55898317|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
55898318|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898319|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898320|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55898321|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
55898322|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55898323|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
55898324|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55898325|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55898326|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55898327|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55898328|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898329|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55898330|NCT02445300|Laxatives|laxatives|mesh-ancestor
55898331|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55898332|NCT02445066|Vitamin D|vitamin d|mesh-list
55898333|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
55898334|NCT02445066|Vitamins|vitamins|mesh-ancestor
55898335|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
55898336|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898337|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55898338|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55898339|NCT03197298|Clopidogrel|clopidogrel|mesh-list
55898340|NCT03197298|Ticagrelor|ticagrelor|mesh-list
55898341|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55898342|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55898343|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55898344|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55898345|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
55898346|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898347|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898348|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898349|NCT00357448|Interleukin-2|interleukin-2|mesh-list
55898350|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
55898351|NCT00357448|Immunotoxins|immunotoxins|mesh-list
55898352|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898353|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55898354|NCT00357448|Analgesics|analgesics|mesh-ancestor
55898355|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
55898356|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898357|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898358|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
55898359|NCT05715658|Dabigatran|dabigatran|mesh-list
55898360|NCT05715658|Antithrombins|antithrombins|mesh-ancestor
55898361|NCT05715658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55898362|NCT05715658|Protease Inhibitors|protease inhibitors|mesh-ancestor
55898363|NCT05715658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898364|NCT05715658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898365|NCT05715658|Anticoagulants|anticoagulants|mesh-ancestor
55898366|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55898367|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55898368|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55898369|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55898370|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898373|NCT02443194|Analgesics|analgesics|mesh-ancestor
55898374|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
55898375|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898376|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
56055450|NCT01203371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56055452|NCT01203371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56055454|NCT01549977|Gout Suppressants|gout suppressants|mesh-ancestor
56055455|NCT01549977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055456|NCT05494125|Ropivacaine|ropivacaine|mesh-list
56055457|NCT05494125|Anesthetics, Local|anesthetics, local|mesh-ancestor
56055458|NCT05494125|Anesthetics|anesthetics|mesh-ancestor
56055459|NCT05494125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055460|NCT05494125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055461|NCT05494125|Sensory System Agents|sensory system agents|mesh-ancestor
56055462|NCT05494125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055463|NCT00357617|Celecoxib|celecoxib|mesh-list
56055464|NCT00357617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56055465|NCT00357617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56055466|NCT00357617|Analgesics|analgesics|mesh-ancestor
56055467|NCT00357617|Sensory System Agents|sensory system agents|mesh-ancestor
56055468|NCT00357617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055469|NCT00357617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055470|NCT00357617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898377|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55898378|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
55898379|NCT03193944|Vitamin D|vitamin d|mesh-list
55898380|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
55898381|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
55898382|NCT03193944|Vitamins|vitamins|mesh-list
55898383|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
55898384|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898385|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55898386|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55898387|NCT00357604|Ritonavir|ritonavir|mesh-list
55898388|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55898389|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
55898390|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55898391|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55898392|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55898393|NCT00357604|Norgestimate|norgestimate|mesh-list
55898394|NCT00357604|Norgestrel|norgestrel|mesh-list
55898395|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55898396|NCT00357604|Estradiol|estradiol|mesh-list
55898397|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55898398|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55898399|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55898400|NCT00357604|Protease Inhibitors|protease inhibitors|mesh-ancestor
55898401|NCT00357604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898402|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898403|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55898404|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55898405|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
55898406|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055471|NCT00357617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055472|NCT00357617|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56055473|NCT00357617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56055474|NCT00357617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055475|NCT00357617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055477|NCT01548651|Incretins|incretins|mesh-ancestor
56055478|NCT01548651|Hormones|hormones|mesh-ancestor
56055479|NCT01548651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055480|NCT01548651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055481|NCT01548651|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56055482|NCT01548651|Protease Inhibitors|protease inhibitors|mesh-ancestor
56055483|NCT01548651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055484|NCT01548651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055485|NCT01548651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56055486|NCT01533753|Gabapentin|gabapentin|mesh-list
56055487|NCT01533753|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56055488|NCT01533753|Analgesics|analgesics|mesh-ancestor
56055489|NCT01533753|Sensory System Agents|sensory system agents|mesh-ancestor
56055490|NCT01533753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055491|NCT01533753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055492|NCT01533753|Anticonvulsants|anticonvulsants|mesh-ancestor
56055493|NCT01533753|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56055494|NCT01533753|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56055495|NCT01533753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055496|NCT01533753|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56055497|NCT01533753|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56055498|NCT01533753|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56055499|NCT01533753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055500|NCT01533753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055501|NCT01533753|Antimanic Agents|antimanic agents|mesh-ancestor
56055502|NCT01533753|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55898407|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55898408|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55898409|NCT00357604|Estrogens|estrogens|mesh-ancestor
55898411|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898412|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055503|NCT01533753|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56055504|NCT01533753|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56055505|NCT01533753|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56055506|NCT01533753|Antidepressive Agents|antidepressive agents|mesh-ancestor
56055507|NCT05722301|Methyltestosterone|methyltestosterone|mesh-list
56055508|NCT05722301|Testosterone|testosterone|mesh-list
56055509|NCT05722301|Testosterone undecanoate|testosterone undecanoate|mesh-list
56055510|NCT05722301|Testosterone enanthate|testosterone enanthate|mesh-list
56055511|NCT05722301|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56055512|NCT05722301|Androgens|androgens|mesh-ancestor
56055513|NCT05722301|Hormones|hormones|mesh-ancestor
55898413|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55898414|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
55898415|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55898416|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55898417|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55898418|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55898419|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55898420|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55898421|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55898422|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55898423|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55898424|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898425|NCT03193788|Folic Acid|folic acid|mesh-list
55898426|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
55898427|NCT03193788|Dexamethasone|dexamethasone|mesh-list
55898428|NCT03193788|Pemetrexed|pemetrexed|mesh-list
55898429|NCT03193788|Vitamins|vitamins|mesh-ancestor
55898430|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
55898431|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898432|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898433|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
55898434|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
55898435|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898436|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55898437|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
55898438|NCT03193788|Hormones|hormones|mesh-ancestor
55898439|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898440|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55898441|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898442|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898443|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898444|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55898453|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898456|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
55898457|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55898458|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55898459|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898460|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898461|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
55898462|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
55898463|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55898464|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
55898465|NCT01705145|Ivacaftor|ivacaftor|mesh-list
55898466|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55898467|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55898468|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898469|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55898470|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
55898471|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
55898472|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55898473|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
56055514|NCT05722301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055515|NCT05722301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055516|NCT05722301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56055517|NCT05722301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055518|NCT05722301|Anabolic Agents|anabolic agents|mesh-ancestor
56055519|NCT01534143|Sirolimus|sirolimus|mesh-list
56055520|NCT01534143|Fludarabine|fludarabine|mesh-list
56055521|NCT01534143|Fludarabine phosphate|fludarabine phosphate|mesh-list
56055522|NCT01534143|Bortezomib|bortezomib|mesh-list
55898474|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898475|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55898476|NCT04483830|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55898477|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55898478|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55898479|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898480|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
55898481|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
55898482|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55898483|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55898484|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898485|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898486|NCT02442492|Urological Agents|urological agents|mesh-ancestor
55898487|NCT01704755|Ribavirin|ribavirin|mesh-list
55898488|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
55898489|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898490|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
55898491|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898492|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
55898494|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55898495|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
55898496|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898497|NCT04166669|Itraconazole|itraconazole|mesh-list
55898498|NCT04166669|Rifampin|rifampin|mesh-list
55898499|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
55898500|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898501|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55898502|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55898503|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898504|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898505|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55898506|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
55898507|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898508|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898509|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55898511|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
55898512|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55898520|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55898521|NCT03193710|Remifentanil|remifentanil|mesh-list
55898523|NCT03193710|Sevoflurane|sevoflurane|mesh-list
55898524|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55898525|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55898526|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898527|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55898528|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
55898529|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
55898530|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55898531|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55898532|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55898533|NCT03193710|Narcotics|narcotics|mesh-ancestor
55898534|NCT03193710|Analgesics|analgesics|mesh-ancestor
55898535|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
55898536|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898537|NCT01704599|Vitamins|vitamins|mesh-list
55898538|NCT01704599|Folic Acid|folic acid|mesh-list
56055523|NCT01534143|Busulfan|busulfan|mesh-list
56055525|NCT01534143|Thymoglobulin|thymoglobulin|mesh-list
56055526|NCT01534143|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56055527|NCT01534143|Immunoglobulins|immunoglobulins|mesh-list
56055528|NCT01534143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055529|NCT01534143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55898539|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
55898540|NCT01704599|Pyridoxine|pyridoxine|mesh-list
55898541|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
55898542|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
55898543|NCT01704599|Adalimumab|adalimumab|mesh-list
55898544|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
55898545|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898546|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898547|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898548|NCT01704599|Hematinics|hematinics|mesh-ancestor
55898549|NCT03196362|Metformin|metformin|mesh-list
55898550|NCT03196362|Pioglitazone|pioglitazone|mesh-list
55898551|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55898552|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898553|NCT02449278|Prednisone|prednisone|mesh-list
55898554|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
55898555|NCT02449278|Doxorubicin|doxorubicin|mesh-list
55898556|NCT02449278|Vincristine|vincristine|mesh-list
55898557|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55898558|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
55898559|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898560|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898561|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55898562|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
55898563|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898564|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898565|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55898566|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55898567|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55898568|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55898569|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898570|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898571|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
55898572|NCT02449278|Hormones|hormones|mesh-ancestor
55898573|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898574|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55898575|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55898576|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
55898577|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
55898578|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
55898579|NCT03388788|CGP 12177|cgp 12177|mesh-list
55898580|NCT03388788|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55898581|NCT03388788|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55898582|NCT03388788|Adrenergic Agents|adrenergic agents|mesh-ancestor
55898586|NCT03388788|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55898587|NCT03388788|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55898589|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898590|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55898591|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898592|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898593|NCT03099486|Leucovorin|leucovorin|mesh-list
55898594|NCT03099486|Antidotes|antidotes|mesh-ancestor
55898595|NCT03099486|Protective Agents|protective agents|mesh-ancestor
55898596|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898597|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
55898598|NCT03099486|Vitamins|vitamins|mesh-ancestor
55898599|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
55898600|NCT00358228|Rimonabant|rimonabant|mesh-list
55898601|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55898602|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
55898603|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55898604|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898605|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898606|NCT00358228|Hormones|hormones|mesh-ancestor
55898607|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898608|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055530|NCT01534143|Antimetabolites|antimetabolites|mesh-ancestor
56055531|NCT01534143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055532|NCT01534143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055533|NCT01534143|Immunologic Factors|immunologic factors|mesh-ancestor
56055534|NCT01534143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055535|NCT01534143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56055536|NCT01534143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055537|NCT01534143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55898609|NCT05710198|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55898610|NCT05710198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55898611|NCT05710198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55898612|NCT05710198|Nootropic Agents|nootropic agents|mesh-ancestor
55898613|NCT05709028|Fosfomycin|fosfomycin|mesh-list
55898614|NCT05709028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55898615|NCT05709028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898616|NCT03420508|Ensartinib|ensartinib|mesh-list
55898617|NCT03420508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898618|NCT03420508|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55898619|NCT03420508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898620|NCT03420508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898621|NCT03416530|TIC10 compound|tic10 compound|mesh-list
55898622|NCT03416530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898623|NCT01336530|Oxethazaine|oxethazaine|mesh-list
55898624|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55898625|NCT01336530|Antacids|antacids|mesh-list
55898626|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
55898627|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55898628|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
55898629|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898630|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898631|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55898633|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
55898634|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55898635|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
55898636|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898637|NCT00777348|Reproterol|reproterol|mesh-list
55898638|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55898639|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55898640|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
55898641|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898642|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898643|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898644|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55898645|NCT00777348|Autonomic Agents|autonomic agents|mesh-ancestor
55898646|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898647|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55898648|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
55898649|NCT03836560|Nicotine|nicotine|mesh-list
55898650|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55898651|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
55898652|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898655|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55898656|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
55898657|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898658|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898659|NCT04483596|Melatonin|melatonin|mesh-list
55898660|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
55898661|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898662|NCT04483596|Protective Agents|protective agents|mesh-ancestor
55898663|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898664|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55898665|NCT05721586|Listerine|listerine|mesh-list
55898666|NCT05721586|Fluorides|fluorides|mesh-list
55898667|NCT05721586|Fluorides, Topical|fluorides, topical|mesh-list
55898668|NCT05721586|Sodium Fluoride|sodium fluoride|mesh-list
55898669|NCT05721586|Cariostatic Agents|cariostatic agents|mesh-ancestor
56055538|NCT01534143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055539|NCT01534143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56055540|NCT01534143|Antifungal Agents|antifungal agents|mesh-ancestor
56055541|NCT01534143|Alkylating Agents|alkylating agents|mesh-ancestor
56055542|NCT01534143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56055543|NCT01534143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56055544|NCT05722067|Calcium|calcium|mesh-list
56055545|NCT05722067|Ionophores|ionophores|mesh-list
56055546|NCT05722067|Calcium Ionophores|calcium ionophores|mesh-list
56055547|NCT05722067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55898670|NCT05721586|Protective Agents|protective agents|mesh-ancestor
55898671|NCT05721586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898672|NCT05721586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55898673|NCT05721586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898674|NCT03295396|TIC10 compound|tic10 compound|mesh-list
55898675|NCT03295396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898676|NCT02978482|Durvalumab|durvalumab|mesh-list
55898677|NCT02978482|Tremelimumab|tremelimumab|mesh-list
55898678|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55898679|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55898680|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898681|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
55898682|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898683|NCT00357682|Aspirin|aspirin|mesh-list
55898684|NCT00357682|Esomeprazole|esomeprazole|mesh-list
55898685|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55898686|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55898687|NCT00357682|Analgesics|analgesics|mesh-ancestor
55898688|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
55898689|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898690|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898691|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898692|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898693|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55898694|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55898695|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898696|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55898697|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55898698|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898699|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
55898700|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55898701|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55898702|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55898703|NCT00105027|Triamcinolone|triamcinolone|mesh-list
55898704|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55898705|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55898706|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55898707|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898708|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
55898709|NCT00105027|Hormones|hormones|mesh-ancestor
55898710|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898711|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898712|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55898713|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
55898714|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055602|NCT05258565|Plasminogen|plasminogen|mesh-list
55898715|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898716|NCT03145012|Ranitidine|ranitidine|mesh-list
55898717|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
55898718|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55898719|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55898720|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55898721|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
55898722|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
55898723|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055548|NCT05722067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055549|NCT05722067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56055550|NCT05722067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055551|NCT01692171|Heparin|heparin|mesh-list
56055552|NCT01692171|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56055553|NCT01692171|Tinzaparin|tinzaparin|mesh-list
56055554|NCT01692171|Dalteparin|dalteparin|mesh-list
56055555|NCT01692171|Anticoagulants|anticoagulants|mesh-ancestor
56055556|NCT01692171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56055557|NCT01692171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56055558|NCT01692171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055559|NCT05723315|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56055560|NCT05723315|Natriuretic Agents|natriuretic agents|mesh-ancestor
56055561|NCT05723315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055562|NCT05715671|Esketamine|esketamine|mesh-list
56055563|NCT05715671|Antidepressive Agents|antidepressive agents|mesh-ancestor
56055564|NCT05715671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56055565|NCT05721755|Paclitaxel|paclitaxel|mesh-list
56055566|NCT05721755|Cisplatin|cisplatin|mesh-list
56055567|NCT05721755|Carboplatin|carboplatin|mesh-list
56055568|NCT05721755|Pembrolizumab|pembrolizumab|mesh-list
56055570|NCT05721755|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56055571|NCT05721755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56055572|NCT05721755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055573|NCT05721755|Tubulin Modulators|tubulin modulators|mesh-ancestor
56055574|NCT05721755|Antimitotic Agents|antimitotic agents|mesh-ancestor
56055575|NCT05721755|Mitosis Modulators|mitosis modulators|mesh-ancestor
56055576|NCT05721755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055577|NCT05721755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55898724|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898725|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898726|NCT03832660|Valsartan|valsartan|mesh-list
55898727|NCT03832660|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55898728|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55898729|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55898730|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55898731|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898733|NCT03132532|Etoposide|etoposide|mesh-list
55898734|NCT03132532|Podophyllotoxin|podophyllotoxin|mesh-list
55898735|NCT03132532|Cisplatin|cisplatin|mesh-list
55898736|NCT03132532|Carboplatin|carboplatin|mesh-list
55898737|NCT03132532|Pemetrexed|pemetrexed|mesh-list
55898738|NCT03132532|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55898739|NCT03132532|Etoposide phosphate|etoposide phosphate|mesh-list
56055579|NCT05721755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56055580|NCT05721755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055581|NCT05721755|Immunologic Factors|immunologic factors|mesh-ancestor
56055582|NCT05721755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055583|NCT00570531|Paclitaxel|paclitaxel|mesh-list
56055584|NCT00570531|Bevacizumab|bevacizumab|mesh-list
56055585|NCT00570531|Fluorouracil|fluorouracil|mesh-list
56055586|NCT00570531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56055587|NCT00570531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055588|NCT00570531|Tubulin Modulators|tubulin modulators|mesh-ancestor
56055589|NCT00570531|Antimitotic Agents|antimitotic agents|mesh-ancestor
56055590|NCT00570531|Mitosis Modulators|mitosis modulators|mesh-ancestor
56055591|NCT00570531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055592|NCT00570531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055593|NCT00570531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56055594|NCT00570531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56055595|NCT00570531|Growth Substances|growth substances|mesh-ancestor
56055596|NCT00570531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055597|NCT00570531|Growth Inhibitors|growth inhibitors|mesh-ancestor
56055598|NCT00570531|Antimetabolites|antimetabolites|mesh-ancestor
56055599|NCT00570531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56055601|NCT00570531|Immunologic Factors|immunologic factors|mesh-ancestor
56055603|NCT05258565|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56055604|NCT05258565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56055605|NCT05258565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55898740|NCT03132532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55898741|NCT03132532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898742|NCT03132532|Tubulin Modulators|tubulin modulators|mesh-ancestor
55898743|NCT03132532|Antimitotic Agents|antimitotic agents|mesh-ancestor
55898744|NCT03132532|Mitosis Modulators|mitosis modulators|mesh-ancestor
55898745|NCT03132532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898746|NCT03132532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55898747|NCT03132532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55898748|NCT03132532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898749|NCT03132532|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55898751|NCT03132532|Keratolytic Agents|keratolytic agents|mesh-ancestor
55898752|NCT03132532|Dermatologic Agents|dermatologic agents|mesh-ancestor
55898753|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55898754|NCT00030147|Estradiol|estradiol|mesh-list
55898755|NCT00030147|Estrogens|estrogens|mesh-ancestor
55898756|NCT00030147|Hormones|hormones|mesh-ancestor
55898757|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898758|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898759|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56055606|NCT05258565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055607|NCT05715437|Ketamine|ketamine|mesh-list
56055608|NCT05715437|Bupivacaine|bupivacaine|mesh-list
56055609|NCT05715437|Anesthetics, Local|anesthetics, local|mesh-ancestor
56055610|NCT05715437|Anesthetics|anesthetics|mesh-ancestor
56055611|NCT05715437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055612|NCT05715437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055613|NCT05715437|Sensory System Agents|sensory system agents|mesh-ancestor
56055614|NCT05715437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055615|NCT05715437|Analgesics|analgesics|mesh-ancestor
56055616|NCT05715437|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56055617|NCT05715437|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56055618|NCT05715437|Anesthetics, General|anesthetics, general|mesh-ancestor
56055619|NCT05715437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56055620|NCT05715437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56055621|NCT05715437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055622|NCT05715437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055623|NCT05721443|Cetuximab|cetuximab|mesh-list
56055624|NCT05721443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055625|NCT05721443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055626|NCT05715281|Atezolizumab|atezolizumab|mesh-list
56055627|NCT05715281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56055628|NCT05715281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055629|NCT05715281|Immunologic Factors|immunologic factors|mesh-ancestor
56055630|NCT05715281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055631|NCT00523809|Bevacizumab|bevacizumab|mesh-list
56055632|NCT00523809|Fludarabine|fludarabine|mesh-list
56055633|NCT00523809|Fludarabine phosphate|fludarabine phosphate|mesh-list
56055634|NCT00523809|Melphalan|melphalan|mesh-list
55898760|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
55898761|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55898762|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55898763|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55898764|NCT02709486|Tanezumab|tanezumab|mesh-list
55898765|NCT02709486|Analgesics|analgesics|mesh-ancestor
55898766|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
55898767|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898768|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898769|NCT00106431|Romidepsin|romidepsin|mesh-list
55898770|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55898771|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898772|NCT03107416|Bumetanide|bumetanide|mesh-list
55898773|NCT03107416|Diuretics|diuretics|mesh-ancestor
55898774|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
56055635|NCT00523809|Thymoglobulin|thymoglobulin|mesh-list
56055636|NCT00523809|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56055637|NCT00523809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055638|NCT00523809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055639|NCT00523809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56055640|NCT00523809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56055641|NCT00523809|Growth Substances|growth substances|mesh-ancestor
55898778|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898780|NCT03085810|Immunologic Factors|immunologic factors|mesh-ancestor
55898781|NCT03085810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898782|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55898783|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
55898784|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55898785|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
55898786|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898787|NCT03833596|Prednisone|prednisone|mesh-list
55898788|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898789|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
55898790|NCT03833596|Hormones|hormones|mesh-ancestor
55898791|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55898792|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898793|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55898794|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898803|NCT02831998|Ethanol|ethanol|mesh-list
55898804|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
55898805|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55898806|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55898807|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898808|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55898809|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898810|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
55898811|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
55898812|NCT02434614|Cisplatin|cisplatin|mesh-list
55898813|NCT02434614|Docetaxel|docetaxel|mesh-list
55898814|NCT02434614|Fluorouracil|fluorouracil|mesh-list
55898815|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898816|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
55898817|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
55898818|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
55898819|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898820|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
55898821|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55898822|NCT02434614|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55898823|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
55898824|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898826|NCT05720260|Fulvestrant|fulvestrant|mesh-list
55898827|NCT05720260|Goserelin|goserelin|mesh-list
55898828|NCT05720260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55898829|NCT05720260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898830|NCT05720260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55898831|NCT05720260|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55898832|NCT05720260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55898833|NCT05720260|Hormone Antagonists|hormone antagonists|mesh-ancestor
55898834|NCT05720260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055643|NCT00523809|Growth Inhibitors|growth inhibitors|mesh-ancestor
56055644|NCT00523809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56055645|NCT00523809|Antimetabolites|antimetabolites|mesh-ancestor
56055646|NCT00523809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055647|NCT00523809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055649|NCT00523809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56055650|NCT00523809|Alkylating Agents|alkylating agents|mesh-ancestor
56055651|NCT00523809|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56055653|NCT00501345|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56055654|NCT00501345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56055655|NCT00501345|Analgesics|analgesics|mesh-ancestor
56055656|NCT00501345|Sensory System Agents|sensory system agents|mesh-ancestor
56055657|NCT00501345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055658|NCT00501345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898835|NCT05720260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898836|NCT05720026|Docetaxel|docetaxel|mesh-list
55898837|NCT05720026|Trastuzumab|trastuzumab|mesh-list
55898838|NCT05720026|Pertuzumab|pertuzumab|mesh-list
55898840|NCT05720026|Tubulin Modulators|tubulin modulators|mesh-ancestor
55898841|NCT05720026|Antimitotic Agents|antimitotic agents|mesh-ancestor
55898842|NCT05720026|Mitosis Modulators|mitosis modulators|mesh-ancestor
55898843|NCT05720026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898844|NCT05720026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55898845|NCT04483674|Tenofovir|tenofovir|mesh-list
55898846|NCT04483674|Emtricitabine|emtricitabine|mesh-list
55898847|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
55898848|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898849|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55898850|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55898851|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898852|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898854|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55898855|NCT02438982|Rituximab|rituximab|mesh-list
55898856|NCT02438982|Tacrolimus|tacrolimus|mesh-list
55898857|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
55898858|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55898859|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898860|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
55898861|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898862|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898863|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55898864|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898865|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898866|NCT02425774|Prucalopride|prucalopride|mesh-list
55898867|NCT02425774|Laxatives|laxatives|mesh-ancestor
55898868|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55898869|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55898870|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55898871|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
55898872|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898873|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898874|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898878|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
55898879|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055659|NCT00501345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56055660|NCT00501345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055661|NCT00501345|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56055662|NCT00501345|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56055663|NCT00501345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898880|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898881|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55898882|NCT02420002|Analgesics|analgesics|mesh-ancestor
55898883|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
55898884|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898886|NCT05629702|Nabiximols|nabiximols|mesh-list
55898887|NCT05629702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55898888|NCT05629702|Alkylating Agents|alkylating agents|mesh-ancestor
55898889|NCT05629702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898890|NCT05629702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898891|NCT05629702|Analgesics|analgesics|mesh-ancestor
55898892|NCT05629702|Sensory System Agents|sensory system agents|mesh-ancestor
55898893|NCT05629702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898894|NCT05629702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898895|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
55898896|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55898897|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55898898|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55898899|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55898900|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898901|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
55898902|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898903|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898904|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55898905|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898906|NCT03117894|Acetaminophen|acetaminophen|mesh-list
55898907|NCT03117894|Etoricoxib|etoricoxib|mesh-list
55898908|NCT03117894|Morphine|morphine|mesh-list
55898909|NCT03117894|Remifentanil|remifentanil|mesh-list
55898910|NCT03117894|Ondansetron|ondansetron|mesh-list
55898911|NCT03117894|Propofol|propofol|mesh-list
55898912|NCT03117894|Ropivacaine|ropivacaine|mesh-list
55898913|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55898914|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55898915|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898916|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55898917|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
55898918|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
55898919|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55898920|NCT03117894|Narcotics|narcotics|mesh-ancestor
55898921|NCT03117894|Analgesics|analgesics|mesh-ancestor
55898922|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
55898923|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898924|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
55898925|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55898926|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
55898927|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
55898928|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
55898929|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55898930|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
55898931|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
55898932|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55898933|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
55898934|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898935|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898936|NCT03117894|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55898937|NCT03117894|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55898938|NCT03117894|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55898939|NCT03117894|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55898940|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55898941|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55898942|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55898943|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56055664|NCT00501345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56055665|NCT00501345|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56055666|NCT00501345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055667|NCT00501345|Antipyretics|antipyretics|mesh-ancestor
56055668|NCT00357773|Azithromycin|azithromycin|mesh-list
56055669|NCT00357773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56055670|NCT00357773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055671|NCT00487461|Simvastatin|simvastatin|mesh-list
56055672|NCT00487461|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56055673|NCT00487461|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56055674|NCT00487461|Antimetabolites|antimetabolites|mesh-ancestor
56055675|NCT00487461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055676|NCT00487461|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56055677|NCT00487461|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56055678|NCT00487461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055679|NCT04972383|Hyaluronic Acid|hyaluronic acid|mesh-list
56055680|NCT04972383|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55898944|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55898945|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55898946|NCT00357292|Azithromycin|azithromycin|mesh-list
55898947|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55898948|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898949|NCT05625802|Ropivacaine|ropivacaine|mesh-list
55898958|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55898959|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898961|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
55898962|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898963|NCT02042326|Sirolimus|sirolimus|mesh-list
55898964|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55898965|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55898966|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55898967|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898968|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
55898969|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55898970|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
55898971|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898972|NCT05718544|Sufentanil|sufentanil|mesh-list
55898973|NCT05718544|Dexmedetomidine|dexmedetomidine|mesh-list
55898974|NCT05718544|Esketamine|esketamine|mesh-list
55898975|NCT05718544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55898976|NCT05718544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55898977|NCT05718544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898978|NCT05718544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55898979|NCT05718544|Analgesics|analgesics|mesh-ancestor
55898980|NCT05718544|Sensory System Agents|sensory system agents|mesh-ancestor
55898981|NCT05718544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898982|NCT05718544|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55898983|NCT05718544|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55898984|NCT05718544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55898985|NCT05718544|Adrenergic Agents|adrenergic agents|mesh-ancestor
55898986|NCT05718544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898987|NCT05718544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898988|NCT05718544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55898989|NCT05718544|Narcotics|narcotics|mesh-ancestor
55898990|NCT05718544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55898991|NCT05718544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56055681|NCT04972383|Immunologic Factors|immunologic factors|mesh-ancestor
56055684|NCT04972383|Protective Agents|protective agents|mesh-ancestor
56055685|NCT00356187|Propranolol|propranolol|mesh-list
56055686|NCT00356187|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55899181|NCT00109005|Growth Substances|growth substances|mesh-ancestor
56055687|NCT00356187|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56055688|NCT00356187|Adrenergic Agents|adrenergic agents|mesh-ancestor
56055689|NCT00356187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055690|NCT00356187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055691|NCT00356187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055692|NCT00356187|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56055693|NCT00356187|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56055694|NCT00356187|Vasodilator Agents|vasodilator agents|mesh-ancestor
56055695|NCT02224729|Dexamethasone|dexamethasone|mesh-list
56055696|NCT02224729|Bortezomib|bortezomib|mesh-list
56055697|NCT02224729|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56055698|NCT02224729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56055699|NCT02224729|Antiemetics|antiemetics|mesh-ancestor
56055700|NCT02224729|Autonomic Agents|autonomic agents|mesh-ancestor
56055701|NCT02224729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055702|NCT02224729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055703|NCT02224729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56055704|NCT02224729|Glucocorticoids|glucocorticoids|mesh-ancestor
55898992|NCT05718544|Anesthetics, General|anesthetics, general|mesh-ancestor
55898993|NCT05718544|Anesthetics|anesthetics|mesh-ancestor
55898994|NCT05718544|Antidepressive Agents|antidepressive agents|mesh-ancestor
55898995|NCT05718544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55898996|NCT05616598|Ribavirin|ribavirin|mesh-list
55898997|NCT05616598|Sofosbuvir|sofosbuvir|mesh-list
55898998|NCT05616598|Simeprevir|simeprevir|mesh-list
55898999|NCT05616598|Antimetabolites|antimetabolites|mesh-ancestor
55899000|NCT05616598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899001|NCT05616598|Antiviral Agents|antiviral agents|mesh-ancestor
55899002|NCT05616598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899003|NCT05616598|Protease Inhibitors|protease inhibitors|mesh-ancestor
55899004|NCT05616598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899005|NCT03187392|Lidocaine|lidocaine|mesh-list
55899006|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
55899007|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
55899008|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899009|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899010|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
55899011|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899012|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55899013|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55899014|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55899015|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55899016|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899017|NCT01464268|Riboflavin|riboflavin|mesh-list
55899018|NCT01464268|Dextrans|dextrans|mesh-list
55899019|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
55899023|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56055705|NCT02224729|Hormones|hormones|mesh-ancestor
56055706|NCT02224729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055707|NCT02224729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56055708|NCT02224729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055709|NCT02224729|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56055710|NCT02224729|Alkylating Agents|alkylating agents|mesh-ancestor
55899024|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
55899025|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
55899026|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
55899027|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
55899028|NCT05717062|Varespladib methyl|varespladib methyl|mesh-list
55899029|NCT05717062|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
55899030|NCT05717062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899031|NCT05717062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899032|NCT00215787|Lansoprazole|lansoprazole|mesh-list
55899033|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
55899034|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55899035|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899036|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55899037|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899038|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899039|NCT05716984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55899040|NCT05716984|Natriuretic Agents|natriuretic agents|mesh-ancestor
55899041|NCT05716984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899042|NCT05601154|Listerine|listerine|mesh-list
55899043|NCT05601154|Fluorides|fluorides|mesh-list
55899044|NCT05601154|Sodium Fluoride|sodium fluoride|mesh-list
55899045|NCT05601154|Cariostatic Agents|cariostatic agents|mesh-ancestor
55899046|NCT05601154|Protective Agents|protective agents|mesh-ancestor
55899047|NCT05601154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899048|NCT05601154|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55899049|NCT05601154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899050|NCT05716906|Melatonin|melatonin|mesh-list
55899051|NCT05716906|Antioxidants|antioxidants|mesh-ancestor
55899052|NCT05716906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899054|NCT05716906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899055|NCT05716906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899056|NCT00216099|Folic Acid|folic acid|mesh-list
55899057|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
55899058|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
55899059|NCT00216099|Pemetrexed|pemetrexed|mesh-list
55899060|NCT00216099|Vitamins|vitamins|mesh-ancestor
55899061|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
55899062|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899063|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899064|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899065|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899066|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55899067|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55899068|NCT00216099|Hematinics|hematinics|mesh-ancestor
55899069|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
55899070|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
55899071|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899072|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
55899073|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55899074|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55899075|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899076|NCT04565925|Urological Agents|urological agents|mesh-ancestor
55899077|NCT00039195|Prednisone|prednisone|mesh-list
55899078|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
55899079|NCT00039195|Ifosfamide|ifosfamide|mesh-list
55899080|NCT00039195|Rituximab|rituximab|mesh-list
55899081|NCT00039195|Carboplatin|carboplatin|mesh-list
55899082|NCT00039195|Doxorubicin|doxorubicin|mesh-list
55899083|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55899084|NCT00039195|Etoposide|etoposide|mesh-list
55899085|NCT00039195|Vincristine|vincristine|mesh-list
55899086|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55899087|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
56055711|NCT02224729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055712|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
56055713|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055714|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055715|NCT00305643|Celecoxib|celecoxib|mesh-list
56055716|NCT00305643|Capecitabine|capecitabine|mesh-list
56055717|NCT00305643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56055718|NCT00305643|Antimetabolites|antimetabolites|mesh-ancestor
56055719|NCT00305643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055720|NCT00305643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055721|NCT00305643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55899088|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899089|NCT00039195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55899090|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55899091|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
55899092|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899093|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899094|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55899095|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899096|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55899097|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55899099|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899100|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55899101|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
55899102|NCT00039195|Hormones|hormones|mesh-ancestor
55899103|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899104|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55899105|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55899106|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
55899107|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
55899108|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
55899109|NCT05591170|Cholecalciferol|cholecalciferol|mesh-list
55899110|NCT05591170|Vitamin D|vitamin d|mesh-list
55899111|NCT05591170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55899112|NCT05591170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899113|NCT05591170|Vitamins|vitamins|mesh-ancestor
55899114|NCT05591170|Micronutrients|micronutrients|mesh-ancestor
55899115|NCT05591170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55899116|NCT00218439|Paroxetine|paroxetine|mesh-list
55899117|NCT00218439|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55899118|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55899119|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55899120|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899121|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899122|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
55899123|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899124|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55899125|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
55899126|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55899127|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55899128|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55899129|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899130|NCT04344730|Dexamethasone|dexamethasone|mesh-list
55899131|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
55899132|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55899133|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
55899134|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
55899135|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899136|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055723|NCT00305643|Analgesics|analgesics|mesh-ancestor
56055724|NCT00305643|Sensory System Agents|sensory system agents|mesh-ancestor
56055725|NCT00305643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055726|NCT00305643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055727|NCT00305643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56055728|NCT00305643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055729|NCT00305643|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56055730|NCT00305643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56055731|NCT00305643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055732|NCT03004105|Durvalumab|durvalumab|mesh-list
56055736|NCT00271011|Cetuximab|cetuximab|mesh-list
56055737|NCT00271011|Mitomycins|mitomycins|mesh-list
55899137|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899138|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
55899139|NCT04344730|Hormones|hormones|mesh-ancestor
55899140|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899141|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55899142|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899143|NCT05716672|Lazertinib|lazertinib|mesh-list
55899144|NCT05716672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55899145|NCT05716672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899146|NCT05716672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899148|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
55899149|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55899150|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
55899151|NCT00358384|Calcipotriene|calcipotriene|mesh-list
55899152|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55899153|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55899154|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
55899155|NCT00358384|Hormones|hormones|mesh-ancestor
55899156|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899157|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899158|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55899159|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
55899160|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
55899161|NCT02959060|Rifampin|rifampin|mesh-list
55899162|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55899163|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
55899164|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55899165|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899166|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
55899167|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55899168|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899172|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55899173|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55899174|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55899175|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55899176|NCT00109005|Lenalidomide|lenalidomide|mesh-list
55899177|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
55899178|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899179|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55899180|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55899183|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899184|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
56055738|NCT00271011|Mitomycin|mitomycin|mesh-list
56055739|NCT00271011|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56055740|NCT00271011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56055742|NCT00271011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055743|NCT00271011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055744|NCT00271011|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56055745|NCT00271011|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56055746|NCT00271011|Alkylating Agents|alkylating agents|mesh-ancestor
56055747|NCT00271011|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56055748|NCT03312530|Atezolizumab|atezolizumab|mesh-list
56055749|NCT03312530|Venetoclax|venetoclax|mesh-list
56055750|NCT03312530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055751|NCT05697965|Vancomycin|vancomycin|mesh-list
56055752|NCT05697965|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56055753|NCT05697965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899185|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55899186|NCT05353348|Hematinics|hematinics|mesh-ancestor
55899187|NCT05552950|Antiviral Agents|antiviral agents|mesh-list
55899188|NCT05552950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899189|NCT05551936|Rituximab|rituximab|mesh-list
55899190|NCT05551936|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55899191|NCT05551936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899192|NCT05551936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899193|NCT05551936|Immunologic Factors|immunologic factors|mesh-ancestor
55899194|NCT05551936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899195|NCT05551936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55899196|NCT05551936|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55899197|NCT05551936|Alkylating Agents|alkylating agents|mesh-ancestor
55899198|NCT05551936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899199|NCT05715814|Empagliflozin|empagliflozin|mesh-list
55899200|NCT05715814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55899201|NCT05715814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899202|NCT05715814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55899203|NCT05715814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899204|NCT05547100|Olanzapine|olanzapine|mesh-list
55899205|NCT05547100|Antiemetics|antiemetics|mesh-ancestor
55899206|NCT05547100|Autonomic Agents|autonomic agents|mesh-ancestor
55899207|NCT05547100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899208|NCT05547100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899209|NCT05547100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899210|NCT05547100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55899211|NCT05547100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55899212|NCT05547100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899213|NCT05547100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55899214|NCT05547100|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55899215|NCT05547100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55899216|NCT05547100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55899217|NCT05547100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899218|NCT05547100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899219|NCT05547100|Serotonin Agents|serotonin agents|mesh-ancestor
55899220|NCT00109473|Prednisone|prednisone|mesh-list
55899221|NCT00109473|Hormones|hormones|mesh-list
55899222|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55899223|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
55899224|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055754|NCT00179127|Insulin Glargine|insulin glargine|mesh-list
56055755|NCT00179127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56055756|NCT00179127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055757|NCT05720273|Calcitriol|calcitriol|mesh-list
56055758|NCT05720273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56055759|NCT05720273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055760|NCT05720273|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55899225|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899226|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55899227|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899228|NCT05136976|Rituximab|rituximab|mesh-list
55899229|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899230|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899231|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
55899232|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899233|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55899234|NCT00044655|Olanzapine|olanzapine|mesh-list
55899235|NCT00044655|Risperidone|risperidone|mesh-list
55899241|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899242|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899243|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899244|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55899245|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55899246|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899247|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55899248|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55899249|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
55899250|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
55899251|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
55899252|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899253|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899254|NCT00044655|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55899255|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55899256|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55899257|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
55899258|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
55899259|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55899260|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55899261|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55899262|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55899263|NCT05130892|Tranilast|tranilast|mesh-list
55899264|NCT05130892|Colchicine|colchicine|mesh-list
55899265|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
55899266|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55899267|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
55899268|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
55899269|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
55899270|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899271|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899272|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55899273|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55899274|NCT05130892|Analgesics|analgesics|mesh-ancestor
55899275|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
55899276|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899277|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899278|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55899279|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55899280|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55899281|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55899282|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55899283|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
56055761|NCT05720273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56055762|NCT05720273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055764|NCT05720273|Vitamins|vitamins|mesh-ancestor
56055765|NCT05720273|Micronutrients|micronutrients|mesh-ancestor
56055766|NCT05720273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56055767|NCT00183963|Tamoxifen|tamoxifen|mesh-list
56055768|NCT00183963|Fulvestrant|fulvestrant|mesh-list
56055769|NCT00183963|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56055770|NCT00183963|Hormone Antagonists|hormone antagonists|mesh-ancestor
56055771|NCT00183963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055772|NCT00183963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899284|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
55899285|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899286|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55899287|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55899288|NCT05312242|Folic Acid|folic acid|mesh-list
55899289|NCT05312242|Micronutrients|micronutrients|mesh-list
55899290|NCT05312242|Trace Elements|trace elements|mesh-list
55899291|NCT05312242|Hematinics|hematinics|mesh-ancestor
55899292|NCT05312242|Vitamin B Complex|vitamin b complex|mesh-ancestor
55899293|NCT05312242|Vitamins|vitamins|mesh-ancestor
55899294|NCT05312242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899295|NCT00223665|Leuprolide|leuprolide|mesh-list
55899296|NCT00223665|Flutamide|flutamide|mesh-list
55899297|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55899298|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
55899299|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55899300|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899301|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55899302|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899303|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
55899304|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
55899305|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899306|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
55899307|NCT05311540|Astringents|astringents|mesh-ancestor
55899308|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899309|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
55899310|NCT00223821|Oxybutynin|oxybutynin|mesh-list
55899311|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
55899312|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
55899313|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899316|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55899317|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
55899318|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899319|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899320|NCT00223821|Urological Agents|urological agents|mesh-ancestor
55899321|NCT00359164|Bevacizumab|bevacizumab|mesh-list
55899322|NCT00359164|Verteporfin|verteporfin|mesh-list
55899323|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899324|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899325|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55899326|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55899327|NCT00359164|Growth Substances|growth substances|mesh-ancestor
55899328|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899329|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
55899330|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55899331|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
55899332|NCT00224289|Latanoprost|latanoprost|mesh-list
55899333|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55899334|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55899335|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
56055773|NCT00183963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56055774|NCT00183963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055775|NCT00183963|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56055776|NCT00183963|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56055777|NCT00183963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56055778|NCT00183963|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56055779|NCT00176631|Docetaxel|docetaxel|mesh-list
56055780|NCT00176631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055782|NCT00176631|Antimitotic Agents|antimitotic agents|mesh-ancestor
56055783|NCT00176631|Mitosis Modulators|mitosis modulators|mesh-ancestor
56055784|NCT00176631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055785|NCT05719961|Insulin|insulin|mesh-list
56055786|NCT05719961|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56055787|NCT05719961|Insulin Aspart|insulin aspart|mesh-list
56055788|NCT05719961|Insulin, Long-Acting|insulin, long-acting|mesh-list
56055789|NCT05719961|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
56055790|NCT05719961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56055791|NCT05719961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055792|NCT01910636|Sofosbuvir|sofosbuvir|mesh-list
56055793|NCT01910636|Antiviral Agents|antiviral agents|mesh-ancestor
56055794|NCT01910636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055795|NCT04317807|Levetiracetam|levetiracetam|mesh-list
56055796|NCT04317807|Anticonvulsants|anticonvulsants|mesh-ancestor
56055797|NCT04317807|Nootropic Agents|nootropic agents|mesh-ancestor
56055798|NCT05719883|Sirolimus|sirolimus|mesh-list
56055799|NCT05719883|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56055800|NCT05719883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899336|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899337|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899338|NCT00045435|Cyclosporine|cyclosporine|mesh-list
55899339|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
55899340|NCT00045435|Fludarabine|fludarabine|mesh-list
55899341|NCT00045435|Fludarabine phosphate|fludarabine phosphate|mesh-list
55899342|NCT00045435|Cyclosporins|cyclosporins|mesh-list
55899343|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899344|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55899345|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
55899346|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899347|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55899348|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
55899349|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899350|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899351|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
56055801|NCT05719883|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56055802|NCT05719883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055803|NCT05719883|Antifungal Agents|antifungal agents|mesh-ancestor
56055804|NCT05719883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055805|NCT05719883|Immunologic Factors|immunologic factors|mesh-ancestor
56055806|NCT05719883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055807|NCT00118053|Carboplatin|carboplatin|mesh-list
56055808|NCT00118053|Docetaxel|docetaxel|mesh-list
56055809|NCT00118053|Trastuzumab|trastuzumab|mesh-list
56055810|NCT00118053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055811|NCT00118053|Tubulin Modulators|tubulin modulators|mesh-ancestor
56055812|NCT00118053|Antimitotic Agents|antimitotic agents|mesh-ancestor
56055813|NCT00118053|Mitosis Modulators|mitosis modulators|mesh-ancestor
55899352|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899353|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
55899354|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55899355|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55899356|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55899357|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55899358|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
55899359|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55899360|NCT00111657|Rasburicase|rasburicase|mesh-list
55899361|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
55899362|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55899363|NCT05292586|Beclomethasone|beclomethasone|mesh-list
55899364|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
55899365|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55899366|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
55899367|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899368|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899369|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55899370|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
55899371|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55899372|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55899373|NCT05292586|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55899374|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
55899375|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899376|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899377|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55899378|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
55899380|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899382|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
55899383|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55899384|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55899385|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
55899386|NCT02097303|Hormones|hormones|mesh-ancestor
55899387|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899390|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899391|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55899392|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899393|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899394|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
55899395|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55899396|NCT00703326|Docetaxel|docetaxel|mesh-list
55899397|NCT00703326|Ramucirumab|ramucirumab|mesh-list
55899398|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899399|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
55899400|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
55899401|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
55899402|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899403|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
55899404|NCT02097537|Miotics|miotics|mesh-ancestor
55899405|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
56055814|NCT00118053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055815|NCT00118053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899406|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899407|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899408|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55899409|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
55899410|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
55899411|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55899412|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55899413|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
55899414|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899415|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899416|NCT02097849|Interferons|interferons|mesh-list
55899417|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55899418|NCT02097849|Vaccines|vaccines|mesh-list
55899419|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55899420|NCT02097849|Immunologic Factors|immunologic factors|mesh-ancestor
55899421|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899422|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899423|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
55899424|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899426|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55899427|NCT05513560|Pentoxifylline|pentoxifylline|mesh-list
55899428|NCT05513560|Ibudilast|ibudilast|mesh-list
55899431|NCT05513560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899432|NCT05513560|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55899435|NCT05513560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899437|NCT05513560|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55899438|NCT05513560|Antioxidants|antioxidants|mesh-ancestor
55899439|NCT05513560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55899440|NCT05513560|Autonomic Agents|autonomic agents|mesh-ancestor
55899441|NCT05513560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899442|NCT05513560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55899443|NCT05513560|Respiratory System Agents|respiratory system agents|mesh-ancestor
55899444|NCT00047697|Donepezil|donepezil|mesh-list
55899445|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55899446|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899447|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899448|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
55899449|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899450|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899451|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
55899452|NCT05094154|Penicillins|penicillins|mesh-list
55899453|NCT05094154|Cephalosporins|cephalosporins|mesh-list
55899454|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55899455|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899456|NCT02429700|Paclitaxel|paclitaxel|mesh-list
55899457|NCT02429700|Etoposide|etoposide|mesh-list
55899458|NCT02429700|Carboplatin|carboplatin|mesh-list
55899459|NCT02429700|Bleomycin|bleomycin|mesh-list
55899460|NCT02429700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55899461|NCT02429700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899462|NCT02429700|Tubulin Modulators|tubulin modulators|mesh-ancestor
55899463|NCT02429700|Antimitotic Agents|antimitotic agents|mesh-ancestor
55899465|NCT02429700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899467|NCT02429700|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55899468|NCT02429700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055824|NCT04225611|Dexamethasone|dexamethasone|mesh-list
56055825|NCT04225611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56055826|NCT04225611|Antiemetics|antiemetics|mesh-ancestor
56055827|NCT04225611|Autonomic Agents|autonomic agents|mesh-ancestor
56055828|NCT04225611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055829|NCT04225611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055830|NCT04225611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56055831|NCT04225611|Glucocorticoids|glucocorticoids|mesh-ancestor
56055832|NCT04225611|Hormones|hormones|mesh-ancestor
56055833|NCT04225611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055834|NCT04225611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56055835|NCT04225611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899469|NCT02429700|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55899472|NCT02437812|Metformin|metformin|mesh-list
55899473|NCT02437812|Paclitaxel|paclitaxel|mesh-list
55899474|NCT02437812|Carboplatin|carboplatin|mesh-list
55899475|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55899476|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899477|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
55899478|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
55899479|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
55899480|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899481|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55899482|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899483|NCT00112593|Cyclosporine|cyclosporine|mesh-list
55899484|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
55899485|NCT00112593|Fludarabine|fludarabine|mesh-list
55899486|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
55899488|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899489|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55899490|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
55899491|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899492|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55899493|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
55899494|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899495|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899496|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
55899497|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899498|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
55899499|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55899500|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55899501|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55899502|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55899503|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
55899504|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55899506|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
55899507|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
55899508|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
55899509|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55899510|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
55899511|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
55899512|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899513|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55899514|NCT00112671|Sorafenib|sorafenib|mesh-list
55899515|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899516|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55899517|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055837|NCT00379977|Immunologic Factors|immunologic factors|mesh-ancestor
56055838|NCT00379977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055839|NCT05669885|Sildenafil Citrate|sildenafil citrate|mesh-list
56055840|NCT05669885|Vasodilator Agents|vasodilator agents|mesh-ancestor
56055841|NCT05669885|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56055842|NCT05669885|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56055843|NCT05669885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055844|NCT05669885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055845|NCT05669885|Urological Agents|urological agents|mesh-ancestor
56055846|NCT00955929|Sildenafil Citrate|sildenafil citrate|mesh-list
55899518|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899519|NCT05279092|Dexamethasone|dexamethasone|mesh-list
55899520|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
55899521|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55899522|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55899523|NCT05279092|Prednisolone|prednisolone|mesh-list
55899524|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
55899525|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
55899526|NCT05279092|Bupivacaine|bupivacaine|mesh-list
55899527|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55899528|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
55899529|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55899530|NCT05279092|BB 1101|bb 1101|mesh-list
55899531|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55899532|NCT05279092|Antiemetics|antiemetics|mesh-ancestor
55899533|NCT05279092|Autonomic Agents|autonomic agents|mesh-ancestor
55899534|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899535|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899536|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899537|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
55899538|NCT05279092|Hormones|hormones|mesh-ancestor
55899539|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899540|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55899542|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
55899544|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899545|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
55899546|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55899547|NCT05279092|Protective Agents|protective agents|mesh-ancestor
55899548|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
55899549|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899550|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899551|NCT02437656|Metformin|metformin|mesh-list
55899552|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55899553|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899554|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
55899555|NCT05273632|Oxytocin|oxytocin|mesh-list
55899556|NCT05273632|Oxytocics|oxytocics|mesh-ancestor
55899557|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55899558|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899559|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55899560|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55899561|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899562|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
55899563|NCT05273632|Coagulants|coagulants|mesh-ancestor
55899564|NCT02429622|Paclitaxel|paclitaxel|mesh-list
55899565|NCT02429622|Nedaplatin|nedaplatin|mesh-list
55899566|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55899567|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899568|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
55899569|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
55899570|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
55899571|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899572|NCT02429466|Guadecitabine|guadecitabine|mesh-list
55899573|NCT02429466|Azacitidine|azacitidine|mesh-list
56055847|NCT00955929|Alprostadil|alprostadil|mesh-list
56055848|NCT00955929|Vasodilator Agents|vasodilator agents|mesh-ancestor
56055849|NCT00955929|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56055850|NCT00955929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56055851|NCT00955929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055852|NCT00955929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055853|NCT00955929|Urological Agents|urological agents|mesh-ancestor
55899574|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899575|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55899576|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
55899577|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899578|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899579|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
55899580|NCT02429388|Spironolactone|spironolactone|mesh-list
55899581|NCT02429388|Diuretics|diuretics|mesh-list
55899582|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
55899583|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55899584|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
55899585|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899586|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899587|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
55899588|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55899589|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899590|NCT02429232|Pioglitazone|pioglitazone|mesh-list
55899591|NCT02429232|Linagliptin|linagliptin|mesh-list
55899592|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55899593|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899594|NCT02429232|Incretins|incretins|mesh-ancestor
55899595|NCT02429232|Hormones|hormones|mesh-ancestor
55899596|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899597|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55899598|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
55899599|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899600|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899601|NCT03189732|Metformin|metformin|mesh-list
55899602|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55899603|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899605|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55899606|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
55899607|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55899608|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899609|NCT05232994|Metformin|metformin|mesh-list
55899610|NCT05232994|Esomeprazole|esomeprazole|mesh-list
55899611|NCT05232994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55899612|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899613|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55899614|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899617|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899618|NCT02436798|Ondansetron|ondansetron|mesh-list
55899619|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
55899620|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
55899621|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899622|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899623|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899625|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
55899626|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55899627|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
55899628|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899629|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899630|NCT02436798|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55899631|NCT02436798|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55899632|NCT02436798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899633|NCT02436798|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55899634|NCT02436798|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55899635|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
55899636|NCT03185130|Promethazine|promethazine|mesh-list
56055854|NCT00955929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56055859|NCT00357851|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56055860|NCT00357851|Protease Inhibitors|protease inhibitors|mesh-ancestor
56055861|NCT00357851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899637|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
55899638|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55899639|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55899640|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899641|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899642|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
55899643|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
55899644|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
55899645|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899646|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
55899647|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
55899648|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899649|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55899650|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
55899651|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
55899652|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899653|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899654|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55899655|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
55899656|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
55899657|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55899658|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55899659|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55899660|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55899661|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
55899662|NCT00358618|Propofol|propofol|mesh-list
55899663|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55899664|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899665|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899666|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55899667|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
55899668|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
55899669|NCT02428764|Gemcitabine|gemcitabine|mesh-list
55899670|NCT02428764|Carboplatin|carboplatin|mesh-list
55899671|NCT02428764|Nimotuzumab|nimotuzumab|mesh-list
55899672|NCT02428764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899673|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55899674|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
55899675|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899676|NCT02428764|Antiviral Agents|antiviral agents|mesh-ancestor
55899677|NCT02428764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899678|NCT02428764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899679|NCT02428764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55899680|NCT02428764|Immunologic Factors|immunologic factors|mesh-ancestor
55899681|NCT02428764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899682|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899683|NCT00358696|Tenofovir|tenofovir|mesh-list
55899684|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
55899685|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899686|NCT00358696|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55899687|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55899688|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899689|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899692|NCT05050942|Octreotide|octreotide|mesh-list
55899693|NCT05050942|Lanreotide|lanreotide|mesh-list
55899694|NCT05050942|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899695|NCT05050942|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55899696|NCT05050942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899697|NCT05429476|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55899698|NCT05429476|Plasminogen|plasminogen|mesh-list
56055862|NCT00357851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055863|NCT05664659|Misoprostol|misoprostol|mesh-list
56055864|NCT05664659|Oxytocin|oxytocin|mesh-list
56055865|NCT05664659|Carbetocin|carbetocin|mesh-list
56055866|NCT05664659|Oxytocics|oxytocics|mesh-ancestor
56055867|NCT05664659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56055868|NCT05664659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055869|NCT05664659|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56055870|NCT05664659|Abortifacient Agents|abortifacient agents|mesh-ancestor
56055871|NCT05664659|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56055872|NCT05664659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56055873|NCT00358319|Valproic Acid|valproic acid|mesh-list
56055874|NCT00358319|Anticonvulsants|anticonvulsants|mesh-ancestor
56055875|NCT00358319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055876|NCT00358319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055877|NCT00358319|GABA Agents|gaba agents|mesh-ancestor
56055878|NCT00358319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055879|NCT00358319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055880|NCT00358319|Antimanic Agents|antimanic agents|mesh-ancestor
56055881|NCT00358319|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56055882|NCT00358319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055883|NCT00358319|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56055884|NCT05663801|Magnesium Sulfate|magnesium sulfate|mesh-list
56055885|NCT05663801|Ketamine|ketamine|mesh-list
56055886|NCT05663801|Bupivacaine|bupivacaine|mesh-list
56055887|NCT05663801|Anesthetics, Local|anesthetics, local|mesh-ancestor
56055888|NCT05663801|Anesthetics|anesthetics|mesh-ancestor
56055889|NCT05663801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055890|NCT05663801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055891|NCT05663801|Sensory System Agents|sensory system agents|mesh-ancestor
56055892|NCT05663801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055893|NCT05663801|Analgesics|analgesics|mesh-ancestor
56055894|NCT05663801|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56055895|NCT05663801|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56055896|NCT05663801|Anesthetics, General|anesthetics, general|mesh-ancestor
56055902|NCT05663801|Anticonvulsants|anticonvulsants|mesh-ancestor
56055903|NCT05663801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56055904|NCT05663801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56055905|NCT05663801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56055906|NCT05663801|Tocolytic Agents|tocolytic agents|mesh-ancestor
56055907|NCT05663801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56055908|NCT03866499|Gefitinib|gefitinib|mesh-list
56055909|NCT03866499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055910|NCT03866499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56055911|NCT03866499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055912|NCT03866499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055913|NCT05653193|Interferons|interferons|mesh-list
56055914|NCT05653193|Interferon-gamma|interferon-gamma|mesh-list
56055915|NCT05653193|Clotrimazole|clotrimazole|mesh-list
56055916|NCT05653193|Miconazole|miconazole|mesh-list
56055917|NCT05653193|Antifungal Agents|antifungal agents|mesh-list
56055918|NCT05653193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055919|NCT05653193|Antiviral Agents|antiviral agents|mesh-ancestor
56055920|NCT05653193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56055921|NCT05653193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56055922|NCT05653193|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56055923|NCT05653193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56055924|NCT05653193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56055925|NCT05653193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055926|NCT05653193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56055927|NCT05653193|Hormone Antagonists|hormone antagonists|mesh-ancestor
56055928|NCT05653193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56055929|NCT05653193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055930|NCT05653193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56055931|NCT05653193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55899699|NCT05429476|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55899700|NCT05429476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55899701|NCT05429476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899702|NCT00360178|Amlodipine|amlodipine|mesh-list
55899703|NCT00360178|Valsartan|valsartan|mesh-list
55899704|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55899705|NCT00360178|Candesartan|candesartan|mesh-list
55899706|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55899707|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55899708|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55899709|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899710|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56055932|NCT00000105|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56055933|NCT00000105|Freund's Adjuvant|freund's adjuvant|mesh-list
56055934|NCT00000105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56055935|NCT00000105|Immunologic Factors|immunologic factors|mesh-ancestor
56055936|NCT00000105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055937|NCT00000117|Immunoglobulins|immunoglobulins|mesh-list
56055938|NCT00000117|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56055940|NCT00000117|Immunologic Factors|immunologic factors|mesh-ancestor
56055941|NCT00000117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055942|NCT05714345|Cyclophosphamide|cyclophosphamide|mesh-list
56055943|NCT05714345|Fludarabine|fludarabine|mesh-list
56056135|NCT00000735|Antiviral Agents|antiviral agents|mesh-ancestor
56055944|NCT05714345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56055945|NCT05714345|Immunologic Factors|immunologic factors|mesh-ancestor
56055946|NCT05714345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055947|NCT05714345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055948|NCT05714345|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56055949|NCT05714345|Alkylating Agents|alkylating agents|mesh-ancestor
56055950|NCT05714345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055951|NCT05714345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56055952|NCT05714345|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56055953|NCT00000123|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
56055954|NCT00000123|Vasodilator Agents|vasodilator agents|mesh-ancestor
56055955|NCT00000123|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56055956|NCT00000123|Protective Agents|protective agents|mesh-ancestor
56055957|NCT00000123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055959|NCT00380133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56055960|NCT00380133|Glucocorticoids|glucocorticoids|mesh-ancestor
56055961|NCT00380133|Hormones|hormones|mesh-ancestor
56055963|NCT00380133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055976|NCT00000189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56055977|NCT00000189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56055978|NCT00000189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56055979|NCT00000189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56055980|NCT00000189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055981|NCT00000189|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55899711|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899712|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
55899713|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55899714|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55899715|NCT00360178|Diuretics|diuretics|mesh-ancestor
55899716|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
55899717|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55899718|NCT00421720|Sufentanil|sufentanil|mesh-list
55899719|NCT00421720|Remifentanil|remifentanil|mesh-list
55899720|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55899721|NCT00421720|Narcotics|narcotics|mesh-ancestor
55899722|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899723|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899724|NCT00421720|Analgesics|analgesics|mesh-ancestor
55899725|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
55899726|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899727|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55899728|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55899729|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
55899730|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
55899731|NCT05383456|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55899732|NCT05383456|Antiviral Agents|antiviral agents|mesh-ancestor
55899733|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899734|NCT05008276|Dextrans|dextrans|mesh-list
55899735|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
55899736|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
55899737|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
55899738|NCT05382286|Gemcitabine|gemcitabine|mesh-list
55899739|NCT05382286|Paclitaxel|paclitaxel|mesh-list
55899740|NCT05382286|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55899741|NCT05382286|Carboplatin|carboplatin|mesh-list
55899742|NCT05382286|Pembrolizumab|pembrolizumab|mesh-list
55899743|NCT05382286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55899744|NCT05382286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899745|NCT05382286|Tubulin Modulators|tubulin modulators|mesh-ancestor
55899746|NCT05382286|Antimitotic Agents|antimitotic agents|mesh-ancestor
55899747|NCT05382286|Mitosis Modulators|mitosis modulators|mesh-ancestor
55899748|NCT05382286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899749|NCT05382286|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55899750|NCT05382286|Antimetabolites|antimetabolites|mesh-ancestor
55899751|NCT05382286|Antiviral Agents|antiviral agents|mesh-ancestor
55899752|NCT05382286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899753|NCT05382286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899754|NCT05382286|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55899755|NCT05382286|Immunologic Factors|immunologic factors|mesh-ancestor
55899756|NCT05382286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899757|NCT05382286|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899758|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
55899759|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899760|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55899761|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55899762|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899763|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899764|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
55899767|NCT04492306|Protective Agents|protective agents|mesh-ancestor
55899768|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899769|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55899770|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
55899771|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899772|NCT04469842|Mycophenolic Acid|mycophenolic acid|mesh-list
55899773|NCT04469842|Prednisone|prednisone|mesh-list
55899774|NCT04469842|Azathioprine|azathioprine|mesh-list
55899775|NCT04469842|Tacrolimus|tacrolimus|mesh-list
55899776|NCT04469842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55899777|NCT04469842|Glucocorticoids|glucocorticoids|mesh-ancestor
56055982|NCT00000189|Serotonin Agents|serotonin agents|mesh-ancestor
56055983|NCT00000189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56055984|NCT00000189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56055985|NCT02681211|Diphenhydramine|diphenhydramine|mesh-list
56055986|NCT02681211|Promethazine|promethazine|mesh-list
56055987|NCT02681211|Ketorolac|ketorolac|mesh-list
56055988|NCT02681211|Metoclopramide|metoclopramide|mesh-list
56055989|NCT02681211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55899778|NCT04469842|Hormones|hormones|mesh-ancestor
55899779|NCT04469842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899780|NCT04469842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899781|NCT04469842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55899782|NCT04469842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899783|NCT04469842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55899784|NCT04469842|Immunologic Factors|immunologic factors|mesh-ancestor
55899785|NCT04469842|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55899786|NCT04469842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899787|NCT04469842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899788|NCT04469842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55899789|NCT04469842|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55899790|NCT04469842|Antitubercular Agents|antitubercular agents|mesh-ancestor
55899791|NCT04469842|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55899792|NCT04469842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899793|NCT04469842|Antimetabolites|antimetabolites|mesh-ancestor
55899794|NCT04469842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55899795|NCT04469842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55899796|NCT04941898|Factor VIII|factor viii|mesh-list
55899797|NCT04941898|BAX 855|bax 855|mesh-list
55899798|NCT04941898|Coagulants|coagulants|mesh-ancestor
55899799|NCT04468360|Pregnanolone|pregnanolone|mesh-list
55899800|NCT04468360|Brexanolone|brexanolone|mesh-list
55899801|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
55899802|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899803|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899804|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
55899805|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899806|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899807|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
55899808|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
55899809|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
55899810|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899811|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55899812|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899813|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899814|NCT04907110|Niacinamide|niacinamide|mesh-list
55899815|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
55899816|NCT04907110|Vitamins|vitamins|mesh-ancestor
55899818|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899819|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
55899820|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899821|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55899822|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899823|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899824|NCT04887298|Annamycin|annamycin|mesh-list
55899825|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55899826|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899827|NCT02977000|Propranolol|propranolol|mesh-list
55899828|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55899829|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55899830|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
55899831|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899832|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899833|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899834|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55899835|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55755036|NCT05655689|Vancomycin|vancomycin|mesh-list
56055990|NCT02681211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56055991|NCT02681211|Analgesics|analgesics|mesh-ancestor
56055992|NCT02681211|Sensory System Agents|sensory system agents|mesh-ancestor
56055993|NCT02681211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56055994|NCT02681211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56055995|NCT02681211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56055996|NCT02681211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56055997|NCT02681211|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56055998|NCT02681211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899837|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
55899838|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55899843|NCT00112827|Lenograstim|lenograstim|mesh-list
55899844|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55899845|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
55899846|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899847|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55899848|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55899849|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
55899850|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899851|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899852|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55899853|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55899854|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55899855|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55899856|NCT00112827|Growth Substances|growth substances|mesh-ancestor
55899857|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
55899859|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55899860|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55899861|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55899862|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
55899863|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899864|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899865|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899866|NCT04343170|Folic Acid|folic acid|mesh-list
55899867|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
55899868|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
55899869|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
55899870|NCT04343170|Vitamins|vitamins|mesh-ancestor
55899871|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
55899872|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899873|NCT04343170|Hematinics|hematinics|mesh-ancestor
55899874|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
55899875|NCT00226239|Docetaxel|docetaxel|mesh-list
55899876|NCT00226239|Cetuximab|cetuximab|mesh-list
55899878|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
55899879|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
55899880|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
55899881|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899882|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899887|NCT00227019|Folic Acid|folic acid|mesh-list
55899888|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
55899889|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
55899890|NCT00227019|Dexamethasone|dexamethasone|mesh-list
55899891|NCT00227019|Bevacizumab|bevacizumab|mesh-list
55899892|NCT00227019|Pemetrexed|pemetrexed|mesh-list
55899893|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899894|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899895|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55899896|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55899897|NCT00227019|Growth Substances|growth substances|mesh-ancestor
55899898|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899899|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
55899900|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
55899901|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55899902|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
56055999|NCT02681211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056000|NCT02681211|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56056001|NCT02681211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56056002|NCT02681211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056003|NCT02681211|Anesthetics, Local|anesthetics, local|mesh-ancestor
56056004|NCT02681211|Anesthetics|anesthetics|mesh-ancestor
56056005|NCT02681211|Antiemetics|antiemetics|mesh-ancestor
56056006|NCT02681211|Autonomic Agents|autonomic agents|mesh-ancestor
56056007|NCT02681211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56056008|NCT02681211|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56056009|NCT02681211|Histamine Antagonists|histamine antagonists|mesh-ancestor
56056010|NCT02681211|Histamine Agents|histamine agents|mesh-ancestor
56056011|NCT02681211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056012|NCT02681211|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56056013|NCT02681211|Antipruritics|antipruritics|mesh-ancestor
56056014|NCT02681211|Dermatologic Agents|dermatologic agents|mesh-ancestor
56056015|NCT02681211|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56056016|NCT02681211|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56056017|NCT02681211|Dopamine Agents|dopamine agents|mesh-ancestor
56056018|NCT00000195|Naltrexone|naltrexone|mesh-list
56056019|NCT00000195|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55899903|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
55899904|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899905|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899906|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
55899907|NCT00227019|Hormones|hormones|mesh-ancestor
55899908|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55899909|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55899910|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899911|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899912|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55899913|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55899914|NCT00227019|Hematinics|hematinics|mesh-ancestor
55899916|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55899917|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899918|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55899919|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55899920|NCT00113217|Growth Substances|growth substances|mesh-ancestor
55899921|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899922|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
55899924|NCT04718116|Tapentadol|tapentadol|mesh-list
55899925|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55899926|NCT04718116|Narcotics|narcotics|mesh-ancestor
55899927|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899929|NCT04718116|Analgesics|analgesics|mesh-ancestor
55899930|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
55899931|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899932|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55899933|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55899934|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55899935|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056020|NCT00000195|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56056021|NCT00000195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056022|NCT00000195|Sensory System Agents|sensory system agents|mesh-ancestor
56056023|NCT00000195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056025|NCT05716607|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56056026|NCT05716607|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56056027|NCT05716607|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56056028|NCT05716607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56056029|NCT05688371|Dexmedetomidine|dexmedetomidine|mesh-list
56056030|NCT05688371|Morphine|morphine|mesh-list
56056031|NCT05688371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56056032|NCT05688371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056033|NCT05688371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056034|NCT05688371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56056035|NCT05688371|Analgesics|analgesics|mesh-ancestor
56056036|NCT05688371|Sensory System Agents|sensory system agents|mesh-ancestor
56056037|NCT05688371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056038|NCT05688371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56056039|NCT05688371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56056040|NCT05688371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56056041|NCT05688371|Adrenergic Agents|adrenergic agents|mesh-ancestor
56056042|NCT05688371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056043|NCT05688371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056044|NCT05688371|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56056045|NCT05688371|Narcotics|narcotics|mesh-ancestor
56056046|NCT00000201|Selegiline|selegiline|mesh-list
56056047|NCT00000201|Antidepressive Agents|antidepressive agents|mesh-ancestor
56056048|NCT00000201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56056050|NCT00000201|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56056051|NCT00000201|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56056052|NCT00000201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899936|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
55899937|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899938|NCT04429503|Aflibercept|aflibercept|mesh-list
55899939|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55899940|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55899941|NCT04429503|Growth Substances|growth substances|mesh-ancestor
55899942|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056053|NCT00000201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056054|NCT00000201|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56056055|NCT00000201|Protective Agents|protective agents|mesh-ancestor
56056056|NCT00000201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056057|NCT00000207|Buprenorphine|buprenorphine|mesh-list
56056058|NCT00000207|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56056059|NCT00000207|Narcotics|narcotics|mesh-ancestor
56056060|NCT00000207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056061|NCT00000207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056062|NCT00000207|Analgesics|analgesics|mesh-ancestor
56056063|NCT00000207|Sensory System Agents|sensory system agents|mesh-ancestor
56056064|NCT00000207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056065|NCT00000207|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56056066|NCT02295774|Methylene Blue|methylene blue|mesh-list
56056067|NCT02295774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056068|NCT02295774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056069|NCT01807611|Mycophenolic Acid|mycophenolic acid|mesh-list
56056070|NCT01807611|Cyclophosphamide|cyclophosphamide|mesh-list
56056072|NCT01807611|Mechlorethamine|mechlorethamine|mesh-list
56056073|NCT01807611|Thiotepa|thiotepa|mesh-list
56056074|NCT01807611|Fludarabine|fludarabine|mesh-list
56056075|NCT01807611|Lenograstim|lenograstim|mesh-list
56056076|NCT01807611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056077|NCT01807611|Immunologic Factors|immunologic factors|mesh-ancestor
56056078|NCT01807611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056079|NCT01807611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056080|NCT01807611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56056081|NCT01807611|Alkylating Agents|alkylating agents|mesh-ancestor
56056082|NCT01807611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056083|NCT01807611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899943|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
55899944|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899945|NCT04717414|Luspatercept|luspatercept|mesh-list
55899946|NCT04717414|Hematinics|hematinics|mesh-ancestor
55899947|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
55899948|NCT04276792|Narcotics|narcotics|mesh-ancestor
55899949|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899950|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899951|NCT04276792|Analgesics|analgesics|mesh-ancestor
55899952|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
55899953|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899954|NCT00053703|Olanzapine|olanzapine|mesh-list
55899955|NCT00053703|Risperidone|risperidone|mesh-list
55899956|NCT00053703|Molindone|molindone|mesh-list
55899957|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55899958|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
56056084|NCT01807611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56056085|NCT01807611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56056086|NCT01807611|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56056087|NCT01807611|Antitubercular Agents|antitubercular agents|mesh-ancestor
56056088|NCT01807611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56056089|NCT01807611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056090|NCT01807611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056091|NCT01807611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56056092|NCT02977949|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56056093|NCT02977949|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56056094|NCT02977949|Hormone Antagonists|hormone antagonists|mesh-ancestor
56056095|NCT02977949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56056096|NCT02977949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056097|NCT02977949|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56056098|NCT02977949|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56056099|NCT02977949|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56056101|NCT01692717|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56056102|NCT01692717|Atorvastatin|atorvastatin|mesh-list
56056103|NCT01692717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56056104|NCT01692717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56056105|NCT01692717|Antimetabolites|antimetabolites|mesh-ancestor
56056106|NCT01692717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056107|NCT01692717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56056136|NCT00000735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056108|NCT01692717|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56056109|NCT01692717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056110|NCT01692717|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56056111|NCT01692717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56056112|NCT01692717|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56056113|NCT01692717|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56056114|NCT01692717|Diuretics|diuretics|mesh-ancestor
56056115|NCT01692717|Natriuretic Agents|natriuretic agents|mesh-ancestor
56056116|NCT01692717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056117|NCT01692717|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56056120|NCT00355277|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56056122|NCT00355277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56056123|NCT00355277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56056124|NCT00355277|Analgesics|analgesics|mesh-ancestor
56056125|NCT00355277|Sensory System Agents|sensory system agents|mesh-ancestor
56056126|NCT00355277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056127|NCT00355277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056128|NCT00355277|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56056129|NCT00355277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56056130|NCT00355277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55899959|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899960|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899961|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899962|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55899963|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55899964|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899965|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55899966|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55899967|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
55899968|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
55899969|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
55899970|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55899971|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55899972|NCT00053703|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55899973|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55899974|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55899975|NCT02975440|Rifampin|rifampin|mesh-list
55899976|NCT02975440|Midazolam|midazolam|mesh-list
55899977|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55899978|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55899979|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55899980|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899981|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55899982|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55899983|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55899984|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55899985|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
55899987|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
55899988|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
55899989|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55899990|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899993|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55899994|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55899995|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
55899996|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55899997|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899998|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55899999|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55900000|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55900001|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55900002|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55900003|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55900004|NCT00231309|Lenograstim|lenograstim|mesh-list
55900005|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55900006|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
55900007|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900008|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
55900009|NCT04267120|Lenvatinib|lenvatinib|mesh-list
55900010|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900011|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056131|NCT00355277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056133|NCT00355277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056134|NCT00000735|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56056138|NCT00000213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56056139|NCT00000213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56056140|NCT00000213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56056141|NCT00000213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056142|NCT00000213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056143|NCT00000213|Serotonin Agents|serotonin agents|mesh-ancestor
55900013|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900014|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900015|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
55900016|NCT04265872|Bortezomib|bortezomib|mesh-list
55900017|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900018|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900019|NCT00232479|Carboplatin|carboplatin|mesh-list
55900020|NCT00232479|Docetaxel|docetaxel|mesh-list
55900021|NCT00232479|Trastuzumab|trastuzumab|mesh-list
55900022|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900023|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
55900024|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
55900025|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
55900026|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900027|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900028|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
55900029|NCT04710628|Lenvatinib|lenvatinib|mesh-list
55900030|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900031|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900032|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55900033|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900034|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900035|NCT00233103|Sertraline|sertraline|mesh-list
55900036|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
55900037|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55900038|NCT00233103|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55900039|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55900040|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900041|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900042|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900043|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
55900044|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900045|NCT00703014|Progesterone|progesterone|mesh-list
55900046|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55900047|NCT00703014|Ganirelix|ganirelix|mesh-list
55900048|NCT00703014|Progestins|progestins|mesh-ancestor
55900049|NCT00703014|Hormones|hormones|mesh-ancestor
55900050|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900051|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900052|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
55900053|NCT02433522|Rituximab|rituximab|mesh-list
55900054|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900055|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900056|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
55900057|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900058|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900059|NCT00118131|Docetaxel|docetaxel|mesh-list
55900060|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056144|NCT00000213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056145|NCT00000213|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56056146|NCT00000213|Antidepressive Agents|antidepressive agents|mesh-ancestor
56056147|NCT00000213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56056148|NCT00000213|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56056149|NCT00000213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56056150|NCT00000213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056152|NCT00000219|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56056153|NCT00000219|Narcotics|narcotics|mesh-ancestor
56056154|NCT00000219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056155|NCT00000219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056156|NCT00000219|Analgesics|analgesics|mesh-ancestor
55900061|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
55900062|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
55900063|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
55900072|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900073|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
55900074|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55900075|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900076|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
55900079|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55900080|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900081|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55900082|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55900083|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900084|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900085|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900086|NCT04342858|Listerine|listerine|mesh-list
55900087|NCT04342858|Fluorides|fluorides|mesh-list
55900088|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
55900089|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
55900090|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900091|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
55900092|NCT04342858|Protective Agents|protective agents|mesh-ancestor
55900093|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55900094|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900095|NCT02429076|Propofol|propofol|mesh-list
55900096|NCT02429076|Sevoflurane|sevoflurane|mesh-list
55900097|NCT02429076|Methylphenidate|methylphenidate|mesh-list
55900098|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55900099|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900100|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900101|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55900102|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
55900104|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55900105|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55900106|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55900107|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55900108|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55900109|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900110|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900111|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
55900114|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55900115|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
55900116|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56056157|NCT00000219|Sensory System Agents|sensory system agents|mesh-ancestor
56056158|NCT00000219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056159|NCT00000219|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56056160|NCT00000225|Buprenorphine|buprenorphine|mesh-list
56056161|NCT00000225|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56056162|NCT00000225|Narcotics|narcotics|mesh-ancestor
56056163|NCT00000225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056164|NCT00000225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056165|NCT00000225|Analgesics|analgesics|mesh-ancestor
56056166|NCT00000225|Sensory System Agents|sensory system agents|mesh-ancestor
56056167|NCT00000225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056168|NCT00000225|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56056169|NCT02294604|Chlorhexidine|chlorhexidine|mesh-list
56056170|NCT02294604|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56056171|NCT02294604|Povidone-Iodine|povidone-iodine|mesh-list
56056172|NCT02294604|Povidone|povidone|mesh-list
56056173|NCT02294604|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55900117|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900118|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55900119|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55900120|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55900121|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
55900122|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55900123|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55900124|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
55900125|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900126|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
55900127|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55900128|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55900129|NCT04670224|Anesthetics|anesthetics|mesh-list
55900130|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900140|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900141|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55900142|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900143|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900144|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55900145|NCT00361114|Renal Agents|renal agents|mesh-ancestor
55900146|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
55900147|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55900151|NCT04665856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900152|NCT04665856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55900153|NCT04665856|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55900154|NCT04665856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55900155|NCT04665856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900156|NCT04665856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900157|NCT05442580|Cyclophosphamide|cyclophosphamide|mesh-list
55900158|NCT05442580|Fludarabine|fludarabine|mesh-list
55900159|NCT05442580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55900160|NCT05442580|Immunologic Factors|immunologic factors|mesh-ancestor
55900161|NCT05442580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900162|NCT05442580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900163|NCT05442580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55900164|NCT05442580|Alkylating Agents|alkylating agents|mesh-ancestor
56056174|NCT02294604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056175|NCT02294604|Disinfectants|disinfectants|mesh-ancestor
56056176|NCT02294604|Dermatologic Agents|dermatologic agents|mesh-ancestor
56056177|NCT02294604|Plasma Substitutes|plasma substitutes|mesh-ancestor
56056178|NCT02294604|Blood Substitutes|blood substitutes|mesh-ancestor
55900172|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900173|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900174|NCT00702624|Progestins|progestins|mesh-ancestor
55900175|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
55900176|NCT03915496|Abrocitinib|abrocitinib|mesh-list
55900177|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55900178|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900179|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900180|NCT00702546|Hormones|hormones|mesh-list
55900181|NCT00702546|Progesterone|progesterone|mesh-list
55900182|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55900183|NCT00702546|Ganirelix|ganirelix|mesh-list
55900184|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900185|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900187|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
55900188|NCT03876262|Ivermectin|ivermectin|mesh-list
55900189|NCT03876262|Moxidectin|moxidectin|mesh-list
55900190|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55900191|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900192|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
55900193|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
55900194|NCT04648930|Omalizumab|omalizumab|mesh-list
55900195|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55900196|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55900197|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
55900198|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
55900199|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56056195|NCT01645176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056196|NCT01645176|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56056197|NCT01645176|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56056198|NCT01645176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056199|NCT01645176|Antimalarials|antimalarials|mesh-ancestor
56056200|NCT01645176|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56056201|NCT01645176|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55900206|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55900207|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
55900208|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900209|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900211|NCT02428686|Hematinics|hematinics|mesh-ancestor
55900212|NCT02432976|Insulin|insulin|mesh-list
55900213|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55900214|NCT02432976|Exenatide|exenatide|mesh-list
55900215|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
55900216|NCT02432976|Incretins|incretins|mesh-list
55900217|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55900218|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900219|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55900220|NCT02432976|Hormones|hormones|mesh-ancestor
55900221|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900222|NCT02428374|Clopidogrel|clopidogrel|mesh-list
55900223|NCT02428374|Ticagrelor|ticagrelor|mesh-list
55900224|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55900225|NCT02428374|Simvastatin|simvastatin|mesh-list
55900226|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55900227|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55900228|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55900229|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55900232|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900233|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900234|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55900235|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55900236|NCT02428374|Antimetabolites|antimetabolites|mesh-ancestor
55900237|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55900238|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55900239|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900240|NCT04614610|Lidocaine|lidocaine|mesh-list
55900241|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
55900242|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
55900243|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900244|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900245|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
55900246|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900247|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55900248|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55900249|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55900250|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900251|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900252|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55900253|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
55900254|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55900255|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
55900256|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900257|NCT04606576|Insulin|insulin|mesh-list
55900258|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55900259|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55900260|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900261|NCT02428062|Phenylephrine|phenylephrine|mesh-list
55900262|NCT02428062|Dopamine|dopamine|mesh-list
55900263|NCT02428062|Epinephrine|epinephrine|mesh-list
55900264|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
55900265|NCT02428062|Norepinephrine|norepinephrine|mesh-list
55900266|NCT02428062|Ephedrine|ephedrine|mesh-list
56056203|NCT01645176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056204|NCT03465735|Heparin|heparin|mesh-list
56056205|NCT03465735|Enoxaparin|enoxaparin|mesh-list
56056206|NCT03465735|Dalteparin|dalteparin|mesh-list
56056207|NCT03465735|Warfarin|warfarin|mesh-list
56056208|NCT03465735|Rivaroxaban|rivaroxaban|mesh-list
56056209|NCT03465735|Dabigatran|dabigatran|mesh-list
56056210|NCT03465735|Apixaban|apixaban|mesh-list
56056211|NCT03465735|Edoxaban|edoxaban|mesh-list
56056212|NCT03465735|Anticoagulants|anticoagulants|mesh-ancestor
56056213|NCT03465735|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55900267|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55900268|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900269|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55900285|NCT02428062|Protective Agents|protective agents|mesh-ancestor
55900286|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55900289|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
55900290|NCT04594798|Rituximab|rituximab|mesh-list
55900291|NCT04594798|Doxorubicin|doxorubicin|mesh-list
55900292|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55900293|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
55900294|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900295|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900296|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55900297|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
55900298|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900299|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900300|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55900301|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900302|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55900303|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55900304|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55900305|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900306|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55900307|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
55900308|NCT04594798|Hormones|hormones|mesh-ancestor
55900309|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900310|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55900320|NCT04108156|Ranibizumab|ranibizumab|mesh-list
55900321|NCT04108156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55900322|NCT04108156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55900323|NCT04108156|Growth Substances|growth substances|mesh-ancestor
55900795|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
55900324|NCT04108156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900325|NCT04108156|Growth Inhibitors|growth inhibitors|mesh-ancestor
55900326|NCT04108156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900327|NCT02432664|Midazolam|midazolam|mesh-list
55900328|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55900329|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55900330|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900331|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900332|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55900333|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55900335|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55900336|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
55900337|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
55900338|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
55900339|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
55900341|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900342|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
55900343|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900344|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900345|NCT00361894|Enoxaparin|enoxaparin|mesh-list
55900346|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
55900347|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55900348|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
55900349|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56056214|NCT03465735|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56056215|NCT03465735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056216|NCT03465735|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56056217|NCT03465735|Antithrombins|antithrombins|mesh-ancestor
56056218|NCT03465735|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56056219|NCT03465735|Protease Inhibitors|protease inhibitors|mesh-ancestor
56056220|NCT03465735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056221|NCT05637671|Paroxetine|paroxetine|mesh-list
56056222|NCT05637671|Oxybutynin|oxybutynin|mesh-list
56056223|NCT05637671|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56056224|NCT05637671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56056225|NCT05637671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56056226|NCT05637671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056227|NCT05637671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900350|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
55900351|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900352|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900353|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
55900354|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55900355|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55900357|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900358|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900359|NCT04550494|Talazoparib|talazoparib|mesh-list
55900360|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55900361|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900362|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900363|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900364|NCT00361348|Heparin|heparin|mesh-list
55900365|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
55900366|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55900367|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55900368|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900369|NCT02431728|Melatonin|melatonin|mesh-list
55900370|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
55900371|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900372|NCT02431728|Protective Agents|protective agents|mesh-ancestor
55900373|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900374|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900375|NCT04343326|Menthol|menthol|mesh-list
55900376|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
55900377|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
55900378|NCT00362206|Simvastatin|simvastatin|mesh-list
55900379|NCT00362206|Pravastatin|pravastatin|mesh-list
55900380|NCT00362206|Fenofibrate|fenofibrate|mesh-list
55900381|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55900382|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55900383|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
55900384|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900385|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55900386|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55900387|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900388|NCT02404870|Canagliflozin|canagliflozin|mesh-list
55900389|NCT02404870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55900390|NCT02404870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900391|NCT02404870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55900392|NCT02404870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900393|NCT03669718|Cemiplimab|cemiplimab|mesh-list
56056228|NCT05637671|Serotonin Agents|serotonin agents|mesh-ancestor
56056229|NCT05637671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056230|NCT05637671|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56056231|NCT05637671|Antidepressive Agents|antidepressive agents|mesh-ancestor
56056232|NCT05637671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56056233|NCT05637671|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56056234|NCT05637671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56056235|NCT05637671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056236|NCT05637671|Parasympatholytics|parasympatholytics|mesh-ancestor
56056237|NCT05637671|Autonomic Agents|autonomic agents|mesh-ancestor
56056238|NCT05637671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056239|NCT05637671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56056240|NCT05637671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56056241|NCT05637671|Cholinergic Agents|cholinergic agents|mesh-ancestor
56056242|NCT05637671|Urological Agents|urological agents|mesh-ancestor
56056243|NCT02322216|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56056244|NCT02322216|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56056245|NCT02322216|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56056246|NCT02322216|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56056247|NCT02322216|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56056248|NCT02322216|Analgesics|analgesics|mesh-ancestor
56056249|NCT02322216|Sensory System Agents|sensory system agents|mesh-ancestor
56056250|NCT02322216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056252|NCT02322216|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56056253|NCT02322216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056254|NCT02322216|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56056255|NCT02322216|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56056256|NCT02322216|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56056257|NCT02322216|Histamine Antagonists|histamine antagonists|mesh-ancestor
56056258|NCT02322216|Histamine Agents|histamine agents|mesh-ancestor
56056259|NCT02322216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056260|NCT02322216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056262|NCT03447639|Povidone|povidone|mesh-list
56056266|NCT03447639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056267|NCT05631899|Cyclophosphamide|cyclophosphamide|mesh-list
56056268|NCT05631899|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56056269|NCT05631899|Paclitaxel|paclitaxel|mesh-list
56056270|NCT05631899|Antibodies|antibodies|mesh-list
56056271|NCT05631899|Immunoglobulins|immunoglobulins|mesh-list
56056272|NCT05631899|Antibodies, Blocking|antibodies, blocking|mesh-list
56056273|NCT05631899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056274|NCT05631899|Immunologic Factors|immunologic factors|mesh-ancestor
56056275|NCT05631899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056276|NCT05631899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056277|NCT05631899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56056278|NCT05631899|Alkylating Agents|alkylating agents|mesh-ancestor
56056279|NCT05631899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056280|NCT05631899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056281|NCT05631899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56056282|NCT05631899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56056283|NCT05631899|Tubulin Modulators|tubulin modulators|mesh-ancestor
56056284|NCT05631899|Antimitotic Agents|antimitotic agents|mesh-ancestor
56056285|NCT05631899|Mitosis Modulators|mitosis modulators|mesh-ancestor
56056286|NCT03425799|Tranexamic Acid|tranexamic acid|mesh-list
56056287|NCT03425799|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56056288|NCT03425799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56056289|NCT03425799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056290|NCT03425799|Hemostatics|hemostatics|mesh-ancestor
55900394|NCT03669718|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900395|NCT03669718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900396|NCT02314468|Glycerol|glycerol|mesh-list
55900397|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55900398|NCT02314468|Protective Agents|protective agents|mesh-ancestor
55900399|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900400|NCT01704287|Paclitaxel|paclitaxel|mesh-list
55900401|NCT01704287|Carboplatin|carboplatin|mesh-list
55900402|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
55900403|NCT01704287|Temozolomide|temozolomide|mesh-list
55900404|NCT01704287|Dacarbazine|dacarbazine|mesh-list
55900405|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55900406|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900407|NCT01704287|Tubulin Modulators|tubulin modulators|mesh-ancestor
55900408|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
55900409|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
55900410|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900411|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900412|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55900413|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
55900414|NCT00362752|Norfloxacin|norfloxacin|mesh-list
55900421|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900422|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56056291|NCT03425799|Coagulants|coagulants|mesh-ancestor
56056292|NCT03363633|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
56056293|NCT03363633|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
56056294|NCT03363633|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56056296|NCT03360903|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56056297|NCT03360903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056298|NCT03360903|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56056299|NCT03360903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056300|NCT03360903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056301|NCT03360903|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56056302|NCT03360903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56056303|NCT03360903|Purinergic Agents|purinergic agents|mesh-ancestor
56056304|NCT03360903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056305|NCT00000231|Buprenorphine|buprenorphine|mesh-list
56056306|NCT00000231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56056307|NCT00000231|Narcotics|narcotics|mesh-ancestor
56056308|NCT00000231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056309|NCT00000231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056310|NCT00000231|Analgesics|analgesics|mesh-ancestor
56056311|NCT00000231|Sensory System Agents|sensory system agents|mesh-ancestor
56056312|NCT00000231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056313|NCT00000231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56056314|NCT00000237|Buprenorphine|buprenorphine|mesh-list
56056315|NCT00000237|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56056316|NCT00000237|Narcotics|narcotics|mesh-ancestor
56056317|NCT00000237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056318|NCT00000237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056319|NCT00000237|Analgesics|analgesics|mesh-ancestor
56056320|NCT00000237|Sensory System Agents|sensory system agents|mesh-ancestor
56056321|NCT00000237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900423|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55900424|NCT00118209|Prednisone|prednisone|mesh-list
55900425|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
55900426|NCT00118209|Rituximab|rituximab|mesh-list
55900427|NCT00118209|Doxorubicin|doxorubicin|mesh-list
55900428|NCT00118209|Etoposide|etoposide|mesh-list
55900429|NCT00118209|Vincristine|vincristine|mesh-list
55900430|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55900431|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
55900432|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900433|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900434|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56056322|NCT00000237|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56056323|NCT00000765|Zidovudine|zidovudine|mesh-list
56056324|NCT00000765|Antimetabolites|antimetabolites|mesh-ancestor
56056325|NCT00000765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056326|NCT00000765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56056327|NCT00000765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56056328|NCT00000765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056329|NCT00000765|Antiviral Agents|antiviral agents|mesh-ancestor
56056330|NCT00000765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056331|NCT00000765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56056332|NCT00000765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056333|NCT00000243|Buprenorphine|buprenorphine|mesh-list
56056334|NCT00000243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56056335|NCT00000243|Narcotics|narcotics|mesh-ancestor
56056336|NCT00000243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056337|NCT00000243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056338|NCT00000243|Analgesics|analgesics|mesh-ancestor
56056339|NCT00000243|Sensory System Agents|sensory system agents|mesh-ancestor
55900435|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
55900436|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900437|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900438|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55900796|NCT04768439|Vitamin D|vitamin d|mesh-list
55900439|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900440|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55900441|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55900442|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55900443|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900445|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
55900446|NCT00118209|Hormones|hormones|mesh-ancestor
55900447|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900448|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55900449|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55900450|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
55900451|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
55900452|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
55900453|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
55900454|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900455|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900456|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55900457|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900458|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
55900459|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
55900460|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55900461|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55900462|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900463|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900464|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900465|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900466|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
55900467|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
55900468|NCT01682837|Citric Acid|citric acid|mesh-list
55900469|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
55900470|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
55900471|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55900472|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
55900473|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
55900474|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056340|NCT00000243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056341|NCT00000243|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56056342|NCT00000771|Paromomycin|paromomycin|mesh-list
56056343|NCT00000771|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56056344|NCT00000771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056345|NCT00000771|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56056346|NCT00000771|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56056347|NCT05575505|Pentoxifylline|pentoxifylline|mesh-list
56056348|NCT05575505|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56056349|NCT05575505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056350|NCT05575505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056351|NCT05575505|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56056352|NCT05575505|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56056353|NCT05575505|Protective Agents|protective agents|mesh-ancestor
56056354|NCT05575505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900475|NCT01682837|Diuretics|diuretics|mesh-ancestor
55900476|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
55900477|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900478|NCT01682837|Expectorants|expectorants|mesh-ancestor
55900479|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
55900480|NCT01682837|Cathartics|cathartics|mesh-ancestor
55900481|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55900482|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
55900483|NCT02213068|Abatacept|abatacept|mesh-list
55900484|NCT02213068|Tacrolimus|tacrolimus|mesh-list
55900488|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55900489|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900490|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900491|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55900502|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900503|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900504|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
55900505|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55900506|NCT04483284|Estrogens|estrogens|mesh-ancestor
55900507|NCT04483284|Hormones|hormones|mesh-ancestor
55900508|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900509|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900510|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55900511|NCT04483284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900512|NCT00235833|Adalimumab|adalimumab|mesh-list
55900513|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55900514|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900515|NCT00255801|Doxorubicin|doxorubicin|mesh-list
55900516|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55900517|NCT00255801|Bexarotene|bexarotene|mesh-list
55900518|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55900519|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900520|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56056355|NCT05575505|Vasodilator Agents|vasodilator agents|mesh-ancestor
56056356|NCT05575505|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56056358|NCT00000249|Nitrous Oxide|nitrous oxide|mesh-list
56056359|NCT00000249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56056360|NCT00000249|Anesthetics, General|anesthetics, general|mesh-ancestor
56056361|NCT00000249|Anesthetics|anesthetics|mesh-ancestor
56056362|NCT00000249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056363|NCT00000249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056364|NCT00000249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56056365|NCT00000249|Analgesics|analgesics|mesh-ancestor
56056366|NCT00000249|Sensory System Agents|sensory system agents|mesh-ancestor
56056367|NCT00000249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056368|NCT00000261|Nitrous Oxide|nitrous oxide|mesh-list
56056369|NCT00000261|Sevoflurane|sevoflurane|mesh-list
55900521|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55900522|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900523|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900524|NCT02431416|Hormones|hormones|mesh-list
55900525|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900526|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900527|NCT04751955|Capecitabine|capecitabine|mesh-list
55900528|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55900529|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
55900530|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900531|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900532|NCT01682759|Metformin|metformin|mesh-list
55900533|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
55900543|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900544|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
55900545|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55900546|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55900547|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55900548|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900549|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900550|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
55900551|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900552|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900553|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55900554|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900556|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55900557|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
55900558|NCT00240981|Testosterone|testosterone|mesh-list
55900559|NCT00240981|Androgens|androgens|mesh-ancestor
55900564|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900565|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55900566|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900567|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900568|NCT04134923|Corticosterone|corticosterone|mesh-list
55900569|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55900570|NCT02126553|Lenalidomide|lenalidomide|mesh-list
55900571|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
55900572|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900573|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55900574|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55900575|NCT02126553|Growth Substances|growth substances|mesh-ancestor
55900576|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
55900577|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900578|NCT01703741|Testosterone|testosterone|mesh-list
55900579|NCT01703741|Androgens|androgens|mesh-ancestor
55900581|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900582|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900583|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
55900584|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55900585|NCT02425176|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55900586|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55900587|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55900588|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900589|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900590|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
55900591|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900592|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900593|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55900594|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900595|NCT02430714|Lenvatinib|lenvatinib|mesh-list
55900596|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900608|NCT02426736|Bupivacaine|bupivacaine|mesh-list
55900609|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55900610|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
55900611|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
55900612|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900613|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900614|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55900615|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
55900617|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900618|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55900619|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900620|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
55900621|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
55900622|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900623|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
55900624|NCT03182634|Olaparib|olaparib|mesh-list
55900625|NCT03182634|Fulvestrant|fulvestrant|mesh-list
55900626|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55900627|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900628|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900629|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900630|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55900631|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55900641|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
55900642|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55900643|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55900644|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900645|NCT03185364|Urological Agents|urological agents|mesh-ancestor
55900646|NCT02424552|Vitamin D|vitamin d|mesh-list
55900647|NCT02424552|Cholecalciferol|cholecalciferol|mesh-list
55900648|NCT02424552|Vitamins|vitamins|mesh-ancestor
55900649|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
55900650|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900651|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55900652|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55900653|NCT03182088|Norepinephrine|norepinephrine|mesh-list
55900654|NCT03182088|Bupivacaine|bupivacaine|mesh-list
55900655|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
55900656|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
55900657|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900660|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900661|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55900662|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55900663|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
55900664|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900665|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900666|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
55900667|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
55900668|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55900669|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
55900670|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55900671|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
55900672|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55900673|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900674|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55900675|NCT02425722|Linaclotide|linaclotide|mesh-list
55900676|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55900677|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
55900678|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900679|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55900681|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55900682|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55900683|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55900684|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
55900685|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900686|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900687|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900688|NCT03609580|Urological Agents|urological agents|mesh-ancestor
55900689|NCT02061514|Propofol|propofol|mesh-list
55900690|NCT02061514|Desflurane|desflurane|mesh-list
55900691|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55900692|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900693|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900694|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55900695|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
55900696|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
55900700|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900702|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
55900703|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55900704|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900705|NCT03179280|Insulin|insulin|mesh-list
55900706|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
55900707|NCT03179280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55900708|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900709|NCT01681433|Prednisone|prednisone|mesh-list
55900710|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
55900711|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55900712|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
55900713|NCT01681433|Hormones|hormones|mesh-ancestor
55900714|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900715|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900716|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55900717|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900728|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900729|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900730|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55900731|NCT01703117|Protective Agents|protective agents|mesh-ancestor
55900732|NCT01702961|Cytarabine|cytarabine|mesh-list
55900733|NCT01702961|Etoposide|etoposide|mesh-list
55900734|NCT01702961|Rituximab|rituximab|mesh-list
55900735|NCT01702961|Melphalan|melphalan|mesh-list
55900736|NCT01702961|Carmustine|carmustine|mesh-list
55900737|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55900738|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900739|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55900740|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55900741|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900742|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900743|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55900744|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
55900745|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
55740316|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55900746|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900747|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55900748|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
55900749|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900750|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900751|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900752|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55900753|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
55900754|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55900756|NCT01702025|Methazolamide|methazolamide|mesh-list
55900757|NCT01702025|Theophylline|theophylline|mesh-list
55900758|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55900759|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
55900760|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900761|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900762|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55900763|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
55900764|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55900765|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900766|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900767|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
55900768|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55900769|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55900788|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
55900789|NCT02426112|Azithromycin|azithromycin|mesh-list
55900790|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55900791|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900792|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
55900793|NCT03117192|Astringents|astringents|mesh-ancestor
55900794|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900818|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900819|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900820|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
55900821|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900822|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55900823|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55900824|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55900825|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900834|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
55900835|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900836|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900837|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55900838|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55900839|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55900840|NCT02416128|Prednisolone|prednisolone|mesh-list
55900841|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55900842|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
55900845|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55900846|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
55900847|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55900848|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
55900849|NCT02416128|Hormones|hormones|mesh-ancestor
56056370|NCT00000261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56056371|NCT00000261|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56056372|NCT00000261|Anesthetics, General|anesthetics, general|mesh-ancestor
56056373|NCT00000261|Anesthetics|anesthetics|mesh-ancestor
56056374|NCT00000261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056375|NCT00000261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056376|NCT00000261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56056377|NCT00000261|Analgesics|analgesics|mesh-ancestor
56056378|NCT00000261|Sensory System Agents|sensory system agents|mesh-ancestor
56056379|NCT00000261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056380|NCT00000801|Cytarabine|cytarabine|mesh-list
56056381|NCT00000801|Dexamethasone|dexamethasone|mesh-list
56056382|NCT00000801|Cyclophosphamide|cyclophosphamide|mesh-list
56056415|NCT00000801|Mitosis Modulators|mitosis modulators|mesh-ancestor
56056416|NCT00000267|Risperidone|risperidone|mesh-list
56056417|NCT00000267|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56056418|NCT00000267|Serotonin Agents|serotonin agents|mesh-ancestor
56056419|NCT00000267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056420|NCT00000267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056421|NCT00000267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056422|NCT00000267|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56056423|NCT00000267|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56056424|NCT00000267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056425|NCT00000267|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56056426|NCT00000267|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56056427|NCT00000267|Dopamine Agents|dopamine agents|mesh-ancestor
56056428|NCT00000807|Etoposide|etoposide|mesh-list
56056429|NCT00000807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56056430|NCT00000807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056431|NCT00000807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56056432|NCT00000807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56056433|NCT00000807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056434|NCT00000807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056442|NCT00001677|Antimetabolites|antimetabolites|mesh-ancestor
56056443|NCT00001677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056456|NCT00001689|Antimitotic Agents|antimitotic agents|mesh-ancestor
56056457|NCT00001689|Mitosis Modulators|mitosis modulators|mesh-ancestor
56056458|NCT00001689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056459|NCT00001713|Heparin|heparin|mesh-list
56056460|NCT00001713|Plasminogen|plasminogen|mesh-list
56056461|NCT00001713|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56056462|NCT00001713|Warfarin|warfarin|mesh-list
56056463|NCT00001713|Anticoagulants|anticoagulants|mesh-ancestor
56056464|NCT00001713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56056465|NCT00001713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56056466|NCT00001713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056467|NCT00000273|Fentanyl|fentanyl|mesh-list
56056468|NCT00000273|Morphine|morphine|mesh-list
56056469|NCT00000273|Oxycodone|oxycodone|mesh-list
56056470|NCT00000273|Buprenorphine|buprenorphine|mesh-list
56056471|NCT00000273|Methadone|methadone|mesh-list
56056472|NCT00000273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56056473|NCT00000273|Narcotics|narcotics|mesh-ancestor
56056474|NCT00000273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56056475|NCT00000273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056476|NCT00000273|Analgesics|analgesics|mesh-ancestor
56056477|NCT00000273|Sensory System Agents|sensory system agents|mesh-ancestor
56056478|NCT00000273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056479|NCT00000273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56056480|NCT00000273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56056482|NCT00000273|Anesthetics|anesthetics|mesh-ancestor
56056507|NCT00000279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056508|NCT00000825|Aldesleukin|aldesleukin|mesh-list
56056509|NCT00000825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056510|NCT00000825|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56056511|NCT00000825|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056512|NCT00000825|Antiviral Agents|antiviral agents|mesh-ancestor
56056513|NCT00000825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056514|NCT00000285|Phenytoin|phenytoin|mesh-list
56056515|NCT00000285|Anticonvulsants|anticonvulsants|mesh-ancestor
56056516|NCT00000285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56056557|NCT00000291|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56056558|NCT00000291|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56056559|NCT00000291|Adrenergic Agents|adrenergic agents|mesh-ancestor
56056560|NCT00000291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056561|NCT00000291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056562|NCT00000291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056563|NCT00000291|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56056564|NCT00000291|Sympathomimetics|sympathomimetics|mesh-ancestor
56056565|NCT00000291|Autonomic Agents|autonomic agents|mesh-ancestor
56056566|NCT00000291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056567|NCT00000291|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56056574|NCT00000861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056575|NCT00000861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56056576|NCT00000861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056577|NCT00000861|Antiviral Agents|antiviral agents|mesh-ancestor
56056578|NCT00000861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056579|NCT00000297|Labetalol|labetalol|mesh-list
56056580|NCT00000297|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56056581|NCT00000297|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56056582|NCT00000297|Adrenergic Agents|adrenergic agents|mesh-ancestor
56056583|NCT00000297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056584|NCT00000297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056585|NCT00000297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056586|NCT00000297|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56056587|NCT00000297|Sympathomimetics|sympathomimetics|mesh-ancestor
56056588|NCT00000297|Autonomic Agents|autonomic agents|mesh-ancestor
56056589|NCT00000297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056595|NCT00359879|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56056596|NCT00359879|Incretins|incretins|mesh-ancestor
56056597|NCT00359879|Hormones|hormones|mesh-ancestor
56056598|NCT00359879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56056599|NCT00000303|Baclofen|baclofen|mesh-list
56056600|NCT00000303|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56056601|NCT00000303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056602|NCT00000303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56056603|NCT00000303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056604|NCT00000303|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56056605|NCT00000303|GABA Agonists|gaba agonists|mesh-ancestor
56056606|NCT00000303|GABA Agents|gaba agents|mesh-ancestor
56056607|NCT00000303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056608|NCT00000303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056609|NCT00001785|Interferons|interferons|mesh-list
56056610|NCT00001785|Interferon-beta|interferon-beta|mesh-list
56056611|NCT00001785|Interferon beta-1a|interferon beta-1a|mesh-list
56056612|NCT00001785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056613|NCT00001785|Antiviral Agents|antiviral agents|mesh-ancestor
56056614|NCT00001785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056615|NCT00001785|Immunologic Factors|immunologic factors|mesh-ancestor
56056616|NCT00001785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056617|NCT00001785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56056618|NCT00001827|Aldesleukin|aldesleukin|mesh-list
56056644|NCT00001839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056645|NCT00001839|Dermatologic Agents|dermatologic agents|mesh-ancestor
56056646|NCT00001839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056647|NCT00001839|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56056648|NCT05536349|Valacyclovir|valacyclovir|mesh-list
56056649|NCT05536349|Venetoclax|venetoclax|mesh-list
56056650|NCT05536349|Obinutuzumab|obinutuzumab|mesh-list
56056651|NCT05536349|Allopurinol|allopurinol|mesh-list
56056652|NCT05536349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056653|NCT05536349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56056654|NCT05536349|Antimetabolites|antimetabolites|mesh-ancestor
56056655|NCT05536349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056656|NCT05536349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056699|NCT00000897|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56056700|NCT00000897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56056702|NCT00000897|Antiviral Agents|antiviral agents|mesh-ancestor
56056703|NCT00000897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056704|NCT00000897|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56056705|NCT00000897|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056706|NCT05347979|Dabigatran|dabigatran|mesh-list
56056707|NCT05347979|Antithrombins|antithrombins|mesh-ancestor
56056708|NCT05347979|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56056709|NCT05347979|Protease Inhibitors|protease inhibitors|mesh-ancestor
56056710|NCT05347979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056711|NCT05347979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056712|NCT05347979|Anticoagulants|anticoagulants|mesh-ancestor
56056713|NCT05533697|Pembrolizumab|pembrolizumab|mesh-list
56056714|NCT05533697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56056715|NCT05533697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056716|NCT00000909|Aldesleukin|aldesleukin|mesh-list
56056717|NCT00000909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056718|NCT00000909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56056719|NCT00000909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56056720|NCT00000909|Antiviral Agents|antiviral agents|mesh-ancestor
56056721|NCT00000909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056722|NCT05444699|Prednisolone|prednisolone|mesh-list
56056723|NCT05444699|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56056724|NCT05444699|Methylprednisolone|methylprednisolone|mesh-list
56056725|NCT05444699|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56056726|NCT05444699|Prednisolone acetate|prednisolone acetate|mesh-list
55740321|NCT03731923|Liver Extracts|liver extracts|mesh-list
56056727|NCT05444699|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56056728|NCT05444699|Prednisolone phosphate|prednisolone phosphate|mesh-list
56056729|NCT05444699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56056730|NCT05444699|Glucocorticoids|glucocorticoids|mesh-ancestor
56056742|NCT00001863|Leflunomide|leflunomide|mesh-list
56056743|NCT00001863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056744|NCT00001863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056745|NCT00001863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056746|NCT00001863|Immunologic Factors|immunologic factors|mesh-ancestor
56056747|NCT00001863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056748|NCT05530655|Lisinopril|lisinopril|mesh-list
56056749|NCT05530655|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56056750|NCT05530655|Protease Inhibitors|protease inhibitors|mesh-ancestor
56056751|NCT05530655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056752|NCT05530655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056753|NCT05530655|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56056754|NCT05530655|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56056755|NCT05530655|Protective Agents|protective agents|mesh-ancestor
56056756|NCT05530655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056757|NCT00000921|Prednisone|prednisone|mesh-list
56056758|NCT00000921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56056759|NCT00000921|Glucocorticoids|glucocorticoids|mesh-ancestor
56056760|NCT00000921|Hormones|hormones|mesh-ancestor
56056761|NCT00000921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56056762|NCT00000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056763|NCT00000921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56056764|NCT00000921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056765|NCT02321436|Botulinum Toxins|botulinum toxins|mesh-list
56056766|NCT02321436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56056767|NCT02321436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56056768|NCT02321436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56056769|NCT02321436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56056770|NCT02321436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056771|NCT02321436|Cholinergic Agents|cholinergic agents|mesh-ancestor
56056772|NCT02321436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900850|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900851|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056777|NCT05325515|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56056778|NCT05325515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056780|NCT00000939|Didanosine|didanosine|mesh-list
56056781|NCT00000939|Stavudine|stavudine|mesh-list
56056782|NCT00000939|Hydroxyurea|hydroxyurea|mesh-list
56056783|NCT00000939|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56056784|NCT00000939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56056785|NCT00000939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056786|NCT00000939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056787|NCT00000939|Antiviral Agents|antiviral agents|mesh-ancestor
56056833|NCT05322707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056834|NCT05322707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056835|NCT05322707|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56056836|NCT05322707|Respiratory System Agents|respiratory system agents|mesh-ancestor
56056837|NCT05322707|Glucocorticoids|glucocorticoids|mesh-ancestor
56056839|NCT05322707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56056840|NCT05322707|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56056841|NCT05322707|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56056842|NCT05322707|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56056843|NCT05322707|Adrenergic Agents|adrenergic agents|mesh-ancestor
56056844|NCT05322707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056845|NCT05322707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056846|NCT02319642|Certolizumab Pegol|certolizumab pegol|mesh-list
56056847|NCT02319642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56056848|NCT02319642|Immunologic Factors|immunologic factors|mesh-ancestor
56056849|NCT02319642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056850|NCT02319642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056851|NCT00001893|Etanercept|etanercept|mesh-list
56056852|NCT00001893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56056853|NCT00001893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56056854|NCT00001893|Analgesics|analgesics|mesh-ancestor
56056855|NCT00001893|Sensory System Agents|sensory system agents|mesh-ancestor
56056856|NCT00001893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56056857|NCT00001893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056858|NCT00001893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56056859|NCT00001893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56056877|NCT00000987|Doxorubicin|doxorubicin|mesh-list
56056878|NCT00000987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56056879|NCT00000987|Bleomycin|bleomycin|mesh-list
56056880|NCT00000987|Vincristine|vincristine|mesh-list
56056881|NCT00000987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56056882|NCT00000987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056934|NCT00359177|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56056935|NCT00359177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56056936|NCT00359177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056937|NCT00001017|Fluconazole|fluconazole|mesh-list
56056938|NCT00001017|Amphotericin B|amphotericin b|mesh-list
56056939|NCT00001017|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56056940|NCT00001017|Antifungal Agents|antifungal agents|mesh-ancestor
56056941|NCT00001017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056942|NCT00001017|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56056943|NCT00001017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56056944|NCT00001017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056945|NCT00001017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056946|NCT00001017|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56056947|NCT00001017|Hormone Antagonists|hormone antagonists|mesh-ancestor
56056948|NCT00001017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56056949|NCT00001017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056950|NCT00001017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56056951|NCT00001017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56056952|NCT00001017|Amebicides|amebicides|mesh-ancestor
56056953|NCT00001017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56056954|NCT00001017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56056955|NCT00001017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56056956|NCT02279862|Ipilimumab|ipilimumab|mesh-list
56056957|NCT02279862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56056958|NCT02279862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056959|NCT02279862|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56056960|NCT02279862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056961|NCT00001965|Cyclosporine|cyclosporine|mesh-list
56056962|NCT00001965|Cyclosporins|cyclosporins|mesh-list
56056963|NCT00001965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056974|NCT05513027|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56056975|NCT05513027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056977|NCT00001023|Clarithromycin|clarithromycin|mesh-list
56056978|NCT00001023|Rifabutin|rifabutin|mesh-list
56056979|NCT00001023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56056980|NCT00001023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056981|NCT00001023|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56056982|NCT00001023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56056983|NCT00001023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56056984|NCT00001023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56056985|NCT00001023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56056986|NCT00001023|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56056987|NCT00001023|Antitubercular Agents|antitubercular agents|mesh-ancestor
56056988|NCT00001035|Interferons|interferons|mesh-list
56056989|NCT00001035|Interferon-alpha|interferon-alpha|mesh-list
56056990|NCT00001035|Interferon alpha-2|interferon alpha-2|mesh-list
56056991|NCT00001035|Zidovudine|zidovudine|mesh-list
56056992|NCT00001035|Didanosine|didanosine|mesh-list
56056993|NCT00001035|Zalcitabine|zalcitabine|mesh-list
56056994|NCT00001035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56056995|NCT00001035|Antiviral Agents|antiviral agents|mesh-ancestor
56056996|NCT00001035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56056997|NCT00001035|Immunologic Factors|immunologic factors|mesh-ancestor
56056998|NCT00001035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56056999|NCT00001035|Antimetabolites|antimetabolites|mesh-ancestor
56057000|NCT00001035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057001|NCT00001035|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057002|NCT00001035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057003|NCT00001035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057004|NCT00001035|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057005|NCT00001035|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057006|NCT05503901|Timolol|timolol|mesh-list
56057009|NCT05503901|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56057010|NCT05503901|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56057013|NCT05503901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057014|NCT05503901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057015|NCT05503901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56057016|NCT05503901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56057017|NCT00001053|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56057018|NCT00001053|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56057019|NCT00001053|Immunologic Factors|immunologic factors|mesh-ancestor
56057020|NCT00001053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057022|NCT00001053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057023|NCT00001053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56057025|NCT00001989|Trichosanthin|trichosanthin|mesh-list
56057026|NCT00001989|Antimetabolites|antimetabolites|mesh-ancestor
56057027|NCT00001989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057028|NCT00001989|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057029|NCT00001989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057030|NCT00001989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057031|NCT00001989|Antiviral Agents|antiviral agents|mesh-ancestor
56057032|NCT00001989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057033|NCT00001989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55900857|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55900858|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55900859|NCT02416128|Protective Agents|protective agents|mesh-ancestor
55900861|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55900862|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900863|NCT03106818|Ketorolac|ketorolac|mesh-list
55900864|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
55900865|NCT03106818|Bupivacaine|bupivacaine|mesh-list
55900866|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
55900867|NCT03106818|Anesthetics|anesthetics|mesh-list
55900868|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55900869|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900870|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
55900871|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900872|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55900873|NCT03106818|Analgesics|analgesics|mesh-ancestor
55900874|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55900875|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55900876|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55900877|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55900878|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900879|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900880|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55900881|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
55900882|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55900883|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900884|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56057037|NCT00001989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56057038|NCT00001989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057039|NCT00001989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56057040|NCT00001989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057041|NCT00001059|Doxorubicin|doxorubicin|mesh-list
56057042|NCT00001059|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56057049|NCT00001059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057050|NCT00001059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057051|NCT00001059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56057052|NCT00001059|Tubulin Modulators|tubulin modulators|mesh-ancestor
56057053|NCT00001059|Antimitotic Agents|antimitotic agents|mesh-ancestor
56057090|NCT00002007|Zidovudine|zidovudine|mesh-list
56057091|NCT00002007|Sargramostim|sargramostim|mesh-list
56057092|NCT00002007|Antimetabolites|antimetabolites|mesh-ancestor
56057093|NCT00002007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057094|NCT00002007|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057095|NCT00002007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057096|NCT00002007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057097|NCT00002007|Antiviral Agents|antiviral agents|mesh-ancestor
56057098|NCT00002007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057099|NCT00002007|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057100|NCT00002007|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057101|NCT00002007|Immunologic Factors|immunologic factors|mesh-ancestor
56057102|NCT00002007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057104|NCT00001095|Zidovudine|zidovudine|mesh-list
56057105|NCT00001095|Nevirapine|nevirapine|mesh-list
56057106|NCT00001095|Stavudine|stavudine|mesh-list
56057107|NCT00001095|Indinavir|indinavir|mesh-list
56057108|NCT00001095|Amprenavir|amprenavir|mesh-list
56057109|NCT00001095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057110|NCT00001095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057111|NCT00001095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057112|NCT00001095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057113|NCT00001095|Antiviral Agents|antiviral agents|mesh-ancestor
56057143|NCT05493215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057144|NCT00002013|Zidovudine|zidovudine|mesh-list
56057145|NCT00002013|Antimetabolites|antimetabolites|mesh-ancestor
56057146|NCT00002013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057147|NCT00002013|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057148|NCT00002013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057149|NCT00002013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057150|NCT00002013|Antiviral Agents|antiviral agents|mesh-ancestor
56057151|NCT00002013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057152|NCT00002013|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057153|NCT00002013|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057154|NCT00359333|Gemcitabine|gemcitabine|mesh-list
56057155|NCT00359333|Docetaxel|docetaxel|mesh-list
56057156|NCT00359333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56057157|NCT00359333|Antimetabolites|antimetabolites|mesh-ancestor
56057158|NCT00359333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057159|NCT00359333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057160|NCT00359333|Antiviral Agents|antiviral agents|mesh-ancestor
56057161|NCT00359333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057183|NCT00001107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057184|NCT00001107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56057185|NCT00001107|Hormone Antagonists|hormone antagonists|mesh-ancestor
56057186|NCT00001107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56057187|NCT00001107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057188|NCT00001107|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56057189|NCT00001107|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56057190|NCT00001107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56057191|NCT00001107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56057192|NCT00002019|Amphotericin B|amphotericin b|mesh-list
56057193|NCT00002019|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56057194|NCT00002019|Amebicides|amebicides|mesh-ancestor
56057195|NCT00002019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56057196|NCT00002019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56057197|NCT00002019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057198|NCT00002019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057199|NCT00002019|Antifungal Agents|antifungal agents|mesh-ancestor
56057224|NCT00001155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057225|NCT00001155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56057226|NCT00002037|Trifluridine|trifluridine|mesh-list
56057227|NCT00002037|Antimetabolites|antimetabolites|mesh-ancestor
56057390|NCT05017571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56057228|NCT00002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057229|NCT00002037|Antiviral Agents|antiviral agents|mesh-ancestor
56057230|NCT00002037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057231|NCT00001197|Hydroxyurea|hydroxyurea|mesh-list
56057232|NCT00001197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057233|NCT00001197|Antisickling Agents|antisickling agents|mesh-ancestor
56057281|NCT00001209|Doxorubicin|doxorubicin|mesh-list
56057282|NCT00001209|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56057283|NCT00001209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057284|NCT00001209|Immunologic Factors|immunologic factors|mesh-ancestor
56057285|NCT00001209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057286|NCT00001209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56057287|NCT00001209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56057288|NCT00001209|Alkylating Agents|alkylating agents|mesh-ancestor
56057289|NCT00001209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057290|NCT00001209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057291|NCT00001209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56057292|NCT00001209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56057293|NCT00001209|Tubulin Modulators|tubulin modulators|mesh-ancestor
56057294|NCT00001209|Antimitotic Agents|antimitotic agents|mesh-ancestor
56057295|NCT00001209|Mitosis Modulators|mitosis modulators|mesh-ancestor
56057296|NCT00001209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56057297|NCT00001209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56057298|NCT00001209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56057299|NCT00001209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057300|NCT00002049|Thymopentin|thymopentin|mesh-list
56057330|NCT05043077|Cholinergic Agents|cholinergic agents|mesh-ancestor
56057331|NCT00002055|Pentamidine|pentamidine|mesh-list
56057332|NCT00002055|Antifungal Agents|antifungal agents|mesh-ancestor
56057333|NCT00002055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057334|NCT00002055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56057335|NCT00002055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56057336|NCT00002055|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56057337|NCT05031455|Aspirin|aspirin|mesh-list
56057338|NCT05031455|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56057339|NCT05031455|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56057340|NCT05031455|Analgesics|analgesics|mesh-ancestor
56057341|NCT05031455|Sensory System Agents|sensory system agents|mesh-ancestor
56057342|NCT05031455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56057343|NCT05031455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057344|NCT05031455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56057345|NCT05031455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56057346|NCT05031455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56057347|NCT05031455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56057348|NCT05031455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057349|NCT05031455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56057350|NCT05031455|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56057351|NCT05031455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057352|NCT05031455|Antipyretics|antipyretics|mesh-ancestor
56057353|NCT05029973|Bevacizumab|bevacizumab|mesh-list
56057354|NCT05029973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56057355|NCT05029973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057356|NCT05029973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56057357|NCT05029973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56057358|NCT05029973|Growth Substances|growth substances|mesh-ancestor
56057359|NCT05029973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057360|NCT05029973|Growth Inhibitors|growth inhibitors|mesh-ancestor
56057367|NCT00002067|Megestrol|megestrol|mesh-list
56057372|NCT00002067|Contraceptive Agents|contraceptive agents|mesh-ancestor
56057373|NCT00002067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56057374|NCT00002067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057375|NCT00002067|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56057376|NCT00002067|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56057377|NCT00002067|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56057378|NCT00002067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057379|NCT00002067|Appetite Stimulants|appetite stimulants|mesh-ancestor
56057380|NCT00002067|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56057381|NCT05442983|Probenecid|probenecid|mesh-list
56057382|NCT05442983|Uricosuric Agents|uricosuric agents|mesh-ancestor
56057383|NCT05442983|Gout Suppressants|gout suppressants|mesh-ancestor
56057384|NCT05442983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56057385|NCT05442983|Renal Agents|renal agents|mesh-ancestor
56057386|NCT00380835|Amrubicin|amrubicin|mesh-list
56057387|NCT00380835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057388|NCT05017571|Colchicine|colchicine|mesh-list
56057389|NCT05017571|Gout Suppressants|gout suppressants|mesh-ancestor
56057394|NCT05017571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057395|NCT05017571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057396|NCT00001311|Heparin|heparin|mesh-list
56057397|NCT00001311|Anticoagulants|anticoagulants|mesh-ancestor
56057398|NCT00001311|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56057399|NCT00001311|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56057400|NCT00001311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057401|NCT05016713|Chlorhexidine|chlorhexidine|mesh-list
56057402|NCT05016713|Fluorides|fluorides|mesh-list
56057403|NCT05016713|Cariostatic Agents|cariostatic agents|mesh-ancestor
56057412|NCT00001317|Interferon-gamma|interferon-gamma|mesh-list
56057413|NCT00001317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057414|NCT00001317|Antiviral Agents|antiviral agents|mesh-ancestor
56057415|NCT00001317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057416|NCT00001335|Topotecan|topotecan|mesh-list
56057417|NCT00001335|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56057418|NCT00001335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56057419|NCT00001335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057420|NCT00001335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057421|NCT00001335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057422|NCT00002079|Miglustat|miglustat|mesh-list
56057423|NCT00002079|Zidovudine|zidovudine|mesh-list
56057424|NCT00002079|Antimetabolites|antimetabolites|mesh-ancestor
56057425|NCT00002079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057426|NCT00002079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057427|NCT00002079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057428|NCT00002079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784609|NCT04892069|Insulin|insulin|mesh-list
56057429|NCT00002079|Antiviral Agents|antiviral agents|mesh-ancestor
56057430|NCT00002079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057431|NCT00002079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057432|NCT00002079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057433|NCT00002079|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56057434|NCT00002079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56057435|NCT00002079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057436|NCT00002085|Azithromycin|azithromycin|mesh-list
56057437|NCT00002085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057438|NCT00002085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057439|NCT00001383|Paclitaxel|paclitaxel|mesh-list
56057442|NCT00001383|Tubulin Modulators|tubulin modulators|mesh-ancestor
56057457|NCT00001407|Interferons|interferons|mesh-list
56057458|NCT00001407|Interferon-gamma|interferon-gamma|mesh-list
56057459|NCT00001407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057460|NCT00001407|Antiviral Agents|antiviral agents|mesh-ancestor
56057461|NCT00001407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057462|NCT00002097|Nystatin|nystatin|mesh-list
56057463|NCT00002097|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057464|NCT00002097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057465|NCT00002097|Antifungal Agents|antifungal agents|mesh-ancestor
56057466|NCT00002097|Ionophores|ionophores|mesh-ancestor
56057467|NCT00002097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56057468|NCT00002097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057469|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
56057470|NCT04989803|Fludarabine|fludarabine|mesh-list
56057471|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057472|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
56057473|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057474|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56057475|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56057476|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
56057477|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057512|NCT00002103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057513|NCT00002103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057514|NCT00002103|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56057516|NCT00001437|Pentoxifylline|pentoxifylline|mesh-list
56057517|NCT00001437|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56057518|NCT00001437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057519|NCT00001437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057520|NCT00001437|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56057521|NCT00001437|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56057522|NCT00001437|Protective Agents|protective agents|mesh-ancestor
56057523|NCT00001437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057524|NCT00001437|Vasodilator Agents|vasodilator agents|mesh-ancestor
56057525|NCT00001437|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56057526|NCT00001437|Antioxidants|antioxidants|mesh-ancestor
56057527|NCT00360191|Buspirone|buspirone|mesh-list
56057530|NCT00360191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56057531|NCT00360191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057532|NCT00360191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56057533|NCT00360191|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56057534|NCT00360191|Serotonin Agents|serotonin agents|mesh-ancestor
56057535|NCT00360191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56057536|NCT00360191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057537|NCT00001443|Indinavir|indinavir|mesh-list
56057538|NCT00001443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56057539|NCT00001443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56057540|NCT00001443|Protease Inhibitors|protease inhibitors|mesh-ancestor
56057541|NCT00001443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057553|NCT00001449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057554|NCT00001449|Antiviral Agents|antiviral agents|mesh-ancestor
56057555|NCT00001449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057556|NCT00001449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057557|NCT00001449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057558|NCT00001449|Immunologic Factors|immunologic factors|mesh-ancestor
56057559|NCT00001449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057560|NCT00001449|Antidotes|antidotes|mesh-ancestor
56057561|NCT00001449|Protective Agents|protective agents|mesh-ancestor
56057562|NCT00001449|Vitamin B Complex|vitamin b complex|mesh-ancestor
56057563|NCT00001449|Vitamins|vitamins|mesh-ancestor
56057564|NCT00001449|Micronutrients|micronutrients|mesh-ancestor
56057565|NCT00002109|Zidovudine|zidovudine|mesh-list
56057566|NCT00002109|Didanosine|didanosine|mesh-list
56057567|NCT00002109|Stavudine|stavudine|mesh-list
56057568|NCT00002109|Zalcitabine|zalcitabine|mesh-list
56057569|NCT00002109|Thymopentin|thymopentin|mesh-list
56057570|NCT00002109|Antimetabolites|antimetabolites|mesh-ancestor
56057571|NCT00002109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057572|NCT00002109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057573|NCT00002109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057574|NCT00002109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057575|NCT00002109|Antiviral Agents|antiviral agents|mesh-ancestor
56057576|NCT00002109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057577|NCT00002109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057578|NCT00002109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057579|NCT00002109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56057580|NCT00002109|Immunologic Factors|immunologic factors|mesh-ancestor
56057581|NCT00002109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057582|NCT00359567|Palonosetron|palonosetron|mesh-list
56057584|NCT00359567|Antiemetics|antiemetics|mesh-ancestor
56057585|NCT00359567|Autonomic Agents|autonomic agents|mesh-ancestor
56057586|NCT00359567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56057587|NCT00359567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057588|NCT00359567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56057597|NCT00381147|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56057598|NCT00381147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057599|NCT00381147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057600|NCT00381147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56057601|NCT00381147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56057603|NCT05210465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56057604|NCT05210465|Sympathomimetics|sympathomimetics|mesh-ancestor
56057605|NCT05210465|Autonomic Agents|autonomic agents|mesh-ancestor
56057606|NCT05210465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56057607|NCT05210465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057608|NCT05210465|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56057609|NCT05210465|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56057610|NCT05210465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56057611|NCT05210465|Adrenergic Agents|adrenergic agents|mesh-ancestor
56057612|NCT05210465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56057613|NCT05210465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057614|NCT05210465|Protective Agents|protective agents|mesh-ancestor
56057615|NCT00002115|Adefovir|adefovir|mesh-list
56057616|NCT00002115|Antiviral Agents|antiviral agents|mesh-ancestor
56057617|NCT00002115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057618|NCT00002115|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057619|NCT00002115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057620|NCT00002115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057621|NCT00002115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057622|NCT04983407|Gemcitabine|gemcitabine|mesh-list
56057623|NCT04983407|Paclitaxel|paclitaxel|mesh-list
56057624|NCT04983407|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56057625|NCT04983407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057626|NCT04983407|Tubulin Modulators|tubulin modulators|mesh-ancestor
56057629|NCT04983407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057634|NCT04983407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057635|NCT04983407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057636|NCT04983407|Immunologic Factors|immunologic factors|mesh-ancestor
56057637|NCT04983407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057638|NCT00001569|Paclitaxel|paclitaxel|mesh-list
56057639|NCT00001569|Cisplatin|cisplatin|mesh-list
56057640|NCT00001569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56057641|NCT00001569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057642|NCT00001569|Tubulin Modulators|tubulin modulators|mesh-ancestor
56057643|NCT00001569|Antimitotic Agents|antimitotic agents|mesh-ancestor
56057644|NCT00001569|Mitosis Modulators|mitosis modulators|mesh-ancestor
56057645|NCT00001569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057646|NCT00001587|Melphalan|melphalan|mesh-list
56057647|NCT00001587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56057648|NCT00001587|Alkylating Agents|alkylating agents|mesh-ancestor
56057649|NCT00001587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057650|NCT00001587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057651|NCT00001587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56057652|NCT00001587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057653|NCT00001587|Immunologic Factors|immunologic factors|mesh-ancestor
56057654|NCT00001587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057655|NCT00002127|Thalidomide|thalidomide|mesh-list
55784835|NCT04452461|Vitamins|vitamins|mesh-ancestor
56057656|NCT00002127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56057657|NCT00002127|Immunologic Factors|immunologic factors|mesh-ancestor
56057682|NCT00380913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56057683|NCT00380913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057684|NCT00380913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56057685|NCT00380913|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56057686|NCT00380913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56057688|NCT00380913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56057689|NCT00002133|Itraconazole|itraconazole|mesh-list
56057690|NCT00002133|Antifungal Agents|antifungal agents|mesh-ancestor
56057691|NCT00002133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057692|NCT00002133|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56057693|NCT00002133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56057694|NCT00002133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057695|NCT00002133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057696|NCT00002133|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56057697|NCT00002133|Hormone Antagonists|hormone antagonists|mesh-ancestor
56057698|NCT00002133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56057699|NCT00002133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057700|NCT00002133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56057702|NCT00001629|Giapreza|giapreza|mesh-list
56057703|NCT00001629|Angiotensinogen|angiotensinogen|mesh-list
56057733|NCT00002301|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057734|NCT00002301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057735|NCT00002301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057736|NCT05414201|Adalimumab|adalimumab|mesh-list
56057737|NCT05414201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56057738|NCT05414201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56057739|NCT00002307|Zidovudine|zidovudine|mesh-list
56057740|NCT00002307|Stavudine|stavudine|mesh-list
56057741|NCT00002307|Antimetabolites|antimetabolites|mesh-ancestor
56057742|NCT00002307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057743|NCT00002307|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057744|NCT00002307|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057745|NCT00002307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057746|NCT00002307|Antiviral Agents|antiviral agents|mesh-ancestor
56057747|NCT00002307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057748|NCT00002307|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057749|NCT00002307|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057750|NCT00002313|Didanosine|didanosine|mesh-list
56057751|NCT00002313|Nystatin|nystatin|mesh-list
56057752|NCT00002313|Antimetabolites|antimetabolites|mesh-ancestor
56057753|NCT00002313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057754|NCT00002313|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057755|NCT00002313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057756|NCT00002313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057757|NCT00002313|Antiviral Agents|antiviral agents|mesh-ancestor
56057758|NCT00002313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057759|NCT00002313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057760|NCT00002313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057761|NCT00002313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057763|NCT00002313|Ionophores|ionophores|mesh-ancestor
56057778|NCT04685421|Anesthetics, Local|anesthetics, local|mesh-ancestor
56057779|NCT04685421|Anesthetics|anesthetics|mesh-ancestor
56057780|NCT04685421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56057781|NCT04685421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057782|NCT04685421|Sensory System Agents|sensory system agents|mesh-ancestor
56057783|NCT04685421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56057784|NCT00002319|Doxorubicin|doxorubicin|mesh-list
56057785|NCT00002319|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56057786|NCT00002319|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56057787|NCT00002319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56057788|NCT00002319|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56057789|NCT00002319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56057790|NCT00002319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057791|NCT00002319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057793|NCT00002163|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057794|NCT00002163|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057795|NCT00002163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057796|NCT00002163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900886|NCT03106818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55900887|NCT01592045|Aldesleukin|aldesleukin|mesh-list
55900888|NCT01592045|Molgramostim|molgramostim|mesh-list
55900889|NCT01592045|Dinutuximab|dinutuximab|mesh-list
55900890|NCT01592045|Isotretinoin|isotretinoin|mesh-list
55900891|NCT01592045|Sargramostim|sargramostim|mesh-list
55900892|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900893|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55900894|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55900895|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
55900896|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55900897|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
55900898|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
55900899|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900900|NCT03178656|Sorafenib|sorafenib|mesh-list
55900901|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55900902|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55900903|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900904|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900905|NCT01590797|Metformin|metformin|mesh-list
55900906|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55900907|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55900908|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900909|NCT01590797|Incretins|incretins|mesh-ancestor
55900910|NCT01590797|Hormones|hormones|mesh-ancestor
55900911|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900912|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55900913|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
55900914|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900915|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900916|NCT01867606|Immunoglobulins|immunoglobulins|mesh-list
55900917|NCT01867606|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56057797|NCT00002163|Antiviral Agents|antiviral agents|mesh-ancestor
56057798|NCT00002163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057799|NCT00002163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057800|NCT00002163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057801|NCT05180591|BCG Vaccine|bcg vaccine|mesh-list
56057802|NCT05180591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56057803|NCT05180591|Immunologic Factors|immunologic factors|mesh-ancestor
56057804|NCT05180591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057805|NCT00002325|Fluconazole|fluconazole|mesh-list
56057806|NCT00002325|Antifungal Agents|antifungal agents|mesh-ancestor
56057807|NCT00002325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057808|NCT00002325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56057809|NCT00002325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56057810|NCT00002325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057811|NCT00002325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057812|NCT00002325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56057813|NCT00002325|Hormone Antagonists|hormone antagonists|mesh-ancestor
56057814|NCT00002325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56057815|NCT00002325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057816|NCT00002325|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56057817|NCT00002325|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56057818|NCT00002331|Clarithromycin|clarithromycin|mesh-list
56057821|NCT00002331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057822|NCT00002331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057823|NCT00002331|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56057824|NCT00002331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057825|NCT00002331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057831|NCT00002337|Vesnarinone|vesnarinone|mesh-list
56057839|NCT00002337|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56057840|NCT00002337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057841|NCT00002337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057842|NCT00002337|Protective Agents|protective agents|mesh-ancestor
56057843|NCT00002169|Nelfinavir|nelfinavir|mesh-list
56057844|NCT00002169|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56057845|NCT00002169|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56057846|NCT00002169|Protease Inhibitors|protease inhibitors|mesh-ancestor
56057847|NCT00002169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057848|NCT00002169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057849|NCT00002169|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057850|NCT00002169|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057851|NCT00002169|Antiviral Agents|antiviral agents|mesh-ancestor
56057852|NCT00002169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057853|NCT02293902|Folic Acid|folic acid|mesh-list
56057854|NCT02293902|Methotrexate|methotrexate|mesh-list
56057855|NCT02293902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56057856|NCT02293902|Abortifacient Agents|abortifacient agents|mesh-ancestor
56057857|NCT02293902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56057858|NCT02293902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057859|NCT02293902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56057860|NCT02293902|Antimetabolites|antimetabolites|mesh-ancestor
56057892|NCT05168735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56057893|NCT05168735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057894|NCT00002349|Stavudine|stavudine|mesh-list
56057895|NCT00002349|Antimetabolites|antimetabolites|mesh-ancestor
56057896|NCT00002349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057897|NCT00002349|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057898|NCT00002349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057899|NCT00002349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057900|NCT00002349|Antiviral Agents|antiviral agents|mesh-ancestor
56057901|NCT00002349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057902|NCT00002349|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057903|NCT00002349|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56057904|NCT04706013|Pyridoxal|pyridoxal|mesh-list
56057905|NCT04706013|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
56057906|NCT04706013|Vitamin B Complex|vitamin b complex|mesh-ancestor
56057907|NCT04706013|Vitamins|vitamins|mesh-ancestor
56057908|NCT04706013|Micronutrients|micronutrients|mesh-ancestor
56057909|NCT04706013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56057910|NCT00002355|Fomivirsen|fomivirsen|mesh-list
56057911|NCT00002355|Antiviral Agents|antiviral agents|mesh-ancestor
56057912|NCT00002355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057913|NCT02278614|Timolol|timolol|mesh-list
56057914|NCT02278614|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56057915|NCT02278614|Latanoprost|latanoprost|mesh-list
56057916|NCT02278614|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56057917|NCT02278614|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56057918|NCT02278614|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56057919|NCT02278614|Adrenergic Agents|adrenergic agents|mesh-ancestor
56057941|NCT00002181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057942|NCT00002181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057943|NCT00002367|Lamivudine|lamivudine|mesh-list
56057944|NCT00002367|Zidovudine|zidovudine|mesh-list
56057945|NCT00002367|Saquinavir|saquinavir|mesh-list
56057946|NCT00002367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56057947|NCT00002367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56057948|NCT00002367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56057949|NCT00002367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057950|NCT00002367|Antiviral Agents|antiviral agents|mesh-ancestor
56057951|NCT00002367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057952|NCT00002367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56057954|NCT00002367|Antimetabolites|antimetabolites|mesh-ancestor
56057955|NCT00002367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55785165|NCT02985619|Hormones|hormones|mesh-ancestor
56057956|NCT00002367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56057957|NCT00002367|Protease Inhibitors|protease inhibitors|mesh-ancestor
56057958|NCT00002367|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56057959|NCT00002367|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56057961|NCT00002187|Antiviral Agents|antiviral agents|mesh-ancestor
56058227|NCT00002451|Protease Inhibitors|protease inhibitors|mesh-ancestor
56057962|NCT00002187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057963|NCT00002373|Maribavir|maribavir|mesh-list
56057964|NCT00002373|Antiviral Agents|antiviral agents|mesh-ancestor
56057965|NCT00002373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057966|NCT00002379|Lamivudine|lamivudine|mesh-list
56057967|NCT00002379|Zidovudine|zidovudine|mesh-list
56057968|NCT00002379|Stavudine|stavudine|mesh-list
56057969|NCT00002379|Adefovir|adefovir|mesh-list
56057989|NCT00359723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56057990|NCT00359723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56057991|NCT00359723|Dopamine Agents|dopamine agents|mesh-ancestor
56057992|NCT00359723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56057993|NCT00002193|Amprenavir|amprenavir|mesh-list
56057994|NCT00002193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56057995|NCT00002193|Antitubercular Agents|antitubercular agents|mesh-ancestor
56057996|NCT00002193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56057997|NCT00002193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56057998|NCT00002193|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56057999|NCT00002193|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058000|NCT00002193|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058001|NCT00002193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058002|NCT00002193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058003|NCT00002193|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058004|NCT00002193|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058005|NCT00002193|Antiviral Agents|antiviral agents|mesh-ancestor
56058006|NCT00002391|Lamivudine|lamivudine|mesh-list
56058007|NCT00002391|Zidovudine|zidovudine|mesh-list
56058008|NCT00002391|Abacavir|abacavir|mesh-list
56058009|NCT00002391|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058010|NCT00002391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058011|NCT00002391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058012|NCT00002391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058013|NCT00002391|Antiviral Agents|antiviral agents|mesh-ancestor
56058014|NCT00002391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058015|NCT00002391|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058016|NCT00002391|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058017|NCT00002391|Antimetabolites|antimetabolites|mesh-ancestor
56058018|NCT00002199|Lamivudine|lamivudine|mesh-list
56058019|NCT00002199|Zidovudine|zidovudine|mesh-list
56058020|NCT00002199|Abacavir|abacavir|mesh-list
56058021|NCT00002199|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56058032|NCT00002199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56058033|NCT00002199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058035|NCT00002397|Lamivudine|lamivudine|mesh-list
56058036|NCT00002397|Stavudine|stavudine|mesh-list
56058037|NCT00002397|Nelfinavir|nelfinavir|mesh-list
56058038|NCT00002397|Saquinavir|saquinavir|mesh-list
56058039|NCT00002397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058040|NCT00002397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058041|NCT00002397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058042|NCT00002397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058043|NCT00002397|Antiviral Agents|antiviral agents|mesh-ancestor
56058044|NCT00002397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058045|NCT00002397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058046|NCT00002397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058047|NCT00002397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56058048|NCT00002397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058049|NCT00002397|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058050|NCT00002397|Antimetabolites|antimetabolites|mesh-ancestor
56058052|NCT00002397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56058053|NCT00002205|Abacavir|abacavir|mesh-list
56058054|NCT00002205|Amprenavir|amprenavir|mesh-list
56058055|NCT00002205|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058056|NCT00002205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058057|NCT00002205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058058|NCT00002205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058059|NCT00002205|Antiviral Agents|antiviral agents|mesh-ancestor
56058060|NCT00002205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058061|NCT00002205|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058062|NCT00002205|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058063|NCT00002205|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56058064|NCT00002205|Antitubercular Agents|antitubercular agents|mesh-ancestor
56058065|NCT00002205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56058066|NCT00002205|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56058067|NCT00002205|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058068|NCT00002205|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058073|NCT02977169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058074|NCT02977169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058075|NCT02977169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058076|NCT02977169|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56058077|NCT02977169|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058078|NCT02977169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058079|NCT02977169|Tubulin Modulators|tubulin modulators|mesh-ancestor
56058080|NCT02977169|Antimitotic Agents|antimitotic agents|mesh-ancestor
56058081|NCT02977169|Mitosis Modulators|mitosis modulators|mesh-ancestor
56058082|NCT00002409|Lamivudine|lamivudine|mesh-list
56058083|NCT00002409|Zidovudine|zidovudine|mesh-list
56058084|NCT00002409|Abacavir|abacavir|mesh-list
56058085|NCT00002409|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56058086|NCT00002409|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058087|NCT00002409|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058088|NCT00002409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058089|NCT00002409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058090|NCT00002409|Antiviral Agents|antiviral agents|mesh-ancestor
56058091|NCT00002409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058092|NCT00002409|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058093|NCT00002409|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058094|NCT00002409|Antimetabolites|antimetabolites|mesh-ancestor
56058095|NCT00002211|Nelfinavir|nelfinavir|mesh-list
56058096|NCT00002211|Didanosine|didanosine|mesh-list
56058097|NCT00002211|Stavudine|stavudine|mesh-list
56058098|NCT00002211|Delavirdine|delavirdine|mesh-list
56058099|NCT00002211|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56058100|NCT00002211|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058101|NCT00002211|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058102|NCT00002211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058118|NCT00002415|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058119|NCT00002415|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058120|NCT00381537|Carbamazepine|carbamazepine|mesh-list
56058121|NCT00381537|Phenobarbital|phenobarbital|mesh-list
56058122|NCT00381537|Anticonvulsants|anticonvulsants|mesh-ancestor
56058123|NCT00381537|Antimanic Agents|antimanic agents|mesh-ancestor
56058124|NCT00381537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56058125|NCT00381537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56058126|NCT00381537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058127|NCT00381537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56058128|NCT00381537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56058129|NCT00381537|Analgesics|analgesics|mesh-ancestor
56058130|NCT00381537|Sensory System Agents|sensory system agents|mesh-ancestor
56058131|NCT00381537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058132|NCT00381537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56058133|NCT00381537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56058134|NCT00381537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058135|NCT00381537|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56058136|NCT00381537|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56058137|NCT00381537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56058138|NCT00381537|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56058139|NCT00381537|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56058140|NCT00381537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56058141|NCT00381537|GABA Modulators|gaba modulators|mesh-ancestor
56058142|NCT00381537|GABA Agents|gaba agents|mesh-ancestor
56058144|NCT00002427|Didanosine|didanosine|mesh-list
56058168|NCT00002217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058169|NCT00002217|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058170|NCT00002217|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058171|NCT00002217|Antimetabolites|antimetabolites|mesh-ancestor
56058172|NCT00002217|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56058173|NCT00002217|Antitubercular Agents|antitubercular agents|mesh-ancestor
56058174|NCT00002217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56058175|NCT00002217|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56058176|NCT00002217|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058177|NCT00002217|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058178|NCT00002223|Ritonavir|ritonavir|mesh-list
56058179|NCT00002223|Indinavir|indinavir|mesh-list
56058180|NCT00002223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56058181|NCT00002223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058182|NCT00002223|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058183|NCT00002223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058184|NCT00002223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058185|NCT00002223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058186|NCT00002223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058199|NCT00002229|Saquinavir|saquinavir|mesh-list
56058224|NCT00002451|Stavudine|stavudine|mesh-list
56058225|NCT00002451|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56058226|NCT00002451|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56058229|NCT00002451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058230|NCT00002451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058231|NCT00002451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058232|NCT00002451|Antiviral Agents|antiviral agents|mesh-ancestor
56058233|NCT00002451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058234|NCT00002451|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56058235|NCT00002451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56058236|NCT00002451|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058237|NCT00002451|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058238|NCT00002451|Antimetabolites|antimetabolites|mesh-ancestor
56058239|NCT00002235|Efavirenz|efavirenz|mesh-list
56058240|NCT00002235|Nelfinavir|nelfinavir|mesh-list
56058241|NCT00002235|Indinavir|indinavir|mesh-list
56058242|NCT00002235|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058243|NCT00002235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058244|NCT00002235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058245|NCT00002235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058246|NCT00002235|Antiviral Agents|antiviral agents|mesh-ancestor
56058272|NCT00002241|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56058273|NCT00002241|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56058274|NCT00002241|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56058275|NCT00002241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058276|NCT00002241|Antimetabolites|antimetabolites|mesh-ancestor
56058277|NCT00002463|Leucovorin|leucovorin|mesh-list
56058278|NCT00002463|Prednisone|prednisone|mesh-list
56058279|NCT00002463|Methotrexate|methotrexate|mesh-list
56058280|NCT00002463|Vincristine|vincristine|mesh-list
56058281|NCT00002463|Procarbazine|procarbazine|mesh-list
56058282|NCT00002463|Mechlorethamine|mechlorethamine|mesh-list
56058283|NCT00002463|Calcium|calcium|mesh-list
56058284|NCT00002463|Levoleucovorin|levoleucovorin|mesh-list
56058285|NCT00002463|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56058286|NCT00002463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058287|NCT00002463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058288|NCT00002463|Glucocorticoids|glucocorticoids|mesh-ancestor
56058289|NCT00002463|Hormones|hormones|mesh-ancestor
56058290|NCT00002463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058291|NCT00002463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058292|NCT00002463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058293|NCT00002463|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56058294|NCT00002463|Abortifacient Agents|abortifacient agents|mesh-ancestor
56058295|NCT00002463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56058296|NCT00002463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56058322|NCT04500899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058323|NCT04500899|Sympathomimetics|sympathomimetics|mesh-ancestor
56058324|NCT04500899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56058325|NCT04500899|Nasal Decongestants|nasal decongestants|mesh-ancestor
56058326|NCT04500899|Respiratory System Agents|respiratory system agents|mesh-ancestor
56058327|NCT04500899|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56058328|NCT04500899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56058329|NCT04500899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56058330|NCT04500899|Adrenergic Agents|adrenergic agents|mesh-ancestor
56058331|NCT04500899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56058332|NCT04500899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058333|NCT04500899|Protective Agents|protective agents|mesh-ancestor
56058334|NCT00002247|Ganciclovir|ganciclovir|mesh-list
56058335|NCT00002247|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
55785509|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
56058336|NCT00002247|Antiviral Agents|antiviral agents|mesh-ancestor
56058337|NCT00002247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058338|NCT00002247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058339|NCT00002247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058340|NCT00002247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058341|NCT00002475|Interferons|interferons|mesh-list
56058342|NCT00002475|Interferon-alpha|interferon-alpha|mesh-list
56058343|NCT00002475|Interferon-gamma|interferon-gamma|mesh-list
56058344|NCT00002475|Cyclophosphamide|cyclophosphamide|mesh-list
56058346|NCT00002475|Sargramostim|sargramostim|mesh-list
56058347|NCT00002475|Immunologic Factors|immunologic factors|mesh-ancestor
56058348|NCT00002475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058369|NCT00002481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058370|NCT00002481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56058371|NCT00002481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058373|NCT00002481|Autonomic Agents|autonomic agents|mesh-ancestor
56058374|NCT00002481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058375|NCT00002481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56058376|NCT00002481|Glucocorticoids|glucocorticoids|mesh-ancestor
56058377|NCT00002481|Hormones|hormones|mesh-ancestor
56058378|NCT00002481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058379|NCT00002481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058380|NCT00002481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058381|NCT00002481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56058382|NCT00002481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56058383|NCT00002481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058384|NCT00002481|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56058385|NCT00002481|Antimetabolites|antimetabolites|mesh-ancestor
56058386|NCT00002481|Antiviral Agents|antiviral agents|mesh-ancestor
56058387|NCT00002481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058388|NCT00002253|Octreotide|octreotide|mesh-list
56058389|NCT00002253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56058390|NCT00002253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058391|NCT00002253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058393|NCT04862585|Promethazine|promethazine|mesh-list
56058394|NCT04862585|Dexamethasone|dexamethasone|mesh-list
56058395|NCT04862585|Dexamethasone acetate|dexamethasone acetate|mesh-list
56058396|NCT04862585|Paclitaxel|paclitaxel|mesh-list
56058397|NCT04862585|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56058398|NCT04862585|Famotidine|famotidine|mesh-list
56058399|NCT04862585|Ranitidine|ranitidine|mesh-list
56058400|NCT04862585|Cimetidine|cimetidine|mesh-list
56058401|NCT04862585|BB 1101|bb 1101|mesh-list
56058402|NCT04862585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058412|NCT04862585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058413|NCT04862585|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56058414|NCT04862585|Glucocorticoids|glucocorticoids|mesh-ancestor
56058416|NCT04862585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058417|NCT04862585|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058418|NCT04862585|Protease Inhibitors|protease inhibitors|mesh-ancestor
56058419|NCT04862585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058420|NCT04862585|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56058421|NCT04862585|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56058422|NCT04862585|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56058423|NCT04862585|Anesthetics, Local|anesthetics, local|mesh-ancestor
56058424|NCT04862585|Anesthetics|anesthetics|mesh-ancestor
56058425|NCT04862585|Sensory System Agents|sensory system agents|mesh-ancestor
56058426|NCT04862585|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56058427|NCT04862585|Histamine Antagonists|histamine antagonists|mesh-ancestor
56058428|NCT04862585|Histamine Agents|histamine agents|mesh-ancestor
56058429|NCT04862585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56058430|NCT04862585|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56058431|NCT04862585|Antipruritics|antipruritics|mesh-ancestor
56058432|NCT04862585|Dermatologic Agents|dermatologic agents|mesh-ancestor
56058433|NCT04862585|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56058434|NCT04862585|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56058435|NCT04862585|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56058436|NCT04862585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56058437|NCT00002487|Methotrexate|methotrexate|mesh-list
56058438|NCT00002487|Dipyridamole|dipyridamole|mesh-list
56058439|NCT00002487|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56058459|NCT00002493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058460|NCT00002493|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56058461|NCT00002493|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56058462|NCT00002493|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56058463|NCT00002493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058464|NCT00002493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058465|NCT00002259|Mitoxantrone|mitoxantrone|mesh-list
56058466|NCT00002259|Analgesics|analgesics|mesh-ancestor
56058467|NCT00002259|Sensory System Agents|sensory system agents|mesh-ancestor
56058468|NCT00002259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058469|NCT00002259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058470|NCT00002259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058471|NCT00002259|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56058472|NCT00002259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56058473|NCT00002259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058474|NCT00002259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058475|NCT00002499|Cytarabine|cytarabine|mesh-list
56058476|NCT00002499|Dexamethasone|dexamethasone|mesh-list
56058477|NCT00002499|Prednisone|prednisone|mesh-list
56058478|NCT00002499|Methotrexate|methotrexate|mesh-list
56058479|NCT00002499|Vincristine|vincristine|mesh-list
56058480|NCT00002499|Daunorubicin|daunorubicin|mesh-list
56058481|NCT00002499|Asparaginase|asparaginase|mesh-list
56058482|NCT00002499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058483|NCT00002499|Antiemetics|antiemetics|mesh-ancestor
56058484|NCT00002499|Autonomic Agents|autonomic agents|mesh-ancestor
56058485|NCT00002499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058486|NCT00002499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058487|NCT00002499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56058488|NCT00002499|Glucocorticoids|glucocorticoids|mesh-ancestor
56058511|NCT00002499|Mitosis Modulators|mitosis modulators|mesh-ancestor
56058512|NCT00002499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56058513|NCT00002499|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56058514|NCT00002499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56058520|NCT00002505|Interferons|interferons|mesh-list
56058521|NCT00002505|Interferon-gamma|interferon-gamma|mesh-list
56058522|NCT00002505|Vaccines|vaccines|mesh-list
56058523|NCT00002505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058524|NCT00002505|Antiviral Agents|antiviral agents|mesh-ancestor
56058525|NCT00002505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058526|NCT00002505|Immunologic Factors|immunologic factors|mesh-ancestor
56058527|NCT00002505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058528|NCT00002265|Zalcitabine|zalcitabine|mesh-list
56058529|NCT00002265|Antimetabolites|antimetabolites|mesh-ancestor
56058530|NCT00002265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058539|NCT04933331|Fluorides|fluorides|mesh-list
56058555|NCT00002517|Thioguanine|thioguanine|mesh-list
56058556|NCT00002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058557|NCT00002517|Antiemetics|antiemetics|mesh-ancestor
56058558|NCT00002517|Autonomic Agents|autonomic agents|mesh-ancestor
56058559|NCT00002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058560|NCT00002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058561|NCT00002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56058562|NCT00002517|Glucocorticoids|glucocorticoids|mesh-ancestor
56058563|NCT00002517|Hormones|hormones|mesh-ancestor
56058564|NCT00002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058565|NCT00002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058566|NCT00002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058567|NCT00002517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058568|NCT00002517|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56058569|NCT00002517|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56058570|NCT00002517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058571|NCT00002517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058572|NCT00002517|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56058573|NCT00002517|Antimetabolites|antimetabolites|mesh-ancestor
56058574|NCT00002517|Antiviral Agents|antiviral agents|mesh-ancestor
56058608|NCT04469075|Glucocorticoids|glucocorticoids|mesh-ancestor
56058609|NCT04469075|Hormones|hormones|mesh-ancestor
56058610|NCT04469075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058611|NCT04469075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058612|NCT04469075|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058613|NCT04469075|Immunologic Factors|immunologic factors|mesh-ancestor
56058614|NCT04469075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058615|NCT04469075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058616|NCT04469075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56058617|NCT04469075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058618|NCT04469075|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56058619|NCT00002523|Leucovorin|leucovorin|mesh-list
56058620|NCT00002523|Fluorouracil|fluorouracil|mesh-list
56058621|NCT00002523|Calcium|calcium|mesh-list
56058622|NCT00002523|Levoleucovorin|levoleucovorin|mesh-list
56058623|NCT00002523|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56058624|NCT00002523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058625|NCT00002523|Antimetabolites|antimetabolites|mesh-ancestor
56058626|NCT00002523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058627|NCT00002523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56058628|NCT00002523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058629|NCT00002523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058630|NCT00002523|Immunologic Factors|immunologic factors|mesh-ancestor
56058631|NCT00002523|Antidotes|antidotes|mesh-ancestor
56058632|NCT00002523|Protective Agents|protective agents|mesh-ancestor
56058658|NCT00002529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058659|NCT00002529|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56058660|NCT00002529|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56058661|NCT00002529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56058663|NCT04832087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56058664|NCT04832087|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56058665|NCT04832087|Protective Agents|protective agents|mesh-ancestor
56058666|NCT04832087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058667|NCT00002283|Trimethoprim|trimethoprim|mesh-list
56058668|NCT00002283|Dapsone|dapsone|mesh-list
56058669|NCT00002283|Sulfamethoxazole|sulfamethoxazole|mesh-list
56058670|NCT00002283|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56058671|NCT00002283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058672|NCT00002283|Renal Agents|renal agents|mesh-ancestor
56058673|NCT00002283|Antimalarials|antimalarials|mesh-ancestor
56058674|NCT00002283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56058675|NCT00002283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56058676|NCT00002283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56058677|NCT00002283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058678|NCT00002283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058679|NCT00002283|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56058680|NCT00002283|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56058681|NCT00002283|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56058682|NCT00002283|Leprostatic Agents|leprostatic agents|mesh-ancestor
56058683|NCT00002283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56058684|NCT04826237|Dexamethasone|dexamethasone|mesh-list
56058685|NCT04826237|Methylprednisolone|methylprednisolone|mesh-list
56058686|NCT04826237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56058687|NCT04826237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56058688|NCT04826237|Prednisolone|prednisolone|mesh-list
56058689|NCT04826237|Prednisolone acetate|prednisolone acetate|mesh-list
56058701|NCT04826237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058702|NCT04826237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058704|NCT04826237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56058705|NCT04826237|Protective Agents|protective agents|mesh-ancestor
56058706|NCT04826237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56058707|NCT04826237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56058708|NCT04826237|Antimetabolites|antimetabolites|mesh-ancestor
56058709|NCT04826237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058710|NCT04826237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058711|NCT04826237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56058712|NCT00002535|Aldesleukin|aldesleukin|mesh-list
56058713|NCT00002535|Indomethacin|indomethacin|mesh-list
56058714|NCT00002535|Cyclophosphamide|cyclophosphamide|mesh-list
56058715|NCT00002535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058716|NCT00002535|Immunologic Factors|immunologic factors|mesh-ancestor
55785878|NCT05091151|Analgesics|analgesics|mesh-ancestor
56058717|NCT00002535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058718|NCT00002535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56058719|NCT00002535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058720|NCT00002535|Alkylating Agents|alkylating agents|mesh-ancestor
56058721|NCT00002535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058722|NCT00002535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058723|NCT00002535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56058739|NCT00002547|Cytarabine|cytarabine|mesh-list
56058751|NCT00002547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058752|NCT00002547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058753|NCT00002547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56058754|NCT00002547|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56058755|NCT00002547|Abortifacient Agents|abortifacient agents|mesh-ancestor
56058756|NCT00002547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56058757|NCT00002547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56058758|NCT00002547|Antimetabolites|antimetabolites|mesh-ancestor
56058759|NCT00002547|Dermatologic Agents|dermatologic agents|mesh-ancestor
56058760|NCT00002547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058761|NCT00002547|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56058762|NCT00002547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058763|NCT00002547|Antiviral Agents|antiviral agents|mesh-ancestor
56058764|NCT00002547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058765|NCT00002547|Antifungal Agents|antifungal agents|mesh-ancestor
56058766|NCT00002547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56058767|NCT00002289|Thymopentin|thymopentin|mesh-list
56058768|NCT00002289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56058808|NCT00002565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058809|NCT00002565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56058810|NCT00002565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56058811|NCT00002565|Alkylating Agents|alkylating agents|mesh-ancestor
56058812|NCT00002565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058813|NCT00002565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058814|NCT00002565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56058815|NCT00002565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56059511|NCT00002757|Mitosis Modulators|mitosis modulators|mesh-ancestor
56058816|NCT00002565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56058817|NCT00002565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56058818|NCT00002565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058819|NCT00002565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058820|NCT00002565|Glucocorticoids|glucocorticoids|mesh-ancestor
56058821|NCT00002565|Hormones|hormones|mesh-ancestor
56058822|NCT00002565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058823|NCT00002565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058824|NCT00002565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058825|NCT00002565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56058826|NCT00002565|Antimetabolites|antimetabolites|mesh-ancestor
56058827|NCT00002565|Antiviral Agents|antiviral agents|mesh-ancestor
56058828|NCT00002565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058829|NCT00002565|Tubulin Modulators|tubulin modulators|mesh-ancestor
56058861|NCT00002571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058862|NCT00002571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56058863|NCT00002571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56058864|NCT00002571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56058865|NCT00002571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56058866|NCT00002571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058867|NCT00002571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56058870|NCT00002571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058871|NCT00002571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058872|NCT00002571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56058874|NCT00002571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56058875|NCT00002571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56058877|NCT00002571|Dermatologic Agents|dermatologic agents|mesh-ancestor
56058878|NCT00002571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56058879|NCT00002571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56058880|NCT00002571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56058881|NCT00002571|Antiviral Agents|antiviral agents|mesh-ancestor
56058882|NCT00002571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058883|NCT00002571|Antidotes|antidotes|mesh-ancestor
56058884|NCT00002571|Protective Agents|protective agents|mesh-ancestor
56058885|NCT00002571|Vitamin B Complex|vitamin b complex|mesh-ancestor
56058886|NCT00002571|Vitamins|vitamins|mesh-ancestor
56058887|NCT00002571|Micronutrients|micronutrients|mesh-ancestor
56058910|NCT04897217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56058911|NCT04897217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058913|NCT04897217|Appetite Stimulants|appetite stimulants|mesh-ancestor
56058914|NCT04897217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56058915|NCT04797767|Cytarabine|cytarabine|mesh-list
56058916|NCT04797767|2-chloro-3'-deoxyadenosine|2-chloro-3'-deoxyadenosine|mesh-list
56058917|NCT04797767|Venetoclax|venetoclax|mesh-list
56058918|NCT04797767|Mitoxantrone|mitoxantrone|mesh-list
56058919|NCT04797767|Cladribine|cladribine|mesh-list
56058920|NCT04797767|Lenograstim|lenograstim|mesh-list
56058921|NCT04797767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56058922|NCT04797767|Antimetabolites|antimetabolites|mesh-ancestor
56058923|NCT04797767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058924|NCT04797767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058925|NCT04797767|Antiviral Agents|antiviral agents|mesh-ancestor
56058926|NCT04797767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058927|NCT04797767|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058928|NCT04797767|Immunologic Factors|immunologic factors|mesh-ancestor
56058929|NCT04797767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058930|NCT04797767|Analgesics|analgesics|mesh-ancestor
56058931|NCT04797767|Sensory System Agents|sensory system agents|mesh-ancestor
56058932|NCT04797767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56058933|NCT04797767|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56058934|NCT04797767|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56058935|NCT04797767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56058936|NCT04797767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56058939|NCT05752461|Enoxaparin|enoxaparin|mesh-list
56058940|NCT05752461|Enoxaparin sodium|enoxaparin sodium|mesh-list
56058941|NCT05752461|Anticoagulants|anticoagulants|mesh-ancestor
56058942|NCT05752461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56058943|NCT05752461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56058944|NCT05752461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058954|NCT00002583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56058956|NCT00002589|Muromonab-CD3|muromonab-cd3|mesh-list
56058957|NCT00002589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058958|NCT00002589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56058959|NCT00002589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56058960|NCT00002589|Antiviral Agents|antiviral agents|mesh-ancestor
56058961|NCT00002589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058962|NCT00002589|Immunologic Factors|immunologic factors|mesh-ancestor
56058963|NCT00002589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058964|NCT00002589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56058966|NCT02223871|Artemether|artemether|mesh-list
56058967|NCT02223871|Primaquine|primaquine|mesh-list
56058968|NCT02223871|Antimalarials|antimalarials|mesh-ancestor
56058969|NCT02223871|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56058970|NCT02223871|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56058971|NCT02223871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56058972|NCT00002595|Toremifene|toremifene|mesh-list
56058973|NCT00002595|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56058974|NCT00002595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56058975|NCT00002595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56058976|NCT00002595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56058977|NCT00002595|Hormone Antagonists|hormone antagonists|mesh-ancestor
56058978|NCT00002595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56058979|NCT00002595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56058980|NCT00002595|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56058981|NCT03004339|Betamethasone|betamethasone|mesh-list
56058982|NCT03004339|Betamethasone Valerate|betamethasone valerate|mesh-list
56059000|NCT00002619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059001|NCT00002619|Alkylating Agents|alkylating agents|mesh-ancestor
56059002|NCT00002619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059003|NCT00002619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56059004|NCT00002619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059005|NCT00002625|Topotecan|topotecan|mesh-list
56059006|NCT00002625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56059007|NCT00002625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56059008|NCT00002625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059009|NCT00002625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059010|NCT00002625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059011|NCT00360737|Antitoxins|antitoxins|mesh-list
56059012|NCT00360737|Botulinum Antitoxin|botulinum antitoxin|mesh-list
56059013|NCT00360737|Immunologic Factors|immunologic factors|mesh-ancestor
56059014|NCT00360737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059015|NCT05752305|Dexamethasone|dexamethasone|mesh-list
56059016|NCT05752305|Methylprednisolone|methylprednisolone|mesh-list
56059017|NCT05752305|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56059018|NCT05752305|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56059019|NCT05752305|Prednisolone|prednisolone|mesh-list
56059020|NCT05752305|Prednisolone acetate|prednisolone acetate|mesh-list
56059021|NCT05752305|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56059022|NCT05752305|Prednisolone phosphate|prednisolone phosphate|mesh-list
56059023|NCT05752305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56059024|NCT05752305|Antiemetics|antiemetics|mesh-ancestor
56059051|NCT04343729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059052|NCT04343729|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56059053|NCT04343729|Protective Agents|protective agents|mesh-ancestor
56059054|NCT04343729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56059055|NCT04343729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059056|NCT00002631|Fluorouracil|fluorouracil|mesh-list
56059057|NCT00002631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059058|NCT00002631|Antimetabolites|antimetabolites|mesh-ancestor
56059059|NCT00002631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059060|NCT00002631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56059061|NCT00002631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059062|NCT00002631|Immunologic Factors|immunologic factors|mesh-ancestor
56059063|NCT00002631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059064|NCT04887857|Azacitidine|azacitidine|mesh-list
56059065|NCT04887857|Venetoclax|venetoclax|mesh-list
56059066|NCT04887857|Cc-486|cc-486|mesh-list
56059067|NCT04887857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56059068|NCT04887857|Antimetabolites|antimetabolites|mesh-ancestor
56059069|NCT04887857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059108|NCT00002643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059109|NCT00002643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56059110|NCT00002643|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059111|NCT00002643|Alkylating Agents|alkylating agents|mesh-ancestor
56059112|NCT00002643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059113|NCT00002643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059114|NCT00002643|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56059115|NCT00002643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56059116|NCT00002643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56059117|NCT00002643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56059118|NCT00002643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059119|NCT00002643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56059120|NCT00002643|Tubulin Modulators|tubulin modulators|mesh-ancestor
56059121|NCT00002643|Antimitotic Agents|antimitotic agents|mesh-ancestor
56059122|NCT00002643|Mitosis Modulators|mitosis modulators|mesh-ancestor
56059123|NCT00002643|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56059124|NCT00002643|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56059125|NCT00002643|Protective Agents|protective agents|mesh-ancestor
56059126|NCT00002643|Trace Elements|trace elements|mesh-ancestor
56059127|NCT00002643|Micronutrients|micronutrients|mesh-ancestor
56059129|NCT00002649|Cyclophosphamide|cyclophosphamide|mesh-list
56059130|NCT00002649|Etoposide|etoposide|mesh-list
56059131|NCT00002649|Etoposide phosphate|etoposide phosphate|mesh-list
56059132|NCT00002649|Interleukin-2|interleukin-2|mesh-list
56059158|NCT03003871|Chlorhexidine|chlorhexidine|mesh-list
56059159|NCT03003871|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56059160|NCT03003871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56059161|NCT03003871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059162|NCT03003871|Disinfectants|disinfectants|mesh-ancestor
56059163|NCT03003871|Dermatologic Agents|dermatologic agents|mesh-ancestor
56059164|NCT00995059|Sirolimus|sirolimus|mesh-list
56059165|NCT00995059|Bortezomib|bortezomib|mesh-list
56059166|NCT00995059|Melphalan|melphalan|mesh-list
56059167|NCT00995059|Tacrolimus|tacrolimus|mesh-list
56059168|NCT00995059|Thymoglobulin|thymoglobulin|mesh-list
56059169|NCT00995059|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56059170|NCT00995059|Immunoglobulins|immunoglobulins|mesh-list
56059171|NCT00995059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059172|NCT00995059|Immunologic Factors|immunologic factors|mesh-ancestor
56059173|NCT00995059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059174|NCT00995059|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56059175|NCT00995059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059176|NCT00995059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059177|NCT00995059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55786333|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
56059215|NCT00002679|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56059216|NCT00002679|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56059217|NCT00002679|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56059218|NCT00002679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56059219|NCT00002691|Leucovorin|leucovorin|mesh-list
56059220|NCT00002691|Cytarabine|cytarabine|mesh-list
56059221|NCT00002691|Dexamethasone|dexamethasone|mesh-list
56059222|NCT00002691|Cyclophosphamide|cyclophosphamide|mesh-list
56059223|NCT00002691|Methotrexate|methotrexate|mesh-list
56059224|NCT00002691|Etoposide|etoposide|mesh-list
56059225|NCT00002691|Vincristine|vincristine|mesh-list
56059226|NCT00002691|Daunorubicin|daunorubicin|mesh-list
56059227|NCT00002691|Asparaginase|asparaginase|mesh-list
56059228|NCT00002691|Levoleucovorin|levoleucovorin|mesh-list
56059229|NCT00002691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059230|NCT00002691|Immunologic Factors|immunologic factors|mesh-ancestor
56059231|NCT00002691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059233|NCT00002691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059234|NCT00002691|Alkylating Agents|alkylating agents|mesh-ancestor
56059235|NCT00002691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059236|NCT00002691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059237|NCT00002691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56059239|NCT00002691|Antiemetics|antiemetics|mesh-ancestor
56059271|NCT03003637|Ipilimumab|ipilimumab|mesh-list
56059272|NCT03003637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56059273|NCT03003637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059274|NCT03003637|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56059275|NCT03003637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059276|NCT04054115|Alprostadil|alprostadil|mesh-list
56059277|NCT04054115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56059278|NCT04054115|Vasodilator Agents|vasodilator agents|mesh-ancestor
56059279|NCT04054115|Urological Agents|urological agents|mesh-ancestor
56059280|NCT00002697|Carboplatin|carboplatin|mesh-list
56059281|NCT00002697|Etoposide|etoposide|mesh-list
56059282|NCT00002697|Ifosfamide|ifosfamide|mesh-list
56059283|NCT00002697|Sargramostim|sargramostim|mesh-list
56059284|NCT00002697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059285|NCT00002697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56059286|NCT00002697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56059287|NCT00002697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56059288|NCT00002697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059289|NCT00002697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059290|NCT00002697|Immunologic Factors|immunologic factors|mesh-ancestor
56059291|NCT00002697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059292|NCT00002697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059293|NCT00002697|Alkylating Agents|alkylating agents|mesh-ancestor
56059294|NCT04488601|Sirolimus|sirolimus|mesh-list
56059295|NCT04488601|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56059296|NCT04488601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059297|NCT04488601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56059298|NCT04488601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059299|NCT04488601|Antifungal Agents|antifungal agents|mesh-ancestor
56059300|NCT04488601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56059301|NCT04488601|Immunologic Factors|immunologic factors|mesh-ancestor
56059302|NCT04488601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059303|NCT05032807|Cannabidiol|cannabidiol|mesh-list
56059304|NCT05032807|Anticonvulsants|anticonvulsants|mesh-ancestor
56059305|NCT00002715|Prednisone|prednisone|mesh-list
56059307|NCT00002715|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56059313|NCT00002715|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56059314|NCT00002715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059315|NCT00002715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56059316|NCT00002715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56059317|NCT00002715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059318|NCT00002715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059319|NCT00002715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56059320|NCT00002715|Glucocorticoids|glucocorticoids|mesh-ancestor
56059321|NCT00002715|Hormones|hormones|mesh-ancestor
56059322|NCT00002715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059323|NCT00002715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059324|NCT00002715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56059325|NCT00002715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56059326|NCT00002715|Tubulin Modulators|tubulin modulators|mesh-ancestor
56059327|NCT00002715|Antimitotic Agents|antimitotic agents|mesh-ancestor
56059328|NCT00002715|Mitosis Modulators|mitosis modulators|mesh-ancestor
56059329|NCT00002715|Alkylating Agents|alkylating agents|mesh-ancestor
56059330|NCT00002715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059331|NCT04972513|Nitric Oxide|nitric oxide|mesh-list
56059332|NCT04972513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56059333|NCT04972513|Autonomic Agents|autonomic agents|mesh-ancestor
56059334|NCT04972513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059335|NCT04972513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059337|NCT04972513|Respiratory System Agents|respiratory system agents|mesh-ancestor
56059338|NCT04972513|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56059339|NCT04972513|Antioxidants|antioxidants|mesh-ancestor
56059340|NCT04972513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059341|NCT04972513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059342|NCT04972513|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56059343|NCT04972513|Vasodilator Agents|vasodilator agents|mesh-ancestor
56059344|NCT04972513|Gasotransmitters|gasotransmitters|mesh-ancestor
56059346|NCT02976467|Fulacimstat|fulacimstat|mesh-list
56059352|NCT02981095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059353|NCT02981095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059354|NCT02981095|Sensory System Agents|sensory system agents|mesh-ancestor
56059355|NCT02981095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059356|NCT00002721|Doxorubicin|doxorubicin|mesh-list
56059357|NCT00002721|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56059358|NCT00002721|Estramustine|estramustine|mesh-list
56059359|NCT00002721|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56059360|NCT00002721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059361|NCT00002721|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56059362|NCT00002721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56059363|NCT00002721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059364|NCT00002721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059365|NCT00002721|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56059366|NCT00002721|Alkylating Agents|alkylating agents|mesh-ancestor
56059367|NCT00002721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56059368|NCT04739345|Pentoxifylline|pentoxifylline|mesh-list
56059369|NCT04739345|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56059370|NCT04739345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059371|NCT04739345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059372|NCT04739345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56059373|NCT04739345|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56059374|NCT04739345|Protective Agents|protective agents|mesh-ancestor
56059375|NCT04739345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059376|NCT04739345|Vasodilator Agents|vasodilator agents|mesh-ancestor
56059377|NCT04739345|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56059378|NCT04739345|Antioxidants|antioxidants|mesh-ancestor
56059379|NCT04354103|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56059395|NCT01625455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059396|NCT05751681|Cetrorelix|cetrorelix|mesh-list
56059397|NCT05751681|Dydrogesterone|dydrogesterone|mesh-list
56059398|NCT05751681|Progestins|progestins|mesh-list
56059399|NCT05751681|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56059400|NCT05751681|Fertility Agents|fertility agents|mesh-ancestor
56059401|NCT05751681|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56059402|NCT05751681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059403|NCT05751681|Hormone Antagonists|hormone antagonists|mesh-ancestor
56059404|NCT05751681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059406|NCT02976623|Metronidazole|metronidazole|mesh-list
56059407|NCT02976623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059408|NCT02976623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56059409|NCT02976623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56059410|NCT02976623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56059411|NCT00002733|Interferons|interferons|mesh-list
56059412|NCT00002733|Interferon-alpha|interferon-alpha|mesh-list
56059413|NCT00002733|Aldesleukin|aldesleukin|mesh-list
56059414|NCT00002733|Cimetidine|cimetidine|mesh-list
56059415|NCT00002733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059416|NCT00002733|Antiviral Agents|antiviral agents|mesh-ancestor
56059417|NCT00002733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059419|NCT00002733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059420|NCT00002733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56059421|NCT00002733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56059422|NCT00002733|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56059423|NCT00002733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059424|NCT00002733|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56059426|NCT00002733|Histamine Agents|histamine agents|mesh-ancestor
56059444|NCT04311671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059445|NCT04311671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059446|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
56059448|NCT01625923|Antiemetics|antiemetics|mesh-ancestor
56059449|NCT01625923|Autonomic Agents|autonomic agents|mesh-ancestor
56059450|NCT01625923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059451|NCT01625923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059452|NCT01625923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059453|NCT01625923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56059454|NCT01625923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56059455|NCT01625923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059456|NCT01625923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56059457|NCT01625923|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56059458|NCT01625923|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56059459|NCT01625923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56059460|NCT01625923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059461|NCT01625923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059462|NCT01625923|Serotonin Agents|serotonin agents|mesh-ancestor
56059463|NCT00002751|Antibodies|antibodies|mesh-list
56059464|NCT00002751|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56059465|NCT00002751|Immunologic Factors|immunologic factors|mesh-ancestor
56059466|NCT00002751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059467|NCT00002757|Cytarabine|cytarabine|mesh-list
56059468|NCT00002757|Prednisone|prednisone|mesh-list
56059469|NCT00002757|Prednisolone|prednisolone|mesh-list
56059470|NCT00002757|Hydrocortisone|hydrocortisone|mesh-list
56059492|NCT00002757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059493|NCT00002757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56059494|NCT00002757|Glucocorticoids|glucocorticoids|mesh-ancestor
56059496|NCT00002757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059497|NCT00002757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56059498|NCT00002757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56059499|NCT00002757|Abortifacient Agents|abortifacient agents|mesh-ancestor
56059500|NCT00002757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56059501|NCT00002757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56059502|NCT00002757|Antimetabolites|antimetabolites|mesh-ancestor
56059503|NCT00002757|Dermatologic Agents|dermatologic agents|mesh-ancestor
56059504|NCT00002757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56059505|NCT00002757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56059506|NCT00002757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56059507|NCT00002757|Antiviral Agents|antiviral agents|mesh-ancestor
56059508|NCT00002757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059509|NCT00002757|Tubulin Modulators|tubulin modulators|mesh-ancestor
56059510|NCT00002757|Antimitotic Agents|antimitotic agents|mesh-ancestor
56059514|NCT00002763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059515|NCT00002763|Antiviral Agents|antiviral agents|mesh-ancestor
56059516|NCT00002763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059517|NCT00002763|Immunologic Factors|immunologic factors|mesh-ancestor
56059542|NCT01631149|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56059543|NCT01631149|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56059545|NCT01631149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059546|NCT01631149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059547|NCT01631149|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56059548|NCT01631149|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56059549|NCT01631149|Cholinergic Agents|cholinergic agents|mesh-ancestor
56059550|NCT01631149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059551|NCT01631149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059552|NCT00002787|Aldesleukin|aldesleukin|mesh-list
56059553|NCT00002787|Interleukin-2|interleukin-2|mesh-list
56059554|NCT00002787|Vaccines|vaccines|mesh-list
55786716|NCT04305145|Infliximab|infliximab|mesh-list
56059555|NCT00002787|Immunoglobulins|immunoglobulins|mesh-list
56059556|NCT00002787|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56059557|NCT00002787|Antibodies|antibodies|mesh-list
56059558|NCT00002787|Sargramostim|sargramostim|mesh-list
56059559|NCT00002787|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56059560|NCT00002787|Immunoglobulin Idiotypes|immunoglobulin idiotypes|mesh-list
56059561|NCT00002787|Immunologic Factors|immunologic factors|mesh-ancestor
56059562|NCT00002787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059563|NCT00002787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059564|NCT00002787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56059565|NCT00002787|Analgesics|analgesics|mesh-ancestor
56059568|NCT00002787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56059592|NCT00002793|Immunologic Factors|immunologic factors|mesh-ancestor
56059593|NCT00002793|Antidotes|antidotes|mesh-ancestor
56059594|NCT00002793|Protective Agents|protective agents|mesh-ancestor
56059595|NCT00002793|Vitamin B Complex|vitamin b complex|mesh-ancestor
56059596|NCT00002793|Vitamins|vitamins|mesh-ancestor
56059597|NCT00002793|Micronutrients|micronutrients|mesh-ancestor
56059598|NCT01632709|Bupivacaine|bupivacaine|mesh-list
56059599|NCT01632709|Anesthetics, Local|anesthetics, local|mesh-ancestor
56059600|NCT01632709|Anesthetics|anesthetics|mesh-ancestor
56059601|NCT01632709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059602|NCT01632709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059603|NCT01632709|Sensory System Agents|sensory system agents|mesh-ancestor
56059604|NCT01632709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059605|NCT05751291|Bupivacaine|bupivacaine|mesh-list
56059606|NCT05751291|Anesthetics, Local|anesthetics, local|mesh-ancestor
56059607|NCT05751291|Anesthetics|anesthetics|mesh-ancestor
56059608|NCT05751291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059609|NCT05751291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059610|NCT05751291|Sensory System Agents|sensory system agents|mesh-ancestor
56059611|NCT05751291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059612|NCT05720949|Dexamethasone|dexamethasone|mesh-list
56059613|NCT05720949|Bupivacaine|bupivacaine|mesh-list
56059614|NCT05720949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56059615|NCT05720949|Antiemetics|antiemetics|mesh-ancestor
56059616|NCT05720949|Autonomic Agents|autonomic agents|mesh-ancestor
56059617|NCT05720949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900920|NCT01867606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900922|NCT02415192|Valsartan|valsartan|mesh-list
55900923|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55900924|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55900925|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900926|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900927|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55900928|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900929|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
55900930|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55900931|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55900932|NCT02415270|Menthol|menthol|mesh-list
55900933|NCT02415270|Nicotine|nicotine|mesh-list
55900934|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55900935|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
55900936|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900937|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900938|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55900939|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55900940|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
55900941|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059618|NCT05720949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059619|NCT05720949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059620|NCT05720949|Glucocorticoids|glucocorticoids|mesh-ancestor
56059621|NCT05720949|Hormones|hormones|mesh-ancestor
56059622|NCT05720949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059623|NCT05720949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56059624|NCT05720949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059625|NCT05720949|Anesthetics, Local|anesthetics, local|mesh-ancestor
56059626|NCT05720949|Anesthetics|anesthetics|mesh-ancestor
56059627|NCT05720949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059628|NCT05720949|Sensory System Agents|sensory system agents|mesh-ancestor
56059629|NCT01634191|Apremilast|apremilast|mesh-list
56059630|NCT01634191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56059631|NCT01634191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56059632|NCT01634191|Analgesics|analgesics|mesh-ancestor
56059633|NCT01634191|Sensory System Agents|sensory system agents|mesh-ancestor
56059634|NCT01634191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059635|NCT01634191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059636|NCT01634191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56059637|NCT01634191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56059638|NCT01634191|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56059639|NCT01634191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56059640|NCT01634191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059668|NCT05688735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059669|NCT04276493|Docetaxel|docetaxel|mesh-list
56059670|NCT04276493|Capecitabine|capecitabine|mesh-list
56059671|NCT04276493|Oxaliplatin|oxaliplatin|mesh-list
56059672|NCT04276493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059673|NCT04276493|Tubulin Modulators|tubulin modulators|mesh-ancestor
56059674|NCT04276493|Antimitotic Agents|antimitotic agents|mesh-ancestor
56059675|NCT04276493|Mitosis Modulators|mitosis modulators|mesh-ancestor
56059676|NCT04276493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059677|NCT04276493|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56059678|NCT04276493|Antimetabolites|antimetabolites|mesh-ancestor
56059680|NCT05687721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56059681|NCT05687721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059682|NCT05670795|Clomiphene|clomiphene|mesh-list
56059683|NCT05670795|Enclomiphene|enclomiphene|mesh-list
56059684|NCT05670795|Zuclomiphene|zuclomiphene|mesh-list
56059685|NCT05670795|Hormones|hormones|mesh-list
56059686|NCT05670795|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56059687|NCT05670795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059688|NCT05670795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059689|NCT05670795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56059690|NCT05670795|Hormone Antagonists|hormone antagonists|mesh-ancestor
56059691|NCT05670795|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56059692|NCT05670795|Fertility Agents|fertility agents|mesh-ancestor
56059719|NCT03942419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059720|NCT03942419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059721|NCT05669313|Rivaroxaban|rivaroxaban|mesh-list
56059722|NCT05669313|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56059723|NCT05669313|Antithrombins|antithrombins|mesh-ancestor
56059724|NCT05669313|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56059725|NCT05669313|Protease Inhibitors|protease inhibitors|mesh-ancestor
56059726|NCT05669313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059727|NCT05669313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059728|NCT05669313|Anticoagulants|anticoagulants|mesh-ancestor
56059729|NCT04343963|Bromides|bromides|mesh-list
56059730|NCT04343963|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
56059731|NCT04343963|Anticonvulsants|anticonvulsants|mesh-ancestor
56059732|NCT04343963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56059733|NCT04343963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059734|NCT04343963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059739|NCT04248179|Ropivacaine|ropivacaine|mesh-list
56059740|NCT04248179|Anesthetics, Local|anesthetics, local|mesh-ancestor
56059741|NCT04248179|Anesthetics|anesthetics|mesh-ancestor
56059742|NCT04248179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059743|NCT04248179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059744|NCT04248179|Sensory System Agents|sensory system agents|mesh-ancestor
56059745|NCT04248179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059746|NCT04248179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56059747|NCT04248179|Narcotics|narcotics|mesh-ancestor
56059748|NCT04248179|Analgesics|analgesics|mesh-ancestor
56059749|NCT04248179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56059762|NCT00361517|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56059763|NCT00361517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059764|NCT03920267|BMS-986165|bms-986165|mesh-list
56059766|NCT03920267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56059767|NCT03920267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059768|NCT03920267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059769|NCT05447507|Dexmedetomidine|dexmedetomidine|mesh-list
56059770|NCT05447507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56059771|NCT05447507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059772|NCT05447507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059773|NCT05447507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56059774|NCT05447507|Analgesics|analgesics|mesh-ancestor
56059775|NCT05447507|Sensory System Agents|sensory system agents|mesh-ancestor
56059776|NCT05447507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059777|NCT05447507|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56059778|NCT05447507|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56059779|NCT05447507|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56059780|NCT05447507|Adrenergic Agents|adrenergic agents|mesh-ancestor
56059781|NCT05447507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56059782|NCT05447507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059784|NCT01635439|Oxytocics|oxytocics|mesh-ancestor
56059785|NCT01635439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56059786|NCT01635439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059787|NCT01636063|Misoprostol|misoprostol|mesh-list
56059788|NCT01636063|Mifepristone|mifepristone|mesh-list
56059789|NCT01636063|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56059790|NCT01636063|Abortifacient Agents|abortifacient agents|mesh-ancestor
56059791|NCT01636063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56059792|NCT01636063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059793|NCT01636063|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56059794|NCT01636063|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059795|NCT01636063|Oxytocics|oxytocics|mesh-ancestor
56059796|NCT01636063|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56059797|NCT01636063|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56059798|NCT01636063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56059799|NCT01636063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56059800|NCT01636063|Contraceptive Agents|contraceptive agents|mesh-ancestor
56059801|NCT01636063|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56059802|NCT01636063|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56059803|NCT01636063|Hormone Antagonists|hormone antagonists|mesh-ancestor
56059804|NCT01636063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059805|NCT01636063|Luteolytic Agents|luteolytic agents|mesh-ancestor
56059806|NCT01636063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56059807|NCT01636063|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56059810|NCT05749575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059811|NCT05749575|Tubulin Modulators|tubulin modulators|mesh-ancestor
56059812|NCT05749575|Antimitotic Agents|antimitotic agents|mesh-ancestor
56059813|NCT05749575|Mitosis Modulators|mitosis modulators|mesh-ancestor
56059814|NCT05749575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059815|NCT04387201|Vitamin B 12|vitamin b 12|mesh-list
56059816|NCT04387201|Hydroxocobalamin|hydroxocobalamin|mesh-list
56059817|NCT04387201|Dulaglutide|dulaglutide|mesh-list
56059818|NCT04387201|Vitamins|vitamins|mesh-ancestor
56059819|NCT04387201|Micronutrients|micronutrients|mesh-ancestor
56059820|NCT04387201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059821|NCT04387201|Vitamin B Complex|vitamin b complex|mesh-ancestor
56059822|NCT04387201|Hematinics|hematinics|mesh-ancestor
56059823|NCT04387201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56059824|NCT05625399|Nivolumab|nivolumab|mesh-list
56059825|NCT05625399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56059826|NCT05625399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059827|NCT05625399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56059828|NCT05625399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059829|NCT04370587|Pembrolizumab|pembrolizumab|mesh-list
56059838|NCT05623761|Cariostatic Agents|cariostatic agents|mesh-ancestor
56059839|NCT05623761|Protective Agents|protective agents|mesh-ancestor
56059840|NCT05623761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059842|NCT05614089|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56059843|NCT05614089|Insulin Glargine|insulin glargine|mesh-list
56059844|NCT05614089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56059845|NCT05614089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059846|NCT04231331|Ertugliflozin|ertugliflozin|mesh-list
56059847|NCT04231331|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56059848|NCT04231331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059849|NCT04231331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56059850|NCT04231331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059851|NCT00361985|Esomeprazole|esomeprazole|mesh-list
56059853|NCT00361985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56059854|NCT00361985|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56059855|NCT00361985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059856|NCT00361985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059857|NCT00362063|Hormones|hormones|mesh-list
56059858|NCT00362063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059859|NCT00362063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059860|NCT00382239|Exenatide|exenatide|mesh-list
56059861|NCT00382239|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56059862|NCT00382239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059863|NCT00382239|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56059864|NCT00382239|Incretins|incretins|mesh-ancestor
56059865|NCT00382239|Hormones|hormones|mesh-ancestor
56059866|NCT00382239|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059867|NCT04004845|Misoprostol|misoprostol|mesh-list
56059868|NCT04004845|Oxytocin|oxytocin|mesh-list
56059869|NCT04004845|Oxytocics|oxytocics|mesh-ancestor
56059870|NCT04004845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56059871|NCT04004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059878|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059880|NCT05571735|Immunologic Factors|immunologic factors|mesh-ancestor
56059881|NCT05571735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059882|NCT04218851|Posaconazole|posaconazole|mesh-list
56059883|NCT04218851|Antifungal Agents|antifungal agents|mesh-ancestor
56059884|NCT04218851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059885|NCT04218851|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56059886|NCT04218851|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56059887|NCT04218851|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56059888|NCT04218851|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56059889|NCT04218851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56059890|NCT04218851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059891|NCT04218851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059892|NCT04218851|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56059893|NCT04218851|Hormone Antagonists|hormone antagonists|mesh-ancestor
56059894|NCT04218851|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56059895|NCT04218851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059896|NCT01637935|Pioglitazone|pioglitazone|mesh-list
56059897|NCT01637935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56059898|NCT01637935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059900|NCT00382083|Ibuprofen|ibuprofen|mesh-list
56059901|NCT00382083|Lidocaine|lidocaine|mesh-list
56059902|NCT00382083|Anesthetics, Local|anesthetics, local|mesh-ancestor
56059903|NCT00382083|Anesthetics|anesthetics|mesh-ancestor
56059904|NCT00382083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56059905|NCT00382083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059906|NCT00382083|Sensory System Agents|sensory system agents|mesh-ancestor
56059907|NCT00382083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059908|NCT00382083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56059922|NCT01640197|Antioxidants|antioxidants|mesh-ancestor
56059923|NCT01640197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059924|NCT01640197|Protective Agents|protective agents|mesh-ancestor
56059925|NCT01640197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059926|NCT01640197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059927|NCT01640197|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56059928|NCT05742399|Hyaluronic Acid|hyaluronic acid|mesh-list
56059929|NCT05742399|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56059930|NCT05742399|Immunologic Factors|immunologic factors|mesh-ancestor
56059931|NCT05742399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787087|NCT05108389|Hemostatics|hemostatics|mesh-list
56059932|NCT05742399|Viscosupplements|viscosupplements|mesh-ancestor
56059933|NCT05742399|Protective Agents|protective agents|mesh-ancestor
56059935|NCT01641445|Anticonvulsants|anticonvulsants|mesh-ancestor
56059936|NCT01641445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56059937|NCT01641445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059938|NCT04185311|Nivolumab|nivolumab|mesh-list
56059939|NCT04185311|Ipilimumab|ipilimumab|mesh-list
56059940|NCT04185311|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
56059941|NCT04185311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56059942|NCT04185311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059943|NCT04185311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56059944|NCT04185311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059945|NCT05513937|Amlodipine|amlodipine|mesh-list
56059946|NCT05513937|Nebivolol|nebivolol|mesh-list
56059947|NCT05513937|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56059948|NCT05513937|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56059949|NCT05513937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56059953|NCT05513937|Vasodilator Agents|vasodilator agents|mesh-ancestor
56059968|NCT04584749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56059969|NCT04584749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56059970|NCT04584749|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56059971|NCT04584749|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56059972|NCT04584749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56059973|NCT04584749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059974|NCT05736861|Ivermectin|ivermectin|mesh-list
56059975|NCT05736861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56059976|NCT05736861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059977|NCT05502315|Nivolumab|nivolumab|mesh-list
56059978|NCT05502315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56059979|NCT05502315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56059980|NCT05502315|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56059982|NCT01644331|Tolvaptan|tolvaptan|mesh-list
56059983|NCT01644331|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56059984|NCT01644331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059985|NCT01644331|Natriuretic Agents|natriuretic agents|mesh-ancestor
56059986|NCT01644331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56059987|NCT00362141|Levetiracetam|levetiracetam|mesh-list
56059988|NCT00362141|Anticonvulsants|anticonvulsants|mesh-ancestor
56059989|NCT00362141|Nootropic Agents|nootropic agents|mesh-ancestor
56059990|NCT05733897|Hydroxychloroquine|hydroxychloroquine|mesh-list
56059991|NCT05733897|Antimalarials|antimalarials|mesh-ancestor
56059992|NCT05733897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56059993|NCT05733897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56059994|NCT05733897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56059995|NCT05733897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56059996|NCT05733897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56059998|NCT05493501|Gemcitabine|gemcitabine|mesh-list
56060011|NCT05493501|Antimetabolites|antimetabolites|mesh-ancestor
56060012|NCT05493501|Antiviral Agents|antiviral agents|mesh-ancestor
56060013|NCT05493501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060014|NCT05493501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060015|NCT05493501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56060016|NCT05493501|Immunologic Factors|immunologic factors|mesh-ancestor
56060017|NCT05493501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060018|NCT05493501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56060019|NCT05493501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56060020|NCT05493501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56060021|NCT01646671|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56060022|NCT01646671|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56060023|NCT01646671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060025|NCT03561259|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56060026|NCT03561259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060027|NCT03561259|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56060028|NCT03561259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060029|NCT03561259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060030|NCT03561259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56060031|NCT03002935|Coenzyme Q10|coenzyme q10|mesh-list
56060032|NCT03002935|Micronutrients|micronutrients|mesh-ancestor
56060033|NCT03002935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060034|NCT03002935|Vitamins|vitamins|mesh-ancestor
56060035|NCT03788291|Rituximab|rituximab|mesh-list
56060036|NCT03788291|Acalabrutinib|acalabrutinib|mesh-list
56060037|NCT03788291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56060038|NCT03788291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060039|NCT03788291|Immunologic Factors|immunologic factors|mesh-ancestor
56060040|NCT03788291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060041|NCT03788291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56060042|NCT04593459|Metformin|metformin|mesh-list
55900942|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900943|NCT02415270|Antipruritics|antipruritics|mesh-ancestor
55900944|NCT02415270|Dermatologic Agents|dermatologic agents|mesh-ancestor
55900945|NCT02415114|Resveratrol|resveratrol|mesh-list
55900946|NCT02415114|Antioxidants|antioxidants|mesh-ancestor
55900947|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900948|NCT02415114|Protective Agents|protective agents|mesh-ancestor
55900949|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900950|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060043|NCT04593459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56060044|NCT04593459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060055|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
56060056|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060057|NCT03775109|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56060058|NCT03775109|Immunologic Factors|immunologic factors|mesh-ancestor
56060059|NCT03775109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060060|NCT03251924|Nivolumab|nivolumab|mesh-list
56060061|NCT03251924|Ipilimumab|ipilimumab|mesh-list
56060062|NCT03251924|Antibodies|antibodies|mesh-list
56060063|NCT03251924|Immunoglobulins|immunoglobulins|mesh-list
56060064|NCT03251924|Antibodies, Blocking|antibodies, blocking|mesh-list
56060065|NCT03251924|Immunologic Factors|immunologic factors|mesh-ancestor
56060066|NCT03251924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060067|NCT03251924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56060068|NCT03251924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060095|NCT03122197|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56060096|NCT03122197|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56060097|NCT03122197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060098|NCT03122197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060099|NCT03122197|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56060100|NCT03122197|Hormone Antagonists|hormone antagonists|mesh-ancestor
56060101|NCT03122197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060102|NCT03122197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060103|NCT04383639|Locust bean gum|locust bean gum|mesh-list
56060104|NCT04383639|Antidiarrheals|antidiarrheals|mesh-ancestor
56060105|NCT04383639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060146|NCT02219581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060147|NCT01437709|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56060149|NCT01437709|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56060150|NCT01437709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56060151|NCT01437709|Alkylating Agents|alkylating agents|mesh-ancestor
56060152|NCT01437709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060153|NCT01437709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060154|NCT01437709|Immunologic Factors|immunologic factors|mesh-ancestor
56060155|NCT01437709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060156|NCT03740165|Paclitaxel|paclitaxel|mesh-list
55787314|NCT04967417|Paclitaxel|paclitaxel|mesh-list
56060158|NCT03740165|Bevacizumab|bevacizumab|mesh-list
56060159|NCT03740165|Carboplatin|carboplatin|mesh-list
56060160|NCT03740165|Pembrolizumab|pembrolizumab|mesh-list
56060161|NCT03740165|Olaparib|olaparib|mesh-list
56060162|NCT03740165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56060163|NCT03740165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060164|NCT03740165|Tubulin Modulators|tubulin modulators|mesh-ancestor
56060176|NCT01912274|Azacitidine|azacitidine|mesh-list
56060207|NCT05735834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56060208|NCT05735834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060209|NCT05735834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060210|NCT05184777|Estradiol|estradiol|mesh-list
56060211|NCT05184777|Progesterone|progesterone|mesh-list
56060212|NCT05184777|Estrogens|estrogens|mesh-ancestor
56060213|NCT05184777|Hormones|hormones|mesh-ancestor
56060214|NCT05184777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060216|NCT05184777|Progestins|progestins|mesh-ancestor
56060217|NCT01912352|Methylphenidate|methylphenidate|mesh-list
56060218|NCT01912352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56060219|NCT01912352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060220|NCT01912352|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56060221|NCT01912352|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56060222|NCT01912352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060223|NCT01912352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060224|NCT01912352|Dopamine Agents|dopamine agents|mesh-ancestor
56060225|NCT01912352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060226|NCT02975843|Beclomethasone|beclomethasone|mesh-list
56060227|NCT02975843|Glycopyrrolate|glycopyrrolate|mesh-list
56060228|NCT02975843|Formoterol Fumarate|formoterol fumarate|mesh-list
56060229|NCT02975843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55900951|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55900952|NCT03178422|Nicotine|nicotine|mesh-list
55900953|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55900954|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
55900955|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900956|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900957|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55900958|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55900959|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
55900960|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060270|NCT05735756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900961|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900962|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55900963|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55900964|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55900965|NCT02414880|Rocuronium|rocuronium|mesh-list
55900966|NCT02414880|Neostigmine|neostigmine|mesh-list
55900967|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55900968|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55900969|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55900970|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900971|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900972|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55900973|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900974|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900975|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
56060230|NCT02975843|Autonomic Agents|autonomic agents|mesh-ancestor
55787385|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56060231|NCT02975843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060232|NCT02975843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060233|NCT02975843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56060234|NCT02975843|Respiratory System Agents|respiratory system agents|mesh-ancestor
56060235|NCT02975843|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56060236|NCT02975843|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56060237|NCT02975843|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56060238|NCT02975843|Adrenergic Agents|adrenergic agents|mesh-ancestor
56060239|NCT02975843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060240|NCT02975843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060241|NCT02975843|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56060242|NCT02975843|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56060243|NCT02975843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56060244|NCT02975843|Cholinergic Agents|cholinergic agents|mesh-ancestor
56060245|NCT02975843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56060246|NCT02975843|Glucocorticoids|glucocorticoids|mesh-ancestor
56060247|NCT02975843|Hormones|hormones|mesh-ancestor
56060248|NCT02975843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060249|NCT01655563|Tacrolimus|tacrolimus|mesh-list
56060250|NCT01655563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56060251|NCT01655563|Immunologic Factors|immunologic factors|mesh-ancestor
55900976|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900977|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55900978|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
55900979|NCT02423694|Dexetimide|dexetimide|mesh-list
55900980|NCT02423694|Citalopram|citalopram|mesh-list
55900981|NCT02423694|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55900982|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55900983|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55900984|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900985|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900986|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
55900987|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755155|NCT03069027|Lidocaine|lidocaine|mesh-list
55900988|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55900996|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55900997|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55900998|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
55901000|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55901001|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
55901002|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901003|NCT02420418|Expectorants|expectorants|mesh-ancestor
55901004|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
55901005|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55901006|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
56060253|NCT01655563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56060254|NCT01655563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060255|NCT01655563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060261|NCT01655719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56060262|NCT01655719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060263|NCT05735756|Citalopram|citalopram|mesh-list
56060264|NCT05735756|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56060265|NCT05735756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56060266|NCT05735756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060267|NCT05735756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060268|NCT05735756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060269|NCT05735756|Serotonin Agents|serotonin agents|mesh-ancestor
56060271|NCT05735756|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56060272|NCT05735756|Antidepressive Agents|antidepressive agents|mesh-ancestor
55901007|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901008|NCT02420418|Protective Agents|protective agents|mesh-ancestor
55901009|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901010|NCT02420418|Antidotes|antidotes|mesh-ancestor
55901011|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
55901012|NCT02414802|Heparin|heparin|mesh-list
55901013|NCT02414802|Calcium heparin|calcium heparin|mesh-list
55901014|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55901015|NCT02414802|Tinzaparin|tinzaparin|mesh-list
55901016|NCT02414802|Dalteparin|dalteparin|mesh-list
55901017|NCT02414802|Calcium|calcium|mesh-list
55901018|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55901019|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901020|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55901021|NCT02414802|Anticoagulants|anticoagulants|mesh-ancestor
55901022|NCT02414802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55901023|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55901024|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901025|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
55901026|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55901027|NCT01701401|Ledipasvir|ledipasvir|mesh-list
55901028|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
55901030|NCT04482504|Vitamin D|vitamin d|mesh-list
55901031|NCT04482504|Vitamins|vitamins|mesh-ancestor
55901032|NCT04482504|Micronutrients|micronutrients|mesh-ancestor
55901033|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901034|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55901035|NCT02414568|Prednisone|prednisone|mesh-list
55901036|NCT02414568|Doxorubicin|doxorubicin|mesh-list
55901037|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55901038|NCT02414568|Vinblastine|vinblastine|mesh-list
55901039|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55901040|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901041|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55901042|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55901043|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901044|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901045|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55901046|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
55901047|NCT02414568|Hormones|hormones|mesh-ancestor
55901048|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060274|NCT01936844|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56060275|NCT01936844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56060276|NCT02987348|Insulin|insulin|mesh-list
56060277|NCT02987348|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56060278|NCT02987348|Exenatide|exenatide|mesh-list
56060279|NCT02987348|Insulin, Long-Acting|insulin, long-acting|mesh-list
56060280|NCT02987348|Glucagon|glucagon|mesh-list
56060281|NCT02987348|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56060282|NCT02987348|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56060283|NCT02987348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060284|NCT02987348|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56060285|NCT02987348|Incretins|incretins|mesh-ancestor
56060286|NCT02987348|Hormones|hormones|mesh-ancestor
56060287|NCT02987348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060288|NCT02987348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060289|NCT01656031|Cytarabine|cytarabine|mesh-list
56060290|NCT01656031|Clofarabine|clofarabine|mesh-list
56060291|NCT01656031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56060292|NCT01656031|Antimetabolites|antimetabolites|mesh-ancestor
56060293|NCT01656031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060294|NCT01656031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060295|NCT01656031|Antiviral Agents|antiviral agents|mesh-ancestor
56060296|NCT01656031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060297|NCT01656031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56060298|NCT01656031|Immunologic Factors|immunologic factors|mesh-ancestor
56060324|NCT01350141|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56060325|NCT05414409|Metformin|metformin|mesh-list
56060326|NCT05414409|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56060327|NCT05414409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060338|NCT05388669|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56060339|NCT05388669|Lazertinib|lazertinib|mesh-list
56060340|NCT05388669|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56060341|NCT05388669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56060342|NCT05388669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740413|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060343|NCT05388669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060344|NCT05388669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56060345|NCT05388669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060346|NCT05388669|Immunologic Factors|immunologic factors|mesh-ancestor
56060347|NCT05388669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060348|NCT01662115|Nicotine|nicotine|mesh-list
56060349|NCT01662115|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56060350|NCT01662115|Autonomic Agents|autonomic agents|mesh-ancestor
56060351|NCT01662115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060352|NCT01662115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060353|NCT01662115|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56060377|NCT01598545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56060378|NCT01598545|Narcotics|narcotics|mesh-ancestor
56060379|NCT01598545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060381|NCT01598545|Analgesics|analgesics|mesh-ancestor
56060382|NCT01598545|Sensory System Agents|sensory system agents|mesh-ancestor
56060383|NCT01598545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060384|NCT01598701|Acetaminophen|acetaminophen|mesh-list
56060385|NCT01598701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56060386|NCT01598701|Analgesics|analgesics|mesh-ancestor
56060387|NCT01598701|Sensory System Agents|sensory system agents|mesh-ancestor
56060388|NCT01598701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060389|NCT01598701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060390|NCT01598701|Antipyretics|antipyretics|mesh-ancestor
56060391|NCT00000309|Risperidone|risperidone|mesh-list
56060392|NCT00000309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56060393|NCT00000309|Serotonin Agents|serotonin agents|mesh-ancestor
56060394|NCT00000309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060395|NCT00000309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060396|NCT00000309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060397|NCT00000309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56060398|NCT00000309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56060399|NCT00000309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060400|NCT00000309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56060401|NCT00000309|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56060402|NCT00000309|Dopamine Agents|dopamine agents|mesh-ancestor
56060403|NCT00000315|Cocaine|cocaine|mesh-list
56060404|NCT00000315|Anesthetics, Local|anesthetics, local|mesh-ancestor
56060405|NCT00000315|Anesthetics|anesthetics|mesh-ancestor
56060406|NCT00000315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060407|NCT00000315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060408|NCT00000315|Sensory System Agents|sensory system agents|mesh-ancestor
56060409|NCT00000315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060410|NCT00000315|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56060411|NCT00000315|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56060416|NCT00000315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060417|NCT00000321|Desipramine|desipramine|mesh-list
56060418|NCT00000321|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56060419|NCT00000321|Antidepressive Agents|antidepressive agents|mesh-ancestor
56060420|NCT00000321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56060421|NCT00000321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060422|NCT00000321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060423|NCT00000321|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56060424|NCT00000321|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56060425|NCT00000321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060426|NCT00000321|Adrenergic Agents|adrenergic agents|mesh-ancestor
56060427|NCT00000321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060428|NCT00000321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060429|NCT05125029|Botulinum Toxins|botulinum toxins|mesh-list
56060430|NCT05125029|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56060431|NCT05125029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060432|NCT05125029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060433|NCT05125029|Cholinergic Agents|cholinergic agents|mesh-ancestor
56060434|NCT05125029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060435|NCT05125029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060436|NCT01940276|Prednisone|prednisone|mesh-list
56060438|NCT01940276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56060439|NCT01940276|Glucocorticoids|glucocorticoids|mesh-ancestor
56060440|NCT01940276|Hormones|hormones|mesh-ancestor
56060441|NCT01940276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060442|NCT01940276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060460|NCT01919216|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56060461|NCT01919216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060462|NCT01919216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060463|NCT01919216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060464|NCT01919216|Serotonin Agents|serotonin agents|mesh-ancestor
56060465|NCT01919216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060466|NCT01919216|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56060467|NCT01919216|Antidepressive Agents|antidepressive agents|mesh-ancestor
56060468|NCT01919216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56060469|NCT01940510|Rifampin|rifampin|mesh-list
56060470|NCT01940510|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56060471|NCT01940510|Antitubercular Agents|antitubercular agents|mesh-ancestor
56060472|NCT01940510|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56060473|NCT01940510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060474|NCT01940510|Leprostatic Agents|leprostatic agents|mesh-ancestor
56060475|NCT01940510|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56060476|NCT01940510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060477|NCT01940510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060478|NCT01940510|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56060479|NCT01940510|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56060480|NCT01940510|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56060481|NCT01940510|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56060482|NCT01940510|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56060483|NCT01940510|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56060484|NCT00380289|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56060503|NCT01919450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060504|NCT01919450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060505|NCT01602679|Progesterone|progesterone|mesh-list
56060506|NCT01602679|Progestins|progestins|mesh-ancestor
56060507|NCT01602679|Hormones|hormones|mesh-ancestor
56060508|NCT01602679|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060509|NCT01602679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060510|NCT01919606|Bupivacaine|bupivacaine|mesh-list
56060511|NCT01919606|Anesthetics, Local|anesthetics, local|mesh-ancestor
56060512|NCT01919606|Anesthetics|anesthetics|mesh-ancestor
56060513|NCT01919606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060514|NCT01919606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060515|NCT01919606|Sensory System Agents|sensory system agents|mesh-ancestor
56060516|NCT01919606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060517|NCT01919996|Azithromycin|azithromycin|mesh-list
56060518|NCT01919996|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56060519|NCT01919996|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060520|NCT05735132|Lidocaine|lidocaine|mesh-list
56060521|NCT05735132|Anesthetics, Local|anesthetics, local|mesh-ancestor
56060522|NCT05735132|Anesthetics|anesthetics|mesh-ancestor
56060523|NCT05735132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060555|NCT05106153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060556|NCT05106153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060557|NCT05106153|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56060558|NCT05106153|GABA Agonists|gaba agonists|mesh-ancestor
56060559|NCT05106153|GABA Agents|gaba agents|mesh-ancestor
56060560|NCT05106153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060561|NCT05106153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060562|NCT05106153|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56060564|NCT01943864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060565|NCT01943864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56060566|NCT01943864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060567|NCT01943864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060568|NCT01607203|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56060569|NCT01607203|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56060570|NCT01607203|Luteolytic Agents|luteolytic agents|mesh-ancestor
56060571|NCT01607203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56060572|NCT01607203|Contraceptive Agents|contraceptive agents|mesh-ancestor
56060573|NCT01607203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56060574|NCT01607203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060575|NCT01607203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56060576|NCT01607203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56060577|NCT01607203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060578|NCT00000333|Benztropine|benztropine|mesh-list
55901049|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901050|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55901051|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55901052|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
56060782|NCT00000447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55901053|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55901054|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
55901055|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
55901056|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
55901057|NCT04348877|Antibodies|antibodies|mesh-list
55901058|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
55901063|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
55901064|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901065|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
55901066|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55901067|NCT02414490|Antibodies|antibodies|mesh-list
55901068|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
55901069|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55901070|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
55901071|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901072|NCT01590017|Cisplatin|cisplatin|mesh-list
55901073|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901074|NCT01700621|Vaccines|vaccines|mesh-list
55901075|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
55901076|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901077|NCT03178500|Clomiphene|clomiphene|mesh-list
55901078|NCT03178500|Enclomiphene|enclomiphene|mesh-list
55901079|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
56060580|NCT00000333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56060581|NCT00000333|Parasympatholytics|parasympatholytics|mesh-ancestor
56060582|NCT00000333|Autonomic Agents|autonomic agents|mesh-ancestor
56060583|NCT00000333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060584|NCT00000333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060585|NCT00000333|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56060586|NCT00000333|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56060587|NCT00000333|Cholinergic Agents|cholinergic agents|mesh-ancestor
56060588|NCT00000333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060589|NCT00000333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060591|NCT00000333|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56060592|NCT00000333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060593|NCT00000333|Dopamine Agents|dopamine agents|mesh-ancestor
56060594|NCT00000339|Risperidone|risperidone|mesh-list
56060595|NCT00000339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56060596|NCT00000339|Serotonin Agents|serotonin agents|mesh-ancestor
56060597|NCT00000339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060598|NCT00000339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060599|NCT00000339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060600|NCT00000339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56060601|NCT00000339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56060602|NCT00000339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060603|NCT00000339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56060604|NCT00000339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56060605|NCT00000339|Dopamine Agents|dopamine agents|mesh-ancestor
56060625|NCT00000357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060626|NCT00000357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56060627|NCT05095311|Cetirizine|cetirizine|mesh-list
56060628|NCT05095311|Nedocromil|nedocromil|mesh-list
56060629|NCT05095311|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56060630|NCT05095311|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56060631|NCT05095311|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56060632|NCT05095311|Histamine Antagonists|histamine antagonists|mesh-ancestor
56060633|NCT05095311|Histamine Agents|histamine agents|mesh-ancestor
56060634|NCT05095311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060635|NCT05095311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060636|NCT05095311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060637|NCT05095311|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
56060638|NCT05095311|Immunologic Factors|immunologic factors|mesh-ancestor
56060639|NCT05095311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56060640|NCT05095311|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56060641|NCT05095311|Respiratory System Agents|respiratory system agents|mesh-ancestor
56060642|NCT01922336|Infliximab|infliximab|mesh-list
56060643|NCT01922336|Dermatologic Agents|dermatologic agents|mesh-ancestor
56060644|NCT01922336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060645|NCT01922336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56060646|NCT05092269|Ustekinumab|ustekinumab|mesh-list
56060647|NCT05092269|Dermatologic Agents|dermatologic agents|mesh-ancestor
56060648|NCT04330755|Magnesium Sulfate|magnesium sulfate|mesh-list
56060649|NCT04330755|Simendan|simendan|mesh-list
56060650|NCT04330755|Analgesics|analgesics|mesh-ancestor
56060651|NCT04330755|Sensory System Agents|sensory system agents|mesh-ancestor
56060652|NCT04330755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060653|NCT04330755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060654|NCT04330755|Anesthetics|anesthetics|mesh-ancestor
56060655|NCT04330755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060656|NCT04330755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56060657|NCT04330755|Anticonvulsants|anticonvulsants|mesh-ancestor
56060667|NCT04330755|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56060668|NCT04330755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060669|NCT04330755|Protective Agents|protective agents|mesh-ancestor
56060670|NCT01608295|Paroxetine|paroxetine|mesh-list
56060671|NCT01608295|Antidepressive Agents|antidepressive agents|mesh-list
56060672|NCT01608295|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56060673|NCT01608295|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56060674|NCT01608295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56060676|NCT01608295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060677|NCT01608295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060679|NCT01608295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060680|NCT01608295|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56060681|NCT01608295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56060682|NCT01608295|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56060683|NCT01608295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56060684|NCT01608295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060685|NCT01608295|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56060686|NCT01608295|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56060688|NCT04713189|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56060689|NCT04713189|Narcotics|narcotics|mesh-ancestor
56060690|NCT04713189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060691|NCT04713189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060692|NCT04713189|Analgesics|analgesics|mesh-ancestor
56060693|NCT04713189|Sensory System Agents|sensory system agents|mesh-ancestor
56060694|NCT04713189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060695|NCT04713189|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56060698|NCT04713189|Anesthetics|anesthetics|mesh-ancestor
56060711|NCT02237989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060712|NCT02237989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060713|NCT02237989|Antipyretics|antipyretics|mesh-ancestor
56060714|NCT00000429|Calcium Carbonate|calcium carbonate|mesh-list
56060715|NCT00000429|Calcium|calcium|mesh-list
56060716|NCT00000429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56060717|NCT00000429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060718|NCT00000429|Antacids|antacids|mesh-ancestor
56060719|NCT00000429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060720|NCT00000429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060721|NCT01673191|Dexamethasone|dexamethasone|mesh-list
56060722|NCT01673191|Prednisolone acetate|prednisolone acetate|mesh-list
56060723|NCT01673191|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56060724|NCT01673191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56060725|NCT01673191|Antiemetics|antiemetics|mesh-ancestor
56060726|NCT01673191|Autonomic Agents|autonomic agents|mesh-ancestor
56060727|NCT01673191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060728|NCT01673191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060729|NCT01673191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060730|NCT01673191|Glucocorticoids|glucocorticoids|mesh-ancestor
56060731|NCT01673191|Hormones|hormones|mesh-ancestor
56060732|NCT01673191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060733|NCT01673191|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56060736|NCT04502433|Poractant alfa|poractant alfa|mesh-list
56060761|NCT00000441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060762|NCT00000441|Antimanic Agents|antimanic agents|mesh-ancestor
56060763|NCT00000441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56060764|NCT00000441|Analgesics|analgesics|mesh-ancestor
56060765|NCT00000441|Sensory System Agents|sensory system agents|mesh-ancestor
56060766|NCT00000441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56060767|NCT00000441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060768|NCT00000441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56060769|NCT00000441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56060770|NCT00000447|Naltrexone|naltrexone|mesh-list
56060771|NCT00000447|Nicotine|nicotine|mesh-list
56060772|NCT00000447|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56060773|NCT00000447|Autonomic Agents|autonomic agents|mesh-ancestor
56060774|NCT00000447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060775|NCT00000447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060776|NCT00000447|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56060777|NCT00000447|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56060778|NCT00000447|Cholinergic Agents|cholinergic agents|mesh-ancestor
56060779|NCT00000447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060780|NCT00000447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060783|NCT00000447|Sensory System Agents|sensory system agents|mesh-ancestor
56060784|NCT01927718|Thalidomide|thalidomide|mesh-list
56060785|NCT01927718|Lenalidomide|lenalidomide|mesh-list
56060786|NCT01927718|Immunologic Factors|immunologic factors|mesh-ancestor
56060787|NCT01927718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060788|NCT01927718|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55901080|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55901081|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
55901082|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55901083|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901084|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55901085|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
55901086|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55901087|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55901088|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55901089|NCT01700387|Topiramate|topiramate|mesh-list
55901090|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
55901091|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55901092|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55901093|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55901094|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901095|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060789|NCT01927718|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56060790|NCT01927718|Growth Substances|growth substances|mesh-ancestor
56060791|NCT01927718|Growth Inhibitors|growth inhibitors|mesh-ancestor
56060792|NCT01927718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060793|NCT01927718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56060794|NCT01927718|Leprostatic Agents|leprostatic agents|mesh-ancestor
56060795|NCT01927718|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56060796|NCT01927718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060797|NCT05066607|Dexamethasone|dexamethasone|mesh-list
56060798|NCT05066607|Pomalidomide|pomalidomide|mesh-list
56060799|NCT05066607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56060800|NCT05066607|Antiemetics|antiemetics|mesh-ancestor
56060801|NCT05066607|Autonomic Agents|autonomic agents|mesh-ancestor
56060802|NCT05066607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060803|NCT05066607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060804|NCT05066607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56060805|NCT05066607|Glucocorticoids|glucocorticoids|mesh-ancestor
56060806|NCT05066607|Hormones|hormones|mesh-ancestor
56060807|NCT05066607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060808|NCT05066607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56060809|NCT05066607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060810|NCT05066607|Immunologic Factors|immunologic factors|mesh-ancestor
56060811|NCT05066607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56060812|NCT05066607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56060813|NCT05066607|Growth Substances|growth substances|mesh-ancestor
56060814|NCT05066607|Growth Inhibitors|growth inhibitors|mesh-ancestor
56060815|NCT01948310|Ranolazine|ranolazine|mesh-list
56060816|NCT01948310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56060817|NCT01948310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060834|NCT01675297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060835|NCT05295537|Liver Extracts|liver extracts|mesh-list
56060836|NCT05295537|Hematinics|hematinics|mesh-ancestor
56060837|NCT02287376|Diclofenac|diclofenac|mesh-list
56060838|NCT02287376|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56060839|NCT02287376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56060840|NCT02287376|Analgesics|analgesics|mesh-ancestor
56060841|NCT02287376|Sensory System Agents|sensory system agents|mesh-ancestor
56060842|NCT02287376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060843|NCT02287376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060845|NCT02287376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56060846|NCT02287376|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56060847|NCT02287376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060848|NCT02287376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060849|NCT01928186|Alovudine|alovudine|mesh-list
56060850|NCT01928186|Antiviral Agents|antiviral agents|mesh-ancestor
56060851|NCT01928186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56060852|NCT05041257|Maytansine|maytansine|mesh-list
56060853|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56060854|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060855|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
56060856|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
56060857|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
56060858|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060863|NCT01611571|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56060864|NCT01611571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060865|NCT01611571|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56060866|NCT01611571|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56060867|NCT01611571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060869|NCT00000477|Lovastatin|lovastatin|mesh-list
56060875|NCT00000477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060876|NCT00000477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56060877|NCT00000477|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56060878|NCT00000477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060880|NCT00000483|Clofibrate|clofibrate|mesh-list
56060881|NCT00000483|Estrogens|estrogens|mesh-list
56060882|NCT00000483|Hormones|hormones|mesh-ancestor
56060883|NCT00000483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56060884|NCT00000483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060885|NCT00000483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56060886|NCT00000483|Antimetabolites|antimetabolites|mesh-ancestor
56060887|NCT00000483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060888|NCT00000483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56060889|NCT00000483|Vasodilator Agents|vasodilator agents|mesh-ancestor
56060890|NCT00000483|Vitamin B Complex|vitamin b complex|mesh-ancestor
56060891|NCT00000483|Vitamins|vitamins|mesh-ancestor
56060892|NCT00000483|Micronutrients|micronutrients|mesh-ancestor
56060893|NCT00000483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56060894|NCT05276973|Paclitaxel|paclitaxel|mesh-list
56060895|NCT05276973|Carboplatin|carboplatin|mesh-list
56060896|NCT05276973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56060897|NCT05276973|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56060898|NCT05276973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56060899|NCT05276973|Tubulin Modulators|tubulin modulators|mesh-ancestor
56060900|NCT05276973|Antimitotic Agents|antimitotic agents|mesh-ancestor
56060901|NCT05276973|Mitosis Modulators|mitosis modulators|mesh-ancestor
56060902|NCT05276973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060903|NCT00000507|Streptokinase|streptokinase|mesh-list
56060904|NCT00000507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56060907|NCT00380445|Vildagliptin|vildagliptin|mesh-list
56060918|NCT01676311|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56060919|NCT01676311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060920|NCT01676311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060921|NCT01676311|Cholinergic Agents|cholinergic agents|mesh-ancestor
56060922|NCT01676311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060923|NCT01676311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060928|NCT01951118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56060929|NCT01951118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060930|NCT01951118|Cholinergic Agents|cholinergic agents|mesh-ancestor
56060931|NCT01951118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060932|NCT01951118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060933|NCT01951118|Nootropic Agents|nootropic agents|mesh-ancestor
56060934|NCT01951820|Lidocaine|lidocaine|mesh-list
56060935|NCT01951820|Tetracaine|tetracaine|mesh-list
56060936|NCT01951820|Carticaine|carticaine|mesh-list
56060937|NCT01951820|Benzocaine|benzocaine|mesh-list
56060938|NCT01951820|Anesthetics, Local|anesthetics, local|mesh-ancestor
56060939|NCT01951820|Anesthetics|anesthetics|mesh-ancestor
56060940|NCT01951820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56060941|NCT01951820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060942|NCT01951820|Sensory System Agents|sensory system agents|mesh-ancestor
56060943|NCT01951820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060944|NCT01951820|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56060945|NCT01951820|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56060946|NCT01951820|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56060947|NCT01951820|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060948|NCT01951820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060959|NCT01614847|Lubricant Eye Drops|lubricant eye drops|mesh-list
56060960|NCT01614847|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56060961|NCT01614847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56060962|NCT00382629|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
56060963|NCT00382629|Antioxidants|antioxidants|mesh-ancestor
56060964|NCT00382629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060965|NCT00382629|Protective Agents|protective agents|mesh-ancestor
56060966|NCT00382629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060967|NCT00000513|Atenolol|atenolol|mesh-list
56060968|NCT00000513|Chlorthalidone|chlorthalidone|mesh-list
56060969|NCT00000513|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56060970|NCT00000513|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56060973|NCT00000513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56060974|NCT00000513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060975|NCT00000513|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56060976|NCT00000513|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56060977|NCT00000513|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56060978|NCT00000513|Adrenergic Agents|adrenergic agents|mesh-ancestor
56060979|NCT00000513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56060980|NCT00000513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56060981|NCT00000513|Diuretics|diuretics|mesh-ancestor
56060982|NCT00000513|Natriuretic Agents|natriuretic agents|mesh-ancestor
56060983|NCT00000513|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56060984|NCT00000513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56060985|NCT00000543|Calcium|calcium|mesh-list
56060986|NCT00000543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56060987|NCT00000543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56060988|NCT00000549|Hormones|hormones|mesh-list
56060989|NCT00000549|Estrogens|estrogens|mesh-list
56060990|NCT00000549|Progestins|progestins|mesh-list
56061002|NCT01701037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061003|NCT00000585|Penicillins|penicillins|mesh-list
56061005|NCT00000585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061006|NCT04988295|Carboplatin|carboplatin|mesh-list
56061007|NCT04988295|Pemetrexed|pemetrexed|mesh-list
56061008|NCT04988295|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
56061009|NCT04988295|Lazertinib|lazertinib|mesh-list
56061010|NCT04988295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061011|NCT04988295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061012|NCT04988295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061013|NCT04988295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56061014|NCT04988295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56061015|NCT04988295|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56061016|NCT04988295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56061017|NCT01701115|Bupivacaine|bupivacaine|mesh-list
56061018|NCT01701115|Anesthetics, Local|anesthetics, local|mesh-list
56061019|NCT01701115|Mepivacaine|mepivacaine|mesh-list
56061020|NCT01701115|Anesthetics|anesthetics|mesh-list
56061021|NCT01701115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56061022|NCT01701115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061023|NCT01701115|Sensory System Agents|sensory system agents|mesh-ancestor
56061024|NCT01701115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061025|NCT00000597|Nandrolone Decanoate|nandrolone decanoate|mesh-list
56061026|NCT00000597|Nandrolone|nandrolone|mesh-list
56061027|NCT00000597|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
56061028|NCT00000597|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56061029|NCT00000597|Androgens|androgens|mesh-ancestor
56061030|NCT00000597|Hormones|hormones|mesh-ancestor
56061031|NCT00000597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56061032|NCT00000597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061033|NCT00000597|Anabolic Agents|anabolic agents|mesh-ancestor
56061034|NCT00000597|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55901096|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
56061035|NCT00000597|Immunologic Factors|immunologic factors|mesh-ancestor
56061036|NCT00000597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061038|NCT01621009|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56061039|NCT01621009|Antidepressive Agents|antidepressive agents|mesh-ancestor
56061040|NCT01621009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56061041|NCT01621009|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56061042|NCT01621009|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56061043|NCT01621009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56061044|NCT01621009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061045|NCT01621009|Dopamine Agents|dopamine agents|mesh-ancestor
56061046|NCT01621009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061047|NCT01621009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061048|NCT01621009|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55788225|NCT04930211|Hormones|hormones|mesh-ancestor
56061049|NCT01621009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56061050|NCT01621009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061051|NCT04830969|Chlorhexidine|chlorhexidine|mesh-list
56061052|NCT04830969|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56061090|NCT04818957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56061091|NCT01621477|Cytarabine|cytarabine|mesh-list
56061092|NCT01621477|Plerixafor|plerixafor|mesh-list
56061093|NCT01621477|Mycophenolic Acid|mycophenolic acid|mesh-list
56061094|NCT01621477|Cyclophosphamide|cyclophosphamide|mesh-list
56061095|NCT01621477|Busulfan|busulfan|mesh-list
56061100|NCT01621477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061101|NCT01621477|Immunologic Factors|immunologic factors|mesh-ancestor
56061103|NCT01621477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061104|NCT01621477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56061105|NCT01621477|Alkylating Agents|alkylating agents|mesh-ancestor
56061106|NCT01621477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061107|NCT01621477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061108|NCT01621477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56061109|NCT01621477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56061110|NCT01621477|Antimetabolites|antimetabolites|mesh-ancestor
56061111|NCT01621477|Antiviral Agents|antiviral agents|mesh-ancestor
56061112|NCT01621477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061113|NCT01621477|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56061114|NCT01621477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061115|NCT01621477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56061116|NCT01621477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56061119|NCT01621477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56061137|NCT01621633|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56061138|NCT01621633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56061139|NCT01621633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061140|NCT05479214|Metformin|metformin|mesh-list
56061141|NCT05479214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56061142|NCT05479214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061143|NCT00000657|Zidovudine|zidovudine|mesh-list
56061144|NCT00000657|Didanosine|didanosine|mesh-list
56061145|NCT00000657|Antimetabolites|antimetabolites|mesh-ancestor
56061146|NCT00000657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061147|NCT00000657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56061148|NCT00000657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56061149|NCT00000657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061150|NCT00000657|Antiviral Agents|antiviral agents|mesh-ancestor
56061151|NCT00000657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061152|NCT00000657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56061153|NCT00000657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56061154|NCT04778397|Cytarabine|cytarabine|mesh-list
56061155|NCT04778397|Azacitidine|azacitidine|mesh-list
56061156|NCT04778397|Daunorubicin|daunorubicin|mesh-list
56061157|NCT04778397|Venetoclax|venetoclax|mesh-list
56061158|NCT04778397|Idarubicin|idarubicin|mesh-list
56061159|NCT04778397|Magrolimab|magrolimab|mesh-list
56061160|NCT04778397|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56061161|NCT04778397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56061162|NCT04778397|Antimetabolites|antimetabolites|mesh-ancestor
56061163|NCT04778397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061164|NCT04778397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061165|NCT04778397|Antiviral Agents|antiviral agents|mesh-ancestor
56061166|NCT04778397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061167|NCT04778397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061168|NCT04778397|Immunologic Factors|immunologic factors|mesh-ancestor
56061169|NCT04778397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061170|NCT04778397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061179|NCT01701505|Anesthetics, Local|anesthetics, local|mesh-ancestor
56061180|NCT01701505|Anesthetics|anesthetics|mesh-ancestor
56061181|NCT01701505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56061182|NCT01701505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061183|NCT01701505|Sensory System Agents|sensory system agents|mesh-ancestor
56061184|NCT01701505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061185|NCT01701505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56061186|NCT01701505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56061187|NCT01701505|Adrenergic Agents|adrenergic agents|mesh-ancestor
56061188|NCT01701505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061189|NCT01701505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061190|NCT01701505|Sympathomimetics|sympathomimetics|mesh-ancestor
56061191|NCT01701505|Autonomic Agents|autonomic agents|mesh-ancestor
56061192|NCT01701505|Nasal Decongestants|nasal decongestants|mesh-ancestor
56061193|NCT01701505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56061194|NCT01701505|Respiratory System Agents|respiratory system agents|mesh-ancestor
56061195|NCT01701505|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56061196|NCT01701505|Mydriatics|mydriatics|mesh-ancestor
56061197|NCT01701505|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56061198|NCT01701505|Protective Agents|protective agents|mesh-ancestor
56061199|NCT00000663|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
56061200|NCT00000663|Immunologic Factors|immunologic factors|mesh-ancestor
56061201|NCT00000663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061203|NCT00000669|Antimetabolites|antimetabolites|mesh-ancestor
56061384|NCT02288156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061204|NCT00000669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061205|NCT00000669|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56061206|NCT00000669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56061207|NCT00000669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061208|NCT00000669|Antiviral Agents|antiviral agents|mesh-ancestor
56061209|NCT00000669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061210|NCT00000669|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56061222|NCT04942899|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56061224|NCT04942899|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56061225|NCT04942899|Hormone Antagonists|hormone antagonists|mesh-ancestor
56061226|NCT04942899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56061227|NCT04942899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061228|NCT00000693|Zidovudine|zidovudine|mesh-list
56061229|NCT00000693|Acyclovir|acyclovir|mesh-list
56061230|NCT00000693|Antimetabolites|antimetabolites|mesh-ancestor
56061231|NCT00000693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061232|NCT00000693|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56061233|NCT00000693|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56061234|NCT00000693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061235|NCT00000693|Antiviral Agents|antiviral agents|mesh-ancestor
56061236|NCT00000693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061237|NCT00000693|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56061238|NCT00000693|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56061239|NCT04752033|Morphine|morphine|mesh-list
56061240|NCT04752033|Hydromorphone|hydromorphone|mesh-list
56061241|NCT04752033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56061242|NCT04752033|Narcotics|narcotics|mesh-ancestor
56061243|NCT04752033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56061244|NCT04752033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061245|NCT04752033|Analgesics|analgesics|mesh-ancestor
56061246|NCT04752033|Sensory System Agents|sensory system agents|mesh-ancestor
56061247|NCT04752033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061248|NCT02987270|Piperaquine|piperaquine|mesh-list
56061249|NCT02987270|Artenimol|artenimol|mesh-list
56061250|NCT02987270|Antimalarials|antimalarials|mesh-ancestor
56061254|NCT00000699|Ribavirin|ribavirin|mesh-list
56061269|NCT00000723|Methotrexate|methotrexate|mesh-list
56061270|NCT00000723|Calcium|calcium|mesh-list
56061271|NCT00000723|Levoleucovorin|levoleucovorin|mesh-list
56061272|NCT00000723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56061273|NCT00000723|Antiemetics|antiemetics|mesh-ancestor
55788445|NCT05229991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56061274|NCT00000723|Autonomic Agents|autonomic agents|mesh-ancestor
56061275|NCT00000723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061276|NCT00000723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061277|NCT00000723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56061278|NCT00000723|Glucocorticoids|glucocorticoids|mesh-ancestor
56061279|NCT00000723|Hormones|hormones|mesh-ancestor
56061280|NCT00000723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56061281|NCT00000723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56061282|NCT00000723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061283|NCT00000723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56061284|NCT00000723|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56061285|NCT00000723|Abortifacient Agents|abortifacient agents|mesh-ancestor
56061286|NCT00000723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56061287|NCT00000723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56061325|NCT04750395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56061326|NCT04750395|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56061327|NCT04750395|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56061328|NCT04750395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56061329|NCT04750395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56061330|NCT04750395|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56061331|NCT04750395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56061332|NCT04750395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56061333|NCT04750395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061334|NCT04750395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061335|NCT04750395|Serotonin Agents|serotonin agents|mesh-ancestor
56061336|NCT04750395|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56061337|NCT04750395|Dopamine Agents|dopamine agents|mesh-ancestor
56061338|NCT04750395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56061378|NCT01704781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061379|NCT02288156|Capsaicin|capsaicin|mesh-list
56061380|NCT02288156|Antipruritics|antipruritics|mesh-ancestor
56061381|NCT02288156|Dermatologic Agents|dermatologic agents|mesh-ancestor
56061382|NCT02288156|Sensory System Agents|sensory system agents|mesh-ancestor
56061383|NCT02288156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061385|NCT04699383|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
56061386|NCT04699383|Allopurinol|allopurinol|mesh-list
56061387|NCT04699383|Antimetabolites|antimetabolites|mesh-ancestor
56061388|NCT04699383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061389|NCT04699383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061390|NCT04699383|Gout Suppressants|gout suppressants|mesh-ancestor
56061391|NCT04699383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061392|NCT04699383|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56061394|NCT04699383|Protective Agents|protective agents|mesh-ancestor
56061395|NCT04699383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061396|NCT04699383|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56061397|NCT04699383|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56061398|NCT04699383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061399|NCT04699383|Schistosomicides|schistosomicides|mesh-ancestor
56061432|NCT04340193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56061433|NCT04340193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061434|NCT04340193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56061435|NCT04340193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061436|NCT05416333|Azelaic acid|azelaic acid|mesh-list
56061437|NCT05416333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061438|NCT05416333|Dermatologic Agents|dermatologic agents|mesh-ancestor
56061439|NCT05423132|Ropivacaine|ropivacaine|mesh-list
56061440|NCT05423132|Anesthetics, Local|anesthetics, local|mesh-ancestor
56061441|NCT05423132|Anesthetics|anesthetics|mesh-ancestor
56061442|NCT05423132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56061443|NCT05423132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061444|NCT05423132|Sensory System Agents|sensory system agents|mesh-ancestor
56061445|NCT05423132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061446|NCT02975219|Bevacizumab|bevacizumab|mesh-list
56061447|NCT02975219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56061448|NCT02975219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061449|NCT02975219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56061450|NCT02975219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56061451|NCT02975219|Growth Substances|growth substances|mesh-ancestor
56061452|NCT02975219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061453|NCT02975219|Growth Inhibitors|growth inhibitors|mesh-ancestor
56061454|NCT04683939|Gemcitabine|gemcitabine|mesh-list
56061455|NCT04683939|Paclitaxel|paclitaxel|mesh-list
56061456|NCT04683939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56061457|NCT04683939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061458|NCT04683939|Tubulin Modulators|tubulin modulators|mesh-ancestor
56061459|NCT04683939|Antimitotic Agents|antimitotic agents|mesh-ancestor
56061460|NCT04683939|Mitosis Modulators|mitosis modulators|mesh-ancestor
56061461|NCT04683939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061474|NCT01686451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061475|NCT01686451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56061476|NCT01686451|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56061477|NCT01686451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061478|NCT00361751|Fenofibrate|fenofibrate|mesh-list
56061479|NCT00361751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56061480|NCT00361751|Antimetabolites|antimetabolites|mesh-ancestor
56061481|NCT00361751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061482|NCT00361751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56061483|NCT05681702|Aspirin|aspirin|mesh-list
56061484|NCT05681702|Clopidogrel|clopidogrel|mesh-list
56061485|NCT05681702|Ticagrelor|ticagrelor|mesh-list
56061486|NCT05681702|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56061487|NCT05681702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56061488|NCT05681702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56061489|NCT05681702|Analgesics|analgesics|mesh-ancestor
56061490|NCT05681702|Sensory System Agents|sensory system agents|mesh-ancestor
56061491|NCT05681702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061492|NCT05681702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061493|NCT05681702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56061494|NCT05681702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061495|NCT05681702|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56061496|NCT05681702|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56061497|NCT05681702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061498|NCT05681702|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56061499|NCT05681702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56061521|NCT03668951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061522|NCT03668951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56061524|NCT03668951|Sensory System Agents|sensory system agents|mesh-ancestor
56061525|NCT03668951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061526|NCT03668951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56061527|NCT03668951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56061528|NCT03668951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56061529|NCT03668951|Adrenergic Agents|adrenergic agents|mesh-ancestor
56061530|NCT03668951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061531|NCT03668951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061532|NCT04889703|Salicylic Acid|salicylic acid|mesh-list
56061533|NCT04889703|Salicylates|salicylates|mesh-list
56061534|NCT04889703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061535|NCT04889703|Antifungal Agents|antifungal agents|mesh-ancestor
56061536|NCT04889703|Keratolytic Agents|keratolytic agents|mesh-ancestor
56061537|NCT04889703|Dermatologic Agents|dermatologic agents|mesh-ancestor
56061538|NCT04889703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56061539|NCT04889703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56061540|NCT04889703|Analgesics|analgesics|mesh-ancestor
56061541|NCT04889703|Sensory System Agents|sensory system agents|mesh-ancestor
56061542|NCT04889703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061543|NCT04889703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061544|NCT04889703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56061545|NCT04889703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061546|NCT04889703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56061547|NCT04889703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061548|NCT04889703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061549|NCT00421811|Melphalan|melphalan|mesh-list
56061550|NCT00421811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56061551|NCT00421811|Alkylating Agents|alkylating agents|mesh-ancestor
56061552|NCT00421811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061553|NCT00421811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901097|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901098|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901099|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55901100|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901101|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
55901102|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56061555|NCT00421811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061556|NCT00421811|Immunologic Factors|immunologic factors|mesh-ancestor
56061557|NCT00421811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061570|NCT05676476|Antihypertensive Agents|antihypertensive agents|mesh-list
56061571|NCT03363893|Fulvestrant|fulvestrant|mesh-list
56061572|NCT03363893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56061573|NCT03363893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061574|NCT03363893|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56061575|NCT03363893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56061576|NCT03363893|Hormone Antagonists|hormone antagonists|mesh-ancestor
56061577|NCT03363893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788750|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
56061578|NCT03363893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061579|NCT04660539|Mycophenolic Acid|mycophenolic acid|mesh-list
56061580|NCT04660539|Azathioprine|azathioprine|mesh-list
56061581|NCT04660539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56061582|NCT04660539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061583|NCT04660539|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56061595|NCT04659603|Gemcitabine|gemcitabine|mesh-list
56061609|NCT04659603|Antimitotic Agents|antimitotic agents|mesh-ancestor
56061610|NCT04659603|Mitosis Modulators|mitosis modulators|mesh-ancestor
56061615|NCT04312659|Dermatologic Agents|dermatologic agents|mesh-ancestor
56061616|NCT04312659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56061617|NCT04312659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061618|NCT01687387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56061619|NCT04642365|Atezolizumab|atezolizumab|mesh-list
56061620|NCT04642365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061621|NCT02403323|Etrolizumab|etrolizumab|mesh-list
56061622|NCT02403323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56061623|NCT02403323|Immunologic Factors|immunologic factors|mesh-ancestor
56061624|NCT02403323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061625|NCT01706263|Salicylic Acid|salicylic acid|mesh-list
56061626|NCT01706263|Salicylates|salicylates|mesh-list
56061627|NCT01706263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061628|NCT01706263|Antifungal Agents|antifungal agents|mesh-ancestor
56061629|NCT01706263|Keratolytic Agents|keratolytic agents|mesh-ancestor
56061630|NCT01706263|Dermatologic Agents|dermatologic agents|mesh-ancestor
56061631|NCT01706263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56061633|NCT01706263|Analgesics|analgesics|mesh-ancestor
56061657|NCT04342247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56061658|NCT04342247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061664|NCT04852887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061665|NCT04852887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56061666|NCT04852887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56061667|NCT04852887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061668|NCT04852887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061669|NCT04852887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56061670|NCT04852887|Hormone Antagonists|hormone antagonists|mesh-ancestor
56061671|NCT04852887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56061672|NCT04852887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061673|NCT04852887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56061674|NCT04852887|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56061675|NCT04852887|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56061676|NCT04852887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56061677|NCT05738642|Thrombin|thrombin|mesh-list
56061678|NCT05738642|Hemostatics|hemostatics|mesh-ancestor
56061679|NCT05738642|Coagulants|coagulants|mesh-ancestor
56061680|NCT01690663|Dexamethasone|dexamethasone|mesh-list
56061681|NCT01690663|Bupivacaine|bupivacaine|mesh-list
56061682|NCT01690663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56061683|NCT01690663|Antiemetics|antiemetics|mesh-ancestor
56061684|NCT01690663|Autonomic Agents|autonomic agents|mesh-ancestor
56061685|NCT01690663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061686|NCT01690663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061687|NCT01690663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56061688|NCT01690663|Glucocorticoids|glucocorticoids|mesh-ancestor
56061700|NCT05738564|Anesthetics, Local|anesthetics, local|mesh-ancestor
56061701|NCT05738564|Anesthetics|anesthetics|mesh-ancestor
56061702|NCT05738564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56061703|NCT05738564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061704|NCT05738564|Sensory System Agents|sensory system agents|mesh-ancestor
56061705|NCT05738564|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061706|NCT05738564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56061707|NCT05738564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56061708|NCT05738564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56061709|NCT05738564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56061710|NCT05738564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061711|NCT05738564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56061712|NCT05738564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56061713|NCT05738564|Adrenergic Agents|adrenergic agents|mesh-ancestor
56061714|NCT05738564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061715|NCT05738564|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56061716|NCT05738564|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56061718|NCT05738564|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56061719|NCT05738564|Respiratory System Agents|respiratory system agents|mesh-ancestor
56061720|NCT05738564|Mydriatics|mydriatics|mesh-ancestor
56061721|NCT05738564|Sympathomimetics|sympathomimetics|mesh-ancestor
56061722|NCT05738564|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56061723|NCT05738564|Nasal Decongestants|nasal decongestants|mesh-ancestor
56061724|NCT05343572|Plerixafor|plerixafor|mesh-list
56061725|NCT05343572|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56061726|NCT05343572|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56061747|NCT05738408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061748|NCT05738408|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56061749|NCT05738408|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56061750|NCT05738408|Cholinergic Agents|cholinergic agents|mesh-ancestor
56061751|NCT05738408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56061752|NCT05738408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061753|NCT03414229|Pembrolizumab|pembrolizumab|mesh-list
56061754|NCT03414229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56061755|NCT03414229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061756|NCT01352117|Tenofovir|tenofovir|mesh-list
56061757|NCT01352117|Emtricitabine|emtricitabine|mesh-list
56061758|NCT01352117|Efavirenz|efavirenz|mesh-list
56061759|NCT01352117|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56061760|NCT01352117|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56061761|NCT01352117|Etoposide|etoposide|mesh-list
56061762|NCT01352117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56061763|NCT01352117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061764|NCT01352117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56061766|NCT01352117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061767|NCT01352117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061768|NCT01352117|Antiviral Agents|antiviral agents|mesh-ancestor
56061769|NCT01352117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061770|NCT01352117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56061771|NCT01352117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56061772|NCT01352117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56061792|NCT02974439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56061793|NCT02974439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56061794|NCT02974439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061795|NCT02974439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56061796|NCT02974439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061797|NCT02974439|Vasodilator Agents|vasodilator agents|mesh-ancestor
56061798|NCT03345823|Upadacitinib|upadacitinib|mesh-list
56061799|NCT03345823|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56061800|NCT03345823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55788971|NCT01573429|Hormones|hormones|mesh-ancestor
56061801|NCT03345823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061802|NCT03345823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061803|NCT03345823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061805|NCT03340727|Caffeine citrate|caffeine citrate|mesh-list
56061806|NCT03340727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061807|NCT03340727|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56061808|NCT03340727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061809|NCT03340727|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56061845|NCT01707043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061846|NCT01707043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56061847|NCT01707043|Respiratory System Agents|respiratory system agents|mesh-ancestor
56061848|NCT01707043|Dermatologic Agents|dermatologic agents|mesh-ancestor
56061849|NCT01707043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56061850|NCT01707043|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56061851|NCT01707043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56061852|NCT01707043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061853|NCT01707043|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56061854|NCT01707043|Vitamins|vitamins|mesh-ancestor
56061855|NCT01707043|Micronutrients|micronutrients|mesh-ancestor
56061856|NCT01707043|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56061857|NCT04599855|Esketamine|esketamine|mesh-list
56061858|NCT04599855|Antidepressive Agents|antidepressive agents|mesh-ancestor
56061859|NCT04599855|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56061860|NCT05559164|Atorvastatin|atorvastatin|mesh-list
56061861|NCT05559164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56061862|NCT05559164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56061863|NCT05559164|Antimetabolites|antimetabolites|mesh-ancestor
56061864|NCT05559164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061865|NCT05559164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56061866|NCT05559164|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56061867|NCT05559164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061868|NCT04258839|Brexpiprazole|brexpiprazole|mesh-list
56061869|NCT04258839|Serotonin Agents|serotonin agents|mesh-ancestor
56061895|NCT05058872|Hormones|hormones|mesh-ancestor
56061896|NCT05058872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56061897|NCT05058872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061898|NCT05058872|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56061899|NCT05058872|Contraceptive Agents|contraceptive agents|mesh-ancestor
56061900|NCT05058872|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56061901|NCT05058872|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56061902|NCT05058872|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56061903|NCT05058872|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56061904|NCT05058872|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56061905|NCT04595565|Carboplatin|carboplatin|mesh-list
56061906|NCT04595565|Capecitabine|capecitabine|mesh-list
56061907|NCT04595565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061908|NCT04595565|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56061909|NCT04595565|Antimetabolites|antimetabolites|mesh-ancestor
56061910|NCT04595565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061911|NCT02284880|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56061912|NCT02284880|Anticonvulsants|anticonvulsants|mesh-ancestor
56061948|NCT02324543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061949|NCT02324543|Antiviral Agents|antiviral agents|mesh-ancestor
56061950|NCT02324543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56061951|NCT02324543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56061952|NCT02324543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061953|NCT02324543|Immunologic Factors|immunologic factors|mesh-ancestor
56061954|NCT02324543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061955|NCT02324543|Tubulin Modulators|tubulin modulators|mesh-ancestor
56061958|NCT02324543|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56061959|NCT02324543|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56061960|NCT01708603|Ustekinumab|ustekinumab|mesh-list
56061962|NCT01708603|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56061963|NCT01708603|Dermatologic Agents|dermatologic agents|mesh-ancestor
56061964|NCT01708603|Immunologic Factors|immunologic factors|mesh-ancestor
56061965|NCT01708603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061966|NCT03523221|Dexamethasone|dexamethasone|mesh-list
56061967|NCT03523221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56061968|NCT03523221|Antiemetics|antiemetics|mesh-ancestor
56061969|NCT03523221|Autonomic Agents|autonomic agents|mesh-ancestor
56061970|NCT03523221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56061971|NCT03523221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061972|NCT03523221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56061973|NCT03523221|Glucocorticoids|glucocorticoids|mesh-ancestor
56061974|NCT03523221|Hormones|hormones|mesh-ancestor
56061975|NCT03523221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56061976|NCT03523221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56061977|NCT03523221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061978|NCT03337919|Nivolumab|nivolumab|mesh-list
56061979|NCT03337919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56061980|NCT03337919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56061981|NCT03337919|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56061982|NCT03337919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56061983|NCT03492177|Selexipag|selexipag|mesh-list
56061989|NCT03467373|Rituximab|rituximab|mesh-list
56061990|NCT03467373|Doxorubicin|doxorubicin|mesh-list
56061991|NCT03467373|Vincristine|vincristine|mesh-list
56061992|NCT03467373|Obinutuzumab|obinutuzumab|mesh-list
56061993|NCT03467373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56061994|NCT03467373|Immunologic Factors|immunologic factors|mesh-ancestor
56061995|NCT03467373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56061996|NCT03467373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56061997|NCT03467373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56061998|NCT03467373|Alkylating Agents|alkylating agents|mesh-ancestor
56061999|NCT03467373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062000|NCT03467373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062001|NCT03467373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56062002|NCT03467373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062003|NCT03467373|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56062004|NCT03467373|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56062005|NCT03467373|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56062009|NCT03467373|Hormones|hormones|mesh-ancestor
56062045|NCT03300947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56062046|NCT03300947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56062047|NCT03300947|GABA Modulators|gaba modulators|mesh-ancestor
56062048|NCT03300947|GABA Agents|gaba agents|mesh-ancestor
56062049|NCT03300947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062050|NCT03300947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062052|NCT03543839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062053|NCT03543839|Immunologic Factors|immunologic factors|mesh-ancestor
56062054|NCT03543839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062055|NCT04173507|Avelumab|avelumab|mesh-list
56062056|NCT04173507|Talazoparib|talazoparib|mesh-list
56062057|NCT04173507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56062058|NCT04173507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062059|NCT04173507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062060|NCT04173507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56062061|NCT04173507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062062|NCT04173507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062063|NCT04173507|Immunologic Factors|immunologic factors|mesh-ancestor
56062064|NCT04173507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062065|NCT05033756|Pembrolizumab|pembrolizumab|mesh-list
56062066|NCT05033756|Olaparib|olaparib|mesh-list
56062067|NCT05033756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062068|NCT05033756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062069|NCT05033756|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56062070|NCT05033756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062071|NCT05033756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062072|NCT03532295|Bevacizumab|bevacizumab|mesh-list
56062073|NCT03532295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062074|NCT03532295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062075|NCT03532295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56062076|NCT03532295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56062077|NCT03532295|Growth Substances|growth substances|mesh-ancestor
56062078|NCT03532295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062079|NCT03532295|Growth Inhibitors|growth inhibitors|mesh-ancestor
56062083|NCT02980562|Cathartics|cathartics|mesh-ancestor
56062084|NCT02980562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56062085|NCT02980562|Laxatives|laxatives|mesh-ancestor
56062086|NCT03266393|Tacrolimus|tacrolimus|mesh-list
55740535|NCT03381833|Hepcidins|hepcidins|mesh-list
56062087|NCT03266393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062088|NCT03266393|Immunologic Factors|immunologic factors|mesh-ancestor
56062089|NCT03266393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062090|NCT03266393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56062091|NCT03266393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062092|NCT03266393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062093|NCT03246347|Docetaxel|docetaxel|mesh-list
56062094|NCT03246347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062095|NCT03246347|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062096|NCT03246347|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062097|NCT03246347|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062098|NCT03246347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062099|NCT03223103|Poly ICLC|poly iclc|mesh-list
56062100|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
56062101|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
56062102|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062103|NCT00421967|Ketorolac|ketorolac|mesh-list
56062104|NCT00421967|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56062105|NCT00421967|Epinephrine|epinephrine|mesh-list
56062106|NCT00421967|Racepinephrine|racepinephrine|mesh-list
56062107|NCT00421967|Ropivacaine|ropivacaine|mesh-list
56062108|NCT00421967|Epinephryl borate|epinephryl borate|mesh-list
56062109|NCT00421967|Anesthetics, Local|anesthetics, local|mesh-ancestor
56062110|NCT00421967|Anesthetics|anesthetics|mesh-ancestor
56062111|NCT00421967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062117|NCT00421967|Analgesics|analgesics|mesh-ancestor
56062130|NCT00421967|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56062131|NCT00421967|Respiratory System Agents|respiratory system agents|mesh-ancestor
56062133|NCT00421967|Sympathomimetics|sympathomimetics|mesh-ancestor
56062134|NCT00421967|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56062135|NCT04451187|Zopiclone|zopiclone|mesh-list
56062136|NCT04451187|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56062137|NCT04451187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062138|NCT04451187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062139|NCT03209687|Menotropins|menotropins|mesh-list
56062140|NCT03209687|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56062141|NCT03209687|Fertility Agents|fertility agents|mesh-ancestor
56062142|NCT03209687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56062143|NCT03209687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062144|NCT04997798|Trastuzumab|trastuzumab|mesh-list
56062145|NCT04997798|Exemestane|exemestane|mesh-list
56062146|NCT04997798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062147|NCT04997798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062148|NCT04997798|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56062149|NCT04997798|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56062150|NCT04997798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062151|NCT04997798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062152|NCT04997798|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56062153|NCT04997798|Hormone Antagonists|hormone antagonists|mesh-ancestor
56062154|NCT04997798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062155|NCT04997798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062156|NCT00362531|Prednisone|prednisone|mesh-list
56062157|NCT00362531|Tacrolimus|tacrolimus|mesh-list
56062158|NCT00362531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56062159|NCT00362531|Glucocorticoids|glucocorticoids|mesh-ancestor
56062160|NCT00362531|Hormones|hormones|mesh-ancestor
56062161|NCT00362531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062172|NCT04990388|Cetirizine|cetirizine|mesh-list
56062173|NCT04990388|Ibuprofen|ibuprofen|mesh-list
56062174|NCT04990388|Famotidine|famotidine|mesh-list
56062175|NCT04990388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56062176|NCT04990388|Analgesics|analgesics|mesh-ancestor
56062177|NCT04990388|Sensory System Agents|sensory system agents|mesh-ancestor
55789349|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56062178|NCT04990388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062179|NCT04990388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062180|NCT04990388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56062181|NCT04990388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56062182|NCT04990388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56062183|NCT04990388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56062184|NCT04990388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062185|NCT04990388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062189|NCT04990388|Histamine Antagonists|histamine antagonists|mesh-ancestor
56062190|NCT04990388|Histamine Agents|histamine agents|mesh-ancestor
56062191|NCT04990388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062192|NCT04990388|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56062193|NCT04990388|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56062194|NCT04990388|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56062198|NCT04330443|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56062219|NCT02422615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062220|NCT02422615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062221|NCT04964960|Paclitaxel|paclitaxel|mesh-list
56062222|NCT04964960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56062223|NCT04964960|Carboplatin|carboplatin|mesh-list
56062224|NCT04964960|Pembrolizumab|pembrolizumab|mesh-list
56062225|NCT04964960|Pemetrexed|pemetrexed|mesh-list
56062226|NCT04964960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062227|NCT04964960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062228|NCT04964960|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062229|NCT04964960|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062230|NCT04964960|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062231|NCT04964960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062232|NCT04964960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062233|NCT04964960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062234|NCT04964960|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55740537|NCT02976337|Naloxone|naloxone|mesh-list
56062235|NCT04964960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56062236|NCT05114486|Pilocarpine|pilocarpine|mesh-list
56062237|NCT05114486|Miotics|miotics|mesh-ancestor
56062238|NCT05114486|Autonomic Agents|autonomic agents|mesh-ancestor
56062239|NCT05114486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062240|NCT05114486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062241|NCT05114486|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56062242|NCT05114486|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56062243|NCT05114486|Cholinergic Agents|cholinergic agents|mesh-ancestor
56062244|NCT05114486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062245|NCT05114486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062262|NCT02259517|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56062263|NCT02259517|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56062264|NCT02259517|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56062265|NCT02259517|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56062266|NCT02259517|Adrenergic Agents|adrenergic agents|mesh-ancestor
56062267|NCT04358588|Nitric Oxide|nitric oxide|mesh-list
56062268|NCT04358588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56062269|NCT04358588|Autonomic Agents|autonomic agents|mesh-ancestor
56062270|NCT04358588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062271|NCT04358588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062272|NCT04358588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56062273|NCT04358588|Respiratory System Agents|respiratory system agents|mesh-ancestor
56062274|NCT04358588|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56062275|NCT04358588|Antioxidants|antioxidants|mesh-ancestor
56062276|NCT04358588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062277|NCT04358588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062278|NCT04358588|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56062279|NCT04358588|Vasodilator Agents|vasodilator agents|mesh-ancestor
56062280|NCT04358588|Gasotransmitters|gasotransmitters|mesh-ancestor
56062281|NCT04358588|Protective Agents|protective agents|mesh-ancestor
56062282|NCT04388163|Gentian Violet|gentian violet|mesh-list
56062283|NCT04388163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56062284|NCT04388163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56062285|NCT03166761|Dexamethasone|dexamethasone|mesh-list
56062286|NCT03166761|Triamcinolone|triamcinolone|mesh-list
56062287|NCT03166761|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56062288|NCT03166761|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56062289|NCT03166761|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56062290|NCT03166761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56062291|NCT03166761|Antiemetics|antiemetics|mesh-ancestor
56062292|NCT03166761|Autonomic Agents|autonomic agents|mesh-ancestor
56062293|NCT03166761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062294|NCT03166761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062295|NCT03166761|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56062302|NCT03166761|Immunologic Factors|immunologic factors|mesh-ancestor
56062303|NCT03166761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062304|NCT03166761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062305|NCT04377555|Ocrelizumab|ocrelizumab|mesh-list
56062306|NCT04377555|Immunologic Factors|immunologic factors|mesh-ancestor
56062307|NCT04377555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062308|NCT04042155|Rivaroxaban|rivaroxaban|mesh-list
56062309|NCT04042155|Apixaban|apixaban|mesh-list
56062310|NCT04042155|Edoxaban|edoxaban|mesh-list
56062311|NCT04042155|Dabigatran|dabigatran|mesh-list
56062312|NCT04042155|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56062313|NCT04042155|Antithrombins|antithrombins|mesh-ancestor
56062314|NCT04042155|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56062315|NCT04042155|Protease Inhibitors|protease inhibitors|mesh-ancestor
56062316|NCT04042155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062317|NCT04042155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062318|NCT04042155|Anticoagulants|anticoagulants|mesh-ancestor
56062319|NCT04195256|Dexmedetomidine|dexmedetomidine|mesh-list
56062320|NCT04195256|Ketamine|ketamine|mesh-list
56062321|NCT04195256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56062322|NCT04195256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062323|NCT04195256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062324|NCT04195256|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56062325|NCT04195256|Analgesics|analgesics|mesh-ancestor
56062326|NCT04195256|Sensory System Agents|sensory system agents|mesh-ancestor
56062327|NCT04195256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062328|NCT04195256|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56062329|NCT04195256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56062330|NCT04195256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56062331|NCT04195256|Adrenergic Agents|adrenergic agents|mesh-ancestor
56062332|NCT04195256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062333|NCT04195256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062334|NCT04195256|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56062335|NCT04195256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56062343|NCT00002901|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062344|NCT00002901|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062345|NCT00002901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062346|NCT04194944|Carboplatin|carboplatin|mesh-list
56062347|NCT04194944|Pembrolizumab|pembrolizumab|mesh-list
56062348|NCT04194944|Pemetrexed|pemetrexed|mesh-list
56062349|NCT04194944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062350|NCT04194944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062351|NCT04194944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062352|NCT04194944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062353|NCT04194944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56062354|NCT04194944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56062355|NCT00002907|Bryostatin 1|bryostatin 1|mesh-list
56062356|NCT00002907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56062357|NCT00002907|Immunologic Factors|immunologic factors|mesh-ancestor
56062358|NCT00002907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062360|NCT01710787|Phenylephrine|phenylephrine|mesh-list
56062361|NCT01710787|Oxymetazoline|oxymetazoline|mesh-list
56062363|NCT01710787|Anesthetics, Local|anesthetics, local|mesh-ancestor
56062364|NCT01710787|Anesthetics|anesthetics|mesh-ancestor
56062365|NCT01710787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062366|NCT01710787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062367|NCT01710787|Sensory System Agents|sensory system agents|mesh-ancestor
56062368|NCT01710787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062369|NCT01710787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56062370|NCT01710787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56062371|NCT01710787|Adrenergic Agents|adrenergic agents|mesh-ancestor
56062372|NCT01710787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062373|NCT01710787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062374|NCT01710787|Sympathomimetics|sympathomimetics|mesh-ancestor
56062375|NCT01710787|Autonomic Agents|autonomic agents|mesh-ancestor
56062376|NCT01710787|Nasal Decongestants|nasal decongestants|mesh-ancestor
56062382|NCT01710787|Protective Agents|protective agents|mesh-ancestor
56062383|NCT01711177|Travoprost|travoprost|mesh-list
56062384|NCT01711177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56062385|NCT02277990|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56062386|NCT02277990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56062387|NCT01715233|Leucovorin|leucovorin|mesh-list
56062388|NCT01715233|Carboplatin|carboplatin|mesh-list
56062389|NCT01715233|Docetaxel|docetaxel|mesh-list
56062390|NCT01715233|Fluorouracil|fluorouracil|mesh-list
56062391|NCT01715233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062392|NCT01715233|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062393|NCT01715233|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062394|NCT01715233|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062395|NCT01715233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062396|NCT01715233|Antimetabolites|antimetabolites|mesh-ancestor
56062397|NCT01715233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56062398|NCT01715233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062399|NCT01715233|Immunologic Factors|immunologic factors|mesh-ancestor
56062400|NCT01715233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062401|NCT01715233|Antidotes|antidotes|mesh-ancestor
56062402|NCT01715233|Protective Agents|protective agents|mesh-ancestor
56062403|NCT01715233|Vitamin B Complex|vitamin b complex|mesh-ancestor
56062404|NCT01715233|Vitamins|vitamins|mesh-ancestor
56062405|NCT01715233|Micronutrients|micronutrients|mesh-ancestor
56062406|NCT05145283|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56062407|NCT05145283|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56062408|NCT05145283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062409|NCT05145283|Immunologic Factors|immunologic factors|mesh-ancestor
56062426|NCT04826588|Hormones|hormones|mesh-ancestor
56062431|NCT04826588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062432|NCT04826588|Immunologic Factors|immunologic factors|mesh-ancestor
56062433|NCT01719367|Atenolol|atenolol|mesh-list
56062434|NCT01719367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56062435|NCT01719367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56062436|NCT01719367|Sympatholytics|sympatholytics|mesh-ancestor
56062437|NCT01719367|Autonomic Agents|autonomic agents|mesh-ancestor
56062438|NCT01719367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062439|NCT01719367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062440|NCT01719367|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56062441|NCT01719367|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56062442|NCT01719367|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56062443|NCT01719367|Adrenergic Agents|adrenergic agents|mesh-ancestor
56062445|NCT01719367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062447|NCT02276040|Anesthetics, Local|anesthetics, local|mesh-ancestor
56062448|NCT02276040|Anesthetics|anesthetics|mesh-ancestor
56062449|NCT02276040|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062450|NCT02276040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062451|NCT02276040|Sensory System Agents|sensory system agents|mesh-ancestor
56062452|NCT02276040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062453|NCT02250703|Midazolam|midazolam|mesh-list
56062454|NCT02250703|Dexmedetomidine|dexmedetomidine|mesh-list
56062455|NCT02250703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56062456|NCT02250703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062457|NCT02250703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062458|NCT02250703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56062459|NCT02250703|Analgesics|analgesics|mesh-ancestor
56062460|NCT02250703|Sensory System Agents|sensory system agents|mesh-ancestor
56062461|NCT02250703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062462|NCT02250703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56062463|NCT02250703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56062464|NCT02250703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56062469|NCT02250703|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56062470|NCT02250703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56062471|NCT02250703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56062472|NCT02250703|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56062473|NCT02250703|Anesthetics, General|anesthetics, general|mesh-ancestor
56062475|NCT02250703|GABA Modulators|gaba modulators|mesh-ancestor
56062476|NCT02250703|GABA Agents|gaba agents|mesh-ancestor
56062477|NCT02314728|Misoprostol|misoprostol|mesh-list
56062478|NCT02314728|Oxytocin|oxytocin|mesh-list
56062479|NCT02314728|Oxytocics|oxytocics|mesh-ancestor
56062480|NCT02314728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56062481|NCT02314728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062482|NCT02314728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56062483|NCT02314728|Abortifacient Agents|abortifacient agents|mesh-ancestor
56062484|NCT02314728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56062485|NCT02314728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56062486|NCT03135860|Nitric Oxide|nitric oxide|mesh-list
56062487|NCT03135860|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56062488|NCT03135860|Autonomic Agents|autonomic agents|mesh-ancestor
56062489|NCT03135860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062490|NCT03135860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062491|NCT03135860|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56062492|NCT03135860|Respiratory System Agents|respiratory system agents|mesh-ancestor
56062493|NCT03135860|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56062494|NCT03135860|Antioxidants|antioxidants|mesh-ancestor
56062495|NCT03135860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062496|NCT03135860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062497|NCT03135860|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56062498|NCT03135860|Vasodilator Agents|vasodilator agents|mesh-ancestor
56062499|NCT03135860|Gasotransmitters|gasotransmitters|mesh-ancestor
56062500|NCT03135860|Protective Agents|protective agents|mesh-ancestor
56062514|NCT01646268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062515|NCT01646268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062516|NCT01646268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062524|NCT03070184|Metoprolol|metoprolol|mesh-list
56062525|NCT03070184|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56062526|NCT03070184|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56062527|NCT03070184|Sympatholytics|sympatholytics|mesh-ancestor
56062528|NCT03070184|Autonomic Agents|autonomic agents|mesh-ancestor
56062529|NCT03070184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062530|NCT03070184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062531|NCT03070184|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56062532|NCT03070184|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56062533|NCT03070184|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56062534|NCT03070184|Adrenergic Agents|adrenergic agents|mesh-ancestor
56062535|NCT03070184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062536|NCT03070184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062537|NCT03988634|Valsartan|valsartan|mesh-list
56062538|NCT03988634|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56062539|NCT03988634|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56062540|NCT03988634|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56062541|NCT03988634|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56062542|NCT03988634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062543|NCT02294630|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56062544|NCT02294630|Respiratory System Agents|respiratory system agents|mesh-ancestor
56062545|NCT01722487|Chlorambucil|chlorambucil|mesh-list
56062546|NCT01722487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56062547|NCT01722487|Alkylating Agents|alkylating agents|mesh-ancestor
56062549|NCT01722487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062555|NCT02795858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56062556|NCT02795858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062557|NCT02795858|Hormones|hormones|mesh-ancestor
56062558|NCT02795858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062559|NCT02795858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062560|NCT02730962|Vancomycin|vancomycin|mesh-list
56062561|NCT02730962|Clindamycin|clindamycin|mesh-list
56062562|NCT02730962|Clindamycin palmitate|clindamycin palmitate|mesh-list
56062563|NCT02730962|Clindamycin phosphate|clindamycin phosphate|mesh-list
56062564|NCT02730962|Neomycin|neomycin|mesh-list
56062565|NCT02730962|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56062566|NCT02730962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56062567|NCT02730962|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56062568|NCT02730962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062569|NCT02730962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062570|NCT02296346|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56062571|NCT02296346|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56062572|NCT02296346|Methylprednisolone|methylprednisolone|mesh-list
56062573|NCT02296346|Prednisolone|prednisolone|mesh-list
56062574|NCT02296346|Prednisolone acetate|prednisolone acetate|mesh-list
56062575|NCT02296346|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56062576|NCT02296346|Prednisolone phosphate|prednisolone phosphate|mesh-list
56062577|NCT02296346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56062578|NCT02296346|Glucocorticoids|glucocorticoids|mesh-ancestor
56062579|NCT02296346|Hormones|hormones|mesh-ancestor
56062580|NCT02296346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062581|NCT02296346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062582|NCT02296346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56062583|NCT02296346|Protective Agents|protective agents|mesh-ancestor
56062601|NCT03836066|Growth Inhibitors|growth inhibitors|mesh-ancestor
56062602|NCT02372630|Linagliptin|linagliptin|mesh-list
56062603|NCT02372630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56062604|NCT02372630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062605|NCT02372630|Incretins|incretins|mesh-ancestor
56062606|NCT02372630|Hormones|hormones|mesh-ancestor
56062607|NCT02372630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062608|NCT02372630|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56062609|NCT02372630|Protease Inhibitors|protease inhibitors|mesh-ancestor
56062610|NCT02372630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062611|NCT02372630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062612|NCT02318654|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56062613|NCT02318654|Anesthetics, Local|anesthetics, local|mesh-ancestor
56062614|NCT02318654|Anesthetics|anesthetics|mesh-ancestor
56062615|NCT02318654|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062708|NCT04726969|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56062616|NCT02318654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062617|NCT02318654|Sensory System Agents|sensory system agents|mesh-ancestor
56062618|NCT02318654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062619|NCT02318654|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56062620|NCT04349930|Cannabidiol|cannabidiol|mesh-list
56062621|NCT04349930|Anticonvulsants|anticonvulsants|mesh-ancestor
56062622|NCT02303990|Pembrolizumab|pembrolizumab|mesh-list
56062623|NCT02303990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062624|NCT02303990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062625|NCT04585958|Trastuzumab|trastuzumab|mesh-list
56062626|NCT04585958|Olaparib|olaparib|mesh-list
56062627|NCT04585958|Camptothecin|camptothecin|mesh-list
56062628|NCT04585958|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56062629|NCT04585958|Immunoconjugates|immunoconjugates|mesh-list
55789804|NCT04887311|Tempol|tempol|mesh-list
56062630|NCT04585958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062631|NCT04585958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062642|NCT02307812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062643|NCT02307812|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062644|NCT02307812|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062645|NCT02307812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062646|NCT02307812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062647|NCT01727089|Bevacizumab|bevacizumab|mesh-list
56062648|NCT01727089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56062649|NCT01727089|Endothelial Growth Factors|endothelial growth factors|mesh-list
56062650|NCT01727089|Antibodies|antibodies|mesh-list
56062651|NCT01727089|Immunoglobulins|immunoglobulins|mesh-list
56062652|NCT01727089|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56062653|NCT01727089|Immunoglobulin G|immunoglobulin g|mesh-list
56062654|NCT01727089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062655|NCT01727089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56062656|NCT01727089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56062657|NCT01727089|Growth Substances|growth substances|mesh-ancestor
56062658|NCT01727089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062659|NCT01727089|Growth Inhibitors|growth inhibitors|mesh-ancestor
56062660|NCT01727089|Immunologic Factors|immunologic factors|mesh-ancestor
56062661|NCT01727791|Pregabalin|pregabalin|mesh-list
56062662|NCT01727791|Analgesics|analgesics|mesh-ancestor
56062663|NCT01727791|Sensory System Agents|sensory system agents|mesh-ancestor
56062664|NCT01727791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062665|NCT01727791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062666|NCT01727791|Anticonvulsants|anticonvulsants|mesh-ancestor
56062667|NCT01727791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56062668|NCT01727791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56062669|NCT01727791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062670|NCT01727791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56062671|NCT01727791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56062672|NCT01727791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56062673|NCT01727791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062674|NCT01727791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56062682|NCT01728337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062683|NCT01728337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062684|NCT01728337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56062685|NCT01728337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062686|NCT02247193|Botulinum Toxins|botulinum toxins|mesh-list
56062687|NCT02247193|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56062688|NCT02247193|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56062689|NCT02247193|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56062690|NCT02247193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56062691|NCT02247193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062692|NCT02247193|Cholinergic Agents|cholinergic agents|mesh-ancestor
56062693|NCT02247193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062694|NCT02247193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062695|NCT02247193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56062696|NCT02247193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56062698|NCT02245087|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56062699|NCT02245087|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56062700|NCT02245087|Antimetabolites|antimetabolites|mesh-ancestor
56062701|NCT02245087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789873|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062702|NCT02245087|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56062703|NCT02245087|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56062704|NCT02245087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062706|NCT04726969|Albendazole|albendazole|mesh-list
56062707|NCT04726969|Moxidectin|moxidectin|mesh-list
56062728|NCT03174275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062729|NCT03174275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56062730|NCT01731691|Protease Inhibitors|protease inhibitors|mesh-list
56062731|NCT01731691|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56062732|NCT01731691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062733|NCT01731691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062734|NCT01731691|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56062735|NCT01731691|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56062736|NCT02247739|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56062737|NCT02247739|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56062738|NCT02247739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062739|NCT02247739|Immunologic Factors|immunologic factors|mesh-ancestor
56062740|NCT02247739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062741|NCT02975141|Gemcitabine|gemcitabine|mesh-list
56062743|NCT02975141|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56062744|NCT02975141|Afatinib|afatinib|mesh-list
56062745|NCT02975141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062746|NCT02975141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062747|NCT02975141|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062748|NCT02975141|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062749|NCT02975141|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062750|NCT02975141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062751|NCT02975141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56062752|NCT02975141|Antimetabolites|antimetabolites|mesh-ancestor
56062753|NCT02975141|Antiviral Agents|antiviral agents|mesh-ancestor
56062754|NCT02975141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56062755|NCT02975141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062756|NCT02975141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56062757|NCT02975141|Immunologic Factors|immunologic factors|mesh-ancestor
56062758|NCT02975141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062760|NCT03452891|Simvastatin|simvastatin|mesh-list
55901103|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
55901104|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55901105|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55901106|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56062761|NCT03452891|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56062762|NCT03452891|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56062763|NCT03452891|Antimetabolites|antimetabolites|mesh-ancestor
56062764|NCT03452891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062765|NCT03452891|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56062766|NCT03452891|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56062767|NCT03452891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062768|NCT04341935|Linagliptin|linagliptin|mesh-list
56062769|NCT04341935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56062770|NCT04341935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062771|NCT04341935|Incretins|incretins|mesh-ancestor
56062772|NCT04341935|Hormones|hormones|mesh-ancestor
56062773|NCT04341935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56062774|NCT04341935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56062775|NCT04341935|Protease Inhibitors|protease inhibitors|mesh-ancestor
56062776|NCT04341935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062777|NCT04341935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062778|NCT05317039|Calcium|calcium|mesh-list
56062779|NCT05317039|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56062780|NCT05317039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062781|NCT05316883|Clozapine|clozapine|mesh-list
56062782|NCT05316883|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56062783|NCT05316883|Serotonin Agents|serotonin agents|mesh-ancestor
56062784|NCT05316883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062785|NCT05316883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062786|NCT05316883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062787|NCT05316883|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56062788|NCT05316883|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56062789|NCT05316883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56062790|NCT05316883|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56062791|NCT05316883|GABA Antagonists|gaba antagonists|mesh-ancestor
56062803|NCT03990363|Verinurad|verinurad|mesh-list
56062804|NCT03990363|Antimetabolites|antimetabolites|mesh-ancestor
56062805|NCT03990363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062806|NCT03990363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062807|NCT03990363|Gout Suppressants|gout suppressants|mesh-ancestor
56062808|NCT03990363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56062809|NCT03990363|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56062810|NCT03990363|Antioxidants|antioxidants|mesh-ancestor
56062812|NCT03990363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062813|NCT04341857|Antibodies|antibodies|mesh-list
56062814|NCT04341857|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56062815|NCT04341857|Immunologic Factors|immunologic factors|mesh-ancestor
56062816|NCT04341857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062817|NCT00002913|Paclitaxel|paclitaxel|mesh-list
56062818|NCT00002913|Topotecan|topotecan|mesh-list
56062819|NCT00002913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062820|NCT00002913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062821|NCT00002913|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062822|NCT00002913|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062823|NCT00002913|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062824|NCT00002913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062825|NCT00002913|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56062826|NCT00002913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56062827|NCT00002913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062828|NCT00002919|Doxorubicin|doxorubicin|mesh-list
56062853|NCT00002919|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062855|NCT03083405|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56062856|NCT03083405|Antidepressive Agents|antidepressive agents|mesh-ancestor
56062857|NCT03083405|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56062858|NCT03083405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56062859|NCT03083405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56062860|NCT03083405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56062861|NCT03083405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062862|NCT03083405|Adrenergic Agents|adrenergic agents|mesh-ancestor
56062863|NCT03083405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56062864|NCT03083405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062865|NCT00383799|Amiodarone|amiodarone|mesh-list
56062866|NCT00383799|Procainamide|procainamide|mesh-list
56062867|NCT00383799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56062868|NCT00383799|Vasodilator Agents|vasodilator agents|mesh-ancestor
56062869|NCT00383799|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56062870|NCT00383799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56062871|NCT00383799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062872|NCT00383799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56062873|NCT00383799|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56062874|NCT00383799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56062875|NCT00383799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062876|NCT00383799|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56062880|NCT04635241|Heparin|heparin|mesh-list
56062900|NCT03954483|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56062901|NCT03954483|GABA Modulators|gaba modulators|mesh-ancestor
56062902|NCT03954483|GABA Agents|gaba agents|mesh-ancestor
56062903|NCT04545541|Heparin|heparin|mesh-list
56062904|NCT04545541|Calcium heparin|calcium heparin|mesh-list
56062905|NCT04545541|Anticoagulants|anticoagulants|mesh-ancestor
56062906|NCT04545541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56062907|NCT04545541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56062908|NCT04545541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062909|NCT00002925|Aldesleukin|aldesleukin|mesh-list
56062910|NCT00002925|Etoposide|etoposide|mesh-list
56062911|NCT00002925|Daunorubicin|daunorubicin|mesh-list
56062912|NCT00002925|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062913|NCT00002925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062914|NCT00002925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56062915|NCT00002925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56062916|NCT00002925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062917|NCT00002925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062918|NCT00002925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56062919|NCT00002925|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56062956|NCT00002943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56062957|NCT00002949|Paclitaxel|paclitaxel|mesh-list
56062958|NCT00002949|Vinorelbine|vinorelbine|mesh-list
56062959|NCT00002949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56062960|NCT00002949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56062961|NCT00002949|Tubulin Modulators|tubulin modulators|mesh-ancestor
56062962|NCT00002949|Antimitotic Agents|antimitotic agents|mesh-ancestor
56062963|NCT00002949|Mitosis Modulators|mitosis modulators|mesh-ancestor
56062964|NCT00002949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062965|NCT05315557|Terlipressin|terlipressin|mesh-list
56062966|NCT05315557|Vasopressins|vasopressins|mesh-list
56062967|NCT05315557|Arginine Vasopressin|arginine vasopressin|mesh-list
56062968|NCT05315557|Hemostatics|hemostatics|mesh-ancestor
56062969|NCT05315557|Coagulants|coagulants|mesh-ancestor
56062970|NCT05315557|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56062973|NCT05315557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062974|NCT05315557|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56062975|NCT00002955|Leucovorin|leucovorin|mesh-list
56062976|NCT00002955|Trimetrexate|trimetrexate|mesh-list
56062977|NCT00002955|Fluorouracil|fluorouracil|mesh-list
56062978|NCT00002955|Calcium|calcium|mesh-list
56062979|NCT00002955|Levoleucovorin|levoleucovorin|mesh-list
56062980|NCT00002955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56062981|NCT00002955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56062982|NCT00002955|Antimetabolites|antimetabolites|mesh-ancestor
56062983|NCT00002955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56062984|NCT00002955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063008|NCT02877303|Mercaptopurine|mercaptopurine|mesh-list
56063009|NCT02877303|Ofatumumab|ofatumumab|mesh-list
56063010|NCT02877303|Blinatumomab|blinatumomab|mesh-list
56063011|NCT02877303|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56063012|NCT02877303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56063013|NCT02877303|Muromonab-CD3|muromonab-cd3|mesh-list
56063014|NCT02877303|Antibodies|antibodies|mesh-list
56063015|NCT02877303|Immunoglobulins|immunoglobulins|mesh-list
56063016|NCT02877303|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56063017|NCT02877303|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56063018|NCT02877303|BB 1101|bb 1101|mesh-list
56063019|NCT02877303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063020|NCT02877303|Immunologic Factors|immunologic factors|mesh-ancestor
56063021|NCT02877303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063022|NCT02877303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063023|NCT02877303|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063024|NCT02877303|Alkylating Agents|alkylating agents|mesh-ancestor
56063025|NCT02877303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063026|NCT02877303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063027|NCT02877303|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56063028|NCT02877303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56063030|NCT02877303|Autonomic Agents|autonomic agents|mesh-ancestor
56063031|NCT02877303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063032|NCT02877303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56063033|NCT02877303|Glucocorticoids|glucocorticoids|mesh-ancestor
56063034|NCT02877303|Hormones|hormones|mesh-ancestor
56063035|NCT02877303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56063036|NCT02877303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56063037|NCT02877303|Protease Inhibitors|protease inhibitors|mesh-ancestor
56063056|NCT00002961|Cyclosporine|cyclosporine|mesh-list
56063057|NCT00002961|Cyclophosphamide|cyclophosphamide|mesh-list
56063058|NCT00002961|Busulfan|busulfan|mesh-list
56063059|NCT00002961|Methotrexate|methotrexate|mesh-list
56063060|NCT00002961|Etoposide|etoposide|mesh-list
56063061|NCT00002961|Etoposide phosphate|etoposide phosphate|mesh-list
56063062|NCT00002961|Cyclosporins|cyclosporins|mesh-list
56063063|NCT00002961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063064|NCT00002961|Immunologic Factors|immunologic factors|mesh-ancestor
56063065|NCT00002961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063066|NCT00002961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063067|NCT00002961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063068|NCT00002961|Alkylating Agents|alkylating agents|mesh-ancestor
56063069|NCT00002961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063070|NCT00002961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063071|NCT00002961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56063072|NCT00002961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56063073|NCT00002961|Abortifacient Agents|abortifacient agents|mesh-ancestor
56063074|NCT00002961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56063075|NCT00002961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063076|NCT00002961|Antimetabolites|antimetabolites|mesh-ancestor
56063079|NCT00002961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56063080|NCT00002961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56063081|NCT00002961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063082|NCT00002961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063083|NCT00002961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063084|NCT00002961|Antifungal Agents|antifungal agents|mesh-ancestor
56063085|NCT00002961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063086|NCT00002961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56063101|NCT00002967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55740571|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
56063102|NCT00002967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063103|NCT00002967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063104|NCT00002967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063105|NCT00002967|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56063106|NCT00002967|Hormone Antagonists|hormone antagonists|mesh-ancestor
56063107|NCT00002967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56063108|NCT00002967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56063109|NCT00002967|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56063110|NCT00002967|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56063111|NCT00002967|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56063112|NCT00002967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56063114|NCT04246177|Lenvatinib|lenvatinib|mesh-list
56063115|NCT04246177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56063116|NCT04246177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063117|NCT04246177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56063118|NCT04246177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063119|NCT04246177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063120|NCT00002973|Melphalan|melphalan|mesh-list
56063121|NCT00002973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063122|NCT00002973|Alkylating Agents|alkylating agents|mesh-ancestor
56063123|NCT00002973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063124|NCT00002973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063125|NCT00002973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56063126|NCT00002973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063127|NCT00002973|Immunologic Factors|immunologic factors|mesh-ancestor
56063128|NCT00002973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063129|NCT00002985|Doxorubicin|doxorubicin|mesh-list
56063130|NCT00002985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56063142|NCT02767557|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063143|NCT02767557|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063144|NCT02767557|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063145|NCT02767557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063146|NCT02767557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063147|NCT02767557|Antimetabolites|antimetabolites|mesh-ancestor
56063148|NCT02767557|Antiviral Agents|antiviral agents|mesh-ancestor
56063149|NCT02767557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063150|NCT02767557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063151|NCT02767557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063152|NCT02767557|Immunologic Factors|immunologic factors|mesh-ancestor
56063153|NCT02767557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063154|NCT00363389|Misoprostol|misoprostol|mesh-list
56063156|NCT00363389|Abortifacient Agents|abortifacient agents|mesh-ancestor
56063157|NCT00363389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56063158|NCT00363389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063159|NCT00363389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56063160|NCT00363389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56063161|NCT00363389|Oxytocics|oxytocics|mesh-ancestor
56063162|NCT03057431|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56063163|NCT03057431|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56063164|NCT03057431|Diuretics|diuretics|mesh-ancestor
56063165|NCT03057431|Natriuretic Agents|natriuretic agents|mesh-ancestor
56063166|NCT03057431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063167|NCT03057431|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56063168|NCT03057431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56063169|NCT03057431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063170|NCT00003003|Mitoxantrone|mitoxantrone|mesh-list
56063171|NCT00003003|Mitomycins|mitomycins|mesh-list
56063172|NCT00003003|Mitomycin|mitomycin|mesh-list
56063173|NCT00003003|Sargramostim|sargramostim|mesh-list
56063174|NCT00003003|Immunologic Factors|immunologic factors|mesh-ancestor
56063177|NCT00003003|Analgesics|analgesics|mesh-ancestor
56063184|NCT00003003|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063185|NCT00003003|Alkylating Agents|alkylating agents|mesh-ancestor
56063186|NCT00003003|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56063189|NCT00003009|Aldesleukin|aldesleukin|mesh-list
56063190|NCT00003009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063191|NCT00003009|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56063192|NCT00003009|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56063193|NCT00003009|Antiviral Agents|antiviral agents|mesh-ancestor
56063194|NCT00003009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063195|NCT00003015|Carboplatin|carboplatin|mesh-list
56063196|NCT00003015|Vincristine|vincristine|mesh-list
56063197|NCT00003015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063198|NCT00003015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063199|NCT00003015|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063200|NCT00003015|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063201|NCT00003015|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063202|NCT00003015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063203|NCT04204837|Nivolumab|nivolumab|mesh-list
56063204|NCT04204837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56063205|NCT04204837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063206|NCT04204837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56063207|NCT04204837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063233|NCT03839823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063234|NCT03839823|Immunologic Factors|immunologic factors|mesh-ancestor
56063235|NCT03839823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063236|NCT03839823|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56063237|NCT03839823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56063238|NCT03839823|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56063239|NCT03839823|Hormone Antagonists|hormone antagonists|mesh-ancestor
56063242|NCT00003027|Interferons|interferons|mesh-list
56063243|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
56063244|NCT00003027|Aldesleukin|aldesleukin|mesh-list
56063245|NCT00003027|Dacarbazine|dacarbazine|mesh-list
56063246|NCT00003027|Vinblastine|vinblastine|mesh-list
56063247|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063248|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
56063249|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063250|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
56063251|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063252|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56063253|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56063254|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063255|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
56063256|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063257|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063258|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063259|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063260|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063262|NCT00003039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063263|NCT00003039|Growth Inhibitors|growth inhibitors|mesh-ancestor
56063264|NCT00003039|Growth Substances|growth substances|mesh-ancestor
56063269|NCT00383877|Insulin|insulin|mesh-list
56063277|NCT00003057|Octreotide|octreotide|mesh-list
56063278|NCT00003057|Loperamide|loperamide|mesh-list
56063279|NCT00003057|Antidiarrheals|antidiarrheals|mesh-list
56063280|NCT00003057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56063281|NCT00003057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56063282|NCT00003057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063283|NCT00003063|Leucovorin|leucovorin|mesh-list
56063284|NCT00003063|Interferons|interferons|mesh-list
56063285|NCT00003063|Interferon-alpha|interferon-alpha|mesh-list
56063286|NCT00003063|Levamisole|levamisole|mesh-list
56063287|NCT00003063|Fluorouracil|fluorouracil|mesh-list
56063288|NCT00003063|Calcium|calcium|mesh-list
56063289|NCT00003063|Levoleucovorin|levoleucovorin|mesh-list
56063290|NCT00003063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56063291|NCT00003063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063292|NCT00003063|Antimetabolites|antimetabolites|mesh-ancestor
56063293|NCT00003063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063294|NCT00003063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063295|NCT00003063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063296|NCT00003063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063297|NCT00003063|Immunologic Factors|immunologic factors|mesh-ancestor
56063298|NCT00003063|Antiviral Agents|antiviral agents|mesh-ancestor
56063299|NCT00003063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063300|NCT00003063|Antidotes|antidotes|mesh-ancestor
56063301|NCT00003063|Protective Agents|protective agents|mesh-ancestor
56063302|NCT00003063|Vitamin B Complex|vitamin b complex|mesh-ancestor
56063303|NCT00003063|Vitamins|vitamins|mesh-ancestor
56063304|NCT00003063|Micronutrients|micronutrients|mesh-ancestor
56063305|NCT00003063|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56063306|NCT00003063|Antinematodal Agents|antinematodal agents|mesh-ancestor
56063307|NCT00003063|Anthelmintics|anthelmintics|mesh-ancestor
56063308|NCT00003063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56063309|NCT00003063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063310|NCT00003075|Fenretinide|fenretinide|mesh-list
56063311|NCT00003075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063312|NCT00003075|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56063313|NCT00003075|Protective Agents|protective agents|mesh-ancestor
56063321|NCT00003081|Alkylating Agents|alkylating agents|mesh-ancestor
56063322|NCT00003081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063323|NCT00003081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063324|NCT00003081|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56063325|NCT00003081|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063327|NCT02348385|Dextroamphetamine|dextroamphetamine|mesh-list
56063328|NCT02348385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56063329|NCT02348385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063330|NCT02348385|Sympathomimetics|sympathomimetics|mesh-ancestor
56063332|NCT02348385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063333|NCT02348385|Dopamine Agents|dopamine agents|mesh-ancestor
56063334|NCT02348385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063335|NCT02348385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063336|NCT02348385|Adrenergic Agents|adrenergic agents|mesh-ancestor
56063337|NCT02348385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56063338|NCT02348385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56063339|NCT02348385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56063340|NCT02348385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56063341|NCT00003087|Paclitaxel|paclitaxel|mesh-list
56063342|NCT00003087|Cisplatin|cisplatin|mesh-list
56063343|NCT00003087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063344|NCT00003087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063345|NCT00003087|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063346|NCT00003087|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063347|NCT00003087|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063348|NCT00003087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063349|NCT00003093|Cyclophosphamide|cyclophosphamide|mesh-list
56063366|NCT00003093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063367|NCT00003093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063368|NCT00003093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063369|NCT00003093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063370|NCT00003093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063371|NCT00003093|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56063372|NCT00003099|Tamoxifen|tamoxifen|mesh-list
56063373|NCT00003099|Fenretinide|fenretinide|mesh-list
56063374|NCT00003099|Retinamide|retinamide|mesh-list
56063375|NCT00003099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56063376|NCT00003099|Hormone Antagonists|hormone antagonists|mesh-ancestor
56063377|NCT00003099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56063378|NCT00003099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063379|NCT00003099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56063380|NCT00003099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063381|NCT00003099|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56063382|NCT00003099|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56063423|NCT05709301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56063424|NCT05709301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063425|NCT05709301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063442|NCT02240329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063443|NCT02240329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063444|NCT00003123|Amifostine|amifostine|mesh-list
56063445|NCT00003123|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56063446|NCT00003123|Protective Agents|protective agents|mesh-ancestor
56063447|NCT00003123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063448|NCT05115409|Rituximab|rituximab|mesh-list
56063449|NCT05115409|Antibodies|antibodies|mesh-list
56063450|NCT05115409|Immunologic Factors|immunologic factors|mesh-ancestor
56063451|NCT05115409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063452|NCT05115409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56063453|NCT05115409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063454|NCT05115409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063455|NCT03981523|Benzonidazole|benzonidazole|mesh-list
56063456|NCT03981523|Nifurtimox|nifurtimox|mesh-list
56063457|NCT03981523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063458|NCT03981523|Immunologic Factors|immunologic factors|mesh-ancestor
56063459|NCT03981523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063460|NCT03981523|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56063461|NCT03981523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56063462|NCT03981523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56063463|NCT03981523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063464|NCT03965923|Tenofovir|tenofovir|mesh-list
56063465|NCT03965923|Emtricitabine|emtricitabine|mesh-list
55790706|NCT02455141|Taxane|taxane|mesh-list
56063501|NCT03962725|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56063503|NCT03861793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56063504|NCT03861793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063505|NCT05699473|Calcium, Dietary|calcium, dietary|mesh-list
56063506|NCT05699473|Tetrahydrofolates|tetrahydrofolates|mesh-list
56063507|NCT05699473|Calcium|calcium|mesh-list
56063508|NCT05699473|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56063509|NCT05699473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063510|NCT05699473|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56063511|NCT05699473|Vitamin B Complex|vitamin b complex|mesh-ancestor
56063512|NCT05699473|Vitamins|vitamins|mesh-ancestor
56063513|NCT05699473|Micronutrients|micronutrients|mesh-ancestor
56063514|NCT02210559|Gemcitabine|gemcitabine|mesh-list
56063516|NCT02210559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063517|NCT02210559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063518|NCT02210559|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063519|NCT02210559|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063520|NCT02210559|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063521|NCT02210559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063522|NCT02210559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063523|NCT02210559|Antimetabolites|antimetabolites|mesh-ancestor
56063524|NCT02210559|Antiviral Agents|antiviral agents|mesh-ancestor
56063525|NCT02210559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063526|NCT02210559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063551|NCT03699631|Tacrolimus|tacrolimus|mesh-list
56063552|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56063553|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
56063554|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56063555|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063556|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063557|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
56063558|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063559|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063560|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
56063561|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063562|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56063563|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063564|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
56063565|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063566|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56063567|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56063568|NCT03669133|Vitamin E|vitamin e|mesh-list
56063569|NCT03669133|Vitamins|vitamins|mesh-ancestor
56063570|NCT03669133|Micronutrients|micronutrients|mesh-ancestor
56063571|NCT03669133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063572|NCT03669133|Antioxidants|antioxidants|mesh-ancestor
56063573|NCT03669133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063574|NCT03669133|Protective Agents|protective agents|mesh-ancestor
56063575|NCT02114229|Cyclophosphamide|cyclophosphamide|mesh-list
56063576|NCT02114229|Carboplatin|carboplatin|mesh-list
56063577|NCT02114229|Methotrexate|methotrexate|mesh-list
56063578|NCT02114229|Etoposide|etoposide|mesh-list
56063579|NCT02114229|Etoposide phosphate|etoposide phosphate|mesh-list
56063580|NCT02114229|Vincristine|vincristine|mesh-list
56063581|NCT02114229|Topotecan|topotecan|mesh-list
56063582|NCT02114229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063583|NCT02114229|Immunologic Factors|immunologic factors|mesh-ancestor
56063584|NCT02114229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063585|NCT02114229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063586|NCT02114229|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063590|NCT02114229|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56063591|NCT02114229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56063592|NCT02114229|Abortifacient Agents|abortifacient agents|mesh-ancestor
56063593|NCT02114229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56063594|NCT02114229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063595|NCT02114229|Antimetabolites|antimetabolites|mesh-ancestor
56063596|NCT02114229|Dermatologic Agents|dermatologic agents|mesh-ancestor
56063597|NCT02114229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063598|NCT02114229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56063599|NCT02114229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56063600|NCT02114229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063601|NCT02114229|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063602|NCT02114229|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063603|NCT02114229|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063604|NCT02114229|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063605|NCT02114229|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063606|NCT02114229|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56063608|NCT03439891|Sorafenib|sorafenib|mesh-list
56063609|NCT03439891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56063610|NCT03439891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063611|NCT03439891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56063612|NCT03439891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063613|NCT03439891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56063614|NCT03439891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063615|NCT00003141|Cyclophosphamide|cyclophosphamide|mesh-list
56063616|NCT00003141|Thiotepa|thiotepa|mesh-list
56063617|NCT00003141|Cisplatin|cisplatin|mesh-list
56063618|NCT00003141|Carboplatin|carboplatin|mesh-list
56063619|NCT00003141|Etoposide|etoposide|mesh-list
56063620|NCT00003141|Vincristine|vincristine|mesh-list
56063622|NCT00003141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063623|NCT00003141|Immunologic Factors|immunologic factors|mesh-ancestor
56063624|NCT00003141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063625|NCT00003141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55901107|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
55901108|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063626|NCT00003141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063627|NCT00003141|Alkylating Agents|alkylating agents|mesh-ancestor
56063628|NCT00003141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063629|NCT00003141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063630|NCT00003141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56063631|NCT00003141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063632|NCT00003141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063633|NCT00003141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063634|NCT00003141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063635|NCT00003141|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56063636|NCT00003141|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063637|NCT00003141|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063638|NCT00003141|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063640|NCT04867135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56063641|NCT04867135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063643|NCT04860661|Antidepressive Agents|antidepressive agents|mesh-ancestor
56063644|NCT04860661|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56063645|NCT01740817|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56063646|NCT01740817|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56063647|NCT01740817|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56063648|NCT01740817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56063649|NCT04728217|Factor VIII|factor viii|mesh-list
56063650|NCT04728217|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
56063651|NCT04728217|Coagulants|coagulants|mesh-ancestor
56063652|NCT04728217|Immunologic Factors|immunologic factors|mesh-ancestor
56063653|NCT04728217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063654|NCT04581343|Gemcitabine|gemcitabine|mesh-list
56063655|NCT04581343|Paclitaxel|paclitaxel|mesh-list
56063656|NCT04581343|Spartalizumab|spartalizumab|mesh-list
56063657|NCT04581343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063669|NCT04581343|Immunologic Factors|immunologic factors|mesh-ancestor
56063670|NCT04581343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063671|NCT04581343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56063672|NCT01743859|Lenalidomide|lenalidomide|mesh-list
56063673|NCT01743859|Azacitidine|azacitidine|mesh-list
56063674|NCT01743859|Immunologic Factors|immunologic factors|mesh-ancestor
56063675|NCT01743859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063676|NCT01743859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56063677|NCT01743859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56063678|NCT01743859|Growth Substances|growth substances|mesh-ancestor
56063679|NCT01743859|Growth Inhibitors|growth inhibitors|mesh-ancestor
56063680|NCT01743859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063681|NCT01743859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063682|NCT01743859|Antimetabolites|antimetabolites|mesh-ancestor
56063683|NCT01743859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063684|NCT01743859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063685|NCT01746043|Minocycline|minocycline|mesh-list
56063686|NCT01746043|Modafinil|modafinil|mesh-list
56063687|NCT01746043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56063688|NCT01746043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063689|NCT01746043|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56063690|NCT01746043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063691|NCT01746043|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56063692|NCT01746043|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56063719|NCT01746511|Protective Agents|protective agents|mesh-ancestor
56063720|NCT01746511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063721|NCT01746979|Gemcitabine|gemcitabine|mesh-list
56063722|NCT01746979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063723|NCT01746979|Antimetabolites|antimetabolites|mesh-ancestor
56063724|NCT01746979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063725|NCT01746979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063726|NCT01746979|Antiviral Agents|antiviral agents|mesh-ancestor
56063727|NCT01746979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063728|NCT01746979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063729|NCT01746979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063730|NCT01746979|Immunologic Factors|immunologic factors|mesh-ancestor
56063731|NCT01746979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063732|NCT04514653|Ranibizumab|ranibizumab|mesh-list
56063733|NCT04514653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56063734|NCT04514653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56063735|NCT04514653|Growth Substances|growth substances|mesh-ancestor
56063736|NCT04514653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063737|NCT04514653|Growth Inhibitors|growth inhibitors|mesh-ancestor
56063738|NCT04514653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063774|NCT01754623|Capecitabine|capecitabine|mesh-list
56063775|NCT01754623|Docetaxel|docetaxel|mesh-list
56063776|NCT01754623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063777|NCT01754623|Antimetabolites|antimetabolites|mesh-ancestor
56063778|NCT01754623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063779|NCT01754623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063780|NCT01754623|Antiviral Agents|antiviral agents|mesh-ancestor
56063781|NCT01754623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063782|NCT01754623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063783|NCT01754623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063784|NCT01754623|Immunologic Factors|immunologic factors|mesh-ancestor
56063785|NCT01754623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063786|NCT01754623|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063787|NCT01754623|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063788|NCT01754623|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063789|NCT01755169|Ketamine|ketamine|mesh-list
56063790|NCT01755169|Analgesics|analgesics|mesh-ancestor
56063791|NCT01755169|Sensory System Agents|sensory system agents|mesh-ancestor
56063792|NCT01755169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063793|NCT01755169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063794|NCT01755169|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56063795|NCT01755169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56063796|NCT01755169|Anesthetics, General|anesthetics, general|mesh-ancestor
56063797|NCT01755169|Anesthetics|anesthetics|mesh-ancestor
56063798|NCT01755169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56063799|NCT01755169|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56063800|NCT01755169|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56063801|NCT01755169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063802|NCT01755169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063803|NCT01755949|Colchicine|colchicine|mesh-list
56063804|NCT01755949|Gout Suppressants|gout suppressants|mesh-ancestor
56063805|NCT01755949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063806|NCT01755949|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063807|NCT01755949|Antimitotic Agents|antimitotic agents|mesh-ancestor
56063808|NCT01755949|Mitosis Modulators|mitosis modulators|mesh-ancestor
56063809|NCT01755949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063811|NCT01756885|Varenicline|varenicline|mesh-list
56063812|NCT01756885|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56063813|NCT01756885|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56063814|NCT01756885|Cholinergic Agents|cholinergic agents|mesh-ancestor
56063815|NCT01756885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063816|NCT01756885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063817|NCT01756885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063818|NCT04172701|Cholinergic Agents|cholinergic agents|mesh-list
56063819|NCT04172701|Muscarinic Antagonists|muscarinic antagonists|mesh-list
56063820|NCT04172701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063821|NCT04172701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063822|NCT04172701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063823|NCT04172701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56063824|NCT05554939|Cyclophosphamide|cyclophosphamide|mesh-list
56063825|NCT05554939|Fludarabine|fludarabine|mesh-list
56063826|NCT05554939|Fludarabine phosphate|fludarabine phosphate|mesh-list
56063827|NCT05554939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063828|NCT05554939|Immunologic Factors|immunologic factors|mesh-ancestor
56063829|NCT05554939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063830|NCT05554939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063831|NCT05554939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56063832|NCT05554939|Alkylating Agents|alkylating agents|mesh-ancestor
56063833|NCT05554939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063834|NCT05554939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063835|NCT05554939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56063836|NCT05554939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063837|NCT05554939|Antimetabolites|antimetabolites|mesh-ancestor
56063838|NCT01760785|Valproic Acid|valproic acid|mesh-list
56063839|NCT01760785|Anticonvulsants|anticonvulsants|mesh-ancestor
56063840|NCT01760785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063841|NCT01760785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063842|NCT01760785|GABA Agents|gaba agents|mesh-ancestor
55791013|NCT04847687|Prednisolone|prednisolone|mesh-list
56063843|NCT01760785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063853|NCT04062097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063854|NCT04062097|Antithrombins|antithrombins|mesh-ancestor
56063855|NCT04062097|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56063856|NCT04062097|Protease Inhibitors|protease inhibitors|mesh-ancestor
56063857|NCT04062097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063858|NCT04062097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063859|NCT04062097|Anticoagulants|anticoagulants|mesh-ancestor
56063860|NCT04062097|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56063861|NCT04062097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56063862|NCT04062097|Hemostatics|hemostatics|mesh-ancestor
56063863|NCT04062097|Coagulants|coagulants|mesh-ancestor
56063864|NCT02241655|Anesthetics|anesthetics|mesh-list
56063865|NCT02241655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56063866|NCT02241655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063867|NCT04005079|Ofloxacin|ofloxacin|mesh-list
56063868|NCT04005079|Prednisolone|prednisolone|mesh-list
56063869|NCT04005079|Pilocarpine|pilocarpine|mesh-list
56063870|NCT04005079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56063871|NCT04005079|Glucocorticoids|glucocorticoids|mesh-ancestor
56063872|NCT04005079|Hormones|hormones|mesh-ancestor
56063873|NCT04005079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56063874|NCT04005079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063875|NCT04005079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56063876|NCT04005079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063877|NCT04005079|Autonomic Agents|autonomic agents|mesh-ancestor
56063899|NCT01762501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063900|NCT01762501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56063901|NCT01762501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063902|NCT01762501|Vasodilator Agents|vasodilator agents|mesh-ancestor
56063903|NCT01762501|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56063904|NCT01762501|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56063905|NCT05539963|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56063906|NCT05539963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063907|NCT01764607|Sirolimus|sirolimus|mesh-list
56063908|NCT01764607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56063909|NCT01764607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063910|NCT01764607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063911|NCT01764607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063912|NCT01764607|Antifungal Agents|antifungal agents|mesh-ancestor
56063913|NCT01764607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063914|NCT01764607|Immunologic Factors|immunologic factors|mesh-ancestor
56063915|NCT01764607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063916|NCT01764685|Topiramate|topiramate|mesh-list
56063917|NCT01764685|Anticonvulsants|anticonvulsants|mesh-ancestor
55791093|NCT05430217|Serotonin Agents|serotonin agents|mesh-ancestor
56063918|NCT01764685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56063919|NCT01764685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063920|NCT01766713|Ezetimibe|ezetimibe|mesh-list
56063921|NCT01766713|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56063922|NCT01766713|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56063923|NCT01766713|Antimetabolites|antimetabolites|mesh-ancestor
56063924|NCT01766713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063925|NCT01766713|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56063926|NCT01767103|Deferiprone|deferiprone|mesh-list
56063927|NCT01767103|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56063944|NCT01769209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063945|NCT01769209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56063946|NCT01769209|Glucocorticoids|glucocorticoids|mesh-ancestor
56063947|NCT01769209|Hormones|hormones|mesh-ancestor
56063948|NCT01769209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56063949|NCT01769209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56063950|NCT01769209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56063951|NCT01769209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56063952|NCT01769209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56063953|NCT01769209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56063954|NCT01769209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56063955|NCT01769209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56063956|NCT01769209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56063957|NCT01769209|Abortifacient Agents|abortifacient agents|mesh-ancestor
56063958|NCT01769209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56063959|NCT01769209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56063960|NCT01769209|Antimetabolites|antimetabolites|mesh-ancestor
56063961|NCT01769209|Dermatologic Agents|dermatologic agents|mesh-ancestor
56063962|NCT01769209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56063963|NCT01769209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56063964|NCT01769209|Immunologic Factors|immunologic factors|mesh-ancestor
56063965|NCT01769209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56063966|NCT01769209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56063968|NCT01769209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56063969|NCT01769209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56063970|NCT01769209|Tubulin Modulators|tubulin modulators|mesh-ancestor
56063989|NCT01771627|Nicotine|nicotine|mesh-list
56063990|NCT01771627|Varenicline|varenicline|mesh-list
56063991|NCT01771627|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56063992|NCT01771627|Autonomic Agents|autonomic agents|mesh-ancestor
56063993|NCT01771627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56063994|NCT01771627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56063995|NCT01771627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56063996|NCT01771627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56063997|NCT01771627|Cholinergic Agents|cholinergic agents|mesh-ancestor
56063998|NCT01771627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56063999|NCT01771627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064000|NCT03781765|Methylphenidate|methylphenidate|mesh-list
56064001|NCT03781765|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56064002|NCT03781765|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56064003|NCT03781765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064004|NCT03781765|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56064005|NCT03781765|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56064006|NCT03781765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56064045|NCT01777945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064046|NCT01777945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56064047|NCT01777945|Antimetabolites|antimetabolites|mesh-ancestor
56064048|NCT03012581|Nivolumab|nivolumab|mesh-list
56064049|NCT03012581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064050|NCT03012581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064051|NCT03012581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56064052|NCT03012581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064053|NCT05473273|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56064054|NCT05473273|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56064055|NCT05473273|Estradiol|estradiol|mesh-list
56064056|NCT05473273|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56064057|NCT05473273|Progesterone|progesterone|mesh-list
56064058|NCT05473273|Estrogens|estrogens|mesh-ancestor
56064059|NCT05473273|Hormones|hormones|mesh-ancestor
56064060|NCT05473273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064061|NCT05473273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064062|NCT05473273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56064063|NCT05473273|Contraceptive Agents|contraceptive agents|mesh-ancestor
56064064|NCT05473273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56064065|NCT05473273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56064066|NCT05473273|Progestins|progestins|mesh-ancestor
56064067|NCT05451043|Gemcitabine|gemcitabine|mesh-list
56064068|NCT05451043|Paclitaxel|paclitaxel|mesh-list
56064069|NCT05451043|Durvalumab|durvalumab|mesh-list
56064070|NCT05451043|Tremelimumab|tremelimumab|mesh-list
56064071|NCT05451043|Propranolol|propranolol|mesh-list
56064072|NCT05451043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56064092|NCT05451043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56064093|NCT05451043|Vasodilator Agents|vasodilator agents|mesh-ancestor
56064094|NCT02652169|Amikacin|amikacin|mesh-list
56064095|NCT02652169|Teicoplanin|teicoplanin|mesh-list
56064096|NCT02652169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064097|NCT02652169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064098|NCT02478775|Cetrorelix|cetrorelix|mesh-list
56064099|NCT02478775|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56064100|NCT02478775|Fertility Agents|fertility agents|mesh-ancestor
56064101|NCT02478775|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56064102|NCT02478775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064103|NCT02478775|Hormone Antagonists|hormone antagonists|mesh-ancestor
56064108|NCT01783561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56064109|NCT01783561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064110|NCT01783561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56064111|NCT01783561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064112|NCT01783561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56064113|NCT01783561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56064114|NCT01783561|Purinergic Agents|purinergic agents|mesh-ancestor
56064115|NCT01783561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064117|NCT02452931|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56064118|NCT02452931|Fertility Agents|fertility agents|mesh-ancestor
56064119|NCT02452931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56064120|NCT02452931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064121|NCT02452931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56064122|NCT02452931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064123|NCT04744727|Acetaminophen|acetaminophen|mesh-list
56064124|NCT04744727|Meperidine|meperidine|mesh-list
56064125|NCT04744727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56064126|NCT04744727|Analgesics|analgesics|mesh-ancestor
56064127|NCT04744727|Sensory System Agents|sensory system agents|mesh-ancestor
56064131|NCT04744727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56064132|NCT04744727|Narcotics|narcotics|mesh-ancestor
56064133|NCT04744727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064134|NCT04744727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56064135|NCT02454179|Pembrolizumab|pembrolizumab|mesh-list
56064136|NCT02454179|Acalabrutinib|acalabrutinib|mesh-list
56064137|NCT02454179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064138|NCT02454179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064139|NCT02041533|Gemcitabine|gemcitabine|mesh-list
56064141|NCT02041533|Carboplatin|carboplatin|mesh-list
56064142|NCT02041533|Nivolumab|nivolumab|mesh-list
56064143|NCT02041533|Pemetrexed|pemetrexed|mesh-list
56064144|NCT02041533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56064145|NCT02041533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791317|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
56064146|NCT02041533|Tubulin Modulators|tubulin modulators|mesh-ancestor
56064147|NCT02041533|Antimitotic Agents|antimitotic agents|mesh-ancestor
56064148|NCT02041533|Mitosis Modulators|mitosis modulators|mesh-ancestor
56064149|NCT02041533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064150|NCT02041533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56064151|NCT02041533|Antimetabolites|antimetabolites|mesh-ancestor
56064152|NCT02041533|Antiviral Agents|antiviral agents|mesh-ancestor
56064153|NCT02041533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064154|NCT02041533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064155|NCT02041533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56064156|NCT02041533|Immunologic Factors|immunologic factors|mesh-ancestor
56064157|NCT02041533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064158|NCT02041533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064159|NCT02041533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56064160|NCT02041533|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56064161|NCT02041533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56064162|NCT02260531|Trastuzumab|trastuzumab|mesh-list
56064163|NCT02260531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064170|NCT02458235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064171|NCT02115997|Prednisone|prednisone|mesh-list
56064172|NCT02115997|Methylprednisolone|methylprednisolone|mesh-list
56064173|NCT02115997|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56064174|NCT02115997|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56064175|NCT02115997|Prednisolone|prednisolone|mesh-list
56064176|NCT02115997|Prednisolone acetate|prednisolone acetate|mesh-list
56064177|NCT02115997|Rituximab|rituximab|mesh-list
56064178|NCT02115997|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56064179|NCT02115997|Prednisolone phosphate|prednisolone phosphate|mesh-list
56064180|NCT02115997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064181|NCT02115997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064182|NCT02115997|Immunologic Factors|immunologic factors|mesh-ancestor
56064183|NCT02115997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064184|NCT02115997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56064185|NCT02115997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064186|NCT02115997|Glucocorticoids|glucocorticoids|mesh-ancestor
56064187|NCT02115997|Hormones|hormones|mesh-ancestor
56064188|NCT02115997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064189|NCT02115997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56064190|NCT02115997|Antiemetics|antiemetics|mesh-ancestor
56064191|NCT02115997|Autonomic Agents|autonomic agents|mesh-ancestor
56064192|NCT02115997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064193|NCT02115997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56064194|NCT02115997|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56064195|NCT02115997|Protective Agents|protective agents|mesh-ancestor
56064196|NCT01805323|Dexamethasone|dexamethasone|mesh-list
56064197|NCT01805323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064198|NCT01805323|Antiemetics|antiemetics|mesh-ancestor
56064199|NCT01805323|Autonomic Agents|autonomic agents|mesh-ancestor
56064200|NCT01805323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064201|NCT01805323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064202|NCT01805323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56064203|NCT01805323|Glucocorticoids|glucocorticoids|mesh-ancestor
56064204|NCT01805323|Hormones|hormones|mesh-ancestor
56064207|NCT01805323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064211|NCT01641055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064213|NCT01788631|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56064214|NCT01788631|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56064215|NCT01788631|Purinergic Agonists|purinergic agonists|mesh-ancestor
56064216|NCT01788631|Purinergic Agents|purinergic agents|mesh-ancestor
56064217|NCT01788631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064218|NCT01788631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064219|NCT01788631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064220|NCT00907283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56064221|NCT00907283|Deferiprone|deferiprone|mesh-list
56064222|NCT00907283|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56064223|NCT00907283|Chelating Agents|chelating agents|mesh-ancestor
56064224|NCT00907283|Sequestering Agents|sequestering agents|mesh-ancestor
56064225|NCT00907283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064226|NCT01789255|Cyclosporine|cyclosporine|mesh-list
56064227|NCT01789255|Methotrexate|methotrexate|mesh-list
56064228|NCT01789255|Vorinostat|vorinostat|mesh-list
56064229|NCT01789255|Tacrolimus|tacrolimus|mesh-list
56064230|NCT01789255|Cyclosporins|cyclosporins|mesh-list
56064231|NCT01789255|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56064232|NCT01789255|Abortifacient Agents|abortifacient agents|mesh-ancestor
56064233|NCT01789255|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56064234|NCT01789255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064235|NCT01789255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56064236|NCT01789255|Antimetabolites|antimetabolites|mesh-ancestor
56064237|NCT01789255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064238|NCT01789255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064239|NCT01789255|Dermatologic Agents|dermatologic agents|mesh-ancestor
56064240|NCT01789255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064241|NCT01789255|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56064242|NCT01789255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56064249|NCT01789255|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56064250|NCT02464163|Hemagglutinins|hemagglutinins|mesh-list
56064251|NCT02464163|Agglutinins|agglutinins|mesh-ancestor
56064252|NCT02464163|Immunologic Factors|immunologic factors|mesh-ancestor
56064253|NCT02464163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064254|NCT01808755|Trimethoprim|trimethoprim|mesh-list
56064255|NCT01808755|Sulfamethoxazole|sulfamethoxazole|mesh-list
56064256|NCT01808755|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56064257|NCT01808755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064258|NCT01808755|Renal Agents|renal agents|mesh-ancestor
56064259|NCT01808755|Antimalarials|antimalarials|mesh-ancestor
56064260|NCT01808755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56064261|NCT01808755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56064262|NCT01808755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56064263|NCT01808755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064264|NCT01808755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064265|NCT01808755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56064266|NCT01808755|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56064267|NCT01808755|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56064268|NCT02694809|Bazedoxifene|bazedoxifene|mesh-list
56064269|NCT02694809|Estrogens|estrogens|mesh-list
56064270|NCT02694809|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56064271|NCT02694809|Hormones|hormones|mesh-ancestor
56064272|NCT02694809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064273|NCT02694809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064274|NCT02694809|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56064275|NCT02694809|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56064276|NCT02694809|Hormone Antagonists|hormone antagonists|mesh-ancestor
56064278|NCT00568997|Pimecrolimus|pimecrolimus|mesh-list
56064293|NCT00362687|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56064294|NCT00362687|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55791466|NCT03042923|Mannitol|mannitol|mesh-list
56064295|NCT00362687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56064296|NCT00362687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064297|NCT00362687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064298|NCT00362687|Antiviral Agents|antiviral agents|mesh-ancestor
56064299|NCT00362687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064300|NCT00362687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56064301|NCT00362687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56064302|NCT01790659|Gentamicins|gentamicins|mesh-list
56064303|NCT01790659|Paromomycin|paromomycin|mesh-list
56064304|NCT01790659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064305|NCT01790659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064306|NCT01790659|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56064307|NCT01790659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064308|NCT01790659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064309|NCT01790659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56064310|NCT01790659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56064311|NCT00544115|Cyclosporine|cyclosporine|mesh-list
56064313|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
56064314|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
56064315|NCT00544115|Melphalan|melphalan|mesh-list
56064316|NCT00544115|Busulfan|busulfan|mesh-list
56064317|NCT00544115|Methotrexate|methotrexate|mesh-list
56064318|NCT00544115|Fludarabine|fludarabine|mesh-list
56064319|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
56064320|NCT00544115|Etoposide|etoposide|mesh-list
56064321|NCT00544115|Tacrolimus|tacrolimus|mesh-list
56064322|NCT00544115|Cyclosporins|cyclosporins|mesh-list
56064323|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56064324|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
56064325|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064326|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56064327|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56064328|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
56064332|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56064333|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
56064334|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56064335|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56064336|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
56064337|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
56064338|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064339|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56064340|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56064341|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56064342|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56064343|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56064344|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56064345|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
56064346|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064347|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56064348|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56064349|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
56064350|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064351|NCT02469701|Nivolumab|nivolumab|mesh-list
56064352|NCT02469701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064353|NCT02469701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064354|NCT02469701|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56064355|NCT02469701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064356|NCT01733953|Atorvastatin|atorvastatin|mesh-list
56064357|NCT01733953|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56064358|NCT01733953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56064359|NCT01733953|Antimetabolites|antimetabolites|mesh-ancestor
56064360|NCT01733953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064361|NCT01733953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56064374|NCT01736527|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56064375|NCT01736527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56064376|NCT01796665|Clindamycin|clindamycin|mesh-list
56064377|NCT01796665|Clindamycin palmitate|clindamycin palmitate|mesh-list
56064378|NCT01796665|Clindamycin phosphate|clindamycin phosphate|mesh-list
56064379|NCT01796665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56064380|NCT01796665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064381|NCT01796665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064382|NCT01796665|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56064383|NCT01796665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064384|NCT01796665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064385|NCT01796665|Dermatologic Agents|dermatologic agents|mesh-ancestor
56064386|NCT02586857|Acalabrutinib|acalabrutinib|mesh-list
56064387|NCT02586857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064388|NCT01798225|Doxycycline|doxycycline|mesh-list
56064389|NCT01798225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064390|NCT01798225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064391|NCT01798225|Antimalarials|antimalarials|mesh-ancestor
56064393|NCT01798225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56064434|NCT02471651|Aflibercept|aflibercept|mesh-list
56064435|NCT02471651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064436|NCT02471651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56064437|NCT02471651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56064438|NCT02471651|Growth Substances|growth substances|mesh-ancestor
56064439|NCT02471651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064441|NCT02471651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064442|NCT02471651|Antiemetics|antiemetics|mesh-ancestor
56064443|NCT02471651|Autonomic Agents|autonomic agents|mesh-ancestor
56064444|NCT02471651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064445|NCT02471651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56064446|NCT02471651|Glucocorticoids|glucocorticoids|mesh-ancestor
56064447|NCT02471651|Hormones|hormones|mesh-ancestor
56064448|NCT02471651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064449|NCT02471651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56064450|NCT02477423|Gentamicins|gentamicins|mesh-list
56064451|NCT02477423|Ampicillin|ampicillin|mesh-list
56064452|NCT02477423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064453|NCT02477423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064454|NCT02477423|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56064455|NCT02477423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064456|NCT02477423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064457|NCT00363701|Esomeprazole|esomeprazole|mesh-list
56064458|NCT00363701|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56064459|NCT00363701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56064460|NCT00363701|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56064461|NCT00363701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064462|NCT00363701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064463|NCT04744571|Aspirin|aspirin|mesh-list
56064464|NCT04744571|Metoprolol|metoprolol|mesh-list
56064465|NCT04744571|Clopidogrel|clopidogrel|mesh-list
56064466|NCT04744571|Ticagrelor|ticagrelor|mesh-list
56064467|NCT04744571|Atorvastatin|atorvastatin|mesh-list
56064477|NCT04744571|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56064478|NCT04744571|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56064479|NCT04744571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064480|NCT04744571|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56064481|NCT04744571|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56064482|NCT04744571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064483|NCT04744571|Antipyretics|antipyretics|mesh-ancestor
56064484|NCT04744571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56064485|NCT04744571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56064486|NCT04744571|Antimetabolites|antimetabolites|mesh-ancestor
56064487|NCT04744571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56064488|NCT04744571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56064489|NCT04744571|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56064490|NCT04744571|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56064491|NCT04744571|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56064493|NCT04744571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064494|NCT04744571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56064495|NCT04744571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56064497|NCT04744571|Autonomic Agents|autonomic agents|mesh-ancestor
56064498|NCT04744571|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56064499|NCT04744571|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56064500|NCT04744571|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56064501|NCT04744571|Adrenergic Agents|adrenergic agents|mesh-ancestor
56064502|NCT00363155|KRN 7000|krn 7000|mesh-list
56064503|NCT00363155|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56064504|NCT00363155|Immunologic Factors|immunologic factors|mesh-ancestor
56064505|NCT00363155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064506|NCT00363155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064507|NCT02519387|Buprenorphine|buprenorphine|mesh-list
56064508|NCT02519387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56064509|NCT02519387|Narcotics|narcotics|mesh-ancestor
56064515|NCT02519387|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56064516|NCT02257957|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56064517|NCT02257957|Hyaluronic Acid|hyaluronic acid|mesh-list
56064518|NCT02257957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56064519|NCT02257957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56064520|NCT02257957|Immunologic Factors|immunologic factors|mesh-ancestor
56064521|NCT02257957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064522|NCT02257957|Viscosupplements|viscosupplements|mesh-ancestor
56064523|NCT02257957|Protective Agents|protective agents|mesh-ancestor
56064524|NCT02524769|Estrogens|estrogens|mesh-list
56064525|NCT02524769|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56064526|NCT02524769|Hormones|hormones|mesh-ancestor
56064527|NCT02524769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064528|NCT02524769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064530|NCT02525549|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56064531|NCT02525549|Dermatologic Agents|dermatologic agents|mesh-ancestor
56064532|NCT02525549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56064533|NCT02525549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56064535|NCT02525549|Sensory System Agents|sensory system agents|mesh-ancestor
56064536|NCT02525549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064537|NCT02525549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064538|NCT02525549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064539|NCT02525549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56064540|NCT01878799|Sofosbuvir|sofosbuvir|mesh-list
56064541|NCT01878799|Ledipasvir|ledipasvir|mesh-list
56064542|NCT01878799|Antiviral Agents|antiviral agents|mesh-ancestor
56064543|NCT01878799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064544|NCT02527265|Insulin|insulin|mesh-list
56064545|NCT02527265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56064546|NCT02527265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064547|NCT01879345|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56064548|NCT01879345|Anticonvulsants|anticonvulsants|mesh-ancestor
56064549|NCT01879345|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56064550|NCT01879345|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56064551|NCT01879345|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56064553|NCT01804075|Morphine|morphine|mesh-list
56064555|NCT01804075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56064556|NCT01804075|Narcotics|narcotics|mesh-ancestor
56064557|NCT01804075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064558|NCT01804075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064559|NCT01804075|Analgesics|analgesics|mesh-ancestor
56064560|NCT01804075|Sensory System Agents|sensory system agents|mesh-ancestor
56064561|NCT01804075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064562|NCT01804075|Antitussive Agents|antitussive agents|mesh-ancestor
56064563|NCT01804075|Respiratory System Agents|respiratory system agents|mesh-ancestor
56064564|NCT02416193|Vitamin D|vitamin d|mesh-list
56064565|NCT02416193|Ergocalciferols|ergocalciferols|mesh-list
56064566|NCT02416193|Cholecalciferol|cholecalciferol|mesh-list
56064567|NCT02416193|Vitamins|vitamins|mesh-list
56064568|NCT02416193|Micronutrients|micronutrients|mesh-ancestor
56064569|NCT02416193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064570|NCT02416193|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56064571|NCT02416193|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56064572|NCT02530151|Clonidine|clonidine|mesh-list
56064573|NCT02530151|Morphine|morphine|mesh-list
56064574|NCT02530151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56064575|NCT02530151|Narcotics|narcotics|mesh-ancestor
56064576|NCT02530151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064577|NCT02530151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064578|NCT02530151|Analgesics|analgesics|mesh-ancestor
56064579|NCT02530151|Sensory System Agents|sensory system agents|mesh-ancestor
56064580|NCT02530151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064581|NCT02530151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56064582|NCT02530151|Sympatholytics|sympatholytics|mesh-ancestor
56064583|NCT02530151|Autonomic Agents|autonomic agents|mesh-ancestor
56064584|NCT02530151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56064585|NCT02530151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56064586|NCT02530151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56064599|NCT01804465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56064600|NCT01804465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064601|NCT02531321|Levonorgestrel|levonorgestrel|mesh-list
56064602|NCT02531321|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56064603|NCT02531321|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56064604|NCT02531321|Estradiol|estradiol|mesh-list
56064605|NCT02531321|Estrogens|estrogens|mesh-ancestor
56064606|NCT02531321|Hormones|hormones|mesh-ancestor
56064607|NCT02531321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064608|NCT02531321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064609|NCT02531321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56064610|NCT02531321|Contraceptive Agents|contraceptive agents|mesh-ancestor
56064611|NCT02531321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56064612|NCT02531321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56064613|NCT02531321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56064614|NCT02531321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56064615|NCT02531321|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56064616|NCT02531321|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56064617|NCT01805089|Melatonin|melatonin|mesh-list
56064618|NCT01805089|Antioxidants|antioxidants|mesh-ancestor
56064619|NCT01805089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064620|NCT01805089|Protective Agents|protective agents|mesh-ancestor
56064621|NCT01805089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064622|NCT01805089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064623|NCT02417129|Rituximab|rituximab|mesh-list
56064624|NCT02417129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064645|NCT02419547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064646|NCT02419547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064647|NCT02419547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56064648|NCT02419547|Anesthetics, General|anesthetics, general|mesh-ancestor
56064651|NCT02419547|Narcotics|narcotics|mesh-ancestor
56064652|NCT02419547|Analgesics|analgesics|mesh-ancestor
56064653|NCT02419547|Sensory System Agents|sensory system agents|mesh-ancestor
56064654|NCT02419547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064655|NCT02419547|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56064656|NCT02419547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56064657|NCT02419547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56064658|NCT02419547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56064659|NCT02419547|GABA Modulators|gaba modulators|mesh-ancestor
56064660|NCT02419547|GABA Agents|gaba agents|mesh-ancestor
56064661|NCT02419547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064662|NCT02419547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064663|NCT02419547|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56064664|NCT02419547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56064665|NCT02533427|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56064666|NCT02533427|Norgestimate|norgestimate|mesh-list
56064667|NCT02533427|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56064668|NCT02533427|Estradiol|estradiol|mesh-list
56064669|NCT02533427|Estrogens|estrogens|mesh-ancestor
56064670|NCT02533427|Hormones|hormones|mesh-ancestor
56064671|NCT02533427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064672|NCT02533427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064673|NCT02533427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56064674|NCT02533427|Contraceptive Agents|contraceptive agents|mesh-ancestor
56064675|NCT02533427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56064686|NCT05328427|Cariostatic Agents|cariostatic agents|mesh-ancestor
56064687|NCT05328427|Protective Agents|protective agents|mesh-ancestor
56064688|NCT05328427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064690|NCT02533505|Formoterol Fumarate|formoterol fumarate|mesh-list
56064691|NCT02533505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064692|NCT02533505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56064693|NCT02533505|Autonomic Agents|autonomic agents|mesh-ancestor
56064694|NCT02533505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064695|NCT02533505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064696|NCT02533505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56064697|NCT02533505|Respiratory System Agents|respiratory system agents|mesh-ancestor
56064698|NCT02533505|Glucocorticoids|glucocorticoids|mesh-ancestor
56064699|NCT02533505|Hormones|hormones|mesh-ancestor
56064700|NCT02533505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064701|NCT02533505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56064702|NCT02533505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56064703|NCT02533505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56064704|NCT02533505|Adrenergic Agents|adrenergic agents|mesh-ancestor
56064705|NCT02533505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064706|NCT02533505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064707|NCT04341545|Letrozole|letrozole|mesh-list
56064708|NCT04341545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064709|NCT04341545|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56064710|NCT04341545|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56064711|NCT04341545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064732|NCT02420015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56064733|NCT02420015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56064734|NCT02420015|Dopamine Agents|dopamine agents|mesh-ancestor
56064735|NCT02420015|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56064736|NCT02420015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56064737|NCT02420015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064738|NCT05326867|Lidocaine|lidocaine|mesh-list
56064739|NCT05326867|Anesthetics, Local|anesthetics, local|mesh-ancestor
56064740|NCT05326867|Anesthetics|anesthetics|mesh-ancestor
56064741|NCT05326867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064742|NCT05326867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064743|NCT05326867|Sensory System Agents|sensory system agents|mesh-ancestor
56064744|NCT05326867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064745|NCT05326867|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56064746|NCT05326867|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56064747|NCT05326867|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56064748|NCT05326867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56064749|NCT05326867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791922|NCT04836143|Mitogens|mitogens|mesh-list
56064751|NCT05324995|Epinephrine|epinephrine|mesh-list
56064752|NCT05324995|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56064753|NCT05324995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56064754|NCT05324995|Adrenergic Agents|adrenergic agents|mesh-ancestor
56064755|NCT05324995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064756|NCT05324995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064757|NCT05324995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064758|NCT05324995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56064759|NCT05324995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56064760|NCT05324995|Autonomic Agents|autonomic agents|mesh-ancestor
56064761|NCT05324995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064762|NCT05324995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56064763|NCT05324995|Respiratory System Agents|respiratory system agents|mesh-ancestor
56064771|NCT05324995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064772|NCT05324995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56064773|NCT05324995|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56064774|NCT05324995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56064775|NCT05324995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064776|NCT05318521|Ibuprofen|ibuprofen|mesh-list
56064777|NCT05318521|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56064778|NCT05318521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56064779|NCT05318521|Analgesics|analgesics|mesh-ancestor
56064780|NCT05318521|Sensory System Agents|sensory system agents|mesh-ancestor
56064781|NCT05318521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064782|NCT05318521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064783|NCT05318521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064784|NCT05318521|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56064785|NCT05318521|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56064786|NCT05318521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064787|NCT05318521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064788|NCT02420873|Maytansine|maytansine|mesh-list
56064789|NCT02420873|Lorvotuzumab mertansine|lorvotuzumab mertansine|mesh-list
56064790|NCT02420873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56064791|NCT02420873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064792|NCT02420873|Tubulin Modulators|tubulin modulators|mesh-ancestor
56064793|NCT02420873|Antimitotic Agents|antimitotic agents|mesh-ancestor
56064794|NCT02420873|Mitosis Modulators|mitosis modulators|mesh-ancestor
56064821|NCT02535611|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56064822|NCT02535611|Dopamine Agents|dopamine agents|mesh-ancestor
56064823|NCT02535611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791999|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
56064824|NCT02535611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064825|NCT02535611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064826|NCT02535611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56064827|NCT02535611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56064828|NCT01823497|Morphine|morphine|mesh-list
56064829|NCT01823497|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56064830|NCT01823497|Narcotics|narcotics|mesh-ancestor
56064831|NCT01823497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064832|NCT01823497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064833|NCT01823497|Analgesics|analgesics|mesh-ancestor
56064834|NCT01823497|Sensory System Agents|sensory system agents|mesh-ancestor
56064835|NCT01823497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064836|NCT00363935|Dexmedetomidine|dexmedetomidine|mesh-list
56064837|NCT00363935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56064838|NCT00363935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064839|NCT00363935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064858|NCT02537873|Cocaine|cocaine|mesh-list
56064869|NCT02537873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064870|NCT02537873|Dopamine Agents|dopamine agents|mesh-ancestor
56064871|NCT02537873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56064872|NCT02537951|Lidocaine|lidocaine|mesh-list
56064873|NCT02537951|Prilocaine|prilocaine|mesh-list
56064874|NCT02537951|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56064875|NCT02537951|Capsaicin|capsaicin|mesh-list
56064876|NCT02537951|Anesthetics, Local|anesthetics, local|mesh-ancestor
56064877|NCT02537951|Anesthetics|anesthetics|mesh-ancestor
56064878|NCT02537951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064879|NCT02537951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064880|NCT02537951|Sensory System Agents|sensory system agents|mesh-ancestor
56064881|NCT02537951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064882|NCT02537951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56064883|NCT02537951|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56064884|NCT02537951|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56064885|NCT02537951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56064886|NCT02537951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064887|NCT02537951|Antipruritics|antipruritics|mesh-ancestor
56064888|NCT02537951|Dermatologic Agents|dermatologic agents|mesh-ancestor
56064889|NCT02537951|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56064890|NCT02487485|Sirolimus|sirolimus|mesh-list
56064891|NCT02487485|Ketamine|ketamine|mesh-list
56064892|NCT02487485|Analgesics|analgesics|mesh-ancestor
56064893|NCT02487485|Sensory System Agents|sensory system agents|mesh-ancestor
56064894|NCT02487485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064895|NCT02487485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064896|NCT02487485|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56064897|NCT02487485|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56064899|NCT02487485|Anesthetics|anesthetics|mesh-ancestor
56064900|NCT02487485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064912|NCT02487563|Decitabine|decitabine|mesh-list
56064913|NCT02487563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56064914|NCT02487563|Antimetabolites|antimetabolites|mesh-ancestor
56064915|NCT02487563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56064916|NCT02487563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064917|NCT02487563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56064918|NCT02427737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56064919|NCT02427737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56064920|NCT02427737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064922|NCT02489357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56064923|NCT02489357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064924|NCT02490293|Cephalosporins|cephalosporins|mesh-list
56064925|NCT02490293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064926|NCT02490293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064927|NCT02539511|Ketamine|ketamine|mesh-list
56064928|NCT02539511|Analgesics|analgesics|mesh-ancestor
56064929|NCT02539511|Sensory System Agents|sensory system agents|mesh-ancestor
56064930|NCT02539511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064931|NCT02539511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56064932|NCT02539511|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56064941|NCT02493257|Ethanol|ethanol|mesh-list
56064964|NCT02545907|Thalidomide|thalidomide|mesh-list
56064965|NCT02545907|Dexamethasone|dexamethasone|mesh-list
56064966|NCT02545907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56064967|NCT02545907|Antiemetics|antiemetics|mesh-ancestor
56064968|NCT02545907|Autonomic Agents|autonomic agents|mesh-ancestor
56064969|NCT02545907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56064970|NCT02545907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792146|NCT05062681|Prednisolone|prednisolone|mesh-list
56064971|NCT02545907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56064973|NCT02545907|Hormones|hormones|mesh-ancestor
56064974|NCT02545907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56064975|NCT02545907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56064976|NCT02545907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56064977|NCT02545907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56064978|NCT02545907|Immunologic Factors|immunologic factors|mesh-ancestor
56064979|NCT02545907|Leprostatic Agents|leprostatic agents|mesh-ancestor
56064980|NCT02545907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56064981|NCT02545907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56064982|NCT02545907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56065020|NCT02547779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56065021|NCT00559585|Abatacept|abatacept|mesh-list
56065022|NCT00559585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56065023|NCT00559585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065024|NCT00559585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065025|NCT00559585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56065026|NCT00559585|Immunologic Factors|immunologic factors|mesh-ancestor
56065027|NCT00559585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065028|NCT00559585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56065030|NCT01824901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065031|NCT01824901|Tubulin Modulators|tubulin modulators|mesh-ancestor
56065032|NCT01824901|Antimitotic Agents|antimitotic agents|mesh-ancestor
56065033|NCT01824901|Mitosis Modulators|mitosis modulators|mesh-ancestor
56065034|NCT01824901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065035|NCT00559507|Saracatinib|saracatinib|mesh-list
56065036|NCT00559507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065037|NCT00559507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065038|NCT00559507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065039|NCT04969627|Metformin|metformin|mesh-list
56065040|NCT04969627|Exenatide|exenatide|mesh-list
56065041|NCT04969627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56065042|NCT04969627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065046|NCT04969627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065048|NCT04953325|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56065049|NCT04953325|Immunologic Factors|immunologic factors|mesh-ancestor
56065051|NCT01826851|Bupivacaine|bupivacaine|mesh-list
56065064|NCT02499497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065065|NCT01827475|Acetaminophen|acetaminophen|mesh-list
56065066|NCT01827475|Ibuprofen|ibuprofen|mesh-list
56065067|NCT01827475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065069|NCT01827475|Sensory System Agents|sensory system agents|mesh-ancestor
56065070|NCT01827475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065071|NCT01827475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065072|NCT01827475|Antipyretics|antipyretics|mesh-ancestor
56065073|NCT01827475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56065074|NCT01827475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065075|NCT01827475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56065076|NCT01827475|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56065077|NCT01827475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065078|NCT01827475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065079|NCT02434523|Amitriptyline|amitriptyline|mesh-list
56065080|NCT02434523|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56065081|NCT02434523|Antidepressive Agents|antidepressive agents|mesh-ancestor
56065082|NCT02434523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56065083|NCT02434523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065084|NCT02434523|Analgesics|analgesics|mesh-ancestor
56065085|NCT02434523|Sensory System Agents|sensory system agents|mesh-ancestor
56065115|NCT01829503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065116|NCT01829503|Antiviral Agents|antiviral agents|mesh-ancestor
56065117|NCT01829503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065118|NCT01829503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56065119|NCT01829503|Immunologic Factors|immunologic factors|mesh-ancestor
56065120|NCT01829503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065121|NCT01829503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065122|NCT04654507|Dexamethasone|dexamethasone|mesh-list
56065123|NCT04654507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065124|NCT04654507|Antiemetics|antiemetics|mesh-ancestor
56065125|NCT04654507|Autonomic Agents|autonomic agents|mesh-ancestor
56065126|NCT04654507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065127|NCT04654507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065128|NCT04654507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56065129|NCT04654507|Glucocorticoids|glucocorticoids|mesh-ancestor
56065130|NCT04654507|Hormones|hormones|mesh-ancestor
56065131|NCT04654507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065132|NCT04654507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56065133|NCT04654507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065134|NCT05742763|Acetaminophen|acetaminophen|mesh-list
56065135|NCT05742763|Ibuprofen|ibuprofen|mesh-list
56065136|NCT05742763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065137|NCT05742763|Analgesics|analgesics|mesh-ancestor
56065138|NCT05742763|Sensory System Agents|sensory system agents|mesh-ancestor
56065139|NCT05742763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065140|NCT05742763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065141|NCT05742763|Antipyretics|antipyretics|mesh-ancestor
56065142|NCT05742763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56065143|NCT05742763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065144|NCT05742763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56065160|NCT02504723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56065162|NCT02504723|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56065163|NCT02504723|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56065164|NCT02439281|Clonidine|clonidine|mesh-list
56065165|NCT02439281|Ropivacaine|ropivacaine|mesh-list
56065166|NCT02439281|Anesthetics, Local|anesthetics, local|mesh-ancestor
56065167|NCT02439281|Anesthetics|anesthetics|mesh-ancestor
56065168|NCT02439281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065169|NCT02439281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065170|NCT02439281|Sensory System Agents|sensory system agents|mesh-ancestor
56065171|NCT02439281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065172|NCT02439281|Analgesics|analgesics|mesh-ancestor
56065173|NCT02439281|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56065174|NCT02439281|Sympatholytics|sympatholytics|mesh-ancestor
56065176|NCT02439281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56065177|NCT02439281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56065178|NCT02439281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56065179|NCT02439281|Adrenergic Agents|adrenergic agents|mesh-ancestor
56065180|NCT02439281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065181|NCT02439281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065187|NCT02505269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56065188|NCT02505269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065189|NCT02505269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56065190|NCT02505269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56065191|NCT02505269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065192|NCT02505269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065201|NCT00422123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065202|NCT00422123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065204|NCT00559273|Hematinics|hematinics|mesh-ancestor
56065206|NCT02506673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56065207|NCT02506673|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56065208|NCT02506673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065209|NCT02506673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065210|NCT02506673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56065211|NCT02506673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56065212|NCT02506673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56065213|NCT02506673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56065214|NCT02506673|Anesthetics, General|anesthetics, general|mesh-ancestor
56065215|NCT02506673|Anesthetics|anesthetics|mesh-ancestor
56065216|NCT02506673|GABA Modulators|gaba modulators|mesh-ancestor
56065217|NCT02506673|GABA Agents|gaba agents|mesh-ancestor
56065218|NCT02506673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065219|NCT02506673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065220|NCT02508077|Calcium, Dietary|calcium, dietary|mesh-list
56065221|NCT02508077|Leucovorin|leucovorin|mesh-list
56065222|NCT02508077|Folic Acid|folic acid|mesh-list
56065223|NCT02508077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56065224|NCT02508077|Panitumumab|panitumumab|mesh-list
56065225|NCT02508077|Fluorouracil|fluorouracil|mesh-list
56065226|NCT02508077|Irinotecan|irinotecan|mesh-list
56065227|NCT02508077|Camptothecin|camptothecin|mesh-list
56065228|NCT02508077|Antibodies|antibodies|mesh-list
56065229|NCT02508077|Immunoglobulins|immunoglobulins|mesh-list
56065230|NCT02508077|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56065231|NCT02508077|Calcium|calcium|mesh-list
56065232|NCT02508077|Levoleucovorin|levoleucovorin|mesh-list
56065233|NCT02508077|Immunologic Factors|immunologic factors|mesh-ancestor
56065234|NCT02508077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065235|NCT02508077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065236|NCT02508077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56065237|NCT02508077|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56065244|NCT02508077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065245|NCT02508077|Antidotes|antidotes|mesh-ancestor
56065246|NCT02508077|Protective Agents|protective agents|mesh-ancestor
56065247|NCT02508077|Vitamin B Complex|vitamin b complex|mesh-ancestor
56065249|NCT02508077|Micronutrients|micronutrients|mesh-ancestor
56065250|NCT02508077|Hematinics|hematinics|mesh-ancestor
56065251|NCT02508077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56065252|NCT04550377|Cannabidiol|cannabidiol|mesh-list
56065253|NCT04550377|Anticonvulsants|anticonvulsants|mesh-ancestor
56065254|NCT00558259|Dabigatran|dabigatran|mesh-list
56065255|NCT00558259|Antithrombins|antithrombins|mesh-ancestor
56065256|NCT00558259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56065257|NCT00558259|Protease Inhibitors|protease inhibitors|mesh-ancestor
56065258|NCT00558259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065259|NCT00558259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065260|NCT00558259|Anticoagulants|anticoagulants|mesh-ancestor
56065261|NCT02508389|Avasopasem manganese|avasopasem manganese|mesh-list
56065262|NCT02508389|Antioxidants|antioxidants|mesh-ancestor
56065263|NCT02508389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065264|NCT02508389|Protective Agents|protective agents|mesh-ancestor
56065265|NCT02508389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065266|NCT02509481|Ivermectin|ivermectin|mesh-list
56065267|NCT02509481|Albendazole|albendazole|mesh-list
56065268|NCT02509481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56065269|NCT02509481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065270|NCT02509481|Anthelmintics|anthelmintics|mesh-ancestor
55792450|NCT03096457|Paromomycin|paromomycin|mesh-list
56065271|NCT02509481|Anticestodal Agents|anticestodal agents|mesh-ancestor
56065272|NCT02509481|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56065273|NCT02509481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56065280|NCT02561897|Edoxaban|edoxaban|mesh-list
56065291|NCT02512679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065292|NCT02512679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56065293|NCT02512679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56065294|NCT02512679|Alkylating Agents|alkylating agents|mesh-ancestor
56065295|NCT02512679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065296|NCT02512679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065297|NCT02512679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56065298|NCT02562521|Nicotine|nicotine|mesh-list
56065299|NCT02562521|Varenicline|varenicline|mesh-list
56065300|NCT02562521|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56065301|NCT02562521|Autonomic Agents|autonomic agents|mesh-ancestor
56065302|NCT02562521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065303|NCT02562521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065304|NCT02562521|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56065305|NCT02562521|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56065306|NCT02562521|Cholinergic Agents|cholinergic agents|mesh-ancestor
56065307|NCT02562521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065308|NCT02562521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065309|NCT02562755|Sorafenib|sorafenib|mesh-list
56065310|NCT02562755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065311|NCT02562755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56065312|NCT02562755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065313|NCT02562755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065314|NCT05446883|Paclitaxel|paclitaxel|mesh-list
56065315|NCT05446883|Carboplatin|carboplatin|mesh-list
56065316|NCT05446883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56065317|NCT05446883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065338|NCT00558103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065339|NCT02974361|Ibuprofen|ibuprofen|mesh-list
56065340|NCT02974361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56065341|NCT02974361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065342|NCT02974361|Analgesics|analgesics|mesh-ancestor
56065343|NCT02974361|Sensory System Agents|sensory system agents|mesh-ancestor
56065344|NCT02974361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065345|NCT02974361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065346|NCT02974361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792528|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
56065348|NCT02974361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56065349|NCT02974361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065350|NCT02974361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065351|NCT05690815|Tenofovir|tenofovir|mesh-list
56065352|NCT05690815|Emtricitabine|emtricitabine|mesh-list
56065353|NCT05690815|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
56065354|NCT05690815|Antiviral Agents|antiviral agents|mesh-ancestor
56065355|NCT05690815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065356|NCT05690815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56065357|NCT05690815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56065358|NCT05690815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065360|NCT05690815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56065390|NCT04218773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065391|NCT04218773|Sympathomimetics|sympathomimetics|mesh-ancestor
56065392|NCT04218773|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56065393|NCT04218773|Nasal Decongestants|nasal decongestants|mesh-ancestor
56065394|NCT04218773|Respiratory System Agents|respiratory system agents|mesh-ancestor
56065395|NCT04218773|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56065396|NCT04218773|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56065397|NCT04218773|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56065398|NCT04218773|Adrenergic Agents|adrenergic agents|mesh-ancestor
56065399|NCT04218773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065400|NCT04218773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065401|NCT04218773|Protective Agents|protective agents|mesh-ancestor
56065403|NCT00558025|Antioxidants|antioxidants|mesh-ancestor
56065404|NCT00558025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065405|NCT00558025|Protective Agents|protective agents|mesh-ancestor
56065406|NCT00558025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065407|NCT00558025|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56065408|NCT00558025|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56065409|NCT00558025|Dopamine Agonists|dopamine agonists|mesh-ancestor
56065410|NCT00558025|Dopamine Agents|dopamine agents|mesh-ancestor
56065411|NCT00558025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065412|NCT02576249|Methylprednisolone|methylprednisolone|mesh-list
56065413|NCT02576249|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56065414|NCT02576249|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56065415|NCT02576249|Prednisolone|prednisolone|mesh-list
56065416|NCT02576249|Prednisolone acetate|prednisolone acetate|mesh-list
56065417|NCT02576249|Ropivacaine|ropivacaine|mesh-list
56065418|NCT02576249|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56065419|NCT02576249|Prednisolone phosphate|prednisolone phosphate|mesh-list
56065435|NCT02576249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56065436|NCT02576249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065437|NCT03868657|Moxifloxacin|moxifloxacin|mesh-list
56065438|NCT03868657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56065439|NCT03868657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065440|NCT03868657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56065441|NCT03868657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56065442|NCT03868657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065443|NCT03868657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065444|NCT03868657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065446|NCT01834261|Oxytocics|oxytocics|mesh-ancestor
56065447|NCT01834261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56065448|NCT01834261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065449|NCT02578901|Tranexamic Acid|tranexamic acid|mesh-list
56065450|NCT02578901|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56065451|NCT02578901|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56065452|NCT02578901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065453|NCT02578901|Hemostatics|hemostatics|mesh-ancestor
56065454|NCT02578901|Coagulants|coagulants|mesh-ancestor
56065455|NCT02579057|Furosemide|furosemide|mesh-list
56065456|NCT02579057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56065457|NCT02579057|Diuretics|diuretics|mesh-ancestor
56065458|NCT02579057|Natriuretic Agents|natriuretic agents|mesh-ancestor
56065459|NCT02579057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065460|NCT02579057|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56065461|NCT02579057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56065463|NCT00557245|Tenofovir|tenofovir|mesh-list
56065480|NCT04743011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56065481|NCT04743011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56065482|NCT04743011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065483|NCT03528941|Lamivudine|lamivudine|mesh-list
56065484|NCT03528941|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56065485|NCT03528941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56065486|NCT03528941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065487|NCT03528941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065488|NCT03528941|Antiviral Agents|antiviral agents|mesh-ancestor
56065489|NCT03528941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065490|NCT03528941|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56065491|NCT03528941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56065492|NCT01836133|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56065493|NCT01836133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065494|NCT01836133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56065495|NCT01836133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065496|NCT01836133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065497|NCT00365183|Pemetrexed|pemetrexed|mesh-list
56065498|NCT00365183|Motexafin gadolinium|motexafin gadolinium|mesh-list
56065499|NCT00365183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065500|NCT00365183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065501|NCT00365183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065502|NCT00365183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56065503|NCT00365183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56065504|NCT00365183|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56065505|NCT00365183|Dermatologic Agents|dermatologic agents|mesh-ancestor
56065506|NCT03422861|Nabilone|nabilone|mesh-list
56065507|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
56065508|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
56065524|NCT01837069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56065525|NCT01837069|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56065526|NCT01837069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065527|NCT01837069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56065528|NCT01837069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56065529|NCT01837069|Sympatholytics|sympatholytics|mesh-ancestor
56065530|NCT01837069|Autonomic Agents|autonomic agents|mesh-ancestor
56065531|NCT01837069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065532|NCT01837069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065533|NCT01837069|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56065534|NCT01837069|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56065535|NCT01837069|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56065537|NCT01837069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065538|NCT01837069|Protease Inhibitors|protease inhibitors|mesh-ancestor
56065539|NCT01837069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56065540|NCT01837069|Protective Agents|protective agents|mesh-ancestor
56065542|NCT00555061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56065543|NCT00555061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065544|NCT02289690|Carboplatin|carboplatin|mesh-list
56065546|NCT02289690|Veliparib|veliparib|mesh-list
56065547|NCT02289690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065653|NCT02274792|Analgesics|analgesics|mesh-ancestor
56065548|NCT02289690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56065549|NCT02289690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56065550|NCT02289690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56065551|NCT02289690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065552|NCT02289690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065553|NCT02289690|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56065554|NCT02268955|Ibuprofen|ibuprofen|mesh-list
56065555|NCT02268955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56065556|NCT02268955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065557|NCT02268955|Analgesics|analgesics|mesh-ancestor
56065558|NCT02268955|Sensory System Agents|sensory system agents|mesh-ancestor
56065559|NCT02268955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065561|NCT02268955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065562|NCT02268955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56065563|NCT02268955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56065564|NCT02268955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065565|NCT02268955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065566|NCT02585843|Spironolactone|spironolactone|mesh-list
56065567|NCT02585843|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56065568|NCT02585843|Hormone Antagonists|hormone antagonists|mesh-ancestor
56065569|NCT02585843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065571|NCT02585843|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56065572|NCT02585843|Diuretics|diuretics|mesh-ancestor
56065573|NCT02585843|Natriuretic Agents|natriuretic agents|mesh-ancestor
56065574|NCT01838317|Pioglitazone|pioglitazone|mesh-list
56065575|NCT01838317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56065576|NCT01838317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065577|NCT05249231|Fluorides|fluorides|mesh-list
56065578|NCT05249231|Cariostatic Agents|cariostatic agents|mesh-ancestor
56065579|NCT05249231|Protective Agents|protective agents|mesh-ancestor
56065580|NCT05249231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065581|NCT05249153|Sufentanil|sufentanil|mesh-list
56065582|NCT05249153|Dexmedetomidine|dexmedetomidine|mesh-list
56065584|NCT05249153|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56065585|NCT05249153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065586|NCT05249153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065589|NCT05249153|Sensory System Agents|sensory system agents|mesh-ancestor
56065590|NCT05249153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065598|NCT05249153|Narcotics|narcotics|mesh-ancestor
56065608|NCT02961257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065609|NCT02961257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065610|NCT02961257|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56065611|NCT02961257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065612|NCT02961257|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56065613|NCT02961257|Immunologic Factors|immunologic factors|mesh-ancestor
56065614|NCT02271217|4-Aminopyridine|4-aminopyridine|mesh-list
56065615|NCT02271217|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56065616|NCT02271217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56065617|NCT02271217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065618|NCT02989519|Progesterone|progesterone|mesh-list
56065619|NCT02989519|Dydrogesterone|dydrogesterone|mesh-list
56065620|NCT02989519|Progestins|progestins|mesh-ancestor
56065621|NCT02989519|Hormones|hormones|mesh-ancestor
56065622|NCT02989519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065623|NCT02989519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065624|NCT02429375|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56065625|NCT02429375|Mocetinostat|mocetinostat|mesh-list
56065626|NCT02429375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56065627|NCT02429375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065628|NCT02429375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56065629|NCT02429375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065630|NCT02429375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065631|NCT02289456|Paclitaxel|paclitaxel|mesh-list
56065632|NCT02289456|Carboplatin|carboplatin|mesh-list
56065633|NCT02289456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56065634|NCT02289456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065635|NCT02289456|Tubulin Modulators|tubulin modulators|mesh-ancestor
56065636|NCT02289456|Antimitotic Agents|antimitotic agents|mesh-ancestor
56065637|NCT02289456|Mitosis Modulators|mitosis modulators|mesh-ancestor
56065649|NCT02274948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065650|NCT02274792|Etanercept|etanercept|mesh-list
56065651|NCT02274792|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56065652|NCT02274792|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065654|NCT02274792|Sensory System Agents|sensory system agents|mesh-ancestor
56065655|NCT02274792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065656|NCT02274792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065657|NCT02274792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065658|NCT02274792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56065659|NCT02274792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56065660|NCT02274792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56065662|NCT05432466|Celiprolol|celiprolol|mesh-list
56065663|NCT05432466|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56065664|NCT05432466|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56065665|NCT05432466|Sympathomimetics|sympathomimetics|mesh-ancestor
56065666|NCT05432466|Autonomic Agents|autonomic agents|mesh-ancestor
56065667|NCT05432466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065668|NCT05432466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065669|NCT05432466|Vasodilator Agents|vasodilator agents|mesh-ancestor
56065670|NCT05432466|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56065671|NCT05432466|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56065672|NCT05432466|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56065673|NCT05432466|Adrenergic Agents|adrenergic agents|mesh-ancestor
56065674|NCT05432466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065675|NCT05432466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065676|NCT02592629|Triamcinolone|triamcinolone|mesh-list
56065677|NCT02592629|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56065678|NCT02592629|Lidocaine|lidocaine|mesh-list
56065679|NCT02592629|Ethyl Chloride|ethyl chloride|mesh-list
56065680|NCT02592629|Anesthetics, Local|anesthetics, local|mesh-ancestor
56065681|NCT02592629|Anesthetics|anesthetics|mesh-ancestor
56065682|NCT02592629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065683|NCT02592629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065684|NCT02592629|Sensory System Agents|sensory system agents|mesh-ancestor
56065685|NCT02592629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065687|NCT02592629|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56065688|NCT02592629|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56065689|NCT02592629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56065690|NCT02592629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065691|NCT02592629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065693|NCT02592629|Hormones|hormones|mesh-ancestor
56065694|NCT02592629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065695|NCT02592629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56065696|NCT02592629|Immunologic Factors|immunologic factors|mesh-ancestor
56065697|NCT05627557|Acetaminophen|acetaminophen|mesh-list
56065698|NCT05627557|Diphenhydramine|diphenhydramine|mesh-list
56065699|NCT05627557|Promethazine|promethazine|mesh-list
56065700|NCT05627557|Prednisone|prednisone|mesh-list
56065701|NCT05627557|Methylprednisolone|methylprednisolone|mesh-list
56065702|NCT05627557|Obinutuzumab|obinutuzumab|mesh-list
56065703|NCT05627557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065704|NCT05627557|Glucocorticoids|glucocorticoids|mesh-ancestor
56065705|NCT05627557|Hormones|hormones|mesh-ancestor
56065707|NCT05627557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065708|NCT05627557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56065709|NCT05627557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065710|NCT05627557|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065711|NCT05627557|Analgesics|analgesics|mesh-ancestor
56065712|NCT05627557|Sensory System Agents|sensory system agents|mesh-ancestor
56065713|NCT05627557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065714|NCT05627557|Antipyretics|antipyretics|mesh-ancestor
56065715|NCT05627557|Antiemetics|antiemetics|mesh-ancestor
56065716|NCT05627557|Autonomic Agents|autonomic agents|mesh-ancestor
56065717|NCT05627557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56065718|NCT05627557|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56065719|NCT05627557|Protective Agents|protective agents|mesh-ancestor
56065730|NCT05627557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065731|NCT05627557|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56065732|NCT05627557|Antipruritics|antipruritics|mesh-ancestor
56065733|NCT05627557|Dermatologic Agents|dermatologic agents|mesh-ancestor
56065734|NCT02596451|Diclofenac|diclofenac|mesh-list
56065735|NCT02596451|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56065736|NCT02596451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56065737|NCT02596451|Analgesics|analgesics|mesh-ancestor
56065738|NCT02596451|Sensory System Agents|sensory system agents|mesh-ancestor
56065739|NCT02596451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065740|NCT02596451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065741|NCT02596451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065742|NCT02596451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56065743|NCT02596451|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56065745|NCT02596451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065746|NCT01839799|Gemcitabine|gemcitabine|mesh-list
56065747|NCT01839799|Paclitaxel|paclitaxel|mesh-list
56065748|NCT01839799|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56065749|NCT01839799|Folfirinox|folfirinox|mesh-list
56065750|NCT01839799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56065751|NCT01839799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065752|NCT01839799|Tubulin Modulators|tubulin modulators|mesh-ancestor
56065753|NCT01839799|Antimitotic Agents|antimitotic agents|mesh-ancestor
56065754|NCT01839799|Mitosis Modulators|mitosis modulators|mesh-ancestor
56065755|NCT01839799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065756|NCT01839799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56065757|NCT01839799|Antimetabolites|antimetabolites|mesh-ancestor
56065758|NCT01839799|Antiviral Agents|antiviral agents|mesh-ancestor
56065759|NCT01839799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065760|NCT01839799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065761|NCT01839799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56065762|NCT01839799|Immunologic Factors|immunologic factors|mesh-ancestor
56065763|NCT01839799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065764|NCT03062059|Gemcitabine|gemcitabine|mesh-list
56065765|NCT03062059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56065766|NCT03062059|Antimetabolites|antimetabolites|mesh-ancestor
56065767|NCT03062059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065769|NCT03062059|Antiviral Agents|antiviral agents|mesh-ancestor
56065770|NCT03062059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065771|NCT03062059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065772|NCT03062059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56065773|NCT03062059|Immunologic Factors|immunologic factors|mesh-ancestor
56065774|NCT03062059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065775|NCT02597543|Regadenoson|regadenoson|mesh-list
56065776|NCT02597543|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56065777|NCT02597543|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56065778|NCT02597543|Purinergic Agonists|purinergic agonists|mesh-ancestor
56065779|NCT02597543|Purinergic Agents|purinergic agents|mesh-ancestor
56065780|NCT02597543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065781|NCT02597543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065782|NCT02597543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065783|NCT00553501|Rituximab|rituximab|mesh-list
56065784|NCT00553501|Epratuzumab|epratuzumab|mesh-list
56065785|NCT00553501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56065786|NCT00553501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065787|NCT00553501|Immunologic Factors|immunologic factors|mesh-ancestor
56065788|NCT00553501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065789|NCT00553501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56065790|NCT02599649|Nivolumab|nivolumab|mesh-list
56065791|NCT02599649|Azacitidine|azacitidine|mesh-list
56065792|NCT02599649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56065793|NCT02599649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065794|NCT02599649|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56065795|NCT02599649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065796|NCT02599649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56065797|NCT02599649|Antimetabolites|antimetabolites|mesh-ancestor
56065798|NCT02599649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065799|NCT01840345|Acetylcysteine|acetylcysteine|mesh-list
56065800|NCT01840345|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56065801|NCT01840345|Antiviral Agents|antiviral agents|mesh-ancestor
56065802|NCT01840345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065803|NCT01840345|Expectorants|expectorants|mesh-ancestor
56065804|NCT01840345|Respiratory System Agents|respiratory system agents|mesh-ancestor
56065806|NCT01840345|Antioxidants|antioxidants|mesh-ancestor
56065807|NCT01840345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065808|NCT01840345|Protective Agents|protective agents|mesh-ancestor
56065809|NCT01840345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065810|NCT01840345|Antidotes|antidotes|mesh-ancestor
56065811|NCT02990533|Methyltestosterone|methyltestosterone|mesh-list
56065812|NCT02990533|Testosterone|testosterone|mesh-list
56065813|NCT02990533|Testosterone undecanoate|testosterone undecanoate|mesh-list
56065814|NCT02990533|Testosterone enanthate|testosterone enanthate|mesh-list
56065815|NCT02990533|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56065816|NCT02990533|Androgens|androgens|mesh-ancestor
56065817|NCT02990533|Hormones|hormones|mesh-ancestor
56065818|NCT02990533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065819|NCT02990533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065821|NCT02990533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065822|NCT02990533|Anabolic Agents|anabolic agents|mesh-ancestor
56065823|NCT00364481|Omeprazole|omeprazole|mesh-list
56065825|NCT00364481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56065826|NCT00364481|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56065827|NCT00364481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065828|NCT00364481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065829|NCT02601833|Fluorides|fluorides|mesh-list
56065830|NCT02601833|Cariostatic Agents|cariostatic agents|mesh-ancestor
56065831|NCT02601833|Protective Agents|protective agents|mesh-ancestor
56065832|NCT02601833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065833|NCT00553267|Amlodipine|amlodipine|mesh-list
56065834|NCT00553267|Telmisartan|telmisartan|mesh-list
56065847|NCT00364559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56065848|NCT00364559|Antimetabolites|antimetabolites|mesh-ancestor
56065849|NCT00364559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065850|NCT00364559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56065851|NCT00364559|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56065852|NCT00364559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065853|NCT02271984|Praziquantel|praziquantel|mesh-list
56065854|NCT02271984|Anthelmintics|anthelmintics|mesh-ancestor
56065855|NCT02271984|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56065856|NCT02271984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065857|NCT02604173|Budesonide|budesonide|mesh-list
56065858|NCT02604173|Acetazolamide|acetazolamide|mesh-list
56065859|NCT02604173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56065860|NCT02604173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56065861|NCT02604173|Autonomic Agents|autonomic agents|mesh-ancestor
56065862|NCT02604173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065863|NCT02604173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065864|NCT02604173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56065865|NCT02604173|Respiratory System Agents|respiratory system agents|mesh-ancestor
56065866|NCT02604173|Glucocorticoids|glucocorticoids|mesh-ancestor
56065867|NCT02604173|Hormones|hormones|mesh-ancestor
56065868|NCT02604173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56065869|NCT02604173|Anticonvulsants|anticonvulsants|mesh-ancestor
56065870|NCT02604173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56065871|NCT02604173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065872|NCT02604173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065873|NCT02604173|Diuretics|diuretics|mesh-ancestor
56065874|NCT02604173|Natriuretic Agents|natriuretic agents|mesh-ancestor
56065875|NCT02287038|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56065876|NCT02287038|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56065877|NCT02287038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56065878|NCT02287038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56065889|NCT00365339|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56065890|NCT00365339|Protease Inhibitors|protease inhibitors|mesh-ancestor
56065891|NCT00365339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065892|NCT00365339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065893|NCT00365339|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56065894|NCT00365339|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56065895|NCT00365339|Antiviral Agents|antiviral agents|mesh-ancestor
56065896|NCT00365339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56065897|NCT00365339|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56065898|NCT00365339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56065899|NCT00365339|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56065900|NCT00365339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56065901|NCT00365339|Antidepressive Agents|antidepressive agents|mesh-ancestor
56065902|NCT00365339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56065903|NCT00365339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56065904|NCT00365339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56065905|NCT00365339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065906|NCT00365339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065907|NCT00365339|Dopamine Agonists|dopamine agonists|mesh-ancestor
56065908|NCT00365339|Dopamine Agents|dopamine agents|mesh-ancestor
55740625|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56065909|NCT00365339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56065910|NCT00365339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56065911|NCT00365339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56065912|NCT00365339|Serotonin Agents|serotonin agents|mesh-ancestor
56065936|NCT05589181|Sensory System Agents|sensory system agents|mesh-ancestor
56065937|NCT05589181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56065938|NCT05589181|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56065939|NCT00366119|Ramipril|ramipril|mesh-list
56065940|NCT00366119|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56065941|NCT00366119|Protease Inhibitors|protease inhibitors|mesh-ancestor
56065942|NCT00366119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065943|NCT00366119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793136|NCT03086005|Metformin|metformin|mesh-list
56065944|NCT00366119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56065945|NCT05371301|Paclitaxel|paclitaxel|mesh-list
56065946|NCT05371301|Carboplatin|carboplatin|mesh-list
56065947|NCT05371301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56065948|NCT05371301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065949|NCT05371301|Tubulin Modulators|tubulin modulators|mesh-ancestor
56065950|NCT05371301|Antimitotic Agents|antimitotic agents|mesh-ancestor
56065951|NCT05371301|Mitosis Modulators|mitosis modulators|mesh-ancestor
56065952|NCT05371301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065953|NCT02285166|Hypolipidemic Agents|hypolipidemic agents|mesh-list
56065954|NCT02285166|Antimetabolites|antimetabolites|mesh-ancestor
56065955|NCT02285166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065956|NCT02285166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56065957|NCT02605187|Acetaminophen|acetaminophen|mesh-list
56065958|NCT02605187|Ibuprofen|ibuprofen|mesh-list
56065959|NCT02605187|Morphine|morphine|mesh-list
56065960|NCT02605187|Gabapentin|gabapentin|mesh-list
56065961|NCT02605187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56065962|NCT02605187|Narcotics|narcotics|mesh-ancestor
56065963|NCT02605187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56065964|NCT02605187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56065965|NCT02605187|Analgesics|analgesics|mesh-ancestor
56065966|NCT02605187|Sensory System Agents|sensory system agents|mesh-ancestor
55790856|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
56065992|NCT02989207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56065993|NCT02989207|Alkylating Agents|alkylating agents|mesh-ancestor
56065994|NCT02989207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56065995|NCT02989207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56065996|NCT02989207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56065997|NCT02647099|Aspirin|aspirin|mesh-list
56065998|NCT02647099|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56065999|NCT02647099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56066000|NCT02647099|Analgesics|analgesics|mesh-ancestor
56066001|NCT02647099|Sensory System Agents|sensory system agents|mesh-ancestor
56066002|NCT02647099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066003|NCT02647099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066004|NCT02647099|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56066005|NCT02647099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066006|NCT02647099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56066007|NCT02647099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56066008|NCT02647099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066017|NCT02608229|Paclitaxel|paclitaxel|mesh-list
56066018|NCT02608229|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56066019|NCT02608229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56066020|NCT02608229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066021|NCT02608229|Tubulin Modulators|tubulin modulators|mesh-ancestor
56066022|NCT02608229|Antimitotic Agents|antimitotic agents|mesh-ancestor
56066023|NCT02608229|Mitosis Modulators|mitosis modulators|mesh-ancestor
56066024|NCT02608229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066025|NCT02608229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56066026|NCT02608229|Antimetabolites|antimetabolites|mesh-ancestor
56066027|NCT02608229|Antiviral Agents|antiviral agents|mesh-ancestor
56066028|NCT02608229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066032|NCT02608229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066034|NCT01642212|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56066035|NCT01642212|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56066036|NCT01642212|Autonomic Agents|autonomic agents|mesh-ancestor
56066037|NCT01642212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066038|NCT01642212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066039|NCT01642212|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56066040|NCT01642212|Respiratory System Agents|respiratory system agents|mesh-ancestor
56066041|NCT01642212|Glucocorticoids|glucocorticoids|mesh-ancestor
56066042|NCT01642212|Hormones|hormones|mesh-ancestor
56066043|NCT01642212|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56066044|NCT05649618|Cyclophosphamide|cyclophosphamide|mesh-list
56066045|NCT05649618|Fludarabine|fludarabine|mesh-list
56066046|NCT05649618|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066060|NCT00552175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066061|NCT00552175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066062|NCT00552175|Analgesics|analgesics|mesh-ancestor
56066063|NCT00552175|Sensory System Agents|sensory system agents|mesh-ancestor
56066064|NCT00552175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066065|NCT00552175|Antidepressive Agents|antidepressive agents|mesh-ancestor
56066070|NCT01644474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56066071|NCT01644474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56066072|NCT01644474|Antimetabolites|antimetabolites|mesh-ancestor
56066073|NCT01644474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066074|NCT01644474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56066075|NCT01644474|Immunologic Factors|immunologic factors|mesh-ancestor
56066076|NCT01644474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066077|NCT02989129|Quercetin|quercetin|mesh-list
56066078|NCT02989129|Antioxidants|antioxidants|mesh-ancestor
56066079|NCT02989129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066080|NCT02989129|Protective Agents|protective agents|mesh-ancestor
56066081|NCT02989129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066082|NCT04879524|Botulinum Toxins|botulinum toxins|mesh-list
56066083|NCT04879524|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56066116|NCT02285010|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56066118|NCT02285010|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56066119|NCT02285010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56066120|NCT02285010|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56066129|NCT02617667|Cyclosporins|cyclosporins|mesh-list
56066130|NCT02617667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066131|NCT02617667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066132|NCT02617667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066133|NCT02617667|Immunologic Factors|immunologic factors|mesh-ancestor
56066134|NCT02617667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066135|NCT02617667|Antifungal Agents|antifungal agents|mesh-ancestor
56066136|NCT02617667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066137|NCT02617667|Dermatologic Agents|dermatologic agents|mesh-ancestor
56066138|NCT02617667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066139|NCT02617667|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56066140|NCT03023449|Nitric Oxide|nitric oxide|mesh-list
56066141|NCT03023449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56066142|NCT03023449|Autonomic Agents|autonomic agents|mesh-ancestor
56066143|NCT03023449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066144|NCT03023449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066152|NCT03023449|Vasodilator Agents|vasodilator agents|mesh-ancestor
56066153|NCT03023449|Gasotransmitters|gasotransmitters|mesh-ancestor
56066154|NCT03023449|Protective Agents|protective agents|mesh-ancestor
56066217|NCT04665037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066218|NCT04665037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066219|NCT04665037|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56066220|NCT04665037|Hormone Antagonists|hormone antagonists|mesh-ancestor
56066221|NCT04665037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56066222|NCT04665037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066223|NCT05452577|Estazolam|estazolam|mesh-list
56066224|NCT05452577|Anticonvulsants|anticonvulsants|mesh-ancestor
56066225|NCT05452577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56066226|NCT05452577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56066227|NCT05452577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56066228|NCT05452577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066229|NCT05452577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56066230|NCT05452577|GABA Modulators|gaba modulators|mesh-ancestor
56066231|NCT05452577|GABA Agents|gaba agents|mesh-ancestor
56066232|NCT05452577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066233|NCT05452577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066234|NCT05464615|Amoxicillin|amoxicillin|mesh-list
56066235|NCT05464615|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56066236|NCT05464615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066237|NCT00364871|Naltrexone|naltrexone|mesh-list
56066249|NCT00364871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56066250|NCT00364871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066251|NCT00364871|Dopamine Agents|dopamine agents|mesh-ancestor
56066252|NCT00364871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066254|NCT00364871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56066255|NCT00364871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066256|NCT00551161|Memantine|memantine|mesh-list
56066257|NCT00551161|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56066258|NCT00551161|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56066259|NCT00551161|Dopamine Agents|dopamine agents|mesh-ancestor
56066260|NCT00551161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066261|NCT00551161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066293|NCT05298449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066294|NCT05298449|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56066295|NCT05298449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56066546|NCT05104723|Tofacitinib|tofacitinib|mesh-list
56066296|NCT05298449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066297|NCT05298449|Cholinergic Agents|cholinergic agents|mesh-ancestor
56066298|NCT05298449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066299|NCT01852669|Furosemide|furosemide|mesh-list
56066300|NCT01852669|Diuretics|diuretics|mesh-ancestor
56066301|NCT01852669|Natriuretic Agents|natriuretic agents|mesh-ancestor
56066302|NCT01852669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066303|NCT01852669|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56066304|NCT01852669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56066305|NCT01852669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066306|NCT05259839|Dexamethasone|dexamethasone|mesh-list
56066307|NCT05259839|Lenalidomide|lenalidomide|mesh-list
56066308|NCT05259839|Daratumumab|daratumumab|mesh-list
56066309|NCT05259839|Pomalidomide|pomalidomide|mesh-list
56066310|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56066311|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
56066312|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
56066313|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066345|NCT04741295|Heparin|heparin|mesh-list
56066346|NCT04741295|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56066347|NCT04741295|Tinzaparin|tinzaparin|mesh-list
56066348|NCT04741295|Dalteparin|dalteparin|mesh-list
56066349|NCT04741295|Anticoagulants|anticoagulants|mesh-ancestor
56066350|NCT04741295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56066351|NCT04741295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56066352|NCT04741295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066353|NCT00550537|Paclitaxel|paclitaxel|mesh-list
56066354|NCT00550537|Bevacizumab|bevacizumab|mesh-list
56066355|NCT00550537|Carboplatin|carboplatin|mesh-list
56066356|NCT00550537|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56066357|NCT00550537|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56066358|NCT00550537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066359|NCT00550537|Tubulin Modulators|tubulin modulators|mesh-ancestor
56066360|NCT00550537|Antimitotic Agents|antimitotic agents|mesh-ancestor
56066361|NCT00550537|Mitosis Modulators|mitosis modulators|mesh-ancestor
56066362|NCT00550537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066363|NCT00550537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56066364|NCT00550537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56066365|NCT00550537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56066366|NCT00550537|Growth Substances|growth substances|mesh-ancestor
56066367|NCT00550537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066368|NCT00550537|Growth Inhibitors|growth inhibitors|mesh-ancestor
56066369|NCT00550537|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56066370|NCT00550537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066371|NCT04801043|Imipenem|imipenem|mesh-list
56066372|NCT04801043|Cilastatin|cilastatin|mesh-list
56066373|NCT04801043|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56066374|NCT04801043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066375|NCT04801043|Protease Inhibitors|protease inhibitors|mesh-ancestor
56066376|NCT04801043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066377|NCT04801043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066378|NCT05706701|Nicotine|nicotine|mesh-list
56066379|NCT05706701|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56066380|NCT05706701|Autonomic Agents|autonomic agents|mesh-ancestor
56066385|NCT05706701|Cholinergic Agents|cholinergic agents|mesh-ancestor
56066386|NCT05706701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066387|NCT05706701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066388|NCT04734197|Cyclosporine|cyclosporine|mesh-list
56066389|NCT04734197|Mycophenolic Acid|mycophenolic acid|mesh-list
56066390|NCT04734197|Betamethasone|betamethasone|mesh-list
56066391|NCT04734197|Betamethasone Valerate|betamethasone valerate|mesh-list
56066392|NCT04734197|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56066393|NCT04734197|Betamethasone benzoate|betamethasone benzoate|mesh-list
56066394|NCT04734197|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56066395|NCT04734197|Lifitegrast|lifitegrast|mesh-list
56066396|NCT04734197|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56066397|NCT04734197|Cyclosporins|cyclosporins|mesh-list
56066398|NCT04734197|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56066399|NCT04734197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066400|NCT04734197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066401|NCT04734197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066402|NCT04734197|Immunologic Factors|immunologic factors|mesh-ancestor
56066403|NCT04734197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066404|NCT04734197|Antifungal Agents|antifungal agents|mesh-ancestor
56066405|NCT04734197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066406|NCT04734197|Dermatologic Agents|dermatologic agents|mesh-ancestor
56066407|NCT04734197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066408|NCT04734197|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56066409|NCT04734197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56066434|NCT00550147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56066435|NCT05688215|Calcium, Dietary|calcium, dietary|mesh-list
56066438|NCT05688215|Fluorouracil|fluorouracil|mesh-list
56066439|NCT05688215|Oxaliplatin|oxaliplatin|mesh-list
56066440|NCT05688215|Irinotecan|irinotecan|mesh-list
56066441|NCT05688215|Calcium|calcium|mesh-list
56066442|NCT05688215|Levoleucovorin|levoleucovorin|mesh-list
56066443|NCT05688215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56066444|NCT05688215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066445|NCT05688215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56066446|NCT05688215|Antimetabolites|antimetabolites|mesh-ancestor
56066447|NCT05688215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066448|NCT05688215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56066449|NCT05688215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066450|NCT05688215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066451|NCT05688215|Immunologic Factors|immunologic factors|mesh-ancestor
56066452|NCT05688215|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56066453|NCT05688215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56066454|NCT05688215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066455|NCT05688215|Antidotes|antidotes|mesh-ancestor
56066456|NCT05688215|Protective Agents|protective agents|mesh-ancestor
56066457|NCT05688215|Vitamin B Complex|vitamin b complex|mesh-ancestor
56066458|NCT05688215|Vitamins|vitamins|mesh-ancestor
56066459|NCT05688215|Micronutrients|micronutrients|mesh-ancestor
56066460|NCT05688215|Hematinics|hematinics|mesh-ancestor
56066461|NCT00557401|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
56066462|NCT00557401|Baclofen|baclofen|mesh-list
56066463|NCT00557401|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56066484|NCT04191499|Palbociclib|palbociclib|mesh-list
56066485|NCT04191499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56066486|NCT04191499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066488|NCT04191499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56066489|NCT04191499|Hormone Antagonists|hormone antagonists|mesh-ancestor
56066490|NCT04191499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56066491|NCT04191499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066492|NCT04191499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56066493|NCT04191499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066494|NCT04191499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066495|NCT02624843|Ethanol|ethanol|mesh-list
56066496|NCT02624843|Benzyl Alcohol|benzyl alcohol|mesh-list
56066497|NCT02624843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56066498|NCT02624843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066499|NCT02624843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56066501|NCT02624843|Anesthetics, Local|anesthetics, local|mesh-ancestor
56066502|NCT02624843|Anesthetics|anesthetics|mesh-ancestor
56066503|NCT02624843|Sensory System Agents|sensory system agents|mesh-ancestor
56066504|NCT02624843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066505|NCT02279641|Allopurinol|allopurinol|mesh-list
56066506|NCT02279641|Verinurad|verinurad|mesh-list
56066507|NCT02279641|Antimetabolites|antimetabolites|mesh-ancestor
56066508|NCT02279641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066509|NCT02279641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066510|NCT02279641|Gout Suppressants|gout suppressants|mesh-ancestor
56066511|NCT02279641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066512|NCT02279641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56066513|NCT02279641|Antioxidants|antioxidants|mesh-ancestor
56066528|NCT05154955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56066529|NCT05142709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56066530|NCT05142709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066531|NCT05142709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066532|NCT04992143|Sorafenib|sorafenib|mesh-list
56066533|NCT04992143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066534|NCT04992143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56066535|NCT04992143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066536|NCT04992143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066537|NCT04485065|Azacitidine|azacitidine|mesh-list
56066538|NCT04485065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56066539|NCT04485065|Antimetabolites|antimetabolites|mesh-ancestor
56066540|NCT04485065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066541|NCT04485065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066542|NCT04485065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066543|NCT03769129|Pembrolizumab|pembrolizumab|mesh-list
56066544|NCT03769129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56066545|NCT03769129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066547|NCT05104723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56066548|NCT05104723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066549|NCT05104723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066551|NCT00367445|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56066552|NCT00367445|Insulin Glargine|insulin glargine|mesh-list
56066553|NCT00367445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56066554|NCT00367445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066555|NCT01866943|Tranexamic Acid|tranexamic acid|mesh-list
56066556|NCT01866943|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56066557|NCT01866943|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56066558|NCT01866943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066559|NCT01866943|Hemostatics|hemostatics|mesh-ancestor
56066572|NCT01868425|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56066574|NCT01868425|Anesthetics, General|anesthetics, general|mesh-ancestor
56066575|NCT01868425|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56066576|NCT01868425|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56066577|NCT01868425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066578|NCT01868425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066579|NCT01868425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56066580|NCT01868425|Antipyretics|antipyretics|mesh-ancestor
56066581|NCT01868425|Anticonvulsants|anticonvulsants|mesh-ancestor
56066582|NCT01868425|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56066583|NCT01868425|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56066584|NCT01868425|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56066585|NCT01868425|Antimanic Agents|antimanic agents|mesh-ancestor
56066587|NCT00550459|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56066588|NCT00550459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066589|NCT00550459|Natriuretic Agents|natriuretic agents|mesh-ancestor
56066590|NCT00550459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066591|NCT01871077|Ketorolac|ketorolac|mesh-list
56066592|NCT01871077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56066593|NCT01871077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56066594|NCT01871077|Analgesics|analgesics|mesh-ancestor
56066595|NCT01871077|Sensory System Agents|sensory system agents|mesh-ancestor
56066596|NCT01871077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066597|NCT01871077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066598|NCT01871077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56066599|NCT01871077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066600|NCT01871077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56066601|NCT01871077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066602|NCT01871077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066603|NCT04896073|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
56066604|NCT04896073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56066605|NCT04896073|Alkylating Agents|alkylating agents|mesh-ancestor
56066606|NCT04896073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066607|NCT04896073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066608|NCT03192397|Mycophenolic Acid|mycophenolic acid|mesh-list
56066609|NCT03192397|Sirolimus|sirolimus|mesh-list
56066610|NCT03192397|Cyclophosphamide|cyclophosphamide|mesh-list
56066611|NCT03192397|Melphalan|melphalan|mesh-list
56066612|NCT03192397|Fludarabine|fludarabine|mesh-list
56066613|NCT03192397|Fludarabine phosphate|fludarabine phosphate|mesh-list
56066614|NCT03192397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066615|NCT03192397|Immunologic Factors|immunologic factors|mesh-ancestor
56066616|NCT03192397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066617|NCT03192397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066618|NCT03192397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56066619|NCT03192397|Alkylating Agents|alkylating agents|mesh-ancestor
56066620|NCT03192397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066621|NCT03192397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066622|NCT03192397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56066623|NCT03192397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56066624|NCT03192397|Antimetabolites|antimetabolites|mesh-ancestor
56066625|NCT03192397|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56066626|NCT03192397|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56066627|NCT03192397|Antitubercular Agents|antitubercular agents|mesh-ancestor
56066628|NCT03192397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56066629|NCT03192397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066630|NCT03192397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066656|NCT02823145|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56066657|NCT02823145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56066658|NCT02823145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066659|NCT02823145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066660|NCT02823145|Serotonin Agents|serotonin agents|mesh-ancestor
56066661|NCT02823145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066662|NCT02280811|Aldesleukin|aldesleukin|mesh-list
56066663|NCT02280811|Cyclophosphamide|cyclophosphamide|mesh-list
56066664|NCT02280811|Fludarabine|fludarabine|mesh-list
56066665|NCT02280811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066666|NCT02280811|Immunologic Factors|immunologic factors|mesh-ancestor
56066667|NCT02280811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066668|NCT02280811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066669|NCT02280811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56066670|NCT02280811|Alkylating Agents|alkylating agents|mesh-ancestor
56066671|NCT02280811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066672|NCT02280811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066673|NCT02280811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56066674|NCT02280811|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56066675|NCT02280811|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56066676|NCT02280811|Antiviral Agents|antiviral agents|mesh-ancestor
56066677|NCT02280811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066678|NCT01930747|Remifentanil|remifentanil|mesh-list
56066679|NCT01930747|Sevoflurane|sevoflurane|mesh-list
56066680|NCT01930747|Rocuronium|rocuronium|mesh-list
56066681|NCT01930747|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56066682|NCT01930747|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56066683|NCT01930747|Anesthetics, General|anesthetics, general|mesh-ancestor
56066684|NCT01930747|Anesthetics|anesthetics|mesh-ancestor
56066685|NCT01930747|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56066686|NCT01930747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066692|NCT01930747|Narcotics|narcotics|mesh-ancestor
56066700|NCT02639429|Abortifacient Agents|abortifacient agents|mesh-ancestor
56066701|NCT02639429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56066702|NCT02639429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066703|NCT02639429|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56066704|NCT02639429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56066705|NCT02639429|Oxytocics|oxytocics|mesh-ancestor
56066706|NCT01936363|Niacinamide|niacinamide|mesh-list
56066707|NCT01936363|Vitamin B Complex|vitamin b complex|mesh-ancestor
56066708|NCT01936363|Vitamins|vitamins|mesh-ancestor
56066709|NCT01936363|Micronutrients|micronutrients|mesh-ancestor
56066710|NCT01936363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066711|NCT04893629|Digoxin|digoxin|mesh-list
56066712|NCT04893629|Captopril|captopril|mesh-list
56066713|NCT04893629|Furosemide|furosemide|mesh-list
56066714|NCT04893629|Diuretics|diuretics|mesh-ancestor
56066715|NCT04893629|Natriuretic Agents|natriuretic agents|mesh-ancestor
56066718|NCT04893629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56066719|NCT04893629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066720|NCT04893629|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56066721|NCT04893629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56066722|NCT04893629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066723|NCT04893629|Protective Agents|protective agents|mesh-ancestor
56066724|NCT04893629|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56066725|NCT04893629|Protease Inhibitors|protease inhibitors|mesh-ancestor
56066726|NCT04893629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56066727|NCT04891991|Infliximab|infliximab|mesh-list
56066728|NCT04891991|Dermatologic Agents|dermatologic agents|mesh-ancestor
56066729|NCT04891991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56066730|NCT04891991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066745|NCT01936519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066746|NCT01936519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066747|NCT01936519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56066748|NCT01936519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56066749|NCT01936519|Antitubercular Agents|antitubercular agents|mesh-ancestor
56066750|NCT01936519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56066751|NCT04507841|Niraparib|niraparib|mesh-list
56066752|NCT04507841|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56066753|NCT04507841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066754|NCT04507841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066755|NCT04507841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066756|NCT01936909|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56066757|NCT01936909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066758|NCT01938079|Ketamine|ketamine|mesh-list
56066759|NCT01938079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56066760|NCT01938079|Analgesics|analgesics|mesh-ancestor
56066761|NCT01938079|Sensory System Agents|sensory system agents|mesh-ancestor
56066762|NCT01938079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066763|NCT01938079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067235|NCT02205047|Immunologic Factors|immunologic factors|mesh-ancestor
56066764|NCT01938079|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56066765|NCT01938079|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56066766|NCT01938079|Anesthetics, General|anesthetics, general|mesh-ancestor
56066767|NCT01938079|Anesthetics|anesthetics|mesh-ancestor
56066768|NCT01938079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793964|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56066769|NCT01938079|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56066770|NCT01938079|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56066771|NCT01938079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066772|NCT01938079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066774|NCT02641691|Tetrahydrofolates|tetrahydrofolates|mesh-list
56066775|NCT02641691|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56066776|NCT02641691|Fluorouracil|fluorouracil|mesh-list
56066777|NCT02641691|Oxaliplatin|oxaliplatin|mesh-list
56066778|NCT02641691|Levoleucovorin|levoleucovorin|mesh-list
56066779|NCT02641691|Antimetabolites|antimetabolites|mesh-ancestor
55901109|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066780|NCT02641691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066782|NCT02641691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066783|NCT02641691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56066784|NCT02641691|Immunologic Factors|immunologic factors|mesh-ancestor
56066785|NCT02641691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066786|NCT02641691|Antidotes|antidotes|mesh-ancestor
56066787|NCT02641691|Protective Agents|protective agents|mesh-ancestor
56066788|NCT02641691|Vitamin B Complex|vitamin b complex|mesh-ancestor
56066789|NCT02641691|Vitamins|vitamins|mesh-ancestor
56066790|NCT02641691|Micronutrients|micronutrients|mesh-ancestor
56066791|NCT04047251|Topotecan|topotecan|mesh-list
56066792|NCT04047251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56066793|NCT04047251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56066794|NCT04047251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066795|NCT04047251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066796|NCT04047251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066797|NCT04045613|Atezolizumab|atezolizumab|mesh-list
56066798|NCT04045613|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56066799|NCT04045613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066800|NCT04045613|Immunologic Factors|immunologic factors|mesh-ancestor
56066801|NCT04045613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066802|NCT05588999|Salicylic Acid|salicylic acid|mesh-list
56066803|NCT05588999|Salicylates|salicylates|mesh-list
56066804|NCT05588999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066805|NCT05588999|Antifungal Agents|antifungal agents|mesh-ancestor
56066806|NCT05588999|Keratolytic Agents|keratolytic agents|mesh-ancestor
56066819|NCT03867851|Heparin|heparin|mesh-list
56066828|NCT01643928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066829|NCT01643928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066830|NCT04234997|Suvorexant|suvorexant|mesh-list
56066831|NCT04234997|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56066832|NCT04234997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56066833|NCT04234997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56066834|NCT04234997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066835|NCT04234997|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56066836|NCT04234997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066837|NCT04234997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066838|NCT03750071|Avelumab|avelumab|mesh-list
56066839|NCT03750071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56066840|NCT03750071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066841|NCT03635567|Paclitaxel|paclitaxel|mesh-list
56066842|NCT03635567|Bevacizumab|bevacizumab|mesh-list
56066843|NCT03635567|Carboplatin|carboplatin|mesh-list
56066844|NCT03635567|Pembrolizumab|pembrolizumab|mesh-list
56066845|NCT03635567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56066846|NCT03635567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066847|NCT03635567|Tubulin Modulators|tubulin modulators|mesh-ancestor
56066848|NCT03635567|Antimitotic Agents|antimitotic agents|mesh-ancestor
56066849|NCT03635567|Mitosis Modulators|mitosis modulators|mesh-ancestor
56066850|NCT03635567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066851|NCT03635567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56066852|NCT03635567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56066853|NCT03635567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56066854|NCT03635567|Growth Substances|growth substances|mesh-ancestor
56066855|NCT03635567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066856|NCT03635567|Growth Inhibitors|growth inhibitors|mesh-ancestor
56066857|NCT05588531|Cefepime|cefepime|mesh-list
56066858|NCT05588531|Avibactam|avibactam|mesh-list
56066859|NCT05588531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56066860|NCT05588531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56066861|NCT05588531|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56066862|NCT05588531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066879|NCT05588297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56066880|NCT05588297|Growth Substances|growth substances|mesh-ancestor
56066881|NCT05588297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066882|NCT05588297|Growth Inhibitors|growth inhibitors|mesh-ancestor
56066883|NCT05588297|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56066884|NCT05588297|Antimetabolites|antimetabolites|mesh-ancestor
56066885|NCT05588297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066886|NCT05588297|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56066888|NCT05588219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56066889|NCT05588219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066890|NCT05588219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066891|NCT02303405|Pioglitazone|pioglitazone|mesh-list
56066892|NCT02303405|Hydroxychloroquine|hydroxychloroquine|mesh-list
56066893|NCT02303405|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56066894|NCT02303405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066895|NCT02303405|Antimalarials|antimalarials|mesh-ancestor
56066914|NCT05587361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066915|NCT05587361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066916|NCT05587361|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56066917|NCT05587361|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56066918|NCT05587361|Cholinergic Agents|cholinergic agents|mesh-ancestor
56066919|NCT05587361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56066920|NCT05587361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066921|NCT05587361|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56066922|NCT05587361|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56066923|NCT05587361|Adrenergic Agents|adrenergic agents|mesh-ancestor
56066924|NCT05587361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56066925|NCT05587361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56066926|NCT05587361|Vasodilator Agents|vasodilator agents|mesh-ancestor
56066927|NCT01943461|Avelumab|avelumab|mesh-list
56066928|NCT01943461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56066929|NCT01943461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56066930|NCT01943461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066931|NCT01943461|Immunologic Factors|immunologic factors|mesh-ancestor
56066932|NCT01943461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066933|NCT00422435|Paclitaxel|paclitaxel|mesh-list
56066934|NCT00422435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56066935|NCT00422435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066936|NCT00422435|Tubulin Modulators|tubulin modulators|mesh-ancestor
56066937|NCT00422435|Antimitotic Agents|antimitotic agents|mesh-ancestor
56066938|NCT00422435|Mitosis Modulators|mitosis modulators|mesh-ancestor
56066939|NCT00422435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066940|NCT05586971|Allopurinol|allopurinol|mesh-list
56066941|NCT05586971|Antimetabolites|antimetabolites|mesh-ancestor
56066942|NCT05586971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066943|NCT05586971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066944|NCT05586971|Gout Suppressants|gout suppressants|mesh-ancestor
56066945|NCT05586971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56066946|NCT05586971|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56066948|NCT05586971|Protective Agents|protective agents|mesh-ancestor
56066949|NCT05586971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066950|NCT00702481|Nimotuzumab|nimotuzumab|mesh-list
55901110|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066951|NCT00702481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066952|NCT00702481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56066954|NCT03559049|Pembrolizumab|pembrolizumab|mesh-list
56066955|NCT03559049|Pemetrexed|pemetrexed|mesh-list
56066956|NCT03559049|Rucaparib|rucaparib|mesh-list
56066957|NCT03559049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56066958|NCT03559049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56066959|NCT03559049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56066960|NCT03559049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56066961|NCT03559049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56066962|NCT03559049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56066963|NCT03559049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56066964|NCT05559437|Bupivacaine|bupivacaine|mesh-list
56066965|NCT05559437|Levobupivacaine|levobupivacaine|mesh-list
56066966|NCT05559437|Anesthetics, Local|anesthetics, local|mesh-ancestor
56066967|NCT05559437|Anesthetics|anesthetics|mesh-ancestor
56066968|NCT05559437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56066969|NCT05559437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56066970|NCT05559437|Sensory System Agents|sensory system agents|mesh-ancestor
56066971|NCT05559437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56066972|NCT00367211|Naproxen|naproxen|mesh-list
56066973|NCT00367211|Omeprazole|omeprazole|mesh-list
56066974|NCT00367211|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56066975|NCT00367211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56067000|NCT02646449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067001|NCT02646449|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56067002|NCT02646449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56067003|NCT02646449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56067004|NCT02646449|Adrenergic Agents|adrenergic agents|mesh-ancestor
56067005|NCT02646449|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56067006|NCT02646449|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56067007|NCT02646449|Serotonin Agents|serotonin agents|mesh-ancestor
56067008|NCT02646449|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56067009|NCT04339361|Lidocaine|lidocaine|mesh-list
56067010|NCT04339361|Dinoprostone|dinoprostone|mesh-list
56067011|NCT04339361|Anesthetics, Local|anesthetics, local|mesh-ancestor
56067012|NCT04339361|Anesthetics|anesthetics|mesh-ancestor
56067013|NCT04339361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067014|NCT04339361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067015|NCT04339361|Sensory System Agents|sensory system agents|mesh-ancestor
56067016|NCT04339361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067017|NCT04339361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56067018|NCT04339361|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56067019|NCT04339361|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56067020|NCT04339361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56067021|NCT04339361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067023|NCT04339361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56067024|NCT05369351|Mirabegron|mirabegron|mesh-list
56067026|NCT05369351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56067056|NCT05318573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067057|NCT02653391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56067058|NCT02653391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56067059|NCT05303987|Dexmedetomidine|dexmedetomidine|mesh-list
56067060|NCT05303987|Propofol|propofol|mesh-list
56067061|NCT05303987|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56067062|NCT05303987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067063|NCT05303987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067064|NCT05303987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56067065|NCT05303987|Anesthetics, General|anesthetics, general|mesh-ancestor
56067066|NCT05303987|Anesthetics|anesthetics|mesh-ancestor
56067067|NCT05303987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56067068|NCT05303987|Analgesics|analgesics|mesh-ancestor
56067069|NCT05303987|Sensory System Agents|sensory system agents|mesh-ancestor
56067070|NCT05303987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067071|NCT05303987|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56067072|NCT05303987|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56067073|NCT05303987|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56067074|NCT05303987|Adrenergic Agents|adrenergic agents|mesh-ancestor
56067075|NCT05303987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067076|NCT05303987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067078|NCT02654483|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56067079|NCT02654483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067080|NCT02654483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067081|NCT02654483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067082|NCT02655653|Tranexamic Acid|tranexamic acid|mesh-list
56067089|NCT05167487|Cisplatin|cisplatin|mesh-list
56067104|NCT00367913|Ciprofloxacin|ciprofloxacin|mesh-list
56067105|NCT00367913|Rifampin|rifampin|mesh-list
56067106|NCT00367913|Ethambutol|ethambutol|mesh-list
56067107|NCT00367913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56067108|NCT00367913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067109|NCT00367913|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56067110|NCT00367913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067111|NCT00367913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067112|NCT00367913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56067113|NCT00367913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56067114|NCT00367913|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56067115|NCT00367913|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56067116|NCT00367913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067117|NCT00367913|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56067118|NCT00367913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56067119|NCT00367913|Antitubercular Agents|antitubercular agents|mesh-ancestor
56067120|NCT00367913|Leprostatic Agents|leprostatic agents|mesh-ancestor
56067121|NCT00367913|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56067122|NCT00367913|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56067123|NCT00367913|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56067124|NCT00367913|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56067125|NCT00367913|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56067126|NCT00367913|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56067127|NCT00367913|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56067128|NCT03007979|Letrozole|letrozole|mesh-list
56067129|NCT03007979|Fulvestrant|fulvestrant|mesh-list
56067130|NCT03007979|Palbociclib|palbociclib|mesh-list
56067131|NCT03007979|Goserelin|goserelin|mesh-list
56067132|NCT03007979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067133|NCT03007979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56067134|NCT03007979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56067135|NCT03007979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067137|NCT03007979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56067143|NCT03007979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56067144|NCT02659787|Buprenorphine|buprenorphine|mesh-list
56067145|NCT02659787|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56067146|NCT02659787|Narcotics|narcotics|mesh-ancestor
56067147|NCT02659787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067148|NCT02659787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067149|NCT02659787|Analgesics|analgesics|mesh-ancestor
56067150|NCT02659787|Sensory System Agents|sensory system agents|mesh-ancestor
56067151|NCT02659787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067152|NCT02659787|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56067154|NCT05044871|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56067155|NCT05044871|Bevacizumab|bevacizumab|mesh-list
56067156|NCT05044871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56067157|NCT05044871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067158|NCT05044871|Tubulin Modulators|tubulin modulators|mesh-ancestor
56067159|NCT05044871|Antimitotic Agents|antimitotic agents|mesh-ancestor
56067160|NCT05044871|Mitosis Modulators|mitosis modulators|mesh-ancestor
56067161|NCT05044871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067162|NCT05044871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067163|NCT05044871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56067164|NCT05044871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56067165|NCT05044871|Growth Substances|growth substances|mesh-ancestor
56067166|NCT05044871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067167|NCT05044871|Growth Inhibitors|growth inhibitors|mesh-ancestor
56067169|NCT04931693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56067191|NCT04817969|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56067192|NCT04817969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067194|NCT05649228|Antipruritics|antipruritics|mesh-ancestor
56067195|NCT05649228|Dermatologic Agents|dermatologic agents|mesh-ancestor
56067196|NCT05649228|Sensory System Agents|sensory system agents|mesh-ancestor
56067197|NCT05649228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067198|NCT05649228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067199|NCT02350517|Paclitaxel|paclitaxel|mesh-list
56067200|NCT02350517|Endostar protein|endostar protein|mesh-list
56067201|NCT02350517|Endostatins|endostatins|mesh-list
56067202|NCT02350517|Nedaplatin|nedaplatin|mesh-list
56067203|NCT02350517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56067204|NCT02350517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067205|NCT02350517|Tubulin Modulators|tubulin modulators|mesh-ancestor
56067206|NCT02350517|Antimitotic Agents|antimitotic agents|mesh-ancestor
56067207|NCT02350517|Mitosis Modulators|mitosis modulators|mesh-ancestor
56067208|NCT02350517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067209|NCT02350517|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56067210|NCT02350517|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56067211|NCT02350517|Growth Substances|growth substances|mesh-ancestor
56067212|NCT02350517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067213|NCT02350517|Growth Inhibitors|growth inhibitors|mesh-ancestor
56067214|NCT02270736|Botulinum Toxins|botulinum toxins|mesh-list
56067215|NCT02270736|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56067216|NCT02270736|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56067217|NCT02270736|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56067218|NCT02270736|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56067219|NCT02270736|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56067220|NCT02270736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067221|NCT02270736|Cholinergic Agents|cholinergic agents|mesh-ancestor
56067222|NCT02270736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067234|NCT02205047|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067236|NCT02205047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067237|NCT02205047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067238|NCT01585805|Gemcitabine|gemcitabine|mesh-list
56067239|NCT01585805|Cisplatin|cisplatin|mesh-list
56067240|NCT01585805|Veliparib|veliparib|mesh-list
56067241|NCT01585805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067242|NCT01585805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56067243|NCT01585805|Antimetabolites|antimetabolites|mesh-ancestor
56067244|NCT01585805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067245|NCT01585805|Antiviral Agents|antiviral agents|mesh-ancestor
56067246|NCT01585805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067247|NCT01585805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067248|NCT01585805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067249|NCT01585805|Immunologic Factors|immunologic factors|mesh-ancestor
56067251|NCT01585805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56067252|NCT04878198|Melatonin|melatonin|mesh-list
56067253|NCT04878198|Antioxidants|antioxidants|mesh-ancestor
56067254|NCT04878198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067255|NCT04878198|Protective Agents|protective agents|mesh-ancestor
56067256|NCT04878198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067257|NCT04878198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067258|NCT04651595|Morphine|morphine|mesh-list
56067259|NCT04651595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56067260|NCT04651595|Narcotics|narcotics|mesh-ancestor
56067261|NCT04651595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067262|NCT04651595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067263|NCT04651595|Analgesics|analgesics|mesh-ancestor
56067264|NCT04651595|Sensory System Agents|sensory system agents|mesh-ancestor
56067265|NCT04651595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067266|NCT02669615|Melphalan|melphalan|mesh-list
56067267|NCT02669615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56067268|NCT02669615|Alkylating Agents|alkylating agents|mesh-ancestor
56067269|NCT02669615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067271|NCT02669615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56067272|NCT02669615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067273|NCT02669615|Immunologic Factors|immunologic factors|mesh-ancestor
56067274|NCT02669615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067275|NCT02672111|Buprenorphine|buprenorphine|mesh-list
56067276|NCT02672111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56067277|NCT02672111|Narcotics|narcotics|mesh-ancestor
56067278|NCT02672111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067279|NCT02672111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067280|NCT02672111|Analgesics|analgesics|mesh-ancestor
56067281|NCT02672111|Sensory System Agents|sensory system agents|mesh-ancestor
56067282|NCT02672111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067283|NCT02672111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56067284|NCT00586391|Ipilimumab|ipilimumab|mesh-list
56067285|NCT00586391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067286|NCT00586391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067287|NCT00586391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56067288|NCT00586391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067289|NCT05432843|Pregabalin|pregabalin|mesh-list
56067290|NCT05432843|Analgesics|analgesics|mesh-ancestor
56067291|NCT05432843|Sensory System Agents|sensory system agents|mesh-ancestor
56067292|NCT05432843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067293|NCT05432843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067294|NCT05432843|Anticonvulsants|anticonvulsants|mesh-ancestor
56067295|NCT05432843|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56067296|NCT05432843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56067297|NCT05432843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067298|NCT05432843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56067317|NCT02680301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067318|NCT02680301|Glucocorticoids|glucocorticoids|mesh-ancestor
56067320|NCT02680301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56067321|NCT02680301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067322|NCT02680301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067323|NCT02680301|Immunologic Factors|immunologic factors|mesh-ancestor
56067325|NCT02680301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067326|NCT02680457|Insulin|insulin|mesh-list
56067327|NCT02680457|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56067328|NCT02680457|Insulin Glargine|insulin glargine|mesh-list
56067329|NCT02680457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56067330|NCT02680457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067331|NCT02283762|Riociguat|riociguat|mesh-list
56067333|NCT02283762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067334|NCT02692391|Indomethacin|indomethacin|mesh-list
56067335|NCT02692391|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56067336|NCT02692391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56067337|NCT02692391|Analgesics|analgesics|mesh-ancestor
56067338|NCT02692391|Sensory System Agents|sensory system agents|mesh-ancestor
56067339|NCT02692391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067340|NCT02692391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067341|NCT02692391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067342|NCT02692391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56067343|NCT02692391|Gout Suppressants|gout suppressants|mesh-ancestor
56067344|NCT02692391|Tocolytic Agents|tocolytic agents|mesh-ancestor
56067345|NCT02692391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56067362|NCT02697071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067363|NCT02697071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067364|NCT02697071|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56067365|NCT02697071|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56067366|NCT02697071|Anesthetics, General|anesthetics, general|mesh-ancestor
55794562|NCT04340141|Fluorouracil|fluorouracil|mesh-list
56067367|NCT02697071|Anesthetics|anesthetics|mesh-ancestor
56067368|NCT02697071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067369|NCT02697071|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56067370|NCT02697071|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56067371|NCT02697071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067372|NCT02697071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067373|NCT02283294|Warfarin|warfarin|mesh-list
56067374|NCT02283294|Apixaban|apixaban|mesh-list
56067375|NCT02283294|Anticoagulants|anticoagulants|mesh-ancestor
56067376|NCT02283294|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56067377|NCT02283294|Antithrombins|antithrombins|mesh-ancestor
56067378|NCT02283294|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56067379|NCT02283294|Protease Inhibitors|protease inhibitors|mesh-ancestor
56067380|NCT02283294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067381|NCT02283294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067382|NCT05648994|Paclitaxel|paclitaxel|mesh-list
56067383|NCT05648994|Cyclophosphamide|cyclophosphamide|mesh-list
56067384|NCT05648994|Fludarabine|fludarabine|mesh-list
56067385|NCT05648994|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56067386|NCT05648994|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56067387|NCT05648994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067388|NCT05648994|Tubulin Modulators|tubulin modulators|mesh-ancestor
56067389|NCT05648994|Antimitotic Agents|antimitotic agents|mesh-ancestor
56067390|NCT05648994|Mitosis Modulators|mitosis modulators|mesh-ancestor
56067391|NCT05648994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067392|NCT05648994|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067393|NCT05648994|Immunologic Factors|immunologic factors|mesh-ancestor
56067402|NCT04869306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067403|NCT04869306|Viscosupplements|viscosupplements|mesh-ancestor
56067404|NCT04869306|Protective Agents|protective agents|mesh-ancestor
56067406|NCT02268864|Antiviral Agents|antiviral agents|mesh-ancestor
56067407|NCT02268864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067408|NCT02268864|Protease Inhibitors|protease inhibitors|mesh-ancestor
56067409|NCT02268864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067410|NCT02268864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067411|NCT04859946|Cyclophosphamide|cyclophosphamide|mesh-list
56067412|NCT04859946|Busulfan|busulfan|mesh-list
56067413|NCT04859946|Thiotepa|thiotepa|mesh-list
56067414|NCT04859946|Fludarabine|fludarabine|mesh-list
56067415|NCT04859946|Tacrolimus|tacrolimus|mesh-list
56067416|NCT04859946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067417|NCT04859946|Immunologic Factors|immunologic factors|mesh-ancestor
56067418|NCT04859946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067419|NCT04859946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56067420|NCT04859946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56067421|NCT04859946|Alkylating Agents|alkylating agents|mesh-ancestor
56067422|NCT04859946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067423|NCT04859946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067424|NCT04859946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56067425|NCT04859946|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56067426|NCT04859946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067427|NCT02703779|Plerixafor|plerixafor|mesh-list
56067428|NCT02703779|Bortezomib|bortezomib|mesh-list
56067429|NCT02703779|Lenograstim|lenograstim|mesh-list
56067430|NCT02703779|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56067431|NCT02703779|Immunologic Factors|immunologic factors|mesh-ancestor
56067432|NCT02703779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067433|NCT02703779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067434|NCT02703779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56067435|NCT02703779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56067445|NCT02268396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067446|NCT02268396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067447|NCT02268396|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56067448|NCT02268396|Respiratory System Agents|respiratory system agents|mesh-ancestor
56067449|NCT02268396|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56067450|NCT02268396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56067451|NCT02268396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56067452|NCT02268396|Adrenergic Agents|adrenergic agents|mesh-ancestor
56067453|NCT02268396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067454|NCT02268396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067455|NCT02268396|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56067456|NCT02268396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56067457|NCT02268396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56067458|NCT02268396|Cholinergic Agents|cholinergic agents|mesh-ancestor
56067459|NCT05648526|Ketamine|ketamine|mesh-list
56067460|NCT05648526|Analgesics|analgesics|mesh-ancestor
56067461|NCT05648526|Sensory System Agents|sensory system agents|mesh-ancestor
56067462|NCT05648526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067463|NCT05648526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067464|NCT05648526|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56067465|NCT05648526|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56067466|NCT05648526|Anesthetics, General|anesthetics, general|mesh-ancestor
56067467|NCT05648526|Anesthetics|anesthetics|mesh-ancestor
56067468|NCT05648526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067469|NCT05648526|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56067470|NCT05648526|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56067471|NCT05648526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067472|NCT05648526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067473|NCT02705807|Epoprostenol|epoprostenol|mesh-list
56067490|NCT04868838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067491|NCT05278715|Carboplatin|carboplatin|mesh-list
56067492|NCT05278715|Vincristine|vincristine|mesh-list
56067493|NCT05278715|Endostatins|endostatins|mesh-list
56067494|NCT05278715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067495|NCT05278715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56067496|NCT05278715|Tubulin Modulators|tubulin modulators|mesh-ancestor
56067497|NCT05278715|Antimitotic Agents|antimitotic agents|mesh-ancestor
56067498|NCT05278715|Mitosis Modulators|mitosis modulators|mesh-ancestor
56067499|NCT05278715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067500|NCT05278715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56067501|NCT05278715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56067502|NCT05278715|Growth Substances|growth substances|mesh-ancestor
56067503|NCT05278715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067504|NCT05278715|Growth Inhibitors|growth inhibitors|mesh-ancestor
56067505|NCT02712047|Fluticasone|fluticasone|mesh-list
56067506|NCT02712047|Xhance|xhance|mesh-list
56067507|NCT02712047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067508|NCT02712047|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56067509|NCT02712047|Autonomic Agents|autonomic agents|mesh-ancestor
56067510|NCT02712047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067511|NCT02712047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067512|NCT02712047|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56067513|NCT02712047|Respiratory System Agents|respiratory system agents|mesh-ancestor
56067514|NCT02712047|Dermatologic Agents|dermatologic agents|mesh-ancestor
56067515|NCT02712047|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56067516|NCT02717273|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56067517|NCT02717273|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56067518|NCT02717273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794713|NCT05189535|Paclitaxel|paclitaxel|mesh-list
56067519|NCT02717273|Antitubercular Agents|antitubercular agents|mesh-ancestor
56067520|NCT00369239|Risperidone|risperidone|mesh-list
56067521|NCT00369239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56067522|NCT00369239|Serotonin Agents|serotonin agents|mesh-ancestor
56067523|NCT00369239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067528|NCT00369239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067529|NCT00369239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56067530|NCT00369239|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56067531|NCT00369239|Dopamine Agents|dopamine agents|mesh-ancestor
56067532|NCT03833921|Prednisone|prednisone|mesh-list
56067533|NCT03833921|Abiraterone Acetate|abiraterone acetate|mesh-list
56067534|NCT03833921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067535|NCT03833921|Glucocorticoids|glucocorticoids|mesh-ancestor
56067536|NCT03833921|Hormones|hormones|mesh-ancestor
56067537|NCT03833921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56067538|NCT03833921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067539|NCT03833921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56067540|NCT03833921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067541|NCT03833921|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56067542|NCT03833921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067543|NCT03833921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067544|NCT03833921|Hormone Antagonists|hormone antagonists|mesh-ancestor
56067545|NCT03833921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56067546|NCT05215925|Carboplatin|carboplatin|mesh-list
56067547|NCT05215925|Docetaxel|docetaxel|mesh-list
56067548|NCT05215925|Pemetrexed|pemetrexed|mesh-list
56067549|NCT05215925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067550|NCT05215925|Tubulin Modulators|tubulin modulators|mesh-ancestor
56067551|NCT05215925|Antimitotic Agents|antimitotic agents|mesh-ancestor
56067552|NCT05215925|Mitosis Modulators|mitosis modulators|mesh-ancestor
56067553|NCT05215925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067554|NCT05215925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067555|NCT05215925|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56067556|NCT05215925|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56067557|NCT05159687|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56067558|NCT05159687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56067559|NCT05159687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56067568|NCT02721017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067569|NCT02721017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067571|NCT02721017|Sensory System Agents|sensory system agents|mesh-ancestor
56067572|NCT02721017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067573|NCT02721017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56067574|NCT02721017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56067576|NCT02721017|Anesthetics|anesthetics|mesh-ancestor
56067577|NCT02721641|Trastuzumab|trastuzumab|mesh-list
56067578|NCT02721641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067579|NCT02721641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067580|NCT03649061|Etanercept|etanercept|mesh-list
56067581|NCT03649061|Leflunomide|leflunomide|mesh-list
56067582|NCT03649061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56067583|NCT03649061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56067584|NCT03649061|Analgesics|analgesics|mesh-ancestor
56067585|NCT03649061|Sensory System Agents|sensory system agents|mesh-ancestor
56067586|NCT03649061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067587|NCT03649061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067588|NCT03649061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067589|NCT03649061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56067590|NCT03649061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56067622|NCT00085735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56067623|NCT00085735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56067624|NCT00085735|Alkylating Agents|alkylating agents|mesh-ancestor
56067625|NCT00085735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067626|NCT00085735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067627|NCT00085735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56067628|NCT00085735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56067629|NCT00085735|Tubulin Modulators|tubulin modulators|mesh-ancestor
56067630|NCT00085735|Antimitotic Agents|antimitotic agents|mesh-ancestor
56067631|NCT00085735|Mitosis Modulators|mitosis modulators|mesh-ancestor
56067632|NCT03578783|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56067633|NCT03578783|Anesthetics, Local|anesthetics, local|mesh-ancestor
56067634|NCT03578783|Anesthetics|anesthetics|mesh-ancestor
56067635|NCT03578783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067636|NCT03578783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067637|NCT03578783|Sensory System Agents|sensory system agents|mesh-ancestor
56067638|NCT03578783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067640|NCT03538457|Acetaminophen|acetaminophen|mesh-list
56067641|NCT03538457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56067642|NCT03538457|Analgesics|analgesics|mesh-ancestor
56067643|NCT03538457|Sensory System Agents|sensory system agents|mesh-ancestor
56067644|NCT03538457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067646|NCT03538457|Antipyretics|antipyretics|mesh-ancestor
56067672|NCT02731313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067673|NCT02281591|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56067675|NCT02281591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56067676|NCT02281591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56067677|NCT02281591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56067844|NCT04768231|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56067678|NCT02281591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067679|NCT02731469|Darbepoetin alfa|darbepoetin alfa|mesh-list
56067680|NCT02731469|Hematinics|hematinics|mesh-ancestor
56067681|NCT05107427|Avelumab|avelumab|mesh-list
56067682|NCT05107427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067683|NCT05107427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067684|NCT03445949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56067685|NCT01944319|Meropenem|meropenem|mesh-list
56067686|NCT01944319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56067687|NCT01944319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067688|NCT00368303|Paroxetine|paroxetine|mesh-list
56067689|NCT00368303|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56067690|NCT00368303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56067691|NCT00368303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56067692|NCT00368303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067693|NCT00368303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56067694|NCT00368303|Serotonin Agents|serotonin agents|mesh-ancestor
56067695|NCT00368303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067698|NCT00368303|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56067720|NCT00369395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56067721|NCT00369395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56067722|NCT00369395|Growth Substances|growth substances|mesh-ancestor
56067723|NCT00369395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067725|NCT00369395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067726|NCT01947907|Hormones|hormones|mesh-list
56067727|NCT01947907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56067728|NCT01947907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067729|NCT01948141|Nintedanib|nintedanib|mesh-list
56067730|NCT01948141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067731|NCT01948141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56067732|NCT01948141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067733|NCT01948141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067734|NCT04938323|BCG Vaccine|bcg vaccine|mesh-list
56067735|NCT04938323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56067736|NCT04938323|Immunologic Factors|immunologic factors|mesh-ancestor
56067737|NCT04938323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067738|NCT05446493|Tadalafil|tadalafil|mesh-list
56067739|NCT05446493|Vasodilator Agents|vasodilator agents|mesh-ancestor
56067740|NCT05446493|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56067741|NCT05446493|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56067770|NCT05445011|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56067771|NCT05445011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56067772|NCT05445011|Antimetabolites|antimetabolites|mesh-ancestor
56067773|NCT04782245|Dapagliflozin|dapagliflozin|mesh-list
56067774|NCT04782245|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56067775|NCT04782245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067776|NCT04782245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56067777|NCT04782245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067778|NCT04770155|Bosentan|bosentan|mesh-list
56067779|NCT04770155|Sildenafil Citrate|sildenafil citrate|mesh-list
56067780|NCT04770155|Vasodilator Agents|vasodilator agents|mesh-ancestor
56067781|NCT04770155|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56067782|NCT04770155|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56067783|NCT04770155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067784|NCT04770155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067785|NCT04770155|Urological Agents|urological agents|mesh-ancestor
56067786|NCT04770155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56067828|NCT04739111|Immunologic Factors|immunologic factors|mesh-ancestor
56067829|NCT04739111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067830|NCT04768231|Rifampin|rifampin|mesh-list
56067831|NCT04768231|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56067832|NCT04768231|Antitubercular Agents|antitubercular agents|mesh-ancestor
56067833|NCT04768231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56067834|NCT04768231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067836|NCT04768231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56067837|NCT04768231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067838|NCT04768231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067839|NCT04768231|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56067840|NCT04768231|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56067841|NCT04768231|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56067842|NCT04768231|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56067843|NCT04768231|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56067845|NCT05452187|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56067846|NCT05452187|Immunologic Factors|immunologic factors|mesh-ancestor
56067847|NCT05452187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067848|NCT01889797|Rituximab|rituximab|mesh-list
56067849|NCT01889797|Obinutuzumab|obinutuzumab|mesh-list
56067850|NCT01889797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067851|NCT01889797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067852|NCT01889797|Immunologic Factors|immunologic factors|mesh-ancestor
56067853|NCT01889797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067854|NCT01889797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56067855|NCT00369551|Paclitaxel|paclitaxel|mesh-list
56067856|NCT00369551|Bevacizumab|bevacizumab|mesh-list
56067857|NCT00369551|Carboplatin|carboplatin|mesh-list
56067858|NCT00369551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56067859|NCT00369551|Antibodies|antibodies|mesh-list
56067869|NCT00369551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56067870|NCT00369551|Growth Substances|growth substances|mesh-ancestor
56067871|NCT00369551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067872|NCT00369551|Growth Inhibitors|growth inhibitors|mesh-ancestor
56067873|NCT00369551|Immunologic Factors|immunologic factors|mesh-ancestor
56067874|NCT04537793|Ivacaftor|ivacaftor|mesh-list
56067875|NCT04537793|Elexacaftor|elexacaftor|mesh-list
56067876|NCT04537793|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56067877|NCT04537793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56067878|NCT04537793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067879|NCT04458545|Heroin|heroin|mesh-list
56067880|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56067881|NCT04458545|Narcotics|narcotics|mesh-ancestor
56067882|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56067883|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067884|NCT04458545|Analgesics|analgesics|mesh-ancestor
56067885|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
56067886|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067887|NCT05451173|Durvalumab|durvalumab|mesh-list
56067888|NCT05451173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067889|NCT05451173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067891|NCT04408625|Prednisone|prednisone|mesh-list
56067892|NCT04408625|Methylprednisolone|methylprednisolone|mesh-list
56067893|NCT04408625|Rituximab|rituximab|mesh-list
56067894|NCT04408625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067895|NCT04408625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067896|NCT04408625|Immunologic Factors|immunologic factors|mesh-ancestor
56067897|NCT04408625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067898|NCT04408625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56067899|NCT04408625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067900|NCT04408625|Glucocorticoids|glucocorticoids|mesh-ancestor
56067902|NCT04408625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56067903|NCT04408625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56067904|NCT04408625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56067905|NCT04408625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067909|NCT04408625|Antiemetics|antiemetics|mesh-ancestor
56067910|NCT04408625|Autonomic Agents|autonomic agents|mesh-ancestor
56067911|NCT04408625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56067912|NCT04408625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56067913|NCT04408625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56067914|NCT04408625|Protective Agents|protective agents|mesh-ancestor
56067915|NCT05437601|Carotenoids|carotenoids|mesh-list
56067916|NCT05437601|Antioxidants|antioxidants|mesh-ancestor
56067917|NCT05437601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067918|NCT05437601|Protective Agents|protective agents|mesh-ancestor
56067919|NCT05437601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067920|NCT05449145|Vitamin D|vitamin d|mesh-list
56067921|NCT05449145|Vitamins|vitamins|mesh-ancestor
56067922|NCT05449145|Micronutrients|micronutrients|mesh-ancestor
56067923|NCT05449145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067924|NCT05449145|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56067925|NCT05447039|Montelukast|montelukast|mesh-list
56067926|NCT05447039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56067927|NCT05447039|Respiratory System Agents|respiratory system agents|mesh-ancestor
56067928|NCT05447039|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56067929|NCT05447039|Hormone Antagonists|hormone antagonists|mesh-ancestor
56067930|NCT05447039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56067931|NCT05447039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067932|NCT05447039|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56067933|NCT05447039|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56067934|NCT05447039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067936|NCT05446805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067937|NCT05446727|Ropivacaine|ropivacaine|mesh-list
56067955|NCT05448365|Pyridoxine|pyridoxine|mesh-list
56067956|NCT05448365|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
56067957|NCT05448365|Micronutrients|micronutrients|mesh-ancestor
56067958|NCT05448365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067959|NCT05448365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56067960|NCT05448365|Vitamin B Complex|vitamin b complex|mesh-ancestor
56067961|NCT05448365|Antioxidants|antioxidants|mesh-ancestor
56067962|NCT05448365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067963|NCT05448365|Protective Agents|protective agents|mesh-ancestor
56067964|NCT05448365|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56067965|NCT05448365|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56067966|NCT05448365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067967|NCT05448365|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56067968|NCT03137771|Gemcitabine|gemcitabine|mesh-list
56067969|NCT03137771|Docetaxel|docetaxel|mesh-list
56067970|NCT03137771|Pembrolizumab|pembrolizumab|mesh-list
56067971|NCT03137771|Pemetrexed|pemetrexed|mesh-list
56067972|NCT03137771|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56067973|NCT03137771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56067974|NCT03137771|Antimetabolites|antimetabolites|mesh-ancestor
56067975|NCT03137771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56067976|NCT03137771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56067977|NCT03137771|Antiviral Agents|antiviral agents|mesh-ancestor
56067978|NCT03137771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56067979|NCT03137771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56067980|NCT03137771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56067981|NCT03137771|Immunologic Factors|immunologic factors|mesh-ancestor
56067982|NCT03137771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56067983|NCT03137771|Tubulin Modulators|tubulin modulators|mesh-ancestor
56067984|NCT03137771|Antimitotic Agents|antimitotic agents|mesh-ancestor
56067985|NCT03137771|Mitosis Modulators|mitosis modulators|mesh-ancestor
56067986|NCT03137771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56067987|NCT03137771|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56067988|NCT03137771|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56067989|NCT03137771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56067995|NCT00370799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56067996|NCT00370799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56067998|NCT00370799|Hormones|hormones|mesh-ancestor
56067999|NCT00370799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068000|NCT00370799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068001|NCT00370799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56068002|NCT00370799|Respiratory System Agents|respiratory system agents|mesh-ancestor
56068003|NCT05444777|Ketamine|ketamine|mesh-list
56068004|NCT05444777|Analgesics|analgesics|mesh-ancestor
56068005|NCT05444777|Sensory System Agents|sensory system agents|mesh-ancestor
56068006|NCT05444777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068007|NCT05444777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068008|NCT05444777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56068009|NCT05444777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56068010|NCT05444777|Anesthetics, General|anesthetics, general|mesh-ancestor
56068011|NCT05444777|Anesthetics|anesthetics|mesh-ancestor
56068012|NCT05444777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068013|NCT05444777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56068014|NCT05444777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56068015|NCT05444777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068016|NCT05444777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068017|NCT02661971|Leucovorin|leucovorin|mesh-list
56068018|NCT02661971|Docetaxel|docetaxel|mesh-list
56068019|NCT02661971|Fluorouracil|fluorouracil|mesh-list
56068020|NCT02661971|Oxaliplatin|oxaliplatin|mesh-list
56068021|NCT02661971|Ramucirumab|ramucirumab|mesh-list
56068022|NCT02661971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068023|NCT02661971|Tubulin Modulators|tubulin modulators|mesh-ancestor
56068024|NCT02661971|Antimitotic Agents|antimitotic agents|mesh-ancestor
56068025|NCT02661971|Mitosis Modulators|mitosis modulators|mesh-ancestor
56068026|NCT02661971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068027|NCT02661971|Antimetabolites|antimetabolites|mesh-ancestor
56068028|NCT02661971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56068029|NCT02661971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56068030|NCT02661971|Immunologic Factors|immunologic factors|mesh-ancestor
56068033|NCT02661971|Protective Agents|protective agents|mesh-ancestor
56068034|NCT02661971|Vitamin B Complex|vitamin b complex|mesh-ancestor
56068036|NCT02661971|Micronutrients|micronutrients|mesh-ancestor
56068037|NCT05442905|Anesthetics|anesthetics|mesh-list
56068038|NCT05442905|Propofol|propofol|mesh-list
56068041|NCT05442905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068042|NCT05442905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068043|NCT05442905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56068044|NCT05442905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56068045|NCT05442905|Anesthetics, General|anesthetics, general|mesh-ancestor
56068046|NCT05442905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56068047|NCT05442905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56068048|NCT05442905|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56068049|NCT05442905|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56068050|NCT05442905|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56068051|NCT05442905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068052|NCT05442905|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56068053|NCT05442905|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56068054|NCT05442905|Cholinergic Agents|cholinergic agents|mesh-ancestor
56068055|NCT05442905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068056|NCT05442905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068057|NCT00369863|Triamcinolone|triamcinolone|mesh-list
56068058|NCT00369863|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56068059|NCT00369863|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56068060|NCT00369863|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56068061|NCT00369863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068062|NCT00369863|Glucocorticoids|glucocorticoids|mesh-ancestor
56068063|NCT00369863|Hormones|hormones|mesh-ancestor
56068064|NCT00369863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068067|NCT00369863|Immunologic Factors|immunologic factors|mesh-ancestor
56068075|NCT02656511|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56068076|NCT02656511|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56068077|NCT02656511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068078|NCT02656511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068079|NCT02656511|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56068080|NCT02656511|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56068081|NCT02656511|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56068082|NCT02656511|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56068083|NCT01890343|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56068084|NCT01890343|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56068085|NCT01890343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068086|NCT02588027|Ibuprofen|ibuprofen|mesh-list
56068087|NCT02588027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56068088|NCT02588027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56068089|NCT02588027|Analgesics|analgesics|mesh-ancestor
56068090|NCT02588027|Sensory System Agents|sensory system agents|mesh-ancestor
56068091|NCT02588027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068092|NCT02588027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068093|NCT02588027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068094|NCT02588027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56068095|NCT02588027|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56068096|NCT02588027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068097|NCT02588027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068098|NCT05735431|Fluticasone|fluticasone|mesh-list
56068099|NCT05735431|Formoterol Fumarate|formoterol fumarate|mesh-list
56068100|NCT05735431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068101|NCT05735431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56068102|NCT05735431|Autonomic Agents|autonomic agents|mesh-ancestor
56068103|NCT05735431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068104|NCT05735431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068117|NCT04483583|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56068118|NCT04483583|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56068119|NCT04483583|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56068120|NCT04483583|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56068121|NCT04483583|Purinergic Agents|purinergic agents|mesh-ancestor
56068122|NCT04483583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068123|NCT04483583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068124|NCT04483583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068125|NCT04449965|Povidone-Iodine|povidone-iodine|mesh-list
56068126|NCT04449965|Povidone|povidone|mesh-list
56068127|NCT04449965|Plasma Substitutes|plasma substitutes|mesh-ancestor
56068128|NCT04449965|Blood Substitutes|blood substitutes|mesh-ancestor
56068129|NCT04449965|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56068130|NCT04449965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068131|NCT01951339|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56068132|NCT01951339|Glimepiride|glimepiride|mesh-list
56068133|NCT01951339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56068134|NCT01951339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068137|NCT01951339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068138|NCT01951339|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56068139|NCT01951339|Protease Inhibitors|protease inhibitors|mesh-ancestor
56068140|NCT01951339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068141|NCT01951339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068142|NCT01951339|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56068143|NCT01951339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56068144|NCT01951339|Immunologic Factors|immunologic factors|mesh-ancestor
56068145|NCT05431673|Doxycycline|doxycycline|mesh-list
56068146|NCT05431673|Ciprofloxacin|ciprofloxacin|mesh-list
56068147|NCT05431673|Rifampin|rifampin|mesh-list
56068148|NCT05431673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56068149|NCT05431673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068150|NCT05431673|Antimalarials|antimalarials|mesh-ancestor
56068151|NCT05431673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56068156|NCT05431673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068157|NCT05431673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068158|NCT05431673|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56068159|NCT05431673|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56068160|NCT05431673|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56068161|NCT05431673|Antitubercular Agents|antitubercular agents|mesh-ancestor
56068162|NCT05431673|Leprostatic Agents|leprostatic agents|mesh-ancestor
56068163|NCT05431673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56068164|NCT05431673|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56068165|NCT05431673|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56068166|NCT05431673|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56068167|NCT05431673|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56068168|NCT05431673|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56068169|NCT05431673|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56068170|NCT01951651|Exenatide|exenatide|mesh-list
56068171|NCT01951651|Glipizide|glipizide|mesh-list
56068172|NCT01951651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56068173|NCT01951651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068174|NCT01951651|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56068175|NCT01951651|Incretins|incretins|mesh-ancestor
56068176|NCT01951651|Hormones|hormones|mesh-ancestor
56068177|NCT01951651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068178|NCT02466581|Hydroxychloroquine|hydroxychloroquine|mesh-list
56068179|NCT02466581|Sulfasalazine|sulfasalazine|mesh-list
56068180|NCT02466581|Prednisolone|prednisolone|mesh-list
56068181|NCT02466581|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56068182|NCT02466581|Methylprednisolone|methylprednisolone|mesh-list
56068183|NCT02466581|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56068184|NCT02466581|Prednisolone acetate|prednisolone acetate|mesh-list
56068185|NCT02466581|Abatacept|abatacept|mesh-list
56068186|NCT02466581|Certolizumab Pegol|certolizumab pegol|mesh-list
56068187|NCT02466581|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56068197|NCT02466581|Autonomic Agents|autonomic agents|mesh-ancestor
56068198|NCT02466581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068199|NCT02466581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56068200|NCT02466581|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56068201|NCT02466581|Protective Agents|protective agents|mesh-ancestor
56068202|NCT02466581|Antimalarials|antimalarials|mesh-ancestor
56068203|NCT02466581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56068204|NCT02466581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56068205|NCT02466581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068206|NCT02466581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068207|NCT02466581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068208|NCT02466581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56068209|NCT02466581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56068210|NCT02466581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56068211|NCT02466581|Immunologic Factors|immunologic factors|mesh-ancestor
56068212|NCT02466581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56068213|NCT02466581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56068214|NCT02466581|Analgesics|analgesics|mesh-ancestor
56068215|NCT02466581|Sensory System Agents|sensory system agents|mesh-ancestor
56068216|NCT01951963|Ketamine|ketamine|mesh-list
56068217|NCT01951963|Morphine|morphine|mesh-list
56068218|NCT01951963|Analgesics|analgesics|mesh-ancestor
56068219|NCT01951963|Sensory System Agents|sensory system agents|mesh-ancestor
56068220|NCT01951963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068221|NCT01951963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068222|NCT01951963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56068223|NCT01951963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56068224|NCT01951963|Anesthetics, General|anesthetics, general|mesh-ancestor
56068226|NCT01951963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068227|NCT01951963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56068228|NCT01951963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56068229|NCT01951963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068230|NCT01951963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068231|NCT01951963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56068232|NCT01951963|Narcotics|narcotics|mesh-ancestor
56068233|NCT02377271|Bosentan|bosentan|mesh-list
56068234|NCT02377271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56068235|NCT02377271|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56068236|NCT02377271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068237|NCT01894555|Aspirin|aspirin|mesh-list
56068238|NCT01894555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56068239|NCT01894555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56068240|NCT01894555|Analgesics|analgesics|mesh-ancestor
56068241|NCT01894555|Sensory System Agents|sensory system agents|mesh-ancestor
56068242|NCT01894555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068243|NCT01894555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068244|NCT01894555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068245|NCT01894555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56068246|NCT01894555|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56068247|NCT01894555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56068248|NCT01894555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068249|NCT01894555|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56068250|NCT01894555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56068251|NCT01894555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068252|NCT01894555|Antipyretics|antipyretics|mesh-ancestor
56068253|NCT02344355|Ascorbic Acid|ascorbic acid|mesh-list
56068254|NCT02344355|Temozolomide|temozolomide|mesh-list
56068255|NCT02344355|Vitamins|vitamins|mesh-ancestor
56068256|NCT02344355|Micronutrients|micronutrients|mesh-ancestor
56068257|NCT02344355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068258|NCT02344355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56068259|NCT02344355|Alkylating Agents|alkylating agents|mesh-ancestor
56068260|NCT02344355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068261|NCT02344355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068262|NCT02344355|Antioxidants|antioxidants|mesh-ancestor
56068263|NCT02344355|Protective Agents|protective agents|mesh-ancestor
56068264|NCT05735353|Methamphetamine|methamphetamine|mesh-list
56068265|NCT05735353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56068266|NCT05735353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068267|NCT05735353|Sympathomimetics|sympathomimetics|mesh-ancestor
56068268|NCT05735353|Autonomic Agents|autonomic agents|mesh-ancestor
56068270|NCT05735353|Dopamine Agents|dopamine agents|mesh-ancestor
56068271|NCT05735353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795465|NCT05022147|Dopamine Agents|dopamine agents|mesh-ancestor
56068272|NCT05735353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068273|NCT05735353|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068274|NCT05735353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56068275|NCT05735353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56068276|NCT05735353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56068277|NCT05735353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56068278|NCT01953211|Contraceptive Agents|contraceptive agents|mesh-list
56068279|NCT01953211|Norinyl|norinyl|mesh-list
56068280|NCT01953211|Contraceptives, Oral|contraceptives, oral|mesh-list
56068281|NCT01953211|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56068282|NCT01953211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56068283|NCT01953211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068284|NCT01953211|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56068285|NCT01953211|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56068286|NCT01953211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56068287|NCT02028221|Metformin|metformin|mesh-list
56068288|NCT02028221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56068289|NCT02028221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068291|NCT05735197|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56068292|NCT05735197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068294|NCT05735197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068316|NCT00370253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068317|NCT00370253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068318|NCT00370253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068319|NCT00370253|Sympathomimetics|sympathomimetics|mesh-ancestor
56068320|NCT00370253|Autonomic Agents|autonomic agents|mesh-ancestor
56068456|NCT05161637|Anesthetics, Local|anesthetics, local|mesh-ancestor
56068321|NCT00370253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068323|NCT01491815|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56068324|NCT01491815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068325|NCT01491815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068326|NCT01491815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56068327|NCT01491815|Immunologic Factors|immunologic factors|mesh-ancestor
56068328|NCT01491815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068329|NCT01491815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56068330|NCT04359953|Azithromycin|azithromycin|mesh-list
56068331|NCT04359953|Hydroxychloroquine|hydroxychloroquine|mesh-list
56068332|NCT04359953|Telmisartan|telmisartan|mesh-list
56068333|NCT04359953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56068334|NCT04359953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068335|NCT04359953|Antimalarials|antimalarials|mesh-ancestor
56068336|NCT04359953|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56068337|NCT04359953|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56068338|NCT04359953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068339|NCT04359953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068340|NCT04359953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56068341|NCT04359953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56068343|NCT04359953|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56068359|NCT01211405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068360|NCT01211405|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56068361|NCT01211405|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56068362|NCT01211405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56068363|NCT01211405|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068365|NCT04338191|Fluorouracil|fluorouracil|mesh-list
56068366|NCT04338191|Oxaliplatin|oxaliplatin|mesh-list
56068367|NCT04338191|Irinotecan|irinotecan|mesh-list
56068368|NCT04338191|Levoleucovorin|levoleucovorin|mesh-list
56068369|NCT04338191|Antimetabolites|antimetabolites|mesh-ancestor
56068370|NCT04338191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068371|NCT04338191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56068372|NCT04338191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068373|NCT04338191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56068374|NCT04338191|Immunologic Factors|immunologic factors|mesh-ancestor
56068375|NCT04338191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068376|NCT04338191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56068377|NCT04338191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56068378|NCT04338191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068379|NCT04338191|Antidotes|antidotes|mesh-ancestor
56068380|NCT04338191|Protective Agents|protective agents|mesh-ancestor
56068381|NCT04338191|Vitamin B Complex|vitamin b complex|mesh-ancestor
56068382|NCT04338191|Vitamins|vitamins|mesh-ancestor
56068383|NCT04338191|Micronutrients|micronutrients|mesh-ancestor
56068384|NCT04303559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56068385|NCT04303559|Immunologic Factors|immunologic factors|mesh-ancestor
56068386|NCT04303559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068387|NCT00481091|Navitoclax|navitoclax|mesh-list
56068388|NCT00481091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068406|NCT00371111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068407|NCT00371111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56068408|NCT00371111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56068409|NCT00371111|Growth Substances|growth substances|mesh-ancestor
56068410|NCT00371111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068411|NCT00371111|Growth Inhibitors|growth inhibitors|mesh-ancestor
56068412|NCT00371111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068413|NCT00371111|Glucocorticoids|glucocorticoids|mesh-ancestor
56068414|NCT00371111|Hormones|hormones|mesh-ancestor
56068415|NCT00371111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068416|NCT05454683|Melatonin|melatonin|mesh-list
56068417|NCT05454683|Antioxidants|antioxidants|mesh-ancestor
56068418|NCT05454683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068419|NCT05454683|Protective Agents|protective agents|mesh-ancestor
56068420|NCT05454683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068421|NCT05454683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068422|NCT05193071|Aspirin|aspirin|mesh-list
56068423|NCT05193071|Clopidogrel|clopidogrel|mesh-list
56068424|NCT05193071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56068425|NCT05193071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56068426|NCT05193071|Analgesics|analgesics|mesh-ancestor
56068427|NCT05193071|Sensory System Agents|sensory system agents|mesh-ancestor
56068428|NCT05193071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068453|NCT05180825|Mitosis Modulators|mitosis modulators|mesh-ancestor
56068454|NCT05161637|Bupivacaine|bupivacaine|mesh-list
56068455|NCT05161637|Ropivacaine|ropivacaine|mesh-list
56068458|NCT05161637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068459|NCT05161637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068460|NCT05161637|Sensory System Agents|sensory system agents|mesh-ancestor
56068461|NCT05161637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068462|NCT05139095|Apatinib|apatinib|mesh-list
56068463|NCT05139095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068464|NCT05139095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56068465|NCT05139095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068466|NCT05139095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068467|NCT05453435|Entecavir|entecavir|mesh-list
56068468|NCT05453435|Antiviral Agents|antiviral agents|mesh-ancestor
56068469|NCT05453435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068470|NCT03029845|Propranolol|propranolol|mesh-list
56068471|NCT03029845|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56068472|NCT03029845|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56068473|NCT03029845|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068474|NCT03029845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068475|NCT03029845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068476|NCT03029845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068477|NCT03029845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56068478|NCT03029845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56068479|NCT03029845|Vasodilator Agents|vasodilator agents|mesh-ancestor
56068480|NCT05451719|Capecitabine|capecitabine|mesh-list
56068500|NCT01898689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068501|NCT01898689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068502|NCT01898689|Sensory System Agents|sensory system agents|mesh-ancestor
56068503|NCT01898689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068506|NCT04021121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068507|NCT04021121|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56068508|NCT04021121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068509|NCT04021121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068511|NCT05062577|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56068512|NCT05062577|ASP8062|asp8062|mesh-list
56068513|NCT05062577|Naloxone|naloxone|mesh-list
56068514|NCT05062577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56068515|NCT05062577|Narcotics|narcotics|mesh-ancestor
56068516|NCT05062577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068517|NCT05062577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068518|NCT05062577|Analgesics|analgesics|mesh-ancestor
56068519|NCT05062577|Sensory System Agents|sensory system agents|mesh-ancestor
56068520|NCT05062577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068521|NCT05062577|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56068522|NCT05062577|GABA Modulators|gaba modulators|mesh-ancestor
56068523|NCT05062577|GABA Agents|gaba agents|mesh-ancestor
56068524|NCT05062577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068525|NCT05062577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068526|NCT05448989|Atropine|atropine|mesh-list
56068527|NCT05448989|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56068528|NCT05448989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56068529|NCT05448989|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56068530|NCT05448989|Autonomic Agents|autonomic agents|mesh-ancestor
56068531|NCT05448989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068532|NCT05448989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068533|NCT05448989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56068540|NCT05448989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068541|NCT05448989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068543|NCT00370565|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56068544|NCT00370565|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56068545|NCT00370565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068546|NCT05039723|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56068547|NCT05039723|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56068548|NCT05039723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068549|NCT05039723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068550|NCT05039723|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56068551|NCT05039723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56068552|NCT05039723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068553|NCT05039723|Cholinergic Agents|cholinergic agents|mesh-ancestor
56068554|NCT05039723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068555|NCT03970655|Dexamethasone|dexamethasone|mesh-list
56068556|NCT03970655|Dexamethasone acetate|dexamethasone acetate|mesh-list
56068557|NCT03970655|Epinephrine|epinephrine|mesh-list
56068558|NCT03970655|Racepinephrine|racepinephrine|mesh-list
56068559|NCT03970655|Bupivacaine|bupivacaine|mesh-list
56068560|NCT03970655|Epinephryl borate|epinephryl borate|mesh-list
56068562|NCT03970655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068564|NCT03970655|Autonomic Agents|autonomic agents|mesh-ancestor
56068565|NCT03970655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068566|NCT03970655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068567|NCT03970655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56068568|NCT03970655|Glucocorticoids|glucocorticoids|mesh-ancestor
56068569|NCT03970655|Hormones|hormones|mesh-ancestor
56068570|NCT03970655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068571|NCT03970655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56068572|NCT03970655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068573|NCT03970655|Protease Inhibitors|protease inhibitors|mesh-ancestor
56068574|NCT03970655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068579|NCT03970655|Sensory System Agents|sensory system agents|mesh-ancestor
56068580|NCT03970655|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56068581|NCT03970655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56068582|NCT03970655|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068583|NCT03970655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068584|NCT03970655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56068585|NCT03970655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56068586|NCT03970655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56068587|NCT03970655|Respiratory System Agents|respiratory system agents|mesh-ancestor
56068588|NCT03970655|Mydriatics|mydriatics|mesh-ancestor
56068589|NCT03970655|Sympathomimetics|sympathomimetics|mesh-ancestor
56068590|NCT03970655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56068591|NCT00370019|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56068592|NCT00370019|Medroxyprogesterone|medroxyprogesterone|mesh-list
56068594|NCT00370019|Estrogens|estrogens|mesh-ancestor
56068595|NCT00370019|Hormones|hormones|mesh-ancestor
56068596|NCT00370019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068597|NCT00370019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068598|NCT00370019|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56068599|NCT00370019|Contraceptive Agents|contraceptive agents|mesh-ancestor
56068600|NCT00370019|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56068601|NCT00370019|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56068602|NCT00370019|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56068603|NCT00370019|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56068604|NCT00370019|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56068605|NCT00370019|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56068606|NCT00370019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56068607|NCT00370019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068608|NCT03888131|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56068609|NCT03888131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56068610|NCT03888131|Respiratory System Agents|respiratory system agents|mesh-ancestor
56068611|NCT01900249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56068612|NCT01900249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56068613|NCT04969211|Iloperidone|iloperidone|mesh-list
56068614|NCT04969211|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56068616|NCT04969211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068617|NCT04969211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068618|NCT04969211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56068619|NCT01901575|Remifentanil|remifentanil|mesh-list
56068620|NCT01901575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56068621|NCT01901575|Narcotics|narcotics|mesh-ancestor
56068622|NCT01901575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068623|NCT01901575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068624|NCT01901575|Analgesics|analgesics|mesh-ancestor
56068625|NCT01901575|Sensory System Agents|sensory system agents|mesh-ancestor
56068626|NCT01901575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068627|NCT03754049|Dexamethasone|dexamethasone|mesh-list
56068628|NCT03754049|Dexamethasone acetate|dexamethasone acetate|mesh-list
56068629|NCT03754049|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56068631|NCT03754049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068632|NCT03754049|Antiemetics|antiemetics|mesh-ancestor
56068633|NCT03754049|Autonomic Agents|autonomic agents|mesh-ancestor
56068634|NCT03754049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790879|NCT01799629|Glycerol|glycerol|mesh-list
56068635|NCT03754049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068636|NCT03754049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56068637|NCT03754049|Glucocorticoids|glucocorticoids|mesh-ancestor
56068638|NCT03754049|Hormones|hormones|mesh-ancestor
56068639|NCT03754049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068640|NCT03754049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56068641|NCT03754049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068642|NCT03754049|Protease Inhibitors|protease inhibitors|mesh-ancestor
56068643|NCT03754049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068664|NCT04947527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068666|NCT05005403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56068667|NCT05005403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068668|NCT03029533|Leuprolide|leuprolide|mesh-list
56068669|NCT03029533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56068670|NCT03029533|Fertility Agents|fertility agents|mesh-ancestor
56068671|NCT03029533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56068672|NCT03029533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068673|NCT03029533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56068674|NCT03029533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068675|NCT04921007|Bupivacaine|bupivacaine|mesh-list
56068676|NCT04921007|Anesthetics, Local|anesthetics, local|mesh-ancestor
56068677|NCT04921007|Anesthetics|anesthetics|mesh-ancestor
56068678|NCT04921007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068679|NCT04921007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068680|NCT04921007|Sensory System Agents|sensory system agents|mesh-ancestor
56068681|NCT04921007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068682|NCT01904071|Morphine|morphine|mesh-list
56068683|NCT01904071|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56068684|NCT01904071|Narcotics|narcotics|mesh-ancestor
56068685|NCT01904071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068686|NCT01904071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068687|NCT01904071|Analgesics|analgesics|mesh-ancestor
56068688|NCT01904071|Sensory System Agents|sensory system agents|mesh-ancestor
56068689|NCT01904071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068690|NCT03620981|Brexpiprazole|brexpiprazole|mesh-list
56068691|NCT03620981|Serotonin Agents|serotonin agents|mesh-ancestor
56068692|NCT03620981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068693|NCT03620981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068694|NCT03620981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068695|NCT03620981|Dopamine Agonists|dopamine agonists|mesh-ancestor
56068696|NCT03620981|Dopamine Agents|dopamine agents|mesh-ancestor
56068697|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56068698|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56068699|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56068702|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56068703|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56068704|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068705|NCT01907113|Empagliflozin|empagliflozin|mesh-list
56068706|NCT01907113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56068707|NCT01907113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068708|NCT01907113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56068709|NCT01907113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068710|NCT00370643|Insulin|insulin|mesh-list
56068711|NCT00370643|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56068712|NCT00370643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56068713|NCT00370643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068714|NCT01908127|Salicylic Acid|salicylic acid|mesh-list
56068715|NCT01908127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068716|NCT01908127|Antifungal Agents|antifungal agents|mesh-ancestor
56068718|NCT01908127|Dermatologic Agents|dermatologic agents|mesh-ancestor
56068719|NCT04679831|Praziquantel|praziquantel|mesh-list
56068720|NCT04679831|Anthelmintics|anthelmintics|mesh-ancestor
56068721|NCT04679831|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56068722|NCT04679831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068723|NCT01908751|Vitamin D|vitamin d|mesh-list
56068724|NCT01908751|Ergocalciferols|ergocalciferols|mesh-list
56068725|NCT01908751|Cholecalciferol|cholecalciferol|mesh-list
56068726|NCT01908751|Vitamins|vitamins|mesh-list
56068727|NCT01908751|Micronutrients|micronutrients|mesh-ancestor
56068728|NCT01908751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068729|NCT01908751|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56068731|NCT00370721|Bevacizumab|bevacizumab|mesh-list
56068750|NCT01909141|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
56068751|NCT01909141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56068752|NCT01909141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068753|NCT01909141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068754|NCT01909141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068755|NCT01909141|Estrogens|estrogens|mesh-ancestor
56068756|NCT01909141|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56068757|NCT01909141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068758|NCT01909141|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56068759|NCT01909141|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56068760|NCT01909141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068761|NCT01909141|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56068762|NCT01909141|Hormone Antagonists|hormone antagonists|mesh-ancestor
56068765|NCT01909141|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56068766|NCT01909141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068767|NCT01909141|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56068768|NCT01909141|Fertility Agents|fertility agents|mesh-ancestor
56068769|NCT01909141|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56068770|NCT01909141|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56068771|NCT04527887|Dexamethasone|dexamethasone|mesh-list
56068772|NCT04527887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068773|NCT04527887|Antiemetics|antiemetics|mesh-ancestor
56068774|NCT04527887|Autonomic Agents|autonomic agents|mesh-ancestor
56068775|NCT04527887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068776|NCT04527887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068777|NCT04527887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56068778|NCT04527887|Glucocorticoids|glucocorticoids|mesh-ancestor
56068779|NCT04527887|Hormones|hormones|mesh-ancestor
56068780|NCT04527887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56068781|NCT04527887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56068792|NCT01910311|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56068793|NCT01910311|Antitubercular Agents|antitubercular agents|mesh-ancestor
56068794|NCT01910311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56068795|NCT01910311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56068796|NCT01910311|Leprostatic Agents|leprostatic agents|mesh-ancestor
56068797|NCT01910311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56068798|NCT01910311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795994|NCT05554055|Dalteparin|dalteparin|mesh-list
56068799|NCT01910311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068800|NCT01910311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56068801|NCT01910311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56068802|NCT01910311|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56068803|NCT01910311|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56068804|NCT01910311|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56068805|NCT01910311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56068806|NCT04404959|Ropivacaine|ropivacaine|mesh-list
56068807|NCT04404959|Anesthetics|anesthetics|mesh-list
56068808|NCT04404959|Anesthetics, Local|anesthetics, local|mesh-ancestor
56068809|NCT04404959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068810|NCT04404959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068812|NCT04404959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068813|NCT04403711|Dexmedetomidine|dexmedetomidine|mesh-list
56068814|NCT04403711|Anesthetics|anesthetics|mesh-list
56068815|NCT04403711|Anesthetics, Local|anesthetics, local|mesh-list
56068816|NCT04403711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56068817|NCT04403711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068818|NCT04403711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068819|NCT04403711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56068832|NCT01911169|Micronutrients|micronutrients|mesh-ancestor
56068833|NCT01911169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068834|NCT01911169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56068835|NCT01911169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56068836|NCT04403087|Trimebutine|trimebutine|mesh-list
56068837|NCT04403087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56068838|NCT04403087|Parasympatholytics|parasympatholytics|mesh-ancestor
56068839|NCT04403087|Autonomic Agents|autonomic agents|mesh-ancestor
56068840|NCT04403087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068841|NCT04403087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068842|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56068843|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
56068844|NCT04358393|Azacitidine|azacitidine|mesh-list
56068845|NCT04358393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56068846|NCT04358393|Antimetabolites|antimetabolites|mesh-ancestor
56068847|NCT04358393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068848|NCT04358393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068888|NCT05732701|Sympathomimetics|sympathomimetics|mesh-ancestor
56068889|NCT05732701|Autonomic Agents|autonomic agents|mesh-ancestor
56068890|NCT05732701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068891|NCT05732701|Nasal Decongestants|nasal decongestants|mesh-ancestor
56068892|NCT05732701|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56068893|NCT05732701|Respiratory System Agents|respiratory system agents|mesh-ancestor
56068894|NCT04768985|Acalabrutinib|acalabrutinib|mesh-list
56068895|NCT04768985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068896|NCT04210037|Paclitaxel|paclitaxel|mesh-list
56068897|NCT04210037|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56068898|NCT04210037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56068899|NCT04210037|Tubulin Modulators|tubulin modulators|mesh-ancestor
56068902|NCT04210037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068903|NCT04184609|Bromides|bromides|mesh-list
56068904|NCT04184609|Albuterol|albuterol|mesh-list
56068905|NCT04184609|Ipratropium|ipratropium|mesh-list
56068906|NCT04184609|Anticonvulsants|anticonvulsants|mesh-ancestor
56068907|NCT04184609|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56068908|NCT04184609|Autonomic Agents|autonomic agents|mesh-ancestor
56068909|NCT04184609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068910|NCT04184609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068911|NCT04184609|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56068912|NCT04184609|Respiratory System Agents|respiratory system agents|mesh-ancestor
56068913|NCT04184609|Tocolytic Agents|tocolytic agents|mesh-ancestor
56068914|NCT04184609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56068915|NCT04184609|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56068916|NCT04184609|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56068917|NCT04184609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56068928|NCT04177355|Antacids|antacids|mesh-ancestor
56068935|NCT03273023|Immunologic Factors|immunologic factors|mesh-ancestor
56068936|NCT03273023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068937|NCT03273023|Trace Elements|trace elements|mesh-ancestor
56068938|NCT03273023|Micronutrients|micronutrients|mesh-ancestor
56068939|NCT00371501|Aspirin|aspirin|mesh-list
56068940|NCT00371501|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56068941|NCT00371501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56068942|NCT00371501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56068943|NCT00371501|Analgesics|analgesics|mesh-ancestor
56068944|NCT00371501|Sensory System Agents|sensory system agents|mesh-ancestor
56068945|NCT00371501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068946|NCT00371501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068947|NCT00371501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068948|NCT00371501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56068949|NCT00371501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56068950|NCT00371501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56068951|NCT00371501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068952|NCT00371501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56068953|NCT00371501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56068954|NCT00371501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56068955|NCT00371501|Antipyretics|antipyretics|mesh-ancestor
56068956|NCT00371501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56068957|NCT00371501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56068958|NCT00371501|Antimetabolites|antimetabolites|mesh-ancestor
56068959|NCT00371501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56068960|NCT00371501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56068961|NCT03251651|Dexmedetomidine|dexmedetomidine|mesh-list
56068962|NCT03251651|Propofol|propofol|mesh-list
56068963|NCT03251651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56068964|NCT03251651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56068965|NCT03251651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068966|NCT03251651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56068967|NCT03251651|Anesthetics, General|anesthetics, general|mesh-ancestor
56068968|NCT03251651|Anesthetics|anesthetics|mesh-ancestor
56068969|NCT03251651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56068970|NCT03251651|Analgesics|analgesics|mesh-ancestor
55901111|NCT01587989|Methotrexate|methotrexate|mesh-list
56068971|NCT03251651|Sensory System Agents|sensory system agents|mesh-ancestor
56068972|NCT03251651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068973|NCT03251651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56068974|NCT03251651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56068976|NCT03251651|Adrenergic Agents|adrenergic agents|mesh-ancestor
56068977|NCT03251651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56068978|NCT03251651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56068979|NCT05738707|Vaccines|vaccines|mesh-list
56068980|NCT05738707|Immunologic Factors|immunologic factors|mesh-ancestor
56068981|NCT05738707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068982|NCT05738629|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56068983|NCT05738629|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56068984|NCT05349071|Methylprednisolone|methylprednisolone|mesh-list
56068985|NCT05349071|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56068986|NCT05349071|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56068988|NCT05349071|Prednisolone acetate|prednisolone acetate|mesh-list
56068989|NCT05349071|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56068990|NCT05349071|Prednisolone phosphate|prednisolone phosphate|mesh-list
56068991|NCT05349071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56068992|NCT05349071|Antiemetics|antiemetics|mesh-ancestor
56068993|NCT05349071|Autonomic Agents|autonomic agents|mesh-ancestor
56068994|NCT05349071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56068995|NCT05349071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56068996|NCT05349071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56068997|NCT05349071|Glucocorticoids|glucocorticoids|mesh-ancestor
56068998|NCT05349071|Hormones|hormones|mesh-ancestor
56068999|NCT05349071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069000|NCT05349071|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56069001|NCT05349071|Protective Agents|protective agents|mesh-ancestor
56069014|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56069015|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069016|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
56069017|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069019|NCT05725135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56069020|NCT05725135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56069021|NCT05725135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069022|NCT05725135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56069024|NCT05725135|Anesthetics|anesthetics|mesh-ancestor
56069025|NCT05738317|Paclitaxel|paclitaxel|mesh-list
56069026|NCT05738317|Bevacizumab|bevacizumab|mesh-list
56069027|NCT05738317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56069028|NCT05738317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069029|NCT05738317|Tubulin Modulators|tubulin modulators|mesh-ancestor
56069030|NCT05738317|Antimitotic Agents|antimitotic agents|mesh-ancestor
56069031|NCT05738317|Mitosis Modulators|mitosis modulators|mesh-ancestor
56069032|NCT05738317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069033|NCT05738317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56069034|NCT05738317|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56069035|NCT05738317|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56069036|NCT05738317|Growth Substances|growth substances|mesh-ancestor
56069037|NCT05738317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069039|NCT02284555|Mupirocin|mupirocin|mesh-list
56069040|NCT02284555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56069041|NCT02284555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069042|NCT02284555|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56069043|NCT02284555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069044|NCT02284555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069045|NCT05498389|Osimertinib|osimertinib|mesh-list
56069060|NCT03029689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069062|NCT02287909|Ticagrelor|ticagrelor|mesh-list
56069063|NCT02287909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56069064|NCT02287909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56069065|NCT02287909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56069066|NCT02287909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56069067|NCT02287909|Purinergic Agents|purinergic agents|mesh-ancestor
56069068|NCT02287909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069069|NCT02287909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069071|NCT04335383|Antibodies|antibodies|mesh-list
56069072|NCT04335383|Immunologic Factors|immunologic factors|mesh-ancestor
56069073|NCT04335383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069074|NCT00371579|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56069075|NCT00371579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56069076|NCT00371579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56069077|NCT00371579|Antimetabolites|antimetabolites|mesh-ancestor
56069078|NCT00371579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069079|NCT00371579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56069080|NCT00371579|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56069081|NCT00371579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069082|NCT02833805|Mycophenolic Acid|mycophenolic acid|mesh-list
56069083|NCT02833805|Cyclophosphamide|cyclophosphamide|mesh-list
56069084|NCT02833805|Fludarabine|fludarabine|mesh-list
56069085|NCT02833805|Tacrolimus|tacrolimus|mesh-list
56069086|NCT02833805|Thymoglobulin|thymoglobulin|mesh-list
56069087|NCT02833805|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56069088|NCT02833805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56069089|NCT02833805|Immunologic Factors|immunologic factors|mesh-ancestor
56069090|NCT02833805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069091|NCT02833805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56069092|NCT02833805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56069093|NCT02833805|Alkylating Agents|alkylating agents|mesh-ancestor
56069098|NCT02833805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069099|NCT02833805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56069100|NCT02833805|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56069101|NCT02833805|Antitubercular Agents|antitubercular agents|mesh-ancestor
56069102|NCT02833805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56069229|NCT05417659|Micronutrients|micronutrients|mesh-ancestor
56069103|NCT02833805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069104|NCT02327195|Methylphenidate|methylphenidate|mesh-list
56069105|NCT02327195|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56069106|NCT02327195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069107|NCT02327195|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56069108|NCT02327195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56069109|NCT02327195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56069110|NCT02327195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069111|NCT02327195|Dopamine Agents|dopamine agents|mesh-ancestor
56069112|NCT02327195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069113|NCT05463601|Tamoxifen|tamoxifen|mesh-list
56069114|NCT05463601|Letrozole|letrozole|mesh-list
56069115|NCT05463601|Fulvestrant|fulvestrant|mesh-list
56069116|NCT05463601|Exemestane|exemestane|mesh-list
56069117|NCT05463601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069118|NCT05463601|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56069119|NCT05463601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56069149|NCT04768465|Cholinergic Agents|cholinergic agents|mesh-ancestor
56069150|NCT04768465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069152|NCT05448547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069153|NCT05448547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069154|NCT01614665|Tacrolimus|tacrolimus|mesh-list
56069155|NCT01614665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56069156|NCT01614665|Immunologic Factors|immunologic factors|mesh-ancestor
56069157|NCT01614665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069158|NCT01614665|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56069159|NCT01614665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069160|NCT01614665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069162|NCT05691829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56069163|NCT05691829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069181|NCT00371735|Artesunate|artesunate|mesh-list
56069182|NCT00371735|Dapsone|dapsone|mesh-list
56069183|NCT00371735|Chlorproguanil|chlorproguanil|mesh-list
56069184|NCT00371735|Proguanil|proguanil|mesh-list
56069185|NCT00371735|Antimalarials|antimalarials|mesh-ancestor
56069186|NCT00371735|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56069187|NCT00371735|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56069188|NCT00371735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069189|NCT00371735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069190|NCT00371735|Antiviral Agents|antiviral agents|mesh-ancestor
56069191|NCT00371735|Schistosomicides|schistosomicides|mesh-ancestor
56069192|NCT00371735|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56069193|NCT00371735|Anthelmintics|anthelmintics|mesh-ancestor
56069194|NCT00371735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56069195|NCT00371735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069196|NCT00371735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069197|NCT00371735|Leprostatic Agents|leprostatic agents|mesh-ancestor
56069198|NCT00371735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56069199|NCT00371735|Antimetabolites|antimetabolites|mesh-ancestor
56069200|NCT05688475|Dexamethasone|dexamethasone|mesh-list
56069201|NCT05688475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56069202|NCT05688475|Antiemetics|antiemetics|mesh-ancestor
56069205|NCT05688475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069206|NCT05688475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56069207|NCT05688475|Glucocorticoids|glucocorticoids|mesh-ancestor
56069208|NCT05688475|Hormones|hormones|mesh-ancestor
56069209|NCT05688475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069210|NCT05688475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56069211|NCT05688475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069212|NCT05052307|Vaccines|vaccines|mesh-list
56069213|NCT05052307|Immunologic Factors|immunologic factors|mesh-ancestor
56069214|NCT05052307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069215|NCT05332457|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56069216|NCT05332457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56069217|NCT05332457|Adrenergic Agents|adrenergic agents|mesh-ancestor
56069218|NCT05332457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069219|NCT05332457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069220|NCT05332457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069221|NCT05417659|Niacin|niacin|mesh-list
56069222|NCT05417659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56069223|NCT05417659|Antimetabolites|antimetabolites|mesh-ancestor
56069224|NCT05417659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069225|NCT05417659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56069226|NCT05417659|Vasodilator Agents|vasodilator agents|mesh-ancestor
56069227|NCT05417659|Vitamin B Complex|vitamin b complex|mesh-ancestor
56069228|NCT05417659|Vitamins|vitamins|mesh-ancestor
56069230|NCT05417659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069231|NCT02762513|Axitinib|axitinib|mesh-list
55790886|NCT03044093|Mifepristone|mifepristone|mesh-list
56069233|NCT02762513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56069234|NCT02762513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069249|NCT02767271|Luliconazole|luliconazole|mesh-list
56069250|NCT02767271|Antifungal Agents|antifungal agents|mesh-ancestor
56069251|NCT02767271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069252|NCT05647993|Azithromycin|azithromycin|mesh-list
56069253|NCT05647993|Cefazolin|cefazolin|mesh-list
56069254|NCT05647993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56069255|NCT05647993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069256|NCT02741687|Insulin|insulin|mesh-list
56069257|NCT02741687|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56069258|NCT02741687|Insulin Glargine|insulin glargine|mesh-list
56069259|NCT02741687|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56069260|NCT02741687|Insulin Aspart|insulin aspart|mesh-list
56069261|NCT02741687|Insulin Lispro|insulin lispro|mesh-list
56069262|NCT02741687|Insulin Detemir|insulin detemir|mesh-list
56069263|NCT02741687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56069264|NCT02741687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069265|NCT02741687|Incretins|incretins|mesh-ancestor
56069266|NCT02741687|Hormones|hormones|mesh-ancestor
56069267|NCT02741687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069268|NCT02741687|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56069269|NCT02741687|Protease Inhibitors|protease inhibitors|mesh-ancestor
56069270|NCT02741687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069271|NCT02741687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069272|NCT05361499|Amoxicillin|amoxicillin|mesh-list
56069273|NCT05361499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56069274|NCT05361499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069275|NCT04337099|Tempol|tempol|mesh-list
56069276|NCT04337099|TEMPO|tempo|mesh-list
56069277|NCT04337099|TEMPOL-H|tempol-h|mesh-list
56069278|NCT04337099|Antioxidants|antioxidants|mesh-ancestor
56069280|NCT04337099|Protective Agents|protective agents|mesh-ancestor
56069299|NCT05113901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56069300|NCT05113901|Prednisolone|prednisolone|mesh-list
56069301|NCT05113901|Prednisolone acetate|prednisolone acetate|mesh-list
56069302|NCT05113901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56069303|NCT05113901|Prednisolone phosphate|prednisolone phosphate|mesh-list
56069304|NCT05113901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56069305|NCT05113901|Antiemetics|antiemetics|mesh-ancestor
56069306|NCT05113901|Autonomic Agents|autonomic agents|mesh-ancestor
56069307|NCT05113901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069308|NCT05113901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069309|NCT05113901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56069310|NCT05113901|Glucocorticoids|glucocorticoids|mesh-ancestor
56069311|NCT05113901|Hormones|hormones|mesh-ancestor
56069312|NCT05113901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069313|NCT05113901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56069314|NCT05113901|Protective Agents|protective agents|mesh-ancestor
56069315|NCT05113901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56069316|NCT05113901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069317|NCT05627791|Oxytocin|oxytocin|mesh-list
56069318|NCT05627791|Oxytocics|oxytocics|mesh-ancestor
56069319|NCT05627791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56069320|NCT05627791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069321|NCT02771093|Alogliptin|alogliptin|mesh-list
56069322|NCT02771093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56069323|NCT02771093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069324|NCT02771093|Incretins|incretins|mesh-ancestor
56069325|NCT02771093|Hormones|hormones|mesh-ancestor
56069342|NCT04337879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069343|NCT02745353|Naloxegol|naloxegol|mesh-list
56069344|NCT02745353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56069345|NCT02745353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069346|NCT02745353|Sensory System Agents|sensory system agents|mesh-ancestor
56069347|NCT02745353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069348|NCT04778839|Paclitaxel|paclitaxel|mesh-list
56069349|NCT04778839|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56069350|NCT04778839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56069351|NCT04778839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069352|NCT04778839|Tubulin Modulators|tubulin modulators|mesh-ancestor
56069353|NCT04778839|Antimitotic Agents|antimitotic agents|mesh-ancestor
56069354|NCT04778839|Mitosis Modulators|mitosis modulators|mesh-ancestor
56069355|NCT04778839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069356|NCT05602207|Abrocitinib|abrocitinib|mesh-list
56069357|NCT05602207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56069359|NCT05602207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069360|NCT04739761|Trastuzumab|trastuzumab|mesh-list
56069361|NCT04739761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56069362|NCT04739761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069363|NCT05248321|Tranexamic Acid|tranexamic acid|mesh-list
56069364|NCT05248321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56069365|NCT05248321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56069366|NCT05248321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069367|NCT05248321|Hemostatics|hemostatics|mesh-ancestor
56069368|NCT05248321|Coagulants|coagulants|mesh-ancestor
56069369|NCT05598619|Ascorbic Acid|ascorbic acid|mesh-list
56069370|NCT05598619|Vitamins|vitamins|mesh-ancestor
56069371|NCT05598619|Micronutrients|micronutrients|mesh-ancestor
56069372|NCT05598619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069373|NCT05598619|Antioxidants|antioxidants|mesh-ancestor
56069374|NCT05598619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069375|NCT05598619|Protective Agents|protective agents|mesh-ancestor
56069376|NCT02746991|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
56069379|NCT02746991|Hormones|hormones|mesh-ancestor
56069380|NCT02746991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069381|NCT02746991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069382|NCT02747615|Tranexamic Acid|tranexamic acid|mesh-list
56069383|NCT02747615|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56069384|NCT02747615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56069385|NCT02747615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069386|NCT02747615|Hemostatics|hemostatics|mesh-ancestor
56069387|NCT02747615|Coagulants|coagulants|mesh-ancestor
56069388|NCT02775617|Azithromycin|azithromycin|mesh-list
56069389|NCT02775617|Ivermectin|ivermectin|mesh-list
56069390|NCT02775617|Permethrin|permethrin|mesh-list
56069391|NCT02775617|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56069392|NCT02775617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069393|NCT02775617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56069394|NCT02775617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069395|NCT02775617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069396|NCT00371813|Varenicline|varenicline|mesh-list
55796601|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
56069397|NCT00371813|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56069398|NCT00371813|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56069399|NCT00371813|Cholinergic Agents|cholinergic agents|mesh-ancestor
56069400|NCT00371813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069401|NCT00371813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069403|NCT04711135|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
56069404|NCT04711135|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56069405|NCT04711135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069406|NCT02748785|Methotrexate|methotrexate|mesh-list
56069407|NCT02748785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56069408|NCT02748785|Abortifacient Agents|abortifacient agents|mesh-ancestor
56069409|NCT02748785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56069410|NCT02748785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069411|NCT02748785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56069421|NCT02748785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56069423|NCT02295553|Propofol|propofol|mesh-list
56069424|NCT02295553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56069425|NCT02295553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56069426|NCT02295553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069427|NCT02295553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56069428|NCT02295553|Anesthetics, General|anesthetics, general|mesh-ancestor
56069429|NCT02295553|Anesthetics|anesthetics|mesh-ancestor
56069430|NCT02295553|Analgesics|analgesics|mesh-ancestor
56069431|NCT02295553|Sensory System Agents|sensory system agents|mesh-ancestor
56069432|NCT02295553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069433|NCT02295553|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56069434|NCT02295553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56069435|NCT02295553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56069436|NCT02295553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069437|NCT02295553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069438|NCT02296099|Bupivacaine|bupivacaine|mesh-list
56069439|NCT02296099|Anesthetics, Local|anesthetics, local|mesh-ancestor
56069440|NCT02296099|Anesthetics|anesthetics|mesh-ancestor
56069441|NCT02296099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56069442|NCT02296099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069443|NCT02296099|Sensory System Agents|sensory system agents|mesh-ancestor
56069444|NCT02296099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069445|NCT05455073|Folic Acid|folic acid|mesh-list
56069467|NCT04692103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069468|NCT05559931|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56069469|NCT05559931|Hallucinogens|hallucinogens|mesh-ancestor
56069470|NCT05559931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069471|NCT05559931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56069472|NCT05559931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56069474|NCT05559931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069475|NCT05559931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069476|NCT05559931|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56069477|NCT04120415|Vedolizumab|vedolizumab|mesh-list
56069478|NCT04120415|Vaccines|vaccines|mesh-list
56069479|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
56069480|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069481|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56069482|NCT04669171|Rituximab|rituximab|mesh-list
56069483|NCT04669171|Lenalidomide|lenalidomide|mesh-list
56069484|NCT04669171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56069485|NCT04669171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069486|NCT04669171|Immunologic Factors|immunologic factors|mesh-ancestor
56069487|NCT04669171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069488|NCT04669171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56069489|NCT04669171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56069490|NCT04669171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56069491|NCT04669171|Growth Substances|growth substances|mesh-ancestor
56069492|NCT04669171|Growth Inhibitors|growth inhibitors|mesh-ancestor
56069493|NCT04657081|Decitabine|decitabine|mesh-list
56069494|NCT04657081|Venetoclax|venetoclax|mesh-list
56069495|NCT04657081|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56069496|NCT04657081|Antimetabolites|antimetabolites|mesh-ancestor
56069497|NCT04657081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069498|NCT04657081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069499|NCT04657081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069500|NCT05545891|Aripiprazole|aripiprazole|mesh-list
56069501|NCT05545891|Antidepressive Agents|antidepressive agents|mesh-ancestor
56069508|NCT05545891|Dopamine Agents|dopamine agents|mesh-ancestor
56069509|NCT05545891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069510|NCT05545891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069511|NCT05545891|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56069512|NCT05545891|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56069513|NCT05545891|Serotonin Agents|serotonin agents|mesh-ancestor
56069514|NCT05545891|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56069515|NCT05545891|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56069516|NCT05545891|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56069517|NCT05545891|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56069518|NCT04757675|Dexmedetomidine|dexmedetomidine|mesh-list
56069520|NCT04757675|Esketamine|esketamine|mesh-list
56069521|NCT04757675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56069522|NCT04757675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56069523|NCT04757675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069524|NCT04757675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56069525|NCT04757675|Analgesics|analgesics|mesh-ancestor
56069526|NCT04757675|Sensory System Agents|sensory system agents|mesh-ancestor
56069527|NCT04757675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069528|NCT04757675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56069529|NCT04757675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56069530|NCT04757675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56069531|NCT04757675|Adrenergic Agents|adrenergic agents|mesh-ancestor
56069532|NCT04757675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069533|NCT04757675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069554|NCT04611529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069555|NCT04603807|Crizotinib|crizotinib|mesh-list
56069556|NCT04603807|Entrectinib|entrectinib|mesh-list
56069557|NCT04603807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069558|NCT04603807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56069559|NCT04603807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069560|NCT04603807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069561|NCT05323721|Pyrimethamine|pyrimethamine|mesh-list
56069562|NCT05323721|Piperaquine|piperaquine|mesh-list
56069563|NCT05323721|Sulfadoxine|sulfadoxine|mesh-list
56069564|NCT05323721|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56069565|NCT05323721|Amodiaquine|amodiaquine|mesh-list
56069566|NCT05323721|Artenimol|artenimol|mesh-list
56069567|NCT05323721|Antimalarials|antimalarials|mesh-ancestor
56069568|NCT05323721|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56069569|NCT05323721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56069570|NCT05323721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069571|NCT05323721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56069572|NCT05323721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069573|NCT05323721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069574|NCT05323721|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56069575|NCT05323721|Renal Agents|renal agents|mesh-ancestor
56069576|NCT05288075|Glycopyrrolate|glycopyrrolate|mesh-list
56069577|NCT05288075|Charcoal|charcoal|mesh-list
56069578|NCT05288075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56069579|NCT05288075|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56069580|NCT05288075|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56069581|NCT05288075|Cholinergic Agents|cholinergic agents|mesh-ancestor
56069601|NCT04566991|Siderophores|siderophores|mesh-ancestor
56069602|NCT04566991|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56069603|NCT04566991|Chelating Agents|chelating agents|mesh-ancestor
56069604|NCT04566991|Sequestering Agents|sequestering agents|mesh-ancestor
56069605|NCT04566991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069606|NCT04535401|Calcium, Dietary|calcium, dietary|mesh-list
56069607|NCT04535401|Leucovorin|leucovorin|mesh-list
56069608|NCT04535401|Folic Acid|folic acid|mesh-list
56069609|NCT04535401|Fluorouracil|fluorouracil|mesh-list
56069610|NCT04535401|Irinotecan|irinotecan|mesh-list
56069611|NCT04535401|Camptothecin|camptothecin|mesh-list
56069612|NCT04535401|Calcium|calcium|mesh-list
56069613|NCT04535401|Levoleucovorin|levoleucovorin|mesh-list
56069614|NCT04535401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56069615|NCT04535401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069616|NCT04535401|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56069617|NCT04535401|Antimetabolites|antimetabolites|mesh-ancestor
56069618|NCT04535401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069619|NCT04535401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56069620|NCT04535401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069621|NCT04535401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56069622|NCT04535401|Immunologic Factors|immunologic factors|mesh-ancestor
56069623|NCT04535401|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56069624|NCT04535401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56069625|NCT04535401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069626|NCT04535401|Antidotes|antidotes|mesh-ancestor
56069627|NCT04535401|Protective Agents|protective agents|mesh-ancestor
56069628|NCT04535401|Vitamin B Complex|vitamin b complex|mesh-ancestor
56069629|NCT04535401|Vitamins|vitamins|mesh-ancestor
56069630|NCT04535401|Micronutrients|micronutrients|mesh-ancestor
56069631|NCT04535401|Hematinics|hematinics|mesh-ancestor
56069632|NCT04535401|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56069650|NCT04645823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069651|NCT04645823|Sensory System Agents|sensory system agents|mesh-ancestor
56069652|NCT04645823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069653|NCT04645823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56069654|NCT04645823|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56069655|NCT04645823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56069656|NCT04645823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56069657|NCT04645823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069658|NCT04645823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56069659|NCT04645823|Narcotics|narcotics|mesh-ancestor
56069660|NCT04645823|Analgesics|analgesics|mesh-ancestor
56069661|NCT04645823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56069662|NCT04645823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56069663|NCT04645823|Anesthetics, General|anesthetics, general|mesh-ancestor
56069664|NCT04645823|Anticoagulants|anticoagulants|mesh-ancestor
56069665|NCT04645823|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56069666|NCT04645823|Chelating Agents|chelating agents|mesh-ancestor
56069667|NCT04645823|Sequestering Agents|sequestering agents|mesh-ancestor
56069668|NCT03860207|Antibodies|antibodies|mesh-list
56069669|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
56069670|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56069671|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
56069672|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069697|NCT04365049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56069698|NCT04365049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069699|NCT04365049|Tubulin Modulators|tubulin modulators|mesh-ancestor
56069700|NCT04365049|Antimitotic Agents|antimitotic agents|mesh-ancestor
56069701|NCT04365049|Mitosis Modulators|mitosis modulators|mesh-ancestor
56069702|NCT04365049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069703|NCT04365049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56069704|NCT04365049|Antimetabolites|antimetabolites|mesh-ancestor
56069705|NCT04365049|Antiviral Agents|antiviral agents|mesh-ancestor
56069706|NCT04365049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069708|NCT04365049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56069709|NCT04365049|Immunologic Factors|immunologic factors|mesh-ancestor
56069710|NCT04365049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069711|NCT04606901|Glycopyrrolate|glycopyrrolate|mesh-list
56069712|NCT04606901|Neostigmine|neostigmine|mesh-list
56069713|NCT04606901|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56069714|NCT04606901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069715|NCT04606901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069716|NCT04606901|Cholinergic Agents|cholinergic agents|mesh-ancestor
56069717|NCT04606901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069718|NCT04606901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069719|NCT04606901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56069720|NCT04606901|Autonomic Agents|autonomic agents|mesh-ancestor
56069721|NCT04606901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069722|NCT04606901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56069723|NCT04606901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56069724|NCT04606901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56069725|NCT03092011|Clonidine|clonidine|mesh-list
56069726|NCT03092011|Morphine|morphine|mesh-list
56069727|NCT03092011|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56069728|NCT03092011|Narcotics|narcotics|mesh-ancestor
56069729|NCT03092011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56069740|NCT03092011|Adrenergic Agents|adrenergic agents|mesh-ancestor
56069741|NCT03092011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069742|NCT03092011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069743|NCT00372515|Gefitinib|gefitinib|mesh-list
56069744|NCT00372515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069745|NCT00372515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56069746|NCT00372515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069747|NCT00372515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069748|NCT04448119|Favipiravir|favipiravir|mesh-list
56069749|NCT04448119|Antiviral Agents|antiviral agents|mesh-ancestor
56069750|NCT04448119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069751|NCT04706507|Ganciclovir|ganciclovir|mesh-list
56069752|NCT04706507|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56069753|NCT04706507|Antiviral Agents|antiviral agents|mesh-ancestor
56069754|NCT04706507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069755|NCT04706507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56069756|NCT04706507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069757|NCT04706507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069758|NCT03047473|Avelumab|avelumab|mesh-list
56069759|NCT03047473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56069760|NCT03047473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069761|NCT03339635|Methyltestosterone|methyltestosterone|mesh-list
56069762|NCT03339635|Testosterone|testosterone|mesh-list
56069763|NCT03339635|Testosterone undecanoate|testosterone undecanoate|mesh-list
56069764|NCT03339635|Testosterone enanthate|testosterone enanthate|mesh-list
56069765|NCT03339635|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56069766|NCT03339635|Androgens|androgens|mesh-ancestor
56069767|NCT03339635|Hormones|hormones|mesh-ancestor
56069768|NCT03339635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069769|NCT03339635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069770|NCT03339635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56069771|NCT03339635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069772|NCT03339635|Anabolic Agents|anabolic agents|mesh-ancestor
56069773|NCT03069131|Rifaximin|rifaximin|mesh-list
56069774|NCT03069131|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56069777|NCT02990845|Pembrolizumab|pembrolizumab|mesh-list
56069778|NCT02990845|Leuprolide|leuprolide|mesh-list
56069779|NCT02990845|Exemestane|exemestane|mesh-list
56069780|NCT02990845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56069781|NCT02990845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069782|NCT02990845|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56069783|NCT02990845|Fertility Agents|fertility agents|mesh-ancestor
56069784|NCT02990845|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56069785|NCT02990845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069786|NCT02990845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56069787|NCT02990845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56069788|NCT02990845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56069789|NCT02990845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069790|NCT02990845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069791|NCT02990845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56069792|NCT02990845|Hormone Antagonists|hormone antagonists|mesh-ancestor
56069793|NCT02990845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069794|NCT04438213|Ertugliflozin|ertugliflozin|mesh-list
56069795|NCT04438213|Metolazone|metolazone|mesh-list
56069796|NCT04438213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56069797|NCT04438213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069798|NCT04438213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56069799|NCT04438213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069800|NCT04438213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56069801|NCT04438213|Diuretics|diuretics|mesh-ancestor
56069802|NCT04438213|Natriuretic Agents|natriuretic agents|mesh-ancestor
56069803|NCT04438213|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56069804|NCT04438213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56069805|NCT01987219|Bromides|bromides|mesh-list
56069806|NCT01987219|Albuterol|albuterol|mesh-list
56069807|NCT01987219|Ipratropium|ipratropium|mesh-list
56069808|NCT01987219|Anticonvulsants|anticonvulsants|mesh-ancestor
56069809|NCT01987219|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56069810|NCT01987219|Autonomic Agents|autonomic agents|mesh-ancestor
56069813|NCT01987219|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56069816|NCT01987219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56069817|NCT01987219|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56069818|NCT01987219|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56069819|NCT01987219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56069820|NCT01987219|Adrenergic Agents|adrenergic agents|mesh-ancestor
56069821|NCT01987219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069822|NCT01987219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069823|NCT01987219|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56069824|NCT01987219|Cholinergic Agents|cholinergic agents|mesh-ancestor
56069825|NCT02917993|Osimertinib|osimertinib|mesh-list
56069826|NCT02917993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069827|NCT02917993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56069828|NCT02917993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069829|NCT02917993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069830|NCT04405349|Atezolizumab|atezolizumab|mesh-list
56069831|NCT04405349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069833|NCT04265053|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
56069834|NCT04265053|Estradiol|estradiol|mesh-list
56069835|NCT04265053|Testosterone|testosterone|mesh-list
56069836|NCT04265053|Ganirelix|ganirelix|mesh-list
56069837|NCT04265053|Estrogens|estrogens|mesh-ancestor
56069838|NCT04265053|Hormones|hormones|mesh-ancestor
56069839|NCT04265053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069840|NCT04265053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069841|NCT04265053|Androgens|androgens|mesh-ancestor
56069842|NCT04265053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56069843|NCT04265053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56069844|NCT04265053|Analgesics|analgesics|mesh-ancestor
56069845|NCT04265053|Sensory System Agents|sensory system agents|mesh-ancestor
56069846|NCT04265053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069847|NCT04265053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55740743|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
56069848|NCT04265053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56069857|NCT04332497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56069858|NCT04332497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069859|NCT04332497|Analgesics|analgesics|mesh-ancestor
56069860|NCT04332497|Sensory System Agents|sensory system agents|mesh-ancestor
56069861|NCT04332497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56069862|NCT04332497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56069863|NCT04332497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56069864|NCT04332497|Anesthetics, General|anesthetics, general|mesh-ancestor
56069865|NCT04332497|Anesthetics|anesthetics|mesh-ancestor
56069866|NCT04332497|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56069867|NCT04332497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56069868|NCT04332497|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56069869|NCT04332497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56069870|NCT04332497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56069871|NCT04332497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069872|NCT04332497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069873|NCT02633137|Cytarabine|cytarabine|mesh-list
56069874|NCT02633137|Lenalidomide|lenalidomide|mesh-list
56069875|NCT02633137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56069876|NCT02633137|Antimetabolites|antimetabolites|mesh-ancestor
56069877|NCT02633137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069878|NCT02633137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069879|NCT02633137|Antiviral Agents|antiviral agents|mesh-ancestor
56069880|NCT02633137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069881|NCT02633137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56069882|NCT02633137|Immunologic Factors|immunologic factors|mesh-ancestor
56069883|NCT02633137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069884|NCT02633137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56069885|NCT02633137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56069886|NCT02633137|Growth Substances|growth substances|mesh-ancestor
56069898|NCT04707209|Sirolimus|sirolimus|mesh-list
56069899|NCT04707209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56069900|NCT04707209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069901|NCT04707209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56069902|NCT04707209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069904|NCT04707209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56069905|NCT04707209|Immunologic Factors|immunologic factors|mesh-ancestor
56069906|NCT04707209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069907|NCT01989793|Losartan|losartan|mesh-list
56069908|NCT01989793|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56069909|NCT01989793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56069910|NCT01989793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56069911|NCT01989793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56069912|NCT01989793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069913|NCT01992523|Ticagrelor|ticagrelor|mesh-list
56069914|NCT01992523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56069915|NCT01992523|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56069916|NCT01992523|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56069917|NCT01992523|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56069918|NCT01992523|Purinergic Agents|purinergic agents|mesh-ancestor
56069919|NCT01992523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56069920|NCT01992523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069921|NCT01992523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069923|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
56069924|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
56069925|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069926|NCT04188665|Coagulants|coagulants|mesh-ancestor
56069947|NCT00373451|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56069948|NCT00373451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069950|NCT00373451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56069951|NCT00373451|Protease Inhibitors|protease inhibitors|mesh-ancestor
56069952|NCT00373451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069953|NCT00373451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56069954|NCT01387763|Interferons|interferons|mesh-list
56069955|NCT01387763|Interferon-alpha|interferon-alpha|mesh-list
56069956|NCT01387763|Interferon alpha-2|interferon alpha-2|mesh-list
56069957|NCT01387763|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56069958|NCT01387763|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56069959|NCT01387763|Hydroxyurea|hydroxyurea|mesh-list
56069960|NCT01387763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56069961|NCT01387763|Antiviral Agents|antiviral agents|mesh-ancestor
56069962|NCT01387763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069963|NCT01387763|Immunologic Factors|immunologic factors|mesh-ancestor
56069964|NCT01387763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069965|NCT01387763|Antisickling Agents|antisickling agents|mesh-ancestor
56069966|NCT01387763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56069967|NCT01387763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069968|NCT01387763|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56069969|NCT00373061|Omalizumab|omalizumab|mesh-list
56069970|NCT00373061|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56069971|NCT00373061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56069972|NCT00373061|Respiratory System Agents|respiratory system agents|mesh-ancestor
56069973|NCT00707213|Deoxyglucose|deoxyglucose|mesh-list
56069974|NCT00707213|Antimetabolites|antimetabolites|mesh-ancestor
56069975|NCT00707213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56069976|NCT00707213|Antiviral Agents|antiviral agents|mesh-ancestor
56069977|NCT00707213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56069978|NCT01993849|Acetylcysteine|acetylcysteine|mesh-list
56069979|NCT01993849|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56069980|NCT01993849|Antiviral Agents|antiviral agents|mesh-ancestor
56069988|NCT01993849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069989|NCT01993849|Antidotes|antidotes|mesh-ancestor
56069990|NCT02778113|Glucagon|glucagon|mesh-list
56069991|NCT02778113|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56069992|NCT02778113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56069993|NCT02778113|Hormones|hormones|mesh-ancestor
56069994|NCT02778113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56069995|NCT02778113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56069996|NCT02778113|Incretins|incretins|mesh-ancestor
56069997|NCT04982237|Paclitaxel|paclitaxel|mesh-list
56069998|NCT04982237|Bevacizumab|bevacizumab|mesh-list
56069999|NCT04982237|Carboplatin|carboplatin|mesh-list
56070000|NCT04982237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56070001|NCT04982237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070002|NCT04982237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56070003|NCT04982237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56070004|NCT04982237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56070005|NCT04982237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070006|NCT04982237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56070007|NCT04982237|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56070008|NCT04982237|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56070009|NCT04982237|Growth Substances|growth substances|mesh-ancestor
56070010|NCT04982237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070012|NCT01996657|Warfarin|warfarin|mesh-list
56070013|NCT01996657|Anticoagulants|anticoagulants|mesh-ancestor
56070014|NCT04227847|Azacitidine|azacitidine|mesh-list
56070015|NCT04227847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56070016|NCT04227847|Antimetabolites|antimetabolites|mesh-ancestor
56070017|NCT04227847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070018|NCT04227847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070019|NCT04227847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070021|NCT02316379|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56070022|NCT02316379|Anesthetics, General|anesthetics, general|mesh-ancestor
56070023|NCT02316379|Anesthetics|anesthetics|mesh-ancestor
56070028|NCT02303977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56070029|NCT02303977|Antimetabolites|antimetabolites|mesh-ancestor
56070030|NCT02303977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070031|NCT02303977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070032|NCT02303977|Antiviral Agents|antiviral agents|mesh-ancestor
56070033|NCT02303977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070034|NCT02303977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070035|NCT02303977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56070036|NCT02303977|Immunologic Factors|immunologic factors|mesh-ancestor
56070037|NCT02303977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070038|NCT01997515|Ketamine|ketamine|mesh-list
56070039|NCT01997515|Analgesics|analgesics|mesh-ancestor
56070040|NCT01997515|Sensory System Agents|sensory system agents|mesh-ancestor
56070041|NCT01997515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070042|NCT01997515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070043|NCT01997515|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56070044|NCT01997515|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56070045|NCT01997515|Anesthetics, General|anesthetics, general|mesh-ancestor
56070046|NCT01997515|Anesthetics|anesthetics|mesh-ancestor
56070047|NCT01997515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070082|NCT02789033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56070083|NCT02789033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56070085|NCT02789033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56070086|NCT02789033|Chelating Agents|chelating agents|mesh-ancestor
56070087|NCT02789033|Sequestering Agents|sequestering agents|mesh-ancestor
56070088|NCT02789033|Hemostatics|hemostatics|mesh-ancestor
56070089|NCT02789033|Coagulants|coagulants|mesh-ancestor
56070090|NCT00372827|Travoprost|travoprost|mesh-list
56070091|NCT00372827|Brinzolamide|brinzolamide|mesh-list
56070092|NCT00372827|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56070093|NCT00372827|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56070094|NCT00372827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070095|NCT00372827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070096|NCT02278315|Dexamethasone|dexamethasone|mesh-list
56070097|NCT02278315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56070098|NCT02278315|Antiemetics|antiemetics|mesh-ancestor
56070099|NCT02278315|Autonomic Agents|autonomic agents|mesh-ancestor
56070100|NCT02278315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070101|NCT02278315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070102|NCT02278315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56070103|NCT02278315|Glucocorticoids|glucocorticoids|mesh-ancestor
56070104|NCT02278315|Hormones|hormones|mesh-ancestor
56070106|NCT02278315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56070107|NCT02278315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070108|NCT02795117|Ivermectin|ivermectin|mesh-list
56070109|NCT02795117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56070110|NCT02795117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070111|NCT04879589|Abiraterone Acetate|abiraterone acetate|mesh-list
56070130|NCT00373607|Piperaquine|piperaquine|mesh-list
56070132|NCT00373607|Antimalarials|antimalarials|mesh-ancestor
56070133|NCT00373607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56070134|NCT00373607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56070135|NCT00373607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070136|NCT00373607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070137|NCT00373607|Antiviral Agents|antiviral agents|mesh-ancestor
56070139|NCT00373607|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56070140|NCT00373607|Anthelmintics|anthelmintics|mesh-ancestor
56070141|NCT02882711|Ketamine|ketamine|mesh-list
56070142|NCT02882711|Analgesics|analgesics|mesh-ancestor
56070143|NCT02882711|Sensory System Agents|sensory system agents|mesh-ancestor
56070144|NCT02882711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070145|NCT02882711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070146|NCT02882711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56070147|NCT02882711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56070148|NCT02882711|Anesthetics, General|anesthetics, general|mesh-ancestor
56070149|NCT02882711|Anesthetics|anesthetics|mesh-ancestor
56070150|NCT02882711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070151|NCT02882711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56070152|NCT02882711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56070153|NCT02882711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070154|NCT02882711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070155|NCT02794337|Sorafenib|sorafenib|mesh-list
56070156|NCT02794337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797352|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56070157|NCT02794337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56070158|NCT02794337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070175|NCT02895035|Adrenergic Agents|adrenergic agents|mesh-ancestor
56070176|NCT02895035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070177|NCT02895035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070178|NCT02895035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070179|NCT02895035|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56070180|NCT02895035|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56070181|NCT02895035|Autonomic Agents|autonomic agents|mesh-ancestor
56070182|NCT02895035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070183|NCT02895035|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56070184|NCT02895035|Respiratory System Agents|respiratory system agents|mesh-ancestor
56070185|NCT02895035|Mydriatics|mydriatics|mesh-ancestor
56070186|NCT02895035|Sympathomimetics|sympathomimetics|mesh-ancestor
56070187|NCT02895035|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56070188|NCT02895035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56070189|NCT02895035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56070190|NCT02895035|Analgesics|analgesics|mesh-ancestor
56070191|NCT02895035|Sensory System Agents|sensory system agents|mesh-ancestor
56070192|NCT02895035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56070193|NCT02895035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56070194|NCT02895035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56070195|NCT02895035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070196|NCT02895035|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56070197|NCT02895035|Nasal Decongestants|nasal decongestants|mesh-ancestor
56070198|NCT02895035|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56070200|NCT02802449|Vitamin D|vitamin d|mesh-list
56070201|NCT02802449|Ergocalciferols|ergocalciferols|mesh-list
56070202|NCT02802449|Cholecalciferol|cholecalciferol|mesh-list
56070203|NCT02802449|Calcifediol|calcifediol|mesh-list
56070205|NCT02802449|Vitamins|vitamins|mesh-list
56070221|NCT02803229|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56070222|NCT02803229|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56070223|NCT02803229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56070225|NCT01938001|Rituximab|rituximab|mesh-list
56070226|NCT01938001|Lenalidomide|lenalidomide|mesh-list
56070227|NCT01938001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56070228|NCT01938001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070229|NCT01938001|Immunologic Factors|immunologic factors|mesh-ancestor
56070230|NCT01938001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070231|NCT01938001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56070232|NCT01938001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56070233|NCT01938001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55797425|NCT04971577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070234|NCT01938001|Growth Substances|growth substances|mesh-ancestor
56070235|NCT01938001|Growth Inhibitors|growth inhibitors|mesh-ancestor
56070236|NCT02805179|Temozolomide|temozolomide|mesh-list
56070237|NCT02805179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56070238|NCT02805179|Alkylating Agents|alkylating agents|mesh-ancestor
56070239|NCT02805179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070240|NCT02805179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070241|NCT02896595|Anesthetics|anesthetics|mesh-list
56070242|NCT02896595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070272|NCT01754779|Sodium Citrate|sodium citrate|mesh-list
56070273|NCT01754779|Anticoagulants|anticoagulants|mesh-ancestor
56070274|NCT01754779|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56070275|NCT01754779|Chelating Agents|chelating agents|mesh-ancestor
56070277|NCT01754779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070278|NCT01754779|Diuretics|diuretics|mesh-ancestor
56070279|NCT01754779|Natriuretic Agents|natriuretic agents|mesh-ancestor
56070280|NCT01754779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070281|NCT01754779|Expectorants|expectorants|mesh-ancestor
56070282|NCT01754779|Respiratory System Agents|respiratory system agents|mesh-ancestor
56070283|NCT02304458|Nivolumab|nivolumab|mesh-list
56070284|NCT02304458|Ipilimumab|ipilimumab|mesh-list
56070285|NCT02304458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56070286|NCT02304458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070287|NCT02304458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56070288|NCT02304458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070289|NCT02149277|Lenograstim|lenograstim|mesh-list
56070290|NCT02149277|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56070291|NCT02149277|Immunologic Factors|immunologic factors|mesh-ancestor
56070292|NCT02149277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070293|NCT02896907|Calcium, Dietary|calcium, dietary|mesh-list
56070294|NCT02896907|Vitamins|vitamins|mesh-list
56070295|NCT02896907|Leucovorin|leucovorin|mesh-list
56070297|NCT02896907|Tetrahydrofolates|tetrahydrofolates|mesh-list
56070298|NCT02896907|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
56070299|NCT02896907|Fluorouracil|fluorouracil|mesh-list
56070300|NCT02896907|Oxaliplatin|oxaliplatin|mesh-list
56070301|NCT02896907|Irinotecan|irinotecan|mesh-list
56070302|NCT02896907|Camptothecin|camptothecin|mesh-list
56070303|NCT02896907|Calcium|calcium|mesh-list
56070304|NCT02896907|Levoleucovorin|levoleucovorin|mesh-list
56070305|NCT02896907|Micronutrients|micronutrients|mesh-ancestor
56070306|NCT02896907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070307|NCT02896907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56070308|NCT02896907|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56070309|NCT02896907|Antimetabolites|antimetabolites|mesh-ancestor
56070310|NCT02896907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070313|NCT02896907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56070314|NCT02896907|Immunologic Factors|immunologic factors|mesh-ancestor
56070315|NCT02896907|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56070316|NCT02896907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56070317|NCT02896907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070318|NCT02896907|Antidotes|antidotes|mesh-ancestor
56070319|NCT02896907|Protective Agents|protective agents|mesh-ancestor
56070320|NCT02896907|Vitamin B Complex|vitamin b complex|mesh-ancestor
56070321|NCT02896907|Antioxidants|antioxidants|mesh-ancestor
56070322|NCT02896907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56070323|NCT02005549|Bevacizumab|bevacizumab|mesh-list
56070324|NCT02005549|Docetaxel|docetaxel|mesh-list
56070325|NCT02005549|Capecitabine|capecitabine|mesh-list
56070326|NCT02005549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56070327|NCT02005549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070328|NCT02005549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56070329|NCT02005549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56070330|NCT02005549|Growth Substances|growth substances|mesh-ancestor
56070331|NCT02005549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070332|NCT02005549|Growth Inhibitors|growth inhibitors|mesh-ancestor
56070333|NCT02005549|Tubulin Modulators|tubulin modulators|mesh-ancestor
56070334|NCT02005549|Antimitotic Agents|antimitotic agents|mesh-ancestor
56070335|NCT02005549|Mitosis Modulators|mitosis modulators|mesh-ancestor
56070336|NCT02005549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070337|NCT02005549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56070338|NCT02005549|Antimetabolites|antimetabolites|mesh-ancestor
56070339|NCT04349696|Mitiglinide|mitiglinide|mesh-list
56070340|NCT04349696|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56070341|NCT04349696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070342|NCT02810873|Copper|copper|mesh-list
56070343|NCT02810873|Deoxyglucose|deoxyglucose|mesh-list
56070344|NCT02810873|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56070345|NCT02810873|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56070346|NCT02810873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070347|NCT02810873|Trace Elements|trace elements|mesh-ancestor
56070348|NCT02810873|Micronutrients|micronutrients|mesh-ancestor
56070352|NCT02810873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070353|NCT01716806|Nivolumab|nivolumab|mesh-list
56070354|NCT01716806|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56070355|NCT01716806|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56070356|NCT01716806|Dacarbazine|dacarbazine|mesh-list
56070357|NCT01716806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56070358|NCT01716806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070359|NCT01716806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56070360|NCT01716806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070361|NCT01716806|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56070362|NCT01716806|Alkylating Agents|alkylating agents|mesh-ancestor
56070363|NCT04492358|Prednisone|prednisone|mesh-list
56070364|NCT04492358|Colchicine|colchicine|mesh-list
56070365|NCT04492358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56070366|NCT04492358|Glucocorticoids|glucocorticoids|mesh-ancestor
56070367|NCT04492358|Hormones|hormones|mesh-ancestor
56070368|NCT04492358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56070369|NCT04492358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070370|NCT04492358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56070371|NCT04492358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070372|NCT04492358|Gout Suppressants|gout suppressants|mesh-ancestor
56070373|NCT04492358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56070374|NCT04492358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56070375|NCT04492358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56070376|NCT04492358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56070378|NCT03526874|Lidocaine|lidocaine|mesh-list
56070402|NCT01081951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56070403|NCT01081951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070404|NCT01081951|Tubulin Modulators|tubulin modulators|mesh-ancestor
56070405|NCT01081951|Antimitotic Agents|antimitotic agents|mesh-ancestor
56070406|NCT01081951|Mitosis Modulators|mitosis modulators|mesh-ancestor
56070407|NCT01081951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070408|NCT01081951|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56070409|NCT01081951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070410|NCT03440372|Ozanimod|ozanimod|mesh-list
56070411|NCT03440372|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56070412|NCT03440372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070413|NCT03440372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56070414|NCT03440372|Immunologic Factors|immunologic factors|mesh-ancestor
56070415|NCT03440372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070416|NCT01066663|Pyrimethamine|pyrimethamine|mesh-list
56070417|NCT01066663|Antimalarials|antimalarials|mesh-ancestor
56070418|NCT01066663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56070419|NCT01066663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56070420|NCT01066663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070421|NCT01066663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56070422|NCT01066663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070423|NCT01066663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070424|NCT01959685|Enclomiphene|enclomiphene|mesh-list
56070425|NCT01959685|Clomiphene|clomiphene|mesh-list
56070426|NCT01959685|Zuclomiphene|zuclomiphene|mesh-list
56070427|NCT01959685|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56070428|NCT01959685|Hormone Antagonists|hormone antagonists|mesh-ancestor
56070429|NCT01959685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56070430|NCT01959685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070431|NCT01959685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56070432|NCT01959685|Fertility Agents|fertility agents|mesh-ancestor
56070436|NCT03422822|Abrocitinib|abrocitinib|mesh-list
56070441|NCT02901899|Guadecitabine|guadecitabine|mesh-list
56070442|NCT02901899|Azacitidine|azacitidine|mesh-list
56070443|NCT02901899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56070444|NCT02901899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740752|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56070445|NCT02901899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56070446|NCT02901899|Antimetabolites|antimetabolites|mesh-ancestor
56070447|NCT02901899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070448|NCT02901899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070449|NCT04333589|Favipiravir|favipiravir|mesh-list
56070450|NCT04333589|Antiviral Agents|antiviral agents|mesh-ancestor
56070451|NCT04333589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070452|NCT02902913|Ibuprofen|ibuprofen|mesh-list
56070453|NCT02902913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56070454|NCT02902913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56070455|NCT02902913|Analgesics|analgesics|mesh-ancestor
56070456|NCT02902913|Sensory System Agents|sensory system agents|mesh-ancestor
56070457|NCT02902913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070458|NCT02902913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070459|NCT02902913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56070460|NCT02902913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797660|NCT02579603|Pirfenidone|pirfenidone|mesh-list
56070461|NCT02902913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56070462|NCT02902913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070463|NCT02902913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070464|NCT03417986|Thiethylperazine|thiethylperazine|mesh-list
56070465|NCT03417986|Antiemetics|antiemetics|mesh-ancestor
56070467|NCT03417986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070468|NCT03417986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070469|NCT03417986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56070470|NCT03417986|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56070471|NCT03417986|Dopamine Agents|dopamine agents|mesh-ancestor
56070472|NCT03417986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070474|NCT01192568|Oxybutynin|oxybutynin|mesh-list
56070479|NCT01192568|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56070480|NCT01192568|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56070481|NCT01192568|Cholinergic Agents|cholinergic agents|mesh-ancestor
56070482|NCT01192568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070483|NCT01192568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070484|NCT01192568|Urological Agents|urological agents|mesh-ancestor
56070485|NCT04349228|Hydroxychloroquine|hydroxychloroquine|mesh-list
56070486|NCT04349228|Antimalarials|antimalarials|mesh-ancestor
56070487|NCT04349228|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56070488|NCT04349228|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56070489|NCT04349228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070490|NCT04349228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070491|NCT04349228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070492|NCT04349228|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56070494|NCT02301416|Phentermine|phentermine|mesh-list
56070495|NCT02301416|Anticonvulsants|anticonvulsants|mesh-ancestor
56070496|NCT02301416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56070497|NCT02301416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070498|NCT02301416|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56070499|NCT02301416|Appetite Depressants|appetite depressants|mesh-ancestor
56070500|NCT02301416|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56070501|NCT02301416|Sympathomimetics|sympathomimetics|mesh-ancestor
56070502|NCT02301416|Autonomic Agents|autonomic agents|mesh-ancestor
56070503|NCT02301416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070504|NCT02301416|Adrenergic Agents|adrenergic agents|mesh-ancestor
56070507|NCT02815709|Morphine|morphine|mesh-list
56070527|NCT02912195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070528|NCT02912195|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56070529|NCT02912195|Narcotics|narcotics|mesh-ancestor
56070530|NCT02912195|Analgesics|analgesics|mesh-ancestor
56070531|NCT01960075|Fosphenytoin|fosphenytoin|mesh-list
56070532|NCT01960075|Levetiracetam|levetiracetam|mesh-list
56070533|NCT01960075|Valproic Acid|valproic acid|mesh-list
56070534|NCT01960075|Anticonvulsants|anticonvulsants|mesh-ancestor
56070535|NCT01960075|Nootropic Agents|nootropic agents|mesh-ancestor
55797735|NCT05546957|Antipyretics|antipyretics|mesh-ancestor
56070536|NCT01960075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070537|NCT01960075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070538|NCT01960075|GABA Agents|gaba agents|mesh-ancestor
56070539|NCT01960075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070540|NCT01960075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070541|NCT01960075|Antimanic Agents|antimanic agents|mesh-ancestor
56070542|NCT01960075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56070543|NCT01960075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070544|NCT01960075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56070545|NCT01960075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56070546|NCT01960075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56070566|NCT01960387|Cytarabine|cytarabine|mesh-list
56070581|NCT02823431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070582|NCT02823431|Sensory System Agents|sensory system agents|mesh-ancestor
56070583|NCT02823431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070584|NCT02823431|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56070585|NCT02823431|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56070586|NCT02823431|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56070587|NCT02823431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56070588|NCT02823431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070589|NCT02824913|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56070590|NCT02824913|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56070591|NCT03008213|Palonosetron|palonosetron|mesh-list
56070592|NCT03008213|Antiemetics|antiemetics|mesh-ancestor
56070593|NCT03008213|Autonomic Agents|autonomic agents|mesh-ancestor
56070594|NCT03008213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070595|NCT03008213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070596|NCT03008213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56070597|NCT03008213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56070598|NCT03008213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56070599|NCT03008213|Serotonin Agents|serotonin agents|mesh-ancestor
56070635|NCT00374621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56070636|NCT00374621|Oxytocics|oxytocics|mesh-ancestor
56070637|NCT00374621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
56070642|NCT00374621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070643|NCT03012191|Gentamicins|gentamicins|mesh-list
56070644|NCT03012191|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56070645|NCT03012191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070646|NCT03012191|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56070647|NCT03012191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070648|NCT03012191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070649|NCT01994486|Sofosbuvir|sofosbuvir|mesh-list
56070650|NCT01994486|Antiviral Agents|antiviral agents|mesh-ancestor
56070651|NCT01994486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070652|NCT01967641|Buprenorphine|buprenorphine|mesh-list
56070653|NCT01967641|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56070654|NCT01967641|Naloxone|naloxone|mesh-list
56070655|NCT01967641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56070656|NCT01967641|Narcotics|narcotics|mesh-ancestor
55740757|NCT02766335|Docetaxel|docetaxel|mesh-list
56070657|NCT01967641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070658|NCT01967641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070659|NCT01967641|Analgesics|analgesics|mesh-ancestor
56070660|NCT01967641|Sensory System Agents|sensory system agents|mesh-ancestor
56070661|NCT01967641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070662|NCT01967641|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56070663|NCT01968421|Broncho-Vaxom|broncho-vaxom|mesh-list
56070680|NCT01969201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56070681|NCT01969201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070682|NCT01962428|Ticagrelor|ticagrelor|mesh-list
56070683|NCT01962428|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56070684|NCT01962428|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55797882|NCT04964869|Epinephrine|epinephrine|mesh-list
56070685|NCT01962428|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56070686|NCT01962428|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56070687|NCT01962428|Purinergic Agents|purinergic agents|mesh-ancestor
56070688|NCT01962428|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070689|NCT01962428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070690|NCT01962428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070691|NCT01999400|Mesalamine|mesalamine|mesh-list
56070692|NCT01999400|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56070693|NCT01999400|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56070694|NCT01999400|Analgesics|analgesics|mesh-ancestor
56070695|NCT01999400|Sensory System Agents|sensory system agents|mesh-ancestor
56070696|NCT01999400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070697|NCT01999400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070698|NCT01999400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56070699|NCT01999400|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56070700|NCT01969435|Cytarabine|cytarabine|mesh-list
56070701|NCT01969435|Etoposide|etoposide|mesh-list
56070702|NCT01969435|Melphalan|melphalan|mesh-list
56070703|NCT01969435|Carmustine|carmustine|mesh-list
56070704|NCT01969435|Etoposide phosphate|etoposide phosphate|mesh-list
56070727|NCT01965002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070728|NCT01965002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070729|NCT01965002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56070730|NCT01965002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56070731|NCT01965002|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56070732|NCT01965002|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56070733|NCT01965002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070734|NCT01965002|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56070735|NCT01965002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56070736|NCT01965002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070738|NCT01965002|Anticoagulants|anticoagulants|mesh-ancestor
56070739|NCT02304757|Alendronate|alendronate|mesh-list
56070740|NCT02304757|Methylene diphosphonate|methylene diphosphonate|mesh-list
56070741|NCT02304757|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56070742|NCT02304757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070743|NCT01969747|Empagliflozin|empagliflozin|mesh-list
56070744|NCT01969747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56070745|NCT01969747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070746|NCT01969747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56070747|NCT01969747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070748|NCT02002832|Risperidone|risperidone|mesh-list
56070749|NCT02002832|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56070750|NCT02002832|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56070751|NCT02002832|Serotonin Agents|serotonin agents|mesh-ancestor
56070752|NCT02002832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070854|NCT02918357|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56070753|NCT02002832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070754|NCT02002832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070755|NCT02002832|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56070756|NCT02002832|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56070767|NCT01966718|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56070768|NCT01966718|Hormones|hormones|mesh-ancestor
56070769|NCT01966718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56070770|NCT01966718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070771|NCT02308501|Alcaftadine|alcaftadine|mesh-list
56070772|NCT02308501|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56070773|NCT02308501|Histamine Antagonists|histamine antagonists|mesh-ancestor
56070774|NCT02308501|Histamine Agents|histamine agents|mesh-ancestor
56070775|NCT02308501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070776|NCT02308501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070777|NCT02308501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070778|NCT02006108|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
56070779|NCT02006108|Hematinics|hematinics|mesh-ancestor
56070780|NCT02006108|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56070781|NCT02006108|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56070782|NCT02006342|Insulin|insulin|mesh-list
56070783|NCT02006342|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56070784|NCT02006342|Insulin Glargine|insulin glargine|mesh-list
56070785|NCT02006342|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56070786|NCT02006342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070787|NCT01968356|Ethanol|ethanol|mesh-list
56070788|NCT01968356|Chlorhexidine|chlorhexidine|mesh-list
56070789|NCT01968356|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56070790|NCT01968356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56070791|NCT01968356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070792|NCT01968356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070793|NCT01968356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070794|NCT01968356|Disinfectants|disinfectants|mesh-ancestor
56070795|NCT01968356|Dermatologic Agents|dermatologic agents|mesh-ancestor
56070796|NCT02311933|Tamoxifen|tamoxifen|mesh-list
56070797|NCT02311933|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56070798|NCT02311933|Hormone Antagonists|hormone antagonists|mesh-ancestor
56070800|NCT02311933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070809|NCT02008682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070810|NCT02008682|Incretins|incretins|mesh-ancestor
56070811|NCT02008682|Hormones|hormones|mesh-ancestor
56070812|NCT02008682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56070813|NCT02008682|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56070814|NCT02008682|Protease Inhibitors|protease inhibitors|mesh-ancestor
56070815|NCT02008682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070816|NCT02008682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070817|NCT02915705|Vitamin D|vitamin d|mesh-list
56070818|NCT02915705|Vitamins|vitamins|mesh-ancestor
56070819|NCT02915705|Micronutrients|micronutrients|mesh-ancestor
56070820|NCT02915705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070821|NCT02915705|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56070822|NCT01969916|Regadenoson|regadenoson|mesh-list
56070823|NCT01969916|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56070824|NCT01969916|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56070825|NCT01969916|Purinergic Agonists|purinergic agonists|mesh-ancestor
56070826|NCT01969916|Purinergic Agents|purinergic agents|mesh-ancestor
56070827|NCT01969916|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070828|NCT01969916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070829|NCT01969916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070830|NCT00373919|Erythromycin|erythromycin|mesh-list
56070831|NCT00373919|Erythromycin Estolate|erythromycin estolate|mesh-list
56070832|NCT00373919|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56070833|NCT00373919|Erythromycin stearate|erythromycin stearate|mesh-list
56070834|NCT00373919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56070835|NCT00373919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070836|NCT00373919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56070837|NCT00373919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56070838|NCT00373919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070839|NCT00373919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070848|NCT02918357|Edetic Acid|edetic acid|mesh-list
56070849|NCT02918357|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56070850|NCT02918357|Chelating Agents|chelating agents|mesh-ancestor
56070851|NCT02918357|Sequestering Agents|sequestering agents|mesh-ancestor
56070852|NCT02918357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070853|NCT02918357|Anticoagulants|anticoagulants|mesh-ancestor
56070855|NCT02918357|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56070857|NCT02829983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56070858|NCT02829983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070859|NCT02829983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56070860|NCT02829983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56070861|NCT02829983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070862|NCT02829983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56070863|NCT02829983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56070865|NCT02012192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56070866|NCT02012192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56070867|NCT02012192|Tubulin Modulators|tubulin modulators|mesh-ancestor
56070868|NCT02012192|Antimitotic Agents|antimitotic agents|mesh-ancestor
56070869|NCT02012192|Mitosis Modulators|mitosis modulators|mesh-ancestor
56070870|NCT02012192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070871|NCT02066792|Cycloserine|cycloserine|mesh-list
56070872|NCT02066792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56070873|NCT02066792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070874|NCT02066792|Renal Agents|renal agents|mesh-ancestor
56070875|NCT02066792|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56070876|NCT02066792|Antitubercular Agents|antitubercular agents|mesh-ancestor
56070877|NCT02066792|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56070878|NCT02066792|Antimetabolites|antimetabolites|mesh-ancestor
56070879|NCT02066792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070888|NCT02014363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56070889|NCT02014363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56070891|NCT02014363|Sensory System Agents|sensory system agents|mesh-ancestor
56070892|NCT02014363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070893|NCT02014363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070894|NCT02014363|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56070895|NCT02014363|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56070896|NCT02014363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56070897|NCT02014363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070898|NCT02014363|Adrenergic Agents|adrenergic agents|mesh-ancestor
56070899|NCT02014363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56070900|NCT02067806|Chloroprocaine|chloroprocaine|mesh-list
56070901|NCT02067806|Anesthetics, Local|anesthetics, local|mesh-ancestor
56070902|NCT02067806|Anesthetics|anesthetics|mesh-ancestor
56070903|NCT02067806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070904|NCT02067806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070905|NCT02067806|Sensory System Agents|sensory system agents|mesh-ancestor
56070906|NCT02067806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070907|NCT02833415|Empagliflozin|empagliflozin|mesh-list
56070908|NCT02833415|Glycerol|glycerol|mesh-list
56070909|NCT02833415|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56070910|NCT02833415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56070911|NCT02833415|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56070912|NCT02833415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070913|NCT02833415|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56070914|NCT02833415|Protective Agents|protective agents|mesh-ancestor
56070915|NCT02012348|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56070916|NCT02012348|Benzalkonium Compounds|benzalkonium compounds|mesh-list
56070917|NCT02012348|Triclocarban|triclocarban|mesh-list
56070918|NCT02012348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56070919|NCT02012348|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56070920|NCT02834663|Ranibizumab|ranibizumab|mesh-list
56070921|NCT02834663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56070927|NCT01973036|Oxytocin|oxytocin|mesh-list
56070928|NCT01973036|Oxytocics|oxytocics|mesh-ancestor
56070929|NCT01973036|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56070930|NCT01973036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070931|NCT02017327|Bimatoprost|bimatoprost|mesh-list
56070932|NCT02017327|Latanoprost|latanoprost|mesh-list
56070933|NCT02017327|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56070934|NCT02017327|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56070935|NCT02017327|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56070936|NCT02837237|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
56070937|NCT02837237|Mineralocorticoids|mineralocorticoids|mesh-list
56070938|NCT02837237|Hormone Antagonists|hormone antagonists|mesh-ancestor
56070939|NCT02837237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56070940|NCT02837237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070941|NCT02837237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56070942|NCT02837237|Diuretics|diuretics|mesh-ancestor
56070943|NCT02837237|Natriuretic Agents|natriuretic agents|mesh-ancestor
56070945|NCT02068820|Fluorophosphate|fluorophosphate|mesh-list
56070946|NCT02068820|Cariostatic Agents|cariostatic agents|mesh-ancestor
56070948|NCT02068820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070949|NCT02018107|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56070950|NCT02018107|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56070952|NCT02018653|Calcium, Dietary|calcium, dietary|mesh-list
56070978|NCT01973348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56070979|NCT01973348|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56070981|NCT02839889|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56070982|NCT02839889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070983|NCT02839889|Sensory System Agents|sensory system agents|mesh-ancestor
56070984|NCT02839889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56070985|NCT01971385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56070986|NCT01971385|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
56070987|NCT01971385|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56070988|NCT01971385|Immunologic Factors|immunologic factors|mesh-ancestor
56070989|NCT01971385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070990|NCT02925611|Desflurane|desflurane|mesh-list
56070991|NCT02925611|Isoflurane|isoflurane|mesh-list
56070992|NCT02925611|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56070993|NCT02925611|Anesthetics, General|anesthetics, general|mesh-ancestor
56070994|NCT02925611|Anesthetics|anesthetics|mesh-ancestor
56070995|NCT02925611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56070996|NCT02925611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56070997|NCT00374075|Valproic Acid|valproic acid|mesh-list
56070998|NCT00374075|Anticonvulsants|anticonvulsants|mesh-ancestor
56070999|NCT00374075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071000|NCT00374075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071001|NCT00374075|GABA Agents|gaba agents|mesh-ancestor
56071002|NCT00374075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071003|NCT00374075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071004|NCT00374075|Antimanic Agents|antimanic agents|mesh-ancestor
56071005|NCT00374075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56071007|NCT00374075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56071023|NCT01973335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071024|NCT01973413|Insulin|insulin|mesh-list
56071025|NCT01973413|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56071026|NCT01973413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071027|NCT02021461|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56071028|NCT02021461|Anticonvulsants|anticonvulsants|mesh-ancestor
56071029|NCT02021461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56071030|NCT02021461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56071031|NCT02021461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071033|NCT02929667|Fluoxetine|fluoxetine|mesh-list
56071034|NCT02929667|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56071035|NCT02929667|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56071036|NCT02929667|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071037|NCT02929667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071038|NCT02929667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071039|NCT02929667|Serotonin Agents|serotonin agents|mesh-ancestor
56071040|NCT02929667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071041|NCT02929667|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56071042|NCT02929667|Antidepressive Agents|antidepressive agents|mesh-ancestor
56071043|NCT02929667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56071044|NCT02929667|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56071045|NCT02929667|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56071046|NCT02929667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071047|NCT02021929|Sorafenib|sorafenib|mesh-list
56071048|NCT02021929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071049|NCT02021929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56071050|NCT02021929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071051|NCT02021929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071052|NCT02929823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56071053|NCT02929823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56071054|NCT02023411|Teriparatide|teriparatide|mesh-list
56071055|NCT02023411|Hormones|hormones|mesh-list
56071056|NCT02023411|Parathyroid Hormone|parathyroid hormone|mesh-list
56071058|NCT02023411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071059|NCT02023411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56071060|NCT02023411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56071062|NCT01975519|Immunologic Factors|immunologic factors|mesh-ancestor
56071063|NCT01975519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071064|NCT02934191|Acetaminophen|acetaminophen|mesh-list
56071065|NCT02934191|Celecoxib|celecoxib|mesh-list
56071066|NCT02934191|Oxycodone|oxycodone|mesh-list
56071067|NCT02934191|Calcium Carbonate|calcium carbonate|mesh-list
56071068|NCT02934191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071069|NCT02934191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56071070|NCT02934191|Analgesics|analgesics|mesh-ancestor
56071071|NCT02934191|Sensory System Agents|sensory system agents|mesh-ancestor
56071072|NCT02934191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071073|NCT02934191|Antipyretics|antipyretics|mesh-ancestor
56071074|NCT02934191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56071075|NCT02934191|Narcotics|narcotics|mesh-ancestor
56071076|NCT02934191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071077|NCT02934191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56071078|NCT02934191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071079|NCT02934191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56071080|NCT02934191|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56071081|NCT02934191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56071082|NCT02934191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071083|NCT02934191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071084|NCT02934191|Antacids|antacids|mesh-ancestor
56071085|NCT02934191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56071087|NCT02937623|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56071088|NCT02937623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071102|NCT01977781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071103|NCT01977781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071105|NCT01977781|Autonomic Agents|autonomic agents|mesh-ancestor
56071106|NCT01977781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071107|NCT01977781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56071108|NCT01977781|Glucocorticoids|glucocorticoids|mesh-ancestor
56071109|NCT01977781|Hormones|hormones|mesh-ancestor
56071110|NCT01977781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071111|NCT01977781|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56071112|NCT01977781|Protective Agents|protective agents|mesh-ancestor
56071113|NCT01977781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56071114|NCT01977781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071115|NCT02070302|Botulinum Toxins|botulinum toxins|mesh-list
56071116|NCT02070302|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56071117|NCT02070302|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56071118|NCT02070302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56071119|NCT02070302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071120|NCT02070302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071121|NCT02070302|Cholinergic Agents|cholinergic agents|mesh-ancestor
56071122|NCT02070302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071123|NCT02070302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071124|NCT02070302|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56071125|NCT02070302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071143|NCT02026297|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56071144|NCT02026297|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56071145|NCT02026297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071146|NCT02026297|Hemostatics|hemostatics|mesh-ancestor
56071147|NCT02026297|Coagulants|coagulants|mesh-ancestor
56071148|NCT02070692|Tamoxifen|tamoxifen|mesh-list
56071149|NCT02070692|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56071150|NCT02070692|Hormone Antagonists|hormone antagonists|mesh-ancestor
56071151|NCT02070692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071152|NCT02070692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071153|NCT02070692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56071154|NCT02070692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071155|NCT02070692|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56071156|NCT02070692|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56071157|NCT02070692|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56071158|NCT02015234|Cyclobenzaprine|cyclobenzaprine|mesh-list
56071159|NCT02015234|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56071160|NCT02015234|Antidepressive Agents|antidepressive agents|mesh-ancestor
56071161|NCT02015234|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56071162|NCT02015234|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56071163|NCT02015234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071164|NCT02015234|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56071165|NCT02015234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071166|NCT02015234|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56071167|NCT02015234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071168|NCT02869451|Bupropion|bupropion|mesh-list
56071169|NCT02869451|Nicotine|nicotine|mesh-list
56071170|NCT02869451|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56071171|NCT02869451|Autonomic Agents|autonomic agents|mesh-ancestor
56071174|NCT02869451|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56071185|NCT02869451|Dopamine Agents|dopamine agents|mesh-ancestor
56071186|NCT02869451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56071187|NCT02869451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56071188|NCT02869451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071189|NCT02305316|Opicapone|opicapone|mesh-list
56071190|NCT02305316|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56071191|NCT02305316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071192|NCT02305316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071194|NCT02305316|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56071195|NCT02944565|Daratumumab|daratumumab|mesh-list
56071196|NCT02944565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071197|NCT02870309|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
56071198|NCT02870309|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56071201|NCT02870309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071233|NCT02871011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071234|NCT02871011|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56071235|NCT02871011|Vasodilator Agents|vasodilator agents|mesh-ancestor
56071236|NCT02871011|Gasotransmitters|gasotransmitters|mesh-ancestor
56071237|NCT02871011|Protective Agents|protective agents|mesh-ancestor
56071238|NCT02344238|Riboflavin|riboflavin|mesh-list
56071239|NCT02344238|Vitamin B Complex|vitamin b complex|mesh-ancestor
56071240|NCT02344238|Vitamins|vitamins|mesh-ancestor
56071241|NCT02344238|Micronutrients|micronutrients|mesh-ancestor
56071242|NCT02344238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071243|NCT02344238|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56071244|NCT02344238|Dermatologic Agents|dermatologic agents|mesh-ancestor
56071245|NCT02344316|Melatonin|melatonin|mesh-list
56071246|NCT02344316|Antioxidants|antioxidants|mesh-ancestor
56071248|NCT02344316|Protective Agents|protective agents|mesh-ancestor
56071296|NCT01981759|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56071297|NCT01981759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071298|NCT01981759|Renal Agents|renal agents|mesh-ancestor
56071299|NCT01981759|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56071300|NCT01981759|Antitubercular Agents|antitubercular agents|mesh-ancestor
56071301|NCT01981759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56071302|NCT01981759|Antimetabolites|antimetabolites|mesh-ancestor
56071303|NCT01981759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071304|NCT01980524|Acipimox|acipimox|mesh-list
56071305|NCT01980524|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56071306|NCT01980524|Antimetabolites|antimetabolites|mesh-ancestor
56071307|NCT01980524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071308|NCT01980524|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56071309|NCT01982539|Diclofenac|diclofenac|mesh-list
56071310|NCT01982539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56071311|NCT01982539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56071312|NCT01982539|Analgesics|analgesics|mesh-ancestor
56071313|NCT01982539|Sensory System Agents|sensory system agents|mesh-ancestor
56071314|NCT01982539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071315|NCT01982539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071316|NCT01982539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071317|NCT01982539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56071318|NCT01982539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56071319|NCT01982539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071345|NCT01981772|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56071346|NCT01981772|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56071347|NCT01981772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071348|NCT01981772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071349|NCT01981772|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56071350|NCT01981772|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56071351|NCT01981772|Adrenergic Agents|adrenergic agents|mesh-ancestor
56071352|NCT01981772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071353|NCT01981772|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56071354|NCT01981772|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56071355|NCT01981772|Autonomic Agents|autonomic agents|mesh-ancestor
56071356|NCT01981772|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56071358|NCT01981772|Mydriatics|mydriatics|mesh-ancestor
56071359|NCT01981772|Sympathomimetics|sympathomimetics|mesh-ancestor
56071360|NCT01981772|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56071361|NCT01982240|Bisacodyl|bisacodyl|mesh-list
56071362|NCT01982240|Plecanatide|plecanatide|mesh-list
56071363|NCT01982240|Cathartics|cathartics|mesh-ancestor
56071364|NCT01982240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56071398|NCT01985581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071399|NCT02024204|Fluticasone|fluticasone|mesh-list
56071400|NCT02024204|Xhance|xhance|mesh-list
56071401|NCT02024204|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56071402|NCT02024204|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56071403|NCT02024204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071404|NCT02024204|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56071405|NCT02024204|Autonomic Agents|autonomic agents|mesh-ancestor
56071406|NCT02024204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071407|NCT02024204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071408|NCT02024204|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56071409|NCT02024204|Respiratory System Agents|respiratory system agents|mesh-ancestor
56071410|NCT02024204|Dermatologic Agents|dermatologic agents|mesh-ancestor
56071411|NCT02024204|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56071412|NCT02024204|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56071413|NCT02024204|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56071414|NCT02024204|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56071415|NCT02024204|Adrenergic Agents|adrenergic agents|mesh-ancestor
56071416|NCT02024204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071417|NCT02024204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071418|NCT02024204|Glucocorticoids|glucocorticoids|mesh-ancestor
56071419|NCT02024204|Hormones|hormones|mesh-ancestor
56071420|NCT02024204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071421|NCT02024204|Sympathomimetics|sympathomimetics|mesh-ancestor
56071422|NCT03930745|TOL-463|tol-463|mesh-list
56071423|NCT03930745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071446|NCT02349152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56071447|NCT02349152|Anesthetics, General|anesthetics, general|mesh-ancestor
56071448|NCT02349152|Anesthetics|anesthetics|mesh-ancestor
56071449|NCT02035345|Carboplatin|carboplatin|mesh-list
56071450|NCT02035345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071451|NCT01986361|Flurbiprofen|flurbiprofen|mesh-list
56071452|NCT01986361|Analgesics|analgesics|mesh-ancestor
56071453|NCT01986361|Sensory System Agents|sensory system agents|mesh-ancestor
56071454|NCT01986361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071455|NCT01986361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071456|NCT01986361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56071457|NCT01986361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56071458|NCT01986361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071459|NCT01986361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56071460|NCT01986361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56071461|NCT01986361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071462|NCT01986361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071463|NCT01983020|Lidocaine|lidocaine|mesh-list
56071464|NCT01983020|Ketamine|ketamine|mesh-list
56071465|NCT01983020|Anesthetics, Local|anesthetics, local|mesh-ancestor
56071466|NCT01983020|Anesthetics|anesthetics|mesh-ancestor
56071467|NCT01983020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071468|NCT01983020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071469|NCT01983020|Sensory System Agents|sensory system agents|mesh-ancestor
56071470|NCT01983020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071471|NCT01983020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56071472|NCT01983020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56071473|NCT01983020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56071474|NCT01983020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071475|NCT01983020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071476|NCT01983020|Analgesics|analgesics|mesh-ancestor
56071477|NCT01983020|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56071478|NCT01983020|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56071479|NCT01983020|Anesthetics, General|anesthetics, general|mesh-ancestor
56071480|NCT01983020|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56071484|NCT02058511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071485|NCT02058511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071486|NCT01983566|Omeprazole|omeprazole|mesh-list
56071487|NCT01983566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56071488|NCT01983566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56071489|NCT01983566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56071490|NCT01983566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071491|NCT01983566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071492|NCT01983878|Ramucirumab|ramucirumab|mesh-list
56071493|NCT01983878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071495|NCT02396732|Enoxaparin|enoxaparin|mesh-list
56071496|NCT02396732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56071497|NCT02396732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56071498|NCT02396732|Analgesics|analgesics|mesh-ancestor
56071499|NCT02396732|Sensory System Agents|sensory system agents|mesh-ancestor
56071500|NCT02396732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798706|NCT03053869|Diazepam|diazepam|mesh-list
56071501|NCT02396732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071502|NCT02396732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071505|NCT02396732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56071506|NCT02396732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071507|NCT02396732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56071508|NCT02396732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56071509|NCT02396732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071510|NCT02396732|Antipyretics|antipyretics|mesh-ancestor
56071511|NCT02396732|Anticoagulants|anticoagulants|mesh-ancestor
56071512|NCT02352974|Vitamin D|vitamin d|mesh-list
56071513|NCT02352974|Vitamins|vitamins|mesh-ancestor
56071514|NCT02352974|Micronutrients|micronutrients|mesh-ancestor
56071515|NCT02352974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071516|NCT02352974|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56071517|NCT02353754|Morphine|morphine|mesh-list
56071518|NCT02353754|Bupivacaine|bupivacaine|mesh-list
56071519|NCT02353754|Anesthetics, Local|anesthetics, local|mesh-ancestor
56071520|NCT02353754|Anesthetics|anesthetics|mesh-ancestor
56071523|NCT02353754|Sensory System Agents|sensory system agents|mesh-ancestor
56071524|NCT02353754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071525|NCT02353754|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56071526|NCT02353754|Narcotics|narcotics|mesh-ancestor
56071527|NCT02353754|Analgesics|analgesics|mesh-ancestor
56071528|NCT02354378|Dexmedetomidine|dexmedetomidine|mesh-list
56071529|NCT02354378|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56071530|NCT02354378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071531|NCT02354378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071532|NCT02354378|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56071533|NCT02354378|Analgesics|analgesics|mesh-ancestor
56071534|NCT02354378|Sensory System Agents|sensory system agents|mesh-ancestor
56071535|NCT02354378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071536|NCT02354378|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56071537|NCT02354378|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56071538|NCT02354378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56071539|NCT02354378|Adrenergic Agents|adrenergic agents|mesh-ancestor
56071540|NCT02354378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071541|NCT02354378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071542|NCT02059213|Palbociclib|palbociclib|mesh-list
56071543|NCT02059213|Leuprolide|leuprolide|mesh-list
56071544|NCT02059213|Goserelin|goserelin|mesh-list
56071545|NCT02059213|Bicalutamide|bicalutamide|mesh-list
56071546|NCT02059213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071548|NCT02059213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071573|NCT02354534|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56071574|NCT02354534|Anthelmintics|anthelmintics|mesh-ancestor
56071575|NCT02355158|Clonidine|clonidine|mesh-list
56071576|NCT02355158|Analgesics|analgesics|mesh-ancestor
56071577|NCT02355158|Sensory System Agents|sensory system agents|mesh-ancestor
56071578|NCT02355158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071579|NCT02355158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071580|NCT02355158|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56071581|NCT02355158|Sympatholytics|sympatholytics|mesh-ancestor
56071582|NCT02355158|Autonomic Agents|autonomic agents|mesh-ancestor
56071583|NCT02355158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56071584|NCT02355158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56071585|NCT02355158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56071586|NCT02355158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56071587|NCT02355158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071588|NCT02355158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071589|NCT02033876|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56071590|NCT02033876|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56071591|NCT02033876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56071592|NCT02061397|Sirolimus|sirolimus|mesh-list
56071593|NCT02061397|Everolimus|everolimus|mesh-list
56071594|NCT02061397|Simvastatin|simvastatin|mesh-list
56071595|NCT02061397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071596|NCT02061397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56071597|NCT02061397|Immunologic Factors|immunologic factors|mesh-ancestor
56071598|NCT02061397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071624|NCT02062177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071625|NCT02062177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071627|NCT02034578|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56071628|NCT02034578|Antithrombins|antithrombins|mesh-ancestor
56071629|NCT02034578|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56071630|NCT02034578|Protease Inhibitors|protease inhibitors|mesh-ancestor
56071631|NCT02034578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071632|NCT02034578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071633|NCT02034578|Anticoagulants|anticoagulants|mesh-ancestor
56071634|NCT02403830|Morphine|morphine|mesh-list
56071635|NCT02403830|Methylnaltrexone|methylnaltrexone|mesh-list
56071639|NCT02403830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071640|NCT02403830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071641|NCT02403830|Analgesics|analgesics|mesh-ancestor
56071642|NCT02403830|Sensory System Agents|sensory system agents|mesh-ancestor
56071643|NCT02403830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071644|NCT02403830|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56071645|NCT02403830|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56071646|NCT02403830|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56071647|NCT02403830|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56071648|NCT02403830|Purinergic Agents|purinergic agents|mesh-ancestor
56071649|NCT02403830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071650|NCT02403830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071654|NCT02951195|Ivacaftor|ivacaftor|mesh-list
56071669|NCT02037230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071670|NCT02312882|Tofacitinib|tofacitinib|mesh-list
56071671|NCT02312882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56071672|NCT02312882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071673|NCT02312882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071674|NCT02877095|Furosemide|furosemide|mesh-list
56071675|NCT02877095|Diuretics|diuretics|mesh-ancestor
56071676|NCT02877095|Natriuretic Agents|natriuretic agents|mesh-ancestor
56071677|NCT02877095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071678|NCT02877095|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56071679|NCT02877095|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071680|NCT02877095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071681|NCT02877485|Triamcinolone|triamcinolone|mesh-list
56071682|NCT02877485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56071683|NCT02877485|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56071684|NCT02877485|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56071685|NCT02877485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071686|NCT02877485|Glucocorticoids|glucocorticoids|mesh-ancestor
56071687|NCT02877485|Hormones|hormones|mesh-ancestor
56071688|NCT02877485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071689|NCT02877485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071690|NCT02877485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56071691|NCT02877485|Immunologic Factors|immunologic factors|mesh-ancestor
56071692|NCT02877485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071693|NCT02877485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071715|NCT03028025|Coagulants|coagulants|mesh-ancestor
56071717|NCT02955329|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56071718|NCT02955329|Autonomic Agents|autonomic agents|mesh-ancestor
56071719|NCT02955329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071720|NCT02955329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071721|NCT02955329|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56071722|NCT02955329|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56071723|NCT02955329|Cholinergic Agents|cholinergic agents|mesh-ancestor
56071724|NCT02955329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071725|NCT02955329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071726|NCT02359058|Capecitabine|capecitabine|mesh-list
56071727|NCT02359058|Oxaliplatin|oxaliplatin|mesh-list
56071728|NCT02359058|Ramucirumab|ramucirumab|mesh-list
56071729|NCT02359058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071730|NCT02359058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56071731|NCT02359058|Antimetabolites|antimetabolites|mesh-ancestor
56071732|NCT02359058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071733|NCT02404610|Propofol|propofol|mesh-list
56071734|NCT02404610|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
56071735|NCT02404610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071736|NCT02404610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071737|NCT02404610|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56071738|NCT02404610|Anesthetics, General|anesthetics, general|mesh-ancestor
56071739|NCT02404610|Anesthetics|anesthetics|mesh-ancestor
56071740|NCT03028103|Repaglinide|repaglinide|mesh-list
56071763|NCT03110003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071764|NCT03110003|Sensory System Agents|sensory system agents|mesh-ancestor
56071765|NCT03110003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071766|NCT03114995|Tirofiban|tirofiban|mesh-list
56071767|NCT03114995|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56071768|NCT03114995|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56071769|NCT03114995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071770|NCT03114995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56071771|NCT02959853|Anastrozole|anastrozole|mesh-list
56071772|NCT02959853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56071773|NCT02959853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071774|NCT02959853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56071775|NCT02959853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56071776|NCT02959853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071777|NCT02959853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071778|NCT02959853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56071779|NCT02959853|Hormone Antagonists|hormone antagonists|mesh-ancestor
56071780|NCT02959853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071781|NCT02959853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071782|NCT00374465|Verapamil|verapamil|mesh-list
56071783|NCT00374465|Carvedilol|carvedilol|mesh-list
56071784|NCT00374465|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56071785|NCT00374465|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56071786|NCT00374465|Adrenergic Agents|adrenergic agents|mesh-ancestor
56071787|NCT00374465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071788|NCT00374465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071789|NCT00374465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071790|NCT00374465|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56071791|NCT00374465|Antioxidants|antioxidants|mesh-ancestor
56071792|NCT00374465|Protective Agents|protective agents|mesh-ancestor
56071803|NCT02040116|Immunologic Factors|immunologic factors|mesh-ancestor
56071804|NCT02040116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071805|NCT02040116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56071806|NCT02360774|Canagliflozin|canagliflozin|mesh-list
56071807|NCT02360774|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56071808|NCT02360774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071809|NCT02360774|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56071810|NCT02360774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071812|NCT02361476|Analgesics|analgesics|mesh-ancestor
56071813|NCT02361476|Sensory System Agents|sensory system agents|mesh-ancestor
56071814|NCT02361476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071815|NCT02361476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071816|NCT02361476|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56071817|NCT02361476|Sympatholytics|sympatholytics|mesh-ancestor
56071818|NCT02361476|Autonomic Agents|autonomic agents|mesh-ancestor
56071819|NCT02361476|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56071820|NCT02361476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56071821|NCT02361476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56071822|NCT02361476|Adrenergic Agents|adrenergic agents|mesh-ancestor
56071823|NCT02361476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071824|NCT02361476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071825|NCT02363270|Ketamine|ketamine|mesh-list
56071826|NCT02363270|Analgesics|analgesics|mesh-ancestor
56071827|NCT02363270|Sensory System Agents|sensory system agents|mesh-ancestor
56071828|NCT02363270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071829|NCT02363270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071830|NCT02363270|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56071831|NCT02363270|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56071832|NCT02363270|Anesthetics, General|anesthetics, general|mesh-ancestor
56071833|NCT02363270|Anesthetics|anesthetics|mesh-ancestor
56071847|NCT02042534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071850|NCT02043704|Analgesics|analgesics|mesh-ancestor
56071851|NCT02043704|Sensory System Agents|sensory system agents|mesh-ancestor
56071852|NCT02043704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071853|NCT02043704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071854|NCT02043704|Antipyretics|antipyretics|mesh-ancestor
56071855|NCT02410382|Dexamethasone|dexamethasone|mesh-list
56071856|NCT02410382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071857|NCT02410382|Antiemetics|antiemetics|mesh-ancestor
56071858|NCT02410382|Autonomic Agents|autonomic agents|mesh-ancestor
56071859|NCT02410382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071860|NCT02410382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071861|NCT02410382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56071862|NCT02410382|Glucocorticoids|glucocorticoids|mesh-ancestor
56071863|NCT02410382|Hormones|hormones|mesh-ancestor
56071864|NCT02410382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071865|NCT02410382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56071866|NCT02410382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071867|NCT03038867|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56071868|NCT03038867|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56071869|NCT03038867|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56071870|NCT03038867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071987|NCT02975297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071871|NCT03038867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071872|NCT03038867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071873|NCT03038867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071874|NCT03038867|Analgesics|analgesics|mesh-ancestor
56071875|NCT03038867|Sensory System Agents|sensory system agents|mesh-ancestor
56071892|NCT02965781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071893|NCT03124121|Golimumab|golimumab|mesh-list
56071894|NCT03124121|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56071895|NCT03124121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071896|NCT03124121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56071897|NCT03124121|Immunologic Factors|immunologic factors|mesh-ancestor
56071898|NCT03124121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071899|NCT03042299|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56071900|NCT03042299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56071901|NCT03042299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56071902|NCT03042299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071903|NCT00374699|Bortezomib|bortezomib|mesh-list
56071904|NCT00374699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56071905|NCT00374777|Nitrazepam|nitrazepam|mesh-list
56071906|NCT00374777|Zolpidem|zolpidem|mesh-list
56071907|NCT00374777|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56071908|NCT00374777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56071909|NCT00374777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071910|NCT00374777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071911|NCT00374777|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56071912|NCT00374777|GABA Agonists|gaba agonists|mesh-ancestor
56071913|NCT00374777|GABA Agents|gaba agents|mesh-ancestor
56071914|NCT00374777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071915|NCT00374777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071919|NCT00374777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56071920|NCT00374777|GABA Modulators|gaba modulators|mesh-ancestor
56071921|NCT02044796|Cytarabine|cytarabine|mesh-list
56071935|NCT02044796|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56071936|NCT02044796|Analgesics|analgesics|mesh-ancestor
56071937|NCT02044796|Sensory System Agents|sensory system agents|mesh-ancestor
56071938|NCT02044796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071939|NCT02044796|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56071940|NCT02044796|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56071941|NCT02044796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56071942|NCT02973503|Grazoprevir|grazoprevir|mesh-list
56071943|NCT02973503|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56071944|NCT02973503|Antiviral Agents|antiviral agents|mesh-ancestor
56071945|NCT02973503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56071946|NCT03127943|Lidocaine|lidocaine|mesh-list
56071947|NCT03127943|Anesthetics, Local|anesthetics, local|mesh-ancestor
56071948|NCT03127943|Anesthetics|anesthetics|mesh-ancestor
55799156|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
56071949|NCT03127943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56071950|NCT03127943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071951|NCT03127943|Sensory System Agents|sensory system agents|mesh-ancestor
56071952|NCT03127943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071953|NCT03127943|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56071954|NCT03127943|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56071955|NCT03127943|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56071956|NCT03127943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56071957|NCT03127943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071958|NCT03048383|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56071959|NCT03048383|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56071960|NCT03048383|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56071961|NCT03048383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56071962|NCT03048383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071963|NCT03048383|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56071974|NCT02045264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071975|NCT02045264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56071976|NCT02045264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56071977|NCT02045264|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
56071978|NCT02045264|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
56071979|NCT02045264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071980|NCT02045264|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56071981|NCT02045264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56071982|NCT02045264|Immunologic Factors|immunologic factors|mesh-ancestor
56071984|NCT02975297|Nicotine|nicotine|mesh-list
56071985|NCT02975297|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56071986|NCT02975297|Autonomic Agents|autonomic agents|mesh-ancestor
56071988|NCT02975297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56071989|NCT02975297|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56071990|NCT02975297|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56071991|NCT02975297|Cholinergic Agents|cholinergic agents|mesh-ancestor
56071992|NCT02975297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56071993|NCT02975297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56071995|NCT02975297|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56071996|NCT02975297|Incretins|incretins|mesh-ancestor
56071997|NCT02975297|Hormones|hormones|mesh-ancestor
56071998|NCT02975297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56071999|NCT02046200|Ethanol|ethanol|mesh-list
56072000|NCT02046200|Ivermectin|ivermectin|mesh-list
56072006|NCT02978339|Curcumin|curcumin|mesh-list
56072020|NCT02367872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799238|NCT02433483|Cytarabine|cytarabine|mesh-list
56072021|NCT00374855|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56072022|NCT00374855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56072023|NCT00374855|Diuretics|diuretics|mesh-ancestor
56072024|NCT00374855|Natriuretic Agents|natriuretic agents|mesh-ancestor
56072025|NCT00374855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072026|NCT00374855|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56072027|NCT00374855|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56072028|NCT00374855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072029|NCT02412644|Apremilast|apremilast|mesh-list
56072030|NCT02412644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56072031|NCT02412644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56072032|NCT02412644|Analgesics|analgesics|mesh-ancestor
56072033|NCT02412644|Sensory System Agents|sensory system agents|mesh-ancestor
56072034|NCT02412644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072075|NCT02414204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072076|NCT02414204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072077|NCT02414204|Urological Agents|urological agents|mesh-ancestor
56072078|NCT02049476|Dexamethasone|dexamethasone|mesh-list
56072080|NCT02049476|Antiemetics|antiemetics|mesh-ancestor
56072081|NCT02049476|Autonomic Agents|autonomic agents|mesh-ancestor
56072082|NCT02049476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072083|NCT02049476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072084|NCT02049476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56072085|NCT02049476|Glucocorticoids|glucocorticoids|mesh-ancestor
56072086|NCT02049476|Hormones|hormones|mesh-ancestor
56072087|NCT02049476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56072088|NCT02049476|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56072089|NCT02049476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072090|NCT02989493|Doxazosin|doxazosin|mesh-list
56072091|NCT02989493|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56072092|NCT02989493|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56072093|NCT02989493|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56072094|NCT02989493|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56072095|NCT02989493|Adrenergic Agents|adrenergic agents|mesh-ancestor
56072096|NCT02989493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072097|NCT02989493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072098|NCT02989493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072099|NCT02050334|Caffeic acid|caffeic acid|mesh-list
56072100|NCT02050334|Antioxidants|antioxidants|mesh-ancestor
56072101|NCT02050334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072102|NCT02050334|Protective Agents|protective agents|mesh-ancestor
56072103|NCT02050334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072105|NCT02371850|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56072106|NCT02371850|Autonomic Agents|autonomic agents|mesh-ancestor
56072107|NCT02371850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072118|NCT03145259|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
56072119|NCT03145259|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56072120|NCT03145259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56072121|NCT03145259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56072123|NCT03145259|Sensory System Agents|sensory system agents|mesh-ancestor
56072124|NCT03145259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072125|NCT03145259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072126|NCT03145259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072127|NCT03145259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56072128|NCT03145259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56072129|NCT03145259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072130|NCT03145259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072131|NCT00354692|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56072136|NCT02989727|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56072137|NCT02989727|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56072138|NCT02989727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072139|NCT02989727|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56072140|NCT02989727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072141|NCT02989727|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56072142|NCT02989727|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56072143|NCT02989727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072144|NCT02989727|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56072166|NCT02996591|Antiemetics|antiemetics|mesh-ancestor
55799380|NCT02418585|Citalopram|citalopram|mesh-list
56072167|NCT02996591|Autonomic Agents|autonomic agents|mesh-ancestor
56072168|NCT02996591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072169|NCT02996591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072170|NCT02996591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56072171|NCT02996591|Glucocorticoids|glucocorticoids|mesh-ancestor
56072172|NCT02996591|Hormones|hormones|mesh-ancestor
56072173|NCT02996591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56072174|NCT02996591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56072175|NCT02996591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072176|NCT02996591|Protease Inhibitors|protease inhibitors|mesh-ancestor
56072177|NCT02996591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072178|NCT02996591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072179|NCT02996591|Anesthetics, Local|anesthetics, local|mesh-ancestor
56072180|NCT02996591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072181|NCT02996591|Sensory System Agents|sensory system agents|mesh-ancestor
56072182|NCT02996591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56072183|NCT02996591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56072184|NCT02996591|Anesthetics, General|anesthetics, general|mesh-ancestor
56072185|NCT02996591|Analgesics|analgesics|mesh-ancestor
56072186|NCT02996591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56072187|NCT02996591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56072188|NCT02996591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56072189|NCT02996591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072190|NCT02996591|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56072191|NCT02996591|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56072192|NCT02996591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56072193|NCT02996591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56072194|NCT02996591|GABA Modulators|gaba modulators|mesh-ancestor
56072195|NCT02996591|GABA Agents|gaba agents|mesh-ancestor
56072196|NCT02996591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56072197|NCT02996591|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56072198|NCT02996591|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56072205|NCT03066947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56072206|NCT03066947|Immunologic Factors|immunologic factors|mesh-ancestor
56072207|NCT03066947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072208|NCT03066947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56072209|NCT03066947|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56072210|NCT03066947|Alkylating Agents|alkylating agents|mesh-ancestor
56072211|NCT03066947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072212|NCT03066947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072213|NCT03066947|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56072214|NCT03066947|Antiviral Agents|antiviral agents|mesh-ancestor
56072215|NCT03066947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072216|NCT02043145|Botulinum Toxins|botulinum toxins|mesh-list
56072217|NCT02043145|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56072218|NCT02043145|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56072219|NCT02043145|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56072220|NCT02043145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56072221|NCT02043145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072222|NCT02043145|Cholinergic Agents|cholinergic agents|mesh-ancestor
56072223|NCT02043145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072224|NCT02043145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072225|NCT02043145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56072226|NCT02043145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072228|NCT02062801|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56072229|NCT02062801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072230|NCT02062801|Sympathomimetics|sympathomimetics|mesh-ancestor
56072231|NCT02062801|Autonomic Agents|autonomic agents|mesh-ancestor
56072232|NCT02062801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072233|NCT02062801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56072234|NCT02062801|Adrenergic Agents|adrenergic agents|mesh-ancestor
56072235|NCT02062801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072236|NCT02062801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072244|NCT02063035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56072245|NCT02063035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072246|NCT02063035|Hemostatics|hemostatics|mesh-ancestor
56072247|NCT02063035|Coagulants|coagulants|mesh-ancestor
56072249|NCT00375245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56072250|NCT00375245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072251|NCT00375245|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56072252|NCT00375245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072253|NCT00375245|Antifungal Agents|antifungal agents|mesh-ancestor
56072254|NCT00375245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56072255|NCT00375245|Immunologic Factors|immunologic factors|mesh-ancestor
56072256|NCT00375245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072257|NCT02043379|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56072258|NCT02043379|Immunologic Factors|immunologic factors|mesh-ancestor
56072259|NCT02043379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072260|NCT02054156|Azithromycin|azithromycin|mesh-list
56072261|NCT02054156|Tobramycin|tobramycin|mesh-list
56072262|NCT02054156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56072263|NCT02054156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072264|NCT03159143|Docetaxel|docetaxel|mesh-list
56072265|NCT03159143|Oxaliplatin|oxaliplatin|mesh-list
56072266|NCT03159143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072267|NCT03159143|Tubulin Modulators|tubulin modulators|mesh-ancestor
56072268|NCT03159143|Antimitotic Agents|antimitotic agents|mesh-ancestor
56072269|NCT03159143|Mitosis Modulators|mitosis modulators|mesh-ancestor
56072270|NCT03159143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072271|NCT03068897|Ibuprofen|ibuprofen|mesh-list
56072272|NCT03068897|Tizanidine|tizanidine|mesh-list
56072273|NCT03068897|Baclofen|baclofen|mesh-list
56072274|NCT03068897|Metaxalone|metaxalone|mesh-list
56072275|NCT03068897|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56072276|NCT03068897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56072277|NCT03068897|Analgesics|analgesics|mesh-ancestor
56072278|NCT03068897|Sensory System Agents|sensory system agents|mesh-ancestor
56072279|NCT03068897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072281|NCT03068897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072285|NCT03068897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072286|NCT03068897|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56072288|NCT03068897|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56072289|NCT03068897|GABA Agonists|gaba agonists|mesh-ancestor
56072290|NCT03068897|GABA Agents|gaba agents|mesh-ancestor
56072291|NCT03068897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072292|NCT03068897|Anticonvulsants|anticonvulsants|mesh-ancestor
56072293|NCT03068897|Parasympatholytics|parasympatholytics|mesh-ancestor
56072294|NCT03068897|Autonomic Agents|autonomic agents|mesh-ancestor
56072295|NCT03068897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56072296|NCT03068897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56072297|NCT03068897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56072298|NCT03068897|Adrenergic Agents|adrenergic agents|mesh-ancestor
56072299|NCT02299297|Tofacitinib|tofacitinib|mesh-list
56072300|NCT02299297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56072301|NCT02299297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072302|NCT02299297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072303|NCT03069677|Midazolam|midazolam|mesh-list
56072304|NCT03069677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56072305|NCT03069677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56072306|NCT03069677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072307|NCT03069677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072308|NCT03069677|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56072309|NCT03069677|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56072313|NCT03069677|Anesthetics|anesthetics|mesh-ancestor
56072332|NCT02044393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56072333|NCT02044393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072334|NCT02044393|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56072335|NCT05405465|Golimumab|golimumab|mesh-list
56072336|NCT05405465|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56072337|NCT05405465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072338|NCT05405465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56072339|NCT05405465|Immunologic Factors|immunologic factors|mesh-ancestor
56072340|NCT05405465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072341|NCT02064907|Dexlansoprazole|dexlansoprazole|mesh-list
56072342|NCT02064907|Lansoprazole|lansoprazole|mesh-list
56072343|NCT02064907|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56072344|NCT02064907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56072345|NCT02064907|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56072347|NCT02064907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072348|NCT02064985|Ticagrelor|ticagrelor|mesh-list
56072349|NCT02064985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56072350|NCT02064985|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56072351|NCT02064985|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56072352|NCT02064985|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56072353|NCT02064985|Purinergic Agents|purinergic agents|mesh-ancestor
56072354|NCT02064985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072355|NCT02064985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072356|NCT02064985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072357|NCT03170219|Furosemide|furosemide|mesh-list
56072358|NCT03170219|Diuretics|diuretics|mesh-ancestor
56072359|NCT03170219|Natriuretic Agents|natriuretic agents|mesh-ancestor
56072360|NCT03170219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072362|NCT03170219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56072373|NCT00375557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072374|NCT00375557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072375|NCT00375557|GABA Agents|gaba agents|mesh-ancestor
56072376|NCT00375557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072377|NCT00375557|Antimanic Agents|antimanic agents|mesh-ancestor
56072378|NCT03177395|Acetylcysteine|acetylcysteine|mesh-list
56072379|NCT03177395|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56072380|NCT03177395|Antiviral Agents|antiviral agents|mesh-ancestor
56072381|NCT03177395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072382|NCT03177395|Expectorants|expectorants|mesh-ancestor
56072383|NCT03177395|Respiratory System Agents|respiratory system agents|mesh-ancestor
56072384|NCT03177395|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56072385|NCT03177395|Antioxidants|antioxidants|mesh-ancestor
56072386|NCT03177395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072387|NCT03177395|Protective Agents|protective agents|mesh-ancestor
56072388|NCT03177395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072389|NCT03177395|Antidotes|antidotes|mesh-ancestor
56072390|NCT05282069|Solifenacin Succinate|solifenacin succinate|mesh-list
56072391|NCT05282069|DA-8010|da-8010|mesh-list
56072392|NCT05282069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56072393|NCT05282069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55799607|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
56072394|NCT05282069|Cholinergic Agents|cholinergic agents|mesh-ancestor
56072395|NCT05282069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072396|NCT05282069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072397|NCT05282069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072398|NCT05282069|Urological Agents|urological agents|mesh-ancestor
56072399|NCT05159999|Antihypertensive Agents|antihypertensive agents|mesh-list
56072400|NCT03179345|Pregabalin|pregabalin|mesh-list
56072418|NCT03179345|Antimanic Agents|antimanic agents|mesh-ancestor
56072419|NCT03086213|Lidocaine|lidocaine|mesh-list
56072420|NCT03086213|Sufentanil|sufentanil|mesh-list
56072421|NCT03086213|Dexmedetomidine|dexmedetomidine|mesh-list
56072422|NCT03086213|Dsuvia|dsuvia|mesh-list
56072423|NCT03086213|Ropivacaine|ropivacaine|mesh-list
56072424|NCT03086213|Propofol|propofol|mesh-list
56072425|NCT03086213|Anesthetics, Local|anesthetics, local|mesh-ancestor
56072426|NCT03086213|Anesthetics|anesthetics|mesh-ancestor
56072427|NCT03086213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072428|NCT03086213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072429|NCT03086213|Sensory System Agents|sensory system agents|mesh-ancestor
56072430|NCT03086213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072431|NCT03086213|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56072432|NCT03086213|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56072433|NCT03086213|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56072434|NCT03086213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56072435|NCT03086213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072436|NCT03086213|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56072437|NCT03086213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56072438|NCT03086213|Anesthetics, General|anesthetics, general|mesh-ancestor
56072439|NCT03086213|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56072440|NCT03086213|Analgesics|analgesics|mesh-ancestor
56072441|NCT03086213|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56072442|NCT03086213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56072443|NCT03086213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56072444|NCT03086213|Adrenergic Agents|adrenergic agents|mesh-ancestor
56072467|NCT02382848|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55799682|NCT04871269|Dronabinol|dronabinol|mesh-list
56072468|NCT02382848|Adrenergic Agents|adrenergic agents|mesh-ancestor
56072469|NCT02382848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072470|NCT02382848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072471|NCT02382848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072473|NCT02065687|Paclitaxel|paclitaxel|mesh-list
56072474|NCT02065687|Carboplatin|carboplatin|mesh-list
56072475|NCT02065687|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56072476|NCT02065687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56072477|NCT02065687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072478|NCT02065687|Tubulin Modulators|tubulin modulators|mesh-ancestor
56072479|NCT02065687|Antimitotic Agents|antimitotic agents|mesh-ancestor
56072480|NCT02065687|Mitosis Modulators|mitosis modulators|mesh-ancestor
56072481|NCT02065687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072482|NCT02065687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56072483|NCT02065687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072484|NCT03096353|Naloxone|naloxone|mesh-list
56072485|NCT03096353|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56072486|NCT03096353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072487|NCT03096353|Sensory System Agents|sensory system agents|mesh-ancestor
56072488|NCT03096353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072489|NCT03098615|Efinaconazole|efinaconazole|mesh-list
56072490|NCT03098615|Antifungal Agents|antifungal agents|mesh-ancestor
56072491|NCT03098615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072492|NCT05363501|Naloxone|naloxone|mesh-list
56072493|NCT05363501|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56072494|NCT05363501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072495|NCT05363501|Sensory System Agents|sensory system agents|mesh-ancestor
56072496|NCT05363501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072497|NCT04736927|Midazolam|midazolam|mesh-list
56072498|NCT04736927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56072499|NCT04736927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56072510|NCT04736927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072511|NCT04736927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072513|NCT03810703|Dextroamphetamine|dextroamphetamine|mesh-list
56072514|NCT03810703|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56072515|NCT03810703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072516|NCT03810703|Sympathomimetics|sympathomimetics|mesh-ancestor
56072517|NCT03810703|Autonomic Agents|autonomic agents|mesh-ancestor
56072518|NCT03810703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072519|NCT03810703|Dopamine Agents|dopamine agents|mesh-ancestor
56072520|NCT03810703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072521|NCT03810703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072522|NCT03810703|Adrenergic Agents|adrenergic agents|mesh-ancestor
56072523|NCT03810703|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56072524|NCT03810703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56072525|NCT03810703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56072526|NCT03810703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56072527|NCT05304455|Heparin|heparin|mesh-list
56072528|NCT05304455|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56072529|NCT05304455|Tinzaparin|tinzaparin|mesh-list
56072530|NCT05304455|Dalteparin|dalteparin|mesh-list
56072531|NCT05304455|Dipyridamole|dipyridamole|mesh-list
56072532|NCT05304455|Apixaban|apixaban|mesh-list
56072533|NCT05304455|Anticoagulants|anticoagulants|mesh-ancestor
56072534|NCT05304455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56072535|NCT05304455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56072536|NCT05304455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072537|NCT05304455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56072538|NCT05304455|Antithrombins|antithrombins|mesh-ancestor
56072539|NCT05304455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56072540|NCT05304455|Protease Inhibitors|protease inhibitors|mesh-ancestor
56072553|NCT02389088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56072554|NCT02389088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072556|NCT02068027|Analgesics|analgesics|mesh-ancestor
56072557|NCT02068027|Sensory System Agents|sensory system agents|mesh-ancestor
56072558|NCT02068027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072559|NCT02068027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072560|NCT02068027|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56072561|NCT02068027|Sympatholytics|sympatholytics|mesh-ancestor
56072562|NCT02068027|Autonomic Agents|autonomic agents|mesh-ancestor
56072563|NCT02068027|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56072564|NCT02068027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56072565|NCT02068027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56072566|NCT02068027|Adrenergic Agents|adrenergic agents|mesh-ancestor
56072567|NCT02068027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072568|NCT02068027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072569|NCT02392208|Telavancin|telavancin|mesh-list
56072570|NCT02392208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56072571|NCT02392208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072572|NCT05185583|Methylphenidate|methylphenidate|mesh-list
56072573|NCT05185583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56072574|NCT05185583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072575|NCT05185583|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56072576|NCT05185583|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56072577|NCT05185583|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56072578|NCT05185583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072579|NCT05185583|Dopamine Agents|dopamine agents|mesh-ancestor
56072580|NCT05185583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072581|NCT04645121|Carbon Monoxide|carbon monoxide|mesh-list
56072582|NCT04645121|Antimetabolites|antimetabolites|mesh-ancestor
56072583|NCT04645121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072584|NCT04645121|Gasotransmitters|gasotransmitters|mesh-ancestor
56072585|NCT04645121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072586|NCT04645121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072589|NCT04603937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56072590|NCT04603937|Growth Substances|growth substances|mesh-ancestor
56072591|NCT04603937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072592|NCT04603937|Growth Inhibitors|growth inhibitors|mesh-ancestor
56072593|NCT04603937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072594|NCT02392286|Prednisone|prednisone|mesh-list
56072595|NCT02392286|Methylprednisolone|methylprednisolone|mesh-list
56072596|NCT02392286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072597|NCT02392286|Glucocorticoids|glucocorticoids|mesh-ancestor
56072598|NCT02392286|Hormones|hormones|mesh-ancestor
56072599|NCT02392286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56072600|NCT02392286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072601|NCT02392286|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56072602|NCT02392286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072603|NCT02392286|Antiemetics|antiemetics|mesh-ancestor
56072604|NCT02392286|Autonomic Agents|autonomic agents|mesh-ancestor
56072605|NCT02392286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072606|NCT02392286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56072607|NCT02392286|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56072608|NCT02392286|Protective Agents|protective agents|mesh-ancestor
56072609|NCT04586153|Meplazumab|meplazumab|mesh-list
56072610|NCT04586153|Antiviral Agents|antiviral agents|mesh-ancestor
56072611|NCT04586153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072612|NCT05717738|Bevacizumab|bevacizumab|mesh-list
56072613|NCT05717738|Sorafenib|sorafenib|mesh-list
56072614|NCT05717738|Atezolizumab|atezolizumab|mesh-list
56072615|NCT05717738|Apatinib|apatinib|mesh-list
56072616|NCT05717738|Lenvatinib|lenvatinib|mesh-list
56072617|NCT05717738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56072618|NCT05717738|Antibodies|antibodies|mesh-list
55799843|NCT03612973|Insulin|insulin|mesh-list
56072636|NCT02393378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56072637|NCT02393378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072638|NCT02393378|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56072639|NCT02393378|Antimetabolites|antimetabolites|mesh-ancestor
56072640|NCT02393378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072641|NCT02393378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072642|NCT02393378|Dermatologic Agents|dermatologic agents|mesh-ancestor
56072643|NCT02393378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072644|NCT02393378|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56072645|NCT02393378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56072646|NCT02393378|Immunologic Factors|immunologic factors|mesh-ancestor
56072647|NCT02393378|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56072648|NCT02393378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56072649|NCT02393378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072650|NCT02393378|Hematinics|hematinics|mesh-ancestor
56072651|NCT02393378|Vitamin B Complex|vitamin b complex|mesh-ancestor
56072653|NCT02393378|Micronutrients|micronutrients|mesh-ancestor
56072654|NCT04949477|Acetaminophen|acetaminophen|mesh-list
56072655|NCT04949477|Dexmedetomidine|dexmedetomidine|mesh-list
56072656|NCT04949477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56072657|NCT04949477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072658|NCT04949477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072659|NCT04949477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56072660|NCT04949477|Analgesics|analgesics|mesh-ancestor
56072661|NCT04949477|Sensory System Agents|sensory system agents|mesh-ancestor
56072662|NCT04949477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072663|NCT04949477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56072664|NCT04949477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56072665|NCT04949477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56073029|NCT04630964|Niacin|niacin|mesh-list
56072667|NCT04949477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072674|NCT04873895|Axitinib|axitinib|mesh-list
56072678|NCT04873895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072679|NCT04873895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072680|NCT04873895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072681|NCT04873895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56072682|NCT04873895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072683|NCT04873895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56072685|NCT05717582|Hormones|hormones|mesh-ancestor
56072686|NCT05717582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56072687|NCT05717582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072688|NCT03101033|Betamethasone|betamethasone|mesh-list
56072689|NCT03101033|Betamethasone Valerate|betamethasone valerate|mesh-list
56072690|NCT03101033|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56072691|NCT03101033|Betamethasone benzoate|betamethasone benzoate|mesh-list
55741020|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072692|NCT03101033|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56072693|NCT03101033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072695|NCT03101033|Hormones|hormones|mesh-ancestor
56072696|NCT03101033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56072697|NCT03101033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072698|NCT03101033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56072699|NCT03101033|Respiratory System Agents|respiratory system agents|mesh-ancestor
56072700|NCT02069041|Leucovorin|leucovorin|mesh-list
56072701|NCT02069041|Fluorouracil|fluorouracil|mesh-list
56072702|NCT02069041|Oxaliplatin|oxaliplatin|mesh-list
56072703|NCT02069041|Ramucirumab|ramucirumab|mesh-list
56072704|NCT02069041|Antimetabolites|antimetabolites|mesh-ancestor
56072705|NCT02069041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072706|NCT02069041|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56072707|NCT02069041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072708|NCT02069041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56072709|NCT02069041|Immunologic Factors|immunologic factors|mesh-ancestor
56072722|NCT05423834|Entecavir|entecavir|mesh-list
56072723|NCT05423834|Antiviral Agents|antiviral agents|mesh-ancestor
56072724|NCT05423834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072725|NCT05423834|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56072726|NCT05423834|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56072727|NCT05423834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072728|NCT05423834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072729|NCT05423834|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56072730|NCT05423834|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56072731|NCT03103061|Regadenoson|regadenoson|mesh-list
56072732|NCT03103061|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
56072733|NCT03103061|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56072734|NCT03103061|Purinergic Agonists|purinergic agonists|mesh-ancestor
56072735|NCT03103061|Purinergic Agents|purinergic agents|mesh-ancestor
56072736|NCT03103061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072737|NCT03103061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072738|NCT03103061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072745|NCT03105479|Vancomycin|vancomycin|mesh-list
56072746|NCT03105479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56072747|NCT03105479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072748|NCT00355862|Cyclosporine|cyclosporine|mesh-list
56072749|NCT00355862|Sirolimus|sirolimus|mesh-list
56072750|NCT00355862|Prednisolone|prednisolone|mesh-list
56072751|NCT00355862|Azathioprine|azathioprine|mesh-list
56072752|NCT00355862|Tacrolimus|tacrolimus|mesh-list
56072753|NCT00355862|Cyclosporins|cyclosporins|mesh-list
56072771|NCT00355862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56072773|NCT00355862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56072774|NCT02049151|Cyclophosphamide|cyclophosphamide|mesh-list
56072775|NCT02049151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56072776|NCT02049151|Immunologic Factors|immunologic factors|mesh-ancestor
56072777|NCT02049151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072778|NCT02049151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56072779|NCT02049151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56072780|NCT02049151|Alkylating Agents|alkylating agents|mesh-ancestor
56072781|NCT02049151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072782|NCT02049151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072783|NCT02049151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56072784|NCT03772457|Rivaroxaban|rivaroxaban|mesh-list
56072785|NCT03772457|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56072786|NCT03772457|Antithrombins|antithrombins|mesh-ancestor
56072787|NCT03772457|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56072788|NCT03772457|Protease Inhibitors|protease inhibitors|mesh-ancestor
56072790|NCT03772457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072791|NCT03772457|Anticoagulants|anticoagulants|mesh-ancestor
56072793|NCT02049307|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56072794|NCT02049307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56072795|NCT02049307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56072796|NCT02049307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56072797|NCT02049307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072798|NCT00355628|Fentanyl|fentanyl|mesh-list
56072799|NCT00355628|Citric Acid|citric acid|mesh-list
56072800|NCT00355628|Sodium Citrate|sodium citrate|mesh-list
56072817|NCT02049385|Diazoxide|diazoxide|mesh-list
56072818|NCT02049385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56072819|NCT02049385|Vasodilator Agents|vasodilator agents|mesh-ancestor
56072820|NCT03717155|Gemcitabine|gemcitabine|mesh-list
56072821|NCT03717155|Carboplatin|carboplatin|mesh-list
56072822|NCT03717155|Cetuximab|cetuximab|mesh-list
56072823|NCT03717155|Avelumab|avelumab|mesh-list
56072824|NCT03717155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072825|NCT03717155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56072826|NCT03717155|Antimetabolites|antimetabolites|mesh-ancestor
56072827|NCT03717155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072828|NCT03717155|Antiviral Agents|antiviral agents|mesh-ancestor
56072829|NCT03717155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56072830|NCT03717155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072831|NCT03717155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56072832|NCT03717155|Immunologic Factors|immunologic factors|mesh-ancestor
56072833|NCT03717155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072834|NCT03717155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56072835|NCT03789097|Pembrolizumab|pembrolizumab|mesh-list
56072836|NCT03789097|Poly ICLC|poly iclc|mesh-list
56072837|NCT03789097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56072838|NCT03789097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072839|NCT03789097|Interferon Inducers|interferon inducers|mesh-ancestor
56072840|NCT03789097|Immunologic Factors|immunologic factors|mesh-ancestor
56072841|NCT03789097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072842|NCT03655613|Nivolumab|nivolumab|mesh-list
56072843|NCT03655613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56072844|NCT03655613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072845|NCT03655613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55800065|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
56072846|NCT03655613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072848|NCT04820036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56072849|NCT04820036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072850|NCT03286829|Metoprolol|metoprolol|mesh-list
56072851|NCT03286829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56072857|NCT03286829|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56072858|NCT03286829|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56072859|NCT03286829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56072860|NCT03286829|Adrenergic Agents|adrenergic agents|mesh-ancestor
56072861|NCT03286829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072862|NCT03286829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072864|NCT02051335|Donepezil|donepezil|mesh-list
56072865|NCT02051335|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56072866|NCT02051335|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56072867|NCT02051335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072868|NCT02051335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072869|NCT02051335|Cholinergic Agents|cholinergic agents|mesh-ancestor
56072870|NCT02051335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072871|NCT02051335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072872|NCT02051335|Nootropic Agents|nootropic agents|mesh-ancestor
56072873|NCT02051335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56072874|NCT02051335|Antiemetics|antiemetics|mesh-ancestor
56072875|NCT02051335|Autonomic Agents|autonomic agents|mesh-ancestor
56072880|NCT02051335|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56072881|NCT02051335|Parasympatholytics|parasympatholytics|mesh-ancestor
56072882|NCT03290027|Tazarotene|tazarotene|mesh-list
56072883|NCT03290027|Dermatologic Agents|dermatologic agents|mesh-ancestor
56072884|NCT03290027|Keratolytic Agents|keratolytic agents|mesh-ancestor
56072885|NCT02300077|Fentanyl|fentanyl|mesh-list
56072886|NCT02300077|Morphine|morphine|mesh-list
56072887|NCT02300077|Methadone|methadone|mesh-list
56072903|NCT05272826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56072904|NCT05272826|Antiemetics|antiemetics|mesh-ancestor
56072905|NCT05272826|Autonomic Agents|autonomic agents|mesh-ancestor
56072906|NCT05272826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072907|NCT05272826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072908|NCT05272826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56072911|NCT05272826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56072912|NCT05272826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56072913|NCT05272826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072914|NCT03458429|Lenograstim|lenograstim|mesh-list
56072915|NCT03458429|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56072916|NCT03458429|Immunologic Factors|immunologic factors|mesh-ancestor
56072917|NCT03458429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072918|NCT03291197|Bupivacaine|bupivacaine|mesh-list
56072919|NCT03291197|Anesthetics, Local|anesthetics, local|mesh-ancestor
55800140|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
56072920|NCT03291197|Anesthetics|anesthetics|mesh-ancestor
56072921|NCT03291197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072922|NCT03291197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072923|NCT03291197|Sensory System Agents|sensory system agents|mesh-ancestor
56072924|NCT03291197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56072925|NCT05638880|Empagliflozin|empagliflozin|mesh-list
56072947|NCT00356096|Dopamine Agonists|dopamine agonists|mesh-ancestor
56072948|NCT00356096|Dopamine Agents|dopamine agents|mesh-ancestor
56072949|NCT00356096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072950|NCT05637086|Phenytoin|phenytoin|mesh-list
56072951|NCT05637086|Pentoxifylline|pentoxifylline|mesh-list
56072952|NCT05637086|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56072953|NCT05637086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072954|NCT05637086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072955|NCT05637086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56072956|NCT05637086|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56072957|NCT05637086|Protective Agents|protective agents|mesh-ancestor
56072958|NCT05637086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56072959|NCT05637086|Vasodilator Agents|vasodilator agents|mesh-ancestor
56072960|NCT05637086|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56072961|NCT05637086|Antioxidants|antioxidants|mesh-ancestor
56072962|NCT05637086|Anticonvulsants|anticonvulsants|mesh-ancestor
56072963|NCT05637086|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56072964|NCT05637086|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56072965|NCT05637086|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56072966|NCT05637086|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56072968|NCT03243461|Temozolomide|temozolomide|mesh-list
56072969|NCT03243461|Valproic Acid|valproic acid|mesh-list
56072970|NCT03243461|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56072971|NCT03243461|Alkylating Agents|alkylating agents|mesh-ancestor
56072972|NCT03243461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072973|NCT03243461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56072974|NCT03243461|Anticonvulsants|anticonvulsants|mesh-ancestor
56072975|NCT03243461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56072976|NCT03243461|GABA Agents|gaba agents|mesh-ancestor
56072977|NCT03243461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072990|NCT03296345|Anesthetics, General|anesthetics, general|mesh-ancestor
56072991|NCT03296345|Anesthetics|anesthetics|mesh-ancestor
56072992|NCT03296345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56072993|NCT03296345|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56072994|NCT03296345|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55800220|NCT05531435|Anesthetics|anesthetics|mesh-list
56072995|NCT03296345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56072996|NCT03296345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56072997|NCT00421694|Bicalutamide|bicalutamide|mesh-list
56072998|NCT00421694|Androgen Antagonists|androgen antagonists|mesh-ancestor
56072999|NCT00421694|Hormone Antagonists|hormone antagonists|mesh-ancestor
56073000|NCT00421694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073001|NCT00421694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073002|NCT00421694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073003|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
56073004|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56073005|NCT00376181|Pioglitazone|pioglitazone|mesh-list
56073006|NCT00376181|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56073007|NCT00376181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073008|NCT00376181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073009|NCT00376181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56073010|NCT00376181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56073011|NCT00376181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073012|NCT04736693|Zoledronic Acid|zoledronic acid|mesh-list
56073013|NCT04736693|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56073014|NCT04736693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56073015|NCT04736693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073016|NCT04736693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56073033|NCT04630964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073034|NCT04630964|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56073035|NCT04630964|Vasodilator Agents|vasodilator agents|mesh-ancestor
56073036|NCT04630964|Vitamin B Complex|vitamin b complex|mesh-ancestor
56073037|NCT04630964|Vitamins|vitamins|mesh-ancestor
56073038|NCT04630964|Micronutrients|micronutrients|mesh-ancestor
56073039|NCT04630964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073040|NCT04630964|Hallucinogens|hallucinogens|mesh-ancestor
56073041|NCT04630964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56073042|NCT03138161|Nivolumab|nivolumab|mesh-list
56073043|NCT03138161|Ipilimumab|ipilimumab|mesh-list
56073044|NCT03138161|Trabectedin|trabectedin|mesh-list
56073045|NCT03138161|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56073046|NCT03138161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073047|NCT03138161|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56073048|NCT03138161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073049|NCT03138161|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56073050|NCT03138161|Alkylating Agents|alkylating agents|mesh-ancestor
56073051|NCT05595044|Vitamin D|vitamin d|mesh-list
56073052|NCT05595044|Vitamins|vitamins|mesh-ancestor
56073053|NCT05595044|Micronutrients|micronutrients|mesh-ancestor
56073054|NCT05595044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073055|NCT05595044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56073056|NCT04736381|Mycophenolic Acid|mycophenolic acid|mesh-list
56073057|NCT04736381|Abatacept|abatacept|mesh-list
56073058|NCT04736381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56073059|NCT04736381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073060|NCT04736381|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56073062|NCT04736381|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56073063|NCT04736381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073064|NCT04736381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073065|NCT04736381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073066|NCT04736381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56073067|NCT04736381|Immunologic Factors|immunologic factors|mesh-ancestor
56073068|NCT04736381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073069|NCT04736381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56073071|NCT03302741|Botulinum Toxins|botulinum toxins|mesh-list
56073072|NCT03302741|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56073073|NCT03302741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56073074|NCT03302741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073075|NCT03302741|Cholinergic Agents|cholinergic agents|mesh-ancestor
56073076|NCT03302741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073077|NCT03302741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073078|NCT02792465|Fulvestrant|fulvestrant|mesh-list
56073079|NCT02792465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56073080|NCT02792465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073081|NCT02792465|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56073082|NCT02792465|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56073083|NCT02792465|Hormone Antagonists|hormone antagonists|mesh-ancestor
56073084|NCT02792465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073085|NCT02792465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073086|NCT05573828|Parathyroid Hormone|parathyroid hormone|mesh-list
56073087|NCT05573828|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56073088|NCT05573828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073089|NCT02769611|Ruboxistaurin|ruboxistaurin|mesh-list
56073090|NCT02769611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073091|NCT02769611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073092|NCT05132504|Pembrolizumab|pembrolizumab|mesh-list
56073093|NCT05132504|Folfirinox|folfirinox|mesh-list
56073094|NCT05132504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56073119|NCT03305159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073120|NCT03305159|Disinfectants|disinfectants|mesh-ancestor
56073121|NCT03305159|Dermatologic Agents|dermatologic agents|mesh-ancestor
56073122|NCT03305159|Plasma Substitutes|plasma substitutes|mesh-ancestor
56073123|NCT03305159|Blood Substitutes|blood substitutes|mesh-ancestor
56073125|NCT02366819|Fluorouracil|fluorouracil|mesh-list
56073126|NCT02366819|Oxaliplatin|oxaliplatin|mesh-list
56073127|NCT02366819|Irinotecan|irinotecan|mesh-list
56073128|NCT02366819|Calcium|calcium|mesh-list
56073129|NCT02366819|Levoleucovorin|levoleucovorin|mesh-list
56073130|NCT02366819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56073131|NCT02366819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073132|NCT02366819|Antimetabolites|antimetabolites|mesh-ancestor
56073133|NCT02366819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073134|NCT02366819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56073135|NCT02366819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073136|NCT02366819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56073137|NCT02366819|Immunologic Factors|immunologic factors|mesh-ancestor
56073138|NCT02366819|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56073139|NCT02366819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56073140|NCT02366819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073142|NCT02366819|Protective Agents|protective agents|mesh-ancestor
56073143|NCT02366819|Vitamin B Complex|vitamin b complex|mesh-ancestor
56073144|NCT02366819|Vitamins|vitamins|mesh-ancestor
56073145|NCT02366819|Micronutrients|micronutrients|mesh-ancestor
56073146|NCT05107856|Azacitidine|azacitidine|mesh-list
56073148|NCT05107856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56073149|NCT05107856|Antimetabolites|antimetabolites|mesh-ancestor
56073150|NCT05107856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073151|NCT05107856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073152|NCT05107856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073153|NCT02192021|Doxorubicin|doxorubicin|mesh-list
56073161|NCT05552144|Listerine|listerine|mesh-list
56073164|NCT05552144|Protective Agents|protective agents|mesh-ancestor
56073165|NCT05552144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073166|NCT05552144|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56073167|NCT05552144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073169|NCT03308669|Lasmiditan|lasmiditan|mesh-list
56073170|NCT03308669|Anticonvulsants|anticonvulsants|mesh-ancestor
56073171|NCT03308669|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073172|NCT03308669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073173|NCT03308669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56073174|NCT03308669|Serotonin Agents|serotonin agents|mesh-ancestor
56073175|NCT03308669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073176|NCT03308669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073177|NCT00356252|Carotenoids|carotenoids|mesh-list
56073178|NCT00356252|Antioxidants|antioxidants|mesh-ancestor
56073179|NCT00356252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073180|NCT00356252|Protective Agents|protective agents|mesh-ancestor
56073181|NCT00356252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073182|NCT02056171|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56073183|NCT02056171|Antidepressive Agents|antidepressive agents|mesh-ancestor
56073184|NCT02056171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56073185|NCT02056171|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56073186|NCT02056171|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56073187|NCT02056171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073188|NCT02056171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073189|NCT03312023|Sofosbuvir|sofosbuvir|mesh-list
56073191|NCT03312023|Ledipasvir|ledipasvir|mesh-list
56073213|NCT02342197|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56073214|NCT02342197|Luteolytic Agents|luteolytic agents|mesh-ancestor
56073215|NCT02342197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56073216|NCT02342197|Contraceptive Agents|contraceptive agents|mesh-ancestor
56073217|NCT02342197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56073218|NCT02342197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073219|NCT02342197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56073220|NCT02342197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56073221|NCT02342197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073223|NCT02344225|Ketorolac|ketorolac|mesh-list
56073224|NCT02344225|Caffeine|caffeine|mesh-list
56073225|NCT02344225|Caffeine citrate|caffeine citrate|mesh-list
56073226|NCT02344225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073227|NCT02344225|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56073228|NCT02344225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56073229|NCT02344225|Analgesics|analgesics|mesh-ancestor
56073230|NCT02344225|Sensory System Agents|sensory system agents|mesh-ancestor
56073231|NCT02344225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073232|NCT02344225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073233|NCT02344225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56073234|NCT02344225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56073235|NCT02344225|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56073236|NCT02344225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073237|NCT02344225|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56073238|NCT02344225|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56073239|NCT02344225|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56073240|NCT02344225|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56073241|NCT02344225|Purinergic Agents|purinergic agents|mesh-ancestor
56073254|NCT04298606|Vaccines|vaccines|mesh-list
56073257|NCT04298606|Immunologic Factors|immunologic factors|mesh-ancestor
56073258|NCT04298606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073259|NCT04298606|Mitosis Modulators|mitosis modulators|mesh-ancestor
56073260|NCT04298606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073261|NCT04298606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56073262|NCT03769844|Molgramostim|molgramostim|mesh-list
56073263|NCT03769844|Sargramostim|sargramostim|mesh-list
56073264|NCT03769844|Immunologic Factors|immunologic factors|mesh-ancestor
56073265|NCT03769844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073266|NCT03769844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073268|NCT02347345|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56073269|NCT02347345|Ledipasvir|ledipasvir|mesh-list
56073270|NCT02347345|Antiviral Agents|antiviral agents|mesh-ancestor
56073271|NCT02347345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073272|NCT04624295|Aspirin|aspirin|mesh-list
56073273|NCT04624295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56073274|NCT04624295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56073275|NCT04624295|Analgesics|analgesics|mesh-ancestor
56073276|NCT04624295|Sensory System Agents|sensory system agents|mesh-ancestor
56073277|NCT04624295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073278|NCT04624295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073279|NCT04624295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56073280|NCT04624295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56073281|NCT04624295|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56073282|NCT04624295|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56073283|NCT04624295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073284|NCT04624295|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56073285|NCT04624295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56073302|NCT03768440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073304|NCT03323801|Isotretinoin|isotretinoin|mesh-list
56073305|NCT03323801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073306|NCT03323801|Keratolytic Agents|keratolytic agents|mesh-ancestor
56073307|NCT03323801|Dermatologic Agents|dermatologic agents|mesh-ancestor
56073308|NCT04450355|Nefopam|nefopam|mesh-list
56073309|NCT04450355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56073310|NCT04450355|Analgesics|analgesics|mesh-ancestor
56073311|NCT04450355|Sensory System Agents|sensory system agents|mesh-ancestor
56073312|NCT04450355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073313|NCT04450355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073314|NCT02349685|Anti-Infective Agents|anti-infective agents|mesh-list
56073315|NCT02349685|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56073316|NCT02352259|Bleomycin|bleomycin|mesh-list
56073317|NCT02352259|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56073318|NCT02352259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073319|NCT03326999|Bupivacaine|bupivacaine|mesh-list
56073320|NCT03326999|Anesthetics, Local|anesthetics, local|mesh-ancestor
56073321|NCT03326999|Anesthetics|anesthetics|mesh-ancestor
56073322|NCT03326999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073323|NCT03326999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073324|NCT03326999|Sensory System Agents|sensory system agents|mesh-ancestor
56073325|NCT03326999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073327|NCT02397265|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073328|NCT02397265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073329|NCT00356720|Azithromycin|azithromycin|mesh-list
56073330|NCT00356720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56073331|NCT00356720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073332|NCT04121780|Hormones|hormones|mesh-list
56073333|NCT04121780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073335|NCT00375869|Darbepoetin alfa|darbepoetin alfa|mesh-list
56073347|NCT03198221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56073348|NCT03198221|Antacids|antacids|mesh-ancestor
56073349|NCT03198221|Laxatives|laxatives|mesh-ancestor
56073350|NCT03203681|Methyltestosterone|methyltestosterone|mesh-list
56073351|NCT03203681|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56073352|NCT03203681|Testosterone|testosterone|mesh-list
56073353|NCT03203681|Testosterone undecanoate|testosterone undecanoate|mesh-list
56073354|NCT03203681|Testosterone enanthate|testosterone enanthate|mesh-list
56073355|NCT03203681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56073357|NCT03203681|Anabolic Agents|anabolic agents|mesh-ancestor
56073358|NCT03203681|Hormones|hormones|mesh-ancestor
56073359|NCT03203681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073360|NCT03203681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073361|NCT03203681|Androgens|androgens|mesh-ancestor
56073362|NCT02399917|Azacitidine|azacitidine|mesh-list
56073363|NCT02399917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56073364|NCT02399917|Antimetabolites|antimetabolites|mesh-ancestor
56073365|NCT02399917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073366|NCT02399917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073367|NCT02399917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073372|NCT00356486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073373|NCT00356486|Antiviral Agents|antiviral agents|mesh-ancestor
56073374|NCT00356486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073375|NCT00356486|Immunologic Factors|immunologic factors|mesh-ancestor
56073376|NCT00356486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073377|NCT03331835|Brodalumab|brodalumab|mesh-list
56073378|NCT03331835|Dermatologic Agents|dermatologic agents|mesh-ancestor
56073379|NCT02403895|Paclitaxel|paclitaxel|mesh-list
56073411|NCT02354833|Norepinephrine|norepinephrine|mesh-list
56073412|NCT02354833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56073413|NCT02354833|Mydriatics|mydriatics|mesh-ancestor
56073414|NCT02354833|Autonomic Agents|autonomic agents|mesh-ancestor
56073415|NCT02354833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073416|NCT02354833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073417|NCT02354833|Sympathomimetics|sympathomimetics|mesh-ancestor
56073428|NCT03337724|Paclitaxel|paclitaxel|mesh-list
56073441|NCT03838484|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56073442|NCT03838484|Cholinergic Agents|cholinergic agents|mesh-ancestor
56073443|NCT03838484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073444|NCT03838484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073445|NCT03307616|Nivolumab|nivolumab|mesh-list
56073446|NCT03307616|Ipilimumab|ipilimumab|mesh-list
56073447|NCT03307616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800661|NCT05503667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073448|NCT03307616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073449|NCT03307616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56073450|NCT03307616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073451|NCT05721872|Arsenic Trioxide|arsenic trioxide|mesh-list
56073452|NCT05721872|Isoascorbic acid|isoascorbic acid|mesh-list
56073453|NCT05721872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073454|NCT05721872|Antioxidants|antioxidants|mesh-ancestor
56073455|NCT05721872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073456|NCT05721872|Protective Agents|protective agents|mesh-ancestor
56073457|NCT05721872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073458|NCT02408965|Methylergonovine|methylergonovine|mesh-list
56073459|NCT02408965|Oxytocics|oxytocics|mesh-ancestor
56073460|NCT02408965|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56073461|NCT02408965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073462|NCT03299426|Vaccines|vaccines|mesh-list
56073463|NCT03299426|Immunologic Factors|immunologic factors|mesh-ancestor
56073464|NCT03299426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073465|NCT03220022|Prednisone|prednisone|mesh-list
56073466|NCT03220022|Cortisone|cortisone|mesh-list
56073467|NCT03220022|Cyclophosphamide|cyclophosphamide|mesh-list
56073468|NCT03220022|Rituximab|rituximab|mesh-list
56073487|NCT03220022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073488|NCT03220022|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56073489|NCT03220022|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56073490|NCT03220022|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56073491|NCT03220022|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56073492|NCT03220022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073493|NCT03220022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56073494|NCT03220022|Glucocorticoids|glucocorticoids|mesh-ancestor
56073495|NCT03220022|Hormones|hormones|mesh-ancestor
56073496|NCT03220022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073497|NCT03220022|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56073498|NCT03220022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56073499|NCT03220022|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56073500|NCT03220022|Tubulin Modulators|tubulin modulators|mesh-ancestor
56073501|NCT03220022|Antimitotic Agents|antimitotic agents|mesh-ancestor
56073502|NCT03220022|Mitosis Modulators|mitosis modulators|mesh-ancestor
56073503|NCT03220022|Keratolytic Agents|keratolytic agents|mesh-ancestor
56073504|NCT03220022|Dermatologic Agents|dermatologic agents|mesh-ancestor
56073506|NCT03216356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56073507|NCT03216356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073508|NCT03216356|Renal Agents|renal agents|mesh-ancestor
56073509|NCT03216356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56073510|NCT03216356|Antitubercular Agents|antitubercular agents|mesh-ancestor
56073511|NCT03216356|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56073512|NCT03216356|Antimetabolites|antimetabolites|mesh-ancestor
56073513|NCT03216356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073514|NCT02411929|Ertugliflozin|ertugliflozin|mesh-list
56073515|NCT02411929|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56073516|NCT02411929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073517|NCT02411929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073518|NCT02411929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073519|NCT05721404|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56073520|NCT05721404|Icodextrin|icodextrin|mesh-list
56073521|NCT05721404|Dialysis Solutions|dialysis solutions|mesh-list
56073522|NCT00356954|Ascorbic Acid|ascorbic acid|mesh-list
56073523|NCT00356954|Antioxidants|antioxidants|mesh-ancestor
56073525|NCT00356954|Protective Agents|protective agents|mesh-ancestor
56073526|NCT00356954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073528|NCT00356954|Micronutrients|micronutrients|mesh-ancestor
56073529|NCT02358889|Ranibizumab|ranibizumab|mesh-list
56073530|NCT02358889|Immunoconjugates|immunoconjugates|mesh-list
56073531|NCT02358889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56073532|NCT02358889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56073533|NCT02358889|Growth Substances|growth substances|mesh-ancestor
56073534|NCT02358889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073535|NCT02358889|Growth Inhibitors|growth inhibitors|mesh-ancestor
56073536|NCT02358889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073537|NCT02358889|Immunologic Factors|immunologic factors|mesh-ancestor
56073538|NCT05721170|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56073540|NCT05721170|Adrenergic Agents|adrenergic agents|mesh-ancestor
56073541|NCT05721170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073542|NCT05721170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073543|NCT05721170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073544|NCT03038672|Nivolumab|nivolumab|mesh-list
56073545|NCT03038672|Immunoglobulins|immunoglobulins|mesh-list
56073546|NCT03038672|Immunoglobulin G|immunoglobulin g|mesh-list
56073547|NCT03038672|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56073548|NCT03038672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56073549|NCT03038672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073550|NCT03038672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56073551|NCT03038672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073552|NCT03038672|Immunologic Factors|immunologic factors|mesh-ancestor
56073553|NCT03038672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073554|NCT00358124|Metformin|metformin|mesh-list
56073555|NCT00358124|Insulin Glargine|insulin glargine|mesh-list
56073556|NCT00358124|Rosiglitazone|rosiglitazone|mesh-list
56073559|NCT00358202|Ceftriaxone|ceftriaxone|mesh-list
56073569|NCT02770040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56073570|NCT04736225|Insulin|insulin|mesh-list
56073571|NCT04736225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073572|NCT04736225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073576|NCT03344861|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56073577|NCT03344861|Trioxsalen|trioxsalen|mesh-list
56073578|NCT03344861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073579|NCT03344861|Dermatologic Agents|dermatologic agents|mesh-ancestor
56073580|NCT03344861|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56073581|NCT03348683|Propranolol|propranolol|mesh-list
56073582|NCT03348683|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56073583|NCT03348683|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56073584|NCT03348683|Adrenergic Agents|adrenergic agents|mesh-ancestor
56073585|NCT03348683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073586|NCT03348683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073587|NCT03348683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073588|NCT03348683|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56073589|NCT03348683|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56073590|NCT03348683|Vasodilator Agents|vasodilator agents|mesh-ancestor
56073591|NCT04344782|Bevacizumab|bevacizumab|mesh-list
56073592|NCT04344782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56073593|NCT04344782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073594|NCT04344782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56073595|NCT04344782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56073596|NCT04344782|Growth Substances|growth substances|mesh-ancestor
56073597|NCT04344782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073598|NCT04344782|Growth Inhibitors|growth inhibitors|mesh-ancestor
56073600|NCT00357188|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56073613|NCT00357188|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56073614|NCT00357188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56073616|NCT00357188|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56073617|NCT00357188|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56073618|NCT00357188|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56073619|NCT00357188|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56073621|NCT02360215|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56073622|NCT02360215|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56073623|NCT02360215|Dopamine Agents|dopamine agents|mesh-ancestor
56073624|NCT02360215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073625|NCT02360215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073626|NCT02360215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073627|NCT02360215|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56073628|NCT02360215|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56073629|NCT01349192|Chlorhexidine|chlorhexidine|mesh-list
56073630|NCT01349192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56073631|NCT01349192|Minocycline|minocycline|mesh-list
56073632|NCT01349192|Rifampin|rifampin|mesh-list
56073633|NCT01349192|Trimethoprim|trimethoprim|mesh-list
56073634|NCT01349192|Sulfamethoxazole|sulfamethoxazole|mesh-list
56073635|NCT01349192|Mupirocin|mupirocin|mesh-list
56073636|NCT01349192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56073637|NCT01349192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073638|NCT01349192|Disinfectants|disinfectants|mesh-ancestor
56073639|NCT01349192|Dermatologic Agents|dermatologic agents|mesh-ancestor
56073640|NCT01349192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56073641|NCT01349192|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56073642|NCT01349192|Antitubercular Agents|antitubercular agents|mesh-ancestor
56073643|NCT01349192|Leprostatic Agents|leprostatic agents|mesh-ancestor
56073644|NCT01349192|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56073655|NCT01349192|Antimalarials|antimalarials|mesh-ancestor
56073656|NCT01349192|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56073657|NCT01349192|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56073658|NCT01349192|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56073659|NCT01349192|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56073660|NCT01349192|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56073661|NCT01349192|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56073662|NCT01349192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56073663|NCT02362321|Dexamethasone|dexamethasone|mesh-list
56073664|NCT02362321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56073665|NCT02362321|Antiemetics|antiemetics|mesh-ancestor
56073666|NCT02362321|Autonomic Agents|autonomic agents|mesh-ancestor
56073667|NCT02362321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073668|NCT02362321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073669|NCT02362321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56073670|NCT02362321|Glucocorticoids|glucocorticoids|mesh-ancestor
56073671|NCT02362321|Hormones|hormones|mesh-ancestor
56073672|NCT02362321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073673|NCT02362321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56073674|NCT02362321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073675|NCT00354991|Losartan|losartan|mesh-list
56073676|NCT00354991|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56073677|NCT00354991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56073678|NCT00354991|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56073679|NCT00354991|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56073680|NCT00354991|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56073681|NCT00354991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073682|NCT00354991|Diuretics|diuretics|mesh-ancestor
56073683|NCT00354991|Natriuretic Agents|natriuretic agents|mesh-ancestor
56073687|NCT00357890|Insulin Glargine|insulin glargine|mesh-list
56073699|NCT02112578|Histamine Agents|histamine agents|mesh-ancestor
56073700|NCT02112578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073701|NCT02112578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073702|NCT02112578|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56073703|NCT00358280|Bupivacaine|bupivacaine|mesh-list
56073704|NCT00358280|Ropivacaine|ropivacaine|mesh-list
56073705|NCT00358280|Anesthetics, Local|anesthetics, local|mesh-ancestor
56073706|NCT00358280|Anesthetics|anesthetics|mesh-ancestor
56073707|NCT00358280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073708|NCT00358280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073709|NCT00358280|Sensory System Agents|sensory system agents|mesh-ancestor
56073710|NCT00358280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073711|NCT05719285|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56073712|NCT05719285|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
56073713|NCT05719285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073714|NCT05719285|Antitubercular Agents|antitubercular agents|mesh-ancestor
56073715|NCT02363803|Lidocaine|lidocaine|mesh-list
56073716|NCT02363803|Anesthetics, Local|anesthetics, local|mesh-ancestor
56073717|NCT02363803|Anesthetics|anesthetics|mesh-ancestor
56073718|NCT02363803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073719|NCT02363803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073720|NCT02363803|Sensory System Agents|sensory system agents|mesh-ancestor
56073721|NCT02363803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073722|NCT02363803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56073723|NCT02363803|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55741059|NCT03373903|Everolimus|everolimus|mesh-list
56073747|NCT02368093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073938|NCT03226223|Autonomic Agents|autonomic agents|mesh-ancestor
56073748|NCT02368093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073750|NCT03342937|Capecitabine|capecitabine|mesh-list
56073752|NCT03342937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56073753|NCT03342937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073754|NCT03342937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56073755|NCT03342937|Antimetabolites|antimetabolites|mesh-ancestor
56073756|NCT03342937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073757|NCT05718661|Methamphetamine|methamphetamine|mesh-list
56073758|NCT05718661|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56073759|NCT05718661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073760|NCT05718661|Sympathomimetics|sympathomimetics|mesh-ancestor
56073761|NCT05718661|Autonomic Agents|autonomic agents|mesh-ancestor
56073762|NCT05718661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073763|NCT05718661|Dopamine Agents|dopamine agents|mesh-ancestor
56073764|NCT05718661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073765|NCT05718661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073766|NCT05718661|Adrenergic Agents|adrenergic agents|mesh-ancestor
56073767|NCT05718661|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56073768|NCT05718661|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56073769|NCT05718661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56073770|NCT05718661|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56073772|NCT00354757|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56073773|NCT00354757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56073774|NCT00354757|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56073775|NCT00354757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073776|NCT00354757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073778|NCT02376283|Ticagrelor|ticagrelor|mesh-list
56073779|NCT02376283|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56073780|NCT02376283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56073781|NCT02376283|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56073782|NCT02376283|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55901112|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56073783|NCT02376283|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56073784|NCT02376283|Purinergic Agents|purinergic agents|mesh-ancestor
56073785|NCT02376283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073786|NCT02376283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073787|NCT02376283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073788|NCT00425347|Elotuzumab|elotuzumab|mesh-list
56073789|NCT00425347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073790|NCT05718037|Vaccines|vaccines|mesh-list
56073791|NCT05718037|Immunologic Factors|immunologic factors|mesh-ancestor
56073792|NCT05718037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073793|NCT05717881|Propolis|propolis|mesh-list
56073794|NCT05717881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073795|NCT00355303|Misoprostol|misoprostol|mesh-list
56073796|NCT00355303|Dinoprostone|dinoprostone|mesh-list
56073797|NCT00355303|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56073798|NCT00355303|Abortifacient Agents|abortifacient agents|mesh-ancestor
56073799|NCT00355303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56073800|NCT00355303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073801|NCT00355303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56073802|NCT00355303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56073803|NCT00355303|Oxytocics|oxytocics|mesh-ancestor
56073804|NCT05717569|Vitamin D|vitamin d|mesh-list
56073805|NCT05717569|Vitamins|vitamins|mesh-ancestor
56073806|NCT05717569|Micronutrients|micronutrients|mesh-ancestor
56073807|NCT05717569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073808|NCT05717569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56073809|NCT02385097|Ropivacaine|ropivacaine|mesh-list
56073810|NCT02385097|Chloroprocaine|chloroprocaine|mesh-list
56073832|NCT02393677|Dexmedetomidine|dexmedetomidine|mesh-list
56073833|NCT02393677|Ropivacaine|ropivacaine|mesh-list
56073834|NCT02393677|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56073835|NCT02393677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073836|NCT02393677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073837|NCT02393677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56073838|NCT02393677|Analgesics|analgesics|mesh-ancestor
56073839|NCT02393677|Sensory System Agents|sensory system agents|mesh-ancestor
56073840|NCT02393677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073841|NCT02393677|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56073842|NCT02393677|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56073843|NCT02393677|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56073844|NCT02393677|Adrenergic Agents|adrenergic agents|mesh-ancestor
56073845|NCT02393677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073846|NCT02393677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073848|NCT02393677|Anesthetics|anesthetics|mesh-ancestor
56073849|NCT02394457|Cosyntropin|cosyntropin|mesh-list
56073850|NCT02394457|Hormones|hormones|mesh-ancestor
56073851|NCT02394457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073852|NCT02394457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073853|NCT00355771|Levocetirizine|levocetirizine|mesh-list
56073854|NCT00355771|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56073855|NCT00355771|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56073856|NCT00355771|Histamine Antagonists|histamine antagonists|mesh-ancestor
56073857|NCT00355771|Histamine Agents|histamine agents|mesh-ancestor
56073858|NCT00355771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073859|NCT00355771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073860|NCT00355771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073861|NCT05664139|Paclitaxel|paclitaxel|mesh-list
56073862|NCT05664139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56073863|NCT05664139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073864|NCT05664139|Tubulin Modulators|tubulin modulators|mesh-ancestor
56073865|NCT05664139|Antimitotic Agents|antimitotic agents|mesh-ancestor
56073866|NCT05664139|Mitosis Modulators|mitosis modulators|mesh-ancestor
55901113|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
56073869|NCT03224351|VX-659|vx-659|mesh-list
56073870|NCT03224351|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56073871|NCT03224351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56073872|NCT03224351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073874|NCT05658055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56073875|NCT05658055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073876|NCT05642923|Thiamine|thiamine|mesh-list
56073877|NCT05642923|Vitamins|vitamins|mesh-ancestor
56073878|NCT05642923|Micronutrients|micronutrients|mesh-ancestor
56073879|NCT05642923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073880|NCT05642923|Vitamin B Complex|vitamin b complex|mesh-ancestor
56073881|NCT03906071|Docetaxel|docetaxel|mesh-list
56073882|NCT03906071|Nivolumab|nivolumab|mesh-list
56073883|NCT03906071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073884|NCT03906071|Tubulin Modulators|tubulin modulators|mesh-ancestor
56073885|NCT03906071|Antimitotic Agents|antimitotic agents|mesh-ancestor
56073886|NCT03906071|Mitosis Modulators|mitosis modulators|mesh-ancestor
56073887|NCT03906071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073888|NCT03906071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56073889|NCT03906071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56073890|NCT04865419|Voriconazole|voriconazole|mesh-list
56073891|NCT04865419|Antifungal Agents|antifungal agents|mesh-ancestor
56073892|NCT04865419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073893|NCT04865419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56073894|NCT04865419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56073895|NCT04865419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073896|NCT04865419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073897|NCT04865419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56073898|NCT04865419|Hormone Antagonists|hormone antagonists|mesh-ancestor
56073899|NCT04865419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56073902|NCT01721876|Cytarabine|cytarabine|mesh-list
56073912|NCT03224585|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56073913|NCT03224585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56073915|NCT03423641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073916|NCT01112072|Riboflavin|riboflavin|mesh-list
56073917|NCT01112072|Vitamin B Complex|vitamin b complex|mesh-ancestor
56073918|NCT01112072|Vitamins|vitamins|mesh-ancestor
56073919|NCT01112072|Micronutrients|micronutrients|mesh-ancestor
56073922|NCT01112072|Dermatologic Agents|dermatologic agents|mesh-ancestor
56073923|NCT04825795|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56073924|NCT04825795|Protease Inhibitors|protease inhibitors|mesh-ancestor
56073925|NCT04825795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56073926|NCT04825795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073927|NCT04825795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073928|NCT04825795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073929|NCT05662202|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56073930|NCT05662202|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56073931|NCT05662202|Dermatologic Agents|dermatologic agents|mesh-ancestor
56073932|NCT02029443|Acalabrutinib|acalabrutinib|mesh-list
56073933|NCT02029443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073934|NCT03226223|Methamphetamine|methamphetamine|mesh-list
56073935|NCT03226223|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56073936|NCT03226223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073937|NCT03226223|Sympathomimetics|sympathomimetics|mesh-ancestor
56073939|NCT03226223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073940|NCT03226223|Dopamine Agents|dopamine agents|mesh-ancestor
56073941|NCT03226223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56073942|NCT03226223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073943|NCT03226223|Adrenergic Agents|adrenergic agents|mesh-ancestor
56073944|NCT03226223|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56073945|NCT03226223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56073946|NCT03226223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56073950|NCT05620771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56073951|NCT05620771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56073952|NCT05620771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56073953|NCT05620771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56073954|NCT05620771|Growth Substances|growth substances|mesh-ancestor
56073955|NCT05620771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073956|NCT05620771|Growth Inhibitors|growth inhibitors|mesh-ancestor
56073958|NCT05419297|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56073959|NCT05419297|Narcotics|narcotics|mesh-ancestor
56073960|NCT05419297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56073961|NCT05419297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073962|NCT05419297|Analgesics|analgesics|mesh-ancestor
56073963|NCT05419297|Sensory System Agents|sensory system agents|mesh-ancestor
56073964|NCT05419297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56073965|NCT05419297|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56073966|NCT03226457|Empagliflozin|empagliflozin|mesh-list
56073967|NCT03226457|Furosemide|furosemide|mesh-list
56073968|NCT03226457|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56073969|NCT03226457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073970|NCT03226457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56073971|NCT03226457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56073972|NCT03226457|Diuretics|diuretics|mesh-ancestor
56073973|NCT03226457|Natriuretic Agents|natriuretic agents|mesh-ancestor
56073974|NCT03226457|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56073975|NCT03226457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56073976|NCT03226691|Plerixafor|plerixafor|mesh-list
56073977|NCT03226691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56073978|NCT03226691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56073979|NCT03226691|Antiviral Agents|antiviral agents|mesh-ancestor
56073980|NCT03226691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56073981|NCT00003159|Gemcitabine|gemcitabine|mesh-list
56073982|NCT00003159|Paclitaxel|paclitaxel|mesh-list
56073983|NCT00003159|Vinorelbine|vinorelbine|mesh-list
56073993|NCT00003159|Antimitotic Agents|antimitotic agents|mesh-ancestor
56073994|NCT00003159|Mitosis Modulators|mitosis modulators|mesh-ancestor
56073995|NCT00003159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56073996|NCT00003159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56073997|NCT00003159|Antimetabolites|antimetabolites|mesh-ancestor
56073998|NCT00003159|Antiviral Agents|antiviral agents|mesh-ancestor
56073999|NCT00003159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074000|NCT00003159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074001|NCT00003159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56074002|NCT00003159|Immunologic Factors|immunologic factors|mesh-ancestor
56074003|NCT00003159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074004|NCT00003159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56074005|NCT00003159|Alkylating Agents|alkylating agents|mesh-ancestor
56074006|NCT00003159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56074007|NCT00003159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56074008|NCT03228017|Aspirin|aspirin|mesh-list
56074009|NCT03228017|Atorvastatin|atorvastatin|mesh-list
56074010|NCT03228017|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56074011|NCT03228017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56074012|NCT03228017|Analgesics|analgesics|mesh-ancestor
56074013|NCT03228017|Sensory System Agents|sensory system agents|mesh-ancestor
56074014|NCT03228017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074015|NCT03228017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074016|NCT03228017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56074017|NCT03228017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56074018|NCT03228017|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56074019|NCT03228017|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56074024|NCT03228017|Antipyretics|antipyretics|mesh-ancestor
56074039|NCT00357422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074040|NCT00357422|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074041|NCT00357422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074043|NCT05418049|Baclofen|baclofen|mesh-list
56074044|NCT05418049|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56074045|NCT05418049|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56074047|NCT05418049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074048|NCT05418049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074050|NCT05418049|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56074051|NCT05418049|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56074052|NCT05418049|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56074053|NCT05418049|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56074054|NCT05418049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074055|NCT05418049|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56074056|NCT05418049|GABA Agonists|gaba agonists|mesh-ancestor
56074057|NCT05418049|GABA Agents|gaba agents|mesh-ancestor
56074058|NCT00356005|Azithromycin|azithromycin|mesh-list
56074059|NCT00356005|Artesunate|artesunate|mesh-list
56074060|NCT00356005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56074061|NCT00356005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074062|NCT00356005|Antimalarials|antimalarials|mesh-ancestor
56074063|NCT00356005|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56074064|NCT00356005|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56074065|NCT00356005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074084|NCT00376337|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56074085|NCT00376337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56074086|NCT05395195|Epoetin Alfa|epoetin alfa|mesh-list
56074087|NCT05395195|Hematinics|hematinics|mesh-ancestor
56074088|NCT00003165|Doxorubicin|doxorubicin|mesh-list
56074089|NCT00003165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56074090|NCT00003165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074091|NCT00003165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56074092|NCT00003165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56074093|NCT00003165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074094|NCT00003165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074095|NCT05723510|Rivaroxaban|rivaroxaban|mesh-list
56074096|NCT05723510|Apixaban|apixaban|mesh-list
56074097|NCT05723510|Edoxaban|edoxaban|mesh-list
56074098|NCT05723510|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56074099|NCT05723510|Antithrombins|antithrombins|mesh-ancestor
56074100|NCT05723510|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56074101|NCT05723510|Protease Inhibitors|protease inhibitors|mesh-ancestor
56074102|NCT05723510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074103|NCT05723510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074104|NCT05723510|Anticoagulants|anticoagulants|mesh-ancestor
56074105|NCT00003171|Bryostatin 1|bryostatin 1|mesh-list
56074106|NCT00003171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56074107|NCT00003171|Immunologic Factors|immunologic factors|mesh-ancestor
56074108|NCT00003171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074109|NCT00003171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074110|NCT00003183|Mitoxantrone|mitoxantrone|mesh-list
56074111|NCT00003183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074112|NCT00003183|Analgesics|analgesics|mesh-ancestor
56074113|NCT00003183|Sensory System Agents|sensory system agents|mesh-ancestor
56074114|NCT00003183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074115|NCT00003183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074116|NCT00003183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56074117|NCT00003183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56074118|NCT00003183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074125|NCT00376493|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56074126|NCT00376493|Antimalarials|antimalarials|mesh-ancestor
56074127|NCT02979223|Ascorbic Acid|ascorbic acid|mesh-list
56074128|NCT02979223|Picosulfate sodium|picosulfate sodium|mesh-list
56074129|NCT02979223|Magnesium citrate|magnesium citrate|mesh-list
56074130|NCT02979223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074131|NCT02979223|Antioxidants|antioxidants|mesh-ancestor
56074132|NCT02979223|Protective Agents|protective agents|mesh-ancestor
56074133|NCT02979223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074135|NCT02979223|Micronutrients|micronutrients|mesh-ancestor
56074136|NCT02979223|Cathartics|cathartics|mesh-ancestor
56074137|NCT02979223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56074138|NCT05640674|Acetaminophen|acetaminophen|mesh-list
56074139|NCT05640674|Ibuprofen|ibuprofen|mesh-list
56074140|NCT05640674|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
56074141|NCT05640674|Hydrocodone|hydrocodone|mesh-list
56074142|NCT05640674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56074144|NCT05640674|Sensory System Agents|sensory system agents|mesh-ancestor
56074145|NCT05640674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074146|NCT05640674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074147|NCT05640674|Antipyretics|antipyretics|mesh-ancestor
56074148|NCT05640674|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56074149|NCT05640674|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56074150|NCT05640674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56074151|NCT05640674|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56074152|NCT05640674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074154|NCT05640674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56074175|NCT01768767|Anesthetics, General|anesthetics, general|mesh-ancestor
56074177|NCT01768767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074178|NCT01768767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56074179|NCT01768767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56074180|NCT01768767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074181|NCT01768767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074182|NCT00003195|Interferons|interferons|mesh-list
56074183|NCT00003195|Interferon-alpha|interferon-alpha|mesh-list
56074184|NCT00003195|Busulfan|busulfan|mesh-list
56074185|NCT00003195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074186|NCT00003195|Antiviral Agents|antiviral agents|mesh-ancestor
56074187|NCT00003195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074188|NCT00003195|Immunologic Factors|immunologic factors|mesh-ancestor
56074189|NCT00003195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074190|NCT00003195|Alkylating Agents|alkylating agents|mesh-ancestor
56074191|NCT00003195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074192|NCT00003195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56074193|NCT00003195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56074194|NCT00003195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56074195|NCT03671109|Piperaquine|piperaquine|mesh-list
56074196|NCT03671109|Artenimol|artenimol|mesh-list
56074197|NCT03671109|Antimalarials|antimalarials|mesh-ancestor
56074198|NCT03671109|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56074199|NCT03671109|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56074200|NCT03671109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074202|NCT05716256|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
56074203|NCT05716256|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56074204|NCT05716256|Protease Inhibitors|protease inhibitors|mesh-ancestor
56074205|NCT05716256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074206|NCT05716256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074207|NCT03666273|Pembrolizumab|pembrolizumab|mesh-list
56074208|NCT03666273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56074216|NCT00356083|Sensory System Agents|sensory system agents|mesh-ancestor
56074217|NCT00356083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074218|NCT00356083|Antitussive Agents|antitussive agents|mesh-ancestor
56074219|NCT00356083|Respiratory System Agents|respiratory system agents|mesh-ancestor
56074220|NCT02977832|Alfuzosin|alfuzosin|mesh-list
56074221|NCT02977832|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56074222|NCT02977832|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56074223|NCT02977832|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56074224|NCT02977832|Adrenergic Agents|adrenergic agents|mesh-ancestor
56074225|NCT02977832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074226|NCT02977832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074227|NCT02977832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074228|NCT02977832|Urological Agents|urological agents|mesh-ancestor
56074229|NCT04344236|Chlorhexidine|chlorhexidine|mesh-list
56074230|NCT04344236|Povidone-Iodine|povidone-iodine|mesh-list
56074231|NCT04344236|Povidone|povidone|mesh-list
56074232|NCT04344236|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56074233|NCT04344236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074234|NCT04344236|Disinfectants|disinfectants|mesh-ancestor
56074235|NCT04344236|Plasma Substitutes|plasma substitutes|mesh-ancestor
56074236|NCT04344236|Blood Substitutes|blood substitutes|mesh-ancestor
56074237|NCT00355537|Testosterone|testosterone|mesh-list
56074238|NCT00355537|Androgens|androgens|mesh-ancestor
56074239|NCT00355537|Hormones|hormones|mesh-ancestor
56074240|NCT00355537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074241|NCT00355537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074242|NCT00003207|Doxorubicin|doxorubicin|mesh-list
56074243|NCT00003207|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56074244|NCT00003207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56074245|NCT00003207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074246|NCT00003207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56074260|NCT05552443|Narcotics|narcotics|mesh-ancestor
56074261|NCT05552443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074262|NCT05552443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074263|NCT05552443|Analgesics|analgesics|mesh-ancestor
56074264|NCT05552443|Sensory System Agents|sensory system agents|mesh-ancestor
56074265|NCT05552443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074266|NCT01542021|Androgens|androgens|mesh-list
56074267|NCT01542021|Hormones|hormones|mesh-ancestor
56003769|NCT00000730|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56074856|NCT05468606|Imiquimod|imiquimod|mesh-list
56074268|NCT01542021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074269|NCT01542021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074270|NCT04706897|Lidocaine|lidocaine|mesh-list
56074271|NCT04706897|Dexmedetomidine|dexmedetomidine|mesh-list
56074272|NCT04706897|Ketamine|ketamine|mesh-list
56074273|NCT04706897|Anesthetics, Local|anesthetics, local|mesh-ancestor
56074274|NCT04706897|Anesthetics|anesthetics|mesh-ancestor
56074275|NCT04706897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074276|NCT04706897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074277|NCT04706897|Sensory System Agents|sensory system agents|mesh-ancestor
56074278|NCT04706897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074279|NCT04706897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56074280|NCT04706897|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56074281|NCT04706897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56074282|NCT04706897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56074283|NCT04706897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074284|NCT04706897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56074285|NCT04706897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56074286|NCT04706897|Analgesics|analgesics|mesh-ancestor
56074289|NCT04706897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56074304|NCT00003213|Autonomic Agents|autonomic agents|mesh-ancestor
56074305|NCT00003213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074306|NCT00003213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074307|NCT00003213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56074308|NCT00003213|Glucocorticoids|glucocorticoids|mesh-ancestor
56074309|NCT00003213|Hormones|hormones|mesh-ancestor
56074310|NCT00003213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074311|NCT00003213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56074312|NCT00003213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074313|NCT00003213|Protease Inhibitors|protease inhibitors|mesh-ancestor
56074315|NCT00003213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074316|NCT00003213|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56074317|NCT00003213|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56074318|NCT00003213|Dopamine Agents|dopamine agents|mesh-ancestor
56074319|NCT00003213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074320|NCT00003213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56074321|NCT00003213|Serotonin Agents|serotonin agents|mesh-ancestor
56074322|NCT01445067|Calcitonin|calcitonin|mesh-list
56074323|NCT01445067|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56074324|NCT01445067|Katacalcin|katacalcin|mesh-list
56074325|NCT01445067|Vasodilator Agents|vasodilator agents|mesh-ancestor
56003770|NCT00000730|Sulfamethoxazole|sulfamethoxazole|mesh-list
56074326|NCT01445067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56074327|NCT01445067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074328|NCT01445067|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56074329|NCT02978066|Anesthetics|anesthetics|mesh-list
56074330|NCT02978066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074331|NCT02978066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074332|NCT00003399|Dexamethasone|dexamethasone|mesh-list
56074333|NCT00003399|Paclitaxel|paclitaxel|mesh-list
56074334|NCT00003399|Etoposide|etoposide|mesh-list
56074335|NCT00003399|Cyclophosphamide|cyclophosphamide|mesh-list
56074348|NCT00003399|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56074349|NCT00003399|Alkylating Agents|alkylating agents|mesh-ancestor
56074350|NCT00003399|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56074351|NCT00003399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801558|NCT02484651|Rocuronium|rocuronium|mesh-list
56074352|NCT00003399|Antiemetics|antiemetics|mesh-ancestor
56074353|NCT00003399|Autonomic Agents|autonomic agents|mesh-ancestor
56074354|NCT00003399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074355|NCT00003399|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56074356|NCT00003399|Glucocorticoids|glucocorticoids|mesh-ancestor
56074357|NCT00003399|Hormones|hormones|mesh-ancestor
56074358|NCT00003399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074359|NCT00003399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56074360|NCT00003399|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56074361|NCT00003399|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56074362|NCT00003399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074363|NCT03376061|Tranexamic Acid|tranexamic acid|mesh-list
56074364|NCT03376061|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56074365|NCT03376061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56074366|NCT03376061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074367|NCT03376061|Hemostatics|hemostatics|mesh-ancestor
56074368|NCT03376061|Coagulants|coagulants|mesh-ancestor
56074369|NCT03376295|Tiotropium Bromide|tiotropium bromide|mesh-list
56074370|NCT03376295|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56074371|NCT03376295|Autonomic Agents|autonomic agents|mesh-ancestor
56074372|NCT03376295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074373|NCT03376295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074374|NCT03376295|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56074375|NCT03376295|Respiratory System Agents|respiratory system agents|mesh-ancestor
56074376|NCT03376295|Parasympatholytics|parasympatholytics|mesh-ancestor
56074377|NCT03376295|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56074378|NCT03376295|Cholinergic Agents|cholinergic agents|mesh-ancestor
56074379|NCT03376295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074390|NCT04735523|Antithrombins|antithrombins|mesh-ancestor
56074391|NCT04735523|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56074392|NCT04735523|Protease Inhibitors|protease inhibitors|mesh-ancestor
56074393|NCT04735523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074394|NCT04735523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074395|NCT00003219|Perillyl alcohol|perillyl alcohol|mesh-list
56074396|NCT00003219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074397|NCT00003219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074398|NCT00003219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074399|NCT05715788|Nitric Oxide|nitric oxide|mesh-list
56074400|NCT05715788|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56074401|NCT05715788|Autonomic Agents|autonomic agents|mesh-ancestor
56074402|NCT05715788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074403|NCT05715788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074404|NCT05715788|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56074405|NCT05715788|Respiratory System Agents|respiratory system agents|mesh-ancestor
56074406|NCT05715788|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56074407|NCT05715788|Antioxidants|antioxidants|mesh-ancestor
56074408|NCT05715788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074409|NCT05715788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074410|NCT05715788|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56074412|NCT05715788|Gasotransmitters|gasotransmitters|mesh-ancestor
56074413|NCT05715788|Protective Agents|protective agents|mesh-ancestor
56074414|NCT00003225|Irinotecan|irinotecan|mesh-list
56074415|NCT00003225|Amifostine|amifostine|mesh-list
56074416|NCT00003225|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56074417|NCT00003225|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56074436|NCT03441269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074437|NCT03441269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56074438|NCT03441269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56074439|NCT03441269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56074440|NCT03441269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074441|NCT03441269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074442|NCT03252353|Octreotide|octreotide|mesh-list
56074443|NCT03252353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56074444|NCT03252353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56074445|NCT03252353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074446|NCT05355272|Hormones|hormones|mesh-list
56074447|NCT05355272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074448|NCT05355272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074449|NCT00358358|Fluticasone|fluticasone|mesh-list
56074450|NCT00358358|Xhance|xhance|mesh-list
56074451|NCT00358358|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56074452|NCT00358358|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56074453|NCT00358358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56074454|NCT00358358|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56074455|NCT00358358|Autonomic Agents|autonomic agents|mesh-ancestor
56074456|NCT00358358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074457|NCT00358358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074458|NCT00358358|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56074459|NCT00358358|Respiratory System Agents|respiratory system agents|mesh-ancestor
56074460|NCT00358358|Dermatologic Agents|dermatologic agents|mesh-ancestor
56074461|NCT00358358|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56074462|NCT00358358|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56074463|NCT00358358|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56074464|NCT00358358|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56074465|NCT00358358|Adrenergic Agents|adrenergic agents|mesh-ancestor
56074478|NCT03441581|Eluxadoline|eluxadoline|mesh-list
56074479|NCT03441581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56074480|NCT02265510|Gemcitabine|gemcitabine|mesh-list
56074481|NCT02265510|Dexamethasone|dexamethasone|mesh-list
56074483|NCT02265510|Lenalidomide|lenalidomide|mesh-list
56074484|NCT02265510|Azacitidine|azacitidine|mesh-list
56074485|NCT02265510|Bortezomib|bortezomib|mesh-list
56074486|NCT02265510|Pomalidomide|pomalidomide|mesh-list
56074487|NCT02265510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56074488|NCT02265510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074489|NCT02265510|Tubulin Modulators|tubulin modulators|mesh-ancestor
56074490|NCT02265510|Antimitotic Agents|antimitotic agents|mesh-ancestor
56074491|NCT02265510|Mitosis Modulators|mitosis modulators|mesh-ancestor
56074492|NCT02265510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074493|NCT02265510|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56074494|NCT02265510|Antiemetics|antiemetics|mesh-ancestor
56074495|NCT02265510|Autonomic Agents|autonomic agents|mesh-ancestor
56074496|NCT02265510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074497|NCT02265510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074498|NCT02265510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56074499|NCT02265510|Glucocorticoids|glucocorticoids|mesh-ancestor
56074506|NCT02265510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074507|NCT02265510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074508|NCT02265510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56074525|NCT03254147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074526|NCT03384329|Resveratrol|resveratrol|mesh-list
56074527|NCT03384329|Antioxidants|antioxidants|mesh-ancestor
56074528|NCT03384329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074529|NCT03384329|Protective Agents|protective agents|mesh-ancestor
56074530|NCT03384329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074531|NCT03384329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074532|NCT03384329|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56074533|NCT03443063|Lemborexant|lemborexant|mesh-list
56074534|NCT03443063|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56074535|NCT03443063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074536|NCT03443063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074537|NCT03443063|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56074538|NCT03443063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56074539|NCT03443063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074540|NCT03443063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074541|NCT05327972|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56074542|NCT05327972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56074543|NCT05327972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074544|NCT05327972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074545|NCT05327972|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56074546|NCT05327972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56074547|NCT05327972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074572|NCT01238211|Antimetabolites|antimetabolites|mesh-ancestor
56074573|NCT01238211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074574|NCT01238211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074575|NCT01238211|Antiviral Agents|antiviral agents|mesh-ancestor
56074576|NCT01238211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074628|NCT00003237|Paclitaxel|paclitaxel|mesh-list
56074629|NCT00003237|Cisplatin|cisplatin|mesh-list
56074630|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56074631|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074632|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56074633|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56074634|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56074635|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074636|NCT00003411|Motexafin gadolinium|motexafin gadolinium|mesh-list
56074637|NCT00003411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074638|NCT00003411|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56074639|NCT00003411|Dermatologic Agents|dermatologic agents|mesh-ancestor
56074640|NCT00003243|Aldesleukin|aldesleukin|mesh-list
56074641|NCT00003243|Cyclophosphamide|cyclophosphamide|mesh-list
56074642|NCT00003243|Doxorubicin|doxorubicin|mesh-list
56074643|NCT00003243|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56074644|NCT00003243|Etoposide|etoposide|mesh-list
56074645|NCT00003243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56074646|NCT00003243|Immunologic Factors|immunologic factors|mesh-ancestor
56074647|NCT00003243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074648|NCT00003243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56074649|NCT00003243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56074650|NCT00003243|Alkylating Agents|alkylating agents|mesh-ancestor
56074651|NCT00003243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074652|NCT00003243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074653|NCT00003243|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56074654|NCT00003243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56074655|NCT00003243|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56074656|NCT00003243|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56074657|NCT00003243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075128|NCT05647278|Esomeprazole|esomeprazole|mesh-list
56074658|NCT00003243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56074663|NCT04344158|Sorafenib|sorafenib|mesh-list
56074673|NCT00003249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56074674|NCT00003249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074675|NCT00003249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074676|NCT00003249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56074677|NCT00003249|Hormone Antagonists|hormone antagonists|mesh-ancestor
56074678|NCT00003249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074679|NCT00003249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074680|NCT00003249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56074681|NCT00003249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074682|NCT00003249|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56074683|NCT00003249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56074684|NCT00003249|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56074685|NCT00003255|Carboplatin|carboplatin|mesh-list
56074687|NCT00003255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074688|NCT00003255|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56074689|NCT00003255|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56074690|NCT00003255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074691|NCT00003255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074692|NCT03269435|Metoclopramide|metoclopramide|mesh-list
56074693|NCT03269435|Bupivacaine|bupivacaine|mesh-list
56074694|NCT03269435|Anesthetics, Local|anesthetics, local|mesh-ancestor
56074695|NCT03269435|Anesthetics|anesthetics|mesh-ancestor
56074696|NCT03269435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074697|NCT03269435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074698|NCT03269435|Sensory System Agents|sensory system agents|mesh-ancestor
56074699|NCT03269435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074700|NCT03269435|Antiemetics|antiemetics|mesh-ancestor
56074701|NCT03269435|Autonomic Agents|autonomic agents|mesh-ancestor
56074714|NCT00003261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56074715|NCT00003261|Antimetabolites|antimetabolites|mesh-ancestor
56074716|NCT00003261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074717|NCT00003261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074718|NCT00003261|Dermatologic Agents|dermatologic agents|mesh-ancestor
55790960|NCT04848467|Vaccines|vaccines|mesh-list
56074719|NCT00003261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074720|NCT00003261|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56074721|NCT00003261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56074722|NCT00003261|Immunologic Factors|immunologic factors|mesh-ancestor
56074723|NCT00003261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56074724|NCT00003261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56074725|NCT00003261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56074726|NCT00003261|Antiviral Agents|antiviral agents|mesh-ancestor
56074727|NCT00003261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074728|NCT00003261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56074729|NCT00003261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56074731|NCT03279731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56074732|NCT03279731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074733|NCT03279731|Incretins|incretins|mesh-ancestor
56074734|NCT03279731|Hormones|hormones|mesh-ancestor
56074735|NCT03279731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074736|NCT04530409|Dexamethasone|dexamethasone|mesh-list
56074737|NCT04530409|Methylprednisolone|methylprednisolone|mesh-list
56074738|NCT04530409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56074739|NCT04530409|Antiemetics|antiemetics|mesh-ancestor
56074740|NCT04530409|Autonomic Agents|autonomic agents|mesh-ancestor
56074741|NCT04530409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074742|NCT04530409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074743|NCT04530409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56074744|NCT04530409|Glucocorticoids|glucocorticoids|mesh-ancestor
56074745|NCT04530409|Hormones|hormones|mesh-ancestor
56074746|NCT04530409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074752|NCT04477837|Apixaban|apixaban|mesh-list
56074756|NCT04477837|Antithrombins|antithrombins|mesh-ancestor
56074757|NCT04477837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56074758|NCT04477837|Protease Inhibitors|protease inhibitors|mesh-ancestor
56074759|NCT04477837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074760|NCT04477837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074761|NCT04477837|Anticoagulants|anticoagulants|mesh-ancestor
56074763|NCT04469491|Interferon Type I|interferon type i|mesh-list
56074764|NCT04469491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074765|NCT04469491|Antiviral Agents|antiviral agents|mesh-ancestor
56074766|NCT04469491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074773|NCT05267821|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56074774|NCT05267821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56074775|NCT02264574|Obinutuzumab|obinutuzumab|mesh-list
56074776|NCT02264574|Chlorambucil|chlorambucil|mesh-list
56074777|NCT02264574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56074778|NCT02264574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074779|NCT02264574|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56074780|NCT02264574|Alkylating Agents|alkylating agents|mesh-ancestor
56074781|NCT02264574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074782|NCT04412863|Interferons|interferons|mesh-list
56074783|NCT04412863|Interferon-alpha|interferon-alpha|mesh-list
56074784|NCT04412863|Interferon alpha-2|interferon alpha-2|mesh-list
56074785|NCT04412863|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56074786|NCT04412863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074787|NCT04412863|Antiviral Agents|antiviral agents|mesh-ancestor
56074788|NCT04412863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074789|NCT04412863|Immunologic Factors|immunologic factors|mesh-ancestor
56074790|NCT04412863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074791|NCT03400475|Simvastatin|simvastatin|mesh-list
56074792|NCT03400475|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56074793|NCT03400475|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56074794|NCT03400475|Antimetabolites|antimetabolites|mesh-ancestor
56074795|NCT03400475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074797|NCT03400475|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56074799|NCT01641900|Eszopiclone|eszopiclone|mesh-list
56074800|NCT01641900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56074801|NCT01641900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074802|NCT01641900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074803|NCT03834571|Paclitaxel|paclitaxel|mesh-list
56074804|NCT03834571|Cisplatin|cisplatin|mesh-list
56074805|NCT03834571|Carboplatin|carboplatin|mesh-list
56074806|NCT03834571|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56074807|NCT03834571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56074808|NCT03834571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074809|NCT03834571|Tubulin Modulators|tubulin modulators|mesh-ancestor
56074810|NCT03834571|Antimitotic Agents|antimitotic agents|mesh-ancestor
56074811|NCT03834571|Mitosis Modulators|mitosis modulators|mesh-ancestor
56074812|NCT03834571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074813|NCT05088980|Lidocaine|lidocaine|mesh-list
56074814|NCT05088980|Anesthetics, Local|anesthetics, local|mesh-ancestor
56074815|NCT05088980|Anesthetics|anesthetics|mesh-ancestor
56074816|NCT05088980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074817|NCT05088980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074818|NCT05088980|Sensory System Agents|sensory system agents|mesh-ancestor
56074819|NCT05088980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074821|NCT05088980|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56074822|NCT05088980|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56074823|NCT05088980|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56074824|NCT05088980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074825|NCT04368559|Fluconazole|fluconazole|mesh-list
56074826|NCT04368559|Posaconazole|posaconazole|mesh-list
56074827|NCT04368559|Rezafungin|rezafungin|mesh-list
56074828|NCT04368559|Trimethoprim|trimethoprim|mesh-list
56074829|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
56074830|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56074837|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56074838|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
56074839|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074840|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074841|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56074842|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56074843|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56074844|NCT04368559|Renal Agents|renal agents|mesh-ancestor
56074845|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
56074846|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56074847|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56074848|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56074849|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56074850|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56074851|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56074852|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56074853|NCT00376727|Cetuximab|cetuximab|mesh-list
56074854|NCT00376727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56074855|NCT00376727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074857|NCT05468606|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56074858|NCT05468606|Immunologic Factors|immunologic factors|mesh-ancestor
56074859|NCT05468606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074860|NCT05468606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074861|NCT05468606|Interferon Inducers|interferon inducers|mesh-ancestor
56074862|NCT05079230|Azacitidine|azacitidine|mesh-list
56074863|NCT05079230|Venetoclax|venetoclax|mesh-list
56074864|NCT05079230|Magrolimab|magrolimab|mesh-list
56074865|NCT05079230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56074866|NCT05079230|Antimetabolites|antimetabolites|mesh-ancestor
56074881|NCT04290871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074882|NCT04290871|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56074883|NCT04290871|Vasodilator Agents|vasodilator agents|mesh-ancestor
56074884|NCT04290871|Gasotransmitters|gasotransmitters|mesh-ancestor
56074885|NCT04290871|Protective Agents|protective agents|mesh-ancestor
56074886|NCT03501979|Capecitabine|capecitabine|mesh-list
56074887|NCT03501979|Trastuzumab|trastuzumab|mesh-list
56074889|NCT03501979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56074890|NCT03501979|Antimetabolites|antimetabolites|mesh-ancestor
56074891|NCT03501979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074892|NCT03501979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074893|NCT03501979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56074895|NCT03501979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074896|NCT03465787|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56074897|NCT03465787|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56074898|NCT03465787|Antidepressive Agents|antidepressive agents|mesh-ancestor
56074899|NCT03465787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56074900|NCT03465787|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56074901|NCT03465787|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56074902|NCT03465787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56074903|NCT03465787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074904|NCT03465787|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56074905|NCT03465787|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56074906|NCT03465787|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56074907|NCT03465787|Adrenergic Agents|adrenergic agents|mesh-ancestor
56074908|NCT03465787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56074910|NCT03465787|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56074932|NCT03836287|Anticonvulsants|anticonvulsants|mesh-ancestor
56074933|NCT03403517|Dexamethasone|dexamethasone|mesh-list
56074934|NCT03403517|Methylprednisolone|methylprednisolone|mesh-list
56074935|NCT03403517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56074936|NCT03403517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56074937|NCT03403517|Prednisolone|prednisolone|mesh-list
56074938|NCT03403517|Prednisolone acetate|prednisolone acetate|mesh-list
56074939|NCT03403517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56074940|NCT03403517|Prednisolone phosphate|prednisolone phosphate|mesh-list
56074941|NCT03403517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56074942|NCT03403517|Antiemetics|antiemetics|mesh-ancestor
56074943|NCT03403517|Autonomic Agents|autonomic agents|mesh-ancestor
56074944|NCT03403517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074945|NCT03403517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56074946|NCT03403517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56074947|NCT03403517|Glucocorticoids|glucocorticoids|mesh-ancestor
56074948|NCT03403517|Hormones|hormones|mesh-ancestor
56074949|NCT03403517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56074950|NCT03403517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56074951|NCT03403517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074952|NCT03403517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56074953|NCT03403517|Protective Agents|protective agents|mesh-ancestor
56074958|NCT05247788|Ethanol|ethanol|mesh-list
56074959|NCT05247788|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56074971|NCT02263326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56074972|NCT02263326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56074973|NCT02263326|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56074974|NCT02263326|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56074975|NCT05463848|Pembrolizumab|pembrolizumab|mesh-list
56074976|NCT05463848|Temozolomide|temozolomide|mesh-list
56074977|NCT05463848|Olaparib|olaparib|mesh-list
56074978|NCT05463848|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56074979|NCT05463848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56074980|NCT05463848|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56074981|NCT05463848|Alkylating Agents|alkylating agents|mesh-ancestor
56074982|NCT05463848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56074983|NCT05463848|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56074984|NCT05463848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56074985|NCT05647512|Dexamethasone|dexamethasone|mesh-list
56074986|NCT05647512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56074987|NCT05647512|Antiemetics|antiemetics|mesh-ancestor
56074988|NCT05647512|Autonomic Agents|autonomic agents|mesh-ancestor
56074989|NCT05647512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56074990|NCT05647512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075025|NCT05461508|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56075026|NCT05461508|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56075027|NCT05461508|Anticoagulants|anticoagulants|mesh-ancestor
56075028|NCT05461508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075029|NCT00356941|Docetaxel|docetaxel|mesh-list
56075030|NCT00356941|Oxaliplatin|oxaliplatin|mesh-list
56075031|NCT00356941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075032|NCT00356941|Tubulin Modulators|tubulin modulators|mesh-ancestor
56075033|NCT00356941|Antimitotic Agents|antimitotic agents|mesh-ancestor
56075034|NCT00356941|Mitosis Modulators|mitosis modulators|mesh-ancestor
56075035|NCT00356941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075037|NCT03450083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56075038|NCT03450083|Respiratory System Agents|respiratory system agents|mesh-ancestor
56075039|NCT05455658|Vaccines|vaccines|mesh-list
56075040|NCT05455658|Sargramostim|sargramostim|mesh-list
56075041|NCT05455658|Immunologic Factors|immunologic factors|mesh-ancestor
56075042|NCT05455658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075043|NCT03580343|Tofacitinib|tofacitinib|mesh-list
56075044|NCT03580343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56075045|NCT03580343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075046|NCT03580343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075047|NCT05445440|Leucovorin|leucovorin|mesh-list
56075048|NCT05445440|Sulfasalazine|sulfasalazine|mesh-list
56075049|NCT05445440|Methotrexate|methotrexate|mesh-list
56075050|NCT05445440|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56075051|NCT05445440|Abortifacient Agents|abortifacient agents|mesh-ancestor
56075052|NCT05445440|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56075053|NCT05445440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075055|NCT05445440|Antimetabolites|antimetabolites|mesh-ancestor
56075074|NCT05445440|Sensory System Agents|sensory system agents|mesh-ancestor
56075075|NCT05445440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075076|NCT05445440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56075077|NCT05445440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56075079|NCT05041322|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56075080|NCT05041322|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56075081|NCT05041322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56075082|NCT05041322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075083|NCT05041322|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56075084|NCT05041322|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56075085|NCT05041322|Serotonin Agents|serotonin agents|mesh-ancestor
56075086|NCT05041322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075087|NCT05041322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075088|NCT00422825|Imatinib Mesylate|imatinib mesylate|mesh-list
56075089|NCT00422825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075090|NCT00422825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56075091|NCT00422825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075092|NCT00422825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075093|NCT05229614|Pembrolizumab|pembrolizumab|mesh-list
56075094|NCT05229614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56075095|NCT05229614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075096|NCT05445128|Plerixafor|plerixafor|mesh-list
56075097|NCT05445128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56075098|NCT05445128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56075099|NCT05445128|Antiviral Agents|antiviral agents|mesh-ancestor
56075100|NCT05445128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075101|NCT02260986|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56075102|NCT02260986|Immunologic Factors|immunologic factors|mesh-ancestor
56075103|NCT02260986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075104|NCT05483010|Atorvastatin|atorvastatin|mesh-list
56075108|NCT05483010|Antimetabolites|antimetabolites|mesh-ancestor
56075116|NCT05479812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56075117|NCT05479812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075118|NCT04995536|CPG-oligonucleotide|cpg-oligonucleotide|mesh-list
56075119|NCT04995536|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56075120|NCT04995536|Immunologic Factors|immunologic factors|mesh-ancestor
56075121|NCT04995536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075123|NCT05647356|Androgen Antagonists|androgen antagonists|mesh-ancestor
56075124|NCT05647356|Hormone Antagonists|hormone antagonists|mesh-ancestor
56075125|NCT05647356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56075126|NCT05647356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075127|NCT05647356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075130|NCT05647278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56075131|NCT05647278|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56075132|NCT05647278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075133|NCT05647278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075134|NCT00358748|Hydrocortisone|hydrocortisone|mesh-list
56075135|NCT00358748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56075136|NCT00359606|Tetrahydrouridine|tetrahydrouridine|mesh-list
56075137|NCT00359606|Antimetabolites|antimetabolites|mesh-ancestor
56075138|NCT00359606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075139|NCT00359840|Darbepoetin alfa|darbepoetin alfa|mesh-list
56075140|NCT00359840|Hematinics|hematinics|mesh-ancestor
56075141|NCT02259582|Carboplatin|carboplatin|mesh-list
56075142|NCT02259582|Pemetrexed|pemetrexed|mesh-list
56075143|NCT02259582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075161|NCT02977208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075162|NCT02977208|Anticonvulsants|anticonvulsants|mesh-ancestor
56075163|NCT02977208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56075164|NCT02977208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56075165|NCT02977208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56075166|NCT02977208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56075167|NCT02977208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56075168|NCT02977208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56075169|NCT02977208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075170|NCT02977208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075171|NCT02977208|Antimanic Agents|antimanic agents|mesh-ancestor
56075173|NCT04866108|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56075174|NCT04866108|Antimetabolites|antimetabolites|mesh-ancestor
56075175|NCT04866108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075176|NCT04866108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075177|NCT04343768|Interferons|interferons|mesh-list
56075178|NCT04343768|Ritonavir|ritonavir|mesh-list
56075179|NCT04343768|Lopinavir|lopinavir|mesh-list
56075180|NCT04343768|Interferon-beta|interferon-beta|mesh-list
56075181|NCT04343768|Interferon beta-1a|interferon beta-1a|mesh-list
56075182|NCT04343768|Hydroxychloroquine|hydroxychloroquine|mesh-list
56075183|NCT04343768|Interferon beta-1b|interferon beta-1b|mesh-list
56075184|NCT04343768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075185|NCT04343768|Antiviral Agents|antiviral agents|mesh-ancestor
56075186|NCT04343768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075187|NCT04343768|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56075188|NCT04343768|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56075189|NCT04343768|Protease Inhibitors|protease inhibitors|mesh-ancestor
56075190|NCT04343768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075208|NCT02259348|Melphalan|melphalan|mesh-list
56075209|NCT02259348|Mechlorethamine|mechlorethamine|mesh-list
56075210|NCT02259348|Thiotepa|thiotepa|mesh-list
56075211|NCT02259348|Rituximab|rituximab|mesh-list
56075212|NCT02259348|Fludarabine|fludarabine|mesh-list
56075213|NCT02259348|Fludarabine phosphate|fludarabine phosphate|mesh-list
56075214|NCT02259348|Interleukin-2|interleukin-2|mesh-list
56075215|NCT02259348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075216|NCT02259348|Immunologic Factors|immunologic factors|mesh-ancestor
56075217|NCT02259348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075218|NCT02259348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075219|NCT02259348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56075220|NCT02259348|Alkylating Agents|alkylating agents|mesh-ancestor
56075221|NCT02259348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075222|NCT02259348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075223|NCT02259348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56075224|NCT02259348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56075225|NCT02259348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56075226|NCT02259348|Antimetabolites|antimetabolites|mesh-ancestor
56075227|NCT02259348|Antiviral Agents|antiviral agents|mesh-ancestor
56075228|NCT02259348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075229|NCT02259348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56075230|NCT02259348|Analgesics|analgesics|mesh-ancestor
56075231|NCT02259348|Sensory System Agents|sensory system agents|mesh-ancestor
56075232|NCT02259348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075233|NCT02259348|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56075234|NCT02259348|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56075235|NCT03190915|Trametinib|trametinib|mesh-list
56075236|NCT03190915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075237|NCT03190915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56075252|NCT00357019|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56075253|NCT00357019|Protective Agents|protective agents|mesh-ancestor
56075254|NCT00357019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56075255|NCT03994705|Cyclophosphamide|cyclophosphamide|mesh-list
56075256|NCT03994705|Fludarabine|fludarabine|mesh-list
56075257|NCT03994705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075258|NCT03994705|Immunologic Factors|immunologic factors|mesh-ancestor
56075259|NCT03994705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075260|NCT03994705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075261|NCT03994705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56075262|NCT03994705|Alkylating Agents|alkylating agents|mesh-ancestor
56075263|NCT03994705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075264|NCT03994705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075265|NCT03994705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56075266|NCT03587207|Vaccines|vaccines|mesh-list
56075267|NCT03587207|Immunologic Factors|immunologic factors|mesh-ancestor
56075268|NCT03587207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075269|NCT03592121|Phenylephrine|phenylephrine|mesh-list
56075270|NCT03592121|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56075271|NCT03592121|Mydriatics|mydriatics|mesh-ancestor
56075272|NCT03592121|Autonomic Agents|autonomic agents|mesh-ancestor
56075273|NCT03592121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075274|NCT03592121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075275|NCT03592121|Sympathomimetics|sympathomimetics|mesh-ancestor
56075276|NCT03592121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56075277|NCT03592121|Nasal Decongestants|nasal decongestants|mesh-ancestor
56075278|NCT03592121|Respiratory System Agents|respiratory system agents|mesh-ancestor
56075279|NCT03592121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56075299|NCT03596723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56075300|NCT03596723|Glucocorticoids|glucocorticoids|mesh-ancestor
56075301|NCT03596723|Hormones|hormones|mesh-ancestor
56075302|NCT03596723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56075303|NCT03596723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075304|NCT03596723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56075305|NCT03596723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075306|NCT03596723|Antiemetics|antiemetics|mesh-ancestor
56075307|NCT03596723|Autonomic Agents|autonomic agents|mesh-ancestor
56075308|NCT03596723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075309|NCT03596723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56075310|NCT03596723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56075311|NCT03596723|Protective Agents|protective agents|mesh-ancestor
56075312|NCT03463889|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56075313|NCT03463889|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56075314|NCT03463889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075315|NCT03472469|Acetaminophen|acetaminophen|mesh-list
56075316|NCT03472469|Ketorolac|ketorolac|mesh-list
56075317|NCT03472469|Naproxen|naproxen|mesh-list
56075318|NCT03472469|Celecoxib|celecoxib|mesh-list
56075319|NCT03472469|Lidocaine|lidocaine|mesh-list
56075320|NCT03472469|Pregabalin|pregabalin|mesh-list
56075321|NCT03472469|Gabapentin|gabapentin|mesh-list
56075322|NCT03472469|Tramadol|tramadol|mesh-list
56075323|NCT03472469|Anesthetics, Local|anesthetics, local|mesh-ancestor
56075324|NCT03472469|Anesthetics|anesthetics|mesh-ancestor
56075325|NCT03472469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56075326|NCT03472469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075327|NCT03472469|Sensory System Agents|sensory system agents|mesh-ancestor
56075328|NCT03472469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075329|NCT03472469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56075330|NCT03472469|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56075331|NCT03472469|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56075332|NCT03472469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56075333|NCT03472469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075334|NCT03472469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56075339|NCT03472469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56075340|NCT03472469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56075341|NCT03472469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56075342|NCT03472469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56075343|NCT03472469|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56075344|NCT03472469|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56075345|NCT03472469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075347|NCT03472469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56075348|NCT03472469|Narcotics|narcotics|mesh-ancestor
56075349|NCT03472469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56075350|NCT03472469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56075351|NCT03472469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075352|NCT03472469|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56075353|NCT03472469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075354|NCT03472469|Gout Suppressants|gout suppressants|mesh-ancestor
56075355|NCT03472469|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56075356|NCT04926233|Bromides|bromides|mesh-list
56075359|NCT04926233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56075360|NCT04926233|Autonomic Agents|autonomic agents|mesh-ancestor
56075361|NCT04926233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075362|NCT04926233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075363|NCT04926233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56075364|NCT04926233|Respiratory System Agents|respiratory system agents|mesh-ancestor
56075365|NCT04926233|Parasympatholytics|parasympatholytics|mesh-ancestor
56075366|NCT04926233|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56075367|NCT04926233|Cholinergic Agents|cholinergic agents|mesh-ancestor
56075368|NCT04926233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075369|NCT04926233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075382|NCT04734665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075383|NCT04734665|Growth Inhibitors|growth inhibitors|mesh-ancestor
56075384|NCT04734665|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56075385|NCT04734665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075386|NCT04734665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075387|NCT03112603|Mycophenolic Acid|mycophenolic acid|mesh-list
56075388|NCT03112603|Sirolimus|sirolimus|mesh-list
56075389|NCT03112603|Rituximab|rituximab|mesh-list
56075390|NCT03112603|Methotrexate|methotrexate|mesh-list
56075391|NCT03112603|Everolimus|everolimus|mesh-list
56075392|NCT03112603|Imatinib Mesylate|imatinib mesylate|mesh-list
56075393|NCT03112603|Pentostatin|pentostatin|mesh-list
56075394|NCT03112603|Infliximab|infliximab|mesh-list
56075395|NCT03112603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56075396|NCT03112603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075397|NCT03112603|Immunologic Factors|immunologic factors|mesh-ancestor
56075398|NCT03112603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075399|NCT03112603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075400|NCT03112603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56075401|NCT03112603|Abortifacient Agents|abortifacient agents|mesh-ancestor
56075402|NCT03112603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56075403|NCT03112603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56075404|NCT03112603|Antimetabolites|antimetabolites|mesh-ancestor
56075405|NCT03112603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075420|NCT02258334|Vaccines|vaccines|mesh-list
56075433|NCT05646810|Anesthetics, Local|anesthetics, local|mesh-ancestor
56075434|NCT05646810|Anesthetics|anesthetics|mesh-ancestor
56075435|NCT05646810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56075436|NCT05646810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075437|NCT05646810|Sensory System Agents|sensory system agents|mesh-ancestor
56075438|NCT05646810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075439|NCT05646810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56075440|NCT05646810|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56075441|NCT05646810|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56075442|NCT05646810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56003771|NCT00000730|Pentamidine|pentamidine|mesh-list
56075443|NCT05646810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075444|NCT04960202|Ritonavir|ritonavir|mesh-list
56075445|NCT04960202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56075446|NCT04960202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56075447|NCT04960202|Protease Inhibitors|protease inhibitors|mesh-ancestor
56075448|NCT04960202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075449|NCT04960202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075450|NCT04960202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56075451|NCT04960202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56075452|NCT04960202|Antiviral Agents|antiviral agents|mesh-ancestor
56075453|NCT04960202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075454|NCT04960202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56075455|NCT04960202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56075456|NCT02959112|Indomethacin|indomethacin|mesh-list
56075457|NCT02959112|Epinephrine|epinephrine|mesh-list
56075480|NCT02959112|Tocolytic Agents|tocolytic agents|mesh-ancestor
56075481|NCT02959112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56075482|NCT02959112|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56075483|NCT02959112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075484|NCT05377034|Bevacizumab|bevacizumab|mesh-list
56075485|NCT05377034|Atezolizumab|atezolizumab|mesh-list
56075486|NCT05377034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56075487|NCT05377034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075488|NCT05377034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56075489|NCT05377034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56075490|NCT05377034|Growth Substances|growth substances|mesh-ancestor
56075491|NCT05377034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075492|NCT05377034|Growth Inhibitors|growth inhibitors|mesh-ancestor
56075496|NCT03622619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56075497|NCT03622619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075498|NCT04428359|Vitamin D|vitamin d|mesh-list
56075499|NCT04428359|Vitamins|vitamins|mesh-ancestor
56075500|NCT04428359|Micronutrients|micronutrients|mesh-ancestor
56075501|NCT04428359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075502|NCT04428359|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56075503|NCT02257632|Ranibizumab|ranibizumab|mesh-list
56075504|NCT02257632|Aflibercept|aflibercept|mesh-list
56075505|NCT02257632|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56075506|NCT02257632|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56075507|NCT02257632|Growth Substances|growth substances|mesh-ancestor
56075508|NCT02257632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075509|NCT02257632|Growth Inhibitors|growth inhibitors|mesh-ancestor
56075510|NCT02257632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075511|NCT05436054|Picosulfate sodium|picosulfate sodium|mesh-list
56075512|NCT05436054|Cathartics|cathartics|mesh-ancestor
56075513|NCT05436054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56075523|NCT04932434|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56075524|NCT01642914|Linaclotide|linaclotide|mesh-list
56075525|NCT01642914|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56075526|NCT01642914|Enzyme Activators|enzyme activators|mesh-ancestor
56075527|NCT01642914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075528|NCT01642914|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56075529|NCT04497116|Gemcitabine|gemcitabine|mesh-list
56075530|NCT04497116|Talazoparib|talazoparib|mesh-list
55790963|NCT03104335|Apatinib|apatinib|mesh-list
56075531|NCT04497116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56075532|NCT04497116|Antimetabolites|antimetabolites|mesh-ancestor
56075533|NCT04497116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075534|NCT04497116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075535|NCT04497116|Antiviral Agents|antiviral agents|mesh-ancestor
56075536|NCT04497116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075537|NCT04497116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075538|NCT04497116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075539|NCT04497116|Immunologic Factors|immunologic factors|mesh-ancestor
56075540|NCT04497116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075541|NCT04497116|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56075542|NCT04486352|Bevacizumab|bevacizumab|mesh-list
56075543|NCT04486352|Trastuzumab|trastuzumab|mesh-list
56075544|NCT04486352|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56075545|NCT04486352|Atezolizumab|atezolizumab|mesh-list
56075547|NCT04486352|Maytansine|maytansine|mesh-list
56075548|NCT04486352|Talazoparib|talazoparib|mesh-list
56075549|NCT04486352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56075550|NCT04486352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56075551|NCT04486352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075552|NCT04486352|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56075553|NCT04486352|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56075554|NCT04486352|Growth Substances|growth substances|mesh-ancestor
56075555|NCT04486352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075556|NCT04486352|Growth Inhibitors|growth inhibitors|mesh-ancestor
56075557|NCT04486352|Immunologic Factors|immunologic factors|mesh-ancestor
56075558|NCT04486352|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56075562|NCT04486352|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56075563|NCT04486352|Hormone Antagonists|hormone antagonists|mesh-ancestor
56144722|NCT00808470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075564|NCT04486352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56075565|NCT04486352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56075566|NCT04486352|Tubulin Modulators|tubulin modulators|mesh-ancestor
56075567|NCT04486352|Antimitotic Agents|antimitotic agents|mesh-ancestor
56075568|NCT04486352|Mitosis Modulators|mitosis modulators|mesh-ancestor
56075569|NCT04486352|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56075570|NCT01642602|Dexlansoprazole|dexlansoprazole|mesh-list
56075571|NCT01642602|Lansoprazole|lansoprazole|mesh-list
56075572|NCT01642602|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56075573|NCT01642602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56075574|NCT01642602|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56075575|NCT01642602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075576|NCT01642602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075577|NCT02256540|Resveratrol|resveratrol|mesh-list
56075578|NCT02256540|Estradiol|estradiol|mesh-list
56075579|NCT02256540|Estrogens|estrogens|mesh-ancestor
56075580|NCT02256540|Hormones|hormones|mesh-ancestor
56075581|NCT02256540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56075582|NCT02256540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075583|NCT02256540|Antioxidants|antioxidants|mesh-ancestor
56075584|NCT02256540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075585|NCT02256540|Protective Agents|protective agents|mesh-ancestor
56075586|NCT02256540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075587|NCT02256540|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56075588|NCT04921358|Docetaxel|docetaxel|mesh-list
56075589|NCT04921358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075590|NCT04921358|Tubulin Modulators|tubulin modulators|mesh-ancestor
56075591|NCT04921358|Antimitotic Agents|antimitotic agents|mesh-ancestor
56075592|NCT04921358|Mitosis Modulators|mitosis modulators|mesh-ancestor
56075604|NCT01640184|Vitamin D|vitamin d|mesh-list
56075605|NCT01640184|Vitamins|vitamins|mesh-ancestor
56075606|NCT01640184|Micronutrients|micronutrients|mesh-ancestor
56075607|NCT01640184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075608|NCT01640184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56075609|NCT04904978|Listerine|listerine|mesh-list
56075610|NCT04904978|Sodium Fluoride|sodium fluoride|mesh-list
56075611|NCT04904978|Cariostatic Agents|cariostatic agents|mesh-ancestor
56075612|NCT04904978|Protective Agents|protective agents|mesh-ancestor
56075613|NCT04904978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075614|NCT04904978|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56075615|NCT04904978|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075616|NCT03631433|Acetaminophen|acetaminophen|mesh-list
56075617|NCT03631433|Ibuprofen|ibuprofen|mesh-list
56075618|NCT03631433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56075619|NCT03631433|Analgesics|analgesics|mesh-ancestor
56075620|NCT03631433|Sensory System Agents|sensory system agents|mesh-ancestor
56075621|NCT03631433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075622|NCT03631433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075623|NCT03631433|Antipyretics|antipyretics|mesh-ancestor
56075624|NCT03631433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56075625|NCT03631433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56075626|NCT03631433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075627|NCT03631433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56075628|NCT03631433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075629|NCT03631433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075630|NCT02973659|Oxybutynin|oxybutynin|mesh-list
56075631|NCT02973659|Parasympatholytics|parasympatholytics|mesh-ancestor
56075632|NCT02973659|Autonomic Agents|autonomic agents|mesh-ancestor
56075633|NCT02973659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075634|NCT02973659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075635|NCT02973659|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56075636|NCT02973659|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55802848|NCT05548465|Dsuvia|dsuvia|mesh-list
56075643|NCT04439396|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56075644|NCT04439396|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56075645|NCT04439396|Analgesics|analgesics|mesh-ancestor
56075646|NCT04439396|Sensory System Agents|sensory system agents|mesh-ancestor
56075647|NCT04439396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075648|NCT04439396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075649|NCT04439396|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56075650|NCT04439396|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075651|NCT04439396|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56075652|NCT04439396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075653|NCT04439396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075654|NCT02255760|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56075655|NCT02255760|Immunologic Factors|immunologic factors|mesh-ancestor
56075656|NCT02255760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075657|NCT00360464|Azithromycin|azithromycin|mesh-list
56075658|NCT00360464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56075659|NCT00360464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075660|NCT04825496|Cyclophosphamide|cyclophosphamide|mesh-list
56075661|NCT04825496|Fludarabine|fludarabine|mesh-list
56075662|NCT04825496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075663|NCT04825496|Immunologic Factors|immunologic factors|mesh-ancestor
56075664|NCT04825496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075665|NCT04825496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56075666|NCT04825496|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56075667|NCT04825496|Alkylating Agents|alkylating agents|mesh-ancestor
56075668|NCT04825496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075669|NCT04825496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075670|NCT04825496|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56075671|NCT04434092|Eculizumab|eculizumab|mesh-list
56075672|NCT04434092|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56075685|NCT05651256|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56075686|NCT05651256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075687|NCT04433780|Tenofovir|tenofovir|mesh-list
56075688|NCT04433780|Lamivudine|lamivudine|mesh-list
56075690|NCT04433780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075691|NCT04433780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56075692|NCT04433780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56075693|NCT04433780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075694|NCT04433780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075695|NCT04433780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56075696|NCT04433780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56075697|NCT04297631|Tobramycin|tobramycin|mesh-list
56075698|NCT04297631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56075699|NCT04297631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075700|NCT04818632|Everolimus|everolimus|mesh-list
56075701|NCT04818632|Palbociclib|palbociclib|mesh-list
56075702|NCT04818632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003772|NCT00000730|Trimetrexate|trimetrexate|mesh-list
56075703|NCT04818632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075704|NCT04818632|Immunologic Factors|immunologic factors|mesh-ancestor
56075705|NCT04818632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075706|NCT04818632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56075707|NCT04818632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075708|NCT04818632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075710|NCT04812470|Interleukin-2|interleukin-2|mesh-list
56075711|NCT04812470|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56075712|NCT04812470|Alkylating Agents|alkylating agents|mesh-ancestor
55802917|NCT05547685|Methylene Blue|methylene blue|mesh-list
56075713|NCT04812470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075714|NCT04812470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075715|NCT04812470|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56075727|NCT02976194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075728|NCT02976194|Growth Inhibitors|growth inhibitors|mesh-ancestor
56075729|NCT02976194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075730|NCT00360776|Tipifarnib|tipifarnib|mesh-list
56075731|NCT00360776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075732|NCT02976740|Immunologic Factors|immunologic factors|mesh-list
56075733|NCT02976740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075734|NCT04342910|Paclitaxel|paclitaxel|mesh-list
56075735|NCT04342910|Irinotecan|irinotecan|mesh-list
56075736|NCT04342910|Apatinib|apatinib|mesh-list
56075737|NCT04342910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56075738|NCT04342910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075739|NCT04342910|Tubulin Modulators|tubulin modulators|mesh-ancestor
56075740|NCT04342910|Antimitotic Agents|antimitotic agents|mesh-ancestor
56075741|NCT04342910|Mitosis Modulators|mitosis modulators|mesh-ancestor
56075742|NCT04342910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075743|NCT04342910|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56075744|NCT04342910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56075745|NCT04342910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075746|NCT04342910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56075747|NCT04714073|Itraconazole|itraconazole|mesh-list
56075748|NCT04714073|Antifungal Agents|antifungal agents|mesh-ancestor
56075749|NCT04714073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075750|NCT04714073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56075751|NCT04714073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56075752|NCT04714073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075753|NCT04714073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075754|NCT04714073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56075755|NCT04714073|Hormone Antagonists|hormone antagonists|mesh-ancestor
56075759|NCT04342676|Panitumumab|panitumumab|mesh-list
56075771|NCT04398368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075772|NCT04398368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075773|NCT04398368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075774|NCT04398368|Immunologic Factors|immunologic factors|mesh-ancestor
56075775|NCT04398368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075776|NCT05364762|Cyclophosphamide|cyclophosphamide|mesh-list
56075777|NCT05364762|Tacrolimus|tacrolimus|mesh-list
56075778|NCT05364762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075779|NCT05364762|Immunologic Factors|immunologic factors|mesh-ancestor
56075780|NCT05364762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741108|NCT03382717|Amorolfine|amorolfine|mesh-list
56075782|NCT05364762|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56075783|NCT05364762|Alkylating Agents|alkylating agents|mesh-ancestor
56075784|NCT05364762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075785|NCT05364762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075786|NCT05364762|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56075787|NCT05364762|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56075788|NCT05364762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075789|NCT04871958|Insulin|insulin|mesh-list
56075791|NCT04871958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075792|NCT04342598|Vitamin D|vitamin d|mesh-list
56075793|NCT04342598|Vitamins|vitamins|mesh-ancestor
56075794|NCT04342598|Micronutrients|micronutrients|mesh-ancestor
56075795|NCT04342598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075796|NCT04342598|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56075797|NCT00360854|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56075798|NCT00360854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075799|NCT00360854|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56075800|NCT00360854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075801|NCT00360854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075802|NCT04771130|Posaconazole|posaconazole|mesh-list
56075803|NCT04771130|Azacitidine|azacitidine|mesh-list
56075804|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56075805|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
56075806|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075807|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075810|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56075811|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56075812|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56075813|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56075814|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56075815|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56075816|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56075817|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
56075818|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56075819|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075820|NCT05641818|Vitamin D|vitamin d|mesh-list
56075821|NCT05641818|Vitamins|vitamins|mesh-ancestor
56075822|NCT05641818|Micronutrients|micronutrients|mesh-ancestor
56075823|NCT05641818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075824|NCT05641818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56075825|NCT04762082|Tadalafil|tadalafil|mesh-list
56075826|NCT04762082|Vasodilator Agents|vasodilator agents|mesh-ancestor
56075827|NCT04762082|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56075828|NCT04762082|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56075829|NCT04762082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075830|NCT04762082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075831|NCT04762082|Urological Agents|urological agents|mesh-ancestor
56075832|NCT03514277|Bupivacaine|bupivacaine|mesh-list
56075833|NCT03514277|Anesthetics, Local|anesthetics, local|mesh-ancestor
56075834|NCT03514277|Anesthetics|anesthetics|mesh-ancestor
56075835|NCT03514277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56075855|NCT03984656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56075856|NCT03984656|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56075857|NCT03984656|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56075858|NCT03984656|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56075859|NCT03984656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56075860|NCT03984656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075861|NCT05299944|Cannabidiol|cannabidiol|mesh-list
56075862|NCT05299944|Anticonvulsants|anticonvulsants|mesh-ancestor
56075864|NCT04329494|Cisplatin|cisplatin|mesh-list
56075865|NCT04329494|Doxorubicin|doxorubicin|mesh-list
56075866|NCT04329494|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56075867|NCT04329494|Fluorouracil|fluorouracil|mesh-list
56075868|NCT04329494|Oxaliplatin|oxaliplatin|mesh-list
56075869|NCT04329494|Irinotecan|irinotecan|mesh-list
56075870|NCT04329494|Daunorubicin|daunorubicin|mesh-list
56075872|NCT04329494|Mitomycin|mitomycin|mesh-list
56075873|NCT04329494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075874|NCT04329494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56075875|NCT04329494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56075876|NCT04329494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56075877|NCT04329494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075878|NCT04329494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075879|NCT04329494|Antimetabolites|antimetabolites|mesh-ancestor
56075880|NCT04329494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56075881|NCT04329494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075882|NCT04329494|Immunologic Factors|immunologic factors|mesh-ancestor
56075883|NCT04329494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075905|NCT05625594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56075906|NCT04870866|Niacinamide|niacinamide|mesh-list
56075908|NCT04870866|Nicotinic Acids|nicotinic acids|mesh-list
56075909|NCT04870866|Vitamin B Complex|vitamin b complex|mesh-ancestor
56075910|NCT04870866|Vitamins|vitamins|mesh-ancestor
56075911|NCT04870866|Micronutrients|micronutrients|mesh-ancestor
56075912|NCT04870866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075913|NCT04870866|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56075914|NCT04870866|Antimetabolites|antimetabolites|mesh-ancestor
56075915|NCT04870866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075916|NCT04870866|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56075917|NCT04870866|Vasodilator Agents|vasodilator agents|mesh-ancestor
56075918|NCT03657407|Glycerol|glycerol|mesh-list
56075919|NCT03657407|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56075920|NCT03657407|Protective Agents|protective agents|mesh-ancestor
56075921|NCT03657407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075922|NCT01639560|Varenicline|varenicline|mesh-list
56075923|NCT01639560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56075924|NCT01639560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56075925|NCT01639560|Cholinergic Agents|cholinergic agents|mesh-ancestor
56075926|NCT01639560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56075927|NCT01639560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075928|NCT01639560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075929|NCT04243616|Paclitaxel|paclitaxel|mesh-list
56075930|NCT04243616|Cyclophosphamide|cyclophosphamide|mesh-list
56075931|NCT04243616|Carboplatin|carboplatin|mesh-list
56075932|NCT04243616|Doxorubicin|doxorubicin|mesh-list
56075933|NCT04243616|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56075934|NCT04243616|Cemiplimab|cemiplimab|mesh-list
56075935|NCT04243616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56075936|NCT04243616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075937|NCT04243616|Tubulin Modulators|tubulin modulators|mesh-ancestor
56075938|NCT04243616|Antimitotic Agents|antimitotic agents|mesh-ancestor
56075939|NCT04243616|Mitosis Modulators|mitosis modulators|mesh-ancestor
56075940|NCT04243616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075941|NCT04243616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56075942|NCT04243616|Immunologic Factors|immunologic factors|mesh-ancestor
56075955|NCT05650476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56075956|NCT05650476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075957|NCT05650476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56075959|NCT03954314|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56075960|NCT03954314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56075961|NCT03954314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075962|NCT03954314|Hemostatics|hemostatics|mesh-ancestor
56075963|NCT03954314|Coagulants|coagulants|mesh-ancestor
56075976|NCT03952130|Insulin|insulin|mesh-list
56075977|NCT03952130|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56075978|NCT03952130|Insulin Glargine|insulin glargine|mesh-list
56075979|NCT03952130|Insulin Lispro|insulin lispro|mesh-list
56075981|NCT03952130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075982|NCT04852068|Vaccines|vaccines|mesh-list
56075983|NCT04852068|Immunologic Factors|immunologic factors|mesh-ancestor
56075984|NCT04852068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075986|NCT03661541|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56075987|NCT03661541|Immunologic Factors|immunologic factors|mesh-ancestor
56075988|NCT03661541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075989|NCT03925532|Denosumab|denosumab|mesh-list
56075990|NCT03925532|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56075991|NCT03925532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56075992|NCT05430828|Evolocumab|evolocumab|mesh-list
56075993|NCT05430828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56075994|NCT05430828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56075995|NCT05430828|Antimetabolites|antimetabolites|mesh-ancestor
56075996|NCT05430828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56075997|NCT05430828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56075998|NCT01640964|Terlipressin|terlipressin|mesh-list
56075999|NCT01640964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56076000|NCT01640964|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56076001|NCT03663101|Lidocaine|lidocaine|mesh-list
56076002|NCT03663101|Botulinum Toxins|botulinum toxins|mesh-list
56076003|NCT03663101|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56076004|NCT03663101|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56076005|NCT03663101|Anesthetics, Local|anesthetics, local|mesh-ancestor
56076006|NCT03663101|Anesthetics|anesthetics|mesh-ancestor
55741112|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
56076007|NCT03663101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076008|NCT03663101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076009|NCT03663101|Sensory System Agents|sensory system agents|mesh-ancestor
56076010|NCT03663101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076011|NCT03663101|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56076012|NCT03663101|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56076013|NCT03663101|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56076126|NCT03667547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076014|NCT03663101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56076016|NCT03663101|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56076018|NCT03663101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076019|NCT03663101|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56076021|NCT05430048|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56076022|NCT05430048|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56076023|NCT05430048|Sympatholytics|sympatholytics|mesh-ancestor
56076024|NCT05430048|Autonomic Agents|autonomic agents|mesh-ancestor
56076025|NCT05430048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076026|NCT05430048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076027|NCT05430048|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56076028|NCT05430048|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56076029|NCT05430048|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56076030|NCT05430048|Adrenergic Agents|adrenergic agents|mesh-ancestor
56076031|NCT05430048|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076032|NCT05430048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076033|NCT05430048|Hemostatics|hemostatics|mesh-ancestor
56076034|NCT05430048|Coagulants|coagulants|mesh-ancestor
56076035|NCT05430048|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56076036|NCT05430048|Natriuretic Agents|natriuretic agents|mesh-ancestor
56076037|NCT02975570|Levofloxacin|levofloxacin|mesh-list
56076038|NCT02975570|Ofloxacin|ofloxacin|mesh-list
56076039|NCT02975570|Linezolid|linezolid|mesh-list
56076040|NCT02975570|Pyrazinamide|pyrazinamide|mesh-list
56076041|NCT02975570|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56076042|NCT02975570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076043|NCT02975570|Renal Agents|renal agents|mesh-ancestor
56076044|NCT02975570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56076045|NCT02975570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56076063|NCT04184999|Antiemetics|antiemetics|mesh-ancestor
56076064|NCT04184999|Autonomic Agents|autonomic agents|mesh-ancestor
56076065|NCT04184999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076066|NCT04184999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076067|NCT04184999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56076068|NCT04184999|Glucocorticoids|glucocorticoids|mesh-ancestor
56076069|NCT04184999|Hormones|hormones|mesh-ancestor
56076070|NCT04184999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56076071|NCT04184999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56076072|NCT04184999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076073|NCT04184999|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56076074|NCT04184999|Protective Agents|protective agents|mesh-ancestor
56076075|NCT03912428|Celecoxib|celecoxib|mesh-list
56076076|NCT03912428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56076077|NCT03912428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56076078|NCT03912428|Analgesics|analgesics|mesh-ancestor
56076079|NCT03912428|Sensory System Agents|sensory system agents|mesh-ancestor
56076080|NCT03912428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076081|NCT03912428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076082|NCT03912428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56076083|NCT03912428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56076084|NCT03912428|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56076085|NCT03912428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56076086|NCT03912428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076087|NCT03912428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803300|NCT02579863|Dexamethasone|dexamethasone|mesh-list
56076089|NCT03524339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56076090|NCT03524339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56076091|NCT03524339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56076092|NCT03524339|Adrenergic Agents|adrenergic agents|mesh-ancestor
56076106|NCT05427474|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076107|NCT05427474|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56076108|NCT05427474|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56076109|NCT05427474|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56076110|NCT05427474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076111|NCT05427474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076112|NCT05427474|Antimanic Agents|antimanic agents|mesh-ancestor
56076113|NCT05427474|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56076114|NCT05427474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56076115|NCT05427474|Adrenergic Agents|adrenergic agents|mesh-ancestor
56076116|NCT05427474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56076117|NCT05427474|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56076118|NCT05427474|Vasodilator Agents|vasodilator agents|mesh-ancestor
56076124|NCT03667547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56076125|NCT03667547|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56076127|NCT03667547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076128|NCT00361010|Levetiracetam|levetiracetam|mesh-list
56076129|NCT00361010|Anticonvulsants|anticonvulsants|mesh-ancestor
56076130|NCT00361010|Nootropic Agents|nootropic agents|mesh-ancestor
56076131|NCT00361088|Bortezomib|bortezomib|mesh-list
56076132|NCT00361088|Tipifarnib|tipifarnib|mesh-list
56076133|NCT00361088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901114|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55901115|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901116|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55901117|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
56076151|NCT04172402|Gemcitabine|gemcitabine|mesh-list
56076152|NCT04172402|Nivolumab|nivolumab|mesh-list
56076153|NCT04172402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56076155|NCT04172402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076156|NCT04172402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076157|NCT04172402|Antiviral Agents|antiviral agents|mesh-ancestor
56076158|NCT04172402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076159|NCT04172402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076160|NCT04172402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56076161|NCT04172402|Immunologic Factors|immunologic factors|mesh-ancestor
56076162|NCT04172402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076163|NCT04172402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076164|NCT04172402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56076165|NCT04662242|Selenium|selenium|mesh-list
56076166|NCT04662242|Antioxidants|antioxidants|mesh-ancestor
56076167|NCT04662242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076168|NCT04662242|Protective Agents|protective agents|mesh-ancestor
56076203|NCT04160546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076204|NCT04160546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56076205|NCT04160546|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56076206|NCT04160546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076208|NCT04160546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076209|NCT04160546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56076210|NCT03675581|Nintedanib|nintedanib|mesh-list
56076211|NCT03675581|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56076212|NCT03675581|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56076213|NCT03675581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076214|NCT03675581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56076215|NCT03675581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076216|NCT03675581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076217|NCT03675581|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56076218|NCT03675581|Contraceptive Agents|contraceptive agents|mesh-ancestor
56076219|NCT03675581|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56076220|NCT03675581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076221|NCT03675581|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56003773|NCT00000730|Methylprednisolone|methylprednisolone|mesh-list
56076275|NCT01600716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076277|NCT02975258|Methacholine Chloride|methacholine chloride|mesh-list
56076278|NCT02975258|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56076279|NCT02975258|Autonomic Agents|autonomic agents|mesh-ancestor
56076280|NCT02975258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076281|NCT02975258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076282|NCT02975258|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56076283|NCT02975258|Respiratory System Agents|respiratory system agents|mesh-ancestor
56076284|NCT02975258|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56076285|NCT02975258|Antioxidants|antioxidants|mesh-ancestor
56076286|NCT02975258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076287|NCT02975258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076288|NCT02975258|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56076289|NCT02975258|Vasodilator Agents|vasodilator agents|mesh-ancestor
56076290|NCT02975258|Gasotransmitters|gasotransmitters|mesh-ancestor
56076291|NCT02975258|Protective Agents|protective agents|mesh-ancestor
56076292|NCT02975258|Miotics|miotics|mesh-ancestor
56076293|NCT02975258|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56076294|NCT02975258|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
56076295|NCT02975258|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56076298|NCT05114460|Naloxone|naloxone|mesh-list
56076314|NCT02975102|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56076315|NCT04833114|Carboplatin|carboplatin|mesh-list
56076316|NCT04833114|Etoposide|etoposide|mesh-list
56076317|NCT04833114|Rituximab|rituximab|mesh-list
56076318|NCT04833114|Ifosfamide|ifosfamide|mesh-list
56076319|NCT04833114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076320|NCT04833114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56076321|NCT04833114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56076322|NCT04833114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56076323|NCT04833114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076324|NCT04833114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076325|NCT04833114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076326|NCT04833114|Immunologic Factors|immunologic factors|mesh-ancestor
56076327|NCT04833114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076328|NCT04833114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56076329|NCT04833114|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56076330|NCT04833114|Alkylating Agents|alkylating agents|mesh-ancestor
56076331|NCT00376883|Pamidronate|pamidronate|mesh-list
56076334|NCT05314673|Bevacizumab|bevacizumab|mesh-list
56076371|NCT03785210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076372|NCT03785210|Vasodilator Agents|vasodilator agents|mesh-ancestor
56076373|NCT03785210|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56076374|NCT03785210|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56076375|NCT03785210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076376|NCT03785210|Urological Agents|urological agents|mesh-ancestor
56076378|NCT04098575|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56076379|NCT04098575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076380|NCT04098575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56076381|NCT04098575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076382|NCT03776240|Trastuzumab|trastuzumab|mesh-list
56076383|NCT03776240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076384|NCT03776240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076414|NCT00361790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076415|NCT00361790|Serotonin Agents|serotonin agents|mesh-ancestor
56076416|NCT00361790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076417|NCT00361790|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56076418|NCT00361790|Antidepressive Agents|antidepressive agents|mesh-ancestor
56076419|NCT00361790|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56076420|NCT00361790|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56076421|NCT00361790|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56076422|NCT00361790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076423|NCT00361790|Dopamine Agonists|dopamine agonists|mesh-ancestor
56076424|NCT00361790|Dopamine Agents|dopamine agents|mesh-ancestor
56076425|NCT00361790|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56076426|NCT00361790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56076427|NCT00361790|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56076428|NCT00361790|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56076429|NCT00361790|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56076430|NCT00361790|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56076431|NCT04570332|Pembrolizumab|pembrolizumab|mesh-list
56076432|NCT04570332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076433|NCT04570332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076466|NCT03743246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076467|NCT03743246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076468|NCT03743246|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56076469|NCT03703778|Ascorbic Acid|ascorbic acid|mesh-list
56076470|NCT03703778|Methyltestosterone|methyltestosterone|mesh-list
56076471|NCT03703778|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
56076472|NCT03703778|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56076473|NCT03703778|Androgens|androgens|mesh-list
56076474|NCT03703778|Hormones|hormones|mesh-ancestor
56076475|NCT03703778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56076476|NCT03703778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076477|NCT03703778|Antioxidants|antioxidants|mesh-ancestor
56076478|NCT03703778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076479|NCT03703778|Protective Agents|protective agents|mesh-ancestor
56076480|NCT03703778|Vitamins|vitamins|mesh-ancestor
56076481|NCT03703778|Micronutrients|micronutrients|mesh-ancestor
56076482|NCT03703778|Estrogens|estrogens|mesh-ancestor
56076483|NCT03703778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56076484|NCT03703778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076485|NCT03703778|Anabolic Agents|anabolic agents|mesh-ancestor
56076486|NCT05346666|Midazolam|midazolam|mesh-list
56076487|NCT05346666|Phenobarbital|phenobarbital|mesh-list
56076488|NCT05346666|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56076489|NCT05346666|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56076490|NCT05346666|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076491|NCT05346666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076492|NCT05346666|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56076513|NCT00361166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076514|NCT00361166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076515|NCT00361166|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56076516|NCT00361166|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56076517|NCT00361166|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56076518|NCT00361166|Serotonin Agents|serotonin agents|mesh-ancestor
56076519|NCT00361166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076520|NCT00361166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076521|NCT03674294|Dexamethasone|dexamethasone|mesh-list
56076523|NCT03674294|Palonosetron|palonosetron|mesh-list
56076524|NCT03674294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56076525|NCT03674294|Antiemetics|antiemetics|mesh-ancestor
56076526|NCT03674294|Autonomic Agents|autonomic agents|mesh-ancestor
56076527|NCT03674294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076528|NCT03674294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076529|NCT03674294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56076530|NCT03674294|Glucocorticoids|glucocorticoids|mesh-ancestor
56076531|NCT03674294|Hormones|hormones|mesh-ancestor
55803740|NCT05528887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56076532|NCT03674294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144724|NCT00808470|Provitamins|provitamins|mesh-ancestor
56076533|NCT03674294|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56076534|NCT03674294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076535|NCT03674294|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56076536|NCT03674294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076537|NCT03674294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076541|NCT00377273|Fluorouracil|fluorouracil|mesh-list
56076558|NCT05369364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56076559|NCT05369364|Antiemetics|antiemetics|mesh-ancestor
56076560|NCT05369364|Autonomic Agents|autonomic agents|mesh-ancestor
56076561|NCT05369364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076562|NCT05369364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076563|NCT05369364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56076564|NCT05369364|Glucocorticoids|glucocorticoids|mesh-ancestor
56076565|NCT05369364|Hormones|hormones|mesh-ancestor
56076566|NCT05369364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56076567|NCT05369364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56076568|NCT05369364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076569|NCT05369364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56076570|NCT05369364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076571|NCT05369364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076572|NCT00361244|Irinotecan|irinotecan|mesh-list
56076573|NCT00361244|Cetuximab|cetuximab|mesh-list
56076574|NCT00361244|Sunitinib|sunitinib|mesh-list
56076575|NCT00361244|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56076576|NCT00361244|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56076577|NCT00361244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076578|NCT00361244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076579|NCT00361244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076580|NCT00361244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076581|NCT00361244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56076582|NCT00361244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56076583|NCT00361244|Growth Substances|growth substances|mesh-ancestor
56076584|NCT00361244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076585|NCT00361244|Growth Inhibitors|growth inhibitors|mesh-ancestor
56076602|NCT03381482|Anesthetics|anesthetics|mesh-list
56076603|NCT03381482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076604|NCT03381482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076605|NCT03545165|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56076606|NCT03545165|177Lu-PSMA-617|177lu-psma-617|mesh-list
56076607|NCT03545165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56076608|NCT03545165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076609|NCT04968522|Methylphenidate|methylphenidate|mesh-list
56076610|NCT04968522|Dextroamphetamine|dextroamphetamine|mesh-list
56076611|NCT04968522|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56076613|NCT04968522|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56076614|NCT04968522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56076615|NCT04968522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56076616|NCT04968522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076617|NCT04968522|Dopamine Agents|dopamine agents|mesh-ancestor
56076618|NCT04968522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076619|NCT00361322|Clindamycin|clindamycin|mesh-list
56076620|NCT00361322|Clindamycin palmitate|clindamycin palmitate|mesh-list
56076621|NCT00361322|Clindamycin phosphate|clindamycin phosphate|mesh-list
56076622|NCT00361322|Salicylic Acid|salicylic acid|mesh-list
56076624|NCT00361322|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56076625|NCT00361322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076626|NCT00361322|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56076627|NCT00361322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076629|NCT00361322|Antifungal Agents|antifungal agents|mesh-ancestor
56076650|NCT02974712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56076651|NCT02974712|Anesthetics, General|anesthetics, general|mesh-ancestor
56076652|NCT02974712|Anesthetics|anesthetics|mesh-ancestor
56076653|NCT02974556|Capecitabine|capecitabine|mesh-list
56076654|NCT02974556|Oxaliplatin|oxaliplatin|mesh-list
56076655|NCT02974556|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56076656|NCT02974556|Antimetabolites|antimetabolites|mesh-ancestor
56076657|NCT02974556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076658|NCT02974556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076659|NCT04523142|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56076660|NCT04523142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56076661|NCT03557333|Dihydroergotamine|dihydroergotamine|mesh-list
56076662|NCT03557333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56076663|NCT03557333|Dopamine Agonists|dopamine agonists|mesh-ancestor
56076664|NCT03557333|Dopamine Agents|dopamine agents|mesh-ancestor
56076665|NCT03557333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076666|NCT03557333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076667|NCT03557333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076668|NCT03557333|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56076669|NCT03557333|Analgesics|analgesics|mesh-ancestor
56076670|NCT03557333|Sensory System Agents|sensory system agents|mesh-ancestor
56076671|NCT03557333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076672|NCT04527380|Adalimumab|adalimumab|mesh-list
56076673|NCT04527380|Ixekizumab|ixekizumab|mesh-list
56076674|NCT04527380|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56076677|NCT04957368|Midazolam|midazolam|mesh-list
56076700|NCT04818450|Sensory System Agents|sensory system agents|mesh-ancestor
56076701|NCT04818450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076702|NCT04818450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076703|NCT04818450|Anticonvulsants|anticonvulsants|mesh-ancestor
56076704|NCT04818450|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56076705|NCT04818450|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56076706|NCT04818450|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076707|NCT04818450|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56076708|NCT04818450|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56076709|NCT04818450|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56076710|NCT04818450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076711|NCT04818450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076712|NCT04818450|Antimanic Agents|antimanic agents|mesh-ancestor
56076713|NCT04841148|Hydroxychloroquine|hydroxychloroquine|mesh-list
56076714|NCT04841148|Palbociclib|palbociclib|mesh-list
56076715|NCT04841148|Avelumab|avelumab|mesh-list
56076716|NCT04841148|Antimalarials|antimalarials|mesh-ancestor
56076717|NCT04841148|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56076718|NCT04841148|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56076719|NCT04841148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076720|NCT04841148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076721|NCT04841148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076722|NCT04841148|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56076723|NCT04841148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076724|NCT04841148|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56076725|NCT04841148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076726|NCT04830462|Rifampin|rifampin|mesh-list
56076727|NCT04830462|Isoniazid|isoniazid|mesh-list
56076728|NCT04830462|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56076729|NCT04830462|Antitubercular Agents|antitubercular agents|mesh-ancestor
56076741|NCT04830462|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56076742|NCT04830462|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56076743|NCT04830462|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56076744|NCT04830462|Antimetabolites|antimetabolites|mesh-ancestor
56076745|NCT04830462|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56076746|NCT04829760|Psyllium|psyllium|mesh-list
56076747|NCT04829760|Cathartics|cathartics|mesh-ancestor
56076748|NCT04829760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56076749|NCT03582176|Ketotifen|ketotifen|mesh-list
56076750|NCT03582176|Antipruritics|antipruritics|mesh-ancestor
56076751|NCT03582176|Dermatologic Agents|dermatologic agents|mesh-ancestor
56076752|NCT03582176|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56076753|NCT03582176|Histamine Antagonists|histamine antagonists|mesh-ancestor
56076754|NCT03582176|Histamine Agents|histamine agents|mesh-ancestor
56076755|NCT03582176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076756|NCT03582176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076757|NCT03582176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076758|NCT03582176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56076760|NCT05289804|Anesthetics, Local|anesthetics, local|mesh-list
56076761|NCT05289804|Prilocaine|prilocaine|mesh-list
56076762|NCT05289804|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56076763|NCT05289804|Anesthetics|anesthetics|mesh-list
56076764|NCT05289804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56076765|NCT05289804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076766|NCT05289804|Sensory System Agents|sensory system agents|mesh-ancestor
56076767|NCT05289804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076768|NCT05289804|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56076769|NCT05289804|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56076770|NCT05289804|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56076771|NCT05289804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56076774|NCT03720119|Lidocaine|lidocaine|mesh-list
56076785|NCT03720119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076786|NCT05448872|Valsartan|valsartan|mesh-list
56076787|NCT05448872|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56003774|NCT00000730|Levoleucovorin|levoleucovorin|mesh-list
56076789|NCT05448872|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56076790|NCT05448872|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56076791|NCT05448872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076792|NCT04817826|Durvalumab|durvalumab|mesh-list
56076793|NCT04817826|Tremelimumab|tremelimumab|mesh-list
56076794|NCT04817826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076795|NCT04817826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076796|NCT00362258|Irbesartan|irbesartan|mesh-list
56076797|NCT00362258|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56076798|NCT00362258|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56076799|NCT00362258|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56076800|NCT00362258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076801|NCT00362726|Rosiglitazone|rosiglitazone|mesh-list
56076802|NCT00362726|Ritonavir|ritonavir|mesh-list
56076803|NCT00362726|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56076804|NCT00362726|Maleic acid|maleic acid|mesh-list
56076805|NCT00362726|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56076849|NCT04426968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56076850|NCT04887948|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56076851|NCT04887948|Immunologic Factors|immunologic factors|mesh-ancestor
56076852|NCT04887948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076853|NCT03829488|Plasma-lyte 148|plasma-lyte 148|mesh-list
56076854|NCT03829488|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56076855|NCT03829488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56076857|NCT05369052|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56076858|NCT05369052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741125|NCT03376243|Emollients|emollients|mesh-list
56076859|NCT05369052|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56076860|NCT05369052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56076861|NCT05369052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076862|NCT04049123|Insulin Lispro|insulin lispro|mesh-list
56076863|NCT04049123|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56076864|NCT04049123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076865|NCT04051463|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56076866|NCT04051463|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56076867|NCT04184297|Tiotropium Bromide|tiotropium bromide|mesh-list
56076868|NCT04184297|Olodaterol|olodaterol|mesh-list
56076869|NCT04184297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56076870|NCT04184297|Autonomic Agents|autonomic agents|mesh-ancestor
56076871|NCT04184297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076872|NCT04184297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076873|NCT04184297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56076874|NCT04184297|Respiratory System Agents|respiratory system agents|mesh-ancestor
56076875|NCT04184297|Parasympatholytics|parasympatholytics|mesh-ancestor
56076876|NCT04184297|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56076877|NCT04184297|Cholinergic Agents|cholinergic agents|mesh-ancestor
56076880|NCT04031885|Paclitaxel|paclitaxel|mesh-list
56076893|NCT04031885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56076894|NCT04031885|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56076896|NCT04031885|Hormone Antagonists|hormone antagonists|mesh-ancestor
56076897|NCT04031885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56076898|NCT04031885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076899|NCT01638000|Solifenacin Succinate|solifenacin succinate|mesh-list
56076901|NCT01638000|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56076902|NCT01638000|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56076904|NCT01638000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076905|NCT01638000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076906|NCT01638000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076907|NCT01638000|Urological Agents|urological agents|mesh-ancestor
56076908|NCT01638000|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
56076909|NCT01638000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56076910|NCT01638000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56076911|NCT01638000|Adrenergic Agents|adrenergic agents|mesh-ancestor
56076912|NCT04023695|Lidocaine|lidocaine|mesh-list
56076913|NCT04023695|Epinephrine|epinephrine|mesh-list
56076944|NCT04223843|Autonomic Agents|autonomic agents|mesh-ancestor
56076945|NCT04223843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56076946|NCT04223843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076947|NCT04223843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56076948|NCT04223843|Respiratory System Agents|respiratory system agents|mesh-ancestor
56076949|NCT04223843|Parasympatholytics|parasympatholytics|mesh-ancestor
56076950|NCT04223843|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56076951|NCT04223843|Cholinergic Agents|cholinergic agents|mesh-ancestor
56076952|NCT04223843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56076953|NCT04223843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56076954|NCT05722951|Metformin|metformin|mesh-list
56076955|NCT05722951|Levetiracetam|levetiracetam|mesh-list
56076956|NCT05722951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56076957|NCT05722951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56076958|NCT05722951|Anticonvulsants|anticonvulsants|mesh-ancestor
56076959|NCT05722951|Nootropic Agents|nootropic agents|mesh-ancestor
56076960|NCT04838652|Pembrolizumab|pembrolizumab|mesh-list
56076961|NCT04838652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56076962|NCT04838652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076963|NCT05722795|Imatinib Mesylate|imatinib mesylate|mesh-list
56076964|NCT05722795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56076998|NCT04810494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077000|NCT04810494|Sensory System Agents|sensory system agents|mesh-ancestor
56077001|NCT04810494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077002|NCT04810494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56077003|NCT04810494|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56077004|NCT04810494|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56077005|NCT04810494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56077006|NCT04810494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077007|NCT05722561|Nicotine|nicotine|mesh-list
56077010|NCT05722561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077011|NCT05722561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077012|NCT05722561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56077013|NCT05722561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56077014|NCT05722561|Cholinergic Agents|cholinergic agents|mesh-ancestor
56077015|NCT05722561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077016|NCT05722561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077018|NCT05112601|Ipilimumab|ipilimumab|mesh-list
56077019|NCT05112601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077020|NCT05112601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077021|NCT05112601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56077022|NCT05112601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077023|NCT04317534|Pembrolizumab|pembrolizumab|mesh-list
56077024|NCT04317534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077025|NCT04317534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077026|NCT05722405|Lenalidomide|lenalidomide|mesh-list
56077027|NCT05722405|Ixazomib|ixazomib|mesh-list
56077028|NCT05722405|Glycine|glycine|mesh-list
56077029|NCT05722405|Immunologic Factors|immunologic factors|mesh-ancestor
56077030|NCT05722405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077031|NCT05722405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56077032|NCT05722405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56077035|NCT05722405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077036|NCT05722405|Protease Inhibitors|protease inhibitors|mesh-ancestor
56077037|NCT05722405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077038|NCT05722405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077039|NCT05722405|Glycine Agents|glycine agents|mesh-ancestor
56077040|NCT05722405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077041|NCT05722327|Irinotecan|irinotecan|mesh-list
56077042|NCT05722327|Cetuximab|cetuximab|mesh-list
56077043|NCT05722327|Adagrasib|adagrasib|mesh-list
56077044|NCT05722327|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56077045|NCT05722327|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56077046|NCT05722327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077178|NCT02460133|Ritonavir|ritonavir|mesh-list
56077047|NCT05722327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077048|NCT05722327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077049|NCT05722327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077050|NCT04259658|Calcium|calcium|mesh-list
56077051|NCT04259658|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56077052|NCT04259658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077053|NCT02767531|Orlistat|orlistat|mesh-list
56077054|NCT02767531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077055|NCT02767531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804268|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
56077056|NCT02767531|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56077057|NCT02767531|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56077058|NCT04419246|Tranexamic Acid|tranexamic acid|mesh-list
56077059|NCT04419246|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56077060|NCT04419246|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56077082|NCT04837014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077084|NCT04195698|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56077085|NCT04195698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56077086|NCT04195698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077087|NCT04195698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077088|NCT04195698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077089|NCT02521753|Metformin|metformin|mesh-list
56077090|NCT02521753|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56077091|NCT02521753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077092|NCT04229303|Voriconazole|voriconazole|mesh-list
56077093|NCT04229303|Antifungal Agents|antifungal agents|mesh-ancestor
56077094|NCT04229303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077095|NCT04229303|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56077096|NCT04229303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56077097|NCT04229303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077098|NCT04229303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077099|NCT04229303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56077100|NCT04229303|Hormone Antagonists|hormone antagonists|mesh-ancestor
56077101|NCT04229303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56077102|NCT04229303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077103|NCT04229303|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56077104|NCT05263986|Adagrasib|adagrasib|mesh-list
56077105|NCT05263986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077106|NCT00357643|Vitamin D|vitamin d|mesh-list
56077107|NCT00357643|Calcium|calcium|mesh-list
56077108|NCT00357643|Vitamins|vitamins|mesh-ancestor
56077109|NCT00357643|Micronutrients|micronutrients|mesh-ancestor
56077110|NCT00357643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077111|NCT00357643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56077112|NCT00357643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56077113|NCT04812912|Hormones|hormones|mesh-list
56077124|NCT05395494|Antitubercular Agents|antitubercular agents|mesh-ancestor
56077125|NCT05395494|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56077127|NCT05395494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077128|NCT00357721|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56077129|NCT00357721|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56077130|NCT00357721|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56077131|NCT00357721|Protease Inhibitors|protease inhibitors|mesh-ancestor
56077132|NCT00357721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077133|NCT00357721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077134|NCT00357721|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56077135|NCT00357721|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56077136|NCT00357721|Antiviral Agents|antiviral agents|mesh-ancestor
56077137|NCT00357721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077138|NCT03504410|Cytarabine|cytarabine|mesh-list
56077139|NCT03504410|Fludarabine|fludarabine|mesh-list
56077140|NCT03504410|Etoposide|etoposide|mesh-list
56077141|NCT03504410|Mitoxantrone|mitoxantrone|mesh-list
56077142|NCT03504410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077143|NCT03504410|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56077144|NCT03504410|Antimetabolites|antimetabolites|mesh-ancestor
56077145|NCT03504410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077146|NCT03504410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56077147|NCT03504410|Immunologic Factors|immunologic factors|mesh-ancestor
56077152|NCT03504410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077174|NCT03498014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077175|NCT03498014|Analgesics|analgesics|mesh-ancestor
56077176|NCT03498014|Sensory System Agents|sensory system agents|mesh-ancestor
56077177|NCT03498014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077180|NCT02460133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56077181|NCT02460133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56077182|NCT02460133|Protease Inhibitors|protease inhibitors|mesh-ancestor
56077183|NCT02460133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077184|NCT02460133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077185|NCT02460133|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56077186|NCT02460133|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56077187|NCT02460133|Antiviral Agents|antiviral agents|mesh-ancestor
56077188|NCT02460133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077189|NCT02460133|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56077190|NCT02460133|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56077191|NCT02460133|Antimetabolites|antimetabolites|mesh-ancestor
56077192|NCT02220452|Anesthetics|anesthetics|mesh-list
56077193|NCT02220452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077194|NCT02220452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077195|NCT04256603|Gabapentin|gabapentin|mesh-list
56077196|NCT04256603|Analgesics|analgesics|mesh-ancestor
56077197|NCT04256603|Sensory System Agents|sensory system agents|mesh-ancestor
56077198|NCT04256603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077199|NCT04256603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077222|NCT00362570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077223|NCT00362570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077224|NCT00357253|Capecitabine|capecitabine|mesh-list
56077225|NCT00357253|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56077226|NCT00357253|Antimetabolites|antimetabolites|mesh-ancestor
56077227|NCT00357253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077228|NCT00357253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077229|NCT03541902|Sunitinib|sunitinib|mesh-list
56077230|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077231|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56077232|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56077233|NCT03541902|Growth Substances|growth substances|mesh-ancestor
56077234|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077235|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
56077236|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56077237|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077238|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077239|NCT02159066|Infigratinib|infigratinib|mesh-list
56077240|NCT02159066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077241|NCT02386735|Prednisone|prednisone|mesh-list
56077242|NCT02386735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077243|NCT02386735|Glucocorticoids|glucocorticoids|mesh-ancestor
56077244|NCT02386735|Hormones|hormones|mesh-ancestor
56077245|NCT02386735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56077246|NCT02386735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077247|NCT02386735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56077248|NCT02386735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077249|NCT02068430|Riboflavin|riboflavin|mesh-list
56077266|NCT03137888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077267|NCT03127592|Etodolac|etodolac|mesh-list
56077268|NCT03127592|Cyclobenzaprine|cyclobenzaprine|mesh-list
56077269|NCT03127592|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56077270|NCT03127592|Antidepressive Agents|antidepressive agents|mesh-ancestor
56077271|NCT03127592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56077272|NCT03127592|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56077273|NCT03127592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077274|NCT03127592|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56077275|NCT03127592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077276|NCT03127592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56077277|NCT03127592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077278|NCT03127592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56077279|NCT03127592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56077281|NCT03127592|Sensory System Agents|sensory system agents|mesh-ancestor
56077282|NCT03127592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077283|NCT03127592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077284|NCT03127592|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56077285|NCT03127592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56077286|NCT03127592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077287|NCT03127592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077288|NCT02444234|Tedizolid|tedizolid|mesh-list
56077289|NCT02444234|Oxazolidinones|oxazolidinones|mesh-list
56077317|NCT02306161|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56077318|NCT02306161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077319|NCT02306161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56077327|NCT02444936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077328|NCT02445326|Dexamethasone|dexamethasone|mesh-list
56077329|NCT02445326|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077330|NCT02445326|Antiemetics|antiemetics|mesh-ancestor
56077331|NCT02445326|Autonomic Agents|autonomic agents|mesh-ancestor
56077332|NCT02445326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077333|NCT02445326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077334|NCT02445326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56077335|NCT02445326|Glucocorticoids|glucocorticoids|mesh-ancestor
56077336|NCT02445326|Hormones|hormones|mesh-ancestor
56077337|NCT02445326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56077338|NCT02445326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56077339|NCT02445326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077340|NCT04344457|Hydroxychloroquine|hydroxychloroquine|mesh-list
56077341|NCT04344457|Azithromycin|azithromycin|mesh-list
56077342|NCT04344457|Indomethacin|indomethacin|mesh-list
56077343|NCT04344457|Antimalarials|antimalarials|mesh-ancestor
56077344|NCT04344457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56077345|NCT04344457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56077346|NCT04344457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077347|NCT04344457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077348|NCT04344457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077349|NCT04344457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077350|NCT04344457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56077351|NCT04344457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56077359|NCT04344457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56077360|NCT04344457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56077361|NCT04344457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56077362|NCT01920932|Prednisone|prednisone|mesh-list
56077363|NCT01920932|Prednisolone|prednisolone|mesh-list
56077364|NCT01920932|Cyclophosphamide|cyclophosphamide|mesh-list
56077365|NCT01920932|Dacarbazine|dacarbazine|mesh-list
56077366|NCT01920932|Doxorubicin|doxorubicin|mesh-list
56077367|NCT01920932|Etoposide|etoposide|mesh-list
56077368|NCT01920932|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56077369|NCT01920932|Imidazole|imidazole|mesh-list
56077370|NCT01920932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56077371|NCT01920932|Immunologic Factors|immunologic factors|mesh-ancestor
56077372|NCT01920932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077373|NCT01920932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077374|NCT01920932|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56077375|NCT01920932|Alkylating Agents|alkylating agents|mesh-ancestor
56077376|NCT01920932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077377|NCT01920932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077378|NCT01920932|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56077379|NCT01920932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56077380|NCT01920932|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56077381|NCT01920932|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56077382|NCT01920932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077383|NCT01920932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077384|NCT01920932|Glucocorticoids|glucocorticoids|mesh-ancestor
56077385|NCT01920932|Hormones|hormones|mesh-ancestor
56077386|NCT01920932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56077387|NCT01920932|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56077388|NCT01920932|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56077389|NCT01920932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077391|NCT05720455|Pseudoephedrine|pseudoephedrine|mesh-list
56077392|NCT05720455|Ephedrine|ephedrine|mesh-list
56077393|NCT05720455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56077395|NCT05720455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077396|NCT05720455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077397|NCT05720455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56077398|NCT05720455|Respiratory System Agents|respiratory system agents|mesh-ancestor
56077399|NCT05720455|Nasal Decongestants|nasal decongestants|mesh-ancestor
56077400|NCT05720455|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56077401|NCT05720455|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56077402|NCT05720455|Sympathomimetics|sympathomimetics|mesh-ancestor
56077403|NCT05720455|Adrenergic Agents|adrenergic agents|mesh-ancestor
56077404|NCT05720455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077405|NCT05720455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077406|NCT05720455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56077407|NCT05720455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56077408|NCT05720455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56077409|NCT05720455|Histamine Antagonists|histamine antagonists|mesh-ancestor
56077410|NCT05720455|Histamine Agents|histamine agents|mesh-ancestor
56077412|NCT02446496|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56077413|NCT02446496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077414|NCT00355693|Propofol|propofol|mesh-list
56077415|NCT00355693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56077416|NCT00355693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077417|NCT00355693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077418|NCT00355693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56077419|NCT00355693|Anesthetics, General|anesthetics, general|mesh-ancestor
56077420|NCT00355693|Anesthetics|anesthetics|mesh-ancestor
56077421|NCT02448368|Verinurad|verinurad|mesh-list
56077422|NCT02448368|Gout Suppressants|gout suppressants|mesh-ancestor
56077423|NCT02448368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077424|NCT02448914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56077425|NCT02448914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56077426|NCT02448914|Immunologic Factors|immunologic factors|mesh-ancestor
56077427|NCT02448914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077428|NCT02448914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56077429|NCT02448914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56077433|NCT02448914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077434|NCT03496662|Gemcitabine|gemcitabine|mesh-list
56077436|NCT03496662|Nivolumab|nivolumab|mesh-list
56077437|NCT03496662|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56077438|NCT03496662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077439|NCT03496662|Tubulin Modulators|tubulin modulators|mesh-ancestor
56077440|NCT03496662|Antimitotic Agents|antimitotic agents|mesh-ancestor
56077441|NCT03496662|Mitosis Modulators|mitosis modulators|mesh-ancestor
56077442|NCT03496662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077443|NCT03496662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56077444|NCT03496662|Antimetabolites|antimetabolites|mesh-ancestor
56077445|NCT03496662|Antiviral Agents|antiviral agents|mesh-ancestor
56077446|NCT03496662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077447|NCT03496662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077448|NCT03496662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56077449|NCT03496662|Immunologic Factors|immunologic factors|mesh-ancestor
56077450|NCT03496662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077451|NCT03496662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077452|NCT03496662|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56077453|NCT05002309|Antidepressive Agents|antidepressive agents|mesh-list
56077454|NCT05002309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56077455|NCT05720065|Botulinum Toxins|botulinum toxins|mesh-list
56077456|NCT05720065|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56077457|NCT05720065|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56077458|NCT05720065|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56077459|NCT05720065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56077461|NCT05720065|Cholinergic Agents|cholinergic agents|mesh-ancestor
56077481|NCT01638546|Temozolomide|temozolomide|mesh-list
56077482|NCT01638546|Veliparib|veliparib|mesh-list
56077483|NCT01638546|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56077484|NCT01638546|Alkylating Agents|alkylating agents|mesh-ancestor
56077485|NCT01638546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077486|NCT01638546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077487|NCT01638546|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56077488|NCT01638546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077489|NCT04948489|Norethindrone|norethindrone|mesh-list
56077490|NCT04948489|Norethindrone Acetate|norethindrone acetate|mesh-list
56077491|NCT04948489|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56077492|NCT04948489|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56077493|NCT04948489|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56077494|NCT04948489|Contraceptive Agents|contraceptive agents|mesh-ancestor
56077495|NCT04948489|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56077496|NCT04948489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077497|NCT04948489|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56077498|NCT04948489|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56077499|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
56077500|NCT01593254|Dasatinib|dasatinib|mesh-list
56077501|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077502|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56077503|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077504|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077505|NCT05723341|Morphine|morphine|mesh-list
56077506|NCT05723341|Bupivacaine|bupivacaine|mesh-list
56077507|NCT05723341|Anesthetics, Local|anesthetics, local|mesh-ancestor
56077508|NCT05723341|Anesthetics|anesthetics|mesh-ancestor
56077509|NCT05723341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077510|NCT05723341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077511|NCT05723341|Sensory System Agents|sensory system agents|mesh-ancestor
56077512|NCT05723341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077514|NCT05723341|Narcotics|narcotics|mesh-ancestor
56077520|NCT05718583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077521|NCT05718583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077523|NCT00363350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077524|NCT00363350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077526|NCT00363350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077527|NCT00363350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077528|NCT05717335|Thrombin|thrombin|mesh-list
56077529|NCT05717335|Hemostatics|hemostatics|mesh-ancestor
56077530|NCT05717335|Coagulants|coagulants|mesh-ancestor
56077531|NCT05717257|Dapagliflozin|dapagliflozin|mesh-list
56077532|NCT05717257|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56077533|NCT05717257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077534|NCT05717257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56077535|NCT05717257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077536|NCT04341818|Vitamin D|vitamin d|mesh-list
56077537|NCT04341818|Ergocalciferols|ergocalciferols|mesh-list
56077538|NCT04341818|Cholecalciferol|cholecalciferol|mesh-list
56077539|NCT04341818|Vitamins|vitamins|mesh-list
56077540|NCT04341818|Micronutrients|micronutrients|mesh-ancestor
56077541|NCT04341818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077542|NCT04341818|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56077543|NCT04341818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56077544|NCT00362804|Tetrabenazine|tetrabenazine|mesh-list
56077572|NCT02959255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077573|NCT02959255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077574|NCT05716945|Fluorometholone|fluorometholone|mesh-list
56077575|NCT05716945|Dexamethasone|dexamethasone|mesh-list
56077576|NCT05716945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077577|NCT05716945|Antiemetics|antiemetics|mesh-ancestor
56077578|NCT05716945|Autonomic Agents|autonomic agents|mesh-ancestor
56077579|NCT05716945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077580|NCT05716945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077581|NCT05716945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56077582|NCT05716945|Glucocorticoids|glucocorticoids|mesh-ancestor
56077583|NCT05716945|Hormones|hormones|mesh-ancestor
56077584|NCT05716945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56077585|NCT05716945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56077586|NCT05716945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077587|NCT05716945|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56077588|NCT03012620|Pembrolizumab|pembrolizumab|mesh-list
56077589|NCT03012620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077590|NCT03012620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077592|NCT05716867|Salivary Cystatins|salivary cystatins|mesh-list
56077593|NCT05716867|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56077594|NCT05716867|Protease Inhibitors|protease inhibitors|mesh-ancestor
56077595|NCT05716867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077596|NCT05716867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077597|NCT04341584|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56077598|NCT04341584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077599|NCT01345136|Everolimus|everolimus|mesh-list
56077600|NCT01345136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077601|NCT01345136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56077604|NCT04341428|Lansoprazole|lansoprazole|mesh-list
56077617|NCT02453360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077619|NCT03140670|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56077621|NCT03140670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077622|NCT03140670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077623|NCT02453672|Bevacizumab|bevacizumab|mesh-list
56077624|NCT02453672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077625|NCT02453672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077626|NCT02453672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56077627|NCT02453672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56077628|NCT02453672|Growth Substances|growth substances|mesh-ancestor
56077629|NCT02453672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077630|NCT02453672|Growth Inhibitors|growth inhibitors|mesh-ancestor
56077631|NCT03119064|Irinotecan|irinotecan|mesh-list
56077632|NCT03119064|Temozolomide|temozolomide|mesh-list
56077633|NCT03119064|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56077634|NCT03119064|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56077635|NCT03119064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077636|NCT03119064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077637|NCT03119064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077638|NCT03119064|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56077639|NCT03119064|Alkylating Agents|alkylating agents|mesh-ancestor
56077640|NCT02453750|Bronchodilator Agents|bronchodilator agents|mesh-list
56077641|NCT02453750|Autonomic Agents|autonomic agents|mesh-ancestor
56077642|NCT02453750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077643|NCT02453750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077645|NCT02453750|Respiratory System Agents|respiratory system agents|mesh-ancestor
56077646|NCT03831295|Antibodies|antibodies|mesh-list
56077647|NCT03831295|Immunologic Factors|immunologic factors|mesh-ancestor
56077659|NCT05215158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077660|NCT05215158|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56077661|NCT05215158|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56077662|NCT05215158|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56077663|NCT05215158|Adrenergic Agents|adrenergic agents|mesh-ancestor
56077664|NCT05215158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077665|NCT05215158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077667|NCT02454296|Anesthetics, Local|anesthetics, local|mesh-ancestor
56077668|NCT02454296|Anesthetics|anesthetics|mesh-ancestor
56077669|NCT02454296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077670|NCT02454296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077671|NCT02454296|Sensory System Agents|sensory system agents|mesh-ancestor
56077672|NCT02454296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077673|NCT02454296|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56077674|NCT02454296|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56077675|NCT02454296|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56077676|NCT02454296|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56077677|NCT02454296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077678|NCT03836833|Lamivudine|lamivudine|mesh-list
56077679|NCT03836833|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56077680|NCT03836833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56077681|NCT03836833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077682|NCT03836833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077683|NCT03836833|Antiviral Agents|antiviral agents|mesh-ancestor
56077684|NCT03836833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077685|NCT03836833|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56077686|NCT03836833|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56077687|NCT03101748|Paclitaxel|paclitaxel|mesh-list
56077688|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
56077689|NCT03101748|Doxorubicin|doxorubicin|mesh-list
56077690|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56077698|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
56077699|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56077700|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56077701|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077702|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
56077703|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
56077704|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
56077705|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077706|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56077707|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
56077708|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077709|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077710|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56077711|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
56077712|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56077713|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56077714|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56077715|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56077716|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077718|NCT05710783|Immunologic Factors|immunologic factors|mesh-ancestor
56077719|NCT05710783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077721|NCT05716009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077722|NCT05716009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077723|NCT05710471|Aflibercept|aflibercept|mesh-list
56077724|NCT05710471|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56077730|NCT00358969|Guanfacine|guanfacine|mesh-list
56077744|NCT02896712|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56077745|NCT02896712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077746|NCT05346601|Chiauranib|chiauranib|mesh-list
56077747|NCT05346601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077748|NCT05346601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56077749|NCT05346601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078040|NCT05630833|Nitrofurantoin|nitrofurantoin|mesh-list
56077750|NCT05346601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077751|NCT05325073|Epoetin Alfa|epoetin alfa|mesh-list
56077752|NCT05325073|Hematinics|hematinics|mesh-ancestor
56077753|NCT05525455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56077754|NCT05525455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077755|NCT05525455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077756|NCT04344379|Azithromycin|azithromycin|mesh-list
56077757|NCT04344379|Hydroxychloroquine|hydroxychloroquine|mesh-list
56077758|NCT04344379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56077759|NCT04344379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077760|NCT04344379|Antimalarials|antimalarials|mesh-ancestor
56077761|NCT04344379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56077762|NCT04344379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56077763|NCT04344379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003775|NCT00000730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077764|NCT04344379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077765|NCT04344379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077766|NCT00359125|Mifepristone|mifepristone|mesh-list
56077767|NCT00359125|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56077768|NCT00359125|Abortifacient Agents|abortifacient agents|mesh-ancestor
56077769|NCT00359125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56077770|NCT00359125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077771|NCT00359125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56077772|NCT00359125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56077773|NCT00359125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56077774|NCT00359125|Contraceptive Agents|contraceptive agents|mesh-ancestor
56077775|NCT00359125|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56077776|NCT00359125|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56077777|NCT00359125|Hormone Antagonists|hormone antagonists|mesh-ancestor
56077778|NCT00359125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56077780|NCT00359125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56077781|NCT00359125|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56077782|NCT03042468|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56077783|NCT03042468|177Lu-PSMA-617|177lu-psma-617|mesh-list
56077784|NCT03042468|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56077785|NCT03042468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077786|NCT04450836|Trifluridine|trifluridine|mesh-list
56077787|NCT04450836|Antimetabolites|antimetabolites|mesh-ancestor
56077788|NCT04450836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077789|NCT04450836|Antiviral Agents|antiviral agents|mesh-ancestor
56077790|NCT04450836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077791|NCT05511025|Acetaminophen|acetaminophen|mesh-list
56077792|NCT05511025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56077793|NCT05511025|Analgesics|analgesics|mesh-ancestor
56077794|NCT05511025|Sensory System Agents|sensory system agents|mesh-ancestor
56077795|NCT05511025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077796|NCT05511025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077797|NCT05511025|Antipyretics|antipyretics|mesh-ancestor
56077798|NCT05679193|Propranolol|propranolol|mesh-list
56077799|NCT05679193|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56077800|NCT05679193|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56077801|NCT05679193|Adrenergic Agents|adrenergic agents|mesh-ancestor
56077802|NCT05679193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077803|NCT05679193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077804|NCT05679193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077805|NCT05679193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55805018|NCT01662895|Deferoxamine|deferoxamine|mesh-list
56077806|NCT05679193|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56077807|NCT05679193|Vasodilator Agents|vasodilator agents|mesh-ancestor
56077808|NCT04795752|Cyclosporine|cyclosporine|mesh-list
56077809|NCT04795752|Cyclosporins|cyclosporins|mesh-list
56077810|NCT04795752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077812|NCT04795752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56077821|NCT02977741|Antiemetics|antiemetics|mesh-ancestor
56077822|NCT02977741|Autonomic Agents|autonomic agents|mesh-ancestor
56077823|NCT02977741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077824|NCT02977741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077825|NCT02977741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56077826|NCT02977741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56077827|NCT02977741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56077828|NCT02977741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56077829|NCT02977741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56077830|NCT02977741|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56077831|NCT02977741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56077832|NCT02977741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56077833|NCT02977741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077834|NCT02977741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077835|NCT02977741|Serotonin Agents|serotonin agents|mesh-ancestor
56077836|NCT04334070|Clofazimine|clofazimine|mesh-list
56077837|NCT04334070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077838|NCT04334070|Leprostatic Agents|leprostatic agents|mesh-ancestor
56077839|NCT04334070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56077840|NCT04334070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077841|NCT05292001|Dextrans|dextrans|mesh-list
56077842|NCT05292001|Iron-Dextran Complex|iron-dextran complex|mesh-list
56077843|NCT05292001|Anticoagulants|anticoagulants|mesh-ancestor
56077844|NCT05292001|Plasma Substitutes|plasma substitutes|mesh-ancestor
56077845|NCT05292001|Blood Substitutes|blood substitutes|mesh-ancestor
56077846|NCT05292001|Hematinics|hematinics|mesh-ancestor
56077847|NCT01634178|Apremilast|apremilast|mesh-list
56077848|NCT01634178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56077849|NCT01634178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56077850|NCT01634178|Analgesics|analgesics|mesh-ancestor
56077851|NCT01634178|Sensory System Agents|sensory system agents|mesh-ancestor
56077852|NCT01634178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077853|NCT01634178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077854|NCT01634178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077855|NCT01634178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077861|NCT00359359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077863|NCT04782804|Antibodies|antibodies|mesh-list
56077864|NCT04782804|Immunologic Factors|immunologic factors|mesh-ancestor
56077865|NCT04782804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077866|NCT04782804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56077867|NCT04782804|Antimetabolites|antimetabolites|mesh-ancestor
56077868|NCT04782804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077869|NCT04782804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077870|NCT04227288|Betamethasone|betamethasone|mesh-list
56077871|NCT04227288|Betamethasone Valerate|betamethasone valerate|mesh-list
56077872|NCT04227288|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56077873|NCT04227288|Betamethasone benzoate|betamethasone benzoate|mesh-list
56077874|NCT04227288|Calcipotriene|calcipotriene|mesh-list
56077875|NCT04227288|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56077876|NCT04227288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077877|NCT04227288|Glucocorticoids|glucocorticoids|mesh-ancestor
56077878|NCT04227288|Hormones|hormones|mesh-ancestor
56077879|NCT04227288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56077880|NCT04227288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077881|NCT04227288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56077882|NCT04227288|Respiratory System Agents|respiratory system agents|mesh-ancestor
56077883|NCT04227288|Dermatologic Agents|dermatologic agents|mesh-ancestor
56077884|NCT02724228|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
56077885|NCT02724228|Natriuretic Agents|natriuretic agents|mesh-ancestor
56077886|NCT02724228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077894|NCT05668429|Ibrexafungerp|ibrexafungerp|mesh-list
56077895|NCT05668429|Antifungal Agents|antifungal agents|mesh-ancestor
56077896|NCT05668429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56077897|NCT02698254|Bevacizumab|bevacizumab|mesh-list
56077898|NCT02698254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56077899|NCT02698254|Endothelial Growth Factors|endothelial growth factors|mesh-list
56077900|NCT02698254|Antibodies|antibodies|mesh-list
56077901|NCT02698254|Immunoglobulins|immunoglobulins|mesh-list
56077902|NCT02698254|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56077903|NCT02698254|Immunoglobulin G|immunoglobulin g|mesh-list
56077904|NCT02698254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077905|NCT02698254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56077906|NCT02698254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56077907|NCT02698254|Growth Substances|growth substances|mesh-ancestor
56077908|NCT02698254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077909|NCT02698254|Growth Inhibitors|growth inhibitors|mesh-ancestor
56077910|NCT02698254|Immunologic Factors|immunologic factors|mesh-ancestor
56077911|NCT02978443|Nivolumab|nivolumab|mesh-list
56077912|NCT02978443|Ipilimumab|ipilimumab|mesh-list
56077913|NCT02978443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077914|NCT02978443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077915|NCT02978443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56077916|NCT02978443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077917|NCT02465450|Lenabasum|lenabasum|mesh-list
56077918|NCT02465450|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56077919|NCT02465450|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56077920|NCT02465450|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077921|NCT02465450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077922|NCT02465450|Hormones|hormones|mesh-ancestor
56077923|NCT02465450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56077924|NCT02465450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077925|NCT00608972|Bevacizumab|bevacizumab|mesh-list
56077926|NCT00608972|Carboplatin|carboplatin|mesh-list
56077927|NCT00608972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56077928|NCT00608972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56077929|NCT00608972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56077930|NCT00608972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56077944|NCT02729714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077946|NCT04802382|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56077947|NCT04802382|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56077948|NCT04802382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077949|NCT04802382|Hemostatics|hemostatics|mesh-ancestor
56077950|NCT04802382|Coagulants|coagulants|mesh-ancestor
56077951|NCT05648916|Celecoxib|celecoxib|mesh-list
56077952|NCT05648916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56077953|NCT05648916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56077954|NCT05648916|Analgesics|analgesics|mesh-ancestor
56077955|NCT05648916|Sensory System Agents|sensory system agents|mesh-ancestor
56144726|NCT00810576|Vorinostat|vorinostat|mesh-list
56077956|NCT05648916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56077957|NCT05648916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077958|NCT05648916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56077959|NCT05648916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56077960|NCT05648916|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56077962|NCT05648916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56077963|NCT05648916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077964|NCT05458609|Naltrexone|naltrexone|mesh-list
56077965|NCT05458609|Lemborexant|lemborexant|mesh-list
56077966|NCT05458609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56077967|NCT05458609|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56077968|NCT05458609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56077969|NCT05458609|Sensory System Agents|sensory system agents|mesh-ancestor
56077978|NCT05648058|Promethazine|promethazine|mesh-list
56077991|NCT05648058|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56077992|NCT05648058|Histamine Antagonists|histamine antagonists|mesh-ancestor
56077993|NCT05648058|Histamine Agents|histamine agents|mesh-ancestor
56077994|NCT05648058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56077995|NCT05648058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56077996|NCT05648058|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56077997|NCT05648058|Antipruritics|antipruritics|mesh-ancestor
56077998|NCT05648058|Dermatologic Agents|dermatologic agents|mesh-ancestor
56077999|NCT05648058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56078000|NCT05648058|Analgesics|analgesics|mesh-ancestor
56078002|NCT05649085|Chromium|chromium|mesh-list
56078003|NCT05649085|Trace Elements|trace elements|mesh-ancestor
56078004|NCT05649085|Micronutrients|micronutrients|mesh-ancestor
56078005|NCT05649085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078006|NCT05639712|Fentanyl|fentanyl|mesh-list
56078007|NCT05639712|Morphine|morphine|mesh-list
56078008|NCT05639712|Oxycodone|oxycodone|mesh-list
56078009|NCT05639712|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56078010|NCT05639712|Narcotics|narcotics|mesh-ancestor
56078011|NCT05639712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56078012|NCT05639712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078013|NCT05639712|Analgesics|analgesics|mesh-ancestor
56078014|NCT05639712|Sensory System Agents|sensory system agents|mesh-ancestor
56078015|NCT05639712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078016|NCT05639712|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56078017|NCT05639712|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56078018|NCT05639712|Anesthetics, General|anesthetics, general|mesh-ancestor
56078019|NCT05639712|Anesthetics|anesthetics|mesh-ancestor
56078020|NCT02959411|Tolvaptan|tolvaptan|mesh-list
56078021|NCT02959411|Diuretics|diuretics|mesh-list
56078022|NCT02959411|Natriuretic Agents|natriuretic agents|mesh-ancestor
56078023|NCT02959411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078024|NCT02959411|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56078026|NCT05426161|Botulinum Toxins|botulinum toxins|mesh-list
56078034|NCT05426161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078035|NCT05426161|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56078036|NCT05426161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078037|NCT05170399|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56078038|NCT05170399|Immunologic Factors|immunologic factors|mesh-ancestor
56078039|NCT05170399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078041|NCT05630833|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56078042|NCT05630833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078043|NCT05630833|Renal Agents|renal agents|mesh-ancestor
56078044|NCT05630833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56078045|NCT00359671|Docetaxel|docetaxel|mesh-list
56078046|NCT00359671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078047|NCT00359671|Tubulin Modulators|tubulin modulators|mesh-ancestor
56078048|NCT00359671|Antimitotic Agents|antimitotic agents|mesh-ancestor
56078049|NCT00359671|Mitosis Modulators|mitosis modulators|mesh-ancestor
56078050|NCT00359671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078051|NCT05409391|Insulin|insulin|mesh-list
56078052|NCT05409391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56078053|NCT05409391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078054|NCT05141149|Gemcitabine|gemcitabine|mesh-list
56078055|NCT05141149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56078056|NCT05141149|Antimetabolites|antimetabolites|mesh-ancestor
56078057|NCT05141149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078058|NCT05141149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078059|NCT05141149|Antiviral Agents|antiviral agents|mesh-ancestor
56078060|NCT05141149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078061|NCT05141149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078062|NCT05141149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078063|NCT05141149|Immunologic Factors|immunologic factors|mesh-ancestor
56078064|NCT05141149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078065|NCT02977897|Octreotide|octreotide|mesh-list
56078066|NCT02977897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56078067|NCT02977897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56078075|NCT05114941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078078|NCT00359905|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56078079|NCT00359905|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56078080|NCT00359905|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56078081|NCT00359905|Adrenergic Agents|adrenergic agents|mesh-ancestor
56078082|NCT00359905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078083|NCT00359905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078084|NCT00359905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078085|NCT00359905|Urological Agents|urological agents|mesh-ancestor
56078086|NCT05086939|Hyaluronic Acid|hyaluronic acid|mesh-list
56078087|NCT05086939|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56078088|NCT05086939|Immunologic Factors|immunologic factors|mesh-ancestor
56078089|NCT05086939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078090|NCT05086939|Viscosupplements|viscosupplements|mesh-ancestor
56078091|NCT05086939|Protective Agents|protective agents|mesh-ancestor
56078093|NCT00358813|Antiemetics|antiemetics|mesh-ancestor
56078094|NCT00358813|Autonomic Agents|autonomic agents|mesh-ancestor
56078095|NCT00358813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078096|NCT00358813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078097|NCT00358813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56078098|NCT00358813|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56078099|NCT00358813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078100|NCT00358813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078101|NCT05064085|Capecitabine|capecitabine|mesh-list
56078103|NCT05064085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56078104|NCT05064085|Antimetabolites|antimetabolites|mesh-ancestor
55805321|NCT05475613|Lenvatinib|lenvatinib|mesh-list
56078120|NCT02976805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56078121|NCT02976805|Laxatives|laxatives|mesh-ancestor
56078122|NCT04835623|Cyclosporine|cyclosporine|mesh-list
56078123|NCT04835623|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56078124|NCT04835623|Cyclosporins|cyclosporins|mesh-list
56078125|NCT04835623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078126|NCT04835623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078127|NCT04835623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078128|NCT04835623|Immunologic Factors|immunologic factors|mesh-ancestor
56078129|NCT04835623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078130|NCT04835623|Antifungal Agents|antifungal agents|mesh-ancestor
56078131|NCT04835623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078132|NCT04835623|Dermatologic Agents|dermatologic agents|mesh-ancestor
56078133|NCT04835623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078134|NCT04835623|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56078135|NCT04835623|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56078136|NCT04500613|Dexamethasone|dexamethasone|mesh-list
56078137|NCT04500613|Dexamethasone acetate|dexamethasone acetate|mesh-list
56078138|NCT04500613|Bupivacaine|bupivacaine|mesh-list
56078139|NCT04500613|BB 1101|bb 1101|mesh-list
56078140|NCT04500613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56078141|NCT04500613|Antiemetics|antiemetics|mesh-ancestor
56078142|NCT04500613|Autonomic Agents|autonomic agents|mesh-ancestor
56078143|NCT04500613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078144|NCT04500613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078145|NCT04500613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56078146|NCT04500613|Glucocorticoids|glucocorticoids|mesh-ancestor
56078147|NCT04500613|Hormones|hormones|mesh-ancestor
56078148|NCT04500613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078149|NCT04500613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56078150|NCT04500613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078151|NCT04500613|Protease Inhibitors|protease inhibitors|mesh-ancestor
56078152|NCT04500613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078155|NCT04500613|Anesthetics|anesthetics|mesh-ancestor
56078163|NCT04833907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078164|NCT04833907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078165|NCT04833907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56078166|NCT04833907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078167|NCT04833907|Anticonvulsants|anticonvulsants|mesh-ancestor
56078168|NCT04833907|Nootropic Agents|nootropic agents|mesh-ancestor
56078169|NCT02976259|Dolutegravir|dolutegravir|mesh-list
56078170|NCT02976259|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56078171|NCT02976259|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56078172|NCT02976259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078173|NCT02976259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078174|NCT02976259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56078175|NCT02976259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56078176|NCT02976259|Antiviral Agents|antiviral agents|mesh-ancestor
56078177|NCT02976259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078178|NCT00360295|Azithromycin|azithromycin|mesh-list
56078179|NCT00360295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56078180|NCT00360295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078181|NCT04485013|Pembrolizumab|pembrolizumab|mesh-list
56078182|NCT04485013|Cetuximab|cetuximab|mesh-list
56078183|NCT04485013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56078184|NCT04485013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078186|NCT02976727|Lidocaine|lidocaine|mesh-list
56078187|NCT02976727|Prilocaine|prilocaine|mesh-list
56078188|NCT02976727|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56078189|NCT02976727|Calcipotriene|calcipotriene|mesh-list
56078190|NCT02976727|Vitamins|vitamins|mesh-ancestor
56078191|NCT02976727|Micronutrients|micronutrients|mesh-ancestor
56078192|NCT02976727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078193|NCT02976727|Anesthetics, Local|anesthetics, local|mesh-ancestor
56078194|NCT02976727|Anesthetics|anesthetics|mesh-ancestor
56078195|NCT02976727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56078196|NCT02976727|Sensory System Agents|sensory system agents|mesh-ancestor
56078197|NCT02976727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078205|NCT02976727|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
56078206|NCT02977117|Dialysis Solutions|dialysis solutions|mesh-list
56078207|NCT02977117|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56078208|NCT00360607|Metronidazole|metronidazole|mesh-list
56078209|NCT00360607|Amikacin|amikacin|mesh-list
56078210|NCT00360607|Ceftazidime|ceftazidime|mesh-list
56078211|NCT00360607|Sulbactam|sulbactam|mesh-list
56078212|NCT00360607|Cefoperazone|cefoperazone|mesh-list
56078213|NCT00360607|Sulperazone|sulperazone|mesh-list
56078214|NCT00360607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078215|NCT00360607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56078216|NCT00360607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56078217|NCT00360607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56078218|NCT00360607|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56078219|NCT00360607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078220|NCT00360607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078221|NCT00360607|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56078222|NCT00360607|Renal Agents|renal agents|mesh-ancestor
56078223|NCT00360763|Candesartan|candesartan|mesh-list
56078224|NCT00360763|Candesartan cilexetil|candesartan cilexetil|mesh-list
56078225|NCT00360763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56078226|NCT00360763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56078227|NCT00360763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56078228|NCT00360763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078229|NCT04032301|Ketamine|ketamine|mesh-list
56078230|NCT04032301|Analgesics|analgesics|mesh-ancestor
56078231|NCT04032301|Sensory System Agents|sensory system agents|mesh-ancestor
56078232|NCT04032301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078233|NCT04032301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078234|NCT04032301|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56078236|NCT04032301|Anesthetics, General|anesthetics, general|mesh-ancestor
56078237|NCT04032301|Anesthetics|anesthetics|mesh-ancestor
56078238|NCT04032301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56078246|NCT04010305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078247|NCT04010305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56078248|NCT04010305|Analgesics|analgesics|mesh-ancestor
56078249|NCT04010305|Sensory System Agents|sensory system agents|mesh-ancestor
56078250|NCT04010305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078251|NCT04010305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56078252|NCT04010305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56078253|NCT04010305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56078254|NCT04010305|Adrenergic Agents|adrenergic agents|mesh-ancestor
56078255|NCT04010305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078256|NCT04010305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078258|NCT00361933|Antiviral Agents|antiviral agents|mesh-ancestor
56078259|NCT00361933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078260|NCT04786093|Durvalumab|durvalumab|mesh-list
56078261|NCT04786093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56078262|NCT04786093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078263|NCT02976571|Bupivacaine|bupivacaine|mesh-list
56078264|NCT02976571|Anesthetics, Local|anesthetics, local|mesh-ancestor
56078265|NCT02976571|Anesthetics|anesthetics|mesh-ancestor
56078266|NCT02976571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56078270|NCT04731025|Vancomycin|vancomycin|mesh-list
56078302|NCT04676035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56078303|NCT04676035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56078304|NCT04676035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56078305|NCT04676035|Anesthetics, General|anesthetics, general|mesh-ancestor
56078306|NCT04676035|Anesthetics|anesthetics|mesh-ancestor
56078307|NCT04676035|GABA Modulators|gaba modulators|mesh-ancestor
56078308|NCT04676035|GABA Agents|gaba agents|mesh-ancestor
56078309|NCT04676035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078310|NCT04676035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078311|NCT04676035|Anticoagulants|anticoagulants|mesh-ancestor
56078312|NCT04676035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56078313|NCT04676035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56078314|NCT04676035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56078315|NCT04676035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078316|NCT04676035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56078317|NCT04676035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56078318|NCT04676035|Hemostatics|hemostatics|mesh-ancestor
56078319|NCT04676035|Coagulants|coagulants|mesh-ancestor
56078320|NCT04676035|Vitamins|vitamins|mesh-ancestor
56078321|NCT04676035|Micronutrients|micronutrients|mesh-ancestor
56078322|NCT03926299|Clobetasol|clobetasol|mesh-list
56078323|NCT03926299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56078324|NCT03926299|Glucocorticoids|glucocorticoids|mesh-ancestor
55741184|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078326|NCT03926299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078328|NCT04359199|Cisplatin|cisplatin|mesh-list
56078351|NCT00361075|Progesterone|progesterone|mesh-list
56078352|NCT00361075|Hormones|hormones|mesh-ancestor
56078353|NCT00361075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078354|NCT00361075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078355|NCT00361075|Progestins|progestins|mesh-ancestor
56078356|NCT03844633|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56078357|NCT03844633|Medroxyprogesterone|medroxyprogesterone|mesh-list
56078358|NCT03844633|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56078359|NCT03844633|Contraceptive Agents|contraceptive agents|mesh-ancestor
56078360|NCT03844633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56078361|NCT03844633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078362|NCT03844633|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56078363|NCT03844633|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56078364|NCT03844633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56078365|NCT03844633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078366|NCT03844633|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56078367|NCT03844633|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56078368|NCT03844633|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56078369|NCT00362089|Dronabinol|dronabinol|mesh-list
56078370|NCT00362089|Hallucinogens|hallucinogens|mesh-ancestor
56078371|NCT00362089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078372|NCT00362089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56078373|NCT00362089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56078374|NCT00362089|Analgesics|analgesics|mesh-ancestor
56078375|NCT00362089|Sensory System Agents|sensory system agents|mesh-ancestor
56078376|NCT00362089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078377|NCT00362089|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56078378|NCT00362089|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56078379|NCT00362089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078380|NCT00362089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078381|NCT00362089|Hormones|hormones|mesh-ancestor
56078382|NCT00362089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078383|NCT04666987|Liraglutide|liraglutide|mesh-list
56078384|NCT04666987|Xultophy|xultophy|mesh-list
56078385|NCT04666987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56078386|NCT04666987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078387|NCT04666987|Incretins|incretins|mesh-ancestor
56078388|NCT04666987|Hormones|hormones|mesh-ancestor
56078389|NCT04666987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078390|NCT04318717|Pembrolizumab|pembrolizumab|mesh-list
56078391|NCT04318717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56078392|NCT04318717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078393|NCT03822637|Acetylcysteine|acetylcysteine|mesh-list
56078394|NCT03822637|Albuterol|albuterol|mesh-list
56078395|NCT03822637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56078396|NCT03822637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56078397|NCT03822637|Autonomic Agents|autonomic agents|mesh-ancestor
55741186|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
56078398|NCT03822637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078399|NCT03822637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078400|NCT03822637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56078401|NCT03822637|Respiratory System Agents|respiratory system agents|mesh-ancestor
56078402|NCT03822637|Tocolytic Agents|tocolytic agents|mesh-ancestor
56078403|NCT03822637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56078404|NCT03822637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56078405|NCT03822637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56078406|NCT03822637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56078407|NCT03822637|Adrenergic Agents|adrenergic agents|mesh-ancestor
56078408|NCT03822637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078409|NCT03822637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078410|NCT03822637|Antiviral Agents|antiviral agents|mesh-ancestor
56078411|NCT03822637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078413|NCT03822637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56078414|NCT03822637|Antioxidants|antioxidants|mesh-ancestor
56078415|NCT03822637|Protective Agents|protective agents|mesh-ancestor
56078416|NCT03822637|Antidotes|antidotes|mesh-ancestor
56078417|NCT05444101|Nicotine|nicotine|mesh-list
56078418|NCT05444101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56078419|NCT05444101|Autonomic Agents|autonomic agents|mesh-ancestor
56078420|NCT05444101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078426|NCT05444101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078427|NCT04342819|Empagliflozin|empagliflozin|mesh-list
56078428|NCT04342819|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56078429|NCT04342819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078430|NCT04342819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56078431|NCT04342819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078432|NCT02412306|Blinatumomab|blinatumomab|mesh-list
56078433|NCT02412306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078434|NCT03762018|Bevacizumab|bevacizumab|mesh-list
56078435|NCT03762018|Carboplatin|carboplatin|mesh-list
56078436|NCT03762018|Pemetrexed|pemetrexed|mesh-list
56078437|NCT03762018|Atezolizumab|atezolizumab|mesh-list
56078438|NCT03762018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56078439|NCT03762018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078440|NCT03762018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56078441|NCT03762018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56078442|NCT03762018|Growth Substances|growth substances|mesh-ancestor
56078443|NCT03762018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078444|NCT03762018|Growth Inhibitors|growth inhibitors|mesh-ancestor
56078445|NCT03762018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078446|NCT03762018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078447|NCT03762018|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56078448|NCT03762018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56078449|NCT05616468|Cyclophosphamide|cyclophosphamide|mesh-list
56078451|NCT05616468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078452|NCT05616468|Immunologic Factors|immunologic factors|mesh-ancestor
56078453|NCT05616468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078454|NCT05616468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078455|NCT05616468|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078456|NCT05616468|Alkylating Agents|alkylating agents|mesh-ancestor
56078457|NCT05616468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078467|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078469|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078470|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078471|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56078472|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56078473|NCT05197842|Hormones|hormones|mesh-ancestor
56078474|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078475|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56078481|NCT03768427|Atorvastatin|atorvastatin|mesh-list
56078482|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56078483|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56078484|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
56078485|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078486|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56078487|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56078488|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078489|NCT03764293|Sorafenib|sorafenib|mesh-list
56078490|NCT03764293|Apatinib|apatinib|mesh-list
56078491|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078492|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56078493|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078494|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078495|NCT03659136|Everolimus|everolimus|mesh-list
56078496|NCT03659136|Exemestane|exemestane|mesh-list
56078497|NCT03659136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078498|NCT03659136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078499|NCT03659136|Immunologic Factors|immunologic factors|mesh-ancestor
56078500|NCT03659136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078508|NCT03654768|Imatinib Mesylate|imatinib mesylate|mesh-list
56078510|NCT03654768|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
56078511|NCT03654768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078512|NCT03654768|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56078513|NCT03654768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078514|NCT03654768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078515|NCT01352221|Ferric maltol|ferric maltol|mesh-list
56078516|NCT01352221|Hematinics|hematinics|mesh-ancestor
56078517|NCT03583710|Cisplatin|cisplatin|mesh-list
56078518|NCT03583710|Etoposide|etoposide|mesh-list
56078519|NCT03583710|Etoposide phosphate|etoposide phosphate|mesh-list
56078520|NCT03583710|Podophyllotoxin|podophyllotoxin|mesh-list
56078521|NCT03583710|Mitotane|mitotane|mesh-list
56078522|NCT03583710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078523|NCT03583710|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56078524|NCT03583710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56078525|NCT03583710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56078526|NCT03583710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078527|NCT03583710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078528|NCT03583710|Keratolytic Agents|keratolytic agents|mesh-ancestor
56078529|NCT03583710|Dermatologic Agents|dermatologic agents|mesh-ancestor
56078530|NCT03583710|Tubulin Modulators|tubulin modulators|mesh-ancestor
56078531|NCT03583710|Antimitotic Agents|antimitotic agents|mesh-ancestor
56078532|NCT03583710|Mitosis Modulators|mitosis modulators|mesh-ancestor
56078533|NCT03583710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56078534|NCT04418154|Paclitaxel|paclitaxel|mesh-list
56078535|NCT04418154|Cyclophosphamide|cyclophosphamide|mesh-list
56078536|NCT04418154|Epirubicin|epirubicin|mesh-list
56078537|NCT04418154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56078538|NCT04418154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56078556|NCT05195034|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56078557|NCT05195034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56078558|NCT05195034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078559|NCT05195034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56078560|NCT05195034|Analgesics|analgesics|mesh-ancestor
56078561|NCT05195034|Sensory System Agents|sensory system agents|mesh-ancestor
56078562|NCT05195034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078563|NCT05195034|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56078564|NCT05195034|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56078565|NCT05195034|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56078566|NCT05195034|Adrenergic Agents|adrenergic agents|mesh-ancestor
56078567|NCT05195034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078568|NCT05195034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078569|NCT05496894|Mitoxantrone|mitoxantrone|mesh-list
56078570|NCT05496894|Analgesics|analgesics|mesh-ancestor
56078571|NCT05496894|Sensory System Agents|sensory system agents|mesh-ancestor
56078572|NCT05496894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078573|NCT05496894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078574|NCT05496894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078575|NCT05496894|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56078576|NCT05496894|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56078577|NCT05496894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078578|NCT05496894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078579|NCT02065362|Cyclophosphamide|cyclophosphamide|mesh-list
56078580|NCT02065362|Fludarabine|fludarabine|mesh-list
56078581|NCT02065362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078582|NCT02065362|Immunologic Factors|immunologic factors|mesh-ancestor
56078601|NCT04789668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078602|NCT04448886|Pembrolizumab|pembrolizumab|mesh-list
56078603|NCT04448886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56078604|NCT04448886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078605|NCT02389218|Sotalol|sotalol|mesh-list
56078606|NCT02389218|Flecainide|flecainide|mesh-list
56078607|NCT02389218|Propafenone|propafenone|mesh-list
56078608|NCT02389218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56078609|NCT02389218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56078610|NCT02389218|Adrenergic Agents|adrenergic agents|mesh-ancestor
56078611|NCT02389218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56078612|NCT02389218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078613|NCT02389218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078614|NCT02389218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56078615|NCT02389218|Sympatholytics|sympatholytics|mesh-ancestor
56078616|NCT02389218|Autonomic Agents|autonomic agents|mesh-ancestor
56078617|NCT02389218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078618|NCT02389218|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56078619|NCT02389218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56078620|NCT02389218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56078621|NCT01953120|Abatacept|abatacept|mesh-list
56078622|NCT01953120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56078623|NCT01953120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078624|NCT01953120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078625|NCT01953120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078626|NCT01953120|Immunologic Factors|immunologic factors|mesh-ancestor
56078627|NCT01953120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078628|NCT01953120|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078629|NCT01634100|Empagliflozin|empagliflozin|mesh-list
56078630|NCT01634100|Rifampin|rifampin|mesh-list
56078631|NCT01634100|Probenecid|probenecid|mesh-list
56078632|NCT01634100|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56078634|NCT01634100|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56078641|NCT01634100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56078642|NCT01634100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078643|NCT01634100|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56078644|NCT01634100|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56078645|NCT01634100|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56078646|NCT01634100|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56078647|NCT01634100|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56078648|NCT01634100|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56078649|NCT01634100|Uricosuric Agents|uricosuric agents|mesh-ancestor
56078650|NCT01634100|Gout Suppressants|gout suppressants|mesh-ancestor
56078651|NCT01634100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078652|NCT01634100|Renal Agents|renal agents|mesh-ancestor
56078653|NCT03662659|Nivolumab|nivolumab|mesh-list
56078654|NCT03662659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56078655|NCT03662659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078656|NCT03662659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56078657|NCT03662659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078658|NCT03661645|Dexamethasone|dexamethasone|mesh-list
56078659|NCT03661645|Dexamethasone acetate|dexamethasone acetate|mesh-list
56078660|NCT03661645|Methylprednisolone|methylprednisolone|mesh-list
56078661|NCT03661645|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56078662|NCT03661645|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56078663|NCT03661645|BB 1101|bb 1101|mesh-list
56078664|NCT03661645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56078665|NCT03661645|Antiemetics|antiemetics|mesh-ancestor
56078666|NCT03661645|Autonomic Agents|autonomic agents|mesh-ancestor
56078667|NCT03661645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078668|NCT03661645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078686|NCT01633944|Sensory System Agents|sensory system agents|mesh-ancestor
56078687|NCT01633944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078688|NCT01633944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56078689|NCT04592419|Aflibercept|aflibercept|mesh-list
56078690|NCT04592419|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56078691|NCT04592419|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56078692|NCT04592419|Growth Substances|growth substances|mesh-ancestor
56078693|NCT04592419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078694|NCT04592419|Growth Inhibitors|growth inhibitors|mesh-ancestor
56078695|NCT04592419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078697|NCT00589316|Mycophenolic Acid|mycophenolic acid|mesh-list
56078698|NCT00589316|Cadexomer iodine|cadexomer iodine|mesh-list
56078699|NCT00589316|Cyclophosphamide|cyclophosphamide|mesh-list
56078700|NCT00589316|Fludarabine|fludarabine|mesh-list
56078701|NCT00589316|Fludarabine phosphate|fludarabine phosphate|mesh-list
56078702|NCT00589316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56078703|NCT00589316|Tacrolimus|tacrolimus|mesh-list
56078704|NCT00589316|Antibodies|antibodies|mesh-list
56078706|NCT00589316|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56078707|NCT00589316|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078708|NCT00589316|Immunologic Factors|immunologic factors|mesh-ancestor
56078709|NCT00589316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078710|NCT00589316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078711|NCT00589316|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078712|NCT00589316|Alkylating Agents|alkylating agents|mesh-ancestor
56078713|NCT00589316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078714|NCT00589316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078715|NCT00589316|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56078716|NCT00589316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56078731|NCT00544466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078732|NCT00544466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56078733|NCT00544466|Antimetabolites|antimetabolites|mesh-ancestor
56078734|NCT00544466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078735|NCT00544466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078736|NCT00544466|Immunologic Factors|immunologic factors|mesh-ancestor
56078737|NCT00544466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078738|NCT00544466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078739|NCT00544466|Alkylating Agents|alkylating agents|mesh-ancestor
56078740|NCT00544466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56078741|NCT00362245|Amikacin|amikacin|mesh-list
56078742|NCT00362245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56078743|NCT00362245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078744|NCT04786548|Celecoxib|celecoxib|mesh-list
56078745|NCT04786548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56078746|NCT04786548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56078747|NCT04786548|Analgesics|analgesics|mesh-ancestor
56078748|NCT04786548|Sensory System Agents|sensory system agents|mesh-ancestor
56078749|NCT04786548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078750|NCT04786548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078751|NCT04786548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56078752|NCT04786548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078753|NCT04786548|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56078754|NCT04786548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56078755|NCT04786548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078756|NCT04786548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078757|NCT00361543|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
56078758|NCT00361543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56078759|NCT00361543|Hormone Antagonists|hormone antagonists|mesh-ancestor
56078760|NCT00361543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078771|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56078772|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
56078773|NCT00565851|Antibodies|antibodies|mesh-list
56078774|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
56078775|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56078776|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
56078777|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56078778|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078779|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
56078780|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
56078781|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
56078782|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078783|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56078784|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56078785|NCT00565851|Growth Substances|growth substances|mesh-ancestor
56078786|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078787|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
56078788|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
56078789|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56078790|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
56078792|NCT00565851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078793|NCT00565851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078794|NCT00565851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078795|NCT00003417|Carmustine|carmustine|mesh-list
56078796|NCT00003417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078797|NCT00003417|Alkylating Agents|alkylating agents|mesh-ancestor
56078798|NCT00003417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078799|NCT00003417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078800|NCT04329429|Trastuzumab|trastuzumab|mesh-list
56078801|NCT04329429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56078802|NCT04329429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078803|NCT00003423|Cytarabine|cytarabine|mesh-list
56078804|NCT00003423|Dexamethasone|dexamethasone|mesh-list
56078808|NCT00003423|Etoposide|etoposide|mesh-list
56078813|NCT00003423|Thioguanine|thioguanine|mesh-list
56078814|NCT00003423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078815|NCT00003423|Immunologic Factors|immunologic factors|mesh-ancestor
56078816|NCT00003423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078817|NCT00003423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078818|NCT00003423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078819|NCT00003423|Alkylating Agents|alkylating agents|mesh-ancestor
56003776|NCT00000730|Antidotes|antidotes|mesh-ancestor
56078820|NCT00003423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078822|NCT00003423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56078823|NCT00003423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56078824|NCT00003423|Antiemetics|antiemetics|mesh-ancestor
56078825|NCT00003423|Autonomic Agents|autonomic agents|mesh-ancestor
56078826|NCT00003423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078827|NCT00003423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56078828|NCT00003423|Glucocorticoids|glucocorticoids|mesh-ancestor
56078829|NCT00003423|Hormones|hormones|mesh-ancestor
56078830|NCT00003423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56078831|NCT00003423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56078832|NCT00003423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56078833|NCT00003423|Abortifacient Agents|abortifacient agents|mesh-ancestor
56078834|NCT00003423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56078835|NCT00003423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56078836|NCT00003423|Antimetabolites|antimetabolites|mesh-ancestor
56078837|NCT00003423|Dermatologic Agents|dermatologic agents|mesh-ancestor
56078838|NCT00003423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078839|NCT00003423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56078840|NCT00003423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56078841|NCT00003423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56078842|NCT00003423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56078857|NCT00003273|Vincristine|vincristine|mesh-list
56078858|NCT00003273|Levoleucovorin|levoleucovorin|mesh-list
56078859|NCT00003273|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078860|NCT00003273|Immunologic Factors|immunologic factors|mesh-ancestor
56078861|NCT00003273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078862|NCT00003273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078863|NCT00003273|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078864|NCT00003273|Alkylating Agents|alkylating agents|mesh-ancestor
56144727|NCT00810576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078865|NCT00003273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078866|NCT00003273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078867|NCT00003273|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56078868|NCT00003273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56078870|NCT00003273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56078871|NCT00003273|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56078872|NCT00003273|Antimetabolites|antimetabolites|mesh-ancestor
56078873|NCT00003273|Dermatologic Agents|dermatologic agents|mesh-ancestor
56078874|NCT00003273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078875|NCT00003273|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56078876|NCT00003273|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56078877|NCT00003273|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56078878|NCT00003273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56078879|NCT00003273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56078880|NCT00003273|Antidotes|antidotes|mesh-ancestor
56078881|NCT00003273|Protective Agents|protective agents|mesh-ancestor
56078882|NCT00003273|Vitamin B Complex|vitamin b complex|mesh-ancestor
56078883|NCT00003273|Vitamins|vitamins|mesh-ancestor
56078884|NCT00003273|Micronutrients|micronutrients|mesh-ancestor
56078885|NCT00003273|Tubulin Modulators|tubulin modulators|mesh-ancestor
56078886|NCT00003273|Antimitotic Agents|antimitotic agents|mesh-ancestor
56078887|NCT00003273|Mitosis Modulators|mitosis modulators|mesh-ancestor
56078901|NCT00003279|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56078902|NCT00383487|Calcitriol|calcitriol|mesh-list
56078903|NCT00383487|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
56078904|NCT00383487|Naproxen|naproxen|mesh-list
56078905|NCT00383487|Naproxen-n-butyl nitrate|naproxen-n-butyl nitrate|mesh-list
56078906|NCT00383487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56078907|NCT00383487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56078908|NCT00383487|Analgesics|analgesics|mesh-ancestor
56078909|NCT00383487|Sensory System Agents|sensory system agents|mesh-ancestor
56078910|NCT00383487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078911|NCT00383487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078912|NCT00383487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56078913|NCT00383487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078914|NCT00383487|Gout Suppressants|gout suppressants|mesh-ancestor
56078915|NCT00383487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56078916|NCT00383487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078917|NCT00383487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078918|NCT00383487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56078919|NCT00383487|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56078920|NCT00383487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56078921|NCT00383487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56078923|NCT00383487|Micronutrients|micronutrients|mesh-ancestor
56078924|NCT00383487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56078925|NCT00383487|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56078926|NCT00003429|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56078927|NCT00003429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56078928|NCT00003429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078929|NCT00003435|Antiviral Agents|antiviral agents|mesh-list
56078931|NCT00003435|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56078932|NCT00003435|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078944|NCT00003441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078946|NCT00002805|Cobalt|cobalt|mesh-list
56078947|NCT00002805|Cytarabine|cytarabine|mesh-list
56078948|NCT00002805|Hydrocortisone|hydrocortisone|mesh-list
56078949|NCT00002805|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56078950|NCT00002805|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56078951|NCT00002805|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56078952|NCT00002805|Methotrexate|methotrexate|mesh-list
56078953|NCT00002805|Etoposide|etoposide|mesh-list
56078954|NCT00002805|Mitoxantrone|mitoxantrone|mesh-list
56078955|NCT00002805|Cladribine|cladribine|mesh-list
56078956|NCT00002805|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56078957|NCT00002805|Abortifacient Agents|abortifacient agents|mesh-ancestor
56078958|NCT00002805|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56078959|NCT00002805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078960|NCT00002805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56078961|NCT00002805|Antimetabolites|antimetabolites|mesh-ancestor
56078962|NCT00002805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078963|NCT00002805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078964|NCT00002805|Dermatologic Agents|dermatologic agents|mesh-ancestor
56078965|NCT00002805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078966|NCT00002805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56078967|NCT00002805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078968|NCT00002805|Immunologic Factors|immunologic factors|mesh-ancestor
56078969|NCT00002805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56078970|NCT00002805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56078971|NCT00002805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56078972|NCT00002805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56078973|NCT00002805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56078974|NCT00002805|Antiviral Agents|antiviral agents|mesh-ancestor
56078975|NCT00002805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56078976|NCT00002805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56078977|NCT00002805|Analgesics|analgesics|mesh-ancestor
56078978|NCT00002805|Sensory System Agents|sensory system agents|mesh-ancestor
56078985|NCT00003297|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56078986|NCT00003297|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56078987|NCT00003297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56078988|NCT00003297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56078989|NCT00003297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56078991|NCT00003297|Sensory System Agents|sensory system agents|mesh-ancestor
56078992|NCT00003297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56078993|NCT00003297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56078994|NCT00003297|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56003777|NCT00000730|Protective Agents|protective agents|mesh-ancestor
56078995|NCT00003297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56078997|NCT00003297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56078998|NCT00003297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56078999|NCT00003297|Immunologic Factors|immunologic factors|mesh-ancestor
56079000|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
56079001|NCT00003309|Etoposide|etoposide|mesh-list
56079002|NCT00003309|Vincristine|vincristine|mesh-list
56079003|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079004|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
56079005|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079006|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079007|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079008|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
56079009|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079010|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079011|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079012|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079013|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079014|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55806228|NCT02556203|Clopidogrel|clopidogrel|mesh-list
56079015|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079026|NCT00003447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079027|NCT00003447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079028|NCT00003447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079029|NCT00003447|Immunologic Factors|immunologic factors|mesh-ancestor
56079030|NCT00003447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079031|NCT00003447|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079032|NCT00003447|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079033|NCT00003447|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079034|NCT00003447|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079035|NCT00003315|Amphotericin B|amphotericin b|mesh-list
56079036|NCT00003315|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56079037|NCT00003315|Sargramostim|sargramostim|mesh-list
56079038|NCT00003315|Immunologic Factors|immunologic factors|mesh-ancestor
56079039|NCT00003315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079040|NCT00003315|Amebicides|amebicides|mesh-ancestor
56079041|NCT00003315|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56079042|NCT00003315|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56079043|NCT00003315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079044|NCT00003315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56079045|NCT00003315|Antifungal Agents|antifungal agents|mesh-ancestor
56079046|NCT00002817|Sargramostim|sargramostim|mesh-list
56079047|NCT00002817|Immunologic Factors|immunologic factors|mesh-ancestor
56079048|NCT00002817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079049|NCT00003465|Temozolomide|temozolomide|mesh-list
56079050|NCT00003465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079051|NCT00003465|Alkylating Agents|alkylating agents|mesh-ancestor
56079052|NCT00003465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079053|NCT00003465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079054|NCT00002823|Etoposide|etoposide|mesh-list
56079055|NCT00002823|Vinorelbine|vinorelbine|mesh-list
56079056|NCT00002823|Vinblastine|vinblastine|mesh-list
56079058|NCT00002823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079059|NCT00002823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079060|NCT00002823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079061|NCT00002823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079062|NCT00002823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079064|NCT00002823|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079065|NCT00002823|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079066|NCT00002823|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079068|NCT00361621|Cyclophosphamide|cyclophosphamide|mesh-list
56079069|NCT00361621|Rituximab|rituximab|mesh-list
56079070|NCT00361621|Doxorubicin|doxorubicin|mesh-list
56079071|NCT00361621|Vincristine|vincristine|mesh-list
56079072|NCT00361621|Bortezomib|bortezomib|mesh-list
56079073|NCT00361621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079074|NCT00361621|Immunologic Factors|immunologic factors|mesh-ancestor
56079075|NCT00361621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079076|NCT00361621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079077|NCT00361621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079078|NCT00361621|Alkylating Agents|alkylating agents|mesh-ancestor
56079079|NCT00361621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079080|NCT00361621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079081|NCT00361621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079082|NCT00361621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56079083|NCT00361621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56079084|NCT00361621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079085|NCT00361621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079086|NCT00361621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079087|NCT00361621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56079088|NCT00361621|Glucocorticoids|glucocorticoids|mesh-ancestor
56079089|NCT00361621|Hormones|hormones|mesh-ancestor
56079090|NCT00361621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56079091|NCT00361621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56079092|NCT00361621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079093|NCT00361621|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079094|NCT00361621|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079095|NCT00361621|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079097|NCT00003327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079098|NCT00003327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079099|NCT00003327|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079100|NCT00003327|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079101|NCT00003327|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079103|NCT00003339|Interleukin-12|interleukin-12|mesh-list
56079104|NCT00003339|Freund's Adjuvant|freund's adjuvant|mesh-list
56079105|NCT00003339|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56079106|NCT00003339|Immunologic Factors|immunologic factors|mesh-ancestor
56079107|NCT00003339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079108|NCT00003339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56079109|NCT00003339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56079110|NCT00003339|Growth Substances|growth substances|mesh-ancestor
56079111|NCT00003339|Growth Inhibitors|growth inhibitors|mesh-ancestor
56079112|NCT00003339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079113|NCT00002829|Interferons|interferons|mesh-list
56079114|NCT00002829|Interferon-alpha|interferon-alpha|mesh-list
56079115|NCT00002829|Cyclophosphamide|cyclophosphamide|mesh-list
56079116|NCT00002829|Etoposide|etoposide|mesh-list
56079117|NCT00002829|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079118|NCT00002829|Immunologic Factors|immunologic factors|mesh-ancestor
56079119|NCT00002829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079120|NCT00002829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079121|NCT00002829|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079122|NCT00002829|Alkylating Agents|alkylating agents|mesh-ancestor
56079123|NCT00002829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079124|NCT00002829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079125|NCT00002829|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079126|NCT00002829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079127|NCT00002829|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079128|NCT00002829|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079129|NCT00002829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079130|NCT00002829|Antiviral Agents|antiviral agents|mesh-ancestor
56079131|NCT00002829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079132|NCT03614221|Tacrolimus|tacrolimus|mesh-list
56079133|NCT03614221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079134|NCT03614221|Immunologic Factors|immunologic factors|mesh-ancestor
56079135|NCT03614221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079136|NCT03614221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56079137|NCT03614221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741198|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079140|NCT00003345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079141|NCT00003345|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56079142|NCT00003345|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079143|NCT00003345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079144|NCT00003345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079145|NCT03596905|Plecanatide|plecanatide|mesh-list
56079146|NCT03596905|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56079147|NCT03596905|Enzyme Activators|enzyme activators|mesh-ancestor
56079148|NCT03596905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079149|NCT03596905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56079151|NCT00002835|Interferons|interferons|mesh-list
56079152|NCT00002835|Cytarabine|cytarabine|mesh-list
56079153|NCT00002835|Interferon-alpha|interferon-alpha|mesh-list
56079154|NCT00002835|Methylprednisolone|methylprednisolone|mesh-list
56079155|NCT00002835|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56079156|NCT00002835|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56079157|NCT00002835|Prednisolone|prednisolone|mesh-list
56079158|NCT00002835|Prednisolone acetate|prednisolone acetate|mesh-list
56079159|NCT00002835|Cyclophosphamide|cyclophosphamide|mesh-list
56079160|NCT00002835|Melphalan|melphalan|mesh-list
56079161|NCT00002835|Ifosfamide|ifosfamide|mesh-list
56079162|NCT00002835|Carmustine|carmustine|mesh-list
56079163|NCT00002835|Cisplatin|cisplatin|mesh-list
56079164|NCT00002835|Methotrexate|methotrexate|mesh-list
56079165|NCT00002835|Etoposide|etoposide|mesh-list
56079166|NCT00002835|Vincristine|vincristine|mesh-list
56079171|NCT00002835|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56079172|NCT00002835|Prednisolone phosphate|prednisolone phosphate|mesh-list
56079173|NCT00002835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079174|NCT00002835|Immunologic Factors|immunologic factors|mesh-ancestor
56079175|NCT00002835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079176|NCT00002835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079177|NCT00002835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079178|NCT00002835|Alkylating Agents|alkylating agents|mesh-ancestor
56079179|NCT00002835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079183|NCT00002835|Abortifacient Agents|abortifacient agents|mesh-ancestor
56079184|NCT00002835|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56079185|NCT00002835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079186|NCT00002835|Antimetabolites|antimetabolites|mesh-ancestor
56079187|NCT00002835|Dermatologic Agents|dermatologic agents|mesh-ancestor
56079188|NCT00002835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079189|NCT00002835|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56079190|NCT00002835|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56079191|NCT00002835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079192|NCT00002835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079193|NCT00002835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079194|NCT00002835|Antiviral Agents|antiviral agents|mesh-ancestor
56079195|NCT00002835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079196|NCT00002835|Antidotes|antidotes|mesh-ancestor
56079197|NCT00002835|Protective Agents|protective agents|mesh-ancestor
56079198|NCT00002835|Vitamin B Complex|vitamin b complex|mesh-ancestor
56079199|NCT00002835|Vitamins|vitamins|mesh-ancestor
56079200|NCT00002835|Micronutrients|micronutrients|mesh-ancestor
56079201|NCT00002835|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079202|NCT00002835|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079203|NCT00002835|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079204|NCT00002835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56079205|NCT00002835|Antiemetics|antiemetics|mesh-ancestor
56079206|NCT00002835|Autonomic Agents|autonomic agents|mesh-ancestor
56079207|NCT00002835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56079208|NCT00002835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56079209|NCT00002835|Glucocorticoids|glucocorticoids|mesh-ancestor
56079210|NCT00002835|Hormones|hormones|mesh-ancestor
56079211|NCT00002835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56079212|NCT00002835|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56079213|NCT00002835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56079214|NCT00002835|Analgesics|analgesics|mesh-ancestor
56079215|NCT00002835|Sensory System Agents|sensory system agents|mesh-ancestor
56079216|NCT00002835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56079223|NCT04560673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079224|NCT04560673|Analgesics|analgesics|mesh-ancestor
56079225|NCT04560673|Sensory System Agents|sensory system agents|mesh-ancestor
56079226|NCT04560673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56079227|NCT04560673|Antidepressive Agents|antidepressive agents|mesh-ancestor
56079228|NCT04560673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56079229|NCT04560673|Dopamine Agents|dopamine agents|mesh-ancestor
56079230|NCT00003351|Irinotecan|irinotecan|mesh-list
56079231|NCT00003351|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56079232|NCT00003351|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079233|NCT00003351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079234|NCT00003351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079235|NCT00003351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079236|NCT00361153|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
56079237|NCT00361153|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56079238|NCT00361153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56079239|NCT00361153|Antimetabolites|antimetabolites|mesh-ancestor
56079240|NCT00361153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079241|NCT00361153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56079242|NCT00002847|Interferons|interferons|mesh-list
56079243|NCT00002847|Interferon-alpha|interferon-alpha|mesh-list
56079244|NCT00002847|Aldesleukin|aldesleukin|mesh-list
55806464|NCT05494307|Danazol|danazol|mesh-list
56079245|NCT00002847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079246|NCT00002847|Antiviral Agents|antiviral agents|mesh-ancestor
56079247|NCT00002847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079248|NCT00002847|Immunologic Factors|immunologic factors|mesh-ancestor
56079249|NCT00002847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079250|NCT00002847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56079251|NCT00002847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56079252|NCT03576001|Methyltestosterone|methyltestosterone|mesh-list
56079254|NCT03576001|Testosterone undecanoate|testosterone undecanoate|mesh-list
56079255|NCT03576001|Testosterone enanthate|testosterone enanthate|mesh-list
56079256|NCT03576001|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56079268|NCT00003519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079269|NCT00003519|Immunologic Factors|immunologic factors|mesh-ancestor
56079270|NCT00003519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079271|NCT00003519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079272|NCT00003519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079273|NCT00003519|Alkylating Agents|alkylating agents|mesh-ancestor
56079274|NCT00003519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079275|NCT00003519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079276|NCT00003519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079277|NCT00003519|Tubulin Modulators|tubulin modulators|mesh-ancestor
55741202|NCT02520115|Dexamethasone|dexamethasone|mesh-list
56079278|NCT00003519|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079279|NCT00003519|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079280|NCT00003519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56079281|NCT00003519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079282|NCT00003519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079283|NCT00003519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079284|NCT04220827|Paclitaxel|paclitaxel|mesh-list
56079285|NCT04220827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56079286|NCT04220827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079287|NCT04220827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079288|NCT04220827|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079289|NCT04220827|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079290|NCT04220827|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079291|NCT04220827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079292|NCT04552795|Lamivudine|lamivudine|mesh-list
56079293|NCT04552795|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56079294|NCT04552795|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56079295|NCT04552795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079297|NCT04552795|Antiviral Agents|antiviral agents|mesh-ancestor
56079304|NCT00002865|Dexamethasone|dexamethasone|mesh-list
56079305|NCT00002865|Hydrocortisone|hydrocortisone|mesh-list
56079306|NCT00002865|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56079307|NCT00002865|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56079308|NCT00002865|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56079309|NCT00002865|Cyclophosphamide|cyclophosphamide|mesh-list
56079310|NCT00002865|Ifosfamide|ifosfamide|mesh-list
56079311|NCT00002865|Doxorubicin|doxorubicin|mesh-list
56079312|NCT00002865|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56079313|NCT00002865|Methotrexate|methotrexate|mesh-list
56079314|NCT00002865|Etoposide|etoposide|mesh-list
56079315|NCT00002865|Vincristine|vincristine|mesh-list
56079316|NCT00002865|Levoleucovorin|levoleucovorin|mesh-list
56079317|NCT00002865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806531|NCT05487521|Antiemetics|antiemetics|mesh-ancestor
56079318|NCT00002865|Immunologic Factors|immunologic factors|mesh-ancestor
56079319|NCT00002865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079320|NCT00002865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079321|NCT00002865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079322|NCT00002865|Alkylating Agents|alkylating agents|mesh-ancestor
56079323|NCT00002865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079324|NCT00002865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079325|NCT00002865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079326|NCT00002865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56079327|NCT00002865|Antiemetics|antiemetics|mesh-ancestor
56079328|NCT00002865|Autonomic Agents|autonomic agents|mesh-ancestor
56079329|NCT00002865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56079330|NCT00002865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56079331|NCT00002865|Glucocorticoids|glucocorticoids|mesh-ancestor
56079332|NCT00002865|Hormones|hormones|mesh-ancestor
56079333|NCT00002865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56079334|NCT00002865|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56079335|NCT00002865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56079336|NCT00002865|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079345|NCT00002865|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56079346|NCT00002865|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56079347|NCT00002865|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079349|NCT00002865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079350|NCT00002865|Antidotes|antidotes|mesh-ancestor
56079351|NCT00002865|Protective Agents|protective agents|mesh-ancestor
56079352|NCT00002865|Vitamin B Complex|vitamin b complex|mesh-ancestor
56079354|NCT00002865|Micronutrients|micronutrients|mesh-ancestor
56079355|NCT00002865|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079356|NCT00002865|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079357|NCT00002865|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079358|NCT00002865|Trace Elements|trace elements|mesh-ancestor
56079359|NCT00361309|Sunitinib|sunitinib|mesh-list
56079360|NCT00361309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079361|NCT00361309|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56079362|NCT00361309|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56079363|NCT00361309|Growth Substances|growth substances|mesh-ancestor
56079364|NCT00361309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079365|NCT00361309|Growth Inhibitors|growth inhibitors|mesh-ancestor
56079366|NCT00361309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56079367|NCT00361309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079368|NCT00361309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079369|NCT04154943|Cemiplimab|cemiplimab|mesh-list
56079370|NCT04154943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56079371|NCT04154943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079372|NCT00361387|Methylphenidate|methylphenidate|mesh-list
56079373|NCT00361387|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56079374|NCT00361387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079379|NCT00361387|Dopamine Agents|dopamine agents|mesh-ancestor
56079392|NCT04530487|Tacrolimus|tacrolimus|mesh-list
56079393|NCT04530487|Cyclosporins|cyclosporins|mesh-list
56079394|NCT04530487|Thymoglobulin|thymoglobulin|mesh-list
55806612|NCT05475431|Bismuth|bismuth|mesh-list
56079395|NCT04530487|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56079396|NCT04530487|Immunoglobulins|immunoglobulins|mesh-list
56079397|NCT04530487|Antibodies|antibodies|mesh-list
56079398|NCT04530487|gamma-Globulins|gamma-globulins|mesh-list
56079399|NCT04530487|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56079400|NCT04530487|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56079401|NCT04530487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079402|NCT04530487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079403|NCT04530487|Antimetabolites|antimetabolites|mesh-ancestor
56079404|NCT04530487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079405|NCT04530487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079406|NCT04530487|Immunologic Factors|immunologic factors|mesh-ancestor
56079407|NCT04530487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079408|NCT04530487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079409|NCT04530487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079410|NCT04530487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079411|NCT04530487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079412|NCT04530487|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56079413|NCT04530487|Antifungal Agents|antifungal agents|mesh-ancestor
56079414|NCT04530487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079415|NCT04530487|Dermatologic Agents|dermatologic agents|mesh-ancestor
56079416|NCT04530487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079417|NCT04530487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56079418|NCT04530487|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56079419|NCT04530487|Antitubercular Agents|antitubercular agents|mesh-ancestor
56079420|NCT04530487|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56079421|NCT04530487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079422|NCT04530487|Alkylating Agents|alkylating agents|mesh-ancestor
56079423|NCT04530487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079424|NCT04530487|Keratolytic Agents|keratolytic agents|mesh-ancestor
56079434|NCT04342351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56079435|NCT04342351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56079436|NCT04342351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079437|NCT04342351|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56079438|NCT04342351|Protease Inhibitors|protease inhibitors|mesh-ancestor
56079439|NCT04342351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079440|NCT04342273|Moxifloxacin|moxifloxacin|mesh-list
56079441|NCT04342273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56079442|NCT04342273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079443|NCT04342273|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079444|NCT04342273|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079445|NCT04342273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079446|NCT04342273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079447|NCT04342273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079448|NCT03504241|Mycophenolic Acid|mycophenolic acid|mesh-list
56079450|NCT03504241|Prednisone|prednisone|mesh-list
56079451|NCT03504241|Alemtuzumab|alemtuzumab|mesh-list
56079452|NCT03504241|Abatacept|abatacept|mesh-list
56079453|NCT03504241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56079454|NCT03504241|Glucocorticoids|glucocorticoids|mesh-ancestor
56079455|NCT03504241|Hormones|hormones|mesh-ancestor
56079456|NCT03504241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56079457|NCT03504241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079458|NCT03504241|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56079459|NCT03504241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079460|NCT03504241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56079478|NCT00003375|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079479|NCT00003375|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079480|NCT00003375|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079481|NCT00003375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079482|NCT00003375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079483|NCT00003375|Alkylating Agents|alkylating agents|mesh-ancestor
56079484|NCT03499249|Acetylcysteine|acetylcysteine|mesh-list
56079485|NCT03499249|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56079486|NCT03499249|Antiviral Agents|antiviral agents|mesh-ancestor
56079487|NCT03499249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079488|NCT03499249|Expectorants|expectorants|mesh-ancestor
56079489|NCT03499249|Respiratory System Agents|respiratory system agents|mesh-ancestor
56079490|NCT03499249|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56079491|NCT03499249|Antioxidants|antioxidants|mesh-ancestor
56079492|NCT03499249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079493|NCT03499249|Protective Agents|protective agents|mesh-ancestor
56079494|NCT03499249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079495|NCT03499249|Antidotes|antidotes|mesh-ancestor
56079496|NCT03498391|Ketamine|ketamine|mesh-list
56079497|NCT03498391|Propofol|propofol|mesh-list
56079498|NCT03498391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56079499|NCT03498391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56079500|NCT03498391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079501|NCT03498391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56079502|NCT03498391|Anesthetics, General|anesthetics, general|mesh-ancestor
56079503|NCT03498391|Anesthetics|anesthetics|mesh-ancestor
56079504|NCT03498391|Analgesics|analgesics|mesh-ancestor
56079505|NCT03498391|Sensory System Agents|sensory system agents|mesh-ancestor
56079506|NCT03498391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56079507|NCT03498391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56079509|NCT03498391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56079523|NCT00003543|Immunologic Factors|immunologic factors|mesh-ancestor
56079524|NCT00003543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079525|NCT00003543|Antimetabolites|antimetabolites|mesh-ancestor
56079526|NCT00003543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079527|NCT00003543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079528|NCT00003543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079529|NCT00003543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079530|NCT00003543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079531|NCT00003543|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079532|NCT00003543|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079533|NCT00003543|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079534|NCT00003543|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079535|NCT00003543|Alkylating Agents|alkylating agents|mesh-ancestor
56079536|NCT00003543|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56079537|NCT00003549|Cyclophosphamide|cyclophosphamide|mesh-list
56079538|NCT00003549|Fluorouracil|fluorouracil|mesh-list
56079539|NCT00003549|Methotrexate|methotrexate|mesh-list
56079540|NCT00003549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079541|NCT00003549|Immunologic Factors|immunologic factors|mesh-ancestor
56079542|NCT00003549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079543|NCT00003549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079544|NCT00003549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079545|NCT00003549|Alkylating Agents|alkylating agents|mesh-ancestor
56079546|NCT00003549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079547|NCT00003549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079548|NCT00003549|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079549|NCT00003549|Antimetabolites|antimetabolites|mesh-ancestor
56079550|NCT00003549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079551|NCT00003549|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56079552|NCT00003549|Abortifacient Agents|abortifacient agents|mesh-ancestor
56079553|NCT00003549|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56079554|NCT00003549|Dermatologic Agents|dermatologic agents|mesh-ancestor
56079555|NCT00003549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079556|NCT00003549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56079557|NCT00003549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56079559|NCT00002883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079560|NCT00002883|Antimetabolites|antimetabolites|mesh-ancestor
56079561|NCT00002883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079562|NCT00002883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079563|NCT00002883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079564|NCT00002883|Immunologic Factors|immunologic factors|mesh-ancestor
56079565|NCT00002883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079569|NCT00002889|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56079570|NCT00002889|Fertility Agents|fertility agents|mesh-ancestor
56079571|NCT00002889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56079572|NCT00002889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079573|NCT00002889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56079574|NCT00002889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079575|NCT00002889|Androgen Antagonists|androgen antagonists|mesh-ancestor
56079576|NCT00002889|Hormone Antagonists|hormone antagonists|mesh-ancestor
56079577|NCT00002889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56079579|NCT03492463|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56079580|NCT03492463|Autonomic Agents|autonomic agents|mesh-ancestor
56079581|NCT03492463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56079582|NCT03492463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079583|NCT03492463|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56079584|NCT03492463|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56079585|NCT03492463|Cholinergic Agents|cholinergic agents|mesh-ancestor
56079586|NCT03492463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56079587|NCT03492463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079588|NCT00003945|Topotecan|topotecan|mesh-list
56079589|NCT00003945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079590|NCT00003945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56079591|NCT00003945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079601|NCT00003957|Paclitaxel|paclitaxel|mesh-list
56079602|NCT00003957|Etoposide|etoposide|mesh-list
56079603|NCT00003957|Cyclophosphamide|cyclophosphamide|mesh-list
56079604|NCT00003957|Melphalan|melphalan|mesh-list
56079605|NCT00003957|Mitoxantrone|mitoxantrone|mesh-list
56079606|NCT00003957|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079607|NCT00003957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079608|NCT00003957|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079609|NCT00003957|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079610|NCT00003957|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079611|NCT00003957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079612|NCT00003957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079613|NCT00003957|Immunologic Factors|immunologic factors|mesh-ancestor
56079614|NCT00003957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079615|NCT00003957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079616|NCT00003957|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079617|NCT00003957|Alkylating Agents|alkylating agents|mesh-ancestor
56079618|NCT00003957|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079619|NCT00003957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079620|NCT00003957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079621|NCT00003957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079622|NCT00003957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079623|NCT00003957|Antimetabolites|antimetabolites|mesh-ancestor
56079624|NCT00003957|Antiviral Agents|antiviral agents|mesh-ancestor
56079625|NCT00003957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079626|NCT00003957|Analgesics|analgesics|mesh-ancestor
56079627|NCT00003957|Sensory System Agents|sensory system agents|mesh-ancestor
56079628|NCT00003957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56079629|NCT00004833|Immunoglobulins|immunoglobulins|mesh-list
56079631|NCT00004833|gamma-Globulins|gamma-globulins|mesh-list
56079632|NCT00004833|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56079633|NCT00004833|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56079634|NCT00004833|Immunologic Factors|immunologic factors|mesh-ancestor
56079635|NCT00004833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079636|NCT00003555|Paclitaxel|paclitaxel|mesh-list
56079643|NCT00003555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079644|NCT00003555|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56079645|NCT00003555|Protective Agents|protective agents|mesh-ancestor
56079646|NCT00003555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079647|NCT00003963|Rituximab|rituximab|mesh-list
56079648|NCT00003963|Vinorelbine|vinorelbine|mesh-list
56079649|NCT00003963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56079650|NCT00003963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079651|NCT00003963|Immunologic Factors|immunologic factors|mesh-ancestor
56079652|NCT00003963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079653|NCT00003963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079654|NCT00003963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079655|NCT00003963|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079656|NCT00003963|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079657|NCT00003963|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079658|NCT00003963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079659|NCT00004845|Naproxen|naproxen|mesh-list
56079660|NCT00004845|Rofecoxib|rofecoxib|mesh-list
56079972|NCT00362323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56079661|NCT00004845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56079662|NCT00004845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56079663|NCT00004845|Analgesics|analgesics|mesh-ancestor
56079664|NCT00004845|Sensory System Agents|sensory system agents|mesh-ancestor
56079665|NCT00004845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56079666|NCT00004845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079667|NCT00004845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56079690|NCT00004857|Fludarabine phosphate|fludarabine phosphate|mesh-list
56079691|NCT00004857|Alemtuzumab|alemtuzumab|mesh-list
56079692|NCT00004857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079693|NCT00004857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079694|NCT00004857|Antimetabolites|antimetabolites|mesh-ancestor
56079695|NCT00004857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079696|NCT00004857|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079697|NCT00004857|Immunologic Factors|immunologic factors|mesh-ancestor
56079698|NCT00004857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079699|NCT00004857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56079700|NCT03476239|Blinatumomab|blinatumomab|mesh-list
56079701|NCT03476239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079702|NCT00004863|Paclitaxel|paclitaxel|mesh-list
56079703|NCT00004863|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079704|NCT00004863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079705|NCT00004863|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079706|NCT00004863|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079707|NCT00004863|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079708|NCT00004863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079709|NCT00004875|Heparin|heparin|mesh-list
56079710|NCT00004875|Enoxaparin|enoxaparin|mesh-list
56079711|NCT00004875|Anticoagulants|anticoagulants|mesh-ancestor
56079712|NCT00004875|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56079713|NCT00004875|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56079714|NCT00004875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079715|NCT00003561|Interferons|interferons|mesh-list
56079716|NCT00003561|Interferon-alpha|interferon-alpha|mesh-list
56079717|NCT00003561|Sargramostim|sargramostim|mesh-list
56079718|NCT00003561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079723|NCT00003567|Temozolomide|temozolomide|mesh-list
56079737|NCT00003573|Vincristine|vincristine|mesh-list
56079738|NCT00003573|Lenograstim|lenograstim|mesh-list
56079739|NCT00003573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079740|NCT00003573|Immunologic Factors|immunologic factors|mesh-ancestor
56079741|NCT00003573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079742|NCT00003573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079743|NCT00003573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079744|NCT00003573|Alkylating Agents|alkylating agents|mesh-ancestor
56079745|NCT00003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079746|NCT00003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079747|NCT00003573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079748|NCT00003573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079749|NCT00003573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079750|NCT00003573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079751|NCT00003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079752|NCT00003573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56079753|NCT00003573|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079754|NCT00003573|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079755|NCT00003573|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079756|NCT03468985|Nivolumab|nivolumab|mesh-list
56079757|NCT03468985|Ipilimumab|ipilimumab|mesh-list
56079758|NCT03468985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56079759|NCT03468985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079760|NCT03468985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56079761|NCT03468985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079762|NCT00003585|Interferons|interferons|mesh-list
56079763|NCT00003585|Interferon-alpha|interferon-alpha|mesh-list
56079764|NCT00003585|Aldesleukin|aldesleukin|mesh-list
56079765|NCT00003585|Fluorouracil|fluorouracil|mesh-list
56079766|NCT00003585|Isotretinoin|isotretinoin|mesh-list
56079767|NCT00003585|Antimetabolites|antimetabolites|mesh-ancestor
56079768|NCT00003585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079780|NCT00003591|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079781|NCT00003591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079782|NCT00003591|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079783|NCT00003591|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079784|NCT00003591|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079785|NCT00003591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079786|NCT02975323|Carvedilol|carvedilol|mesh-list
56079787|NCT02975323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56079788|NCT02975323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56079789|NCT02975323|Adrenergic Agents|adrenergic agents|mesh-ancestor
56079790|NCT02975323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56079791|NCT02975323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079792|NCT02975323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079793|NCT02975323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56079794|NCT02975323|Antioxidants|antioxidants|mesh-ancestor
56079795|NCT02975323|Protective Agents|protective agents|mesh-ancestor
56079796|NCT02975323|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56079797|NCT02975323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56079798|NCT02975323|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56079799|NCT02975323|Vasodilator Agents|vasodilator agents|mesh-ancestor
56079800|NCT02975323|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56079801|NCT02975323|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56079802|NCT00003597|Carboplatin|carboplatin|mesh-list
56079804|NCT00003597|Ifosfamide|ifosfamide|mesh-list
56079805|NCT00003597|Lenograstim|lenograstim|mesh-list
56079806|NCT00003597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079807|NCT00003597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079808|NCT00003597|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079809|NCT00003597|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079810|NCT00003597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079817|NCT00004005|Leucovorin|leucovorin|mesh-list
56079823|NCT00004005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079824|NCT00004005|Antimetabolites|antimetabolites|mesh-ancestor
56079825|NCT00004005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079826|NCT00004005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079827|NCT00004005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003778|NCT00000730|Vitamin B Complex|vitamin b complex|mesh-ancestor
56079828|NCT00004005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079829|NCT00004005|Immunologic Factors|immunologic factors|mesh-ancestor
56079830|NCT00004005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56079831|NCT00004005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079832|NCT00004005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079833|NCT00004005|Antidotes|antidotes|mesh-ancestor
56079834|NCT00004005|Protective Agents|protective agents|mesh-ancestor
56079835|NCT00004005|Vitamin B Complex|vitamin b complex|mesh-ancestor
56079836|NCT00004005|Vitamins|vitamins|mesh-ancestor
56079837|NCT00004005|Micronutrients|micronutrients|mesh-ancestor
56079838|NCT00003603|Dexamethasone|dexamethasone|mesh-list
56079839|NCT00003603|Prednisolone|prednisolone|mesh-list
56079840|NCT00003603|Cyclophosphamide|cyclophosphamide|mesh-list
56079841|NCT00003603|Melphalan|melphalan|mesh-list
56079842|NCT00003603|Lomustine|lomustine|mesh-list
56079843|NCT00003603|Idarubicin|idarubicin|mesh-list
56079844|NCT00003603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079845|NCT00003603|Immunologic Factors|immunologic factors|mesh-ancestor
56079846|NCT00003603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079847|NCT00003603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079848|NCT00003603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079849|NCT00003603|Alkylating Agents|alkylating agents|mesh-ancestor
55807054|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56079850|NCT00003603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079851|NCT00003603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079852|NCT00003603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079853|NCT00003603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56079854|NCT00003603|Antiemetics|antiemetics|mesh-ancestor
56079866|NCT00004887|Paclitaxel|paclitaxel|mesh-list
56079867|NCT00004887|Vinblastine|vinblastine|mesh-list
56079868|NCT00004887|Carboplatin|carboplatin|mesh-list
56079869|NCT00004887|Ifosfamide|ifosfamide|mesh-list
56079870|NCT00004887|Mitomycins|mitomycins|mesh-list
56079871|NCT00004887|Mitomycin|mitomycin|mesh-list
56079872|NCT00004887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079873|NCT00004887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079874|NCT00004887|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079875|NCT00004887|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079876|NCT00004887|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079877|NCT00004887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079878|NCT00004887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079879|NCT00004887|Alkylating Agents|alkylating agents|mesh-ancestor
56079880|NCT00004887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56079881|NCT00004887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56079882|NCT00004887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079883|NCT00004893|Interleukin-12|interleukin-12|mesh-list
56079884|NCT00004893|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56079885|NCT00004893|Immunologic Factors|immunologic factors|mesh-ancestor
56079886|NCT00004893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079887|NCT00004893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56079888|NCT00004893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56079889|NCT00004893|Growth Substances|growth substances|mesh-ancestor
56079890|NCT00004893|Growth Inhibitors|growth inhibitors|mesh-ancestor
56079891|NCT00004893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079892|NCT04513951|Leucovorin|leucovorin|mesh-list
56079893|NCT04513951|Fluorouracil|fluorouracil|mesh-list
56079894|NCT04513951|Oxaliplatin|oxaliplatin|mesh-list
56079895|NCT04513951|Irinotecan|irinotecan|mesh-list
56079896|NCT04513951|Cetuximab|cetuximab|mesh-list
56079897|NCT04513951|Avelumab|avelumab|mesh-list
56079898|NCT04513951|Levoleucovorin|levoleucovorin|mesh-list
56079899|NCT04513951|Antimetabolites|antimetabolites|mesh-ancestor
56079901|NCT04513951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079910|NCT04513951|Protective Agents|protective agents|mesh-ancestor
56079911|NCT04513951|Vitamin B Complex|vitamin b complex|mesh-ancestor
56079912|NCT04513951|Vitamins|vitamins|mesh-ancestor
56079913|NCT04513951|Micronutrients|micronutrients|mesh-ancestor
56079914|NCT04513951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56079915|NCT00004011|Paclitaxel|paclitaxel|mesh-list
56079916|NCT00004011|Carboplatin|carboplatin|mesh-list
56079917|NCT00004011|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079918|NCT00004011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079919|NCT00004011|Tubulin Modulators|tubulin modulators|mesh-ancestor
56079920|NCT00004011|Antimitotic Agents|antimitotic agents|mesh-ancestor
56079921|NCT00004011|Mitosis Modulators|mitosis modulators|mesh-ancestor
56079922|NCT00004011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079923|NCT03448393|Cyclophosphamide|cyclophosphamide|mesh-list
56079924|NCT03448393|Fludarabine|fludarabine|mesh-list
56079925|NCT03448393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079926|NCT03448393|Immunologic Factors|immunologic factors|mesh-ancestor
56079927|NCT03448393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079928|NCT03448393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079929|NCT03448393|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079930|NCT03448393|Alkylating Agents|alkylating agents|mesh-ancestor
56079931|NCT03448393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079932|NCT03448393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079933|NCT03448393|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079934|NCT00004017|Antibodies|antibodies|mesh-list
56079935|NCT00004017|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56079936|NCT00004017|Immunologic Factors|immunologic factors|mesh-ancestor
56079937|NCT00004017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079938|NCT00003615|Denileukin diftitox|denileukin diftitox|mesh-list
56079939|NCT00003615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079940|NCT00004905|Interferons|interferons|mesh-list
56079941|NCT00004905|Cytarabine|cytarabine|mesh-list
56079942|NCT00004905|Interferon-alpha|interferon-alpha|mesh-list
56079943|NCT00004905|Cyclophosphamide|cyclophosphamide|mesh-list
56079944|NCT00004905|Etoposide|etoposide|mesh-list
56079945|NCT00004905|Idarubicin|idarubicin|mesh-list
56079946|NCT00004905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56079947|NCT00004905|Immunologic Factors|immunologic factors|mesh-ancestor
55901118|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901119|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079948|NCT00004905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079949|NCT00004905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56079950|NCT00004905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56079951|NCT00004905|Alkylating Agents|alkylating agents|mesh-ancestor
56079952|NCT00004905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079953|NCT00004905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079954|NCT00004905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56079955|NCT00004905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56079956|NCT00004905|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56079957|NCT00004905|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079958|NCT00004905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079959|NCT00004905|Antiviral Agents|antiviral agents|mesh-ancestor
56079960|NCT00004905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56079961|NCT00004905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56079962|NCT00004905|Antimetabolites|antimetabolites|mesh-ancestor
56079963|NCT00004905|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56079965|NCT00004029|Vaccines|vaccines|mesh-list
56079966|NCT00004029|Immunologic Factors|immunologic factors|mesh-ancestor
56079967|NCT00004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079968|NCT00362323|Metformin|metformin|mesh-list
56079969|NCT00362323|Fenofibrate|fenofibrate|mesh-list
56079970|NCT00362323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56079971|NCT00362323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56079974|NCT00362323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079975|NCT00362323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56079976|NCT00004917|Epoetin Alfa|epoetin alfa|mesh-list
56079977|NCT00004917|Hematinics|hematinics|mesh-ancestor
56079978|NCT00421915|Etanercept|etanercept|mesh-list
56079981|NCT00421915|Analgesics|analgesics|mesh-ancestor
56079990|NCT00362713|Ipilimumab|ipilimumab|mesh-list
56079991|NCT00362713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56079992|NCT00362713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56079993|NCT00362713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56079994|NCT00362713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56079995|NCT00004047|Exatecan|exatecan|mesh-list
56079996|NCT00004047|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56079997|NCT00004047|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56079998|NCT00004047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56079999|NCT00004047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080000|NCT00004047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080001|NCT00003627|Fluorouracil|fluorouracil|mesh-list
56080002|NCT00003627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080003|NCT00003627|Antimetabolites|antimetabolites|mesh-ancestor
56080004|NCT00003627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080005|NCT00003627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080006|NCT00003627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080007|NCT00003627|Immunologic Factors|immunologic factors|mesh-ancestor
56080008|NCT00003627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080009|NCT00004059|Fluorouracil|fluorouracil|mesh-list
56080010|NCT00004059|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56080011|NCT00004059|Antimetabolites|antimetabolites|mesh-ancestor
56080012|NCT00004059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080013|NCT00004059|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080014|NCT00004059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080015|NCT00004059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080016|NCT00004059|Immunologic Factors|immunologic factors|mesh-ancestor
56080018|NCT00004059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56080019|NCT00004059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080020|NCT00003633|Prednisone|prednisone|mesh-list
56080032|NCT00003633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080033|NCT00003633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080034|NCT00003633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56080035|NCT00003633|Analgesics|analgesics|mesh-ancestor
56080036|NCT00003633|Sensory System Agents|sensory system agents|mesh-ancestor
56080037|NCT00003633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080038|NCT00003633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080039|NCT00003633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080040|NCT00003633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080041|NCT00003633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080042|NCT00003633|Alkylating Agents|alkylating agents|mesh-ancestor
56080043|NCT02363335|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56080044|NCT02363335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56080045|NCT02363335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080046|NCT02363335|Incretins|incretins|mesh-ancestor
56080047|NCT02363335|Hormones|hormones|mesh-ancestor
56080048|NCT02363335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080049|NCT02363335|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56080050|NCT02363335|Protease Inhibitors|protease inhibitors|mesh-ancestor
56080051|NCT02363335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080052|NCT02363335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080053|NCT00003639|Interferons|interferons|mesh-list
56080054|NCT00003639|Interferon-alpha|interferon-alpha|mesh-list
56080055|NCT00003639|Dexamethasone|dexamethasone|mesh-list
56080056|NCT00003639|Idarubicin|idarubicin|mesh-list
56080057|NCT00003639|Chlorambucil|chlorambucil|mesh-list
56080058|NCT00003639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080059|NCT00003639|Antiemetics|antiemetics|mesh-ancestor
56080060|NCT00003639|Autonomic Agents|autonomic agents|mesh-ancestor
56080061|NCT00003639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080062|NCT00003639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080063|NCT00003639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56080064|NCT00003639|Glucocorticoids|glucocorticoids|mesh-ancestor
56080065|NCT00003639|Hormones|hormones|mesh-ancestor
56080066|NCT00003639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080070|NCT00003639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080071|NCT00003639|Immunologic Factors|immunologic factors|mesh-ancestor
56080072|NCT00003639|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56080341|NCT00004179|Glucocorticoids|glucocorticoids|mesh-ancestor
56080073|NCT00003639|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080074|NCT00003639|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080075|NCT00003639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080076|NCT00003639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080077|NCT00003639|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080079|NCT00004923|Docetaxel|docetaxel|mesh-list
56080080|NCT00004923|Irinotecan|irinotecan|mesh-list
56080081|NCT00004923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080082|NCT00004923|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080083|NCT00004923|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080084|NCT00004923|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080085|NCT00004923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080086|NCT00004923|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56080087|NCT00004923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080088|NCT00004923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080089|NCT02317783|Deoxyglucose|deoxyglucose|mesh-list
56080090|NCT02317783|Flutemetamol|flutemetamol|mesh-list
56080091|NCT02317783|Antimetabolites|antimetabolites|mesh-ancestor
56080092|NCT02317783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080093|NCT02317783|Antiviral Agents|antiviral agents|mesh-ancestor
56080094|NCT02317783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080095|NCT02317783|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56080096|NCT00004071|Prednisone|prednisone|mesh-list
56080097|NCT00004071|Mitoxantrone|mitoxantrone|mesh-list
56080098|NCT00004071|Leflunomide|leflunomide|mesh-list
56080099|NCT00004071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080100|NCT00004071|Glucocorticoids|glucocorticoids|mesh-ancestor
56080101|NCT00004071|Hormones|hormones|mesh-ancestor
56080114|NCT00004071|Immunologic Factors|immunologic factors|mesh-ancestor
56080116|NCT00004077|Ifosfamide|ifosfamide|mesh-list
56080117|NCT00004077|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080118|NCT00004077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080119|NCT00004077|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080120|NCT00004077|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080121|NCT00004077|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080122|NCT00004077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080123|NCT00004077|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080124|NCT00004077|Alkylating Agents|alkylating agents|mesh-ancestor
56080125|NCT00004083|Cisplatin|cisplatin|mesh-list
56080126|NCT00004083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080127|NCT00004941|Infliximab|infliximab|mesh-list
56080128|NCT00004941|Antibodies|antibodies|mesh-list
56080129|NCT00004941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56080130|NCT00004941|Immunologic Factors|immunologic factors|mesh-ancestor
56080131|NCT00004941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080132|NCT00004941|Dermatologic Agents|dermatologic agents|mesh-ancestor
56080133|NCT00004941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56080134|NCT00004941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080135|NCT00003657|Carboplatin|carboplatin|mesh-list
56080136|NCT00003657|Etoposide|etoposide|mesh-list
56080137|NCT00003657|Ifosfamide|ifosfamide|mesh-list
56080138|NCT00003657|Amifostine|amifostine|mesh-list
56080139|NCT00003657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080140|NCT00003657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080141|NCT00003657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080142|NCT00003657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080143|NCT00003657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080144|NCT00003657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080150|NCT00004089|Paclitaxel|paclitaxel|mesh-list
56080160|NCT00004089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080161|NCT00004089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080162|NCT00004089|Immunologic Factors|immunologic factors|mesh-ancestor
56080163|NCT00004089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080164|NCT00004089|Antisickling Agents|antisickling agents|mesh-ancestor
56080165|NCT00004089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080166|NCT00004089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56080168|NCT00004095|Irinotecan|irinotecan|mesh-list
56080169|NCT00004095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080170|NCT00004095|Antimetabolites|antimetabolites|mesh-ancestor
56080171|NCT00004095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080172|NCT00004095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080173|NCT00004095|Antiviral Agents|antiviral agents|mesh-ancestor
56080174|NCT00004095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080175|NCT00004095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080176|NCT00004095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080177|NCT00004095|Immunologic Factors|immunologic factors|mesh-ancestor
56080178|NCT00004095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080179|NCT00004095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56080180|NCT00004095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080181|NCT00003663|Dexamethasone|dexamethasone|mesh-list
56080182|NCT00003663|Rituximab|rituximab|mesh-list
56080183|NCT00003663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56080184|NCT00003663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080212|NCT00004125|Cyclophosphamide|cyclophosphamide|mesh-list
56080213|NCT00004125|Doxorubicin|doxorubicin|mesh-list
56080214|NCT00004125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56080215|NCT00004125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080216|NCT00004125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080217|NCT00004125|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080218|NCT00004125|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080219|NCT00004125|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080220|NCT00004125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080221|NCT00004125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080222|NCT00004125|Immunologic Factors|immunologic factors|mesh-ancestor
56080223|NCT00004125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080224|NCT00004125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080225|NCT00004125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080226|NCT00004125|Alkylating Agents|alkylating agents|mesh-ancestor
56080227|NCT00004125|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56080229|NCT00004125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080230|NCT00004125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080231|NCT00004125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080232|NCT00004125|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56080233|NCT00004125|Hormone Antagonists|hormone antagonists|mesh-ancestor
56080234|NCT00004125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080235|NCT00004125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56080260|NCT00003681|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56080261|NCT00003681|Protective Agents|protective agents|mesh-ancestor
56080262|NCT00003681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080264|NCT00005007|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56080265|NCT00005007|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56080266|NCT00005007|Analgesics|analgesics|mesh-ancestor
56080267|NCT00005007|Sensory System Agents|sensory system agents|mesh-ancestor
56080268|NCT00005007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080269|NCT00005007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080270|NCT00005007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080271|NCT00005007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080272|NCT00005007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56080273|NCT00005007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080274|NCT00005007|Immunologic Factors|immunologic factors|mesh-ancestor
56080275|NCT00384579|Botulinum Toxins|botulinum toxins|mesh-list
56080276|NCT00384579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56080277|NCT00384579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56080278|NCT00384579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080279|NCT00384579|Cholinergic Agents|cholinergic agents|mesh-ancestor
56080280|NCT00384579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56080314|NCT00005025|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56080316|NCT00005025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080317|NCT00005025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56080318|NCT00005025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080319|NCT00005025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080320|NCT00004179|Prednisone|prednisone|mesh-list
56080321|NCT00004179|Cyclophosphamide|cyclophosphamide|mesh-list
56080322|NCT00004179|Rituximab|rituximab|mesh-list
56080323|NCT00004179|Doxorubicin|doxorubicin|mesh-list
56080324|NCT00004179|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56080325|NCT00004179|Vincristine|vincristine|mesh-list
56080326|NCT00004179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080327|NCT00004179|Immunologic Factors|immunologic factors|mesh-ancestor
56080328|NCT00004179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080329|NCT00004179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080330|NCT00004179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080331|NCT00004179|Alkylating Agents|alkylating agents|mesh-ancestor
56080332|NCT00004179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080333|NCT00004179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080334|NCT00004179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56080335|NCT00004179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56080336|NCT00004179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56080337|NCT00004179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080338|NCT00004179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080339|NCT00004179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080340|NCT00004179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080343|NCT00004179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080344|NCT00004179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56080355|NCT00003687|Analgesics|analgesics|mesh-ancestor
56080356|NCT00003687|Sensory System Agents|sensory system agents|mesh-ancestor
56080357|NCT00003687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080358|NCT00003687|Antitussive Agents|antitussive agents|mesh-ancestor
56080359|NCT00003687|Respiratory System Agents|respiratory system agents|mesh-ancestor
56080360|NCT00003687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56080361|NCT00003687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56080362|NCT00003687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56080363|NCT00003687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080364|NCT00004197|Prednisone|prednisone|mesh-list
56080365|NCT00004197|Cyclophosphamide|cyclophosphamide|mesh-list
56080366|NCT00004197|Doxorubicin|doxorubicin|mesh-list
56080367|NCT00004197|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56080368|NCT00004197|Vincristine|vincristine|mesh-list
56080369|NCT00004197|Mitoxantrone|mitoxantrone|mesh-list
56080370|NCT00004197|Sargramostim|sargramostim|mesh-list
56080371|NCT00004197|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56080372|NCT00004197|Vaccines|vaccines|mesh-list
56080373|NCT00004197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080374|NCT00004197|Immunologic Factors|immunologic factors|mesh-ancestor
56080375|NCT00004197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080376|NCT00004197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080377|NCT00004197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080378|NCT00004197|Alkylating Agents|alkylating agents|mesh-ancestor
56080379|NCT00004197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080380|NCT00004197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080381|NCT00004197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56080403|NCT00003693|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080404|NCT00003693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080406|NCT00005031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080407|NCT00005031|Alkylating Agents|alkylating agents|mesh-ancestor
56080408|NCT00005031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080409|NCT00005031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080410|NCT00005037|Temozolomide|temozolomide|mesh-list
56080411|NCT00005037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080412|NCT00005037|Alkylating Agents|alkylating agents|mesh-ancestor
56080413|NCT00005037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080414|NCT00005037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080415|NCT00004203|Oxaliplatin|oxaliplatin|mesh-list
56080416|NCT00004203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080417|NCT00004209|Mitomycins|mitomycins|mesh-list
56080418|NCT00004209|Mitomycin|mitomycin|mesh-list
56080419|NCT00004209|Vinblastine|vinblastine|mesh-list
56080420|NCT00004209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080421|NCT00004209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56080422|NCT00004209|Alkylating Agents|alkylating agents|mesh-ancestor
56080423|NCT00004209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080424|NCT00004209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56080425|NCT00004209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003779|NCT00000730|Vitamins|vitamins|mesh-ancestor
56080427|NCT00004209|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080452|NCT00004221|Cyclophosphamide|cyclophosphamide|mesh-list
56080453|NCT00004221|Carboplatin|carboplatin|mesh-list
56080454|NCT00004221|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56080455|NCT00004221|Topotecan|topotecan|mesh-list
56080456|NCT00004221|Lenograstim|lenograstim|mesh-list
56080457|NCT00004221|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080458|NCT00004221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080459|NCT00004221|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080460|NCT00004221|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080461|NCT00004221|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080462|NCT00004221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080463|NCT00004221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080464|NCT00004221|Immunologic Factors|immunologic factors|mesh-ancestor
56080465|NCT00004221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080466|NCT00004221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080467|NCT00004221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080468|NCT00004221|Alkylating Agents|alkylating agents|mesh-ancestor
56080469|NCT00004221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56080470|NCT00004221|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56080471|NCT00004221|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56080472|NCT00004221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080473|NCT00004221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080476|NCT00003711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56080477|NCT00003711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080478|NCT00003711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080479|NCT00003711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080480|NCT00003711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080481|NCT00003711|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56080482|NCT00003711|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56080495|NCT00003621|Alkylating Agents|alkylating agents|mesh-ancestor
56080496|NCT00385359|Albuterol|albuterol|mesh-list
56080497|NCT00385359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56080498|NCT00385359|Autonomic Agents|autonomic agents|mesh-ancestor
56080499|NCT00385359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080500|NCT00385359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080501|NCT00385359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56080502|NCT00385359|Respiratory System Agents|respiratory system agents|mesh-ancestor
56080503|NCT00385359|Tocolytic Agents|tocolytic agents|mesh-ancestor
56080504|NCT00385359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56080505|NCT00385359|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56080506|NCT00385359|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56080507|NCT00385359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56080508|NCT00385359|Adrenergic Agents|adrenergic agents|mesh-ancestor
56080509|NCT00385359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56080510|NCT00385359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080511|NCT00004233|Leucovorin|leucovorin|mesh-list
56080512|NCT00004233|Fluorouracil|fluorouracil|mesh-list
56080513|NCT00004233|Calcium|calcium|mesh-list
56080514|NCT00004233|Levoleucovorin|levoleucovorin|mesh-list
56080515|NCT00004233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56080516|NCT00004233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080517|NCT00004233|Antimetabolites|antimetabolites|mesh-ancestor
56080518|NCT00004233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080520|NCT00004233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080521|NCT00004233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080522|NCT00004233|Immunologic Factors|immunologic factors|mesh-ancestor
56080523|NCT00004233|Antidotes|antidotes|mesh-ancestor
56080524|NCT00004233|Protective Agents|protective agents|mesh-ancestor
56080525|NCT00004233|Vitamin B Complex|vitamin b complex|mesh-ancestor
56080526|NCT00004233|Vitamins|vitamins|mesh-ancestor
56080537|NCT00003717|Alkylating Agents|alkylating agents|mesh-ancestor
56080538|NCT00003717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56080539|NCT00003723|Gemcitabine|gemcitabine|mesh-list
56080540|NCT00003723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080541|NCT00003723|Antimetabolites|antimetabolites|mesh-ancestor
56080542|NCT00003723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080543|NCT00003723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080544|NCT00003723|Antiviral Agents|antiviral agents|mesh-ancestor
56080545|NCT00003723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080547|NCT00003723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080548|NCT00003723|Immunologic Factors|immunologic factors|mesh-ancestor
56080549|NCT00003723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080550|NCT00005061|Bevacizumab|bevacizumab|mesh-list
56080551|NCT00005061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56080552|NCT00005061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080553|NCT00005061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56080554|NCT00005061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56080555|NCT00005061|Growth Substances|growth substances|mesh-ancestor
56080556|NCT00005061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080557|NCT00005061|Growth Inhibitors|growth inhibitors|mesh-ancestor
56080558|NCT00004245|Salicylates|salicylates|mesh-list
56080559|NCT00004245|Sodium Salicylate|sodium salicylate|mesh-list
56080560|NCT00004245|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56080561|NCT00004245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56080562|NCT00004245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56080563|NCT00004245|Analgesics|analgesics|mesh-ancestor
56080564|NCT00004245|Sensory System Agents|sensory system agents|mesh-ancestor
56080565|NCT00004245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080566|NCT00004245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080567|NCT00004245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080568|NCT00004245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080569|NCT00004245|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56080570|NCT00004245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080572|NCT00004251|Letrozole|letrozole|mesh-list
56080577|NCT00004251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080578|NCT00004251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56080579|NCT00004251|Hormone Antagonists|hormone antagonists|mesh-ancestor
56080580|NCT00004251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080581|NCT00004251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080582|NCT00005067|Motexafin lutetium|motexafin lutetium|mesh-list
56080583|NCT00005067|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56080584|NCT00005067|Dermatologic Agents|dermatologic agents|mesh-ancestor
56080585|NCT00004257|Fluorouracil|fluorouracil|mesh-list
56080586|NCT00004257|Oxaliplatin|oxaliplatin|mesh-list
56080587|NCT00004257|Antimetabolites|antimetabolites|mesh-ancestor
56080588|NCT00004257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080589|NCT00004257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080590|NCT00004257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080591|NCT00004257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080592|NCT00004257|Immunologic Factors|immunologic factors|mesh-ancestor
56080593|NCT00004257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080595|NCT00003729|Fludarabine|fludarabine|mesh-list
56080596|NCT00003729|Fludarabine phosphate|fludarabine phosphate|mesh-list
56080597|NCT00003729|Idarubicin|idarubicin|mesh-list
56080598|NCT00003729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080599|NCT00003729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080600|NCT00003729|Antimetabolites|antimetabolites|mesh-ancestor
56080601|NCT00003729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080602|NCT00003729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080603|NCT00003729|Immunologic Factors|immunologic factors|mesh-ancestor
56080604|NCT00003729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080605|NCT00003729|Antiviral Agents|antiviral agents|mesh-ancestor
56080611|NCT00004263|Cytarabine|cytarabine|mesh-list
56080621|NCT00004263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080622|NCT00004263|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56080623|NCT00004263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080624|NCT00003735|Topotecan|topotecan|mesh-list
56080625|NCT00003735|10-hydroxycamptothecin|10-hydroxycamptothecin|mesh-list
56080626|NCT00003735|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56080627|NCT00003735|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080628|NCT00003735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080629|NCT00003735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080630|NCT00003735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080631|NCT00003735|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56080632|NCT00005073|Zoledronic Acid|zoledronic acid|mesh-list
56080633|NCT00005073|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56080634|NCT00005073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080635|NCT00004275|Hormones|hormones|mesh-list
56080636|NCT00004275|Oxandrolone|oxandrolone|mesh-list
56080637|NCT00004275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080638|NCT00004275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080639|NCT00004275|Androgens|androgens|mesh-ancestor
56080640|NCT00004275|Anabolic Agents|anabolic agents|mesh-ancestor
56080641|NCT00003741|Antibodies|antibodies|mesh-list
56080642|NCT00003741|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56080643|NCT00003741|Immunologic Factors|immunologic factors|mesh-ancestor
56080644|NCT00003741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080645|NCT00003747|Carboplatin|carboplatin|mesh-list
56080646|NCT00003747|Temozolomide|temozolomide|mesh-list
56080647|NCT00003747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080648|NCT00003747|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080649|NCT00003747|Alkylating Agents|alkylating agents|mesh-ancestor
56080650|NCT00003747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080651|NCT00004311|Leuprolide|leuprolide|mesh-list
56080652|NCT00004311|Spironolactone|spironolactone|mesh-list
56080662|NCT00004311|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56080663|NCT00004311|Diuretics|diuretics|mesh-ancestor
56080664|NCT00004311|Natriuretic Agents|natriuretic agents|mesh-ancestor
56080665|NCT00004317|Leucovorin|leucovorin|mesh-list
56080666|NCT00004317|Pyrimethamine|pyrimethamine|mesh-list
56080667|NCT00004317|Sulfadiazine|sulfadiazine|mesh-list
56080668|NCT00004317|Spiramycin|spiramycin|mesh-list
56080669|NCT00004317|Calcium|calcium|mesh-list
56080670|NCT00004317|Levoleucovorin|levoleucovorin|mesh-list
56080671|NCT00004317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56080672|NCT00004317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080673|NCT00004317|Antidotes|antidotes|mesh-ancestor
56080674|NCT00004317|Protective Agents|protective agents|mesh-ancestor
56080675|NCT00004317|Vitamin B Complex|vitamin b complex|mesh-ancestor
56080676|NCT00004317|Vitamins|vitamins|mesh-ancestor
56080677|NCT00004317|Micronutrients|micronutrients|mesh-ancestor
56080678|NCT00004317|Antimalarials|antimalarials|mesh-ancestor
56080679|NCT00004317|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56080680|NCT00004317|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56080681|NCT00004317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080682|NCT00004317|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56080683|NCT00004317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080684|NCT00004317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080685|NCT00004317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56080686|NCT00004317|Coccidiostats|coccidiostats|mesh-ancestor
56080687|NCT00005091|Exatecan|exatecan|mesh-list
56080688|NCT00005091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56080690|NCT00005091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080691|NCT00005091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080693|NCT00004323|Cyclosporine|cyclosporine|mesh-list
56080713|NCT00004323|Dermatologic Agents|dermatologic agents|mesh-ancestor
56080714|NCT00004323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080715|NCT00004323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56080716|NCT00004323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56080717|NCT00004323|Antifungal Agents|antifungal agents|mesh-ancestor
56080718|NCT00004323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080719|NCT00004323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56080720|NCT00004323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080722|NCT00004323|Autonomic Agents|autonomic agents|mesh-ancestor
56080723|NCT00004323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080724|NCT00004323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56080725|NCT00004323|Glucocorticoids|glucocorticoids|mesh-ancestor
56080726|NCT00004323|Hormones|hormones|mesh-ancestor
56080727|NCT00004323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080728|NCT00004323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56080729|NCT00004323|Protective Agents|protective agents|mesh-ancestor
56080730|NCT00003753|Dexamethasone|dexamethasone|mesh-list
56080731|NCT00003753|Irinotecan|irinotecan|mesh-list
56080732|NCT00003753|Floxuridine|floxuridine|mesh-list
56080735|NCT00003753|Autonomic Agents|autonomic agents|mesh-ancestor
56080736|NCT00003753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080737|NCT00003753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080738|NCT00003753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56080739|NCT00003753|Glucocorticoids|glucocorticoids|mesh-ancestor
56080740|NCT00003753|Hormones|hormones|mesh-ancestor
56080741|NCT00003753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080742|NCT00003753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56080743|NCT00003753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080744|NCT00003753|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56080745|NCT00003753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080746|NCT00003753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080754|NCT00003759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080755|NCT00003759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080756|NCT00003759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080757|NCT00003759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080758|NCT00003759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080759|NCT00003759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080760|NCT00003765|Carmustine|carmustine|mesh-list
56080761|NCT00003765|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56080762|NCT00003765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080763|NCT00003765|Alkylating Agents|alkylating agents|mesh-ancestor
56080764|NCT00003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080765|NCT00003765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080766|NCT00003765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080767|NCT00003771|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56080768|NCT00003771|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56080769|NCT00003771|Norethindrone|norethindrone|mesh-list
56080770|NCT00003771|Norethindrone Acetate|norethindrone acetate|mesh-list
56080771|NCT00003771|Estradiol|estradiol|mesh-list
56080772|NCT00003771|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56080773|NCT00003771|Estrogens|estrogens|mesh-ancestor
56080774|NCT00003771|Hormones|hormones|mesh-ancestor
56080775|NCT00003771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080776|NCT00003771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080777|NCT00003771|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56080778|NCT00003771|Contraceptive Agents|contraceptive agents|mesh-ancestor
56080779|NCT00003771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56080780|NCT00003771|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56080781|NCT00003771|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56080782|NCT00003771|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56080783|NCT00003771|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56080784|NCT00004359|Methoxsalen|methoxsalen|mesh-list
56080785|NCT00004359|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56080786|NCT00004359|Dermatologic Agents|dermatologic agents|mesh-ancestor
56080787|NCT00004401|Immunoglobulins|immunoglobulins|mesh-list
56080793|NCT00004401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080794|NCT00003783|Leucovorin|leucovorin|mesh-list
56080795|NCT00003783|Cytarabine|cytarabine|mesh-list
56080796|NCT00003783|Dexamethasone|dexamethasone|mesh-list
56080797|NCT00003783|Prednisone|prednisone|mesh-list
56080798|NCT00003783|Cyclophosphamide|cyclophosphamide|mesh-list
56080799|NCT00003783|Methotrexate|methotrexate|mesh-list
56080800|NCT00003783|Etoposide|etoposide|mesh-list
56080801|NCT00003783|Vincristine|vincristine|mesh-list
56080802|NCT00003783|Daunorubicin|daunorubicin|mesh-list
56080803|NCT00003783|Asparaginase|asparaginase|mesh-list
56080804|NCT00003783|Mercaptopurine|mercaptopurine|mesh-list
56080805|NCT00003783|Idarubicin|idarubicin|mesh-list
56080806|NCT00003783|Levoleucovorin|levoleucovorin|mesh-list
56080807|NCT00003783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080808|NCT00003783|Immunologic Factors|immunologic factors|mesh-ancestor
56080809|NCT00003783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080810|NCT00003783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56080811|NCT00003783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080812|NCT00003783|Alkylating Agents|alkylating agents|mesh-ancestor
56080813|NCT00003783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080814|NCT00003783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080815|NCT00003783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56080816|NCT00003783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56080817|NCT00003783|Antiemetics|antiemetics|mesh-ancestor
56080818|NCT00003783|Autonomic Agents|autonomic agents|mesh-ancestor
56080819|NCT00003783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080820|NCT00003783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56080821|NCT00003783|Glucocorticoids|glucocorticoids|mesh-ancestor
56080823|NCT00003783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56080824|NCT00003783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56080825|NCT00003783|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56080826|NCT00003783|Abortifacient Agents|abortifacient agents|mesh-ancestor
56080827|NCT00003783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56080828|NCT00003783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56080835|NCT00003783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56080836|NCT00003783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56080838|NCT00003783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080839|NCT00003783|Antidotes|antidotes|mesh-ancestor
56080840|NCT00003783|Protective Agents|protective agents|mesh-ancestor
56080841|NCT00003783|Vitamin B Complex|vitamin b complex|mesh-ancestor
56080842|NCT00003783|Vitamins|vitamins|mesh-ancestor
56080843|NCT00003783|Micronutrients|micronutrients|mesh-ancestor
56080844|NCT00003783|Tubulin Modulators|tubulin modulators|mesh-ancestor
56080845|NCT00003783|Antimitotic Agents|antimitotic agents|mesh-ancestor
56080846|NCT00003783|Mitosis Modulators|mitosis modulators|mesh-ancestor
56080847|NCT00003783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56080848|NCT00003789|Melphalan|melphalan|mesh-list
56080849|NCT00003789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56080850|NCT00003789|Alkylating Agents|alkylating agents|mesh-ancestor
56080851|NCT00003789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080852|NCT00003789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080853|NCT00003789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56080854|NCT00003789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080855|NCT00003789|Immunologic Factors|immunologic factors|mesh-ancestor
56080856|NCT00003789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080857|NCT00004407|Immunoglobulins|immunoglobulins|mesh-list
56080858|NCT00004407|Antibodies|antibodies|mesh-list
56080859|NCT00004407|gamma-Globulins|gamma-globulins|mesh-list
56080860|NCT00004407|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56080861|NCT00004407|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56080862|NCT00004407|Immunologic Factors|immunologic factors|mesh-ancestor
56080863|NCT00004407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080864|NCT00004419|Mitogens|mitogens|mesh-list
56080865|NCT00004419|Mitosis Modulators|mitosis modulators|mesh-ancestor
56003780|NCT00000730|Micronutrients|micronutrients|mesh-ancestor
56080867|NCT00004431|Baclofen|baclofen|mesh-list
56080868|NCT00004431|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56080869|NCT00004431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080870|NCT00004431|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56080876|NCT00004431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080877|NCT00384891|BCG Vaccine|bcg vaccine|mesh-list
56080878|NCT00384891|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56080879|NCT00384891|Immunologic Factors|immunologic factors|mesh-ancestor
56080880|NCT00384891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080881|NCT04712799|Xylometazoline|xylometazoline|mesh-list
56080882|NCT04712799|Nasal Decongestants|nasal decongestants|mesh-ancestor
56080883|NCT04712799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56081135|NCT02472314|Bupivacaine|bupivacaine|mesh-list
56080884|NCT04712799|Respiratory System Agents|respiratory system agents|mesh-ancestor
56080885|NCT00384969|Sorafenib|sorafenib|mesh-list
56080886|NCT00384969|Everolimus|everolimus|mesh-list
56080887|NCT00384969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080888|NCT00384969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56080889|NCT00384969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080890|NCT00384969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080891|NCT00384969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080892|NCT00384969|Immunologic Factors|immunologic factors|mesh-ancestor
56080893|NCT00384969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080894|NCT00385437|Mirtazapine|mirtazapine|mesh-list
56080895|NCT00385437|Antidepressive Agents|antidepressive agents|mesh-ancestor
56080896|NCT00385437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56080897|NCT00385437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56080898|NCT00385437|Histamine Antagonists|histamine antagonists|mesh-ancestor
56080899|NCT00385437|Histamine Agents|histamine agents|mesh-ancestor
56080900|NCT00385437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56080901|NCT00385437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080903|NCT00385437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56080924|NCT00004467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080926|NCT00004479|Midodrine|midodrine|mesh-list
56080927|NCT00004479|Sympathomimetics|sympathomimetics|mesh-ancestor
56080928|NCT00004479|Autonomic Agents|autonomic agents|mesh-ancestor
56080929|NCT00004479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080930|NCT00004479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080931|NCT00004479|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56080932|NCT00004479|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56080933|NCT00004479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56080934|NCT00004479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56080935|NCT00004479|Adrenergic Agents|adrenergic agents|mesh-ancestor
56080936|NCT00004479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56080937|NCT00004479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080938|NCT00004485|Cyclosporine|cyclosporine|mesh-list
56080939|NCT00004485|Mycophenolic Acid|mycophenolic acid|mesh-list
56080940|NCT00004485|Fludarabine|fludarabine|mesh-list
56080941|NCT00004485|Cyclosporins|cyclosporins|mesh-list
56080942|NCT00004485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56080943|NCT00004485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080944|NCT00004485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56080945|NCT00004485|Immunologic Factors|immunologic factors|mesh-ancestor
56080946|NCT00004485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080947|NCT00004485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56080948|NCT00004485|Antifungal Agents|antifungal agents|mesh-ancestor
56080949|NCT00004485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56080950|NCT00004485|Dermatologic Agents|dermatologic agents|mesh-ancestor
56080970|NCT00003819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080971|NCT00003825|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
56080972|NCT00003825|Anticoagulants|anticoagulants|mesh-ancestor
56080973|NCT00004551|Nicotine|nicotine|mesh-list
56080974|NCT00004551|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56080975|NCT00004551|Autonomic Agents|autonomic agents|mesh-ancestor
56080976|NCT00004551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56080977|NCT00004551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56080978|NCT00004551|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56080979|NCT00004551|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56080980|NCT00004551|Cholinergic Agents|cholinergic agents|mesh-ancestor
56080981|NCT00004551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56080982|NCT00004551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080983|NCT02678312|Enalapril|enalapril|mesh-list
56080984|NCT02678312|Enalaprilat|enalaprilat|mesh-list
56080985|NCT02678312|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56080987|NCT02678312|Protease Inhibitors|protease inhibitors|mesh-ancestor
56080988|NCT02678312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741246|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56080989|NCT02678312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56080990|NCT02678312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55808181|NCT05291845|Vaccines|vaccines|mesh-list
56080991|NCT02678312|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56080992|NCT00003843|Irinotecan|irinotecan|mesh-list
56080993|NCT00003843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56080995|NCT00003843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081012|NCT00004575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56081013|NCT00004575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56081014|NCT00004575|Hormone Antagonists|hormone antagonists|mesh-ancestor
56081136|NCT02472314|Anesthetics, Local|anesthetics, local|mesh-ancestor
56081015|NCT00004575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081016|NCT00004575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081017|NCT00004575|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56081018|NCT00004575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56081019|NCT00004575|Vasodilator Agents|vasodilator agents|mesh-ancestor
56081020|NCT00004575|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
56081021|NCT00004575|Protease Inhibitors|protease inhibitors|mesh-ancestor
56081022|NCT00004581|Ritonavir|ritonavir|mesh-list
56081023|NCT00004581|Lopinavir|lopinavir|mesh-list
56081024|NCT00004581|Nevirapine|nevirapine|mesh-list
56081025|NCT00004581|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56081026|NCT00004581|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56081027|NCT00004581|Protease Inhibitors|protease inhibitors|mesh-ancestor
56081028|NCT00004581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081029|NCT00004581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081030|NCT00004581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56081031|NCT00004581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56081032|NCT00004581|Antiviral Agents|antiviral agents|mesh-ancestor
56081033|NCT00004581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081034|NCT00004581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56081035|NCT00004581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56081036|NCT00004581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56081058|NCT00362960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56081059|NCT00362960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56081060|NCT00362960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081062|NCT00003867|Irinotecan|irinotecan|mesh-list
56081069|NCT00003867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081070|NCT00004665|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56081071|NCT00004665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56081072|NCT00004665|Immunologic Factors|immunologic factors|mesh-ancestor
56081073|NCT00004665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081075|NCT00363584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081076|NCT00363584|Antimetabolites|antimetabolites|mesh-ancestor
56081077|NCT00363584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081078|NCT00363584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081079|NCT00003873|Fluorouracil|fluorouracil|mesh-list
56081080|NCT00003873|Eniluracil|eniluracil|mesh-list
56081081|NCT00003873|Antimetabolites|antimetabolites|mesh-ancestor
56081082|NCT00003873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081083|NCT00003873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081084|NCT00003873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081085|NCT00003873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081086|NCT00003873|Immunologic Factors|immunologic factors|mesh-ancestor
56081104|NCT00004689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56081105|NCT00004689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56081106|NCT00004689|Antitubercular Agents|antitubercular agents|mesh-ancestor
56081107|NCT00004689|Leprostatic Agents|leprostatic agents|mesh-ancestor
56081108|NCT00004689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56081109|NCT00004689|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56081110|NCT00004689|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56081111|NCT00004689|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56081112|NCT00004689|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56081113|NCT00004689|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56081114|NCT00004689|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56081115|NCT00004695|Interleukin-2|interleukin-2|mesh-list
56081116|NCT00004695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081117|NCT00004695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56081118|NCT00004695|Analgesics|analgesics|mesh-ancestor
56081119|NCT00004695|Sensory System Agents|sensory system agents|mesh-ancestor
56081120|NCT00004695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081121|NCT00004695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081122|NCT02570984|Omalizumab|omalizumab|mesh-list
56081123|NCT02570984|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56081124|NCT02570984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56081125|NCT02570984|Respiratory System Agents|respiratory system agents|mesh-ancestor
56081126|NCT00004731|Ubiquinone|ubiquinone|mesh-list
56081127|NCT00004731|Coenzyme Q10|coenzyme q10|mesh-list
56081128|NCT00004731|Micronutrients|micronutrients|mesh-ancestor
56081129|NCT00004731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081130|NCT00004731|Vitamins|vitamins|mesh-ancestor
56081131|NCT00003885|Arsenic Trioxide|arsenic trioxide|mesh-list
56081132|NCT00003885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081133|NCT00003891|Lurtotecan|lurtotecan|mesh-list
56081134|NCT00003891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081138|NCT02472314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56081139|NCT02472314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081144|NCT00004755|Antimetabolites|antimetabolites|mesh-ancestor
56081145|NCT00004755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081146|NCT00004755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081147|NCT00004755|Gout Suppressants|gout suppressants|mesh-ancestor
56081148|NCT00004755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081149|NCT00004755|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56081150|NCT00004755|Antioxidants|antioxidants|mesh-ancestor
56081151|NCT00004755|Protective Agents|protective agents|mesh-ancestor
56081152|NCT00004755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081154|NCT00004755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56081155|NCT00004755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081156|NCT00003897|Sargramostim|sargramostim|mesh-list
56081157|NCT00003897|Immunologic Factors|immunologic factors|mesh-ancestor
56081158|NCT00003897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081159|NCT00003909|Motexafin gadolinium|motexafin gadolinium|mesh-list
56081160|NCT00003909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081161|NCT00003909|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56081162|NCT00003909|Dermatologic Agents|dermatologic agents|mesh-ancestor
56081163|NCT00004767|Sodium Benzoate|sodium benzoate|mesh-list
56081164|NCT00004767|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56081165|NCT00004767|Phenylacetic acid|phenylacetic acid|mesh-list
56081166|NCT00004767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081167|NCT00004767|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081168|NCT00004767|Antimetabolites|antimetabolites|mesh-ancestor
56081169|NCT00004767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081170|NCT00004767|Antifungal Agents|antifungal agents|mesh-ancestor
56081171|NCT00004767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081172|NCT00004785|Dexamethasone|dexamethasone|mesh-list
56081173|NCT00004785|Methylprednisolone|methylprednisolone|mesh-list
56081174|NCT00004785|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56081175|NCT00004785|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56081188|NCT00004785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081189|NCT00004785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56081190|NCT00004785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081191|NCT00004785|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56081192|NCT00004785|Protective Agents|protective agents|mesh-ancestor
56081193|NCT00004815|Hormones|hormones|mesh-list
56081194|NCT00004815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081195|NCT00004815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081196|NCT02279823|Minoxidil|minoxidil|mesh-list
56081197|NCT02279823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56081198|NCT02279823|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56081199|NCT02279823|Vasodilator Agents|vasodilator agents|mesh-ancestor
56081200|NCT04040361|Pembrolizumab|pembrolizumab|mesh-list
56081201|NCT04040361|Ramucirumab|ramucirumab|mesh-list
56081202|NCT04040361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56081203|NCT04040361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081204|NCT00386061|Rimonabant|rimonabant|mesh-list
56081205|NCT00386061|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56081206|NCT00386061|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
56081207|NCT00386061|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56081208|NCT00386061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56081209|NCT00386061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081210|NCT00386061|Hormones|hormones|mesh-ancestor
56081211|NCT00386061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081212|NCT00386061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081213|NCT00005571|Eculizumab|eculizumab|mesh-list
56081214|NCT00005571|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56081232|NCT00005583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081233|NCT00005583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56081234|NCT00005583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081235|NCT00005583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081236|NCT00005583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081237|NCT00005583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081238|NCT00005589|Cytarabine|cytarabine|mesh-list
56081239|NCT00005589|Cyclophosphamide|cyclophosphamide|mesh-list
56081240|NCT00005589|Melphalan|melphalan|mesh-list
56081241|NCT00005589|Carmustine|carmustine|mesh-list
56081242|NCT00005589|Rituximab|rituximab|mesh-list
56081243|NCT00005589|Etoposide|etoposide|mesh-list
56081244|NCT00005589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081245|NCT00005589|Immunologic Factors|immunologic factors|mesh-ancestor
56081246|NCT00005589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081248|NCT00005589|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56081249|NCT00005589|Alkylating Agents|alkylating agents|mesh-ancestor
56081250|NCT00005589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081251|NCT00005589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081252|NCT00005589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56081253|NCT00005589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56081254|NCT00005589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56081255|NCT00005589|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081256|NCT00005589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081257|NCT00005589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081258|NCT00005589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081259|NCT00005589|Antimetabolites|antimetabolites|mesh-ancestor
56081260|NCT00005589|Antiviral Agents|antiviral agents|mesh-ancestor
56081261|NCT00005589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081262|NCT00005601|Cytarabine|cytarabine|mesh-list
56081263|NCT00005601|Dexamethasone|dexamethasone|mesh-list
56081264|NCT00005601|Rituximab|rituximab|mesh-list
56081265|NCT00005601|Sargramostim|sargramostim|mesh-list
56081266|NCT00005601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56081273|NCT00005601|Autonomic Agents|autonomic agents|mesh-ancestor
56081274|NCT00005601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081275|NCT00005601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56081276|NCT00005601|Glucocorticoids|glucocorticoids|mesh-ancestor
56081278|NCT00005601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741253|NCT03369847|Hormones|hormones|mesh-ancestor
56081279|NCT00005601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56081280|NCT00005601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081282|NCT00005601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081284|NCT00005601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081285|NCT00005601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081286|NCT00005607|Leucovorin|leucovorin|mesh-list
56081287|NCT00005607|Fluorouracil|fluorouracil|mesh-list
56081288|NCT00005607|Irinotecan|irinotecan|mesh-list
56081289|NCT00005607|Calcium|calcium|mesh-list
56081290|NCT00005607|Levoleucovorin|levoleucovorin|mesh-list
56081291|NCT00005607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56081292|NCT00005607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081293|NCT00005607|Antimetabolites|antimetabolites|mesh-ancestor
56081294|NCT00005607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081295|NCT00005607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081296|NCT00005607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081297|NCT00005607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081298|NCT00005607|Immunologic Factors|immunologic factors|mesh-ancestor
56081299|NCT00005607|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56081300|NCT00005607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081320|NCT00005613|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081321|NCT00005613|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081322|NCT00005613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081323|NCT00005625|Trabectedin|trabectedin|mesh-list
56081324|NCT00005625|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56081325|NCT00005625|Alkylating Agents|alkylating agents|mesh-ancestor
56081326|NCT00005625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081327|NCT00005625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081329|NCT00005631|Carboplatin|carboplatin|mesh-list
56081330|NCT00005631|Etoposide|etoposide|mesh-list
56081331|NCT00005631|Ifosfamide|ifosfamide|mesh-list
56081332|NCT00005631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56081333|NCT00005631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081334|NCT00005631|Immunologic Factors|immunologic factors|mesh-ancestor
56081335|NCT00005631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081336|NCT00005631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081337|NCT00005631|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56081338|NCT00005631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081339|NCT00005631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081340|NCT00005631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081341|NCT00005631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081342|NCT00005631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56081343|NCT00005631|Alkylating Agents|alkylating agents|mesh-ancestor
56081344|NCT00005637|Temozolomide|temozolomide|mesh-list
56081345|NCT00005637|Carmustine|carmustine|mesh-list
56081346|NCT00005637|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56081347|NCT00005637|Alkylating Agents|alkylating agents|mesh-ancestor
56081348|NCT00005637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081349|NCT00005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081352|NCT00005643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56081353|NCT00005643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081356|NCT00005643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081360|NCT00005649|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56081361|NCT00005649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081362|NCT00005649|Tubulin Modulators|tubulin modulators|mesh-ancestor
56081363|NCT00005649|Antimitotic Agents|antimitotic agents|mesh-ancestor
56081364|NCT00005649|Mitosis Modulators|mitosis modulators|mesh-ancestor
56081365|NCT00005649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081366|NCT00005649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081367|NCT00005649|Antimetabolites|antimetabolites|mesh-ancestor
56081369|NCT00005673|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56081370|NCT00005673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56081372|NCT00005673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081373|NCT00005673|Antiviral Agents|antiviral agents|mesh-ancestor
56081374|NCT00005673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081375|NCT00005673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56081376|NCT00005673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56081377|NCT02247349|Nivolumab|nivolumab|mesh-list
56081378|NCT02247349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56081379|NCT02247349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081380|NCT02247349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56081381|NCT02247349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081382|NCT03390673|Bevacizumab|bevacizumab|mesh-list
56081383|NCT03390673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56081384|NCT03390673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081385|NCT03390673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56081386|NCT03390673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56081387|NCT03390673|Growth Substances|growth substances|mesh-ancestor
56081388|NCT03390673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081389|NCT03390673|Growth Inhibitors|growth inhibitors|mesh-ancestor
56081390|NCT02974933|Pemetrexed|pemetrexed|mesh-list
56081391|NCT02974933|Apatinib|apatinib|mesh-list
56081392|NCT02974933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081393|NCT02974933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081394|NCT02974933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081398|NCT00005769|Hormones|hormones|mesh-list
56081399|NCT00005769|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081400|NCT00005769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081401|NCT00005775|Amino-acid, glucose, and electrolyte solution|amino-acid, glucose, and electrolyte solution|mesh-list
56081402|NCT00005775|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56081403|NCT00005775|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56081404|NCT00005787|Epoetin Alfa|epoetin alfa|mesh-list
56081405|NCT00005787|Flt3 ligand protein|flt3 ligand protein|mesh-list
56081406|NCT00005787|Sargramostim|sargramostim|mesh-list
56081407|NCT00005787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56081408|NCT00005787|Immunologic Factors|immunologic factors|mesh-ancestor
56081409|NCT00005787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081410|NCT00005787|Hematinics|hematinics|mesh-ancestor
56081411|NCT00005787|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56081412|NCT00005787|Protective Agents|protective agents|mesh-ancestor
56081413|NCT00005793|Cytarabine|cytarabine|mesh-list
56081414|NCT00005793|Etoposide|etoposide|mesh-list
56081415|NCT00005793|Daunorubicin|daunorubicin|mesh-list
56081416|NCT00005793|Topotecan|topotecan|mesh-list
56081417|NCT00005793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56081418|NCT00005793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081419|NCT00005793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081420|NCT00005793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081421|NCT00005793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081422|NCT00005793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081423|NCT00005793|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081424|NCT00005793|Antimetabolites|antimetabolites|mesh-ancestor
56081425|NCT00005793|Antiviral Agents|antiviral agents|mesh-ancestor
56081426|NCT00005793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081427|NCT00005793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081428|NCT00005793|Immunologic Factors|immunologic factors|mesh-ancestor
56081429|NCT00005793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081430|NCT00005793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56081438|NCT00005799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56081440|NCT00005799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081441|NCT00005799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081442|NCT00005799|Immunologic Factors|immunologic factors|mesh-ancestor
56081894|NCT02424968|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081443|NCT00005799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081444|NCT00005799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081445|NCT00005799|Antifungal Agents|antifungal agents|mesh-ancestor
56081446|NCT00005799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081447|NCT00005799|Dermatologic Agents|dermatologic agents|mesh-ancestor
56081448|NCT00005799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081449|NCT00005799|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56081450|NCT00005799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56081451|NCT00005799|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56081452|NCT00005799|Antitubercular Agents|antitubercular agents|mesh-ancestor
56081453|NCT00005799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56081455|NCT00386373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081456|NCT00386373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56081457|NCT00386373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081458|NCT00386373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081459|NCT00005811|Topotecan|topotecan|mesh-list
56081460|NCT00005811|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56081461|NCT00005811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081462|NCT00005811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081463|NCT00005811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081464|NCT00005811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081465|NCT02520518|Dapagliflozin|dapagliflozin|mesh-list
56081466|NCT02520518|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56081483|NCT01689987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081484|NCT01689987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081485|NCT01689987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56081486|NCT01689987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56081487|NCT01689987|Antiemetics|antiemetics|mesh-ancestor
56081488|NCT01689987|Autonomic Agents|autonomic agents|mesh-ancestor
56081489|NCT01689987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081490|NCT01689987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56081491|NCT01689987|Glucocorticoids|glucocorticoids|mesh-ancestor
56081492|NCT01689987|Hormones|hormones|mesh-ancestor
56081493|NCT01689987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081494|NCT01689987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56081495|NCT01689987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56081496|NCT01689987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081497|NCT01689987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56081498|NCT01689987|Antifungal Agents|antifungal agents|mesh-ancestor
56081499|NCT01689987|Antimalarials|antimalarials|mesh-ancestor
56081500|NCT01689987|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56081501|NCT01689987|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56081502|NCT01689987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081503|NCT01689987|Protease Inhibitors|protease inhibitors|mesh-ancestor
56081504|NCT01689987|Dermatologic Agents|dermatologic agents|mesh-ancestor
56081505|NCT01680939|Ibuprofen|ibuprofen|mesh-list
56081506|NCT01680939|Morphine|morphine|mesh-list
56081507|NCT01680939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56081509|NCT01680939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56081510|NCT01680939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081511|NCT01680939|Analgesics|analgesics|mesh-ancestor
55741319|NCT03370627|Antibodies|antibodies|mesh-list
56081512|NCT01680939|Sensory System Agents|sensory system agents|mesh-ancestor
56081515|NCT01680939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56081526|NCT01689597|Analgesics|analgesics|mesh-ancestor
56081527|NCT01689597|Sensory System Agents|sensory system agents|mesh-ancestor
56081528|NCT01689597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081529|NCT02163733|Osimertinib|osimertinib|mesh-list
56081530|NCT02163733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081531|NCT02163733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56081532|NCT02163733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081533|NCT02163733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081534|NCT04823247|Interleukin-23|interleukin-23|mesh-list
56081535|NCT04823247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56081536|NCT04823247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56081537|NCT04823247|Growth Substances|growth substances|mesh-ancestor
56081538|NCT04823247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081539|NCT04823247|Growth Inhibitors|growth inhibitors|mesh-ancestor
56081540|NCT04823247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081542|NCT02483000|Cytarabine|cytarabine|mesh-list
56081543|NCT02483000|Etoposide|etoposide|mesh-list
56081544|NCT02483000|Podophyllotoxin|podophyllotoxin|mesh-list
56081545|NCT02483000|Etoposide phosphate|etoposide phosphate|mesh-list
56081546|NCT02483000|Melphalan|melphalan|mesh-list
56081547|NCT02483000|Mechlorethamine|mechlorethamine|mesh-list
56081548|NCT02483000|Carmustine|carmustine|mesh-list
56081549|NCT02483000|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56081550|NCT02483000|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56081552|NCT02483000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081579|NCT02420210|Obinutuzumab|obinutuzumab|mesh-list
56081580|NCT02420210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56081581|NCT02420210|Antiemetics|antiemetics|mesh-ancestor
56081582|NCT02420210|Autonomic Agents|autonomic agents|mesh-ancestor
56081583|NCT02420210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081584|NCT02420210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081585|NCT02420210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56081586|NCT02420210|Glucocorticoids|glucocorticoids|mesh-ancestor
56081587|NCT02420210|Hormones|hormones|mesh-ancestor
56081588|NCT02420210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081589|NCT02420210|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56081590|NCT02420210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081591|NCT02420210|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56081592|NCT02420210|Alkylating Agents|alkylating agents|mesh-ancestor
56081593|NCT02420210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081594|NCT02420210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56081596|NCT04829799|Lidocaine|lidocaine|mesh-list
56081597|NCT04829799|Phenylephrine|phenylephrine|mesh-list
56081598|NCT04829799|Oxymetazoline|oxymetazoline|mesh-list
56081599|NCT04829799|Anesthetics, Local|anesthetics, local|mesh-ancestor
56081600|NCT04829799|Anesthetics|anesthetics|mesh-ancestor
56081601|NCT04829799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56081602|NCT04829799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081603|NCT04829799|Sensory System Agents|sensory system agents|mesh-ancestor
56081604|NCT04829799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081605|NCT04829799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56081606|NCT04829799|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56081607|NCT04829799|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56081608|NCT04829799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56081609|NCT04829799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081610|NCT04829799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56081621|NCT04829799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56081622|NCT04829799|Nasal Decongestants|nasal decongestants|mesh-ancestor
56081623|NCT04829799|Respiratory System Agents|respiratory system agents|mesh-ancestor
56081624|NCT04829799|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56081625|NCT04829799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56081626|NCT04829799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56081627|NCT04829799|Adrenergic Agents|adrenergic agents|mesh-ancestor
56081628|NCT04829799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56081629|NCT04829799|Protective Agents|protective agents|mesh-ancestor
56081632|NCT04824417|Antifungal Agents|antifungal agents|mesh-ancestor
56081633|NCT04824417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081634|NCT04824417|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56081635|NCT04824417|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56081636|NCT04824417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081637|NCT04824417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081638|NCT04824417|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56081639|NCT04824417|Hormone Antagonists|hormone antagonists|mesh-ancestor
56081640|NCT04824417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081641|NCT04824417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081642|NCT04824417|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56081643|NCT01789333|Riboflavin|riboflavin|mesh-list
56081644|NCT01789333|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56081645|NCT01789333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56081646|NCT01789333|Vitamin B Complex|vitamin b complex|mesh-ancestor
56081647|NCT01789333|Vitamins|vitamins|mesh-ancestor
56081648|NCT01789333|Micronutrients|micronutrients|mesh-ancestor
56081649|NCT01789333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081650|NCT01789333|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56081651|NCT01789333|Dermatologic Agents|dermatologic agents|mesh-ancestor
56081652|NCT02524106|Bococizumab|bococizumab|mesh-list
56081663|NCT01761877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081664|NCT01761877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081666|NCT01761877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081667|NCT01761877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081668|NCT01761877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56081669|NCT01761877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081670|NCT01761877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081671|NCT04821375|Bazedoxifene|bazedoxifene|mesh-list
56081672|NCT04821375|Estrogens|estrogens|mesh-list
56081673|NCT04821375|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56081674|NCT04821375|Hormones|hormones|mesh-ancestor
56081675|NCT04821375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081676|NCT04821375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081677|NCT04821375|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56081678|NCT04821375|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56081679|NCT04821375|Hormone Antagonists|hormone antagonists|mesh-ancestor
56081680|NCT04821375|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56081682|NCT02488070|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56081683|NCT02488070|Chelating Agents|chelating agents|mesh-ancestor
56081684|NCT02488070|Sequestering Agents|sequestering agents|mesh-ancestor
56081685|NCT02488070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081686|NCT02488070|Anticoagulants|anticoagulants|mesh-ancestor
56081687|NCT02488070|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56081688|NCT02488070|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56081689|NCT04116541|Trametinib|trametinib|mesh-list
56081690|NCT04116541|Dabrafenib|dabrafenib|mesh-list
56081691|NCT04116541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081692|NCT04116541|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56081707|NCT03306979|Antioxidants|antioxidants|mesh-ancestor
56081708|NCT03306979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081709|NCT03306979|Protective Agents|protective agents|mesh-ancestor
56081710|NCT03306979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081711|NCT03306979|Antidotes|antidotes|mesh-ancestor
56081712|NCT00362869|Levofloxacin|levofloxacin|mesh-list
56081713|NCT00362869|Ofloxacin|ofloxacin|mesh-list
56081714|NCT00362869|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56081715|NCT00362869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081716|NCT00362869|Renal Agents|renal agents|mesh-ancestor
56081717|NCT00362869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56081718|NCT00362869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56081719|NCT00362869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56081720|NCT00362869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081721|NCT00362869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081722|NCT00362869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081723|NCT00362869|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56081724|NCT00362869|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56081725|NCT03257215|Vitamin D|vitamin d|mesh-list
56081726|NCT03257215|Ergocalciferols|ergocalciferols|mesh-list
56081727|NCT03257215|Cholecalciferol|cholecalciferol|mesh-list
56081728|NCT03257215|Vitamins|vitamins|mesh-list
56081729|NCT03257215|Micronutrients|micronutrients|mesh-ancestor
56081730|NCT03257215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081731|NCT03257215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56081732|NCT03257215|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56081733|NCT02422940|4-Aminopyridine|4-aminopyridine|mesh-list
56081734|NCT02422940|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56081735|NCT02422940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56081736|NCT02422940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081738|NCT00588523|Busulfan|busulfan|mesh-list
56081739|NCT00588523|Thiotepa|thiotepa|mesh-list
56081741|NCT00588523|Alkylating Agents|alkylating agents|mesh-ancestor
56081749|NCT02974387|Fluorometholone|fluorometholone|mesh-list
56081750|NCT02974387|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56081751|NCT02974387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56081752|NCT02974387|Glucocorticoids|glucocorticoids|mesh-ancestor
56081754|NCT02974387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081755|NCT02974387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081756|NCT00493831|Nicotine|nicotine|mesh-list
56081757|NCT00493831|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56081758|NCT00493831|Autonomic Agents|autonomic agents|mesh-ancestor
56081759|NCT00493831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081760|NCT00493831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081761|NCT00493831|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56081762|NCT00493831|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56081763|NCT00493831|Cholinergic Agents|cholinergic agents|mesh-ancestor
56081764|NCT00493831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56081765|NCT00493831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081767|NCT00430183|Leuprolide|leuprolide|mesh-list
56081768|NCT00430183|Goserelin|goserelin|mesh-list
56081769|NCT00430183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081770|NCT00430183|Tubulin Modulators|tubulin modulators|mesh-ancestor
56081771|NCT00430183|Antimitotic Agents|antimitotic agents|mesh-ancestor
56081772|NCT00430183|Mitosis Modulators|mitosis modulators|mesh-ancestor
56081773|NCT00430183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081774|NCT00430183|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56081775|NCT00430183|Fertility Agents|fertility agents|mesh-ancestor
56081776|NCT00430183|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56081777|NCT00430183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081778|NCT00430183|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56081779|NCT00362947|Parnaparin|parnaparin|mesh-list
56081780|NCT00362947|Anticoagulants|anticoagulants|mesh-ancestor
56081781|NCT00362947|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56081782|NCT00362947|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56081791|NCT00363025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081792|NCT02444143|Tacrolimus|tacrolimus|mesh-list
56081793|NCT02444143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081794|NCT02444143|Immunologic Factors|immunologic factors|mesh-ancestor
56081795|NCT02444143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081796|NCT02444143|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56081797|NCT02444143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081798|NCT02444143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081799|NCT03161431|Pembrolizumab|pembrolizumab|mesh-list
56081800|NCT03161431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56081801|NCT03161431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081802|NCT02445859|Cefuroxime|cefuroxime|mesh-list
56081803|NCT02445859|Cefuroxime axetil|cefuroxime axetil|mesh-list
56081804|NCT02445859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56081805|NCT02445859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081806|NCT02446483|Rabeprazole|rabeprazole|mesh-list
56081807|NCT02446483|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56081808|NCT02446483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56081809|NCT02446483|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56081810|NCT02446483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081811|NCT02446483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081812|NCT00362635|Clevudine|clevudine|mesh-list
56081813|NCT00362635|Antiviral Agents|antiviral agents|mesh-ancestor
56081814|NCT00362635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081815|NCT04744753|Calcium|calcium|mesh-list
56081842|NCT02421211|Antiviral Agents|antiviral agents|mesh-ancestor
56081843|NCT02421211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081844|NCT02421211|Protease Inhibitors|protease inhibitors|mesh-ancestor
56081845|NCT02421211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081846|NCT02421211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081848|NCT00363259|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56081849|NCT00363259|Antimetabolites|antimetabolites|mesh-ancestor
56081850|NCT00363259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081851|NCT00363259|Antiviral Agents|antiviral agents|mesh-ancestor
56081852|NCT00363259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081853|NCT03091075|Oxandrolone|oxandrolone|mesh-list
56081854|NCT03091075|Androgens|androgens|mesh-ancestor
56081855|NCT03091075|Hormones|hormones|mesh-ancestor
56081856|NCT03091075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081857|NCT03091075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081858|NCT03091075|Anabolic Agents|anabolic agents|mesh-ancestor
56081859|NCT03089905|Dexmedetomidine|dexmedetomidine|mesh-list
56081860|NCT03089905|Remifentanil|remifentanil|mesh-list
56081861|NCT03089905|Sevoflurane|sevoflurane|mesh-list
56081862|NCT03089905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56081863|NCT03089905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56081864|NCT03089905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081865|NCT03089905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56081866|NCT03089905|Analgesics|analgesics|mesh-ancestor
56081867|NCT03089905|Sensory System Agents|sensory system agents|mesh-ancestor
56081868|NCT03089905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56081869|NCT03089905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56081870|NCT03089905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56081871|NCT03089905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56081872|NCT03089905|Adrenergic Agents|adrenergic agents|mesh-ancestor
56081873|NCT03089905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56081876|NCT03089905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56081884|NCT02424968|Thymoglobulin|thymoglobulin|mesh-list
56081885|NCT02424968|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56081886|NCT02424968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081887|NCT02424968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081888|NCT02424968|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56081889|NCT02424968|Immunologic Factors|immunologic factors|mesh-ancestor
56081890|NCT02424968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081891|NCT02424968|Antifungal Agents|antifungal agents|mesh-ancestor
56081892|NCT02424968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56081893|NCT02424968|Dermatologic Agents|dermatologic agents|mesh-ancestor
56081895|NCT02424968|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55809069|NCT02291289|Pertuzumab|pertuzumab|mesh-list
56081896|NCT02424968|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56081897|NCT02424968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081898|NCT02424968|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56081899|NCT02424968|Antitubercular Agents|antitubercular agents|mesh-ancestor
56081900|NCT02424968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56081901|NCT02424799|GSK2646264|gsk2646264|mesh-list
56081902|NCT02424799|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56081903|NCT02424799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56081904|NCT02424799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081905|NCT02492750|Dexamethasone|dexamethasone|mesh-list
56081907|NCT02492750|Lenalidomide|lenalidomide|mesh-list
56081932|NCT00363337|Aripiprazole|aripiprazole|mesh-list
56081933|NCT00363337|Antidepressive Agents|antidepressive agents|mesh-ancestor
56081934|NCT00363337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56081935|NCT00363337|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56081936|NCT00363337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56081937|NCT00363337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56081938|NCT00363337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081939|NCT00363337|Dopamine Agonists|dopamine agonists|mesh-ancestor
56081940|NCT00363337|Dopamine Agents|dopamine agents|mesh-ancestor
56081941|NCT00363337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56081942|NCT00363337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081943|NCT00363337|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56081944|NCT00363337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56081945|NCT00363337|Serotonin Agents|serotonin agents|mesh-ancestor
56081946|NCT00363337|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56081947|NCT00363337|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56081948|NCT00363337|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56081949|NCT00363337|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56081950|NCT02493452|Plecanatide|plecanatide|mesh-list
56081951|NCT02493452|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56081952|NCT02493452|Enzyme Activators|enzyme activators|mesh-ancestor
56081953|NCT02493452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081954|NCT02493452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56081955|NCT02429869|Everolimus|everolimus|mesh-list
56081956|NCT02429869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56081960|NCT02428478|Desipramine|desipramine|mesh-list
56081979|NCT04341493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56081980|NCT04341493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56081981|NCT02432287|Metformin|metformin|mesh-list
56081982|NCT02432287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56081983|NCT02432287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081984|NCT02532998|Fludrocortisone|fludrocortisone|mesh-list
56081985|NCT02532998|Eplerenone|eplerenone|mesh-list
56081986|NCT02532998|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56081987|NCT02532998|Hormone Antagonists|hormone antagonists|mesh-ancestor
56081988|NCT02532998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56081989|NCT02532998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56081990|NCT02532998|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56081991|NCT02532998|Diuretics|diuretics|mesh-ancestor
56081992|NCT02532998|Natriuretic Agents|natriuretic agents|mesh-ancestor
56081993|NCT02532998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56081994|NCT02532998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56081995|NCT03026101|Nitroglycerin|nitroglycerin|mesh-list
56081996|NCT03026101|Vasodilator Agents|vasodilator agents|mesh-ancestor
56081997|NCT02453581|Artefenomel|artefenomel|mesh-list
56081998|NCT02453581|Antimalarials|antimalarials|mesh-ancestor
56081999|NCT02453581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56082000|NCT02453581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56082001|NCT02453581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082002|NCT02533466|Listerine|listerine|mesh-list
56082003|NCT02533466|Fluorides|fluorides|mesh-list
56082004|NCT02533466|Sodium Fluoride|sodium fluoride|mesh-list
56082029|NCT02454283|Vanoxerine|vanoxerine|mesh-list
56082030|NCT02454283|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56082031|NCT02454283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56082032|NCT02454283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56082033|NCT02454283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082034|NCT02454283|Dopamine Agents|dopamine agents|mesh-ancestor
56082035|NCT02454283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082036|NCT02454283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082037|NCT02437669|Hydromorphone|hydromorphone|mesh-list
56082038|NCT02437669|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56082039|NCT02437669|Narcotics|narcotics|mesh-ancestor
56082040|NCT02437669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082041|NCT02437669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082042|NCT02437669|Analgesics|analgesics|mesh-ancestor
56082043|NCT02437669|Sensory System Agents|sensory system agents|mesh-ancestor
56082044|NCT02437669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082045|NCT02430818|Ketamine|ketamine|mesh-list
56082046|NCT02430818|Morphine|morphine|mesh-list
56082047|NCT02430818|Analgesics|analgesics|mesh-ancestor
56082048|NCT02430818|Sensory System Agents|sensory system agents|mesh-ancestor
56082049|NCT02430818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082050|NCT02430818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082051|NCT02430818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56082052|NCT02430818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56082053|NCT02430818|Anesthetics, General|anesthetics, general|mesh-ancestor
56082054|NCT02430818|Anesthetics|anesthetics|mesh-ancestor
56082055|NCT02430818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082056|NCT02430818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56082057|NCT02430818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56082058|NCT02430818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082062|NCT02455453|Estradiol|estradiol|mesh-list
56082073|NCT02519023|Oxycodone|oxycodone|mesh-list
56082074|NCT02519023|Bupivacaine|bupivacaine|mesh-list
56082075|NCT02519023|Anesthetics, Local|anesthetics, local|mesh-ancestor
56082076|NCT02519023|Anesthetics|anesthetics|mesh-ancestor
56082077|NCT02519023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082078|NCT02519023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082079|NCT02519023|Sensory System Agents|sensory system agents|mesh-ancestor
56082080|NCT02519023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082081|NCT02519023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56082082|NCT02519023|Analgesics|analgesics|mesh-ancestor
56082083|NCT02519023|Antipyretics|antipyretics|mesh-ancestor
56082084|NCT02519023|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56082085|NCT02519023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082086|NCT02519023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082087|NCT02519023|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56082088|NCT02519023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082089|NCT02519023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082090|NCT02519023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56082091|NCT02519023|Narcotics|narcotics|mesh-ancestor
55791066|NCT05579769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082093|NCT02519023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56082094|NCT02519023|Adrenergic Agents|adrenergic agents|mesh-ancestor
56082095|NCT02519023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082096|NCT02519023|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56082097|NCT02519023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56082098|NCT02519023|Autonomic Agents|autonomic agents|mesh-ancestor
56082099|NCT02519023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56082100|NCT02519023|Respiratory System Agents|respiratory system agents|mesh-ancestor
56082101|NCT02519023|Mydriatics|mydriatics|mesh-ancestor
56082102|NCT02519023|Sympathomimetics|sympathomimetics|mesh-ancestor
56082120|NCT02498522|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56082121|NCT02498522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082122|NCT02919787|Irinotecan|irinotecan|mesh-list
56082124|NCT02919787|Oxaliplatin|oxaliplatin|mesh-list
56082125|NCT02919787|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56082126|NCT02919787|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56082127|NCT02919787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082128|NCT02919787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082129|NCT02919787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082130|NCT02919787|Antimetabolites|antimetabolites|mesh-ancestor
56082131|NCT02919787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56082132|NCT02919787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56082133|NCT02919787|Immunologic Factors|immunologic factors|mesh-ancestor
56082134|NCT02919787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082135|NCT02459275|Metoclopramide|metoclopramide|mesh-list
56082136|NCT02459275|Antiemetics|antiemetics|mesh-ancestor
56082137|NCT02459275|Autonomic Agents|autonomic agents|mesh-ancestor
56082138|NCT02459275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082139|NCT02459275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082140|NCT02459275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56082141|NCT02459275|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56082142|NCT02459275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56082143|NCT02459275|Dopamine Agents|dopamine agents|mesh-ancestor
56082144|NCT02459275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082145|NCT02459275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082146|NCT02524561|Estradiol|estradiol|mesh-list
56082147|NCT02524561|Progesterone|progesterone|mesh-list
56082166|NCT04743739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082167|NCT04743739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56082168|NCT04743739|Antifungal Agents|antifungal agents|mesh-ancestor
56082169|NCT04743739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082170|NCT04743739|Dermatologic Agents|dermatologic agents|mesh-ancestor
56082171|NCT04743739|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56082172|NCT02461693|Caffeine|caffeine|mesh-list
56082173|NCT02461693|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56082174|NCT02461693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082175|NCT02461693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56082176|NCT02461693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741335|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56082177|NCT02461693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082178|NCT02461693|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56082179|NCT02461693|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56082180|NCT02461693|Purinergic Agents|purinergic agents|mesh-ancestor
56082181|NCT02461693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082183|NCT02525653|Paclitaxel|paclitaxel|mesh-list
56082184|NCT02525653|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56082185|NCT02525653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56082186|NCT02525653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082187|NCT02525653|Tubulin Modulators|tubulin modulators|mesh-ancestor
56082188|NCT02525653|Antimitotic Agents|antimitotic agents|mesh-ancestor
56082189|NCT02525653|Mitosis Modulators|mitosis modulators|mesh-ancestor
56082190|NCT02525653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082191|NCT02525653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56082192|NCT02525653|Antimetabolites|antimetabolites|mesh-ancestor
56082193|NCT02525653|Antiviral Agents|antiviral agents|mesh-ancestor
56082194|NCT02525653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082199|NCT02431754|Tadalafil|tadalafil|mesh-list
56082205|NCT02431754|Urological Agents|urological agents|mesh-ancestor
56082206|NCT02500628|Metformin|metformin|mesh-list
56082207|NCT02500628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56082208|NCT02500628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082209|NCT02526667|Chlorhexidine|chlorhexidine|mesh-list
56082210|NCT02526667|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56082211|NCT02526667|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56082212|NCT02526667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082213|NCT02526667|Disinfectants|disinfectants|mesh-ancestor
56082214|NCT02526667|Dermatologic Agents|dermatologic agents|mesh-ancestor
56082215|NCT02535806|Cytarabine|cytarabine|mesh-list
56082216|NCT02535806|Dexamethasone|dexamethasone|mesh-list
56082217|NCT02535806|Hydrocortisone|hydrocortisone|mesh-list
56082218|NCT02535806|Methotrexate|methotrexate|mesh-list
56082219|NCT02535806|Vincristine|vincristine|mesh-list
56082220|NCT02535806|Bortezomib|bortezomib|mesh-list
56082221|NCT02535806|Mitoxantrone|mitoxantrone|mesh-list
56082222|NCT02535806|Pegaspargase|pegaspargase|mesh-list
56082223|NCT02535806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082224|NCT02535806|Antiemetics|antiemetics|mesh-ancestor
56082225|NCT02535806|Autonomic Agents|autonomic agents|mesh-ancestor
56082226|NCT02535806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082227|NCT02535806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082228|NCT02535806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56082229|NCT02535806|Glucocorticoids|glucocorticoids|mesh-ancestor
56082230|NCT02535806|Hormones|hormones|mesh-ancestor
56082231|NCT02535806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082232|NCT02535806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56082233|NCT02535806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082234|NCT02535806|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56082235|NCT02535806|Abortifacient Agents|abortifacient agents|mesh-ancestor
56082236|NCT02535806|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56082251|NCT02535806|Antimitotic Agents|antimitotic agents|mesh-ancestor
56082252|NCT02535806|Mitosis Modulators|mitosis modulators|mesh-ancestor
56082254|NCT02535806|Sensory System Agents|sensory system agents|mesh-ancestor
56082255|NCT02535806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56082256|NCT02535806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56082257|NCT02536040|Fluorides|fluorides|mesh-list
56082258|NCT02536040|Cariostatic Agents|cariostatic agents|mesh-ancestor
56082259|NCT02536040|Protective Agents|protective agents|mesh-ancestor
56082260|NCT02536040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082261|NCT02537444|Pembrolizumab|pembrolizumab|mesh-list
56082262|NCT02537444|Acalabrutinib|acalabrutinib|mesh-list
56082263|NCT02537444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56082264|NCT02537444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082265|NCT02464033|Vitamin D|vitamin d|mesh-list
56082266|NCT02464033|Cholecalciferol|cholecalciferol|mesh-list
56082267|NCT02464033|Etanercept|etanercept|mesh-list
56082270|NCT02464033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082271|NCT02464033|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56082272|NCT02464033|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56082273|NCT02464033|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56082274|NCT02464033|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56082275|NCT02464033|Analgesics|analgesics|mesh-ancestor
56082276|NCT02464033|Sensory System Agents|sensory system agents|mesh-ancestor
56082277|NCT02464033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082278|NCT02464033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082279|NCT02464033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082280|NCT02464033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56082281|NCT02464033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56082282|NCT02464033|Immunologic Factors|immunologic factors|mesh-ancestor
56082283|NCT02432456|Acetaminophen|acetaminophen|mesh-list
56082286|NCT02432456|Narcotics|narcotics|mesh-list
56082293|NCT02432456|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56082294|NCT02432456|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56082295|NCT02432456|Anesthetics, General|anesthetics, general|mesh-ancestor
56082296|NCT02432456|Anesthetics|anesthetics|mesh-ancestor
56082297|NCT02432456|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082298|NCT02432456|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56082299|NCT02432456|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56082300|NCT02432456|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082301|NCT02432456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082302|NCT02432456|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56082303|NCT02432456|Antipyretics|antipyretics|mesh-ancestor
56082304|NCT02432456|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56082305|NCT02432456|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082306|NCT02432456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082307|NCT02432456|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56082308|NCT02432456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082310|NCT02432456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56082311|NCT02432456|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56082312|NCT02432456|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56082313|NCT02432456|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56082314|NCT02531971|Fentanyl|fentanyl|mesh-list
56082315|NCT02531971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56082316|NCT02531971|Narcotics|narcotics|mesh-ancestor
56082317|NCT02531971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082345|NCT02464657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082346|NCT02464657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56082347|NCT02464657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082348|NCT02464657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56082349|NCT02464657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56082350|NCT02464657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082351|NCT02464657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56082353|NCT02464657|Antiviral Agents|antiviral agents|mesh-ancestor
56082354|NCT02464657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082355|NCT02464657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56082356|NCT02464657|Immunologic Factors|immunologic factors|mesh-ancestor
56082357|NCT02464657|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56082358|NCT02464657|Protective Agents|protective agents|mesh-ancestor
56082359|NCT02464657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56082360|NCT02464657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56082361|NCT02464657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56082362|NCT02464657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082363|NCT02535949|Tranexamic Acid|tranexamic acid|mesh-list
56082364|NCT02535949|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56082365|NCT02535949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56082366|NCT02535949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082367|NCT02535949|Hemostatics|hemostatics|mesh-ancestor
56082368|NCT02535949|Coagulants|coagulants|mesh-ancestor
56082369|NCT02536105|Methylphenidate|methylphenidate|mesh-list
56082370|NCT02536105|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56082371|NCT02536105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082372|NCT02536105|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56082373|NCT02536105|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56082374|NCT02536105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56082375|NCT02536105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082376|NCT02536105|Dopamine Agents|dopamine agents|mesh-ancestor
56082377|NCT02536105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082384|NCT02758951|Bevacizumab|bevacizumab|mesh-list
56083182|NCT04798482|Adrenergic Agents|adrenergic agents|mesh-ancestor
56082385|NCT02758951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56082386|NCT02758951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082387|NCT02758951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56082388|NCT02758951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56082389|NCT02758951|Growth Substances|growth substances|mesh-ancestor
56082390|NCT02758951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082391|NCT02758951|Growth Inhibitors|growth inhibitors|mesh-ancestor
56082392|NCT02436668|Gemcitabine|gemcitabine|mesh-list
56082393|NCT02436668|Paclitaxel|paclitaxel|mesh-list
56082395|NCT02436668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082396|NCT02436668|Tubulin Modulators|tubulin modulators|mesh-ancestor
56082397|NCT02436668|Antimitotic Agents|antimitotic agents|mesh-ancestor
56082398|NCT02436668|Mitosis Modulators|mitosis modulators|mesh-ancestor
56082399|NCT02436668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082400|NCT02436668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56082401|NCT02436668|Antimetabolites|antimetabolites|mesh-ancestor
56082402|NCT02436668|Antiviral Agents|antiviral agents|mesh-ancestor
56082403|NCT02436668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082404|NCT02436668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082406|NCT02436668|Immunologic Factors|immunologic factors|mesh-ancestor
56082407|NCT02436668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082408|NCT02503982|Valganciclovir|valganciclovir|mesh-list
56082435|NCT02439164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56082436|NCT02439164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56082437|NCT02439164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082438|NCT02439164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082439|NCT02439164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56082440|NCT02439164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56082441|NCT02439164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56082442|NCT02439164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56082443|NCT02439164|Anesthetics, General|anesthetics, general|mesh-ancestor
56082444|NCT02439164|Anesthetics|anesthetics|mesh-ancestor
56082445|NCT02439164|GABA Modulators|gaba modulators|mesh-ancestor
56082446|NCT02439164|GABA Agents|gaba agents|mesh-ancestor
56082447|NCT02439164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082448|NCT02439164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082449|NCT02440178|Micafungin|micafungin|mesh-list
56082450|NCT02440178|Antifungal Agents|antifungal agents|mesh-ancestor
56082451|NCT02440178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082452|NCT05078606|Anesthetics|anesthetics|mesh-list
56082453|NCT05078606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082454|NCT05078606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082455|NCT02546570|Oxytocin|oxytocin|mesh-list
56082456|NCT02546570|Oxytocics|oxytocics|mesh-ancestor
56082457|NCT02546570|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56082458|NCT02546570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082459|NCT02548910|Sodium Citrate|sodium citrate|mesh-list
56082460|NCT02548910|Citric Acid|citric acid|mesh-list
56082461|NCT02548910|Anticoagulants|anticoagulants|mesh-ancestor
56082462|NCT02548910|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56082463|NCT02548910|Chelating Agents|chelating agents|mesh-ancestor
56082464|NCT02548910|Sequestering Agents|sequestering agents|mesh-ancestor
56082465|NCT02548910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082480|NCT02538679|Sensory System Agents|sensory system agents|mesh-ancestor
56082481|NCT02538679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082482|NCT02538679|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56082483|NCT02538679|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56082484|NCT02538679|Adrenergic Agents|adrenergic agents|mesh-ancestor
56082485|NCT02538679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082486|NCT02538679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082487|NCT02538679|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56082488|NCT02538679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56082489|NCT02538679|Autonomic Agents|autonomic agents|mesh-ancestor
56082490|NCT02538679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56082491|NCT02538679|Respiratory System Agents|respiratory system agents|mesh-ancestor
56082492|NCT02538679|Mydriatics|mydriatics|mesh-ancestor
56082493|NCT02538679|Sympathomimetics|sympathomimetics|mesh-ancestor
56082494|NCT02538679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56082495|NCT02511236|Nicotine|nicotine|mesh-list
56082496|NCT02511236|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56082497|NCT02511236|Autonomic Agents|autonomic agents|mesh-ancestor
56082498|NCT02511236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082499|NCT02511236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082500|NCT02511236|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56082501|NCT02511236|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56082502|NCT02511236|Cholinergic Agents|cholinergic agents|mesh-ancestor
56082503|NCT02511236|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082504|NCT02511236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082505|NCT02551094|Colchicine|colchicine|mesh-list
56082506|NCT02551094|Gout Suppressants|gout suppressants|mesh-ancestor
56082507|NCT02551094|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082510|NCT02551094|Mitosis Modulators|mitosis modulators|mesh-ancestor
56082511|NCT02551094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082512|NCT02551094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082514|NCT02513498|Glycine|glycine|mesh-list
56082515|NCT02513498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082520|NCT02513498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082521|NCT02513498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082522|NCT04787354|Capecitabine|capecitabine|mesh-list
56082523|NCT04787354|Oxaliplatin|oxaliplatin|mesh-list
56082524|NCT04787354|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56082525|NCT04787354|Antimetabolites|antimetabolites|mesh-ancestor
56082526|NCT04787354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082527|NCT04787354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082528|NCT02514044|Adderall|adderall|mesh-list
56082529|NCT02514044|Dextroamphetamine|dextroamphetamine|mesh-list
56082530|NCT02514044|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56082531|NCT02514044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082532|NCT02514044|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56082533|NCT02514044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56082534|NCT02514044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56082535|NCT02514044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082536|NCT02514044|Dopamine Agents|dopamine agents|mesh-ancestor
56082537|NCT02514044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082538|NCT02555228|Simethicone|simethicone|mesh-list
56082539|NCT02555228|Antifoaming Agents|antifoaming agents|mesh-ancestor
56082573|NCT04631510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56082574|NCT04631510|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56082575|NCT04631510|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56082576|NCT04631510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082577|NCT04631510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082578|NCT04631510|Antimanic Agents|antimanic agents|mesh-ancestor
56082579|NCT04542434|Niclosamide|niclosamide|mesh-list
56082580|NCT04542434|Anticestodal Agents|anticestodal agents|mesh-ancestor
56082581|NCT04542434|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56082582|NCT04542434|Anthelmintics|anthelmintics|mesh-ancestor
56082583|NCT04542434|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56082584|NCT04542434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082585|NCT04542434|Antinematodal Agents|antinematodal agents|mesh-ancestor
56082586|NCT04186286|Propranolol|propranolol|mesh-list
56082587|NCT04186286|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56082588|NCT04186286|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56082589|NCT04186286|Adrenergic Agents|adrenergic agents|mesh-ancestor
56082590|NCT04186286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082591|NCT04186286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082592|NCT04186286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082593|NCT04186286|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56082594|NCT04186286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56082595|NCT04186286|Vasodilator Agents|vasodilator agents|mesh-ancestor
56082623|NCT02561702|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56082624|NCT02561702|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56082625|NCT02561702|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56082626|NCT02561702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56082627|NCT02561702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082628|NCT02563496|Chloroquine|chloroquine|mesh-list
56082629|NCT02563496|Tafenoquine|tafenoquine|mesh-list
56082630|NCT02563496|Amebicides|amebicides|mesh-ancestor
56082631|NCT02563496|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56082632|NCT02563496|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56082633|NCT02563496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082634|NCT02563496|Antimalarials|antimalarials|mesh-ancestor
56082635|NCT02563496|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082636|NCT02540161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56082637|NCT02540161|Immunologic Factors|immunologic factors|mesh-ancestor
56082638|NCT02540161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082640|NCT02568644|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56082641|NCT02568644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56082642|NCT02568644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56082643|NCT02568644|Analgesics|analgesics|mesh-ancestor
56082644|NCT02568644|Sensory System Agents|sensory system agents|mesh-ancestor
56082645|NCT02568644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082646|NCT02568644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082647|NCT02568644|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082648|NCT02568644|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56082649|NCT02568644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082650|NCT02568644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082651|NCT02541409|Interferons|interferons|mesh-list
56082652|NCT02541409|Ribavirin|ribavirin|mesh-list
56082653|NCT02541409|Interferon-alpha|interferon-alpha|mesh-list
56082654|NCT02541409|Interferon alpha-2|interferon alpha-2|mesh-list
56082655|NCT02541409|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56082665|NCT02569658|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56082666|NCT02569658|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56082667|NCT02569658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082669|NCT02569658|Coagulants|coagulants|mesh-ancestor
56082670|NCT02541565|Prednisone|prednisone|mesh-list
56082671|NCT02541565|Cortisone|cortisone|mesh-list
56082672|NCT02541565|Cyclophosphamide|cyclophosphamide|mesh-list
56082673|NCT02541565|Rituximab|rituximab|mesh-list
56082674|NCT02541565|Doxorubicin|doxorubicin|mesh-list
56082675|NCT02541565|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56082676|NCT02541565|Pembrolizumab|pembrolizumab|mesh-list
56082677|NCT02541565|Vincristine|vincristine|mesh-list
56082678|NCT02541565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56082679|NCT02541565|Antibodies|antibodies|mesh-list
56082680|NCT02541565|Immunoglobulins|immunoglobulins|mesh-list
56082681|NCT02541565|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56082682|NCT02541565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56082683|NCT02541565|Immunologic Factors|immunologic factors|mesh-ancestor
56082684|NCT02541565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082685|NCT02541565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082686|NCT02541565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56082687|NCT02541565|Alkylating Agents|alkylating agents|mesh-ancestor
56082688|NCT02541565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082689|NCT02541565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082690|NCT02541565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56082691|NCT02541565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56082692|NCT02541565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56082693|NCT02541565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56082694|NCT02541565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082695|NCT02541565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082696|NCT02541565|Glucocorticoids|glucocorticoids|mesh-ancestor
56082697|NCT02541565|Hormones|hormones|mesh-ancestor
56082698|NCT02541565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082705|NCT04707950|Oxytocin|oxytocin|mesh-list
56082709|NCT04707950|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56082710|NCT04707950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56082711|NCT04707950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082712|NCT04707950|Hemostatics|hemostatics|mesh-ancestor
56082713|NCT04707950|Coagulants|coagulants|mesh-ancestor
56082714|NCT04044560|Blinatumomab|blinatumomab|mesh-list
56082715|NCT04044560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082716|NCT03807440|Empagliflozin|empagliflozin|mesh-list
56082717|NCT03807440|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56082718|NCT03807440|Linagliptin|linagliptin|mesh-list
56082719|NCT03807440|Metformin|metformin|mesh-list
56082720|NCT03807440|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
56082721|NCT03807440|Glucagon|glucagon|mesh-list
56082722|NCT03807440|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56082723|NCT03807440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082724|NCT03807440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56082725|NCT03807440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082726|NCT03807440|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56082727|NCT03807440|Hormones|hormones|mesh-ancestor
56082728|NCT03807440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082729|NCT03807440|Incretins|incretins|mesh-ancestor
56082730|NCT03807440|Protease Inhibitors|protease inhibitors|mesh-ancestor
56082731|NCT03807440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082732|NCT03256916|Nelfinavir|nelfinavir|mesh-list
56082733|NCT03256916|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56082734|NCT03256916|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56082735|NCT03256916|Protease Inhibitors|protease inhibitors|mesh-ancestor
56082736|NCT03256916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082757|NCT03169166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082758|NCT03169166|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56082759|NCT03169166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56082761|NCT02582840|Dapagliflozin|dapagliflozin|mesh-list
56082762|NCT02582840|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56082763|NCT02582840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082764|NCT02582840|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56082765|NCT02582840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082766|NCT00364988|Pioglitazone|pioglitazone|mesh-list
56082767|NCT00364988|Losartan|losartan|mesh-list
56082768|NCT00364988|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56082769|NCT00364988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082770|NCT00364988|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56082771|NCT00364988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56082772|NCT00364988|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56082773|NCT00364988|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56082774|NCT00364988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082775|NCT00365222|Temozolomide|temozolomide|mesh-list
56082776|NCT00365222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56082777|NCT00365222|Alkylating Agents|alkylating agents|mesh-ancestor
55741345|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
56082778|NCT00365222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082779|NCT00365222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082780|NCT03119012|Aspirin|aspirin|mesh-list
56082781|NCT03119012|Clopidogrel|clopidogrel|mesh-list
56082782|NCT03119012|Ticagrelor|ticagrelor|mesh-list
56082783|NCT03119012|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56082784|NCT03119012|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56082785|NCT03119012|Analgesics|analgesics|mesh-ancestor
56082786|NCT03119012|Sensory System Agents|sensory system agents|mesh-ancestor
56082787|NCT03119012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082788|NCT03119012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082789|NCT03119012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082793|NCT03119012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082794|NCT03119012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56082795|NCT03119012|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56082796|NCT03119012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082797|NCT03119012|Antipyretics|antipyretics|mesh-ancestor
56082798|NCT03119012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56082799|NCT03119012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56082800|NCT03119012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56082801|NCT03119012|Purinergic Agents|purinergic agents|mesh-ancestor
56082802|NCT03119012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082803|NCT02584868|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
56082804|NCT02584868|Plasma Substitutes|plasma substitutes|mesh-ancestor
56082854|NCT00364442|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56082855|NCT00364442|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56082856|NCT00364442|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56082857|NCT00364442|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56082858|NCT00364442|Adrenergic Agents|adrenergic agents|mesh-ancestor
56082859|NCT00364442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082860|NCT00364442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082862|NCT05371574|Analgesics|analgesics|mesh-ancestor
56082863|NCT05371574|Sensory System Agents|sensory system agents|mesh-ancestor
56082864|NCT05371574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082865|NCT05371574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082866|NCT05371574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56082867|NCT05371574|Sympatholytics|sympatholytics|mesh-ancestor
56082868|NCT05371574|Autonomic Agents|autonomic agents|mesh-ancestor
56082870|NCT05371574|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56082871|NCT05371574|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56082872|NCT05371574|Adrenergic Agents|adrenergic agents|mesh-ancestor
56082873|NCT05371574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56082874|NCT05371574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082875|NCT05371340|Quercetin|quercetin|mesh-list
56082876|NCT05371340|Antioxidants|antioxidants|mesh-ancestor
56082877|NCT05371340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082878|NCT05371340|Protective Agents|protective agents|mesh-ancestor
56082879|NCT05371340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082880|NCT02601170|Hyaluronic Acid|hyaluronic acid|mesh-list
55810050|NCT05561361|Spironolactone|spironolactone|mesh-list
56082881|NCT02601170|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56082882|NCT02601170|Immunologic Factors|immunologic factors|mesh-ancestor
56082883|NCT02601170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082897|NCT00422240|Dermatologic Agents|dermatologic agents|mesh-ancestor
56082898|NCT00422240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56082899|NCT00422240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56082900|NCT00422240|Analgesics|analgesics|mesh-ancestor
56082901|NCT00422240|Sensory System Agents|sensory system agents|mesh-ancestor
56082902|NCT00422240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082903|NCT00422240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082904|NCT00422240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56082905|NCT00422240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56082906|NCT05624606|Vaccines|vaccines|mesh-list
56082907|NCT05624606|Immunologic Factors|immunologic factors|mesh-ancestor
56082908|NCT05624606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082909|NCT02605304|Ribavirin|ribavirin|mesh-list
56082910|NCT02605304|Sofosbuvir|sofosbuvir|mesh-list
56082911|NCT02605304|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56082912|NCT02605304|Ledipasvir|ledipasvir|mesh-list
56082913|NCT02605304|Antimetabolites|antimetabolites|mesh-ancestor
56082914|NCT02605304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082915|NCT02605304|Antiviral Agents|antiviral agents|mesh-ancestor
56082916|NCT02605304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082917|NCT05365880|Lidocaine|lidocaine|mesh-list
56082918|NCT05365880|Anesthetics, Local|anesthetics, local|mesh-ancestor
56082919|NCT05365880|Anesthetics|anesthetics|mesh-ancestor
56082920|NCT05365880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082921|NCT05365880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082922|NCT05365880|Sensory System Agents|sensory system agents|mesh-ancestor
56082923|NCT05365880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56082924|NCT05365880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56082925|NCT05365880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56082929|NCT05362994|Sirolimus|sirolimus|mesh-list
56082942|NCT02607254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082944|NCT02607254|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56082945|NCT02607254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56082946|NCT02607254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082947|NCT02607254|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56082948|NCT02607254|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56082949|NCT02607254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56082950|NCT02607254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56082951|NCT02607254|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56082952|NCT02611154|Testosterone|testosterone|mesh-list
56082953|NCT02611154|Androgens|androgens|mesh-ancestor
56082954|NCT02611154|Hormones|hormones|mesh-ancestor
56082955|NCT02611154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56082956|NCT02611154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56082957|NCT02617784|Oseltamivir|oseltamivir|mesh-list
56082958|NCT02617784|Antiviral Agents|antiviral agents|mesh-ancestor
56082959|NCT02617784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082960|NCT02617784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082961|NCT02617784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082962|NCT05525858|Bevacizumab|bevacizumab|mesh-list
56082963|NCT05525858|Trastuzumab|trastuzumab|mesh-list
56082964|NCT05525858|Pertuzumab|pertuzumab|mesh-list
56082965|NCT05525858|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
56082966|NCT05525858|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56082967|NCT05525858|Atezolizumab|atezolizumab|mesh-list
56082968|NCT05525858|Vemurafenib|vemurafenib|mesh-list
56082971|NCT05525858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56082972|NCT05525858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56082973|NCT05525858|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56082984|NCT05525858|Mitosis Modulators|mitosis modulators|mesh-ancestor
56082985|NCT04936334|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56082986|NCT04936334|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56082987|NCT04936334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082988|NCT00365612|Tenofovir|tenofovir|mesh-list
56082989|NCT00365612|Emtricitabine|emtricitabine|mesh-list
56082990|NCT00365612|Efavirenz|efavirenz|mesh-list
56082991|NCT00365612|Antiviral Agents|antiviral agents|mesh-ancestor
56082992|NCT00365612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56082993|NCT00365612|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56082994|NCT00365612|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56082995|NCT00365612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56082996|NCT00365612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56082997|NCT00365612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56082998|NCT00365612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56082999|NCT00365612|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56083000|NCT00365612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56083001|NCT00365612|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56083002|NCT00365612|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56083003|NCT00365612|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56083004|NCT00365612|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56083005|NCT02974166|Ibuprofen|ibuprofen|mesh-list
56083006|NCT02974166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56083007|NCT02974166|Cyclobenzaprine|cyclobenzaprine|mesh-list
56083008|NCT02974166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56083010|NCT02974166|Analgesics|analgesics|mesh-ancestor
56083011|NCT02974166|Sensory System Agents|sensory system agents|mesh-ancestor
56083012|NCT02974166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083013|NCT02974166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083014|NCT02974166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083015|NCT02974166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56083016|NCT02974166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083017|NCT02974166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083021|NCT02974166|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56083022|NCT02974166|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56083023|NCT02974166|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56083024|NCT02974166|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083025|NCT04870034|Palbociclib|palbociclib|mesh-list
56083026|NCT04870034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083027|NCT04870034|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56083028|NCT04870034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144728|NCT00810576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55810208|NCT02462473|Olanzapine|olanzapine|mesh-list
56083029|NCT04870034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083030|NCT05731778|Listerine|listerine|mesh-list
56083031|NCT05731778|Fluorides|fluorides|mesh-list
56083032|NCT05731778|Sodium Fluoride|sodium fluoride|mesh-list
56083033|NCT05731778|Tin Fluorides|tin fluorides|mesh-list
56083034|NCT05731778|Cariostatic Agents|cariostatic agents|mesh-ancestor
56083035|NCT05731778|Protective Agents|protective agents|mesh-ancestor
56083036|NCT05731778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083037|NCT05731778|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56083038|NCT05731778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083039|NCT00422318|Benzbromarone|benzbromarone|mesh-list
56083040|NCT00422318|Uricosuric Agents|uricosuric agents|mesh-ancestor
56083041|NCT00422318|Gout Suppressants|gout suppressants|mesh-ancestor
56083042|NCT00422318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083043|NCT00422318|Renal Agents|renal agents|mesh-ancestor
56083044|NCT00364754|Tesmilifene|tesmilifene|mesh-list
56083045|NCT00364754|Histamine Antagonists|histamine antagonists|mesh-ancestor
56083046|NCT00364754|Histamine Agents|histamine agents|mesh-ancestor
56083047|NCT00364754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083048|NCT00364754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083049|NCT00364754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083050|NCT00364754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56083051|NCT00366236|Nitazoxanide|nitazoxanide|mesh-list
56083052|NCT00366236|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56083053|NCT00366236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083054|NCT04741880|Lidocaine|lidocaine|mesh-list
56083055|NCT04741880|Anesthetics, Local|anesthetics, local|mesh-ancestor
56083060|NCT04741880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083061|NCT04741880|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56083062|NCT04741880|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56083063|NCT04741880|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56083064|NCT04741880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56083065|NCT04741880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083066|NCT04742504|Benralizumab|benralizumab|mesh-list
56083067|NCT04742504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56083068|NCT04742504|Respiratory System Agents|respiratory system agents|mesh-ancestor
56083069|NCT00365924|Teriparatide|teriparatide|mesh-list
56083070|NCT00365924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56083071|NCT00365924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083072|NCT00365924|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56083073|NCT05360030|Ketamine|ketamine|mesh-list
56083074|NCT05360030|Naloxone|naloxone|mesh-list
56083075|NCT05360030|Analgesics|analgesics|mesh-ancestor
56083076|NCT05360030|Sensory System Agents|sensory system agents|mesh-ancestor
56083077|NCT05360030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083078|NCT05360030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083079|NCT05360030|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56083080|NCT05360030|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56083081|NCT05360030|Anesthetics, General|anesthetics, general|mesh-ancestor
56083082|NCT05360030|Anesthetics|anesthetics|mesh-ancestor
56083083|NCT05360030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083084|NCT05360030|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56083085|NCT05360030|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56083086|NCT05360030|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083087|NCT05360030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083088|NCT05360030|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56083089|NCT04158362|Paclitaxel|paclitaxel|mesh-list
56083091|NCT04158362|Letrozole|letrozole|mesh-list
56083100|NCT04158362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56083101|NCT04158362|Antimetabolites|antimetabolites|mesh-ancestor
56083102|NCT04158362|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56083103|NCT04158362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56083104|NCT04158362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083105|NCT04158362|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56083106|NCT04158362|Hormone Antagonists|hormone antagonists|mesh-ancestor
56083107|NCT04158362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083108|NCT04158362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083109|NCT04158362|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56083110|NCT04158362|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56083111|NCT05730218|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56083112|NCT05730218|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56083115|NCT05272202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083116|NCT05272202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083117|NCT05272202|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56083118|NCT05272202|Anesthetics, General|anesthetics, general|mesh-ancestor
56083119|NCT05272202|Anesthetics|anesthetics|mesh-ancestor
56083120|NCT01575834|Denosumab|denosumab|mesh-list
56083121|NCT01575834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56083122|NCT01575834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083123|NCT04718792|Psilocybin|psilocybin|mesh-list
56083124|NCT04718792|Hallucinogens|hallucinogens|mesh-ancestor
56083125|NCT04718792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083126|NCT04718792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56083127|NCT05707442|Acetazolamide|acetazolamide|mesh-list
56083128|NCT05707442|Anticonvulsants|anticonvulsants|mesh-ancestor
56083129|NCT05707442|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56083130|NCT05707442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083131|NCT05707442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083132|NCT05707442|Diuretics|diuretics|mesh-ancestor
56083133|NCT05707442|Natriuretic Agents|natriuretic agents|mesh-ancestor
56083134|NCT05707442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083142|NCT04604132|Tubulin Modulators|tubulin modulators|mesh-ancestor
56083143|NCT04604132|Antimitotic Agents|antimitotic agents|mesh-ancestor
56083144|NCT04604132|Mitosis Modulators|mitosis modulators|mesh-ancestor
56083145|NCT04604132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083146|NCT04604132|Immunologic Factors|immunologic factors|mesh-ancestor
56083147|NCT04604132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083148|NCT05193188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56083149|NCT05193188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083150|NCT05193188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083151|NCT04799262|Prednisone|prednisone|mesh-list
56083152|NCT04799262|Tofacitinib|tofacitinib|mesh-list
56083153|NCT04799262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56083154|NCT04799262|Glucocorticoids|glucocorticoids|mesh-ancestor
56083155|NCT04799262|Hormones|hormones|mesh-ancestor
56083156|NCT04799262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083157|NCT04799262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083158|NCT04799262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56083159|NCT04799262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083160|NCT04799262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56083161|NCT04799262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083162|NCT04799262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083163|NCT00851136|Bevacizumab|bevacizumab|mesh-list
56083164|NCT00851136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56083165|NCT00851136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083166|NCT00851136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56083167|NCT00851136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56083168|NCT00851136|Growth Substances|growth substances|mesh-ancestor
56083169|NCT00851136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083170|NCT00851136|Growth Inhibitors|growth inhibitors|mesh-ancestor
56083171|NCT04798482|Dexmedetomidine|dexmedetomidine|mesh-list
56083172|NCT04798482|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56083176|NCT04798482|Analgesics|analgesics|mesh-ancestor
56083179|NCT04798482|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56083180|NCT04798482|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56083181|NCT04798482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56083183|NCT04798482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083184|NCT04798482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083185|NCT00366470|Cholecalciferol|cholecalciferol|mesh-list
56083186|NCT00366470|Vitamin D|vitamin d|mesh-list
56083187|NCT00366470|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56083188|NCT00366470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083189|NCT00366470|Vitamins|vitamins|mesh-ancestor
56083190|NCT00366470|Micronutrients|micronutrients|mesh-ancestor
56083191|NCT00366470|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56083192|NCT04537286|Paclitaxel|paclitaxel|mesh-list
56083193|NCT04537286|Cisplatin|cisplatin|mesh-list
56083194|NCT04537286|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56083195|NCT04537286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083196|NCT04537286|Tubulin Modulators|tubulin modulators|mesh-ancestor
56083197|NCT04537286|Antimitotic Agents|antimitotic agents|mesh-ancestor
56083198|NCT04537286|Mitosis Modulators|mitosis modulators|mesh-ancestor
56083199|NCT04537286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083200|NCT02620904|Mifepristone|mifepristone|mesh-list
56083201|NCT02620904|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56083202|NCT02620904|Abortifacient Agents|abortifacient agents|mesh-ancestor
56083203|NCT02620904|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56083204|NCT02620904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083205|NCT02620904|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56083206|NCT02620904|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56083207|NCT02620904|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56083208|NCT02620904|Contraceptive Agents|contraceptive agents|mesh-ancestor
56083209|NCT02620904|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55741351|NCT03370159|Vitamins|vitamins|mesh-ancestor
56083221|NCT00300768|Antinematodal Agents|antinematodal agents|mesh-ancestor
56083222|NCT02621060|Magnesium Oxide|magnesium oxide|mesh-list
56083223|NCT02621060|Antacids|antacids|mesh-ancestor
56083224|NCT02621060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083225|NCT02621060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56083226|NCT04740554|Prednisone|prednisone|mesh-list
56083227|NCT04740554|Deflazacort|deflazacort|mesh-list
56083228|NCT04740554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56083230|NCT04740554|Hormones|hormones|mesh-ancestor
56083231|NCT04740554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083232|NCT04740554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083233|NCT04740554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56083234|NCT04740554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083235|NCT04740554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56083236|NCT04740554|Immunologic Factors|immunologic factors|mesh-ancestor
56083237|NCT04506086|Blinatumomab|blinatumomab|mesh-list
56083238|NCT04506086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083239|NCT02624180|Colchicine|colchicine|mesh-list
56083240|NCT02624180|Gout Suppressants|gout suppressants|mesh-ancestor
56083241|NCT02624180|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083242|NCT02624180|Tubulin Modulators|tubulin modulators|mesh-ancestor
56083243|NCT02624180|Antimitotic Agents|antimitotic agents|mesh-ancestor
56083244|NCT02624180|Mitosis Modulators|mitosis modulators|mesh-ancestor
56083245|NCT02624180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083246|NCT02624180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083247|NCT05068232|Carboplatin|carboplatin|mesh-list
56083248|NCT05068232|Etoposide|etoposide|mesh-list
55810427|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083249|NCT05068232|Durvalumab|durvalumab|mesh-list
56083250|NCT05068232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083251|NCT05068232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56083252|NCT05068232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56083264|NCT02628236|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56083265|NCT02628236|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56083266|NCT02628236|Dermatologic Agents|dermatologic agents|mesh-ancestor
56083268|NCT02629094|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56083269|NCT02629094|Hormone Antagonists|hormone antagonists|mesh-ancestor
56083270|NCT02629094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083271|NCT02629094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083272|NCT02629094|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56083273|NCT02629094|Diuretics|diuretics|mesh-ancestor
56083274|NCT02629094|Natriuretic Agents|natriuretic agents|mesh-ancestor
56083275|NCT02629094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56083277|NCT02630030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083278|NCT02630030|Protease Inhibitors|protease inhibitors|mesh-ancestor
56083279|NCT02630030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083280|NCT02630030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083283|NCT04289792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56083284|NCT04289792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083285|NCT04289792|Tubulin Modulators|tubulin modulators|mesh-ancestor
56083286|NCT04289792|Antimitotic Agents|antimitotic agents|mesh-ancestor
56083287|NCT04289792|Mitosis Modulators|mitosis modulators|mesh-ancestor
55741354|NCT04522297|Epinephrine|epinephrine|mesh-list
56083288|NCT04289792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083289|NCT04289792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56083290|NCT04289792|Antimetabolites|antimetabolites|mesh-ancestor
56083291|NCT04289792|Antiviral Agents|antiviral agents|mesh-ancestor
56083292|NCT04289792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083293|NCT04289792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083294|NCT04289792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56083295|NCT04289792|Immunologic Factors|immunologic factors|mesh-ancestor
56083296|NCT04289792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083297|NCT02631590|Gemcitabine|gemcitabine|mesh-list
56083298|NCT02631590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083301|NCT02631590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083302|NCT02631590|Antiviral Agents|antiviral agents|mesh-ancestor
56083303|NCT02631590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083304|NCT02631590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083305|NCT02631590|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56083306|NCT02631590|Immunologic Factors|immunologic factors|mesh-ancestor
56083307|NCT02631590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083308|NCT02253654|Epoetin Alfa|epoetin alfa|mesh-list
56083309|NCT02253654|Hematinics|hematinics|mesh-ancestor
56083311|NCT02252406|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56083312|NCT02252406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56083313|NCT02252406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083314|NCT02252016|Grazoprevir|grazoprevir|mesh-list
56083315|NCT02252016|Antiviral Agents|antiviral agents|mesh-ancestor
56083316|NCT02252016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083317|NCT04784442|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56083319|NCT04784442|Antimetabolites|antimetabolites|mesh-ancestor
56083320|NCT04784442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083321|NCT04784442|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56083322|NCT04784442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083323|NCT04784442|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56083324|NCT04784442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083325|NCT02706847|Upadacitinib|upadacitinib|mesh-list
56083326|NCT02706847|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
56083327|NCT02706847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56083328|NCT02706847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083330|NCT02706847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083345|NCT02544607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083346|NCT02544607|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56083347|NCT02544607|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56083348|NCT02544607|Anesthetics, General|anesthetics, general|mesh-ancestor
56083349|NCT02544607|Anesthetics|anesthetics|mesh-ancestor
56083350|NCT02544607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083351|NCT02544607|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56083352|NCT02544607|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56083353|NCT02544607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083354|NCT02544607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083355|NCT00363571|Acetazolamide|acetazolamide|mesh-list
56083356|NCT00363571|Anticonvulsants|anticonvulsants|mesh-ancestor
56083357|NCT00363571|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56083358|NCT00363571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083359|NCT00363571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083360|NCT00363571|Diuretics|diuretics|mesh-ancestor
56083362|NCT00363571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083363|NCT04744675|Triamcinolone|triamcinolone|mesh-list
56083364|NCT04744675|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56083365|NCT04744675|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56083366|NCT04744675|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56083367|NCT04744675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56083368|NCT04744675|Glucocorticoids|glucocorticoids|mesh-ancestor
56083369|NCT04744675|Hormones|hormones|mesh-ancestor
56083370|NCT04744675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083371|NCT04744675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083372|NCT04744675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56083373|NCT04744675|Immunologic Factors|immunologic factors|mesh-ancestor
56083374|NCT04744675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083388|NCT02624479|Antitubercular Agents|antitubercular agents|mesh-ancestor
56083389|NCT02624479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56083390|NCT02624479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083391|NCT02624479|Chelating Agents|chelating agents|mesh-ancestor
56083392|NCT02624479|Sequestering Agents|sequestering agents|mesh-ancestor
56083393|NCT02472223|Povidone-Iodine|povidone-iodine|mesh-list
56083395|NCT02472223|Lubricant Eye Drops|lubricant eye drops|mesh-list
56083396|NCT02472223|Plasma Substitutes|plasma substitutes|mesh-ancestor
56083397|NCT02472223|Blood Substitutes|blood substitutes|mesh-ancestor
56083398|NCT02472223|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56083399|NCT02472223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083400|NCT02472223|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56083401|NCT02472223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56083402|NCT02247960|Ciprofloxacin|ciprofloxacin|mesh-list
56083403|NCT02247960|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56083404|NCT02247960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083405|NCT02247960|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56083406|NCT02247960|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56083407|NCT02247960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083408|NCT02247960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083409|NCT02247960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083410|NCT02247960|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56083411|NCT02247960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56083413|NCT02473783|Antidepressive Agents|antidepressive agents|mesh-ancestor
56083414|NCT02473783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56083415|NCT02473783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56083416|NCT02473783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56083419|NCT02473783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083434|NCT00366938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56083435|NCT00366938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083436|NCT00366938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083437|NCT00366938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56083438|NCT00366938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56083439|NCT00366938|Analgesics|analgesics|mesh-ancestor
56083440|NCT00366938|Sensory System Agents|sensory system agents|mesh-ancestor
56083441|NCT00366938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083442|NCT00366938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083443|NCT00366938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56083444|NCT00366938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083445|NCT05026320|Diclofenac|diclofenac|mesh-list
56083446|NCT05026320|Naproxen|naproxen|mesh-list
56083447|NCT05026320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56083448|NCT05026320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56083449|NCT05026320|Analgesics|analgesics|mesh-ancestor
56083450|NCT05026320|Sensory System Agents|sensory system agents|mesh-ancestor
56083451|NCT05026320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083452|NCT05026320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083453|NCT05026320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56083454|NCT05026320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083455|NCT05026320|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56083456|NCT05026320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083457|NCT05026320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083458|NCT05026320|Gout Suppressants|gout suppressants|mesh-ancestor
56083459|NCT04068272|Bosentan|bosentan|mesh-list
56083460|NCT04068272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56083477|NCT02243202|Autonomic Agents|autonomic agents|mesh-ancestor
56083478|NCT02243202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083479|NCT02243202|Adrenergic Agents|adrenergic agents|mesh-ancestor
56083480|NCT02243202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083482|NCT04050410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56083483|NCT02207946|Botulinum Toxins|botulinum toxins|mesh-list
56083484|NCT02207946|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56083485|NCT02207946|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56083486|NCT02207946|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56083487|NCT02207946|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56083488|NCT02207946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56083489|NCT02207946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083490|NCT02207946|Cholinergic Agents|cholinergic agents|mesh-ancestor
56083491|NCT02207946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083492|NCT02207946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083493|NCT02207946|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56083494|NCT02207946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083495|NCT03973268|Complement Factor H|complement factor h|mesh-list
56083496|NCT03973268|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56083497|NCT03973268|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56083499|NCT03973268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083500|NCT04235036|Rituximab|rituximab|mesh-list
56083501|NCT04235036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56083502|NCT04235036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083503|NCT04235036|Immunologic Factors|immunologic factors|mesh-ancestor
56083504|NCT04235036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083505|NCT04235036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083506|NCT02560051|Ketoconazole|ketoconazole|mesh-list
56083507|NCT02560051|Docetaxel|docetaxel|mesh-list
56083508|NCT02560051|Doxorubicin|doxorubicin|mesh-list
56083509|NCT02560051|Estramustine|estramustine|mesh-list
56083510|NCT02560051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083511|NCT02560051|Tubulin Modulators|tubulin modulators|mesh-ancestor
56083512|NCT02560051|Antimitotic Agents|antimitotic agents|mesh-ancestor
56083513|NCT02560051|Mitosis Modulators|mitosis modulators|mesh-ancestor
56083515|NCT02560051|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56083516|NCT02560051|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56083517|NCT02560051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56083518|NCT02560051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083519|NCT02560051|Antifungal Agents|antifungal agents|mesh-ancestor
56083520|NCT02560051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083521|NCT02560051|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56083522|NCT02560051|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56083523|NCT02560051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56083524|NCT02560051|Hormone Antagonists|hormone antagonists|mesh-ancestor
56083525|NCT02560051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083526|NCT02560051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083527|NCT02560051|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56083528|NCT02560051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56083529|NCT02560051|Alkylating Agents|alkylating agents|mesh-ancestor
56083530|NCT02560051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56083531|NCT03786770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56083533|NCT03786770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56083534|NCT03786770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083535|NCT03786770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083536|NCT03786770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56083537|NCT03786770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56083538|NCT03786770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083540|NCT03786770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083541|NCT04219280|Methylphenidate|methylphenidate|mesh-list
56083542|NCT04219280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56083543|NCT04219280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083556|NCT02474407|Autonomic Agents|autonomic agents|mesh-ancestor
56083557|NCT02474407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083558|NCT02474407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083559|NCT02474407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56083560|NCT02474407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56083561|NCT02474407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083562|NCT02474407|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56083563|NCT02474407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56083565|NCT02474407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56083566|NCT02474407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56083567|NCT02474407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56083568|NCT02474407|Anesthetics, General|anesthetics, general|mesh-ancestor
56083569|NCT02474407|Anesthetics|anesthetics|mesh-ancestor
56083570|NCT02474407|GABA Modulators|gaba modulators|mesh-ancestor
56083571|NCT02474407|GABA Agents|gaba agents|mesh-ancestor
56083572|NCT02474407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083573|NCT02474407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083574|NCT05588492|Rifamycins|rifamycins|mesh-list
56083575|NCT05588492|Rifamycin SV|rifamycin sv|mesh-list
56083576|NCT05588492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56083577|NCT05588492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083578|NCT05588492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083579|NCT03777956|Lacosamide|lacosamide|mesh-list
56083580|NCT03777956|Anticonvulsants|anticonvulsants|mesh-ancestor
56083581|NCT03777956|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56083582|NCT03777956|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56083583|NCT03777956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56083584|NCT03777956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083603|NCT02564029|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56083604|NCT02564029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083605|NCT02564029|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56083606|NCT02564029|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56083610|NCT02564029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083611|NCT02564029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083612|NCT05588336|Morphine|morphine|mesh-list
56083613|NCT05588336|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56083614|NCT05588336|Narcotics|narcotics|mesh-ancestor
56083615|NCT05588336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083616|NCT05588336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083617|NCT05588336|Analgesics|analgesics|mesh-ancestor
56083618|NCT05588336|Sensory System Agents|sensory system agents|mesh-ancestor
56083619|NCT05588336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083620|NCT02564497|Abatacept|abatacept|mesh-list
56083621|NCT02564497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56083622|NCT02564497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083623|NCT02564497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083624|NCT02564497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56083625|NCT02564497|Immunologic Factors|immunologic factors|mesh-ancestor
56083626|NCT02564497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083627|NCT02564497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083629|NCT03678428|Oxaliplatin|oxaliplatin|mesh-list
56083630|NCT03678428|Irinotecan|irinotecan|mesh-list
56083632|NCT03678428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083652|NCT02565901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083653|NCT02565901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56083654|NCT02565901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083655|NCT02565901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56083656|NCT02565901|Antifungal Agents|antifungal agents|mesh-ancestor
56083657|NCT02565901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56083658|NCT02565901|Immunologic Factors|immunologic factors|mesh-ancestor
56083659|NCT02565901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083660|NCT03926624|Cytarabine|cytarabine|mesh-list
56083661|NCT03926624|Fludarabine|fludarabine|mesh-list
56083662|NCT03926624|Etoposide|etoposide|mesh-list
56083663|NCT03926624|Azacitidine|azacitidine|mesh-list
56083664|NCT03926624|Decitabine|decitabine|mesh-list
56083665|NCT03926624|Venetoclax|venetoclax|mesh-list
56083666|NCT03926624|Mitoxantrone|mitoxantrone|mesh-list
56083667|NCT03926624|Idarubicin|idarubicin|mesh-list
56083668|NCT03926624|Cladribine|cladribine|mesh-list
56083669|NCT03926624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083670|NCT03926624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56083671|NCT03926624|Antimetabolites|antimetabolites|mesh-ancestor
56083672|NCT03926624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083673|NCT03926624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56083674|NCT03926624|Immunologic Factors|immunologic factors|mesh-ancestor
56083675|NCT03926624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083676|NCT03926624|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56083677|NCT03926624|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56083702|NCT05588102|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56083703|NCT05588102|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56083704|NCT05588102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083705|NCT05588102|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56083706|NCT05588102|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56083707|NCT05588102|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56083708|NCT05588102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083709|NCT05588102|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56083710|NCT05588102|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56083711|NCT02506933|Vaccines|vaccines|mesh-list
56083712|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
56083713|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083714|NCT04744441|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56083715|NCT04744441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083716|NCT03551210|Levofloxacin|levofloxacin|mesh-list
56083717|NCT03551210|Ofloxacin|ofloxacin|mesh-list
56083718|NCT03551210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56083719|NCT03551210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083720|NCT03551210|Renal Agents|renal agents|mesh-ancestor
56083721|NCT03551210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56083722|NCT03551210|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56083723|NCT03551210|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56083724|NCT03551210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083725|NCT03551210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083726|NCT03551210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083727|NCT03551210|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56083728|NCT03551210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56083729|NCT02482675|Caseins|caseins|mesh-list
56083730|NCT02482675|Chelating Agents|chelating agents|mesh-ancestor
56083732|NCT02482675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083733|NCT00364195|Tesmilifene|tesmilifene|mesh-list
56083735|NCT00364195|Histamine Agents|histamine agents|mesh-ancestor
56083740|NCT02566369|Trifarotene|trifarotene|mesh-list
56083741|NCT02566369|Dermatologic Agents|dermatologic agents|mesh-ancestor
56083742|NCT02569723|Oxaliplatin|oxaliplatin|mesh-list
56083743|NCT02569723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083744|NCT02570425|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
56083745|NCT02570425|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56083746|NCT02570425|Respiratory System Agents|respiratory system agents|mesh-ancestor
56083747|NCT02571439|Ropivacaine|ropivacaine|mesh-list
56083748|NCT02571439|Anesthetics, Local|anesthetics, local|mesh-ancestor
56083749|NCT02571439|Anesthetics|anesthetics|mesh-ancestor
56083750|NCT02571439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083751|NCT02571439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083752|NCT02571439|Sensory System Agents|sensory system agents|mesh-ancestor
56083753|NCT02571439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083754|NCT02572609|Ambroxol|ambroxol|mesh-list
56083755|NCT02572609|Expectorants|expectorants|mesh-ancestor
56083756|NCT02572609|Respiratory System Agents|respiratory system agents|mesh-ancestor
56083757|NCT02573857|Artefenomel|artefenomel|mesh-list
56083758|NCT02573857|Antimalarials|antimalarials|mesh-ancestor
56083759|NCT02573857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56083760|NCT02573857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56083761|NCT02573857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083762|NCT02577601|Levonorgestrel|levonorgestrel|mesh-list
56083763|NCT02577601|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56083764|NCT02577601|Ulipristal acetate|ulipristal acetate|mesh-list
56083765|NCT02577601|Contraceptives, Oral|contraceptives, oral|mesh-list
56083788|NCT02207634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083790|NCT02484859|Metoprolol|metoprolol|mesh-list
56083791|NCT02484859|Remifentanil|remifentanil|mesh-list
56083792|NCT02484859|Tramadol|tramadol|mesh-list
56083793|NCT02484859|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56083794|NCT02484859|Narcotics|narcotics|mesh-ancestor
56083795|NCT02484859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083796|NCT02484859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083797|NCT02484859|Analgesics|analgesics|mesh-ancestor
56083798|NCT02484859|Sensory System Agents|sensory system agents|mesh-ancestor
56083799|NCT02484859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083800|NCT02484859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56083801|NCT02484859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56083802|NCT02484859|Sympatholytics|sympatholytics|mesh-ancestor
56083803|NCT02484859|Autonomic Agents|autonomic agents|mesh-ancestor
56083804|NCT02484859|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56083805|NCT02484859|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56083806|NCT02484859|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56083807|NCT02484859|Adrenergic Agents|adrenergic agents|mesh-ancestor
56083808|NCT02484859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083809|NCT02484859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083810|NCT04436731|Phentolamine|phentolamine|mesh-list
56083811|NCT04436731|Phenylephrine|phenylephrine|mesh-list
56083812|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
56083813|NCT04436731|Norepinephrine|norepinephrine|mesh-list
56083814|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
56083815|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56083816|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56083819|NCT04436731|Analgesics|analgesics|mesh-ancestor
56083836|NCT04436731|Protective Agents|protective agents|mesh-ancestor
56083837|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56083838|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56083839|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56083840|NCT04341727|Azithromycin|azithromycin|mesh-list
56083841|NCT04341727|Hydroxychloroquine|hydroxychloroquine|mesh-list
56083842|NCT04341727|Chloroquine|chloroquine|mesh-list
56083843|NCT04341727|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56083844|NCT04341727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56083845|NCT04341727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083846|NCT04341727|Antimalarials|antimalarials|mesh-ancestor
56083847|NCT04341727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56083848|NCT04341727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56083849|NCT04341727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083850|NCT04341727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083851|NCT04341727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56083852|NCT04341727|Amebicides|amebicides|mesh-ancestor
56083853|NCT04341727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56083854|NCT04341727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56083855|NCT04341727|Analgesics|analgesics|mesh-ancestor
56083856|NCT04341727|Sensory System Agents|sensory system agents|mesh-ancestor
56083857|NCT04341727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083858|NCT04341727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083859|NCT04341727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56083860|NCT04341727|Filaricides|filaricides|mesh-ancestor
56083861|NCT04341727|Antinematodal Agents|antinematodal agents|mesh-ancestor
56083862|NCT04341727|Anthelmintics|anthelmintics|mesh-ancestor
56083863|NCT00367094|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56083864|NCT00367094|Benazepril|benazepril|mesh-list
56083865|NCT00367094|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56083866|NCT00367094|Diuretics|diuretics|mesh-ancestor
56083867|NCT00367094|Natriuretic Agents|natriuretic agents|mesh-ancestor
56083868|NCT00367094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083869|NCT00367094|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56083870|NCT00367094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56083871|NCT00367094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083872|NCT00367094|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55901120|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
56083873|NCT00367094|Protease Inhibitors|protease inhibitors|mesh-ancestor
56083874|NCT00367094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56083876|NCT02581111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56083877|NCT02581111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083878|NCT02581111|Sensory System Agents|sensory system agents|mesh-ancestor
56083879|NCT02581111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083880|NCT05587400|Dobutamine|dobutamine|mesh-list
56083881|NCT05587400|Nitric Oxide|nitric oxide|mesh-list
56083882|NCT05587400|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56083883|NCT05587400|Autonomic Agents|autonomic agents|mesh-ancestor
56083884|NCT05587400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083885|NCT05587400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083886|NCT05587400|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56083887|NCT05587400|Respiratory System Agents|respiratory system agents|mesh-ancestor
56083888|NCT05587400|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56083889|NCT05587400|Antioxidants|antioxidants|mesh-ancestor
56083890|NCT05587400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083891|NCT05587400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56083892|NCT05587400|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56083893|NCT05587400|Vasodilator Agents|vasodilator agents|mesh-ancestor
56083894|NCT05587400|Gasotransmitters|gasotransmitters|mesh-ancestor
56083895|NCT05587400|Protective Agents|protective agents|mesh-ancestor
56083896|NCT05587400|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56083897|NCT05587400|Sympathomimetics|sympathomimetics|mesh-ancestor
56083898|NCT05587400|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56083899|NCT05587400|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56083900|NCT05587400|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56083901|NCT05587400|Adrenergic Agents|adrenergic agents|mesh-ancestor
56083902|NCT04339868|Terlipressin|terlipressin|mesh-list
56083903|NCT04339868|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56083904|NCT04339868|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56083905|NCT00367172|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
56083916|NCT02490631|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56083917|NCT02490631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56083918|NCT02490631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083919|NCT02490631|Disinfectants|disinfectants|mesh-ancestor
56083920|NCT02490631|Dermatologic Agents|dermatologic agents|mesh-ancestor
56083921|NCT02207556|Doxycycline|doxycycline|mesh-list
56083922|NCT02207556|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56083923|NCT02207556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083924|NCT02207556|Antimalarials|antimalarials|mesh-ancestor
56083925|NCT02207556|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56083926|NCT02207556|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56083927|NCT02587117|Prednisolone|prednisolone|mesh-list
55811108|NCT03052725|Reslizumab|reslizumab|mesh-list
56083929|NCT02587117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56083930|NCT02587117|Glucocorticoids|glucocorticoids|mesh-ancestor
56083931|NCT02587117|Hormones|hormones|mesh-ancestor
56083932|NCT02587117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56083933|NCT02587117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083934|NCT02587117|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56083935|NCT02587117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083936|NCT02587117|Protective Agents|protective agents|mesh-ancestor
56083937|NCT02587117|Antioxidants|antioxidants|mesh-ancestor
56083938|NCT02587117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56083939|NCT02587117|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56083941|NCT02587351|Metoprolol|metoprolol|mesh-list
56083942|NCT02587351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56083943|NCT02587351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56083944|NCT02587351|Sympatholytics|sympatholytics|mesh-ancestor
56083945|NCT02587351|Autonomic Agents|autonomic agents|mesh-ancestor
56083946|NCT02587351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083947|NCT02587351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083949|NCT02587351|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56083960|NCT05553314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083961|NCT05553314|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56083962|NCT05553314|Antioxidants|antioxidants|mesh-ancestor
56083963|NCT05553314|Protective Agents|protective agents|mesh-ancestor
56083964|NCT05553314|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56083965|NCT05553314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56083966|NCT05553314|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56083967|NCT05553314|Vasodilator Agents|vasodilator agents|mesh-ancestor
56083968|NCT05553314|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56083969|NCT05553314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56083970|NCT03260504|Aldesleukin|aldesleukin|mesh-list
56083971|NCT03260504|Pembrolizumab|pembrolizumab|mesh-list
56083972|NCT03260504|Interleukin-2|interleukin-2|mesh-list
56083973|NCT03260504|Immunoglobulins|immunoglobulins|mesh-list
56083974|NCT03260504|Immunoglobulin G|immunoglobulin g|mesh-list
56083975|NCT03260504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56083976|NCT03260504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56083977|NCT03260504|Immunologic Factors|immunologic factors|mesh-ancestor
56083978|NCT03260504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56083979|NCT03260504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56083980|NCT03260504|Analgesics|analgesics|mesh-ancestor
56083981|NCT03260504|Sensory System Agents|sensory system agents|mesh-ancestor
56083982|NCT03260504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56083983|NCT03260504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56083984|NCT03260504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56083985|NCT03260504|Antiviral Agents|antiviral agents|mesh-ancestor
56083986|NCT03260504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56083987|NCT00422396|Fenofibrate|fenofibrate|mesh-list
56083988|NCT00422396|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56084007|NCT05249023|Butyric Acid|butyric acid|mesh-list
56084008|NCT05249023|Histamine Antagonists|histamine antagonists|mesh-ancestor
56084009|NCT05249023|Histamine Agents|histamine agents|mesh-ancestor
56084010|NCT05249023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084011|NCT05249023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084012|NCT05249023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084013|NCT02495779|Tenofovir|tenofovir|mesh-list
56084028|NCT05216497|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
56084029|NCT05216497|Antiviral Agents|antiviral agents|mesh-ancestor
56084030|NCT05216497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084032|NCT02502487|Tetracaine|tetracaine|mesh-list
56084033|NCT02502487|Anesthetics, Local|anesthetics, local|mesh-ancestor
56084034|NCT02502487|Anesthetics|anesthetics|mesh-ancestor
56084035|NCT02502487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084036|NCT02502487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084037|NCT02502487|Sensory System Agents|sensory system agents|mesh-ancestor
56084038|NCT02502487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084049|NCT03238196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084050|NCT03238196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084052|NCT02632045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56084053|NCT02632045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084054|NCT02632045|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56084055|NCT02632045|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56084056|NCT02632045|Hormone Antagonists|hormone antagonists|mesh-ancestor
56084057|NCT02632045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56084058|NCT02632045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084059|NCT02503735|Sofosbuvir|sofosbuvir|mesh-list
56084060|NCT02503735|Ledipasvir|ledipasvir|mesh-list
56084061|NCT02503735|Antiviral Agents|antiviral agents|mesh-ancestor
56084062|NCT02503735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084063|NCT04001881|Anesthetics|anesthetics|mesh-list
56084064|NCT04001881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084065|NCT04001881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084066|NCT03019640|Cytarabine|cytarabine|mesh-list
56084067|NCT03019640|Rituximab|rituximab|mesh-list
56084068|NCT03019640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56084069|NCT03019640|Etoposide|etoposide|mesh-list
56084070|NCT03019640|Lenalidomide|lenalidomide|mesh-list
56084071|NCT03019640|Etoposide phosphate|etoposide phosphate|mesh-list
56084072|NCT03019640|Melphalan|melphalan|mesh-list
56084073|NCT03019640|Mechlorethamine|mechlorethamine|mesh-list
56084074|NCT03019640|Carmustine|carmustine|mesh-list
56084076|NCT03019640|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56084077|NCT03019640|Antibodies|antibodies|mesh-list
56084096|NCT03019640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56084097|NCT03019640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56084098|NCT03019640|Growth Substances|growth substances|mesh-ancestor
56084099|NCT03019640|Growth Inhibitors|growth inhibitors|mesh-ancestor
56084100|NCT03019640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56084101|NCT03019640|Alkylating Agents|alkylating agents|mesh-ancestor
56084102|NCT03019640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56084103|NCT03019640|Keratolytic Agents|keratolytic agents|mesh-ancestor
56084104|NCT03019640|Dermatologic Agents|dermatologic agents|mesh-ancestor
56084105|NCT03019640|Tubulin Modulators|tubulin modulators|mesh-ancestor
56084106|NCT03019640|Antimitotic Agents|antimitotic agents|mesh-ancestor
56084107|NCT03019640|Mitosis Modulators|mitosis modulators|mesh-ancestor
56084108|NCT02136901|Hyaluronic Acid|hyaluronic acid|mesh-list
56084132|NCT02977286|Bisacodyl|bisacodyl|mesh-list
56084133|NCT02977286|Magnesium citrate|magnesium citrate|mesh-list
56084134|NCT02977286|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
56084135|NCT02977286|Cathartics|cathartics|mesh-ancestor
56084136|NCT02977286|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56084137|NCT02977286|Laxatives|laxatives|mesh-ancestor
56084138|NCT02977286|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56084139|NCT02977286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084140|NCT02977286|Sensory System Agents|sensory system agents|mesh-ancestor
56084141|NCT02977286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084142|NCT02977286|Antidiarrheals|antidiarrheals|mesh-ancestor
56084143|NCT05345210|Amoxicillin|amoxicillin|mesh-list
56084144|NCT05345210|Clarithromycin|clarithromycin|mesh-list
56084145|NCT05345210|Tetracycline|tetracycline|mesh-list
56084146|NCT05345210|Furazolidone|furazolidone|mesh-list
56084147|NCT05345210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56084148|NCT05345210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084149|NCT05345210|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55811333|NCT04446039|Sertraline|sertraline|mesh-list
56084150|NCT05345210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084151|NCT05345210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084152|NCT05345210|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56084153|NCT05345210|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56084154|NCT05345210|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56084155|NCT05345210|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56084156|NCT05345210|Renal Agents|renal agents|mesh-ancestor
56084157|NCT05345210|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56084182|NCT02508259|Anthelmintics|anthelmintics|mesh-ancestor
56084183|NCT02508259|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56084184|NCT02508259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084185|NCT02508259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084186|NCT02508259|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56084187|NCT02508259|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56084188|NCT02848820|Amoxicillin|amoxicillin|mesh-list
56084189|NCT02848820|Gentamicins|gentamicins|mesh-list
56084190|NCT02848820|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56084191|NCT02848820|Clavulanic Acids|clavulanic acids|mesh-list
56084192|NCT02848820|Clavulanic Acid|clavulanic acid|mesh-list
56084193|NCT02848820|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56084194|NCT02848820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084195|NCT02848820|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56084196|NCT02848820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084197|NCT02848820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084198|NCT02848820|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56084199|NCT00534469|Cytarabine|cytarabine|mesh-list
56084200|NCT00534469|Aldesleukin|aldesleukin|mesh-list
56084201|NCT00534469|Etoposide|etoposide|mesh-list
56084202|NCT00534469|Idarubicin|idarubicin|mesh-list
56084203|NCT00534469|Busulfan|busulfan|mesh-list
56084204|NCT00534469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56084205|NCT00534469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084206|NCT00534469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56084207|NCT00534469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56084208|NCT00534469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084209|NCT00534469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084210|NCT00534469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56084211|NCT00534469|Antimetabolites|antimetabolites|mesh-ancestor
56084212|NCT00534469|Antiviral Agents|antiviral agents|mesh-ancestor
56084213|NCT00534469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084214|NCT00534469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56084215|NCT00534469|Immunologic Factors|immunologic factors|mesh-ancestor
56084217|NCT00534469|Alkylating Agents|alkylating agents|mesh-ancestor
56084224|NCT02240628|Tetracaine|tetracaine|mesh-list
56084225|NCT02240628|Anesthetics, Local|anesthetics, local|mesh-ancestor
56084227|NCT02240628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084228|NCT02240628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084230|NCT02240628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084231|NCT02240628|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56084232|NCT02240628|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56084233|NCT02240628|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56084234|NCT02240628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56084235|NCT02240628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084236|NCT02589067|Chlorhexidine|chlorhexidine|mesh-list
56084237|NCT02589067|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56084238|NCT02589067|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56084239|NCT02589067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084240|NCT02589067|Disinfectants|disinfectants|mesh-ancestor
56084241|NCT02589067|Dermatologic Agents|dermatologic agents|mesh-ancestor
56084242|NCT02511379|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56084243|NCT02511379|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56084244|NCT02207400|Listerine|listerine|mesh-list
56084245|NCT02207400|Fluorides|fluorides|mesh-list
56084246|NCT02207400|Sodium Fluoride|sodium fluoride|mesh-list
56084247|NCT02207400|Cariostatic Agents|cariostatic agents|mesh-ancestor
56084248|NCT02207400|Protective Agents|protective agents|mesh-ancestor
56084249|NCT02207400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084250|NCT02207400|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56084273|NCT02512783|Lidocaine|lidocaine|mesh-list
56084274|NCT02512783|Propofol|propofol|mesh-list
56084275|NCT02512783|Anesthetics, Local|anesthetics, local|mesh-ancestor
56084276|NCT02512783|Anesthetics|anesthetics|mesh-ancestor
56084277|NCT02512783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084278|NCT02512783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084279|NCT02512783|Sensory System Agents|sensory system agents|mesh-ancestor
56084280|NCT02512783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084281|NCT02512783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56084282|NCT02512783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56084283|NCT02512783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56084284|NCT02512783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56084285|NCT02512783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084286|NCT02512783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56084287|NCT02512783|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56084288|NCT02512783|Anesthetics, General|anesthetics, general|mesh-ancestor
56084289|NCT02513095|Dantrolene|dantrolene|mesh-list
56084290|NCT02513095|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56084291|NCT02513095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084292|NCT02513095|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56084293|NCT02513095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084294|NCT02513719|Everolimus|everolimus|mesh-list
56084295|NCT02513719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084296|NCT02513719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56084297|NCT02513719|Immunologic Factors|immunologic factors|mesh-ancestor
56084298|NCT02513719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084299|NCT00363727|Ropinirole|ropinirole|mesh-list
56084300|NCT00363727|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56084301|NCT00363727|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56084302|NCT00363727|Dopamine Agonists|dopamine agonists|mesh-ancestor
56084303|NCT00363727|Dopamine Agents|dopamine agents|mesh-ancestor
55811487|NCT00098475|Ichthammol|ichthammol|mesh-list
56084304|NCT00363727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084308|NCT05673811|Paclitaxel|paclitaxel|mesh-list
56084312|NCT05673811|Antimitotic Agents|antimitotic agents|mesh-ancestor
56084313|NCT05673811|Mitosis Modulators|mitosis modulators|mesh-ancestor
56084314|NCT05673811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084315|NCT05673811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56084316|NCT05673811|Antimetabolites|antimetabolites|mesh-ancestor
56084317|NCT05673811|Antiviral Agents|antiviral agents|mesh-ancestor
56084318|NCT05673811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084319|NCT05673811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084320|NCT05673811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56084321|NCT05673811|Immunologic Factors|immunologic factors|mesh-ancestor
56084322|NCT05673811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084323|NCT04340869|Theobromine|theobromine|mesh-list
56084324|NCT04340869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56084325|NCT04340869|Autonomic Agents|autonomic agents|mesh-ancestor
56084326|NCT04340869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084327|NCT04340869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084328|NCT04340869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56084329|NCT04340869|Respiratory System Agents|respiratory system agents|mesh-ancestor
56084330|NCT04340869|Vasodilator Agents|vasodilator agents|mesh-ancestor
56084333|NCT00366067|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56084334|NCT00366067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56084335|NCT00366067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56084336|NCT00366067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084337|NCT00366067|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56084338|NCT00366067|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56084339|NCT00364429|Lorazepam|lorazepam|mesh-list
56084340|NCT00364429|Risperidone|risperidone|mesh-list
56084341|NCT00364429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56084342|NCT00364429|Serotonin Agents|serotonin agents|mesh-ancestor
56084343|NCT00364429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084344|NCT00364429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084345|NCT00364429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084346|NCT00364429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56084347|NCT00364429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56084348|NCT00364429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084349|NCT00364429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56084350|NCT00364429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56084351|NCT00364429|Dopamine Agents|dopamine agents|mesh-ancestor
56084352|NCT00364429|Anticonvulsants|anticonvulsants|mesh-ancestor
56084353|NCT00364429|Antiemetics|antiemetics|mesh-ancestor
56084354|NCT00364429|Autonomic Agents|autonomic agents|mesh-ancestor
56084355|NCT00364429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084356|NCT00364429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56084357|NCT00364429|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56084358|NCT00364429|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56084359|NCT00364429|GABA Modulators|gaba modulators|mesh-ancestor
56084360|NCT00364429|GABA Agents|gaba agents|mesh-ancestor
56084362|NCT05619289|Ergocalciferols|ergocalciferols|mesh-list
56084363|NCT05619289|Vitamins|vitamins|mesh-ancestor
56084364|NCT05619289|Micronutrients|micronutrients|mesh-ancestor
56084365|NCT05619289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084366|NCT05619289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56084367|NCT05619289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56084368|NCT02593903|Trimethoprim|trimethoprim|mesh-list
56084369|NCT02593903|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56084370|NCT02593903|Sulfamethoxazole|sulfamethoxazole|mesh-list
56084371|NCT02593903|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56084372|NCT02593903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084373|NCT02593903|Renal Agents|renal agents|mesh-ancestor
56084374|NCT02593903|Antimalarials|antimalarials|mesh-ancestor
56084375|NCT02593903|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56084376|NCT02593903|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56084377|NCT02593903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56084378|NCT02593903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084380|NCT02593903|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56084392|NCT02596867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56084393|NCT02596867|Vasodilator Agents|vasodilator agents|mesh-ancestor
56084394|NCT02597101|Metformin|metformin|mesh-list
56084395|NCT02597101|Saxagliptin|saxagliptin|mesh-list
56084396|NCT02597101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56084397|NCT02597101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084398|NCT02597101|Incretins|incretins|mesh-ancestor
56084399|NCT02597101|Hormones|hormones|mesh-ancestor
56084400|NCT02597101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56084401|NCT02597101|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56084402|NCT02597101|Protease Inhibitors|protease inhibitors|mesh-ancestor
56084403|NCT02597101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084404|NCT02597101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084406|NCT02600611|Iclaprim|iclaprim|mesh-list
56084407|NCT02600611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56084408|NCT02600611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084409|NCT02600611|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56084410|NCT02600611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084411|NCT02600611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084412|NCT02600767|Lumefantrine|lumefantrine|mesh-list
56084413|NCT02600767|Artemether|artemether|mesh-list
56084414|NCT02600767|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56084415|NCT02600767|Antimalarials|antimalarials|mesh-ancestor
56084416|NCT02600767|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56084417|NCT02600767|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56084418|NCT02600767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084419|NCT00365287|Cyclosporine|cyclosporine|mesh-list
56084420|NCT00365287|Mycophenolic Acid|mycophenolic acid|mesh-list
56084421|NCT00365287|Cyclophosphamide|cyclophosphamide|mesh-list
56084422|NCT00365287|Fludarabine|fludarabine|mesh-list
56084423|NCT00365287|Fludarabine phosphate|fludarabine phosphate|mesh-list
56084426|NCT00365287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56084427|NCT00365287|Immunologic Factors|immunologic factors|mesh-ancestor
56084428|NCT00365287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084429|NCT00365287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56084431|NCT00365287|Alkylating Agents|alkylating agents|mesh-ancestor
56084432|NCT00365287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084433|NCT00365287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084434|NCT00365287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56084435|NCT00365287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56084436|NCT00365287|Antimetabolites|antimetabolites|mesh-ancestor
56084437|NCT00365287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084438|NCT00365287|Antifungal Agents|antifungal agents|mesh-ancestor
56084439|NCT00365287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084440|NCT00365287|Dermatologic Agents|dermatologic agents|mesh-ancestor
56084441|NCT00365287|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56084442|NCT00365287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56084443|NCT00365287|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56084444|NCT00365287|Antitubercular Agents|antitubercular agents|mesh-ancestor
56084445|NCT00365287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56084446|NCT04743193|Sevoflurane|sevoflurane|mesh-list
56084447|NCT04743193|Anesthetics|anesthetics|mesh-ancestor
56084448|NCT04743193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084449|NCT04743193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084450|NCT04743193|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56084451|NCT04743193|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56084452|NCT04743193|Anesthetics, General|anesthetics, general|mesh-ancestor
56084453|NCT05572645|Trastuzumab|trastuzumab|mesh-list
56084454|NCT05572645|Pertuzumab|pertuzumab|mesh-list
56084455|NCT05572645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56084456|NCT05572645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084457|NCT02608177|Linagliptin|linagliptin|mesh-list
56084458|NCT02608177|Glipizide|glipizide|mesh-list
56084459|NCT02608177|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56084461|NCT02608177|Incretins|incretins|mesh-ancestor
56084476|NCT02611765|Penicillin G Benzathine|penicillin g benzathine|mesh-list
56084477|NCT02611765|Penicillin G Procaine|penicillin g procaine|mesh-list
56084478|NCT02611765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56084479|NCT02611765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084481|NCT05552287|Dermatologic Agents|dermatologic agents|mesh-ancestor
56084482|NCT05552287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56084483|NCT05552287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56084484|NCT02616523|Lidocaine|lidocaine|mesh-list
56084485|NCT02616523|Fentanyl|fentanyl|mesh-list
56084486|NCT02616523|Dexmedetomidine|dexmedetomidine|mesh-list
56084487|NCT02616523|Anesthetics, Local|anesthetics, local|mesh-ancestor
56084488|NCT02616523|Anesthetics|anesthetics|mesh-ancestor
56084489|NCT02616523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084490|NCT02616523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084491|NCT02616523|Sensory System Agents|sensory system agents|mesh-ancestor
56084492|NCT02616523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084493|NCT02616523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56084494|NCT02616523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56084495|NCT02616523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56084496|NCT02616523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56084497|NCT02616523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084498|NCT02616523|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56084499|NCT02616523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56084501|NCT02616523|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56084502|NCT02616523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56084503|NCT02616523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56084504|NCT02616523|Adrenergic Agents|adrenergic agents|mesh-ancestor
56084505|NCT02616523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084506|NCT02616523|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56084507|NCT02616523|Narcotics|narcotics|mesh-ancestor
56084508|NCT02616523|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56084535|NCT05528419|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56084537|NCT05528419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084538|NCT05731843|Ruzasvir|ruzasvir|mesh-list
56084539|NCT05731843|Antiviral Agents|antiviral agents|mesh-ancestor
56084540|NCT05731843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56084541|NCT05485831|Cannabidiol|cannabidiol|mesh-list
56084542|NCT05485831|Anticonvulsants|anticonvulsants|mesh-ancestor
56084543|NCT05480293|Ranibizumab|ranibizumab|mesh-list
56084544|NCT05480293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56084545|NCT05480293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56084546|NCT05480293|Growth Substances|growth substances|mesh-ancestor
56084547|NCT05480293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084548|NCT05480293|Growth Inhibitors|growth inhibitors|mesh-ancestor
56084549|NCT05480293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084550|NCT05449327|Rivaroxaban|rivaroxaban|mesh-list
56084551|NCT05449327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56084552|NCT05449327|Antithrombins|antithrombins|mesh-ancestor
56084556|NCT05449327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084557|NCT05449327|Anticoagulants|anticoagulants|mesh-ancestor
56084558|NCT00365755|Cyclophosphamide|cyclophosphamide|mesh-list
56084560|NCT00365755|Carboplatin|carboplatin|mesh-list
56084561|NCT00365755|Etoposide|etoposide|mesh-list
56084562|NCT00365755|Vincristine|vincristine|mesh-list
56084563|NCT00365755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56084564|NCT00365755|Immunologic Factors|immunologic factors|mesh-ancestor
56084565|NCT00365755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084566|NCT00365755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56084567|NCT00365755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56084568|NCT00365755|Alkylating Agents|alkylating agents|mesh-ancestor
56084569|NCT00365755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084570|NCT00365755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084571|NCT00365755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56084572|NCT00365755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56084573|NCT00365755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56084574|NCT00365755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56084575|NCT00365755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084576|NCT00365755|Tubulin Modulators|tubulin modulators|mesh-ancestor
56084580|NCT05730907|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56084581|NCT05730907|Vasodilator Agents|vasodilator agents|mesh-ancestor
56084582|NCT05730907|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56084583|NCT05730907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56084584|NCT05730907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084585|NCT05730907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084600|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
56084601|NCT05730751|Anesthetics|anesthetics|mesh-list
56084602|NCT05730751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084603|NCT05730751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811777|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084604|NCT05355337|Pramipexole|pramipexole|mesh-list
56084605|NCT05355337|Antioxidants|antioxidants|mesh-ancestor
56084606|NCT05355337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084607|NCT05355337|Protective Agents|protective agents|mesh-ancestor
56084608|NCT05355337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084609|NCT05355337|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56084610|NCT05355337|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56084611|NCT05355337|Dopamine Agonists|dopamine agonists|mesh-ancestor
56084612|NCT05355337|Dopamine Agents|dopamine agents|mesh-ancestor
56084613|NCT05355337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084614|NCT04340401|Capecitabine|capecitabine|mesh-list
56084615|NCT04340401|Oxaliplatin|oxaliplatin|mesh-list
56084616|NCT04340401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56084617|NCT04340401|Antimetabolites|antimetabolites|mesh-ancestor
56084618|NCT04340401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084619|NCT04340401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084620|NCT05281471|Gemcitabine|gemcitabine|mesh-list
56084621|NCT05281471|Paclitaxel|paclitaxel|mesh-list
56084622|NCT05281471|Docetaxel|docetaxel|mesh-list
56084623|NCT05281471|Bevacizumab|bevacizumab|mesh-list
56084624|NCT05281471|Carboplatin|carboplatin|mesh-list
56084625|NCT05281471|Doxorubicin|doxorubicin|mesh-list
56084626|NCT05281471|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56084649|NCT05281471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56084650|NCT05725837|Fluoxetine|fluoxetine|mesh-list
56084651|NCT05725837|Paroxetine|paroxetine|mesh-list
56084652|NCT05725837|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56084653|NCT05725837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56084654|NCT05725837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56084655|NCT05725837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084656|NCT05725837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084657|NCT05725837|Serotonin Agents|serotonin agents|mesh-ancestor
56084658|NCT05725837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084659|NCT05725837|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56084660|NCT05725837|Antidepressive Agents|antidepressive agents|mesh-ancestor
56084661|NCT05725837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56084662|NCT05725837|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56084663|NCT05725837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56084664|NCT05725837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084698|NCT04622839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084699|NCT04622839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56084700|NCT04622839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56084701|NCT04622839|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56084702|NCT04622839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084703|NCT04622839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084704|NCT04622839|Antipyretics|antipyretics|mesh-ancestor
56084705|NCT02619409|Bupivacaine|bupivacaine|mesh-list
56084706|NCT02619409|Anesthetics, Local|anesthetics, local|mesh-ancestor
56084707|NCT02619409|Anesthetics|anesthetics|mesh-ancestor
56084708|NCT02619409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084709|NCT02619409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084710|NCT02619409|Sensory System Agents|sensory system agents|mesh-ancestor
56084711|NCT02619409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084712|NCT02619799|Magnesium Sulfate|magnesium sulfate|mesh-list
56084714|NCT02619799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56084715|NCT02619799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56084716|NCT02619799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084717|NCT02619799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084718|NCT02619799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56084719|NCT02619799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56084720|NCT02619799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56084721|NCT02619799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56084722|NCT02619799|Anesthetics, General|anesthetics, general|mesh-ancestor
56084723|NCT02619799|Anesthetics|anesthetics|mesh-ancestor
56084736|NCT02619799|Tocolytic Agents|tocolytic agents|mesh-ancestor
56084737|NCT02619799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56084738|NCT04592809|Midazolam|midazolam|mesh-list
56084739|NCT04592809|Ketamine|ketamine|mesh-list
56084740|NCT04592809|Analgesics|analgesics|mesh-ancestor
56084741|NCT04592809|Sensory System Agents|sensory system agents|mesh-ancestor
56084742|NCT04592809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084743|NCT04592809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084744|NCT04592809|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56084745|NCT04592809|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56084746|NCT04592809|Anesthetics, General|anesthetics, general|mesh-ancestor
56084747|NCT04592809|Anesthetics|anesthetics|mesh-ancestor
56084748|NCT04592809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56084749|NCT04592809|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56084750|NCT04592809|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56084751|NCT04592809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084752|NCT04592809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084753|NCT04592809|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56084754|NCT04592809|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56084755|NCT04592809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56084756|NCT04592809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55811925|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
56084757|NCT04592809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56084758|NCT04592809|GABA Modulators|gaba modulators|mesh-ancestor
56084760|NCT04741165|Bevacizumab|bevacizumab|mesh-list
56084762|NCT04741165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56084763|NCT04741165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084764|NCT04741165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56084765|NCT04741165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56084766|NCT04741165|Growth Substances|growth substances|mesh-ancestor
56084767|NCT04741165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084783|NCT02625181|Morphine|morphine|mesh-list
56084784|NCT02625181|Remifentanil|remifentanil|mesh-list
56084785|NCT02625181|Oxycodone|oxycodone|mesh-list
56084786|NCT02625181|Methadone|methadone|mesh-list
56084787|NCT02625181|Hydromorphone|hydromorphone|mesh-list
56084788|NCT02625181|Hydrocodone|hydrocodone|mesh-list
56084789|NCT02625181|Alfentanil|alfentanil|mesh-list
56084790|NCT02625181|Haloperidol|haloperidol|mesh-list
56084791|NCT02625181|Ondansetron|ondansetron|mesh-list
56084792|NCT02625181|Aprepitant|aprepitant|mesh-list
56084793|NCT02625181|Metoclopramide|metoclopramide|mesh-list
56084794|NCT02625181|Palonosetron|palonosetron|mesh-list
56084795|NCT02625181|Granisetron|granisetron|mesh-list
56084796|NCT02625181|Ramosetron|ramosetron|mesh-list
56084797|NCT02625181|Tropisetron|tropisetron|mesh-list
56084798|NCT02625181|Dolasetron|dolasetron|mesh-list
56084799|NCT02625181|Anesthetics|anesthetics|mesh-list
56084800|NCT02625181|Propofol|propofol|mesh-list
56084801|NCT02625181|Sevoflurane|sevoflurane|mesh-list
56084802|NCT02625181|Desflurane|desflurane|mesh-list
56084803|NCT02625181|Isoflurane|isoflurane|mesh-list
56084804|NCT02625181|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
56084805|NCT02625181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56084806|NCT02625181|Antiemetics|antiemetics|mesh-ancestor
56084807|NCT02625181|Autonomic Agents|autonomic agents|mesh-ancestor
56084808|NCT02625181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084809|NCT02625181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084810|NCT02625181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56084811|NCT02625181|Glucocorticoids|glucocorticoids|mesh-ancestor
56084812|NCT02625181|Hormones|hormones|mesh-ancestor
56084820|NCT02625181|Analgesics|analgesics|mesh-ancestor
56084838|NCT02625181|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56084839|NCT02625181|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56084841|NCT02625181|Respiratory System Agents|respiratory system agents|mesh-ancestor
56084842|NCT02625181|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56084843|NCT02625181|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56084844|NCT02625181|Dopamine Agents|dopamine agents|mesh-ancestor
56084845|NCT02625181|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56084846|NCT02625181|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56084847|NCT02625181|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56084848|NCT02625181|Mydriatics|mydriatics|mesh-ancestor
56084849|NCT02625181|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56084850|NCT02625181|Cholinergic Agents|cholinergic agents|mesh-ancestor
56084851|NCT02625181|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56084852|NCT02625181|Parasympatholytics|parasympatholytics|mesh-ancestor
56084853|NCT02625181|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56084854|NCT02625181|Histamine Antagonists|histamine antagonists|mesh-ancestor
56084855|NCT02625181|Histamine Agents|histamine agents|mesh-ancestor
56084856|NCT02625181|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56084857|NCT02625181|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56084858|NCT02625181|Anesthetics, Local|anesthetics, local|mesh-ancestor
56084859|NCT04363801|Leucovorin|leucovorin|mesh-list
56084860|NCT04363801|Fluorouracil|fluorouracil|mesh-list
56084861|NCT04363801|Capecitabine|capecitabine|mesh-list
56084862|NCT04363801|Oxaliplatin|oxaliplatin|mesh-list
56084863|NCT04363801|Calcium|calcium|mesh-list
56084864|NCT04363801|Levoleucovorin|levoleucovorin|mesh-list
56084865|NCT04363801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56084866|NCT04363801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084867|NCT04363801|Antimetabolites|antimetabolites|mesh-ancestor
56084868|NCT04363801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084884|NCT02630017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084885|NCT02630017|Dopamine Agents|dopamine agents|mesh-ancestor
56084886|NCT02630017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084887|NCT02630719|Timolol|timolol|mesh-list
56084888|NCT02630719|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56084889|NCT02630719|Lubricant Eye Drops|lubricant eye drops|mesh-list
56084890|NCT02630719|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56084891|NCT02630719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56084892|NCT02630719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56084893|NCT02630719|Adrenergic Agents|adrenergic agents|mesh-ancestor
56084894|NCT02630719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084895|NCT02630719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084896|NCT02630719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084897|NCT02630719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56084898|NCT02630719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56084899|NCT04979377|Insulin|insulin|mesh-list
56084900|NCT04979377|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56084902|NCT04979377|Testosterone|testosterone|mesh-list
56084903|NCT04979377|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56084904|NCT04979377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56084905|NCT04979377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084906|NCT04979377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56084907|NCT04979377|Androgens|androgens|mesh-ancestor
56084908|NCT04979377|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56084909|NCT04979377|Immunologic Factors|immunologic factors|mesh-ancestor
56084910|NCT02633371|Oxybutynin|oxybutynin|mesh-list
56084911|NCT02633371|Parasympatholytics|parasympatholytics|mesh-ancestor
56084912|NCT02633371|Autonomic Agents|autonomic agents|mesh-ancestor
56084913|NCT02633371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084914|NCT02633371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812076|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56084928|NCT04159519|Autonomic Agents|autonomic agents|mesh-ancestor
56084929|NCT04159519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084930|NCT04159519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084931|NCT04159519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56084932|NCT04159519|Respiratory System Agents|respiratory system agents|mesh-ancestor
56084933|NCT04159519|Glucocorticoids|glucocorticoids|mesh-ancestor
56084934|NCT04159519|Hormones|hormones|mesh-ancestor
56084935|NCT04159519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56084936|NCT04159519|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56084937|NCT04159519|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56084938|NCT04159519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56084939|NCT04159519|Adrenergic Agents|adrenergic agents|mesh-ancestor
56084940|NCT04159519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56084941|NCT04159519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084942|NCT04159519|Tocolytic Agents|tocolytic agents|mesh-ancestor
56084943|NCT04159519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56084944|NCT04913311|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56084945|NCT04913311|Dimercaprol|dimercaprol|mesh-list
56084946|NCT04913311|Chelating Agents|chelating agents|mesh-ancestor
56084947|NCT04913311|Sequestering Agents|sequestering agents|mesh-ancestor
56084948|NCT04913311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084949|NCT04913311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084950|NCT04054375|Prednisone|prednisone|mesh-list
56084951|NCT04054375|Prednisolone|prednisolone|mesh-list
56084952|NCT04054375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56084953|NCT04054375|Glucocorticoids|glucocorticoids|mesh-ancestor
56084954|NCT04054375|Hormones|hormones|mesh-ancestor
56084955|NCT04054375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56084956|NCT04054375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084957|NCT04054375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56084958|NCT04054375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084959|NCT02634073|Lamivudine|lamivudine|mesh-list
56084969|NCT02634073|Cathartics|cathartics|mesh-ancestor
56084970|NCT02634073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56084971|NCT00366691|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56084972|NCT00366691|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56084974|NCT00367393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56084975|NCT00367393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56084976|NCT00367393|Analgesics|analgesics|mesh-ancestor
56084977|NCT00367393|Sensory System Agents|sensory system agents|mesh-ancestor
56084978|NCT00367393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56084979|NCT00367393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56084980|NCT00367393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56084981|NCT00367393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56084982|NCT00367393|Dermatologic Agents|dermatologic agents|mesh-ancestor
56084983|NCT00367393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56084984|NCT00367393|Immunologic Factors|immunologic factors|mesh-ancestor
56084985|NCT00367393|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56084986|NCT00367393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56084987|NCT00367393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56084988|NCT00367471|Paclitaxel|paclitaxel|mesh-list
56084989|NCT00367471|Carboplatin|carboplatin|mesh-list
56084991|NCT00367471|Lapatinib|lapatinib|mesh-list
56084992|NCT00367471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56084993|NCT00367471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56084994|NCT00367471|Tubulin Modulators|tubulin modulators|mesh-ancestor
56085023|NCT02638597|Antimetabolites|antimetabolites|mesh-ancestor
56085024|NCT02638597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085025|NCT02638597|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56085026|NCT02638597|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56085027|NCT02638597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56085028|NCT02638597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085029|NCT02206620|Donepezil|donepezil|mesh-list
56085030|NCT02206620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56085031|NCT02206620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085032|NCT02206620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085033|NCT02206620|Cholinergic Agents|cholinergic agents|mesh-ancestor
56085034|NCT02206620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085035|NCT02206620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085036|NCT02206620|Nootropic Agents|nootropic agents|mesh-ancestor
56085037|NCT02239926|Ranolazine|ranolazine|mesh-list
56085038|NCT02239926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56085039|NCT02239926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56085040|NCT02239926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085041|NCT02239692|Picosulfate sodium|picosulfate sodium|mesh-list
56085042|NCT02239692|Cathartics|cathartics|mesh-ancestor
56085043|NCT02239692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56085044|NCT02641561|Indomethacin|indomethacin|mesh-list
56085045|NCT02641561|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56085046|NCT02641561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56085047|NCT02641561|Analgesics|analgesics|mesh-ancestor
56085048|NCT02641561|Sensory System Agents|sensory system agents|mesh-ancestor
56085051|NCT02641561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56085072|NCT04781088|Pembrolizumab|pembrolizumab|mesh-list
56085474|NCT05073692|Glucagon|glucagon|mesh-list
56085073|NCT04781088|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56085074|NCT04781088|Lenvatinib|lenvatinib|mesh-list
56085075|NCT04781088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56085076|NCT04781088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085077|NCT04781088|Tubulin Modulators|tubulin modulators|mesh-ancestor
56085078|NCT04781088|Antimitotic Agents|antimitotic agents|mesh-ancestor
56085079|NCT04781088|Mitosis Modulators|mitosis modulators|mesh-ancestor
56085080|NCT04781088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085081|NCT04781088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085082|NCT04781088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56085083|NCT04781088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085084|NCT00367081|Pyrimethamine|pyrimethamine|mesh-list
56085085|NCT00367081|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56085086|NCT00367081|Sulfadiazine|sulfadiazine|mesh-list
56085087|NCT00367081|Antimalarials|antimalarials|mesh-ancestor
56085088|NCT00367081|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56085089|NCT00367081|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56085090|NCT00367081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085091|NCT00367081|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56085092|NCT00367081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085093|NCT00367081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085094|NCT00367081|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56085095|NCT00367081|Renal Agents|renal agents|mesh-ancestor
56085121|NCT04074265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085122|NCT04074265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085123|NCT04074265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56085124|NCT04074265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56085125|NCT04074265|Autonomic Agents|autonomic agents|mesh-ancestor
56085126|NCT04074265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56085127|NCT04074265|Respiratory System Agents|respiratory system agents|mesh-ancestor
56085128|NCT04074265|Mydriatics|mydriatics|mesh-ancestor
56085129|NCT04074265|Sympathomimetics|sympathomimetics|mesh-ancestor
56085130|NCT04074265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56085131|NCT04074265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56085132|NCT04074265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56085133|NCT04074265|Analgesics|analgesics|mesh-ancestor
56085134|NCT04074265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56085135|NCT04074265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085136|NCT04074265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56085137|NCT04074265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085138|NCT05342376|Dexmedetomidine|dexmedetomidine|mesh-list
56085139|NCT05342376|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56085140|NCT05342376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085141|NCT05342376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085142|NCT05342376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56085143|NCT05342376|Analgesics|analgesics|mesh-ancestor
56085144|NCT05342376|Sensory System Agents|sensory system agents|mesh-ancestor
56085145|NCT05342376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085146|NCT05342376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56085147|NCT05342376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56085149|NCT05342376|Adrenergic Agents|adrenergic agents|mesh-ancestor
56085150|NCT05342376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085151|NCT05342376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085152|NCT03330847|Olaparib|olaparib|mesh-list
56085153|NCT03330847|Adavosertib|adavosertib|mesh-list
56085160|NCT04776096|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56085161|NCT04776096|Bepotastine besilate|bepotastine besilate|mesh-list
56085162|NCT04776096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56085163|NCT04776096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56085164|NCT04776096|Analgesics|analgesics|mesh-ancestor
56085165|NCT04776096|Sensory System Agents|sensory system agents|mesh-ancestor
56085166|NCT04776096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085167|NCT04776096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085168|NCT04776096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56085169|NCT04776096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085170|NCT04776096|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56085171|NCT04776096|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56085172|NCT04776096|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56085173|NCT04776096|Histamine Antagonists|histamine antagonists|mesh-ancestor
56085174|NCT04776096|Histamine Agents|histamine agents|mesh-ancestor
56085175|NCT04776096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085177|NCT03899155|Nivolumab|nivolumab|mesh-list
56085220|NCT02169414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085221|NCT02169414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085222|NCT02169414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085223|NCT02169414|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56085224|NCT02169414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085225|NCT02169414|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56085226|NCT03213457|Norethindrone|norethindrone|mesh-list
56085227|NCT03213457|Norethindrone Acetate|norethindrone acetate|mesh-list
56085229|NCT03213457|Estrogens|estrogens|mesh-ancestor
56085230|NCT03213457|Hormones|hormones|mesh-ancestor
56085231|NCT03213457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085232|NCT03213457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085233|NCT03213457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56085234|NCT03213457|Contraceptive Agents|contraceptive agents|mesh-ancestor
56085235|NCT03213457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56085236|NCT03213457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56085237|NCT03213457|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56085238|NCT03213457|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56085239|NCT03213457|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56085240|NCT02201940|Sofosbuvir|sofosbuvir|mesh-list
56085241|NCT02201940|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56085242|NCT02201940|Velpatasvir|velpatasvir|mesh-list
56085243|NCT02201940|Antiviral Agents|antiviral agents|mesh-ancestor
56085244|NCT02201940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085245|NCT05588869|Cyclosporine|cyclosporine|mesh-list
56085246|NCT05588869|Cyclosporins|cyclosporins|mesh-list
56085247|NCT05588869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085248|NCT05588869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085249|NCT05588869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56085250|NCT05588869|Immunologic Factors|immunologic factors|mesh-ancestor
56085251|NCT05588869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085252|NCT05588869|Antifungal Agents|antifungal agents|mesh-ancestor
56085253|NCT05588869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085259|NCT02169336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085260|NCT02169336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085261|NCT02169336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56085262|NCT02169336|Analgesics|analgesics|mesh-ancestor
56085263|NCT02169336|Sensory System Agents|sensory system agents|mesh-ancestor
56085264|NCT02169336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085265|NCT02169336|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56085266|NCT02169336|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56085267|NCT02169336|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56085268|NCT02169336|Adrenergic Agents|adrenergic agents|mesh-ancestor
56085269|NCT02169336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085270|NCT02169336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085271|NCT03043807|Docetaxel|docetaxel|mesh-list
56085272|NCT03043807|Leuprolide|leuprolide|mesh-list
56085273|NCT03043807|Abiraterone Acetate|abiraterone acetate|mesh-list
56085274|NCT03043807|Bicalutamide|bicalutamide|mesh-list
56085275|NCT03043807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085276|NCT03043807|Tubulin Modulators|tubulin modulators|mesh-ancestor
56085277|NCT03043807|Antimitotic Agents|antimitotic agents|mesh-ancestor
56085278|NCT03043807|Mitosis Modulators|mitosis modulators|mesh-ancestor
56085279|NCT03043807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085280|NCT03043807|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56085281|NCT03043807|Fertility Agents|fertility agents|mesh-ancestor
56085282|NCT03043807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56085283|NCT03043807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085284|NCT03043807|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56085285|NCT03043807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56085286|NCT03043807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085304|NCT03206047|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56085306|NCT03206047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085307|NCT03206047|Immunologic Factors|immunologic factors|mesh-ancestor
56085308|NCT03206047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085309|NCT03206047|Interferon Inducers|interferon inducers|mesh-ancestor
56085310|NCT03206047|Laxatives|laxatives|mesh-ancestor
56085311|NCT03206047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56085312|NCT03206047|Antiviral Agents|antiviral agents|mesh-ancestor
56085313|NCT03206047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085314|NCT03206047|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56085315|NCT03206047|Antimetabolites|antimetabolites|mesh-ancestor
56085316|NCT03206047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085317|NCT03206047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085318|NCT05588557|Bupivacaine|bupivacaine|mesh-list
56085319|NCT05588557|Anesthetics, Local|anesthetics, local|mesh-ancestor
56085320|NCT05588557|Anesthetics|anesthetics|mesh-ancestor
56085321|NCT05588557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085322|NCT05588557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085323|NCT05588557|Sensory System Agents|sensory system agents|mesh-ancestor
56085324|NCT05588557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085325|NCT02672917|Gemcitabine|gemcitabine|mesh-list
56085326|NCT02672917|Paclitaxel|paclitaxel|mesh-list
56085327|NCT02672917|Folfirinox|folfirinox|mesh-list
56085328|NCT02672917|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56085329|NCT02672917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085330|NCT02672917|Tubulin Modulators|tubulin modulators|mesh-ancestor
56085331|NCT02672917|Antimitotic Agents|antimitotic agents|mesh-ancestor
56085332|NCT02672917|Mitosis Modulators|mitosis modulators|mesh-ancestor
56085333|NCT02672917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085334|NCT02672917|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56085335|NCT02672917|Antimetabolites|antimetabolites|mesh-ancestor
56085336|NCT02672917|Antiviral Agents|antiviral agents|mesh-ancestor
56085348|NCT01632306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085349|NCT01632306|Tubulin Modulators|tubulin modulators|mesh-ancestor
56085350|NCT01632306|Antimitotic Agents|antimitotic agents|mesh-ancestor
56085351|NCT01632306|Mitosis Modulators|mitosis modulators|mesh-ancestor
56085352|NCT01632306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085353|NCT01632306|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56085354|NCT01632306|Antimetabolites|antimetabolites|mesh-ancestor
56085355|NCT01632306|Antiviral Agents|antiviral agents|mesh-ancestor
56085356|NCT01632306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085357|NCT01632306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085358|NCT01632306|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56085359|NCT01632306|Immunologic Factors|immunologic factors|mesh-ancestor
56085360|NCT01632306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085362|NCT01632306|Protective Agents|protective agents|mesh-ancestor
56085363|NCT01632306|Vitamin B Complex|vitamin b complex|mesh-ancestor
56085364|NCT01632306|Vitamins|vitamins|mesh-ancestor
56085365|NCT01632306|Micronutrients|micronutrients|mesh-ancestor
56085366|NCT02201784|Ropivacaine|ropivacaine|mesh-list
56085367|NCT02201784|Levobupivacaine|levobupivacaine|mesh-list
56085406|NCT02168946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085407|NCT02650856|Tranexamic Acid|tranexamic acid|mesh-list
56085408|NCT02650856|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56085409|NCT02650856|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56085410|NCT02650856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085411|NCT02650856|Hemostatics|hemostatics|mesh-ancestor
56085412|NCT02650856|Coagulants|coagulants|mesh-ancestor
56085414|NCT02168478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56085415|NCT02168478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085416|NCT02168478|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56085417|NCT02168478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085418|NCT02168478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085419|NCT00367874|Buprenorphine|buprenorphine|mesh-list
56085420|NCT00367874|Valproic Acid|valproic acid|mesh-list
56085421|NCT00367874|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56085423|NCT00367874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085424|NCT00367874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085426|NCT00367874|Sensory System Agents|sensory system agents|mesh-ancestor
56085427|NCT00367874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085428|NCT00367874|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56085429|NCT00367874|Anticonvulsants|anticonvulsants|mesh-ancestor
56085430|NCT00367874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085431|NCT00367874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085432|NCT00367874|GABA Agents|gaba agents|mesh-ancestor
56085456|NCT02302976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085457|NCT02302976|Sensory System Agents|sensory system agents|mesh-ancestor
56085458|NCT02302976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085459|NCT02302976|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56085460|NCT02302976|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56085461|NCT02302976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56085462|NCT02302976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56085463|NCT02302976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085465|NCT02302976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085466|NCT05073692|Liraglutide|liraglutide|mesh-list
56085467|NCT05073692|Empagliflozin|empagliflozin|mesh-list
56085468|NCT05073692|Exenatide|exenatide|mesh-list
56085469|NCT05073692|Glimepiride|glimepiride|mesh-list
56085470|NCT05073692|Linagliptin|linagliptin|mesh-list
56085471|NCT05073692|Saxagliptin|saxagliptin|mesh-list
56085472|NCT05073692|Alogliptin|alogliptin|mesh-list
56085473|NCT05073692|Glipizide|glipizide|mesh-list
56085475|NCT05073692|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56085476|NCT05073692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56085477|NCT05073692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085478|NCT05073692|Incretins|incretins|mesh-ancestor
56085479|NCT05073692|Hormones|hormones|mesh-ancestor
56085480|NCT05073692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085481|NCT05073692|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56085482|NCT05073692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085483|NCT05073692|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56085484|NCT05073692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56085485|NCT05073692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56085486|NCT05073692|Immunologic Factors|immunologic factors|mesh-ancestor
56085487|NCT05073692|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56085488|NCT05073692|Protease Inhibitors|protease inhibitors|mesh-ancestor
56085499|NCT02244164|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085500|NCT02244164|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56085501|NCT02244164|Protease Inhibitors|protease inhibitors|mesh-ancestor
56085502|NCT02244164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085503|NCT02244164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085505|NCT02152670|Methylphenidate|methylphenidate|mesh-list
56085506|NCT02152670|alpha-Methyltyrosine|alpha-methyltyrosine|mesh-list
56085507|NCT02152670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56085508|NCT02152670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085509|NCT02152670|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56085510|NCT02152670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56085511|NCT02152670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56085512|NCT02152670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085513|NCT02152670|Dopamine Agents|dopamine agents|mesh-ancestor
56085514|NCT02152670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085515|NCT02152670|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56085517|NCT02152670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085518|NCT02152670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56085519|NCT02152670|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56085520|NCT02152670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085521|NCT02028806|Leucovorin|leucovorin|mesh-list
56085522|NCT02028806|Oxaliplatin|oxaliplatin|mesh-list
56085523|NCT02028806|Irinotecan|irinotecan|mesh-list
56085548|NCT04740086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085550|NCT04739618|Ipilimumab|ipilimumab|mesh-list
56085551|NCT04739618|Sargramostim|sargramostim|mesh-list
56085552|NCT04739618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085553|NCT04739618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085554|NCT04739618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56085555|NCT04739618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085556|NCT04739618|Immunologic Factors|immunologic factors|mesh-ancestor
56085557|NCT04739618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085558|NCT02684942|Fentanyl|fentanyl|mesh-list
56085559|NCT02684942|Meperidine|meperidine|mesh-list
56085560|NCT02684942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56085561|NCT02684942|Narcotics|narcotics|mesh-ancestor
56085562|NCT02684942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085563|NCT02684942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085564|NCT02684942|Analgesics|analgesics|mesh-ancestor
56085565|NCT02684942|Sensory System Agents|sensory system agents|mesh-ancestor
56085566|NCT02684942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085567|NCT02684942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56085568|NCT02684942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56085569|NCT02684942|Anesthetics, General|anesthetics, general|mesh-ancestor
56085570|NCT02684942|Anesthetics|anesthetics|mesh-ancestor
56085571|NCT04739774|Itraconazole|itraconazole|mesh-list
56085572|NCT04739774|Antifungal Agents|antifungal agents|mesh-ancestor
56085573|NCT04739774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085574|NCT04739774|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55741414|NCT03362047|Macitentan|macitentan|mesh-list
56085576|NCT04739774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085577|NCT04739774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085578|NCT04739774|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56085579|NCT04739774|Hormone Antagonists|hormone antagonists|mesh-ancestor
56085580|NCT04739774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085581|NCT04739774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085582|NCT04739774|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56085587|NCT02660918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085589|NCT02660918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085591|NCT00367315|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56085592|NCT00367315|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56085593|NCT00367315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812750|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
56085594|NCT00367315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085595|NCT00367315|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56085596|NCT00367315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56085598|NCT00367315|Sensory System Agents|sensory system agents|mesh-ancestor
56085599|NCT00367315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085600|NCT00367315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085601|NCT00367315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56085602|NCT00367315|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085603|NCT01192555|Cyclophosphamide|cyclophosphamide|mesh-list
56085604|NCT01192555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56085605|NCT01192555|Immunologic Factors|immunologic factors|mesh-ancestor
56085606|NCT01192555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085607|NCT01192555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085608|NCT01192555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56085609|NCT01192555|Alkylating Agents|alkylating agents|mesh-ancestor
56085610|NCT01192555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085611|NCT01192555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085612|NCT01192555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56085613|NCT05441761|Gemcitabine|gemcitabine|mesh-list
56085629|NCT05441761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085631|NCT05441761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085632|NCT05441761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085633|NCT05441761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56085634|NCT05441761|Immunologic Factors|immunologic factors|mesh-ancestor
56085635|NCT05441761|Analgesics|analgesics|mesh-ancestor
56085636|NCT05441761|Sensory System Agents|sensory system agents|mesh-ancestor
56085637|NCT05441761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56085638|NCT05441761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56085639|NCT05587621|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
56085640|NCT05587621|Ezetimibe|ezetimibe|mesh-list
56085641|NCT05587621|Evolocumab|evolocumab|mesh-list
56085642|NCT05587621|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56085643|NCT05587621|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56085644|NCT05587621|Antimetabolites|antimetabolites|mesh-ancestor
56085645|NCT05587621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085646|NCT05587621|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56085647|NCT05587621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085648|NCT05587621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56085649|NCT05587621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085650|NCT04739215|Dapagliflozin|dapagliflozin|mesh-list
56085651|NCT04739215|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56085652|NCT04739215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085653|NCT04739215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56085654|NCT04739215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085655|NCT02688829|Sirolimus|sirolimus|mesh-list
56085657|NCT02688829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085658|NCT02688829|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56085664|NCT02688842|Sirolimus|sirolimus|mesh-list
56085672|NCT02688842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085673|NCT02689063|Acetaminophen|acetaminophen|mesh-list
56085674|NCT02689063|Ibuprofen|ibuprofen|mesh-list
56085675|NCT02689063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56085676|NCT02689063|Analgesics|analgesics|mesh-ancestor
56085677|NCT02689063|Sensory System Agents|sensory system agents|mesh-ancestor
56085678|NCT02689063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085679|NCT02689063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085680|NCT02689063|Antipyretics|antipyretics|mesh-ancestor
56085681|NCT02689063|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56085682|NCT02689063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56085683|NCT02689063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085684|NCT02689063|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56085685|NCT02689063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085686|NCT02689063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085687|NCT00367861|Imatinib Mesylate|imatinib mesylate|mesh-list
56085688|NCT00367861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085689|NCT00367861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56085690|NCT00367861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085691|NCT00367861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085692|NCT02666846|Ibuprofen|ibuprofen|mesh-list
56085693|NCT02666846|Diclofenac|diclofenac|mesh-list
56085697|NCT02666846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56085698|NCT02666846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56085699|NCT02666846|Analgesics|analgesics|mesh-ancestor
56085700|NCT02666846|Sensory System Agents|sensory system agents|mesh-ancestor
56085701|NCT02666846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085719|NCT02643979|Sensory System Agents|sensory system agents|mesh-ancestor
56085720|NCT02643979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085721|NCT02643979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56085722|NCT02643979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56085723|NCT02643979|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56085724|NCT02643979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085725|NCT02643979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085726|NCT05587231|Fluorometholone|fluorometholone|mesh-list
56085727|NCT05587231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56085728|NCT05587231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085729|NCT05587231|Glucocorticoids|glucocorticoids|mesh-ancestor
56085731|NCT05587231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085732|NCT05587231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56085733|NCT02667704|Nintedanib|nintedanib|mesh-list
56085734|NCT02667704|Bosentan|bosentan|mesh-list
56085735|NCT02667704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085736|NCT02667704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56085737|NCT02667704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085738|NCT02667704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085739|NCT02667704|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56085740|NCT02667704|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56085741|NCT02645617|Imidacloprid|imidacloprid|mesh-list
56085742|NCT02645617|Cholinergic Agents|cholinergic agents|mesh-ancestor
56085767|NCT02691416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56085768|NCT02691416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085769|NCT02691416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085770|NCT02691416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56085771|NCT02691416|Anesthetics, General|anesthetics, general|mesh-ancestor
56085772|NCT02691416|Anesthetics|anesthetics|mesh-ancestor
56085773|NCT02691416|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56085774|NCT02691416|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56085775|NCT02650999|Pembrolizumab|pembrolizumab|mesh-list
56085776|NCT02650999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085777|NCT02650999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085783|NCT05502211|Lidocaine|lidocaine|mesh-list
56085784|NCT05502211|Fentanyl|fentanyl|mesh-list
56085785|NCT05502211|Anesthetics, Local|anesthetics, local|mesh-ancestor
56085786|NCT05502211|Anesthetics|anesthetics|mesh-ancestor
56085787|NCT05502211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085788|NCT05502211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085789|NCT05502211|Sensory System Agents|sensory system agents|mesh-ancestor
56085790|NCT05502211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56085791|NCT05502211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56085792|NCT05502211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56085793|NCT05502211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56085794|NCT05502211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56085795|NCT05502211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085796|NCT05502211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56085797|NCT05502211|Narcotics|narcotics|mesh-ancestor
56085814|NCT04708106|Dermatologic Agents|dermatologic agents|mesh-ancestor
56085815|NCT02697188|Methyltestosterone|methyltestosterone|mesh-list
56085816|NCT02697188|Testosterone|testosterone|mesh-list
56085817|NCT02697188|Testosterone undecanoate|testosterone undecanoate|mesh-list
56085818|NCT02697188|Testosterone enanthate|testosterone enanthate|mesh-list
56085819|NCT02697188|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56085820|NCT02697188|Androgens|androgens|mesh-ancestor
56085821|NCT02697188|Hormones|hormones|mesh-ancestor
56085822|NCT02697188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085823|NCT02697188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085824|NCT02697188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56085825|NCT02697188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085826|NCT02697188|Anabolic Agents|anabolic agents|mesh-ancestor
56085827|NCT04707560|Heparin|heparin|mesh-list
56085828|NCT04707560|Anticoagulants|anticoagulants|mesh-ancestor
56085829|NCT04707560|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56085830|NCT04707560|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56085831|NCT04707560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741420|NCT02518789|Midazolam|midazolam|mesh-list
56085833|NCT02653183|Laxatives|laxatives|mesh-ancestor
56085834|NCT02653183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56085835|NCT02701400|Durvalumab|durvalumab|mesh-list
56085836|NCT02701400|Ipilimumab|ipilimumab|mesh-list
56085837|NCT02701400|Tremelimumab|tremelimumab|mesh-list
56085838|NCT02701400|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085839|NCT02701400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085864|NCT05470465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56085865|NCT05470465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085866|NCT05470465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085867|NCT05470465|Serotonin Agents|serotonin agents|mesh-ancestor
56085868|NCT05470465|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56085869|NCT05470465|Antidepressive Agents|antidepressive agents|mesh-ancestor
56085870|NCT05470465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56085871|NCT05470465|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56085872|NCT05470465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56085873|NCT05470465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56085874|NCT00368030|Eszopiclone|eszopiclone|mesh-list
56085875|NCT00368030|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56085876|NCT00368030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56085877|NCT00368030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085878|NCT02656069|Glucagon|glucagon|mesh-list
56085879|NCT02656069|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56085880|NCT02656069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56085881|NCT02656069|Hormones|hormones|mesh-ancestor
56085882|NCT02656069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085883|NCT02656069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085884|NCT02656069|Incretins|incretins|mesh-ancestor
56085885|NCT05351762|Paclitaxel|paclitaxel|mesh-list
56085886|NCT05351762|Nimotuzumab|nimotuzumab|mesh-list
56085887|NCT05351762|Nedaplatin|nedaplatin|mesh-list
56085888|NCT05351762|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56085889|NCT05351762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085890|NCT05351762|Tubulin Modulators|tubulin modulators|mesh-ancestor
56085891|NCT05351762|Antimitotic Agents|antimitotic agents|mesh-ancestor
56085892|NCT05351762|Mitosis Modulators|mitosis modulators|mesh-ancestor
56085893|NCT05351762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085907|NCT02710981|Urological Agents|urological agents|mesh-ancestor
56085908|NCT02710981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56085909|NCT02710981|Hormone Antagonists|hormone antagonists|mesh-ancestor
56085910|NCT02710981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56085911|NCT02710981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085912|NCT02710981|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56085913|NCT02710981|Fertility Agents|fertility agents|mesh-ancestor
56085914|NCT02710981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56085915|NCT02710981|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56085916|NCT02710981|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56085918|NCT04193228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56085919|NCT04193228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56085920|NCT04738838|Oxytocin|oxytocin|mesh-list
56085921|NCT04738838|Oxytocics|oxytocics|mesh-ancestor
56085922|NCT04738838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56085923|NCT04738838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085924|NCT04739917|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
56085925|NCT04739917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56085926|NCT04739917|Immunologic Factors|immunologic factors|mesh-ancestor
56085927|NCT04739917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085928|NCT05343481|Nivolumab|nivolumab|mesh-list
56085929|NCT05343481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56085930|NCT05343481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56085931|NCT05343481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56085932|NCT05343481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085933|NCT05303636|Drospirenone|drospirenone|mesh-list
56085935|NCT05303636|Hormone Antagonists|hormone antagonists|mesh-ancestor
56085954|NCT02659501|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56085955|NCT02659501|Narcotics|narcotics|mesh-ancestor
56085956|NCT02659501|Analgesics|analgesics|mesh-ancestor
56085957|NCT02659501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56085958|NCT02659501|Antipyretics|antipyretics|mesh-ancestor
56085959|NCT02659501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56085960|NCT02659501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56085961|NCT02659501|Adrenergic Agents|adrenergic agents|mesh-ancestor
56085962|NCT02659501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56085963|NCT02659501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56085964|NCT02659501|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56085965|NCT02659501|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56085967|NCT02659501|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56085969|NCT02659501|Mydriatics|mydriatics|mesh-ancestor
56085970|NCT02659501|Sympathomimetics|sympathomimetics|mesh-ancestor
56085971|NCT02659501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56085972|NCT02659501|Antitussive Agents|antitussive agents|mesh-ancestor
56085973|NCT02659501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56085974|NCT02659501|Anticonvulsants|anticonvulsants|mesh-ancestor
56085975|NCT02659501|Antiemetics|antiemetics|mesh-ancestor
56085976|NCT02659501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56085977|NCT02659501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56085978|NCT02659501|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56085979|NCT02659501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56085980|NCT02659501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56085981|NCT02659501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56085982|NCT02659501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56085983|NCT02659501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56085984|NCT02659501|Anesthetics, General|anesthetics, general|mesh-ancestor
56085985|NCT02659501|GABA Modulators|gaba modulators|mesh-ancestor
56085986|NCT02659501|GABA Agents|gaba agents|mesh-ancestor
56085987|NCT02659501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56085988|NCT02659501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56085989|NCT02659501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56085990|NCT00367939|Amlodipine|amlodipine|mesh-list
56085991|NCT00367939|Valsartan|valsartan|mesh-list
56085996|NCT00367939|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56085997|NCT00367939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56085998|NCT00367939|Vasodilator Agents|vasodilator agents|mesh-ancestor
56085999|NCT00367939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56086000|NCT00367939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56086001|NCT02720107|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
56086002|NCT02720107|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
56086003|NCT02720107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086004|NCT02720107|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56086005|NCT02720107|Immunologic Factors|immunologic factors|mesh-ancestor
56086006|NCT02720107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086007|NCT02722837|Sofosbuvir|sofosbuvir|mesh-list
56086008|NCT02722837|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
56086009|NCT02722837|Velpatasvir|velpatasvir|mesh-list
56086010|NCT02722837|Antiviral Agents|antiviral agents|mesh-ancestor
56086011|NCT02722837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086012|NCT02710526|Buprenorphine|buprenorphine|mesh-list
56086013|NCT02710526|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56086014|NCT02710526|Narcotics|narcotics|mesh-ancestor
56086015|NCT02710526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086016|NCT02710526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086017|NCT02710526|Analgesics|analgesics|mesh-ancestor
56086018|NCT02710526|Sensory System Agents|sensory system agents|mesh-ancestor
56086019|NCT02710526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086020|NCT02710526|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56086021|NCT02664961|Bevacizumab|bevacizumab|mesh-list
56086022|NCT02664961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56086023|NCT02664961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086024|NCT02664961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56086025|NCT02664961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56086039|NCT02713178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086040|NCT02713178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086041|NCT02713178|Sensory System Agents|sensory system agents|mesh-ancestor
55813208|NCT02187861|Rituximab|rituximab|mesh-list
56086042|NCT02713178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086043|NCT04130438|Nebivolol|nebivolol|mesh-list
56086044|NCT04130438|Diltiazem|diltiazem|mesh-list
56086045|NCT04130438|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56086046|NCT04130438|Vasodilator Agents|vasodilator agents|mesh-ancestor
56086047|NCT04130438|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56086048|NCT04130438|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56086049|NCT04130438|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56086050|NCT04130438|Adrenergic Agents|adrenergic agents|mesh-ancestor
56086051|NCT04130438|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086052|NCT04130438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086053|NCT04130438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086054|NCT04130438|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56086055|NCT04130438|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56086056|NCT04130438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56086057|NCT04048850|Grazoprevir|grazoprevir|mesh-list
56086058|NCT04048850|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
56086060|NCT04048850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144731|NCT00811434|Lactulose|lactulose|mesh-list
56144733|NCT00812604|Analgesics|analgesics|mesh-list
56144755|NCT00814788|Immunologic Factors|immunologic factors|mesh-ancestor
56144756|NCT00814788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144758|NCT00814788|Hormone Antagonists|hormone antagonists|mesh-ancestor
56144759|NCT00814788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144760|NCT00820872|Carboplatin|carboplatin|mesh-list
56144761|NCT00820872|Docetaxel|docetaxel|mesh-list
56144762|NCT00820872|Trastuzumab|trastuzumab|mesh-list
56144763|NCT00820872|Lapatinib|lapatinib|mesh-list
56144764|NCT00820872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144765|NCT00820872|Tubulin Modulators|tubulin modulators|mesh-ancestor
56144766|NCT00820872|Antimitotic Agents|antimitotic agents|mesh-ancestor
56144767|NCT00820872|Mitosis Modulators|mitosis modulators|mesh-ancestor
56144768|NCT00820872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144769|NCT00820872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56144770|NCT00820872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56144771|NCT00820872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144772|NCT00821184|Solifenacin Succinate|solifenacin succinate|mesh-list
56144773|NCT00821184|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56144774|NCT00821184|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56144775|NCT00821184|Cholinergic Agents|cholinergic agents|mesh-ancestor
56144776|NCT00821184|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086085|NCT02714504|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56086086|NCT02714504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086087|NCT02714504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086088|NCT02714504|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56086089|NCT02714504|Hormone Antagonists|hormone antagonists|mesh-ancestor
56086090|NCT02714504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086091|NCT02714504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086092|NCT02714504|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56086093|NCT02714504|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56086094|NCT02714504|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56086095|NCT02714504|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56086096|NCT05221502|Bedaquiline|bedaquiline|mesh-list
56086097|NCT05221502|Diarylquinolines|diarylquinolines|mesh-list
56086098|NCT05221502|Antitubercular Agents|antitubercular agents|mesh-ancestor
56086099|NCT05221502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56086100|NCT05221502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086102|NCT02730247|Ramucirumab|ramucirumab|mesh-list
56086103|NCT02730247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56086104|NCT02730247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086109|NCT03889106|Ribavirin|ribavirin|mesh-list
56086139|NCT03697850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086140|NCT02730884|ON 01910|on 01910|mesh-list
56086141|NCT02730884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086142|NCT02730884|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56086143|NCT02730884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086144|NCT02730884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086145|NCT02732587|Saracatinib|saracatinib|mesh-list
56086146|NCT02732587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086147|NCT02732587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086148|NCT02732587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086150|NCT02731820|Cholecalciferol|cholecalciferol|mesh-list
56086151|NCT02731820|Potassium Citrate|potassium citrate|mesh-list
56086152|NCT02731820|Calcium Carbonate|calcium carbonate|mesh-list
56086153|NCT02731820|Calcium|calcium|mesh-list
56086154|NCT02731820|Vitamins|vitamins|mesh-ancestor
56086155|NCT02731820|Micronutrients|micronutrients|mesh-ancestor
56086156|NCT02731820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086157|NCT02731820|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56086158|NCT02731820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56086159|NCT02731820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086160|NCT02731820|Antacids|antacids|mesh-ancestor
56086161|NCT02731820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56086162|NCT02731820|Diuretics|diuretics|mesh-ancestor
56086163|NCT02731820|Natriuretic Agents|natriuretic agents|mesh-ancestor
56086164|NCT02731820|Expectorants|expectorants|mesh-ancestor
56086165|NCT02731820|Respiratory System Agents|respiratory system agents|mesh-ancestor
56086166|NCT02732899|Sirolimus|sirolimus|mesh-list
56086167|NCT02732899|Aflibercept|aflibercept|mesh-list
56086168|NCT02732899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56086169|NCT02732899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086170|NCT02732899|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56086171|NCT02732899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086173|NCT02732899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56086174|NCT02732899|Immunologic Factors|immunologic factors|mesh-ancestor
56086178|NCT02732899|Growth Substances|growth substances|mesh-ancestor
56086179|NCT02732899|Growth Inhibitors|growth inhibitors|mesh-ancestor
56086180|NCT02733757|Clonidine|clonidine|mesh-list
56086181|NCT02733757|Analgesics|analgesics|mesh-ancestor
56086182|NCT02733757|Sensory System Agents|sensory system agents|mesh-ancestor
56086183|NCT02733757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086184|NCT02733757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086185|NCT02733757|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56086186|NCT02733757|Sympatholytics|sympatholytics|mesh-ancestor
56086187|NCT02733757|Autonomic Agents|autonomic agents|mesh-ancestor
56086188|NCT02733757|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56086189|NCT02733757|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56086190|NCT02733757|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56086191|NCT02733757|Adrenergic Agents|adrenergic agents|mesh-ancestor
56086192|NCT02733757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086193|NCT02733757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086194|NCT00368264|Infliximab|infliximab|mesh-list
56086195|NCT00368264|Dermatologic Agents|dermatologic agents|mesh-ancestor
56086196|NCT00368264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56086197|NCT00368264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56086198|NCT02734147|Ascorbic Acid|ascorbic acid|mesh-list
56086199|NCT02734147|Antioxidants|antioxidants|mesh-ancestor
56086200|NCT02734147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086201|NCT02734147|Protective Agents|protective agents|mesh-ancestor
56086202|NCT02734147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086203|NCT02734147|Vitamins|vitamins|mesh-ancestor
56086204|NCT02734147|Micronutrients|micronutrients|mesh-ancestor
56086205|NCT00368342|Azithromycin|azithromycin|mesh-list
56086206|NCT00368342|Clarithromycin|clarithromycin|mesh-list
56086207|NCT00368342|Erythromycin|erythromycin|mesh-list
56086208|NCT00368342|Erythromycin Estolate|erythromycin estolate|mesh-list
56086209|NCT00368342|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55813444|NCT05334329|Fludarabine|fludarabine|mesh-list
56086210|NCT00368342|Erythromycin stearate|erythromycin stearate|mesh-list
56086211|NCT00368342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56086212|NCT00368342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086213|NCT00368342|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56086214|NCT00368342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086268|NCT02736175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56086269|NCT02736175|Antiemetics|antiemetics|mesh-ancestor
56086270|NCT02736175|Autonomic Agents|autonomic agents|mesh-ancestor
56086271|NCT02736175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086272|NCT02736175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086273|NCT02736175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56086274|NCT02736175|Glucocorticoids|glucocorticoids|mesh-ancestor
56086275|NCT02736175|Hormones|hormones|mesh-ancestor
56086276|NCT02736175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086277|NCT02736175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56086278|NCT02736175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086279|NCT00369356|Prednisone|prednisone|mesh-list
56086280|NCT00369356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56086281|NCT00369356|Glucocorticoids|glucocorticoids|mesh-ancestor
56086282|NCT00369356|Hormones|hormones|mesh-ancestor
56086283|NCT00369356|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086284|NCT00369356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086287|NCT04947085|Ketamine|ketamine|mesh-list
56086323|NCT04805125|Vaccines|vaccines|mesh-list
56086324|NCT04805125|Immunologic Factors|immunologic factors|mesh-ancestor
56086325|NCT04805125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086326|NCT00368017|Pioglitazone|pioglitazone|mesh-list
56086327|NCT00368017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56086328|NCT00368017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086329|NCT00367627|Albendazole|albendazole|mesh-list
56086330|NCT00367627|Anthelmintics|anthelmintics|mesh-ancestor
56086331|NCT00367627|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56086332|NCT00367627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086333|NCT00367627|Anticestodal Agents|anticestodal agents|mesh-ancestor
56086334|NCT00367627|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56086335|NCT00367627|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56086336|NCT00367627|Tubulin Modulators|tubulin modulators|mesh-ancestor
56086337|NCT00367627|Antimitotic Agents|antimitotic agents|mesh-ancestor
56086338|NCT00367627|Mitosis Modulators|mitosis modulators|mesh-ancestor
56086339|NCT00367627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086340|NCT00367627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086341|NCT05443789|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56086342|NCT05443789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086343|NCT05443789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086348|NCT04738981|Basiliximab|basiliximab|mesh-list
56086349|NCT04738981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56086350|NCT04738981|Immunologic Factors|immunologic factors|mesh-ancestor
56086351|NCT04738981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086352|NCT05428969|Azacitidine|azacitidine|mesh-list
56086353|NCT05428969|Venetoclax|venetoclax|mesh-list
56086354|NCT05428969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56086355|NCT05428969|Antimetabolites|antimetabolites|mesh-ancestor
56086356|NCT05428969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086370|NCT05442931|Anticonvulsants|anticonvulsants|mesh-ancestor
56086371|NCT05442931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55741458|NCT03357757|Avelumab|avelumab|mesh-list
56086372|NCT05442931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56086373|NCT05442931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086374|NCT05442931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56086375|NCT05442931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56086376|NCT05442931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56086377|NCT05442931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086378|NCT05442931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56086379|NCT05442931|Anesthetics|anesthetics|mesh-ancestor
56086380|NCT05442931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56086381|NCT05442931|Tocolytic Agents|tocolytic agents|mesh-ancestor
56086382|NCT05442931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56086383|NCT05442931|Vasodilator Agents|vasodilator agents|mesh-ancestor
56086384|NCT05439499|Letrozole|letrozole|mesh-list
56086385|NCT05439499|Anastrozole|anastrozole|mesh-list
56086386|NCT05439499|Goserelin|goserelin|mesh-list
56086387|NCT05439499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086388|NCT05439499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56086389|NCT05439499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56086390|NCT05439499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086391|NCT05439499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086392|NCT05439499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56086393|NCT05439499|Hormone Antagonists|hormone antagonists|mesh-ancestor
56086394|NCT05439499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086395|NCT05439499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086396|NCT05439499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56086397|NCT04036435|BMS-986165|bms-986165|mesh-list
56086398|NCT04036435|Dermatologic Agents|dermatologic agents|mesh-ancestor
56086399|NCT04036435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56086400|NCT04036435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086411|NCT05448001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56086412|NCT05448001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56086413|NCT05448001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56086414|NCT05448001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086415|NCT05448001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086416|NCT05340673|Petrolatum|petrolatum|mesh-list
56086417|NCT05340673|Mineral Oil|mineral oil|mesh-list
56086418|NCT05340673|Emollients|emollients|mesh-ancestor
56086419|NCT05340673|Dermatologic Agents|dermatologic agents|mesh-ancestor
56086420|NCT05447455|Anesthetics|anesthetics|mesh-list
56086421|NCT05447455|Anesthetics, Local|anesthetics, local|mesh-list
56086422|NCT05447455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086423|NCT05447455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086424|NCT05447455|Sensory System Agents|sensory system agents|mesh-ancestor
56086425|NCT05447455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086434|NCT00369733|Darbepoetin alfa|darbepoetin alfa|mesh-list
56086435|NCT00369733|Hematinics|hematinics|mesh-ancestor
56086436|NCT00368719|Tacrolimus|tacrolimus|mesh-list
56086437|NCT00368719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56086438|NCT00368719|Immunologic Factors|immunologic factors|mesh-ancestor
56086439|NCT00368719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086440|NCT00368719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56086441|NCT00368719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144786|NCT05209620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56086442|NCT00368719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086443|NCT00369811|Fentanyl|fentanyl|mesh-list
56086444|NCT00369811|Oxycodone|oxycodone|mesh-list
56086445|NCT00369811|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56086446|NCT00369811|Narcotics|narcotics|mesh-ancestor
56086447|NCT00369811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086448|NCT00369811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086464|NCT03615547|Fertility Agents|fertility agents|mesh-ancestor
56086465|NCT03615547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56086466|NCT03615547|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56086467|NCT03615547|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56086468|NCT03593317|Spironolactone|spironolactone|mesh-list
56086469|NCT03593317|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56086470|NCT03593317|Hormone Antagonists|hormone antagonists|mesh-ancestor
56086471|NCT03593317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086472|NCT03593317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086473|NCT03593317|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56086474|NCT03593317|Diuretics|diuretics|mesh-ancestor
56086475|NCT03593317|Natriuretic Agents|natriuretic agents|mesh-ancestor
56086476|NCT03423121|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
56086477|NCT03423121|Antiviral Agents|antiviral agents|mesh-ancestor
56086478|NCT03423121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086479|NCT03423121|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56086480|NCT03423121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56086481|NCT05023993|Niacinamide|niacinamide|mesh-list
56086482|NCT05023993|Niacin|niacin|mesh-list
56086483|NCT05023993|Nicotinic Acids|nicotinic acids|mesh-list
56086484|NCT05023993|Vitamin B Complex|vitamin b complex|mesh-ancestor
56086485|NCT05023993|Vitamins|vitamins|mesh-ancestor
56086486|NCT05023993|Micronutrients|micronutrients|mesh-ancestor
56086487|NCT05023993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086488|NCT05023993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56086489|NCT05023993|Antimetabolites|antimetabolites|mesh-ancestor
56086490|NCT05023993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086491|NCT05023993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56086492|NCT05023993|Vasodilator Agents|vasodilator agents|mesh-ancestor
56086493|NCT03105128|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56086494|NCT03105128|Immunologic Factors|immunologic factors|mesh-ancestor
56086496|NCT03122509|Durvalumab|durvalumab|mesh-list
56086513|NCT05320393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086514|NCT05320393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086515|NCT05320393|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56086516|NCT05320393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56086517|NCT05320393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086518|NCT05320393|Cholinergic Agents|cholinergic agents|mesh-ancestor
56086519|NCT05320393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086521|NCT05315947|Anticonvulsants|anticonvulsants|mesh-ancestor
56086522|NCT00369434|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
56086523|NCT00369434|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56086524|NCT00369434|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56086525|NCT00369434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56086526|NCT00369434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086527|NCT00369434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086528|NCT00369434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086529|NCT00369434|Antidepressive Agents|antidepressive agents|mesh-ancestor
56086530|NCT00369434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56086552|NCT05243953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086553|NCT05243953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086554|NCT05243953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56086555|NCT05243953|Respiratory System Agents|respiratory system agents|mesh-ancestor
56086556|NCT05243953|Parasympatholytics|parasympatholytics|mesh-ancestor
56086557|NCT05243953|Vasodilator Agents|vasodilator agents|mesh-ancestor
56086558|NCT02757313|Dronabinol|dronabinol|mesh-list
56086559|NCT02757313|Hallucinogens|hallucinogens|mesh-ancestor
56086560|NCT02757313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086561|NCT02757313|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56086562|NCT02757313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56086563|NCT02757313|Analgesics|analgesics|mesh-ancestor
56086564|NCT02757313|Sensory System Agents|sensory system agents|mesh-ancestor
56086565|NCT02757313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086566|NCT02757313|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56086567|NCT02757313|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56086568|NCT02757313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086569|NCT02757313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086570|NCT02757313|Hormones|hormones|mesh-ancestor
56086571|NCT02757313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086572|NCT02514278|Capecitabine|capecitabine|mesh-list
56086574|NCT02514278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56086575|NCT02514278|Antimetabolites|antimetabolites|mesh-ancestor
56086576|NCT02514278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086577|NCT02514278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086578|NCT02379806|Enoxaparin|enoxaparin|mesh-list
56086579|NCT02379806|Anticoagulants|anticoagulants|mesh-ancestor
56086580|NCT02379806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56086581|NCT02379806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56086582|NCT02379806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086583|NCT02358356|Capecitabine|capecitabine|mesh-list
56086584|NCT02358356|Temozolomide|temozolomide|mesh-list
56086585|NCT02358356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56086586|NCT02358356|Antimetabolites|antimetabolites|mesh-ancestor
56086590|NCT02358356|Alkylating Agents|alkylating agents|mesh-ancestor
56086592|NCT04700761|Anesthetics|anesthetics|mesh-list
56086593|NCT04700761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086594|NCT04700761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086595|NCT04700761|Narcotics|narcotics|mesh-ancestor
56086596|NCT04700761|Analgesics|analgesics|mesh-ancestor
56086597|NCT04700761|Sensory System Agents|sensory system agents|mesh-ancestor
56086598|NCT04700761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086599|NCT04651088|Potassium Citrate|potassium citrate|mesh-list
56086600|NCT04651088|Diuretics|diuretics|mesh-ancestor
56086601|NCT04651088|Natriuretic Agents|natriuretic agents|mesh-ancestor
56086602|NCT04651088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086603|NCT04651088|Expectorants|expectorants|mesh-ancestor
56086604|NCT04651088|Respiratory System Agents|respiratory system agents|mesh-ancestor
56086605|NCT02315768|Obinutuzumab|obinutuzumab|mesh-list
56086606|NCT02315768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56086607|NCT02315768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086608|NCT04595617|Antibodies|antibodies|mesh-list
56086609|NCT04595617|Immunologic Factors|immunologic factors|mesh-ancestor
56086610|NCT04595617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086611|NCT02162810|Prednisolone|prednisolone|mesh-list
56086612|NCT02162810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56086613|NCT02162810|Glucocorticoids|glucocorticoids|mesh-ancestor
56086614|NCT02162810|Hormones|hormones|mesh-ancestor
56086615|NCT02162810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086616|NCT02162810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086617|NCT02162810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56086618|NCT02162810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086619|NCT00368498|Teicoplanin|teicoplanin|mesh-list
56086620|NCT00368498|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56086621|NCT00368498|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086622|NCT05172817|Adalimumab|adalimumab|mesh-list
56086623|NCT05172817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56086624|NCT05172817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56086625|NCT05145907|Pembrolizumab|pembrolizumab|mesh-list
56086633|NCT04563325|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56086634|NCT04563325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086635|NCT04563325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086636|NCT01689740|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56086638|NCT01689740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086639|NCT01689740|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56086640|NCT01689740|Serotonin Agents|serotonin agents|mesh-ancestor
56086641|NCT01689740|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086642|NCT01689740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086643|NCT01689740|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56086644|NCT01689740|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56086645|NCT01689740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56086646|NCT01689740|Adrenergic Agents|adrenergic agents|mesh-ancestor
56086647|NCT04545151|Verapamil|verapamil|mesh-list
56086648|NCT04545151|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56086649|NCT04545151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56086650|NCT04545151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56086651|NCT04545151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086652|NCT04545151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56086653|NCT04545151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086654|NCT04545151|Vasodilator Agents|vasodilator agents|mesh-ancestor
56086655|NCT00961142|Fludarabine|fludarabine|mesh-list
56086656|NCT00961142|Melphalan|melphalan|mesh-list
56086657|NCT00961142|Thiotepa|thiotepa|mesh-list
56086658|NCT00961142|Thymoglobulin|thymoglobulin|mesh-list
56086659|NCT00961142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086660|NCT00961142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086661|NCT00961142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56086662|NCT00961142|Immunologic Factors|immunologic factors|mesh-ancestor
56086663|NCT00961142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741465|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
56086684|NCT04562792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086686|NCT04523701|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56086687|NCT04523701|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56086688|NCT04523701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56086690|NCT04338373|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56086691|NCT04338373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56086692|NCT04338373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56086693|NCT04338373|Autonomic Agents|autonomic agents|mesh-ancestor
56086694|NCT04338373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086695|NCT04338373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086722|NCT00059930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086723|NCT00059930|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56086724|NCT00059930|Antimetabolites|antimetabolites|mesh-ancestor
56086725|NCT00059930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086726|NCT00059930|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56086727|NCT00059930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56086728|NCT00059930|Immunologic Factors|immunologic factors|mesh-ancestor
56086729|NCT00059930|Antidotes|antidotes|mesh-ancestor
56086730|NCT00059930|Protective Agents|protective agents|mesh-ancestor
56086731|NCT00059930|Vitamin B Complex|vitamin b complex|mesh-ancestor
56086732|NCT00059930|Vitamins|vitamins|mesh-ancestor
56086733|NCT00059930|Micronutrients|micronutrients|mesh-ancestor
56086734|NCT00369031|polysaccharide-K|polysaccharide-k|mesh-list
56086735|NCT00369031|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56086736|NCT00369031|Immunologic Factors|immunologic factors|mesh-ancestor
56086737|NCT00369031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086738|NCT00369031|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56086740|NCT00369031|Antiviral Agents|antiviral agents|mesh-ancestor
56086741|NCT00369031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086742|NCT00369031|Interferon Inducers|interferon inducers|mesh-ancestor
56086743|NCT00369031|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56086744|NCT00369031|Protective Agents|protective agents|mesh-ancestor
56086746|NCT05443178|Ethambutol|ethambutol|mesh-list
56086747|NCT05443178|Chloroquine|chloroquine|mesh-list
56086774|NCT05064319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086775|NCT05064319|Antimanic Agents|antimanic agents|mesh-ancestor
56086777|NCT05061901|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56086778|NCT05061901|Protease Inhibitors|protease inhibitors|mesh-ancestor
56086779|NCT05061901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086780|NCT05061901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086781|NCT05061901|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56086782|NCT05061901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56086783|NCT05061901|Protective Agents|protective agents|mesh-ancestor
56086784|NCT05061901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086785|NCT04338919|Aspirin|aspirin|mesh-list
56086786|NCT04338919|Ticagrelor|ticagrelor|mesh-list
56086787|NCT04338919|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56086788|NCT04338919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56086789|NCT04338919|Analgesics|analgesics|mesh-ancestor
56086790|NCT04338919|Sensory System Agents|sensory system agents|mesh-ancestor
56086791|NCT04338919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086792|NCT04338919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086793|NCT04338919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56086794|NCT04338919|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56086795|NCT04338919|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56086828|NCT00369889|Bevacizumab|bevacizumab|mesh-list
56086829|NCT00369889|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56086830|NCT00369889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56086831|NCT00369889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086832|NCT00369889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56086833|NCT00369889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56086834|NCT00369889|Growth Substances|growth substances|mesh-ancestor
56086835|NCT00369889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086836|NCT00369889|Growth Inhibitors|growth inhibitors|mesh-ancestor
56086837|NCT00369889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56086838|NCT00369889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086839|NCT00369889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086840|NCT00369044|Prednisone|prednisone|mesh-list
56086841|NCT00369044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56086842|NCT00369044|Glucocorticoids|glucocorticoids|mesh-ancestor
56086843|NCT00369044|Hormones|hormones|mesh-ancestor
56086844|NCT00369044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56086845|NCT00369044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086846|NCT00369044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56086847|NCT00369044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086848|NCT00370045|Bivalirudin|bivalirudin|mesh-list
56086849|NCT00370045|Eptifibatide|eptifibatide|mesh-list
56086850|NCT00370045|Antithrombins|antithrombins|mesh-ancestor
56086851|NCT00370045|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56086852|NCT00370045|Protease Inhibitors|protease inhibitors|mesh-ancestor
56086853|NCT00370045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086854|NCT00370045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086855|NCT00370045|Anticoagulants|anticoagulants|mesh-ancestor
56086856|NCT00370045|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56086857|NCT05441150|Ketamine|ketamine|mesh-list
56086858|NCT05441150|Analgesics|analgesics|mesh-ancestor
56086859|NCT05441150|Sensory System Agents|sensory system agents|mesh-ancestor
56086860|NCT05441150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086861|NCT05441150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086862|NCT05441150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56086864|NCT05441150|Anesthetics, General|anesthetics, general|mesh-ancestor
56086865|NCT05441150|Anesthetics|anesthetics|mesh-ancestor
56086866|NCT05441150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086867|NCT05441150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56086868|NCT05441150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56086869|NCT05441150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086870|NCT05441150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086871|NCT04270214|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56086872|NCT04270214|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56086873|NCT04270214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56086874|NCT04270214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086875|NCT04270214|Cholinergic Agents|cholinergic agents|mesh-ancestor
56086876|NCT04270214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086877|NCT04270214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086878|NCT04238624|Trametinib|trametinib|mesh-list
56086879|NCT04238624|Dabrafenib|dabrafenib|mesh-list
56086880|NCT04238624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086881|NCT04238624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56086882|NCT04238624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56086883|NCT04238624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086884|NCT05438810|Fulvestrant|fulvestrant|mesh-list
56086885|NCT05438810|Goserelin|goserelin|mesh-list
56086886|NCT05438810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56086887|NCT05438810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56086888|NCT05438810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56086908|NCT05451121|Anesthetics|anesthetics|mesh-ancestor
56086909|NCT05451121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56086912|NCT05451121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086913|NCT05451121|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56086914|NCT05451121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56086915|NCT05451121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56086916|NCT05451121|Adrenergic Agents|adrenergic agents|mesh-ancestor
56086917|NCT05451121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086918|NCT05451121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086919|NCT04967443|Prazosin|prazosin|mesh-list
56086920|NCT04967443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56086921|NCT04967443|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56086922|NCT04967443|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56086923|NCT04967443|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56086924|NCT04967443|Adrenergic Agents|adrenergic agents|mesh-ancestor
56086925|NCT04967443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086926|NCT04967443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086927|NCT04967443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086928|NCT04697017|Salicylic Acid|salicylic acid|mesh-list
56086929|NCT04697017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56086930|NCT04697017|Antifungal Agents|antifungal agents|mesh-ancestor
56086931|NCT04697017|Keratolytic Agents|keratolytic agents|mesh-ancestor
56086932|NCT04697017|Dermatologic Agents|dermatologic agents|mesh-ancestor
56086956|NCT04739384|Ticagrelor|ticagrelor|mesh-list
56086957|NCT04739384|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56086958|NCT04739384|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56086959|NCT04739384|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56086960|NCT04739384|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56086961|NCT04739384|Purinergic Agents|purinergic agents|mesh-ancestor
56086962|NCT04739384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086963|NCT04739384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56086964|NCT04739384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086965|NCT04704596|Anesthetics|anesthetics|mesh-list
56086966|NCT04704596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086967|NCT04704596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086970|NCT05450497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56086971|NCT05450497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56086972|NCT05450497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56086973|NCT05450497|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56086974|NCT05450497|Anesthetics, General|anesthetics, general|mesh-ancestor
56086975|NCT05450497|Anesthetics|anesthetics|mesh-ancestor
56086976|NCT05450497|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56086977|NCT05450497|Analgesics|analgesics|mesh-ancestor
56086978|NCT05450497|Sensory System Agents|sensory system agents|mesh-ancestor
56086979|NCT05450497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56086980|NCT05450497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56086981|NCT05450497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56086982|NCT05450497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56086983|NCT05450497|Adrenergic Agents|adrenergic agents|mesh-ancestor
56086984|NCT05450497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56086985|NCT05450497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087000|NCT05447702|Mitosis Modulators|mitosis modulators|mesh-ancestor
56087001|NCT05447702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087002|NCT05447702|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087003|NCT05447702|Immunologic Factors|immunologic factors|mesh-ancestor
56087004|NCT05447702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087005|NCT05447702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087006|NCT05447702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56087007|NCT05447702|Alkylating Agents|alkylating agents|mesh-ancestor
56087008|NCT05447702|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56087009|NCT05447702|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56087010|NCT05447702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087011|NCT05447702|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56087012|NCT05447702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56087013|NCT05447702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56087014|NCT05449028|Bismuth|bismuth|mesh-list
56087015|NCT05449028|Antacids|antacids|mesh-ancestor
56087016|NCT05449028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087017|NCT05449028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087018|NCT04845139|Nivolumab|nivolumab|mesh-list
56087019|NCT04845139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087020|NCT04845139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087021|NCT04845139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56087022|NCT04845139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087023|NCT04738526|Lithium Carbonate|lithium carbonate|mesh-list
56087024|NCT04738526|Antidepressive Agents|antidepressive agents|mesh-ancestor
56087025|NCT04738526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56087026|NCT04738526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087047|NCT04806919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087048|NCT04793659|Fasudil|fasudil|mesh-list
56087049|NCT04793659|1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine|1-(5-isoquinolinesulfonyl)-2-methylpiperazine|mesh-list
56087050|NCT04793659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56087051|NCT04793659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56087052|NCT04793659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087053|NCT04793659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56087054|NCT04793659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087055|NCT04793659|Vasodilator Agents|vasodilator agents|mesh-ancestor
56087056|NCT04793659|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56087057|NCT04793659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087058|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56087059|NCT04539626|Estradiol|estradiol|mesh-list
56087060|NCT04539626|Estrogens|estrogens|mesh-list
56087061|NCT04539626|Hormones|hormones|mesh-ancestor
56087063|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087064|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56087065|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
56087066|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56087067|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56087068|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56087069|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56087070|NCT05448937|Eugenol|eugenol|mesh-list
56087071|NCT05448937|Zinc Oxide|zinc oxide|mesh-list
56087072|NCT05448937|Dermatologic Agents|dermatologic agents|mesh-ancestor
56087073|NCT05448937|Sunscreening Agents|sunscreening agents|mesh-ancestor
56087074|NCT05448937|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56087094|NCT05448781|Antimitotic Agents|antimitotic agents|mesh-ancestor
56087095|NCT05448781|Mitosis Modulators|mitosis modulators|mesh-ancestor
56087096|NCT05448781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087097|NCT05448781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087098|NCT05448781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56087099|NCT05448781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56087100|NCT05448781|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56087101|NCT05448781|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56087102|NCT05448781|Growth Substances|growth substances|mesh-ancestor
56087103|NCT05448781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087104|NCT05448781|Growth Inhibitors|growth inhibitors|mesh-ancestor
56087105|NCT03182426|Liraglutide|liraglutide|mesh-list
56087106|NCT03182426|Plerixafor|plerixafor|mesh-list
56087107|NCT03182426|Etanercept|etanercept|mesh-list
56087108|NCT03182426|Alemtuzumab|alemtuzumab|mesh-list
56087109|NCT03182426|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
56087110|NCT03182426|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56087111|NCT03182426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087112|NCT03182426|Incretins|incretins|mesh-ancestor
56087113|NCT03182426|Hormones|hormones|mesh-ancestor
56087114|NCT03182426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087115|NCT03182426|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56087116|NCT03182426|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56087117|NCT03182426|Analgesics|analgesics|mesh-ancestor
56087118|NCT03182426|Sensory System Agents|sensory system agents|mesh-ancestor
56087119|NCT03182426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087120|NCT03182426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087121|NCT03182426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087122|NCT03182426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087123|NCT03182426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087124|NCT03182426|Immunologic Factors|immunologic factors|mesh-ancestor
56087126|NCT03182426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087133|NCT03233347|Brentuximab Vedotin|brentuximab vedotin|mesh-list
56087134|NCT03233347|Doxorubicin|doxorubicin|mesh-list
56087135|NCT03233347|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56087137|NCT03233347|Dacarbazine|dacarbazine|mesh-list
56087138|NCT03233347|Vinblastine|vinblastine|mesh-list
56087139|NCT03233347|Antibodies|antibodies|mesh-list
56087140|NCT03233347|Immunoglobulins|immunoglobulins|mesh-list
56087141|NCT03233347|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56087142|NCT03233347|Immunoconjugates|immunoconjugates|mesh-list
56087143|NCT03233347|Imidazole|imidazole|mesh-list
56087144|NCT03233347|Immunologic Factors|immunologic factors|mesh-ancestor
56087145|NCT03233347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087146|NCT03233347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087147|NCT03233347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56087148|NCT03233347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56087149|NCT03233347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56087150|NCT03233347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087151|NCT03233347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087152|NCT03233347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56087153|NCT03233347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56087154|NCT03233347|Alkylating Agents|alkylating agents|mesh-ancestor
56087155|NCT03233347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56087156|NCT03233347|Tubulin Modulators|tubulin modulators|mesh-ancestor
56087157|NCT03233347|Antimitotic Agents|antimitotic agents|mesh-ancestor
56087158|NCT03233347|Mitosis Modulators|mitosis modulators|mesh-ancestor
56087159|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
56087160|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56087161|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087162|NCT03215719|Cisplatin|cisplatin|mesh-list
56087163|NCT03215719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087164|NCT03134755|Mometasone Furoate|mometasone furoate|mesh-list
56087165|NCT03134755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087179|NCT03036488|Mitosis Modulators|mitosis modulators|mesh-ancestor
56087180|NCT03036488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087181|NCT03036488|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087182|NCT03036488|Immunologic Factors|immunologic factors|mesh-ancestor
56087183|NCT03036488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087184|NCT03036488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087185|NCT03036488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56087186|NCT03036488|Alkylating Agents|alkylating agents|mesh-ancestor
56087187|NCT03036488|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56087188|NCT03036488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56087189|NCT03036488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56087190|NCT03036488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56087191|NCT03036488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087192|NCT03036488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087193|NCT03036488|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56087194|NCT04417465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56087195|NCT04417465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087196|NCT04417465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087198|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087199|NCT04475432|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56087200|NCT04475432|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56087201|NCT00370825|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56087202|NCT00370825|Miltefosine|miltefosine|mesh-list
56087203|NCT00370825|Antifungal Agents|antifungal agents|mesh-ancestor
56087204|NCT00370825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087205|NCT00370825|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56087206|NCT00370825|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56087207|NCT00370825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087208|NCT04450316|Naltrexone|naltrexone|mesh-list
56087214|NCT05377424|Istradefylline|istradefylline|mesh-list
56087223|NCT02535247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087224|NCT02535247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087225|NCT04417920|Mitomycins|mitomycins|mesh-list
56087226|NCT04417920|Mitomycin|mitomycin|mesh-list
56087227|NCT04417920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56087228|NCT04417920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087229|NCT04417920|Alkylating Agents|alkylating agents|mesh-ancestor
56087230|NCT04417920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087231|NCT04417920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56087232|NCT04417920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087234|NCT02626130|Ipilimumab|ipilimumab|mesh-list
56087235|NCT02626130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087236|NCT02626130|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087237|NCT02626130|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56087238|NCT02626130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087239|NCT02618720|Ornidazole|ornidazole|mesh-list
56087240|NCT02618720|Amebicides|amebicides|mesh-ancestor
56087241|NCT02618720|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56087242|NCT02618720|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56087243|NCT02618720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087244|NCT02618720|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56087245|NCT03758989|Prednisone|prednisone|mesh-list
56087246|NCT03758989|Cyclophosphamide|cyclophosphamide|mesh-list
56087247|NCT03758989|Rituximab|rituximab|mesh-list
56087248|NCT03758989|Doxorubicin|doxorubicin|mesh-list
56087249|NCT03758989|Vincristine|vincristine|mesh-list
56087250|NCT03758989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087251|NCT03758989|Immunologic Factors|immunologic factors|mesh-ancestor
56087252|NCT03758989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087253|NCT03758989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087254|NCT03758989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56087255|NCT03758989|Alkylating Agents|alkylating agents|mesh-ancestor
56087256|NCT03758989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087264|NCT03758989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087265|NCT03758989|Glucocorticoids|glucocorticoids|mesh-ancestor
56087266|NCT03758989|Hormones|hormones|mesh-ancestor
56087267|NCT03758989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087268|NCT03758989|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56087269|NCT03758989|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56087270|NCT03758989|Tubulin Modulators|tubulin modulators|mesh-ancestor
56087271|NCT03758989|Antimitotic Agents|antimitotic agents|mesh-ancestor
56087272|NCT03758989|Mitosis Modulators|mitosis modulators|mesh-ancestor
56087273|NCT03657043|Tisotumab vedotin|tisotumab vedotin|mesh-list
56087274|NCT03657043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087275|NCT03657043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087276|NCT02042989|Vorinostat|vorinostat|mesh-list
56087277|NCT02042989|Ixazomib|ixazomib|mesh-list
56087278|NCT02042989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087279|NCT02042989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56087280|NCT02042989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087281|NCT02042989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087282|NCT02042989|Protease Inhibitors|protease inhibitors|mesh-ancestor
56087283|NCT02229578|Lidocaine|lidocaine|mesh-list
56087284|NCT02229578|Anesthetics, Local|anesthetics, local|mesh-ancestor
56087285|NCT02229578|Anesthetics|anesthetics|mesh-ancestor
56087286|NCT02229578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56087287|NCT02229578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087288|NCT02229578|Sensory System Agents|sensory system agents|mesh-ancestor
56087289|NCT02229578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087290|NCT02229578|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56087291|NCT02229578|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56087292|NCT02229578|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56087293|NCT02229578|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56087294|NCT02229578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087303|NCT01958593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56087304|NCT01958593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56087305|NCT01958593|Adrenergic Agents|adrenergic agents|mesh-ancestor
56087306|NCT04093531|Ustekinumab|ustekinumab|mesh-list
56087307|NCT04093531|Dermatologic Agents|dermatologic agents|mesh-ancestor
56087308|NCT04065841|Licogliflozin|licogliflozin|mesh-list
56087309|NCT04065841|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56087310|NCT04065841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087311|NCT04065841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56087312|NCT04065841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087313|NCT05208944|Cemiplimab|cemiplimab|mesh-list
56087314|NCT05208944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087315|NCT05208944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087316|NCT01809379|Cisplatin|cisplatin|mesh-list
56087317|NCT01809379|Doxorubicin|doxorubicin|mesh-list
56087318|NCT01809379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087319|NCT01809379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56087320|NCT01809379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56087321|NCT01809379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56087322|NCT01809379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087323|NCT01809379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087324|NCT02229396|Dapagliflozin|dapagliflozin|mesh-list
56087325|NCT02229396|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56087326|NCT02229396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087327|NCT02229396|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56087328|NCT02229396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087330|NCT04046575|Carboplatin|carboplatin|mesh-list
56087331|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56087332|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087347|NCT00370370|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56087348|NCT00370370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087349|NCT00370370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087350|NCT00370370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56087351|NCT00370370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56087352|NCT00370370|Growth Substances|growth substances|mesh-ancestor
56087353|NCT00370370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087354|NCT00370370|Growth Inhibitors|growth inhibitors|mesh-ancestor
56087355|NCT00370370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087356|NCT00370370|Glucocorticoids|glucocorticoids|mesh-ancestor
56087357|NCT00370370|Hormones|hormones|mesh-ancestor
56087358|NCT00370370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087359|NCT00370370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087360|NCT00370370|Immunologic Factors|immunologic factors|mesh-ancestor
56087371|NCT01265030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087372|NCT03236935|Pembrolizumab|pembrolizumab|mesh-list
56087373|NCT03236935|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
56087374|NCT03236935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087375|NCT03236935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087376|NCT03236935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087377|NCT03236935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087389|NCT00370591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56087390|NCT00370591|Autonomic Agents|autonomic agents|mesh-ancestor
56087391|NCT00370591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087392|NCT00370591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087393|NCT00370591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56087394|NCT00370591|Respiratory System Agents|respiratory system agents|mesh-ancestor
56087395|NCT00370591|Dermatologic Agents|dermatologic agents|mesh-ancestor
56087396|NCT00370591|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56087397|NCT00370591|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56087398|NCT00370591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56087399|NCT00370591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56087400|NCT00370591|Adrenergic Agents|adrenergic agents|mesh-ancestor
56087401|NCT00370591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087402|NCT00370591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087403|NCT03956173|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56087404|NCT03956173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087405|NCT00371527|Ipratropium|ipratropium|mesh-list
56087406|NCT00371527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56087407|NCT00371527|Autonomic Agents|autonomic agents|mesh-ancestor
56087442|NCT04027322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56087443|NCT04027322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087444|NCT04027322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56087445|NCT04027322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56087446|NCT04027322|Respiratory System Agents|respiratory system agents|mesh-ancestor
56087447|NCT03845257|Dimercaprol|dimercaprol|mesh-list
56087448|NCT03845257|Chelating Agents|chelating agents|mesh-ancestor
56087449|NCT03845257|Sequestering Agents|sequestering agents|mesh-ancestor
56087450|NCT03845257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087451|NCT00371072|Mitomycins|mitomycins|mesh-list
56087486|NCT03924518|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087487|NCT03924518|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56087488|NCT03924518|Serotonin Agents|serotonin agents|mesh-ancestor
56087489|NCT03924518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087490|NCT03924518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087491|NCT03924518|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56087493|NCT05454085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56087494|NCT05454085|Estrogens|estrogens|mesh-ancestor
56087495|NCT05454085|Hormones|hormones|mesh-ancestor
56087496|NCT05454085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087497|NCT05454085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087498|NCT05454085|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56087499|NCT05454085|Antioxidants|antioxidants|mesh-ancestor
56087500|NCT05454085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087501|NCT05454085|Protective Agents|protective agents|mesh-ancestor
56087502|NCT03886922|Cromakalim|cromakalim|mesh-list
56087503|NCT03886922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56087504|NCT03886922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56087505|NCT03886922|Autonomic Agents|autonomic agents|mesh-ancestor
56087506|NCT03886922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087507|NCT03886922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087508|NCT03886922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56087509|NCT03886922|Respiratory System Agents|respiratory system agents|mesh-ancestor
56087510|NCT03886922|Parasympatholytics|parasympatholytics|mesh-ancestor
56087511|NCT03886922|Vasodilator Agents|vasodilator agents|mesh-ancestor
56087512|NCT05453552|Cyclophosphamide|cyclophosphamide|mesh-list
56087513|NCT05453552|Busulfan|busulfan|mesh-list
56087514|NCT05453552|Fludarabine|fludarabine|mesh-list
56087515|NCT05453552|Decitabine|decitabine|mesh-list
56087516|NCT05453552|Lenograstim|lenograstim|mesh-list
56087517|NCT05453552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087531|NCT03787082|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56087532|NCT03787082|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56087533|NCT03787082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087534|NCT03787082|Disinfectants|disinfectants|mesh-ancestor
56087535|NCT03787082|Dermatologic Agents|dermatologic agents|mesh-ancestor
56087536|NCT02165202|Rilpivirine|rilpivirine|mesh-list
56087537|NCT02165202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56087538|NCT02165202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56087539|NCT02165202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087540|NCT02165202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087541|NCT02165202|Antiviral Agents|antiviral agents|mesh-ancestor
56087542|NCT02165202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087543|NCT02165202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56087544|NCT02165202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56087545|NCT01628874|Lidocaine|lidocaine|mesh-list
56087546|NCT01628874|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
56087547|NCT01628874|Anesthetics, Local|anesthetics, local|mesh-ancestor
56087548|NCT01628874|Anesthetics|anesthetics|mesh-ancestor
56087549|NCT01628874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56087550|NCT01628874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087551|NCT01628874|Sensory System Agents|sensory system agents|mesh-ancestor
56087552|NCT01628874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087553|NCT01628874|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56087554|NCT01628874|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56087555|NCT01628874|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56087579|NCT02196714|Autonomic Agents|autonomic agents|mesh-ancestor
56087580|NCT02196714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087581|NCT02196714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087582|NCT02196714|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56087583|NCT02196714|Respiratory System Agents|respiratory system agents|mesh-ancestor
56087584|NCT02196714|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56087585|NCT02196714|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56087586|NCT02196714|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56087587|NCT02196714|Adrenergic Agents|adrenergic agents|mesh-ancestor
56087588|NCT02196714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087589|NCT02196714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087590|NCT02196714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56087591|NCT02196714|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56087592|NCT02196714|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56087593|NCT02196714|Cholinergic Agents|cholinergic agents|mesh-ancestor
56087594|NCT05453929|Rocuronium|rocuronium|mesh-list
56087595|NCT05453929|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56087596|NCT05453929|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56087597|NCT05453929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56087598|NCT05453929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087599|NCT05453929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087600|NCT00370760|Dexamethasone|dexamethasone|mesh-list
56087601|NCT00370760|Colchicine|colchicine|mesh-list
56087602|NCT00370760|Heparin|heparin|mesh-list
56087603|NCT00370760|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56087604|NCT00370760|Tinzaparin|tinzaparin|mesh-list
56087605|NCT00370760|Dalteparin|dalteparin|mesh-list
56087606|NCT00370760|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087607|NCT00370760|Antiemetics|antiemetics|mesh-ancestor
56087608|NCT00370760|Autonomic Agents|autonomic agents|mesh-ancestor
56087609|NCT00370760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087610|NCT00370760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087611|NCT00370760|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087612|NCT00370760|Glucocorticoids|glucocorticoids|mesh-ancestor
56087613|NCT00370760|Hormones|hormones|mesh-ancestor
56087614|NCT00370760|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087617|NCT00370760|Anticoagulants|anticoagulants|mesh-ancestor
56087618|NCT00370760|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56087619|NCT00370760|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56087620|NCT00370760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087621|NCT00370760|Gout Suppressants|gout suppressants|mesh-ancestor
56087622|NCT00370760|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087623|NCT00370760|Tubulin Modulators|tubulin modulators|mesh-ancestor
56087624|NCT00370760|Antimitotic Agents|antimitotic agents|mesh-ancestor
56087625|NCT00370760|Mitosis Modulators|mitosis modulators|mesh-ancestor
56087626|NCT03737461|Lidocaine|lidocaine|mesh-list
56087627|NCT03737461|Anesthetics, Local|anesthetics, local|mesh-ancestor
56087628|NCT03737461|Anesthetics|anesthetics|mesh-ancestor
56087629|NCT03737461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56087630|NCT03737461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087631|NCT03737461|Sensory System Agents|sensory system agents|mesh-ancestor
56087632|NCT03737461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087633|NCT03737461|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56087634|NCT03737461|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56087635|NCT03737461|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56087636|NCT03737461|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56087637|NCT03737461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087638|NCT05203562|Letrozole|letrozole|mesh-list
56087639|NCT05203562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087640|NCT05203562|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56087641|NCT05203562|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56087642|NCT05203562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087643|NCT05203562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087644|NCT05203562|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56087645|NCT05203562|Hormone Antagonists|hormone antagonists|mesh-ancestor
56087646|NCT05203562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087647|NCT05203562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087649|NCT05453851|Pancreatin|pancreatin|mesh-list
56087651|NCT03448718|Olaparib|olaparib|mesh-list
56087654|NCT03448718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087655|NCT03448718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087656|NCT04766762|Flunarizine|flunarizine|mesh-list
56087657|NCT04766762|Anticonvulsants|anticonvulsants|mesh-ancestor
56087658|NCT04766762|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56087659|NCT04766762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56087660|NCT04766762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087661|NCT04766762|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56087662|NCT04766762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087663|NCT04766762|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56087664|NCT04766762|Histamine Antagonists|histamine antagonists|mesh-ancestor
56087665|NCT04766762|Histamine Agents|histamine agents|mesh-ancestor
56087666|NCT04766762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087667|NCT04766762|Vasodilator Agents|vasodilator agents|mesh-ancestor
56087668|NCT04330040|Olaparib|olaparib|mesh-list
56087669|NCT04330040|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56087670|NCT04330040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087671|NCT04330040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087672|NCT04330040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087673|NCT02737891|Metoprolol|metoprolol|mesh-list
56087674|NCT02737891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56087675|NCT02737891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56087676|NCT02737891|Sympatholytics|sympatholytics|mesh-ancestor
56087677|NCT02737891|Autonomic Agents|autonomic agents|mesh-ancestor
56087678|NCT02737891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087679|NCT02737891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087680|NCT02737891|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56087681|NCT02737891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56087682|NCT02737891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56087684|NCT02737891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087685|NCT02737891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087694|NCT03698461|Fluorouracil|fluorouracil|mesh-list
56087695|NCT03698461|Oxaliplatin|oxaliplatin|mesh-list
56087696|NCT03698461|Atezolizumab|atezolizumab|mesh-list
56087697|NCT03698461|Levoleucovorin|levoleucovorin|mesh-list
56087698|NCT03698461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087699|NCT03698461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087700|NCT03698461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56087701|NCT03698461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56087702|NCT03698461|Growth Substances|growth substances|mesh-ancestor
56087703|NCT03698461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087704|NCT03698461|Growth Inhibitors|growth inhibitors|mesh-ancestor
56087705|NCT03698461|Antimetabolites|antimetabolites|mesh-ancestor
56087706|NCT03698461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087707|NCT03698461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56087708|NCT03698461|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087709|NCT03698461|Immunologic Factors|immunologic factors|mesh-ancestor
56087710|NCT03698461|Antidotes|antidotes|mesh-ancestor
56087711|NCT03698461|Protective Agents|protective agents|mesh-ancestor
56087714|NCT03698461|Micronutrients|micronutrients|mesh-ancestor
56087715|NCT02196558|Quetmolimab|quetmolimab|mesh-list
56087716|NCT02196558|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087717|NCT04852484|Ketamine|ketamine|mesh-list
56087718|NCT04852484|Morphine|morphine|mesh-list
56087719|NCT04852484|Anesthetics|anesthetics|mesh-list
56087720|NCT04852484|Anesthetics, Local|anesthetics, local|mesh-list
56087744|NCT02196324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087745|NCT02196324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087746|NCT04790474|Dexamethasone|dexamethasone|mesh-list
56087747|NCT04790474|Pomalidomide|pomalidomide|mesh-list
56087748|NCT04790474|Ixazomib|ixazomib|mesh-list
56087749|NCT04790474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087750|NCT04790474|Antiemetics|antiemetics|mesh-ancestor
56087751|NCT04790474|Autonomic Agents|autonomic agents|mesh-ancestor
56087752|NCT04790474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087753|NCT04790474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087754|NCT04790474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087755|NCT04790474|Glucocorticoids|glucocorticoids|mesh-ancestor
56087756|NCT04790474|Hormones|hormones|mesh-ancestor
56087757|NCT04790474|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087758|NCT04790474|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56087759|NCT04790474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087760|NCT04790474|Immunologic Factors|immunologic factors|mesh-ancestor
56087761|NCT04790474|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56087762|NCT04790474|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56087763|NCT04790474|Growth Substances|growth substances|mesh-ancestor
56087764|NCT04790474|Growth Inhibitors|growth inhibitors|mesh-ancestor
56087765|NCT04790474|Protease Inhibitors|protease inhibitors|mesh-ancestor
56087766|NCT04790474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087767|NCT04790474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087768|NCT05450419|Vitamin D|vitamin d|mesh-list
56087769|NCT05450419|Cholecalciferol|cholecalciferol|mesh-list
56087770|NCT05450419|Vitamins|vitamins|mesh-ancestor
56087771|NCT05450419|Micronutrients|micronutrients|mesh-ancestor
56087772|NCT05450419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087773|NCT05450419|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56087774|NCT05450419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56087775|NCT05443009|Lidocaine|lidocaine|mesh-list
56087776|NCT05443009|Carticaine|carticaine|mesh-list
56087784|NCT05443009|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56087785|NCT05443009|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56087786|NCT05443009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56087787|NCT05443009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087788|NCT00370669|Triamcinolone|triamcinolone|mesh-list
56087789|NCT00370669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56087790|NCT00370669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56087791|NCT00370669|Bevacizumab|bevacizumab|mesh-list
56087792|NCT00370669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56087793|NCT00370669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56087794|NCT00370669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087795|NCT00370669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56087796|NCT00370669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56087797|NCT00370669|Growth Substances|growth substances|mesh-ancestor
56087798|NCT00370669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087799|NCT00370669|Growth Inhibitors|growth inhibitors|mesh-ancestor
56087801|NCT00370669|Glucocorticoids|glucocorticoids|mesh-ancestor
56087803|NCT00370669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56087804|NCT00370669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087805|NCT00370669|Immunologic Factors|immunologic factors|mesh-ancestor
56087806|NCT00370669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087807|NCT00370669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087808|NCT05413369|Metformin|metformin|mesh-list
56087809|NCT05413369|Insulin Glargine|insulin glargine|mesh-list
56087810|NCT05413369|Lixisenatide|lixisenatide|mesh-list
56087811|NCT05413369|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
56087812|NCT05413369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56087813|NCT05413369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087826|NCT04337450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56087827|NCT04337450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087828|NCT04337450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087829|NCT04337450|Antiviral Agents|antiviral agents|mesh-ancestor
56087830|NCT04337450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087831|NCT04337450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56087832|NCT04337450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56087833|NCT04337450|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56087834|NCT04337450|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56087836|NCT02740543|Xhance|xhance|mesh-list
56087837|NCT02740543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087838|NCT02740543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56087839|NCT02740543|Autonomic Agents|autonomic agents|mesh-ancestor
56087840|NCT02740543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087841|NCT02740543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087842|NCT02740543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56087843|NCT02740543|Respiratory System Agents|respiratory system agents|mesh-ancestor
56087844|NCT02740543|Dermatologic Agents|dermatologic agents|mesh-ancestor
56087845|NCT02740543|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56087846|NCT00370747|Ecabet|ecabet|mesh-list
56087847|NCT00370747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087848|NCT00370747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56087849|NCT00370747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087850|NCT00370747|Protease Inhibitors|protease inhibitors|mesh-ancestor
56087851|NCT00370747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087852|NCT00370747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087853|NCT00370747|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56087854|NCT00370747|Protective Agents|protective agents|mesh-ancestor
56087855|NCT00370747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087856|NCT00370747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087857|NCT02752256|Plasminogen|plasminogen|mesh-list
56087858|NCT02752256|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56087859|NCT02752256|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56087860|NCT02752256|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55901121|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901122|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55901123|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901124|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
55901125|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087862|NCT02227446|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56087863|NCT02227446|Vancomycin|vancomycin|mesh-list
55815095|NCT04987463|Sirolimus|sirolimus|mesh-list
56087864|NCT02227446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087865|NCT04738058|Lactoferrin|lactoferrin|mesh-list
56087866|NCT04738058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087867|NCT04092452|PF-06700841|pf-06700841|mesh-list
56087868|NCT04092452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56087869|NCT04092452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087870|NCT04092452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087871|NCT02227368|Ticagrelor|ticagrelor|mesh-list
56087872|NCT02227368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087873|NCT02227368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087874|NCT02227368|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56087875|NCT02227368|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56087876|NCT02227368|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56087877|NCT02227368|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56087878|NCT02227368|Purinergic Agents|purinergic agents|mesh-ancestor
56087879|NCT02227368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087880|NCT05291299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56087881|NCT02162862|Bupropion|bupropion|mesh-list
56087882|NCT02162862|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56087883|NCT02162862|Antidepressive Agents|antidepressive agents|mesh-ancestor
56087884|NCT02162862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56087885|NCT02162862|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56087886|NCT02162862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56087887|NCT02162862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56087888|NCT02162862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087889|NCT02162862|Dopamine Agents|dopamine agents|mesh-ancestor
56087890|NCT02162862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56087891|NCT02162862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087892|NCT02162862|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56087893|NCT02162862|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55901126|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55901127|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
56087894|NCT02162862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087895|NCT05277727|Fucoidan|fucoidan|mesh-list
56087896|NCT05277727|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56087897|NCT05277727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56087898|NCT05277727|Anticoagulants|anticoagulants|mesh-ancestor
56087899|NCT05277727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087900|NCT03377179|Hydroxychloroquine|hydroxychloroquine|mesh-list
56087901|NCT03377179|Antimalarials|antimalarials|mesh-ancestor
56087902|NCT03377179|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56087903|NCT03377179|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56087904|NCT03377179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56087905|NCT03377179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087906|NCT03377179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087907|NCT03377179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087908|NCT02226198|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56087910|NCT02226198|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56087911|NCT02226198|Antimetabolites|antimetabolites|mesh-ancestor
56087912|NCT02226198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087913|NCT02226198|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56087914|NCT02226198|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56087915|NCT02226198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087916|NCT02754518|Valsartan|valsartan|mesh-list
56087917|NCT02754518|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56087918|NCT02754518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56087919|NCT02754518|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56087920|NCT02754518|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56087921|NCT02754518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087922|NCT02751385|Nintedanib|nintedanib|mesh-list
56087923|NCT02751385|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56087924|NCT02751385|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56087925|NCT02751385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087926|NCT02751385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56087931|NCT02751385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56087932|NCT02751385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087933|NCT02751385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56087934|NCT02751385|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56087935|NCT02751385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56087936|NCT02751385|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56087937|NCT02751385|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56087938|NCT02751385|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
56087939|NCT02751385|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56087940|NCT02751385|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56087942|NCT05349032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56087943|NCT05349032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56087944|NCT05349032|Analgesics|analgesics|mesh-ancestor
56087945|NCT05349032|Sensory System Agents|sensory system agents|mesh-ancestor
56087946|NCT05349032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087947|NCT05349032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087948|NCT05349032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56087949|NCT05349032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56087950|NCT05349032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56087951|NCT05349032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56087952|NCT05349032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56087954|NCT05057689|Midazolam|midazolam|mesh-list
56087955|NCT05057689|Dexmedetomidine|dexmedetomidine|mesh-list
56087956|NCT05057689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56087957|NCT05057689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56087958|NCT05057689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56087959|NCT05057689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56087960|NCT05057689|Analgesics|analgesics|mesh-ancestor
56087961|NCT05057689|Sensory System Agents|sensory system agents|mesh-ancestor
56087962|NCT05057689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56087971|NCT05057689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56087972|NCT05057689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56087973|NCT05057689|Anesthetics, General|anesthetics, general|mesh-ancestor
56087974|NCT05057689|Anesthetics|anesthetics|mesh-ancestor
56087975|NCT05057689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56087976|NCT05057689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56087977|NCT05057689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56087978|NCT05057689|GABA Modulators|gaba modulators|mesh-ancestor
56087979|NCT05057689|GABA Agents|gaba agents|mesh-ancestor
56087980|NCT05032183|Leucovorin|leucovorin|mesh-list
56087981|NCT05032183|Cytarabine|cytarabine|mesh-list
56087982|NCT05032183|Dexamethasone|dexamethasone|mesh-list
56087983|NCT05032183|Dexamethasone acetate|dexamethasone acetate|mesh-list
56087984|NCT05032183|Prednisone|prednisone|mesh-list
56087985|NCT05032183|Cortisone|cortisone|mesh-list
56087986|NCT05032183|Cyclophosphamide|cyclophosphamide|mesh-list
56087987|NCT05032183|Rituximab|rituximab|mesh-list
56087988|NCT05032183|Methotrexate|methotrexate|mesh-list
56087989|NCT05032183|Vincristine|vincristine|mesh-list
56087990|NCT05032183|Mercaptopurine|mercaptopurine|mesh-list
56087991|NCT05032183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56087992|NCT05032183|Antibodies|antibodies|mesh-list
56087993|NCT05032183|Immunoglobulins|immunoglobulins|mesh-list
56087994|NCT05032183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56087995|NCT05032183|Lenograstim|lenograstim|mesh-list
56087996|NCT05032183|BB 1101|bb 1101|mesh-list
56087998|NCT05032183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56087999|NCT05032183|Immunologic Factors|immunologic factors|mesh-ancestor
56088000|NCT05032183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088001|NCT05032183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56088002|NCT05032183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56088003|NCT05032183|Alkylating Agents|alkylating agents|mesh-ancestor
56088004|NCT05032183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088005|NCT05032183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088018|NCT05032183|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56088019|NCT05032183|Abortifacient Agents|abortifacient agents|mesh-ancestor
56088021|NCT05032183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56088022|NCT05032183|Antimetabolites|antimetabolites|mesh-ancestor
56088023|NCT05032183|Dermatologic Agents|dermatologic agents|mesh-ancestor
56088024|NCT05032183|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56088025|NCT05032183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56088026|NCT05032183|Antiviral Agents|antiviral agents|mesh-ancestor
56088027|NCT05032183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088028|NCT05032183|Antidotes|antidotes|mesh-ancestor
56088029|NCT05032183|Protective Agents|protective agents|mesh-ancestor
56088030|NCT05032183|Vitamin B Complex|vitamin b complex|mesh-ancestor
56088031|NCT05032183|Vitamins|vitamins|mesh-ancestor
56088032|NCT05032183|Micronutrients|micronutrients|mesh-ancestor
56088033|NCT05032183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56088034|NCT05032183|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56088035|NCT05032183|Tubulin Modulators|tubulin modulators|mesh-ancestor
56088036|NCT05032183|Antimitotic Agents|antimitotic agents|mesh-ancestor
56088037|NCT05032183|Mitosis Modulators|mitosis modulators|mesh-ancestor
56088038|NCT04737980|Dexamethasone|dexamethasone|mesh-list
56088039|NCT04737980|Bupivacaine|bupivacaine|mesh-list
56088040|NCT04737980|Ropivacaine|ropivacaine|mesh-list
56088041|NCT04737980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088042|NCT04737980|Antiemetics|antiemetics|mesh-ancestor
56088043|NCT04737980|Autonomic Agents|autonomic agents|mesh-ancestor
56088044|NCT04737980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088045|NCT04737980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088046|NCT04737980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56088047|NCT04737980|Glucocorticoids|glucocorticoids|mesh-ancestor
56088048|NCT04737980|Hormones|hormones|mesh-ancestor
56088049|NCT04737980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088061|NCT03559868|Protective Agents|protective agents|mesh-ancestor
56088062|NCT03559868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088063|NCT00371696|Acetaminophen|acetaminophen|mesh-list
56088064|NCT00371696|Diclofenac|diclofenac|mesh-list
56088065|NCT00371696|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56088066|NCT00371696|Analgesics|analgesics|mesh-ancestor
56088067|NCT00371696|Sensory System Agents|sensory system agents|mesh-ancestor
56088068|NCT00371696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088069|NCT00371696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088070|NCT00371696|Antipyretics|antipyretics|mesh-ancestor
56088071|NCT00371696|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56088072|NCT00371696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088073|NCT00371696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56088074|NCT00371696|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56088075|NCT00371696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088076|NCT00371696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088077|NCT02756624|Cetirizine|cetirizine|mesh-list
56088078|NCT02756624|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56088079|NCT02756624|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56088080|NCT02756624|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56088081|NCT02756624|Histamine Antagonists|histamine antagonists|mesh-ancestor
56088114|NCT04738045|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56088115|NCT04738045|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56088116|NCT04738045|Protease Inhibitors|protease inhibitors|mesh-ancestor
56088117|NCT04738045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088118|NCT04738045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088119|NCT04738045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56088120|NCT04738045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56088121|NCT04738045|Antiviral Agents|antiviral agents|mesh-ancestor
56088122|NCT04738045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088123|NCT04738045|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56088124|NCT04738045|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56088125|NCT04738045|Antimetabolites|antimetabolites|mesh-ancestor
56088126|NCT02226120|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56088127|NCT02226120|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56088128|NCT02226120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088129|NCT04587973|Dexmedetomidine|dexmedetomidine|mesh-list
56088130|NCT04587973|Ropivacaine|ropivacaine|mesh-list
56088131|NCT04587973|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56088132|NCT04587973|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088133|NCT04587973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088134|NCT04587973|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56088135|NCT04587973|Analgesics|analgesics|mesh-ancestor
56088136|NCT04587973|Sensory System Agents|sensory system agents|mesh-ancestor
56088137|NCT04587973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088138|NCT04587973|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56088139|NCT04587973|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56088140|NCT04587973|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56088141|NCT04587973|Adrenergic Agents|adrenergic agents|mesh-ancestor
56088142|NCT04587973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088144|NCT04587973|Anesthetics, Local|anesthetics, local|mesh-ancestor
56088154|NCT02753881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088155|NCT02753881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56088156|NCT02753881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56088157|NCT02753881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088158|NCT02753881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088159|NCT00425360|Gemcitabine|gemcitabine|mesh-list
56088160|NCT00425360|Capecitabine|capecitabine|mesh-list
56088161|NCT00425360|Sargramostim|sargramostim|mesh-list
56088162|NCT00425360|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55815379|NCT02481947|Laxatives|laxatives|mesh-list
56088163|NCT00425360|Antimetabolites|antimetabolites|mesh-ancestor
56088164|NCT00425360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088165|NCT00425360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088166|NCT00425360|Antiviral Agents|antiviral agents|mesh-ancestor
56088167|NCT00425360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088168|NCT00425360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088169|NCT00425360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56088170|NCT00425360|Immunologic Factors|immunologic factors|mesh-ancestor
56088171|NCT00425360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088173|NCT04337606|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56088174|NCT04337606|Antimetabolites|antimetabolites|mesh-ancestor
56088175|NCT04337606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088176|NCT04337606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088177|NCT04337606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088178|NCT01190306|Riboflavin|riboflavin|mesh-list
56088179|NCT01190306|Vitamin B Complex|vitamin b complex|mesh-ancestor
56088180|NCT01190306|Vitamins|vitamins|mesh-ancestor
56088203|NCT04336904|Antiviral Agents|antiviral agents|mesh-ancestor
56088204|NCT04336904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088205|NCT02767934|Pembrolizumab|pembrolizumab|mesh-list
56088206|NCT02767934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088207|NCT02767934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088208|NCT02194998|Ritonavir|ritonavir|mesh-list
56088209|NCT02194998|Ribavirin|ribavirin|mesh-list
56088210|NCT02194998|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56088211|NCT02194998|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56088212|NCT02194998|Protease Inhibitors|protease inhibitors|mesh-ancestor
56088213|NCT02194998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088214|NCT02194998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088215|NCT02194998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56088216|NCT02194998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56088217|NCT02194998|Antiviral Agents|antiviral agents|mesh-ancestor
56088218|NCT02194998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088219|NCT02194998|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56088220|NCT02194998|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56088221|NCT02194998|Antimetabolites|antimetabolites|mesh-ancestor
56088222|NCT02194062|Fluticasone|fluticasone|mesh-list
56088223|NCT02194062|Xhance|xhance|mesh-list
56088224|NCT02194062|Budesonide|budesonide|mesh-list
56088225|NCT02194062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088226|NCT02194062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56088227|NCT02194062|Autonomic Agents|autonomic agents|mesh-ancestor
56088230|NCT02194062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56088252|NCT02192970|Growth Substances|growth substances|mesh-ancestor
56088253|NCT02192970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088254|NCT02192970|Growth Inhibitors|growth inhibitors|mesh-ancestor
56088255|NCT05180318|Ketamine|ketamine|mesh-list
56088256|NCT05180318|Esketamine|esketamine|mesh-list
56088257|NCT05180318|Analgesics|analgesics|mesh-ancestor
56088258|NCT05180318|Sensory System Agents|sensory system agents|mesh-ancestor
56088259|NCT05180318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088260|NCT05180318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088261|NCT05180318|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56088262|NCT05180318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56088263|NCT05180318|Anesthetics, General|anesthetics, general|mesh-ancestor
56088264|NCT05180318|Anesthetics|anesthetics|mesh-ancestor
56088265|NCT05180318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088266|NCT05180318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56088267|NCT05180318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56088268|NCT05180318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088269|NCT05180318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088270|NCT05180318|Antidepressive Agents|antidepressive agents|mesh-ancestor
56088271|NCT05180318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56088272|NCT05457296|Hydrocortisone|hydrocortisone|mesh-list
56088273|NCT05457296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088274|NCT05456438|Tea Tree Oil|tea tree oil|mesh-list
56088275|NCT05456438|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56088276|NCT05456438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088277|NCT02744846|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56088278|NCT02744846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088279|NCT02762071|Bupivacaine|bupivacaine|mesh-list
56088280|NCT02762071|Anesthetics, Local|anesthetics, local|mesh-ancestor
56088281|NCT02762071|Anesthetics|anesthetics|mesh-ancestor
56088282|NCT02762071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088283|NCT02762071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088296|NCT04336891|Hormones|hormones|mesh-ancestor
56088297|NCT04336891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088298|NCT04336891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088299|NCT04336891|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56088300|NCT04336891|Contraceptive Agents|contraceptive agents|mesh-ancestor
56088301|NCT04336891|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56088302|NCT04336891|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56088303|NCT04336891|Androgens|androgens|mesh-ancestor
56088304|NCT04336891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56088305|NCT04336891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088306|NCT04336891|Anabolic Agents|anabolic agents|mesh-ancestor
56088307|NCT04337918|Nitric Oxide|nitric oxide|mesh-list
56088308|NCT04337918|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56088309|NCT04337918|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56088310|NCT04337918|Autonomic Agents|autonomic agents|mesh-ancestor
56088311|NCT04337918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088312|NCT04337918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088313|NCT04337918|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55815525|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56088314|NCT04337918|Respiratory System Agents|respiratory system agents|mesh-ancestor
56088315|NCT04337918|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56088316|NCT04337918|Antioxidants|antioxidants|mesh-ancestor
56088317|NCT04337918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088318|NCT04337918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088319|NCT04337918|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56088320|NCT04337918|Vasodilator Agents|vasodilator agents|mesh-ancestor
56088321|NCT04337918|Gasotransmitters|gasotransmitters|mesh-ancestor
56088322|NCT04337918|Protective Agents|protective agents|mesh-ancestor
56088323|NCT02747186|Lidocaine|lidocaine|mesh-list
56088324|NCT02747186|Anesthetics, Local|anesthetics, local|mesh-ancestor
56088325|NCT02747186|Anesthetics|anesthetics|mesh-ancestor
56088328|NCT02747186|Sensory System Agents|sensory system agents|mesh-ancestor
56088337|NCT02766517|Dermatologic Agents|dermatologic agents|mesh-ancestor
56088338|NCT02766517|Sensory System Agents|sensory system agents|mesh-ancestor
56088339|NCT02766517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088340|NCT02766517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088341|NCT04336046|Bupivacaine|bupivacaine|mesh-list
56088342|NCT04336046|Anesthetics, Local|anesthetics, local|mesh-ancestor
56088343|NCT04336046|Anesthetics|anesthetics|mesh-ancestor
56088344|NCT04336046|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088345|NCT04336046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088346|NCT04336046|Sensory System Agents|sensory system agents|mesh-ancestor
56088347|NCT04336046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088348|NCT05348239|Copper|copper|mesh-list
56088349|NCT05348239|Chlorophyllin|chlorophyllin|mesh-list
56088350|NCT05348239|Trace Elements|trace elements|mesh-ancestor
56088351|NCT05348239|Micronutrients|micronutrients|mesh-ancestor
56088352|NCT05348239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088353|NCT05348239|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
56088354|NCT05348239|Protective Agents|protective agents|mesh-ancestor
56088355|NCT02766673|Albuterol|albuterol|mesh-list
56088356|NCT02766673|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56088357|NCT02766673|Autonomic Agents|autonomic agents|mesh-ancestor
56088358|NCT02766673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088359|NCT02766673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088360|NCT02766673|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56088361|NCT02766673|Respiratory System Agents|respiratory system agents|mesh-ancestor
56088362|NCT02766673|Tocolytic Agents|tocolytic agents|mesh-ancestor
56088363|NCT02766673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56088364|NCT02766673|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56088365|NCT02766673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56088381|NCT04337593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088382|NCT04337593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56088383|NCT04337593|Immunologic Factors|immunologic factors|mesh-ancestor
56088384|NCT04337593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088385|NCT05339581|Pembrolizumab|pembrolizumab|mesh-list
56088386|NCT05339581|Lenvatinib|lenvatinib|mesh-list
56088387|NCT05339581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088388|NCT05339581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815601|NCT01879618|Dalteparin|dalteparin|mesh-list
56088389|NCT05339581|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56088390|NCT05339581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088391|NCT05339581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088392|NCT04766918|Hyaluronic Acid|hyaluronic acid|mesh-list
56088393|NCT04766918|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56088394|NCT04766918|Immunologic Factors|immunologic factors|mesh-ancestor
56088395|NCT04766918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088396|NCT04766918|Viscosupplements|viscosupplements|mesh-ancestor
56088397|NCT04766918|Protective Agents|protective agents|mesh-ancestor
56088398|NCT04064684|Budesonide|budesonide|mesh-list
56088399|NCT04064684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088400|NCT04064684|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56088401|NCT04064684|Autonomic Agents|autonomic agents|mesh-ancestor
56088402|NCT04064684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088403|NCT04064684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088404|NCT04064684|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56088405|NCT04064684|Respiratory System Agents|respiratory system agents|mesh-ancestor
56088406|NCT04064684|Glucocorticoids|glucocorticoids|mesh-ancestor
56088407|NCT04064684|Hormones|hormones|mesh-ancestor
56088516|NCT04507022|Estradiol|estradiol|mesh-list
56088408|NCT04064684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088425|NCT02748889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088426|NCT02748889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56088427|NCT02748889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56088428|NCT02748889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56088430|NCT02748889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088431|NCT05390528|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56088432|NCT05390528|Immunologic Factors|immunologic factors|mesh-ancestor
56088433|NCT05390528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088434|NCT04654988|Prednisone|prednisone|mesh-list
56088435|NCT04654988|Azathioprine|azathioprine|mesh-list
56088436|NCT04654988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088437|NCT04654988|Glucocorticoids|glucocorticoids|mesh-ancestor
56088438|NCT04654988|Hormones|hormones|mesh-ancestor
56088439|NCT04654988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088440|NCT04654988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088441|NCT04654988|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56088442|NCT04654988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088444|NCT04654988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088445|NCT04654988|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56088446|NCT04654988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56088447|NCT04654988|Immunologic Factors|immunologic factors|mesh-ancestor
56088448|NCT04654988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56088449|NCT02224560|Cannabidiol|cannabidiol|mesh-list
56088450|NCT02224560|Anticonvulsants|anticonvulsants|mesh-ancestor
56088451|NCT00372710|Zoledronic Acid|zoledronic acid|mesh-list
56088452|NCT00372710|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56088453|NCT00372710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088454|NCT02973776|Clobetasol|clobetasol|mesh-list
56088455|NCT02973776|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56088456|NCT02973776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088466|NCT02161458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088467|NCT02161458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088468|NCT02161458|Serotonin Agents|serotonin agents|mesh-ancestor
56088469|NCT02161458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088470|NCT02161458|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56088471|NCT02161458|Antidepressive Agents|antidepressive agents|mesh-ancestor
56088472|NCT02161458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56088473|NCT02161458|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56088474|NCT02161458|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56088475|NCT02161458|Parasympatholytics|parasympatholytics|mesh-ancestor
56088476|NCT02161458|Autonomic Agents|autonomic agents|mesh-ancestor
56088477|NCT02161458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088478|NCT02161458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56088479|NCT02161458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56088480|NCT02161458|Cholinergic Agents|cholinergic agents|mesh-ancestor
56088482|NCT04737889|Methotrexate|methotrexate|mesh-list
56088483|NCT04737889|Lenalidomide|lenalidomide|mesh-list
56088484|NCT04737889|Temozolomide|temozolomide|mesh-list
56088485|NCT04737889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088486|NCT04737889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088487|NCT04737889|Immunologic Factors|immunologic factors|mesh-ancestor
56088488|NCT04737889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088489|NCT04737889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56088490|NCT04737889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56088491|NCT04737889|Abortifacient Agents|abortifacient agents|mesh-ancestor
56088492|NCT04737889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56088493|NCT04737889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56088494|NCT04737889|Antimetabolites|antimetabolites|mesh-ancestor
56088495|NCT04737889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088496|NCT04737889|Dermatologic Agents|dermatologic agents|mesh-ancestor
56088497|NCT04737889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088498|NCT04737889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56088505|NCT04737889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56088507|NCT04191096|Pembrolizumab|pembrolizumab|mesh-list
56088508|NCT04191096|Androgens|androgens|mesh-list
56088509|NCT04191096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088510|NCT04191096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088511|NCT04191096|Hormones|hormones|mesh-ancestor
56088512|NCT04191096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088513|NCT04191096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088514|NCT04507022|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56088515|NCT04507022|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
56088517|NCT04507022|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56088518|NCT04507022|Progesterone|progesterone|mesh-list
56088519|NCT04507022|Aromatase Inhibitors|aromatase inhibitors|mesh-list
56088520|NCT04507022|Estrogens|estrogens|mesh-ancestor
56088521|NCT04507022|Hormones|hormones|mesh-ancestor
56088523|NCT04507022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088524|NCT04507022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56088525|NCT04507022|Contraceptive Agents|contraceptive agents|mesh-ancestor
56088526|NCT04507022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56088527|NCT04507022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56088528|NCT04507022|Progestins|progestins|mesh-ancestor
56088529|NCT04507022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56088530|NCT04507022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088531|NCT04507022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088532|NCT04507022|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56088533|NCT04507022|Hormone Antagonists|hormone antagonists|mesh-ancestor
56088534|NCT00372788|Pemetrexed|pemetrexed|mesh-list
56088535|NCT00372788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088536|NCT00372788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088537|NCT00372788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815747|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
56088538|NCT00372788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56088539|NCT00372788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56088541|NCT00372476|Vinorelbine|vinorelbine|mesh-list
56088542|NCT00372476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088543|NCT00372476|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56088544|NCT00372476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088545|NCT00372476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088546|NCT00372476|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56088547|NCT00372476|Tubulin Modulators|tubulin modulators|mesh-ancestor
56088548|NCT00372476|Antimitotic Agents|antimitotic agents|mesh-ancestor
56088549|NCT00372476|Mitosis Modulators|mitosis modulators|mesh-ancestor
56088550|NCT05450029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
56088551|NCT05450029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088552|NCT05450029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088553|NCT04737967|Memantine|memantine|mesh-list
56088554|NCT04737967|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56088555|NCT04737967|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56088556|NCT04737967|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56088557|NCT04737967|Dopamine Agents|dopamine agents|mesh-ancestor
56088558|NCT04737967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088559|NCT04737967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741514|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56088560|NCT04737967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088561|NCT04737967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56088562|NCT04737967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56088564|NCT04737967|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56088565|NCT04737967|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56088566|NCT04737967|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56088584|NCT05158153|Natriuretic Agents|natriuretic agents|mesh-ancestor
56088585|NCT05158153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088586|NCT05158153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56088587|NCT05158153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56088588|NCT05158153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088590|NCT04367090|Trastuzumab|trastuzumab|mesh-list
56088591|NCT04367090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088592|NCT04367090|Tubulin Modulators|tubulin modulators|mesh-ancestor
56088593|NCT04367090|Antimitotic Agents|antimitotic agents|mesh-ancestor
56088594|NCT04367090|Mitosis Modulators|mitosis modulators|mesh-ancestor
56088595|NCT04367090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088596|NCT04367090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088597|NCT04233476|Arginyl-glycyl-aspartic acid|arginyl-glycyl-aspartic acid|mesh-list
56088598|NCT04233476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088599|NCT00371995|Amphotericin B|amphotericin b|mesh-list
56088600|NCT00371995|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56088601|NCT00371995|Miltefosine|miltefosine|mesh-list
56088602|NCT00371995|Amebicides|amebicides|mesh-ancestor
56088603|NCT00371995|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56088604|NCT00371995|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56088605|NCT00371995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088606|NCT00371995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56088607|NCT00371995|Antifungal Agents|antifungal agents|mesh-ancestor
56088608|NCT00371995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088611|NCT04767074|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56088612|NCT04767074|Expectorants|expectorants|mesh-ancestor
56088613|NCT04767074|Respiratory System Agents|respiratory system agents|mesh-ancestor
56088627|NCT00372307|Pimecrolimus|pimecrolimus|mesh-list
56088628|NCT00372307|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56088629|NCT00372307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56088630|NCT00372307|Analgesics|analgesics|mesh-ancestor
56088631|NCT00372307|Sensory System Agents|sensory system agents|mesh-ancestor
56088632|NCT00372307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088633|NCT00372307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088634|NCT00372307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088635|NCT00372307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56088636|NCT00372307|Dermatologic Agents|dermatologic agents|mesh-ancestor
56088637|NCT00372307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56088638|NCT00372307|Immunologic Factors|immunologic factors|mesh-ancestor
56088639|NCT00372307|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56088640|NCT00372307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088641|NCT00372307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088642|NCT04647110|Crizotinib|crizotinib|mesh-list
56088643|NCT04647110|Ceritinib|ceritinib|mesh-list
56088644|NCT04647110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088645|NCT04647110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56088646|NCT04647110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088647|NCT04647110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088648|NCT04061330|Ketamine|ketamine|mesh-list
56088649|NCT04061330|Morphine|morphine|mesh-list
56088650|NCT04061330|Analgesics|analgesics|mesh-ancestor
56088651|NCT04061330|Sensory System Agents|sensory system agents|mesh-ancestor
56088652|NCT04061330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088653|NCT04061330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088654|NCT04061330|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56088655|NCT04061330|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56088656|NCT04061330|Anesthetics, General|anesthetics, general|mesh-ancestor
56088657|NCT04061330|Anesthetics|anesthetics|mesh-ancestor
56088658|NCT04061330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088659|NCT04061330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56088660|NCT04061330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56088665|NCT00372632|Pyrimethamine|pyrimethamine|mesh-list
56088666|NCT00372632|Sulfadoxine|sulfadoxine|mesh-list
56088667|NCT00372632|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56088668|NCT00372632|Antimalarials|antimalarials|mesh-ancestor
56088669|NCT00372632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56088670|NCT00372632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56088671|NCT00372632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088672|NCT00372632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56088673|NCT00372632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088674|NCT00372632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088675|NCT00372632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56088676|NCT00372632|Renal Agents|renal agents|mesh-ancestor
56088677|NCT05125237|Amiloride|amiloride|mesh-list
56088678|NCT05125237|Triamterene|triamterene|mesh-list
56088679|NCT05125237|Diuretics|diuretics|mesh-ancestor
56088680|NCT05125237|Natriuretic Agents|natriuretic agents|mesh-ancestor
56088681|NCT05125237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088682|NCT05125237|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
56088683|NCT05125237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55815897|NCT04939883|Protective Agents|protective agents|mesh-ancestor
56088684|NCT05125237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56088685|NCT05125237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088686|NCT05125237|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
56088687|NCT05125237|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56088688|NCT01674140|Tamoxifen|tamoxifen|mesh-list
56088689|NCT01674140|Everolimus|everolimus|mesh-list
56088690|NCT01674140|Letrozole|letrozole|mesh-list
56088691|NCT01674140|Anastrozole|anastrozole|mesh-list
56088692|NCT01674140|Leuprolide|leuprolide|mesh-list
56088693|NCT01674140|Exemestane|exemestane|mesh-list
56088694|NCT01674140|Goserelin|goserelin|mesh-list
56088695|NCT01674140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088696|NCT01674140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088697|NCT01674140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56088698|NCT01674140|Immunologic Factors|immunologic factors|mesh-ancestor
56088705|NCT01674140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088706|NCT01674140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56088707|NCT01674140|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56088708|NCT01674140|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56088709|NCT01674140|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56088710|NCT01674140|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56088711|NCT01674140|Fertility Agents|fertility agents|mesh-ancestor
56088712|NCT01674140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56088713|NCT04792021|Acetylcysteine|acetylcysteine|mesh-list
56088714|NCT04792021|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56088715|NCT04792021|Antiviral Agents|antiviral agents|mesh-ancestor
56088716|NCT04792021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088717|NCT04792021|Expectorants|expectorants|mesh-ancestor
56088718|NCT04792021|Respiratory System Agents|respiratory system agents|mesh-ancestor
56088719|NCT04792021|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56088720|NCT04792021|Antioxidants|antioxidants|mesh-ancestor
56088721|NCT04792021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088722|NCT04792021|Protective Agents|protective agents|mesh-ancestor
56088723|NCT04792021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088724|NCT04792021|Antidotes|antidotes|mesh-ancestor
56088726|NCT03713437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56088727|NCT03713437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088728|NCT04334005|Vitamin D|vitamin d|mesh-list
56088729|NCT04334005|Vitamins|vitamins|mesh-ancestor
56088730|NCT04334005|Micronutrients|micronutrients|mesh-ancestor
56088733|NCT00966914|Paclitaxel|paclitaxel|mesh-list
56088752|NCT04432285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088753|NCT04432285|Cholinergic Agents|cholinergic agents|mesh-ancestor
56088754|NCT04432285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088755|NCT04432285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088756|NCT04430959|Candesartan|candesartan|mesh-list
56088757|NCT04430959|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56088758|NCT04430959|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55815972|NCT04182555|Bilirubin|bilirubin|mesh-list
56088759|NCT04430959|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56088760|NCT04430959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088761|NCT04737655|Beclomethasone|beclomethasone|mesh-list
56088762|NCT04737655|Glycopyrrolate|glycopyrrolate|mesh-list
56088763|NCT04737655|Formoterol Fumarate|formoterol fumarate|mesh-list
56088764|NCT04737655|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56088765|NCT04737655|Autonomic Agents|autonomic agents|mesh-ancestor
56088766|NCT04737655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088767|NCT04737655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088768|NCT04737655|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56088769|NCT04737655|Respiratory System Agents|respiratory system agents|mesh-ancestor
56088770|NCT04737655|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56088771|NCT04737655|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56088772|NCT04737655|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56088773|NCT04737655|Adrenergic Agents|adrenergic agents|mesh-ancestor
56088774|NCT04737655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088775|NCT04737655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088776|NCT04737655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56088777|NCT04737655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56088778|NCT04737655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56088779|NCT04737655|Cholinergic Agents|cholinergic agents|mesh-ancestor
56088780|NCT04737655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088782|NCT04737655|Hormones|hormones|mesh-ancestor
56088793|NCT05055752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56088794|NCT05055752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56088796|NCT05055752|Sensory System Agents|sensory system agents|mesh-ancestor
56088797|NCT05055752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088798|NCT05055752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088799|NCT05055752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088800|NCT05055752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56088801|NCT05055752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56088802|NCT05055752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56088803|NCT05055752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088804|NCT05055752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56088805|NCT05055752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56088806|NCT05055752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088807|NCT05055752|Antipyretics|antipyretics|mesh-ancestor
56088808|NCT04336189|Pyrimethamine|pyrimethamine|mesh-list
56088809|NCT04336189|Piperaquine|piperaquine|mesh-list
56088810|NCT04336189|Sulfadoxine|sulfadoxine|mesh-list
56088811|NCT04336189|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
56088812|NCT04336189|Artenimol|artenimol|mesh-list
56088813|NCT04336189|Antimalarials|antimalarials|mesh-ancestor
56088814|NCT04336189|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56088816|NCT04336189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088817|NCT04336189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56088818|NCT04336189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56088819|NCT04336189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088820|NCT04336189|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56088821|NCT04336189|Renal Agents|renal agents|mesh-ancestor
56088822|NCT05037032|Naltrexone|naltrexone|mesh-list
56088823|NCT05037032|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56088824|NCT05037032|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56088825|NCT05037032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088826|NCT05037032|Sensory System Agents|sensory system agents|mesh-ancestor
56088827|NCT05037032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088833|NCT04181515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088834|NCT04181515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088835|NCT04181515|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56088836|NCT04181515|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56088837|NCT04181515|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56088838|NCT04181515|Adrenergic Agents|adrenergic agents|mesh-ancestor
56088839|NCT04181515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088840|NCT04181515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56088841|NCT04181515|Urological Agents|urological agents|mesh-ancestor
56088843|NCT04180969|Yohimbine|yohimbine|mesh-list
56088844|NCT04180969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088845|NCT04180969|Mydriatics|mydriatics|mesh-ancestor
56088846|NCT04180969|Autonomic Agents|autonomic agents|mesh-ancestor
56088847|NCT04180969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088848|NCT04180969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088849|NCT04180969|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56088850|NCT04180969|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55741518|NCT04521517|Imidacloprid|imidacloprid|mesh-list
56088851|NCT04180969|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56088852|NCT04180969|Adrenergic Agents|adrenergic agents|mesh-ancestor
56088853|NCT04180969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56088882|NCT04762381|Autonomic Agents|autonomic agents|mesh-ancestor
56088883|NCT04762381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088884|NCT04762381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088885|NCT04762381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56088886|NCT04762381|Hormones|hormones|mesh-ancestor
56088887|NCT04762381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56088888|NCT04762381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56088889|NCT04762381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088890|NCT01547468|Analgesics, Opioid|analgesics, opioid|mesh-list
56088891|NCT01547468|Narcotics|narcotics|mesh-ancestor
56088892|NCT01547468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56088893|NCT01547468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088894|NCT01547468|Analgesics|analgesics|mesh-ancestor
56088895|NCT01547468|Sensory System Agents|sensory system agents|mesh-ancestor
56088896|NCT01547468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088897|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
56088898|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56088899|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56088900|NCT04900220|Prednisolone|prednisolone|mesh-list
56088901|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
56088902|NCT04900220|Betamethasone|betamethasone|mesh-list
56088903|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56088904|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
56088905|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56088906|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
56088910|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56088928|NCT00373412|Immunologic Factors|immunologic factors|mesh-ancestor
56088929|NCT00373412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088930|NCT00373178|Metformin|metformin|mesh-list
56088931|NCT00373178|Rosiglitazone|rosiglitazone|mesh-list
56088932|NCT00373178|Hypoglycemic Agents|hypoglycemic agents|mesh-list
56088933|NCT00373178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088934|NCT03254732|Pembrolizumab|pembrolizumab|mesh-list
56088935|NCT03254732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56088936|NCT03254732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088938|NCT01163383|Cadexomer iodine|cadexomer iodine|mesh-list
56088939|NCT01163383|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56088940|NCT01163383|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56088941|NCT01163383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56088942|NCT01163383|Trace Elements|trace elements|mesh-ancestor
56088943|NCT01163383|Micronutrients|micronutrients|mesh-ancestor
56088944|NCT01163383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088945|NCT01163383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56088987|NCT02885636|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56088988|NCT02885636|Autonomic Agents|autonomic agents|mesh-ancestor
56088989|NCT02885636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56088990|NCT02885636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56088991|NCT02885636|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56088992|NCT02885636|Respiratory System Agents|respiratory system agents|mesh-ancestor
56088993|NCT02885636|Tocolytic Agents|tocolytic agents|mesh-ancestor
56088994|NCT02885636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56088995|NCT02885636|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56088996|NCT02885636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56088997|NCT02885636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56088998|NCT02885636|Adrenergic Agents|adrenergic agents|mesh-ancestor
56088999|NCT02885636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089000|NCT02885636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089001|NCT00373087|Entacapone|entacapone|mesh-list
56089002|NCT00373087|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56089003|NCT00373087|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56089004|NCT00373087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089005|NCT00373087|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56089006|NCT00373087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089007|NCT03619213|Dapagliflozin|dapagliflozin|mesh-list
56089008|NCT03619213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56089009|NCT03619213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901128|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55901129|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55901130|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55901134|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901135|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901136|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55901137|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55901138|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55901139|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55901140|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55901141|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
55901142|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
56089013|NCT02892110|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56089014|NCT02892110|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56089015|NCT02892110|Cholinergic Agents|cholinergic agents|mesh-ancestor
56089016|NCT02892110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089017|NCT02892110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089018|NCT02892110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901144|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901145|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
55901146|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55901147|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901148|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901149|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
55901150|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901151|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901153|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
55901154|NCT01697579|Aprepitant|aprepitant|mesh-list
55901155|NCT01697579|Serotonin|serotonin|mesh-list
55901156|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
55901157|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
55901158|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901159|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901160|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55901161|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
55901162|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
55901163|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55901164|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
55901165|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901166|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901167|NCT01697579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55901168|NCT01697579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55901169|NCT01697579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901170|NCT01697579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55901171|NCT01697579|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55901172|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55901173|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55901174|NCT01586195|Vemurafenib|vemurafenib|mesh-list
55901175|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089673|NCT03032965|Isoproterenol|isoproterenol|mesh-list
55901176|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55901177|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901178|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901179|NCT01697345|Testosterone|testosterone|mesh-list
55901180|NCT01697345|Androgens|androgens|mesh-ancestor
55901182|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55901183|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901184|NCT01802632|Osimertinib|osimertinib|mesh-list
55901185|NCT01802632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901186|NCT01802632|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55901187|NCT01802632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901188|NCT01802632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901189|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
55901190|NCT03467386|Tacrolimus|tacrolimus|mesh-list
55901191|NCT03467386|Lenograstim|lenograstim|mesh-list
55901192|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901193|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
56089019|NCT02779166|Celecoxib|celecoxib|mesh-list
56089020|NCT02779166|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56089021|NCT02779166|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56089022|NCT02779166|Analgesics|analgesics|mesh-ancestor
56089023|NCT02779166|Sensory System Agents|sensory system agents|mesh-ancestor
56089024|NCT02779166|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089025|NCT02779166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089026|NCT02779166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089027|NCT02779166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56089028|NCT02779166|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56089029|NCT02779166|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56089030|NCT02779166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089031|NCT02779166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089032|NCT00373165|Ganciclovir|ganciclovir|mesh-list
56089033|NCT00373165|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56089034|NCT00373165|Antiviral Agents|antiviral agents|mesh-ancestor
56089035|NCT00373165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089036|NCT00373165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56089037|NCT00373165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089038|NCT00373165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089039|NCT04333550|Deferoxamine|deferoxamine|mesh-list
56089040|NCT04333550|Siderophores|siderophores|mesh-ancestor
56089041|NCT04333550|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56089042|NCT04333550|Chelating Agents|chelating agents|mesh-ancestor
56089043|NCT04333550|Sequestering Agents|sequestering agents|mesh-ancestor
56089044|NCT04333550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089045|NCT02827838|Durvalumab|durvalumab|mesh-list
56089046|NCT02827838|Immunoglobulins|immunoglobulins|mesh-list
56089047|NCT02827838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56089054|NCT02902172|Ibuprofen|ibuprofen|mesh-list
56089064|NCT02902172|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56089065|NCT02902172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089066|NCT02902172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089068|NCT04233229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56089069|NCT04233229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089070|NCT04208347|Oxaliplatin|oxaliplatin|mesh-list
56089071|NCT04208347|Apatinib|apatinib|mesh-list
55741523|NCT01675167|Buprenorphine|buprenorphine|mesh-list
56089072|NCT04208347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089073|NCT04208347|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56089074|NCT04208347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089075|NCT04208347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089076|NCT02777749|Bupivacaine|bupivacaine|mesh-list
56089077|NCT02777749|Anesthetics, Local|anesthetics, local|mesh-ancestor
56089078|NCT02777749|Anesthetics|anesthetics|mesh-ancestor
56089079|NCT02777749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089080|NCT02777749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089081|NCT02777749|Sensory System Agents|sensory system agents|mesh-ancestor
56089082|NCT02777749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089083|NCT02785172|Clobetasol|clobetasol|mesh-list
56089084|NCT02785172|Halobetasol|halobetasol|mesh-list
56089085|NCT02785172|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56089086|NCT02785172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089087|NCT02785172|Glucocorticoids|glucocorticoids|mesh-ancestor
56089088|NCT02785172|Hormones|hormones|mesh-ancestor
56089090|NCT02785172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089110|NCT02062489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089111|NCT02062489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56089674|NCT03032965|Analgesics|analgesics|mesh-ancestor
56089112|NCT02062489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56089114|NCT02780869|Thrombin|thrombin|mesh-list
56089115|NCT02780869|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
56089116|NCT02780869|Hemostatics|hemostatics|mesh-ancestor
56089117|NCT02780869|Coagulants|coagulants|mesh-ancestor
56089118|NCT02908490|Sildenafil Citrate|sildenafil citrate|mesh-list
56089119|NCT02908490|Vasodilator Agents|vasodilator agents|mesh-ancestor
56089120|NCT02908490|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56089121|NCT02908490|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56089122|NCT02908490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089123|NCT02908490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089124|NCT02908490|Urological Agents|urological agents|mesh-ancestor
56089125|NCT02911844|Fulvestrant|fulvestrant|mesh-list
56089126|NCT02911844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089127|NCT02911844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089128|NCT02911844|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56089129|NCT02911844|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56089130|NCT02911844|Hormone Antagonists|hormone antagonists|mesh-ancestor
56089131|NCT02911844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089132|NCT02911844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089133|NCT02790788|Methylprednisolone|methylprednisolone|mesh-list
56089134|NCT02790788|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56089135|NCT02790788|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56089136|NCT02790788|Prednisolone|prednisolone|mesh-list
56089138|NCT02790788|Hydrocortisone|hydrocortisone|mesh-list
56089156|NCT02915744|Paclitaxel|paclitaxel|mesh-list
56089157|NCT02915744|Vinorelbine|vinorelbine|mesh-list
56089158|NCT02915744|Docetaxel|docetaxel|mesh-list
56089159|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56089160|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
56089161|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56089162|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089163|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
56089164|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
56089165|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
56089166|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089167|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56089168|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
56089169|NCT02915744|Antiviral Agents|antiviral agents|mesh-ancestor
56089170|NCT02915744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089171|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089172|NCT02915744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56089173|NCT02915744|Immunologic Factors|immunologic factors|mesh-ancestor
56089174|NCT02915744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089175|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56089212|NCT01821781|Alemtuzumab|alemtuzumab|mesh-list
56089214|NCT01821781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089215|NCT01821781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089216|NCT01821781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56089217|NCT01821781|Immunologic Factors|immunologic factors|mesh-ancestor
56089218|NCT01821781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089219|NCT01821781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56089220|NCT01821781|Alkylating Agents|alkylating agents|mesh-ancestor
56089221|NCT01821781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56089222|NCT01821781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56089223|NCT02794844|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
56089224|NCT02794844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089225|NCT02794844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089226|NCT02783443|Anesthetics|anesthetics|mesh-list
56089227|NCT02783443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089228|NCT02783443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089229|NCT00373568|Miltefosine|miltefosine|mesh-list
56089267|NCT00373646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089268|NCT03001453|Epinephrine|epinephrine|mesh-list
56089269|NCT03001453|Bupivacaine|bupivacaine|mesh-list
56089270|NCT03001453|Anesthetics, Local|anesthetics, local|mesh-ancestor
56089271|NCT03001453|Anesthetics|anesthetics|mesh-ancestor
56089272|NCT03001453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089273|NCT03001453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089274|NCT03001453|Sensory System Agents|sensory system agents|mesh-ancestor
56089275|NCT03001453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089276|NCT03001453|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56089277|NCT03001453|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56089278|NCT03001453|Adrenergic Agents|adrenergic agents|mesh-ancestor
56089279|NCT03001453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089280|NCT03001453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089281|NCT03001453|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56089282|NCT03001453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56089283|NCT03001453|Autonomic Agents|autonomic agents|mesh-ancestor
56089284|NCT03001453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56089285|NCT03001453|Respiratory System Agents|respiratory system agents|mesh-ancestor
56089286|NCT03001453|Mydriatics|mydriatics|mesh-ancestor
56089287|NCT03001453|Sympathomimetics|sympathomimetics|mesh-ancestor
56089288|NCT03001453|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56089321|NCT02786719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56089322|NCT02786719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56089323|NCT02786719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56089324|NCT02786719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56089325|NCT02786719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089326|NCT02786719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56089327|NCT02786719|Tubulin Modulators|tubulin modulators|mesh-ancestor
56089328|NCT02786719|Antimitotic Agents|antimitotic agents|mesh-ancestor
56089329|NCT02786719|Mitosis Modulators|mitosis modulators|mesh-ancestor
56089330|NCT02786719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56089331|NCT03003949|Estradiol|estradiol|mesh-list
56089332|NCT03003949|Progesterone|progesterone|mesh-list
56089333|NCT03003949|Estrogens|estrogens|mesh-ancestor
56089334|NCT03003949|Hormones|hormones|mesh-ancestor
56089335|NCT03003949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089336|NCT03003949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089337|NCT03003949|Progestins|progestins|mesh-ancestor
56089338|NCT03007225|Chlorotrianisene|chlorotrianisene|mesh-list
56089339|NCT03007225|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
56089340|NCT03007225|Estrogens|estrogens|mesh-ancestor
56089341|NCT03007225|Hormones|hormones|mesh-ancestor
56089342|NCT03007225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089343|NCT03007225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089344|NCT03007225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089345|NCT03007225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089346|NCT02800148|Azelaic acid|azelaic acid|mesh-list
56089353|NCT02791945|Antiviral Agents|antiviral agents|mesh-ancestor
56089354|NCT02791945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089355|NCT02791945|Expectorants|expectorants|mesh-ancestor
56089356|NCT02791945|Respiratory System Agents|respiratory system agents|mesh-ancestor
56089357|NCT02791945|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56089358|NCT02791945|Antioxidants|antioxidants|mesh-ancestor
56089359|NCT02791945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089360|NCT02791945|Protective Agents|protective agents|mesh-ancestor
56089361|NCT02791945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089362|NCT02791945|Antidotes|antidotes|mesh-ancestor
56089363|NCT02793817|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56089364|NCT02793817|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56089365|NCT02804594|Acetylcysteine|acetylcysteine|mesh-list
56089366|NCT02804594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56089368|NCT02804594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089369|NCT02804594|Expectorants|expectorants|mesh-ancestor
56089370|NCT02804594|Respiratory System Agents|respiratory system agents|mesh-ancestor
56089371|NCT02804594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56089372|NCT02804594|Antioxidants|antioxidants|mesh-ancestor
56089373|NCT02804594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089374|NCT02804594|Protective Agents|protective agents|mesh-ancestor
56089375|NCT02804594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089376|NCT02804594|Antidotes|antidotes|mesh-ancestor
56089377|NCT00374192|Eszopiclone|eszopiclone|mesh-list
56089378|NCT00374192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56089379|NCT00374192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089380|NCT00374192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089381|NCT02806544|Tamoxifen|tamoxifen|mesh-list
56089382|NCT02806544|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56089383|NCT02806544|Hormone Antagonists|hormone antagonists|mesh-ancestor
56089384|NCT02806544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089385|NCT02806544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089386|NCT02806544|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089387|NCT02806544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089388|NCT02806544|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56089389|NCT02806544|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56089390|NCT02806544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56089393|NCT00374348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56089394|NCT00374348|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56089395|NCT00374348|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56089396|NCT00374348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089397|NCT00374348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089398|NCT00374348|Dopamine Agonists|dopamine agonists|mesh-ancestor
56089399|NCT00374348|Dopamine Agents|dopamine agents|mesh-ancestor
56089400|NCT00374348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089401|NCT00374348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089402|NCT00374348|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56089403|NCT00374348|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56089404|NCT00374348|Serotonin Agents|serotonin agents|mesh-ancestor
55901194|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901195|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55901196|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55901197|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
55901198|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901199|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901200|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55901201|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55901202|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901211|NCT01352962|Antiviral Agents|antiviral agents|mesh-ancestor
55901212|NCT01352962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901213|NCT01352962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901214|NCT01352962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901215|NCT01352962|Immunologic Factors|immunologic factors|mesh-ancestor
55901216|NCT01352962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901217|NCT01352962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55901218|NCT01352962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55901219|NCT01352962|Growth Substances|growth substances|mesh-ancestor
55901220|NCT01352962|Growth Inhibitors|growth inhibitors|mesh-ancestor
55901221|NCT03465592|Nivolumab|nivolumab|mesh-list
55901222|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55901223|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089415|NCT02933372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089416|NCT02902237|Thromboplastin|thromboplastin|mesh-list
56089417|NCT02902237|Hemostatics|hemostatics|mesh-ancestor
56089418|NCT02902237|Coagulants|coagulants|mesh-ancestor
56089419|NCT02903407|Midazolam|midazolam|mesh-list
56089420|NCT02903407|Dexmedetomidine|dexmedetomidine|mesh-list
56089421|NCT02903407|Propofol|propofol|mesh-list
56089422|NCT02903407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56089423|NCT02903407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901224|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55901225|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901226|NCT02441062|Edotreotide|edotreotide|mesh-list
55901227|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55901228|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901229|NCT02442700|Pitavastatin|pitavastatin|mesh-list
55901230|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55901231|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55901232|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55901233|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
55901234|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901235|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901236|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55901237|NCT00619528|Alemtuzumab|alemtuzumab|mesh-list
55901239|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901241|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
55901242|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
55901243|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901244|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901245|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55901246|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55901247|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55901248|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901249|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55901250|NCT00568672|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55901251|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55901252|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901253|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089424|NCT02903407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089425|NCT02903407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56089426|NCT02903407|Anesthetics, General|anesthetics, general|mesh-ancestor
56089427|NCT02903407|Anesthetics|anesthetics|mesh-ancestor
56089428|NCT02903407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56089429|NCT02903407|Analgesics|analgesics|mesh-ancestor
56089430|NCT02903407|Sensory System Agents|sensory system agents|mesh-ancestor
56089431|NCT02903407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089432|NCT02903407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56089433|NCT02903407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56089434|NCT02903407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56089435|NCT02903407|Adrenergic Agents|adrenergic agents|mesh-ancestor
56089436|NCT02903407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089437|NCT02903407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089438|NCT02903407|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56089439|NCT02903407|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56089440|NCT02903407|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56089441|NCT02903407|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56089443|NCT02903407|GABA Agents|gaba agents|mesh-ancestor
56089444|NCT02905981|Citric Acid|citric acid|mesh-list
56089445|NCT02905981|Sodium Citrate|sodium citrate|mesh-list
56089446|NCT02905981|Anticoagulants|anticoagulants|mesh-ancestor
56089447|NCT02905981|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56089448|NCT02905981|Chelating Agents|chelating agents|mesh-ancestor
56089449|NCT02905981|Sequestering Agents|sequestering agents|mesh-ancestor
56089450|NCT02905981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089451|NCT00374023|Vitamin A|vitamin a|mesh-list
56089452|NCT00374023|Vitamins|vitamins|mesh-ancestor
56089453|NCT00374023|Micronutrients|micronutrients|mesh-ancestor
56089454|NCT00374023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089455|NCT02812238|Niacinamide|niacinamide|mesh-list
56089457|NCT02812238|Nicotinic Acids|nicotinic acids|mesh-list
56089458|NCT02812238|Vitamin B Complex|vitamin b complex|mesh-ancestor
56089459|NCT02812238|Vitamins|vitamins|mesh-ancestor
56089460|NCT02812238|Micronutrients|micronutrients|mesh-ancestor
56089461|NCT02812238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089466|NCT02812238|Vasodilator Agents|vasodilator agents|mesh-ancestor
56089467|NCT03015961|Bupivacaine|bupivacaine|mesh-list
56089468|NCT03015961|Anesthetics, Local|anesthetics, local|mesh-ancestor
56089469|NCT03015961|Anesthetics|anesthetics|mesh-ancestor
56089470|NCT03015961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089471|NCT03015961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089472|NCT03015961|Sensory System Agents|sensory system agents|mesh-ancestor
56089473|NCT03015961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089474|NCT03018223|Mycophenolic Acid|mycophenolic acid|mesh-list
56089475|NCT03018223|Sirolimus|sirolimus|mesh-list
56089476|NCT03018223|Cyclophosphamide|cyclophosphamide|mesh-list
56089477|NCT03018223|Busulfan|busulfan|mesh-list
56089478|NCT03018223|Fludarabine|fludarabine|mesh-list
56089479|NCT03018223|Lenograstim|lenograstim|mesh-list
56089480|NCT03018223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56089481|NCT03018223|Immunologic Factors|immunologic factors|mesh-ancestor
56089482|NCT03018223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089483|NCT03018223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56089484|NCT03018223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56089485|NCT03018223|Alkylating Agents|alkylating agents|mesh-ancestor
56089486|NCT03018223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089487|NCT03018223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089488|NCT03018223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56089489|NCT03018223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56089490|NCT03018223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56089491|NCT03018223|Antitubercular Agents|antitubercular agents|mesh-ancestor
56089492|NCT03018223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56089493|NCT03018223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089494|NCT03018223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089495|NCT03018223|Antifungal Agents|antifungal agents|mesh-ancestor
56089496|NCT03018223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56089497|NCT03018925|Golimumab|golimumab|mesh-list
56089510|NCT03019783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56089511|NCT03019783|Antiviral Agents|antiviral agents|mesh-ancestor
56089512|NCT03019783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089513|NCT03019939|Isavuconazole|isavuconazole|mesh-list
56089514|NCT03019939|Antifungal Agents|antifungal agents|mesh-ancestor
56089515|NCT03019939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089516|NCT03020095|Ritonavir|ritonavir|mesh-list
56089517|NCT03020095|Ribavirin|ribavirin|mesh-list
56089518|NCT03020095|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56089519|NCT03020095|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56089521|NCT03020095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089522|NCT03020095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089523|NCT03020095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56089524|NCT03020095|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56089525|NCT03020095|Antiviral Agents|antiviral agents|mesh-ancestor
56089526|NCT03020095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089741|NCT03035929|Dexamethasone|dexamethasone|mesh-list
56089527|NCT03020095|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56089528|NCT03020095|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56089529|NCT03020095|Antimetabolites|antimetabolites|mesh-ancestor
56089530|NCT02934698|Ivacaftor|ivacaftor|mesh-list
56089531|NCT02934698|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56089532|NCT02934698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56089533|NCT02934698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089534|NCT03021343|Colchicine|colchicine|mesh-list
56089535|NCT03021343|Gout Suppressants|gout suppressants|mesh-ancestor
56089536|NCT03021343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56089537|NCT03021343|Tubulin Modulators|tubulin modulators|mesh-ancestor
56089538|NCT03021343|Antimitotic Agents|antimitotic agents|mesh-ancestor
56089539|NCT03021343|Mitosis Modulators|mitosis modulators|mesh-ancestor
56089558|NCT02937506|Anesthetics, General|anesthetics, general|mesh-ancestor
56089559|NCT02937506|Anesthetics|anesthetics|mesh-ancestor
56089560|NCT02937506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56089561|NCT02937506|Narcotics|narcotics|mesh-ancestor
56089562|NCT02937506|Analgesics|analgesics|mesh-ancestor
56089563|NCT02937506|Sensory System Agents|sensory system agents|mesh-ancestor
56089564|NCT02937506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089565|NCT02937506|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56089566|NCT02937506|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56089567|NCT02937506|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56089568|NCT02937506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56089569|NCT02937506|GABA Modulators|gaba modulators|mesh-ancestor
56089570|NCT02937506|GABA Agents|gaba agents|mesh-ancestor
56089571|NCT02937506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089572|NCT02937506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089573|NCT03026803|Capecitabine|capecitabine|mesh-list
56089574|NCT03026803|Oxaliplatin|oxaliplatin|mesh-list
56089575|NCT03026803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56089576|NCT03026803|Antimetabolites|antimetabolites|mesh-ancestor
56089577|NCT03026803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089578|NCT03026803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089579|NCT03027661|Bupivacaine|bupivacaine|mesh-list
56089580|NCT03027661|Anesthetics, Local|anesthetics, local|mesh-ancestor
56089581|NCT03027661|Anesthetics|anesthetics|mesh-ancestor
56089582|NCT03027661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089583|NCT03027661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089609|NCT02794441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089610|NCT02794441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089611|NCT02794441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089612|NCT02941640|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56089613|NCT02941640|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56089614|NCT02941640|beta-Endorphin|beta-endorphin|mesh-list
56089615|NCT02941640|Hormones|hormones|mesh-ancestor
56089616|NCT02941640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089617|NCT02941640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089618|NCT02941640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089619|NCT02941640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089620|NCT02823080|Cetrorelix|cetrorelix|mesh-list
56089621|NCT02823080|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56089622|NCT02823080|Fertility Agents|fertility agents|mesh-ancestor
56089623|NCT02823080|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56089624|NCT02823080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089625|NCT02823080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56089626|NCT02823080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089627|NCT03022916|Efinaconazole|efinaconazole|mesh-list
56089628|NCT03022916|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56089629|NCT03022916|Antifungal Agents|antifungal agents|mesh-ancestor
56089630|NCT03022916|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089659|NCT00373802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56089660|NCT00373802|Nasal Decongestants|nasal decongestants|mesh-ancestor
56089661|NCT00373802|Respiratory System Agents|respiratory system agents|mesh-ancestor
56089662|NCT00373802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56089663|NCT00373802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56089664|NCT00373802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56089665|NCT00373802|Adrenergic Agents|adrenergic agents|mesh-ancestor
56089666|NCT00373802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089667|NCT00373802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089668|NCT00373802|Protective Agents|protective agents|mesh-ancestor
56089669|NCT02945150|Grazoprevir|grazoprevir|mesh-list
56089670|NCT02945150|Antiviral Agents|antiviral agents|mesh-ancestor
56089671|NCT02945150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089672|NCT03032965|Adenosine|adenosine|mesh-list
56089675|NCT03032965|Sensory System Agents|sensory system agents|mesh-ancestor
56089676|NCT03032965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089679|NCT03032965|Vasodilator Agents|vasodilator agents|mesh-ancestor
56089680|NCT03032965|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56089681|NCT03032965|Purinergic Agonists|purinergic agonists|mesh-ancestor
56089682|NCT03032965|Purinergic Agents|purinergic agents|mesh-ancestor
56089683|NCT03032965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089684|NCT03032965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089685|NCT03032965|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56089686|NCT03032965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56089687|NCT03032965|Adrenergic Agents|adrenergic agents|mesh-ancestor
56089688|NCT03032965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56089689|NCT03032965|Autonomic Agents|autonomic agents|mesh-ancestor
56089690|NCT03032965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56089691|NCT03032965|Respiratory System Agents|respiratory system agents|mesh-ancestor
56089692|NCT03032965|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56089700|NCT03030638|Autonomic Agents|autonomic agents|mesh-ancestor
56089701|NCT03030638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089702|NCT03030638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089703|NCT03030638|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56089704|NCT03030638|Respiratory System Agents|respiratory system agents|mesh-ancestor
56089705|NCT02949674|Bupivacaine|bupivacaine|mesh-list
56089706|NCT02949674|Ropivacaine|ropivacaine|mesh-list
56089707|NCT02949674|Anesthetics, Local|anesthetics, local|mesh-ancestor
56089708|NCT02949674|Anesthetics|anesthetics|mesh-ancestor
56089709|NCT02949674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089710|NCT02949674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089711|NCT02949674|Sensory System Agents|sensory system agents|mesh-ancestor
56089712|NCT02949674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089713|NCT03033511|Dexamethasone|dexamethasone|mesh-list
56089714|NCT03033511|Dexamethasone acetate|dexamethasone acetate|mesh-list
56089715|NCT03033511|BB 1101|bb 1101|mesh-list
56089716|NCT03033511|Immunoconjugates|immunoconjugates|mesh-list
56089717|NCT03033511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089718|NCT03033511|Antiemetics|antiemetics|mesh-ancestor
56089719|NCT03033511|Autonomic Agents|autonomic agents|mesh-ancestor
56089720|NCT03033511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089721|NCT03033511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089722|NCT03033511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55901254|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901255|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
55901256|NCT00544414|Leucovorin|leucovorin|mesh-list
55901257|NCT00544414|Gemcitabine|gemcitabine|mesh-list
55901258|NCT00544414|Docetaxel|docetaxel|mesh-list
55901265|NCT00544414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901267|NCT00544414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901268|NCT00544414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901269|NCT00544414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901272|NCT00544414|Tubulin Modulators|tubulin modulators|mesh-ancestor
55901273|NCT00544414|Antimitotic Agents|antimitotic agents|mesh-ancestor
55901274|NCT00544414|Mitosis Modulators|mitosis modulators|mesh-ancestor
55901275|NCT00544414|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55901276|NCT00544414|Antidotes|antidotes|mesh-ancestor
55901277|NCT00544414|Protective Agents|protective agents|mesh-ancestor
55901278|NCT00544414|Vitamin B Complex|vitamin b complex|mesh-ancestor
55901279|NCT00544414|Vitamins|vitamins|mesh-ancestor
55901280|NCT00544414|Micronutrients|micronutrients|mesh-ancestor
55901281|NCT02448862|Fentanyl|fentanyl|mesh-list
55901282|NCT02448862|Analgesics|analgesics|mesh-list
55901283|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56089724|NCT03033511|Hormones|hormones|mesh-ancestor
56089725|NCT03033511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089726|NCT03033511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089727|NCT03033511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089728|NCT03033511|Protease Inhibitors|protease inhibitors|mesh-ancestor
56089729|NCT03033511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089730|NCT03033511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089731|NCT03033511|Immunologic Factors|immunologic factors|mesh-ancestor
56089732|NCT02951312|Glycopyrrolate|glycopyrrolate|mesh-list
56089733|NCT02951312|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56089734|NCT02951312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56089735|NCT02951312|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56089736|NCT02951312|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56089737|NCT02951312|Cholinergic Agents|cholinergic agents|mesh-ancestor
56089738|NCT02951312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089739|NCT02951312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089740|NCT02951312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089781|NCT02802241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089782|NCT02802241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089783|NCT02802241|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56089784|NCT02802241|Parasympatholytics|parasympatholytics|mesh-ancestor
56089785|NCT03035708|Varenicline|varenicline|mesh-list
56089786|NCT03035708|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56089787|NCT03035708|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56089788|NCT03035708|Cholinergic Agents|cholinergic agents|mesh-ancestor
56089789|NCT03035708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901284|NCT02448862|Narcotics|narcotics|mesh-ancestor
55901285|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901286|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901287|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
55901288|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901289|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55901290|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55901291|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
55901292|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
55901293|NCT01697267|Rituximab|rituximab|mesh-list
55901294|NCT01697267|Azathioprine|azathioprine|mesh-list
55901295|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55901296|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901297|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
55901298|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901299|NCT01697267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55901300|NCT01697267|Antimetabolites|antimetabolites|mesh-ancestor
55901301|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901302|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55901303|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901304|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
55901305|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55901306|NCT00362986|Protective Agents|protective agents|mesh-ancestor
55901307|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901308|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
55901309|NCT00363376|Zonisamide|zonisamide|mesh-list
55901310|NCT00363376|Olanzapine|olanzapine|mesh-list
55901311|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
55901312|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
55901313|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901314|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901315|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55901316|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55901317|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55901318|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901319|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55901320|NCT00363376|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55901321|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55901322|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901323|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901324|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901325|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
55901326|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
55901327|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56089790|NCT03035708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089791|NCT03035708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089792|NCT00374426|Sertraline|sertraline|mesh-list
56089793|NCT00374426|Antidepressive Agents|antidepressive agents|mesh-ancestor
56089794|NCT00374426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56089795|NCT00374426|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56089796|NCT00374426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56089797|NCT00374426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56089798|NCT00374426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089799|NCT00374426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089800|NCT00374426|Serotonin Agents|serotonin agents|mesh-ancestor
56089801|NCT00374426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089802|NCT02916745|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56089803|NCT02916745|Trioxsalen|trioxsalen|mesh-list
56089804|NCT02916745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089805|NCT02916745|Dermatologic Agents|dermatologic agents|mesh-ancestor
56089806|NCT02916745|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56089807|NCT02954198|Mycophenolic Acid|mycophenolic acid|mesh-list
56089808|NCT02954198|Prednisone|prednisone|mesh-list
56089809|NCT02954198|Methylprednisolone|methylprednisolone|mesh-list
56089810|NCT02954198|Everolimus|everolimus|mesh-list
56089811|NCT02954198|Tacrolimus|tacrolimus|mesh-list
56089812|NCT02954198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089841|NCT02956070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089842|NCT02956070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089843|NCT02956070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56089844|NCT02956070|Glucocorticoids|glucocorticoids|mesh-ancestor
56089845|NCT02956070|Hormones|hormones|mesh-ancestor
56089846|NCT02956070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089847|NCT02956070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089848|NCT02956070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089849|NCT02956070|Protease Inhibitors|protease inhibitors|mesh-ancestor
56089850|NCT02956070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089857|NCT02956616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089858|NCT02956616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089860|NCT02956616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56089861|NCT02956616|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56089862|NCT02956616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089863|NCT02956616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089864|NCT02958956|Pioglitazone|pioglitazone|mesh-list
56089865|NCT02958956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56089866|NCT02958956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089867|NCT02834624|Poractant alfa|poractant alfa|mesh-list
56089868|NCT02834624|Calfactant|calfactant|mesh-list
56089869|NCT02834624|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
56089870|NCT02834624|Respiratory System Agents|respiratory system agents|mesh-ancestor
56089871|NCT02837744|Hemostatics|hemostatics|mesh-list
56089872|NCT02837744|Coagulants|coagulants|mesh-ancestor
56089883|NCT03041636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089884|NCT03041636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089885|NCT03043105|Thalidomide|thalidomide|mesh-list
56089886|NCT03043105|Prednisone|prednisone|mesh-list
56089887|NCT03043105|Cyclophosphamide|cyclophosphamide|mesh-list
56089888|NCT03043105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56089889|NCT03043105|Immunologic Factors|immunologic factors|mesh-ancestor
56089890|NCT03043105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089891|NCT03043105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55901328|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55901329|NCT02451202|Rocuronium|rocuronium|mesh-list
55901330|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55901331|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55901332|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55901333|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901334|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901335|NCT02452060|Ketamine|ketamine|mesh-list
55901336|NCT02452060|Analgesics|analgesics|mesh-ancestor
55901337|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
55901338|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901339|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901340|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55901341|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55901342|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
55901343|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
55901348|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901350|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55901351|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901352|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
55901353|NCT02452528|Promethazine|promethazine|mesh-list
55901354|NCT02452528|Tenofovir|tenofovir|mesh-list
55901355|NCT02452528|Entecavir|entecavir|mesh-list
55901356|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
55901357|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901358|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55901359|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55901360|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901361|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901362|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55901363|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55901364|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55901365|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55901366|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901367|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901368|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
55901369|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
55901370|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
55901371|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901372|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
55901373|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
55901374|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56089892|NCT03043105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56089893|NCT03043105|Alkylating Agents|alkylating agents|mesh-ancestor
56089894|NCT03043105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089895|NCT03043105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089896|NCT03043105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56089897|NCT03043105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56089900|NCT03043105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56089901|NCT03043105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56089902|NCT03043105|Leprostatic Agents|leprostatic agents|mesh-ancestor
56089903|NCT03043105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56089904|NCT03043105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089905|NCT03043105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56089906|NCT03043105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56089907|NCT03043105|Growth Substances|growth substances|mesh-ancestor
56089908|NCT03043105|Growth Inhibitors|growth inhibitors|mesh-ancestor
56089909|NCT00374647|Mycophenolic Acid|mycophenolic acid|mesh-list
56089910|NCT00374647|Sirolimus|sirolimus|mesh-list
56089911|NCT00374647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56089912|NCT00374647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089913|NCT00374647|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56089914|NCT00374647|Antitubercular Agents|antitubercular agents|mesh-ancestor
56089915|NCT00374647|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56089916|NCT00374647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56089917|NCT00374647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56089918|NCT00374647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089919|NCT00374647|Antifungal Agents|antifungal agents|mesh-ancestor
56089920|NCT00374647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56089921|NCT00374647|Immunologic Factors|immunologic factors|mesh-ancestor
56089936|NCT02969876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56089937|NCT02969876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56089938|NCT02969876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56089939|NCT02969876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089940|NCT02969876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089941|NCT02969876|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56089942|NCT02969876|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56089944|NCT02969876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089945|NCT02969876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56089947|NCT02969876|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56089948|NCT02969876|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56089949|NCT02969876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56089950|NCT02969876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56089952|NCT02970032|Calcium heparin|calcium heparin|mesh-list
56089953|NCT02970032|Anticoagulants|anticoagulants|mesh-ancestor
56089954|NCT02970032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56089955|NCT02970032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56089956|NCT02970032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089957|NCT02813551|Torsemide|torsemide|mesh-list
56089958|NCT02813551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56089959|NCT02813551|Diuretics|diuretics|mesh-ancestor
56089960|NCT02813551|Natriuretic Agents|natriuretic agents|mesh-ancestor
56089961|NCT02813551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089962|NCT02813551|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56089963|NCT02813551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56089964|NCT02813551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089965|NCT02817763|Dipyrone|dipyrone|mesh-list
56089966|NCT02817763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56089976|NCT02846792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56089977|NCT02846792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56089978|NCT02846792|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56089979|NCT02846792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56089980|NCT03053401|Anesthetics|anesthetics|mesh-list
56089981|NCT03053401|Anesthetics, Local|anesthetics, local|mesh-list
56089983|NCT03053401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089984|NCT03053401|Sensory System Agents|sensory system agents|mesh-ancestor
56089985|NCT03053401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089986|NCT03054103|Midazolam|midazolam|mesh-list
56089987|NCT03054103|Ketamine|ketamine|mesh-list
56089988|NCT03054103|Analgesics|analgesics|mesh-ancestor
56089989|NCT03054103|Sensory System Agents|sensory system agents|mesh-ancestor
56089990|NCT03054103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56089991|NCT03054103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56089992|NCT03054103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56089993|NCT03054103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56089994|NCT03054103|Anesthetics, General|anesthetics, general|mesh-ancestor
56089995|NCT03054103|Anesthetics|anesthetics|mesh-ancestor
56089996|NCT03054103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56089997|NCT03054103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56089998|NCT03054103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56089999|NCT03054103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090000|NCT03054103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090001|NCT03054103|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56090002|NCT03054103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56090003|NCT03054103|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56090004|NCT03054103|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56090005|NCT03054103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56090006|NCT03054103|GABA Modulators|gaba modulators|mesh-ancestor
56090007|NCT03054103|GABA Agents|gaba agents|mesh-ancestor
56090008|NCT03043274|Cangrelor|cangrelor|mesh-list
55901375|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55901376|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
55901377|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
55901378|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901379|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55901380|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
55901381|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
56090009|NCT03043274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56090010|NCT03043274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56090011|NCT03043274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56090012|NCT03043274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56090013|NCT03043274|Purinergic Agents|purinergic agents|mesh-ancestor
56090014|NCT03043274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090015|NCT03043274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090016|NCT03043274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090017|NCT03054805|Magnesium Oxide|magnesium oxide|mesh-list
56090018|NCT03054805|Antacids|antacids|mesh-ancestor
56090019|NCT03054805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090021|NCT00374101|Omeprazole|omeprazole|mesh-list
56090022|NCT00374101|Pantoprazole|pantoprazole|mesh-list
56090023|NCT00374101|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56090024|NCT00374101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090025|NCT00374101|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56090026|NCT00374101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090027|NCT00374101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090028|NCT00373789|Botulinum Toxins|botulinum toxins|mesh-list
56090029|NCT00373789|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56090030|NCT00373789|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56090031|NCT00373789|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56090032|NCT00373789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56090033|NCT00373789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090034|NCT00373789|Cholinergic Agents|cholinergic agents|mesh-ancestor
56090035|NCT00373789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090036|NCT00373789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090037|NCT00373789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56090038|NCT00373789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090039|NCT04736953|Sirolimus|sirolimus|mesh-list
56090040|NCT04736953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56090041|NCT04736953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901382|NCT02702388|Lenvatinib|lenvatinib|mesh-list
56090047|NCT04736953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090048|NCT03062605|Povidone-Iodine|povidone-iodine|mesh-list
56090049|NCT03062605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56090050|NCT03062605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090051|NCT02931253|Metformin|metformin|mesh-list
56090052|NCT02931253|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56090053|NCT02931253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090054|NCT03050294|Desoximetasone|desoximetasone|mesh-list
56090055|NCT03050294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090056|NCT03050294|Glucocorticoids|glucocorticoids|mesh-ancestor
56090057|NCT03050294|Hormones|hormones|mesh-ancestor
56090058|NCT03050294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090059|NCT03050294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090060|NCT02831569|Loxoprofen|loxoprofen|mesh-list
56090061|NCT02831569|Methocarbamol|methocarbamol|mesh-list
56090062|NCT02831569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56090063|NCT02831569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56090064|NCT02831569|Analgesics|analgesics|mesh-ancestor
56090065|NCT02831569|Sensory System Agents|sensory system agents|mesh-ancestor
56090066|NCT02831569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090067|NCT02831569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090068|NCT02831569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090069|NCT02831569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56090070|NCT02831569|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56090071|NCT02831569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56090072|NCT03065179|Nivolumab|nivolumab|mesh-list
56090073|NCT03065179|Ipilimumab|ipilimumab|mesh-list
56090074|NCT03065179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56090075|NCT03065179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090076|NCT03065179|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56090077|NCT03065179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090078|NCT02988050|Lidocaine|lidocaine|mesh-list
56090082|NCT02988050|Bupivacaine|bupivacaine|mesh-list
56090083|NCT02988050|Propofol|propofol|mesh-list
56090084|NCT02988050|Anesthetics, Local|anesthetics, local|mesh-ancestor
56090085|NCT02988050|Anesthetics|anesthetics|mesh-ancestor
56090086|NCT02988050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090087|NCT02988050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090088|NCT02988050|Sensory System Agents|sensory system agents|mesh-ancestor
56090089|NCT02988050|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090090|NCT02988050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56090091|NCT02988050|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56090092|NCT02988050|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56090093|NCT02988050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56090094|NCT02988050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090095|NCT02988050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56090096|NCT02988050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56090097|NCT02988050|Anesthetics, General|anesthetics, general|mesh-ancestor
56090098|NCT02988050|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56090099|NCT02988050|Analgesics|analgesics|mesh-ancestor
56090100|NCT02988050|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56090101|NCT02988050|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56090102|NCT02988050|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56090103|NCT02988050|Adrenergic Agents|adrenergic agents|mesh-ancestor
56090104|NCT02988050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090105|NCT02988050|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56090106|NCT02988050|Narcotics|narcotics|mesh-ancestor
56090107|NCT02988050|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56090108|NCT02988050|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56090109|NCT02988050|Autonomic Agents|autonomic agents|mesh-ancestor
56090110|NCT02988050|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56090111|NCT02988050|Respiratory System Agents|respiratory system agents|mesh-ancestor
56090112|NCT02988050|Mydriatics|mydriatics|mesh-ancestor
56090113|NCT02988050|Sympathomimetics|sympathomimetics|mesh-ancestor
55901383|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901384|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55901385|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901386|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901388|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
55901389|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55901390|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55901391|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901392|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090114|NCT02988050|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56090115|NCT02988986|Tamoxifen|tamoxifen|mesh-list
56090116|NCT02988986|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55817330|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090117|NCT02988986|Hormone Antagonists|hormone antagonists|mesh-ancestor
56090118|NCT02988986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090119|NCT02988986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090120|NCT02988986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56090121|NCT02988986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090122|NCT02988986|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56090123|NCT02988986|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56090124|NCT02988986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56090126|NCT02832115|Nitroglycerin|nitroglycerin|mesh-list
56090127|NCT02832115|Anesthetics, Local|anesthetics, local|mesh-list
56090128|NCT02832115|Anesthetics|anesthetics|mesh-list
56090129|NCT02832115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090130|NCT02832115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090131|NCT02832115|Sensory System Agents|sensory system agents|mesh-ancestor
56090412|NCT03121820|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56090132|NCT02832115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090133|NCT02832115|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56090134|NCT02832115|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56090135|NCT02832115|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56090136|NCT02832115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56090137|NCT02832115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090138|NCT02832115|Vasodilator Agents|vasodilator agents|mesh-ancestor
56090139|NCT03054506|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
56090140|NCT03054506|Laxatives|laxatives|mesh-ancestor
56090159|NCT02935699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090160|NCT02935699|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56090161|NCT02935699|Antipruritics|antipruritics|mesh-ancestor
56090162|NCT02935699|Dermatologic Agents|dermatologic agents|mesh-ancestor
56090163|NCT02936479|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56090164|NCT02936479|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56090165|NCT02936479|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56090166|NCT02936479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56090167|NCT02936479|Immunologic Factors|immunologic factors|mesh-ancestor
56090168|NCT02936479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090169|NCT02841241|Esmolol|esmolol|mesh-list
56090170|NCT02841241|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56090171|NCT02841241|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56090172|NCT02841241|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56090173|NCT02841241|Adrenergic Agents|adrenergic agents|mesh-ancestor
56090174|NCT02841241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090175|NCT02841241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090176|NCT02841241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090177|NCT00374881|Phenylephrine|phenylephrine|mesh-list
56090178|NCT00374881|Oxymetazoline|oxymetazoline|mesh-list
56090179|NCT00374881|Morphine|morphine|mesh-list
56090212|NCT02846233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56090213|NCT02846233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090214|NCT02846233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090215|NCT02846233|Incretins|incretins|mesh-ancestor
56090216|NCT02846233|Hormones|hormones|mesh-ancestor
56090217|NCT02846233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090218|NCT02865590|Cimetidine|cimetidine|mesh-list
56090219|NCT02865590|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56090220|NCT02865590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090221|NCT02865590|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56090222|NCT02865590|Histamine Antagonists|histamine antagonists|mesh-ancestor
56090223|NCT02865590|Histamine Agents|histamine agents|mesh-ancestor
56090224|NCT02865590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090225|NCT02865590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090226|NCT02865590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090227|NCT02865590|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56090228|NCT02865590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56090229|NCT02865590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090230|NCT02868242|Sofosbuvir|sofosbuvir|mesh-list
56090231|NCT02868242|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
56090232|NCT02868242|Ledipasvir|ledipasvir|mesh-list
56090233|NCT02868242|Antiviral Agents|antiviral agents|mesh-ancestor
56090234|NCT02868242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090236|NCT03075553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56090237|NCT03075553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090240|NCT03054740|Ethyl Chloride|ethyl chloride|mesh-list
56090258|NCT02997722|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56090259|NCT02997722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090260|NCT02997722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090261|NCT03108482|Celecoxib|celecoxib|mesh-list
56090262|NCT03108482|Tramadol|tramadol|mesh-list
56090263|NCT03108482|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56090264|NCT03108482|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56090265|NCT03108482|Analgesics|analgesics|mesh-ancestor
56090266|NCT03108482|Sensory System Agents|sensory system agents|mesh-ancestor
56090267|NCT03108482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090268|NCT03108482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090269|NCT03108482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090270|NCT03108482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56090271|NCT03108482|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56090272|NCT03108482|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56090273|NCT03108482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090413|NCT03121820|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56090274|NCT03108482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090275|NCT03108482|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56090276|NCT03108482|Narcotics|narcotics|mesh-ancestor
56090277|NCT03108482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090278|NCT02850601|Dexamethasone|dexamethasone|mesh-list
56090279|NCT02850601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090280|NCT02850601|Antiemetics|antiemetics|mesh-ancestor
56090281|NCT02850601|Autonomic Agents|autonomic agents|mesh-ancestor
56090282|NCT02850601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090306|NCT02874092|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56090307|NCT02874092|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56090308|NCT02874092|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56090309|NCT02874092|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56090311|NCT02874092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090312|NCT02874092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090313|NCT02874092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090314|NCT02876900|Asenapine|asenapine|mesh-list
56090315|NCT02876900|Maleic acid|maleic acid|mesh-list
56090316|NCT02876900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090317|NCT02876900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090318|NCT02876900|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56090319|NCT02876900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56090320|NCT02876900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090321|NCT02876900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090322|NCT02876900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56090323|NCT02878382|Calcipotriene|calcipotriene|mesh-list
56090324|NCT02878382|Dermatologic Agents|dermatologic agents|mesh-ancestor
56090325|NCT03117140|Dexamethasone|dexamethasone|mesh-list
56090326|NCT03117140|Clonidine|clonidine|mesh-list
56090327|NCT03117140|Buprenorphine|buprenorphine|mesh-list
56090328|NCT03117140|Ropivacaine|ropivacaine|mesh-list
56090329|NCT03117140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090330|NCT03117140|Antiemetics|antiemetics|mesh-ancestor
56090331|NCT03117140|Autonomic Agents|autonomic agents|mesh-ancestor
56090332|NCT03117140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090333|NCT03117140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090334|NCT03117140|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090335|NCT03117140|Glucocorticoids|glucocorticoids|mesh-ancestor
56090336|NCT03117140|Hormones|hormones|mesh-ancestor
56090337|NCT03117140|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090338|NCT03117140|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56090339|NCT03117140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090345|NCT03117140|Narcotics|narcotics|mesh-ancestor
56090346|NCT03117140|Analgesics|analgesics|mesh-ancestor
56090347|NCT03117140|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56090348|NCT03117140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56090349|NCT03117140|Sympatholytics|sympatholytics|mesh-ancestor
56090350|NCT03117140|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56090351|NCT03117140|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56090352|NCT03117140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56090353|NCT03117140|Adrenergic Agents|adrenergic agents|mesh-ancestor
56090354|NCT03117140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090355|NCT03117140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090356|NCT03118466|Cytarabine|cytarabine|mesh-list
56090357|NCT03118466|Etoposide|etoposide|mesh-list
56090358|NCT03118466|Mitoxantrone|mitoxantrone|mesh-list
56090359|NCT03118466|Lenalidomide|lenalidomide|mesh-list
56090360|NCT03118466|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56090361|NCT03118466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090362|NCT03118466|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56090363|NCT03118466|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56090364|NCT03118466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090365|NCT03118466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090367|NCT03118466|Antimetabolites|antimetabolites|mesh-ancestor
56090399|NCT03070730|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56090400|NCT03070730|Adrenergic Agents|adrenergic agents|mesh-ancestor
56090401|NCT03070730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090402|NCT03070730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090403|NCT03070730|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56090404|NCT03070730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56090405|NCT05405270|Imiquimod|imiquimod|mesh-list
56090406|NCT05405270|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56090407|NCT05405270|Immunologic Factors|immunologic factors|mesh-ancestor
56090408|NCT05405270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090409|NCT05405270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090410|NCT05405270|Interferon Inducers|interferon inducers|mesh-ancestor
56090415|NCT03121820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090416|NCT03121820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090417|NCT03121820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090418|NCT03121820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56090419|NCT03121820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56090420|NCT03123614|Loteprednol Etabonate|loteprednol etabonate|mesh-list
56090421|NCT03123614|Prednisolone|prednisolone|mesh-list
56090422|NCT03123614|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56090423|NCT03123614|Methylprednisolone|methylprednisolone|mesh-list
56090424|NCT03123614|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56090425|NCT03123614|Prednisolone acetate|prednisolone acetate|mesh-list
56090426|NCT03123614|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56090427|NCT03123614|Prednisolone phosphate|prednisolone phosphate|mesh-list
56090428|NCT03123614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090429|NCT03123614|Glucocorticoids|glucocorticoids|mesh-ancestor
56090430|NCT03123614|Hormones|hormones|mesh-ancestor
56090431|NCT03123614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090432|NCT03123614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090434|NCT03123614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090437|NCT03123614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090438|NCT03123614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090439|NCT03123614|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56090441|NCT03123614|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56090442|NCT03123848|Darunavir|darunavir|mesh-list
56090443|NCT03123848|Cobicistat|cobicistat|mesh-list
56090444|NCT03123848|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
56090445|NCT03123848|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56090446|NCT03123848|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56090447|NCT03123848|Protease Inhibitors|protease inhibitors|mesh-ancestor
56090448|NCT03123848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090449|NCT03123848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090450|NCT03123848|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56090452|NCT03123848|Antiviral Agents|antiviral agents|mesh-ancestor
56090497|NCT00374894|Chelating Agents|chelating agents|mesh-ancestor
56090498|NCT00374894|Sequestering Agents|sequestering agents|mesh-ancestor
56090499|NCT00374894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090500|NCT03088267|Amphetamine|amphetamine|mesh-list
56090501|NCT03088267|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56090502|NCT03088267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090503|NCT03088267|Sympathomimetics|sympathomimetics|mesh-ancestor
56090504|NCT03088267|Autonomic Agents|autonomic agents|mesh-ancestor
56090505|NCT03088267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090506|NCT03088267|Dopamine Agents|dopamine agents|mesh-ancestor
56090507|NCT03088267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090508|NCT03088267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090509|NCT03088267|Adrenergic Agents|adrenergic agents|mesh-ancestor
56090510|NCT03088267|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56090511|NCT03088267|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56090512|NCT03088267|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56090513|NCT03088267|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56090514|NCT03088345|Vasopressins|vasopressins|mesh-list
56090515|NCT03088345|Arginine Vasopressin|arginine vasopressin|mesh-list
56090516|NCT03088345|Hemostatics|hemostatics|mesh-ancestor
56090517|NCT03088345|Coagulants|coagulants|mesh-ancestor
56090518|NCT03088345|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56090519|NCT03088345|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56090520|NCT03088345|Natriuretic Agents|natriuretic agents|mesh-ancestor
56090521|NCT03088345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090522|NCT03127514|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
56090523|NCT03127514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090524|NCT02858713|Betamethasone|betamethasone|mesh-list
56090525|NCT02858713|Betamethasone Valerate|betamethasone valerate|mesh-list
56090526|NCT02858713|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56090527|NCT02858713|Betamethasone benzoate|betamethasone benzoate|mesh-list
55901394|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55901395|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
55901396|NCT01696877|Molgramostim|molgramostim|mesh-list
55901397|NCT01696877|Sargramostim|sargramostim|mesh-list
55901398|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901399|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
55901400|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090528|NCT02858713|Calcipotriene|calcipotriene|mesh-list
56090529|NCT02858713|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56090530|NCT02858713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090531|NCT02858713|Glucocorticoids|glucocorticoids|mesh-ancestor
56090532|NCT02858713|Hormones|hormones|mesh-ancestor
56090533|NCT02858713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090534|NCT02858713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090535|NCT02858713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56090536|NCT02858713|Respiratory System Agents|respiratory system agents|mesh-ancestor
56090537|NCT02858713|Dermatologic Agents|dermatologic agents|mesh-ancestor
56090538|NCT00375050|Riluzole|riluzole|mesh-list
56090539|NCT00375050|Anticonvulsants|anticonvulsants|mesh-ancestor
56090540|NCT00375050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56090541|NCT00375050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56090542|NCT00375050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090543|NCT00375050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090544|NCT00375050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090545|NCT00375050|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56090546|NCT00375050|Protective Agents|protective agents|mesh-ancestor
56090582|NCT05057858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56090583|NCT05057858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090584|NCT05057858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090585|NCT05057858|Antiviral Agents|antiviral agents|mesh-ancestor
56090586|NCT05057858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090587|NCT05057858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56090588|NCT05057858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56090589|NCT04707092|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56090590|NCT04707092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090591|NCT02953561|Azacitidine|azacitidine|mesh-list
56090593|NCT02953561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56090594|NCT02953561|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56090595|NCT02953561|Antimetabolites|antimetabolites|mesh-ancestor
56090596|NCT02953561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901402|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55901403|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
55901404|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901405|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901406|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55901407|NCT02416102|Losartan|losartan|mesh-list
55901408|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55901409|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55901410|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55901411|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55901412|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090606|NCT03090620|Autonomic Agents|autonomic agents|mesh-ancestor
56090607|NCT03090620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090608|NCT03090620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090609|NCT03090620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090610|NCT03090620|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56090611|NCT03090620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090612|NCT03090620|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56090613|NCT03090620|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56090614|NCT03090620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56090615|NCT03090620|GABA Modulators|gaba modulators|mesh-ancestor
56090616|NCT03090620|GABA Agents|gaba agents|mesh-ancestor
56090617|NCT03090620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090618|NCT03090620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090619|NCT03090620|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56090620|NCT03090620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090621|NCT03090620|Cholinergic Agents|cholinergic agents|mesh-ancestor
56090622|NCT03090620|Miotics|miotics|mesh-ancestor
56090623|NCT02953873|Mycophenolic Acid|mycophenolic acid|mesh-list
56090624|NCT02953873|Prednisone|prednisone|mesh-list
56090625|NCT02953873|Methylprednisolone|methylprednisolone|mesh-list
56090626|NCT02953873|Tacrolimus|tacrolimus|mesh-list
56090627|NCT02953873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090628|NCT02953873|Glucocorticoids|glucocorticoids|mesh-ancestor
56090629|NCT02953873|Hormones|hormones|mesh-ancestor
56090630|NCT02953873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090631|NCT02953873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090632|NCT02953873|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56090635|NCT02953873|Immunologic Factors|immunologic factors|mesh-ancestor
56090651|NCT03091478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56090652|NCT03091478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090653|NCT02867605|Hyaluronic Acid|hyaluronic acid|mesh-list
56090654|NCT02867605|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56090655|NCT02867605|Immunologic Factors|immunologic factors|mesh-ancestor
56090656|NCT02867605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090663|NCT00375596|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56090664|NCT00375596|Histamine Antagonists|histamine antagonists|mesh-ancestor
56090665|NCT00375596|Histamine Agents|histamine agents|mesh-ancestor
56090666|NCT00375596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090667|NCT00375596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090668|NCT00375596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090669|NCT00375596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56090670|NCT03093272|Prednisone|prednisone|mesh-list
56090671|NCT03093272|Docetaxel|docetaxel|mesh-list
56090672|NCT03093272|Leuprolide|leuprolide|mesh-list
56090673|NCT03093272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090674|NCT03093272|Tubulin Modulators|tubulin modulators|mesh-ancestor
56090675|NCT03093272|Antimitotic Agents|antimitotic agents|mesh-ancestor
56090676|NCT03093272|Mitosis Modulators|mitosis modulators|mesh-ancestor
56090677|NCT03093272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090678|NCT03093272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090679|NCT03093272|Glucocorticoids|glucocorticoids|mesh-ancestor
56090680|NCT03093272|Hormones|hormones|mesh-ancestor
56090681|NCT03093272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090682|NCT03093272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090683|NCT03093272|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56090684|NCT03093272|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56090685|NCT03093272|Fertility Agents|fertility agents|mesh-ancestor
56090686|NCT03093272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56090687|NCT03100123|Aspirin|aspirin|mesh-list
56090688|NCT03100123|Heparin|heparin|mesh-list
56090690|NCT03100123|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56090691|NCT03100123|Tinzaparin|tinzaparin|mesh-list
56090692|NCT03100123|Dalteparin|dalteparin|mesh-list
56090693|NCT03100123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56090694|NCT03100123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56090695|NCT03100123|Analgesics|analgesics|mesh-ancestor
56090696|NCT03100123|Sensory System Agents|sensory system agents|mesh-ancestor
56090697|NCT03100123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090698|NCT03100123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090699|NCT03100123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090700|NCT03100123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56090701|NCT03100123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56090702|NCT03100123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56090703|NCT03100123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090704|NCT03100123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56090705|NCT03100123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56090707|NCT03100123|Antipyretics|antipyretics|mesh-ancestor
56090708|NCT03100123|Anticoagulants|anticoagulants|mesh-ancestor
56090709|NCT02957305|Misoprostol|misoprostol|mesh-list
56090711|NCT02957305|Abortifacient Agents|abortifacient agents|mesh-ancestor
56090712|NCT02957305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56090745|NCT03098420|Morphine|morphine|mesh-list
56090746|NCT03098420|Bupivacaine|bupivacaine|mesh-list
56090747|NCT03098420|Ropivacaine|ropivacaine|mesh-list
56090748|NCT03098420|BB 1101|bb 1101|mesh-list
56090749|NCT03098420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090750|NCT03098420|Antiemetics|antiemetics|mesh-ancestor
56090751|NCT03098420|Autonomic Agents|autonomic agents|mesh-ancestor
56090752|NCT03098420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090753|NCT03098420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090754|NCT03098420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090755|NCT03098420|Glucocorticoids|glucocorticoids|mesh-ancestor
56090756|NCT03098420|Hormones|hormones|mesh-ancestor
56090757|NCT03098420|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090758|NCT03098420|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56090759|NCT03098420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090760|NCT03098420|Protease Inhibitors|protease inhibitors|mesh-ancestor
56090761|NCT03098420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090762|NCT03098420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090763|NCT03098420|Anesthetics, Local|anesthetics, local|mesh-ancestor
56090764|NCT03098420|Anesthetics|anesthetics|mesh-ancestor
56090765|NCT03098420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090766|NCT03098420|Sensory System Agents|sensory system agents|mesh-ancestor
56090767|NCT03098420|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56090768|NCT03098420|Narcotics|narcotics|mesh-ancestor
56090769|NCT03098420|Analgesics|analgesics|mesh-ancestor
56090770|NCT02878057|Apatinib|apatinib|mesh-list
56090771|NCT02878057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090794|NCT04468568|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56090795|NCT04468568|Respiratory System Agents|respiratory system agents|mesh-ancestor
56090796|NCT04468568|Sympathomimetics|sympathomimetics|mesh-ancestor
56090797|NCT04468568|Tocolytic Agents|tocolytic agents|mesh-ancestor
56090798|NCT04468568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56090799|NCT04468568|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56090800|NCT04468568|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56090801|NCT04468568|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56090802|NCT04468568|Adrenergic Agents|adrenergic agents|mesh-ancestor
56090803|NCT04468568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090804|NCT04468568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090805|NCT04468568|Hormone Antagonists|hormone antagonists|mesh-ancestor
56090806|NCT04468568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090807|NCT04393454|Sirolimus|sirolimus|mesh-list
56090808|NCT04393454|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56090809|NCT04393454|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090810|NCT04393454|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56090811|NCT04393454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090812|NCT04393454|Antifungal Agents|antifungal agents|mesh-ancestor
56090813|NCT04393454|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56090814|NCT04393454|Immunologic Factors|immunologic factors|mesh-ancestor
56090815|NCT04393454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090816|NCT03168308|Glycopyrrolate|glycopyrrolate|mesh-list
56090846|NCT03115177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56090847|NCT03174158|Nicotine|nicotine|mesh-list
56090848|NCT03174158|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56090849|NCT03174158|Autonomic Agents|autonomic agents|mesh-ancestor
56090850|NCT03174158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56090851|NCT03174158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090854|NCT03174158|Cholinergic Agents|cholinergic agents|mesh-ancestor
56090855|NCT03174158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090856|NCT03174158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090857|NCT03115801|Pembrolizumab|pembrolizumab|mesh-list
56090858|NCT03115801|Nivolumab|nivolumab|mesh-list
56090859|NCT03115801|Atezolizumab|atezolizumab|mesh-list
56090860|NCT03115801|Immunologic Factors|immunologic factors|mesh-list
56090861|NCT03115801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56090862|NCT03115801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090863|NCT03115801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56090864|NCT03115801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090865|NCT03115801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090866|NCT00422708|Anesthetics|anesthetics|mesh-list
56090867|NCT00422708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56090868|NCT00422708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090869|NCT05405257|Oxytocin|oxytocin|mesh-list
56090870|NCT05405257|Oxytocics|oxytocics|mesh-ancestor
56090871|NCT05405257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56090872|NCT05405257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090873|NCT03117517|Metformin|metformin|mesh-list
55818072|NCT02092467|Analgesics|analgesics|mesh-ancestor
56090874|NCT03117517|Pioglitazone|pioglitazone|mesh-list
56090875|NCT03117517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56090876|NCT03117517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090877|NCT00375284|Pramipexole|pramipexole|mesh-list
56090878|NCT00375284|Antioxidants|antioxidants|mesh-ancestor
55901415|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901417|NCT02458690|Norepinephrine|norepinephrine|mesh-list
55901418|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
55901419|NCT02458690|Serotonin|serotonin|mesh-list
55901420|NCT02458690|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55901421|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
55901422|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55901423|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56090879|NCT00375284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090881|NCT00375284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090882|NCT00375284|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56090883|NCT00375284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56090884|NCT00375284|Dopamine Agonists|dopamine agonists|mesh-ancestor
56090885|NCT00375284|Dopamine Agents|dopamine agents|mesh-ancestor
56090886|NCT00375284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090887|NCT02966275|Glucagon|glucagon|mesh-list
56090888|NCT02966275|Pancrelipase|pancrelipase|mesh-list
56090889|NCT02966275|Pancreatin|pancreatin|mesh-list
56090890|NCT02966275|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56090891|NCT02966275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56090892|NCT02966275|Hormones|hormones|mesh-ancestor
56090893|NCT02966275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090894|NCT02966275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090895|NCT02966275|Incretins|incretins|mesh-ancestor
56090896|NCT04122170|Aspirin|aspirin|mesh-list
56090897|NCT04122170|Ticagrelor|ticagrelor|mesh-list
56090898|NCT04122170|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56090899|NCT04122170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56090900|NCT04122170|Analgesics|analgesics|mesh-ancestor
56090933|NCT03795350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090935|NCT03795350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56090936|NCT03795350|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56090937|NCT03795350|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56090938|NCT03795350|Cholinergic Agents|cholinergic agents|mesh-ancestor
56090939|NCT03795350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56090940|NCT03795350|Glucocorticoids|glucocorticoids|mesh-ancestor
55901427|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901428|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
55901429|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
55901430|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901431|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55901432|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55901433|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55901434|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
55901435|NCT02458690|Protective Agents|protective agents|mesh-ancestor
55901436|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55901437|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
55901438|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55901439|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901440|NCT02458768|Menotropins|menotropins|mesh-list
55901441|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55901442|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
55901443|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55901444|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901445|NCT02418676|Insulin|insulin|mesh-list
55901446|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55901447|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901448|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55901449|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
55901450|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901451|NCT02419638|Immunologic Factors|immunologic factors|mesh-ancestor
55901452|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901453|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
55901454|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55901455|NCT02422836|Protective Agents|protective agents|mesh-ancestor
55901456|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901457|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
55901458|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
55901459|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55901462|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
55901463|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901464|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901465|NCT02423980|Glucagon|glucagon|mesh-list
55901466|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56090944|NCT03118843|Antiviral Agents|antiviral agents|mesh-ancestor
56090945|NCT03118843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090947|NCT03624062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56090948|NCT03624062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090949|NCT05364866|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56090950|NCT02222922|Fluconazole|fluconazole|mesh-list
56090951|NCT02222922|Avelumab|avelumab|mesh-list
56090952|NCT02222922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56090953|NCT02222922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56090954|NCT02222922|Antifungal Agents|antifungal agents|mesh-ancestor
56090955|NCT02222922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56090956|NCT02222922|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56090957|NCT02222922|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56090958|NCT02222922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56090959|NCT02222922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090960|NCT02222922|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56090961|NCT02222922|Hormone Antagonists|hormone antagonists|mesh-ancestor
56090962|NCT02222922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56090963|NCT02222922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56090964|NCT02222922|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56090965|NCT02222922|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56090994|NCT02161146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56090995|NCT02161146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56090997|NCT03447782|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56090998|NCT03447782|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56090999|NCT03447782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091000|NCT03447782|Sensory System Agents|sensory system agents|mesh-ancestor
56091001|NCT03447782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091002|NCT03123055|Pembrolizumab|pembrolizumab|mesh-list
56091003|NCT03123055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091004|NCT03123055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091005|NCT02969317|Tiotropium Bromide|tiotropium bromide|mesh-list
56091006|NCT02969317|Olodaterol|olodaterol|mesh-list
56091007|NCT02969317|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56091008|NCT02969317|Autonomic Agents|autonomic agents|mesh-ancestor
56091009|NCT02969317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091010|NCT02969317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091011|NCT02969317|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56091012|NCT02969317|Respiratory System Agents|respiratory system agents|mesh-ancestor
56091013|NCT02969317|Parasympatholytics|parasympatholytics|mesh-ancestor
56091014|NCT02969317|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56091015|NCT02969317|Cholinergic Agents|cholinergic agents|mesh-ancestor
56091016|NCT02969317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091017|NCT02969317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091018|NCT00375362|Nitroglycerin|nitroglycerin|mesh-list
56091019|NCT00375362|Vasodilator Agents|vasodilator agents|mesh-ancestor
56091020|NCT05347082|Cholecalciferol|cholecalciferol|mesh-list
56091021|NCT05347082|Vitamin D|vitamin d|mesh-list
56091022|NCT05347082|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56091023|NCT05347082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091024|NCT05347082|Vitamins|vitamins|mesh-ancestor
56091038|NCT03087578|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56091039|NCT03087578|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56091040|NCT03087578|Adrenergic Agents|adrenergic agents|mesh-ancestor
56091041|NCT03087578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091042|NCT03087578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091043|NCT03087578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091044|NCT03087578|Urological Agents|urological agents|mesh-ancestor
56091045|NCT02807558|Azacitidine|azacitidine|mesh-list
56091046|NCT02807558|Daratumumab|daratumumab|mesh-list
56091047|NCT02807558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56091048|NCT02807558|Antimetabolites|antimetabolites|mesh-ancestor
56091049|NCT02807558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091050|NCT02807558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091051|NCT02807558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091052|NCT05324384|Sirolimus|sirolimus|mesh-list
56091053|NCT05324384|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56091054|NCT05324384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091055|NCT05324384|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56091056|NCT05324384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091057|NCT05324384|Antifungal Agents|antifungal agents|mesh-ancestor
56091058|NCT05324384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56091088|NCT03132571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091089|NCT03132571|Sensory System Agents|sensory system agents|mesh-ancestor
56091090|NCT03132571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091091|NCT03132571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56091092|NCT03132571|Antidepressive Agents|antidepressive agents|mesh-ancestor
56091093|NCT03132571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56091094|NCT03132571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56091095|NCT03132571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56091096|NCT03132571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901467|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55901468|NCT02423980|Hormones|hormones|mesh-ancestor
55901469|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55901470|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901471|NCT02423980|Incretins|incretins|mesh-ancestor
55901472|NCT03176316|Naloxone|naloxone|mesh-list
55901473|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55901474|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901475|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
55901476|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901477|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
55901478|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901479|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
55901480|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901481|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55901482|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55901483|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
55901484|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901485|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901486|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55901487|NCT02974426|Cisplatin|cisplatin|mesh-list
55901488|NCT02974426|Carboplatin|carboplatin|mesh-list
55901495|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55901496|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55901497|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
55901498|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
55901499|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
55901500|NCT02413554|Rivastigmine|rivastigmine|mesh-list
55901501|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55901502|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901503|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901504|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
55901505|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901506|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901507|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55901508|NCT02413554|Protective Agents|protective agents|mesh-ancestor
56091097|NCT03132571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091099|NCT03132571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091100|NCT03132571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56091101|NCT03132571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56091102|NCT03132571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091104|NCT05267054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091105|NCT05267054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091106|NCT05267054|Immunologic Factors|immunologic factors|mesh-ancestor
56091107|NCT05267054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091108|NCT05267054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56091109|NCT02374424|Obinutuzumab|obinutuzumab|mesh-list
56091110|NCT02374424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091111|NCT02374424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091112|NCT04964089|Aflibercept|aflibercept|mesh-list
56091113|NCT04964089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56091114|NCT04964089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56091115|NCT04964089|Growth Substances|growth substances|mesh-ancestor
56091116|NCT04964089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091117|NCT04964089|Growth Inhibitors|growth inhibitors|mesh-ancestor
56091118|NCT04964089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091119|NCT02002130|Aluminum sulfate|aluminum sulfate|mesh-list
56091120|NCT02002130|gamma-Aminobutyric Acid|gamma-aminobutyric acid|mesh-list
56091121|NCT02002130|Butyric Acid|butyric acid|mesh-list
56091122|NCT02002130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56091123|NCT02002130|Immunologic Factors|immunologic factors|mesh-ancestor
56091124|NCT02002130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091125|NCT02002130|GABA Agents|gaba agents|mesh-ancestor
56091126|NCT02002130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091127|NCT02002130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091128|NCT02002130|Histamine Antagonists|histamine antagonists|mesh-ancestor
56091129|NCT02002130|Histamine Agents|histamine agents|mesh-ancestor
56091130|NCT01306994|Adenosine|adenosine|mesh-list
56091131|NCT01306994|Analgesics|analgesics|mesh-ancestor
56091139|NCT01306994|Purinergic Agents|purinergic agents|mesh-ancestor
56091140|NCT01306994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091141|NCT01306994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091142|NCT02979301|Tamoxifen|tamoxifen|mesh-list
56091143|NCT02979301|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56091144|NCT02979301|Hormone Antagonists|hormone antagonists|mesh-ancestor
56091145|NCT02979301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56091146|NCT02979301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091147|NCT02979301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56091148|NCT02979301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091149|NCT02979301|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56091150|NCT02979301|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56091151|NCT02979301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56091152|NCT00375440|Tranexamic Acid|tranexamic acid|mesh-list
56091153|NCT00375440|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56091154|NCT00375440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56091155|NCT00375440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091156|NCT00375440|Hemostatics|hemostatics|mesh-ancestor
56091157|NCT00375440|Coagulants|coagulants|mesh-ancestor
56091158|NCT04791943|Melatonin|melatonin|mesh-list
56091159|NCT04791943|Antioxidants|antioxidants|mesh-ancestor
56091160|NCT04791943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091161|NCT04791943|Protective Agents|protective agents|mesh-ancestor
56091162|NCT04791943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091163|NCT04791943|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091164|NCT05113004|Mycophenolic Acid|mycophenolic acid|mesh-list
56091165|NCT05113004|Hydroxychloroquine|hydroxychloroquine|mesh-list
56091166|NCT05113004|Leflunomide|leflunomide|mesh-list
56091167|NCT05113004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56091168|NCT05113004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901509|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
55901510|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55901511|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
55901512|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55901513|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
55901514|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901515|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901516|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
55901517|NCT02465632|Clindamycin|clindamycin|mesh-list
55901518|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
55901519|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
55901520|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55901521|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55901522|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901523|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55901524|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901525|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901526|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
55901528|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55901529|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901530|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901532|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901533|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901534|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55901535|NCT02703636|Protective Agents|protective agents|mesh-ancestor
55901536|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
55901537|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55901538|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55901539|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901540|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
55901541|NCT02422056|Coagulants|coagulants|mesh-ancestor
55901542|NCT02466958|Milnacipran|milnacipran|mesh-list
55901543|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
55901544|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55901545|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55901546|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901547|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901548|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901549|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901550|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
55901551|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55901552|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55901553|NCT02466958|Analgesics|analgesics|mesh-ancestor
55901554|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
55901555|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901556|NCT02467504|Folic Acid|folic acid|mesh-list
55901557|NCT02467504|Loxoprofen|loxoprofen|mesh-list
55901558|NCT02467504|Hematinics|hematinics|mesh-ancestor
55901562|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901563|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55901564|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55901565|NCT02467504|Analgesics|analgesics|mesh-ancestor
55901566|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
55901567|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901568|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55901569|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55901570|NCT02413086|Chitosan|chitosan|mesh-list
55901571|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55901572|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55901574|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901575|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55901576|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
56091169|NCT05113004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56091170|NCT05113004|Antitubercular Agents|antitubercular agents|mesh-ancestor
56091171|NCT05113004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56091172|NCT05113004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091173|NCT05113004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091174|NCT05113004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091176|NCT05113004|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56091179|NCT05113004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56091180|NCT05113004|Immunologic Factors|immunologic factors|mesh-ancestor
56091181|NCT05113004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091182|NCT02983981|Desoximetasone|desoximetasone|mesh-list
56091183|NCT02983981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56091184|NCT02983981|Glucocorticoids|glucocorticoids|mesh-ancestor
56091185|NCT02983981|Hormones|hormones|mesh-ancestor
56091186|NCT02983981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56091187|NCT02983981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091188|NCT00375583|Albendazole|albendazole|mesh-list
56091189|NCT00375583|Anthelmintics|anthelmintics|mesh-ancestor
56091190|NCT00375583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56091200|NCT03143569|Heparin|heparin|mesh-list
56091223|NCT03149887|Sensory System Agents|sensory system agents|mesh-ancestor
56091224|NCT03149887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091225|NCT02988349|Listerine|listerine|mesh-list
56091226|NCT02988349|Sodium Fluoride|sodium fluoride|mesh-list
56091227|NCT02988349|Cariostatic Agents|cariostatic agents|mesh-ancestor
56091228|NCT02988349|Protective Agents|protective agents|mesh-ancestor
56091229|NCT02988349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091230|NCT02988349|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56091231|NCT02988349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091232|NCT02159352|Ritonavir|ritonavir|mesh-list
56091233|NCT02159352|Lopinavir|lopinavir|mesh-list
56091234|NCT02159352|Darunavir|darunavir|mesh-list
56091235|NCT02159352|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56091236|NCT02159352|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56091237|NCT02159352|Protease Inhibitors|protease inhibitors|mesh-ancestor
56091238|NCT02159352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091239|NCT02159352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091240|NCT02159352|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56091241|NCT02159352|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56091242|NCT02159352|Antiviral Agents|antiviral agents|mesh-ancestor
56091243|NCT02159352|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091244|NCT02159352|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56091245|NCT02159352|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56091246|NCT02187744|Carboplatin|carboplatin|mesh-list
56091247|NCT02187744|Docetaxel|docetaxel|mesh-list
56091248|NCT02187744|Trastuzumab|trastuzumab|mesh-list
56091249|NCT02187744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091250|NCT02187744|Tubulin Modulators|tubulin modulators|mesh-ancestor
56091251|NCT02187744|Antimitotic Agents|antimitotic agents|mesh-ancestor
56091252|NCT02187744|Mitosis Modulators|mitosis modulators|mesh-ancestor
56091253|NCT02187744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091254|NCT02187744|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091255|NCT03154333|Diacetylrhein|diacetylrhein|mesh-list
56091256|NCT03154333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56091257|NCT04393441|Lubricant Eye Drops|lubricant eye drops|mesh-list
56091260|NCT02995915|Bupropion|bupropion|mesh-list
56091264|NCT02995915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091265|NCT02995915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091266|NCT02995915|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56091267|NCT02995915|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56091268|NCT02995915|Cholinergic Agents|cholinergic agents|mesh-ancestor
56091269|NCT02995915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091270|NCT02995915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091271|NCT02995915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56091272|NCT02995915|Antidepressive Agents|antidepressive agents|mesh-ancestor
56091273|NCT02995915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56091274|NCT02995915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56091275|NCT02995915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56091276|NCT02995915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56091277|NCT02995915|Dopamine Agents|dopamine agents|mesh-ancestor
56091278|NCT02995915|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56091279|NCT02995915|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56091280|NCT02995915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091282|NCT03163303|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56091283|NCT03163303|Autonomic Agents|autonomic agents|mesh-ancestor
56091284|NCT03163303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091285|NCT03163303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091313|NCT03185546|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56091314|NCT03185546|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56091315|NCT03185546|Cholinergic Agents|cholinergic agents|mesh-ancestor
56091316|NCT03185546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091317|NCT03185546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091318|NCT02186652|Pantoprazole|pantoprazole|mesh-list
56091320|NCT02186652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56091321|NCT02186652|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56091322|NCT02186652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091323|NCT02186652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091324|NCT03606889|Bupivacaine|bupivacaine|mesh-list
56091325|NCT03606889|Anesthetics, Local|anesthetics, local|mesh-ancestor
56091326|NCT03606889|Anesthetics|anesthetics|mesh-ancestor
56091327|NCT03606889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091328|NCT03606889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091329|NCT03606889|Sensory System Agents|sensory system agents|mesh-ancestor
56091330|NCT03606889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091331|NCT05363917|Folic Acid|folic acid|mesh-list
56091332|NCT05363917|Vitamin B Complex|vitamin b complex|mesh-list
56091333|NCT05363917|Hematinics|hematinics|mesh-ancestor
56091334|NCT05363917|Vitamins|vitamins|mesh-ancestor
56091368|NCT04736186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56091369|NCT04736186|Antidotes|antidotes|mesh-ancestor
56091370|NCT04736186|Protective Agents|protective agents|mesh-ancestor
56091371|NCT04736186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091372|NCT03085147|Olaparib|olaparib|mesh-list
56091373|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56091374|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091375|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091376|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091377|NCT04941170|Bupivacaine|bupivacaine|mesh-list
56091378|NCT04941170|Anesthetics, Local|anesthetics, local|mesh-ancestor
56091379|NCT04941170|Anesthetics|anesthetics|mesh-ancestor
56091380|NCT04941170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091381|NCT04941170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091382|NCT04941170|Sensory System Agents|sensory system agents|mesh-ancestor
56091383|NCT04941170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091384|NCT05357911|Digoxin|digoxin|mesh-list
56091385|NCT05357911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56091386|NCT05357911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56091387|NCT05357911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091388|NCT05357911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091389|NCT05357911|Protective Agents|protective agents|mesh-ancestor
56091390|NCT05357911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091391|NCT03374839|Nivolumab|nivolumab|mesh-list
56091392|NCT03374839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091416|NCT02221674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091417|NCT02221674|Analgesics|analgesics|mesh-ancestor
56091418|NCT02221674|Sensory System Agents|sensory system agents|mesh-ancestor
56091419|NCT02221674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091420|NCT02221674|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56091421|NCT02221674|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56091422|NCT02221674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56091423|NCT02221674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091424|NCT02221674|Adrenergic Agents|adrenergic agents|mesh-ancestor
56091425|NCT02221674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091426|NCT04736719|Warfarin|warfarin|mesh-list
56091427|NCT04736719|Apixaban|apixaban|mesh-list
56091428|NCT04736719|Anticoagulants|anticoagulants|mesh-ancestor
56091429|NCT04736719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56091430|NCT04736719|Antithrombins|antithrombins|mesh-ancestor
56091431|NCT04736719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56091432|NCT04736719|Protease Inhibitors|protease inhibitors|mesh-ancestor
56091433|NCT04736719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091434|NCT04736719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091435|NCT02221284|Alogliptin|alogliptin|mesh-list
55741560|NCT03123445|Endostatins|endostatins|mesh-list
56091436|NCT02221284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56091437|NCT02221284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091438|NCT02221284|Incretins|incretins|mesh-ancestor
56091439|NCT02221284|Hormones|hormones|mesh-ancestor
56091441|NCT02221284|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56091463|NCT04736108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091464|NCT04736108|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56091465|NCT04736108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091466|NCT04736108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091467|NCT04736108|Hormone Antagonists|hormone antagonists|mesh-ancestor
56091468|NCT04736108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56091469|NCT04736329|Telmisartan|telmisartan|mesh-list
56091470|NCT04736329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56091471|NCT04736329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56091618|NCT02076217|Copper|copper|mesh-list
56091472|NCT04736329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56091473|NCT04736329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091474|NCT02971033|Ezetimibe|ezetimibe|mesh-list
56091475|NCT02971033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56091476|NCT02971033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56091477|NCT02971033|Antimetabolites|antimetabolites|mesh-ancestor
56091478|NCT02971033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091479|NCT02971033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56091480|NCT05406674|Cisplatin|cisplatin|mesh-list
56091481|NCT05406674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091482|NCT05341375|Anesthetics|anesthetics|mesh-list
56091483|NCT05341375|Esketamine|esketamine|mesh-list
56091484|NCT05341375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091485|NCT05341375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091486|NCT05341375|Antidepressive Agents|antidepressive agents|mesh-ancestor
56091487|NCT05341375|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56091488|NCT03196232|Pembrolizumab|pembrolizumab|mesh-list
56091489|NCT03196232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091490|NCT03196232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091491|NCT04356716|Sildenafil Citrate|sildenafil citrate|mesh-list
56091492|NCT04356716|Vasodilator Agents|vasodilator agents|mesh-ancestor
56091498|NCT03200587|Avelumab|avelumab|mesh-list
56091506|NCT03198884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091507|NCT03198884|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56091508|NCT03198884|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56091509|NCT03198884|Antiviral Agents|antiviral agents|mesh-ancestor
56091510|NCT03198884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091511|NCT03198884|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56091512|NCT03198884|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56091513|NCT03198884|Protease Inhibitors|protease inhibitors|mesh-ancestor
56091515|NCT01801189|Analgesics|analgesics|mesh-ancestor
56091516|NCT01801189|Sensory System Agents|sensory system agents|mesh-ancestor
56091517|NCT01801189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091518|NCT01801189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091519|NCT01801189|Anticonvulsants|anticonvulsants|mesh-ancestor
56091520|NCT01801189|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56091521|NCT01801189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56091522|NCT01801189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091523|NCT01801189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56091524|NCT01801189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56091525|NCT01801189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56091526|NCT01801189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091527|NCT01801189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56091528|NCT04275362|Cimetidine|cimetidine|mesh-list
56091529|NCT04275362|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56091530|NCT04275362|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56091531|NCT04275362|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56091532|NCT04275362|Histamine Antagonists|histamine antagonists|mesh-ancestor
56091533|NCT04275362|Histamine Agents|histamine agents|mesh-ancestor
56091534|NCT04275362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091535|NCT04275362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091540|NCT05178043|Nivolumab|nivolumab|mesh-list
56091548|NCT00716755|Serotonin Agents|serotonin agents|mesh-ancestor
56091549|NCT00716755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091550|NCT00716755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091551|NCT00716755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091552|NCT00716755|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56091553|NCT00716755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56091554|NCT00716755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091556|NCT00716755|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56091557|NCT00716755|Dopamine Agents|dopamine agents|mesh-ancestor
56091558|NCT00716755|Antiemetics|antiemetics|mesh-ancestor
56091559|NCT00716755|Autonomic Agents|autonomic agents|mesh-ancestor
56091560|NCT00716755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091561|NCT00716755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56091562|NCT00716755|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56091609|NCT04708171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091610|NCT03290378|Tramadol|tramadol|mesh-list
56091611|NCT03290378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56091612|NCT03290378|Narcotics|narcotics|mesh-ancestor
56091613|NCT03290378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091614|NCT03290378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091615|NCT03290378|Analgesics|analgesics|mesh-ancestor
56091616|NCT03290378|Sensory System Agents|sensory system agents|mesh-ancestor
56091617|NCT03290378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091619|NCT02076217|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56091620|NCT02076217|Contraceptive Agents|contraceptive agents|mesh-list
56091621|NCT02076217|Medroxyprogesterone|medroxyprogesterone|mesh-list
56091622|NCT02076217|Etonogestrel|etonogestrel|mesh-list
56091623|NCT02076217|Desogestrel|desogestrel|mesh-list
56091624|NCT02076217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56091625|NCT02076217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091626|NCT02076217|Trace Elements|trace elements|mesh-ancestor
56091627|NCT02076217|Micronutrients|micronutrients|mesh-ancestor
56091628|NCT02076217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56091629|NCT02076217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56091630|NCT02076217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56091631|NCT02076217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56091632|NCT02076217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56091633|NCT02076217|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56091634|NCT02076217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56091635|NCT02076217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091636|NCT02076217|Progestins|progestins|mesh-ancestor
56091637|NCT02076217|Hormones|hormones|mesh-ancestor
56091638|NCT02076217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56091639|NCT03291080|Tretinoin|tretinoin|mesh-list
56091641|NCT03291080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091642|NCT03291080|Keratolytic Agents|keratolytic agents|mesh-ancestor
56091643|NCT03291080|Dermatologic Agents|dermatologic agents|mesh-ancestor
56091645|NCT04874545|Sevoflurane|sevoflurane|mesh-list
56091646|NCT04874545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56091648|NCT04874545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091649|NCT04874545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56091650|NCT04874545|Anesthetics, General|anesthetics, general|mesh-ancestor
56091651|NCT04874545|Anesthetics|anesthetics|mesh-ancestor
56091652|NCT04874545|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56091653|NCT04874545|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56091654|NCT04535713|Gemcitabine|gemcitabine|mesh-list
56091655|NCT04535713|Docetaxel|docetaxel|mesh-list
56091656|NCT04535713|Doxorubicin|doxorubicin|mesh-list
56091657|NCT04535713|Nivolumab|nivolumab|mesh-list
56091658|NCT04535713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56091659|NCT04535713|Antimetabolites|antimetabolites|mesh-ancestor
56091660|NCT04535713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091661|NCT04535713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091662|NCT04535713|Antiviral Agents|antiviral agents|mesh-ancestor
56091663|NCT04535713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091664|NCT04535713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091665|NCT04535713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56091666|NCT04535713|Immunologic Factors|immunologic factors|mesh-ancestor
56091667|NCT04535713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091668|NCT04535713|Tubulin Modulators|tubulin modulators|mesh-ancestor
56091669|NCT04535713|Antimitotic Agents|antimitotic agents|mesh-ancestor
56091670|NCT04535713|Mitosis Modulators|mitosis modulators|mesh-ancestor
56091671|NCT04535713|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56091672|NCT04535713|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56091673|NCT04535713|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56091674|NCT04535713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091675|NCT04535713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56091676|NCT03181009|Omalizumab|omalizumab|mesh-list
56091677|NCT03181009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56091678|NCT03181009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56091679|NCT03181009|Respiratory System Agents|respiratory system agents|mesh-ancestor
56091680|NCT04430569|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56091681|NCT04430569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56091682|NCT04430569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56091683|NCT04430569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091684|NCT03296072|Listerine|listerine|mesh-list
56091687|NCT03296072|Tin Fluorides|tin fluorides|mesh-list
56091688|NCT03296072|Cariostatic Agents|cariostatic agents|mesh-ancestor
56091689|NCT03296072|Protective Agents|protective agents|mesh-ancestor
56091690|NCT03296072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091691|NCT03296072|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56091692|NCT03296072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091693|NCT03185065|Amantadine|amantadine|mesh-list
56091694|NCT03185065|Methylphenidate|methylphenidate|mesh-list
56091695|NCT03185065|Modafinil|modafinil|mesh-list
56091696|NCT03185065|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56091697|NCT03185065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091698|NCT03185065|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56091699|NCT03185065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56092045|NCT03242408|Androgens|androgens|mesh-ancestor
56091700|NCT03185065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56091701|NCT03185065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091702|NCT03185065|Dopamine Agents|dopamine agents|mesh-ancestor
56091703|NCT03185065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091704|NCT03185065|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56091705|NCT03185065|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56091706|NCT03185065|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56091708|NCT03185065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56091709|NCT03185065|Antiviral Agents|antiviral agents|mesh-ancestor
56091710|NCT03185065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56091740|NCT03189589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56091741|NCT03189589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091742|NCT03189589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091743|NCT03216902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56091744|NCT03216902|Latanoprost|latanoprost|mesh-list
56091745|NCT03216902|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56091746|NCT03190213|Pembrolizumab|pembrolizumab|mesh-list
56091747|NCT03190213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091748|NCT03190213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091749|NCT01632150|Thalidomide|thalidomide|mesh-list
56091750|NCT01632150|Dexamethasone|dexamethasone|mesh-list
56091751|NCT01632150|Dexamethasone acetate|dexamethasone acetate|mesh-list
56091752|NCT01632150|Cyclophosphamide|cyclophosphamide|mesh-list
56091753|NCT01632150|Elotuzumab|elotuzumab|mesh-list
56091754|NCT01632150|BB 1101|bb 1101|mesh-list
56091755|NCT01632150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56091756|NCT01632150|Immunologic Factors|immunologic factors|mesh-ancestor
56091757|NCT01632150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091758|NCT01632150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56091759|NCT01632150|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56091765|NCT01632150|Antiemetics|antiemetics|mesh-ancestor
56091796|NCT03297944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56091797|NCT03297944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56091798|NCT03297944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56091799|NCT03297944|GABA Modulators|gaba modulators|mesh-ancestor
56091800|NCT04333004|Pembrolizumab|pembrolizumab|mesh-list
56091801|NCT04333004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091802|NCT04333004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091803|NCT03219866|Budesonide|budesonide|mesh-list
56091804|NCT03219866|Tiotropium Bromide|tiotropium bromide|mesh-list
56091805|NCT03219866|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56091806|NCT03219866|Ipratropium|ipratropium|mesh-list
56091807|NCT03219866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56091808|NCT03219866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56091809|NCT03219866|Autonomic Agents|autonomic agents|mesh-ancestor
56091810|NCT03219866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091811|NCT03219866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091812|NCT03219866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56091813|NCT03219866|Respiratory System Agents|respiratory system agents|mesh-ancestor
56091814|NCT03219866|Glucocorticoids|glucocorticoids|mesh-ancestor
56091815|NCT03219866|Hormones|hormones|mesh-ancestor
56091816|NCT03219866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56091817|NCT03219866|Parasympatholytics|parasympatholytics|mesh-ancestor
56091818|NCT03219866|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56091819|NCT03219866|Cholinergic Agents|cholinergic agents|mesh-ancestor
56091820|NCT03219866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56091845|NCT02158806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091846|NCT02158806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56091847|NCT02158806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56091848|NCT02158806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56091849|NCT02158806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56091850|NCT02158806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091851|NCT02158806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56091852|NCT02158806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56091853|NCT02158806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56091855|NCT03197389|Pembrolizumab|pembrolizumab|mesh-list
56091856|NCT03197389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56091857|NCT03197389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56091858|NCT03198871|Acetaminophen|acetaminophen|mesh-list
56091859|NCT03198871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56091860|NCT03198871|Analgesics|analgesics|mesh-ancestor
56091861|NCT03198871|Sensory System Agents|sensory system agents|mesh-ancestor
56091862|NCT03198871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091863|NCT03198871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091864|NCT03198871|Antipyretics|antipyretics|mesh-ancestor
55741588|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
56091866|NCT02157948|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56091899|NCT03424681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56091900|NCT03424681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091901|NCT03424681|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56091902|NCT03424681|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56091903|NCT03424681|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56091904|NCT03424681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56091905|NCT03303794|Bupivacaine|bupivacaine|mesh-list
56091906|NCT03303794|Anesthetics, Local|anesthetics, local|mesh-ancestor
56091907|NCT03303794|Anesthetics|anesthetics|mesh-ancestor
56091908|NCT03303794|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091909|NCT03303794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091910|NCT03303794|Sensory System Agents|sensory system agents|mesh-ancestor
56091911|NCT03303794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091912|NCT03305822|Insulin Lispro|insulin lispro|mesh-list
56091913|NCT03305822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56091914|NCT03305822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091915|NCT03435614|Analgesics|analgesics|mesh-list
56091916|NCT03435614|Narcotics|narcotics|mesh-list
56091917|NCT03435614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091918|NCT03435614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091919|NCT03435614|Sensory System Agents|sensory system agents|mesh-ancestor
56091920|NCT03435614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56091921|NCT03437564|Vortioxetine|vortioxetine|mesh-list
56091922|NCT03437564|Antidepressive Agents|antidepressive agents|mesh-ancestor
56091923|NCT03437564|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56091924|NCT03437564|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56091925|NCT03437564|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56091926|NCT03437564|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56091927|NCT03437564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091928|NCT03437564|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56091929|NCT03437564|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56091930|NCT03437564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56091936|NCT03437564|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56091937|NCT03437564|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56091938|NCT03438266|Hyaluronic Acid|hyaluronic acid|mesh-list
56091939|NCT03438266|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56091940|NCT03438266|Immunologic Factors|immunologic factors|mesh-ancestor
56091941|NCT03438266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091942|NCT03438266|Viscosupplements|viscosupplements|mesh-ancestor
56091943|NCT03438266|Protective Agents|protective agents|mesh-ancestor
56091944|NCT03315104|Immunoglobulins|immunoglobulins|mesh-list
56091945|NCT03315104|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56091946|NCT03315104|gamma-Globulins|gamma-globulins|mesh-list
56091947|NCT03315104|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56091948|NCT03315104|Immunologic Factors|immunologic factors|mesh-ancestor
56091949|NCT03315104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56091950|NCT03228914|Phenylephrine|phenylephrine|mesh-list
56091951|NCT03228914|Epinephrine|epinephrine|mesh-list
56091952|NCT03228914|Oxymetazoline|oxymetazoline|mesh-list
56091953|NCT03228914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56091995|NCT04332536|Respiratory System Agents|respiratory system agents|mesh-ancestor
56091996|NCT03236168|Ivermectin|ivermectin|mesh-list
56091997|NCT03236168|Permethrin|permethrin|mesh-list
56092000|NCT03236168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092001|NCT03236168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092002|NCT03236168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092003|NCT03236168|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56092004|NCT03236168|Cholinergic Agents|cholinergic agents|mesh-ancestor
56092005|NCT03236168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092006|NCT03236168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092007|NCT03306589|Molgramostim|molgramostim|mesh-list
56092008|NCT03306589|Sargramostim|sargramostim|mesh-list
56092009|NCT03306589|Cantharidin|cantharidin|mesh-list
56092010|NCT03306589|Immunologic Factors|immunologic factors|mesh-ancestor
56092011|NCT03306589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092012|NCT03306589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092013|NCT03306589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092014|NCT03306589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092015|NCT03312517|Suvorexant|suvorexant|mesh-list
56092016|NCT03312517|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56092017|NCT03312517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56092018|NCT03312517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092019|NCT03312517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092020|NCT03312517|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56092021|NCT03312517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092022|NCT03312517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092023|NCT03315559|Nemiralisib|nemiralisib|mesh-list
56092024|NCT03315559|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56092025|NCT03315559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092026|NCT03315559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092027|NCT03239522|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56092028|NCT03239522|Glycine|glycine|mesh-list
56092029|NCT03239522|Glycine Agents|glycine agents|mesh-ancestor
56092033|NCT03210337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56092034|NCT03242408|Methyltestosterone|methyltestosterone|mesh-list
56092035|NCT03242408|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56092036|NCT03242408|Testosterone|testosterone|mesh-list
56092037|NCT03242408|Testosterone undecanoate|testosterone undecanoate|mesh-list
56092038|NCT03242408|Testosterone enanthate|testosterone enanthate|mesh-list
56092039|NCT03242408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56092040|NCT03242408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901577|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
55901578|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
55901579|NCT02413086|Coagulants|coagulants|mesh-ancestor
55901580|NCT02468830|Mirabegron|mirabegron|mesh-list
55901581|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55901582|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55901583|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55901584|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
55901585|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901586|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901587|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901588|NCT02468830|Urological Agents|urological agents|mesh-ancestor
55901589|NCT02470234|Methylphenidate|methylphenidate|mesh-list
55901590|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55901591|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901592|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55901593|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55901594|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901595|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901597|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901599|NCT02418702|Analgesics|analgesics|mesh-ancestor
55901600|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
55901601|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901602|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901603|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55901604|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55901605|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
55901606|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
55901607|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901608|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55901609|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55901610|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901611|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901612|NCT02412930|Tramadol|tramadol|mesh-list
55901613|NCT02412930|Bupivacaine|bupivacaine|mesh-list
55901614|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
55901615|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
55901616|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901617|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901618|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
55901619|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901620|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55901621|NCT02412930|Narcotics|narcotics|mesh-ancestor
55901622|NCT02412930|Analgesics|analgesics|mesh-ancestor
55901623|NCT02432716|Insulin|insulin|mesh-list
55901624|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55901625|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
55901626|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55901627|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901628|NCT02418624|Carboplatin|carboplatin|mesh-list
55901629|NCT02418624|Olaparib|olaparib|mesh-list
55901630|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901631|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55901632|NCT02418624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092041|NCT03242408|Anabolic Agents|anabolic agents|mesh-ancestor
56092042|NCT03242408|Hormones|hormones|mesh-ancestor
56092043|NCT03242408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56092044|NCT03242408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092048|NCT03459794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092050|NCT03211117|Doxorubicin|doxorubicin|mesh-list
56092051|NCT03211117|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56092052|NCT03211117|Pembrolizumab|pembrolizumab|mesh-list
56092053|NCT03211117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092054|NCT03211117|Tubulin Modulators|tubulin modulators|mesh-ancestor
56092055|NCT03211117|Antimitotic Agents|antimitotic agents|mesh-ancestor
56092056|NCT03211117|Mitosis Modulators|mitosis modulators|mesh-ancestor
56092057|NCT03211117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092058|NCT03211117|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56092059|NCT03211117|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56092060|NCT03211117|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56092061|NCT03211117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092062|NCT03211117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56092063|NCT00376285|Fenofibrate|fenofibrate|mesh-list
56092064|NCT00376285|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56092065|NCT00376285|Antimetabolites|antimetabolites|mesh-ancestor
56092066|NCT00376285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092067|NCT00376285|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56092068|NCT03460652|Serdexmethylphenidate and dexmethylphenidate|serdexmethylphenidate and dexmethylphenidate|mesh-list
56092069|NCT03460652|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56092070|NCT03460652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092071|NCT03321097|Botulinum Toxins|botulinum toxins|mesh-list
56092072|NCT03321097|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56092073|NCT03321097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56092074|NCT03321097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092075|NCT03321097|Cholinergic Agents|cholinergic agents|mesh-ancestor
56092079|NCT03245762|Oxytocics|oxytocics|mesh-ancestor
56092080|NCT03245762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56092081|NCT03245762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092082|NCT03322657|Glycopyrrolate|glycopyrrolate|mesh-list
56092083|NCT03322657|Neostigmine|neostigmine|mesh-list
56092084|NCT03322657|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56092085|NCT03322657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741590|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092086|NCT03322657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092087|NCT03322657|Cholinergic Agents|cholinergic agents|mesh-ancestor
56092088|NCT03322657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092089|NCT03322657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092090|NCT03322657|Parasympathomimetics|parasympathomimetics|mesh-ancestor
56092091|NCT03322657|Autonomic Agents|autonomic agents|mesh-ancestor
56092092|NCT03322657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092093|NCT03322657|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56092094|NCT03322657|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56092095|NCT03322657|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56092097|NCT03324451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56092098|NCT03324451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092099|NCT03247790|Lasmiditan|lasmiditan|mesh-list
56092100|NCT03247790|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56092101|NCT03247790|Serotonin Agents|serotonin agents|mesh-ancestor
56092102|NCT03247790|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092103|NCT03247790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092104|NCT03247790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092124|NCT03468920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092126|NCT02181816|Amlodipine|amlodipine|mesh-list
56092127|NCT02181816|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56092128|NCT02181816|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56092129|NCT02181816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56092130|NCT02181816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56092131|NCT02181816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092132|NCT02181816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56092133|NCT02181816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092134|NCT02181816|Vasodilator Agents|vasodilator agents|mesh-ancestor
56092135|NCT02181816|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56092136|NCT02181816|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56092137|NCT04761822|Vaccines|vaccines|mesh-list
56092138|NCT04761822|Immunologic Factors|immunologic factors|mesh-ancestor
56092139|NCT04761822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092140|NCT03256136|Carboplatin|carboplatin|mesh-list
56092141|NCT03256136|Nivolumab|nivolumab|mesh-list
56092142|NCT03256136|Pemetrexed|pemetrexed|mesh-list
56092143|NCT03256136|Ipilimumab|ipilimumab|mesh-list
56092177|NCT03270332|Adrenergic Agents|adrenergic agents|mesh-ancestor
56092178|NCT03270332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092179|NCT03270332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092180|NCT03355820|Antibodies|antibodies|mesh-list
56092181|NCT03355820|Immunologic Factors|immunologic factors|mesh-ancestor
56092182|NCT03355820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092183|NCT03357614|Amoxicillin|amoxicillin|mesh-list
56092184|NCT03357614|Ciprofloxacin|ciprofloxacin|mesh-list
56092185|NCT03357614|Clavulanic Acid|clavulanic acid|mesh-list
56092186|NCT03357614|Clavulanic Acids|clavulanic acids|mesh-list
56092187|NCT03357614|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56092188|NCT03357614|Ertapenem|ertapenem|mesh-list
56092189|NCT03357614|Lactams|lactams|mesh-list
56092190|NCT03357614|Probenecid|probenecid|mesh-list
56092191|NCT03357614|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56092192|NCT03357614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092193|NCT03357614|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56092194|NCT03357614|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56092195|NCT03357614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092196|NCT03357614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092197|NCT03357614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092198|NCT03357614|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56092199|NCT03357614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56092200|NCT03357614|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56092201|NCT03357614|Uricosuric Agents|uricosuric agents|mesh-ancestor
56092202|NCT03357614|Gout Suppressants|gout suppressants|mesh-ancestor
56092203|NCT03357614|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56092204|NCT03357614|Renal Agents|renal agents|mesh-ancestor
56092205|NCT03275870|Hydroxychloroquine|hydroxychloroquine|mesh-list
56092206|NCT03275870|Antimalarials|antimalarials|mesh-ancestor
56092224|NCT00376376|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56092225|NCT00376376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092226|NCT00376376|Renal Agents|renal agents|mesh-ancestor
56092227|NCT00376376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56092228|NCT00376376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55819363|NCT01810042|Ranibizumab|ranibizumab|mesh-list
56092229|NCT00376376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56092231|NCT00376376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092232|NCT00376376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092233|NCT00376376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56092234|NCT00376376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56092235|NCT02181504|Ranibizumab|ranibizumab|mesh-list
56092236|NCT02181504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56092237|NCT02181504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56092238|NCT02181504|Growth Substances|growth substances|mesh-ancestor
56092239|NCT02181504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092240|NCT02181504|Growth Inhibitors|growth inhibitors|mesh-ancestor
56092241|NCT02181504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092243|NCT02213094|Niacinamide|niacinamide|mesh-list
56092244|NCT02213094|Niacin|niacin|mesh-list
56092245|NCT02213094|Nicotinic Acids|nicotinic acids|mesh-list
56092246|NCT02213094|Vitamin B Complex|vitamin b complex|mesh-list
56092247|NCT02213094|Micronutrients|micronutrients|mesh-ancestor
56092248|NCT02213094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092249|NCT02213094|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56092250|NCT02213094|Antimetabolites|antimetabolites|mesh-ancestor
56092251|NCT02213094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092252|NCT02213094|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56092253|NCT02213094|Vasodilator Agents|vasodilator agents|mesh-ancestor
56092254|NCT01629966|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
56092255|NCT01629966|Antidepressive Agents|antidepressive agents|mesh-ancestor
56092256|NCT01629966|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56092257|NCT01629966|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56092258|NCT01629966|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55901636|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56092259|NCT01629966|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56092260|NCT01629966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092261|NCT01629966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092262|NCT01629966|Serotonin Agents|serotonin agents|mesh-ancestor
56092263|NCT01629966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092264|NCT01629966|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
56092265|NCT01629966|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56092266|NCT02177838|Cetuximab|cetuximab|mesh-list
56092267|NCT02177838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56092268|NCT02177838|Antibodies|antibodies|mesh-list
56092269|NCT02177838|Immunoglobulins|immunoglobulins|mesh-list
56092270|NCT02177838|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56092271|NCT02177838|Immunologic Factors|immunologic factors|mesh-ancestor
56092272|NCT02177838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092273|NCT02177838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092274|NCT03283436|Bupivacaine|bupivacaine|mesh-list
56092275|NCT03283436|Anesthetics, Local|anesthetics, local|mesh-ancestor
56092276|NCT03283436|Anesthetics|anesthetics|mesh-ancestor
56092277|NCT03283436|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092278|NCT03283436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092279|NCT03283436|Sensory System Agents|sensory system agents|mesh-ancestor
56092315|NCT03383588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56092316|NCT03383588|Narcotics|narcotics|mesh-ancestor
56092317|NCT03383588|Analgesics|analgesics|mesh-ancestor
56092318|NCT03383588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56092320|NCT03383588|Anesthetics, General|anesthetics, general|mesh-ancestor
56092321|NCT03383588|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56092322|NCT03383588|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56092323|NCT03383588|Adrenergic Agents|adrenergic agents|mesh-ancestor
56092324|NCT03383588|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092325|NCT03383588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092326|NCT03383588|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56092327|NCT03383588|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56092328|NCT03383588|Autonomic Agents|autonomic agents|mesh-ancestor
56092329|NCT03383588|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56092330|NCT03383588|Respiratory System Agents|respiratory system agents|mesh-ancestor
56092331|NCT03383588|Mydriatics|mydriatics|mesh-ancestor
56092332|NCT03383588|Sympathomimetics|sympathomimetics|mesh-ancestor
56092333|NCT03383588|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56092334|NCT03388268|Vancomycin|vancomycin|mesh-list
56092335|NCT03388268|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56092336|NCT03388268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092337|NCT03393494|Adapalene|adapalene|mesh-list
56092338|NCT03393494|Benzoyl Peroxide|benzoyl peroxide|mesh-list
56092339|NCT03393494|Dermatologic Agents|dermatologic agents|mesh-ancestor
56092340|NCT03393494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56092341|NCT03393494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56092342|NCT03393494|Analgesics|analgesics|mesh-ancestor
56092364|NCT02176356|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56092365|NCT02176356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092366|NCT02176356|Cholinergic Agents|cholinergic agents|mesh-ancestor
56092367|NCT02176356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092368|NCT02176356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092369|NCT02176356|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56092370|NCT02176356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092371|NCT02176356|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56092372|NCT02176356|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56092373|NCT02176356|Immunologic Factors|immunologic factors|mesh-ancestor
56092374|NCT02176356|Viscosupplements|viscosupplements|mesh-ancestor
56092375|NCT02176356|Protective Agents|protective agents|mesh-ancestor
56092376|NCT03591068|Fluticasone|fluticasone|mesh-list
56092377|NCT03591068|Xhance|xhance|mesh-list
56092378|NCT03591068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56092379|NCT03591068|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56092380|NCT03591068|Autonomic Agents|autonomic agents|mesh-ancestor
56092381|NCT03591068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092382|NCT03591068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092383|NCT03591068|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55741596|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
56092384|NCT03591068|Respiratory System Agents|respiratory system agents|mesh-ancestor
56092385|NCT03591068|Dermatologic Agents|dermatologic agents|mesh-ancestor
56092386|NCT03591068|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56092387|NCT03395990|Chloroprocaine|chloroprocaine|mesh-list
56092388|NCT03395990|Procaine|procaine|mesh-list
56092389|NCT03395990|Anesthetics, Local|anesthetics, local|mesh-ancestor
56092390|NCT03395990|Anesthetics|anesthetics|mesh-ancestor
56092391|NCT03395990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092392|NCT03395990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092393|NCT03395990|Sensory System Agents|sensory system agents|mesh-ancestor
56092394|NCT03395990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092395|NCT02175966|Ribavirin|ribavirin|mesh-list
56092396|NCT02175966|Sofosbuvir|sofosbuvir|mesh-list
56092397|NCT02175966|Antimetabolites|antimetabolites|mesh-ancestor
56092404|NCT01599234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092405|NCT01599234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092407|NCT02136576|Sodium Fluoride|sodium fluoride|mesh-list
56092408|NCT02136576|Cariostatic Agents|cariostatic agents|mesh-ancestor
56092409|NCT02136576|Protective Agents|protective agents|mesh-ancestor
56092410|NCT02136576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092411|NCT02136576|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56092412|NCT02136576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092414|NCT03397394|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56092415|NCT03397394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092416|NCT03397394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092417|NCT03397394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092418|NCT03398330|Oxycodone|oxycodone|mesh-list
56092419|NCT03398330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56092420|NCT03398330|Narcotics|narcotics|mesh-ancestor
56092421|NCT03398330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092422|NCT03398330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092423|NCT03398330|Analgesics|analgesics|mesh-ancestor
56092424|NCT03398330|Sensory System Agents|sensory system agents|mesh-ancestor
56092425|NCT03398330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092426|NCT00376766|Levetiracetam|levetiracetam|mesh-list
56092427|NCT00376766|Anticonvulsants|anticonvulsants|mesh-ancestor
56092428|NCT00376766|Nootropic Agents|nootropic agents|mesh-ancestor
56092429|NCT03403712|Dexamethasone|dexamethasone|mesh-list
56092430|NCT03403712|Palonosetron|palonosetron|mesh-list
56092431|NCT03403712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56092432|NCT03403712|Antiemetics|antiemetics|mesh-ancestor
56092433|NCT03403712|Autonomic Agents|autonomic agents|mesh-ancestor
56092434|NCT03403712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092435|NCT03403712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092436|NCT03403712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56092437|NCT03403712|Glucocorticoids|glucocorticoids|mesh-ancestor
56092438|NCT03403712|Hormones|hormones|mesh-ancestor
56092439|NCT03403712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56092443|NCT03403712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56092444|NCT03403712|Serotonin Agents|serotonin agents|mesh-ancestor
56092445|NCT03403712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092446|NCT03403712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092447|NCT03404648|Choline|choline|mesh-list
56092448|NCT03404648|Lipotropic Agents|lipotropic agents|mesh-ancestor
56092449|NCT03404648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56092450|NCT03404648|Antimetabolites|antimetabolites|mesh-ancestor
56092451|NCT03404648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092452|NCT03404648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56092453|NCT03404648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56092454|NCT03404648|Nootropic Agents|nootropic agents|mesh-ancestor
56092455|NCT03383198|Bupivacaine|bupivacaine|mesh-list
56092456|NCT03383198|Anesthetics, Local|anesthetics, local|mesh-ancestor
56092457|NCT03383198|Anesthetics|anesthetics|mesh-ancestor
56092458|NCT03383198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092459|NCT03383198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092460|NCT03383198|Sensory System Agents|sensory system agents|mesh-ancestor
56092461|NCT03383198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092462|NCT03413618|Rivaroxaban|rivaroxaban|mesh-list
56092463|NCT03413618|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56092464|NCT03413618|Antithrombins|antithrombins|mesh-ancestor
56092465|NCT03413618|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56092466|NCT03413618|Protease Inhibitors|protease inhibitors|mesh-ancestor
56092467|NCT03413618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092493|NCT03528512|Sensory System Agents|sensory system agents|mesh-ancestor
56092494|NCT03528512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092495|NCT03528512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092496|NCT03528512|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56092497|NCT03528512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56092498|NCT03528512|Anesthetics, General|anesthetics, general|mesh-ancestor
56092499|NCT03528512|Anesthetics|anesthetics|mesh-ancestor
56092500|NCT03528512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092501|NCT03528512|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56092502|NCT03528512|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56092503|NCT03528512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092504|NCT03528512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092505|NCT03528512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56092506|NCT03528512|Narcotics|narcotics|mesh-ancestor
56092507|NCT03528512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56092509|NCT03528512|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56092510|NCT03528512|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56092511|NCT03528512|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56092512|NCT03528512|GABA Modulators|gaba modulators|mesh-ancestor
56092513|NCT03528512|GABA Agents|gaba agents|mesh-ancestor
56092514|NCT02133924|Prednisone|prednisone|mesh-list
56092515|NCT02133924|Methylprednisolone|methylprednisolone|mesh-list
56092516|NCT02133924|Natalizumab|natalizumab|mesh-list
56092517|NCT02133924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56092518|NCT02133924|Glucocorticoids|glucocorticoids|mesh-ancestor
56092519|NCT02133924|Hormones|hormones|mesh-ancestor
56092520|NCT02133924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56092521|NCT02133924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092538|NCT03537404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092540|NCT03537404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56092541|NCT03537404|Antiviral Agents|antiviral agents|mesh-ancestor
56092542|NCT03537404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092543|NCT03537404|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56092544|NCT03537404|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56092545|NCT03537404|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56092546|NCT03537404|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56092547|NCT03537404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56092548|NCT03537404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56092549|NCT03626714|Tacrolimus|tacrolimus|mesh-list
56092550|NCT03626714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56092551|NCT03626714|Immunologic Factors|immunologic factors|mesh-ancestor
56092552|NCT03626714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092553|NCT03626714|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56092554|NCT03626714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092555|NCT03626714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092592|NCT03633344|Trace Elements|trace elements|mesh-ancestor
56092593|NCT03633344|Micronutrients|micronutrients|mesh-ancestor
56092594|NCT03633344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092595|NCT02171130|Glucagon|glucagon|mesh-list
56092596|NCT02171130|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
56092597|NCT02171130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56092598|NCT02171130|Hormones|hormones|mesh-ancestor
56092599|NCT02171130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56092600|NCT02171130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092601|NCT02171130|Incretins|incretins|mesh-ancestor
56092602|NCT04749810|Eculizumab|eculizumab|mesh-list
56092603|NCT04749810|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56092604|NCT04749810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56092605|NCT04749810|Immunologic Factors|immunologic factors|mesh-ancestor
55741602|NCT03360955|Anesthetics|anesthetics|mesh-list
56092606|NCT04749810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092608|NCT00377078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092609|NCT04495712|Spironolactone|spironolactone|mesh-list
56092610|NCT04495712|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56092611|NCT04495712|Hormone Antagonists|hormone antagonists|mesh-ancestor
56092612|NCT04495712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56092613|NCT04495712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092614|NCT04495712|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56092616|NCT04495712|Natriuretic Agents|natriuretic agents|mesh-ancestor
56092617|NCT03553940|Vaccines|vaccines|mesh-list
56092618|NCT03553940|Immunologic Factors|immunologic factors|mesh-ancestor
56092619|NCT03553940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092620|NCT04456634|Lumefantrine|lumefantrine|mesh-list
56092621|NCT04456634|Artemether|artemether|mesh-list
56092622|NCT04456634|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
56092623|NCT04456634|Antimalarials|antimalarials|mesh-ancestor
56092624|NCT04456634|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56092625|NCT04456634|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56092626|NCT04456634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092627|NCT00377624|Hyaluronic Acid|hyaluronic acid|mesh-list
56092628|NCT00377624|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56092629|NCT00377624|Immunologic Factors|immunologic factors|mesh-ancestor
56092631|NCT00377624|Viscosupplements|viscosupplements|mesh-ancestor
56092632|NCT00377624|Protective Agents|protective agents|mesh-ancestor
56092633|NCT03562988|Vitamins|vitamins|mesh-list
56092634|NCT03562988|Ascorbic Acid|ascorbic acid|mesh-list
56092635|NCT03562988|Micronutrients|micronutrients|mesh-ancestor
56092636|NCT03562988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092637|NCT03562988|Antioxidants|antioxidants|mesh-ancestor
56092638|NCT03562988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092639|NCT03562988|Protective Agents|protective agents|mesh-ancestor
56092640|NCT03644108|Guaifenesin|guaifenesin|mesh-list
56092641|NCT03644108|Expectorants|expectorants|mesh-ancestor
56092642|NCT03644108|Respiratory System Agents|respiratory system agents|mesh-ancestor
56092643|NCT04713956|Cyclophosphamide|cyclophosphamide|mesh-list
56092644|NCT04713956|Busulfan|busulfan|mesh-list
56092645|NCT04713956|Fludarabine|fludarabine|mesh-list
56092646|NCT04713956|Decitabine|decitabine|mesh-list
56092647|NCT04713956|Lenograstim|lenograstim|mesh-list
56092648|NCT04713956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56092649|NCT04713956|Immunologic Factors|immunologic factors|mesh-ancestor
56092650|NCT04713956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092652|NCT04713956|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56092653|NCT04713956|Alkylating Agents|alkylating agents|mesh-ancestor
56092654|NCT04713956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092655|NCT04713956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092656|NCT04713956|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56092657|NCT04713956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56092658|NCT04713956|Antimetabolites|antimetabolites|mesh-ancestor
56092659|NCT04713956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092660|NCT04713956|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56092661|NCT04425746|Afamelanotide|afamelanotide|mesh-list
56092676|NCT04734782|Immunologic Factors|immunologic factors|mesh-ancestor
56092677|NCT04734782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092678|NCT04390022|Ivermectin|ivermectin|mesh-list
56092679|NCT04390022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56092680|NCT04390022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092681|NCT04374500|Verapamil|verapamil|mesh-list
56092682|NCT04374500|Nitroprusside|nitroprusside|mesh-list
56092683|NCT04374500|Acetylcholine|acetylcholine|mesh-list
56092684|NCT04374500|Vasodilator Agents|vasodilator agents|mesh-list
56092685|NCT04374500|Bradykinin|bradykinin|mesh-list
55819815|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
56092686|NCT04374500|Substance P|substance p|mesh-list
56092687|NCT04374500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56092688|NCT04374500|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56092689|NCT04374500|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56092690|NCT04374500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092691|NCT04374500|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56092692|NCT04374500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092693|NCT04374500|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56092694|NCT04374500|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
56092695|NCT04374500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56092696|NCT04374500|Cholinergic Agents|cholinergic agents|mesh-ancestor
56092697|NCT04374500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092698|NCT04370834|Immunoglobulins|immunoglobulins|mesh-list
56092699|NCT04370834|Immunoglobulin G|immunoglobulin g|mesh-list
56092700|NCT04370834|Immunologic Factors|immunologic factors|mesh-ancestor
56092701|NCT04370834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092702|NCT03570476|Olaparib|olaparib|mesh-list
56092703|NCT03570476|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
56092704|NCT03570476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092705|NCT03570476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092706|NCT03570476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092707|NCT03571724|Menthol|menthol|mesh-list
56092708|NCT03571724|Nicotine|nicotine|mesh-list
56092709|NCT03571724|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56092710|NCT03571724|Autonomic Agents|autonomic agents|mesh-ancestor
56092711|NCT03571724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092714|NCT03571724|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56092724|NCT03572972|Anticoagulants|anticoagulants|mesh-ancestor
56092725|NCT03572972|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56092726|NCT03572972|Antithrombins|antithrombins|mesh-ancestor
56092727|NCT03572972|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56092728|NCT03572972|Protease Inhibitors|protease inhibitors|mesh-ancestor
56092729|NCT03572972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092730|NCT03572972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092731|NCT04352660|Mitomycins|mitomycins|mesh-list
56092732|NCT04352660|Mitomycin|mitomycin|mesh-list
56092733|NCT04352660|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56092734|NCT04352660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092735|NCT04352660|Alkylating Agents|alkylating agents|mesh-ancestor
56092736|NCT04352660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092737|NCT04352660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56092738|NCT04352660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092739|NCT04343222|Bromfenac|bromfenac|mesh-list
56092740|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
56092741|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56092742|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55901638|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
55901639|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
55901640|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901641|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901642|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55901643|NCT02440204|Narcotics|narcotics|mesh-ancestor
55901644|NCT02440204|Analgesics|analgesics|mesh-ancestor
55901645|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
55901646|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901647|NCT02410590|Atropine|atropine|mesh-list
55901648|NCT02410590|Rocuronium|rocuronium|mesh-list
56092743|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56092744|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56092745|NCT04343222|Analgesics|analgesics|mesh-ancestor
56092746|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
56092747|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092748|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092749|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56092750|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56092751|NCT04342130|Morphine|morphine|mesh-list
56092752|NCT04342130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56092753|NCT04342130|Narcotics|narcotics|mesh-ancestor
56092754|NCT04342130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092755|NCT04342130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092756|NCT04342130|Analgesics|analgesics|mesh-ancestor
56092757|NCT04342130|Sensory System Agents|sensory system agents|mesh-ancestor
56092758|NCT04342130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901651|NCT02410590|Neostigmine|neostigmine|mesh-list
55901652|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55901653|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55901654|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55901655|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901656|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901658|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55901659|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55901660|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
55901661|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55901662|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
55901663|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
55901664|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
55901665|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55901666|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55901667|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
55901668|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901669|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901670|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55901671|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901672|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55901673|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
55901674|NCT02517580|Vitamin K|vitamin k|mesh-list
55901675|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
55901676|NCT02517580|Vitamins|vitamins|mesh-ancestor
55901677|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
55901678|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901679|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55901680|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55901681|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901682|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
55901683|NCT02517580|Coagulants|coagulants|mesh-ancestor
56092759|NCT04338074|Tranexamic Acid|tranexamic acid|mesh-list
56092760|NCT04338074|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56092761|NCT04338074|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56092762|NCT04338074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092763|NCT04338074|Hemostatics|hemostatics|mesh-ancestor
56092764|NCT04338074|Coagulants|coagulants|mesh-ancestor
56092765|NCT03964220|Tiotropium Bromide|tiotropium bromide|mesh-list
56092766|NCT03964220|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56092767|NCT03964220|Autonomic Agents|autonomic agents|mesh-ancestor
56092768|NCT03964220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092769|NCT03964220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092770|NCT03964220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56092771|NCT03964220|Respiratory System Agents|respiratory system agents|mesh-ancestor
56092772|NCT03964220|Parasympatholytics|parasympatholytics|mesh-ancestor
56092773|NCT03964220|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56092774|NCT03964220|Cholinergic Agents|cholinergic agents|mesh-ancestor
56092775|NCT03964220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092776|NCT03964220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092777|NCT04337138|Gemtuzumab|gemtuzumab|mesh-list
56092778|NCT04337138|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56092779|NCT04337138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092780|NCT04334876|Antibodies|antibodies|mesh-list
56092782|NCT04334876|Immunologic Factors|immunologic factors|mesh-ancestor
56092783|NCT04334876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092784|NCT00422773|Cetuximab|cetuximab|mesh-list
56092785|NCT00422773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56092786|NCT00422773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092787|NCT03329209|Vedolizumab|vedolizumab|mesh-list
56092788|NCT03329209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56092789|NCT03661346|Labetalol|labetalol|mesh-list
56092790|NCT03661346|Esmolol|esmolol|mesh-list
56092791|NCT03661346|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56092792|NCT03661346|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55901684|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
55901685|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901686|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
55901687|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901688|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901689|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55901690|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
55901691|NCT02412150|Remifentanil|remifentanil|mesh-list
56092793|NCT03661346|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56092794|NCT03661346|Adrenergic Agents|adrenergic agents|mesh-ancestor
56092795|NCT03661346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092796|NCT03661346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092797|NCT03661346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092798|NCT03661346|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56092799|NCT03661346|Sympathomimetics|sympathomimetics|mesh-ancestor
56092800|NCT03661346|Autonomic Agents|autonomic agents|mesh-ancestor
56092801|NCT03661346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092802|NCT03661346|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56092803|NCT03661346|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56092804|NCT03329911|Paclitaxel|paclitaxel|mesh-list
56092805|NCT03329911|Carboplatin|carboplatin|mesh-list
56092806|NCT03329911|Bevacizumab|bevacizumab|mesh-list
56092807|NCT03329911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56092808|NCT03329911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56092809|NCT03329911|Tubulin Modulators|tubulin modulators|mesh-ancestor
56092810|NCT03329911|Antimitotic Agents|antimitotic agents|mesh-ancestor
56092811|NCT03329911|Mitosis Modulators|mitosis modulators|mesh-ancestor
56092812|NCT03329911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092813|NCT03329911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56092819|NCT04322396|Azithromycin|azithromycin|mesh-list
56092844|NCT03336853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092845|NCT03664544|Edaravone|edaravone|mesh-list
56092846|NCT03664544|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56092847|NCT03664544|Antioxidants|antioxidants|mesh-ancestor
56092848|NCT03664544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092849|NCT03664544|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56092850|NCT03664544|Protective Agents|protective agents|mesh-ancestor
56092857|NCT03225313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092858|NCT03225313|Sensory System Agents|sensory system agents|mesh-ancestor
56092859|NCT03225313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092860|NCT03949244|Latanoprost|latanoprost|mesh-list
56092861|NCT03949244|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56092862|NCT03949244|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56092863|NCT03948386|Bupivacaine|bupivacaine|mesh-list
56092864|NCT03948386|Mepivacaine|mepivacaine|mesh-list
56092865|NCT03948386|Anesthetics, Local|anesthetics, local|mesh-ancestor
56092898|NCT03670160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092899|NCT03670160|Anticonvulsants|anticonvulsants|mesh-ancestor
56092900|NCT03670160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56092901|NCT03670160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092902|NCT03670160|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56092903|NCT03670160|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56092904|NCT03670160|GABA Modulators|gaba modulators|mesh-ancestor
56092905|NCT03670160|GABA Agents|gaba agents|mesh-ancestor
56092906|NCT03670160|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56092907|NCT03670160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56092908|NCT03670160|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56092909|NCT00375895|Cyclosporine|cyclosporine|mesh-list
56092910|NCT00375895|Cyclosporins|cyclosporins|mesh-list
56092911|NCT00375895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092912|NCT00375895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901693|NCT02412150|Anesthetics|anesthetics|mesh-list
55901694|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
55901695|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55901696|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901697|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901698|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55901699|NCT02412150|Analgesics|analgesics|mesh-ancestor
55901700|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
55901701|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901702|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55901703|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55901704|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55901705|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
55901706|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901707|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901708|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55901709|NCT02412150|Narcotics|narcotics|mesh-ancestor
55901710|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
55901711|NCT02523196|Cholic Acids|cholic acids|mesh-list
55901712|NCT02523196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55901713|NCT02418078|Anesthetics|anesthetics|mesh-list
55901714|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901715|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901717|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55901719|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
55901720|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901721|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901722|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56092913|NCT00375895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56092914|NCT00375895|Immunologic Factors|immunologic factors|mesh-ancestor
56092915|NCT00375895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092916|NCT00375895|Antifungal Agents|antifungal agents|mesh-ancestor
56092917|NCT00375895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56092918|NCT00375895|Dermatologic Agents|dermatologic agents|mesh-ancestor
56092919|NCT00375895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56092920|NCT00375895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56092921|NCT03338803|Linagliptin|linagliptin|mesh-list
56092922|NCT03338803|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56092923|NCT03338803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092924|NCT03338803|Incretins|incretins|mesh-ancestor
56092925|NCT03338803|Hormones|hormones|mesh-ancestor
56092926|NCT03338803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56092927|NCT03338803|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56092928|NCT03338803|Protease Inhibitors|protease inhibitors|mesh-ancestor
56092929|NCT03338803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56092930|NCT03338803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092931|NCT00422864|Leucovorin|leucovorin|mesh-list
56092932|NCT00422864|Fluorouracil|fluorouracil|mesh-list
56092968|NCT03696758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56092969|NCT03696758|Urological Agents|urological agents|mesh-ancestor
56092970|NCT03696758|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56092971|NCT03696758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56092972|NCT03696758|Sympatholytics|sympatholytics|mesh-ancestor
56092973|NCT03696758|Autonomic Agents|autonomic agents|mesh-ancestor
56092974|NCT03696758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56092975|NCT03696758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092976|NCT03696758|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56092977|NCT03696758|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56092978|NCT03696758|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56092979|NCT03696758|Adrenergic Agents|adrenergic agents|mesh-ancestor
56092980|NCT03696758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56092981|NCT03233737|Anesthetics|anesthetics|mesh-list
56092983|NCT03233737|Benzocaine|benzocaine|mesh-list
56092984|NCT03233737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56092985|NCT03233737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56092986|NCT03233737|Anesthetics, Local|anesthetics, local|mesh-ancestor
56092987|NCT03233737|Sensory System Agents|sensory system agents|mesh-ancestor
56093022|NCT03473665|Gout Suppressants|gout suppressants|mesh-ancestor
56093023|NCT03473665|Tocolytic Agents|tocolytic agents|mesh-ancestor
56093024|NCT03473665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56093026|NCT03717506|Clindamycin palmitate|clindamycin palmitate|mesh-list
56093027|NCT03717506|Clindamycin phosphate|clindamycin phosphate|mesh-list
56093028|NCT03717506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56093029|NCT03717506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093030|NCT03717506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56093031|NCT03717506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093032|NCT03717506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093033|NCT03861338|Buprenorphine|buprenorphine|mesh-list
56093034|NCT03861338|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56093035|NCT03861338|Narcotics|narcotics|mesh-ancestor
56093036|NCT03861338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093037|NCT03861338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093038|NCT03861338|Analgesics|analgesics|mesh-ancestor
56093039|NCT03861338|Sensory System Agents|sensory system agents|mesh-ancestor
56093040|NCT03861338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093041|NCT03861338|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56093043|NCT00377780|Doxorubicin|doxorubicin|mesh-list
56093044|NCT00377780|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56093045|NCT00377780|Trastuzumab|trastuzumab|mesh-list
56093046|NCT00377780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093047|NCT00377780|Tubulin Modulators|tubulin modulators|mesh-ancestor
56093048|NCT00377780|Antimitotic Agents|antimitotic agents|mesh-ancestor
56093049|NCT00377780|Mitosis Modulators|mitosis modulators|mesh-ancestor
56093050|NCT00377780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093051|NCT00377780|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56093052|NCT00377780|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56093053|NCT00377780|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56093054|NCT00377780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093056|NCT00376519|Cyclosporine|cyclosporine|mesh-list
56093062|NCT00376519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56093063|NCT00376519|Immunologic Factors|immunologic factors|mesh-ancestor
56093064|NCT00376519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093065|NCT00376519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56093066|NCT00376519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56093067|NCT00376519|Alkylating Agents|alkylating agents|mesh-ancestor
56093068|NCT00376519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093069|NCT00376519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093070|NCT00376519|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56093071|NCT00376519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56093073|NCT00376519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093074|NCT00376519|Antifungal Agents|antifungal agents|mesh-ancestor
56093075|NCT00376519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093076|NCT00376519|Dermatologic Agents|dermatologic agents|mesh-ancestor
56093078|NCT00376519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56093079|NCT00376519|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56093081|NCT00376519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56093082|NCT03373591|Bupivacaine|bupivacaine|mesh-list
56093083|NCT03373591|Anesthetics, Local|anesthetics, local|mesh-ancestor
56093114|NCT04121078|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56093115|NCT04121078|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56093116|NCT04121078|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56093117|NCT04121078|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56093118|NCT03248947|Buprenorphine|buprenorphine|mesh-list
56093119|NCT03248947|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56093121|NCT03248947|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56093122|NCT03248947|Narcotics|narcotics|mesh-ancestor
56093123|NCT03248947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093124|NCT03248947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093125|NCT03248947|Analgesics|analgesics|mesh-ancestor
56093126|NCT03248947|Sensory System Agents|sensory system agents|mesh-ancestor
56093127|NCT03248947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093128|NCT03248947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56093129|NCT04114058|Bupivacaine|bupivacaine|mesh-list
56093130|NCT04114058|Anesthetics, Local|anesthetics, local|mesh-ancestor
56093131|NCT04114058|Anesthetics|anesthetics|mesh-ancestor
56093132|NCT04114058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093133|NCT04114058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093134|NCT04114058|Sensory System Agents|sensory system agents|mesh-ancestor
56093135|NCT04114058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093136|NCT03862040|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56093137|NCT03862040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093138|NCT00376831|Fentanyl|fentanyl|mesh-list
56093139|NCT00376831|Midazolam|midazolam|mesh-list
56093140|NCT00376831|Ketamine|ketamine|mesh-list
56093141|NCT00376831|Analgesics|analgesics|mesh-ancestor
56093142|NCT00376831|Sensory System Agents|sensory system agents|mesh-ancestor
56093143|NCT00376831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093144|NCT00376831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093145|NCT00376831|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56093146|NCT00376831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56093147|NCT00376831|Anesthetics, General|anesthetics, general|mesh-ancestor
56093148|NCT00376831|Anesthetics|anesthetics|mesh-ancestor
56093149|NCT00376831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093151|NCT00376831|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56093152|NCT00376831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093153|NCT00376831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093154|NCT00376831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56093155|NCT00376831|Narcotics|narcotics|mesh-ancestor
56093156|NCT00376831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56093157|NCT00376831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56093158|NCT00376831|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56093159|NCT00376831|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56093160|NCT00376831|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093161|NCT00376831|GABA Modulators|gaba modulators|mesh-ancestor
56093162|NCT00376831|GABA Agents|gaba agents|mesh-ancestor
56093165|NCT03857750|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56093167|NCT03857750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093168|NCT03857750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093169|NCT03828422|Calcium|calcium|mesh-list
56093170|NCT03828422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56093172|NCT03852524|Methylnaltrexone|methylnaltrexone|mesh-list
56093207|NCT04039412|Ofloxacin|ofloxacin|mesh-list
56093208|NCT04039412|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56093209|NCT04039412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093210|NCT04039412|Renal Agents|renal agents|mesh-ancestor
56093211|NCT04039412|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56093212|NCT04039412|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56093213|NCT04039412|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56093214|NCT04039412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093215|NCT04039412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093216|NCT04039412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093217|NCT04039412|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56093218|NCT04039412|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56093219|NCT03831854|Lamotrigine|lamotrigine|mesh-list
56093220|NCT03831854|Ketamine|ketamine|mesh-list
56093221|NCT03831854|Analgesics|analgesics|mesh-ancestor
56093222|NCT03831854|Sensory System Agents|sensory system agents|mesh-ancestor
56093223|NCT03831854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093224|NCT03831854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093225|NCT03831854|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56093226|NCT03831854|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56093227|NCT03831854|Anesthetics, General|anesthetics, general|mesh-ancestor
56093228|NCT03831854|Anesthetics|anesthetics|mesh-ancestor
56093229|NCT03831854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093230|NCT03831854|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56093231|NCT03831854|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56093232|NCT03831854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093234|NCT03831854|Anticonvulsants|anticonvulsants|mesh-ancestor
56093253|NCT03806270|Anesthetics|anesthetics|mesh-ancestor
56093254|NCT03806270|GABA Modulators|gaba modulators|mesh-ancestor
56093255|NCT03806270|GABA Agents|gaba agents|mesh-ancestor
56093256|NCT03806270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093257|NCT03806270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093258|NCT03806270|Antipruritics|antipruritics|mesh-ancestor
56093259|NCT03806270|Dermatologic Agents|dermatologic agents|mesh-ancestor
56093260|NCT03806270|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56093261|NCT03806270|Histamine Antagonists|histamine antagonists|mesh-ancestor
56093262|NCT03806270|Histamine Agents|histamine agents|mesh-ancestor
56093263|NCT03497845|Vaccines|vaccines|mesh-list
56093264|NCT03497845|Immunologic Factors|immunologic factors|mesh-ancestor
56093265|NCT03497845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093266|NCT04036292|Varenicline|varenicline|mesh-list
56093267|NCT04036292|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56093268|NCT04036292|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56093269|NCT04036292|Cholinergic Agents|cholinergic agents|mesh-ancestor
56093270|NCT04036292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093271|NCT04036292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093272|NCT04036292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901728|NCT02524054|Diuretics|diuretics|mesh-ancestor
55901729|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
55901730|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901731|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55901732|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901733|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901735|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901736|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
55901737|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901738|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55901739|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55901740|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
55901741|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901742|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901743|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55901745|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55901746|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
55901747|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901748|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
56093273|NCT03501043|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56093274|NCT03501043|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56093275|NCT03501043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56093276|NCT03501043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093277|NCT03501043|Cholinergic Agents|cholinergic agents|mesh-ancestor
56093278|NCT03501043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093279|NCT03501043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093280|NCT00377390|Omalizumab|omalizumab|mesh-list
56093281|NCT00377390|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56093282|NCT00377390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56093283|NCT00377390|Respiratory System Agents|respiratory system agents|mesh-ancestor
56093284|NCT03820388|Propofol|propofol|mesh-list
56093285|NCT03820388|Etomidate|etomidate|mesh-list
56093286|NCT03820388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56093287|NCT03820388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093288|NCT03820388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093289|NCT03820388|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56093290|NCT03820388|Anesthetics, General|anesthetics, general|mesh-ancestor
56093326|NCT04018664|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56093327|NCT04018664|Narcotics|narcotics|mesh-ancestor
56093328|NCT04018664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093329|NCT04018664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093330|NCT04018664|Analgesics|analgesics|mesh-ancestor
56093331|NCT04018664|Sensory System Agents|sensory system agents|mesh-ancestor
56093332|NCT04018664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093333|NCT03506347|Vancomycin|vancomycin|mesh-list
56093334|NCT03506347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56093335|NCT03506347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093336|NCT03266419|Rocuronium|rocuronium|mesh-list
56093337|NCT03266419|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56093338|NCT03266419|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56093340|NCT03266419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093341|NCT03266419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093342|NCT00377468|Dronabinol|dronabinol|mesh-list
56093343|NCT00377468|Hallucinogens|hallucinogens|mesh-ancestor
56093344|NCT00377468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093345|NCT00377468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093346|NCT00377468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56093347|NCT00377468|Analgesics|analgesics|mesh-ancestor
56093348|NCT00377468|Sensory System Agents|sensory system agents|mesh-ancestor
56093349|NCT00377468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093350|NCT00377468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56093351|NCT00377468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56093352|NCT00377468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093353|NCT00377468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093354|NCT00377468|Hormones|hormones|mesh-ancestor
56093355|NCT00377468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56093356|NCT03799484|Lidocaine|lidocaine|mesh-list
56093357|NCT03799484|Prilocaine|prilocaine|mesh-list
56093358|NCT03799484|Petrolatum|petrolatum|mesh-list
56093359|NCT03799484|Botulinum Toxins|botulinum toxins|mesh-list
56093360|NCT03799484|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56093361|NCT03799484|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56093362|NCT03799484|Anesthetics, Local|anesthetics, local|mesh-ancestor
56093363|NCT03799484|Anesthetics|anesthetics|mesh-ancestor
56093364|NCT03799484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093365|NCT03799484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093366|NCT03799484|Sensory System Agents|sensory system agents|mesh-ancestor
56093367|NCT03799484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093368|NCT03799484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56093369|NCT03799484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56093370|NCT03799484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55820488|NCT02390219|Ivacaftor|ivacaftor|mesh-list
56093371|NCT03799484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56093372|NCT03799484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093373|NCT03799484|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56093374|NCT03799484|Cholinergic Agents|cholinergic agents|mesh-ancestor
56093375|NCT03799484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093376|NCT03799484|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56093377|NCT03799484|Emollients|emollients|mesh-ancestor
56093378|NCT03799484|Dermatologic Agents|dermatologic agents|mesh-ancestor
56093382|NCT00377546|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56093383|NCT00377546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56093384|NCT00377546|Analgesics|analgesics|mesh-ancestor
56093385|NCT00377546|Sensory System Agents|sensory system agents|mesh-ancestor
56093386|NCT00377546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093393|NCT04290494|Plasminogen|plasminogen|mesh-list
56093405|NCT03232892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093406|NCT03232892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56093407|NCT03232892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093408|NCT03232892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093409|NCT03510481|Lumefantrine|lumefantrine|mesh-list
56093410|NCT03510481|Artemether|artemether|mesh-list
56093411|NCT03510481|Antimalarials|antimalarials|mesh-ancestor
56093412|NCT03510481|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56093413|NCT03510481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56093414|NCT03510481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093415|NCT03109418|Ketamine|ketamine|mesh-list
56093416|NCT03109418|Analgesics|analgesics|mesh-ancestor
56093417|NCT03109418|Sensory System Agents|sensory system agents|mesh-ancestor
56093418|NCT03109418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093419|NCT03109418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093420|NCT03109418|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56093421|NCT03109418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56093422|NCT03109418|Anesthetics, General|anesthetics, general|mesh-ancestor
56093423|NCT03109418|Anesthetics|anesthetics|mesh-ancestor
56093424|NCT03109418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093425|NCT03109418|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56093426|NCT03109418|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56093427|NCT03109418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093428|NCT03109418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093429|NCT03771560|Leucovorin|leucovorin|mesh-list
56093430|NCT03771560|Folic Acid|folic acid|mesh-list
56093431|NCT03771560|Levoleucovorin|levoleucovorin|mesh-list
56093432|NCT03771560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093433|NCT03771560|Antidotes|antidotes|mesh-ancestor
56093434|NCT03771560|Protective Agents|protective agents|mesh-ancestor
56093435|NCT03771560|Vitamin B Complex|vitamin b complex|mesh-ancestor
56093436|NCT03771560|Vitamins|vitamins|mesh-ancestor
56093437|NCT03771560|Micronutrients|micronutrients|mesh-ancestor
56093438|NCT03771560|Hematinics|hematinics|mesh-ancestor
56093439|NCT03767738|Aflibercept|aflibercept|mesh-list
56093440|NCT03767738|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56093441|NCT03767738|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56093445|NCT03767738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093446|NCT02973620|Simendan|simendan|mesh-list
56093447|NCT02973620|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56093448|NCT02973620|Vasodilator Agents|vasodilator agents|mesh-ancestor
56093449|NCT02973620|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
56093450|NCT02973620|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56093451|NCT02973620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093452|NCT02973620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093453|NCT02973620|Protective Agents|protective agents|mesh-ancestor
56093454|NCT02973620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093456|NCT05313386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56093457|NCT05313386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093458|NCT05313386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093459|NCT05313386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56093460|NCT05313386|Analgesics|analgesics|mesh-ancestor
56093461|NCT05313386|Sensory System Agents|sensory system agents|mesh-ancestor
56093462|NCT05313386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093463|NCT05313386|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56093464|NCT05313386|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56093465|NCT05313386|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56093466|NCT05313386|Adrenergic Agents|adrenergic agents|mesh-ancestor
56093467|NCT05313386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093468|NCT05313386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093469|NCT03031340|Pregabalin|pregabalin|mesh-list
56093470|NCT03031340|Analgesics|analgesics|mesh-ancestor
56093471|NCT03031340|Sensory System Agents|sensory system agents|mesh-ancestor
56093472|NCT03031340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093473|NCT03031340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093474|NCT03031340|Anticonvulsants|anticonvulsants|mesh-ancestor
56093475|NCT03031340|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56093476|NCT03031340|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56093478|NCT03031340|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56093486|NCT03405259|Protective Agents|protective agents|mesh-ancestor
56093487|NCT03405259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093488|NCT03513757|Lidocaine|lidocaine|mesh-list
56093489|NCT03513757|Glycopyrrolate|glycopyrrolate|mesh-list
56093490|NCT03513757|Dexmedetomidine|dexmedetomidine|mesh-list
56093491|NCT03513757|Nitrous Oxide|nitrous oxide|mesh-list
56093492|NCT03513757|Propofol|propofol|mesh-list
56093493|NCT03513757|Sevoflurane|sevoflurane|mesh-list
56093494|NCT03513757|Anesthetics, Local|anesthetics, local|mesh-ancestor
56093495|NCT03513757|Anesthetics|anesthetics|mesh-ancestor
56093496|NCT03513757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093497|NCT03513757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093498|NCT03513757|Sensory System Agents|sensory system agents|mesh-ancestor
56093499|NCT03513757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093500|NCT03513757|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56093501|NCT03513757|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56093502|NCT03513757|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56093503|NCT03513757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56093504|NCT03513757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093505|NCT03513757|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56093506|NCT03513757|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56093507|NCT03513757|Anesthetics, General|anesthetics, general|mesh-ancestor
56093508|NCT03513757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56093509|NCT03513757|Analgesics|analgesics|mesh-ancestor
56093538|NCT03760640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093539|NCT03275623|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56093540|NCT03275623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093541|NCT03756038|Lorazepam|lorazepam|mesh-list
56093542|NCT03756038|Anticonvulsants|anticonvulsants|mesh-ancestor
56093543|NCT03756038|Antiemetics|antiemetics|mesh-ancestor
56093544|NCT03756038|Autonomic Agents|autonomic agents|mesh-ancestor
56093545|NCT03756038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093546|NCT03756038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093548|NCT03756038|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56093549|NCT03756038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093550|NCT03756038|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56093551|NCT03756038|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56093552|NCT03756038|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093553|NCT03756038|GABA Modulators|gaba modulators|mesh-ancestor
56093554|NCT03756038|GABA Agents|gaba agents|mesh-ancestor
56093555|NCT03756038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093556|NCT03756038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093557|NCT03754556|Levonorgestrel|levonorgestrel|mesh-list
56093558|NCT03754556|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56093595|NCT03415243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093596|NCT03415243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093598|NCT03415243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56093599|NCT03415243|Mydriatics|mydriatics|mesh-ancestor
56093600|NCT03415243|Autonomic Agents|autonomic agents|mesh-ancestor
56093601|NCT03415243|Sympathomimetics|sympathomimetics|mesh-ancestor
56093602|NCT03415243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56093604|NCT03415243|Respiratory System Agents|respiratory system agents|mesh-ancestor
56093605|NCT03415243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56093606|NCT03415243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56093607|NCT03415243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56093608|NCT03415243|Adrenergic Agents|adrenergic agents|mesh-ancestor
56093609|NCT03415243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093610|NCT03415243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093611|NCT03415243|Protective Agents|protective agents|mesh-ancestor
56093612|NCT03415243|Antitussive Agents|antitussive agents|mesh-ancestor
56093613|NCT03415243|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56093614|NCT03415243|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56093615|NCT02892500|Betamethasone|betamethasone|mesh-list
56093616|NCT02892500|Betamethasone Valerate|betamethasone valerate|mesh-list
56093617|NCT02892500|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56093618|NCT02892500|Betamethasone benzoate|betamethasone benzoate|mesh-list
56093619|NCT02892500|Bupivacaine|bupivacaine|mesh-list
56093620|NCT02892500|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56093621|NCT02892500|Anesthetics, Local|anesthetics, local|mesh-ancestor
56093623|NCT02892500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093624|NCT02892500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093625|NCT02892500|Sensory System Agents|sensory system agents|mesh-ancestor
56093626|NCT02892500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093627|NCT02892500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56093639|NCT00378404|Docetaxel|docetaxel|mesh-list
56093640|NCT00378404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093641|NCT00378404|Tubulin Modulators|tubulin modulators|mesh-ancestor
56093644|NCT00378404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093645|NCT03742154|Varenicline|varenicline|mesh-list
56093646|NCT03742154|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56093647|NCT03742154|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56093648|NCT03742154|Cholinergic Agents|cholinergic agents|mesh-ancestor
56093649|NCT03742154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093650|NCT03742154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093651|NCT03742154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093652|NCT02734940|Lidocaine|lidocaine|mesh-list
56093653|NCT02734940|Fentanyl|fentanyl|mesh-list
56093654|NCT02734940|Ketamine|ketamine|mesh-list
56093655|NCT02734940|Dexmedetomidine|dexmedetomidine|mesh-list
56093656|NCT02734940|Morphine|morphine|mesh-list
56093657|NCT02734940|Anesthetics, Local|anesthetics, local|mesh-ancestor
56093658|NCT02734940|Anesthetics|anesthetics|mesh-ancestor
56093659|NCT02734940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093660|NCT02734940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093661|NCT02734940|Sensory System Agents|sensory system agents|mesh-ancestor
56093662|NCT02734940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093663|NCT02734940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56093664|NCT02734940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56093665|NCT02734940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56093667|NCT02734940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093668|NCT02734940|Analgesics|analgesics|mesh-ancestor
56093669|NCT02734940|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56093680|NCT02734940|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56093681|NCT02734940|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56093682|NCT02734940|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56093683|NCT02734940|Adrenergic Agents|adrenergic agents|mesh-ancestor
56093684|NCT00378092|Risperidone|risperidone|mesh-list
56093685|NCT00378092|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56093686|NCT00378092|Serotonin Agents|serotonin agents|mesh-ancestor
56093687|NCT00378092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093688|NCT00378092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093689|NCT00378092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093690|NCT00378092|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56093691|NCT00378092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56093692|NCT00378092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901749|NCT02417610|Protective Agents|protective agents|mesh-ancestor
55901750|NCT03116490|Anesthetics|anesthetics|mesh-list
55901751|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901752|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901753|NCT02417298|Ketamine|ketamine|mesh-list
55901754|NCT02417298|Analgesics|analgesics|mesh-ancestor
55901755|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
55901756|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901757|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901758|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55901759|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55901760|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
55901761|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
55901762|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901763|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55901764|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55901765|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901766|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901767|NCT02525536|Trebananib|trebananib|mesh-list
55901768|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55901769|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55901770|NCT02525536|Growth Substances|growth substances|mesh-ancestor
55901771|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901772|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
55901773|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901774|NCT02411994|Artesunate|artesunate|mesh-list
55901775|NCT02411994|Lumefantrine|lumefantrine|mesh-list
55901776|NCT02411994|Artemether|artemether|mesh-list
55901777|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55901778|NCT02411994|Pyronaridine|pyronaridine|mesh-list
55901779|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
55901780|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55901781|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55901782|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901787|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
55901788|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
55901789|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55901790|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55901791|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55901792|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
55901793|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55901794|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901795|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901796|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
55901797|NCT03177720|Imipenem|imipenem|mesh-list
55901798|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55901799|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093693|NCT00378092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093694|NCT00378092|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56093695|NCT00378092|Dopamine Agents|dopamine agents|mesh-ancestor
56093696|NCT01347632|Metronidazole|metronidazole|mesh-list
56093697|NCT01347632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093698|NCT01347632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56093699|NCT01347632|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56093700|NCT01347632|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56093701|NCT02679560|Bupivacaine|bupivacaine|mesh-list
56093702|NCT02679560|Ropivacaine|ropivacaine|mesh-list
56093703|NCT02679560|Anesthetics, Local|anesthetics, local|mesh-ancestor
56093704|NCT02679560|Anesthetics|anesthetics|mesh-ancestor
56093705|NCT02679560|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093706|NCT02679560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093707|NCT02679560|Sensory System Agents|sensory system agents|mesh-ancestor
56093708|NCT02679560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093709|NCT03723980|Propolis|propolis|mesh-list
56093710|NCT03723980|Calcium|calcium|mesh-list
56093711|NCT03723980|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56093712|NCT03723980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093713|NCT03723980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093714|NCT01240304|Gemcitabine|gemcitabine|mesh-list
56093715|NCT01240304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56093716|NCT01240304|Antimetabolites|antimetabolites|mesh-ancestor
56093717|NCT01240304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093718|NCT01240304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093719|NCT01240304|Antiviral Agents|antiviral agents|mesh-ancestor
56093720|NCT01240304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093721|NCT01240304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093722|NCT01240304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56093723|NCT01240304|Immunologic Factors|immunologic factors|mesh-ancestor
56093724|NCT01240304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093725|NCT02614586|Ondansetron|ondansetron|mesh-list
56093726|NCT02614586|Antiemetics|antiemetics|mesh-ancestor
56093727|NCT02614586|Autonomic Agents|autonomic agents|mesh-ancestor
56093728|NCT02614586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093729|NCT02614586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093730|NCT02614586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56093731|NCT02614586|Antipruritics|antipruritics|mesh-ancestor
56093732|NCT02614586|Dermatologic Agents|dermatologic agents|mesh-ancestor
56093733|NCT02614586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56093734|NCT02614586|Serotonin Agents|serotonin agents|mesh-ancestor
56093735|NCT02614586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093736|NCT02614586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093737|NCT02614586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56093738|NCT02614586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56093740|NCT02614586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093741|NCT02614586|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56093742|NCT01211756|Oxytocin|oxytocin|mesh-list
56093743|NCT01211756|Oxytocics|oxytocics|mesh-ancestor
56093744|NCT01211756|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56093745|NCT01211756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093746|NCT03591458|Amitriptyline|amitriptyline|mesh-list
56093747|NCT03591458|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56093748|NCT03591458|Antidepressive Agents|antidepressive agents|mesh-ancestor
56093749|NCT03591458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093750|NCT03591458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56093751|NCT03591458|Analgesics|analgesics|mesh-ancestor
56093765|NCT03565328|Vitamins|vitamins|mesh-ancestor
56093786|NCT02593682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56093787|NCT02593682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093788|NCT02593682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093789|NCT02593682|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56093790|NCT02593682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093791|NCT02593682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093792|NCT01200602|Megestrol|megestrol|mesh-list
56093793|NCT01200602|Megestrol Acetate|megestrol acetate|mesh-list
56093794|NCT01200602|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56093796|NCT01200602|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56093797|NCT01200602|Contraceptive Agents|contraceptive agents|mesh-ancestor
56093798|NCT01200602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56093799|NCT01200602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093800|NCT01200602|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56093801|NCT01200602|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56093802|NCT01200602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56093803|NCT01200602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093804|NCT01200602|Appetite Stimulants|appetite stimulants|mesh-ancestor
56093805|NCT01200602|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56093806|NCT01194908|Tamoxifen|tamoxifen|mesh-list
56093807|NCT01194908|Decitabine|decitabine|mesh-list
56093808|NCT01194908|Panobinostat|panobinostat|mesh-list
56093809|NCT01194908|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56093823|NCT01163084|Leuprolide|leuprolide|mesh-list
56093834|NCT01155518|Hormones|hormones|mesh-ancestor
56093835|NCT01155518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56093836|NCT01155518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093837|NCT01155518|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56093838|NCT01155518|Hormone Antagonists|hormone antagonists|mesh-ancestor
56093839|NCT01155518|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56093840|NCT01155518|Fertility Agents|fertility agents|mesh-ancestor
56093841|NCT01155518|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56093842|NCT01155518|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56093843|NCT01155518|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56093844|NCT03490916|Acetazolamide|acetazolamide|mesh-list
56093845|NCT03490916|Anticonvulsants|anticonvulsants|mesh-ancestor
56093846|NCT03490916|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56093847|NCT03490916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093848|NCT03490916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093849|NCT03490916|Diuretics|diuretics|mesh-ancestor
56093850|NCT03490916|Natriuretic Agents|natriuretic agents|mesh-ancestor
56093851|NCT03490916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093852|NCT03333746|Nivolumab|nivolumab|mesh-list
56093853|NCT03333746|Lenalidomide|lenalidomide|mesh-list
56093854|NCT03333746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56093859|NCT03333746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093860|NCT03333746|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55901800|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55901801|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55901802|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901803|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901804|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901805|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55901806|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55901808|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901809|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
55901810|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901811|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55901812|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093861|NCT03333746|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56093862|NCT03333746|Growth Substances|growth substances|mesh-ancestor
56093863|NCT03333746|Growth Inhibitors|growth inhibitors|mesh-ancestor
56093866|NCT01139996|Sensory System Agents|sensory system agents|mesh-ancestor
56093867|NCT01139996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093868|NCT01139996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093869|NCT01139996|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56093870|NCT01139996|Sympatholytics|sympatholytics|mesh-ancestor
56093871|NCT01139996|Autonomic Agents|autonomic agents|mesh-ancestor
56093872|NCT01139996|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56093873|NCT01139996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56093874|NCT01139996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56093875|NCT01139996|Adrenergic Agents|adrenergic agents|mesh-ancestor
56093876|NCT01139996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093877|NCT01139996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093878|NCT02417870|Aldesleukin|aldesleukin|mesh-list
56093879|NCT02417870|Interleukin-2|interleukin-2|mesh-list
56093880|NCT02417870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56093881|NCT02417870|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56093882|NCT02417870|Analgesics|analgesics|mesh-ancestor
56093883|NCT02417870|Sensory System Agents|sensory system agents|mesh-ancestor
56093884|NCT02417870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56093885|NCT02417870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093886|NCT02417870|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56093887|NCT02417870|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56093888|NCT02417870|Antiviral Agents|antiviral agents|mesh-ancestor
56093889|NCT02417870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56093890|NCT01131884|Alendronate|alendronate|mesh-list
56093891|NCT01131884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56093892|NCT01131884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093893|NCT02389712|Lamotrigine|lamotrigine|mesh-list
56093894|NCT02389712|Fluoxetine|fluoxetine|mesh-list
56093895|NCT02389712|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56093896|NCT02389712|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56093899|NCT02389712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093900|NCT02389712|Serotonin Agents|serotonin agents|mesh-ancestor
56093901|NCT02389712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093902|NCT02389712|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56093903|NCT02389712|Antidepressive Agents|antidepressive agents|mesh-ancestor
56093904|NCT02389712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093909|NCT02389712|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56093910|NCT02389712|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56093911|NCT02389712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56093912|NCT02389712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56093913|NCT02389712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56093914|NCT02389712|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56093915|NCT02369744|Tamsulosin|tamsulosin|mesh-list
56093916|NCT02369744|Silodosin|silodosin|mesh-list
56093917|NCT02369744|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56093918|NCT02369744|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56093951|NCT01078844|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56093952|NCT00376051|Citalopram|citalopram|mesh-list
56093953|NCT00376051|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56093954|NCT00376051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56093955|NCT00376051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56093956|NCT00376051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093957|NCT00376051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56093958|NCT00376051|Serotonin Agents|serotonin agents|mesh-ancestor
56093959|NCT00376051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56093960|NCT00376051|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56093961|NCT00376051|Antidepressive Agents|antidepressive agents|mesh-ancestor
56093962|NCT00376051|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56093963|NCT01072526|Cyclosporine|cyclosporine|mesh-list
56093964|NCT01072526|Lubricant Eye Drops|lubricant eye drops|mesh-list
56093965|NCT01072526|Cyclosporins|cyclosporins|mesh-list
56093966|NCT01072526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56093967|NCT01072526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56093968|NCT01072526|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56093969|NCT01072526|Immunologic Factors|immunologic factors|mesh-ancestor
56093970|NCT01072526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094005|NCT00378638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56094006|NCT00378638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094007|NCT00378638|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56094008|NCT00378638|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56094009|NCT00378638|Growth Substances|growth substances|mesh-ancestor
56094010|NCT00378638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094011|NCT00378638|Growth Inhibitors|growth inhibitors|mesh-ancestor
56094012|NCT03582553|Naringenin|naringenin|mesh-list
56094013|NCT03582553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56094014|NCT03582553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56094015|NCT03582553|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56094016|NCT03582553|Hormone Antagonists|hormone antagonists|mesh-ancestor
56094017|NCT03582553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094018|NCT03582553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094019|NCT01025492|Fenofibric acid|fenofibric acid|mesh-list
56094020|NCT01025492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56094021|NCT01025492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56094022|NCT01025492|Antimetabolites|antimetabolites|mesh-ancestor
56094023|NCT01025492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094024|NCT01025492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56094025|NCT04331834|Hydroxychloroquine|hydroxychloroquine|mesh-list
56094026|NCT04331834|Antimalarials|antimalarials|mesh-ancestor
56094027|NCT04331834|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56094028|NCT04331834|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56094051|NCT02200328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094052|NCT02200328|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56094053|NCT02200328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56094054|NCT02200328|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56094059|NCT04327843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094060|NCT04327843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094061|NCT04327843|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56094062|NCT04327843|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56094063|NCT04327843|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56094064|NCT04327843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094065|NCT04327843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56094066|NCT04327843|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56094067|NCT04327843|Dopamine Agents|dopamine agents|mesh-ancestor
56094068|NCT04327843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094069|NCT04327843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094070|NCT04327843|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56094071|NCT02147834|Ranolazine|ranolazine|mesh-list
56094072|NCT02147834|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56094073|NCT02147834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56094075|NCT00979550|Imiquimod|imiquimod|mesh-list
56094103|NCT02043860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56094104|NCT02043860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094105|NCT01974284|Ethanol|ethanol|mesh-list
56094106|NCT01974284|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56094107|NCT01974284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094108|NCT01974284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094109|NCT01974284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094110|NCT00869414|Insulin|insulin|mesh-list
56094111|NCT00869414|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56094112|NCT00869414|Insulin Glargine|insulin glargine|mesh-list
56094113|NCT00869414|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56094114|NCT00869414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094115|NCT00843986|Conivaptan|conivaptan|mesh-list
56094116|NCT00843986|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
56094117|NCT00843986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094118|NCT00843986|Natriuretic Agents|natriuretic agents|mesh-ancestor
56094119|NCT00843986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094159|NCT03610633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56094160|NCT03610633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094161|NCT00832520|Mirtazapine|mirtazapine|mesh-list
56094162|NCT00832520|Antidepressive Agents|antidepressive agents|mesh-ancestor
56094163|NCT00832520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56094166|NCT00832520|Histamine Agents|histamine agents|mesh-ancestor
56094167|NCT00832520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094168|NCT00832520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094169|NCT00832520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094170|NCT00832520|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56094171|NCT00832520|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56094172|NCT00832520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094173|NCT00832520|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56094174|NCT00832520|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56094175|NCT00832520|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56094176|NCT00832520|Adrenergic Agents|adrenergic agents|mesh-ancestor
56094177|NCT00832520|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56094178|NCT00832520|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56094179|NCT00832520|Serotonin Agents|serotonin agents|mesh-ancestor
56094180|NCT00832520|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56094181|NCT03545893|Ibuprofen|ibuprofen|mesh-list
56094182|NCT03545893|Oxycodone|oxycodone|mesh-list
56094183|NCT03545893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56094184|NCT03545893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56094185|NCT03545893|Analgesics|analgesics|mesh-ancestor
56094186|NCT03545893|Sensory System Agents|sensory system agents|mesh-ancestor
56094187|NCT03545893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094188|NCT03545893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094189|NCT03545893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094190|NCT03545893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094191|NCT03545893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56094192|NCT03545893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094193|NCT03545893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094196|NCT03545893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094197|NCT01877564|Metformin|metformin|mesh-list
56094198|NCT01877564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56094199|NCT01877564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094200|NCT00376987|Zinc Oxide|zinc oxide|mesh-list
56094201|NCT00376987|Dermatologic Agents|dermatologic agents|mesh-ancestor
56094202|NCT00376987|Sunscreening Agents|sunscreening agents|mesh-ancestor
56094203|NCT00376987|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56094205|NCT00376987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094206|NCT01889420|Everolimus|everolimus|mesh-list
56094207|NCT01889420|Pomalidomide|pomalidomide|mesh-list
56094208|NCT01889420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094209|NCT01889420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094210|NCT01889420|Immunologic Factors|immunologic factors|mesh-ancestor
56094211|NCT01889420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094212|NCT01889420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56094253|NCT00379262|Antimetabolites|antimetabolites|mesh-ancestor
56094254|NCT00379262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094255|NCT00379262|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56094256|NCT00379262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094257|NCT00379262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094258|NCT00379262|Immunologic Factors|immunologic factors|mesh-ancestor
56094259|NCT00379262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094261|NCT00793520|Levomilnacipran|levomilnacipran|mesh-list
56094262|NCT00793520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56094263|NCT00793520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56094264|NCT00793520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56094265|NCT00793520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094266|NCT00793520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094267|NCT00793520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094268|NCT00793520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55821394|NCT04608331|Analgesics|analgesics|mesh-ancestor
56094270|NCT00793520|Sensory System Agents|sensory system agents|mesh-ancestor
56094304|NCT04490239|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56094305|NCT04490239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094306|NCT00791336|Nelfinavir|nelfinavir|mesh-list
56094307|NCT00791336|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56094308|NCT00791336|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56094309|NCT00791336|Protease Inhibitors|protease inhibitors|mesh-ancestor
56094310|NCT00791336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094311|NCT00791336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094312|NCT00791336|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56094313|NCT00791336|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56094314|NCT00791336|Antiviral Agents|antiviral agents|mesh-ancestor
56094315|NCT00791336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094316|NCT00771602|Rituximab|rituximab|mesh-list
56094317|NCT00771602|Alemtuzumab|alemtuzumab|mesh-list
56094318|NCT00771602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56094319|NCT00771602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094320|NCT00771602|Immunologic Factors|immunologic factors|mesh-ancestor
56094321|NCT00771602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094322|NCT00771602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094323|NCT01804166|Golimumab|golimumab|mesh-list
56094324|NCT01804166|Infliximab|infliximab|mesh-list
56094325|NCT01804166|Dermatologic Agents|dermatologic agents|mesh-ancestor
56094326|NCT01804166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56094327|NCT01804166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094328|NCT01804166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56094329|NCT01804166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094330|NCT01804166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094331|NCT01804166|Immunologic Factors|immunologic factors|mesh-ancestor
56094332|NCT01804166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094333|NCT04459585|Dabigatran|dabigatran|mesh-list
56094349|NCT01797380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094350|NCT01797380|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56094351|NCT01797380|Antidepressive Agents|antidepressive agents|mesh-ancestor
56094352|NCT01797380|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56094353|NCT00732680|Botulinum Toxins|botulinum toxins|mesh-list
56094354|NCT00732680|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56094355|NCT00732680|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56094356|NCT00732680|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56094357|NCT00732680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56094358|NCT00732680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094359|NCT00732680|Cholinergic Agents|cholinergic agents|mesh-ancestor
56094360|NCT00732680|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094361|NCT00732680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094362|NCT00732680|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56094363|NCT00732680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094364|NCT00726830|Morphine|morphine|mesh-list
56094365|NCT00726830|Oxycodone|oxycodone|mesh-list
56094366|NCT00726830|Methadone|methadone|mesh-list
56094367|NCT00726830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56094368|NCT00726830|Narcotics|narcotics|mesh-ancestor
56094369|NCT00726830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094370|NCT00726830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094371|NCT00726830|Analgesics|analgesics|mesh-ancestor
56094372|NCT00726830|Sensory System Agents|sensory system agents|mesh-ancestor
56094373|NCT00726830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094374|NCT00726830|Antitussive Agents|antitussive agents|mesh-ancestor
56094375|NCT00726830|Respiratory System Agents|respiratory system agents|mesh-ancestor
56094376|NCT00691652|Rituximab|rituximab|mesh-list
56094377|NCT00691652|Clofarabine|clofarabine|mesh-list
56094378|NCT00691652|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56094379|NCT00691652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094392|NCT00685880|Betamethasone|betamethasone|mesh-list
56094393|NCT00685880|Betamethasone acetate phosphate|betamethasone acetate phosphate|mesh-list
56094394|NCT00685880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094395|NCT00685880|Glucocorticoids|glucocorticoids|mesh-ancestor
56094396|NCT00685880|Hormones|hormones|mesh-ancestor
56094397|NCT00685880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094398|NCT00685880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094399|NCT00685880|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56094400|NCT00685880|Respiratory System Agents|respiratory system agents|mesh-ancestor
56094401|NCT00685880|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56094402|NCT00685880|Autonomic Agents|autonomic agents|mesh-ancestor
56094403|NCT00685880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094404|NCT00681044|Melphalan|melphalan|mesh-list
56094405|NCT00681044|Immunologic Factors|immunologic factors|mesh-ancestor
56094406|NCT00681044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094407|NCT00681044|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56094408|NCT00681044|Alkylating Agents|alkylating agents|mesh-ancestor
56094409|NCT00681044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094410|NCT00681044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094411|NCT00681044|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56094415|NCT03632083|Disinfectants|disinfectants|mesh-ancestor
56094445|NCT03636061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094446|NCT00661466|Bupivacaine|bupivacaine|mesh-list
56094447|NCT00661466|Anesthetics, Local|anesthetics, local|mesh-ancestor
56094448|NCT00661466|Anesthetics|anesthetics|mesh-ancestor
56094449|NCT00661466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094450|NCT00661466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094451|NCT00661466|Sensory System Agents|sensory system agents|mesh-ancestor
56094452|NCT00661466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094453|NCT00639626|Insulin Detemir|insulin detemir|mesh-list
56094454|NCT00639626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56094455|NCT00639626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094456|NCT01718444|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56094457|NCT01718444|Clomiphene|clomiphene|mesh-list
56094458|NCT01718444|Enclomiphene|enclomiphene|mesh-list
56094459|NCT01718444|Zuclomiphene|zuclomiphene|mesh-list
56094460|NCT01718444|Medroxyprogesterone|medroxyprogesterone|mesh-list
56094461|NCT01718444|Progestins|progestins|mesh-list
56094462|NCT01718444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56094463|NCT01718444|Hormone Antagonists|hormone antagonists|mesh-ancestor
56094464|NCT01718444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094465|NCT01718444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094466|NCT01718444|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56094467|NCT01718444|Fertility Agents|fertility agents|mesh-ancestor
56094468|NCT01718444|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56094469|NCT01718444|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56094470|NCT01718444|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56094471|NCT01718444|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56094472|NCT01718444|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56094473|NCT01718444|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56094474|NCT01718444|Contraceptive Agents|contraceptive agents|mesh-ancestor
56094479|NCT01718444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094488|NCT00638222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56094489|NCT00638222|Antioxidants|antioxidants|mesh-ancestor
56094490|NCT00638222|Protective Agents|protective agents|mesh-ancestor
56094491|NCT00638222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56094492|NCT00638222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56094493|NCT00638222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56094494|NCT00638222|Vasodilator Agents|vasodilator agents|mesh-ancestor
56094495|NCT00638222|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56094496|NCT00638222|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56094498|NCT00634322|Antidotes|antidotes|mesh-ancestor
56094499|NCT00634322|Protective Agents|protective agents|mesh-ancestor
56094764|NCT04285346|Neurosteroids|neurosteroids|mesh-ancestor
56094500|NCT00634322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094501|NCT00634322|Vitamin B Complex|vitamin b complex|mesh-ancestor
56094502|NCT00634322|Vitamins|vitamins|mesh-ancestor
56094503|NCT00634322|Micronutrients|micronutrients|mesh-ancestor
56094504|NCT00379886|Thiopental|thiopental|mesh-list
56094505|NCT00379886|Propofol|propofol|mesh-list
56094506|NCT00379886|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56094507|NCT00379886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094508|NCT00379886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094509|NCT00379886|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56094510|NCT00379886|Anesthetics, General|anesthetics, general|mesh-ancestor
56094511|NCT00379886|Anesthetics|anesthetics|mesh-ancestor
56094512|NCT00379886|Anticonvulsants|anticonvulsants|mesh-ancestor
56094513|NCT00379886|GABA Modulators|gaba modulators|mesh-ancestor
56094514|NCT00379886|GABA Agents|gaba agents|mesh-ancestor
56094515|NCT00379886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094516|NCT00379886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094517|NCT01705106|Celecoxib|celecoxib|mesh-list
56094518|NCT01705106|Capecitabine|capecitabine|mesh-list
56094537|NCT00624650|Vasopressins|vasopressins|mesh-list
56094538|NCT00624650|Arginine Vasopressin|arginine vasopressin|mesh-list
56094539|NCT00624650|Epinephrine|epinephrine|mesh-list
56094540|NCT00624650|Racepinephrine|racepinephrine|mesh-list
56094541|NCT00624650|Oxymetazoline|oxymetazoline|mesh-list
56094542|NCT00624650|Norepinephrine|norepinephrine|mesh-list
56094543|NCT00624650|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
56094544|NCT00624650|Epinephryl borate|epinephryl borate|mesh-list
56094545|NCT00624650|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56094546|NCT00624650|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56094547|NCT00624650|Adrenergic Agents|adrenergic agents|mesh-ancestor
56094548|NCT00624650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094549|NCT00624650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094550|NCT00624650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094551|NCT00624650|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55901820|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55901822|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
55901823|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
56094563|NCT00624650|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56094564|NCT00624650|Nasal Decongestants|nasal decongestants|mesh-ancestor
56094565|NCT00624650|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56094566|NCT00624650|Protective Agents|protective agents|mesh-ancestor
55821690|NCT04792567|Siponimod|siponimod|mesh-list
56094568|NCT00624650|Coagulants|coagulants|mesh-ancestor
56094569|NCT00624650|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56094570|NCT00624650|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56094571|NCT00377065|Raltegravir Potassium|raltegravir potassium|mesh-list
56094572|NCT00377065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56094573|NCT00377065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56094574|NCT00377065|Antiviral Agents|antiviral agents|mesh-ancestor
56094575|NCT00377065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901824|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
55901825|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55901826|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901827|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
55901828|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
55901829|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55901830|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901831|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901832|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55901833|NCT03174678|Analgesics|analgesics|mesh-ancestor
55901834|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
55901835|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901836|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55901837|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55901838|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55901839|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
55901840|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094576|NCT00377065|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56094577|NCT00377065|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56094578|NCT00377065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094579|NCT00377065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094581|NCT00377143|Anticoagulants|anticoagulants|mesh-ancestor
56094583|NCT00610532|Phenytoin|phenytoin|mesh-list
56094584|NCT00610532|Anticonvulsants|anticonvulsants|mesh-ancestor
56094585|NCT00610532|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56094586|NCT00610532|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56094587|NCT00610532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56094588|NCT00610532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094589|NCT00610532|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56094590|NCT00610532|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56094591|NCT00610532|Uricosuric Agents|uricosuric agents|mesh-ancestor
56094592|NCT00610532|Gout Suppressants|gout suppressants|mesh-ancestor
56094593|NCT00610532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094594|NCT00610532|Renal Agents|renal agents|mesh-ancestor
56094595|NCT03642457|Bupivacaine|bupivacaine|mesh-list
56094596|NCT03642457|Anesthetics, Local|anesthetics, local|mesh-ancestor
56094597|NCT03642457|Anesthetics|anesthetics|mesh-ancestor
56094598|NCT03642457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094599|NCT03642457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094600|NCT03642457|Sensory System Agents|sensory system agents|mesh-ancestor
56094601|NCT03642457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094627|NCT03644095|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
56094628|NCT03644095|Expectorants|expectorants|mesh-ancestor
56094629|NCT03644095|Respiratory System Agents|respiratory system agents|mesh-ancestor
56094630|NCT03644095|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56094631|NCT03644095|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56094632|NCT03644095|Adrenergic Agents|adrenergic agents|mesh-ancestor
56094633|NCT03644095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094634|NCT03644095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094635|NCT03644095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094636|NCT03644095|Appetite Depressants|appetite depressants|mesh-ancestor
56094637|NCT03644095|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56094638|NCT03644095|Sympathomimetics|sympathomimetics|mesh-ancestor
56094639|NCT03644095|Autonomic Agents|autonomic agents|mesh-ancestor
56094640|NCT03644095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094641|NCT03644095|Nasal Decongestants|nasal decongestants|mesh-ancestor
56094642|NCT03644095|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56094643|NCT01633814|Estradiol|estradiol|mesh-list
56094685|NCT04342663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094686|NCT04342663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56094687|NCT04342663|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56094688|NCT04342663|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56094689|NCT04342663|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56094690|NCT04342663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094691|NCT04342663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094692|NCT04342663|Serotonin Agents|serotonin agents|mesh-ancestor
56094693|NCT04342663|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56094694|NCT04342663|Antidepressive Agents|antidepressive agents|mesh-ancestor
56094695|NCT04342663|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56094696|NCT04342663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56094697|NCT04342663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094698|NCT04342663|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56094699|NCT00589550|Interferons|interferons|mesh-list
56094700|NCT00589550|Interferon-alpha|interferon-alpha|mesh-list
56094701|NCT00589550|Interferon alpha-2|interferon alpha-2|mesh-list
56094702|NCT00589550|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56094703|NCT00589550|Sorafenib|sorafenib|mesh-list
56094739|NCT04429880|Oxytocics|oxytocics|mesh-ancestor
56094740|NCT04429880|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56094741|NCT04429880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094742|NCT04706546|Sildenafil Citrate|sildenafil citrate|mesh-list
56094743|NCT04706546|Vasodilator Agents|vasodilator agents|mesh-ancestor
56094744|NCT04706546|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56094745|NCT04706546|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56094746|NCT04706546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094747|NCT04706546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094748|NCT04706546|Urological Agents|urological agents|mesh-ancestor
56094749|NCT04311632|Mycophenolic Acid|mycophenolic acid|mesh-list
56094750|NCT04311632|Tacrolimus|tacrolimus|mesh-list
56094751|NCT04311632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094752|NCT04311632|Immunologic Factors|immunologic factors|mesh-ancestor
56094753|NCT04311632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094754|NCT04311632|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56094755|NCT04311632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094756|NCT04311632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094757|NCT04311632|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56094758|NCT04311632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094759|NCT04311632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56094760|NCT04311632|Antitubercular Agents|antitubercular agents|mesh-ancestor
56094761|NCT04311632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56094762|NCT04311632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094763|NCT04285346|Ganaxolone|ganaxolone|mesh-list
56094765|NCT04285346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56094766|NCT04285346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094767|NCT04285346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094768|NCT04285346|GABA Modulators|gaba modulators|mesh-ancestor
56094769|NCT04285346|GABA Agents|gaba agents|mesh-ancestor
56094770|NCT01692158|Heparin|heparin|mesh-list
56094782|NCT01570634|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56094784|NCT01570634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56094785|NCT03928327|Itraconazole|itraconazole|mesh-list
56094786|NCT03928327|Rifampin|rifampin|mesh-list
56094787|NCT03928327|Antifungal Agents|antifungal agents|mesh-ancestor
56094788|NCT03928327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094789|NCT03928327|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56094790|NCT03928327|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56094791|NCT03928327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094792|NCT03928327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094793|NCT03928327|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55821914|NCT02619253|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56094794|NCT03928327|Hormone Antagonists|hormone antagonists|mesh-ancestor
56094795|NCT03928327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094796|NCT03928327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094797|NCT03928327|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56094798|NCT03928327|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56094811|NCT01055756|Ephedrine|ephedrine|mesh-list
56094833|NCT00652574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094834|NCT00652574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56094835|NCT00652574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094836|NCT00652574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094837|NCT01550510|Ascorbic Acid|ascorbic acid|mesh-list
56094838|NCT01550510|Irinotecan|irinotecan|mesh-list
56094839|NCT01550510|Camptothecin|camptothecin|mesh-list
56094840|NCT01550510|Vitamins|vitamins|mesh-ancestor
56094841|NCT01550510|Micronutrients|micronutrients|mesh-ancestor
56094842|NCT01550510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094843|NCT01550510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56094844|NCT01550510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56094845|NCT01550510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094846|NCT01550510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094847|NCT01550510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094848|NCT01550510|Antioxidants|antioxidants|mesh-ancestor
56094849|NCT01550510|Protective Agents|protective agents|mesh-ancestor
56094850|NCT01550510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56094851|NCT04333225|Hydroxychloroquine|hydroxychloroquine|mesh-list
56094852|NCT04333225|Antimalarials|antimalarials|mesh-ancestor
56094853|NCT04333225|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56094854|NCT04333225|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56094855|NCT04333225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094856|NCT04333225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094857|NCT04333225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094858|NCT04333225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094859|NCT00556400|Contraceptive Agents|contraceptive agents|mesh-list
56094860|NCT00556400|Contraceptives, Oral|contraceptives, oral|mesh-list
56094861|NCT00556400|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56094862|NCT00556400|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56094863|NCT00556400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094865|NCT00521924|Cyclosporine|cyclosporine|mesh-list
56094878|NCT00521924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094879|NCT00521924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094880|NCT00521924|Dermatologic Agents|dermatologic agents|mesh-ancestor
56094881|NCT00521924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094882|NCT00521924|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56094883|NCT00521924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56094884|NCT00521924|Immunologic Factors|immunologic factors|mesh-ancestor
56094885|NCT00521924|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56094886|NCT00521924|Antifungal Agents|antifungal agents|mesh-ancestor
56094887|NCT00521924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094888|NCT00521924|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56094889|NCT00521924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56094890|NCT00521924|Amebicides|amebicides|mesh-ancestor
56094891|NCT00521924|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56094892|NCT00521924|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56094893|NCT00521924|Antimalarials|antimalarials|mesh-ancestor
56094894|NCT00521924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56094895|NCT00521924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56094897|NCT00521924|Sensory System Agents|sensory system agents|mesh-ancestor
56094898|NCT00521924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094899|NCT00521924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094900|NCT03927781|Pregabalin|pregabalin|mesh-list
56094901|NCT03927781|Analgesics|analgesics|mesh-ancestor
56094902|NCT03927781|Sensory System Agents|sensory system agents|mesh-ancestor
56094903|NCT03927781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094904|NCT03927781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094905|NCT03927781|Anticonvulsants|anticonvulsants|mesh-ancestor
56094906|NCT03927781|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56094907|NCT03927781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56094909|NCT03927781|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56094918|NCT00379964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094919|NCT01545518|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56094921|NCT01545518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094922|NCT01526408|Famciclovir|famciclovir|mesh-list
56094923|NCT01526408|Antiviral Agents|antiviral agents|mesh-ancestor
56094924|NCT01526408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094925|NCT01526408|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56094926|NCT01526408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094927|NCT01526408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094928|NCT04713644|Propofol|propofol|mesh-list
56094929|NCT04713644|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56094930|NCT04713644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094931|NCT04713644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094932|NCT04713644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56094933|NCT04713644|Anesthetics, General|anesthetics, general|mesh-ancestor
56094934|NCT04713644|Anesthetics|anesthetics|mesh-ancestor
56094935|NCT00000734|Zidovudine|zidovudine|mesh-list
56094936|NCT00000734|Trimethoprim|trimethoprim|mesh-list
56094937|NCT00000734|Sulfamethoxazole|sulfamethoxazole|mesh-list
56094938|NCT00000734|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56094940|NCT00000734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094941|NCT00000734|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56094942|NCT00000734|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56094966|NCT00000764|Interferon-alpha|interferon-alpha|mesh-list
56094967|NCT00000764|Interferon alpha-2|interferon alpha-2|mesh-list
56094968|NCT00000764|Isotretinoin|isotretinoin|mesh-list
56094969|NCT00000764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094970|NCT00000764|Antiviral Agents|antiviral agents|mesh-ancestor
56094971|NCT00000764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56094972|NCT00000764|Immunologic Factors|immunologic factors|mesh-ancestor
56094973|NCT00000764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094974|NCT00000764|Dermatologic Agents|dermatologic agents|mesh-ancestor
56094976|NCT03909763|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56094977|NCT03909763|Hormone Antagonists|hormone antagonists|mesh-ancestor
56094978|NCT03909763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56094979|NCT03909763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094980|NCT00484718|Celecoxib|celecoxib|mesh-list
56094981|NCT00484718|Oxycodone|oxycodone|mesh-list
56094982|NCT00484718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56094983|NCT00484718|Narcotics|narcotics|mesh-ancestor
56094984|NCT00484718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56094985|NCT00484718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56094986|NCT00484718|Analgesics|analgesics|mesh-ancestor
56094987|NCT00484718|Sensory System Agents|sensory system agents|mesh-ancestor
56094988|NCT00484718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56094989|NCT00484718|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56094990|NCT00484718|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56094991|NCT00484718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56094992|NCT00484718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56094993|NCT00484718|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56094994|NCT00484718|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56094995|NCT00484718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56094996|NCT00484718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56094997|NCT03665155|Daratumumab|daratumumab|mesh-list
56094998|NCT03665155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56094999|NCT00477230|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
56095000|NCT00448682|Leucovorin|leucovorin|mesh-list
56095001|NCT00448682|Docetaxel|docetaxel|mesh-list
56095002|NCT00448682|Oxaliplatin|oxaliplatin|mesh-list
56095003|NCT00448682|Floxuridine|floxuridine|mesh-list
56095006|NCT00448682|Tubulin Modulators|tubulin modulators|mesh-ancestor
56095007|NCT00448682|Antimitotic Agents|antimitotic agents|mesh-ancestor
56095008|NCT00448682|Mitosis Modulators|mitosis modulators|mesh-ancestor
56095009|NCT00448682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095010|NCT00448682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095012|NCT00448682|Protective Agents|protective agents|mesh-ancestor
56095013|NCT00448682|Vitamin B Complex|vitamin b complex|mesh-ancestor
56095014|NCT00448682|Vitamins|vitamins|mesh-ancestor
56095015|NCT00448682|Micronutrients|micronutrients|mesh-ancestor
56095016|NCT00448682|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56095017|NCT00448682|Antimetabolites|antimetabolites|mesh-ancestor
56095018|NCT04713488|Vaccines|vaccines|mesh-list
56095019|NCT04713488|Immunologic Factors|immunologic factors|mesh-ancestor
55822138|NCT01971645|Dexamethasone|dexamethasone|mesh-list
56095020|NCT04713488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095021|NCT03675451|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56095022|NCT03675451|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56095023|NCT03675451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095024|NCT00380120|Warfarin|warfarin|mesh-list
56095025|NCT00380120|Anticoagulants|anticoagulants|mesh-ancestor
56095026|NCT00000770|Zidovudine|zidovudine|mesh-list
56095027|NCT00000770|Nevirapine|nevirapine|mesh-list
56095028|NCT00000770|Didanosine|didanosine|mesh-list
56095029|NCT00000770|Antimetabolites|antimetabolites|mesh-ancestor
56095033|NCT00000770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095057|NCT00000776|Amphotericin B|amphotericin b|mesh-list
56095058|NCT00000776|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56095059|NCT00000776|Flucytosine|flucytosine|mesh-list
56095060|NCT00000776|Dexamethasone|dexamethasone|mesh-list
56095061|NCT00000776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56095062|NCT00000776|Antiemetics|antiemetics|mesh-ancestor
56095063|NCT00000776|Autonomic Agents|autonomic agents|mesh-ancestor
56095064|NCT00000776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095065|NCT00000776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095066|NCT00000776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56095067|NCT00000776|Glucocorticoids|glucocorticoids|mesh-ancestor
56095068|NCT00000776|Hormones|hormones|mesh-ancestor
56095069|NCT00000776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56095119|NCT00000800|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56095120|NCT00000800|Narcotics|narcotics|mesh-ancestor
56095121|NCT00000800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095122|NCT00000800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095123|NCT00000800|Analgesics|analgesics|mesh-ancestor
56095124|NCT00000800|Sensory System Agents|sensory system agents|mesh-ancestor
56095125|NCT00000800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095126|NCT00000800|Antitussive Agents|antitussive agents|mesh-ancestor
56095127|NCT00000800|Respiratory System Agents|respiratory system agents|mesh-ancestor
56095128|NCT03679975|Riluzole|riluzole|mesh-list
56095129|NCT03679975|Anticonvulsants|anticonvulsants|mesh-ancestor
56095130|NCT03679975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56095131|NCT03679975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56095132|NCT03679975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56095133|NCT03679975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095134|NCT03679975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095135|NCT03679975|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56095136|NCT03679975|Protective Agents|protective agents|mesh-ancestor
56095137|NCT03887299|Disinfectants|disinfectants|mesh-list
56095138|NCT03887299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095139|NCT03684265|Meloxicam|meloxicam|mesh-list
56095140|NCT03684265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56095141|NCT03684265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56095142|NCT03684265|Analgesics|analgesics|mesh-ancestor
56095143|NCT03684265|Sensory System Agents|sensory system agents|mesh-ancestor
56095144|NCT03684265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095145|NCT03684265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095146|NCT03684265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56095147|NCT03684265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56095148|NCT03684265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56095149|NCT03684265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56095150|NCT03684265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095151|NCT03684265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095152|NCT00218036|Dexetimide|dexetimide|mesh-list
56095153|NCT00218036|Modafinil|modafinil|mesh-list
55901841|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901842|NCT02409498|Bupivacaine|bupivacaine|mesh-list
55901843|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
55901844|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
56095155|NCT00218036|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56095156|NCT00218036|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56095157|NCT00218036|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56095158|NCT00218036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095159|NCT00218036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56095160|NCT00218036|Serotonin Agents|serotonin agents|mesh-ancestor
56095161|NCT00218036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095162|NCT00218036|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56095163|NCT00218036|Antidepressive Agents|antidepressive agents|mesh-ancestor
56095164|NCT00218036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56095165|NCT00218036|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56095166|NCT00218036|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56095167|NCT00218036|Parasympatholytics|parasympatholytics|mesh-ancestor
56095168|NCT00218036|Autonomic Agents|autonomic agents|mesh-ancestor
56095169|NCT00218036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095170|NCT00218036|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56095171|NCT00218036|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56095172|NCT00218036|Cholinergic Agents|cholinergic agents|mesh-ancestor
56095177|NCT00233090|Modafinil|modafinil|mesh-list
56095206|NCT00000818|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095207|NCT00000818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095208|NCT00000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095209|NCT00000818|Antiviral Agents|antiviral agents|mesh-ancestor
56095210|NCT00000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095211|NCT00000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095212|NCT00000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095213|NCT00177866|Celecoxib|celecoxib|mesh-list
56095214|NCT00177866|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56095215|NCT00177866|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56095216|NCT00177866|Analgesics|analgesics|mesh-ancestor
56095217|NCT00177866|Sensory System Agents|sensory system agents|mesh-ancestor
56095218|NCT00177866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095219|NCT00177866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095220|NCT00177866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56095221|NCT00177866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56095222|NCT00177866|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56095223|NCT00177866|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56095224|NCT00177866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095225|NCT00177866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095226|NCT00089414|Drospirenone|drospirenone|mesh-list
56095227|NCT00089414|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56095229|NCT00089414|Estradiol|estradiol|mesh-list
56095256|NCT03704467|Carboplatin|carboplatin|mesh-list
56095257|NCT03704467|Avelumab|avelumab|mesh-list
56095258|NCT03704467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095259|NCT03704467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56095260|NCT00000842|Mitogens|mitogens|mesh-list
56095261|NCT00000842|Mitosis Modulators|mitosis modulators|mesh-ancestor
56095262|NCT00000842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095263|NCT02145260|Dialysis Solutions|dialysis solutions|mesh-list
56095264|NCT02145260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56095265|NCT00000848|Indinavir|indinavir|mesh-list
56095323|NCT03714919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095324|NCT03714919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095325|NCT03714919|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56095326|NCT03714919|Analgesics|analgesics|mesh-ancestor
56095327|NCT03714919|Sensory System Agents|sensory system agents|mesh-ancestor
56095328|NCT03714919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095329|NCT03714919|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56095330|NCT03714919|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56095331|NCT03714919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56095332|NCT03714919|Adrenergic Agents|adrenergic agents|mesh-ancestor
56095333|NCT03714919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56095334|NCT03714919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095335|NCT03714919|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56095336|NCT03714919|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56095337|NCT03714919|Anesthetics, General|anesthetics, general|mesh-ancestor
56095338|NCT03714919|Anesthetics|anesthetics|mesh-ancestor
56095339|NCT03714919|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56095340|NCT03714919|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56095341|NCT03714919|Antipyretics|antipyretics|mesh-ancestor
56095379|NCT04218799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095380|NCT04218799|Disinfectants|disinfectants|mesh-ancestor
56095381|NCT04218799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56095382|NCT04218799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56095383|NCT04218799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095384|NCT04218799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095386|NCT04204057|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
56095388|NCT04204057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095389|NCT00001736|Cysteamine|cysteamine|mesh-list
56095390|NCT00001736|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56095391|NCT00001736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095392|NCT00000884|polysaccharide-K|polysaccharide-k|mesh-list
56095393|NCT00000884|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56095394|NCT00000884|Immunologic Factors|immunologic factors|mesh-ancestor
56095395|NCT00000884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095396|NCT00000884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56095397|NCT00000884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095398|NCT00000884|Antiviral Agents|antiviral agents|mesh-ancestor
56095399|NCT00000884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095400|NCT00000884|Interferon Inducers|interferon inducers|mesh-ancestor
56095407|NCT00000896|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
55901845|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901846|NCT02409498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901847|NCT02409498|Sensory System Agents|sensory system agents|mesh-ancestor
55901848|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901849|NCT02409186|Paclitaxel|paclitaxel|mesh-list
55901850|NCT02409186|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55901851|NCT02409186|Cisplatin|cisplatin|mesh-list
55901852|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
55901853|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55901854|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095409|NCT00000896|Interleukin-12|interleukin-12|mesh-list
56095410|NCT00000896|Sargramostim|sargramostim|mesh-list
56095411|NCT00000896|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095412|NCT00000896|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095413|NCT00000896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095414|NCT00000896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095415|NCT00000896|Antiviral Agents|antiviral agents|mesh-ancestor
56095416|NCT00000896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095417|NCT00000896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095418|NCT00000896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095419|NCT00000896|Antimetabolites|antimetabolites|mesh-ancestor
56095420|NCT00000896|Immunologic Factors|immunologic factors|mesh-ancestor
56095421|NCT00000896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095422|NCT00000896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095423|NCT00000896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56095424|NCT00000896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56095425|NCT00000896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56095426|NCT00000896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56095427|NCT00000896|Protease Inhibitors|protease inhibitors|mesh-ancestor
56095428|NCT00000896|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56095429|NCT00000896|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56095430|NCT00000896|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56095431|NCT00000896|Growth Substances|growth substances|mesh-ancestor
56095432|NCT00000896|Growth Inhibitors|growth inhibitors|mesh-ancestor
56095433|NCT00001790|Micafungin|micafungin|mesh-list
56095437|NCT00000902|Nelfinavir|nelfinavir|mesh-list
56095438|NCT00000902|Lamivudine|lamivudine|mesh-list
55901859|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55901862|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
55901863|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55901864|NCT02410746|Narcotics|narcotics|mesh-ancestor
55901865|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901866|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901867|NCT02410746|Analgesics|analgesics|mesh-ancestor
55901868|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
55901869|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863925|NCT01976507|Dabigatran|dabigatran|mesh-list
56095439|NCT00000902|Zidovudine|zidovudine|mesh-list
56095440|NCT00000902|Nevirapine|nevirapine|mesh-list
56095441|NCT00000902|Didanosine|didanosine|mesh-list
56095442|NCT00000902|Stavudine|stavudine|mesh-list
56095443|NCT00000902|Zalcitabine|zalcitabine|mesh-list
56095444|NCT00000902|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56095445|NCT00000902|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56095446|NCT00000902|Protease Inhibitors|protease inhibitors|mesh-ancestor
56095447|NCT00000902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095448|NCT00000902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095449|NCT00000902|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095450|NCT00000902|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095451|NCT00000902|Antiviral Agents|antiviral agents|mesh-ancestor
56095452|NCT00000902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095453|NCT00000902|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56095742|NCT00000260|Analgesics|analgesics|mesh-ancestor
56095454|NCT00000902|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56095455|NCT00000902|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095456|NCT00000902|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095457|NCT00000902|Antimetabolites|antimetabolites|mesh-ancestor
56095458|NCT00000902|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56095459|NCT00000902|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56095460|NCT04331600|Chloroquine|chloroquine|mesh-list
56095461|NCT04331600|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
56095462|NCT04331600|Amebicides|amebicides|mesh-ancestor
56095463|NCT04331600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56095464|NCT04331600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56095465|NCT04331600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095466|NCT04331600|Antimalarials|antimalarials|mesh-ancestor
56095467|NCT04331600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56095468|NCT04331600|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56095469|NCT04331600|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56095470|NCT04331600|Analgesics|analgesics|mesh-ancestor
56095471|NCT04331600|Sensory System Agents|sensory system agents|mesh-ancestor
55822587|NCT04787341|Panitumumab|panitumumab|mesh-list
56095472|NCT04331600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095473|NCT04331600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095474|NCT04331600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55901870|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56095475|NCT04331600|Filaricides|filaricides|mesh-ancestor
56095476|NCT04331600|Antinematodal Agents|antinematodal agents|mesh-ancestor
56095477|NCT04331600|Anthelmintics|anthelmintics|mesh-ancestor
56095479|NCT00000188|Antidepressive Agents|antidepressive agents|mesh-ancestor
56095480|NCT00000188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56095481|NCT00000188|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56095482|NCT00000188|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56095483|NCT00000188|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
56095484|NCT00000188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095485|NCT00000188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095486|NCT00000188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56095487|NCT00000188|Protective Agents|protective agents|mesh-ancestor
56095488|NCT00000188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095491|NCT00000914|Indinavir|indinavir|mesh-list
56095492|NCT00000914|Efavirenz|efavirenz|mesh-list
56095493|NCT00000914|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56095494|NCT00000914|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56095495|NCT00000914|Protease Inhibitors|protease inhibitors|mesh-ancestor
56095496|NCT00000914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095497|NCT00000914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095498|NCT00000914|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095499|NCT00000914|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095500|NCT00000914|Antiviral Agents|antiviral agents|mesh-ancestor
56095501|NCT00000914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095504|NCT00000914|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095525|NCT00000920|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56095526|NCT00000920|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095527|NCT00000920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095529|NCT00000938|Doxycycline|doxycycline|mesh-list
56095530|NCT00000938|Ceftriaxone|ceftriaxone|mesh-list
56095531|NCT00000938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56095532|NCT00000938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095533|NCT00000938|Antimalarials|antimalarials|mesh-ancestor
56095534|NCT00000938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56095535|NCT00000938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56095536|NCT00001862|Etanercept|etanercept|mesh-list
56095537|NCT00001862|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56095538|NCT00001862|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56095539|NCT00001862|Analgesics|analgesics|mesh-ancestor
56095540|NCT00001862|Sensory System Agents|sensory system agents|mesh-ancestor
56095541|NCT00001862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095542|NCT00001862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095543|NCT00001862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56095544|NCT00001862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56095545|NCT00001862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56095546|NCT00001862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56095547|NCT00001862|Immunologic Factors|immunologic factors|mesh-ancestor
56095548|NCT00000194|Cycloserine|cycloserine|mesh-list
56095577|NCT00000212|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56095578|NCT00000212|Antidepressive Agents|antidepressive agents|mesh-ancestor
56095579|NCT00000212|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56095580|NCT00000212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095842|NCT00001034|Antiviral Agents|antiviral agents|mesh-ancestor
56095581|NCT00000212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095582|NCT00000212|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56095583|NCT00000212|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56095584|NCT00000212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56095585|NCT00000212|Adrenergic Agents|adrenergic agents|mesh-ancestor
56095586|NCT00000212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56095587|NCT00000212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095588|NCT00000944|Lamivudine|lamivudine|mesh-list
56095589|NCT00000944|Zidovudine|zidovudine|mesh-list
56095590|NCT00000944|Indinavir|indinavir|mesh-list
56095591|NCT00000944|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095592|NCT00000944|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095593|NCT00000944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095594|NCT00000944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095595|NCT00000944|Antiviral Agents|antiviral agents|mesh-ancestor
56095596|NCT00000944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095597|NCT00000944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095603|NCT00000950|Pyridoxine|pyridoxine|mesh-list
56095629|NCT00000950|Micronutrients|micronutrients|mesh-ancestor
56095630|NCT00000950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095631|NCT00000218|Carbamazepine|carbamazepine|mesh-list
56095632|NCT00000218|Anticonvulsants|anticonvulsants|mesh-ancestor
56095633|NCT00000218|Antimanic Agents|antimanic agents|mesh-ancestor
56095634|NCT00000218|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56095635|NCT00000218|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095636|NCT00000218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095637|NCT00000218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56095638|NCT00000218|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56095639|NCT00000218|Analgesics|analgesics|mesh-ancestor
56095640|NCT00000218|Sensory System Agents|sensory system agents|mesh-ancestor
56095641|NCT00000218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095642|NCT00000218|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56095643|NCT00000218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56095644|NCT00000218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095645|NCT00000218|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56095646|NCT00000218|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56095647|NCT00000224|Buprenorphine|buprenorphine|mesh-list
56095648|NCT00000224|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56095649|NCT00000224|Narcotics|narcotics|mesh-ancestor
56095683|NCT00000236|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56095684|NCT00000974|Pentamidine|pentamidine|mesh-list
56095685|NCT00000974|Antifungal Agents|antifungal agents|mesh-ancestor
56095686|NCT00000974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095687|NCT00000974|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56095688|NCT00000974|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56095689|NCT00000974|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56095690|NCT00000242|Carbamazepine|carbamazepine|mesh-list
56095691|NCT00000242|Anticonvulsants|anticonvulsants|mesh-ancestor
56095692|NCT00000242|Antimanic Agents|antimanic agents|mesh-ancestor
56095693|NCT00000242|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56095694|NCT00000242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095695|NCT00000242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095696|NCT00000242|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56095697|NCT00000242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56095698|NCT00000242|Analgesics|analgesics|mesh-ancestor
56095699|NCT00000242|Sensory System Agents|sensory system agents|mesh-ancestor
56095700|NCT00000242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095701|NCT00000242|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56095702|NCT00000242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56144787|NCT05209620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095704|NCT00000242|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56095705|NCT00000242|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56095706|NCT00000980|Spiramycin|spiramycin|mesh-list
56095707|NCT00000980|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56095730|NCT00000254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095731|NCT00000254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56095732|NCT00000254|Analgesics|analgesics|mesh-ancestor
56095733|NCT00000254|Sensory System Agents|sensory system agents|mesh-ancestor
56095734|NCT00000254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095735|NCT00000260|Nitrous Oxide|nitrous oxide|mesh-list
56095736|NCT00000260|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56095737|NCT00000260|Anesthetics, General|anesthetics, general|mesh-ancestor
56095738|NCT00000260|Anesthetics|anesthetics|mesh-ancestor
56095739|NCT00000260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095740|NCT00000260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095741|NCT00000260|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56095743|NCT00000260|Sensory System Agents|sensory system agents|mesh-ancestor
56095744|NCT00000260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095745|NCT00000266|Flupenthixol|flupenthixol|mesh-list
56095746|NCT00000266|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
56095747|NCT00000266|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56095748|NCT00000266|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56095749|NCT00000266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095750|NCT00000266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095751|NCT00000266|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56095752|NCT00000266|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56095753|NCT00000266|Dopamine Agents|dopamine agents|mesh-ancestor
56095754|NCT00000266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56095755|NCT00000266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095757|NCT00001016|Trimetrexate|trimetrexate|mesh-list
56095758|NCT00001016|Calcium|calcium|mesh-list
56095759|NCT00001016|Levoleucovorin|levoleucovorin|mesh-list
56095760|NCT00001016|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56095761|NCT00001016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095765|NCT00001016|Vitamins|vitamins|mesh-ancestor
56095775|NCT03811951|Insulin|insulin|mesh-list
56095776|NCT03811951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56095777|NCT03811951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822890|NCT04197089|Vitamin D|vitamin d|mesh-list
56095778|NCT04332289|Deuterium Oxide|deuterium oxide|mesh-list
56095779|NCT04332289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095780|NCT04332289|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56095781|NCT04332289|Protective Agents|protective agents|mesh-ancestor
56095782|NCT04332289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095783|NCT00001022|Zidovudine|zidovudine|mesh-list
56095784|NCT00001022|Didanosine|didanosine|mesh-list
56095785|NCT00001022|Zalcitabine|zalcitabine|mesh-list
56095786|NCT00001022|Antimetabolites|antimetabolites|mesh-ancestor
56095787|NCT00001022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095788|NCT00001022|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56095789|NCT00001022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095790|NCT00001022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095791|NCT00001022|Antiviral Agents|antiviral agents|mesh-ancestor
56095792|NCT00001022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095793|NCT00001022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56095794|NCT00001022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56095795|NCT05218148|Oxaliplatin|oxaliplatin|mesh-list
56095796|NCT05218148|Trastuzumab|trastuzumab|mesh-list
56095797|NCT05218148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095798|NCT05218148|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56095800|NCT00001934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56095801|NCT00001934|Immunologic Factors|immunologic factors|mesh-ancestor
56095802|NCT00001934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095803|NCT00000278|Disulfiram|disulfiram|mesh-list
56095804|NCT00000278|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56095805|NCT00000278|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56095806|NCT00000278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095808|NCT00001028|Dapsone|dapsone|mesh-list
56095818|NCT00001028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56095819|NCT00001028|Antifungal Agents|antifungal agents|mesh-ancestor
56095820|NCT00001028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56095821|NCT00001940|Voriconazole|voriconazole|mesh-list
56095822|NCT00001940|Antifungal Agents|antifungal agents|mesh-ancestor
56095823|NCT00001940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095824|NCT00001940|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56095825|NCT00001940|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56095826|NCT00001940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095827|NCT00001940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095828|NCT00001940|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56095829|NCT00001940|Hormone Antagonists|hormone antagonists|mesh-ancestor
56095830|NCT00001940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56095831|NCT00001940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095832|NCT00001940|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56095833|NCT03907033|Bupivacaine|bupivacaine|mesh-list
56095834|NCT03907033|Anesthetics, Local|anesthetics, local|mesh-ancestor
56095835|NCT03907033|Anesthetics|anesthetics|mesh-ancestor
56095836|NCT03907033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095837|NCT03907033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095838|NCT03907033|Sensory System Agents|sensory system agents|mesh-ancestor
56095839|NCT03907033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095840|NCT00001034|Ganciclovir|ganciclovir|mesh-list
56095841|NCT00001034|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56095843|NCT00001034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095844|NCT00001034|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095845|NCT00001034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095846|NCT00001034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095847|NCT03818815|Amoxicillin|amoxicillin|mesh-list
56095848|NCT03818815|Clavulanic Acid|clavulanic acid|mesh-list
56095849|NCT03818815|Clavulanic Acids|clavulanic acids|mesh-list
56095850|NCT03818815|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
56095851|NCT03818815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56095854|NCT03818815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095855|NCT03818815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095856|NCT00001958|Hydroxyurea|hydroxyurea|mesh-list
56095857|NCT00001958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56095858|NCT00001958|Antisickling Agents|antisickling agents|mesh-ancestor
56095859|NCT00001958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095860|NCT00001958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095861|NCT00001958|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56095862|NCT00001964|Cyclosporine|cyclosporine|mesh-list
56095863|NCT00001964|Cyclosporins|cyclosporins|mesh-list
56095864|NCT00001964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095865|NCT00001964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095866|NCT00001964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56095867|NCT00001964|Immunologic Factors|immunologic factors|mesh-ancestor
56095868|NCT00001964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095869|NCT00001964|Antifungal Agents|antifungal agents|mesh-ancestor
56095870|NCT00001964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095871|NCT00001964|Dermatologic Agents|dermatologic agents|mesh-ancestor
56095872|NCT00001964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56095873|NCT00001964|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56095874|NCT03801265|Ropivacaine|ropivacaine|mesh-list
56095875|NCT03801265|Anesthetics, Local|anesthetics, local|mesh-ancestor
56095876|NCT03801265|Anesthetics|anesthetics|mesh-ancestor
56095877|NCT03801265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095878|NCT03801265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864323|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864324|NCT01725529|Ribavirin|ribavirin|mesh-list
55864325|NCT01725529|Simeprevir|simeprevir|mesh-list
55864326|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
55864327|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864328|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
55864332|NCT01744093|Doxycycline|doxycycline|mesh-list
55901871|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55901872|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55901873|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55901874|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55901875|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901876|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901877|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
55901878|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
55901879|NCT03177174|Docetaxel|docetaxel|mesh-list
55901880|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901881|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
56095879|NCT03801265|Sensory System Agents|sensory system agents|mesh-ancestor
56095880|NCT03801265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095882|NCT00000290|Anesthetics, Local|anesthetics, local|mesh-ancestor
56095883|NCT00000290|Anesthetics|anesthetics|mesh-ancestor
56095884|NCT00000290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095885|NCT00000290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095887|NCT00000290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095888|NCT00000290|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56095889|NCT00000290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56095890|NCT00000290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56095891|NCT00000290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56095892|NCT00000290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095893|NCT00000290|Dopamine Agents|dopamine agents|mesh-ancestor
56095894|NCT00000290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56095895|NCT00000302|Buprenorphine|buprenorphine|mesh-list
56095896|NCT00000302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56095897|NCT00000302|Narcotics|narcotics|mesh-ancestor
56095898|NCT00000302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56095899|NCT00000302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095900|NCT00000302|Analgesics|analgesics|mesh-ancestor
56095931|NCT00000308|Amphetamine|amphetamine|mesh-list
56095932|NCT00000308|Dextroamphetamine|dextroamphetamine|mesh-list
56095933|NCT00000308|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56095934|NCT00000308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095935|NCT00000308|Sympathomimetics|sympathomimetics|mesh-ancestor
56095936|NCT00000308|Autonomic Agents|autonomic agents|mesh-ancestor
56095937|NCT00000308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095938|NCT00000308|Dopamine Agents|dopamine agents|mesh-ancestor
56095939|NCT00000308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56095940|NCT00000308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095941|NCT00000308|Adrenergic Agents|adrenergic agents|mesh-ancestor
56095942|NCT00000308|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56095943|NCT00000308|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56095944|NCT00000308|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56095945|NCT00000308|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56095946|NCT00001994|Atovaquone|atovaquone|mesh-list
56095947|NCT00001994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56095948|NCT00001994|Antimalarials|antimalarials|mesh-ancestor
56095949|NCT00001994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56095950|NCT00001994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56095951|NCT00001994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56095952|NCT00001994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095953|NCT00000320|Buprenorphine|buprenorphine|mesh-list
56095983|NCT03979807|Olodaterol|olodaterol|mesh-list
56095984|NCT03979807|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56095985|NCT03979807|Autonomic Agents|autonomic agents|mesh-ancestor
56095986|NCT03979807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56095987|NCT03979807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56095988|NCT03979807|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56095989|NCT03979807|Respiratory System Agents|respiratory system agents|mesh-ancestor
56095990|NCT03979807|Parasympatholytics|parasympatholytics|mesh-ancestor
56095991|NCT03979807|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56095992|NCT03979807|Cholinergic Agents|cholinergic agents|mesh-ancestor
56095993|NCT03979807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56095994|NCT03979807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56095995|NCT03979807|Anticonvulsants|anticonvulsants|mesh-ancestor
56095996|NCT00001082|Adefovir|adefovir|mesh-list
56095997|NCT00001082|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56095998|NCT00001082|Antiviral Agents|antiviral agents|mesh-ancestor
56095999|NCT00001082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096000|NCT00001082|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096001|NCT00001082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096002|NCT00001082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096003|NCT00001082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096004|NCT00002006|Zidovudine|zidovudine|mesh-list
56096005|NCT00002006|Sargramostim|sargramostim|mesh-list
56096006|NCT00002006|Antimetabolites|antimetabolites|mesh-ancestor
56096007|NCT00002006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096008|NCT00002006|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096009|NCT00002006|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096010|NCT00002006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096011|NCT00002006|Antiviral Agents|antiviral agents|mesh-ancestor
56096012|NCT00002006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096013|NCT00002006|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096014|NCT00002006|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096015|NCT00002006|Immunologic Factors|immunologic factors|mesh-ancestor
56096016|NCT00002006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096017|NCT04169113|Opiate Alkaloids|opiate alkaloids|mesh-list
56096018|NCT04169113|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56096020|NCT04169113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56096021|NCT04169113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096022|NCT04169113|Analgesics|analgesics|mesh-ancestor
56096023|NCT04169113|Sensory System Agents|sensory system agents|mesh-ancestor
56096024|NCT04169113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096025|NCT00002012|Interferons|interferons|mesh-list
56096026|NCT00002012|Interferon-alpha|interferon-alpha|mesh-list
56096027|NCT00002012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096028|NCT00002012|Antiviral Agents|antiviral agents|mesh-ancestor
56096029|NCT00002012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096030|NCT00002012|Immunologic Factors|immunologic factors|mesh-ancestor
56096031|NCT00002012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096032|NCT00380354|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
56096033|NCT00380354|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56096034|NCT00380354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56096035|NCT00380354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096036|NCT00380354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096038|NCT03799783|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56096039|NCT03799783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56096040|NCT03799783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096041|NCT03799783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56096051|NCT00001088|Bupivacaine|bupivacaine|mesh-list
56096067|NCT00001094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096068|NCT00001094|Antiviral Agents|antiviral agents|mesh-ancestor
56096069|NCT00001094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096070|NCT00001094|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096071|NCT00001094|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096072|NCT00001094|Antimetabolites|antimetabolites|mesh-ancestor
56096073|NCT00001094|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56096074|NCT00001094|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56096075|NCT00001094|Protease Inhibitors|protease inhibitors|mesh-ancestor
56096076|NCT00001094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56144788|NCT05206812|Durvalumab|durvalumab|mesh-list
56096077|NCT00001094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56096078|NCT00001100|Ganciclovir|ganciclovir|mesh-list
56096079|NCT00001100|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56096080|NCT00001100|Antiviral Agents|antiviral agents|mesh-ancestor
56096081|NCT00001100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096082|NCT00001100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096083|NCT00001100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096084|NCT00001100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096085|NCT00000332|Nimodipine|nimodipine|mesh-list
56096086|NCT00000332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56096087|NCT00000332|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56096117|NCT00002018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096118|NCT00002018|Immunologic Factors|immunologic factors|mesh-ancestor
56096119|NCT00002018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096120|NCT00002024|Ganciclovir|ganciclovir|mesh-list
56096121|NCT00002024|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56096122|NCT00002024|Antiviral Agents|antiviral agents|mesh-ancestor
56096123|NCT00002024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096124|NCT00002024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096125|NCT00002024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096126|NCT00002024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096127|NCT00001106|Zidovudine|zidovudine|mesh-list
56096128|NCT00001106|Antimetabolites|antimetabolites|mesh-ancestor
56096129|NCT00001106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096130|NCT00001106|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096131|NCT00001106|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096132|NCT00001106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096133|NCT00001106|Antiviral Agents|antiviral agents|mesh-ancestor
56096134|NCT00001106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096135|NCT00001106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096136|NCT00001106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096137|NCT00000344|Buprenorphine|buprenorphine|mesh-list
56096138|NCT00000344|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56096139|NCT00000344|Naloxone|naloxone|mesh-list
56096168|NCT00001112|Interferon-gamma|interferon-gamma|mesh-list
56096169|NCT00001112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096170|NCT00001112|Antiviral Agents|antiviral agents|mesh-ancestor
56096171|NCT00001112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096172|NCT00001112|Antimetabolites|antimetabolites|mesh-ancestor
56096173|NCT00001112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096174|NCT00001112|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096175|NCT00001112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096176|NCT00001112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096177|NCT00001112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096178|NCT00001112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096179|NCT00002036|Immune Sera|immune sera|mesh-list
56096180|NCT00002036|Immunologic Factors|immunologic factors|mesh-ancestor
56096181|NCT00002036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096182|NCT03782701|Brimonidine Tartrate|brimonidine tartrate|mesh-list
56096183|NCT03782701|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56096184|NCT03782701|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56096185|NCT03782701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56096186|NCT03782701|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56096187|NCT03782701|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55864636|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
55864637|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864638|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
55864639|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864640|NCT00830362|Propranolol|propranolol|mesh-list
55864641|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55901882|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
55901883|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
55901884|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901885|NCT03177252|Lidocaine|lidocaine|mesh-list
55901886|NCT03177252|Bupivacaine|bupivacaine|mesh-list
55901887|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
55901888|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
55901889|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901890|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901891|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
55901892|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901893|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55901894|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55901895|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55901896|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901897|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901898|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
55901899|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55901900|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901901|NCT02408562|Becaplermin|becaplermin|mesh-list
55901902|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
55901903|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
56096189|NCT03782701|Adrenergic Agents|adrenergic agents|mesh-ancestor
56096190|NCT03782701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096191|NCT03782701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096192|NCT03782701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096194|NCT00000374|Risperidone|risperidone|mesh-list
56096195|NCT00000374|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56096196|NCT00000374|Serotonin Agents|serotonin agents|mesh-ancestor
56096197|NCT00000374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096198|NCT00000374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096199|NCT00000374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096200|NCT00000374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56096201|NCT00000374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56096202|NCT00000374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56096203|NCT00000374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56096204|NCT00000374|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56096205|NCT00000374|Dopamine Agents|dopamine agents|mesh-ancestor
56096206|NCT00000374|Antiemetics|antiemetics|mesh-ancestor
56096207|NCT00000374|Autonomic Agents|autonomic agents|mesh-ancestor
56096208|NCT00000374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096209|NCT00000374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56096210|NCT00000374|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56096211|NCT00000374|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56096212|NCT00000374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56096213|NCT00002042|Epoetin Alfa|epoetin alfa|mesh-list
56096214|NCT00002042|Hematinics|hematinics|mesh-ancestor
56096215|NCT03789175|Niacinamide|niacinamide|mesh-list
56096216|NCT03789175|Niacin|niacin|mesh-list
56096236|NCT00002048|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096237|NCT00002054|Pentamidine|pentamidine|mesh-list
56096238|NCT00002054|Antifungal Agents|antifungal agents|mesh-ancestor
56096239|NCT00002054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096240|NCT00002054|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56096241|NCT00002054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56096242|NCT00002054|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56096243|NCT00002060|Inosine Pranobex|inosine pranobex|mesh-list
56096244|NCT00002060|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56096245|NCT00002060|Immunologic Factors|immunologic factors|mesh-ancestor
56096246|NCT00002060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096247|NCT00002060|Antiviral Agents|antiviral agents|mesh-ancestor
56096248|NCT00002060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096249|NCT00002066|Thymopentin|thymopentin|mesh-list
56096250|NCT00002066|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56096251|NCT00002066|Immunologic Factors|immunologic factors|mesh-ancestor
56096252|NCT00002066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096253|NCT00002072|Epoetin Alfa|epoetin alfa|mesh-list
56096254|NCT00002072|Hematinics|hematinics|mesh-ancestor
56096255|NCT00002078|Interferons|interferons|mesh-list
56096256|NCT00002078|Interferon-alpha|interferon-alpha|mesh-list
56096257|NCT00002078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096291|NCT04131517|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
56096292|NCT04131517|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
56096293|NCT04131517|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56096294|NCT04131517|Contraceptive Agents|contraceptive agents|mesh-ancestor
56096295|NCT04131517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56096296|NCT04131517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096297|NCT04131517|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56096298|NCT04131517|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56096299|NCT04131517|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56096300|NCT04131517|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55864757|NCT00807586|Hormones|hormones|mesh-ancestor
55864758|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864759|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864760|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55864761|NCT00807586|Protective Agents|protective agents|mesh-ancestor
55864762|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55864763|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864764|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
55901904|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55901905|NCT02408562|Growth Substances|growth substances|mesh-ancestor
55901906|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901907|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55901908|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
55901909|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901910|NCT02701764|Pregabalin|pregabalin|mesh-list
55901911|NCT02701764|Analgesics|analgesics|mesh-ancestor
55901912|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
55901913|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901914|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901915|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
55755271|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
55901916|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55901917|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55901918|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901919|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55901920|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55901921|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55901922|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901923|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55901926|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
55901927|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55901928|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901929|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55901930|NCT03174288|Diuretics|diuretics|mesh-ancestor
55901931|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
55901932|NCT02532010|Cytarabine|cytarabine|mesh-list
55901933|NCT02532010|Decitabine|decitabine|mesh-list
55901934|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55901935|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
55901936|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901938|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
56096301|NCT04131517|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56096302|NCT04131517|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
55823404|NCT01605370|Metoprolol|metoprolol|mesh-list
56096303|NCT04131517|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56096304|NCT04131517|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56096305|NCT00001256|Prednisone|prednisone|mesh-list
56096306|NCT00001256|Methotrexate|methotrexate|mesh-list
56096307|NCT00001256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56096308|NCT00001256|Glucocorticoids|glucocorticoids|mesh-ancestor
56096309|NCT00001256|Hormones|hormones|mesh-ancestor
56096310|NCT00001256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56096311|NCT00001256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096312|NCT00001256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56096313|NCT00001256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096314|NCT00001256|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56096315|NCT00001256|Abortifacient Agents|abortifacient agents|mesh-ancestor
56096316|NCT00001256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56096317|NCT00001256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56096318|NCT00001256|Antimetabolites|antimetabolites|mesh-ancestor
56096319|NCT00001256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096320|NCT00001256|Dermatologic Agents|dermatologic agents|mesh-ancestor
56096321|NCT00001256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096322|NCT00001256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56096323|NCT00001256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56096324|NCT00001256|Immunologic Factors|immunologic factors|mesh-ancestor
56096325|NCT00001256|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56096347|NCT03782233|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
56096348|NCT03782233|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56096349|NCT03782233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56096350|NCT03782233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096351|NCT03782233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096352|NCT00002090|Azithromycin|azithromycin|mesh-list
56096353|NCT00002090|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56096354|NCT00002090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096355|NCT00002096|Zidovudine|zidovudine|mesh-list
56096356|NCT00002096|Didanosine|didanosine|mesh-list
56096357|NCT00002096|Ganciclovir|ganciclovir|mesh-list
56096358|NCT00002096|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56096359|NCT00002096|Antimetabolites|antimetabolites|mesh-ancestor
56096360|NCT00002096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096361|NCT00002096|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096362|NCT00002096|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096363|NCT00002096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096364|NCT00002096|Antiviral Agents|antiviral agents|mesh-ancestor
56096365|NCT00002096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096366|NCT00002096|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096367|NCT00002096|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096368|NCT00002102|Leucovorin|leucovorin|mesh-list
56096369|NCT00002102|Trimetrexate|trimetrexate|mesh-list
56096370|NCT00002102|Calcium|calcium|mesh-list
56096371|NCT00002102|Levoleucovorin|levoleucovorin|mesh-list
56096373|NCT00002102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096396|NCT00002108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096397|NCT00002108|Antimetabolites|antimetabolites|mesh-ancestor
56096398|NCT00381134|Losartan|losartan|mesh-list
56096399|NCT00381134|Spironolactone|spironolactone|mesh-list
56096400|NCT00381134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56096401|NCT00381134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56096402|NCT00381134|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56096403|NCT00381134|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56096404|NCT00381134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096405|NCT00381134|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56096406|NCT00381134|Hormone Antagonists|hormone antagonists|mesh-ancestor
56096407|NCT00381134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56096408|NCT00381134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096409|NCT00381134|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56096410|NCT00381134|Diuretics|diuretics|mesh-ancestor
56096411|NCT00381134|Natriuretic Agents|natriuretic agents|mesh-ancestor
56096412|NCT00000506|Phentermine|phentermine|mesh-list
56096413|NCT00000506|Fenfluramine|fenfluramine|mesh-list
56096414|NCT00000506|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56096415|NCT00000506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096416|NCT00000506|Appetite Depressants|appetite depressants|mesh-ancestor
56096417|NCT00000506|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56096418|NCT00000506|Sympathomimetics|sympathomimetics|mesh-ancestor
56096419|NCT00000506|Autonomic Agents|autonomic agents|mesh-ancestor
56096420|NCT00000506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096421|NCT00000506|Adrenergic Agents|adrenergic agents|mesh-ancestor
56096422|NCT00000506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096423|NCT00000506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096442|NCT00000512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096443|NCT00000512|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56096444|NCT00000512|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56096445|NCT00000512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096446|NCT00000512|Sequestering Agents|sequestering agents|mesh-ancestor
56096447|NCT00380822|Miglitol|miglitol|mesh-list
56096448|NCT00380822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096449|NCT00380822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096450|NCT00380822|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56096451|NCT00380822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823560|NCT05648318|Lactulose|lactulose|mesh-list
56096452|NCT00380822|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56096454|NCT00000542|Lisinopril|lisinopril|mesh-list
56096455|NCT00000542|Chlorthalidone|chlorthalidone|mesh-list
56096456|NCT00000542|Doxazosin|doxazosin|mesh-list
56096457|NCT00000542|Pravastatin|pravastatin|mesh-list
56096458|NCT00000542|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56096459|NCT00000542|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56096500|NCT00002120|Antimalarials|antimalarials|mesh-ancestor
56096501|NCT00002120|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56096502|NCT00002120|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56096503|NCT00002120|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56096505|NCT00002120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096506|NCT00002120|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56096507|NCT00002120|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56096508|NCT00002120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56096509|NCT00002120|Leprostatic Agents|leprostatic agents|mesh-ancestor
56096510|NCT00002120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56096511|NCT00002120|Antifungal Agents|antifungal agents|mesh-ancestor
56096512|NCT00002120|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56096513|NCT00002120|Antimetabolites|antimetabolites|mesh-ancestor
56096514|NCT00002120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096515|NCT00002126|Lenograstim|lenograstim|mesh-list
56096516|NCT00002126|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56096517|NCT00002126|Immunologic Factors|immunologic factors|mesh-ancestor
56096518|NCT00002126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096519|NCT03231397|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56096520|NCT03231397|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56096521|NCT03231397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096522|NCT05065424|Atropine|atropine|mesh-list
56096523|NCT05065424|Fentanyl|fentanyl|mesh-list
56096524|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56096525|NCT05065424|Narcotics|narcotics|mesh-ancestor
56096526|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56096527|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096528|NCT05065424|Analgesics|analgesics|mesh-ancestor
56096529|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
56096530|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096531|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56096532|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56096533|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
56096534|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
56096539|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56096540|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
56096541|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
56096542|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
56096543|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56096544|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56096545|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
56096546|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096547|NCT03189433|Dantrolene|dantrolene|mesh-list
56096548|NCT03189433|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56096549|NCT03189433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096550|NCT03189433|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56096551|NCT03189433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096552|NCT00002132|Itraconazole|itraconazole|mesh-list
56096553|NCT00002132|Fluconazole|fluconazole|mesh-list
56096554|NCT00002132|Antifungal Agents|antifungal agents|mesh-ancestor
56096555|NCT00002132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096556|NCT00002132|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56096557|NCT00002132|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56096558|NCT00002132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096559|NCT00002132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096560|NCT00002132|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56096561|NCT00002132|Hormone Antagonists|hormone antagonists|mesh-ancestor
56096562|NCT00002132|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56096563|NCT00002132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096564|NCT00002132|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56096585|NCT00000578|Autonomic Agents|autonomic agents|mesh-ancestor
56096586|NCT00000578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096587|NCT00000578|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56096588|NCT00000578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096589|NCT00000578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096590|NCT00000578|Vasodilator Agents|vasodilator agents|mesh-ancestor
56096591|NCT00000578|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56096592|NCT00000578|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56096593|NCT00000578|Purinergic Agents|purinergic agents|mesh-ancestor
56096594|NCT00000578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56096595|NCT03774745|Mifepristone|mifepristone|mesh-list
56096596|NCT03774745|Progesterone|progesterone|mesh-list
56096597|NCT03774745|Progestins|progestins|mesh-ancestor
56096598|NCT03774745|Hormones|hormones|mesh-ancestor
56096599|NCT03774745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56096600|NCT03774745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096601|NCT03774745|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56096603|NCT03774745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56096604|NCT03774745|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56096606|NCT03774745|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56096607|NCT03774745|Contraceptive Agents|contraceptive agents|mesh-ancestor
56096608|NCT03774745|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56096609|NCT03774745|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56096610|NCT03774745|Hormone Antagonists|hormone antagonists|mesh-ancestor
56096611|NCT03774745|Luteolytic Agents|luteolytic agents|mesh-ancestor
56096612|NCT03774745|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56096613|NCT03774745|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56096614|NCT00000584|Immunoglobulins|immunoglobulins|mesh-list
56096615|NCT00000584|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56096616|NCT00000584|Antibodies|antibodies|mesh-list
56096617|NCT00000584|Immunologic Factors|immunologic factors|mesh-ancestor
56096619|NCT00000590|Immunoglobulins|immunoglobulins|mesh-list
56096628|NCT02973464|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56096629|NCT02973464|Antiviral Agents|antiviral agents|mesh-ancestor
56096630|NCT02973464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096631|NCT02973464|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096632|NCT02973464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096633|NCT02973464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096634|NCT00000626|Doxorubicin|doxorubicin|mesh-list
56096635|NCT00000626|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56096636|NCT00000626|Bleomycin|bleomycin|mesh-list
56096637|NCT00000626|Dacarbazine|dacarbazine|mesh-list
56096638|NCT00000626|Vinblastine|vinblastine|mesh-list
56096639|NCT00000626|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56096640|NCT00000626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096641|NCT00000626|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56096642|NCT00000626|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56096643|NCT00000626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096644|NCT00000626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096645|NCT00000626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56096646|NCT00000626|Alkylating Agents|alkylating agents|mesh-ancestor
56096647|NCT00000626|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56096681|NCT04713254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56096682|NCT04713254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096683|NCT04713254|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56096684|NCT04713254|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56096686|NCT04713254|Autonomic Agents|autonomic agents|mesh-ancestor
56096687|NCT04713254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56096688|NCT04713254|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56096689|NCT04713254|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56096690|NCT04713254|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56096691|NCT04713254|Adrenergic Agents|adrenergic agents|mesh-ancestor
56096693|NCT00002156|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56096694|NCT00002156|Fomivirsen|fomivirsen|mesh-list
56096695|NCT00002156|Antiviral Agents|antiviral agents|mesh-ancestor
56096744|NCT00000638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55865196|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096745|NCT00000638|Vitamin B Complex|vitamin b complex|mesh-ancestor
56096747|NCT00000638|Micronutrients|micronutrients|mesh-ancestor
56096748|NCT00000638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096749|NCT00000650|Ditiocarb|ditiocarb|mesh-list
56096750|NCT00000650|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56096751|NCT00000650|Immunologic Factors|immunologic factors|mesh-ancestor
56096752|NCT00000650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096753|NCT00000650|Antiviral Agents|antiviral agents|mesh-ancestor
56096754|NCT00000650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096755|NCT00000650|Chelating Agents|chelating agents|mesh-ancestor
56096756|NCT00000650|Sequestering Agents|sequestering agents|mesh-ancestor
56096757|NCT00000650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096758|NCT00000656|Zidovudine|zidovudine|mesh-list
56096759|NCT00000656|Didanosine|didanosine|mesh-list
56096760|NCT00000656|Antimetabolites|antimetabolites|mesh-ancestor
56096761|NCT00000656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096762|NCT00000656|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096763|NCT00000656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096764|NCT00000656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096765|NCT00000656|Antiviral Agents|antiviral agents|mesh-ancestor
56096766|NCT00000656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096767|NCT00000656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096768|NCT00000656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096769|NCT00000662|Zidovudine|zidovudine|mesh-list
56096770|NCT00000662|Antimetabolites|antimetabolites|mesh-ancestor
55741721|NCT05126901|Ferric maltol|ferric maltol|mesh-list
56096791|NCT00002168|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096793|NCT00002168|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56096794|NCT00002168|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56096795|NCT00002168|Protease Inhibitors|protease inhibitors|mesh-ancestor
56096796|NCT00001442|Paclitaxel|paclitaxel|mesh-list
56096797|NCT00001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56096798|NCT00001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096799|NCT00001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56096800|NCT00001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56096801|NCT00001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56096802|NCT00001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096803|NCT00002174|Thalidomide|thalidomide|mesh-list
56096804|NCT00002174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56096805|NCT00002174|Immunologic Factors|immunologic factors|mesh-ancestor
56096806|NCT00002174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096807|NCT00002174|Leprostatic Agents|leprostatic agents|mesh-ancestor
56096808|NCT00002174|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56096809|NCT00002174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096810|NCT00002174|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56096811|NCT00002174|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56096812|NCT00002174|Growth Substances|growth substances|mesh-ancestor
56096813|NCT00002174|Growth Inhibitors|growth inhibitors|mesh-ancestor
56096814|NCT00002174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096815|NCT00000668|Ganciclovir|ganciclovir|mesh-list
55865292|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096840|NCT00000692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096841|NCT00000692|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56096842|NCT00000692|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56096843|NCT00000692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096844|NCT00000698|Ganciclovir|ganciclovir|mesh-list
56096845|NCT00000698|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56096846|NCT00000698|Antiviral Agents|antiviral agents|mesh-ancestor
56096847|NCT00000698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096848|NCT00000698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096849|NCT00000698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096850|NCT00000698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096852|NCT00002180|Antiviral Agents|antiviral agents|mesh-ancestor
56096853|NCT00002180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096854|NCT00002180|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096855|NCT00002180|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096856|NCT00002180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096857|NCT00002180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096858|NCT00002180|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096859|NCT00002180|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096861|NCT00002186|Antiviral Agents|antiviral agents|mesh-ancestor
56096862|NCT00002186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096863|NCT00001502|Carboplatin|carboplatin|mesh-list
56096864|NCT00001502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096865|NCT00002192|Azithromycin|azithromycin|mesh-list
56096866|NCT00002192|Clarithromycin|clarithromycin|mesh-list
56096867|NCT00002192|Ethambutol|ethambutol|mesh-list
56096868|NCT00002192|Rifapentine|rifapentine|mesh-list
56096869|NCT00002192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56096872|NCT00002192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096882|NCT00002198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096883|NCT00002198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096884|NCT00002198|Antiviral Agents|antiviral agents|mesh-ancestor
56096885|NCT00002198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096886|NCT00002198|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096887|NCT00002198|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096888|NCT00000704|Zalcitabine|zalcitabine|mesh-list
56096889|NCT00000704|Antimetabolites|antimetabolites|mesh-ancestor
56096890|NCT00000704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096891|NCT00000704|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096892|NCT00000704|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096893|NCT00000704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096894|NCT00000704|Antiviral Agents|antiviral agents|mesh-ancestor
56096895|NCT00000704|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096896|NCT00000704|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096897|NCT00000704|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096898|NCT00000728|Zidovudine|zidovudine|mesh-list
56096899|NCT00000728|Aldesleukin|aldesleukin|mesh-list
56096900|NCT00000728|Antimetabolites|antimetabolites|mesh-ancestor
56096901|NCT00000728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096902|NCT00000728|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56096903|NCT00000728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096904|NCT00000728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096906|NCT00000728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096907|NCT00000728|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56096908|NCT00000728|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56096909|NCT00000728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096910|NCT00001520|Neostigmine|neostigmine|mesh-list
56096911|NCT00001520|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56096925|NCT00002294|Antifungal Agents|antifungal agents|mesh-ancestor
56096926|NCT00002294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096927|NCT00002294|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56096928|NCT00002294|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56096929|NCT00002294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096930|NCT00002294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096931|NCT00002294|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56096932|NCT00002294|Hormone Antagonists|hormone antagonists|mesh-ancestor
56096933|NCT00002294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56096934|NCT00002294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096935|NCT00002294|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56096936|NCT00002294|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56096937|NCT03758365|Triamcinolone|triamcinolone|mesh-list
56096938|NCT03758365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
56096939|NCT03758365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56096940|NCT03758365|Hydrocortisone|hydrocortisone|mesh-list
56096941|NCT03758365|Betamethasone|betamethasone|mesh-list
56096942|NCT03758365|Betamethasone Valerate|betamethasone valerate|mesh-list
56096943|NCT03758365|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56096944|NCT03758365|Betamethasone benzoate|betamethasone benzoate|mesh-list
56096945|NCT03758365|Clobetasol|clobetasol|mesh-list
56096946|NCT03758365|Desonide|desonide|mesh-list
56096947|NCT03758365|Hydrocortisone-17-butyrate|hydrocortisone-17-butyrate|mesh-list
56096973|NCT00002300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56096974|NCT00002300|Appetite Stimulants|appetite stimulants|mesh-ancestor
56096975|NCT00002300|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56096976|NCT00002306|Fluconazole|fluconazole|mesh-list
56096977|NCT00002306|Antifungal Agents|antifungal agents|mesh-ancestor
56096978|NCT00002306|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56096979|NCT00002306|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56096980|NCT00002306|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56096981|NCT00002306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56096982|NCT00002306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56096983|NCT00002306|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56096984|NCT00002306|Hormone Antagonists|hormone antagonists|mesh-ancestor
56096985|NCT00002306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56096986|NCT00002306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56096987|NCT00002306|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56096988|NCT00002306|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56096989|NCT00002210|Delavirdine|delavirdine|mesh-list
56096990|NCT00002210|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55741723|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
56096991|NCT00002210|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56096992|NCT00002210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097023|NCT00002312|Delavirdine|delavirdine|mesh-list
56097024|NCT00002312|Antimetabolites|antimetabolites|mesh-ancestor
56097025|NCT00002312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097026|NCT00002312|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097027|NCT00002312|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097028|NCT00002312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097029|NCT00002312|Antiviral Agents|antiviral agents|mesh-ancestor
56097030|NCT00002312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097031|NCT00002312|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097032|NCT00002312|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097033|NCT00002318|Doxorubicin|doxorubicin|mesh-list
56097034|NCT00002318|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56097035|NCT00002318|Bleomycin|bleomycin|mesh-list
56097036|NCT00002318|Vincristine|vincristine|mesh-list
56097037|NCT00002318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56097038|NCT00002318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097039|NCT00002318|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097040|NCT00002318|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097041|NCT00002318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097042|NCT00002318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097043|NCT00002318|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56097044|NCT00002318|Tubulin Modulators|tubulin modulators|mesh-ancestor
56097045|NCT00002318|Antimitotic Agents|antimitotic agents|mesh-ancestor
56097048|NCT00002228|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56097049|NCT00002228|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56097050|NCT00002228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097070|NCT00001628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097071|NCT00001628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56097073|NCT00002234|Efavirenz|efavirenz|mesh-list
56097074|NCT00002234|Didanosine|didanosine|mesh-list
56097075|NCT00002234|Adefovir|adefovir|mesh-list
56097076|NCT00002234|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56097077|NCT00002234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097078|NCT00002234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097079|NCT00002234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097080|NCT00002234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097081|NCT00002234|Antiviral Agents|antiviral agents|mesh-ancestor
56097082|NCT00002234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097083|NCT00002234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097084|NCT00002234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097085|NCT00002234|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56097086|NCT00002234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56097087|NCT00002234|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56097088|NCT00002234|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56097089|NCT00002234|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56097090|NCT00002234|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56097091|NCT00002234|Antimetabolites|antimetabolites|mesh-ancestor
56097092|NCT04070287|Antibodies|antibodies|mesh-list
56097093|NCT04070287|Immunoglobulins|immunoglobulins|mesh-list
56097094|NCT04070287|Immunologic Factors|immunologic factors|mesh-ancestor
56097095|NCT04070287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097096|NCT00002324|Zidovudine|zidovudine|mesh-list
56097097|NCT00002324|Nevirapine|nevirapine|mesh-list
56097098|NCT00002324|Antimetabolites|antimetabolites|mesh-ancestor
56097099|NCT00002324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097102|NCT00002324|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097115|NCT00002330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097116|NCT03740659|Levofloxacin|levofloxacin|mesh-list
56097117|NCT03740659|Ofloxacin|ofloxacin|mesh-list
56097118|NCT03740659|Dexamethasone|dexamethasone|mesh-list
56097119|NCT03740659|Dexamethasone acetate|dexamethasone acetate|mesh-list
56097120|NCT03740659|BB 1101|bb 1101|mesh-list
56097121|NCT03740659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56097122|NCT03740659|Antiemetics|antiemetics|mesh-ancestor
56097123|NCT03740659|Autonomic Agents|autonomic agents|mesh-ancestor
56097124|NCT03740659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097125|NCT03740659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097126|NCT03740659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56097127|NCT03740659|Glucocorticoids|glucocorticoids|mesh-ancestor
56097128|NCT03740659|Hormones|hormones|mesh-ancestor
56097129|NCT03740659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824233|NCT01719172|Hemostatics|hemostatics|mesh-list
56097130|NCT03740659|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56097131|NCT03740659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097132|NCT03740659|Protease Inhibitors|protease inhibitors|mesh-ancestor
56097133|NCT03740659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097134|NCT03740659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097135|NCT03740659|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56097136|NCT03740659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097137|NCT03740659|Renal Agents|renal agents|mesh-ancestor
56097138|NCT03740659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56097139|NCT03740659|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097140|NCT03740659|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097141|NCT03740659|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56097142|NCT03740659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56097143|NCT00002336|Clarithromycin|clarithromycin|mesh-list
56097144|NCT00002336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56097145|NCT00002336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865563|NCT01692301|Diuretics|diuretics|mesh-ancestor
55865566|NCT01592773|Memantine|memantine|mesh-list
55901939|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55901940|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55901941|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
55901942|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901943|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901944|NCT02406300|Bupivacaine|bupivacaine|mesh-list
55901945|NCT02406300|Ropivacaine|ropivacaine|mesh-list
55901946|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
56097146|NCT00002336|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56097148|NCT00002336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097149|NCT00002336|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56097150|NCT00002336|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56097151|NCT00001646|Voriconazole|voriconazole|mesh-list
56097152|NCT00001646|Amphotericin B|amphotericin b|mesh-list
56097153|NCT00001646|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56097154|NCT00001646|Antifungal Agents|antifungal agents|mesh-ancestor
56097155|NCT00001646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097156|NCT00001646|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56097157|NCT00001646|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56097158|NCT00001646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097159|NCT00001646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097160|NCT00001646|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56097165|NCT00001646|Amebicides|amebicides|mesh-ancestor
56097203|NCT00002270|Immunologic Factors|immunologic factors|mesh-ancestor
56097204|NCT00002270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097205|NCT00002270|Antimetabolites|antimetabolites|mesh-ancestor
56097206|NCT00002270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097207|NCT00002270|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097208|NCT00002270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097209|NCT00002270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901947|NCT02406300|Sevoflurane|sevoflurane|mesh-list
55901948|NCT02406300|Desflurane|desflurane|mesh-list
55901949|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
55901950|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
55901951|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901952|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901953|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
55791353|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
55901955|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55901956|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55901957|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
55901958|NCT02538016|Tolvaptan|tolvaptan|mesh-list
55901959|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55901960|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901961|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
55901962|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901963|NCT02406144|Dexamethasone|dexamethasone|mesh-list
55901964|NCT02406144|Lenalidomide|lenalidomide|mesh-list
55901965|NCT02406144|Ixazomib|ixazomib|mesh-list
55901966|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55901967|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
55901968|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
55901969|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901970|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901971|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55901972|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
55901973|NCT02406144|Hormones|hormones|mesh-ancestor
55901974|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55901975|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55901976|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901977|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
55901978|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55901979|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55901980|NCT02406144|Growth Substances|growth substances|mesh-ancestor
55901981|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
55901982|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
55901983|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55901984|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901986|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55901987|NCT02416752|Narcotics|narcotics|mesh-ancestor
55901988|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55901989|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901990|NCT02416752|Analgesics|analgesics|mesh-ancestor
55901991|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
55901992|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55901993|NCT02405910|Gemcitabine|gemcitabine|mesh-list
55901994|NCT02405910|Paclitaxel|paclitaxel|mesh-list
55901995|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55901996|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901997|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
55901998|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
56097210|NCT00002270|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097211|NCT00002270|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097212|NCT00002354|Stavudine|stavudine|mesh-list
56097215|NCT00002354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097217|NCT00002354|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097218|NCT00002354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097219|NCT00002354|Antiviral Agents|antiviral agents|mesh-ancestor
56097221|NCT00002354|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097222|NCT00002354|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097223|NCT00002354|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56097224|NCT00002354|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56097225|NCT00002354|Protease Inhibitors|protease inhibitors|mesh-ancestor
56097226|NCT04039867|Gemcitabine|gemcitabine|mesh-list
56097227|NCT04039867|Oxaliplatin|oxaliplatin|mesh-list
56097228|NCT04039867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097229|NCT04039867|Antimetabolites|antimetabolites|mesh-ancestor
56097230|NCT04039867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097231|NCT04039867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097232|NCT04039867|Antiviral Agents|antiviral agents|mesh-ancestor
56097233|NCT04039867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097234|NCT04039867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097235|NCT04039867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097236|NCT04039867|Immunologic Factors|immunologic factors|mesh-ancestor
56097237|NCT04039867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097238|NCT00002360|Didanosine|didanosine|mesh-list
56097239|NCT00002360|Antimetabolites|antimetabolites|mesh-ancestor
56097240|NCT00002360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865697|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56097255|NCT00002276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097256|NCT00002276|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56097257|NCT00002276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097258|NCT00002276|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56097259|NCT00002276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097260|NCT00002276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097261|NCT00002276|Antimetabolites|antimetabolites|mesh-ancestor
56097262|NCT00002276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097263|NCT00002276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097264|NCT00002276|Antiviral Agents|antiviral agents|mesh-ancestor
56097265|NCT00002276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097266|NCT00002276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097267|NCT00002276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097268|NCT00378547|Acetaminophen|acetaminophen|mesh-list
56097269|NCT00378547|Dexamethasone|dexamethasone|mesh-list
56097270|NCT00378547|Dexamethasone acetate|dexamethasone acetate|mesh-list
56097271|NCT00378547|Pregabalin|pregabalin|mesh-list
56097272|NCT00378547|BB 1101|bb 1101|mesh-list
56097273|NCT00378547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56097274|NCT00378547|Antiemetics|antiemetics|mesh-ancestor
56097275|NCT00378547|Autonomic Agents|autonomic agents|mesh-ancestor
56097276|NCT00378547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097277|NCT00378547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097278|NCT00378547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56097279|NCT00378547|Glucocorticoids|glucocorticoids|mesh-ancestor
56097280|NCT00378547|Hormones|hormones|mesh-ancestor
56097281|NCT00378547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56097282|NCT00378547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56097283|NCT00378547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097285|NCT00378547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097286|NCT00378547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097287|NCT00378547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56097289|NCT00378547|Sensory System Agents|sensory system agents|mesh-ancestor
56097290|NCT00378547|Antipyretics|antipyretics|mesh-ancestor
55902003|NCT02405910|Antiviral Agents|antiviral agents|mesh-ancestor
55902004|NCT02405910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902005|NCT02405910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097292|NCT00378547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56097293|NCT00378547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56097294|NCT00378547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56097295|NCT00378547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56097296|NCT00378547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56097297|NCT00378547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56097298|NCT00378547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56097299|NCT00002282|Fluconazole|fluconazole|mesh-list
56097300|NCT00002282|Clotrimazole|clotrimazole|mesh-list
56097302|NCT00002282|Antifungal Agents|antifungal agents|mesh-ancestor
56097303|NCT00002282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097304|NCT00002282|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56097305|NCT00002282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56097307|NCT00002282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097308|NCT00002282|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56097309|NCT00002282|Hormone Antagonists|hormone antagonists|mesh-ancestor
56097310|NCT00002282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56097311|NCT00002282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097312|NCT00002282|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56097316|NCT02658877|Omalizumab|omalizumab|mesh-list
56097341|NCT00002366|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56097343|NCT00378313|Paclitaxel|paclitaxel|mesh-list
56097344|NCT00378313|Epirubicin|epirubicin|mesh-list
56097345|NCT00378313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56097346|NCT00378313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097347|NCT00378313|Tubulin Modulators|tubulin modulators|mesh-ancestor
56097348|NCT00378313|Antimitotic Agents|antimitotic agents|mesh-ancestor
56097349|NCT00378313|Mitosis Modulators|mitosis modulators|mesh-ancestor
56097350|NCT00378313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097351|NCT00378313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097352|NCT00378313|Antimetabolites|antimetabolites|mesh-ancestor
56097353|NCT00378313|Antiviral Agents|antiviral agents|mesh-ancestor
56097354|NCT00378313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097355|NCT00378313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097356|NCT00378313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097357|NCT00378313|Immunologic Factors|immunologic factors|mesh-ancestor
56097358|NCT00378313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097359|NCT00378313|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56097360|NCT00378313|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097361|NCT00378313|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097362|NCT00002372|Nelfinavir|nelfinavir|mesh-list
56097363|NCT00002372|Indinavir|indinavir|mesh-list
56097364|NCT00002372|Saquinavir|saquinavir|mesh-list
56097365|NCT00002372|Amprenavir|amprenavir|mesh-list
56097366|NCT00002372|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56097367|NCT00002372|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56097368|NCT00002372|Protease Inhibitors|protease inhibitors|mesh-ancestor
56097371|NCT00002372|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55865827|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55865828|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56097391|NCT00002378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097392|NCT00002378|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097393|NCT00002378|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097394|NCT00002378|Antiviral Agents|antiviral agents|mesh-ancestor
56097395|NCT00002378|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097396|NCT00002378|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56097397|NCT00002378|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56097398|NCT00002378|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097399|NCT00002378|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097400|NCT00002378|Antimetabolites|antimetabolites|mesh-ancestor
56097402|NCT02589145|Gemcitabine|gemcitabine|mesh-list
56097403|NCT02589145|Dexamethasone|dexamethasone|mesh-list
56097404|NCT02589145|Rituximab|rituximab|mesh-list
56097405|NCT02589145|Lenalidomide|lenalidomide|mesh-list
56097406|NCT02589145|Melphalan|melphalan|mesh-list
56097407|NCT02589145|Busulfan|busulfan|mesh-list
56097408|NCT02589145|Vorinostat|vorinostat|mesh-list
56097443|NCT02589145|Vitamins|vitamins|mesh-ancestor
56097444|NCT02589145|Micronutrients|micronutrients|mesh-ancestor
56097445|NCT00002384|Cidofovir|cidofovir|mesh-list
56097446|NCT00002384|Antiviral Agents|antiviral agents|mesh-ancestor
56097447|NCT00002384|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097448|NCT00002384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097449|NCT00002384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097450|NCT02568007|Cyproheptadine|cyproheptadine|mesh-list
56097451|NCT02568007|Antipruritics|antipruritics|mesh-ancestor
56097452|NCT02568007|Dermatologic Agents|dermatologic agents|mesh-ancestor
56097453|NCT02568007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56097454|NCT02568007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56097455|NCT02568007|Histamine Antagonists|histamine antagonists|mesh-ancestor
56097456|NCT02568007|Histamine Agents|histamine agents|mesh-ancestor
56097457|NCT02568007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56097458|NCT02568007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097459|NCT02568007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097460|NCT02568007|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56097463|NCT00002390|Abacavir|abacavir|mesh-list
56097500|NCT00002420|Antiviral Agents|antiviral agents|mesh-ancestor
56097501|NCT00002420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097502|NCT00002420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097503|NCT00002420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097504|NCT00381368|Ibandronic Acid|ibandronic acid|mesh-list
56097505|NCT00381368|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56097506|NCT00381368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097507|NCT05722418|Cyclophosphamide|cyclophosphamide|mesh-list
56097564|NCT04331210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56097565|NCT04331210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56097567|NCT04331210|Sensory System Agents|sensory system agents|mesh-ancestor
56097568|NCT04331210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097569|NCT04331210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097570|NCT04331210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56097571|NCT04331210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56097572|NCT04331210|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56097573|NCT04331210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097574|NCT04331210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097575|NCT00002426|Adefovir|adefovir|mesh-list
56097576|NCT00002426|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
56097577|NCT00002426|Antiviral Agents|antiviral agents|mesh-ancestor
56097578|NCT00002426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097579|NCT00002426|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097580|NCT00002426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097623|NCT02487277|Antiviral Agents|antiviral agents|mesh-ancestor
56097624|NCT02487277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097625|NCT02487277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097626|NCT02487277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097627|NCT02487277|Immunologic Factors|immunologic factors|mesh-ancestor
56097628|NCT02487277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097629|NCT00002438|Itraconazole|itraconazole|mesh-list
56097630|NCT00002438|Antifungal Agents|antifungal agents|mesh-ancestor
56097631|NCT00002438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097632|NCT00002438|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56097633|NCT00002438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56097634|NCT00002438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097635|NCT00002438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097636|NCT00002438|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56097637|NCT00002438|Hormone Antagonists|hormone antagonists|mesh-ancestor
56097638|NCT00002438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56097639|NCT00002438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097678|NCT00002450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097679|NCT00002450|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56097680|NCT00002450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097681|NCT00002450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097682|NCT00002450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097683|NCT00002450|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56097684|NCT00002450|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56097685|NCT03277183|Epoetin Alfa|epoetin alfa|mesh-list
56097686|NCT03277183|Hematinics|hematinics|mesh-ancestor
56097744|NCT00002492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097745|NCT00002492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56097746|NCT00002492|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56097747|NCT00002492|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56097748|NCT00002492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097749|NCT00002492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097750|NCT05751512|Methotrexate|methotrexate|mesh-list
56097751|NCT05751512|Cetuximab|cetuximab|mesh-list
56097752|NCT05751512|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56097753|NCT05751512|Abortifacient Agents|abortifacient agents|mesh-ancestor
56097754|NCT05751512|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56097755|NCT05751512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56097756|NCT05751512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097757|NCT05751512|Antimetabolites|antimetabolites|mesh-ancestor
56097758|NCT05751512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56097759|NCT05751512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097760|NCT05751512|Dermatologic Agents|dermatologic agents|mesh-ancestor
56097761|NCT05751512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56097762|NCT05751512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56097763|NCT05751512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56097764|NCT05751512|Immunologic Factors|immunologic factors|mesh-ancestor
56097795|NCT00002498|Antimetabolites|antimetabolites|mesh-ancestor
56097796|NCT00002498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097797|NCT00002498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56097798|NCT00002498|Abortifacient Agents|abortifacient agents|mesh-ancestor
56097799|NCT00002498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56097800|NCT00002498|Dermatologic Agents|dermatologic agents|mesh-ancestor
56097802|NCT00002498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56097865|NCT00002516|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56097867|NCT00002516|Antimitotic Agents|antimitotic agents|mesh-ancestor
56097868|NCT00002516|Mitosis Modulators|mitosis modulators|mesh-ancestor
56097869|NCT00002516|Trace Elements|trace elements|mesh-ancestor
56097870|NCT00002516|Micronutrients|micronutrients|mesh-ancestor
56097871|NCT00002516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56097872|NCT00002516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097873|NCT00002516|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56097874|NCT00002516|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56097876|NCT00002522|Etoposide|etoposide|mesh-list
56097929|NCT00002534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56097930|NCT00002534|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56097931|NCT00002534|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56097932|NCT00002534|Antimetabolites|antimetabolites|mesh-ancestor
56097933|NCT00002534|Antiviral Agents|antiviral agents|mesh-ancestor
56097934|NCT00002534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56097935|NCT00002534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56097936|NCT00002534|Antiemetics|antiemetics|mesh-ancestor
56097937|NCT00002534|Autonomic Agents|autonomic agents|mesh-ancestor
56097938|NCT00002534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56097941|NCT00002534|Hormones|hormones|mesh-ancestor
56097995|NCT00378625|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56097996|NCT00378625|Anthelmintics|anthelmintics|mesh-ancestor
56097997|NCT04005391|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56097998|NCT04005391|Contraceptive Agents|contraceptive agents|mesh-list
56097999|NCT04005391|Levonorgestrel|levonorgestrel|mesh-list
56098000|NCT04005391|Medroxyprogesterone|medroxyprogesterone|mesh-list
56098001|NCT04005391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56098002|NCT04005391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098003|NCT04005391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56098004|NCT04005391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56098005|NCT04005391|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56098006|NCT04005391|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56098007|NCT04005391|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56098008|NCT04005391|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56098009|NCT04005391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098010|NCT04005391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098011|NCT00002552|Leucovorin|leucovorin|mesh-list
56098012|NCT00002552|Cytarabine|cytarabine|mesh-list
56098013|NCT00002552|Hydrocortisone|hydrocortisone|mesh-list
56098014|NCT00002552|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56098015|NCT00002552|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56098016|NCT00002552|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56098017|NCT00002552|Cyclophosphamide|cyclophosphamide|mesh-list
56098018|NCT00002552|Carmustine|carmustine|mesh-list
56098019|NCT00002552|Methotrexate|methotrexate|mesh-list
56098020|NCT00002552|Etoposide|etoposide|mesh-list
56098021|NCT00002552|Sargramostim|sargramostim|mesh-list
56098022|NCT00002552|Levoleucovorin|levoleucovorin|mesh-list
56098023|NCT00002552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098024|NCT00002552|Immunologic Factors|immunologic factors|mesh-ancestor
56098025|NCT00002552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098026|NCT00002552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098027|NCT00002552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098028|NCT00002552|Alkylating Agents|alkylating agents|mesh-ancestor
56098029|NCT00002552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825137|NCT04307576|Blinatumomab|blinatumomab|mesh-list
56098034|NCT00002552|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56098035|NCT00002552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098036|NCT00002552|Antimetabolites|antimetabolites|mesh-ancestor
56098037|NCT00002552|Dermatologic Agents|dermatologic agents|mesh-ancestor
56098038|NCT00002552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098039|NCT00002552|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56098040|NCT00002552|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56098041|NCT00002552|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098042|NCT00002552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098043|NCT00002552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098101|NCT00002576|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56098102|NCT00002576|Vincristine|vincristine|mesh-list
56098103|NCT00002576|Mitoxantrone|mitoxantrone|mesh-list
56098104|NCT00002576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098105|NCT00002576|Immunologic Factors|immunologic factors|mesh-ancestor
56098106|NCT00002576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098107|NCT00002576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098108|NCT00002576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098109|NCT00002576|Alkylating Agents|alkylating agents|mesh-ancestor
56098110|NCT00002576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098111|NCT00002576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098112|NCT00002576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098163|NCT00002582|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56098164|NCT00002582|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56098165|NCT00002582|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56098166|NCT00002582|Fertility Agents|fertility agents|mesh-ancestor
56098168|NCT00002588|Topotecan|topotecan|mesh-list
56098169|NCT00002588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098170|NCT00002588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098171|NCT00002588|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098172|NCT00002588|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098173|NCT00002588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098174|NCT00002588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098175|NCT00002588|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56098176|NCT02239627|Clonidine|clonidine|mesh-list
56098178|NCT02239627|Sensory System Agents|sensory system agents|mesh-ancestor
56098181|NCT02239627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56098223|NCT00002600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098224|NCT00002600|Immunologic Factors|immunologic factors|mesh-ancestor
56098225|NCT00002600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098226|NCT00002600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098227|NCT00002600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098228|NCT00002600|Alkylating Agents|alkylating agents|mesh-ancestor
56098229|NCT00002600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098230|NCT00002600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098231|NCT00002600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098232|NCT02177773|Octreotide|octreotide|mesh-list
56098233|NCT02177773|Edotreotide|edotreotide|mesh-list
56098290|NCT02145169|Anesthetics, General|anesthetics, general|mesh-ancestor
56098291|NCT02145169|Anesthetics|anesthetics|mesh-ancestor
56098292|NCT02145169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56098293|NCT02145169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098294|NCT02145169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56098295|NCT02145169|Analgesics|analgesics|mesh-ancestor
56098296|NCT02145169|Sensory System Agents|sensory system agents|mesh-ancestor
56098297|NCT02145169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098298|NCT02110069|Sirolimus|sirolimus|mesh-list
56098299|NCT02110069|Vincristine|vincristine|mesh-list
56098356|NCT04331054|Respiratory System Agents|respiratory system agents|mesh-ancestor
56098357|NCT00002654|Cobalt|cobalt|mesh-list
56098358|NCT00002654|Trace Elements|trace elements|mesh-ancestor
56098359|NCT00002654|Micronutrients|micronutrients|mesh-ancestor
56098360|NCT00002654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098361|NCT01426555|Zoledronic Acid|zoledronic acid|mesh-list
56098362|NCT01426555|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56098363|NCT01426555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098364|NCT01434745|Simvastatin|simvastatin|mesh-list
56098365|NCT01434745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56098372|NCT01401049|Lidocaine|lidocaine|mesh-list
56098420|NCT00002678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56098421|NCT00002678|Glucocorticoids|glucocorticoids|mesh-ancestor
56098423|NCT00002678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098424|NCT00002678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098425|NCT00002678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098426|NCT00002678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098427|NCT00002678|Alkylating Agents|alkylating agents|mesh-ancestor
56098428|NCT00002678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098429|NCT00002678|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098430|NCT00002678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098431|NCT00002678|Immunologic Factors|immunologic factors|mesh-ancestor
56098432|NCT01397695|Bevacizumab|bevacizumab|mesh-list
56098437|NCT01397695|Growth Substances|growth substances|mesh-ancestor
56098481|NCT00002696|Immunologic Factors|immunologic factors|mesh-ancestor
56098482|NCT00002696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098483|NCT00002696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098484|NCT00002696|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098485|NCT00002696|Alkylating Agents|alkylating agents|mesh-ancestor
56098486|NCT00002696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098487|NCT00002696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098488|NCT00002696|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098489|NCT00002696|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56098490|NCT00002696|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098491|NCT00002696|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098546|NCT00002714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098547|NCT00002714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098548|NCT00002714|Glucocorticoids|glucocorticoids|mesh-ancestor
56098550|NCT00002714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098551|NCT00002714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098552|NCT00002714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098553|NCT00002714|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56098554|NCT00002714|Tubulin Modulators|tubulin modulators|mesh-ancestor
56098555|NCT00002714|Antimitotic Agents|antimitotic agents|mesh-ancestor
56098556|NCT00002714|Mitosis Modulators|mitosis modulators|mesh-ancestor
56098557|NCT00002714|Alkylating Agents|alkylating agents|mesh-ancestor
56098558|NCT00002714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098560|NCT00002720|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56098561|NCT00002720|Hormone Antagonists|hormone antagonists|mesh-ancestor
56098562|NCT00002720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098564|NCT00002720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098599|NCT05599789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098600|NCT05599789|Tubulin Modulators|tubulin modulators|mesh-ancestor
56098601|NCT05599789|Antimitotic Agents|antimitotic agents|mesh-ancestor
56098602|NCT05599789|Mitosis Modulators|mitosis modulators|mesh-ancestor
56098603|NCT05599789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098604|NCT05599789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56098606|NCT05599555|Immunologic Factors|immunologic factors|mesh-ancestor
56098607|NCT05599555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098608|NCT00002738|Leucovorin|leucovorin|mesh-list
56098609|NCT00002738|Trimetrexate|trimetrexate|mesh-list
56098610|NCT00002738|Calcium|calcium|mesh-list
56098611|NCT00002738|Levoleucovorin|levoleucovorin|mesh-list
56098612|NCT00002738|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56098613|NCT00002738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098615|NCT00002738|Protective Agents|protective agents|mesh-ancestor
56098616|NCT00002738|Vitamin B Complex|vitamin b complex|mesh-ancestor
56098617|NCT00002738|Vitamins|vitamins|mesh-ancestor
56098618|NCT00002738|Micronutrients|micronutrients|mesh-ancestor
56098619|NCT00002738|Antifungal Agents|antifungal agents|mesh-ancestor
56098620|NCT00002738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56098621|NCT00002738|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098622|NCT00002738|Antimetabolites|antimetabolites|mesh-ancestor
56098623|NCT00002738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098624|NCT00002738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098625|NCT00002738|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56098626|NCT00002738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56098627|NCT04706455|Hyaluronic Acid|hyaluronic acid|mesh-list
56098628|NCT04706455|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56098629|NCT04706455|Immunologic Factors|immunologic factors|mesh-ancestor
56098630|NCT04706455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098631|NCT04706455|Viscosupplements|viscosupplements|mesh-ancestor
56098632|NCT04706455|Protective Agents|protective agents|mesh-ancestor
56098646|NCT00002744|Daunorubicin|daunorubicin|mesh-list
56098647|NCT00002744|Asparaginase|asparaginase|mesh-list
56098648|NCT00002744|Mercaptopurine|mercaptopurine|mesh-list
56098649|NCT00002744|Pegaspargase|pegaspargase|mesh-list
56098650|NCT00002744|Thioguanine|thioguanine|mesh-list
56098651|NCT00002744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098652|NCT00002744|Immunologic Factors|immunologic factors|mesh-ancestor
56098653|NCT00002744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098654|NCT00002744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098655|NCT00002744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098656|NCT00002744|Alkylating Agents|alkylating agents|mesh-ancestor
56098657|NCT00002744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098658|NCT00002744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098659|NCT00002744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098660|NCT00002744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098661|NCT00002744|Antiemetics|antiemetics|mesh-ancestor
56098662|NCT00002744|Autonomic Agents|autonomic agents|mesh-ancestor
56098663|NCT00002744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098664|NCT00002744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56098665|NCT00002744|Glucocorticoids|glucocorticoids|mesh-ancestor
56098666|NCT00002744|Hormones|hormones|mesh-ancestor
56098667|NCT00002744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098668|NCT00002744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098669|NCT00002744|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56098670|NCT00002744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56098671|NCT00002744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56098673|NCT00002744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56098689|NCT01788475|Dexamethasone|dexamethasone|mesh-list
56098692|NCT01788475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098693|NCT01788475|Antiemetics|antiemetics|mesh-ancestor
56098694|NCT01788475|Autonomic Agents|autonomic agents|mesh-ancestor
56098695|NCT01788475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098696|NCT01788475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098697|NCT01788475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56098698|NCT01788475|Glucocorticoids|glucocorticoids|mesh-ancestor
56098700|NCT01788475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098761|NCT00002756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098762|NCT00002756|Immunologic Factors|immunologic factors|mesh-ancestor
56098763|NCT00002756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098764|NCT00002756|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098765|NCT00002756|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098766|NCT00002756|Alkylating Agents|alkylating agents|mesh-ancestor
56098767|NCT00002756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098768|NCT00002756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098769|NCT00002756|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56098770|NCT00002756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56098772|NCT00002756|Hormones|hormones|mesh-ancestor
56098773|NCT00002756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098774|NCT00002756|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098775|NCT00002756|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56098776|NCT00002756|Abortifacient Agents|abortifacient agents|mesh-ancestor
56098820|NCT05749016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098821|NCT05749016|Tubulin Modulators|tubulin modulators|mesh-ancestor
56098822|NCT05749016|Antimitotic Agents|antimitotic agents|mesh-ancestor
56098823|NCT05749016|Mitosis Modulators|mitosis modulators|mesh-ancestor
56098824|NCT05749016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098825|NCT05749016|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56098826|NCT01756573|Bupivacaine|bupivacaine|mesh-list
56098827|NCT01756573|Anesthetics, Local|anesthetics, local|mesh-ancestor
56098828|NCT01756573|Anesthetics|anesthetics|mesh-ancestor
56098829|NCT01756573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56098830|NCT01756573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098831|NCT01756573|Sensory System Agents|sensory system agents|mesh-ancestor
56098832|NCT01756573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098879|NCT05599243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098881|NCT00002774|Fluorouracil|fluorouracil|mesh-list
56098882|NCT00002774|Tirapazamine|tirapazamine|mesh-list
56098883|NCT00002774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098884|NCT00002774|Antimetabolites|antimetabolites|mesh-ancestor
56098885|NCT00002774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56098886|NCT00002774|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56098887|NCT00002774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098888|NCT00002774|Immunologic Factors|immunologic factors|mesh-ancestor
56098889|NCT00002774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098890|NCT01126957|Fentanyl|fentanyl|mesh-list
56098891|NCT01126957|Ketamine|ketamine|mesh-list
56098943|NCT01122511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098944|NCT01122511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56098945|NCT01122511|Glucocorticoids|glucocorticoids|mesh-ancestor
55826038|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56098947|NCT01122511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56098948|NCT01122511|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56098949|NCT01122511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098950|NCT01122511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56098951|NCT01122511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56098952|NCT01122511|Growth Substances|growth substances|mesh-ancestor
56098953|NCT01122511|Growth Inhibitors|growth inhibitors|mesh-ancestor
56098955|NCT05535218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56098956|NCT05535218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56098957|NCT05531708|Cyclophosphamide|cyclophosphamide|mesh-list
56098958|NCT05531708|Fludarabine|fludarabine|mesh-list
56098959|NCT05531708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56098960|NCT05531708|Immunologic Factors|immunologic factors|mesh-ancestor
56098961|NCT05531708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56098962|NCT05531708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56098963|NCT05531708|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56098964|NCT05531708|Alkylating Agents|alkylating agents|mesh-ancestor
56098996|NCT00378937|Sensory System Agents|sensory system agents|mesh-ancestor
56098997|NCT00378937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56098998|NCT00378937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56098999|NCT00378937|Antipyretics|antipyretics|mesh-ancestor
56099000|NCT00378937|Antitussive Agents|antitussive agents|mesh-ancestor
56099001|NCT00378937|Respiratory System Agents|respiratory system agents|mesh-ancestor
56099002|NCT00002792|Cyclosporine|cyclosporine|mesh-list
56099003|NCT00002792|Cyclophosphamide|cyclophosphamide|mesh-list
56099004|NCT00002792|Busulfan|busulfan|mesh-list
56099005|NCT00002792|Methotrexate|methotrexate|mesh-list
56099006|NCT00002792|Tacrolimus|tacrolimus|mesh-list
56099007|NCT00002792|Cyclosporins|cyclosporins|mesh-list
56099008|NCT00002792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099009|NCT00002792|Immunologic Factors|immunologic factors|mesh-ancestor
56099010|NCT00002792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099011|NCT00002792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56099012|NCT00002792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56099013|NCT00002792|Alkylating Agents|alkylating agents|mesh-ancestor
56099015|NCT00002792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099056|NCT05594407|Anesthetics|anesthetics|mesh-ancestor
56099057|NCT05594407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099058|NCT05594407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099060|NCT05594407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099061|NCT05594407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56099062|NCT05594407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56099063|NCT05594407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56099064|NCT05594407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56099065|NCT05594407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099120|NCT04403516|Hormones|hormones|mesh-ancestor
56099121|NCT04403516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56099122|NCT04403516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56099123|NCT04403516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099124|NCT04403516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56099125|NCT04403516|Protective Agents|protective agents|mesh-ancestor
56099126|NCT01555489|Ascorbic Acid|ascorbic acid|mesh-list
56099127|NCT01555489|Vitamins|vitamins|mesh-ancestor
56099128|NCT01555489|Micronutrients|micronutrients|mesh-ancestor
56099129|NCT01555489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099130|NCT01555489|Antioxidants|antioxidants|mesh-ancestor
56099131|NCT01555489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099132|NCT01555489|Protective Agents|protective agents|mesh-ancestor
56099133|NCT05243654|Metformin|metformin|mesh-list
56099134|NCT05243654|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56099135|NCT05243654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099136|NCT01035073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56099137|NCT01035073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56099175|NCT05296759|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56099176|NCT05296759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099177|NCT05296759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099178|NCT05296759|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56099179|NCT05296759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56099180|NCT05296759|Antimanic Agents|antimanic agents|mesh-ancestor
56099181|NCT05296759|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56099182|NCT05296759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56099183|NCT05296759|Antidepressive Agents|antidepressive agents|mesh-ancestor
56099184|NCT05296759|Dopamine Agents|dopamine agents|mesh-ancestor
56099239|NCT00539617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099241|NCT00539617|Protective Agents|protective agents|mesh-ancestor
56099242|NCT00539617|Vitamin B Complex|vitamin b complex|mesh-ancestor
56099243|NCT00539617|Vitamins|vitamins|mesh-ancestor
56099244|NCT00539617|Micronutrients|micronutrients|mesh-ancestor
56099245|NCT00539617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56099246|NCT00539617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099247|NCT05467514|Liraglutide|liraglutide|mesh-list
56099248|NCT05467514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56099249|NCT05467514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099250|NCT05467514|Incretins|incretins|mesh-ancestor
56099252|NCT05467514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56099253|NCT00976339|Vitamin D|vitamin d|mesh-list
56099254|NCT00976339|Cholecalciferol|cholecalciferol|mesh-list
56099255|NCT00976339|Vitamins|vitamins|mesh-ancestor
56099301|NCT00954187|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56099302|NCT00954187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56099303|NCT00954187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099304|NCT00954187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56099305|NCT00954187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56099306|NCT00954187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56099307|NCT00954187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099308|NCT00954187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099309|NCT00954187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56099310|NCT00954187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56099311|NCT00954187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099312|NCT00954187|Antimanic Agents|antimanic agents|mesh-ancestor
56099315|NCT04796012|Temozolomide|temozolomide|mesh-list
56099316|NCT04796012|Atezolizumab|atezolizumab|mesh-list
56099317|NCT04796012|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56099318|NCT04796012|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56099319|NCT04796012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099320|NCT04796012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099321|NCT04796012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099322|NCT04796012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56099323|NCT04796012|Tubulin Modulators|tubulin modulators|mesh-ancestor
56099324|NCT04796012|Antimitotic Agents|antimitotic agents|mesh-ancestor
56099325|NCT04796012|Mitosis Modulators|mitosis modulators|mesh-ancestor
56099326|NCT04796012|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56099327|NCT04796012|Alkylating Agents|alkylating agents|mesh-ancestor
56099328|NCT00947791|Midazolam|midazolam|mesh-list
56099329|NCT00947791|Ketamine|ketamine|mesh-list
56099330|NCT00947791|Analgesics|analgesics|mesh-ancestor
56099342|NCT00947791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099343|NCT00947791|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56099344|NCT00947791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56099345|NCT00947791|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56099346|NCT00947791|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56099347|NCT00947791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099348|NCT00947791|GABA Modulators|gaba modulators|mesh-ancestor
56099349|NCT00947791|GABA Agents|gaba agents|mesh-ancestor
56099350|NCT05136326|Capecitabine|capecitabine|mesh-list
56099351|NCT05136326|Temozolomide|temozolomide|mesh-list
56099352|NCT05136326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56099353|NCT05136326|Antimetabolites|antimetabolites|mesh-ancestor
56099354|NCT05136326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099355|NCT05136326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099356|NCT05136326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56099357|NCT05136326|Alkylating Agents|alkylating agents|mesh-ancestor
56099358|NCT05387941|Dexamethasone|dexamethasone|mesh-list
56099359|NCT05387941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56099360|NCT05387941|Antiemetics|antiemetics|mesh-ancestor
56099361|NCT05387941|Autonomic Agents|autonomic agents|mesh-ancestor
56099362|NCT05387941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099363|NCT05387941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099364|NCT05387941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56099365|NCT05387941|Glucocorticoids|glucocorticoids|mesh-ancestor
56099366|NCT05387941|Hormones|hormones|mesh-ancestor
56099367|NCT05387941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56099368|NCT05387941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56099369|NCT05387941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099370|NCT00379015|Cyclophosphamide|cyclophosphamide|mesh-list
56099371|NCT00379015|Docetaxel|docetaxel|mesh-list
56099372|NCT00379015|Trastuzumab|trastuzumab|mesh-list
56099384|NCT00379015|Antimitotic Agents|antimitotic agents|mesh-ancestor
56099385|NCT00379015|Mitosis Modulators|mitosis modulators|mesh-ancestor
56099386|NCT00379015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56099387|NCT00379015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56099388|NCT00379015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56099389|NCT00379015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56099390|NCT00379015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099392|NCT00911053|Antioxidants|antioxidants|mesh-ancestor
56099393|NCT00911053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099394|NCT00911053|Protective Agents|protective agents|mesh-ancestor
56099395|NCT00911053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099448|NCT00476827|Antimetabolites|antimetabolites|mesh-ancestor
56099449|NCT00476827|Antiviral Agents|antiviral agents|mesh-ancestor
56099450|NCT00476827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56099451|NCT00476827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099452|NCT00476827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099453|NCT00476827|Immunologic Factors|immunologic factors|mesh-ancestor
56099454|NCT00476827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56099455|NCT00476827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56099456|NCT00459121|Paclitaxel|paclitaxel|mesh-list
56099457|NCT00459121|Carboplatin|carboplatin|mesh-list
56099458|NCT00459121|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56099459|NCT00459121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099511|NCT05033522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099512|NCT05033522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56099513|NCT05033522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099514|NCT05033522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099515|NCT00314353|Bevacizumab|bevacizumab|mesh-list
56099516|NCT00314353|Capecitabine|capecitabine|mesh-list
56099517|NCT00314353|Oxaliplatin|oxaliplatin|mesh-list
56099518|NCT00314353|Irinotecan|irinotecan|mesh-list
56099519|NCT00314353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56099520|NCT00314353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099521|NCT00314353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56099558|NCT05007392|Febuxostat|febuxostat|mesh-list
56099574|NCT00379249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099575|NCT05357690|Bupivacaine|bupivacaine|mesh-list
56099576|NCT05357690|Anesthetics, Local|anesthetics, local|mesh-ancestor
56099577|NCT05357690|Anesthetics|anesthetics|mesh-ancestor
56099578|NCT05357690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099579|NCT05357690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099580|NCT05357690|Sensory System Agents|sensory system agents|mesh-ancestor
56099581|NCT05357690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099582|NCT00801931|Cyclophosphamide|cyclophosphamide|mesh-list
56099583|NCT00801931|Melphalan|melphalan|mesh-list
56099584|NCT00801931|Busulfan|busulfan|mesh-list
56099585|NCT00801931|Thiotepa|thiotepa|mesh-list
56099586|NCT00801931|Fludarabine|fludarabine|mesh-list
56099587|NCT00801931|Alemtuzumab|alemtuzumab|mesh-list
56099588|NCT00801931|Phenytoin|phenytoin|mesh-list
56099589|NCT00801931|Fosphenytoin|fosphenytoin|mesh-list
56099590|NCT00801931|Thymoglobulin|thymoglobulin|mesh-list
56099591|NCT00801931|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56099592|NCT00801931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56099593|NCT00801931|Immunologic Factors|immunologic factors|mesh-ancestor
56099594|NCT00801931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099595|NCT00801931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56099631|NCT00019747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099633|NCT05048719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56099634|NCT05048719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099635|NCT00759577|Solifenacin Succinate|solifenacin succinate|mesh-list
56099636|NCT00759577|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56099637|NCT00759577|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56099638|NCT00759577|Cholinergic Agents|cholinergic agents|mesh-ancestor
56099639|NCT00759577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099640|NCT00759577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099641|NCT00759577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099642|NCT00759577|Urological Agents|urological agents|mesh-ancestor
56099644|NCT00746239|Citalopram|citalopram|mesh-list
56099694|NCT00402883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099695|NCT00402883|Growth Inhibitors|growth inhibitors|mesh-ancestor
56099696|NCT00402883|Vitamins|vitamins|mesh-ancestor
56099697|NCT00402883|Micronutrients|micronutrients|mesh-ancestor
56099698|NCT00402883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099699|NCT00402883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099700|NCT00402883|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56099762|NCT04531982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099763|NCT04531982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099764|NCT04531982|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099765|NCT04531982|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56099766|NCT04531982|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56099767|NCT04531982|Serotonin Agents|serotonin agents|mesh-ancestor
56099768|NCT04531982|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099769|NCT04531982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099770|NCT00726037|Denileukin diftitox|denileukin diftitox|mesh-list
56099771|NCT00726037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099772|NCT05278676|Dotinurad|dotinurad|mesh-list
56099773|NCT05278676|Uricosuric Agents|uricosuric agents|mesh-ancestor
56099777|NCT00703885|Alprazolam|alprazolam|mesh-list
56099826|NCT00673309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56099827|NCT00673309|Vasodilator Agents|vasodilator agents|mesh-ancestor
56099828|NCT00673309|Androgens|androgens|mesh-ancestor
56099829|NCT00673309|Anabolic Agents|anabolic agents|mesh-ancestor
56099830|NCT04508036|Fibrin fragment D|fibrin fragment d|mesh-list
56099831|NCT04508036|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56099832|NCT04508036|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56099833|NCT04508036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099834|NCT04508036|Hemostatics|hemostatics|mesh-ancestor
56099835|NCT04508036|Coagulants|coagulants|mesh-ancestor
56099836|NCT04828057|Timolol|timolol|mesh-list
56099837|NCT04828057|Bimatoprost|bimatoprost|mesh-list
56099838|NCT04828057|Travoprost|travoprost|mesh-list
56099839|NCT04828057|Latanoprost|latanoprost|mesh-list
56099840|NCT04828057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099841|NCT04828057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56099842|NCT04828057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56099843|NCT04828057|Adrenergic Agents|adrenergic agents|mesh-ancestor
56099844|NCT04828057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099845|NCT04828057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099846|NCT04828057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56099847|NCT04828057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56099848|NCT04828057|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56099849|NCT04828057|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56099850|NCT02973451|Bupivacaine|bupivacaine|mesh-list
56099851|NCT02973451|Anesthetics, Local|anesthetics, local|mesh-ancestor
56099876|NCT00668785|Growth Substances|growth substances|mesh-ancestor
56099877|NCT00668785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099878|NCT00668785|Growth Inhibitors|growth inhibitors|mesh-ancestor
56099879|NCT00668785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56099880|NCT00655057|Citalopram|citalopram|mesh-list
56099881|NCT00655057|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56099882|NCT00655057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56099883|NCT00655057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56099884|NCT00655057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099885|NCT00655057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56099887|NCT00655057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099888|NCT00655057|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56099889|NCT00655057|Antidepressive Agents|antidepressive agents|mesh-ancestor
56099890|NCT00655057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56099891|NCT00000211|Buprenorphine|buprenorphine|mesh-list
56099892|NCT00000211|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56099893|NCT00000211|Narcotics|narcotics|mesh-ancestor
56099894|NCT00000211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099895|NCT00000211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099896|NCT00000211|Analgesics|analgesics|mesh-ancestor
56099897|NCT00000211|Sensory System Agents|sensory system agents|mesh-ancestor
56099928|NCT00000223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56099929|NCT00000223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56099930|NCT00000223|Analgesics|analgesics|mesh-ancestor
56099931|NCT00000223|Sensory System Agents|sensory system agents|mesh-ancestor
56099932|NCT00000223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56099933|NCT00000223|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56099934|NCT00000229|Buprenorphine|buprenorphine|mesh-list
56099935|NCT00000229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56099936|NCT00000229|Narcotics|narcotics|mesh-ancestor
56099939|NCT00000229|Analgesics|analgesics|mesh-ancestor
56099995|NCT00379405|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56099996|NCT00379405|Protease Inhibitors|protease inhibitors|mesh-ancestor
56099997|NCT00379405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56099998|NCT00379405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56099999|NCT00379405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100000|NCT00379405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100001|NCT00379405|Antiviral Agents|antiviral agents|mesh-ancestor
56100002|NCT00379405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100003|NCT00379405|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56100004|NCT00379405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56100005|NCT00379483|Deferasirox|deferasirox|mesh-list
56100006|NCT00379483|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56100007|NCT00379483|Chelating Agents|chelating agents|mesh-ancestor
56100008|NCT00379483|Sequestering Agents|sequestering agents|mesh-ancestor
56100009|NCT00379483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100010|NCT00607477|Minoxidil|minoxidil|mesh-list
56100011|NCT00607477|Hydralazine|hydralazine|mesh-list
56100012|NCT00607477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56100013|NCT00607477|Vasodilator Agents|vasodilator agents|mesh-ancestor
56100014|NCT04423861|Nitazoxanide|nitazoxanide|mesh-list
56100015|NCT04423861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56100016|NCT04423861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100017|NCT00000271|Desipramine|desipramine|mesh-list
56100018|NCT00000271|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56100019|NCT00000271|Antidepressive Agents|antidepressive agents|mesh-ancestor
56100020|NCT00000271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100021|NCT00000271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100043|NCT00599131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100044|NCT00599131|Tubulin Modulators|tubulin modulators|mesh-ancestor
56100045|NCT00599131|Antimitotic Agents|antimitotic agents|mesh-ancestor
56100046|NCT00599131|Mitosis Modulators|mitosis modulators|mesh-ancestor
56100047|NCT00599131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100049|NCT00599131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56100050|NCT00599131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56100051|NCT00599131|Immunologic Factors|immunologic factors|mesh-ancestor
56100052|NCT00599131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100053|NCT00599131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56100055|NCT04302350|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56100056|NCT04302350|Anesthetics, General|anesthetics, general|mesh-ancestor
56100057|NCT04302350|Anesthetics|anesthetics|mesh-ancestor
56100058|NCT04302350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56100059|NCT04302350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100060|NCT04302350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56100061|NCT04302350|Analgesics|analgesics|mesh-ancestor
56100062|NCT04302350|Sensory System Agents|sensory system agents|mesh-ancestor
56100063|NCT04302350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100064|NCT00584935|Rituximab|rituximab|mesh-list
56100065|NCT00584935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56100066|NCT00584935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100067|NCT00584935|Immunologic Factors|immunologic factors|mesh-ancestor
56100068|NCT00584935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100069|NCT00584935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56100089|NCT00000289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100090|NCT00000289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100091|NCT00000289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56100093|NCT00000289|Dermatologic Agents|dermatologic agents|mesh-ancestor
56100094|NCT00000289|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56100095|NCT00000289|Serotonin Agents|serotonin agents|mesh-ancestor
56100096|NCT00000289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100097|NCT00000289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100098|NCT00000289|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56100099|NCT00000289|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56100100|NCT00000289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56100101|NCT00000289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100102|NCT00000289|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56100103|NCT00000295|Progesterone|progesterone|mesh-list
56100104|NCT00000295|Progestins|progestins|mesh-ancestor
56100105|NCT00000295|Hormones|hormones|mesh-ancestor
56100106|NCT00000295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56100107|NCT00000295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100108|NCT04294628|Trastuzumab|trastuzumab|mesh-list
56100109|NCT04294628|Camptothecin|camptothecin|mesh-list
56100110|NCT04294628|Immunoconjugates|immunoconjugates|mesh-list
56100111|NCT04294628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56100112|NCT04294628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100113|NCT04294628|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56100114|NCT04294628|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56100115|NCT04294628|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56100116|NCT04294628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100117|NCT04294628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100118|NCT04294628|Immunologic Factors|immunologic factors|mesh-ancestor
56100119|NCT04294628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100120|NCT00000733|Ribavirin|ribavirin|mesh-list
56100121|NCT00000733|Antimetabolites|antimetabolites|mesh-ancestor
56100122|NCT00000733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100124|NCT00000733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868483|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55902006|NCT02405910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55902007|NCT02405910|Immunologic Factors|immunologic factors|mesh-ancestor
56100126|NCT04246723|Sofosbuvir|sofosbuvir|mesh-list
56100127|NCT04246723|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56100128|NCT04246723|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56100129|NCT04246723|Protease Inhibitors|protease inhibitors|mesh-ancestor
56100130|NCT04246723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100131|NCT04246723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100132|NCT04246723|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100133|NCT04246723|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100134|NCT04246723|Antiviral Agents|antiviral agents|mesh-ancestor
56100135|NCT04246723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100191|NCT04181203|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56100192|NCT04181203|Fertility Agents|fertility agents|mesh-ancestor
56100193|NCT04181203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56100194|NCT04181203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56100195|NCT04181203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100196|NCT04181203|Luteolytic Agents|luteolytic agents|mesh-ancestor
56100197|NCT04181203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56100259|NCT00000781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100260|NCT00000781|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100261|NCT00000781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100262|NCT00000781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100263|NCT00000781|Antiviral Agents|antiviral agents|mesh-ancestor
56100264|NCT00000781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100265|NCT00000781|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100266|NCT00000781|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100267|NCT00000781|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56100268|NCT00000781|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56100269|NCT00000349|Flupenthixol|flupenthixol|mesh-list
56100270|NCT00000349|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
56100271|NCT00000349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56100316|NCT00000361|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56100317|NCT00000361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56100318|NCT00000361|Immunologic Factors|immunologic factors|mesh-ancestor
56100319|NCT00000361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56100320|NCT00000361|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100321|NCT00000811|Azithromycin|azithromycin|mesh-list
56100322|NCT00000811|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56100323|NCT00000811|Trimethoprim|trimethoprim|mesh-list
56100324|NCT00000811|Sulfamethoxazole|sulfamethoxazole|mesh-list
56100326|NCT00000811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56100327|NCT00000811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100328|NCT00000811|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56100329|NCT00000811|Renal Agents|renal agents|mesh-ancestor
56100330|NCT00000811|Antimalarials|antimalarials|mesh-ancestor
56100331|NCT00000811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56100332|NCT00000811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56100333|NCT00000811|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56100334|NCT00000811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100335|NCT00000811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100372|NCT00000379|Fluoxetine|fluoxetine|mesh-list
56100373|NCT00000379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56100374|NCT00000379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56100375|NCT00000379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56100376|NCT00000379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100377|NCT00000379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100378|NCT00000379|Serotonin Agents|serotonin agents|mesh-ancestor
56100379|NCT00000379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100381|NCT00000379|Antidepressive Agents|antidepressive agents|mesh-ancestor
56100437|NCT04233164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100438|NCT00000841|Lamivudine|lamivudine|mesh-list
56100439|NCT00000841|Zidovudine|zidovudine|mesh-list
56100440|NCT00000841|Stavudine|stavudine|mesh-list
56100441|NCT00000841|Indinavir|indinavir|mesh-list
56100442|NCT00000841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100443|NCT00000841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100444|NCT00000841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100445|NCT00000841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100446|NCT00000841|Antiviral Agents|antiviral agents|mesh-ancestor
56100447|NCT00000841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100448|NCT00000841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100449|NCT00000841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100450|NCT00000841|Antimetabolites|antimetabolites|mesh-ancestor
56100501|NCT00002912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100502|NCT00002912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100503|NCT00002912|Analgesics|analgesics|mesh-ancestor
56100504|NCT00002912|Sensory System Agents|sensory system agents|mesh-ancestor
56100505|NCT00002912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100506|NCT00002912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100507|NCT04183790|Ivacaftor|ivacaftor|mesh-list
56100508|NCT04183790|Elexacaftor|elexacaftor|mesh-list
56100509|NCT04183790|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56100510|NCT04183790|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56100511|NCT04183790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100512|NCT00000445|Naltrexone|naltrexone|mesh-list
56100513|NCT00000445|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56100514|NCT00000445|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56100515|NCT00000445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100516|NCT00000445|Sensory System Agents|sensory system agents|mesh-ancestor
56100517|NCT00000445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100518|NCT00000451|Naltrexone|naltrexone|mesh-list
56100519|NCT00000451|Sertraline|sertraline|mesh-list
56100520|NCT00000451|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56100522|NCT00000451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100523|NCT00000451|Sensory System Agents|sensory system agents|mesh-ancestor
56100524|NCT00000451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56100525|NCT00000451|Antidepressive Agents|antidepressive agents|mesh-ancestor
56100526|NCT00000451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100527|NCT00000451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56100528|NCT00000451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56100529|NCT00000451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56100530|NCT00000451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100531|NCT00000451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100543|NCT00000865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100544|NCT00000865|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100545|NCT00000865|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100546|NCT00000865|Antimetabolites|antimetabolites|mesh-ancestor
56100548|NCT04175600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56100549|NCT00000469|Aspirin|aspirin|mesh-list
56100550|NCT00000469|Lovastatin|lovastatin|mesh-list
56100551|NCT00000469|L 647318|l 647318|mesh-list
56100552|NCT00000469|Dihydromevinolin|dihydromevinolin|mesh-list
56100553|NCT00000469|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56100554|NCT00000469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56100555|NCT00000469|Analgesics|analgesics|mesh-ancestor
56100560|NCT00000469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56100606|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
56100607|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55741805|NCT05124951|Carboplatin|carboplatin|mesh-list
56100608|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100609|NCT03121586|Pimavanserin|pimavanserin|mesh-list
56100610|NCT03121586|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56100611|NCT03121586|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56100612|NCT03121586|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56100613|NCT03121586|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56100614|NCT03121586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56100615|NCT03121586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100616|NCT03121586|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56100617|NCT03121586|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56100618|NCT03121586|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56100619|NCT03121586|Serotonin Agents|serotonin agents|mesh-ancestor
56100620|NCT03121586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56100621|NCT03121586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100623|NCT00000901|Stavudine|stavudine|mesh-list
56100624|NCT00000901|Indinavir|indinavir|mesh-list
56100625|NCT00000901|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100626|NCT00000901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100637|NCT00000541|Vitamins|vitamins|mesh-list
56100661|NCT00000913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100662|NCT00000913|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100663|NCT00000913|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100664|NCT00000913|Antiviral Agents|antiviral agents|mesh-ancestor
56100665|NCT00000913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100666|NCT00000913|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56100667|NCT00000913|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56100668|NCT00000547|Enalapril|enalapril|mesh-list
56100669|NCT00000547|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56100670|NCT00000547|Protease Inhibitors|protease inhibitors|mesh-ancestor
56100671|NCT00000547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100723|NCT00000937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100724|NCT00000613|Genistein|genistein|mesh-list
56100725|NCT00000613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56100726|NCT00000613|Protective Agents|protective agents|mesh-ancestor
56100727|NCT00000613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56100728|NCT00000613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100729|NCT00000613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56100730|NCT00000613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100731|NCT00000613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100732|NCT00000613|Phytoestrogens|phytoestrogens|mesh-ancestor
56100734|NCT00000613|Estrogens|estrogens|mesh-ancestor
56100788|NCT00000655|Sulfamethoxazole|sulfamethoxazole|mesh-list
56100789|NCT00000655|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56100790|NCT00000655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100791|NCT00000655|Renal Agents|renal agents|mesh-ancestor
56100792|NCT00000655|Antimalarials|antimalarials|mesh-ancestor
56100793|NCT00000655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56100794|NCT00000655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56100795|NCT00000655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56100796|NCT00000655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100855|NCT00000979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100856|NCT00000979|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100857|NCT00000979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100858|NCT00000979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100859|NCT00000979|Antiviral Agents|antiviral agents|mesh-ancestor
56100860|NCT00000979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100861|NCT00000979|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100862|NCT00000979|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100863|NCT00000991|Zidovudine|zidovudine|mesh-list
56100864|NCT00000991|Trimethoprim|trimethoprim|mesh-list
56100865|NCT00000991|Sulfamethoxazole|sulfamethoxazole|mesh-list
56100866|NCT00000991|Dapsone|dapsone|mesh-list
56100867|NCT00000991|Pentamidine|pentamidine|mesh-list
56100868|NCT00000991|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
56100869|NCT00000991|Antimetabolites|antimetabolites|mesh-ancestor
56100870|NCT00000991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100871|NCT00000991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100872|NCT00000991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100873|NCT00000991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100874|NCT00000991|Antiviral Agents|antiviral agents|mesh-ancestor
56100875|NCT00000991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100876|NCT00000991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100877|NCT00000991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100878|NCT00000991|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56100879|NCT00000991|Renal Agents|renal agents|mesh-ancestor
56100880|NCT00000991|Antimalarials|antimalarials|mesh-ancestor
56100881|NCT00000991|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56100887|NCT00000991|Leprostatic Agents|leprostatic agents|mesh-ancestor
56100894|NCT00000673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100895|NCT00000673|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100896|NCT00000673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100897|NCT00000673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100899|NCT00000685|Antimetabolites|antimetabolites|mesh-ancestor
56100900|NCT00000685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100901|NCT00000685|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100902|NCT00000685|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100903|NCT00000685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100904|NCT00000685|Antiviral Agents|antiviral agents|mesh-ancestor
56100905|NCT00000685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100906|NCT00000685|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100907|NCT00000685|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100909|NCT00002972|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56100910|NCT00002972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56100949|NCT00000997|Antiviral Agents|antiviral agents|mesh-ancestor
56100950|NCT00000997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100951|NCT00000997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56100952|NCT00000997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56100953|NCT00000697|Foscarnet|foscarnet|mesh-list
56100954|NCT00000697|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56100955|NCT00000697|Antiviral Agents|antiviral agents|mesh-ancestor
56100956|NCT00000697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56100957|NCT00000697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56100958|NCT00000697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56100959|NCT00000697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56100960|NCT00000697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56100961|NCT02466074|Acetazolamide|acetazolamide|mesh-list
56100962|NCT02466074|Anticonvulsants|anticonvulsants|mesh-ancestor
56100966|NCT02466074|Diuretics|diuretics|mesh-ancestor
56101013|NCT00000703|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56101014|NCT00000703|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101015|NCT00000703|Antiviral Agents|antiviral agents|mesh-ancestor
56101016|NCT00000703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101017|NCT00000703|Antidotes|antidotes|mesh-ancestor
56101018|NCT00000703|Protective Agents|protective agents|mesh-ancestor
56101019|NCT00000703|Vitamin B Complex|vitamin b complex|mesh-ancestor
56101020|NCT00000703|Vitamins|vitamins|mesh-ancestor
56101021|NCT00000703|Micronutrients|micronutrients|mesh-ancestor
56101022|NCT00000703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56101023|NCT00000703|Tubulin Modulators|tubulin modulators|mesh-ancestor
56101024|NCT00000703|Antimitotic Agents|antimitotic agents|mesh-ancestor
56101025|NCT00000703|Mitosis Modulators|mitosis modulators|mesh-ancestor
56101026|NCT00000703|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101027|NCT00000703|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101028|NCT00000703|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101029|NCT00000703|Gout Suppressants|gout suppressants|mesh-ancestor
56101030|NCT00000703|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56101073|NCT00001015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101074|NCT00000709|Zidovudine|zidovudine|mesh-list
56101075|NCT00000709|Antimetabolites|antimetabolites|mesh-ancestor
56101136|NCT00001057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101137|NCT00001057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101138|NCT00001057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101139|NCT00002293|Nystatin|nystatin|mesh-list
56101140|NCT00002293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56101141|NCT00002293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101142|NCT00002293|Antifungal Agents|antifungal agents|mesh-ancestor
56101143|NCT00002293|Ionophores|ionophores|mesh-ancestor
56101144|NCT00002293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56101145|NCT00002293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101146|NCT00002299|Interferons|interferons|mesh-list
56101147|NCT00002299|Interferon-beta|interferon-beta|mesh-list
56101148|NCT00002299|Ganciclovir|ganciclovir|mesh-list
56101149|NCT00002299|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56101150|NCT00002299|Interferon beta-1b|interferon beta-1b|mesh-list
56101151|NCT00002299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101152|NCT00002299|Antiviral Agents|antiviral agents|mesh-ancestor
56101153|NCT00002299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101154|NCT00002299|Immunologic Factors|immunologic factors|mesh-ancestor
56101155|NCT00002299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101156|NCT00002299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101157|NCT00002299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101158|NCT00002299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101159|NCT00002299|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56101160|NCT00001063|Zidovudine|zidovudine|mesh-list
56101161|NCT00001063|Didanosine|didanosine|mesh-list
56101162|NCT00001063|Stavudine|stavudine|mesh-list
56101163|NCT00001063|Antimetabolites|antimetabolites|mesh-ancestor
56101183|NCT00002305|Hormone Antagonists|hormone antagonists|mesh-ancestor
56101184|NCT00002305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56101185|NCT00002305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101186|NCT00002305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56101187|NCT00002305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56101188|NCT00002305|Amebicides|amebicides|mesh-ancestor
56101189|NCT00002305|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56101190|NCT00002305|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56101193|NCT00001081|Nitazoxanide|nitazoxanide|mesh-list
56101249|NCT00002996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56101250|NCT00002996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56101251|NCT00002996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56101252|NCT00002996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101254|NCT00001135|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101255|NCT00001135|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101256|NCT00001135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101257|NCT00001135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101258|NCT00001135|Antiviral Agents|antiviral agents|mesh-ancestor
56101259|NCT00001135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101260|NCT00001135|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101261|NCT00001135|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101262|NCT00001135|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56101263|NCT00001135|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56101264|NCT00003002|Sargramostim|sargramostim|mesh-list
56101265|NCT00003002|Immunologic Factors|immunologic factors|mesh-ancestor
56101266|NCT00003002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101267|NCT00001891|Dobutamine|dobutamine|mesh-list
56101268|NCT00001891|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56101269|NCT00001891|Sympathomimetics|sympathomimetics|mesh-ancestor
56101270|NCT00001891|Autonomic Agents|autonomic agents|mesh-ancestor
56101271|NCT00001891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56101272|NCT00001891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101273|NCT00001891|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56101274|NCT00001891|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56101275|NCT00001891|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56101276|NCT00001891|Adrenergic Agents|adrenergic agents|mesh-ancestor
56101277|NCT00001891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869622|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869626|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
55902008|NCT02405910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902009|NCT02539108|Vaccines|vaccines|mesh-list
55902010|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
55902011|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902012|NCT02406066|Oxazepam|oxazepam|mesh-list
55902013|NCT02406066|Metyrapone|metyrapone|mesh-list
55902015|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902016|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902017|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56101278|NCT00001891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101280|NCT00383864|Interferons|interferons|mesh-list
56101281|NCT00383864|Ribavirin|ribavirin|mesh-list
56101282|NCT00383864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101283|NCT00383864|Antiviral Agents|antiviral agents|mesh-ancestor
56101284|NCT00383864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101286|NCT00383864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101287|NCT00003008|Ritonavir|ritonavir|mesh-list
56101288|NCT00003008|Nelfinavir|nelfinavir|mesh-list
56101289|NCT00003008|Indinavir|indinavir|mesh-list
56101290|NCT00003008|Saquinavir|saquinavir|mesh-list
56101291|NCT00003008|Paclitaxel|paclitaxel|mesh-list
56101292|NCT00003008|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56101293|NCT00003008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101294|NCT00003008|Tubulin Modulators|tubulin modulators|mesh-ancestor
56101295|NCT00003008|Antimitotic Agents|antimitotic agents|mesh-ancestor
56101296|NCT00003008|Mitosis Modulators|mitosis modulators|mesh-ancestor
56101297|NCT00003008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101298|NCT00003008|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56101299|NCT00003008|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56101332|NCT00002341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101333|NCT00002341|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56101335|NCT00002347|Nevirapine|nevirapine|mesh-list
56101336|NCT00002347|Zalcitabine|zalcitabine|mesh-list
56101337|NCT00002347|Saquinavir|saquinavir|mesh-list
56101338|NCT00002347|Antimetabolites|antimetabolites|mesh-ancestor
56101339|NCT00002347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101340|NCT00002347|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101341|NCT00002347|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101342|NCT00002347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101343|NCT00002347|Antiviral Agents|antiviral agents|mesh-ancestor
56101344|NCT00002347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101345|NCT00002347|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101346|NCT00002347|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101347|NCT00002347|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56101348|NCT00002347|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56101349|NCT00002347|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56101350|NCT00002347|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56101351|NCT00002347|Protease Inhibitors|protease inhibitors|mesh-ancestor
56101352|NCT00002347|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56101354|NCT00001237|Molgramostim|molgramostim|mesh-list
56101385|NCT00001963|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56101386|NCT00001963|Vasodilator Agents|vasodilator agents|mesh-ancestor
56101387|NCT00001963|Gasotransmitters|gasotransmitters|mesh-ancestor
56101388|NCT00001963|Protective Agents|protective agents|mesh-ancestor
56101389|NCT00001963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56101390|NCT00001963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56101391|NCT00001963|Analgesics|analgesics|mesh-ancestor
56101392|NCT00001963|Sensory System Agents|sensory system agents|mesh-ancestor
56101393|NCT00001963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56101394|NCT00001963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56101395|NCT00002377|Valganciclovir|valganciclovir|mesh-list
56101396|NCT00002377|Ganciclovir|ganciclovir|mesh-list
56101397|NCT00002377|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56101398|NCT00002377|Antiviral Agents|antiviral agents|mesh-ancestor
56101399|NCT00002377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101400|NCT00002377|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101401|NCT00002377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101402|NCT00002377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101404|NCT00001339|Etoposide|etoposide|mesh-list
56101405|NCT00001339|Vincristine|vincristine|mesh-list
56101406|NCT00001339|Mitotane|mitotane|mesh-list
56101407|NCT00001339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56101408|NCT00001339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101409|NCT00001339|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56101410|NCT00001339|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56101412|NCT00001339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101413|NCT00001339|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56101414|NCT00001339|Tubulin Modulators|tubulin modulators|mesh-ancestor
56101415|NCT00001339|Antimitotic Agents|antimitotic agents|mesh-ancestor
56101416|NCT00001339|Mitosis Modulators|mitosis modulators|mesh-ancestor
56101417|NCT00001339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56101418|NCT00001993|Miglustat|miglustat|mesh-list
56101426|NCT00001993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101427|NCT00001993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101428|NCT00001993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101429|NCT00001993|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
56101430|NCT00001993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56101431|NCT00001993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101432|NCT00001999|Ganciclovir|ganciclovir|mesh-list
56101433|NCT00001999|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56101434|NCT00001999|Immunoglobulins|immunoglobulins|mesh-list
56101436|NCT00001999|Antiviral Agents|antiviral agents|mesh-ancestor
56101437|NCT00001999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101438|NCT00001999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101439|NCT00001999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101440|NCT00001999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101441|NCT00001999|Immunologic Factors|immunologic factors|mesh-ancestor
56101442|NCT00001999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101486|NCT00002017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101487|NCT00002017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56101488|NCT00002017|Analgesics|analgesics|mesh-ancestor
56101489|NCT00002017|Sensory System Agents|sensory system agents|mesh-ancestor
56101490|NCT00002017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56101491|NCT00002017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101492|NCT00002023|Zidovudine|zidovudine|mesh-list
56101493|NCT00002023|Antimetabolites|antimetabolites|mesh-ancestor
56101494|NCT00002023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101495|NCT00002023|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101496|NCT00002023|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101506|NCT00002035|Zidovudine|zidovudine|mesh-list
56101548|NCT00002065|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56101549|NCT00002065|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
56101550|NCT00002065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101551|NCT00002065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101552|NCT00002071|Epoetin Alfa|epoetin alfa|mesh-list
56101553|NCT00002071|Hematinics|hematinics|mesh-ancestor
56101554|NCT00002395|Topotecan|topotecan|mesh-list
56101555|NCT00002395|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56101556|NCT00002395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56101557|NCT00002395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101559|NCT00002395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101560|NCT00002401|Lamivudine|lamivudine|mesh-list
56101561|NCT00002401|Zidovudine|zidovudine|mesh-list
56101562|NCT00002401|Delavirdine|delavirdine|mesh-list
56101611|NCT00002419|Antiviral Agents|antiviral agents|mesh-ancestor
56101612|NCT00002419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101613|NCT00002419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56101614|NCT00002419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101615|NCT00002419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56101616|NCT00002419|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56101617|NCT00002419|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56101618|NCT00002419|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56101619|NCT00002419|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101620|NCT00002419|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101621|NCT00002419|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56101673|NCT00002095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101674|NCT00002095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101675|NCT00002095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101676|NCT00002101|Clarithromycin|clarithromycin|mesh-list
56101677|NCT00002101|Ethambutol|ethambutol|mesh-list
56101678|NCT00002101|Rifabutin|rifabutin|mesh-list
56101679|NCT00002101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56101680|NCT00002101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101681|NCT00002101|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56101682|NCT00002101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101683|NCT00002101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101684|NCT00002101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56101685|NCT00002101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56101686|NCT00002101|Antitubercular Agents|antitubercular agents|mesh-ancestor
56101687|NCT00002101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56101732|NCT04329650|Autonomic Agents|autonomic agents|mesh-ancestor
56101733|NCT04329650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56101734|NCT04329650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101735|NCT04329650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56101736|NCT04329650|Glucocorticoids|glucocorticoids|mesh-ancestor
56101738|NCT04329650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56101739|NCT04329650|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56101740|NCT04329650|Protective Agents|protective agents|mesh-ancestor
56101741|NCT04329650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56101742|NCT04329650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101743|NCT00002443|Zidovudine|zidovudine|mesh-list
56101744|NCT00002443|Indinavir|indinavir|mesh-list
56101745|NCT00002443|Antimetabolites|antimetabolites|mesh-ancestor
56101746|NCT00002443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101747|NCT00002443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101748|NCT00002443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101749|NCT00002443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101750|NCT00002443|Antiviral Agents|antiviral agents|mesh-ancestor
56101751|NCT00002443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101752|NCT00002443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101789|NCT00001579|Antidotes|antidotes|mesh-ancestor
56101790|NCT00001579|Protective Agents|protective agents|mesh-ancestor
56101791|NCT00001579|Vitamin B Complex|vitamin b complex|mesh-ancestor
56101792|NCT00001579|Vitamins|vitamins|mesh-ancestor
56101793|NCT00001579|Micronutrients|micronutrients|mesh-ancestor
56101794|NCT00001579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101795|NCT00003020|Immunotoxins|immunotoxins|mesh-list
56101796|NCT00003020|Immunologic Factors|immunologic factors|mesh-ancestor
56101797|NCT00003020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101798|NCT00002131|Vesnarinone|vesnarinone|mesh-list
56101799|NCT00002131|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56101800|NCT00002131|Immunologic Factors|immunologic factors|mesh-ancestor
56101803|NCT00002131|Antiviral Agents|antiviral agents|mesh-ancestor
56101850|NCT00002149|Clavulanic Acid|clavulanic acid|mesh-list
56101851|NCT00002149|Clavulanic Acids|clavulanic acids|mesh-list
56101852|NCT00002149|Pseudoephedrine|pseudoephedrine|mesh-list
56101857|NCT00002149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101858|NCT00002149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101859|NCT00002149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56101860|NCT00002149|Autonomic Agents|autonomic agents|mesh-ancestor
56101861|NCT00002149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56101862|NCT00002149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56101863|NCT00002149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56101864|NCT00002149|Respiratory System Agents|respiratory system agents|mesh-ancestor
56101865|NCT00002149|Nasal Decongestants|nasal decongestants|mesh-ancestor
56101874|NCT02973295|Silymarin|silymarin|mesh-list
56101907|NCT00002155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56101908|NCT00002155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56101909|NCT00002155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56101910|NCT00002155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56101911|NCT00002155|Antiviral Agents|antiviral agents|mesh-ancestor
56101912|NCT00002155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56101913|NCT00002155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56101914|NCT00002155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56101915|NCT00002155|Antimetabolites|antimetabolites|mesh-ancestor
56101916|NCT00002155|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56101919|NCT00003038|Suramin|suramin|mesh-list
56101972|NCT00003050|Cyclophosphamide|cyclophosphamide|mesh-list
56101973|NCT00003050|Doxorubicin|doxorubicin|mesh-list
56101974|NCT00003050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56101975|NCT00003050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56101976|NCT00003050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56101977|NCT00003050|Tubulin Modulators|tubulin modulators|mesh-ancestor
56101978|NCT00003050|Antimitotic Agents|antimitotic agents|mesh-ancestor
56101979|NCT00003050|Mitosis Modulators|mitosis modulators|mesh-ancestor
56101980|NCT00003050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102038|NCT00002185|Protease Inhibitors|protease inhibitors|mesh-ancestor
56102039|NCT00002185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102040|NCT00002185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102041|NCT00002185|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102042|NCT00002185|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102043|NCT00002185|Antiviral Agents|antiviral agents|mesh-ancestor
56102044|NCT00002185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102045|NCT05752279|Plasma-lyte 148|plasma-lyte 148|mesh-list
56102046|NCT05752279|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56102047|NCT05752279|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56102048|NCT00003062|Temozolomide|temozolomide|mesh-list
56102104|NCT00003068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102105|NCT00003068|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56102106|NCT00003068|Protective Agents|protective agents|mesh-ancestor
56102110|NCT00003080|Tamoxifen|tamoxifen|mesh-list
56102111|NCT00003080|Melphalan|melphalan|mesh-list
56102112|NCT00003080|Thiotepa|thiotepa|mesh-list
56102113|NCT00003080|Mitoxantrone|mitoxantrone|mesh-list
56102836|NCT00002287|Antiviral Agents|antiviral agents|mesh-ancestor
56102114|NCT00003080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102115|NCT00003080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102116|NCT00003080|Alkylating Agents|alkylating agents|mesh-ancestor
56102117|NCT00003080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102118|NCT00003080|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102119|NCT00003080|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102120|NCT00003080|Immunologic Factors|immunologic factors|mesh-ancestor
56102121|NCT00003080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102122|NCT00003080|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56102123|NCT00003080|Hormone Antagonists|hormone antagonists|mesh-ancestor
56102124|NCT00003080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56102125|NCT00003080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56102126|NCT00003080|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56102127|NCT00003080|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56102128|NCT00003080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56102152|NCT01568918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56102153|NCT01568918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102154|NCT01568918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102155|NCT01568918|Urological Agents|urological agents|mesh-ancestor
56102156|NCT00003086|Cyclophosphamide|cyclophosphamide|mesh-list
56102157|NCT00003086|Carboplatin|carboplatin|mesh-list
56102158|NCT00003086|Doxorubicin|doxorubicin|mesh-list
56102159|NCT00003086|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56102160|NCT00003086|Fluorouracil|fluorouracil|mesh-list
56102162|NCT00003086|Ifosfamide|ifosfamide|mesh-list
56102163|NCT00003086|Thiotepa|thiotepa|mesh-list
56102164|NCT00003086|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
56102165|NCT00003086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102166|NCT00003086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102167|NCT00003086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102168|NCT00003086|Immunologic Factors|immunologic factors|mesh-ancestor
56102169|NCT00003086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102170|NCT00003086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102171|NCT00003086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102172|NCT00003086|Alkylating Agents|alkylating agents|mesh-ancestor
56102173|NCT00003086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102174|NCT00003086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56102175|NCT00003086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102176|NCT00003086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102177|NCT00003086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102178|NCT00003086|Antimetabolites|antimetabolites|mesh-ancestor
56102179|NCT00003086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56102199|NCT00381199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102200|NCT00381199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102201|NCT00381199|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56102202|NCT00381199|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56102203|NCT00381199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56102204|NCT00381199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102205|NCT00381199|Adrenergic Agents|adrenergic agents|mesh-ancestor
56102206|NCT00381199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56102208|NCT00381199|Autonomic Agents|autonomic agents|mesh-ancestor
56102209|NCT00381199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56102210|NCT00381199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56102262|NCT00002215|Emivirine|emivirine|mesh-list
56102263|NCT00002215|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56102264|NCT00002215|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56102265|NCT00002215|Protease Inhibitors|protease inhibitors|mesh-ancestor
56102266|NCT00002215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102267|NCT00002215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102268|NCT00002215|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102269|NCT00002215|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102270|NCT00002215|Antiviral Agents|antiviral agents|mesh-ancestor
56102271|NCT00002215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102272|NCT00002215|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56102327|NCT00002233|Protease Inhibitors|protease inhibitors|mesh-ancestor
56102328|NCT00002233|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56102329|NCT00002233|Antitubercular Agents|antitubercular agents|mesh-ancestor
56102330|NCT00002233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56102331|NCT00002527|Aspirin|aspirin|mesh-list
56102332|NCT00002527|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56102333|NCT00002527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56102334|NCT00002527|Analgesics|analgesics|mesh-ancestor
56102335|NCT00002527|Sensory System Agents|sensory system agents|mesh-ancestor
56102336|NCT00002527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102337|NCT00002527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102338|NCT00002527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56102339|NCT00002527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102340|NCT00002527|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56102341|NCT00002527|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56102342|NCT00002527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102343|NCT00002527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56102344|NCT00002527|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56102345|NCT00002527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102346|NCT00002527|Antipyretics|antipyretics|mesh-ancestor
56102347|NCT03688178|Temozolomide|temozolomide|mesh-list
56102348|NCT03688178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102349|NCT03688178|Alkylating Agents|alkylating agents|mesh-ancestor
56102350|NCT03688178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102351|NCT03688178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102352|NCT00002533|Fluconazole|fluconazole|mesh-list
56102353|NCT00002533|Antifungal Agents|antifungal agents|mesh-ancestor
56102354|NCT00002533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829418|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102355|NCT00002533|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56102356|NCT00002533|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56102357|NCT00002533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102358|NCT00002533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102359|NCT00002533|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56102362|NCT00002533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102363|NCT00002533|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56102364|NCT00002533|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56102365|NCT00002539|Doxorubicin|doxorubicin|mesh-list
56102366|NCT00002539|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56102367|NCT00002539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102368|NCT00002539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56102369|NCT00002539|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102370|NCT00002539|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102371|NCT00002539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102372|NCT00002539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102373|NCT00381589|Bromides|bromides|mesh-list
56102374|NCT00381589|Ipratropium|ipratropium|mesh-list
56102375|NCT00381589|Anticonvulsants|anticonvulsants|mesh-ancestor
56102376|NCT00381589|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56102377|NCT00381589|Autonomic Agents|autonomic agents|mesh-ancestor
56102378|NCT00381589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102379|NCT00381589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102380|NCT00381589|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56102381|NCT00381589|Respiratory System Agents|respiratory system agents|mesh-ancestor
56102382|NCT00381589|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56102383|NCT00381589|Cholinergic Agents|cholinergic agents|mesh-ancestor
56102384|NCT00381589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56102385|NCT00381589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102386|NCT00002239|Ritonavir|ritonavir|mesh-list
56102387|NCT00002239|Amprenavir|amprenavir|mesh-list
56102388|NCT00002239|Abacavir|abacavir|mesh-list
56102389|NCT00002239|Enfuvirtide|enfuvirtide|mesh-list
56102390|NCT00002239|Efavirenz|efavirenz|mesh-list
56102391|NCT00002239|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56102392|NCT00002239|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56102393|NCT00002239|Protease Inhibitors|protease inhibitors|mesh-ancestor
56102394|NCT00002239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102396|NCT00002239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102404|NCT00002239|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56102405|NCT00002239|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56102406|NCT00002239|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56102407|NCT00002239|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56102408|NCT00002239|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56102409|NCT00002239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56102410|NCT00002239|Antitubercular Agents|antitubercular agents|mesh-ancestor
56102414|NCT00383474|Bortezomib|bortezomib|mesh-list
56102470|NCT05751733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102471|NCT05751733|Growth Inhibitors|growth inhibitors|mesh-ancestor
56102472|NCT05751733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56102473|NCT05751733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102474|NCT05751733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870836|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870837|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870839|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102475|NCT00002798|Cytarabine|cytarabine|mesh-list
56102476|NCT00002798|Aldesleukin|aldesleukin|mesh-list
56102477|NCT00002798|Dexamethasone|dexamethasone|mesh-list
56102478|NCT00002798|Hydrocortisone|hydrocortisone|mesh-list
56102479|NCT00002798|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56102480|NCT00002798|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56102526|NCT00002798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56102527|NCT00002798|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56102528|NCT00002798|Analgesics|analgesics|mesh-ancestor
56102529|NCT00002798|Sensory System Agents|sensory system agents|mesh-ancestor
56102530|NCT00002798|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102531|NCT00002798|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102532|NCT00002251|Ganciclovir|ganciclovir|mesh-list
56102533|NCT00002251|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56102534|NCT00002251|Antiviral Agents|antiviral agents|mesh-ancestor
56102535|NCT00002251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102536|NCT00002251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102537|NCT00002251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102538|NCT00002251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102539|NCT00002257|Ganciclovir|ganciclovir|mesh-list
56102540|NCT00002257|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56102541|NCT00002257|Antiviral Agents|antiviral agents|mesh-ancestor
56102542|NCT00002257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741914|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102543|NCT00002257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102544|NCT00002257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102545|NCT00002257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102547|NCT00003134|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56102548|NCT00003134|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102576|NCT00002804|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102577|NCT00002804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102578|NCT00002804|Alkylating Agents|alkylating agents|mesh-ancestor
56102579|NCT00002804|Protective Agents|protective agents|mesh-ancestor
56102580|NCT00002804|Trace Elements|trace elements|mesh-ancestor
56102581|NCT00002804|Micronutrients|micronutrients|mesh-ancestor
56102582|NCT00002810|Melphalan|melphalan|mesh-list
56102583|NCT00002810|Immunologic Factors|immunologic factors|mesh-ancestor
56102584|NCT00002810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102585|NCT00002810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102586|NCT00002810|Alkylating Agents|alkylating agents|mesh-ancestor
56102587|NCT00002810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102588|NCT00002810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102589|NCT00002810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102590|NCT00002810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102591|NCT00003140|Letrozole|letrozole|mesh-list
56102592|NCT00003140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102593|NCT00003140|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56102594|NCT00003140|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56102595|NCT00003140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102596|NCT00003140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102597|NCT00003140|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56102598|NCT00003140|Hormone Antagonists|hormone antagonists|mesh-ancestor
56102600|NCT00003140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102626|NCT00002551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102627|NCT00002551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56102628|NCT00002551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102629|NCT00002551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102630|NCT00002551|Immunologic Factors|immunologic factors|mesh-ancestor
56102631|NCT00002551|Antidotes|antidotes|mesh-ancestor
56102632|NCT00002551|Protective Agents|protective agents|mesh-ancestor
56102633|NCT00002551|Vitamin B Complex|vitamin b complex|mesh-ancestor
56102634|NCT00002551|Vitamins|vitamins|mesh-ancestor
56102635|NCT00002551|Micronutrients|micronutrients|mesh-ancestor
56102636|NCT00002551|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56102637|NCT00002551|Antinematodal Agents|antinematodal agents|mesh-ancestor
56102638|NCT00002551|Anthelmintics|anthelmintics|mesh-ancestor
56102639|NCT00002551|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56102640|NCT00002551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102641|NCT00002551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102642|NCT00003146|Melphalan|melphalan|mesh-list
56102643|NCT00003146|Busulfan|busulfan|mesh-list
56102644|NCT00003146|Thiotepa|thiotepa|mesh-list
56102645|NCT00003146|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102646|NCT00003146|Alkylating Agents|alkylating agents|mesh-ancestor
56102834|NCT00002287|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102647|NCT00003146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102648|NCT00003146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102649|NCT00003146|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102650|NCT00003146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102651|NCT00003146|Immunologic Factors|immunologic factors|mesh-ancestor
56102654|NCT00003398|Thiotepa|thiotepa|mesh-list
56102677|NCT00002263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102678|NCT00002816|Leucovorin|leucovorin|mesh-list
56102679|NCT00002816|Cobalt|cobalt|mesh-list
56102680|NCT00002816|Cytarabine|cytarabine|mesh-list
56102681|NCT00002816|Dexamethasone|dexamethasone|mesh-list
56102682|NCT00002816|Hydrocortisone|hydrocortisone|mesh-list
56102683|NCT00002816|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56102684|NCT00002816|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56102685|NCT00002816|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56102686|NCT00002816|Methotrexate|methotrexate|mesh-list
56102687|NCT00002816|Etoposide|etoposide|mesh-list
56102688|NCT00002816|Vincristine|vincristine|mesh-list
56102689|NCT00002816|Asparaginase|asparaginase|mesh-list
56102690|NCT00002816|Ifosfamide|ifosfamide|mesh-list
56102691|NCT00002816|Idarubicin|idarubicin|mesh-list
56102692|NCT00002816|Pegaspargase|pegaspargase|mesh-list
56102693|NCT00002816|Thioguanine|thioguanine|mesh-list
56102694|NCT00002816|Levoleucovorin|levoleucovorin|mesh-list
56102695|NCT00002816|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56102696|NCT00002816|Antiemetics|antiemetics|mesh-ancestor
56102698|NCT00002816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102699|NCT00002816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102700|NCT00002816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56102701|NCT00002816|Glucocorticoids|glucocorticoids|mesh-ancestor
56102702|NCT00002816|Hormones|hormones|mesh-ancestor
56102703|NCT00002816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56102704|NCT00002816|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56102705|NCT00002816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102706|NCT00002816|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56102707|NCT00002816|Abortifacient Agents|abortifacient agents|mesh-ancestor
56102708|NCT00002816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56102724|NCT00002816|Antidotes|antidotes|mesh-ancestor
56102725|NCT00002816|Protective Agents|protective agents|mesh-ancestor
56102726|NCT00002816|Vitamin B Complex|vitamin b complex|mesh-ancestor
56102727|NCT00002816|Vitamins|vitamins|mesh-ancestor
56102728|NCT00002816|Micronutrients|micronutrients|mesh-ancestor
56102729|NCT00002816|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102730|NCT00002816|Antimitotic Agents|antimitotic agents|mesh-ancestor
56102731|NCT00002816|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102732|NCT00002816|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102733|NCT00002816|Alkylating Agents|alkylating agents|mesh-ancestor
56102734|NCT00002816|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56102735|NCT00002816|Trace Elements|trace elements|mesh-ancestor
56102736|NCT00002269|Zidovudine|zidovudine|mesh-list
56102737|NCT00002269|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
56102738|NCT00002269|Antimetabolites|antimetabolites|mesh-ancestor
56102739|NCT00002269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102740|NCT00002269|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56102741|NCT00002269|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56102742|NCT00002269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102743|NCT00002269|Antiviral Agents|antiviral agents|mesh-ancestor
56102744|NCT00002269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102745|NCT00002269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102753|NCT00003152|Prednisone|prednisone|mesh-list
55871128|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56102778|NCT05751421|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56102779|NCT05751421|Anesthetics, Local|anesthetics, local|mesh-ancestor
56102780|NCT05751421|Anesthetics|anesthetics|mesh-ancestor
56102781|NCT05751421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56102782|NCT05751421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102783|NCT05751421|Sensory System Agents|sensory system agents|mesh-ancestor
56102784|NCT05751421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102785|NCT05751421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56102786|NCT05751421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56102787|NCT05751421|Analgesics|analgesics|mesh-ancestor
56102788|NCT05751421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56102789|NCT05751421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56102790|NCT05751421|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56102791|NCT05751421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56102792|NCT05751421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102793|NCT05751421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102795|NCT00002822|Ifosfamide|ifosfamide|mesh-list
56102835|NCT00002287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102837|NCT00002287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102838|NCT00002287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56102839|NCT00002287|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56102840|NCT00002828|Fluorouracil|fluorouracil|mesh-list
56102841|NCT00002828|Raltitrexed|raltitrexed|mesh-list
56102842|NCT00002828|Antimetabolites|antimetabolites|mesh-ancestor
56102843|NCT00002828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102844|NCT00002828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56102845|NCT00002828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102846|NCT00002828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102847|NCT00002828|Immunologic Factors|immunologic factors|mesh-ancestor
56102848|NCT00002828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102849|NCT00002828|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56102850|NCT00002828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102851|NCT00003410|Motexafin gadolinium|motexafin gadolinium|mesh-list
56102852|NCT00003410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102853|NCT00003410|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56102854|NCT00003410|Dermatologic Agents|dermatologic agents|mesh-ancestor
56102856|NCT05751265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102857|NCT05751265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102858|NCT05751265|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102859|NCT05751265|Antimitotic Agents|antimitotic agents|mesh-ancestor
56102860|NCT05751265|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102861|NCT05751265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102862|NCT00384020|Citalopram|citalopram|mesh-list
56102863|NCT00384020|Paroxetine|paroxetine|mesh-list
56102864|NCT00384020|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56102865|NCT00384020|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55871181|NCT05689047|Antiviral Agents|antiviral agents|mesh-ancestor
55902018|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902019|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902020|NCT02406066|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55902021|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55902022|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55902023|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
55902024|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
55902025|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902026|NCT02408328|Caffeine|caffeine|mesh-list
55902027|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
55902028|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102866|NCT00384020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56102867|NCT00384020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102868|NCT00384020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56102869|NCT00384020|Serotonin Agents|serotonin agents|mesh-ancestor
56102870|NCT00384020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102871|NCT00384020|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56102872|NCT00384020|Antidepressive Agents|antidepressive agents|mesh-ancestor
56102873|NCT00384020|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56102874|NCT00384020|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56102875|NCT00384020|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56102876|NCT00384020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102877|NCT05725213|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56102878|NCT05725213|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56102879|NCT05725213|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56102880|NCT05725213|Dermatologic Agents|dermatologic agents|mesh-ancestor
56102881|NCT00002557|Leucovorin|leucovorin|mesh-list
56102882|NCT00002557|Doxorubicin|doxorubicin|mesh-list
56102883|NCT00002557|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56102884|NCT00002557|Etoposide|etoposide|mesh-list
56102885|NCT00002557|Methotrexate|methotrexate|mesh-list
56102886|NCT00002557|Calcium|calcium|mesh-list
56102887|NCT00002557|Levoleucovorin|levoleucovorin|mesh-list
56102888|NCT00002557|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56102889|NCT00002557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102917|NCT00003158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102919|NCT00003158|Antimitotic Agents|antimitotic agents|mesh-ancestor
56102920|NCT00003158|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102921|NCT00003158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102922|NCT00003158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56102923|NCT00003158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56102924|NCT00003158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102925|NCT05751187|Folic Acid|folic acid|mesh-list
56102926|NCT05751187|Vitamin B 12|vitamin b 12|mesh-list
56102927|NCT05751187|Dexamethasone|dexamethasone|mesh-list
56102928|NCT05751187|Bevacizumab|bevacizumab|mesh-list
56102929|NCT05751187|Pembrolizumab|pembrolizumab|mesh-list
56102930|NCT05751187|Carboplatin|carboplatin|mesh-list
56102931|NCT05751187|Pemetrexed|pemetrexed|mesh-list
56102932|NCT05751187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56102933|NCT05751187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102934|NCT05751187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56102935|NCT05751187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56102936|NCT05751187|Growth Substances|growth substances|mesh-ancestor
56102937|NCT05751187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102938|NCT05751187|Growth Inhibitors|growth inhibitors|mesh-ancestor
56102939|NCT05751187|Vitamins|vitamins|mesh-ancestor
56102940|NCT05751187|Micronutrients|micronutrients|mesh-ancestor
56102941|NCT05751187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56102942|NCT05751187|Antiemetics|antiemetics|mesh-ancestor
56102943|NCT05751187|Autonomic Agents|autonomic agents|mesh-ancestor
56102944|NCT05751187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56102945|NCT05751187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56102946|NCT05751187|Glucocorticoids|glucocorticoids|mesh-ancestor
56102947|NCT05751187|Hormones|hormones|mesh-ancestor
56102948|NCT05751187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56102949|NCT05751187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56102950|NCT05751187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56102961|NCT00003416|Antiemetics|antiemetics|mesh-ancestor
56102962|NCT00003416|Autonomic Agents|autonomic agents|mesh-ancestor
56102963|NCT00003416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830023|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
56102964|NCT00003416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56102965|NCT00003416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56102966|NCT00003416|Glucocorticoids|glucocorticoids|mesh-ancestor
56102967|NCT00003416|Hormones|hormones|mesh-ancestor
56102968|NCT00003416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56102969|NCT00003416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56102970|NCT00003416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102971|NCT00003416|Antiviral Agents|antiviral agents|mesh-ancestor
56102972|NCT00003416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56102973|NCT00003416|Immunologic Factors|immunologic factors|mesh-ancestor
56102974|NCT00003416|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102975|NCT00003416|Alkylating Agents|alkylating agents|mesh-ancestor
56102976|NCT00003416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102977|NCT00003416|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56102978|NCT00003416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56102979|NCT00002569|Vincristine|vincristine|mesh-list
56102980|NCT00002569|Lomustine|lomustine|mesh-list
56102981|NCT00002569|Procarbazine|procarbazine|mesh-list
56102982|NCT00002569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56102983|NCT00002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56102984|NCT00002569|Tubulin Modulators|tubulin modulators|mesh-ancestor
56102985|NCT00002569|Antimitotic Agents|antimitotic agents|mesh-ancestor
56102986|NCT00002569|Mitosis Modulators|mitosis modulators|mesh-ancestor
56102987|NCT00002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56102988|NCT00002569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56102989|NCT00002569|Alkylating Agents|alkylating agents|mesh-ancestor
56102990|NCT00002840|Vincristine|vincristine|mesh-list
56102991|NCT00002840|Lomustine|lomustine|mesh-list
56102992|NCT00002840|Procarbazine|procarbazine|mesh-list
56102993|NCT00002840|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55871343|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103000|NCT00002840|Alkylating Agents|alkylating agents|mesh-ancestor
56103002|NCT00002846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103003|NCT00002846|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56103004|NCT00002846|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56103005|NCT00002846|Antiviral Agents|antiviral agents|mesh-ancestor
56103006|NCT00002846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103007|NCT05720767|Itraconazole|itraconazole|mesh-list
56103008|NCT05720767|Rifampin|rifampin|mesh-list
56103009|NCT05720767|Antifungal Agents|antifungal agents|mesh-ancestor
56103010|NCT05720767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103011|NCT05720767|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56103012|NCT05720767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56103013|NCT05720767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103014|NCT05720767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103015|NCT05720767|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55871398|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871399|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
55871400|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55871401|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56103055|NCT00003422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103221|NCT00002882|Interferons|interferons|mesh-list
56103056|NCT00003422|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103057|NCT00003422|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103058|NCT00003422|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103059|NCT00003422|Immunologic Factors|immunologic factors|mesh-ancestor
55871402|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56103060|NCT00003422|Antidotes|antidotes|mesh-ancestor
56103061|NCT00003422|Protective Agents|protective agents|mesh-ancestor
56103062|NCT00003422|Vitamin B Complex|vitamin b complex|mesh-ancestor
56103111|NCT00002870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103112|NCT00002870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103113|NCT00002870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103114|NCT00002870|Antimetabolites|antimetabolites|mesh-ancestor
56103115|NCT00002870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103116|NCT00002870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103117|NCT00002870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103118|NCT00002870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103119|NCT00002870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103122|NCT00002581|Fluorouracil|fluorouracil|mesh-list
56103123|NCT00002581|Methotrexate|methotrexate|mesh-list
56103124|NCT00002581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103125|NCT00002581|Immunologic Factors|immunologic factors|mesh-ancestor
56103126|NCT00002581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103127|NCT00002581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103128|NCT00002581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103129|NCT00002581|Alkylating Agents|alkylating agents|mesh-ancestor
56103164|NCT00002587|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103165|NCT00002587|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103166|NCT00002587|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103167|NCT00002587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103168|NCT00002587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56103169|NCT00002587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103170|NCT00002587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103172|NCT00002876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103173|NCT00002876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103174|NCT00002876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103175|NCT00002876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103176|NCT00002876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103177|NCT00002876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103179|NCT00002593|Levamisole|levamisole|mesh-list
56103180|NCT00002593|Fluorouracil|fluorouracil|mesh-list
56103181|NCT00002593|Calcium|calcium|mesh-list
56103182|NCT00002593|Levoleucovorin|levoleucovorin|mesh-list
56103183|NCT00002593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56103184|NCT00002593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103185|NCT00002593|Antimetabolites|antimetabolites|mesh-ancestor
56103186|NCT00002593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103187|NCT00002593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103188|NCT00002593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103189|NCT00002593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103190|NCT00002593|Immunologic Factors|immunologic factors|mesh-ancestor
56103191|NCT00002593|Antidotes|antidotes|mesh-ancestor
56103192|NCT00002593|Protective Agents|protective agents|mesh-ancestor
56103193|NCT00002593|Vitamin B Complex|vitamin b complex|mesh-ancestor
56103194|NCT00002593|Vitamins|vitamins|mesh-ancestor
56103195|NCT00002593|Micronutrients|micronutrients|mesh-ancestor
56103196|NCT00002593|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56103197|NCT00002593|Antinematodal Agents|antinematodal agents|mesh-ancestor
56103198|NCT00002593|Anthelmintics|anthelmintics|mesh-ancestor
56103199|NCT00002593|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56103203|NCT00003194|Thiotepa|thiotepa|mesh-list
56103204|NCT00003194|Carboplatin|carboplatin|mesh-list
56103205|NCT00003194|Etoposide|etoposide|mesh-list
56103206|NCT00003194|Topotecan|topotecan|mesh-list
56103207|NCT00003194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103208|NCT00003194|Immunologic Factors|immunologic factors|mesh-ancestor
56103209|NCT00003194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103210|NCT00003194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103211|NCT00003194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103212|NCT00003194|Alkylating Agents|alkylating agents|mesh-ancestor
56103213|NCT00003194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103214|NCT00003194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103216|NCT00003194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103217|NCT00003194|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103218|NCT00003194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103219|NCT00003194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103220|NCT00003194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56103256|NCT00002888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103257|NCT00002888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103258|NCT00002888|Immunologic Factors|immunologic factors|mesh-ancestor
56103259|NCT00002888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103260|NCT00002599|Cobalt|cobalt|mesh-list
56103261|NCT00002599|Interferons|interferons|mesh-list
56103262|NCT00002599|Interferon-alpha|interferon-alpha|mesh-list
56103263|NCT00002599|Prednisone|prednisone|mesh-list
56103264|NCT00002599|Methylprednisolone|methylprednisolone|mesh-list
56103265|NCT00002599|Cyclophosphamide|cyclophosphamide|mesh-list
56103266|NCT00002599|Melphalan|melphalan|mesh-list
56103267|NCT00002599|Carmustine|carmustine|mesh-list
56103268|NCT00002599|Doxorubicin|doxorubicin|mesh-list
56103269|NCT00002599|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103270|NCT00002599|Vincristine|vincristine|mesh-list
56103271|NCT00002599|Sargramostim|sargramostim|mesh-list
56103272|NCT00002599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103273|NCT00002599|Immunologic Factors|immunologic factors|mesh-ancestor
56103274|NCT00002599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103275|NCT00002599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103276|NCT00002599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103277|NCT00002599|Alkylating Agents|alkylating agents|mesh-ancestor
56103278|NCT00002599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103279|NCT00002599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103280|NCT00002599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103281|NCT00002599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103283|NCT00002599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103309|NCT00003440|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103310|NCT00003440|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103311|NCT00003440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103312|NCT00003440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56103313|NCT00003200|Docetaxel|docetaxel|mesh-list
56103314|NCT00003200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103315|NCT00003200|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103316|NCT00003200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103317|NCT00003200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103318|NCT00003200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103319|NCT00003206|Paclitaxel|paclitaxel|mesh-list
56103320|NCT00003206|Carboplatin|carboplatin|mesh-list
56103321|NCT00003206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103322|NCT00003206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103323|NCT00003206|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103324|NCT00003206|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103325|NCT00003206|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103326|NCT00003206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103327|NCT00003446|Leucovorin|leucovorin|mesh-list
56103328|NCT00003446|Trimetrexate|trimetrexate|mesh-list
56103329|NCT00003446|Fluorouracil|fluorouracil|mesh-list
56103330|NCT00003446|Calcium|calcium|mesh-list
56103331|NCT00003446|Levoleucovorin|levoleucovorin|mesh-list
56103332|NCT00003446|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56103333|NCT00003446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103334|NCT00003446|Antimetabolites|antimetabolites|mesh-ancestor
56103335|NCT00003446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103336|NCT00003446|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103337|NCT00003446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103338|NCT00003446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103339|NCT00003446|Immunologic Factors|immunologic factors|mesh-ancestor
56103340|NCT00003446|Antidotes|antidotes|mesh-ancestor
55830391|NCT04798469|Testosterone|testosterone|mesh-list
56103341|NCT00003446|Protective Agents|protective agents|mesh-ancestor
56103342|NCT00003446|Vitamin B Complex|vitamin b complex|mesh-ancestor
56103343|NCT00003446|Vitamins|vitamins|mesh-ancestor
56103345|NCT00003446|Antifungal Agents|antifungal agents|mesh-ancestor
56103347|NCT00003446|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56103348|NCT00003446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103349|NCT00003938|Amphotericin B|amphotericin b|mesh-list
56103350|NCT00003938|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56103351|NCT00003938|Amebicides|amebicides|mesh-ancestor
56103352|NCT00003938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56103353|NCT00003938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56103354|NCT00003938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103355|NCT00003938|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56103356|NCT00003938|Antifungal Agents|antifungal agents|mesh-ancestor
56103357|NCT00003212|Doxorubicin|doxorubicin|mesh-list
56103358|NCT00003212|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103359|NCT00003212|Ifosfamide|ifosfamide|mesh-list
56103360|NCT00003212|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103361|NCT00003212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103362|NCT00003212|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103363|NCT00003212|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103364|NCT00003212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103365|NCT00003212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103366|NCT00003212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103367|NCT00003212|Alkylating Agents|alkylating agents|mesh-ancestor
56103368|NCT00002611|Dactinomycin|dactinomycin|mesh-list
56103369|NCT00002611|Cyclophosphamide|cyclophosphamide|mesh-list
56103370|NCT00002611|Doxorubicin|doxorubicin|mesh-list
56103371|NCT00002611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103372|NCT00002611|Etoposide|etoposide|mesh-list
55902029|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55902030|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902031|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55902032|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902033|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55902034|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55902035|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
55902036|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902037|NCT02539342|Calcium|calcium|mesh-list
55902038|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55902039|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902040|NCT02405988|Remifentanil|remifentanil|mesh-list
55902041|NCT02405988|Naloxone|naloxone|mesh-list
55902042|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55902043|NCT02405988|Narcotics|narcotics|mesh-ancestor
55755292|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
55902044|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902045|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902046|NCT02405988|Analgesics|analgesics|mesh-ancestor
55902047|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
55902048|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103373|NCT00002611|Vincristine|vincristine|mesh-list
56103374|NCT00002611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103375|NCT00002611|Immunologic Factors|immunologic factors|mesh-ancestor
56103376|NCT00002611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103377|NCT00002611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103378|NCT00002611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103379|NCT00002611|Alkylating Agents|alkylating agents|mesh-ancestor
56103380|NCT00002611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103381|NCT00002611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103382|NCT00002611|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103383|NCT00002611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103384|NCT00002611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103385|NCT00002611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103386|NCT00002611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103387|NCT00002611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103388|NCT00002611|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103389|NCT00002611|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103390|NCT00002611|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103391|NCT00002611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56103392|NCT00002611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103393|NCT00002611|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56103394|NCT00002611|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56103396|NCT00003944|Cyclophosphamide|cyclophosphamide|mesh-list
56103397|NCT00003944|Carboplatin|carboplatin|mesh-list
56103398|NCT00003944|Topotecan|topotecan|mesh-list
55902049|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55902050|NCT02542150|Ethanol|ethanol|mesh-list
55902051|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55902052|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902053|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902054|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902055|NCT02542462|Vaccines|vaccines|mesh-list
55902056|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
55902057|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902058|NCT03173898|Anesthetics|anesthetics|mesh-list
55902059|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902060|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902062|NCT02408172|Amlodipine|amlodipine|mesh-list
55902063|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55902064|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55902065|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55902066|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902067|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55902068|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902069|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
56103399|NCT00003944|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103400|NCT00003944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103401|NCT00003944|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103402|NCT00003944|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103403|NCT00003944|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103404|NCT00003944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103405|NCT00003944|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103406|NCT00003944|Immunologic Factors|immunologic factors|mesh-ancestor
56103407|NCT00003944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103408|NCT00003944|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103409|NCT00003944|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103410|NCT00003944|Alkylating Agents|alkylating agents|mesh-ancestor
56103411|NCT00003944|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103412|NCT00003944|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56103413|NCT00003944|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103414|NCT00003944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103415|NCT00003950|Cyclosporine|cyclosporine|mesh-list
56103417|NCT00003950|Cyclosporins|cyclosporins|mesh-list
56103418|NCT00003950|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56103419|NCT00003950|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103420|NCT00003950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103421|NCT00003950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103422|NCT00003950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103423|NCT00003950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103424|NCT00003950|Immunologic Factors|immunologic factors|mesh-ancestor
56103425|NCT00003950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103426|NCT00003950|Antifungal Agents|antifungal agents|mesh-ancestor
56103427|NCT00003950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103428|NCT00003950|Dermatologic Agents|dermatologic agents|mesh-ancestor
56103429|NCT00003950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103430|NCT00003950|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56103431|NCT00003464|Temozolomide|temozolomide|mesh-list
56103437|NCT00003230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103438|NCT00003230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103439|NCT00003230|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103440|NCT00003230|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103441|NCT00003230|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103442|NCT00003230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103443|NCT00003956|Leucovorin|leucovorin|mesh-list
56103444|NCT00003956|Fluorouracil|fluorouracil|mesh-list
56103445|NCT00003956|Calcium|calcium|mesh-list
56103446|NCT00003956|Levoleucovorin|levoleucovorin|mesh-list
56103447|NCT00003956|Lonafarnib|lonafarnib|mesh-list
56103448|NCT00003956|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56103449|NCT00003956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103450|NCT00003956|Antimetabolites|antimetabolites|mesh-ancestor
56103451|NCT00003956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103452|NCT00003956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103453|NCT00003956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103454|NCT00003956|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103455|NCT00003956|Immunologic Factors|immunologic factors|mesh-ancestor
56103456|NCT00003956|Antidotes|antidotes|mesh-ancestor
56103457|NCT00003956|Protective Agents|protective agents|mesh-ancestor
56103458|NCT00003956|Vitamin B Complex|vitamin b complex|mesh-ancestor
56103459|NCT00003956|Vitamins|vitamins|mesh-ancestor
56103460|NCT00003956|Micronutrients|micronutrients|mesh-ancestor
56103461|NCT00003956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103462|NCT00002623|Carboplatin|carboplatin|mesh-list
56103463|NCT00002623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103489|NCT00003974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103490|NCT00003974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103491|NCT00003974|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103492|NCT00002635|Lenograstim|lenograstim|mesh-list
56103493|NCT00002635|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56103494|NCT00002635|Immunologic Factors|immunologic factors|mesh-ancestor
56103495|NCT00002635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103496|NCT00003242|Paclitaxel|paclitaxel|mesh-list
56103497|NCT00003242|Bryostatin 1|bryostatin 1|mesh-list
56103498|NCT00003242|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103499|NCT00003242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103500|NCT00003242|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103501|NCT00003242|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103502|NCT00003242|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103503|NCT00003242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103504|NCT00003242|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56103505|NCT00003242|Immunologic Factors|immunologic factors|mesh-ancestor
56103506|NCT00003242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103507|NCT05665699|Allopurinol|allopurinol|mesh-list
56103508|NCT05665699|Antimetabolites|antimetabolites|mesh-ancestor
56103509|NCT05665699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103510|NCT05665699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103511|NCT05665699|Gout Suppressants|gout suppressants|mesh-ancestor
56103512|NCT05665699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103513|NCT05665699|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56103514|NCT05665699|Antioxidants|antioxidants|mesh-ancestor
56103515|NCT05665699|Protective Agents|protective agents|mesh-ancestor
56103516|NCT05665699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103518|NCT05664061|Xhance|xhance|mesh-list
56103519|NCT05664061|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
56103520|NCT05664061|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56103521|NCT05664061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56103532|NCT05664061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56103533|NCT05664061|Adrenergic Agents|adrenergic agents|mesh-ancestor
56103534|NCT05664061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56103535|NCT05664061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103536|NCT05664061|Glucocorticoids|glucocorticoids|mesh-ancestor
56103537|NCT05664061|Hormones|hormones|mesh-ancestor
56103538|NCT05664061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55902072|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
55902073|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902074|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55902075|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55902076|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55902077|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
55902078|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902079|NCT04481100|Itraconazole|itraconazole|mesh-list
56103539|NCT05664061|Sympathomimetics|sympathomimetics|mesh-ancestor
56103540|NCT00003248|Rituximab|rituximab|mesh-list
56103541|NCT00003248|Fludarabine|fludarabine|mesh-list
56103542|NCT00003248|Fludarabine phosphate|fludarabine phosphate|mesh-list
56103543|NCT00003248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56103544|NCT00003248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103545|NCT00003248|Immunologic Factors|immunologic factors|mesh-ancestor
56103546|NCT00003248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103547|NCT00003248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103548|NCT00003248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103549|NCT00003248|Antimetabolites|antimetabolites|mesh-ancestor
56103550|NCT00003248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103551|NCT00003248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103552|NCT05663905|Ambroxol|ambroxol|mesh-list
56103553|NCT05663905|Expectorants|expectorants|mesh-ancestor
56103554|NCT05663905|Respiratory System Agents|respiratory system agents|mesh-ancestor
56103555|NCT00002641|Doxorubicin|doxorubicin|mesh-list
56103556|NCT00002641|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103557|NCT00002641|Ifosfamide|ifosfamide|mesh-list
56103558|NCT00002641|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103559|NCT00002641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103560|NCT00002641|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103561|NCT00002641|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103562|NCT00002641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103563|NCT00002641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103564|NCT00002641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103565|NCT00002641|Alkylating Agents|alkylating agents|mesh-ancestor
56103566|NCT00003992|Tamoxifen|tamoxifen|mesh-list
56103567|NCT00003992|Paclitaxel|paclitaxel|mesh-list
56103568|NCT00003992|Cyclophosphamide|cyclophosphamide|mesh-list
56103569|NCT00003992|Doxorubicin|doxorubicin|mesh-list
56103570|NCT00003992|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56103571|NCT00003992|Trastuzumab|trastuzumab|mesh-list
56103572|NCT00003992|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103573|NCT00003992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103574|NCT00003992|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103575|NCT00003992|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103576|NCT00003992|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103577|NCT00003992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103578|NCT00003992|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103579|NCT00003992|Immunologic Factors|immunologic factors|mesh-ancestor
56103580|NCT00003992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103581|NCT00003992|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103582|NCT00003992|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103584|NCT00003992|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103585|NCT00003992|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103586|NCT00003992|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103625|NCT00002653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103626|NCT00002653|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103627|NCT00002653|Alkylating Agents|alkylating agents|mesh-ancestor
56103628|NCT00002653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103629|NCT00002653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103630|NCT00002653|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103631|NCT00002653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103632|NCT00002653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103633|NCT00002653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103634|NCT00002653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103635|NCT00002653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56103638|NCT00002653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103639|NCT00002653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103640|NCT00003254|Fluorouracil|fluorouracil|mesh-list
56103641|NCT00003254|Eniluracil|eniluracil|mesh-list
56103642|NCT00003254|Antimetabolites|antimetabolites|mesh-ancestor
56103643|NCT00003254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103644|NCT00003254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103645|NCT00003254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103646|NCT00003254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55902080|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
55902081|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902082|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55902083|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55902084|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103647|NCT00003254|Immunologic Factors|immunologic factors|mesh-ancestor
56103648|NCT00003254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103649|NCT00003254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103651|NCT00002659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103652|NCT00003998|Paclitaxel|paclitaxel|mesh-list
56103653|NCT00003998|Docetaxel|docetaxel|mesh-list
56103654|NCT00003998|Carboplatin|carboplatin|mesh-list
56103655|NCT00003998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103656|NCT00003998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103657|NCT00003998|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103658|NCT00003998|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103659|NCT00003998|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103660|NCT00003998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103661|NCT00004004|Procarbazine|procarbazine|mesh-list
56103662|NCT00004004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103663|NCT00003260|Leucovorin|leucovorin|mesh-list
56103664|NCT00003260|Fluorouracil|fluorouracil|mesh-list
56103665|NCT00003260|Oxaliplatin|oxaliplatin|mesh-list
56103666|NCT00003260|Irinotecan|irinotecan|mesh-list
56103667|NCT00003260|Calcium|calcium|mesh-list
56103668|NCT00003260|Levoleucovorin|levoleucovorin|mesh-list
56103669|NCT00003260|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56103670|NCT00003260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103672|NCT00003260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103673|NCT00003260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103674|NCT00003260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103675|NCT00003260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103676|NCT00003260|Immunologic Factors|immunologic factors|mesh-ancestor
56103677|NCT00003260|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56103678|NCT00003260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103696|NCT00002665|Asparaginase|asparaginase|mesh-list
56103697|NCT00002665|Mercaptopurine|mercaptopurine|mesh-list
56103698|NCT00002665|Thioguanine|thioguanine|mesh-list
56103699|NCT00002665|Levoleucovorin|levoleucovorin|mesh-list
56103700|NCT00002665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103701|NCT00002665|Immunologic Factors|immunologic factors|mesh-ancestor
56103702|NCT00002665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103703|NCT00002665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103704|NCT00002665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103705|NCT00002665|Alkylating Agents|alkylating agents|mesh-ancestor
56103706|NCT00002665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103707|NCT00002665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103708|NCT00002665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103709|NCT00002665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56103710|NCT00002665|Antiemetics|antiemetics|mesh-ancestor
56103711|NCT00002665|Autonomic Agents|autonomic agents|mesh-ancestor
56103712|NCT00002665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103713|NCT00002665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56103714|NCT00002665|Glucocorticoids|glucocorticoids|mesh-ancestor
56103715|NCT00002665|Hormones|hormones|mesh-ancestor
56103716|NCT00002665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103717|NCT00002665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103718|NCT00002665|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103746|NCT00003536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56103748|NCT00003536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103749|NCT00003536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103750|NCT00003536|Dermatologic Agents|dermatologic agents|mesh-ancestor
56103751|NCT00003536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103752|NCT00003536|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56103753|NCT00003536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103754|NCT00003536|Immunologic Factors|immunologic factors|mesh-ancestor
56103755|NCT00003536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103756|NCT00003536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56103757|NCT00003266|Methylphenidate|methylphenidate|mesh-list
56103758|NCT00003266|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56103759|NCT00003266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103760|NCT00003266|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56103761|NCT00003266|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56103762|NCT00003266|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56103763|NCT00003266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103764|NCT00003266|Dopamine Agents|dopamine agents|mesh-ancestor
56103765|NCT00003266|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56103767|NCT05749393|Calcium heparin|calcium heparin|mesh-list
56103768|NCT05749393|Anticoagulants|anticoagulants|mesh-ancestor
56103769|NCT05749393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56103770|NCT05749393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56103771|NCT05749393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103772|NCT00003542|Interferons|interferons|mesh-list
56103773|NCT00003542|Interferon-alpha|interferon-alpha|mesh-list
56103774|NCT00003542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103775|NCT00003542|Antiviral Agents|antiviral agents|mesh-ancestor
56103776|NCT00003542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103777|NCT00003542|Immunologic Factors|immunologic factors|mesh-ancestor
56103779|NCT00004010|Prednisone|prednisone|mesh-list
56103790|NCT00004010|Immunologic Factors|immunologic factors|mesh-ancestor
56103791|NCT00004010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103792|NCT00004010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103793|NCT00004010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103795|NCT00004010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103796|NCT00004010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103797|NCT00004010|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103798|NCT00004010|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56103799|NCT00004010|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56103800|NCT00004010|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103801|NCT00004010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103802|NCT00004010|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56103804|NCT00004010|Hormones|hormones|mesh-ancestor
56103805|NCT00004010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103806|NCT00004010|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103807|NCT00004010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103808|NCT00004010|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103844|NCT00004028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103845|NCT00004028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103846|NCT00003554|Prednisone|prednisone|mesh-list
56103847|NCT00003554|Rituximab|rituximab|mesh-list
56103848|NCT00003554|Melphalan|melphalan|mesh-list
56103849|NCT00003554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56103850|NCT00003554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103851|NCT00003554|Immunologic Factors|immunologic factors|mesh-ancestor
56103852|NCT00003554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103853|NCT00003554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103854|NCT00003554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56103855|NCT00003554|Glucocorticoids|glucocorticoids|mesh-ancestor
56103856|NCT00003554|Hormones|hormones|mesh-ancestor
56103857|NCT00003554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103858|NCT00003554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103859|NCT00003554|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103860|NCT00003554|Alkylating Agents|alkylating agents|mesh-ancestor
56103861|NCT00003554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103862|NCT00003554|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56103863|NCT00003554|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103864|NCT00003284|Paclitaxel|paclitaxel|mesh-list
56103865|NCT00003284|Etoposide|etoposide|mesh-list
56103866|NCT00003284|Carboplatin|carboplatin|mesh-list
56103867|NCT00003284|Ifosfamide|ifosfamide|mesh-list
56103868|NCT00003284|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56103869|NCT00003284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103870|NCT00003284|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103871|NCT00003284|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103872|NCT00003284|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103873|NCT00003284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103874|NCT00003284|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55902085|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902086|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55902087|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
55902088|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55902089|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902090|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55902091|NCT02405598|Albuterol|albuterol|mesh-list
56103876|NCT00003284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103877|NCT00003284|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56103878|NCT00003284|Alkylating Agents|alkylating agents|mesh-ancestor
56103879|NCT00384410|Nabilone|nabilone|mesh-list
56103880|NCT00384410|Antiemetics|antiemetics|mesh-ancestor
56103881|NCT00384410|Autonomic Agents|autonomic agents|mesh-ancestor
56103882|NCT00384410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56103883|NCT00384410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103884|NCT00384410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56103885|NCT00384410|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56103886|NCT00384410|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56103887|NCT00384410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56103888|NCT00384410|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56103889|NCT00004040|Interferons|interferons|mesh-list
56103890|NCT00004040|Interferon-alpha|interferon-alpha|mesh-list
56103891|NCT00004040|Rituximab|rituximab|mesh-list
56103892|NCT00004040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56103893|NCT00004040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103894|NCT00004040|Immunologic Factors|immunologic factors|mesh-ancestor
56103895|NCT00004040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103896|NCT00004040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56103897|NCT00004040|Antiviral Agents|antiviral agents|mesh-ancestor
56103898|NCT00004040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56103899|NCT00004046|Exatecan|exatecan|mesh-list
56103900|NCT00004046|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56103901|NCT00004046|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56103902|NCT00004046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103903|NCT00004046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103904|NCT00004046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103905|NCT00003560|Carboplatin|carboplatin|mesh-list
56103906|NCT00003560|Docetaxel|docetaxel|mesh-list
56103907|NCT00003560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103908|NCT00003560|Tubulin Modulators|tubulin modulators|mesh-ancestor
56103909|NCT00003560|Antimitotic Agents|antimitotic agents|mesh-ancestor
56103910|NCT00003560|Mitosis Modulators|mitosis modulators|mesh-ancestor
56103911|NCT00003560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103914|NCT00003290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103915|NCT00382213|Olmesartan|olmesartan|mesh-list
56103916|NCT00382213|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56103917|NCT00382213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56103918|NCT00382213|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56103919|NCT00382213|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56103920|NCT00382213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103921|NCT05748925|Dapagliflozin|dapagliflozin|mesh-list
56103922|NCT05748925|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56103923|NCT05748925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103924|NCT05748925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56103925|NCT05748925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103926|NCT00003572|Mycophenolic Acid|mycophenolic acid|mesh-list
56103927|NCT00003572|Tacrolimus|tacrolimus|mesh-list
56103928|NCT00003572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56103929|NCT00003572|Immunologic Factors|immunologic factors|mesh-ancestor
56103930|NCT00003572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103931|NCT00003572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56103932|NCT00003572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103935|NCT00003572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103966|NCT00003296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103967|NCT00004064|Oregovomab|oregovomab|mesh-list
56103968|NCT00004064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56103969|NCT00004064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103970|NCT00382057|Anastrozole|anastrozole|mesh-list
56103971|NCT00382057|Goserelin|goserelin|mesh-list
56103972|NCT00382057|Testosterone|testosterone|mesh-list
56103973|NCT00382057|Androgens|androgens|mesh-ancestor
56103974|NCT00382057|Hormones|hormones|mesh-ancestor
56103975|NCT00382057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56103976|NCT00382057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56103977|NCT00382057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56103978|NCT00382057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56103979|NCT00382057|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56103980|NCT00382057|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56103981|NCT00382057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56103982|NCT00382057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56103983|NCT00382057|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56103984|NCT00382057|Hormone Antagonists|hormone antagonists|mesh-ancestor
56103986|NCT00003578|Prednisone|prednisone|mesh-list
56103987|NCT00003578|Cyclophosphamide|cyclophosphamide|mesh-list
56103988|NCT00003578|Melphalan|melphalan|mesh-list
56103989|NCT00003578|Carmustine|carmustine|mesh-list
56103990|NCT00003578|Doxorubicin|doxorubicin|mesh-list
56104018|NCT00003578|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104019|NCT00003578|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104020|NCT00003584|Prednisone|prednisone|mesh-list
56104021|NCT00003584|Estramustine|estramustine|mesh-list
56104022|NCT00003584|Vinorelbine|vinorelbine|mesh-list
56104023|NCT00003584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56104024|NCT00003584|Glucocorticoids|glucocorticoids|mesh-ancestor
56104025|NCT00003584|Hormones|hormones|mesh-ancestor
56104026|NCT00003584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104027|NCT00003584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104028|NCT00003584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55831075|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
56104029|NCT00003584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104030|NCT00003584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104031|NCT00003584|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104032|NCT00003584|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104033|NCT00003584|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104034|NCT00003584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104035|NCT00003584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104036|NCT00003584|Alkylating Agents|alkylating agents|mesh-ancestor
56104037|NCT00002701|Cytarabine|cytarabine|mesh-list
56104038|NCT00002701|Cyclophosphamide|cyclophosphamide|mesh-list
56104039|NCT00002701|Busulfan|busulfan|mesh-list
56104040|NCT00002701|Methotrexate|methotrexate|mesh-list
56104041|NCT00002701|Etoposide|etoposide|mesh-list
56104042|NCT00002701|Mercaptopurine|mercaptopurine|mesh-list
56104043|NCT00002701|Mitoxantrone|mitoxantrone|mesh-list
56104044|NCT00002701|Idarubicin|idarubicin|mesh-list
56104045|NCT00002701|Tretinoin|tretinoin|mesh-list
56104046|NCT00002701|Thioguanine|thioguanine|mesh-list
56104047|NCT00002701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104048|NCT00002701|Immunologic Factors|immunologic factors|mesh-ancestor
56104049|NCT00002701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104050|NCT00002701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104052|NCT00002701|Alkylating Agents|alkylating agents|mesh-ancestor
56104061|NCT00002701|Dermatologic Agents|dermatologic agents|mesh-ancestor
56104062|NCT00002701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104063|NCT00002701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56104064|NCT00002701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56104065|NCT00002701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104066|NCT00002701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104067|NCT00002701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104068|NCT00002701|Antiviral Agents|antiviral agents|mesh-ancestor
56104069|NCT00002701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104070|NCT00002701|Analgesics|analgesics|mesh-ancestor
56104071|NCT00002701|Sensory System Agents|sensory system agents|mesh-ancestor
56104072|NCT00002701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104073|NCT00002701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104074|NCT00002701|Keratolytic Agents|keratolytic agents|mesh-ancestor
56104075|NCT00004070|Interleukin-12|interleukin-12|mesh-list
56104076|NCT00004070|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56104077|NCT00004070|Immunologic Factors|immunologic factors|mesh-ancestor
56104078|NCT00004070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104079|NCT00004070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56104080|NCT00004070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56104116|NCT00002707|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104117|NCT00002707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104118|NCT00002707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104119|NCT00002707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104120|NCT00002707|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56104121|NCT00002707|Hormone Antagonists|hormone antagonists|mesh-ancestor
56104122|NCT00002707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104123|NCT00002707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56104124|NCT00002707|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56104125|NCT00002707|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56104126|NCT00002707|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56104128|NCT00003596|Mitomycins|mitomycins|mesh-list
56104129|NCT00003596|Mitomycin|mitomycin|mesh-list
56104130|NCT00003596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104131|NCT00003596|Antimetabolites|antimetabolites|mesh-ancestor
56104132|NCT00003596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104133|NCT00003596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104134|NCT00003596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104135|NCT00003596|Immunologic Factors|immunologic factors|mesh-ancestor
56104136|NCT00003596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104137|NCT00003596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104138|NCT00003596|Alkylating Agents|alkylating agents|mesh-ancestor
56104139|NCT00003596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56104140|NCT00003596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104141|NCT00002719|Cytarabine|cytarabine|mesh-list
56104142|NCT00002719|Etoposide|etoposide|mesh-list
55902092|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55902093|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
55902094|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902095|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902096|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55902097|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
55902098|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
55902099|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55902100|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55902101|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55902102|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56104143|NCT00002719|Mitoxantrone|mitoxantrone|mesh-list
56104144|NCT00002719|Idarubicin|idarubicin|mesh-list
56104145|NCT00002719|Carmustine|carmustine|mesh-list
56104146|NCT00002719|Amsacrine|amsacrine|mesh-list
56104147|NCT00002719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104148|NCT00002719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104149|NCT00002719|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104150|NCT00002719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104151|NCT00002719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104152|NCT00002719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104153|NCT00002719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104154|NCT00002719|Antimetabolites|antimetabolites|mesh-ancestor
56104155|NCT00002719|Antiviral Agents|antiviral agents|mesh-ancestor
56104156|NCT00002719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104157|NCT00002719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104158|NCT00002719|Immunologic Factors|immunologic factors|mesh-ancestor
55902103|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
55902104|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902105|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902106|NCT03173508|Acetazolamide|acetazolamide|mesh-list
55902107|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
55902108|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55902109|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902110|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902111|NCT03173508|Diuretics|diuretics|mesh-ancestor
55902112|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
55902113|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902114|NCT03173430|Blinatumomab|blinatumomab|mesh-list
55902115|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902117|NCT02407782|Permethrin|permethrin|mesh-list
55902118|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55902119|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902120|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902121|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902122|NCT02405364|Dexamethasone|dexamethasone|mesh-list
55902123|NCT02405364|Lenalidomide|lenalidomide|mesh-list
55902124|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55902127|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902128|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902129|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55902130|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
55902131|NCT02405364|Hormones|hormones|mesh-ancestor
55902132|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55902133|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55902134|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902135|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
55902136|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55902137|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55902138|NCT02405364|Growth Substances|growth substances|mesh-ancestor
55902139|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
56104159|NCT00002719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104160|NCT00002719|Analgesics|analgesics|mesh-ancestor
56104161|NCT00002719|Sensory System Agents|sensory system agents|mesh-ancestor
56104162|NCT00002719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104163|NCT00002719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104164|NCT00002719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104165|NCT00002719|Alkylating Agents|alkylating agents|mesh-ancestor
56104167|NCT00003326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104168|NCT00003326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104169|NCT00003326|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104170|NCT00003326|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104171|NCT00003326|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104172|NCT00003326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104173|NCT00002725|Bryostatin 1|bryostatin 1|mesh-list
56104174|NCT00002725|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56104175|NCT00002725|Immunologic Factors|immunologic factors|mesh-ancestor
56104176|NCT00002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104177|NCT00002725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104178|NCT00003602|Cytarabine|cytarabine|mesh-list
56104215|NCT00003332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104216|NCT00003614|Paclitaxel|paclitaxel|mesh-list
56104217|NCT00003614|Estramustine|estramustine|mesh-list
56104218|NCT00003614|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104219|NCT00003614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104220|NCT00003614|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104221|NCT00003614|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104222|NCT00003614|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104223|NCT00003614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104224|NCT00003614|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104225|NCT00003614|Alkylating Agents|alkylating agents|mesh-ancestor
56104226|NCT00003614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55902140|NCT02405130|Epinephrine|epinephrine|mesh-list
55902141|NCT02405130|Racepinephrine|racepinephrine|mesh-list
55902142|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
55902146|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902147|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902148|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902149|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55902150|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55902151|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
55902152|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902153|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55902154|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
55902155|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
55902156|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
55902157|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55902158|NCT03171090|Anesthetics|anesthetics|mesh-list
55902159|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
55902160|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902161|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902162|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
55902163|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902164|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55902165|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
55902166|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902167|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55902168|NCT02407626|Propofol|propofol|mesh-list
55902169|NCT02407626|Sevoflurane|sevoflurane|mesh-list
55902170|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55902171|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902172|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902173|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55902174|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
55902175|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
55755326|NCT04504175|Ketamine|ketamine|mesh-list
55902176|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55902177|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55902178|NCT02407392|Acetic Acid|acetic acid|mesh-list
55902179|NCT02407392|Retinol acetate|retinol acetate|mesh-list
55902180|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56104227|NCT00004094|Paclitaxel|paclitaxel|mesh-list
56104228|NCT00004094|Carboplatin|carboplatin|mesh-list
56104229|NCT00004094|Fluorouracil|fluorouracil|mesh-list
56104230|NCT00004094|Hydroxyurea|hydroxyurea|mesh-list
56104231|NCT00004094|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104232|NCT00004094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104233|NCT00004094|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104234|NCT00004094|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104235|NCT00004094|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104236|NCT00004094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104237|NCT00004094|Antimetabolites|antimetabolites|mesh-ancestor
56104238|NCT00004094|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104239|NCT00004094|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104240|NCT00004094|Immunologic Factors|immunologic factors|mesh-ancestor
56104241|NCT00004094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104242|NCT00004094|Antisickling Agents|antisickling agents|mesh-ancestor
56104243|NCT00004094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104244|NCT00004094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56104245|NCT00004100|Gemcitabine|gemcitabine|mesh-list
56104246|NCT00004100|Vinorelbine|vinorelbine|mesh-list
56104248|NCT00004100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104249|NCT00004100|Antimetabolites|antimetabolites|mesh-ancestor
56104250|NCT00004100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104251|NCT00004100|Antiviral Agents|antiviral agents|mesh-ancestor
56104252|NCT00004100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104253|NCT00004100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104254|NCT00004100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104255|NCT00004100|Immunologic Factors|immunologic factors|mesh-ancestor
56104256|NCT00004100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104257|NCT00004100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104258|NCT00004100|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104259|NCT00004100|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104260|NCT00004100|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104261|NCT00002737|Interferons|interferons|mesh-list
56104262|NCT00002737|Interferon-alpha|interferon-alpha|mesh-list
56104267|NCT00002737|Immunologic Factors|immunologic factors|mesh-ancestor
56104268|NCT00002737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104269|NCT00002737|Dermatologic Agents|dermatologic agents|mesh-ancestor
56104270|NCT00003338|Epratuzumab|epratuzumab|mesh-list
56104271|NCT00003338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56104272|NCT00003338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104273|NCT00003620|Alvocidib|alvocidib|mesh-list
56104274|NCT00003620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104275|NCT00003620|Growth Inhibitors|growth inhibitors|mesh-ancestor
56104276|NCT00003620|Growth Substances|growth substances|mesh-ancestor
56104277|NCT00003620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104278|NCT00003620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56104279|NCT00003620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902181|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902182|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55902183|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
55902184|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902185|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55902186|NCT02407392|Protective Agents|protective agents|mesh-ancestor
55902187|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902188|NCT02551432|Paclitaxel|paclitaxel|mesh-list
55902189|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
55902190|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55902191|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902192|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
55902193|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
55902194|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
55902195|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902196|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55902197|NCT02407548|Vitamin E|vitamin e|mesh-list
55902198|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
55902199|NCT02407548|Ubiquinone|ubiquinone|mesh-list
55902200|NCT02407548|Vitamins|vitamins|mesh-ancestor
55902201|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
55902202|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902203|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
55902204|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902205|NCT02407548|Protective Agents|protective agents|mesh-ancestor
55902206|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
55902207|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
55902208|NCT01695317|Vitamins|vitamins|mesh-ancestor
55902209|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
55902210|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902211|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
55902212|NCT02551744|Pantoprazole|pantoprazole|mesh-list
55902214|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55902215|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
55902216|NCT02551744|Histamine|histamine|mesh-list
55902217|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55902219|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902220|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902221|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
55902222|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
55902223|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56104280|NCT00003620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104282|NCT00003344|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56104283|NCT00003344|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104284|NCT00003344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104285|NCT00003344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104286|NCT00003344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104287|NCT00003626|Dolastatin 10|dolastatin 10|mesh-list
56104288|NCT00003626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104289|NCT00003626|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104290|NCT00003626|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104291|NCT00003626|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104292|NCT00003626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104293|NCT00003632|Cytarabine|cytarabine|mesh-list
56104294|NCT00003632|Methotrexate|methotrexate|mesh-list
56104295|NCT00003632|Etoposide|etoposide|mesh-list
56104296|NCT00003632|Melphalan|melphalan|mesh-list
56104297|NCT00003632|Carmustine|carmustine|mesh-list
56104298|NCT00003632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56104299|NCT00003632|Abortifacient Agents|abortifacient agents|mesh-ancestor
56104300|NCT00003632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56104301|NCT00003632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104303|NCT00003632|Antimetabolites|antimetabolites|mesh-ancestor
56104333|NCT00004112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104334|NCT00004112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104335|NCT00004112|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55831372|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
56104336|NCT00004112|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56104337|NCT00004112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104338|NCT00004112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104339|NCT00004112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104340|NCT00004112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104341|NCT00004112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56104342|NCT00004112|Glucocorticoids|glucocorticoids|mesh-ancestor
56104344|NCT00004112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104345|NCT00004112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56104346|NCT00004112|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104347|NCT00004112|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104348|NCT00004112|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104349|NCT00004112|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104350|NCT00003350|Paclitaxel|paclitaxel|mesh-list
56104351|NCT00003350|Doxorubicin|doxorubicin|mesh-list
56104352|NCT00003350|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56104353|NCT00003350|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104354|NCT00003350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104355|NCT00003350|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104384|NCT00003356|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56104385|NCT00003356|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56104386|NCT00003356|Antiviral Agents|antiviral agents|mesh-ancestor
56104387|NCT00003356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104388|NCT05582707|Pioglitazone|pioglitazone|mesh-list
56104389|NCT05582707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56104390|NCT05582707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104391|NCT00003638|Cyclophosphamide|cyclophosphamide|mesh-list
56104392|NCT00003638|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56104393|NCT00003638|Detox adjuvant|detox adjuvant|mesh-list
56104394|NCT00003638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104396|NCT00003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104397|NCT00003638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104398|NCT00003638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104399|NCT00003638|Alkylating Agents|alkylating agents|mesh-ancestor
56104400|NCT00003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104401|NCT00003638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104402|NCT00003638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104403|NCT00003638|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56104404|NCT00004142|Fluorouracil|fluorouracil|mesh-list
56104405|NCT00004142|Floxuridine|floxuridine|mesh-list
56104406|NCT00004142|Antimetabolites|antimetabolites|mesh-ancestor
56104407|NCT00004142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104408|NCT00004142|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104409|NCT00004142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104410|NCT00004142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104411|NCT00004142|Immunologic Factors|immunologic factors|mesh-ancestor
56104412|NCT00004142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104427|NCT00003650|Vincristine|vincristine|mesh-list
56104428|NCT00003650|Daunorubicin|daunorubicin|mesh-list
56104429|NCT00003650|Asparaginase|asparaginase|mesh-list
56104430|NCT00003650|Mercaptopurine|mercaptopurine|mesh-list
56104431|NCT00003650|Mitoxantrone|mitoxantrone|mesh-list
56104432|NCT00003650|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104433|NCT00003650|Immunologic Factors|immunologic factors|mesh-ancestor
56104434|NCT00003650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104435|NCT00003650|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104436|NCT00003650|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104437|NCT00003650|Alkylating Agents|alkylating agents|mesh-ancestor
56104438|NCT00003650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104439|NCT00003650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104440|NCT00003650|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104441|NCT00003650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56104442|NCT00003650|Antiemetics|antiemetics|mesh-ancestor
56104443|NCT00003650|Autonomic Agents|autonomic agents|mesh-ancestor
56104444|NCT00003650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104445|NCT00003650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56104446|NCT00003650|Glucocorticoids|glucocorticoids|mesh-ancestor
56104482|NCT00002755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104483|NCT00002755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104484|NCT00002755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104485|NCT00002755|Alkylating Agents|alkylating agents|mesh-ancestor
56104486|NCT00002755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104487|NCT00002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104488|NCT00002755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104489|NCT00002755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104490|NCT00002755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104491|NCT00002755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104492|NCT00002755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104494|NCT00002755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104495|NCT00002755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56104496|NCT00002755|Abortifacient Agents|abortifacient agents|mesh-ancestor
56104497|NCT00002755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56104498|NCT00002755|Dermatologic Agents|dermatologic agents|mesh-ancestor
56104499|NCT00002755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56104500|NCT00002755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56104501|NCT00002755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56104502|NCT00002755|Hormone Antagonists|hormone antagonists|mesh-ancestor
56104503|NCT00002755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104504|NCT00002755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56104505|NCT00002755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56104506|NCT00002755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56104507|NCT00002755|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56104508|NCT00002755|Trace Elements|trace elements|mesh-ancestor
56104509|NCT00002755|Micronutrients|micronutrients|mesh-ancestor
56104510|NCT00002761|Interferons|interferons|mesh-list
56104511|NCT00002761|Cytarabine|cytarabine|mesh-list
56104512|NCT00002761|Interferon-gamma|interferon-gamma|mesh-list
56104513|NCT00002761|Cyclosporine|cyclosporine|mesh-list
56104514|NCT00002761|Cyclophosphamide|cyclophosphamide|mesh-list
56104515|NCT00002761|Busulfan|busulfan|mesh-list
56104516|NCT00002761|Idarubicin|idarubicin|mesh-list
55902224|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902225|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
55902226|NCT04743544|Voriconazole|voriconazole|mesh-list
55902227|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
55902228|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902229|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55902230|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55902231|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902232|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902233|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55902234|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
55902235|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55902236|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902239|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55902240|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
55902241|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902242|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902243|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
55902244|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902245|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55902246|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
55902247|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902248|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902249|NCT02407314|Aspirin|aspirin|mesh-list
55902250|NCT02407314|Ticagrelor|ticagrelor|mesh-list
55902251|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55902252|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55902253|NCT02407314|Analgesics|analgesics|mesh-ancestor
55902254|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
55902255|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902256|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902257|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55902258|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55902259|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55902260|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55902261|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902262|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55902263|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55902264|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902265|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
55902266|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55902267|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55902268|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55902269|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
55902270|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902271|NCT02407080|Interferons|interferons|mesh-list
55902272|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
55902273|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
55902274|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55902275|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902276|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
55902277|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902278|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
55902279|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902280|NCT04743622|Latanoprost|latanoprost|mesh-list
55902281|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55902282|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55902283|NCT02701296|Epinephrine|epinephrine|mesh-list
56104522|NCT00002761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104523|NCT00002761|Alkylating Agents|alkylating agents|mesh-ancestor
56104524|NCT00002761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104525|NCT00002761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104526|NCT00002761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104527|NCT00002761|Antiviral Agents|antiviral agents|mesh-ancestor
56104528|NCT00002761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104529|NCT00002761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104530|NCT00002761|Antimetabolites|antimetabolites|mesh-ancestor
56104531|NCT00002761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104532|NCT00002761|Antifungal Agents|antifungal agents|mesh-ancestor
56104533|NCT00002761|Dermatologic Agents|dermatologic agents|mesh-ancestor
56104534|NCT00002761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56104535|NCT00002761|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104536|NCT00002761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104537|NCT00002761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104538|NCT00382135|Tadalafil|tadalafil|mesh-list
56104639|NCT00003380|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104640|NCT00003380|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104641|NCT00003380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104642|NCT00003380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104643|NCT00003380|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104645|NCT05557591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56104647|NCT00002779|Fludarabine|fludarabine|mesh-list
56104648|NCT00002779|Fludarabine phosphate|fludarabine phosphate|mesh-list
56104649|NCT00002779|Octreotide|octreotide|mesh-list
56104650|NCT00002779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104651|NCT00002779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104652|NCT00002779|Antimetabolites|antimetabolites|mesh-ancestor
56104703|NCT00002785|Vincristine|vincristine|mesh-list
56104704|NCT00002785|Daunorubicin|daunorubicin|mesh-list
56104705|NCT00002785|Asparaginase|asparaginase|mesh-list
56104706|NCT00002785|Mercaptopurine|mercaptopurine|mesh-list
56104707|NCT00002785|Pegaspargase|pegaspargase|mesh-list
56104708|NCT00002785|Cyclosporins|cyclosporins|mesh-list
56104709|NCT00002785|Levoleucovorin|levoleucovorin|mesh-list
56104710|NCT00002785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104711|NCT00002785|Immunologic Factors|immunologic factors|mesh-ancestor
56104712|NCT00002785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104713|NCT00002785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56104714|NCT00002785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56104715|NCT00002785|Alkylating Agents|alkylating agents|mesh-ancestor
56104716|NCT00002785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104717|NCT00002785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104718|NCT00002785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56104719|NCT00002785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56104721|NCT00002785|Autonomic Agents|autonomic agents|mesh-ancestor
56104722|NCT00002785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104723|NCT00002785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56104724|NCT00002785|Glucocorticoids|glucocorticoids|mesh-ancestor
56104726|NCT00002785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104727|NCT00002785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56104728|NCT00002785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56104729|NCT00002785|Abortifacient Agents|abortifacient agents|mesh-ancestor
56104730|NCT00002785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56104731|NCT00002785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104732|NCT00002785|Antimetabolites|antimetabolites|mesh-ancestor
56104733|NCT00002785|Dermatologic Agents|dermatologic agents|mesh-ancestor
56104734|NCT00002785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104735|NCT00002785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56104736|NCT00002785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56104737|NCT00002785|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104738|NCT00002785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56104739|NCT00002785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104741|NCT00002785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104742|NCT00002785|Antidotes|antidotes|mesh-ancestor
56104806|NCT00384566|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56104807|NCT00384566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56104808|NCT00384566|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56104809|NCT00384566|Vasodilator Agents|vasodilator agents|mesh-ancestor
56104810|NCT00384566|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56104811|NCT00384566|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56104812|NCT05501665|Deoxyglucose|deoxyglucose|mesh-list
56104813|NCT05501665|Paclitaxel|paclitaxel|mesh-list
56104827|NCT05501665|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56104828|NCT05501665|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56104829|NCT05501665|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56104831|NCT05501665|Antiviral Agents|antiviral agents|mesh-ancestor
56104833|NCT00004832|Amifampridine|amifampridine|mesh-list
56104872|NCT00004838|Antidotes|antidotes|mesh-ancestor
56104873|NCT00004838|Protective Agents|protective agents|mesh-ancestor
56104874|NCT00004838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104875|NCT00004838|Chelating Agents|chelating agents|mesh-ancestor
56104876|NCT00004838|Sequestering Agents|sequestering agents|mesh-ancestor
56104877|NCT00004838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104878|NCT00004202|Paclitaxel|paclitaxel|mesh-list
56104879|NCT00004202|Carboplatin|carboplatin|mesh-list
56104880|NCT00004202|Efaproxiral|efaproxiral|mesh-list
56104881|NCT00004202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56104882|NCT00004202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104883|NCT00004202|Tubulin Modulators|tubulin modulators|mesh-ancestor
56104884|NCT00004202|Antimitotic Agents|antimitotic agents|mesh-ancestor
56104885|NCT00004202|Mitosis Modulators|mitosis modulators|mesh-ancestor
56104886|NCT00004202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104887|NCT00004202|Antisickling Agents|antisickling agents|mesh-ancestor
56104890|NCT04472767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56104891|NCT04472767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104892|NCT04472767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56104893|NCT04472767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104894|NCT00003686|Pilocarpine|pilocarpine|mesh-list
56104895|NCT00003686|Miotics|miotics|mesh-ancestor
56104896|NCT00003686|Autonomic Agents|autonomic agents|mesh-ancestor
56104897|NCT00003686|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56104898|NCT00003686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104899|NCT00003686|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
56104900|NCT00003686|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56104901|NCT00003686|Cholinergic Agents|cholinergic agents|mesh-ancestor
56104902|NCT00003686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56104927|NCT00004862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104928|NCT00004862|Antimetabolites|antimetabolites|mesh-ancestor
56104929|NCT00004862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104930|NCT00004862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56104931|NCT00004862|Immunologic Factors|immunologic factors|mesh-ancestor
56104932|NCT00004862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104933|NCT00004862|Antiviral Agents|antiviral agents|mesh-ancestor
56104934|NCT00004862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56104935|NCT00004220|Gemcitabine|gemcitabine|mesh-list
56104936|NCT00004220|Oxaliplatin|oxaliplatin|mesh-list
56104937|NCT00004220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56104938|NCT00004220|Antimetabolites|antimetabolites|mesh-ancestor
56104939|NCT00004220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104974|NCT00003710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56104975|NCT00003710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56104976|NCT00003710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56104977|NCT00003710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104978|NCT00003710|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56104979|NCT00003710|Alkylating Agents|alkylating agents|mesh-ancestor
56104980|NCT00003710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56104981|NCT00004232|Cyclosporine|cyclosporine|mesh-list
56104982|NCT00004232|Prednisone|prednisone|mesh-list
56104983|NCT00004232|Methylprednisolone|methylprednisolone|mesh-list
56104984|NCT00004232|Cyclosporins|cyclosporins|mesh-list
56104985|NCT00004232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56104986|NCT00004232|Glucocorticoids|glucocorticoids|mesh-ancestor
56104987|NCT00004232|Hormones|hormones|mesh-ancestor
56104988|NCT00004232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56104989|NCT00004232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56104990|NCT00004232|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56104991|NCT00004232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56104992|NCT00004232|Immunologic Factors|immunologic factors|mesh-ancestor
56105030|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
56105031|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56105032|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105033|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
56105034|NCT05231629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56105035|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56105036|NCT05231629|Growth Substances|growth substances|mesh-ancestor
56105037|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
56105039|NCT00004874|Tositumomab I-131|tositumomab i-131|mesh-list
56105040|NCT00004874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56105041|NCT00004874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105042|NCT00004874|Trace Elements|trace elements|mesh-ancestor
56105043|NCT00004874|Micronutrients|micronutrients|mesh-ancestor
56105044|NCT00004874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105045|NCT00004874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105046|NCT00004244|Interferons|interferons|mesh-list
56105047|NCT00004244|Interferon-alpha|interferon-alpha|mesh-list
56105048|NCT00004244|Interleukin-12|interleukin-12|mesh-list
56105049|NCT00004244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105050|NCT00004244|Antiviral Agents|antiviral agents|mesh-ancestor
56105051|NCT00004244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105052|NCT00004244|Immunologic Factors|immunologic factors|mesh-ancestor
56105053|NCT00004244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105054|NCT00004244|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56105055|NCT00004244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56105056|NCT00004244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56105057|NCT00004244|Growth Substances|growth substances|mesh-ancestor
56105058|NCT00004244|Growth Inhibitors|growth inhibitors|mesh-ancestor
56105059|NCT00004880|Vaccines|vaccines|mesh-list
56105060|NCT00004880|Immunologic Factors|immunologic factors|mesh-ancestor
56105085|NCT00003728|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56105086|NCT00003728|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56105087|NCT00003728|Cyclophosphamide|cyclophosphamide|mesh-list
56105088|NCT00003728|Doxorubicin|doxorubicin|mesh-list
56105089|NCT00003728|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56105090|NCT00003728|Methotrexate|methotrexate|mesh-list
56105091|NCT00003728|Etoposide|etoposide|mesh-list
56105092|NCT00003728|Vincristine|vincristine|mesh-list
56105093|NCT00003728|Daunorubicin|daunorubicin|mesh-list
56105094|NCT00003728|Asparaginase|asparaginase|mesh-list
56105095|NCT00003728|Mercaptopurine|mercaptopurine|mesh-list
56105096|NCT00003728|Mitoxantrone|mitoxantrone|mesh-list
56105097|NCT00003728|Thioguanine|thioguanine|mesh-list
56105098|NCT00003728|Vindesine|vindesine|mesh-list
56105099|NCT00003728|Levoleucovorin|levoleucovorin|mesh-list
56105100|NCT00003728|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105101|NCT00003728|Immunologic Factors|immunologic factors|mesh-ancestor
56105102|NCT00003728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105103|NCT00003728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56105106|NCT00003728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105107|NCT00003728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105108|NCT00003728|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56105109|NCT00003728|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56105111|NCT00003728|Autonomic Agents|autonomic agents|mesh-ancestor
56105112|NCT00003728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105113|NCT00003728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56105114|NCT00003728|Glucocorticoids|glucocorticoids|mesh-ancestor
56105115|NCT00003728|Hormones|hormones|mesh-ancestor
56105116|NCT00003728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105117|NCT00003728|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56105118|NCT00003728|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56105119|NCT00003728|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56105120|NCT00003728|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105121|NCT00003728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105122|NCT00003728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56105123|NCT00003728|Abortifacient Agents|abortifacient agents|mesh-ancestor
56105124|NCT00003728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56105125|NCT00003728|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56105126|NCT00003728|Antimetabolites|antimetabolites|mesh-ancestor
56105127|NCT00003728|Dermatologic Agents|dermatologic agents|mesh-ancestor
56105128|NCT00003728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56105129|NCT00003728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56105130|NCT00003728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56105131|NCT00003728|Antiviral Agents|antiviral agents|mesh-ancestor
56105132|NCT00003728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105133|NCT00003728|Antidotes|antidotes|mesh-ancestor
56105134|NCT00003728|Protective Agents|protective agents|mesh-ancestor
56105135|NCT00003728|Vitamin B Complex|vitamin b complex|mesh-ancestor
56105136|NCT00003728|Vitamins|vitamins|mesh-ancestor
56105137|NCT00003728|Micronutrients|micronutrients|mesh-ancestor
56105146|NCT00004886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105147|NCT00004886|Tubulin Modulators|tubulin modulators|mesh-ancestor
56105148|NCT00004886|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105149|NCT00004886|Mitosis Modulators|mitosis modulators|mesh-ancestor
56105150|NCT00004886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105151|NCT00003734|Triptorelin Pamoate|triptorelin pamoate|mesh-list
56105153|NCT00003734|Luteolytic Agents|luteolytic agents|mesh-ancestor
56105154|NCT00003734|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56105155|NCT00003734|Contraceptive Agents|contraceptive agents|mesh-ancestor
56105156|NCT00003734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56105157|NCT00003734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105158|NCT00003734|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56105159|NCT00003734|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56105160|NCT00003734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105161|NCT00003734|Androgen Antagonists|androgen antagonists|mesh-ancestor
56105162|NCT00003734|Hormone Antagonists|hormone antagonists|mesh-ancestor
56105163|NCT00003734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105164|NCT00003740|Trastuzumab|trastuzumab|mesh-list
56105165|NCT00003740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56105166|NCT00003740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105200|NCT00004892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105201|NCT00004892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105202|NCT00004892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105203|NCT00004268|Midodrine|midodrine|mesh-list
56105204|NCT00004268|Sympathomimetics|sympathomimetics|mesh-ancestor
56105205|NCT00004268|Autonomic Agents|autonomic agents|mesh-ancestor
56105206|NCT00004268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105383|NCT00003776|Antimetabolites|antimetabolites|mesh-ancestor
56105207|NCT00004268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105211|NCT00004268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56105212|NCT00004268|Adrenergic Agents|adrenergic agents|mesh-ancestor
56105213|NCT00004268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105214|NCT00004268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105215|NCT00004274|Estrogens|estrogens|mesh-list
56105216|NCT00004274|Hormones|hormones|mesh-ancestor
56105217|NCT00004274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105218|NCT00004274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105219|NCT05467891|Letrozole|letrozole|mesh-list
56105220|NCT05467891|Fulvestrant|fulvestrant|mesh-list
56105221|NCT05467891|Anastrozole|anastrozole|mesh-list
56105222|NCT05467891|Exemestane|exemestane|mesh-list
56105223|NCT05467891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105224|NCT05467891|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56105225|NCT05467891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56105226|NCT05467891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105227|NCT05467891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105228|NCT05467891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56105229|NCT05467891|Hormone Antagonists|hormone antagonists|mesh-ancestor
56105230|NCT05467891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105231|NCT05467891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105232|NCT05467891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56105233|NCT05467891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56105234|NCT00004904|Methylprednisolone|methylprednisolone|mesh-list
56105235|NCT00004904|Cyclophosphamide|cyclophosphamide|mesh-list
56105236|NCT00004904|Etoposide|etoposide|mesh-list
56105237|NCT00004904|Cladribine|cladribine|mesh-list
56105238|NCT00004904|Tacrolimus|tacrolimus|mesh-list
56105239|NCT00004904|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56105290|NCT00003758|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56105291|NCT00003758|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105292|NCT00003758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105293|NCT00004310|Clomipramine|clomipramine|mesh-list
56105294|NCT00004310|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56105295|NCT00004310|Antidepressive Agents|antidepressive agents|mesh-ancestor
56105296|NCT00004310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56105297|NCT00004310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56105298|NCT00004310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56105299|NCT00004310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56105300|NCT00004310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105301|NCT00004310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105302|NCT00004310|Serotonin Agents|serotonin agents|mesh-ancestor
56105303|NCT00004310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105304|NCT00004922|Irinotecan|irinotecan|mesh-list
56105306|NCT00004922|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105344|NCT00004328|Protease Inhibitors|protease inhibitors|mesh-ancestor
56105345|NCT00004328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105346|NCT00004328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105347|NCT00004328|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56105348|NCT00004328|Chelating Agents|chelating agents|mesh-ancestor
56105349|NCT00004328|Sequestering Agents|sequestering agents|mesh-ancestor
56105350|NCT00004934|Paclitaxel|paclitaxel|mesh-list
56105351|NCT00004934|Carboplatin|carboplatin|mesh-list
56105352|NCT00004934|Epirubicin|epirubicin|mesh-list
56105353|NCT00004934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56105354|NCT00004934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105355|NCT00004934|Tubulin Modulators|tubulin modulators|mesh-ancestor
56105356|NCT00004934|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105366|NCT00003776|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56105367|NCT00003776|Methotrexate|methotrexate|mesh-list
56105368|NCT00003776|Ifosfamide|ifosfamide|mesh-list
56105369|NCT00003776|Calcium|calcium|mesh-list
56105370|NCT00003776|Levoleucovorin|levoleucovorin|mesh-list
56105371|NCT00003776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105372|NCT00003776|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56105373|NCT00003776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56105374|NCT00003776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105375|NCT00003776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105376|NCT00003776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105377|NCT00003776|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56105378|NCT00003776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105379|NCT00003776|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56105380|NCT00003776|Abortifacient Agents|abortifacient agents|mesh-ancestor
56105381|NCT00003776|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56105382|NCT00003776|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56105385|NCT00003776|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56105386|NCT00003776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105387|NCT00003776|Immunologic Factors|immunologic factors|mesh-ancestor
56105388|NCT00003776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56105389|NCT00003776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56105390|NCT00003776|Antidotes|antidotes|mesh-ancestor
56105391|NCT00003776|Protective Agents|protective agents|mesh-ancestor
56105392|NCT00003776|Vitamin B Complex|vitamin b complex|mesh-ancestor
56105393|NCT00003776|Vitamins|vitamins|mesh-ancestor
56105470|NCT02972762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105471|NCT02972762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56105472|NCT02972762|Anesthetics, General|anesthetics, general|mesh-ancestor
56105474|NCT00004358|Calcitonin|calcitonin|mesh-list
56105475|NCT00004358|Salmon calcitonin|salmon calcitonin|mesh-list
56105476|NCT00004358|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
56105477|NCT00004358|Katacalcin|katacalcin|mesh-list
56105478|NCT00004358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56105479|NCT00004358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105480|NCT00004358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55832488|NCT02094937|Fluticasone|fluticasone|mesh-list
56105481|NCT00004358|Vasodilator Agents|vasodilator agents|mesh-ancestor
56105482|NCT00004364|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56105483|NCT00004364|Hemostatics|hemostatics|mesh-ancestor
56105484|NCT00004364|Coagulants|coagulants|mesh-ancestor
56105485|NCT00004364|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56105486|NCT00004364|Natriuretic Agents|natriuretic agents|mesh-ancestor
56105487|NCT00004364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105488|NCT00005000|Lamivudine|lamivudine|mesh-list
56105489|NCT00005000|Zidovudine|zidovudine|mesh-list
56105490|NCT00005000|Efavirenz|efavirenz|mesh-list
56105491|NCT00005000|Didanosine|didanosine|mesh-list
56105492|NCT00005000|Stavudine|stavudine|mesh-list
56105493|NCT00005000|Nelfinavir|nelfinavir|mesh-list
56105494|NCT00005000|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56105495|NCT00005000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56105496|NCT00005000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56105497|NCT00005000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105499|NCT00005000|Antiviral Agents|antiviral agents|mesh-ancestor
56105509|NCT00005000|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56105510|NCT00005000|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56105511|NCT00005000|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56105512|NCT00005000|Protease Inhibitors|protease inhibitors|mesh-ancestor
56105513|NCT00005000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56105514|NCT00005000|Immunologic Factors|immunologic factors|mesh-ancestor
56105515|NCT00005000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105516|NCT00004376|Guanfacine|guanfacine|mesh-list
56105517|NCT00004376|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56105518|NCT00004376|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56105519|NCT00004376|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56105520|NCT00004376|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56105521|NCT00004376|Adrenergic Agents|adrenergic agents|mesh-ancestor
56105522|NCT00004376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105523|NCT00004376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105524|NCT00004376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105525|NCT00005006|Alendronate|alendronate|mesh-list
56105526|NCT00005006|Teriparatide|teriparatide|mesh-list
56105527|NCT00005006|Hormones|hormones|mesh-list
56105528|NCT00005006|Parathyroid Hormone|parathyroid hormone|mesh-list
56105529|NCT00005006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105530|NCT00005006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105531|NCT00005006|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56105532|NCT00005006|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56105533|NCT00004382|Tin mesoporphyrin|tin mesoporphyrin|mesh-list
56105534|NCT00004382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105535|NCT00004382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105536|NCT00005012|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56105537|NCT00005012|Antiviral Agents|antiviral agents|mesh-ancestor
56105552|NCT00003812|Mitosis Modulators|mitosis modulators|mesh-ancestor
56105553|NCT00003812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105554|NCT00003812|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56105555|NCT00003812|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105556|NCT00003812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105557|NCT00003812|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56105558|NCT00005018|Efavirenz|efavirenz|mesh-list
56105559|NCT00005018|Abacavir|abacavir|mesh-list
56105560|NCT00005018|Didanosine|didanosine|mesh-list
56105561|NCT00005018|Hydroxyurea|hydroxyurea|mesh-list
56105797|NCT00005060|Mitosis Modulators|mitosis modulators|mesh-ancestor
56105562|NCT00005018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56105563|NCT00005018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56105564|NCT00005018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105565|NCT00005018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105566|NCT00005018|Antiviral Agents|antiviral agents|mesh-ancestor
56105567|NCT00005018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105568|NCT00005018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56105569|NCT00005018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56105570|NCT00005018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56105571|NCT00005018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56105572|NCT00005018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56105573|NCT00005018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56105574|NCT00005018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105575|NCT00005018|Antisickling Agents|antisickling agents|mesh-ancestor
56105576|NCT00005018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56105577|NCT00005018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56105578|NCT00005018|Antimetabolites|antimetabolites|mesh-ancestor
56105579|NCT00003824|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56105595|NCT00005024|Cyclophosphamide|cyclophosphamide|mesh-list
56105596|NCT00005024|Carboplatin|carboplatin|mesh-list
56105597|NCT00005024|Doxorubicin|doxorubicin|mesh-list
56105598|NCT00005024|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56105599|NCT00005024|Granisetron|granisetron|mesh-list
56105600|NCT00005024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105601|NCT00005024|Immunologic Factors|immunologic factors|mesh-ancestor
56105602|NCT00005024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105603|NCT00005024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56105604|NCT00005024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105605|NCT00005024|Alkylating Agents|alkylating agents|mesh-ancestor
56105606|NCT00005024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105607|NCT00005024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105608|NCT00005024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56105609|NCT00005024|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56105610|NCT00005024|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56105611|NCT00005024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105612|NCT00005024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105613|NCT00005024|Antiemetics|antiemetics|mesh-ancestor
56105614|NCT00005024|Autonomic Agents|autonomic agents|mesh-ancestor
56105615|NCT00005024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105616|NCT00005024|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56105617|NCT00005024|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56105618|NCT00005024|Serotonin Agents|serotonin agents|mesh-ancestor
56105619|NCT00005024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105620|NCT00005030|Lonafarnib|lonafarnib|mesh-list
56105621|NCT00005030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105622|NCT00005030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105740|NCT00003860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56105741|NCT00003860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105742|NCT00003860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105743|NCT00003860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105744|NCT00003860|Alkylating Agents|alkylating agents|mesh-ancestor
56105746|NCT05167825|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56105747|NCT05167825|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56105750|NCT00005048|Paclitaxel|paclitaxel|mesh-list
56105777|NCT00005054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105778|NCT00005054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105779|NCT04742101|Azacitidine|azacitidine|mesh-list
55832790|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105780|NCT04742101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56105782|NCT04742101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105783|NCT04742101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105784|NCT04742101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56105785|NCT00004478|Droxidopa|droxidopa|mesh-list
56105786|NCT00004478|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56105787|NCT00004478|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56105788|NCT00003878|Carmustine|carmustine|mesh-list
56105789|NCT00003878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105790|NCT00003878|Alkylating Agents|alkylating agents|mesh-ancestor
56105791|NCT00003878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105792|NCT00003878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105793|NCT00005060|Docetaxel|docetaxel|mesh-list
56105794|NCT00005060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105795|NCT00005060|Tubulin Modulators|tubulin modulators|mesh-ancestor
56105796|NCT00005060|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105798|NCT00005060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105799|NCT00003884|Zoledronic Acid|zoledronic acid|mesh-list
56105800|NCT00003884|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56105801|NCT00003884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105802|NCT00005066|Carmustine|carmustine|mesh-list
56105803|NCT00005066|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56105820|NCT00005072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56105821|NCT00005072|Analgesics|analgesics|mesh-ancestor
56105822|NCT00005072|Sensory System Agents|sensory system agents|mesh-ancestor
56105823|NCT00005072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105824|NCT00005072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105825|NCT00004496|Hormones|hormones|mesh-list
56105826|NCT00004496|alpha-MSH|alpha-msh|mesh-list
56105827|NCT00004496|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
56105828|NCT00004496|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
56105829|NCT00004496|beta-Endorphin|beta-endorphin|mesh-list
56105830|NCT00004496|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56105831|NCT00004496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105832|NCT00004496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56105833|NCT00004496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105834|NCT00003902|Capecitabine|capecitabine|mesh-list
56105835|NCT00003902|Vinorelbine|vinorelbine|mesh-list
56105836|NCT00003902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56105837|NCT00003902|Antimetabolites|antimetabolites|mesh-ancestor
56105838|NCT00003902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105839|NCT00003902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105872|NCT00005078|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105873|NCT00005078|Mitosis Modulators|mitosis modulators|mesh-ancestor
56105874|NCT00005078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105875|NCT04698031|Aspirin|aspirin|mesh-list
56105876|NCT04698031|Clopidogrel|clopidogrel|mesh-list
56105877|NCT04698031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56105878|NCT04698031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56105879|NCT04698031|Analgesics|analgesics|mesh-ancestor
56105880|NCT04698031|Sensory System Agents|sensory system agents|mesh-ancestor
56105881|NCT04698031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56105882|NCT04698031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105883|NCT04698031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56105884|NCT04698031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56105885|NCT04698031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56105886|NCT04698031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56105887|NCT04698031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105888|NCT04698031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56105894|NCT04698031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56105922|NCT00003926|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56105923|NCT00003926|Alkylating Agents|alkylating agents|mesh-ancestor
56105924|NCT00003926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105925|NCT00003926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105926|NCT00003926|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56105927|NCT00003926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105928|NCT00003926|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56105929|NCT00003926|Protective Agents|protective agents|mesh-ancestor
56105931|NCT05122819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56105932|NCT05122819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56105933|NCT00005090|Cyclophosphamide|cyclophosphamide|mesh-list
56105934|NCT00005090|Dacarbazine|dacarbazine|mesh-list
56105935|NCT00005090|Carmustine|carmustine|mesh-list
56105936|NCT00005090|Doxorubicin|doxorubicin|mesh-list
56105937|NCT00005090|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56105938|NCT00005090|Etoposide|etoposide|mesh-list
56105939|NCT00005090|Bleomycin|bleomycin|mesh-list
56105940|NCT00005090|Vinblastine|vinblastine|mesh-list
56105941|NCT00005090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56105942|NCT00005090|Immunologic Factors|immunologic factors|mesh-ancestor
56105944|NCT00005090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56105976|NCT00005096|Docetaxel|docetaxel|mesh-list
56105977|NCT00005096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105978|NCT00005096|Tubulin Modulators|tubulin modulators|mesh-ancestor
56105979|NCT00005096|Antimitotic Agents|antimitotic agents|mesh-ancestor
56105980|NCT00005096|Mitosis Modulators|mitosis modulators|mesh-ancestor
56105981|NCT00005096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56105982|NCT05396833|Avelumab|avelumab|mesh-list
56105983|NCT05396833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56105984|NCT05396833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56105985|NCT00004640|Chlorhexidine|chlorhexidine|mesh-list
56105986|NCT00004640|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56105987|NCT00004640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56105989|NCT05104099|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56105990|NCT05104099|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56105991|NCT05104099|Dermatologic Agents|dermatologic agents|mesh-ancestor
56105992|NCT00004646|Prednisone|prednisone|mesh-list
56105993|NCT00004646|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56105994|NCT00004646|Glucocorticoids|glucocorticoids|mesh-ancestor
56105995|NCT00004646|Hormones|hormones|mesh-ancestor
56106059|NCT00004688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56106060|NCT00004688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106061|NCT00004688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106062|NCT00004688|Immunologic Factors|immunologic factors|mesh-ancestor
56106063|NCT00004688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106064|NCT00004688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56106065|NCT00004688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106066|NCT00004688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56106067|NCT00004688|Alkylating Agents|alkylating agents|mesh-ancestor
56106068|NCT00004688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56106070|NCT00004694|Anticoagulants|anticoagulants|mesh-ancestor
56106071|NCT00004694|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56106072|NCT00004694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56106073|NCT00004694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106109|NCT00004736|Nelfinavir|nelfinavir|mesh-list
56106110|NCT00004736|Isoniazid|isoniazid|mesh-list
56106111|NCT00004736|Pyrazinamide|pyrazinamide|mesh-list
56106112|NCT00004736|Ethambutol|ethambutol|mesh-list
56106113|NCT00004736|Rifabutin|rifabutin|mesh-list
56106114|NCT00004736|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56106115|NCT00004736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56106116|NCT00004736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106117|NCT00004736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106118|NCT00004736|Antiviral Agents|antiviral agents|mesh-ancestor
56106119|NCT00004736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106120|NCT00004736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56106121|NCT00004736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56106122|NCT00004736|Antimetabolites|antimetabolites|mesh-ancestor
56106123|NCT00004736|Antitubercular Agents|antitubercular agents|mesh-ancestor
56106124|NCT00004736|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56106125|NCT00004736|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56106126|NCT00004736|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56106127|NCT00004736|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56106128|NCT00004736|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56106129|NCT00004736|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56106130|NCT00004736|Protease Inhibitors|protease inhibitors|mesh-ancestor
56106131|NCT00004736|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56106132|NCT00004748|Methotrexate|methotrexate|mesh-list
56106133|NCT00004748|Colchicine|colchicine|mesh-list
56106134|NCT00004748|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56106135|NCT00004748|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56106136|NCT00004748|Abortifacient Agents|abortifacient agents|mesh-ancestor
56106137|NCT00004748|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56106138|NCT00004748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106139|NCT00004748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56106141|NCT00004748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106142|NCT00004748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106143|NCT00004748|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106144|NCT00004748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106145|NCT00004748|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56106147|NCT00004748|Immunologic Factors|immunologic factors|mesh-ancestor
56106148|NCT00004748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106149|NCT00004748|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56106150|NCT00004748|Gout Suppressants|gout suppressants|mesh-ancestor
56106151|NCT00004748|Tubulin Modulators|tubulin modulators|mesh-ancestor
56106152|NCT00004748|Antimitotic Agents|antimitotic agents|mesh-ancestor
56106153|NCT00004748|Mitosis Modulators|mitosis modulators|mesh-ancestor
56106154|NCT00004748|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56106155|NCT00004748|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56106157|NCT04585477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56106159|NCT00004754|Epoprostenol|epoprostenol|mesh-list
56106160|NCT00004754|Tezosentan|tezosentan|mesh-list
56106161|NCT00004754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56106162|NCT00004754|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56106163|NCT00004754|Vasodilator Agents|vasodilator agents|mesh-ancestor
56106164|NCT00005576|Aldesleukin|aldesleukin|mesh-list
56106165|NCT00005576|Interleukin-2|interleukin-2|mesh-list
56106166|NCT00005576|Dinutuximab|dinutuximab|mesh-list
56106172|NCT00005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106173|NCT00005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106174|NCT00005576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56106175|NCT00005576|Analgesics|analgesics|mesh-ancestor
56106176|NCT00005576|Sensory System Agents|sensory system agents|mesh-ancestor
56106177|NCT00005576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106178|NCT00005576|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56106179|NCT00005576|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56106182|NCT00005576|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106183|NCT04567303|Ranibizumab|ranibizumab|mesh-list
56106184|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56106185|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56106186|NCT04567303|Growth Substances|growth substances|mesh-ancestor
56106187|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106188|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
56106189|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106190|NCT04562467|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
56106191|NCT04562467|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56106192|NCT04562467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56106193|NCT04713163|Vaccines|vaccines|mesh-list
56106194|NCT04713163|Immunologic Factors|immunologic factors|mesh-ancestor
56106195|NCT04713163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106196|NCT00004772|Immunoglobulins|immunoglobulins|mesh-list
56106197|NCT00004772|Antibodies|antibodies|mesh-list
56106198|NCT00004772|gamma-Globulins|gamma-globulins|mesh-list
56106199|NCT00004772|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56106200|NCT00004772|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56106201|NCT00004772|Immunologic Factors|immunologic factors|mesh-ancestor
56106202|NCT00004772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106203|NCT04712929|Fluconazole|fluconazole|mesh-list
56106204|NCT04712929|Antifungal Agents|antifungal agents|mesh-ancestor
56106234|NCT00004784|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56106235|NCT00004784|Abortifacient Agents|abortifacient agents|mesh-ancestor
56106236|NCT00004784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56106237|NCT00004784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106238|NCT00004784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56106240|NCT00004784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106241|NCT00004784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106242|NCT00004784|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106243|NCT00004784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106245|NCT00004784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106246|NCT00004784|Immunologic Factors|immunologic factors|mesh-ancestor
56106247|NCT00004784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106248|NCT00004784|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56106249|NCT00004784|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56106250|NCT00004784|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56106251|NCT00004796|Lactulose|lactulose|mesh-list
56106252|NCT00004796|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56106253|NCT00004802|Dichlorphenamide|dichlorphenamide|mesh-list
56106254|NCT00004802|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
56106255|NCT00004802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106256|NCT00004802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106257|NCT00004808|Fluconazole|fluconazole|mesh-list
56106258|NCT00004808|Antifungal Agents|antifungal agents|mesh-ancestor
56106259|NCT00004808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106262|NCT00004808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106279|NCT00004826|Serotonin Agents|serotonin agents|mesh-ancestor
56106280|NCT00004826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106281|NCT00004826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106282|NCT00004826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106283|NCT00004826|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56106284|NCT00004826|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56106285|NCT00004826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56106286|NCT00004826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56106287|NCT00004826|GABA Antagonists|gaba antagonists|mesh-ancestor
56106288|NCT00004826|GABA Agents|gaba agents|mesh-ancestor
56106289|NCT04555603|Pembrolizumab|pembrolizumab|mesh-list
56106290|NCT04555603|Avelumab|avelumab|mesh-list
56106291|NCT04555603|Axitinib|axitinib|mesh-list
56106292|NCT04555603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56106293|NCT04555603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106294|NCT04555603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56106295|NCT04555603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106296|NCT04555603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106297|NCT04552327|Diclofenac|diclofenac|mesh-list
56106298|NCT04552327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56106299|NCT04552327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56106300|NCT04552327|Analgesics|analgesics|mesh-ancestor
56106301|NCT04552327|Sensory System Agents|sensory system agents|mesh-ancestor
56106302|NCT04552327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106303|NCT04552327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106304|NCT04552327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56106305|NCT04552327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106306|NCT04552327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56106307|NCT04552327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106309|NCT00005612|Paclitaxel|paclitaxel|mesh-list
56106323|NCT00005612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106324|NCT00005612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56106325|NCT00005612|Alkylating Agents|alkylating agents|mesh-ancestor
56106326|NCT00005612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56106327|NCT00005612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56106328|NCT00005612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56106329|NCT00005612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106330|NCT00005612|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56106332|NCT04536337|Antiviral Agents|antiviral agents|mesh-ancestor
56106333|NCT04536337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106334|NCT00005618|Arsenic Trioxide|arsenic trioxide|mesh-list
56106335|NCT00005618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106336|NCT04534153|Fexofenadine|fexofenadine|mesh-list
56106337|NCT04534153|Terfenadine|terfenadine|mesh-list
56106338|NCT04534153|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56106339|NCT04534153|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56106341|NCT04534153|Histamine Antagonists|histamine antagonists|mesh-ancestor
56106342|NCT04534153|Histamine Agents|histamine agents|mesh-ancestor
56106343|NCT04534153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106375|NCT00005642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106376|NCT00005642|Growth Inhibitors|growth inhibitors|mesh-ancestor
56106377|NCT00005642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106378|NCT00005642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56106379|NCT00005642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106380|NCT00005642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106381|NCT00005648|Gemcitabine|gemcitabine|mesh-list
56106383|NCT00005648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56106384|NCT00005648|Antimetabolites|antimetabolites|mesh-ancestor
56106385|NCT00005648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106386|NCT00005648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106387|NCT00005648|Antiviral Agents|antiviral agents|mesh-ancestor
56106388|NCT00005648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106389|NCT00005648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106390|NCT00005648|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106391|NCT00005648|Immunologic Factors|immunologic factors|mesh-ancestor
56106392|NCT00005648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106393|NCT04512235|Dexamethasone|dexamethasone|mesh-list
56106394|NCT04512235|Cyclophosphamide|cyclophosphamide|mesh-list
56106395|NCT04512235|Bortezomib|bortezomib|mesh-list
56106396|NCT04512235|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106397|NCT04512235|Immunologic Factors|immunologic factors|mesh-ancestor
56106398|NCT04512235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106399|NCT04512235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106400|NCT04512235|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56106401|NCT04512235|Alkylating Agents|alkylating agents|mesh-ancestor
56106423|NCT00005654|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56106424|NCT00005654|Fertility Agents|fertility agents|mesh-ancestor
56106425|NCT00005654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56106426|NCT00005654|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56106427|NCT00005654|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56106428|NCT00005684|Heparin|heparin|mesh-list
56106429|NCT00005684|Warfarin|warfarin|mesh-list
56106430|NCT00005684|Anticoagulants|anticoagulants|mesh-ancestor
56106431|NCT00005684|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56106432|NCT00005684|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56106433|NCT00005684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106434|NCT00386282|Misoprostol|misoprostol|mesh-list
56106435|NCT00386282|Mifepristone|mifepristone|mesh-list
56106436|NCT00386282|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56106437|NCT00386282|Abortifacient Agents|abortifacient agents|mesh-ancestor
56106438|NCT00386282|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56106439|NCT00386282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106440|NCT00386282|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56106441|NCT00386282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56106442|NCT00386282|Oxytocics|oxytocics|mesh-ancestor
56106443|NCT00386282|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
56106444|NCT00386282|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56106445|NCT00386282|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56106446|NCT00386282|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56106447|NCT00386282|Contraceptive Agents|contraceptive agents|mesh-ancestor
56106448|NCT00386282|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
56106449|NCT00386282|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
56106450|NCT00386282|Hormone Antagonists|hormone antagonists|mesh-ancestor
56106451|NCT00386282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106452|NCT00386282|Luteolytic Agents|luteolytic agents|mesh-ancestor
56106453|NCT00386282|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56106454|NCT00386282|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56106455|NCT05029921|Ustekinumab|ustekinumab|mesh-list
56106456|NCT05029921|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106458|NCT04456699|Bevacizumab|bevacizumab|mesh-list
56106459|NCT04456699|Fluorouracil|fluorouracil|mesh-list
56106462|NCT04456699|Levoleucovorin|levoleucovorin|mesh-list
56106463|NCT04456699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56106464|NCT04456699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106465|NCT04456699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56106466|NCT04456699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56106467|NCT04456699|Growth Substances|growth substances|mesh-ancestor
56106468|NCT04456699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106469|NCT04456699|Growth Inhibitors|growth inhibitors|mesh-ancestor
56106470|NCT04456699|Antimetabolites|antimetabolites|mesh-ancestor
56106471|NCT04456699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106472|NCT04456699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56106473|NCT04456699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106474|NCT04456699|Immunologic Factors|immunologic factors|mesh-ancestor
56106475|NCT04456699|Antidotes|antidotes|mesh-ancestor
56106476|NCT04456699|Protective Agents|protective agents|mesh-ancestor
56106477|NCT04456699|Vitamin B Complex|vitamin b complex|mesh-ancestor
56106479|NCT04456699|Micronutrients|micronutrients|mesh-ancestor
56106480|NCT04456699|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56106481|NCT04456699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106482|NCT00385658|Simvastatin|simvastatin|mesh-list
56106483|NCT00385658|Ezetimibe|ezetimibe|mesh-list
56106484|NCT00385658|Fenofibrate|fenofibrate|mesh-list
56106485|NCT00385658|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56106515|NCT00005762|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56106516|NCT00005762|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56106517|NCT00005762|Antitubercular Agents|antitubercular agents|mesh-ancestor
56106518|NCT00005762|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56106519|NCT00005768|Estrogens|estrogens|mesh-list
56106520|NCT00005768|Hormones|hormones|mesh-ancestor
56106521|NCT00005768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106522|NCT00005768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106523|NCT00005774|Pulmonary Surfactants|pulmonary surfactants|mesh-list
56106524|NCT00005774|Respiratory System Agents|respiratory system agents|mesh-ancestor
56106525|NCT00005786|Arsenic Trioxide|arsenic trioxide|mesh-list
56106526|NCT00005786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106527|NCT00005792|Etoposide|etoposide|mesh-list
56106528|NCT00005792|Melphalan|melphalan|mesh-list
56106529|NCT00005792|Topotecan|topotecan|mesh-list
56106530|NCT00005792|Etoposide phosphate|etoposide phosphate|mesh-list
56106531|NCT00005792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56106532|NCT00005792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106533|NCT00005792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56106535|NCT00005792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106536|NCT00005792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106537|NCT00005792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56106538|NCT00005792|Alkylating Agents|alkylating agents|mesh-ancestor
56106539|NCT00005792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56106540|NCT00005792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106541|NCT00005792|Immunologic Factors|immunologic factors|mesh-ancestor
56106542|NCT00005792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106543|NCT00005792|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56106544|NCT00005798|Cyclophosphamide|cyclophosphamide|mesh-list
56106545|NCT00005798|Thiotepa|thiotepa|mesh-list
56106557|NCT00005804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106558|NCT00005804|Immunologic Factors|immunologic factors|mesh-ancestor
56106559|NCT00005804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106560|NCT00005804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106561|NCT00005804|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56106562|NCT00005804|Alkylating Agents|alkylating agents|mesh-ancestor
56106563|NCT00005804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106564|NCT00005804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106565|NCT00005804|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56106567|NCT00005810|Docetaxel|docetaxel|mesh-list
56106568|NCT00005810|Estramustine|estramustine|mesh-list
56106569|NCT00005810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106570|NCT00005810|Tubulin Modulators|tubulin modulators|mesh-ancestor
56106571|NCT00005810|Antimitotic Agents|antimitotic agents|mesh-ancestor
56106572|NCT00005810|Mitosis Modulators|mitosis modulators|mesh-ancestor
56106573|NCT00005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106574|NCT00005810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56106575|NCT00005810|Alkylating Agents|alkylating agents|mesh-ancestor
56106576|NCT00005810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56106577|NCT00385970|Leucovorin|leucovorin|mesh-list
56106578|NCT00385970|polysaccharide-K|polysaccharide-k|mesh-list
56106579|NCT00385970|Tegafur|tegafur|mesh-list
56106580|NCT00385970|Calcium|calcium|mesh-list
56106581|NCT00385970|Levoleucovorin|levoleucovorin|mesh-list
56106582|NCT00385970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56106583|NCT00385970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106584|NCT00385970|Antidotes|antidotes|mesh-ancestor
56106585|NCT00385970|Protective Agents|protective agents|mesh-ancestor
56106586|NCT00385970|Vitamin B Complex|vitamin b complex|mesh-ancestor
56106588|NCT00385970|Micronutrients|micronutrients|mesh-ancestor
56106589|NCT00385970|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56106590|NCT00385970|Antimetabolites|antimetabolites|mesh-ancestor
56106591|NCT00385970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106592|NCT00385970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106593|NCT00385970|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56106594|NCT00385970|Immunologic Factors|immunologic factors|mesh-ancestor
56106595|NCT00385970|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56106596|NCT00385970|Antiviral Agents|antiviral agents|mesh-ancestor
56106597|NCT00385970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106598|NCT00385970|Interferon Inducers|interferon inducers|mesh-ancestor
56106599|NCT00385970|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56106600|NCT05006677|Vitamin K|vitamin k|mesh-list
56106601|NCT05006677|Anticoagulants|anticoagulants|mesh-list
56106602|NCT05006677|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
56106603|NCT05006677|Vitamins|vitamins|mesh-ancestor
56106604|NCT05006677|Micronutrients|micronutrients|mesh-ancestor
56106605|NCT05006677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106606|NCT05006677|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56106607|NCT05006677|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55833615|NCT02081690|Macitentan|macitentan|mesh-list
56106608|NCT05006677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106610|NCT05006677|Coagulants|coagulants|mesh-ancestor
56106611|NCT00386126|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
56106612|NCT00386126|Hematinics|hematinics|mesh-ancestor
56106613|NCT05298085|Oxytocin|oxytocin|mesh-list
56106614|NCT05298085|Oxytocics|oxytocics|mesh-ancestor
56106642|NCT00423163|Micafungin|micafungin|mesh-list
56106643|NCT00423163|Antifungal Agents|antifungal agents|mesh-ancestor
56106644|NCT00423163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106645|NCT00423163|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56106647|NCT00423163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106648|NCT00423163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106649|NCT00423163|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56106650|NCT00423163|Hormone Antagonists|hormone antagonists|mesh-ancestor
56106651|NCT00423163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106652|NCT00423163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106653|NCT00423163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56106654|NCT04379635|Paclitaxel|paclitaxel|mesh-list
56106655|NCT04379635|Carboplatin|carboplatin|mesh-list
56106656|NCT04379635|Pemetrexed|pemetrexed|mesh-list
56106657|NCT04379635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56106658|NCT04379635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106659|NCT04379635|Tubulin Modulators|tubulin modulators|mesh-ancestor
56106660|NCT04379635|Antimitotic Agents|antimitotic agents|mesh-ancestor
56106694|NCT04338061|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56106696|NCT04338061|Analgesics|analgesics|mesh-ancestor
56106697|NCT04338061|Sensory System Agents|sensory system agents|mesh-ancestor
56106698|NCT04338061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106699|NCT04338061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106700|NCT04338061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56106701|NCT04338061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106702|NCT04338061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106703|NCT04338061|Immunologic Factors|immunologic factors|mesh-ancestor
56106704|NCT02210702|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56106710|NCT02210702|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
56106711|NCT02210702|Estrogens|estrogens|mesh-ancestor
56106712|NCT02210702|Hormones|hormones|mesh-ancestor
56106713|NCT02210702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56106714|NCT02210702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106715|NCT02210702|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56106716|NCT02210702|Contraceptive Agents|contraceptive agents|mesh-ancestor
56106717|NCT02210702|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56106718|NCT02210702|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56106719|NCT02210702|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56106720|NCT02210702|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56106742|NCT02278172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106743|NCT02278172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56106744|NCT02278172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56106745|NCT04971031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56106746|NCT04971031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56106747|NCT04566224|Pyrithione zinc|pyrithione zinc|mesh-list
56106748|NCT04566224|Keratolytic Agents|keratolytic agents|mesh-ancestor
56106749|NCT04566224|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106750|NCT02210858|Tipifarnib|tipifarnib|mesh-list
56106751|NCT02210858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106752|NCT04564430|Clonidine|clonidine|mesh-list
56106753|NCT04564430|Analgesics|analgesics|mesh-ancestor
56106754|NCT04564430|Sensory System Agents|sensory system agents|mesh-ancestor
56106755|NCT04564430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106756|NCT04564430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106757|NCT04564430|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56106758|NCT04564430|Sympatholytics|sympatholytics|mesh-ancestor
56106759|NCT04564430|Autonomic Agents|autonomic agents|mesh-ancestor
56106760|NCT04564430|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56106770|NCT04563962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106771|NCT04563962|Sympathomimetics|sympathomimetics|mesh-ancestor
56106772|NCT04563962|Autonomic Agents|autonomic agents|mesh-ancestor
56106773|NCT04563962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106775|NCT04563962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106776|NCT04563962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106777|NCT04563962|Adrenergic Agents|adrenergic agents|mesh-ancestor
56106778|NCT04563962|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56106779|NCT04563962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56106780|NCT04563962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56106781|NCT04563962|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56106783|NCT02211482|Dolutegravir|dolutegravir|mesh-list
56106784|NCT02211482|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56106785|NCT02211482|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56106786|NCT02211482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106787|NCT02211482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106788|NCT02211482|Antiviral Agents|antiviral agents|mesh-ancestor
56106789|NCT02211482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106790|NCT02211482|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56106791|NCT02211482|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56106792|NCT02211482|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56106793|NCT02211482|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56106794|NCT04929847|Emollients|emollients|mesh-list
56106795|NCT04929847|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106796|NCT04561934|Fluorides|fluorides|mesh-list
56106797|NCT04561934|Cariostatic Agents|cariostatic agents|mesh-ancestor
56106798|NCT04561934|Protective Agents|protective agents|mesh-ancestor
56106799|NCT04561934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106800|NCT05252533|Ustekinumab|ustekinumab|mesh-list
56106801|NCT05252533|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106802|NCT03606499|Ustekinumab|ustekinumab|mesh-list
56106803|NCT03606499|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106804|NCT04330495|Hydroxychloroquine|hydroxychloroquine|mesh-list
56106805|NCT04330495|Antimalarials|antimalarials|mesh-ancestor
56106806|NCT04330495|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56106807|NCT04330495|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56106808|NCT04330495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56106809|NCT04330495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106810|NCT04330495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106811|NCT04330495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106812|NCT04181359|Nitric Oxide|nitric oxide|mesh-list
56106813|NCT04181359|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56106814|NCT04181359|Autonomic Agents|autonomic agents|mesh-ancestor
56106815|NCT04181359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106816|NCT04181359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107427|NCT00003001|Vitamins|vitamins|mesh-ancestor
56106823|NCT04181359|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56106824|NCT04181359|Vasodilator Agents|vasodilator agents|mesh-ancestor
56106825|NCT04181359|Gasotransmitters|gasotransmitters|mesh-ancestor
56106826|NCT04181359|Protective Agents|protective agents|mesh-ancestor
56106827|NCT04563260|Palonosetron|palonosetron|mesh-list
56106828|NCT04563260|Antiemetics|antiemetics|mesh-ancestor
56106829|NCT04563260|Autonomic Agents|autonomic agents|mesh-ancestor
56106830|NCT04563260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106831|NCT04563260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106832|NCT04563260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56106833|NCT04563260|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56106834|NCT04563260|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56106835|NCT04563260|Serotonin Agents|serotonin agents|mesh-ancestor
56106836|NCT04563260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106837|NCT04563260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106839|NCT04173793|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56106840|NCT04173793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56106841|NCT04173793|Antimetabolites|antimetabolites|mesh-ancestor
56106844|NCT04561466|Bezafibrate|bezafibrate|mesh-list
56106865|NCT04561856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106867|NCT04909801|Methotrexate|methotrexate|mesh-list
56106868|NCT04909801|Abatacept|abatacept|mesh-list
56106869|NCT04909801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56106870|NCT04909801|Abortifacient Agents|abortifacient agents|mesh-ancestor
56106871|NCT04909801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56106872|NCT04909801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106873|NCT04909801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56106874|NCT04909801|Antimetabolites|antimetabolites|mesh-ancestor
56106875|NCT04909801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106876|NCT04909801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56106877|NCT04909801|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106878|NCT04909801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106879|NCT04909801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56106880|NCT04909801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56106881|NCT04909801|Immunologic Factors|immunologic factors|mesh-ancestor
56106882|NCT04909801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106883|NCT04909801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56106884|NCT04909801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56106885|NCT04909801|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56106886|NCT00382681|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56106888|NCT04173403|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56106889|NCT04173403|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56106890|NCT04173403|Antimetabolites|antimetabolites|mesh-ancestor
56106891|NCT04173403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106892|NCT04173403|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56106893|NCT03539887|Ketamine|ketamine|mesh-list
56106894|NCT03539887|Analgesics|analgesics|mesh-ancestor
56106895|NCT03539887|Sensory System Agents|sensory system agents|mesh-ancestor
56106896|NCT03539887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106897|NCT03539887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106898|NCT03539887|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56106899|NCT03539887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56106900|NCT03539887|Anesthetics, General|anesthetics, general|mesh-ancestor
56106901|NCT03539887|Anesthetics|anesthetics|mesh-ancestor
56106902|NCT03539887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56106903|NCT03539887|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56106904|NCT03539887|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56106905|NCT03539887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56106906|NCT03539887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106907|NCT04123717|Acetaminophen|acetaminophen|mesh-list
56106909|NCT04123717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56106910|NCT04123717|Analgesics|analgesics|mesh-ancestor
56106911|NCT04123717|Sensory System Agents|sensory system agents|mesh-ancestor
56106912|NCT04123717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106913|NCT04123717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106914|NCT04123717|Antipyretics|antipyretics|mesh-ancestor
56106915|NCT04123717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56106916|NCT04123717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56106917|NCT04123717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56106918|NCT04123717|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56106919|NCT04123717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56106920|NCT04123717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106921|NCT03472495|Diltiazem|diltiazem|mesh-list
56106922|NCT03472495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56106923|NCT03472495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56106924|NCT03472495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56106925|NCT03472495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56106926|NCT03472495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56106927|NCT03472495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106928|NCT03472495|Vasodilator Agents|vasodilator agents|mesh-ancestor
56106929|NCT04094701|Analgesics, Opioid|analgesics, opioid|mesh-list
56106930|NCT04094701|Narcotics|narcotics|mesh-ancestor
56106931|NCT04094701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56106932|NCT04094701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106933|NCT04094701|Analgesics|analgesics|mesh-ancestor
56106934|NCT04094701|Sensory System Agents|sensory system agents|mesh-ancestor
56106935|NCT04094701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56106936|NCT03466411|Ustekinumab|ustekinumab|mesh-list
56106937|NCT03466411|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56106938|NCT03466411|Dermatologic Agents|dermatologic agents|mesh-ancestor
56106939|NCT03466411|Immunologic Factors|immunologic factors|mesh-ancestor
56106940|NCT03466411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56106952|NCT04068103|Calcium, Dietary|calcium, dietary|mesh-list
56106953|NCT04068103|Leucovorin|leucovorin|mesh-list
56106954|NCT04068103|Folic Acid|folic acid|mesh-list
56106955|NCT04068103|Fluorouracil|fluorouracil|mesh-list
56107012|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56107013|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107014|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107015|NCT03970447|Temozolomide|temozolomide|mesh-list
56107016|NCT03970447|Lomustine|lomustine|mesh-list
56107017|NCT03970447|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
56107018|NCT03970447|GDC-0084|gdc-0084|mesh-list
56107019|NCT03970447|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107020|NCT03970447|Alkylating Agents|alkylating agents|mesh-ancestor
56107061|NCT03818581|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
56107062|NCT03818581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56107063|NCT03818581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107064|NCT00002905|Zidovudine|zidovudine|mesh-list
56107065|NCT00002905|Didanosine|didanosine|mesh-list
56107066|NCT00002905|Cyclophosphamide|cyclophosphamide|mesh-list
56107067|NCT00002905|Prednimustine|prednimustine|mesh-list
56107068|NCT00002905|Doxorubicin|doxorubicin|mesh-list
56107069|NCT00002905|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56107070|NCT00002905|Etoposide|etoposide|mesh-list
56107071|NCT00002905|Mitoxantrone|mitoxantrone|mesh-list
56107072|NCT00002905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107095|NCT00002905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56107097|NCT00002911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107098|NCT00002911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107119|NCT00383851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107146|NCT02636569|Sensory System Agents|sensory system agents|mesh-ancestor
56107147|NCT02636569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56107148|NCT02636569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107149|NCT02636569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56107150|NCT02636569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107151|NCT02636569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56107152|NCT02636569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107153|NCT02636569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107154|NCT02461927|Midazolam|midazolam|mesh-list
56107155|NCT02461927|Naltrexone|naltrexone|mesh-list
56107227|NCT03693781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107229|NCT02283853|Interferon-beta|interferon-beta|mesh-list
56107230|NCT02283853|Interferon beta-1a|interferon beta-1a|mesh-list
56107231|NCT02283853|Dimethyl Fumarate|dimethyl fumarate|mesh-list
56107232|NCT02283853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107233|NCT02283853|Antiviral Agents|antiviral agents|mesh-ancestor
56107234|NCT02283853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107235|NCT02283853|Dermatologic Agents|dermatologic agents|mesh-ancestor
56107256|NCT03668041|Antimanic Agents|antimanic agents|mesh-ancestor
56107257|NCT03668041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56107258|NCT03668041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56107259|NCT03668041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56107260|NCT03668041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56107261|NCT03668041|Serotonin Agents|serotonin agents|mesh-ancestor
56107262|NCT03668041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56107263|NCT03668041|Antidepressive Agents|antidepressive agents|mesh-ancestor
56107264|NCT00002965|Interferons|interferons|mesh-list
56107265|NCT00002965|Interferon-alpha|interferon-alpha|mesh-list
56107266|NCT00002965|Interferon alpha-2|interferon alpha-2|mesh-list
56107267|NCT00002965|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56107268|NCT00002965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107269|NCT00002965|Antiviral Agents|antiviral agents|mesh-ancestor
56107270|NCT00002965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107271|NCT00002965|Immunologic Factors|immunologic factors|mesh-ancestor
56107272|NCT00002965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107273|NCT00002971|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
56107274|NCT00002971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107305|NCT00003397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107306|NCT00003397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107307|NCT00003397|Immunologic Factors|immunologic factors|mesh-ancestor
56107308|NCT00003397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107309|NCT00003397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107310|NCT00003397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107311|NCT00003397|Alkylating Agents|alkylating agents|mesh-ancestor
56107312|NCT00003397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107313|NCT00003397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56107314|NCT00003397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56107315|NCT00003397|Antiemetics|antiemetics|mesh-ancestor
56107316|NCT00003397|Autonomic Agents|autonomic agents|mesh-ancestor
56107317|NCT00003397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56107318|NCT00003397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56107319|NCT00003397|Glucocorticoids|glucocorticoids|mesh-ancestor
56107321|NCT00003397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107322|NCT00003397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56107323|NCT00003397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107359|NCT00002989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107360|NCT00002989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107361|NCT00002995|Dactinomycin|dactinomycin|mesh-list
56107362|NCT00002995|Cyclophosphamide|cyclophosphamide|mesh-list
56107363|NCT00002995|Vincristine|vincristine|mesh-list
55834368|NCT01846221|Clonidine|clonidine|mesh-list
56107364|NCT00002995|Sargramostim|sargramostim|mesh-list
56107367|NCT00002995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107368|NCT00002995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107369|NCT00002995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107370|NCT00002995|Alkylating Agents|alkylating agents|mesh-ancestor
56107371|NCT00002995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107372|NCT00002995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107373|NCT00002995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107374|NCT00002995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107375|NCT00002995|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107376|NCT00002995|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107377|NCT00002995|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107378|NCT00002995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56107379|NCT00002995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107380|NCT00002995|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107381|NCT00002995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56107382|NCT00002995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107383|NCT00002995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56107384|NCT01925131|Prednisone|prednisone|mesh-list
56107385|NCT01925131|Cyclophosphamide|cyclophosphamide|mesh-list
56107386|NCT01925131|Vincristine|vincristine|mesh-list
56107387|NCT01925131|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
56107404|NCT01925131|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107405|NCT01925131|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107406|NCT01925131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56107407|NCT01925131|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107408|NCT00003001|Leucovorin|leucovorin|mesh-list
56107409|NCT00003001|Gemcitabine|gemcitabine|mesh-list
56107410|NCT00003001|Fluorouracil|fluorouracil|mesh-list
56107411|NCT00003001|Calcium|calcium|mesh-list
56107412|NCT00003001|Levoleucovorin|levoleucovorin|mesh-list
56107413|NCT00003001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107414|NCT00003001|Antimetabolites|antimetabolites|mesh-ancestor
56107415|NCT00003001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107416|NCT00003001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107417|NCT00003001|Antiviral Agents|antiviral agents|mesh-ancestor
56107418|NCT00003001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107419|NCT00003001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107420|NCT00003001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107421|NCT00003001|Immunologic Factors|immunologic factors|mesh-ancestor
56107422|NCT00003001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107423|NCT00003001|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56107424|NCT00003001|Antidotes|antidotes|mesh-ancestor
56107425|NCT00003001|Protective Agents|protective agents|mesh-ancestor
56107426|NCT00003001|Vitamin B Complex|vitamin b complex|mesh-ancestor
56107467|NCT00003439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107468|NCT00003439|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56107469|NCT00003439|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56107470|NCT00003439|Growth Substances|growth substances|mesh-ancestor
56107471|NCT00003439|Growth Inhibitors|growth inhibitors|mesh-ancestor
56107472|NCT00003439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107473|NCT00003007|Interferons|interferons|mesh-list
56107475|NCT00003007|Dexamethasone|dexamethasone|mesh-list
56107476|NCT00003007|Cyclophosphamide|cyclophosphamide|mesh-list
56107477|NCT00003007|Melphalan|melphalan|mesh-list
56107478|NCT00003007|Sargramostim|sargramostim|mesh-list
56107479|NCT00003007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107480|NCT00003007|Immunologic Factors|immunologic factors|mesh-ancestor
56107481|NCT00003007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107482|NCT00003007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107483|NCT00003007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107484|NCT00003007|Alkylating Agents|alkylating agents|mesh-ancestor
56107485|NCT00003007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107486|NCT00003007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107487|NCT00003007|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107504|NCT01478035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107505|NCT01478035|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56107506|NCT01478035|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56107508|NCT00003013|Paclitaxel|paclitaxel|mesh-list
56107509|NCT00003013|Cyclophosphamide|cyclophosphamide|mesh-list
56107510|NCT00003013|Doxorubicin|doxorubicin|mesh-list
56107511|NCT00003013|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56107512|NCT00003013|Fluorouracil|fluorouracil|mesh-list
56107513|NCT00003013|Methotrexate|methotrexate|mesh-list
56107514|NCT00003013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107515|NCT00003013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107516|NCT00003013|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107517|NCT00003013|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107518|NCT00003013|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107519|NCT00003013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107520|NCT00003013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107521|NCT00003013|Immunologic Factors|immunologic factors|mesh-ancestor
56107522|NCT00003013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107523|NCT00003013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107524|NCT00003013|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107525|NCT00003013|Alkylating Agents|alkylating agents|mesh-ancestor
56107526|NCT00003013|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107527|NCT00003013|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107528|NCT00003013|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107529|NCT00003013|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107530|NCT00003013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107531|NCT00003013|Antimetabolites|antimetabolites|mesh-ancestor
56107532|NCT00003013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107533|NCT00003013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56107534|NCT00003013|Abortifacient Agents|abortifacient agents|mesh-ancestor
56107535|NCT00003013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56107536|NCT00003013|Dermatologic Agents|dermatologic agents|mesh-ancestor
56107537|NCT00003013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56107538|NCT00003013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56107540|NCT00003013|Hormone Antagonists|hormone antagonists|mesh-ancestor
56107541|NCT00003013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107542|NCT00003013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56107543|NCT00003013|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56107544|NCT00003013|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56107545|NCT00003013|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56107546|NCT00003445|Docetaxel|docetaxel|mesh-list
56107547|NCT00003445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107548|NCT00003445|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107549|NCT00003445|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107550|NCT00003445|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107551|NCT00003445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107552|NCT00003451|Interferons|interferons|mesh-list
56107553|NCT00003451|Interferon-alpha|interferon-alpha|mesh-list
56107554|NCT00003451|Interleukin-12|interleukin-12|mesh-list
56107555|NCT00003451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107556|NCT00003451|Antiviral Agents|antiviral agents|mesh-ancestor
56107557|NCT00003451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107558|NCT00003451|Immunologic Factors|immunologic factors|mesh-ancestor
56107559|NCT00003451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108144|NCT00002887|Vindesine|vindesine|mesh-list
56107560|NCT00003451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56107561|NCT00003451|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56107562|NCT00003451|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56107563|NCT00003451|Growth Substances|growth substances|mesh-ancestor
56107564|NCT00003451|Growth Inhibitors|growth inhibitors|mesh-ancestor
56107565|NCT00003463|Irinotecan|irinotecan|mesh-list
56107566|NCT00003463|Carmustine|carmustine|mesh-list
56107567|NCT00003463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56107568|NCT00003463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107569|NCT00003463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107570|NCT00003463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107571|NCT00003463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107573|NCT00003463|Alkylating Agents|alkylating agents|mesh-ancestor
56107580|NCT00003019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107581|NCT00003019|Antimetabolites|antimetabolites|mesh-ancestor
56107582|NCT00003019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107583|NCT00003019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107584|NCT00003019|Dermatologic Agents|dermatologic agents|mesh-ancestor
56107585|NCT00003019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107586|NCT00003019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56107587|NCT00003019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107588|NCT00003019|Immunologic Factors|immunologic factors|mesh-ancestor
56107589|NCT00003019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107590|NCT00003019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56107591|NCT00003019|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107592|NCT00003019|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107593|NCT00003019|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107594|NCT00003019|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107596|NCT01120249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107597|NCT01120249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107598|NCT01120249|Immunologic Factors|immunologic factors|mesh-ancestor
56107599|NCT01120249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107600|NCT00003493|Dexamethasone|dexamethasone|mesh-list
56107601|NCT00003493|Doxorubicin|doxorubicin|mesh-list
56107602|NCT00003493|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56107603|NCT00003493|Vincristine|vincristine|mesh-list
56107604|NCT00003493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56107605|NCT00003493|Antiemetics|antiemetics|mesh-ancestor
56107606|NCT00003493|Autonomic Agents|autonomic agents|mesh-ancestor
56107607|NCT00003493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56107608|NCT00003493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107627|NCT00788125|Ifosfamide|ifosfamide|mesh-list
56107628|NCT00788125|Etoposide phosphate|etoposide phosphate|mesh-list
56107629|NCT00788125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107630|NCT00788125|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107631|NCT00788125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107632|NCT00788125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107633|NCT00788125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107634|NCT00788125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107635|NCT00788125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56107636|NCT00788125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107637|NCT00788125|Alkylating Agents|alkylating agents|mesh-ancestor
56107638|NCT00003031|Voriconazole|voriconazole|mesh-list
56107639|NCT00003031|Amphotericin B|amphotericin b|mesh-list
56107640|NCT00003031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56107641|NCT00003031|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
56107642|NCT00003031|Deoxycholic Acid|deoxycholic acid|mesh-list
56107643|NCT00003031|Antifungal Agents|antifungal agents|mesh-ancestor
56107644|NCT00003031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107645|NCT00003031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56107646|NCT00003031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56107647|NCT00003031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107648|NCT00003031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107649|NCT00003031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56107650|NCT00003031|Hormone Antagonists|hormone antagonists|mesh-ancestor
56107651|NCT00003031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107652|NCT00003031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107653|NCT00003031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56107654|NCT00003031|Amebicides|amebicides|mesh-ancestor
56107655|NCT00003031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56107656|NCT00003031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56107657|NCT00003031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56107658|NCT00003031|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56107660|NCT00003517|Leuprolide|leuprolide|mesh-list
56107665|NCT00003517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107666|NCT00003517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107667|NCT00003517|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56107668|NCT00003517|Fertility Agents|fertility agents|mesh-ancestor
56107669|NCT00003517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56107670|NCT00003517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56107671|NCT00003517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107672|NCT00003517|Hormone Antagonists|hormone antagonists|mesh-ancestor
56107673|NCT00003037|Gemcitabine|gemcitabine|mesh-list
56107674|NCT00003037|Docetaxel|docetaxel|mesh-list
56107675|NCT00003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107676|NCT00003037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107677|NCT00003037|Antimetabolites|antimetabolites|mesh-ancestor
56107678|NCT00003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107679|NCT00003037|Antiviral Agents|antiviral agents|mesh-ancestor
56107680|NCT00003037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107681|NCT00003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107682|NCT00003037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107683|NCT00003037|Immunologic Factors|immunologic factors|mesh-ancestor
56107684|NCT00003037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107689|NCT00002803|Doxorubicin|doxorubicin|mesh-list
56107717|NCT00383929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56107718|NCT00383929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107719|NCT00383929|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56107720|NCT00383929|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56107722|NCT00003541|Cyclophosphamide|cyclophosphamide|mesh-list
56107723|NCT00003541|Ifosfamide|ifosfamide|mesh-list
56107724|NCT00003541|Carboplatin|carboplatin|mesh-list
56107725|NCT00003541|Doxorubicin|doxorubicin|mesh-list
56107726|NCT00003541|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56107727|NCT00003541|Etoposide|etoposide|mesh-list
56107728|NCT00003541|Vincristine|vincristine|mesh-list
56107729|NCT00003541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107730|NCT00003541|Immunologic Factors|immunologic factors|mesh-ancestor
56107731|NCT00003541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107732|NCT00003541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107733|NCT00003541|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107734|NCT00003541|Alkylating Agents|alkylating agents|mesh-ancestor
56107735|NCT00003541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107736|NCT00003541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107772|NCT00002809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56107773|NCT00002809|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107774|NCT00002809|Antimetabolites|antimetabolites|mesh-ancestor
56107775|NCT00002809|Dermatologic Agents|dermatologic agents|mesh-ancestor
56107776|NCT00002809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107777|NCT00002809|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56107778|NCT00002809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56107779|NCT00002809|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56107780|NCT00383539|Vaccines|vaccines|mesh-list
56107781|NCT00383539|Immunologic Factors|immunologic factors|mesh-ancestor
56107782|NCT00383539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107783|NCT00002827|Cobalt|cobalt|mesh-list
56107784|NCT00002827|Doxorubicin|doxorubicin|mesh-list
56107785|NCT00002827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56107786|NCT00002827|Bleomycin|bleomycin|mesh-list
56107787|NCT00002827|Etoposide|etoposide|mesh-list
56107788|NCT00002827|Dexrazoxane|dexrazoxane|mesh-list
56107789|NCT00002827|Vincristine|vincristine|mesh-list
56107790|NCT00002827|Razoxane|razoxane|mesh-list
56107791|NCT00002827|Lenograstim|lenograstim|mesh-list
56107792|NCT00002827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107793|NCT00002827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107794|NCT00002827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107795|NCT00002827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107796|NCT00002827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107797|NCT00002827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107798|NCT00002827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107799|NCT00002827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56107800|NCT00002827|Immunologic Factors|immunologic factors|mesh-ancestor
56107801|NCT00002827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107802|NCT00002827|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107819|NCT00003565|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107820|NCT00003565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107821|NCT00003049|Leucovorin|leucovorin|mesh-list
56107822|NCT00003049|Fluorouracil|fluorouracil|mesh-list
56107823|NCT00003049|Calcium|calcium|mesh-list
56107824|NCT00003049|Levoleucovorin|levoleucovorin|mesh-list
56107825|NCT00003049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56107826|NCT00003049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107827|NCT00003049|Antimetabolites|antimetabolites|mesh-ancestor
56107828|NCT00003049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107829|NCT00003049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107830|NCT00003049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107831|NCT00003049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107832|NCT00003049|Immunologic Factors|immunologic factors|mesh-ancestor
56107833|NCT00003049|Antidotes|antidotes|mesh-ancestor
56107834|NCT00003049|Protective Agents|protective agents|mesh-ancestor
56107835|NCT00003049|Vitamin B Complex|vitamin b complex|mesh-ancestor
56107836|NCT00003049|Vitamins|vitamins|mesh-ancestor
56107837|NCT00003049|Micronutrients|micronutrients|mesh-ancestor
56107838|NCT00003055|Irinotecan|irinotecan|mesh-list
56107839|NCT00003055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107840|NCT00003055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56107841|NCT00003055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107842|NCT00003055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107843|NCT00003055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107844|NCT00002833|Cytarabine|cytarabine|mesh-list
56107845|NCT00002833|Cyclosporine|cyclosporine|mesh-list
56107846|NCT00002833|Methylprednisolone|methylprednisolone|mesh-list
56107847|NCT00002833|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56107866|NCT00002833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107867|NCT00002833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107868|NCT00002833|Antifungal Agents|antifungal agents|mesh-ancestor
56107869|NCT00002833|Dermatologic Agents|dermatologic agents|mesh-ancestor
56107870|NCT00002833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107871|NCT00002833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56107872|NCT00002833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56107873|NCT00002833|Antiemetics|antiemetics|mesh-ancestor
56107874|NCT00002833|Autonomic Agents|autonomic agents|mesh-ancestor
56107875|NCT00002833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56107876|NCT00002833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56107877|NCT00002833|Glucocorticoids|glucocorticoids|mesh-ancestor
56107878|NCT00002833|Hormones|hormones|mesh-ancestor
56107879|NCT00002833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56107880|NCT00002833|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56107881|NCT00002833|Protective Agents|protective agents|mesh-ancestor
56107882|NCT00002833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56107883|NCT00002833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56107884|NCT00002833|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107885|NCT00002833|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107886|NCT00003061|Cytarabine|cytarabine|mesh-list
56107887|NCT00003061|Methotrexate|methotrexate|mesh-list
56107888|NCT00003061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56107889|NCT00003061|Abortifacient Agents|abortifacient agents|mesh-ancestor
56107890|NCT00003061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56107891|NCT00003061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107892|NCT00003061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107893|NCT00003061|Antimetabolites|antimetabolites|mesh-ancestor
56107894|NCT00003061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107908|NCT00003577|Epirubicin|epirubicin|mesh-list
56107911|NCT00003577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107912|NCT00003577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56107913|NCT00003577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56107914|NCT00003577|Alkylating Agents|alkylating agents|mesh-ancestor
56107915|NCT00003577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107916|NCT00003577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107917|NCT00003577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56107918|NCT00003577|Antimetabolites|antimetabolites|mesh-ancestor
56107919|NCT00003577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107920|NCT00003577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56107921|NCT00003577|Abortifacient Agents|abortifacient agents|mesh-ancestor
56107922|NCT00003577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56107923|NCT00003577|Dermatologic Agents|dermatologic agents|mesh-ancestor
56107924|NCT00003577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107925|NCT00003577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56107926|NCT00003577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56107928|NCT00003577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56107929|NCT00003577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56107931|NCT00002839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107932|NCT00002839|Antimetabolites|antimetabolites|mesh-ancestor
56107960|NCT00003067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107962|NCT00003589|Paclitaxel|paclitaxel|mesh-list
56107963|NCT00003589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56107964|NCT00003589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56107965|NCT00003589|Tubulin Modulators|tubulin modulators|mesh-ancestor
56107966|NCT00003589|Antimitotic Agents|antimitotic agents|mesh-ancestor
56107967|NCT00003589|Mitosis Modulators|mitosis modulators|mesh-ancestor
56107968|NCT00003589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56107969|NCT00003589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56107970|NCT00003589|Antimetabolites|antimetabolites|mesh-ancestor
56107971|NCT00003589|Antiviral Agents|antiviral agents|mesh-ancestor
56107972|NCT00003589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56107973|NCT00003589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56107974|NCT00003589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56107976|NCT00003589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56107977|NCT00003595|Prednisone|prednisone|mesh-list
56107978|NCT00003595|Cyclophosphamide|cyclophosphamide|mesh-list
56107979|NCT00003595|Rituximab|rituximab|mesh-list
56107980|NCT00003595|Doxorubicin|doxorubicin|mesh-list
56108017|NCT00003079|Bryostatin 1|bryostatin 1|mesh-list
56108018|NCT00003079|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108019|NCT00003079|Antimetabolites|antimetabolites|mesh-ancestor
56108020|NCT00003079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108021|NCT00003079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108022|NCT00003079|Antiviral Agents|antiviral agents|mesh-ancestor
56108023|NCT00003079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108024|NCT00003079|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108025|NCT00003079|Immunologic Factors|immunologic factors|mesh-ancestor
56108026|NCT00003079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108027|NCT00003079|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56108028|NCT00003601|Tretinoin|tretinoin|mesh-list
56108029|NCT00003601|Fenretinide|fenretinide|mesh-list
56108030|NCT00003601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108031|NCT00003601|Keratolytic Agents|keratolytic agents|mesh-ancestor
56108032|NCT00003601|Dermatologic Agents|dermatologic agents|mesh-ancestor
56108033|NCT00003601|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56108034|NCT00003601|Protective Agents|protective agents|mesh-ancestor
56108035|NCT00003601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108036|NCT00002869|Interferons|interferons|mesh-list
56108037|NCT00002869|Cytarabine|cytarabine|mesh-list
56108038|NCT00002869|Interferon-alpha|interferon-alpha|mesh-list
56108039|NCT00002869|Hydroxyurea|hydroxyurea|mesh-list
56108040|NCT00002869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108041|NCT00002869|Antiviral Agents|antiviral agents|mesh-ancestor
56108042|NCT00002869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108043|NCT00002869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108044|NCT00002869|Antimetabolites|antimetabolites|mesh-ancestor
56108085|NCT00002881|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56108086|NCT00002881|Fertility Agents|fertility agents|mesh-ancestor
56108087|NCT00002881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56108088|NCT00002881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108089|NCT00002881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56108090|NCT00002881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108091|NCT00002881|Androgen Antagonists|androgen antagonists|mesh-ancestor
56108092|NCT00002881|Hormone Antagonists|hormone antagonists|mesh-ancestor
56108093|NCT00002881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56108094|NCT00002881|Antinematodal Agents|antinematodal agents|mesh-ancestor
56108095|NCT00002881|Anthelmintics|anthelmintics|mesh-ancestor
56108096|NCT00002881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56108097|NCT00002881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108098|NCT00002881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56108099|NCT00002881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56108100|NCT00003091|Interferons|interferons|mesh-list
56108101|NCT00003091|Interferon-alpha|interferon-alpha|mesh-list
56108102|NCT00003091|Aldesleukin|aldesleukin|mesh-list
56108103|NCT00003091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108129|NCT00003619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108130|NCT00003619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108131|NCT00003619|Antiviral Agents|antiviral agents|mesh-ancestor
56108132|NCT00003619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108133|NCT00003619|Alkylating Agents|alkylating agents|mesh-ancestor
56108134|NCT00003619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108135|NCT00003619|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108136|NCT00003619|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56108137|NCT00003619|Antioxidants|antioxidants|mesh-ancestor
56108138|NCT00003619|Protective Agents|protective agents|mesh-ancestor
56108139|NCT00003619|Dermatologic Agents|dermatologic agents|mesh-ancestor
56108140|NCT00002887|Etoposide|etoposide|mesh-list
56108141|NCT00002887|Vinorelbine|vinorelbine|mesh-list
56108142|NCT00002887|Hydroxyurea|hydroxyurea|mesh-list
56108143|NCT00002887|Vinblastine|vinblastine|mesh-list
56108145|NCT00002887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108146|NCT00002887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108147|NCT00002887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108148|NCT00002887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108149|NCT00002887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108150|NCT00002887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108151|NCT00002887|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108152|NCT00002887|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108153|NCT00002887|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108154|NCT00002887|Antisickling Agents|antisickling agents|mesh-ancestor
56108155|NCT00002887|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56108156|NCT00003937|Cisplatin|cisplatin|mesh-list
56108157|NCT00003937|Doxorubicin|doxorubicin|mesh-list
56108158|NCT00003937|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56108174|NCT00003937|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108175|NCT00003937|Antimetabolites|antimetabolites|mesh-ancestor
56108176|NCT00003937|Dermatologic Agents|dermatologic agents|mesh-ancestor
56108215|NCT00003637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108216|NCT00003637|Immunologic Factors|immunologic factors|mesh-ancestor
56108217|NCT00003637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108219|NCT00003943|Cyclophosphamide|cyclophosphamide|mesh-list
56108220|NCT00003943|Carboplatin|carboplatin|mesh-list
56108221|NCT00003943|Topotecan|topotecan|mesh-list
56108222|NCT00003943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108223|NCT00003943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108224|NCT00003943|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108225|NCT00003943|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108226|NCT00003943|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108227|NCT00003943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108228|NCT00003943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108229|NCT00003943|Immunologic Factors|immunologic factors|mesh-ancestor
56108230|NCT00003943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108231|NCT00003943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108232|NCT00003943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108233|NCT00003943|Alkylating Agents|alkylating agents|mesh-ancestor
56108234|NCT00003943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108235|NCT00003943|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56108236|NCT00003943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108237|NCT00003943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108238|NCT00003955|Dactinomycin|dactinomycin|mesh-list
56108239|NCT00003955|Cyclophosphamide|cyclophosphamide|mesh-list
56108240|NCT00003955|Irinotecan|irinotecan|mesh-list
56108241|NCT00003955|Vincristine|vincristine|mesh-list
56108265|NCT00003103|Oblimersen|oblimersen|mesh-list
56108266|NCT00003103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108267|NCT00003103|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108268|NCT00003103|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108269|NCT00003103|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108270|NCT00003103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108271|NCT00003109|Irinotecan|irinotecan|mesh-list
56108272|NCT00003109|Raltitrexed|raltitrexed|mesh-list
56108273|NCT00003109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56108274|NCT00003109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108275|NCT00003109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108276|NCT00003109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108277|NCT00003109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108278|NCT00003109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108280|NCT00003109|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56108281|NCT00003643|Paclitaxel|paclitaxel|mesh-list
56108282|NCT00003643|Etoposide|etoposide|mesh-list
56108283|NCT00003643|Bleomycin|bleomycin|mesh-list
56108284|NCT00003643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108285|NCT00003643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108286|NCT00003643|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108287|NCT00003643|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108288|NCT00003643|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108289|NCT00003643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108290|NCT00003643|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108291|NCT00003643|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108292|NCT00003643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108293|NCT00003643|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56108310|NCT00003661|Dermatologic Agents|dermatologic agents|mesh-ancestor
56108311|NCT00003661|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108312|NCT00003661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56108313|NCT00003661|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56108314|NCT00003661|Antiemetics|antiemetics|mesh-ancestor
56108315|NCT00003661|Autonomic Agents|autonomic agents|mesh-ancestor
56108316|NCT00003661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56108317|NCT00003661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56108318|NCT00003661|Glucocorticoids|glucocorticoids|mesh-ancestor
56108319|NCT00003661|Hormones|hormones|mesh-ancestor
56108320|NCT00003661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56108321|NCT00003661|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56108322|NCT00003661|Protective Agents|protective agents|mesh-ancestor
56108323|NCT00003661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108324|NCT00003661|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108325|NCT00003661|Alkylating Agents|alkylating agents|mesh-ancestor
56108326|NCT00003661|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108327|NCT00003967|Etoposide|etoposide|mesh-list
56108328|NCT00003967|Topotecan|topotecan|mesh-list
56108329|NCT00003967|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108330|NCT00003967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108331|NCT00003967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108332|NCT00003967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108333|NCT00003967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108334|NCT00003967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108335|NCT00003967|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56108336|NCT00003115|Hydromorphone|hydromorphone|mesh-list
56108337|NCT00003115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56108338|NCT00003115|Narcotics|narcotics|mesh-ancestor
56108349|NCT00003667|Razoxane|razoxane|mesh-list
56108357|NCT00003667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108358|NCT00003667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108359|NCT00003667|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108360|NCT00003667|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56108361|NCT00003667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108362|NCT00003667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108363|NCT00003667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108364|NCT00003667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108365|NCT00003667|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108366|NCT00003667|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108367|NCT00003667|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108368|NCT00003667|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56108369|NCT00003667|Protective Agents|protective agents|mesh-ancestor
56108370|NCT00003667|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56108372|NCT00003673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56108373|NCT00003673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108374|NCT00003679|Tamoxifen|tamoxifen|mesh-list
56108375|NCT00003679|Cyclophosphamide|cyclophosphamide|mesh-list
56108376|NCT00003679|Docetaxel|docetaxel|mesh-list
56108377|NCT00003679|Doxorubicin|doxorubicin|mesh-list
56108378|NCT00003679|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56108379|NCT00003679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108380|NCT00003679|Immunologic Factors|immunologic factors|mesh-ancestor
56108408|NCT00384553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56108409|NCT00384553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108410|NCT00384553|Immunologic Factors|immunologic factors|mesh-ancestor
56108411|NCT00384553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108412|NCT00384553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108413|NCT00003991|Aldesleukin|aldesleukin|mesh-list
56108414|NCT00003991|Histamine|histamine|mesh-list
56108415|NCT00003991|Histamine phosphate|histamine phosphate|mesh-list
56108416|NCT00003991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108417|NCT00003991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56108418|NCT00003991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56108419|NCT00003991|Antiviral Agents|antiviral agents|mesh-ancestor
56108420|NCT00003991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108421|NCT00003991|Histamine Agonists|histamine agonists|mesh-ancestor
56108422|NCT00003991|Histamine Agents|histamine agents|mesh-ancestor
56108423|NCT00003991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56108424|NCT00003991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108425|NCT00003991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108426|NCT00003997|Irofulven|irofulven|mesh-list
56108427|NCT00003997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108428|NCT00003997|Alkylating Agents|alkylating agents|mesh-ancestor
56108429|NCT00003997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108459|NCT00004003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108460|NCT00004003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108461|NCT00004003|Immunologic Factors|immunologic factors|mesh-ancestor
56108462|NCT00004003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108463|NCT00004009|Tipifarnib|tipifarnib|mesh-list
56108464|NCT00004009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108465|NCT00003133|Gemcitabine|gemcitabine|mesh-list
56108466|NCT00003133|Paclitaxel|paclitaxel|mesh-list
56108469|NCT00003133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108470|NCT00003133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108471|NCT00003133|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108472|NCT00003133|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108473|NCT00003133|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108474|NCT00003133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108475|NCT00003133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108476|NCT00003133|Antimetabolites|antimetabolites|mesh-ancestor
56108477|NCT00003133|Antiviral Agents|antiviral agents|mesh-ancestor
56108478|NCT00003133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108479|NCT00003133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108480|NCT00003133|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108481|NCT00003133|Immunologic Factors|immunologic factors|mesh-ancestor
56108482|NCT00003133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108483|NCT00003133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56108484|NCT00003133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108510|NCT00003697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108511|NCT02972983|Daptomycin|daptomycin|mesh-list
56108512|NCT02972983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56108513|NCT02972983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108514|NCT00003709|Carbendazim|carbendazim|mesh-list
56108515|NCT00003709|Antinematodal Agents|antinematodal agents|mesh-ancestor
56108516|NCT00003709|Anthelmintics|anthelmintics|mesh-ancestor
56108517|NCT00003709|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56108518|NCT00003709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108519|NCT00003145|Cyclosporine|cyclosporine|mesh-list
56108520|NCT00003145|Mycophenolic Acid|mycophenolic acid|mesh-list
56108521|NCT00003145|Fludarabine|fludarabine|mesh-list
56108522|NCT00003145|Fludarabine phosphate|fludarabine phosphate|mesh-list
56108523|NCT00003145|Cyclosporins|cyclosporins|mesh-list
56108524|NCT00003145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108525|NCT00003145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108527|NCT00003145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108528|NCT00003145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108529|NCT00003145|Immunologic Factors|immunologic factors|mesh-ancestor
56108530|NCT00003145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108531|NCT00003145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108532|NCT00003145|Antifungal Agents|antifungal agents|mesh-ancestor
56108533|NCT00003145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108534|NCT00003145|Dermatologic Agents|dermatologic agents|mesh-ancestor
56108535|NCT00003145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108536|NCT00003145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56108543|NCT00004039|Prednisone|prednisone|mesh-list
56108560|NCT00004039|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108561|NCT00004039|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108562|NCT00004039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108563|NCT00004039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56108564|NCT00004039|Glucocorticoids|glucocorticoids|mesh-ancestor
56108566|NCT00004039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56108567|NCT00004039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56108568|NCT00004039|Antiviral Agents|antiviral agents|mesh-ancestor
56108569|NCT00004039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108570|NCT00004039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108571|NCT00004039|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108572|NCT00004039|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108573|NCT00004039|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108574|NCT00003151|Amoxicillin|amoxicillin|mesh-list
56108576|NCT00003151|Clarithromycin|clarithromycin|mesh-list
56108577|NCT00003151|Tetracycline|tetracycline|mesh-list
56108578|NCT00003151|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56108579|NCT00003151|Omeprazole|omeprazole|mesh-list
56108580|NCT00003151|Bismuth|bismuth|mesh-list
56108581|NCT00003151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56108582|NCT00003151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108583|NCT00003151|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56108584|NCT00003151|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56108585|NCT00003151|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56108586|NCT00003151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56108587|NCT00003151|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56108588|NCT00003151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108589|NCT00003151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108590|NCT00003151|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56108605|NCT00003715|Immunologic Factors|immunologic factors|mesh-ancestor
56108606|NCT00003715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108607|NCT00003715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108608|NCT00003715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108609|NCT00003715|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108611|NCT00003715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108612|NCT00003715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108613|NCT00003715|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108614|NCT00003715|Antiviral Agents|antiviral agents|mesh-ancestor
56108615|NCT00003715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108616|NCT00003715|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56108617|NCT00004051|Irinotecan|irinotecan|mesh-list
56108618|NCT00004051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56108619|NCT00004051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108620|NCT00004051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108621|NCT00004051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108622|NCT00004051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108623|NCT00003727|Gemcitabine|gemcitabine|mesh-list
56108624|NCT00003727|Interferons|interferons|mesh-list
56108625|NCT00003727|Interferon-alpha|interferon-alpha|mesh-list
56108626|NCT00003727|Cyclophosphamide|cyclophosphamide|mesh-list
56108627|NCT00003727|Melphalan|melphalan|mesh-list
56108628|NCT00003727|Carmustine|carmustine|mesh-list
56108629|NCT00003727|Etoposide|etoposide|mesh-list
56108630|NCT00003727|Sargramostim|sargramostim|mesh-list
56108631|NCT00003727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108654|NCT00003157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108655|NCT00003157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108656|NCT00003157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108657|NCT00003157|Immunologic Factors|immunologic factors|mesh-ancestor
56108658|NCT00003157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108659|NCT00004057|Paclitaxel|paclitaxel|mesh-list
56108660|NCT00004057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108661|NCT00004057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108662|NCT00004057|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108663|NCT00004057|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108664|NCT00004057|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108665|NCT00004057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108666|NCT00004063|Gemcitabine|gemcitabine|mesh-list
56108670|NCT00004063|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108671|NCT00004063|Antimetabolites|antimetabolites|mesh-ancestor
56108672|NCT00004063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108673|NCT00004063|Antiviral Agents|antiviral agents|mesh-ancestor
56108674|NCT00004063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108675|NCT00004063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108676|NCT00004063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108677|NCT00004063|Immunologic Factors|immunologic factors|mesh-ancestor
56108678|NCT00004063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108680|NCT00003733|Carboplatin|carboplatin|mesh-list
56108681|NCT00003733|Topotecan|topotecan|mesh-list
56108682|NCT00003733|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108683|NCT00003733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108684|NCT00003733|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108685|NCT00003733|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108686|NCT00003733|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108687|NCT00003733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108688|NCT00003733|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56108689|NCT00003733|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108690|NCT00003733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108692|NCT00003739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56108693|NCT00003739|Immunologic Factors|immunologic factors|mesh-ancestor
56108694|NCT00003739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108695|NCT00003745|Topotecan|topotecan|mesh-list
56108696|NCT00003745|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56108697|NCT00003745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108698|NCT00003745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108699|NCT00003745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108700|NCT00003745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108701|NCT00003163|Cyclophosphamide|cyclophosphamide|mesh-list
56108702|NCT00003163|Melphalan|melphalan|mesh-list
56108703|NCT00003163|Sargramostim|sargramostim|mesh-list
56108704|NCT00003163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108705|NCT00003163|Immunologic Factors|immunologic factors|mesh-ancestor
56108706|NCT00003163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108707|NCT00003163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108708|NCT00003163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108709|NCT00003163|Alkylating Agents|alkylating agents|mesh-ancestor
56108710|NCT00003163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108711|NCT00003163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108712|NCT00003163|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108741|NCT00003175|Antimetabolites|antimetabolites|mesh-ancestor
56108742|NCT00003175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108743|NCT00003175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108744|NCT00003175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108745|NCT00003175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108746|NCT00003175|Immunologic Factors|immunologic factors|mesh-ancestor
56108747|NCT00003175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108749|NCT00004099|Fluorouracil|fluorouracil|mesh-list
56108750|NCT00004099|Calcium|calcium|mesh-list
56108751|NCT00004099|Levoleucovorin|levoleucovorin|mesh-list
56108752|NCT00004099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108753|NCT00004099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56108754|NCT00004099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108755|NCT00004099|Antimetabolites|antimetabolites|mesh-ancestor
56108756|NCT00004099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108757|NCT00004099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108758|NCT00004099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108759|NCT00004099|Immunologic Factors|immunologic factors|mesh-ancestor
56108760|NCT00004099|Antidotes|antidotes|mesh-ancestor
56108761|NCT00004099|Protective Agents|protective agents|mesh-ancestor
56108762|NCT00004099|Vitamin B Complex|vitamin b complex|mesh-ancestor
56108763|NCT00004099|Vitamins|vitamins|mesh-ancestor
56108764|NCT00004099|Micronutrients|micronutrients|mesh-ancestor
56108765|NCT00003763|Folic Acid|folic acid|mesh-list
56108792|NCT00004105|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108793|NCT00004105|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108794|NCT00004105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108795|NCT00004105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108796|NCT00004105|Alkylating Agents|alkylating agents|mesh-ancestor
56108797|NCT00004105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56108799|NCT00003187|Cyclosporine|cyclosporine|mesh-list
56108800|NCT00003187|Methylprednisolone|methylprednisolone|mesh-list
56108801|NCT00003187|Cyclophosphamide|cyclophosphamide|mesh-list
56108802|NCT00003187|Methotrexate|methotrexate|mesh-list
56108803|NCT00003187|Cyclosporins|cyclosporins|mesh-list
56108804|NCT00003187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108805|NCT00003187|Immunologic Factors|immunologic factors|mesh-ancestor
56108806|NCT00003187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108807|NCT00003187|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56108808|NCT00003187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108809|NCT00003187|Alkylating Agents|alkylating agents|mesh-ancestor
56108810|NCT00003187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108811|NCT00003187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108812|NCT00003187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56108813|NCT00003187|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56108814|NCT00003187|Abortifacient Agents|abortifacient agents|mesh-ancestor
56108815|NCT00003187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56108816|NCT00003187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108817|NCT00003187|Antimetabolites|antimetabolites|mesh-ancestor
56108818|NCT00003187|Dermatologic Agents|dermatologic agents|mesh-ancestor
56108819|NCT00003187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108840|NCT00003775|Leflunomide|leflunomide|mesh-list
56108841|NCT00003775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108842|NCT00003775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108843|NCT00003775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108844|NCT00003775|Immunologic Factors|immunologic factors|mesh-ancestor
56108845|NCT00003775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108846|NCT00004123|Doxorubicin|doxorubicin|mesh-list
56108847|NCT00004123|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56108848|NCT00004123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56108849|NCT00004123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108850|NCT00004123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56108851|NCT00004123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108852|NCT00004123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108853|NCT00004123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108854|NCT00003781|Docetaxel|docetaxel|mesh-list
56108855|NCT00003781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108856|NCT00003781|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108857|NCT00003781|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108858|NCT00003781|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108859|NCT00003781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108860|NCT00003193|Paclitaxel|paclitaxel|mesh-list
56108861|NCT00003193|Amifostine|amifostine|mesh-list
56108862|NCT00003193|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108863|NCT00003193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108883|NCT00004135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108888|NCT00004141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108889|NCT00004141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56108890|NCT00004141|Alkylating Agents|alkylating agents|mesh-ancestor
56108891|NCT00004141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108892|NCT00004141|Immunologic Factors|immunologic factors|mesh-ancestor
56108893|NCT00004141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108894|NCT02972905|Nemiralisib|nemiralisib|mesh-list
56108895|NCT02972905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56108896|NCT02972905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108897|NCT02972905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108899|NCT00003799|Fluorouracil|fluorouracil|mesh-list
56108900|NCT00003799|Oxaliplatin|oxaliplatin|mesh-list
56108901|NCT00003799|Calcium|calcium|mesh-list
56108902|NCT00003799|Levoleucovorin|levoleucovorin|mesh-list
56108903|NCT00003799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56108904|NCT00003799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108905|NCT00003799|Antimetabolites|antimetabolites|mesh-ancestor
56108906|NCT00003799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108907|NCT00003799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108908|NCT00003799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108909|NCT00003799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108933|NCT00003211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108934|NCT00003211|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108935|NCT00003211|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108936|NCT00003211|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108937|NCT00003211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56108938|NCT00003211|Protective Agents|protective agents|mesh-ancestor
56108939|NCT00003805|Vancomycin|vancomycin|mesh-list
56108940|NCT00003805|Tazobactam|tazobactam|mesh-list
56108941|NCT00003805|Piperacillin|piperacillin|mesh-list
56108942|NCT00003805|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56108943|NCT00003805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56108944|NCT00003805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108945|NCT00003805|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56108950|NCT00004159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108951|NCT00004159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108952|NCT00004159|Tubulin Modulators|tubulin modulators|mesh-ancestor
56108953|NCT00004159|Antimitotic Agents|antimitotic agents|mesh-ancestor
56108954|NCT00004159|Mitosis Modulators|mitosis modulators|mesh-ancestor
56108955|NCT00004159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108956|NCT00004159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56108957|NCT00004159|Antimetabolites|antimetabolites|mesh-ancestor
56108958|NCT00004159|Antiviral Agents|antiviral agents|mesh-ancestor
56108959|NCT00004159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56108960|NCT00004159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108961|NCT00004159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56108962|NCT00004159|Immunologic Factors|immunologic factors|mesh-ancestor
56108963|NCT00004159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108964|NCT00003811|Etoposide|etoposide|mesh-list
56108965|NCT00003811|Bleomycin|bleomycin|mesh-list
56108966|NCT00003811|Amifostine|amifostine|mesh-list
56108967|NCT00003811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108968|NCT00003811|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56108969|NCT00003811|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55835939|NCT02098733|Pioglitazone|pioglitazone|mesh-list
56108970|NCT00003811|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56108971|NCT00003811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56108972|NCT00003811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56108973|NCT00003811|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56108974|NCT00003811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56108975|NCT00003811|Protective Agents|protective agents|mesh-ancestor
56108976|NCT00003811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108977|NCT00004177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56108979|NCT00004177|Immunoglobulins|immunoglobulins|mesh-list
56108980|NCT00004177|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56108981|NCT00004177|Immunologic Factors|immunologic factors|mesh-ancestor
56108982|NCT00004177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56108983|NCT00004177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56108984|NCT00003817|Ondansetron|ondansetron|mesh-list
56108985|NCT00003817|Granisetron|granisetron|mesh-list
56108986|NCT00003817|Tropisetron|tropisetron|mesh-list
56108987|NCT00003817|Dolasetron|dolasetron|mesh-list
56108988|NCT00003817|Antiemetics|antiemetics|mesh-ancestor
56108989|NCT00003817|Autonomic Agents|autonomic agents|mesh-ancestor
56108990|NCT00003817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56108991|NCT00003817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109020|NCT04329403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56109021|NCT04329403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56109022|NCT04329403|Analgesics|analgesics|mesh-ancestor
56109023|NCT04329403|Sensory System Agents|sensory system agents|mesh-ancestor
56109024|NCT04329403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109025|NCT04329403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109026|NCT04329403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56109027|NCT04329403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109028|NCT04329403|Dermatologic Agents|dermatologic agents|mesh-ancestor
56109029|NCT00003217|Cytarabine|cytarabine|mesh-list
56109030|NCT00003217|Dexamethasone|dexamethasone|mesh-list
56109031|NCT00003217|Cyclophosphamide|cyclophosphamide|mesh-list
56109032|NCT00003217|Doxorubicin|doxorubicin|mesh-list
56109033|NCT00003217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56109034|NCT00003217|Methotrexate|methotrexate|mesh-list
56109035|NCT00003217|Vincristine|vincristine|mesh-list
56109036|NCT00003217|Lenograstim|lenograstim|mesh-list
56109037|NCT00003217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836019|NCT01448824|Ketoconazole|ketoconazole|mesh-list
56109076|NCT00004183|Antimetabolites|antimetabolites|mesh-ancestor
56109077|NCT00004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109078|NCT00004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109079|NCT00003223|Fenretinide|fenretinide|mesh-list
56109081|NCT00003223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109082|NCT00003223|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56109083|NCT00003223|Protective Agents|protective agents|mesh-ancestor
56109084|NCT00003223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109085|NCT00004189|Cisplatin|cisplatin|mesh-list
56109086|NCT00004189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109087|NCT00003229|Aldesleukin|aldesleukin|mesh-list
56109088|NCT00003229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109089|NCT00003229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56109090|NCT00003229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56109091|NCT00003229|Antiviral Agents|antiviral agents|mesh-ancestor
56109092|NCT00003229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109093|NCT00003835|Leucovorin|leucovorin|mesh-list
56109094|NCT00003835|Fluorouracil|fluorouracil|mesh-list
56109095|NCT00003835|Irinotecan|irinotecan|mesh-list
56109096|NCT00003835|Calcium|calcium|mesh-list
56109097|NCT00003835|Levoleucovorin|levoleucovorin|mesh-list
56109098|NCT00003835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56109099|NCT00003835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109100|NCT00003835|Antimetabolites|antimetabolites|mesh-ancestor
56109101|NCT00003835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109102|NCT00003835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109103|NCT00003835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109104|NCT00003835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109105|NCT00003835|Immunologic Factors|immunologic factors|mesh-ancestor
56109106|NCT00003835|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56109107|NCT00003835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109112|NCT00003835|Vitamins|vitamins|mesh-ancestor
56109122|NCT00003847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109123|NCT00003847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109124|NCT00003847|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109125|NCT00003847|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109126|NCT00003847|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109127|NCT00004195|Eniluracil|eniluracil|mesh-list
56109128|NCT00004195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109129|NCT00004195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109130|NCT00003853|Esorubicin|esorubicin|mesh-list
56109131|NCT00003853|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56109132|NCT00003853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109133|NCT00385021|Leucovorin|leucovorin|mesh-list
56109134|NCT00385021|Fluorouracil|fluorouracil|mesh-list
56109135|NCT00385021|Oxaliplatin|oxaliplatin|mesh-list
56109136|NCT00385021|Bevacizumab|bevacizumab|mesh-list
56109137|NCT00385021|Antimetabolites|antimetabolites|mesh-ancestor
56109138|NCT00385021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109139|NCT00385021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109140|NCT00385021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109141|NCT00385021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109142|NCT00385021|Immunologic Factors|immunologic factors|mesh-ancestor
56109143|NCT00385021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109144|NCT00385021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56109145|NCT00385021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56109173|NCT00004201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109174|NCT00003241|Phenylacetic acid|phenylacetic acid|mesh-list
56109227|NCT00004219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109232|NCT00003877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109233|NCT00003877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109234|NCT00003877|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109235|NCT00003877|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109236|NCT00003877|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109237|NCT00003877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109238|NCT00003877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109239|NCT00003877|Immunologic Factors|immunologic factors|mesh-ancestor
56109240|NCT00003877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109241|NCT00003877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109242|NCT00003877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109244|NCT00003877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56109245|NCT00003883|Itraconazole|itraconazole|mesh-list
56109253|NCT00003883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56109254|NCT00003883|Hormone Antagonists|hormone antagonists|mesh-ancestor
56109255|NCT00003883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109256|NCT00003883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109257|NCT00003883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56109258|NCT00003883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56109259|NCT00003883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56109260|NCT04225819|Vitamin D|vitamin d|mesh-list
56109261|NCT04225819|Cholecalciferol|cholecalciferol|mesh-list
56109262|NCT04225819|Vitamins|vitamins|mesh-ancestor
56109263|NCT04225819|Micronutrients|micronutrients|mesh-ancestor
56109264|NCT04225819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109265|NCT04225819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56109266|NCT04225819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56109267|NCT00003253|Paclitaxel|paclitaxel|mesh-list
56109268|NCT00003253|Antineoplastic Agents|antineoplastic agents|mesh-list
56109269|NCT00003253|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109270|NCT00003253|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109271|NCT00003253|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109272|NCT00003253|Mitosis Modulators|mitosis modulators|mesh-ancestor
55836239|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56109273|NCT00003253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109283|NCT00004237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109284|NCT00004237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109285|NCT00004237|Alkylating Agents|alkylating agents|mesh-ancestor
56109286|NCT00004237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109287|NCT00004237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109288|NCT00004237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56109289|NCT00004237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56109290|NCT00004237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109291|NCT00004237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109292|NCT00004237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109293|NCT00004237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109294|NCT00004237|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109295|NCT00004237|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109296|NCT00004237|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109297|NCT00004237|Analgesics|analgesics|mesh-ancestor
56109298|NCT00004237|Sensory System Agents|sensory system agents|mesh-ancestor
56109299|NCT00004237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109300|NCT00003259|Vinorelbine|vinorelbine|mesh-list
56109301|NCT00003259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109302|NCT00003259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109303|NCT00003259|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109304|NCT00003259|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109305|NCT00003259|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109306|NCT00003259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109307|NCT00003913|Methylprednisolone|methylprednisolone|mesh-list
56109308|NCT00003913|Cyclophosphamide|cyclophosphamide|mesh-list
56109309|NCT00003913|Busulfan|busulfan|mesh-list
56109317|NCT00003913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109318|NCT00003913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109319|NCT00003913|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56109320|NCT00003913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56109321|NCT00003913|Antiemetics|antiemetics|mesh-ancestor
56109322|NCT00003913|Autonomic Agents|autonomic agents|mesh-ancestor
56109323|NCT00003913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109324|NCT00003913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56109325|NCT00003913|Glucocorticoids|glucocorticoids|mesh-ancestor
56109326|NCT00003913|Hormones|hormones|mesh-ancestor
56109327|NCT00003913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109328|NCT00003913|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56109329|NCT00003913|Protective Agents|protective agents|mesh-ancestor
56109330|NCT00004243|Docetaxel|docetaxel|mesh-list
56109331|NCT00004243|Oxaliplatin|oxaliplatin|mesh-list
56109332|NCT00004243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109333|NCT00004243|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109334|NCT00004243|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109335|NCT00004243|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109336|NCT00004243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109337|NCT00004249|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56109357|NCT00003925|Antidotes|antidotes|mesh-ancestor
56109358|NCT00003925|Protective Agents|protective agents|mesh-ancestor
56109359|NCT00003925|Vitamin B Complex|vitamin b complex|mesh-ancestor
56109361|NCT00003925|Micronutrients|micronutrients|mesh-ancestor
56109362|NCT00004255|Methylprednisolone|methylprednisolone|mesh-list
56109363|NCT00004255|Cyclophosphamide|cyclophosphamide|mesh-list
56109364|NCT00004255|Fludarabine|fludarabine|mesh-list
56109365|NCT00004255|Fludarabine phosphate|fludarabine phosphate|mesh-list
56109366|NCT00004255|Tacrolimus|tacrolimus|mesh-list
56109367|NCT00004255|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56109368|NCT00004255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109369|NCT00004255|Immunologic Factors|immunologic factors|mesh-ancestor
56109370|NCT00004255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109371|NCT00004255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109372|NCT00004255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109373|NCT00004255|Alkylating Agents|alkylating agents|mesh-ancestor
56109374|NCT00004255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109375|NCT00004255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109376|NCT00004255|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56109377|NCT00004255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109378|NCT00004255|Antimetabolites|antimetabolites|mesh-ancestor
56109386|NCT00004255|Glucocorticoids|glucocorticoids|mesh-ancestor
56109387|NCT00004255|Hormones|hormones|mesh-ancestor
56109388|NCT00004255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109389|NCT00004255|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56109390|NCT00004255|Protective Agents|protective agents|mesh-ancestor
56109391|NCT00004261|Antibodies|antibodies|mesh-list
56109392|NCT00004261|Immunologic Factors|immunologic factors|mesh-ancestor
56109393|NCT00004261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109394|NCT00003283|Prednisone|prednisone|mesh-list
56109395|NCT00003283|Octreotide|octreotide|mesh-list
56109396|NCT00003283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56109397|NCT00003283|Glucocorticoids|glucocorticoids|mesh-ancestor
56109398|NCT00003283|Hormones|hormones|mesh-ancestor
56109399|NCT00003283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109400|NCT00003283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109401|NCT00003283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56109402|NCT00003283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109403|NCT00003283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56109404|NCT00004297|Diazepam|diazepam|mesh-list
56109405|NCT00004297|Lorazepam|lorazepam|mesh-list
56109406|NCT00004297|Anticonvulsants|anticonvulsants|mesh-ancestor
56109407|NCT00004297|Antiemetics|antiemetics|mesh-ancestor
56109408|NCT00004297|Autonomic Agents|autonomic agents|mesh-ancestor
56109409|NCT00004297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109410|NCT00004297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109411|NCT00004297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56109412|NCT00004297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56109413|NCT00004297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56109414|NCT00004297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56109415|NCT00004297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56109416|NCT00004297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56109417|NCT00004297|GABA Modulators|gaba modulators|mesh-ancestor
56109418|NCT00004297|GABA Agents|gaba agents|mesh-ancestor
56109419|NCT00004297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56109420|NCT00004297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109421|NCT00004297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56109423|NCT00004297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56109424|NCT00004297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56109425|NCT00004297|Anesthetics, General|anesthetics, general|mesh-ancestor
56109426|NCT00004297|Anesthetics|anesthetics|mesh-ancestor
56109427|NCT00004855|Ritonavir|ritonavir|mesh-list
56109428|NCT00004855|Lopinavir|lopinavir|mesh-list
56109429|NCT00004855|Lamivudine|lamivudine|mesh-list
56109434|NCT00004855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56109435|NCT00004855|Protease Inhibitors|protease inhibitors|mesh-ancestor
56109436|NCT00004855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109437|NCT00004855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109439|NCT00004855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56109440|NCT00004855|Antiviral Agents|antiviral agents|mesh-ancestor
56109441|NCT00004855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109442|NCT00004855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56109443|NCT00004855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56109444|NCT00004855|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56109445|NCT00004855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56109446|NCT00004855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56109447|NCT00004855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56109448|NCT00004855|Antimetabolites|antimetabolites|mesh-ancestor
56109449|NCT00003289|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
56109450|NCT00003289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109451|NCT00003289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56109452|NCT00003289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109453|NCT00003289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109454|NCT00004861|Gemcitabine|gemcitabine|mesh-list
56109455|NCT00004861|Tacedinaline|tacedinaline|mesh-list
56109456|NCT00004861|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109457|NCT00004861|Antimetabolites|antimetabolites|mesh-ancestor
56109458|NCT00004861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109459|NCT00004861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109460|NCT00004861|Antiviral Agents|antiviral agents|mesh-ancestor
56109479|NCT00003301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109480|NCT00003301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109481|NCT00003301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109482|NCT00003307|Amifostine|amifostine|mesh-list
56109483|NCT00003307|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56109484|NCT00003307|Protective Agents|protective agents|mesh-ancestor
56109485|NCT00003307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109486|NCT00004327|Octreotide|octreotide|mesh-list
56109487|NCT00004327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56109488|NCT00004327|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56109489|NCT00004327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109490|NCT00003313|Paclitaxel|paclitaxel|mesh-list
56109491|NCT00003313|Carboplatin|carboplatin|mesh-list
56109492|NCT00003313|Amifostine|amifostine|mesh-list
56109493|NCT00003313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109494|NCT00003313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109495|NCT00003313|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109496|NCT00003313|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109497|NCT00003313|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109498|NCT00003313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109499|NCT00003313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109500|NCT00003313|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56109501|NCT00003313|Protective Agents|protective agents|mesh-ancestor
56109502|NCT00004867|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56109503|NCT00004867|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56109504|NCT00004867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109505|NCT00004873|Docetaxel|docetaxel|mesh-list
56109527|NCT00004339|Chelating Agents|chelating agents|mesh-ancestor
56109528|NCT00004339|Sequestering Agents|sequestering agents|mesh-ancestor
56109529|NCT00004339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109530|NCT00004339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109531|NCT00004339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56109532|NCT00004339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56109533|NCT00004339|Growth Substances|growth substances|mesh-ancestor
56109534|NCT00004339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109535|NCT00004339|Growth Inhibitors|growth inhibitors|mesh-ancestor
56109536|NCT00004339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109537|NCT00003331|Leucovorin|leucovorin|mesh-list
56109538|NCT00003331|Fluorouracil|fluorouracil|mesh-list
56109539|NCT00003331|Topotecan|topotecan|mesh-list
56109540|NCT00003331|Calcium|calcium|mesh-list
56109541|NCT00003331|Levoleucovorin|levoleucovorin|mesh-list
56109542|NCT00003331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56109543|NCT00003331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109544|NCT00003331|Antimetabolites|antimetabolites|mesh-ancestor
56109545|NCT00003331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109584|NCT00003337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109585|NCT00003343|Prednisone|prednisone|mesh-list
56109586|NCT00003343|Mitoxantrone|mitoxantrone|mesh-list
56109587|NCT00003343|Prinomastat|prinomastat|mesh-list
56109588|NCT00003343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56109589|NCT00003343|Glucocorticoids|glucocorticoids|mesh-ancestor
56109590|NCT00003343|Hormones|hormones|mesh-ancestor
56109887|NCT00005065|Carboplatin|carboplatin|mesh-list
56109591|NCT00003343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109592|NCT00003343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109593|NCT00003343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56109594|NCT00003343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109595|NCT00003343|Analgesics|analgesics|mesh-ancestor
56109596|NCT00003343|Sensory System Agents|sensory system agents|mesh-ancestor
56109597|NCT00003343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109598|NCT00003343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109599|NCT00003343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109600|NCT00003343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109601|NCT00003343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109602|NCT00003343|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
56109603|NCT00003343|Protease Inhibitors|protease inhibitors|mesh-ancestor
56109604|NCT00004903|Interferons|interferons|mesh-list
56109605|NCT00004903|Cytarabine|cytarabine|mesh-list
56109606|NCT00004903|Interferon-alpha|interferon-alpha|mesh-list
56109607|NCT00004903|Cyclophosphamide|cyclophosphamide|mesh-list
56109608|NCT00004903|Melphalan|melphalan|mesh-list
56109609|NCT00004903|Etoposide|etoposide|mesh-list
56109610|NCT00004903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109611|NCT00004903|Immunologic Factors|immunologic factors|mesh-ancestor
56109632|NCT00004357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56109633|NCT00004357|Prednisolone phosphate|prednisolone phosphate|mesh-list
56109634|NCT00004357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56109635|NCT00004357|Antiemetics|antiemetics|mesh-ancestor
56109636|NCT00004357|Autonomic Agents|autonomic agents|mesh-ancestor
56109637|NCT00004357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56109638|NCT00004357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109639|NCT00004357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56109640|NCT00004357|Glucocorticoids|glucocorticoids|mesh-ancestor
56109641|NCT00004357|Hormones|hormones|mesh-ancestor
56109642|NCT00004357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56109643|NCT00004357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56109644|NCT00004357|Protective Agents|protective agents|mesh-ancestor
56109645|NCT00004357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56109646|NCT00004357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109647|NCT00004363|Chlorpropamide|chlorpropamide|mesh-list
56109648|NCT00004363|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
56109649|NCT00004363|Hemostatics|hemostatics|mesh-ancestor
56109650|NCT00004363|Coagulants|coagulants|mesh-ancestor
56109651|NCT00004363|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
56109652|NCT00004363|Natriuretic Agents|natriuretic agents|mesh-ancestor
56109653|NCT00004363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109654|NCT00004363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56109655|NCT04069117|Letrozole|letrozole|mesh-list
56109657|NCT04069117|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56109658|NCT04069117|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56109665|NCT00004921|Paclitaxel|paclitaxel|mesh-list
56109682|NCT00004933|Hydroxyurea|hydroxyurea|mesh-list
56109683|NCT00004933|Homoharringtonine|homoharringtonine|mesh-list
56109684|NCT00004933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109685|NCT00004933|Antisickling Agents|antisickling agents|mesh-ancestor
56109686|NCT00004933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109687|NCT00004933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109688|NCT00004933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56109689|NCT00004933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109690|NCT00004933|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56109702|NCT00004981|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56109703|NCT00004981|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56109704|NCT00004981|Antimetabolites|antimetabolites|mesh-ancestor
56109730|NCT00003361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109731|NCT00003361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109732|NCT00003361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109733|NCT00003367|Vitamin E|vitamin e|mesh-list
56109734|NCT00003367|Vitamins|vitamins|mesh-ancestor
56109735|NCT00003367|Micronutrients|micronutrients|mesh-ancestor
56109736|NCT00003367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109737|NCT00003367|Antioxidants|antioxidants|mesh-ancestor
56109738|NCT00003367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109739|NCT00003367|Protective Agents|protective agents|mesh-ancestor
56109740|NCT00003379|Paclitaxel|paclitaxel|mesh-list
56109741|NCT00003379|Cisplatin|cisplatin|mesh-list
56109742|NCT00003379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109743|NCT00003379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109744|NCT00003379|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109745|NCT00003379|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109746|NCT00003379|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109747|NCT00003379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109748|NCT00003385|Paclitaxel|paclitaxel|mesh-list
56109749|NCT00003385|Carboplatin|carboplatin|mesh-list
56109750|NCT00003385|Doxorubicin|doxorubicin|mesh-list
56109751|NCT00003385|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56109752|NCT00003385|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109753|NCT00003385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109754|NCT00003385|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109755|NCT00003385|Antimitotic Agents|antimitotic agents|mesh-ancestor
55791461|NCT04861103|Enoxaparin|enoxaparin|mesh-list
56109766|NCT00005005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56109767|NCT00005005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109768|NCT00004393|Risperidone|risperidone|mesh-list
56109769|NCT00004393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56109770|NCT00004393|Serotonin Agents|serotonin agents|mesh-ancestor
56109771|NCT00004393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56109772|NCT00004393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109773|NCT00004393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109774|NCT00004393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56109776|NCT00004393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56109777|NCT00004393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56109778|NCT00004393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56109779|NCT00004393|Dopamine Agents|dopamine agents|mesh-ancestor
56109807|NCT00005017|Efavirenz|efavirenz|mesh-list
56109808|NCT00005017|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56109809|NCT00005017|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56109810|NCT00005017|Protease Inhibitors|protease inhibitors|mesh-ancestor
56109811|NCT00005017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109812|NCT00005017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109813|NCT00005017|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56109814|NCT00005017|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56109815|NCT00005017|Antiviral Agents|antiviral agents|mesh-ancestor
56109816|NCT00005017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109817|NCT00005017|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56109818|NCT00005017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56109819|NCT00005017|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56109820|NCT00005017|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56109821|NCT00005017|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56109822|NCT00005017|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56109823|NCT00005017|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56109824|NCT00005017|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56109825|NCT00005017|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56109826|NCT00005017|Antimetabolites|antimetabolites|mesh-ancestor
56109827|NCT00005017|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56109828|NCT00005017|Antitubercular Agents|antitubercular agents|mesh-ancestor
56109829|NCT00005017|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56109830|NCT00005023|Sargramostim|sargramostim|mesh-list
56109831|NCT00005023|Immunologic Factors|immunologic factors|mesh-ancestor
56109832|NCT00005023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109833|NCT00005029|Topotecan|topotecan|mesh-list
56109852|NCT00004465|Shiga Toxins|shiga toxins|mesh-list
56109853|NCT00004465|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56109854|NCT00004465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109855|NCT00004465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109856|NCT00005569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
56109857|NCT00005569|Protease Inhibitors|protease inhibitors|mesh-list
56109858|NCT00005569|Secretory Leukocyte Peptidase Inhibitor|secretory leukocyte peptidase inhibitor|mesh-list
56109859|NCT00005569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109860|NCT00005569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109861|NCT00005569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56109862|NCT00005569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56109863|NCT00005569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56109864|NCT00005569|Antiviral Agents|antiviral agents|mesh-ancestor
56109865|NCT00005569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56109866|NCT00005569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56109868|NCT00005575|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56109869|NCT00005575|Antidepressive Agents|antidepressive agents|mesh-ancestor
56109880|NCT00005059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109881|NCT00005059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109882|NCT00005059|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109883|NCT00005059|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109884|NCT00005059|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109885|NCT00005059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109889|NCT00005065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109890|NCT00005065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109891|NCT00005065|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109892|NCT00005065|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109893|NCT00005065|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109894|NCT00005065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109895|NCT00005065|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56109896|NCT00005065|Dermatologic Agents|dermatologic agents|mesh-ancestor
56109897|NCT00386191|Clopidogrel|clopidogrel|mesh-list
56109898|NCT00386191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56109899|NCT00386191|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56109900|NCT00386191|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56109901|NCT00386191|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56109902|NCT00386191|Purinergic Agents|purinergic agents|mesh-ancestor
56109903|NCT00386191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56109904|NCT00386191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109905|NCT00386191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109906|NCT00386269|Codeine|codeine|mesh-list
56109907|NCT00386269|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56109908|NCT00386269|Narcotics|narcotics|mesh-ancestor
56109909|NCT00386269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56109910|NCT00386269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109911|NCT00386269|Analgesics|analgesics|mesh-ancestor
56109920|NCT00005581|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56109921|NCT00005581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109922|NCT00005581|Tubulin Modulators|tubulin modulators|mesh-ancestor
56109923|NCT00005581|Antimitotic Agents|antimitotic agents|mesh-ancestor
56109924|NCT00005581|Mitosis Modulators|mitosis modulators|mesh-ancestor
56109925|NCT00005581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109926|NCT00005581|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109927|NCT00005581|Immunologic Factors|immunologic factors|mesh-ancestor
56109928|NCT00005581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109929|NCT00005581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56109930|NCT00005581|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56109931|NCT00005581|Alkylating Agents|alkylating agents|mesh-ancestor
56109932|NCT00005581|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56109933|NCT00005581|Antimetabolites|antimetabolites|mesh-ancestor
56109934|NCT00005581|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109935|NCT00005581|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56109936|NCT00005581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56109937|NCT00005581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109938|NCT00005581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109939|NCT00005077|Oxaliplatin|oxaliplatin|mesh-list
56109940|NCT00005077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109941|NCT00004489|Cholecalciferol|cholecalciferol|mesh-list
56109942|NCT00004489|Vitamin D|vitamin d|mesh-list
56109943|NCT00004489|Alendronate|alendronate|mesh-list
56109944|NCT00004489|Calcium Carbonate|calcium carbonate|mesh-list
56109945|NCT00004489|Calcium|calcium|mesh-list
56109946|NCT00004489|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56109947|NCT00004489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109956|NCT00005593|Fludarabine phosphate|fludarabine phosphate|mesh-list
56109957|NCT00005593|Topotecan|topotecan|mesh-list
56109958|NCT00005593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56109959|NCT00005593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56109960|NCT00005593|Antimetabolites|antimetabolites|mesh-ancestor
56109961|NCT00005593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56109962|NCT00005593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56109963|NCT00005593|Immunologic Factors|immunologic factors|mesh-ancestor
56109964|NCT00005593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109965|NCT00005593|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56109966|NCT00005593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56109967|NCT00005593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56109968|NCT00004495|Folic Acid|folic acid|mesh-list
56109969|NCT00004495|Pyridoxine|pyridoxine|mesh-list
56109970|NCT00004495|Vitamin B 12|vitamin b 12|mesh-list
56109971|NCT00004495|Hydroxocobalamin|hydroxocobalamin|mesh-list
56109972|NCT00004495|Hematinics|hematinics|mesh-ancestor
56109973|NCT00004495|Vitamin B Complex|vitamin b complex|mesh-ancestor
56109974|NCT00004495|Vitamins|vitamins|mesh-ancestor
56109975|NCT00004495|Micronutrients|micronutrients|mesh-ancestor
56109976|NCT00004495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56109977|NCT00005089|Prednisone|prednisone|mesh-list
56109978|NCT00005089|Cyclophosphamide|cyclophosphamide|mesh-list
56109979|NCT00005089|Rituximab|rituximab|mesh-list
56110000|NCT00005089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110001|NCT00005089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56110002|NCT00005089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56110003|NCT00005089|Tubulin Modulators|tubulin modulators|mesh-ancestor
56110004|NCT00005089|Antimitotic Agents|antimitotic agents|mesh-ancestor
56110005|NCT00005089|Mitosis Modulators|mitosis modulators|mesh-ancestor
56110006|NCT00005599|Paclitaxel|paclitaxel|mesh-list
56110007|NCT00005599|Bryostatin 1|bryostatin 1|mesh-list
56110008|NCT00005599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56110009|NCT00005599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110010|NCT00005599|Tubulin Modulators|tubulin modulators|mesh-ancestor
56110011|NCT00005599|Antimitotic Agents|antimitotic agents|mesh-ancestor
56110012|NCT00005599|Mitosis Modulators|mitosis modulators|mesh-ancestor
56110013|NCT00005599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110014|NCT00005599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56110015|NCT00005599|Immunologic Factors|immunologic factors|mesh-ancestor
56110016|NCT00005599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110017|NCT00004567|Mycophenolic Acid|mycophenolic acid|mesh-list
56110018|NCT00004567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56110019|NCT00004567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110020|NCT00004567|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56110021|NCT00004567|Antitubercular Agents|antitubercular agents|mesh-ancestor
56110022|NCT00004567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56110051|NCT00004573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110052|NCT00004573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110053|NCT00005623|Cyproterone Acetate|cyproterone acetate|mesh-list
56110054|NCT00005623|Cyproterone|cyproterone|mesh-list
56110055|NCT00005623|Androgen Antagonists|androgen antagonists|mesh-ancestor
56110056|NCT00005623|Hormone Antagonists|hormone antagonists|mesh-ancestor
56110057|NCT00005623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110058|NCT00005623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110059|NCT00005623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110060|NCT00005623|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56110061|NCT00005623|Contraceptive Agents|contraceptive agents|mesh-ancestor
56110062|NCT00005623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56110064|NCT00005119|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56110065|NCT00005119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110066|NCT00004585|Lamivudine|lamivudine|mesh-list
56110067|NCT00004585|Zidovudine|zidovudine|mesh-list
56110068|NCT00004585|Efavirenz|efavirenz|mesh-list
56110069|NCT00004585|Abacavir|abacavir|mesh-list
56110070|NCT00004585|Dideoxynucleosides|dideoxynucleosides|mesh-list
56110071|NCT00004585|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
56110072|NCT00004585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56110073|NCT00004585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56110074|NCT00004585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110075|NCT00004585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110076|NCT00004585|Antiviral Agents|antiviral agents|mesh-ancestor
56110077|NCT00004585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110078|NCT00004585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56110079|NCT00004585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56110080|NCT00004585|Antimetabolites|antimetabolites|mesh-ancestor
56110081|NCT00004585|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56110082|NCT00004585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56110083|NCT00004585|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56110084|NCT00004585|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56110089|NCT00005635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56110090|NCT00005635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110091|NCT00005635|Tubulin Modulators|tubulin modulators|mesh-ancestor
56110092|NCT00005635|Antimitotic Agents|antimitotic agents|mesh-ancestor
56110093|NCT00005635|Mitosis Modulators|mitosis modulators|mesh-ancestor
56110094|NCT00005635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110095|NCT00005635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56110096|NCT00005641|Leucovorin|leucovorin|mesh-list
56110097|NCT00005641|Cyclosporine|cyclosporine|mesh-list
56110098|NCT00005641|Methylprednisolone|methylprednisolone|mesh-list
56110099|NCT00005641|Cyclophosphamide|cyclophosphamide|mesh-list
56110100|NCT00005641|Busulfan|busulfan|mesh-list
56110101|NCT00005641|Methotrexate|methotrexate|mesh-list
56110102|NCT00005641|Cyclosporins|cyclosporins|mesh-list
56110103|NCT00005641|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55837067|NCT05119166|Vitamins|vitamins|mesh-ancestor
56110104|NCT00005641|Levoleucovorin|levoleucovorin|mesh-list
56110105|NCT00005641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110106|NCT00005641|Immunologic Factors|immunologic factors|mesh-ancestor
56110148|NCT00005647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56110149|NCT00005647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56110150|NCT00005647|Growth Substances|growth substances|mesh-ancestor
56110151|NCT00005647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110152|NCT00005647|Growth Inhibitors|growth inhibitors|mesh-ancestor
56110153|NCT00005647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56110154|NCT00005647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110155|NCT00005665|Interferons|interferons|mesh-list
56110156|NCT00005665|Interferon-alpha|interferon-alpha|mesh-list
56110157|NCT00005665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110158|NCT00005665|Antiviral Agents|antiviral agents|mesh-ancestor
56110159|NCT00005665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110160|NCT00005665|Immunologic Factors|immunologic factors|mesh-ancestor
56110161|NCT00005665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110162|NCT00004669|Hydrocortisone|hydrocortisone|mesh-list
56110163|NCT00004669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56110164|NCT00385411|Valproic Acid|valproic acid|mesh-list
56110165|NCT00385411|Anticonvulsants|anticonvulsants|mesh-ancestor
56110166|NCT00385411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110167|NCT00385411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110168|NCT00385411|GABA Agents|gaba agents|mesh-ancestor
56110169|NCT00385411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110170|NCT00385411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110171|NCT00385411|Antimanic Agents|antimanic agents|mesh-ancestor
56110172|NCT00385411|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56110173|NCT00385411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56110174|NCT00385411|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56110176|NCT00004699|Mitosis Modulators|mitosis modulators|mesh-ancestor
56110177|NCT00004699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110179|NCT00004705|Diuretics|diuretics|mesh-ancestor
56110180|NCT00004705|Natriuretic Agents|natriuretic agents|mesh-ancestor
56110191|NCT00004747|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56110192|NCT00004747|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56110193|NCT00004747|Immunologic Factors|immunologic factors|mesh-ancestor
56110194|NCT00004747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110195|NCT00004759|Methylprednisolone|methylprednisolone|mesh-list
56110196|NCT00004759|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56110197|NCT00004759|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56110198|NCT00004759|Prednisolone|prednisolone|mesh-list
56110199|NCT00004759|Prednisolone acetate|prednisolone acetate|mesh-list
56110200|NCT00004759|Tirilazad|tirilazad|mesh-list
56110201|NCT00004759|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56110202|NCT00004759|Prednisolone phosphate|prednisolone phosphate|mesh-list
56110203|NCT00004759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56110204|NCT00004759|Antiemetics|antiemetics|mesh-ancestor
56110205|NCT00004759|Autonomic Agents|autonomic agents|mesh-ancestor
56110206|NCT00004759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110207|NCT00004759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110208|NCT00004759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56110209|NCT00004759|Glucocorticoids|glucocorticoids|mesh-ancestor
56110210|NCT00004759|Hormones|hormones|mesh-ancestor
56110211|NCT00004759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110212|NCT00004759|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56110213|NCT00004759|Protective Agents|protective agents|mesh-ancestor
56110214|NCT00004759|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56110215|NCT00004759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110216|NCT00004759|Antioxidants|antioxidants|mesh-ancestor
56110217|NCT00004759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110218|NCT00004771|Leuprolide|leuprolide|mesh-list
56110219|NCT00004771|Testosterone|testosterone|mesh-list
56110220|NCT00004771|Androgens|androgens|mesh-ancestor
56110221|NCT00004771|Hormones|hormones|mesh-ancestor
56110222|NCT00004771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110230|NCT00004789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110231|NCT00004789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110232|NCT00004795|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
56110233|NCT00004795|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56110234|NCT00004795|Immunologic Factors|immunologic factors|mesh-ancestor
56110235|NCT00004795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110236|NCT00004807|Topiramate|topiramate|mesh-list
56110237|NCT00004807|Dextromethorphan|dextromethorphan|mesh-list
56110238|NCT00004807|Donepezil|donepezil|mesh-list
56110239|NCT00004807|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
56110240|NCT00004807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742036|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56110241|NCT00004807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110242|NCT00004807|Cholinergic Agents|cholinergic agents|mesh-ancestor
56110243|NCT00004807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110244|NCT00004807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110245|NCT00004807|Nootropic Agents|nootropic agents|mesh-ancestor
56110246|NCT00004807|Anticonvulsants|anticonvulsants|mesh-ancestor
56110247|NCT00004807|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56110248|NCT00004807|Antitussive Agents|antitussive agents|mesh-ancestor
56110249|NCT00004807|Respiratory System Agents|respiratory system agents|mesh-ancestor
56110250|NCT00004807|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56110251|NCT00004807|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56110252|NCT00004825|Insulin|insulin|mesh-list
56110270|NCT00385645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56110271|NCT00385645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56110272|NCT00385645|Antiviral Agents|antiviral agents|mesh-ancestor
56110273|NCT00385645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110274|NCT00385645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56110275|NCT00385645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56110276|NCT00385645|Antimetabolites|antimetabolites|mesh-ancestor
56110277|NCT00385957|Lamivudine|lamivudine|mesh-list
56110278|NCT00385957|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56110279|NCT00385957|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56110280|NCT00385957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110281|NCT00385957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110282|NCT00385957|Antiviral Agents|antiviral agents|mesh-ancestor
56110283|NCT00385957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110284|NCT00385957|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56110285|NCT00385957|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56110286|NCT00005773|Nitric Oxide|nitric oxide|mesh-list
56110287|NCT00005773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56110288|NCT00005773|Autonomic Agents|autonomic agents|mesh-ancestor
56110289|NCT00005773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110290|NCT00005773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110291|NCT00005773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56110322|NCT00005797|Cyclophosphamide|cyclophosphamide|mesh-list
56110324|NCT00005797|Etoposide|etoposide|mesh-list
56110325|NCT00005797|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110326|NCT00005797|Immunologic Factors|immunologic factors|mesh-ancestor
56110327|NCT00005797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110328|NCT00005797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56110329|NCT00005797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56110330|NCT00005797|Alkylating Agents|alkylating agents|mesh-ancestor
56110331|NCT00005797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110332|NCT00005797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110333|NCT00005797|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56110334|NCT00005797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56110335|NCT00005797|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56110336|NCT00005797|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56110337|NCT00005797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110338|NCT00005815|Thalidomide|thalidomide|mesh-list
56110339|NCT00005815|Temozolomide|temozolomide|mesh-list
56110340|NCT00005815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56110342|NCT00005815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110344|NCT00005815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56110345|NCT00005815|Immunologic Factors|immunologic factors|mesh-ancestor
56110346|NCT00005815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110347|NCT00005815|Leprostatic Agents|leprostatic agents|mesh-ancestor
56110348|NCT00005815|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56110349|NCT00005815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110350|NCT00005815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56110351|NCT00005815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56110352|NCT00005815|Growth Substances|growth substances|mesh-ancestor
56110353|NCT00005815|Growth Inhibitors|growth inhibitors|mesh-ancestor
56110354|NCT02132754|Pembrolizumab|pembrolizumab|mesh-list
56110355|NCT02132754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56110356|NCT02132754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110357|NCT02151786|Lansoprazole|lansoprazole|mesh-list
56110358|NCT02151786|Dexlansoprazole|dexlansoprazole|mesh-list
56110359|NCT02151786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56110360|NCT02151786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56110361|NCT02151786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56110362|NCT02151786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110363|NCT02151786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110364|NCT02106156|Interferons|interferons|mesh-list
56110366|NCT02106156|Interferon-alpha|interferon-alpha|mesh-list
56110367|NCT02106156|Interferon alpha-2|interferon alpha-2|mesh-list
56110368|NCT02106156|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56110850|NCT04741698|Propranolol|propranolol|mesh-list
56110369|NCT02106156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110370|NCT02106156|Antiviral Agents|antiviral agents|mesh-ancestor
56110371|NCT02106156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110372|NCT02106156|Antimetabolites|antimetabolites|mesh-ancestor
56110373|NCT02106156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110374|NCT02106156|Immunologic Factors|immunologic factors|mesh-ancestor
56110375|NCT02106156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110376|NCT02131272|Insulin|insulin|mesh-list
56110377|NCT02131272|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56110378|NCT02131272|Insulin Detemir|insulin detemir|mesh-list
56110379|NCT02131272|Isophane Insulin, Human|isophane insulin, human|mesh-list
56110380|NCT02131272|Insulin, Isophane|insulin, isophane|mesh-list
56110381|NCT02131272|Isophane insulin, beef|isophane insulin, beef|mesh-list
56110384|NCT02130882|Benralizumab|benralizumab|mesh-list
56110413|NCT02104752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110414|NCT02104752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110415|NCT02104752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56110416|NCT02104752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56110417|NCT02104752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110418|NCT02104752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110419|NCT02104752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110420|NCT02128932|Insulin Glargine|insulin glargine|mesh-list
56110421|NCT02128932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56110422|NCT02128932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110423|NCT02128542|Sofosbuvir|sofosbuvir|mesh-list
56110424|NCT02128542|Antiviral Agents|antiviral agents|mesh-ancestor
56110425|NCT02128542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110426|NCT02127372|Cisplatin|cisplatin|mesh-list
56110427|NCT02127372|Docetaxel|docetaxel|mesh-list
56110428|NCT02127372|Imatinib Mesylate|imatinib mesylate|mesh-list
56110429|NCT02127372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110430|NCT02127372|Tubulin Modulators|tubulin modulators|mesh-ancestor
56110431|NCT02127372|Antimitotic Agents|antimitotic agents|mesh-ancestor
56110432|NCT02127372|Mitosis Modulators|mitosis modulators|mesh-ancestor
56110433|NCT02127372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110434|NCT02127372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56110435|NCT02127372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110463|NCT02146248|Medroxyprogesterone|medroxyprogesterone|mesh-list
56110464|NCT02146248|Contraceptives, Oral|contraceptives, oral|mesh-list
56110465|NCT02146248|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
56110466|NCT02146248|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56110467|NCT02146248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110468|NCT02146248|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56110469|NCT02146248|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56110470|NCT02146248|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56110471|NCT02146248|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56110472|NCT02146248|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56110473|NCT02146248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56110474|NCT02146248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110475|NCT02124564|Lacosamide|lacosamide|mesh-list
56110476|NCT02124564|Anticonvulsants|anticonvulsants|mesh-ancestor
56110477|NCT02124564|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56110478|NCT02124564|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56110479|NCT02124564|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56110480|NCT02124564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110481|NCT02100696|Etrolizumab|etrolizumab|mesh-list
56110482|NCT02100696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56110483|NCT02100696|Immunologic Factors|immunologic factors|mesh-ancestor
56110485|NCT02123472|Cephalexin|cephalexin|mesh-list
56110515|NCT02100228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110516|NCT02100228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56110518|NCT02100228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56110519|NCT02100228|Protease Inhibitors|protease inhibitors|mesh-ancestor
56110520|NCT02100228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110521|NCT02100228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56110522|NCT02100228|Hemostatics|hemostatics|mesh-ancestor
56110523|NCT02100228|Coagulants|coagulants|mesh-ancestor
56110524|NCT02099838|Metformin|metformin|mesh-list
56110525|NCT02099838|Pioglitazone|pioglitazone|mesh-list
56110526|NCT02099838|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56110527|NCT02099838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110528|NCT02099682|Lansoprazole|lansoprazole|mesh-list
56110529|NCT02099682|Dexlansoprazole|dexlansoprazole|mesh-list
56110530|NCT02099682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56110531|NCT02099682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56110532|NCT02099682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56110533|NCT02099682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110534|NCT02099682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110535|NCT04733040|Felzartamab|felzartamab|mesh-list
56110536|NCT04733040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110537|NCT04733040|Immunologic Factors|immunologic factors|mesh-ancestor
56110549|NCT02122770|Docetaxel|docetaxel|mesh-list
56110550|NCT02122770|Carboplatin|carboplatin|mesh-list
56110551|NCT02122770|Pevonedistat|pevonedistat|mesh-list
56110552|NCT02122770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56110553|NCT02122770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110554|NCT02122770|Tubulin Modulators|tubulin modulators|mesh-ancestor
56110555|NCT02122770|Antimitotic Agents|antimitotic agents|mesh-ancestor
56110556|NCT02122770|Mitosis Modulators|mitosis modulators|mesh-ancestor
56110557|NCT02122770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110558|NCT02122770|Antifungal Agents|antifungal agents|mesh-ancestor
56110559|NCT02122770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110560|NCT02122770|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56110561|NCT02122770|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56110562|NCT02122770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110563|NCT02122770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56110590|NCT02097108|Raltegravir Potassium|raltegravir potassium|mesh-list
56110591|NCT02097108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56110592|NCT02097108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56110593|NCT02097108|Antiviral Agents|antiviral agents|mesh-ancestor
56110594|NCT02097108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110595|NCT02097108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56110596|NCT02097108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56110597|NCT02097108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110598|NCT02097108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110599|NCT02096952|Methylphenidate|methylphenidate|mesh-list
56110600|NCT02096952|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56110601|NCT02096952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110602|NCT02096952|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56110603|NCT02096952|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56110604|NCT02096952|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56110606|NCT02096952|Dopamine Agents|dopamine agents|mesh-ancestor
56110645|NCT02119416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110646|NCT02119416|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56110647|NCT02119416|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56110648|NCT02119416|Purinergic Agents|purinergic agents|mesh-ancestor
56110649|NCT02119416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110650|NCT02140164|Minocycline|minocycline|mesh-list
56110651|NCT02140164|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56110652|NCT02140164|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110653|NCT02119260|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56110654|NCT02119104|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56110655|NCT02119104|Immunologic Factors|immunologic factors|mesh-ancestor
56110656|NCT02119104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110657|NCT02119026|Bevacizumab|bevacizumab|mesh-list
56110658|NCT02119026|Capecitabine|capecitabine|mesh-list
56110659|NCT02119026|Oxaliplatin|oxaliplatin|mesh-list
56110660|NCT02119026|Irinotecan|irinotecan|mesh-list
56110661|NCT02119026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56110662|NCT02119026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110663|NCT02119026|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56110664|NCT02119026|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56110665|NCT02119026|Growth Substances|growth substances|mesh-ancestor
56110666|NCT02119026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110667|NCT02119026|Growth Inhibitors|growth inhibitors|mesh-ancestor
56110668|NCT02119026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56110669|NCT02119026|Antimetabolites|antimetabolites|mesh-ancestor
56110670|NCT02119026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110671|NCT02119026|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56110690|NCT02095158|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56110691|NCT02095158|Protective Agents|protective agents|mesh-ancestor
56110692|NCT02118714|Atrasentan|atrasentan|mesh-list
56110693|NCT02118714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110694|NCT02118714|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
56110695|NCT02118714|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
56110696|NCT02118714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110697|NCT02138916|Benralizumab|benralizumab|mesh-list
56110698|NCT02138916|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56110699|NCT02138916|Respiratory System Agents|respiratory system agents|mesh-ancestor
56110700|NCT02118012|Ribavirin|ribavirin|mesh-list
56110701|NCT02118012|Antimetabolites|antimetabolites|mesh-ancestor
56110702|NCT02118012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110703|NCT02118012|Antiviral Agents|antiviral agents|mesh-ancestor
56110704|NCT02118012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110705|NCT02138838|Cinacalcet|cinacalcet|mesh-list
56110706|NCT02138838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56110707|NCT02138838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110708|NCT02138838|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
56110709|NCT02138838|Hormone Antagonists|hormone antagonists|mesh-ancestor
55837667|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110710|NCT02138838|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110711|NCT02092350|Grazoprevir|grazoprevir|mesh-list
56110712|NCT02092350|Antiviral Agents|antiviral agents|mesh-ancestor
56110739|NCT02091414|Dermatologic Agents|dermatologic agents|mesh-ancestor
56110740|NCT02091414|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56110741|NCT02091414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56110742|NCT02091414|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56110743|NCT02091414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110744|NCT02091414|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56110745|NCT02091414|Antitubercular Agents|antitubercular agents|mesh-ancestor
56110746|NCT02091414|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56110747|NCT04731558|Enoxaparin|enoxaparin|mesh-list
56110748|NCT04731558|Dalteparin|dalteparin|mesh-list
56110749|NCT04731558|Tinzaparin|tinzaparin|mesh-list
56110750|NCT04731558|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56110751|NCT04731558|Anticoagulants|anticoagulants|mesh-ancestor
56110752|NCT04731558|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56110753|NCT04731558|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56110754|NCT04731558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110755|NCT02116530|Dexamethasone|dexamethasone|mesh-list
56110756|NCT02116530|Cyclophosphamide|cyclophosphamide|mesh-list
56110758|NCT02116530|Ondansetron|ondansetron|mesh-list
56110759|NCT02116530|Olanzapine|olanzapine|mesh-list
56110760|NCT02116530|Aprepitant|aprepitant|mesh-list
56110761|NCT02116530|Fosaprepitant|fosaprepitant|mesh-list
56110762|NCT02116530|Palonosetron|palonosetron|mesh-list
56110763|NCT02116530|Granisetron|granisetron|mesh-list
56110793|NCT02116530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56110794|NCT02116530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56110795|NCT02116530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56110796|NCT02116530|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56110797|NCT02116530|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56110798|NCT02116530|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56110799|NCT02116530|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
56110800|NCT02116530|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56110801|NCT02072226|Aspirin|aspirin|mesh-list
56110802|NCT02072226|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
56110803|NCT02072226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56110804|NCT02072226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56110805|NCT02072226|Analgesics|analgesics|mesh-ancestor
56110806|NCT02072226|Sensory System Agents|sensory system agents|mesh-ancestor
56110807|NCT02072226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110808|NCT02072226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110809|NCT02072226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56110810|NCT02072226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56110811|NCT02072226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56110812|NCT02072226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56110813|NCT02072226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110814|NCT02072226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56110815|NCT02072226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56110816|NCT02072226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110817|NCT02072226|Antipyretics|antipyretics|mesh-ancestor
56110818|NCT04730856|Tinzaparin|tinzaparin|mesh-list
56110819|NCT04730856|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
56110837|NCT02115282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110838|NCT02115282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56110839|NCT02114892|Resveratrol|resveratrol|mesh-list
56110840|NCT02114892|Antioxidants|antioxidants|mesh-ancestor
56110841|NCT02114892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110842|NCT02114892|Protective Agents|protective agents|mesh-ancestor
56110843|NCT02114892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110844|NCT02114892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110845|NCT02114892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56110847|NCT02070744|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
56110848|NCT02070744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56110849|NCT02070744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110851|NCT04741698|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56110852|NCT04741698|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56110853|NCT04741698|Adrenergic Agents|adrenergic agents|mesh-ancestor
56110854|NCT04741698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110855|NCT04741698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110857|NCT04741698|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56110858|NCT04741698|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56110859|NCT04741698|Vasodilator Agents|vasodilator agents|mesh-ancestor
56110860|NCT02111850|Aldesleukin|aldesleukin|mesh-list
56110861|NCT02111850|Cyclophosphamide|cyclophosphamide|mesh-list
56110862|NCT02111850|Fludarabine|fludarabine|mesh-list
56110876|NCT02085252|Bicalutamide|bicalutamide|mesh-list
56110885|NCT02085252|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56110886|NCT02085252|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56110887|NCT02084238|Interleukin-2|interleukin-2|mesh-list
56110888|NCT02084238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110889|NCT02084238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56110890|NCT02084238|Analgesics|analgesics|mesh-ancestor
56110891|NCT02084238|Sensory System Agents|sensory system agents|mesh-ancestor
56110892|NCT02084238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110893|NCT02084238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110894|NCT02084082|Metformin|metformin|mesh-list
56110895|NCT02084082|Linagliptin|linagliptin|mesh-list
56110896|NCT02084082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56110897|NCT02084082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110898|NCT02084082|Incretins|incretins|mesh-ancestor
56110899|NCT02084082|Hormones|hormones|mesh-ancestor
56110900|NCT02084082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56110901|NCT02084082|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56110902|NCT02084082|Protease Inhibitors|protease inhibitors|mesh-ancestor
56110903|NCT02084082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110904|NCT02084082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110905|NCT02083926|Ketamine|ketamine|mesh-list
56110906|NCT02083926|Analgesics|analgesics|mesh-ancestor
56110907|NCT02083926|Sensory System Agents|sensory system agents|mesh-ancestor
56110908|NCT02083926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110909|NCT02083926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110910|NCT02083926|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56110911|NCT02083926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56110912|NCT02083926|Anesthetics, General|anesthetics, general|mesh-ancestor
56110913|NCT02083926|Anesthetics|anesthetics|mesh-ancestor
56110914|NCT02083926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56110915|NCT02083926|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56110927|NCT02109744|Antimetabolites|antimetabolites|mesh-ancestor
56110928|NCT02109744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110929|NCT02109744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110930|NCT02109744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56110931|NCT02108964|Nazartinib|nazartinib|mesh-list
56110932|NCT02108964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110933|NCT04185402|Azithromycin|azithromycin|mesh-list
56110934|NCT04185402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56110935|NCT04185402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110936|NCT04728360|Ustekinumab|ustekinumab|mesh-list
56110937|NCT04728360|Dermatologic Agents|dermatologic agents|mesh-ancestor
56110938|NCT02066298|Mometasone Furoate|mometasone furoate|mesh-list
56110939|NCT02066298|Tiotropium Bromide|tiotropium bromide|mesh-list
56110940|NCT02066298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56110941|NCT02066298|Autonomic Agents|autonomic agents|mesh-ancestor
56110942|NCT02066298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110943|NCT02066298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110944|NCT02066298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56110945|NCT02066298|Respiratory System Agents|respiratory system agents|mesh-ancestor
56110946|NCT02066298|Parasympatholytics|parasympatholytics|mesh-ancestor
56110947|NCT02066298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56110948|NCT02066298|Cholinergic Agents|cholinergic agents|mesh-ancestor
56110949|NCT02066298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56110950|NCT02066298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56110951|NCT02066298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56110952|NCT02066298|Dermatologic Agents|dermatologic agents|mesh-ancestor
56110953|NCT02066298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56110976|NCT02082522|Immunologic Factors|immunologic factors|mesh-ancestor
56110977|NCT02082522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110978|NCT02082522|Dermatologic Agents|dermatologic agents|mesh-ancestor
56110979|NCT02082522|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56110981|NCT04723446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56110982|NCT04723446|Hydrogen Peroxide|hydrogen peroxide|mesh-list
56110984|NCT04723446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56110985|NCT04723446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56110987|NCT04723446|Dermatologic Agents|dermatologic agents|mesh-ancestor
56110988|NCT02082210|Ramucirumab|ramucirumab|mesh-list
56110989|NCT02082210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56110990|NCT02107014|Naltrexone|naltrexone|mesh-list
56110991|NCT02107014|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56110992|NCT02107014|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56110993|NCT02107014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56110994|NCT02107014|Sensory System Agents|sensory system agents|mesh-ancestor
56110995|NCT02107014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56110996|NCT01624974|Montelukast|montelukast|mesh-list
56111007|NCT01624662|Xhance|xhance|mesh-list
56111031|NCT02064894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111032|NCT02064894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56111033|NCT02064894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56111034|NCT02064894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111035|NCT02064894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111036|NCT02064816|Interferon beta-1a|interferon beta-1a|mesh-list
56111037|NCT02064816|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56111038|NCT02064816|Immunologic Factors|immunologic factors|mesh-ancestor
56111039|NCT02064816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111040|NCT02064816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111041|NCT02064816|Antiviral Agents|antiviral agents|mesh-ancestor
56111042|NCT02064816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111043|NCT01624194|Oxytocin|oxytocin|mesh-list
56111044|NCT01624194|Oxytocics|oxytocics|mesh-ancestor
56111045|NCT01624194|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56111046|NCT01624194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111047|NCT02079636|Gemcitabine|gemcitabine|mesh-list
56111048|NCT02079636|Pembrolizumab|pembrolizumab|mesh-list
56111049|NCT02079636|Pemetrexed|pemetrexed|mesh-list
56111050|NCT02079636|Ramucirumab|ramucirumab|mesh-list
56111051|NCT02079636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56111052|NCT02079636|Antimetabolites|antimetabolites|mesh-ancestor
56111053|NCT02079636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111054|NCT02079636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111055|NCT02079636|Antiviral Agents|antiviral agents|mesh-ancestor
56111056|NCT02079636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111057|NCT02079636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111058|NCT02079636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56111059|NCT02079636|Immunologic Factors|immunologic factors|mesh-ancestor
56111068|NCT02045862|Mirabegron|mirabegron|mesh-list
56111077|NCT02045862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56111078|NCT02045862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56111079|NCT02045862|Adrenergic Agents|adrenergic agents|mesh-ancestor
56111080|NCT04182984|Mycophenolic Acid|mycophenolic acid|mesh-list
56111082|NCT04182984|Azathioprine|azathioprine|mesh-list
56111089|NCT04182984|Hormones|hormones|mesh-ancestor
56111090|NCT04182984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111091|NCT04182984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111110|NCT02044302|Morphine|morphine|mesh-list
56111114|NCT02044302|Botulinum Toxins|botulinum toxins|mesh-list
56111115|NCT02044302|Anesthetics, Local|anesthetics, local|mesh-ancestor
56111117|NCT02044302|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56111118|NCT02044302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111119|NCT02044302|Sensory System Agents|sensory system agents|mesh-ancestor
56111120|NCT02044302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111121|NCT02044302|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56111122|NCT02044302|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56111123|NCT02044302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56111124|NCT02044302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111125|NCT02044302|Cholinergic Agents|cholinergic agents|mesh-ancestor
56111126|NCT02044302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111127|NCT02062944|Sirolimus|sirolimus|mesh-list
56111150|NCT02043366|Sufentanil|sufentanil|mesh-list
56111151|NCT02043366|Remifentanil|remifentanil|mesh-list
56111152|NCT02043366|Butorphanol|butorphanol|mesh-list
56111174|NCT02060370|Sunitinib|sunitinib|mesh-list
56111175|NCT02060370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111176|NCT02060370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56111177|NCT02060370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56111178|NCT02060370|Growth Substances|growth substances|mesh-ancestor
56111179|NCT02060370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111180|NCT02060370|Growth Inhibitors|growth inhibitors|mesh-ancestor
56111181|NCT02060370|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56111182|NCT02060370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111183|NCT02060370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111186|NCT01622088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111235|NCT02019420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56111237|NCT02019420|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56111238|NCT02019420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111239|NCT02019420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111240|NCT02058966|Entacapone|entacapone|mesh-list
56111241|NCT02058966|Methamphetamine|methamphetamine|mesh-list
55838193|NCT01609023|Rituximab|rituximab|mesh-list
56111242|NCT02058966|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56111259|NCT02017860|Everolimus|everolimus|mesh-list
56111288|NCT02015676|Antimitotic Agents|antimitotic agents|mesh-ancestor
56111289|NCT02015676|Mitosis Modulators|mitosis modulators|mesh-ancestor
56111290|NCT02015676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111291|NCT02015676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111333|NCT01622868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111334|NCT02014740|Metformin|metformin|mesh-list
56111335|NCT02014740|Liraglutide|liraglutide|mesh-list
56111336|NCT02014740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56111337|NCT02014740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111338|NCT02014740|Incretins|incretins|mesh-ancestor
56111339|NCT02014740|Hormones|hormones|mesh-ancestor
56111340|NCT02014740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111341|NCT02014584|Dutasteride|dutasteride|mesh-list
56111342|NCT02014584|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56111343|NCT02014584|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56111344|NCT02014584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111388|NCT02036502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111389|NCT02036502|Antiemetics|antiemetics|mesh-ancestor
56111390|NCT02036502|Autonomic Agents|autonomic agents|mesh-ancestor
56111391|NCT02036502|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111392|NCT02036502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111393|NCT02036502|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56111394|NCT02036502|Glucocorticoids|glucocorticoids|mesh-ancestor
56111396|NCT02036502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111400|NCT02036502|Immunologic Factors|immunologic factors|mesh-ancestor
56111435|NCT02034552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111436|NCT02034552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111437|NCT02034552|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56111438|NCT02034552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111439|NCT02034552|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56111440|NCT02034552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111441|NCT02034552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111442|NCT02034552|Hormone Antagonists|hormone antagonists|mesh-ancestor
56111443|NCT02034552|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56111445|NCT02011386|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56111446|NCT02011386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111447|NCT02011386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56111448|NCT02011386|Immunologic Factors|immunologic factors|mesh-ancestor
56111449|NCT02011386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111450|NCT02034162|Mebendazole|mebendazole|mesh-list
56111451|NCT02034162|Piperazine|piperazine|mesh-list
56111452|NCT02034162|Piperazine citrate|piperazine citrate|mesh-list
56111453|NCT02034162|DMP 777|dmp 777|mesh-list
56111454|NCT02034162|Antinematodal Agents|antinematodal agents|mesh-ancestor
56111455|NCT02034162|Anthelmintics|anthelmintics|mesh-ancestor
56111456|NCT02034162|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56111457|NCT02034162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111458|NCT02034162|Tubulin Modulators|tubulin modulators|mesh-ancestor
56111459|NCT02034162|Antimitotic Agents|antimitotic agents|mesh-ancestor
56111460|NCT02034162|Mitosis Modulators|mitosis modulators|mesh-ancestor
56111462|NCT02034162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111483|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111484|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111485|NCT04675788|Progestins|progestins|mesh-ancestor
56111486|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56111487|NCT04673448|Niraparib|niraparib|mesh-list
56111488|NCT04673448|Immunoglobulins|immunoglobulins|mesh-list
56111489|NCT04673448|Immunoglobulin G|immunoglobulin g|mesh-list
56111490|NCT04673448|Immunologic Factors|immunologic factors|mesh-ancestor
56111491|NCT04673448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111492|NCT04673448|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56111493|NCT04673448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111494|NCT04673448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111495|NCT04673448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111540|NCT02007096|Sensory System Agents|sensory system agents|mesh-ancestor
56111541|NCT02007096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111543|NCT02006706|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
56111544|NCT02006706|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
56111545|NCT02006706|Prednisolone|prednisolone|mesh-list
56111546|NCT02006706|Prednisolone acetate|prednisolone acetate|mesh-list
56111547|NCT02006706|Rituximab|rituximab|mesh-list
56111548|NCT02006706|Methotrexate|methotrexate|mesh-list
56111549|NCT02006706|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
56111550|NCT02006706|Prednisolone phosphate|prednisolone phosphate|mesh-list
56111552|NCT02006706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111584|NCT02048904|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56111585|NCT02048904|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56111586|NCT02048904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111587|NCT02048904|Incretins|incretins|mesh-ancestor
56111588|NCT02048904|Hormones|hormones|mesh-ancestor
56111589|NCT02048904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56111590|NCT02048904|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56111591|NCT02048904|Protease Inhibitors|protease inhibitors|mesh-ancestor
56111592|NCT02048904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111593|NCT02048904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111594|NCT02006628|Cannabidiol|cannabidiol|mesh-list
56111595|NCT02006628|Anticonvulsants|anticonvulsants|mesh-ancestor
56111596|NCT02029638|Acetaminophen|acetaminophen|mesh-list
56111597|NCT02029638|Diphenhydramine|diphenhydramine|mesh-list
56111598|NCT02029638|Promethazine|promethazine|mesh-list
56111599|NCT02029638|Mycophenolic Acid|mycophenolic acid|mesh-list
56111600|NCT02029638|Prednisone|prednisone|mesh-list
56111601|NCT02029638|Methylprednisolone|methylprednisolone|mesh-list
56111602|NCT02029638|Cyclophosphamide|cyclophosphamide|mesh-list
56111603|NCT02029638|Fludarabine|fludarabine|mesh-list
56111604|NCT02029638|Thymoglobulin|thymoglobulin|mesh-list
56111605|NCT02029638|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56111606|NCT02029638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56111607|NCT02029638|Immunologic Factors|immunologic factors|mesh-ancestor
56111608|NCT02029638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111609|NCT02029638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56111610|NCT02029638|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56111611|NCT02029638|Alkylating Agents|alkylating agents|mesh-ancestor
56111612|NCT02029638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111613|NCT02029638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111614|NCT02029638|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56111615|NCT02029638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111629|NCT02029638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111630|NCT02029638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111631|NCT02029638|Antiemetics|antiemetics|mesh-ancestor
56111632|NCT02029638|Autonomic Agents|autonomic agents|mesh-ancestor
56111633|NCT02029638|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56111634|NCT02029638|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56111635|NCT02029638|Protective Agents|protective agents|mesh-ancestor
56111636|NCT02029638|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56111637|NCT02029638|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56111676|NCT02027376|Antimitotic Agents|antimitotic agents|mesh-ancestor
56111677|NCT02027376|Mitosis Modulators|mitosis modulators|mesh-ancestor
56111678|NCT02027376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111679|NCT01994226|Naproxen|naproxen|mesh-list
56111680|NCT01994226|Colchicine|colchicine|mesh-list
56111681|NCT01994226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56111682|NCT01994226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56111683|NCT01994226|Analgesics|analgesics|mesh-ancestor
56111684|NCT01994226|Sensory System Agents|sensory system agents|mesh-ancestor
56111685|NCT01994226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111686|NCT01994226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111687|NCT01994226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56111688|NCT01994226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56111689|NCT01994226|Gout Suppressants|gout suppressants|mesh-ancestor
56111690|NCT01994226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56111692|NCT01994226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111693|NCT01994226|Tubulin Modulators|tubulin modulators|mesh-ancestor
56111694|NCT01994226|Antimitotic Agents|antimitotic agents|mesh-ancestor
56111695|NCT01994226|Mitosis Modulators|mitosis modulators|mesh-ancestor
56111696|NCT01994226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111697|NCT02002884|Botulinum Toxins|botulinum toxins|mesh-list
56111698|NCT02002884|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56111699|NCT02002884|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56111700|NCT02002884|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
56111701|NCT02002884|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56111702|NCT02002884|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56111703|NCT02002884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111704|NCT02002884|Cholinergic Agents|cholinergic agents|mesh-ancestor
56111705|NCT02002884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111706|NCT02002884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111707|NCT02002884|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56111708|NCT02002884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111710|NCT02023866|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56111711|NCT02023866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111712|NCT01967940|Atazanavir Sulfate|atazanavir sulfate|mesh-list
56111713|NCT01967940|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56111714|NCT01967940|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56111715|NCT01967940|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56111716|NCT01967940|Protease Inhibitors|protease inhibitors|mesh-ancestor
56111717|NCT01967940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111718|NCT01967940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111719|NCT01967940|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56111720|NCT01967940|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56111721|NCT01967940|Antiviral Agents|antiviral agents|mesh-ancestor
56111749|NCT01999218|Protease Inhibitors|protease inhibitors|mesh-ancestor
56111750|NCT01999218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111751|NCT01999218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111752|NCT01999218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56111753|NCT01999218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56111754|NCT01999218|Immunologic Factors|immunologic factors|mesh-ancestor
56111755|NCT01999218|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56111756|NCT01967628|Vitamin D|vitamin d|mesh-list
56111757|NCT01967628|Cholecalciferol|cholecalciferol|mesh-list
56111758|NCT01967628|Vitamins|vitamins|mesh-ancestor
56111759|NCT01967628|Micronutrients|micronutrients|mesh-ancestor
56111760|NCT01967628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111761|NCT01967628|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56111762|NCT01967628|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56111763|NCT01998906|Paclitaxel|paclitaxel|mesh-list
56111764|NCT01998906|Doxorubicin|doxorubicin|mesh-list
56111765|NCT01998906|Trastuzumab|trastuzumab|mesh-list
56111766|NCT01998906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56111767|NCT01998906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111768|NCT01998906|Tubulin Modulators|tubulin modulators|mesh-ancestor
56111769|NCT01998906|Antimitotic Agents|antimitotic agents|mesh-ancestor
56111770|NCT01998906|Mitosis Modulators|mitosis modulators|mesh-ancestor
56111771|NCT01998906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111777|NCT01967550|Diclofenac|diclofenac|mesh-list
56111795|NCT01989468|Immunologic Factors|immunologic factors|mesh-ancestor
56111796|NCT01989468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111797|NCT01989156|Menthol|menthol|mesh-list
56111798|NCT01989156|Antipruritics|antipruritics|mesh-ancestor
56111813|NCT01987596|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56111814|NCT01987596|Immunologic Factors|immunologic factors|mesh-ancestor
56111815|NCT01987596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111816|NCT01964898|Nicotine|nicotine|mesh-list
56111817|NCT01964898|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56111818|NCT01964898|Autonomic Agents|autonomic agents|mesh-ancestor
56111819|NCT01964898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111820|NCT01964898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111821|NCT01964898|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56111822|NCT01964898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56111823|NCT01964898|Cholinergic Agents|cholinergic agents|mesh-ancestor
56111824|NCT01964898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111825|NCT01964898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111826|NCT01964352|Tiotropium Bromide|tiotropium bromide|mesh-list
56111827|NCT01964352|Olodaterol|olodaterol|mesh-list
56111828|NCT01964352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56111829|NCT01964352|Autonomic Agents|autonomic agents|mesh-ancestor
56111830|NCT01964352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111913|NCT01985334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111914|NCT01985334|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56111915|NCT01985334|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56111916|NCT01985334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56111917|NCT01985334|Cholinergic Agents|cholinergic agents|mesh-ancestor
56111918|NCT01985334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56111919|NCT01985334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111920|NCT01944774|Moxifloxacin|moxifloxacin|mesh-list
56111921|NCT01944774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56111922|NCT01944774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56111923|NCT01944774|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56111924|NCT01944774|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56111925|NCT01944774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111926|NCT01944774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111927|NCT01944774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111928|NCT04665648|Nicorandil|nicorandil|mesh-list
56111929|NCT04665648|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56111930|NCT04665648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56111931|NCT04665648|Vasodilator Agents|vasodilator agents|mesh-ancestor
56111932|NCT04665648|Vitamin B Complex|vitamin b complex|mesh-ancestor
56111933|NCT04665648|Vitamins|vitamins|mesh-ancestor
56111934|NCT04665648|Micronutrients|micronutrients|mesh-ancestor
56111935|NCT04665648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111936|NCT01944462|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56111948|NCT01942590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56111949|NCT01942590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56111950|NCT01942590|Respiratory System Agents|respiratory system agents|mesh-ancestor
56111952|NCT01984242|Bevacizumab|bevacizumab|mesh-list
56111953|NCT01984242|Sunitinib|sunitinib|mesh-list
56111954|NCT01984242|Atezolizumab|atezolizumab|mesh-list
56111955|NCT01984242|Antibodies|antibodies|mesh-list
56111956|NCT01984242|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56111957|NCT01984242|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56111958|NCT01984242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56111959|NCT01984242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56111960|NCT01984242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56111961|NCT01984242|Growth Substances|growth substances|mesh-ancestor
56111962|NCT01984242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56111963|NCT01984242|Growth Inhibitors|growth inhibitors|mesh-ancestor
56111964|NCT01984242|Immunologic Factors|immunologic factors|mesh-ancestor
56111965|NCT01984242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56111966|NCT01984242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111967|NCT01984242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56111968|NCT01960842|Levodopa|levodopa|mesh-list
56111969|NCT01960842|Carbidopa|carbidopa|mesh-list
56111970|NCT01960842|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
56111971|NCT01960842|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56111972|NCT01960842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56111997|NCT01983774|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
56111998|NCT01983774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56111999|NCT01983774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112000|NCT01982682|Mycophenolic Acid|mycophenolic acid|mesh-list
56112001|NCT01982682|Cyclophosphamide|cyclophosphamide|mesh-list
56112002|NCT01982682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56112003|NCT01982682|Immunologic Factors|immunologic factors|mesh-ancestor
56112004|NCT01982682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112005|NCT01982682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112006|NCT01982682|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56112007|NCT01982682|Alkylating Agents|alkylating agents|mesh-ancestor
56112008|NCT01982682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112009|NCT01982682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112010|NCT01982682|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56112011|NCT01982682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55742062|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
56112013|NCT01982682|Antitubercular Agents|antitubercular agents|mesh-ancestor
56112014|NCT01982682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56112015|NCT01982682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112052|NCT01939314|Sensory System Agents|sensory system agents|mesh-ancestor
56112053|NCT01939314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112054|NCT01939158|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56112055|NCT01939158|Immunologic Factors|immunologic factors|mesh-ancestor
56112056|NCT01939158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112057|NCT01939002|Interferons|interferons|mesh-list
56112058|NCT01939002|Interferon-beta|interferon-beta|mesh-list
55839008|NCT01408030|Estrogens|estrogens|mesh-list
56112059|NCT01939002|Interferon beta-1a|interferon beta-1a|mesh-list
56112060|NCT01939002|Naproxen|naproxen|mesh-list
56112061|NCT01939002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
56112062|NCT01939002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56112063|NCT01939002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112064|NCT01939002|Antiviral Agents|antiviral agents|mesh-ancestor
56112065|NCT01939002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112066|NCT01939002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56112067|NCT01939002|Analgesics|analgesics|mesh-ancestor
56112068|NCT01939002|Sensory System Agents|sensory system agents|mesh-ancestor
56112069|NCT01939002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112070|NCT01939002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112071|NCT01939002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112136|NCT01959672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56112162|NCT04650282|Anesthetics, Local|anesthetics, local|mesh-ancestor
56112163|NCT04650282|Anesthetics|anesthetics|mesh-ancestor
56112164|NCT04650282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56112165|NCT04650282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112166|NCT04650282|Sensory System Agents|sensory system agents|mesh-ancestor
56112167|NCT04650282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112168|NCT04650282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56112169|NCT04650282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56112170|NCT04650282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56112171|NCT04650282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56112172|NCT04650282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112173|NCT01937364|Baclofen|baclofen|mesh-list
56112174|NCT01937364|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56112175|NCT01937364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112176|NCT01937364|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56112177|NCT01937364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112178|NCT01937364|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
56112179|NCT01937364|GABA Agonists|gaba agonists|mesh-ancestor
56112180|NCT01937364|GABA Agents|gaba agents|mesh-ancestor
56112181|NCT01937364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112182|NCT01937364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112183|NCT01979952|Nintedanib|nintedanib|mesh-list
56112184|NCT01979952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112185|NCT01979952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56112186|NCT01979952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112187|NCT01979952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112188|NCT01936974|Gemcitabine|gemcitabine|mesh-list
56112189|NCT01936974|Bevacizumab|bevacizumab|mesh-list
56112190|NCT01936974|Carboplatin|carboplatin|mesh-list
56112191|NCT01936974|Oxaliplatin|oxaliplatin|mesh-list
56112192|NCT01936974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56112203|NCT01936974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112204|NCT01936974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112205|NCT01936974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56112206|NCT01936974|Immunologic Factors|immunologic factors|mesh-ancestor
56112207|NCT01959516|Glycopyrrolate|glycopyrrolate|mesh-list
56112208|NCT01959516|Tiotropium Bromide|tiotropium bromide|mesh-list
56112209|NCT01959516|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56112210|NCT01959516|Autonomic Agents|autonomic agents|mesh-ancestor
56112211|NCT01959516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112212|NCT01959516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112214|NCT01959516|Respiratory System Agents|respiratory system agents|mesh-ancestor
56112255|NCT01620138|Dopamine Agonists|dopamine agonists|mesh-ancestor
56112256|NCT01620138|Dopamine Agents|dopamine agents|mesh-ancestor
56112257|NCT01620138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112258|NCT01620138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112259|NCT01932996|Nicotine|nicotine|mesh-list
56112260|NCT01932996|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56112261|NCT01932996|Autonomic Agents|autonomic agents|mesh-ancestor
56112266|NCT01932996|Cholinergic Agents|cholinergic agents|mesh-ancestor
56112267|NCT01932996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112268|NCT01932996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112270|NCT01932762|Grazoprevir|grazoprevir|mesh-list
56112271|NCT01932762|Antimetabolites|antimetabolites|mesh-ancestor
56112308|NCT01930188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112309|NCT01930188|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56112310|NCT01930188|Protease Inhibitors|protease inhibitors|mesh-ancestor
56112311|NCT01930188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112312|NCT01930188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112313|NCT01976364|Methotrexate|methotrexate|mesh-list
56112314|NCT01976364|Tofacitinib|tofacitinib|mesh-list
56112315|NCT01976364|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56112316|NCT01976364|Abortifacient Agents|abortifacient agents|mesh-ancestor
56112317|NCT01976364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56112318|NCT01976364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112319|NCT01976364|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56112320|NCT01976364|Antimetabolites|antimetabolites|mesh-ancestor
56112321|NCT01976364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112322|NCT01976364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112325|NCT01976364|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56112326|NCT01976364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56112327|NCT01976364|Immunologic Factors|immunologic factors|mesh-ancestor
56112328|NCT01976364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112329|NCT01976364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56112330|NCT01976364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56112331|NCT03493152|Everolimus|everolimus|mesh-list
56112332|NCT03493152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112333|NCT03493152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56112334|NCT03493152|Immunologic Factors|immunologic factors|mesh-ancestor
56112335|NCT03493152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112336|NCT01929876|Itraconazole|itraconazole|mesh-list
56112337|NCT01929876|Antifungal Agents|antifungal agents|mesh-ancestor
56112338|NCT01929876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112339|NCT01929876|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56112340|NCT01929876|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56112341|NCT01929876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112342|NCT01929876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112343|NCT01929876|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56112344|NCT01929876|Hormone Antagonists|hormone antagonists|mesh-ancestor
56112381|NCT03910439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112382|NCT03895307|Anesthetics|anesthetics|mesh-list
56112408|NCT00378755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112410|NCT00378833|Niacinamide|niacinamide|mesh-list
56112411|NCT00378833|Nicotinic Acids|nicotinic acids|mesh-list
56112412|NCT00378833|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56112413|NCT00378833|Antimetabolites|antimetabolites|mesh-ancestor
56112431|NCT02995967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112432|NCT03888365|Treprostinil|treprostinil|mesh-list
56112433|NCT03888365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56112434|NCT00377975|Pioglitazone|pioglitazone|mesh-list
56112436|NCT00377975|Caffeine|caffeine|mesh-list
56112437|NCT00377975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56112441|NCT00377975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112465|NCT02994251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112466|NCT02994251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56112467|NCT02994251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56112468|NCT02994251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56112469|NCT02994251|Alkylating Agents|alkylating agents|mesh-ancestor
56112470|NCT02994251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56112472|NCT02936999|Cholecalciferol|cholecalciferol|mesh-list
56112473|NCT02936999|Vitamins|vitamins|mesh-ancestor
56112474|NCT02936999|Micronutrients|micronutrients|mesh-ancestor
56112475|NCT02936999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112476|NCT02936999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56112477|NCT02936999|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56112478|NCT02826551|Bupivacaine|bupivacaine|mesh-list
56112479|NCT02826551|Anesthetics, Local|anesthetics, local|mesh-ancestor
56112480|NCT02826551|Anesthetics|anesthetics|mesh-ancestor
56112481|NCT02826551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56112483|NCT02826551|Sensory System Agents|sensory system agents|mesh-ancestor
56112522|NCT01340885|Cholinergic Agents|cholinergic agents|mesh-ancestor
56112523|NCT01340885|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56112524|NCT01340885|Protective Agents|protective agents|mesh-ancestor
56112525|NCT01326923|Cetuximab|cetuximab|mesh-list
56112526|NCT01326923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56112527|NCT01326923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112529|NCT03855059|Dexamethasone acetate|dexamethasone acetate|mesh-list
56112530|NCT03855059|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56112531|NCT03855059|BB 1101|bb 1101|mesh-list
56112532|NCT03855059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112533|NCT03855059|Antiemetics|antiemetics|mesh-ancestor
56112534|NCT03855059|Autonomic Agents|autonomic agents|mesh-ancestor
56112535|NCT03855059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112536|NCT03855059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112537|NCT03855059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56112538|NCT03855059|Glucocorticoids|glucocorticoids|mesh-ancestor
56112539|NCT03855059|Hormones|hormones|mesh-ancestor
56112540|NCT03855059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112541|NCT03855059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56112542|NCT03855059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112543|NCT03855059|Protease Inhibitors|protease inhibitors|mesh-ancestor
56112544|NCT03855059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112546|NCT01301963|Plerixafor|plerixafor|mesh-list
56112573|NCT02708849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56112574|NCT02708849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113303|NCT00379457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56112575|NCT02708849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112576|NCT02708849|Anticonvulsants|anticonvulsants|mesh-ancestor
56112578|NCT02708849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56112579|NCT02708849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56112580|NCT02708849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56112581|NCT02708849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55839536|NCT01890122|Hormones|hormones|mesh-ancestor
56112582|NCT02708849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56112583|NCT02708849|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56112584|NCT01222871|Triamcinolone|triamcinolone|mesh-list
56112585|NCT01222871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56112586|NCT01222871|Glucocorticoids|glucocorticoids|mesh-ancestor
56112588|NCT01222871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112589|NCT01222871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112590|NCT01219673|Minocycline|minocycline|mesh-list
56112591|NCT01219673|Modafinil|modafinil|mesh-list
56112592|NCT01219673|Bupropion|bupropion|mesh-list
56112593|NCT01219673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56112594|NCT01219673|Antidepressive Agents|antidepressive agents|mesh-ancestor
56112595|NCT01219673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56112596|NCT01219673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56112597|NCT01219673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56112622|NCT01216631|Autonomic Agents|autonomic agents|mesh-ancestor
56112623|NCT01216631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112624|NCT01216631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112625|NCT01216631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56112626|NCT01216631|Glucocorticoids|glucocorticoids|mesh-ancestor
56112627|NCT01216631|Hormones|hormones|mesh-ancestor
56112628|NCT01216631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56112629|NCT01216631|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56112630|NCT01216631|Protective Agents|protective agents|mesh-ancestor
56112631|NCT01216631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56112632|NCT01216631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112633|NCT01216631|Dermatologic Agents|dermatologic agents|mesh-ancestor
56112634|NCT01216631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112635|NCT02693717|Pemetrexed|pemetrexed|mesh-list
56112636|NCT02693717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56112637|NCT02693717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112722|NCT00378911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112724|NCT03822377|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56112725|NCT03822377|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
56112726|NCT03822377|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
56112728|NCT03822377|Purinergic Agents|purinergic agents|mesh-ancestor
56112729|NCT03822377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56112730|NCT03822377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112731|NCT03822377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112732|NCT02501759|Pentetic Acid|pentetic acid|mesh-list
56112733|NCT02501759|Antidotes|antidotes|mesh-ancestor
56112734|NCT02501759|Protective Agents|protective agents|mesh-ancestor
56112735|NCT02501759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112736|NCT02501759|Chelating Agents|chelating agents|mesh-ancestor
56112737|NCT02501759|Sequestering Agents|sequestering agents|mesh-ancestor
56112738|NCT02501759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112739|NCT02501759|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56112740|NCT02499887|Prednisone|prednisone|mesh-list
56112741|NCT02499887|Albuterol|albuterol|mesh-list
56112774|NCT02504099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56112775|NCT02504099|Antimetabolites|antimetabolites|mesh-ancestor
56112781|NCT01094561|Secretin|secretin|mesh-list
56112811|NCT03796013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56112812|NCT03796013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112813|NCT03796013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112814|NCT03793751|Dexmedetomidine|dexmedetomidine|mesh-list
56112815|NCT03793751|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56112816|NCT03793751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56112817|NCT03793751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112818|NCT03793751|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56112819|NCT03793751|Analgesics|analgesics|mesh-ancestor
56112820|NCT03793751|Sensory System Agents|sensory system agents|mesh-ancestor
56112821|NCT03793751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112822|NCT03793751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56112823|NCT03793751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56112861|NCT01009931|Protease Inhibitors|protease inhibitors|mesh-ancestor
56112862|NCT01009931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112863|NCT01009931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112864|NCT01009931|Lipotropic Agents|lipotropic agents|mesh-ancestor
56112865|NCT01009931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56112866|NCT01009931|Antimetabolites|antimetabolites|mesh-ancestor
56112867|NCT01009931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56112868|NCT01009931|Nootropic Agents|nootropic agents|mesh-ancestor
56112869|NCT01009931|Analgesics|analgesics|mesh-ancestor
56112872|NCT01009931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56112873|NCT01009931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112874|NCT03792191|Fentanyl|fentanyl|mesh-list
56112875|NCT03792191|Bupivacaine|bupivacaine|mesh-list
56112876|NCT03792191|Anesthetics, Local|anesthetics, local|mesh-ancestor
56112877|NCT03792191|Anesthetics|anesthetics|mesh-ancestor
56112878|NCT03792191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56112879|NCT03792191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112880|NCT03792191|Sensory System Agents|sensory system agents|mesh-ancestor
56112881|NCT03792191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56112882|NCT03792191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56112884|NCT03792191|Analgesics|analgesics|mesh-ancestor
56112885|NCT03792191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56112886|NCT03792191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56112887|NCT03792191|Anesthetics, General|anesthetics, general|mesh-ancestor
56112888|NCT00986999|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56112889|NCT00986999|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56112890|NCT00986999|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56112891|NCT00986999|Antimetabolites|antimetabolites|mesh-ancestor
56112892|NCT00986999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112893|NCT00986999|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56112894|NCT00986999|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56112895|NCT00986999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112896|NCT00983645|Cyclosporine|cyclosporine|mesh-list
56112897|NCT00983645|Tacrolimus|tacrolimus|mesh-list
56112898|NCT00983645|Cyclosporins|cyclosporins|mesh-list
56112899|NCT00983645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56112900|NCT00983645|Immunologic Factors|immunologic factors|mesh-ancestor
56112901|NCT00983645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56112902|NCT00983645|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56112903|NCT00983645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112904|NCT00983645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112905|NCT00983645|Antifungal Agents|antifungal agents|mesh-ancestor
56112906|NCT00983645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112907|NCT00983645|Dermatologic Agents|dermatologic agents|mesh-ancestor
56112908|NCT00983645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56112992|NCT02017379|Erythromycin stearate|erythromycin stearate|mesh-list
56112993|NCT02017379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56112994|NCT02017379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56112995|NCT02017379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56112996|NCT02017379|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56112997|NCT02017379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56112998|NCT02017379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56112999|NCT01997567|Ropivacaine|ropivacaine|mesh-list
56113000|NCT01997567|Anesthetics, Local|anesthetics, local|mesh-ancestor
56113001|NCT01997567|Anesthetics|anesthetics|mesh-ancestor
56113002|NCT01997567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113003|NCT01997567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113004|NCT01997567|Sensory System Agents|sensory system agents|mesh-ancestor
56113005|NCT01997567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113006|NCT00825227|Modafinil|modafinil|mesh-list
56113017|NCT01978535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113044|NCT01938833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56113045|NCT01938833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113047|NCT01938833|Antimitotic Agents|antimitotic agents|mesh-ancestor
56113048|NCT01938833|Mitosis Modulators|mitosis modulators|mesh-ancestor
56113049|NCT01938833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113051|NCT01893359|Riboflavin|riboflavin|mesh-list
56113068|NCT00795665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56113069|NCT00795665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56113070|NCT00795665|Growth Substances|growth substances|mesh-ancestor
56113071|NCT00795665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113072|NCT00795665|Growth Inhibitors|growth inhibitors|mesh-ancestor
56113073|NCT00795665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56113074|NCT00795665|Alkylating Agents|alkylating agents|mesh-ancestor
56113075|NCT00795665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113076|NCT00791843|Hormones|hormones|mesh-list
56113077|NCT00791843|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
56113078|NCT00791843|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56113079|NCT00791843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113080|NCT01836809|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
56113081|NCT01836809|Natriuretic Agents|natriuretic agents|mesh-ancestor
56113082|NCT01836809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113083|NCT00780455|Interferons|interferons|mesh-list
56113084|NCT00780455|Interferon-beta|interferon-beta|mesh-list
56113085|NCT00780455|Interferon beta-1b|interferon beta-1b|mesh-list
56113087|NCT00780455|Antiviral Agents|antiviral agents|mesh-ancestor
56113120|NCT04713527|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56113121|NCT04713527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113123|NCT00716807|Naloxone|naloxone|mesh-list
56113124|NCT00716807|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56113125|NCT00716807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113126|NCT00716807|Sensory System Agents|sensory system agents|mesh-ancestor
56113127|NCT00716807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113168|NCT03248141|Factor VIII|factor viii|mesh-list
56113169|NCT03248141|Coagulants|coagulants|mesh-ancestor
56113170|NCT00378365|Arsenic Trioxide|arsenic trioxide|mesh-list
56113171|NCT00378365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113172|NCT05313425|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56113173|NCT05313425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56113174|NCT01754987|Ascorbic Acid|ascorbic acid|mesh-list
56113175|NCT01754987|Sorafenib|sorafenib|mesh-list
56113177|NCT01754987|Micronutrients|micronutrients|mesh-ancestor
56113178|NCT01754987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113179|NCT01754987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113180|NCT01754987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56113181|NCT01754987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113183|NCT01754987|Antioxidants|antioxidants|mesh-ancestor
56113216|NCT00616577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113217|NCT00616343|Zonisamide|zonisamide|mesh-list
56113218|NCT00616343|Anticonvulsants|anticonvulsants|mesh-ancestor
56113219|NCT00616343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56113220|NCT00616343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56113221|NCT00616343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113222|NCT00616343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56113223|NCT00616343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113224|NCT05599919|Nitric Oxide|nitric oxide|mesh-list
56113225|NCT05599919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56113226|NCT05599919|Autonomic Agents|autonomic agents|mesh-ancestor
56113227|NCT05599919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113228|NCT05599919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113229|NCT05599919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56113230|NCT05599919|Respiratory System Agents|respiratory system agents|mesh-ancestor
56113231|NCT05599919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56113232|NCT05599919|Antioxidants|antioxidants|mesh-ancestor
56113233|NCT05599919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113234|NCT05599919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113235|NCT05599919|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
56113236|NCT05599919|Vasodilator Agents|vasodilator agents|mesh-ancestor
56113237|NCT05599919|Gasotransmitters|gasotransmitters|mesh-ancestor
56113259|NCT00608465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56113260|NCT00608465|Diuretics|diuretics|mesh-ancestor
56113261|NCT00608465|Natriuretic Agents|natriuretic agents|mesh-ancestor
56113262|NCT00608777|Betamethasone|betamethasone|mesh-list
56113263|NCT00608777|Calcipotriene|calcipotriene|mesh-list
56113264|NCT00608777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56113265|NCT00608777|Glucocorticoids|glucocorticoids|mesh-ancestor
56113267|NCT00608777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56113268|NCT00608777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113269|NCT00608777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56113270|NCT00608777|Respiratory System Agents|respiratory system agents|mesh-ancestor
56113271|NCT00608777|Dermatologic Agents|dermatologic agents|mesh-ancestor
56113272|NCT00379457|Dactinomycin|dactinomycin|mesh-list
56113273|NCT00379457|Cyclophosphamide|cyclophosphamide|mesh-list
56113274|NCT00379457|Ifosfamide|ifosfamide|mesh-list
56113275|NCT00379457|Carboplatin|carboplatin|mesh-list
56113276|NCT00379457|Doxorubicin|doxorubicin|mesh-list
56113277|NCT00379457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56113278|NCT00379457|Etoposide|etoposide|mesh-list
56113279|NCT00379457|Vincristine|vincristine|mesh-list
56113280|NCT00379457|Topotecan|topotecan|mesh-list
56113281|NCT00379457|Vinorelbine|vinorelbine|mesh-list
56113299|NCT00379457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56113301|NCT00379457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113302|NCT00379457|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56113304|NCT01629329|Aspirin|aspirin|mesh-list
56113346|NCT00423059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56113347|NCT00423059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113348|NCT00423059|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56113349|NCT00423059|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56113350|NCT00423059|Growth Substances|growth substances|mesh-ancestor
56113351|NCT00423059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113352|NCT00423059|Growth Inhibitors|growth inhibitors|mesh-ancestor
56113353|NCT00585611|Atorvastatin|atorvastatin|mesh-list
56113354|NCT00585611|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56113355|NCT00585611|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56113356|NCT00585611|Antimetabolites|antimetabolites|mesh-ancestor
56113357|NCT00585611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113358|NCT00585611|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56113359|NCT00585611|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56113360|NCT00585611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113361|NCT00379691|Phenylephrine|phenylephrine|mesh-list
56113362|NCT00379691|Oxymetazoline|oxymetazoline|mesh-list
56113363|NCT00379691|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56113364|NCT00379691|Mydriatics|mydriatics|mesh-ancestor
56113365|NCT00379691|Autonomic Agents|autonomic agents|mesh-ancestor
56113366|NCT00379691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113367|NCT00379691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113368|NCT00379691|Sympathomimetics|sympathomimetics|mesh-ancestor
56113369|NCT00379691|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55840370|NCT01827332|Oxytocin|oxytocin|mesh-list
56113398|NCT00000737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113399|NCT00000737|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
56113400|NCT00000737|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
56113402|NCT00000737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113403|NCT00000737|Hormones|hormones|mesh-ancestor
56113404|NCT00000737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56113405|NCT00000737|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56113421|NCT00528437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113422|NCT00528437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56113423|NCT00528437|Alkylating Agents|alkylating agents|mesh-ancestor
56113424|NCT00528437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113425|NCT00528437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56113426|NCT00528437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56113427|NCT00528437|Immunologic Factors|immunologic factors|mesh-ancestor
56113428|NCT00528437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113429|NCT00528437|Keratolytic Agents|keratolytic agents|mesh-ancestor
56113430|NCT00528437|Dermatologic Agents|dermatologic agents|mesh-ancestor
56113431|NCT00000743|Zidovudine|zidovudine|mesh-list
56113432|NCT00000743|Antimetabolites|antimetabolites|mesh-ancestor
56113433|NCT00000743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113434|NCT00000743|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56113435|NCT00000743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113436|NCT00000743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113437|NCT00000743|Antiviral Agents|antiviral agents|mesh-ancestor
56113438|NCT00000743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113439|NCT00000743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56113482|NCT00428207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113483|NCT00000791|Zidovudine|zidovudine|mesh-list
56113484|NCT00000791|Antimetabolites|antimetabolites|mesh-ancestor
56113485|NCT00000791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113486|NCT00000791|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56113504|NCT00374543|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56113505|NCT00374543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56113506|NCT00374543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113507|NCT00374543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56113508|NCT00374543|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56113509|NCT00374543|Dopamine Agents|dopamine agents|mesh-ancestor
56113510|NCT00000803|Zidovudine|zidovudine|mesh-list
56113511|NCT00000803|Didanosine|didanosine|mesh-list
56113512|NCT00000803|Delavirdine|delavirdine|mesh-list
56113513|NCT00000803|Antimetabolites|antimetabolites|mesh-ancestor
56113514|NCT00000803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113515|NCT00000803|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56113516|NCT00000803|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113517|NCT00000803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113518|NCT00000803|Antiviral Agents|antiviral agents|mesh-ancestor
56113553|NCT01351415|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56113556|NCT00281879|Mycophenolic Acid|mycophenolic acid|mesh-list
56113557|NCT00281879|Methylprednisolone|methylprednisolone|mesh-list
56113591|NCT00281879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113592|NCT00281879|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56113593|NCT00281879|Antifungal Agents|antifungal agents|mesh-ancestor
56113594|NCT00281879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56113595|NCT00281879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56113596|NCT00281879|Antitubercular Agents|antitubercular agents|mesh-ancestor
56113597|NCT00281879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56113606|NCT00281879|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56113607|NCT00281879|Protective Agents|protective agents|mesh-ancestor
56113608|NCT00000809|Aluminum Hydroxide|aluminum hydroxide|mesh-list
56113609|NCT00000809|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56113610|NCT00000809|Immunologic Factors|immunologic factors|mesh-ancestor
56113611|NCT00000809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113613|NCT00000809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113614|NCT00000809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56113615|NCT05091203|Vitamin D|vitamin d|mesh-list
56113616|NCT05091203|Vitamins|vitamins|mesh-ancestor
56113617|NCT05091203|Micronutrients|micronutrients|mesh-ancestor
56113618|NCT05091203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113619|NCT05091203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56113620|NCT00240227|Prazosin|prazosin|mesh-list
56113621|NCT00240227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56113622|NCT00240227|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56113623|NCT00240227|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56113656|NCT00000839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113657|NCT00000839|Antiviral Agents|antiviral agents|mesh-ancestor
56113658|NCT00000839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113659|NCT00000839|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56113660|NCT00000839|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56113661|NCT00133679|Sildenafil Citrate|sildenafil citrate|mesh-list
56113662|NCT00133679|Vasodilator Agents|vasodilator agents|mesh-ancestor
56113663|NCT00133679|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56113664|NCT00133679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56113665|NCT00133679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113666|NCT00133679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113667|NCT00133679|Urological Agents|urological agents|mesh-ancestor
56113668|NCT00000875|Acetaminophen|acetaminophen|mesh-list
56113669|NCT00000875|Diphenhydramine|diphenhydramine|mesh-list
56113670|NCT00000875|Promethazine|promethazine|mesh-list
56113671|NCT00000875|Lamivudine|lamivudine|mesh-list
56113672|NCT00000875|Zidovudine|zidovudine|mesh-list
56113673|NCT00000875|Aldesleukin|aldesleukin|mesh-list
56113674|NCT00000875|Indinavir|indinavir|mesh-list
56113675|NCT00000875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56113676|NCT00000875|Analgesics|analgesics|mesh-ancestor
56113677|NCT00000875|Sensory System Agents|sensory system agents|mesh-ancestor
56113678|NCT00000875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113679|NCT00000875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113680|NCT00000875|Antipyretics|antipyretics|mesh-ancestor
56113681|NCT00000875|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56113682|NCT00000875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56113707|NCT00000875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56113708|NCT00000875|Protease Inhibitors|protease inhibitors|mesh-ancestor
56113709|NCT04941833|Desogestrel|desogestrel|mesh-list
56113710|NCT04941833|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56113711|NCT04941833|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56113712|NCT04941833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56113713|NCT04941833|Contraceptive Agents|contraceptive agents|mesh-ancestor
56113714|NCT04941833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56113715|NCT04941833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113716|NCT04941833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56113717|NCT04941833|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56113718|NCT04941833|Progestins|progestins|mesh-ancestor
56113719|NCT04941833|Hormones|hormones|mesh-ancestor
56113720|NCT04941833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56113721|NCT04841369|Vaccines|vaccines|mesh-list
56113722|NCT04841369|Immunologic Factors|immunologic factors|mesh-ancestor
56113723|NCT04841369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113724|NCT00002975|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56113725|NCT00002975|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56113726|NCT00002975|Dermatologic Agents|dermatologic agents|mesh-ancestor
56113727|NCT00521885|Enoxaparin|enoxaparin|mesh-list
56113728|NCT00521885|Fondaparinux|fondaparinux|mesh-list
56113729|NCT00521885|Anticoagulants|anticoagulants|mesh-ancestor
56113730|NCT00521885|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56113731|NCT00521885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56113733|NCT00521885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56114719|NCT00000701|Zidovudine|zidovudine|mesh-list
56113758|NCT00000887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113759|NCT00000887|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56113760|NCT00000887|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56113761|NCT00000887|Antimetabolites|antimetabolites|mesh-ancestor
56113762|NCT00000887|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56113763|NCT00000887|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56113764|NCT00000887|Protease Inhibitors|protease inhibitors|mesh-ancestor
56113765|NCT04755647|Nitric Oxide|nitric oxide|mesh-list
56113766|NCT04755647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56113767|NCT04755647|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56113768|NCT04755647|Autonomic Agents|autonomic agents|mesh-ancestor
56113769|NCT04755647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113770|NCT04755647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113771|NCT04755647|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56113772|NCT04755647|Respiratory System Agents|respiratory system agents|mesh-ancestor
56113773|NCT04755647|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56113774|NCT04755647|Antioxidants|antioxidants|mesh-ancestor
56113775|NCT04755647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113776|NCT04755647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113777|NCT04755647|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55840733|NCT03024580|Exemestane|exemestane|mesh-list
56113778|NCT04755647|Vasodilator Agents|vasodilator agents|mesh-ancestor
56113779|NCT04755647|Gasotransmitters|gasotransmitters|mesh-ancestor
56113780|NCT04755647|Protective Agents|protective agents|mesh-ancestor
56113781|NCT04716725|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
56113782|NCT04716725|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56113783|NCT04716725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113784|NCT00000119|Heparin|heparin|mesh-list
56113785|NCT00000119|Anticoagulants|anticoagulants|mesh-ancestor
56113802|NCT00000923|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56113803|NCT00000923|Antimetabolites|antimetabolites|mesh-ancestor
56113804|NCT00000923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56113805|NCT00000923|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56113806|NCT00000923|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56113807|NCT00000923|Protease Inhibitors|protease inhibitors|mesh-ancestor
56113808|NCT00000161|Aspirin|aspirin|mesh-list
56113809|NCT00000161|Vitamins|vitamins|mesh-list
56113810|NCT00000161|Vitamin E|vitamin e|mesh-list
56113811|NCT00000161|Beta Carotene|beta carotene|mesh-list
56113812|NCT00000161|Carotenoids|carotenoids|mesh-list
56113813|NCT00000161|Micronutrients|micronutrients|mesh-ancestor
56113814|NCT00000161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113815|NCT00000161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56113816|NCT00000161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56113817|NCT00000161|Analgesics|analgesics|mesh-ancestor
56113833|NCT00000929|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56113834|NCT00000929|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56113835|NCT00000929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113836|NCT00000929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56113837|NCT00000929|Contraceptive Agents|contraceptive agents|mesh-ancestor
56113838|NCT00000929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56113839|NCT00000929|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56113840|NCT00000935|Immunoglobulins|immunoglobulins|mesh-list
56113842|NCT00000935|gamma-Globulins|gamma-globulins|mesh-list
56113843|NCT00000935|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
56113844|NCT00000935|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
56113845|NCT00000935|Immunologic Factors|immunologic factors|mesh-ancestor
56113846|NCT00000935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113847|NCT00000197|Propranolol|propranolol|mesh-list
56113848|NCT00000197|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56113849|NCT00000197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56113850|NCT00000197|Adrenergic Agents|adrenergic agents|mesh-ancestor
56113851|NCT00000197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113852|NCT00000197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113853|NCT00000197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113854|NCT00000197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56113855|NCT00000197|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56113856|NCT00000197|Vasodilator Agents|vasodilator agents|mesh-ancestor
56113857|NCT04375631|Cytarabine|cytarabine|mesh-list
56113858|NCT04375631|Cyclosporine|cyclosporine|mesh-list
56113859|NCT04375631|Mycophenolic Acid|mycophenolic acid|mesh-list
56113882|NCT04375631|Dermatologic Agents|dermatologic agents|mesh-ancestor
56113883|NCT04375631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56113884|NCT04375631|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56113885|NCT04375631|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56113886|NCT04375631|Antitubercular Agents|antitubercular agents|mesh-ancestor
56113887|NCT04375631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56113888|NCT04375631|Analgesics|analgesics|mesh-ancestor
56113889|NCT04375631|Sensory System Agents|sensory system agents|mesh-ancestor
56113890|NCT04375631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113891|NCT04375631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56113892|NCT04375631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56113893|NCT00000947|Azithromycin|azithromycin|mesh-list
56113894|NCT00000947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56113895|NCT00000947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56113896|NCT00000203|Buprenorphine|buprenorphine|mesh-list
56113897|NCT00000203|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56113898|NCT00000203|Narcotics|narcotics|mesh-ancestor
56113899|NCT00000203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113900|NCT00000203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113901|NCT00000203|Analgesics|analgesics|mesh-ancestor
56113902|NCT00000203|Sensory System Agents|sensory system agents|mesh-ancestor
56113903|NCT00000203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113936|NCT00000227|Buprenorphine|buprenorphine|mesh-list
56113937|NCT00000227|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56113938|NCT00000227|Narcotics|narcotics|mesh-ancestor
56113939|NCT00000227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113940|NCT00000227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113941|NCT00000227|Analgesics|analgesics|mesh-ancestor
56113942|NCT00000227|Sensory System Agents|sensory system agents|mesh-ancestor
56113943|NCT00000227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113944|NCT00000227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56113945|NCT00000233|Buprenorphine|buprenorphine|mesh-list
56113946|NCT00000233|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56113947|NCT00000233|Narcotics|narcotics|mesh-ancestor
56113948|NCT00000233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113949|NCT00000233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113950|NCT00000233|Analgesics|analgesics|mesh-ancestor
56113951|NCT00000233|Sensory System Agents|sensory system agents|mesh-ancestor
56113952|NCT00000233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113953|NCT00000233|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56113954|NCT00000239|Buprenorphine|buprenorphine|mesh-list
56113955|NCT00000239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56113956|NCT00000239|Narcotics|narcotics|mesh-ancestor
56113957|NCT00000239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56113958|NCT00000239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113959|NCT00000239|Analgesics|analgesics|mesh-ancestor
56113960|NCT00000239|Sensory System Agents|sensory system agents|mesh-ancestor
56113961|NCT00000239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113962|NCT00000239|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56113963|NCT00000245|Desipramine|desipramine|mesh-list
56113964|NCT00000245|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56113965|NCT00000245|Antidepressive Agents|antidepressive agents|mesh-ancestor
56113966|NCT00000245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56113967|NCT00000245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56113980|NCT00000263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113981|NCT00000263|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56113982|NCT00000263|Anesthetics, General|anesthetics, general|mesh-ancestor
56113983|NCT00000263|Anesthetics|anesthetics|mesh-ancestor
56113984|NCT00000263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56113985|NCT00000263|Analgesics|analgesics|mesh-ancestor
56113986|NCT00000263|Sensory System Agents|sensory system agents|mesh-ancestor
56113987|NCT00000263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113988|NCT00000269|Pergolide|pergolide|mesh-list
56113989|NCT00000269|Dopamine Agonists|dopamine agonists|mesh-ancestor
56113990|NCT00000269|Dopamine Agents|dopamine agents|mesh-ancestor
56113991|NCT00000269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56113992|NCT00000269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56113993|NCT00000269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56113994|NCT04038515|Menthol|menthol|mesh-list
56113996|NCT04038515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56113997|NCT04038515|Autonomic Agents|autonomic agents|mesh-ancestor
56113998|NCT04038515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56113999|NCT04038515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114000|NCT04038515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56114001|NCT04038515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56114003|NCT04038515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114004|NCT04038515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114005|NCT04038515|Antipruritics|antipruritics|mesh-ancestor
56114031|NCT00000989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114032|NCT00000989|Antiviral Agents|antiviral agents|mesh-ancestor
56114033|NCT00000989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114034|NCT00000989|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114035|NCT00000989|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114036|NCT00000989|Immunologic Factors|immunologic factors|mesh-ancestor
56114037|NCT00000989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114038|NCT03617705|Ethanol|ethanol|mesh-list
56114039|NCT03617705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56114040|NCT03617705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114041|NCT03617705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114042|NCT03617705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114043|NCT00000995|Zidovudine|zidovudine|mesh-list
56114044|NCT00000995|Ganciclovir|ganciclovir|mesh-list
56114045|NCT00000995|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56114046|NCT00000995|Antimetabolites|antimetabolites|mesh-ancestor
56114047|NCT00000995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114048|NCT00000995|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114049|NCT00000995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114050|NCT00000995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114051|NCT00000995|Antiviral Agents|antiviral agents|mesh-ancestor
56114052|NCT00000995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114053|NCT00000995|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114054|NCT00000995|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114055|NCT03493685|Irbesartan|irbesartan|mesh-list
56114056|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56114080|NCT03121001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56114082|NCT03121001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114083|NCT03121001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114084|NCT03121001|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56114085|NCT03121001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56114086|NCT03121001|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56114087|NCT03121001|Antitubercular Agents|antitubercular agents|mesh-ancestor
56114088|NCT03121001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56114089|NCT03121001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114090|NCT03121001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114093|NCT03055247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56114094|NCT03055247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56114095|NCT03055247|Analgesics|analgesics|mesh-ancestor
56114096|NCT03055247|Sensory System Agents|sensory system agents|mesh-ancestor
56114097|NCT03055247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114098|NCT03055247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114099|NCT03055247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56114100|NCT03055247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56114101|NCT03055247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56114102|NCT03055247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114103|NCT03055247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114104|NCT00001049|Zidovudine|zidovudine|mesh-list
56114105|NCT00001049|Didanosine|didanosine|mesh-list
56114128|NCT00000275|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56114129|NCT00000275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56114130|NCT00000275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114131|NCT00000275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114132|NCT00000275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56114133|NCT00000275|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56114134|NCT00000275|Dopamine Agents|dopamine agents|mesh-ancestor
56114135|NCT00000275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114136|NCT00000275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114137|NCT00001061|Ganciclovir|ganciclovir|mesh-list
56114138|NCT00001061|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56114139|NCT00001061|Foscarnet|foscarnet|mesh-list
56114140|NCT00001061|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56114141|NCT00001061|Antiviral Agents|antiviral agents|mesh-ancestor
56114142|NCT00001061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114143|NCT00001061|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114144|NCT00001061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114145|NCT00001061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114146|NCT00001061|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114147|NCT00000281|Amantadine|amantadine|mesh-list
56114148|NCT00000281|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56114149|NCT00000281|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56114150|NCT00000281|Antiviral Agents|antiviral agents|mesh-ancestor
56114151|NCT00000281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114152|NCT00000281|Dopamine Agents|dopamine agents|mesh-ancestor
56114153|NCT00000281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114154|NCT00000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114155|NCT00000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114156|NCT00000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56114157|NCT00000281|Analgesics|analgesics|mesh-ancestor
56114158|NCT00000281|Sensory System Agents|sensory system agents|mesh-ancestor
56114170|NCT00001067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114171|NCT00001067|Antimetabolites|antimetabolites|mesh-ancestor
56114172|NCT00001079|Methyltestosterone|methyltestosterone|mesh-list
56114173|NCT00001079|Megestrol|megestrol|mesh-list
56114174|NCT00001079|Megestrol Acetate|megestrol acetate|mesh-list
56114175|NCT00001079|Testosterone|testosterone|mesh-list
56114176|NCT00001079|Testosterone undecanoate|testosterone undecanoate|mesh-list
56114177|NCT00001079|Testosterone enanthate|testosterone enanthate|mesh-list
56114178|NCT00001079|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56114179|NCT00001079|Androgens|androgens|mesh-ancestor
56114180|NCT00001079|Hormones|hormones|mesh-ancestor
56114181|NCT00001079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56114182|NCT00001079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114183|NCT00001079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56114184|NCT00001079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114185|NCT00001079|Anabolic Agents|anabolic agents|mesh-ancestor
56114186|NCT00001079|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56114187|NCT00001079|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56114188|NCT00001079|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56114224|NCT00001091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114225|NCT00001091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114226|NCT00001091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56114227|NCT00001091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56114229|NCT00000299|Buprenorphine|buprenorphine|mesh-list
56114230|NCT00000299|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56114231|NCT00000299|Narcotics|narcotics|mesh-ancestor
56114232|NCT00000299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114233|NCT00000299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114234|NCT00000299|Analgesics|analgesics|mesh-ancestor
56114235|NCT00000299|Sensory System Agents|sensory system agents|mesh-ancestor
56114236|NCT00000299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114237|NCT00000299|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56114238|NCT00000305|Dextroamphetamine|dextroamphetamine|mesh-list
55841197|NCT04194658|Letrozole|letrozole|mesh-list
56114239|NCT00000305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56114240|NCT00000305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114241|NCT00000305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56114242|NCT00000305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56114243|NCT00000305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56114244|NCT00000305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114246|NCT00000305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114248|NCT00000311|Methadone|methadone|mesh-list
56114249|NCT00000311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56114271|NCT00001115|Acyclovir|acyclovir|mesh-list
56114272|NCT00001115|Antiviral Agents|antiviral agents|mesh-ancestor
56114273|NCT00001115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114274|NCT00001757|Voriconazole|voriconazole|mesh-list
56114275|NCT00001757|Antifungal Agents|antifungal agents|mesh-ancestor
56114276|NCT00001757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114277|NCT00001757|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56114278|NCT00001757|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56114279|NCT00001757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114280|NCT00001757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114281|NCT00001757|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56114282|NCT00001757|Hormone Antagonists|hormone antagonists|mesh-ancestor
56114283|NCT00001757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56114284|NCT00001757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114285|NCT00001757|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56114286|NCT00001133|Ritonavir|ritonavir|mesh-list
56114287|NCT00001133|Indinavir|indinavir|mesh-list
56114288|NCT00001133|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56114289|NCT00001133|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56114325|NCT00000347|Serotonin Agents|serotonin agents|mesh-ancestor
56114326|NCT00000347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114327|NCT00000347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114328|NCT00000347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114329|NCT00000347|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56114330|NCT00000347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56114331|NCT00000347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114332|NCT00000347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56114333|NCT00000347|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56114334|NCT00000347|Dopamine Agents|dopamine agents|mesh-ancestor
56114335|NCT00001835|Oxaliplatin|oxaliplatin|mesh-list
56114336|NCT00001835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114337|NCT00001193|Melphalan|melphalan|mesh-list
56114338|NCT00001193|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56114339|NCT00001193|Alkylating Agents|alkylating agents|mesh-ancestor
56114340|NCT00001193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114341|NCT00001193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114347|NCT00000353|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56114348|NCT00000353|Naloxone|naloxone|mesh-list
56114349|NCT00000353|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56114350|NCT00000353|Narcotics|narcotics|mesh-ancestor
56114353|NCT00000353|Analgesics|analgesics|mesh-ancestor
56114373|NCT00000389|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56114374|NCT00000389|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56114375|NCT00000389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114376|NCT00000389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114377|NCT00000389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56114378|NCT00000389|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56114379|NCT00000389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56114380|NCT00000389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56114381|NCT00000389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114390|NCT00001877|Pentoxifylline|pentoxifylline|mesh-list
56114391|NCT00001877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56114392|NCT00001877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114393|NCT00001877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114394|NCT00001877|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56114395|NCT00001877|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56114396|NCT00001877|Protective Agents|protective agents|mesh-ancestor
56114397|NCT00001877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114398|NCT00001877|Vasodilator Agents|vasodilator agents|mesh-ancestor
56114399|NCT00001877|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56114400|NCT00001877|Antioxidants|antioxidants|mesh-ancestor
56114401|NCT00380939|Atorvastatin|atorvastatin|mesh-list
56114402|NCT00380939|Pravastatin|pravastatin|mesh-list
56114433|NCT00001901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56114434|NCT00001901|Immunologic Factors|immunologic factors|mesh-ancestor
56114436|NCT00000437|Nicotine|nicotine|mesh-list
56114437|NCT00000437|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56114438|NCT00000437|Autonomic Agents|autonomic agents|mesh-ancestor
56114439|NCT00000437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114440|NCT00000437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114441|NCT00000437|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56114442|NCT00000437|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56114443|NCT00000437|Cholinergic Agents|cholinergic agents|mesh-ancestor
56114444|NCT00000437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56114445|NCT00000437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114446|NCT00000437|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56114447|NCT00000437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56114448|NCT00000437|Sensory System Agents|sensory system agents|mesh-ancestor
56114449|NCT00000443|Ondansetron|ondansetron|mesh-list
56114450|NCT00000443|Antiemetics|antiemetics|mesh-ancestor
56114451|NCT00000443|Autonomic Agents|autonomic agents|mesh-ancestor
56114452|NCT00000443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114481|NCT00001307|Sensory System Agents|sensory system agents|mesh-ancestor
56114482|NCT00001307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114483|NCT00001307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114484|NCT04713761|Carboplatin|carboplatin|mesh-list
56114485|NCT04713761|Pemetrexed|pemetrexed|mesh-list
56114486|NCT04713761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114487|NCT04713761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114488|NCT04713761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114489|NCT04713761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56114490|NCT04713761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114491|NCT00001937|Fluconazole|fluconazole|mesh-list
56114492|NCT00001937|Antifungal Agents|antifungal agents|mesh-ancestor
56114493|NCT00001937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114494|NCT00001937|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56114521|NCT00001955|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56114522|NCT00001955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114523|NCT00001955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114524|NCT00001955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56114525|NCT00001955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56114526|NCT00001955|Immunologic Factors|immunologic factors|mesh-ancestor
56114527|NCT04943783|Atorvastatin|atorvastatin|mesh-list
56114528|NCT04943783|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56114529|NCT04943783|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56114530|NCT04943783|Antimetabolites|antimetabolites|mesh-ancestor
56115155|NCT00002387|Antiviral Agents|antiviral agents|mesh-ancestor
56114531|NCT04943783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114532|NCT04943783|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56114533|NCT04943783|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56114534|NCT04943783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114535|NCT00000605|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56114536|NCT00000605|Medroxyprogesterone|medroxyprogesterone|mesh-list
56114538|NCT00000605|Estrogens|estrogens|mesh-list
56114539|NCT00000605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56114551|NCT00000617|Azithromycin|azithromycin|mesh-list
56114577|NCT00001991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114579|NCT00001997|Didanosine|didanosine|mesh-list
56114580|NCT00001997|Interleukin-2|interleukin-2|mesh-list
56114581|NCT00001997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114582|NCT00001997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56114583|NCT00001997|Analgesics|analgesics|mesh-ancestor
56114584|NCT00001997|Sensory System Agents|sensory system agents|mesh-ancestor
56114585|NCT00001997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114586|NCT00001997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114587|NCT00001997|Antimetabolites|antimetabolites|mesh-ancestor
56114588|NCT00001997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114589|NCT00001997|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114590|NCT00001997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114591|NCT00001997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114592|NCT00001997|Antiviral Agents|antiviral agents|mesh-ancestor
56114593|NCT00001997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114594|NCT00001997|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114595|NCT00001997|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114596|NCT00002003|Etoposide|etoposide|mesh-list
56114597|NCT00002003|Mitoxantrone|mitoxantrone|mesh-list
56114598|NCT00002003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56114599|NCT00002003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114600|NCT00002003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56114601|NCT00002003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56114602|NCT00002003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114604|NCT00002003|Analgesics|analgesics|mesh-ancestor
56114626|NCT00000629|Antimanic Agents|antimanic agents|mesh-ancestor
56114627|NCT00000629|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56114628|NCT00000629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56114629|NCT00000629|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56114630|NCT00000647|Interferons|interferons|mesh-list
56114631|NCT00000647|Interferon-alpha|interferon-alpha|mesh-list
56114632|NCT00000647|Zidovudine|zidovudine|mesh-list
56114633|NCT00000647|CD4 Immunoadhesins|cd4 immunoadhesins|mesh-list
56114634|NCT00000647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114635|NCT00000647|Antiviral Agents|antiviral agents|mesh-ancestor
56114636|NCT00000647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114637|NCT00000647|Immunologic Factors|immunologic factors|mesh-ancestor
56114638|NCT00000647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114639|NCT00000647|Antimetabolites|antimetabolites|mesh-ancestor
56114640|NCT00000647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114641|NCT00000647|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114642|NCT00000647|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114643|NCT00000647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114644|NCT00000647|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114645|NCT00000647|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114646|NCT00000653|Zalcitabine|zalcitabine|mesh-list
56114647|NCT00000653|Antimetabolites|antimetabolites|mesh-ancestor
56114648|NCT00000653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114649|NCT00000653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114679|NCT00381017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114680|NCT00381017|Immunologic Factors|immunologic factors|mesh-ancestor
56114681|NCT00381017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114682|NCT00002015|Ganciclovir|ganciclovir|mesh-list
56114683|NCT00002015|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
55841637|NCT03929224|Bacitracin|bacitracin|mesh-list
56114684|NCT00002015|Antiviral Agents|antiviral agents|mesh-ancestor
56114685|NCT00002015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114696|NCT00002021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114698|NCT00002027|Coccidiostats|coccidiostats|mesh-ancestor
56114699|NCT00002027|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56114700|NCT00002027|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56114701|NCT00002027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114702|NCT00000695|Interferons|interferons|mesh-list
56114703|NCT00000695|Zidovudine|zidovudine|mesh-list
56114704|NCT00000695|Interferon-beta|interferon-beta|mesh-list
56114705|NCT00000695|Interferon beta-1b|interferon beta-1b|mesh-list
56114744|NCT00000725|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114745|NCT00000725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114746|NCT00000725|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114747|NCT00000725|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114748|NCT00002033|Zidovudine|zidovudine|mesh-list
56114749|NCT00002033|Antimetabolites|antimetabolites|mesh-ancestor
56114750|NCT00002033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114751|NCT00002033|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114752|NCT00002033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114753|NCT00002033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114754|NCT00002033|Antiviral Agents|antiviral agents|mesh-ancestor
56114755|NCT00002033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114756|NCT00002033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114757|NCT00002033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114758|NCT00002039|Foscarnet|foscarnet|mesh-list
56114759|NCT00002039|Phosphonoacetic Acid|phosphonoacetic acid|mesh-list
56114760|NCT00002039|Antiviral Agents|antiviral agents|mesh-ancestor
56114761|NCT00002039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114762|NCT00002039|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114763|NCT00002039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114764|NCT00002039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114765|NCT00002039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114766|NCT00000731|Acetaminophen|acetaminophen|mesh-list
56114767|NCT00000731|Zidovudine|zidovudine|mesh-list
56114768|NCT00000731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56114769|NCT00000731|Analgesics|analgesics|mesh-ancestor
56114770|NCT00000731|Sensory System Agents|sensory system agents|mesh-ancestor
56114771|NCT00000731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56114772|NCT00000731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114773|NCT00000731|Antipyretics|antipyretics|mesh-ancestor
56114774|NCT00000731|Antimetabolites|antimetabolites|mesh-ancestor
56114775|NCT00000731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114776|NCT00000731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114777|NCT00000731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114778|NCT00000731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114782|NCT00000731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114783|NCT00002045|Zidovudine|zidovudine|mesh-list
56114784|NCT00002045|Antimetabolites|antimetabolites|mesh-ancestor
56114785|NCT00002045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114786|NCT00002045|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114787|NCT00002045|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114788|NCT00002045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114789|NCT00002045|Antiviral Agents|antiviral agents|mesh-ancestor
56114790|NCT00002045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114791|NCT00002045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114792|NCT00002045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114794|NCT00002051|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56114795|NCT00002051|Immunologic Factors|immunologic factors|mesh-ancestor
56114796|NCT00002051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114797|NCT00001499|Paclitaxel|paclitaxel|mesh-list
56114798|NCT00001499|Cisplatin|cisplatin|mesh-list
56114799|NCT00001499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56114800|NCT00001499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114801|NCT00001499|Tubulin Modulators|tubulin modulators|mesh-ancestor
56114802|NCT00001499|Antimitotic Agents|antimitotic agents|mesh-ancestor
56114803|NCT00001499|Mitosis Modulators|mitosis modulators|mesh-ancestor
56114804|NCT00001499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114805|NCT00002057|Nystatin|nystatin|mesh-list
56114806|NCT00002057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56114807|NCT00002057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114808|NCT00002057|Antifungal Agents|antifungal agents|mesh-ancestor
56114809|NCT00002057|Ionophores|ionophores|mesh-ancestor
56114810|NCT00002057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56114811|NCT00002057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114812|NCT00002297|Inosine Pranobex|inosine pranobex|mesh-list
56114813|NCT00002297|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56114814|NCT00002297|Immunologic Factors|immunologic factors|mesh-ancestor
56114815|NCT00002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114816|NCT00002297|Antiviral Agents|antiviral agents|mesh-ancestor
56114817|NCT00002297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114850|NCT00002309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114851|NCT00002315|Acyclovir|acyclovir|mesh-list
56114852|NCT00002315|5-propynylarabinofuranosyluracil|5-propynylarabinofuranosyluracil|mesh-list
56114853|NCT00002315|Antiviral Agents|antiviral agents|mesh-ancestor
56114888|NCT00002081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114889|NCT00002081|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56114890|NCT00002081|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56114891|NCT00002081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114892|NCT00002081|Antiviral Agents|antiviral agents|mesh-ancestor
56114893|NCT00002081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114894|NCT00002081|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114895|NCT00002081|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114896|NCT00002093|Doxorubicin|doxorubicin|mesh-list
56114897|NCT00002093|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56114898|NCT00002093|Daunorubicin|daunorubicin|mesh-list
56114899|NCT00002093|Bleomycin|bleomycin|mesh-list
56114900|NCT00002093|Vincristine|vincristine|mesh-list
56114901|NCT00002093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56114902|NCT00002093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114903|NCT00002093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56114904|NCT00002093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56114905|NCT00002093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114906|NCT00002093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114907|NCT00002093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56114908|NCT00002093|Tubulin Modulators|tubulin modulators|mesh-ancestor
56114909|NCT00002093|Antimitotic Agents|antimitotic agents|mesh-ancestor
56114910|NCT00002093|Mitosis Modulators|mitosis modulators|mesh-ancestor
56114911|NCT00002099|Didanosine|didanosine|mesh-list
56114912|NCT00002099|Lentinan|lentinan|mesh-list
56114929|NCT00002321|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114930|NCT00002321|Antiviral Agents|antiviral agents|mesh-ancestor
56114931|NCT00002321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114932|NCT00002327|Cidofovir|cidofovir|mesh-list
56114933|NCT00002327|Antiviral Agents|antiviral agents|mesh-ancestor
56114934|NCT00002327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114935|NCT00002327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114936|NCT00002327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114937|NCT00002333|Saquinavir|saquinavir|mesh-list
56114938|NCT00002333|Zalcitabine|zalcitabine|mesh-list
56114939|NCT00002333|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56114940|NCT00002333|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56114941|NCT00002333|Protease Inhibitors|protease inhibitors|mesh-ancestor
56114942|NCT00002333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114943|NCT00002333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114944|NCT00002333|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56114945|NCT00002333|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56114946|NCT00002333|Antiviral Agents|antiviral agents|mesh-ancestor
56114947|NCT00002333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56114950|NCT00002333|Antimetabolites|antimetabolites|mesh-ancestor
56114973|NCT00002105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56114974|NCT00002105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114975|NCT00002105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56114976|NCT00002105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56114977|NCT00002105|Tubulin Modulators|tubulin modulators|mesh-ancestor
56114978|NCT00002105|Antimitotic Agents|antimitotic agents|mesh-ancestor
56114979|NCT00002105|Mitosis Modulators|mitosis modulators|mesh-ancestor
56114980|NCT00002345|Megestrol|megestrol|mesh-list
56114981|NCT00002345|Megestrol Acetate|megestrol acetate|mesh-list
56114982|NCT00002345|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56114983|NCT00002345|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56114984|NCT00002345|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56114985|NCT00002345|Contraceptive Agents|contraceptive agents|mesh-ancestor
56114986|NCT00002345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56114987|NCT00002345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56114988|NCT00002345|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56114989|NCT00002345|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56114990|NCT00002345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56114991|NCT00002345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56114992|NCT00002345|Appetite Stimulants|appetite stimulants|mesh-ancestor
56114993|NCT00002345|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56114995|NCT00002111|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56114996|NCT00002111|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56114997|NCT00002111|Protease Inhibitors|protease inhibitors|mesh-ancestor
56114998|NCT00002111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56114999|NCT00002111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115000|NCT00002111|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115001|NCT00002111|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115017|NCT00002357|Antimetabolites|antimetabolites|mesh-ancestor
56115018|NCT00002357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115019|NCT00002357|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115281|NCT00002447|Ritonavir|ritonavir|mesh-list
56115020|NCT00002357|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115021|NCT00002357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115022|NCT00002357|Antiviral Agents|antiviral agents|mesh-ancestor
56115023|NCT00002357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115024|NCT00002357|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115025|NCT00002357|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115026|NCT00002117|Zidovudine|zidovudine|mesh-list
56115027|NCT00002117|Zalcitabine|zalcitabine|mesh-list
56115028|NCT00002117|Antimetabolites|antimetabolites|mesh-ancestor
56115029|NCT00002117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115030|NCT00002117|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115031|NCT00002117|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115032|NCT00002117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115033|NCT00002117|Antiviral Agents|antiviral agents|mesh-ancestor
56115034|NCT00002117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115035|NCT00002117|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115036|NCT00002117|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115037|NCT00002123|Didanosine|didanosine|mesh-list
56115038|NCT00002123|Delavirdine|delavirdine|mesh-list
56115039|NCT00002123|Antimetabolites|antimetabolites|mesh-ancestor
56115040|NCT00002123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115041|NCT00002123|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115042|NCT00002123|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115043|NCT00002123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115044|NCT00002123|Antiviral Agents|antiviral agents|mesh-ancestor
56115045|NCT00002123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115046|NCT00002123|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115060|NCT05752409|Esketamine|esketamine|mesh-list
56115061|NCT05752409|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56115062|NCT05752409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56115063|NCT05752409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115064|NCT05752409|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56115065|NCT05752409|Anesthetics, General|anesthetics, general|mesh-ancestor
56115067|NCT05752409|Analgesics|analgesics|mesh-ancestor
56115068|NCT05752409|Sensory System Agents|sensory system agents|mesh-ancestor
56115069|NCT05752409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56115070|NCT05752409|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56115071|NCT05752409|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56115072|NCT05752409|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56115073|NCT05752409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56115074|NCT05752409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115075|NCT05752409|Antidepressive Agents|antidepressive agents|mesh-ancestor
56115076|NCT05752409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56115077|NCT00002129|Vesnarinone|vesnarinone|mesh-list
56115078|NCT00002129|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56115079|NCT00002129|Immunologic Factors|immunologic factors|mesh-ancestor
56115080|NCT00002129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115114|NCT00002369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115115|NCT00002369|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115116|NCT00002369|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115117|NCT00002369|Antimetabolites|antimetabolites|mesh-ancestor
56115118|NCT00002369|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115119|NCT00002369|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115120|NCT00002369|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115121|NCT00002375|Nelfinavir|nelfinavir|mesh-list
56115122|NCT00002375|Indinavir|indinavir|mesh-list
56115123|NCT00002375|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115124|NCT00002375|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55842092|NCT03580876|Azathioprine|azathioprine|mesh-list
56115138|NCT00002381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115139|NCT00002381|Antiviral Agents|antiviral agents|mesh-ancestor
56115140|NCT00002381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115141|NCT00002381|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115142|NCT00002381|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115143|NCT00002381|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56115144|NCT00002381|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56115145|NCT00002381|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115146|NCT00002381|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115147|NCT00002381|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115148|NCT00002381|Antimetabolites|antimetabolites|mesh-ancestor
56115149|NCT00002387|Efavirenz|efavirenz|mesh-list
56115150|NCT00002387|Indinavir|indinavir|mesh-list
56115151|NCT00002387|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115152|NCT00002387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115153|NCT00002387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115154|NCT00002387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115156|NCT00002387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115157|NCT00002387|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56115158|NCT00002387|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56115159|NCT00002387|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56115160|NCT00002387|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56115175|NCT00002393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115176|NCT00002393|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56115177|NCT00002393|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56115178|NCT00002393|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56115179|NCT00002393|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56115180|NCT00002393|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56115181|NCT00002393|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56115182|NCT00002393|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115184|NCT00002393|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115185|NCT00002393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115186|NCT00002393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115187|NCT00002399|Fluconazole|fluconazole|mesh-list
56115188|NCT00002399|Posaconazole|posaconazole|mesh-list
56115189|NCT00002399|Antifungal Agents|antifungal agents|mesh-ancestor
56115190|NCT00002399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115191|NCT00002399|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56115192|NCT00002399|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56115193|NCT00002399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115194|NCT00002399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115195|NCT00002399|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56115222|NCT00002417|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115223|NCT00002417|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115224|NCT00002417|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115225|NCT00002417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115226|NCT00002417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115227|NCT00002417|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115228|NCT00002417|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115229|NCT00002417|Antiviral Agents|antiviral agents|mesh-ancestor
56115230|NCT00002423|Lamivudine|lamivudine|mesh-list
56115231|NCT00002423|Abacavir|abacavir|mesh-list
56115232|NCT00002423|Nelfinavir|nelfinavir|mesh-list
56115233|NCT00002423|Indinavir|indinavir|mesh-list
56115234|NCT00002423|Amprenavir|amprenavir|mesh-list
56115238|NCT00002423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115239|NCT00002423|Antiviral Agents|antiviral agents|mesh-ancestor
56115240|NCT00002423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115241|NCT00002423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115242|NCT00002423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115243|NCT00002423|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115244|NCT00002423|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115245|NCT00002423|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115246|NCT00002423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56115247|NCT00002423|Antitubercular Agents|antitubercular agents|mesh-ancestor
56115248|NCT00002423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115249|NCT02973581|Acetaminophen|acetaminophen|mesh-list
56115250|NCT02973581|Dipyrone|dipyrone|mesh-list
56115251|NCT02973581|Lidocaine|lidocaine|mesh-list
56115252|NCT02973581|Bupivacaine|bupivacaine|mesh-list
56115253|NCT02973581|Proxymetacaine|proxymetacaine|mesh-list
56115254|NCT02973581|Anesthetics, Local|anesthetics, local|mesh-ancestor
56115255|NCT02973581|Anesthetics|anesthetics|mesh-ancestor
56115256|NCT02973581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56115261|NCT02973581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56115262|NCT02973581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56115263|NCT02973581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56115264|NCT02973581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115265|NCT02973581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56115268|NCT02973581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56115269|NCT02973581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56115270|NCT02973581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56115271|NCT00002435|Zidovudine|zidovudine|mesh-list
56115272|NCT00002435|Antimetabolites|antimetabolites|mesh-ancestor
56115273|NCT00002435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115274|NCT00002435|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115275|NCT00002435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115276|NCT00002435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115277|NCT00002435|Antiviral Agents|antiviral agents|mesh-ancestor
56115278|NCT00002435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115279|NCT00002435|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115280|NCT00002435|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115284|NCT00002447|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115285|NCT00002447|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115286|NCT00002447|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115287|NCT00002447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115288|NCT00002447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115289|NCT00002447|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115290|NCT00002447|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115291|NCT00002447|Antiviral Agents|antiviral agents|mesh-ancestor
56115295|NCT00002447|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115296|NCT00002447|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115297|NCT00002447|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56115303|NCT00002453|Antiviral Agents|antiviral agents|mesh-ancestor
56115304|NCT00002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115305|NCT00002453|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115306|NCT00002453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115307|NCT00002453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115308|NCT00002453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115309|NCT00002453|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115310|NCT00002453|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115311|NCT00002465|Megestrol|megestrol|mesh-list
56115312|NCT00002465|Megestrol Acetate|megestrol acetate|mesh-list
56115313|NCT00002465|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56115314|NCT00002465|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56115315|NCT00002465|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56115316|NCT00002465|Contraceptive Agents|contraceptive agents|mesh-ancestor
56115317|NCT00002465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56115318|NCT00002465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115319|NCT00002465|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56115320|NCT00002465|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56115321|NCT00002465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56115322|NCT00002465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115323|NCT00002465|Appetite Stimulants|appetite stimulants|mesh-ancestor
56115324|NCT00002465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56115337|NCT00002471|Vincristine|vincristine|mesh-list
56115338|NCT00002471|Daunorubicin|daunorubicin|mesh-list
56115339|NCT00002471|Asparaginase|asparaginase|mesh-list
56115340|NCT00002471|Levoleucovorin|levoleucovorin|mesh-list
56115341|NCT00002471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115342|NCT00002471|Immunologic Factors|immunologic factors|mesh-ancestor
56115343|NCT00002471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115344|NCT00002471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56115345|NCT00002471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115346|NCT00002471|Alkylating Agents|alkylating agents|mesh-ancestor
56115347|NCT00002471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115348|NCT00002471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115349|NCT00002471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56115350|NCT00002471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56115351|NCT00002471|Antiemetics|antiemetics|mesh-ancestor
56115352|NCT00002471|Autonomic Agents|autonomic agents|mesh-ancestor
56115353|NCT00002471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56115354|NCT00002471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56115355|NCT00002471|Glucocorticoids|glucocorticoids|mesh-ancestor
56115356|NCT00002471|Hormones|hormones|mesh-ancestor
56115402|NCT00002489|Cyclophosphamide|cyclophosphamide|mesh-list
56115405|NCT00002489|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56115406|NCT00002489|Methotrexate|methotrexate|mesh-list
56115407|NCT00002489|Etoposide|etoposide|mesh-list
56115408|NCT00002489|Vincristine|vincristine|mesh-list
56115409|NCT00002489|Levoleucovorin|levoleucovorin|mesh-list
56115410|NCT00002489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115411|NCT00002489|Immunologic Factors|immunologic factors|mesh-ancestor
56115412|NCT00002489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115413|NCT00002489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56115414|NCT00002489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115415|NCT00002489|Alkylating Agents|alkylating agents|mesh-ancestor
56115416|NCT00002489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115475|NCT00002159|Amphotericin B|amphotericin b|mesh-list
56115476|NCT00002159|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56115477|NCT00002159|Antifungal Agents|antifungal agents|mesh-ancestor
56115478|NCT00002159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115479|NCT00002159|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56115480|NCT00002159|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56115481|NCT00002159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115482|NCT00002159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115483|NCT00002159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56115485|NCT00002159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56115486|NCT00002159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115487|NCT00002159|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56115489|NCT00002159|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56115490|NCT00002159|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56115491|NCT00002159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115493|NCT00002165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115494|NCT00002165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115495|NCT00002165|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115496|NCT00002165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115497|NCT00002165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115498|NCT00002165|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115499|NCT00002165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115500|NCT00002165|Antiviral Agents|antiviral agents|mesh-ancestor
56115507|NCT00002171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115508|NCT00002171|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115509|NCT00002171|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115510|NCT00002171|Antiviral Agents|antiviral agents|mesh-ancestor
56115511|NCT00002171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115512|NCT00002177|Nelfinavir|nelfinavir|mesh-list
56115513|NCT00002177|Didanosine|didanosine|mesh-list
56115514|NCT00002177|Stavudine|stavudine|mesh-list
56115515|NCT00002177|Hydroxyurea|hydroxyurea|mesh-list
56115516|NCT00002177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115517|NCT00002177|Antisickling Agents|antisickling agents|mesh-ancestor
56115518|NCT00002177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115519|NCT00002177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115520|NCT00002177|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115522|NCT00002177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115523|NCT00002177|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115524|NCT00002177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115525|NCT00002177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115526|NCT00002177|Antiviral Agents|antiviral agents|mesh-ancestor
56115527|NCT00002177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115528|NCT00002177|Antimetabolites|antimetabolites|mesh-ancestor
56115529|NCT00002177|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115530|NCT00002183|Lamivudine|lamivudine|mesh-list
56115531|NCT00002183|Zidovudine|zidovudine|mesh-list
56115532|NCT00002183|Abacavir|abacavir|mesh-list
56115533|NCT00002183|Amprenavir|amprenavir|mesh-list
56115534|NCT00002183|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115535|NCT00002183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115536|NCT00002183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115537|NCT00002183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115551|NCT00002189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115553|NCT00002189|Antimitotic Agents|antimitotic agents|mesh-ancestor
56115554|NCT00002189|Mitosis Modulators|mitosis modulators|mesh-ancestor
56115555|NCT00002189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115556|NCT00002195|Lamivudine|lamivudine|mesh-list
56115557|NCT00002195|Zidovudine|zidovudine|mesh-list
56115558|NCT00002195|Amprenavir|amprenavir|mesh-list
56115559|NCT00002195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115560|NCT00002195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115561|NCT00002195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115562|NCT00002195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115563|NCT00002195|Antiviral Agents|antiviral agents|mesh-ancestor
56115564|NCT00002195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115565|NCT00002195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115586|NCT00002201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56115588|NCT00002213|Abacavir|abacavir|mesh-list
56115589|NCT00002213|Amprenavir|amprenavir|mesh-list
56115590|NCT00002213|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115591|NCT00002213|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115592|NCT00002213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115593|NCT00002213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115594|NCT00002213|Antiviral Agents|antiviral agents|mesh-ancestor
56115595|NCT00002213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115596|NCT00002213|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56115597|NCT00002213|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56115598|NCT00002213|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56115599|NCT00002213|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56115600|NCT00002213|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56115601|NCT00002213|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56115602|NCT00002213|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115603|NCT00002213|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115604|NCT00002213|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56115605|NCT00002213|Antitubercular Agents|antitubercular agents|mesh-ancestor
56115606|NCT00002213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115607|NCT00002213|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56115608|NCT00002213|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56115609|NCT00002213|Protease Inhibitors|protease inhibitors|mesh-ancestor
56115610|NCT00381251|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
56115611|NCT00381251|Estrogens|estrogens|mesh-ancestor
56115612|NCT00381251|Hormones|hormones|mesh-ancestor
56115613|NCT00381251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56115615|NCT00002219|Nelfinavir|nelfinavir|mesh-list
56115629|NCT00002225|Efavirenz|efavirenz|mesh-list
56115630|NCT00002225|Didanosine|didanosine|mesh-list
56115631|NCT00002225|Stavudine|stavudine|mesh-list
56115632|NCT00002225|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115633|NCT00002225|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115634|NCT00002225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115635|NCT00002225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115636|NCT00002225|Antiviral Agents|antiviral agents|mesh-ancestor
56115637|NCT00002225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115638|NCT00002225|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
56115639|NCT00002225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56115640|NCT00002225|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
56115641|NCT00002225|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56115642|NCT00002225|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56115643|NCT00002225|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56115644|NCT00002225|Antimetabolites|antimetabolites|mesh-ancestor
56115645|NCT00002225|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115646|NCT00002225|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115647|NCT00002243|Calanolide A|calanolide a|mesh-list
56115648|NCT00002243|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115649|NCT00002243|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115650|NCT00002243|Antiviral Agents|antiviral agents|mesh-ancestor
56115651|NCT00002243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115652|NCT00002249|Levofloxacin|levofloxacin|mesh-list
56115653|NCT00002249|Ofloxacin|ofloxacin|mesh-list
56115654|NCT00002249|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56115655|NCT00002249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115656|NCT00002249|Renal Agents|renal agents|mesh-ancestor
56115657|NCT00002249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56115658|NCT00002249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115659|NCT00002249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115665|NCT00002255|Zidovudine|zidovudine|mesh-list
56115669|NCT00002255|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56115670|NCT00002255|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115671|NCT00002255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115672|NCT00002255|Antiviral Agents|antiviral agents|mesh-ancestor
56115673|NCT00002255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115674|NCT00002255|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115675|NCT00002255|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115676|NCT00002255|Hematinics|hematinics|mesh-ancestor
56115677|NCT00002261|Vaccines|vaccines|mesh-list
56115678|NCT00002261|Immunologic Factors|immunologic factors|mesh-ancestor
56115679|NCT00002261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115680|NCT00002507|Mitomycins|mitomycins|mesh-list
56115681|NCT00002507|Mitomycin|mitomycin|mesh-list
56115682|NCT00002507|Porfiromycin|porfiromycin|mesh-list
56115683|NCT00002507|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56115684|NCT00002507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115685|NCT00002507|Alkylating Agents|alkylating agents|mesh-ancestor
56115686|NCT00002507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115687|NCT00002507|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115724|NCT00002285|Antiviral Agents|antiviral agents|mesh-ancestor
56115725|NCT00002285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115726|NCT00002285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56115727|NCT00002285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56115728|NCT00002531|Leucovorin|leucovorin|mesh-list
56115729|NCT00002531|Cytarabine|cytarabine|mesh-list
56115730|NCT00002531|Dexamethasone|dexamethasone|mesh-list
56115731|NCT00002531|Prednisolone|prednisolone|mesh-list
56115732|NCT00002531|Cyclophosphamide|cyclophosphamide|mesh-list
56115733|NCT00002531|Ifosfamide|ifosfamide|mesh-list
56115734|NCT00002531|Doxorubicin|doxorubicin|mesh-list
56115735|NCT00002531|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56115736|NCT00002531|Methotrexate|methotrexate|mesh-list
56115737|NCT00002531|Etoposide|etoposide|mesh-list
56115738|NCT00002531|Vincristine|vincristine|mesh-list
56115739|NCT00002531|Daunorubicin|daunorubicin|mesh-list
56115740|NCT00002531|Asparaginase|asparaginase|mesh-list
56115747|NCT00002531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115748|NCT00002531|Immunologic Factors|immunologic factors|mesh-ancestor
56115749|NCT00002531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115750|NCT00002531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56115751|NCT00002531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115752|NCT00002531|Alkylating Agents|alkylating agents|mesh-ancestor
56115777|NCT00002531|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56115778|NCT00002531|Antiviral Agents|antiviral agents|mesh-ancestor
56115779|NCT00002531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115780|NCT00002531|Antidotes|antidotes|mesh-ancestor
56115781|NCT00002531|Protective Agents|protective agents|mesh-ancestor
56115782|NCT00002531|Vitamin B Complex|vitamin b complex|mesh-ancestor
56115784|NCT00002531|Micronutrients|micronutrients|mesh-ancestor
56115785|NCT00002531|Tubulin Modulators|tubulin modulators|mesh-ancestor
56115807|NCT00002549|Cyclophosphamide|cyclophosphamide|mesh-list
56115809|NCT00002549|Etoposide|etoposide|mesh-list
56115810|NCT00002549|Daunorubicin|daunorubicin|mesh-list
56115811|NCT00002549|Mitoxantrone|mitoxantrone|mesh-list
56115812|NCT00002549|Idarubicin|idarubicin|mesh-list
56115813|NCT00002549|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55842771|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56115834|NCT00002555|Cobalt|cobalt|mesh-list
56115844|NCT00002561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115845|NCT00002561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115846|NCT00002561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115847|NCT00002561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115848|NCT00002561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115864|NCT05751629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56115865|NCT05751629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115866|NCT05751629|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56115867|NCT05751629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56115868|NCT05751629|Growth Substances|growth substances|mesh-ancestor
56115869|NCT05751629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115870|NCT05751629|Growth Inhibitors|growth inhibitors|mesh-ancestor
56115871|NCT05751629|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56115872|NCT05751629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115873|NCT05751629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115875|NCT00002579|Cyclophosphamide|cyclophosphamide|mesh-list
56115876|NCT00002579|Fluorouracil|fluorouracil|mesh-list
56115877|NCT00002579|Methotrexate|methotrexate|mesh-list
56115878|NCT00002579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115879|NCT00002579|Immunologic Factors|immunologic factors|mesh-ancestor
56115880|NCT00002579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115881|NCT00002579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56115882|NCT00002579|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56115883|NCT00002579|Alkylating Agents|alkylating agents|mesh-ancestor
56115884|NCT00002579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56115885|NCT00002579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115886|NCT00002579|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56115887|NCT00002579|Antimetabolites|antimetabolites|mesh-ancestor
56115888|NCT00002579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56115889|NCT00002579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55755688|NCT04129151|Palbociclib|palbociclib|mesh-list
56115891|NCT00002579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55842845|NCT03152890|Insulin|insulin|mesh-list
56115892|NCT00002579|Dermatologic Agents|dermatologic agents|mesh-ancestor
56115893|NCT00002579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56115894|NCT00002579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56115895|NCT00002579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56115896|NCT00002579|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56115897|NCT00002579|Hormone Antagonists|hormone antagonists|mesh-ancestor
56115898|NCT00002579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56115899|NCT00002579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56115900|NCT00002579|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56115901|NCT00002579|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56115902|NCT00002579|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56115904|NCT00002585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115905|NCT05704049|Dexamethasone|dexamethasone|mesh-list
56115906|NCT05704049|Dexamethasone acetate|dexamethasone acetate|mesh-list
56115945|NCT00002615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56115946|NCT00002615|Immunologic Factors|immunologic factors|mesh-ancestor
56115947|NCT00002615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115948|NCT00002615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56115949|NCT00002615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56115950|NCT00002615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56115955|NCT00002621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56115956|NCT00002621|Antiviral Agents|antiviral agents|mesh-ancestor
56115957|NCT00002621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56115958|NCT00002621|Immunologic Factors|immunologic factors|mesh-ancestor
56115959|NCT00002621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56115960|NCT00002627|Paclitaxel|paclitaxel|mesh-list
56115961|NCT00002627|Cyclophosphamide|cyclophosphamide|mesh-list
56115962|NCT00002627|Carboplatin|carboplatin|mesh-list
56115977|NCT00002633|Goserelin|goserelin|mesh-list
56116007|NCT00002657|Etoposide|etoposide|mesh-list
56116008|NCT00002657|Vincristine|vincristine|mesh-list
56116009|NCT00002657|Bleomycin|bleomycin|mesh-list
56116010|NCT00002657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116011|NCT00002657|Immunologic Factors|immunologic factors|mesh-ancestor
56116012|NCT00002657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116013|NCT00002657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116014|NCT00002657|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56116015|NCT00002657|Alkylating Agents|alkylating agents|mesh-ancestor
56116016|NCT00002657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116017|NCT00002657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116018|NCT00002657|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56116019|NCT00002657|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56116020|NCT00002657|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56116021|NCT00002657|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56116022|NCT00002657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116023|NCT00002657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56116024|NCT00002657|Glucocorticoids|glucocorticoids|mesh-ancestor
56116025|NCT00002657|Hormones|hormones|mesh-ancestor
56116026|NCT00002657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116027|NCT00002657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56116028|NCT00002657|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56116029|NCT00002657|Abortifacient Agents|abortifacient agents|mesh-ancestor
56116057|NCT05673785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56116058|NCT05673785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116059|NCT05673785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56116060|NCT05673785|Glucocorticoids|glucocorticoids|mesh-ancestor
56116062|NCT05673785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116063|NCT05673785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56116064|NCT05673785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56116065|NCT05671991|Empagliflozin|empagliflozin|mesh-list
56116066|NCT05671991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56116067|NCT05671991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116069|NCT05671991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116070|NCT00381875|Sargramostim|sargramostim|mesh-list
56116071|NCT00381875|Freund's Adjuvant|freund's adjuvant|mesh-list
56116072|NCT00381875|Immunologic Factors|immunologic factors|mesh-ancestor
56116073|NCT00381875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116074|NCT00381875|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56116115|NCT00002681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116116|NCT00002681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116117|NCT00002681|Immunologic Factors|immunologic factors|mesh-ancestor
56116118|NCT00002681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116119|NCT02973113|Nivolumab|nivolumab|mesh-list
56116120|NCT02973113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56116121|NCT02973113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116122|NCT02973113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56116123|NCT02973113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116124|NCT00002687|Aldesleukin|aldesleukin|mesh-list
56116125|NCT00002687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116126|NCT00002687|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56116127|NCT00002687|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56116128|NCT00002687|Antiviral Agents|antiviral agents|mesh-ancestor
56116129|NCT00002687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116176|NCT00002723|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56116177|NCT05645393|Estrogens|estrogens|mesh-list
56116178|NCT05645393|Hormones|hormones|mesh-ancestor
56116187|NCT00002735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116188|NCT00002735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116189|NCT00002735|Immunologic Factors|immunologic factors|mesh-ancestor
56116190|NCT00002735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116191|NCT00002735|Trace Elements|trace elements|mesh-ancestor
56116192|NCT00002735|Micronutrients|micronutrients|mesh-ancestor
56116194|NCT00002747|Fluorouracil|fluorouracil|mesh-list
55843144|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
56116195|NCT00002747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116196|NCT00002747|Antimetabolites|antimetabolites|mesh-ancestor
56116197|NCT00002747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116198|NCT00002747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116199|NCT00002747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116200|NCT00002747|Immunologic Factors|immunologic factors|mesh-ancestor
56116204|NCT02973035|Amlodipine|amlodipine|mesh-list
56116225|NCT00002759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116226|NCT00002759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116227|NCT00002759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116228|NCT00002759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116229|NCT00002759|Immunologic Factors|immunologic factors|mesh-ancestor
56116230|NCT00002759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116231|NCT00002759|Antifungal Agents|antifungal agents|mesh-ancestor
56116232|NCT00002759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116233|NCT00002759|Dermatologic Agents|dermatologic agents|mesh-ancestor
56116234|NCT00002759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116235|NCT00002759|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56116236|NCT00002759|Anticonvulsants|anticonvulsants|mesh-ancestor
56116237|NCT00002759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56116240|NCT00002759|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56116242|NCT00002759|GABA Modulators|gaba modulators|mesh-ancestor
56116243|NCT00002759|GABA Agents|gaba agents|mesh-ancestor
56116244|NCT00002759|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56116245|NCT00002759|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56116246|NCT00002759|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56116247|NCT00002765|Immunotoxins|immunotoxins|mesh-list
56116248|NCT00002765|Immunologic Factors|immunologic factors|mesh-ancestor
56116249|NCT00002765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116250|NCT00002771|Interferons|interferons|mesh-list
56116251|NCT00002771|Cytarabine|cytarabine|mesh-list
56116252|NCT00002771|Interferon-alpha|interferon-alpha|mesh-list
56116253|NCT00002771|Busulfan|busulfan|mesh-list
56116254|NCT00002771|Idarubicin|idarubicin|mesh-list
56116255|NCT00002771|Hydroxyurea|hydroxyurea|mesh-list
56116256|NCT00002771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116257|NCT00002771|Antiviral Agents|antiviral agents|mesh-ancestor
56116258|NCT00002771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116259|NCT00002771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116260|NCT00002771|Antimetabolites|antimetabolites|mesh-ancestor
56116261|NCT00002771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116262|NCT00002771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116263|NCT00002771|Immunologic Factors|immunologic factors|mesh-ancestor
56116264|NCT00002771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116265|NCT00002771|Alkylating Agents|alkylating agents|mesh-ancestor
56116266|NCT00002771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56116267|NCT00002771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56116282|NCT00002777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116283|NCT00002777|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
56116284|NCT00002777|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
56116285|NCT00002777|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56116286|NCT00002777|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56116287|NCT00002777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56116288|NCT00002777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116289|NCT00002783|Leucovorin|leucovorin|mesh-list
56116290|NCT00002783|Fluorouracil|fluorouracil|mesh-list
56116291|NCT00002783|Floxuridine|floxuridine|mesh-list
56116292|NCT00002783|Calcium|calcium|mesh-list
56116293|NCT00002783|Levoleucovorin|levoleucovorin|mesh-list
56116294|NCT00002783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116295|NCT00002783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56116296|NCT00002783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116297|NCT00002783|Antimetabolites|antimetabolites|mesh-ancestor
56116298|NCT00002783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116299|NCT00002783|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116300|NCT00002783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116301|NCT00002783|Immunologic Factors|immunologic factors|mesh-ancestor
56116302|NCT00002783|Antidotes|antidotes|mesh-ancestor
56116303|NCT00002783|Protective Agents|protective agents|mesh-ancestor
56116304|NCT00002783|Vitamin B Complex|vitamin b complex|mesh-ancestor
56116305|NCT00002783|Vitamins|vitamins|mesh-ancestor
56116306|NCT00002783|Micronutrients|micronutrients|mesh-ancestor
56116307|NCT00002789|Cyclosporine|cyclosporine|mesh-list
56116308|NCT00002789|Cyclophosphamide|cyclophosphamide|mesh-list
56116309|NCT00002789|Busulfan|busulfan|mesh-list
56116310|NCT00002789|Methotrexate|methotrexate|mesh-list
56116311|NCT00002789|Cyclosporins|cyclosporins|mesh-list
56116312|NCT00002789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116313|NCT00002789|Immunologic Factors|immunologic factors|mesh-ancestor
56116314|NCT00002789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116316|NCT00002789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56116317|NCT00002789|Alkylating Agents|alkylating agents|mesh-ancestor
56116318|NCT00002789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116319|NCT00002789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116320|NCT00002789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56116321|NCT00002789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56116323|NCT00002789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56116324|NCT00002789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116325|NCT00002789|Antimetabolites|antimetabolites|mesh-ancestor
56116326|NCT00002789|Dermatologic Agents|dermatologic agents|mesh-ancestor
56116327|NCT00002789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116328|NCT00002789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56116329|NCT00002789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56116330|NCT00002789|Antifungal Agents|antifungal agents|mesh-ancestor
56116331|NCT00002789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116332|NCT00002789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56116371|NCT05749445|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56116372|NCT05749445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56116374|NCT05749367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56116375|NCT05749367|Anesthetics, Local|anesthetics, local|mesh-ancestor
56116376|NCT05749367|Anesthetics|anesthetics|mesh-ancestor
56116377|NCT05749367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56116378|NCT05749367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116379|NCT05749367|Sensory System Agents|sensory system agents|mesh-ancestor
56116380|NCT05749367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116381|NCT05749289|Octreotide|octreotide|mesh-list
56116382|NCT05749289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56116383|NCT05749289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56116384|NCT05749289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116385|NCT05749211|Niraparib|niraparib|mesh-list
56116433|NCT05561387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116434|NCT05561387|Immunologic Factors|immunologic factors|mesh-ancestor
56116435|NCT05561387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56116436|NCT05561387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56116437|NCT05561387|Growth Substances|growth substances|mesh-ancestor
56116438|NCT05561387|Growth Inhibitors|growth inhibitors|mesh-ancestor
56116439|NCT05561387|Dermatologic Agents|dermatologic agents|mesh-ancestor
56116441|NCT05545319|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56116442|NCT05545319|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56116443|NCT05545319|Protease Inhibitors|protease inhibitors|mesh-ancestor
56116444|NCT05545319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116445|NCT05545319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116446|NCT05545319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56116447|NCT05545319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56116448|NCT05545319|Antiviral Agents|antiviral agents|mesh-ancestor
56116449|NCT05545319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116450|NCT05545319|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56116451|NCT05545319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56116453|NCT05523869|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56116454|NCT05523869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56116455|NCT05523869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116456|NCT05523869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116457|NCT05523869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116463|NCT05522465|Dexamethasone|dexamethasone|mesh-list
56116464|NCT05522465|Prednisone|prednisone|mesh-list
56116465|NCT05522465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56116486|NCT05237297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116487|NCT05237297|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
56116488|NCT05237297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56116489|NCT05237297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116490|NCT05237297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116491|NCT05237297|Gout Suppressants|gout suppressants|mesh-ancestor
56116493|NCT05215691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56116494|NCT05215691|Narcotics|narcotics|mesh-ancestor
56116495|NCT05215691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56116496|NCT05215691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116497|NCT05215691|Analgesics|analgesics|mesh-ancestor
56116498|NCT05215691|Sensory System Agents|sensory system agents|mesh-ancestor
56116499|NCT05215691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116500|NCT05204147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56116501|NCT05204147|Antibodies|antibodies|mesh-list
55843447|NCT01561989|Vaccines|vaccines|mesh-list
56116503|NCT05204147|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56116504|NCT05204147|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
56116505|NCT05204147|Immunologic Factors|immunologic factors|mesh-ancestor
56116506|NCT05204147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116507|NCT05204147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116508|NCT05204147|Chelating Agents|chelating agents|mesh-ancestor
56116509|NCT05204147|Sequestering Agents|sequestering agents|mesh-ancestor
56116510|NCT05204147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116536|NCT05168423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116538|NCT05168423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56116539|NCT05168423|Dermatologic Agents|dermatologic agents|mesh-ancestor
56116540|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
56116541|NCT05167409|Cetuximab|cetuximab|mesh-list
56116542|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56116543|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116544|NCT04798781|Pembrolizumab|pembrolizumab|mesh-list
56116545|NCT04798781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56116546|NCT04798781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116547|NCT05406713|Pembrolizumab|pembrolizumab|mesh-list
56116548|NCT05406713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56116549|NCT05406713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116550|NCT04783415|Acalabrutinib|acalabrutinib|mesh-list
56116551|NCT04783415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116552|NCT05406479|Bedaquiline|bedaquiline|mesh-list
56116553|NCT05406479|Antitubercular Agents|antitubercular agents|mesh-ancestor
56116554|NCT05406479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56116562|NCT05124977|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56116584|NCT00382421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56116585|NCT00382421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116586|NCT00382421|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56116587|NCT00382421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116588|NCT00382421|Vasodilator Agents|vasodilator agents|mesh-ancestor
56116589|NCT00382421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56116590|NCT00382421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56116591|NCT00382421|Analgesics|analgesics|mesh-ancestor
56116592|NCT00382421|Sensory System Agents|sensory system agents|mesh-ancestor
56116593|NCT00382421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116594|NCT00382421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56116595|NCT00382421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116596|NCT00382421|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56116597|NCT00382421|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56116598|NCT00382421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56116614|NCT05343455|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56116615|NCT05343455|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56116616|NCT04673357|Ustekinumab|ustekinumab|mesh-list
56116617|NCT04673357|Dermatologic Agents|dermatologic agents|mesh-ancestor
56116618|NCT05069831|Abrocitinib|abrocitinib|mesh-list
56116619|NCT05069831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56116620|NCT05069831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116621|NCT05069831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116622|NCT04658849|Pioglitazone|pioglitazone|mesh-list
56116623|NCT04658849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56116624|NCT04658849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116625|NCT05049863|Mycophenolic Acid|mycophenolic acid|mesh-list
56116626|NCT05049863|Irinotecan|irinotecan|mesh-list
56116627|NCT05049863|Allopurinol|allopurinol|mesh-list
56116628|NCT05049863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56116629|NCT05049863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56116630|NCT05049863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116631|NCT05049863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116632|NCT05049863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116633|NCT05049863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56116634|NCT05049863|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56116638|NCT05049863|Antimetabolites|antimetabolites|mesh-ancestor
56116640|NCT05049863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116641|NCT05049863|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56116642|NCT05049863|Antioxidants|antioxidants|mesh-ancestor
56116643|NCT05049863|Protective Agents|protective agents|mesh-ancestor
56116644|NCT05049863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116645|NCT05312255|Propranolol|propranolol|mesh-list
56116646|NCT05312255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
56116647|NCT05312255|Adrenergic Agents|adrenergic agents|mesh-list
56116648|NCT05312255|Adrenergic Antagonists|adrenergic antagonists|mesh-list
56116649|NCT05312255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56116650|NCT05312255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116651|NCT05312255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116652|NCT05312255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56116653|NCT05312255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56116654|NCT05312255|Vasodilator Agents|vasodilator agents|mesh-ancestor
56116686|NCT05289167|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56116710|NCT00382889|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56116711|NCT00382889|Autonomic Agents|autonomic agents|mesh-ancestor
56116712|NCT00382889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56116713|NCT00382889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116714|NCT00382889|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56116715|NCT00382889|Respiratory System Agents|respiratory system agents|mesh-ancestor
56116716|NCT00382889|Tocolytic Agents|tocolytic agents|mesh-ancestor
56116717|NCT00382889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56116718|NCT00382889|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56116719|NCT00382889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56116720|NCT00382889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56116721|NCT00382889|Adrenergic Agents|adrenergic agents|mesh-ancestor
56116722|NCT00382889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56116723|NCT00382889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843672|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
56116724|NCT00382889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56116766|NCT04571879|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56116767|NCT04571879|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56116768|NCT04571879|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56116769|NCT04571879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56116770|NCT04571879|Anesthetics, General|anesthetics, general|mesh-ancestor
56116771|NCT04571879|GABA Modulators|gaba modulators|mesh-ancestor
56116773|NCT04571879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56116774|NCT04563533|Vaccines|vaccines|mesh-list
56116775|NCT04563533|Immunologic Factors|immunologic factors|mesh-ancestor
56116776|NCT04563533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116777|NCT05251259|Montelukast|montelukast|mesh-list
56116778|NCT05251259|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56116779|NCT05251259|Respiratory System Agents|respiratory system agents|mesh-ancestor
56116780|NCT05251259|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
56116781|NCT05251259|Hormone Antagonists|hormone antagonists|mesh-ancestor
56116782|NCT05251259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116783|NCT05251259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116784|NCT05251259|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56116785|NCT05251259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56116786|NCT05251259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116787|NCT04940039|Risperidone|risperidone|mesh-list
56116788|NCT04940039|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56116789|NCT04940039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56116790|NCT04940039|Serotonin Agents|serotonin agents|mesh-ancestor
56116791|NCT04940039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56116792|NCT04940039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116815|NCT04332107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56116816|NCT04332107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116817|NCT04329065|Paclitaxel|paclitaxel|mesh-list
56116818|NCT04329065|Trastuzumab|trastuzumab|mesh-list
56116819|NCT04329065|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56116820|NCT04329065|Pertuzumab|pertuzumab|mesh-list
56116821|NCT04329065|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
56116822|NCT04329065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56116823|NCT04329065|Vaccines|vaccines|mesh-list
56116824|NCT04329065|Antibodies|antibodies|mesh-list
56116825|NCT04329065|Immunoglobulins|immunoglobulins|mesh-list
56116826|NCT04329065|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56116837|NCT04328285|Lopinavir|lopinavir|mesh-list
56116838|NCT04328285|Hydroxychloroquine|hydroxychloroquine|mesh-list
56116839|NCT04328285|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56116840|NCT04328285|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56116841|NCT04328285|Protease Inhibitors|protease inhibitors|mesh-ancestor
56116842|NCT04328285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56116843|NCT04328285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116844|NCT04328285|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56116845|NCT04328285|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56116846|NCT04328285|Antiviral Agents|antiviral agents|mesh-ancestor
56116847|NCT04328285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116848|NCT04328285|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56116849|NCT04328285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56116850|NCT04328285|Antimalarials|antimalarials|mesh-ancestor
56116851|NCT04328285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56116852|NCT04328285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56116855|NCT04928261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56116856|NCT04928261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116857|NCT04925375|Abatacept|abatacept|mesh-list
56116858|NCT04925375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56116859|NCT04925375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116860|NCT04925375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116861|NCT04925375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116862|NCT04925375|Immunologic Factors|immunologic factors|mesh-ancestor
56116863|NCT04925375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116864|NCT04925375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116865|NCT04920539|Dronabinol|dronabinol|mesh-list
56116866|NCT04920539|Hallucinogens|hallucinogens|mesh-ancestor
56116867|NCT04920539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116868|NCT04920539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55843822|NCT03570814|Ivermectin|ivermectin|mesh-list
56116900|NCT04882241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116901|NCT04882241|Immunologic Factors|immunologic factors|mesh-ancestor
56116902|NCT04882241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116904|NCT04882241|Protective Agents|protective agents|mesh-ancestor
56116917|NCT04207931|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56116919|NCT04207931|Clobetasol|clobetasol|mesh-list
56116920|NCT04207931|Minoxidil|minoxidil|mesh-list
56116921|NCT04207931|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56116922|NCT04207931|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56116923|NCT04207931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56116924|NCT04207931|Glucocorticoids|glucocorticoids|mesh-ancestor
56116925|NCT04207931|Hormones|hormones|mesh-ancestor
56116926|NCT04207931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56116927|NCT04207931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116928|NCT04207931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116948|NCT03596645|Dermatologic Agents|dermatologic agents|mesh-ancestor
56116949|NCT03596645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56116950|NCT03596645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56116951|NCT03596645|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
56116952|NCT03596645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56116953|NCT03596645|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116954|NCT03596645|Immunologic Factors|immunologic factors|mesh-ancestor
56116955|NCT03596645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56116956|NCT03575195|Rifaximin|rifaximin|mesh-list
56116957|NCT03575195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56116958|NCT03575195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56116959|NCT03575195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56116961|NCT00002897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56116962|NCT00002897|Antimetabolites|antimetabolites|mesh-ancestor
56116963|NCT00002897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56116964|NCT00002897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56116965|NCT00002897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56116993|NCT00002921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56116995|NCT00002921|Anthelmintics|anthelmintics|mesh-ancestor
56117013|NCT00383591|Immunologic Factors|immunologic factors|mesh-ancestor
56117014|NCT00383591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117016|NCT03185819|Esketamine|esketamine|mesh-list
56117017|NCT03185819|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56117018|NCT03185819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56117019|NCT03185819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56117020|NCT03185819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117021|NCT03185819|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56117022|NCT03185819|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56117072|NCT00002945|Alkylating Agents|alkylating agents|mesh-ancestor
56117073|NCT00002945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117074|NCT00002945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117075|NCT00002945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117076|NCT00002945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117077|NCT00002945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117078|NCT00002945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117079|NCT00002945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117080|NCT00002945|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56117082|NCT00002945|Antiviral Agents|antiviral agents|mesh-ancestor
56117083|NCT00002945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117084|NCT00002945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56117085|NCT00002945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56117086|NCT00002945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117087|NCT00002951|Fluorouracil|fluorouracil|mesh-list
56117088|NCT00002951|Hydroxyurea|hydroxyurea|mesh-list
56117089|NCT00002951|Antimetabolites|antimetabolites|mesh-ancestor
56117535|NCT00003425|Immunologic Factors|immunologic factors|mesh-ancestor
56117090|NCT00002951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117091|NCT00002951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56117092|NCT00002951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117093|NCT00002951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117094|NCT00002951|Immunologic Factors|immunologic factors|mesh-ancestor
56117095|NCT00002951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117096|NCT00002951|Antisickling Agents|antisickling agents|mesh-ancestor
56117097|NCT00002951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117104|NCT03058289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117105|NCT03058289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56117107|NCT03058289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56117108|NCT03058289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117109|NCT00002963|Aminolevulinic Acid|aminolevulinic acid|mesh-list
56117110|NCT00002963|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56117111|NCT00002963|Dermatologic Agents|dermatologic agents|mesh-ancestor
56117112|NCT00002969|Paclitaxel|paclitaxel|mesh-list
56117113|NCT00002969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117114|NCT00002969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117115|NCT00002969|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117116|NCT00002969|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117117|NCT00002969|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117118|NCT00002969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117119|NCT00002987|Prednisolone|prednisolone|mesh-list
56117120|NCT00002987|Cyclophosphamide|cyclophosphamide|mesh-list
56117121|NCT00002987|Doxorubicin|doxorubicin|mesh-list
56117122|NCT00002987|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56117123|NCT00002987|Etoposide|etoposide|mesh-list
56117124|NCT00002987|Vincristine|vincristine|mesh-list
56117125|NCT00002987|Bleomycin|bleomycin|mesh-list
56117126|NCT00002987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117127|NCT00002987|Immunologic Factors|immunologic factors|mesh-ancestor
56117128|NCT00002987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117129|NCT00002987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117130|NCT00002987|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117131|NCT00002987|Alkylating Agents|alkylating agents|mesh-ancestor
56117132|NCT00002987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117133|NCT00002987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117134|NCT00002987|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117135|NCT00002987|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117136|NCT00002987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117137|NCT00002987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117138|NCT00002987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117139|NCT00002987|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117140|NCT00002987|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117141|NCT00002987|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117142|NCT00002987|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117143|NCT00002987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56117144|NCT00002987|Glucocorticoids|glucocorticoids|mesh-ancestor
56117145|NCT00002987|Hormones|hormones|mesh-ancestor
56117146|NCT00002987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117186|NCT01928082|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56117187|NCT01928082|Contraceptive Agents|contraceptive agents|mesh-ancestor
56117188|NCT01928082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56117189|NCT01928082|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56117190|NCT02908685|Risdiplam|risdiplam|mesh-list
56117191|NCT02908685|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56117192|NCT02908685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56117193|NCT02908685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117194|NCT00002999|Fluorouracil|fluorouracil|mesh-list
56117195|NCT00002999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117196|NCT00002999|Antimetabolites|antimetabolites|mesh-ancestor
56117197|NCT00002999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117198|NCT00002999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56117199|NCT00002999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117200|NCT00002999|Immunologic Factors|immunologic factors|mesh-ancestor
56117201|NCT00002999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117202|NCT03911453|Rucaparib|rucaparib|mesh-list
56117203|NCT03911453|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56117204|NCT03911453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117205|NCT03911453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117206|NCT03911453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117207|NCT00003005|Cordycepin|cordycepin|mesh-list
56117239|NCT03850067|Nivolumab|nivolumab|mesh-list
56117240|NCT03850067|Etoposide|etoposide|mesh-list
56117241|NCT03850067|Pulrodemstat besilate|pulrodemstat besilate|mesh-list
56117242|NCT03850067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117243|NCT03850067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56117244|NCT03850067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56117245|NCT03850067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117246|NCT03850067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117247|NCT03850067|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117248|NCT03850067|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117249|NCT03850067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117250|NCT00003029|Fluorouracil|fluorouracil|mesh-list
56117251|NCT00003029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117252|NCT00003029|Antimetabolites|antimetabolites|mesh-ancestor
56117253|NCT00003029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117254|NCT00003029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56117255|NCT00003029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117257|NCT00003029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117258|NCT00003035|Tamoxifen|tamoxifen|mesh-list
56117259|NCT00003035|Paclitaxel|paclitaxel|mesh-list
56117261|NCT00003035|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56117262|NCT00003035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117263|NCT00003035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117288|NCT00003053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117289|NCT00003065|Paclitaxel|paclitaxel|mesh-list
56117290|NCT00003065|Topotecan|topotecan|mesh-list
56117291|NCT00003065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117292|NCT00003065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117293|NCT00003065|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117294|NCT00003065|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117295|NCT00003065|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117296|NCT00003065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117297|NCT00003065|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56117298|NCT00003065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117299|NCT00003065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117300|NCT04329611|Hydroxychloroquine|hydroxychloroquine|mesh-list
56117301|NCT04329611|Antimalarials|antimalarials|mesh-ancestor
56117302|NCT04329611|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56117303|NCT04329611|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56117304|NCT04329611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117305|NCT04329611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117306|NCT04329611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117307|NCT04329611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117308|NCT00383357|Zolpidem|zolpidem|mesh-list
56117309|NCT00383357|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56117310|NCT00383357|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56117311|NCT00383357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56117312|NCT00383357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117313|NCT00383357|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
56117315|NCT00383357|GABA Agents|gaba agents|mesh-ancestor
56117316|NCT00383357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56117317|NCT00383357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117318|NCT00003089|Paclitaxel|paclitaxel|mesh-list
56117319|NCT00003089|Carboplatin|carboplatin|mesh-list
56117320|NCT00003089|Amifostine|amifostine|mesh-list
56117321|NCT00003089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117322|NCT00003089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117323|NCT00003089|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117326|NCT00003089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117327|NCT00003089|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56117328|NCT00003089|Protective Agents|protective agents|mesh-ancestor
56117329|NCT00003089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117330|NCT02180711|Rituximab|rituximab|mesh-list
56117331|NCT02180711|Lenalidomide|lenalidomide|mesh-list
56117332|NCT02180711|Acalabrutinib|acalabrutinib|mesh-list
56117333|NCT02180711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56117334|NCT02180711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117335|NCT02180711|Immunologic Factors|immunologic factors|mesh-ancestor
56117336|NCT02180711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117337|NCT02180711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117338|NCT02180711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56117339|NCT02180711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56117340|NCT02180711|Growth Substances|growth substances|mesh-ancestor
56117341|NCT02180711|Growth Inhibitors|growth inhibitors|mesh-ancestor
56117342|NCT02145143|Vemurafenib|vemurafenib|mesh-list
56117343|NCT02145143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117344|NCT02145143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56117345|NCT02145143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117346|NCT02145143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117348|NCT03713801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56117349|NCT03713801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117350|NCT00003101|Vincristine|vincristine|mesh-list
56117378|NCT01958021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117379|NCT01958021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117380|NCT00003107|Interleukin-12|interleukin-12|mesh-list
56117381|NCT00003107|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56117382|NCT00003107|Immunologic Factors|immunologic factors|mesh-ancestor
56117383|NCT00003107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117384|NCT00003107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56117385|NCT00003107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56117386|NCT00003107|Growth Substances|growth substances|mesh-ancestor
56117404|NCT00003113|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117405|NCT00003113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117407|NCT01545557|Hyaluronic Acid|hyaluronic acid|mesh-list
56117408|NCT01545557|Anesthetics, Local|anesthetics, local|mesh-ancestor
56117419|NCT01545557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56117420|NCT01545557|Immunologic Factors|immunologic factors|mesh-ancestor
56117422|NCT01545557|Protective Agents|protective agents|mesh-ancestor
56117423|NCT00003119|Cyclophosphamide|cyclophosphamide|mesh-list
56117424|NCT00003119|Carboplatin|carboplatin|mesh-list
56117425|NCT00003119|Doxorubicin|doxorubicin|mesh-list
56117426|NCT00003119|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56117427|NCT00003119|Etoposide|etoposide|mesh-list
56117428|NCT00003119|Sargramostim|sargramostim|mesh-list
56117429|NCT00003119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117430|NCT00003119|Immunologic Factors|immunologic factors|mesh-ancestor
56117431|NCT00003119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117432|NCT00003119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117433|NCT00003119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117434|NCT00003119|Alkylating Agents|alkylating agents|mesh-ancestor
56117435|NCT00003119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755713|NCT04083963|Paclitaxel|paclitaxel|mesh-list
56117463|NCT00003401|Alkylating Agents|alkylating agents|mesh-ancestor
56117464|NCT00003401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117465|NCT00003401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56117466|NCT00003401|Antiemetics|antiemetics|mesh-ancestor
56117467|NCT00003401|Autonomic Agents|autonomic agents|mesh-ancestor
56117481|NCT00003125|Aldesleukin|aldesleukin|mesh-list
56117482|NCT00003125|Vaccines|vaccines|mesh-list
56117483|NCT00003125|Sargramostim|sargramostim|mesh-list
56117484|NCT00003125|Immunologic Factors|immunologic factors|mesh-ancestor
56117485|NCT00003125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117488|NCT00003125|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56117489|NCT00003125|Antiviral Agents|antiviral agents|mesh-ancestor
56117490|NCT00003125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117491|NCT00003131|Gemtuzumab|gemtuzumab|mesh-list
56117492|NCT00003131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56117493|NCT00003131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117494|NCT00384371|Botulinum Toxins|botulinum toxins|mesh-list
56117495|NCT00384371|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56117496|NCT00384371|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56117497|NCT00384371|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56117498|NCT00384371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56117499|NCT00384371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117500|NCT00384371|Cholinergic Agents|cholinergic agents|mesh-ancestor
56117501|NCT00384371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56117502|NCT00384371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117503|NCT00384371|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56117504|NCT00384371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56117505|NCT00423215|Insulin Glargine|insulin glargine|mesh-list
56117506|NCT00423215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56117507|NCT00423215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117508|NCT00003413|Paclitaxel|paclitaxel|mesh-list
56117509|NCT00003413|Melphalan|melphalan|mesh-list
56117510|NCT00003413|Carmustine|carmustine|mesh-list
56117511|NCT00003413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117512|NCT00003413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117513|NCT00003413|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117527|NCT00003137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117528|NCT00003137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117529|NCT00003419|Antiviral Agents|antiviral agents|mesh-list
56117530|NCT00003419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117531|NCT00003425|Cyclophosphamide|cyclophosphamide|mesh-list
56117532|NCT00003425|Melphalan|melphalan|mesh-list
56117533|NCT00003425|Amifostine|amifostine|mesh-list
56117534|NCT00003425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117536|NCT00003425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117537|NCT00003425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117538|NCT00003425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117539|NCT00003425|Alkylating Agents|alkylating agents|mesh-ancestor
56117540|NCT00003425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117541|NCT00003425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117542|NCT00003425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117543|NCT00003425|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56117544|NCT00003425|Protective Agents|protective agents|mesh-ancestor
56117546|NCT00330551|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56117547|NCT00330551|Serotonin Agents|serotonin agents|mesh-ancestor
56117548|NCT00330551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56117549|NCT00330551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117550|NCT00330551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117551|NCT00330551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56117552|NCT00330551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56117573|NCT00003143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117574|NCT00003431|Flt3 ligand protein|flt3 ligand protein|mesh-list
56117575|NCT00003431|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56117576|NCT00003431|Immunologic Factors|immunologic factors|mesh-ancestor
56117577|NCT00003431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117578|NCT00003431|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56117579|NCT00003431|Protective Agents|protective agents|mesh-ancestor
56117581|NCT00003149|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56117582|NCT00003149|Immunologic Factors|immunologic factors|mesh-ancestor
56117583|NCT00003149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117584|NCT00003149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56117585|NCT00003149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56117586|NCT00003149|Growth Substances|growth substances|mesh-ancestor
56117587|NCT00003149|Growth Inhibitors|growth inhibitors|mesh-ancestor
56117588|NCT00003149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117589|NCT00003437|Cytarabine|cytarabine|mesh-list
56117590|NCT00003437|Dexamethasone|dexamethasone|mesh-list
56117591|NCT00003437|Prednisolone|prednisolone|mesh-list
56117592|NCT00003437|Cyclophosphamide|cyclophosphamide|mesh-list
56117593|NCT00003437|Doxorubicin|doxorubicin|mesh-list
56117594|NCT00003437|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56117595|NCT00003437|Methotrexate|methotrexate|mesh-list
56117596|NCT00003437|Vincristine|vincristine|mesh-list
56117597|NCT00003437|Daunorubicin|daunorubicin|mesh-list
56117598|NCT00003437|Asparaginase|asparaginase|mesh-list
56117599|NCT00003437|Mercaptopurine|mercaptopurine|mesh-list
56117600|NCT00003437|Pegaspargase|pegaspargase|mesh-list
56117601|NCT00003437|Thioguanine|thioguanine|mesh-list
56117602|NCT00003437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117603|NCT00003437|Immunologic Factors|immunologic factors|mesh-ancestor
56117604|NCT00003437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117605|NCT00003437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117619|NCT00003437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117620|NCT00003437|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117621|NCT00003437|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117622|NCT00003437|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117623|NCT00003437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117624|NCT00003437|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56117625|NCT00003437|Abortifacient Agents|abortifacient agents|mesh-ancestor
56117626|NCT00003437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56117701|NCT00002819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117702|NCT00002819|Immunologic Factors|immunologic factors|mesh-ancestor
56117703|NCT00002819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117704|NCT00002819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117705|NCT00002819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117706|NCT00002819|Alkylating Agents|alkylating agents|mesh-ancestor
56117707|NCT00002819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117708|NCT00002819|Analgesics|analgesics|mesh-ancestor
56117709|NCT00002819|Sensory System Agents|sensory system agents|mesh-ancestor
56117735|NCT00002831|Immunologic Factors|immunologic factors|mesh-ancestor
56117736|NCT00002831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117737|NCT00002831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56117738|NCT00002831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117739|NCT00002831|Alkylating Agents|alkylating agents|mesh-ancestor
56117740|NCT00002831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117741|NCT00002831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117742|NCT00002831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56117743|NCT00002831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56117744|NCT00002831|Abortifacient Agents|abortifacient agents|mesh-ancestor
56117745|NCT00002831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56117746|NCT00002831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56117747|NCT00002831|Antimetabolites|antimetabolites|mesh-ancestor
56117749|NCT00002831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117750|NCT00002831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56117751|NCT00002831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56117752|NCT00002831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56117753|NCT00002831|Antifungal Agents|antifungal agents|mesh-ancestor
56117754|NCT00002831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117755|NCT00002831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56117756|NCT00002831|Antiemetics|antiemetics|mesh-ancestor
56117757|NCT00002831|Autonomic Agents|autonomic agents|mesh-ancestor
56117758|NCT00002831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56117759|NCT00002831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56117783|NCT00002837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56117784|NCT00002837|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56117785|NCT00002837|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56117786|NCT00002837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56117788|NCT00003461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56117789|NCT00003461|Immunologic Factors|immunologic factors|mesh-ancestor
56117790|NCT00003461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117791|NCT00003467|Carmustine|carmustine|mesh-list
56117792|NCT00003467|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117793|NCT00003467|Alkylating Agents|alkylating agents|mesh-ancestor
56117794|NCT00003467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117795|NCT00003467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117796|NCT00002849|Interferons|interferons|mesh-list
56117797|NCT00002849|Interferon-alpha|interferon-alpha|mesh-list
56117798|NCT00002849|Dexamethasone|dexamethasone|mesh-list
56117799|NCT00002849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56117800|NCT00002849|Antiemetics|antiemetics|mesh-ancestor
56117801|NCT00002849|Autonomic Agents|autonomic agents|mesh-ancestor
56117802|NCT00002849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56117803|NCT00002849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117804|NCT00002849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56117805|NCT00002849|Glucocorticoids|glucocorticoids|mesh-ancestor
56117806|NCT00002849|Hormones|hormones|mesh-ancestor
56117807|NCT00002849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117809|NCT00002849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117833|NCT00002855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56117834|NCT00002855|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56117835|NCT00002855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56117836|NCT00002855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56117837|NCT00002855|Hormone Antagonists|hormone antagonists|mesh-ancestor
56117838|NCT00002855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56117839|NCT00002855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117840|NCT00002855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56117841|NCT00002855|Androgen Antagonists|androgen antagonists|mesh-ancestor
56117842|NCT00002855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117843|NCT00002855|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117844|NCT00002855|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117845|NCT00002855|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117846|NCT00002855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56117847|NCT00002855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117848|NCT00002855|Alkylating Agents|alkylating agents|mesh-ancestor
56117849|NCT00003173|Thiotepa|thiotepa|mesh-list
56117850|NCT00003173|Immunologic Factors|immunologic factors|mesh-ancestor
56117851|NCT00003173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117852|NCT00003173|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56117853|NCT00003173|Alkylating Agents|alkylating agents|mesh-ancestor
56117854|NCT00003173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56117855|NCT00003173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117883|NCT00002879|Immunologic Factors|immunologic factors|mesh-ancestor
56117884|NCT00002879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117885|NCT00003185|Cyclophosphamide|cyclophosphamide|mesh-list
56117886|NCT00003185|Sargramostim|sargramostim|mesh-list
56117887|NCT00003185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117910|NCT00003935|Tubulin Modulators|tubulin modulators|mesh-ancestor
56117911|NCT00003935|Antimitotic Agents|antimitotic agents|mesh-ancestor
56117912|NCT00003935|Mitosis Modulators|mitosis modulators|mesh-ancestor
56117914|NCT00003191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117915|NCT00003191|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56117916|NCT00003191|Protective Agents|protective agents|mesh-ancestor
56117917|NCT00003191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56117919|NCT00003941|Ifosfamide|ifosfamide|mesh-list
56117920|NCT00003941|Bleomycin|bleomycin|mesh-list
56117921|NCT00003941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56117922|NCT00003941|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56117989|NCT00003203|Carboplatin|carboplatin|mesh-list
56117990|NCT00003203|Vincristine|vincristine|mesh-list
56117991|NCT00003203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56117992|NCT00003203|Immunologic Factors|immunologic factors|mesh-ancestor
56117993|NCT00003203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118022|NCT00003209|Fluorouracil|fluorouracil|mesh-list
56118023|NCT00003209|Methotrexate|methotrexate|mesh-list
56118024|NCT00003209|Ifosfamide|ifosfamide|mesh-list
56118025|NCT00003209|Mitomycins|mitomycins|mesh-list
56118026|NCT00003209|Mitomycin|mitomycin|mesh-list
56118027|NCT00003209|Bleomycin|bleomycin|mesh-list
56118028|NCT00003209|Vinblastine|vinblastine|mesh-list
56118029|NCT00003209|Vindesine|vindesine|mesh-list
56118030|NCT00003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118031|NCT00003209|Antimetabolites|antimetabolites|mesh-ancestor
56118032|NCT00003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118033|NCT00003209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118034|NCT00003209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118035|NCT00003209|Immunologic Factors|immunologic factors|mesh-ancestor
56118036|NCT00003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118037|NCT00003209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56118038|NCT00003209|Abortifacient Agents|abortifacient agents|mesh-ancestor
56118039|NCT00003209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56118040|NCT00003209|Dermatologic Agents|dermatologic agents|mesh-ancestor
56118041|NCT00003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118042|NCT00003209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56118081|NCT00003215|Doxorubicin|doxorubicin|mesh-list
56118082|NCT00003215|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56118097|NCT00003215|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56118098|NCT00003215|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118099|NCT00003215|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118100|NCT00003215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118101|NCT00003215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56118102|NCT00003215|Glucocorticoids|glucocorticoids|mesh-ancestor
56118104|NCT00003215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56118105|NCT00003215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56118106|NCT00003215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56118107|NCT00003215|Abortifacient Agents|abortifacient agents|mesh-ancestor
56118108|NCT00003215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56118109|NCT00003215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118110|NCT00003215|Antimetabolites|antimetabolites|mesh-ancestor
56118111|NCT00003215|Dermatologic Agents|dermatologic agents|mesh-ancestor
56118112|NCT00003215|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56118113|NCT00003215|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56118114|NCT00003215|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118115|NCT00003215|Antiviral Agents|antiviral agents|mesh-ancestor
56118116|NCT00003215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118117|NCT00003215|Antidotes|antidotes|mesh-ancestor
56118118|NCT00003215|Protective Agents|protective agents|mesh-ancestor
56118119|NCT00003215|Vitamin B Complex|vitamin b complex|mesh-ancestor
56118120|NCT00003215|Vitamins|vitamins|mesh-ancestor
56118121|NCT00003215|Micronutrients|micronutrients|mesh-ancestor
56118122|NCT00003215|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118123|NCT00003215|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118124|NCT00003215|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118125|NCT00003215|Antiemetics|antiemetics|mesh-ancestor
56118126|NCT00003215|Autonomic Agents|autonomic agents|mesh-ancestor
56118127|NCT00003215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742214|NCT03353857|Hormones|hormones|mesh-ancestor
56118128|NCT00003215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56118129|NCT00003215|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56118131|NCT00003215|Sensory System Agents|sensory system agents|mesh-ancestor
56118132|NCT00003995|Trastuzumab|trastuzumab|mesh-list
56118133|NCT00003995|Irinotecan|irinotecan|mesh-list
56118134|NCT00003995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56118135|NCT00003995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118156|NCT00004001|Sensory System Agents|sensory system agents|mesh-ancestor
56118157|NCT00004001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56118158|NCT00004001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118159|NCT00004001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118160|NCT00004001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118161|NCT00004001|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118162|NCT00004001|Alkylating Agents|alkylating agents|mesh-ancestor
56118163|NCT00003593|Cytarabine|cytarabine|mesh-list
56118164|NCT00003593|Hydrocortisone|hydrocortisone|mesh-list
56118165|NCT00003593|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56118186|NCT00003593|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56118188|NCT00003593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118190|NCT00003593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56118191|NCT00003593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118192|NCT00003593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118193|NCT00003599|Vitamin E|vitamin e|mesh-list
56118194|NCT00003599|Tocopherols|tocopherols|mesh-list
56118195|NCT00003599|alpha-Tocopherol|alpha-tocopherol|mesh-list
56118196|NCT00003599|Isotretinoin|isotretinoin|mesh-list
56118197|NCT00003599|Vitamins|vitamins|mesh-ancestor
56118198|NCT00003599|Micronutrients|micronutrients|mesh-ancestor
56118199|NCT00003599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118200|NCT00003599|Antioxidants|antioxidants|mesh-ancestor
56118201|NCT00003599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118202|NCT00003599|Protective Agents|protective agents|mesh-ancestor
56118203|NCT00003599|Dermatologic Agents|dermatologic agents|mesh-ancestor
56118204|NCT00003605|Cyclophosphamide|cyclophosphamide|mesh-list
56118206|NCT00003605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118207|NCT00003605|Immunologic Factors|immunologic factors|mesh-ancestor
56118208|NCT00003605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118209|NCT00003605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118210|NCT00003605|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118211|NCT00003605|Alkylating Agents|alkylating agents|mesh-ancestor
56118212|NCT00003605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118213|NCT00003605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118214|NCT00003605|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56118216|NCT00003611|Acitretin|acitretin|mesh-list
56118234|NCT00003617|Alkylating Agents|alkylating agents|mesh-ancestor
56118235|NCT00003617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118236|NCT00003617|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
56118237|NCT00003617|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56118238|NCT00003617|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56118239|NCT00004013|Paclitaxel|paclitaxel|mesh-list
56118240|NCT00004013|Trastuzumab|trastuzumab|mesh-list
56118241|NCT00004013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118242|NCT00004013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118243|NCT00004013|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118244|NCT00004013|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118245|NCT00004013|Mitosis Modulators|mitosis modulators|mesh-ancestor
55845204|NCT01865552|Etanercept|etanercept|mesh-list
56118246|NCT00004013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118247|NCT00004013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56118248|NCT00004025|Aldesleukin|aldesleukin|mesh-list
56118249|NCT00004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118250|NCT00004025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56118251|NCT00004025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56118252|NCT00004025|Antiviral Agents|antiviral agents|mesh-ancestor
56118253|NCT00004025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118254|NCT00004037|Docetaxel|docetaxel|mesh-list
56118255|NCT00004037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118256|NCT00004037|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118257|NCT00004037|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118294|NCT00004061|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118295|NCT00004061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118296|NCT00004061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118298|NCT00004067|Cyclophosphamide|cyclophosphamide|mesh-list
56118299|NCT00004067|Doxorubicin|doxorubicin|mesh-list
56118300|NCT00004067|Trastuzumab|trastuzumab|mesh-list
56118301|NCT00004067|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56118302|NCT00004067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118303|NCT00004067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118304|NCT00004067|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118305|NCT00004067|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118306|NCT00004067|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118307|NCT00004067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118308|NCT00004067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118309|NCT00004067|Immunologic Factors|immunologic factors|mesh-ancestor
56118310|NCT00004067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118311|NCT00004067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118312|NCT00004067|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118313|NCT00004067|Alkylating Agents|alkylating agents|mesh-ancestor
56118314|NCT00004067|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56118347|NCT00004097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118348|NCT00004097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118349|NCT00004097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118350|NCT00004097|Immunologic Factors|immunologic factors|mesh-ancestor
55742217|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
56118351|NCT00004097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118352|NCT00004103|Irinotecan|irinotecan|mesh-list
56118353|NCT00004103|Floxuridine|floxuridine|mesh-list
56118354|NCT00004103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118355|NCT00004103|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56118356|NCT00004103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118357|NCT00004103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118358|NCT00004103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118359|NCT00004103|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118360|NCT00004103|Antimetabolites|antimetabolites|mesh-ancestor
56118361|NCT00004109|Doxorubicin|doxorubicin|mesh-list
56118362|NCT00004109|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56118363|NCT00004109|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56118364|NCT00004109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118365|NCT00004109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118366|NCT00004109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118367|NCT00004109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118368|NCT00004109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118369|NCT00003239|Interferons|interferons|mesh-list
56118370|NCT00003239|Cytarabine|cytarabine|mesh-list
56118371|NCT00003239|Interferon-alpha|interferon-alpha|mesh-list
56118394|NCT00003245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118395|NCT00003245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118396|NCT00004127|Leucovorin|leucovorin|mesh-list
56118397|NCT00004127|Fluorouracil|fluorouracil|mesh-list
56118398|NCT00004127|Oxaliplatin|oxaliplatin|mesh-list
56118399|NCT00004127|Calcium|calcium|mesh-list
56118400|NCT00004127|Levoleucovorin|levoleucovorin|mesh-list
56118401|NCT00004127|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56118402|NCT00004127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118404|NCT00004127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118405|NCT00004127|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118406|NCT00004127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118407|NCT00004127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118408|NCT00004127|Immunologic Factors|immunologic factors|mesh-ancestor
56118409|NCT00004127|Antidotes|antidotes|mesh-ancestor
56118410|NCT00004127|Protective Agents|protective agents|mesh-ancestor
56118411|NCT00004127|Vitamin B Complex|vitamin b complex|mesh-ancestor
56118413|NCT00004127|Micronutrients|micronutrients|mesh-ancestor
56118414|NCT00003251|Paclitaxel|paclitaxel|mesh-list
56118415|NCT00003251|Amifostine|amifostine|mesh-list
56118416|NCT00003251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118417|NCT00003251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118425|NCT00004139|Gemcitabine|gemcitabine|mesh-list
56118449|NCT00004145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118450|NCT00004145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118451|NCT00004145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118452|NCT00004145|Alkylating Agents|alkylating agents|mesh-ancestor
56118453|NCT00004145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118454|NCT00004145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118455|NCT00004145|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56118456|NCT00004145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118457|NCT00004145|Antimetabolites|antimetabolites|mesh-ancestor
56118458|NCT00003263|Interferons|interferons|mesh-list
56118459|NCT00003263|Interferon-alpha|interferon-alpha|mesh-list
56118460|NCT00003263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118461|NCT00003263|Antiviral Agents|antiviral agents|mesh-ancestor
56118462|NCT00003263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118463|NCT00003263|Immunologic Factors|immunologic factors|mesh-ancestor
56118464|NCT00003263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118465|NCT00004157|Oprelvekin|oprelvekin|mesh-list
56118466|NCT00004157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118467|NCT00003269|Cyclophosphamide|cyclophosphamide|mesh-list
56118468|NCT00003269|Etoposide|etoposide|mesh-list
56118469|NCT00003269|Sargramostim|sargramostim|mesh-list
56118470|NCT00003269|Amifostine|amifostine|mesh-list
56118471|NCT00003269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118472|NCT00003269|Immunologic Factors|immunologic factors|mesh-ancestor
56118473|NCT00003269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845413|NCT04407442|Hormones|hormones|mesh-ancestor
56118474|NCT00003269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118475|NCT00003269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118486|NCT00004163|Trastuzumab|trastuzumab|mesh-list
56118494|NCT00003281|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118495|NCT00003281|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118496|NCT00003281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118497|NCT00003281|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56118637|NCT00003311|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118498|NCT00003281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118499|NCT00003281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118500|NCT00003287|Leucovorin|leucovorin|mesh-list
56118501|NCT00003287|Fluorouracil|fluorouracil|mesh-list
56118502|NCT00003287|Oxaliplatin|oxaliplatin|mesh-list
56118503|NCT00003287|Calcium|calcium|mesh-list
56118504|NCT00003287|Levoleucovorin|levoleucovorin|mesh-list
56118505|NCT00003287|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56118506|NCT00003287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118507|NCT00003287|Antimetabolites|antimetabolites|mesh-ancestor
56118508|NCT00003287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118509|NCT00003287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118510|NCT00003287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118511|NCT00003287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118512|NCT00003287|Immunologic Factors|immunologic factors|mesh-ancestor
56118513|NCT00003287|Antidotes|antidotes|mesh-ancestor
56118514|NCT00003287|Protective Agents|protective agents|mesh-ancestor
56118515|NCT00003287|Vitamin B Complex|vitamin b complex|mesh-ancestor
56118516|NCT00003287|Vitamins|vitamins|mesh-ancestor
56118517|NCT00003287|Micronutrients|micronutrients|mesh-ancestor
56118518|NCT00004187|Capecitabine|capecitabine|mesh-list
56118519|NCT00004187|Oxaliplatin|oxaliplatin|mesh-list
56118545|NCT00004199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118546|NCT00004199|Antimetabolites|antimetabolites|mesh-ancestor
56118547|NCT00004199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118548|NCT00004199|Antiviral Agents|antiviral agents|mesh-ancestor
56118549|NCT00004199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118550|NCT00004199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118551|NCT00004199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118552|NCT00004199|Immunologic Factors|immunologic factors|mesh-ancestor
56118553|NCT00004199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118554|NCT00004199|Matrix Metalloproteinase Inhibitors|matrix metalloproteinase inhibitors|mesh-ancestor
56118555|NCT00004199|Protease Inhibitors|protease inhibitors|mesh-ancestor
56118556|NCT00003299|Paclitaxel|paclitaxel|mesh-list
56118557|NCT00003299|Etoposide|etoposide|mesh-list
56118558|NCT00003299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118559|NCT00003299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118560|NCT00003299|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118561|NCT00003299|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118562|NCT00003299|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118563|NCT00003299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118564|NCT00003299|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118565|NCT00003299|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118598|NCT00003311|Cyclophosphamide|cyclophosphamide|mesh-list
56118599|NCT00003311|Doxorubicin|doxorubicin|mesh-list
56118600|NCT00003311|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56118601|NCT00003311|Methotrexate|methotrexate|mesh-list
56118602|NCT00003311|Vincristine|vincristine|mesh-list
56118603|NCT00003311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118604|NCT00003311|Immunologic Factors|immunologic factors|mesh-ancestor
56118605|NCT00003311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118606|NCT00003311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56118607|NCT00003311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118608|NCT00003311|Alkylating Agents|alkylating agents|mesh-ancestor
56118609|NCT00003311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118610|NCT00003311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118611|NCT00003311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56118612|NCT00003311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56118613|NCT00003311|Antiemetics|antiemetics|mesh-ancestor
56118614|NCT00003311|Autonomic Agents|autonomic agents|mesh-ancestor
56118615|NCT00003311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56118616|NCT00003311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56118617|NCT00003311|Glucocorticoids|glucocorticoids|mesh-ancestor
56118618|NCT00003311|Hormones|hormones|mesh-ancestor
56118619|NCT00003311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56118620|NCT00003311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56118621|NCT00003311|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56118622|NCT00003311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118623|NCT00003311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118624|NCT00003311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118625|NCT00003311|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56118626|NCT00003311|Abortifacient Agents|abortifacient agents|mesh-ancestor
55845560|NCT04305106|Heparin|heparin|mesh-list
56118627|NCT00003311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56118628|NCT00003311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118629|NCT00003311|Antimetabolites|antimetabolites|mesh-ancestor
56118630|NCT00003311|Dermatologic Agents|dermatologic agents|mesh-ancestor
56118641|NCT00003317|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118642|NCT00003317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118643|NCT00003317|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118644|NCT00003317|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118645|NCT00003317|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118646|NCT00003317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118647|NCT00004217|Cytarabine|cytarabine|mesh-list
56118648|NCT00004217|Daunorubicin|daunorubicin|mesh-list
56118649|NCT00004217|Sargramostim|sargramostim|mesh-list
56118650|NCT00004217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118651|NCT00004217|Antimetabolites|antimetabolites|mesh-ancestor
56118652|NCT00004217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118653|NCT00004217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118654|NCT00004217|Antiviral Agents|antiviral agents|mesh-ancestor
56118655|NCT00004217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118656|NCT00004217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118657|NCT00004217|Immunologic Factors|immunologic factors|mesh-ancestor
56118692|NCT00004229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118693|NCT00004229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56118694|NCT00004229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56118695|NCT00004229|Growth Substances|growth substances|mesh-ancestor
56118696|NCT00004229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118697|NCT00004229|Growth Inhibitors|growth inhibitors|mesh-ancestor
56118698|NCT00004235|Docetaxel|docetaxel|mesh-list
56118699|NCT00004235|Irinotecan|irinotecan|mesh-list
56118700|NCT00004235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118701|NCT00004235|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118702|NCT00004235|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118703|NCT00004235|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118704|NCT00004235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118705|NCT00004235|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56118706|NCT00004235|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118707|NCT00004235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118708|NCT00003335|Cyclosporine|cyclosporine|mesh-list
56118709|NCT00003335|Methylprednisolone|methylprednisolone|mesh-list
56118711|NCT00003335|Busulfan|busulfan|mesh-list
56118712|NCT00003335|Cyclosporins|cyclosporins|mesh-list
56118713|NCT00003335|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56118714|NCT00003335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118715|NCT00003335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118716|NCT00003335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118717|NCT00003335|Immunologic Factors|immunologic factors|mesh-ancestor
56118718|NCT00003335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118743|NCT00004253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118744|NCT00004253|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118745|NCT00004253|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118746|NCT00004253|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118747|NCT00004253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118749|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
56118750|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118751|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56118752|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
56118753|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118754|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118755|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56118756|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118757|NCT00004265|Paclitaxel|paclitaxel|mesh-list
56118758|NCT00004265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56118759|NCT00004265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118760|NCT00004265|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118761|NCT00004265|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118762|NCT00004265|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118763|NCT00004265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118797|NCT00004865|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118798|NCT00004865|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118799|NCT00004865|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118800|NCT00004865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118801|NCT00004865|Antimetabolites|antimetabolites|mesh-ancestor
56118802|NCT00004865|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118803|NCT00004865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118804|NCT00004865|Immunologic Factors|immunologic factors|mesh-ancestor
56118805|NCT00004865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118806|NCT00004865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56118807|NCT00004361|Citric Acid|citric acid|mesh-list
56118808|NCT00004361|Sodium Citrate|sodium citrate|mesh-list
56118810|NCT00004361|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56118811|NCT00004361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118812|NCT00004361|Anticoagulants|anticoagulants|mesh-ancestor
56118813|NCT00004361|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
56118814|NCT00004361|Chelating Agents|chelating agents|mesh-ancestor
56118815|NCT00004361|Sequestering Agents|sequestering agents|mesh-ancestor
56118816|NCT00004361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118817|NCT00004373|Alprazolam|alprazolam|mesh-list
56118818|NCT00004373|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56118819|NCT00004373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56118820|NCT00004373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118821|NCT00004373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56118822|NCT00004373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56118823|NCT00004373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56118843|NCT00004403|Phenytoin|phenytoin|mesh-list
56118844|NCT00004403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56118846|NCT00004403|Autonomic Agents|autonomic agents|mesh-ancestor
56118847|NCT00004403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56118848|NCT00004403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118849|NCT00004403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56118850|NCT00004403|Glucocorticoids|glucocorticoids|mesh-ancestor
56118851|NCT00004403|Hormones|hormones|mesh-ancestor
56118852|NCT00004403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56118853|NCT00004403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55845782|NCT01769456|Emtricitabine|emtricitabine|mesh-list
56118854|NCT00004403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118855|NCT00004403|Anthelmintics|anthelmintics|mesh-ancestor
56118856|NCT00004403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56118857|NCT00004403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56118858|NCT00004403|Anticestodal Agents|anticestodal agents|mesh-ancestor
56118859|NCT00004403|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56118860|NCT00004403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56118861|NCT00004403|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118862|NCT00004403|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118863|NCT00004403|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118864|NCT00004403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118865|NCT00004403|Anticonvulsants|anticonvulsants|mesh-ancestor
56118866|NCT00004403|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56118867|NCT00004403|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56118868|NCT00004403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56118869|NCT00004403|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56118870|NCT00004403|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56118873|NCT00004889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118888|NCT00004901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118889|NCT00004901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118890|NCT00004901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118891|NCT00004901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118892|NCT00004901|Immunologic Factors|immunologic factors|mesh-ancestor
56118893|NCT00004901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118894|NCT00004901|Antisickling Agents|antisickling agents|mesh-ancestor
56118895|NCT00004901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118896|NCT00004901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56118897|NCT00004433|Pergolide|pergolide|mesh-list
56118898|NCT00004433|Dopamine Agonists|dopamine agonists|mesh-ancestor
56118899|NCT00004433|Dopamine Agents|dopamine agents|mesh-ancestor
56118900|NCT00004433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56118901|NCT00004433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118902|NCT00004433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118903|NCT00004913|Leucovorin|leucovorin|mesh-list
56118904|NCT00004913|Docetaxel|docetaxel|mesh-list
56118905|NCT00004913|Fluorouracil|fluorouracil|mesh-list
56118906|NCT00004913|Calcium|calcium|mesh-list
56118907|NCT00004913|Levoleucovorin|levoleucovorin|mesh-list
56118908|NCT00004913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118909|NCT00004913|Tubulin Modulators|tubulin modulators|mesh-ancestor
56118910|NCT00004913|Antimitotic Agents|antimitotic agents|mesh-ancestor
56118911|NCT00004913|Mitosis Modulators|mitosis modulators|mesh-ancestor
56118912|NCT00004913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118913|NCT00004913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56118914|NCT00004913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118915|NCT00004913|Antimetabolites|antimetabolites|mesh-ancestor
56118916|NCT00004913|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118935|NCT00004925|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56118936|NCT00004925|Trastuzumab|trastuzumab|mesh-list
56119478|NCT00385931|Valsartan|valsartan|mesh-list
56118937|NCT00004925|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56118938|NCT00004925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118939|NCT00004925|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56118940|NCT00004925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56118941|NCT00004925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56118942|NCT00004925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118943|NCT00004925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56118945|NCT00004931|Fluorouracil|fluorouracil|mesh-list
56118946|NCT00004931|Oxaliplatin|oxaliplatin|mesh-list
56118947|NCT00004931|Calcium|calcium|mesh-list
56118948|NCT00004931|Levoleucovorin|levoleucovorin|mesh-list
56118949|NCT00004931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56118950|NCT00004931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118951|NCT00004931|Antimetabolites|antimetabolites|mesh-ancestor
56118952|NCT00004931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56118953|NCT00004931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56118954|NCT00004931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56118955|NCT00004931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56118956|NCT00004931|Immunologic Factors|immunologic factors|mesh-ancestor
56118957|NCT00004931|Antidotes|antidotes|mesh-ancestor
56118958|NCT00004931|Protective Agents|protective agents|mesh-ancestor
56118985|NCT00004985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56118986|NCT00004997|Leucovorin|leucovorin|mesh-list
56118987|NCT00004997|Antidotes|antidotes|mesh-ancestor
56118988|NCT00004997|Protective Agents|protective agents|mesh-ancestor
56118989|NCT00004997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118990|NCT00004997|Vitamin B Complex|vitamin b complex|mesh-ancestor
56118991|NCT00004997|Vitamins|vitamins|mesh-ancestor
56118992|NCT00004997|Micronutrients|micronutrients|mesh-ancestor
56118993|NCT00005009|Vaccines|vaccines|mesh-list
56118994|NCT00005009|Immunologic Factors|immunologic factors|mesh-ancestor
56118995|NCT00005009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56118996|NCT00004583|Ritonavir|ritonavir|mesh-list
56118997|NCT00004583|Lopinavir|lopinavir|mesh-list
56118998|NCT00004583|Nelfinavir|nelfinavir|mesh-list
56118999|NCT00004583|Lamivudine|lamivudine|mesh-list
56119000|NCT00004583|Stavudine|stavudine|mesh-list
56119001|NCT00004583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56119002|NCT00004583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56119003|NCT00004583|Protease Inhibitors|protease inhibitors|mesh-ancestor
56119004|NCT00004583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119005|NCT00004583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119006|NCT00004583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56119007|NCT00004583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56119008|NCT00004583|Antiviral Agents|antiviral agents|mesh-ancestor
56119009|NCT00004583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119010|NCT00004583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56119037|NCT00005021|Carboplatin|carboplatin|mesh-list
56119038|NCT00005021|Topotecan|topotecan|mesh-list
56119039|NCT00005021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119040|NCT00005021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119041|NCT00005021|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119042|NCT00005021|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119043|NCT00005021|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119044|NCT00005021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119045|NCT00005021|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56119046|NCT00005021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119047|NCT00005021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119048|NCT00004643|Cytarabine|cytarabine|mesh-list
56119049|NCT00004643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119050|NCT00004643|Antimetabolites|antimetabolites|mesh-ancestor
56119051|NCT00004643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119052|NCT00004643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119053|NCT00004643|Antiviral Agents|antiviral agents|mesh-ancestor
56119054|NCT00004643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119055|NCT00004643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119056|NCT00004643|Immunologic Factors|immunologic factors|mesh-ancestor
56119057|NCT00004643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119058|NCT00005033|Trastuzumab|trastuzumab|mesh-list
56119059|NCT00005033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56119087|NCT00005051|Carboplatin|carboplatin|mesh-list
56119088|NCT00005051|Topotecan|topotecan|mesh-list
56119089|NCT00005051|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119090|NCT00005051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119091|NCT00005051|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119092|NCT00005051|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119093|NCT00005051|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119479|NCT00385931|Simvastatin|simvastatin|mesh-list
56119094|NCT00005051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119095|NCT00005051|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56119096|NCT00005051|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119097|NCT00005051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119098|NCT00004697|Choline|choline|mesh-list
56119099|NCT00004697|Lipotropic Agents|lipotropic agents|mesh-ancestor
56119100|NCT00004697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56119101|NCT00004697|Antimetabolites|antimetabolites|mesh-ancestor
56119102|NCT00004697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119103|NCT00004697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56119104|NCT00004697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56119105|NCT00004697|Nootropic Agents|nootropic agents|mesh-ancestor
56119106|NCT00004727|Aspirin|aspirin|mesh-list
56119107|NCT00004727|Ticlopidine|ticlopidine|mesh-list
56119108|NCT00004727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56119138|NCT00004739|Antiviral Agents|antiviral agents|mesh-ancestor
56119139|NCT00004739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119140|NCT00005057|Ganciclovir|ganciclovir|mesh-list
56119141|NCT00005057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
56119142|NCT00005057|Antiviral Agents|antiviral agents|mesh-ancestor
56119143|NCT00005057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119144|NCT00005057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56119145|NCT00005057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119146|NCT00005057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119147|NCT00004757|Acyclovir|acyclovir|mesh-list
56119148|NCT00004757|Antiviral Agents|antiviral agents|mesh-ancestor
56119149|NCT00004757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119150|NCT00005069|Arsenic Trioxide|arsenic trioxide|mesh-list
56119151|NCT00005069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119152|NCT00004763|Leuprolide|leuprolide|mesh-list
56119153|NCT00004763|Ethinyl Estradiol|ethinyl estradiol|mesh-list
56119154|NCT00004763|Norethindrone|norethindrone|mesh-list
56119155|NCT00004763|Norethindrone Acetate|norethindrone acetate|mesh-list
55846082|NCT01573767|Fluticasone|fluticasone|mesh-list
56119156|NCT00004763|Norinyl|norinyl|mesh-list
56119157|NCT00004763|Estradiol|estradiol|mesh-list
56119158|NCT00004763|Estrogens|estrogens|mesh-ancestor
56119159|NCT00004763|Hormones|hormones|mesh-ancestor
56119160|NCT00004763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119161|NCT00004763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119162|NCT00004763|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56119163|NCT00004763|Contraceptive Agents|contraceptive agents|mesh-ancestor
56119188|NCT00005087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119190|NCT00005087|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119191|NCT00005087|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119192|NCT00005087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119193|NCT00004799|Vaccines|vaccines|mesh-list
56119194|NCT00004799|Immunologic Factors|immunologic factors|mesh-ancestor
56119195|NCT00004799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119196|NCT00005093|Gemcitabine|gemcitabine|mesh-list
56119197|NCT00005093|Tacedinaline|tacedinaline|mesh-list
56119198|NCT00005093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119199|NCT00005093|Antimetabolites|antimetabolites|mesh-ancestor
56119200|NCT00005093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119201|NCT00005093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119202|NCT00005093|Antiviral Agents|antiviral agents|mesh-ancestor
56119203|NCT00005093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119204|NCT00005093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119205|NCT00005093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119206|NCT00005093|Immunologic Factors|immunologic factors|mesh-ancestor
56119207|NCT00005093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119208|NCT00005093|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56119209|NCT00004811|Itraconazole|itraconazole|mesh-list
56119210|NCT00004811|Antifungal Agents|antifungal agents|mesh-ancestor
56119211|NCT00004811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119212|NCT00004811|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56119213|NCT00004811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56119214|NCT00004811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119215|NCT00004811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119216|NCT00004811|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56119217|NCT00004811|Hormone Antagonists|hormone antagonists|mesh-ancestor
56119230|NCT00004817|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56119231|NCT00004817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56119232|NCT00004817|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56119233|NCT00004817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56119234|NCT00004817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56119235|NCT00004817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56119236|NCT00004817|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
56119237|NCT00004817|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56119238|NCT00005117|Pravastatin|pravastatin|mesh-list
56119239|NCT00005117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56119240|NCT00005117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56119241|NCT00005117|Antimetabolites|antimetabolites|mesh-ancestor
56119242|NCT00005117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119243|NCT00005117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56119244|NCT00005117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56119245|NCT00005117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119246|NCT00385385|KRM 1648|krm 1648|mesh-list
56119247|NCT00385385|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56119248|NCT00385385|Antitubercular Agents|antitubercular agents|mesh-ancestor
56119252|NCT00385463|Montelukast|montelukast|mesh-list
56119284|NCT00005585|Cyclophosphamide|cyclophosphamide|mesh-list
56119285|NCT00005585|Methotrexate|methotrexate|mesh-list
56119286|NCT00005585|Vincristine|vincristine|mesh-list
56119287|NCT00005585|Daunorubicin|daunorubicin|mesh-list
56119288|NCT00005585|Asparaginase|asparaginase|mesh-list
56119289|NCT00005585|Mercaptopurine|mercaptopurine|mesh-list
56119290|NCT00005585|Pegaspargase|pegaspargase|mesh-list
56119291|NCT00005585|Thioguanine|thioguanine|mesh-list
56119292|NCT00005585|Levoleucovorin|levoleucovorin|mesh-list
56119293|NCT00005585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119294|NCT00005585|Immunologic Factors|immunologic factors|mesh-ancestor
56119295|NCT00005585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119296|NCT00005585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56119297|NCT00005585|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119298|NCT00005585|Alkylating Agents|alkylating agents|mesh-ancestor
56119375|NCT00005603|Asparaginase|asparaginase|mesh-list
56119407|NCT00005603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56119408|NCT00005603|Antiviral Agents|antiviral agents|mesh-ancestor
56119409|NCT00005603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119410|NCT00005603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119411|NCT00005603|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119412|NCT00005603|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119413|NCT00005603|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119414|NCT00005609|Rituximab|rituximab|mesh-list
56119415|NCT00005609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56119416|NCT00005609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119417|NCT00005609|Immunologic Factors|immunologic factors|mesh-ancestor
56119418|NCT00005609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119419|NCT00005609|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56119420|NCT00005615|Interferons|interferons|mesh-list
56119421|NCT00005615|Interferon-alpha|interferon-alpha|mesh-list
56119428|NCT00005627|Docetaxel|docetaxel|mesh-list
56119448|NCT00385853|Temozolomide|temozolomide|mesh-list
56119449|NCT00385853|Vatalanib|vatalanib|mesh-list
56119450|NCT00385853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119451|NCT00385853|Alkylating Agents|alkylating agents|mesh-ancestor
56119452|NCT00385853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119453|NCT00385853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119454|NCT00385853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56119455|NCT00385853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119456|NCT00005765|Nicotine|nicotine|mesh-list
56119457|NCT00005765|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56119458|NCT00005765|Autonomic Agents|autonomic agents|mesh-ancestor
56119459|NCT00005765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119460|NCT00005765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846378|NCT01923376|Laxatives|laxatives|mesh-ancestor
56119461|NCT00005765|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56119462|NCT00005765|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56119463|NCT00005765|Cholinergic Agents|cholinergic agents|mesh-ancestor
56119464|NCT00005765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56119465|NCT00005765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119466|NCT00005777|Dexamethasone|dexamethasone|mesh-list
56119467|NCT00005777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56119468|NCT00005777|Antiemetics|antiemetics|mesh-ancestor
56119469|NCT00005777|Autonomic Agents|autonomic agents|mesh-ancestor
56119470|NCT00005777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119471|NCT00005777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119472|NCT00005777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56119473|NCT00005777|Glucocorticoids|glucocorticoids|mesh-ancestor
56119474|NCT00005777|Hormones|hormones|mesh-ancestor
56119475|NCT00005777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119476|NCT00005777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56119477|NCT00005777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119480|NCT00385931|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56119481|NCT00385931|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56119484|NCT00385931|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56119485|NCT00385931|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56119486|NCT00385931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119487|NCT00385931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56119488|NCT00385931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56119489|NCT00385931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56119503|NCT00005807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119504|NCT00005813|Antibodies|antibodies|mesh-list
56119505|NCT00005813|Antibodies, Bispecific|antibodies, bispecific|mesh-list
56119506|NCT00005813|Immunologic Factors|immunologic factors|mesh-ancestor
56119507|NCT00005813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119508|NCT04567433|Hydrocortisone|hydrocortisone|mesh-list
56119509|NCT04567433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56119510|NCT00003647|Dacarbazine|dacarbazine|mesh-list
56119512|NCT00003647|Alkylating Agents|alkylating agents|mesh-ancestor
56119549|NCT00003671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119550|NCT00003671|Alkylating Agents|alkylating agents|mesh-ancestor
56119551|NCT00003671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119552|NCT00003671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119553|NCT00003671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56119554|NCT00003671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56119555|NCT00003671|Antiemetics|antiemetics|mesh-ancestor
56119556|NCT00003671|Autonomic Agents|autonomic agents|mesh-ancestor
56119557|NCT00003671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119558|NCT00003671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56119559|NCT00003671|Glucocorticoids|glucocorticoids|mesh-ancestor
56119560|NCT00003671|Hormones|hormones|mesh-ancestor
56119561|NCT00003671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119562|NCT00003671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56119563|NCT00003671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56119564|NCT00003671|Abortifacient Agents|abortifacient agents|mesh-ancestor
56119565|NCT00003671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56119566|NCT00003671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119567|NCT00003671|Antimetabolites|antimetabolites|mesh-ancestor
56119568|NCT00003671|Dermatologic Agents|dermatologic agents|mesh-ancestor
56119569|NCT00003671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119572|NCT00003671|Antiviral Agents|antiviral agents|mesh-ancestor
56119596|NCT00384605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119597|NCT00384605|Hormones|hormones|mesh-ancestor
56119598|NCT00384605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119599|NCT00384605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119600|NCT00003683|Doxorubicin|doxorubicin|mesh-list
56119601|NCT00003683|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56119602|NCT00003683|Ifosfamide|ifosfamide|mesh-list
56119603|NCT00003683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56119604|NCT00003683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119605|NCT00003683|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56119606|NCT00003683|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119607|NCT00003683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119611|NCT00003701|Paclitaxel|paclitaxel|mesh-list
56119612|NCT00003701|Vinblastine|vinblastine|mesh-list
56119613|NCT00003701|Carboplatin|carboplatin|mesh-list
56119614|NCT00003701|Doxorubicin|doxorubicin|mesh-list
56119616|NCT00003701|Methotrexate|methotrexate|mesh-list
56119617|NCT00003701|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119618|NCT00003701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119619|NCT00003701|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119620|NCT00003701|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119621|NCT00003701|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119622|NCT00003701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119623|NCT00003701|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56119643|NCT00003707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119644|NCT00003707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119645|NCT00003707|Antiviral Agents|antiviral agents|mesh-ancestor
56119646|NCT00003707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119647|NCT00003707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119648|NCT00003707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119649|NCT00003707|Immunologic Factors|immunologic factors|mesh-ancestor
56119650|NCT00003707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119651|NCT00003719|Irinotecan|irinotecan|mesh-list
56119652|NCT00003719|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56119653|NCT00003719|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119654|NCT00003719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119655|NCT00003719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119656|NCT00003719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119657|NCT00003725|Valrubicin|valrubicin|mesh-list
56119658|NCT00003725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119659|NCT00003725|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56119660|NCT00003725|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119661|NCT00003725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119662|NCT00003725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119663|NCT00003731|Temozolomide|temozolomide|mesh-list
56119664|NCT00003731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119665|NCT00003731|Alkylating Agents|alkylating agents|mesh-ancestor
56119666|NCT00003731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119667|NCT00003731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119668|NCT00003743|Aldesleukin|aldesleukin|mesh-list
56119669|NCT00003743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119670|NCT00003743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56119671|NCT00003743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56119672|NCT00003743|Antiviral Agents|antiviral agents|mesh-ancestor
56119673|NCT00003743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119674|NCT00384917|Ketoconazole|ketoconazole|mesh-list
56119675|NCT00384917|Antifungal Agents|antifungal agents|mesh-ancestor
56119676|NCT00384917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119677|NCT00384917|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56119678|NCT00384917|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56119679|NCT00384917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119680|NCT00384917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119681|NCT00384917|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56119682|NCT00384917|Hormone Antagonists|hormone antagonists|mesh-ancestor
56119683|NCT00384917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144791|NCT05131152|Cyclosporine|cyclosporine|mesh-list
55846605|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
56119684|NCT00384917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119685|NCT00384917|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56119686|NCT05444153|Empagliflozin|empagliflozin|mesh-list
56119687|NCT05444153|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56119695|NCT00003797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119696|NCT00003797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119697|NCT00003797|Antiviral Agents|antiviral agents|mesh-ancestor
56119727|NCT00003815|Bleomycin|bleomycin|mesh-list
56119728|NCT00003815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119729|NCT00003815|Immunologic Factors|immunologic factors|mesh-ancestor
56119730|NCT00003815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119731|NCT00003815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56119732|NCT00003815|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119733|NCT00003815|Alkylating Agents|alkylating agents|mesh-ancestor
56119734|NCT00003815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119735|NCT00003815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119736|NCT00003815|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56119737|NCT00003815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56119738|NCT00003815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56119739|NCT00003815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119740|NCT00003815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119741|NCT00003815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119742|NCT00003815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119743|NCT00003815|Antimetabolites|antimetabolites|mesh-ancestor
56119744|NCT00003815|Antiviral Agents|antiviral agents|mesh-ancestor
56119745|NCT00003815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119746|NCT00003815|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119747|NCT00003815|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119748|NCT00003815|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119749|NCT00003815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56119750|NCT00003815|Glucocorticoids|glucocorticoids|mesh-ancestor
56119751|NCT00003815|Hormones|hormones|mesh-ancestor
56119752|NCT00003815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119753|NCT00003815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56119754|NCT00003821|Aminopterin|aminopterin|mesh-list
55846691|NCT01904149|Tramadol|tramadol|mesh-list
56119755|NCT00003821|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56119756|NCT00003821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119757|NCT00003821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119758|NCT00003827|Cytarabine|cytarabine|mesh-list
56119767|NCT00003827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56119768|NCT00003827|Immunologic Factors|immunologic factors|mesh-ancestor
56119769|NCT00003827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119770|NCT00003827|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56119771|NCT00003827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119772|NCT00003827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119773|NCT00003827|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56119774|NCT00003827|Protective Agents|protective agents|mesh-ancestor
56119775|NCT00003851|Gemcitabine|gemcitabine|mesh-list
56119776|NCT00003851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56119777|NCT00003851|Antimetabolites|antimetabolites|mesh-ancestor
56119778|NCT00003851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119779|NCT00003851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119780|NCT00003851|Antiviral Agents|antiviral agents|mesh-ancestor
56119843|NCT00003899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56119845|NCT00003899|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56119846|NCT00003917|Topotecan|topotecan|mesh-list
56119847|NCT00003917|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56119848|NCT00003917|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119849|NCT00003917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119850|NCT00003917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119851|NCT00003917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119852|NCT00003923|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
56119853|NCT00003923|Trioxsalen|trioxsalen|mesh-list
56119854|NCT00003923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119855|NCT00003923|Dermatologic Agents|dermatologic agents|mesh-ancestor
56119856|NCT00003923|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56119893|NCT02210819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119895|NCT04564469|Furosemide|furosemide|mesh-list
56119896|NCT04564469|Diuretics|diuretics|mesh-ancestor
56119897|NCT04564469|Natriuretic Agents|natriuretic agents|mesh-ancestor
56119898|NCT04564469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119899|NCT04564469|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56119900|NCT04564469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56119901|NCT04564469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119902|NCT04564001|Infliximab|infliximab|mesh-list
56119903|NCT04564001|Dermatologic Agents|dermatologic agents|mesh-ancestor
56119904|NCT04564001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56119905|NCT04564001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56119906|NCT04568603|Islatravir|islatravir|mesh-list
56119907|NCT04568603|Methadone|methadone|mesh-list
56119908|NCT04568603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56119909|NCT04568603|Narcotics|narcotics|mesh-ancestor
56119910|NCT04568603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144792|NCT05131152|Cyclosporins|cyclosporins|mesh-list
56119911|NCT04568603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119912|NCT04568603|Analgesics|analgesics|mesh-ancestor
56119913|NCT04568603|Sensory System Agents|sensory system agents|mesh-ancestor
56119914|NCT04568603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119915|NCT04568603|Antitussive Agents|antitussive agents|mesh-ancestor
56119916|NCT04568603|Respiratory System Agents|respiratory system agents|mesh-ancestor
56119917|NCT04568603|Antiviral Agents|antiviral agents|mesh-ancestor
56119918|NCT04568603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56119919|NCT04568603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119920|NCT04568603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119921|NCT04568603|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56119922|NCT04568603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56119934|NCT04563299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56119935|NCT04563299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119936|NCT04563299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56119937|NCT04563299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119938|NCT04563299|Antiemetics|antiemetics|mesh-ancestor
56119939|NCT04563299|Autonomic Agents|autonomic agents|mesh-ancestor
56119940|NCT04563299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56119941|NCT04563299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56119942|NCT04563299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56119943|NCT04563299|Protective Agents|protective agents|mesh-ancestor
56119944|NCT04561817|Paclitaxel|paclitaxel|mesh-list
56119945|NCT04561817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56119946|NCT04561817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119947|NCT04561817|Tubulin Modulators|tubulin modulators|mesh-ancestor
56119948|NCT04561817|Antimitotic Agents|antimitotic agents|mesh-ancestor
56119949|NCT04561817|Mitosis Modulators|mitosis modulators|mesh-ancestor
56119950|NCT04561817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119951|NCT02211833|Pemetrexed|pemetrexed|mesh-list
56119952|NCT02211833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119954|NCT02211833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119955|NCT02211833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56119956|NCT02211833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56119957|NCT02211443|Antibodies|antibodies|mesh-list
56119958|NCT02211443|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56119959|NCT02211443|Immunologic Factors|immunologic factors|mesh-ancestor
56119960|NCT02211443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56119961|NCT02211521|Hyaluronic Acid|hyaluronic acid|mesh-list
56119962|NCT02211521|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56119965|NCT02211521|Viscosupplements|viscosupplements|mesh-ancestor
56119979|NCT01948908|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56119980|NCT01948908|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56119981|NCT01948908|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56119982|NCT01948908|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56119983|NCT01948908|Anesthetics, General|anesthetics, general|mesh-ancestor
56119984|NCT01948908|Anesthetics|anesthetics|mesh-ancestor
56119985|NCT01948908|GABA Modulators|gaba modulators|mesh-ancestor
55846903|NCT03110926|Vitamins|vitamins|mesh-ancestor
56119986|NCT01948908|GABA Agents|gaba agents|mesh-ancestor
56119987|NCT01948908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56119988|NCT01948908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119989|NCT01925274|Irinotecan|irinotecan|mesh-list
56119990|NCT01925274|Cetuximab|cetuximab|mesh-list
56119991|NCT01925274|Gedatolisib|gedatolisib|mesh-list
56119992|NCT01925274|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56119993|NCT01925274|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56119994|NCT01925274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56119995|NCT01925274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56119996|NCT01925274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56119997|NCT01925274|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56119998|NCT01925274|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56119999|NCT01948830|Ranibizumab|ranibizumab|mesh-list
56120000|NCT01948830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56120001|NCT01948830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56120029|NCT01946880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56120030|NCT01946880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120031|NCT01946880|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56120032|NCT01946880|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56120033|NCT01946880|Antitubercular Agents|antitubercular agents|mesh-ancestor
56120034|NCT01946880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56120035|NCT01946880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120036|NCT01946880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120037|NCT01946880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120038|NCT01946880|Antimalarials|antimalarials|mesh-ancestor
56120039|NCT01946880|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56120040|NCT01946880|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56120041|NCT01946880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56120042|NCT01946880|Amebicides|amebicides|mesh-ancestor
56120043|NCT01946880|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56120044|NCT01946880|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56120045|NCT01946880|Analgesics|analgesics|mesh-ancestor
56120046|NCT01946880|Sensory System Agents|sensory system agents|mesh-ancestor
56120047|NCT01946880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120048|NCT01946880|Filaricides|filaricides|mesh-ancestor
56120049|NCT01946880|Antinematodal Agents|antinematodal agents|mesh-ancestor
56120050|NCT01946880|Anthelmintics|anthelmintics|mesh-ancestor
56120051|NCT01972152|Glucagon|glucagon|mesh-list
56120052|NCT01972152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56120053|NCT01972152|Hormones|hormones|mesh-ancestor
56120054|NCT01972152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120055|NCT01972152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120056|NCT01972074|Memantine|memantine|mesh-list
55742242|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
56120057|NCT01972074|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56120074|NCT01618266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120075|NCT01618266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56120076|NCT01618266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120077|NCT01918332|Valsartan|valsartan|mesh-list
56120078|NCT01918332|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
56120079|NCT01918332|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56120080|NCT01918332|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56120081|NCT01918332|Antimetabolites|antimetabolites|mesh-ancestor
56120082|NCT01918332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120083|NCT01918332|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56120084|NCT01918332|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56120085|NCT01918332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120086|NCT01918332|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56120087|NCT01918332|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56120088|NCT01918332|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56120089|NCT01922934|Topiramate|topiramate|mesh-list
56120090|NCT01922934|Phentermine|phentermine|mesh-list
56120091|NCT01922934|Anticonvulsants|anticonvulsants|mesh-ancestor
56120092|NCT01922934|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56120093|NCT01922934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120094|NCT01922934|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56120095|NCT01922934|Appetite Depressants|appetite depressants|mesh-ancestor
56120096|NCT01922934|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
56120097|NCT01922934|Sympathomimetics|sympathomimetics|mesh-ancestor
56120098|NCT01922934|Autonomic Agents|autonomic agents|mesh-ancestor
56120099|NCT01922934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120118|NCT01917006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120119|NCT01916226|Cetirizine|cetirizine|mesh-list
56120120|NCT01916226|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56120121|NCT01916226|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
56120122|NCT01916226|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56120123|NCT01916226|Histamine Antagonists|histamine antagonists|mesh-ancestor
56120124|NCT01916226|Histamine Agents|histamine agents|mesh-ancestor
56120125|NCT01916226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120126|NCT01916226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120127|NCT01916226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120128|NCT01915914|Fluticasone|fluticasone|mesh-list
56120129|NCT01915914|Xhance|xhance|mesh-list
56120130|NCT01915914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56120131|NCT01915914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56120132|NCT01915914|Autonomic Agents|autonomic agents|mesh-ancestor
56120133|NCT01915914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120134|NCT01915914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847055|NCT00981526|Telmisartan|telmisartan|mesh-list
56120135|NCT01915914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56120136|NCT01915914|Respiratory System Agents|respiratory system agents|mesh-ancestor
56120137|NCT01915914|Dermatologic Agents|dermatologic agents|mesh-ancestor
56120138|NCT01915914|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56120140|NCT01968954|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56120141|NCT01968954|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56120142|NCT01968954|Antimetabolites|antimetabolites|mesh-ancestor
56120143|NCT01968954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120163|NCT01620060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120164|NCT01620060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56120165|NCT01620060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56120166|NCT01620060|Serotonin Agents|serotonin agents|mesh-ancestor
56120167|NCT01620060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56120168|NCT01620060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56120169|NCT01620060|Dopamine Agents|dopamine agents|mesh-ancestor
56120170|NCT01914666|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
56120171|NCT01914666|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56120172|NCT01914666|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56120173|NCT01914666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56120174|NCT01914666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120175|NCT01914666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120176|NCT01914666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120177|NCT01914666|Analgesics|analgesics|mesh-ancestor
56120178|NCT01914666|Sensory System Agents|sensory system agents|mesh-ancestor
56120179|NCT01914666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120180|NCT01914666|Antidepressive Agents|antidepressive agents|mesh-ancestor
56120215|NCT01911780|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56120216|NCT01911780|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56120217|NCT01911780|Diuretics|diuretics|mesh-ancestor
56120218|NCT01911780|Natriuretic Agents|natriuretic agents|mesh-ancestor
56120219|NCT01911780|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56120220|NCT01911546|Everolimus|everolimus|mesh-list
56120221|NCT01911546|Tacrolimus|tacrolimus|mesh-list
56120222|NCT01911546|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56120223|NCT01911546|Immunologic Factors|immunologic factors|mesh-ancestor
56120224|NCT01911546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120225|NCT01911546|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56120226|NCT01911546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120227|NCT01911546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120228|NCT01911546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120229|NCT01908816|Ranibizumab|ranibizumab|mesh-list
56120230|NCT01908816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56120231|NCT01908816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56120232|NCT01908816|Growth Substances|growth substances|mesh-ancestor
56120233|NCT01908816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120234|NCT01908816|Growth Inhibitors|growth inhibitors|mesh-ancestor
56120235|NCT01908816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120236|NCT01908582|Rifampin|rifampin|mesh-list
56120237|NCT01908582|Evacetrapib|evacetrapib|mesh-list
56120238|NCT01908582|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56120239|NCT01908582|Antitubercular Agents|antitubercular agents|mesh-ancestor
56120240|NCT01908582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56120241|NCT01908582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120242|NCT01908582|Leprostatic Agents|leprostatic agents|mesh-ancestor
56120243|NCT01908582|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56120260|NCT01907100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120261|NCT01907100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120262|NCT01907100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56120263|NCT01907100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56120264|NCT01907100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56120265|NCT01889862|Dextrans|dextrans|mesh-list
56120266|NCT01889862|Anticoagulants|anticoagulants|mesh-ancestor
56120267|NCT01889862|Plasma Substitutes|plasma substitutes|mesh-ancestor
56120268|NCT01889862|Blood Substitutes|blood substitutes|mesh-ancestor
56120269|NCT01887288|Capecitabine|capecitabine|mesh-list
56120270|NCT01887288|Digoxin|digoxin|mesh-list
56120271|NCT01887288|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56120272|NCT01887288|Antimetabolites|antimetabolites|mesh-ancestor
56120273|NCT01887288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120274|NCT01887288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120275|NCT01887288|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56120276|NCT01887288|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56120277|NCT01887288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120278|NCT01887288|Protective Agents|protective agents|mesh-ancestor
56120279|NCT01887288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120280|NCT03405714|Brivaracetam|brivaracetam|mesh-list
56120281|NCT03405714|Anticonvulsants|anticonvulsants|mesh-ancestor
56120282|NCT01885182|Oxycodone|oxycodone|mesh-list
55847205|NCT05604898|Antibodies|antibodies|mesh-list
56120284|NCT01885182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56120285|NCT01885182|Narcotics|narcotics|mesh-ancestor
56120312|NCT01904760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120313|NCT01904760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120314|NCT01904058|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56120315|NCT01904058|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56120316|NCT01904058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56120317|NCT01881126|Timolol|timolol|mesh-list
56120318|NCT01881126|Bimatoprost|bimatoprost|mesh-list
56120319|NCT01881126|Travoprost|travoprost|mesh-list
56120320|NCT01881126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120321|NCT01881126|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56120322|NCT01881126|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56120323|NCT01881126|Adrenergic Agents|adrenergic agents|mesh-ancestor
56120324|NCT01881126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120325|NCT01881126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120326|NCT01881126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56120327|NCT01881126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56120328|NCT01880736|Insulin|insulin|mesh-list
56120329|NCT01880736|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56120330|NCT01880736|Insulin, Long-Acting|insulin, long-acting|mesh-list
56120331|NCT01880736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56120332|NCT01880736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120333|NCT01880424|Linaclotide|linaclotide|mesh-list
56120334|NCT01880424|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
56120335|NCT01880424|Enzyme Activators|enzyme activators|mesh-ancestor
56120336|NCT01880424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120337|NCT01880424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56120338|NCT01862874|Vaccines|vaccines|mesh-list
56120339|NCT01862874|Immunologic Factors|immunologic factors|mesh-ancestor
56120340|NCT01862874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120341|NCT01903434|Evacetrapib|evacetrapib|mesh-list
56120342|NCT01903434|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56120355|NCT01903356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120356|NCT01903356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120357|NCT01862640|Brexpiprazole|brexpiprazole|mesh-list
56120358|NCT01862640|Serotonin Agents|serotonin agents|mesh-ancestor
56120360|NCT01862640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120361|NCT01862640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120365|NCT01902966|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56120366|NCT01902966|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56120367|NCT01902966|Adrenergic Agents|adrenergic agents|mesh-ancestor
56120368|NCT01902966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120369|NCT01902966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120370|NCT01902966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120371|NCT01902966|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56120372|NCT01902966|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56120373|NCT01902966|Vasodilator Agents|vasodilator agents|mesh-ancestor
56120374|NCT01862328|Gemcitabine|gemcitabine|mesh-list
56120376|NCT01862328|Docetaxel|docetaxel|mesh-list
56120377|NCT01862328|Carboplatin|carboplatin|mesh-list
56120378|NCT01862328|Pevonedistat|pevonedistat|mesh-list
56120379|NCT01862328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56120380|NCT01862328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120381|NCT01862328|Tubulin Modulators|tubulin modulators|mesh-ancestor
56120404|NCT01862250|Adrenergic Agents|adrenergic agents|mesh-ancestor
56120405|NCT01862250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120406|NCT01862250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120408|NCT01876446|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56120409|NCT01876446|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56120410|NCT01876446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120411|NCT01876446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120412|NCT01876446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120413|NCT04414800|Fentanyl|fentanyl|mesh-list
56120414|NCT04414800|Ketamine|ketamine|mesh-list
56120415|NCT04414800|Analgesics|analgesics|mesh-ancestor
56120416|NCT04414800|Sensory System Agents|sensory system agents|mesh-ancestor
56120417|NCT04414800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120418|NCT04414800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120419|NCT04414800|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56120420|NCT04414800|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56120421|NCT04414800|Anesthetics, General|anesthetics, general|mesh-ancestor
56120422|NCT04414800|Anesthetics|anesthetics|mesh-ancestor
56120423|NCT04414800|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120424|NCT04414800|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56120425|NCT04414800|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56120455|NCT01876368|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56120456|NCT01876368|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
56120457|NCT01876368|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56120458|NCT01876368|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56120459|NCT01876368|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56120460|NCT01876368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120461|NCT01873950|Quinidine|quinidine|mesh-list
56120462|NCT01873950|Quinidine gluconate|quinidine gluconate|mesh-list
56120463|NCT01873950|Verapamil|verapamil|mesh-list
56120464|NCT01873950|Dofetilide|dofetilide|mesh-list
56120465|NCT01873950|Ranolazine|ranolazine|mesh-list
56120466|NCT01873950|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56120467|NCT01873950|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56120468|NCT01873950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56120469|NCT01873950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120577|NCT01853982|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
56120578|NCT01853982|Ceftolozane|ceftolozane|mesh-list
56120579|NCT01853982|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
56120580|NCT01853982|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56120581|NCT01853982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120582|NCT01853982|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56120583|NCT01853982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120584|NCT01853982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120585|NCT01853982|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56120586|NCT01853982|Renal Agents|renal agents|mesh-ancestor
56120587|NCT01853280|Methylphenidate|methylphenidate|mesh-list
56120588|NCT01853280|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56120589|NCT01853280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120590|NCT01853280|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
56120591|NCT01853280|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56120592|NCT01853280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56120593|NCT01853280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120594|NCT01853280|Dopamine Agents|dopamine agents|mesh-ancestor
56120595|NCT01853280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56120596|NCT01891890|Lamotrigine|lamotrigine|mesh-list
56120597|NCT01891890|Oxcarbazepine|oxcarbazepine|mesh-list
56120628|NCT01869192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56120629|NCT01869192|Immunologic Factors|immunologic factors|mesh-ancestor
56120630|NCT01869192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120631|NCT01869192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56120632|NCT01869192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56120633|NCT01869192|Alkylating Agents|alkylating agents|mesh-ancestor
56120634|NCT01869192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120635|NCT01869192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120636|NCT01869192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56120637|NCT01869192|Tubulin Modulators|tubulin modulators|mesh-ancestor
56120638|NCT01869192|Antimitotic Agents|antimitotic agents|mesh-ancestor
56120639|NCT01869192|Mitosis Modulators|mitosis modulators|mesh-ancestor
56120640|NCT01869192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56120641|NCT01869192|Antimetabolites|antimetabolites|mesh-ancestor
56120642|NCT01869192|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56120643|NCT01869192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56120644|NCT01869192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56120645|NCT01869192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120646|NCT01851720|Fentanyl|fentanyl|mesh-list
56120647|NCT01851720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56120648|NCT01851720|Narcotics|narcotics|mesh-ancestor
55847589|NCT01456468|Tretinoin|tretinoin|mesh-list
56120649|NCT01851720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56120650|NCT01851720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120652|NCT01851720|Sensory System Agents|sensory system agents|mesh-ancestor
56120654|NCT01851720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56120673|NCT01868022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120674|NCT01868022|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56120675|NCT01868022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56120676|NCT01850004|Dasatinib|dasatinib|mesh-list
56120677|NCT01850004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120678|NCT01850004|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56120679|NCT01850004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120680|NCT01850004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120681|NCT01867710|Dexamethasone|dexamethasone|mesh-list
56120682|NCT01867710|Prednisone|prednisone|mesh-list
56120683|NCT01867710|Abiraterone Acetate|abiraterone acetate|mesh-list
56120684|NCT01867710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56120685|NCT01867710|Antiemetics|antiemetics|mesh-ancestor
56120686|NCT01867710|Autonomic Agents|autonomic agents|mesh-ancestor
56120687|NCT01867710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56120688|NCT01867710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120689|NCT01867710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56120690|NCT01867710|Glucocorticoids|glucocorticoids|mesh-ancestor
56120691|NCT01867710|Hormones|hormones|mesh-ancestor
56120692|NCT01867710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120693|NCT01867710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56120694|NCT01867710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120695|NCT01867710|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56120696|NCT01867710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120697|NCT01867710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120698|NCT01867710|Hormone Antagonists|hormone antagonists|mesh-ancestor
56120699|NCT01867710|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56120700|NCT01832766|Dronabinol|dronabinol|mesh-list
56120701|NCT01832766|Hallucinogens|hallucinogens|mesh-ancestor
56120702|NCT01832766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120703|NCT01832766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56120714|NCT01832532|Liraglutide|liraglutide|mesh-list
56120715|NCT01832532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56120716|NCT01832532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120717|NCT01832532|Incretins|incretins|mesh-ancestor
56120718|NCT01832532|Hormones|hormones|mesh-ancestor
56120719|NCT01832532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120720|NCT04414956|Vitamin K|vitamin k|mesh-list
56120801|NCT01803282|Vitamin B Complex|vitamin b complex|mesh-ancestor
56120802|NCT01803282|Vitamins|vitamins|mesh-ancestor
56120803|NCT01803282|Micronutrients|micronutrients|mesh-ancestor
56120804|NCT01803282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56120805|NCT01803282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56120806|NCT01844778|Tobramycin|tobramycin|mesh-list
56120807|NCT01844778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56120808|NCT01844778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120809|NCT01802580|Fluocinonide|fluocinonide|mesh-list
56120810|NCT01802580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56120811|NCT01802580|Glucocorticoids|glucocorticoids|mesh-ancestor
56120812|NCT01802580|Hormones|hormones|mesh-ancestor
56121091|NCT01817790|Dermatologic Agents|dermatologic agents|mesh-ancestor
56120813|NCT01802580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120814|NCT01802580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120815|NCT01802580|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56120816|NCT01611090|Rituximab|rituximab|mesh-list
56120817|NCT01611090|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56120818|NCT01611090|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56120848|NCT01827384|Everolimus|everolimus|mesh-list
56120854|NCT01827384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56120855|NCT01827384|Immunologic Factors|immunologic factors|mesh-ancestor
56120856|NCT01827384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120857|NCT01827384|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56120858|NCT01827384|Alkylating Agents|alkylating agents|mesh-ancestor
56120859|NCT01827384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120860|NCT01827384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56120861|NCT01827384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120862|NCT01827384|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56120863|NCT01844076|Quinacrine|quinacrine|mesh-list
56120864|NCT01844076|Capecitabine|capecitabine|mesh-list
56120865|NCT01844076|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56120866|NCT01844076|Antimetabolites|antimetabolites|mesh-ancestor
56120867|NCT01844076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120868|NCT01844076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120869|NCT01844076|Anticestodal Agents|anticestodal agents|mesh-ancestor
56120870|NCT01844076|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
56120871|NCT01844076|Anthelmintics|anthelmintics|mesh-ancestor
56120872|NCT01844076|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56120873|NCT01844076|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56120874|NCT01844076|Antimalarials|antimalarials|mesh-ancestor
56120875|NCT01844076|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56120876|NCT01844076|Antinematodal Agents|antinematodal agents|mesh-ancestor
56120877|NCT01844076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120878|NCT01826448|Vemurafenib|vemurafenib|mesh-list
56120879|NCT01826448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120880|NCT01826448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56120881|NCT01826448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120882|NCT01826448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120883|NCT01826370|Linagliptin|linagliptin|mesh-list
56120896|NCT01799226|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
56120897|NCT01799226|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56120898|NCT01799226|Antimetabolites|antimetabolites|mesh-ancestor
56120899|NCT01799226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120900|NCT01799226|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56120901|NCT01798992|Metoprolol|metoprolol|mesh-list
56120902|NCT01798992|Carvedilol|carvedilol|mesh-list
56120903|NCT01798992|Doxazosin|doxazosin|mesh-list
56120904|NCT01798992|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56120905|NCT01798992|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56120906|NCT01798992|Sympatholytics|sympatholytics|mesh-ancestor
56120925|NCT01798056|Immunologic Factors|immunologic factors|mesh-ancestor
56120926|NCT01798056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120927|NCT01824342|Denosumab|denosumab|mesh-list
56120928|NCT01824342|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56120929|NCT01824342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120930|NCT01823328|Ketamine|ketamine|mesh-list
56120931|NCT01823328|Etomidate|etomidate|mesh-list
56120932|NCT01823328|Analgesics|analgesics|mesh-ancestor
56120933|NCT01823328|Sensory System Agents|sensory system agents|mesh-ancestor
56120936|NCT01823328|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56120958|NCT01797432|Glucocorticoids|glucocorticoids|mesh-ancestor
56120960|NCT01797432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120961|NCT01797432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120962|NCT01797432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56120963|NCT01797432|Immunologic Factors|immunologic factors|mesh-ancestor
56120964|NCT01797432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56120965|NCT01797432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56120966|NCT01797120|Everolimus|everolimus|mesh-list
56120967|NCT01797120|Fulvestrant|fulvestrant|mesh-list
56120968|NCT01797120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56120969|NCT01797120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56120970|NCT01797120|Immunologic Factors|immunologic factors|mesh-ancestor
56120971|NCT01797120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56120972|NCT01797120|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56120973|NCT01797120|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
56120974|NCT01797120|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56120975|NCT01797120|Hormone Antagonists|hormone antagonists|mesh-ancestor
56120976|NCT01797120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56120977|NCT01796964|Aflibercept|aflibercept|mesh-list
56120978|NCT01796964|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56120979|NCT01796964|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56121010|NCT01794780|Cholinergic Agents|cholinergic agents|mesh-ancestor
56121011|NCT01794780|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56121012|NCT01794780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121013|NCT01794780|Vasodilator Agents|vasodilator agents|mesh-ancestor
56121014|NCT01794780|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
56121015|NCT01794780|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
56121016|NCT01794780|Purinergic Agents|purinergic agents|mesh-ancestor
56121017|NCT01838616|Oxycodone|oxycodone|mesh-list
56121018|NCT01838616|Tapentadol|tapentadol|mesh-list
56121019|NCT01838616|Naloxone|naloxone|mesh-list
56121020|NCT01838616|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56121021|NCT01838616|Narcotics|narcotics|mesh-ancestor
56121022|NCT01838616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121023|NCT01838616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121024|NCT01838616|Analgesics|analgesics|mesh-ancestor
56121025|NCT01838616|Sensory System Agents|sensory system agents|mesh-ancestor
56121026|NCT01838616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121027|NCT01838616|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56121028|NCT01838616|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55847964|NCT02688556|Cyclosporine|cyclosporine|mesh-list
56121029|NCT01838616|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56121030|NCT01838616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121031|NCT01838616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121032|NCT01838616|Adrenergic Agents|adrenergic agents|mesh-ancestor
56121033|NCT01838616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121034|NCT01794000|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
56121035|NCT01794000|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56121036|NCT01609218|Charcoal|charcoal|mesh-list
56121037|NCT01609218|Antidotes|antidotes|mesh-ancestor
56121038|NCT01609218|Protective Agents|protective agents|mesh-ancestor
56121039|NCT01609218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121040|NCT04580472|Clindamycin|clindamycin|mesh-list
56121041|NCT04580472|Clindamycin palmitate|clindamycin palmitate|mesh-list
56121042|NCT04580472|Clindamycin phosphate|clindamycin phosphate|mesh-list
56121049|NCT01611558|Ipilimumab|ipilimumab|mesh-list
56121050|NCT01611558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56121051|NCT01611558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121052|NCT01611558|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56121053|NCT01611558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121054|NCT01818726|Deferasirox|deferasirox|mesh-list
56121055|NCT01818726|Iron Chelating Agents|iron chelating agents|mesh-ancestor
56121056|NCT01818726|Chelating Agents|chelating agents|mesh-ancestor
56121057|NCT01818726|Sequestering Agents|sequestering agents|mesh-ancestor
56121058|NCT01818726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121059|NCT01818336|Amoxicillin|amoxicillin|mesh-list
56121060|NCT01818336|Penicillins|penicillins|mesh-list
56121061|NCT01818336|Penicillin G|penicillin g|mesh-list
56121062|NCT01818336|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56121063|NCT01818336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121064|NCT01818258|Ritonavir|ritonavir|mesh-list
56121065|NCT01818258|Lopinavir|lopinavir|mesh-list
56121066|NCT01818258|Lamivudine|lamivudine|mesh-list
56121067|NCT01818258|Zidovudine|zidovudine|mesh-list
56121068|NCT01818258|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56121069|NCT01818258|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56121070|NCT01818258|Protease Inhibitors|protease inhibitors|mesh-ancestor
56121071|NCT01818258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121072|NCT01818258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121073|NCT01818258|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56121074|NCT01818258|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56121075|NCT01818258|Antiviral Agents|antiviral agents|mesh-ancestor
56121076|NCT01818258|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121077|NCT01818258|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56121078|NCT01818258|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56121080|NCT01818258|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56121081|NCT01818258|Antimetabolites|antimetabolites|mesh-ancestor
56121082|NCT01817790|Fluticasone|fluticasone|mesh-list
56121083|NCT01817790|Xhance|xhance|mesh-list
56121084|NCT01817790|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121085|NCT01817790|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56121088|NCT01817790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121089|NCT01817790|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56121090|NCT01817790|Respiratory System Agents|respiratory system agents|mesh-ancestor
56121095|NCT01793688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56121096|NCT01793688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121097|NCT01793688|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
56121098|NCT01793688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121099|NCT01793688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121100|NCT01793610|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
56121101|NCT01793610|Hallucinogens|hallucinogens|mesh-ancestor
56121102|NCT01793610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848056|NCT05604118|Aspirin|aspirin|mesh-list
56121103|NCT01793610|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56121104|NCT01793610|Serotonin Agents|serotonin agents|mesh-ancestor
56121106|NCT01793610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121107|NCT01793610|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56121143|NCT04414566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121144|NCT04414566|Tubulin Modulators|tubulin modulators|mesh-ancestor
56121145|NCT04414566|Antimitotic Agents|antimitotic agents|mesh-ancestor
56121146|NCT04414566|Mitosis Modulators|mitosis modulators|mesh-ancestor
56121147|NCT01791894|Arsenic Trioxide|arsenic trioxide|mesh-list
56121148|NCT01791894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121149|NCT04592016|Diclofenac|diclofenac|mesh-list
56121150|NCT04592016|Coal Tar|coal tar|mesh-list
56121151|NCT04592016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56121152|NCT04592016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56121153|NCT04592016|Analgesics|analgesics|mesh-ancestor
56121154|NCT04592016|Sensory System Agents|sensory system agents|mesh-ancestor
56121155|NCT04592016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121156|NCT04592016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121157|NCT04592016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121158|NCT04592016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121159|NCT04592016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56121160|NCT04592016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121161|NCT04592016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121162|NCT04592016|Keratolytic Agents|keratolytic agents|mesh-ancestor
56121163|NCT04592016|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121164|NCT01837680|Insulin|insulin|mesh-list
56121165|NCT01837680|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
56121184|NCT01790568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121185|NCT01790568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121186|NCT01790568|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121187|NCT01790568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121188|NCT01790568|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56121189|NCT01790568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121190|NCT01790568|Immunologic Factors|immunologic factors|mesh-ancestor
56121191|NCT01790568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121192|NCT01790568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56121193|NCT01790568|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56121194|NCT01790568|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56121195|NCT01836198|Clarithromycin|clarithromycin|mesh-list
56121196|NCT01836198|Ketoconazole|ketoconazole|mesh-list
56121197|NCT01836198|Gemfibrozil|gemfibrozil|mesh-list
56121219|NCT01816074|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56121220|NCT01816074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121221|NCT01816074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121222|NCT01816074|Dopamine Agents|dopamine agents|mesh-ancestor
56121223|NCT01816074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121224|NCT04586166|Imidacloprid|imidacloprid|mesh-list
56121225|NCT04586166|Cholinergic Agents|cholinergic agents|mesh-ancestor
56121226|NCT04586166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121227|NCT04586166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121228|NCT04586166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121229|NCT01815918|Hydrocortisone|hydrocortisone|mesh-list
56121230|NCT01815918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121231|NCT01789320|Triamcinolone|triamcinolone|mesh-list
56121246|NCT01788228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121247|NCT01607346|Ezogabine|ezogabine|mesh-list
56121248|NCT01607346|Anticonvulsants|anticonvulsants|mesh-ancestor
56121249|NCT01607346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121250|NCT01607346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121251|NCT01815138|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
56121252|NCT01815138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56121255|NCT01606800|Interferon alpha-2|interferon alpha-2|mesh-list
56121284|NCT01814046|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56121285|NCT01814046|Alkylating Agents|alkylating agents|mesh-ancestor
56121286|NCT01814046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121287|NCT01814046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121288|NCT01814046|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56121289|NCT01814046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56121290|NCT01814046|Analgesics|analgesics|mesh-ancestor
56121291|NCT01814046|Sensory System Agents|sensory system agents|mesh-ancestor
56121292|NCT01814046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121293|NCT01814046|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56121294|NCT01814046|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56121295|NCT01814046|Antiviral Agents|antiviral agents|mesh-ancestor
56121296|NCT01814046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56121297|NCT01813890|Tapentadol|tapentadol|mesh-list
56121298|NCT01813890|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56121299|NCT01813890|Narcotics|narcotics|mesh-ancestor
56121300|NCT01813890|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121301|NCT01813890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121302|NCT01813890|Analgesics|analgesics|mesh-ancestor
56121303|NCT01813890|Sensory System Agents|sensory system agents|mesh-ancestor
56121304|NCT01813890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121305|NCT01813890|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56121306|NCT01813890|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56121307|NCT01813890|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121308|NCT01813890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121309|NCT01813890|Adrenergic Agents|adrenergic agents|mesh-ancestor
56121310|NCT01813890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121311|NCT01813422|Evolocumab|evolocumab|mesh-list
56121312|NCT01813422|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56121313|NCT01813422|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56121314|NCT01813422|Antimetabolites|antimetabolites|mesh-ancestor
56121326|NCT01770912|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
56121327|NCT01770912|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
56121328|NCT01770912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121329|NCT01770912|Glucocorticoids|glucocorticoids|mesh-ancestor
56121330|NCT01770912|Hormones|hormones|mesh-ancestor
56121331|NCT01770912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121332|NCT01770912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121333|NCT01770912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121334|NCT01770912|Immunologic Factors|immunologic factors|mesh-ancestor
56121335|NCT01770912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121336|NCT01770912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121338|NCT01811706|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
56121339|NCT01811706|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121340|NCT01811706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121342|NCT01811238|Naloxone|naloxone|mesh-list
56121343|NCT01811238|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56121344|NCT01811238|Narcotics|narcotics|mesh-ancestor
56121345|NCT01811238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121346|NCT01811238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121347|NCT01811238|Analgesics|analgesics|mesh-ancestor
56121348|NCT01811238|Sensory System Agents|sensory system agents|mesh-ancestor
56121349|NCT01811238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121350|NCT01811238|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56121351|NCT01769508|Fluorouracil|fluorouracil|mesh-list
56121352|NCT01769508|Oxaliplatin|oxaliplatin|mesh-list
56121354|NCT01769508|Antimetabolites|antimetabolites|mesh-ancestor
56121355|NCT01769508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121357|NCT01769508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121370|NCT01810380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121371|NCT01810380|Serotonin Agents|serotonin agents|mesh-ancestor
56121372|NCT01810380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121373|NCT01810380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121374|NCT01810380|Dopamine Agonists|dopamine agonists|mesh-ancestor
56121375|NCT01810380|Dopamine Agents|dopamine agents|mesh-ancestor
56121376|NCT01810302|Nicardipine|nicardipine|mesh-list
56121377|NCT01810302|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56121378|NCT01810302|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56121379|NCT01810302|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56121380|NCT01810302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121381|NCT01810302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56121382|NCT01810302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121383|NCT01810302|Vasodilator Agents|vasodilator agents|mesh-ancestor
56121384|NCT01783938|Nivolumab|nivolumab|mesh-list
56121385|NCT01783938|Ipilimumab|ipilimumab|mesh-list
56121386|NCT01783938|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56121387|NCT01783938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121388|NCT01783938|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56121389|NCT01783938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121390|NCT01768572|Hydroxychloroquine|hydroxychloroquine|mesh-list
56121391|NCT01768572|Sulfasalazine|sulfasalazine|mesh-list
56121392|NCT01768572|Methotrexate|methotrexate|mesh-list
56121393|NCT01768572|Leflunomide|leflunomide|mesh-list
56121394|NCT01768572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56121395|NCT01768572|Abortifacient Agents|abortifacient agents|mesh-ancestor
56121396|NCT01768572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56121414|NCT01768572|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56121415|NCT01768572|Analgesics|analgesics|mesh-ancestor
56121416|NCT01768572|Sensory System Agents|sensory system agents|mesh-ancestor
56121417|NCT01768572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121418|NCT01768572|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121419|NCT01768572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56121420|NCT01783548|Beclomethasone|beclomethasone|mesh-list
56121421|NCT01783548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121422|NCT01783548|Glucocorticoids|glucocorticoids|mesh-ancestor
56121423|NCT01783548|Hormones|hormones|mesh-ancestor
56121424|NCT01783548|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121425|NCT01783548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121426|NCT01783548|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56121427|NCT01783548|Respiratory System Agents|respiratory system agents|mesh-ancestor
56121428|NCT01809210|Gemcitabine|gemcitabine|mesh-list
56121429|NCT01809210|Carboplatin|carboplatin|mesh-list
56121430|NCT01809210|Pemetrexed|pemetrexed|mesh-list
56121431|NCT01809210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121432|NCT01809210|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56121433|NCT01809210|Antimetabolites|antimetabolites|mesh-ancestor
56121443|NCT01809132|Zinc|zinc|mesh-list
56121470|NCT01809132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56121471|NCT01809132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121472|NCT01809132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121473|NCT01809132|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56121474|NCT01809132|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56121475|NCT01809132|Vasodilator Agents|vasodilator agents|mesh-ancestor
56121476|NCT01809132|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56121477|NCT01809132|Antioxidants|antioxidants|mesh-ancestor
56121478|NCT01809132|Astringents|astringents|mesh-ancestor
56121479|NCT01809132|Dermatologic Agents|dermatologic agents|mesh-ancestor
56121480|NCT01766778|Metformin|metformin|mesh-list
56121481|NCT01766778|Vildagliptin|vildagliptin|mesh-list
56121482|NCT01766778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56121483|NCT01766778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121484|NCT01766778|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56121485|NCT01766778|Protease Inhibitors|protease inhibitors|mesh-ancestor
56121486|NCT01766778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121487|NCT01766778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121488|NCT01808196|Losartan|losartan|mesh-list
56121527|NCT01807182|Fludarabine phosphate|fludarabine phosphate|mesh-list
56121528|NCT01807182|Interleukin-2|interleukin-2|mesh-list
56121529|NCT01807182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121530|NCT01807182|Immunologic Factors|immunologic factors|mesh-ancestor
56121531|NCT01807182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121532|NCT01807182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121533|NCT01807182|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56121534|NCT01807182|Alkylating Agents|alkylating agents|mesh-ancestor
56121535|NCT01807182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121536|NCT01807182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121537|NCT01807182|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56121538|NCT01807182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56121539|NCT01807182|Antimetabolites|antimetabolites|mesh-ancestor
56121540|NCT01807182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56121541|NCT01807182|Analgesics|analgesics|mesh-ancestor
56121681|NCT01777152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121682|NCT01777152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121683|NCT01777152|Glucocorticoids|glucocorticoids|mesh-ancestor
56121685|NCT01777152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121725|NCT01755702|Acetaminophen|acetaminophen|mesh-list
56121726|NCT01755702|Ibuprofen|ibuprofen|mesh-list
56121727|NCT01755702|Caffeine|caffeine|mesh-list
56121728|NCT01755702|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56121729|NCT01755702|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56121730|NCT01755702|Analgesics|analgesics|mesh-ancestor
56121731|NCT01755702|Sensory System Agents|sensory system agents|mesh-ancestor
56121732|NCT01755702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121984|NCT01727700|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56121733|NCT01755702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121734|NCT01755702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56121735|NCT01755702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56121736|NCT01755702|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56121737|NCT01755702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121787|NCT04413864|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56121788|NCT04413864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121789|NCT04413864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121790|NCT04413864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56121792|NCT04413864|Sensory System Agents|sensory system agents|mesh-ancestor
56121793|NCT04413864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121794|NCT04413864|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56121795|NCT04413864|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56121797|NCT04413864|Adrenergic Agents|adrenergic agents|mesh-ancestor
56121798|NCT04413864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56121799|NCT04413864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121800|NCT01755234|Propofol|propofol|mesh-list
56121807|NCT01755234|Anesthetics|anesthetics|mesh-ancestor
56121808|NCT01755234|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56121809|NCT01755234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56121810|NCT01730586|Paclitaxel|paclitaxel|mesh-list
56121811|NCT01730586|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56121812|NCT01730586|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56121813|NCT01730586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121814|NCT01730586|Tubulin Modulators|tubulin modulators|mesh-ancestor
56121815|NCT01730586|Antimitotic Agents|antimitotic agents|mesh-ancestor
56121816|NCT01730586|Mitosis Modulators|mitosis modulators|mesh-ancestor
56121817|NCT01730586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121818|NCT01755156|Metformin|metformin|mesh-list
56121819|NCT01755156|Insulin Glargine|insulin glargine|mesh-list
56121820|NCT01755156|Glimepiride|glimepiride|mesh-list
56121821|NCT01755156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56121822|NCT01755156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121823|NCT01755156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56121824|NCT01755156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56121825|NCT01755156|Immunologic Factors|immunologic factors|mesh-ancestor
56121826|NCT01754376|Aldesleukin|aldesleukin|mesh-list
56121827|NCT01754376|Interleukin-2|interleukin-2|mesh-list
56121828|NCT01754376|Vemurafenib|vemurafenib|mesh-list
56121829|NCT01754376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121830|NCT01754376|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56121831|NCT01754376|Analgesics|analgesics|mesh-ancestor
56121832|NCT01754376|Sensory System Agents|sensory system agents|mesh-ancestor
56121833|NCT01754376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121834|NCT01754376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121842|NCT01605396|Exemestane|exemestane|mesh-list
56121843|NCT01605396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56121844|NCT01605396|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56121845|NCT01605396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56121846|NCT01605396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121847|NCT01605396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121848|NCT01605396|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56121849|NCT01605396|Hormone Antagonists|hormone antagonists|mesh-ancestor
56121850|NCT01605396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121851|NCT01605396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121852|NCT01730118|Mitogens|mitogens|mesh-list
56121853|NCT01730118|Mitosis Modulators|mitosis modulators|mesh-ancestor
56121855|NCT01730040|Atorvastatin|atorvastatin|mesh-list
56121906|NCT01729728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56121907|NCT01729728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56121908|NCT01729728|Analgesics|analgesics|mesh-ancestor
56121909|NCT01729728|Sensory System Agents|sensory system agents|mesh-ancestor
56121910|NCT01729728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56121911|NCT01729728|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56121912|NCT01729728|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56121975|NCT01703286|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56121976|NCT01703286|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56121977|NCT01703286|Protease Inhibitors|protease inhibitors|mesh-ancestor
56121978|NCT01703286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56121979|NCT01703286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56121980|NCT01727700|Aripiprazole|aripiprazole|mesh-list
56121981|NCT01727700|Antidepressive Agents|antidepressive agents|mesh-ancestor
56121982|NCT01727700|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56121983|NCT01727700|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56122003|NCT01725282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56122004|NCT01725282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122006|NCT01725126|Liraglutide|liraglutide|mesh-list
56122007|NCT01725126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56122008|NCT01725126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122009|NCT01725126|Incretins|incretins|mesh-ancestor
56122011|NCT01725126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122012|NCT01751724|Caffeine|caffeine|mesh-list
56122013|NCT01751724|Caffeine citrate|caffeine citrate|mesh-list
56122014|NCT01751724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122015|NCT01751724|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56122023|NCT01751646|Vitamin D|vitamin d|mesh-list
56122038|NCT01751568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122039|NCT01751568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122040|NCT01751178|Ethanol|ethanol|mesh-list
56122041|NCT01751178|Chlorhexidine|chlorhexidine|mesh-list
56122042|NCT01751178|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
56122043|NCT01751178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
56122044|NCT01751178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122045|NCT01751178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56122046|NCT01751178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122047|NCT01751178|Disinfectants|disinfectants|mesh-ancestor
56122048|NCT01751178|Dermatologic Agents|dermatologic agents|mesh-ancestor
56122049|NCT01606254|Paliperidone Palmitate|paliperidone palmitate|mesh-list
56122050|NCT01606254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56122051|NCT01606254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56122052|NCT01606254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56122053|NCT01606254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122095|NCT01701258|Amisulpride|amisulpride|mesh-list
56122096|NCT01701258|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56122097|NCT01701258|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56122098|NCT01701258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56122100|NCT01701258|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56122101|NCT01701258|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56122102|NCT01701258|Dopamine Agents|dopamine agents|mesh-ancestor
56122103|NCT01701258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122104|NCT01701258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122105|NCT01701258|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56122106|NCT01701258|Antidepressive Agents|antidepressive agents|mesh-ancestor
56122107|NCT01700946|Cytarabine|cytarabine|mesh-list
56122108|NCT01700946|Aldesleukin|aldesleukin|mesh-list
56122109|NCT01700946|Dexamethasone|dexamethasone|mesh-list
56122110|NCT01700946|Hydrocortisone|hydrocortisone|mesh-list
56122111|NCT01700946|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
56122112|NCT01700946|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
56122113|NCT01700946|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
56122114|NCT01700946|Cyclophosphamide|cyclophosphamide|mesh-list
56122115|NCT01700946|Rituximab|rituximab|mesh-list
56122116|NCT01700946|Methotrexate|methotrexate|mesh-list
56122117|NCT01700946|Etoposide|etoposide|mesh-list
56122118|NCT01700946|Vincristine|vincristine|mesh-list
56122149|NCT01700946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56122150|NCT01700946|Antimetabolites|antimetabolites|mesh-ancestor
56122151|NCT01700946|Dermatologic Agents|dermatologic agents|mesh-ancestor
56122152|NCT01700946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122153|NCT01700946|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56122154|NCT01700946|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56122155|NCT01700946|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56122156|NCT01700946|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56122157|NCT01700946|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56122158|NCT01700946|Antiviral Agents|antiviral agents|mesh-ancestor
56122159|NCT01700946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122160|NCT01700946|Tubulin Modulators|tubulin modulators|mesh-ancestor
56122161|NCT01700946|Antimitotic Agents|antimitotic agents|mesh-ancestor
56122162|NCT01700946|Mitosis Modulators|mitosis modulators|mesh-ancestor
56122163|NCT01700946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56122164|NCT01700946|Analgesics|analgesics|mesh-ancestor
56122165|NCT01700946|Sensory System Agents|sensory system agents|mesh-ancestor
56122166|NCT01700946|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56122167|NCT01700946|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56122168|NCT01748994|Pioglitazone|pioglitazone|mesh-list
56122169|NCT01748994|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56122170|NCT01748994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122171|NCT01721070|Ketoconazole|ketoconazole|mesh-list
56122172|NCT01721070|Sufentanil|sufentanil|mesh-list
56122173|NCT01721070|Dsuvia|dsuvia|mesh-list
56122174|NCT01721070|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56122175|NCT01721070|Narcotics|narcotics|mesh-ancestor
56122176|NCT01721070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56122196|NCT01748292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56122197|NCT01748292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56122198|NCT01748292|Growth Substances|growth substances|mesh-ancestor
56122199|NCT01748292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122200|NCT01748292|Growth Inhibitors|growth inhibitors|mesh-ancestor
56122201|NCT01748292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122202|NCT01720602|Letrozole|letrozole|mesh-list
56122203|NCT01720602|Anastrozole|anastrozole|mesh-list
56122204|NCT01720602|Vorinostat|vorinostat|mesh-list
56122205|NCT01720602|Exemestane|exemestane|mesh-list
56122206|NCT01720602|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56122207|NCT01720602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122208|NCT01720602|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56122209|NCT01720602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56122210|NCT01720602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122211|NCT01720602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122213|NCT01720602|Hormone Antagonists|hormone antagonists|mesh-ancestor
56122214|NCT01720602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122215|NCT01720602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122216|NCT01720602|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56122249|NCT01698918|Letrozole|letrozole|mesh-list
56122250|NCT01698918|Exemestane|exemestane|mesh-list
56122251|NCT01698918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56122252|NCT01698918|Antiemetics|antiemetics|mesh-ancestor
56122253|NCT01698918|Autonomic Agents|autonomic agents|mesh-ancestor
56122254|NCT01698918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122255|NCT01698918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122256|NCT01698918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56122257|NCT01698918|Glucocorticoids|glucocorticoids|mesh-ancestor
56122258|NCT01698918|Hormones|hormones|mesh-ancestor
56122259|NCT01698918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122260|NCT01698918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56122261|NCT01698918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122262|NCT01698918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122263|NCT01698918|Immunologic Factors|immunologic factors|mesh-ancestor
56122264|NCT01698918|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56122265|NCT01698918|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56122266|NCT01698918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122267|NCT01698918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122268|NCT01698918|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56122269|NCT01698918|Hormone Antagonists|hormone antagonists|mesh-ancestor
56122270|NCT01717638|Vaccines|vaccines|mesh-list
56122271|NCT01717638|Immunologic Factors|immunologic factors|mesh-ancestor
56122272|NCT01717638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122273|NCT01745094|Solifenacin Succinate|solifenacin succinate|mesh-list
56122274|NCT01745094|Mirabegron|mirabegron|mesh-list
56122275|NCT01745094|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56122276|NCT01745094|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56122277|NCT01745094|Cholinergic Agents|cholinergic agents|mesh-ancestor
56122278|NCT01745094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122279|NCT01745094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122294|NCT01744782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122295|NCT01604850|Sofosbuvir|sofosbuvir|mesh-list
56122296|NCT01604850|Antiviral Agents|antiviral agents|mesh-ancestor
56122297|NCT01604850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122298|NCT01742286|Ceritinib|ceritinib|mesh-list
56122299|NCT01742286|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122300|NCT01742286|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56122301|NCT01742286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122302|NCT01742286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122303|NCT01716234|Posaconazole|posaconazole|mesh-list
56122304|NCT01716234|Antifungal Agents|antifungal agents|mesh-ancestor
56122305|NCT01716234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122306|NCT01716234|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56122307|NCT01716234|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56122308|NCT01716234|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56122309|NCT01716234|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56122310|NCT01716234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56122311|NCT01716234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122312|NCT01716234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122313|NCT01716234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56122314|NCT01716234|Hormone Antagonists|hormone antagonists|mesh-ancestor
56122315|NCT01716234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122316|NCT01716234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122317|NCT01716156|Ribavirin|ribavirin|mesh-list
56122318|NCT01716156|Grazoprevir|grazoprevir|mesh-list
56122319|NCT01716156|Antimetabolites|antimetabolites|mesh-ancestor
56122342|NCT01696032|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56122343|NCT01696032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122344|NCT01696032|Tubulin Modulators|tubulin modulators|mesh-ancestor
56122345|NCT01696032|Antimitotic Agents|antimitotic agents|mesh-ancestor
56122346|NCT01696032|Mitosis Modulators|mitosis modulators|mesh-ancestor
56122347|NCT01696032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122348|NCT01696032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56122349|NCT01696032|Antimetabolites|antimetabolites|mesh-ancestor
56122350|NCT01696032|Antiviral Agents|antiviral agents|mesh-ancestor
56122351|NCT01696032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122352|NCT01696032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122356|NCT01696032|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56122357|NCT01696032|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56122358|NCT01696032|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56122359|NCT01696032|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56122360|NCT01695954|Ritonavir|ritonavir|mesh-list
56122361|NCT01695954|Darunavir|darunavir|mesh-list
56122362|NCT01695954|Efavirenz|efavirenz|mesh-list
56122363|NCT01695954|Pitavastatin|pitavastatin|mesh-list
56122364|NCT01695954|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56122365|NCT01695954|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56122392|NCT01694706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122393|NCT01715298|Glycopyrrolate|glycopyrrolate|mesh-list
56122394|NCT01715298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56122395|NCT01715298|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56122396|NCT01715298|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56122449|NCT01737840|Histamine Agents|histamine agents|mesh-ancestor
56122450|NCT01737840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122451|NCT01737840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122452|NCT01711866|Rotigotine|rotigotine|mesh-list
55849397|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56122453|NCT01711866|Dopamine Agonists|dopamine agonists|mesh-ancestor
56122454|NCT01711866|Dopamine Agents|dopamine agents|mesh-ancestor
56122455|NCT01711866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56122456|NCT01711866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122457|NCT01711866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122459|NCT01691508|Prednisolone|prednisolone|mesh-list
56122462|NCT01691508|Hormones|hormones|mesh-ancestor
56122509|NCT01681212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56122510|NCT01681212|Alkylating Agents|alkylating agents|mesh-ancestor
56122511|NCT01687296|Fluticasone|fluticasone|mesh-list
56122513|NCT01687296|Prednisone|prednisone|mesh-list
56122515|NCT01687296|Albuterol|albuterol|mesh-list
56122516|NCT01687296|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56122517|NCT01687296|Glucocorticoids|glucocorticoids|mesh-ancestor
56122518|NCT01687296|Hormones|hormones|mesh-ancestor
56122519|NCT01687296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122520|NCT01687296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122521|NCT01687296|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56122522|NCT01687296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122523|NCT01687296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56122524|NCT01687296|Autonomic Agents|autonomic agents|mesh-ancestor
56122525|NCT01687296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122526|NCT01687296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55849476|NCT02022280|Lansoprazole|lansoprazole|mesh-list
56122527|NCT01687296|Respiratory System Agents|respiratory system agents|mesh-ancestor
56122528|NCT01687296|Dermatologic Agents|dermatologic agents|mesh-ancestor
56122575|NCT01568034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122576|NCT01568034|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
56122577|NCT01568034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122578|NCT01568034|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56122579|NCT01687218|Tenofovir|tenofovir|mesh-list
56122580|NCT01687218|Emtricitabine|emtricitabine|mesh-list
56122581|NCT01687218|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56122582|NCT01687218|Glycerol|glycerol|mesh-list
56122583|NCT01687218|Antiviral Agents|antiviral agents|mesh-ancestor
56122584|NCT01687218|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56122585|NCT01687218|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56122586|NCT01687218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56122588|NCT01687218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122589|NCT01687218|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56122590|NCT01687218|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56122591|NCT01687218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
56122592|NCT01687218|Protective Agents|protective agents|mesh-ancestor
56122593|NCT01687218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122594|NCT01686828|Letrozole|letrozole|mesh-list
56122595|NCT01686828|Methyltestosterone|methyltestosterone|mesh-list
56122596|NCT01686828|Acyline|acyline|mesh-list
56122597|NCT01686828|Testosterone|testosterone|mesh-list
56122598|NCT01686828|Testosterone undecanoate|testosterone undecanoate|mesh-list
56122599|NCT01686828|Testosterone enanthate|testosterone enanthate|mesh-list
56122600|NCT01686828|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56122601|NCT01686828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122602|NCT01686828|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56122621|NCT01592370|Autonomic Agents|autonomic agents|mesh-ancestor
56122622|NCT01592370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122623|NCT01592370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122624|NCT01592370|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56122625|NCT01592370|Glucocorticoids|glucocorticoids|mesh-ancestor
56122626|NCT01592370|Hormones|hormones|mesh-ancestor
56122627|NCT01592370|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122628|NCT01592370|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56122629|NCT01592370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122630|NCT01592370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122631|NCT01592370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56122632|NCT01592370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122633|NCT01592370|Immunologic Factors|immunologic factors|mesh-ancestor
56122634|NCT01592370|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56122635|NCT01592370|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56122636|NCT01592370|Growth Substances|growth substances|mesh-ancestor
56122637|NCT01592370|Growth Inhibitors|growth inhibitors|mesh-ancestor
56122638|NCT01603602|Botulinum Toxins|botulinum toxins|mesh-list
56122639|NCT01603602|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56122640|NCT01603602|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56122641|NCT01603602|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56122642|NCT01603602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56122643|NCT01603602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122644|NCT01603602|Cholinergic Agents|cholinergic agents|mesh-ancestor
56122668|NCT01684878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56122669|NCT01684878|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122670|NCT01684722|Vitamin D|vitamin d|mesh-list
56122671|NCT01684722|Ergocalciferols|ergocalciferols|mesh-list
56122672|NCT01684722|Cholecalciferol|cholecalciferol|mesh-list
56122673|NCT01684722|Vitamins|vitamins|mesh-list
56122674|NCT01684722|Micronutrients|micronutrients|mesh-ancestor
56122675|NCT01684722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849621|NCT02257138|Decitabine|decitabine|mesh-list
56122676|NCT01684722|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56122677|NCT01684722|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56122679|NCT01592292|Etanercept|etanercept|mesh-list
56122680|NCT01592292|Rituximab|rituximab|mesh-list
56122681|NCT01592292|Infliximab|infliximab|mesh-list
56122682|NCT01592292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122690|NCT01592292|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56122692|NCT01592292|Analgesics|analgesics|mesh-ancestor
56122693|NCT01592292|Sensory System Agents|sensory system agents|mesh-ancestor
56122718|NCT01543152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122719|NCT01543152|Immunologic Factors|immunologic factors|mesh-ancestor
56122720|NCT01543152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122721|NCT01543152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56122722|NCT01543152|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56122723|NCT01543152|Alkylating Agents|alkylating agents|mesh-ancestor
56122724|NCT01543152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122725|NCT01543152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122726|NCT01543152|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56122727|NCT01565148|Ranibizumab|ranibizumab|mesh-list
56122728|NCT01565148|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56122729|NCT01565148|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56122730|NCT01565148|Growth Substances|growth substances|mesh-ancestor
56122731|NCT01565148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122732|NCT01565148|Growth Inhibitors|growth inhibitors|mesh-ancestor
56122733|NCT01565148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122734|NCT04410354|Remdesivir|remdesivir|mesh-list
56122735|NCT04410354|Antimetabolites|antimetabolites|mesh-ancestor
56122736|NCT04410354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122737|NCT04410354|Antiviral Agents|antiviral agents|mesh-ancestor
56122760|NCT01563354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56122762|NCT01563354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122763|NCT01563354|Hormones|hormones|mesh-ancestor
56122764|NCT01563354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56122765|NCT03027960|Empagliflozin|empagliflozin|mesh-list
56122766|NCT03027960|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
56122767|NCT03027960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122768|NCT03027960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56122769|NCT03027960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122770|NCT01539642|Sufentanil|sufentanil|mesh-list
56122771|NCT01539642|Dsuvia|dsuvia|mesh-list
56122772|NCT01539642|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56122801|NCT01538472|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56122803|NCT01562028|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56122804|NCT01562028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56122805|NCT01562028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122806|NCT01562028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56122807|NCT01562028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56122808|NCT01562028|Growth Substances|growth substances|mesh-ancestor
56122809|NCT01562028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122810|NCT01562028|Growth Inhibitors|growth inhibitors|mesh-ancestor
56122811|NCT01562028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56122812|NCT01562028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122854|NCT01585272|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56122855|NCT01585272|Protective Agents|protective agents|mesh-ancestor
56122856|NCT01585194|Nivolumab|nivolumab|mesh-list
56122888|NCT01584648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56122889|NCT01584648|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56122890|NCT01584648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56122891|NCT01584648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122892|NCT01559454|Buprenorphine|buprenorphine|mesh-list
56122893|NCT01559454|Methadone|methadone|mesh-list
56122894|NCT01559454|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
56122895|NCT01559454|Naloxone|naloxone|mesh-list
56122896|NCT01559454|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56122897|NCT01559454|Narcotics|narcotics|mesh-ancestor
56122898|NCT01559454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56122899|NCT01559454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122900|NCT01559454|Analgesics|analgesics|mesh-ancestor
56122901|NCT01559454|Sensory System Agents|sensory system agents|mesh-ancestor
56122902|NCT01559454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56122947|NCT01582308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122948|NCT01558674|Torsemide|torsemide|mesh-list
56122949|NCT01558674|Furosemide|furosemide|mesh-list
56122950|NCT01558674|Diuretics|diuretics|mesh-ancestor
56122951|NCT01558674|Natriuretic Agents|natriuretic agents|mesh-ancestor
56122952|NCT01558674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56122953|NCT01558674|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56122954|NCT01558674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56122955|NCT01558674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56122956|NCT01558674|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56122957|NCT01535040|Memantine|memantine|mesh-list
56122958|NCT01535040|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56122959|NCT01535040|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55821098|NCT02325401|Cisplatin|cisplatin|mesh-list
56123020|NCT01579578|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56123021|NCT01579578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123022|NCT01579578|Tubulin Modulators|tubulin modulators|mesh-ancestor
56123023|NCT01579578|Antimitotic Agents|antimitotic agents|mesh-ancestor
56123025|NCT01579578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123026|NCT01578486|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
56123027|NCT01578486|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56123028|NCT01578486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56123029|NCT01578486|Analgesics|analgesics|mesh-ancestor
56123030|NCT01578486|Sensory System Agents|sensory system agents|mesh-ancestor
56123031|NCT01578486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123032|NCT01578486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123033|NCT01578486|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123034|NCT01578486|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123036|NCT01555164|Ranolazine|ranolazine|mesh-list
56123037|NCT01555164|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56123038|NCT01555164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123039|NCT01555164|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56123040|NCT01555164|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123070|NCT01554618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123074|NCT01554618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123075|NCT01531998|Dexamethasone|dexamethasone|mesh-list
56123076|NCT01531998|Lenalidomide|lenalidomide|mesh-list
56123077|NCT01531998|Bortezomib|bortezomib|mesh-list
56123078|NCT01531998|Siltuximab|siltuximab|mesh-list
56123079|NCT01531998|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123080|NCT01531998|Antiemetics|antiemetics|mesh-ancestor
56123081|NCT01531998|Autonomic Agents|autonomic agents|mesh-ancestor
56123082|NCT01531998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123083|NCT01531998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123084|NCT01531998|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56123085|NCT01531998|Glucocorticoids|glucocorticoids|mesh-ancestor
56123086|NCT01531998|Hormones|hormones|mesh-ancestor
56123087|NCT01531998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123088|NCT01531998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56123089|NCT01531998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123090|NCT01531998|Immunologic Factors|immunologic factors|mesh-ancestor
56123091|NCT01531998|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56123092|NCT01531998|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56123121|NCT02072928|Botulinum Toxins|botulinum toxins|mesh-list
56123122|NCT02072928|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56123123|NCT02072928|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
56123124|NCT02072928|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56123125|NCT02072928|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123126|NCT02072928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123128|NCT02072928|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123134|NCT01529346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56123135|NCT01529346|Analgesics|analgesics|mesh-ancestor
56123136|NCT01529346|Sensory System Agents|sensory system agents|mesh-ancestor
56123137|NCT01529346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123138|NCT01529346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123139|NCT01529346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123140|NCT01529346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123141|NCT01529346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56123142|NCT01529346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123143|NCT01529346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123144|NCT01529268|Cysteamine|cysteamine|mesh-list
56123145|NCT01529268|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
56123146|NCT01529268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123147|NCT01529112|Lenvatinib|lenvatinib|mesh-list
56123148|NCT01529112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123149|NCT01529112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56123150|NCT01529112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123151|NCT01529112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123163|NCT01528254|Metformin|metformin|mesh-list
56123164|NCT01528254|Vildagliptin|vildagliptin|mesh-list
56123165|NCT01528254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56123166|NCT01528254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123167|NCT01528254|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56123168|NCT01528254|Protease Inhibitors|protease inhibitors|mesh-ancestor
56123169|NCT01528254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123170|NCT01528254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123171|NCT01574274|Pegaspargase|pegaspargase|mesh-list
56123172|NCT01574274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123173|NCT01526148|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56123174|NCT01526148|Lithium Carbonate|lithium carbonate|mesh-list
56123175|NCT01526148|Antidepressive Agents|antidepressive agents|mesh-ancestor
56123176|NCT01526148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56123177|NCT01526148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56123178|NCT01526148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56123179|NCT01526148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56123180|NCT01526148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123181|NCT01526148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123182|NCT01526148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123246|NCT01547286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123247|NCT01547286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123248|NCT01524978|Cetuximab|cetuximab|mesh-list
56123249|NCT01524978|Vemurafenib|vemurafenib|mesh-list
56123250|NCT01524978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56123251|NCT01524978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123252|NCT01524978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56123253|NCT01524978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123254|NCT01524978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123255|NCT01524198|Budesonide|budesonide|mesh-list
56123256|NCT01524198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123257|NCT01524198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56123258|NCT01524198|Autonomic Agents|autonomic agents|mesh-ancestor
56123259|NCT01524198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123260|NCT01524198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123261|NCT01524198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56123263|NCT01524198|Glucocorticoids|glucocorticoids|mesh-ancestor
56123290|NCT01546038|Cytarabine|cytarabine|mesh-list
56123291|NCT01546038|Decitabine|decitabine|mesh-list
56123292|NCT01546038|Daunorubicin|daunorubicin|mesh-list
56123293|NCT01546038|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56123294|NCT01546038|Antimetabolites|antimetabolites|mesh-ancestor
56123295|NCT01546038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123296|NCT01546038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123297|NCT01546038|Antiviral Agents|antiviral agents|mesh-ancestor
56123298|NCT01546038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123299|NCT01546038|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123300|NCT01546038|Immunologic Factors|immunologic factors|mesh-ancestor
56123301|NCT01546038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123302|NCT01546038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56123303|NCT01546038|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56123304|NCT01546038|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56123305|NCT01546038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123306|NCT01571232|Dexamethasone|dexamethasone|mesh-list
56123307|NCT01571232|Bevacizumab|bevacizumab|mesh-list
56123308|NCT01571232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56123309|NCT01571232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123310|NCT01571232|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56123311|NCT01571232|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56123312|NCT01571232|Growth Substances|growth substances|mesh-ancestor
56123313|NCT01571232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123314|NCT01571232|Growth Inhibitors|growth inhibitors|mesh-ancestor
56123315|NCT01571232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123317|NCT01571232|Autonomic Agents|autonomic agents|mesh-ancestor
56123318|NCT01571232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123319|NCT01571232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56123336|NCT01522950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123337|NCT01522950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123338|NCT01522950|Vasodilator Agents|vasodilator agents|mesh-ancestor
56123339|NCT01522950|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56123340|NCT01522950|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56123341|NCT01522950|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56123342|NCT01522404|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
56123343|NCT01522404|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
56123344|NCT01522404|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55850298|NCT01547260|Growth Substances|growth substances|mesh-ancestor
56123345|NCT01522404|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123346|NCT01522404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123347|NCT01522404|Adrenergic Agents|adrenergic agents|mesh-ancestor
56123348|NCT01522404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123349|NCT01522404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123351|NCT03911466|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56123352|NCT03911466|Narcotics|narcotics|mesh-ancestor
56123353|NCT03911466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56123354|NCT03911466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123355|NCT03911466|Analgesics|analgesics|mesh-ancestor
56123356|NCT03911466|Sensory System Agents|sensory system agents|mesh-ancestor
56123357|NCT03911466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123358|NCT03911466|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56123359|NCT01543776|Abiraterone Acetate|abiraterone acetate|mesh-list
56123360|NCT01543776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123361|NCT01543776|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56123362|NCT01543776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123379|NCT01517802|Glucocorticoids|glucocorticoids|mesh-ancestor
56123381|NCT01517802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123382|NCT01517802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123383|NCT01517802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56123384|NCT01517802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123385|NCT01517802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56123386|NCT01517802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742347|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123387|NCT01517802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123388|NCT01517802|Hormone Antagonists|hormone antagonists|mesh-ancestor
56123389|NCT01517802|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56123390|NCT04714710|Canrenoic Acid|canrenoic acid|mesh-list
56123391|NCT04714710|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56123392|NCT04714710|Hormone Antagonists|hormone antagonists|mesh-ancestor
56123393|NCT04714710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123394|NCT04714710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123395|NCT04714710|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56123431|NCT01489254|Immunologic Factors|immunologic factors|mesh-ancestor
56123432|NCT01489254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123433|NCT01489254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123434|NCT01489254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123436|NCT01489020|Immunologic Factors|immunologic factors|mesh-ancestor
56123437|NCT01489020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123438|NCT01514682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
56123439|NCT01514448|Everolimus|everolimus|mesh-list
56123440|NCT01514448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123441|NCT01514448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123442|NCT01514448|Immunologic Factors|immunologic factors|mesh-ancestor
56123443|NCT01514448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123444|NCT01514370|Interferons|interferons|mesh-list
56123445|NCT01514370|Interferon-beta|interferon-beta|mesh-list
56123446|NCT01514370|Interferon beta-1a|interferon beta-1a|mesh-list
56123447|NCT01514370|Curcumin|curcumin|mesh-list
56123448|NCT01514370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123449|NCT01514370|Antiviral Agents|antiviral agents|mesh-ancestor
56123450|NCT01514370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123451|NCT01514370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56123452|NCT01514370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56123453|NCT01514370|Analgesics|analgesics|mesh-ancestor
56123454|NCT01514370|Sensory System Agents|sensory system agents|mesh-ancestor
56123455|NCT01514370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123482|NCT01519518|Heparin|heparin|mesh-list
56123483|NCT01519518|Calcium heparin|calcium heparin|mesh-list
56123484|NCT01519518|Bivalirudin|bivalirudin|mesh-list
56123485|NCT01519518|Anticoagulants|anticoagulants|mesh-ancestor
56123486|NCT01519518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56123487|NCT01519518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56123488|NCT01519518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123489|NCT01519518|Antithrombins|antithrombins|mesh-ancestor
56123490|NCT01519518|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56123491|NCT01519518|Protease Inhibitors|protease inhibitors|mesh-ancestor
56123492|NCT01519518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123493|NCT01518972|Prazosin|prazosin|mesh-list
55850443|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
56123494|NCT01518972|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56123495|NCT01518972|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56123496|NCT01518972|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56123497|NCT01518972|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56123498|NCT01518972|Adrenergic Agents|adrenergic agents|mesh-ancestor
56123508|NCT04672512|Glucocorticoids|glucocorticoids|mesh-ancestor
56123509|NCT04672512|Hormones|hormones|mesh-ancestor
56123510|NCT04672512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821758|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123527|NCT01463982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123528|NCT01463982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123529|NCT01463982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56123530|NCT01463982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56123531|NCT01463982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123532|NCT01510158|Allopurinol|allopurinol|mesh-list
56123533|NCT01510158|Lesinurad|lesinurad|mesh-list
56123534|NCT01510158|Antimetabolites|antimetabolites|mesh-ancestor
56123535|NCT01510158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123536|NCT01510158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123537|NCT01510158|Gout Suppressants|gout suppressants|mesh-ancestor
56123538|NCT01510158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123539|NCT01510158|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56123540|NCT01510158|Antioxidants|antioxidants|mesh-ancestor
56123541|NCT01510158|Protective Agents|protective agents|mesh-ancestor
56123542|NCT01510158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123543|NCT01510158|Uricosuric Agents|uricosuric agents|mesh-ancestor
56123544|NCT01510158|Renal Agents|renal agents|mesh-ancestor
56123555|NCT01484496|Belimumab|belimumab|mesh-list
56123556|NCT01484496|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123557|NCT01484496|Immunologic Factors|immunologic factors|mesh-ancestor
56123558|NCT01484496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123559|NCT01509846|Vaccines|vaccines|mesh-list
56123560|NCT01509846|Immunologic Factors|immunologic factors|mesh-ancestor
56123561|NCT01509846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123562|NCT01462344|Fluticasone|fluticasone|mesh-list
56123564|NCT01462344|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
56123565|NCT01462344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56123566|NCT01462344|Autonomic Agents|autonomic agents|mesh-ancestor
56123567|NCT01462344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123568|NCT01462344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850518|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
56123570|NCT01462344|Respiratory System Agents|respiratory system agents|mesh-ancestor
56123633|NCT02985216|Pregabalin|pregabalin|mesh-list
56123634|NCT02985216|Analgesics|analgesics|mesh-ancestor
56123635|NCT02985216|Sensory System Agents|sensory system agents|mesh-ancestor
56123636|NCT02985216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123637|NCT02985216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123638|NCT02985216|Anticonvulsants|anticonvulsants|mesh-ancestor
56123639|NCT02985216|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56123640|NCT02985216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123641|NCT02985216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850595|NCT04776226|Citalopram|citalopram|mesh-list
56123642|NCT02985216|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56123643|NCT02985216|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56123644|NCT02985216|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56123646|NCT02985216|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56123661|NCT01506726|Analgesics|analgesics|mesh-ancestor
56123662|NCT01506726|Sensory System Agents|sensory system agents|mesh-ancestor
56123663|NCT01506726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123664|NCT01506726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123665|NCT01506726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123666|NCT01506726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56123667|NCT01506726|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56123668|NCT01506726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123669|NCT01506726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123670|NCT01506726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123671|NCT01506726|Antifungal Agents|antifungal agents|mesh-ancestor
56123672|NCT01506726|Keratolytic Agents|keratolytic agents|mesh-ancestor
56123673|NCT01506726|Dermatologic Agents|dermatologic agents|mesh-ancestor
56123674|NCT01505868|Carboplatin|carboplatin|mesh-list
56123675|NCT01505868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123676|NCT01505634|Ciprofloxacin|ciprofloxacin|mesh-list
56123677|NCT01505634|Imipenem|imipenem|mesh-list
56123678|NCT01505634|Relebactam|relebactam|mesh-list
56123765|NCT01458210|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56123766|NCT01458210|Contraceptive Agents|contraceptive agents|mesh-ancestor
56123767|NCT01458210|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56123768|NCT01458210|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56123769|NCT01458210|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56123770|NCT01458210|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56123771|NCT01457118|Etirinotecan pegol|etirinotecan pegol|mesh-list
56123772|NCT01457118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123773|NCT01457118|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56123774|NCT01457118|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56123775|NCT01457118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123776|NCT01457118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123777|NCT01501110|Acetylcysteine|acetylcysteine|mesh-list
56123778|NCT01501110|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56123779|NCT01501110|Antiviral Agents|antiviral agents|mesh-ancestor
56123780|NCT01501110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123781|NCT01501110|Expectorants|expectorants|mesh-ancestor
56123782|NCT01501110|Respiratory System Agents|respiratory system agents|mesh-ancestor
56123783|NCT01501110|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56123784|NCT01501110|Antioxidants|antioxidants|mesh-ancestor
56123785|NCT01501110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123806|NCT01454934|Vinorelbine|vinorelbine|mesh-list
56123807|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56123808|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
56123809|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123810|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123811|NCT01454934|Antiviral Agents|antiviral agents|mesh-ancestor
56123812|NCT01454934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123813|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123814|NCT01454934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123815|NCT01454934|Immunologic Factors|immunologic factors|mesh-ancestor
56123816|NCT01454934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123817|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
56123818|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
56123819|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
56123820|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56123821|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56123822|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56123823|NCT01454778|Paclitaxel|paclitaxel|mesh-list
56123824|NCT01454778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56123825|NCT01454778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123826|NCT01454778|Tubulin Modulators|tubulin modulators|mesh-ancestor
56123827|NCT01454778|Antimitotic Agents|antimitotic agents|mesh-ancestor
56123828|NCT01454778|Mitosis Modulators|mitosis modulators|mesh-ancestor
56123829|NCT01454778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123830|NCT01454076|Clarithromycin|clarithromycin|mesh-list
56123831|NCT01454076|Rifampin|rifampin|mesh-list
56123839|NCT01454076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123840|NCT01454076|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56123841|NCT01454076|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56123842|NCT01454076|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56123843|NCT01454076|Antitubercular Agents|antitubercular agents|mesh-ancestor
56123844|NCT01454076|Leprostatic Agents|leprostatic agents|mesh-ancestor
56123845|NCT01454076|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56123846|NCT01454076|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56123847|NCT01454076|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56123848|NCT01454076|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56123849|NCT01454076|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56123850|NCT01454076|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56123851|NCT01454076|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56123852|NCT01454076|Antifungal Agents|antifungal agents|mesh-ancestor
56123853|NCT01454076|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56123854|NCT01454076|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56123855|NCT01454076|Hormone Antagonists|hormone antagonists|mesh-ancestor
56123856|NCT01454076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123857|NCT01454076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123865|NCT01453374|Naltrexone|naltrexone|mesh-list
56123891|NCT01453140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123892|NCT01453140|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56123893|NCT01453140|Antimetabolites|antimetabolites|mesh-ancestor
56123894|NCT01453140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123895|NCT01499940|Vitamin D|vitamin d|mesh-list
56123896|NCT01499940|Cholecalciferol|cholecalciferol|mesh-list
56123897|NCT01499940|Vitamins|vitamins|mesh-ancestor
56123898|NCT01499940|Micronutrients|micronutrients|mesh-ancestor
56123899|NCT01499940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123900|NCT01499940|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56123901|NCT01499940|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56123902|NCT01499160|Everolimus|everolimus|mesh-list
56123903|NCT01499160|Letrozole|letrozole|mesh-list
56123904|NCT01499160|Lapatinib|lapatinib|mesh-list
56123905|NCT01499160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123906|NCT01499160|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56123907|NCT01499160|Immunologic Factors|immunologic factors|mesh-ancestor
56123908|NCT01499160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123909|NCT01499160|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56123910|NCT01499160|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56123911|NCT01499160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123912|NCT01499160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123944|NCT01496976|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56123945|NCT01496976|Growth Substances|growth substances|mesh-ancestor
56123946|NCT01496976|Growth Inhibitors|growth inhibitors|mesh-ancestor
56123947|NCT01496976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56123948|NCT01496976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56123949|NCT01496976|Antiemetics|antiemetics|mesh-ancestor
56123950|NCT01496976|Autonomic Agents|autonomic agents|mesh-ancestor
56123951|NCT01496976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123952|NCT01496976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56123953|NCT01496976|Glucocorticoids|glucocorticoids|mesh-ancestor
56123955|NCT01496976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56123956|NCT01496976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56123957|NCT01496976|Protective Agents|protective agents|mesh-ancestor
56123958|NCT01496976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56123959|NCT01475838|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
56123960|NCT01475838|Antiviral Agents|antiviral agents|mesh-ancestor
56123961|NCT01475838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56123962|NCT01475838|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56123963|NCT01475838|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56123964|NCT01451814|Nicotine|nicotine|mesh-list
56123965|NCT01451814|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56123966|NCT01451814|Autonomic Agents|autonomic agents|mesh-ancestor
56123967|NCT01451814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56123968|NCT01451814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123969|NCT01451814|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56123970|NCT01451814|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56123971|NCT01451814|Cholinergic Agents|cholinergic agents|mesh-ancestor
56123972|NCT01451814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123973|NCT01451814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123974|NCT01496430|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
56123976|NCT01496430|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56123984|NCT04408326|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56123985|NCT04408326|Protease Inhibitors|protease inhibitors|mesh-ancestor
56123986|NCT04408326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56123987|NCT04408326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123988|NCT01474746|Sertraline|sertraline|mesh-list
56123989|NCT01474746|Antidepressive Agents|antidepressive agents|mesh-ancestor
56123990|NCT01474746|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56123991|NCT01474746|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
56123992|NCT01474746|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56123993|NCT01474746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56123994|NCT01474746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56123995|NCT01474746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56123996|NCT01474746|Serotonin Agents|serotonin agents|mesh-ancestor
56123997|NCT01474746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56123998|NCT01450800|Nitrofurantoin|nitrofurantoin|mesh-list
56124045|NCT01449630|Sensory System Agents|sensory system agents|mesh-ancestor
56124046|NCT01449630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124095|NCT01491672|Everolimus|everolimus|mesh-list
56124096|NCT01491672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124097|NCT01491672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56124098|NCT01491672|Immunologic Factors|immunologic factors|mesh-ancestor
56124099|NCT01491672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124100|NCT01447446|Ribavirin|ribavirin|mesh-list
56124101|NCT01447446|Interferon-alpha|interferon-alpha|mesh-list
56124102|NCT01447446|Interferon alpha-2|interferon alpha-2|mesh-list
56124103|NCT01447446|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
56124104|NCT01447446|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56124105|NCT01447446|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56124106|NCT01447446|Antimetabolites|antimetabolites|mesh-ancestor
55742373|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
56124107|NCT01447446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124165|NCT01446042|Androgens|androgens|mesh-ancestor
56124166|NCT01446042|Hormones|hormones|mesh-ancestor
56124167|NCT01446042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56124168|NCT01446042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124169|NCT01446042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56124170|NCT01446042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124171|NCT01446042|Anabolic Agents|anabolic agents|mesh-ancestor
56124172|NCT01445886|Calcitriol|calcitriol|mesh-list
56124173|NCT01445886|Calcipotriene|calcipotriene|mesh-list
56124174|NCT01445886|Dermatologic Agents|dermatologic agents|mesh-ancestor
56124175|NCT01445886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56124176|NCT01445886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124177|NCT01445886|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56124178|NCT01445886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56124179|NCT01445886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124180|NCT01445886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56124182|NCT01445886|Micronutrients|micronutrients|mesh-ancestor
56124183|NCT01445886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56124184|NCT01470612|Tofacitinib|tofacitinib|mesh-list
56124185|NCT01470612|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56124186|NCT01470612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124187|NCT01470612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124214|NCT01440816|Growth Inhibitors|growth inhibitors|mesh-ancestor
56124215|NCT01440816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124216|NCT03026244|Vitamin D|vitamin d|mesh-list
56124217|NCT03026244|Caseins|caseins|mesh-list
56124218|NCT03026244|Vitamins|vitamins|mesh-ancestor
56124219|NCT03026244|Micronutrients|micronutrients|mesh-ancestor
56124220|NCT03026244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124221|NCT03026244|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56124222|NCT03026244|Chelating Agents|chelating agents|mesh-ancestor
56124227|NCT01470144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56124228|NCT01470144|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56124229|NCT01470144|Vasodilator Agents|vasodilator agents|mesh-ancestor
56124230|NCT01443858|Meclizine|meclizine|mesh-list
56124231|NCT01443858|Nicotine|nicotine|mesh-list
56124232|NCT01443858|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
56124233|NCT01443858|Autonomic Agents|autonomic agents|mesh-ancestor
56124234|NCT01443858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124235|NCT01443858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124236|NCT01443858|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56124237|NCT01443858|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56124238|NCT01443858|Cholinergic Agents|cholinergic agents|mesh-ancestor
56124239|NCT01443858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124240|NCT01443858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124265|NCT01443078|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56124266|NCT01443078|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56124267|NCT01443078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56124269|NCT01439880|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56124270|NCT01439880|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56124271|NCT01439880|Antimetabolites|antimetabolites|mesh-ancestor
56124272|NCT01439880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124273|NCT01439880|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56124274|NCT01469364|Aztreonam|aztreonam|mesh-list
56124275|NCT01469364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56124276|NCT01469364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124277|NCT01439568|Carboplatin|carboplatin|mesh-list
56124278|NCT01439568|Etoposide|etoposide|mesh-list
56124279|NCT01439568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124280|NCT01439568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56124281|NCT01439568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56124282|NCT01439568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56124285|NCT01469052|Axitinib|axitinib|mesh-list
56124321|NCT01442376|Dermatologic Agents|dermatologic agents|mesh-ancestor
56124322|NCT01442376|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56124323|NCT01442376|Serotonin Agents|serotonin agents|mesh-ancestor
56124324|NCT01442376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124325|NCT01442376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124326|NCT01442376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56124327|NCT01442376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56124328|NCT01442376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56124329|NCT01442376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56124330|NCT01442376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56124331|NCT01442376|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
56124333|NCT01442064|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56124334|NCT01442064|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56124335|NCT01442064|Growth Substances|growth substances|mesh-ancestor
56124336|NCT01442064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124337|NCT01442064|Growth Inhibitors|growth inhibitors|mesh-ancestor
56124338|NCT01442064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124339|NCT01441596|Vinorelbine|vinorelbine|mesh-list
56124340|NCT01441596|Afatinib|afatinib|mesh-list
56124341|NCT01441596|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56124347|NCT01441596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56124348|NCT01441596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124349|NCT01441440|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
56124350|NCT01441440|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
56124351|NCT01441440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56124352|NCT01441440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56124353|NCT01441440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124354|NCT01441440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124355|NCT01441440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124356|NCT01441440|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
56124357|NCT01441440|Antidepressive Agents|antidepressive agents|mesh-ancestor
56124358|NCT01441440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56124359|NCT03026478|Betamethasone|betamethasone|mesh-list
56124360|NCT03026478|Betamethasone Valerate|betamethasone valerate|mesh-list
56124361|NCT03026478|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
56124362|NCT03026478|Betamethasone benzoate|betamethasone benzoate|mesh-list
56124363|NCT03026478|Clobetasol|clobetasol|mesh-list
56124364|NCT03026478|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
56124365|NCT03026478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56124366|NCT03026478|Glucocorticoids|glucocorticoids|mesh-ancestor
56124367|NCT03026478|Hormones|hormones|mesh-ancestor
56124369|NCT03026478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124388|NCT01437540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124389|NCT01437540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124390|NCT01437540|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56124391|NCT01437540|Respiratory System Agents|respiratory system agents|mesh-ancestor
56124392|NCT01437540|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56124393|NCT01437540|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56124394|NCT01437540|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56124395|NCT01437540|Adrenergic Agents|adrenergic agents|mesh-ancestor
56124396|NCT01437540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124397|NCT01437540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124398|NCT01437540|Anticonvulsants|anticonvulsants|mesh-ancestor
56124399|NCT01420536|Salicylic Acid|salicylic acid|mesh-list
56124400|NCT01420536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56124401|NCT01420536|Antifungal Agents|antifungal agents|mesh-ancestor
56124402|NCT01420536|Keratolytic Agents|keratolytic agents|mesh-ancestor
56124403|NCT01420536|Dermatologic Agents|dermatologic agents|mesh-ancestor
56124404|NCT01467492|Interferons|interferons|mesh-list
56124406|NCT01467492|Interferon-alpha|interferon-alpha|mesh-list
56124407|NCT01467492|Interferon alpha-2|interferon alpha-2|mesh-list
56124408|NCT01467492|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
56124409|NCT01467492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124410|NCT01467492|Antiviral Agents|antiviral agents|mesh-ancestor
56124442|NCT01418352|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56124443|NCT01436370|Vaccines|vaccines|mesh-list
56124444|NCT01436370|Immunologic Factors|immunologic factors|mesh-ancestor
56124445|NCT01436370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124446|NCT01465464|Orantinib|orantinib|mesh-list
56124447|NCT01465464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56124448|NCT01465464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124449|NCT01465464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124450|NCT01465386|Bortezomib|bortezomib|mesh-list
56124451|NCT01465386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124452|NCT04082364|Trastuzumab|trastuzumab|mesh-list
56124453|NCT04082364|Margetuximab|margetuximab|mesh-list
56124454|NCT04082364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56124455|NCT04082364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124456|NCT01465230|Lenalidomide|lenalidomide|mesh-list
56124457|NCT01465230|Immunologic Factors|immunologic factors|mesh-ancestor
56124458|NCT01465230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124459|NCT01465230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56124460|NCT01465230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56124461|NCT01465230|Growth Substances|growth substances|mesh-ancestor
56124462|NCT01465230|Growth Inhibitors|growth inhibitors|mesh-ancestor
56124463|NCT01465230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124464|NCT03820830|Palbociclib|palbociclib|mesh-list
56124465|NCT03820830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124466|NCT03820830|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56124467|NCT03820830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124468|NCT03820830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124478|NCT01393158|Apremilast|apremilast|mesh-list
56124489|NCT01393158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124490|NCT01393158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124491|NCT01413360|Vitamins|vitamins|mesh-list
56124492|NCT01413360|Ascorbic Acid|ascorbic acid|mesh-list
56124493|NCT01413360|Micronutrients|micronutrients|mesh-ancestor
56124494|NCT01413360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124495|NCT01413360|Antioxidants|antioxidants|mesh-ancestor
56124496|NCT01413360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124497|NCT01413360|Protective Agents|protective agents|mesh-ancestor
56124498|NCT03815448|Methotrexate|methotrexate|mesh-list
56124499|NCT03815448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56124500|NCT03815448|Abortifacient Agents|abortifacient agents|mesh-ancestor
56124501|NCT03815448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56124502|NCT03815448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124503|NCT03815448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56124504|NCT03815448|Antimetabolites|antimetabolites|mesh-ancestor
56124506|NCT03815448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124546|NCT01392300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124547|NCT01392300|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
56124548|NCT01392300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56124549|NCT01392300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124551|NCT01392300|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56124552|NCT01432626|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56124553|NCT01432626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124554|NCT01432626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902950|NCT04024462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56124555|NCT01432626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124556|NCT01432626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56124558|NCT01391130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124576|NCT01390584|Prednisone|prednisone|mesh-list
56124577|NCT01390584|Cyclophosphamide|cyclophosphamide|mesh-list
56124578|NCT01390584|Dacarbazine|dacarbazine|mesh-list
56124579|NCT01390584|Doxorubicin|doxorubicin|mesh-list
56124580|NCT01390584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56124581|NCT01390584|Etoposide|etoposide|mesh-list
56124582|NCT01390584|Vincristine|vincristine|mesh-list
56124583|NCT01390584|Etoposide phosphate|etoposide phosphate|mesh-list
56124584|NCT01390584|Bleomycin|bleomycin|mesh-list
56124585|NCT01390584|Vinblastine|vinblastine|mesh-list
56124586|NCT01390584|Podophyllotoxin|podophyllotoxin|mesh-list
56124587|NCT01390584|Procarbazine|procarbazine|mesh-list
56124588|NCT01390584|Imidazole|imidazole|mesh-list
56124589|NCT01390584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56124590|NCT01390584|Immunologic Factors|immunologic factors|mesh-ancestor
56124591|NCT01390584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56124592|NCT01390584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56124593|NCT01390584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56124594|NCT01390584|Alkylating Agents|alkylating agents|mesh-ancestor
56124595|NCT01390584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56124596|NCT01390584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56124597|NCT01390584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56124598|NCT01390584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56124604|NCT01390584|Hormones|hormones|mesh-ancestor
56124619|NCT01408914|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56124620|NCT01408914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902286|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
55902287|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902288|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902289|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
55902290|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902291|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55902292|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55902293|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
55902294|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902295|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902344|NCT02562898|Antiviral Agents|antiviral agents|mesh-ancestor
55902345|NCT02562898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902346|NCT02562898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902347|NCT02562898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55902348|NCT02562898|Immunologic Factors|immunologic factors|mesh-ancestor
55902349|NCT02562898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902350|NCT03168594|Cisplatin|cisplatin|mesh-list
55902351|NCT03168594|Irinotecan|irinotecan|mesh-list
55902352|NCT03168594|Etoposide|etoposide|mesh-list
55902353|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902354|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55902355|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55902356|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902357|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902358|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55902359|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55902360|NCT02563834|Insulin|insulin|mesh-list
55902361|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55902362|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902363|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
55902364|NCT02564926|Glimepiride|glimepiride|mesh-list
55902365|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55902366|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902367|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55902368|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902369|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55902370|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55902371|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
55902372|NCT02565628|PF-06669571|pf-06669571|mesh-list
55902373|NCT02565628|Dopamine Agonists|dopamine agonists|mesh-ancestor
55902385|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55902386|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55902387|NCT02567968|Purinergic Agents|purinergic agents|mesh-ancestor
55902388|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902389|NCT02571634|Fentanyl|fentanyl|mesh-list
55902390|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55902391|NCT02571634|Narcotics|narcotics|mesh-ancestor
55902392|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902393|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902394|NCT02571634|Analgesics|analgesics|mesh-ancestor
55902395|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
55902396|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902397|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55902398|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55902399|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
55902400|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
55902401|NCT02404038|NuvaRing|nuvaring|mesh-list
55902402|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
55902403|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55902404|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
55902408|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55902436|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55902437|NCT02574832|Narcotics|narcotics|mesh-ancestor
55902438|NCT02574832|Analgesics|analgesics|mesh-ancestor
55902439|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55902440|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55902441|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
55902442|NCT02406690|Leuprolide|leuprolide|mesh-list
55902443|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55902444|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55902445|NCT02406690|Estradiol|estradiol|mesh-list
55902446|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55902447|NCT02406690|Progesterone|progesterone|mesh-list
55902448|NCT02406690|Estrogens|estrogens|mesh-ancestor
55902449|NCT02406690|Hormones|hormones|mesh-ancestor
55902450|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55902451|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902452|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55902453|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
55902454|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55902496|NCT00364000|Calcium|calcium|mesh-list
55902497|NCT00364000|Sevelamer|sevelamer|mesh-list
55902498|NCT00364000|Calcium acetate|calcium acetate|mesh-list
55902499|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55902500|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902501|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
55902502|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
55902503|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902504|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
55902505|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55902506|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55902507|NCT05249452|Hydroxyurea|hydroxyurea|mesh-list
55902508|NCT05249452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902509|NCT05249452|Antisickling Agents|antisickling agents|mesh-ancestor
55902510|NCT05249452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902511|NCT05249452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902512|NCT05249452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55902513|NCT03970252|Calcium, Dietary|calcium, dietary|mesh-list
55902514|NCT03970252|Leucovorin|leucovorin|mesh-list
55902515|NCT03970252|Folic Acid|folic acid|mesh-list
55902516|NCT03970252|Fluorouracil|fluorouracil|mesh-list
55902550|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55902551|NCT03169764|Leucovorin|leucovorin|mesh-list
55902552|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
55902553|NCT03169764|Bevacizumab|bevacizumab|mesh-list
55902554|NCT03169764|Fluorouracil|fluorouracil|mesh-list
55902555|NCT03169764|Capecitabine|capecitabine|mesh-list
55902556|NCT03169764|Nivolumab|nivolumab|mesh-list
55902557|NCT03169764|Cetuximab|cetuximab|mesh-list
55902558|NCT03169764|Fulvestrant|fulvestrant|mesh-list
55902559|NCT03169764|Avelumab|avelumab|mesh-list
55902560|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902561|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902562|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55902563|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
55902564|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902565|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55902566|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55902567|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
55902568|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55902569|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55902570|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55902571|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55902572|NCT03169764|Growth Substances|growth substances|mesh-ancestor
55902573|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
55902574|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
55902577|NCT03169764|Antidotes|antidotes|mesh-ancestor
55902601|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55902602|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902603|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55902604|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55902605|NCT02399592|Growth Substances|growth substances|mesh-ancestor
55902606|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902607|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
55902609|NCT03801304|Vinorelbine|vinorelbine|mesh-list
55902610|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902611|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55902612|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
55902613|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
55902614|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
55902615|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902617|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55902618|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55902619|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
55902620|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902621|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902622|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55902623|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
55902624|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
55902625|NCT02696850|Hormones|hormones|mesh-ancestor
55902626|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55902650|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
55902651|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902652|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55902653|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55902654|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
55902655|NCT02601976|Ribavirin|ribavirin|mesh-list
55902656|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55902657|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
55902658|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902659|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
55902660|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902661|NCT02603926|Pregnanolone|pregnanolone|mesh-list
55902662|NCT02603926|Brexanolone|brexanolone|mesh-list
55902663|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
55902664|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902665|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902666|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
55902669|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
55902708|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902709|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
55902710|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
55902711|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
55902712|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902713|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55902714|NCT02395458|Amoxicillin|amoxicillin|mesh-list
55902715|NCT02395458|Metronidazole|metronidazole|mesh-list
55902716|NCT02395458|Clarithromycin|clarithromycin|mesh-list
55902717|NCT02395458|Omeprazole|omeprazole|mesh-list
55902718|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55902719|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902720|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55902721|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55902722|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55902723|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55902724|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55902725|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902726|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902727|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55902728|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55902729|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55902730|NCT02402400|Ticagrelor|ticagrelor|mesh-list
55902731|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55902732|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55902733|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55902756|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902757|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902758|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902759|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55902760|NCT02616250|Ivermectin|ivermectin|mesh-list
55902762|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55902763|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902764|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55902765|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55902766|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55902767|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55902768|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
55902769|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902770|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902771|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902772|NCT02698410|Temozolomide|temozolomide|mesh-list
55902773|NCT02698410|Lanreotide|lanreotide|mesh-list
55902774|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55902775|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
55902776|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902777|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902786|NCT02699892|Rituximab|rituximab|mesh-list
55902802|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902803|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55902804|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902805|NCT05730634|Atorvastatin|atorvastatin|mesh-list
55902806|NCT05730634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55902807|NCT05730634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55902808|NCT05730634|Antimetabolites|antimetabolites|mesh-ancestor
55902809|NCT05730634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902811|NCT05730634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55902812|NCT05730634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55902813|NCT05705830|Serotonin|serotonin|mesh-list
55902814|NCT05705830|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55902815|NCT05705830|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55902816|NCT05705830|Serotonin Agents|serotonin agents|mesh-ancestor
55902817|NCT05705830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55902818|NCT05705830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902819|NCT05705830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902820|NCT05705830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55902855|NCT04050540|Doxycycline|doxycycline|mesh-list
55902856|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55902858|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
55902859|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55902860|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55902861|NCT03167268|Lycopene|lycopene|mesh-list
55902872|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902873|NCT04485052|Azacitidine|azacitidine|mesh-list
55902874|NCT04485052|Decitabine|decitabine|mesh-list
55902875|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55902876|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
55902877|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902909|NCT04145674|Methadone|methadone|mesh-list
55902910|NCT04145674|D-methadone|d-methadone|mesh-list
55902911|NCT04145674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55902912|NCT04145674|Narcotics|narcotics|mesh-ancestor
55902913|NCT04145674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55902914|NCT04145674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902915|NCT04145674|Analgesics|analgesics|mesh-ancestor
55902916|NCT04145674|Sensory System Agents|sensory system agents|mesh-ancestor
55902917|NCT04145674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55902918|NCT04145674|Antitussive Agents|antitussive agents|mesh-ancestor
55902919|NCT04145674|Respiratory System Agents|respiratory system agents|mesh-ancestor
55902920|NCT04145674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55902921|NCT02394054|Vasopressins|vasopressins|mesh-list
55902922|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
55902923|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
55902924|NCT02394054|Coagulants|coagulants|mesh-ancestor
55756004|NCT03108287|Antacids|antacids|mesh-ancestor
55902938|NCT04024462|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55902939|NCT04024462|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55902940|NCT04024462|Alkylating Agents|alkylating agents|mesh-ancestor
55902941|NCT04024462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902942|NCT04024462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55902943|NCT04024462|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55902944|NCT04024462|Tubulin Modulators|tubulin modulators|mesh-ancestor
55902945|NCT04024462|Antimitotic Agents|antimitotic agents|mesh-ancestor
55902946|NCT04024462|Mitosis Modulators|mitosis modulators|mesh-ancestor
55902947|NCT04024462|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55902948|NCT04024462|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55902949|NCT04024462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55902951|NCT04024462|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55902952|NCT04024462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55902953|NCT02393664|Bupivacaine|bupivacaine|mesh-list
55902954|NCT02393664|Propofol|propofol|mesh-list
55902955|NCT02393664|Sevoflurane|sevoflurane|mesh-list
55902956|NCT02393664|Rocuronium|rocuronium|mesh-list
55902957|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
55902972|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55902973|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902975|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
55902976|NCT02397486|Vitamins|vitamins|mesh-ancestor
55902977|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
55902978|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55902979|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
55902980|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903025|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
55903026|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
55903027|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55903028|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55903029|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903030|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55903031|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903032|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903033|NCT03103750|Calcitriol|calcitriol|mesh-list
55903034|NCT03103750|Amphetamine|amphetamine|mesh-list
55903035|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
55903036|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55903038|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55903039|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55903040|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903041|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55903042|NCT03103750|Vitamins|vitamins|mesh-ancestor
55903043|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
55903067|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55903068|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
55903069|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903070|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903071|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55903072|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
55903073|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55903074|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
55903075|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903076|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903077|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55903078|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
55903079|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
55903080|NCT03081052|Protective Agents|protective agents|mesh-ancestor
55903081|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
55903082|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
55903083|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
55903084|NCT03015610|Lansoprazole|lansoprazole|mesh-list
55903085|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
55903086|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55903087|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55903088|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55903089|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903090|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903091|NCT00422344|Sunitinib|sunitinib|mesh-list
55903092|NCT00422344|Everolimus|everolimus|mesh-list
55715174|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
55903096|NCT00422344|Growth Substances|growth substances|mesh-ancestor
55903112|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903114|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
55903115|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903116|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55903117|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55903118|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
55903119|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55903120|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55903121|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55903122|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55903123|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903125|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55903126|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
55715221|NCT02295280|Anesthetics|anesthetics|mesh-ancestor
55903154|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55903155|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903156|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
55903157|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
55903158|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
55903159|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903160|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55903161|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903163|NCT02085148|Vincristine|vincristine|mesh-list
55903164|NCT02085148|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55903165|NCT02085148|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55715406|NCT02220803|Diuretics|diuretics|mesh-ancestor
55903191|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903192|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903193|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
55903194|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55903195|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903196|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55903197|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55903198|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55903199|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903200|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
55903201|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903202|NCT04317430|Niclosamide|niclosamide|mesh-list
55903203|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
55903204|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55903205|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
55903206|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55903207|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903208|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
55903209|NCT04277884|Firibastat|firibastat|mesh-list
55903212|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
55903213|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903214|NCT00367822|Ropinirole|ropinirole|mesh-list
55903215|NCT00367822|Lisuride|lisuride|mesh-list
55903216|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55903217|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55903218|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
55903219|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
55903220|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903221|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903222|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715567|NCT04467931|Reserpine|reserpine|mesh-list
55903232|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55903233|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
55903234|NCT02643862|Omalizumab|omalizumab|mesh-list
55903235|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55903236|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55903237|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
55903238|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
55903239|NCT01694771|Olodaterol|olodaterol|mesh-list
55903240|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55903241|NCT01694771|Autonomic Agents|autonomic agents|mesh-ancestor
55903242|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903243|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903244|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55903245|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
55903246|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
55903247|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55903248|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
55903249|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903250|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903251|NCT02651272|Macitentan|macitentan|mesh-list
55903271|NCT03924323|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55903272|NCT03924323|Antidepressive Agents|antidepressive agents|mesh-ancestor
55903273|NCT03924323|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55903274|NCT01581281|Topiramate|topiramate|mesh-list
55903275|NCT01581281|Amitriptyline|amitriptyline|mesh-list
55903276|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
55903277|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55903278|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903279|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55903280|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
55715737|NCT02363127|Progestins|progestins|mesh-ancestor
55903291|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903292|NCT01580969|Minocycline|minocycline|mesh-list
55903294|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55903295|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903296|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55903297|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55903298|NCT01580969|Growth Substances|growth substances|mesh-ancestor
55903299|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903300|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
55903301|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55903302|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903303|NCT02696226|Aspirin|aspirin|mesh-list
55903304|NCT02696226|Warfarin|warfarin|mesh-list
55903331|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
55903332|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903333|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55903334|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903335|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903336|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
55903337|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903338|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55903339|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55903340|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903341|NCT03167112|Antidotes|antidotes|mesh-ancestor
55903347|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
55903348|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55903349|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
55903350|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903351|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903352|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55903353|NCT03167034|Acetazolamide|acetazolamide|mesh-list
55903354|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
55903355|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55903356|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903357|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903358|NCT03167034|Diuretics|diuretics|mesh-ancestor
55903359|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
55903360|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903361|NCT01578551|Metformin|metformin|mesh-list
55903362|NCT01578551|Biguanides|biguanides|mesh-list
55903363|NCT01578551|Paclitaxel|paclitaxel|mesh-list
55903364|NCT01578551|Bevacizumab|bevacizumab|mesh-list
55903365|NCT01578551|Carboplatin|carboplatin|mesh-list
55903366|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55715965|NCT03514069|Temozolomide|temozolomide|mesh-list
55903370|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
55903371|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903372|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55903373|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55903374|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55903375|NCT01578551|Growth Substances|growth substances|mesh-ancestor
55903376|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903377|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
55903378|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55903379|NCT01692197|Cytarabine|cytarabine|mesh-list
55903380|NCT01692197|Dexamethasone|dexamethasone|mesh-list
55903381|NCT01692197|Idarubicin|idarubicin|mesh-list
55903382|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903383|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
55903384|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
55903385|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903386|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903387|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55903388|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
55903421|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903422|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903423|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55903424|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
55903425|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
55903426|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55903427|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
55903428|NCT03166254|Vaccines|vaccines|mesh-list
55903429|NCT03166254|Poly ICLC|poly iclc|mesh-list
55903430|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
55903431|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903486|NCT02653144|Anesthetics|anesthetics|mesh-list
55903487|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903488|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
55903489|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
55903490|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903491|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903492|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55903493|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
55903494|NCT02653144|Hormones|hormones|mesh-ancestor
55903495|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903496|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55903497|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903498|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55903499|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903500|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55903501|NCT02653144|Analgesics|analgesics|mesh-ancestor
55903502|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
55903503|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55716045|NCT03333343|Trametinib|trametinib|mesh-list
55903504|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55903505|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55903506|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
55903507|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903508|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903509|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
55903510|NCT00118365|Eflornithine|eflornithine|mesh-list
55903511|NCT00118365|Sulindac|sulindac|mesh-list
55903512|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903532|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903533|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903534|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55903535|NCT03165240|Diuretics|diuretics|mesh-ancestor
55903536|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
55903537|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55903538|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
55903539|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55716232|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903546|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55903547|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
55903548|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903549|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903550|NCT03028909|Oseltamivir|oseltamivir|mesh-list
55903551|NCT03028909|MEDI8852|medi8852|mesh-list
55903552|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
55903553|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903554|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903555|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903556|NCT02654860|Acetaminophen|acetaminophen|mesh-list
55903557|NCT02654860|Bupivacaine|bupivacaine|mesh-list
55903558|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
55903559|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
55903560|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903561|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903562|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
55903563|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903564|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55903597|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903598|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55903599|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903600|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903601|NCT01688921|Vaccines|vaccines|mesh-list
55903602|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
55903603|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903604|NCT00118755|Bevacizumab|bevacizumab|mesh-list
55903605|NCT00118755|Capecitabine|capecitabine|mesh-list
55903606|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
55903607|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55903608|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903609|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55903610|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55903611|NCT00118755|Growth Substances|growth substances|mesh-ancestor
55903612|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903613|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
55903614|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55903615|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
55903616|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903617|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55903618|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55903660|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903661|NCT00121251|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903663|NCT00121251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903664|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55903665|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
55903666|NCT02664220|Povidone|povidone|mesh-list
55903667|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
55903668|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
55903669|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55903670|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903671|NCT04339348|Lidocaine|lidocaine|mesh-list
55903672|NCT04339348|Prilocaine|prilocaine|mesh-list
55903673|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55903674|NCT04339348|Misoprostol|misoprostol|mesh-list
55903675|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
55903676|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
55903677|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903678|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903679|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
55903691|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
55903705|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903706|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55903707|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55903708|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55903709|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903710|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903711|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55903712|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55903713|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55903714|NCT02664922|Narcotics|narcotics|mesh-ancestor
55903715|NCT02666950|Cytarabine|cytarabine|mesh-list
55903716|NCT02666950|Adavosertib|adavosertib|mesh-list
55903717|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55903718|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
55903719|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903720|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903721|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
55903722|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903723|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55903724|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
55903725|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903726|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903728|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55903729|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
55903730|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55903731|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55903733|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55903751|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55903753|NCT01687283|Hormones|hormones|mesh-ancestor
55903754|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903755|NCT02684370|Ustekinumab|ustekinumab|mesh-list
55903756|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55903757|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
55903758|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
55903759|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903760|NCT02669914|Durvalumab|durvalumab|mesh-list
55903761|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55716527|NCT02231255|Pramipexole|pramipexole|mesh-list
55903762|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903763|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
55903764|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55903765|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55903766|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55903767|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55903768|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903769|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
55903770|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55903771|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903772|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55903773|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903774|NCT04739410|Ivermectin|ivermectin|mesh-list
55903775|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55903803|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55903804|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
55903805|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903806|NCT00368056|Eszopiclone|eszopiclone|mesh-list
55903807|NCT00368056|Zopiclone|zopiclone|mesh-list
55903808|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55903809|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55903810|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903811|NCT01685801|Ivacaftor|ivacaftor|mesh-list
55903812|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55903813|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55903814|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903815|NCT01684943|Insulin|insulin|mesh-list
55903816|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55903817|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903818|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
55903819|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55903820|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55903821|NCT05339542|Prednisolone|prednisolone|mesh-list
55903822|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
55903823|NCT05339542|Lidocaine|lidocaine|mesh-list
55903824|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55903825|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
55903826|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
55903827|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
55716554|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
55903876|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903878|NCT05248984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55903879|NCT05248984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55903880|NCT05248984|Analgesics|analgesics|mesh-ancestor
55903881|NCT05248984|Sensory System Agents|sensory system agents|mesh-ancestor
55903882|NCT05248984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903883|NCT05248984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903884|NCT05248984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903885|NCT05248984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55903886|NCT05248984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55903887|NCT05248984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903888|NCT05248984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903889|NCT00368602|Timolol|timolol|mesh-list
55903891|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
55903905|NCT04707508|Metformin|metformin|mesh-list
55903906|NCT04707508|Valsartan|valsartan|mesh-list
55903907|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55903908|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903909|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55903910|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55903911|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55903912|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903914|NCT05145400|Lenalidomide|lenalidomide|mesh-list
55903915|NCT05145400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55903916|NCT05145400|Antiemetics|antiemetics|mesh-ancestor
55903917|NCT05145400|Autonomic Agents|autonomic agents|mesh-ancestor
55903918|NCT05145400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55903919|NCT05145400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55903920|NCT05145400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55903921|NCT05145400|Glucocorticoids|glucocorticoids|mesh-ancestor
55903922|NCT05145400|Hormones|hormones|mesh-ancestor
55903923|NCT05145400|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55903924|NCT05145400|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55903925|NCT05145400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903926|NCT05145400|Immunologic Factors|immunologic factors|mesh-ancestor
55903927|NCT05145400|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55903928|NCT05145400|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55903929|NCT05145400|Growth Substances|growth substances|mesh-ancestor
55903930|NCT05145400|Growth Inhibitors|growth inhibitors|mesh-ancestor
55903931|NCT01567865|Vaccines|vaccines|mesh-list
55903932|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
55903934|NCT05049226|Vaccines|vaccines|mesh-list
55903951|NCT05005000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903952|NCT01567163|Docetaxel|docetaxel|mesh-list
55903953|NCT01567163|Ramucirumab|ramucirumab|mesh-list
55903954|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55903955|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
55903956|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
55903957|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
55903958|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55903959|NCT05002114|Cannabidiol|cannabidiol|mesh-list
55903960|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
55903961|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
55903962|NCT04973566|Etanercept|etanercept|mesh-list
55903963|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
55903964|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55903966|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55903967|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55903969|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904010|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
55904011|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904012|NCT04344184|Protective Agents|protective agents|mesh-ancestor
55904013|NCT01566773|Bromides|bromides|mesh-list
55904015|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55904016|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
55904017|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904018|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904019|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55904020|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
55904021|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
55904022|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55904023|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
55904024|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904025|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904026|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
55904069|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904070|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55904071|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55904096|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55904097|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55904098|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55904099|NCT03417388|Analgesics|analgesics|mesh-ancestor
55904100|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
55904101|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904102|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904103|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904104|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904105|NCT03417388|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55904106|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55904107|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904108|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55904110|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904135|NCT03382834|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55904136|NCT03382834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55904137|NCT03382834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55904138|NCT03382834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904139|NCT03382834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716837|NCT04530383|Metformin|metformin|mesh-list
55904140|NCT03382834|Antiviral Agents|antiviral agents|mesh-ancestor
55904141|NCT03382834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55904143|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
55904144|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904145|NCT02691702|Protective Agents|protective agents|mesh-ancestor
55904146|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904147|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904148|NCT01564277|Allopurinol|allopurinol|mesh-list
55904149|NCT01564277|Rasburicase|rasburicase|mesh-list
55904150|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
55904151|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904152|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904153|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
55904154|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904155|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55904156|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
55904157|NCT01564277|Protective Agents|protective agents|mesh-ancestor
55904158|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904159|NCT03361306|Elotuzumab|elotuzumab|mesh-list
55904160|NCT03361306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904161|NCT01563185|Ibuprofen|ibuprofen|mesh-list
55904162|NCT01563185|Famotidine|famotidine|mesh-list
55904163|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55904164|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55904165|NCT01563185|Analgesics|analgesics|mesh-ancestor
55904166|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
55904167|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904168|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904169|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904170|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904173|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904174|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55904175|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55904176|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55716873|NCT02232035|Diazepam|diazepam|mesh-list
55904177|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
55904178|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
55904179|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904180|NCT02974660|Protamines|protamines|mesh-list
55904181|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
55904182|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904183|NCT02974660|Coagulants|coagulants|mesh-ancestor
55904184|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
55904185|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
55904186|NCT01563029|Fluticasone|fluticasone|mesh-list
55904187|NCT01563029|Xhance|xhance|mesh-list
55904188|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904189|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55904190|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
55904191|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904192|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904193|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55904194|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
55904195|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
55904225|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904226|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55904227|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904228|NCT04113317|Lenograstim|lenograstim|mesh-list
55904229|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55904230|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
55904231|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904232|NCT04341844|Methylene Blue|methylene blue|mesh-list
55904233|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904234|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904235|NCT01561313|Adalimumab|adalimumab|mesh-list
55904236|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904237|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904266|NCT01559675|Hormones|hormones|mesh-ancestor
55904286|NCT03228394|GABA Modulators|gaba modulators|mesh-ancestor
55904287|NCT03228394|GABA Agents|gaba agents|mesh-ancestor
55904288|NCT00362596|Acyclovir|acyclovir|mesh-list
55904289|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
55904290|NCT00362596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55904291|NCT02974504|Linagliptin|linagliptin|mesh-list
55904292|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55904293|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904294|NCT02974504|Incretins|incretins|mesh-ancestor
55904295|NCT02974504|Hormones|hormones|mesh-ancestor
55904296|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55904297|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55904298|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
55904299|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904300|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904305|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
55904306|NCT03013504|Docetaxel|docetaxel|mesh-list
55904307|NCT03013504|Trastuzumab|trastuzumab|mesh-list
55904308|NCT03013504|Epirubicin|epirubicin|mesh-list
55904309|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904310|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
55904311|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904312|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904313|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55904314|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
55904315|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904316|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904318|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
55904336|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55904337|NCT01559129|Growth Substances|growth substances|mesh-ancestor
55904338|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
55904339|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904341|NCT02691468|Trace Elements|trace elements|mesh-ancestor
55904342|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
55904343|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904344|NCT03162120|Metoprolol|metoprolol|mesh-list
55904345|NCT03162120|Flecainide|flecainide|mesh-list
55904346|NCT03162120|Ranolazine|ranolazine|mesh-list
55904347|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55904348|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55904349|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
55904350|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
55904351|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904352|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904353|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55904354|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55904355|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55904356|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
55904357|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904358|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904359|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55904360|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55904361|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55904362|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
55904363|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55904364|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
55904369|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
55904380|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55904381|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55904382|NCT02678286|Analgesics|analgesics|mesh-ancestor
55904383|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
55904384|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904385|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904386|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904387|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904388|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55904389|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55904390|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904391|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904393|NCT03164694|Pemetrexed|pemetrexed|mesh-list
55904394|NCT03164694|Apatinib|apatinib|mesh-list
55904395|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904396|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904397|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904398|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55717001|NCT02232347|Sufentanil|sufentanil|mesh-list
55904399|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55904400|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55904401|NCT04775550|Dexamethasone|dexamethasone|mesh-list
55904402|NCT04775550|Lenalidomide|lenalidomide|mesh-list
55904403|NCT04775550|Bortezomib|bortezomib|mesh-list
55904404|NCT04775550|Daratumumab|daratumumab|mesh-list
55904405|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904406|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
55904407|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
55904408|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904409|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904428|NCT02998528|Ipilimumab|ipilimumab|mesh-list
55904429|NCT02998528|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55904430|NCT02998528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904431|NCT02998528|Tubulin Modulators|tubulin modulators|mesh-ancestor
55904432|NCT02998528|Antimitotic Agents|antimitotic agents|mesh-ancestor
55904433|NCT02998528|Mitosis Modulators|mitosis modulators|mesh-ancestor
55742501|NCT05135715|Trastuzumab|trastuzumab|mesh-list
55904434|NCT02998528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904435|NCT02998528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55904436|NCT02998528|Antimetabolites|antimetabolites|mesh-ancestor
55904437|NCT02998528|Antiviral Agents|antiviral agents|mesh-ancestor
55904438|NCT02998528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55904439|NCT02998528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904440|NCT02998528|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904441|NCT02998528|Immunologic Factors|immunologic factors|mesh-ancestor
55904442|NCT02998528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904443|NCT02998528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55904444|NCT02998528|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55904445|NCT02998528|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55904446|NCT02998528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55904447|NCT02930902|Gemcitabine|gemcitabine|mesh-list
55904448|NCT02930902|Paclitaxel|paclitaxel|mesh-list
55904449|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55904450|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
55904451|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55904477|NCT02824276|Analgesics|analgesics|mesh-ancestor
55904478|NCT02824276|Sensory System Agents|sensory system agents|mesh-ancestor
55904479|NCT02824276|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904480|NCT02767804|Crizotinib|crizotinib|mesh-list
55904481|NCT02767804|Ensartinib|ensartinib|mesh-list
55904482|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904657|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904483|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55904484|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904485|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904486|NCT02741128|Vaccines|vaccines|mesh-list
55904487|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
55904488|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904489|NCT01566721|Trastuzumab|trastuzumab|mesh-list
55904490|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55904491|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904492|NCT01541215|Metformin|metformin|mesh-list
55904493|NCT01541215|Liraglutide|liraglutide|mesh-list
55904494|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55904496|NCT01541215|Incretins|incretins|mesh-ancestor
55904533|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
55904534|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904535|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904536|NCT04756271|Antibodies|antibodies|mesh-list
55904537|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
55904538|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
55904539|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904541|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904542|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
55904543|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55904544|NCT01537783|Mupirocin|mupirocin|mesh-list
55904545|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55904546|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55904547|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
55904548|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
55904549|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55904550|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55904551|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904552|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904553|NCT01556165|Rasagiline|rasagiline|mesh-list
55904554|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55904555|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717095|NCT02229617|Hormones|hormones|mesh-ancestor
55904556|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904588|NCT01582945|Analgesics|analgesics|mesh-ancestor
55904589|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
55904590|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904591|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904592|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55904593|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55904594|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
55904595|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
55904596|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904597|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55904598|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55904599|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904600|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904601|NCT01565083|Trastuzumab|trastuzumab|mesh-list
55904602|NCT01565083|Pertuzumab|pertuzumab|mesh-list
55904603|NCT01565083|Vinorelbine|vinorelbine|mesh-list
55904604|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55904605|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904606|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55904607|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
55904608|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
55904640|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904641|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904642|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
55904643|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55904644|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55904645|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904646|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55904647|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55904648|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55904649|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904650|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55904651|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55904652|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55904653|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904654|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904655|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55904656|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55904660|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904661|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55904662|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
55904663|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904664|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904665|NCT01536535|Prednisone|prednisone|mesh-list
55904666|NCT01536535|Mesalamine|mesalamine|mesh-list
55904667|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904668|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
55904669|NCT01536535|Hormones|hormones|mesh-ancestor
55904682|NCT01536379|Belimumab|belimumab|mesh-list
55904683|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904684|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
55904685|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904686|NCT01536067|Bortezomib|bortezomib|mesh-list
55904687|NCT01536067|Ofatumumab|ofatumumab|mesh-list
55904688|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904689|NCT04410211|Midazolam|midazolam|mesh-list
55904690|NCT04410211|Sevoflurane|sevoflurane|mesh-list
55904691|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55904692|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55904693|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55904694|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904695|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55904696|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55904697|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55904698|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55904699|NCT04410211|Anesthetics, General|anesthetics, general|mesh-ancestor
55904700|NCT04410211|Anesthetics|anesthetics|mesh-ancestor
55904701|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
55904702|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
55904703|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717198|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55904792|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55904793|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
55904794|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904795|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904797|NCT01549613|Daptomycin|daptomycin|mesh-list
55904798|NCT01549613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55904799|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55904800|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
55904801|NCT04106219|Topotecan|topotecan|mesh-list
55904802|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904803|NCT04106219|Immunologic Factors|immunologic factors|mesh-ancestor
55904804|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904805|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904806|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55904807|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
55904808|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904809|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904837|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55904838|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55904839|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
55904840|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904841|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55904842|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55904844|NCT01544153|Nicotine|nicotine|mesh-list
55904845|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55904846|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
55904847|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904848|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904849|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55904850|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55904851|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
55904852|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55904853|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904854|NCT01543685|Celecoxib|celecoxib|mesh-list
55904855|NCT01543685|Indomethacin|indomethacin|mesh-list
55904900|NCT01539083|Dexamethasone|dexamethasone|mesh-list
55904901|NCT01539083|Prednisolone|prednisolone|mesh-list
55904902|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
55904903|NCT01539083|Bortezomib|bortezomib|mesh-list
55904904|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904905|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
55904906|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904907|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55904908|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55904909|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
55904910|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55904911|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55904912|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55904913|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904914|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
55904915|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
55904916|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904917|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55904919|NCT01539083|Hormones|hormones|mesh-ancestor
55904927|NCT01539083|Growth Substances|growth substances|mesh-ancestor
55904928|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
55904929|NCT01537133|Fluticasone|fluticasone|mesh-list
55904930|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55904931|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55904932|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
55904933|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904934|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904936|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
55904937|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
55904938|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55904939|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55904940|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55904973|NCT01534637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55904974|NCT01534637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55904975|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55904976|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
55904977|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55904978|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
55904979|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55904980|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55904981|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55904982|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717454|NCT02345187|Micronutrients|micronutrients|mesh-list
55905044|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905045|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905046|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55905047|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55905048|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
55905049|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
55905050|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
55905051|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55905052|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
55905054|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55905055|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55905056|NCT02689518|Growth Substances|growth substances|mesh-ancestor
55905057|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905058|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
55905059|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905060|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
55905096|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55905097|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55905098|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905099|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55905100|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
55905102|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55905103|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55905104|NCT03164382|Sorafenib|sorafenib|mesh-list
55905105|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905106|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55905107|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905108|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905109|NCT03161340|Sirolimus|sirolimus|mesh-list
55717572|NCT03798743|Docetaxel|docetaxel|mesh-list
55905155|NCT03163914|Norepinephrine|norepinephrine|mesh-list
55905156|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55905157|NCT03163914|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55905158|NCT03163914|Adrenergic Agents|adrenergic agents|mesh-ancestor
55905159|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905160|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905161|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905162|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55905163|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55905164|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
55905165|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905166|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55905167|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
55905168|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
55905176|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905177|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905178|NCT03163680|Omeprazole|omeprazole|mesh-list
55905179|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55905180|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55905181|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55905182|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905183|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905191|NCT05421858|Fluconazole|fluconazole|mesh-list
55905192|NCT05421858|Caspofungin|caspofungin|mesh-list
55905193|NCT05421858|Antifungal Agents|antifungal agents|mesh-ancestor
55905194|NCT05421858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905195|NCT05421858|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55905196|NCT05421858|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55905205|NCT04574232|Triamcinolone|triamcinolone|mesh-list
55905228|NCT04548648|Isavuconazole|isavuconazole|mesh-list
55905229|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
55905230|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905231|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
55905232|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905233|NCT04443348|Paclitaxel|paclitaxel|mesh-list
55905234|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
55905235|NCT04443348|Carboplatin|carboplatin|mesh-list
55905236|NCT04443348|Doxorubicin|doxorubicin|mesh-list
55905237|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
55905238|NCT04443348|Capecitabine|capecitabine|mesh-list
55905239|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55905240|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905241|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
55905242|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
55905243|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
55905244|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905245|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905246|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
55905247|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905248|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55905249|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55905250|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
55905251|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55905252|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55905253|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55905254|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55905277|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55905278|NCT02671500|Velpatasvir|velpatasvir|mesh-list
55905279|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
55905280|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905281|NCT02671266|Oxytocin|oxytocin|mesh-list
55905282|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
55905283|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55905284|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905285|NCT03160404|Zolpidem|zolpidem|mesh-list
55905286|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55905287|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55905288|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55905289|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905290|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55905291|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
55905292|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
55905293|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905294|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905295|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
55905296|NCT03162588|Hematinics|hematinics|mesh-ancestor
55905333|NCT04797780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905334|NCT04797780|Antimetabolites|antimetabolites|mesh-ancestor
55905335|NCT04797780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905336|NCT04797780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905337|NCT04797780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905338|NCT03114072|Methamphetamine|methamphetamine|mesh-list
55905339|NCT03114072|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55905340|NCT03114072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905341|NCT03114072|Sympathomimetics|sympathomimetics|mesh-ancestor
55905342|NCT03114072|Autonomic Agents|autonomic agents|mesh-ancestor
55905343|NCT03114072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905344|NCT03114072|Dopamine Agents|dopamine agents|mesh-ancestor
55905345|NCT03114072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905346|NCT03114072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905347|NCT03114072|Adrenergic Agents|adrenergic agents|mesh-ancestor
55905348|NCT03114072|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55905349|NCT03114072|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55905350|NCT03114072|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55905351|NCT03114072|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55905353|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
55905354|NCT02388516|Vitamins|vitamins|mesh-ancestor
55905372|NCT02135874|BB 1101|bb 1101|mesh-list
55905373|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
55905374|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905375|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905376|NCT02135874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55905377|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55905378|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
55905379|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
55905380|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905381|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55905382|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
55905383|NCT02135874|Hormones|hormones|mesh-ancestor
55905384|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905385|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55905386|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
55905387|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905411|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
55905412|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55905413|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905414|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55905415|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905417|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55905418|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
55905419|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
55905420|NCT02985671|Acetaminophen|acetaminophen|mesh-list
55905421|NCT02985671|Diclofenac|diclofenac|mesh-list
55905422|NCT02985671|Orphenadrine|orphenadrine|mesh-list
55905423|NCT02985671|Caffeine|caffeine|mesh-list
55905424|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55905425|NCT02985671|Analgesics|analgesics|mesh-ancestor
55905426|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
55905429|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
55905471|NCT01527149|Dexamethasone acetate|dexamethasone acetate|mesh-list
55905472|NCT01527149|Cyclophosphamide|cyclophosphamide|mesh-list
55905473|NCT01527149|Doxorubicin|doxorubicin|mesh-list
55905474|NCT01527149|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55905475|NCT01527149|Methotrexate|methotrexate|mesh-list
55905476|NCT01527149|Vincristine|vincristine|mesh-list
55905477|NCT01527149|Ofatumumab|ofatumumab|mesh-list
55905478|NCT01527149|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55905479|NCT01527149|BB 1101|bb 1101|mesh-list
55905480|NCT01527149|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905481|NCT01527149|Immunologic Factors|immunologic factors|mesh-ancestor
55905482|NCT01527149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905483|NCT01527149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55905484|NCT01527149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55905485|NCT01527149|Alkylating Agents|alkylating agents|mesh-ancestor
55905486|NCT01527149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717888|NCT02306785|Mesalamine|mesalamine|mesh-list
55905502|NCT01527149|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55905503|NCT01527149|Abortifacient Agents|abortifacient agents|mesh-ancestor
55905504|NCT01527149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55905505|NCT01527149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905507|NCT01527149|Dermatologic Agents|dermatologic agents|mesh-ancestor
55905508|NCT01527149|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55905509|NCT01527149|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55905510|NCT01527149|Antiviral Agents|antiviral agents|mesh-ancestor
55905511|NCT01527149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905512|NCT01527149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55905513|NCT01527149|Tubulin Modulators|tubulin modulators|mesh-ancestor
55905514|NCT01527149|Antimitotic Agents|antimitotic agents|mesh-ancestor
55905515|NCT01527149|Mitosis Modulators|mitosis modulators|mesh-ancestor
55905516|NCT01527149|Protease Inhibitors|protease inhibitors|mesh-ancestor
55905517|NCT01526057|Rituximab|rituximab|mesh-list
55905518|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55905519|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905520|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
55717953|NCT04718025|Aspirin|aspirin|mesh-list
55905527|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905529|NCT01525901|Mecasermin|mecasermin|mesh-list
55905530|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905531|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
55905532|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905538|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
55905539|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
55905540|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
55905541|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55905542|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905544|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55905572|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55905573|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
55905575|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55905576|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55905577|NCT00246441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905578|NCT00246519|Atenolol|atenolol|mesh-list
55905579|NCT00246519|Metoprolol|metoprolol|mesh-list
55905580|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55905581|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
55905582|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55905583|NCT00246519|Diuretics|diuretics|mesh-ancestor
55905584|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
55905585|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905586|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55905587|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55905588|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905589|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55905590|NCT00246519|Sympatholytics|sympatholytics|mesh-ancestor
55905591|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
55905592|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905593|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55905594|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55905595|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55905596|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
55905620|NCT00248547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55905621|NCT00248547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55905622|NCT00248547|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55905623|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55905626|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
55905627|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55905628|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55905629|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
55905630|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905634|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55905635|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905636|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55905637|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55905638|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905639|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905640|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905641|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
55905643|NCT00249249|Pitavastatin|pitavastatin|mesh-list
55905692|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905693|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55905694|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905695|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
55905696|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55718176|NCT04463953|Ixazomib|ixazomib|mesh-list
55905717|NCT04117581|Vitamin D|vitamin d|mesh-list
55905718|NCT04117581|Cholecalciferol|cholecalciferol|mesh-list
55905719|NCT04117581|Vitamins|vitamins|mesh-ancestor
55905720|NCT04117581|Micronutrients|micronutrients|mesh-ancestor
55905721|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905722|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55905723|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55905724|NCT00272337|Aspirin|aspirin|mesh-list
55905725|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55905726|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55905727|NCT00272337|Analgesics|analgesics|mesh-ancestor
55905728|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
55905729|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905730|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905731|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55905770|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55905771|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905772|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55905773|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55905774|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
55905775|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55905776|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905777|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55905778|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55905779|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905780|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905781|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905782|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55905783|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55905784|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
55905785|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
55905786|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
55905787|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55905788|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55905789|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55905790|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905791|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905792|NCT01578499|Methotrexate|methotrexate|mesh-list
55905793|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55905794|NCT01578499|Bexarotene|bexarotene|mesh-list
55905795|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55905814|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
55905815|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55905816|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905817|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
55905818|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55905819|NCT01561963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905820|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905821|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55905822|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55905823|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55905824|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55905825|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55905826|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55905843|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
55905844|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905845|NCT01534351|Tamsulosin|tamsulosin|mesh-list
55905846|NCT01534351|Finasteride|finasteride|mesh-list
55905847|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55905848|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55905849|NCT01534351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55718437|NCT03510871|Nivolumab|nivolumab|mesh-list
55905864|NCT02120352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905885|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905886|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55905887|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905889|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
55905890|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55905891|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55905892|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55905893|NCT01534195|Protective Agents|protective agents|mesh-ancestor
55905894|NCT01560949|Gemcitabine|gemcitabine|mesh-list
55905895|NCT01560949|Fluorouracil|fluorouracil|mesh-list
55905938|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55905939|NCT01664910|Rituximab|rituximab|mesh-list
55905940|NCT01664910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55905941|NCT01664910|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
55905942|NCT01664910|Methotrexate|methotrexate|mesh-list
55905943|NCT01664910|Fludarabine|fludarabine|mesh-list
55905944|NCT01664910|Fludarabine phosphate|fludarabine phosphate|mesh-list
55905945|NCT01664910|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55905946|NCT01664910|Antibodies|antibodies|mesh-list
55905947|NCT01664910|Immunoglobulins|immunoglobulins|mesh-list
55905948|NCT01664910|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55905949|NCT01664910|Tacrolimus|tacrolimus|mesh-list
55905950|NCT01664910|Thymoglobulin|thymoglobulin|mesh-list
55905951|NCT01664910|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55905952|NCT01664910|Immunologic Factors|immunologic factors|mesh-ancestor
55905953|NCT01664910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906743|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
55905954|NCT01664910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55905955|NCT01664910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55905956|NCT01664910|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55905957|NCT01664910|Abortifacient Agents|abortifacient agents|mesh-ancestor
55905958|NCT01664910|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55905959|NCT01664910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55905960|NCT01664910|Antimetabolites|antimetabolites|mesh-ancestor
55905961|NCT01664910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905962|NCT01664910|Dermatologic Agents|dermatologic agents|mesh-ancestor
55905963|NCT01664910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905964|NCT01664910|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55905965|NCT01664910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55905966|NCT01664910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55905967|NCT01664910|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55905983|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55905984|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55905985|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55905987|NCT01790529|Cefuroxime|cefuroxime|mesh-list
55905988|NCT01790529|Cefuroxime axetil|cefuroxime axetil|mesh-list
55905989|NCT01790529|Anesthetics|anesthetics|mesh-list
55905990|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55905991|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55905992|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55905993|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55905994|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55905995|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55905996|NCT05569746|Immunoglobulins|immunoglobulins|mesh-list
55905997|NCT05569746|Immunoglobulin Fragments|immunoglobulin fragments|mesh-list
55905998|NCT05569746|Shiga Toxins|shiga toxins|mesh-list
55905999|NCT05569746|Immunologic Factors|immunologic factors|mesh-ancestor
55906000|NCT05569746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906001|NCT05569746|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55906002|NCT05569746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906003|NCT05569746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906004|NCT01533181|Topotecan|topotecan|mesh-list
55906005|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55906006|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55906007|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906008|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906009|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906010|NCT04641507|Tadalafil|tadalafil|mesh-list
55906011|NCT04641507|Tamsulosin|tamsulosin|mesh-list
55906031|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
55906032|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906033|NCT00512070|Protective Agents|protective agents|mesh-ancestor
55906034|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906035|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906036|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
55906037|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
55906038|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906039|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906040|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55906041|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55906042|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55906043|NCT00512070|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55906044|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55906045|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55906046|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906047|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
55906048|NCT05668026|Venetoclax|venetoclax|mesh-list
55906049|NCT05668026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906050|NCT05661552|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55906051|NCT05661552|Ezetimibe|ezetimibe|mesh-list
55906052|NCT05661552|Evolocumab|evolocumab|mesh-list
55906053|NCT05661552|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55906054|NCT05661552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55906055|NCT05661552|Antimetabolites|antimetabolites|mesh-ancestor
55906056|NCT05661552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906057|NCT05661552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55718986|NCT02313337|Fentanyl|fentanyl|mesh-list
55906141|NCT05549154|Micronutrients|micronutrients|mesh-ancestor
55906142|NCT05549154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906143|NCT05549154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55906144|NCT05549154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55906145|NCT01518257|Botulinum Toxins|botulinum toxins|mesh-list
55906146|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55906147|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55906148|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55906154|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55906155|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906156|NCT02391636|Oxytocin|oxytocin|mesh-list
55906157|NCT02391636|Carbetocin|carbetocin|mesh-list
55906161|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55906162|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
55906163|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906164|NCT02383212|Paclitaxel|paclitaxel|mesh-list
55906165|NCT02383212|Docetaxel|docetaxel|mesh-list
55906166|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
55906167|NCT02383212|Carboplatin|carboplatin|mesh-list
55906168|NCT02383212|Pemetrexed|pemetrexed|mesh-list
55906169|NCT02383212|Cemiplimab|cemiplimab|mesh-list
55906170|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55906171|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906172|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
55906173|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
55906174|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
55906175|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906176|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55906177|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
55906178|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906179|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55906214|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
55906215|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55906216|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906217|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55906218|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
55906219|NCT01529749|Losartan|losartan|mesh-list
55906220|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55906221|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55906222|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55906223|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55906224|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906225|NCT01529749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55906226|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55906228|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906229|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55906230|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55906231|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906232|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55906233|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55906234|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55906235|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55906236|NCT04101721|Aflibercept|aflibercept|mesh-list
55906237|NCT04101721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55906238|NCT04101721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55906239|NCT04101721|Growth Substances|growth substances|mesh-ancestor
55906317|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55906319|NCT01511939|Sensory System Agents|sensory system agents|mesh-ancestor
55906320|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906321|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906322|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55906323|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55719496|NCT03491527|Pemetrexed|pemetrexed|mesh-list
55906324|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906325|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906326|NCT01576705|Leucovorin|leucovorin|mesh-list
55906327|NCT01576705|Folic Acid|folic acid|mesh-list
55906328|NCT01576705|Hormones|hormones|mesh-list
55906329|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
55906330|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906331|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906332|NCT01576705|Antidotes|antidotes|mesh-ancestor
55906333|NCT01576705|Protective Agents|protective agents|mesh-ancestor
55906334|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
55906335|NCT01576705|Vitamins|vitamins|mesh-ancestor
55906336|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
55906337|NCT01576705|Hematinics|hematinics|mesh-ancestor
55906338|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
55906339|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55906340|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906341|NCT02382666|Rolapitant|rolapitant|mesh-list
55906342|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55906343|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906346|NCT00145041|Vincristine|vincristine|mesh-list
55906365|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906366|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55906367|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906368|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
55906369|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906370|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906378|NCT02382354|Propofol|propofol|mesh-list
55906379|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55906380|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906381|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906382|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55906390|NCT01510145|Travoprost|travoprost|mesh-list
55906423|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
55906424|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906425|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55906426|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55906427|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55906428|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
55906429|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906449|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55719652|NCT02321761|Analgesics|analgesics|mesh-ancestor
55906487|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55906488|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
55906489|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906490|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55906491|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55906492|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55906493|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906494|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
55906495|NCT01527487|Docetaxel|docetaxel|mesh-list
55906496|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55719695|NCT02182687|Doxorubicin|doxorubicin|mesh-list
55906509|NCT05030298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55906510|NCT05030298|Alkylating Agents|alkylating agents|mesh-ancestor
55906511|NCT05030298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906512|NCT05030298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906514|NCT01506947|Hematinics|hematinics|mesh-ancestor
55906550|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906551|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906552|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55906553|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55906554|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
55906555|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906556|NCT01559935|Clarithromycin|clarithromycin|mesh-list
55906557|NCT01559935|Dexamethasone|dexamethasone|mesh-list
55906558|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
55906559|NCT01559935|Lenalidomide|lenalidomide|mesh-list
55906560|NCT01559935|BB 1101|bb 1101|mesh-list
55906561|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55906562|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
55906563|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
55906564|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906565|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906566|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906567|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
55906568|NCT01559935|Hormones|hormones|mesh-ancestor
56144576|NCT00798018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906569|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906570|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55906571|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906572|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
55906573|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906574|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906575|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
55906576|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55906577|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55906578|NCT01559935|Growth Substances|growth substances|mesh-ancestor
55906579|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
55906580|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55906581|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906582|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55719887|NCT04588727|Purinergic Agents|purinergic agents|mesh-ancestor
55906583|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55906584|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55906585|NCT01790997|Aspirin|aspirin|mesh-list
55906586|NCT01790997|Clopidogrel|clopidogrel|mesh-list
55906587|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55906588|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55906589|NCT01790997|Analgesics|analgesics|mesh-ancestor
55906590|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
55906591|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906592|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906593|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55906594|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55906595|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55906596|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55906597|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906598|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55906599|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55906600|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906602|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55906603|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55906604|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55906605|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
55906606|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906607|NCT02385474|Fluorides|fluorides|mesh-list
55906608|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
55906609|NCT02385474|Protective Agents|protective agents|mesh-ancestor
55906610|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906611|NCT02390310|Lidocaine|lidocaine|mesh-list
55906612|NCT02390310|Prilocaine|prilocaine|mesh-list
55906613|NCT02390310|Anesthetics|anesthetics|mesh-list
55906629|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906630|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906631|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55906632|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
55906633|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55906634|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55906635|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55906636|NCT02381028|Emollients|emollients|mesh-list
55906637|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
55906638|NCT00326781|Nicotine|nicotine|mesh-list
55906639|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55906640|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
55906641|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144577|NCT00798720|Bortezomib|bortezomib|mesh-list
55906642|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906643|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55906644|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55906686|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906687|NCT00329433|Heparin|heparin|mesh-list
55906688|NCT00329433|Desirudin|desirudin|mesh-list
55906689|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
55906690|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55906691|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55906692|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906693|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
55906694|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55906695|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906696|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
55906697|NCT02389842|Palbociclib|palbociclib|mesh-list
55906698|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906699|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55742654|NCT03122353|Vitamins|vitamins|mesh-ancestor
55906700|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906701|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906702|NCT05233332|Vemurafenib|vemurafenib|mesh-list
55906703|NCT05233332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906704|NCT05233332|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55906705|NCT05233332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906706|NCT05233332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906736|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906737|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55906738|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
55906739|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906740|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55906741|NCT03706053|Midodrine|midodrine|mesh-list
55906742|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
55906744|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906745|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720001|NCT01590719|Leucovorin|leucovorin|mesh-list
55906746|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55906747|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55906748|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55906749|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55906750|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
55906751|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906752|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906754|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55906755|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55906756|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906757|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906758|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
55906759|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906760|NCT00330915|Pemetrexed|pemetrexed|mesh-list
55906761|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906783|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
55906784|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906785|NCT04861584|Antiviral Agents|antiviral agents|mesh-ancestor
55906786|NCT04861584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906787|NCT04861584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906788|NCT04861584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55906851|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
55906852|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906853|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906854|NCT00333177|Risperidone|risperidone|mesh-list
55906855|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55906856|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
55906857|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906858|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906859|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906860|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55906861|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55906862|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906863|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55906900|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55906901|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
55906902|NCT00295503|Bevacizumab|bevacizumab|mesh-list
55906903|NCT00295503|Pemetrexed|pemetrexed|mesh-list
55906904|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55906905|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906906|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55906907|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55906908|NCT00295503|Growth Substances|growth substances|mesh-ancestor
55906909|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906910|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
55906911|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906912|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906913|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55906914|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55906915|NCT02371590|Lenalidomide|lenalidomide|mesh-list
55906916|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
55906917|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
55906918|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906919|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55906920|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55906921|NCT02371590|Growth Substances|growth substances|mesh-ancestor
55906922|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
55906923|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55906924|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55906925|NCT00298155|Ketoconazole|ketoconazole|mesh-list
55906948|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
55906949|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
55906950|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906951|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906952|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906953|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
55906954|NCT01499849|Hormones|hormones|mesh-ancestor
55906955|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55906956|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55906957|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907370|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906958|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55906959|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
55906960|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55906961|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906962|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55906963|NCT01880541|Anesthetics|anesthetics|mesh-list
55906964|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55906965|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906966|NCT00298233|Oseltamivir|oseltamivir|mesh-list
55906967|NCT00298233|Antiviral Agents|antiviral agents|mesh-ancestor
55906968|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906969|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55906970|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55906971|NCT02376972|Rifaximin|rifaximin|mesh-list
55906972|NCT02376972|Metronidazole|metronidazole|mesh-list
55906973|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55906974|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55906975|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55906976|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55906977|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55906978|NCT02378532|Chloroquine|chloroquine|mesh-list
55906979|NCT02378532|Temozolomide|temozolomide|mesh-list
55906980|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55906990|NCT01498679|Fluticasone|fluticasone|mesh-list
55906992|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55906993|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55906994|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
55906995|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55906996|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55906997|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55906998|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
55906999|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
55907000|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55907002|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55907003|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55907004|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
55907005|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907006|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55907007|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
55907008|NCT01000467|Protective Agents|protective agents|mesh-ancestor
55907009|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907011|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55907012|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907013|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
55907014|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55907015|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55907016|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
55907021|NCT01526551|Vaccines|vaccines|mesh-list
55907040|NCT00343083|Paclitaxel|paclitaxel|mesh-list
55907041|NCT00343083|Carboplatin|carboplatin|mesh-list
55907042|NCT00343083|Cetuximab|cetuximab|mesh-list
55907043|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55907044|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907045|NCT00343083|Tubulin Modulators|tubulin modulators|mesh-ancestor
55907046|NCT00343083|Antimitotic Agents|antimitotic agents|mesh-ancestor
55907047|NCT00343083|Mitosis Modulators|mitosis modulators|mesh-ancestor
55907048|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907049|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55907050|NCT00343785|Cyclosporine|cyclosporine|mesh-list
55907051|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
55907052|NCT00343785|Methotrexate|methotrexate|mesh-list
55907053|NCT00343785|Cyclosporins|cyclosporins|mesh-list
55907054|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
55907055|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55907056|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
55907057|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55907058|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
55907059|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907060|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55907061|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55907062|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
55907063|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144578|NCT00798720|Vorinostat|vorinostat|mesh-list
55907091|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907092|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907093|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55766291|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
55907094|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55907095|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
55907096|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907097|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907098|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
55907099|NCT00343863|Hormones|hormones|mesh-ancestor
55907100|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907101|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55907102|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55907103|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55907104|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55907105|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907106|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
55907107|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
55907146|NCT00345969|Hormones|hormones|mesh-ancestor
55907147|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907148|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907149|NCT01498445|Decitabine|decitabine|mesh-list
55907150|NCT01498445|Dasatinib|dasatinib|mesh-list
55907151|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55907152|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
55907153|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907154|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907155|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907156|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55907157|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
55907158|NCT01525615|Olodaterol|olodaterol|mesh-list
55907159|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55907160|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
55907161|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907162|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907163|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55907164|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
55907201|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907203|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55907204|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55907205|NCT01524991|Gemcitabine|gemcitabine|mesh-list
55907206|NCT01524991|Ipilimumab|ipilimumab|mesh-list
55907207|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720444|NCT01255709|Racepinephrine|racepinephrine|mesh-list
55907287|NCT02375880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55907288|NCT02375880|Immunologic Factors|immunologic factors|mesh-ancestor
55907289|NCT02375880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907290|NCT01524679|Interferons|interferons|mesh-list
55907291|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
55907292|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
55907293|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55907294|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907295|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
55907296|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907297|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
55907298|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907299|NCT02365272|Amikacin|amikacin|mesh-list
55907300|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55907301|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907302|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55720636|NCT01057667|Ribavirin|ribavirin|mesh-list
55907339|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55907340|NCT01498289|Leucovorin|leucovorin|mesh-list
55907341|NCT01498289|Docetaxel|docetaxel|mesh-list
55907342|NCT01498289|Fluorouracil|fluorouracil|mesh-list
55907343|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
55907344|NCT01498289|Irinotecan|irinotecan|mesh-list
55907345|NCT01498289|Calcium|calcium|mesh-list
55907346|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
55907347|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907348|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
55907357|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
55907358|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55907359|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55907360|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907361|NCT01498289|Antidotes|antidotes|mesh-ancestor
55907362|NCT01498289|Protective Agents|protective agents|mesh-ancestor
55907363|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
55907364|NCT01498289|Vitamins|vitamins|mesh-ancestor
55907365|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
55907366|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
55907367|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
55907368|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55907369|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55907371|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907372|NCT02364882|Urological Agents|urological agents|mesh-ancestor
55907373|NCT02364804|Aprepitant|aprepitant|mesh-list
55907374|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
55907375|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
55720777|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55907376|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907377|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907382|NCT01524133|Sertraline|sertraline|mesh-list
55907393|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55907394|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907395|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907396|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907397|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55907398|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55907399|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907400|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55907402|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55907404|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
55907405|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55907406|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
55907407|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
55907408|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907409|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742703|NCT04502017|Clopidogrel|clopidogrel|mesh-list
55907410|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55907411|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907412|NCT04110301|Lenalidomide|lenalidomide|mesh-list
55907450|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55907451|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55907452|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907454|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55907455|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
55907456|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907457|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907458|NCT02375022|Endostar protein|endostar protein|mesh-list
55907464|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
55907465|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907466|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55907467|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55907483|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907485|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55907486|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
55907487|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55907488|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907489|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55907490|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907491|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
55907492|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55907495|NCT01557283|Etanercept|etanercept|mesh-list
55907519|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55907520|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907521|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907522|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
55907523|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55907524|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55907525|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
55907526|NCT00350025|Paclitaxel|paclitaxel|mesh-list
55907527|NCT00350025|Cetuximab|cetuximab|mesh-list
55907528|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55907529|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907530|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
55907531|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
55907532|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
55907533|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720997|NCT05354102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907534|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55907535|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55907536|NCT01496807|Ipilimumab|ipilimumab|mesh-list
55907537|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55907538|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907539|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55908153|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55907540|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907541|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
55907542|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907568|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907569|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
55907570|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907571|NCT01495793|Rotigotine|rotigotine|mesh-list
55907572|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
55907573|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
55907574|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721013|NCT01660334|Voriconazole|voriconazole|mesh-list
55721014|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
55721015|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721016|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55721017|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55721018|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721020|NCT01660334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55907575|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907576|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907577|NCT02374008|Dexamethasone|dexamethasone|mesh-list
55907578|NCT02374008|Ketorolac|ketorolac|mesh-list
55907579|NCT02374008|Ropivacaine|ropivacaine|mesh-list
55907580|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55907581|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
55907582|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
55907583|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907584|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907585|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907624|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907625|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
55907626|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55907627|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55907629|NCT02373384|Protective Agents|protective agents|mesh-ancestor
55907630|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907631|NCT02373384|Diuretics|diuretics|mesh-ancestor
55907632|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
55907633|NCT02373384|Expectorants|expectorants|mesh-ancestor
55907634|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
55907635|NCT01494467|Azelaic acid|azelaic acid|mesh-list
55907636|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907640|NCT02881086|Prednisolone|prednisolone|mesh-list
55907641|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
55907642|NCT02881086|Rituximab|rituximab|mesh-list
55907643|NCT02881086|Methotrexate|methotrexate|mesh-list
55907644|NCT02881086|Fludarabine|fludarabine|mesh-list
55907645|NCT02881086|Vincristine|vincristine|mesh-list
55907685|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
55907686|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
55907687|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55907688|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55907689|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55907690|NCT03922542|Riboflavin|riboflavin|mesh-list
55907691|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
55907692|NCT03922542|Vitamins|vitamins|mesh-ancestor
55907693|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
55907694|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907695|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55907696|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
55907697|NCT01493687|Azelaic acid|azelaic acid|mesh-list
55907698|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907700|NCT02362308|Eplerenone|eplerenone|mesh-list
55907701|NCT02362308|Spironolactone|spironolactone|mesh-list
55907702|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
55907703|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
55907704|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
55907705|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907706|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907707|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55907708|NCT02362308|Diuretics|diuretics|mesh-ancestor
55907725|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55907726|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55907727|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907728|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55907729|NCT01523587|Afatinib|afatinib|mesh-list
55907730|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907731|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55907732|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908154|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
55907733|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907734|NCT00310401|Albuterol|albuterol|mesh-list
55907735|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55907736|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
55907737|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907738|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907739|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55907740|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
55907741|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
55907742|NCT00310401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55907743|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55907744|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55907745|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55907746|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
55907747|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55907748|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907749|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
55907750|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55907751|NCT00310791|Hormones|hormones|mesh-list
55907752|NCT00310791|Estradiol|estradiol|mesh-list
55907753|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55907754|NCT00310791|Estrogens|estrogens|mesh-list
55907755|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
55907756|NCT00310791|Progestins|progestins|mesh-list
55907757|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907758|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907759|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55721540|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721541|NCT03141645|Ondansetron|ondansetron|mesh-list
55721542|NCT03141645|Antiemetics|antiemetics|mesh-ancestor
55721543|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
55721544|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721545|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907760|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
55907761|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55907762|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55907763|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55907764|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55907765|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55907766|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55907767|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
55907768|NCT02362152|Diclofenac|diclofenac|mesh-list
55907769|NCT02362152|Fluorouracil|fluorouracil|mesh-list
55907770|NCT02362152|Imiquimod|imiquimod|mesh-list
55907771|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
55907772|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907773|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55721612|NCT02035137|Irinotecan|irinotecan|mesh-list
55907774|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907775|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55907776|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
55907792|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907793|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55907794|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
55907795|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55907796|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55907798|NCT01493531|Protective Agents|protective agents|mesh-ancestor
55907799|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907800|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
55907802|NCT02105415|Ketamine|ketamine|mesh-list
55907803|NCT02105415|Propofol|propofol|mesh-list
55907804|NCT02105415|Etomidate|etomidate|mesh-list
55907805|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55907806|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907807|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907808|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55907809|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
55907849|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55907850|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
55907851|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55907852|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55907853|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55907854|NCT02365740|Insulin|insulin|mesh-list
55907855|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55907856|NCT02365740|Hormones|hormones|mesh-list
55907857|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55907858|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907859|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907860|NCT02437110|Ritonavir|ritonavir|mesh-list
55907861|NCT02437110|Darunavir|darunavir|mesh-list
55907862|NCT02437110|Tenofovir|tenofovir|mesh-list
55907863|NCT02437110|Dolutegravir|dolutegravir|mesh-list
55907910|NCT02372916|Growth Substances|growth substances|mesh-ancestor
55907911|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907912|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
55907913|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907915|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
55907916|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907917|NCT01572727|Paclitaxel|paclitaxel|mesh-list
55907918|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55907919|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907920|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
55907921|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
55907922|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
56144579|NCT00798720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907923|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907924|NCT02359266|Vitamin D|vitamin d|mesh-list
55907925|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
55907926|NCT02359266|Vitamins|vitamins|mesh-ancestor
55907927|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
55907928|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907929|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55907930|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55907931|NCT02359500|Octreotide|octreotide|mesh-list
55907932|NCT02359500|Edotreotide|edotreotide|mesh-list
55907933|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55907934|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55907935|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55907936|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55907937|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907958|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907959|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55907960|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55907961|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55907962|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55907963|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55907964|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
55907965|NCT02985697|Anesthetics|anesthetics|mesh-ancestor
55907966|NCT02985697|GABA Modulators|gaba modulators|mesh-ancestor
55907967|NCT02985697|GABA Agents|gaba agents|mesh-ancestor
55907968|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55907969|NCT02372760|Lidocaine|lidocaine|mesh-list
55907970|NCT02372760|Anesthetics|anesthetics|mesh-list
55907971|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
55907972|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55907973|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907974|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
55907975|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55907976|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55907977|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55907978|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55907979|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55907980|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55907981|NCT00352911|Mifepristone|mifepristone|mesh-list
55907982|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55907983|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
55907984|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55907985|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55907986|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55907987|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55907988|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55907992|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
55907993|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55907994|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
55907995|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55907996|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55907997|NCT00353301|Sirolimus|sirolimus|mesh-list
55907998|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55907999|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908000|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55908001|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908155|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908002|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908003|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55908004|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908005|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55908006|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
55908007|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55908008|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
55908009|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908011|NCT02372604|Levocetirizine|levocetirizine|mesh-list
55908012|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55908013|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55908014|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
55908015|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
55908016|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908017|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908018|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908019|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55908020|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
55908021|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55908022|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908024|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55908029|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55908030|NCT02358642|Protective Agents|protective agents|mesh-ancestor
55908031|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908032|NCT03160248|Apremilast|apremilast|mesh-list
55908033|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55908034|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55908035|NCT03160248|Analgesics|analgesics|mesh-ancestor
55908036|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
55908037|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908038|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908039|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908040|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55908041|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55908042|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55908043|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908044|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908045|NCT01522651|Dronedarone|dronedarone|mesh-list
55908046|NCT01522651|Ranolazine|ranolazine|mesh-list
55908087|NCT04438980|Prednisolone|prednisolone|mesh-list
55908088|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
55908089|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55908090|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
55908091|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908092|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
55908093|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
55908094|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908095|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908096|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908097|NCT04438980|Glucocorticoids|glucocorticoids|mesh-ancestor
55908099|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908100|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55908101|NCT04438980|Protective Agents|protective agents|mesh-ancestor
55908102|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55908103|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908104|NCT03824847|Clarithromycin|clarithromycin|mesh-list
55908105|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55908106|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908107|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55908108|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908112|NCT01554163|Celecoxib|celecoxib|mesh-list
55908139|NCT03818607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908140|NCT02361060|Atropine|atropine|mesh-list
55908141|NCT02361060|Neostigmine|neostigmine|mesh-list
55908142|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55908143|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55908144|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55908145|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
55908146|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908147|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908148|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55908149|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
55908150|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
55908151|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
55908152|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55908156|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908157|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55908158|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908160|NCT02360982|Fentanyl|fentanyl|mesh-list
55908194|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908195|NCT02358018|Edotreotide|edotreotide|mesh-list
55908196|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55908197|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908198|NCT01552915|Methylphenidate|methylphenidate|mesh-list
55908199|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55722381|NCT02283658|Letrozole|letrozole|mesh-list
55908200|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55908201|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908202|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55908203|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55908204|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55908205|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908206|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
55908207|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908209|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
55908210|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
55908211|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908248|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908249|NCT02360202|Clobetasol|clobetasol|mesh-list
55908250|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908251|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
55908252|NCT02360202|Hormones|hormones|mesh-ancestor
55908253|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908254|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908255|NCT00322101|Cyclosporine|cyclosporine|mesh-list
55908256|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
55908257|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
55908258|NCT00322101|Busulfan|busulfan|mesh-list
55908259|NCT00322101|Methotrexate|methotrexate|mesh-list
55908260|NCT00322101|Fludarabine|fludarabine|mesh-list
55908261|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
55908262|NCT00322101|Tacrolimus|tacrolimus|mesh-list
55908309|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55908310|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55908311|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908312|NCT04337970|Axitinib|axitinib|mesh-list
55908313|NCT04337970|Talazoparib|talazoparib|mesh-list
55908314|NCT04337970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908315|NCT04337970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55908316|NCT04337970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908317|NCT04337970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908318|NCT04337970|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55908319|NCT03153852|Glycolic acid|glycolic acid|mesh-list
55722496|NCT05083455|Enoxaparin|enoxaparin|mesh-list
55908320|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
55908373|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908374|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55908375|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
55908376|NCT02357004|Protective Agents|protective agents|mesh-ancestor
55908377|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55908378|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55908379|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55908380|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
55908381|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55908382|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55908383|NCT02357004|Diuretics|diuretics|mesh-ancestor
55908384|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
55908385|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55908386|NCT01570387|Dexamethasone|dexamethasone|mesh-list
55908387|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
55908388|NCT01570387|Pomalidomide|pomalidomide|mesh-list
55908390|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908391|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
55908392|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
55908393|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908394|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908395|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908396|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
55908397|NCT01570387|Hormones|hormones|mesh-ancestor
55908398|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908422|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908423|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55908424|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908425|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908426|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55908427|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
55908428|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908429|NCT01519765|Misoprostol|misoprostol|mesh-list
55908430|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55908431|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
55908432|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55908433|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908434|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55908435|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908436|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
55908439|NCT03147066|Dezocine|dezocine|mesh-list
55908481|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55908482|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908483|NCT02351232|Incretins|incretins|mesh-ancestor
55908484|NCT02351232|Hormones|hormones|mesh-ancestor
55908485|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908486|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
55908487|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
55908488|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55908489|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908490|NCT02355678|Acetaminophen|acetaminophen|mesh-list
55908491|NCT02355678|Dexamethasone|dexamethasone|mesh-list
55908544|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908545|NCT02355054|Choline|choline|mesh-list
55908546|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
55908547|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55908548|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
55908549|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908550|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908551|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55908552|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
55908553|NCT04478448|Favipiravir|favipiravir|mesh-list
55908554|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
55908555|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908557|NCT04478526|Serotonin|serotonin|mesh-list
55908558|NCT04478526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55908559|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
55908560|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55908561|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55908562|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
55908563|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908564|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908565|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908595|NCT03159078|Polymyxin B|polymyxin b|mesh-list
55908596|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55908597|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908598|NCT01551745|Bevacizumab|bevacizumab|mesh-list
55908599|NCT01551745|Vaccines|vaccines|mesh-list
55908600|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
55908601|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908602|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55908603|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908604|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55908605|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55908606|NCT01551745|Growth Substances|growth substances|mesh-ancestor
55908607|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
55908608|NCT02350530|Bevacizumab|bevacizumab|mesh-list
55908609|NCT02350530|Fluorouracil|fluorouracil|mesh-list
55908610|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
55908611|NCT02350530|Irinotecan|irinotecan|mesh-list
55908612|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55908613|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908614|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55908652|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55908653|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55908654|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
55908655|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908656|NCT03158610|Capecitabine|capecitabine|mesh-list
55908657|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55908658|NCT03158610|Antimetabolites|antimetabolites|mesh-ancestor
55722773|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
55908659|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908660|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908662|NCT00323739|Everolimus|everolimus|mesh-list
55908663|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55908664|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908665|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55908666|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55908667|NCT00323739|Growth Substances|growth substances|mesh-ancestor
55908668|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908669|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
55908670|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55908671|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
55908672|NCT02350218|Alprostadil|alprostadil|mesh-list
55908673|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55908674|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
55908676|NCT00390429|Docetaxel|docetaxel|mesh-list
55908677|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55908678|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55908679|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
55908680|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
55908682|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908683|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55908684|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908685|NCT02349828|Acyclovir|acyclovir|mesh-list
55908686|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
55908687|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908688|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
55908689|NCT02353182|Remifentanil|remifentanil|mesh-list
55908690|NCT02353182|Bupivacaine|bupivacaine|mesh-list
55908691|NCT02353182|Ropivacaine|ropivacaine|mesh-list
55908692|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
55908693|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
55908694|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908695|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908696|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
55908697|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908698|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55908699|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55908700|NCT02353182|Analgesics|analgesics|mesh-ancestor
55908701|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55908702|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55908703|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55908752|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908754|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
55908755|NCT02349282|Calcifediol|calcifediol|mesh-list
55908756|NCT02349282|Vitamins|vitamins|mesh-ancestor
55908757|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
55908758|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908759|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55908760|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55908761|NCT02349204|Zaleplon|zaleplon|mesh-list
55908762|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
55908763|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55908764|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908765|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908766|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
55908767|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
55908769|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908770|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
55908771|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55908807|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908808|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55742792|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55908809|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908810|NCT02345304|Digoxin|digoxin|mesh-list
55908811|NCT02345304|Midazolam|midazolam|mesh-list
55908812|NCT02345304|Omeprazole|omeprazole|mesh-list
55908813|NCT02345304|Warfarin|warfarin|mesh-list
55908814|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55908815|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55908816|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55908817|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908818|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55908819|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55908820|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55908821|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55908826|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908827|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908828|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
55908829|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55908830|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908831|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55908832|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908833|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55908834|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55908851|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
55908852|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
55908854|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
55908855|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55908856|NCT00394329|Beclomethasone|beclomethasone|mesh-list
55908857|NCT00394329|Albuterol|albuterol|mesh-list
55908858|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55908859|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
55908860|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908861|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908862|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55908863|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
55908864|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
55723029|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
55723030|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55723031|NCT00834197|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55723032|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
55723033|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
55723034|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908876|NCT03146052|Simethicone|simethicone|mesh-list
55908877|NCT03146052|Bisacodyl|bisacodyl|mesh-list
55908878|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908879|NCT03146052|Cathartics|cathartics|mesh-ancestor
55908880|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55908881|NCT03146052|Laxatives|laxatives|mesh-ancestor
55742808|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
55908882|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
55908884|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
55908885|NCT01549951|Prednisone|prednisone|mesh-list
55908886|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55908887|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
55908888|NCT01549951|Hormones|hormones|mesh-ancestor
55908889|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55908890|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908891|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55908934|NCT00396201|Plerixafor|plerixafor|mesh-list
55908935|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55908936|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55908937|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
55908938|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908939|NCT03145896|Vitamin D|vitamin d|mesh-list
55908940|NCT03145896|Vitamins|vitamins|mesh-ancestor
55908941|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
55908942|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908943|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55908944|NCT02341872|Calcium|calcium|mesh-list
55908945|NCT02341872|Fluorides|fluorides|mesh-list
55908946|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55908947|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908948|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
55908949|NCT02341872|Protective Agents|protective agents|mesh-ancestor
55908950|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55908952|NCT00360399|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55908953|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55908954|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55908955|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908956|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55908957|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
55908958|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908959|NCT00360399|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55908960|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
55908961|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55908962|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908963|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55908964|NCT00360399|Analgesics|analgesics|mesh-ancestor
55908975|NCT02344602|Febuxostat|febuxostat|mesh-list
55908977|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55908979|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
55908980|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55908981|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908982|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
55908983|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
55908984|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55908985|NCT02348346|Protective Agents|protective agents|mesh-ancestor
55908986|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55908988|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55908989|NCT00361257|Minocycline|minocycline|mesh-list
55908990|NCT00361257|Tetracycline|tetracycline|mesh-list
55908991|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55908992|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55908993|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55908994|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55908995|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55908996|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
55723285|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
55908997|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
55908998|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
55908999|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909027|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55909028|NCT02337192|Curcumin|curcumin|mesh-list
55909029|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55909030|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55909031|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909032|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
55909033|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
55723337|NCT04992026|Prednisone|prednisone|mesh-list
55909034|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55909035|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55909036|NCT02337192|Analgesics|analgesics|mesh-ancestor
55909037|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
55909038|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909039|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909040|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909041|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909042|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909043|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909044|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909045|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
55909046|NCT03111966|Grazoprevir|grazoprevir|mesh-list
55909047|NCT03111966|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55909081|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
55909082|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909083|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55909084|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55742832|NCT04800393|Propofol|propofol|mesh-list
55909086|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
55909087|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909088|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
55909089|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55909091|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55909092|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
55909093|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909094|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55909095|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909096|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909097|NCT02336568|Oxytocin|oxytocin|mesh-list
55909098|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
55909099|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55909100|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909101|NCT05253768|Glycerol|glycerol|mesh-list
55909102|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55909103|NCT05253768|Protective Agents|protective agents|mesh-ancestor
55909104|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909105|NCT04630938|Lidocaine|lidocaine|mesh-list
55909106|NCT04630938|Morphine|morphine|mesh-list
55909107|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
55909108|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
55909109|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909110|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909111|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
55909112|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909113|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55909114|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55909115|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55909116|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55909119|NCT04630938|Narcotics|narcotics|mesh-ancestor
55909120|NCT04630938|Analgesics|analgesics|mesh-ancestor
55909121|NCT04594746|Amiodarone|amiodarone|mesh-list
55909122|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55909123|NCT04594746|Vasodilator Agents|vasodilator agents|mesh-ancestor
55909124|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55909125|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55909126|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909127|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55909128|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55909129|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55909130|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909131|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55909132|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55909133|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55909134|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
55909135|NCT02790138|Vedolizumab|vedolizumab|mesh-list
55909136|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55909137|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909146|NCT02339844|Aripiprazole|aripiprazole|mesh-list
55909172|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909173|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
55909174|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909175|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55909176|NCT02331576|Narcotics|narcotics|mesh-ancestor
55909177|NCT02331576|Analgesics|analgesics|mesh-ancestor
55909178|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55909179|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55909180|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
55909181|NCT00400803|Gemcitabine|gemcitabine|mesh-list
55909182|NCT00400803|Bevacizumab|bevacizumab|mesh-list
55909183|NCT00400803|Carboplatin|carboplatin|mesh-list
55909184|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55909185|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909186|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55909187|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55909188|NCT00400803|Growth Substances|growth substances|mesh-ancestor
55909199|NCT04681443|Phenol|phenol|mesh-list
55909229|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
55909230|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909231|NCT02330952|Prednisone|prednisone|mesh-list
55909232|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909233|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
55909234|NCT02330952|Hormones|hormones|mesh-ancestor
55909235|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909236|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909237|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55909238|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909239|NCT02338830|Progesterone|progesterone|mesh-list
55909240|NCT02338830|Progestins|progestins|mesh-ancestor
55909241|NCT02338830|Hormones|hormones|mesh-ancestor
55909242|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909243|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909244|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55909245|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55909246|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909247|NCT00364377|Incretins|incretins|mesh-ancestor
55909248|NCT00364377|Hormones|hormones|mesh-ancestor
55909249|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909250|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55909251|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
55909252|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909253|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909254|NCT04175886|Tofacitinib|tofacitinib|mesh-list
55909255|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55909256|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909257|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909258|NCT02338674|Tenofovir|tenofovir|mesh-list
55909259|NCT02338674|Telbivudine|telbivudine|mesh-list
55909260|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
55909261|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909262|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55909267|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55909271|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909272|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55909273|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55909274|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55909275|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909276|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909277|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55909278|NCT01826838|Dasatinib|dasatinib|mesh-list
55909279|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909280|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55909282|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909283|NCT00365391|Bevacizumab|bevacizumab|mesh-list
55909284|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55909285|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55909286|NCT00365391|Antibodies|antibodies|mesh-list
55909287|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
55909288|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55909289|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909290|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55909291|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55909292|NCT00365391|Growth Substances|growth substances|mesh-ancestor
55909293|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909332|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909333|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909334|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
55909342|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
55909343|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909344|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909346|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55909400|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55909401|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909403|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
55909404|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
55909405|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909406|NCT00365859|Aripiprazole|aripiprazole|mesh-list
55909407|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
55909408|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55909409|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55909410|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55909411|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909412|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909413|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
55909414|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
55909415|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909416|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909418|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55909455|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55909456|NCT03144882|Analgesics|analgesics|mesh-ancestor
55909457|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
55909458|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909459|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909460|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55909461|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909462|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909463|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909464|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909465|NCT01793259|Methotrexate|methotrexate|mesh-list
55909466|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55909467|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
55909516|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55909517|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55909518|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55909519|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909521|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55909522|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909523|NCT02333838|Fludarabine|fludarabine|mesh-list
55909524|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
55909525|NCT02333838|Busulfan|busulfan|mesh-list
55909526|NCT02333838|Thiotepa|thiotepa|mesh-list
55909527|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909528|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55909529|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
55909530|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909531|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55909532|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
55909533|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909534|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
55909535|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55909572|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909573|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909574|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909575|NCT02333682|Vitamin D|vitamin d|mesh-list
55909576|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
55909577|NCT02333682|Calcifediol|calcifediol|mesh-list
55909578|NCT02333682|Vitamins|vitamins|mesh-ancestor
55909579|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
55909580|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909581|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55909582|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55909583|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55909584|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55909585|NCT02326350|Aspirin|aspirin|mesh-list
55909586|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55909587|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55909588|NCT02326350|Analgesics|analgesics|mesh-ancestor
55909601|NCT02326194|Vaccines|vaccines|mesh-list
55909628|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55909629|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55909630|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55909631|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55909632|NCT03145194|Purinergic Agents|purinergic agents|mesh-ancestor
55723963|NCT04750759|Niclosamide|niclosamide|mesh-list
55909641|NCT02039700|Lesinurad|lesinurad|mesh-list
55909642|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
55909643|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55909644|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
55909645|NCT02039700|Renal Agents|renal agents|mesh-ancestor
55909646|NCT05076474|Orlistat|orlistat|mesh-list
55909647|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909648|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909649|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55909650|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55909651|NCT02328144|Metronidazole|metronidazole|mesh-list
55909652|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909653|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55909654|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55909655|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55909656|NCT02327676|Emtricitabine|emtricitabine|mesh-list
55909657|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
55909658|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55909659|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55909660|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55909661|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909662|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909686|NCT03111186|Narcotics|narcotics|mesh-ancestor
55909687|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909689|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724111|NCT02812667|Nivolumab|nivolumab|mesh-list
55909690|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55909691|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909692|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909694|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909695|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909696|NCT03142620|Vitamin D|vitamin d|mesh-list
55909697|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
55909698|NCT03142620|Amoxicillin|amoxicillin|mesh-list
55909699|NCT03142620|Clarithromycin|clarithromycin|mesh-list
55909700|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
55909701|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55909702|NCT03142620|Esomeprazole|esomeprazole|mesh-list
55909703|NCT03142620|Vitamins|vitamins|mesh-ancestor
55909704|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
55909721|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
55909722|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909724|NCT03110952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909725|NCT03110952|Protective Agents|protective agents|mesh-ancestor
55909726|NCT03110952|Vitamins|vitamins|mesh-ancestor
55909727|NCT03110952|Micronutrients|micronutrients|mesh-ancestor
55909728|NCT03143244|Ketorolac|ketorolac|mesh-list
55909729|NCT03143244|Midazolam|midazolam|mesh-list
55909731|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55909732|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909733|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724273|NCT00873275|Protective Agents|protective agents|mesh-ancestor
55909734|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55909768|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55909769|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55909770|NCT01489189|Growth Substances|growth substances|mesh-ancestor
55909771|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909772|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
55909773|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909774|NCT01549873|Propofol|propofol|mesh-list
55909775|NCT01549873|Desflurane|desflurane|mesh-list
55909776|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55909777|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55909778|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909779|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55909780|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
55909781|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
55909782|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55909783|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
55909784|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
55909785|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909786|NCT04106401|Gasotransmitters|gasotransmitters|mesh-ancestor
55909787|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909788|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909790|NCT01488487|Pasireotide|pasireotide|mesh-list
55909791|NCT01488487|Somatostatin|somatostatin|mesh-list
55909792|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909793|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55909796|NCT01488487|Hormones|hormones|mesh-ancestor
55909819|NCT01516879|Evolocumab|evolocumab|mesh-list
55909820|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55909821|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55909822|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
55909823|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909824|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55724450|NCT00662597|Vadimezan|vadimezan|mesh-list
55909825|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55909826|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909828|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
55909829|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
55909830|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909831|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909832|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55909833|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55909834|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55909835|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55724522|NCT02280629|Mesalamine|mesalamine|mesh-list
55909836|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
55909837|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909872|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
55909873|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
55909874|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909875|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909876|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
55909877|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55909878|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
55909879|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
55909880|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55909881|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55909882|NCT01794273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55909883|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
55909884|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909885|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909886|NCT01794273|Protective Agents|protective agents|mesh-ancestor
55909887|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55909888|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
55909889|NCT01795599|Mifepristone|mifepristone|mesh-list
55909890|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55909891|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
55909892|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55909893|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909894|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55909895|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55910412|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909896|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55909897|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
55909898|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55909899|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55909900|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
55909901|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909902|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
55909903|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55909904|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55909905|NCT01794351|Resveratrol|resveratrol|mesh-list
55909906|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
55909907|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909909|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909910|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909911|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55909913|NCT04409431|Racepinephrine|racepinephrine|mesh-list
55909914|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
55909915|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55909916|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55909917|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
55909918|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55909919|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909920|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909921|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55909934|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
55909935|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
55909936|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909937|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909938|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55909939|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
55909940|NCT01794507|Hormones|hormones|mesh-ancestor
55909941|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55909942|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55909943|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55909944|NCT00412425|Palonosetron|palonosetron|mesh-list
55909945|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
55909946|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
55909947|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55909948|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55909949|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55909950|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55909951|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55909952|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
55909953|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144580|NCT00798720|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55909954|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909955|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
55909956|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55909957|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55909958|NCT05287503|Ambroxol|ambroxol|mesh-list
55909959|NCT05287503|Expectorants|expectorants|mesh-ancestor
55909960|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
55909961|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55909962|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
55909963|NCT00415857|Vaccines|vaccines|mesh-list
55909964|NCT00415857|Sargramostim|sargramostim|mesh-list
55909965|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
55909974|NCT05287191|Digoxin|digoxin|mesh-list
55909983|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
55909984|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55909985|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55909986|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55909987|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55909988|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
55909989|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55909990|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55909991|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55909992|NCT05287191|Protective Agents|protective agents|mesh-ancestor
55909993|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
55909994|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55909995|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55909996|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55909997|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55910557|NCT00389805|Bortezomib|bortezomib|mesh-list
55909998|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55909999|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55910000|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55910001|NCT03491631|Apatinib|apatinib|mesh-list
55910002|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910003|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55910004|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910005|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910006|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
55910007|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55910008|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
55910010|NCT05287035|Dexamethasone|dexamethasone|mesh-list
55910028|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
55910029|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55910030|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55910031|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
55910032|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910033|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910034|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910035|NCT00420459|Aripiprazole|aripiprazole|mesh-list
55910036|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
55910037|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55910038|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55910039|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55910040|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55910041|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910042|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
55910043|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
55910044|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910045|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910046|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55910047|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55910048|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
55724773|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55910055|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
55910056|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910057|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910058|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
55910059|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55910060|NCT00420771|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55910067|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
55910069|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55910070|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55910071|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910072|NCT04750317|Tofacitinib|tofacitinib|mesh-list
55910073|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55910074|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910075|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910076|NCT01996449|Amlodipine|amlodipine|mesh-list
55910077|NCT01996449|Eplerenone|eplerenone|mesh-list
55910078|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55910079|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55910080|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910126|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910127|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55910128|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910129|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910130|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
55910131|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910142|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910143|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55910144|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55910145|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55910146|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55910147|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910148|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910149|NCT01487161|Triamcinolone|triamcinolone|mesh-list
55910150|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55910151|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55910153|NCT01487161|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55910154|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55910155|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
55910156|NCT01487161|Hormones|hormones|mesh-ancestor
55910157|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910158|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910159|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55910160|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
55910161|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910162|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910165|NCT00429507|Analgesics|analgesics|mesh-ancestor
55910176|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910177|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910178|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55910179|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55910180|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
55910181|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
55910182|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55910183|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55910184|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55910185|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910186|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910187|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55910188|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55910189|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910233|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55910234|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910235|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910236|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910237|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
55910238|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55910239|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55910240|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55910241|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55910242|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55910243|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55910244|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55910245|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55910246|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910247|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910248|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910249|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910250|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55910251|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
55910252|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55910253|NCT01484951|Timolol|timolol|mesh-list
55910254|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55910255|NCT01484951|Brinzolamide|brinzolamide|mesh-list
55910256|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55910257|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55910258|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55910259|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
55910267|NCT01484873|Exenatide|exenatide|mesh-list
55910277|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55910278|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55910279|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910280|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
55910281|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910282|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55910283|NCT01513759|Plasminogen|plasminogen|mesh-list
55910284|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55910285|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55910286|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910287|NCT01484561|Tofacitinib|tofacitinib|mesh-list
55910288|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55910290|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910291|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
55910292|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55910293|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
55910294|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910295|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910296|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55910297|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
55910298|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
55910299|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55910300|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
55910301|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910302|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910303|NCT01485991|Simeprevir|simeprevir|mesh-list
55910304|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
55910305|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910306|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
55910307|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910308|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910309|NCT00379821|Azithromycin|azithromycin|mesh-list
55910310|NCT00379821|Artesunate|artesunate|mesh-list
55910311|NCT00379821|Chloroquine|chloroquine|mesh-list
55910315|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55910316|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910317|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
55910318|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55725119|NCT01642732|Everolimus|everolimus|mesh-list
55910319|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55910320|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910321|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
55910322|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
55910323|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55910324|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
55910325|NCT00379821|Amebicides|amebicides|mesh-ancestor
55910326|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55910327|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910328|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910329|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
55910330|NCT01482767|Interferons|interferons|mesh-list
55910331|NCT01482767|Ribavirin|ribavirin|mesh-list
55910332|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
55910333|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
55910334|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55910335|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910336|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
55910337|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910338|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
55910339|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910340|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
55910367|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55910368|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910369|NCT01512745|Apatinib|apatinib|mesh-list
55910370|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910371|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55910372|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910373|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910374|NCT01478321|Bevacizumab|bevacizumab|mesh-list
55910375|NCT01478321|Temozolomide|temozolomide|mesh-list
55910376|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55910377|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910378|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55910379|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55910380|NCT01478321|Growth Substances|growth substances|mesh-ancestor
55910381|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910382|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
55910383|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55910384|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
55910385|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910386|NCT01544491|Everolimus|everolimus|mesh-list
55910394|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55910395|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55910396|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910397|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55910398|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
55910400|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910401|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910402|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55910403|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55910404|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
55910405|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
55910406|NCT00439413|Selegiline|selegiline|mesh-list
55910407|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
55910408|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55910409|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55910410|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55910411|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55910413|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910414|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55910415|NCT00439413|Protective Agents|protective agents|mesh-ancestor
55910416|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910456|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
55910457|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
55910458|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
55910459|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910460|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910461|NCT01796613|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55910462|NCT01796613|Desogestrel|desogestrel|mesh-list
55910463|NCT01796613|Etonogestrel|etonogestrel|mesh-list
55910464|NCT01796613|NuvaRing|nuvaring|mesh-list
55910465|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55910466|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55910467|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55910468|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
55910469|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55910470|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910471|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55910472|NCT01796613|Estrogens|estrogens|mesh-ancestor
55910473|NCT01796613|Hormones|hormones|mesh-ancestor
55910474|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910475|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55910476|NCT01796613|Progestins|progestins|mesh-ancestor
55910477|NCT00442611|Abatacept|abatacept|mesh-list
55910478|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55910479|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910480|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910481|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55910503|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910504|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910505|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55910506|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
55910507|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55910508|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55910509|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55910510|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55910511|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55910512|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
55910513|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55910514|NCT00442689|Diuretics|diuretics|mesh-ancestor
55910515|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
55725381|NCT00561743|Dexamethasone|dexamethasone|mesh-list
55910516|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
55910517|NCT00442689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55910518|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910519|NCT01484977|Lacosamide|lacosamide|mesh-list
55910520|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
55910521|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55910522|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55910523|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910524|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910525|NCT00442767|Insulin|insulin|mesh-list
55910526|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55910527|NCT00442767|Pramlintide|pramlintide|mesh-list
55910528|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
55910529|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910530|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910531|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
55910532|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55910535|NCT00445263|Tirofiban|tirofiban|mesh-list
55910544|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910545|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910546|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55910547|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55910548|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55910549|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55910550|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55910551|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
55910552|NCT04388709|Interferons|interferons|mesh-list
55910553|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910554|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
55910555|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910556|NCT00389805|Pemetrexed|pemetrexed|mesh-list
55910558|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910559|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910561|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55910602|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55910603|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910604|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55910605|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55910606|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55910607|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55910608|NCT01473953|Liraglutide|liraglutide|mesh-list
55910609|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910610|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910611|NCT01473953|Incretins|incretins|mesh-ancestor
55910613|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910663|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55910664|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910665|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910667|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910668|NCT01482169|Adenosine|adenosine|mesh-list
55910669|NCT01482169|Regadenoson|regadenoson|mesh-list
55910670|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55910671|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55910672|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
55910673|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
55725567|NCT03336541|Ketamine|ketamine|mesh-list
55910674|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910675|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910676|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910677|NCT01482169|Analgesics|analgesics|mesh-ancestor
55910721|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910722|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55910723|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55910724|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55910725|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55910726|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910727|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910729|NCT01472081|Ipilimumab|ipilimumab|mesh-list
55910730|NCT01472081|Sunitinib|sunitinib|mesh-list
55910731|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55910732|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910783|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910784|NCT04618523|Artesunate|artesunate|mesh-list
55910785|NCT04618523|Lumefantrine|lumefantrine|mesh-list
55910786|NCT04618523|Artemether|artemether|mesh-list
55725610|NCT00457457|Tamsulosin|tamsulosin|mesh-list
55910787|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55910788|NCT04618523|Amodiaquine|amodiaquine|mesh-list
55910789|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
55910790|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55910791|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55910792|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910793|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910794|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
55910795|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
55910796|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55910797|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
55910798|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55910799|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
55910800|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910801|NCT01479439|Losartan|losartan|mesh-list
55910802|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55910803|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55910804|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55910805|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55910806|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910837|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
55910838|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
55910839|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910840|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
55910841|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55910842|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910843|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
55910844|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55910845|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55910846|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55910847|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55910848|NCT01506271|Imipenem|imipenem|mesh-list
55910849|NCT01506271|Relebactam|relebactam|mesh-list
55910850|NCT01506271|Cilastatin|cilastatin|mesh-list
55910851|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55742928|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
55910852|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910853|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
55910854|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910855|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910856|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55910858|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
55910887|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910888|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55910889|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55910890|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910892|NCT01476475|Insulin|insulin|mesh-list
55910893|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55910894|NCT01476475|Metformin|metformin|mesh-list
55910895|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
55910896|NCT01476475|Lixisenatide|lixisenatide|mesh-list
55910897|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910898|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910899|NCT01460719|Vaccines|vaccines|mesh-list
55910900|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
55910901|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910903|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55910904|NCT00448227|Famciclovir|famciclovir|mesh-list
55910905|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
55910906|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910907|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55910908|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910909|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910910|NCT00529191|Atorvastatin|atorvastatin|mesh-list
55910911|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55910912|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55910913|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
55910914|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910915|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55910916|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55910917|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910930|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55910931|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55910932|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910933|NCT00449007|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55910934|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
55910935|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
55910936|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55910937|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910939|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55910940|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910941|NCT01468181|Dulaglutide|dulaglutide|mesh-list
55910942|NCT01468181|Biguanides|biguanides|mesh-list
55910943|NCT01468181|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
55910944|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
55910945|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910946|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910947|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910948|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910949|NCT01693562|Durvalumab|durvalumab|mesh-list
55910950|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55910951|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910952|NCT00461331|Insulin|insulin|mesh-list
55910953|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55910954|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
55910955|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
55910956|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55910957|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
55910958|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55910959|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910960|NCT00531453|Thalidomide|thalidomide|mesh-list
55910961|NCT00531453|Dexamethasone|dexamethasone|mesh-list
55910962|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
55910963|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
55910964|NCT00531453|Bortezomib|bortezomib|mesh-list
55910965|NCT00531453|BB 1101|bb 1101|mesh-list
55910966|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55910967|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
55910968|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55910969|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55910970|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55910971|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
55910972|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55910973|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55910974|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55910975|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55910976|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
55910977|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
55910978|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55910979|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55910980|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
55910982|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55910983|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55910984|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
55910985|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55910986|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
55910987|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55725885|NCT00360035|Obatoclax|obatoclax|mesh-list
55910988|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55910989|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55910990|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55910991|NCT00531453|Growth Substances|growth substances|mesh-ancestor
55910992|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
55910993|NCT00531843|PENTA|penta|mesh-list
55910994|NCT00531843|Fondaparinux|fondaparinux|mesh-list
55910995|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55910996|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
55911014|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911015|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55911016|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55911017|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55911018|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
55911019|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55911020|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911021|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
55911022|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55911023|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55911024|NCT01692626|Analgesics|analgesics|mesh-ancestor
55911025|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
55911026|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911027|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911028|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55911029|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55911030|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
55911046|NCT01475461|Incretins|incretins|mesh-ancestor
55911069|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55911071|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911072|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55911073|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55911074|NCT01503229|Prednisone|prednisone|mesh-list
55911075|NCT01503229|Cortisone|cortisone|mesh-list
55911076|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
55911077|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55911078|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
55911079|NCT01503229|Hormones|hormones|mesh-ancestor
55911080|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55911081|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911082|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55725899|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911084|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55911085|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911086|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911087|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
55911088|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55911089|NCT01460407|Clarithromycin|clarithromycin|mesh-list
55911090|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55911091|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911092|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55911093|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911094|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911095|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55725935|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911102|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55911103|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55911104|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
55911105|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911106|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55911107|NCT01502293|Interleukin-12|interleukin-12|mesh-list
55911108|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55911109|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
55911110|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911111|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55911112|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55911113|NCT01502293|Growth Substances|growth substances|mesh-ancestor
55911114|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
55911115|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911116|NCT01588184|Bevacizumab|bevacizumab|mesh-list
55911117|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911118|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911119|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55911120|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55911121|NCT01588184|Growth Substances|growth substances|mesh-ancestor
55911123|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
55911154|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55911155|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55911156|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911157|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
55911158|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911159|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
55911160|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911161|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
55911162|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911163|NCT01466387|Vaccines|vaccines|mesh-list
55911164|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
55911165|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911166|NCT00535743|Bromides|bromides|mesh-list
55911167|NCT00535743|Rocuronium|rocuronium|mesh-list
55911168|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
55911169|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55911170|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55911171|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55911172|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911173|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911174|NCT01564784|Cytarabine|cytarabine|mesh-list
55911175|NCT01564784|Fludarabine|fludarabine|mesh-list
55911176|NCT01564784|Mitoxantrone|mitoxantrone|mesh-list
55911177|NCT01564784|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
55911178|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911179|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55911204|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
55911205|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911206|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55911207|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55911208|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
55911209|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911210|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911213|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55911214|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55911216|NCT00536913|Budesonide|budesonide|mesh-list
55911217|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
55911219|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55911261|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911262|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911263|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55911264|NCT01690988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55911265|NCT01690988|Anesthetics, General|anesthetics, general|mesh-ancestor
55911266|NCT01690988|Anesthetics|anesthetics|mesh-ancestor
55911267|NCT01690988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911268|NCT01690988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55911269|NCT01690988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55911270|NCT01690988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911282|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55911283|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55911284|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
55742938|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55911285|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911325|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55911326|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
55911327|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
55911328|NCT04345341|Bupivacaine|bupivacaine|mesh-list
55911329|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
55911330|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
55911331|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911332|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911333|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
55911334|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911335|NCT01465763|Tofacitinib|tofacitinib|mesh-list
55911336|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55911337|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911389|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
55911390|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
55911391|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55911392|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
55911393|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
55911394|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911395|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911396|NCT00541671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726296|NCT02478398|Autonomic Agents|autonomic agents|mesh-ancestor
55911397|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55911398|NCT01563536|Ritonavir|ritonavir|mesh-list
55911399|NCT01563536|Ribavirin|ribavirin|mesh-list
55911400|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55911401|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55911402|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
55911403|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911404|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911405|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55911406|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55911407|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
55911408|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911409|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55911410|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55911411|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
55911440|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911441|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55911442|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911443|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
55911444|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55911445|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
55911446|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911447|NCT03022773|Carotenoids|carotenoids|mesh-list
55911448|NCT03022773|Antioxidants|antioxidants|mesh-ancestor
55911449|NCT03022773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911450|NCT03022773|Protective Agents|protective agents|mesh-ancestor
55726345|NCT05259007|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55911451|NCT03022773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911452|NCT02954991|Nivolumab|nivolumab|mesh-list
55911453|NCT02954991|Mocetinostat|mocetinostat|mesh-list
55911454|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55911455|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911456|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55911457|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911458|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55911460|NCT02892591|Oxycodone|oxycodone|mesh-list
55911461|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55911462|NCT02892591|Narcotics|narcotics|mesh-ancestor
55911463|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911464|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911465|NCT02892591|Analgesics|analgesics|mesh-ancestor
55911466|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
55911467|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911468|NCT00470301|Paclitaxel|paclitaxel|mesh-list
55911469|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
55911486|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55911487|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55911488|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55911489|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911490|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55911491|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
55911492|NCT00544713|Glycerol|glycerol|mesh-list
55911493|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55911494|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55911495|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55911496|NCT00544713|Protective Agents|protective agents|mesh-ancestor
55911497|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911498|NCT00544713|Laxatives|laxatives|mesh-ancestor
55911499|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55911500|NCT00545181|Metronidazole|metronidazole|mesh-list
55911501|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911502|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55911503|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55911504|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55911505|NCT01797315|Sirolimus|sirolimus|mesh-list
55911506|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55911507|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911508|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55911509|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55911510|NCT01797315|Antifungal Agents|antifungal agents|mesh-ancestor
55911539|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55911540|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55911541|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
55911542|NCT01464827|Ritonavir|ritonavir|mesh-list
55911543|NCT01464827|Ribavirin|ribavirin|mesh-list
55911544|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55911545|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55911546|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
55911547|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911548|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911549|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55911550|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55911551|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
55911552|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911553|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55911554|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55911599|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911600|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55911601|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55911729|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55911730|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55911731|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55911732|NCT00478569|Hormones|hormones|mesh-list
55911733|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
55911734|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55911735|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911736|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55911737|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
55911738|NCT00479037|Hormones|hormones|mesh-list
55911739|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
55726543|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
55911744|NCT02985229|Misoprostol|misoprostol|mesh-list
55911745|NCT02985229|Mifepristone|mifepristone|mesh-list
55911746|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55911747|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
55911748|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55911749|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911750|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55911751|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55911752|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
55911753|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55911754|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55726606|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55726607|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
55726608|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726609|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726611|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
55726612|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
55726613|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726614|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726615|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
55726616|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726617|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55726618|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55911758|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55911759|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55911760|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
55911761|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55911762|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
55911763|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55911764|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55911765|NCT00479115|Plerixafor|plerixafor|mesh-list
55911766|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55911767|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55911768|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
55911769|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911770|NCT01472965|Ethanol|ethanol|mesh-list
55911771|NCT01472965|Heparin|heparin|mesh-list
55911772|NCT01472965|Calcium heparin|calcium heparin|mesh-list
55911773|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
55911774|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55911775|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55911776|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911781|NCT00480987|Cytarabine|cytarabine|mesh-list
55726749|NCT04848220|APD791|apd791|mesh-list
55911807|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911808|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911809|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55911811|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
55911812|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911813|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55911814|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55911815|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55911816|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
55911817|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911818|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911819|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55911820|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55911865|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55911866|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55911867|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911868|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911869|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
55911870|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55911871|NCT00554853|Pioglitazone|pioglitazone|mesh-list
55911872|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
55911873|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55911874|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911875|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
55911876|NCT00556491|Minocycline|minocycline|mesh-list
55911877|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55911878|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55911879|NCT02685969|Flutemetamol|flutemetamol|mesh-list
55911880|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55911881|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911882|NCT00483561|Etoposide|etoposide|mesh-list
55911883|NCT00483561|Gefitinib|gefitinib|mesh-list
55911895|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911896|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911897|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
55911898|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911899|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55911900|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55911901|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
55911902|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55911903|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911904|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55726946|NCT00004181|Busulfan|busulfan|mesh-list
55911905|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55911906|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
55911907|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55911908|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
55911909|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
55911910|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
55911911|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55911912|NCT02850081|Atorvastatin|atorvastatin|mesh-list
55911913|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
55911914|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55911915|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55911916|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
55911918|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55911925|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
55911926|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55911927|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911928|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
55911929|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55911930|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55911931|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911932|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55911933|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55911934|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55911935|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55911936|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55911937|NCT01471171|Bromides|bromides|mesh-list
55911938|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
55911939|NCT01471093|Rebamipide|rebamipide|mesh-list
55911940|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55911941|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55911942|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55911943|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55911944|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
55911945|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911946|NCT01471093|Protective Agents|protective agents|mesh-ancestor
55911949|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
55911976|NCT01453855|Travoprost|travoprost|mesh-list
55911977|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55911978|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55911980|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
55911981|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
55911982|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55911983|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55911984|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
55911985|NCT01469065|Vitamins|vitamins|mesh-ancestor
55911986|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
55911987|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55911988|NCT01586156|Carvedilol|carvedilol|mesh-list
55911989|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55911990|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55911991|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
55912005|NCT01459913|Ribavirin|ribavirin|mesh-list
55912035|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55912036|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55912037|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55912038|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912039|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
55912040|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912042|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55912043|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55912044|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55912045|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912046|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55912047|NCT01456169|Diuretics|diuretics|mesh-ancestor
55912048|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
55912093|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912094|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55912097|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
55912098|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55912099|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
55912100|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
55912101|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
55912102|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912103|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912104|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
55912105|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912106|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55912107|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
55912118|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912119|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55912120|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
55912121|NCT01450007|Hormones|hormones|mesh-ancestor
55912122|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912123|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55912124|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912125|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
55912126|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912127|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912129|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
55912130|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912131|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
55912132|NCT01496365|Pregabalin|pregabalin|mesh-list
55912133|NCT01496365|Analgesics|analgesics|mesh-ancestor
55912134|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
55912135|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912136|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912137|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
55912138|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55912139|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55912140|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912141|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55912150|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55912151|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912152|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55912154|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912155|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912156|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
55912157|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55912158|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55912159|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55912160|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55912161|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912162|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
55912163|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912164|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912165|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55912166|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912167|NCT01453153|Gemcitabine|gemcitabine|mesh-list
55912168|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55912169|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
55912170|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912175|NCT01453153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55912176|NCT01453153|Immunologic Factors|immunologic factors|mesh-ancestor
55912177|NCT01453153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912178|NCT01584440|Quinidine|quinidine|mesh-list
55912179|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
55912180|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
55912181|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
55912182|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55912183|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55912184|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912185|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912186|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912187|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55912188|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55912189|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
55912190|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55912191|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
55912192|NCT01584440|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55912193|NCT01584440|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55912194|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912195|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912196|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55912197|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55912198|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
55727343|NCT05446571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912199|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55912200|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55912201|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55912202|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55912203|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55912207|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
55912208|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912209|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912210|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55912211|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55912212|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55912213|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912214|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55912215|NCT01687478|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55913729|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
55912216|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55912217|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55912221|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55912222|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
55912223|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55912224|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55912225|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912226|NCT01468909|Paclitaxel|paclitaxel|mesh-list
55912227|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55912228|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55742967|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
55912229|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912230|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
55912231|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
55912232|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
55912233|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912234|NCT01687166|Acifluorfen|acifluorfen|mesh-list
55912235|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912236|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912237|NCT01561976|Metformin|metformin|mesh-list
55912238|NCT01561976|Glimepiride|glimepiride|mesh-list
55912239|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55912240|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912241|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55912242|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55912243|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
55912244|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55912245|NCT01686932|Vildagliptin|vildagliptin|mesh-list
55912246|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55912247|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912248|NCT01686932|Incretins|incretins|mesh-ancestor
55912249|NCT01686932|Hormones|hormones|mesh-ancestor
55912262|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55912263|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
55912264|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912265|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912266|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
55912267|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55912268|NCT01561898|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55912275|NCT01561898|Serotonin Agents|serotonin agents|mesh-ancestor
55912276|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912277|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912278|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55912279|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55912280|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
55912281|NCT01452529|Hydrocodone|hydrocodone|mesh-list
55912329|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912330|NCT01467661|Anagrelide|anagrelide|mesh-list
55912331|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55912332|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55912333|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912334|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55912335|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55912336|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55912337|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55912338|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55912339|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912340|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55912341|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55912348|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
55912349|NCT01559012|Clonidine|clonidine|mesh-list
55912350|NCT01559012|Analgesics|analgesics|mesh-ancestor
55912351|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
55912361|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912362|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912377|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55912378|NCT01467583|PENTA|penta|mesh-list
55912379|NCT01467583|Fondaparinux|fondaparinux|mesh-list
55912380|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55728162|NCT04796584|Antibodies|antibodies|mesh-list
55912392|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
55912393|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55912394|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55912395|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
55912396|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912397|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912398|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55912399|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
55912400|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
55912401|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55912402|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
55912447|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55912448|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55912449|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
55912450|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912451|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912452|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55912459|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55912460|NCT01451515|Cytarabine|cytarabine|mesh-list
55912461|NCT01451515|Dexamethasone|dexamethasone|mesh-list
55912462|NCT01451515|Prednisone|prednisone|mesh-list
55728368|NCT01038778|Analgesics|analgesics|mesh-ancestor
55912533|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55912534|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
55912535|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
55912536|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912537|NCT01541930|Metronidazole|metronidazole|mesh-list
55912538|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912539|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55912540|NCT01541930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55912541|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55912550|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
55912551|NCT03028298|Citric Acid|citric acid|mesh-list
55912552|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
55912553|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
55912554|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55912555|NCT03028298|Chelating Agents|chelating agents|mesh-ancestor
55912556|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
55912557|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912558|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
55912559|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55912560|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55912561|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912562|NCT03028298|Urological Agents|urological agents|mesh-ancestor
55912563|NCT02986100|Rucaparib|rucaparib|mesh-list
55912583|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912585|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
55912586|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912587|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55912592|NCT01556438|Dexamethasone|dexamethasone|mesh-list
55912628|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55912629|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55912630|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55912631|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912632|NCT01466179|Blinatumomab|blinatumomab|mesh-list
55912640|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
55912641|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55756449|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55728706|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
55912707|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55912708|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912709|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
55912710|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912711|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55912712|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55912713|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
55912714|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912715|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55912716|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55912717|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912718|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
55912719|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55728863|NCT03899961|Oxytocin|oxytocin|mesh-list
55912733|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912734|NCT01572740|Incretins|incretins|mesh-ancestor
55912735|NCT01572740|Hormones|hormones|mesh-ancestor
55912736|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55912737|NCT01491607|Vaccines|vaccines|mesh-list
55912738|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
55742979|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
55912739|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912740|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
55912741|NCT02338713|Antacids|antacids|mesh-ancestor
55912742|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912743|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55912744|NCT00557349|Omeprazole|omeprazole|mesh-list
55912745|NCT00557349|Famotidine|famotidine|mesh-list
55912746|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55912747|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55912765|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55912766|NCT01553084|Autonomic Agents|autonomic agents|mesh-ancestor
55912767|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912768|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912769|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55912770|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55912771|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
55912772|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912773|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912775|NCT01552928|Anagrelide|anagrelide|mesh-list
55912776|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55912777|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912778|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55729055|NCT03158883|Avelumab|avelumab|mesh-list
55912779|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55912780|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912781|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912782|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55912783|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55912784|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55912785|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55912786|NCT01448707|Ritonavir|ritonavir|mesh-list
55912787|NCT01448707|Darunavir|darunavir|mesh-list
55912788|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55912789|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55912790|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
55912791|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912792|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912793|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55729061|NCT03517631|Busulfan|busulfan|mesh-list
55912796|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55912797|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55912798|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55912799|NCT01536704|Nicotine|nicotine|mesh-list
55912800|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55912801|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
55912802|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912803|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912804|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55912805|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55912827|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55912828|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
55912829|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55912830|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55912831|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55912832|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55912833|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55912834|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55912880|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912881|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
55912883|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55912884|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912888|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55912889|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55912891|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
55912892|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55912893|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55912894|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55912895|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55912896|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912897|NCT00490269|Hormones|hormones|mesh-ancestor
55912899|NCT05621655|Vaccines|vaccines|mesh-list
55912932|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
55912933|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912934|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55912941|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
55912942|NCT00491751|Protective Agents|protective agents|mesh-ancestor
55912943|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55912944|NCT01420549|Simvastatin|simvastatin|mesh-list
55912945|NCT01420549|Ezetimibe|ezetimibe|mesh-list
55912946|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55912947|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55912948|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
55912949|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912950|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55912951|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55912952|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912953|NCT01440595|Ribavirin|ribavirin|mesh-list
55912954|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55912955|NCT01440595|Grazoprevir|grazoprevir|mesh-list
55912956|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
55912957|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55912984|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55912985|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
55912986|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55912987|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55912988|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55912989|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55912990|NCT00498615|Fasudil|fasudil|mesh-list
55912991|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55912992|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55912995|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55912996|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
55912997|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55912998|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55912999|NCT00498927|Temozolomide|temozolomide|mesh-list
55913000|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913001|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
55913002|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913003|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913004|NCT05555901|Bevacizumab|bevacizumab|mesh-list
55913005|NCT05555901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913007|NCT05555901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55913008|NCT05555901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55913009|NCT05555901|Growth Substances|growth substances|mesh-ancestor
55913010|NCT05555901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913011|NCT05555901|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913012|NCT00499473|Sunitinib|sunitinib|mesh-list
55913013|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913014|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55913015|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55913016|NCT00499473|Growth Substances|growth substances|mesh-ancestor
55913017|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913018|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913019|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55913020|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913021|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913022|NCT00501891|Bevacizumab|bevacizumab|mesh-list
55913025|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913033|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913034|NCT01798017|Misoprostol|misoprostol|mesh-list
55913035|NCT01798017|Mifepristone|mifepristone|mesh-list
55913036|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55913037|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
55913038|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55913039|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913040|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55913041|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55913048|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55913050|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
55913051|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55913052|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
55913053|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55913054|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55913058|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913059|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55913060|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
55913061|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913062|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913063|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
55913064|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913065|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
55913066|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913067|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55913068|NCT05418777|Trimethoprim|trimethoprim|mesh-list
55913133|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55913134|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55913135|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55913136|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913137|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55913138|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913139|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
55913141|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
55913142|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55913143|NCT00513435|Saracatinib|saracatinib|mesh-list
55913144|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913145|NCT00513435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913146|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913147|NCT00513747|Rituximab|rituximab|mesh-list
55913148|NCT00513747|Fludarabine|fludarabine|mesh-list
55913149|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
55913150|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913158|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913169|NCT00514215|Molgramostim|molgramostim|mesh-list
55913219|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
55913220|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55913221|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913222|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
55913223|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
55913224|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
55913225|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913226|NCT03121677|Poly I-C|poly i-c|mesh-list
55913227|NCT03121677|Rituximab|rituximab|mesh-list
55913228|NCT03121677|Nivolumab|nivolumab|mesh-list
55913229|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55913230|NCT03121677|Poly ICLC|poly iclc|mesh-list
55913231|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913232|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913236|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55913237|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913238|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
55913240|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55913241|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
55913242|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913243|NCT02871687|Simvastatin|simvastatin|mesh-list
55913244|NCT02871687|Pravastatin|pravastatin|mesh-list
55913245|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55913246|NCT02871687|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55913247|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
55913248|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913250|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55913251|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913253|NCT00525057|Tinzaparin|tinzaparin|mesh-list
55913254|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55913255|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
55913284|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913285|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
55913286|NCT00525603|Rituximab|rituximab|mesh-list
55913287|NCT00525603|Fludarabine|fludarabine|mesh-list
55913288|NCT00525603|Fludarabine phosphate|fludarabine phosphate|mesh-list
55913289|NCT00525603|Alemtuzumab|alemtuzumab|mesh-list
55913290|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913291|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
55913292|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913293|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913294|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913295|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
55730444|NCT04457323|Metoprolol|metoprolol|mesh-list
55913300|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55913301|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
55913302|NCT00398307|Cisplatin|cisplatin|mesh-list
55913303|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913304|NCT00564447|Azithromycin|azithromycin|mesh-list
55913305|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
55913306|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55913307|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913308|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55913309|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55913310|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913311|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913355|NCT01572038|Trastuzumab|trastuzumab|mesh-list
55913357|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55913358|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913359|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
55913360|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
55913361|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
55913362|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913363|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913364|NCT01448213|Fluorometholone|fluorometholone|mesh-list
55913365|NCT01448213|Prednisolone|prednisolone|mesh-list
55913366|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55913367|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
55913368|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55730680|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55913377|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55913378|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913379|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
55913380|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
55913381|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913382|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55913383|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55913432|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
55913433|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913434|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913435|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55913436|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55913437|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55913438|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55913439|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55913440|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
55913441|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913442|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55913443|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
55913444|NCT01447433|Calcium|calcium|mesh-list
55913445|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55913446|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913447|NCT01447433|Antacids|antacids|mesh-ancestor
55913449|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55913489|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913490|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913491|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
55913492|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913493|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913494|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55913495|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55913496|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55913497|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55913498|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913499|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55913500|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913501|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
55913502|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
55913503|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
55913505|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55913506|NCT01446809|Ifosfamide|ifosfamide|mesh-list
55913507|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
55913508|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55913509|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913510|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55913511|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55913512|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730757|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55913526|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
55913527|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913528|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913529|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55913530|NCT04387929|Antibodies|antibodies|mesh-list
55913531|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
55913532|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913533|NCT05361291|Dexamethasone|dexamethasone|mesh-list
55913534|NCT05361291|Lidocaine|lidocaine|mesh-list
55913535|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55913536|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
55913537|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
55913538|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913539|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913540|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55913541|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
55913542|NCT05361291|Hormones|hormones|mesh-ancestor
55913543|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55913544|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55913545|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913546|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913547|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
55913548|NCT05361291|Anesthetics|anesthetics|mesh-ancestor
55913549|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55913551|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55913552|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55913553|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55913554|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55913555|NCT01445951|Insulin|insulin|mesh-list
55913556|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55913558|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55913559|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913560|NCT03169101|Nicotine|nicotine|mesh-list
55913561|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55913562|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
55913563|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913564|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913565|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55913566|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55913567|NCT03169101|Cholinergic Agents|cholinergic agents|mesh-ancestor
55913568|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913569|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913570|NCT03072771|Cytarabine|cytarabine|mesh-list
55913571|NCT03072771|Etoposide|etoposide|mesh-list
55913572|NCT03072771|Melphalan|melphalan|mesh-list
55913573|NCT03072771|Carmustine|carmustine|mesh-list
55913575|NCT03072771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55913576|NCT03072771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913577|NCT03072771|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55913578|NCT03072771|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55913579|NCT03072771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913580|NCT03072771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913586|NCT03072771|Immunologic Factors|immunologic factors|mesh-ancestor
55913587|NCT03072771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913588|NCT03072771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913598|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55913599|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913600|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913601|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913602|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55913603|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55913604|NCT05214339|Bevacizumab|bevacizumab|mesh-list
55913605|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913606|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913660|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913662|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913663|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
55913664|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913665|NCT00569673|Docetaxel|docetaxel|mesh-list
55913666|NCT00569673|Trabectedin|trabectedin|mesh-list
55913667|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913668|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
55913669|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
55913670|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
55913671|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913672|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913673|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
55913674|NCT01551212|Everolimus|everolimus|mesh-list
55913675|NCT01551212|Tacrolimus|tacrolimus|mesh-list
55913676|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913718|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
55913719|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55913720|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913721|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913722|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913728|NCT00574587|Paclitaxel|paclitaxel|mesh-list
55913733|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55913734|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913735|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
55913736|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
55913737|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
55913772|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55913773|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55913775|NCT00604461|Carboplatin|carboplatin|mesh-list
55913776|NCT00604461|Pemetrexed|pemetrexed|mesh-list
55913777|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913778|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913779|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55913780|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55913781|NCT00604461|Growth Substances|growth substances|mesh-ancestor
55913782|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913783|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913784|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913785|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913786|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55913787|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55913788|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55913789|NCT04417569|Estradiol|estradiol|mesh-list
55913790|NCT04417569|Progesterone|progesterone|mesh-list
55913791|NCT04417569|Hormones|hormones|mesh-ancestor
55913792|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730983|NCT03130855|Carticaine|carticaine|mesh-list
55913798|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
55913799|NCT00606489|Ibuprofen|ibuprofen|mesh-list
55913800|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55913801|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55913802|NCT00606489|Analgesics|analgesics|mesh-ancestor
55913803|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
55913804|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913805|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913806|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55913807|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913811|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55913812|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55913813|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55913814|NCT00578331|Analgesics|analgesics|mesh-ancestor
55913815|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
55913816|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913817|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913818|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55913819|NCT00578331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913820|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55913821|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55913822|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55913823|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
55913824|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
55913825|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913826|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913827|NCT00607113|Bevacizumab|bevacizumab|mesh-list
55913828|NCT00607113|Everolimus|everolimus|mesh-list
55913829|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913830|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913831|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55913832|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55913833|NCT00607113|Growth Substances|growth substances|mesh-ancestor
55913834|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913835|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
55913836|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913837|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
55913838|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55913839|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55913840|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913841|NCT01549964|Incretins|incretins|mesh-ancestor
55913842|NCT01549964|Hormones|hormones|mesh-ancestor
55913843|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55913844|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55913846|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913847|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913848|NCT00579111|Fludarabine|fludarabine|mesh-list
55913850|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
55913851|NCT00579111|Tacrolimus|tacrolimus|mesh-list
55913853|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913854|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55913855|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
55913856|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913857|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55913858|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55913859|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
55913860|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55913861|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55913862|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55913863|NCT04363437|Colchicine|colchicine|mesh-list
55913864|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
55913902|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
55913903|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913904|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55913905|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55731051|NCT02820961|Exemestane|exemestane|mesh-list
55913928|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913930|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
55913931|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55913932|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
55913933|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
55913934|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55913935|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
55913936|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
55913937|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55913938|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
55913939|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913940|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913941|NCT01549652|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55913942|NCT01549652|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55913943|NCT01549652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55913944|NCT01549652|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55913945|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55913947|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
55913948|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
55913949|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55913950|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55913951|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913952|NCT01534520|Lidocaine|lidocaine|mesh-list
55913953|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
55913954|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
55913965|NCT00611325|Bortezomib|bortezomib|mesh-list
55913980|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913981|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
55913982|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55913983|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
55913984|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55913985|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55913986|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55913987|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55913988|NCT01534208|Enclomiphene|enclomiphene|mesh-list
55913989|NCT01534208|Clomiphene|clomiphene|mesh-list
55913990|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
55913991|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55913992|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
55913993|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55913994|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55913995|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55913996|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
55913997|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55913998|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55913999|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55914000|NCT01548638|Galantamine|galantamine|mesh-list
55914001|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55914002|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914003|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914029|NCT02740179|Diuretics|diuretics|mesh-ancestor
55914030|NCT02740179|Natriuretic Agents|natriuretic agents|mesh-ancestor
55914031|NCT02740179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55914032|NCT01533428|Capsaicin|capsaicin|mesh-list
55914033|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
55914034|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
55914035|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
55914036|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914037|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914044|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55914045|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914046|NCT04066725|Analgesics|analgesics|mesh-ancestor
55914047|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
55914048|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914049|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914058|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
55914097|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914098|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55914099|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55914100|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
55914101|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
55914102|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914103|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914104|NCT00583011|Anesthetics|anesthetics|mesh-list
55914105|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914106|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914107|NCT01547390|Aspirin|aspirin|mesh-list
55914108|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55914109|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914110|NCT01547390|Analgesics|analgesics|mesh-ancestor
55914147|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
55914148|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914149|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914150|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
55914151|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914152|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55914153|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55914154|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55914155|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55914156|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914157|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55914158|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914159|NCT00617097|Analgesics|analgesics|mesh-ancestor
55914160|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55914164|NCT01532414|Enclomiphene|enclomiphene|mesh-list
55914201|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55914202|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55914203|NCT01575899|Renal Agents|renal agents|mesh-ancestor
55914207|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55914208|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55914209|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55914210|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55914211|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55914212|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55914213|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
55914214|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914215|NCT00620061|Lubiprostone|lubiprostone|mesh-list
55914216|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55914217|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743002|NCT05555797|Keratolytic Agents|keratolytic agents|mesh-ancestor
55914218|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914219|NCT04122443|Acetaminophen|acetaminophen|mesh-list
55914221|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914222|NCT04122443|Analgesics|analgesics|mesh-ancestor
55914223|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
55914224|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914225|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914226|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
55914227|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55914228|NCT04122443|Narcotics|narcotics|mesh-ancestor
55914229|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914230|NCT00587769|Bupropion|bupropion|mesh-list
55914231|NCT00587769|Varenicline|varenicline|mesh-list
55914232|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55914233|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
55914245|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55914246|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55914247|NCT00587769|Cholinergic Agents|cholinergic agents|mesh-ancestor
55914248|NCT00623181|Vaccines|vaccines|mesh-list
55914249|NCT00623181|Immunologic Factors|immunologic factors|mesh-ancestor
55914250|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914251|NCT03433833|Digoxin|digoxin|mesh-list
55914252|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55914255|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914256|NCT03433833|Protective Agents|protective agents|mesh-ancestor
55914257|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914258|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
55914259|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
55914260|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
55914261|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55914262|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
55914263|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914264|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914265|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55914266|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
55914267|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55914269|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55914296|NCT05247177|Ketamine|ketamine|mesh-list
55914297|NCT05247177|Anesthetics|anesthetics|mesh-list
55914298|NCT05247177|Sevoflurane|sevoflurane|mesh-list
55914299|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914300|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914301|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55914302|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914303|NCT05247177|Analgesics|analgesics|mesh-ancestor
55914304|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
55914305|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914306|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55914307|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55914308|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55914309|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
55914310|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914311|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914312|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55914313|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55914314|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
55914315|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55914316|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55914317|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55914318|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55914319|NCT00624195|Etravirine|etravirine|mesh-list
55914320|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55914321|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55914322|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55914342|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55914343|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
55914344|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55914345|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55914346|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55914347|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55914348|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55914349|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55914350|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55914351|NCT02140593|Rocuronium|rocuronium|mesh-list
55914352|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55914353|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55914354|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55914355|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914356|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914357|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
55914358|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55914359|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55914360|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55914361|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55914362|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914363|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
55914364|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914389|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55914390|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914391|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55914392|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
55914393|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55914394|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55914395|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
55914546|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55914396|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914397|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
55914398|NCT02776605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914399|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55914400|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55914401|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
55914402|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914403|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55914404|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55914405|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
55914406|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
55914407|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
55914408|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55731370|NCT03502343|Gemcitabine|gemcitabine|mesh-list
55914410|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55914411|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55914412|NCT00627861|Metoprolol|metoprolol|mesh-list
55914413|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55914414|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55914415|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
55914434|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
55914435|NCT00669279|Protective Agents|protective agents|mesh-ancestor
55914436|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55914437|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55914438|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55914439|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
55914440|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55914441|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55914442|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55914443|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
55914444|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
55914445|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914446|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55914447|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
55914448|NCT02394795|Leucovorin|leucovorin|mesh-list
55914449|NCT02394795|Bevacizumab|bevacizumab|mesh-list
55914450|NCT02394795|Panitumumab|panitumumab|mesh-list
55914451|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
55914452|NCT02394795|Fluorouracil|fluorouracil|mesh-list
55914453|NCT02394795|Calcium|calcium|mesh-list
55914454|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
55914455|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55914456|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914457|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55914458|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55914459|NCT02394795|Growth Substances|growth substances|mesh-ancestor
55914460|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914461|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
55914462|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55914478|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914480|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914481|NCT04409522|Melatonin|melatonin|mesh-list
55914482|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
55914483|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914484|NCT04409522|Protective Agents|protective agents|mesh-ancestor
55914485|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914486|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914487|NCT00672243|Sirolimus|sirolimus|mesh-list
55914488|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55914489|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914490|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55914491|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914492|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914535|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
55914536|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
55914537|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
55914538|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914539|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55914540|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
55914541|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914542|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914543|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55914544|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
55914545|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55914547|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
55914549|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55914550|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
55914551|NCT00631449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914552|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55914553|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55914554|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914555|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914556|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
55914557|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55914558|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55914559|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
55914560|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914561|NCT01440101|Natalizumab|natalizumab|mesh-list
55914562|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
55914563|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914564|NCT01530464|Ambrisentan|ambrisentan|mesh-list
55914565|NCT01530464|Aminophylline|aminophylline|mesh-list
55914566|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55914567|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55914568|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
55914571|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55914574|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55914575|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914576|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914577|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55914578|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55914579|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
55914580|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914581|NCT01530464|Protective Agents|protective agents|mesh-ancestor
55914582|NCT00633399|Ziprasidone|ziprasidone|mesh-list
55914583|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55914584|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
55914585|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914586|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914587|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731437|NCT05150431|Analgesics|analgesics|mesh-ancestor
55914590|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914591|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55914592|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55914593|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
55914594|NCT01077843|Etoricoxib|etoricoxib|mesh-list
55914595|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
55914596|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55914597|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55914599|NCT01077843|Analgesics|analgesics|mesh-ancestor
55914622|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55914623|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55914624|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
55914625|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914626|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55914627|NCT00674115|Omeprazole|omeprazole|mesh-list
55914628|NCT00674115|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
55914629|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55914630|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55914631|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55914632|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914633|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914634|NCT02142153|Olorofim|olorofim|mesh-list
55914635|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
55914636|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914637|NCT00674583|Vaccines|vaccines|mesh-list
55914638|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
55914639|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914640|NCT01420081|Gedatolisib|gedatolisib|mesh-list
55914641|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55914642|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914662|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914663|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914664|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55914665|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
56144582|NCT00798720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914666|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55914667|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914668|NCT01439555|Simvastatin|simvastatin|mesh-list
55914669|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55914670|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55914671|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
55914672|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914673|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55914674|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55914675|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914676|NCT00674739|Imiquimod|imiquimod|mesh-list
55914677|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55914685|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914686|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914687|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55914688|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55914689|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55914690|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55914691|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
55914692|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
55914693|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
55914694|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
55914695|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914696|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914697|NCT03027908|Fluorides|fluorides|mesh-list
55914698|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
55914699|NCT03027908|Protective Agents|protective agents|mesh-ancestor
55914700|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914701|NCT00638937|Saracatinib|saracatinib|mesh-list
55914702|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55914703|NCT00638937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914704|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914705|NCT01439009|Tolvaptan|tolvaptan|mesh-list
55914706|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55914708|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
55914723|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914724|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914725|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55914726|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914728|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
55914729|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914730|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55914731|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914732|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55914733|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55914734|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
55914735|NCT01571453|Vortioxetine|vortioxetine|mesh-list
55914736|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55914737|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55914738|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55914739|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55914740|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914741|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914742|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914743|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55914744|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
55914770|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
55914771|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55914772|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55914773|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914774|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914775|NCT01444651|Urological Agents|urological agents|mesh-ancestor
55914776|NCT01570751|Insulin|insulin|mesh-list
55914777|NCT01570751|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55914778|NCT01570751|Insulin Glargine|insulin glargine|mesh-list
55914779|NCT01570751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55914780|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914781|NCT01419535|Mifepristone|mifepristone|mesh-list
55914782|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55914783|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
55914784|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55914785|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914786|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55914787|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55914788|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55915032|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
55914790|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55914791|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55914792|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
55914793|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55914794|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
55914795|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55914796|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55914816|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
55914817|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914818|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914819|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55914821|NCT02075125|Ticagrelor|ticagrelor|mesh-list
55914822|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55914823|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55914824|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55914825|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55914826|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55914827|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
55914828|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914829|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914830|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914831|NCT00678015|Masoprocol|masoprocol|mesh-list
55914832|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
55914833|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914834|NCT00678015|Protective Agents|protective agents|mesh-ancestor
55914835|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914836|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
55914837|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55914838|NCT00678015|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55914839|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55914840|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55914841|NCT00678015|Analgesics|analgesics|mesh-ancestor
55914842|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
55914843|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914844|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55914845|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914846|NCT01437995|Fluticasone|fluticasone|mesh-list
55914857|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
55914858|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55914859|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55914860|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55914861|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55914862|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
55914863|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914864|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914865|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
55914866|NCT01437995|Hormones|hormones|mesh-ancestor
55914867|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55914868|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
55914869|NCT00641745|Risperidone|risperidone|mesh-list
55914870|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55914871|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55914872|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
55914873|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914874|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914875|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914876|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55914909|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55914910|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55914911|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
55914912|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914913|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
55914915|NCT00588159|Gabapentin|gabapentin|mesh-list
55914916|NCT00588159|Analgesics|analgesics|mesh-ancestor
55914917|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
55914918|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914919|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914920|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
55914921|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55914922|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55914923|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914924|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55914925|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55914926|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55914927|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914928|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914929|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
55914930|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55914931|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55914932|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
55914933|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
55914934|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
55914935|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
55914936|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55914937|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55914938|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
55914939|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
55914940|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55914941|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
55914953|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55914954|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914955|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
55914956|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55914957|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55914958|NCT00589329|Metronidazole|metronidazole|mesh-list
55914959|NCT00589329|Erythromycin|erythromycin|mesh-list
55914960|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
55914961|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55914962|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
55914963|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55914979|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55914980|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55914981|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
55914982|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55914983|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55914984|NCT00589563|Sirolimus|sirolimus|mesh-list
55914985|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
55914986|NCT00589563|Melphalan|melphalan|mesh-list
55914987|NCT00589563|Methotrexate|methotrexate|mesh-list
55914988|NCT00589563|Fludarabine|fludarabine|mesh-list
55914989|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
55914990|NCT00589563|Etoposide|etoposide|mesh-list
55914991|NCT00589563|Tacrolimus|tacrolimus|mesh-list
55914992|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55914993|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55914994|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
55914995|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55914996|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55914997|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55914998|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
55914999|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915000|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915001|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55915002|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55915003|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
55915004|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55915005|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55915006|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
55915007|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
55915008|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915009|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55915010|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55915014|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55915015|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55915016|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915017|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55915018|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
55915019|NCT00645333|Docetaxel|docetaxel|mesh-list
55915020|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915021|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
55915022|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
55915023|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
55915024|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915025|NCT00646581|Insulin|insulin|mesh-list
55915026|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55915027|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55915028|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915029|NCT00648375|Propranolol|propranolol|mesh-list
55915030|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55915031|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55915033|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915034|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915067|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915068|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55915069|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55915070|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
55915071|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915072|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55915073|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55915074|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55915075|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55915076|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55915077|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55915078|NCT01438489|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55915079|NCT01438489|Immunologic Factors|immunologic factors|mesh-ancestor
55915080|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915081|NCT00654927|4-Aminopyridine|4-aminopyridine|mesh-list
55915082|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55915083|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55915084|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915086|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55915087|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
55915088|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915089|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915090|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55915091|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
55915092|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55915093|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55915094|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55915095|NCT01418209|Estradiol|estradiol|mesh-list
55915096|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55915097|NCT01418209|Progesterone|progesterone|mesh-list
55915098|NCT01418209|Estrogens|estrogens|mesh-ancestor
55915099|NCT01418209|Hormones|hormones|mesh-ancestor
55915100|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55915101|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915102|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55915103|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
55915104|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55915105|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55915106|NCT01418209|Progestins|progestins|mesh-ancestor
55915107|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55915108|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55915109|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55915110|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915111|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144583|NCT00799578|Cysteamine|cysteamine|mesh-list
55915112|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55915113|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
55915114|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55915115|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
55915116|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55915117|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55915118|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
55915119|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915120|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55915121|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55915122|NCT01417195|Menotropins|menotropins|mesh-list
55915123|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55915124|NCT01417195|Hormones|hormones|mesh-ancestor
55915126|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915145|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55915146|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
55915147|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915148|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915149|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55915150|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
55915151|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915152|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915153|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55915154|NCT01438177|Amebicides|amebicides|mesh-ancestor
55915155|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55915157|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915158|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
55915159|NCT01442779|Interferons|interferons|mesh-list
55915160|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
55915161|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915162|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
55915163|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915165|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915167|NCT01436201|Digoxin|digoxin|mesh-list
55915199|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
55915200|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55915201|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
55915202|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915203|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915204|NCT01416181|Natalizumab|natalizumab|mesh-list
55915205|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
55915206|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915207|NCT03026023|Ribavirin|ribavirin|mesh-list
55915208|NCT03026023|Grazoprevir|grazoprevir|mesh-list
55915209|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
55915210|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915211|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
55915212|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915213|NCT01441765|Pidilizumab|pidilizumab|mesh-list
55915261|NCT04069273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915262|NCT04069273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915263|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55915264|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55915265|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915266|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55915267|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55915268|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55915269|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915270|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
55915271|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915273|NCT04063267|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55915274|NCT04063267|Autonomic Agents|autonomic agents|mesh-ancestor
55915275|NCT04063267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915276|NCT04063267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915277|NCT04063267|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55915278|NCT04063267|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55915317|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915318|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55915319|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
55915321|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55915322|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55915323|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55915324|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
55915325|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
55915326|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
55915327|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915328|NCT02074735|Choline|choline|mesh-list
55915329|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55915330|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
55915331|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55915332|NCT02074735|Antimetabolites|antimetabolites|mesh-ancestor
55915333|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915334|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55915371|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55915372|NCT01514240|Analgesics|analgesics|mesh-ancestor
55915373|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
55915374|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915375|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915376|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55915377|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915378|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55915379|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
55915380|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55731878|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
55915381|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55915382|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915432|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55915433|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
55915434|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
55915436|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915438|NCT01414075|Trace Elements|trace elements|mesh-ancestor
55915439|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
55915440|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915441|NCT01513460|Glycopyrrolate|glycopyrrolate|mesh-list
55915442|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
55915443|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55915444|NCT01513460|Autonomic Agents|autonomic agents|mesh-ancestor
55915445|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915446|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915447|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55915448|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
55915449|NCT01513460|Parasympatholytics|parasympatholytics|mesh-ancestor
55915450|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55915451|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
55915452|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915453|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915454|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55915455|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55731937|NCT02319941|Ticagrelor|ticagrelor|mesh-list
55915464|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
55915465|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915466|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915467|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55915468|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55915469|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
55915470|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55915471|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55732025|NCT03821545|Analgesics|analgesics|mesh-ancestor
55915472|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55915473|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55915474|NCT01417481|Glycine|glycine|mesh-list
55915475|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
55915476|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915477|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915478|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915479|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
55915480|NCT01392469|Bosentan|bosentan|mesh-list
55915481|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
55915483|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55915484|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915485|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915486|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
55915487|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55915488|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55915489|NCT01392469|Urological Agents|urological agents|mesh-ancestor
55915490|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55915491|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55915493|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55915495|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915497|NCT01435577|Analgesics|analgesics|mesh-ancestor
55915498|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
55915499|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915500|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55915501|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55915502|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55915503|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915504|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
55915505|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915506|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
55915507|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
55732224|NCT04034459|Vitamins|vitamins|mesh-ancestor
55915509|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55915510|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915511|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915512|NCT04039087|Urological Agents|urological agents|mesh-ancestor
55915513|NCT01411891|Chlorhexidine|chlorhexidine|mesh-list
55915514|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55915515|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915516|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
55915551|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55915552|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55915553|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55915554|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
55915555|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915556|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915557|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915558|NCT01544114|Naproxen|naproxen|mesh-list
55915559|NCT01544114|Esomeprazole|esomeprazole|mesh-list
55915560|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55915562|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55915563|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915564|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915565|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55915566|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55915608|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55915609|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915610|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55915611|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915612|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915613|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
55915614|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915616|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55915617|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55915618|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915619|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55915620|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55915621|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55915622|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55915623|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915624|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915660|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55915661|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55915662|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915663|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55915664|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55915665|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915666|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
55915667|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55915668|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
55732493|NCT02616055|XL647|xl647|mesh-list
55915669|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55915670|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
55915671|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
55915672|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55915673|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55915674|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55915675|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915676|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915677|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55915678|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55915679|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915716|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915717|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55915718|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
55915719|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55915720|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55915721|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
55915722|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915723|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
55915724|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915725|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55915726|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55915727|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55915728|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55915729|NCT01390441|Analgesics|analgesics|mesh-ancestor
55915730|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
55915732|NCT01390441|Antipyretics|antipyretics|mesh-ancestor
55915733|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55915734|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
55915735|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
55915773|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55915774|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55915775|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
55915776|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915777|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915778|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55915779|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915780|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55915781|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
55915782|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
55915783|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915784|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55915785|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
55915786|NCT01412879|Hormones|hormones|mesh-ancestor
55915787|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55915788|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55915789|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55915790|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55915791|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55915792|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915793|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55915794|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
55915795|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55915796|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55915797|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
55915798|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
55915818|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
55915819|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915820|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55915821|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55915822|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55915823|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
55915824|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915825|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915826|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55915827|NCT03142776|Clarithromycin|clarithromycin|mesh-list
55915828|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915829|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55915830|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55915831|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915832|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55915833|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55915874|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55915875|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55915876|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55915877|NCT04051957|Diuretics|diuretics|mesh-ancestor
55915878|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
55915879|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915880|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
55915881|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55915882|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915883|NCT05084196|Melatonin|melatonin|mesh-list
55915884|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
55915885|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915886|NCT05084196|Protective Agents|protective agents|mesh-ancestor
55915887|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915888|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915889|NCT00591123|Leucovorin|leucovorin|mesh-list
55915890|NCT00591123|Fluorouracil|fluorouracil|mesh-list
55915891|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
55915893|NCT00591123|Levoleucovorin|levoleucovorin|mesh-list
55915894|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915895|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
55915896|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915897|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55915898|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915899|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55915900|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
55915901|NCT00591123|Antidotes|antidotes|mesh-ancestor
55915902|NCT00591123|Protective Agents|protective agents|mesh-ancestor
55915903|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
55915904|NCT00591123|Vitamins|vitamins|mesh-ancestor
55915905|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
55915915|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55915916|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915917|NCT00591825|Renal Agents|renal agents|mesh-ancestor
55915918|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55915919|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
55915920|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55915922|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915923|NCT01429285|Hydromorphone|hydromorphone|mesh-list
55915924|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55915925|NCT01429285|Narcotics|narcotics|mesh-ancestor
55915926|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55915927|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915928|NCT01429285|Analgesics|analgesics|mesh-ancestor
55915929|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
55915930|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55915931|NCT00594945|Clonazepam|clonazepam|mesh-list
55915932|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
55915933|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
55915935|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55915970|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55915971|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55915972|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
55915973|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55915974|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55915975|NCT03968562|Emollients|emollients|mesh-ancestor
55915976|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
55915977|NCT03425292|Bevacizumab|bevacizumab|mesh-list
55915979|NCT03425292|Ipilimumab|ipilimumab|mesh-list
55915980|NCT03425292|Temozolomide|temozolomide|mesh-list
55915981|NCT03425292|Lomustine|lomustine|mesh-list
55915982|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55915983|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55915984|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55915985|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55915986|NCT03425292|Growth Substances|growth substances|mesh-ancestor
55915987|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55915988|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
55915989|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55915990|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55915992|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
55916027|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916028|NCT01428193|Progestins|progestins|mesh-ancestor
55916029|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
55916030|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
55916031|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55916032|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916033|NCT03864276|Propofol|propofol|mesh-list
55916034|NCT03864276|Desflurane|desflurane|mesh-list
55916035|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
55916036|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916037|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916038|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55916039|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55916040|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
55916041|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55916042|NCT05083026|Antibodies|antibodies|mesh-list
55916043|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
55916044|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
55916045|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916046|NCT03141918|Curcumin|curcumin|mesh-list
55916047|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55916048|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55916049|NCT03141918|Analgesics|analgesics|mesh-ancestor
55916050|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
55916053|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55916078|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55916079|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55916080|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
55916081|NCT03139500|Anesthetics|anesthetics|mesh-ancestor
55916082|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
55916083|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
55916084|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916085|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916086|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55916087|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55916088|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55916089|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55916090|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55916091|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
55916092|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916093|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916094|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916096|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55916136|NCT03768414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916137|NCT03768414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916138|NCT03768414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55916139|NCT03768414|Immunologic Factors|immunologic factors|mesh-ancestor
55916140|NCT03768414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916141|NCT04044001|Isoniazid|isoniazid|mesh-list
55916142|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
55916143|NCT04044001|Ethambutol|ethambutol|mesh-list
55916144|NCT04044001|Dolutegravir|dolutegravir|mesh-list
55916145|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
55916146|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55916147|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916148|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916149|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916150|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55916151|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55916152|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
55916153|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55916154|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55916155|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55916156|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55916157|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55916158|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
55916159|NCT00684723|Lovastatin|lovastatin|mesh-list
55916160|NCT00684723|L 647318|l 647318|mesh-list
55916161|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
55916162|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55916163|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55916164|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
55916166|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55916181|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916183|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
55916184|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55916185|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916187|NCT04387539|Simeprevir|simeprevir|mesh-list
55916188|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
55916189|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916190|NCT04387539|Protease Inhibitors|protease inhibitors|mesh-ancestor
55916191|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916192|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916193|NCT00664755|Nicotine|nicotine|mesh-list
55916194|NCT00664755|Varenicline|varenicline|mesh-list
55916195|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55916196|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
55916197|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916198|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916199|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55916200|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55916201|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
55916202|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916203|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916204|NCT01525628|Tolbutamide|tolbutamide|mesh-list
55916205|NCT01525628|Interferons|interferons|mesh-list
55916206|NCT01525628|Tenofovir|tenofovir|mesh-list
55916207|NCT01525628|Ribavirin|ribavirin|mesh-list
55916208|NCT01525628|Midazolam|midazolam|mesh-list
55916209|NCT01525628|Caffeine|caffeine|mesh-list
55916210|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916211|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
55916229|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916230|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55916231|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55916232|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
55916233|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55916234|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55916235|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55916236|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55916237|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
55916238|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55916239|NCT00665457|Celecoxib|celecoxib|mesh-list
55916241|NCT00665457|Docetaxel|docetaxel|mesh-list
55916242|NCT00665457|Doxorubicin|doxorubicin|mesh-list
55916243|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55916244|NCT00665457|Capecitabine|capecitabine|mesh-list
55916245|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55916246|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
55916247|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916248|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55916249|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55916250|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
55916251|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916252|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916253|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55916254|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
55916255|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
55916256|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
55916257|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55916258|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55916259|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55916276|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55916277|NCT02320695|Ethanol|ethanol|mesh-list
55916278|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916279|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
55916280|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55916281|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916282|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916283|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55916284|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916285|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916286|NCT01426009|Bromides|bromides|mesh-list
55916287|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
55916288|NCT01426009|Ipratropium|ipratropium|mesh-list
55916289|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55732845|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
55916290|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
55916291|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916335|NCT03473574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916336|NCT03473574|Antiviral Agents|antiviral agents|mesh-ancestor
55916337|NCT03473574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916338|NCT03473574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916339|NCT03473574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55916340|NCT03473574|Immunologic Factors|immunologic factors|mesh-ancestor
55916341|NCT03473574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916342|NCT03473574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55916343|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
55916344|NCT01404949|Tretinoin|tretinoin|mesh-list
55916345|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916351|NCT00601965|Citalopram|citalopram|mesh-list
55916398|NCT00602355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55916399|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55916400|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55916401|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916402|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916403|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
55916404|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916405|NCT01425463|Glycine|glycine|mesh-list
55916406|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
55916407|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916408|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916409|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916410|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55916411|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
55916412|NCT02144259|Etonogestrel|etonogestrel|mesh-list
55916413|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55732939|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
55916414|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55916415|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55916416|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
55916417|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55916418|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916419|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55916420|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55916421|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55916422|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55916423|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916430|NCT01388647|Carboplatin|carboplatin|mesh-list
55916431|NCT01388647|Trastuzumab|trastuzumab|mesh-list
55916432|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916433|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55916435|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55916436|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916437|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733138|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
55916438|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55916441|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55916442|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55916443|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916444|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916445|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916446|NCT04508634|Metformin|metformin|mesh-list
55916447|NCT04508634|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55916448|NCT04508634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916449|NCT00705003|Melatonin|melatonin|mesh-list
55916450|NCT00705003|Buspirone|buspirone|mesh-list
55916451|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
55916452|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916453|NCT00705003|Protective Agents|protective agents|mesh-ancestor
55916454|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916455|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916466|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916468|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55916469|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
55916470|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916471|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916472|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55916473|NCT00690495|Propofol|propofol|mesh-list
55916474|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55916475|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916476|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916477|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55916478|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
55916479|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
55916480|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55916482|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55916483|NCT00691197|Protective Agents|protective agents|mesh-ancestor
55916484|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916485|NCT00691197|Laxatives|laxatives|mesh-ancestor
55916486|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55916487|NCT02997969|Vaccines|vaccines|mesh-list
55916488|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
55916489|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
55916490|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916491|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55916492|NCT04351230|Trastuzumab|trastuzumab|mesh-list
55916493|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55916494|NCT04351230|Maytansine|maytansine|mesh-list
55916495|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
55916496|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55916497|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916498|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55916499|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
55916501|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
55916502|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916503|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
55916504|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916505|NCT04200534|Nicotine|nicotine|mesh-list
55916506|NCT04200534|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55916507|NCT04200534|Autonomic Agents|autonomic agents|mesh-ancestor
55916508|NCT04200534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733343|NCT03131375|Analgesics|analgesics|mesh-ancestor
55916509|NCT04200534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916510|NCT04200534|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55916511|NCT04200534|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55916512|NCT04200534|Cholinergic Agents|cholinergic agents|mesh-ancestor
55916513|NCT04200534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916562|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
55916563|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
55916564|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55916565|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55916566|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55916568|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
55916569|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55916570|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55916571|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55916572|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
55916573|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
55916574|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916575|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916576|NCT01388335|Warfarin|warfarin|mesh-list
55916580|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55916581|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
55916582|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916583|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916584|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916585|NCT03359460|Lenalidomide|lenalidomide|mesh-list
55916613|NCT00856947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55916614|NCT00856947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55916616|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916617|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
55916618|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
55916619|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
55916620|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916621|NCT00159744|Olanzapine|olanzapine|mesh-list
55916622|NCT00159744|Asenapine|asenapine|mesh-list
55916623|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
55916624|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
55916625|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916626|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916627|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55916628|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55916629|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55916630|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916631|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55916632|NCT00159744|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55916633|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55916634|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55916635|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916636|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916638|NCT04041973|Lumefantrine|lumefantrine|mesh-list
55916639|NCT04041973|Artemether|artemether|mesh-list
55916640|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55916663|NCT01795911|Antiviral Agents|antiviral agents|mesh-ancestor
55916664|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916665|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
55916666|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916668|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
55916669|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55916670|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916671|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55916672|NCT03137082|Guanfacine|guanfacine|mesh-list
55916673|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55916674|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55916675|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55916676|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55916677|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
55916678|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916679|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916680|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916681|NCT03519906|Metoprolol|metoprolol|mesh-list
55916682|NCT03519906|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55916716|NCT00695409|Melphalan|melphalan|mesh-list
55916717|NCT00695409|Carmustine|carmustine|mesh-list
55916718|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55916719|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55916720|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916721|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
55916722|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916723|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55916724|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55916725|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55916726|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55916727|NCT00695409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916728|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916729|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55916730|NCT00695409|Antimetabolites|antimetabolites|mesh-ancestor
55916731|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
55916732|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916733|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55916734|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55916771|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55916772|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55916773|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55916774|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916775|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55916776|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55916777|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916779|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
55916780|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
55916781|NCT02990403|Progestins|progestins|mesh-ancestor
55916782|NCT00697203|Pravastatin|pravastatin|mesh-list
55916783|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
55916784|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55916785|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55916786|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
55916787|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916788|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55916789|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55916790|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916791|NCT05086848|Leucovorin|leucovorin|mesh-list
55916792|NCT05086848|Fluorouracil|fluorouracil|mesh-list
55916793|NCT05086848|Irinotecan|irinotecan|mesh-list
55916794|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
55916796|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55916823|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
55916824|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916825|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
55916826|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
55916827|NCT01795131|Vitamins|vitamins|mesh-ancestor
55916828|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
55916829|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916830|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
55916831|NCT01795131|Hematinics|hematinics|mesh-ancestor
55916832|NCT03137004|Docetaxel|docetaxel|mesh-list
55916833|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916834|NCT03137004|Tubulin Modulators|tubulin modulators|mesh-ancestor
55916835|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
55916836|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
55916837|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916838|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
55916839|NCT03113994|Vitamin D|vitamin d|mesh-list
55916840|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
55916841|NCT03113994|Ubiquinone|ubiquinone|mesh-list
55916842|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
55916843|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55916844|NCT03113994|Calcium|calcium|mesh-list
55916845|NCT03113994|Vitamins|vitamins|mesh-ancestor
55916846|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
55916847|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916848|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55733549|NCT05134415|Menthol|menthol|mesh-list
55916849|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55916850|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55916851|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55916852|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
55916853|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916854|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55916855|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55916856|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55916857|NCT03113994|Antacids|antacids|mesh-ancestor
55916858|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55916859|NCT02003742|Tamsulosin|tamsulosin|mesh-list
55916860|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55916861|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55916862|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55916863|NCT02003742|Adrenergic Agents|adrenergic agents|mesh-ancestor
55916864|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916865|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916866|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916867|NCT02003742|Urological Agents|urological agents|mesh-ancestor
55916868|NCT03134118|Nivolumab|nivolumab|mesh-list
55916869|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55916870|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55916871|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55916873|NCT05085912|Ethanol|ethanol|mesh-list
55916923|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55916924|NCT05079672|Analgesics|analgesics|mesh-ancestor
55916925|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
55916926|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916927|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55916928|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55916932|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916933|NCT04766827|Paclitaxel|paclitaxel|mesh-list
55916934|NCT04766827|Docetaxel|docetaxel|mesh-list
55916935|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55916936|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55916937|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733621|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733630|NCT03795233|Vancomycin|vancomycin|mesh-list
55733631|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55733632|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733634|NCT03645863|Trace Elements|trace elements|mesh-ancestor
55733635|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
55733636|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916938|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
55916939|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
55916940|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
55916941|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916943|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
55916944|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55916945|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55916946|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55916947|NCT02996409|Lidocaine|lidocaine|mesh-list
55916948|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
55916949|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
55916950|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55916951|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916952|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
55916953|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916968|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916970|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55916971|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55916972|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55916973|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55916974|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55916975|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55916976|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
55916977|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55916978|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
55916979|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55916980|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55916981|NCT01421641|Lidocaine|lidocaine|mesh-list
55916982|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
55917025|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
55917026|NCT01517100|Dronabinol|dronabinol|mesh-list
55917027|NCT01517100|Nabilone|nabilone|mesh-list
55917028|NCT01517100|Antiemetics|antiemetics|mesh-ancestor
55917029|NCT01517100|Autonomic Agents|autonomic agents|mesh-ancestor
55917030|NCT01517100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917031|NCT01517100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917032|NCT01517100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55917033|NCT01517100|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55917034|NCT01517100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55917035|NCT01517100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917036|NCT01517100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55917037|NCT01517100|Hallucinogens|hallucinogens|mesh-ancestor
55917038|NCT01517100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55917039|NCT01517100|Analgesics|analgesics|mesh-ancestor
55733730|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
55917041|NCT01517100|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55917045|NCT01517100|Hormones|hormones|mesh-ancestor
55917085|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55917086|NCT01400113|Asenapine|asenapine|mesh-list
55917087|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55917088|NCT01400113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55917089|NCT01400113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917090|NCT01400113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917091|NCT01400113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55917092|NCT01399723|Amoxicillin|amoxicillin|mesh-list
55917093|NCT01399723|Penicillins|penicillins|mesh-list
55917094|NCT01399723|Penicillin G|penicillin g|mesh-list
55917095|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
55917096|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
55917097|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55917098|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917099|NCT04771962|Sevoflurane|sevoflurane|mesh-list
55917100|NCT04771962|Desflurane|desflurane|mesh-list
55917101|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55917102|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55917105|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917109|NCT04726098|BB 1101|bb 1101|mesh-list
55917142|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917143|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55917144|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
55917145|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
55917146|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55917147|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
55917148|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917149|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917150|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
55917151|NCT05084118|Landiolol|landiolol|mesh-list
55917152|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55917153|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55917154|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
55917155|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917156|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917157|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917158|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55917159|NCT03025009|Insulin|insulin|mesh-list
55917160|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55917161|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
55917162|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55917163|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917164|NCT03135912|Terbinafine|terbinafine|mesh-list
55917165|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
55917166|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917167|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917189|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917190|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55917191|NCT04335084|Antimalarials|antimalarials|mesh-ancestor
55917192|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55917193|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55917194|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917195|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917196|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917197|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917198|NCT02992743|Cyclophosphamide|cyclophosphamide|mesh-list
55917199|NCT02992743|Fludarabine|fludarabine|mesh-list
55917200|NCT02992743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917201|NCT02992743|Immunologic Factors|immunologic factors|mesh-ancestor
55917202|NCT02992743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917203|NCT02992743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917204|NCT02992743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55917205|NCT02992743|Alkylating Agents|alkylating agents|mesh-ancestor
55917207|NCT02992743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917244|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917245|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55917246|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55917247|NCT02995707|Growth Substances|growth substances|mesh-ancestor
55917248|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
55917249|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917251|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55917252|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917253|NCT01396447|Cariprazine|cariprazine|mesh-list
55917254|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55917255|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55917256|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917257|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917258|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55917259|NCT05738148|Vasopressins|vasopressins|mesh-list
55917260|NCT05738148|Arginine Vasopressin|arginine vasopressin|mesh-list
55917261|NCT05738148|Epinephrine|epinephrine|mesh-list
55917262|NCT05738148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55917263|NCT05738148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55917264|NCT05738148|Adrenergic Agents|adrenergic agents|mesh-ancestor
55917265|NCT05738148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917299|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55917300|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917301|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917302|NCT00707655|Zalutumumab|zalutumumab|mesh-list
55917303|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55917304|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917305|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55917306|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917307|NCT04089150|Leucovorin|leucovorin|mesh-list
55917314|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55917315|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917316|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
55917317|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
55917318|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
55917319|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917320|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55917321|NCT04089150|Antimetabolites|antimetabolites|mesh-ancestor
55917322|NCT04089150|Antiviral Agents|antiviral agents|mesh-ancestor
55917323|NCT04089150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917324|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917325|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917326|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
55917327|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917328|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55917329|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55917330|NCT04089150|Antidotes|antidotes|mesh-ancestor
55917331|NCT04089150|Protective Agents|protective agents|mesh-ancestor
55917332|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
55917333|NCT04089150|Vitamins|vitamins|mesh-ancestor
55917334|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
55917335|NCT02076919|Acrizanib|acrizanib|mesh-list
55917340|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917341|NCT02076997|Methotrexate|methotrexate|mesh-list
55917342|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55917343|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
55917344|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55917345|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917346|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55917347|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
55917348|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917349|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917350|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
55917351|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917352|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55917353|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917354|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
55917355|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917356|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55917357|NCT05365165|Sevoflurane|sevoflurane|mesh-list
55917397|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
55917398|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917399|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917400|NCT00716079|Analgesics|analgesics|mesh-ancestor
55917401|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
55917402|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55917403|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55917404|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55917405|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55917406|NCT00716079|Protective Agents|protective agents|mesh-ancestor
55734071|NCT05165615|Insulin|insulin|mesh-list
55917407|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
55917408|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55917409|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55917410|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
55917411|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55917412|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55917413|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55917414|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55917415|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
55917416|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55917417|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
55917419|NCT01270191|Exenatide|exenatide|mesh-list
55917445|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
55917446|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917447|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917448|NCT01381549|Imipenem|imipenem|mesh-list
55917449|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
55917450|NCT01381549|Cilastatin|cilastatin|mesh-list
55917451|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55917452|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917453|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
55917454|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917455|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917456|NCT00159432|Bevacizumab|bevacizumab|mesh-list
55917459|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55917460|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917505|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55917506|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917507|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917508|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55917509|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55917510|NCT01396057|Dexamethasone|dexamethasone|mesh-list
55917511|NCT01396057|Ranibizumab|ranibizumab|mesh-list
55917512|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55917513|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
55917514|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
55917515|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917516|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917517|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55917518|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
55917519|NCT01396057|Hormones|hormones|mesh-ancestor
56144585|NCT00799578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917521|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55917563|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
55917564|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917565|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917566|NCT01395901|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55917567|NCT01395901|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55917568|NCT01395901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917569|NCT01395901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55917570|NCT01395901|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55917571|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55917573|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
55917574|NCT01395823|Vitamins|vitamins|mesh-ancestor
55917575|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
55917577|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55917578|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55917579|NCT02993991|Durvalumab|durvalumab|mesh-list
55917580|NCT02993991|Mocetinostat|mocetinostat|mesh-list
55917581|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55917620|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55917621|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55917622|NCT02998905|Analgesics|analgesics|mesh-ancestor
55917623|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
55917624|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917625|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917626|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55917627|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917628|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55917629|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55917630|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917631|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55917683|NCT02835222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917684|NCT04386447|Oxytocin|oxytocin|mesh-list
55917685|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
55917686|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55917687|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917688|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
55917689|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55917690|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917691|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55917692|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
55917693|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55917694|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55917695|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55917696|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917697|NCT01380535|Methoxsalen|methoxsalen|mesh-list
55917698|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55917699|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
55917744|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
55917745|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55917746|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917747|NCT05090592|Atropine|atropine|mesh-list
55917748|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55917749|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55917750|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55917751|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
55917752|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917753|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917754|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55917755|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
55917756|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
55917757|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
55917759|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55917760|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
55917761|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55917762|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917814|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917816|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
55917817|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
55917818|NCT05364385|Hormones|hormones|mesh-ancestor
55917819|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55917820|NCT00726375|Etanercept|etanercept|mesh-list
55917821|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55917822|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55917823|NCT00726375|Analgesics|analgesics|mesh-ancestor
55917824|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
55917825|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917826|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917827|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55917828|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55917829|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55917830|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917831|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
55917833|NCT02693184|Calcium|calcium|mesh-list
55917834|NCT02693184|Vitamins|vitamins|mesh-ancestor
55917835|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
55917836|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917865|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55917866|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917867|NCT04407715|Anesthetics|anesthetics|mesh-list
55917868|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917869|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917870|NCT00727857|Metformin|metformin|mesh-list
55917871|NCT00727857|Pioglitazone|pioglitazone|mesh-list
55917872|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55917873|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917874|NCT05092152|Propofol|propofol|mesh-list
55917875|NCT05092152|Esketamine|esketamine|mesh-list
55917876|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55917877|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917878|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917879|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55917880|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
55917881|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
55917882|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
55917922|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917923|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917925|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55917926|NCT04793100|Aflibercept|aflibercept|mesh-list
55917927|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55917928|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55917929|NCT04793100|Growth Substances|growth substances|mesh-ancestor
55917930|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917931|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
55917932|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55917933|NCT04760028|Anesthetics|anesthetics|mesh-list
55917934|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55917935|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917936|NCT05366101|Valsartan|valsartan|mesh-list
55917937|NCT05366101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55917938|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55917940|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55917941|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55917942|NCT04993560|Vaccines|vaccines|mesh-list
55917972|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55917973|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55917974|NCT00717405|Growth Substances|growth substances|mesh-ancestor
55917975|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55917976|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
55917978|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
55917980|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55917981|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
55917982|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55917983|NCT04022239|Rituximab|rituximab|mesh-list
55917984|NCT04022239|Fludarabine|fludarabine|mesh-list
55917985|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55917986|NCT04022239|Tacrolimus|tacrolimus|mesh-list
55917987|NCT04022239|Antibodies|antibodies|mesh-list
55917988|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
55917989|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55917990|NCT04022239|Lenograstim|lenograstim|mesh-list
55917991|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55917992|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
55918008|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
55918028|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918029|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
55918030|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
55918031|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918032|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918033|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55918034|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
55918035|NCT01277289|Hormones|hormones|mesh-ancestor
55918036|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918037|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55918038|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918039|NCT01525082|Bevacizumab|bevacizumab|mesh-list
55918040|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55918041|NCT01525082|Capecitabine|capecitabine|mesh-list
55918042|NCT01525082|Temozolomide|temozolomide|mesh-list
55918043|NCT01525082|Antibodies|antibodies|mesh-list
55918044|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
55918045|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55918046|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918047|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55918048|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55918049|NCT01525082|Growth Substances|growth substances|mesh-ancestor
55918050|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918051|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
55918052|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
55918053|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55734157|NCT01857115|Antiemetics|antiemetics|mesh-ancestor
55918055|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918059|NCT03599791|Xhance|xhance|mesh-list
55918073|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55918074|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55918075|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
55918076|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
55918077|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918078|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55918079|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55918080|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55918081|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
55918082|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918083|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918084|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918085|NCT01488578|Urological Agents|urological agents|mesh-ancestor
55918086|NCT00720369|Ubiquinone|ubiquinone|mesh-list
55918087|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
55918088|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
55918089|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918090|NCT00720369|Vitamins|vitamins|mesh-ancestor
55918091|NCT01524770|Dulaglutide|dulaglutide|mesh-list
55918092|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55918093|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918094|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
55918095|NCT04088864|Fludarabine|fludarabine|mesh-list
55918096|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55918097|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
55918098|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918099|NCT04088864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55918100|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55918101|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
55918102|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918103|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918104|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55918105|NCT02991339|Dexamethasone|dexamethasone|mesh-list
55918115|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
55918117|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918118|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55918119|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918120|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
55918121|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918122|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918124|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55918125|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918126|NCT05632549|Biotin|biotin|mesh-list
55918127|NCT05632549|Vitamin B Complex|vitamin b complex|mesh-ancestor
55918128|NCT05632549|Vitamins|vitamins|mesh-ancestor
55918129|NCT05632549|Micronutrients|micronutrients|mesh-ancestor
55918130|NCT05632549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918131|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55918132|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55918133|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55918171|NCT05632159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55918172|NCT05632159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918173|NCT04017013|Lidocaine|lidocaine|mesh-list
55918174|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
55918175|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
55918176|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55918177|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918178|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
55918179|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918180|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55918181|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55918182|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55918183|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55918184|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918185|NCT01277913|Vitamin D|vitamin d|mesh-list
55918186|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
55918187|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
55918188|NCT01277913|Vitamins|vitamins|mesh-list
55918189|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
55918190|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918191|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55918192|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55918223|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918224|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55918225|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55918226|NCT00730353|Growth Substances|growth substances|mesh-ancestor
55918227|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918228|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
55918229|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55918230|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918231|NCT01272531|Valproic Acid|valproic acid|mesh-list
55918232|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
55918233|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
55918234|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918235|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918236|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
55918237|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918238|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918239|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
55918240|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55918241|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55918242|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55918243|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
55918276|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55918277|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
55918278|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918279|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55918280|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
55918281|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
55918282|NCT01274559|Vitamins|vitamins|mesh-ancestor
55918283|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
55918284|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918285|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
55918286|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
55918287|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55918288|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55918289|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918290|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918291|NCT01409993|Urological Agents|urological agents|mesh-ancestor
55918292|NCT01409915|Molgramostim|molgramostim|mesh-list
55918295|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918296|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918297|NCT01272921|Bupivacaine|bupivacaine|mesh-list
55918298|NCT01272921|Ropivacaine|ropivacaine|mesh-list
55918299|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
55918300|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
55918301|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55918302|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918303|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
55918323|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55918324|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55918325|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
55918326|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918327|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918328|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918329|NCT03594565|Fluticasone|fluticasone|mesh-list
55918330|NCT03594565|Xhance|xhance|mesh-list
55918331|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918332|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55918333|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
55918334|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918335|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918336|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55918337|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
55918338|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
55918339|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55918340|NCT01430585|Letrozole|letrozole|mesh-list
55918341|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918342|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55918343|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55918344|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918346|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55918374|NCT05633719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918375|NCT01408901|Molgramostim|molgramostim|mesh-list
55918376|NCT01408901|Sargramostim|sargramostim|mesh-list
55918377|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
55918378|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918379|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918380|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
55918381|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
55918382|NCT02080195|Fludarabine|fludarabine|mesh-list
55918383|NCT02080195|Tacrolimus|tacrolimus|mesh-list
55918384|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
55918385|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55918386|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55918387|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
55918388|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918389|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55918391|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
55918392|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918393|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918394|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55918402|NCT04044131|Sorbitol|sorbitol|mesh-list
55918431|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55918432|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918433|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55918434|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55918436|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918437|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55918438|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55918439|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
55918440|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918441|NCT00219349|Citalopram|citalopram|mesh-list
55918442|NCT00219349|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55918443|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55918444|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55918445|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918446|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918447|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
55918448|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918449|NCT00219349|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55918450|NCT00219349|Antidepressive Agents|antidepressive agents|mesh-ancestor
55918451|NCT00219349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55918452|NCT00218257|Progesterone|progesterone|mesh-list
55918453|NCT00218257|Progestins|progestins|mesh-ancestor
55918454|NCT00218257|Hormones|hormones|mesh-ancestor
55918606|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918455|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918456|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918457|NCT01523366|Clopidogrel|clopidogrel|mesh-list
55918458|NCT01523366|Ticagrelor|ticagrelor|mesh-list
55918459|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55918460|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55918461|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55918462|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55918463|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
55918464|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918465|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918466|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918467|NCT03024697|Anesthetics|anesthetics|mesh-list
55918468|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
55918469|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55918470|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918471|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
55918481|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55918482|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55918483|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918484|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55918485|NCT03780127|Serotonin Agents|serotonin agents|mesh-ancestor
55918486|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918488|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55918489|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55918490|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55918491|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55918513|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918514|NCT00215137|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55918515|NCT00215137|Antidepressive Agents|antidepressive agents|mesh-ancestor
55918516|NCT00215137|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55918518|NCT04406779|Autoantibodies|autoantibodies|mesh-list
55918519|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918520|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918521|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
55918522|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
55918523|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918524|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918525|NCT03598075|Pramlintide|pramlintide|mesh-list
55918526|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55918527|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918528|NCT03984097|Dexamethasone|dexamethasone|mesh-list
55918529|NCT03984097|Lenalidomide|lenalidomide|mesh-list
55918530|NCT03984097|Bortezomib|bortezomib|mesh-list
55918531|NCT03984097|Pomalidomide|pomalidomide|mesh-list
55918532|NCT03984097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918533|NCT03984097|Antiemetics|antiemetics|mesh-ancestor
55918534|NCT03984097|Autonomic Agents|autonomic agents|mesh-ancestor
55918535|NCT03984097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918536|NCT03984097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918537|NCT03984097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55918538|NCT03984097|Glucocorticoids|glucocorticoids|mesh-ancestor
55918539|NCT03984097|Hormones|hormones|mesh-ancestor
55918540|NCT03984097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918541|NCT03984097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55918542|NCT03984097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918543|NCT03984097|Immunologic Factors|immunologic factors|mesh-ancestor
55918545|NCT03984097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55918546|NCT03984097|Growth Substances|growth substances|mesh-ancestor
55918547|NCT03984097|Growth Inhibitors|growth inhibitors|mesh-ancestor
55918548|NCT03976063|Nifedipine|nifedipine|mesh-list
55918549|NCT03976063|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55918550|NCT03976063|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55918551|NCT03976063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918552|NCT03976063|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55918553|NCT03976063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918554|NCT03976063|Vasodilator Agents|vasodilator agents|mesh-ancestor
55918555|NCT03976063|Tocolytic Agents|tocolytic agents|mesh-ancestor
55918556|NCT03976063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55918604|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918605|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55918855|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
55918608|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55918609|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
55918610|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55918611|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918612|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55918613|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55918614|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
55918615|NCT04510584|Bevacizumab|bevacizumab|mesh-list
55918616|NCT04510584|Atezolizumab|atezolizumab|mesh-list
55918617|NCT04510584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55918618|NCT04510584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918619|NCT04510584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55918620|NCT04510584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55918621|NCT04510584|Growth Substances|growth substances|mesh-ancestor
55918622|NCT04510584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918623|NCT04510584|Growth Inhibitors|growth inhibitors|mesh-ancestor
55918624|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55918625|NCT04198129|Amoxicillin|amoxicillin|mesh-list
55918626|NCT04198129|Clindamycin|clindamycin|mesh-list
55918627|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
55918628|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
55918629|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55918630|NCT04198129|Ampicillin|ampicillin|mesh-list
55918632|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55918633|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918634|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
55918635|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55918636|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918637|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918638|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55918639|NCT03591757|Tolcapone|tolcapone|mesh-list
55918640|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55918641|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55918642|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55918643|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918644|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918646|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55918647|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55918648|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
55918649|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55918650|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55918651|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
55918652|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
55918653|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55918771|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55918772|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
55918773|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918774|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918776|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918777|NCT04197115|Protective Agents|protective agents|mesh-ancestor
55918778|NCT04126200|Dexamethasone|dexamethasone|mesh-list
55918779|NCT04126200|Lenalidomide|lenalidomide|mesh-list
55918780|NCT04126200|Pomalidomide|pomalidomide|mesh-list
55918781|NCT04126200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55918782|NCT04126200|Antiemetics|antiemetics|mesh-ancestor
55918783|NCT04126200|Autonomic Agents|autonomic agents|mesh-ancestor
55918784|NCT04126200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918785|NCT04126200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918786|NCT04126200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55918787|NCT04126200|Glucocorticoids|glucocorticoids|mesh-ancestor
55918788|NCT04126200|Hormones|hormones|mesh-ancestor
55918789|NCT04126200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918790|NCT04126200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55918791|NCT04126200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918792|NCT04126200|Immunologic Factors|immunologic factors|mesh-ancestor
55918793|NCT04126200|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55918799|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
55918800|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918801|NCT02467452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918802|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55918803|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
55918804|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
55918805|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55918806|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
55918854|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55918856|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918857|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918858|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55918859|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55918860|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55918861|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55918862|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
55918863|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918864|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918865|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55918866|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
55918910|NCT04195321|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55918911|NCT04195321|Mydriatics|mydriatics|mesh-ancestor
55918912|NCT04195321|Autonomic Agents|autonomic agents|mesh-ancestor
55918913|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55918914|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918915|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
55918916|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55918917|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
55918918|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
55918919|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55918920|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55918921|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55918926|NCT03965845|Palbociclib|palbociclib|mesh-list
55918972|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55918973|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918975|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
55918976|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
55918977|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918978|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55918979|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
55918980|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55918981|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55918982|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55918983|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
55918984|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55918985|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55918986|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55918988|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55918990|NCT03962647|Letrozole|letrozole|mesh-list
55918991|NCT03962647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55918992|NCT03962647|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55918993|NCT03962647|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55918994|NCT03962647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55918995|NCT03962647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55918996|NCT03962647|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55918997|NCT03962647|Hormone Antagonists|hormone antagonists|mesh-ancestor
55918998|NCT03962647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55918999|NCT03962647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919000|NCT05286996|Anesthetics|anesthetics|mesh-list
55919001|NCT05286996|Anesthetics, Local|anesthetics, local|mesh-list
55919002|NCT05286996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55919003|NCT05286996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919004|NCT05286996|Sensory System Agents|sensory system agents|mesh-ancestor
55919005|NCT05286996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919006|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
55919007|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55919008|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
55919009|NCT05092074|Velpatasvir|velpatasvir|mesh-list
55919010|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
55919011|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919012|NCT02080273|Listerine|listerine|mesh-list
55919013|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
55919014|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
55919015|NCT02080273|Protective Agents|protective agents|mesh-ancestor
55919016|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919017|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55919018|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919019|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
55919020|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55919021|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
55919022|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
55919023|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55919024|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919025|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55919026|NCT04199143|Analgesics|analgesics|mesh-ancestor
55919027|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
55919028|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919029|NCT04616274|Venetoclax|venetoclax|mesh-list
55919031|NCT04613622|Venetoclax|venetoclax|mesh-list
55919032|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919033|NCT04515186|Miltefosine|miltefosine|mesh-list
55919056|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55919057|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55919058|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55919059|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55919060|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919061|NCT03832465|Levofloxacin|levofloxacin|mesh-list
55919062|NCT03832465|Ofloxacin|ofloxacin|mesh-list
55919063|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55919064|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55919065|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919066|NCT03832465|Renal Agents|renal agents|mesh-ancestor
55919067|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55919068|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55919069|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55919070|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919075|NCT04190173|Prucalopride|prucalopride|mesh-list
55919115|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55919116|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919117|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
55919118|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919119|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55919120|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55919121|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
55919122|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919123|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919124|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55919125|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55919126|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
55919127|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55919177|NCT04195633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55919178|NCT01270971|Tavaborole|tavaborole|mesh-list
55919179|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55919180|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
55919191|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919192|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919193|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55919194|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
55919195|NCT04128774|Hormones|hormones|mesh-ancestor
55919196|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919197|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55919198|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919199|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
55919200|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919201|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919202|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
55919203|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55919204|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
55919205|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919206|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
55919207|NCT00732225|Protective Agents|protective agents|mesh-ancestor
55919208|NCT04194775|Lenvatinib|lenvatinib|mesh-list
55919209|NCT04194775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919210|NCT04194775|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55919211|NCT04194775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919212|NCT04194775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919213|NCT04026685|Phenylephrine|phenylephrine|mesh-list
55919214|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
55919215|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55919216|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
55769040|NCT05480631|Mitogens|mitogens|mesh-list
55919222|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
55919223|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
55919224|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55919225|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55919226|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55919227|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
55919228|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919427|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
55919229|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919266|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
55919267|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55919268|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919269|NCT03933631|Ofloxacin|ofloxacin|mesh-list
55919270|NCT03933631|Prednisolone|prednisolone|mesh-list
55919271|NCT03933631|Prednisolone acetate|prednisolone acetate|mesh-list
55919272|NCT03933631|Pilocarpine|pilocarpine|mesh-list
55919273|NCT03933631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55919274|NCT03933631|Glucocorticoids|glucocorticoids|mesh-ancestor
55919275|NCT03933631|Hormones|hormones|mesh-ancestor
55919276|NCT03933631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919277|NCT03933631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919278|NCT03933631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55919279|NCT03933631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919280|NCT03933631|Autonomic Agents|autonomic agents|mesh-ancestor
55919281|NCT03933631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919282|NCT03933631|Miotics|miotics|mesh-ancestor
55919283|NCT03933631|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55919284|NCT03933631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55919285|NCT03933631|Cholinergic Agents|cholinergic agents|mesh-ancestor
55919286|NCT03933631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919287|NCT03933631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919288|NCT03933631|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55919289|NCT03933631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919290|NCT03933631|Renal Agents|renal agents|mesh-ancestor
55919291|NCT03933631|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55919292|NCT03933631|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55919293|NCT03933631|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55919294|NCT03933631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919295|NCT03933631|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55919308|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55919309|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55919310|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55919311|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55919312|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
55919313|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919314|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919315|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919316|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
55919317|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
55919318|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919319|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
55919320|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55919321|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
55919322|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55919345|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55919346|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55919347|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919348|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919350|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55919351|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919352|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
55919353|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919354|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55919355|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
55919356|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919409|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919410|NCT00722553|Hematinics|hematinics|mesh-ancestor
55919411|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55919412|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919413|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919414|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919415|NCT03022747|Allopurinol|allopurinol|mesh-list
55919416|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
55919417|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919418|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919419|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
55919420|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55919421|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55919422|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
55919423|NCT03022747|Protective Agents|protective agents|mesh-ancestor
55919424|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919425|NCT03928015|Analgesics|analgesics|mesh-list
55919426|NCT03928015|Dronabinol|dronabinol|mesh-list
55919464|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919465|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919466|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55919467|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55919468|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
55919469|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919470|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919471|NCT04716114|Cytarabine|cytarabine|mesh-list
55919472|NCT04716114|Fludarabine|fludarabine|mesh-list
55919527|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
55919528|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55919529|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55919530|NCT04025593|Growth Substances|growth substances|mesh-ancestor
55919531|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
55919532|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55919533|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
55919534|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55919535|NCT01279707|Epratuzumab|epratuzumab|mesh-list
55919536|NCT01279707|Veltuzumab|veltuzumab|mesh-list
55919537|NCT01279707|Antibodies|antibodies|mesh-list
55919538|NCT01279707|Immunoglobulins|immunoglobulins|mesh-list
55919539|NCT01279707|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55919540|NCT01279707|Immunologic Factors|immunologic factors|mesh-ancestor
55919541|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919542|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919543|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
55919544|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55919545|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
55919546|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55919547|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919548|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55919549|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55919550|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55919551|NCT02595060|Molgramostim|molgramostim|mesh-list
55919552|NCT02595060|Sargramostim|sargramostim|mesh-list
55919553|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919554|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
55919555|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919558|NCT03023124|Doxorubicin|doxorubicin|mesh-list
55919575|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55919576|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
55919577|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919578|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55919579|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55919580|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
55919581|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919582|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919583|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55919584|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55919585|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55919586|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55919587|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919588|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55919589|NCT03022123|Glucocorticoids|glucocorticoids|mesh-ancestor
55919590|NCT03022123|Hormones|hormones|mesh-ancestor
55919591|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55919592|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55919593|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55919595|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
55919596|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
55919597|NCT02700451|Acetaminophen|acetaminophen|mesh-list
55919598|NCT02700451|Ketorolac|ketorolac|mesh-list
55919599|NCT02700451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55919600|NCT02700451|Analgesics|analgesics|mesh-ancestor
55919604|NCT02700451|Antipyretics|antipyretics|mesh-ancestor
55919621|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
55919622|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919623|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55919624|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55919625|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55919626|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919627|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
55919628|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55919629|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919630|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55919631|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55919636|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55919637|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919638|NCT00723099|Cyclosporine|cyclosporine|mesh-list
55919639|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
55919640|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
55919641|NCT00723099|Fludarabine|fludarabine|mesh-list
55919642|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
55919675|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55919676|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55919678|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
55919679|NCT05100186|Dexamethasone|dexamethasone|mesh-list
55919680|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55919681|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
55919682|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
55919683|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919684|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919685|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55919686|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
55919741|NCT01276041|Trastuzumab|trastuzumab|mesh-list
55919742|NCT01276041|Pertuzumab|pertuzumab|mesh-list
55919743|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55919744|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55919745|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
55919746|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
55919747|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
55919748|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919749|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55919750|NCT04150770|Infliximab|infliximab|mesh-list
55919751|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
55919823|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
55919824|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919825|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919826|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919827|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55919828|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
55919829|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919830|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55919831|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
55919832|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
55919833|NCT04023565|Perindopril|perindopril|mesh-list
55919889|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55919890|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55919891|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55919892|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
55919893|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55919894|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55919895|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55919896|NCT04144933|Anesthetics, General|anesthetics, general|mesh-ancestor
55919897|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55919898|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55919899|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
55919900|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55919950|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919951|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55919953|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55919954|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55919955|NCT04148599|Lidocaine|lidocaine|mesh-list
55919956|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
55919957|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
55919958|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
55743116|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
55919959|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55919960|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55919961|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
55919962|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55919963|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55919964|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55919965|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55919966|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55919967|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55919968|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55919969|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55919970|NCT04148599|Analgesics|analgesics|mesh-ancestor
55919971|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55919972|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55919999|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920000|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920001|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
55920002|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920003|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55920004|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55920005|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55920006|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55920007|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920008|NCT03769285|Niacinamide|niacinamide|mesh-list
55920009|NCT03769285|Niacin|niacin|mesh-list
55920010|NCT03769285|Nicotinic Acids|nicotinic acids|mesh-list
55920011|NCT03769285|Vitamin B Complex|vitamin b complex|mesh-ancestor
55920058|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55920059|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920060|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55920062|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55920063|NCT04143451|Imiquimod|imiquimod|mesh-list
55920064|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55920065|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
55920066|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920067|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920068|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
55920069|NCT05105412|Gemcitabine|gemcitabine|mesh-list
55920070|NCT05105412|Lenalidomide|lenalidomide|mesh-list
55920090|NCT04766047|Analgesics|analgesics|mesh-ancestor
55920120|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920121|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55920122|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55920123|NCT04405843|Ivermectin|ivermectin|mesh-list
55920124|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55920125|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920126|NCT04316364|Paclitaxel|paclitaxel|mesh-list
55920127|NCT04316364|Carboplatin|carboplatin|mesh-list
55920128|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55920129|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920130|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
55920131|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
55920132|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
55920133|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920134|NCT03916003|Primaquine|primaquine|mesh-list
55920135|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
55920136|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55920137|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55920138|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920139|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
55920140|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55920141|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920142|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
55920143|NCT03937843|Carboplatin|carboplatin|mesh-list
55920144|NCT03937843|Etoposide|etoposide|mesh-list
55920145|NCT03937843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920146|NCT03937843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55920147|NCT03937843|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55920148|NCT03937843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55920149|NCT03937843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920150|NCT03937843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920151|NCT04018872|Itraconazole|itraconazole|mesh-list
55920152|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
55920153|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920154|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55920156|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920159|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
55920160|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920161|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920162|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55920169|NCT03896737|Thalidomide|thalidomide|mesh-list
55920170|NCT03896737|Dexamethasone|dexamethasone|mesh-list
55920171|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
55920172|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
55920173|NCT03896737|Bortezomib|bortezomib|mesh-list
55734512|NCT03447691|Propofol|propofol|mesh-list
55920174|NCT03896737|Daratumumab|daratumumab|mesh-list
55920175|NCT03896737|BB 1101|bb 1101|mesh-list
55920176|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920177|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
55920178|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920179|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55920180|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55920181|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
55920182|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920183|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920184|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55920185|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920186|NCT03896737|Antiemetics|antiemetics|mesh-ancestor
55920187|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
55920188|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920189|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55920190|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
55920208|NCT04685772|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55920209|NCT04685772|Prednisolone phosphate|prednisolone phosphate|mesh-list
55920210|NCT04685772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920211|NCT04685772|Antiemetics|antiemetics|mesh-ancestor
55920212|NCT04685772|Autonomic Agents|autonomic agents|mesh-ancestor
55920213|NCT04685772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920214|NCT04685772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920215|NCT04685772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55920216|NCT04685772|Glucocorticoids|glucocorticoids|mesh-ancestor
55920217|NCT04685772|Hormones|hormones|mesh-ancestor
55920218|NCT04685772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920219|NCT04685772|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55920220|NCT04685772|Protective Agents|protective agents|mesh-ancestor
55920221|NCT04685772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55920222|NCT04685772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920271|NCT05068752|Vemurafenib|vemurafenib|mesh-list
55920272|NCT05068752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920273|NCT05068752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55920274|NCT05068752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920275|NCT05068752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920276|NCT03588715|Interferons|interferons|mesh-list
55920277|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
55920278|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
55920279|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55920280|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
55920281|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920282|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
55920283|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920284|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
55920285|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920286|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
55920287|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920288|NCT04140409|Octreotide|octreotide|mesh-list
55920289|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55920292|NCT04527432|Antibodies|antibodies|mesh-list
55920326|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920327|NCT05109390|Cyclosporine|cyclosporine|mesh-list
55920328|NCT05109390|Simethicone|simethicone|mesh-list
55920329|NCT05109390|Omeprazole|omeprazole|mesh-list
55920330|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
55920331|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
55920332|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
55920333|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
55920334|NCT05109390|Antacids|antacids|mesh-list
55920335|NCT05109390|Tacrolimus|tacrolimus|mesh-list
55920336|NCT05109390|Cyclosporins|cyclosporins|mesh-list
55920337|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920338|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920339|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
55920340|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55920341|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920342|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920343|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
55920344|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920345|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
55920346|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55920347|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55920348|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55920349|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
55920350|NCT05109390|Emollients|emollients|mesh-ancestor
55920351|NCT04030182|Vitamin D|vitamin d|mesh-list
55920352|NCT04030182|Vitamins|vitamins|mesh-ancestor
55920353|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
55920354|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920355|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55920361|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920362|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920363|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
55920364|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920365|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55920366|NCT05109312|Analgesics|analgesics|mesh-ancestor
55920367|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
55920368|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55920369|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920370|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55920371|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55920372|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920373|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920374|NCT03661632|Nivolumab|nivolumab|mesh-list
55920375|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55920376|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920377|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55920378|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920379|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
55920380|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55920381|NCT04748250|Estrogens|estrogens|mesh-ancestor
55920405|NCT03512262|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55920406|NCT03512262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920407|NCT03512262|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55920409|NCT03456882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55920410|NCT03456882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55920411|NCT03456882|Analgesics|analgesics|mesh-ancestor
55920412|NCT03456882|Sensory System Agents|sensory system agents|mesh-ancestor
55920413|NCT03456882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920414|NCT03456882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920415|NCT03456882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920416|NCT03456882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55920417|NCT03456882|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55920418|NCT01482962|Gemcitabine|gemcitabine|mesh-list
55920419|NCT01482962|Romidepsin|romidepsin|mesh-list
55920420|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55920421|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
55920422|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920423|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920424|NCT01482962|Antiviral Agents|antiviral agents|mesh-ancestor
55920425|NCT01482962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920426|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920427|NCT01482962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920457|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920458|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55920459|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55920460|NCT03895801|Prednisone|prednisone|mesh-list
55920461|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
55920462|NCT03895801|Vilobelimab|vilobelimab|mesh-list
55920463|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920464|NCT03895801|Hormones|hormones|mesh-ancestor
55920465|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920466|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920467|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55920468|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920469|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55920470|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920471|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
55920517|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
55920518|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920519|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920582|NCT03020953|Estrogens|estrogens|mesh-list
55920583|NCT03020953|Hormones|hormones|mesh-ancestor
55920584|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920585|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920603|NCT03625986|Nicotine|nicotine|mesh-list
55920604|NCT03625986|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55920605|NCT03625986|Autonomic Agents|autonomic agents|mesh-ancestor
55920606|NCT03625986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920607|NCT03625986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920608|NCT03625986|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55920609|NCT03625986|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55920610|NCT03625986|Cholinergic Agents|cholinergic agents|mesh-ancestor
55920611|NCT03625986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55920612|NCT03625986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920613|NCT05583175|Venetoclax|venetoclax|mesh-list
55920614|NCT05583175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920615|NCT03891901|Isoniazid|isoniazid|mesh-list
55920616|NCT03891901|Rifabutin|rifabutin|mesh-list
55920617|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
55920618|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920619|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55920620|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920621|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920622|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
55920623|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55920637|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55920638|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55920642|NCT05040126|Bedaquiline|bedaquiline|mesh-list
55920662|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55920664|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55920665|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
55920666|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920667|NCT03069300|Expectorants|expectorants|mesh-ancestor
55920668|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
55920669|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55920670|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
55920671|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920672|NCT03069300|Protective Agents|protective agents|mesh-ancestor
55920673|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920674|NCT03069300|Antidotes|antidotes|mesh-ancestor
55920675|NCT05582317|Simvastatin|simvastatin|mesh-list
55920676|NCT05582317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55920677|NCT05582317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55920678|NCT05582317|Antimetabolites|antimetabolites|mesh-ancestor
55920679|NCT05582317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920680|NCT05582317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55920681|NCT05582317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55920682|NCT05582317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920683|NCT03891355|Dexamethasone|dexamethasone|mesh-list
55920685|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920686|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
55920687|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
55920688|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920689|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920690|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55920691|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
55920692|NCT03891355|Hormones|hormones|mesh-ancestor
55920693|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920694|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55920695|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920696|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
55920697|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55920698|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55920699|NCT03891355|Growth Substances|growth substances|mesh-ancestor
55920700|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
55920701|NCT05582083|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
55920702|NCT05582083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55920703|NCT05582083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920704|NCT05582083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920705|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
55920706|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
55920707|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55920708|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920709|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920710|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55920711|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
55920712|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55920713|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920714|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55920715|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
55920716|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55920717|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920718|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920719|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920720|NCT05702359|Vitamin D|vitamin d|mesh-list
55920721|NCT05702359|Ergocalciferols|ergocalciferols|mesh-list
55920725|NCT05702359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920733|NCT03586141|Analgesics|analgesics|mesh-ancestor
55920734|NCT03586141|Sensory System Agents|sensory system agents|mesh-ancestor
55920735|NCT03586141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55920736|NCT03586141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920737|NCT03586141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55920738|NCT03586141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55920739|NCT03020563|Bupivacaine|bupivacaine|mesh-list
55920740|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
55920741|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
55920742|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920743|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920744|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
55920794|NCT03583255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55920795|NCT03583255|Glucocorticoids|glucocorticoids|mesh-ancestor
55920796|NCT03583255|Hormones|hormones|mesh-ancestor
55920797|NCT03583255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920798|NCT03583255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55920799|NCT03583255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920800|NCT03583255|Protease Inhibitors|protease inhibitors|mesh-ancestor
55920801|NCT03583255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920802|NCT03583255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920803|NCT03583255|Dermatologic Agents|dermatologic agents|mesh-ancestor
55920804|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55920805|NCT03585751|Simvastatin|simvastatin|mesh-list
55920806|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920807|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55920808|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55920809|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
55920810|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920811|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55920812|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55920813|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920814|NCT03583333|Linezolid|linezolid|mesh-list
55920815|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55920816|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920817|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55920818|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920819|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920820|NCT03585673|Docetaxel|docetaxel|mesh-list
55920821|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
55920822|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920824|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
55920825|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
55920826|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920828|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
55920829|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55920830|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55920831|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920832|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55920833|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920834|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55920835|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55920836|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55920837|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55920838|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55920839|NCT03899467|Androgens|androgens|mesh-list
55920840|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
55920841|NCT03899467|Hormones|hormones|mesh-ancestor
55920842|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920843|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920844|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
55920845|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
55920846|NCT03582475|Cisplatin|cisplatin|mesh-list
55920847|NCT03582475|Carboplatin|carboplatin|mesh-list
55920848|NCT03582475|Docetaxel|docetaxel|mesh-list
55920849|NCT03582475|Pembrolizumab|pembrolizumab|mesh-list
55920850|NCT03582475|Etoposide|etoposide|mesh-list
55920852|NCT03582475|Podophyllotoxin|podophyllotoxin|mesh-list
55920884|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55920885|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
55920886|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920887|NCT03158389|Sirolimus|sirolimus|mesh-list
55920888|NCT03158389|Atezolizumab|atezolizumab|mesh-list
55920889|NCT03158389|Palbociclib|palbociclib|mesh-list
55920890|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920891|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55920892|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920893|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920894|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55920895|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920896|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55920897|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
55920898|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920899|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
55920900|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920901|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
55920902|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920903|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
55920904|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920905|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55920906|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55920907|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
55920908|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920909|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920910|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55920911|NCT05118048|Chrysarobin|chrysarobin|mesh-list
55920912|NCT05118048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55920928|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920929|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55920930|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
55920932|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55920933|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55920934|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920935|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55920936|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55920937|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55920938|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55920939|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920940|NCT04405375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55920941|NCT04405375|Antimetabolites|antimetabolites|mesh-ancestor
55920942|NCT04405375|Antiviral Agents|antiviral agents|mesh-ancestor
55920943|NCT04405375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920944|NCT04405375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55920945|NCT04405375|Immunologic Factors|immunologic factors|mesh-ancestor
55920946|NCT05118672|Acetaminophen|acetaminophen|mesh-list
55920947|NCT05118672|Fexofenadine|fexofenadine|mesh-list
55920948|NCT05118672|Phenylephrine|phenylephrine|mesh-list
55920949|NCT05118672|Oxymetazoline|oxymetazoline|mesh-list
55920950|NCT05118672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55920951|NCT05118672|Analgesics|analgesics|mesh-ancestor
55920952|NCT05118672|Sensory System Agents|sensory system agents|mesh-ancestor
55920979|NCT03029611|Carboplatin|carboplatin|mesh-list
55920980|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55920981|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55920982|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55920983|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
55920984|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
55920985|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
55920986|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55920988|NCT05701501|Vitamins|vitamins|mesh-ancestor
55920989|NCT05701501|Micronutrients|micronutrients|mesh-ancestor
55920990|NCT05701501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55920991|NCT05701501|Vitamin B Complex|vitamin b complex|mesh-ancestor
55920992|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
55920993|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55920994|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
55920995|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55920996|NCT03589495|Expectorants|expectorants|mesh-ancestor
55920997|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
55920998|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55920999|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
55921001|NCT03589495|Protective Agents|protective agents|mesh-ancestor
55921034|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55921035|NCT03583489|Ondansetron|ondansetron|mesh-list
55921036|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
55921037|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
55921038|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921039|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921040|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55921041|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
55921042|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
55921103|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921104|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921105|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921106|NCT03059173|Inositol|inositol|mesh-list
55921107|NCT03059173|Clomiphene|clomiphene|mesh-list
55921108|NCT03059173|Enclomiphene|enclomiphene|mesh-list
55921109|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
55921110|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55921111|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
55921112|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921113|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921114|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55921115|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
55921116|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55921117|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55921118|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55921119|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
55921161|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55921162|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
55921163|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55921164|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921165|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55921166|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55921167|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55921168|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55921169|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55921170|NCT03874494|Aripiprazole|aripiprazole|mesh-list
55921171|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
55921172|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
55921173|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55921174|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55921189|NCT03156439|Huperzine A|huperzine a|mesh-list
55921222|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
55921223|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921224|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921225|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55921226|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
55921227|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921229|NCT04510194|Ivermectin|ivermectin|mesh-list
55921230|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
55921231|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55921232|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921233|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55921234|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921235|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55921236|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55921237|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921238|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55921239|NCT04510194|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55921240|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55921241|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55921242|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921243|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921244|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
55921245|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55921246|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
55921247|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55921248|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55921249|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921251|NCT03155971|Paclitaxel|paclitaxel|mesh-list
55921266|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55921267|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921268|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921269|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
55921270|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
55921271|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55921272|NCT03155893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55921273|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921274|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55921275|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55921276|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921277|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921278|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921279|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55921280|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
55921281|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55921282|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921283|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55921284|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55921285|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55921286|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
55921287|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55921318|NCT05698147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55921319|NCT05698147|Antimetabolites|antimetabolites|mesh-ancestor
55921320|NCT05698147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921321|NCT05698147|Dermatologic Agents|dermatologic agents|mesh-ancestor
55921322|NCT05698147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921323|NCT05698147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55921324|NCT05698147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55921325|NCT05698147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55921326|NCT03156907|Buprenorphine|buprenorphine|mesh-list
55921327|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55921328|NCT03156907|Narcotics|narcotics|mesh-ancestor
55921329|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921330|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921331|NCT03156907|Analgesics|analgesics|mesh-ancestor
55921332|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
55921333|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921334|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55921335|NCT03156829|Betamethasone|betamethasone|mesh-list
55921336|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55921337|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
55921339|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921340|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921370|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921371|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921373|NCT05119452|Etanercept|etanercept|mesh-list
55921374|NCT05119452|Golimumab|golimumab|mesh-list
55921375|NCT05119452|Infliximab|infliximab|mesh-list
55921376|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
55921377|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
55921378|NCT05119452|Tofacitinib|tofacitinib|mesh-list
55921379|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55921380|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
55921381|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55921382|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55921383|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55921384|NCT05119452|Analgesics|analgesics|mesh-ancestor
55921385|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
55921386|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921387|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921388|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55921389|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
55921390|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55921391|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921424|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55921425|NCT01670773|Analgesics|analgesics|mesh-ancestor
55921426|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
55921427|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921428|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921429|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55921431|NCT05228418|Naltrexone|naltrexone|mesh-list
55921432|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55921433|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55921434|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921435|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
55921436|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921437|NCT01676233|Insulin|insulin|mesh-list
55921438|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55921439|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
55921440|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55921441|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921442|NCT02939742|Betamethasone|betamethasone|mesh-list
55921481|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
55921482|NCT04746937|Norfloxacin|norfloxacin|mesh-list
55921483|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55921484|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921485|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55921486|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55921487|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55921488|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921489|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921490|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921491|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55921492|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55921493|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
55921494|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55921495|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55921496|NCT05220319|Prednisolone|prednisolone|mesh-list
55921497|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
55921498|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55921499|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
55921500|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55921501|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
55921502|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
55921503|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921531|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55921532|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
55921533|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
55921534|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
55921535|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921536|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921537|NCT04497870|Peppermint oil|peppermint oil|mesh-list
55921538|NCT04497870|Menthol|menthol|mesh-list
55921539|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
55921540|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
55921541|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
55921542|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
55921543|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921544|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921545|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55921546|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
55921547|NCT03154723|Vitamin A|vitamin a|mesh-list
55921548|NCT03154723|Vitamins|vitamins|mesh-ancestor
55921560|NCT03154567|Yohimbine|yohimbine|mesh-list
55921561|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
55921562|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
55921563|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921564|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921565|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55921566|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55921570|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921571|NCT03154567|Urological Agents|urological agents|mesh-ancestor
55921572|NCT04310748|Anesthetics|anesthetics|mesh-list
55921573|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921574|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921576|NCT03154645|Acetazolamide|acetazolamide|mesh-list
55921577|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55921578|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55921579|NCT03154645|Analgesics|analgesics|mesh-ancestor
55921580|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
55921581|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921582|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921583|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55921584|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55921585|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55921586|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921587|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921588|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
55921589|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55921590|NCT03154645|Diuretics|diuretics|mesh-ancestor
55921591|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
55921592|NCT01631292|Vitamin D|vitamin d|mesh-list
55921593|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
55921594|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
55921608|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55921609|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921610|NCT05222256|Simendan|simendan|mesh-list
55921611|NCT05222256|Epinephrine|epinephrine|mesh-list
55921612|NCT05222256|Racepinephrine|racepinephrine|mesh-list
55921613|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
55921614|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55921615|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55921616|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
55921617|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921922|NCT03855007|Prednisone|prednisone|mesh-list
55921618|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921619|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921620|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55921621|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55921622|NCT05222256|Autonomic Agents|autonomic agents|mesh-ancestor
55921623|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55921624|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55921625|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
55921626|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
55921636|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
55921637|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55921638|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55921639|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55921640|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921641|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921642|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55921643|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55921644|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55921645|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55921647|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
55921648|NCT00698022|Risperidone|risperidone|mesh-list
55921649|NCT00698022|Mifepristone|mifepristone|mesh-list
55921650|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55921651|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
55921652|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921653|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921654|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921655|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55921689|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921690|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55921691|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55921692|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
55921693|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55921694|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
55921695|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
55921696|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
55921697|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55921698|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55921699|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55921700|NCT02570503|Analgesics|analgesics|mesh-ancestor
55921701|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55921702|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55921703|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55921704|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921705|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55921706|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
55921707|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55921708|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
55921709|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55921710|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55921711|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921712|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55921713|NCT02492269|Analgesics|analgesics|mesh-ancestor
55921714|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
55921737|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55921738|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921739|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55921740|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921742|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55921744|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55921745|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921746|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55921747|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
55921748|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
55921749|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
55921750|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921751|NCT03153085|Ipilimumab|ipilimumab|mesh-list
55921752|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55921753|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921754|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55921755|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921756|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
55921757|NCT03589339|Nivolumab|nivolumab|mesh-list
55921758|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55921759|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921788|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55921789|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921790|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921791|NCT03413995|Rucaparib|rucaparib|mesh-list
55921792|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55921793|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921794|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921795|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921796|NCT04508244|Propranolol|propranolol|mesh-list
55921797|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55921798|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55921799|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
55921800|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921801|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921802|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921803|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55921845|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921846|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921847|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921848|NCT01674205|Vaccines|vaccines|mesh-list
55921849|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
55921850|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921851|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
55921852|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
55921853|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
55921854|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55921855|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
55921856|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55921857|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55921858|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
55921859|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921860|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921861|NCT03151057|Idelalisib|idelalisib|mesh-list
55921862|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921863|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921864|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921866|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55921867|NCT01674283|Hormones|hormones|mesh-ancestor
55921868|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921869|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921870|NCT04404517|Adalimumab|adalimumab|mesh-list
55921871|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55921872|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55921873|NCT01674517|Montelukast|montelukast|mesh-list
55921874|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55921875|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
55921876|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55921877|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
55921878|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921879|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921880|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55921881|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55921882|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921884|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921885|NCT01670071|Risperidone|risperidone|mesh-list
55921886|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55921887|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55921888|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
55921889|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55921892|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55921912|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55921913|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55921914|NCT03861091|Risedronic Acid|risedronic acid|mesh-list
55921915|NCT03861091|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55921916|NCT03861091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55921917|NCT03861091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921918|NCT03861091|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55921919|NCT03861091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921920|NCT03861091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55921921|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
55921924|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55921925|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
55921926|NCT03855007|Hormones|hormones|mesh-ancestor
55921927|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55921928|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921929|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55921930|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55921931|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55921961|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55921962|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55921963|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
55921964|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55921965|NCT01675999|Antidotes|antidotes|mesh-ancestor
55921966|NCT01675999|Protective Agents|protective agents|mesh-ancestor
55921967|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
55921968|NCT01675999|Vitamins|vitamins|mesh-ancestor
55921969|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
55921970|NCT01425359|Ranolazine|ranolazine|mesh-list
55921971|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55921972|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55921973|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921974|NCT04404361|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
55921975|NCT04404361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55921976|NCT04404361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55921977|NCT04404361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55921978|NCT03875755|Inositol|inositol|mesh-list
55921979|NCT03875755|Vitamin B Complex|vitamin b complex|mesh-ancestor
55921980|NCT03875755|Vitamins|vitamins|mesh-ancestor
55921981|NCT03875755|Micronutrients|micronutrients|mesh-ancestor
55922021|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922022|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
55922023|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922024|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922025|NCT04115748|Adalimumab|adalimumab|mesh-list
55922026|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922077|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922078|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55922079|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
55922080|NCT02082769|Protective Agents|protective agents|mesh-ancestor
55922081|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922082|NCT03751423|Fentanyl|fentanyl|mesh-list
55922083|NCT03751423|Ketamine|ketamine|mesh-list
55922084|NCT03751423|Morphine|morphine|mesh-list
55922085|NCT03751423|Analgesics|analgesics|mesh-ancestor
55922086|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
55922087|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922088|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922089|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55922090|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55922091|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
55922092|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
55922093|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922094|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55922095|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55922096|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922097|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922098|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55922099|NCT03751423|Narcotics|narcotics|mesh-ancestor
55922100|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55922101|NCT03745729|Allopurinol|allopurinol|mesh-list
55922102|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
55922103|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922104|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922105|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
55922106|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922107|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55922108|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
55922109|NCT03745729|Protective Agents|protective agents|mesh-ancestor
55922110|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922111|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
55922112|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55922113|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
55922114|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922115|NCT04904952|Expectorants|expectorants|mesh-ancestor
55922116|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
55922117|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55922118|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
55922119|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922120|NCT04904952|Protective Agents|protective agents|mesh-ancestor
55922121|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922122|NCT04904952|Antidotes|antidotes|mesh-ancestor
55922124|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55922125|NCT03661411|Clopidogrel|clopidogrel|mesh-list
55922126|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55922127|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55922128|NCT03661411|Analgesics|analgesics|mesh-ancestor
55922140|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
55922165|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55922166|NCT03742297|Growth Substances|growth substances|mesh-ancestor
55922167|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
55922168|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55922169|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
55922170|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922171|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55922172|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922173|NCT01677403|Tobramycin|tobramycin|mesh-list
55922174|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55922175|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922176|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
55922177|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55922178|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55922179|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55922180|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
55922182|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922183|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922184|NCT03441750|Metformin|metformin|mesh-list
55922185|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55922220|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55922221|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55922222|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922223|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922224|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55922225|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55922226|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922227|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
55922228|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922229|NCT03825757|Aspirin|aspirin|mesh-list
55922230|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
55922231|NCT03825757|Salicylates|salicylates|mesh-list
55922232|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922233|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
55922283|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55922284|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
55922285|NCT03644485|Tacrolimus|tacrolimus|mesh-list
55922286|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922287|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
55922288|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922289|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55922290|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922291|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922292|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55922293|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922294|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55922295|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
55922296|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55922297|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922298|NCT03807037|Tocotrienols|tocotrienols|mesh-list
55922299|NCT03807037|Vitamin E|vitamin e|mesh-list
55922300|NCT03807037|Tocopherols|tocopherols|mesh-list
55922301|NCT03807037|Tocovid|tocovid|mesh-list
55922302|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
55734767|NCT05303311|Meperidine|meperidine|mesh-list
55922303|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922304|NCT03807037|Protective Agents|protective agents|mesh-ancestor
55922305|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922307|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
55922308|NCT03805789|Protease Inhibitors|protease inhibitors|mesh-list
55922309|NCT03805789|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55922315|NCT03805399|Sirolimus|sirolimus|mesh-list
55922331|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
55922332|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922333|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922334|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55922335|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55922336|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922337|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55922338|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
55922339|NCT03802591|Capecitabine|capecitabine|mesh-list
55922340|NCT03802591|Oxaliplatin|oxaliplatin|mesh-list
55922341|NCT03802591|Antibodies|antibodies|mesh-list
55922342|NCT03802591|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55922343|NCT03802591|Immunologic Factors|immunologic factors|mesh-ancestor
55922344|NCT03802591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922345|NCT03802591|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55922346|NCT03802591|Antimetabolites|antimetabolites|mesh-ancestor
55922347|NCT03802591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922348|NCT03802591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922349|NCT03725059|Paclitaxel|paclitaxel|mesh-list
55922350|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
55922351|NCT03725059|Doxorubicin|doxorubicin|mesh-list
55922352|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
55922353|NCT03725059|Epirubicin|epirubicin|mesh-list
55922354|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55922355|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922356|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
55922357|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
55922358|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
55922391|NCT04403503|Thrombin|thrombin|mesh-list
55922392|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55922393|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
55922394|NCT04403503|Coagulants|coagulants|mesh-ancestor
55922395|NCT00249795|Irbesartan|irbesartan|mesh-list
55922396|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55922397|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55922398|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55922399|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922400|NCT04404127|Basiliximab|basiliximab|mesh-list
55922401|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922402|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
55922403|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922404|NCT02651220|Adapalene|adapalene|mesh-list
55743161|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
55922405|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
55922406|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55922407|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
55922408|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55922409|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55922411|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
55922412|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922413|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922441|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55922442|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55922443|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
55922444|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
55922445|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922446|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922447|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922448|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55922449|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
55922450|NCT04209504|Bupivacaine|bupivacaine|mesh-list
55922451|NCT04209504|Ropivacaine|ropivacaine|mesh-list
55922452|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
55922453|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
55922454|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922455|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922456|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
55922457|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922458|NCT03704610|Infliximab|infliximab|mesh-list
55922459|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
55922460|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55922495|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55922496|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922497|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922498|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55922499|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55922500|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55922501|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55922502|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
55922504|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
55922505|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
55922506|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922507|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922508|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922509|NCT03792763|Denosumab|denosumab|mesh-list
55922510|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55922511|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55922512|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922513|NCT04412694|Dexamethasone|dexamethasone|mesh-list
55922514|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
55922515|NCT04412694|BB 1101|bb 1101|mesh-list
55922516|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922517|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
55922518|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
55922519|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922520|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922523|NCT04412694|Hormones|hormones|mesh-ancestor
55922545|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922546|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922547|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
55922548|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
55922549|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922550|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
55922551|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55922552|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
55922555|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55922556|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922557|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922558|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
55922559|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922560|NCT01274247|Benzocaine|benzocaine|mesh-list
55922561|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
55922562|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
55922563|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922564|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922600|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
55922601|NCT01274403|Hormones|hormones|mesh-ancestor
55922602|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55922603|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922604|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55922605|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922606|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55922607|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
55922608|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922609|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55922610|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922611|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
55922612|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
55922613|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55922614|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922615|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55922616|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55922617|NCT01274403|Growth Substances|growth substances|mesh-ancestor
55922618|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
55922619|NCT03700099|Docetaxel|docetaxel|mesh-list
55922620|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922621|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
55922622|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
55922651|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55922652|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922653|NCT03772717|Immunoglobulins|immunoglobulins|mesh-list
55922654|NCT03772717|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55922655|NCT03772717|gamma-Globulins|gamma-globulins|mesh-list
55922656|NCT03772717|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55922657|NCT03772717|Immunologic Factors|immunologic factors|mesh-ancestor
55922658|NCT03772717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922659|NCT02652156|Bupivacaine|bupivacaine|mesh-list
55922660|NCT02652156|Ropivacaine|ropivacaine|mesh-list
55922661|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
55922662|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
55922663|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922664|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922665|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
55922666|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922667|NCT03699865|Nicotine|nicotine|mesh-list
55922668|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55922670|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922671|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922672|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55922673|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55922674|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
55922675|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922676|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922677|NCT03699319|Leucovorin|leucovorin|mesh-list
55922678|NCT03699319|Folic Acid|folic acid|mesh-list
55922679|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
55922680|NCT03699319|Irinotecan|irinotecan|mesh-list
55922681|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
55922698|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922700|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922701|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922702|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55922703|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
55922704|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55922705|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55922706|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55922707|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922708|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922709|NCT02117076|Gabapentin|gabapentin|mesh-list
55922710|NCT02117076|Analgesics|analgesics|mesh-ancestor
55922711|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
55922712|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922713|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922714|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
55922715|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55922716|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55922717|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55922718|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55922719|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55922720|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55922721|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922722|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922723|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
55922743|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922744|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
55922745|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
55922746|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
55922747|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55922748|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55922749|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
55922750|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
55922751|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922752|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922753|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922754|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55922755|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
55922756|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55922757|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55922758|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
55922759|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55922760|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55922761|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55922762|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922763|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55922764|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55922765|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922766|NCT03704688|Trametinib|trametinib|mesh-list
55922767|NCT03704688|Ponatinib|ponatinib|mesh-list
55922768|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922792|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55922793|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55922794|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55922796|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922797|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922798|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922799|NCT03767257|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
55922800|NCT03767257|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55922801|NCT03767257|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55922802|NCT03767257|Antimetabolites|antimetabolites|mesh-ancestor
55922803|NCT03767257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922804|NCT03767257|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55922805|NCT03765541|Cytarabine|cytarabine|mesh-list
55922806|NCT03765541|Dexamethasone|dexamethasone|mesh-list
55922807|NCT03765541|Azacitidine|azacitidine|mesh-list
55922808|NCT03765541|Amsacrine|amsacrine|mesh-list
55922809|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55922810|NCT03765541|Antiemetics|antiemetics|mesh-ancestor
55922811|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
55922812|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922813|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922814|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55922815|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
55922844|NCT00005803|Cytarabine|cytarabine|mesh-list
55922845|NCT00005803|Cyclosporine|cyclosporine|mesh-list
55922846|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
55922847|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
55922848|NCT00005803|Melphalan|melphalan|mesh-list
55922849|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
55922850|NCT00005803|Carmustine|carmustine|mesh-list
55922851|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55922852|NCT00005803|Fludarabine|fludarabine|mesh-list
55922853|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
55922854|NCT00005803|Etoposide|etoposide|mesh-list
55922855|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
55922856|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
55922857|NCT00005803|Cyclosporins|cyclosporins|mesh-list
55922858|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55922859|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
55922860|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922861|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55922862|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55922863|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
55922864|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922865|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922866|NCT00005803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55922867|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55922868|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
55922869|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55922870|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55922871|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55922872|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922874|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922875|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
55922876|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
55922877|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55922878|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55922879|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55922880|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
55922881|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55922882|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
55922884|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
55922885|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
55922886|NCT00244725|Warfarin|warfarin|mesh-list
55922887|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
55922888|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
55922889|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55922890|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922891|NCT04185012|Benralizumab|benralizumab|mesh-list
55922892|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55922893|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
55922894|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
55922895|NCT01275183|Cisplatin|cisplatin|mesh-list
55922896|NCT01275183|Docetaxel|docetaxel|mesh-list
55922898|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
55922899|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
55922900|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
55922901|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922902|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55922903|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55922904|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
55922905|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922941|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922942|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
55922943|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
55922944|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55922945|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55922946|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55922947|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55922948|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922949|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
55922950|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55922951|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55922952|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55922953|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55922954|NCT01505114|Tenofovir|tenofovir|mesh-list
55922955|NCT01505114|Emtricitabine|emtricitabine|mesh-list
55922956|NCT01505114|Maraviroc|maraviroc|mesh-list
55922957|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
55922958|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55922959|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55922960|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55922961|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922962|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922963|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55922964|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55922965|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55922966|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55922967|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55922987|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
55922988|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
55922989|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
55922990|NCT03663205|Cisplatin|cisplatin|mesh-list
55922991|NCT03663205|Carboplatin|carboplatin|mesh-list
55922992|NCT03663205|Pemetrexed|pemetrexed|mesh-list
55922993|NCT03663205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55922994|NCT03663205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55922995|NCT03663205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55922996|NCT03663205|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55922997|NCT03663205|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55922998|NCT01275729|Furosemide|furosemide|mesh-list
55922999|NCT01275729|Diuretics|diuretics|mesh-ancestor
55923000|NCT01275729|Natriuretic Agents|natriuretic agents|mesh-ancestor
55923001|NCT01275729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923002|NCT01275729|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55923003|NCT01275729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923004|NCT01275729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923007|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923042|NCT00245037|Fludarabine|fludarabine|mesh-list
55923043|NCT00245037|Busulfan|busulfan|mesh-list
55923044|NCT00245037|Phenytoin|phenytoin|mesh-list
55923045|NCT00245037|Cyclosporins|cyclosporins|mesh-list
55923046|NCT00245037|Lenograstim|lenograstim|mesh-list
55923047|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55734867|NCT03443869|Acyclovir|acyclovir|mesh-list
55923049|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55923050|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923051|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55923052|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
55923053|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923054|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923055|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
55923056|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923057|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55923058|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55923059|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
55923060|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55923061|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55923062|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
55923096|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923097|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55923099|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
55923100|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55923101|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923103|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55923104|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
55923105|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
55923106|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923107|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923108|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55923109|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
55923110|NCT05347381|Hormones|hormones|mesh-ancestor
55923111|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55923112|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55923113|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923114|NCT02651688|Enclomiphene|enclomiphene|mesh-list
55923115|NCT02651688|Clomiphene|clomiphene|mesh-list
55923149|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923151|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55923152|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923153|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
55923154|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
55923155|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55923156|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55923157|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55923158|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55923159|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55923160|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
55923161|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923162|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923163|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923164|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
55923165|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55923166|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
55923167|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55923168|NCT00762177|Triclosan|triclosan|mesh-list
55923169|NCT00762177|Fluorides|fluorides|mesh-list
55923170|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
55923171|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
55923172|NCT00762177|Protective Agents|protective agents|mesh-ancestor
55923173|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923174|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55923175|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923182|NCT03458455|Nivolumab|nivolumab|mesh-list
55923197|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923198|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55923199|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923200|NCT00777855|Rifampin|rifampin|mesh-list
55923201|NCT00777855|Warfarin|warfarin|mesh-list
55923202|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
55923203|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55923204|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
55923205|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55923206|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923207|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
55923208|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55923209|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923210|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923211|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55923212|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55923213|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55923214|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55923215|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55923216|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55923217|NCT03523429|Blinatumomab|blinatumomab|mesh-list
55923218|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923219|NCT05125380|Acetic Acid|acetic acid|mesh-list
55923220|NCT05125380|Retinol acetate|retinol acetate|mesh-list
55923246|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923247|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923248|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
55923249|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
55923251|NCT03807297|Sevoflurane|sevoflurane|mesh-list
55923252|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55923253|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923254|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923255|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55923256|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
55923257|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
55923258|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55923259|NCT03807297|Analgesics|analgesics|mesh-ancestor
55923260|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
55923261|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923262|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55923263|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55923264|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55923265|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
55923266|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923267|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923268|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55923270|NCT03573349|Ketamine|ketamine|mesh-list
55923418|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55923297|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923298|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55923299|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
55923300|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55923301|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
55923302|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923303|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55923304|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55923305|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55923306|NCT03458221|Androgen Antagonists|androgen antagonists|mesh-ancestor
55923308|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923309|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923310|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923311|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55923312|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55923313|NCT03513445|Epinephrine|epinephrine|mesh-list
55923314|NCT03513445|Morphine|morphine|mesh-list
55923315|NCT03513445|Ropivacaine|ropivacaine|mesh-list
55923316|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55923317|NCT03513445|Narcotics|narcotics|mesh-ancestor
55923318|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923349|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
55923350|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923351|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55923353|NCT00758667|Protective Agents|protective agents|mesh-ancestor
55923354|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923355|NCT05041920|Omeprazole|omeprazole|mesh-list
55923356|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55923357|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55923358|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55923359|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923360|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923361|NCT03567577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55923362|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55923363|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55923364|NCT03508921|Trimethoprim|trimethoprim|mesh-list
55923365|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
55923366|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55923367|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55923368|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923369|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
55923370|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55923371|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923372|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923373|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55923374|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923375|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923376|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
55923377|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923394|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
55923395|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923396|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923397|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
55923398|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923399|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55923400|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
55923401|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55923402|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923403|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923404|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55923405|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
55923406|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55923407|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55923408|NCT00778167|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55923409|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923410|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55923411|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923412|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923413|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
55923414|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923416|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
55923417|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55923421|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923425|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923427|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55923430|NCT04345419|Remdesivir|remdesivir|mesh-list
55923432|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923433|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
55923434|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923435|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
55923436|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55923437|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923438|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923439|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
55923440|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55923441|NCT00759603|Rituximab|rituximab|mesh-list
55923442|NCT00759603|Lenalidomide|lenalidomide|mesh-list
55923443|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55923444|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923445|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
55923446|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923447|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55923448|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55923449|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55923450|NCT00759603|Growth Substances|growth substances|mesh-ancestor
55923451|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
55923452|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55923453|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55923454|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55923455|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923456|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923457|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55923458|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55923459|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55923460|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
55923461|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756697|NCT02445547|Hormones|hormones|mesh-list
55923462|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923463|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55923464|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55923465|NCT03809325|Dopamine Agents|dopamine agents|mesh-ancestor
55923466|NCT03510390|Metformin|metformin|mesh-list
55923467|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55923468|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923469|NCT03806673|Bupivacaine|bupivacaine|mesh-list
55923470|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
55923471|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
55923472|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923473|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923474|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
55923475|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923476|NCT03291990|Temozolomide|temozolomide|mesh-list
55923477|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55923478|NCT03291990|Alkylating Agents|alkylating agents|mesh-ancestor
55923479|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923480|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923518|NCT04762147|Narcotics|narcotics|mesh-ancestor
55923519|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923520|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923521|NCT04762147|Analgesics|analgesics|mesh-ancestor
55923522|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
55923523|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923524|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55923525|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55923526|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
55923527|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
55923528|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55923529|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
55923530|NCT04273737|Amantadine|amantadine|mesh-list
55923531|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55923532|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55923533|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
55923534|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923535|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
55923536|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923537|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923538|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923539|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55923540|NCT04273737|Analgesics|analgesics|mesh-ancestor
55923541|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
55923542|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923543|NCT02963064|Antibodies|antibodies|mesh-list
55923544|NCT02963064|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55923545|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
55923564|NCT04325880|Mirabegron|mirabegron|mesh-list
55923565|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55923566|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55923567|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55923568|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
55923569|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923570|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923571|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923572|NCT04325880|Urological Agents|urological agents|mesh-ancestor
55923573|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55923574|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55923575|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
55923576|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55923577|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55923578|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55923579|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55923580|NCT04846218|Progesterone|progesterone|mesh-list
55923581|NCT04846218|Progestins|progestins|mesh-ancestor
55923582|NCT04846218|Hormones|hormones|mesh-ancestor
55923583|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55923584|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923585|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
55923586|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55923587|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
55923588|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55923589|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55923590|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55923591|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923592|NCT02512692|Gemcitabine|gemcitabine|mesh-list
55923593|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923607|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55923608|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923609|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923611|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55923612|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55923613|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
55923614|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55923615|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923616|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55923617|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
55923618|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55923619|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923620|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923621|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55923623|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
55923624|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923625|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55923626|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55923627|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55923628|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
55923629|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923630|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923654|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923656|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55923657|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55923658|NCT04572828|Analgesics|analgesics|mesh-ancestor
55923659|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
55923660|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923661|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923662|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55923663|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55923664|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
55923665|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55923666|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923667|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923670|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55923712|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55923713|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
55923714|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923715|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923716|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55923717|NCT03806049|Paclitaxel|paclitaxel|mesh-list
55923718|NCT03806049|Bevacizumab|bevacizumab|mesh-list
55923719|NCT03806049|Carboplatin|carboplatin|mesh-list
55923720|NCT03806049|Niraparib|niraparib|mesh-list
55923721|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55923722|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923723|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
55923724|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
55923725|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
55923726|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923727|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55923728|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55923729|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55923730|NCT03806049|Growth Substances|growth substances|mesh-ancestor
55923765|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923766|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
55923767|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923768|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923770|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923773|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55923774|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55923775|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55923776|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
55923777|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923778|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923779|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55923780|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
55923781|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55923782|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55923783|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923784|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55923785|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
55923786|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55923787|NCT03451591|Protective Agents|protective agents|mesh-ancestor
55923788|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55923792|NCT03451591|Diuretics|diuretics|mesh-ancestor
55923814|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55923815|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923816|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
55923817|NCT02149173|Protective Agents|protective agents|mesh-ancestor
55923818|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923819|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
55923820|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
55923821|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923822|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55923823|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923824|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923825|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
55923826|NCT03805503|Procaine|procaine|mesh-list
55923827|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
55923828|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
55923829|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923830|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923831|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
55923832|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923833|NCT01504412|Pregabalin|pregabalin|mesh-list
55923834|NCT01504412|Analgesics|analgesics|mesh-ancestor
55923835|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
55923836|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923838|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
55923862|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
55923863|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923864|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923865|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55923866|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55923867|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55923868|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923869|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55923870|NCT00088465|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55923871|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55923872|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55923873|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923874|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55923875|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
55923876|NCT04405674|Paclitaxel|paclitaxel|mesh-list
55923877|NCT04405674|Bevacizumab|bevacizumab|mesh-list
55923882|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
55923883|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
55923884|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
55923885|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923886|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55923887|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55923888|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55923889|NCT04405674|Growth Substances|growth substances|mesh-ancestor
55923890|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923891|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
55923892|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923893|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55923894|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55923895|NCT00088153|Progesterone|progesterone|mesh-list
55923896|NCT00088153|Estrogens|estrogens|mesh-list
55923897|NCT00088153|Progestins|progestins|mesh-ancestor
55923898|NCT00088153|Hormones|hormones|mesh-ancestor
55923899|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55923900|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923901|NCT02074358|Apixaban|apixaban|mesh-list
55923902|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55923903|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
55923904|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55923905|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
55923906|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923907|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923908|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
55923909|NCT05743725|Magnesium Sulfate|magnesium sulfate|mesh-list
55923910|NCT05743725|Dexmedetomidine|dexmedetomidine|mesh-list
55923911|NCT05743725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55923912|NCT05743725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923913|NCT05743725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923953|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923954|NCT04094558|Lactulose|lactulose|mesh-list
55923955|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55923956|NCT01502228|Sunitinib|sunitinib|mesh-list
55923957|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55923958|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55923959|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55923960|NCT01502228|Growth Substances|growth substances|mesh-ancestor
55923961|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923962|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
55923963|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55923964|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55923965|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55923966|NCT05011812|Ritonavir|ritonavir|mesh-list
55923967|NCT05011812|Midazolam|midazolam|mesh-list
55923968|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55923969|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55923970|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55923971|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55923972|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55923988|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
55923989|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55923990|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55923991|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55923993|NCT05535231|Turmeric extract|turmeric extract|mesh-list
55923994|NCT05535231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55923995|NCT05535231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55923996|NCT05535231|Analgesics|analgesics|mesh-ancestor
55923997|NCT05535231|Sensory System Agents|sensory system agents|mesh-ancestor
55923998|NCT05535231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55923999|NCT05535231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924000|NCT05535231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924001|NCT05535231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924002|NCT05535231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924044|NCT05743179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924046|NCT01479764|Neostigmine|neostigmine|mesh-list
55924047|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55924048|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924049|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924050|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
55924051|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924052|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924053|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55924054|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
55924055|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924056|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55924057|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55924058|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55924061|NCT01479530|Rasagiline|rasagiline|mesh-list
55924062|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55924063|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924064|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924065|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55924110|NCT05743101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55924111|NCT05743101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924113|NCT05743101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55924114|NCT05743101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55924115|NCT05743101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55924116|NCT05743101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924117|NCT05743101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924118|NCT05743101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924119|NCT05743101|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55924120|NCT05743101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55924121|NCT01500434|Aspirin|aspirin|mesh-list
55924122|NCT01500434|Ticlopidine|ticlopidine|mesh-list
55924123|NCT01500434|Clopidogrel|clopidogrel|mesh-list
55924124|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55924125|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924126|NCT01500434|Analgesics|analgesics|mesh-ancestor
55924127|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
55924128|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924129|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924130|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924131|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924132|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55924133|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55924134|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924135|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55924136|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55924152|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924153|NCT00794547|Calcitriol|calcitriol|mesh-list
55924154|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55924155|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924156|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55924157|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55924158|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924159|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55924160|NCT00794547|Vitamins|vitamins|mesh-ancestor
55924161|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
55924162|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55924163|NCT03493165|Everolimus|everolimus|mesh-list
55924164|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924165|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924184|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55924185|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55924187|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924188|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
55924189|NCT03804723|Hormones|hormones|mesh-ancestor
55924190|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55924191|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924192|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55924193|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924194|NCT00797277|Lorazepam|lorazepam|mesh-list
55924195|NCT00797277|Haloperidol|haloperidol|mesh-list
55924196|NCT00797277|Olanzapine|olanzapine|mesh-list
55924197|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
55924198|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
55924199|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
55924200|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924201|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924202|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55924203|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55924204|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55924205|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924233|NCT05742789|Anesthetics, General|anesthetics, general|mesh-ancestor
55924235|NCT05742789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55924236|NCT05742789|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55924237|NCT01500278|Adalimumab|adalimumab|mesh-list
55924238|NCT01500278|Methotrexate|methotrexate|mesh-list
55924239|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
55924240|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55924241|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
55924242|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55924243|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924244|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55924245|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
55924246|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924247|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924248|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
55924249|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924250|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55924251|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924252|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
55924253|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924254|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55924278|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55924279|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924280|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
55924281|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924282|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924283|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55924284|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
55924285|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924286|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924287|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55924288|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55924289|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
55924290|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55924291|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55924292|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
55924293|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
55924294|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924295|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55924296|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55924297|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55924298|NCT01478828|Lovastatin|lovastatin|mesh-list
55924299|NCT01478828|L 647318|l 647318|mesh-list
55924300|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
55924301|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55924308|NCT00085423|Aldesleukin|aldesleukin|mesh-list
55924309|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
55924310|NCT00085423|Fludarabine|fludarabine|mesh-list
55924311|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
55924312|NCT00085423|Interleukin-2|interleukin-2|mesh-list
55924313|NCT00085423|Molgramostim|molgramostim|mesh-list
55924314|NCT00085423|Sargramostim|sargramostim|mesh-list
55924315|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924316|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
55924317|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924318|NCT00085423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924319|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55924320|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
55924321|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924322|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924323|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55924324|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55924325|NCT00085423|Antimetabolites|antimetabolites|mesh-ancestor
55924326|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924327|NCT00085423|Analgesics|analgesics|mesh-ancestor
55924328|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
55924329|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924330|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55924331|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55924333|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924336|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55924337|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924338|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
55924339|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
55924340|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
55924341|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924342|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924343|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924344|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
55924345|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924346|NCT03087877|Acetaminophen|acetaminophen|mesh-list
55924347|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924348|NCT03087877|Analgesics|analgesics|mesh-ancestor
55924349|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
55924350|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924351|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924352|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
55924353|NCT05742477|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55924354|NCT05742477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924355|NCT03447379|Aspirin|aspirin|mesh-list
55924356|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55924382|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924383|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55924384|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55924385|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55924386|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924387|NCT05740449|Decitabine|decitabine|mesh-list
55924388|NCT05740449|Venetoclax|venetoclax|mesh-list
55924389|NCT05740449|Navitoclax|navitoclax|mesh-list
55924390|NCT05740449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55924391|NCT05740449|Antimetabolites|antimetabolites|mesh-ancestor
55924392|NCT05740449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924393|NCT05740449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924394|NCT05740449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924395|NCT03485677|Eliglustat|eliglustat|mesh-list
55924396|NCT03485677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924397|NCT03485677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924398|NCT05358249|Cetuximab|cetuximab|mesh-list
55924399|NCT05358249|Trametinib|trametinib|mesh-list
55924400|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924401|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924402|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55924403|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924404|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924405|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
55924406|NCT01677949|Etoposide|etoposide|mesh-list
55924407|NCT01677949|Clofarabine|clofarabine|mesh-list
55924408|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924409|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
55924410|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924428|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924429|NCT03483883|Antiviral Agents|antiviral agents|mesh-ancestor
55924430|NCT03483883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924431|NCT03483883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924432|NCT03483883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924433|NCT03483883|Immunologic Factors|immunologic factors|mesh-ancestor
55924434|NCT03483883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924435|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924436|NCT03482167|Niacinamide|niacinamide|mesh-list
55924437|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
55924438|NCT03482167|Vitamins|vitamins|mesh-ancestor
55924439|NCT03482167|Micronutrients|micronutrients|mesh-ancestor
55924440|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924441|NCT00799227|Dexamethasone|dexamethasone|mesh-list
55924442|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924443|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
55924444|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
55924445|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924446|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924447|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55924448|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
55924449|NCT00799227|Hormones|hormones|mesh-ancestor
55924450|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55924451|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55924452|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924453|NCT03803787|Budesonide|budesonide|mesh-list
55924454|NCT03803787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924455|NCT03803787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55924456|NCT03803787|Autonomic Agents|autonomic agents|mesh-ancestor
55924457|NCT03803787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735064|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924468|NCT00770133|Naphazoline|naphazoline|mesh-list
55924469|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
55924470|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
55924471|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55924472|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
55924473|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
55924474|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924475|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924476|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924477|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55924478|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55924479|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55924480|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
55924481|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
55924482|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55924483|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
55924484|NCT00770757|Pomalidomide|pomalidomide|mesh-list
55924485|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
55924486|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924487|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55924488|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55924489|NCT00770757|Growth Substances|growth substances|mesh-ancestor
55924490|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
55924492|NCT01425281|Everolimus|everolimus|mesh-list
55924499|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
55924500|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924501|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55924502|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55924503|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924504|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
55924505|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
55924506|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55924507|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924508|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924509|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924510|NCT04113720|Analgesics|analgesics|mesh-ancestor
55924511|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
55924512|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924513|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55735089|NCT01709981|Colchicine|colchicine|mesh-list
55924515|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55924516|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
55924517|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924518|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924519|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
55924520|NCT04113720|Anesthetics|anesthetics|mesh-ancestor
55924521|NCT01402817|Sunitinib|sunitinib|mesh-list
55924522|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924523|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55924524|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55924525|NCT01402817|Growth Substances|growth substances|mesh-ancestor
55924526|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924527|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
55924528|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55924543|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
55924544|NCT00081289|Irinotecan|irinotecan|mesh-list
55924545|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
55924546|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
55924547|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924548|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55924549|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924550|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924551|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
55924552|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924553|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55924554|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55924555|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924556|NCT00081289|Antidotes|antidotes|mesh-ancestor
55924557|NCT00081289|Protective Agents|protective agents|mesh-ancestor
55924558|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
55924559|NCT00081289|Vitamins|vitamins|mesh-ancestor
55924560|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
55924563|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924564|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924565|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55924566|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55924567|NCT01478594|Growth Substances|growth substances|mesh-ancestor
55924568|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924569|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
55924570|NCT01424813|Albuterol|albuterol|mesh-list
55924571|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55924572|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
55924588|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924589|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924590|NCT03480061|Analgesics|analgesics|mesh-ancestor
55924591|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
55924592|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924593|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55924594|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55924596|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
55924597|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924598|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924599|NCT03389022|Ketamine|ketamine|mesh-list
55924600|NCT03389022|Analgesics|analgesics|mesh-ancestor
55924601|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
55924602|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924603|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924604|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55924605|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55924606|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
55924607|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
55924609|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55924610|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55924611|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924612|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924613|NCT00080899|Fenretinide|fenretinide|mesh-list
55924614|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924615|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55924616|NCT00080899|Protective Agents|protective agents|mesh-ancestor
55924617|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924618|NCT03627858|Beclomethasone|beclomethasone|mesh-list
55924619|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
55924620|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
55924630|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
55924631|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924632|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924633|NCT03627858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924634|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
55924635|NCT03627858|Hormones|hormones|mesh-ancestor
55924636|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55924637|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55924638|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55924639|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55924640|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
55924641|NCT03086785|Apatinib|apatinib|mesh-list
55924642|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924643|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55924644|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924645|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924646|NCT03259698|Tenofovir|tenofovir|mesh-list
55924647|NCT03259698|Emtricitabine|emtricitabine|mesh-list
55924648|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
55924649|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
55924650|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924651|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55924652|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55924653|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924654|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924655|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55924656|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55924657|NCT00089635|Panitumumab|panitumumab|mesh-list
55924658|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924659|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924660|NCT03445728|Nicorandil|nicorandil|mesh-list
55924665|NCT03445728|Vitamins|vitamins|mesh-ancestor
55924674|NCT03159000|Anesthetics, Local|anesthetics, local|mesh-ancestor
55924675|NCT03159000|Anesthetics|anesthetics|mesh-ancestor
55924676|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924677|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924678|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
55924679|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924680|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55924681|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55924683|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55924684|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924685|NCT00086671|Antibodies|antibodies|mesh-list
55924686|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55924687|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
55924688|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924689|NCT02464878|Etanercept|etanercept|mesh-list
55924690|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
55924691|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55924692|NCT02464878|Basiliximab|basiliximab|mesh-list
55924693|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55924694|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
55924695|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55924696|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924697|NCT02464878|Analgesics|analgesics|mesh-ancestor
55924698|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
55924699|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924700|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924701|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924702|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924703|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55924704|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924705|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
55924706|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55924707|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55924708|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
55924709|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924711|NCT02010606|Bevacizumab|bevacizumab|mesh-list
55924712|NCT02010606|Temozolomide|temozolomide|mesh-list
55924713|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924714|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924715|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55924716|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55924717|NCT02010606|Growth Substances|growth substances|mesh-ancestor
55924718|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924719|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
55924720|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55924721|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
55924722|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924723|NCT00084253|Ritonavir|ritonavir|mesh-list
55924724|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55924725|NCT00084253|Lamivudine|lamivudine|mesh-list
55924726|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55924727|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55924728|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
55924729|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924730|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924731|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55924732|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55924733|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
55924734|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924735|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55924736|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55924737|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55924738|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55924739|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
55924755|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924756|NCT00083941|Analgesics|analgesics|mesh-ancestor
55924757|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
55924758|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924759|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924760|NCT02856438|Dexamethasone|dexamethasone|mesh-list
55924761|NCT02856438|Lenalidomide|lenalidomide|mesh-list
55924762|NCT02856438|Elotuzumab|elotuzumab|mesh-list
55924763|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55924764|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
55924765|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
55924766|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924767|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924768|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55924769|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
55924770|NCT02856438|Hormones|hormones|mesh-ancestor
55924771|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55924772|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55924773|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924774|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
55924775|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55924776|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55924777|NCT02856438|Growth Substances|growth substances|mesh-ancestor
55924778|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
55924779|NCT01678495|Plasminogen|plasminogen|mesh-list
55924780|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55924781|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55924782|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55924783|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924784|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
55924785|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924786|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55924787|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55924788|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924789|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
55924792|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55924793|NCT01678651|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55924794|NCT01678651|Hormones|hormones|mesh-ancestor
55924795|NCT01678651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55924796|NCT01678651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924797|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55924798|NCT03084523|Hematinics|hematinics|mesh-ancestor
55924799|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55924800|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55924801|NCT04094090|Riboflavin|riboflavin|mesh-list
55924802|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
55924803|NCT04094090|Vitamins|vitamins|mesh-ancestor
55924804|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
55924805|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735158|NCT03463967|Lycopene|lycopene|mesh-list
55924806|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55924807|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
55924808|NCT04670796|Trastuzumab|trastuzumab|mesh-list
55924809|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924810|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924811|NCT02525796|Eplerenone|eplerenone|mesh-list
55924812|NCT02525796|Amiloride|amiloride|mesh-list
55924813|NCT02525796|Cinacalcet|cinacalcet|mesh-list
55924814|NCT02525796|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55924815|NCT02525796|Hormone Antagonists|hormone antagonists|mesh-ancestor
55924816|NCT02525796|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55924817|NCT02525796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924818|NCT02525796|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55924819|NCT02525796|Diuretics|diuretics|mesh-ancestor
55924820|NCT02525796|Natriuretic Agents|natriuretic agents|mesh-ancestor
55924821|NCT02525796|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55924822|NCT02525796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55924823|NCT02525796|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
55924824|NCT02525796|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
55924825|NCT02525796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55924826|NCT02525796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55924827|NCT02525796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924828|NCT02525796|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55924830|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55924831|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924832|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
55924833|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
55924834|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
55924835|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924836|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
55924837|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924838|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924839|NCT03083197|Azithromycin|azithromycin|mesh-list
55924840|NCT03083197|Doxycycline|doxycycline|mesh-list
55924841|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55924842|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924843|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
55924847|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55924848|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55924849|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55924850|NCT01678963|Protective Agents|protective agents|mesh-ancestor
55924851|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924852|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924853|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55924854|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55924855|NCT01678963|Growth Substances|growth substances|mesh-ancestor
55924856|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
55924857|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55924858|NCT00790335|Plasminogen|plasminogen|mesh-list
55924859|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55924860|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55735176|NCT04222595|Vaccines|vaccines|mesh-list
55924876|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924877|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55924878|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
55924879|NCT04402411|Narcotics|narcotics|mesh-ancestor
55924880|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924881|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924882|NCT04402411|Analgesics|analgesics|mesh-ancestor
55924883|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
55924884|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924885|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
55924886|NCT05265507|Ondansetron|ondansetron|mesh-list
55924887|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
55924888|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
55924889|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924890|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924891|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55924892|NCT05265507|Antipruritics|antipruritics|mesh-ancestor
55924893|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
55924894|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55924895|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
55924896|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924897|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924898|NCT05265507|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55924899|NCT05265507|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55924900|NCT05265507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924901|NCT05265507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55924902|NCT05265507|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55924903|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55924904|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55924905|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55924906|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
55924907|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55924909|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55924910|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55924911|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55924912|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55924913|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
55924914|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735192|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
55924915|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924916|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924917|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55924919|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
55924920|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924921|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55924922|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
55924923|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55924924|NCT05135286|Analgesics|analgesics|mesh-ancestor
55924925|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
55924926|NCT05135286|Protective Agents|protective agents|mesh-ancestor
55924927|NCT03089671|Vitamins|vitamins|mesh-list
55924928|NCT03089671|Riboflavin|riboflavin|mesh-list
55924929|NCT03089671|Vitamin B Complex|vitamin b complex|mesh-list
55924934|NCT05136924|Varenicline|varenicline|mesh-list
55924940|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924941|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
55924942|NCT00791037|Sargramostim|sargramostim|mesh-list
55924943|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55924944|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
55924945|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924946|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55924947|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55924949|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924950|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924951|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55924952|NCT04403191|Ondansetron|ondansetron|mesh-list
55924953|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
55924954|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
55924955|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55924956|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55924957|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55924958|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
55924959|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
55924960|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55924961|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
55924962|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924963|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924964|NCT04403191|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55924965|NCT04403191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55924966|NCT04403191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55924988|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55924989|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55924990|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
55924991|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55924992|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55924993|NCT01401959|Trastuzumab|trastuzumab|mesh-list
55924994|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55924995|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55924996|NCT04767035|Midazolam|midazolam|mesh-list
55924997|NCT04767035|Ketamine|ketamine|mesh-list
55924998|NCT04767035|Analgesics|analgesics|mesh-ancestor
55924999|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
55925000|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925001|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925002|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55925003|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55925005|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
55925006|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925007|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55925008|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55925009|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925010|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925011|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55925012|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55925013|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55925014|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55925015|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55925016|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
55925017|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
55925018|NCT05222529|Glycopyrrolate|glycopyrrolate|mesh-list
55925019|NCT05222529|Bromides|bromides|mesh-list
55925020|NCT05222529|Anticonvulsants|anticonvulsants|mesh-ancestor
55925021|NCT05222529|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55925022|NCT05222529|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55925028|NCT03081169|Heparin|heparin|mesh-list
55925029|NCT03081169|Enoxaparin|enoxaparin|mesh-list
55925030|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
55925031|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
55925032|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55925033|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55925034|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925035|NCT03803163|Treprostinil|treprostinil|mesh-list
55925036|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55925037|NCT05287308|Paclitaxel|paclitaxel|mesh-list
55925038|NCT05287308|Docetaxel|docetaxel|mesh-list
55925039|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55925040|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
55925041|NCT05287308|Doxorubicin|doxorubicin|mesh-list
55925042|NCT05287308|Epirubicin|epirubicin|mesh-list
55925043|NCT05287308|Pirarubicin|pirarubicin|mesh-list
55925044|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55925045|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925046|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
55925047|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
55925048|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
55925049|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925050|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55925051|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
55925052|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925054|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55925055|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
55925056|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55925057|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55925058|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55925059|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55925061|NCT00801723|Budesonide|budesonide|mesh-list
55925062|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925063|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55925064|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
55925065|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925066|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925067|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55925068|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
55925069|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
55925070|NCT00801723|Hormones|hormones|mesh-ancestor
55925071|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925072|NCT05346211|Curcumin|curcumin|mesh-list
55925073|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55925074|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55925075|NCT05346211|Analgesics|analgesics|mesh-ancestor
55925076|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
55925077|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925078|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925079|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925080|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55925081|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925082|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925083|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925084|NCT05694897|Magnesium Sulfate|magnesium sulfate|mesh-list
55925085|NCT05694897|Bupivacaine|bupivacaine|mesh-list
55925086|NCT05694897|Anesthetics, Local|anesthetics, local|mesh-ancestor
55925087|NCT05694897|Anesthetics|anesthetics|mesh-ancestor
55925088|NCT05694897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925089|NCT05694897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925090|NCT05694897|Sensory System Agents|sensory system agents|mesh-ancestor
55925091|NCT05694897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925092|NCT05694897|Analgesics|analgesics|mesh-ancestor
55925093|NCT05694897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55925094|NCT05694897|Anticonvulsants|anticonvulsants|mesh-ancestor
55925095|NCT05694897|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55925096|NCT05694897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925097|NCT05694897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925098|NCT05694897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55925099|NCT05694897|Tocolytic Agents|tocolytic agents|mesh-ancestor
55925100|NCT05694897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55925101|NCT01478048|Dexamethasone|dexamethasone|mesh-list
55925102|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
55925103|NCT01478048|Bortezomib|bortezomib|mesh-list
55925104|NCT01478048|Elotuzumab|elotuzumab|mesh-list
55925105|NCT01478048|BB 1101|bb 1101|mesh-list
55925106|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925107|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
55925108|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
55925109|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925110|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925111|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55925112|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
55925113|NCT01478048|Hormones|hormones|mesh-ancestor
55925114|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925115|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55925116|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925117|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
55925142|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55925143|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55925144|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55925150|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55925151|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55925153|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
55925154|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925155|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925156|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55925157|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55925158|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
55925159|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55925160|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55925161|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
55925163|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925164|NCT03088891|Protective Agents|protective agents|mesh-ancestor
55925165|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925166|NCT01477892|Remifentanil|remifentanil|mesh-list
55925167|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55925168|NCT01477892|Narcotics|narcotics|mesh-ancestor
55925169|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925170|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925171|NCT01477892|Analgesics|analgesics|mesh-ancestor
55925172|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
55925173|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925174|NCT00801801|Docetaxel|docetaxel|mesh-list
55925175|NCT00801801|Sorafenib|sorafenib|mesh-list
55925176|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925177|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
55925178|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
55925179|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
55925180|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925181|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55925182|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925183|NCT01499576|Acetic Acid|acetic acid|mesh-list
55925184|NCT01499576|Retinol acetate|retinol acetate|mesh-list
55925185|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55925186|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925187|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55925188|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
55925189|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925190|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55925192|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925193|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
55925194|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
55925195|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55925196|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925197|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55925198|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925199|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925200|NCT00802113|Fludarabine|fludarabine|mesh-list
55925201|NCT00802113|Busulfan|busulfan|mesh-list
55925202|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55925218|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
55925219|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925220|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925221|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55925222|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
55925223|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
55925224|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55925225|NCT00773955|Acetic Acid|acetic acid|mesh-list
55925226|NCT00773955|Retinol acetate|retinol acetate|mesh-list
55925227|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
55925228|NCT00773955|Gossypol|gossypol|mesh-list
55925229|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55925230|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925231|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55925232|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
55925254|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925255|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925256|NCT04608266|Camostat|camostat|mesh-list
55925257|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
55925258|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925259|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925260|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55925261|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55925262|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55925263|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55925264|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
55925265|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925266|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925267|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55925268|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55925269|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55925270|NCT04460352|Leucovorin|leucovorin|mesh-list
55925271|NCT04460352|Paclitaxel|paclitaxel|mesh-list
55925272|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55925273|NCT04460352|Carboplatin|carboplatin|mesh-list
55925286|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
55925287|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55925288|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55925291|NCT04460352|Protective Agents|protective agents|mesh-ancestor
55925292|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
55925293|NCT04460352|Vitamins|vitamins|mesh-ancestor
55925294|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
55925295|NCT03083353|Isradipine|isradipine|mesh-list
55925296|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55925297|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55925298|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925299|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925300|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55925301|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925302|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
55925303|NCT01421303|Etanercept|etanercept|mesh-list
55925304|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55925305|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55925306|NCT01421303|Analgesics|analgesics|mesh-ancestor
55925307|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
55925308|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925309|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925310|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925311|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55925312|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55925313|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55925314|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
55925315|NCT03703375|Gemcitabine|gemcitabine|mesh-list
55925316|NCT03703375|Azacitidine|azacitidine|mesh-list
55925317|NCT03703375|Romidepsin|romidepsin|mesh-list
55925318|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55925324|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925325|NCT03703375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55925326|NCT03703375|Immunologic Factors|immunologic factors|mesh-ancestor
55925327|NCT03703375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925328|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55925329|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55925330|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55925331|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55925332|NCT05303688|Analgesics|analgesics|mesh-ancestor
55925333|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
55925334|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925335|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925336|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925337|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55925338|NCT04383717|Azithromycin|azithromycin|mesh-list
55925339|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
55925341|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
55925342|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55925371|NCT05685277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925372|NCT05685277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55925373|NCT05685277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925374|NCT05685277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925375|NCT05685277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55925376|NCT05685277|Protease Inhibitors|protease inhibitors|mesh-ancestor
55925377|NCT05685277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925379|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
55925380|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925381|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55925382|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925383|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55925384|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925385|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55925386|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55925387|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
55925388|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925389|NCT01421225|Insulin|insulin|mesh-list
55925390|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55925391|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55925392|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925393|NCT05689021|Prednisone|prednisone|mesh-list
55925394|NCT05689021|Cortisone|cortisone|mesh-list
55925395|NCT05689021|Abiraterone Acetate|abiraterone acetate|mesh-list
55925397|NCT05689021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925398|NCT05689021|Glucocorticoids|glucocorticoids|mesh-ancestor
55925399|NCT05689021|Hormones|hormones|mesh-ancestor
55925405|NCT05689021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925414|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55925415|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
55925416|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925418|NCT05688631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925423|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55925424|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925425|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925426|NCT05007873|Decitabine|decitabine|mesh-list
55925427|NCT05007873|Dasatinib|dasatinib|mesh-list
55925428|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55925429|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
55925430|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925431|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925432|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925433|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55925434|NCT01474772|Pregabalin|pregabalin|mesh-list
55925435|NCT01474772|Analgesics|analgesics|mesh-ancestor
55925436|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
55925437|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925438|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925439|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
55925440|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55925441|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925444|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55925458|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925459|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55925460|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55925461|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925462|NCT03801759|Protective Agents|protective agents|mesh-ancestor
55925464|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925465|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55925466|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55925467|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
55925468|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55925469|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925470|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55925471|NCT03082573|Hormones|hormones|mesh-ancestor
55925472|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925473|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925474|NCT04970901|Gemcitabine|gemcitabine|mesh-list
55925475|NCT04970901|Lenalidomide|lenalidomide|mesh-list
55925476|NCT04970901|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
55925477|NCT04970901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55925478|NCT04970901|Antimetabolites|antimetabolites|mesh-ancestor
55925479|NCT04970901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925480|NCT04970901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925481|NCT04970901|Antiviral Agents|antiviral agents|mesh-ancestor
55925482|NCT04970901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925483|NCT04970901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925484|NCT04970901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55925485|NCT04970901|Immunologic Factors|immunologic factors|mesh-ancestor
55925486|NCT04970901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925488|NCT04970901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55925489|NCT04970901|Growth Substances|growth substances|mesh-ancestor
55925490|NCT04970901|Growth Inhibitors|growth inhibitors|mesh-ancestor
55925491|NCT04970901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55925492|NCT01497938|Insulin|insulin|mesh-list
55925493|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55925494|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925495|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
55925496|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
55925497|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925498|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55925499|NCT04301310|Rifampin|rifampin|mesh-list
55925500|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55925501|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
55925502|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55925503|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925504|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
55925505|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55925507|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925508|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55925509|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55925510|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55925511|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55925512|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55925513|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55925514|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
55925515|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925516|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
55925517|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
55925518|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
55925524|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925525|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
55925526|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925527|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55925528|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55925529|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55925530|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925531|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925532|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55925533|NCT00804609|Narcotics|narcotics|mesh-ancestor
55925534|NCT00804609|Analgesics|analgesics|mesh-ancestor
55925535|NCT03082183|Rifampin|rifampin|mesh-list
55925536|NCT03082183|BI 425809|bi 425809|mesh-list
55925537|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55925538|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
55925539|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55925540|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925541|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
55925542|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55925543|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925544|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925545|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55925546|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55925547|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55925548|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55925549|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55925550|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55925551|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
55925552|NCT05665387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55735322|NCT04452929|Erenumab|erenumab|mesh-list
55925564|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925565|NCT00804999|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55925566|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55925568|NCT04283604|Methylphenidate|methylphenidate|mesh-list
55925569|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55925570|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925571|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55925572|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55925573|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925574|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925575|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
55925576|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925577|NCT00810303|Efavirenz|efavirenz|mesh-list
55925578|NCT00810303|Ezetimibe|ezetimibe|mesh-list
55925579|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55925580|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55925581|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
55925582|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925583|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55925584|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55925586|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925596|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
55925597|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925598|NCT05645107|Immunoglobulins|immunoglobulins|mesh-list
55925599|NCT05645107|gamma-Globulins|gamma-globulins|mesh-list
55925600|NCT05645107|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55925601|NCT05645107|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55925602|NCT05645107|Immunologic Factors|immunologic factors|mesh-ancestor
55925603|NCT05645107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925604|NCT04227756|Psilocybin|psilocybin|mesh-list
55925605|NCT04227756|Mescaline|mescaline|mesh-list
55925607|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925608|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55925609|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55925610|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
55925611|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925612|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925613|NCT01460342|Tadalafil|tadalafil|mesh-list
55925614|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
55735334|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
55925618|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925619|NCT01460342|Urological Agents|urological agents|mesh-ancestor
55925620|NCT05044962|Rilpivirine|rilpivirine|mesh-list
55925621|NCT05044962|Cabotegravir|cabotegravir|mesh-list
55925645|NCT05044962|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55925646|NCT05044962|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55925648|NCT04198506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55925649|NCT04198506|Immunologic Factors|immunologic factors|mesh-ancestor
55925650|NCT04198506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925651|NCT04198506|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55925652|NCT04198506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925653|NCT04198506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925654|NCT00775671|Metoprolol|metoprolol|mesh-list
55925655|NCT00775671|Nebivolol|nebivolol|mesh-list
55925656|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55925657|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55925658|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
55925659|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
55925660|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925661|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925662|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55925663|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55925664|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55925665|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
55925666|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925667|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925668|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
55925669|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55925670|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55925671|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55925672|NCT05634967|Ofatumumab|ofatumumab|mesh-list
55925673|NCT05634967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925674|NCT03800745|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55925675|NCT03800745|Laxatives|laxatives|mesh-ancestor
55925676|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55925677|NCT01459796|Rilonacept|rilonacept|mesh-list
55925678|NCT01459796|Allopurinol|allopurinol|mesh-list
55925679|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
55925680|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735347|NCT05103501|Cisplatin|cisplatin|mesh-list
55925688|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925690|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55925691|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925692|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55925693|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925694|NCT03386539|Mycophenolic Acid|mycophenolic acid|mesh-list
55925695|NCT03386539|Everolimus|everolimus|mesh-list
55925696|NCT03386539|Tacrolimus|tacrolimus|mesh-list
55925697|NCT03386539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55925698|NCT03386539|Immunologic Factors|immunologic factors|mesh-ancestor
55925699|NCT03386539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925700|NCT03386539|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55925701|NCT03386539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925702|NCT03386539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925703|NCT03386539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925704|NCT03386539|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55925731|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
55925732|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925733|NCT01459718|Siderophores|siderophores|mesh-ancestor
55925734|NCT04918407|Empagliflozin|empagliflozin|mesh-list
55925735|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55925736|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925737|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55925738|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925739|NCT04989660|Phenol|phenol|mesh-list
55925740|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55925741|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925742|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
55925743|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55925744|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55925745|NCT02970318|Rituximab|rituximab|mesh-list
55925746|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55925747|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
55925748|NCT02970318|Idelalisib|idelalisib|mesh-list
55925749|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55925750|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925751|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
55925752|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925753|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55925754|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55925755|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
55925756|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925757|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925758|NCT04663347|Gemcitabine|gemcitabine|mesh-list
55925759|NCT04663347|Cytarabine|cytarabine|mesh-list
55925760|NCT04663347|Dexamethasone|dexamethasone|mesh-list
55925761|NCT04663347|Prednisone|prednisone|mesh-list
55925762|NCT04663347|Cyclophosphamide|cyclophosphamide|mesh-list
55925771|NCT04663347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55925772|NCT04663347|Immunologic Factors|immunologic factors|mesh-ancestor
55925773|NCT04663347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925774|NCT04663347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55925775|NCT04663347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55925776|NCT04663347|Alkylating Agents|alkylating agents|mesh-ancestor
55925777|NCT04663347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925778|NCT04663347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925779|NCT04663347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55925780|NCT04663347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55925781|NCT04663347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55925782|NCT04663347|Antiemetics|antiemetics|mesh-ancestor
55925783|NCT04663347|Autonomic Agents|autonomic agents|mesh-ancestor
55925784|NCT04663347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925817|NCT05615467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55925818|NCT05615467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925819|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
55925820|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55925821|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925822|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925823|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55925824|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55925825|NCT03800433|Protective Agents|protective agents|mesh-ancestor
55925826|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925827|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
55925828|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55925829|NCT03800433|Antioxidants|antioxidants|mesh-ancestor
55925830|NCT03395899|Bevacizumab|bevacizumab|mesh-list
55925831|NCT03395899|Atezolizumab|atezolizumab|mesh-list
55925832|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55925833|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925834|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55925835|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55925836|NCT03395899|Growth Substances|growth substances|mesh-ancestor
55925837|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925838|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
55925840|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55925841|NCT02900976|Antibodies|antibodies|mesh-list
55925842|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
55925843|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55925844|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
55925845|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925846|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925847|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55925848|NCT05602597|Itraconazole|itraconazole|mesh-list
55925849|NCT05602597|Fluconazole|fluconazole|mesh-list
55925855|NCT05602597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55925856|NCT05602597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925857|NCT05602597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925858|NCT05602597|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55925859|NCT05602597|Hormone Antagonists|hormone antagonists|mesh-ancestor
55925860|NCT05602597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55925861|NCT05602597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925862|NCT05602597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55925863|NCT05602597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55925865|NCT05602597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55925866|NCT05602597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55925867|NCT05602597|Antitubercular Agents|antitubercular agents|mesh-ancestor
55925868|NCT05602597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55925869|NCT05602597|Leprostatic Agents|leprostatic agents|mesh-ancestor
55925870|NCT05602597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55925871|NCT05602597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55925872|NCT05602597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55925873|NCT05602597|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55925874|NCT05602597|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55925875|NCT05602597|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55925876|NCT05602597|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55925877|NCT05602597|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55925878|NCT05602597|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55925880|NCT04608201|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55925881|NCT04608201|Autonomic Agents|autonomic agents|mesh-ancestor
55925889|NCT03323437|Risperidone|risperidone|mesh-list
55925890|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55925891|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
55925892|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925893|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925894|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925895|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55925896|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55925897|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925898|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55925899|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55925900|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
55925901|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
55925902|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
55925903|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55925904|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55925905|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925906|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925907|NCT04110444|Urological Agents|urological agents|mesh-ancestor
55925908|NCT04520217|Imipramine|imipramine|mesh-list
55925909|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55925911|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55925912|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55925913|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55925914|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55925915|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925916|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
55925917|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55925918|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925919|NCT04951986|Levofloxacin|levofloxacin|mesh-list
55925931|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55925932|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55925933|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55925934|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55925935|NCT04951986|Renal Agents|renal agents|mesh-ancestor
55925936|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55925938|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55925939|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55925940|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55925941|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55925942|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55925943|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55925944|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
55925945|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
55925946|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55925947|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55925948|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55925957|NCT04278859|Antibodies|antibodies|mesh-list
55925987|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55925988|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55925990|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
55925991|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925992|NCT02647788|Acetaminophen|acetaminophen|mesh-list
55925993|NCT02647788|Ibuprofen|ibuprofen|mesh-list
55925995|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55925996|NCT02647788|Analgesics|analgesics|mesh-ancestor
55925997|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
55925998|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55925999|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926000|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
55926001|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55926002|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926003|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926004|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55926005|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926006|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926007|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55926008|NCT02647788|Narcotics|narcotics|mesh-ancestor
55926009|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926010|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
55926011|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
55926012|NCT03319537|Pemetrexed|pemetrexed|mesh-list
55926013|NCT03319537|Pevonedistat|pevonedistat|mesh-list
55926014|NCT03319537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926015|NCT03319537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926016|NCT03319537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926017|NCT03319537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55926018|NCT03319537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55926019|NCT04382859|Bupivacaine|bupivacaine|mesh-list
55926027|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926028|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926029|NCT04084860|Ketamine|ketamine|mesh-list
55926030|NCT04084860|Analgesics|analgesics|mesh-ancestor
55926031|NCT04084860|Sensory System Agents|sensory system agents|mesh-ancestor
55926032|NCT04084860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926033|NCT04084860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926034|NCT04084860|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55926035|NCT04084860|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55926036|NCT04084860|Anesthetics, General|anesthetics, general|mesh-ancestor
55926037|NCT04084860|Anesthetics|anesthetics|mesh-ancestor
55926038|NCT04084860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926039|NCT04084860|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55926040|NCT04084860|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55926041|NCT04084860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926042|NCT04084860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926043|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55926044|NCT04134663|Oxytocin|oxytocin|mesh-list
55926045|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
55926046|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55926047|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926048|NCT05431764|Gemcitabine|gemcitabine|mesh-list
55926049|NCT05431764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55926050|NCT05431764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926051|NCT05431764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926052|NCT05431764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55926053|NCT05431764|Antimetabolites|antimetabolites|mesh-ancestor
55926054|NCT05431764|Antiviral Agents|antiviral agents|mesh-ancestor
55926055|NCT05431764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926056|NCT05431764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926071|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
55926072|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
55926073|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926074|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55926075|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55926076|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926077|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55926078|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55926079|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55926080|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926081|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
55926082|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
55926083|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
55926084|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
55926085|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
55926086|NCT00843531|Everolimus|everolimus|mesh-list
55926087|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55926088|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926089|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926091|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926092|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55926093|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926094|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926095|NCT00812877|Calcium|calcium|mesh-list
55926096|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55926097|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926098|NCT00813111|Epinephrine|epinephrine|mesh-list
55926099|NCT00813111|Bupivacaine|bupivacaine|mesh-list
55926100|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
55926101|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
55926102|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926103|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926109|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926110|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926111|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55926112|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55926113|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
55926114|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55926115|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
55926116|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
55926117|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
55926118|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55926119|NCT00845481|Calcitriol|calcitriol|mesh-list
55926120|NCT00845481|Betamethasone|betamethasone|mesh-list
55926121|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926122|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
55926123|NCT00845481|Hormones|hormones|mesh-ancestor
55926124|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926125|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926126|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55926127|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
55926128|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55926129|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55926130|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55926131|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926132|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55926133|NCT00845481|Vitamins|vitamins|mesh-ancestor
55926134|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
55926135|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55926136|NCT03641001|Micronutrients|micronutrients|mesh-list
55926137|NCT03641001|Trace Elements|trace elements|mesh-list
55926138|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926139|NCT01421069|Etanercept|etanercept|mesh-list
55926140|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55926141|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55926142|NCT01421069|Analgesics|analgesics|mesh-ancestor
55926143|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
55926144|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926145|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926146|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926147|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926148|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55926149|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926150|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
55926151|NCT04276233|Albuterol|albuterol|mesh-list
55926152|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55926153|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
55926154|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926155|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926156|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55926157|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
55926159|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55926160|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55926161|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55926162|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55926163|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
55926164|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926165|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926166|NCT04681430|Gabexate|gabexate|mesh-list
55926167|NCT04681430|Camostat|camostat|mesh-list
55926168|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
55926169|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926170|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926657|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926202|NCT05686993|Histamine Antagonists|histamine antagonists|mesh-ancestor
55926204|NCT05686993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926205|NCT03379051|Lenalidomide|lenalidomide|mesh-list
55926207|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
55926208|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926209|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55926210|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55926211|NCT03379051|Growth Substances|growth substances|mesh-ancestor
55926212|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
55926213|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926214|NCT01473836|Metronidazole|metronidazole|mesh-list
55926215|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
55926216|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926217|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55926218|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55926219|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55926220|NCT03340909|Prednisolone|prednisolone|mesh-list
55926221|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926222|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
55926223|NCT03340909|Hormones|hormones|mesh-ancestor
55926224|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926225|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926226|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55926227|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926228|NCT05686915|Cobalt|cobalt|mesh-list
55926229|NCT05686915|Chromium|chromium|mesh-list
55926230|NCT05686915|Trace Elements|trace elements|mesh-ancestor
55926231|NCT05686915|Micronutrients|micronutrients|mesh-ancestor
55926232|NCT05686915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926233|NCT05384119|Palbociclib|palbociclib|mesh-list
55926241|NCT05384119|Hormone Antagonists|hormone antagonists|mesh-ancestor
55926242|NCT05384119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926243|NCT05384119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926245|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
55926246|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
55926247|NCT03643965|Budesonide|budesonide|mesh-list
55926248|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926249|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55926250|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
55926251|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926252|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926253|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55926254|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
55926255|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
55926256|NCT03643965|Hormones|hormones|mesh-ancestor
55926257|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926258|NCT02979522|Doxorubicin|doxorubicin|mesh-list
55926259|NCT02979522|Dacarbazine|dacarbazine|mesh-list
55926260|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55926261|NCT02979522|Vinblastine|vinblastine|mesh-list
55926262|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55926263|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926264|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55926265|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55926266|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926267|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926268|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55926286|NCT04401007|Lidocaine|lidocaine|mesh-list
55926287|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
55926288|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
55926289|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926290|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926291|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
55926292|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926293|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55926294|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55926295|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55926296|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55926297|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926298|NCT01496846|Lidocaine|lidocaine|mesh-list
55926299|NCT01496846|Carticaine|carticaine|mesh-list
55926300|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
55926301|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
55926302|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926303|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926304|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
55926305|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926306|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55926307|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55926308|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55926309|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55926310|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926311|NCT00964002|Efavirenz|efavirenz|mesh-list
55926314|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926329|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926330|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926331|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926332|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926333|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55926334|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55926335|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926336|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55926337|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55926338|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926339|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
55926340|NCT02710851|Vaccines|vaccines|mesh-list
55926341|NCT02710851|Immunologic Factors|immunologic factors|mesh-ancestor
55926342|NCT02710851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926343|NCT02577120|Decanoic acid|decanoic acid|mesh-list
55926344|NCT02577120|Petrolatum|petrolatum|mesh-list
55926345|NCT02577120|Emollients|emollients|mesh-ancestor
55926346|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
55926347|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
55926348|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926349|NCT01399697|Methotrexate|methotrexate|mesh-list
55735486|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55926350|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55926351|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
55926352|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55926353|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926354|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55926355|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
55926356|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926357|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926358|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
55926359|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926360|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55926361|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926362|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
55926369|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926370|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55926371|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
55926372|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55926373|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
55926374|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
55926375|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926376|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926377|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55926379|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55926380|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55926381|NCT00818805|Analgesics|analgesics|mesh-ancestor
55926382|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
55926383|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926384|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926385|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926386|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926387|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55926388|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55926389|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55926420|NCT01473602|Teriparatide|teriparatide|mesh-list
55926421|NCT01473602|Calcium|calcium|mesh-list
55926422|NCT01473602|Vitamins|vitamins|mesh-ancestor
55926423|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
55926424|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926425|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55926426|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55926427|NCT03336073|Dexamethasone|dexamethasone|mesh-list
55926428|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
55926429|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926430|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
55926753|NCT03245437|Oxytocin|oxytocin|mesh-list
55926431|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926432|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926433|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55926434|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
55926435|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926436|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926437|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55926438|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926439|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
55926440|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
55926441|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926442|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55926443|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
55926444|NCT03336073|Hormones|hormones|mesh-ancestor
55926445|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926447|NCT05334433|Anesthetics|anesthetics|mesh-list
55926463|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926464|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926465|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55926466|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
55735507|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55735508|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
55735514|NCT04636671|Dexamethasone|dexamethasone|mesh-list
55837471|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
55837472|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837473|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
55926468|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
55926469|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
55926470|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926471|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926472|NCT03300427|Valsartan|valsartan|mesh-list
55926473|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55926474|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55926475|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55926476|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55926477|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926478|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
55926479|NCT00818961|Busulfan|busulfan|mesh-list
55926480|NCT00818961|Rituximab|rituximab|mesh-list
55926481|NCT00818961|Methotrexate|methotrexate|mesh-list
55926482|NCT00818961|Fludarabine|fludarabine|mesh-list
55926483|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
55926484|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
55926485|NCT00818961|Tacrolimus|tacrolimus|mesh-list
55926486|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926487|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
55926488|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926489|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926508|NCT05431218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55926509|NCT05431218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926510|NCT05431218|Vitamins|vitamins|mesh-ancestor
55926511|NCT05431218|Micronutrients|micronutrients|mesh-ancestor
55926512|NCT05431218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55926513|NCT05431062|Bupivacaine|bupivacaine|mesh-list
55926514|NCT05431062|Anesthetics, Local|anesthetics, local|mesh-ancestor
55926515|NCT05431062|Anesthetics|anesthetics|mesh-ancestor
55926516|NCT05431062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926517|NCT05431062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926518|NCT05431062|Sensory System Agents|sensory system agents|mesh-ancestor
55926519|NCT05431062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926521|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926522|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
55926523|NCT00819507|Hormones|hormones|mesh-ancestor
55926524|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926525|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926526|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55926527|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55926528|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
55926529|NCT03696121|Coagulants|coagulants|mesh-ancestor
55926530|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55926531|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
55926532|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926533|NCT01995669|Lenalidomide|lenalidomide|mesh-list
55926534|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
55926535|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
55926536|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926537|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55926538|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55926539|NCT01995669|Growth Substances|growth substances|mesh-ancestor
55926540|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
55926546|NCT01457924|Ofatumumab|ofatumumab|mesh-list
55926550|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926552|NCT05237115|Clarithromycin|clarithromycin|mesh-list
55926553|NCT05237115|Esomeprazole|esomeprazole|mesh-list
55926560|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926561|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926562|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55926563|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55926564|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55926565|NCT05237115|Antacids|antacids|mesh-ancestor
55926566|NCT04040621|Ceftazidime|ceftazidime|mesh-list
55926567|NCT04040621|Avibactam|avibactam|mesh-list
55926568|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
55926569|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55926570|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926571|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55926572|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926573|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926574|NCT00856791|ON 01910|on 01910|mesh-list
55926575|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926576|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55926577|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926578|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926579|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
55926580|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55926581|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55926582|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926583|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
55926585|NCT05090371|Ofatumumab|ofatumumab|mesh-list
55926586|NCT05090371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926587|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
55926588|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55926589|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926590|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926591|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55926592|NCT00857727|Analgesics|analgesics|mesh-ancestor
55926593|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
55926594|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926595|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55926596|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55926597|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55926598|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
55926599|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926600|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926601|NCT00857961|Testosterone|testosterone|mesh-list
55926602|NCT00857961|Androgens|androgens|mesh-ancestor
55926604|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926605|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926606|NCT03839433|Ciclesonide|ciclesonide|mesh-list
55926607|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
55926608|NCT03839433|Hormones|hormones|mesh-ancestor
55926609|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926610|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926611|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55926612|NCT05033041|Metoclopramide|metoclopramide|mesh-list
55926630|NCT05029063|Anticoagulants|anticoagulants|mesh-ancestor
55926643|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926644|NCT02150499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55926645|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
55926646|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
55926647|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55926648|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55926649|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55926650|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55926651|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
55926652|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926653|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926654|NCT03287947|Nintedanib|nintedanib|mesh-list
55926655|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926656|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55926658|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926659|NCT05685667|Hyaluronic Acid|hyaluronic acid|mesh-list
55926660|NCT05685667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55926661|NCT05685667|Immunologic Factors|immunologic factors|mesh-ancestor
55926662|NCT05685667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926663|NCT05685667|Viscosupplements|viscosupplements|mesh-ancestor
55926664|NCT05685667|Protective Agents|protective agents|mesh-ancestor
55926665|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
55926666|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55926667|NCT00859131|Daclizumab|daclizumab|mesh-list
55926668|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
55926669|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926670|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926671|NCT00859833|Adenosine|adenosine|mesh-list
55926672|NCT00859833|Regadenoson|regadenoson|mesh-list
55926673|NCT00859833|Analgesics|analgesics|mesh-ancestor
55926674|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
55926675|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926676|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926677|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55926678|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
55735546|NCT02935205|Indomethacin|indomethacin|mesh-list
55926680|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
55926681|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
55926682|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926683|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926684|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55926685|NCT02154477|Insulin|insulin|mesh-list
55926686|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55926687|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926688|NCT00860379|Selenium|selenium|mesh-list
55926689|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
55926690|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926691|NCT00860379|Protective Agents|protective agents|mesh-ancestor
55926692|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926702|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926703|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55926704|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55926705|NCT00860457|Growth Substances|growth substances|mesh-ancestor
55926706|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
55926708|NCT00827073|Tetracaine|tetracaine|mesh-list
55926709|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
55926710|NCT00827073|Anesthetics|anesthetics|mesh-ancestor
55926711|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926712|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926713|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
55926714|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926715|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55926716|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55926717|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55926718|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55926719|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926720|NCT00860847|Ubiquinone|ubiquinone|mesh-list
55926721|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
55926722|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
55926723|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926724|NCT00860847|Vitamins|vitamins|mesh-ancestor
55926725|NCT04347733|Triamcinolone|triamcinolone|mesh-list
55926726|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55926727|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55926728|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55926729|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55926730|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
55926731|NCT04347733|Hormones|hormones|mesh-ancestor
55926732|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926733|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926734|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926738|NCT02155101|Ritonavir|ritonavir|mesh-list
55926743|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55926745|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926746|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926748|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55926749|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
55926750|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926751|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55926752|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55926755|NCT03245437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55926756|NCT03245437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926757|NCT02155257|Gabapentin|gabapentin|mesh-list
55926765|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55926766|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926767|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55926768|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55926769|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55926770|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926771|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926788|NCT04382625|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55926789|NCT04382625|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55926790|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926791|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55926792|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926793|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926794|NCT01673646|Pasireotide|pasireotide|mesh-list
55926795|NCT01673646|Hormones|hormones|mesh-ancestor
55926796|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926797|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926798|NCT05296837|Doxycycline|doxycycline|mesh-list
55926799|NCT05296837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55926800|NCT05296837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926801|NCT05296837|Antimalarials|antimalarials|mesh-ancestor
55926802|NCT05296837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55926803|NCT05296837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55926804|NCT02647944|Liraglutide|liraglutide|mesh-list
55926805|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55926806|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926807|NCT02647944|Incretins|incretins|mesh-ancestor
55926808|NCT02647944|Hormones|hormones|mesh-ancestor
55926809|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55926810|NCT00862563|Topiramate|topiramate|mesh-list
55926811|NCT00862563|Zonisamide|zonisamide|mesh-list
55926812|NCT00862563|Levetiracetam|levetiracetam|mesh-list
55926813|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
55926814|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55926815|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926816|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
55926817|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55926818|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55926819|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926820|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55926822|NCT04399525|Loratadine|loratadine|mesh-list
55926823|NCT04399525|Levocetirizine|levocetirizine|mesh-list
55926824|NCT04399525|Desloratadine|desloratadine|mesh-list
55926825|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55926863|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55926864|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926865|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926866|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55926867|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
55926868|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
55926878|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926879|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55926881|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55926899|NCT01397825|Mitosis Modulators|mitosis modulators|mesh-ancestor
55926900|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926902|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55926903|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926904|NCT05353764|Ropivacaine|ropivacaine|mesh-list
55926905|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
55926906|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
55926907|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55926908|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926909|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
55926911|NCT00831987|Vaccines|vaccines|mesh-list
55926912|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
55926913|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926914|NCT05239884|Nicotine|nicotine|mesh-list
55926915|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55926916|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
55926917|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55926918|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926919|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55926922|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55926926|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55926927|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
55926928|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926929|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55926930|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55926931|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
55926932|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55926949|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
55926950|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55926951|NCT00834171|Tobramycin|tobramycin|mesh-list
55926952|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55926953|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926954|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55926955|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55926956|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
55926957|NCT05205577|Iodine|iodine|mesh-list
55926958|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55926959|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55926960|NCT05205577|Trace Elements|trace elements|mesh-ancestor
55926961|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
55926962|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926963|NCT00835185|Leucovorin|leucovorin|mesh-list
55926967|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
55926968|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55926969|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55926970|NCT00835185|Antidotes|antidotes|mesh-ancestor
55926971|NCT00835185|Protective Agents|protective agents|mesh-ancestor
55926972|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55926973|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
55926974|NCT00835185|Vitamins|vitamins|mesh-ancestor
55926975|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
55926976|NCT00835185|Hematinics|hematinics|mesh-ancestor
55926977|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55926978|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
55927049|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
55927050|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55927051|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55927052|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55927053|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
55927054|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927055|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927056|NCT00838695|Protective Agents|protective agents|mesh-ancestor
55927057|NCT04775173|Sirolimus|sirolimus|mesh-list
55927058|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55927059|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927060|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55927061|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927062|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
55927063|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927064|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
55927065|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927075|NCT01396265|Afatinib|afatinib|mesh-list
55927076|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55927077|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
55927078|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55927079|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927080|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
55927081|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55927082|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927083|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927084|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55927085|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55927086|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55927087|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55927088|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55927102|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
55927103|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
55927104|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927105|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55927106|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55927107|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927108|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55927109|NCT00839319|Testosterone|testosterone|mesh-list
55927110|NCT00839319|Acyline|acyline|mesh-list
55927111|NCT00839319|Androgens|androgens|mesh-ancestor
55927113|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927114|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927115|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55927116|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
55927118|NCT03212989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927119|NCT03212989|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55927120|NCT03212989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927121|NCT03212989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927122|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55927123|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55927124|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55927125|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55927126|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927127|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55927128|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55927129|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55735713|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55735714|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735715|NCT05104437|Vaccines|vaccines|mesh-list
55735716|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
55735717|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927148|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55927149|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55927150|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55927151|NCT05233722|Sirolimus|sirolimus|mesh-list
55927152|NCT05233722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927165|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927166|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927167|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
55927168|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927169|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55927170|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55927171|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55927172|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55927173|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55927174|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55927175|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55927176|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55927177|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55927178|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55927179|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55927180|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55927181|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55927183|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
55927184|NCT03104634|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55927185|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
55927201|NCT03224767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927202|NCT03257761|Durvalumab|durvalumab|mesh-list
55927203|NCT03257761|Guadecitabine|guadecitabine|mesh-list
55927204|NCT03257761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55927205|NCT03257761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927206|NCT00871689|Aldesleukin|aldesleukin|mesh-list
55927207|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
55927208|NCT00871689|Fludarabine|fludarabine|mesh-list
55927209|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
55927210|NCT00871689|Interleukin-2|interleukin-2|mesh-list
55927211|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927212|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
55927213|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927214|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55927215|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55927216|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
55927217|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927218|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927219|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55927220|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55927221|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
55927222|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
55927223|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927224|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55927225|NCT00871689|Analgesics|analgesics|mesh-ancestor
55927226|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
55927227|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927229|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55927230|NCT04174170|Sertraline|sertraline|mesh-list
55927231|NCT04174170|Brexpiprazole|brexpiprazole|mesh-list
55927232|NCT04174170|Antidepressive Agents|antidepressive agents|mesh-ancestor
55927233|NCT04174170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55927234|NCT04174170|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55927235|NCT04174170|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55927236|NCT04174170|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55927237|NCT04174170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927238|NCT04174170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927239|NCT04174170|Serotonin Agents|serotonin agents|mesh-ancestor
55927240|NCT04174170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927241|NCT04174170|Dopamine Agonists|dopamine agonists|mesh-ancestor
55927242|NCT04174170|Dopamine Agents|dopamine agents|mesh-ancestor
55927243|NCT02084797|Vasopressins|vasopressins|mesh-list
55927357|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927358|NCT03957876|Cytarabine|cytarabine|mesh-list
55927359|NCT03957876|Daunorubicin|daunorubicin|mesh-list
55927360|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55927361|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
55927362|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927363|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927364|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
55927365|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927366|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927441|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55927442|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
55927443|NCT04634539|Antiviral Agents|antiviral agents|mesh-ancestor
55927444|NCT04634539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927445|NCT04634539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927446|NCT04634539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927447|NCT04634539|Immunologic Factors|immunologic factors|mesh-ancestor
55927448|NCT04634539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927449|NCT03750786|Leucovorin|leucovorin|mesh-list
55927450|NCT03750786|Antidotes|antidotes|mesh-ancestor
55927451|NCT03750786|Protective Agents|protective agents|mesh-ancestor
55927452|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927453|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
55927454|NCT03750786|Vitamins|vitamins|mesh-ancestor
55927455|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
55927456|NCT04457245|Fluorides|fluorides|mesh-list
55927457|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
55927458|NCT04457245|Protective Agents|protective agents|mesh-ancestor
55927459|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927460|NCT03828799|Folfirinox|folfirinox|mesh-list
55927461|NCT03828799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927462|NCT03710460|Metformin|metformin|mesh-list
55927463|NCT03710460|Dapagliflozin|dapagliflozin|mesh-list
55927464|NCT03710460|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55927465|NCT03710460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927466|NCT03710460|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55927467|NCT03710460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927468|NCT01395017|Dasatinib|dasatinib|mesh-list
55927555|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927557|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55927559|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55927560|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927561|NCT02804022|Morphine|morphine|mesh-list
55927562|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55927563|NCT02804022|Narcotics|narcotics|mesh-ancestor
55927564|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55927565|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927566|NCT02804022|Analgesics|analgesics|mesh-ancestor
55927567|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
55927568|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927569|NCT00876993|Bevacizumab|bevacizumab|mesh-list
55927570|NCT00876993|Irinotecan|irinotecan|mesh-list
55927571|NCT00876993|Temozolomide|temozolomide|mesh-list
55927572|NCT00876993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55927573|NCT00876993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756992|NCT03278483|Rifampin|rifampin|mesh-list
55927615|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55927616|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
55927617|NCT04380597|Calcipotriene|calcipotriene|mesh-list
55927618|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55927619|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55927620|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
55927621|NCT04380597|Hormones|hormones|mesh-ancestor
55927650|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927671|NCT00883233|Analgesics|analgesics|mesh-ancestor
55927672|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
55927673|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927674|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927675|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55927676|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55927677|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
55927678|NCT01394939|Irinotecan|irinotecan|mesh-list
55927679|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55927680|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55927681|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927682|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927683|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927684|NCT01394627|Eplerenone|eplerenone|mesh-list
55927685|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55927687|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927688|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927689|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55927690|NCT01394627|Diuretics|diuretics|mesh-ancestor
55735977|NCT02418182|Acetaminophen|acetaminophen|mesh-list
55927699|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
55927700|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927701|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927702|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55927703|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55927704|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55927705|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
55927706|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927707|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927709|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55927710|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927711|NCT01391663|Incretins|incretins|mesh-ancestor
55927712|NCT01391663|Hormones|hormones|mesh-ancestor
55927713|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55927714|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55927715|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
55927731|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55927732|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
55927733|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927734|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927735|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55927736|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55927737|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
55927738|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55927739|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55927740|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
55927741|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
55927742|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927743|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55927744|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55927745|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55927746|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55927747|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55927748|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
55927749|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55927750|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927751|NCT05072106|Bosentan|bosentan|mesh-list
55927752|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55927753|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55927754|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927755|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55927756|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
55927757|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927758|NCT03367533|Ketamine|ketamine|mesh-list
55927759|NCT03367533|Analgesics|analgesics|mesh-ancestor
55735995|NCT02387372|Renal Agents|renal agents|mesh-ancestor
55927777|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927778|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
55927779|NCT05071482|HH-GV-678|hh-gv-678|mesh-list
55927780|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55927781|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55927782|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927783|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927784|NCT03213249|Gentamicins|gentamicins|mesh-list
55927785|NCT03213249|Cefazolin|cefazolin|mesh-list
55927786|NCT03213249|Bacitracin|bacitracin|mesh-list
55927787|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55927788|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55927789|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55927790|NCT03213249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927791|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927792|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55927793|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
55927794|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55927795|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55927796|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927797|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55927798|NCT03317067|Analgesics|analgesics|mesh-ancestor
55927799|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
55927800|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55927801|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55927855|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55927856|NCT03212781|Ferrous fumarate|ferrous fumarate|mesh-list
55927857|NCT03212781|Dextrans|dextrans|mesh-list
55927858|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
55927859|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
55927860|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
55927861|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
55927862|NCT03212781|Trace Elements|trace elements|mesh-ancestor
55927863|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
55927864|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927865|NCT03212781|Hematinics|hematinics|mesh-ancestor
55927866|NCT03212937|Carboplatin|carboplatin|mesh-list
55927867|NCT03212937|Etoposide|etoposide|mesh-list
55927868|NCT03212937|Ifosfamide|ifosfamide|mesh-list
55927869|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736037|NCT02425826|Apremilast|apremilast|mesh-list
55927889|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
55927890|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55927891|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55927892|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
55927893|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927894|NCT03940326|Levetiracetam|levetiracetam|mesh-list
55927895|NCT03940326|Valproic Acid|valproic acid|mesh-list
55927896|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
55927897|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
55927898|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55927899|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55927900|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
55927901|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55927902|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55927903|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
55927904|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55927905|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736060|NCT02656173|Tamsulosin|tamsulosin|mesh-list
55928045|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55928046|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55928047|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
55928048|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928049|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55928050|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
55928051|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
55928052|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
55928053|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55928054|NCT03211455|Lidocaine|lidocaine|mesh-list
55928055|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
55928056|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
55928057|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928058|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928059|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
55928060|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928061|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55928062|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55928063|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55928064|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55928065|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928066|NCT04375033|Buprenorphine|buprenorphine|mesh-list
55928067|NCT04375033|Naloxone|naloxone|mesh-list
55928068|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55928069|NCT04375033|Narcotics|narcotics|mesh-ancestor
55928070|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928071|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928073|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
55928074|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928075|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55928076|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
55928077|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928078|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928079|NCT03598309|Curcumin|curcumin|mesh-list
55928080|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55928082|NCT03598309|Analgesics|analgesics|mesh-ancestor
55928083|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
55928084|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928085|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928086|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55928087|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55928088|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928089|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928090|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928091|NCT01389323|Interferons|interferons|mesh-list
55928092|NCT01389323|Ribavirin|ribavirin|mesh-list
55928093|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
55928094|NCT01389323|Interferon alpha-2|interferon alpha-2|mesh-list
55928095|NCT01389323|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55928096|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928097|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
55928098|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928099|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
55928100|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928101|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
55928102|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928103|NCT05310591|Nivolumab|nivolumab|mesh-list
55928104|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928105|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928106|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55736252|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
55928107|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928108|NCT05314569|Fentanyl|fentanyl|mesh-list
55928109|NCT05314569|Midazolam|midazolam|mesh-list
55928110|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
55928111|NCT05314569|Ketamine|ketamine|mesh-list
55928112|NCT05314569|Isoflurane|isoflurane|mesh-list
55928113|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55928114|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928115|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928116|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55928122|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55928123|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
55928124|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928125|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928126|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55928127|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55928128|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
55928129|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
55928130|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55928131|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55928132|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55928133|NCT05314569|Narcotics|narcotics|mesh-ancestor
55928134|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55928135|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55928136|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55928137|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55928138|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
55928139|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
55928140|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55928141|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55928142|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
55928143|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55928144|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55928145|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928146|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
55928147|NCT03167905|Fentanyl|fentanyl|mesh-list
55928148|NCT03167905|Meperidine|meperidine|mesh-list
55928149|NCT03167905|Remifentanil|remifentanil|mesh-list
55928150|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
55928151|NCT03167905|Ropivacaine|ropivacaine|mesh-list
55928152|NCT03167905|Entonox|entonox|mesh-list
55928170|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928173|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928174|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928175|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55928176|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55928177|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55928178|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
55928179|NCT02638389|Sirolimus|sirolimus|mesh-list
55928180|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55928181|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928182|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55928183|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928184|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
55928185|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928186|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
55928187|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928188|NCT01494584|Ezogabine|ezogabine|mesh-list
55928189|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
55928190|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55928191|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928192|NCT03211143|Esomeprazole|esomeprazole|mesh-list
55736275|NCT02657031|Ketamine|ketamine|mesh-list
55928234|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55928235|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928236|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55928237|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
55928238|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
55928239|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928240|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55928241|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
55928242|NCT00882895|Hormones|hormones|mesh-ancestor
55928243|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55928244|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55928245|NCT00882895|Protective Agents|protective agents|mesh-ancestor
55928246|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55928247|NCT02629809|Cyclophosphamide|cyclophosphamide|mesh-list
55928248|NCT02629809|Fludarabine|fludarabine|mesh-list
55928249|NCT02629809|Fludarabine phosphate|fludarabine phosphate|mesh-list
55928250|NCT02629809|Obinutuzumab|obinutuzumab|mesh-list
55928251|NCT02629809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928252|NCT02629809|Immunologic Factors|immunologic factors|mesh-ancestor
55928253|NCT02629809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928254|NCT02629809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736285|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
55928324|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
55928325|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928326|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928327|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55928328|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
55928329|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
55928330|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
55928331|NCT01830465|Rituximab|rituximab|mesh-list
55928332|NCT01830465|Bortezomib|bortezomib|mesh-list
55928333|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928334|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928335|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
55928336|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928337|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55928338|NCT03485911|Berotralstat|berotralstat|mesh-list
55928339|NCT03485911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928345|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928346|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55928347|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55928348|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55928349|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55928350|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
55928351|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
55928352|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
55928353|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
55928354|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928355|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928356|NCT01456130|Alogliptin|alogliptin|mesh-list
55928357|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
55928374|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55928375|NCT03219645|Analgesics|analgesics|mesh-ancestor
55928376|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
55928377|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928378|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928379|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55928380|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55928381|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55928382|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55928383|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928384|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55928385|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55928386|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928387|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
55928388|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
55928389|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55928390|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928391|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
55928392|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55928393|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928394|NCT01387607|Pregabalin|pregabalin|mesh-list
55928395|NCT01387607|Analgesics|analgesics|mesh-ancestor
55928396|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
55928397|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928445|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928446|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928448|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928449|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55928450|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928451|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928452|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
55928453|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928454|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
55928455|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928456|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55928457|NCT04025489|Vitamin D|vitamin d|mesh-list
55928458|NCT04025489|Vitamins|vitamins|mesh-ancestor
55928459|NCT04025489|Micronutrients|micronutrients|mesh-ancestor
55928460|NCT04025489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928470|NCT03451045|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55928471|NCT03451045|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55928472|NCT03451045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928473|NCT03451045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928474|NCT03451045|Hormones|hormones|mesh-ancestor
55928475|NCT03451045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55928476|NCT03451045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928477|NCT03451045|Hallucinogens|hallucinogens|mesh-ancestor
55928478|NCT03451045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55928479|NCT03451045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736356|NCT03432923|Benzocaine|benzocaine|mesh-list
55928523|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928524|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
55928525|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
55928526|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
55928527|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928528|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55928529|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55928530|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928531|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
55928532|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55928533|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
55928534|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55928535|NCT03415854|Gemcitabine|gemcitabine|mesh-list
55928537|NCT03415854|Cisplatin|cisplatin|mesh-list
55928538|NCT03415854|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55928539|NCT03415854|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55736381|NCT03437213|Anesthetics|anesthetics|mesh-list
55928566|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55928567|NCT01831323|Cathartics|cathartics|mesh-ancestor
55928568|NCT03221400|Leucovorin|leucovorin|mesh-list
55928569|NCT03221400|Folic Acid|folic acid|mesh-list
55928570|NCT03221400|Fluorouracil|fluorouracil|mesh-list
55928571|NCT03221400|Niraparib|niraparib|mesh-list
55928572|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
55928573|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
55928574|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928575|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55928576|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928577|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928578|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
55928579|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928580|NCT03221400|Antidotes|antidotes|mesh-ancestor
55928586|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55928587|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928588|NCT01384877|Lidocaine|lidocaine|mesh-list
55928589|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
55928590|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
55928591|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928592|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928593|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
55928594|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928600|NCT00114517|Hormones|hormones|mesh-list
55928608|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55928609|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55928610|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
55928611|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928612|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55928613|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55928614|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928615|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55928616|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55928617|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55928618|NCT03099720|Ropivacaine|ropivacaine|mesh-list
55928619|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
55928620|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
55928621|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928622|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928623|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
55928624|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928625|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
55928626|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55928627|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928628|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928629|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736424|NCT03579693|Niacin|niacin|mesh-list
55928649|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
55928650|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928652|NCT01383707|Bevacizumab|bevacizumab|mesh-list
55928653|NCT01383707|Fluorouracil|fluorouracil|mesh-list
55928654|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
55928655|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
55928656|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928657|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928658|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55928659|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55928660|NCT01383707|Growth Substances|growth substances|mesh-ancestor
55928661|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928662|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
55928663|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
55928664|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928665|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55928666|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928667|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
55928668|NCT01383707|Antidotes|antidotes|mesh-ancestor
55928673|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
55928674|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55928675|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
55928676|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55928677|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
55928678|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928679|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928680|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
55928681|NCT03306901|Fluorouracil|fluorouracil|mesh-list
55928682|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928683|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
55928684|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928685|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55928686|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928687|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
55928688|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928689|NCT01455428|Pregabalin|pregabalin|mesh-list
55928690|NCT01455428|Analgesics|analgesics|mesh-ancestor
55928691|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
55928692|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928693|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928694|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
55928695|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55928696|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55928697|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928698|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55928699|NCT01455428|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55928700|NCT01455428|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55928701|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928702|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55928703|NCT01831947|Ranibizumab|ranibizumab|mesh-list
55928706|NCT01831947|Growth Substances|growth substances|mesh-ancestor
55928714|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
55928715|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928716|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928717|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55928718|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55928719|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928720|NCT01383161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928721|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928722|NCT00894699|Sufentanil|sufentanil|mesh-list
55928723|NCT00894699|Triazolam|triazolam|mesh-list
55928724|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55928725|NCT00894699|Narcotics|narcotics|mesh-ancestor
55928726|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928727|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928728|NCT00894699|Analgesics|analgesics|mesh-ancestor
55928729|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
55928730|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928731|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55928732|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55928733|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
55928734|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
55928735|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55928736|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55928737|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55928738|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
55928739|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
55928740|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928741|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928742|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
55928743|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928744|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928745|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55928746|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
55928747|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55928748|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55928749|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
55736445|NCT02991807|Everolimus|everolimus|mesh-list
55928759|NCT03217227|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
55928760|NCT03217227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928761|NCT03217227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928762|NCT03217227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928763|NCT03217227|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55928764|NCT01832415|Bevacizumab|bevacizumab|mesh-list
55928765|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55928766|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928767|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55928768|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55928769|NCT01832415|Growth Substances|growth substances|mesh-ancestor
55928770|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928771|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
55928772|NCT01455194|Ciclesonide|ciclesonide|mesh-list
55928773|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
55928774|NCT01455194|Hormones|hormones|mesh-ancestor
55928775|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55928776|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928777|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55928778|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
55928779|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55928780|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55928781|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928782|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55928783|NCT03216759|Analgesics|analgesics|mesh-ancestor
55928784|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
55928785|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55928786|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55928787|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55928791|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928793|NCT04023071|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55928794|NCT04023071|Rituximab|rituximab|mesh-list
55928795|NCT04023071|Fludarabine|fludarabine|mesh-list
55928796|NCT04023071|Obinutuzumab|obinutuzumab|mesh-list
55928797|NCT04023071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928798|NCT04023071|Immunologic Factors|immunologic factors|mesh-ancestor
55928799|NCT04023071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928800|NCT04023071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55928801|NCT04023071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55928802|NCT04023071|Alkylating Agents|alkylating agents|mesh-ancestor
55928803|NCT04023071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928804|NCT04023071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928805|NCT04023071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55928889|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
55928890|NCT03138720|Antiviral Agents|antiviral agents|mesh-ancestor
55928891|NCT03138720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928892|NCT03138720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928893|NCT03138720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55928895|NCT03138720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928896|NCT03304717|Tenofovir|tenofovir|mesh-list
55928897|NCT03304717|Emtricitabine|emtricitabine|mesh-list
55928898|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
55928899|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928900|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55928901|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55928902|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928903|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928904|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55928925|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
55928926|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55928936|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55928937|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144588|NCT00799812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928938|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928939|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55928940|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55928941|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55928942|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55928944|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
55928945|NCT03258385|Vitamins|vitamins|mesh-ancestor
55928946|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
55928947|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928948|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
55928972|NCT03083821|Entecavir|entecavir|mesh-list
55928973|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
55928974|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55928975|NCT05367869|Methylene Blue|methylene blue|mesh-list
55928976|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55928977|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928978|NCT01720095|Niacin|niacin|mesh-list
55928979|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
55928980|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55928981|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
55928982|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55928983|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55928984|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
55928985|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
55928986|NCT01720095|Vitamins|vitamins|mesh-ancestor
55928987|NCT01720095|Micronutrients|micronutrients|mesh-ancestor
55928988|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55928989|NCT05366777|Acetaminophen|acetaminophen|mesh-list
55928990|NCT05366777|Ibuprofen|ibuprofen|mesh-list
55928991|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55928992|NCT05366777|Analgesics|analgesics|mesh-ancestor
55928993|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
55928996|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
55929001|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929002|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929003|NCT04021043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55929004|NCT04021043|Nivolumab|nivolumab|mesh-list
55929005|NCT04021043|Ipilimumab|ipilimumab|mesh-list
55929006|NCT04021043|Antibodies|antibodies|mesh-list
55929007|NCT04021043|Immunoglobulins|immunoglobulins|mesh-list
55929008|NCT04021043|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55929009|NCT04021043|Immunologic Factors|immunologic factors|mesh-ancestor
55929010|NCT04021043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929011|NCT04021043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929012|NCT04021043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55929013|NCT04021043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929014|NCT03836157|Bevacizumab|bevacizumab|mesh-list
55929015|NCT03836157|Maytansine|maytansine|mesh-list
55929016|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55929017|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929018|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55929019|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55736523|NCT03431909|Coagulants|coagulants|mesh-ancestor
55929038|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
55929039|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55929040|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55929041|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55929042|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929043|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55929044|NCT03080545|Vitamins|vitamins|mesh-ancestor
55929045|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
55929046|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55929047|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
55929048|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
55929049|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55929050|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55929051|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929060|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929061|NCT04283617|Insulin|insulin|mesh-list
55929062|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55929063|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929064|NCT05247619|Paclitaxel|paclitaxel|mesh-list
55929065|NCT05247619|Bevacizumab|bevacizumab|mesh-list
55929066|NCT05247619|Carboplatin|carboplatin|mesh-list
55736527|NCT03436121|Midazolam|midazolam|mesh-list
55929081|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
55929082|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929083|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929084|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55929085|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
55929086|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929087|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55929088|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
56144589|NCT00799812|Dermatologic Agents|dermatologic agents|mesh-ancestor
55929089|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55929102|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
55929103|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
55929104|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929105|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
55929106|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929107|NCT01833351|Protective Agents|protective agents|mesh-ancestor
55929108|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55929109|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55929110|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55929111|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929112|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
55929113|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929114|NCT03049189|Everolimus|everolimus|mesh-list
55929115|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55929116|NCT03049189|Edotreotide|edotreotide|mesh-list
55929117|NCT03049189|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
55929143|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55929144|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55929145|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55929146|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55929147|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929148|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
55929149|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929156|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736562|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
55929195|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929196|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55929197|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55929198|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
55929232|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55929233|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929234|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
55929236|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55929237|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929238|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55929239|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
55929240|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55929241|NCT05066802|Folfirinox|folfirinox|mesh-list
55929242|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929243|NCT04379739|Apatinib|apatinib|mesh-list
55929244|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929245|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55929246|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929247|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929248|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55929249|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929250|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929251|NCT05248633|Dexamethasone|dexamethasone|mesh-list
55929252|NCT05248633|Lenalidomide|lenalidomide|mesh-list
55929253|NCT05248633|Bortezomib|bortezomib|mesh-list
55929259|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55929260|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
55929261|NCT05248633|Hormones|hormones|mesh-ancestor
55929262|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55929263|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55929264|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929265|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
55929266|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55929267|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55929268|NCT05248633|Growth Substances|growth substances|mesh-ancestor
55929269|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
55929270|NCT00216203|Pemetrexed|pemetrexed|mesh-list
55929271|NCT00216203|Cetuximab|cetuximab|mesh-list
55929272|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929273|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929274|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929275|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55929276|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55929277|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55929278|NCT01727271|Interferons|interferons|mesh-list
55929279|NCT01727271|Tenofovir|tenofovir|mesh-list
55929280|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
55929281|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
55929282|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55929283|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929284|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
55929285|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929286|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55929287|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55929288|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929289|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929290|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55929291|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55929292|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
55929293|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929294|NCT00653796|Atorvastatin|atorvastatin|mesh-list
55929295|NCT00653796|Ezetimibe|ezetimibe|mesh-list
55929297|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55929298|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
55929299|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929300|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55929337|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55929338|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55929339|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929340|NCT01721031|Tramadol|tramadol|mesh-list
55929341|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55929342|NCT01721031|Narcotics|narcotics|mesh-ancestor
55929343|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929344|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929345|NCT01721031|Analgesics|analgesics|mesh-ancestor
55929346|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
55929347|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929348|NCT03218683|Venetoclax|venetoclax|mesh-list
55929349|NCT03218683|AZD5991|azd5991|mesh-list
55929350|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929351|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
55929352|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
55929353|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929354|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55929355|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55929356|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55929357|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929358|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
55929359|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929360|NCT00370890|Gemcitabine|gemcitabine|mesh-list
55929361|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929362|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55929363|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
55929371|NCT02669953|Aflibercept|aflibercept|mesh-list
55929372|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55929373|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55929374|NCT02669953|Growth Substances|growth substances|mesh-ancestor
55929375|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929376|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
55929377|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929378|NCT03216967|Everolimus|everolimus|mesh-list
55929379|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929380|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55929381|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
55929382|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929383|NCT01721655|Spironolactone|spironolactone|mesh-list
55929384|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55929385|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
56144590|NCT00801138|Dexamethasone|dexamethasone|mesh-list
55929386|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55929387|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929388|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55929390|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
55929432|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55929433|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55929434|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929435|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929436|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929437|NCT02488135|Hemostatics|hemostatics|mesh-list
55929438|NCT02488135|Coagulants|coagulants|mesh-ancestor
55929439|NCT01727973|Doxycycline|doxycycline|mesh-list
55929440|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55929441|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929442|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
55929443|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55929444|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55929445|NCT03100734|Etanercept|etanercept|mesh-list
55929446|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55929447|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55929448|NCT03100734|Analgesics|analgesics|mesh-ancestor
55929449|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
55929450|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736715|NCT03434951|Bupivacaine|bupivacaine|mesh-list
55929471|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929472|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929473|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55929474|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55929476|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929477|NCT01722201|Risperidone|risperidone|mesh-list
55929478|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55929479|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
55929480|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55929481|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929482|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929483|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55929484|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55929485|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929486|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55929487|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55929488|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
55929489|NCT01722513|Alprostadil|alprostadil|mesh-list
55929490|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55929491|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
55929492|NCT01722513|Urological Agents|urological agents|mesh-ancestor
55929493|NCT03179995|Octreotide|octreotide|mesh-list
55929494|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55929495|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55929496|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929497|NCT01728441|Paclitaxel|paclitaxel|mesh-list
55929498|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55929499|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55929500|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929501|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
55929513|NCT05246293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929514|NCT04984200|Mydriatics|mydriatics|mesh-list
55929515|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
55929516|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929517|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929525|NCT00912873|Ropivacaine|ropivacaine|mesh-list
55929526|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
55929527|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
55929528|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55929529|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929530|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
55929531|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55929532|NCT01494038|Isoniazid|isoniazid|mesh-list
55929533|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
55929534|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55929535|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929536|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55929537|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55929538|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
55929539|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929540|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55929632|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
55929633|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929634|NCT02398825|Ponatinib|ponatinib|mesh-list
55929635|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55929636|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55929637|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929638|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929639|NCT01723059|Amoxicillin|amoxicillin|mesh-list
55929640|NCT01723059|Metronidazole|metronidazole|mesh-list
55929641|NCT01723059|Clarithromycin|clarithromycin|mesh-list
55929642|NCT01723059|Omeprazole|omeprazole|mesh-list
55929643|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55929644|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929645|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55929646|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55929647|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55929648|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55929649|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55929650|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929651|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929652|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55929653|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55929654|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55929655|NCT04379271|Calcium|calcium|mesh-list
55929656|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55929657|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55929658|NCT01728909|Oxytocin|oxytocin|mesh-list
55929659|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
55929662|NCT01922713|Vitamin A|vitamin a|mesh-list
55929674|NCT05061732|Amoxicillin|amoxicillin|mesh-list
55929675|NCT05061732|Metronidazole|metronidazole|mesh-list
55929676|NCT05061732|Clarithromycin|clarithromycin|mesh-list
55929677|NCT05061732|Doxycycline|doxycycline|mesh-list
55929678|NCT05061732|Levofloxacin|levofloxacin|mesh-list
55929679|NCT05061732|Tetracycline|tetracycline|mesh-list
55929680|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
55929681|NCT05061732|Rabeprazole|rabeprazole|mesh-list
55929682|NCT05061732|Bismuth|bismuth|mesh-list
55929683|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55929684|NCT05061732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55929685|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55929686|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55929687|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55929688|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55743283|NCT02507323|Ticagrelor|ticagrelor|mesh-list
55929689|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55929690|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55929691|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55930006|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
55930007|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55930008|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55737400|NCT03423667|Antidotes|antidotes|mesh-ancestor
56000942|NCT00634972|Analgesics|analgesics|mesh-ancestor
56000943|NCT00634972|Sensory System Agents|sensory system agents|mesh-ancestor
56000944|NCT00634972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56000945|NCT00634972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56000946|NCT00634972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56000982|NCT00380146|Antimalarials|antimalarials|mesh-ancestor
56000983|NCT00380146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56000984|NCT00380146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56000985|NCT00380146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56000986|NCT00380146|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56000987|NCT00380146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000988|NCT00380146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000989|NCT00380146|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56000990|NCT00380146|Renal Agents|renal agents|mesh-ancestor
56000991|NCT03521154|Osimertinib|osimertinib|mesh-list
56000992|NCT03521154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56000993|NCT03521154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56000994|NCT03521154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56000995|NCT03521154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56000996|NCT00496756|Sorafenib|sorafenib|mesh-list
56000997|NCT00496756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001109|NCT00000778|Vitamin B Complex|vitamin b complex|mesh-ancestor
55757978|NCT04423731|Antidotes|antidotes|mesh-ancestor
56001111|NCT00000778|Micronutrients|micronutrients|mesh-ancestor
56001112|NCT00000778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001123|NCT05600686|Prednisone|prednisone|mesh-list
56001124|NCT05600686|Cortisone|cortisone|mesh-list
56001125|NCT05600686|Cyclophosphamide|cyclophosphamide|mesh-list
56001126|NCT05600686|Rituximab|rituximab|mesh-list
56001127|NCT05600686|Doxorubicin|doxorubicin|mesh-list
56001128|NCT05600686|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56001129|NCT05600686|Etoposide|etoposide|mesh-list
55737766|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
56001398|NCT02649764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001399|NCT02649764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56001400|NCT02649764|Immunologic Factors|immunologic factors|mesh-ancestor
56001401|NCT02649764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001402|NCT02649764|Antiviral Agents|antiviral agents|mesh-ancestor
56001403|NCT02649764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56001404|NCT04051996|Decitabine|decitabine|mesh-list
56001405|NCT04051996|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56001406|NCT04051996|Antimetabolites|antimetabolites|mesh-ancestor
56001407|NCT04051996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001623|NCT02795156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56001624|NCT02795156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001625|NCT02599454|Atezolizumab|atezolizumab|mesh-list
56001626|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001627|NCT02790710|Propranolol|propranolol|mesh-list
56001628|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56001629|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56001630|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
56001631|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56001632|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56001633|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001634|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56001635|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56001636|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
56001637|NCT02279654|Lenalidomide|lenalidomide|mesh-list
56001638|NCT02279654|Immunologic Factors|immunologic factors|mesh-ancestor
56001639|NCT02279654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56001640|NCT02279654|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56001641|NCT02279654|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56001643|NCT02279654|Growth Inhibitors|growth inhibitors|mesh-ancestor
56001644|NCT02279654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56001932|NCT00000976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56002080|NCT00000262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002081|NCT00000262|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56002082|NCT00000262|Analgesics|analgesics|mesh-ancestor
56002083|NCT00000262|Sensory System Agents|sensory system agents|mesh-ancestor
56002084|NCT00000262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738952|NCT03423823|Growth Substances|growth substances|mesh-ancestor
56002206|NCT04331470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56002207|NCT04331470|Adrenergic Agents|adrenergic agents|mesh-ancestor
55723312|NCT04875364|Eszopiclone|eszopiclone|mesh-list
55723372|NCT05038982|Abrocitinib|abrocitinib|mesh-list
55723445|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
55723522|NCT04215848|Budesonide|budesonide|mesh-list
56002208|NCT04331470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002209|NCT04331470|Amebicides|amebicides|mesh-ancestor
56002210|NCT04331470|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56002211|NCT04331470|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56002216|NCT04331470|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56002217|NCT04331470|Immunologic Factors|immunologic factors|mesh-ancestor
56002218|NCT00001090|Sargramostim|sargramostim|mesh-list
56002219|NCT00001090|Immunologic Factors|immunologic factors|mesh-ancestor
56002220|NCT00001090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002221|NCT01147627|Insulin|insulin|mesh-list
55724090|NCT03298061|Hormones|hormones|mesh-ancestor
56002222|NCT01147627|Pioglitazone|pioglitazone|mesh-list
56002223|NCT01147627|Exenatide|exenatide|mesh-list
56002260|NCT00000274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56002261|NCT00000274|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56002262|NCT00000274|Dopamine Agents|dopamine agents|mesh-ancestor
56002263|NCT00000274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002264|NCT00000274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002266|NCT02743598|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56002267|NCT02743598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002270|NCT02743598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56002271|NCT00000280|Nimodipine|nimodipine|mesh-list
56002272|NCT00000280|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56002273|NCT00000280|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56002274|NCT00000280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002275|NCT00000280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002276|NCT00000280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56002277|NCT00000280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002278|NCT00000280|Vasodilator Agents|vasodilator agents|mesh-ancestor
56002279|NCT00000286|Nefazodone|nefazodone|mesh-list
56002280|NCT00000286|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55727919|NCT04311502|Micronutrients|micronutrients|mesh-ancestor
56002281|NCT00000286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56002282|NCT00000286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002405|NCT02734004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002407|NCT02734004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
56002408|NCT02734004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002409|NCT02734004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002410|NCT01227655|Levodopa|levodopa|mesh-list
56002411|NCT01227655|Carbidopa|carbidopa|mesh-list
56002412|NCT01227655|Opicapone|opicapone|mesh-list
56002461|NCT00001996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002462|NCT00001996|Antifungal Agents|antifungal agents|mesh-ancestor
56002463|NCT00001996|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
56002465|NCT02725424|Oxaliplatin|oxaliplatin|mesh-list
56002466|NCT02725424|Trastuzumab|trastuzumab|mesh-list
56002467|NCT02725424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002468|NCT02725424|Tubulin Modulators|tubulin modulators|mesh-ancestor
56002469|NCT02725424|Antimitotic Agents|antimitotic agents|mesh-ancestor
56002470|NCT02725424|Mitosis Modulators|mitosis modulators|mesh-ancestor
56002471|NCT02725424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002472|NCT02725424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56002473|NCT01189279|Bimatoprost|bimatoprost|mesh-list
56002474|NCT01189279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56002475|NCT00001108|Ritonavir|ritonavir|mesh-list
55729732|NCT02303873|Alendronate|alendronate|mesh-list
56002476|NCT00001108|Nelfinavir|nelfinavir|mesh-list
56002477|NCT00001108|Saquinavir|saquinavir|mesh-list
56002478|NCT00001108|Lamivudine|lamivudine|mesh-list
56002548|NCT00002002|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56002549|NCT00002002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002550|NCT00002002|Renal Agents|renal agents|mesh-ancestor
56002551|NCT00002002|Antimalarials|antimalarials|mesh-ancestor
56002552|NCT00002002|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56002553|NCT00002002|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56002554|NCT00002002|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55729803|NCT03135795|Parecoxib|parecoxib|mesh-list
56002576|NCT00380380|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56002577|NCT00380380|Protease Inhibitors|protease inhibitors|mesh-ancestor
56002578|NCT00380380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002579|NCT00380380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002580|NCT01228903|Allopurinol|allopurinol|mesh-list
56002581|NCT01228903|Antimetabolites|antimetabolites|mesh-ancestor
56002582|NCT01228903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002583|NCT01228903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002584|NCT01228903|Gout Suppressants|gout suppressants|mesh-ancestor
56002585|NCT01228903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56002658|NCT00000340|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
56002659|NCT00000340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002660|NCT00002020|Zidovudine|zidovudine|mesh-list
56002662|NCT00002020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002663|NCT00002020|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55738792|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56002664|NCT00002020|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56002665|NCT00002020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002666|NCT00002020|Antiviral Agents|antiviral agents|mesh-ancestor
56002667|NCT00002020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002668|NCT00002020|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56002669|NCT00002020|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56002670|NCT00002026|Acyclovir|acyclovir|mesh-list
56002671|NCT00002026|Antiviral Agents|antiviral agents|mesh-ancestor
56002672|NCT00002026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002673|NCT00000352|Dextromethorphan|dextromethorphan|mesh-list
56002674|NCT00000352|Antitussive Agents|antitussive agents|mesh-ancestor
56002675|NCT00000352|Respiratory System Agents|respiratory system agents|mesh-ancestor
56002676|NCT00000352|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56002677|NCT00000352|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56002678|NCT00000352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002732|NCT00000376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56002733|NCT00000376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002734|NCT00000376|Adrenergic Agents|adrenergic agents|mesh-ancestor
56002735|NCT00000376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56002736|NCT00000376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002737|NCT02143388|Cisplatin|cisplatin|mesh-list
56002738|NCT02143388|Capecitabine|capecitabine|mesh-list
56002739|NCT02143388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002740|NCT02143388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56002741|NCT02143388|Antimetabolites|antimetabolites|mesh-ancestor
56002742|NCT02143388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002743|NCT00001228|Interferons|interferons|mesh-list
56002744|NCT00001228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56002745|NCT00001228|Antiviral Agents|antiviral agents|mesh-ancestor
56002746|NCT00001228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002747|NCT02483936|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
56002748|NCT02483936|Olmesartan|olmesartan|mesh-list
56002749|NCT02483936|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
56002750|NCT02483936|Chlorthalidone|chlorthalidone|mesh-list
56002751|NCT02483936|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56002752|NCT02483936|Diuretics|diuretics|mesh-ancestor
56002753|NCT02483936|Natriuretic Agents|natriuretic agents|mesh-ancestor
56002754|NCT02483936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002755|NCT02483936|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56002756|NCT02483936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56002757|NCT02483936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002758|NCT02483936|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
56002759|NCT02483936|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56002760|NCT00002038|Fluconazole|fluconazole|mesh-list
56002761|NCT00002038|Antifungal Agents|antifungal agents|mesh-ancestor
56002762|NCT00002038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56002763|NCT00002038|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56002764|NCT00002038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56002765|NCT00002038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56002766|NCT00002038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002767|NCT00002038|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56002873|NCT00000412|Micronutrients|micronutrients|mesh-ancestor
56002874|NCT00002056|Pentamidine|pentamidine|mesh-list
56002875|NCT00002056|Antifungal Agents|antifungal agents|mesh-ancestor
56002920|NCT00380770|Antimetabolites|antimetabolites|mesh-ancestor
56002921|NCT01231399|Calcium, Dietary|calcium, dietary|mesh-list
56002922|NCT01231399|Leucovorin|leucovorin|mesh-list
56002923|NCT01231399|Fluorouracil|fluorouracil|mesh-list
56002924|NCT01231399|Oxaliplatin|oxaliplatin|mesh-list
56002925|NCT01231399|Everolimus|everolimus|mesh-list
56002926|NCT01231399|Calcium|calcium|mesh-list
56002927|NCT01231399|Levoleucovorin|levoleucovorin|mesh-list
56002928|NCT01231399|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56002929|NCT01231399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56002930|NCT01231399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56002931|NCT01231399|Antimetabolites|antimetabolites|mesh-ancestor
56002932|NCT01231399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56002933|NCT01231399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56002999|NCT00000448|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
56003000|NCT00000448|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
56003001|NCT00000448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003002|NCT00000448|Sensory System Agents|sensory system agents|mesh-ancestor
56003003|NCT00000448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003005|NCT00001318|Interferon-gamma|interferon-gamma|mesh-list
56003006|NCT00001318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003007|NCT00001318|Antiviral Agents|antiviral agents|mesh-ancestor
56003008|NCT00001318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003009|NCT00002074|Fluconazole|fluconazole|mesh-list
56003010|NCT00002074|Amphotericin B|amphotericin b|mesh-list
56003011|NCT00002074|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
56003012|NCT00002074|Antifungal Agents|antifungal agents|mesh-ancestor
56003013|NCT00002074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003014|NCT00002074|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56003015|NCT00002074|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56003016|NCT00002074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003017|NCT00002074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003018|NCT00002074|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56003019|NCT00002074|Hormone Antagonists|hormone antagonists|mesh-ancestor
56003020|NCT00002074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56003071|NCT00000496|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56003072|NCT00000496|Analgesics|analgesics|mesh-ancestor
56003073|NCT00000496|Sensory System Agents|sensory system agents|mesh-ancestor
56003094|NCT00002086|Immunologic Factors|immunologic factors|mesh-ancestor
56003095|NCT00002086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003096|NCT00002086|Antimetabolites|antimetabolites|mesh-ancestor
56003097|NCT00002086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003098|NCT00002086|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003099|NCT00002086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003100|NCT00002086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003101|NCT00002086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003102|NCT00002086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003103|NCT01151449|R04929097|r04929097|mesh-list
56003104|NCT01151449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003105|NCT01151449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003106|NCT00001384|Paclitaxel|paclitaxel|mesh-list
56003107|NCT00001384|Cyclophosphamide|cyclophosphamide|mesh-list
56003108|NCT00001384|Doxorubicin|doxorubicin|mesh-list
56003109|NCT00001384|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
56003110|NCT00001384|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56003111|NCT00001384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739527|NCT03126721|Midazolam|midazolam|mesh-list
56003159|NCT02122562|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56003160|NCT02122562|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56003161|NCT02122562|Anesthetics, General|anesthetics, general|mesh-ancestor
56003162|NCT02122562|Anesthetics|anesthetics|mesh-ancestor
56003163|NCT02122562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56003164|NCT02122562|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56003165|NCT02122562|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56003166|NCT02122562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56003167|NCT02122562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003168|NCT00002098|Didanosine|didanosine|mesh-list
56003169|NCT00002098|Lentinan|lentinan|mesh-list
56003170|NCT00002098|Antimetabolites|antimetabolites|mesh-ancestor
56003171|NCT00002098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003172|NCT00002098|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003173|NCT00002098|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003174|NCT00002098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003175|NCT00002098|Antiviral Agents|antiviral agents|mesh-ancestor
56003176|NCT00002098|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003177|NCT00002098|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003178|NCT00002098|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003179|NCT00002098|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56003180|NCT00002098|Immunologic Factors|immunologic factors|mesh-ancestor
56003181|NCT00002098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738802|NCT03417947|Vitamin D|vitamin d|mesh-list
56003182|NCT00002098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003183|NCT02705300|Leucovorin|leucovorin|mesh-list
56003184|NCT02705300|Tocotrienols|tocotrienols|mesh-list
56003185|NCT02705300|Vitamin E|vitamin e|mesh-list
56003186|NCT02705300|Tocopherols|tocopherols|mesh-list
56003187|NCT02705300|Fluorouracil|fluorouracil|mesh-list
56003188|NCT02705300|Oxaliplatin|oxaliplatin|mesh-list
56003189|NCT02705300|Irinotecan|irinotecan|mesh-list
56003190|NCT02705300|Levoleucovorin|levoleucovorin|mesh-list
56003191|NCT02705300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003192|NCT02705300|Antimetabolites|antimetabolites|mesh-ancestor
55739565|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56003210|NCT01196377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003211|NCT01196377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003213|NCT01196377|Respiratory System Agents|respiratory system agents|mesh-ancestor
56003214|NCT01196377|Tocolytic Agents|tocolytic agents|mesh-ancestor
56003215|NCT01196377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56003216|NCT01196377|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
56003217|NCT01196377|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56003218|NCT01196377|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56003219|NCT01196377|Adrenergic Agents|adrenergic agents|mesh-ancestor
56003220|NCT01196377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56003221|NCT01196377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003223|NCT00001426|Cyclophosphamide|cyclophosphamide|mesh-list
56003224|NCT00001426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56003225|NCT00001426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003226|NCT00001426|Tubulin Modulators|tubulin modulators|mesh-ancestor
56003227|NCT00001426|Antimitotic Agents|antimitotic agents|mesh-ancestor
56003228|NCT00001426|Mitosis Modulators|mitosis modulators|mesh-ancestor
56003229|NCT00001426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003230|NCT00001426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003231|NCT00001426|Immunologic Factors|immunologic factors|mesh-ancestor
56003232|NCT00001426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003233|NCT00001426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56003234|NCT00001426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56003235|NCT00001426|Alkylating Agents|alkylating agents|mesh-ancestor
56003236|NCT00001426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56003238|NCT02463266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003239|NCT00002104|Thalidomide|thalidomide|mesh-list
56003240|NCT00002104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003327|NCT00001498|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56003328|NCT00001498|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56003329|NCT00001498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003330|NCT00001498|Antimetabolites|antimetabolites|mesh-ancestor
56003331|NCT00001498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56003332|NCT00001498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56003333|NCT00001498|Abortifacient Agents|abortifacient agents|mesh-ancestor
56003334|NCT00001498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56003335|NCT00001498|Dermatologic Agents|dermatologic agents|mesh-ancestor
56003336|NCT00001498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56003337|NCT00001498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003339|NCT00001498|Protective Agents|protective agents|mesh-ancestor
56003340|NCT00001498|Vitamin B Complex|vitamin b complex|mesh-ancestor
56003341|NCT00001498|Vitamins|vitamins|mesh-ancestor
56003342|NCT00001498|Micronutrients|micronutrients|mesh-ancestor
56003343|NCT00001504|Tretinoin|tretinoin|mesh-list
56003344|NCT00001504|Alitretinoin|alitretinoin|mesh-list
56003345|NCT00001504|Isotretinoin|isotretinoin|mesh-list
56003584|NCT00002146|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003585|NCT00002146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003586|NCT04389554|Fibrin fragment D|fibrin fragment d|mesh-list
56003587|NCT04389554|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
56003588|NCT04389554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56003589|NCT04389554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003590|NCT04389554|Hemostatics|hemostatics|mesh-ancestor
56003591|NCT04389554|Coagulants|coagulants|mesh-ancestor
56003592|NCT03051516|Vaccines|vaccines|mesh-list
56003593|NCT03051516|Immunologic Factors|immunologic factors|mesh-ancestor
56003594|NCT03051516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003595|NCT01029587|Eculizumab|eculizumab|mesh-list
56003596|NCT01029587|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56003597|NCT01029587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56003598|NCT01029587|Immunologic Factors|immunologic factors|mesh-ancestor
56003599|NCT01029587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003600|NCT00000664|Zidovudine|zidovudine|mesh-list
56003601|NCT00000664|Interleukin-2|interleukin-2|mesh-list
56003602|NCT00000664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003603|NCT00000664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56003604|NCT00000664|Analgesics|analgesics|mesh-ancestor
56003605|NCT00000664|Sensory System Agents|sensory system agents|mesh-ancestor
56003606|NCT00000664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003624|NCT00000670|Antiviral Agents|antiviral agents|mesh-ancestor
56003625|NCT00000670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003626|NCT00000670|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003627|NCT00000670|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003628|NCT00000670|Uricosuric Agents|uricosuric agents|mesh-ancestor
56003629|NCT00000670|Gout Suppressants|gout suppressants|mesh-ancestor
56003630|NCT00000670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56003661|NCT01894412|Sensory System Agents|sensory system agents|mesh-ancestor
56003865|NCT02427620|Doxorubicin|doxorubicin|mesh-list
56003662|NCT01894412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003663|NCT01894412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740942|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56003674|NCT00000700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003694|NCT00000706|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003695|NCT00000706|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003696|NCT00000706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003697|NCT00000706|Antiviral Agents|antiviral agents|mesh-ancestor
56003701|NCT00000706|Antimalarials|antimalarials|mesh-ancestor
56003702|NCT00000706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56003703|NCT00000706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56003704|NCT00000706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
56003705|NCT00000706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003706|NCT00000706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56003707|NCT00000706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003708|NCT00000706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56003726|NCT00002302|Epoetin Alfa|epoetin alfa|mesh-list
56003727|NCT00002302|Hematinics|hematinics|mesh-ancestor
56003728|NCT00002170|Nelfinavir|nelfinavir|mesh-list
56003729|NCT00002170|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56003730|NCT00002170|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56003742|NCT00002308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003743|NCT00002308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003744|NCT00002308|Antiviral Agents|antiviral agents|mesh-ancestor
56003745|NCT00002308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003746|NCT00002308|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003747|NCT00002308|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003748|NCT00000724|Leucovorin|leucovorin|mesh-list
56003749|NCT00000724|Trimetrexate|trimetrexate|mesh-list
56003750|NCT00000724|Calcium|calcium|mesh-list
56003751|NCT00000724|Levoleucovorin|levoleucovorin|mesh-list
56003788|NCT00000730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56003789|NCT00000730|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56003790|NCT00000730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003791|NCT00000730|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
56003792|NCT00000730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003793|NCT00000730|Renal Agents|renal agents|mesh-ancestor
56003794|NCT00000730|Antimalarials|antimalarials|mesh-ancestor
56003795|NCT00000730|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56003796|NCT00000730|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56003797|NCT00000730|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56003798|NCT00000730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003799|NCT00000730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003800|NCT00000730|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56003801|NCT00000730|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
56003802|NCT00000730|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56003803|NCT00000730|Antifungal Agents|antifungal agents|mesh-ancestor
56003804|NCT00000730|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55738843|NCT03407521|Isosorbide|isosorbide|mesh-list
56003806|NCT00000730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56003807|NCT00000730|Antimetabolites|antimetabolites|mesh-ancestor
56003808|NCT00002176|Nelfinavir|nelfinavir|mesh-list
56003809|NCT00002176|Didanosine|didanosine|mesh-list
56003810|NCT00002176|Stavudine|stavudine|mesh-list
56003811|NCT00002176|Hydroxyurea|hydroxyurea|mesh-list
56003820|NCT00002176|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003825|NCT00002176|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003826|NCT01990196|Dasatinib|dasatinib|mesh-list
56003827|NCT01990196|Trametinib|trametinib|mesh-list
56003828|NCT01990196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791855|NCT04785287|Nivolumab|nivolumab|mesh-list
56003829|NCT01990196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56003830|NCT01990196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003831|NCT01990196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003832|NCT00381316|Technetium tc-99m tetrofosmin|technetium tc-99m tetrofosmin|mesh-list
56003833|NCT00381316|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56003834|NCT00381316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003835|NCT00002182|Megestrol|megestrol|mesh-list
56003836|NCT00002182|Megestrol Acetate|megestrol acetate|mesh-list
56003837|NCT00002182|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
56003856|NCT00002320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003857|NCT00002320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003858|NCT00002320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003859|NCT00002320|Antimetabolites|antimetabolites|mesh-ancestor
56003860|NCT02427620|Cytarabine|cytarabine|mesh-list
56003861|NCT02427620|Dexamethasone|dexamethasone|mesh-list
56003862|NCT02427620|Dexamethasone acetate|dexamethasone acetate|mesh-list
56003863|NCT02427620|Cyclophosphamide|cyclophosphamide|mesh-list
56003864|NCT02427620|Rituximab|rituximab|mesh-list
56003870|NCT02427620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56003871|NCT02427620|Antibodies|antibodies|mesh-list
56003904|NCT02427620|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56003905|NCT02427620|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003906|NCT02427620|Antiviral Agents|antiviral agents|mesh-ancestor
56003907|NCT02427620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003919|NCT02167217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56003920|NCT02167217|Glucocorticoids|glucocorticoids|mesh-ancestor
56003921|NCT02167217|Hormones|hormones|mesh-ancestor
56003922|NCT02167217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56003923|NCT02167217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56003924|NCT02167217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56003925|NCT02167217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56003926|NCT02167217|Antiemetics|antiemetics|mesh-ancestor
56003927|NCT02167217|Autonomic Agents|autonomic agents|mesh-ancestor
56003928|NCT02167217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56003929|NCT02167217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56003930|NCT02167217|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56003931|NCT02167217|Protective Agents|protective agents|mesh-ancestor
56003932|NCT00002326|Zidovudine|zidovudine|mesh-list
56003933|NCT00002326|Adefovir|adefovir|mesh-list
56003934|NCT00002326|Antimetabolites|antimetabolites|mesh-ancestor
56003935|NCT00002326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003936|NCT00002326|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56003937|NCT00002326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56003938|NCT00002326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003939|NCT00002326|Antiviral Agents|antiviral agents|mesh-ancestor
56003940|NCT00002326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56003941|NCT00002326|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56003942|NCT00002326|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56003952|NCT01152697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56003953|NCT01152697|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56003954|NCT01152697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56003955|NCT01152697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56003956|NCT01152697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56003957|NCT01152697|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56003959|NCT01152697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56003960|NCT01152697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003961|NCT01152697|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56003982|NCT05571644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56003983|NCT05571644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56003984|NCT05571644|Antidotes|antidotes|mesh-ancestor
56003985|NCT05571644|Protective Agents|protective agents|mesh-ancestor
56003992|NCT03011281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56003993|NCT00002194|Clarithromycin|clarithromycin|mesh-list
56003994|NCT00002194|Erythromycin|erythromycin|mesh-list
56003995|NCT00002194|Erythromycin Estolate|erythromycin estolate|mesh-list
56003996|NCT00002194|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
56003997|NCT00002194|Erythromycin stearate|erythromycin stearate|mesh-list
56003999|NCT00002194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56004000|NCT00002194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004001|NCT00002194|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56004002|NCT00002194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004003|NCT00002194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004004|NCT00002194|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56004005|NCT00002194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56004006|NCT00002194|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004007|NCT00002194|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004008|NCT00002194|Antiviral Agents|antiviral agents|mesh-ancestor
56004009|NCT00002194|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004010|NCT00002194|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004011|NCT00002194|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56004012|NCT00002194|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56004013|NCT00002194|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56004014|NCT02413736|Imatinib Mesylate|imatinib mesylate|mesh-list
56004015|NCT02413736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004016|NCT02413736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56004017|NCT02413736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004018|NCT02413736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004019|NCT04756622|Acetylcysteine|acetylcysteine|mesh-list
56004026|NCT04756622|Antioxidants|antioxidants|mesh-ancestor
56004027|NCT04756622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004028|NCT04756622|Protective Agents|protective agents|mesh-ancestor
56004029|NCT04756622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004032|NCT00002344|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56004033|NCT00002344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004034|NCT01198327|Ranibizumab|ranibizumab|mesh-list
56004035|NCT01198327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56004036|NCT01198327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56004037|NCT01198327|Growth Substances|growth substances|mesh-ancestor
56004038|NCT01198327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004077|NCT00002212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004078|NCT00002362|Emtricitabine|emtricitabine|mesh-list
56004079|NCT00002362|Efavirenz|efavirenz|mesh-list
56004080|NCT00002362|Abacavir|abacavir|mesh-list
56004081|NCT00002362|Stavudine|stavudine|mesh-list
56004120|NCT00002368|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004121|NCT00002368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004122|NCT00002368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004144|NCT00995501|Anesthetics|anesthetics|mesh-list
56004145|NCT00995501|Sodium sulfate|sodium sulfate|mesh-list
56004146|NCT00995501|BB 1101|bb 1101|mesh-list
56004147|NCT00995501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56004148|NCT00995501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004149|NCT00995501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56004150|NCT00995501|Antiemetics|antiemetics|mesh-ancestor
56004151|NCT00995501|Autonomic Agents|autonomic agents|mesh-ancestor
56004164|NCT00002374|Ritonavir|ritonavir|mesh-list
56004165|NCT00002374|Nelfinavir|nelfinavir|mesh-list
56004166|NCT00002374|Saquinavir|saquinavir|mesh-list
56004167|NCT00002374|Stavudine|stavudine|mesh-list
56004168|NCT00002374|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56004169|NCT00002374|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56004170|NCT00002374|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004171|NCT00002374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004172|NCT00002374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004173|NCT00002374|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004174|NCT00002374|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004175|NCT00002374|Antiviral Agents|antiviral agents|mesh-ancestor
56004176|NCT00002374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004177|NCT00002374|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56004178|NCT00002374|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56004179|NCT00002374|Antimetabolites|antimetabolites|mesh-ancestor
56004180|NCT00002374|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004181|NCT00002374|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004182|NCT00002380|Nelfinavir|nelfinavir|mesh-list
56004183|NCT00002380|Saquinavir|saquinavir|mesh-list
56004184|NCT00002380|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56004306|NCT00002230|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56004307|NCT00002230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004308|NCT00002230|Antisickling Agents|antisickling agents|mesh-ancestor
56004309|NCT00002230|Antimetabolites|antimetabolites|mesh-ancestor
56004310|NCT00002230|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004311|NCT00002230|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004312|NCT03009877|Fentanyl|fentanyl|mesh-list
56004313|NCT03009877|Midazolam|midazolam|mesh-list
56004314|NCT03009877|Propofol|propofol|mesh-list
56004315|NCT03009877|Rocuronium|rocuronium|mesh-list
56004316|NCT03009877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56004317|NCT03009877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56004318|NCT03009877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004319|NCT03009877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56004320|NCT03009877|Anesthetics, General|anesthetics, general|mesh-ancestor
56004321|NCT03009877|Anesthetics|anesthetics|mesh-ancestor
56004322|NCT03009877|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56004323|NCT03009877|Narcotics|narcotics|mesh-ancestor
56004417|NCT05593757|Adrenergic Agents|adrenergic agents|mesh-ancestor
56004418|NCT05593757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004443|NCT02393690|Micronutrients|micronutrients|mesh-ancestor
56004444|NCT02393690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004554|NCT01897454|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56004555|NCT01897454|Antidotes|antidotes|mesh-ancestor
56004556|NCT01897454|Protective Agents|protective agents|mesh-ancestor
56004557|NCT01897454|Vitamin B Complex|vitamin b complex|mesh-ancestor
56004558|NCT01897454|Vitamins|vitamins|mesh-ancestor
56004559|NCT01897454|Micronutrients|micronutrients|mesh-ancestor
56004560|NCT01897454|Hematinics|hematinics|mesh-ancestor
56004561|NCT01897454|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56004562|NCT01243567|Timolol|timolol|mesh-list
56004563|NCT01243567|Bimatoprost|bimatoprost|mesh-list
56004564|NCT01243567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56004565|NCT01243567|Latanoprost|latanoprost|mesh-list
56004566|NCT01243567|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56004567|NCT01243567|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56004568|NCT01243567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56004570|NCT01243567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004571|NCT01243567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004576|NCT01001195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
56004578|NCT01001195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56004579|NCT00381472|Ropinirole|ropinirole|mesh-list
56004580|NCT00381472|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
56004581|NCT00381472|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
56004582|NCT00381472|Dopamine Agonists|dopamine agonists|mesh-ancestor
56004583|NCT00381472|Dopamine Agents|dopamine agents|mesh-ancestor
56004584|NCT00381472|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56004585|NCT00381472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004586|NCT00381472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004587|NCT02185729|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
56004588|NCT02185729|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
56004589|NCT02185729|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
56004590|NCT02185729|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56004591|NCT01460654|Alendronate|alendronate|mesh-list
56004592|NCT01460654|Methyltestosterone|methyltestosterone|mesh-list
56004593|NCT01460654|Testosterone|testosterone|mesh-list
56004594|NCT01460654|Testosterone undecanoate|testosterone undecanoate|mesh-list
56004595|NCT01460654|Testosterone enanthate|testosterone enanthate|mesh-list
56004596|NCT01460654|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56004597|NCT01460654|Androgens|androgens|mesh-ancestor
56004598|NCT01460654|Hormones|hormones|mesh-ancestor
56004599|NCT01460654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731842|NCT04780204|Tenofovir|tenofovir|mesh-list
56004600|NCT01460654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004601|NCT01460654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56004603|NCT01460654|Anabolic Agents|anabolic agents|mesh-ancestor
56004604|NCT01460654|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56004605|NCT01001975|Sunscreening Agents|sunscreening agents|mesh-list
56004606|NCT01001975|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56004660|NCT05751304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004661|NCT05751304|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56004662|NCT05751304|Analgesics|analgesics|mesh-ancestor
56004704|NCT01002755|Growth Substances|growth substances|mesh-ancestor
56004705|NCT01002755|Growth Inhibitors|growth inhibitors|mesh-ancestor
56004706|NCT01002755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004708|NCT00002434|Trimetrexate|trimetrexate|mesh-list
56004709|NCT00002434|Calcium|calcium|mesh-list
56004710|NCT00002434|Levoleucovorin|levoleucovorin|mesh-list
56004711|NCT00002434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56004712|NCT00002434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004713|NCT00002434|Antidotes|antidotes|mesh-ancestor
56004714|NCT00002434|Protective Agents|protective agents|mesh-ancestor
56004715|NCT00002434|Vitamin B Complex|vitamin b complex|mesh-ancestor
56004716|NCT00002434|Vitamins|vitamins|mesh-ancestor
56004717|NCT00002434|Micronutrients|micronutrients|mesh-ancestor
56004727|NCT00002278|Coccidiostats|coccidiostats|mesh-ancestor
56004728|NCT00002278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56004757|NCT00002440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004758|NCT00002440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004759|NCT00002440|Antiviral Agents|antiviral agents|mesh-ancestor
56004760|NCT00002440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004834|NCT00002290|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
56004835|NCT00002290|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56004836|NCT00002290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004837|NCT00002290|Antiviral Agents|antiviral agents|mesh-ancestor
56004838|NCT00002290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004839|NCT00002290|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004840|NCT00002290|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56004841|NCT01003769|Acetic Acid|acetic acid|mesh-list
56004842|NCT01003769|Lenalidomide|lenalidomide|mesh-list
56004843|NCT01003769|Retinol acetate|retinol acetate|mesh-list
56004844|NCT01003769|Gossypol acetic acid|gossypol acetic acid|mesh-list
56004845|NCT01003769|Gossypol|gossypol|mesh-list
56004846|NCT01003769|Immunologic Factors|immunologic factors|mesh-ancestor
56004847|NCT01003769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004848|NCT01003769|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56004849|NCT01003769|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56004850|NCT01003769|Growth Substances|growth substances|mesh-ancestor
56004851|NCT01003769|Growth Inhibitors|growth inhibitors|mesh-ancestor
56004852|NCT01003769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004853|NCT01003769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56004854|NCT01003769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56004858|NCT01003769|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56004859|NCT01003769|Contraceptive Agents|contraceptive agents|mesh-ancestor
56004860|NCT01003769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56004861|NCT01003769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56004862|NCT01003769|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56004863|NCT01003769|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56004864|NCT01003769|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56004865|NCT00002452|Indinavir|indinavir|mesh-list
56004866|NCT00002452|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
56004867|NCT00002452|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56004868|NCT00002452|Protease Inhibitors|protease inhibitors|mesh-ancestor
56004869|NCT00002452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56004870|NCT00002452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004871|NCT00002452|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56004880|NCT01004393|Sensory System Agents|sensory system agents|mesh-ancestor
56004881|NCT01004393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004882|NCT00002458|Antibodies|antibodies|mesh-list
56004883|NCT00002458|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56004884|NCT00002458|Immunologic Factors|immunologic factors|mesh-ancestor
56004885|NCT00002458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004886|NCT00002470|Interferons|interferons|mesh-list
56004887|NCT00002470|Interferon-alpha|interferon-alpha|mesh-list
56004888|NCT00002470|Fluorouracil|fluorouracil|mesh-list
56004889|NCT00002470|Antimetabolites|antimetabolites|mesh-ancestor
56004890|NCT00002470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56004891|NCT00002470|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56004892|NCT00002470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56004893|NCT00002470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56004894|NCT00002470|Immunologic Factors|immunologic factors|mesh-ancestor
56004895|NCT00002470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004896|NCT00002470|Antiviral Agents|antiviral agents|mesh-ancestor
56004983|NCT05750992|Anesthetics, Local|anesthetics, local|mesh-ancestor
56004985|NCT05750992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56004986|NCT05750992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56004987|NCT05750992|Sensory System Agents|sensory system agents|mesh-ancestor
56004988|NCT05750992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56004989|NCT05750992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56004991|NCT05750992|Analgesics|analgesics|mesh-ancestor
56004992|NCT05750992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56004993|NCT05750992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56004994|NCT05750992|Anesthetics, General|anesthetics, general|mesh-ancestor
56004995|NCT01004939|PENTA|penta|mesh-list
56004996|NCT01004939|Fondaparinux|fondaparinux|mesh-list
56004997|NCT01004939|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56004998|NCT01004939|Antithrombins|antithrombins|mesh-ancestor
56004999|NCT01004939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
56005000|NCT01004939|Protease Inhibitors|protease inhibitors|mesh-ancestor
56005001|NCT01004939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005002|NCT01004939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005003|NCT01004939|Anticoagulants|anticoagulants|mesh-ancestor
56005004|NCT01004939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56005005|NCT01004939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
56005006|NCT05750758|Rivaroxaban|rivaroxaban|mesh-list
56005065|NCT00002494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56005066|NCT00002494|Immunologic Factors|immunologic factors|mesh-ancestor
56005067|NCT00002494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005068|NCT00002494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56005069|NCT00002494|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56005070|NCT00002494|Alkylating Agents|alkylating agents|mesh-ancestor
56005071|NCT00002494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005072|NCT00002494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005073|NCT00002494|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56005074|NCT00002494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56005076|NCT00002494|Autonomic Agents|autonomic agents|mesh-ancestor
56005077|NCT00002494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56005078|NCT00002494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56005079|NCT00002494|Glucocorticoids|glucocorticoids|mesh-ancestor
56005080|NCT00002494|Hormones|hormones|mesh-ancestor
56005081|NCT00002494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005082|NCT00002494|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56005083|NCT00002494|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56005084|NCT00002494|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56005085|NCT00002494|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56005086|NCT00002494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005087|NCT00002494|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56005088|NCT00002494|Abortifacient Agents|abortifacient agents|mesh-ancestor
56005089|NCT00002494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56005090|NCT00002494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56005093|NCT00002494|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56005094|NCT00002494|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56005095|NCT00002494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56005096|NCT00002494|Antiviral Agents|antiviral agents|mesh-ancestor
56005097|NCT00002494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005098|NCT00002494|Antidotes|antidotes|mesh-ancestor
56005099|NCT00002494|Protective Agents|protective agents|mesh-ancestor
56005100|NCT00002494|Vitamin B Complex|vitamin b complex|mesh-ancestor
56005101|NCT00002494|Vitamins|vitamins|mesh-ancestor
56005102|NCT00002494|Micronutrients|micronutrients|mesh-ancestor
56005103|NCT00002494|Tubulin Modulators|tubulin modulators|mesh-ancestor
56005104|NCT00002494|Antimitotic Agents|antimitotic agents|mesh-ancestor
56005105|NCT00002494|Mitosis Modulators|mitosis modulators|mesh-ancestor
56005106|NCT00002494|Trace Elements|trace elements|mesh-ancestor
56005107|NCT04991324|Vitamin D|vitamin d|mesh-list
56005108|NCT04991324|Cholecalciferol|cholecalciferol|mesh-list
56005109|NCT04991324|Vitamins|vitamins|mesh-ancestor
56005110|NCT04991324|Micronutrients|micronutrients|mesh-ancestor
56005111|NCT04991324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005112|NCT04991324|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56005113|NCT04991324|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56005114|NCT00002506|Interferons|interferons|mesh-list
56005115|NCT00002506|Interferon-alpha|interferon-alpha|mesh-list
56005116|NCT00002506|Isotretinoin|isotretinoin|mesh-list
56005117|NCT00002506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005118|NCT00002506|Antiviral Agents|antiviral agents|mesh-ancestor
56005119|NCT00002506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005120|NCT00002506|Immunologic Factors|immunologic factors|mesh-ancestor
56005121|NCT00002506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56005122|NCT00002506|Dermatologic Agents|dermatologic agents|mesh-ancestor
56005123|NCT01895894|Mycophenolic Acid|mycophenolic acid|mesh-list
56005124|NCT01895894|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56005125|NCT01895894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56005126|NCT01895894|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56005127|NCT01895894|Antitubercular Agents|antitubercular agents|mesh-ancestor
56005128|NCT01895894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56005129|NCT01895894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56005130|NCT01895894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56005368|NCT00002542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56005494|NCT05449535|Respiratory System Agents|respiratory system agents|mesh-ancestor
56005496|NCT04253561|Pertuzumab|pertuzumab|mesh-list
56005516|NCT05663866|Abortifacient Agents|abortifacient agents|mesh-ancestor
56005517|NCT05663866|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56005518|NCT05663866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56005519|NCT05663866|Antimetabolites|antimetabolites|mesh-ancestor
56005591|NCT04094207|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
56005847|NCT00002548|Alkylating Agents|alkylating agents|mesh-ancestor
56005848|NCT00002548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56005849|NCT00002548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930063|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55930064|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930065|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
55930066|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55930067|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55930068|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55930069|NCT01724931|Aminopterin|aminopterin|mesh-list
55930070|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55930071|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930072|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930074|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55930075|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
55930076|NCT01725009|Levetiracetam|levetiracetam|mesh-list
55930077|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
55930078|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
55930079|NCT01725087|Tapentadol|tapentadol|mesh-list
55930080|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55930105|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930160|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930161|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930163|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
55930164|NCT04759729|Cholecalciferol|cholecalciferol|mesh-list
55930165|NCT04759729|Vitamins|vitamins|mesh-list
55930166|NCT04759729|Micronutrients|micronutrients|mesh-ancestor
55930167|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930168|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55798153|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55930169|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55930170|NCT05053386|Epirubicin|epirubicin|mesh-list
55930171|NCT05053386|Idarubicin|idarubicin|mesh-list
55930172|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55930173|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930174|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55930175|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55930176|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930177|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930178|NCT01725243|Carbetocin|carbetocin|mesh-list
55930179|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
55930180|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55930181|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930182|NCT01725477|Methylene Blue|methylene blue|mesh-list
55930183|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930184|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930185|NCT03096990|Apremilast|apremilast|mesh-list
55930186|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55930187|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55930192|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55930193|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930194|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55930195|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55930196|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930197|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930198|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
55930199|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55930200|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930201|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
55930202|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
55930203|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
55930204|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
55930205|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
55930207|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
55930220|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
55930221|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55930222|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55930223|NCT03836781|Analgesics|analgesics|mesh-ancestor
55930224|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
55930225|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930226|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930227|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55930228|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930229|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55930230|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930231|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930232|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55930234|NCT01360866|Fluoxetine|fluoxetine|mesh-list
55930235|NCT01360866|Paroxetine|paroxetine|mesh-list
55930236|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55930237|NCT01360866|Sertraline|sertraline|mesh-list
55930238|NCT01360866|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55930239|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55930240|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55930263|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55930264|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55930265|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
55930266|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930267|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
55930268|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
55930269|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
55930270|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930271|NCT01046643|Estradiol|estradiol|mesh-list
55930272|NCT01046643|Progesterone|progesterone|mesh-list
55930273|NCT01046643|Estrogens|estrogens|mesh-ancestor
55930274|NCT01046643|Hormones|hormones|mesh-ancestor
55930275|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930276|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930277|NCT01046643|Progestins|progestins|mesh-ancestor
55930278|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
55930279|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
55930280|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930281|NCT03096756|Protective Agents|protective agents|mesh-ancestor
55930361|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930362|NCT04471818|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55930377|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930379|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55930380|NCT04434378|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55930381|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55930382|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
55930383|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55930384|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930385|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930386|NCT04434378|Urological Agents|urological agents|mesh-ancestor
55930387|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
55930388|NCT00981799|Methotrexate|methotrexate|mesh-list
55930389|NCT00981799|Etoposide|etoposide|mesh-list
55930390|NCT00981799|Lenograstim|lenograstim|mesh-list
55930391|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55930392|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
55930393|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930394|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55930395|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55930396|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
55930398|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930412|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55930413|NCT05033106|Bevacizumab|bevacizumab|mesh-list
55930414|NCT05033106|Ranibizumab|ranibizumab|mesh-list
55930415|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55930416|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930417|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55930418|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55930419|NCT05033106|Growth Substances|growth substances|mesh-ancestor
55930420|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930421|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
55930422|NCT03095040|Everolimus|everolimus|mesh-list
55930423|NCT03095040|Vorolanib|vorolanib|mesh-list
55930424|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930425|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55930426|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
55930427|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930428|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55930429|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55930430|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930431|NCT03099499|TIC10 compound|tic10 compound|mesh-list
55930432|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930433|NCT03096522|Phenytoin|phenytoin|mesh-list
55930434|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
55930435|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55930460|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55930461|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
55930516|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930679|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930680|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930682|NCT05039580|Antibodies|antibodies|mesh-list
55930683|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55930684|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
55930685|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930686|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55930687|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
55930688|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
55930689|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930690|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55930691|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
55930692|NCT05039580|Hormones|hormones|mesh-ancestor
55930693|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55930694|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55930695|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55930696|NCT05025228|Acetaminophen|acetaminophen|mesh-list
55930697|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55930698|NCT05025228|Analgesics|analgesics|mesh-ancestor
55930699|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
55930700|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930713|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930714|NCT03597893|Oxytocin|oxytocin|mesh-list
55930715|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
55930716|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55930717|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930718|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55930719|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
55930720|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930721|NCT05024448|Prednisone|prednisone|mesh-list
55930722|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55930723|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
55930788|NCT03595319|Sevoflurane|sevoflurane|mesh-list
55930789|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55930790|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55930791|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
55793652|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
55930908|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55930909|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55930910|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55930911|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930912|NCT03406689|Nepafenac|nepafenac|mesh-list
55930913|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
55930914|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55930915|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55930916|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55930917|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55930918|NCT03406689|Analgesics|analgesics|mesh-ancestor
55930919|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
55930920|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55930937|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55930938|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55930939|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
55931263|NCT05023122|Vitamin D|vitamin d|mesh-list
55931264|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
55931265|NCT05023122|Calcium|calcium|mesh-list
55931266|NCT05023122|Vitamins|vitamins|mesh-ancestor
55931267|NCT05023122|Micronutrients|micronutrients|mesh-ancestor
55931281|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
55931282|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55798057|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798058|NCT03057769|Indomethacin|indomethacin|mesh-list
55798059|NCT03057769|Epinephrine|epinephrine|mesh-list
55931283|NCT04194905|Estradiol|estradiol|mesh-list
55931284|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55931285|NCT04194905|Estrogens|estrogens|mesh-ancestor
55931286|NCT04194905|Hormones|hormones|mesh-ancestor
55931287|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798060|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55798062|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
55798063|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798064|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798065|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798066|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55798067|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55798068|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
55798069|NCT03057769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798070|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55798071|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
55798073|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
55798074|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55798075|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55798076|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55798077|NCT03057769|Analgesics|analgesics|mesh-ancestor
55798078|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
55798079|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798080|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931288|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931289|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55931290|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
55931291|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55931292|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55798081|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
55798082|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
55798083|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55798084|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55798085|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798086|NCT04633577|Lidocaine|lidocaine|mesh-list
55798087|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
55798088|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
55798089|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798090|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798091|NCT04633577|Sensory System Agents|sensory system agents|mesh-ancestor
55798092|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798154|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
55798093|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55798094|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55798095|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55798096|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798097|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798098|NCT04941625|Cystatins|cystatins|mesh-list
55931293|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55931294|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55931295|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55931296|NCT05017428|Niacinamide|niacinamide|mesh-list
55931297|NCT05017428|Niacin|niacin|mesh-list
55798099|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55798100|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
55798101|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798102|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798103|NCT03534323|Venetoclax|venetoclax|mesh-list
55798104|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798105|NCT04406389|Heparin|heparin|mesh-list
55798106|NCT04406389|Calcium heparin|calcium heparin|mesh-list
55798107|NCT04406389|Enoxaparin|enoxaparin|mesh-list
55798108|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
55798109|NCT04406389|Argatroban|argatroban|mesh-list
55798110|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
55798112|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55798113|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798114|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
55798115|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55798116|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
55798117|NCT04406389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798118|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55798119|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55798120|NCT04921657|Simvastatin|simvastatin|mesh-list
55798121|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55931298|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
55931299|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
55931300|NCT05017428|Vitamins|vitamins|mesh-ancestor
55931301|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
55931302|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931303|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55931304|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
55931305|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931306|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55931307|NCT05017428|Vasodilator Agents|vasodilator agents|mesh-ancestor
55798122|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55798123|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
55798124|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798125|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55798126|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55798127|NCT04921657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798128|NCT04930471|Metformin|metformin|mesh-list
55798129|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55798130|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798131|NCT04418401|Antibodies|antibodies|mesh-list
55798133|NCT04418401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798134|NCT04940689|Lidocaine|lidocaine|mesh-list
55798135|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
55798136|NCT04940689|Remifentanil|remifentanil|mesh-list
55798137|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
55798138|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
55798139|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798140|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798141|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
55798142|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798143|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55798144|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55798145|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55931309|NCT00013611|Interleukin-2|interleukin-2|mesh-list
55931310|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931311|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55931312|NCT00013611|Analgesics|analgesics|mesh-ancestor
55931313|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
55931314|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931315|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931316|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55798150|NCT04940689|Analgesics|analgesics|mesh-ancestor
55798151|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55798152|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55798155|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798156|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55798157|NCT04940689|Narcotics|narcotics|mesh-ancestor
55798158|NCT05530811|Dexamethasone|dexamethasone|mesh-list
55798159|NCT05530811|Bupivacaine|bupivacaine|mesh-list
55798160|NCT05530811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798161|NCT05530811|Antiemetics|antiemetics|mesh-ancestor
55798162|NCT05530811|Autonomic Agents|autonomic agents|mesh-ancestor
55798163|NCT05530811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798164|NCT05530811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931332|NCT05017116|Entecavir|entecavir|mesh-list
55798165|NCT05530811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55798166|NCT05530811|Glucocorticoids|glucocorticoids|mesh-ancestor
55798167|NCT05530811|Hormones|hormones|mesh-ancestor
55931333|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
55931334|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931335|NCT05022030|Cetuximab|cetuximab|mesh-list
55931336|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798168|NCT05530811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798170|NCT05530811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798171|NCT05530811|Anesthetics, Local|anesthetics, local|mesh-ancestor
55798172|NCT05530811|Anesthetics|anesthetics|mesh-ancestor
55798173|NCT05530811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798174|NCT05530811|Sensory System Agents|sensory system agents|mesh-ancestor
55798175|NCT04940845|Denosumab|denosumab|mesh-list
55798176|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55798177|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798178|NCT04921111|Aluminum phosphate|aluminum phosphate|mesh-list
55931339|NCT03845543|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55931340|NCT03845543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931341|NCT03845543|Tubulin Modulators|tubulin modulators|mesh-ancestor
55931342|NCT03845543|Antimitotic Agents|antimitotic agents|mesh-ancestor
55931343|NCT03845543|Mitosis Modulators|mitosis modulators|mesh-ancestor
55798184|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931344|NCT03845543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931345|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
55931346|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55931347|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55931348|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931349|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
55931350|NCT04192643|Coagulants|coagulants|mesh-ancestor
55931351|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
55931352|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55931353|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931354|NCT00010257|Paclitaxel|paclitaxel|mesh-list
55931355|NCT00010257|Carboplatin|carboplatin|mesh-list
55931356|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55931357|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931358|NCT00010257|Tubulin Modulators|tubulin modulators|mesh-ancestor
55931359|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
55798185|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55798186|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55798187|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55931360|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
55931361|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931362|NCT05022186|Cannabidiol|cannabidiol|mesh-list
55931363|NCT05022186|Tramiprosate|tramiprosate|mesh-list
55931364|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
55931365|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
55931366|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
55798188|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798189|NCT03057145|Olaparib|olaparib|mesh-list
55798190|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55798191|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931367|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931368|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931369|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931370|NCT02240043|Hormones|hormones|mesh-list
55931372|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798192|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798193|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931375|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55931376|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55931377|NCT03404037|Growth Substances|growth substances|mesh-ancestor
55931378|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931379|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
55798197|NCT05421065|Sensory System Agents|sensory system agents|mesh-ancestor
55931383|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
55931384|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931385|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931386|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
55931387|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798198|NCT05421065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798199|NCT05421065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798200|NCT05421065|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55798201|NCT05421065|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55798202|NCT05421065|Anesthetics, General|anesthetics, general|mesh-ancestor
55798203|NCT05421065|Anesthetics|anesthetics|mesh-ancestor
55931388|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55931389|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55931390|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55931391|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55931392|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798207|NCT05421065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798208|NCT05421065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798209|NCT05421065|Hallucinogens|hallucinogens|mesh-ancestor
55798210|NCT05421065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55798211|NCT05411237|Paclitaxel|paclitaxel|mesh-list
55798212|NCT05411237|Doxorubicin|doxorubicin|mesh-list
55798213|NCT05411237|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55931395|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55931396|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55931397|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55931398|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55931399|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55931400|NCT04190927|Estradiol|estradiol|mesh-list
55931401|NCT04190927|Progesterone|progesterone|mesh-list
55931402|NCT04190927|Estrogens|estrogens|mesh-ancestor
55931403|NCT04190927|Hormones|hormones|mesh-ancestor
55931404|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931405|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931406|NCT04190927|Progestins|progestins|mesh-ancestor
55931407|NCT00919191|Adapalene|adapalene|mesh-list
55798214|NCT05411237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55798215|NCT05411237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798216|NCT05411237|Tubulin Modulators|tubulin modulators|mesh-ancestor
55931408|NCT00919191|Tretinoin|tretinoin|mesh-list
55931409|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55931410|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
55931411|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55931412|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55931413|NCT00919191|Analgesics|analgesics|mesh-ancestor
55931414|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
55931415|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931416|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931421|NCT03962465|Cytarabine|cytarabine|mesh-list
55931422|NCT03962465|Prednisone|prednisone|mesh-list
55931423|NCT03962465|Methotrexate|methotrexate|mesh-list
55798217|NCT05411237|Antimitotic Agents|antimitotic agents|mesh-ancestor
55798218|NCT05411237|Mitosis Modulators|mitosis modulators|mesh-ancestor
55798219|NCT05411237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798220|NCT05411237|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55931424|NCT03962465|Vincristine|vincristine|mesh-list
55931425|NCT03962465|Daunorubicin|daunorubicin|mesh-list
55931426|NCT03962465|Pegaspargase|pegaspargase|mesh-list
55931440|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931441|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
55931442|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931443|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55931451|NCT03962465|Tubulin Modulators|tubulin modulators|mesh-ancestor
55931452|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
55931453|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
55931454|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55798221|NCT05411237|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55798222|NCT05411237|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55798223|NCT05411237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798224|NCT04940143|Botulinum Toxins|botulinum toxins|mesh-list
55798225|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55798226|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55798227|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55798228|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798229|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798231|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798232|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931455|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55931456|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55931457|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798233|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55798234|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798236|NCT04939675|Zonisamide|zonisamide|mesh-list
55798243|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55931458|NCT05021406|Carvedilol|carvedilol|mesh-list
55931459|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55931460|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55931461|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
55931462|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931473|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55931474|NCT04766177|Bumetanide|bumetanide|mesh-list
55931475|NCT04766177|Diuretics|diuretics|mesh-ancestor
55931476|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
55798252|NCT04939441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798253|NCT04939441|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55798254|NCT04939441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55931477|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931478|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55931479|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798255|NCT04939441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798256|NCT04939441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798257|NCT04939441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55798258|NCT04939441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55798260|NCT04938583|Bevacizumab|bevacizumab|mesh-list
55931480|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931481|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
55931482|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
55931483|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55931484|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55931485|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931486|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931487|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931488|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931489|NCT05016180|Ropivacaine|ropivacaine|mesh-list
55931490|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
55931491|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
55931492|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931493|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931494|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
55931495|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931497|NCT03023501|Analgesics|analgesics|mesh-ancestor
55931498|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
55931499|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931500|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931501|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
55931502|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55931503|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55931504|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931505|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55931506|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55931507|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55931508|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931509|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931510|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
55798262|NCT04938583|Oregovomab|oregovomab|mesh-list
55798263|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55798264|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798265|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
55798266|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
55798267|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
55931512|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55931513|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55931514|NCT05015322|Prednisolone|prednisolone|mesh-list
55931515|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
55931518|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
55798268|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798269|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798270|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55798271|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55798272|NCT04938583|Growth Substances|growth substances|mesh-ancestor
55798273|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798274|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
55798276|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
55798277|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55798278|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931519|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
55931521|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931522|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931523|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
55931524|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931525|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55931526|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
55931527|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
55931528|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55931529|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
55931530|NCT05015322|Hormones|hormones|mesh-ancestor
55798279|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798280|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55798281|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55798282|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55798283|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55798284|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
55931531|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931532|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55931533|NCT05015322|Protective Agents|protective agents|mesh-ancestor
55931534|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55931535|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931537|NCT04195139|Temozolomide|temozolomide|mesh-list
55798286|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
55798287|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
55798288|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931538|NCT04195139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55931541|NCT04195139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931542|NCT04195139|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55931543|NCT04195139|Alkylating Agents|alkylating agents|mesh-ancestor
55931544|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
55798289|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798290|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
55798291|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55931545|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931546|NCT00919503|Cyclosporine|cyclosporine|mesh-list
55931547|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
55931548|NCT00919503|Methotrexate|methotrexate|mesh-list
55798292|NCT04928365|Antibodies|antibodies|mesh-list
55798293|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55798294|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
55798295|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798296|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
55931549|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
55931550|NCT00919503|Fludarabine|fludarabine|mesh-list
55931551|NCT00919503|Treosulfan|treosulfan|mesh-list
55931552|NCT00919503|Busulfan|busulfan|mesh-list
55931553|NCT00919503|Tacrolimus|tacrolimus|mesh-list
55931554|NCT00919503|Cyclosporins|cyclosporins|mesh-list
55931555|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
55798297|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55798298|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55798299|NCT04938037|Prednisolone|prednisolone|mesh-list
55798300|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
55798301|NCT04938037|Bupivacaine|bupivacaine|mesh-list
55798302|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55798303|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
55798304|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
55798305|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
55798306|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798307|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798308|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
55798309|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931556|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55931557|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55931558|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
55798312|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
55798313|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55798314|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
55798316|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798317|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55798318|NCT04938037|Protective Agents|protective agents|mesh-ancestor
55798319|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55798320|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798321|NCT04937569|Ivermectin|ivermectin|mesh-list
55798322|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55798323|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798324|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
55798325|NCT04937101|Codeine|codeine|mesh-list
55798326|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55931559|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55931560|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931561|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55931562|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
55931563|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931564|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798327|NCT04937101|Narcotics|narcotics|mesh-ancestor
55798329|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931565|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
55931566|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931567|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55931568|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931569|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
55931570|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931571|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55931572|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55931573|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
55931575|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55931576|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55931577|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
55931578|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55798333|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
55798334|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
55798335|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
55798337|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55798338|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
55798339|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
55798340|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798341|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798342|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55798343|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55931579|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55931580|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
55931581|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55931582|NCT05020704|Empagliflozin|empagliflozin|mesh-list
55931583|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55931584|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931585|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55798344|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55798345|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55798346|NCT04936711|Bupivacaine|bupivacaine|mesh-list
55798347|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
55798348|NCT04936711|Anesthetics|anesthetics|mesh-ancestor
55798352|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931586|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931588|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55931589|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55931590|NCT02979665|Growth Substances|growth substances|mesh-ancestor
55931591|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931592|NCT02979665|Growth Inhibitors|growth inhibitors|mesh-ancestor
55798354|NCT04431349|Ticagrelor|ticagrelor|mesh-list
55798355|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55931593|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931594|NCT03092076|Ticagrelor|ticagrelor|mesh-list
55931595|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55931596|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55931597|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55931598|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55931599|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
55931600|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931601|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931602|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931604|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
55931605|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931607|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931608|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798367|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
55798368|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931610|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
55931611|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
55931612|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55931613|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931614|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931615|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
55931616|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55931617|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931618|NCT02240433|Sorafenib|sorafenib|mesh-list
55931619|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931620|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55931621|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931622|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931623|NCT03403647|Vitamin D|vitamin d|mesh-list
55931624|NCT03403647|Vitamins|vitamins|mesh-ancestor
55931625|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
55798369|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798370|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
55798371|NCT04927039|Iloprost|iloprost|mesh-list
55798372|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55798373|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
55798374|NCT04917679|Diacetylrhein|diacetylrhein|mesh-list
55798375|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798376|NCT02443155|Liraglutide|liraglutide|mesh-list
55798377|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55931626|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931630|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55931631|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931632|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798378|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798379|NCT02443155|Incretins|incretins|mesh-ancestor
55798380|NCT02443155|Hormones|hormones|mesh-ancestor
55798384|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55798385|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798386|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798387|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55798389|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
55798390|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798391|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55798392|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55798393|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55798394|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
55798395|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798396|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798397|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55798398|NCT04935541|Narcotics|narcotics|mesh-ancestor
55798399|NCT04935073|Cetrorelix|cetrorelix|mesh-list
55798400|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55798401|NCT04935073|Hormones|hormones|mesh-ancestor
55798402|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798404|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55798405|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
55798406|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55798407|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
55798408|NCT04917757|Dexamethasone|dexamethasone|mesh-list
55798409|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798412|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798413|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798415|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
55798416|NCT04917757|Hormones|hormones|mesh-ancestor
55931633|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
55931634|NCT03403101|Irinotecan|irinotecan|mesh-list
55931635|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931636|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55931637|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55931638|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931639|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931640|NCT00211757|Valproic Acid|valproic acid|mesh-list
55931641|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
55931642|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931643|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931645|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931646|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798417|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798418|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55798419|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798420|NCT04916899|Rifampin|rifampin|mesh-list
55798421|NCT04916899|Isoniazid|isoniazid|mesh-list
55798422|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
55798423|NCT04916899|Ethambutol|ethambutol|mesh-list
55798424|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55798425|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
55798426|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55931648|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55931649|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931650|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55931651|NCT04373967|Metformin|metformin|mesh-list
55931652|NCT04373967|Liraglutide|liraglutide|mesh-list
55931653|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55931654|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931655|NCT04373967|Incretins|incretins|mesh-ancestor
55798427|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798428|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
55798429|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55798430|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798431|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798432|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55798433|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55798434|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55798435|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55798436|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55798437|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55798438|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55931656|NCT04373967|Hormones|hormones|mesh-ancestor
55931658|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
55931659|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55931660|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
55931661|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931662|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
55931663|NCT04026191|Protective Agents|protective agents|mesh-ancestor
55931665|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
55931666|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
55931667|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931668|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798439|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55798440|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
55798441|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55931669|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
55931670|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931671|NCT00921843|Methadone|methadone|mesh-list
55931672|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55931673|NCT00921843|Narcotics|narcotics|mesh-ancestor
55931674|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931675|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931676|NCT00921843|Analgesics|analgesics|mesh-ancestor
55931677|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
55931678|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931679|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
55931680|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
55931681|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
55931682|NCT04020653|Lumefantrine|lumefantrine|mesh-list
55931683|NCT04020653|Artemether|artemether|mesh-list
55931684|NCT04020653|Artemisinins|artemisinins|mesh-list
55931685|NCT04020653|Artemisinin|artemisinin|mesh-list
55931686|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55931687|NCT04020653|Citric Acid|citric acid|mesh-list
55931688|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
55798443|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798444|NCT04916665|Teduglutide|teduglutide|mesh-list
55798445|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55931689|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
55931694|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
55931695|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55931696|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55931697|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798446|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55798447|NCT04916665|Protective Agents|protective agents|mesh-ancestor
55798448|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798449|NCT04916509|Fulvestrant|fulvestrant|mesh-list
55798452|NCT04916509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55798453|NCT04916509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798454|NCT04916509|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55798455|NCT04916509|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55798456|NCT04916509|Hormone Antagonists|hormone antagonists|mesh-ancestor
55798457|NCT04916509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798458|NCT04916509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798459|NCT04916509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55931698|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55931699|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
55931700|NCT04020653|Trace Elements|trace elements|mesh-ancestor
55931701|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
55931702|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798460|NCT04916509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798461|NCT04916509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798462|NCT04916509|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55798463|NCT04916353|Triamcinolone|triamcinolone|mesh-list
55798464|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55798465|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55931703|NCT05008458|Arginine Vasopressin|arginine vasopressin|mesh-list
55931704|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
55931705|NCT05008458|Coagulants|coagulants|mesh-ancestor
55931706|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55931707|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55931708|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
55931709|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931710|NCT02080637|Ambrisentan|ambrisentan|mesh-list
55931711|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55931713|NCT05019690|Apatinib|apatinib|mesh-list
55798466|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55798467|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798468|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
55798469|NCT04916353|Hormones|hormones|mesh-ancestor
55798470|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798471|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931714|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55931715|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55931716|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931722|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931723|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
55931724|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55798472|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55798473|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
55931725|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931726|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931727|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55931728|NCT04029467|Analgesics|analgesics|mesh-ancestor
55931729|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
55931730|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931731|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55931732|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55743314|NCT02517307|Heparin|heparin|mesh-list
55798474|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931734|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
55931735|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931736|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931737|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55931739|NCT03402321|Coagulants|coagulants|mesh-ancestor
55798475|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798476|NCT03056599|Gemcitabine|gemcitabine|mesh-list
55798477|NCT03056599|Interferons|interferons|mesh-list
55798478|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
55798479|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
55798480|NCT03056599|Aldesleukin|aldesleukin|mesh-list
55798481|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
55798483|NCT03056599|Doxorubicin|doxorubicin|mesh-list
55798484|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
55798487|NCT03056599|Ipilimumab|ipilimumab|mesh-list
55798488|NCT03056599|Atezolizumab|atezolizumab|mesh-list
55798489|NCT03056599|Durvalumab|durvalumab|mesh-list
55798490|NCT03056599|Avelumab|avelumab|mesh-list
55798491|NCT03056599|Trabectedin|trabectedin|mesh-list
55798492|NCT03056599|Olaratumab|olaratumab|mesh-list
55798493|NCT03056599|Entrectinib|entrectinib|mesh-list
55798494|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55798495|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
55931740|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
55931741|NCT03402165|Ledipasvir|ledipasvir|mesh-list
55931742|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55931743|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
55931744|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931745|NCT03402087|Leucovorin|leucovorin|mesh-list
55931746|NCT03402087|Methotrexate|methotrexate|mesh-list
55931747|NCT03402087|BMS-986165|bms-986165|mesh-list
55931748|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55931749|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
55931750|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55931751|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931752|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55931753|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
55931754|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931755|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931756|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
55931757|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931758|NCT03402087|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55931759|NCT03402087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931760|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
55931761|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931762|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55931763|NCT03402087|Antidotes|antidotes|mesh-ancestor
55931767|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
55931768|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55931769|NCT04020263|Simendan|simendan|mesh-list
55931770|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55931771|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
55931772|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55931773|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55931774|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931775|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931776|NCT04020263|Protective Agents|protective agents|mesh-ancestor
55931777|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931778|NCT05013060|Butyric Acid|butyric acid|mesh-list
55931779|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
55798496|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798497|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798498|NCT03056599|Antiviral Agents|antiviral agents|mesh-ancestor
55798499|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798500|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798501|NCT03056599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55798502|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
55931780|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
55931781|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931782|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931786|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55931788|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931789|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55931790|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55931791|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931792|NCT00925119|Atenolol|atenolol|mesh-list
55931793|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55931794|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55931795|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
55931796|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
55931797|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798503|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798504|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
55798505|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
55798506|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
55798507|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55798508|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55931798|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144593|NCT00801138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55931799|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55931800|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55931801|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55931802|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
55931809|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
55931810|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931811|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931812|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55931813|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55931814|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55931816|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931817|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931819|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
55931820|NCT05018988|Cholecalciferol|cholecalciferol|mesh-list
55931821|NCT05018988|Vitamins|vitamins|mesh-list
55931822|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
55931823|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931824|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55931825|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55931826|NCT04028765|Misoprostol|misoprostol|mesh-list
55931827|NCT04028765|Oxytocin|oxytocin|mesh-list
55931828|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
55931829|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55931830|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931831|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55931832|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
55931833|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55931834|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55931835|NCT02241759|Moxifloxacin|moxifloxacin|mesh-list
55931836|NCT02241759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55931837|NCT02241759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931838|NCT02241759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55931839|NCT02241759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55798509|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55798510|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798511|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55798513|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55798514|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55798515|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
55798516|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55798517|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
55931840|NCT02241759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931841|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931842|NCT02241759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931843|NCT04434144|Azithromycin|azithromycin|mesh-list
55931844|NCT04434144|Doxycycline|doxycycline|mesh-list
55931845|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
55931846|NCT04434144|Ivermectin|ivermectin|mesh-list
55798518|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55931848|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931849|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
55931850|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55931851|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55798519|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798520|NCT04915963|Vitamin D|vitamin d|mesh-list
55798521|NCT04915963|Vitamins|vitamins|mesh-ancestor
55931852|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931853|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931854|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931855|NCT04022135|Folic Acid|folic acid|mesh-list
55931856|NCT04022135|Hematinics|hematinics|mesh-ancestor
55931857|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
55931858|NCT04022135|Vitamins|vitamins|mesh-ancestor
55931860|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931861|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
55798524|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55798525|NCT04915807|Paclitaxel|paclitaxel|mesh-list
55931862|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55931863|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931864|NCT04957758|Varenicline|varenicline|mesh-list
55931865|NCT04957758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55931866|NCT04957758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55931867|NCT04957758|Cholinergic Agents|cholinergic agents|mesh-ancestor
55798527|NCT04915807|Ramucirumab|ramucirumab|mesh-list
55798528|NCT04915807|Taxane|taxane|mesh-list
55931868|NCT04957758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931869|NCT04957758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931870|NCT04957758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931872|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
55931873|NCT04028141|Ketamine|ketamine|mesh-list
55931874|NCT04028141|Propofol|propofol|mesh-list
55798530|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798531|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
55798532|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
55798533|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
55798534|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931875|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55931876|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931877|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931878|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55798535|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55798536|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55798537|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798539|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55798540|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798541|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55798542|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
55798543|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798544|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798545|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55798546|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
55798547|NCT01360021|Glucocorticoids|glucocorticoids|mesh-ancestor
55798548|NCT01360021|Hormones|hormones|mesh-ancestor
55794329|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798550|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55798552|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798553|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55798555|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55798556|NCT02497287|Sertraline|sertraline|mesh-list
55798557|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
55798558|NCT02497287|Esketamine|esketamine|mesh-list
55798559|NCT02497287|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55798560|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55798561|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798562|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798563|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798565|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798566|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55798567|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55798568|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798569|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55798570|NCT02497287|Analgesics|analgesics|mesh-ancestor
55798571|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
55798572|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
55798573|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55798574|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55798575|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55798576|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
55798577|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931879|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
55931880|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
55931881|NCT04028141|Analgesics|analgesics|mesh-ancestor
55931882|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
55931883|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931884|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55931885|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55931886|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55798580|NCT02458287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55798581|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
55798582|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798583|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55798585|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55798586|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55798587|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798588|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931887|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798589|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55798590|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
55798591|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
55798592|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798593|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798596|NCT04943211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798597|NCT02496039|Quinidine|quinidine|mesh-list
55798598|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
55798599|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
55798600|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
55931888|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931890|NCT03401541|Calcifediol|calcifediol|mesh-list
55931891|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
55931892|NCT03401541|Vitamins|vitamins|mesh-ancestor
55931893|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
55931894|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931895|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55931896|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55931898|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55931899|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55931900|NCT03953261|Analgesics|analgesics|mesh-ancestor
55798601|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55798602|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55798604|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798605|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798606|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55798607|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55798608|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
55798609|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55798610|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
55798611|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55931901|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
55931902|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931903|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931904|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55931905|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55931906|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798612|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55798613|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798614|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798615|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55798616|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55931907|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931908|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931909|NCT02242149|Diacetylrhein|diacetylrhein|mesh-list
55931910|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55931911|NCT03022565|Vorinostat|vorinostat|mesh-list
55931912|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798617|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
55931913|NCT03022565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55931914|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931915|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798619|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55798620|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798621|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55798622|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55798623|NCT04922359|Lidocaine|lidocaine|mesh-list
55798624|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
55798625|NCT04922359|Anesthetics|anesthetics|mesh-ancestor
55931916|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
55931917|NCT03079050|Lansoprazole|lansoprazole|mesh-list
55931918|NCT03079050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55931919|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55931920|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55798631|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55798632|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55798633|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798634|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798638|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55798639|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
55798640|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798641|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798642|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798643|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55798649|NCT04910347|Nivolumab|nivolumab|mesh-list
55798650|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798651|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798652|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55798653|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798654|NCT02439957|Valganciclovir|valganciclovir|mesh-list
55798655|NCT02439957|Brincidofovir|brincidofovir|mesh-list
55798656|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
55798657|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55931921|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931922|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931923|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
55931924|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55931925|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55931926|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931927|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55931928|NCT03834129|Analgesics|analgesics|mesh-ancestor
55931929|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
55931930|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931931|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55931932|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55931933|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55931934|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
55931935|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931936|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798658|NCT02457195|Granisetron|granisetron|mesh-list
55798659|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
55798660|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
55798661|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798662|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798663|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55798664|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55798665|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
55798666|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798667|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798668|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
55798669|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55931937|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
55931942|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55931943|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931944|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798670|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55798672|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
55931945|NCT03833895|Phenylephrine|phenylephrine|mesh-list
55931946|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
55931947|NCT03833895|Norepinephrine|norepinephrine|mesh-list
55931948|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55931949|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
55931950|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
55931951|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931952|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931953|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
55798674|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55798675|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
55798676|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798677|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798678|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
55931954|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55931955|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
55931956|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
55931957|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55798679|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931960|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
55931961|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931962|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931963|NCT03833895|Protective Agents|protective agents|mesh-ancestor
55798690|NCT03054259|Protective Agents|protective agents|mesh-ancestor
55798691|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55931964|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55931965|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55931967|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931968|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931969|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55931970|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
55931971|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55931972|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55931973|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55931974|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
55931975|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55931976|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931977|NCT03950609|Everolimus|everolimus|mesh-list
55931978|NCT03950609|Lenvatinib|lenvatinib|mesh-list
55931979|NCT03950609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931980|NCT03950609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55931981|NCT03950609|Immunologic Factors|immunologic factors|mesh-ancestor
55931982|NCT03950609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55931983|NCT03950609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55931985|NCT03950609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931986|NCT05000892|Paclitaxel|paclitaxel|mesh-list
55931987|NCT05000892|Carboplatin|carboplatin|mesh-list
55798693|NCT01653327|Analgesics|analgesics|mesh-ancestor
55931988|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55931989|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55931990|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
55931991|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
55931992|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
55931993|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55931994|NCT02703623|Prednisone|prednisone|mesh-list
55798694|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
55798695|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55931995|NCT02703623|Cortisone|cortisone|mesh-list
55931996|NCT02703623|Carboplatin|carboplatin|mesh-list
55931997|NCT02703623|Ipilimumab|ipilimumab|mesh-list
55931998|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
55931999|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798701|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798702|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55798703|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55798704|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798705|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798708|NCT03053869|Alprazolam|alprazolam|mesh-list
55798709|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
55798710|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
55798711|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
55798712|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798713|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798714|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55798715|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55798716|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798717|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55798718|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55798719|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55932001|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
55932002|NCT02703623|Hormones|hormones|mesh-ancestor
55932003|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55932004|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932005|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55932006|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55932007|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55798726|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55798727|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55798728|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
55798729|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
55798730|NCT03053947|Ketamine|ketamine|mesh-list
55798731|NCT03053947|Analgesics|analgesics|mesh-ancestor
55932008|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932009|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55932010|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932011|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
55798732|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
55798733|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798734|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932012|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55932013|NCT04372407|Itraconazole|itraconazole|mesh-list
55932014|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
55932015|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932016|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55932017|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55932018|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798735|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55798736|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55798737|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
55932019|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932020|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55932021|NCT04372407|Hormone Antagonists|hormone antagonists|mesh-ancestor
56144594|NCT00801138|Antiemetics|antiemetics|mesh-ancestor
55932022|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798739|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798748|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798749|NCT04893733|Hematinics|hematinics|mesh-ancestor
55798751|NCT02493855|Ribavirin|ribavirin|mesh-list
55932023|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932024|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55932026|NCT02242383|Telmisartan|telmisartan|mesh-list
55932027|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55932028|NCT02242383|Diuretics|diuretics|mesh-ancestor
55798764|NCT04892563|Morphine|morphine|mesh-list
55798765|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55798766|NCT04892563|Narcotics|narcotics|mesh-ancestor
55932032|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55932033|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932034|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55932035|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55932036|NCT04366089|Azithromycin|azithromycin|mesh-list
55932037|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
55932038|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55932039|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932040|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
55932041|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55932042|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55932043|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794388|NCT05315713|Atezolizumab|atezolizumab|mesh-list
55794389|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794390|NCT05209425|Vitamin D|vitamin d|mesh-list
55794397|NCT04793243|Vitamin D|vitamin d|mesh-list
55794398|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
55794399|NCT04793243|Vitamins|vitamins|mesh-ancestor
55794400|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
55794401|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798773|NCT04909255|Mirabegron|mirabegron|mesh-list
55932044|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932045|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932046|NCT03079830|Pirinitramide|pirinitramide|mesh-list
55932047|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55932048|NCT03079830|Narcotics|narcotics|mesh-ancestor
55932049|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932050|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932051|NCT03079830|Analgesics|analgesics|mesh-ancestor
55932052|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
55932053|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932054|NCT02242695|Clotrimazole|clotrimazole|mesh-list
55798774|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55798775|NCT04909255|Oxybutynin|oxybutynin|mesh-list
55798776|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55798777|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55798778|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
55798779|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798780|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798781|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798782|NCT04909255|Urological Agents|urological agents|mesh-ancestor
55798783|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55798784|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55798785|NCT04909255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55932055|NCT02242695|Dequalinium|dequalinium|mesh-list
55932056|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55932057|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932058|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
55932059|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55932060|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55932061|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794413|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
55932069|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798789|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798790|NCT04891861|Rivaroxaban|rivaroxaban|mesh-list
55798791|NCT04891861|Apixaban|apixaban|mesh-list
55798792|NCT04891861|Edoxaban|edoxaban|mesh-list
55932071|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55932072|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55932073|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55932074|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798793|NCT04891861|Dabigatran|dabigatran|mesh-list
55798794|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55798795|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
55798796|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55798797|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
55798798|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798799|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798800|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
55798806|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798807|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798808|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55798809|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
55798810|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55798811|NCT04901923|Itraconazole|itraconazole|mesh-list
55798812|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
55798813|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
55798814|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798815|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55932075|NCT04999878|Gemcitabine|gemcitabine|mesh-list
55932076|NCT04999878|Dexamethasone|dexamethasone|mesh-list
55932077|NCT04999878|Etoposide|etoposide|mesh-list
55798816|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55798817|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932078|NCT04999878|Cisplatin|cisplatin|mesh-list
55932079|NCT04999878|Pegaspargase|pegaspargase|mesh-list
55932080|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55932081|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
55932082|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
55932083|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932084|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932085|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55932086|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
55932087|NCT04999878|Hormones|hormones|mesh-ancestor
55932088|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55932089|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55932090|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932091|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55932093|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932094|NCT04999878|Antiviral Agents|antiviral agents|mesh-ancestor
55798818|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798819|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55798820|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
55798821|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798822|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798823|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55798824|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798826|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55798827|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55798828|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
55798829|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798830|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798831|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55932097|NCT04999878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55932098|NCT04999878|Immunologic Factors|immunologic factors|mesh-ancestor
55798837|NCT03050827|Oxybutynin|oxybutynin|mesh-list
55798838|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
55798839|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
55932099|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55932100|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55932103|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55932104|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
55932105|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932106|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932107|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
55932108|NCT04457856|Plonmarlimab|plonmarlimab|mesh-list
55932109|NCT04457856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55932110|NCT04457856|Antiviral Agents|antiviral agents|mesh-ancestor
55932111|NCT04457856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932112|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55932113|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
55932114|NCT05006898|Pilocarpine|pilocarpine|mesh-list
55932115|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55798843|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55798844|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
55932116|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55932117|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55932118|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55932119|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
55932120|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932121|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932122|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932123|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
55798845|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798846|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798847|NCT03050827|Urological Agents|urological agents|mesh-ancestor
55798849|NCT02438787|Ustekinumab|ustekinumab|mesh-list
55798850|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
55798852|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798853|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55798854|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
55798855|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798856|NCT04901065|Lidocaine|lidocaine|mesh-list
55798857|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
55798858|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
55798859|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798860|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798861|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
55798862|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798863|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55932125|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932126|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
55932127|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55932128|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
55932129|NCT05006898|Miotics|miotics|mesh-ancestor
55932130|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55932131|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55932132|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
55932133|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
55932134|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55932135|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55798864|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55932139|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932140|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932141|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932142|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55932143|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
55932144|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55932145|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932146|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55932147|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55932148|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55932150|NCT03076320|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55932151|NCT03076320|Dermatologic Agents|dermatologic agents|mesh-ancestor
55932152|NCT03076320|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55932153|NCT03076320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55932154|NCT03076320|Analgesics|analgesics|mesh-ancestor
55932155|NCT03076320|Sensory System Agents|sensory system agents|mesh-ancestor
55932156|NCT03076320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932157|NCT03076320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798866|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55932158|NCT03076320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55932159|NCT03076320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932160|NCT04365309|Aspirin|aspirin|mesh-list
55932161|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55932162|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55932163|NCT04365309|Analgesics|analgesics|mesh-ancestor
55932164|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
55932165|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932166|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932167|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55932168|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55798867|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798868|NCT02493777|Methylphenidate|methylphenidate|mesh-list
55798869|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55932169|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55932170|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55932171|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932172|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55932173|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55932174|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798870|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798871|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55798872|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55932176|NCT04365231|Azithromycin|azithromycin|mesh-list
55932177|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
55932178|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55932179|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932183|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932184|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932185|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932186|NCT02243553|Vitamin K|vitamin k|mesh-list
55932187|NCT02243553|Ritonavir|ritonavir|mesh-list
55932188|NCT02243553|Tipranavir|tipranavir|mesh-list
55932189|NCT02243553|Digoxin|digoxin|mesh-list
55932190|NCT02243553|Midazolam|midazolam|mesh-list
55798874|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932192|NCT02243553|Caffeine|caffeine|mesh-list
55932193|NCT02243553|Omeprazole|omeprazole|mesh-list
55932194|NCT02243553|Warfarin|warfarin|mesh-list
55932195|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55932196|NCT02243553|Vitamins|vitamins|mesh-ancestor
55932197|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
55932198|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932199|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55932200|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55932201|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798876|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798877|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55798879|NCT04906915|Analgesics|analgesics|mesh-ancestor
55798880|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
55798881|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798882|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798883|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55798884|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55932202|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55932203|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55932204|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55932205|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55932206|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
55932207|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
55932208|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
55932209|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
55798885|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
55798886|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
55798887|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798888|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55798889|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55798890|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798891|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798892|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55798893|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
55932210|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932211|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932212|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55932213|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55932214|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
55932215|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798901|NCT04900129|Menthol|menthol|mesh-list
55798902|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55798903|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55798904|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55798905|NCT04900129|Analgesics|analgesics|mesh-ancestor
55798906|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
55794451|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
55798909|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798910|NCT04900129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55798911|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55798912|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798913|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798914|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
55798915|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
55798916|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
55798917|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798918|NCT04900129|Expectorants|expectorants|mesh-ancestor
55798919|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
55798920|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55798921|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
55798922|NCT04900129|Protective Agents|protective agents|mesh-ancestor
55798923|NCT04900129|Antidotes|antidotes|mesh-ancestor
55932216|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55932217|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55932218|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
55932219|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932220|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55932221|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55932222|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
55932223|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55932224|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55798937|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55798938|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798939|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55798940|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
55798941|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798943|NCT02492997|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55798944|NCT02492997|Protective Agents|protective agents|mesh-ancestor
55798945|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798946|NCT04393207|Dexamethasone|dexamethasone|mesh-list
55798947|NCT04393207|Dexamethasone acetate|dexamethasone acetate|mesh-list
55798948|NCT04393207|Methylprednisolone|methylprednisolone|mesh-list
55798949|NCT04393207|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55798950|NCT04393207|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55798951|NCT04393207|Prednisolone|prednisolone|mesh-list
55798952|NCT04393207|Prednisolone acetate|prednisolone acetate|mesh-list
55932228|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55932229|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55932230|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55932231|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55932232|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55932233|NCT02243553|Protective Agents|protective agents|mesh-ancestor
55932234|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55932235|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55798953|NCT04393207|Bupivacaine|bupivacaine|mesh-list
55798962|NCT04393207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55798965|NCT04393207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798967|NCT04393207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798968|NCT04393207|Protease Inhibitors|protease inhibitors|mesh-ancestor
55798969|NCT04393207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798970|NCT04393207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798971|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
55798972|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
55798973|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798974|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
55798975|NCT04393207|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55798976|NCT04393207|Protective Agents|protective agents|mesh-ancestor
55798977|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
55798978|NCT02492841|Calcium|calcium|mesh-list
55798979|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55798980|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798981|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55798982|NCT04814875|Carboplatin|carboplatin|mesh-list
55798983|NCT04814875|Doxorubicin|doxorubicin|mesh-list
55798984|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55798985|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932236|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
55932237|NCT02243553|Coagulants|coagulants|mesh-ancestor
55932238|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
55932239|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
55932240|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55932241|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55932242|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
55798986|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55798987|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55798988|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55932243|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55932244|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
55932245|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55932246|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932247|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55932248|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55932249|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55932250|NCT05006664|Prednisone|prednisone|mesh-list
55932251|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
55932252|NCT05006664|Doxorubicin|doxorubicin|mesh-list
55932253|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55932255|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
55932256|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55932257|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55932258|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
55932259|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932260|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932261|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55932262|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
55932263|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932264|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932265|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55932266|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55932267|NCT05006664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55932268|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55932269|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932270|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55932271|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
55932272|NCT05006664|Hormones|hormones|mesh-ancestor
55932274|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55932275|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55932276|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55932277|NCT04346901|Methimazole|methimazole|mesh-list
55932278|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
55798993|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798994|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798995|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55798996|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55798997|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
55798998|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798999|NCT02492763|Metformin|metformin|mesh-list
55799000|NCT02492763|Liraglutide|liraglutide|mesh-list
55932279|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
55932280|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55932281|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932282|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55932283|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55932284|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932285|NCT04364607|Neostigmine|neostigmine|mesh-list
55799002|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799003|NCT02492763|Incretins|incretins|mesh-ancestor
55799005|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799006|NCT04899817|Granisetron|granisetron|mesh-list
55932286|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55932287|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932288|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932289|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
55932290|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932291|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932292|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55932293|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
55799008|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
55799009|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799010|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799011|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55799012|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55799013|NCT04899817|Serotonin Agents|serotonin agents|mesh-ancestor
55799014|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932294|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932296|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932297|NCT02245269|Ritonavir|ritonavir|mesh-list
55932298|NCT02245269|Tipranavir|tipranavir|mesh-list
55932299|NCT02245269|Atorvastatin|atorvastatin|mesh-list
55799015|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799016|NCT04905667|Trastuzumab|trastuzumab|mesh-list
55799017|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55799018|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799019|NCT03151811|Dexamethasone|dexamethasone|mesh-list
55799020|NCT03151811|Dexamethasone acetate|dexamethasone acetate|mesh-list
55799021|NCT03151811|Melphalan|melphalan|mesh-list
55799022|NCT03151811|Pomalidomide|pomalidomide|mesh-list
55932300|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55932301|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55932302|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
55932303|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932304|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55932305|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55799023|NCT03151811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55799025|NCT03151811|Autonomic Agents|autonomic agents|mesh-ancestor
55799026|NCT03151811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799027|NCT03151811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799028|NCT03151811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55799029|NCT03151811|Glucocorticoids|glucocorticoids|mesh-ancestor
55799030|NCT03151811|Hormones|hormones|mesh-ancestor
55799031|NCT03151811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799032|NCT03151811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55799033|NCT03151811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799034|NCT03151811|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55799035|NCT03151811|Alkylating Agents|alkylating agents|mesh-ancestor
55799036|NCT03151811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799037|NCT03151811|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55799038|NCT03151811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799039|NCT03151811|Immunologic Factors|immunologic factors|mesh-ancestor
55799040|NCT03151811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55932306|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932307|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55932308|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55932309|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
55932310|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55932311|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55932312|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
55799041|NCT03151811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55799042|NCT03151811|Growth Substances|growth substances|mesh-ancestor
55799043|NCT03151811|Growth Inhibitors|growth inhibitors|mesh-ancestor
55799045|NCT04397107|Interleukin-2|interleukin-2|mesh-list
55799046|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799047|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55799048|NCT04397107|Analgesics|analgesics|mesh-ancestor
55799049|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
55799050|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799051|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799053|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55799054|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
55799055|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799056|NCT02453841|Phenylephrine|phenylephrine|mesh-list
55799057|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
55799058|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55799059|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55799060|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
55799061|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799062|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799063|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799064|NCT02453841|Sympathomimetics|sympathomimetics|mesh-ancestor
55799065|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
55799066|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799067|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
55799068|NCT02453841|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55799069|NCT02453841|Respiratory System Agents|respiratory system agents|mesh-ancestor
55799070|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55799071|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
55799072|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55799085|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55799087|NCT04888663|Trastuzumab|trastuzumab|mesh-list
55799088|NCT04888663|Ramucirumab|ramucirumab|mesh-list
55799089|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55799094|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799095|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55799097|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55799098|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
55799099|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
55799100|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
55932313|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932314|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55932315|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55932316|NCT04364139|Metoprolol|metoprolol|mesh-list
55932318|NCT04364139|Ramipril|ramipril|mesh-list
55932319|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55932320|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55932321|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55932322|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932323|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55932324|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932325|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
55932326|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55932327|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
55799104|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55799105|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799106|NCT03051841|Dexamethasone|dexamethasone|mesh-list
55932329|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932330|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55932331|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55932332|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55932333|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
55932334|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932335|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55799107|NCT03051841|Bortezomib|bortezomib|mesh-list
55799108|NCT03051841|CKD-581|ckd-581|mesh-list
55799109|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55799110|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
55799111|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
55799112|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799113|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799114|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55799115|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
55932336|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
55932337|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932339|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55932340|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55799117|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799118|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55799119|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799120|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799121|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799122|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55799123|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
55932341|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55932342|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
55932343|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932344|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932345|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932346|NCT02244255|Urological Agents|urological agents|mesh-ancestor
55932347|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
55932348|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
55932349|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55932350|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55799124|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799125|NCT02436759|Phenylephrine|phenylephrine|mesh-list
55799126|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
55799127|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55799128|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55799129|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55799130|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55799131|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
55932351|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932352|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932353|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932354|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932355|NCT00923949|Pioglitazone|pioglitazone|mesh-list
55799132|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799133|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799134|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799135|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
55799136|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
55799137|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799138|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
55799139|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55799140|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
55799141|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55799142|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
55799143|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55799144|NCT02436759|Protective Agents|protective agents|mesh-ancestor
55799145|NCT04888741|Cyclosporine|cyclosporine|mesh-list
55799146|NCT04888741|Sirolimus|sirolimus|mesh-list
55799147|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
55799148|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
55932356|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55932357|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932358|NCT04376541|Fentanyl|fentanyl|mesh-list
55932359|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55932360|NCT04376541|Narcotics|narcotics|mesh-ancestor
55932361|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932362|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799149|NCT04888741|Cyclosporins|cyclosporins|mesh-list
55799150|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
55799151|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799152|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
55799153|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799154|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799160|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799161|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
55799162|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799163|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
55932364|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
55932365|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932366|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55932367|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55799164|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55799165|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55799166|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55799167|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
55799168|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55799169|NCT04918173|Antithrombin III|antithrombin iii|mesh-list
55799170|NCT04918173|Antithrombins|antithrombins|mesh-ancestor
55799171|NCT04918173|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55799172|NCT04918173|Protease Inhibitors|protease inhibitors|mesh-ancestor
55799173|NCT04918173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799174|NCT04918173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799175|NCT04918173|Anticoagulants|anticoagulants|mesh-ancestor
55799176|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
55799177|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
55799178|NCT04904185|Fludarabine|fludarabine|mesh-list
55799179|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
55799180|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799181|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
55799182|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799183|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799184|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55799185|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
55799186|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799187|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799188|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55799189|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55799190|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55932369|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
55932370|NCT04376307|Anesthetics|anesthetics|mesh-list
55932371|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932372|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932373|NCT02244489|Capecitabine|capecitabine|mesh-list
55932374|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
55932375|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
55799201|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
55932376|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55932378|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932379|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932380|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55932381|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932382|NCT02244567|Metformin|metformin|mesh-list
55932383|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799202|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799203|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799204|NCT04887649|Morphine|morphine|mesh-list
55799205|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55932384|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55932385|NCT04376073|Niraparib|niraparib|mesh-list
55932386|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55932387|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799218|NCT02436135|Idelalisib|idelalisib|mesh-list
55799219|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799220|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799221|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799222|NCT04917861|Vaccines|vaccines|mesh-list
55799223|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
55799229|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55799230|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55799231|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
55799315|NCT04898101|Acalabrutinib|acalabrutinib|mesh-list
55932388|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932389|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932392|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55932393|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
55932394|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55932395|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
55932396|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794525|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794526|NCT05370729|Antidotes|antidotes|mesh-ancestor
55794527|NCT05471531|Vaccines|vaccines|mesh-list
55794528|NCT05471531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55794529|NCT05471531|Immunologic Factors|immunologic factors|mesh-ancestor
55794530|NCT05471531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932407|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55932408|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799232|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799233|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799234|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799235|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55799236|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55799237|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
55799239|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
55799240|NCT02433483|Methotrexate|methotrexate|mesh-list
55799241|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55932409|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932410|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932411|NCT04363359|Vaccines|vaccines|mesh-list
55932412|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
55799242|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
55799243|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55799244|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799245|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55799246|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
55799247|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799248|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799249|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
55932413|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932414|NCT02244879|Resveratrol|resveratrol|mesh-list
55932415|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
55932416|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932417|NCT02244879|Protective Agents|protective agents|mesh-ancestor
55932418|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932419|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932420|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55932421|NCT04457232|FAPI-46|fapi-46|mesh-list
55932422|NCT04457232|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55932423|NCT04457232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932424|NCT04362735|Vedolizumab|vedolizumab|mesh-list
55932425|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55932426|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
55932427|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55932428|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
55932429|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799252|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799253|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
55794532|NCT05204667|Aspirin|aspirin|mesh-list
55794533|NCT05204667|Methocarbamol|methocarbamol|mesh-list
55794534|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55794535|NCT05204667|Analgesics|analgesics|mesh-ancestor
55794536|NCT05204667|Sensory System Agents|sensory system agents|mesh-ancestor
55932431|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55932432|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
55932433|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55932434|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
55932435|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932436|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932437|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55932438|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
55932439|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
55932440|NCT04375995|Protective Agents|protective agents|mesh-ancestor
55932441|NCT04993014|Trastuzumab|trastuzumab|mesh-list
55932442|NCT04993014|Pertuzumab|pertuzumab|mesh-list
55932443|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55932444|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932445|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
55932446|NCT05005494|Analgesics|analgesics|mesh-ancestor
55932447|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
55932448|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932458|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
55932459|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55932461|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55932462|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932463|NCT03074994|Anesthetics|anesthetics|mesh-list
55932464|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
55932465|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932466|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932467|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
55794537|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794538|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794539|NCT05204667|Antipyretics|antipyretics|mesh-ancestor
55794540|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55932469|NCT04025177|Indomethacin|indomethacin|mesh-list
55932470|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55932471|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55932472|NCT04025177|Analgesics|analgesics|mesh-ancestor
55932473|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
55932474|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932475|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932476|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55932477|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799281|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55799282|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55799283|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55932478|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
55932479|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
55932480|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55932481|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55932482|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932483|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932485|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55932486|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
55932487|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932488|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
55932489|NCT04358055|Protective Agents|protective agents|mesh-ancestor
55799284|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799285|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799286|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55932490|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55932491|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
55932492|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932493|NCT02985281|Ribavirin|ribavirin|mesh-list
55932494|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
55932495|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
55799287|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
55799288|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55799289|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55799290|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
55799291|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
55799292|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55799293|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799294|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
55799295|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799296|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55799297|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
55799298|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799304|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
55932496|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932497|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
55932498|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932499|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
55932500|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
55932501|NCT00927849|Glycerol|glycerol|mesh-list
55932502|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55932503|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55799305|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55799306|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799311|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55799312|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799313|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55799314|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799316|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799317|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
55932504|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932505|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
55932506|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932507|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932508|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55932509|NCT00927849|Protective Agents|protective agents|mesh-ancestor
55932510|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
55932511|NCT04149587|Brodalumab|brodalumab|mesh-list
55799318|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799319|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799320|NCT04887493|Alprostadil|alprostadil|mesh-list
55799321|NCT04887493|Misoprostol|misoprostol|mesh-list
55799322|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55932512|NCT04149587|Dermatologic Agents|dermatologic agents|mesh-ancestor
55932513|NCT04992468|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55932514|NCT04992468|Hormones|hormones|mesh-ancestor
55799323|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
55799325|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799327|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55799328|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
55799329|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55799330|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
55799331|NCT04887493|Urological Agents|urological agents|mesh-ancestor
55932515|NCT04992468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55932516|NCT04992468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932517|NCT02985125|Everolimus|everolimus|mesh-list
55932518|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799333|NCT02486757|Progesterone|progesterone|mesh-list
55799334|NCT02486757|Estrogens|estrogens|mesh-ancestor
55799335|NCT02486757|Hormones|hormones|mesh-ancestor
55799336|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799337|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799338|NCT02486757|Progestins|progestins|mesh-ancestor
55799339|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55799340|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
55799341|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55799342|NCT03051529|Anesthetics|anesthetics|mesh-list
55799343|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799344|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799345|NCT04886869|Caffeine|caffeine|mesh-list
55799346|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55799347|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799348|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55799349|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799350|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932519|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55932520|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
55932521|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932522|NCT04912596|Albuterol|albuterol|mesh-list
55932523|NCT04912596|Procaterol|procaterol|mesh-list
55932524|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
55932525|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55932526|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
55932527|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799359|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799360|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799361|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799362|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55799363|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
55799364|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55799366|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55799367|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799368|NCT04882813|Incretins|incretins|mesh-ancestor
55799369|NCT04882813|Hormones|hormones|mesh-ancestor
55932528|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932529|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55932530|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
55932531|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
55932532|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55799371|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55799372|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
55799373|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799374|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799375|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55932533|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55932534|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55932535|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55932536|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
55932537|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932538|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932539|NCT04912596|Miotics|miotics|mesh-ancestor
55932540|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55932541|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
55932542|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55932543|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55799376|NCT02576639|CNP520|cnp520|mesh-list
55799377|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932545|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
55932546|NCT00936741|Mifepristone|mifepristone|mesh-list
56144595|NCT00801138|Autonomic Agents|autonomic agents|mesh-ancestor
55932547|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55932548|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
55932549|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55932550|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932551|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55932552|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55932553|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55932554|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
55932555|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55932556|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55932557|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
55932558|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55932559|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
55932560|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55932561|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55932562|NCT04024865|Domperidone|domperidone|mesh-list
55932565|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799378|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799379|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55799381|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55799382|NCT02418585|Sertraline|sertraline|mesh-list
55799383|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
55799384|NCT02418585|Esketamine|esketamine|mesh-list
55799385|NCT02418585|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55799386|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55799387|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55799388|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932566|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932567|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55932568|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55932569|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
55932570|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932571|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932572|NCT04024241|Cytarabine|cytarabine|mesh-list
55932573|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
55799389|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799390|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
55799391|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799392|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55932574|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55932575|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
55932576|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932577|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932578|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
55932579|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932580|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55932581|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
55932582|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932583|NCT04024241|Analgesics|analgesics|mesh-ancestor
55932584|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
55932585|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932586|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55932587|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55932588|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932589|NCT04024163|Benzonidazole|benzonidazole|mesh-list
55932590|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55932591|NCT04024163|Immunologic Factors|immunologic factors|mesh-ancestor
55932592|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932593|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55932594|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55932595|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55932596|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932597|NCT04996290|Ropivacaine|ropivacaine|mesh-list
55932598|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
55932599|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
55932600|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932601|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932602|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
55932603|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932606|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932607|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
55932608|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
55932609|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
55932610|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932611|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55932612|NCT04023617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55932614|NCT04023149|Interleukin-2|interleukin-2|mesh-list
55932615|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932616|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55799393|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55799394|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932618|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
55932619|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932620|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932621|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55932622|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55799395|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55799396|NCT02418585|Analgesics|analgesics|mesh-ancestor
55799397|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
55799398|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
55799399|NCT05529875|Propofol|propofol|mesh-list
55799400|NCT05529875|Sevoflurane|sevoflurane|mesh-list
55799401|NCT05529875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55799402|NCT05529875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799403|NCT05529875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799404|NCT05529875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55799405|NCT05529875|Anesthetics, General|anesthetics, general|mesh-ancestor
55932624|NCT04023149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932625|NCT04023305|Sevoflurane|sevoflurane|mesh-list
55932626|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55932627|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55799412|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799413|NCT03051451|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55799414|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55799415|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55799416|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799417|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799418|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
55799419|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55799420|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
55799421|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55799422|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55799423|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55799424|NCT03051451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799425|NCT02417961|Benralizumab|benralizumab|mesh-list
55799426|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55799433|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799434|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55799435|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
55799436|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799437|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799438|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55799439|NCT04883125|Pioglitazone|pioglitazone|mesh-list
55799440|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55799441|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799442|NCT05474183|Dexmedetomidine|dexmedetomidine|mesh-list
55799443|NCT05474183|Ketamine|ketamine|mesh-list
55799444|NCT05474183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55799445|NCT05474183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799446|NCT05474183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799447|NCT05474183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55799448|NCT05474183|Analgesics|analgesics|mesh-ancestor
55932628|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
55932629|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
55932630|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932631|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799449|NCT05474183|Sensory System Agents|sensory system agents|mesh-ancestor
55799450|NCT05474183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799451|NCT05474183|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55799452|NCT05474183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55799453|NCT05474183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55799454|NCT05474183|Adrenergic Agents|adrenergic agents|mesh-ancestor
55799455|NCT05474183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799456|NCT05474183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799457|NCT05474183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55799458|NCT05474183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55799459|NCT05474183|Anesthetics, General|anesthetics, general|mesh-ancestor
55799463|NCT04885777|Lidocaine|lidocaine|mesh-list
55799464|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
55799465|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
55799466|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799467|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932633|NCT04149275|Ipilimumab|ipilimumab|mesh-list
55932634|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55932635|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932636|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55932637|NCT04149275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932638|NCT04148963|Loxapine|loxapine|mesh-list
55932639|NCT04148963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55932640|NCT04148963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55932641|NCT04148963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799468|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
55799469|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799470|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55799471|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55799472|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55799473|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55799474|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799475|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
55799476|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
55799477|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799478|NCT02632721|Decitabine|decitabine|mesh-list
55799479|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55799480|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
55799481|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799488|NCT05529095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799489|NCT05529095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55799490|NCT05529095|Dopamine Agonists|dopamine agonists|mesh-ancestor
55799491|NCT05529095|Dopamine Agents|dopamine agents|mesh-ancestor
55799492|NCT05529095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932642|NCT04148963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932643|NCT04148963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55932644|NCT04148963|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55932646|NCT04148963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932647|NCT04148963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932648|NCT04022837|Pantoprazole|pantoprazole|mesh-list
55932649|NCT04022837|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55932664|NCT04148885|Mitosis Modulators|mitosis modulators|mesh-ancestor
55932665|NCT04148885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932667|NCT04022525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932668|NCT04022525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799502|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55799503|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55799504|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932669|NCT04022525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55932670|NCT04022525|Immunologic Factors|immunologic factors|mesh-ancestor
55932671|NCT04022525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932673|NCT04022291|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55932674|NCT04022291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55932675|NCT04022291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932676|NCT03074448|Picosulfate sodium|picosulfate sodium|mesh-list
55799505|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
55799506|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
55799508|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799509|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55799510|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
55799511|NCT03051373|Antiviral Agents|antiviral agents|mesh-ancestor
55799512|NCT03051373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799513|NCT03051373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932677|NCT03074448|Cathartics|cathartics|mesh-ancestor
55932678|NCT03074448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55932679|NCT04021433|Ketamine|ketamine|mesh-list
55932680|NCT04021433|Analgesics|analgesics|mesh-ancestor
55932681|NCT04021433|Sensory System Agents|sensory system agents|mesh-ancestor
55932682|NCT04021433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932683|NCT04021433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932684|NCT04021433|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55799514|NCT03051373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799515|NCT03051373|Immunologic Factors|immunologic factors|mesh-ancestor
55799516|NCT03051373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799517|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55799519|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55932685|NCT04021433|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55932686|NCT04021433|Anesthetics, General|anesthetics, general|mesh-ancestor
55932687|NCT04021433|Anesthetics|anesthetics|mesh-ancestor
55932688|NCT04021433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932689|NCT04021433|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55799520|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55799521|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
55799522|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799523|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55799524|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55799525|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932690|NCT04021433|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55932691|NCT04021433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799526|NCT05534243|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
55799527|NCT05534243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55799528|NCT05534243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799529|NCT05534243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799530|NCT05467475|Esomeprazole|esomeprazole|mesh-list
55799531|NCT05467475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55799532|NCT05467475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55799533|NCT05467475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55799534|NCT05467475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932692|NCT04021433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932693|NCT04147481|Anesthetics|anesthetics|mesh-list
55932694|NCT04147481|Anesthetics, Local|anesthetics, local|mesh-list
55932695|NCT04147481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799535|NCT05467475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799536|NCT04895137|Bevacizumab|bevacizumab|mesh-list
55799537|NCT04895137|Antibodies|antibodies|mesh-list
55799538|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55799539|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55799540|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799541|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55799544|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799545|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
55799546|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
55799547|NCT02332577|Amoxicillin|amoxicillin|mesh-list
55799548|NCT02332577|Pristinamycin|pristinamycin|mesh-list
55799549|NCT02332577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55799550|NCT02332577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799551|NCT02326805|Metronidazole|metronidazole|mesh-list
55799552|NCT02326805|Vaccines|vaccines|mesh-list
55799553|NCT02326805|Immunologic Factors|immunologic factors|mesh-ancestor
55799554|NCT02326805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799555|NCT02326805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799556|NCT02326805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55799557|NCT02326805|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55799558|NCT02326805|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55932696|NCT04147481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932697|NCT04147481|Sensory System Agents|sensory system agents|mesh-ancestor
55932698|NCT04147481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932699|NCT04148261|Hydrocortisone|hydrocortisone|mesh-list
55932700|NCT04148261|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55932701|NCT04148261|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55932702|NCT04148261|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55932703|NCT04148261|Epinephrine|epinephrine|mesh-list
55932704|NCT04148261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55932705|NCT04148261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55932706|NCT04148261|Adrenergic Agents|adrenergic agents|mesh-ancestor
55932707|NCT04148261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932708|NCT04148261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932713|NCT04148261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799560|NCT03048877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799561|NCT03048877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55799562|NCT03048877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799563|NCT03048877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799564|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
55799565|NCT01595581|Testosterone|testosterone|mesh-list
55932715|NCT04148261|Respiratory System Agents|respiratory system agents|mesh-ancestor
55932716|NCT04148261|Mydriatics|mydriatics|mesh-ancestor
55932717|NCT04148261|Sympathomimetics|sympathomimetics|mesh-ancestor
55932718|NCT04148261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55932719|NCT04148261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55932721|NCT03072264|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55932722|NCT03072264|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55932723|NCT03072264|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55932724|NCT03072264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932725|NCT03072264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932726|NCT03072264|Serotonin Agents|serotonin agents|mesh-ancestor
55932727|NCT03072264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932728|NCT03072264|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55932729|NCT03072264|Antidepressive Agents|antidepressive agents|mesh-ancestor
55799566|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
55799567|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
55932730|NCT03072264|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55932731|NCT03072264|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55932732|NCT03072264|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55932733|NCT03072264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932734|NCT04991064|Titanium dioxide|titanium dioxide|mesh-list
55932735|NCT04991064|Sunscreening Agents|sunscreening agents|mesh-ancestor
55932736|NCT04991064|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55799568|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55799569|NCT01595581|Androgens|androgens|mesh-ancestor
55799570|NCT01595581|Hormones|hormones|mesh-ancestor
55799571|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799572|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932737|NCT04991064|Protective Agents|protective agents|mesh-ancestor
55932738|NCT04991064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932739|NCT04991064|Dermatologic Agents|dermatologic agents|mesh-ancestor
55932740|NCT04991064|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55932741|NCT00928083|Artefenomel|artefenomel|mesh-list
55932750|NCT04361721|Sensory System Agents|sensory system agents|mesh-ancestor
55932751|NCT04361721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932752|NCT04361721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932753|NCT04361643|Lenalidomide|lenalidomide|mesh-list
55932754|NCT04361643|Immunologic Factors|immunologic factors|mesh-ancestor
55932755|NCT04361643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932756|NCT04361643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55932757|NCT04361643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55932758|NCT04361643|Growth Substances|growth substances|mesh-ancestor
55932759|NCT04361643|Growth Inhibitors|growth inhibitors|mesh-ancestor
55799573|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55932760|NCT04361643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932762|NCT04406051|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55932763|NCT04406051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55932764|NCT04406051|Adrenergic Agents|adrenergic agents|mesh-ancestor
55932765|NCT04406051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932766|NCT04406051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932767|NCT04406051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932768|NCT04406051|Sympathomimetics|sympathomimetics|mesh-ancestor
55932769|NCT04406051|Autonomic Agents|autonomic agents|mesh-ancestor
55932770|NCT04406051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932771|NCT04406051|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55932772|NCT04991298|Fentanyl|fentanyl|mesh-list
55932773|NCT04991298|Midazolam|midazolam|mesh-list
55932774|NCT04991298|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55932775|NCT04991298|Narcotics|narcotics|mesh-ancestor
55932776|NCT04991298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55932777|NCT04991298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932778|NCT04991298|Analgesics|analgesics|mesh-ancestor
55932779|NCT04991298|Sensory System Agents|sensory system agents|mesh-ancestor
55932780|NCT04991298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55932781|NCT04991298|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55932782|NCT04991298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55932783|NCT04991298|Anesthetics, General|anesthetics, general|mesh-ancestor
55932784|NCT04991298|Anesthetics|anesthetics|mesh-ancestor
55799574|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799575|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
55799576|NCT01954979|Abatacept|abatacept|mesh-list
55799577|NCT01954979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55799578|NCT01954979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799579|NCT01954979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799580|NCT01954979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799581|NCT01954979|Immunologic Factors|immunologic factors|mesh-ancestor
55799582|NCT01954979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799583|NCT01954979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799584|NCT04885153|Fenofibrate|fenofibrate|mesh-list
55932791|NCT04991298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932792|NCT04991298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932793|NCT04361175|Letrozole|letrozole|mesh-list
55932794|NCT04361175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932795|NCT04361175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932796|NCT04361175|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55932797|NCT04361175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55932798|NCT04361175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932799|NCT04361175|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55932800|NCT04361175|Hormone Antagonists|hormone antagonists|mesh-ancestor
55932801|NCT04361175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55932802|NCT04361175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932803|NCT04368819|Allopurinol|allopurinol|mesh-list
55932804|NCT04368819|Antimetabolites|antimetabolites|mesh-ancestor
55932805|NCT04368819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932806|NCT04368819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932807|NCT04368819|Gout Suppressants|gout suppressants|mesh-ancestor
55932808|NCT04368819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932809|NCT04368819|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55932810|NCT04368819|Antioxidants|antioxidants|mesh-ancestor
55932811|NCT04368819|Protective Agents|protective agents|mesh-ancestor
55932812|NCT04368819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932813|NCT04368585|Simethicone|simethicone|mesh-list
55932814|NCT04368585|Omeprazole|omeprazole|mesh-list
55932825|NCT04368585|Antifoaming Agents|antifoaming agents|mesh-ancestor
55932826|NCT04368585|Emollients|emollients|mesh-ancestor
55932827|NCT04368585|Dermatologic Agents|dermatologic agents|mesh-ancestor
55932828|NCT04368585|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55932829|NCT04368585|Immunologic Factors|immunologic factors|mesh-ancestor
55932830|NCT04368585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932831|NCT04368585|Antacids|antacids|mesh-ancestor
55932832|NCT04368585|Antioxidants|antioxidants|mesh-ancestor
55932833|NCT04368585|Protective Agents|protective agents|mesh-ancestor
55932834|NCT04361331|Lenvatinib|lenvatinib|mesh-list
55932835|NCT04361331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743358|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
55932836|NCT04361331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55932890|NCT05620641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55932891|NCT05620641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55932900|NCT05620641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55932901|NCT05620641|Serotonin Agents|serotonin agents|mesh-ancestor
55932902|NCT05620641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55932903|NCT04360785|Methotrexate|methotrexate|mesh-list
55932904|NCT04360785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55932905|NCT04360785|Abortifacient Agents|abortifacient agents|mesh-ancestor
55932906|NCT04360785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55932907|NCT04360785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932908|NCT04360785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55932909|NCT04360785|Antimetabolites|antimetabolites|mesh-ancestor
55743359|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932910|NCT04360785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932911|NCT04360785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932912|NCT04360785|Dermatologic Agents|dermatologic agents|mesh-ancestor
55932913|NCT04360785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932914|NCT04360785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55932915|NCT04360785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55932916|NCT04360785|Immunologic Factors|immunologic factors|mesh-ancestor
55932917|NCT04360785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55932918|NCT04360785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55932920|NCT04360317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55932921|NCT04360317|Tubulin Modulators|tubulin modulators|mesh-ancestor
55932922|NCT04360317|Antimitotic Agents|antimitotic agents|mesh-ancestor
55932923|NCT04360317|Mitosis Modulators|mitosis modulators|mesh-ancestor
55932924|NCT04360317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932925|NCT03074136|Sodium Hypochlorite|sodium hypochlorite|mesh-list
55932927|NCT03074136|Disinfectants|disinfectants|mesh-ancestor
55932928|NCT03074136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55932929|NCT04146155|Liraglutide|liraglutide|mesh-list
55932930|NCT04146155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55932931|NCT04146155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932932|NCT04146155|Incretins|incretins|mesh-ancestor
55932933|NCT04146155|Hormones|hormones|mesh-ancestor
55932934|NCT04146155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55932935|NCT04990752|Urinastatin|urinastatin|mesh-list
55932936|NCT04990752|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55932937|NCT04990752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55932938|NCT04990752|Protease Inhibitors|protease inhibitors|mesh-ancestor
55932939|NCT04990752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932941|NCT02245191|Phenylephrine|phenylephrine|mesh-list
55932950|NCT02245191|Sympathomimetics|sympathomimetics|mesh-ancestor
55932958|NCT02245191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932959|NCT02245191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932960|NCT02245191|Protective Agents|protective agents|mesh-ancestor
55932961|NCT02245191|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55932962|NCT04145921|Tacrine|tacrine|mesh-list
55932963|NCT04145921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55932964|NCT04145921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55932965|NCT04145921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932966|NCT04145921|Cholinergic Agents|cholinergic agents|mesh-ancestor
55932967|NCT04145921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55932968|NCT04145921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932987|NCT02635386|Dapagliflozin|dapagliflozin|mesh-list
55932988|NCT02635386|Exenatide|exenatide|mesh-list
55932989|NCT02635386|Topiramate|topiramate|mesh-list
55932990|NCT02635386|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55932991|NCT02635386|Phentermine|phentermine|mesh-list
55932992|NCT02635386|Glucagon|glucagon|mesh-list
55932993|NCT02635386|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55932994|NCT02635386|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55932995|NCT02635386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55932996|NCT02635386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55932997|NCT02635386|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55932998|NCT02635386|Incretins|incretins|mesh-ancestor
55932999|NCT02635386|Hormones|hormones|mesh-ancestor
56144596|NCT00801138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933000|NCT02635386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933001|NCT02635386|Anticonvulsants|anticonvulsants|mesh-ancestor
55933002|NCT02635386|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55933003|NCT02635386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55933004|NCT02635386|Appetite Depressants|appetite depressants|mesh-ancestor
55933005|NCT02635386|Sympathomimetics|sympathomimetics|mesh-ancestor
55933006|NCT02635386|Autonomic Agents|autonomic agents|mesh-ancestor
55933007|NCT02635386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933008|NCT02635386|Adrenergic Agents|adrenergic agents|mesh-ancestor
55933009|NCT02635386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933018|NCT00934635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933019|NCT00934635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933025|NCT00934635|Dopamine Agents|dopamine agents|mesh-ancestor
55933026|NCT00934635|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55933027|NCT00934635|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55933028|NCT04359537|Hydroxychloroquine|hydroxychloroquine|mesh-list
55933029|NCT04359537|Antimalarials|antimalarials|mesh-ancestor
55933030|NCT04359537|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55933031|NCT04359537|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55933032|NCT04359537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933033|NCT04359537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933034|NCT04359537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933035|NCT04359537|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55933036|NCT03923699|Anesthetics|anesthetics|mesh-list
55933037|NCT03923699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933038|NCT03923699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933039|NCT03922997|Atezolizumab|atezolizumab|mesh-list
55933040|NCT03922997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933041|NCT04356417|Antimalarials|antimalarials|mesh-list
55933073|NCT05580887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933074|NCT05580887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55933075|NCT05580887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55933076|NCT05580887|Alkylating Agents|alkylating agents|mesh-ancestor
55933077|NCT05580887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55933078|NCT05580887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55933079|NCT05580887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55933080|NCT05580887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55933081|NCT05580887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933084|NCT04994262|Dermatologic Agents|dermatologic agents|mesh-ancestor
55933094|NCT00939159|Panobinostat|panobinostat|mesh-list
55933106|NCT04994574|Olodaterol|olodaterol|mesh-list
55933107|NCT04994574|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55933108|NCT04994574|Autonomic Agents|autonomic agents|mesh-ancestor
55933109|NCT04994574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933110|NCT04994574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933111|NCT04994574|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55799587|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799589|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55933112|NCT04994574|Respiratory System Agents|respiratory system agents|mesh-ancestor
55933113|NCT04994574|Parasympatholytics|parasympatholytics|mesh-ancestor
55933114|NCT04994574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55933115|NCT04994574|Cholinergic Agents|cholinergic agents|mesh-ancestor
55933116|NCT04994574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933117|NCT04994574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933118|NCT04355637|Budesonide|budesonide|mesh-list
55933119|NCT04355637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55933124|NCT04355637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55933125|NCT04355637|Respiratory System Agents|respiratory system agents|mesh-ancestor
55933126|NCT04355637|Glucocorticoids|glucocorticoids|mesh-ancestor
55933127|NCT04355637|Hormones|hormones|mesh-ancestor
55933128|NCT04355637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933129|NCT04367025|Oxaliplatin|oxaliplatin|mesh-list
55933130|NCT04367025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933131|NCT03076710|Bupivacaine|bupivacaine|mesh-list
55933132|NCT03076710|Anesthetics, Local|anesthetics, local|mesh-ancestor
55933133|NCT03076710|Anesthetics|anesthetics|mesh-ancestor
55933134|NCT03076710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933135|NCT03076710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933136|NCT03076710|Sensory System Agents|sensory system agents|mesh-ancestor
55933137|NCT03076710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933139|NCT04143581|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55933140|NCT04143581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933141|NCT04143581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55933142|NCT04143581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933143|NCT03071172|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55933144|NCT03071172|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55933145|NCT03071172|Progesterone|progesterone|mesh-list
55933146|NCT03071172|Hormones|hormones|mesh-ancestor
55933147|NCT03071172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933148|NCT03071172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933149|NCT03071172|Progestins|progestins|mesh-ancestor
55933150|NCT03071172|Luteolytic Agents|luteolytic agents|mesh-ancestor
55933151|NCT03071172|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55933152|NCT03071172|Contraceptive Agents|contraceptive agents|mesh-ancestor
55933153|NCT03071172|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55933154|NCT03071172|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55933155|NCT03071172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55933156|NCT03071172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933157|NCT03070938|Anti-Infective Agents|anti-infective agents|mesh-list
55933158|NCT03070938|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55933159|NCT04143815|Botulinum Toxins|botulinum toxins|mesh-list
55933160|NCT04143815|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55933161|NCT04143815|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55933162|NCT04143815|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55933163|NCT04143815|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55794626|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
55799593|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
55799594|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933165|NCT04143815|Cholinergic Agents|cholinergic agents|mesh-ancestor
55933166|NCT04143815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933167|NCT04143815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933168|NCT04143815|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55933169|NCT04143815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933171|NCT04355247|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55933172|NCT04355247|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55933174|NCT04355247|Prednisolone acetate|prednisolone acetate|mesh-list
55933175|NCT04355247|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55933176|NCT04355247|Prednisolone phosphate|prednisolone phosphate|mesh-list
55933177|NCT04355247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55933178|NCT04355247|Antiemetics|antiemetics|mesh-ancestor
55933179|NCT04355247|Autonomic Agents|autonomic agents|mesh-ancestor
55933180|NCT04355247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933181|NCT04355247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933182|NCT04355247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55933183|NCT04355247|Glucocorticoids|glucocorticoids|mesh-ancestor
55933184|NCT04355247|Hormones|hormones|mesh-ancestor
55933185|NCT04355247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933186|NCT04355247|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55933187|NCT04355247|Protective Agents|protective agents|mesh-ancestor
55933188|NCT04355247|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55933189|NCT04355247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933190|NCT03903809|Epoetin Alfa|epoetin alfa|mesh-list
55933191|NCT03903809|Hematinics|hematinics|mesh-ancestor
55933192|NCT04987554|Immunoferon|immunoferon|mesh-list
55933193|NCT04987554|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55933194|NCT04987554|Immunologic Factors|immunologic factors|mesh-ancestor
55933195|NCT04987554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933205|NCT04358367|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55933206|NCT04358367|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55933207|NCT04358367|Adrenergic Agents|adrenergic agents|mesh-ancestor
55933208|NCT04358367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933209|NCT04358367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933210|NCT04987242|Rasburicase|rasburicase|mesh-list
55933211|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
55933221|NCT00936663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933222|NCT00936663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55933223|NCT00936663|Protease Inhibitors|protease inhibitors|mesh-ancestor
55933224|NCT00936663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933225|NCT00936663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933226|NCT03903185|Sofosbuvir|sofosbuvir|mesh-list
55933227|NCT03903185|Ledipasvir|ledipasvir|mesh-list
55933228|NCT03903185|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55933229|NCT03903185|Antiviral Agents|antiviral agents|mesh-ancestor
55933230|NCT03903185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933231|NCT03917303|Adalimumab|adalimumab|mesh-list
55933241|NCT05583149|Immunologic Factors|immunologic factors|mesh-ancestor
55933242|NCT05583149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933243|NCT05583149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55933244|NCT05583149|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55933245|NCT05583149|Alkylating Agents|alkylating agents|mesh-ancestor
55933246|NCT05583149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933247|NCT05583149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933248|NCT05583149|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55933249|NCT04366869|Salicylic Acid|salicylic acid|mesh-list
55933250|NCT04366869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933253|NCT04366869|Dermatologic Agents|dermatologic agents|mesh-ancestor
55933254|NCT04989270|Anesthetics|anesthetics|mesh-list
55933255|NCT04989270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933256|NCT04989270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933257|NCT05583071|Rituximab|rituximab|mesh-list
55933258|NCT05583071|Methotrexate|methotrexate|mesh-list
55933259|NCT05583071|Lenalidomide|lenalidomide|mesh-list
55933260|NCT05583071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55933261|NCT05583071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933262|NCT05583071|Immunologic Factors|immunologic factors|mesh-ancestor
55933263|NCT05583071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933264|NCT05583071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55933265|NCT05583071|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55933266|NCT05583071|Abortifacient Agents|abortifacient agents|mesh-ancestor
55933267|NCT05583071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55933268|NCT05583071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55933269|NCT05583071|Antimetabolites|antimetabolites|mesh-ancestor
55933270|NCT05583071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933281|NCT04989348|Progestins|progestins|mesh-list
55933282|NCT04989348|Hormone Antagonists|hormone antagonists|mesh-list
55933283|NCT04989348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933284|NCT04989348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933288|NCT04346823|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55933289|NCT04346823|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55933290|NCT04346823|Anesthetics, General|anesthetics, general|mesh-ancestor
55933291|NCT04346823|Anesthetics|anesthetics|mesh-ancestor
55933292|NCT04346823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933293|NCT04346823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933294|NCT05582837|Topiramate|topiramate|mesh-list
55933295|NCT05582837|Nortriptyline|nortriptyline|mesh-list
55933296|NCT05582837|Anticonvulsants|anticonvulsants|mesh-ancestor
55933297|NCT05582837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55933298|NCT05582837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933299|NCT05582837|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55933300|NCT05582837|Antidepressive Agents|antidepressive agents|mesh-ancestor
55933301|NCT05582837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55933302|NCT05582837|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55933303|NCT05582837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55933304|NCT05582837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55933305|NCT05582837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933309|NCT04728633|Ethiodized Oil|ethiodized oil|mesh-list
55933310|NCT04728633|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55933311|NCT04728633|Alkylating Agents|alkylating agents|mesh-ancestor
55933312|NCT04728633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933314|NCT05003700|Lenvatinib|lenvatinib|mesh-list
55933323|NCT04143191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933324|NCT04661007|Lenalidomide|lenalidomide|mesh-list
55933325|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
55933326|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933327|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55933328|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55933329|NCT04661007|Growth Substances|growth substances|mesh-ancestor
55933330|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
55933331|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799598|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55799599|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55799600|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799601|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799602|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55799603|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55799604|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55799605|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55799606|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
55799608|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
55799609|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
55799610|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799611|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799612|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
55799613|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
55799614|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
55799615|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799616|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55933332|NCT03647657|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55933333|NCT03647657|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55933334|NCT03647657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933335|NCT04461288|Nicotine|nicotine|mesh-list
55933336|NCT04461288|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55933337|NCT04461288|Autonomic Agents|autonomic agents|mesh-ancestor
55933338|NCT04461288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933339|NCT04461288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933340|NCT04461288|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55933341|NCT04461288|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55933342|NCT04461288|Cholinergic Agents|cholinergic agents|mesh-ancestor
55933343|NCT04461288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933344|NCT04461288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933346|NCT05582135|Esketamine|esketamine|mesh-list
55933347|NCT05582135|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55933348|NCT05582135|Narcotics|narcotics|mesh-ancestor
55933349|NCT05582135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933350|NCT05582135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933354|NCT05582135|Antidepressive Agents|antidepressive agents|mesh-ancestor
55933355|NCT05582135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55933357|NCT03070704|Xultophy|xultophy|mesh-list
55933358|NCT03070704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55933359|NCT03070704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933360|NCT03070704|Incretins|incretins|mesh-ancestor
55933362|NCT03070704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933363|NCT03069768|Varenicline|varenicline|mesh-list
55933364|NCT03069768|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55933365|NCT03069768|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55933366|NCT03069768|Cholinergic Agents|cholinergic agents|mesh-ancestor
55933367|NCT03069768|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933368|NCT03069768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799617|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55799618|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55799619|NCT01610687|Nabiximols|nabiximols|mesh-list
55933369|NCT03069768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933371|NCT04141553|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55933372|NCT04141553|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55933373|NCT04141553|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55933374|NCT04141553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933375|NCT04141553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55933376|NCT04141553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933377|NCT04141553|Vasodilator Agents|vasodilator agents|mesh-ancestor
55933379|NCT04141163|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55933380|NCT04141163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933381|NCT00942825|Cisplatin|cisplatin|mesh-list
55933382|NCT00942825|Pemetrexed|pemetrexed|mesh-list
55933383|NCT00942825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933384|NCT00942825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933385|NCT00942825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933386|NCT00942825|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55933387|NCT00942825|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55933388|NCT04544943|Gentamicins|gentamicins|mesh-list
55933389|NCT04544943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55933390|NCT04544943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933391|NCT04544943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55933392|NCT04544943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933393|NCT04544943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933394|NCT04140461|Amphotericin B|amphotericin b|mesh-list
55933395|NCT04140461|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55933396|NCT04140461|Flucytosine|flucytosine|mesh-list
55933397|NCT04140461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933410|NCT03021629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55933411|NCT03021395|Decitabine|decitabine|mesh-list
55933412|NCT03021395|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55933417|NCT03021317|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55933419|NCT03021317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933420|NCT03021317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933421|NCT04987632|Letrozole|letrozole|mesh-list
55799623|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799624|NCT04884919|Chitosan|chitosan|mesh-list
55799625|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55799626|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55933422|NCT04987632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933423|NCT04987632|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55933424|NCT04987632|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55933425|NCT04987632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933426|NCT04987632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933427|NCT04987632|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55933428|NCT04987632|Hormone Antagonists|hormone antagonists|mesh-ancestor
55933429|NCT04987632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933430|NCT04987632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933432|NCT03032367|Antitubercular Agents|antitubercular agents|mesh-ancestor
55933433|NCT03032367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55933434|NCT03032367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933435|NCT02634606|Tocotrienols|tocotrienols|mesh-list
55933436|NCT02634606|Vitamin E|vitamin e|mesh-list
55933437|NCT02634606|Tocopherols|tocopherols|mesh-list
55933438|NCT02634606|Antioxidants|antioxidants|mesh-ancestor
55933439|NCT02634606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933440|NCT02634606|Protective Agents|protective agents|mesh-ancestor
55933441|NCT02634606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933442|NCT02634606|Vitamins|vitamins|mesh-ancestor
55933443|NCT02634606|Micronutrients|micronutrients|mesh-ancestor
55933447|NCT05002686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55933448|NCT05002686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933449|NCT05002686|Tubulin Modulators|tubulin modulators|mesh-ancestor
55933450|NCT05002686|Antimitotic Agents|antimitotic agents|mesh-ancestor
55933451|NCT05002686|Mitosis Modulators|mitosis modulators|mesh-ancestor
55933452|NCT05002686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933453|NCT05002686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55933454|NCT05002686|Antimetabolites|antimetabolites|mesh-ancestor
55933455|NCT03588689|Ropivacaine|ropivacaine|mesh-list
55933456|NCT03588689|Anesthetics, Local|anesthetics, local|mesh-ancestor
55933457|NCT03588689|Anesthetics|anesthetics|mesh-ancestor
55933458|NCT03588689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933459|NCT03588689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933460|NCT03588689|Sensory System Agents|sensory system agents|mesh-ancestor
55933461|NCT03588689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933462|NCT04985526|Octenidine|octenidine|mesh-list
55933463|NCT04985526|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933464|NCT04985526|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55933465|NCT03588611|Hirudins|hirudins|mesh-list
55933466|NCT03588611|Bivalirudin|bivalirudin|mesh-list
55933467|NCT03588611|Antithrombins|antithrombins|mesh-ancestor
55933468|NCT03588611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55933471|NCT03588611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933472|NCT03588611|Anticoagulants|anticoagulants|mesh-ancestor
55933473|NCT03588611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55933474|NCT03588611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55933475|NCT03588533|Capecitabine|capecitabine|mesh-list
55933476|NCT03588533|Trastuzumab|trastuzumab|mesh-list
55933477|NCT03588533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933478|NCT03588533|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55933479|NCT03588533|Antimetabolites|antimetabolites|mesh-ancestor
55933480|NCT03588533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933481|NCT03588533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55933482|NCT03068442|Flutemetamol|flutemetamol|mesh-list
55933483|NCT03068442|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55933484|NCT03068442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933485|NCT00939705|Topiramate|topiramate|mesh-list
55933486|NCT00939705|Anticonvulsants|anticonvulsants|mesh-ancestor
55933487|NCT00939705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55799634|NCT04129931|Imatinib Mesylate|imatinib mesylate|mesh-list
55799635|NCT04129931|Broncho-Vaxom|broncho-vaxom|mesh-list
55799636|NCT04129931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799637|NCT04129931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55799638|NCT04129931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799639|NCT04129931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799640|NCT04129931|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55933488|NCT00939705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933490|NCT05001672|Antiviral Agents|antiviral agents|mesh-ancestor
55933491|NCT05001672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933492|NCT05001672|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55933493|NCT05001672|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55933494|NCT05001672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933502|NCT03587285|Abiraterone Acetate|abiraterone acetate|mesh-list
55933503|NCT03587285|Bicalutamide|bicalutamide|mesh-list
55933504|NCT03587285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55933505|NCT03587285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799648|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
55799649|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799650|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
55799651|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799652|NCT04872283|Aspirin|aspirin|mesh-list
55799653|NCT04872283|Acetaminophen|acetaminophen|mesh-list
55799654|NCT04872283|Ketorolac|ketorolac|mesh-list
55799655|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55799656|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55799657|NCT04872283|Oxycodone|oxycodone|mesh-list
55799658|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55799659|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55799660|NCT04872283|Analgesics|analgesics|mesh-ancestor
55799661|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
55799662|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799663|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933506|NCT03587285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55933507|NCT03587285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933508|NCT03587285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933509|NCT03587285|Hormone Antagonists|hormone antagonists|mesh-ancestor
55933510|NCT03587285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933511|NCT03587285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933512|NCT03587285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55933515|NCT03587129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933516|NCT03587129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55933517|NCT03587129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933518|NCT03587129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933519|NCT02245503|Tamsulosin|tamsulosin|mesh-list
55933520|NCT02245503|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55933521|NCT02245503|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55933522|NCT02245503|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55933523|NCT02245503|Adrenergic Agents|adrenergic agents|mesh-ancestor
55933524|NCT02245503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799669|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55799670|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55799671|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799672|NCT04872283|Antipyretics|antipyretics|mesh-ancestor
55799673|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55799674|NCT04872283|Narcotics|narcotics|mesh-ancestor
55799675|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799676|NCT05182385|Venetoclax|venetoclax|mesh-list
55933525|NCT02245503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933526|NCT02245503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933527|NCT02245503|Urological Agents|urological agents|mesh-ancestor
55933531|NCT03586817|Antiemetics|antiemetics|mesh-ancestor
55933532|NCT03586817|Autonomic Agents|autonomic agents|mesh-ancestor
55933533|NCT03586817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799677|NCT05182385|Blinatumomab|blinatumomab|mesh-list
55799678|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799679|NCT05533619|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55799684|NCT04871269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933534|NCT03586817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933535|NCT03586817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55933536|NCT03586817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55933537|NCT03586817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55933538|NCT03586817|Serotonin Agents|serotonin agents|mesh-ancestor
55799686|NCT04871269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55799687|NCT04871269|Analgesics|analgesics|mesh-ancestor
55799688|NCT04871269|Sensory System Agents|sensory system agents|mesh-ancestor
55799689|NCT04871269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799690|NCT04871269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55799691|NCT04871269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55799692|NCT04871269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799693|NCT04871269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799694|NCT04871269|Hormones|hormones|mesh-ancestor
55799695|NCT04871269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799696|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
55799697|NCT04389073|Bevacizumab|bevacizumab|mesh-list
55799698|NCT04389073|Capecitabine|capecitabine|mesh-list
55799699|NCT04389073|Vinorelbine|vinorelbine|mesh-list
55799700|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799701|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
55799702|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799703|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799704|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55799705|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
55799706|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799707|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799708|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55799709|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55799710|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55799711|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55799715|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
55799716|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55799717|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
55799718|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
55799719|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
55799720|NCT04371445|Dexamethasone|dexamethasone|mesh-list
55933539|NCT03586817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799724|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55799725|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
55799726|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55799727|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
55799728|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55933540|NCT03586817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933541|NCT03586817|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55933542|NCT03891173|Vinorelbine|vinorelbine|mesh-list
55933543|NCT03891173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933544|NCT03891173|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55933545|NCT03891173|Tubulin Modulators|tubulin modulators|mesh-ancestor
55799729|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
55799738|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799739|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55799740|NCT04371445|Protective Agents|protective agents|mesh-ancestor
55799741|NCT03049267|Apremilast|apremilast|mesh-list
55799742|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55799743|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55799744|NCT03049267|Analgesics|analgesics|mesh-ancestor
55799745|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
55799746|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799747|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799748|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55799749|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799750|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55799751|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55799752|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799753|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799754|NCT05524259|Folic Acid|folic acid|mesh-list
55799756|NCT05524259|Inositol|inositol|mesh-list
55799757|NCT05524259|Hematinics|hematinics|mesh-ancestor
55799758|NCT05524259|Vitamins|vitamins|mesh-ancestor
55799759|NCT05524259|Micronutrients|micronutrients|mesh-ancestor
55799760|NCT05524259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799774|NCT05257993|Folfirinox|folfirinox|mesh-list
55799775|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55799776|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799777|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
55799778|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
55799779|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
55933546|NCT03891173|Antimitotic Agents|antimitotic agents|mesh-ancestor
55933547|NCT03891173|Mitosis Modulators|mitosis modulators|mesh-ancestor
55933548|NCT03891173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933550|NCT03585725|Antimetabolites|antimetabolites|mesh-ancestor
55933551|NCT03585725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933552|NCT03585725|Antiviral Agents|antiviral agents|mesh-ancestor
55799780|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799784|NCT05257993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799785|NCT05257993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799786|NCT05257993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799787|NCT05257993|Immunologic Factors|immunologic factors|mesh-ancestor
55799788|NCT05257993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799790|NCT05533073|Tramadol|tramadol|mesh-list
55799791|NCT05533073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55799792|NCT05533073|Narcotics|narcotics|mesh-ancestor
55799793|NCT05533073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799794|NCT05533073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799795|NCT05533073|Analgesics|analgesics|mesh-ancestor
55799796|NCT05533073|Sensory System Agents|sensory system agents|mesh-ancestor
55799797|NCT05533073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799801|NCT05533073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799802|NCT05533073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55799803|NCT05533073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55799804|NCT05533073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799805|NCT05533073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799806|NCT04050553|Tirzepatide|tirzepatide|mesh-list
55799807|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55799808|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799809|NCT04050553|Incretins|incretins|mesh-ancestor
55933553|NCT03585725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933554|NCT03585569|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55933555|NCT03585569|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55933556|NCT03585569|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55933557|NCT03585569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55933558|NCT03585569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933559|NCT03585569|Cholinergic Agents|cholinergic agents|mesh-ancestor
55933560|NCT03585569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933561|NCT03585569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933562|NCT03585569|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55933563|NCT03585569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933564|NCT03585179|Tranexamic Acid|tranexamic acid|mesh-list
55933565|NCT03585179|Hydroquinone|hydroquinone|mesh-list
55933566|NCT03585179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55933567|NCT03585179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55933568|NCT03585179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933569|NCT03585179|Hemostatics|hemostatics|mesh-ancestor
55933570|NCT03585179|Coagulants|coagulants|mesh-ancestor
55933571|NCT03585179|Antioxidants|antioxidants|mesh-ancestor
55933572|NCT03585179|Protective Agents|protective agents|mesh-ancestor
55933573|NCT03585179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933574|NCT03585179|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55933576|NCT03585101|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55933577|NCT03585101|Antiviral Agents|antiviral agents|mesh-ancestor
55933578|NCT03585101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933580|NCT03584087|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55933581|NCT03584087|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55933583|NCT03834363|Morphine|morphine|mesh-list
55933584|NCT03834363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55933585|NCT03834363|Narcotics|narcotics|mesh-ancestor
55933586|NCT03834363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933587|NCT03834363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933588|NCT03834363|Analgesics|analgesics|mesh-ancestor
55799811|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799812|NCT03946891|Furosemide|furosemide|mesh-list
55799813|NCT03946891|Diuretics|diuretics|mesh-ancestor
55799814|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
55799815|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799816|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55799817|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55799818|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799819|NCT04300049|Glucagon|glucagon|mesh-list
55799820|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55799821|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55799822|NCT04300049|Hormones|hormones|mesh-ancestor
55799823|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799824|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799825|NCT04300049|Incretins|incretins|mesh-ancestor
55799826|NCT03849625|Aspirin|aspirin|mesh-list
55799827|NCT03849625|Acetaminophen|acetaminophen|mesh-list
55799828|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55799829|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55799830|NCT03849625|Analgesics|analgesics|mesh-ancestor
55799831|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
55799832|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799833|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799835|NCT03849625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799836|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55799837|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55799838|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799839|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55799840|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55799841|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799842|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
55799844|NCT03612973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55799845|NCT03612973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799846|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55799847|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
55799848|NCT03049345|Methylene Blue|methylene blue|mesh-list
55799849|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799850|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799851|NCT03300817|Poly ICLC|poly iclc|mesh-list
55799852|NCT03300817|Interferon Inducers|interferon inducers|mesh-ancestor
55799853|NCT03300817|Immunologic Factors|immunologic factors|mesh-ancestor
55799854|NCT03300817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799855|NCT05526911|Tenofovir|tenofovir|mesh-list
55799856|NCT05526911|Lamivudine|lamivudine|mesh-list
55799857|NCT05526911|Dolutegravir|dolutegravir|mesh-list
55933589|NCT03834363|Sensory System Agents|sensory system agents|mesh-ancestor
55933590|NCT03834363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933591|NCT03834363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55933592|NCT03834363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55799861|NCT05526911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55799865|NCT05526911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55799866|NCT05526911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55799867|NCT05526911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55799868|NCT05526911|Anesthetics, General|anesthetics, general|mesh-ancestor
55799869|NCT05526911|Anesthetics|anesthetics|mesh-ancestor
55799870|NCT05526911|GABA Modulators|gaba modulators|mesh-ancestor
55799871|NCT05526911|GABA Agents|gaba agents|mesh-ancestor
55799872|NCT05526911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799873|NCT05526911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799874|NCT05526911|Antiviral Agents|antiviral agents|mesh-ancestor
55799875|NCT05526911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799876|NCT05526911|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55799877|NCT05526911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55799878|NCT05526911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799879|NCT05526911|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55799880|NCT05526911|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55799881|NCT05526911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55799882|NCT05526911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55799883|NCT05526911|Protective Agents|protective agents|mesh-ancestor
55799884|NCT05526911|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55799885|NCT05526911|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55799886|NCT04870489|Isotretinoin|isotretinoin|mesh-list
55799887|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
55799888|NCT02574845|Metformin|metformin|mesh-list
55799889|NCT02574845|Furosemide|furosemide|mesh-list
55799890|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55799891|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55799892|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799893|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55933593|NCT03834363|Anesthetics, General|anesthetics, general|mesh-ancestor
55933594|NCT03834363|Anesthetics|anesthetics|mesh-ancestor
55933595|NCT03031353|Misoprostol|misoprostol|mesh-list
55933596|NCT03031353|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55933597|NCT03031353|Abortifacient Agents|abortifacient agents|mesh-ancestor
55933598|NCT03031353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55933599|NCT03031353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799894|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55799895|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
55799896|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799897|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55799900|NCT02574845|Diuretics|diuretics|mesh-ancestor
55799901|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
55799902|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55799903|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55799904|NCT05334485|Bromides|bromides|mesh-list
55799905|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55799906|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
55799907|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55799908|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799909|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799910|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
55799911|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799912|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799913|NCT05231941|Lidocaine|lidocaine|mesh-list
55933602|NCT03031353|Oxytocics|oxytocics|mesh-ancestor
55933605|NCT05702957|Enclomiphene|enclomiphene|mesh-list
55799914|NCT05231941|Ropivacaine|ropivacaine|mesh-list
55799915|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
55799916|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
55799917|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55799921|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55799922|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55799923|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55933606|NCT05702957|Zuclomiphene|zuclomiphene|mesh-list
55933607|NCT05702957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933608|NCT05702957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799936|NCT05146739|Immunologic Factors|immunologic factors|mesh-ancestor
55799937|NCT05146739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799938|NCT05146739|Antiviral Agents|antiviral agents|mesh-ancestor
55799939|NCT05146739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799940|NCT05146739|Antidotes|antidotes|mesh-ancestor
55799941|NCT05146739|Protective Agents|protective agents|mesh-ancestor
55799942|NCT05146739|Vitamin B Complex|vitamin b complex|mesh-ancestor
55799943|NCT05146739|Vitamins|vitamins|mesh-ancestor
55799944|NCT05146739|Micronutrients|micronutrients|mesh-ancestor
55799945|NCT05522231|Everolimus|everolimus|mesh-list
55799946|NCT05522231|Axitinib|axitinib|mesh-list
55799947|NCT05522231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799948|NCT05522231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799949|NCT05522231|Immunologic Factors|immunologic factors|mesh-ancestor
55799950|NCT05522231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799951|NCT05522231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55799952|NCT05522231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933609|NCT05702957|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55799972|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55933610|NCT05702957|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55933611|NCT05702957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933612|NCT05702957|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55933613|NCT05702957|Hormone Antagonists|hormone antagonists|mesh-ancestor
55933614|NCT05702957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933615|NCT05702957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933616|NCT05702957|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55933617|NCT05702957|Fertility Agents|fertility agents|mesh-ancestor
55933618|NCT05702957|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55933619|NCT05702957|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55933620|NCT05702957|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55933621|NCT04405505|Paclitaxel|paclitaxel|mesh-list
55933622|NCT04405505|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55933623|NCT04405505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933624|NCT04405505|Tubulin Modulators|tubulin modulators|mesh-ancestor
55933625|NCT04405505|Antimitotic Agents|antimitotic agents|mesh-ancestor
55933626|NCT04405505|Mitosis Modulators|mitosis modulators|mesh-ancestor
55933627|NCT04405505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933630|NCT03580733|Clotrimazole|clotrimazole|mesh-list
55933631|NCT03580733|Miconazole|miconazole|mesh-list
55933632|NCT03580733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933633|NCT03580733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933634|NCT03580733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933635|NCT03580733|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55933636|NCT03580733|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55933637|NCT03580733|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55799953|NCT05522231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799954|NCT04877509|Vitamin D|vitamin d|mesh-list
55933638|NCT03580733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55933639|NCT03580733|Hormone Antagonists|hormone antagonists|mesh-ancestor
55933640|NCT03580733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933641|NCT03580733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933642|NCT03580733|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55933643|NCT03580733|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55933644|NCT03461445|Tacrolimus|tacrolimus|mesh-list
55933645|NCT03461445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55933646|NCT03461445|Immunologic Factors|immunologic factors|mesh-ancestor
55933647|NCT03461445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933648|NCT03461445|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55933650|NCT03461445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933651|NCT04939662|Bevacizumab|bevacizumab|mesh-list
55933652|NCT04939662|Olaparib|olaparib|mesh-list
55933653|NCT04939662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55933654|NCT04939662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933655|NCT04939662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55933656|NCT04939662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55933657|NCT04939662|Growth Substances|growth substances|mesh-ancestor
55933658|NCT04939662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933659|NCT04939662|Growth Inhibitors|growth inhibitors|mesh-ancestor
55933660|NCT04939662|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55933661|NCT04939662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933662|NCT04939662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933663|NCT05581979|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55933664|NCT05581979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55799955|NCT04877509|Vitamin A|vitamin a|mesh-list
55799956|NCT04877509|Selenium|selenium|mesh-list
55799958|NCT04877509|Vitamins|vitamins|mesh-ancestor
55933665|NCT05581979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933666|NCT05331144|Losartan|losartan|mesh-list
55933667|NCT05331144|Amlodipine|amlodipine|mesh-list
55933668|NCT05331144|Calcium Channel Blockers|calcium channel blockers|mesh-list
55799960|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799961|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
55799962|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799963|NCT04877509|Protective Agents|protective agents|mesh-ancestor
55799964|NCT04877509|Trace Elements|trace elements|mesh-ancestor
55799965|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55799966|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
55799967|NCT03044743|Fludarabine|fludarabine|mesh-list
55799968|NCT03044743|Interleukin-2|interleukin-2|mesh-list
55799969|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799970|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
55799971|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799973|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55799974|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
55799975|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799976|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799977|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55799978|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55799979|NCT03044743|Analgesics|analgesics|mesh-ancestor
55933670|NCT05331144|Giapreza|giapreza|mesh-list
55933671|NCT05331144|Calcium|calcium|mesh-list
55933672|NCT05331144|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55933673|NCT05331144|Angiotensinogen|angiotensinogen|mesh-list
55933674|NCT05331144|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55933675|NCT05331144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933676|NCT05331144|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55799980|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
55799981|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799982|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55799984|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55799985|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55799986|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
55799987|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933677|NCT05331144|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55933678|NCT05331144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933679|NCT05331144|Vasodilator Agents|vasodilator agents|mesh-ancestor
55933680|NCT05331144|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55799988|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55799989|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55799990|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799991|NCT03044587|Leucovorin|leucovorin|mesh-list
55799992|NCT03044587|Gemcitabine|gemcitabine|mesh-list
55799993|NCT03044587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799994|NCT03044587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55799995|NCT03044587|Antimetabolites|antimetabolites|mesh-ancestor
55799996|NCT03044587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933681|NCT05331144|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55933682|NCT05331144|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55933683|NCT05331144|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55933684|NCT05331144|Protease Inhibitors|protease inhibitors|mesh-ancestor
55933685|NCT05331144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933686|NCT03580499|Vitamins|vitamins|mesh-list
55933687|NCT03580499|Vitamin B 6|vitamin b 6|mesh-list
55933688|NCT03580499|Pyridoxal|pyridoxal|mesh-list
55933689|NCT03580499|Pyridoxine|pyridoxine|mesh-list
55933690|NCT03580499|Vitamin B Complex|vitamin b complex|mesh-list
55933691|NCT03580499|Micronutrients|micronutrients|mesh-ancestor
55933692|NCT03580499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933693|NCT00951561|Ibuprofen|ibuprofen|mesh-list
55933699|NCT00951561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933700|NCT00951561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55933701|NCT00951561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55933702|NCT00951561|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55933703|NCT00951561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933704|NCT00951561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933705|NCT03031119|Atorvastatin|atorvastatin|mesh-list
55933706|NCT03031119|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55933707|NCT03031119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55799997|NCT03044587|Antiviral Agents|antiviral agents|mesh-ancestor
55799998|NCT03044587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55799999|NCT03044587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800000|NCT03044587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800001|NCT03044587|Immunologic Factors|immunologic factors|mesh-ancestor
55800002|NCT03044587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800003|NCT03044587|Antidotes|antidotes|mesh-ancestor
55800004|NCT03044587|Protective Agents|protective agents|mesh-ancestor
55800005|NCT03044587|Vitamin B Complex|vitamin b complex|mesh-ancestor
55800006|NCT03044587|Vitamins|vitamins|mesh-ancestor
55800007|NCT03044587|Micronutrients|micronutrients|mesh-ancestor
55800008|NCT05532215|Misoprostol|misoprostol|mesh-list
55800009|NCT05532215|Oxytocin|oxytocin|mesh-list
55800010|NCT05532215|Oxytocics|oxytocics|mesh-ancestor
55933708|NCT03031119|Antimetabolites|antimetabolites|mesh-ancestor
55933709|NCT03031119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933710|NCT03031119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55933711|NCT03031119|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55933712|NCT03031119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933714|NCT03076203|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55933715|NCT03076203|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55933716|NCT03076203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933717|NCT03076203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933718|NCT03076203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800011|NCT05532215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55800012|NCT05532215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800013|NCT05532215|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55800014|NCT05532215|Abortifacient Agents|abortifacient agents|mesh-ancestor
55800015|NCT05532215|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55800016|NCT05532215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55800018|NCT05521997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800019|NCT05525351|Dexmedetomidine|dexmedetomidine|mesh-list
55800020|NCT05525351|Alfentanil|alfentanil|mesh-list
55800021|NCT05525351|Propofol|propofol|mesh-list
55800022|NCT05525351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55800023|NCT05525351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800024|NCT05525351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800025|NCT05525351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55933719|NCT02943057|Ganciclovir|ganciclovir|mesh-list
55933720|NCT02943057|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
55933721|NCT02943057|Antiviral Agents|antiviral agents|mesh-ancestor
55933722|NCT02943057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933723|NCT02943057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55933724|NCT02943057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800026|NCT05525351|Anesthetics, General|anesthetics, general|mesh-ancestor
55800028|NCT05525351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55800029|NCT05525351|Analgesics|analgesics|mesh-ancestor
55800030|NCT05525351|Sensory System Agents|sensory system agents|mesh-ancestor
55800031|NCT05525351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800032|NCT05525351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55800033|NCT05525351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55800034|NCT05525351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55800035|NCT05525351|Adrenergic Agents|adrenergic agents|mesh-ancestor
55800036|NCT05525351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800037|NCT05525351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800038|NCT05525351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55800039|NCT05525351|Narcotics|narcotics|mesh-ancestor
55800040|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
55800041|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800042|NCT05521763|Vaccines|vaccines|mesh-list
55800043|NCT05521763|Immunologic Factors|immunologic factors|mesh-ancestor
55933725|NCT02943057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933727|NCT03581903|Immunologic Factors|immunologic factors|mesh-ancestor
55933728|NCT03581903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933729|NCT02783547|Azacitidine|azacitidine|mesh-list
55933730|NCT02783547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55933731|NCT02783547|Antimetabolites|antimetabolites|mesh-ancestor
55933732|NCT02783547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933733|NCT02783547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933734|NCT02783547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933735|NCT02555007|Vinorelbine|vinorelbine|mesh-list
55933736|NCT02555007|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55933737|NCT02555007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933738|NCT02555007|Tubulin Modulators|tubulin modulators|mesh-ancestor
55933739|NCT02555007|Antimitotic Agents|antimitotic agents|mesh-ancestor
55933742|NCT03898037|Metformin|metformin|mesh-list
55800044|NCT05521763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800045|NCT05100017|Methocarbamol|methocarbamol|mesh-list
55800046|NCT05100017|Oxybutynin|oxybutynin|mesh-list
55800047|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
55800048|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
55800049|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800050|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800051|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55800052|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55800070|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55800071|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55933744|NCT03898037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933745|NCT02381535|Cisplatin|cisplatin|mesh-list
55933746|NCT02381535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933748|NCT03897881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55933749|NCT03897881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933750|NCT03617718|Glycine|glycine|mesh-list
55933751|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
55933752|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933753|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933754|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933755|NCT04982874|Furosemide|furosemide|mesh-list
55933756|NCT04982874|Diuretics|diuretics|mesh-ancestor
55933757|NCT04982874|Natriuretic Agents|natriuretic agents|mesh-ancestor
55933758|NCT04982874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933759|NCT04982874|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55933760|NCT04982874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55933761|NCT04982874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933762|NCT03584711|Panitumumab|panitumumab|mesh-list
55800073|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800075|NCT04876807|Omeprazole|omeprazole|mesh-list
55800076|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55800077|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55800078|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55800079|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933763|NCT03584711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55933764|NCT03584711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933765|NCT05301192|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
55933766|NCT05301192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55933767|NCT05301192|Vasodilator Agents|vasodilator agents|mesh-ancestor
55933768|NCT03897491|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55800080|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800081|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800082|NCT05518409|Donepezil|donepezil|mesh-list
55800083|NCT05518409|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55800084|NCT05518409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800085|NCT05518409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800086|NCT05518409|Cholinergic Agents|cholinergic agents|mesh-ancestor
55800087|NCT05518409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800088|NCT05518409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800089|NCT05518409|Nootropic Agents|nootropic agents|mesh-ancestor
55800090|NCT04876573|Cyproheptadine|cyproheptadine|mesh-list
55800091|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
55800092|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
55800093|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55800094|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55800095|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
55800096|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
55800097|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800098|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800099|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800100|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55800101|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
55800102|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55800103|NCT05092451|Cyclophosphamide|cyclophosphamide|mesh-list
55800104|NCT05092451|Fludarabine|fludarabine|mesh-list
55800105|NCT05092451|Fludarabine phosphate|fludarabine phosphate|mesh-list
55800106|NCT05092451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800107|NCT05092451|Immunologic Factors|immunologic factors|mesh-ancestor
55800108|NCT05092451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800109|NCT05092451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800110|NCT05092451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55800111|NCT05092451|Alkylating Agents|alkylating agents|mesh-ancestor
55800112|NCT05092451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800113|NCT05092451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800114|NCT05092451|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55933769|NCT03897491|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55933770|NCT03897491|Dermatologic Agents|dermatologic agents|mesh-ancestor
55933771|NCT03068208|Methylene Blue|methylene blue|mesh-list
55933772|NCT03068208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933773|NCT03068208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933774|NCT03067974|Ketamine|ketamine|mesh-list
55933775|NCT03067974|Analgesics|analgesics|mesh-ancestor
55933776|NCT03067974|Sensory System Agents|sensory system agents|mesh-ancestor
55800115|NCT05092451|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55800117|NCT04864717|Doxycycline|doxycycline|mesh-list
55800118|NCT04864717|Isotretinoin|isotretinoin|mesh-list
55800119|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55800120|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800121|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
55800122|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55800123|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55800124|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
55800125|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
55933777|NCT03067974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933778|NCT03067974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933779|NCT03067974|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55933780|NCT03067974|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55800128|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800129|NCT04876261|Protective Agents|protective agents|mesh-ancestor
55800130|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800131|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55800133|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55800134|NCT02613871|Ledipasvir|ledipasvir|mesh-list
55800135|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
55800136|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800137|NCT04869709|Betamethasone|betamethasone|mesh-list
55800138|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
55800139|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55800141|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55800142|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55800143|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
55800144|NCT04869709|Hormones|hormones|mesh-ancestor
55800145|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800146|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800147|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55800148|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
55800149|NCT02612077|Bevacizumab|bevacizumab|mesh-list
55800150|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800151|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800152|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55800153|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55800154|NCT02612077|Growth Substances|growth substances|mesh-ancestor
55800155|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800156|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
55800157|NCT04622735|Acetaminophen|acetaminophen|mesh-list
55800158|NCT04622735|Nefopam|nefopam|mesh-list
55800159|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55800160|NCT04622735|Analgesics|analgesics|mesh-ancestor
55800168|NCT05531591|Nortriptyline|nortriptyline|mesh-list
55800169|NCT05531591|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55800170|NCT05531591|Antidepressive Agents|antidepressive agents|mesh-ancestor
55800171|NCT05531591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55800172|NCT05531591|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55800184|NCT05531591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800185|NCT05531591|Dopamine Agonists|dopamine agonists|mesh-ancestor
55800186|NCT05531591|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55800187|NCT05531591|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55800188|NCT05531591|Serotonin Agents|serotonin agents|mesh-ancestor
55800189|NCT05531591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55800190|NCT05531591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55800191|NCT05531591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55800192|NCT05531591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55800193|NCT05531591|Antimanic Agents|antimanic agents|mesh-ancestor
55800194|NCT05531591|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55933781|NCT03067974|Anesthetics, General|anesthetics, general|mesh-ancestor
55933782|NCT03067974|Anesthetics|anesthetics|mesh-ancestor
55933783|NCT03067974|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55933784|NCT03067974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55933785|NCT03067974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55933786|NCT03067974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55933787|NCT03067974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800196|NCT05531591|Adrenergic Agents|adrenergic agents|mesh-ancestor
55800197|NCT05060549|Cariprazine|cariprazine|mesh-list
55800198|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55800200|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800201|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800202|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55800203|NCT05048615|Itraconazole|itraconazole|mesh-list
55800204|NCT05048615|Azacitidine|azacitidine|mesh-list
55800206|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55800207|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
55800208|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800209|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800210|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800211|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
55800212|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933938|NCT05730036|Elotuzumab|elotuzumab|mesh-list
55800213|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55800214|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55800215|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55800216|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
55800217|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800219|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55800221|NCT05531435|Anesthetics, Local|anesthetics, local|mesh-list
55800222|NCT05531435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800223|NCT05531435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800224|NCT05531435|Sensory System Agents|sensory system agents|mesh-ancestor
55800225|NCT05531435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800226|NCT05517239|Gemcitabine|gemcitabine|mesh-list
55800227|NCT05517239|Oxaliplatin|oxaliplatin|mesh-list
55800228|NCT05517239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55800229|NCT05517239|Antimetabolites|antimetabolites|mesh-ancestor
55800230|NCT05517239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800231|NCT05517239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800232|NCT05517239|Antiviral Agents|antiviral agents|mesh-ancestor
55800233|NCT05517239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800234|NCT05517239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800235|NCT05517239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800236|NCT05517239|Immunologic Factors|immunologic factors|mesh-ancestor
55800237|NCT05517239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800238|NCT05519813|Metformin|metformin|mesh-list
55933788|NCT05104866|Gemcitabine|gemcitabine|mesh-list
55933789|NCT05104866|Capecitabine|capecitabine|mesh-list
55933790|NCT05104866|Vinorelbine|vinorelbine|mesh-list
55933791|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55933792|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
55933793|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933794|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800245|NCT05519579|Abortifacient Agents|abortifacient agents|mesh-ancestor
55800246|NCT05519579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55800247|NCT05519579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800248|NCT05519579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55800249|NCT05519579|Antimetabolites|antimetabolites|mesh-ancestor
55800250|NCT05519579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800251|NCT05519579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800252|NCT05519579|Dermatologic Agents|dermatologic agents|mesh-ancestor
55800253|NCT05519579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800254|NCT05519579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55800255|NCT05519579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800256|NCT05519579|Immunologic Factors|immunologic factors|mesh-ancestor
55800257|NCT05519579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800258|NCT05519579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55800259|NCT05516849|Oxandrolone|oxandrolone|mesh-list
55800260|NCT05516849|Androgens|androgens|mesh-ancestor
55800261|NCT05516849|Hormones|hormones|mesh-ancestor
55933796|NCT05104866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933798|NCT05104866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55933799|NCT05104866|Immunologic Factors|immunologic factors|mesh-ancestor
55933800|NCT05104866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933801|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55933802|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
55933803|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
55933804|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
55933805|NCT03573401|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55800262|NCT05516849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800263|NCT05516849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800264|NCT05516849|Anabolic Agents|anabolic agents|mesh-ancestor
55800266|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
55800267|NCT02613403|Antimetabolites|antimetabolites|mesh-ancestor
55800268|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800269|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
55800279|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800280|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800281|NCT05519111|Dronabinol|dronabinol|mesh-list
55800282|NCT05519111|Hallucinogens|hallucinogens|mesh-ancestor
55800283|NCT05519111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800284|NCT05519111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55800285|NCT05519111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55800286|NCT05519111|Analgesics|analgesics|mesh-ancestor
55800287|NCT05519111|Sensory System Agents|sensory system agents|mesh-ancestor
55800288|NCT05519111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800289|NCT05519111|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55933806|NCT03573401|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55933807|NCT03573401|Dermatologic Agents|dermatologic agents|mesh-ancestor
55933808|NCT03582137|Cannabidiol|cannabidiol|mesh-list
55933809|NCT03582137|Anticonvulsants|anticonvulsants|mesh-ancestor
55933810|NCT04405193|Acetylcysteine|acetylcysteine|mesh-list
55933811|NCT04405193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55933812|NCT04405193|Antiviral Agents|antiviral agents|mesh-ancestor
55800290|NCT05519111|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55800291|NCT05519111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800292|NCT05519111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933813|NCT04405193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933815|NCT04405193|Respiratory System Agents|respiratory system agents|mesh-ancestor
55933816|NCT04405193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55933817|NCT04405193|Antioxidants|antioxidants|mesh-ancestor
55933818|NCT04405193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800293|NCT05519111|Hormones|hormones|mesh-ancestor
55800307|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
55800308|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55800309|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55800310|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800311|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800312|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800313|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800314|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
55800315|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55800316|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55800317|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800318|NCT03044041|Hemostatics|hemostatics|mesh-ancestor
55800319|NCT03044041|Coagulants|coagulants|mesh-ancestor
55800320|NCT05518799|Midazolam|midazolam|mesh-list
55800321|NCT05518799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55800322|NCT05518799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55800323|NCT05518799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800324|NCT05518799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800325|NCT05518799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55800326|NCT05518799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55800327|NCT05518799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55800328|NCT05518799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55800329|NCT05518799|Anesthetics, General|anesthetics, general|mesh-ancestor
55800330|NCT05518799|Anesthetics|anesthetics|mesh-ancestor
55800331|NCT05518799|GABA Modulators|gaba modulators|mesh-ancestor
55800332|NCT05518799|GABA Agents|gaba agents|mesh-ancestor
55800333|NCT05518799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800334|NCT05518799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800335|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55800336|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55800337|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800338|NCT05516303|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55800339|NCT05516303|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55800340|NCT05516303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800341|NCT05516303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800342|NCT05516303|Immunologic Factors|immunologic factors|mesh-ancestor
55800343|NCT05516303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800344|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
55800345|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800346|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800347|NCT05512325|Bevacizumab|bevacizumab|mesh-list
55933819|NCT04405193|Protective Agents|protective agents|mesh-ancestor
55933820|NCT04405193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933822|NCT05227833|Pantoprazole|pantoprazole|mesh-list
55933823|NCT05227833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55933824|NCT05227833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55933825|NCT05227833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55933826|NCT05227833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933827|NCT05227833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933829|NCT05083299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55933830|NCT05083299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55933831|NCT05083299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933832|NCT05083299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55933833|NCT05083299|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55933834|NCT05083299|Serotonin Agents|serotonin agents|mesh-ancestor
55933835|NCT05083299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794749|NCT02633059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933836|NCT05083299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933837|NCT05701475|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55933838|NCT05701475|Dermatologic Agents|dermatologic agents|mesh-ancestor
55933839|NCT03035253|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55933840|NCT03035253|Immunologic Factors|immunologic factors|mesh-ancestor
55933841|NCT03035253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933842|NCT04405271|Tenofovir|tenofovir|mesh-list
55933843|NCT04405271|Emtricitabine|emtricitabine|mesh-list
55933844|NCT04405271|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
55933845|NCT04405271|Antiviral Agents|antiviral agents|mesh-ancestor
55933846|NCT04405271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55933847|NCT04405271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55800348|NCT05512325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800349|NCT05512325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800350|NCT05512325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55933848|NCT04405271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55933849|NCT04405271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933850|NCT04405271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933851|NCT04405271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55933852|NCT04405271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55933853|NCT03034941|Metformin|metformin|mesh-list
55933854|NCT03034941|Liraglutide|liraglutide|mesh-list
55800351|NCT05512325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55800352|NCT05512325|Growth Substances|growth substances|mesh-ancestor
55800353|NCT05512325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800354|NCT05512325|Growth Inhibitors|growth inhibitors|mesh-ancestor
55933855|NCT03034941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55933856|NCT03034941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933857|NCT03034941|Incretins|incretins|mesh-ancestor
55933858|NCT03034941|Hormones|hormones|mesh-ancestor
55933859|NCT03034941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933860|NCT03030105|Scopolamine|scopolamine|mesh-list
55933861|NCT03030105|Donepezil|donepezil|mesh-list
55933862|NCT03030105|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55800356|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
55800358|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
55800359|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800360|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55800361|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55800362|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55800366|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55800367|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800368|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55800369|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55800370|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55933863|NCT03030105|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55933864|NCT03030105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55933865|NCT03030105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55933866|NCT03030105|Cholinergic Agents|cholinergic agents|mesh-ancestor
55933867|NCT03030105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800371|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55800372|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
55800373|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800374|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800376|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55800377|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800378|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800379|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
55800380|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800381|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800382|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55800395|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55800396|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55800397|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55800398|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800399|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55933868|NCT03030105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933869|NCT03030105|Nootropic Agents|nootropic agents|mesh-ancestor
55933870|NCT03030105|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55933871|NCT03030105|Antiemetics|antiemetics|mesh-ancestor
55933872|NCT03030105|Autonomic Agents|autonomic agents|mesh-ancestor
55933873|NCT03030105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933906|NCT03034707|Vitamins|vitamins|mesh-ancestor
55933937|NCT05730036|Pomalidomide|pomalidomide|mesh-list
55933939|NCT05730036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55933940|NCT05730036|Antiemetics|antiemetics|mesh-ancestor
55933941|NCT05730036|Autonomic Agents|autonomic agents|mesh-ancestor
55933942|NCT05730036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55933943|NCT05730036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55933944|NCT05730036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55933945|NCT05730036|Glucocorticoids|glucocorticoids|mesh-ancestor
55933946|NCT05730036|Hormones|hormones|mesh-ancestor
55933947|NCT05730036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55933948|NCT05730036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55933949|NCT05730036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55933950|NCT05730036|Immunologic Factors|immunologic factors|mesh-ancestor
55933951|NCT05730036|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55933952|NCT05730036|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55933953|NCT05730036|Growth Substances|growth substances|mesh-ancestor
55933954|NCT05730036|Growth Inhibitors|growth inhibitors|mesh-ancestor
55933958|NCT03068832|Poly I-C|poly i-c|mesh-list
55933995|NCT03033537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55934067|NCT01672151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55934068|NCT01672151|Immunologic Factors|immunologic factors|mesh-ancestor
55934069|NCT01672151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934070|NCT05729646|Oxaliplatin|oxaliplatin|mesh-list
55934071|NCT05729646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934072|NCT01672229|Bortezomib|bortezomib|mesh-list
55934073|NCT01672229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934074|NCT01672307|Minoxidil|minoxidil|mesh-list
55934075|NCT01672307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55934076|NCT01672307|Vasodilator Agents|vasodilator agents|mesh-ancestor
55934077|NCT03067194|Celecoxib|celecoxib|mesh-list
55934078|NCT03067194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55934079|NCT03067194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55934080|NCT03067194|Analgesics|analgesics|mesh-ancestor
55934081|NCT03067194|Sensory System Agents|sensory system agents|mesh-ancestor
55934082|NCT03067194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934083|NCT03067194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934084|NCT03067194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55934085|NCT03067194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934087|NCT03067194|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55934088|NCT03067194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934089|NCT03067194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934090|NCT05629494|Ibuprofen|ibuprofen|mesh-list
55934091|NCT05629494|Naproxen|naproxen|mesh-list
55934092|NCT05629494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55934093|NCT05629494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55934094|NCT05629494|Analgesics|analgesics|mesh-ancestor
55934095|NCT05629494|Sensory System Agents|sensory system agents|mesh-ancestor
55934096|NCT05629494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934097|NCT05629494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934098|NCT05629494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55934109|NCT00952653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934110|NCT00952653|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55934111|NCT00952653|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55934112|NCT00952653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55934113|NCT00952653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55934114|NCT00952653|Anesthetics, General|anesthetics, general|mesh-ancestor
55934115|NCT00952653|Anesthetics|anesthetics|mesh-ancestor
55934116|NCT00952653|GABA Modulators|gaba modulators|mesh-ancestor
55934174|NCT04404881|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55934183|NCT01674257|Hematinics|hematinics|mesh-ancestor
55934247|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934249|NCT01675895|Levobupivacaine|levobupivacaine|mesh-list
55934250|NCT01675895|Anesthetics|anesthetics|mesh-list
55934251|NCT01675895|Anesthetics, Local|anesthetics, local|mesh-ancestor
55934252|NCT01675895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934261|NCT01675973|Ranolazine|ranolazine|mesh-list
55934315|NCT01676363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934316|NCT01676363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934317|NCT00956709|Ropivacaine|ropivacaine|mesh-list
55934318|NCT00956709|Levobupivacaine|levobupivacaine|mesh-list
55934319|NCT00956709|Anesthetics, Local|anesthetics, local|mesh-ancestor
55934385|NCT04422431|Growth Substances|growth substances|mesh-ancestor
55934386|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934387|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
55934388|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934390|NCT04265651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934391|NCT04055753|Doxorubicin|doxorubicin|mesh-list
55934392|NCT04055753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55934393|NCT04055753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934394|NCT04055753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55934395|NCT04055753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55934396|NCT04055753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934448|NCT00961233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55934449|NCT00961233|Autonomic Agents|autonomic agents|mesh-ancestor
55934450|NCT00961233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934451|NCT00961233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934454|NCT00961233|Glucocorticoids|glucocorticoids|mesh-ancestor
55934520|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55934521|NCT01695941|Rituximab|rituximab|mesh-list
55934522|NCT01695941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55934523|NCT01695941|Bortezomib|bortezomib|mesh-list
55934524|NCT01695941|Antibodies|antibodies|mesh-list
55934525|NCT01695941|Immunoglobulins|immunoglobulins|mesh-list
55934526|NCT01695941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55934589|NCT02633046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934591|NCT01676597|Pentoxifylline|pentoxifylline|mesh-list
55934592|NCT01676597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55934593|NCT01676597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934594|NCT01676597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55934595|NCT01676597|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55934596|NCT01676597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934597|NCT01676597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934598|NCT01676597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55934599|NCT01676597|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55934600|NCT01676597|Protective Agents|protective agents|mesh-ancestor
55934601|NCT01676597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934602|NCT01676597|Vasodilator Agents|vasodilator agents|mesh-ancestor
55934603|NCT01676597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55934604|NCT01676597|Antioxidants|antioxidants|mesh-ancestor
55934605|NCT04374630|Paclitaxel|paclitaxel|mesh-list
55934606|NCT04374630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55934607|NCT04374630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934608|NCT04374630|Tubulin Modulators|tubulin modulators|mesh-ancestor
55934609|NCT04374630|Antimitotic Agents|antimitotic agents|mesh-ancestor
55934610|NCT04374630|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934611|NCT04374630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934615|NCT04364802|Iodine|iodine|mesh-list
55934642|NCT05491278|Narcotics|narcotics|mesh-ancestor
55934643|NCT05491278|Analgesics|analgesics|mesh-ancestor
55934644|NCT05491278|Sensory System Agents|sensory system agents|mesh-ancestor
55934645|NCT05491278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55934718|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55934719|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55934791|NCT03914742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934792|NCT03914742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934793|NCT03914742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934794|NCT03065868|Clarithromycin|clarithromycin|mesh-list
55934796|NCT03065868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55934797|NCT03065868|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55934798|NCT03065868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144597|NCT00801138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934799|NCT03065868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934852|NCT03824483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55934853|NCT03824483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934854|NCT03824483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934856|NCT03814109|Indapamide|indapamide|mesh-list
55934926|NCT00964431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55934927|NCT00964431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934928|NCT00964431|Gout Suppressants|gout suppressants|mesh-ancestor
55934929|NCT00964431|Tocolytic Agents|tocolytic agents|mesh-ancestor
55934930|NCT00964431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55934931|NCT05475054|Liver Extracts|liver extracts|mesh-list
55934932|NCT05475054|Hematinics|hematinics|mesh-ancestor
55934933|NCT01017003|Colchicine|colchicine|mesh-list
55934934|NCT01017003|Gout Suppressants|gout suppressants|mesh-ancestor
55934935|NCT01017003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55934936|NCT01017003|Tubulin Modulators|tubulin modulators|mesh-ancestor
55934937|NCT01017003|Antimitotic Agents|antimitotic agents|mesh-ancestor
55934938|NCT01017003|Mitosis Modulators|mitosis modulators|mesh-ancestor
55934939|NCT01017003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55934940|NCT01017003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55934941|NCT01017237|Midazolam|midazolam|mesh-list
55934942|NCT01017237|Dexmedetomidine|dexmedetomidine|mesh-list
55934943|NCT01017237|Ketamine|ketamine|mesh-list
55934944|NCT01017237|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55934945|NCT01017237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55934984|NCT03788759|Protective Agents|protective agents|mesh-ancestor
55934985|NCT03788759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55934986|NCT03788759|Vitamin B Complex|vitamin b complex|mesh-ancestor
55934987|NCT03788759|Vitamins|vitamins|mesh-ancestor
55934988|NCT03788759|Micronutrients|micronutrients|mesh-ancestor
55934990|NCT00967551|Trace Elements|trace elements|mesh-list
55934991|NCT00967551|Micronutrients|micronutrients|mesh-list
55935055|NCT02246049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55935056|NCT02246049|Antimetabolites|antimetabolites|mesh-ancestor
55935057|NCT02246049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935058|NCT02246049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935059|NCT02246049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935064|NCT02246049|Antidotes|antidotes|mesh-ancestor
55935126|NCT02083679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55935127|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55935128|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55935129|NCT03769025|Narcotics|narcotics|mesh-ancestor
55935130|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55935198|NCT00976521|Anticoagulants|anticoagulants|mesh-ancestor
55935199|NCT00976521|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55935200|NCT04410588|Fentanyl|fentanyl|mesh-list
55935269|NCT03738917|Respiratory System Agents|respiratory system agents|mesh-ancestor
55935276|NCT03738917|Autonomic Agents|autonomic agents|mesh-ancestor
55935344|NCT03727061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935345|NCT03727061|Immunologic Factors|immunologic factors|mesh-ancestor
55935420|NCT03719105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55935422|NCT03719105|Alkylating Agents|alkylating agents|mesh-ancestor
55935493|NCT03709043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55935494|NCT03709043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55935495|NCT03709043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935565|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55935639|NCT03675737|Antimetabolites|antimetabolites|mesh-ancestor
55935640|NCT03675737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935641|NCT03675737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55935642|NCT03675737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935643|NCT03675737|Immunologic Factors|immunologic factors|mesh-ancestor
55935644|NCT03675737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935646|NCT00981825|Triclosan|triclosan|mesh-list
55935647|NCT00981825|Fluorides|fluorides|mesh-list
55935648|NCT00981825|Sodium Fluoride|sodium fluoride|mesh-list
55935649|NCT00981825|Cariostatic Agents|cariostatic agents|mesh-ancestor
55935650|NCT00981825|Protective Agents|protective agents|mesh-ancestor
55935703|NCT00983541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55935704|NCT00983541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55935777|NCT04762901|Carboplatin|carboplatin|mesh-list
55935778|NCT04762901|Doxorubicin|doxorubicin|mesh-list
55935779|NCT04762901|Niraparib|niraparib|mesh-list
55935780|NCT04762901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55935849|NCT00989157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55935850|NCT00989157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935851|NCT00989157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935852|NCT00989157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935921|NCT02394834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55935922|NCT02394834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55935923|NCT02394834|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55935924|NCT02394834|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55935926|NCT02394834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935927|NCT02394834|Growth Inhibitors|growth inhibitors|mesh-ancestor
55935928|NCT02394834|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55935929|NCT02394834|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55935930|NCT02394834|Antimetabolites|antimetabolites|mesh-ancestor
55935938|NCT02394834|Vitamins|vitamins|mesh-ancestor
55935983|NCT05576207|Micronutrients|micronutrients|mesh-list
55935984|NCT05576207|Trace Elements|trace elements|mesh-list
55935985|NCT05576207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935986|NCT04294134|6-chloro-2-(1-piperazinyl)pyrazine|6-chloro-2-(1-piperazinyl)pyrazine|mesh-list
55935987|NCT04294134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55935988|NCT04294134|Serotonin Agents|serotonin agents|mesh-ancestor
55935989|NCT04294134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55935990|NCT04294134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55935991|NCT04294134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55935995|NCT04437888|Ketamine|ketamine|mesh-list
55935996|NCT04437888|Analgesics|analgesics|mesh-ancestor
55935997|NCT04437888|Sensory System Agents|sensory system agents|mesh-ancestor
55935998|NCT04437888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55935999|NCT04437888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936000|NCT04437888|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55936001|NCT04437888|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55936002|NCT04437888|Anesthetics, General|anesthetics, general|mesh-ancestor
55936003|NCT04437888|Anesthetics|anesthetics|mesh-ancestor
55936040|NCT00991809|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55936115|NCT04374903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936116|NCT04374903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55936125|NCT00995475|Xhance|xhance|mesh-list
55936189|NCT04981704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55936191|NCT04981704|Anticonvulsants|anticonvulsants|mesh-ancestor
55936262|NCT00998205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936263|NCT00998205|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55936335|NCT01024335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55936336|NCT01001559|Norepinephrine|norepinephrine|mesh-list
55936337|NCT01001559|Serotonin|serotonin|mesh-list
55936341|NCT01001559|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55936404|NCT01004991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55936405|NCT01004991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55936406|NCT01004991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936474|NCT01050153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55936475|NCT01050153|Analgesics|analgesics|mesh-ancestor
55936549|NCT01053819|Sensory System Agents|sensory system agents|mesh-ancestor
55936552|NCT01053819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55936772|NCT01076283|GABA Agents|gaba agents|mesh-ancestor
55936773|NCT01076283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936774|NCT01076283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55936775|NCT01076283|Antipruritics|antipruritics|mesh-ancestor
55936776|NCT01076283|Dermatologic Agents|dermatologic agents|mesh-ancestor
55936777|NCT01076283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55936780|NCT01076283|Histamine Agents|histamine agents|mesh-ancestor
55936839|NCT01077921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55936912|NCT01081041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55936913|NCT01081041|Antimetabolites|antimetabolites|mesh-ancestor
55936982|NCT04730531|Anesthetics|anesthetics|mesh-ancestor
55936983|NCT04730531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55936984|NCT04730531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55936985|NCT04730531|Sensory System Agents|sensory system agents|mesh-ancestor
55936986|NCT04730531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55936987|NCT04730531|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55936988|NCT04730531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55936989|NCT04730531|Adrenergic Agents|adrenergic agents|mesh-ancestor
55936990|NCT04730531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55936991|NCT04730531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937044|NCT01096875|Antimetabolites|antimetabolites|mesh-ancestor
55937045|NCT01096875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144599|NCT00801138|Glucocorticoids|glucocorticoids|mesh-ancestor
55937114|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55937120|NCT03152981|Remifentanil|remifentanil|mesh-list
55937190|NCT01101867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55937266|NCT01110135|Etoposide phosphate|etoposide phosphate|mesh-list
55937267|NCT01110135|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55937339|NCT01114503|Antiemetics|antiemetics|mesh-ancestor
55937340|NCT01114503|Autonomic Agents|autonomic agents|mesh-ancestor
55937341|NCT01114503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937342|NCT01114503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937411|NCT01044693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937412|NCT01044693|Urological Agents|urological agents|mesh-ancestor
55937413|NCT01044693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55937414|NCT01044693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55937415|NCT01044693|Sympatholytics|sympatholytics|mesh-ancestor
55937479|NCT04582383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55937480|NCT04582383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937481|NCT04582383|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55937482|NCT04582383|Diuretics|diuretics|mesh-ancestor
55937549|NCT01162551|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55937550|NCT01162551|Antifungal Agents|antifungal agents|mesh-ancestor
55937551|NCT01163097|Heparin|heparin|mesh-list
55937621|NCT01176435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937622|NCT01176435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937623|NCT01176435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55937693|NCT01183533|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55937768|NCT03565835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55937769|NCT03565835|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55937770|NCT03565835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55937771|NCT03565835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937838|NCT02079077|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55937913|NCT03529487|Sympathomimetics|sympathomimetics|mesh-ancestor
55937914|NCT03529487|Autonomic Agents|autonomic agents|mesh-ancestor
55937915|NCT03529487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55937916|NCT03529487|Nasal Decongestants|nasal decongestants|mesh-ancestor
55937917|NCT03529487|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55937918|NCT03529487|Respiratory System Agents|respiratory system agents|mesh-ancestor
55937919|NCT03529487|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55937920|NCT03529487|Mydriatics|mydriatics|mesh-ancestor
55937921|NCT03529487|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55937922|NCT03529487|Protective Agents|protective agents|mesh-ancestor
55937923|NCT03527927|Muscarinic Antagonists|muscarinic antagonists|mesh-list
55937924|NCT03527927|Cholinergic Agents|cholinergic agents|mesh-ancestor
55937925|NCT03527927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55937926|NCT03527927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55937927|NCT03527927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938044|NCT01195467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938143|NCT03485417|Antidepressive Agents|antidepressive agents|mesh-ancestor
55938144|NCT03485417|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55938214|NCT00088595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938289|NCT01201863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55938362|NCT04270175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55938435|NCT01679795|Anabolic Agents|anabolic agents|mesh-ancestor
55938436|NCT01679795|Hormones|hormones|mesh-ancestor
55938437|NCT01206465|Fluorouracil|fluorouracil|mesh-list
55938438|NCT01206465|Antimetabolites|antimetabolites|mesh-ancestor
55938445|NCT01207401|Lidocaine|lidocaine|mesh-list
55938506|NCT01209195|Paclitaxel|paclitaxel|mesh-list
55938507|NCT01209195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55938508|NCT01209195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938509|NCT01209195|Tubulin Modulators|tubulin modulators|mesh-ancestor
55938510|NCT01209195|Antimitotic Agents|antimitotic agents|mesh-ancestor
55938511|NCT01209195|Mitosis Modulators|mitosis modulators|mesh-ancestor
55938512|NCT01209195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938513|NCT03084809|Leucovorin|leucovorin|mesh-list
55938514|NCT03084809|Oxaliplatin|oxaliplatin|mesh-list
55938515|NCT03084809|Fluorouracil|fluorouracil|mesh-list
55938516|NCT03084809|Levoleucovorin|levoleucovorin|mesh-list
55938517|NCT03084809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55938518|NCT03084809|Antidotes|antidotes|mesh-ancestor
55938519|NCT03084809|Protective Agents|protective agents|mesh-ancestor
55938520|NCT03084809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938521|NCT03084809|Vitamin B Complex|vitamin b complex|mesh-ancestor
55938569|NCT03084419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938642|NCT00083915|Growth Substances|growth substances|mesh-ancestor
55938643|NCT00083915|Growth Inhibitors|growth inhibitors|mesh-ancestor
55938714|NCT03011463|Autonomic Agents|autonomic agents|mesh-ancestor
55938718|NCT03011463|Cholinergic Agents|cholinergic agents|mesh-ancestor
55938789|NCT05685407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55938790|NCT05685407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55938791|NCT05685407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55938792|NCT05685407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55938793|NCT05685407|Purinergic Agents|purinergic agents|mesh-ancestor
55938794|NCT05685407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55938795|NCT04761029|Tramadol|tramadol|mesh-list
55938796|NCT04761029|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55938797|NCT04761029|Narcotics|narcotics|mesh-ancestor
55938798|NCT04761029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55938799|NCT04761029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55938852|NCT05687123|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55938854|NCT04400747|Cholecalciferol|cholecalciferol|mesh-list
55938924|NCT05685719|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55938925|NCT05685719|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55939072|NCT01225263|Vitamin D|vitamin d|mesh-list
55939143|NCT04989413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939145|NCT04989413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55939146|NCT04989413|Analgesics|analgesics|mesh-ancestor
55939147|NCT04989413|Sensory System Agents|sensory system agents|mesh-ancestor
55939148|NCT04989413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939149|NCT04989413|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55939150|NCT04989413|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55939208|NCT01230177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55939209|NCT01230177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939210|NCT01230177|Immunologic Factors|immunologic factors|mesh-ancestor
55939211|NCT02984657|Anesthetics|anesthetics|mesh-list
55939212|NCT02984657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55939213|NCT02984657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939214|NCT01158651|Everolimus|everolimus|mesh-list
55939215|NCT01158651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939216|NCT01158651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939217|NCT01158651|Immunologic Factors|immunologic factors|mesh-ancestor
55939218|NCT01158651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939219|NCT04852679|Lanreotide|lanreotide|mesh-list
55939271|NCT04731467|Antimitotic Agents|antimitotic agents|mesh-ancestor
55939272|NCT04731467|Mitosis Modulators|mitosis modulators|mesh-ancestor
55939275|NCT04731467|Antimetabolites|antimetabolites|mesh-ancestor
55939347|NCT04584125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939353|NCT04348409|Nitazoxanide|nitazoxanide|mesh-list
55939425|NCT01237353|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55939426|NCT01237353|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55939427|NCT01237353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939428|NCT01237353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939429|NCT01237353|Lipotropic Agents|lipotropic agents|mesh-ancestor
55939430|NCT01237353|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55939431|NCT01237353|Antimetabolites|antimetabolites|mesh-ancestor
55939432|NCT01237353|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55939434|NCT03634241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55939435|NCT03634241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939436|NCT04410341|Vildagliptin|vildagliptin|mesh-list
55939437|NCT04410341|Citalopram|citalopram|mesh-list
55939438|NCT04410341|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55939442|NCT04410341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939484|NCT04354649|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55939485|NCT04354649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55939486|NCT04354649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939487|NCT04354649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939488|NCT04354649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55939489|NCT01244451|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55939490|NCT01244451|Ofatumumab|ofatumumab|mesh-list
55939491|NCT01244451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55939492|NCT01244451|Alkylating Agents|alkylating agents|mesh-ancestor
55939493|NCT01244451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939494|NCT01244451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939495|NCT05632211|Golimumab|golimumab|mesh-list
55939496|NCT05632211|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55939497|NCT05632211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55939498|NCT05632211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939499|NCT05632211|Immunologic Factors|immunologic factors|mesh-ancestor
55939500|NCT05632211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939501|NCT01246401|Naltrexone|naltrexone|mesh-list
55939502|NCT01246401|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55939503|NCT01246401|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55939504|NCT01246401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939505|NCT01246401|Sensory System Agents|sensory system agents|mesh-ancestor
55939506|NCT01246401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939507|NCT05627375|Anticoagulants|anticoagulants|mesh-list
55939508|NCT01281501|Scopolamine|scopolamine|mesh-list
55939509|NCT01281501|Pantoprazole|pantoprazole|mesh-list
55939510|NCT01281501|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
55939533|NCT03353831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55939534|NCT03353831|Growth Substances|growth substances|mesh-ancestor
55939535|NCT03353831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939536|NCT03353831|Growth Inhibitors|growth inhibitors|mesh-ancestor
55939537|NCT01246713|Acetaminophen|acetaminophen|mesh-list
55939538|NCT01246713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55939539|NCT01246713|Analgesics|analgesics|mesh-ancestor
55939540|NCT01246713|Sensory System Agents|sensory system agents|mesh-ancestor
55939541|NCT01246713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939542|NCT01246713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939543|NCT01246713|Antipyretics|antipyretics|mesh-ancestor
55939544|NCT01246791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55939545|NCT01246791|Norethindrone|norethindrone|mesh-list
55939546|NCT01246791|Norinyl|norinyl|mesh-list
55939547|NCT01246791|Estradiol|estradiol|mesh-list
55939548|NCT01246791|Estrogens|estrogens|mesh-ancestor
55939549|NCT01246791|Hormones|hormones|mesh-ancestor
55939550|NCT01246791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55939551|NCT01246791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939769|NCT01289457|Cytarabine|cytarabine|mesh-list
55939552|NCT01246791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55939553|NCT01246791|Contraceptive Agents|contraceptive agents|mesh-ancestor
55939554|NCT01246791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55939555|NCT01246791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55939556|NCT01246791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55939560|NCT05345639|Ropivacaine|ropivacaine|mesh-list
55939586|NCT04248335|GABA Agents|gaba agents|mesh-ancestor
55939587|NCT04248335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55939588|NCT04248335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939589|NCT04248335|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55939590|NCT04248335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55939591|NCT04248335|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55939592|NCT04248335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939593|NCT04746209|Blinatumomab|blinatumomab|mesh-list
55939594|NCT04746209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939596|NCT04176419|Celecoxib|celecoxib|mesh-list
55939650|NCT01285635|Mitosis Modulators|mitosis modulators|mesh-ancestor
55939651|NCT01285635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939653|NCT01286259|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55939654|NCT01286259|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
55939655|NCT01286259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55939656|NCT01286259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939657|NCT01286805|Bupivacaine|bupivacaine|mesh-list
55939658|NCT01286805|Anesthetics, Local|anesthetics, local|mesh-ancestor
55939659|NCT01286805|Anesthetics|anesthetics|mesh-ancestor
55939660|NCT01286805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55939661|NCT01286805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939662|NCT01286805|Sensory System Agents|sensory system agents|mesh-ancestor
55939663|NCT01286805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939664|NCT01288521|Ketoconazole|ketoconazole|mesh-list
55939665|NCT01288521|Tacrolimus|tacrolimus|mesh-list
55939666|NCT01288521|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55939668|NCT01288521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939669|NCT01288521|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55939704|NCT00632359|Lenalidomide|lenalidomide|mesh-list
55939705|NCT00632359|Immunologic Factors|immunologic factors|mesh-ancestor
55939706|NCT00632359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939707|NCT00632359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55939708|NCT00632359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55939709|NCT00632359|Growth Substances|growth substances|mesh-ancestor
55939710|NCT00632359|Growth Inhibitors|growth inhibitors|mesh-ancestor
55939711|NCT00632359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939712|NCT03954899|Melatonin|melatonin|mesh-list
55939713|NCT03954899|Antioxidants|antioxidants|mesh-ancestor
55939714|NCT03954899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939715|NCT03954899|Protective Agents|protective agents|mesh-ancestor
55939716|NCT03954899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939717|NCT03954899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55939718|NCT03934307|Irbesartan|irbesartan|mesh-list
55939719|NCT03934307|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55939720|NCT03934307|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55939721|NCT03934307|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55939722|NCT03934307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939723|NCT03924635|Budesonide|budesonide|mesh-list
55939724|NCT03924635|Albuterol|albuterol|mesh-list
55939725|NCT03924635|Formoterol Fumarate|formoterol fumarate|mesh-list
55939726|NCT03924635|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55939727|NCT03924635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55939753|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
55939754|NCT03879629|Protective Agents|protective agents|mesh-ancestor
55939755|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55939756|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55939757|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55939758|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
55939759|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55939760|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55939761|NCT04398251|Febuxostat|febuxostat|mesh-list
55939762|NCT04398251|Gout Suppressants|gout suppressants|mesh-ancestor
55939763|NCT04398251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55939764|NCT00632203|Temozolomide|temozolomide|mesh-list
55939765|NCT00632203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55939766|NCT00632203|Alkylating Agents|alkylating agents|mesh-ancestor
55939767|NCT00632203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939768|NCT00632203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939773|NCT01289457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55939774|NCT01289457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55939775|NCT01289457|Antimetabolites|antimetabolites|mesh-ancestor
55939776|NCT01289457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939805|NCT01251315|Respiratory System Agents|respiratory system agents|mesh-ancestor
55939806|NCT01251315|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55939808|NCT01251315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55939809|NCT01251315|Protective Agents|protective agents|mesh-ancestor
55939810|NCT01251315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939876|NCT03253133|Narcotics|narcotics|mesh-ancestor
55939877|NCT03253133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55939878|NCT03253133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939879|NCT03253133|Analgesics|analgesics|mesh-ancestor
55939880|NCT03253133|Sensory System Agents|sensory system agents|mesh-ancestor
55939881|NCT03253133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939882|NCT01255449|Albuterol|albuterol|mesh-list
55939883|NCT01255449|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55939884|NCT01255449|Autonomic Agents|autonomic agents|mesh-ancestor
55939885|NCT01255449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939886|NCT01255449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55939887|NCT01255449|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55939888|NCT01255449|Respiratory System Agents|respiratory system agents|mesh-ancestor
55939893|NCT01255449|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55939938|NCT00630877|Nicotinic Acids|nicotinic acids|mesh-list
55939939|NCT00630877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55939940|NCT00630877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55939941|NCT00630877|Analgesics|analgesics|mesh-ancestor
55939942|NCT00630877|Sensory System Agents|sensory system agents|mesh-ancestor
55939943|NCT00630877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55939944|NCT00630877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940005|NCT02134301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55940006|NCT02134301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940007|NCT04397393|Midazolam|midazolam|mesh-list
55940008|NCT04397393|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55940009|NCT04397393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55940010|NCT04397393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940011|NCT04397393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940012|NCT04397393|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55940013|NCT04397393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55940014|NCT04397393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55940015|NCT04397393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55940016|NCT04397393|Anesthetics, General|anesthetics, general|mesh-ancestor
55940017|NCT04397393|Anesthetics|anesthetics|mesh-ancestor
55940018|NCT04397393|GABA Modulators|gaba modulators|mesh-ancestor
55940068|NCT04275115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940069|NCT00633997|Vildagliptin|vildagliptin|mesh-list
55940070|NCT00633997|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55940071|NCT00633997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940072|NCT00633997|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55940073|NCT00633997|Protease Inhibitors|protease inhibitors|mesh-ancestor
55940074|NCT00633997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940075|NCT00633997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940133|NCT01924273|Talaporfin|talaporfin|mesh-list
55940134|NCT01924273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940135|NCT01924273|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55940136|NCT01924273|Dermatologic Agents|dermatologic agents|mesh-ancestor
55940137|NCT00667121|Tamoxifen|tamoxifen|mesh-list
55940138|NCT00667121|Gabapentin|gabapentin|mesh-list
55940139|NCT00667121|Dexetimide|dexetimide|mesh-list
55940140|NCT00667121|Citalopram|citalopram|mesh-list
55940141|NCT00667121|Sertraline|sertraline|mesh-list
55940142|NCT00667121|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55940143|NCT00667121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940144|NCT00667121|Analgesics|analgesics|mesh-ancestor
55940145|NCT00667121|Sensory System Agents|sensory system agents|mesh-ancestor
55940148|NCT00667121|Anticonvulsants|anticonvulsants|mesh-ancestor
55940196|NCT03097783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940197|NCT03097783|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55940198|NCT03097783|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55940199|NCT03097783|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55940200|NCT03097783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55940201|NCT03097783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940202|NCT04346407|Dronabinol|dronabinol|mesh-list
55940203|NCT04346407|Hallucinogens|hallucinogens|mesh-ancestor
55940262|NCT03057847|Antiviral Agents|antiviral agents|mesh-ancestor
55940263|NCT03057847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940264|NCT01925911|Midazolam|midazolam|mesh-list
55940265|NCT01925911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55940266|NCT01925911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55940267|NCT01925911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940268|NCT01925911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940269|NCT01925911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55940270|NCT01925911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55940271|NCT01925911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55940272|NCT01925911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55940273|NCT01925911|Anesthetics, General|anesthetics, general|mesh-ancestor
55940274|NCT01925911|Anesthetics|anesthetics|mesh-ancestor
55940275|NCT01925911|GABA Modulators|gaba modulators|mesh-ancestor
55940321|NCT05601817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940322|NCT05601817|Protective Agents|protective agents|mesh-ancestor
55940323|NCT05601817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940324|NCT05601817|Vitamins|vitamins|mesh-ancestor
55940325|NCT05601817|Micronutrients|micronutrients|mesh-ancestor
55940326|NCT01926379|Isoniazid|isoniazid|mesh-list
55940327|NCT01926379|Antitubercular Agents|antitubercular agents|mesh-ancestor
55940328|NCT01926379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55940329|NCT01926379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940335|NCT05249309|Ketamine|ketamine|mesh-list
55940389|NCT02392637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55940390|NCT02392637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940391|NCT02392637|Tubulin Modulators|tubulin modulators|mesh-ancestor
55940392|NCT02392637|Antimitotic Agents|antimitotic agents|mesh-ancestor
55940393|NCT02392637|Mitosis Modulators|mitosis modulators|mesh-ancestor
55940394|NCT02392637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940395|NCT02392637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55940396|NCT02392637|Antimetabolites|antimetabolites|mesh-ancestor
55940397|NCT02392637|Antiviral Agents|antiviral agents|mesh-ancestor
55940398|NCT02392637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940399|NCT02392637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55940400|NCT02392637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55940401|NCT02392637|Immunologic Factors|immunologic factors|mesh-ancestor
55940402|NCT02392637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940403|NCT05600881|Methylphenidate|methylphenidate|mesh-list
55940404|NCT05600881|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55940405|NCT05600881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940446|NCT05604859|gamma-Globulins|gamma-globulins|mesh-list
55940447|NCT05604859|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55940448|NCT05604859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55940449|NCT05604859|Antiemetics|antiemetics|mesh-ancestor
55940450|NCT05604859|Autonomic Agents|autonomic agents|mesh-ancestor
55795088|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55940451|NCT05604859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940452|NCT05604859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940453|NCT05604859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55940454|NCT05604859|Glucocorticoids|glucocorticoids|mesh-ancestor
55940456|NCT05604859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940457|NCT05604859|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55940458|NCT05604859|Protective Agents|protective agents|mesh-ancestor
55940459|NCT05604859|Anticoagulants|anticoagulants|mesh-ancestor
55940460|NCT05604859|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55940461|NCT05604859|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55940462|NCT05604859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55940502|NCT03342911|Paclitaxel|paclitaxel|mesh-list
55940503|NCT03342911|Carboplatin|carboplatin|mesh-list
55940504|NCT03342911|Nivolumab|nivolumab|mesh-list
55940505|NCT03342911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55940506|NCT03342911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940507|NCT03342911|Tubulin Modulators|tubulin modulators|mesh-ancestor
55940508|NCT03342911|Antimitotic Agents|antimitotic agents|mesh-ancestor
55940573|NCT04394533|Anesthetics|anesthetics|mesh-ancestor
55940574|NCT04394533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940575|NCT04394533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940576|NCT04394533|Sensory System Agents|sensory system agents|mesh-ancestor
55940577|NCT04394533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55940578|NCT03047005|Naltrexone|naltrexone|mesh-list
55940579|NCT03047005|Bupropion|bupropion|mesh-list
55940580|NCT03047005|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55940592|NCT03047005|Dopamine Agents|dopamine agents|mesh-ancestor
55940714|NCT03015259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940721|NCT03236545|Estradiol|estradiol|mesh-list
55940786|NCT03267277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940791|NCT00634049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940792|NCT04123249|Propofol|propofol|mesh-list
55940793|NCT04123249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
55940794|NCT04123249|Anesthetics|anesthetics|mesh-list
55940795|NCT04123249|Sevoflurane|sevoflurane|mesh-list
55940796|NCT04123249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55940797|NCT04123249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55940798|NCT04123249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940799|NCT04123249|Anesthetics, General|anesthetics, general|mesh-ancestor
55940800|NCT04123249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55940801|NCT04123249|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55940802|NCT04758871|Progesterone|progesterone|mesh-list
55940803|NCT04758871|Dydrogesterone|dydrogesterone|mesh-list
55940804|NCT04758871|Progestins|progestins|mesh-ancestor
55940805|NCT04758871|Hormones|hormones|mesh-ancestor
55940806|NCT04758871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940807|NCT04758871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940842|NCT00632099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55940843|NCT00632099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940913|NCT03830827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55940914|NCT03098563|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
55940915|NCT03098563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940916|NCT03098485|Azithromycin|azithromycin|mesh-list
55940917|NCT03098485|Levofloxacin|levofloxacin|mesh-list
55940918|NCT03098485|Ofloxacin|ofloxacin|mesh-list
55940919|NCT03098485|Cefpodoxime|cefpodoxime|mesh-list
55940920|NCT03098485|Cefpodoxime proxetil|cefpodoxime proxetil|mesh-list
55940921|NCT03098485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55940922|NCT03098485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55940923|NCT03098485|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55940977|NCT03064867|Venetoclax|venetoclax|mesh-list
55940978|NCT03064867|Ifosfamide|ifosfamide|mesh-list
55940979|NCT03064867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55940980|NCT03064867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55940981|NCT03064867|Immunologic Factors|immunologic factors|mesh-ancestor
55940982|NCT03064867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55940983|NCT03064867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55940984|NCT03064867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55940985|NCT03064867|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55940986|NCT03064867|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55940992|NCT04120987|Lifitegrast|lifitegrast|mesh-list
55941041|NCT03056755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55941042|NCT03056755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55941113|NCT00634829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941115|NCT00634517|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55941116|NCT00634517|Autonomic Agents|autonomic agents|mesh-ancestor
55941117|NCT00634517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941118|NCT00634517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941119|NCT00634517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55941181|NCT02921893|Protease Inhibitors|protease inhibitors|mesh-ancestor
55941182|NCT02921893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941183|NCT02921893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941257|NCT03115151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55941258|NCT03115151|Anesthetics, General|anesthetics, general|mesh-ancestor
55941259|NCT01263717|Hormones|hormones|mesh-list
55941260|NCT01263717|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
55941261|NCT01263717|Tesamorelin|tesamorelin|mesh-list
55941262|NCT01263717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941263|NCT01263717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941321|NCT01922141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55941322|NCT01922141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941323|NCT01922141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55941324|NCT01922141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941325|NCT01922141|Vasodilator Agents|vasodilator agents|mesh-ancestor
55941326|NCT01922141|Diuretics|diuretics|mesh-ancestor
55941327|NCT01922141|Natriuretic Agents|natriuretic agents|mesh-ancestor
55941328|NCT01922141|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55941330|NCT01922141|Protease Inhibitors|protease inhibitors|mesh-ancestor
55941386|NCT01922375|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55941387|NCT01922375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55941388|NCT01922375|Adrenergic Agents|adrenergic agents|mesh-ancestor
55941389|NCT01922375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55941390|NCT01922375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55941391|NCT01922375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941392|NCT01922375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55941393|NCT01922375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55941394|NCT01922375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55941450|NCT01922765|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55941451|NCT01922765|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55941523|NCT01270659|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55941524|NCT01270659|Fentanyl|fentanyl|mesh-list
55941525|NCT01270659|Oxycodone|oxycodone|mesh-list
55941526|NCT01270659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55941598|NCT01920737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55941599|NCT01920737|Glucocorticoids|glucocorticoids|mesh-ancestor
55941600|NCT01920737|Hormones|hormones|mesh-ancestor
55941601|NCT01920737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55941602|NCT01920737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55941603|NCT01920737|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55941604|NCT01920737|Abortifacient Agents|abortifacient agents|mesh-ancestor
55941605|NCT01920737|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55941606|NCT01920737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55941607|NCT01920737|Antimetabolites|antimetabolites|mesh-ancestor
55941608|NCT01920737|Dermatologic Agents|dermatologic agents|mesh-ancestor
55941609|NCT01920737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55941610|NCT01920737|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55941611|NCT01920737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55941658|NCT01302483|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55941659|NCT01302483|Respiratory System Agents|respiratory system agents|mesh-ancestor
55941660|NCT01302483|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55941662|NCT01302483|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55941663|NCT01302483|Protective Agents|protective agents|mesh-ancestor
55941664|NCT04769583|Metronidazole|metronidazole|mesh-list
55941665|NCT04769583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941666|NCT04769583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55941667|NCT04769583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55941668|NCT04769583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55941669|NCT01279317|Acetic Acid|acetic acid|mesh-list
55941670|NCT01279317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55941671|NCT01279317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55941672|NCT01304589|Milnacipran|milnacipran|mesh-list
55941673|NCT01304589|Levomilnacipran|levomilnacipran|mesh-list
55941674|NCT01304589|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55941675|NCT01304589|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55941717|NCT01925027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55941718|NCT01925027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55941723|NCT01305213|Bevacizumab|bevacizumab|mesh-list
55941792|NCT03100253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55941793|NCT03100253|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55941802|NCT01924091|Dapivirine|dapivirine|mesh-list
55941866|NCT01925729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55941867|NCT01925729|Autonomic Agents|autonomic agents|mesh-ancestor
55941868|NCT01925729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55941869|NCT01925729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55941870|NCT01925729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55941871|NCT01925729|Respiratory System Agents|respiratory system agents|mesh-ancestor
55941872|NCT01925729|Nasal Decongestants|nasal decongestants|mesh-ancestor
55942008|NCT04394897|Narcotics|narcotics|mesh-ancestor
55942009|NCT04394897|Analgesics|analgesics|mesh-ancestor
55942010|NCT04394897|Sensory System Agents|sensory system agents|mesh-ancestor
55942011|NCT04394897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942013|NCT05607641|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55942014|NCT05607641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55942015|NCT05607641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55942017|NCT05607641|Analgesics|analgesics|mesh-ancestor
55942077|NCT05608499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55942078|NCT05608499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942079|NCT05608499|Glucocorticoids|glucocorticoids|mesh-ancestor
55942081|NCT05608499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942082|NCT05608499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942083|NCT05601167|Ritonavir|ritonavir|mesh-list
55942084|NCT05601167|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55942085|NCT05601167|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55942086|NCT05601167|Protease Inhibitors|protease inhibitors|mesh-ancestor
55942087|NCT05601167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942088|NCT05601167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942089|NCT05601167|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55942090|NCT05601167|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55942091|NCT05601167|Antiviral Agents|antiviral agents|mesh-ancestor
55942092|NCT05601167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942093|NCT05601167|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55942094|NCT05601167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55942095|NCT05605613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55942096|NCT05605613|Antibodies|antibodies|mesh-list
55942097|NCT05605613|Immunologic Factors|immunologic factors|mesh-ancestor
55942098|NCT05605613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942100|NCT05605613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942127|NCT05603975|Esketamine|esketamine|mesh-list
55942128|NCT05603975|Antidepressive Agents|antidepressive agents|mesh-ancestor
55942129|NCT05603975|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55942130|NCT03029429|Theophylline|theophylline|mesh-list
55942131|NCT03029429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55942132|NCT03029429|Autonomic Agents|autonomic agents|mesh-ancestor
55942133|NCT03029429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942134|NCT03029429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942135|NCT03029429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55942136|NCT03029429|Respiratory System Agents|respiratory system agents|mesh-ancestor
55942137|NCT03029429|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55942138|NCT03029429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942139|NCT03029429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942191|NCT04129697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942192|NCT04129697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942193|NCT04129697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55942194|NCT04129697|Glucocorticoids|glucocorticoids|mesh-ancestor
55942195|NCT04129697|Hormones|hormones|mesh-ancestor
55942196|NCT04129697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942197|NCT04129697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55942198|NCT04129697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942199|NCT04129697|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55942200|NCT04129697|Protective Agents|protective agents|mesh-ancestor
55942201|NCT03311555|Docetaxel|docetaxel|mesh-list
55942202|NCT03311555|Androgens|androgens|mesh-list
55942203|NCT03311555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942204|NCT03311555|Tubulin Modulators|tubulin modulators|mesh-ancestor
55942205|NCT03311555|Antimitotic Agents|antimitotic agents|mesh-ancestor
55942206|NCT03311555|Mitosis Modulators|mitosis modulators|mesh-ancestor
55942207|NCT03311555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942208|NCT03311555|Hormones|hormones|mesh-ancestor
55942209|NCT03311555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942213|NCT02760667|Cisplatin|cisplatin|mesh-list
55942245|NCT02697253|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55942317|NCT01647828|Antiviral Agents|antiviral agents|mesh-ancestor
55942318|NCT01647828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942319|NCT01647828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942320|NCT01647828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942321|NCT01647828|Immunologic Factors|immunologic factors|mesh-ancestor
55942322|NCT01647828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942323|NCT03825367|Nivolumab|nivolumab|mesh-list
55942324|NCT03825367|Azacitidine|azacitidine|mesh-list
55942325|NCT03825367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55942326|NCT03825367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942327|NCT03825367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55942328|NCT03825367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942329|NCT03825367|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55942379|NCT01243476|Growth Inhibitors|growth inhibitors|mesh-ancestor
55942380|NCT01243476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942452|NCT03061032|Antimetabolites|antimetabolites|mesh-ancestor
55942528|NCT01455025|Antiviral Agents|antiviral agents|mesh-ancestor
55942529|NCT01455025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942530|NCT03060798|Desflurane|desflurane|mesh-list
55942531|NCT03060798|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55942532|NCT03060798|Anesthetics, General|anesthetics, general|mesh-ancestor
55942533|NCT03060798|Anesthetics|anesthetics|mesh-ancestor
55942534|NCT03060798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55942535|NCT03060798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942536|NCT04426890|Omalizumab|omalizumab|mesh-list
55942543|NCT01451593|Phenytoin|phenytoin|mesh-list
55942596|NCT02584933|Ceritinib|ceritinib|mesh-list
55942597|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942598|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55942599|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942600|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942601|NCT04852458|Hydrocortisone|hydrocortisone|mesh-list
55942602|NCT04852458|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55942603|NCT04852458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942604|NCT01455883|Glimepiride|glimepiride|mesh-list
55942605|NCT01455883|Exenatide|exenatide|mesh-list
55942606|NCT01455883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55942607|NCT01455883|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55942608|NCT01455883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942609|NCT01455883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942657|NCT04962672|Anesthetics, General|anesthetics, general|mesh-ancestor
55942658|NCT04962672|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55942659|NCT04962672|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55942660|NCT03829345|Olaparib|olaparib|mesh-list
55942661|NCT03829345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55942662|NCT03829345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942663|NCT03829345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942664|NCT03829345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942665|NCT01456351|Rituximab|rituximab|mesh-list
55942666|NCT01456351|Fludarabine|fludarabine|mesh-list
55942677|NCT02541955|Hormones|hormones|mesh-ancestor
55942721|NCT02967289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942722|NCT02967289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942723|NCT00988169|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55942724|NCT00988169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942725|NCT00988169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55942726|NCT00988169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942727|NCT00988169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942728|NCT02967133|Paclitaxel|paclitaxel|mesh-list
55942729|NCT02967133|Nivolumab|nivolumab|mesh-list
55942738|NCT04961970|Leucovorin|leucovorin|mesh-list
55942787|NCT02965027|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55942789|NCT02965027|Adrenergic Agents|adrenergic agents|mesh-ancestor
55942790|NCT02965027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55942791|NCT02965027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942792|NCT02965027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942793|NCT04961268|Acetaminophen|acetaminophen|mesh-list
55942794|NCT04961268|Ibuprofen|ibuprofen|mesh-list
55942795|NCT04961268|Tramadol|tramadol|mesh-list
55942796|NCT04961268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55942797|NCT04961268|Analgesics|analgesics|mesh-ancestor
55942798|NCT04961268|Sensory System Agents|sensory system agents|mesh-ancestor
55942851|NCT04392427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942852|NCT04392427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55942853|NCT01457131|Cyclophosphamide|cyclophosphamide|mesh-list
55942854|NCT01457131|Fludarabine|fludarabine|mesh-list
55942855|NCT01457131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55942856|NCT01457131|Immunologic Factors|immunologic factors|mesh-ancestor
55942857|NCT01457131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942858|NCT01457131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55942859|NCT01457131|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55942860|NCT01457131|Alkylating Agents|alkylating agents|mesh-ancestor
55942861|NCT01457131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942862|NCT01457131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942863|NCT01457131|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55942864|NCT03057990|Pyrimethamine|pyrimethamine|mesh-list
55942865|NCT03057990|Antimalarials|antimalarials|mesh-ancestor
55942866|NCT03057990|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55942867|NCT03057990|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55942868|NCT03057990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55942869|NCT03057990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55942870|NCT03057990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55942871|NCT03057990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942872|NCT01455337|Prednisolone|prednisolone|mesh-list
55942873|NCT01455337|Pentoxifylline|pentoxifylline|mesh-list
55942874|NCT01455337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55942875|NCT01455337|Glucocorticoids|glucocorticoids|mesh-ancestor
55942876|NCT01455337|Hormones|hormones|mesh-ancestor
55942877|NCT01455337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55942878|NCT01455337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942880|NCT01455337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55942897|NCT03059316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55942898|NCT03059316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55942899|NCT03059316|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55942900|NCT03059316|Sympathomimetics|sympathomimetics|mesh-ancestor
55942901|NCT03059316|Autonomic Agents|autonomic agents|mesh-ancestor
55942902|NCT03059316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55942903|NCT03059316|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
56144623|NCT00801684|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56144624|NCT00801684|Contraceptive Agents|contraceptive agents|mesh-ancestor
56144625|NCT00801684|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56144626|NCT00801684|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56144627|NCT00801684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56144628|NCT00801684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144630|NCT00803010|Methotrexate|methotrexate|mesh-list
56144632|NCT00803010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56144633|NCT00803010|Abortifacient Agents|abortifacient agents|mesh-ancestor
56144634|NCT00803010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56144637|NCT00803010|Antimetabolites|antimetabolites|mesh-ancestor
55942969|NCT05586919|Ethanol|ethanol|mesh-list
55943042|NCT04959786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943043|NCT04959786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55943045|NCT01452451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55943046|NCT01452451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943047|NCT01452451|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55943048|NCT01452451|Incretins|incretins|mesh-ancestor
55943049|NCT01452451|Hormones|hormones|mesh-ancestor
55943050|NCT01452451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55943051|NCT04951128|Anesthetics|anesthetics|mesh-list
55943052|NCT04951128|Anesthetics, Local|anesthetics, local|mesh-list
55943054|NCT04951128|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943055|NCT04951128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943056|NCT04951128|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55943057|NCT04951128|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55943103|NCT04942002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55943104|NCT04942002|Antiemetics|antiemetics|mesh-ancestor
55943105|NCT04942002|Autonomic Agents|autonomic agents|mesh-ancestor
55943106|NCT04942002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943107|NCT04942002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943108|NCT04942002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55943109|NCT04942002|Glucocorticoids|glucocorticoids|mesh-ancestor
55943110|NCT04942002|Hormones|hormones|mesh-ancestor
55943170|NCT04843423|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55943171|NCT01459081|Zanamivir|zanamivir|mesh-list
55943172|NCT01459081|Antiviral Agents|antiviral agents|mesh-ancestor
55943173|NCT01459081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943174|NCT01459081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943175|NCT01459081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943176|NCT04421196|Analgesics, Opioid|analgesics, opioid|mesh-list
55943177|NCT04421196|Analgesics|analgesics|mesh-list
55943178|NCT04421196|Narcotics|narcotics|mesh-ancestor
55943179|NCT04421196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943180|NCT04421196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943183|NCT01459315|Dolutegravir|dolutegravir|mesh-list
55943235|NCT04390789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55943236|NCT04390789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943237|NCT04948164|Naproxen|naproxen|mesh-list
55943238|NCT04948164|Sumatriptan|sumatriptan|mesh-list
55943239|NCT04948164|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55943240|NCT04948164|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55943241|NCT04948164|Analgesics|analgesics|mesh-ancestor
55943242|NCT04948164|Sensory System Agents|sensory system agents|mesh-ancestor
55943243|NCT04948164|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943244|NCT04948164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943245|NCT04948164|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55943246|NCT04948164|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55943256|NCT02808871|Pirfenidone|pirfenidone|mesh-list
55943295|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943296|NCT02467621|Pantoprazole|pantoprazole|mesh-list
55943297|NCT02467621|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55943298|NCT02467621|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55943299|NCT02467621|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55943300|NCT02467621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943301|NCT02467621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943303|NCT04937946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55943304|NCT04937946|Narcotics|narcotics|mesh-ancestor
55943360|NCT02181075|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55943361|NCT02181075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943362|NCT02181075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943363|NCT02181075|Hematinics|hematinics|mesh-ancestor
55943364|NCT01359735|Bacitracin|bacitracin|mesh-list
55943365|NCT01359735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55943366|NCT01359735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943367|NCT01359735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55943368|NCT01361217|Midazolam|midazolam|mesh-list
55943421|NCT04271839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943422|NCT04271839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943423|NCT04271839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55943424|NCT04271839|Respiratory System Agents|respiratory system agents|mesh-ancestor
55943425|NCT04271839|Dermatologic Agents|dermatologic agents|mesh-ancestor
55943426|NCT04271839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55795099|NCT05474729|Minocycline|minocycline|mesh-list
55943427|NCT04271839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55943428|NCT04271839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55943429|NCT04271839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55943430|NCT04271839|Adrenergic Agents|adrenergic agents|mesh-ancestor
55943483|NCT01454635|Sertraline|sertraline|mesh-list
55943557|NCT02181231|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55943558|NCT02181231|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55943559|NCT02181231|Narcotics|narcotics|mesh-ancestor
55943560|NCT02181231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55943561|NCT02181231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943562|NCT02181231|Analgesics|analgesics|mesh-ancestor
55943564|NCT02181231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55943565|NCT02181231|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55943566|NCT02181231|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55943567|NCT02181231|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55943568|NCT02181231|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55943569|NCT02181231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943570|NCT02181231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55943571|NCT02181231|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55943572|NCT02181231|Antidepressive Agents|antidepressive agents|mesh-ancestor
55943573|NCT02181231|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55943574|NCT04922034|Amoxicillin|amoxicillin|mesh-list
55943575|NCT04922034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55943576|NCT04922034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943577|NCT01364259|Amifostine|amifostine|mesh-list
55943578|NCT01364259|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55943579|NCT01364259|Protective Agents|protective agents|mesh-ancestor
55943580|NCT01364259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943581|NCT01321437|Axitinib|axitinib|mesh-list
55943582|NCT01321437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943583|NCT01321437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55943605|NCT04407390|Nicotinic Acids|nicotinic acids|mesh-list
55943606|NCT04407390|Vitamin B Complex|vitamin b complex|mesh-ancestor
55943608|NCT04407390|Micronutrients|micronutrients|mesh-ancestor
55943609|NCT04407390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943610|NCT04407390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55943611|NCT04407390|Antimetabolites|antimetabolites|mesh-ancestor
55943615|NCT02181387|Acetaminophen|acetaminophen|mesh-list
55943672|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943673|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55943674|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
55943675|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943676|NCT04934514|Antiviral Agents|antiviral agents|mesh-ancestor
55943677|NCT04934514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943678|NCT04934514|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943679|NCT04934514|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943680|NCT04934514|Immunologic Factors|immunologic factors|mesh-ancestor
55943736|NCT02771197|Alkylating Agents|alkylating agents|mesh-ancestor
55943737|NCT02771197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55943738|NCT01369875|Aldesleukin|aldesleukin|mesh-list
55943739|NCT01369875|Cyclophosphamide|cyclophosphamide|mesh-list
55943740|NCT01369875|Fludarabine|fludarabine|mesh-list
55943741|NCT01369875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943742|NCT01369875|Immunologic Factors|immunologic factors|mesh-ancestor
55943743|NCT01369875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943744|NCT01369875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55943745|NCT01369875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55943746|NCT01369875|Alkylating Agents|alkylating agents|mesh-ancestor
55943747|NCT01369875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943800|NCT04920708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55943801|NCT04920708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55943802|NCT04920708|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55943803|NCT04920708|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55943804|NCT04920708|Hormone Antagonists|hormone antagonists|mesh-ancestor
55943805|NCT04920708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55943807|NCT04920708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55943867|NCT02588443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55943870|NCT02588443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943871|NCT02588443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943872|NCT02588443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943873|NCT02588443|Immunologic Factors|immunologic factors|mesh-ancestor
55943874|NCT02588443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55943875|NCT02741323|Maraviroc|maraviroc|mesh-list
55943936|NCT04037241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55943937|NCT04037241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55943938|NCT04037241|Antimetabolites|antimetabolites|mesh-ancestor
55943939|NCT04037241|Antiviral Agents|antiviral agents|mesh-ancestor
55943940|NCT04037241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55943941|NCT04037241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55943942|NCT04037241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55943943|NCT04037241|Immunologic Factors|immunologic factors|mesh-ancestor
55943944|NCT04037241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944002|NCT04918524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55944003|NCT04918524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944004|NCT04918524|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55944005|NCT04918524|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55944006|NCT04918524|Analgesics|analgesics|mesh-ancestor
55944007|NCT04918524|Sensory System Agents|sensory system agents|mesh-ancestor
55944008|NCT04918524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944009|NCT04918524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944010|NCT04918524|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55944011|NCT04918524|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55944012|NCT04918524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944013|NCT04918524|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55944014|NCT04918524|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55944015|NCT04918524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944062|NCT02552641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944063|NCT02552641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944064|NCT02552641|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55944065|NCT02552641|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55944066|NCT02552641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55944067|NCT02620020|Fasinumab|fasinumab|mesh-list
55944068|NCT02620020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55944069|NCT02620020|Analgesics|analgesics|mesh-ancestor
55944070|NCT02620020|Sensory System Agents|sensory system agents|mesh-ancestor
55944071|NCT02620020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944072|NCT02620020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944073|NCT02551237|Capecitabine|capecitabine|mesh-list
55944074|NCT02551237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55944075|NCT02551237|Antimetabolites|antimetabolites|mesh-ancestor
55944122|NCT02414269|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55944123|NCT02414269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944124|NCT04928586|Pirfenidone|pirfenidone|mesh-list
55944125|NCT04928586|Analgesics|analgesics|mesh-ancestor
55944126|NCT04928586|Sensory System Agents|sensory system agents|mesh-ancestor
55944127|NCT04928586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944128|NCT04928586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944129|NCT04928586|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55944130|NCT04928586|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55944131|NCT04928586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944132|NCT04928586|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944133|NCT04928586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944134|NCT03054168|Goserelin|goserelin|mesh-list
55944135|NCT03054168|Testosterone|testosterone|mesh-list
55944136|NCT03054168|Hormones|hormones|mesh-ancestor
55944138|NCT03054168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944180|NCT04757779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944181|NCT04757779|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55944182|NCT04757779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55944183|NCT04757779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944184|NCT03053856|Paclitaxel|paclitaxel|mesh-list
55944185|NCT03053856|Pembrolizumab|pembrolizumab|mesh-list
55944186|NCT03053856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55944187|NCT03053856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944188|NCT03053856|Tubulin Modulators|tubulin modulators|mesh-ancestor
55944189|NCT03053856|Antimitotic Agents|antimitotic agents|mesh-ancestor
55944190|NCT03053856|Mitosis Modulators|mitosis modulators|mesh-ancestor
55944193|NCT02389309|Sirolimus|sirolimus|mesh-list
55944242|NCT02384083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55944243|NCT02384083|Glucocorticoids|glucocorticoids|mesh-ancestor
55944245|NCT02384083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944246|NCT02384083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55944247|NCT02384083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944248|NCT02384083|Immunologic Factors|immunologic factors|mesh-ancestor
55944249|NCT02384083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55944250|NCT02384083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55944251|NCT02384083|Growth Substances|growth substances|mesh-ancestor
55944252|NCT02384083|Growth Inhibitors|growth inhibitors|mesh-ancestor
55944253|NCT02384083|Antimitotic Agents|antimitotic agents|mesh-ancestor
55944254|NCT02384083|Mitosis Modulators|mitosis modulators|mesh-ancestor
55944256|NCT04926480|Anesthetics|anesthetics|mesh-list
55944304|NCT02461537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944305|NCT02461537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944306|NCT05028673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55944307|NCT05028673|Antacids|antacids|mesh-list
55944308|NCT05028673|Magnesium Hydroxide|magnesium hydroxide|mesh-list
55944309|NCT05028673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55944310|NCT05028673|Immunologic Factors|immunologic factors|mesh-ancestor
55944311|NCT05028673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944312|NCT05028673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944313|NCT05028673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55944314|NCT04916574|Antibodies|antibodies|mesh-list
55944315|NCT04916574|Immunologic Factors|immunologic factors|mesh-ancestor
55944317|NCT02460445|Cyproterone Acetate|cyproterone acetate|mesh-list
55944366|NCT02358967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944368|NCT02358967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944369|NCT02358967|Protective Agents|protective agents|mesh-ancestor
55944370|NCT03052998|Ivermectin|ivermectin|mesh-list
55944371|NCT03052998|Anticonvulsants|anticonvulsants|mesh-list
55944373|NCT03052998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944374|NCT02354131|Bevacizumab|bevacizumab|mesh-list
55944375|NCT02354131|Niraparib|niraparib|mesh-list
55944376|NCT02354131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944377|NCT02354131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944378|NCT02354131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55944379|NCT02354131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55944380|NCT02354131|Growth Substances|growth substances|mesh-ancestor
55944381|NCT02354131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944382|NCT02354131|Growth Inhibitors|growth inhibitors|mesh-ancestor
55944427|NCT02346253|Hormone Antagonists|hormone antagonists|mesh-ancestor
55944428|NCT02346253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944429|NCT02346253|Luteolytic Agents|luteolytic agents|mesh-ancestor
55944430|NCT02346253|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55944431|NCT02346253|Contraceptive Agents|contraceptive agents|mesh-ancestor
55944432|NCT02346253|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55944433|NCT01378377|Niacinamide|niacinamide|mesh-list
55944434|NCT01378377|Sirolimus|sirolimus|mesh-list
55944435|NCT01378377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55944436|NCT01378377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944437|NCT01378377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55944438|NCT01378377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944439|NCT01378377|Antifungal Agents|antifungal agents|mesh-ancestor
55944440|NCT01378377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944441|NCT01378377|Immunologic Factors|immunologic factors|mesh-ancestor
55944442|NCT01378377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944443|NCT01378377|Vitamin B Complex|vitamin b complex|mesh-ancestor
55944445|NCT01378377|Micronutrients|micronutrients|mesh-ancestor
55944446|NCT03012321|Prednisone|prednisone|mesh-list
55944447|NCT03012321|Olaparib|olaparib|mesh-list
55944448|NCT03012321|Abiraterone Acetate|abiraterone acetate|mesh-list
55944449|NCT03012321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944450|NCT03012321|Glucocorticoids|glucocorticoids|mesh-ancestor
55944451|NCT03012321|Hormones|hormones|mesh-ancestor
55944452|NCT03012321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55944453|NCT03012321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944454|NCT03012321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55944475|NCT04915482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944476|NCT04907838|cyclo(Trp-Asp-Pro-Val-Leu)|cyclo(trp-asp-pro-val-leu)|mesh-list
55944477|NCT04907838|BQ 788|bq 788|mesh-list
55944478|NCT04907838|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55944479|NCT04907838|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55944480|NCT04907838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944481|NCT04907838|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55944483|NCT03056274|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55944541|NCT01332357|Respiratory System Agents|respiratory system agents|mesh-ancestor
55944542|NCT01332357|Dermatologic Agents|dermatologic agents|mesh-ancestor
55944543|NCT01332357|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55944544|NCT01332357|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55944545|NCT01332357|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55944546|NCT01332357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55944547|NCT01332357|Adrenergic Agents|adrenergic agents|mesh-ancestor
55944548|NCT01332357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55944604|NCT00986921|Luteolytic Agents|luteolytic agents|mesh-ancestor
55944605|NCT00986921|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55944606|NCT00986921|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55944607|NCT01383759|Dexamethasone|dexamethasone|mesh-list
55944608|NCT01383759|Dexamethasone acetate|dexamethasone acetate|mesh-list
55944609|NCT01383759|Bortezomib|bortezomib|mesh-list
55944610|NCT01383759|BB 1101|bb 1101|mesh-list
55944611|NCT01383759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944612|NCT01383759|Antiemetics|antiemetics|mesh-ancestor
55944613|NCT01383759|Autonomic Agents|autonomic agents|mesh-ancestor
55944673|NCT02337985|Immunologic Factors|immunologic factors|mesh-ancestor
55944674|NCT02337985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944675|NCT02337985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55944676|NCT02337985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55944677|NCT02337985|Alkylating Agents|alkylating agents|mesh-ancestor
55944678|NCT02337985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944679|NCT02337985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944680|NCT02337985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55944681|NCT02337985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944682|NCT02337985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55944683|NCT02337985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55944684|NCT02337985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55944685|NCT02337985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944686|NCT02337985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55944687|NCT02337985|Glucocorticoids|glucocorticoids|mesh-ancestor
55944732|NCT02422381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55944733|NCT02422381|Antimetabolites|antimetabolites|mesh-ancestor
55944734|NCT02422381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944735|NCT02422381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944736|NCT02422381|Antiviral Agents|antiviral agents|mesh-ancestor
55944737|NCT02422381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55944738|NCT02422381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944739|NCT02422381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55944740|NCT02422381|Immunologic Factors|immunologic factors|mesh-ancestor
55743692|NCT02729545|Estrogens|estrogens|mesh-ancestor
55944799|NCT02292979|Vinblastine|vinblastine|mesh-list
55944800|NCT02292979|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55944801|NCT02292979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55944802|NCT02292979|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55944803|NCT02292979|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55944804|NCT02292979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55944805|NCT02292979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55944806|NCT02292979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55944807|NCT02292979|Alkylating Agents|alkylating agents|mesh-ancestor
55944808|NCT02292979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55944809|NCT02292979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55944859|NCT05026567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55944860|NCT05026567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944861|NCT05026567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55944862|NCT05026567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55944863|NCT05026567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55944864|NCT05026567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55944865|NCT05026567|Anesthetics, General|anesthetics, general|mesh-ancestor
55944866|NCT05026567|Anesthetics|anesthetics|mesh-ancestor
55944867|NCT05026567|GABA Modulators|gaba modulators|mesh-ancestor
55944868|NCT05026567|GABA Agents|gaba agents|mesh-ancestor
55944869|NCT05026567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55944923|NCT04899570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55944924|NCT04899570|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55944925|NCT04899570|Tubulin Modulators|tubulin modulators|mesh-ancestor
55944926|NCT04899570|Antimitotic Agents|antimitotic agents|mesh-ancestor
55944927|NCT04899570|Mitosis Modulators|mitosis modulators|mesh-ancestor
55944928|NCT02274415|Vaccines|vaccines|mesh-list
55944929|NCT02274415|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55944930|NCT02274415|Immunologic Factors|immunologic factors|mesh-ancestor
55944931|NCT02274415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944932|NCT03049878|Acetaminophen|acetaminophen|mesh-list
55944933|NCT03049878|Codeine|codeine|mesh-list
55944934|NCT03049878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55944935|NCT03049878|Analgesics|analgesics|mesh-ancestor
55944936|NCT03049878|Sensory System Agents|sensory system agents|mesh-ancestor
55944983|NCT04891458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55944984|NCT04891458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55944985|NCT04891458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55944986|NCT04891458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55944987|NCT04891458|Anesthetics, General|anesthetics, general|mesh-ancestor
55944988|NCT04891458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55944989|NCT04891458|Analgesics|analgesics|mesh-ancestor
55944990|NCT04891458|Sensory System Agents|sensory system agents|mesh-ancestor
55944991|NCT04891458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55944992|NCT04891458|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55944994|NCT04891458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55945045|NCT01391559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945046|NCT01391559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945048|NCT01335789|Oxytocics|oxytocics|mesh-ancestor
55945049|NCT01335789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55945050|NCT01335789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945051|NCT02202135|Vancomycin|vancomycin|mesh-list
55945052|NCT02202135|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55945053|NCT02202135|Aztreonam|aztreonam|mesh-list
55945054|NCT02202135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55945055|NCT02202135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945056|NCT01335867|Vigabatrin|vigabatrin|mesh-list
55945057|NCT01335867|Anticonvulsants|anticonvulsants|mesh-ancestor
55945058|NCT01335867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945059|NCT01335867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945060|NCT01335867|GABA Agents|gaba agents|mesh-ancestor
55945061|NCT01335867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945104|NCT04890522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55945105|NCT04890522|Immunologic Factors|immunologic factors|mesh-ancestor
55945106|NCT04890522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945108|NCT01525069|Dexamethasone|dexamethasone|mesh-list
55945109|NCT01525069|Oxaliplatin|oxaliplatin|mesh-list
55945110|NCT01525069|Floxuridine|floxuridine|mesh-list
55945111|NCT01525069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945112|NCT01525069|Antiemetics|antiemetics|mesh-ancestor
55945113|NCT01525069|Autonomic Agents|autonomic agents|mesh-ancestor
55945114|NCT01525069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945115|NCT01525069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945116|NCT01525069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945117|NCT01525069|Glucocorticoids|glucocorticoids|mesh-ancestor
55945118|NCT01525069|Hormones|hormones|mesh-ancestor
55945119|NCT01525069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55945120|NCT01525069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55945121|NCT01525069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945160|NCT01894867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945161|NCT01894867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945162|NCT01521403|Metronidazole|metronidazole|mesh-list
55945163|NCT01521403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945164|NCT01521403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55945165|NCT01521403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55945166|NCT01521403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55945167|NCT04881942|Menthol|menthol|mesh-list
55945168|NCT04881942|Nicotine|nicotine|mesh-list
55945169|NCT04881942|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55945170|NCT04881942|Autonomic Agents|autonomic agents|mesh-ancestor
55945171|NCT04881942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945172|NCT04881942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945173|NCT04881942|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55945174|NCT04881942|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55945175|NCT04881942|Cholinergic Agents|cholinergic agents|mesh-ancestor
55945176|NCT04881942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945177|NCT04881942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945178|NCT04881942|Antipruritics|antipruritics|mesh-ancestor
55945179|NCT04881942|Dermatologic Agents|dermatologic agents|mesh-ancestor
55945217|NCT02248597|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55945218|NCT02248597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945219|NCT02248597|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55945220|NCT02248597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55945221|NCT02248597|Antitubercular Agents|antitubercular agents|mesh-ancestor
55945222|NCT02248597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55945223|NCT02248597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945224|NCT04882020|Hydrocortisone|hydrocortisone|mesh-list
55945225|NCT04882020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945226|NCT03071861|Darbepoetin alfa|darbepoetin alfa|mesh-list
55945227|NCT03071861|Hematinics|hematinics|mesh-ancestor
55945282|NCT04881474|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55946321|NCT02935361|Guadecitabine|guadecitabine|mesh-list
55945284|NCT04881474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945285|NCT00981149|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55945286|NCT00981149|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55945287|NCT00981149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55945290|NCT00981149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945346|NCT05583643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945347|NCT05583643|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55945348|NCT05583643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55945349|NCT05583643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55945350|NCT05583643|Antimetabolites|antimetabolites|mesh-ancestor
55795122|NCT03066115|Ketorolac|ketorolac|mesh-list
55945351|NCT05583643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945352|NCT05583643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55945353|NCT05583643|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55945354|NCT05583643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55945355|NCT02225275|Lenalidomide|lenalidomide|mesh-list
55945356|NCT02225275|Obinutuzumab|obinutuzumab|mesh-list
55945357|NCT02225275|Immunologic Factors|immunologic factors|mesh-ancestor
55945408|NCT04430556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945409|NCT04430556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945410|NCT04430556|Serotonin Agents|serotonin agents|mesh-ancestor
55945411|NCT04430556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945412|NCT04897854|Folfirinox|folfirinox|mesh-list
55945413|NCT04897854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945414|NCT01892527|Cetuximab|cetuximab|mesh-list
55945415|NCT01892527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55945416|NCT01892527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945417|NCT02213575|Minocycline|minocycline|mesh-list
55945418|NCT02213575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55945419|NCT02213575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55945420|NCT01399827|Methylphenidate|methylphenidate|mesh-list
55945421|NCT01399827|Amphetamine|amphetamine|mesh-list
55945422|NCT01399827|Adderall|adderall|mesh-list
55945423|NCT01399827|Dextroamphetamine|dextroamphetamine|mesh-list
55945425|NCT01399827|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55945464|NCT02196961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945465|NCT02196961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55945466|NCT02196961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945467|NCT02177071|Methotrexate|methotrexate|mesh-list
55945468|NCT02177071|Mercaptopurine|mercaptopurine|mesh-list
55945469|NCT02177071|Azathioprine|azathioprine|mesh-list
55945470|NCT02177071|Infliximab|infliximab|mesh-list
55945534|NCT02166463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945535|NCT02166463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945536|NCT02166463|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55945537|NCT02166463|Protective Agents|protective agents|mesh-ancestor
55945538|NCT02166463|Keratolytic Agents|keratolytic agents|mesh-ancestor
55945539|NCT02166463|Dermatologic Agents|dermatologic agents|mesh-ancestor
55945540|NCT04889196|Fluorides|fluorides|mesh-list
55945602|NCT04125719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945603|NCT04125719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55945604|NCT04125719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945605|NCT01428973|Mycophenolic Acid|mycophenolic acid|mesh-list
55945607|NCT01428973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55945608|NCT01428973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945609|NCT01428973|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55945668|NCT03004001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945669|NCT04395222|Fludarabine|fludarabine|mesh-list
55945741|NCT05257902|Antimetabolites|antimetabolites|mesh-ancestor
55945742|NCT05257902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945743|NCT05257902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945744|NCT05257902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55945745|NCT05257902|Nootropic Agents|nootropic agents|mesh-ancestor
55945746|NCT02143219|Leucovorin|leucovorin|mesh-list
55945747|NCT02143219|Folic Acid|folic acid|mesh-list
55945748|NCT02143219|Irinotecan|irinotecan|mesh-list
55945749|NCT02143219|Oxaliplatin|oxaliplatin|mesh-list
55945750|NCT02143219|Levoleucovorin|levoleucovorin|mesh-list
55945751|NCT02143219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55945752|NCT02143219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55945806|NCT03830957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55945807|NCT03830957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55945808|NCT03830957|Adrenergic Agents|adrenergic agents|mesh-ancestor
55945809|NCT03830957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55945810|NCT03830957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945811|NCT04121819|Cytarabine|cytarabine|mesh-list
55945812|NCT04121819|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55945813|NCT04121819|Antimetabolites|antimetabolites|mesh-ancestor
55945814|NCT04121819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945827|NCT05189730|Paclitaxel|paclitaxel|mesh-list
55945873|NCT02124421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55945874|NCT02124421|Tubulin Modulators|tubulin modulators|mesh-ancestor
55945875|NCT02124421|Antimitotic Agents|antimitotic agents|mesh-ancestor
55945876|NCT02124421|Mitosis Modulators|mitosis modulators|mesh-ancestor
55945877|NCT02124421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55945878|NCT05256342|Etoricoxib|etoricoxib|mesh-list
55945879|NCT05256342|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55945881|NCT05256342|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55945935|NCT05205252|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55945936|NCT05205252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55945937|NCT05205252|Antiemetics|antiemetics|mesh-ancestor
55945938|NCT05205252|Autonomic Agents|autonomic agents|mesh-ancestor
55945939|NCT05205252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55945940|NCT05205252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55945941|NCT05205252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55945942|NCT05205252|Glucocorticoids|glucocorticoids|mesh-ancestor
55945943|NCT05205252|Hormones|hormones|mesh-ancestor
55945946|NCT05205252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946001|NCT02980835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946002|NCT02980835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946003|NCT02980835|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55946004|NCT02980835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55946005|NCT02980835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55946006|NCT02980835|Respiratory System Agents|respiratory system agents|mesh-ancestor
55946007|NCT02980835|Mydriatics|mydriatics|mesh-ancestor
55946008|NCT02980835|Sympathomimetics|sympathomimetics|mesh-ancestor
55946009|NCT02980835|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55946010|NCT03824327|Papaverine|papaverine|mesh-list
55946029|NCT04871802|Taxifolin|taxifolin|mesh-list
55946063|NCT03589014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946064|NCT03589014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946065|NCT03589014|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55946066|NCT03589014|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55946067|NCT03589014|Vasodilator Agents|vasodilator agents|mesh-ancestor
55946068|NCT03123978|Niclosamide|niclosamide|mesh-list
55946069|NCT03123978|Anticestodal Agents|anticestodal agents|mesh-ancestor
55946070|NCT03123978|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55946071|NCT03123978|Anthelmintics|anthelmintics|mesh-ancestor
55946072|NCT03123978|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55946075|NCT04884906|Paclitaxel|paclitaxel|mesh-list
55946129|NCT03825809|Analgesics|analgesics|mesh-ancestor
55946130|NCT03825809|Sensory System Agents|sensory system agents|mesh-ancestor
55946131|NCT03825809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946132|NCT03825809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946133|NCT03825809|Antipyretics|antipyretics|mesh-ancestor
55946134|NCT03825809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55946135|NCT03825809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946136|NCT03825809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946137|NCT03825809|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55946138|NCT03825809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55946194|NCT02948543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946195|NCT03824171|Cholecalciferol|cholecalciferol|mesh-list
55946196|NCT03824171|Vitamin D|vitamin d|mesh-list
55946197|NCT03824171|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55946198|NCT03824171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55946199|NCT03824171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946200|NCT03824171|Vitamins|vitamins|mesh-ancestor
55946201|NCT03824171|Micronutrients|micronutrients|mesh-ancestor
55946202|NCT03824171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55946203|NCT03824171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55946204|NCT03824171|Hormone Antagonists|hormone antagonists|mesh-ancestor
55946205|NCT03824171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946206|NCT03824171|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55946257|NCT02064673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946258|NCT02064673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946259|NCT04392713|Ivermectin|ivermectin|mesh-list
55946260|NCT04392713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55946261|NCT04392713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946262|NCT03823625|Nivolumab|nivolumab|mesh-list
55946263|NCT03823625|Ipilimumab|ipilimumab|mesh-list
55946264|NCT03823625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55946268|NCT02053909|Aspirin|aspirin|mesh-list
55946324|NCT02935361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946325|NCT02935361|Immunologic Factors|immunologic factors|mesh-ancestor
55946326|NCT02935361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946327|NCT02935361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55946328|NCT02935361|Antimetabolites|antimetabolites|mesh-ancestor
55946329|NCT02935361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946330|NCT02935361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946331|NCT02614794|Capecitabine|capecitabine|mesh-list
55946383|NCT03044808|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55946384|NCT03044808|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55946385|NCT03044808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55946386|NCT03044808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946387|NCT04430166|Antibodies|antibodies|mesh-list
55946388|NCT04430166|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55946389|NCT04430166|Immunologic Factors|immunologic factors|mesh-ancestor
55946390|NCT04430166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946449|NCT04864782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946450|NCT04864782|Tubulin Modulators|tubulin modulators|mesh-ancestor
55946451|NCT04864782|Antimitotic Agents|antimitotic agents|mesh-ancestor
55946452|NCT04864782|Mitosis Modulators|mitosis modulators|mesh-ancestor
55946453|NCT04864782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946454|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55946455|NCT04875702|Allopurinol|allopurinol|mesh-list
55946456|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
55946457|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946458|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946459|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
55946460|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55946461|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55946511|NCT02740985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55946512|NCT02740985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55946514|NCT02740985|Hormone Antagonists|hormone antagonists|mesh-ancestor
55946515|NCT02740985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946516|NCT02740985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946517|NCT02740985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55946518|NCT03046290|Lidocaine|lidocaine|mesh-list
55946519|NCT03046290|Ropivacaine|ropivacaine|mesh-list
55946520|NCT03046290|Anesthetics, Local|anesthetics, local|mesh-ancestor
55946521|NCT03046290|Anesthetics|anesthetics|mesh-ancestor
55743727|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946574|NCT04553003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946575|NCT04553003|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55946576|NCT04553003|Nootropic Agents|nootropic agents|mesh-ancestor
55946577|NCT03044184|Tranylcypromine|tranylcypromine|mesh-list
55946578|NCT03044184|Tranexamic Acid|tranexamic acid|mesh-list
55946579|NCT03044184|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55946580|NCT03044184|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55946581|NCT03044184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946583|NCT03044184|Coagulants|coagulants|mesh-ancestor
55946584|NCT03044184|Antidepressive Agents|antidepressive agents|mesh-ancestor
55946585|NCT03044184|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55946586|NCT03044184|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55946587|NCT03044184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946588|NCT03044184|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55946589|NCT03044184|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55946590|NCT03044184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946592|NCT03047772|Atorvastatin|atorvastatin|mesh-list
55946628|NCT03822065|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55946629|NCT03822065|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55946630|NCT03822065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55946631|NCT03822065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946632|NCT03822065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946633|NCT03822065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946634|NCT03822065|Antidepressive Agents|antidepressive agents|mesh-ancestor
55946635|NCT03822065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55946636|NCT03821987|Cyclophosphamide|cyclophosphamide|mesh-list
55946637|NCT03821987|Busulfan|busulfan|mesh-list
55946638|NCT03821987|Fludarabine|fludarabine|mesh-list
55946692|NCT03820193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946693|NCT03820193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946694|NCT03820193|Anticonvulsants|anticonvulsants|mesh-ancestor
55946695|NCT03820193|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55946696|NCT03820193|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55946697|NCT03820193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946698|NCT03820193|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55946699|NCT03820193|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55946700|NCT03820193|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55946701|NCT03820193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55946702|NCT03820193|Antimanic Agents|antimanic agents|mesh-ancestor
55946757|NCT04867980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946758|NCT04867980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946759|NCT04868058|Ropivacaine|ropivacaine|mesh-list
55946760|NCT04868058|Anesthetics, Local|anesthetics, local|mesh-ancestor
55946761|NCT04868058|Anesthetics|anesthetics|mesh-ancestor
55946762|NCT04868058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55946763|NCT04868058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946764|NCT04868058|Sensory System Agents|sensory system agents|mesh-ancestor
55946765|NCT04868058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55946766|NCT01450241|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55946767|NCT01450241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55946768|NCT04391621|Triamcinolone|triamcinolone|mesh-list
55946769|NCT04391621|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55946770|NCT04391621|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55946771|NCT04391621|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55946772|NCT04391621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55946816|NCT04873284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946817|NCT04873284|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55946818|NCT04873284|Glucocorticoids|glucocorticoids|mesh-ancestor
55946819|NCT04873284|Hormones|hormones|mesh-ancestor
55946820|NCT04873284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55946821|NCT04873284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55946822|NCT04873284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55946882|NCT01451333|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55946883|NCT01451333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55946884|NCT01451333|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55946885|NCT01451333|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55946886|NCT01451333|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55946887|NCT01451333|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55946888|NCT01702831|Lenalidomide|lenalidomide|mesh-list
55946889|NCT01702831|Melphalan|melphalan|mesh-list
55946890|NCT01702831|Busulfan|busulfan|mesh-list
55946891|NCT01702831|Immunologic Factors|immunologic factors|mesh-ancestor
55946903|NCT03045510|Decitabine|decitabine|mesh-list
55946944|NCT01452113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55946945|NCT01452113|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55946947|NCT01452113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55946948|NCT01452113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946949|NCT02022709|Fluvoxamine|fluvoxamine|mesh-list
55946950|NCT02022709|Sertraline|sertraline|mesh-list
55946951|NCT02022709|Fluoxetine|fluoxetine|mesh-list
55946952|NCT02022709|Paroxetine|paroxetine|mesh-list
55946953|NCT02022709|Citalopram|citalopram|mesh-list
55946954|NCT02022709|Antidepressive Agents|antidepressive agents|mesh-ancestor
55946955|NCT02022709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55946956|NCT02022709|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55946957|NCT02022709|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55946958|NCT02022709|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55946959|NCT02022709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55946960|NCT02022709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947005|NCT01896349|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55947006|NCT01896349|Nortriptyline|nortriptyline|mesh-list
55947007|NCT01896349|Imipramine|imipramine|mesh-list
55947008|NCT01896349|Clomipramine|clomipramine|mesh-list
55947009|NCT01896349|Antidepressive Agents|antidepressive agents|mesh-list
55947010|NCT01896349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55947011|NCT01896349|Serotonin Agents|serotonin agents|mesh-ancestor
55947049|NCT01452737|Bisacodyl|bisacodyl|mesh-list
55947075|NCT01659307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55947076|NCT01659307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55947077|NCT01659307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55947078|NCT01659307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55947079|NCT01659307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947080|NCT01659307|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55947081|NCT01659307|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55947082|NCT01659307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947083|NCT01659307|Antipyretics|antipyretics|mesh-ancestor
55947084|NCT01594476|Levonorgestrel|levonorgestrel|mesh-list
55947085|NCT01594476|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55947087|NCT01594476|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55947136|NCT01454609|Adrenergic Agents|adrenergic agents|mesh-ancestor
55947137|NCT01454609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947138|NCT01454609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947139|NCT03042234|Insulin|insulin|mesh-list
55947140|NCT03042234|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55947141|NCT03042234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55947142|NCT03042234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947143|NCT02905799|Resveratrol|resveratrol|mesh-list
55947144|NCT02905799|Antioxidants|antioxidants|mesh-ancestor
55947145|NCT02905799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947200|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
55947204|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
55947277|NCT04778137|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55947278|NCT04778137|Respiratory System Agents|respiratory system agents|mesh-ancestor
55947279|NCT03815929|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55947280|NCT03815929|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55947281|NCT03815929|Estradiol|estradiol|mesh-list
55947282|NCT03815929|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55947283|NCT03815929|Estrogens|estrogens|mesh-ancestor
55947284|NCT03815929|Hormones|hormones|mesh-ancestor
55947285|NCT03815929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55947286|NCT03815929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947287|NCT03815929|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55947288|NCT03815929|Contraceptive Agents|contraceptive agents|mesh-ancestor
55947289|NCT03815929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55947290|NCT03815929|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55947291|NCT00394147|Gemcitabine|gemcitabine|mesh-list
55947292|NCT00394147|Pemetrexed|pemetrexed|mesh-list
55947293|NCT00394147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55947294|NCT00394147|Antimetabolites|antimetabolites|mesh-ancestor
55947295|NCT00394147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947341|NCT00332605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947342|NCT00332605|Protective Agents|protective agents|mesh-ancestor
55947343|NCT00332605|Antidotes|antidotes|mesh-ancestor
55947344|NCT01458743|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55947345|NCT01458743|Cephalosporins|cephalosporins|mesh-list
55947346|NCT01458743|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55947347|NCT01458743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55947348|NCT01415583|Dexamethasone|dexamethasone|mesh-list
55947349|NCT01415583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55947351|NCT01415583|Autonomic Agents|autonomic agents|mesh-ancestor
55947352|NCT01415583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947354|NCT01415583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55947404|NCT01459211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947405|NCT01459211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55947406|NCT01459211|Glucocorticoids|glucocorticoids|mesh-ancestor
55947407|NCT01459211|Hormones|hormones|mesh-ancestor
55947408|NCT01459211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55947409|NCT01459211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55947410|NCT01459211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55947411|NCT01459211|Immunologic Factors|immunologic factors|mesh-ancestor
55947474|NCT01459367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55947475|NCT01459367|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55947476|NCT01459367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947544|NCT01456481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947545|NCT01456481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55947546|NCT01456481|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55947547|NCT01456481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55947548|NCT01456481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55947549|NCT01456481|Adrenergic Agents|adrenergic agents|mesh-ancestor
55947550|NCT01456481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55947551|NCT01456481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947552|NCT02872259|Pembrolizumab|pembrolizumab|mesh-list
55947553|NCT02872259|Trametinib|trametinib|mesh-list
55947609|NCT01459679|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55947611|NCT01459679|Vitamins|vitamins|mesh-ancestor
55947621|NCT01455857|Exenatide|exenatide|mesh-list
55947685|NCT01419639|Immunologic Factors|immunologic factors|mesh-ancestor
55947758|NCT01039285|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
55743749|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
55947759|NCT01039285|Respiratory System Agents|respiratory system agents|mesh-ancestor
55947760|NCT03043482|Calcitriol|calcitriol|mesh-list
55947761|NCT03043482|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55947762|NCT03043482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947763|NCT03043482|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55947764|NCT03043482|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55947766|NCT03043482|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55947824|NCT01420653|Ibuprofen|ibuprofen|mesh-list
55947826|NCT01420653|Analgesics|analgesics|mesh-ancestor
55947827|NCT01420653|Sensory System Agents|sensory system agents|mesh-ancestor
55947828|NCT01420653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743750|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55947830|NCT01420653|Antipyretics|antipyretics|mesh-ancestor
55947831|NCT01420653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55947832|NCT01420653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55947833|NCT01420653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55947834|NCT01420653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55947835|NCT01420653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947889|NCT00962845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947891|NCT04390685|Tacrolimus|tacrolimus|mesh-list
55947892|NCT04390685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55947894|NCT04390685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55947895|NCT04390685|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55947896|NCT04390685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947958|NCT01545141|Analgesics|analgesics|mesh-ancestor
55947959|NCT01545141|Sensory System Agents|sensory system agents|mesh-ancestor
55947960|NCT01545141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55947961|NCT01545141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55947962|NCT01545141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55947963|NCT01545141|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55947964|NCT01545141|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55947965|NCT01545141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55947966|NCT01545141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55947967|NCT01545141|Interferon Inducers|interferon inducers|mesh-ancestor
55947968|NCT02849639|Scopolamine|scopolamine|mesh-list
55947969|NCT02849639|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55947971|NCT02849639|Antiemetics|antiemetics|mesh-ancestor
55948021|NCT04847622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948023|NCT04847622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948024|NCT04781803|Cyclosporine|cyclosporine|mesh-list
55948025|NCT04781803|Cyclosporins|cyclosporins|mesh-list
55948026|NCT04781803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948027|NCT04781803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948028|NCT04781803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948088|NCT04773301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948090|NCT04780945|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55948091|NCT04780945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948092|NCT04780945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948093|NCT04780945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948094|NCT05021315|Povidone-Iodine|povidone-iodine|mesh-list
55948095|NCT05021315|Povidone|povidone|mesh-list
55948096|NCT05021315|Plasma Substitutes|plasma substitutes|mesh-ancestor
55948097|NCT05021315|Blood Substitutes|blood substitutes|mesh-ancestor
55948098|NCT05021315|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55948099|NCT05021315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948100|NCT04859322|Glucagon|glucagon|mesh-list
55948101|NCT04859322|Somatostatin|somatostatin|mesh-list
55948104|NCT04859322|Hormones|hormones|mesh-ancestor
55948150|NCT04846452|Antimitotic Agents|antimitotic agents|mesh-ancestor
55948151|NCT04846452|Mitosis Modulators|mitosis modulators|mesh-ancestor
55948152|NCT04846452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948153|NCT04846452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948154|NCT04846452|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55948155|NCT04846452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55948156|NCT04859244|Remdesivir|remdesivir|mesh-list
55948157|NCT04859244|GS-441524|gs-441524|mesh-list
55948158|NCT04859244|Antimetabolites|antimetabolites|mesh-ancestor
55948159|NCT04859244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948160|NCT04859244|Antiviral Agents|antiviral agents|mesh-ancestor
55948161|NCT04859244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948162|NCT05028725|Lugol's solution|lugol's solution|mesh-list
55948163|NCT05028725|Hemostatics|hemostatics|mesh-ancestor
55948164|NCT05028725|Coagulants|coagulants|mesh-ancestor
55948165|NCT01549587|Listerine|listerine|mesh-list
55948167|NCT01549587|Fluorides|fluorides|mesh-list
55948212|NCT04772287|Docetaxel|docetaxel|mesh-list
55948213|NCT04772287|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55948214|NCT04772287|Cisplatin|cisplatin|mesh-list
55948215|NCT04772287|Carboplatin|carboplatin|mesh-list
55948216|NCT04772287|Pemetrexed|pemetrexed|mesh-list
55948217|NCT04772287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55948218|NCT04772287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948219|NCT04772287|Tubulin Modulators|tubulin modulators|mesh-ancestor
55948222|NCT04772287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948223|NCT04772287|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55948224|NCT04772287|Antimetabolites|antimetabolites|mesh-ancestor
55948225|NCT04772287|Antiviral Agents|antiviral agents|mesh-ancestor
55948226|NCT04772287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55948227|NCT04772287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948228|NCT04772287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948229|NCT04772287|Immunologic Factors|immunologic factors|mesh-ancestor
55948271|NCT03040830|Hormones|hormones|mesh-ancestor
55948272|NCT03040830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948273|NCT03040830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948274|NCT04390295|Metformin|metformin|mesh-list
55948275|NCT04390295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55948276|NCT04390295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948277|NCT03030235|Dapagliflozin|dapagliflozin|mesh-list
55948278|NCT03030235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55948279|NCT03030235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948280|NCT03030235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55948336|NCT02950051|Immunologic Factors|immunologic factors|mesh-ancestor
55948337|NCT02950051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948338|NCT02950051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55948339|NCT02950051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55948340|NCT02950051|Alkylating Agents|alkylating agents|mesh-ancestor
55948341|NCT02950051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948342|NCT02950051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948343|NCT02950051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55948344|NCT02950051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55948345|NCT01890941|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55948346|NCT01890941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55948348|NCT01891019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948349|NCT01891019|Immunologic Factors|immunologic factors|mesh-ancestor
55948350|NCT01891019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948396|NCT02983097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55948397|NCT02983097|Growth Substances|growth substances|mesh-ancestor
55948398|NCT02983097|Growth Inhibitors|growth inhibitors|mesh-ancestor
55948399|NCT00750841|Cediranib|cediranib|mesh-list
55948400|NCT00750841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948401|NCT00750841|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55948402|NCT00750841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948403|NCT00750841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948404|NCT01891175|Anesthetics|anesthetics|mesh-list
55948405|NCT01891175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948406|NCT01891175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948407|NCT02347865|Denosumab|denosumab|mesh-list
55948408|NCT02347865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55948409|NCT02347865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948410|NCT01550367|Hydroxychloroquine|hydroxychloroquine|mesh-list
55948457|NCT01892813|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55948458|NCT01892813|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55948459|NCT01892813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55948460|NCT01892813|Dopamine Agents|dopamine agents|mesh-ancestor
55948461|NCT01892813|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55948462|NCT01892813|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55948463|NCT01892813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948523|NCT05606497|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948524|NCT05606497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55948525|NCT05606497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948526|NCT05606497|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55948527|NCT05606497|Respiratory System Agents|respiratory system agents|mesh-ancestor
55948533|NCT04778917|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55948535|NCT04778917|Dalteparin|dalteparin|mesh-list
55948536|NCT04778917|Calcium heparin|calcium heparin|mesh-list
55948537|NCT04778917|Calcium|calcium|mesh-list
55948584|NCT00053989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948585|NCT00053989|Immunologic Factors|immunologic factors|mesh-ancestor
55948586|NCT00053989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948588|NCT00053989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55948589|NCT00053989|Alkylating Agents|alkylating agents|mesh-ancestor
55948594|NCT00053989|Antimetabolites|antimetabolites|mesh-ancestor
55948721|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
55948722|NCT02670707|Hormones|hormones|mesh-ancestor
55948723|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948724|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948725|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55948726|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55948727|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55948728|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
55948729|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948776|NCT02661503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948777|NCT02661503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55948778|NCT02661503|Glucocorticoids|glucocorticoids|mesh-ancestor
55948780|NCT02661503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55948781|NCT02661503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55948782|NCT02661503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55948783|NCT02661503|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55948784|NCT02661503|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55948785|NCT02661503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948786|NCT02661503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55948787|NCT02661503|Tubulin Modulators|tubulin modulators|mesh-ancestor
55948788|NCT02661503|Antimitotic Agents|antimitotic agents|mesh-ancestor
55948789|NCT02661503|Mitosis Modulators|mitosis modulators|mesh-ancestor
55948833|NCT01431105|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55948834|NCT01431105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948835|NCT03038958|Prilocaine|prilocaine|mesh-list
55948836|NCT03038958|Chloroprocaine|chloroprocaine|mesh-list
55948837|NCT03038958|Anesthetics, Local|anesthetics, local|mesh-ancestor
55948838|NCT03038958|Anesthetics|anesthetics|mesh-ancestor
55948839|NCT03038958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55948840|NCT03038958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948843|NCT04840290|Paclitaxel|paclitaxel|mesh-list
55948903|NCT02588105|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55948904|NCT02588105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55948905|NCT02588105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948906|NCT02588105|Antidotes|antidotes|mesh-ancestor
55948907|NCT02588105|Protective Agents|protective agents|mesh-ancestor
55948908|NCT02588105|Vitamin B Complex|vitamin b complex|mesh-ancestor
55948909|NCT02588105|Vitamins|vitamins|mesh-ancestor
55948910|NCT02588105|Micronutrients|micronutrients|mesh-ancestor
55948911|NCT02588105|Hematinics|hematinics|mesh-ancestor
55948912|NCT02588105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55948913|NCT02588105|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55948914|NCT01488279|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55948915|NCT01488279|Dexamethasone|dexamethasone|mesh-list
55948916|NCT01488279|Dexamethasone acetate|dexamethasone acetate|mesh-list
55948917|NCT01488279|BB 1101|bb 1101|mesh-list
55948918|NCT01488279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948919|NCT01488279|Antiemetics|antiemetics|mesh-ancestor
55948965|NCT04843098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948966|NCT01490931|Ketorolac|ketorolac|mesh-list
55948967|NCT01490931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55948968|NCT01490931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55948969|NCT01490931|Analgesics|analgesics|mesh-ancestor
55948970|NCT01490931|Sensory System Agents|sensory system agents|mesh-ancestor
55948971|NCT01490931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55948972|NCT01490931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948973|NCT01490931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55948975|NCT01490931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55948976|NCT01490931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55948977|NCT01490931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55948978|NCT02562365|Cyclophosphamide|cyclophosphamide|mesh-list
55948979|NCT02562365|Carboplatin|carboplatin|mesh-list
55948980|NCT02562365|Etoposide|etoposide|mesh-list
55948981|NCT02562365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55948982|NCT02562365|Immunologic Factors|immunologic factors|mesh-ancestor
55948983|NCT02562365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55948984|NCT02562365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55948985|NCT02562365|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55948986|NCT02562365|Alkylating Agents|alkylating agents|mesh-ancestor
55948994|NCT01491633|Dasatinib|dasatinib|mesh-list
55949016|NCT04839198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949017|NCT04839198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949018|NCT04839198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55949019|NCT04839198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55949020|NCT04839198|Cholinergic Agents|cholinergic agents|mesh-ancestor
55949021|NCT04839198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949022|NCT04839198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949039|NCT01436799|Alfentanil|alfentanil|mesh-list
55949083|NCT02479451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949084|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
55949085|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55949086|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55949087|NCT02444429|Prednisolone|prednisolone|mesh-list
55949088|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
55949089|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55949090|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
55949091|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55949147|NCT01894061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949148|NCT01894061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55949149|NCT01894061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55949150|NCT01894061|Growth Substances|growth substances|mesh-ancestor
55949151|NCT01894061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949152|NCT01894061|Growth Inhibitors|growth inhibitors|mesh-ancestor
55949153|NCT01894061|Immunologic Factors|immunologic factors|mesh-ancestor
55949155|NCT01561053|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55949156|NCT01561053|Antibodies|antibodies|mesh-list
55949157|NCT01561053|Immunologic Factors|immunologic factors|mesh-ancestor
55743788|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55949158|NCT01561053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949159|NCT02324387|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
55949160|NCT02324387|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55949161|NCT02324387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949204|NCT01441245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949205|NCT01441245|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55949206|NCT01441245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55949207|NCT01441245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949208|NCT02298257|Doxorubicin|doxorubicin|mesh-list
55949209|NCT02298257|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55949211|NCT02298257|Dacarbazine|dacarbazine|mesh-list
55949271|NCT04833738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949272|NCT04833738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55949273|NCT04833738|Immunologic Factors|immunologic factors|mesh-ancestor
55949274|NCT04833738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949275|NCT04833738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949276|NCT04833738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55949277|NCT04833738|Viscosupplements|viscosupplements|mesh-ancestor
55949278|NCT04833738|Protective Agents|protective agents|mesh-ancestor
55949337|NCT03037944|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55949338|NCT03037944|Hormone Antagonists|hormone antagonists|mesh-ancestor
55949339|NCT03037944|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55949340|NCT03037944|Diuretics|diuretics|mesh-ancestor
55949341|NCT03037944|Natriuretic Agents|natriuretic agents|mesh-ancestor
55949342|NCT03060473|Amoxicillin|amoxicillin|mesh-list
55949343|NCT03060473|Azithromycin|azithromycin|mesh-list
55949344|NCT03060473|Erythromycin|erythromycin|mesh-list
55949345|NCT03060473|Erythromycin Estolate|erythromycin estolate|mesh-list
55949346|NCT03060473|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55949347|NCT03060473|Erythromycin stearate|erythromycin stearate|mesh-list
55949348|NCT03060473|Ampicillin|ampicillin|mesh-list
55949349|NCT03060473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55949350|NCT03060473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55949398|NCT04832880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949400|NCT04832880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55949401|NCT01447017|Carbamide Peroxide|carbamide peroxide|mesh-list
55949402|NCT01447017|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55949403|NCT01447017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55949404|NCT01894295|Vitamin D|vitamin d|mesh-list
55949405|NCT01894295|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55949463|NCT02140151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55949464|NCT02140151|Growth Substances|growth substances|mesh-ancestor
55949465|NCT02140151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949466|NCT02140151|Growth Inhibitors|growth inhibitors|mesh-ancestor
55949467|NCT02140151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949468|NCT02135315|Isosorbide|isosorbide|mesh-list
55949469|NCT02135315|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55949470|NCT02135315|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55949471|NCT02135315|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55949472|NCT02135315|Diuretics|diuretics|mesh-ancestor
55949473|NCT02135315|Natriuretic Agents|natriuretic agents|mesh-ancestor
55949474|NCT02135315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949525|NCT02101775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949526|NCT02101775|Antiviral Agents|antiviral agents|mesh-ancestor
55949527|NCT02101775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55949528|NCT02101775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55949529|NCT02101775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55949530|NCT02101775|Immunologic Factors|immunologic factors|mesh-ancestor
55949531|NCT02101775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949532|NCT02099591|Naloxegol|naloxegol|mesh-list
55949533|NCT02099591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55949534|NCT02099591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949535|NCT02099591|Sensory System Agents|sensory system agents|mesh-ancestor
55949536|NCT02099591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949537|NCT01568073|Levodopa|levodopa|mesh-list
55949588|NCT02062463|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55949589|NCT02062463|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55949590|NCT02062463|Adrenergic Agents|adrenergic agents|mesh-ancestor
55949591|NCT02062463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55949592|NCT02062463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949593|NCT01501929|Metoprolol|metoprolol|mesh-list
55949594|NCT01501929|Nebivolol|nebivolol|mesh-list
55949595|NCT01501929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55949596|NCT01501929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55949597|NCT01501929|Sympatholytics|sympatholytics|mesh-ancestor
55949598|NCT01501929|Autonomic Agents|autonomic agents|mesh-ancestor
55949599|NCT01501929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949601|NCT01501929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55949602|NCT01501929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55949603|NCT01501929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55949617|NCT02049593|Irinotecan|irinotecan|mesh-list
55949646|NCT01449747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949723|NCT04836156|Immunologic Factors|immunologic factors|mesh-ancestor
55949724|NCT04836156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949725|NCT04836156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55949726|NCT04836156|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55949727|NCT04836156|Alkylating Agents|alkylating agents|mesh-ancestor
55949728|NCT04836156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949729|NCT04836156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949730|NCT04836156|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55949731|NCT04836156|Tubulin Modulators|tubulin modulators|mesh-ancestor
55949732|NCT04836156|Antimitotic Agents|antimitotic agents|mesh-ancestor
55949787|NCT01431755|Lidocaine|lidocaine|mesh-list
55949788|NCT01431755|Hyaluronic Acid|hyaluronic acid|mesh-list
55949789|NCT01431755|Anesthetics, Local|anesthetics, local|mesh-ancestor
55949790|NCT01431755|Anesthetics|anesthetics|mesh-ancestor
55949791|NCT01431755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55949792|NCT01431755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949793|NCT01431755|Sensory System Agents|sensory system agents|mesh-ancestor
55949794|NCT01431755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949795|NCT01431755|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55949796|NCT01431755|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55949797|NCT01431755|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55949798|NCT01431755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55949799|NCT01431755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949800|NCT01431755|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55949801|NCT01431755|Immunologic Factors|immunologic factors|mesh-ancestor
55949802|NCT01431755|Viscosupplements|viscosupplements|mesh-ancestor
55949864|NCT04304040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55949865|NCT04304040|Immunologic Factors|immunologic factors|mesh-ancestor
55949866|NCT04304040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949867|NCT00156013|Clofarabine|clofarabine|mesh-list
55949868|NCT00156013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55949870|NCT00156013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55949871|NCT00156013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55949872|NCT01358669|Denosumab|denosumab|mesh-list
55949873|NCT01358669|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55949874|NCT01358669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949916|NCT01576809|Analgesics|analgesics|mesh-ancestor
55949917|NCT01576809|Sensory System Agents|sensory system agents|mesh-ancestor
55949918|NCT01576809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55949919|NCT01576809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949920|NCT01576809|Antipyretics|antipyretics|mesh-ancestor
55949921|NCT01576809|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55949922|NCT01576809|Mydriatics|mydriatics|mesh-ancestor
55949923|NCT01576809|Autonomic Agents|autonomic agents|mesh-ancestor
55949924|NCT01576809|Sympathomimetics|sympathomimetics|mesh-ancestor
55949925|NCT01576809|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55949926|NCT01576809|Nasal Decongestants|nasal decongestants|mesh-ancestor
55949927|NCT01576809|Respiratory System Agents|respiratory system agents|mesh-ancestor
55949928|NCT01576809|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55949929|NCT01576809|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55949930|NCT01576809|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55949979|NCT01319981|Vincristine|vincristine|mesh-list
55949980|NCT01319981|Imatinib Mesylate|imatinib mesylate|mesh-list
55949981|NCT01319981|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55949982|NCT01319981|Prednisolone phosphate|prednisolone phosphate|mesh-list
55949983|NCT01319981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55949984|NCT01319981|Immunologic Factors|immunologic factors|mesh-ancestor
55949985|NCT01319981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55949986|NCT01319981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55949987|NCT01319981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55949988|NCT01319981|Alkylating Agents|alkylating agents|mesh-ancestor
55949989|NCT01319981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950042|NCT00065611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950043|NCT00066781|Gemcitabine|gemcitabine|mesh-list
55950044|NCT00066781|Irinotecan|irinotecan|mesh-list
55950045|NCT00066781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950046|NCT00066781|Antimetabolites|antimetabolites|mesh-ancestor
55950047|NCT00066781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950048|NCT00066781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950049|NCT00066781|Antiviral Agents|antiviral agents|mesh-ancestor
55950058|NCT01189643|Irinotecan|irinotecan|mesh-list
55950110|NCT01061411|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55950111|NCT01061411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950112|NCT01061411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55950113|NCT01061411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55950114|NCT01061411|Growth Substances|growth substances|mesh-ancestor
55950115|NCT01061411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950116|NCT01061411|Growth Inhibitors|growth inhibitors|mesh-ancestor
55950117|NCT01061411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55950118|NCT01061411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950119|NCT01061411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950120|NCT01061411|Anticoagulants|anticoagulants|mesh-ancestor
55950121|NCT01061411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55950175|NCT04834986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950176|NCT04827966|Calcium, Dietary|calcium, dietary|mesh-list
55950177|NCT04827966|Listerine|listerine|mesh-list
55950178|NCT04827966|Calcium|calcium|mesh-list
55950179|NCT04827966|Fluorides|fluorides|mesh-list
55950180|NCT04827966|Sodium Fluoride|sodium fluoride|mesh-list
55950181|NCT04827966|Caseins|caseins|mesh-list
55950182|NCT04827966|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55950185|NCT04827966|Cariostatic Agents|cariostatic agents|mesh-ancestor
55950243|NCT01896323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55950244|NCT01896323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55950245|NCT01896323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950246|NCT01896323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950247|NCT01896323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55950248|NCT01896323|Hormone Antagonists|hormone antagonists|mesh-ancestor
55950250|NCT01896323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950309|NCT02096029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950311|NCT02205801|Anesthetics, Local|anesthetics, local|mesh-ancestor
55950312|NCT02205801|Anesthetics|anesthetics|mesh-ancestor
55950313|NCT02205801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950314|NCT02205801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950315|NCT02205801|Sensory System Agents|sensory system agents|mesh-ancestor
55950316|NCT02205801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950317|NCT02096107|Everolimus|everolimus|mesh-list
55950318|NCT02096107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950374|NCT05617950|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55950375|NCT05617950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55950376|NCT05617950|Analgesics|analgesics|mesh-ancestor
55950377|NCT05617950|Sensory System Agents|sensory system agents|mesh-ancestor
55950378|NCT05617950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950379|NCT05617950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950380|NCT05617950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55950381|NCT05617950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55950382|NCT05617950|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55950383|NCT05617950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950384|NCT05617950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950385|NCT04834752|Esomeprazole|esomeprazole|mesh-list
55950386|NCT04834752|Omeprazole|omeprazole|mesh-list
55950387|NCT04834752|Rabeprazole|rabeprazole|mesh-list
55950388|NCT04834752|Pantoprazole|pantoprazole|mesh-list
55950389|NCT04834752|Lansoprazole|lansoprazole|mesh-list
55950433|NCT05617872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55950434|NCT05617872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950435|NCT04198727|Capecitabine|capecitabine|mesh-list
55950436|NCT04198727|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55950437|NCT04198727|Antimetabolites|antimetabolites|mesh-ancestor
55950438|NCT04198727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950439|NCT04198727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950440|NCT00437255|Betamethasone|betamethasone|mesh-list
55950441|NCT00437255|Betamethasone Valerate|betamethasone valerate|mesh-list
55950442|NCT00437255|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55950443|NCT00437255|Betamethasone benzoate|betamethasone benzoate|mesh-list
55950444|NCT00437255|Clobetasol|clobetasol|mesh-list
55950445|NCT00437255|Calcipotriene|calcipotriene|mesh-list
55950446|NCT00437255|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55950449|NCT00437255|Hormones|hormones|mesh-ancestor
55950495|NCT01579305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55950496|NCT01579305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950497|NCT00212147|Nitrous Oxide|nitrous oxide|mesh-list
55950498|NCT00212147|Anesthetics|anesthetics|mesh-list
55950499|NCT00212147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950500|NCT00212147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950501|NCT00212147|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55950502|NCT00212147|Anesthetics, General|anesthetics, general|mesh-ancestor
55950503|NCT00212147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55950504|NCT00212147|Analgesics|analgesics|mesh-ancestor
55950505|NCT00212147|Sensory System Agents|sensory system agents|mesh-ancestor
55950506|NCT00212147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950507|NCT04820010|Insulin|insulin|mesh-list
55950508|NCT04820010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55950557|NCT04825938|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55950558|NCT04825938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950559|NCT04825938|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950560|NCT04825938|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950561|NCT04825938|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950562|NCT04825938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950564|NCT04826016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55950624|NCT01467999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950625|NCT05617482|Anesthetics|anesthetics|mesh-list
55950626|NCT05617482|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950627|NCT05617482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950628|NCT01470027|Acetylcysteine|acetylcysteine|mesh-list
55950629|NCT01470027|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55950630|NCT01470027|Antiviral Agents|antiviral agents|mesh-ancestor
55950631|NCT01470027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950632|NCT01470027|Expectorants|expectorants|mesh-ancestor
55950633|NCT01470027|Respiratory System Agents|respiratory system agents|mesh-ancestor
55950634|NCT01470027|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55950635|NCT01470027|Antioxidants|antioxidants|mesh-ancestor
55950636|NCT01470027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950637|NCT01470027|Protective Agents|protective agents|mesh-ancestor
55950638|NCT01470027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950639|NCT01470027|Antidotes|antidotes|mesh-ancestor
55950680|NCT02604342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950681|NCT02604342|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55950682|NCT02604342|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55950684|NCT04781777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55950685|NCT04781777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950686|NCT04781075|Bupivacaine|bupivacaine|mesh-list
55950687|NCT04781075|Anesthetics, Local|anesthetics, local|mesh-ancestor
55950688|NCT04781075|Anesthetics|anesthetics|mesh-ancestor
55950689|NCT04781075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55950690|NCT04781075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950691|NCT04781075|Sensory System Agents|sensory system agents|mesh-ancestor
55950692|NCT04781075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950693|NCT01586091|Fexofenadine|fexofenadine|mesh-list
55950694|NCT01586091|Levocetirizine|levocetirizine|mesh-list
55795295|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55950695|NCT01586091|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55950696|NCT01586091|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55950697|NCT01586091|Histamine Antagonists|histamine antagonists|mesh-ancestor
55950698|NCT01586091|Histamine Agents|histamine agents|mesh-ancestor
55950699|NCT01586091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950701|NCT01586091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950733|NCT01587027|Respiratory System Agents|respiratory system agents|mesh-ancestor
55950734|NCT01587027|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55950736|NCT01587027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950737|NCT01587027|Vasodilator Agents|vasodilator agents|mesh-ancestor
55950738|NCT01587027|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55950739|NCT01587027|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55950740|NCT01587027|Purinergic Agents|purinergic agents|mesh-ancestor
55950741|NCT01587027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950742|NCT01587027|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55950743|NCT01587027|Protective Agents|protective agents|mesh-ancestor
55950744|NCT01587027|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55950745|NCT01587027|Diuretics|diuretics|mesh-ancestor
55950746|NCT01587027|Natriuretic Agents|natriuretic agents|mesh-ancestor
55950747|NCT04807140|Paclitaxel|paclitaxel|mesh-list
55950748|NCT04807140|Carboplatin|carboplatin|mesh-list
55950749|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55950750|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950751|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
55950752|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
55950753|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
55950754|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950786|NCT04754789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55950788|NCT04754789|Analgesics|analgesics|mesh-ancestor
55950789|NCT04754789|Sensory System Agents|sensory system agents|mesh-ancestor
55950790|NCT04754789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950791|NCT04754789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950792|NCT04754789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55950793|NCT04754789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55950794|NCT04754789|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55950795|NCT04754789|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55950796|NCT04754789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950797|NCT04754789|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55950798|NCT04754789|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55950799|NCT04754789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55950800|NCT04754789|Antipyretics|antipyretics|mesh-ancestor
55950801|NCT04754789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55950843|NCT04778813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55950844|NCT04778813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55950845|NCT04778813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950846|NCT04778813|Antiviral Agents|antiviral agents|mesh-ancestor
55950847|NCT04778813|Schistosomicides|schistosomicides|mesh-ancestor
55950848|NCT04778813|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55950849|NCT04778813|Anthelmintics|anthelmintics|mesh-ancestor
55950850|NCT04817982|Dexamethasone|dexamethasone|mesh-list
55950851|NCT04817982|Dexamethasone acetate|dexamethasone acetate|mesh-list
55950912|NCT03699995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55950913|NCT03699995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55950914|NCT03699995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55950915|NCT03699995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55950916|NCT03699995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950917|NCT01515345|Clopidogrel|clopidogrel|mesh-list
55950918|NCT01515345|Ticagrelor|ticagrelor|mesh-list
55950919|NCT01515345|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55950920|NCT01515345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55950921|NCT01515345|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55950922|NCT01515345|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55950923|NCT01515345|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55950924|NCT01515345|Purinergic Agents|purinergic agents|mesh-ancestor
55950925|NCT01515345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55950926|NCT01515345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55950927|NCT01515345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950928|NCT01492400|Dexamethasone|dexamethasone|mesh-list
55950929|NCT01492400|Ranibizumab|ranibizumab|mesh-list
55950930|NCT01492400|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55950931|NCT01492400|Antiemetics|antiemetics|mesh-ancestor
55950932|NCT01492400|Autonomic Agents|autonomic agents|mesh-ancestor
55950933|NCT01492400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950934|NCT01492400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950935|NCT01492400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55950936|NCT01492400|Glucocorticoids|glucocorticoids|mesh-ancestor
55950937|NCT01492400|Hormones|hormones|mesh-ancestor
55950940|NCT01492400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55950958|NCT01515657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55950959|NCT01515657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55950960|NCT01515657|Analgesics|analgesics|mesh-ancestor
55950961|NCT01515657|Sensory System Agents|sensory system agents|mesh-ancestor
55954089|NCT01662297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55950962|NCT01515657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55950963|NCT01515657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55950964|NCT01515657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55950965|NCT01515657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951027|NCT02090075|Protease Inhibitors|protease inhibitors|mesh-ancestor
55951028|NCT02090075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951029|NCT02090075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951030|NCT04817202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55951031|NCT04817202|Antibodies|antibodies|mesh-list
55951032|NCT04817202|Immunoglobulins|immunoglobulins|mesh-list
55951033|NCT04817202|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55951034|NCT04817202|Immunologic Factors|immunologic factors|mesh-ancestor
55951035|NCT04817202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951037|NCT04775303|Cyclosporine|cyclosporine|mesh-list
55951090|NCT00074269|Cyclosporine|cyclosporine|mesh-list
55951091|NCT00074269|Methotrexate|methotrexate|mesh-list
55951092|NCT00074269|Fludarabine phosphate|fludarabine phosphate|mesh-list
55951093|NCT00074269|Fludarabine|fludarabine|mesh-list
55951095|NCT00074269|Cyclosporins|cyclosporins|mesh-list
55951096|NCT00074269|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55951097|NCT00074269|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55951098|NCT00074269|Abortifacient Agents|abortifacient agents|mesh-ancestor
55951099|NCT00074269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55951100|NCT00074269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951101|NCT00074269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55951102|NCT00074269|Antimetabolites|antimetabolites|mesh-ancestor
55951103|NCT00074269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951104|NCT00074269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951105|NCT00074269|Dermatologic Agents|dermatologic agents|mesh-ancestor
55951106|NCT00074269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951107|NCT00074269|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55951108|NCT00074269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951109|NCT00074269|Immunologic Factors|immunologic factors|mesh-ancestor
55795321|NCT02632747|Ramipril|ramipril|mesh-list
55951112|NCT00074269|Antifungal Agents|antifungal agents|mesh-ancestor
55951144|NCT00074815|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55951145|NCT00074815|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55951146|NCT00074815|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55951148|NCT04772729|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55951149|NCT04772729|Insulin Aspart|insulin aspart|mesh-list
55951150|NCT04772729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55951151|NCT04772729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951152|NCT05562375|Tolonium Chloride|tolonium chloride|mesh-list
55951153|NCT05562375|Hemostatics|hemostatics|mesh-ancestor
55951154|NCT05562375|Coagulants|coagulants|mesh-ancestor
55951155|NCT05562375|Heparin Antagonists|heparin antagonists|mesh-ancestor
55951156|NCT05562375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951158|NCT00075829|Dexamethasone|dexamethasone|mesh-list
55951159|NCT00075829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55951204|NCT04771559|Immunologic Factors|immunologic factors|mesh-ancestor
55951205|NCT04771559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951206|NCT02592876|Rituximab|rituximab|mesh-list
55951207|NCT02592876|Carboplatin|carboplatin|mesh-list
55951208|NCT02592876|Etoposide|etoposide|mesh-list
55951209|NCT02592876|Ifosfamide|ifosfamide|mesh-list
55951210|NCT02592876|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55951211|NCT02592876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951212|NCT02592876|Immunologic Factors|immunologic factors|mesh-ancestor
55951213|NCT02592876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951214|NCT02592876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951215|NCT02592876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55951216|NCT02592876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55951218|NCT02592876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951267|NCT00176839|Alkylating Agents|alkylating agents|mesh-ancestor
55951268|NCT00176839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951269|NCT00176839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951270|NCT00176839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55951271|NCT00176839|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55951272|NCT00176917|Cyclophosphamide|cyclophosphamide|mesh-list
55951273|NCT00176917|Busulfan|busulfan|mesh-list
55951274|NCT00176917|Thymoglobulin|thymoglobulin|mesh-list
55951275|NCT00176917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951276|NCT00176917|Immunologic Factors|immunologic factors|mesh-ancestor
55951277|NCT00176917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951278|NCT00176917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951279|NCT00176917|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55951280|NCT00176917|Alkylating Agents|alkylating agents|mesh-ancestor
55951281|NCT00176917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951282|NCT00176917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951283|NCT00176917|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55951284|NCT02664155|Vitamin K|vitamin k|mesh-list
55951285|NCT02664155|Heparin|heparin|mesh-list
55951286|NCT02664155|Rivaroxaban|rivaroxaban|mesh-list
55951287|NCT02664155|Apixaban|apixaban|mesh-list
55951288|NCT02664155|Vitamins|vitamins|mesh-ancestor
55951289|NCT02664155|Micronutrients|micronutrients|mesh-ancestor
55951290|NCT02664155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951321|NCT04753151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55951322|NCT04753151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951323|NCT04753151|Hemostatics|hemostatics|mesh-ancestor
55951324|NCT04753151|Coagulants|coagulants|mesh-ancestor
55951327|NCT05606315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55951328|NCT05606315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55951329|NCT05606315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951330|NCT05606315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55951331|NCT05606315|Anesthetics, General|anesthetics, general|mesh-ancestor
55951332|NCT05606315|Anesthetics|anesthetics|mesh-ancestor
55795327|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
55951333|NCT05606315|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55951386|NCT05566743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55951387|NCT05566743|Antimetabolites|antimetabolites|mesh-ancestor
55951388|NCT05566743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951389|NCT05566743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951390|NCT05566665|Meropenem|meropenem|mesh-list
55951391|NCT05566665|Tazobactam|tazobactam|mesh-list
55951392|NCT05566665|Ceftazidime|ceftazidime|mesh-list
55951393|NCT05566665|Avibactam|avibactam|mesh-list
55951394|NCT05566665|Ceftolozane|ceftolozane|mesh-list
55951395|NCT05566665|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
55951396|NCT05566665|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
55951397|NCT05566665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55951398|NCT05566665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951399|NCT05566665|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55951400|NCT05566665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951401|NCT05566665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951445|NCT05417087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55951446|NCT05417087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55951447|NCT05417087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951448|NCT05417087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951449|NCT05417087|Serotonin Agents|serotonin agents|mesh-ancestor
55951450|NCT05417087|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55951451|NCT05417087|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55951452|NCT05417087|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55951453|NCT05417087|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55951454|NCT05331131|Ketamine|ketamine|mesh-list
55951455|NCT05331131|Analgesics|analgesics|mesh-ancestor
55951456|NCT05331131|Sensory System Agents|sensory system agents|mesh-ancestor
55951503|NCT01527045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951504|NCT01527045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55951506|NCT01527045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951507|NCT01527045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951508|NCT01527045|Immunologic Factors|immunologic factors|mesh-ancestor
55951509|NCT01527045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951510|NCT01527045|Antifungal Agents|antifungal agents|mesh-ancestor
55951511|NCT01527045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951512|NCT01527045|Dermatologic Agents|dermatologic agents|mesh-ancestor
55951513|NCT01527045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55951514|NCT01527045|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55951515|NCT01527045|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55951516|NCT01527045|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55743834|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
55951565|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951566|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55951567|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
55951568|NCT01527513|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55951569|NCT01527513|Anticonvulsants|anticonvulsants|mesh-ancestor
55951570|NCT01527513|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55951571|NCT01527513|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55951632|NCT00078559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951633|NCT00078559|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55951634|NCT00078559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955203|NCT01466660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951635|NCT00078559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951636|NCT00078559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55951637|NCT00078559|Analgesics|analgesics|mesh-ancestor
55951638|NCT00078559|Sensory System Agents|sensory system agents|mesh-ancestor
55951639|NCT00078559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55951640|NCT00078559|Antipyretics|antipyretics|mesh-ancestor
55951641|NCT00078559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55951642|NCT00078559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55951643|NCT00078559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55951694|NCT00078715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951695|NCT00078715|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55951697|NCT00078715|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55951698|NCT00078715|Adrenergic Agents|adrenergic agents|mesh-ancestor
55951699|NCT00078715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55951700|NCT00078715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951701|NCT00078715|Urological Agents|urological agents|mesh-ancestor
55951761|NCT01533207|Antiviral Agents|antiviral agents|mesh-ancestor
55951763|NCT01533207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951764|NCT01533207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951765|NCT01533207|Immunologic Factors|immunologic factors|mesh-ancestor
55951766|NCT01533207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951767|NCT01533207|Tubulin Modulators|tubulin modulators|mesh-ancestor
55951768|NCT01533207|Antimitotic Agents|antimitotic agents|mesh-ancestor
55951769|NCT01533207|Mitosis Modulators|mitosis modulators|mesh-ancestor
55951770|NCT01533207|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55951771|NCT01533207|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55951772|NCT01533207|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55951825|NCT01535001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951827|NCT01535001|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55951828|NCT01535001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55951829|NCT01535001|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55951830|NCT01535001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951831|NCT01535001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951832|NCT03000777|Melatonin|melatonin|mesh-list
55951833|NCT03000777|Antioxidants|antioxidants|mesh-ancestor
55951834|NCT03000777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951889|NCT01535937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951890|NCT01535937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55951891|NCT01535937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55951892|NCT01535937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55951893|NCT01535937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55951894|NCT01535937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55951895|NCT01535937|GABA Modulators|gaba modulators|mesh-ancestor
55951896|NCT01535937|GABA Agents|gaba agents|mesh-ancestor
55951897|NCT04813848|Fluorides|fluorides|mesh-list
55951898|NCT04813848|Cariostatic Agents|cariostatic agents|mesh-ancestor
55951899|NCT04813848|Protective Agents|protective agents|mesh-ancestor
55951900|NCT04813848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951901|NCT02999841|Vildagliptin|vildagliptin|mesh-list
55951902|NCT02999841|Acarbose|acarbose|mesh-list
55951903|NCT02999841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55951904|NCT02999841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951905|NCT02999841|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55951906|NCT02999841|Protease Inhibitors|protease inhibitors|mesh-ancestor
55951907|NCT02999841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951908|NCT02999841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951909|NCT02999841|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55951944|NCT04803318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55951945|NCT04803318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55951946|NCT04803318|Immunologic Factors|immunologic factors|mesh-ancestor
55951947|NCT04803318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951948|NCT04803318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55951949|NCT04803318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55951950|NCT04803318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55951951|NCT01537185|Aluminum sulfate|aluminum sulfate|mesh-list
55951952|NCT01537185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55951953|NCT01537185|Immunologic Factors|immunologic factors|mesh-ancestor
55951954|NCT01537185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55951955|NCT04803162|Omeprazole|omeprazole|mesh-list
55951956|NCT04803162|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55951959|NCT04803162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952006|NCT01538745|Anesthetics, General|anesthetics, general|mesh-ancestor
55952008|NCT01538745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952009|NCT01538745|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55952010|NCT01538745|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55952011|NCT01538745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952012|NCT01538745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952013|NCT01538745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55952072|NCT04794738|Narcotics|narcotics|mesh-ancestor
55952073|NCT04794738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952074|NCT04794738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952075|NCT04794738|Analgesics|analgesics|mesh-ancestor
55952076|NCT04794738|Sensory System Agents|sensory system agents|mesh-ancestor
55952077|NCT04794738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952078|NCT04794426|Fluorides|fluorides|mesh-list
55952079|NCT04794426|Cariostatic Agents|cariostatic agents|mesh-ancestor
55952080|NCT04794426|Protective Agents|protective agents|mesh-ancestor
55952081|NCT04794426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952082|NCT04794504|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55952083|NCT04794504|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55952084|NCT04794504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952085|NCT04794504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952086|NCT04794504|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55952087|NCT04794504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55952091|NCT05073315|Adalimumab|adalimumab|mesh-list
55952131|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55952132|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
55952133|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55952134|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55952135|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55952136|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55952137|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55952138|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952139|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55952140|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
55952141|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55952142|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55952191|NCT04814433|Coagulants|coagulants|mesh-ancestor
55952192|NCT04814433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55952193|NCT04814433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55952194|NCT04814433|Adrenergic Agents|adrenergic agents|mesh-ancestor
55952195|NCT04814433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952196|NCT04814433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55952197|NCT04814433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55952198|NCT04814433|Autonomic Agents|autonomic agents|mesh-ancestor
55952201|NCT04814433|Mydriatics|mydriatics|mesh-ancestor
55952259|NCT02248233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55952260|NCT02248233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952261|NCT02248233|Vasodilator Agents|vasodilator agents|mesh-ancestor
55952262|NCT04790838|Fluticasone|fluticasone|mesh-list
55952263|NCT04790838|Xhance|xhance|mesh-list
55952264|NCT04790838|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55952265|NCT04790838|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55952266|NCT04790838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952267|NCT04790838|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55952326|NCT02219997|beta-Endorphin|beta-endorphin|mesh-list
55952327|NCT02219997|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55952328|NCT02219997|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55952329|NCT02219997|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55952330|NCT02219997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952331|NCT02219997|Sympathomimetics|sympathomimetics|mesh-ancestor
55952332|NCT02219997|Autonomic Agents|autonomic agents|mesh-ancestor
55952333|NCT02219997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952392|NCT04790136|Cannabidiol|cannabidiol|mesh-list
55952393|NCT04790136|Anticonvulsants|anticonvulsants|mesh-ancestor
55952394|NCT04339101|Sirolimus|sirolimus|mesh-list
55952395|NCT04339101|Fludarabine|fludarabine|mesh-list
55952396|NCT04339101|Melphalan|melphalan|mesh-list
55952397|NCT04339101|Mechlorethamine|mechlorethamine|mesh-list
55952398|NCT04339101|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55952399|NCT04339101|Tacrolimus|tacrolimus|mesh-list
55952400|NCT04339101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952401|NCT04339101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952402|NCT04339101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55952403|NCT04339101|Immunologic Factors|immunologic factors|mesh-ancestor
55952404|NCT04339101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952405|NCT04339101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55952406|NCT04339101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952454|NCT04214691|Sensory System Agents|sensory system agents|mesh-ancestor
55952455|NCT04214691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952456|NCT04214691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952457|NCT04214691|Antipyretics|antipyretics|mesh-ancestor
55952458|NCT04786158|Apomorphine|apomorphine|mesh-list
55952459|NCT04786158|Emetics|emetics|mesh-ancestor
55952461|NCT04786158|Autonomic Agents|autonomic agents|mesh-ancestor
55952521|NCT04786002|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55952524|NCT04788654|Acetaminophen|acetaminophen|mesh-list
55952525|NCT04788654|Dexamethasone|dexamethasone|mesh-list
55952527|NCT04788654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952528|NCT04788654|Antiemetics|antiemetics|mesh-ancestor
55952529|NCT04788654|Autonomic Agents|autonomic agents|mesh-ancestor
55952530|NCT04788654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952531|NCT04788654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952532|NCT04788654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55952533|NCT04788654|Glucocorticoids|glucocorticoids|mesh-ancestor
55952534|NCT04788654|Hormones|hormones|mesh-ancestor
55952535|NCT04788654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55952586|NCT03002649|Tofacitinib|tofacitinib|mesh-list
55952587|NCT03002649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952588|NCT03002649|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55952589|NCT03002649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952590|NCT04785222|Dexmedetomidine|dexmedetomidine|mesh-list
55952591|NCT04785222|Bupivacaine|bupivacaine|mesh-list
55952592|NCT04785222|Anesthetics, Local|anesthetics, local|mesh-ancestor
55952593|NCT04785222|Anesthetics|anesthetics|mesh-ancestor
55952594|NCT04785222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952595|NCT04785222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952596|NCT04785222|Sensory System Agents|sensory system agents|mesh-ancestor
55952597|NCT04785222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952598|NCT04785222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55952599|NCT04785222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55952600|NCT04785222|Analgesics|analgesics|mesh-ancestor
55952601|NCT04785222|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55952642|NCT02247687|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55952643|NCT04784988|BAX 855|bax 855|mesh-list
55952644|NCT04784988|Coagulants|coagulants|mesh-ancestor
55952645|NCT04784910|Lansoprazole|lansoprazole|mesh-list
55952646|NCT04784910|Dexlansoprazole|dexlansoprazole|mesh-list
55952647|NCT04784910|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55952648|NCT04784910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55952649|NCT04784910|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55952650|NCT04784910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952653|NCT01625013|Viscosupplements|viscosupplements|mesh-ancestor
55952711|NCT01625169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952712|NCT03933813|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55952713|NCT03933813|Hematinics|hematinics|mesh-ancestor
55952714|NCT01628601|Timolol|timolol|mesh-list
55952715|NCT01628601|Bimatoprost|bimatoprost|mesh-list
55952716|NCT01628601|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55952717|NCT01628601|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55952718|NCT01628601|Adrenergic Agents|adrenergic agents|mesh-ancestor
55952719|NCT01628601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55952720|NCT01628601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952721|NCT01628601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952722|NCT01628601|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55952775|NCT02995083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952776|NCT02995083|Sensory System Agents|sensory system agents|mesh-ancestor
55952777|NCT02995083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55952778|NCT02995083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55952779|NCT02995083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55952780|NCT02995083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55952781|NCT02995083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55952782|NCT02995083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952783|NCT02995083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55952784|NCT02995083|Antiemetics|antiemetics|mesh-ancestor
55952846|NCT05466318|Antimetabolites|antimetabolites|mesh-ancestor
55952847|NCT05466318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952848|NCT05466318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952849|NCT05466318|Antiviral Agents|antiviral agents|mesh-ancestor
55952850|NCT05466318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55952851|NCT05466318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952852|NCT05466318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55952853|NCT05466318|Immunologic Factors|immunologic factors|mesh-ancestor
55952925|NCT05087381|Fluvoxamine|fluvoxamine|mesh-list
55952926|NCT05087381|Bromhexine|bromhexine|mesh-list
55952927|NCT05087381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952928|NCT05087381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952929|NCT05087381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55952930|NCT05087381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55952931|NCT05087381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952932|NCT05087381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55952933|NCT05087381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55952934|NCT05087381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55952935|NCT05087381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55952958|NCT05087381|Expectorants|expectorants|mesh-ancestor
55952989|NCT01639599|Hormones|hormones|mesh-ancestor
55952990|NCT01639599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55952991|NCT01639599|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55952992|NCT01639599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55952993|NCT01639599|Protease Inhibitors|protease inhibitors|mesh-ancestor
55952994|NCT01639599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55952995|NCT01639599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55952996|NCT01639599|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55952997|NCT01639599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55952998|NCT01639599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55952999|NCT01639599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55953049|NCT03172897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55953050|NCT03172897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55953051|NCT03172897|Adrenergic Agents|adrenergic agents|mesh-ancestor
55953052|NCT03172897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953053|NCT03172897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953055|NCT00086723|Plasminogen|plasminogen|mesh-list
55953056|NCT00086723|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55953057|NCT00086723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55953058|NCT00086723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55953060|NCT00086723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55953115|NCT03849651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953116|NCT03849651|Immunologic Factors|immunologic factors|mesh-ancestor
55953117|NCT03849651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953118|NCT03849651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55953119|NCT03849651|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55953120|NCT03849651|Alkylating Agents|alkylating agents|mesh-ancestor
55953121|NCT03849651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953122|NCT03849651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953123|NCT03849651|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55953124|NCT05574985|Vaccines|vaccines|mesh-list
55953125|NCT05574985|Immunologic Factors|immunologic factors|mesh-ancestor
55953176|NCT04714541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953177|NCT04714541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55953178|NCT04714541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55953179|NCT04714541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953180|NCT04714541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953182|NCT02414724|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953183|NCT02414724|Antimetabolites|antimetabolites|mesh-ancestor
55953184|NCT02414724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953185|NCT02414724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953186|NCT02414724|Antiviral Agents|antiviral agents|mesh-ancestor
55953187|NCT02414724|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953237|NCT03693807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953238|NCT03693807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55953239|NCT03693807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55953240|NCT03693807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55953241|NCT01646151|Bimatoprost|bimatoprost|mesh-list
55953243|NCT03692481|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55953244|NCT03692481|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55953245|NCT03692481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953246|NCT03692403|Quinagolide|quinagolide|mesh-list
55953247|NCT03692403|Dopamine Agonists|dopamine agonists|mesh-ancestor
55953248|NCT03692403|Dopamine Agents|dopamine agents|mesh-ancestor
55953249|NCT03692403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953250|NCT03692403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953297|NCT01898377|Mycophenolic Acid|mycophenolic acid|mesh-list
55953298|NCT01898377|Imatinib Mesylate|imatinib mesylate|mesh-list
55953299|NCT01898377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55953300|NCT01898377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953301|NCT01898377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55953302|NCT01898377|Antitubercular Agents|antitubercular agents|mesh-ancestor
55957186|NCT02250807|Sofosbuvir|sofosbuvir|mesh-list
55953303|NCT01898377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55953304|NCT01898377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953360|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55953361|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953362|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953363|NCT00193453|Gemcitabine|gemcitabine|mesh-list
55953364|NCT00193453|Docetaxel|docetaxel|mesh-list
55953365|NCT00193453|Cetuximab|cetuximab|mesh-list
55953366|NCT00193453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55953367|NCT00193453|Antimetabolites|antimetabolites|mesh-ancestor
55953368|NCT00193453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953428|NCT00194779|Tamoxifen|tamoxifen|mesh-list
55953429|NCT00194779|Vinorelbine|vinorelbine|mesh-list
55953430|NCT00194779|Cyclophosphamide|cyclophosphamide|mesh-list
55953431|NCT00194779|Doxorubicin|doxorubicin|mesh-list
55953432|NCT00194779|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55953433|NCT00194779|Capecitabine|capecitabine|mesh-list
55953434|NCT00194779|Methotrexate|methotrexate|mesh-list
55953435|NCT00194779|Trastuzumab|trastuzumab|mesh-list
55953436|NCT00194779|Letrozole|letrozole|mesh-list
55953437|NCT00194779|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55953438|NCT00194779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953439|NCT00194779|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953440|NCT00194779|Antimitotic Agents|antimitotic agents|mesh-ancestor
55953441|NCT00194779|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953442|NCT00194779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953444|NCT00194779|Immunologic Factors|immunologic factors|mesh-ancestor
55953488|NCT02096575|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55953489|NCT02096575|Anesthetics, General|anesthetics, general|mesh-ancestor
55953490|NCT02096575|Anesthetics|anesthetics|mesh-ancestor
55953491|NCT02096575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55953492|NCT02096575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953494|NCT02096575|Analgesics|analgesics|mesh-ancestor
55953495|NCT02096575|Sensory System Agents|sensory system agents|mesh-ancestor
55953496|NCT02096575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953497|NCT04338984|Fentanyl|fentanyl|mesh-list
55953498|NCT04338984|Ropivacaine|ropivacaine|mesh-list
55953556|NCT00195403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55953557|NCT00195403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55953558|NCT00195403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55953559|NCT00195403|Immunologic Factors|immunologic factors|mesh-ancestor
55953560|NCT04643327|Levetiracetam|levetiracetam|mesh-list
55953561|NCT04643327|Anticonvulsants|anticonvulsants|mesh-ancestor
55953562|NCT04643327|Nootropic Agents|nootropic agents|mesh-ancestor
55953563|NCT00095875|Carboplatin|carboplatin|mesh-list
55953565|NCT00095875|Fluorouracil|fluorouracil|mesh-list
55953566|NCT00095875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953567|NCT00095875|Tubulin Modulators|tubulin modulators|mesh-ancestor
55953568|NCT00095875|Antimitotic Agents|antimitotic agents|mesh-ancestor
55953569|NCT00095875|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953570|NCT00095875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953620|NCT00006227|Mitosis Modulators|mitosis modulators|mesh-ancestor
55953621|NCT00006227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953622|NCT00097669|Folic Acid|folic acid|mesh-list
55953623|NCT00097669|Hematinics|hematinics|mesh-ancestor
55953624|NCT00097669|Vitamin B Complex|vitamin b complex|mesh-ancestor
55953625|NCT00097669|Vitamins|vitamins|mesh-ancestor
55953626|NCT00097669|Micronutrients|micronutrients|mesh-ancestor
55953627|NCT00097669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953628|NCT05612880|Androgens|androgens|mesh-list
55953629|NCT05612880|Hormones|hormones|mesh-ancestor
55953630|NCT05612880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55953632|NCT03995628|Dexamethasone|dexamethasone|mesh-list
55953686|NCT00023309|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55953687|NCT00023309|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55953688|NCT00023309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953689|NCT00023309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953690|NCT00023309|Antiviral Agents|antiviral agents|mesh-ancestor
55953691|NCT00023309|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953692|NCT00023309|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55953754|NCT01647945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953755|NCT00100165|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
55953756|NCT00100165|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55953757|NCT00100165|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55953758|NCT00100165|Cholinergic Agents|cholinergic agents|mesh-ancestor
55953759|NCT00100165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55953760|NCT00100165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953761|NCT00100165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953762|NCT04351191|Hydroxychloroquine|hydroxychloroquine|mesh-list
55953763|NCT04351191|Chloroquine|chloroquine|mesh-list
55953764|NCT04351191|Antimalarials|antimalarials|mesh-ancestor
55953765|NCT04351191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55953766|NCT04351191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55953767|NCT04351191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55953768|NCT04351191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55953769|NCT04351191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55953814|NCT01490060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55953815|NCT01490060|Antiemetics|antiemetics|mesh-ancestor
55953816|NCT01490060|Autonomic Agents|autonomic agents|mesh-ancestor
55953817|NCT01490060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953818|NCT01490060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953819|NCT01490060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55953820|NCT01490060|Glucocorticoids|glucocorticoids|mesh-ancestor
55953821|NCT01490060|Hormones|hormones|mesh-ancestor
55953822|NCT01490060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55953823|NCT01490060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55953824|NCT01490060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953839|NCT04090736|Azacitidine|azacitidine|mesh-list
55953874|NCT01452152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953876|NCT05557110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55953877|NCT01451762|Diphenhydramine|diphenhydramine|mesh-list
55953878|NCT01451762|Promethazine|promethazine|mesh-list
55953944|NCT01451606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55953945|NCT01451606|Antidepressive Agents|antidepressive agents|mesh-ancestor
55953946|NCT01451606|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55953949|NCT05556720|Immunologic Factors|immunologic factors|mesh-ancestor
55953950|NCT05556720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55953951|NCT00204373|Lansoprazole|lansoprazole|mesh-list
55953952|NCT00204373|Dexlansoprazole|dexlansoprazole|mesh-list
55953953|NCT00204373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55953954|NCT00204373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55953955|NCT00204373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55953956|NCT00204373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954009|NCT00033917|Analgesics|analgesics|mesh-ancestor
55954010|NCT00033917|Sensory System Agents|sensory system agents|mesh-ancestor
55954011|NCT00033917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954012|NCT00033917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954013|NCT00033917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954014|NCT00033917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954015|NCT00033917|Gout Suppressants|gout suppressants|mesh-ancestor
55954016|NCT00033917|Tocolytic Agents|tocolytic agents|mesh-ancestor
55954017|NCT00033917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55954018|NCT00033917|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55954019|NCT00033917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954020|NCT00033917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954021|NCT00036569|Interferons|interferons|mesh-list
55954022|NCT00036569|Interferon-alpha|interferon-alpha|mesh-list
55954023|NCT00036569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954024|NCT00036569|Antiviral Agents|antiviral agents|mesh-ancestor
55954025|NCT00036569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954026|NCT00036569|Immunologic Factors|immunologic factors|mesh-ancestor
55954028|NCT01660893|Phenylephrine|phenylephrine|mesh-list
55954068|NCT01946373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954069|NCT01946373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954070|NCT01946373|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55954071|NCT01946373|Alkylating Agents|alkylating agents|mesh-ancestor
55954072|NCT01946373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954073|NCT01946373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954074|NCT01946373|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55954075|NCT01946373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954076|NCT01946373|Antimetabolites|antimetabolites|mesh-ancestor
55954077|NCT01946373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55954078|NCT01946373|Analgesics|analgesics|mesh-ancestor
55954079|NCT01946373|Sensory System Agents|sensory system agents|mesh-ancestor
55954080|NCT01946373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954081|NCT01662297|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55954082|NCT01662297|Trazodone|trazodone|mesh-list
55954083|NCT01662297|Antidepressive Agents|antidepressive agents|mesh-ancestor
55954084|NCT01662297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55954085|NCT01662297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55954086|NCT01662297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55954087|NCT01662297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55954088|NCT01662297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954090|NCT01662297|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55954091|NCT01662297|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55954118|NCT00040937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55954119|NCT00040937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55954121|NCT00040937|Autonomic Agents|autonomic agents|mesh-ancestor
55954122|NCT00040937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55954123|NCT00040937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55954124|NCT00040937|Glucocorticoids|glucocorticoids|mesh-ancestor
55954125|NCT00040937|Hormones|hormones|mesh-ancestor
55954126|NCT00040937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55954127|NCT00040937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55954128|NCT00040937|Leprostatic Agents|leprostatic agents|mesh-ancestor
55954129|NCT00040937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55954130|NCT00040937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954131|NCT00040937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55954132|NCT00040937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55954133|NCT00040937|Growth Substances|growth substances|mesh-ancestor
55954134|NCT00040937|Growth Inhibitors|growth inhibitors|mesh-ancestor
55954135|NCT04756895|Vancomycin|vancomycin|mesh-list
55954136|NCT04756895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55954137|NCT04756895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954138|NCT02234115|Leuprolide|leuprolide|mesh-list
55954139|NCT02234115|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55954141|NCT02234115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55954142|NCT02234115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954143|NCT02234115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55954144|NCT02234115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954168|NCT01663935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55954169|NCT01663935|Dopamine Agents|dopamine agents|mesh-ancestor
55954170|NCT01663935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954171|NCT01663935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954172|NCT01663935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954173|NCT01663935|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55954174|NCT01663935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954176|NCT01664559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55954178|NCT01664559|Analgesics|analgesics|mesh-ancestor
55954230|NCT01604109|Serotonin Agents|serotonin agents|mesh-ancestor
55954231|NCT01604109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954232|NCT01604109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954233|NCT01604109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954234|NCT01604109|Chelating Agents|chelating agents|mesh-ancestor
55954235|NCT01604109|Sequestering Agents|sequestering agents|mesh-ancestor
55954236|NCT03089957|Urinastatin|urinastatin|mesh-list
55954237|NCT03089957|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55954297|NCT00048893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55954298|NCT00048893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954299|NCT00048893|Tubulin Modulators|tubulin modulators|mesh-ancestor
55954300|NCT00048893|Antimitotic Agents|antimitotic agents|mesh-ancestor
55954301|NCT00048893|Mitosis Modulators|mitosis modulators|mesh-ancestor
55954302|NCT00048893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954303|NCT00048893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954304|NCT00048893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954306|NCT00048893|Alkylating Agents|alkylating agents|mesh-ancestor
55954362|NCT03089645|Immunologic Factors|immunologic factors|mesh-ancestor
55954363|NCT03089645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954364|NCT02587962|Pembrolizumab|pembrolizumab|mesh-list
55954365|NCT02587962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55954366|NCT02587962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954367|NCT01931033|Oxytocin|oxytocin|mesh-list
55954368|NCT01931033|Oxytocics|oxytocics|mesh-ancestor
55954369|NCT01931033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55954370|NCT01931033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954430|NCT00105001|Sirolimus|sirolimus|mesh-list
55954431|NCT00105001|Fludarabine|fludarabine|mesh-list
55954432|NCT00105001|Fludarabine phosphate|fludarabine phosphate|mesh-list
55954433|NCT00105001|Tacrolimus|tacrolimus|mesh-list
55954434|NCT00105001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954435|NCT00105001|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954436|NCT00105001|Antimetabolites|antimetabolites|mesh-ancestor
55954437|NCT00105001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954438|NCT00105001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954439|NCT00105001|Immunologic Factors|immunologic factors|mesh-ancestor
55954440|NCT00105001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954449|NCT02642640|Melatonin|melatonin|mesh-list
55954492|NCT00054353|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55954493|NCT00054353|Antitubercular Agents|antitubercular agents|mesh-ancestor
55954494|NCT00054353|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55954495|NCT00054353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55954496|NCT00054353|Alkylating Agents|alkylating agents|mesh-ancestor
55954497|NCT00054353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55954498|NCT00208975|Cyclophosphamide|cyclophosphamide|mesh-list
55954499|NCT00208975|Rituximab|rituximab|mesh-list
55954500|NCT00208975|Fludarabine|fludarabine|mesh-list
55954501|NCT00208975|Mitoxantrone|mitoxantrone|mesh-list
55954502|NCT00208975|Sargramostim|sargramostim|mesh-list
55954503|NCT00208975|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954504|NCT00208975|Immunologic Factors|immunologic factors|mesh-ancestor
55954505|NCT00208975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954506|NCT00208975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954507|NCT00208975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55954509|NCT00208975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954510|NCT00208975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55954552|NCT05555628|Salicylic Acid|salicylic acid|mesh-list
55954553|NCT05555628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55954554|NCT05555628|Antifungal Agents|antifungal agents|mesh-ancestor
55954555|NCT05555628|Keratolytic Agents|keratolytic agents|mesh-ancestor
55954556|NCT05555628|Dermatologic Agents|dermatologic agents|mesh-ancestor
55954557|NCT01757418|Immunoglobulins|immunoglobulins|mesh-list
55954558|NCT01757418|Antibodies|antibodies|mesh-list
55954559|NCT01757418|gamma-Globulins|gamma-globulins|mesh-list
55954560|NCT01757418|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55954561|NCT01757418|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55954564|NCT00217399|Sorafenib|sorafenib|mesh-list
55954618|NCT04329624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954619|NCT04329624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954620|NCT04329624|Protective Agents|protective agents|mesh-ancestor
55954621|NCT04329624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954622|NCT00559182|Omeprazole|omeprazole|mesh-list
55954623|NCT00559182|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55954624|NCT00559182|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55954625|NCT00559182|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55954626|NCT00559182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954628|NCT00218023|Naltrexone|naltrexone|mesh-list
55954683|NCT00476190|Doxorubicin|doxorubicin|mesh-list
55954684|NCT00476190|Methotrexate|methotrexate|mesh-list
55954685|NCT00476190|Etoposide|etoposide|mesh-list
55954686|NCT00476190|Vincristine|vincristine|mesh-list
55954687|NCT00476190|Asparaginase|asparaginase|mesh-list
55954688|NCT00476190|Pegaspargase|pegaspargase|mesh-list
55954689|NCT00476190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954690|NCT00476190|Immunologic Factors|immunologic factors|mesh-ancestor
55954691|NCT00476190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954692|NCT00476190|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55954693|NCT00476190|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55954694|NCT00476190|Alkylating Agents|alkylating agents|mesh-ancestor
55954699|NCT00476190|Antiemetics|antiemetics|mesh-ancestor
55954747|NCT00221299|Hormones|hormones|mesh-list
55954748|NCT00221299|Parathyroid Hormone|parathyroid hormone|mesh-list
55954749|NCT00221299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55954750|NCT00221299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954751|NCT00221299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55954752|NCT00221299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55954753|NCT00221299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954809|NCT00110461|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55954810|NCT00110461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55954811|NCT00110461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954812|NCT00110461|Dopamine Agonists|dopamine agonists|mesh-ancestor
55954813|NCT00110461|Dopamine Agents|dopamine agents|mesh-ancestor
55954814|NCT00110461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55954815|NCT00110461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954816|NCT00110461|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55954874|NCT05700006|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55954875|NCT05700006|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55954876|NCT05700006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55954877|NCT05700006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954878|NCT05700006|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55954879|NCT05700006|Hormone Antagonists|hormone antagonists|mesh-ancestor
55954880|NCT05700006|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55954881|NCT05700006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954882|NCT00115297|Montelukast|montelukast|mesh-list
55954883|NCT00115297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55954935|NCT00227617|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55954936|NCT00227617|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55954937|NCT00227617|Growth Substances|growth substances|mesh-ancestor
55954938|NCT00227617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55954939|NCT00227617|Growth Inhibitors|growth inhibitors|mesh-ancestor
55954941|NCT00227617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55954942|NCT00227617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55954943|NCT00227617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55954944|NCT00227617|Immunologic Factors|immunologic factors|mesh-ancestor
55954945|NCT00227617|Antidotes|antidotes|mesh-ancestor
55954946|NCT00227617|Protective Agents|protective agents|mesh-ancestor
55954947|NCT00227617|Vitamin B Complex|vitamin b complex|mesh-ancestor
55954998|NCT01439126|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55954999|NCT01439126|Sympatholytics|sympatholytics|mesh-ancestor
55955000|NCT01439126|Autonomic Agents|autonomic agents|mesh-ancestor
55955001|NCT01439126|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55955002|NCT01439126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55955003|NCT01439126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55955004|NCT01439126|Adrenergic Agents|adrenergic agents|mesh-ancestor
55955005|NCT01439126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955006|NCT01439126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955007|NCT00066677|Docetaxel|docetaxel|mesh-list
55955008|NCT00066677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955009|NCT00066677|Tubulin Modulators|tubulin modulators|mesh-ancestor
55955010|NCT00066677|Antimitotic Agents|antimitotic agents|mesh-ancestor
55955011|NCT00066677|Mitosis Modulators|mitosis modulators|mesh-ancestor
55955012|NCT00066677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955013|NCT01615731|Digoxin|digoxin|mesh-list
55955055|NCT01675635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955056|NCT01675635|Analgesics|analgesics|mesh-ancestor
55955057|NCT01675635|Sensory System Agents|sensory system agents|mesh-ancestor
55955058|NCT01675635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955059|NCT01615809|Amphotericin B|amphotericin b|mesh-list
55955060|NCT01615809|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55955061|NCT01615809|Amebicides|amebicides|mesh-ancestor
55955062|NCT01615809|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55955063|NCT01615809|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55955064|NCT01615809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955065|NCT01615809|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55955066|NCT01615809|Antifungal Agents|antifungal agents|mesh-ancestor
55955067|NCT01676415|Mometasone Furoate|mometasone furoate|mesh-list
55955068|NCT01676415|Prednisone|prednisone|mesh-list
55955069|NCT01676415|Glucocorticoids|glucocorticoids|mesh-list
55955070|NCT01676415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55955072|NCT01676415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955073|NCT01676415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955115|NCT01707381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55955116|NCT01707381|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55955118|NCT05552586|Antioxidants|antioxidants|mesh-ancestor
55955119|NCT05552586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955120|NCT05552586|Protective Agents|protective agents|mesh-ancestor
55955121|NCT05552586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955122|NCT05552586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55955123|NCT00069329|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55955125|NCT00072449|Rituximab|rituximab|mesh-list
55955182|NCT00074165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55955183|NCT00074165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55955184|NCT00074165|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55955185|NCT00074165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55955186|NCT00074165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55955187|NCT00074165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955188|NCT00074165|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55955189|NCT00074165|Antimetabolites|antimetabolites|mesh-ancestor
55955190|NCT00074165|Antiviral Agents|antiviral agents|mesh-ancestor
55955191|NCT00074165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955192|NCT00074165|Antidotes|antidotes|mesh-ancestor
55955193|NCT00074165|Protective Agents|protective agents|mesh-ancestor
55955194|NCT00074165|Antioxidants|antioxidants|mesh-ancestor
55955195|NCT00074165|Antitubercular Agents|antitubercular agents|mesh-ancestor
55955196|NCT00074165|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55955197|NCT00074165|Chelating Agents|chelating agents|mesh-ancestor
55955198|NCT00074165|Sequestering Agents|sequestering agents|mesh-ancestor
55955199|NCT01466660|Gefitinib|gefitinib|mesh-list
55955200|NCT01466660|Afatinib|afatinib|mesh-list
55955201|NCT01466660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955202|NCT01466660|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55955204|NCT01466660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955205|NCT05710887|Nitrous Oxide|nitrous oxide|mesh-list
55955237|NCT01466348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55955238|NCT01466348|Analgesics|analgesics|mesh-ancestor
55955239|NCT01466348|Sensory System Agents|sensory system agents|mesh-ancestor
55955240|NCT01466348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955241|NCT01466348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955242|NCT01466348|Antipyretics|antipyretics|mesh-ancestor
55955243|NCT01466348|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55955244|NCT01466348|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55955245|NCT01466348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955246|NCT01466348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955247|NCT01466348|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55955248|NCT01466348|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55955249|NCT01466348|Purinergic Agents|purinergic agents|mesh-ancestor
55955250|NCT01466348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955251|NCT01466270|Donepezil|donepezil|mesh-list
55955259|NCT02235987|Octreotide|octreotide|mesh-list
55955294|NCT01438814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955295|NCT01681095|Tryptophan|tryptophan|mesh-list
55955296|NCT01681095|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55955298|NCT01681095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55955299|NCT05550870|Fenugreek seed meal|fenugreek seed meal|mesh-list
55955300|NCT05550870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55955301|NCT05550870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955302|NCT00121225|Vorinostat|vorinostat|mesh-list
55955303|NCT00121225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955365|NCT00235573|Vitamin B Complex|vitamin b complex|mesh-ancestor
55955366|NCT00235573|Hematinics|hematinics|mesh-ancestor
55955367|NCT01687179|Sirolimus|sirolimus|mesh-list
55955368|NCT01687179|Hydroxychloroquine|hydroxychloroquine|mesh-list
55955369|NCT01687179|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55955370|NCT01687179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955371|NCT01687179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55955372|NCT01687179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955373|NCT01687179|Antifungal Agents|antifungal agents|mesh-ancestor
55955432|NCT05340309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955433|NCT00125515|Naltrexone|naltrexone|mesh-list
55955434|NCT00125515|Memantine|memantine|mesh-list
55955435|NCT00125515|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55955436|NCT00125515|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55955437|NCT00125515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955438|NCT00125515|Sensory System Agents|sensory system agents|mesh-ancestor
55955439|NCT00125515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955440|NCT00125515|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55955441|NCT00125515|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55955442|NCT00125515|Dopamine Agents|dopamine agents|mesh-ancestor
55955447|NCT00125593|Simvastatin|simvastatin|mesh-list
55955496|NCT04753177|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55955497|NCT04753177|Hormone Antagonists|hormone antagonists|mesh-ancestor
55955498|NCT04753177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55955499|NCT04753177|Luteolytic Agents|luteolytic agents|mesh-ancestor
55955500|NCT04753177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55955501|NCT04753177|Contraceptive Agents|contraceptive agents|mesh-ancestor
55955502|NCT04753177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55955503|NCT04753177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55955504|NCT01691313|Vanoxerine|vanoxerine|mesh-list
55955505|NCT01691313|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55955506|NCT01691313|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55955507|NCT01691313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55955508|NCT01691313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955509|NCT01691313|Dopamine Agents|dopamine agents|mesh-ancestor
55955510|NCT01691313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955554|NCT00238615|Tubulin Modulators|tubulin modulators|mesh-ancestor
55955555|NCT00238615|Antimitotic Agents|antimitotic agents|mesh-ancestor
55955556|NCT00238615|Mitosis Modulators|mitosis modulators|mesh-ancestor
55955557|NCT00238615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955558|NCT02243943|Neostigmine|neostigmine|mesh-list
55955559|NCT02243943|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55955560|NCT02243943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955561|NCT02243943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955562|NCT02243943|Cholinergic Agents|cholinergic agents|mesh-ancestor
55955563|NCT02243943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55955620|NCT05168475|Infliximab|infliximab|mesh-list
55955621|NCT05168475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55955622|NCT05168475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955623|NCT05168475|Immunologic Factors|immunologic factors|mesh-ancestor
55955624|NCT05168475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955625|NCT05168475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955626|NCT05168475|Dermatologic Agents|dermatologic agents|mesh-ancestor
55955627|NCT05168475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55955628|NCT03088709|Mycophenolic Acid|mycophenolic acid|mesh-list
55955629|NCT03088709|Cyclophosphamide|cyclophosphamide|mesh-list
55955630|NCT03088709|Tacrolimus|tacrolimus|mesh-list
55955683|NCT02959905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955684|NCT02959905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55955685|NCT02959905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55955686|NCT02959905|Antimetabolites|antimetabolites|mesh-ancestor
55955687|NCT00134017|Cyclophosphamide|cyclophosphamide|mesh-list
55955688|NCT00134017|Busulfan|busulfan|mesh-list
55955689|NCT00134017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955690|NCT00134017|Immunologic Factors|immunologic factors|mesh-ancestor
55955691|NCT00134017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955692|NCT00134017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55841921|NCT04414137|Daptomycin|daptomycin|mesh-list
55955693|NCT00134017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55955694|NCT00134017|Alkylating Agents|alkylating agents|mesh-ancestor
55955695|NCT00134017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955696|NCT00134017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955697|NCT00134017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55955698|NCT04783051|Pyrimethamine|pyrimethamine|mesh-list
55955699|NCT04783051|Sulfadoxine|sulfadoxine|mesh-list
55955700|NCT04783051|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55955701|NCT04783051|Antimalarials|antimalarials|mesh-ancestor
55955702|NCT04783051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55955703|NCT04783051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55955704|NCT04783051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955705|NCT04783051|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55955706|NCT04783051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955732|NCT00245635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955733|NCT00245635|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55955734|NCT00245635|Antidepressive Agents|antidepressive agents|mesh-ancestor
55955735|NCT00245635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55955736|NCT00245635|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55955737|NCT00245635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55955738|NCT00245635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955739|NCT00141115|Levetiracetam|levetiracetam|mesh-list
55955740|NCT00141115|Anticonvulsants|anticonvulsants|mesh-ancestor
55955741|NCT00141115|Nootropic Agents|nootropic agents|mesh-ancestor
55955742|NCT00249379|Acamprosate|acamprosate|mesh-list
55955743|NCT00249379|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55955746|NCT00141739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55955791|NCT00145249|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55955792|NCT00145249|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55955793|NCT00145249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55955794|NCT00153803|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55955795|NCT00153803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955796|NCT00153803|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55955797|NCT00153803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955798|NCT00153803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955799|NCT00252967|Atorvastatin|atorvastatin|mesh-list
55955800|NCT00252967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55955801|NCT00252967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55955802|NCT00252967|Antimetabolites|antimetabolites|mesh-ancestor
55955803|NCT00252967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955804|NCT00252967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55955853|NCT00159263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955854|NCT00159263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955855|NCT00159263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55955856|NCT00159263|Respiratory System Agents|respiratory system agents|mesh-ancestor
55955857|NCT00159263|Glucocorticoids|glucocorticoids|mesh-ancestor
55955858|NCT00159263|Hormones|hormones|mesh-ancestor
55955870|NCT00159965|Sertraline|sertraline|mesh-list
55955919|NCT01898039|Immunologic Factors|immunologic factors|mesh-ancestor
55955920|NCT01898039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955921|NCT01898039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55955922|NCT01898039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55955923|NCT01898039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55955924|NCT01898039|Alkylating Agents|alkylating agents|mesh-ancestor
55955925|NCT01898039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955926|NCT01898039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55955927|NCT01898039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55955928|NCT00099047|Celecoxib|celecoxib|mesh-list
55955929|NCT00099047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55955930|NCT00099047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55955931|NCT00099047|Analgesics|analgesics|mesh-ancestor
55955932|NCT00099047|Sensory System Agents|sensory system agents|mesh-ancestor
55955933|NCT00099047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55955934|NCT00099047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55955975|NCT02098993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55955976|NCT02098993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55955977|NCT04930107|Fluconazole|fluconazole|mesh-list
55955978|NCT04930107|Antifungal Agents|antifungal agents|mesh-ancestor
55955979|NCT04930107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55955980|NCT04930107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55955981|NCT04930107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55955982|NCT04930107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55955990|NCT00100841|Leucovorin|leucovorin|mesh-list
55956042|NCT00445965|Antibodies|antibodies|mesh-list
55956113|NCT00258817|Immunologic Factors|immunologic factors|mesh-ancestor
55956114|NCT00258817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956115|NCT05686863|Remifentanil|remifentanil|mesh-list
55956116|NCT05686863|Propofol|propofol|mesh-list
55956117|NCT05686863|Esketamine|esketamine|mesh-list
55956118|NCT05686863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55956119|NCT05686863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55956120|NCT05686863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956121|NCT05686863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55956122|NCT05686863|Anesthetics, General|anesthetics, general|mesh-ancestor
55956123|NCT05686863|Anesthetics|anesthetics|mesh-ancestor
55956124|NCT05686863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55956125|NCT05686863|Narcotics|narcotics|mesh-ancestor
55956126|NCT05686863|Analgesics|analgesics|mesh-ancestor
55956127|NCT05686863|Sensory System Agents|sensory system agents|mesh-ancestor
55956128|NCT05686863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956129|NCT05686863|Antidepressive Agents|antidepressive agents|mesh-ancestor
55956130|NCT05686863|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55956173|NCT01717053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55956174|NCT01717053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956175|NCT01717053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55956176|NCT01717053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956177|NCT01717053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55956178|NCT01717053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956179|NCT01717053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956180|NCT01717053|Hormone Antagonists|hormone antagonists|mesh-ancestor
55956181|NCT01717053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55956182|NCT01666314|Prednisone|prednisone|mesh-list
55956183|NCT01666314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956184|NCT01666314|Glucocorticoids|glucocorticoids|mesh-ancestor
55956185|NCT01666314|Hormones|hormones|mesh-ancestor
55956186|NCT01666314|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55956234|NCT05535738|Hormones|hormones|mesh-ancestor
55956308|NCT05699148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55956309|NCT05699148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956311|NCT04638517|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55956312|NCT04638517|Hormone Antagonists|hormone antagonists|mesh-ancestor
55956313|NCT04638517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55956314|NCT04638517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956326|NCT05539872|Insulin|insulin|mesh-list
55956377|NCT04617457|Folic Acid|folic acid|mesh-list
55956378|NCT04617457|Oxaliplatin|oxaliplatin|mesh-list
55956379|NCT04617457|Irinotecan|irinotecan|mesh-list
55956380|NCT04617457|Fluorouracil|fluorouracil|mesh-list
55956381|NCT04617457|Levoleucovorin|levoleucovorin|mesh-list
55956382|NCT04617457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956383|NCT04617457|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55956384|NCT04617457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55956385|NCT04617457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956386|NCT04617457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956387|NCT04617457|Antidotes|antidotes|mesh-ancestor
55956388|NCT04617457|Protective Agents|protective agents|mesh-ancestor
55956389|NCT04617457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956390|NCT04617457|Vitamin B Complex|vitamin b complex|mesh-ancestor
55956391|NCT04617457|Vitamins|vitamins|mesh-ancestor
55956392|NCT04617457|Micronutrients|micronutrients|mesh-ancestor
55956393|NCT04617457|Hematinics|hematinics|mesh-ancestor
55956394|NCT04617457|Antimetabolites|antimetabolites|mesh-ancestor
55956437|NCT00267085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956438|NCT04476511|Cholecalciferol|cholecalciferol|mesh-list
55956439|NCT04476511|Vitamin D|vitamin d|mesh-list
55956440|NCT04476511|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55956441|NCT04476511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956443|NCT04476511|Micronutrients|micronutrients|mesh-ancestor
55956444|NCT04476511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55956445|NCT04275999|Ivermectin|ivermectin|mesh-list
55956446|NCT04275999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55956447|NCT04275999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956448|NCT05609565|Bupivacaine|bupivacaine|mesh-list
55956449|NCT05609565|Prilocaine|prilocaine|mesh-list
55956450|NCT05609565|Anesthetics|anesthetics|mesh-list
55956451|NCT05609565|Anesthetics, Local|anesthetics, local|mesh-ancestor
55956454|NCT05609565|Sensory System Agents|sensory system agents|mesh-ancestor
55956496|NCT01722435|Analgesics|analgesics|mesh-ancestor
55956497|NCT01722435|Sensory System Agents|sensory system agents|mesh-ancestor
55956498|NCT01722435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956500|NCT00029107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55956501|NCT00029107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956502|NCT00029107|Immunologic Factors|immunologic factors|mesh-ancestor
55956503|NCT00029107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956565|NCT02240667|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55956566|NCT02240667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55956567|NCT02240667|Hemostatics|hemostatics|mesh-ancestor
55956568|NCT02240667|Coagulants|coagulants|mesh-ancestor
55956569|NCT03203850|Deferasirox|deferasirox|mesh-list
55956570|NCT03203850|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55956571|NCT03203850|Chelating Agents|chelating agents|mesh-ancestor
55956572|NCT03203850|Sequestering Agents|sequestering agents|mesh-ancestor
55956573|NCT03203850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956574|NCT00272311|Aspirin|aspirin|mesh-list
55956575|NCT00272311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55956629|NCT01729845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55956630|NCT01729845|Immunologic Factors|immunologic factors|mesh-ancestor
55956631|NCT01729845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956632|NCT01729845|Analgesics|analgesics|mesh-ancestor
55956633|NCT01729845|Sensory System Agents|sensory system agents|mesh-ancestor
55956634|NCT01729845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956635|NCT01729845|Keratolytic Agents|keratolytic agents|mesh-ancestor
55956636|NCT01729845|Dermatologic Agents|dermatologic agents|mesh-ancestor
55956637|NCT01729845|Tubulin Modulators|tubulin modulators|mesh-ancestor
55956638|NCT01729845|Antimitotic Agents|antimitotic agents|mesh-ancestor
55956639|NCT01729845|Mitosis Modulators|mitosis modulators|mesh-ancestor
55956640|NCT01729923|Celecoxib|celecoxib|mesh-list
55956641|NCT01729923|Capecitabine|capecitabine|mesh-list
55956642|NCT01729923|Benzenesulfonamide|benzenesulfonamide|mesh-list
55956643|NCT01729923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55956644|NCT01729923|Antimetabolites|antimetabolites|mesh-ancestor
55956645|NCT01729923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956646|NCT01729923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956647|NCT01729923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55956648|NCT01729923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55956649|NCT01729923|Analgesics|analgesics|mesh-ancestor
55956650|NCT01729923|Sensory System Agents|sensory system agents|mesh-ancestor
55956651|NCT01729923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956652|NCT01729923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956653|NCT01729923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956654|NCT01729923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55956655|NCT01729923|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55956656|NCT01729923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55956658|NCT01729923|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55956659|NCT02584452|Dexamethasone|dexamethasone|mesh-list
55956660|NCT02584452|Fentanyl|fentanyl|mesh-list
55956661|NCT02584452|Bupivacaine|bupivacaine|mesh-list
55956662|NCT02584452|Ropivacaine|ropivacaine|mesh-list
55956663|NCT02584452|Mepivacaine|mepivacaine|mesh-list
55956664|NCT02584452|Propofol|propofol|mesh-list
55956665|NCT02584452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55956666|NCT02584452|Antiemetics|antiemetics|mesh-ancestor
55956746|NCT02243007|Tubulin Modulators|tubulin modulators|mesh-ancestor
55956747|NCT02243007|Antimitotic Agents|antimitotic agents|mesh-ancestor
55956817|NCT02582814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956818|NCT02582814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55956819|NCT02582814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956820|NCT01736865|Cholecalciferol|cholecalciferol|mesh-list
55956821|NCT01736865|Vitamin D|vitamin d|mesh-list
55956822|NCT01736865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55956823|NCT01736865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956824|NCT01736865|Vitamins|vitamins|mesh-ancestor
55956825|NCT01736865|Micronutrients|micronutrients|mesh-ancestor
55956826|NCT01736865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55956827|NCT01736943|Doxorubicin|doxorubicin|mesh-list
55956828|NCT01736943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55956830|NCT01736943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55956831|NCT01736943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956832|NCT01736943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55956877|NCT01744821|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55956878|NCT04369365|Azithromycin|azithromycin|mesh-list
55956879|NCT04369365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55956880|NCT04369365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956881|NCT01745055|Methotrexate|methotrexate|mesh-list
55956882|NCT01745055|Tofacitinib|tofacitinib|mesh-list
55956883|NCT01745055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55956884|NCT01745055|Abortifacient Agents|abortifacient agents|mesh-ancestor
55956885|NCT01745055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55956886|NCT01745055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956887|NCT01745055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55956888|NCT01745055|Antimetabolites|antimetabolites|mesh-ancestor
55956889|NCT01745055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956890|NCT01745055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55956891|NCT01745055|Dermatologic Agents|dermatologic agents|mesh-ancestor
55956892|NCT01745055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55956936|NCT04246359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55956937|NCT05213169|Apomorphine|apomorphine|mesh-list
55956938|NCT05213169|Emetics|emetics|mesh-ancestor
55956939|NCT05213169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55956940|NCT05213169|Autonomic Agents|autonomic agents|mesh-ancestor
55956941|NCT05213169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55956942|NCT05213169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55956943|NCT05213169|Dopamine Agonists|dopamine agonists|mesh-ancestor
55956944|NCT05213169|Dopamine Agents|dopamine agents|mesh-ancestor
55956945|NCT05213169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55956946|NCT05213169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55956947|NCT05192265|Artesunate|artesunate|mesh-list
55957001|NCT01748799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957002|NCT01748799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957003|NCT01748799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957004|NCT01748799|Anticonvulsants|anticonvulsants|mesh-ancestor
55957005|NCT01748799|Analgesics|analgesics|mesh-ancestor
55957006|NCT01748799|Sensory System Agents|sensory system agents|mesh-ancestor
55957007|NCT01748799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957008|NCT01748799|Hallucinogens|hallucinogens|mesh-ancestor
55957009|NCT01748799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957010|NCT01748799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55957011|NCT01748799|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55957012|NCT01748799|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55957013|NCT01748799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957064|NCT05156268|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55957065|NCT05156268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957066|NCT05156268|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55957067|NCT05156268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957068|NCT05156268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957069|NCT01749501|Rocuronium|rocuronium|mesh-list
55957070|NCT01749501|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55957071|NCT01749501|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55957072|NCT01749501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55957073|NCT01749501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957074|NCT01749501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957075|NCT02255175|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55957076|NCT02255175|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55957077|NCT02255175|Estradiol|estradiol|mesh-list
55957078|NCT02255175|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55957118|NCT01438424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957119|NCT01438424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957120|NCT01438424|Antiviral Agents|antiviral agents|mesh-ancestor
55957121|NCT01438424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957122|NCT01438424|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55957123|NCT01438424|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55957124|NCT04315272|Azithromycin|azithromycin|mesh-list
55957125|NCT04315272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55957126|NCT04315272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957185|NCT05267886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957189|NCT02250807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957190|NCT02250807|Protease Inhibitors|protease inhibitors|mesh-ancestor
55957191|NCT02250807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957192|NCT02250807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957193|NCT05694936|Cetuximab|cetuximab|mesh-list
55957194|NCT05694936|Panitumumab|panitumumab|mesh-list
55957195|NCT05694936|Valproic Acid|valproic acid|mesh-list
55957196|NCT05694936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55957197|NCT05694936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957198|NCT05694936|Anticonvulsants|anticonvulsants|mesh-ancestor
55957199|NCT05694936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957200|NCT05694936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957201|NCT05694936|GABA Agents|gaba agents|mesh-ancestor
55957202|NCT05694936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957203|NCT05694936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957204|NCT05694936|Antimanic Agents|antimanic agents|mesh-ancestor
55957205|NCT05694936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55957206|NCT05694936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957207|NCT05694936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957208|NCT00168389|Dexamethasone|dexamethasone|mesh-list
55957209|NCT00168389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55957210|NCT00168389|Antiemetics|antiemetics|mesh-ancestor
55957211|NCT00168389|Autonomic Agents|autonomic agents|mesh-ancestor
55957212|NCT00168389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957213|NCT00168389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957214|NCT00168389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55957215|NCT00168389|Glucocorticoids|glucocorticoids|mesh-ancestor
55957216|NCT00168389|Hormones|hormones|mesh-ancestor
55957217|NCT00168389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55957218|NCT00168389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55957227|NCT02252445|Anesthetics|anesthetics|mesh-ancestor
55957228|NCT02252445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55957229|NCT02252445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55957231|NCT04592952|Salmon calcitonin|salmon calcitonin|mesh-list
55957232|NCT04592952|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55957233|NCT04592952|Erenumab|erenumab|mesh-list
55957234|NCT04592952|Katacalcin|katacalcin|mesh-list
55957235|NCT04592952|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55957237|NCT04592952|Analgesics|analgesics|mesh-ancestor
55957292|NCT05696574|Abortifacient Agents|abortifacient agents|mesh-ancestor
55957293|NCT05696574|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55957294|NCT05696574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957295|NCT05696574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55957296|NCT05696574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55957297|NCT05696574|Oxytocics|oxytocics|mesh-ancestor
55957298|NCT00112151|Methyltestosterone|methyltestosterone|mesh-list
55957299|NCT00112151|Testosterone|testosterone|mesh-list
55957300|NCT00112151|Testosterone undecanoate|testosterone undecanoate|mesh-list
55957301|NCT00112151|Testosterone enanthate|testosterone enanthate|mesh-list
55957302|NCT00112151|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55957303|NCT00112151|Androgens|androgens|mesh-ancestor
55957304|NCT00112151|Hormones|hormones|mesh-ancestor
55957305|NCT00112151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55957306|NCT00112151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957307|NCT00112151|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55957348|NCT03718065|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55957349|NCT03718065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957351|NCT03718065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957352|NCT03718065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55957353|NCT03718065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55957354|NCT03718065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55957355|NCT03718065|Adrenergic Agents|adrenergic agents|mesh-ancestor
55957356|NCT03718065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957357|NCT03718065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957358|NCT00177047|Cyclophosphamide|cyclophosphamide|mesh-list
55957359|NCT00177047|Melphalan|melphalan|mesh-list
55957360|NCT00177047|Lenograstim|lenograstim|mesh-list
55957362|NCT00177047|Immunologic Factors|immunologic factors|mesh-ancestor
55957363|NCT00177047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957364|NCT00177047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957365|NCT00177047|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55957406|NCT04129398|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55957407|NCT04129398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957408|NCT04129398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957409|NCT04129398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957411|NCT04129398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957412|NCT00178919|Trimethaphan|trimethaphan|mesh-list
55957413|NCT00178919|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
55957414|NCT00178919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957415|NCT00178919|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55957416|NCT00178919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55957417|NCT00178919|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
55957418|NCT00178919|Autonomic Agents|autonomic agents|mesh-ancestor
55957419|NCT00178919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957420|NCT00178919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957421|NCT00178919|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55957465|NCT05656248|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55957466|NCT05656248|Antimetabolites|antimetabolites|mesh-ancestor
55957467|NCT05656248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957468|NCT05656248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957469|NCT05656248|Dermatologic Agents|dermatologic agents|mesh-ancestor
55957470|NCT05656248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957471|NCT05656248|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55957472|NCT05656248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55957473|NCT05656248|Immunologic Factors|immunologic factors|mesh-ancestor
55957474|NCT05656248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55957475|NCT05656248|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55957483|NCT05577000|Fludarabine|fludarabine|mesh-list
55957528|NCT00125957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55957529|NCT00125957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957530|NCT00125957|Dopamine Agents|dopamine agents|mesh-ancestor
55957531|NCT00125957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957532|NCT00125957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957533|NCT00125957|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55957534|NCT00125957|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55957535|NCT00125957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957536|NCT00183443|Valproic Acid|valproic acid|mesh-list
55957537|NCT00183443|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55957538|NCT00183443|Antidepressive Agents|antidepressive agents|mesh-ancestor
55957539|NCT00183443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957540|NCT00183443|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55957541|NCT00183443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55957542|NCT00183443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957543|NCT00183443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957544|NCT00183443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957546|NCT00183443|Antimanic Agents|antimanic agents|mesh-ancestor
55957585|NCT00186017|Autonomic Agents|autonomic agents|mesh-ancestor
55957586|NCT00186017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957587|NCT00186017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957588|NCT00186017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55957589|NCT00186017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55957590|NCT00186017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55957591|NCT00186017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55957592|NCT00186017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55957593|NCT00186017|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55957594|NCT00186017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55957595|NCT00186017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55957596|NCT00186017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957597|NCT00186017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55957648|NCT00186875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55957651|NCT00186875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55957652|NCT00186875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55957653|NCT00186875|Protease Inhibitors|protease inhibitors|mesh-ancestor
55957654|NCT00186875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55957655|NCT00186875|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55957656|NCT00186875|Abortifacient Agents|abortifacient agents|mesh-ancestor
55957657|NCT00186875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55957658|NCT00186875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55957659|NCT00186875|Antimetabolites|antimetabolites|mesh-ancestor
55957660|NCT00186875|Dermatologic Agents|dermatologic agents|mesh-ancestor
55957661|NCT00186875|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55957662|NCT00186875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55957709|NCT02579772|Antioxidants|antioxidants|mesh-ancestor
55957710|NCT02579772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55957711|NCT02579772|Protective Agents|protective agents|mesh-ancestor
55957712|NCT02579772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957713|NCT02579772|Antidotes|antidotes|mesh-ancestor
55957715|NCT05535036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55957716|NCT05535036|Antiemetics|antiemetics|mesh-ancestor
55957717|NCT05535036|Autonomic Agents|autonomic agents|mesh-ancestor
55957718|NCT05535036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55957719|NCT05535036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957722|NCT05535036|Hormones|hormones|mesh-ancestor
55957769|NCT01790737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55957770|NCT04953156|Nitroglycerin|nitroglycerin|mesh-list
55957776|NCT04953156|Analgesics|analgesics|mesh-ancestor
55957842|NCT00187655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55957914|NCT01790971|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55957989|NCT01809639|Progestins|progestins|mesh-ancestor
55957990|NCT01809639|Hormones|hormones|mesh-ancestor
55957991|NCT01809639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55957992|NCT01809639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957993|NCT05391750|Venetoclax|venetoclax|mesh-list
55957994|NCT05391750|Immunoglobulins|immunoglobulins|mesh-list
55957995|NCT05391750|Immunoglobulin G|immunoglobulin g|mesh-list
55957996|NCT05391750|Immunologic Factors|immunologic factors|mesh-ancestor
55957997|NCT05391750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55957998|NCT05391750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55957999|NCT01763931|Digoxin|digoxin|mesh-list
55958000|NCT01763931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55958049|NCT02566395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958050|NCT02566395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958051|NCT02566395|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55958053|NCT01811355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55958054|NCT01811355|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55958055|NCT01811355|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55958056|NCT01811355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55958057|NCT01811355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958058|NCT02437071|Pembrolizumab|pembrolizumab|mesh-list
55958059|NCT02437071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958113|NCT03787680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958115|NCT03787680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958188|NCT00138203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958263|NCT01818063|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55958335|NCT05643066|Anesthetics|anesthetics|mesh-ancestor
55958410|NCT00257933|Hormones|hormones|mesh-ancestor
55958411|NCT00257933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55958412|NCT00257933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958413|NCT00257933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55958414|NCT00257933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958415|NCT00257933|Antiemetics|antiemetics|mesh-ancestor
55958416|NCT00257933|Autonomic Agents|autonomic agents|mesh-ancestor
55958417|NCT00257933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958418|NCT00257933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55958419|NCT00257933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55958420|NCT00257933|Protective Agents|protective agents|mesh-ancestor
55958421|NCT01734525|Anidulafungin|anidulafungin|mesh-list
55958422|NCT01734525|Antifungal Agents|antifungal agents|mesh-ancestor
55958423|NCT01734525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958424|NCT01819935|Vancomycin|vancomycin|mesh-list
55958425|NCT01819935|Linezolid|linezolid|mesh-list
55958426|NCT01819935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55958427|NCT01819935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55958428|NCT01819935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55958429|NCT01819935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958431|NCT01821105|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55958464|NCT01736085|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55958466|NCT01736085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55958537|NCT01898507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958538|NCT01898507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55958610|NCT01775865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958682|NCT05501574|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55958683|NCT05501574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958684|NCT05501574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958685|NCT01779375|Metformin|metformin|mesh-list
55958752|NCT00218387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958753|NCT00218387|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55958754|NCT00218387|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55958755|NCT00218387|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55958756|NCT00218387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958759|NCT00218465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961101|NCT00340379|Serotonin Agents|serotonin agents|mesh-ancestor
55958819|NCT05327751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958892|NCT01899755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55958893|NCT01899755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55958894|NCT01899755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958895|NCT01899833|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
55958896|NCT01899833|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55958897|NCT01899833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958898|NCT00229619|Rituximab|rituximab|mesh-list
55958899|NCT00229619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55958900|NCT00229619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55958901|NCT00229619|Immunologic Factors|immunologic factors|mesh-ancestor
55958902|NCT00229619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55958903|NCT00229619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55958904|NCT00281021|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55958953|NCT02261727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55958954|NCT02261727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55958955|NCT02261727|Vasodilator Agents|vasodilator agents|mesh-ancestor
55959028|NCT01791465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959029|NCT01791465|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55959030|NCT01791465|Incretins|incretins|mesh-ancestor
55959101|NCT01794039|Growth Inhibitors|growth inhibitors|mesh-ancestor
55959102|NCT01794039|Protease Inhibitors|protease inhibitors|mesh-ancestor
55959103|NCT01794039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959104|NCT01794039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55959105|NCT01794039|Dermatologic Agents|dermatologic agents|mesh-ancestor
55959106|NCT00281827|Gemcitabine|gemcitabine|mesh-list
55959107|NCT00281827|Thalidomide|thalidomide|mesh-list
55959108|NCT00281827|Carboplatin|carboplatin|mesh-list
55959109|NCT00281827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959110|NCT00281827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55959167|NCT00052429|Immunologic Factors|immunologic factors|mesh-ancestor
55959168|NCT00052429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959169|NCT01435616|Insulin Glargine|insulin glargine|mesh-list
55959170|NCT01435616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55959171|NCT01435616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959172|NCT03972397|Bupivacaine|bupivacaine|mesh-list
55959173|NCT03972397|Anesthetics, Local|anesthetics, local|mesh-ancestor
55959174|NCT03972397|Anesthetics|anesthetics|mesh-ancestor
55959175|NCT03972397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959176|NCT03972397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959234|NCT00287989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959309|NCT01650701|Rituximab|rituximab|mesh-list
55959383|NCT03366415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959459|NCT00287729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959460|NCT01433978|Maleic acid|maleic acid|mesh-list
55959532|NCT05098067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55959533|NCT05098067|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55959534|NCT05098067|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55959535|NCT05098067|Sensory System Agents|sensory system agents|mesh-ancestor
55959536|NCT05098067|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55959537|NCT05098067|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55959538|NCT05098067|Dopamine Agents|dopamine agents|mesh-ancestor
55959546|NCT01852383|Analgesics|analgesics|mesh-ancestor
55959599|NCT05748561|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55959600|NCT05748561|Protective Agents|protective agents|mesh-ancestor
55959601|NCT05748561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55959672|NCT00299221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55959673|NCT00299221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959745|NCT00300469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55959746|NCT00300469|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55959747|NCT00300469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55959891|NCT00303823|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55959892|NCT00303823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55959893|NCT00303823|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55959894|NCT00300677|Voriconazole|voriconazole|mesh-list
55959895|NCT00300677|Antifungal Agents|antifungal agents|mesh-ancestor
55959896|NCT00300677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55959897|NCT00300677|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55959961|NCT01393964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55959962|NCT01393964|Antiemetics|antiemetics|mesh-ancestor
55959963|NCT01393964|Autonomic Agents|autonomic agents|mesh-ancestor
55959964|NCT01393964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55959965|NCT01393964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55959966|NCT01393964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55959967|NCT01393964|Glucocorticoids|glucocorticoids|mesh-ancestor
55959968|NCT01393964|Hormones|hormones|mesh-ancestor
55959969|NCT01393964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55959980|NCT01790555|Diazepam|diazepam|mesh-list
55960025|NCT01393730|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55960099|NCT04047836|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55960100|NCT04047836|Autonomic Agents|autonomic agents|mesh-ancestor
55960171|NCT00339079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55960172|NCT00339079|Serotonin Agents|serotonin agents|mesh-ancestor
55960320|NCT01791751|Zuclomiphene|zuclomiphene|mesh-list
55960321|NCT01791751|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55960322|NCT01791751|Hormone Antagonists|hormone antagonists|mesh-ancestor
55960323|NCT01791751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55960324|NCT01791751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960325|NCT01791751|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55960326|NCT01791751|Fertility Agents|fertility agents|mesh-ancestor
55960327|NCT01791751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55960328|NCT01791751|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55960329|NCT01791751|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55960330|NCT05266261|Cholecalciferol|cholecalciferol|mesh-list
55960331|NCT05266261|Ibandronic Acid|ibandronic acid|mesh-list
55960332|NCT05266261|Calcium Carbonate|calcium carbonate|mesh-list
55960333|NCT05266261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55960334|NCT05266261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960336|NCT05266261|Micronutrients|micronutrients|mesh-ancestor
55960337|NCT05266261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55960378|NCT05265793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960385|NCT04005599|Magnesium Sulfate|magnesium sulfate|mesh-list
55960457|NCT00317941|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55960531|NCT04971187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960532|NCT04971187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55960533|NCT04971187|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55960534|NCT04971187|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55960536|NCT00353977|Immunologic Factors|immunologic factors|mesh-ancestor
55960537|NCT00353977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960538|NCT00320281|Botulinum Toxins|botulinum toxins|mesh-list
55960539|NCT00320281|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55960540|NCT00320281|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55960541|NCT00320281|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55960542|NCT00320281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55960544|NCT00320281|Cholinergic Agents|cholinergic agents|mesh-ancestor
55960590|NCT00320749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55960591|NCT00320749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960592|NCT00320749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55960593|NCT00320749|Immunologic Factors|immunologic factors|mesh-ancestor
55960594|NCT00320749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55960595|NCT00320749|Tubulin Modulators|tubulin modulators|mesh-ancestor
55960596|NCT00320749|Antimitotic Agents|antimitotic agents|mesh-ancestor
55960597|NCT00320749|Mitosis Modulators|mitosis modulators|mesh-ancestor
55960598|NCT00354913|Imatinib Mesylate|imatinib mesylate|mesh-list
55960599|NCT00354913|Hydroxyurea|hydroxyurea|mesh-list
55960600|NCT00354913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55960601|NCT00354913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55960602|NCT00354913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960654|NCT01431950|Dermatologic Agents|dermatologic agents|mesh-ancestor
55960727|NCT00558753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55960729|NCT00324259|Estradiol|estradiol|mesh-list
55960805|NCT00395161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55960879|NCT01794169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55960880|NCT01794169|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55960954|NCT00358501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55960955|NCT00358501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961026|NCT00358579|Vasopressins|vasopressins|mesh-list
55961027|NCT00358579|Arginine Vasopressin|arginine vasopressin|mesh-list
55961028|NCT00358579|Epinephrine|epinephrine|mesh-list
55961029|NCT00358579|Racepinephrine|racepinephrine|mesh-list
55961030|NCT00358579|Epinephryl borate|epinephryl borate|mesh-list
55961031|NCT00358579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961032|NCT00358579|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55961033|NCT00358579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55961034|NCT00358579|Adrenergic Agents|adrenergic agents|mesh-ancestor
55961096|NCT00340379|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55961097|NCT00340379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55961098|NCT00340379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55961099|NCT00340379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961100|NCT00340379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55961102|NCT00340379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961103|NCT00340379|Antiemetics|antiemetics|mesh-ancestor
55961104|NCT00340379|Autonomic Agents|autonomic agents|mesh-ancestor
55961105|NCT00340379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961106|NCT00340379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55961107|NCT00340379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55961108|NCT00340379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55961109|NCT00340379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55961157|NCT03873805|Cyclophosphamide|cyclophosphamide|mesh-list
55961158|NCT03873805|Fludarabine|fludarabine|mesh-list
55961159|NCT03873805|Fludarabine phosphate|fludarabine phosphate|mesh-list
55961160|NCT03873805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55961161|NCT03873805|Immunologic Factors|immunologic factors|mesh-ancestor
55961162|NCT03873805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961163|NCT03873805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961164|NCT03873805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55961165|NCT03873805|Alkylating Agents|alkylating agents|mesh-ancestor
55961166|NCT03873805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961167|NCT03873805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961168|NCT03873805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55961169|NCT03873805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55961170|NCT03873805|Antimetabolites|antimetabolites|mesh-ancestor
55961171|NCT03873805|Antiviral Agents|antiviral agents|mesh-ancestor
55961216|NCT00352001|Immunologic Factors|immunologic factors|mesh-ancestor
55961218|NCT00352001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55961290|NCT00558519|Dexamethasone|dexamethasone|mesh-list
55961291|NCT00558519|Cyclophosphamide|cyclophosphamide|mesh-list
55961292|NCT00558519|Doxorubicin|doxorubicin|mesh-list
55961365|NCT00403117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55961367|NCT03023631|Immunologic Factors|immunologic factors|mesh-ancestor
55961368|NCT03023631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55961369|NCT03554083|Atezolizumab|atezolizumab|mesh-list
55961370|NCT03554083|Vemurafenib|vemurafenib|mesh-list
55961386|NCT01389596|Pregabalin|pregabalin|mesh-list
55961434|NCT02111863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961435|NCT02111863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55961507|NCT01791647|Vitamins|vitamins|mesh-ancestor
55961509|NCT00363883|Vorinostat|vorinostat|mesh-list
55961580|NCT05299125|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
55961652|NCT00555477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55961653|NCT00555477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55961654|NCT00555477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55961723|NCT00412243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55961724|NCT00412243|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55961799|NCT01794533|Sympathomimetics|sympathomimetics|mesh-ancestor
55961800|NCT01794533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55961801|NCT00412867|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55961802|NCT00412867|Plasminogen|plasminogen|mesh-list
55961803|NCT00412867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55961804|NCT00412867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55961805|NCT00412867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55961806|NCT01730833|Paclitaxel|paclitaxel|mesh-list
55961807|NCT01730833|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55961808|NCT01730833|Trastuzumab|trastuzumab|mesh-list
55961809|NCT01730833|Pertuzumab|pertuzumab|mesh-list
55961810|NCT01730833|Antibodies|antibodies|mesh-list
55961811|NCT01730833|Immunoglobulins|immunoglobulins|mesh-list
55961812|NCT01730833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55961860|NCT01791881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55961934|NCT01792037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55961935|NCT01792037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55962006|NCT00374803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55962078|NCT01794767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962079|NCT01425632|Bepotastine besilate|bepotastine besilate|mesh-list
55962080|NCT01425632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55962152|NCT00365417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55962153|NCT00365417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55962154|NCT00365417|Alkylating Agents|alkylating agents|mesh-ancestor
55962226|NCT00427765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55962227|NCT00427765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55962228|NCT00427765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55962229|NCT00427765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962230|NCT00427765|Immunologic Factors|immunologic factors|mesh-ancestor
55962231|NCT00427765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962232|NCT04346017|Complement System Proteins|complement system proteins|mesh-list
55962233|NCT04346017|Immunologic Factors|immunologic factors|mesh-ancestor
55962234|NCT04346017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962236|NCT00384865|Simvastatin|simvastatin|mesh-list
55962238|NCT00384865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55962288|NCT05286931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55962361|NCT01795235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55962364|NCT01795235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962433|NCT03562975|Immunologic Factors|immunologic factors|mesh-ancestor
55962508|NCT00438451|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55962580|NCT00461851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55962581|NCT00461851|Immunologic Factors|immunologic factors|mesh-ancestor
55962582|NCT00461851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962652|NCT00400439|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55962727|NCT00448357|Fludarabine phosphate|fludarabine phosphate|mesh-list
55962728|NCT00448357|Fludarabine|fludarabine|mesh-list
55962729|NCT00448357|Busulfan|busulfan|mesh-list
55962730|NCT00448357|Tacrolimus|tacrolimus|mesh-list
55962731|NCT00448357|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55962732|NCT00448357|Thymoglobulin|thymoglobulin|mesh-list
55962733|NCT00448357|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55962734|NCT00448357|Abortifacient Agents|abortifacient agents|mesh-ancestor
55962735|NCT00448357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55962738|NCT00448357|Antimetabolites|antimetabolites|mesh-ancestor
55962793|NCT00382031|Immunologic Factors|immunologic factors|mesh-ancestor
55962794|NCT00382031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55962866|NCT00450463|Molgramostim|molgramostim|mesh-list
55962939|NCT00386477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963013|NCT00475501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963089|NCT04372927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55963090|NCT04372927|Immunologic Factors|immunologic factors|mesh-ancestor
55963091|NCT04372927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963092|NCT04372927|Keratolytic Agents|keratolytic agents|mesh-ancestor
55963093|NCT04372927|Dermatologic Agents|dermatologic agents|mesh-ancestor
55963094|NCT04372927|Tubulin Modulators|tubulin modulators|mesh-ancestor
55963095|NCT04372927|Antimitotic Agents|antimitotic agents|mesh-ancestor
55963096|NCT04372927|Mitosis Modulators|mitosis modulators|mesh-ancestor
55963098|NCT01381874|Prednisolone|prednisolone|mesh-list
55963099|NCT01381874|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55963100|NCT01381874|Methylprednisolone|methylprednisolone|mesh-list
55963101|NCT01381874|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55963151|NCT05365178|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55963156|NCT00479089|Docetaxel|docetaxel|mesh-list
55963224|NCT00387959|Antitubercular Agents|antitubercular agents|mesh-ancestor
55963225|NCT00387959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55963297|NCT00414167|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55963298|NCT00414167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963299|NCT01380782|Nintedanib|nintedanib|mesh-list
55963300|NCT01380782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963301|NCT01380782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55963302|NCT01380782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963303|NCT01380782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963304|NCT04245865|Leucovorin|leucovorin|mesh-list
55963305|NCT04245865|Tocotrienols|tocotrienols|mesh-list
55963306|NCT04245865|Vitamin E|vitamin e|mesh-list
55963307|NCT04245865|Tocopherols|tocopherols|mesh-list
55963308|NCT04245865|Bevacizumab|bevacizumab|mesh-list
55963309|NCT04245865|Fluorouracil|fluorouracil|mesh-list
55963437|NCT05368376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963438|NCT05368376|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55963439|NCT05368376|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55963440|NCT05368376|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55963441|NCT05368376|Adrenergic Agents|adrenergic agents|mesh-ancestor
55963442|NCT05368376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963443|NCT05368376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963444|NCT05368376|Sympathomimetics|sympathomimetics|mesh-ancestor
55963445|NCT05368376|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55963446|NCT05368376|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55963447|NCT00482911|Cyclophosphamide|cyclophosphamide|mesh-list
55963448|NCT00482911|Lenalidomide|lenalidomide|mesh-list
55963498|NCT00420017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963568|NCT00486031|Analgesics|analgesics|mesh-ancestor
55963575|NCT04019834|Bupivacaine|bupivacaine|mesh-list
55963640|NCT00488059|Antiviral Agents|antiviral agents|mesh-ancestor
55963642|NCT00488059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963716|NCT02113241|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55963789|NCT01395758|Antimetabolites|antimetabolites|mesh-ancestor
55963790|NCT01395758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963791|NCT01395758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55963793|NCT01395758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55963794|NCT01395758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55963795|NCT01395758|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55963796|NCT01395758|Immunologic Factors|immunologic factors|mesh-ancestor
55963797|NCT01395758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55963854|NCT00435539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963855|NCT00464711|Citalopram|citalopram|mesh-list
55963856|NCT00464711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55963857|NCT00464711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55963858|NCT00464711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55963859|NCT00464711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55963860|NCT00464711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55963928|NCT00535925|Antipyretics|antipyretics|mesh-ancestor
55963994|NCT00435929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964225|NCT05630222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55964226|NCT05630222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964227|NCT05630222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55964228|NCT05630222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55964229|NCT05630222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964230|NCT05630222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964231|NCT03594188|Anesthetics|anesthetics|mesh-list
55964232|NCT03594188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964233|NCT03594188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964234|NCT00539695|Aldesleukin|aldesleukin|mesh-list
55964235|NCT00539695|Interleukin-2|interleukin-2|mesh-list
55964287|NCT05632328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964288|NCT05632328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964289|NCT05632328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55964290|NCT05632328|Immunologic Factors|immunologic factors|mesh-ancestor
55964291|NCT05632328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964292|NCT03976310|Benralizumab|benralizumab|mesh-list
55964293|NCT03976310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55964295|NCT03599726|Donepezil|donepezil|mesh-list
55964354|NCT02982889|Anesthetics|anesthetics|mesh-ancestor
55964355|NCT02982889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964357|NCT02982889|Sensory System Agents|sensory system agents|mesh-ancestor
55964425|NCT03591536|Vasodilator Agents|vasodilator agents|mesh-ancestor
55964426|NCT03591536|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55964502|NCT00503113|Ibandronic Acid|ibandronic acid|mesh-list
55964503|NCT00503113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55964504|NCT00503113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964505|NCT00542971|Cytarabine|cytarabine|mesh-list
55964506|NCT00542971|Sorafenib|sorafenib|mesh-list
55964507|NCT00542971|Idarubicin|idarubicin|mesh-list
55964508|NCT00542971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55964509|NCT00542971|Antimetabolites|antimetabolites|mesh-ancestor
55964510|NCT00542971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964511|NCT00542971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55964512|NCT00542971|Antiviral Agents|antiviral agents|mesh-ancestor
55964513|NCT00542971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964514|NCT00542971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55964522|NCT00504751|Dexamethasone|dexamethasone|mesh-list
55964564|NCT05630768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964636|NCT03597308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55964637|NCT03597308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964638|NCT03597308|Antipyretics|antipyretics|mesh-ancestor
55964639|NCT03597308|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55964640|NCT03597308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55964641|NCT03597308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55964642|NCT03597308|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55964643|NCT03597308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964703|NCT03596294|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55964704|NCT03596294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55964772|NCT00439673|GABA Agents|gaba agents|mesh-ancestor
55964847|NCT00509665|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55964849|NCT00513799|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55964850|NCT00513799|Mupirocin|mupirocin|mesh-list
55964851|NCT00513799|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55964852|NCT00513799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964853|NCT00513799|Disinfectants|disinfectants|mesh-ancestor
55964854|NCT00513799|Dermatologic Agents|dermatologic agents|mesh-ancestor
55964914|NCT00474851|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55964915|NCT00215150|Ziprasidone|ziprasidone|mesh-list
55964916|NCT00215150|Sertraline|sertraline|mesh-list
55964917|NCT00215150|Antidepressive Agents|antidepressive agents|mesh-ancestor
55964918|NCT00215150|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55964919|NCT00215150|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55964920|NCT00215150|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55964921|NCT00215150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55964922|NCT00215150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964923|NCT00215150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55964924|NCT00215150|Serotonin Agents|serotonin agents|mesh-ancestor
55964925|NCT00215150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55964926|NCT00215150|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55964927|NCT00215150|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55964928|NCT00215150|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55964929|NCT00215150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55964930|NCT00215150|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55964931|NCT00215150|Dopamine Agents|dopamine agents|mesh-ancestor
55964932|NCT04192994|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55964933|NCT04192994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55964934|NCT04198844|Warfarin|warfarin|mesh-list
55964935|NCT04198844|Apixaban|apixaban|mesh-list
55964936|NCT04198844|Anticoagulants|anticoagulants|mesh-ancestor
55964966|NCT00547105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55964967|NCT04195100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55964968|NCT04195100|Pilocarpine|pilocarpine|mesh-list
55964969|NCT04195100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55964970|NCT04195100|Miotics|miotics|mesh-ancestor
55964980|NCT04193774|Benoxinate|benoxinate|mesh-list
55842546|NCT03154918|Antiviral Agents|antiviral agents|mesh-ancestor
55965037|NCT03948464|Respiratory System Agents|respiratory system agents|mesh-ancestor
55965038|NCT04196270|Ropivacaine|ropivacaine|mesh-list
55965111|NCT00548431|Mercaptopurine|mercaptopurine|mesh-list
55965112|NCT00548431|Antimetabolites|antimetabolites|mesh-ancestor
55965113|NCT00548431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965114|NCT00548431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55965115|NCT00548431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965116|NCT00548431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965117|NCT00548431|Immunologic Factors|immunologic factors|mesh-ancestor
55965120|NCT00548431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965178|NCT04023110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965179|NCT04023110|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55965180|NCT04023110|Antioxidants|antioxidants|mesh-ancestor
55965181|NCT04023110|Protective Agents|protective agents|mesh-ancestor
55965182|NCT04023110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55965183|NCT04023110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55965184|NCT04023110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55965185|NCT04023110|Vasodilator Agents|vasodilator agents|mesh-ancestor
55965186|NCT04023110|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55965319|NCT00551707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965320|NCT00551707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55965321|NCT00551707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965322|NCT00551707|Antiemetics|antiemetics|mesh-ancestor
55965323|NCT00551707|Autonomic Agents|autonomic agents|mesh-ancestor
55965324|NCT00551707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965325|NCT00551707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55965326|NCT00551707|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55965327|NCT00551707|Protective Agents|protective agents|mesh-ancestor
55965335|NCT04193930|Hormones|hormones|mesh-list
55965385|NCT03830918|Temozolomide|temozolomide|mesh-list
55965386|NCT03830918|Atezolizumab|atezolizumab|mesh-list
55965461|NCT05533567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55965462|NCT05533567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55965463|NCT05533567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965464|NCT05533567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55965465|NCT05533567|Anesthetics, General|anesthetics, general|mesh-ancestor
55965466|NCT05533567|Anesthetics|anesthetics|mesh-ancestor
55965467|NCT05533567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55965468|NCT05533567|Narcotics|narcotics|mesh-ancestor
55965469|NCT05533567|Analgesics|analgesics|mesh-ancestor
55965470|NCT05533567|Sensory System Agents|sensory system agents|mesh-ancestor
55965471|NCT05533567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965472|NCT05533567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55965524|NCT00475319|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55965525|NCT00475319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55965526|NCT00475319|Antioxidants|antioxidants|mesh-ancestor
55965527|NCT00475319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965528|NCT00475319|Protective Agents|protective agents|mesh-ancestor
55965529|NCT00475319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55965530|NCT00475319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965531|NCT04026074|Clonidine|clonidine|mesh-list
55965532|NCT04026074|Fentanyl|fentanyl|mesh-list
55965588|NCT04345471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965589|NCT04345471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55965662|NCT04025918|Protective Agents|protective agents|mesh-ancestor
55965736|NCT00478361|Paclitaxel|paclitaxel|mesh-list
55965737|NCT00478361|Doxorubicin|doxorubicin|mesh-list
55965738|NCT00478361|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55965739|NCT00478361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55965740|NCT00478361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55965741|NCT00478361|Tubulin Modulators|tubulin modulators|mesh-ancestor
55965742|NCT00478361|Antimitotic Agents|antimitotic agents|mesh-ancestor
55965743|NCT00478361|Mitosis Modulators|mitosis modulators|mesh-ancestor
55965744|NCT00478361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55965745|NCT00478361|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55965746|NCT00478361|Antimetabolites|antimetabolites|mesh-ancestor
55965747|NCT00478361|Antiviral Agents|antiviral agents|mesh-ancestor
55965748|NCT00478361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55965749|NCT00478361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55965750|NCT00478361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55965795|NCT00450983|Fludarabine phosphate|fludarabine phosphate|mesh-list
55965796|NCT00450983|Fludarabine|fludarabine|mesh-list
55965797|NCT00450983|Thiotepa|thiotepa|mesh-list
55965798|NCT00450983|Muromonab-CD3|muromonab-cd3|mesh-list
55965799|NCT00450983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55965800|NCT00450983|Abortifacient Agents|abortifacient agents|mesh-ancestor
55965801|NCT00450983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55965804|NCT00450983|Antimetabolites|antimetabolites|mesh-ancestor
55965862|NCT01797601|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55965863|NCT01797601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55965938|NCT00452387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55965939|NCT00452387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55965941|NCT03945656|Insulin|insulin|mesh-list
55966011|NCT00567229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966012|NCT00567229|Immunologic Factors|immunologic factors|mesh-ancestor
55966013|NCT00567229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966014|NCT00567229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55966015|NCT00567229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55966016|NCT00567229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55966017|NCT00567229|Growth Substances|growth substances|mesh-ancestor
55966018|NCT00567229|Growth Inhibitors|growth inhibitors|mesh-ancestor
55966019|NCT04148846|Dexamethasone|dexamethasone|mesh-list
55966020|NCT04148846|Ketoprofen|ketoprofen|mesh-list
55966021|NCT04148846|Theophylline|theophylline|mesh-list
55966078|NCT00487721|Protective Agents|protective agents|mesh-ancestor
55966079|NCT00487721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966154|NCT00489281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966228|NCT02120261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55966229|NCT02120261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55966230|NCT02120261|Immunologic Factors|immunologic factors|mesh-ancestor
55966300|NCT01798537|Ionophores|ionophores|mesh-ancestor
55966376|NCT04147208|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55966377|NCT04147208|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55966378|NCT04147208|Antiviral Agents|antiviral agents|mesh-ancestor
55966449|NCT03588494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966450|NCT03588494|Growth Inhibitors|growth inhibitors|mesh-ancestor
55966451|NCT03588494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966452|NCT00550277|Panobinostat|panobinostat|mesh-list
55966453|NCT00550277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966454|NCT00550277|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55966455|NCT00550277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966456|NCT00550277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966457|NCT03921242|Metformin|metformin|mesh-list
55966458|NCT03921242|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55966459|NCT03921242|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55966460|NCT03921242|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55966461|NCT03921242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966462|NCT03921242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966463|NCT03921242|Protease Inhibitors|protease inhibitors|mesh-ancestor
55966464|NCT03921242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966465|NCT00550589|Cidofovir|cidofovir|mesh-list
55966466|NCT00550589|Antiviral Agents|antiviral agents|mesh-ancestor
55966467|NCT00550589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966470|NCT04144712|Caffeine|caffeine|mesh-list
55966502|NCT00496379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966503|NCT02985086|Cefoxitin|cefoxitin|mesh-list
55966504|NCT02985086|Misoprostol|misoprostol|mesh-list
55966505|NCT02985086|Oxytocin|oxytocin|mesh-list
55966574|NCT03905798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55966646|NCT03587324|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55966718|NCT04142762|Itraconazole|itraconazole|mesh-list
55966719|NCT04142762|Rifampin|rifampin|mesh-list
55966792|NCT04221477|Hormones|hormones|mesh-ancestor
55966794|NCT04221477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55966867|NCT05605899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55966943|NCT00610987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966944|NCT04140578|Ertapenem|ertapenem|mesh-list
55966946|NCT04140578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55966947|NCT00574171|Capecitabine|capecitabine|mesh-list
55966948|NCT00574171|Lapatinib|lapatinib|mesh-list
55966949|NCT00574171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55966950|NCT00574171|Antimetabolites|antimetabolites|mesh-ancestor
55966951|NCT00574171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55966952|NCT00574171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55966953|NCT00574171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55966954|NCT00574171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55966955|NCT03585998|Cisplatin|cisplatin|mesh-list
55966956|NCT03585998|Etoposide|etoposide|mesh-list
55966957|NCT03585998|Durvalumab|durvalumab|mesh-list
55966958|NCT03585998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967004|NCT00499109|Vinorelbine|vinorelbine|mesh-list
55967005|NCT00499109|Antineoplastic Agents|antineoplastic agents|mesh-list
55967078|NCT00615433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967151|NCT00615589|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55967225|NCT03589898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967298|NCT00504023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967299|NCT00504023|Interferon Inducers|interferon inducers|mesh-ancestor
55967373|NCT03583424|Melphalan|melphalan|mesh-list
55967374|NCT03583424|Venetoclax|venetoclax|mesh-list
55967375|NCT03583424|Mechlorethamine|mechlorethamine|mesh-list
55967376|NCT03583424|Carmustine|carmustine|mesh-list
55967377|NCT03583424|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55967378|NCT03583424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55967379|NCT03583424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967380|NCT03583424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55967381|NCT03583424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55967382|NCT03583424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55967383|NCT03583424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967440|NCT00578461|Alkylating Agents|alkylating agents|mesh-ancestor
55967441|NCT00578461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967442|NCT00578461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55967511|NCT00505895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55967512|NCT00505895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55967513|NCT00505895|Antimetabolites|antimetabolites|mesh-ancestor
55967514|NCT00505895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55967515|NCT00505895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55967517|NCT00505895|Alkylating Agents|alkylating agents|mesh-ancestor
55967656|NCT00621049|Bevacizumab|bevacizumab|mesh-list
55967657|NCT00621049|Carboplatin|carboplatin|mesh-list
55967658|NCT00621049|Docetaxel|docetaxel|mesh-list
55967659|NCT00621049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55967673|NCT00508469|Timolol|timolol|mesh-list
55967728|NCT00580957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967800|NCT03029780|Ipilimumab|ipilimumab|mesh-list
55967805|NCT00624559|Celecoxib|celecoxib|mesh-list
55967874|NCT03029234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55967876|NCT03029234|Autonomic Agents|autonomic agents|mesh-ancestor
55967877|NCT03029234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55967878|NCT03029234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55967879|NCT03029234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55967881|NCT03029234|Hormones|hormones|mesh-ancestor
55967944|NCT01661647|Anesthetics|anesthetics|mesh-list
55968016|NCT00630253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968169|NCT04459117|Sensory System Agents|sensory system agents|mesh-ancestor
55968170|NCT04459117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968171|NCT04459117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968172|NCT04459117|Antipyretics|antipyretics|mesh-ancestor
55968173|NCT00515411|Leucovorin|leucovorin|mesh-list
55968174|NCT00515411|Cisplatin|cisplatin|mesh-list
55968175|NCT00515411|Docetaxel|docetaxel|mesh-list
55968176|NCT00515411|Fluorouracil|fluorouracil|mesh-list
55968177|NCT00515411|Trastuzumab|trastuzumab|mesh-list
55968178|NCT00515411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968179|NCT00515411|Tubulin Modulators|tubulin modulators|mesh-ancestor
55968180|NCT00515411|Antimitotic Agents|antimitotic agents|mesh-ancestor
55968181|NCT00515411|Mitosis Modulators|mitosis modulators|mesh-ancestor
55968182|NCT00515411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968232|NCT00586573|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55968233|NCT01799005|Micronutrients|micronutrients|mesh-list
55968234|NCT01799005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968235|NCT00515879|Cycloserine|cycloserine|mesh-list
55968236|NCT00515879|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55968237|NCT00515879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968238|NCT00515879|Renal Agents|renal agents|mesh-ancestor
55968239|NCT00515879|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55968240|NCT00515879|Antitubercular Agents|antitubercular agents|mesh-ancestor
55968241|NCT00515879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55968242|NCT00515879|Antimetabolites|antimetabolites|mesh-ancestor
55968295|NCT00516503|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55968296|NCT00516503|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55968365|NCT00636649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968366|NCT00636649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968367|NCT00636649|Serotonin Agents|serotonin agents|mesh-ancestor
55968368|NCT00636649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968369|NCT00636649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55968370|NCT00636649|Antidepressive Agents|antidepressive agents|mesh-ancestor
55968372|NCT05061524|Omalizumab|omalizumab|mesh-list
55842840|NCT01594125|Nintedanib|nintedanib|mesh-list
55968433|NCT00524225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968434|NCT00669019|Saracatinib|saracatinib|mesh-list
55968435|NCT00669019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968436|NCT00669019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968437|NCT00669019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968438|NCT05560373|Huperzine A|huperzine a|mesh-list
55968439|NCT05560373|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55968440|NCT05560373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968441|NCT05560373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968442|NCT05560373|Cholinergic Agents|cholinergic agents|mesh-ancestor
55968443|NCT05560373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55968444|NCT05560373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968445|NCT05560373|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55968446|NCT05560373|Protective Agents|protective agents|mesh-ancestor
55968448|NCT00670267|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55968492|NCT00641563|Dexmedetomidine|dexmedetomidine|mesh-list
55968493|NCT00641563|Remifentanil|remifentanil|mesh-list
55968494|NCT00641563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55968495|NCT00641563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55968496|NCT00641563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968497|NCT00641563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55968498|NCT00641563|Analgesics|analgesics|mesh-ancestor
55968499|NCT00641563|Sensory System Agents|sensory system agents|mesh-ancestor
55968500|NCT00641563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968501|NCT00641563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55968502|NCT00641563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55968503|NCT00641563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55968555|NCT03152474|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55968557|NCT03152474|Vitamins|vitamins|mesh-ancestor
55968633|NCT04120766|Vitamin B Complex|vitamin b complex|mesh-ancestor
55968634|NCT04120766|Vitamins|vitamins|mesh-ancestor
55968635|NCT04120766|Micronutrients|micronutrients|mesh-ancestor
55968707|NCT01670084|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55968711|NCT01670084|Mesna|mesna|mesh-list
55968782|NCT00675259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968783|NCT00675259|Growth Inhibitors|growth inhibitors|mesh-ancestor
55968855|NCT02115074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55968856|NCT02115074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55968857|NCT02115074|Analgesics|analgesics|mesh-ancestor
55968858|NCT02115074|Sensory System Agents|sensory system agents|mesh-ancestor
55968859|NCT02115074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55968860|NCT02115074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55968861|NCT02115074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55968862|NCT02115074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55968863|NCT02115074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55968864|NCT02115074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55968865|NCT02115074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968866|NCT02115074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968867|NCT01674686|Sarpogrelate|sarpogrelate|mesh-list
55968868|NCT01674686|Atorvastatin|atorvastatin|mesh-list
55968869|NCT01674686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55968913|NCT03161132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968914|NCT03161132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55968915|NCT03161132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55968916|NCT03161132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55968917|NCT03161132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55968918|NCT03161132|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55968919|NCT03844256|Capecitabine|capecitabine|mesh-list
55968920|NCT03844256|Nivolumab|nivolumab|mesh-list
55968921|NCT03844256|Ipilimumab|ipilimumab|mesh-list
55968922|NCT03844256|Mitomycins|mitomycins|mesh-list
55968923|NCT03844256|Mitomycin|mitomycin|mesh-list
55968924|NCT03844256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55968925|NCT03844256|Antimetabolites|antimetabolites|mesh-ancestor
55968927|NCT03844256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55968975|NCT02510300|Velpatasvir|velpatasvir|mesh-list
55968976|NCT02510300|Antiviral Agents|antiviral agents|mesh-ancestor
55968977|NCT02510300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55968978|NCT00678535|Capecitabine|capecitabine|mesh-list
55968979|NCT00678535|Cetuximab|cetuximab|mesh-list
55969047|NCT00557193|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55969121|NCT00660517|Xhance|xhance|mesh-list
55969126|NCT00660517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55969127|NCT00660517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969128|NCT00660517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55969129|NCT00660517|Respiratory System Agents|respiratory system agents|mesh-ancestor
55969131|NCT00660517|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55969132|NCT00660517|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
55969133|NCT00660517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969134|NCT00660517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969135|NCT00660517|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55969136|NCT00660517|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55969200|NCT03749018|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55969203|NCT03749018|Vincristine|vincristine|mesh-list
55969204|NCT03749018|Etoposide phosphate|etoposide phosphate|mesh-list
55969205|NCT03749018|Podophyllotoxin|podophyllotoxin|mesh-list
55969206|NCT03749018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55969208|NCT03749018|Immunoglobulins|immunoglobulins|mesh-list
55969209|NCT03749018|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55969210|NCT03749018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55969211|NCT03749018|Immunologic Factors|immunologic factors|mesh-ancestor
55969212|NCT03749018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969213|NCT03749018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55969214|NCT03749018|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55969225|NCT03749018|Hormones|hormones|mesh-ancestor
55969264|NCT03025269|Immunologic Factors|immunologic factors|mesh-ancestor
55969265|NCT03025269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969266|NCT03745430|Ramucirumab|ramucirumab|mesh-list
55969267|NCT03745430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969268|NCT03874052|Venetoclax|venetoclax|mesh-list
55969269|NCT03874052|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
55969270|NCT03874052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969271|NCT03874052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55969272|NCT03874052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969273|NCT03874052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969274|NCT03873818|Pembrolizumab|pembrolizumab|mesh-list
55969275|NCT03873818|Ipilimumab|ipilimumab|mesh-list
55969276|NCT03873818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969277|NCT03873818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969278|NCT03873818|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55969280|NCT03744026|Carboplatin|carboplatin|mesh-list
55969318|NCT03869450|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55969319|NCT03869450|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55969320|NCT03869450|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55969321|NCT03869450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969322|NCT03869450|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55969323|NCT03869450|Immunologic Factors|immunologic factors|mesh-ancestor
55969324|NCT03869450|Viscosupplements|viscosupplements|mesh-ancestor
55969325|NCT03869450|Protective Agents|protective agents|mesh-ancestor
55969332|NCT03864926|Tacrolimus|tacrolimus|mesh-list
55969383|NCT03781388|Anesthetics, Local|anesthetics, local|mesh-ancestor
55969462|NCT03716180|Paclitaxel|paclitaxel|mesh-list
55969534|NCT03704714|Immunoglobulins|immunoglobulins|mesh-list
55969609|NCT00681889|Ranibizumab|ranibizumab|mesh-list
55969610|NCT00681889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55969683|NCT00662545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969684|NCT00662545|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55969685|NCT00662545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55969686|NCT00662545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969687|NCT00662545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969688|NCT00662545|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55969689|NCT03539198|Nivolumab|nivolumab|mesh-list
55969690|NCT03539198|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55969691|NCT03539198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969692|NCT03539198|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55969693|NCT03539198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969746|NCT03605654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969747|NCT03605654|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55969748|NCT03605654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55969749|NCT03605654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969750|NCT03605654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55969751|NCT03605654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55969752|NCT03605654|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55969753|NCT03605654|Antitubercular Agents|antitubercular agents|mesh-ancestor
55969754|NCT03605654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55969755|NCT03605654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55969756|NCT02336438|(1-6)-alpha-glucomannan|(1-6)-alpha-glucomannan|mesh-list
55969757|NCT02336438|Cathartics|cathartics|mesh-ancestor
55969758|NCT02336438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55969880|NCT00393211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55969952|NCT01799161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55969958|NCT00006110|Paclitaxel|paclitaxel|mesh-list
55970025|NCT03510884|Nicotinic Acids|nicotinic acids|mesh-list
55970027|NCT03510884|Niacinamide|niacinamide|mesh-list
55970028|NCT03510884|Atorvastatin|atorvastatin|mesh-list
55970029|NCT03510884|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55970030|NCT03510884|Simvastatin|simvastatin|mesh-list
55970031|NCT03510884|Ezetimibe|ezetimibe|mesh-list
55970032|NCT03510884|Pravastatin|pravastatin|mesh-list
55970033|NCT03510884|Lovastatin|lovastatin|mesh-list
55970034|NCT03510884|Cholestyramine Resin|cholestyramine resin|mesh-list
55970035|NCT03510884|Fenofibrate|fenofibrate|mesh-list
55970036|NCT03510884|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55970037|NCT03510884|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55970038|NCT03510884|Antimetabolites|antimetabolites|mesh-ancestor
55970042|NCT03510884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970088|NCT02123849|Sensory System Agents|sensory system agents|mesh-ancestor
55970237|NCT00698035|Estradiol|estradiol|mesh-list
55970238|NCT00698035|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55970239|NCT00698035|Androgens|androgens|mesh-ancestor
55970240|NCT00698035|Hormones|hormones|mesh-ancestor
55970241|NCT00698035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55970242|NCT00698035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970308|NCT03487016|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55970381|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55970382|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
55970455|NCT00701389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55970456|NCT00701389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970457|NCT00701389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970458|NCT02152995|Iodine|iodine|mesh-list
55970459|NCT02152995|Cadexomer iodine|cadexomer iodine|mesh-list
55970460|NCT02152995|Trametinib|trametinib|mesh-list
55970461|NCT02152995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55970462|NCT02152995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55970522|NCT00595231|Anticonvulsants|anticonvulsants|mesh-ancestor
55970602|NCT00703261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970603|NCT00703261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55970604|NCT00703261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55970605|NCT00703261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970606|NCT03478514|Palbociclib|palbociclib|mesh-list
55970607|NCT03478514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55970611|NCT04912115|Midazolam|midazolam|mesh-list
55970671|NCT01678664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55970672|NCT01678664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55970673|NCT01678664|Immunologic Factors|immunologic factors|mesh-ancestor
55970674|NCT01678664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55970675|NCT00597493|Temozolomide|temozolomide|mesh-list
55970677|NCT00597493|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55970678|NCT00597493|Alkylating Agents|alkylating agents|mesh-ancestor
55970736|NCT03450122|Aldesleukin|aldesleukin|mesh-list
55970737|NCT03450122|Cyclophosphamide|cyclophosphamide|mesh-list
55970809|NCT00566813|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55970885|NCT00087698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55970960|NCT02987985|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55970962|NCT02987985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55970963|NCT02987985|Antipyretics|antipyretics|mesh-ancestor
55970964|NCT02987985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55971032|NCT04388189|Antidepressive Agents|antidepressive agents|mesh-ancestor
55971033|NCT04388189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55971109|NCT01943565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971110|NCT01943565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971111|NCT01943565|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55971112|NCT01943565|Narcotics|narcotics|mesh-ancestor
55971113|NCT01943565|Analgesics|analgesics|mesh-ancestor
55971114|NCT01943565|Sensory System Agents|sensory system agents|mesh-ancestor
55971115|NCT01943565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971116|NCT03316859|Naloxegol|naloxegol|mesh-list
55971117|NCT03316859|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55971118|NCT03316859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971119|NCT03316859|Sensory System Agents|sensory system agents|mesh-ancestor
55971120|NCT03316859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971121|NCT04401878|Lidocaine|lidocaine|mesh-list
55971172|NCT01881087|Levobupivacaine|levobupivacaine|mesh-list
55971173|NCT01881087|Anesthetics, Local|anesthetics, local|mesh-ancestor
55971174|NCT01881087|Anesthetics|anesthetics|mesh-ancestor
55971243|NCT02476409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971244|NCT02476409|Natriuretic Agents|natriuretic agents|mesh-ancestor
55971245|NCT02476409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971246|NCT01269853|Bevacizumab|bevacizumab|mesh-list
55971247|NCT01269853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55971248|NCT01269853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55971249|NCT01269853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55971250|NCT01269853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55971310|NCT01887171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971311|NCT01887171|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55971312|NCT01887171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971313|NCT01887171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971314|NCT00713479|Varenicline|varenicline|mesh-list
55971315|NCT00713479|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55971316|NCT00713479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55971317|NCT00713479|Cholinergic Agents|cholinergic agents|mesh-ancestor
55971318|NCT00713479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971319|NCT00713479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971320|NCT00713479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971322|NCT03467750|Morphine|morphine|mesh-list
55971323|NCT03467750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55971447|NCT00557973|Baclofen|baclofen|mesh-list
55971519|NCT00727597|Efavirenz|efavirenz|mesh-list
55971553|NCT01893879|Ketoprofen|ketoprofen|mesh-list
55971593|NCT00571961|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55971594|NCT00571961|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55971595|NCT00571961|Protease Inhibitors|protease inhibitors|mesh-ancestor
55971596|NCT00571961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971597|NCT00571961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971598|NCT00571961|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55971599|NCT00571961|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55971600|NCT00571961|Antiviral Agents|antiviral agents|mesh-ancestor
55971601|NCT00571961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55971659|NCT04386499|Resveratrol|resveratrol|mesh-list
55971660|NCT04386499|Hematinics|hematinics|mesh-ancestor
55971661|NCT04386499|Vitamin B Complex|vitamin b complex|mesh-ancestor
55971662|NCT04386499|Vitamins|vitamins|mesh-ancestor
55971663|NCT04386499|Micronutrients|micronutrients|mesh-ancestor
55971664|NCT04386499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971665|NCT04386499|Antioxidants|antioxidants|mesh-ancestor
55971666|NCT04386499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971667|NCT04386499|Protective Agents|protective agents|mesh-ancestor
55971668|NCT04386499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55971669|NCT04386499|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55971670|NCT00573287|Risperidone|risperidone|mesh-list
55971671|NCT00573287|Clozapine|clozapine|mesh-list
55971723|NCT00620425|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55971724|NCT00620425|Serotonin Agents|serotonin agents|mesh-ancestor
55971725|NCT00620425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971726|NCT00620425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971727|NCT00620425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971728|NCT01277107|Zaleplon|zaleplon|mesh-list
55971729|NCT01277107|Anticonvulsants|anticonvulsants|mesh-ancestor
55971730|NCT01277107|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55971731|NCT01277107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971732|NCT01277107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971733|NCT01277107|GABA Modulators|gaba modulators|mesh-ancestor
55971734|NCT01277107|GABA Agents|gaba agents|mesh-ancestor
55971735|NCT01277107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971736|NCT01277107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971737|NCT01277185|Calcium, Dietary|calcium, dietary|mesh-list
55971783|NCT01277731|Prednisolone|prednisolone|mesh-list
55971856|NCT01903005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971857|NCT01903005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55971858|NCT00614029|Sumatriptan|sumatriptan|mesh-list
55971859|NCT00614029|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55971860|NCT00614029|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55971861|NCT00614029|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55971862|NCT00614029|Serotonin Agents|serotonin agents|mesh-ancestor
55971863|NCT00614029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55971864|NCT00614029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971865|NCT00614029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971866|NCT01905423|Albendazole|albendazole|mesh-list
55971867|NCT01905423|Diethylcarbamazine|diethylcarbamazine|mesh-list
55971869|NCT01905423|Mebendazole|mebendazole|mesh-list
55971919|NCT01907607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55971921|NCT00753337|Trace Elements|trace elements|mesh-ancestor
55971922|NCT00753337|Micronutrients|micronutrients|mesh-ancestor
55971923|NCT00753337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971924|NCT01911351|Nitrous Oxide|nitrous oxide|mesh-list
55971925|NCT01911351|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55971926|NCT01911351|Anesthetics, General|anesthetics, general|mesh-ancestor
55971927|NCT01911351|Anesthetics|anesthetics|mesh-ancestor
55971928|NCT01911351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55971929|NCT01911351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971930|NCT01911351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55971931|NCT01911351|Analgesics|analgesics|mesh-ancestor
55971983|NCT01913535|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55971984|NCT01913535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55971985|NCT01913535|Sensory System Agents|sensory system agents|mesh-ancestor
55971986|NCT01913535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55971987|NCT01914159|Ranibizumab|ranibizumab|mesh-list
55971988|NCT01914159|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55971989|NCT01914159|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55971990|NCT01914159|Growth Substances|growth substances|mesh-ancestor
55971992|NCT01914159|Growth Inhibitors|growth inhibitors|mesh-ancestor
55972048|NCT00578903|Immunologic Factors|immunologic factors|mesh-ancestor
55972049|NCT00578903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972050|NCT00578903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55972051|NCT00578903|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55972052|NCT00578903|Alkylating Agents|alkylating agents|mesh-ancestor
55972053|NCT00578903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972067|NCT01918761|Pemetrexed|pemetrexed|mesh-list
55972119|NCT00580229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55972120|NCT00580229|Glucocorticoids|glucocorticoids|mesh-ancestor
55972121|NCT00580229|Hormones|hormones|mesh-ancestor
55972122|NCT00580229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55972123|NCT00580229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972124|NCT00580229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55972125|NCT00580229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972126|NCT00580853|Bupropion|bupropion|mesh-list
55972127|NCT00580853|Varenicline|varenicline|mesh-list
55972128|NCT00580853|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55972129|NCT00580853|Antidepressive Agents|antidepressive agents|mesh-ancestor
55972130|NCT00580853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55972131|NCT00580853|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55972132|NCT00580853|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55972133|NCT00580853|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55972134|NCT00580853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972135|NCT00580853|Dopamine Agents|dopamine agents|mesh-ancestor
55972136|NCT00580853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972137|NCT00580853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972138|NCT00580853|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55972139|NCT00580853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55972140|NCT00580853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972141|NCT00580853|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55972142|NCT00580853|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55972167|NCT01922115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972168|NCT01922115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972169|NCT01922115|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55972170|NCT01922115|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55972171|NCT01922115|Cholinergic Agents|cholinergic agents|mesh-ancestor
55972172|NCT01922115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972173|NCT01922115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972174|NCT01922115|Urological Agents|urological agents|mesh-ancestor
55972233|NCT01927887|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55972234|NCT01927887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55972235|NCT00081458|Teduglutide|teduglutide|mesh-list
55972236|NCT00081458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55972237|NCT00081458|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55972238|NCT00081458|Protective Agents|protective agents|mesh-ancestor
55972239|NCT00081458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972240|NCT00610727|Prochlorperazine|prochlorperazine|mesh-list
55972241|NCT00610727|Antiemetics|antiemetics|mesh-ancestor
55972242|NCT00610727|Autonomic Agents|autonomic agents|mesh-ancestor
55972243|NCT00610727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972244|NCT00610727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972290|NCT00585377|Growth Substances|growth substances|mesh-ancestor
55972291|NCT00585377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972292|NCT00585377|Growth Inhibitors|growth inhibitors|mesh-ancestor
55972293|NCT00585377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55972294|NCT00585377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972295|NCT00585377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972303|NCT00610883|Cyclophosphamide|cyclophosphamide|mesh-list
55972354|NCT00611351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972355|NCT00611351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55972356|NCT00611351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55972357|NCT00611351|Alkylating Agents|alkylating agents|mesh-ancestor
55972358|NCT00611351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972359|NCT00611351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972422|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
55972424|NCT03080324|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55972425|NCT03080324|Narcotics|narcotics|mesh-ancestor
55972426|NCT03080324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972427|NCT03080324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972428|NCT03080324|Analgesics|analgesics|mesh-ancestor
55972429|NCT03080324|Sensory System Agents|sensory system agents|mesh-ancestor
55972430|NCT03080324|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972436|NCT03083834|Hormones|hormones|mesh-ancestor
55972489|NCT03402152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972490|NCT03402152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972491|NCT03402152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55972492|NCT03402152|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55972493|NCT03402152|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55972494|NCT03402152|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55972495|NCT03402152|Adrenergic Agents|adrenergic agents|mesh-ancestor
55972496|NCT03402152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972497|NCT03402152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972498|NCT03402152|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55972499|NCT03402152|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55972501|NCT03402152|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55972502|NCT03402152|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55972503|NCT03402152|Dopamine Agents|dopamine agents|mesh-ancestor
55972548|NCT00587483|Sensory System Agents|sensory system agents|mesh-ancestor
55972549|NCT00587483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972550|NCT00587483|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55972551|NCT00587483|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55972552|NCT00587483|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55972553|NCT00587483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55972554|NCT00587483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972555|NCT00587483|Vasodilator Agents|vasodilator agents|mesh-ancestor
55972612|NCT00616109|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55972613|NCT00616109|Growth Substances|growth substances|mesh-ancestor
55972614|NCT00616109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972615|NCT00616109|Growth Inhibitors|growth inhibitors|mesh-ancestor
55972616|NCT00616109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55972617|NCT00616109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972618|NCT00616109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55972619|NCT04401488|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55972620|NCT04401488|Immunologic Factors|immunologic factors|mesh-ancestor
55972621|NCT04401488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972635|NCT00249769|Immunologic Factors|immunologic factors|mesh-ancestor
55972673|NCT05445921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55972674|NCT05445921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972675|NCT05445921|Sensory System Agents|sensory system agents|mesh-ancestor
55972676|NCT05445921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55972677|NCT03390296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55972678|NCT03390296|Avelumab|avelumab|mesh-list
55972679|NCT03390296|Gemtuzumab|gemtuzumab|mesh-list
55972680|NCT03390296|Azacitidine|azacitidine|mesh-list
55972681|NCT03390296|Venetoclax|venetoclax|mesh-list
55972682|NCT03390296|Calicheamicins|calicheamicins|mesh-list
55972683|NCT03390296|Antibodies|antibodies|mesh-list
55972684|NCT03390296|Immunoglobulins|immunoglobulins|mesh-list
55972685|NCT03390296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55972686|NCT03390296|Maleic acid|maleic acid|mesh-list
55972687|NCT03390296|Immunologic Factors|immunologic factors|mesh-ancestor
55972689|NCT03390296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55972737|NCT03837873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55972738|NCT03837873|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55972739|NCT03837873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55972740|NCT03837873|Antimetabolites|antimetabolites|mesh-ancestor
55972808|NCT05736549|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55972817|NCT05736549|BB 1101|bb 1101|mesh-list
55972881|NCT00733993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55972882|NCT00733993|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55972883|NCT01271257|Misoprostol|misoprostol|mesh-list
55972884|NCT01271257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55972885|NCT01271257|Abortifacient Agents|abortifacient agents|mesh-ancestor
55972886|NCT01271257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55972887|NCT01271257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972888|NCT01271257|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55972889|NCT01271257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55972890|NCT01271257|Oxytocics|oxytocics|mesh-ancestor
55972891|NCT05692869|Propranolol|propranolol|mesh-list
55972945|NCT05667285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55972946|NCT03398252|Doxazosin|doxazosin|mesh-list
55972947|NCT03398252|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55972948|NCT03398252|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55972949|NCT03398252|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55972950|NCT03398252|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55972951|NCT03398252|Adrenergic Agents|adrenergic agents|mesh-ancestor
55972952|NCT03398252|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55972954|NCT03398252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973181|NCT03382106|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55973182|NCT03382106|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55973183|NCT03382106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973184|NCT03382106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973185|NCT03382106|Urological Agents|urological agents|mesh-ancestor
55973187|NCT05039619|Diphenhydramine|diphenhydramine|mesh-list
55973189|NCT05039619|Mycophenolic Acid|mycophenolic acid|mesh-list
55973190|NCT05039619|Prednisone|prednisone|mesh-list
55973191|NCT05039619|Methylprednisolone|methylprednisolone|mesh-list
55973323|NCT00674219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973324|NCT00674219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55973394|NCT05593653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55973395|NCT05593653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973396|NCT04954287|Vaccines|vaccines|mesh-list
55973397|NCT04954287|Immunologic Factors|immunologic factors|mesh-ancestor
55973398|NCT04954287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973399|NCT00735787|Adalimumab|adalimumab|mesh-list
55973400|NCT00735787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55973461|NCT04771871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973463|NCT04771871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55973464|NCT04771871|Alkylating Agents|alkylating agents|mesh-ancestor
55973465|NCT04771871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55973531|NCT00674765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55973532|NCT00674765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973534|NCT05567601|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55973535|NCT05567601|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55973536|NCT05567601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55973537|NCT05567601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55973538|NCT05567601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55973539|NCT05567601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55973540|NCT05567601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55973596|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
55973597|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55973598|NCT00244933|Estrogens|estrogens|mesh-ancestor
55973599|NCT00244933|Hormones|hormones|mesh-ancestor
55973600|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55973601|NCT05539053|Acetylcysteine|acetylcysteine|mesh-list
55973602|NCT05539053|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55973604|NCT05539053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55973605|NCT05539053|Expectorants|expectorants|mesh-ancestor
55973606|NCT05539053|Respiratory System Agents|respiratory system agents|mesh-ancestor
55973607|NCT05539053|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55973661|NCT00680225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55973663|NCT00680225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55973730|NCT00632411|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55973803|NCT01279213|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55973804|NCT01279213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55973812|NCT01279213|GABA Agents|gaba agents|mesh-ancestor
55973892|NCT03298802|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55974041|NCT05564390|Venetoclax|venetoclax|mesh-list
55974042|NCT05564390|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55974043|NCT05564390|Antimetabolites|antimetabolites|mesh-ancestor
55974044|NCT05564390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974045|NCT05564390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974046|NCT05564390|Antiviral Agents|antiviral agents|mesh-ancestor
55974047|NCT05564390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974048|NCT05564390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55974049|NCT05564390|Immunologic Factors|immunologic factors|mesh-ancestor
55974050|NCT05564390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974051|NCT05564390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974052|NCT05564390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55974053|NCT05564390|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55974054|NCT05564390|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55974055|NCT05563766|Itraconazole|itraconazole|mesh-list
55974056|NCT05563766|Antifungal Agents|antifungal agents|mesh-ancestor
55974057|NCT05563766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974058|NCT05563766|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55974059|NCT05563766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55974060|NCT05563766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974061|NCT05563766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974062|NCT05563766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55974063|NCT05563766|Hormone Antagonists|hormone antagonists|mesh-ancestor
55974064|NCT05563766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974088|NCT02652429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974089|NCT02652429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55974090|NCT02652429|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55974091|NCT02652429|Vasodilator Agents|vasodilator agents|mesh-ancestor
55974101|NCT02294253|Naloxone|naloxone|mesh-list
55974163|NCT00685295|Narcotics|narcotics|mesh-ancestor
55974234|NCT03333668|Adrenergic Agents|adrenergic agents|mesh-ancestor
55974235|NCT03280160|Ofatumumab|ofatumumab|mesh-list
55974308|NCT03793439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974381|NCT03028701|Formoterol Fumarate|formoterol fumarate|mesh-list
55974382|NCT03028701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55974383|NCT03028701|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55974452|NCT03686306|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55974526|NCT03480971|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55974527|NCT03480971|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55974528|NCT04023669|Gemcitabine|gemcitabine|mesh-list
55974529|NCT04023669|Cyclophosphamide|cyclophosphamide|mesh-list
55974530|NCT04023669|Lenograstim|lenograstim|mesh-list
55974531|NCT04023669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55974532|NCT04023669|Immunologic Factors|immunologic factors|mesh-ancestor
55974533|NCT04023669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974534|NCT04023669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55974535|NCT04023669|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55974546|NCT00646763|Lenograstim|lenograstim|mesh-list
55974590|NCT03235232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974591|NCT03235232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974592|NCT03235232|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55974593|NCT03235232|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55974594|NCT03235232|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55974596|NCT01781637|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55974597|NCT01781637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55974598|NCT01781637|Respiratory System Agents|respiratory system agents|mesh-ancestor
55974599|NCT00652145|Mesalamine|mesalamine|mesh-list
55974600|NCT00652145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55974601|NCT00652145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55974652|NCT04761848|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55974653|NCT04761848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55974654|NCT04761848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974655|NCT03277196|Ivacaftor|ivacaftor|mesh-list
55974656|NCT03277196|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55974657|NCT03277196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55974658|NCT03277196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974659|NCT04278248|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55974660|NCT04278248|Immunologic Factors|immunologic factors|mesh-ancestor
55974714|NCT00654329|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55974715|NCT00654329|Narcotics|narcotics|mesh-ancestor
55974716|NCT00654329|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55974717|NCT00654329|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55974718|NCT00654329|Anesthetics, General|anesthetics, general|mesh-ancestor
55974719|NCT00654329|Anesthetics|anesthetics|mesh-ancestor
55974720|NCT00695435|Tobramycin|tobramycin|mesh-list
55974721|NCT00695435|Tobramycin, Dexamethasone Drug Combination|tobramycin, dexamethasone drug combination|mesh-list
55974778|NCT03931551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55974779|NCT03931551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974780|NCT03931551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974781|NCT00696293|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55974782|NCT00696293|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55974783|NCT00696293|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55974784|NCT00696293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55974785|NCT00696293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974840|NCT00697541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974841|NCT03889275|Durvalumab|durvalumab|mesh-list
55974842|NCT03889275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55974843|NCT03889275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55974844|NCT00657917|Gentamicins|gentamicins|mesh-list
55974845|NCT00657917|Paromomycin|paromomycin|mesh-list
55974846|NCT00657917|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55974847|NCT00657917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55974848|NCT00657917|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55974853|NCT01959945|Vaccines|vaccines|mesh-list
55974906|NCT01963845|Incretins|incretins|mesh-ancestor
55974907|NCT01963845|Hormones|hormones|mesh-ancestor
55974908|NCT01963845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974909|NCT01963845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55974910|NCT01963845|Protease Inhibitors|protease inhibitors|mesh-ancestor
55974911|NCT01963845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55974913|NCT03807765|Nivolumab|nivolumab|mesh-list
55974968|NCT04277702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55974969|NCT04277702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55974970|NCT04277702|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55974971|NCT04277702|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55974972|NCT04277702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55974973|NCT03962894|Prednisolone|prednisolone|mesh-list
55974976|NCT03962894|Hormones|hormones|mesh-ancestor
55975034|NCT04493216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975036|NCT04493216|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55975037|NCT04493216|Antiviral Agents|antiviral agents|mesh-ancestor
55975038|NCT04493216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55975039|NCT03721965|Prednisone|prednisone|mesh-list
55975040|NCT03721965|Methylprednisolone|methylprednisolone|mesh-list
55975041|NCT03721965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55975042|NCT03721965|Glucocorticoids|glucocorticoids|mesh-ancestor
55975043|NCT03721965|Hormones|hormones|mesh-ancestor
55975044|NCT03721965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55975048|NCT03721965|Antiemetics|antiemetics|mesh-ancestor
55975099|NCT00699803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975100|NCT00699803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975101|NCT00699803|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55975102|NCT00699803|Protective Agents|protective agents|mesh-ancestor
55975103|NCT01967433|Diphenhydramine|diphenhydramine|mesh-list
55975105|NCT01967433|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55975106|NCT01967433|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55975107|NCT01967433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55975108|NCT01967433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975166|NCT00658697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975168|NCT00658697|Hormone Antagonists|hormone antagonists|mesh-ancestor
55975169|NCT00658697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55975170|NCT03873116|Berotralstat|berotralstat|mesh-list
55975171|NCT03873116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975172|NCT03873116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975173|NCT04399226|Dexmedetomidine|dexmedetomidine|mesh-list
55975227|NCT03223376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55975299|NCT04639310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975301|NCT03246074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55975302|NCT03246074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975303|NCT03246074|Tubulin Modulators|tubulin modulators|mesh-ancestor
55975304|NCT03246074|Antimitotic Agents|antimitotic agents|mesh-ancestor
55975305|NCT03246074|Mitosis Modulators|mitosis modulators|mesh-ancestor
55975306|NCT03246074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975307|NCT02300727|Curcumin|curcumin|mesh-list
55975308|NCT02300727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55975309|NCT02300727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55975310|NCT02300727|Analgesics|analgesics|mesh-ancestor
55975311|NCT02300727|Sensory System Agents|sensory system agents|mesh-ancestor
55975312|NCT02300727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55975313|NCT02300727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975358|NCT00659945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55975359|NCT00659945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975360|NCT00659945|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55975361|NCT00659945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55975362|NCT00659945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55975363|NCT00659945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55975364|NCT00659945|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55975365|NCT00659945|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55975366|NCT04387565|Vanadium|vanadium|mesh-list
55975424|NCT00661583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975425|NCT00661583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55975426|NCT00661583|Alkylating Agents|alkylating agents|mesh-ancestor
55975427|NCT00661583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975428|NCT00661583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55975429|NCT00661583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975430|NCT00661895|Metoprolol|metoprolol|mesh-list
55975431|NCT00661895|Atenolol|atenolol|mesh-list
55975432|NCT00661895|Amlodipine|amlodipine|mesh-list
55975433|NCT00661895|Valsartan|valsartan|mesh-list
55975435|NCT00661895|Clonidine|clonidine|mesh-list
55975489|NCT02996825|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55975490|NCT02996825|Immunologic Factors|immunologic factors|mesh-ancestor
55975491|NCT02996825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975492|NCT02996825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55975493|NCT02996825|Tubulin Modulators|tubulin modulators|mesh-ancestor
55975494|NCT02996825|Antimitotic Agents|antimitotic agents|mesh-ancestor
55975495|NCT02996825|Mitosis Modulators|mitosis modulators|mesh-ancestor
55975497|NCT02301039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55975498|NCT02301039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975499|NCT00662675|Pancrelipase|pancrelipase|mesh-list
55975500|NCT00662675|Pancreatin|pancreatin|mesh-list
55975501|NCT00662675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55975548|NCT04372940|Coagulants|coagulants|mesh-ancestor
55975549|NCT00592475|Conivaptan|conivaptan|mesh-list
55975550|NCT00592475|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55975552|NCT00592475|Natriuretic Agents|natriuretic agents|mesh-ancestor
55975611|NCT01990677|Natriuretic Agents|natriuretic agents|mesh-ancestor
55975612|NCT01990677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55975613|NCT03678753|Cenobamate|cenobamate|mesh-list
55975614|NCT03678753|Anticonvulsants|anticonvulsants|mesh-ancestor
55975615|NCT00593645|Cytarabine|cytarabine|mesh-list
55975616|NCT00593645|Clofarabine|clofarabine|mesh-list
55975617|NCT00593645|Thymoglobulin|thymoglobulin|mesh-list
55975618|NCT00593645|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55975619|NCT00593645|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55975620|NCT00593645|Antimetabolites|antimetabolites|mesh-ancestor
55975678|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
55975679|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
55975680|NCT02661035|Fludarabine|fludarabine|mesh-list
55975681|NCT02661035|Allopurinol|allopurinol|mesh-list
55975682|NCT02661035|Tacrolimus|tacrolimus|mesh-list
55975683|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55975684|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55975685|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
55975686|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55975687|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55975688|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55975689|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
55975690|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55975691|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55975692|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55975693|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
55975694|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55975695|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975696|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55975697|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55975734|NCT04317404|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55975735|NCT04317404|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55975736|NCT04317404|Glucocorticoids|glucocorticoids|mesh-ancestor
55975737|NCT04317404|Hormones|hormones|mesh-ancestor
55975806|NCT03173612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55975810|NCT03173612|Analgesics|analgesics|mesh-ancestor
55975878|NCT00240331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55975952|NCT03809923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55976026|NCT00714233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55976027|NCT00714233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55976028|NCT00746395|Lubiprostone|lubiprostone|mesh-list
55976029|NCT00746395|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55976096|NCT02997215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55976098|NCT02997215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55976169|NCT04385563|Antimitotic Agents|antimitotic agents|mesh-ancestor
55976170|NCT04385563|Mitosis Modulators|mitosis modulators|mesh-ancestor
55976171|NCT04385563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976172|NCT04385563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976173|NCT03568838|Enoxaparin|enoxaparin|mesh-list
55976174|NCT03568838|Anticoagulants|anticoagulants|mesh-ancestor
55976175|NCT03568838|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55976176|NCT03568838|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55976237|NCT03809455|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55976238|NCT03809455|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55976239|NCT03809455|Anesthetics, General|anesthetics, general|mesh-ancestor
55976240|NCT03809455|Anesthetics|anesthetics|mesh-ancestor
55976241|NCT03618134|Durvalumab|durvalumab|mesh-list
55976242|NCT03618134|Ipilimumab|ipilimumab|mesh-list
55976243|NCT03618134|Tremelimumab|tremelimumab|mesh-list
55976244|NCT03618134|Immunoglobulins|immunoglobulins|mesh-list
55976245|NCT03618134|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55976246|NCT03618134|Immunoglobulin G|immunoglobulin g|mesh-list
55976247|NCT03618134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55976248|NCT03618134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55976249|NCT03618134|Immunologic Factors|immunologic factors|mesh-ancestor
55976250|NCT03618134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976298|NCT01276613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976299|NCT01276613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55976369|NCT00706589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976370|NCT00706589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976371|NCT00706589|Dopamine Agonists|dopamine agonists|mesh-ancestor
55976372|NCT00706589|Dopamine Agents|dopamine agents|mesh-ancestor
55976373|NCT00706589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976374|NCT00706589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55976375|NCT00706589|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55976376|NCT00706589|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55976377|NCT00706589|Serotonin Agents|serotonin agents|mesh-ancestor
55976378|NCT00706589|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55976379|NCT00706589|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55976380|NCT00706589|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55976381|NCT00706589|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55976382|NCT01276769|Paclitaxel|paclitaxel|mesh-list
55976383|NCT01276769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55976384|NCT01276769|Carboplatin|carboplatin|mesh-list
55976385|NCT01276769|Epirubicin|epirubicin|mesh-list
55976386|NCT01276769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55976396|NCT01279681|Leucovorin|leucovorin|mesh-list
55976425|NCT01276925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55976426|NCT01276925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976490|NCT03186326|Growth Substances|growth substances|mesh-ancestor
55976570|NCT04276688|Antiviral Agents|antiviral agents|mesh-ancestor
55976644|NCT01270997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976649|NCT01278745|Rituximab|rituximab|mesh-list
55976717|NCT01272089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55976718|NCT01272089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55976719|NCT01272089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55976720|NCT01272089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55976721|NCT01272089|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55976722|NCT01272089|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55976723|NCT01272089|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55976724|NCT01272089|Histamine Antagonists|histamine antagonists|mesh-ancestor
55976725|NCT01272089|Histamine Agents|histamine agents|mesh-ancestor
55976726|NCT01272089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55976786|NCT00720473|Lamotrigine|lamotrigine|mesh-list
55976856|NCT01276327|Protease Inhibitors|protease inhibitors|mesh-ancestor
55976857|NCT01276327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55976859|NCT05245760|Paclitaxel|paclitaxel|mesh-list
55976927|NCT02144675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55976933|NCT02144675|Nootropic Agents|nootropic agents|mesh-ancestor
55977001|NCT00638456|Dexlansoprazole|dexlansoprazole|mesh-list
55977073|NCT01273831|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55977074|NCT01273831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977075|NCT01273831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977076|NCT01273831|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55977077|NCT01273831|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55977078|NCT01273831|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55977079|NCT01273831|Cholinergic Agents|cholinergic agents|mesh-ancestor
55977080|NCT01273831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55977081|NCT01273831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977082|NCT00735917|Saracatinib|saracatinib|mesh-list
55977083|NCT00735917|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55977084|NCT00735917|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55977134|NCT00707759|Immunologic Factors|immunologic factors|mesh-ancestor
55977145|NCT01273727|BB 1101|bb 1101|mesh-list
55977207|NCT00723749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55977209|NCT00723827|Temozolomide|temozolomide|mesh-list
55977216|NCT00779311|Sorafenib|sorafenib|mesh-list
55977278|NCT02993159|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55977353|NCT05313529|Linagliptin|linagliptin|mesh-list
55977425|NCT00742313|Coagulants|coagulants|mesh-ancestor
55977426|NCT00742469|Rifaximin|rifaximin|mesh-list
55977427|NCT00742469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55977430|NCT01275599|Buprenorphine|buprenorphine|mesh-list
55977500|NCT00763867|Sildenafil Citrate|sildenafil citrate|mesh-list
55977501|NCT00763867|Vasodilator Agents|vasodilator agents|mesh-ancestor
55977503|NCT00763867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55977575|NCT01279343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977577|NCT01279343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55977579|NCT01278797|Amlodipine|amlodipine|mesh-list
55977580|NCT01278797|Telmisartan|telmisartan|mesh-list
55977581|NCT01278797|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
55977582|NCT01278797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55977583|NCT01278797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55977584|NCT01278797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55977585|NCT01278797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977586|NCT01278797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55977587|NCT01278797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977588|NCT01278797|Vasodilator Agents|vasodilator agents|mesh-ancestor
55977589|NCT01278797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55977590|NCT01278797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55977591|NCT01272635|Azithromycin|azithromycin|mesh-list
55977592|NCT01272635|Prednisolone|prednisolone|mesh-list
55977593|NCT01272635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55977594|NCT01272635|Methylprednisolone|methylprednisolone|mesh-list
55977631|NCT01270841|Hormone Antagonists|hormone antagonists|mesh-ancestor
55977632|NCT01270841|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55977633|NCT01270841|Fertility Agents|fertility agents|mesh-ancestor
55977634|NCT01270841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55977635|NCT01270841|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55977636|NCT01270841|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55977637|NCT01278407|Donepezil|donepezil|mesh-list
55977638|NCT01278407|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55977639|NCT01278407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977640|NCT01278407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977641|NCT01278407|Cholinergic Agents|cholinergic agents|mesh-ancestor
55977642|NCT01278407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55977643|NCT01278407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977644|NCT01278407|Nootropic Agents|nootropic agents|mesh-ancestor
55977690|NCT00786019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977691|NCT00786019|Antioxidants|antioxidants|mesh-ancestor
55977692|NCT00786019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977693|NCT00786019|Protective Agents|protective agents|mesh-ancestor
55977694|NCT01277861|Fentanyl|fentanyl|mesh-list
55977695|NCT01277861|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55977696|NCT01277861|Narcotics|narcotics|mesh-ancestor
55977757|NCT01272791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977758|NCT01272791|Immunologic Factors|immunologic factors|mesh-ancestor
55977759|NCT01272791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977760|NCT01272791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55977762|NCT00765661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977763|NCT00765661|Immunologic Factors|immunologic factors|mesh-ancestor
55977764|NCT00765661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977765|NCT00765661|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55977766|NCT00765661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977767|NCT00765661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977768|NCT00765895|Nortriptyline|nortriptyline|mesh-list
55977769|NCT00765895|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55977770|NCT00765895|Antidepressive Agents|antidepressive agents|mesh-ancestor
55977771|NCT00765895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55977772|NCT00765895|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55977773|NCT00765895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55977774|NCT00765895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55977775|NCT00765895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977776|NCT00765895|Adrenergic Agents|adrenergic agents|mesh-ancestor
55977777|NCT00765895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55977778|NCT00765895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977779|NCT01276457|Cyclosporine|cyclosporine|mesh-list
55977780|NCT01276457|Everolimus|everolimus|mesh-list
55977781|NCT01276457|Cyclosporins|cyclosporins|mesh-list
55977782|NCT01276457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55977783|NCT01276457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55977784|NCT01276457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55977785|NCT01276457|Immunologic Factors|immunologic factors|mesh-ancestor
55977786|NCT01276457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55977787|NCT01276457|Antifungal Agents|antifungal agents|mesh-ancestor
55977788|NCT01276457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55977789|NCT01276457|Dermatologic Agents|dermatologic agents|mesh-ancestor
55977794|NCT03804931|Prednisone|prednisone|mesh-list
55977795|NCT03804931|Mesalamine|mesalamine|mesh-list
55977869|NCT03806933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55977945|NCT01276379|Vitamin B Complex|vitamin b complex|mesh-ancestor
55977946|NCT01276379|Vitamins|vitamins|mesh-ancestor
55978022|NCT03803449|Midazolam|midazolam|mesh-list
55978023|NCT03803449|Propofol|propofol|mesh-list
55978024|NCT03803449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55978025|NCT03803449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55978026|NCT03803449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978093|NCT03803215|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55978165|NCT03801733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55978319|NCT00248651|Citalopram|citalopram|mesh-list
55978320|NCT00248651|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55978333|NCT00248651|Analgesics|analgesics|mesh-ancestor
55978391|NCT03800641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55978392|NCT03800641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978393|NCT03800641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978394|NCT03800641|Analgesics|analgesics|mesh-ancestor
55978395|NCT03800641|Sensory System Agents|sensory system agents|mesh-ancestor
55978396|NCT03800641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978399|NCT03800641|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55978459|NCT00763061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978460|NCT00763061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978461|NCT00763061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55978462|NCT00763061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55978463|NCT03806335|Anesthetics|anesthetics|mesh-list
55978464|NCT03806335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55978465|NCT03806335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978466|NCT03806777|Dexmedetomidine|dexmedetomidine|mesh-list
55978467|NCT03806777|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55978468|NCT03806777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55978469|NCT03806777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978471|NCT03806777|Analgesics|analgesics|mesh-ancestor
55978606|NCT04894123|Antimetabolites|antimetabolites|mesh-ancestor
55978607|NCT04894123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978610|NCT01982643|Naltrexone|naltrexone|mesh-list
55978674|NCT00245063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978675|NCT00245063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55978676|NCT02151487|Dexamethasone|dexamethasone|mesh-list
55978677|NCT02151487|Dexamethasone acetate|dexamethasone acetate|mesh-list
55978678|NCT02151487|Clonidine|clonidine|mesh-list
55978679|NCT02151487|Ropivacaine|ropivacaine|mesh-list
55978680|NCT02151487|BB 1101|bb 1101|mesh-list
55978681|NCT02151487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978743|NCT00799435|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55978818|NCT03378297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55978819|NCT03378297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55978821|NCT03378297|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55978822|NCT03378297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55978823|NCT03378297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978824|NCT03378297|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55978825|NCT03378297|Hormone Antagonists|hormone antagonists|mesh-ancestor
55978826|NCT03378297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55978827|NCT03378297|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55978828|NCT03378297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55978829|NCT03378297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55978830|NCT03378297|Analgesics|analgesics|mesh-ancestor
55978831|NCT03378297|Sensory System Agents|sensory system agents|mesh-ancestor
55978832|NCT03378297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55978833|NCT03378297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55978839|NCT03378297|Antipyretics|antipyretics|mesh-ancestor
55978875|NCT00800839|Fludarabine|fludarabine|mesh-list
55978876|NCT00800839|Fludarabine phosphate|fludarabine phosphate|mesh-list
55978947|NCT01985763|Hormones|hormones|mesh-ancestor
55978948|NCT01985763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55978949|NCT04266301|Azacitidine|azacitidine|mesh-list
55978950|NCT04266301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55795583|NCT03064633|Dexamethasone|dexamethasone|mesh-list
55978952|NCT04266301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55978953|NCT04266301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979015|NCT00816751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979016|NCT00816751|Hemostatics|hemostatics|mesh-ancestor
55979017|NCT00816751|Coagulants|coagulants|mesh-ancestor
55979018|NCT00816751|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55979019|NCT00816751|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55979020|NCT00816751|Natriuretic Agents|natriuretic agents|mesh-ancestor
55979021|NCT00816829|Fenofibrate|fenofibrate|mesh-list
55979022|NCT00816829|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55979023|NCT00816829|Antimetabolites|antimetabolites|mesh-ancestor
55979024|NCT00816829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979026|NCT02062359|Aldesleukin|aldesleukin|mesh-list
55979027|NCT02062359|Cyclophosphamide|cyclophosphamide|mesh-list
55979028|NCT02062359|Fludarabine|fludarabine|mesh-list
55979042|NCT02397291|Inositol|inositol|mesh-list
55979077|NCT00817999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55979078|NCT00817999|Purinergic Agents|purinergic agents|mesh-ancestor
55979079|NCT00817999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979080|NCT00817999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979081|NCT00817999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979082|NCT03839485|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55979083|NCT03839485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55979084|NCT03839485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979085|NCT03839485|Antitubercular Agents|antitubercular agents|mesh-ancestor
55979140|NCT02062905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55979142|NCT02062905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979143|NCT00820573|Metformin|metformin|mesh-list
55979144|NCT00820573|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55979145|NCT00820573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55979146|NCT00820573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979147|NCT00820573|Incretins|incretins|mesh-ancestor
55979215|NCT04349241|Favipiravir|favipiravir|mesh-list
55979282|NCT02071095|Antiviral Agents|antiviral agents|mesh-ancestor
55979283|NCT02071095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979284|NCT02348359|Ranibizumab|ranibizumab|mesh-list
55979285|NCT02348359|Aflibercept|aflibercept|mesh-list
55979286|NCT02348359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979287|NCT02348359|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55979288|NCT02348359|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55979289|NCT02348359|Growth Substances|growth substances|mesh-ancestor
55979290|NCT02348359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979291|NCT02348359|Growth Inhibitors|growth inhibitors|mesh-ancestor
55979292|NCT02406885|Apixaban|apixaban|mesh-list
55979293|NCT02406885|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55979294|NCT02406885|Antithrombins|antithrombins|mesh-ancestor
55979295|NCT02406885|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55979296|NCT02406885|Protease Inhibitors|protease inhibitors|mesh-ancestor
55979297|NCT02406885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979343|NCT02019069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979344|NCT02019069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979346|NCT02019069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979347|NCT02019069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55979348|NCT02019069|Immunologic Factors|immunologic factors|mesh-ancestor
55979349|NCT02019069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979350|NCT02019069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55979351|NCT02019069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55979352|NCT02019069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55979353|NCT02019069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979354|NCT00821821|Edaravone|edaravone|mesh-list
55979355|NCT00821821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55979356|NCT00821821|Antioxidants|antioxidants|mesh-ancestor
55979357|NCT00821821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979358|NCT00821821|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55979359|NCT00821821|Protective Agents|protective agents|mesh-ancestor
55979360|NCT00821821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979361|NCT00822523|Botulinum Toxins|botulinum toxins|mesh-list
55979362|NCT00822523|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55979363|NCT00822523|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55979364|NCT00822523|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55979365|NCT00822523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55979393|NCT00823303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55979394|NCT00823303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55979395|NCT00823303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979466|NCT02413203|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55979467|NCT02413203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55979468|NCT02413203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979469|NCT02413203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979471|NCT02153983|Gout Suppressants|gout suppressants|mesh-ancestor
55979472|NCT02153983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55979473|NCT02153983|Tubulin Modulators|tubulin modulators|mesh-ancestor
55979474|NCT02153983|Antimitotic Agents|antimitotic agents|mesh-ancestor
55979475|NCT02153983|Mitosis Modulators|mitosis modulators|mesh-ancestor
55979476|NCT02153983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979477|NCT02153983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979478|NCT02348775|Acetylcysteine|acetylcysteine|mesh-list
55979479|NCT02348775|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55979480|NCT02348775|Glycine|glycine|mesh-list
55979481|NCT02348775|Antiviral Agents|antiviral agents|mesh-ancestor
55979482|NCT02348775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55979483|NCT02348775|Expectorants|expectorants|mesh-ancestor
55979484|NCT02348775|Respiratory System Agents|respiratory system agents|mesh-ancestor
55979485|NCT02348775|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55979486|NCT02348775|Antioxidants|antioxidants|mesh-ancestor
55979487|NCT02348775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979520|NCT02349477|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55979521|NCT02349477|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55979522|NCT02349477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979523|NCT02349477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979524|NCT02349477|Antimanic Agents|antimanic agents|mesh-ancestor
55979525|NCT00828295|Palonosetron|palonosetron|mesh-list
55979526|NCT00828295|Antiemetics|antiemetics|mesh-ancestor
55979527|NCT00828295|Autonomic Agents|autonomic agents|mesh-ancestor
55979528|NCT00828295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55979529|NCT00828295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979530|NCT00828295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55979531|NCT00828295|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55979532|NCT00828295|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55979533|NCT00828295|Serotonin Agents|serotonin agents|mesh-ancestor
55979534|NCT00828295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55979536|NCT02350569|Sofosbuvir|sofosbuvir|mesh-list
55979578|NCT00241631|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55979579|NCT00241631|Respiratory System Agents|respiratory system agents|mesh-ancestor
55979580|NCT00241631|Dermatologic Agents|dermatologic agents|mesh-ancestor
55979581|NCT00241631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55979582|NCT00241631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55979583|NCT00241631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55979584|NCT00241631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55979585|NCT00241631|Vasodilator Agents|vasodilator agents|mesh-ancestor
55979643|NCT00766649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55979644|NCT00766649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55979645|NCT00766649|Antifungal Agents|antifungal agents|mesh-ancestor
55979646|NCT00766649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55979647|NCT00766649|Immunologic Factors|immunologic factors|mesh-ancestor
55979649|NCT02352831|Capecitabine|capecitabine|mesh-list
55979713|NCT00767507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979714|NCT02029755|Anesthetics|anesthetics|mesh-list
55979715|NCT02029755|Anesthetics, Local|anesthetics, local|mesh-list
55983417|NCT01834885|Glucocorticoids|glucocorticoids|mesh-ancestor
55979716|NCT02029755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55979717|NCT02029755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979786|NCT02359305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979787|NCT02359305|Antipyretics|antipyretics|mesh-ancestor
55979860|NCT02368431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55979937|NCT00768599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55980008|NCT03808805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55980161|NCT02388321|Sensory System Agents|sensory system agents|mesh-ancestor
55980162|NCT02388321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980235|NCT04383977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55980309|NCT00354861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980324|NCT04345445|Hormones|hormones|mesh-ancestor
55980457|NCT03831113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980458|NCT03831113|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55980459|NCT04807101|Midazolam|midazolam|mesh-list
55980531|NCT05664971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55980608|NCT03835013|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55980609|NCT03835013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55980611|NCT03835013|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55980755|NCT04290689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55980756|NCT04290689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55980757|NCT00801827|Fallypride|fallypride|mesh-list
55980764|NCT04112823|Dexamethasone|dexamethasone|mesh-list
55980826|NCT05051735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55980901|NCT04923113|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55980902|NCT04923113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55981046|NCT04436458|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55981047|NCT04436458|Anthelmintics|anthelmintics|mesh-ancestor
55981120|NCT00534430|Busulfan|busulfan|mesh-list
55981121|NCT00534430|Cyclosporins|cyclosporins|mesh-list
55981122|NCT00534430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55981192|NCT05372536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55981193|NCT00849251|Dexamethasone|dexamethasone|mesh-list
55981267|NCT05105074|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55981268|NCT05105074|Narcotics|narcotics|mesh-ancestor
55981417|NCT05536414|Antidepressive Agents|antidepressive agents|mesh-ancestor
55981493|NCT00860015|Gemcitabine|gemcitabine|mesh-list
55981565|NCT00822107|Natriuretic Agents|natriuretic agents|mesh-ancestor
55981570|NCT05236907|Midazolam|midazolam|mesh-list
55981716|NCT00857545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
55981717|NCT00857545|Immunologic Factors|immunologic factors|mesh-ancestor
55981788|NCT00366652|Adrenergic Agents|adrenergic agents|mesh-ancestor
55981789|NCT00366730|Nitazoxanide|nitazoxanide|mesh-list
55981936|NCT00355719|Antiviral Agents|antiviral agents|mesh-ancestor
55981937|NCT00355719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55982007|NCT04986579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982083|NCT00863551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982090|NCT03838575|Chlorhexidine|chlorhexidine|mesh-list
55982158|NCT00866749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55982159|NCT00866749|Immunologic Factors|immunologic factors|mesh-ancestor
55982231|NCT05342818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55982306|NCT05144542|Nicotine|nicotine|mesh-list
55982316|NCT05028946|Muromonab-CD3|muromonab-cd3|mesh-list
55982382|NCT02697292|Immunologic Factors|immunologic factors|mesh-ancestor
55982383|NCT02697292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982454|NCT01622335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55982529|NCT00895921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55982531|NCT00895921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55982604|NCT00885079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982762|NCT03214627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982764|NCT00888511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982834|NCT02669173|Growth Substances|growth substances|mesh-ancestor
55982835|NCT02669173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55982836|NCT02669173|Growth Inhibitors|growth inhibitors|mesh-ancestor
55982837|NCT02669173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55982838|NCT02669173|Antimetabolites|antimetabolites|mesh-ancestor
55982904|NCT05444452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55982905|NCT05444452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55982976|NCT01830829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55982977|NCT01830829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55983060|NCT05441254|Paclitaxel|paclitaxel|mesh-list
55983124|NCT00363532|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55983200|NCT05394142|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55983273|NCT02475070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55983275|NCT02475070|Protease Inhibitors|protease inhibitors|mesh-ancestor
55983343|NCT00905515|Cyclosporine|cyclosporine|mesh-list
55983345|NCT00905515|Cyclosporins|cyclosporins|mesh-list
55983492|NCT01839097|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55983497|NCT01835665|Nimodipine|nimodipine|mesh-list
55983561|NCT04380025|Immunologic Factors|immunologic factors|mesh-ancestor
55983633|NCT03218059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55983706|NCT02494180|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55983707|NCT02494180|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55983782|NCT01720615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55983857|NCT05449366|Paclitaxel|paclitaxel|mesh-list
55983858|NCT05449366|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55983859|NCT05449366|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55983931|NCT01726465|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55983933|NCT01726465|Prednisolone|prednisolone|mesh-list
55984157|NCT05531994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984158|NCT05531994|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55984230|NCT02311920|Alkylating Agents|alkylating agents|mesh-ancestor
55984231|NCT02153723|Glatiramer Acetate|glatiramer acetate|mesh-list
55984305|NCT02859064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55984377|NCT00371020|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55984378|NCT00371020|Tinzaparin|tinzaparin|mesh-list
55984451|NCT00370240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55984452|NCT03408145|Hyaluronic Acid|hyaluronic acid|mesh-list
55984528|NCT00872027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55984567|NCT01723735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55984643|NCT04262206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55984717|NCT05523102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55984718|NCT05523102|Antipyretics|antipyretics|mesh-ancestor
55984793|NCT01729897|Narcotics|narcotics|mesh-ancestor
55984868|NCT03929068|Levodopa|levodopa|mesh-list
55984953|NCT03772613|Heparin|heparin|mesh-list
55985018|NCT05527548|Alendronate|alendronate|mesh-list
55985088|NCT04981158|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55985162|NCT04295850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55985244|NCT04337632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55985245|NCT05349058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55985317|NCT02748070|Hormones|hormones|mesh-ancestor
55985393|NCT02756572|Alkylating Agents|alkylating agents|mesh-ancestor
55985467|NCT05513976|Febuxostat|febuxostat|mesh-list
55985539|NCT05720559|Folic Acid|folic acid|mesh-list
55985614|NCT00915967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55985687|NCT02767492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985762|NCT01042093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55985768|NCT03400735|Cefdinir|cefdinir|mesh-list
55985855|NCT00372658|Lidocaine|lidocaine|mesh-list
55985906|NCT05337436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55985907|NCT04755712|Sufentanil|sufentanil|mesh-list
55986003|NCT05456542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55986004|NCT05456542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986005|NCT03215693|Ensartinib|ensartinib|mesh-list
55986076|NCT04225078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986078|NCT04225078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55986377|NCT03213977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55986453|NCT04380857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986526|NCT00014911|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55986527|NCT00014911|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55986597|NCT03213353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986673|NCT02240173|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55986746|NCT03218657|Androgens|androgens|mesh-list
55986747|NCT03218657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55986821|NCT01833767|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55986822|NCT01833767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55986893|NCT01834547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55986894|NCT01834547|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55987040|NCT03836885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55987111|NCT03210545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55987113|NCT04372849|Insulin|insulin|mesh-list
55987259|NCT04371601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55987260|NCT04371601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987273|NCT02242357|Telmisartan|telmisartan|mesh-list
55987331|NCT01726205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55987406|NCT03402295|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55987479|NCT02157103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55987552|NCT04367155|Tranexamic Acid|tranexamic acid|mesh-list
55987628|NCT01721915|Vitamins|vitamins|mesh-ancestor
55987629|NCT01721915|Micronutrients|micronutrients|mesh-ancestor
55987701|NCT04357093|Sodium Fluoride|sodium fluoride|mesh-list
55987702|NCT04357093|Cariostatic Agents|cariostatic agents|mesh-ancestor
55987776|NCT04378283|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55987777|NCT04378283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55987850|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55987859|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
55987925|NCT00373126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988001|NCT02793154|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55988002|NCT01723553|Corticosterone|corticosterone|mesh-list
55988074|NCT04364425|Anesthetics|anesthetics|mesh-ancestor
55988147|NCT00373594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988221|NCT00939367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55988222|NCT00939367|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55988223|NCT00939367|GABA Agonists|gaba agonists|mesh-ancestor
55988224|NCT00939367|GABA Agents|gaba agents|mesh-ancestor
55988225|NCT00939367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55988226|NCT00939367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988227|NCT03168880|Paclitaxel|paclitaxel|mesh-list
55988228|NCT03168880|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55988229|NCT03168880|Carboplatin|carboplatin|mesh-list
55988230|NCT03168880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55988231|NCT03168880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55988232|NCT03168880|Tubulin Modulators|tubulin modulators|mesh-ancestor
55988233|NCT03168880|Antimitotic Agents|antimitotic agents|mesh-ancestor
55988234|NCT03168880|Mitosis Modulators|mitosis modulators|mesh-ancestor
55988235|NCT03168880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55988292|NCT01049009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55988365|NCT02921386|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55988440|NCT01047293|Oxaliplatin|oxaliplatin|mesh-list
55988441|NCT01047293|Everolimus|everolimus|mesh-list
55988442|NCT01047293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55988513|NCT00931489|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55988590|NCT04362241|Prednisolone phosphate|prednisolone phosphate|mesh-list
55988591|NCT04362241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55988592|NCT04362241|Glucocorticoids|glucocorticoids|mesh-ancestor
55988662|NCT03035305|Renal Agents|renal agents|mesh-ancestor
55988738|NCT04361149|Dermatologic Agents|dermatologic agents|mesh-ancestor
55988809|NCT03033199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55988879|NCT04359823|L 647318|l 647318|mesh-list
55988955|NCT02946892|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55988956|NCT02946892|Antioxidants|antioxidants|mesh-ancestor
55989029|NCT01042535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55989104|NCT03400709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989107|NCT03400709|Antidotes|antidotes|mesh-ancestor
55989184|NCT03400241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55989186|NCT03400241|Anticonvulsants|anticonvulsants|mesh-ancestor
55989256|NCT00924209|Immunologic Factors|immunologic factors|mesh-ancestor
55989257|NCT00924209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55989329|NCT02978001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55989330|NCT02978313|Cetuximab|cetuximab|mesh-list
55989404|NCT00357981|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55989407|NCT03030703|Inositol|inositol|mesh-list
55989553|NCT04358497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55989554|NCT04358497|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55989555|NCT04358497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55989556|NCT04358497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989557|NCT04358497|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55989558|NCT04358497|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55989559|NCT02851108|Primaquine|primaquine|mesh-list
55989560|NCT02851108|Phenothiazine|phenothiazine|mesh-list
55989561|NCT02851108|Methylene Blue|methylene blue|mesh-list
55989631|NCT00358293|Tizanidine|tizanidine|mesh-list
55989849|NCT02242253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55989850|NCT02242253|Cholinergic Agents|cholinergic agents|mesh-ancestor
55989924|NCT01006369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55989925|NCT01006369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55989994|NCT01008319|Fertility Agents|fertility agents|mesh-ancestor
55990012|NCT00967369|Etoposide|etoposide|mesh-list
55990069|NCT05462613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990144|NCT05595993|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55990145|NCT05595993|Protective Agents|protective agents|mesh-ancestor
55990219|NCT00932477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55990294|NCT02881996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55990299|NCT04367831|Heparin|heparin|mesh-list
55990369|NCT03054844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55990390|NCT00359697|Mannitol|mannitol|mesh-list
55990445|NCT05108259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55990446|NCT02244281|Tamsulosin|tamsulosin|mesh-list
55990455|NCT03054922|Plasma-lyte 148|plasma-lyte 148|mesh-list
55990518|NCT02244515|Dexmedetomidine|dexmedetomidine|mesh-list
55990519|NCT02244515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55990520|NCT02244515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55990886|NCT03126682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55990887|NCT03126682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55990959|NCT04772547|Anticonvulsants|anticonvulsants|mesh-ancestor
55990962|NCT04772547|GABA Agents|gaba agents|mesh-ancestor
55991034|NCT05017545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55991179|NCT00360945|Alkylating Agents|alkylating agents|mesh-ancestor
55991180|NCT00360945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765972|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55766040|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55766041|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766050|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
55766110|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766185|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55766187|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766258|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55766327|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55766328|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55766472|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766473|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
55766474|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55766546|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55766547|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55766548|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
55766618|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55766694|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55766775|NCT03174821|Insulin|insulin|mesh-list
55766841|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55766842|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
55766981|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55767053|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
55767054|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767125|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767126|NCT05508633|Mebeverine|mebeverine|mesh-list
55782976|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55782977|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
55767252|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
55767325|NCT05504967|Sensory System Agents|sensory system agents|mesh-ancestor
55767326|NCT02565147|Heparin|heparin|mesh-list
55767397|NCT05504577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55767398|NCT05504577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767399|NCT05504577|Hemostatics|hemostatics|mesh-ancestor
55767401|NCT05504577|Antidepressive Agents|antidepressive agents|mesh-ancestor
55767402|NCT05504577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55767403|NCT05504577|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55767404|NCT05504577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767405|NCT05504577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55767406|NCT05504577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55767407|NCT05504577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767408|NCT05504577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767409|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
55767410|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
55767411|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55767412|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55767413|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55767414|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767415|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767416|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55767417|NCT05504265|Flurbiprofen|flurbiprofen|mesh-list
55767418|NCT05504265|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
55767472|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55767545|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
55767547|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
55767619|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
55767620|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55767692|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55767696|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55767765|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55767766|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55767837|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55767984|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768056|NCT05498025|Antidotes|antidotes|mesh-ancestor
55768057|NCT05498025|Protective Agents|protective agents|mesh-ancestor
55768128|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
55768129|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768200|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55768273|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55768346|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55768484|NCT05492487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55768485|NCT05492487|Appetite Stimulants|appetite stimulants|mesh-ancestor
55768486|NCT05492487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55768487|NCT04176705|Triamcinolone|triamcinolone|mesh-list
55768488|NCT04176705|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55768489|NCT04176705|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55768491|NCT04176705|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55768550|NCT05489601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55768625|NCT05487963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55768626|NCT05487963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55768699|NCT05482113|Sensory System Agents|sensory system agents|mesh-ancestor
55768769|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55768845|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
55768846|NCT03167333|Protective Agents|protective agents|mesh-ancestor
55768847|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
55768918|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55768919|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55768920|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55768921|NCT03167177|Growth Substances|growth substances|mesh-ancestor
55768922|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
55768923|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
55768924|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55768925|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55768994|NCT05745935|Oxytocin|oxytocin|mesh-list
55769063|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
55769132|NCT05455047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55769133|NCT05454891|Insulin|insulin|mesh-list
55769206|NCT05626439|GABA Modulators|gaba modulators|mesh-ancestor
55769279|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55769292|NCT03142893|Ketoconazole|ketoconazole|mesh-list
55769356|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55769429|NCT05324501|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55769430|NCT05324501|Alkylating Agents|alkylating agents|mesh-ancestor
55769432|NCT05324501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769498|NCT05515601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55769587|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
55769659|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55769660|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55769661|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55769663|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
55769730|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55769731|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55769732|NCT01374425|Growth Substances|growth substances|mesh-ancestor
55769803|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55769804|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55769956|NCT05675579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55769957|NCT05675579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55769958|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55769959|NCT01932125|Bevacizumab|bevacizumab|mesh-list
55770028|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
55770029|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770101|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770102|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
55770178|NCT03489629|Mupirocin|mupirocin|mesh-list
55770179|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55770180|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55770181|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770182|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
55770183|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
55770184|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55770185|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55770243|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55770389|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55770464|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
55770465|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55770537|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55770609|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770610|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55770683|NCT04132427|Cathartics|cathartics|mesh-ancestor
55770684|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55770685|NCT02031640|Beclomethasone|beclomethasone|mesh-list
55770826|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55770827|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55770896|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55770897|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55770899|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55770965|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55770966|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55770967|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
55771037|NCT02365493|Floxacillin|floxacillin|mesh-list
55771038|NCT02365493|Cloxacillin|cloxacillin|mesh-list
55771110|NCT02364089|Racepinephrine|racepinephrine|mesh-list
55771111|NCT02364089|Epinephryl borate|epinephryl borate|mesh-list
55771124|NCT02364089|Mydriatics|mydriatics|mesh-ancestor
55771253|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55771328|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771329|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55771330|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
55771402|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
55771403|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771473|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55771474|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55771476|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55771544|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55771617|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55771618|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
55771625|NCT02357069|Etanercept|etanercept|mesh-list
55771687|NCT02356445|Methotrexate|methotrexate|mesh-list
55771688|NCT02356445|Azathioprine|azathioprine|mesh-list
55771759|NCT02351687|Renal Agents|renal agents|mesh-ancestor
55771760|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
55771761|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
55771823|NCT03159845|Acyclovir|acyclovir|mesh-list
55771894|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55771967|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
55771968|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772038|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55772039|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55772106|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55772108|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772178|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55772179|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772247|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
55772248|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772249|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55772250|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55772251|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55772252|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55783089|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772318|NCT02337413|Laxatives|laxatives|mesh-ancestor
55772319|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55772320|NCT04852367|Doxorubicin|doxorubicin|mesh-list
55772321|NCT04852367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55772322|NCT04852367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783090|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55783091|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55772325|NCT04852367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55772386|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
55772388|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772456|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772458|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
55772590|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55772665|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55772666|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
55772741|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772742|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772813|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55772833|NCT02328521|Nicorandil|nicorandil|mesh-list
55772886|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55772891|NCT03187015|Entinostat|entinostat|mesh-list
55772962|NCT03977363|Anticoagulants|anticoagulants|mesh-list
55773093|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55773094|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773165|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55773166|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55773239|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55773310|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55773311|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55773312|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
55773313|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773314|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55773315|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
55773316|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55773317|NCT02432833|Tacrolimus|tacrolimus|mesh-list
55773318|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55773319|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
55773320|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773321|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55773322|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773323|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773324|NCT02429323|Sevoflurane|sevoflurane|mesh-list
55773325|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55773326|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55773327|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
55773328|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
55773329|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55773330|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773331|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
55773332|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55773333|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55773334|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55773341|NCT04984733|Nivolumab|nivolumab|mesh-list
55773361|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
55773429|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773498|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773564|NCT03143465|Urological Agents|urological agents|mesh-ancestor
55773565|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55773688|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55773689|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55773742|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55773743|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773745|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55773746|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773747|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55773748|NCT03183739|ASP8062|asp8062|mesh-list
55773749|NCT03183739|Analgesics|analgesics|mesh-ancestor
55773750|NCT03183739|Sensory System Agents|sensory system agents|mesh-ancestor
55773751|NCT03183739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55773752|NCT03183739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773753|NCT03183739|GABA Modulators|gaba modulators|mesh-ancestor
55783150|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55773844|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55773845|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55773847|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55773970|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55773971|NCT03139331|Irinotecan|irinotecan|mesh-list
55773972|NCT03139331|Temozolomide|temozolomide|mesh-list
55774034|NCT03281369|Incretins|incretins|mesh-ancestor
55774238|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
55774308|NCT01993186|Protective Agents|protective agents|mesh-ancestor
55774309|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774384|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55774385|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774386|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55774456|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
55774525|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55774732|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55774935|NCT05737511|Dermatologic Agents|dermatologic agents|mesh-ancestor
55774936|NCT05737511|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55775000|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775001|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
55775131|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55775132|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
55775133|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55775196|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55775261|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55775271|NCT03177109|Fluorides|fluorides|mesh-list
55775327|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
55775402|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775611|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55775612|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
55783207|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55775613|NCT02449265|Hormones|hormones|mesh-ancestor
55775678|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55775679|NCT01988662|Growth Substances|growth substances|mesh-ancestor
55775680|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783209|NCT05005715|Analgesics|analgesics|mesh-ancestor
55775742|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55775743|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
55775800|NCT04438421|Protective Agents|protective agents|mesh-ancestor
55775801|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
55775862|NCT05374499|Adrenergic Agents|adrenergic agents|mesh-ancestor
55775935|NCT05099471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55775997|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55783219|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55783220|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55776147|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
55783224|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55776213|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55783234|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55783235|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55783236|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55783237|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55783238|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55776317|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55776385|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
55776468|NCT02399137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55776607|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
55783267|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55776659|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55776661|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
55776776|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783294|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
55783295|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783296|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55783297|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
55783298|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
55783299|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55783301|NCT05254405|Brexanolone|brexanolone|mesh-list
55776880|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
55776951|NCT04555343|Coagulants|coagulants|mesh-ancestor
55776952|NCT04528667|Abivertinib|abivertinib|mesh-list
55776956|NCT04383119|Gemcitabine|gemcitabine|mesh-list
55777008|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55777009|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55777010|NCT04196075|Andrographolide|andrographolide|mesh-list
55777073|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
55777074|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777141|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
55777142|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777143|NCT01675661|Protective Agents|protective agents|mesh-ancestor
55777144|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777145|NCT01675661|Antidotes|antidotes|mesh-ancestor
55777146|NCT04463693|Etonogestrel|etonogestrel|mesh-list
55777147|NCT04463693|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55777148|NCT04463693|Contraceptive Agents|contraceptive agents|mesh-ancestor
55777149|NCT04463693|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55777150|NCT04463693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777151|NCT04463693|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55777153|NCT04014803|Clopidogrel|clopidogrel|mesh-list
55777154|NCT04014803|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55777155|NCT04014803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55777156|NCT04014803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55777433|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777434|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55777436|NCT03906617|Hormones|hormones|mesh-ancestor
55795645|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777502|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777503|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777504|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55777505|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55777506|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
55777507|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55777508|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55777563|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55777564|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777565|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
55777566|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
55777567|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777568|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55777569|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
55777570|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777571|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777572|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55777573|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
55777574|NCT02395237|Glimepiride|glimepiride|mesh-list
55777575|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55777576|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55777577|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777578|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55777579|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
55777580|NCT02394847|Propofol|propofol|mesh-list
55777581|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55777582|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55777583|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777584|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55783347|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
55777605|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55777606|NCT02403037|Dexamethasone|dexamethasone|mesh-list
55777607|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
55777608|NCT02403037|Antiemetics|antiemetics|mesh-list
55777609|NCT02403037|Emetics|emetics|mesh-list
55777610|NCT02403037|BB 1101|bb 1101|mesh-list
55777611|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777612|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
55777613|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777614|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777615|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55777616|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
55777617|NCT02403037|Hormones|hormones|mesh-ancestor
55777657|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777658|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55777659|NCT01980940|Protective Agents|protective agents|mesh-ancestor
55777660|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55777661|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
55777710|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
55777711|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
55777712|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55777713|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55777714|NCT03169777|Antidotes|antidotes|mesh-ancestor
55777715|NCT03169777|Protective Agents|protective agents|mesh-ancestor
55777716|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
55777717|NCT03169777|Vitamins|vitamins|mesh-ancestor
55777718|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
55777731|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
55777766|NCT02004886|Metformin|metformin|mesh-list
55777829|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55777830|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55777831|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777832|NCT02969837|Dexamethasone|dexamethasone|mesh-list
55777833|NCT02969837|Lenalidomide|lenalidomide|mesh-list
55777834|NCT02969837|Elotuzumab|elotuzumab|mesh-list
55777836|NCT02969837|Antiemetics|antiemetics|mesh-ancestor
55777894|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777895|NCT02402491|Aspirin|aspirin|mesh-list
55777896|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
55795660|NCT01697527|Aldesleukin|aldesleukin|mesh-list
55777897|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55777898|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55777899|NCT02402491|Analgesics|analgesics|mesh-ancestor
55777900|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
55777901|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777902|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777903|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55777904|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55777955|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55777956|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55777957|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55777958|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777959|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
55777960|NCT02402179|Tryptophan|tryptophan|mesh-list
55777961|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55777962|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
55777963|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55777964|NCT02401945|Aflibercept|aflibercept|mesh-list
55777965|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55777966|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55777967|NCT02401945|Growth Substances|growth substances|mesh-ancestor
55777968|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777969|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
55777970|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55777972|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55777973|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777974|NCT01977352|Bupivacaine|bupivacaine|mesh-list
55778005|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
55778006|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55778007|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55778008|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778009|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778010|NCT02812433|Urological Agents|urological agents|mesh-ancestor
55778011|NCT02392039|Loratadine|loratadine|mesh-list
55778071|NCT01958476|Methadone|methadone|mesh-list
55778072|NCT01958476|Phenobarbital|phenobarbital|mesh-list
55778073|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55778074|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55778075|NCT01958476|Narcotics|narcotics|mesh-ancestor
55778076|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778077|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778078|NCT01958476|Analgesics|analgesics|mesh-ancestor
55778079|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
55778137|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55778138|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55778140|NCT04746989|Protective Agents|protective agents|mesh-ancestor
55778141|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778142|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
55778143|NCT04746989|Renal Agents|renal agents|mesh-ancestor
55778144|NCT04402385|Aspirin|aspirin|mesh-list
55778145|NCT04402385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55778146|NCT04402385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55778147|NCT04402385|Analgesics|analgesics|mesh-ancestor
55778148|NCT04402385|Sensory System Agents|sensory system agents|mesh-ancestor
55778149|NCT04402385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778150|NCT04402385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778151|NCT04402385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55778152|NCT04402385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55778196|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55778197|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55778198|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55778199|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778200|NCT04512365|Dronabinol|dronabinol|mesh-list
55778201|NCT04512365|Hallucinogens|hallucinogens|mesh-ancestor
55795665|NCT01697527|Vaccines|vaccines|mesh-list
55778202|NCT04512365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778203|NCT04512365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55778204|NCT04512365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55778206|NCT04512365|Sensory System Agents|sensory system agents|mesh-ancestor
55778207|NCT04512365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778208|NCT04512365|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55778209|NCT04512365|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55778210|NCT04512365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778211|NCT04512365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778214|NCT03874091|Epinephrine|epinephrine|mesh-list
55778250|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55778251|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778252|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778313|NCT05403281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55778315|NCT05403281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55778318|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55778381|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
55778382|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55778383|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55778453|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778454|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778525|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778526|NCT04657939|Incretins|incretins|mesh-ancestor
55778527|NCT04657939|Hormones|hormones|mesh-ancestor
55783428|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783429|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55783435|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783437|NCT03105115|Bupivacaine|bupivacaine|mesh-list
55783438|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
55783439|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
55783452|NCT03105349|Grazoprevir|grazoprevir|mesh-list
55783453|NCT03105349|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55778726|NCT04546399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55778787|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778788|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
55778789|NCT05127707|Narcotics|narcotics|mesh-ancestor
55778790|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55778791|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778792|NCT05127707|Analgesics|analgesics|mesh-ancestor
55778793|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
55778794|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778795|NCT05205109|Pembrolizumab|pembrolizumab|mesh-list
55778842|NCT04499495|Analgesics|analgesics|mesh-ancestor
55778843|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
55778844|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55778851|NCT05323175|Ropivacaine|ropivacaine|mesh-list
55778905|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55778906|NCT05133635|Prednisolone|prednisolone|mesh-list
55778907|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
55778974|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
55778975|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55778977|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55779034|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
55779035|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55779036|NCT05030545|Hormones|hormones|mesh-ancestor
55779037|NCT03164161|Endorphins|endorphins|mesh-list
55779263|NCT03114085|Apatinib|apatinib|mesh-list
55779330|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55779403|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779404|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55779405|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55779406|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
55779407|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779409|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55779410|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779412|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
55779413|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55779414|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
55779415|NCT05122169|Povidone|povidone|mesh-list
55779416|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55779417|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55779418|NCT05122169|Disinfectants|disinfectants|mesh-ancestor
55779419|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
55779463|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779464|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55779465|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
55779466|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779467|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779468|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55779469|NCT04564625|Vitamin D|vitamin d|mesh-list
55779470|NCT04564625|Vitamins|vitamins|mesh-ancestor
55779471|NCT04564625|Micronutrients|micronutrients|mesh-ancestor
55779524|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779525|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55779526|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55779527|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55779528|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779529|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55779530|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55779531|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779532|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
55779588|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
55779589|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779590|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779591|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55779592|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
55779593|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
55779595|NCT04121507|Fludarabine|fludarabine|mesh-list
55779596|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779597|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
55779598|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779600|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55779601|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
55779602|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779652|NCT01228331|Thioguanine|thioguanine|mesh-list
55783505|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55779721|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779723|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
55779724|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779725|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
55779726|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779727|NCT01125371|Ethanol|ethanol|mesh-list
55779728|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55779786|NCT02592707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55779787|NCT02592707|Glucocorticoids|glucocorticoids|mesh-ancestor
55779788|NCT02592707|Hormones|hormones|mesh-ancestor
55783509|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55779858|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55779859|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779860|NCT00540995|Etoposide|etoposide|mesh-list
55779861|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
55779862|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
55779863|NCT00540995|Busulfan|busulfan|mesh-list
55783511|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55783512|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
55783513|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
55779865|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779919|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55779920|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
55779921|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55779922|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779923|NCT03576989|Mineral Oil|mineral oil|mesh-list
55779924|NCT03576989|Emollients|emollients|mesh-ancestor
55779925|NCT03576989|Dermatologic Agents|dermatologic agents|mesh-ancestor
55779926|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55779927|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
55779928|NCT03101735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779981|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55779982|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55779983|NCT01641107|Ponatinib|ponatinib|mesh-list
55779984|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55779985|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55779986|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55779987|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55779988|NCT03101423|Interleukin-2|interleukin-2|mesh-list
55780047|NCT03101579|Pemetrexed|pemetrexed|mesh-list
55780048|NCT03101579|Vitamins|vitamins|mesh-ancestor
55780049|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
55780050|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780051|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55780052|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
55780053|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
55780054|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780114|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780115|NCT01797523|Metformin|metformin|mesh-list
55780116|NCT01797523|Everolimus|everolimus|mesh-list
55780117|NCT01797523|Letrozole|letrozole|mesh-list
55780118|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55780119|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780120|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780121|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55780122|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
55780123|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55780124|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55780125|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780126|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780127|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55780128|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
55780129|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780130|NCT03412591|Suvorexant|suvorexant|mesh-list
55780131|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55780132|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55780133|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55780134|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780135|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55780136|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55783522|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55783523|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780137|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780139|NCT03377023|Ipilimumab|ipilimumab|mesh-list
55780140|NCT03377023|Nintedanib|nintedanib|mesh-list
55780141|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55780142|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780143|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55780144|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780145|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55780146|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780151|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55780154|NCT02382679|Vitamins|vitamins|mesh-list
55780222|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55780223|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55780225|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55780226|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55780227|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55780228|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780290|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55780291|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780292|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
55780361|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780362|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55780364|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
55780433|NCT02371993|Choline|choline|mesh-list
55780434|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
55780435|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55780507|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
55780508|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55780509|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
55780510|NCT02376049|Clobetasol|clobetasol|mesh-list
55780511|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
55780512|NCT02376049|Emollients|emollients|mesh-list
55783541|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55780566|NCT01995526|Insulin|insulin|mesh-list
55780639|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780640|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780711|NCT02369965|Antiviral Agents|antiviral agents|mesh-ancestor
55780712|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55780713|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55780714|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55780715|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55780716|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55780717|NCT02640755|Paclitaxel|paclitaxel|mesh-list
55780718|NCT02640755|Fulvestrant|fulvestrant|mesh-list
55780719|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55780720|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780721|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
55780722|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
55780723|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
55780724|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780725|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55780726|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55780727|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55780728|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
55780729|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55780730|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780731|NCT04400539|Nivolumab|nivolumab|mesh-list
55780732|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55780733|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780734|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55780735|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780736|NCT03099785|Rifamycins|rifamycins|mesh-list
55780755|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55780756|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
55780757|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
55780758|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
55780813|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780814|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55780885|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
55780886|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
55780887|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780888|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780889|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55780890|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55780891|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55780892|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
55780893|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55780949|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55780950|NCT03100565|Lidocaine|lidocaine|mesh-list
55780951|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
55780952|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
55780953|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55780954|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780955|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
55795686|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55780956|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55780957|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55781015|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
55781016|NCT02374567|Promethazine|promethazine|mesh-list
55781110|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781111|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781113|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55781114|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55781115|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55781116|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
55781117|NCT02374567|Anesthetics|anesthetics|mesh-ancestor
55781118|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
55781119|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
55781120|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781121|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781122|NCT02374567|Analgesics|analgesics|mesh-ancestor
55781123|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
55781168|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55781169|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
55781171|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55781172|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
55781173|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
55781174|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55781175|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
55781176|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55781177|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55781178|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55781179|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55781180|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
55781181|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55781182|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55781183|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55781184|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55781185|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55781186|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55781223|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
55781224|NCT02368171|Protective Agents|protective agents|mesh-ancestor
55781225|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
55781226|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
55781229|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781297|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781298|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781358|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55781410|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55781411|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55781483|NCT05057663|Fluorouracil|fluorouracil|mesh-list
55781484|NCT05057663|Bleomycin|bleomycin|mesh-list
55781485|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
55783607|NCT02331823|Rifabutin|rifabutin|mesh-list
55783608|NCT02331823|Streptomycin|streptomycin|mesh-list
55783609|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55783610|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55781486|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781487|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55781488|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781489|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55781490|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
55781491|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781493|NCT03097445|Nicotine|nicotine|mesh-list
55781539|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781540|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55783630|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
55783631|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55783632|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
55783633|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55783639|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781592|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
55781639|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
55781640|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781641|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781642|NCT04509115|Analgesics, Opioid|analgesics, opioid|mesh-list
55781643|NCT04509115|Narcotics|narcotics|mesh-ancestor
55781644|NCT04509115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781645|NCT04509115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781646|NCT04509115|Analgesics|analgesics|mesh-ancestor
55781649|NCT05041985|Diazepam|diazepam|mesh-list
55781706|NCT05052515|Choline|choline|mesh-list
55781707|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55781708|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
55781778|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781779|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55781847|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
55781848|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
55781849|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55781923|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55781924|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55781925|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55781926|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55781927|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55781928|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781929|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55781987|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55782058|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55783660|NCT03079895|Nicotine|nicotine|mesh-list
55782132|NCT02351869|Midazolam|midazolam|mesh-list
55782133|NCT02351869|Nitrous Oxide|nitrous oxide|mesh-list
55783661|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55783684|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
55783685|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55783686|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55783687|NCT05003765|Narcotics|narcotics|mesh-ancestor
55783688|NCT05003765|Analgesics|analgesics|mesh-ancestor
55783689|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55783690|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55783691|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
55783692|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55783693|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55783694|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55783695|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55783696|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
55783697|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55783698|NCT02337283|BI 425809|bi 425809|mesh-list
55782225|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782226|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55782227|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
55782228|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
55782229|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55782230|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
55782231|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782232|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782233|NCT05024825|Acetaminophen|acetaminophen|mesh-list
55782234|NCT05024825|Ibuprofen|ibuprofen|mesh-list
55782235|NCT05024825|Gabapentin|gabapentin|mesh-list
55782236|NCT05024825|Hydrocodone|hydrocodone|mesh-list
55782287|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782361|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55782362|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55782363|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
55782364|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782427|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782428|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55782436|NCT01939366|Pregabalin|pregabalin|mesh-list
55782488|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782489|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55783747|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55783748|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783750|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
55782562|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813970|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55783805|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55783806|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55782651|NCT03091595|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55782690|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
55782691|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782692|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782693|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782694|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782698|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
55782754|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55782755|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55782756|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782757|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55782758|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55782760|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
55782818|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55782819|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55782821|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55782886|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55782887|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
55782888|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55782889|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791938|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55791943|NCT04836299|Ivermectin|ivermectin|mesh-list
55799482|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799483|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55783940|NCT02330029|Pinaverium|pinaverium|mesh-list
55783941|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55783960|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55783961|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
55803085|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
55803086|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55803234|NCT05696977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55803235|NCT05696977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55803499|NCT05579509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55803723|NCT05529355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55803724|NCT05529355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55803725|NCT05529355|Growth Substances|growth substances|mesh-ancestor
55803726|NCT05529355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803951|NCT05518513|Anesthetics, Local|anesthetics, local|mesh-ancestor
55803952|NCT05518513|Anesthetics|anesthetics|mesh-ancestor
55803953|NCT05518513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803954|NCT05518513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804000|NCT05525767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55804001|NCT05525767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55804002|NCT05525767|Growth Substances|growth substances|mesh-ancestor
55804178|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804179|NCT04999969|Gemcitabine|gemcitabine|mesh-list
55804181|NCT04999969|Durvalumab|durvalumab|mesh-list
55804182|NCT04999969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55804183|NCT04999969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804303|NCT04847947|Vitamin D|vitamin d|mesh-list
55806212|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806213|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55806214|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
55806442|NCT05482763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55806929|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55806930|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
55806931|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
55806988|NCT05476991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807162|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807163|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55808686|NCT04234867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55808855|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808856|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55808857|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55809897|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55809898|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55809900|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
55810684|NCT01641159|Buspirone|buspirone|mesh-list
55784046|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784047|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
55813968|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814867|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55815270|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55815657|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815658|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
55815659|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55784148|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784151|NCT04433741|Oxytocin|oxytocin|mesh-list
55817059|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
55817378|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55817572|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55817573|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
55784201|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55819140|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
55819141|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55819382|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819488|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819489|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
55819564|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55819663|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
55819664|NCT02420717|Vitamins|vitamins|mesh-ancestor
55819758|NCT02343263|Bupivacaine|bupivacaine|mesh-list
55819836|NCT02081001|Hormones|hormones|mesh-ancestor
55819837|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819838|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819839|NCT02080221|Leucovorin|leucovorin|mesh-list
55784276|NCT04920383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819880|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55820161|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55820181|NCT02395055|Adalimumab|adalimumab|mesh-list
55820268|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820269|NCT02337491|Bevacizumab|bevacizumab|mesh-list
55820270|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
55784360|NCT02327923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55784361|NCT02327923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55820279|NCT01765582|Folic Acid|folic acid|mesh-list
55820414|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55784369|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55784370|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55820778|NCT01983969|Hormones|hormones|mesh-ancestor
55784376|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
55784377|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55784393|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55784394|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55784395|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55784397|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
55784398|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55784399|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
55821134|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55821240|NCT02001987|Methotrexate|methotrexate|mesh-list
55821470|NCT04907851|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55821864|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
55821933|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
55821934|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55784532|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55784533|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55784543|NCT05138575|Empagliflozin|empagliflozin|mesh-list
55784546|NCT05138575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55822466|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822629|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55822809|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822811|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
55823000|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
55823357|NCT01750918|Fluorouracil|fluorouracil|mesh-list
55823389|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55823553|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55823666|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
55823702|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823842|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
55784677|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824047|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
55824195|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824323|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55824324|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
55824396|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824555|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841607|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
55784758|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824737|NCT05065970|Felzartamab|felzartamab|mesh-list
55825008|NCT05369234|Sucralfate|sucralfate|mesh-list
55825009|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55825184|NCT01637402|Prednisone|prednisone|mesh-list
55825449|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825611|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825612|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
55784847|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55784854|NCT03137017|Narcotics|narcotics|mesh-ancestor
55784858|NCT03019003|Durvalumab|durvalumab|mesh-list
55826290|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55826292|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55826459|NCT02180659|Narcotics|narcotics|mesh-ancestor
55784922|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55784923|NCT03217825|Losartan|losartan|mesh-list
55784933|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827130|NCT05544071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827132|NCT05619653|Losartan|losartan|mesh-list
55827452|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
55827453|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
55827454|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55827457|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55827571|NCT04525547|Nintedanib|nintedanib|mesh-list
55827572|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827573|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55827578|NCT04524689|Pemetrexed|pemetrexed|mesh-list
55827758|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827759|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55827761|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55827762|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55827763|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827764|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827765|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827766|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55827797|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55827799|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827800|NCT04285853|Oxycodone|oxycodone|mesh-list
55827801|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55827802|NCT04285853|Narcotics|narcotics|mesh-ancestor
55827803|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827804|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827805|NCT04285853|Analgesics|analgesics|mesh-ancestor
55827806|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
55827849|NCT05402111|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55827850|NCT05402111|Dopamine Agents|dopamine agents|mesh-ancestor
55827851|NCT05402111|Antiemetics|antiemetics|mesh-ancestor
55827852|NCT05402111|Autonomic Agents|autonomic agents|mesh-ancestor
55827859|NCT05402111|Dopamine Agonists|dopamine agonists|mesh-ancestor
55827965|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827966|NCT04060277|Acetic Acid|acetic acid|mesh-list
55828421|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55828422|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55830119|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
55830120|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830506|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55830507|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55831108|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
55831581|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832024|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832129|NCT01473940|Antiviral Agents|antiviral agents|mesh-ancestor
55832130|NCT01473940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55785062|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
55785063|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785064|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832539|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
55832542|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55832995|NCT04701151|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55832996|NCT04701151|Immunologic Factors|immunologic factors|mesh-ancestor
55832997|NCT04701151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832998|NCT02125877|Deferasirox|deferasirox|mesh-list
55832999|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55833242|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833499|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55833500|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
55833501|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
55833906|NCT02079649|Dexamethasone|dexamethasone|mesh-list
55833907|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55833929|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55834010|NCT04697498|Anesthetics|anesthetics|mesh-list
55785121|NCT03114865|Blinatumomab|blinatumomab|mesh-list
55785124|NCT03114865|Antiemetics|antiemetics|mesh-ancestor
55834175|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834365|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834366|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
55834450|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55834451|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55834475|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
55834638|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
55834640|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834720|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
55834721|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835050|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
55785181|NCT02037529|Paclitaxel|paclitaxel|mesh-list
55835242|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
55835243|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
55835244|NCT01990339|Lansoprazole|lansoprazole|mesh-list
55835404|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
55835799|NCT02073929|Liraglutide|liraglutide|mesh-list
55836370|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837033|NCT01915940|Timolol|timolol|mesh-list
55837034|NCT01915940|Bimatoprost|bimatoprost|mesh-list
55837035|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55837115|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
55838105|NCT01413178|Melphalan|melphalan|mesh-list
55838374|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
55838375|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
55785206|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
55838628|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55838629|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795702|NCT04426097|Trace Elements|trace elements|mesh-ancestor
55785210|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55785217|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
55838958|NCT01910389|Tadalafil|tadalafil|mesh-list
55839099|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
55839100|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839245|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
55839387|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
55839388|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55839389|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55839390|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839397|NCT01385566|Vaccines|vaccines|mesh-list
55839497|NCT01778049|Linagliptin|linagliptin|mesh-list
55839498|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55839499|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839503|NCT01778049|Hormones|hormones|mesh-ancestor
55839714|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839715|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55839925|NCT04331938|Anesthetics|anesthetics|mesh-list
55839928|NCT01731951|Imetelstat|imetelstat|mesh-list
55840221|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
55840222|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
55840227|NCT01881230|Antiviral Agents|antiviral agents|mesh-ancestor
55840703|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
55840704|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55840791|NCT03598738|Esomeprazole|esomeprazole|mesh-list
55840792|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55840884|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55840885|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55840886|NCT00217672|Growth Substances|growth substances|mesh-ancestor
55840887|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840888|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
55840889|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
55840890|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
55840924|NCT00213148|Clomiphene|clomiphene|mesh-list
55840996|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55841133|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841328|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841329|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841428|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841431|NCT04027348|Octreotide|octreotide|mesh-list
55841504|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841512|NCT04147390|Tacrolimus|tacrolimus|mesh-list
55841603|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
55841604|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55841605|NCT04149964|Narcotics|narcotics|mesh-ancestor
55841606|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841608|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
55841609|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55841610|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55841690|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841833|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842034|NCT01699815|Acetaminophen|acetaminophen|mesh-list
55842132|NCT05702398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842286|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
55842287|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842434|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55842578|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842579|NCT04040452|Analgesics|analgesics|mesh-ancestor
55842580|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
55842647|NCT03732352|Deoxyglucose|deoxyglucose|mesh-list
55842757|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55842865|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842866|NCT02081638|Analgesics|analgesics|mesh-ancestor
55843008|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55843121|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55843122|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
55843123|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
55843124|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55843125|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
55843126|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843127|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843342|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843343|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55843344|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
55843712|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843714|NCT03772834|Methylphenidate|methylphenidate|mesh-list
55844008|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
55844009|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55844137|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844138|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
55844139|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844140|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844290|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55844385|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
55844386|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55844420|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
55844682|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
55844891|NCT04348006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55844892|NCT04348006|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55844893|NCT04348006|Antiemetics|antiemetics|mesh-ancestor
55844894|NCT04348006|Autonomic Agents|autonomic agents|mesh-ancestor
55845049|NCT03330028|Tubulin Modulators|tubulin modulators|mesh-ancestor
55845050|NCT03330028|Antimitotic Agents|antimitotic agents|mesh-ancestor
55845345|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55785329|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785330|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846041|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785333|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55785334|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55785335|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
55785338|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55846544|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55846545|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846546|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55846547|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55846581|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
55846630|NCT00986986|Niacin|niacin|mesh-list
55846673|NCT03118492|Tacrolimus|tacrolimus|mesh-list
55846791|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846792|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55846898|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847010|NCT05601466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847271|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55847641|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55847642|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55847643|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55847644|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847645|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847646|NCT01459198|Vaccines|vaccines|mesh-list
55847647|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
55847648|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847649|NCT02490904|Eplerenone|eplerenone|mesh-list
55847650|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55847651|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
55847652|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847681|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55785410|NCT04271189|Metformin|metformin|mesh-list
55785411|NCT04271189|Pioglitazone|pioglitazone|mesh-list
55785412|NCT04271189|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55847734|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
55847736|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847737|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847738|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
55847739|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848389|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848507|NCT03829696|Mifepristone|mifepristone|mesh-list
55848508|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
55848728|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848951|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55849173|NCT02543944|Naltrexone|naltrexone|mesh-list
55849175|NCT02543944|Gabapentin|gabapentin|mesh-list
55849278|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55849433|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849434|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55849435|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
55849614|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
55849869|NCT01464034|Dexamethasone|dexamethasone|mesh-list
55849870|NCT01464034|Pomalidomide|pomalidomide|mesh-list
55850055|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55850233|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55850234|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850421|NCT04564612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55850422|NCT04564612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850574|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55850575|NCT01479621|Fluticasone|fluticasone|mesh-list
55850576|NCT01479621|Xhance|xhance|mesh-list
55850744|NCT03364348|Maytansine|maytansine|mesh-list
55850865|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
55850866|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
55850943|NCT02390284|Diuretics|diuretics|mesh-ancestor
55850945|NCT04780750|Docetaxel|docetaxel|mesh-list
55851127|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
55851128|NCT00060424|Cyclosporins|cyclosporins|mesh-list
55851129|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851224|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55851309|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55851420|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55851793|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851794|NCT01471353|Capecitabine|capecitabine|mesh-list
55851795|NCT01471353|Sorafenib|sorafenib|mesh-list
55851976|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851977|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
55789073|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852195|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852196|NCT00113230|Bevacizumab|bevacizumab|mesh-list
55852197|NCT00113230|Capecitabine|capecitabine|mesh-list
55852198|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852199|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852232|NCT00049036|Hormones|hormones|mesh-ancestor
55852236|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
55852377|NCT00218062|Modafinil|modafinil|mesh-list
55852481|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
55852639|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852640|NCT01797302|Vitamin D|vitamin d|mesh-list
55785473|NCT04118387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852828|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55852984|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55852988|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
55853129|NCT01790542|Trace Elements|trace elements|mesh-ancestor
55853130|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
55853268|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
55853269|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853270|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853271|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55853272|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853273|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55853274|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55853655|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853656|NCT01755026|Cefazolin|cefazolin|mesh-list
55853659|NCT00333814|Dexamethasone|dexamethasone|mesh-list
55853825|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854097|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
55854098|NCT00318292|Epinephrine|epinephrine|mesh-list
55854099|NCT00318292|Bupivacaine|bupivacaine|mesh-list
55854518|NCT00366106|Bortezomib|bortezomib|mesh-list
55854520|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
55854784|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55854785|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
55854963|NCT00431626|Dutasteride|dutasteride|mesh-list
55855152|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855160|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55855163|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
55855259|NCT00466960|Sargramostim|sargramostim|mesh-list
55855522|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
55855523|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855524|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855699|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55855952|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55856218|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856219|NCT01445535|Prednisone|prednisone|mesh-list
55856376|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856620|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55856777|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
55857056|NCT01861717|Lanreotide|lanreotide|mesh-list
55857272|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
55857483|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55857484|NCT03998709|Somatostatin|somatostatin|mesh-list
55785568|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
55857486|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55857763|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55857982|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857984|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
55857987|NCT01875991|Etanercept|etanercept|mesh-list
55858165|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858489|NCT04147845|Triamcinolone|triamcinolone|mesh-list
55785577|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
55785578|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858705|NCT04699240|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55858833|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
55785579|NCT03777215|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
55785580|NCT03777215|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55785581|NCT03777215|Vasodilator Agents|vasodilator agents|mesh-ancestor
55858834|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858835|NCT05174650|Atezolizumab|atezolizumab|mesh-list
55858836|NCT05174650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858923|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859077|NCT03481972|Doxycycline|doxycycline|mesh-list
55785589|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55785590|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55859798|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55859833|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
55859982|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
55860007|NCT01799356|Renal Agents|renal agents|mesh-ancestor
55860155|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55860158|NCT00705874|Antiviral Agents|antiviral agents|mesh-ancestor
55785594|NCT05410847|Paclitaxel|paclitaxel|mesh-list
55860438|NCT01154920|Antimetabolites|antimetabolites|mesh-ancestor
55860647|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55860648|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55785612|NCT03726749|Prednisone|prednisone|mesh-list
55861002|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861731|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55861884|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55861921|NCT01770145|Emetics|emetics|mesh-ancestor
55862186|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55862187|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55862188|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
55862291|NCT05701059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862481|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55786996|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
55787135|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55787136|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787137|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55787386|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55865776|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865884|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55788272|NCT04912193|Antithrombins|antithrombins|mesh-list
55788273|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
55788274|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55865977|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865980|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55866085|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55788322|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55788323|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55788324|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55866250|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866251|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866253|NCT00892606|Morphine|morphine|mesh-list
55788328|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
55788332|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788334|NCT02144857|Etanercept|etanercept|mesh-list
55866513|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55866602|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866603|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56124703|NCT03814200|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
56124704|NCT03814200|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
56124705|NCT03814200|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
56124706|NCT03814200|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
56124707|NCT03814200|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
56124708|NCT03814200|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56124709|NCT01426854|Nepafenac|nepafenac|mesh-list
56124710|NCT01426854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56124711|NCT01426854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56124712|NCT01426854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56124713|NCT01426854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56124714|NCT01426854|Analgesics|analgesics|mesh-ancestor
56124715|NCT01426854|Sensory System Agents|sensory system agents|mesh-ancestor
56124718|NCT01426854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56124761|NCT01402284|Lenalidomide|lenalidomide|mesh-list
56124834|NCT03829410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56124905|NCT01387074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56124978|NCT01383954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56125053|NCT01382940|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56125130|NCT01381692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56125131|NCT01381692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56125202|NCT00214968|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
56125272|NCT03596424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
56125273|NCT03596424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56125274|NCT03596424|Anesthetics, General|anesthetics, general|mesh-ancestor
56125421|NCT03597594|Fludarabine|fludarabine|mesh-list
56125422|NCT03597594|Busulfan|busulfan|mesh-list
56125493|NCT05631678|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
56125494|NCT03599778|Apatinib|apatinib|mesh-list
56125566|NCT03976362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56125567|NCT03976362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56125640|NCT03596892|Antimetabolites|antimetabolites|mesh-ancestor
56125718|NCT04196946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125719|NCT04196946|Analgesics|analgesics|mesh-ancestor
56125793|NCT03742986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56125867|NCT04193982|Micronutrients|micronutrients|mesh-ancestor
56125868|NCT04193982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56125939|NCT03023358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56126014|NCT04192110|Natriuretic Agents|natriuretic agents|mesh-ancestor
56126015|NCT04192110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126016|NCT04025736|Tranexamic Acid|tranexamic acid|mesh-list
56126020|NCT04025736|Hemostatics|hemostatics|mesh-ancestor
56126087|NCT04023630|Protease Inhibitors|protease inhibitors|mesh-ancestor
56126090|NCT04147260|Ciprofloxacin|ciprofloxacin|mesh-list
56126162|NCT04020588|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56126163|NCT04020588|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56126311|NCT05583474|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56126312|NCT05583474|Adrenergic Agents|adrenergic agents|mesh-ancestor
56126318|NCT05583474|Sympatholytics|sympatholytics|mesh-ancestor
56126386|NCT05586204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126458|NCT03021330|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56126459|NCT03021330|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56126529|NCT03941730|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
56126611|NCT04147806|Hormones|hormones|mesh-ancestor
56126682|NCT03589326|Autonomic Agents|autonomic agents|mesh-ancestor
56126683|NCT03589326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56126684|NCT03589326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56126685|NCT03589326|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56126686|NCT03589326|Glucocorticoids|glucocorticoids|mesh-ancestor
56126687|NCT03589326|Hormones|hormones|mesh-ancestor
56126688|NCT03589326|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56126689|NCT03589326|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56126755|NCT03309150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56126756|NCT03309150|Tubulin Modulators|tubulin modulators|mesh-ancestor
56126760|NCT03155568|Bupivacaine|bupivacaine|mesh-list
56126828|NCT03156816|Tubulin Modulators|tubulin modulators|mesh-ancestor
56126829|NCT03156816|Antimitotic Agents|antimitotic agents|mesh-ancestor
56126902|NCT03159234|Autonomic Agents|autonomic agents|mesh-ancestor
56126976|NCT03027648|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56127050|NCT01672554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127124|NCT04765098|Hormone Antagonists|hormone antagonists|mesh-ancestor
56127126|NCT04765098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127195|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56127271|NCT04747080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56127420|NCT03865992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56127494|NCT01345656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56127497|NCT01345656|Diuretics|diuretics|mesh-ancestor
56127566|NCT02082678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56127567|NCT02082678|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56127718|NCT03826992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56127719|NCT03826992|Antiviral Agents|antiviral agents|mesh-ancestor
56127793|NCT03825198|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56127794|NCT03825198|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
56127868|NCT03817320|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56127869|NCT03817320|Tubulin Modulators|tubulin modulators|mesh-ancestor
56127942|NCT04403568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56128017|NCT03790488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128092|NCT03456102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56128320|NCT00084864|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
56128396|NCT01678404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56128397|NCT01678404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56128408|NCT03087864|Mitosis Modulators|mitosis modulators|mesh-ancestor
56128481|NCT03473730|Daratumumab|daratumumab|mesh-list
56128483|NCT03081858|Paclitaxel|paclitaxel|mesh-list
56128553|NCT03088722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56128625|NCT03086382|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56128626|NCT03086382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56128793|NCT03347292|Pembrolizumab|pembrolizumab|mesh-list
56128943|NCT04401852|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56128944|NCT04401852|Tocolytic Agents|tocolytic agents|mesh-ancestor
56128945|NCT04401852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56129017|NCT03081702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56129018|NCT03081702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129019|NCT03081702|Antifungal Agents|antifungal agents|mesh-ancestor
56129020|NCT03081702|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56129240|NCT02084706|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56129312|NCT03249558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129313|NCT03249558|Analgesics|analgesics|mesh-ancestor
56129386|NCT03204396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129387|NCT02008656|Leucovorin|leucovorin|mesh-list
56129388|NCT02008656|Fluorouracil|fluorouracil|mesh-list
56129389|NCT02008656|Capecitabine|capecitabine|mesh-list
56129459|NCT03818802|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56129537|NCT03193866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56129608|NCT04397328|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56129685|NCT03286842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56129759|NCT03003546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129760|NCT03003546|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56129761|NCT03564678|Folic Acid|folic acid|mesh-list
56129762|NCT03564678|Vitamin B Complex|vitamin b complex|mesh-list
56129763|NCT03564678|Vitamins|vitamins|mesh-ancestor
56129764|NCT03564678|Micronutrients|micronutrients|mesh-ancestor
56129765|NCT03564678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56129766|NCT03564678|Hematinics|hematinics|mesh-ancestor
56129767|NCT02395614|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56129768|NCT02395614|Gentamicins|gentamicins|mesh-list
56129830|NCT03136146|Immunologic Factors|immunologic factors|mesh-ancestor
56129907|NCT00638508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130052|NCT00634920|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56130124|NCT01923558|Cholinergic Agents|cholinergic agents|mesh-ancestor
56130198|NCT01923870|Hormone Antagonists|hormone antagonists|mesh-ancestor
56134495|NCT00112242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130199|NCT01923870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56130272|NCT00630396|Minocycline|minocycline|mesh-list
56130273|NCT00630396|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56130344|NCT01925898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56130580|NCT03059940|Nicotine|nicotine|mesh-list
56130644|NCT01928628|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
56130717|NCT04124094|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56130793|NCT04126278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56130795|NCT04126278|Glucocorticoids|glucocorticoids|mesh-ancestor
56130869|NCT04129710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55744631|NCT05253573|Nicotine|nicotine|mesh-list
56131014|NCT04126044|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56131015|NCT04126044|Growth Substances|growth substances|mesh-ancestor
56131087|NCT02972424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131171|NCT03884556|Paclitaxel|paclitaxel|mesh-list
56131237|NCT03820206|Tranexamic Acid|tranexamic acid|mesh-list
56131316|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
56131388|NCT03829332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131690|NCT01890408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56131691|NCT01890408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131763|NCT02535312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56131837|NCT02848560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56131924|NCT05027100|Irinotecan|irinotecan|mesh-list
56131988|NCT02730546|Carboplatin|carboplatin|mesh-list
56131989|NCT02730546|Pembrolizumab|pembrolizumab|mesh-list
56131990|NCT02730546|Fluorouracil|fluorouracil|mesh-list
56132062|NCT02716974|Bicalutamide|bicalutamide|mesh-list
56132136|NCT02705196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56132137|NCT02705196|Tubulin Modulators|tubulin modulators|mesh-ancestor
56132214|NCT05586516|Immunologic Factors|immunologic factors|mesh-ancestor
56132215|NCT05586516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132216|NCT04390854|Clotrimazole|clotrimazole|mesh-list
56132360|NCT01453530|Autonomic Agents|autonomic agents|mesh-ancestor
56132437|NCT01989780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56132512|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
56132514|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
56132608|NCT01943994|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
56132609|NCT01943994|Nicotine|nicotine|mesh-list
56132682|NCT05586126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132760|NCT04757532|Hormones|hormones|mesh-ancestor
56132762|NCT04757532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56132834|NCT01895010|Antiemetics|antiemetics|mesh-ancestor
56132911|NCT01424982|Antibodies|antibodies|mesh-list
56132985|NCT00273624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56133061|NCT00262470|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
56133062|NCT00262470|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
56133136|NCT04782960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133213|NCT00869232|Thalidomide|thalidomide|mesh-list
56133214|NCT00869232|Dexamethasone|dexamethasone|mesh-list
56133288|NCT03969420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56133289|NCT03969420|Immunologic Factors|immunologic factors|mesh-ancestor
56133309|NCT04780152|Fluoxetine|fluoxetine|mesh-list
56133382|NCT04779060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56133458|NCT03012984|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56133459|NCT03012984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56133460|NCT03012984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133530|NCT00055692|Growth Inhibitors|growth inhibitors|mesh-ancestor
56133531|NCT00055692|Immunologic Factors|immunologic factors|mesh-ancestor
56133605|NCT02538744|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56133682|NCT00064038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56133683|NCT00064038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56133753|NCT02505750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56133754|NCT00030264|Methotrexate|methotrexate|mesh-list
56133755|NCT00030264|Vinblastine|vinblastine|mesh-list
56133791|NCT00036738|Dasatinib|dasatinib|mesh-list
56133828|NCT00038610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56133829|NCT00038610|Antiemetics|antiemetics|mesh-ancestor
56133903|NCT04531176|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
56134050|NCT00255684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134128|NCT00176826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56134203|NCT00091260|Hormones|hormones|mesh-ancestor
55745128|NCT02485873|Vitamin K|vitamin k|mesh-list
56134278|NCT04118556|Sirolimus|sirolimus|mesh-list
56134353|NCT00098670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134354|NCT00098670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56134425|NCT01899690|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
56134427|NCT01899690|Cephalexin|cephalexin|mesh-list
56134428|NCT01899690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861360|NCT00735826|Vorinostat|vorinostat|mesh-list
56134644|NCT00227994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56134645|NCT00227994|Cholinergic Agents|cholinergic agents|mesh-ancestor
56134719|NCT01899144|Albuterol|albuterol|mesh-list
56134789|NCT00296322|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56134790|NCT00296322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56134862|NCT02100930|Dermatologic Agents|dermatologic agents|mesh-ancestor
56134935|NCT01899066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56134936|NCT01899066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56135009|NCT00134004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56135010|NCT00134004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56135011|NCT00134004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56135012|NCT00134004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56135013|NCT00134004|Antitubercular Agents|antitubercular agents|mesh-ancestor
56135014|NCT00134004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56135015|NCT00134004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56135016|NCT00135798|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
56135085|NCT05201430|Oxaliplatin|oxaliplatin|mesh-list
56135086|NCT05201430|Irinotecan|irinotecan|mesh-list
56135238|NCT00328614|Growth Substances|growth substances|mesh-ancestor
56135313|NCT00343044|Bevacizumab|bevacizumab|mesh-list
56135314|NCT00343044|Topotecan|topotecan|mesh-list
56135385|NCT00350532|Clonidine|clonidine|mesh-list
56135457|NCT00353652|Natriuretic Agents|natriuretic agents|mesh-ancestor
56135530|NCT00357162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56135603|NCT00549978|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56135604|NCT00549978|Autonomic Agents|autonomic agents|mesh-ancestor
56135678|NCT00305682|Cyclophosphamide|cyclophosphamide|mesh-list
56135752|NCT00365274|Glucocorticoids|glucocorticoids|mesh-ancestor
56135825|NCT02448420|Immunologic Factors|immunologic factors|mesh-ancestor
56135900|NCT00391716|Sensory System Agents|sensory system agents|mesh-ancestor
56135913|NCT00392496|Sunitinib|sunitinib|mesh-list
56135974|NCT00397020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56136053|NCT00405288|Pramoxine|pramoxine|mesh-list
56136126|NCT00405522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56136127|NCT00405522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136128|NCT00405522|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56136129|NCT00405522|Anesthetics, General|anesthetics, general|mesh-ancestor
56136130|NCT00405522|Anesthetics|anesthetics|mesh-ancestor
56136131|NCT00405522|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56136132|NCT00405522|Narcotics|narcotics|mesh-ancestor
56136133|NCT00405522|Analgesics|analgesics|mesh-ancestor
56136134|NCT00405522|Sensory System Agents|sensory system agents|mesh-ancestor
56136135|NCT00405522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136136|NCT00461292|Botulinum Toxins|botulinum toxins|mesh-list
56136137|NCT00461292|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
56136192|NCT00408564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56136266|NCT00385008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56136416|NCT04388904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56136491|NCT00389532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56136565|NCT00478218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136566|NCT00478218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136637|NCT00531882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56136638|NCT00531882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56136710|NCT01954524|Urological Agents|urological agents|mesh-ancestor
56136711|NCT00535002|Yohimbine|yohimbine|mesh-list
56136712|NCT00535002|Mydriatics|mydriatics|mesh-ancestor
56136713|NCT00535002|Autonomic Agents|autonomic agents|mesh-ancestor
56136783|NCT00535782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56136784|NCT00431184|Pentazocine|pentazocine|mesh-list
56136859|NCT00538824|Antiemetics|antiemetics|mesh-ancestor
56136860|NCT00538824|Autonomic Agents|autonomic agents|mesh-ancestor
56136861|NCT00538824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56136863|NCT00538824|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56136933|NCT00439296|Antiemetics|antiemetics|mesh-ancestor
56137009|NCT00504504|Bleomycin|bleomycin|mesh-list
56137010|NCT00504504|Vinblastine|vinblastine|mesh-list
56137011|NCT00504504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56137079|NCT02115048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56137080|NCT00546156|Paclitaxel|paclitaxel|mesh-list
56137081|NCT00546156|Cyclophosphamide|cyclophosphamide|mesh-list
56137154|NCT00548418|Growth Substances|growth substances|mesh-ancestor
56137308|NCT00555048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56137381|NCT00527124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56137456|NCT03117972|Fluorouracil|fluorouracil|mesh-list
56137531|NCT02128230|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56137532|NCT02128230|Immunologic Factors|immunologic factors|mesh-ancestor
56137601|NCT05615844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56137676|NCT02129478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56137678|NCT02129478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137754|NCT05198232|Antioxidants|antioxidants|mesh-ancestor
56137830|NCT03781128|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56137832|NCT03781128|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
56137900|NCT03548454|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
56137978|NCT03018366|Estradiol|estradiol|mesh-list
56138051|NCT00610428|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56138126|NCT00612222|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56138127|NCT00612222|Antimetabolites|antimetabolites|mesh-ancestor
56138203|NCT04142502|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56138276|NCT03930732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138350|NCT01115569|Analgesics|analgesics|mesh-ancestor
56138351|NCT01115569|Sensory System Agents|sensory system agents|mesh-ancestor
56138352|NCT01115569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56138353|NCT01115569|Antitussive Agents|antitussive agents|mesh-ancestor
56138354|NCT01115569|Respiratory System Agents|respiratory system agents|mesh-ancestor
56138355|NCT01107886|Saxagliptin|saxagliptin|mesh-list
56138356|NCT01107886|Incretins|incretins|mesh-ancestor
56138357|NCT01107886|Hormones|hormones|mesh-ancestor
56138358|NCT01107886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56138359|NCT01107886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138360|NCT01107886|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56138361|NCT01107886|Protease Inhibitors|protease inhibitors|mesh-ancestor
56138362|NCT01107886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56138363|NCT01107886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56138364|NCT01107886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56138365|NCT01107457|Ixekizumab|ixekizumab|mesh-list
56138366|NCT01107457|Dermatologic Agents|dermatologic agents|mesh-ancestor
56138382|NCT05766670|Vancomycin|vancomycin|mesh-list
56138419|NCT05766605|Micronutrients|micronutrients|mesh-ancestor
56138495|NCT05766384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56138644|NCT05765266|Protective Agents|protective agents|mesh-ancestor
56138645|NCT05765266|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56138646|NCT05765266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56138647|NCT05765240|Hyaluronic Acid|hyaluronic acid|mesh-list
56138648|NCT05765240|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56138649|NCT05765240|Immunologic Factors|immunologic factors|mesh-ancestor
56138650|NCT05765240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56138651|NCT05765240|Viscosupplements|viscosupplements|mesh-ancestor
56138718|NCT05764746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56138876|NCT05643573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
56138877|NCT05643573|Antithrombins|antithrombins|mesh-ancestor
56138887|NCT05628623|Cytarabine|cytarabine|mesh-list
56138949|NCT05555706|Mitosis Modulators|mitosis modulators|mesh-ancestor
56139099|NCT05320380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56139183|NCT05239741|Protective Agents|protective agents|mesh-ancestor
56139186|NCT05239741|Micronutrients|micronutrients|mesh-ancestor
56139258|NCT05140941|Velpatasvir|velpatasvir|mesh-list
56139259|NCT05140941|Antiviral Agents|antiviral agents|mesh-ancestor
56139260|NCT05140941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139335|NCT05056727|Protease Inhibitors|protease inhibitors|mesh-ancestor
56139411|NCT05012631|Losartan|losartan|mesh-list
56139412|NCT05012631|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56139482|NCT04931017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139562|NCT04778267|Dexamethasone|dexamethasone|mesh-list
56139635|NCT04735471|Cyclophosphamide|cyclophosphamide|mesh-list
56139636|NCT04735471|Fludarabine|fludarabine|mesh-list
56139637|NCT04735471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56139708|NCT04616560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139709|NCT04616560|Immunologic Factors|immunologic factors|mesh-ancestor
56139710|NCT04616560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56139711|NCT04578756|Cariprazine|cariprazine|mesh-list
56139712|NCT04578756|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56139713|NCT04578756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56139714|NCT04578756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56139784|NCT04493853|Abiraterone Acetate|abiraterone acetate|mesh-list
56139785|NCT04493853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56139786|NCT04493853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56139787|NCT04493853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139788|NCT04493853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139854|NCT04370301|Antitubercular Agents|antitubercular agents|mesh-ancestor
56139930|NCT04247126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56139931|NCT04247126|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56139932|NCT04247126|Antimetabolites|antimetabolites|mesh-ancestor
56139933|NCT04247126|Antiviral Agents|antiviral agents|mesh-ancestor
56139934|NCT04247126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56139935|NCT04247126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56139936|NCT04247126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56139937|NCT04247126|Immunologic Factors|immunologic factors|mesh-ancestor
56139938|NCT04247126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140069|NCT04099251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56140157|NCT04015180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56140231|NCT03903692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56140238|NCT03831711|Bombesin|bombesin|mesh-list
56140305|NCT03617679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140378|NCT03523585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56140454|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
56140530|NCT02987543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56140531|NCT02987543|Hormone Antagonists|hormone antagonists|mesh-ancestor
55745592|NCT02475421|Hormones|hormones|mesh-ancestor
56140603|NCT02540018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140604|NCT02540018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140609|NCT02496208|Nivolumab|nivolumab|mesh-list
56140758|NCT02003222|BB 1101|bb 1101|mesh-list
56140759|NCT02003222|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56140831|NCT01705184|Growth Substances|growth substances|mesh-ancestor
56140839|NCT01285817|Cyclophosphamide|cyclophosphamide|mesh-list
56140903|NCT01105975|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56140904|NCT01105975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56140905|NCT01063517|Paclitaxel|paclitaxel|mesh-list
56140906|NCT01063517|Olaparib|olaparib|mesh-list
56140907|NCT01063517|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56140908|NCT01063517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56140909|NCT01063517|Tubulin Modulators|tubulin modulators|mesh-ancestor
56140910|NCT01063517|Antimitotic Agents|antimitotic agents|mesh-ancestor
56140911|NCT01063517|Mitosis Modulators|mitosis modulators|mesh-ancestor
56140912|NCT01063517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56140967|NCT04387500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56141042|NCT04379310|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
56141045|NCT04379310|Protease Inhibitors|protease inhibitors|mesh-ancestor
56141115|NCT04374942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56141116|NCT04374318|Dexmedetomidine|dexmedetomidine|mesh-list
56141265|NCT04365036|Pegaspargase|pegaspargase|mesh-list
56141267|NCT04365036|Antimetabolites|antimetabolites|mesh-ancestor
56141340|NCT04359966|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
56141416|NCT04356222|Methotrexate|methotrexate|mesh-list
56141490|NCT04354662|Antidotes|antidotes|mesh-ancestor
56141491|NCT04354662|Protective Agents|protective agents|mesh-ancestor
56141565|NCT04350528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56141566|NCT04350528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56141567|NCT04350528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56141568|NCT04350528|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56141569|NCT04350528|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56141570|NCT04350528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56141571|NCT04350528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56141572|NCT04350528|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56141573|NCT04350528|Dopamine Agents|dopamine agents|mesh-ancestor
56141574|NCT04350528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56141575|NCT04350528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141709|NCT04341870|Azithromycin|azithromycin|mesh-list
56141710|NCT04341870|Hydroxychloroquine|hydroxychloroquine|mesh-list
56141783|NCT04340388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141784|NCT04340388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56141785|NCT04340388|Antimetabolites|antimetabolites|mesh-ancestor
56141854|NCT04336488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56141999|NCT05508594|Sensory System Agents|sensory system agents|mesh-ancestor
56142071|NCT03035214|Autonomic Agents|autonomic agents|mesh-ancestor
56142074|NCT03035214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56142220|NCT03017430|Clonidine|clonidine|mesh-list
56142275|NCT03016806|Mesna|mesna|mesh-list
56142300|NCT03016260|Adalimumab|adalimumab|mesh-list
56142376|NCT03009474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56142450|NCT03005496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56142523|NCT03002844|Antiviral Agents|antiviral agents|mesh-ancestor
56142524|NCT03002844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56142595|NCT02989272|Tocolytic Agents|tocolytic agents|mesh-ancestor
56142596|NCT02989272|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56142597|NCT02989038|Nicotine|nicotine|mesh-list
56142616|NCT02987556|Insulin|insulin|mesh-list
56142667|NCT02980926|Anesthetics|anesthetics|mesh-ancestor
56142685|NCT02979132|Iron|iron|mesh-list
56142743|NCT02974920|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56142744|NCT02974920|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56142819|NCT02641782|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56142890|NCT04745286|Antidepressive Agents|antidepressive agents|mesh-ancestor
56142964|NCT05313828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56142967|NCT05313750|Ofloxacin|ofloxacin|mesh-list
56143038|NCT00580398|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
56143039|NCT00580398|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
56143113|NCT03262662|Varenicline|varenicline|mesh-list
56143263|NCT00597402|Irinotecan|irinotecan|mesh-list
56143264|NCT00597402|Temozolomide|temozolomide|mesh-list
56143335|NCT00626340|Fluoxetine|fluoxetine|mesh-list
56143336|NCT00626340|Estrogens|estrogens|mesh-list
56143406|NCT00637494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56143407|NCT00637494|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
56143481|NCT00660504|Etoposide|etoposide|mesh-list
56143482|NCT00660504|Amrubicin|amrubicin|mesh-list
56143483|NCT00660504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143553|NCT00670956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56143629|NCT00676806|Alkylating Agents|alkylating agents|mesh-ancestor
56143777|NCT00704028|Hematinics|hematinics|mesh-ancestor
56143856|NCT00715884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56143857|NCT00715884|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56143858|NCT00715884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56143929|NCT00720330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56143930|NCT00720330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56144005|NCT00729924|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56144153|NCT00743574|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56144154|NCT00743574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144240|NCT00759642|Lapatinib|lapatinib|mesh-list
56144377|NCT00780234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144452|NCT00788892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144453|NCT00788892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144454|NCT00788892|Antiviral Agents|antiviral agents|mesh-ancestor
56144527|NCT00795210|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144528|NCT00795210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144529|NCT00795288|Simvastatin|simvastatin|mesh-list
56144530|NCT00795288|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56144531|NCT00795288|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56144532|NCT00795288|Antimetabolites|antimetabolites|mesh-ancestor
56144533|NCT00795288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144534|NCT00795288|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56144536|NCT00795288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144542|NCT00795366|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55871773|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
55871774|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871831|NCT01027000|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55871832|NCT01027000|Antifungal Agents|antifungal agents|mesh-ancestor
55871833|NCT05685615|Polymyxins|polymyxins|mesh-list
55871904|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871907|NCT00980746|Anticonvulsants|anticonvulsants|mesh-ancestor
55871979|NCT05500599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55871980|NCT05500599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55872052|NCT03263481|Secretin|secretin|mesh-list
55872053|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55872054|NCT03263481|Hormones|hormones|mesh-ancestor
55872123|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55872195|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872267|NCT04101838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872268|NCT04606797|Nicotine|nicotine|mesh-list
55872269|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55872270|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
55872271|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872272|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872273|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55872274|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55872275|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
55872333|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55872334|NCT01001806|Analgesics|analgesics|mesh-ancestor
55872335|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
55872336|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55872337|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872338|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55872339|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55872340|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55872341|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872399|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872400|NCT04757571|Paroxetine|paroxetine|mesh-list
55872401|NCT04757571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55872402|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55872403|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55872404|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872405|NCT04757571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55872406|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
55872409|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
55872465|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55872467|NCT03284463|Glyburide|glyburide|mesh-list
55872539|NCT04704999|Antimalarials|antimalarials|mesh-ancestor
55872540|NCT04704999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55872541|NCT04197310|Nivolumab|nivolumab|mesh-list
55872542|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55872610|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55872681|NCT04399395|Bupropion|bupropion|mesh-list
55872754|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55872830|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55872841|NCT04415567|Lenvatinib|lenvatinib|mesh-list
55872900|NCT04392375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55872901|NCT04392375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55872902|NCT04392375|Vasodilator Agents|vasodilator agents|mesh-ancestor
55872904|NCT04392375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55872905|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
55872906|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
55872907|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
55872908|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872966|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55872967|NCT04344873|Abatacept|abatacept|mesh-list
55872968|NCT04344873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55872975|NCT01109056|Cyclosporine|cyclosporine|mesh-list
55873035|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
55873036|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55873109|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873110|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55873111|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55873112|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
55873180|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873181|NCT03646461|Nivolumab|nivolumab|mesh-list
55873182|NCT03646461|Cetuximab|cetuximab|mesh-list
55873187|NCT01880957|Lamotrigine|lamotrigine|mesh-list
55873249|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55873250|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55873251|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55873253|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55873317|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55873318|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55873319|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873390|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873391|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55873392|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55873393|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
55873460|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55873462|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
55873532|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
55873533|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55873534|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873535|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55873604|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873605|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873749|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55873750|NCT01085344|Factor VIII|factor viii|mesh-list
55873751|NCT01085344|Coagulants|coagulants|mesh-ancestor
55873822|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55873823|NCT01922427|Analgesics|analgesics|mesh-ancestor
55873824|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
55873844|NCT01090180|Hormones|hormones|mesh-ancestor
55873890|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55873891|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
55873892|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55873893|NCT05273320|Analgesics|analgesics|mesh-ancestor
55873894|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
55873895|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55873896|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55873957|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55873958|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55873959|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55873960|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55875383|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
55874025|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55874026|NCT01048606|Estrogens|estrogens|mesh-ancestor
55874027|NCT01048606|Hormones|hormones|mesh-ancestor
55874028|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55874029|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874031|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
55874032|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
55874093|NCT02623426|Immunologic Factors|immunologic factors|mesh-ancestor
55874094|NCT02623426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874095|NCT02623426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55874096|NCT02623426|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55874097|NCT02623426|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55874100|NCT02182492|Clarithromycin|clarithromycin|mesh-list
55874162|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874164|NCT01171690|Teriparatide|teriparatide|mesh-list
55874165|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55874166|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874167|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55874171|NCT05396742|Ravulizumab|ravulizumab|mesh-list
55874172|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55874176|NCT05389176|Esmolol|esmolol|mesh-list
55874229|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55874230|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55874231|NCT04099836|Growth Substances|growth substances|mesh-ancestor
55874232|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874233|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
55874234|NCT04092894|Suvorexant|suvorexant|mesh-list
55874243|NCT01134952|Sirolimus|sirolimus|mesh-list
55874301|NCT05164848|Afatinib|afatinib|mesh-list
55874302|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874373|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55874374|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55874376|NCT04397289|Heparin|heparin|mesh-list
55874446|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
55874447|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874448|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55874521|NCT01185028|Interferons|interferons|mesh-list
55874522|NCT01185028|Ribavirin|ribavirin|mesh-list
55874523|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
55874524|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874595|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55874667|NCT05439408|Dasatinib|dasatinib|mesh-list
55874668|NCT05439408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55874739|NCT03467178|Carboplatin|carboplatin|mesh-list
55874740|NCT03467178|Doxorubicin|doxorubicin|mesh-list
55874741|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55874742|NCT03467178|Decitabine|decitabine|mesh-list
55874743|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55749784|NCT02454205|Renal Agents|renal agents|mesh-ancestor
55874811|NCT05431920|Calcifediol|calcifediol|mesh-list
55874812|NCT05431920|Vitamins|vitamins|mesh-list
55874813|NCT05431920|Micronutrients|micronutrients|mesh-ancestor
55874814|NCT05431920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874815|NCT05431920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55874880|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55874881|NCT01145638|Hematinics|hematinics|mesh-ancestor
55874882|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
55874883|NCT03466320|Fludarabine|fludarabine|mesh-list
55874894|NCT03466242|Ketamine|ketamine|mesh-list
55874949|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55874950|NCT02522130|Oxytocics|oxytocics|mesh-ancestor
55874953|NCT02522130|Analgesics|analgesics|mesh-ancestor
55875025|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
55875026|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
55875027|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55875028|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875097|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55875167|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875168|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55875238|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875239|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55875240|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55875309|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875310|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55875311|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55875312|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55875382|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55875384|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875385|NCT02460588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55875393|NCT02460588|Hormones|hormones|mesh-ancestor
55875452|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55875454|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55875455|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55875456|NCT01157416|Renal Agents|renal agents|mesh-ancestor
55875519|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55875520|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55875522|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55875523|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55875524|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55875525|NCT01158820|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55875526|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
55875527|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
55875537|NCT03707028|Paclitaxel|paclitaxel|mesh-list
55875586|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55875660|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875661|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
55875662|NCT01212874|Esmolol|esmolol|mesh-list
55875663|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
55875730|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55875731|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
55875732|NCT03449940|Diclofenac|diclofenac|mesh-list
55875877|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55875878|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55875879|NCT03010540|Fentanyl|fentanyl|mesh-list
55875950|NCT00861705|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55876024|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55876025|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876027|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
55876095|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876096|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
55876097|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55876098|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55876106|NCT03437070|Olaratumab|olaratumab|mesh-list
55876167|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55876168|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876238|NCT03433092|Antioxidants|antioxidants|mesh-ancestor
55876239|NCT03433092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876312|NCT00055731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55876313|NCT00055731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55876314|NCT00055731|Analgesics|analgesics|mesh-ancestor
55876315|NCT00055731|Sensory System Agents|sensory system agents|mesh-ancestor
55876316|NCT00055731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876317|NCT00055731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55876318|NCT00055731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55876319|NCT00055731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876320|NCT00055731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55876321|NCT00055731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55876346|NCT00632541|Sorafenib|sorafenib|mesh-list
55876375|NCT01872611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876376|NCT01872611|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55876377|NCT01872611|Protective Agents|protective agents|mesh-ancestor
55876378|NCT01872611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55876379|NCT01872611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55876381|NCT01872611|Sensory System Agents|sensory system agents|mesh-ancestor
55876382|NCT01872611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55876440|NCT00632229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876441|NCT00632229|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55876511|NCT03085563|Anesthetics|anesthetics|mesh-ancestor
55876512|NCT03085563|GABA Modulators|gaba modulators|mesh-ancestor
55876513|NCT03085563|GABA Agents|gaba agents|mesh-ancestor
55876514|NCT03085563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876515|NCT03085563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876516|NCT03085563|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55876517|NCT03085563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55876518|NCT03085563|Analgesics|analgesics|mesh-ancestor
55876519|NCT03085563|Sensory System Agents|sensory system agents|mesh-ancestor
55876520|NCT03085563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55876521|NCT03431766|Chlorhexidine|chlorhexidine|mesh-list
55876522|NCT03431766|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55876524|NCT03431766|Disinfectants|disinfectants|mesh-ancestor
55876574|NCT03434340|Granisetron|granisetron|mesh-list
55876659|NCT03431142|Antipyretics|antipyretics|mesh-ancestor
55876726|NCT00635505|Tocolytic Agents|tocolytic agents|mesh-ancestor
55876798|NCT01925859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55876799|NCT01925859|Glucocorticoids|glucocorticoids|mesh-ancestor
55876800|NCT01925859|Hormones|hormones|mesh-ancestor
55876803|NCT01925859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55876868|NCT01339858|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55876943|NCT01247272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55876944|NCT01247272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55876945|NCT01247272|Serotonin Agents|serotonin agents|mesh-ancestor
55876946|NCT01247272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877010|NCT01928511|Interferon-alpha|interferon-alpha|mesh-list
55877011|NCT01928511|Lamivudine|lamivudine|mesh-list
55877013|NCT01928511|Entecavir|entecavir|mesh-list
55877084|NCT02977494|Autonomic Agents|autonomic agents|mesh-ancestor
55877088|NCT02977494|Glucocorticoids|glucocorticoids|mesh-ancestor
55877156|NCT01929213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55877157|NCT01929213|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55877160|NCT05607615|Betadex|betadex|mesh-list
55877229|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877306|NCT03128346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55877307|NCT03128346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55877380|NCT01253824|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55877381|NCT01253824|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55877454|NCT03154749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55877455|NCT03154749|Immunologic Factors|immunologic factors|mesh-ancestor
55877457|NCT03154749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55877525|NCT03608358|Protease Inhibitors|protease inhibitors|mesh-ancestor
55877526|NCT03608358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55877527|NCT04274907|Pembrolizumab|pembrolizumab|mesh-list
55877528|NCT04274907|Venetoclax|venetoclax|mesh-list
55877529|NCT04274907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55877530|NCT04274907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55877531|NCT01256164|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55877596|NCT03426462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55877670|NCT02546232|Paclitaxel|paclitaxel|mesh-list
55877671|NCT02546232|Carboplatin|carboplatin|mesh-list
55877678|NCT02521038|Ticagrelor|ticagrelor|mesh-list
55877817|NCT03032601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55877889|NCT01295710|Immunologic Factors|immunologic factors|mesh-ancestor
55877890|NCT01295710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55877891|NCT01295710|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55877960|NCT01297348|Norinyl|norinyl|mesh-list
55877961|NCT01297348|Contraceptive Agents|contraceptive agents|mesh-list
55878032|NCT01265446|Sensory System Agents|sensory system agents|mesh-ancestor
55878039|NCT04352062|Amoxicillin|amoxicillin|mesh-list
55878107|NCT01358266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55878108|NCT01358266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55878181|NCT01303744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55878185|NCT01361620|Aspirin|aspirin|mesh-list
55878256|NCT01307956|Immunologic Factors|immunologic factors|mesh-ancestor
55878257|NCT01307956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55878258|NCT01307956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55878332|NCT01275664|Ichthammol|ichthammol|mesh-list
55878333|NCT01275664|BB 1101|bb 1101|mesh-list
55878430|NCT01850615|Insulin|insulin|mesh-list
55878481|NCT01868477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878555|NCT03420534|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55878556|NCT01313494|Albuterol|albuterol|mesh-list
55878571|NCT01407094|Sertraline|sertraline|mesh-list
55878624|NCT01410058|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55878699|NCT01411696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55878700|NCT01411696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55878702|NCT01412164|Sirolimus|sirolimus|mesh-list
55878787|NCT04448496|Hormones|hormones|mesh-ancestor
55878852|NCT03424356|Anesthetics|anesthetics|mesh-ancestor
55878921|NCT01390246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55878924|NCT01390246|Dopamine Agents|dopamine agents|mesh-ancestor
55878993|NCT03417648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55878994|NCT03417648|Protective Agents|protective agents|mesh-ancestor
55878995|NCT01831817|Calcium, Dietary|calcium, dietary|mesh-list
55879064|NCT02520570|Urinastatin|urinastatin|mesh-list
55879115|NCT01394614|Vaccines|vaccines|mesh-list
55879137|NCT01422226|Misoprostol|misoprostol|mesh-list
55879138|NCT01422226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55879213|NCT01830881|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55879233|NCT01396486|Inositol|inositol|mesh-list
55879290|NCT03401736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55879291|NCT03401736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55879292|NCT03401736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55879364|NCT03009058|Antiviral Agents|antiviral agents|mesh-ancestor
55879513|NCT01611155|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55879514|NCT01611155|Antidepressive Agents|antidepressive agents|mesh-ancestor
55879515|NCT01611155|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55879517|NCT01430182|Methadone|methadone|mesh-list
55879518|NCT01430182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55879585|NCT01837823|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55879586|NCT01837823|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55879656|NCT01828073|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55879657|NCT01828073|Antiviral Agents|antiviral agents|mesh-ancestor
55879658|NCT01828073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55879659|NCT01828073|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55879660|NCT01828073|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55879724|NCT04567992|Anesthetics, Local|anesthetics, local|mesh-ancestor
55879725|NCT04567992|Anesthetics|anesthetics|mesh-ancestor
55879797|NCT01435174|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55879799|NCT01436266|Folic Acid|folic acid|mesh-list
55879869|NCT01544998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879942|NCT01545700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55879943|NCT01486810|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55879946|NCT01486810|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55880013|NCT01445626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55880017|NCT02744742|Busulfan|busulfan|mesh-list
55880087|NCT02520180|Immunologic Factors|immunologic factors|mesh-ancestor
55880088|NCT02520180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880089|NCT03391050|Dabrafenib|dabrafenib|mesh-list
55880090|NCT03391050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55880091|NCT03391050|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55880156|NCT01450306|Antimetabolites|antimetabolites|mesh-ancestor
55880227|NCT02731638|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55880302|NCT01497496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55880303|NCT01497496|Glucocorticoids|glucocorticoids|mesh-ancestor
55880373|NCT01458418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55880445|NCT02981212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880517|NCT01470118|Lubricant Eye Drops|lubricant eye drops|mesh-list
55880518|NCT01470118|Alcaftadine|alcaftadine|mesh-list
55880519|NCT01470118|Anticoagulants|anticoagulants|mesh-ancestor
55880593|NCT01511068|Sargramostim|sargramostim|mesh-list
55880664|NCT01566526|Antiemetics|antiemetics|mesh-ancestor
55880737|NCT01514734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750998|NCT02493179|Analgesics|analgesics|mesh-ancestor
55880810|NCT04660890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55880811|NCT04660890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55880882|NCT03386838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55880883|NCT03386838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55880884|NCT03386838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55880956|NCT03383406|Methotrexate|methotrexate|mesh-list
55881028|NCT03093246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881029|NCT03093246|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55881101|NCT01576276|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55881175|NCT04942158|Dermatologic Agents|dermatologic agents|mesh-ancestor
55881176|NCT04942158|Sunscreening Agents|sunscreening agents|mesh-ancestor
55881177|NCT04942158|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55881245|NCT01825577|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55881246|NCT01825577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881317|NCT01579162|Cholic Acids|cholic acids|mesh-list
55881391|NCT03381066|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55881461|NCT01581970|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55881462|NCT01581970|Immunologic Factors|immunologic factors|mesh-ancestor
55881463|NCT01581970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881471|NCT01583686|Aldesleukin|aldesleukin|mesh-list
55881532|NCT01802333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55881533|NCT01802333|Antiviral Agents|antiviral agents|mesh-ancestor
55881534|NCT01802333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881603|NCT04588259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881677|NCT02247310|Immunologic Factors|immunologic factors|mesh-ancestor
55881678|NCT02247310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55881751|NCT01593592|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55881752|NCT01593592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55881753|NCT01593592|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55881822|NCT03005704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55881896|NCT05566834|14-O-phosphonooxymethyltriptolide disodium salt|14-o-phosphonooxymethyltriptolide disodium salt|mesh-list
55881897|NCT05566834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55881898|NCT05566834|Alkylating Agents|alkylating agents|mesh-ancestor
55881967|NCT03004612|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55881968|NCT03004612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882044|NCT03000634|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55882045|NCT03000634|Antiemetics|antiemetics|mesh-ancestor
55882046|NCT03000634|Autonomic Agents|autonomic agents|mesh-ancestor
55882047|NCT03000634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882049|NCT03000634|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55882109|NCT03362268|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55882110|NCT03362268|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55882111|NCT03362268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882112|NCT03362268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882113|NCT04523844|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55882114|NCT04523844|Brinzolamide|brinzolamide|mesh-list
55882115|NCT04523844|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55882176|NCT05672680|Bupivacaine|bupivacaine|mesh-list
55882177|NCT05672680|Anesthetics, Local|anesthetics, local|mesh-ancestor
55882178|NCT05672680|Anesthetics|anesthetics|mesh-ancestor
55882184|NCT05672524|Tucatinib|tucatinib|mesh-list
55882249|NCT03368274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55882251|NCT02247544|Trabectedin|trabectedin|mesh-list
55882322|NCT03361098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882395|NCT05561764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882396|NCT05561764|Protease Inhibitors|protease inhibitors|mesh-ancestor
55882397|NCT05561764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882398|NCT05561764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882399|NCT05561764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55882401|NCT04119180|Ketamine|ketamine|mesh-list
55882402|NCT04119180|Analgesics|analgesics|mesh-ancestor
55882409|NCT04119180|Anesthetics|anesthetics|mesh-ancestor
55882465|NCT03357900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882466|NCT04525326|Bevacizumab|bevacizumab|mesh-list
55882467|NCT04525326|Cetuximab|cetuximab|mesh-list
55882469|NCT04525326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55882539|NCT03359070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882540|NCT03359070|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55882608|NCT03365466|Heparin|heparin|mesh-list
55882609|NCT03365466|Calcium heparin|calcium heparin|mesh-list
55882685|NCT04509102|Adderall|adderall|mesh-list
55882761|NCT03364530|Oxaliplatin|oxaliplatin|mesh-list
55882762|NCT03364530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55882836|NCT03355716|Bupivacaine|bupivacaine|mesh-list
55882911|NCT01626664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55882912|NCT01626664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882913|NCT01626664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55882921|NCT04515966|Lidocaine|lidocaine|mesh-list
55882983|NCT02230696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55882984|NCT02230696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55882985|NCT02230696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55882986|NCT02230696|Respiratory System Agents|respiratory system agents|mesh-ancestor
55882987|NCT02230696|Dermatologic Agents|dermatologic agents|mesh-ancestor
55882988|NCT02230696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55882989|NCT02230696|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
55882990|NCT02230696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55882991|NCT02230696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55882992|NCT02230696|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55882993|NCT02230696|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55882994|NCT02230696|Histamine Antagonists|histamine antagonists|mesh-ancestor
55882995|NCT02230696|Histamine Agents|histamine agents|mesh-ancestor
55882996|NCT02230696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55882997|NCT03355014|Metformin|metformin|mesh-list
55882998|NCT03355014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55882999|NCT03355014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883000|NCT02231086|Leucovorin|leucovorin|mesh-list
55883001|NCT02231086|Fluorouracil|fluorouracil|mesh-list
55883002|NCT02231086|Capecitabine|capecitabine|mesh-list
55883003|NCT02231086|Oxaliplatin|oxaliplatin|mesh-list
55883004|NCT02231086|Antimetabolites|antimetabolites|mesh-ancestor
55883005|NCT02231086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883006|NCT02231086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55883007|NCT02231086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883009|NCT02231086|Immunologic Factors|immunologic factors|mesh-ancestor
55883033|NCT02509546|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55883034|NCT02509546|Purinergic Agonists|purinergic agonists|mesh-ancestor
55883035|NCT02509546|Purinergic Agents|purinergic agents|mesh-ancestor
55883107|NCT01638052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883108|NCT01638052|Sensory System Agents|sensory system agents|mesh-ancestor
55883109|NCT01638052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883181|NCT03352362|Antipyretics|antipyretics|mesh-ancestor
55883182|NCT01598740|Spironolactone|spironolactone|mesh-list
55883183|NCT01598740|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55883253|NCT05585346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55883254|NCT05585346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55883255|NCT05585346|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55883325|NCT05584644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55883397|NCT02378298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55883398|NCT02378298|Dermatologic Agents|dermatologic agents|mesh-ancestor
55883409|NCT02378298|Hormones|hormones|mesh-ancestor
55883471|NCT01691326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883472|NCT01606852|Dexmedetomidine|dexmedetomidine|mesh-list
55883473|NCT01606852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55883477|NCT01606852|Analgesics|analgesics|mesh-ancestor
55883542|NCT01650298|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55883543|NCT01650298|Protease Inhibitors|protease inhibitors|mesh-ancestor
55883544|NCT01650298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883547|NCT05583006|Tenofovir|tenofovir|mesh-list
55883612|NCT03923556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883613|NCT03923556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55883614|NCT03923556|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55883688|NCT03347370|Antiviral Agents|antiviral agents|mesh-ancestor
55883689|NCT03347370|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55883690|NCT03347370|Immunologic Factors|immunologic factors|mesh-ancestor
55883759|NCT01609348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55883760|NCT01609348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55883761|NCT01609348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55883763|NCT01609348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55883831|NCT02506842|Micronutrients|micronutrients|mesh-ancestor
55883832|NCT02506842|Hematinics|hematinics|mesh-ancestor
55883904|NCT02506140|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55883905|NCT02506140|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55883906|NCT02506140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55883907|NCT02506140|Antipyretics|antipyretics|mesh-ancestor
55883976|NCT01653418|Antimetabolites|antimetabolites|mesh-ancestor
55883985|NCT02514642|Clopidogrel|clopidogrel|mesh-list
55884051|NCT02510976|Laxatives|laxatives|mesh-ancestor
55884125|NCT01660672|Nootropic Agents|nootropic agents|mesh-ancestor
55884126|NCT02505048|Rucaparib|rucaparib|mesh-list
55884127|NCT02505048|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55884128|NCT02505048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752061|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884129|NCT02505048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884130|NCT02505048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884198|NCT02501616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55884199|NCT02501616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884200|NCT02501616|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55884202|NCT01788215|Doxycycline|doxycycline|mesh-list
55884268|NCT02509104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55884269|NCT02500680|Vaccines|vaccines|mesh-list
55884340|NCT02499978|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55884341|NCT02499978|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55884342|NCT02499978|Antiviral Agents|antiviral agents|mesh-ancestor
55884413|NCT01622296|Epinephrine|epinephrine|mesh-list
55884414|NCT01622296|Anesthetics, Local|anesthetics, local|mesh-list
55884415|NCT01622296|Anesthetics|anesthetics|mesh-list
55884416|NCT01622296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884434|NCT01622296|Mydriatics|mydriatics|mesh-ancestor
55884484|NCT02234752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55884485|NCT02234752|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55884486|NCT02234752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884487|NCT02234752|Cholinergic Agents|cholinergic agents|mesh-ancestor
55884488|NCT02234752|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55884489|NCT02234752|Autonomic Agents|autonomic agents|mesh-ancestor
55884490|NCT02234752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55884491|NCT02234752|Nootropic Agents|nootropic agents|mesh-ancestor
55884493|NCT01665508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55884494|NCT01665508|Vasodilator Agents|vasodilator agents|mesh-ancestor
55884495|NCT01665508|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55884496|NCT01665508|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55884497|NCT01665508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55884547|NCT02502708|Alkylating Agents|alkylating agents|mesh-ancestor
55884548|NCT02502708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884549|NCT02502708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55884550|NCT02502708|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55884551|NCT02502708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55884552|NCT02502708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55884553|NCT02502708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55884554|NCT02502708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884555|NCT02502708|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55884614|NCT02495922|Autonomic Agents|autonomic agents|mesh-ancestor
55884690|NCT01680172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884691|NCT01680172|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55884762|NCT00708162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55884763|NCT00708162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55884764|NCT00708162|Antiviral Agents|antiviral agents|mesh-ancestor
55884765|NCT00708162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55884766|NCT00708162|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55884767|NCT00708162|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55884768|NCT00708162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55884770|NCT04930042|Ustekinumab|ustekinumab|mesh-list
55884829|NCT01690000|Antioxidants|antioxidants|mesh-ancestor
55884830|NCT01690000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884831|NCT01690000|Protective Agents|protective agents|mesh-ancestor
55884832|NCT01690000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884833|NCT01690000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884834|NCT02495220|Dexmedetomidine|dexmedetomidine|mesh-list
55884835|NCT02495220|Bupivacaine|bupivacaine|mesh-list
55884836|NCT02495220|Anesthetics, Local|anesthetics, local|mesh-ancestor
55884837|NCT02495220|Anesthetics|anesthetics|mesh-ancestor
55884838|NCT02495220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884844|NCT02495220|Analgesics|analgesics|mesh-ancestor
55884893|NCT03336840|Dermatologic Agents|dermatologic agents|mesh-ancestor
55884894|NCT03336840|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55884895|NCT03336840|Histamine Antagonists|histamine antagonists|mesh-ancestor
55884897|NCT03336840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55884898|NCT03336840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884899|NCT03336840|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55884904|NCT03336840|Anesthetics|anesthetics|mesh-ancestor
55884963|NCT02497326|Anticoagulants|anticoagulants|mesh-ancestor
55884964|NCT02497326|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55884965|NCT02497326|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55884966|NCT02497326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55884967|NCT02497326|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55884968|NCT02497326|Narcotics|narcotics|mesh-ancestor
55884969|NCT02497326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55884970|NCT02497326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55884971|NCT02497326|Analgesics|analgesics|mesh-ancestor
55885027|NCT03340662|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55885028|NCT03340662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55885097|NCT01712230|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55885098|NCT01712230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885099|NCT01712230|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55885101|NCT03335436|Gabapentin|gabapentin|mesh-list
55885102|NCT03335436|Analgesics|analgesics|mesh-ancestor
55885103|NCT03335436|Sensory System Agents|sensory system agents|mesh-ancestor
55885104|NCT03335436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885162|NCT04494828|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55885163|NCT04494828|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55885164|NCT04494828|Adrenergic Agents|adrenergic agents|mesh-ancestor
55885165|NCT04494828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885166|NCT04494828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885167|NCT01714336|Tranexamic Acid|tranexamic acid|mesh-list
55885168|NCT01714336|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55885169|NCT01714336|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55885170|NCT01714336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885229|NCT03339804|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55885230|NCT03339804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885231|NCT02248636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
55885232|NCT02248636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885233|NCT02248636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885234|NCT02248636|Cholinergic Agents|cholinergic agents|mesh-ancestor
55885235|NCT02248636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885236|NCT02248636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885238|NCT02491320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885239|NCT02491320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55885240|NCT02491320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55885241|NCT02491320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885247|NCT02491242|Dolutegravir|dolutegravir|mesh-list
55885291|NCT02492412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885292|NCT02492412|Dermatologic Agents|dermatologic agents|mesh-ancestor
55885293|NCT02492412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55885294|NCT02492412|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55886706|NCT02256358|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55885295|NCT03329898|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55885296|NCT03329898|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55885298|NCT03329898|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55885299|NCT03329898|Dydrogesterone|dydrogesterone|mesh-list
55885357|NCT03858322|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55885358|NCT02493582|Apatinib|apatinib|mesh-list
55885359|NCT02493582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885360|NCT02493582|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55885361|NCT02493582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885362|NCT02493582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885363|NCT05560360|Efavirenz|efavirenz|mesh-list
55885364|NCT05560360|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55885365|NCT05560360|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55885423|NCT03328494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55885424|NCT03328494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885425|NCT03328494|Tubulin Modulators|tubulin modulators|mesh-ancestor
55885426|NCT03328494|Antimitotic Agents|antimitotic agents|mesh-ancestor
55885427|NCT03328494|Mitosis Modulators|mitosis modulators|mesh-ancestor
55885428|NCT03328494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885429|NCT02491398|Rituximab|rituximab|mesh-list
55885430|NCT02491398|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55885431|NCT02491398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55885439|NCT03333018|Bromides|bromides|mesh-list
55885487|NCT02242630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885488|NCT02242630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885489|NCT02242630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55885559|NCT03327168|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55885560|NCT03327168|Purinergic Agonists|purinergic agonists|mesh-ancestor
55885561|NCT03327168|Purinergic Agents|purinergic agents|mesh-ancestor
55885562|NCT03327168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55885563|NCT03327168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885566|NCT01726738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885567|NCT01726738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55885570|NCT02492178|Artesunate|artesunate|mesh-list
55885628|NCT03469492|Insulin|insulin|mesh-list
55885629|NCT03469492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55885630|NCT03469492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885631|NCT03331770|Latanoprost|latanoprost|mesh-list
55885632|NCT03331770|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55885697|NCT01808651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885698|NCT01808651|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55885699|NCT01808651|Antidepressive Agents|antidepressive agents|mesh-ancestor
55885700|NCT01808651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55885701|NCT01808651|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55885702|NCT01808651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55885703|NCT01808651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885704|NCT02488590|Bronchodilator Agents|bronchodilator agents|mesh-list
55885706|NCT02488590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55885707|NCT02488590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55885708|NCT02488590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55885709|NCT02488590|Respiratory System Agents|respiratory system agents|mesh-ancestor
55885757|NCT03109314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885762|NCT04566016|Anesthetics|anesthetics|mesh-list
55885827|NCT05315128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55885828|NCT03322488|Metronidazole|metronidazole|mesh-list
55885829|NCT03322488|Doxycycline|doxycycline|mesh-list
55885830|NCT03322488|Ciprofloxacin|ciprofloxacin|mesh-list
55885831|NCT03322488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885832|NCT03322488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55885833|NCT03322488|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55885834|NCT03322488|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55885835|NCT03322488|Antimalarials|antimalarials|mesh-ancestor
55885836|NCT03322488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55885837|NCT03322488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55885838|NCT03322488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885839|NCT03322488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55885840|NCT03322488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885841|NCT03322488|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55885842|NCT03322488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55885843|NCT01808573|Capecitabine|capecitabine|mesh-list
55885844|NCT01808573|Lapatinib|lapatinib|mesh-list
55885884|NCT02990962|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55885885|NCT02990962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55885886|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
55885888|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885957|NCT03833362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55885958|NCT03833362|Antiviral Agents|antiviral agents|mesh-ancestor
55885959|NCT03833362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55885960|NCT03833362|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55885961|NCT03833362|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55885962|NCT03833362|Protease Inhibitors|protease inhibitors|mesh-ancestor
55885963|NCT03833362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55885964|NCT03833362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886024|NCT02727660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886025|NCT02727660|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55886026|NCT02727660|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55886027|NCT02727660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55886028|NCT02727660|Adrenergic Agents|adrenergic agents|mesh-ancestor
55886029|NCT02727660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886030|NCT02727660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886031|NCT02490072|Dexmedetomidine|dexmedetomidine|mesh-list
55886032|NCT02490072|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55886033|NCT02490072|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886034|NCT02490072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886084|NCT03318744|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55886159|NCT05093140|Cyclophosphamide|cyclophosphamide|mesh-list
55886160|NCT05093140|Vincristine|vincristine|mesh-list
55886161|NCT05093140|Doxorubicin|doxorubicin|mesh-list
55886162|NCT05093140|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55886163|NCT05093140|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55886164|NCT05093140|Immunologic Factors|immunologic factors|mesh-ancestor
55886165|NCT05093140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886166|NCT05093140|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55886167|NCT05093140|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55886225|NCT03320928|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55886226|NCT03320928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886227|NCT03320928|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55886228|NCT03320928|Antimetabolites|antimetabolites|mesh-ancestor
55886297|NCT03315000|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55886298|NCT03315000|Autonomic Agents|autonomic agents|mesh-ancestor
55886370|NCT01808326|Chlorambucil|chlorambucil|mesh-list
55886371|NCT01808326|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55886372|NCT01808326|Alkylating Agents|alkylating agents|mesh-ancestor
55886373|NCT01808326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886374|NCT01808326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886375|NCT03317730|Oxycodone|oxycodone|mesh-list
55886376|NCT03317730|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55886377|NCT03317730|Narcotics|narcotics|mesh-ancestor
55886436|NCT03317574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886437|NCT01810666|Factor VIII|factor viii|mesh-list
55886438|NCT01810666|Coagulants|coagulants|mesh-ancestor
55886439|NCT02482272|Lamivudine|lamivudine|mesh-list
55886440|NCT02482272|Adefovir|adefovir|mesh-list
55886441|NCT02482272|Entecavir|entecavir|mesh-list
55886442|NCT02482272|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55886443|NCT02482272|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55886444|NCT02482272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886446|NCT02482272|Antiviral Agents|antiviral agents|mesh-ancestor
55886503|NCT02725866|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55886504|NCT02725866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55886505|NCT02725866|Antimetabolites|antimetabolites|mesh-ancestor
55886506|NCT02481726|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55886507|NCT02481726|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55886508|NCT02481726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886509|NCT03314298|Methyltestosterone|methyltestosterone|mesh-list
55886510|NCT03314298|Anastrozole|anastrozole|mesh-list
55886511|NCT03314298|Testosterone|testosterone|mesh-list
55886515|NCT03314298|Androgens|androgens|mesh-ancestor
55886569|NCT02479074|Hormones|hormones|mesh-ancestor
55886570|NCT02479074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55886571|NCT02479074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886572|NCT02479074|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886573|NCT02479074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886574|NCT02479074|Antiemetics|antiemetics|mesh-ancestor
55886575|NCT02479074|Autonomic Agents|autonomic agents|mesh-ancestor
55886636|NCT03316482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886637|NCT03316482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55886638|NCT03316482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55886642|NCT01772758|Antioxidants|antioxidants|mesh-list
55886779|NCT01827358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55886780|NCT01827358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55886781|NCT01827358|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55886782|NCT01827358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55886783|NCT01827358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886784|NCT01780324|Lidocaine|lidocaine|mesh-list
55886785|NCT01780324|Anesthetics, Local|anesthetics, local|mesh-ancestor
55886786|NCT01780324|Anesthetics|anesthetics|mesh-ancestor
55886787|NCT01780324|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55886788|NCT01780324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886843|NCT02477514|Anesthetics|anesthetics|mesh-ancestor
55886844|NCT02477514|GABA Modulators|gaba modulators|mesh-ancestor
55886845|NCT02477514|GABA Agents|gaba agents|mesh-ancestor
55886846|NCT02477514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886847|NCT02477514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886848|NCT02477514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55886849|NCT02477514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55886850|NCT02477514|Antimetabolites|antimetabolites|mesh-ancestor
55886851|NCT02477514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55886907|NCT01782898|Adrenergic Agents|adrenergic agents|mesh-ancestor
55886908|NCT01782898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55886909|NCT01782898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55886910|NCT01782898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886911|NCT02475876|Clindamycin|clindamycin|mesh-list
55886912|NCT02475876|Clindamycin palmitate|clindamycin palmitate|mesh-list
55886913|NCT02475876|Clindamycin phosphate|clindamycin phosphate|mesh-list
55886915|NCT02475876|Trimethoprim|trimethoprim|mesh-list
55886973|NCT02471820|Doxorubicin|doxorubicin|mesh-list
55886974|NCT02471820|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55886975|NCT02471820|BB 1101|bb 1101|mesh-list
55886976|NCT02471820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55886977|NCT02471820|Antiemetics|antiemetics|mesh-ancestor
55886978|NCT02471820|Autonomic Agents|autonomic agents|mesh-ancestor
55886979|NCT02471820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55886980|NCT02471820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55886981|NCT02471820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55886982|NCT02471820|Glucocorticoids|glucocorticoids|mesh-ancestor
55887037|NCT01783990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887038|NCT01783990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887039|NCT01783990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55887040|NCT01833988|Pancrelipase|pancrelipase|mesh-list
55887041|NCT01833988|Pancreatin|pancreatin|mesh-list
55887042|NCT01833988|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55887043|NCT05363436|Oxycodone|oxycodone|mesh-list
55887044|NCT05363436|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55887045|NCT05363436|Narcotics|narcotics|mesh-ancestor
55887048|NCT05363436|Analgesics|analgesics|mesh-ancestor
55887102|NCT02470026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887103|NCT02470026|Urological Agents|urological agents|mesh-ancestor
55887104|NCT01840072|Antihypertensive Agents|antihypertensive agents|mesh-list
55887106|NCT01807949|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55887107|NCT01807949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887108|NCT01807949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887109|NCT02989558|Aspirin|aspirin|mesh-list
55887110|NCT02989558|Clopidogrel|clopidogrel|mesh-list
55887111|NCT02989558|Ticagrelor|ticagrelor|mesh-list
55887112|NCT02989558|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55887113|NCT02989558|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55887166|NCT01878604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887167|NCT01878604|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55887168|NCT02266810|Mometasone Furoate|mometasone furoate|mesh-list
55887169|NCT02266810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55887170|NCT02266810|Dermatologic Agents|dermatologic agents|mesh-ancestor
55887171|NCT02266810|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55887172|NCT01806623|Fluconazole|fluconazole|mesh-list
55887173|NCT01806623|Antifungal Agents|antifungal agents|mesh-ancestor
55796169|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
55887174|NCT01806623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887175|NCT01806623|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55887176|NCT01806623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55887177|NCT01806623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887179|NCT01806623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55887225|NCT03099564|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55752765|NCT03204097|Alendronate|alendronate|mesh-list
55887295|NCT01855360|Doxycycline|doxycycline|mesh-list
55887296|NCT01855360|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
55888078|NCT02466828|Hematinics|hematinics|mesh-ancestor
55887370|NCT01857232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55887443|NCT00705432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887444|NCT00704964|Ribavirin|ribavirin|mesh-list
55887445|NCT00704964|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55887446|NCT00704964|Interferon-alpha|interferon-alpha|mesh-list
55887447|NCT00704964|Antimetabolites|antimetabolites|mesh-ancestor
55887448|NCT00704964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887449|NCT00704964|Antiviral Agents|antiviral agents|mesh-ancestor
55887450|NCT00704964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55887451|NCT00704964|Immunologic Factors|immunologic factors|mesh-ancestor
55887511|NCT02470650|Abacavir|abacavir|mesh-list
55887512|NCT02470650|Cobicistat|cobicistat|mesh-list
55887513|NCT02470650|Rilpivirine|rilpivirine|mesh-list
55887514|NCT02470650|Elvitegravir|elvitegravir|mesh-list
55887583|NCT02047578|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55887584|NCT04837066|Imidacloprid|imidacloprid|mesh-list
55887585|NCT04837066|Cholinergic Agents|cholinergic agents|mesh-ancestor
55887586|NCT04837066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55887587|NCT04837066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887588|NCT04837066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887589|NCT04807894|Testosterone|testosterone|mesh-list
55887590|NCT04807894|Androgens|androgens|mesh-ancestor
55887591|NCT04807894|Hormones|hormones|mesh-ancestor
55887593|NCT04807894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887656|NCT00552058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55887657|NCT00552058|Immunologic Factors|immunologic factors|mesh-ancestor
55887658|NCT00552058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887659|NCT00552058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55887660|NCT02473302|Tocopherols|tocopherols|mesh-list
55887662|NCT02473302|Tocotrienols|tocotrienols|mesh-list
55887663|NCT02473302|alpha-Tocopherol|alpha-tocopherol|mesh-list
55887664|NCT02473302|Antioxidants|antioxidants|mesh-ancestor
55887665|NCT02473302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887668|NCT02473302|Vitamins|vitamins|mesh-ancestor
55887794|NCT05353192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55887795|NCT05353192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887796|NCT03310242|Vitamin D|vitamin d|mesh-list
55887797|NCT03310242|Vitamins|vitamins|mesh-ancestor
55887798|NCT03310242|Micronutrients|micronutrients|mesh-ancestor
55887799|NCT03310242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55887800|NCT03310242|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55887801|NCT00557128|Lisinopril|lisinopril|mesh-list
55887802|NCT00557128|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55887803|NCT00557128|Protease Inhibitors|protease inhibitors|mesh-ancestor
55887804|NCT00557128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55887805|NCT00557128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887806|NCT00557128|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55887853|NCT00557440|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55887854|NCT00557440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55887855|NCT00557440|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55887926|NCT04491474|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55887927|NCT04491474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55887928|NCT04491474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55887929|NCT04491474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887930|NCT04491474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887931|NCT03308682|(177)Lu-DOTA-EB-TATE|(177)lu-dota-eb-tate|mesh-list
55887932|NCT03308682|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55887933|NCT03308682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55887992|NCT03308136|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55887993|NCT03308136|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55887994|NCT03308136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888064|NCT03302208|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55888065|NCT03302208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55888066|NCT03302208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888067|NCT03302208|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55888068|NCT03302208|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55888069|NCT03302208|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55888070|NCT03302208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55888071|NCT03302208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55888073|NCT03307512|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55888074|NCT03307512|Insulin Lispro|insulin lispro|mesh-list
55888075|NCT03307512|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55888076|NCT03307512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888077|NCT02466828|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55888079|NCT02466828|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55888080|NCT02466828|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55888084|NCT00553462|Paclitaxel|paclitaxel|mesh-list
55888122|NCT05726916|Immunologic Factors|immunologic factors|mesh-ancestor
55888124|NCT00553150|Everolimus|everolimus|mesh-list
55888196|NCT05722704|Dermatologic Agents|dermatologic agents|mesh-ancestor
55888198|NCT02722278|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55888199|NCT02722278|Testosterone|testosterone|mesh-list
55888200|NCT02722278|Testosterone undecanoate|testosterone undecanoate|mesh-list
55888201|NCT02722278|Testosterone enanthate|testosterone enanthate|mesh-list
55888202|NCT02722278|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55888203|NCT02722278|Androgens|androgens|mesh-ancestor
55888204|NCT02722278|Hormones|hormones|mesh-ancestor
55888205|NCT02722278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888206|NCT02722278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888207|NCT02722278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55888257|NCT02467686|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55888260|NCT02467686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888330|NCT04060108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888331|NCT04060108|Adrenergic Agents|adrenergic agents|mesh-ancestor
55888332|NCT04060108|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55888333|NCT04060108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55888399|NCT05456256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55888400|NCT05456256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55888402|NCT02720484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55888403|NCT02720484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55888404|NCT02720484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55888405|NCT02720484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888468|NCT02466438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888469|NCT05587062|Aflibercept|aflibercept|mesh-list
55888470|NCT05587062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55888471|NCT05587062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55888472|NCT05587062|Growth Substances|growth substances|mesh-ancestor
55888473|NCT05587062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888535|NCT02465814|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55888616|NCT02256696|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55888617|NCT02256696|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55888618|NCT02256696|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55888619|NCT02256696|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55888620|NCT02256696|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55888622|NCT02256696|Antimetabolites|antimetabolites|mesh-ancestor
55888623|NCT02256696|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55888624|NCT04936230|Atezolizumab|atezolizumab|mesh-list
55888685|NCT01777997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55888686|NCT01777997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888687|NCT01777997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888691|NCT01770353|Hematinics|hematinics|mesh-ancestor
55888753|NCT01886872|Immunoglobulins|immunoglobulins|mesh-list
55888754|NCT01886872|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55888755|NCT01886872|Immunologic Factors|immunologic factors|mesh-ancestor
55888756|NCT01886872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55888827|NCT03028311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888901|NCT01775189|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55888902|NCT01775189|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55888903|NCT04551963|Clarithromycin|clarithromycin|mesh-list
55888904|NCT04551963|Fluconazole|fluconazole|mesh-list
55888905|NCT04551963|Voriconazole|voriconazole|mesh-list
55888906|NCT04551963|Zanubrutinib|zanubrutinib|mesh-list
55888907|NCT04551963|Diltiazem|diltiazem|mesh-list
55888908|NCT04551963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55888909|NCT04551963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55888910|NCT04551963|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55888911|NCT04551963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55888912|NCT04551963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55888913|NCT04551963|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55888914|NCT04551963|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55888915|NCT04551963|Antifungal Agents|antifungal agents|mesh-ancestor
55888916|NCT04551963|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55888917|NCT04551963|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55888918|NCT04551963|Hormone Antagonists|hormone antagonists|mesh-ancestor
55888919|NCT04551963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888956|NCT03832816|Hormones|hormones|mesh-ancestor
55888957|NCT03832816|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55888958|NCT04231084|Epoprostenol|epoprostenol|mesh-list
55888959|NCT04231084|Nitric Oxide|nitric oxide|mesh-list
55888960|NCT04231084|Vasodilator Agents|vasodilator agents|mesh-list
55888961|NCT04231084|Tezosentan|tezosentan|mesh-list
55888962|NCT04231084|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55888963|NCT04231084|Autonomic Agents|autonomic agents|mesh-ancestor
55888964|NCT04231084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55888965|NCT04231084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889022|NCT03945448|Amphotericin B|amphotericin b|mesh-list
55889023|NCT03945448|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55889024|NCT03945448|Antifungal Agents|antifungal agents|mesh-ancestor
55889025|NCT03945448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889026|NCT03945448|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55889027|NCT03945448|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55889028|NCT03945448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889029|NCT03945448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889030|NCT03945448|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55889031|NCT03945448|Hormone Antagonists|hormone antagonists|mesh-ancestor
55889082|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889084|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
55889085|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889155|NCT04121091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889156|NCT04121091|Protective Agents|protective agents|mesh-ancestor
55889228|NCT01897792|Ascorbic Acid|ascorbic acid|mesh-list
55889229|NCT01897792|Vitamin E|vitamin e|mesh-list
55889230|NCT01897792|Tocopherols|tocopherols|mesh-list
55889231|NCT01897792|Tocotrienols|tocotrienols|mesh-list
55889232|NCT01897792|alpha-Tocopherol|alpha-tocopherol|mesh-list
55889233|NCT01897792|Micronutrients|micronutrients|mesh-ancestor
55889234|NCT01897792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889235|NCT01897792|Antioxidants|antioxidants|mesh-ancestor
55889236|NCT01897792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889237|NCT01897792|Protective Agents|protective agents|mesh-ancestor
55889238|NCT01933984|Fluticasone|fluticasone|mesh-list
55889239|NCT01933984|Fenoterol|fenoterol|mesh-list
55889240|NCT01933984|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55889241|NCT01933984|Bronchodilator Agents|bronchodilator agents|mesh-list
55889293|NCT01937026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889294|NCT01937026|Renal Agents|renal agents|mesh-ancestor
55889295|NCT03672292|Voriconazole|voriconazole|mesh-list
55889296|NCT03672292|Ibrexafungerp|ibrexafungerp|mesh-list
55889297|NCT03672292|Antifungal Agents|antifungal agents|mesh-ancestor
55889298|NCT03672292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889299|NCT03672292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55889300|NCT03672292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55889301|NCT03672292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889302|NCT03672292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889303|NCT03672292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55889355|NCT01902004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889357|NCT01902004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889358|NCT01902004|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55889359|NCT01902004|Antidepressive Agents|antidepressive agents|mesh-ancestor
55889360|NCT01902004|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55889361|NCT01902004|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55889362|NCT01902004|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55889363|NCT01902004|Dopamine Agents|dopamine agents|mesh-ancestor
55889364|NCT01902004|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55889365|NCT01902004|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55889366|NCT01938040|Ibuprofen|ibuprofen|mesh-list
55889367|NCT01938040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55889368|NCT01938040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55889369|NCT01938040|Analgesics|analgesics|mesh-ancestor
55889370|NCT01938040|Sensory System Agents|sensory system agents|mesh-ancestor
55889371|NCT01938040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889372|NCT01938040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889412|NCT02284126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889414|NCT03004833|Doxorubicin|doxorubicin|mesh-list
55889415|NCT03004833|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55889416|NCT03004833|Dacarbazine|dacarbazine|mesh-list
55889417|NCT03004833|Vinblastine|vinblastine|mesh-list
55889418|NCT03004833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55889419|NCT03004833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889420|NCT03004833|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55889422|NCT03004833|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55889479|NCT04124913|Dydrogesterone|dydrogesterone|mesh-list
55889482|NCT04124913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889551|NCT03374800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889552|NCT02983773|Dronabinol|dronabinol|mesh-list
55889553|NCT02983773|Hallucinogens|hallucinogens|mesh-ancestor
55889554|NCT02983773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889555|NCT02983773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55889556|NCT02983773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55889557|NCT02983773|Analgesics|analgesics|mesh-ancestor
55889558|NCT02983773|Sensory System Agents|sensory system agents|mesh-ancestor
55889559|NCT02983773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889560|NCT02983773|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55889561|NCT02983773|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55889562|NCT02983773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55889563|NCT02983773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889564|NCT02983773|Hormones|hormones|mesh-ancestor
55889565|NCT02983773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889566|NCT01941628|Rocuronium|rocuronium|mesh-list
55889567|NCT01941628|Succinylcholine|succinylcholine|mesh-list
55889568|NCT01941628|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55889569|NCT01941628|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55889570|NCT01941628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55889574|NCT02987218|Propofol|propofol|mesh-list
55889606|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55889607|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55889608|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
55889609|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55889610|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889611|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889612|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889613|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889614|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
55889615|NCT01903798|Hormones|hormones|mesh-ancestor
55889616|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55889667|NCT02918721|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55889668|NCT02918721|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55889669|NCT02918721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889670|NCT02918721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55889671|NCT02918721|Immunologic Factors|immunologic factors|mesh-ancestor
55889673|NCT02918721|Protective Agents|protective agents|mesh-ancestor
55889736|NCT01597505|Vancomycin|vancomycin|mesh-list
55889737|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55889809|NCT05735626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55889810|NCT05735626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55889811|NCT05735626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55889812|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55889814|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55889815|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55889877|NCT01955434|Cyclophosphamide|cyclophosphamide|mesh-list
55889878|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55889879|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
55889949|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55889950|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55889951|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55889952|NCT01451229|Analgesics|analgesics|mesh-ancestor
55889953|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
55889954|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55889955|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55889956|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55889957|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55889958|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55889959|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55889960|NCT01451229|Protective Agents|protective agents|mesh-ancestor
55889961|NCT03054519|Metformin|metformin|mesh-list
55889962|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55889964|NCT01921894|Vitamin D|vitamin d|mesh-list
55890010|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890011|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890012|NCT01452477|Tanshinone|tanshinone|mesh-list
55890013|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890014|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55890015|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55890016|NCT01452477|Analgesics|analgesics|mesh-ancestor
55890078|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55890079|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890080|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
55890081|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
55890082|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
55890083|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890084|NCT02910531|Protective Agents|protective agents|mesh-ancestor
55890085|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890086|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
55890087|NCT02910531|Vitamins|vitamins|mesh-ancestor
55890088|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
55890089|NCT02947581|Albendazole|albendazole|mesh-list
55890142|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55890143|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55890144|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890145|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890146|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55890147|NCT04391361|Analgesics|analgesics|mesh-ancestor
55890148|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
55890149|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890150|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55890151|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55890206|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
55890207|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55890208|NCT02085447|Haloperidol|haloperidol|mesh-list
55890209|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55890210|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
55890211|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
55890212|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55890213|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890214|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890215|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55890271|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55890272|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
55890273|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890274|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890275|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55890276|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
55890277|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
55890278|NCT02836899|Protective Agents|protective agents|mesh-ancestor
55890279|NCT02902029|Atezolizumab|atezolizumab|mesh-list
55890280|NCT02902029|Vemurafenib|vemurafenib|mesh-list
55890281|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890285|NCT02933697|Apixaban|apixaban|mesh-list
55890338|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55890339|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55890340|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890341|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55890342|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55890343|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55890344|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55890345|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
55890346|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
55890383|NCT01455909|Exenatide|exenatide|mesh-list
55890401|NCT02415621|Hormone Antagonists|hormone antagonists|mesh-ancestor
55890402|NCT02415621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55890403|NCT02415621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890404|NCT02415621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55890405|NCT02555787|Tacrolimus|tacrolimus|mesh-list
55890406|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55890407|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
55890408|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890466|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
55890467|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
55890468|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
55890469|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
55890470|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55890471|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890472|NCT01457001|Vitamin D|vitamin d|mesh-list
55890473|NCT01457001|Vitamins|vitamins|mesh-list
55890474|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
55890534|NCT05021913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55890535|NCT05021913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55890536|NCT05021913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55890537|NCT05021913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890538|NCT05021913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55890540|NCT05021913|Viscosupplements|viscosupplements|mesh-ancestor
55890543|NCT05025423|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55890599|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890600|NCT01891227|Capecitabine|capecitabine|mesh-list
55890601|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55890602|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55890603|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
55753537|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55890604|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890605|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890606|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55890607|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
55890608|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
55890609|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55890610|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55890622|NCT04391439|Hormones|hormones|mesh-ancestor
55890659|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
55890660|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55890661|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55890662|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55890663|NCT02498613|Misonidazole|misonidazole|mesh-list
55890664|NCT02498613|Olaparib|olaparib|mesh-list
55890665|NCT02498613|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55890666|NCT02498613|Cediranib|cediranib|mesh-list
55890667|NCT02498613|Maleic acid|maleic acid|mesh-list
55890668|NCT02498613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890669|NCT02498613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890726|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55890727|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55890728|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55890729|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55890730|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890731|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55890732|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
55890733|NCT01459887|Hormones|hormones|mesh-ancestor
55890789|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
55890790|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55890791|NCT01893099|Sorafenib|sorafenib|mesh-list
55890792|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890793|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55890794|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55890795|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890796|NCT02327403|Abatacept|abatacept|mesh-list
55890797|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55890856|NCT02334735|Vaccines|vaccines|mesh-list
55890857|NCT02334735|Poly ICLC|poly iclc|mesh-list
55890858|NCT02334735|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55890859|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
55890860|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890861|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
55890862|NCT02334735|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55890863|NCT02329600|Triamcinolone|triamcinolone|mesh-list
55890864|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55890925|NCT01729559|Calcium heparin|calcium heparin|mesh-list
55890926|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
55890927|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
55890928|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55890929|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55890930|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55890931|NCT01926496|Imiquimod|imiquimod|mesh-list
55890932|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55890933|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
55890934|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55890935|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55890936|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
55890937|NCT01728779|Nelfinavir|nelfinavir|mesh-list
55890989|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55890990|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55890991|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55890993|NCT01728077|Brivaracetam|brivaracetam|mesh-list
55891061|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55891062|NCT02282319|Analgesics|analgesics|mesh-ancestor
55891063|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
55891064|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891065|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55891066|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55891067|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55891069|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55891070|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891071|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
55891072|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
55891073|NCT02772081|Poractant alfa|poractant alfa|mesh-list
55891127|NCT02757885|Fludarabine|fludarabine|mesh-list
55891128|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
55891129|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
55891130|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55891131|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
55891132|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55891133|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
55891134|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891135|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55891136|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55891137|NCT02757885|Alkylating Agents|alkylating agents|mesh-ancestor
55891138|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891139|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891140|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55891141|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55891142|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
55891186|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
55891259|NCT02219373|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55891260|NCT02219373|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55891261|NCT02219373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55891262|NCT02219373|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55891263|NCT02219373|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55891264|NCT02219373|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55891265|NCT02219373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55891266|NCT02219373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891267|NCT02219373|Antimanic Agents|antimanic agents|mesh-ancestor
55891269|NCT02219373|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55891344|NCT05586789|Antidepressive Agents|antidepressive agents|mesh-ancestor
55891345|NCT05586789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55891390|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891391|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891392|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55891393|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891394|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891395|NCT05439694|Tranexamic Acid|tranexamic acid|mesh-list
55891396|NCT05439694|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55891397|NCT05439694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55891454|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
55891455|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
55891456|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55891457|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55891458|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891459|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891460|NCT01726049|Urological Agents|urological agents|mesh-ancestor
55891461|NCT02162667|Trastuzumab|trastuzumab|mesh-list
55891462|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891517|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55891518|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55891519|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55891520|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55891521|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891522|NCT05633914|Paclitaxel|paclitaxel|mesh-list
55891523|NCT05633914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55891524|NCT05633914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891525|NCT05633914|Tubulin Modulators|tubulin modulators|mesh-ancestor
55891527|NCT05633914|Mitosis Modulators|mitosis modulators|mesh-ancestor
55891528|NCT05633914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891529|NCT05386030|Lidocaine|lidocaine|mesh-list
55891530|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
55891531|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
55891532|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55891533|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891592|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891599|NCT02156739|Edetic Acid|edetic acid|mesh-list
55891600|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
55891601|NCT02156739|Antidotes|antidotes|mesh-ancestor
55891671|NCT05319730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891672|NCT05319730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55891673|NCT05319730|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55891674|NCT05319730|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55891675|NCT05319730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55891676|NCT05319730|Immunologic Factors|immunologic factors|mesh-ancestor
55891677|NCT05319730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891678|NCT05319730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55891679|NCT02393157|Carboplatin|carboplatin|mesh-list
55891734|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55891735|NCT05022004|Brinzolamide|brinzolamide|mesh-list
55891807|NCT01724021|Prednisolone|prednisolone|mesh-list
55891808|NCT01724021|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55891809|NCT01724021|Methylprednisolone|methylprednisolone|mesh-list
55891810|NCT01724021|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55891811|NCT01724021|Prednisolone acetate|prednisolone acetate|mesh-list
55891812|NCT01724021|Cyclophosphamide|cyclophosphamide|mesh-list
55891813|NCT01724021|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55891814|NCT01724021|Rituximab|rituximab|mesh-list
55891815|NCT01724021|Vincristine|vincristine|mesh-list
55891816|NCT01724021|Doxorubicin|doxorubicin|mesh-list
55891817|NCT01724021|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55891818|NCT01724021|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55891875|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55891876|NCT05192200|Interferons|interferons|mesh-list
55891877|NCT05192200|Interferon-beta|interferon-beta|mesh-list
55891878|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891879|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
55891880|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55891881|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
55891882|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891887|NCT01722071|Oxytocin|oxytocin|mesh-list
55891888|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
55891889|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55891890|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891891|NCT04223752|Tazobactam|tazobactam|mesh-list
55891892|NCT04223752|Ceftolozane|ceftolozane|mesh-list
55891943|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55891944|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
55891945|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55891946|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55891947|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55891948|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
55891949|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55891950|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55891951|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55891952|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55891954|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
55892006|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892007|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892008|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892009|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
55892010|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55892011|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
55892012|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892013|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892014|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55892015|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
55892016|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
55892017|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55892018|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
55892069|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
55892070|NCT02292082|Midazolam|midazolam|mesh-list
55892071|NCT02292082|Morphine|morphine|mesh-list
55892072|NCT02292082|Bupivacaine|bupivacaine|mesh-list
55892144|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892145|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892146|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55892147|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892148|NCT04607122|Landiolol|landiolol|mesh-list
55892149|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55892150|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55892151|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
55892152|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892153|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892156|NCT03099382|Docetaxel|docetaxel|mesh-list
55892209|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892210|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892211|NCT02057133|Tamoxifen|tamoxifen|mesh-list
55892275|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55892276|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892277|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
55892278|NCT02042391|Hormones|hormones|mesh-ancestor
55892279|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892280|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55892281|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55892282|NCT02042391|Antimetabolites|antimetabolites|mesh-ancestor
55892283|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
55892284|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892285|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55892286|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55892287|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55892288|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892289|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55892291|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
55892334|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55892335|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892336|NCT02337634|Silymarin|silymarin|mesh-list
55892337|NCT02337634|Antioxidants|antioxidants|mesh-ancestor
55892338|NCT02337634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892339|NCT02337634|Protective Agents|protective agents|mesh-ancestor
55892340|NCT02337634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892341|NCT01908777|Cytarabine|cytarabine|mesh-list
55892342|NCT01908777|Etoposide|etoposide|mesh-list
55892343|NCT01908777|Melphalan|melphalan|mesh-list
55892344|NCT01908777|Carmustine|carmustine|mesh-list
55892345|NCT01908777|Romidepsin|romidepsin|mesh-list
55892346|NCT01908777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55892347|NCT01908777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892348|NCT01908777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55892349|NCT01908777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55892395|NCT01893567|Hormones|hormones|mesh-ancestor
55892396|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892397|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892398|NCT01485861|Prednisone|prednisone|mesh-list
55892399|NCT01485861|Prednisolone|prednisolone|mesh-list
55892400|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892401|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
55892402|NCT01485861|Hormones|hormones|mesh-ancestor
55892403|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892404|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892405|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55892406|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892407|NCT04847466|Pembrolizumab|pembrolizumab|mesh-list
55892409|NCT04847466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892455|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55892456|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55892457|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55892458|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55892459|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55892460|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55892461|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55892465|NCT02464722|Epinephrine|epinephrine|mesh-list
55892522|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892523|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892524|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55892526|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
55892527|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55892528|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892529|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55892530|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
55892531|NCT01873131|Timolol|timolol|mesh-list
55892532|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892533|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55892534|NCT01873131|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55892583|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55892584|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55892585|NCT02461368|Lidocaine|lidocaine|mesh-list
55892586|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55892587|NCT02461368|Anesthetics, Local|anesthetics, local|mesh-ancestor
55892588|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
55892589|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55892969|NCT00003270|Protective Agents|protective agents|mesh-ancestor
55892590|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892662|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
55892663|NCT03389620|Hormones|hormones|mesh-ancestor
55892664|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892665|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55892666|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892667|NCT02463942|Doxycycline|doxycycline|mesh-list
55892668|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55892669|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892670|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
55892671|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55892672|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55892673|NCT03298542|Golimumab|golimumab|mesh-list
55892674|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55892675|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892724|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55892725|NCT03296358|Dexamethasone|dexamethasone|mesh-list
55892726|NCT03296358|Prednisolone|prednisolone|mesh-list
55892727|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55892728|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
55892729|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
55892730|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55892731|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892732|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55892733|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
55892735|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892736|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55892737|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55892738|NCT04756323|Vaccines|vaccines|mesh-list
55892739|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
55892740|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892741|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
55892743|NCT00469755|Tazarotene|tazarotene|mesh-list
55892780|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55892782|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892783|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892784|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55892785|NCT01992874|Niacinamide|niacinamide|mesh-list
55892786|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
55892787|NCT01992874|Vitamins|vitamins|mesh-ancestor
55892847|NCT01994746|Hormones|hormones|mesh-ancestor
55892848|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892849|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55892850|NCT01994746|Incretins|incretins|mesh-ancestor
55892851|NCT04034238|Tofacitinib|tofacitinib|mesh-list
55892852|NCT04034238|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55892853|NCT04034238|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892854|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892855|NCT00291525|Warfarin|warfarin|mesh-list
55892856|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
55892857|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
55892858|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55892859|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892860|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892861|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55753979|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
55892862|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55892863|NCT01337349|Protective Agents|protective agents|mesh-ancestor
55892902|NCT01436968|Valacyclovir|valacyclovir|mesh-list
55892903|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
55892904|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55892905|NCT02462772|Cabotegravir|cabotegravir|mesh-list
55892906|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55892907|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55892908|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55892909|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55892910|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55892911|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55892912|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55892913|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55892914|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55892915|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55892964|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55892965|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
55892967|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55892968|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55893033|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55893034|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893035|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55893036|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55893037|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
55893038|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55893039|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893040|NCT03294798|Interferons|interferons|mesh-list
55893102|NCT02006056|Serotonin Agents|serotonin agents|mesh-ancestor
55893179|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55893180|NCT03289338|Prednisolone|prednisolone|mesh-list
55893185|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
55893330|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55893331|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
55893401|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55893402|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893403|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55893476|NCT03287076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55893477|NCT03287076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893478|NCT03287076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55893479|NCT03287076|Incretins|incretins|mesh-ancestor
55893578|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
55893649|NCT04389567|Histamine Antagonists|histamine antagonists|mesh-ancestor
55893650|NCT04389567|Histamine Agents|histamine agents|mesh-ancestor
55893723|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55893724|NCT01252719|Vancomycin|vancomycin|mesh-list
55893725|NCT01252719|Oritavancin|oritavancin|mesh-list
55893726|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55893797|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55893868|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55893869|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55893870|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55893871|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55893872|NCT02457312|Letrozole|letrozole|mesh-list
55893873|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55893874|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55893875|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55893876|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55893931|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55893932|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55893933|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
55893934|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55893935|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
55893937|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
55893938|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55893939|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55893940|NCT03268278|Narcotics|narcotics|mesh-ancestor
55893941|NCT03268278|Analgesics|analgesics|mesh-ancestor
55893942|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55893999|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55894000|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55894001|NCT02456844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894002|NCT02456844|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55894069|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55894070|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55894091|NCT03267654|Apatinib|apatinib|mesh-list
55894137|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55894138|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894139|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894283|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894284|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
55894285|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
55894286|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894287|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
55894353|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
55894354|NCT03265002|Cathartics|cathartics|mesh-ancestor
55894355|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55894370|NCT03257514|Vitamins|vitamins|mesh-ancestor
55894428|NCT03257124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894429|NCT03257124|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55894430|NCT03257124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55894431|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894432|NCT02089113|Dexamethasone|dexamethasone|mesh-list
55894433|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894434|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
55894435|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
55894436|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55894437|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894438|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55894439|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
55894441|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55894443|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55894484|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55894488|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
55894560|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
55894561|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55894635|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55894636|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55894708|NCT00907101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55894709|NCT03245970|Atenolol|atenolol|mesh-list
55894797|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
55894798|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55894870|NCT03250494|BB 1101|bb 1101|mesh-list
55894871|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55894872|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
55894944|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55895020|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55895022|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55895023|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
55895024|NCT03249402|Estradiol|estradiol|mesh-list
55895025|NCT03249402|Estrogens|estrogens|mesh-ancestor
55895026|NCT03249402|Hormones|hormones|mesh-ancestor
55895027|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55895084|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
55895087|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
55895230|NCT00734877|Thalidomide|thalidomide|mesh-list
55895231|NCT00734877|Dexamethasone|dexamethasone|mesh-list
55895232|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
55895385|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
55895456|NCT03238092|Estradiol|estradiol|mesh-list
55895457|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55895458|NCT03238092|Testosterone|testosterone|mesh-list
55895530|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55895602|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55895616|NCT03237546|Anesthetics|anesthetics|mesh-list
55895674|NCT00059475|Analgesics|analgesics|mesh-ancestor
55895675|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
55895679|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
55895750|NCT00061893|Vincristine|vincristine|mesh-list
55895751|NCT00061893|Vinblastine|vinblastine|mesh-list
55895752|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55895820|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895821|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55895822|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55895823|NCT01974700|Levetiracetam|levetiracetam|mesh-list
55895824|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
55895825|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
55895826|NCT04753203|Capecitabine|capecitabine|mesh-list
55895827|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55895828|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
55895831|NCT03236610|Tenofovir|tenofovir|mesh-list
55895962|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55895963|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55895964|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55896035|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
55896036|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
55896037|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55896108|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896109|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
55896110|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55896181|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55896256|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55896329|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55896400|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896401|NCT05003037|Carboplatin|carboplatin|mesh-list
55896402|NCT05003037|Pemetrexed|pemetrexed|mesh-list
55896403|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896404|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55896471|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
55896472|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896546|NCT00170157|Bicalutamide|bicalutamide|mesh-list
55896547|NCT00170157|Flutamide|flutamide|mesh-list
55896620|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896694|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
55896767|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896769|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55896839|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55896840|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55896841|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55896842|NCT02404168|Lamotrigine|lamotrigine|mesh-list
55896843|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
55896844|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55896845|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55896846|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55896847|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55896848|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55896849|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55896851|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896852|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55896853|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55896854|NCT04733937|Caseins|caseins|mesh-list
55896898|NCT02384200|Renal Agents|renal agents|mesh-ancestor
55896899|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
55896900|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55896901|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55896903|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
55896968|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
55896969|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
55896970|NCT04554485|Blinatumomab|blinatumomab|mesh-list
55896971|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55896972|NCT01741259|Meperidine|meperidine|mesh-list
55896973|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55896974|NCT01741259|Narcotics|narcotics|mesh-ancestor
55896975|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55896976|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897036|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55897037|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897038|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897107|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
55897108|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
55897109|NCT00094887|Protective Agents|protective agents|mesh-ancestor
55897110|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
55897111|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897113|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55897114|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55897115|NCT00097695|Analgesics|analgesics|mesh-ancestor
55897116|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
55897119|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897173|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55897174|NCT00198081|Analgesics|analgesics|mesh-ancestor
55897246|NCT03212352|Misoprostol|misoprostol|mesh-list
55897247|NCT03212352|Mifepristone|mifepristone|mesh-list
55897248|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55897317|NCT05545072|Immunologic Factors|immunologic factors|mesh-ancestor
55897318|NCT05545072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897390|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55897391|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55897392|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
55897393|NCT03209856|Vitamin D|vitamin d|mesh-list
55897394|NCT03209856|Calcitriol|calcitriol|mesh-list
55897395|NCT03209856|Vitamins|vitamins|mesh-ancestor
55897396|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
55897397|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897398|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55897404|NCT02413918|Iloperidone|iloperidone|mesh-list
55897456|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897457|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55897458|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55897459|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897460|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55897461|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55897462|NCT04943848|Iodine|iodine|mesh-list
55897526|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55897602|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55897603|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55897604|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
55897605|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55897606|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55897607|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55897608|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55897609|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
55897741|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55897742|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55897810|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55897811|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55897884|NCT03222960|Protective Agents|protective agents|mesh-ancestor
55897885|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55897886|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55897888|NCT05681260|Dexamethasone|dexamethasone|mesh-list
55897889|NCT05681260|Dexamethasone acetate|dexamethasone acetate|mesh-list
55897891|NCT05681260|Cyclophosphamide|cyclophosphamide|mesh-list
55897892|NCT05681260|Ifosfamide|ifosfamide|mesh-list
55897893|NCT05681260|Doxorubicin|doxorubicin|mesh-list
55897894|NCT05681260|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55897895|NCT05681260|Methotrexate|methotrexate|mesh-list
55897896|NCT05681260|Etoposide|etoposide|mesh-list
55897953|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55897954|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55898026|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
55898027|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55898028|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55898098|NCT05087914|Naproxen|naproxen|mesh-list
55898099|NCT05087914|Levodopa|levodopa|mesh-list
55898100|NCT05087914|Carbidopa|carbidopa|mesh-list
55898174|NCT02446002|Clonidine|clonidine|mesh-list
55898175|NCT02446002|Naltrexone|naltrexone|mesh-list
55898176|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55898177|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55898178|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898179|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
55898180|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898181|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55898182|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55898183|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55898184|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55898185|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
55898186|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898238|NCT04552223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55898239|NCT04552223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898240|NCT04552223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55898241|NCT04552223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898242|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55898306|NCT02450058|Paclitaxel|paclitaxel|mesh-list
55898307|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
55898308|NCT02450058|Fluorouracil|fluorouracil|mesh-list
55898309|NCT02450058|Epirubicin|epirubicin|mesh-list
55898310|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55898311|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898312|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
55898313|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
55898314|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
55898315|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898371|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898372|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898445|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55898446|NCT03193788|Hematinics|hematinics|mesh-ancestor
55898447|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
55898449|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55898450|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55898451|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
55898452|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898454|NCT00356824|Artesunate|artesunate|mesh-list
55898513|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
55898514|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55898515|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55898516|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55898517|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55898518|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55898519|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55898583|NCT03388788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55898584|NCT03388788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55898585|NCT03388788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898588|NCT03599518|Gefitinib|gefitinib|mesh-list
55898653|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898875|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
55898876|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55898877|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
55898952|NCT05625802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55898953|NCT05625802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55898955|NCT05625802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55898956|NCT03187548|Calcium|calcium|mesh-list
55898957|NCT03187548|Caseins|caseins|mesh-list
55898960|NCT03187548|Chelating Agents|chelating agents|mesh-ancestor
55899020|NCT01464268|Vitamins|vitamins|mesh-ancestor
55899021|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
55899022|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899098|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55899169|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899170|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55899171|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55899239|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55899314|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899315|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55899388|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55899389|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55899466|NCT02429700|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55899541|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55899543|NCT05279092|Anesthetics|anesthetics|mesh-ancestor
55899615|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55899616|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55899690|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55899691|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55899765|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
55899766|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55899839|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55899840|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
55899841|NCT00112827|Melphalan|melphalan|mesh-list
55899842|NCT00112827|Lenalidomide|lenalidomide|mesh-list
55899858|NCT04752111|Esmolol|esmolol|mesh-list
55899923|NCT04718116|Tramadol|tramadol|mesh-list
55899991|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55899992|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
55900064|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900065|NCT02433912|Acetaminophen|acetaminophen|mesh-list
55900066|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
55900067|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55900068|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55900069|NCT02433912|Analgesics|analgesics|mesh-ancestor
55900070|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
55900071|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900131|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900133|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
55900134|NCT00361114|Dapsone|dapsone|mesh-list
55900135|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55900136|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
55900137|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
55900138|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55900139|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55900201|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900202|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900203|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55900204|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
55900205|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
55900270|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55900271|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
55900272|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900273|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900274|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55900275|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55900276|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
55900277|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796272|NCT04964505|Azacitidine|azacitidine|mesh-list
55900278|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55900279|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
55900280|NCT02428062|Mydriatics|mydriatics|mesh-ancestor
55900281|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
55900282|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55900283|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
55900284|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55900288|NCT04594798|Prednisone|prednisone|mesh-list
55900340|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900415|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55900416|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55902002|NCT02405910|Antimetabolites|antimetabolites|mesh-ancestor
55900417|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55900418|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55900419|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55900420|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900485|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55900487|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900561|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900562|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900580|NCT01703741|Hormones|hormones|mesh-ancestor
55900632|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55900633|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
55900634|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55900635|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900637|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55900638|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55900639|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
55900640|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55900697|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55900699|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
55900701|NCT02424318|Topiramate|topiramate|mesh-list
55900770|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
55900771|NCT01702025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55900772|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55900843|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55900844|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
55900918|NCT01867606|Antibodies|antibodies|mesh-list
55900919|NCT01867606|Immunologic Factors|immunologic factors|mesh-ancestor
55900921|NCT02415192|Amlodipine|amlodipine|mesh-list
55900989|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
55900990|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55900991|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55900992|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55900993|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
55900994|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
55900995|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55900999|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
55901059|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901060|NCT03176628|Niacinamide|niacinamide|mesh-list
55901061|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
55901062|NCT03176628|Vitamins|vitamins|mesh-ancestor
55901131|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55901132|NCT01697969|Analgesics|analgesics|mesh-ancestor
55901133|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
55901152|NCT01697579|Ondansetron|ondansetron|mesh-list
55901203|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55901204|NCT01352962|Gemcitabine|gemcitabine|mesh-list
55901205|NCT01352962|Carboplatin|carboplatin|mesh-list
55901206|NCT01352962|Lenalidomide|lenalidomide|mesh-list
55901207|NCT01352962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901208|NCT01352962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55901209|NCT01352962|Antimetabolites|antimetabolites|mesh-ancestor
55901210|NCT01352962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901270|NCT00544414|Immunologic Factors|immunologic factors|mesh-ancestor
55901271|NCT00544414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55901493|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901494|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55901559|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
55901560|NCT02467504|Vitamins|vitamins|mesh-ancestor
55901561|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
55901633|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901635|NCT02440204|Sevoflurane|sevoflurane|mesh-list
55901637|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55901783|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55901784|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
55901785|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
55901786|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55901855|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
55901856|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
55901857|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
55901858|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55901924|NCT03174288|Spironolactone|spironolactone|mesh-list
55901925|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55901999|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
55902000|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55902001|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55902143|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55902145|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
55902218|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55902238|NCT04481802|Acemannan|acemannan|mesh-list
55755436|NCT05626101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842987|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
55798149|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55798169|NCT05530811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55798182|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55798238|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
55798239|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
55798240|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55798241|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798242|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798244|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798245|NCT04939675|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55798246|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55798248|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55798331|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
55798332|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798356|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55798357|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55798358|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55798359|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
55798360|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55798361|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798362|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798363|NCT03055741|Donepezil|donepezil|mesh-list
55798364|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55798365|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798381|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798382|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
55798383|NCT04935541|Remifentanil|remifentanil|mesh-list
55798388|NCT04935541|Analgesics|analgesics|mesh-ancestor
55798522|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
55798523|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798578|NCT02458287|Bococizumab|bococizumab|mesh-list
55798579|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55798584|NCT03056053|Zolpidem|zolpidem|mesh-list
55798626|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798628|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
55798629|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798630|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55798644|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55798645|NCT02495883|Vasodilator Agents|vasodilator agents|mesh-ancestor
55798646|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55798647|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798648|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798680|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55798681|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798682|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
55798683|NCT03054259|Autonomic Agents|autonomic agents|mesh-ancestor
55798684|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798685|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55798686|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
55798687|NCT03054259|Hormones|hormones|mesh-ancestor
55798688|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55798689|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55798699|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
55798707|NCT03053869|Lorazepam|lorazepam|mesh-list
55796442|NCT05535413|Antimetabolites|antimetabolites|mesh-ancestor
55798745|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
55798746|NCT04893733|Vitamins|vitamins|mesh-ancestor
55798747|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
55798750|NCT02493855|Ritonavir|ritonavir|mesh-list
55798760|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55798761|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55798762|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55798763|NCT02493855|Antimetabolites|antimetabolites|mesh-ancestor
55798767|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55798768|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798769|NCT04892563|Analgesics|analgesics|mesh-ancestor
55798770|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
55798786|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
55798787|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
55798788|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
55798873|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55798878|NCT04906915|Ketamine|ketamine|mesh-list
55798894|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55798895|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
55798896|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798897|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
55798898|NCT04900129|Diclofenac|diclofenac|mesh-list
55798899|NCT04900129|Salicylates|salicylates|mesh-list
55798900|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
55798934|NCT02616601|Fluorouracil|fluorouracil|mesh-list
55798935|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
55798954|NCT04393207|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55798955|NCT04393207|Prednisolone phosphate|prednisolone phosphate|mesh-list
55798956|NCT04393207|BB 1101|bb 1101|mesh-list
55798957|NCT04393207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55798958|NCT04393207|Antiemetics|antiemetics|mesh-ancestor
55798959|NCT04393207|Autonomic Agents|autonomic agents|mesh-ancestor
55798960|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55798961|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798963|NCT04393207|Glucocorticoids|glucocorticoids|mesh-ancestor
55799090|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799091|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
55799092|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
55799093|NCT04888663|Mitosis Modulators|mitosis modulators|mesh-ancestor
55799096|NCT02453685|Insulin|insulin|mesh-list
55799155|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55799157|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799158|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799159|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55799191|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
55799193|NCT04898725|Cholecalciferol|cholecalciferol|mesh-list
55799194|NCT04898725|Vitamins|vitamins|mesh-ancestor
55799195|NCT04898725|Micronutrients|micronutrients|mesh-ancestor
55799196|NCT04898725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799197|NCT04898725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55799198|NCT04898725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55799199|NCT04887961|Trabectedin|trabectedin|mesh-list
55799200|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55799224|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799225|NCT02435277|Metformin|metformin|mesh-list
55799226|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55799227|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799250|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799251|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55799264|NCT02419755|Bortezomib|bortezomib|mesh-list
55799265|NCT02419755|Asparaginase|asparaginase|mesh-list
55799266|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
55799267|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
55799268|NCT02419755|Vorinostat|vorinostat|mesh-list
55799269|NCT02419755|Pegaspargase|pegaspargase|mesh-list
55799270|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55799271|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
55799272|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
55799273|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799277|NCT02419755|Hormones|hormones|mesh-ancestor
55799307|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55799308|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799310|NCT04913025|Nivolumab|nivolumab|mesh-list
55799351|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55799352|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55799353|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
55799354|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55799355|NCT04897477|Azacitidine|azacitidine|mesh-list
55799356|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55799357|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55799407|NCT05529875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55799408|NCT05529875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55799409|NCT03051451|Metformin|metformin|mesh-list
55799410|NCT03051451|Fluoxetine|fluoxetine|mesh-list
55799427|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
55799428|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
55799429|NCT02869217|Fludarabine|fludarabine|mesh-list
55799430|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55799431|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
55799432|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799493|NCT05529095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799495|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55799496|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799497|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
55799498|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799499|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799500|NCT03051373|Gemcitabine|gemcitabine|mesh-list
55799501|NCT03051373|Paclitaxel|paclitaxel|mesh-list
55799585|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55799586|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
55799595|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799596|NCT04885075|Midazolam|midazolam|mesh-list
55799597|NCT04885075|Diazepam|diazepam|mesh-list
55799620|NCT01610687|Analgesics|analgesics|mesh-ancestor
55799621|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
55799622|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799627|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
55799628|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799629|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55799630|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
55799631|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
55799632|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
55799633|NCT04884919|Coagulants|coagulants|mesh-ancestor
55799641|NCT04129931|Immunologic Factors|immunologic factors|mesh-ancestor
55799642|NCT04129931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799643|NCT04878835|Ranibizumab|ranibizumab|mesh-list
55799644|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55799645|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55799646|NCT04878835|Growth Substances|growth substances|mesh-ancestor
55799665|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55799666|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55799668|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799722|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55799723|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
55799730|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
55799731|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799732|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799733|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55799734|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
55799736|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55799737|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55799798|NCT05533073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55799799|NCT05533073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55799800|NCT05533073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55799834|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55799860|NCT05526911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55799864|NCT05526911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55799898|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55799899|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55799918|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55799919|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
55799920|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55799924|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55799925|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799927|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
55799928|NCT05146739|Leucovorin|leucovorin|mesh-list
55799929|NCT05146739|Cytarabine|cytarabine|mesh-list
55799931|NCT05146739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55799932|NCT05146739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55799933|NCT05146739|Antimetabolites|antimetabolites|mesh-ancestor
55799934|NCT05146739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55799935|NCT05146739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800027|NCT05525351|Anesthetics|anesthetics|mesh-ancestor
55800054|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800055|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800056|NCT05100017|Urological Agents|urological agents|mesh-ancestor
55800057|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55800058|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55800059|NCT04865185|Ethanol|ethanol|mesh-list
55800060|NCT04865185|Lidocaine|lidocaine|mesh-list
55800061|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55800062|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800063|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800064|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800066|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
55800067|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
55800068|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800069|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55800126|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800173|NCT05531591|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55800174|NCT05531591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55800175|NCT05531591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800176|NCT05531591|Dopamine Agents|dopamine agents|mesh-ancestor
55800177|NCT05531591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800178|NCT05531591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800179|NCT05531591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55800180|NCT05531591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55800181|NCT05531591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800182|NCT05531591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55800183|NCT05531591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55800218|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800271|NCT05002127|Paclitaxel|paclitaxel|mesh-list
55800272|NCT05002127|Trastuzumab|trastuzumab|mesh-list
55800273|NCT05002127|Ramucirumab|ramucirumab|mesh-list
55800274|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55800275|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800276|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
55800277|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
55800278|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
55800294|NCT05519111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800295|NCT05531123|Gemcitabine|gemcitabine|mesh-list
55800296|NCT05531123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800297|NCT05531123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55800298|NCT05531123|Antimetabolites|antimetabolites|mesh-ancestor
55800299|NCT05531123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800300|NCT05531123|Antiviral Agents|antiviral agents|mesh-ancestor
55800301|NCT05531123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800302|NCT05531123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800303|NCT05531123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800304|NCT05531123|Immunologic Factors|immunologic factors|mesh-ancestor
55800305|NCT05531123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800306|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
55800364|NCT03048019|Cangrelor|cangrelor|mesh-list
55800365|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55800383|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
55800384|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800385|NCT04862845|Pregabalin|pregabalin|mesh-list
55800386|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55800387|NCT04862845|Analgesics|analgesics|mesh-ancestor
55800388|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
55800389|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800390|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800391|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
55800392|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55800393|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55800394|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800402|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800403|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
55800405|NCT04862377|Budesonide|budesonide|mesh-list
55800406|NCT04862377|Poractant alfa|poractant alfa|mesh-list
55800407|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55800408|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55800409|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
55800410|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800411|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800412|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55800413|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
55800414|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
55800415|NCT04862377|Hormones|hormones|mesh-ancestor
55800416|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800417|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
55800418|NCT04867993|Amikacin|amikacin|mesh-list
55800457|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
55800458|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55800459|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
55800460|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800461|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800462|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55800463|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55800464|NCT05512013|Ibuprofen|ibuprofen|mesh-list
55800496|NCT04894643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800497|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55800498|NCT05506865|Tiotropium Bromide|tiotropium bromide|mesh-list
55800499|NCT05506865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55800501|NCT05506865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800502|NCT05506865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800503|NCT05506865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55800504|NCT05506865|Respiratory System Agents|respiratory system agents|mesh-ancestor
55800505|NCT05506865|Parasympatholytics|parasympatholytics|mesh-ancestor
55800506|NCT05506865|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55800512|NCT05506787|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55800513|NCT05506319|Vasopressins|vasopressins|mesh-list
55800514|NCT05506319|Arginine Vasopressin|arginine vasopressin|mesh-list
55800515|NCT05506319|Norepinephrine|norepinephrine|mesh-list
55800516|NCT05506319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55800517|NCT05506319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55800518|NCT05506319|Adrenergic Agents|adrenergic agents|mesh-ancestor
55800519|NCT05506319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800520|NCT05506319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800521|NCT05506319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800522|NCT05506319|Sympathomimetics|sympathomimetics|mesh-ancestor
55800523|NCT05506319|Autonomic Agents|autonomic agents|mesh-ancestor
55800524|NCT05506319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800525|NCT05506319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55800526|NCT05506319|Hemostatics|hemostatics|mesh-ancestor
55800527|NCT05506319|Coagulants|coagulants|mesh-ancestor
55800578|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
55800598|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800528|NCT05506319|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55800529|NCT05506319|Natriuretic Agents|natriuretic agents|mesh-ancestor
55800530|NCT05505539|Fluorouracil|fluorouracil|mesh-list
55800531|NCT05505539|Antimetabolites|antimetabolites|mesh-ancestor
55800532|NCT05505539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800533|NCT05505539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55800534|NCT05505539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800535|NCT05505539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800536|NCT05505539|Immunologic Factors|immunologic factors|mesh-ancestor
55800537|NCT05505539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800538|NCT05505461|Antibodies|antibodies|mesh-list
55800539|NCT05505461|Immunologic Factors|immunologic factors|mesh-ancestor
55800540|NCT05505461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800541|NCT05514275|Capecitabine|capecitabine|mesh-list
55800542|NCT05514275|Endostatins|endostatins|mesh-list
55800543|NCT05514275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55800544|NCT05514275|Antimetabolites|antimetabolites|mesh-ancestor
55800545|NCT05514275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800546|NCT05514275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800547|NCT05514275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55800548|NCT05514275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55800549|NCT05514275|Growth Substances|growth substances|mesh-ancestor
55800550|NCT05514275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800551|NCT05514275|Growth Inhibitors|growth inhibitors|mesh-ancestor
55800552|NCT05514119|Fenofibrate|fenofibrate|mesh-list
55800553|NCT05514119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55800554|NCT05514119|Antimetabolites|antimetabolites|mesh-ancestor
55800555|NCT05514119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800556|NCT05514119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55800557|NCT05514041|Varenicline|varenicline|mesh-list
55800558|NCT05514041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55800559|NCT05514041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55800560|NCT05514041|Cholinergic Agents|cholinergic agents|mesh-ancestor
55800825|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
55800561|NCT05514041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800562|NCT05514041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800563|NCT05514041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800564|NCT04667663|Dexamethasone|dexamethasone|mesh-list
55800565|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
55800566|NCT04667663|Daratumumab|daratumumab|mesh-list
55800567|NCT04667663|Pomalidomide|pomalidomide|mesh-list
55800568|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800569|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
55800570|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800571|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800572|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55800573|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
55800574|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800575|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800576|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55800577|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55800579|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
55800580|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800581|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55800582|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
55800584|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800585|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55800586|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55800587|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55800588|NCT04667663|Growth Substances|growth substances|mesh-ancestor
55800589|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
55800591|NCT02570711|Paclitaxel|paclitaxel|mesh-list
55800592|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
55800593|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55800594|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800919|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55800920|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55800921|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55800922|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55800596|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
55800597|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
55800599|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55800600|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
55800601|NCT02570711|Antiviral Agents|antiviral agents|mesh-ancestor
55800602|NCT02570711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800603|NCT02570711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800929|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55800930|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800931|NCT02613169|Isoniazid|isoniazid|mesh-list
55800932|NCT02613169|Antitubercular Agents|antitubercular agents|mesh-ancestor
55800933|NCT02613169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55800934|NCT02613169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800604|NCT02570711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800605|NCT02570711|Immunologic Factors|immunologic factors|mesh-ancestor
55800606|NCT02570711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800608|NCT05513729|Canagliflozin|canagliflozin|mesh-list
55800609|NCT05513729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55800610|NCT05513729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800611|NCT05513729|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55800612|NCT05513729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800613|NCT05504603|Rituximab|rituximab|mesh-list
55800614|NCT05504603|Zanubrutinib|zanubrutinib|mesh-list
55800615|NCT05504603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800948|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55800616|NCT05504603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800617|NCT05504603|Immunologic Factors|immunologic factors|mesh-ancestor
55800618|NCT05504603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800619|NCT05504603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800620|NCT05504603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55800621|NCT05504603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800622|NCT05504603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800623|NCT05504213|Fulvestrant|fulvestrant|mesh-list
55800624|NCT05504213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55800625|NCT05504213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800626|NCT05504213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55800627|NCT05504213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55800629|NCT05504213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800630|NCT05504213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800631|NCT05510219|Obinutuzumab|obinutuzumab|mesh-list
55800632|NCT05510219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800633|NCT05510219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800634|NCT02564471|Doxycycline|doxycycline|mesh-list
55800635|NCT02564471|Chloroquine|chloroquine|mesh-list
55800636|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
55800638|NCT02564471|Proguanil|proguanil|mesh-list
55800639|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55800640|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800641|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
55800642|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55800643|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55800644|NCT02564471|Amebicides|amebicides|mesh-ancestor
55800645|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800646|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55800647|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55800648|NCT02564471|Analgesics|analgesics|mesh-ancestor
55800650|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800651|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800652|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55800653|NCT02564471|Filaricides|filaricides|mesh-ancestor
55800654|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
55800655|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
55800656|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800657|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800658|NCT02564471|Antimetabolites|antimetabolites|mesh-ancestor
55800659|NCT05503667|Bevacizumab|bevacizumab|mesh-list
55800660|NCT05503667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800667|NCT05512481|Temozolomide|temozolomide|mesh-list
55800669|NCT05512481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55800670|NCT05512481|Alkylating Agents|alkylating agents|mesh-ancestor
55800671|NCT05512481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800672|NCT05512481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800673|NCT05512481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55800674|NCT05512481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800675|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
55800676|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
55800677|NCT02563067|Growth Substances|growth substances|mesh-ancestor
55800678|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800679|NCT02568683|Vincristine|vincristine|mesh-list
55800680|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55800681|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800682|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
55800683|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
55800684|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
55800685|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800686|NCT05502731|Adalimumab|adalimumab|mesh-list
55800687|NCT05502731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55800688|NCT05502731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800689|NCT05510141|Nitrous Oxide|nitrous oxide|mesh-list
55800690|NCT05510141|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55800691|NCT05510141|Anesthetics, General|anesthetics, general|mesh-ancestor
55800692|NCT05510141|Anesthetics|anesthetics|mesh-ancestor
55801117|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800693|NCT05510141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800694|NCT05510141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800695|NCT05510141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55800697|NCT05510141|Sensory System Agents|sensory system agents|mesh-ancestor
55800698|NCT05510141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800699|NCT05503043|Lidocaine|lidocaine|mesh-list
55800700|NCT05503043|Anesthetics, Local|anesthetics, local|mesh-ancestor
55800701|NCT05503043|Anesthetics|anesthetics|mesh-ancestor
55800702|NCT05503043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800703|NCT05503043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800704|NCT05503043|Sensory System Agents|sensory system agents|mesh-ancestor
55800705|NCT05503043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800706|NCT05503043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55800707|NCT05503043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55800708|NCT05503043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55800709|NCT05503043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55800710|NCT05503043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800711|NCT02563925|Durvalumab|durvalumab|mesh-list
55800712|NCT02563925|Tremelimumab|tremelimumab|mesh-list
55800713|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800714|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800715|NCT01663727|Paclitaxel|paclitaxel|mesh-list
55800716|NCT01663727|Bevacizumab|bevacizumab|mesh-list
55800717|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55800718|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800719|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
55800720|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
55800721|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
55800722|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800723|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800724|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55800725|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55800726|NCT01663727|Growth Substances|growth substances|mesh-ancestor
55800727|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800728|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
55800730|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55800731|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800732|NCT03042325|Incretins|incretins|mesh-ancestor
55800733|NCT03042325|Hormones|hormones|mesh-ancestor
55800847|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55800734|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800735|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55800736|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
55800737|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800738|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800740|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55800741|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
55800742|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55800743|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800744|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55800745|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
55800746|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800747|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800748|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
55800749|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800755|NCT04342039|Budesonide|budesonide|mesh-list
55801400|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55800785|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55800786|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
55800787|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
55800788|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800789|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800790|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55800791|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
55800792|NCT03043495|Hormones|hormones|mesh-ancestor
55800793|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800794|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55800795|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800796|NCT03043027|Bupivacaine|bupivacaine|mesh-list
55800797|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
55800798|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
55800799|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800800|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800801|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
55800803|NCT04861207|Cladribine|cladribine|mesh-list
55800804|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800805|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800806|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
55800807|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800808|NCT04858087|Lumefantrine|lumefantrine|mesh-list
55800809|NCT04858087|Artemether|artemether|mesh-list
55801492|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801493|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
55800813|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55800814|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800815|NCT03041935|Acetaminophen|acetaminophen|mesh-list
55800816|NCT03041935|Dexamethasone|dexamethasone|mesh-list
55800817|NCT03041935|Ketorolac|ketorolac|mesh-list
55800818|NCT03041935|Morphine|morphine|mesh-list
55800819|NCT03041935|Remifentanil|remifentanil|mesh-list
55800820|NCT03041935|Ondansetron|ondansetron|mesh-list
55800821|NCT03041935|Propofol|propofol|mesh-list
55800822|NCT03041935|Ropivacaine|ropivacaine|mesh-list
55800823|NCT03041935|Sevoflurane|sevoflurane|mesh-list
55800824|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801541|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801575|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55800826|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
55800827|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800828|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800829|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55800830|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
55800831|NCT03041935|Hormones|hormones|mesh-ancestor
55800832|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800833|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55800834|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800835|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55800836|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800837|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55800838|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
55800839|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
55800840|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55800841|NCT03041935|Narcotics|narcotics|mesh-ancestor
55800842|NCT03041935|Analgesics|analgesics|mesh-ancestor
55801736|NCT04360135|Analgesics|analgesics|mesh-ancestor
55800844|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
55800845|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55800848|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55800849|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
55801761|NCT02605837|Hormones|hormones|mesh-ancestor
55800850|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
55800851|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55800852|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
55800853|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800854|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800855|NCT03041935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55800856|NCT03041935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55800858|NCT03041935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55800859|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55800860|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800861|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55800863|NCT03042013|Naquotinib|naquotinib|mesh-list
55800864|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800865|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55800866|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800867|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800868|NCT03042871|Ranibizumab|ranibizumab|mesh-list
55800869|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55800870|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55800871|NCT03042871|Growth Substances|growth substances|mesh-ancestor
55800872|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800873|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
55800874|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800875|NCT03042637|Tacrolimus|tacrolimus|mesh-list
55800876|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800877|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
55800878|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800879|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55800880|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800881|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800882|NCT03045133|Morphine|morphine|mesh-list
55800883|NCT03045133|Methadone|methadone|mesh-list
55800884|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55800885|NCT03045133|Narcotics|narcotics|mesh-ancestor
55800886|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55800887|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800888|NCT03045133|Analgesics|analgesics|mesh-ancestor
55800889|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
55800890|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800891|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
55800892|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
55800893|NCT02609659|Ritonavir|ritonavir|mesh-list
55800895|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55800896|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55800897|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
55800898|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800899|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800900|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55800901|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55800902|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
55800903|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800904|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55800905|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55800906|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
55800908|NCT04429711|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55800909|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800910|NCT04429633|Candesartan|candesartan|mesh-list
55802168|NCT04802785|Emollients|emollients|mesh-ancestor
55802256|NCT04788745|Trimetazidine|trimetazidine|mesh-list
55800911|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55800912|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55802392|NCT03938389|Valsartan|valsartan|mesh-list
55802398|NCT03843853|Bevacizumab|bevacizumab|mesh-list
55802513|NCT05269849|Sirolimus|sirolimus|mesh-list
55800913|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55800914|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800916|NCT03042091|Ethanol|ethanol|mesh-list
55800917|NCT03042091|Neomycin|neomycin|mesh-list
55800918|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800924|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800925|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55800926|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800927|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800928|NCT04859569|Denosumab|denosumab|mesh-list
55800935|NCT02613169|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55800936|NCT02613169|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55800937|NCT02613169|Antimetabolites|antimetabolites|mesh-ancestor
55800938|NCT02613169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800939|NCT02613169|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55800941|NCT04856371|Fulvestrant|fulvestrant|mesh-list
55800942|NCT04856371|Palbociclib|palbociclib|mesh-list
55800943|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800944|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55800945|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55800946|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800947|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800949|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
55800950|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55800951|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800952|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55800953|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55800955|NCT03041779|Acetaminophen|acetaminophen|mesh-list
55800956|NCT03041779|Diclofenac|diclofenac|mesh-list
55800957|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55800958|NCT03041779|Analgesics|analgesics|mesh-ancestor
55800959|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
55800960|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800961|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800962|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
55800963|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55800964|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55800965|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800966|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55800967|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800968|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800969|NCT02612779|Dexamethasone|dexamethasone|mesh-list
55800970|NCT02612779|Nivolumab|nivolumab|mesh-list
55800971|NCT02612779|Pomalidomide|pomalidomide|mesh-list
55800972|NCT02612779|Elotuzumab|elotuzumab|mesh-list
55800973|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55800974|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
55800975|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
55800976|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800977|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800978|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55800979|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
55800980|NCT02612779|Hormones|hormones|mesh-ancestor
55800981|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803587|NCT00352027|Etoposide|etoposide|mesh-list
55800982|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55800983|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800984|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55800985|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55800986|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800987|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
55800988|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55800989|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55800990|NCT02612779|Growth Substances|growth substances|mesh-ancestor
55800991|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
55800994|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55800995|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55800996|NCT04866355|Analgesics|analgesics|mesh-ancestor
55800997|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
55803905|NCT02342223|Protective Agents|protective agents|mesh-ancestor
55804098|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
55800999|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801000|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801001|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801002|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55801003|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801004|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801005|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55801006|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
55801007|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
55801008|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55801009|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
55801010|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55801012|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801013|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55801016|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801018|NCT02607865|Hormones|hormones|mesh-ancestor
55801019|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801020|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55801022|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804579|NCT02565511|CNP520|cnp520|mesh-list
55801023|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804774|NCT04417621|Trametinib|trametinib|mesh-list
55804834|NCT04277845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55805193|NCT05484583|Etoposide|etoposide|mesh-list
55801026|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55805478|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55801027|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801028|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
55801030|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
55801031|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801032|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55801033|NCT04856137|Immunologic Factors|immunologic factors|mesh-ancestor
55801034|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801035|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801037|NCT04855279|Fluorides|fluorides|mesh-list
55801038|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
55801039|NCT04855279|Glycerol|glycerol|mesh-list
55801040|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
55801041|NCT04855279|Protective Agents|protective agents|mesh-ancestor
55801042|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801043|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55801044|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801045|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55801046|NCT04848259|Dexamethasone|dexamethasone|mesh-list
55801047|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
55801048|NCT04848259|BB 1101|bb 1101|mesh-list
55801049|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801050|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
55801051|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
55801052|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801053|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801054|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55801055|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
55801057|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801058|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55801059|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801060|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
55801061|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805765|NCT05508815|Methotrexate|methotrexate|mesh-list
55801062|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805816|NCT04282109|Paclitaxel|paclitaxel|mesh-list
55801063|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55801064|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
55805822|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
55801065|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55801066|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
55801067|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55801068|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801069|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55801070|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55801071|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806064|NCT05490953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806225|NCT02556203|Aspirin|aspirin|mesh-list
55801073|NCT04848181|Finasteride|finasteride|mesh-list
55801074|NCT04848181|Cyproterone|cyproterone|mesh-list
55801075|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55801076|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55801077|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801078|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801080|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801081|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801082|NCT04848181|Urological Agents|urological agents|mesh-ancestor
55801083|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
55801084|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806740|NCT02551991|Antidotes|antidotes|mesh-ancestor
55801085|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55801086|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
55801087|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55801088|NCT04847791|Lactoferrin|lactoferrin|mesh-list
55801089|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801091|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55801092|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801093|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55801094|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801095|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
55801096|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55801097|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
55801098|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801099|NCT04847245|Pregabalin|pregabalin|mesh-list
55801100|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55801101|NCT04847245|Esketamine|esketamine|mesh-list
55801102|NCT04847245|Analgesics|analgesics|mesh-ancestor
55801103|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
55801104|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801105|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801106|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
55801107|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55801108|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55801109|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801110|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55801111|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55801112|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55801113|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801114|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55801115|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55801116|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55801118|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
55801119|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
55801121|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
55801122|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801123|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
55801124|NCT04846621|Calcium|calcium|mesh-list
55801125|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55801126|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801127|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55801128|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801129|NCT04854577|Anesthetics|anesthetics|mesh-list
55801130|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801131|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801132|NCT04839445|Anesthetics|anesthetics|mesh-list
55801133|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801134|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801135|NCT04845607|Amiodarone|amiodarone|mesh-list
55801136|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55801137|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
55801138|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55801139|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55807103|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801140|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801144|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801145|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55801146|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55801147|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55801148|NCT04853797|Calcium|calcium|mesh-list
55801149|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55801150|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801151|NCT04853719|Rivaroxaban|rivaroxaban|mesh-list
55801152|NCT04853719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801153|NCT04853719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801154|NCT04853719|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55801155|NCT04853719|Antithrombins|antithrombins|mesh-ancestor
55801156|NCT04853719|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55801157|NCT04853719|Protease Inhibitors|protease inhibitors|mesh-ancestor
55801158|NCT04853719|Anticoagulants|anticoagulants|mesh-ancestor
55801160|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
55801161|NCT03040531|Alendronate|alendronate|mesh-list
55801162|NCT03040531|Genistein|genistein|mesh-list
55801164|NCT03040531|Vitamins|vitamins|mesh-ancestor
55801165|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
55801166|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801167|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55801168|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55801169|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55801170|NCT03040531|Protective Agents|protective agents|mesh-ancestor
55801171|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807382|NCT01349881|Eflornithine|eflornithine|mesh-list
55801172|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55801173|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801174|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807474|NCT05443555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55801175|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
55801176|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55801177|NCT03040531|Estrogens|estrogens|mesh-ancestor
55801178|NCT03040531|Hormones|hormones|mesh-ancestor
55801179|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807601|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55807819|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
55801180|NCT04838665|Phenylephrine|phenylephrine|mesh-list
55801181|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
55801182|NCT04838665|Tropicamide|tropicamide|mesh-list
55801183|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
55801184|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55807883|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55808199|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55801186|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
55801187|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801188|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801189|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
55801190|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55801191|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
55801192|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
55801193|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55801194|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55801195|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55801198|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801199|NCT04838665|Protective Agents|protective agents|mesh-ancestor
55801200|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55801201|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55801204|NCT04845061|Nebivolol|nebivolol|mesh-list
55801242|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801243|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55801244|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55801245|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
55801246|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55801247|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801248|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
55801250|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801251|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801252|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55809040|NCT04984993|Tadalafil|tadalafil|mesh-list
55801253|NCT04142125|Antithrombins|antithrombins|mesh-ancestor
55801254|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55801255|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
55801256|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
55801257|NCT04852315|Caffeine|caffeine|mesh-list
55801258|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55801259|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801260|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55801262|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801263|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55801264|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55801265|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
55801266|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801267|NCT03038425|Ropivacaine|ropivacaine|mesh-list
55801268|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
55801269|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
55801270|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801271|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809431|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801273|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801274|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
55801275|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55801277|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
55801278|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801279|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801280|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55801282|NCT04852081|Letrozole|letrozole|mesh-list
55801287|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801288|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55809974|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
55801290|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809992|NCT02349633|Palbociclib|palbociclib|mesh-list
55801291|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810038|NCT05649111|Difluprednate|difluprednate|mesh-list
55801292|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55801293|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
55801294|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801295|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810097|NCT01650805|Ponatinib|ponatinib|mesh-list
55801296|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55801297|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55801298|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55801299|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55801300|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55801301|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55810229|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55810230|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55810231|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
55810232|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
55810233|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55810234|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55810235|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55810236|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55810238|NCT05405309|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55810239|NCT05405309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810249|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
55810250|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810251|NCT02538107|Epoetin Alfa|epoetin alfa|mesh-list
55810252|NCT02538107|Hematinics|hematinics|mesh-ancestor
55810253|NCT02211755|Bortezomib|bortezomib|mesh-list
55810254|NCT02211755|Clofarabine|clofarabine|mesh-list
55810255|NCT02211755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810256|NCT02211755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55810257|NCT02211755|Antimetabolites|antimetabolites|mesh-ancestor
55810258|NCT02211755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810259|NCT02272413|Bevacizumab|bevacizumab|mesh-list
55810260|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810261|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810262|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55810263|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55801303|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55801304|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55810265|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810266|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
55810267|NCT05400863|Metformin|metformin|mesh-list
55810268|NCT05400863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55810269|NCT05400863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810270|NCT02120807|Pemetrexed|pemetrexed|mesh-list
55810271|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
55810272|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810273|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810274|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810275|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55810276|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55810277|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55810278|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
55810279|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810280|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810281|NCT02532647|Midazolam|midazolam|mesh-list
55810282|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55810283|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55810284|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810285|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810286|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55810287|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55810288|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55810289|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55810290|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
55810291|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
55810292|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
55810294|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810295|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810296|NCT05443061|Nitroglycerin|nitroglycerin|mesh-list
55810297|NCT05443061|Vasodilator Agents|vasodilator agents|mesh-ancestor
55810298|NCT02537015|Bimatoprost|bimatoprost|mesh-list
55810299|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55810300|NCT01660763|Sufentanil|sufentanil|mesh-list
55810301|NCT01660763|Dsuvia|dsuvia|mesh-list
55810302|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55810303|NCT01660763|Narcotics|narcotics|mesh-ancestor
55810304|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810306|NCT01660763|Analgesics|analgesics|mesh-ancestor
55810344|NCT05388929|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55810345|NCT05416229|Psilocybin|psilocybin|mesh-list
55810346|NCT05416229|Hallucinogens|hallucinogens|mesh-ancestor
55810347|NCT05416229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810348|NCT05416229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55810349|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55810351|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810352|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55810353|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810354|NCT01641939|Trastuzumab|trastuzumab|mesh-list
55810355|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55810356|NCT01641939|Maytansine|maytansine|mesh-list
55810357|NCT01641939|Taxane|taxane|mesh-list
55810358|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810359|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810360|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55810361|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
55810362|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
55810363|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
55810364|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810365|NCT02409355|Gemcitabine|gemcitabine|mesh-list
55810366|NCT02409355|Carboplatin|carboplatin|mesh-list
55810367|NCT02409355|Atezolizumab|atezolizumab|mesh-list
55810368|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810369|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55801305|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801306|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55810370|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
55810371|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810372|NCT02409355|Antiviral Agents|antiviral agents|mesh-ancestor
55810373|NCT02409355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810374|NCT02409355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810375|NCT02409355|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55810376|NCT02409355|Immunologic Factors|immunologic factors|mesh-ancestor
55810378|NCT02438371|Indomethacin|indomethacin|mesh-list
55810379|NCT02438371|Nifedipine|nifedipine|mesh-list
55810380|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55810381|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55810382|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810383|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55810384|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810385|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
55810386|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
55810388|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55810389|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55810390|NCT02438371|Analgesics|analgesics|mesh-ancestor
55810391|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
55810392|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810393|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810394|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810395|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
55810396|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55810397|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810398|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55810399|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
55810400|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55810401|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
55810402|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810403|NCT04920565|Polymyxins|polymyxins|mesh-list
55810404|NCT04920565|Polymyxin B|polymyxin b|mesh-list
55810405|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55810406|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810407|NCT04934683|Propofol|propofol|mesh-list
55810408|NCT04934683|Etomidate|etomidate|mesh-list
55810409|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55810410|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810718|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810411|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810412|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55810437|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55810438|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55810439|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55810440|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55810441|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
55810442|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810443|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810444|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810445|NCT02436889|Urological Agents|urological agents|mesh-ancestor
55810446|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55810447|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55810448|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
55810449|NCT02436577|Ticagrelor|ticagrelor|mesh-list
55810450|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55810451|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55810452|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55810453|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55810454|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
55810455|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810456|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810457|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810458|NCT02459665|Metronidazole|metronidazole|mesh-list
55810459|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810460|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55810461|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55810462|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55810463|NCT02265237|Ritonavir|ritonavir|mesh-list
55810464|NCT02265237|Ribavirin|ribavirin|mesh-list
55810465|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55810484|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55810485|NCT04858269|Paclitaxel|paclitaxel|mesh-list
55810486|NCT04858269|Carboplatin|carboplatin|mesh-list
55810487|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
55810488|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55810489|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810490|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
55810491|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
55810492|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
55810493|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810537|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
55810538|NCT02256969|Mineral Oil|mineral oil|mesh-list
55810539|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55810540|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
55810541|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810542|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
55810543|NCT02256969|Hormones|hormones|mesh-ancestor
55810544|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810545|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810546|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55810547|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810549|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
55810550|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810551|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55810552|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55810553|NCT02256969|Protective Agents|protective agents|mesh-ancestor
55810572|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55810573|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55810574|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55810575|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55810576|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55810578|NCT05429463|Carboplatin|carboplatin|mesh-list
55810579|NCT05429463|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55810580|NCT05429463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55810581|NCT05429463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810582|NCT05429463|Tubulin Modulators|tubulin modulators|mesh-ancestor
55810583|NCT05429463|Antimitotic Agents|antimitotic agents|mesh-ancestor
55810584|NCT05429463|Mitosis Modulators|mitosis modulators|mesh-ancestor
55810585|NCT05429463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810586|NCT02255565|Methylphenidate|methylphenidate|mesh-list
55810587|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55810588|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810589|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55810590|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55810591|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55810592|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810593|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
55810594|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810595|NCT01640301|Aldesleukin|aldesleukin|mesh-list
55810596|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
55810597|NCT01640301|Fludarabine|fludarabine|mesh-list
55810598|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
55810599|NCT01640301|Interleukin-2|interleukin-2|mesh-list
55810600|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55810601|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
55810602|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810603|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810604|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55810605|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
55810606|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810607|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810608|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55810609|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55810610|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
55810611|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55810612|NCT01640301|Analgesics|analgesics|mesh-ancestor
55810613|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
55810614|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810615|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55810616|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55810617|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
55810618|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810619|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
55810620|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
55810621|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55810622|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55810623|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810624|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810625|NCT01642407|Urological Agents|urological agents|mesh-ancestor
55810626|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
55810627|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810628|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810629|NCT02254551|Bortezomib|bortezomib|mesh-list
55810630|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810631|NCT05640375|Methylprednisolone|methylprednisolone|mesh-list
55810632|NCT05640375|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55810633|NCT05640375|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55810634|NCT05640375|Prednisolone|prednisolone|mesh-list
55810635|NCT05640375|Prednisolone acetate|prednisolone acetate|mesh-list
55810642|NCT05640375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810643|NCT05640375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55810644|NCT05640375|Glucocorticoids|glucocorticoids|mesh-ancestor
55810645|NCT05640375|Hormones|hormones|mesh-ancestor
55810646|NCT05640375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810647|NCT05640375|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55810648|NCT05640375|Protective Agents|protective agents|mesh-ancestor
55810649|NCT05640375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55810650|NCT05640375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810651|NCT01641237|Listerine|listerine|mesh-list
55801322|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55801323|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
55801324|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55801326|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801327|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801328|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
55801329|NCT04850755|Nivolumab|nivolumab|mesh-list
55810705|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810706|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810707|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
55810708|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55810709|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55810710|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810711|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
55810712|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
55810713|NCT05369481|Minoxidil|minoxidil|mesh-list
55810714|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
55810715|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
55810716|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55810717|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55810719|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810720|NCT05369481|Urological Agents|urological agents|mesh-ancestor
55810721|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55801330|NCT04850755|Ipilimumab|ipilimumab|mesh-list
55801331|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55801332|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801333|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55801334|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801335|NCT04842487|Prednisone|prednisone|mesh-list
55801336|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
55801337|NCT04842487|Rituximab|rituximab|mesh-list
55801345|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801346|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55801347|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
55801348|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801349|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801350|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55801351|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55801352|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810769|NCT05422365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55810770|NCT05422365|Immunologic Factors|immunologic factors|mesh-ancestor
55810771|NCT05422365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810772|NCT04641273|Pregabalin|pregabalin|mesh-list
55810773|NCT04641273|Analgesics|analgesics|mesh-ancestor
55810774|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
55810775|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810776|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810777|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
55810778|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55810779|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55810780|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810781|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55810782|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55810783|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55810784|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810785|NCT04641273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55810786|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
55810787|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55810789|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
55810790|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
55810791|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810792|NCT04586985|Midazolam|midazolam|mesh-list
55810793|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55810794|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55810795|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810796|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810797|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55810798|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55810799|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55810800|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55810801|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
55810802|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
55810806|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810807|NCT04841343|Triamcinolone|triamcinolone|mesh-list
55810808|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810809|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
55810811|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810814|NCT04561557|Fludarabine|fludarabine|mesh-list
55810815|NCT04561557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55810816|NCT04561557|Immunologic Factors|immunologic factors|mesh-ancestor
55810817|NCT04561557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810818|NCT04561557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810819|NCT04561557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55810820|NCT04561557|Alkylating Agents|alkylating agents|mesh-ancestor
55810821|NCT04561557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810822|NCT04561557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810823|NCT04561557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55810824|NCT05244057|Interferons|interferons|mesh-list
55810825|NCT05244057|Tenofovir|tenofovir|mesh-list
55810826|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
55810827|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
55810828|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55810829|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810830|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
55810831|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810832|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55810833|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55810834|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810835|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810836|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55810837|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55810838|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
55810840|NCT05408403|Anesthetics|anesthetics|mesh-list
55810841|NCT05408403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810842|NCT05408403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810843|NCT04830735|Dasatinib|dasatinib|mesh-list
55810844|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810845|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55810846|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810847|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810848|NCT05335317|Hormones|hormones|mesh-list
55810849|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810850|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810852|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810855|NCT05329779|Brexanolone|brexanolone|mesh-list
55810856|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
55810857|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810858|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810859|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
55810860|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810861|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810862|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
55810863|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
55810864|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
55810865|NCT04464759|Nivolumab|nivolumab|mesh-list
55810866|NCT04464759|Ipilimumab|ipilimumab|mesh-list
55810867|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810868|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810869|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55810870|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810871|NCT04464759|Antimalarials|antimalarials|mesh-ancestor
55796498|NCT05543603|Disinfectants|disinfectants|mesh-ancestor
55810874|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810876|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810877|NCT04850937|Esketamine|esketamine|mesh-list
55810878|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
55810879|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55810880|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55810881|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55810882|NCT04411329|Dexamethasone|dexamethasone|mesh-list
55810883|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
55810884|NCT04411329|Bupivacaine|bupivacaine|mesh-list
55810885|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810886|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
55810887|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
55801353|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
55801355|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810958|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55810959|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
55810960|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810961|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810962|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810963|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55810964|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
55810965|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811018|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811019|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811020|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55811021|NCT03257163|Antimetabolites|antimetabolites|mesh-ancestor
55811022|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811023|NCT03256149|Dexamethasone|dexamethasone|mesh-list
55811024|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811025|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
55811026|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
55811027|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811028|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811029|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811030|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
55811031|NCT03256149|Hormones|hormones|mesh-ancestor
55811032|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811033|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55811034|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811035|NCT03253263|Mecasermin|mecasermin|mesh-list
55811059|NCT05219799|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55811060|NCT05219799|Cholinergic Agents|cholinergic agents|mesh-ancestor
55811061|NCT05219799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55811062|NCT05219799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55811063|NCT05219799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55811064|NCT05219799|Respiratory System Agents|respiratory system agents|mesh-ancestor
55811065|NCT05219799|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55811066|NCT05219799|Protective Agents|protective agents|mesh-ancestor
55811068|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
55811069|NCT01636947|Ondansetron|ondansetron|mesh-list
55811070|NCT01636947|Aprepitant|aprepitant|mesh-list
55811071|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
55811072|NCT01636947|Metoclopramide|metoclopramide|mesh-list
55811073|NCT01636947|Granisetron|granisetron|mesh-list
55811074|NCT01636947|Tropisetron|tropisetron|mesh-list
55811075|NCT01636947|Dolasetron|dolasetron|mesh-list
55811076|NCT01636947|Alizapride|alizapride|mesh-list
55811077|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55811080|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
55811081|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
55811082|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811083|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811084|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811085|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
55811086|NCT01636947|Hormones|hormones|mesh-ancestor
55827592|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55811087|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811088|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55811089|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811090|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
55811091|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811092|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811093|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
55811094|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
55811095|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55811096|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
55811097|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811098|NCT01636947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55811099|NCT01636947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55811100|NCT01636947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811101|NCT01636947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55811102|NCT01636947|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55811103|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55811104|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55811105|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55811106|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
55811107|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55811109|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55811110|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
55811111|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
55811112|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811113|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811114|NCT04793919|Tretinoin|tretinoin|mesh-list
55811115|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
55811116|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
55811117|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811140|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
55811141|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55811142|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811143|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
55811144|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
55811145|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
55811146|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811147|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811148|NCT02774421|Trastuzumab|trastuzumab|mesh-list
55811149|NCT02774421|Molgramostim|molgramostim|mesh-list
55811150|NCT02774421|Sargramostim|sargramostim|mesh-list
55811151|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811152|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811153|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
55811155|NCT04791969|Naltrexone|naltrexone|mesh-list
55811193|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55811194|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55811197|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811198|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55811199|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55811200|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
55811201|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811202|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55811203|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55811204|NCT04803201|Prednisone|prednisone|mesh-list
55811205|NCT04803201|Cyclophosphamide|cyclophosphamide|mesh-list
55811206|NCT04803201|Doxorubicin|doxorubicin|mesh-list
55811207|NCT04803201|Etoposide|etoposide|mesh-list
55811208|NCT04803201|Vincristine|vincristine|mesh-list
55811209|NCT04803201|Azacitidine|azacitidine|mesh-list
55811210|NCT04803201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811211|NCT04803201|Immunologic Factors|immunologic factors|mesh-ancestor
55811212|NCT04803201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811214|NCT04803201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55811215|NCT04803201|Alkylating Agents|alkylating agents|mesh-ancestor
55811216|NCT04803201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811217|NCT04803201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811218|NCT04803201|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55811219|NCT04803201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55811220|NCT04803201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55811221|NCT04803201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55811222|NCT04803201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811223|NCT04803201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811225|NCT04803201|Hormones|hormones|mesh-ancestor
55811226|NCT04803201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811227|NCT04803201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55811228|NCT04803201|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55811229|NCT04803201|Tubulin Modulators|tubulin modulators|mesh-ancestor
55801357|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55801358|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
55801359|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
55801360|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
55801361|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55801362|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55801363|NCT04842487|Growth Substances|growth substances|mesh-ancestor
55801364|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
55801365|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55801366|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55801367|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55811230|NCT04803201|Antimitotic Agents|antimitotic agents|mesh-ancestor
55811231|NCT04803201|Mitosis Modulators|mitosis modulators|mesh-ancestor
55811232|NCT04803201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55811233|NCT04803201|Antimetabolites|antimetabolites|mesh-ancestor
55811234|NCT03846765|Phenylephrine|phenylephrine|mesh-list
55811235|NCT03846765|Dobutamine|dobutamine|mesh-list
55811236|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
55811237|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55811238|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
55811239|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
55811240|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811241|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811242|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
55811243|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55811244|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
55811245|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
55811246|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55811247|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55811248|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55811249|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
55811255|NCT05163405|Bortezomib|bortezomib|mesh-list
55801368|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801369|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
55801370|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55801371|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
55801372|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801373|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801374|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55811276|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55811277|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811278|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
55811279|NCT05190705|Dexamethasone|dexamethasone|mesh-list
55811280|NCT05190705|Dexamethasone acetate|dexamethasone acetate|mesh-list
55811281|NCT05190705|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
55811283|NCT05190705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811284|NCT05190705|Antiemetics|antiemetics|mesh-ancestor
55811285|NCT05190705|Autonomic Agents|autonomic agents|mesh-ancestor
55811286|NCT05190705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811287|NCT05190705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811288|NCT05190705|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811289|NCT05190705|Glucocorticoids|glucocorticoids|mesh-ancestor
55811291|NCT05190705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811292|NCT05190705|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55811293|NCT05190705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811294|NCT05190705|Protease Inhibitors|protease inhibitors|mesh-ancestor
55811308|NCT05180097|Glucocorticoids|glucocorticoids|mesh-ancestor
55811310|NCT05180097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811311|NCT05180097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55811314|NCT05180097|Antimetabolites|antimetabolites|mesh-ancestor
55811350|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55811352|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55811353|NCT04446039|Analgesics|analgesics|mesh-ancestor
55811354|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
55811355|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55811356|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55801375|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
55801376|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55801378|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801379|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801380|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55801381|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
55801382|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
55801383|NCT04842331|Protective Agents|protective agents|mesh-ancestor
55801384|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55811357|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811358|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55811359|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55811360|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55811361|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55811362|NCT04446039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55811363|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
55811364|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
55811365|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55811366|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55811367|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55811368|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
55811369|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55811370|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55811372|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
55811373|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
55811374|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811376|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
55811377|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811379|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55811380|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55811381|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55811382|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811384|NCT04784247|Lenvatinib|lenvatinib|mesh-list
55811385|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811386|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811387|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55811388|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801385|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55801386|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801387|NCT03039985|Lithium Carbonate|lithium carbonate|mesh-list
55801388|NCT03039985|Antidepressive Agents|antidepressive agents|mesh-ancestor
55801389|NCT03039985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55801390|NCT03039985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801391|NCT03039985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801392|NCT03039985|Antimanic Agents|antimanic agents|mesh-ancestor
55811419|NCT03591861|Carmustine|carmustine|mesh-list
55811420|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55811421|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
55811422|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811423|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811426|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811427|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55801393|NCT03039985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55811428|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55811429|NCT01600053|Growth Substances|growth substances|mesh-ancestor
55811430|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
55811431|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811432|NCT03573297|Cariprazine|cariprazine|mesh-list
55811433|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55811434|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55811435|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811436|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811437|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55811438|NCT03569241|Androgens|androgens|mesh-list
55811439|NCT03569241|Hormones|hormones|mesh-ancestor
55811440|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811441|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811442|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
55811443|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
55811444|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55811445|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811446|NCT01068249|Everolimus|everolimus|mesh-list
55811447|NCT01068249|Letrozole|letrozole|mesh-list
55811450|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
55811451|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811452|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55811453|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55811454|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811455|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811456|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55811457|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
55811458|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811459|NCT01035099|Letrozole|letrozole|mesh-list
55811460|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811461|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55811462|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55811463|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811464|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811465|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55811466|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
55811467|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811468|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811470|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
55811471|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
55811472|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811473|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811475|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811476|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55811477|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55811478|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55811479|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55811480|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811481|NCT05238597|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55811482|NCT05238597|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55811483|NCT00098475|Thalidomide|thalidomide|mesh-list
55811484|NCT00098475|Dexamethasone|dexamethasone|mesh-list
55801394|NCT03039985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801395|NCT03039985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801396|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
55801397|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55801398|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801399|NCT04312243|Nitric Oxide|nitric oxide|mesh-list
55801401|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
55801402|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801403|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811486|NCT00098475|Lenalidomide|lenalidomide|mesh-list
55811488|NCT00098475|BB 1101|bb 1101|mesh-list
55801404|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55801405|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
55801406|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55801407|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
55801408|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801409|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801434|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55801410|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55811489|NCT00098475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811491|NCT00098475|Autonomic Agents|autonomic agents|mesh-ancestor
55801412|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
55801417|NCT04837651|Antibodies|antibodies|mesh-list
55801419|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801420|NCT03039205|Clopidogrel|clopidogrel|mesh-list
55801421|NCT03039205|Ticagrelor|ticagrelor|mesh-list
55801422|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55801423|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55801424|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55811492|NCT00098475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811493|NCT00098475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811494|NCT00098475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811495|NCT00098475|Glucocorticoids|glucocorticoids|mesh-ancestor
55811496|NCT00098475|Hormones|hormones|mesh-ancestor
55811497|NCT00098475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811498|NCT00098475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55811499|NCT00098475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811500|NCT00098475|Protease Inhibitors|protease inhibitors|mesh-ancestor
55811502|NCT00098475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811503|NCT00098475|Immunologic Factors|immunologic factors|mesh-ancestor
55811504|NCT00098475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55811505|NCT00098475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55811506|NCT00098475|Growth Substances|growth substances|mesh-ancestor
55811507|NCT00098475|Growth Inhibitors|growth inhibitors|mesh-ancestor
55811508|NCT00098475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811509|NCT00098475|Leprostatic Agents|leprostatic agents|mesh-ancestor
55811510|NCT00098475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55811511|NCT00098475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811512|NCT00098475|Dermatologic Agents|dermatologic agents|mesh-ancestor
55811514|NCT02246673|Verinurad|verinurad|mesh-list
55811516|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55811517|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55811518|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55811538|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811539|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55811540|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55811542|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
55811544|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811547|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
55796526|NCT01665599|Androgens|androgens|mesh-ancestor
55811589|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811590|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811591|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811592|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
55811593|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55811594|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
55811595|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811596|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811597|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55811598|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
55811599|NCT02240121|Rifaximin|rifaximin|mesh-list
55811600|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55811601|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811602|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811603|NCT03967977|Gemcitabine|gemcitabine|mesh-list
55811604|NCT03967977|Carboplatin|carboplatin|mesh-list
55811605|NCT03967977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811606|NCT03967977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55811607|NCT03967977|Antimetabolites|antimetabolites|mesh-ancestor
55811608|NCT03967977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811609|NCT03967977|Antiviral Agents|antiviral agents|mesh-ancestor
55811610|NCT03967977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811611|NCT03967977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811613|NCT03967977|Immunologic Factors|immunologic factors|mesh-ancestor
55811615|NCT04780269|Dinoprostone|dinoprostone|mesh-list
55801427|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801428|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801429|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801430|NCT04837261|Propranolol|propranolol|mesh-list
55801432|NCT04837261|Flecainide|flecainide|mesh-list
55801433|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55801436|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801437|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801438|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811616|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
55811617|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55811635|NCT01632891|Tenofovir|tenofovir|mesh-list
55811636|NCT01632891|Emtricitabine|emtricitabine|mesh-list
55811638|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55811639|NCT01632891|Efavirenz|efavirenz|mesh-list
55801443|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55801445|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55801446|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55801448|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55801449|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55801450|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55801451|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55801453|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55801454|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55801455|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
55801456|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811641|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
55811642|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55811658|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55811659|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55811660|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55811661|NCT01632891|Renal Agents|renal agents|mesh-ancestor
55811662|NCT01632891|Antimalarials|antimalarials|mesh-ancestor
55811663|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55811664|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55811665|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55811666|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55811667|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55811668|NCT02208843|Afatinib|afatinib|mesh-list
55811669|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811670|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55811671|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811672|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811674|NCT02208063|Cefazolin|cefazolin|mesh-list
55811675|NCT02208063|Daptomycin|daptomycin|mesh-list
55811676|NCT02208063|Penicillins|penicillins|mesh-list
55811677|NCT02208063|Cloxacillin|cloxacillin|mesh-list
55811678|NCT02208063|Oxacillin|oxacillin|mesh-list
55811679|NCT02208063|Nafcillin|nafcillin|mesh-list
55811680|NCT02208063|Telavancin|telavancin|mesh-list
55811681|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55811682|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811683|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55811685|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801494|NCT04831255|Hormones|hormones|mesh-ancestor
55801495|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801496|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801497|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55801498|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
55801499|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801500|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801501|NCT02431533|Calcium|calcium|mesh-list
55801502|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55811687|NCT02207907|Fluorides|fluorides|mesh-list
55811688|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
55811689|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
55811690|NCT02207907|Protective Agents|protective agents|mesh-ancestor
55801503|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801505|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55801506|NCT02413593|Ledipasvir|ledipasvir|mesh-list
55801507|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
55801508|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801509|NCT01652703|Evolocumab|evolocumab|mesh-list
55801510|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55801511|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55811691|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811692|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55801512|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
55801513|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811693|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811694|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
55811695|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55811696|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
55811697|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811698|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811699|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55811700|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
55811701|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
55811702|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55811703|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
55811704|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811705|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811707|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55811708|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
55811709|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811710|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811711|NCT02237157|Antiviral Agents|antiviral agents|mesh-ancestor
55811712|NCT02237157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811713|NCT02237157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811714|NCT02237157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811715|NCT02237157|Immunologic Factors|immunologic factors|mesh-ancestor
55811716|NCT02237157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811718|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55811719|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55811720|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55811721|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
55811722|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811723|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811724|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811725|NCT02233803|Budesonide|budesonide|mesh-list
55801514|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55801516|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55811726|NCT02233803|Albuterol|albuterol|mesh-list
55801517|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801518|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
55801519|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
55801520|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
55801521|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801522|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55801523|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801524|NCT02429427|Celecoxib|celecoxib|mesh-list
55801525|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55801526|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55801527|NCT02429427|Analgesics|analgesics|mesh-ancestor
55801528|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
55801529|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801530|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801531|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801532|NCT02429427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801533|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55801534|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55801535|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801536|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801537|NCT02412657|Dexamethasone|dexamethasone|mesh-list
55801538|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811728|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811729|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55811730|NCT02233803|Autonomic Agents|autonomic agents|mesh-ancestor
55811731|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811732|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811733|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55811734|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
55801539|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
55801540|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
55801542|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801557|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801559|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55801560|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55801561|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55801562|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801563|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801564|NCT02410551|Fludarabine|fludarabine|mesh-list
55801565|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
55801567|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801665|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55801568|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55801569|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
55811735|NCT02233803|Glucocorticoids|glucocorticoids|mesh-ancestor
55811736|NCT02233803|Hormones|hormones|mesh-ancestor
55801570|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801571|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55801572|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
55801573|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811737|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811738|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
55811739|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55811740|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55801598|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55811926|NCT02224599|Imiquimod|imiquimod|mesh-list
55801600|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55801601|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55801602|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55801603|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801604|NCT05618353|Colchicine|colchicine|mesh-list
55801605|NCT05618353|Gout Suppressants|gout suppressants|mesh-ancestor
55801606|NCT05618353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55812219|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801608|NCT05618353|Antimitotic Agents|antimitotic agents|mesh-ancestor
55801609|NCT05618353|Mitosis Modulators|mitosis modulators|mesh-ancestor
55801610|NCT05618353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801611|NCT05618353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801612|NCT04822909|Thalidomide|thalidomide|mesh-list
55801613|NCT04822909|Apremilast|apremilast|mesh-list
55801614|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55801615|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55801616|NCT04822909|Analgesics|analgesics|mesh-ancestor
55801617|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
55801618|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801619|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801620|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801621|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801622|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55801623|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55801624|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801625|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801626|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55801627|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
55801628|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
55801629|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55801630|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801631|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55801632|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55801633|NCT04822909|Growth Substances|growth substances|mesh-ancestor
55801634|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
55801635|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801636|NCT04831099|Testosterone|testosterone|mesh-list
55801637|NCT04831099|Androgens|androgens|mesh-ancestor
55801638|NCT04831099|Hormones|hormones|mesh-ancestor
55801639|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801640|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812403|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
55812417|NCT02195583|Zinc|zinc|mesh-list
55801641|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
55801642|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55801649|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
55801650|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55801651|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801652|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801653|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55801654|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55801655|NCT04367935|Protective Agents|protective agents|mesh-ancestor
55801656|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801657|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
55801658|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55801660|NCT04829773|Midazolam|midazolam|mesh-list
55801661|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55801662|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55801663|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801664|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801668|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55801669|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
55801671|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
55801672|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
55801673|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801674|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801675|NCT04829695|Artesunate|artesunate|mesh-list
55801676|NCT04829695|Lumefantrine|lumefantrine|mesh-list
55801677|NCT04829695|Artemether|artemether|mesh-list
55801678|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55801679|NCT04829695|Amodiaquine|amodiaquine|mesh-list
55801680|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
55801681|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55801682|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55801683|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801684|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801685|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
55801686|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
55801687|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55801690|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55801691|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
55801692|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
55801693|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801694|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801695|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55801696|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55801697|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55801698|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
55801699|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801700|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801703|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
55801704|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801706|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
55801707|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801708|NCT04828525|Dexamethasone|dexamethasone|mesh-list
55801709|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801710|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
55801711|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
55801712|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801713|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801714|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55801715|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
55801716|NCT04828525|Hormones|hormones|mesh-ancestor
55801717|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801718|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55801719|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801720|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
55801721|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55801722|NCT04821193|Disinfectants|disinfectants|mesh-list
55801723|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55801724|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55801725|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801726|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
55801727|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
55801728|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55801729|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801730|NCT04827667|Dimercaprol|dimercaprol|mesh-list
55801731|NCT04827667|Chelating Agents|chelating agents|mesh-ancestor
55801732|NCT04827667|Sequestering Agents|sequestering agents|mesh-ancestor
55801733|NCT04827667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801735|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55801737|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
55801738|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801739|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801741|NCT05617885|Leuprolide|leuprolide|mesh-list
55801742|NCT05617885|Goserelin|goserelin|mesh-list
55813209|NCT02187861|Venetoclax|venetoclax|mesh-list
55813316|NCT01887418|Hormones|hormones|mesh-ancestor
55801743|NCT05617885|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55801744|NCT05617885|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55801745|NCT05617885|Fertility Agents|fertility agents|mesh-ancestor
55801746|NCT05617885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55801747|NCT05617885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801748|NCT05617885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55801749|NCT05617885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801750|NCT05617885|Hormones|hormones|mesh-ancestor
55813535|NCT05365451|Renal Agents|renal agents|mesh-ancestor
55802034|NCT02596711|Nicotine|nicotine|mesh-list
55801751|NCT05617885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801752|NCT02605837|Budesonide|budesonide|mesh-list
55801753|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801754|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55801755|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
55801756|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801757|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801758|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55801759|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
55801760|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
55801762|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801763|NCT04834375|Dexamethasone|dexamethasone|mesh-list
55801764|NCT04834375|Dexamethasone acetate|dexamethasone acetate|mesh-list
55801765|NCT04834375|BB 1101|bb 1101|mesh-list
55813633|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55801766|NCT04834375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801768|NCT04834375|Autonomic Agents|autonomic agents|mesh-ancestor
55801769|NCT04834375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801770|NCT04834375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801771|NCT04834375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55801772|NCT04834375|Glucocorticoids|glucocorticoids|mesh-ancestor
55801773|NCT04834375|Hormones|hormones|mesh-ancestor
55801774|NCT04834375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801775|NCT04834375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55801776|NCT04834375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813727|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55801777|NCT04834375|Protease Inhibitors|protease inhibitors|mesh-ancestor
55801778|NCT04834375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801796|NCT02423343|Nivolumab|nivolumab|mesh-list
55801797|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55801798|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801799|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55801800|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801801|NCT04909515|Isotretinoin|isotretinoin|mesh-list
55801802|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
55801803|NCT05617729|Povidone-Iodine|povidone-iodine|mesh-list
55801804|NCT05617729|Povidone|povidone|mesh-list
55801805|NCT05617729|Plasma Substitutes|plasma substitutes|mesh-ancestor
55801806|NCT05617729|Blood Substitutes|blood substitutes|mesh-ancestor
55813783|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
55801807|NCT05617729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55801808|NCT05617729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801810|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55801811|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813933|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55813934|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55813935|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
55813936|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55813937|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813938|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55813939|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
55813940|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813941|NCT02155881|Ciclesonide|ciclesonide|mesh-list
55813942|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
55813943|NCT02155881|Hormones|hormones|mesh-ancestor
55813944|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813945|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813946|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55801822|NCT02406261|Simvastatin|simvastatin|mesh-list
55801823|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55801824|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55801825|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801826|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801827|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55801828|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55801829|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55801830|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55801831|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
55801832|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
55801833|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
55801834|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
55801835|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814000|NCT05350085|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55801836|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801837|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55801839|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
55801840|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55801841|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55801842|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801843|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55801844|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
55801845|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
55801846|NCT02485353|Cytarabine|cytarabine|mesh-list
55801847|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55801848|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
55814049|NCT02118597|Interferons|interferons|mesh-list
55801849|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801850|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801852|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801853|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55801854|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
55801855|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814111|NCT05163041|Nivolumab|nivolumab|mesh-list
55801856|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
55801857|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801858|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801859|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
55814491|NCT05228951|Trastuzumab|trastuzumab|mesh-list
55801860|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801861|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55801862|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55801863|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55814663|NCT05096663|Folic Acid|folic acid|mesh-list
55814792|NCT05046431|Golimumab|golimumab|mesh-list
55815014|NCT05023967|Metformin|metformin|mesh-list
55801864|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55801865|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
55801866|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55801867|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
55801868|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801870|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55801871|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55801872|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
55801873|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
55801874|NCT04826497|Vitamins|vitamins|mesh-ancestor
55801875|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
55801876|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801878|NCT04819243|Talazoparib|talazoparib|mesh-list
55801879|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801880|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55801881|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801882|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801883|NCT02604589|Hydromorphone|hydromorphone|mesh-list
55801884|NCT02604589|Bupivacaine|bupivacaine|mesh-list
55801885|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
55801886|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
55815487|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815488|NCT02045979|Adalimumab|adalimumab|mesh-list
55815489|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815490|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815491|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
55815492|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
55815493|NCT04734405|Fluconazole|fluconazole|mesh-list
55815494|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
55815495|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801887|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801888|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801889|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
55801890|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801891|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55801892|NCT02604589|Narcotics|narcotics|mesh-ancestor
55801893|NCT02604589|Analgesics|analgesics|mesh-ancestor
55801894|NCT04818151|Warfarin|warfarin|mesh-list
55801895|NCT04818151|Apixaban|apixaban|mesh-list
55815813|NCT05112952|Lazertinib|lazertinib|mesh-list
55801897|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55801898|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
55816013|NCT02096835|Hormones|hormones|mesh-ancestor
55801899|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55801900|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
55801901|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801902|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816072|NCT01645735|Vancomycin|vancomycin|mesh-list
55816194|NCT01653743|Hormones|hormones|mesh-ancestor
55816198|NCT02293993|Guadecitabine|guadecitabine|mesh-list
55817782|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818018|NCT05341843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55818229|NCT01843660|Analgesics|analgesics|mesh-ancestor
55801906|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801907|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55801908|NCT04817527|Protective Agents|protective agents|mesh-ancestor
55801909|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801911|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55801912|NCT04357795|Cyclosporins|cyclosporins|mesh-list
55801913|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801914|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801915|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55801916|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
55801917|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801918|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
55801919|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801920|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
55801921|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801922|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55801923|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55801924|NCT02604199|Tenofovir|tenofovir|mesh-list
55801925|NCT02604199|Entecavir|entecavir|mesh-list
55801926|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
55801927|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55801928|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
55801929|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55801930|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55801931|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55801932|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55801933|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55801934|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55801935|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55801936|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
55801937|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55801938|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801939|NCT04807543|Castor Oil|castor oil|mesh-list
55801940|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
55801941|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
55801942|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55801943|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
55801944|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801945|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801946|NCT04807543|Progestins|progestins|mesh-ancestor
55801947|NCT04807543|Hormones|hormones|mesh-ancestor
55716739|NCT03146793|Protective Agents|protective agents|mesh-ancestor
55716880|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55801955|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801956|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801957|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801958|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801959|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55801960|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55717226|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801961|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717711|NCT02349399|Cyproterone|cyproterone|mesh-list
55717784|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55801962|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55801963|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55801964|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718057|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55718705|NCT02327247|Felodipine|felodipine|mesh-list
55718770|NCT02316301|Misoprostol|misoprostol|mesh-list
55718919|NCT03501433|Niacinamide|niacinamide|mesh-list
55801967|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55801968|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55801969|NCT04797793|Analgesics|analgesics|mesh-ancestor
55718988|NCT02313337|Anesthetics|anesthetics|mesh-list
55801970|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
55801971|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55801972|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801973|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55801974|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55801975|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
55801977|NCT04796857|Antibodies|antibodies|mesh-list
55801978|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
55801979|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801980|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55801981|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55801982|NCT04796857|Growth Substances|growth substances|mesh-ancestor
55801983|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
55801984|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719419|NCT03497923|Analgesics|analgesics|mesh-ancestor
55719480|NCT02321293|Curcumin|curcumin|mesh-list
55801986|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55801987|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55801988|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55801989|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55801990|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
55801991|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55801992|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801993|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
55801994|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55801995|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55801996|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55801997|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719675|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55719677|NCT02321839|Growth Substances|growth substances|mesh-ancestor
55719721|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
55720008|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55720102|NCT02264171|Tamsulosin|tamsulosin|mesh-list
55720441|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
55720443|NCT01255709|Epinephrine|epinephrine|mesh-list
55720586|NCT05626829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55720655|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
55720949|NCT05355974|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55721314|NCT02328963|Everolimus|everolimus|mesh-list
55721672|NCT02522780|Mesalamine|mesalamine|mesh-list
55802002|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55802003|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55802004|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
55802005|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722098|NCT05217680|Bevacizumab|bevacizumab|mesh-list
55722162|NCT00978497|Ribavirin|ribavirin|mesh-list
55722669|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
55723180|NCT05180708|Sirolimus|sirolimus|mesh-list
55723250|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
55802006|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802007|NCT04815187|Montelukast|montelukast|mesh-list
55802008|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55802009|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
55802010|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55802011|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
55723804|NCT02322853|Tamoxifen|tamoxifen|mesh-list
55802012|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802013|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802014|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55802015|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55802016|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724096|NCT04071613|Plasminogen|plasminogen|mesh-list
55724363|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
55724508|NCT00656357|Cocaine|cocaine|mesh-list
55724722|NCT04873570|Moxifloxacin|moxifloxacin|mesh-list
55724946|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
55725170|NCT00581477|Droxidopa|droxidopa|mesh-list
55802017|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
55802018|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
55802019|NCT04805827|Gabapentin|gabapentin|mesh-list
55802020|NCT04805827|Analgesics|analgesics|mesh-ancestor
55802021|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
55802022|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802023|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802024|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
55802025|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55802026|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55802027|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725746|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802028|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55802029|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55802030|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55802031|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726893|NCT00035633|Entecavir|entecavir|mesh-list
55802032|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802033|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
55802036|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55802037|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
55802038|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802039|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802040|NCT02596711|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55802041|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55802042|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
55802044|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802045|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
55802046|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
55802047|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
55802048|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
55802049|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55802050|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802051|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802052|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
55802053|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55729108|NCT04542993|Zinc|zinc|mesh-list
55802054|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802055|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802057|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55802058|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55802059|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729558|NCT05089383|Progesterone|progesterone|mesh-list
55802060|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
55802061|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
55802062|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
55802063|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802064|NCT04804423|Listerine|listerine|mesh-list
55802065|NCT04804423|Fluorides|fluorides|mesh-list
55802066|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
55802067|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
55730192|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
55802068|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
55802069|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
55802070|NCT04804423|Protective Agents|protective agents|mesh-ancestor
55730653|NCT04266379|Insulin|insulin|mesh-list
55730692|NCT05095467|Tegafur|tegafur|mesh-list
55731063|NCT04658173|Alfentanil|alfentanil|mesh-list
55731201|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731294|NCT02813655|Hormones|hormones|mesh-ancestor
55731492|NCT02315495|Acarbose|acarbose|mesh-list
55731548|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
55731665|NCT05256745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55802071|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802072|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55802073|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802074|NCT04794049|Lactulose|lactulose|mesh-list
55731732|NCT04462523|Hormones|hormones|mesh-ancestor
55802075|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55802076|NCT04794127|Pioglitazone|pioglitazone|mesh-list
55802077|NCT04794127|Trabectedin|trabectedin|mesh-list
55802078|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55732264|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55802079|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802080|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55802081|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
55802082|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802083|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802084|NCT04804267|Linaclotide|linaclotide|mesh-list
55802085|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55802086|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
55802087|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802088|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55802089|NCT04813471|Folic Acid|folic acid|mesh-list
55802090|NCT04813471|Nicorandil|nicorandil|mesh-list
55802091|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
55802092|NCT04813471|Atorvastatin|atorvastatin|mesh-list
55802093|NCT04813471|Vitamins|vitamins|mesh-ancestor
55732474|NCT05438875|Tretinoin|tretinoin|mesh-list
55802094|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
55802095|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802096|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55802097|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55802098|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
55796566|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802099|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802100|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55802173|NCT02598193|Nintedanib|nintedanib|mesh-list
55802101|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55802102|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802103|NCT04813471|Hematinics|hematinics|mesh-ancestor
55802104|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55802105|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55802106|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
55732857|NCT03489239|Tenofovir|tenofovir|mesh-list
55733135|NCT05152355|Budesonide|budesonide|mesh-list
55802108|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55802109|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55802110|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55802111|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55802112|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802113|NCT04792723|Aspirin|aspirin|mesh-list
55802114|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55802115|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55802116|NCT04792723|Analgesics|analgesics|mesh-ancestor
55802117|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
55802118|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802119|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802120|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55802121|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55802122|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55802123|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55802124|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802125|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55802126|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55802127|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802128|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
55802129|NCT04792333|Firibastat|firibastat|mesh-list
55802130|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55802131|NCT04802785|Aspirin|aspirin|mesh-list
55802132|NCT04802785|Domperidone|domperidone|mesh-list
55802133|NCT04802785|Melatonin|melatonin|mesh-list
55802134|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55802135|NCT04802785|Simethicone|simethicone|mesh-list
55802136|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
55802137|NCT04802785|Citric Acid|citric acid|mesh-list
55733448|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
55802138|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
55802139|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
55802140|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55802141|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
55802142|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
55802143|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802144|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
55802145|NCT04802785|Protective Agents|protective agents|mesh-ancestor
55802146|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802147|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802148|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55802149|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55802150|NCT04802785|Analgesics|analgesics|mesh-ancestor
55802151|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
55802152|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733555|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
55802153|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55802154|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55802155|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55802156|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55733746|NCT05159531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733810|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
55734079|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55802157|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55734498|NCT04928183|Protective Agents|protective agents|mesh-ancestor
55802158|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55802159|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802161|NCT04802785|Antiemetics|antiemetics|mesh-ancestor
55802162|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
55802163|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55802164|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55802165|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
55802166|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802167|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
55802169|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
55735058|NCT02457221|Prednisone|prednisone|mesh-list
55802170|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
55802171|NCT04802785|Antacids|antacids|mesh-ancestor
55802172|NCT02598193|Pirfenidone|pirfenidone|mesh-list
55802174|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802175|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55802176|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735800|NCT05283161|Hormones|hormones|mesh-ancestor
55735944|NCT03441815|Histamine|histamine|mesh-list
55802177|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802178|NCT02598193|Analgesics|analgesics|mesh-ancestor
55802179|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
55802180|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802181|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736046|NCT02425826|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55736047|NCT02425826|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55736186|NCT03890133|Pregabalin|pregabalin|mesh-list
55736244|NCT03438227|Hematinics|hematinics|mesh-ancestor
55802182|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55802183|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55802184|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55802185|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55802187|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55802188|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55737044|NCT03437785|Ethanol|ethanol|mesh-list
55737362|NCT03433807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802189|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
55802190|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737751|NCT01004029|Progestins|progestins|mesh-ancestor
55802191|NCT04801303|Calcitriol|calcitriol|mesh-list
55802192|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55802193|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802194|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55802195|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55737936|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
55738088|NCT02735707|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55738305|NCT03413371|Acetaminophen|acetaminophen|mesh-list
55802196|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802197|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55802198|NCT04801303|Vitamins|vitamins|mesh-ancestor
55802199|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
55738850|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802200|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55802201|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
55739558|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802202|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
55802203|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55802204|NCT04790383|Protective Agents|protective agents|mesh-ancestor
55802205|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802206|NCT05615779|Levan|levan|mesh-list
55802207|NCT05615779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802209|NCT04789915|Amisulpride|amisulpride|mesh-list
55802210|NCT04789915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55802211|NCT04789915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55802212|NCT04789915|Dopamine Agents|dopamine agents|mesh-ancestor
55802213|NCT04789915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802214|NCT04789915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802215|NCT04789915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802216|NCT04789915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55802217|NCT04789915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55802218|NCT04789915|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55802220|NCT04789915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802223|NCT04789915|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55802224|NCT04789915|Antidepressive Agents|antidepressive agents|mesh-ancestor
55802225|NCT02388165|Vaccines|vaccines|mesh-list
55802226|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
55802227|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740408|NCT03383393|Adenosine|adenosine|mesh-list
55740608|NCT03460015|Sevoflurane|sevoflurane|mesh-list
55802229|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55802230|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
55802231|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55802232|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740871|NCT03379987|Narcotics|narcotics|mesh-ancestor
55802233|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55802234|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
55802235|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802236|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802237|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
55802239|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55802240|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55802241|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
55802242|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55802243|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55802244|NCT04788979|Melatonin|melatonin|mesh-list
55802245|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
55802246|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802247|NCT04788979|Protective Agents|protective agents|mesh-ancestor
55741066|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
55802248|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802249|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802251|NCT04811209|Anesthetics|anesthetics|mesh-list
55802252|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802253|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802254|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
55802255|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802258|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
55802259|NCT04788355|Apixaban|apixaban|mesh-list
55802260|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
55802261|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55802262|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55802263|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802264|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802265|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802266|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55741726|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55741785|NCT03366883|Paclitaxel|paclitaxel|mesh-list
55741925|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
55772126|NCT02341703|Metformin|metformin|mesh-list
55742043|NCT04503967|Nivolumab|nivolumab|mesh-list
55742181|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802267|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55802268|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
56145364|NCT00895752|Riluzole|riluzole|mesh-list
55802269|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55802270|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
55802271|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
55802272|NCT04799743|Resveratrol|resveratrol|mesh-list
55802273|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
55802274|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802275|NCT04799743|Protective Agents|protective agents|mesh-ancestor
55802276|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802278|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
56145966|NCT00993798|Bupivacaine|bupivacaine|mesh-list
55802280|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55802281|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55802282|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802283|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
55802284|NCT04788121|Coagulants|coagulants|mesh-ancestor
55802285|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
55802286|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55802287|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55802289|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
55802290|NCT04810819|Dyphylline|dyphylline|mesh-list
55802291|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55802292|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
55802293|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55802294|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
55802295|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
55802296|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802297|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802298|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55802299|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
55802300|NCT04810819|Hormones|hormones|mesh-ancestor
56146166|NCT01011816|Hemostatics|hemostatics|mesh-ancestor
55742682|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55802301|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802302|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55802303|NCT04810819|Protective Agents|protective agents|mesh-ancestor
55802304|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55802305|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802306|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55802307|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55802308|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
55802309|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55802310|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802311|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802312|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
55802313|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55802315|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55742872|NCT05135013|Hormones|hormones|mesh-ancestor
55802316|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802318|NCT04810507|Hormones|hormones|mesh-ancestor
55743007|NCT03955575|Incretins|incretins|mesh-ancestor
55743058|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55802319|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802320|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55802321|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
55802322|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802323|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802325|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55802326|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55802327|NCT04810585|Growth Substances|growth substances|mesh-ancestor
55802328|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802329|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
55743542|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55802331|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
55802332|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802333|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
55802334|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
55802335|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
55802336|NCT04809649|Itraconazole|itraconazole|mesh-list
55802337|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
55802338|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802339|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55802340|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55802341|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802342|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802343|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55802344|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
55802345|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802346|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802347|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55786911|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802348|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55802350|NCT04786795|Pancrelipase|pancrelipase|mesh-list
55802351|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55788560|NCT04529863|Abatacept|abatacept|mesh-list
55788770|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788843|NCT02622113|Canagliflozin|canagliflozin|mesh-list
55802352|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55802353|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
55802354|NCT02596945|Hematinics|hematinics|mesh-ancestor
55802355|NCT04786327|Edetic Acid|edetic acid|mesh-list
55744891|NCT02490865|RNS60|rns60|mesh-list
55802356|NCT04786327|Mitogens|mitogens|mesh-list
55802357|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
55802358|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
55802359|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802360|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
55802361|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55744945|NCT02490085|Insulin|insulin|mesh-list
55745092|NCT05463367|Oxymorphone|oxymorphone|mesh-list
55745237|NCT05456269|Antimetabolites|antimetabolites|mesh-ancestor
55745307|NCT02726113|Vitamin D|vitamin d|mesh-list
55802363|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
55802364|NCT04786327|Antidotes|antidotes|mesh-ancestor
55802365|NCT04786327|Protective Agents|protective agents|mesh-ancestor
55745368|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55802366|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802367|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55802368|NCT04153435|Calcium|calcium|mesh-list
55802369|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55802370|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802371|NCT01667419|Vemurafenib|vemurafenib|mesh-list
55802372|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802373|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55802374|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802375|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802376|NCT04808791|Trifluridine|trifluridine|mesh-list
55802377|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
55802378|NCT04808791|Irinotecan|irinotecan|mesh-list
55802379|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802380|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55802381|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55802382|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802383|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802384|NCT04808791|Antimetabolites|antimetabolites|mesh-ancestor
55802385|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
55802386|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745586|NCT03136809|Copper|copper|mesh-list
55745636|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802388|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
55802389|NCT04023019|Coagulants|coagulants|mesh-ancestor
55802390|NCT04785547|Blinatumomab|blinatumomab|mesh-list
55802391|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802393|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55802394|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55802395|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55802396|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55802397|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802399|NCT03843853|Pemetrexed|pemetrexed|mesh-list
55802400|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55802401|NCT03843853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802402|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55802403|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55802404|NCT03843853|Growth Substances|growth substances|mesh-ancestor
55789032|NCT03520231|Vitamins|vitamins|mesh-ancestor
55746157|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55746305|NCT02038777|Azacitidine|azacitidine|mesh-list
55802405|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746378|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55746584|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746585|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746586|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55746587|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
55746588|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55746589|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55746590|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55746591|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
55746592|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55746593|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55746594|NCT03301207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746595|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55746597|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55746598|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55746599|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55746600|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55746601|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55746603|NCT03301207|Hormones|hormones|mesh-ancestor
55778586|NCT01288625|Amifostine|amifostine|mesh-list
55746604|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746605|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55746606|NCT03311971|Methamphetamine|methamphetamine|mesh-list
55746607|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55746608|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746613|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746734|NCT03299725|Bismuth|bismuth|mesh-list
55802406|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
55802407|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802408|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802409|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55802410|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55802411|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
55802412|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55802413|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
55802414|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802415|NCT05054179|Ropivacaine|ropivacaine|mesh-list
55746877|NCT05302531|Amoxicillin|amoxicillin|mesh-list
55802416|NCT05054179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55802417|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
55802418|NCT05054179|Anesthetics|anesthetics|mesh-ancestor
55802419|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802420|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802421|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
55802422|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802423|NCT03497689|Treprostinil|treprostinil|mesh-list
55802424|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55802425|NCT05611879|Paclitaxel|paclitaxel|mesh-list
55802426|NCT05611879|Carboplatin|carboplatin|mesh-list
55802427|NCT05611879|Pemetrexed|pemetrexed|mesh-list
55802428|NCT05611879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55747146|NCT03337087|Folic Acid|folic acid|mesh-list
55747213|NCT03296137|Aldesleukin|aldesleukin|mesh-list
55802430|NCT05611879|Tubulin Modulators|tubulin modulators|mesh-ancestor
55802431|NCT05611879|Antimitotic Agents|antimitotic agents|mesh-ancestor
55802432|NCT05611879|Mitosis Modulators|mitosis modulators|mesh-ancestor
55802433|NCT05611879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802434|NCT05611879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802435|NCT05611879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55802436|NCT05611879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55802437|NCT04789057|Atorvastatin|atorvastatin|mesh-list
55802438|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55802439|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55802440|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
55802441|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802442|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55802443|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55802444|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802445|NCT05613361|Colistin|colistin|mesh-list
55802446|NCT05613361|Curcumin|curcumin|mesh-list
55747421|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55747544|NCT01653925|Dutasteride|dutasteride|mesh-list
55747600|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55802447|NCT05613361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55802448|NCT05613361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55747736|NCT03363815|Metformin|metformin|mesh-list
55802450|NCT05613361|Sensory System Agents|sensory system agents|mesh-ancestor
55747813|NCT02459977|Basiliximab|basiliximab|mesh-list
55802451|NCT05613361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802452|NCT05613361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747883|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
55748157|NCT03107923|Protective Agents|protective agents|mesh-ancestor
55748222|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
55802453|NCT05613361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55802454|NCT05613361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55802455|NCT05613361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802456|NCT05613361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802457|NCT05613361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802458|NCT05613361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55748344|NCT02714569|Atorvastatin|atorvastatin|mesh-list
55748601|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
55748748|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
55802459|NCT05613361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802460|NCT05611645|Bevacizumab|bevacizumab|mesh-list
55802461|NCT05611645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55802462|NCT05611645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748876|NCT04505657|Celecoxib|celecoxib|mesh-list
55802463|NCT05611645|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55802464|NCT05611645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55748944|NCT05505617|Nitric Oxide|nitric oxide|mesh-list
55802465|NCT05611645|Growth Substances|growth substances|mesh-ancestor
55802466|NCT05611645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802467|NCT05611645|Growth Inhibitors|growth inhibitors|mesh-ancestor
55802469|NCT03267121|Tegafur|tegafur|mesh-list
55749091|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749412|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55749491|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
55802470|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749544|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
55802471|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55749756|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55802472|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750287|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
55750346|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
55750409|NCT04498325|Antibodies|antibodies|mesh-list
55802473|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802474|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55802475|NCT03267121|Antimetabolites|antimetabolites|mesh-ancestor
55802476|NCT02835079|Tamoxifen|tamoxifen|mesh-list
55802477|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55750532|NCT02494973|Oxaliplatin|oxaliplatin|mesh-list
55802479|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802480|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750667|NCT02498015|Ribavirin|ribavirin|mesh-list
55802481|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55802482|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802483|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55750880|NCT05032287|Tamsulosin|tamsulosin|mesh-list
55802484|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55802485|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55802487|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
55802488|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802489|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55802490|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55802491|NCT01667107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55751262|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
55751467|NCT03332069|Cisplatin|cisplatin|mesh-list
55802492|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55802493|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55802495|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802496|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55802497|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
55802498|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802499|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802501|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
55802502|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55802503|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
55802504|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751996|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
55802505|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
55802506|NCT04589611|Protective Agents|protective agents|mesh-ancestor
55802507|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55802508|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802509|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
55802510|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
55802511|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802512|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802514|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55802515|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802516|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55802517|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802518|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
55802519|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55802520|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
55802521|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802522|NCT05240131|Atezolizumab|atezolizumab|mesh-list
55802523|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802524|NCT05188339|Heparin|heparin|mesh-list
55802525|NCT05188339|Citric Acid|citric acid|mesh-list
55752297|NCT05004909|Tretinoin|tretinoin|mesh-list
55802527|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
55802528|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55802529|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
55802530|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
55802531|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802532|NCT05188339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55802533|NCT05188339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55802534|NCT05613205|Vaccines|vaccines|mesh-list
55802535|NCT05613205|Immunologic Factors|immunologic factors|mesh-ancestor
55802536|NCT05613205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802537|NCT05614765|Ezetimibe|ezetimibe|mesh-list
55802538|NCT05614765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55802539|NCT05614765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55802540|NCT05614765|Antimetabolites|antimetabolites|mesh-ancestor
55752422|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55802541|NCT05614765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802542|NCT05614765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55802543|NCT02590003|Paclitaxel|paclitaxel|mesh-list
55802545|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55752917|NCT03201601|Inositol|inositol|mesh-list
55802546|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802547|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
55802548|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
55802549|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
55802550|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802551|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
55753232|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802553|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55802554|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802555|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55753790|NCT02476799|Ketorolac|ketorolac|mesh-list
55802556|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802558|NCT05474053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55802559|NCT05474053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55802560|NCT05474053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55802561|NCT05474053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55802562|NCT05474053|Purinergic Agents|purinergic agents|mesh-ancestor
55753989|NCT04491773|Tadalafil|tadalafil|mesh-list
55754182|NCT03948347|Incretins|incretins|mesh-ancestor
55754346|NCT03309215|Nickel|nickel|mesh-list
55754483|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
55802563|NCT05474053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802564|NCT05474053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802565|NCT05474053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802566|NCT04988035|Remdesivir|remdesivir|mesh-list
55802567|NCT04988035|Antimetabolites|antimetabolites|mesh-ancestor
55802568|NCT04988035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802569|NCT04988035|Antiviral Agents|antiviral agents|mesh-ancestor
55802570|NCT04988035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802571|NCT05473819|Anesthetics|anesthetics|mesh-list
55802572|NCT05473819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802573|NCT05473819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754616|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802575|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55802576|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55754815|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
55802577|NCT04330729|Analgesics|analgesics|mesh-ancestor
55802578|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
55802579|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802580|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802581|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55755002|NCT04794699|Tubulin Modulators|tubulin modulators|mesh-ancestor
55755405|NCT05582811|Riociguat|riociguat|mesh-list
55755479|NCT05565495|Analgesics|analgesics|mesh-ancestor
55755553|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
55802582|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55802583|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55802584|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55802585|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802586|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55802587|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55802588|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802589|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
55802590|NCT05473741|Risperidone|risperidone|mesh-list
55802591|NCT05473741|Aripiprazole|aripiprazole|mesh-list
55755756|NCT04006457|Vaccines|vaccines|mesh-list
55802592|NCT05473741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55756012|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
55802594|NCT05473741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55802595|NCT05473741|Serotonin Agents|serotonin agents|mesh-ancestor
55802596|NCT05473741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802597|NCT05473741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802598|NCT05473741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802599|NCT05473741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55756286|NCT04429347|Analgesics|analgesics|mesh-ancestor
55756425|NCT02730429|Letrozole|letrozole|mesh-list
55756634|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
55802600|NCT05473741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802601|NCT05473741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55802602|NCT05473741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55757167|NCT02458157|Furosemide|furosemide|mesh-list
55802603|NCT05473741|Dopamine Agents|dopamine agents|mesh-ancestor
55802604|NCT05473741|Antidepressive Agents|antidepressive agents|mesh-ancestor
55802605|NCT05473741|Dopamine Agonists|dopamine agonists|mesh-ancestor
55802606|NCT05473741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55802607|NCT05473741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55802609|NCT05473741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55802611|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
55802612|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802613|NCT04762771|Colchicine|colchicine|mesh-list
55802614|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
55758246|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758312|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
55758453|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
55758522|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
55802619|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802620|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802621|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55802622|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55802623|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55802624|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55758578|NCT02621931|Calcitonin|calcitonin|mesh-list
55802625|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802626|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
55802627|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55802628|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802629|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802630|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55802631|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55758956|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55802632|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802633|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
55802634|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802635|NCT04481035|Acetylcysteine|acetylcysteine|mesh-list
55802636|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55802637|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
55802638|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802639|NCT04481035|Expectorants|expectorants|mesh-ancestor
55759153|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55802640|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
55802641|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55802642|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
55802643|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802644|NCT04481035|Protective Agents|protective agents|mesh-ancestor
55802645|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802646|NCT04481035|Antidotes|antidotes|mesh-ancestor
55802647|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
55802648|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55759933|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55760136|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55802649|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
55802650|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802651|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
55802652|NCT03032107|Trastuzumab|trastuzumab|mesh-list
55802653|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55802654|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55802655|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802656|NCT03032107|Tubulin Modulators|tubulin modulators|mesh-ancestor
55802657|NCT03032107|Antimitotic Agents|antimitotic agents|mesh-ancestor
55802658|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
55802659|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761843|NCT03107429|Acetazolamide|acetazolamide|mesh-list
55802660|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55802661|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
55802662|NCT05700955|Pembrolizumab|pembrolizumab|mesh-list
55802663|NCT05700955|Temozolomide|temozolomide|mesh-list
55802664|NCT05700955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55802665|NCT05700955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762115|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
55802666|NCT05700955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55802667|NCT05700955|Alkylating Agents|alkylating agents|mesh-ancestor
55802668|NCT05700955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762812|NCT04225221|Estrogens|estrogens|mesh-ancestor
55762814|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762815|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762816|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55802670|NCT01650519|Ketorolac|ketorolac|mesh-list
55802671|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55802672|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55802673|NCT01650519|Analgesics|analgesics|mesh-ancestor
55802675|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802676|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802677|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55802678|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55763339|NCT02105116|Cytarabine|cytarabine|mesh-list
55802679|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55802680|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802681|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802682|NCT02197039|Esomeprazole|esomeprazole|mesh-list
55802686|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55802687|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55802688|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763472|NCT05540145|Mitosis Modulators|mitosis modulators|mesh-ancestor
55763543|NCT05538507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55763748|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55802689|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802690|NCT02197039|Coagulants|coagulants|mesh-ancestor
55802691|NCT05557903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55802692|NCT05557903|Alemtuzumab|alemtuzumab|mesh-list
55802693|NCT05557903|Antibodies|antibodies|mesh-list
55802694|NCT05557903|Immunoglobulins|immunoglobulins|mesh-list
55802695|NCT05557903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55802696|NCT05557903|Immunologic Factors|immunologic factors|mesh-ancestor
55802697|NCT05557903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802698|NCT05557903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802699|NCT02386839|Mecasermin|mecasermin|mesh-list
55802700|NCT02386839|Growth Substances|growth substances|mesh-ancestor
55764027|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
55802701|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764153|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55802702|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55802703|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
55802704|NCT05347459|Empagliflozin|empagliflozin|mesh-list
55802705|NCT05347459|Linagliptin|linagliptin|mesh-list
55802706|NCT05347459|Vildagliptin|vildagliptin|mesh-list
55802707|NCT05347459|Canagliflozin|canagliflozin|mesh-list
55764398|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
55764473|NCT05533983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55764474|NCT05533983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764476|NCT05627271|Ocrelizumab|ocrelizumab|mesh-list
55764477|NCT05627271|Natalizumab|natalizumab|mesh-list
55764478|NCT05627271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764750|NCT03187691|Amphotericin B|amphotericin b|mesh-list
55765031|NCT02428751|Hormones|hormones|mesh-ancestor
55802708|NCT05347459|Saxagliptin|saxagliptin|mesh-list
55802709|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55802710|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802711|NCT05347459|Incretins|incretins|mesh-ancestor
55802713|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802714|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55802715|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
55802717|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765374|NCT03183557|Vitamin D|vitamin d|mesh-list
55802718|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55802719|NCT05346445|Fluoxetine|fluoxetine|mesh-list
55802720|NCT05346445|Citalopram|citalopram|mesh-list
55802721|NCT05346445|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55802722|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55802723|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55765445|NCT02426177|Sympathomimetics|sympathomimetics|mesh-ancestor
55802724|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802725|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802726|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
55765511|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55765658|NCT02423837|Rituximab|rituximab|mesh-list
55802727|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802728|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55802729|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
55802730|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55802732|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55802733|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802734|NCT01649271|Trastuzumab|trastuzumab|mesh-list
55802735|NCT01649271|Afatinib|afatinib|mesh-list
55802736|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55802737|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802738|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55802739|NCT01649271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802740|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802741|NCT05556889|Iodine|iodine|mesh-list
55802742|NCT05556889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55802743|NCT05556889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802744|NCT05556889|Trace Elements|trace elements|mesh-ancestor
55802745|NCT05556889|Micronutrients|micronutrients|mesh-ancestor
55802746|NCT05556889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802747|NCT04901715|Albuterol|albuterol|mesh-list
55802748|NCT04901715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55802749|NCT04901715|Autonomic Agents|autonomic agents|mesh-ancestor
55802750|NCT04901715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802751|NCT04901715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802752|NCT04901715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55802753|NCT04901715|Respiratory System Agents|respiratory system agents|mesh-ancestor
55802754|NCT04901715|Tocolytic Agents|tocolytic agents|mesh-ancestor
55802755|NCT04901715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55802757|NCT04901715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55802758|NCT04901715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55802759|NCT04901715|Adrenergic Agents|adrenergic agents|mesh-ancestor
55802760|NCT04901715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802761|NCT04901715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802762|NCT02385669|Ipilimumab|ipilimumab|mesh-list
55802763|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55802764|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802767|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
55802768|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55802769|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55802770|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802771|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
55802772|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
55802773|NCT02400333|Ticagrelor|ticagrelor|mesh-list
55802774|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55802775|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55802776|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55802777|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55802778|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
55802779|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802780|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802782|NCT02399475|Hormones|hormones|mesh-list
55802783|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
55802784|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802785|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802787|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
55802788|NCT02399163|Protective Agents|protective agents|mesh-ancestor
55802789|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802790|NCT02397837|Pramipexole|pramipexole|mesh-list
55802791|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
55802792|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802793|NCT02397837|Protective Agents|protective agents|mesh-ancestor
55802794|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802795|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55802796|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55802797|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
55802798|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
55802799|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802800|NCT05549167|Sirolimus|sirolimus|mesh-list
55802801|NCT05549167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55802802|NCT05549167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55802803|NCT05549167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55802804|NCT05549167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802805|NCT05549167|Antifungal Agents|antifungal agents|mesh-ancestor
55802806|NCT05549167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55802807|NCT05549167|Immunologic Factors|immunologic factors|mesh-ancestor
55802808|NCT05549167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802809|NCT05542615|Pirfenidone|pirfenidone|mesh-list
55802810|NCT05542615|Analgesics|analgesics|mesh-ancestor
55802812|NCT05542615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802813|NCT05542615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802814|NCT05542615|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55802816|NCT05542615|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55802817|NCT05542615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55802818|NCT05542615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802820|NCT05700721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55802826|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802827|NCT05542381|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55802828|NCT05542381|Nepafenac|nepafenac|mesh-list
55802829|NCT05542381|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55802830|NCT05542381|Lubricant Eye Drops|lubricant eye drops|mesh-list
55802831|NCT05542381|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55802832|NCT05542381|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55802833|NCT05542381|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55802834|NCT05542381|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55802835|NCT05542381|Analgesics|analgesics|mesh-ancestor
55802836|NCT05542381|Sensory System Agents|sensory system agents|mesh-ancestor
55802837|NCT05542381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802838|NCT05542381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802839|NCT05542381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55802840|NCT05542381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55802841|NCT05542147|Fenofibrate|fenofibrate|mesh-list
55802843|NCT05542147|Antimetabolites|antimetabolites|mesh-ancestor
55802844|NCT05542147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802845|NCT05542147|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55802846|NCT05548465|Sufentanil|sufentanil|mesh-list
55802847|NCT05548465|Remifentanil|remifentanil|mesh-list
55802849|NCT05548465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55866680|NCT03213886|Vitamin D|vitamin d|mesh-list
55764558|NCT02435537|Morphine|morphine|mesh-list
55867377|NCT01724086|Interferons|interferons|mesh-list
55867479|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
55867877|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802851|NCT05548465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802852|NCT05548465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802853|NCT05548465|Analgesics|analgesics|mesh-ancestor
55802854|NCT05548465|Sensory System Agents|sensory system agents|mesh-ancestor
55802855|NCT05548465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802856|NCT05548465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55802857|NCT05548465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55802858|NCT05548465|Anesthetics, General|anesthetics, general|mesh-ancestor
55802859|NCT05548465|Anesthetics|anesthetics|mesh-ancestor
55802860|NCT05548075|Psilocybin|psilocybin|mesh-list
55802861|NCT05548075|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
55802862|NCT05548075|Hallucinogens|hallucinogens|mesh-ancestor
55802863|NCT05548075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802864|NCT05548075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55802865|NCT05548075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55802866|NCT05548075|Serotonin Agents|serotonin agents|mesh-ancestor
55802867|NCT05548075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802868|NCT05548075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802869|NCT05548075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55802870|NCT05554003|Temozolomide|temozolomide|mesh-list
55802871|NCT05554003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55802872|NCT05554003|Alkylating Agents|alkylating agents|mesh-ancestor
55789129|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
55868309|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55789140|NCT05132413|Bevacizumab|bevacizumab|mesh-list
55802873|NCT05554003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802874|NCT05554003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802876|NCT05541757|Anticoagulants|anticoagulants|mesh-ancestor
55802877|NCT05541757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55802878|NCT05541757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55802879|NCT05541757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802881|NCT04326283|Riluzole|riluzole|mesh-list
55868698|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868738|NCT03840915|Gemcitabine|gemcitabine|mesh-list
55868788|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55802882|NCT04326283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802883|NCT04326283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55802884|NCT04326283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869386|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55802885|NCT04326283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869734|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55869942|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55870122|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789189|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
55870615|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55870972|NCT03033316|Dexamethasone|dexamethasone|mesh-list
55789237|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802886|NCT04326283|Anticonvulsants|anticonvulsants|mesh-ancestor
55802887|NCT04326283|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55802888|NCT04326283|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55802889|NCT04326283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802890|NCT04326283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802891|NCT04326283|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55802892|NCT04326283|Protective Agents|protective agents|mesh-ancestor
55802893|NCT05700565|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55802895|NCT05700565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802896|NCT05541445|Pembrolizumab|pembrolizumab|mesh-list
55802897|NCT05541445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55802898|NCT05541445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802900|NCT04325503|Carbidopa|carbidopa|mesh-list
55802902|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55802903|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
55802904|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802905|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802906|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802907|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55802908|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802910|NCT05540977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55802911|NCT05540977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802912|NCT05540977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802913|NCT05540977|Cholinergic Agents|cholinergic agents|mesh-ancestor
55802914|NCT05540977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802915|NCT05540977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802916|NCT05540977|Nootropic Agents|nootropic agents|mesh-ancestor
55802918|NCT05547685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802919|NCT05547685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802920|NCT05540587|Warfarin|warfarin|mesh-list
55802921|NCT05540587|Edoxaban|edoxaban|mesh-list
55802922|NCT05540587|Anticoagulants|anticoagulants|mesh-ancestor
55802923|NCT05540587|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55802924|NCT05540587|Antithrombins|antithrombins|mesh-ancestor
55802925|NCT05540587|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55789506|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802926|NCT05540587|Protease Inhibitors|protease inhibitors|mesh-ancestor
55802927|NCT05540587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55802928|NCT05540587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802930|NCT05540431|Antidotes|antidotes|mesh-ancestor
55802931|NCT05540431|Protective Agents|protective agents|mesh-ancestor
55789507|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
55789508|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55789509|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
55789510|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
55789511|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55789512|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55789513|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55789514|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
55789515|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789516|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789517|NCT04576663|Protective Agents|protective agents|mesh-ancestor
55789518|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55789520|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55789521|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55802932|NCT05540431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802934|NCT05553067|Immunologic Factors|immunologic factors|mesh-ancestor
55802935|NCT05553067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802936|NCT05540275|Bevacizumab|bevacizumab|mesh-list
55802937|NCT05540275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55789522|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789524|NCT04400695|Vinorelbine|vinorelbine|mesh-list
55789525|NCT04400695|Docetaxel|docetaxel|mesh-list
55789527|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55789528|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789529|NCT04400695|Tubulin Modulators|tubulin modulators|mesh-ancestor
55789530|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
55789531|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
55789532|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789533|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55789535|NCT05229055|Ketamine|ketamine|mesh-list
55789536|NCT05229055|Analgesics|analgesics|mesh-ancestor
55789537|NCT05229055|Sensory System Agents|sensory system agents|mesh-ancestor
55802938|NCT05540275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802939|NCT05540275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55802940|NCT05540275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55802941|NCT05540275|Growth Substances|growth substances|mesh-ancestor
55802942|NCT05540275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802943|NCT05540275|Growth Inhibitors|growth inhibitors|mesh-ancestor
55802945|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55802946|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55789538|NCT05229055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789539|NCT05229055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789540|NCT05229055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55789541|NCT05229055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55789542|NCT05229055|Anesthetics, General|anesthetics, general|mesh-ancestor
55789543|NCT05229055|Anesthetics|anesthetics|mesh-ancestor
55789544|NCT05229055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789545|NCT05229055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55789546|NCT05229055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55789547|NCT05229055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789548|NCT05229055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789550|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55789551|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789552|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55789553|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789554|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
55789555|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55789556|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
55789557|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789558|NCT05191225|Rituximab|rituximab|mesh-list
55789559|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55789560|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789561|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
55789562|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789563|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55789573|NCT03909217|Citalopram|citalopram|mesh-list
55789574|NCT03909217|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55789575|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55789576|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55789577|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789578|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789579|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
55789580|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789581|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55789582|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
55789583|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55789584|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55789585|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55789586|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
55789587|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
55789588|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802947|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55802948|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55802949|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802950|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
55802951|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802952|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802953|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55802954|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802956|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55802957|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
55802958|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789589|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55789590|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55789591|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
55789593|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
55789594|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
55789595|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789596|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789597|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
55789598|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789599|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55789600|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55802959|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55802961|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802962|NCT05546359|Dexamethasone|dexamethasone|mesh-list
55802963|NCT05546359|Ondansetron|ondansetron|mesh-list
55789601|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55789602|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55789603|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789606|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789607|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55789608|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
55789609|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
55789610|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789611|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789612|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802965|NCT05546359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55802966|NCT05546359|Antiemetics|antiemetics|mesh-ancestor
55802967|NCT05546359|Autonomic Agents|autonomic agents|mesh-ancestor
55802968|NCT05546359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55802969|NCT05546359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802970|NCT05546359|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55802971|NCT05546359|Glucocorticoids|glucocorticoids|mesh-ancestor
55802972|NCT05546359|Hormones|hormones|mesh-ancestor
55802973|NCT05546359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55802974|NCT05546359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55802975|NCT05546359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55802976|NCT05546359|Antipruritics|antipruritics|mesh-ancestor
55802977|NCT05546359|Dermatologic Agents|dermatologic agents|mesh-ancestor
55802978|NCT05546359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55802979|NCT05546359|Serotonin Agents|serotonin agents|mesh-ancestor
55789613|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55802980|NCT05546359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55802981|NCT05546359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802982|NCT05546359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55802983|NCT05546359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55802984|NCT05546359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55802985|NCT05546359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55802986|NCT05546359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55802987|NCT05546359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55802988|NCT05546359|Dopamine Agents|dopamine agents|mesh-ancestor
55802989|NCT05546359|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55802990|NCT05546359|Antidepressive Agents|antidepressive agents|mesh-ancestor
55802991|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55802992|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
55789614|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55789615|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789616|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
55789617|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55802993|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55802996|NCT05550415|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55802997|NCT05550415|Antimetabolites|antimetabolites|mesh-ancestor
55802998|NCT05550415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55802999|NCT05550415|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55803000|NCT05550415|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55803001|NCT05550415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803002|NCT02586727|Aflibercept|aflibercept|mesh-list
55803003|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55803004|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55789619|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
55789620|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789621|NCT04891679|Misoprostol|misoprostol|mesh-list
55803005|NCT02586727|Growth Substances|growth substances|mesh-ancestor
55803006|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803007|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
55803008|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803009|NCT05550025|Apatinib|apatinib|mesh-list
55803010|NCT05550025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803011|NCT05550025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55803012|NCT05550025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803013|NCT05550025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789622|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55803014|NCT05700253|Hyaluronic Acid|hyaluronic acid|mesh-list
55803015|NCT05700253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55803016|NCT05700253|Immunologic Factors|immunologic factors|mesh-ancestor
55803017|NCT05700253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803018|NCT05700253|Viscosupplements|viscosupplements|mesh-ancestor
55803019|NCT05700253|Protective Agents|protective agents|mesh-ancestor
55803020|NCT05544253|Mitomycins|mitomycins|mesh-list
55789623|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
55789624|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55803021|NCT05544253|Mitomycin|mitomycin|mesh-list
55803022|NCT05544253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55803023|NCT05544253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803024|NCT05544253|Alkylating Agents|alkylating agents|mesh-ancestor
55803025|NCT05544253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803026|NCT05544253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55803027|NCT05544253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803028|NCT05535517|Emollients|emollients|mesh-list
55789625|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789627|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789628|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
55803030|NCT05543941|Povidone-Iodine|povidone-iodine|mesh-list
55803031|NCT05543941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55803032|NCT05543941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803033|NCT02580877|Insulin|insulin|mesh-list
55803034|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55803035|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
55803036|NCT02580877|Methamphetamine|methamphetamine|mesh-list
55803037|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55803038|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789629|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
55789630|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55789631|NCT04913831|Protective Agents|protective agents|mesh-ancestor
55803039|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55803041|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
55803042|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803043|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
55803045|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803046|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
55789632|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789633|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
55789635|NCT04900415|Vitamins|vitamins|mesh-ancestor
55789636|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
55789637|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789638|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
55789639|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55803047|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55803048|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55803049|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55803050|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55803051|NCT02942095|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55803052|NCT02942095|Ixazomib|ixazomib|mesh-list
55803053|NCT02942095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789640|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789641|NCT04900571|Renal Agents|renal agents|mesh-ancestor
55803054|NCT02942095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55803055|NCT02942095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803056|NCT02942095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803057|NCT02942095|Protease Inhibitors|protease inhibitors|mesh-ancestor
55803058|NCT05402293|Lidocaine|lidocaine|mesh-list
55803059|NCT05402293|Anesthetics, Local|anesthetics, local|mesh-ancestor
55803060|NCT05402293|Anesthetics|anesthetics|mesh-ancestor
55803061|NCT05402293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803062|NCT05402293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803063|NCT05402293|Sensory System Agents|sensory system agents|mesh-ancestor
55789642|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55789643|NCT04891211|Vitamin D|vitamin d|mesh-list
55789644|NCT04891211|Vitamins|vitamins|mesh-ancestor
55789645|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
55789646|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789647|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55789648|NCT04817189|Dexamethasone|dexamethasone|mesh-list
55789649|NCT04817189|Ondansetron|ondansetron|mesh-list
55789650|NCT04817189|Palonosetron|palonosetron|mesh-list
55789651|NCT04817189|Granisetron|granisetron|mesh-list
55789652|NCT04817189|Tropisetron|tropisetron|mesh-list
55789653|NCT04817189|Dolasetron|dolasetron|mesh-list
55789654|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55789655|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
55789656|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
55789657|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789658|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803064|NCT05402293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803065|NCT05402293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55803066|NCT05402293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55803067|NCT05402293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55803068|NCT05402293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55803069|NCT05402293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803071|NCT01905631|Promethazine|promethazine|mesh-list
55803072|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55803073|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55803074|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803075|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789659|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55803076|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
55803077|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
55803087|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803088|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55803089|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
55803090|NCT01905631|Dermatologic Agents|dermatologic agents|mesh-ancestor
55803091|NCT05679037|Thioctic Acid|thioctic acid|mesh-list
55803092|NCT05679037|Antioxidants|antioxidants|mesh-ancestor
55803093|NCT05679037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803094|NCT05679037|Protective Agents|protective agents|mesh-ancestor
55803095|NCT05679037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803096|NCT05679037|Vitamin B Complex|vitamin b complex|mesh-ancestor
55803098|NCT05679037|Micronutrients|micronutrients|mesh-ancestor
55789660|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
55803099|NCT05243329|Psilocybin|psilocybin|mesh-list
55803100|NCT05243329|Hallucinogens|hallucinogens|mesh-ancestor
55803101|NCT05243329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803102|NCT05243329|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55803103|NCT05197621|Vaccines|vaccines|mesh-list
55789661|NCT04817189|Hormones|hormones|mesh-ancestor
55789662|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789663|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55803104|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
55789664|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789665|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
55789666|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
55803105|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803106|NCT05678959|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
55803108|NCT05678959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803109|NCT05672407|Tranexamic Acid|tranexamic acid|mesh-list
55803110|NCT05672407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55803111|NCT05672407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55803112|NCT05672407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803113|NCT05672407|Hemostatics|hemostatics|mesh-ancestor
55803114|NCT05672407|Coagulants|coagulants|mesh-ancestor
55803115|NCT05678647|Iron|iron|mesh-list
55789668|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
55789669|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789670|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789671|NCT04817189|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55789672|NCT04817189|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55789673|NCT04817189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789674|NCT04817189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55789675|NCT04817189|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55789676|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55803117|NCT05678647|Micronutrients|micronutrients|mesh-ancestor
55803118|NCT05678647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803119|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
55803120|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55789677|NCT03050957|Menthol|menthol|mesh-list
55789678|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
55789679|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
55789680|NCT04885049|Racecadotril|racecadotril|mesh-list
55789681|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
55789682|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789683|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
55789684|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789685|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789686|NCT04392011|Midazolam|midazolam|mesh-list
55789687|NCT04392011|Dextromethorphan|dextromethorphan|mesh-list
55789688|NCT04392011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55789689|NCT04392011|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55803121|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55803122|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803123|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55803124|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55803125|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
55803126|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803127|NCT02582749|Bicalutamide|bicalutamide|mesh-list
55803128|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55803129|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
55803130|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
55803131|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803132|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789690|NCT04392011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803133|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803134|NCT05695495|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
55803135|NCT05695495|Hallucinogens|hallucinogens|mesh-ancestor
55803136|NCT05695495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803137|NCT05695495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55803138|NCT05695495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55803139|NCT05695495|Serotonin Agents|serotonin agents|mesh-ancestor
55803140|NCT05695495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789691|NCT04392011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789692|NCT04392011|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55789693|NCT04392011|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55789694|NCT04392011|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55789695|NCT04392011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55789696|NCT04392011|Anesthetics, General|anesthetics, general|mesh-ancestor
55789697|NCT04392011|Anesthetics|anesthetics|mesh-ancestor
55789698|NCT04392011|GABA Modulators|gaba modulators|mesh-ancestor
55789699|NCT04392011|GABA Agents|gaba agents|mesh-ancestor
55789700|NCT04392011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55803141|NCT05695495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803142|NCT05695495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55803143|NCT05461261|Prednisolone|prednisolone|mesh-list
55803144|NCT05461261|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55803145|NCT05461261|Methylprednisolone|methylprednisolone|mesh-list
55803146|NCT05461261|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55803147|NCT05461261|Prednisolone acetate|prednisolone acetate|mesh-list
55803148|NCT05461261|Docetaxel|docetaxel|mesh-list
55803149|NCT05461261|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55789701|NCT04392011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789702|NCT04392011|Antitussive Agents|antitussive agents|mesh-ancestor
55789703|NCT04392011|Respiratory System Agents|respiratory system agents|mesh-ancestor
55803151|NCT05461261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803152|NCT05461261|Tubulin Modulators|tubulin modulators|mesh-ancestor
55803153|NCT05461261|Antimitotic Agents|antimitotic agents|mesh-ancestor
55803154|NCT05461261|Mitosis Modulators|mitosis modulators|mesh-ancestor
55803155|NCT05461261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803156|NCT05461261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55803157|NCT05461261|Glucocorticoids|glucocorticoids|mesh-ancestor
55803158|NCT05461261|Hormones|hormones|mesh-ancestor
55803159|NCT05461261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803160|NCT05461261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803161|NCT05461261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55803162|NCT05461261|Antiemetics|antiemetics|mesh-ancestor
55803163|NCT05461261|Autonomic Agents|autonomic agents|mesh-ancestor
55803164|NCT05461261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803165|NCT05461261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789704|NCT04392011|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55803166|NCT05461261|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55803167|NCT05461261|Protective Agents|protective agents|mesh-ancestor
55803168|NCT02586025|Docetaxel|docetaxel|mesh-list
55803169|NCT02586025|Trastuzumab|trastuzumab|mesh-list
55789705|NCT04392011|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55789706|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55789707|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
55803170|NCT02586025|Pertuzumab|pertuzumab|mesh-list
55803171|NCT02586025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803172|NCT02586025|Tubulin Modulators|tubulin modulators|mesh-ancestor
55803173|NCT02586025|Antimitotic Agents|antimitotic agents|mesh-ancestor
55803174|NCT02586025|Mitosis Modulators|mitosis modulators|mesh-ancestor
55789708|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55789710|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789711|NCT04899479|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55789712|NCT04899479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789713|NCT04899479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55789714|NCT04899479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789715|NCT04430621|Hormones|hormones|mesh-list
55789716|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55803175|NCT02586025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803176|NCT02586025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803177|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55803178|NCT05678413|Paclitaxel|paclitaxel|mesh-list
55803179|NCT05678413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55803180|NCT05678413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803181|NCT05678413|Tubulin Modulators|tubulin modulators|mesh-ancestor
55803182|NCT05678413|Antimitotic Agents|antimitotic agents|mesh-ancestor
55803183|NCT05678413|Mitosis Modulators|mitosis modulators|mesh-ancestor
55803184|NCT05678413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803185|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
55803186|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55789717|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789718|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789720|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
55789721|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
55803187|NCT05123365|Antiviral Agents|antiviral agents|mesh-ancestor
55803188|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803189|NCT05123365|Expectorants|expectorants|mesh-ancestor
55803190|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
55803191|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55803192|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
55803193|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803194|NCT05123365|Protective Agents|protective agents|mesh-ancestor
55803195|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803196|NCT05123365|Antidotes|antidotes|mesh-ancestor
55803197|NCT05678335|Hydroxychloroquine|hydroxychloroquine|mesh-list
55803198|NCT05678335|Tacrolimus|tacrolimus|mesh-list
55789722|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
55789723|NCT04884503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789724|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789725|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789726|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
55789727|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789728|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55803199|NCT05678335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55803200|NCT05678335|Immunologic Factors|immunologic factors|mesh-ancestor
55789729|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789730|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803201|NCT05678335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803202|NCT05678335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55803203|NCT05678335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803204|NCT05678335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803205|NCT05678335|Antimalarials|antimalarials|mesh-ancestor
55803206|NCT05678335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55803207|NCT05678335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55803208|NCT05678335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803209|NCT05678335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55803211|NCT02582671|Ribavirin|ribavirin|mesh-list
55803212|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55803213|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55803214|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
55803215|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803216|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803217|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55803218|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55803219|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
55803220|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803221|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55803222|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55803223|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
55803225|NCT05696977|Cyclosporins|cyclosporins|mesh-list
55803226|NCT05696977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803227|NCT05696977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803228|NCT05696977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55803229|NCT05696977|Immunologic Factors|immunologic factors|mesh-ancestor
55803230|NCT05696977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803231|NCT05696977|Antifungal Agents|antifungal agents|mesh-ancestor
55803232|NCT05696977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803233|NCT05696977|Dermatologic Agents|dermatologic agents|mesh-ancestor
55803240|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789731|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
55789732|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789733|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789734|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55789735|NCT04898699|Tenofovir|tenofovir|mesh-list
55789736|NCT04898699|Emtricitabine|emtricitabine|mesh-list
55789737|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55789738|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
55789739|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803241|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55803242|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55803243|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
55803244|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
55803245|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803246|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55803247|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55803248|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789740|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55803249|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803250|NCT02585713|Dalteparin|dalteparin|mesh-list
55803251|NCT02585713|Tinzaparin|tinzaparin|mesh-list
55803252|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55803253|NCT02585713|Apixaban|apixaban|mesh-list
55803254|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55803255|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
55803256|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55803257|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
55803258|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789741|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55789742|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803259|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803260|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
55803261|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55803262|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55803263|NCT05678257|Leucovorin|leucovorin|mesh-list
55803264|NCT05678257|Bevacizumab|bevacizumab|mesh-list
55803265|NCT05678257|Fluorouracil|fluorouracil|mesh-list
55803266|NCT05678257|Irinotecan|irinotecan|mesh-list
55803267|NCT05678257|Levoleucovorin|levoleucovorin|mesh-list
55803268|NCT05678257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803269|NCT05678257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789743|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789744|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55803270|NCT05678257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55796631|NCT04977661|Vitamin E|vitamin e|mesh-list
55803273|NCT05678257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803275|NCT05678257|Antimetabolites|antimetabolites|mesh-ancestor
55803276|NCT05678257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803277|NCT05678257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55803278|NCT05678257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55803279|NCT05678257|Immunologic Factors|immunologic factors|mesh-ancestor
55803280|NCT05678257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55803281|NCT05678257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55803282|NCT05678257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803283|NCT05678257|Antidotes|antidotes|mesh-ancestor
55803284|NCT05678257|Protective Agents|protective agents|mesh-ancestor
55789745|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55789746|NCT04888715|Pirfenidone|pirfenidone|mesh-list
55789747|NCT04888715|Nintedanib|nintedanib|mesh-list
55789748|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789749|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55789750|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803285|NCT05678257|Vitamin B Complex|vitamin b complex|mesh-ancestor
55803286|NCT05678257|Vitamins|vitamins|mesh-ancestor
55803287|NCT05678257|Micronutrients|micronutrients|mesh-ancestor
55803288|NCT05078671|Cobicistat|cobicistat|mesh-list
55803289|NCT05078671|Olaparib|olaparib|mesh-list
55803290|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55803291|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803292|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803293|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789751|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789752|NCT04888715|Analgesics|analgesics|mesh-ancestor
55789753|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
55803294|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55803295|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55803296|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
55803298|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55803299|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55803301|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
55803302|NCT02579863|Lenalidomide|lenalidomide|mesh-list
55803303|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55803304|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
55789754|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789755|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789756|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55789757|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55789758|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55789759|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55789761|NCT04898387|Bimatoprost|bimatoprost|mesh-list
55789762|NCT04898387|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55789763|NCT04898387|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55789764|NCT04898387|Adrenergic Agents|adrenergic agents|mesh-ancestor
55789765|NCT04898387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789766|NCT04898387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789767|NCT04898387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789768|NCT04898387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55803305|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
55803306|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803307|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789769|NCT04898387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55789770|NCT04888403|Paclitaxel|paclitaxel|mesh-list
55789771|NCT04888403|Nedaplatin|nedaplatin|mesh-list
55796646|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
55789772|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55789773|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789774|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
55789775|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
55789776|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
55789777|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789779|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789780|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55803308|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55803309|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
55803311|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789781|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789782|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789783|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55803312|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55803313|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803314|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803315|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
55803316|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55803317|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55803318|NCT02579863|Growth Substances|growth substances|mesh-ancestor
55803319|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
55803320|NCT05677945|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55803321|NCT05677945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55803322|NCT05677945|Simvastatin|simvastatin|mesh-list
55803323|NCT05677945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803324|NCT05677945|Antitubercular Agents|antitubercular agents|mesh-ancestor
55803325|NCT05677945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55803326|NCT05677945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55803327|NCT05677945|Antimetabolites|antimetabolites|mesh-ancestor
55789784|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55789785|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789786|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55803328|NCT05677945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803329|NCT05677945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55803330|NCT05677945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55803331|NCT05677945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803332|NCT05038735|Fulvestrant|fulvestrant|mesh-list
55803333|NCT05038735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55803334|NCT05038735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789788|NCT03050411|Gefitinib|gefitinib|mesh-list
55803335|NCT05038735|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55803336|NCT05038735|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55803337|NCT05038735|Hormone Antagonists|hormone antagonists|mesh-ancestor
55789789|NCT03050411|Osimertinib|osimertinib|mesh-list
55803338|NCT05038735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803339|NCT05038735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803341|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55803342|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803343|NCT02582515|Cycloserine|cycloserine|mesh-list
55803344|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55803345|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789790|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789791|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55803346|NCT02582515|Renal Agents|renal agents|mesh-ancestor
55803347|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55803348|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
55803349|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55803350|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
55803351|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803355|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803356|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803365|NCT05677555|Tubulin Modulators|tubulin modulators|mesh-ancestor
55803366|NCT05677555|Antimitotic Agents|antimitotic agents|mesh-ancestor
55803367|NCT05677555|Mitosis Modulators|mitosis modulators|mesh-ancestor
55803368|NCT05677555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803369|NCT05677555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803370|NCT02343939|Cytarabine|cytarabine|mesh-list
55803376|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803377|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803378|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
55803379|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803380|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55803381|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
55803382|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803383|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803384|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55803385|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55803386|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55803387|NCT02343549|Bevacizumab|bevacizumab|mesh-list
55803388|NCT02343549|Temozolomide|temozolomide|mesh-list
55803389|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803390|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803391|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55803392|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55803393|NCT02343549|Growth Substances|growth substances|mesh-ancestor
55803394|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803395|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
55789805|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
55789806|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789807|NCT04887311|Protective Agents|protective agents|mesh-ancestor
55789808|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789809|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55789810|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789811|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55789812|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55789813|NCT03051503|Fentanyl|fentanyl|mesh-list
55803427|NCT04778527|Antiviral Agents|antiviral agents|mesh-ancestor
55803428|NCT04778527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803429|NCT04778527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55803430|NCT04778527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55803431|NCT04403347|Losartan|losartan|mesh-list
55803432|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
55803433|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55803434|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55803435|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55803436|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803437|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55803438|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803439|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55789815|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55789816|NCT03051503|Narcotics|narcotics|mesh-ancestor
55789817|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789818|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789819|NCT03051503|Analgesics|analgesics|mesh-ancestor
55789820|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
55789821|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789822|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55789823|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55789824|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
55789825|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
55789826|NCT04896125|Bimatoprost|bimatoprost|mesh-list
55789827|NCT04896125|Latanoprost|latanoprost|mesh-list
55789828|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55789829|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55789830|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55789831|NCT04895657|Tazobactam|tazobactam|mesh-list
55789832|NCT04895657|Piperacillin|piperacillin|mesh-list
55803441|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803442|NCT05673655|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55803443|NCT05673655|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55803444|NCT05673655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55803445|NCT05673655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803446|NCT05673655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803447|NCT05673655|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55789833|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55789834|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55803448|NCT05673655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55803449|NCT05673655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803450|NCT05673655|Cholinergic Agents|cholinergic agents|mesh-ancestor
55803451|NCT05673655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55803453|NCT05692297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55803454|NCT05692297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803455|NCT05696509|Anesthetics|anesthetics|mesh-list
55803456|NCT05696509|Propofol|propofol|mesh-list
55803457|NCT05696509|Sevoflurane|sevoflurane|mesh-list
55803458|NCT05696509|Isoflurane|isoflurane|mesh-list
55803459|NCT05696509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803460|NCT05696509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803461|NCT05696509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55803462|NCT05696509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55803464|NCT05696509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55803465|NCT05696509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55789835|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803466|NCT02584855|Ixekizumab|ixekizumab|mesh-list
55803467|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
55803468|NCT02581891|Aflibercept|aflibercept|mesh-list
55803469|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55803470|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55803471|NCT02581891|Growth Substances|growth substances|mesh-ancestor
55803472|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803473|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
55803474|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803475|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
55803476|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
55803477|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55803523|NCT05628883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55789837|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789838|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803524|NCT05628883|Analgesics|analgesics|mesh-ancestor
55803525|NCT05628883|Sensory System Agents|sensory system agents|mesh-ancestor
55803526|NCT05628883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803527|NCT05575219|Clonidine|clonidine|mesh-list
55803528|NCT05575219|Analgesics|analgesics|mesh-ancestor
55803529|NCT05575219|Sensory System Agents|sensory system agents|mesh-ancestor
55803530|NCT05575219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803531|NCT05575219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803532|NCT05575219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55803533|NCT05575219|Sympatholytics|sympatholytics|mesh-ancestor
55803534|NCT05575219|Autonomic Agents|autonomic agents|mesh-ancestor
55803535|NCT05575219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55803536|NCT05575219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55803537|NCT05575219|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55789839|NCT04895423|Cyclosporine|cyclosporine|mesh-list
55789840|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
55789841|NCT04895423|Methotrexate|methotrexate|mesh-list
55803539|NCT05575219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55803540|NCT05575219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803541|NCT04341571|Metformin|metformin|mesh-list
55803542|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55803543|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803544|NCT05568745|Misoprostol|misoprostol|mesh-list
55803545|NCT05568745|Oxytocin|oxytocin|mesh-list
55803546|NCT05568745|Oxytocics|oxytocics|mesh-ancestor
55803547|NCT05568745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55803548|NCT05568745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789842|NCT04895423|Cyclosporins|cyclosporins|mesh-list
55789843|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55789844|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
55789845|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55789846|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789847|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55789848|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
55803549|NCT05568745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55803550|NCT05568745|Abortifacient Agents|abortifacient agents|mesh-ancestor
55803551|NCT05568745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55803552|NCT05568745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55803553|NCT04314895|Paclitaxel|paclitaxel|mesh-list
55803554|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55803555|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55803556|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789849|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789850|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789851|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
55789852|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789853|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55789854|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55789855|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
55789856|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55789857|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55789858|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
55789859|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789860|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55789861|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55789862|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55789863|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
55789864|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55789865|NCT04882163|Gemcitabine|gemcitabine|mesh-list
55789866|NCT04882163|Dexamethasone|dexamethasone|mesh-list
55789868|NCT04882163|Lenalidomide|lenalidomide|mesh-list
55789869|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55789870|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803559|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
55803560|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803561|NCT02581189|Ritonavir|ritonavir|mesh-list
55803562|NCT02581189|Ribavirin|ribavirin|mesh-list
55803563|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55803564|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55803565|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
55803566|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796666|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803567|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789871|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789872|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
55789874|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55789875|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55803568|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55803569|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55803570|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
55803571|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803572|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55803573|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55803574|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
55803575|NCT05569681|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55803576|NCT05569681|Bemiparin|bemiparin|mesh-list
55803577|NCT05569681|Anticoagulants|anticoagulants|mesh-ancestor
55803578|NCT05569681|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55803579|NCT05569681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55803580|NCT05569681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803582|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
55803583|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
55803584|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
55803585|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55803586|NCT00352027|Doxorubicin|doxorubicin|mesh-list
55803588|NCT00352027|Vincristine|vincristine|mesh-list
55803603|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789876|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
55789877|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
55789878|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803604|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55803605|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
55803606|NCT00352027|Hormones|hormones|mesh-ancestor
55803607|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803608|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55803609|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55803610|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
55803611|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
55803612|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
55789879|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789880|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
55789882|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789883|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55789884|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55803613|NCT04084717|Crizotinib|crizotinib|mesh-list
55803614|NCT04084717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803615|NCT04084717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55803616|NCT04084717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803617|NCT04084717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803618|NCT02577523|Levodopa|levodopa|mesh-list
55803619|NCT02577523|Carbidopa|carbidopa|mesh-list
55803620|NCT02577523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55803621|NCT02577523|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55803622|NCT02577523|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55803623|NCT02577523|Dopamine Agents|dopamine agents|mesh-ancestor
55803624|NCT02577523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55803625|NCT02577523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803626|NCT02577523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803627|NCT02577523|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55803628|NCT02577523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803629|NCT04076059|Androgens|androgens|mesh-list
55803630|NCT04076059|Hormones|hormones|mesh-ancestor
55803631|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803632|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803633|NCT02576977|Dexamethasone|dexamethasone|mesh-list
55803634|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
55789886|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789887|NCT04882163|Antiviral Agents|antiviral agents|mesh-ancestor
55803635|NCT02576977|Pomalidomide|pomalidomide|mesh-list
55803636|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55803637|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
55803638|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
55803639|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803640|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789888|NCT04882163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789889|NCT04882163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789890|NCT04882163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55789891|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55789892|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55803644|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803645|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55803646|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803647|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803648|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
55803649|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55803650|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55803651|NCT02576977|Growth Substances|growth substances|mesh-ancestor
55803652|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
55803653|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55803654|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
55803656|NCT04016389|Carboplatin|carboplatin|mesh-list
55803657|NCT04016389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55803658|NCT04016389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803659|NCT04016389|Tubulin Modulators|tubulin modulators|mesh-ancestor
55803660|NCT04016389|Antimitotic Agents|antimitotic agents|mesh-ancestor
55803661|NCT04016389|Mitosis Modulators|mitosis modulators|mesh-ancestor
55803662|NCT04016389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803664|NCT03908437|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55803665|NCT03908437|Naloxone|naloxone|mesh-list
55803666|NCT03908437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55803667|NCT03908437|Narcotics|narcotics|mesh-ancestor
55803669|NCT03908437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803670|NCT03908437|Analgesics|analgesics|mesh-ancestor
55803671|NCT03908437|Sensory System Agents|sensory system agents|mesh-ancestor
55803673|NCT03908437|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55803689|NCT05529667|Paclitaxel|paclitaxel|mesh-list
55803690|NCT05529667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55803691|NCT05529667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789894|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
55803693|NCT05529667|Antimitotic Agents|antimitotic agents|mesh-ancestor
55803694|NCT05529667|Mitosis Modulators|mitosis modulators|mesh-ancestor
55803695|NCT05529667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803696|NCT03571633|Paclitaxel|paclitaxel|mesh-list
55803697|NCT03571633|Trastuzumab|trastuzumab|mesh-list
55803698|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55803700|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
55803701|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
55803702|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
55803703|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803704|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803705|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
55789895|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55789899|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789900|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
55789901|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796684|NCT04224415|Irinotecan|irinotecan|mesh-list
55803706|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55803707|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803708|NCT05533255|Z 350|z 350|mesh-list
55803709|NCT05533255|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55803710|NCT05533255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55803711|NCT05533255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803712|NCT05533255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789902|NCT04885751|Protective Agents|protective agents|mesh-ancestor
55803713|NCT05533255|Hormone Antagonists|hormone antagonists|mesh-ancestor
55803714|NCT05533255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803715|NCT05533255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803716|NCT05529355|Tegafur|tegafur|mesh-list
55803717|NCT05529355|Endostar protein|endostar protein|mesh-list
55803718|NCT05529355|Endostatins|endostatins|mesh-list
55803735|NCT05528887|Cyclophosphamide|cyclophosphamide|mesh-list
55803736|NCT05528887|Fludarabine|fludarabine|mesh-list
55803737|NCT05528887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55789903|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789904|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789905|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
55789906|NCT03049163|Propoxycaine|propoxycaine|mesh-list
55789907|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
55789908|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789909|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803738|NCT05528887|Immunologic Factors|immunologic factors|mesh-ancestor
55803739|NCT05528887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803741|NCT05528887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55803742|NCT05528887|Alkylating Agents|alkylating agents|mesh-ancestor
55803743|NCT05528887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803744|NCT05528887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803745|NCT05528887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55803746|NCT05501821|Pembrolizumab|pembrolizumab|mesh-list
55803747|NCT05501821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803748|NCT05501821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803749|NCT05528653|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
55803750|NCT05528653|Antiviral Agents|antiviral agents|mesh-ancestor
55803751|NCT05528653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803752|NCT05528653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55803753|NCT05528653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55803754|NCT05528653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803755|NCT05528653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803756|NCT05528653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55789910|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
55789911|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
55789912|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789913|NCT04881851|Folic Acid|folic acid|mesh-list
55803757|NCT05528653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55789914|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
55803759|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55803760|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55803761|NCT03009019|Analgesics|analgesics|mesh-ancestor
55803762|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
55803763|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803764|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803765|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55803766|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55803767|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55803768|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55803769|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789916|NCT04881851|Hematinics|hematinics|mesh-ancestor
55789917|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
55803770|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803771|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
55803772|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803773|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803774|NCT02813785|Docetaxel|docetaxel|mesh-list
55803775|NCT02813785|Atezolizumab|atezolizumab|mesh-list
55803776|NCT02813785|Antibodies|antibodies|mesh-list
55803778|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803779|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803780|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
55803783|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803804|NCT05527795|Nasal Decongestants|nasal decongestants|mesh-ancestor
55803805|NCT05527795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55789919|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
55803806|NCT05527795|Respiratory System Agents|respiratory system agents|mesh-ancestor
55803807|NCT05532241|Chlorhexidine|chlorhexidine|mesh-list
55803808|NCT05532241|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55803809|NCT05532241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803810|NCT05532241|Disinfectants|disinfectants|mesh-ancestor
55803811|NCT02431897|Estrogens|estrogens|mesh-list
55803812|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55803813|NCT02431897|Hormones|hormones|mesh-ancestor
55803814|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803815|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803816|NCT05532163|Natalizumab|natalizumab|mesh-list
55803817|NCT05532163|Immunologic Factors|immunologic factors|mesh-ancestor
55803818|NCT05532163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803819|NCT05532085|Analgesics|analgesics|mesh-list
55803820|NCT05532085|Anesthetics|anesthetics|mesh-list
55803821|NCT05532085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55803822|NCT05532085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803823|NCT05532085|Sensory System Agents|sensory system agents|mesh-ancestor
55803824|NCT05532085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803825|NCT02303119|Rituximab|rituximab|mesh-list
55789920|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803826|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803827|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803828|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
55803829|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803830|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55803832|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803833|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55789922|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789923|NCT04881851|Protective Agents|protective agents|mesh-ancestor
55789924|NCT04871633|Azithromycin|azithromycin|mesh-list
55803835|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803836|NCT01640587|Artesunate|artesunate|mesh-list
55803837|NCT01640587|Piperaquine|piperaquine|mesh-list
55803838|NCT01640587|Artenimol|artenimol|mesh-list
55803839|NCT01640587|Mefloquine|mefloquine|mesh-list
55803840|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
55803841|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55803842|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55803843|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803844|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803845|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
55803846|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
55803847|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55803848|NCT01640587|Anthelmintics|anthelmintics|mesh-ancestor
55803849|NCT01610713|Nabiximols|nabiximols|mesh-list
55803850|NCT01610713|Analgesics|analgesics|mesh-ancestor
55803851|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
55803852|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803853|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789925|NCT04871633|Remdesivir|remdesivir|mesh-list
55789926|NCT04871633|Dexamethasone|dexamethasone|mesh-list
55803854|NCT01606189|Nabiximols|nabiximols|mesh-list
55803875|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803877|NCT05111353|Poly ICLC|poly iclc|mesh-list
55803878|NCT05111353|Interferon Inducers|interferon inducers|mesh-ancestor
55803879|NCT05111353|Immunologic Factors|immunologic factors|mesh-ancestor
55803880|NCT05111353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803881|NCT05526469|Bupivacaine|bupivacaine|mesh-list
55803882|NCT05526469|Anesthetics, Local|anesthetics, local|mesh-ancestor
55803883|NCT05526469|Anesthetics|anesthetics|mesh-ancestor
55803884|NCT05526469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789927|NCT04871633|Prednisolone|prednisolone|mesh-list
55789928|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55789931|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
55803885|NCT05526469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803886|NCT05526469|Sensory System Agents|sensory system agents|mesh-ancestor
55803887|NCT05526469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803888|NCT05155033|Aldesleukin|aldesleukin|mesh-list
55803889|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
55803890|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803891|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789932|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789933|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803893|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55803894|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
55803895|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55803897|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55803898|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
55803899|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803900|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
55803901|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55803902|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
55803903|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803904|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
55803906|NCT02393547|Varenicline|varenicline|mesh-list
55803907|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55803908|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55803909|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
55803910|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789934|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789935|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
55789936|NCT04871633|Hormones|hormones|mesh-ancestor
55803911|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803912|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803913|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55803914|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
55803915|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803916|NCT05531383|Memantine|memantine|mesh-list
55803917|NCT05531383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55803918|NCT05531383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55803919|NCT05531383|Dopamine Agents|dopamine agents|mesh-ancestor
55803920|NCT05531383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55803921|NCT05531383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803922|NCT05531383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803923|NCT05531383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55803924|NCT05531383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55803926|NCT02392611|Exemestane|exemestane|mesh-list
55803927|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55803928|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803929|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55803930|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55803931|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
55803932|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55803933|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796690|NCT03239899|Pembrolizumab|pembrolizumab|mesh-list
55803934|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55789937|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789938|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55803935|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55803936|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803937|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803955|NCT05518513|Sensory System Agents|sensory system agents|mesh-ancestor
55803956|NCT05518513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803957|NCT05518279|Tranexamic Acid|tranexamic acid|mesh-list
55803958|NCT05518279|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55803959|NCT05518279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55789939|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789940|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789941|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55789942|NCT04871633|Protective Agents|protective agents|mesh-ancestor
55789943|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55789944|NCT04871633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789945|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
55789946|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
55789947|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
55789948|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55789949|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789950|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55789951|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789953|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789954|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55789955|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803960|NCT05518279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803961|NCT05518279|Hemostatics|hemostatics|mesh-ancestor
55803962|NCT05518279|Coagulants|coagulants|mesh-ancestor
55803964|NCT05523661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55803965|NCT05523661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55803966|NCT05523661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803967|NCT05523661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803968|NCT05523037|Sevoflurane|sevoflurane|mesh-list
55803969|NCT05523037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55803970|NCT05523037|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55803971|NCT05523037|Anesthetics, General|anesthetics, general|mesh-ancestor
55803972|NCT05523037|Anesthetics|anesthetics|mesh-ancestor
55789956|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789957|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55789958|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55789959|NCT04676399|Diuretics|diuretics|mesh-ancestor
55789960|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
55803973|NCT05523037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789961|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803974|NCT05523037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803975|NCT05122741|Aspirin|aspirin|mesh-list
55803976|NCT05122741|Clopidogrel|clopidogrel|mesh-list
55803977|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55803978|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55803979|NCT05122741|Analgesics|analgesics|mesh-ancestor
55803980|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
55803981|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55803982|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55803983|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55803984|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55803985|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55803986|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55803987|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55803988|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55803989|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55803990|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55803991|NCT05122741|Antipyretics|antipyretics|mesh-ancestor
55803992|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55803993|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55803994|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55803995|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
55803996|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55803997|NCT05525767|Bevacizumab|bevacizumab|mesh-list
55803998|NCT05525767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55803999|NCT05525767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804019|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789962|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55804021|NCT02392377|Paclitaxel|paclitaxel|mesh-list
55804022|NCT02392377|Carboplatin|carboplatin|mesh-list
55804023|NCT02392377|Fluorouracil|fluorouracil|mesh-list
55804024|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
55804025|NCT02392377|Calcium|calcium|mesh-list
55804026|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
55804027|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55804028|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804029|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
55804030|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
55804031|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
55804032|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804033|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55804034|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804035|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
55804036|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55804037|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55789963|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55789964|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789965|NCT03047057|Lidocaine|lidocaine|mesh-list
55804039|NCT02392377|Antidotes|antidotes|mesh-ancestor
55804040|NCT02392377|Protective Agents|protective agents|mesh-ancestor
55804041|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
55804042|NCT02392377|Vitamins|vitamins|mesh-ancestor
55804043|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
55804044|NCT02340819|Teduglutide|teduglutide|mesh-list
55804045|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789966|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
55789967|NCT03047057|Anesthetics|anesthetics|mesh-ancestor
55789968|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789969|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789970|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
55804047|NCT02340819|Protective Agents|protective agents|mesh-ancestor
55804048|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789971|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789972|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55804049|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55804050|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55804051|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804052|NCT04903509|Acetaminophen|acetaminophen|mesh-list
55804053|NCT04903509|Liraglutide|liraglutide|mesh-list
55804054|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55804055|NCT04903509|Analgesics|analgesics|mesh-ancestor
55804056|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
55804057|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804058|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804059|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
55789973|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55789974|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55804061|NCT04903509|Incretins|incretins|mesh-ancestor
55789975|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55789976|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789978|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55789979|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789980|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55789981|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
55789982|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
55789983|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789984|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789985|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789986|NCT04525391|Durvalumab|durvalumab|mesh-list
55789987|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55789988|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789990|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55789991|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789992|NCT04361825|Durvalumab|durvalumab|mesh-list
55789993|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55789994|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789995|NCT03046901|Vancomycin|vancomycin|mesh-list
55789996|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55789997|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789998|NCT04423055|Contraceptive Agents|contraceptive agents|mesh-list
55789999|NCT04423055|Etonogestrel|etonogestrel|mesh-list
55790000|NCT04423055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55790001|NCT04423055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790002|NCT04423055|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55790004|NCT03871049|Dexamethasone|dexamethasone|mesh-list
55790005|NCT03871049|Bupivacaine|bupivacaine|mesh-list
55790006|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55790007|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
55790008|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
55804063|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55804064|NCT05517499|Dexamethasone|dexamethasone|mesh-list
55804065|NCT05517499|Dexamethasone acetate|dexamethasone acetate|mesh-list
55804066|NCT05517499|BB 1101|bb 1101|mesh-list
55804067|NCT05517499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55804068|NCT05517499|Antiemetics|antiemetics|mesh-ancestor
55804069|NCT05517499|Autonomic Agents|autonomic agents|mesh-ancestor
55804070|NCT05517499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790009|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790010|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790011|NCT03871049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55790012|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
55804071|NCT05517499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804072|NCT05517499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55804073|NCT05517499|Glucocorticoids|glucocorticoids|mesh-ancestor
55804074|NCT05517499|Hormones|hormones|mesh-ancestor
55790016|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790017|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
55790018|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
55790019|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790020|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
55790021|NCT04870541|Nefopam|nefopam|mesh-list
55790022|NCT04870541|Ondansetron|ondansetron|mesh-list
55790023|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
55790024|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
55790025|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790026|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790027|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55804075|NCT05517499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55804076|NCT05517499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55804077|NCT05517499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804078|NCT05517499|Protease Inhibitors|protease inhibitors|mesh-ancestor
55804079|NCT05517499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804080|NCT05517499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804082|NCT05012371|Lenvatinib|lenvatinib|mesh-list
55804083|NCT05012371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804084|NCT05012371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55804085|NCT05012371|Immunologic Factors|immunologic factors|mesh-ancestor
55804086|NCT05012371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804087|NCT05012371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55804088|NCT05012371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804089|NCT05012371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804090|NCT05512351|Bevacizumab|bevacizumab|mesh-list
55804091|NCT05512351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55804092|NCT05512351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790029|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
55790030|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55790031|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
55790032|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790033|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790034|NCT04870541|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55804093|NCT05512351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55804094|NCT05512351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55804095|NCT05512351|Growth Substances|growth substances|mesh-ancestor
55804096|NCT05512351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804097|NCT05512351|Growth Inhibitors|growth inhibitors|mesh-ancestor
55804100|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55804101|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55790035|NCT04870541|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55804102|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55804103|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804104|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804105|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804106|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
55804107|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804108|NCT02569957|Expectorants|expectorants|mesh-ancestor
55804109|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
55804110|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55804111|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
55804112|NCT02569957|Protective Agents|protective agents|mesh-ancestor
55804113|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804114|NCT02569957|Antidotes|antidotes|mesh-ancestor
55804115|NCT01649427|Tacrolimus|tacrolimus|mesh-list
55804116|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55804117|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
55804118|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804119|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55804120|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804121|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804140|NCT04411693|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55804141|NCT04411693|Growth Substances|growth substances|mesh-ancestor
55804142|NCT04411693|Growth Inhibitors|growth inhibitors|mesh-ancestor
55804143|NCT02336607|Metoprolol|metoprolol|mesh-list
55804144|NCT02336607|Felodipine|felodipine|mesh-list
55804145|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55804146|NCT02336607|Lisinopril|lisinopril|mesh-list
55804147|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55804148|NCT02336607|Diuretics|diuretics|mesh-ancestor
55804149|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
55804150|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804151|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55804152|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804153|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804154|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55804155|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
55804156|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
55804157|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804158|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55804159|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55804160|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55804162|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804163|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55804164|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
55804165|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804166|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55804187|NCT04999969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804188|NCT04999969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55804189|NCT04999969|Antimetabolites|antimetabolites|mesh-ancestor
55804190|NCT04999969|Antiviral Agents|antiviral agents|mesh-ancestor
55804191|NCT04999969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804192|NCT04999969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804193|NCT04999969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55804194|NCT04999969|Immunologic Factors|immunologic factors|mesh-ancestor
55804195|NCT04999969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804196|NCT04999969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55804197|NCT02573311|Tamsulosin|tamsulosin|mesh-list
55804198|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55804199|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55804200|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55804201|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
55804202|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804203|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804204|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804205|NCT02573311|Urological Agents|urological agents|mesh-ancestor
55804206|NCT05520853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55804207|NCT05520853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804208|NCT05520853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804209|NCT05516251|Topiramate|topiramate|mesh-list
55804210|NCT05516251|Anticonvulsants|anticonvulsants|mesh-ancestor
55804211|NCT05516251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55804212|NCT05516251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804214|NCT04292743|Fluorouracil|fluorouracil|mesh-list
55804215|NCT04292743|Oxaliplatin|oxaliplatin|mesh-list
55804216|NCT04292743|Irinotecan|irinotecan|mesh-list
55804217|NCT04292743|Folfirinox|folfirinox|mesh-list
55804218|NCT04292743|Antimetabolites|antimetabolites|mesh-ancestor
55804219|NCT04292743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804220|NCT04292743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55804221|NCT04292743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804222|NCT04292743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55804223|NCT04292743|Immunologic Factors|immunologic factors|mesh-ancestor
55804224|NCT04292743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804225|NCT04292743|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55804226|NCT04292743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55804227|NCT04292743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804228|NCT04292743|Antidotes|antidotes|mesh-ancestor
55804229|NCT04292743|Protective Agents|protective agents|mesh-ancestor
55804230|NCT04292743|Vitamin B Complex|vitamin b complex|mesh-ancestor
55804231|NCT04292743|Vitamins|vitamins|mesh-ancestor
55804232|NCT04292743|Micronutrients|micronutrients|mesh-ancestor
55804233|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55804234|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55804235|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55804236|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804237|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804238|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804239|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804240|NCT05086393|Analgesics|analgesics|mesh-ancestor
55804241|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
55804242|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804243|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
55804244|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55804245|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
55804246|NCT02571049|Sumatriptan|sumatriptan|mesh-list
55804252|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804253|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804254|NCT05515939|Insulin|insulin|mesh-list
55804255|NCT05515939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55804256|NCT05515939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804258|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55804259|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55804260|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804261|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804262|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55804263|NCT04295941|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55804264|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55804265|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804266|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804267|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804269|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55804270|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
55804271|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55804272|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804273|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804274|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
55804275|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55804276|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
55804277|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804278|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804279|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55804280|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
55804281|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
55804282|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55804283|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
55804284|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804285|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804286|NCT05515471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55804287|NCT05515471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55804288|NCT05515315|Paclitaxel|paclitaxel|mesh-list
55804289|NCT05515315|Nedaplatin|nedaplatin|mesh-list
55804290|NCT05515315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55804291|NCT05515315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804292|NCT05515315|Tubulin Modulators|tubulin modulators|mesh-ancestor
55804293|NCT05515315|Antimitotic Agents|antimitotic agents|mesh-ancestor
55804294|NCT05515315|Mitosis Modulators|mitosis modulators|mesh-ancestor
55804295|NCT05515315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804296|NCT05519371|Propofol|propofol|mesh-list
55804297|NCT05519371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55804298|NCT05519371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804299|NCT05519371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804322|NCT05514847|Sensory System Agents|sensory system agents|mesh-ancestor
55804323|NCT05514847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804324|NCT05514847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804325|NCT05514847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55804326|NCT05514847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55804327|NCT05514847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55804328|NCT05514847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55804329|NCT05514847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804330|NCT05514847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55804331|NCT05514847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55804332|NCT05514847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804333|NCT05514847|Antipyretics|antipyretics|mesh-ancestor
55804334|NCT05510323|Prednisolone|prednisolone|mesh-list
55804335|NCT05510323|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55804336|NCT05510323|Methylprednisolone|methylprednisolone|mesh-list
55804337|NCT05510323|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55804338|NCT05510323|Prednisolone acetate|prednisolone acetate|mesh-list
55804339|NCT05510323|Cyclophosphamide|cyclophosphamide|mesh-list
55804340|NCT05510323|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55804341|NCT05510323|Prednisolone phosphate|prednisolone phosphate|mesh-list
55804342|NCT05510323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55804343|NCT05510323|Immunologic Factors|immunologic factors|mesh-ancestor
55804344|NCT05510323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804345|NCT05510323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55804346|NCT05510323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55804347|NCT05510323|Alkylating Agents|alkylating agents|mesh-ancestor
55804348|NCT05510323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804349|NCT05510323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804350|NCT05510323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55804351|NCT05510323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55804352|NCT05510323|Glucocorticoids|glucocorticoids|mesh-ancestor
55804354|NCT05510323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55804355|NCT05510323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55804356|NCT05510323|Antiemetics|antiemetics|mesh-ancestor
55804357|NCT05510323|Autonomic Agents|autonomic agents|mesh-ancestor
55804358|NCT05510323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804359|NCT05510323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55804360|NCT05510323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55804361|NCT05510323|Protective Agents|protective agents|mesh-ancestor
55804362|NCT04843579|Clarithromycin|clarithromycin|mesh-list
55804363|NCT04843579|Dexamethasone|dexamethasone|mesh-list
55804364|NCT04843579|Pomalidomide|pomalidomide|mesh-list
55804365|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55804366|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
55804367|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
55804368|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843167|NCT03654040|Everolimus|everolimus|mesh-list
55804369|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804370|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55804371|NCT04843579|Glucocorticoids|glucocorticoids|mesh-ancestor
55804373|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55804374|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55804375|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804376|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55804377|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804378|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55804379|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804380|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804381|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55804382|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55804383|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
55804384|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55804385|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55804386|NCT04843579|Growth Substances|growth substances|mesh-ancestor
55804387|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
55804388|NCT05507671|BCG Vaccine|bcg vaccine|mesh-list
55804389|NCT05507671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55804390|NCT05507671|Immunologic Factors|immunologic factors|mesh-ancestor
55804391|NCT05507671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804393|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
55804394|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55804395|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
55804396|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804397|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804398|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
55804399|NCT04812379|Aripiprazole|aripiprazole|mesh-list
55804400|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
55804401|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55804402|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55804403|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55804404|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804405|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804406|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
55804407|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
55804408|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804409|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804410|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55804411|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55804412|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
55804413|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55804414|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55804415|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55804417|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
55804418|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55804419|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
55804420|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55804421|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
55804422|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804423|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804424|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
55804425|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
55804426|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55804427|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
55804428|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55804429|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
55804430|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804431|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804432|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
55804433|NCT05506969|Vaccines|vaccines|mesh-list
55804434|NCT05506969|1018 oligonucleotide|1018 oligonucleotide|mesh-list
55804435|NCT05506969|Immunologic Factors|immunologic factors|mesh-ancestor
55804436|NCT05506969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804437|NCT05506969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55804438|NCT04291885|Avelumab|avelumab|mesh-list
55804439|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55804440|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790153|NCT04868903|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55804475|NCT05509153|Antiviral Agents|antiviral agents|mesh-ancestor
55804476|NCT05509153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804477|NCT05509153|Expectorants|expectorants|mesh-ancestor
55804478|NCT05509153|Respiratory System Agents|respiratory system agents|mesh-ancestor
55804479|NCT05509153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55804480|NCT05509153|Antioxidants|antioxidants|mesh-ancestor
55804481|NCT05509153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804482|NCT05509153|Protective Agents|protective agents|mesh-ancestor
55804483|NCT05509153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804484|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55804485|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55804486|NCT04584853|Tamoxifen|tamoxifen|mesh-list
55804487|NCT04584853|Letrozole|letrozole|mesh-list
55804488|NCT04584853|Anastrozole|anastrozole|mesh-list
55804489|NCT04584853|Exemestane|exemestane|mesh-list
55804490|NCT04584853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804491|NCT04584853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55804492|NCT04584853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55804493|NCT04584853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804494|NCT04584853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804515|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
55804516|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804517|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
55804518|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804519|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804520|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55804522|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
55804523|NCT02372799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55804524|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55804525|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804526|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804527|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804529|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804530|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55804531|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
55804532|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55804533|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55804534|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55804535|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804536|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55796702|NCT02452047|Relebactam|relebactam|mesh-list
55804555|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55804556|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
55804557|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
55804558|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
55804559|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55790525|NCT03919435|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55804576|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804577|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804578|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
55804580|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804581|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804582|NCT04549051|Anesthetics|anesthetics|mesh-list
55804583|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
55804584|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804585|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804586|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
55804587|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804588|NCT05505253|Alfacalcidol|alfacalcidol|mesh-list
55804589|NCT05505253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55796704|NCT02452047|Cilastatin|cilastatin|mesh-list
55804597|NCT04697719|Analgesics|analgesics|mesh-ancestor
55804598|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
55804599|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790596|NCT04201873|Poly ICLC|poly iclc|mesh-list
55804600|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804601|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55804602|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55804604|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55804605|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804606|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55790620|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
55804607|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55804608|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804609|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
55804610|NCT05504863|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55804611|NCT05504863|Ferric Compounds|ferric compounds|mesh-list
55804612|NCT05504863|Hematinics|hematinics|mesh-ancestor
55804613|NCT05507983|Tranexamic Acid|tranexamic acid|mesh-list
55804615|NCT05507983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55804616|NCT05507983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804617|NCT05507983|Hemostatics|hemostatics|mesh-ancestor
55804618|NCT05507983|Coagulants|coagulants|mesh-ancestor
55804619|NCT04582669|Triamcinolone|triamcinolone|mesh-list
55804620|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55804621|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55804622|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55804623|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55804624|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
55804625|NCT04582669|Hormones|hormones|mesh-ancestor
55804626|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55804627|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804628|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55804629|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
55804630|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804631|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804632|NCT02335983|Dexamethasone|dexamethasone|mesh-list
55804633|NCT02335983|Lenalidomide|lenalidomide|mesh-list
55804634|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55804635|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
55804636|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
55804637|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804638|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804639|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55804640|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
55804641|NCT02335983|Hormones|hormones|mesh-ancestor
55804642|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55804643|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55804644|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804653|NCT04578691|Protective Agents|protective agents|mesh-ancestor
55804654|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804655|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
55804656|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55804657|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
55804658|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55804659|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55804660|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55804661|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804662|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804663|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
55804664|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804665|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804666|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55804667|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804669|NCT02310789|Pilocarpine|pilocarpine|mesh-list
55804670|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
55804671|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55804672|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804673|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804676|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804677|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804679|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55804680|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
55804681|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804682|NCT02372253|Verapamil|verapamil|mesh-list
55804683|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55804684|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55804685|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804686|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804687|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55804688|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804689|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
55804694|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55804696|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804697|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804698|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55804699|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
55804701|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55804702|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55804703|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55804704|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55804705|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
55804706|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804707|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804708|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55804725|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804726|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804727|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55804728|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
55804729|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55804730|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
55804731|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
55804732|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804733|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804735|NCT04572763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804737|NCT05093959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55804738|NCT05093959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804739|NCT04411537|Capecitabine|capecitabine|mesh-list
55804740|NCT04411537|Irinotecan|irinotecan|mesh-list
55804741|NCT04411537|Antibodies|antibodies|mesh-list
55804742|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
55804743|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804744|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55804745|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
55804746|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804747|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804748|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55804749|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55804750|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804752|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804753|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804754|NCT05503147|Nabiximols|nabiximols|mesh-list
55804755|NCT05503147|Analgesics|analgesics|mesh-ancestor
55804756|NCT05503147|Sensory System Agents|sensory system agents|mesh-ancestor
55804757|NCT05503147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804758|NCT05503147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804759|NCT04619095|Psyllium|psyllium|mesh-list
55804760|NCT04619095|Cathartics|cathartics|mesh-ancestor
55804761|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55804762|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55804763|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55804764|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804765|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
55804766|NCT05502991|Bevacizumab|bevacizumab|mesh-list
55804769|NCT05502991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55804770|NCT05502991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55804771|NCT05502991|Growth Substances|growth substances|mesh-ancestor
55804772|NCT05502991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804773|NCT05502991|Growth Inhibitors|growth inhibitors|mesh-ancestor
55804775|NCT04417621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804776|NCT04417621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55804777|NCT04417621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804778|NCT04417621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804779|NCT02563561|Apaziquone|apaziquone|mesh-list
55804780|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804781|NCT05498233|Pyridoxine|pyridoxine|mesh-list
55804782|NCT05498233|Doxylamine|doxylamine|mesh-list
55804783|NCT05498233|Vitamin B Complex|vitamin b complex|mesh-ancestor
55804784|NCT05498233|Vitamins|vitamins|mesh-ancestor
55804785|NCT05498233|Micronutrients|micronutrients|mesh-ancestor
55804786|NCT05498233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804787|NCT05498233|Antiemetics|antiemetics|mesh-ancestor
55804788|NCT05498233|Autonomic Agents|autonomic agents|mesh-ancestor
55804789|NCT05498233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804790|NCT05498233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55804791|NCT05498233|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55804792|NCT05498233|Histamine Antagonists|histamine antagonists|mesh-ancestor
55804794|NCT05498233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804795|NCT05498233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804796|NCT05499481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55804797|NCT05499481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804799|NCT05497843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804800|NCT05497843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55804801|NCT05497843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804802|NCT05497843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804803|NCT05497765|Silybin|silybin|mesh-list
55804804|NCT05497765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55804805|NCT05497765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804806|NCT05497765|Protective Agents|protective agents|mesh-ancestor
55804807|NCT05497765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804808|NCT04424875|Melatonin|melatonin|mesh-list
55804809|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
55804810|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804811|NCT04424875|Protective Agents|protective agents|mesh-ancestor
55804812|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804813|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804814|NCT04277845|Dexamethasone|dexamethasone|mesh-list
55804815|NCT04277845|Dexamethasone acetate|dexamethasone acetate|mesh-list
55804816|NCT04277845|Lenalidomide|lenalidomide|mesh-list
55804817|NCT04277845|Bortezomib|bortezomib|mesh-list
55804818|NCT04277845|BB 1101|bb 1101|mesh-list
55804819|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55804820|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
55804821|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
55804822|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804823|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804832|NCT04277845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804833|NCT04277845|Immunologic Factors|immunologic factors|mesh-ancestor
55804835|NCT04277845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55804836|NCT04277845|Growth Substances|growth substances|mesh-ancestor
55804837|NCT04277845|Growth Inhibitors|growth inhibitors|mesh-ancestor
55804839|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
55804840|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804841|NCT04471597|Bupivacaine|bupivacaine|mesh-list
55804842|NCT04471597|Anesthetics, Local|anesthetics, local|mesh-ancestor
55804843|NCT04471597|Anesthetics|anesthetics|mesh-ancestor
55804844|NCT04471597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804845|NCT04471597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804846|NCT04471597|Sensory System Agents|sensory system agents|mesh-ancestor
55804847|NCT04471597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804848|NCT05497063|Pyrimethamine|pyrimethamine|mesh-list
55804849|NCT05497063|Sulfadoxine|sulfadoxine|mesh-list
55804850|NCT05497063|Antimalarials|antimalarials|mesh-ancestor
55804851|NCT05497063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55804852|NCT05497063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55804853|NCT05497063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804854|NCT05497063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55804855|NCT05497063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804856|NCT05497063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804857|NCT05497063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55804859|NCT05560945|Listerine|listerine|mesh-list
55804860|NCT05560945|Fluorides|fluorides|mesh-list
55804861|NCT05560945|Sodium Fluoride|sodium fluoride|mesh-list
55804862|NCT05560945|Cariostatic Agents|cariostatic agents|mesh-ancestor
55804863|NCT05560945|Protective Agents|protective agents|mesh-ancestor
55804864|NCT05560945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791034|NCT03103867|Insulin|insulin|mesh-list
55804865|NCT05560945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55804866|NCT05560945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804867|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
55804868|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55804870|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804872|NCT04424563|Coagulants|coagulants|mesh-ancestor
55804873|NCT05495893|Mycophenolic Acid|mycophenolic acid|mesh-list
55804874|NCT05495893|Cyclophosphamide|cyclophosphamide|mesh-list
55804875|NCT05495893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55804876|NCT05495893|Immunologic Factors|immunologic factors|mesh-ancestor
55804883|NCT05495893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55804884|NCT05495893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55804885|NCT05495893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55804886|NCT05495893|Antitubercular Agents|antitubercular agents|mesh-ancestor
55804887|NCT05495893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55804888|NCT05495893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804891|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55804892|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804893|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55804894|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804895|NCT02556307|Ribavirin|ribavirin|mesh-list
55804896|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55804897|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
55804898|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804899|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
55804900|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804903|NCT04352101|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55804904|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55804905|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55804906|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804907|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55804909|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804910|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55804911|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
55804912|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55804913|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55804914|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
55804915|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55804916|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55804917|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804918|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
55804919|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55804920|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804921|NCT05494645|Bupivacaine|bupivacaine|mesh-list
55804922|NCT05494645|Anesthetics, Local|anesthetics, local|mesh-ancestor
55804923|NCT05494645|Anesthetics|anesthetics|mesh-ancestor
55804924|NCT05494645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55804925|NCT05494645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804926|NCT05494645|Sensory System Agents|sensory system agents|mesh-ancestor
55804927|NCT05494645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55804928|NCT05494567|Tadalafil|tadalafil|mesh-list
55804929|NCT05494567|Tamsulosin|tamsulosin|mesh-list
55804930|NCT05494567|Solifenacin Succinate|solifenacin succinate|mesh-list
55804931|NCT05494567|Vasodilator Agents|vasodilator agents|mesh-ancestor
55804948|NCT04339777|Busulfan|busulfan|mesh-list
55804949|NCT04339777|Fludarabine|fludarabine|mesh-list
55804950|NCT04339777|Alemtuzumab|alemtuzumab|mesh-list
55804951|NCT04339777|Tacrolimus|tacrolimus|mesh-list
55804952|NCT04339777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55804953|NCT04339777|Immunologic Factors|immunologic factors|mesh-ancestor
55804954|NCT04339777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55804955|NCT04339777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55804956|NCT04339777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55804957|NCT04339777|Alkylating Agents|alkylating agents|mesh-ancestor
55804958|NCT04339777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55804959|NCT04339777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804960|NCT04339777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55804961|NCT04339777|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55804962|NCT04339777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55804963|NCT04339777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55804964|NCT04339777|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55804965|NCT04339777|Antitubercular Agents|antitubercular agents|mesh-ancestor
55804966|NCT04339777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55804967|NCT04339777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804968|NCT04339777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55804969|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
55804970|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
55804971|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55804973|NCT05494411|Mitomycin|mitomycin|mesh-list
55804974|NCT05494411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55804975|NCT05494411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55804976|NCT05494411|Alkylating Agents|alkylating agents|mesh-ancestor
55804995|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55804996|NCT04080895|Amodiaquine|amodiaquine|mesh-list
55804997|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
55804999|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55805000|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805001|NCT04251169|Paclitaxel|paclitaxel|mesh-list
55805002|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
55805003|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55796742|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
55805008|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805009|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805011|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55805012|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
55805013|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
55805014|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805016|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55805017|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55805019|NCT01662895|Siderophores|siderophores|mesh-ancestor
55805020|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55805021|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
55805022|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
55805023|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805025|NCT05493709|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55805026|NCT05493709|Fertility Agents|fertility agents|mesh-ancestor
55805027|NCT05493709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55805028|NCT05493709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805029|NCT05493709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55791330|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
55791351|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55805030|NCT05493709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805032|NCT05489887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805033|NCT05489887|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55805034|NCT05489887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805035|NCT05489887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805036|NCT05498857|Ephedrine|ephedrine|mesh-list
55805037|NCT05498857|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55805038|NCT05498857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805039|NCT05498857|Sympathomimetics|sympathomimetics|mesh-ancestor
55805040|NCT05498857|Autonomic Agents|autonomic agents|mesh-ancestor
55805041|NCT05498857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805042|NCT05498857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55791386|NCT02684461|Paclitaxel|paclitaxel|mesh-list
55805043|NCT05498857|Adrenergic Agents|adrenergic agents|mesh-ancestor
55805044|NCT05498857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805045|NCT05498857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805047|NCT05489731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805048|NCT05489731|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55805049|NCT05489731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805050|NCT05489731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805051|NCT05498467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55805052|NCT05498467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805053|NCT05489185|Tranexamic Acid|tranexamic acid|mesh-list
55805054|NCT05489185|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55805055|NCT05489185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55805056|NCT05489185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805058|NCT05489185|Coagulants|coagulants|mesh-ancestor
55805059|NCT04235101|Trastuzumab|trastuzumab|mesh-list
55805060|NCT04235101|Niraparib|niraparib|mesh-list
55805061|NCT04235101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805062|NCT04235101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805063|NCT04235101|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55805064|NCT04235101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805065|NCT04235101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805077|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805078|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55805079|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55805080|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
55805081|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805082|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
55805083|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805086|NCT05485519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55805087|NCT05485519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805088|NCT05485519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805089|NCT05485519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55805090|NCT05485519|Analgesics|analgesics|mesh-ancestor
55805091|NCT05485519|Sensory System Agents|sensory system agents|mesh-ancestor
55805092|NCT05485519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805093|NCT05485519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55805094|NCT05485519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55805096|NCT05485519|Adrenergic Agents|adrenergic agents|mesh-ancestor
55805097|NCT05485519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805098|NCT05485519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805099|NCT05485519|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55805100|NCT05485519|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55805101|NCT05485519|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55805102|NCT05485519|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55805103|NCT05485519|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55805104|NCT05485519|Anesthetics, General|anesthetics, general|mesh-ancestor
55805105|NCT05485519|Anesthetics|anesthetics|mesh-ancestor
55805107|NCT05485519|GABA Agents|gaba agents|mesh-ancestor
55805108|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
55805109|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
55805110|NCT02555683|Growth Substances|growth substances|mesh-ancestor
55805111|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805112|NCT02554981|Cyclosporine|cyclosporine|mesh-list
55805113|NCT02554981|Cyclosporins|cyclosporins|mesh-list
55805114|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805115|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805116|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805117|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
55805118|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805119|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
55805120|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805121|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
55805122|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805123|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55805124|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
55796752|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55805134|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805135|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805136|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
55805137|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805138|NCT04071457|Lenalidomide|lenalidomide|mesh-list
55805139|NCT04071457|Daratumumab|daratumumab|mesh-list
55805140|NCT04071457|Immunologic Factors|immunologic factors|mesh-ancestor
55805141|NCT04071457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805142|NCT04071457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55805143|NCT04071457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55805144|NCT04071457|Growth Substances|growth substances|mesh-ancestor
55805145|NCT04071457|Growth Inhibitors|growth inhibitors|mesh-ancestor
55805146|NCT04071457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805147|NCT05485207|Botulinum Toxins|botulinum toxins|mesh-list
55805148|NCT05485207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55805149|NCT05485207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55805150|NCT05485207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55805151|NCT05485207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55805152|NCT05485207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805153|NCT05485207|Cholinergic Agents|cholinergic agents|mesh-ancestor
55805154|NCT05485207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805155|NCT05485207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805156|NCT05485207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55805157|NCT05485207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805159|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805160|NCT03866239|Atezolizumab|atezolizumab|mesh-list
55805161|NCT03866239|Obinutuzumab|obinutuzumab|mesh-list
55805162|NCT03866239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805163|NCT03866239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805164|NCT05488327|Lenalidomide|lenalidomide|mesh-list
55805165|NCT05488327|Immunologic Factors|immunologic factors|mesh-ancestor
55805166|NCT05488327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805167|NCT05488327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55805168|NCT05488327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55805169|NCT05488327|Growth Substances|growth substances|mesh-ancestor
55805170|NCT05488327|Growth Inhibitors|growth inhibitors|mesh-ancestor
55805171|NCT05488327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805172|NCT05488171|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55805173|NCT05488171|Hallucinogens|hallucinogens|mesh-ancestor
55805174|NCT05488171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805175|NCT05488171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55805176|NCT05488171|Serotonin Agents|serotonin agents|mesh-ancestor
55805177|NCT05488171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805178|NCT05488171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805179|NCT05488171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55805180|NCT05488171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55805181|NCT05488171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55805188|NCT05485051|Dermatologic Agents|dermatologic agents|mesh-ancestor
55805190|NCT05484817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55805191|NCT05484817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805192|NCT05484583|Carboplatin|carboplatin|mesh-list
55805194|NCT05484583|Durvalumab|durvalumab|mesh-list
55805195|NCT05484583|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55805196|NCT05484583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805197|NCT05484583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55805198|NCT05484583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55791705|NCT04859621|Vitamin D|vitamin d|mesh-list
55791706|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
55791707|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
55805199|NCT05484583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55805200|NCT05484583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805201|NCT05484583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805202|NCT05484583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805203|NCT05484583|Immunologic Factors|immunologic factors|mesh-ancestor
55805204|NCT05484583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805206|NCT05479747|Sensory System Agents|sensory system agents|mesh-ancestor
55805207|NCT05479747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805208|NCT05479747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805209|NCT05487469|Thymalfasin|thymalfasin|mesh-list
55805210|NCT05487469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55805211|NCT05487469|Immunologic Factors|immunologic factors|mesh-ancestor
55805212|NCT05487469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805213|NCT05484349|Clonidine|clonidine|mesh-list
55805214|NCT05484349|Tizanidine|tizanidine|mesh-list
55805215|NCT05484349|Analgesics|analgesics|mesh-ancestor
55805216|NCT05484349|Sensory System Agents|sensory system agents|mesh-ancestor
55805217|NCT05484349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805218|NCT05484349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805219|NCT05484349|Anticonvulsants|anticonvulsants|mesh-ancestor
55805220|NCT05484349|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55805221|NCT05484349|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55805222|NCT05484349|Parasympatholytics|parasympatholytics|mesh-ancestor
55805235|NCT05479357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55805236|NCT05479357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805237|NCT05487391|Paclitaxel|paclitaxel|mesh-list
55805238|NCT05487391|Vinorelbine|vinorelbine|mesh-list
55805239|NCT05487391|Carboplatin|carboplatin|mesh-list
55805240|NCT05487391|Pemetrexed|pemetrexed|mesh-list
55805241|NCT05487391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55805242|NCT05487391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791820|NCT03036605|Hormones|hormones|mesh-ancestor
55805244|NCT05487391|Antimitotic Agents|antimitotic agents|mesh-ancestor
55805245|NCT05487391|Mitosis Modulators|mitosis modulators|mesh-ancestor
55805246|NCT05487391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805247|NCT05487391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805248|NCT05487391|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55805249|NCT05487391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55805250|NCT05484193|Progesterone|progesterone|mesh-list
55805251|NCT05484193|Progestins|progestins|mesh-ancestor
55805252|NCT05484193|Hormones|hormones|mesh-ancestor
55805253|NCT05484193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55805254|NCT05484193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805255|NCT03796195|Bupivacaine|bupivacaine|mesh-list
55805256|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
55805257|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
55805258|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805259|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805260|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
55805261|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805262|NCT04274335|Tranexamic Acid|tranexamic acid|mesh-list
55796755|NCT02450487|Piroxicam|piroxicam|mesh-list
55805268|NCT04274179|Lamotrigine|lamotrigine|mesh-list
55805269|NCT04274179|Valproic Acid|valproic acid|mesh-list
55805270|NCT04274179|Ethosuximide|ethosuximide|mesh-list
55805271|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
55792023|NCT01659567|Interferons|interferons|mesh-list
55805272|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55805273|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55805274|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805275|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55805276|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805277|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55805278|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55805279|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805281|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55805282|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805284|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805285|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
55805287|NCT05479123|Propranolol|propranolol|mesh-list
55805288|NCT05479123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55805289|NCT05479123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55805290|NCT05479123|Adrenergic Agents|adrenergic agents|mesh-ancestor
55805291|NCT05479123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805292|NCT05479123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805293|NCT05479123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805294|NCT05479123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55805295|NCT05479123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55805296|NCT05479123|Vasodilator Agents|vasodilator agents|mesh-ancestor
55805297|NCT04268407|Amoxicillin|amoxicillin|mesh-list
55805298|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
55805299|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
55805300|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55805301|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55805302|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805303|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55805304|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805305|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805307|NCT05487001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55805308|NCT05487001|Antiemetics|antiemetics|mesh-ancestor
55805309|NCT05487001|Autonomic Agents|autonomic agents|mesh-ancestor
55805310|NCT05487001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805311|NCT05487001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805312|NCT05487001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55805313|NCT05487001|Glucocorticoids|glucocorticoids|mesh-ancestor
55805315|NCT05487001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55805316|NCT05487001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55805317|NCT05487001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805318|NCT05483647|Anesthetics|anesthetics|mesh-list
55805319|NCT05483647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805320|NCT05483647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805322|NCT05475613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55805323|NCT05475613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805324|NCT05475613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55805325|NCT05475613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805326|NCT05475613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805353|NCT05475223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805354|NCT05475223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805355|NCT03684811|Gemcitabine|gemcitabine|mesh-list
55805356|NCT03684811|Nivolumab|nivolumab|mesh-list
55805357|NCT03684811|Azacitidine|azacitidine|mesh-list
55805358|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805359|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55805360|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
55805361|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805362|NCT03684811|Antiviral Agents|antiviral agents|mesh-ancestor
55805363|NCT03684811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805364|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805365|NCT03684811|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805366|NCT03684811|Immunologic Factors|immunologic factors|mesh-ancestor
55805367|NCT03684811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805368|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805369|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55805370|NCT03678025|Prednisone|prednisone|mesh-list
55805371|NCT03678025|Cortisone|cortisone|mesh-list
55805372|NCT03678025|Docetaxel|docetaxel|mesh-list
55805373|NCT03678025|Leuprolide|leuprolide|mesh-list
55805374|NCT03678025|Goserelin|goserelin|mesh-list
55805376|NCT03678025|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55805377|NCT03678025|Flutamide|flutamide|mesh-list
55792478|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805378|NCT03678025|Nilutamide|nilutamide|mesh-list
55805379|NCT03678025|Tryptophan|tryptophan|mesh-list
55805380|NCT03678025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805381|NCT03678025|Tubulin Modulators|tubulin modulators|mesh-ancestor
55805382|NCT03678025|Antimitotic Agents|antimitotic agents|mesh-ancestor
55805383|NCT03678025|Mitosis Modulators|mitosis modulators|mesh-ancestor
55805384|NCT03678025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805385|NCT03678025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55805386|NCT03678025|Glucocorticoids|glucocorticoids|mesh-ancestor
55792508|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805388|NCT03678025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55805389|NCT03678025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805390|NCT03678025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55805391|NCT03678025|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55805392|NCT03678025|Fertility Agents|fertility agents|mesh-ancestor
55805393|NCT03678025|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55805394|NCT03678025|Androgen Antagonists|androgen antagonists|mesh-ancestor
55805395|NCT03678025|Hormone Antagonists|hormone antagonists|mesh-ancestor
55805396|NCT03678025|Luteolytic Agents|luteolytic agents|mesh-ancestor
55805397|NCT03678025|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55805398|NCT03678025|Contraceptive Agents|contraceptive agents|mesh-ancestor
55805399|NCT03678025|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55805400|NCT03678025|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55805401|NCT03678025|Antidepressive Agents|antidepressive agents|mesh-ancestor
55805402|NCT03678025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55805403|NCT04542733|Everolimus|everolimus|mesh-list
55805404|NCT04542733|Tacrolimus|tacrolimus|mesh-list
55805405|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805406|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
55805407|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805408|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55805409|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805410|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805411|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805413|NCT03937219|Ipilimumab|ipilimumab|mesh-list
55796773|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
55805414|NCT03937219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805415|NCT03937219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805416|NCT03937219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55805417|NCT03937219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805418|NCT04424017|Antibodies|antibodies|mesh-list
55805419|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
55805420|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805421|NCT05477797|Lenalidomide|lenalidomide|mesh-list
55805422|NCT05477797|Ixazomib|ixazomib|mesh-list
55805423|NCT05477797|Immunologic Factors|immunologic factors|mesh-ancestor
55805424|NCT05477797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805425|NCT05477797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55805426|NCT05477797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55805427|NCT05477797|Growth Substances|growth substances|mesh-ancestor
55805428|NCT05477797|Growth Inhibitors|growth inhibitors|mesh-ancestor
55805429|NCT05477797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805430|NCT05477797|Protease Inhibitors|protease inhibitors|mesh-ancestor
55805431|NCT05477797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805432|NCT05477797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805433|NCT03386929|Palbociclib|palbociclib|mesh-list
55805434|NCT03386929|Avelumab|avelumab|mesh-list
55805435|NCT03386929|Axitinib|axitinib|mesh-list
55805436|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805437|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55805438|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805439|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805440|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805441|NCT05472337|Colchicine|colchicine|mesh-list
55805442|NCT05472337|Gout Suppressants|gout suppressants|mesh-ancestor
55805443|NCT05472337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805444|NCT05472337|Tubulin Modulators|tubulin modulators|mesh-ancestor
55805445|NCT05472337|Antimitotic Agents|antimitotic agents|mesh-ancestor
55805449|NCT05472259|Leucovorin|leucovorin|mesh-list
55805450|NCT05472259|Fluorouracil|fluorouracil|mesh-list
55805451|NCT05472259|Oxaliplatin|oxaliplatin|mesh-list
55805452|NCT05472259|Irinotecan|irinotecan|mesh-list
55805453|NCT05472259|Antimetabolites|antimetabolites|mesh-ancestor
55805454|NCT05472259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805455|NCT05472259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55805456|NCT05472259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805457|NCT05472259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805458|NCT05472259|Immunologic Factors|immunologic factors|mesh-ancestor
55805459|NCT05472259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805460|NCT05472259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55805461|NCT05472259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55805462|NCT05472259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805463|NCT05472259|Antidotes|antidotes|mesh-ancestor
55805464|NCT05472259|Protective Agents|protective agents|mesh-ancestor
55805465|NCT05472259|Vitamin B Complex|vitamin b complex|mesh-ancestor
55805466|NCT05472259|Vitamins|vitamins|mesh-ancestor
55805469|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55805470|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805471|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805472|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55805473|NCT04266145|Analgesics|analgesics|mesh-ancestor
55805474|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
55805475|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805476|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55805477|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55805479|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
55805480|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805481|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805490|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55805491|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
55805493|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805494|NCT02554903|Macitentan|macitentan|mesh-list
55805495|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55805496|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55805497|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805498|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55805499|NCT03341689|Psilocybin|psilocybin|mesh-list
55805500|NCT03341689|Hallucinogens|hallucinogens|mesh-ancestor
55805501|NCT03341689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805502|NCT03341689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55805503|NCT02332707|Ribavirin|ribavirin|mesh-list
55805504|NCT02332707|Grazoprevir|grazoprevir|mesh-list
55805505|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
55805506|NCT02332707|Ruzasvir|ruzasvir|mesh-list
55805507|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
55805508|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805509|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
55805510|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805511|NCT02370615|Itraconazole|itraconazole|mesh-list
55805512|NCT02370615|Digoxin|digoxin|mesh-list
55805513|NCT02370615|Midazolam|midazolam|mesh-list
55805514|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
55805515|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55805516|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55805517|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805518|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805519|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55805520|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55805521|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55805522|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55805523|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
55805524|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
55805525|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
55805526|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
55805527|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805528|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805529|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
55805530|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805531|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55805532|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55805533|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805534|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55805535|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
55805536|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55805537|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55805539|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55805540|NCT02370615|Protective Agents|protective agents|mesh-ancestor
55805541|NCT02307513|Apremilast|apremilast|mesh-list
55805542|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55805543|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55805545|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
55805546|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805547|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805548|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55805549|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805550|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55805551|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55805552|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805553|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805554|NCT02328105|Paclitaxel|paclitaxel|mesh-list
55805556|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55805557|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55805559|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
55805560|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
55805561|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
55805562|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805564|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
55805565|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
55805566|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
55805567|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805568|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805569|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55805570|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55805571|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805572|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55805573|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55805574|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55805575|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
55805576|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
55805577|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805578|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805579|NCT01646073|Adalimumab|adalimumab|mesh-list
55805580|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55805581|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805582|NCT02551159|Carboplatin|carboplatin|mesh-list
55805583|NCT02551159|Fluorouracil|fluorouracil|mesh-list
55805584|NCT02551159|Cetuximab|cetuximab|mesh-list
55805585|NCT02551159|Durvalumab|durvalumab|mesh-list
55805586|NCT02551159|Tremelimumab|tremelimumab|mesh-list
55805587|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55805588|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805589|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
55805590|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805591|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55805592|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805593|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
55805594|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805595|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805596|NCT03570619|Nivolumab|nivolumab|mesh-list
55805597|NCT03570619|Ipilimumab|ipilimumab|mesh-list
55805598|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805599|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805600|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55805601|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805603|NCT04539379|Analgesics|analgesics|mesh-ancestor
55805604|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
55805605|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805606|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805607|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
55805608|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805609|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55805610|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
55805611|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55805612|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55805613|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805614|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55805615|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
55805616|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55805617|NCT05470075|Tramadol|tramadol|mesh-list
55805618|NCT05470075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55805619|NCT05470075|Narcotics|narcotics|mesh-ancestor
55805620|NCT05470075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805621|NCT05470075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805622|NCT05470075|Analgesics|analgesics|mesh-ancestor
55805623|NCT05470075|Sensory System Agents|sensory system agents|mesh-ancestor
55805624|NCT05470075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805625|NCT05481619|Vedolizumab|vedolizumab|mesh-list
55805626|NCT05481619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55805636|NCT02305563|Cytarabine|cytarabine|mesh-list
55805637|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55805638|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
55805639|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805640|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805641|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
55805642|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805721|NCT04532645|Olaparib|olaparib|mesh-list
55805643|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805644|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
55805645|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805646|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
55805647|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
55805648|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55805649|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55805650|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805651|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805652|NCT02304705|Urological Agents|urological agents|mesh-ancestor
55805653|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
55805654|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805655|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805656|NCT02553265|Carbidopa|carbidopa|mesh-list
55805657|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55805658|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55805659|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
55805660|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805661|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805662|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805663|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55805664|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805665|NCT04567615|Nivolumab|nivolumab|mesh-list
55805666|NCT04567615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805667|NCT04567615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805668|NCT04567615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55805669|NCT04567615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805670|NCT03215095|Durvalumab|durvalumab|mesh-list
55805671|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805672|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805673|NCT01663103|Rilonacept|rilonacept|mesh-list
55805674|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55805675|NCT04810559|Antibodies|antibodies|mesh-list
55805676|NCT04810559|Immunologic Factors|immunologic factors|mesh-ancestor
55805677|NCT04810559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805678|NCT04540211|Paclitaxel|paclitaxel|mesh-list
55805679|NCT04540211|Atezolizumab|atezolizumab|mesh-list
55805680|NCT04540211|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55805681|NCT04540211|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55805682|NCT04540211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805683|NCT04540211|Tubulin Modulators|tubulin modulators|mesh-ancestor
55805684|NCT04540211|Antimitotic Agents|antimitotic agents|mesh-ancestor
55805685|NCT04540211|Mitosis Modulators|mitosis modulators|mesh-ancestor
55805686|NCT04540211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805687|NCT04540211|Immunologic Factors|immunologic factors|mesh-ancestor
55805689|NCT05501639|Tiotropium Bromide|tiotropium bromide|mesh-list
55805690|NCT05501639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55805691|NCT05501639|Autonomic Agents|autonomic agents|mesh-ancestor
55805692|NCT05501639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805693|NCT05501639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805694|NCT05501639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55805695|NCT05501639|Respiratory System Agents|respiratory system agents|mesh-ancestor
55805696|NCT05501639|Parasympatholytics|parasympatholytics|mesh-ancestor
55805697|NCT05501639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55805698|NCT05501639|Cholinergic Agents|cholinergic agents|mesh-ancestor
55805699|NCT05501639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805700|NCT05501639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805702|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805703|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805704|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55805705|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55805706|NCT05284643|Growth Substances|growth substances|mesh-ancestor
55805707|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805708|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
55805710|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55805712|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55805713|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55805714|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805715|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
55805716|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
55805717|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
55805718|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805719|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
55805720|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805722|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55805723|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805724|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805725|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805726|NCT02560025|Cytarabine|cytarabine|mesh-list
55805727|NCT02560025|Daunorubicin|daunorubicin|mesh-list
55805728|NCT02560025|Idarubicin|idarubicin|mesh-list
55805729|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55805730|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
55805731|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805732|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805733|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
55805734|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805735|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805736|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
55805737|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805738|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55805739|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55805740|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55805741|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805742|NCT05500937|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55805743|NCT05500937|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55805744|NCT05500937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55805746|NCT04524455|Blinatumomab|blinatumomab|mesh-list
55805747|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55805748|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
55805749|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
55805750|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805751|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805752|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55805753|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
55805754|NCT04524455|Hormones|hormones|mesh-ancestor
55805755|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55805756|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55805757|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805758|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
55805760|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55805761|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805762|NCT04411901|Vitamins|vitamins|mesh-ancestor
55805763|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
55805764|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55805766|NCT05508815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55805767|NCT05508815|Abortifacient Agents|abortifacient agents|mesh-ancestor
55805768|NCT05508815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55805769|NCT05508815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805770|NCT05508815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55805771|NCT05508815|Antimetabolites|antimetabolites|mesh-ancestor
55805772|NCT05508815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805773|NCT05508815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805774|NCT05508815|Dermatologic Agents|dermatologic agents|mesh-ancestor
55805775|NCT05508815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805776|NCT05508815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55805777|NCT05508815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805778|NCT05508815|Immunologic Factors|immunologic factors|mesh-ancestor
55805779|NCT05508815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805780|NCT05508815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55805781|NCT05508737|Trifluridine|trifluridine|mesh-list
55805782|NCT05508737|Pembrolizumab|pembrolizumab|mesh-list
55805783|NCT05508737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805784|NCT05508737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805785|NCT05508737|Antimetabolites|antimetabolites|mesh-ancestor
55805786|NCT05508737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805787|NCT05508737|Antiviral Agents|antiviral agents|mesh-ancestor
55805788|NCT05508737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805789|NCT05508035|Valsartan|valsartan|mesh-list
55805790|NCT05508035|Ramipril|ramipril|mesh-list
55805791|NCT05508035|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55805792|NCT05508035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55805793|NCT05508035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55805794|NCT05508035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55805795|NCT05508035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805796|NCT05508035|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55805797|NCT05508035|Protease Inhibitors|protease inhibitors|mesh-ancestor
55805801|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55805802|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805803|NCT05507957|Chlorhexidine|chlorhexidine|mesh-list
55805804|NCT05507957|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55805805|NCT05507957|Ethanol|ethanol|mesh-list
55805806|NCT05507957|Povidone-Iodine|povidone-iodine|mesh-list
55805807|NCT05507957|Disinfectants|disinfectants|mesh-list
55805808|NCT05507957|Povidone|povidone|mesh-list
55805810|NCT05507957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805811|NCT05507957|Dermatologic Agents|dermatologic agents|mesh-ancestor
55805812|NCT05507957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805813|NCT05507957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805814|NCT05507957|Plasma Substitutes|plasma substitutes|mesh-ancestor
55805815|NCT05507957|Blood Substitutes|blood substitutes|mesh-ancestor
55805817|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55805819|NCT04282109|Cetuximab|cetuximab|mesh-list
55805820|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55805821|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805823|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
55805824|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
55805825|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805826|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55805827|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55805828|NCT03150173|Buprenorphine|buprenorphine|mesh-list
55805829|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55805830|NCT03150173|Narcotics|narcotics|mesh-ancestor
55805831|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796782|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
55805832|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805833|NCT03150173|Analgesics|analgesics|mesh-ancestor
55805834|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
55805835|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805836|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55805837|NCT05563571|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55805838|NCT05563571|Methylprednisolone|methylprednisolone|mesh-list
55805839|NCT05563571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55805840|NCT05563571|Prednisolone|prednisolone|mesh-list
55805841|NCT05563571|Prednisolone acetate|prednisolone acetate|mesh-list
55805842|NCT05563571|Lidocaine|lidocaine|mesh-list
55805843|NCT05563571|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55805844|NCT05563571|Prednisolone phosphate|prednisolone phosphate|mesh-list
55805845|NCT05563571|Anesthetics, Local|anesthetics, local|mesh-ancestor
55805846|NCT05563571|Anesthetics|anesthetics|mesh-ancestor
55805847|NCT05563571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805848|NCT05563571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805849|NCT05563571|Sensory System Agents|sensory system agents|mesh-ancestor
55805850|NCT05563571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805851|NCT05563571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55805852|NCT05563571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55805853|NCT05563571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55805854|NCT05563571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55805855|NCT05563571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805857|NCT05563571|Antiemetics|antiemetics|mesh-ancestor
55805858|NCT05563571|Autonomic Agents|autonomic agents|mesh-ancestor
55805859|NCT05563571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55805860|NCT05563571|Glucocorticoids|glucocorticoids|mesh-ancestor
55805861|NCT05563571|Hormones|hormones|mesh-ancestor
55805862|NCT05563571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55805864|NCT05563571|Protective Agents|protective agents|mesh-ancestor
55805865|NCT05563571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55805866|NCT05563571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805867|NCT02717507|Carvedilol|carvedilol|mesh-list
55805868|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55805869|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55805870|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
55805871|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55805872|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805873|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805874|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55805875|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
55805876|NCT02717507|Protective Agents|protective agents|mesh-ancestor
55805877|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55805878|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55805879|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55805880|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
55805963|NCT04324463|Gout Suppressants|gout suppressants|mesh-ancestor
55805881|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55805882|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55805884|NCT02489903|Paclitaxel|paclitaxel|mesh-list
55805885|NCT02489903|Etoposide|etoposide|mesh-list
55805886|NCT02489903|Vinorelbine|vinorelbine|mesh-list
55805887|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55805888|NCT02489903|Carboplatin|carboplatin|mesh-list
55805889|NCT02489903|Irinotecan|irinotecan|mesh-list
55805890|NCT02489903|Pemetrexed|pemetrexed|mesh-list
55805892|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55805893|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805895|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
55805896|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
55805897|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805898|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55805899|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
55805900|NCT02489903|Antiviral Agents|antiviral agents|mesh-ancestor
55805901|NCT02489903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805902|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805903|NCT02489903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805904|NCT02489903|Immunologic Factors|immunologic factors|mesh-ancestor
55805905|NCT02489903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805906|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55805907|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55805908|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55805910|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55805911|NCT01174199|Sirolimus|sirolimus|mesh-list
55805912|NCT01174199|Vorinostat|vorinostat|mesh-list
55805913|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55805914|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805915|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55805916|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805917|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
55805918|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805920|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805921|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55805922|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805923|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805924|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55805925|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55805926|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805927|NCT05562869|Abatacept|abatacept|mesh-list
55805928|NCT05562869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55805929|NCT05562869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805930|NCT05562869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805931|NCT05562869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55805932|NCT05562869|Immunologic Factors|immunologic factors|mesh-ancestor
55805933|NCT05562869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805934|NCT05562869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805935|NCT04324463|Aspirin|aspirin|mesh-list
55805936|NCT04324463|Interferons|interferons|mesh-list
55805937|NCT04324463|Interferon-beta|interferon-beta|mesh-list
55805938|NCT04324463|Colchicine|colchicine|mesh-list
55805939|NCT04324463|Rivaroxaban|rivaroxaban|mesh-list
55805940|NCT04324463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805941|NCT04324463|Antiviral Agents|antiviral agents|mesh-ancestor
55805942|NCT04324463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55805943|NCT04324463|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55805944|NCT04324463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55805945|NCT04324463|Analgesics|analgesics|mesh-ancestor
55805946|NCT04324463|Sensory System Agents|sensory system agents|mesh-ancestor
55805947|NCT04324463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805948|NCT04324463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805949|NCT04324463|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55805950|NCT04324463|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55805951|NCT04324463|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55805952|NCT04324463|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55805953|NCT04324463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805954|NCT04324463|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55805956|NCT04324463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805957|NCT04324463|Antipyretics|antipyretics|mesh-ancestor
55805958|NCT04324463|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55805959|NCT04324463|Antithrombins|antithrombins|mesh-ancestor
55805960|NCT04324463|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55805961|NCT04324463|Protease Inhibitors|protease inhibitors|mesh-ancestor
55805962|NCT04324463|Anticoagulants|anticoagulants|mesh-ancestor
55805971|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55805972|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805973|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
55805974|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55805975|NCT04080869|Vitamin A|vitamin a|mesh-list
55805976|NCT04080869|Tretinoin|tretinoin|mesh-list
55805977|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
55805978|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55805979|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
55805980|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
55805981|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
55805982|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805983|NCT04080869|Protective Agents|protective agents|mesh-ancestor
55805984|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805985|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55805986|NCT04080869|Vitamins|vitamins|mesh-ancestor
55805987|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
55805988|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
55805989|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
55805990|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
55805991|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
55805992|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55805993|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55805994|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55805995|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55805996|NCT00560495|Growth Substances|growth substances|mesh-ancestor
55805997|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55805998|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
55805999|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806000|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55806001|NCT02559713|Vedolizumab|vedolizumab|mesh-list
55806002|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55806003|NCT05499065|Cetuximab|cetuximab|mesh-list
55806004|NCT05499065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55806005|NCT05499065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806007|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
55806008|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55806009|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806010|NCT04038437|Venetoclax|venetoclax|mesh-list
55806011|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806012|NCT05498675|Valsartan|valsartan|mesh-list
55806013|NCT05498675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55806014|NCT05498675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55806015|NCT05498675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55806016|NCT05498675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55806017|NCT05498675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806018|NCT05491343|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55806019|NCT05491343|Medroxyprogesterone|medroxyprogesterone|mesh-list
55806020|NCT05491343|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55806021|NCT05491343|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55806022|NCT05491343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55806023|NCT05491343|Contraceptive Agents|contraceptive agents|mesh-ancestor
55806024|NCT05491343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55806025|NCT05491343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806026|NCT05491343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55806027|NCT05491343|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55806028|NCT05491343|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55806029|NCT05491343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55806030|NCT05491343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806032|NCT05498441|Antidepressive Agents|antidepressive agents|mesh-ancestor
55806033|NCT05498441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55806034|NCT05498441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55806035|NCT05498441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55806036|NCT05498441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806037|NCT05498441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806039|NCT05491187|Bupivacaine|bupivacaine|mesh-list
55806041|NCT05491187|Anesthetics|anesthetics|mesh-ancestor
55806042|NCT05491187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806043|NCT05491187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806044|NCT05491187|Sensory System Agents|sensory system agents|mesh-ancestor
55806045|NCT05491187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806046|NCT05491187|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55806047|NCT05491187|Narcotics|narcotics|mesh-ancestor
55806048|NCT05491187|Analgesics|analgesics|mesh-ancestor
55806049|NCT05491187|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55806050|NCT05491187|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55806051|NCT05491187|Anesthetics, General|anesthetics, general|mesh-ancestor
55806052|NCT05485883|Lenvatinib|lenvatinib|mesh-list
55806053|NCT05485883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806054|NCT05485883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55806055|NCT05485883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806056|NCT05485883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806057|NCT05490953|Pentoxifylline|pentoxifylline|mesh-list
55806058|NCT05490953|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55806059|NCT05490953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806062|NCT05490953|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55806063|NCT05490953|Protective Agents|protective agents|mesh-ancestor
55806065|NCT05490953|Vasodilator Agents|vasodilator agents|mesh-ancestor
55806066|NCT05490953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55806067|NCT05490953|Antioxidants|antioxidants|mesh-ancestor
55806069|NCT04273607|Calcium heparin|calcium heparin|mesh-list
55806070|NCT04273607|Enoxaparin|enoxaparin|mesh-list
55806071|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
55806072|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55806073|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55806074|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806075|NCT05476081|Aspirin|aspirin|mesh-list
55806076|NCT05476081|Clopidogrel|clopidogrel|mesh-list
55806077|NCT05476081|Ticagrelor|ticagrelor|mesh-list
55806078|NCT05476081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55806079|NCT05476081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806080|NCT05476081|Analgesics|analgesics|mesh-ancestor
55806081|NCT05476081|Sensory System Agents|sensory system agents|mesh-ancestor
55806082|NCT05476081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806083|NCT05476081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806084|NCT05476081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806085|NCT05476081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806086|NCT05476081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55806087|NCT05476081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55806088|NCT05476081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806089|NCT05476081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55806090|NCT05476081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55806091|NCT05476081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806092|NCT05476081|Antipyretics|antipyretics|mesh-ancestor
55806093|NCT05476081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55806094|NCT05476081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55806095|NCT05476081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55806096|NCT05476081|Purinergic Agents|purinergic agents|mesh-ancestor
55806097|NCT05476081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806098|NCT05476003|Midazolam|midazolam|mesh-list
55806099|NCT05476003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55806100|NCT05476003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55806101|NCT05476003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806102|NCT05476003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806103|NCT05476003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55806104|NCT05476003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55806105|NCT05476003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55806106|NCT05476003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55806107|NCT05476003|Anesthetics, General|anesthetics, general|mesh-ancestor
55806108|NCT05476003|Anesthetics|anesthetics|mesh-ancestor
55806109|NCT05476003|GABA Modulators|gaba modulators|mesh-ancestor
55806111|NCT05476003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806112|NCT05476003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806113|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55806114|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
55806115|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806116|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
55806118|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55806119|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
55806120|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806121|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806122|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806123|NCT02535715|Insulin|insulin|mesh-list
55806124|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55806125|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55806128|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806129|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
55806130|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
55806131|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806132|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806133|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55806136|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55806137|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55806138|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806139|NCT02320435|Trastuzumab|trastuzumab|mesh-list
55806140|NCT02320435|Pertuzumab|pertuzumab|mesh-list
55806141|NCT02320435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55806142|NCT02320435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806143|NCT05434039|Diclofenac|diclofenac|mesh-list
55806144|NCT05434039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55806145|NCT05434039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806146|NCT05434039|Analgesics|analgesics|mesh-ancestor
55806147|NCT05434039|Sensory System Agents|sensory system agents|mesh-ancestor
55806148|NCT05434039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806149|NCT05434039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806150|NCT05434039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806151|NCT05434039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806152|NCT05434039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55806153|NCT05434039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806154|NCT05434039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806156|NCT05466175|Vincristine|vincristine|mesh-list
55806157|NCT05466175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806158|NCT05466175|Glucocorticoids|glucocorticoids|mesh-ancestor
55806159|NCT05466175|Hormones|hormones|mesh-ancestor
55806160|NCT05466175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55806161|NCT05466175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806162|NCT05466175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55806163|NCT05466175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806164|NCT05466175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55806165|NCT05466175|Tubulin Modulators|tubulin modulators|mesh-ancestor
55806166|NCT05466175|Antimitotic Agents|antimitotic agents|mesh-ancestor
55806167|NCT05466175|Mitosis Modulators|mitosis modulators|mesh-ancestor
55806168|NCT05466175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806169|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55806170|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55806171|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55806172|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
55806173|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806174|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55806175|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55806178|NCT05458453|Antidepressive Agents|antidepressive agents|mesh-ancestor
55806179|NCT05458453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55806180|NCT02545933|Aspirin|aspirin|mesh-list
55806181|NCT02545933|Ticagrelor|ticagrelor|mesh-list
55806182|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55806183|NCT02545933|Vorapaxar|vorapaxar|mesh-list
55806184|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55806185|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806186|NCT02545933|Analgesics|analgesics|mesh-ancestor
55806187|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
55806188|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806189|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806190|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806191|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806192|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55806193|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55806194|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806195|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55806196|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55806197|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806198|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
55806199|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55843598|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
55806202|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
55806203|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806204|NCT04260529|Pembrolizumab|pembrolizumab|mesh-list
55806205|NCT04260529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55806206|NCT04260529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806207|NCT02545075|Ipilimumab|ipilimumab|mesh-list
55806216|NCT03007537|Hematinics|hematinics|mesh-ancestor
55806217|NCT03004183|Valacyclovir|valacyclovir|mesh-list
55806218|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
55806219|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55806220|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806221|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
55806222|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806223|NCT02544763|Cannabidiol|cannabidiol|mesh-list
55806224|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
55806226|NCT02556203|Vitamin K|vitamin k|mesh-list
55806227|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
55806229|NCT02556203|Vitamins|vitamins|mesh-ancestor
55806230|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
55806231|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806232|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55806233|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55806234|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55806235|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55806236|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
55806237|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806238|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806239|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55806240|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
55806241|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55806242|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
55806243|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806244|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
55806245|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55806246|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806247|NCT02556203|Analgesics|analgesics|mesh-ancestor
55806248|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
55806249|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806250|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806251|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806253|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55806254|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55806255|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
55806256|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55806257|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
55806258|NCT02556203|Coagulants|coagulants|mesh-ancestor
55806259|NCT05485571|Methotrexate|methotrexate|mesh-list
55806260|NCT05485571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55792586|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55806261|NCT05485571|Abortifacient Agents|abortifacient agents|mesh-ancestor
55806262|NCT05485571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55806263|NCT05485571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792618|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55806264|NCT05485571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55806266|NCT05485571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806267|NCT05485571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806268|NCT05485571|Dermatologic Agents|dermatologic agents|mesh-ancestor
55806269|NCT05485571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806270|NCT05485571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55806271|NCT05485571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55796820|NCT03117751|Blinatumomab|blinatumomab|mesh-list
55806272|NCT05485571|Immunologic Factors|immunologic factors|mesh-ancestor
55806273|NCT05485571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806274|NCT05485571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55806275|NCT05496725|Micafungin|micafungin|mesh-list
55806276|NCT05496725|Antifungal Agents|antifungal agents|mesh-ancestor
55806277|NCT05496725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806278|NCT05490719|Cisplatin|cisplatin|mesh-list
55806279|NCT05490719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806280|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
55806281|NCT04424459|Narcotics|narcotics|mesh-ancestor
55806282|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806283|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806284|NCT04424459|Analgesics|analgesics|mesh-ancestor
55806285|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
55806286|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806287|NCT05485259|Thioctic Acid|thioctic acid|mesh-list
55806288|NCT05485259|Antioxidants|antioxidants|mesh-ancestor
55806289|NCT05485259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806290|NCT05485259|Protective Agents|protective agents|mesh-ancestor
55806291|NCT05485259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806292|NCT05485259|Vitamin B Complex|vitamin b complex|mesh-ancestor
55806293|NCT05485259|Vitamins|vitamins|mesh-ancestor
55806294|NCT05485259|Micronutrients|micronutrients|mesh-ancestor
55806295|NCT05490485|Cisplatin|cisplatin|mesh-list
55806296|NCT05490485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806297|NCT05485103|Glycerol|glycerol|mesh-list
55806298|NCT05485103|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55806299|NCT05485103|Protective Agents|protective agents|mesh-ancestor
55806300|NCT05485103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806302|NCT05490407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806303|NCT05490095|Everolimus|everolimus|mesh-list
55806304|NCT05490095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806305|NCT05490095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806306|NCT05490095|Immunologic Factors|immunologic factors|mesh-ancestor
55806307|NCT05490095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806308|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
55806309|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55806310|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
55806311|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55806312|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
55806313|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806314|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806316|NCT05496179|Metoclopramide|metoclopramide|mesh-list
55806317|NCT05496179|Prucalopride|prucalopride|mesh-list
55806318|NCT05496179|Antiemetics|antiemetics|mesh-ancestor
55806319|NCT05496179|Autonomic Agents|autonomic agents|mesh-ancestor
55806320|NCT05496179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806321|NCT05496179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806322|NCT05496179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55806323|NCT05496179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55806324|NCT05496179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55806325|NCT05496179|Dopamine Agents|dopamine agents|mesh-ancestor
55806326|NCT05496179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806327|NCT05496179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806328|NCT05496179|Laxatives|laxatives|mesh-ancestor
55806329|NCT05496179|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55806330|NCT05496179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55806331|NCT05496179|Serotonin Agents|serotonin agents|mesh-ancestor
55806332|NCT05484401|Ibuprofen|ibuprofen|mesh-list
55806339|NCT05484401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806340|NCT05484401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806341|NCT05484401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55806342|NCT05484401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806343|NCT05484401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806344|NCT05489939|Salicylates|salicylates|mesh-list
55806345|NCT05489939|Methyl salicylate|methyl salicylate|mesh-list
55806346|NCT05489939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55806347|NCT05489939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806348|NCT05489939|Analgesics|analgesics|mesh-ancestor
55806349|NCT05489939|Sensory System Agents|sensory system agents|mesh-ancestor
55806350|NCT05489939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806351|NCT05489939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806352|NCT05489939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806353|NCT05489939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806354|NCT05489939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55806355|NCT05489939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806356|NCT05489939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806358|NCT05495945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55806359|NCT05495945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806360|NCT05495945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806361|NCT05495945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55806362|NCT05495945|Anesthetics, General|anesthetics, general|mesh-ancestor
55806363|NCT05495945|Anesthetics|anesthetics|mesh-ancestor
55806364|NCT04000529|Spartalizumab|spartalizumab|mesh-list
55806365|NCT04000529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55806366|NCT04000529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806367|NCT04000529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806368|NCT03999749|Nivolumab|nivolumab|mesh-list
55806369|NCT03999749|Ipilimumab|ipilimumab|mesh-list
55806370|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55806371|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806372|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55806373|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806374|NCT04139213|Naltrexone|naltrexone|mesh-list
55806375|NCT04139213|Buprenorphine|buprenorphine|mesh-list
55806376|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55806377|NCT04139213|Naloxone|naloxone|mesh-list
55806378|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55806379|NCT04139213|Narcotics|narcotics|mesh-ancestor
55806380|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806381|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806382|NCT04139213|Analgesics|analgesics|mesh-ancestor
55806383|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
55806384|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806392|NCT05494775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806393|NCT05488925|Vitamin E|vitamin e|mesh-list
55806394|NCT05488925|Diclofenac|diclofenac|mesh-list
55806401|NCT05488925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806402|NCT05488925|Analgesics|analgesics|mesh-ancestor
55806403|NCT05488925|Sensory System Agents|sensory system agents|mesh-ancestor
55806404|NCT05488925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806405|NCT05488925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806406|NCT05488925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806407|NCT05488925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55806408|NCT05488925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806409|NCT05488925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806410|NCT05488925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55806411|NCT05488925|Narcotics|narcotics|mesh-ancestor
55806412|NCT05488925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806413|NCT05488925|Antioxidants|antioxidants|mesh-ancestor
55806414|NCT05488925|Protective Agents|protective agents|mesh-ancestor
55806416|NCT05494385|Analgesics|analgesics|mesh-ancestor
55806417|NCT05494385|Sensory System Agents|sensory system agents|mesh-ancestor
55806418|NCT05494385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806419|NCT05494385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806420|NCT05494385|Anticonvulsants|anticonvulsants|mesh-ancestor
55806421|NCT05494385|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55806422|NCT05494385|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55806423|NCT05494385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806424|NCT05494385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55806425|NCT05494385|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55806426|NCT05494385|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55806427|NCT05494385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806428|NCT05494385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806429|NCT05494385|Antimanic Agents|antimanic agents|mesh-ancestor
55806430|NCT05482763|Itraconazole|itraconazole|mesh-list
55806431|NCT05482763|Terbinafine|terbinafine|mesh-list
55806433|NCT05482763|Amorolfine|amorolfine|mesh-list
55806434|NCT05482763|Antifungal Agents|antifungal agents|mesh-ancestor
55806435|NCT05482763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806436|NCT05482763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55806437|NCT05482763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55806438|NCT05482763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806439|NCT05482763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806440|NCT05482763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55806441|NCT05482763|Hormone Antagonists|hormone antagonists|mesh-ancestor
55806444|NCT05482763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55806445|NCT05482373|Oleuropein|oleuropein|mesh-list
55806446|NCT05482373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806447|NCT05482373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55806448|NCT05482373|Vasodilator Agents|vasodilator agents|mesh-ancestor
55806449|NCT05482295|Vaccines|vaccines|mesh-list
55806450|NCT05482295|Immunologic Factors|immunologic factors|mesh-ancestor
55806451|NCT05482295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806452|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
55806453|NCT04245839|Fludarabine|fludarabine|mesh-list
55806454|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806455|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
55806456|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806457|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806458|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55806459|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
55806460|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806461|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806462|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55806465|NCT05494307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55806466|NCT05494307|Autonomic Agents|autonomic agents|mesh-ancestor
55806467|NCT05494307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806468|NCT05494307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806469|NCT05494307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55806470|NCT05494307|Respiratory System Agents|respiratory system agents|mesh-ancestor
55806471|NCT05494307|Sympathomimetics|sympathomimetics|mesh-ancestor
55806472|NCT05494307|Tocolytic Agents|tocolytic agents|mesh-ancestor
55806473|NCT05494307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55806474|NCT05494307|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55806475|NCT05494307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55806476|NCT05494307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55806477|NCT05494307|Adrenergic Agents|adrenergic agents|mesh-ancestor
55806478|NCT05494307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806479|NCT05494307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806480|NCT05494307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55806481|NCT05494307|Hormone Antagonists|hormone antagonists|mesh-ancestor
55806482|NCT05494307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55806483|NCT05488457|Oxytocin|oxytocin|mesh-list
55806484|NCT05488457|Oxytocics|oxytocics|mesh-ancestor
55806485|NCT05488457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55806486|NCT05488457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806487|NCT04051619|Oxytocin|oxytocin|mesh-list
55806488|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
55806489|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55806490|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806491|NCT03907475|Gemcitabine|gemcitabine|mesh-list
55806492|NCT03907475|Paclitaxel|paclitaxel|mesh-list
55806493|NCT03907475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55806494|NCT03907475|Carboplatin|carboplatin|mesh-list
55806495|NCT03907475|Doxorubicin|doxorubicin|mesh-list
55806496|NCT03907475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55806497|NCT03907475|Capecitabine|capecitabine|mesh-list
55806498|NCT03907475|Durvalumab|durvalumab|mesh-list
55806499|NCT03907475|Immunoglobulins|immunoglobulins|mesh-list
55806500|NCT03907475|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55806501|NCT03907475|Immunoglobulin G|immunoglobulin g|mesh-list
55806502|NCT03907475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55806503|NCT03907475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806504|NCT03907475|Tubulin Modulators|tubulin modulators|mesh-ancestor
55806505|NCT03907475|Antimitotic Agents|antimitotic agents|mesh-ancestor
55806506|NCT03907475|Mitosis Modulators|mitosis modulators|mesh-ancestor
55806507|NCT03907475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806508|NCT03907475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55806509|NCT03907475|Antimetabolites|antimetabolites|mesh-ancestor
55806510|NCT03907475|Antiviral Agents|antiviral agents|mesh-ancestor
55806511|NCT03907475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806512|NCT03907475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806513|NCT03907475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806514|NCT03907475|Immunologic Factors|immunologic factors|mesh-ancestor
55806515|NCT03907475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806516|NCT03907475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55806517|NCT03907475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55806523|NCT05487521|Methylprednisolone|methylprednisolone|mesh-list
55806532|NCT05487521|Autonomic Agents|autonomic agents|mesh-ancestor
55806533|NCT05487521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806534|NCT05487521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806535|NCT05487521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55806536|NCT05487521|Glucocorticoids|glucocorticoids|mesh-ancestor
55806537|NCT05487521|Hormones|hormones|mesh-ancestor
55806538|NCT05487521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55806539|NCT05487521|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55806540|NCT05487521|Protective Agents|protective agents|mesh-ancestor
55806541|NCT05487521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55806542|NCT05487521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806543|NCT05481281|Dexmedetomidine|dexmedetomidine|mesh-list
55806544|NCT05481281|Ketamine|ketamine|mesh-list
55806545|NCT05481281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55806546|NCT05481281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806547|NCT05481281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806548|NCT05481281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806549|NCT05481281|Analgesics|analgesics|mesh-ancestor
55806550|NCT05481281|Sensory System Agents|sensory system agents|mesh-ancestor
55806551|NCT05481281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806552|NCT05481281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55806553|NCT05481281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55806554|NCT05481281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55806555|NCT05481281|Adrenergic Agents|adrenergic agents|mesh-ancestor
55806556|NCT05481281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806557|NCT05481281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806558|NCT05481281|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55806559|NCT05481281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55806560|NCT05481281|Anesthetics, General|anesthetics, general|mesh-ancestor
55806561|NCT05481281|Anesthetics|anesthetics|mesh-ancestor
55806562|NCT05481281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55806563|NCT05481281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55806564|NCT05487443|Gemcitabine|gemcitabine|mesh-list
55806565|NCT05487443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55806567|NCT05487443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806568|NCT05487443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806569|NCT05487443|Antiviral Agents|antiviral agents|mesh-ancestor
55806570|NCT05487443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806571|NCT05487443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806572|NCT05487443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806573|NCT05487443|Immunologic Factors|immunologic factors|mesh-ancestor
55806574|NCT05487443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806575|NCT02558231|Selexipag|selexipag|mesh-list
55806576|NCT02558231|Tadalafil|tadalafil|mesh-list
55806577|NCT02558231|Macitentan|macitentan|mesh-list
55806578|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
55806579|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55806580|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55806582|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806583|NCT02558231|Urological Agents|urological agents|mesh-ancestor
55806584|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55806585|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55806586|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55806587|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55806589|NCT05493371|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55806590|NCT05493371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806591|NCT05493371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55806592|NCT05493371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806593|NCT05486819|Propofol|propofol|mesh-list
55806594|NCT05486819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55806595|NCT05486819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806596|NCT05486819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806597|NCT05486819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55806598|NCT05486819|Anesthetics, General|anesthetics, general|mesh-ancestor
55806599|NCT05486819|Anesthetics|anesthetics|mesh-ancestor
55806600|NCT03860987|Prednisone|prednisone|mesh-list
55806601|NCT03860987|Goserelin|goserelin|mesh-list
55806602|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806603|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
55806604|NCT03860987|Hormones|hormones|mesh-ancestor
55806605|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55806606|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806607|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55806608|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806609|NCT05480111|Anesthetics|anesthetics|mesh-list
55806613|NCT05475431|Antacids|antacids|mesh-ancestor
55806625|NCT05492669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55806626|NCT05492669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55806627|NCT05492669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806628|NCT05492591|Valacyclovir|valacyclovir|mesh-list
55806629|NCT05492591|Antiviral Agents|antiviral agents|mesh-ancestor
55806630|NCT05492591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806631|NCT02554721|Aspirin|aspirin|mesh-list
55806632|NCT02554721|Cilostazol|cilostazol|mesh-list
55806633|NCT02554721|Clopidogrel|clopidogrel|mesh-list
55806634|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55806635|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55806636|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55806637|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55806638|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
55806639|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806640|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806641|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806642|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55806643|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806644|NCT02554721|Analgesics|analgesics|mesh-ancestor
55806645|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
55806646|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806647|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806648|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806649|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55806650|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55806651|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55806652|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806653|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
55806654|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55806655|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
55806656|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55806657|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
55806659|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55806710|NCT03418961|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55806711|NCT05479175|Ibuprofen|ibuprofen|mesh-list
55806712|NCT05479175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55806713|NCT05479175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806714|NCT05479175|Analgesics|analgesics|mesh-ancestor
55806715|NCT05479175|Sensory System Agents|sensory system agents|mesh-ancestor
55806716|NCT05479175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806717|NCT05479175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806718|NCT05479175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806719|NCT05479175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806720|NCT05479175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55806721|NCT05479175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806722|NCT05479175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806723|NCT02534935|Vaccines|vaccines|mesh-list
55806724|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
55806725|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806726|NCT02544451|Ivacaftor|ivacaftor|mesh-list
55806727|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55806728|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55806729|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806730|NCT02551991|Leucovorin|leucovorin|mesh-list
55806736|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806737|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806738|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
55806739|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806741|NCT02551991|Protective Agents|protective agents|mesh-ancestor
55806742|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
55806743|NCT02551991|Vitamins|vitamins|mesh-ancestor
55806744|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
55806745|NCT05491811|Bevacizumab|bevacizumab|mesh-list
55806746|NCT05491811|Ensartinib|ensartinib|mesh-list
55806747|NCT05491811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55806748|NCT05491811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806749|NCT05491811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55806750|NCT05491811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55806751|NCT05491811|Growth Substances|growth substances|mesh-ancestor
55806752|NCT05491811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806753|NCT05491811|Growth Inhibitors|growth inhibitors|mesh-ancestor
55806754|NCT05491811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55806755|NCT05491811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806756|NCT05491811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806758|NCT05478785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806760|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
55806761|NCT02880293|Melphalan|melphalan|mesh-list
55806763|NCT02880293|Fludarabine|fludarabine|mesh-list
55806764|NCT02880293|Tacrolimus|tacrolimus|mesh-list
55806765|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806766|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
55806767|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806768|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806769|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55806770|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
55806771|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806772|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806773|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55806774|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55806775|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796845|NCT03117751|Abortifacient Agents|abortifacient agents|mesh-ancestor
55806783|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806785|NCT05478083|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55806786|NCT05478083|Fertility Agents|fertility agents|mesh-ancestor
55806787|NCT05478083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55806788|NCT05478083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806789|NCT05478083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55806790|NCT05478083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806791|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
55806792|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
55806793|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806794|NCT02544217|Protective Agents|protective agents|mesh-ancestor
55806795|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806796|NCT05427565|Caffeine|caffeine|mesh-list
55806797|NCT05427565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55806798|NCT05427565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806799|NCT05427565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55806803|NCT05427565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55806804|NCT05427565|Purinergic Agents|purinergic agents|mesh-ancestor
55806805|NCT05427565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806806|NCT02533453|Exenatide|exenatide|mesh-list
55806807|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55806808|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806809|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55806810|NCT02533453|Incretins|incretins|mesh-ancestor
55806811|NCT02533453|Hormones|hormones|mesh-ancestor
55806812|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55806813|NCT05424835|Capecitabine|capecitabine|mesh-list
55806814|NCT05424835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55806815|NCT05424835|Antimetabolites|antimetabolites|mesh-ancestor
55806816|NCT05424835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806817|NCT05424835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806818|NCT02533375|Adalimumab|adalimumab|mesh-list
55806819|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806820|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806821|NCT01553149|Lenalidomide|lenalidomide|mesh-list
55806822|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
55806823|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806824|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55806825|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55806826|NCT01553149|Growth Substances|growth substances|mesh-ancestor
55806827|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
55806828|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806829|NCT02551055|Paclitaxel|paclitaxel|mesh-list
55806830|NCT02551055|Docetaxel|docetaxel|mesh-list
55806831|NCT02551055|Serabelisib|serabelisib|mesh-list
55806832|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55806833|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806834|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
55806835|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
55806836|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
55806837|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806838|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806839|NCT05470673|Metronidazole|metronidazole|mesh-list
55806840|NCT05470673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806841|NCT05470673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55806842|NCT05470673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55806882|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806884|NCT05469893|Lenalidomide|lenalidomide|mesh-list
55806885|NCT05469893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806886|NCT05469893|Antiemetics|antiemetics|mesh-ancestor
55806887|NCT05469893|Autonomic Agents|autonomic agents|mesh-ancestor
55806888|NCT05469893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806889|NCT05469893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806890|NCT05469893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55806891|NCT05469893|Glucocorticoids|glucocorticoids|mesh-ancestor
55806892|NCT05469893|Hormones|hormones|mesh-ancestor
55806893|NCT05469893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55806894|NCT05469893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55806895|NCT05469893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806896|NCT05469893|Immunologic Factors|immunologic factors|mesh-ancestor
55806897|NCT05469893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55806898|NCT05469893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55806899|NCT05469893|Growth Substances|growth substances|mesh-ancestor
55806900|NCT05469893|Growth Inhibitors|growth inhibitors|mesh-ancestor
55806901|NCT03629171|Cytarabine|cytarabine|mesh-list
55806902|NCT03629171|Daunorubicin|daunorubicin|mesh-list
55806903|NCT03629171|Venetoclax|venetoclax|mesh-list
55806904|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55806905|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
55806906|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806907|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806908|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
55806909|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806910|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55806911|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
55806932|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806933|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806934|NCT05477615|Carboplatin|carboplatin|mesh-list
55806935|NCT05477615|Pemetrexed|pemetrexed|mesh-list
55806936|NCT05477615|Lazertinib|lazertinib|mesh-list
55806937|NCT05477615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55806938|NCT05477615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806941|NCT05477615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55806942|NCT05477615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55806943|NCT05477459|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
55806944|NCT05477459|Hallucinogens|hallucinogens|mesh-ancestor
55806945|NCT05477459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806946|NCT05477459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55806947|NCT05477459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55806948|NCT05477459|Serotonin Agents|serotonin agents|mesh-ancestor
55806949|NCT05477459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806950|NCT05477459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806951|NCT05477459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55806953|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55806954|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55806955|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55806956|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806957|NCT05468957|Hemostatics|hemostatics|mesh-list
55806958|NCT05468957|Coagulants|coagulants|mesh-ancestor
55806959|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
55806960|NCT02547935|Saxagliptin|saxagliptin|mesh-list
55806961|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55806962|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55806963|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55806964|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806965|NCT02547935|Incretins|incretins|mesh-ancestor
55806966|NCT02547935|Hormones|hormones|mesh-ancestor
55806967|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55806968|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55806969|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
55806970|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806971|NCT04258111|Antibodies|antibodies|mesh-list
55806972|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
55806973|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
55806974|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806975|NCT05476991|Aspirin|aspirin|mesh-list
55806976|NCT05476991|Colchicine|colchicine|mesh-list
55806977|NCT05476991|Ticagrelor|ticagrelor|mesh-list
55806978|NCT05476991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55806979|NCT05476991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55806980|NCT05476991|Analgesics|analgesics|mesh-ancestor
55806981|NCT05476991|Sensory System Agents|sensory system agents|mesh-ancestor
55806982|NCT05476991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55806983|NCT05476991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55806984|NCT05476991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55806985|NCT05476991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55806986|NCT05476991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55806987|NCT05476991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55806989|NCT05476991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55806990|NCT05476991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55806991|NCT05476991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55806993|NCT05476991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55806994|NCT05476991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55806995|NCT05476991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55806996|NCT05476991|Purinergic Agents|purinergic agents|mesh-ancestor
55806997|NCT05476991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55806998|NCT05476991|Gout Suppressants|gout suppressants|mesh-ancestor
55806999|NCT05476991|Tubulin Modulators|tubulin modulators|mesh-ancestor
55807000|NCT05476991|Antimitotic Agents|antimitotic agents|mesh-ancestor
55807001|NCT05476991|Mitosis Modulators|mitosis modulators|mesh-ancestor
55807002|NCT05476991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807003|NCT02327169|Paclitaxel|paclitaxel|mesh-list
55807004|NCT02327169|Irinotecan|irinotecan|mesh-list
55807005|NCT02327169|Cetuximab|cetuximab|mesh-list
55807017|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
55807018|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55807019|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55807020|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55807021|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55807022|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807023|NCT02327013|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55807024|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55807025|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55807026|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807027|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807028|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
55807029|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55807030|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55807031|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55807032|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55807035|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55807036|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807037|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55807038|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
55807039|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807040|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807041|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55807042|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
55807043|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
55807044|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55807045|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55807046|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55807048|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
55807049|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807050|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807052|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
55796853|NCT03117751|Antiviral Agents|antiviral agents|mesh-ancestor
55807055|NCT02300259|Itraconazole|itraconazole|mesh-list
55807057|NCT02300259|Tadalafil|tadalafil|mesh-list
55807058|NCT02300259|Simvastatin|simvastatin|mesh-list
55807059|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55807060|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55807061|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
55807062|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807063|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55807064|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55807065|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807066|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
55807067|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807068|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55807069|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55807070|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55807071|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
55807072|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807073|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807074|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55807075|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
55807076|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55807077|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55807078|NCT02300259|Urological Agents|urological agents|mesh-ancestor
55807079|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55807080|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55807081|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55807082|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55807084|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55807085|NCT02300103|Velpatasvir|velpatasvir|mesh-list
55807086|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
55807088|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
55807089|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55807090|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55807091|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807092|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
55807093|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
55807094|NCT02366091|Methotrexate|methotrexate|mesh-list
55807095|NCT02366091|Colchicine|colchicine|mesh-list
55807096|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55807097|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
55807098|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55807099|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807100|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55807101|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
55807102|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807104|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
55807105|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807106|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55807107|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807108|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
55807109|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807110|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55807111|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
55807112|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
55807150|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55807151|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55807152|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807153|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807155|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807156|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
55807157|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807158|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807159|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55807160|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
55807161|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807173|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807174|NCT02365233|Insulin|insulin|mesh-list
55807175|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55807176|NCT02365233|Pioglitazone|pioglitazone|mesh-list
55807177|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55807178|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
55807179|NCT02365233|Saxagliptin|saxagliptin|mesh-list
55807180|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55807181|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55807182|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807183|NCT02365233|Incretins|incretins|mesh-ancestor
55807184|NCT02365233|Hormones|hormones|mesh-ancestor
55792670|NCT05028907|Glucocorticoids|glucocorticoids|mesh-ancestor
55807185|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807187|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807188|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807189|NCT02364999|Paclitaxel|paclitaxel|mesh-list
55807190|NCT02364999|Bevacizumab|bevacizumab|mesh-list
55807191|NCT02364999|Carboplatin|carboplatin|mesh-list
55807192|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55807193|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807194|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
55807195|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
55807196|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
55807197|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807198|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55807199|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55807200|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55807201|NCT02364999|Growth Substances|growth substances|mesh-ancestor
55807202|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807203|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
55807204|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
55807205|NCT02363283|Immunoconjugates|immunoconjugates|mesh-list
55807206|NCT02363283|Immunotoxins|immunotoxins|mesh-list
55807207|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55807208|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
55807209|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807210|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55807211|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807212|NCT02321319|Hydromorphone|hydromorphone|mesh-list
55807213|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55807214|NCT02321319|Narcotics|narcotics|mesh-ancestor
55807215|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55807216|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807217|NCT02321319|Analgesics|analgesics|mesh-ancestor
55807218|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
55807219|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807221|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
55807222|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55807223|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
55807224|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807225|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807226|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
55807227|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807228|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807229|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
55807230|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807231|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
55807232|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807233|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55807234|NCT02294019|Ibuprofen|ibuprofen|mesh-list
55807235|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55807236|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55807237|NCT02294019|Analgesics|analgesics|mesh-ancestor
55807238|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
55807239|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807240|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807241|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807242|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807243|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55807244|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807245|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807246|NCT02320149|Sarecycline|sarecycline|mesh-list
55807247|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55807248|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807249|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
55807250|NCT05450965|Onvansertib|onvansertib|mesh-list
55807251|NCT05450965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55807252|NCT05450965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807253|NCT05450965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807255|NCT05405725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55807256|NCT05405725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807257|NCT05404945|Doxorubicin|doxorubicin|mesh-list
55807258|NCT05404945|Pembrolizumab|pembrolizumab|mesh-list
55807259|NCT05404945|Dacarbazine|dacarbazine|mesh-list
55807260|NCT05404945|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55807261|NCT05404945|Vinblastine|vinblastine|mesh-list
55807262|NCT05404945|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55807263|NCT05404945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807264|NCT05404945|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55807267|NCT05404945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807268|NCT05404945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55807269|NCT05404945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55807270|NCT05404945|Alkylating Agents|alkylating agents|mesh-ancestor
55807271|NCT05404945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55807272|NCT05404945|Tubulin Modulators|tubulin modulators|mesh-ancestor
55807273|NCT05404945|Antimitotic Agents|antimitotic agents|mesh-ancestor
55807274|NCT05404945|Mitosis Modulators|mitosis modulators|mesh-ancestor
55807275|NCT02293863|Oseltamivir|oseltamivir|mesh-list
55807276|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
55807277|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807278|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807279|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807280|NCT02293395|Aspirin|aspirin|mesh-list
55807281|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
55807282|NCT02293395|Clopidogrel|clopidogrel|mesh-list
55807283|NCT02293395|Ticagrelor|ticagrelor|mesh-list
55807284|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55807285|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55807286|NCT02293395|Analgesics|analgesics|mesh-ancestor
55807287|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
55807288|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807294|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807295|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55807296|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55807297|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807298|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
55807299|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55807300|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55807301|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55807302|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
55807303|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807304|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55807305|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
55807306|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55807307|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
55807308|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
55807310|NCT05447065|Vitamins|vitamins|mesh-ancestor
55807311|NCT05447065|Micronutrients|micronutrients|mesh-ancestor
55807312|NCT05447065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807313|NCT05447065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55807314|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
55807315|NCT01351909|Veliparib|veliparib|mesh-list
55807316|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807317|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
55807318|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807319|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807320|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55807321|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
55807322|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807323|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807324|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55807325|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55807326|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807327|NCT05401357|Bimatoprost|bimatoprost|mesh-list
55807328|NCT05401357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55807329|NCT05401357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55807332|NCT05401279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807333|NCT05401279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55807334|NCT05401279|Antimetabolites|antimetabolites|mesh-ancestor
55807335|NCT05401279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807336|NCT05401279|Antiviral Agents|antiviral agents|mesh-ancestor
55807337|NCT05401279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807338|NCT05401279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807339|NCT05401279|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807340|NCT05401279|Immunologic Factors|immunologic factors|mesh-ancestor
55807341|NCT05401279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807342|NCT05451095|Ketamine|ketamine|mesh-list
55807343|NCT05451095|Analgesics|analgesics|mesh-ancestor
55807344|NCT05451095|Sensory System Agents|sensory system agents|mesh-ancestor
55807345|NCT05451095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807346|NCT05451095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807347|NCT05451095|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55807348|NCT05451095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55807349|NCT05451095|Anesthetics, General|anesthetics, general|mesh-ancestor
55807350|NCT05451095|Anesthetics|anesthetics|mesh-ancestor
55807351|NCT05451095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55807352|NCT05451095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55807353|NCT05451095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55807354|NCT05451095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807355|NCT05451095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807356|NCT02954081|Apremilast|apremilast|mesh-list
55807357|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55807358|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55807359|NCT02954081|Analgesics|analgesics|mesh-ancestor
55807360|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
55807361|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807362|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807363|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807364|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807365|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55807366|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55807367|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807368|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807370|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
55807371|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807372|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807373|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807374|NCT01349959|Azacitidine|azacitidine|mesh-list
55807375|NCT01349959|Entinostat|entinostat|mesh-list
55807376|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
55807377|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55807379|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807380|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807381|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807383|NCT01349881|Sulindac|sulindac|mesh-list
55807384|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807385|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55807386|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55807387|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55807388|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807389|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
55807390|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807391|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807392|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55807393|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55807394|NCT01349881|Analgesics|analgesics|mesh-ancestor
55807395|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
55807401|NCT02953457|Durvalumab|durvalumab|mesh-list
55807402|NCT02953457|Ipilimumab|ipilimumab|mesh-list
55807403|NCT02953457|Olaparib|olaparib|mesh-list
55807404|NCT02953457|Tremelimumab|tremelimumab|mesh-list
55807405|NCT02953457|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55807487|NCT05415865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807488|NCT05415865|Sensory System Agents|sensory system agents|mesh-ancestor
55807489|NCT05415865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807490|NCT05415865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55807491|NCT05415865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55807492|NCT05415865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55807493|NCT05415865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55807494|NCT05415865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807496|NCT05415709|Cisplatin|cisplatin|mesh-list
55807497|NCT05415709|Carboplatin|carboplatin|mesh-list
55807498|NCT05415709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55807499|NCT05415709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55807500|NCT05415709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807501|NCT05415709|Tubulin Modulators|tubulin modulators|mesh-ancestor
55807502|NCT05415709|Antimitotic Agents|antimitotic agents|mesh-ancestor
55807503|NCT05415709|Mitosis Modulators|mitosis modulators|mesh-ancestor
55807509|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
55807510|NCT04262843|Tacrolimus|tacrolimus|mesh-list
55807511|NCT04262843|Lenograstim|lenograstim|mesh-list
55807512|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807513|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
55807514|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807515|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807516|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55807517|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
55807518|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807519|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807520|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55807521|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55807522|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
55807523|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
55807524|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807525|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55807526|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807527|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55807528|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55807529|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
55807530|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55807531|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55807532|NCT02552303|Modafinil|modafinil|mesh-list
55807533|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55807534|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807535|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55807536|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55807537|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55807538|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807539|NCT01660711|Leucovorin|leucovorin|mesh-list
55807540|NCT01660711|Fluorouracil|fluorouracil|mesh-list
55807541|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
55807542|NCT01660711|Irinotecan|irinotecan|mesh-list
55807543|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
55807544|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807545|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55796913|NCT02426281|Gemcitabine|gemcitabine|mesh-list
55807546|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807547|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807548|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
55807549|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807550|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55807551|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55807552|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807553|NCT01660711|Antidotes|antidotes|mesh-ancestor
55807554|NCT01660711|Protective Agents|protective agents|mesh-ancestor
55807555|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
55807557|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
55807558|NCT05475665|Amlodipine|amlodipine|mesh-list
55807559|NCT05475665|Irbesartan|irbesartan|mesh-list
55807560|NCT05475665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55807561|NCT05475665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55807562|NCT05475665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55807563|NCT05475665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807564|NCT05475665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55807565|NCT05475665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807566|NCT05475665|Vasodilator Agents|vasodilator agents|mesh-ancestor
55807735|NCT02360475|Vaccines|vaccines|mesh-list
55807567|NCT05475665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55807568|NCT05475665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55807569|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
55807570|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55807572|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807573|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807574|NCT02538965|Lenalidomide|lenalidomide|mesh-list
55807575|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
55807576|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807577|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55807578|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55807579|NCT02538965|Growth Substances|growth substances|mesh-ancestor
55807580|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
55807581|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807583|NCT02543801|Clonidine|clonidine|mesh-list
55807584|NCT02543801|Epinephrine|epinephrine|mesh-list
55807585|NCT02543801|Bupivacaine|bupivacaine|mesh-list
55807588|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
55807589|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55807590|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807591|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
55807592|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807593|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55807594|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55807595|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
55807596|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807597|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807598|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55807599|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55807600|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
55807602|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
55807603|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
55807604|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
55807605|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55807606|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55807607|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55807608|NCT02543801|Analgesics|analgesics|mesh-ancestor
55807609|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807610|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55807611|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55807612|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807613|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55807614|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
55807615|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55807616|NCT02481635|Gemcitabine|gemcitabine|mesh-list
55807617|NCT02481635|Paclitaxel|paclitaxel|mesh-list
55807622|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
55807623|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807624|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55807625|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
55807626|NCT02481635|Antiviral Agents|antiviral agents|mesh-ancestor
55807627|NCT02481635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807628|NCT02481635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807630|NCT02481635|Immunologic Factors|immunologic factors|mesh-ancestor
55807631|NCT02481635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807632|NCT02470091|Denosumab|denosumab|mesh-list
55807633|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55807634|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807635|NCT02362503|Fostemsavir|fostemsavir|mesh-list
55807636|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55807637|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55807638|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
55807639|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807640|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55807641|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55807642|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807643|NCT05411159|Analgesics, Opioid|analgesics, opioid|mesh-list
55807644|NCT05411159|Anesthetics|anesthetics|mesh-list
55807645|NCT05411159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55807648|NCT05411159|Analgesics|analgesics|mesh-ancestor
55807649|NCT05411159|Sensory System Agents|sensory system agents|mesh-ancestor
55807650|NCT05411159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807651|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
55807652|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55807653|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
55807654|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807655|NCT02362425|Expectorants|expectorants|mesh-ancestor
55807656|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
55807657|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55807658|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
55807659|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807660|NCT02362425|Protective Agents|protective agents|mesh-ancestor
55807661|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807662|NCT02362425|Antidotes|antidotes|mesh-ancestor
55807663|NCT02362269|Vitamin D|vitamin d|mesh-list
55807664|NCT02362269|Vitamins|vitamins|mesh-ancestor
55807665|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
55807666|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807667|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55807668|NCT02529995|Osimertinib|osimertinib|mesh-list
55807669|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807670|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55807671|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807672|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807673|NCT05410301|Bevacizumab|bevacizumab|mesh-list
55807674|NCT05410301|Lomustine|lomustine|mesh-list
55807675|NCT05410301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55807676|NCT05410301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807677|NCT05410301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55807678|NCT05410301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55807679|NCT05410301|Growth Substances|growth substances|mesh-ancestor
55807680|NCT05410301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807681|NCT05410301|Growth Inhibitors|growth inhibitors|mesh-ancestor
55807682|NCT05410301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55807683|NCT05410301|Alkylating Agents|alkylating agents|mesh-ancestor
55807684|NCT05410301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807685|NCT02319759|Ustekinumab|ustekinumab|mesh-list
55807686|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
55807687|NCT02318667|Golimumab|golimumab|mesh-list
55807688|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55807689|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807690|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807691|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
55807692|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807694|NCT02292771|Atosiban|atosiban|mesh-list
55807695|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
55807696|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807697|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807698|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
55807699|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55807700|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
55807701|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55807702|NCT02291913|Tamoxifen|tamoxifen|mesh-list
55807703|NCT02291913|Everolimus|everolimus|mesh-list
55807704|NCT02291913|Letrozole|letrozole|mesh-list
55807705|NCT02291913|Fulvestrant|fulvestrant|mesh-list
55807706|NCT02291913|Anastrozole|anastrozole|mesh-list
55807707|NCT02291913|Exemestane|exemestane|mesh-list
55807708|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807709|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807710|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
55807713|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55807714|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807715|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807716|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55807717|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
55807718|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807719|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55807720|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55807721|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55807722|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55807723|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55807725|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55807726|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
55807727|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807728|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55807729|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
55807730|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55807731|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55807732|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807733|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
55807734|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
55807768|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807769|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
55807770|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55807771|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55807772|NCT02389543|Growth Substances|growth substances|mesh-ancestor
55807773|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
55807774|NCT05441605|Chlorhexidine|chlorhexidine|mesh-list
55807775|NCT05441605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55807776|NCT05441605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807777|NCT05441605|Disinfectants|disinfectants|mesh-ancestor
55807778|NCT00843037|Sunitinib|sunitinib|mesh-list
55807779|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807780|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55807781|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55807782|NCT00843037|Growth Substances|growth substances|mesh-ancestor
55807783|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807784|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
55807785|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55807786|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807787|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807788|NCT00602641|Thalidomide|thalidomide|mesh-list
55807789|NCT00602641|Prednisone|prednisone|mesh-list
55807790|NCT00602641|Cortisone|cortisone|mesh-list
55807791|NCT00602641|Lenalidomide|lenalidomide|mesh-list
55807792|NCT00602641|Melphalan|melphalan|mesh-list
55807793|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
55807794|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55807795|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807796|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
55807797|NCT00602641|Hormones|hormones|mesh-ancestor
55807798|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55807799|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807800|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55807801|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807802|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
55807803|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55807804|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55807805|NCT00602641|Growth Substances|growth substances|mesh-ancestor
55807806|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
55807807|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55807808|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
55796944|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55807809|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807810|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55807811|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807812|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
55807813|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55807814|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807815|NCT02531113|Ozanimod|ozanimod|mesh-list
55807816|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55807817|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807818|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55807820|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807821|NCT05441527|Muramidase|muramidase|mesh-list
55807822|NCT05441527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807823|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
55807824|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55807825|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807826|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55807827|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807829|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807830|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807831|NCT05411965|Pioglitazone|pioglitazone|mesh-list
55807832|NCT05411965|Dapagliflozin|dapagliflozin|mesh-list
55807833|NCT05411965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55807834|NCT05411965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807835|NCT05411965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55807836|NCT05411965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807837|NCT04261075|Durvalumab|durvalumab|mesh-list
55807838|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55807839|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807840|NCT05436769|Clarithromycin|clarithromycin|mesh-list
55807841|NCT05436769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55807842|NCT05436769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807843|NCT05436769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55807844|NCT05436769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807845|NCT05436769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807846|NCT05436769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55807847|NCT05436769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55807848|NCT05378737|Exatecan|exatecan|mesh-list
55807849|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55807850|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55807851|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807852|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807853|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807855|NCT03929029|Ipilimumab|ipilimumab|mesh-list
55807856|NCT03929029|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55807857|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55807858|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807859|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55807860|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807862|NCT03929029|Immunologic Factors|immunologic factors|mesh-ancestor
55807863|NCT03929029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807864|NCT01659853|Azelaic acid|azelaic acid|mesh-list
55807865|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55807866|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55807867|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55807868|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55807869|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55807870|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
55807871|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807872|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807873|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807874|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807875|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
55807876|NCT05376553|Docetaxel|docetaxel|mesh-list
55807877|NCT05376553|Cemiplimab|cemiplimab|mesh-list
55807878|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807879|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
55807880|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
55807881|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
55807882|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807885|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
55807886|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55807887|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807888|NCT05434351|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
55807889|NCT05434351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55807890|NCT05434351|Immunologic Factors|immunologic factors|mesh-ancestor
55807891|NCT05434351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807892|NCT05591755|Ketotifen|ketotifen|mesh-list
55807893|NCT05591755|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55807894|NCT05591755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55807895|NCT05591755|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55807896|NCT05591755|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55807897|NCT05591755|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55807898|NCT05591755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55807899|NCT05591755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55807900|NCT05591755|Adrenergic Agents|adrenergic agents|mesh-ancestor
55807901|NCT05591755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807902|NCT05591755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807903|NCT05591755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807904|NCT05591755|Antipruritics|antipruritics|mesh-ancestor
55807905|NCT05591755|Dermatologic Agents|dermatologic agents|mesh-ancestor
55807906|NCT05591755|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55807907|NCT05591755|Histamine Antagonists|histamine antagonists|mesh-ancestor
55807908|NCT05591755|Histamine Agents|histamine agents|mesh-ancestor
55807909|NCT05591755|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55807910|NCT05610085|Levetiracetam|levetiracetam|mesh-list
55807911|NCT05610085|Phenobarbital|phenobarbital|mesh-list
55807912|NCT05610085|Anticonvulsants|anticonvulsants|mesh-ancestor
55807913|NCT05610085|Nootropic Agents|nootropic agents|mesh-ancestor
55807914|NCT05610085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55807915|NCT05610085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55807916|NCT05610085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807917|NCT05610085|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55807918|NCT05610085|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55807919|NCT05610085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807920|NCT05610085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807924|NCT05610085|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55807925|NCT05610085|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55807927|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55807928|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55807929|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
55807930|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807931|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807932|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55807933|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55807934|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
55807935|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55807936|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55807937|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55807938|NCT05564611|Omalizumab|omalizumab|mesh-list
55807939|NCT05564611|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55807940|NCT05564611|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55807941|NCT05564611|Respiratory System Agents|respiratory system agents|mesh-ancestor
55807942|NCT05371015|Ropivacaine|ropivacaine|mesh-list
55807943|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
55807944|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
55807945|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55807946|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807947|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
55807948|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807949|NCT05509933|Budesonide|budesonide|mesh-list
55807950|NCT05509933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55807951|NCT05509933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55807952|NCT05509933|Autonomic Agents|autonomic agents|mesh-ancestor
55807953|NCT05509933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55807954|NCT05509933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807967|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
55807968|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55807969|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807970|NCT05564221|Omalizumab|omalizumab|mesh-list
55807971|NCT05564221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55807972|NCT05564221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55807973|NCT05564221|Respiratory System Agents|respiratory system agents|mesh-ancestor
55807975|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
55807976|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55807977|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
55807978|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807979|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807980|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807981|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55807982|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55807983|NCT05335993|Niraparib|niraparib|mesh-list
55807984|NCT05335993|Oregovomab|oregovomab|mesh-list
55792719|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
55807985|NCT05335993|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55807986|NCT05335993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55807987|NCT05335993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55807988|NCT05335993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55807989|NCT05335993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55807990|NCT05305105|Psilocybin|psilocybin|mesh-list
55807991|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
55807992|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807993|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55807994|NCT05304949|Ranibizumab|ranibizumab|mesh-list
55807995|NCT05304949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55807996|NCT05304949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55807997|NCT05304949|Growth Substances|growth substances|mesh-ancestor
55807998|NCT05304949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55807999|NCT05304949|Growth Inhibitors|growth inhibitors|mesh-ancestor
55808000|NCT05304949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808001|NCT05304871|Cefazolin|cefazolin|mesh-list
55792727|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792728|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792729|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
55808002|NCT05304871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55808003|NCT05304871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55808004|NCT05334277|Bevacizumab|bevacizumab|mesh-list
55808005|NCT05334277|Carboplatin|carboplatin|mesh-list
55808006|NCT05334277|Pemetrexed|pemetrexed|mesh-list
55808007|NCT05334277|Aflutinib|aflutinib|mesh-list
55808008|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55808009|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808010|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55808011|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55808012|NCT05334277|Growth Substances|growth substances|mesh-ancestor
55808013|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808014|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
55808015|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808016|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808017|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55808018|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55808019|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808020|NCT05303935|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55808021|NCT05303935|Antidepressive Agents|antidepressive agents|mesh-ancestor
55808022|NCT05303935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55808023|NCT05303935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55808024|NCT05303935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55808025|NCT05303935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808037|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808038|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808040|NCT05325853|Propoxycaine|propoxycaine|mesh-list
55808041|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
55808042|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
55808043|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808044|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808045|NCT05325853|Sensory System Agents|sensory system agents|mesh-ancestor
55808046|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808047|NCT05353933|Pantoprazole|pantoprazole|mesh-list
55808048|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55808049|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55808050|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55808051|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808052|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808053|NCT05352685|Propofol|propofol|mesh-list
55808054|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55808055|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808056|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808057|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55808059|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
55808061|NCT04249687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55808062|NCT04249687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55808063|NCT04249687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808064|NCT04249687|Cholinergic Agents|cholinergic agents|mesh-ancestor
55808065|NCT04249687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808066|NCT04249687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808067|NCT05351593|Lenalidomide|lenalidomide|mesh-list
55808068|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
55808069|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808071|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55808073|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
55808074|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808077|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55808079|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808080|NCT01659151|Aldesleukin|aldesleukin|mesh-list
55808081|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
55808082|NCT01659151|Fludarabine|fludarabine|mesh-list
55808083|NCT01659151|Interleukin-2|interleukin-2|mesh-list
55808084|NCT01659151|Vemurafenib|vemurafenib|mesh-list
55808085|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55808086|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55808087|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
55808088|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808089|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55808090|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55808091|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
55808092|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808093|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808094|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55808095|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808096|NCT01659151|Analgesics|analgesics|mesh-ancestor
55808097|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
55808098|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808099|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55808100|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55808101|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
55808102|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55808103|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808104|NCT05347069|Aspirin|aspirin|mesh-list
55808105|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55808106|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808107|NCT05347069|Analgesics|analgesics|mesh-ancestor
55808108|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
55808109|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808110|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808111|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55808112|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55808113|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55808114|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55808115|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808116|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55808117|NCT05347069|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55808118|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808119|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
55808120|NCT05516953|Baclofen|baclofen|mesh-list
55808121|NCT05516953|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55808122|NCT05516953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808123|NCT05516953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55808124|NCT05516953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808125|NCT05516953|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55808126|NCT05516953|GABA Agonists|gaba agonists|mesh-ancestor
55808127|NCT05516953|GABA Agents|gaba agents|mesh-ancestor
55808128|NCT05516953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808129|NCT05516953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808130|NCT02522767|Mesalamine|mesalamine|mesh-list
55808131|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55808132|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808133|NCT02522767|Analgesics|analgesics|mesh-ancestor
55808134|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
55808135|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808136|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808137|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55808142|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
55808143|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808144|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808145|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55808146|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55808147|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
55808148|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
55808149|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808150|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55808152|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808153|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808154|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55808155|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55808156|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55808157|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55808158|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55808159|NCT02522377|GABA Modulators|gaba modulators|mesh-ancestor
55808160|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
55808161|NCT05345509|Donepezil|donepezil|mesh-list
55808162|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55808163|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808164|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808165|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
55808166|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808167|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808168|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
55808169|NCT05318755|Testosterone|testosterone|mesh-list
55808170|NCT05318755|Androgens|androgens|mesh-ancestor
55808171|NCT05318755|Hormones|hormones|mesh-ancestor
55808172|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808174|NCT05267743|Lansoprazole|lansoprazole|mesh-list
55808175|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
55808176|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55808177|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55808178|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55808179|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808180|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808197|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792740|NCT05027191|Sevoflurane|sevoflurane|mesh-list
55808198|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808201|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
55808202|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55808203|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55808204|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808206|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
55808207|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55808208|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55808209|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55808210|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
55808211|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
55808212|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808213|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808214|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
55808215|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
55808216|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
55808217|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
55808218|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55808220|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808221|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55808222|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
55808223|NCT05263609|Axitinib|axitinib|mesh-list
55808224|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55808225|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808226|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808227|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808228|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808229|NCT05313997|Diclofenac|diclofenac|mesh-list
55808230|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55808231|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808232|NCT05313997|Analgesics|analgesics|mesh-ancestor
55808233|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
55808234|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808235|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808236|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55808237|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55808238|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55808239|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808240|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808241|NCT05259241|Thrombin|thrombin|mesh-list
55808242|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
55808243|NCT05259241|Coagulants|coagulants|mesh-ancestor
55808244|NCT05511415|Dexmedetomidine|dexmedetomidine|mesh-list
55808245|NCT05511415|Oxytocin|oxytocin|mesh-list
55808246|NCT05511415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55808247|NCT05511415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808248|NCT05511415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808249|NCT05511415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808250|NCT05511415|Analgesics|analgesics|mesh-ancestor
55808251|NCT05511415|Sensory System Agents|sensory system agents|mesh-ancestor
55808252|NCT05511415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808253|NCT05511415|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55808254|NCT05511415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55808255|NCT05511415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55808256|NCT05511415|Adrenergic Agents|adrenergic agents|mesh-ancestor
55808257|NCT05511415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808258|NCT05511415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808259|NCT05511415|Oxytocics|oxytocics|mesh-ancestor
55808262|NCT01657903|Fluorides|fluorides|mesh-list
55808263|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
55808264|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
55808265|NCT01657903|Protective Agents|protective agents|mesh-ancestor
55808266|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808267|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55808270|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55808271|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808272|NCT05256823|Analgesics|analgesics|mesh-ancestor
55808273|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
55808274|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808275|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808277|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55808278|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55808279|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55808280|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808281|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808282|NCT05255653|Cisplatin|cisplatin|mesh-list
55808283|NCT05255653|Carboplatin|carboplatin|mesh-list
55808284|NCT05255653|Durvalumab|durvalumab|mesh-list
55808285|NCT05255653|Olaparib|olaparib|mesh-list
55808286|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55808287|NCT05255653|Megestrol|megestrol|mesh-list
55808288|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
55808289|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
55808290|NCT05255653|Progestins|progestins|mesh-list
55808291|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808292|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808293|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55808294|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55808295|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808296|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55808297|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55808298|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55808299|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
55808300|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55808301|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808302|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55808303|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55808304|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55808305|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55808306|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
55808307|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55808308|NCT05255653|Hormones|hormones|mesh-ancestor
55808309|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808310|NCT05284591|Daratumumab|daratumumab|mesh-list
55808311|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808312|NCT04243837|Pirfenidone|pirfenidone|mesh-list
55808314|NCT04243837|Sensory System Agents|sensory system agents|mesh-ancestor
55808315|NCT04243837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808316|NCT04243837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808317|NCT04243837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55808318|NCT04243837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808319|NCT04243837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55808320|NCT04243837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55808321|NCT04243837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808322|NCT05254171|Gemcitabine|gemcitabine|mesh-list
55808323|NCT05254171|Paclitaxel|paclitaxel|mesh-list
55808324|NCT05254171|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55808325|NCT05254171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808326|NCT05254171|Tubulin Modulators|tubulin modulators|mesh-ancestor
55808328|NCT05254171|Mitosis Modulators|mitosis modulators|mesh-ancestor
55808329|NCT05254171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808330|NCT05254171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55808331|NCT05254171|Antimetabolites|antimetabolites|mesh-ancestor
55808332|NCT05254171|Antiviral Agents|antiviral agents|mesh-ancestor
55808333|NCT05254171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55808334|NCT05254171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808337|NCT05254171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808338|NCT05253937|Epinephrine|epinephrine|mesh-list
55808344|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808346|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55808347|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
55808348|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808349|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55808350|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
55808351|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
55808352|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
55808353|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55808354|NCT05218603|Bortezomib|bortezomib|mesh-list
55808355|NCT05218603|Daratumumab|daratumumab|mesh-list
55808356|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808357|NCT05280769|Lobeline|lobeline|mesh-list
55808358|NCT05280769|Nicotine|nicotine|mesh-list
55808359|NCT05280769|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55808360|NCT05280769|Autonomic Agents|autonomic agents|mesh-ancestor
55808361|NCT05280769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808362|NCT05280769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808363|NCT05280769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55808364|NCT05280769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55808434|NCT04240171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808436|NCT04240171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808437|NCT04240171|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55808438|NCT04240171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55808439|NCT04240171|Immunologic Factors|immunologic factors|mesh-ancestor
55808441|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
55808442|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808444|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
55808445|NCT05273827|Paclitaxel|paclitaxel|mesh-list
55808446|NCT05273827|Pemetrexed|pemetrexed|mesh-list
55808447|NCT05273827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55808448|NCT05273827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808449|NCT05273827|Tubulin Modulators|tubulin modulators|mesh-ancestor
55808450|NCT05273827|Antimitotic Agents|antimitotic agents|mesh-ancestor
55808451|NCT05273827|Mitosis Modulators|mitosis modulators|mesh-ancestor
55808452|NCT05273827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808453|NCT05273827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808454|NCT05273827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55808455|NCT05273827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55808457|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
55808459|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808460|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808461|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
55808462|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808463|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55808470|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
55808471|NCT05243563|Hormones|hormones|mesh-ancestor
55808472|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808473|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808474|NCT05272969|Vitamin D|vitamin d|mesh-list
55808475|NCT05272969|Calcium|calcium|mesh-list
55808476|NCT05272969|Vitamins|vitamins|mesh-ancestor
55808477|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
55808478|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808479|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55808480|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55808481|NCT04126681|Interferons|interferons|mesh-list
55808482|NCT04126681|Imatinib Mesylate|imatinib mesylate|mesh-list
55808483|NCT04126681|Dasatinib|dasatinib|mesh-list
55808484|NCT04126681|Hydroxyurea|hydroxyurea|mesh-list
55808485|NCT04126681|Homoharringtonine|homoharringtonine|mesh-list
55808487|NCT04126681|Antiviral Agents|antiviral agents|mesh-ancestor
55808488|NCT04126681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55808489|NCT04126681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808490|NCT04126681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808491|NCT04126681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808492|NCT04126681|Antisickling Agents|antisickling agents|mesh-ancestor
55808493|NCT04126681|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55808494|NCT04126681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55808495|NCT04126681|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55808496|NCT05208619|Anesthetics|anesthetics|mesh-list
55808497|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808498|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808499|NCT05206747|Methamphetamine|methamphetamine|mesh-list
55808500|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55808501|NCT05206747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808502|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
55808503|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
55808504|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808505|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
55808506|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808507|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808508|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
55808509|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55808510|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55808511|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55808512|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55808513|NCT05206435|Nicotine|nicotine|mesh-list
55808514|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55808515|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
55808516|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808517|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808518|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55808519|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55808573|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808574|NCT05236543|Itraconazole|itraconazole|mesh-list
55808575|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
55808579|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808582|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
55808583|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808584|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797012|NCT05536661|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55808586|NCT05159245|Trastuzumab|trastuzumab|mesh-list
55808587|NCT05159245|Pertuzumab|pertuzumab|mesh-list
55808588|NCT05159245|Atezolizumab|atezolizumab|mesh-list
55808589|NCT05159245|Trametinib|trametinib|mesh-list
55808590|NCT05159245|Vemurafenib|vemurafenib|mesh-list
55808591|NCT05159245|Dabrafenib|dabrafenib|mesh-list
55808592|NCT05159245|Pralsetinib|pralsetinib|mesh-list
55808593|NCT05159245|Entrectinib|entrectinib|mesh-list
55808594|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55808595|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808596|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808597|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808598|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808599|NCT05157841|Bupivacaine|bupivacaine|mesh-list
55808600|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
55808601|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
55808602|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808603|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808604|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
55808605|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808606|NCT05154487|Fulvestrant|fulvestrant|mesh-list
55808607|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55808608|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808609|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55808610|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55808611|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
55808612|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808613|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808614|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
55808615|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55808616|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808618|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
55808619|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55808620|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55808621|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808622|NCT05190445|Paclitaxel|paclitaxel|mesh-list
55808623|NCT05190445|Ramucirumab|ramucirumab|mesh-list
55808624|NCT05190445|Tucatinib|tucatinib|mesh-list
55808625|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55808626|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808627|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
55808628|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
55808629|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
55808630|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808631|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808632|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808633|NCT05189977|Propranolol|propranolol|mesh-list
55808634|NCT05189977|Prazosin|prazosin|mesh-list
55808635|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55808636|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55808637|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
55808638|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808639|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808640|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808641|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55808642|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55797029|NCT05536193|Mitogens|mitogens|mesh-list
55808644|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55808645|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55808647|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
55808648|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808649|NCT05466799|Oxaliplatin|oxaliplatin|mesh-list
55808650|NCT05466799|Irinotecan|irinotecan|mesh-list
55808651|NCT05466799|Folfirinox|folfirinox|mesh-list
55808652|NCT05466799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808653|NCT05466799|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55808654|NCT05466799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55808819|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55808656|NCT05466799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808657|NCT05107999|Doxepin|doxepin|mesh-list
55808658|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
55808659|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
55808660|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55808661|NCT05107999|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55808662|NCT05107999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55808663|NCT05107999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808664|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808665|NCT05107999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55808666|NCT05107999|Histamine Antagonists|histamine antagonists|mesh-ancestor
55808667|NCT05107999|Histamine Agents|histamine agents|mesh-ancestor
55808668|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808669|NCT05186545|Fulvestrant|fulvestrant|mesh-list
55808670|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55808671|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808672|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55808673|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55808674|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
55808675|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808676|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808677|NCT05107765|Pioglitazone|pioglitazone|mesh-list
55808678|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55808679|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808680|NCT05185999|Icodextrin|icodextrin|mesh-list
55808681|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
55808687|NCT04234867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808689|NCT05106127|Lenvatinib|lenvatinib|mesh-list
55808690|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55808691|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808692|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808693|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808694|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808695|NCT05183737|Propolis|propolis|mesh-list
55808696|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55808697|NCT05096845|Vaccines|vaccines|mesh-list
55808698|NCT05096845|Immunologic Factors|immunologic factors|mesh-ancestor
55808699|NCT05096845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808700|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
55808701|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
55808702|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808703|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55808704|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55808705|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
55808706|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808707|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808708|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55808709|NCT05094427|Anesthetics|anesthetics|mesh-list
55808713|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
55808715|NCT05139043|Dexamethasone|dexamethasone|mesh-list
55808716|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
55808717|NCT05139043|Ichthammol|ichthammol|mesh-list
55808718|NCT05139043|BB 1101|bb 1101|mesh-list
55808719|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55808720|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
55808721|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
55808722|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808723|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808724|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55808725|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
55808726|NCT05139043|Hormones|hormones|mesh-ancestor
55808727|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808728|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55808729|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808730|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
55808731|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808732|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808733|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
55808734|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
55808736|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55808737|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808738|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808739|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808740|NCT05175781|Analgesics|analgesics|mesh-ancestor
55808820|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
55808742|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808743|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55808744|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55808745|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55808746|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
55808747|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808748|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808749|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55808750|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55808751|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
55808752|NCT05175781|Anesthetics|anesthetics|mesh-ancestor
55808753|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55808754|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55808755|NCT04421911|Diclofenac|diclofenac|mesh-list
55808756|NCT04421911|Ketoprofen|ketoprofen|mesh-list
55808757|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55808758|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55808759|NCT04421911|Analgesics|analgesics|mesh-ancestor
55808760|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
55808761|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808762|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808763|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55808764|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55808765|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55808766|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808767|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808768|NCT05174611|Vitamin D|vitamin d|mesh-list
55808769|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
55808770|NCT05174611|Vitamins|vitamins|mesh-ancestor
55808771|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
55808772|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808773|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55808774|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55808775|NCT05136703|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55797065|NCT02581163|Ritonavir|ritonavir|mesh-list
55808778|NCT05133817|Norepinephrine|norepinephrine|mesh-list
55808779|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55808780|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55808781|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55808782|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
55808783|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808784|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808785|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808786|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
55808787|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
55808788|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808789|NCT05171335|Lenvatinib|lenvatinib|mesh-list
55808790|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808791|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808792|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808793|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808794|NCT02522299|Nemiralisib|nemiralisib|mesh-list
55808795|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808796|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808797|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808798|NCT05086627|Capecitabine|capecitabine|mesh-list
55808799|NCT05086627|Oxaliplatin|oxaliplatin|mesh-list
55808800|NCT05086627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55808801|NCT05086627|Antimetabolites|antimetabolites|mesh-ancestor
55808802|NCT05086627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808803|NCT05086627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808806|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55808807|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808808|NCT01365091|Incretins|incretins|mesh-ancestor
55808809|NCT01365091|Hormones|hormones|mesh-ancestor
55808810|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808811|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55808812|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
55808813|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808814|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808815|NCT05082025|Fulvestrant|fulvestrant|mesh-list
55808816|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55808817|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808818|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55808821|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808822|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808824|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55808825|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
55808826|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55808827|NCT05081479|Expectorants|expectorants|mesh-ancestor
55808828|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
55808829|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55808830|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
55808831|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808832|NCT05081479|Protective Agents|protective agents|mesh-ancestor
55808833|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808834|NCT05081479|Antidotes|antidotes|mesh-ancestor
55808835|NCT05052931|Paclitaxel|paclitaxel|mesh-list
55808836|NCT05052931|Oxaliplatin|oxaliplatin|mesh-list
55808837|NCT05052931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55808838|NCT05052931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808839|NCT05052931|Tubulin Modulators|tubulin modulators|mesh-ancestor
55808841|NCT05052931|Mitosis Modulators|mitosis modulators|mesh-ancestor
55808842|NCT05052931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808844|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
55808845|NCT05079763|Protective Agents|protective agents|mesh-ancestor
55808846|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808847|NCT05050981|Hormones|hormones|mesh-list
55808848|NCT05050981|Serotonin|serotonin|mesh-list
55808849|NCT05050981|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55808850|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808851|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808852|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55808853|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
55808854|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808858|NCT05123131|Dexamethasone|dexamethasone|mesh-list
55808866|NCT05123131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55808867|NCT05123131|Glucocorticoids|glucocorticoids|mesh-ancestor
55808868|NCT05123131|Hormones|hormones|mesh-ancestor
55808869|NCT05123131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808870|NCT05123131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55808871|NCT05123131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808872|NCT05123131|Immunologic Factors|immunologic factors|mesh-ancestor
55808873|NCT05123131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55808874|NCT05123131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55808875|NCT05123131|Growth Substances|growth substances|mesh-ancestor
55808876|NCT05123131|Growth Inhibitors|growth inhibitors|mesh-ancestor
55808877|NCT05073679|Naltrexone|naltrexone|mesh-list
55808878|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55808879|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55808880|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808881|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
55808882|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808883|NCT05041153|Pembrolizumab|pembrolizumab|mesh-list
55808884|NCT05041153|Lenvatinib|lenvatinib|mesh-list
55808885|NCT05041153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55808886|NCT05041153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808887|NCT05041153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808888|NCT05041153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808889|NCT05041153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808890|NCT05039281|Atezolizumab|atezolizumab|mesh-list
55808891|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55808892|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808893|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
55808894|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808911|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808912|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808913|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808914|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
55808915|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55808916|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
55808917|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
55808918|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808919|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
55808920|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55808921|NCT04226365|Nortriptyline|nortriptyline|mesh-list
55808922|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55808923|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
55808924|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55808925|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55808926|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55808927|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55808928|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808930|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808931|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808932|NCT05062837|Apatinib|apatinib|mesh-list
55808933|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55808934|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55808935|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808936|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808937|NCT05110417|Bromides|bromides|mesh-list
55808938|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55808939|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
55808940|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55808941|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808942|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808943|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
55808944|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55808945|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808946|NCT05033665|Benzocaine|benzocaine|mesh-list
55808947|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
55808948|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
55808949|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808950|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808951|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
55808952|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55808953|NCT05031481|Butoconazole|butoconazole|mesh-list
55808954|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
55808955|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55808956|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
55808957|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55808958|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808959|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55808960|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808961|NCT05057767|Midazolam|midazolam|mesh-list
55808962|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55808963|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55808964|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55808965|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808966|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55808967|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55808980|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808981|NCT04997317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55808982|NCT04997239|Vaccines|vaccines|mesh-list
55808983|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
55808984|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808988|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55808989|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55808990|NCT04216693|Protective Agents|protective agents|mesh-ancestor
55808991|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808993|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55808994|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
55808995|NCT01364389|Hormones|hormones|mesh-ancestor
55808996|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55808997|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55808998|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55808999|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809001|NCT05054881|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55809002|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809003|NCT05054881|Trace Elements|trace elements|mesh-ancestor
55809004|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
55809005|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809006|NCT04949425|Adavosertib|adavosertib|mesh-list
55809007|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809008|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809009|NCT04203901|Nivolumab|nivolumab|mesh-list
55809010|NCT04203901|Ipilimumab|ipilimumab|mesh-list
55809011|NCT04203901|Everolimus|everolimus|mesh-list
55809012|NCT04203901|Lenvatinib|lenvatinib|mesh-list
55809013|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809014|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809015|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55809504|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
55809016|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809017|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55809018|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
55809019|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809020|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55809021|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809022|NCT04421209|Propranolol|propranolol|mesh-list
55809023|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55809024|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55809025|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
55809026|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809027|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809028|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809029|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55809030|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55809031|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
55809032|NCT05019703|Atezolizumab|atezolizumab|mesh-list
55809033|NCT05019703|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55809034|NCT05019703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809035|NCT05019703|Immunologic Factors|immunologic factors|mesh-ancestor
55809036|NCT05019703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809037|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55809038|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55809039|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809041|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
55809042|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55809043|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55809044|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809045|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797116|NCT05695625|Anesthetics|anesthetics|mesh-list
55809046|NCT04984993|Urological Agents|urological agents|mesh-ancestor
55809047|NCT04984837|Gemcitabine|gemcitabine|mesh-list
55809048|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
55809049|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55809050|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
55809051|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809052|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809053|NCT04984837|Antiviral Agents|antiviral agents|mesh-ancestor
55809054|NCT04984837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809055|NCT04984837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809056|NCT04984837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55809057|NCT04984837|Immunologic Factors|immunologic factors|mesh-ancestor
55809058|NCT04984837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809060|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
55809061|NCT04983121|Mitogens|mitogens|mesh-list
55809062|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
55809063|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809064|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
55809065|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809066|NCT02291289|Bevacizumab|bevacizumab|mesh-list
55809067|NCT02291289|Trastuzumab|trastuzumab|mesh-list
55809068|NCT02291289|Cetuximab|cetuximab|mesh-list
55809070|NCT02291289|Capecitabine|capecitabine|mesh-list
55809071|NCT02291289|Fluorouracil|fluorouracil|mesh-list
55809072|NCT02291289|Atezolizumab|atezolizumab|mesh-list
55809073|NCT02291289|Vemurafenib|vemurafenib|mesh-list
55809074|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809075|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809076|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55809077|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55809078|NCT02291289|Growth Substances|growth substances|mesh-ancestor
55809079|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809080|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
55809081|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55809082|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
55809083|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809084|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55809085|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
55809086|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55809087|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809088|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
55809089|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55809090|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809091|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55809092|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
55809093|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809095|NCT02358369|Bimatoprost|bimatoprost|mesh-list
55809096|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55809097|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55809098|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55809099|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55809100|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
55809101|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809102|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809103|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809104|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55809105|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55809106|NCT02316171|Mitomycins|mitomycins|mesh-list
55809107|NCT02316171|Mitomycin|mitomycin|mesh-list
55809108|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55809109|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809110|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
55809111|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809112|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55809113|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809114|NCT02315625|Everolimus|everolimus|mesh-list
55809115|NCT02315625|Sunitinib|sunitinib|mesh-list
55809116|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809117|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55809118|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
55809119|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809121|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55809122|NCT02315625|Growth Substances|growth substances|mesh-ancestor
55809123|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
55809124|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55809125|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809126|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809128|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
55809129|NCT02357979|Protective Agents|protective agents|mesh-ancestor
55809130|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809132|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55809133|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55809134|NCT02357901|Narcotics|narcotics|mesh-ancestor
55809135|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809136|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809137|NCT02357901|Analgesics|analgesics|mesh-ancestor
55809138|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
55809139|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809140|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55809141|NCT01601847|Vitamin D|vitamin d|mesh-list
55809142|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
55809143|NCT01601847|Vitamins|vitamins|mesh-ancestor
55809144|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
55809145|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809146|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55809147|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55809149|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55809150|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
55809151|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809152|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
55809153|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809154|NCT02515045|Moxifloxacin|moxifloxacin|mesh-list
55809155|NCT02515045|Prednisolone|prednisolone|mesh-list
55809156|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55809157|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
55809158|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55809159|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
55809160|NCT02515045|Nepafenac|nepafenac|mesh-list
55809161|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55809162|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
55809163|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809164|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
55809165|NCT02515045|Hormones|hormones|mesh-ancestor
55809166|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809167|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809168|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55809169|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809170|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
55809171|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
55809172|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809596|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
55809173|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55809174|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55809175|NCT02515045|Protective Agents|protective agents|mesh-ancestor
55809176|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55809177|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809178|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55809179|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55809180|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809181|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809182|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55809183|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809184|NCT02515045|Analgesics|analgesics|mesh-ancestor
55809185|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
55809186|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55809187|NCT02513485|Levodopa|levodopa|mesh-list
55809188|NCT02513485|Carbidopa|carbidopa|mesh-list
55809189|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55809190|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55809191|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
55809192|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809193|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809194|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809197|NCT02289417|Apremilast|apremilast|mesh-list
55809198|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55809199|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809200|NCT02289417|Analgesics|analgesics|mesh-ancestor
55809201|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
55809202|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809203|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809204|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809205|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55809206|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55809207|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55809208|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809209|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809211|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
55809212|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
55809213|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809214|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809215|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
55809216|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809217|NCT04979611|Exenatide|exenatide|mesh-list
55809218|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55809219|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809220|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55809221|NCT04979611|Incretins|incretins|mesh-ancestor
55809222|NCT04979611|Hormones|hormones|mesh-ancestor
55809223|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809224|NCT04979065|Vitamin D|vitamin d|mesh-list
55809225|NCT04979065|Vitamins|vitamins|mesh-ancestor
55809226|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
55809227|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809228|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55809229|NCT02288325|Milnacipran|milnacipran|mesh-list
55809230|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
55809231|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55809232|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55809233|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55809234|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809235|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809236|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809237|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
55809238|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55809239|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809240|NCT02288325|Analgesics|analgesics|mesh-ancestor
55809241|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
55809242|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809243|NCT04978051|Icatibant|icatibant|mesh-list
55809244|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55809245|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809246|NCT04978051|Analgesics|analgesics|mesh-ancestor
55809247|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
55809248|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809249|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809250|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809251|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55809252|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55809253|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
55809254|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809255|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55809256|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55809257|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
55809259|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55809260|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809262|NCT05010421|Emollients|emollients|mesh-list
55809263|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809264|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
55809266|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809267|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809268|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
55809270|NCT02504827|Avibactam|avibactam|mesh-list
55809271|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
55809272|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55809273|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809274|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55809275|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809276|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809277|NCT02504671|Folic Acid|folic acid|mesh-list
55809278|NCT02504671|Hematinics|hematinics|mesh-ancestor
55809279|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
55809280|NCT02504671|Vitamins|vitamins|mesh-ancestor
55809281|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
55809282|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809283|NCT02314143|Trametinib|trametinib|mesh-list
55809284|NCT02314143|Dabrafenib|dabrafenib|mesh-list
55809285|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809286|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55809287|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809288|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809289|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
55809290|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55809291|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809292|NCT05007613|Atezolizumab|atezolizumab|mesh-list
55809293|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809294|NCT04971499|Dapansutrile|dapansutrile|mesh-list
55809295|NCT04971499|Pembrolizumab|pembrolizumab|mesh-list
55809296|NCT04971499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809297|NCT04971499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809298|NCT04971499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809299|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
55809300|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55809301|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55809302|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55809303|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55809304|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55809305|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809306|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
55809307|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809308|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809309|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55809310|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809311|NCT02501629|Reslizumab|reslizumab|mesh-list
55809312|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55809313|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
55809314|NCT02501473|Rituximab|rituximab|mesh-list
55809315|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
55809316|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809317|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809318|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
55809319|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809320|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55809321|NCT02501161|Insulin|insulin|mesh-list
55809322|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55809323|NCT02501161|Insulin Glargine|insulin glargine|mesh-list
55809324|NCT02501161|Liraglutide|liraglutide|mesh-list
55809325|NCT02501161|Xultophy|xultophy|mesh-list
55809326|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55809327|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809328|NCT02501161|Incretins|incretins|mesh-ancestor
55809329|NCT02501161|Hormones|hormones|mesh-ancestor
55809346|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55809347|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809348|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809349|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809350|NCT04205539|Analgesics|analgesics|mesh-ancestor
55809351|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
55809352|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809353|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55809354|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55809355|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55809356|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
55809357|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809358|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809359|NCT02313909|Aspirin|aspirin|mesh-list
55809360|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
55809361|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55809362|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809363|NCT02313909|Analgesics|analgesics|mesh-ancestor
55809364|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
55809365|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809366|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809367|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809368|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55809369|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55809370|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55809371|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809372|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55809373|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55809374|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809375|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
55809376|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55809377|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
55809378|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55809379|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
55809380|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
55809381|NCT02287623|Bupivacaine|bupivacaine|mesh-list
55809382|NCT02287623|Anesthetics, Local|anesthetics, local|mesh-ancestor
55809383|NCT02287623|Anesthetics|anesthetics|mesh-ancestor
55809384|NCT02287623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809385|NCT02287623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809387|NCT02287623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809388|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
55809389|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55809390|NCT02287467|Antibodies|antibodies|mesh-list
55809391|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
55809392|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55809393|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
55809394|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809395|NCT02287233|Cytarabine|cytarabine|mesh-list
55809396|NCT02287233|Venetoclax|venetoclax|mesh-list
55809397|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55809399|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809400|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809401|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
55809402|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809403|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55809404|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
55809405|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809406|NCT01646385|Etanercept|etanercept|mesh-list
55809407|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
55809408|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55809409|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809410|NCT01646385|Analgesics|analgesics|mesh-ancestor
55809411|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
55809412|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809413|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809414|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809415|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55809421|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809422|NCT02281773|BI 409306|bi 409306|mesh-list
55809423|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55809424|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809425|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809426|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
55809427|NCT04877613|Fludarabine|fludarabine|mesh-list
55809428|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55809429|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
55809430|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809432|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55809433|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
55809434|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809435|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809436|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55809437|NCT02354235|Canagliflozin|canagliflozin|mesh-list
55809438|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55809439|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809440|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55809441|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809442|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55809443|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
55809444|NCT02284893|Saxagliptin|saxagliptin|mesh-list
55809445|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55809446|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809447|NCT02284893|Incretins|incretins|mesh-ancestor
55809448|NCT02284893|Hormones|hormones|mesh-ancestor
55809449|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809450|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55809451|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
55809452|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809453|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809454|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55809455|NCT04965181|Nicotine|nicotine|mesh-list
55809456|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55809457|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
55809458|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809459|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809460|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55809461|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55809462|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
55809463|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809464|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809465|NCT02483611|Lidocaine|lidocaine|mesh-list
55809466|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
55809467|NCT02483611|Cisatracurium|cisatracurium|mesh-list
55809468|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
55809469|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
55809470|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809471|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809472|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
55809473|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809474|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55809475|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55809476|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55809477|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55809478|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809479|NCT02483611|Analgesics|analgesics|mesh-ancestor
55809480|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
55809481|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55809482|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55809483|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
55809484|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55809485|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55809486|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55809487|NCT02482129|Dexamethasone|dexamethasone|mesh-list
55809488|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55809489|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55809490|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809491|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
55809492|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
55809493|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809494|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809495|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55809496|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
55809498|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809499|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55809501|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
55809502|NCT02495857|Viscosupplements|viscosupplements|mesh-list
55809503|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55809505|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809506|NCT02495857|Protective Agents|protective agents|mesh-ancestor
55809507|NCT02495389|Mirabegron|mirabegron|mesh-list
55809508|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55809509|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55809510|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55809511|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
55809512|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809513|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809514|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809515|NCT02495389|Urological Agents|urological agents|mesh-ancestor
55809516|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55809517|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809518|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55809519|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809520|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809521|NCT02495077|Acetaminophen|acetaminophen|mesh-list
55809522|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
55809524|NCT02495077|Loratadine|loratadine|mesh-list
55809525|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
55809526|NCT02495077|Prednisone|prednisone|mesh-list
55809527|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
55809528|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55809529|NCT02495077|Infliximab|infliximab|mesh-list
55809530|NCT02495077|Tacrolimus|tacrolimus|mesh-list
55809531|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
55809532|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55809533|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809534|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
55809535|NCT02495077|Hormones|hormones|mesh-ancestor
55809536|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809537|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809538|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55809539|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809540|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55809541|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
55809542|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55809543|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809544|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809545|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809546|NCT02495077|Analgesics|analgesics|mesh-ancestor
55809547|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
55809548|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809549|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
55809550|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55809551|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55809565|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
55809566|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
55809567|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55809568|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
55809569|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
55809570|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809571|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55809572|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
55809573|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55809574|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
55809575|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
55809576|NCT02278341|Hematinics|hematinics|mesh-ancestor
55809577|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
55809578|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55809579|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55809580|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809581|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
55809582|NCT02278263|Coagulants|coagulants|mesh-ancestor
55809583|NCT02494921|Prednisone|prednisone|mesh-list
55809584|NCT02494921|Docetaxel|docetaxel|mesh-list
55809585|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809586|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
55809587|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
55809588|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
55809589|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809590|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809591|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
55809592|NCT02494921|Hormones|hormones|mesh-ancestor
55809593|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809594|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809595|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55809663|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809664|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
55809668|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55809669|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809670|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55809671|NCT04957615|Nivolumab|nivolumab|mesh-list
55809672|NCT04957615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809673|NCT04957615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809674|NCT04957615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55809675|NCT04957615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809677|NCT04955743|Lenvatinib|lenvatinib|mesh-list
55809680|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55809681|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809682|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809684|NCT02490475|Pertuzumab|pertuzumab|mesh-list
55809685|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809686|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
55809687|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
55809688|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
55809689|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809690|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809691|NCT02477839|Lacosamide|lacosamide|mesh-list
55809692|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
55809693|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55809694|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55809695|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55809696|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809697|NCT04939987|Acetaminophen|acetaminophen|mesh-list
55809698|NCT04939987|Ketorolac|ketorolac|mesh-list
55809699|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55809700|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55809701|NCT04939987|Ketamine|ketamine|mesh-list
55809702|NCT04939987|Oxycodone|oxycodone|mesh-list
55809703|NCT04939987|Gabapentin|gabapentin|mesh-list
55809704|NCT04939987|Tramadol|tramadol|mesh-list
55809705|NCT04939987|Hydrocodone|hydrocodone|mesh-list
55809706|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
55809707|NCT04939987|Analgesics|analgesics|mesh-ancestor
55809708|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
55809709|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809710|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809711|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55809712|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55809713|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
55809714|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
55809715|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809716|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55809717|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55809718|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809719|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809720|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809721|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
55809722|NCT04939987|Narcotics|narcotics|mesh-ancestor
55809723|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
55809724|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55809725|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55809726|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55809727|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
55809728|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55809729|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809730|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55809731|NCT04939987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55809732|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809733|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
55809734|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
55809735|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55809736|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55809737|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55809739|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809740|NCT02477215|Dexamethasone|dexamethasone|mesh-list
55809741|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55809742|NCT02477215|Ixazomib|ixazomib|mesh-list
55809743|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809744|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
55809745|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
55809746|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809747|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809748|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55809749|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
55809750|NCT02477215|Hormones|hormones|mesh-ancestor
55809751|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809752|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55809753|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809754|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55809755|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
55809756|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809757|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
55809758|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809759|NCT02487199|Ritonavir|ritonavir|mesh-list
55809760|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55809761|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55809762|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
55809763|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809764|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809765|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55809766|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55809767|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
55809768|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809769|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55809770|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55809771|NCT02475733|Metronidazole|metronidazole|mesh-list
55809772|NCT02475733|Meropenem|meropenem|mesh-list
55809773|NCT02475733|Ceftazidime|ceftazidime|mesh-list
55809774|NCT02475733|Avibactam|avibactam|mesh-list
55809775|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
55809776|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809777|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55809778|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55809779|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55809780|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55809781|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809782|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809783|NCT02486653|Tamsulosin|tamsulosin|mesh-list
55809784|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55809785|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55809786|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55809787|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
55809789|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809790|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809791|NCT02486653|Urological Agents|urological agents|mesh-ancestor
55809792|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
55809793|NCT02475265|Estradiol|estradiol|mesh-list
55809794|NCT02475265|Estrogens|estrogens|mesh-ancestor
55809795|NCT02475265|Hormones|hormones|mesh-ancestor
55809796|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809797|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809798|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55809799|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
55809800|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55809801|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55809802|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55809803|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55809804|NCT02450539|Docetaxel|docetaxel|mesh-list
55809805|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809806|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
55809807|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
55809808|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
55809809|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809810|NCT02449915|Bupivacaine|bupivacaine|mesh-list
55809811|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
55809812|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
55809813|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809814|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809815|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
55809816|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809818|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
55809819|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809820|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55809821|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809823|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
55809824|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809825|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55809826|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55809827|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809828|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809829|NCT02472847|Hormones|hormones|mesh-ancestor
55809830|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55809831|NCT02472145|Decitabine|decitabine|mesh-list
55809832|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55809833|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
55809834|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809835|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809836|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809837|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
55809838|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
55809839|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
55809840|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55809841|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55809842|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
55809843|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
55809844|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809845|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809846|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809847|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55809848|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
55809849|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55809850|NCT04912765|Nivolumab|nivolumab|mesh-list
55809851|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809852|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809853|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55809855|NCT02448043|Bimatoprost|bimatoprost|mesh-list
55809862|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809863|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
55809864|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809865|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55809866|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
55809867|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55809868|NCT02417935|Pregabalin|pregabalin|mesh-list
55809869|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55809870|NCT02417935|Analgesics|analgesics|mesh-ancestor
55809871|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
55809872|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809873|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809874|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
55809875|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55809876|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55809877|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809878|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55809879|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55809880|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55809881|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809882|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55809883|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55809884|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55809885|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809886|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
55809887|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
55809888|NCT02447029|Lidocaine|lidocaine|mesh-list
55809905|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55809906|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
55809907|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
55809908|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55809910|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
55809911|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809912|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55809913|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55809914|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55809915|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
55809916|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55809917|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809918|NCT02415595|BMS-955176|bms-955176|mesh-list
55809919|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55810185|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
55809920|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55809921|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
55809922|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809923|NCT02446717|Ribavirin|ribavirin|mesh-list
55809924|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
55809925|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809926|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
55809927|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809928|NCT02469415|Azacitidine|azacitidine|mesh-list
55809929|NCT02469415|Decitabine|decitabine|mesh-list
55809930|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55809931|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
55809932|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809933|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809934|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809935|NCT02446171|Naloxegol|naloxegol|mesh-list
55809936|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55809937|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809938|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
55809939|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809940|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55809941|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
55809944|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
55809945|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809946|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
55809947|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809948|NCT02468557|Paclitaxel|paclitaxel|mesh-list
55809949|NCT02468557|Idelalisib|idelalisib|mesh-list
55809950|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55809951|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809952|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
55809953|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
55809954|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
55809955|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809956|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809957|NCT02413489|Daratumumab|daratumumab|mesh-list
55809958|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809959|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
55809960|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55809961|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
55809962|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55809963|NCT02444533|Bupivacaine|bupivacaine|mesh-list
55809964|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
55809965|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
55809966|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55809967|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809968|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
55809969|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809970|NCT01651039|Dexamethasone|dexamethasone|mesh-list
55809971|NCT01651039|Lenalidomide|lenalidomide|mesh-list
55809972|NCT01651039|Panobinostat|panobinostat|mesh-list
55809973|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55809975|NCT01651039|Autonomic Agents|autonomic agents|mesh-ancestor
55809976|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55809977|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55809978|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55809979|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
55809983|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809984|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
55809985|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55809986|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55809987|NCT01651039|Growth Substances|growth substances|mesh-ancestor
55809994|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55809995|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55809996|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55809997|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55809998|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55809999|NCT02275611|Oxytocin|oxytocin|mesh-list
55810000|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
55810001|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55810002|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810003|NCT01642251|Cisplatin|cisplatin|mesh-list
55810004|NCT01642251|Etoposide|etoposide|mesh-list
55810005|NCT01642251|Etoposide phosphate|etoposide phosphate|mesh-list
55810006|NCT01642251|Veliparib|veliparib|mesh-list
55810007|NCT01642251|Podophyllotoxin|podophyllotoxin|mesh-list
55810008|NCT01642251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810009|NCT01642251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55810010|NCT01642251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55810011|NCT01642251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55810012|NCT01642251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810013|NCT01642251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810014|NCT01642251|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55810015|NCT01642251|Keratolytic Agents|keratolytic agents|mesh-ancestor
55810016|NCT01642251|Dermatologic Agents|dermatologic agents|mesh-ancestor
55810017|NCT01642251|Tubulin Modulators|tubulin modulators|mesh-ancestor
55810018|NCT01642251|Antimitotic Agents|antimitotic agents|mesh-ancestor
55810019|NCT01642251|Mitosis Modulators|mitosis modulators|mesh-ancestor
55810020|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
55810021|NCT04875585|Lenvatinib|lenvatinib|mesh-list
55810022|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810023|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810024|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55810025|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810026|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810027|NCT02273973|Letrozole|letrozole|mesh-list
55810028|NCT02273973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810029|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55810030|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55810031|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810032|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810033|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55810034|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
55810035|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810036|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810037|NCT05649111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55810039|NCT05649111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55810040|NCT05649111|Glucocorticoids|glucocorticoids|mesh-ancestor
55810041|NCT05649111|Hormones|hormones|mesh-ancestor
55810042|NCT05649111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810043|NCT05649111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810044|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
55810045|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55810046|NCT02465515|Incretins|incretins|mesh-ancestor
55810047|NCT02465515|Hormones|hormones|mesh-ancestor
55810057|NCT05561361|Natriuretic Agents|natriuretic agents|mesh-ancestor
55810058|NCT02412631|Varenicline|varenicline|mesh-list
55810059|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55810060|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55810061|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
55810062|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810063|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810064|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810065|NCT02272803|Dexamethasone|dexamethasone|mesh-list
55810066|NCT02272803|Lenalidomide|lenalidomide|mesh-list
55810067|NCT02272803|Elotuzumab|elotuzumab|mesh-list
55810068|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810069|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
55810070|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
55810073|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55810074|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
55810075|NCT02272803|Hormones|hormones|mesh-ancestor
55810076|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810077|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55810078|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810079|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
55810080|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55810081|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55810082|NCT02272803|Growth Substances|growth substances|mesh-ancestor
55810083|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
55810084|NCT02272725|Ibuprofen|ibuprofen|mesh-list
55810085|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55810086|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55810087|NCT02272725|Analgesics|analgesics|mesh-ancestor
55810088|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
55810089|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810090|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810091|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810092|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810093|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55810094|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810095|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810096|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
55810098|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810099|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55810100|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810101|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810102|NCT04922827|Infliximab|infliximab|mesh-list
55810103|NCT04922827|Dermatologic Agents|dermatologic agents|mesh-ancestor
55810104|NCT04922827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55810105|NCT04922827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810107|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810108|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55810109|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810110|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810111|NCT02442271|Ritonavir|ritonavir|mesh-list
55810112|NCT02442271|Ribavirin|ribavirin|mesh-list
55810113|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55810114|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55810115|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
55810116|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810117|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810124|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
55810125|NCT02463409|Theophylline|theophylline|mesh-list
55810126|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55810127|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
55810128|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810129|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810130|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55810131|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
55810132|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55810133|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810134|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810135|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
55810136|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55810137|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55810139|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810141|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810142|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810143|NCT04910503|Dexamethasone|dexamethasone|mesh-list
55810144|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
55810145|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810146|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
55810147|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
55810148|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810149|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810150|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55810151|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
55810152|NCT04910503|Hormones|hormones|mesh-ancestor
55810153|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810154|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55810155|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810156|NCT04910425|Fluorides|fluorides|mesh-list
55810157|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
55810158|NCT04910425|Protective Agents|protective agents|mesh-ancestor
55810159|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810160|NCT02463331|Chloroquine|chloroquine|mesh-list
55810161|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
55810162|NCT02463331|Prednisone|prednisone|mesh-list
55810163|NCT02463331|Azathioprine|azathioprine|mesh-list
55810164|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55810165|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
55810166|NCT02463331|Hormones|hormones|mesh-ancestor
55810167|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55810168|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810170|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810171|NCT02463331|Amebicides|amebicides|mesh-ancestor
55810172|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55810173|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55810174|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810175|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
55810176|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810177|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55810178|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55810180|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
55810181|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810182|NCT02463331|Filaricides|filaricides|mesh-ancestor
55810183|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
55810184|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
55810186|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810187|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55810188|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55810189|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
55810190|NCT02463097|Insulin|insulin|mesh-list
55810191|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55810192|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810193|NCT05427149|Magnesium Sulfate|magnesium sulfate|mesh-list
55810194|NCT05427149|Analgesics|analgesics|mesh-ancestor
55810195|NCT05427149|Sensory System Agents|sensory system agents|mesh-ancestor
55810196|NCT05427149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810197|NCT05427149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810198|NCT05427149|Anesthetics|anesthetics|mesh-ancestor
55810199|NCT05427149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810200|NCT05427149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55810201|NCT05427149|Anticonvulsants|anticonvulsants|mesh-ancestor
55810202|NCT05427149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55810203|NCT05427149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55810204|NCT05427149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810205|NCT05427149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55810206|NCT05427149|Tocolytic Agents|tocolytic agents|mesh-ancestor
55810207|NCT05427149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55810210|NCT02462473|Aripiprazole|aripiprazole|mesh-list
55810211|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55810212|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55810213|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55810214|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
55810215|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810216|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810217|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810218|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55810219|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55810220|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810221|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55810222|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55810223|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
55810224|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
55810225|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
55810226|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810227|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55810228|NCT02462473|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55810240|NCT05405309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810241|NCT05405309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810242|NCT02440789|Sirolimus|sirolimus|mesh-list
55810243|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55810244|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810245|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55810246|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810247|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
55810305|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810307|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
55810308|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810309|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55810310|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55810311|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
55810312|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
55810313|NCT05395091|Denosumab|denosumab|mesh-list
55810314|NCT05395091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55810315|NCT05395091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810316|NCT01937117|Trastuzumab|trastuzumab|mesh-list
55810317|NCT01937117|Pertuzumab|pertuzumab|mesh-list
55810318|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810329|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
55810330|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810331|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810332|NCT02267187|Anesthetics|anesthetics|mesh-list
55810333|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810334|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810335|NCT05388929|Analgesics, Opioid|analgesics, opioid|mesh-list
55810336|NCT05388929|Methocarbamol|methocarbamol|mesh-list
55810337|NCT05388929|Narcotics|narcotics|mesh-ancestor
55810338|NCT05388929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810339|NCT05388929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810340|NCT05388929|Analgesics|analgesics|mesh-ancestor
55810341|NCT05388929|Sensory System Agents|sensory system agents|mesh-ancestor
55810342|NCT05388929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810413|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
55810414|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
55810415|NCT04909333|Exenatide|exenatide|mesh-list
55810416|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55810433|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810434|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55810466|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55810467|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
55810468|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810469|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810470|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55810471|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55810472|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
55810473|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810474|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55810475|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55810476|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
55810477|NCT04874025|Palbociclib|palbociclib|mesh-list
55810478|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810479|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55810480|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810481|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810482|NCT02263365|Loperamide|loperamide|mesh-list
55810483|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
55810494|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810495|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
55810496|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55810497|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55810498|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55810499|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55810500|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810501|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
55810502|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810503|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810504|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55810505|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810506|NCT02260791|Adalimumab|adalimumab|mesh-list
55810509|NCT02260635|Evacetrapib|evacetrapib|mesh-list
55810510|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55810511|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55810512|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
55810513|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810514|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55810515|NCT05646459|Cannabidiol|cannabidiol|mesh-list
55810516|NCT05646459|Anticonvulsants|anticonvulsants|mesh-ancestor
55810517|NCT02259231|Nivolumab|nivolumab|mesh-list
55810518|NCT02259231|Ipilimumab|ipilimumab|mesh-list
55810519|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810520|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810521|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55810522|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810523|NCT02258529|Rituximab|rituximab|mesh-list
55810524|NCT02258529|Idelalisib|idelalisib|mesh-list
55810525|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55810526|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810527|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
55810528|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810529|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55810530|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810531|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810532|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
55810533|NCT02256969|Prednisolone|prednisolone|mesh-list
55810534|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55810535|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
55810536|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55810554|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55810555|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810556|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55810557|NCT02256969|Renal Agents|renal agents|mesh-ancestor
55810558|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55810559|NCT02256969|Emollients|emollients|mesh-ancestor
55810560|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
55810561|NCT05645913|Anticoagulants|anticoagulants|mesh-list
55810562|NCT02256267|Rifampin|rifampin|mesh-list
55810563|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55810564|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
55810565|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55810566|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810567|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
55810568|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55810569|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810570|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810571|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55810653|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
55810654|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
55810655|NCT01641237|Protective Agents|protective agents|mesh-ancestor
55810656|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810657|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55810658|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810659|NCT05650437|Vitamin D|vitamin d|mesh-list
55810660|NCT05650437|Vitamins|vitamins|mesh-ancestor
55810661|NCT05650437|Micronutrients|micronutrients|mesh-ancestor
55810662|NCT05650437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810663|NCT05650437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55810664|NCT05617209|Thrombin|thrombin|mesh-list
55810665|NCT05617209|Hemostatics|hemostatics|mesh-ancestor
55810666|NCT05617209|Coagulants|coagulants|mesh-ancestor
55810667|NCT01639833|Hemostatics|hemostatics|mesh-list
55810668|NCT01639833|Coagulants|coagulants|mesh-ancestor
55810669|NCT01639131|Gemcitabine|gemcitabine|mesh-list
55810670|NCT01639131|Docetaxel|docetaxel|mesh-list
55810671|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55810672|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
55810674|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810689|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55810690|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55810691|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
55810692|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810693|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810694|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
55810695|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55810696|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
55810697|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810698|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810699|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55810700|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
55810701|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55810702|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55810703|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55810704|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
55810722|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
55810723|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55810724|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
55810725|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810726|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
55810727|NCT04853589|Protective Agents|protective agents|mesh-ancestor
55810728|NCT01638429|Rifaximin|rifaximin|mesh-list
55810729|NCT01638429|Neomycin|neomycin|mesh-list
55810730|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55810731|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810732|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55810739|NCT04853355|Spironolactone|spironolactone|mesh-list
55810750|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
55810751|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810752|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55810753|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55810754|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810755|NCT01601535|Irinotecan|irinotecan|mesh-list
55810756|NCT01601535|Temozolomide|temozolomide|mesh-list
55810757|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55810758|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55810759|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810760|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810761|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55810762|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55810763|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
55810764|NCT05422365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55810765|NCT05422365|Immunoglobulins|immunoglobulins|mesh-list
55810766|NCT05422365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55810767|NCT05422365|Antibodies|antibodies|mesh-list
55810768|NCT05422365|gamma-Globulins|gamma-globulins|mesh-list
55810803|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
55810938|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810939|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810940|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
55810941|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55810942|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55810943|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55810944|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55810945|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55810946|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810947|NCT05122767|Dolutegravir|dolutegravir|mesh-list
55810948|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55810949|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55810950|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55810951|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810953|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55810954|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
55810955|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810956|NCT05396859|Decitabine|decitabine|mesh-list
55810957|NCT05396859|Entrectinib|entrectinib|mesh-list
55810966|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810967|NCT04254549|Rifaximin|rifaximin|mesh-list
55810968|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55810969|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810970|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55810971|NCT04225767|Calcium|calcium|mesh-list
55810972|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55810973|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810974|NCT04820673|Sarecycline|sarecycline|mesh-list
55810975|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55810976|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55810977|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
55810978|NCT04114539|Ecopipam|ecopipam|mesh-list
55810979|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55810980|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55810981|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55810982|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810983|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55810984|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55810985|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
55810986|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55810987|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55810988|NCT03312699|Vaccines|vaccines|mesh-list
55810989|NCT03312699|Immunologic Factors|immunologic factors|mesh-ancestor
55810990|NCT03312699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55810991|NCT03301857|Denosumab|denosumab|mesh-list
55810992|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
55810997|NCT03298815|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55810998|NCT03298815|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55810999|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
55811000|NCT03263559|Thiotepa|thiotepa|mesh-list
55811001|NCT03263559|Fludarabine|fludarabine|mesh-list
55811002|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
55811003|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
55811007|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55811008|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55811009|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
55811010|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811011|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811012|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55811013|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
55811014|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811015|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55811017|NCT03257163|Capecitabine|capecitabine|mesh-list
55811036|NCT03253263|Growth Substances|growth substances|mesh-ancestor
55811037|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811038|NCT05219799|Propranolol|propranolol|mesh-list
55811039|NCT05219799|Nitroprusside|nitroprusside|mesh-list
55811040|NCT05219799|Isoproterenol|isoproterenol|mesh-list
55811041|NCT05219799|Norepinephrine|norepinephrine|mesh-list
55811042|NCT05219799|Acetylcholine|acetylcholine|mesh-list
55811043|NCT05219799|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55811044|NCT05219799|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55811045|NCT05219799|Adrenergic Agents|adrenergic agents|mesh-ancestor
55811046|NCT05219799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811047|NCT05219799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811048|NCT05219799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811049|NCT05219799|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55811050|NCT05219799|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55811051|NCT05219799|Vasodilator Agents|vasodilator agents|mesh-ancestor
55811052|NCT05219799|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55811053|NCT05219799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55811054|NCT05219799|Sympathomimetics|sympathomimetics|mesh-ancestor
55811055|NCT05219799|Autonomic Agents|autonomic agents|mesh-ancestor
55811056|NCT05219799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811057|NCT05219799|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55811058|NCT05219799|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55811118|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
55811119|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
55811121|NCT02817633|Carboplatin|carboplatin|mesh-list
55811134|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55811136|NCT05651607|Anticonvulsants|anticonvulsants|mesh-ancestor
55811137|NCT02775435|Paclitaxel|paclitaxel|mesh-list
55811138|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55811139|NCT02775435|Carboplatin|carboplatin|mesh-list
55811154|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811156|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55811157|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55811158|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811159|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
55811160|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811161|NCT05651373|Hydroxychloroquine|hydroxychloroquine|mesh-list
55811162|NCT05651373|Prednisone|prednisone|mesh-list
55811163|NCT05651373|Certolizumab Pegol|certolizumab pegol|mesh-list
55811164|NCT05651373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811165|NCT05651373|Glucocorticoids|glucocorticoids|mesh-ancestor
55811166|NCT05651373|Hormones|hormones|mesh-ancestor
55811167|NCT05651373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811168|NCT05651373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811169|NCT05651373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55811170|NCT05651373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811171|NCT05651373|Antimalarials|antimalarials|mesh-ancestor
55811172|NCT05651373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55811173|NCT05651373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55811176|NCT05651373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811177|NCT05651373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55811178|NCT05651373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811179|NCT05651373|Immunologic Factors|immunologic factors|mesh-ancestor
55811181|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811182|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55811183|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55811184|NCT03905889|Growth Substances|growth substances|mesh-ancestor
55811185|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811186|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
55811187|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55811188|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811189|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811190|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55811191|NCT02527707|Ritonavir|ritonavir|mesh-list
55811250|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811251|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811252|NCT03846765|Protective Agents|protective agents|mesh-ancestor
55811253|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55811254|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55811256|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811257|NCT03822897|Cisplatin|cisplatin|mesh-list
55811258|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811259|NCT02311179|Cimetidine|cimetidine|mesh-list
55811260|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55811261|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811262|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55811263|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
55811264|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
55811265|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811266|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811267|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811269|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55811271|NCT04801953|Nimodipine|nimodipine|mesh-list
55811272|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55811273|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55811274|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55811275|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811312|NCT05180097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811313|NCT05180097|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55811315|NCT05180097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811338|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55811339|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811341|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
55811342|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811343|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55811344|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
55811345|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55811346|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811347|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55811348|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
55811349|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55811389|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811390|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
55811391|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
55811392|NCT05031897|Melphalan|melphalan|mesh-list
55811393|NCT05031897|Fludarabine|fludarabine|mesh-list
55811394|NCT05031897|Tacrolimus|tacrolimus|mesh-list
55811395|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811396|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
55811397|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811398|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55811399|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55811400|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
55811401|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811402|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811403|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55811404|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55811415|NCT01582191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811416|NCT01582191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811418|NCT01582191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811745|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811746|NCT02233647|Cocaine|cocaine|mesh-list
55811747|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
55811748|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
55811749|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811750|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811751|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
55811754|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55811755|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55811756|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55811757|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811758|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
55811759|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811760|NCT01632579|Celecoxib|celecoxib|mesh-list
55811761|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55811762|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55811763|NCT01632579|Analgesics|analgesics|mesh-ancestor
55811764|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
55811765|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811766|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811767|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811769|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55811770|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55811771|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811772|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811774|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55811775|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55811776|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55811778|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811779|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
55811780|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811781|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55811782|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55811783|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55811784|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55811785|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55811880|NCT02226003|Incretins|incretins|mesh-ancestor
55811786|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55811787|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55792858|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
55811788|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55811789|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
55811790|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
55811791|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55811792|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55811793|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811800|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811801|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811802|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
55811803|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811804|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55811806|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
55811809|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55811810|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811811|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
55811812|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811813|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55811814|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55811815|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55811816|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55811817|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811818|NCT04776369|Analgesics|analgesics|mesh-ancestor
55811819|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
55811820|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55811821|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55811822|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
55811823|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55811824|NCT02230527|Clopidogrel|clopidogrel|mesh-list
55811826|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55811827|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55811828|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55811831|NCT02230527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811832|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811833|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811834|NCT03155061|Nivolumab|nivolumab|mesh-list
55811835|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55811836|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811837|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55811838|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811839|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
55811840|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55811841|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811842|NCT02203149|Grazoprevir|grazoprevir|mesh-list
55811843|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
55811844|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811845|NCT02520063|Everolimus|everolimus|mesh-list
55811846|NCT02520063|Letrozole|letrozole|mesh-list
55811847|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811848|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811849|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
55811850|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811851|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55811852|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55811853|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811854|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792871|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55811855|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55811856|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
55811857|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811867|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811868|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811869|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
55811871|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55811872|NCT02226549|Ledipasvir|ledipasvir|mesh-list
55811873|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
55811874|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811875|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55811876|NCT02226003|Glimepiride|glimepiride|mesh-list
55811877|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
55811878|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55811879|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811886|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811888|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811890|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55811891|NCT02469519|Dexamethasone|dexamethasone|mesh-list
55811892|NCT02469519|Betamethasone|betamethasone|mesh-list
55811893|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55811894|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
55811896|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811897|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811898|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811899|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
55811900|NCT02469519|Hormones|hormones|mesh-ancestor
55811901|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55811902|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55811903|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811904|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55811905|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
55811909|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811911|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55811912|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
55811913|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
55811914|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55811915|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
55811916|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55811917|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811919|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55811920|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811921|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811924|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811927|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55811935|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55811936|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55811937|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
55811938|NCT04763577|Bradykinin|bradykinin|mesh-list
55811939|NCT04763577|Kininogens|kininogens|mesh-list
55811940|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
55811941|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55811942|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
55811943|NCT04763577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811944|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811945|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
55811946|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55811948|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
55811949|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811950|NCT02224053|Osimertinib|osimertinib|mesh-list
55811951|NCT02224053|Omeprazole|omeprazole|mesh-list
55811952|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55811953|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55811954|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55811955|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811956|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811958|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55811960|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55811961|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55811962|NCT04762875|Antiviral Agents|antiviral agents|mesh-ancestor
55811963|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811964|NCT04774107|Ribavirin|ribavirin|mesh-list
55811965|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
55811966|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811967|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
55811968|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55811969|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
55811970|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55811971|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55811972|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55811973|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811975|NCT02434939|Morphine|morphine|mesh-list
55811976|NCT02434939|Analgesics|analgesics|mesh-ancestor
55811977|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
55811978|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811979|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55811980|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55811981|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55811982|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
55811988|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55811989|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55811990|NCT02434939|Narcotics|narcotics|mesh-ancestor
55811992|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
55811993|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
55843733|NCT03766750|Hormones|hormones|mesh-ancestor
55811997|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55811999|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55812000|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812001|NCT02434081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55812002|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812003|NCT02222493|Infliximab|infliximab|mesh-list
55812004|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
55812005|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55812006|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55812007|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55812008|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
55812009|NCT01439997|Coagulants|coagulants|mesh-ancestor
55812010|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55812011|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
55812012|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812013|NCT02403271|Durvalumab|durvalumab|mesh-list
55812014|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55812015|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812016|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
55812017|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55812018|NCT02219685|Ledipasvir|ledipasvir|mesh-list
55812019|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
55812020|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812023|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812024|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55812025|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55812026|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55812027|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812028|NCT02198235|Dexamethasone|dexamethasone|mesh-list
55812029|NCT02198235|Buprenorphine|buprenorphine|mesh-list
55812030|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55812031|NCT02198235|Antiemetics|antiemetics|mesh-ancestor
55812032|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
55812033|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812035|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55812036|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
55812037|NCT02198235|Hormones|hormones|mesh-ancestor
55812038|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812039|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55812040|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812042|NCT02198235|Narcotics|narcotics|mesh-ancestor
55812043|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55812044|NCT02198235|Analgesics|analgesics|mesh-ancestor
55812045|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
55812046|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55812047|NCT00346125|Doxorubicin|doxorubicin|mesh-list
55812048|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55812049|NCT00346125|Ifosfamide|ifosfamide|mesh-list
55812050|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55812051|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55812052|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812053|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55812054|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55812055|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812056|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812057|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55812058|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
55812061|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55812062|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
55812063|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812064|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55812066|NCT02217501|Clopidogrel|clopidogrel|mesh-list
55812067|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55812068|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55812069|NCT02217501|Analgesics|analgesics|mesh-ancestor
55812070|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
55812071|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812072|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812073|NCT02217501|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55812074|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55812249|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812250|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812252|NCT02424097|Fluorides|fluorides|mesh-list
55812253|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
55812254|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
55812255|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
55812256|NCT02424097|Protective Agents|protective agents|mesh-ancestor
55812257|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812258|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55812259|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812260|NCT02392507|Paclitaxel|paclitaxel|mesh-list
55812261|NCT02392507|Carboplatin|carboplatin|mesh-list
55812262|NCT02392507|Necitumumab|necitumumab|mesh-list
55812263|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55812264|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812265|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
55812266|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
55812267|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
55812268|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812269|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55812270|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
55812271|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55812272|NCT04904341|Protective Agents|protective agents|mesh-ancestor
55843832|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
55812273|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812274|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
55812275|NCT02385799|Sertraline|sertraline|mesh-list
55812276|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
55812277|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55812278|NCT02385799|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55812279|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55812280|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55812281|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812282|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812283|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
55812284|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812285|NCT02422303|Ketamine|ketamine|mesh-list
55812286|NCT02422303|Analgesics|analgesics|mesh-ancestor
55812287|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
55812288|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812289|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812290|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55812291|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55812292|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
55812293|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
55812294|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55812295|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55812296|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55812297|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812298|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812300|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55812301|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55812302|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812303|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
55792919|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55812304|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55812305|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812306|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55812307|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812310|NCT02384395|Dolutegravir|dolutegravir|mesh-list
55812311|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55812312|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55812313|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812314|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812315|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
55812316|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812317|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55812318|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55812319|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55812320|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55812321|NCT02391337|Digoxin|digoxin|mesh-list
55812322|NCT02391337|Bisoprolol|bisoprolol|mesh-list
55812323|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55812324|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55812325|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812326|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812327|NCT02391337|Protective Agents|protective agents|mesh-ancestor
55812328|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812329|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55812330|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
55812331|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
55812332|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812333|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55812334|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55812335|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55812336|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
55812337|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812338|NCT01649791|Lenalidomide|lenalidomide|mesh-list
55812339|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
55812364|NCT04902625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55812365|NCT04902625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55812366|NCT04902625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55812367|NCT04902625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55812368|NCT04902625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812369|NCT04902625|Dopamine Agents|dopamine agents|mesh-ancestor
55812370|NCT04902625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812371|NCT04902625|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55812372|NCT04902625|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55812373|NCT04902625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812375|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55812376|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55812377|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
55812379|NCT02345161|Albuterol|albuterol|mesh-list
55812380|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
55812381|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55812382|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55812383|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55812384|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
55812385|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812386|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812387|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55812388|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
55812389|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
55812390|NCT02345161|Hormones|hormones|mesh-ancestor
55812391|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812392|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55812393|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55812394|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55812395|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
55812396|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812397|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812398|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
55812399|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55812400|NCT02251275|Tolvaptan|tolvaptan|mesh-list
55812401|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55812402|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812404|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812405|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
55812406|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55812407|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
55812408|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812409|NCT02379637|Expectorants|expectorants|mesh-ancestor
55812410|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
55812411|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55812416|NCT02379637|Antidotes|antidotes|mesh-ancestor
55812418|NCT02195583|Listerine|listerine|mesh-list
55812419|NCT02195583|Fluorides|fluorides|mesh-list
55812420|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
55812421|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
55812422|NCT02195583|Protective Agents|protective agents|mesh-ancestor
55812423|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812424|NCT02195583|Trace Elements|trace elements|mesh-ancestor
55812425|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
55812426|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55812427|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812428|NCT02379091|Leucovorin|leucovorin|mesh-list
55812429|NCT02379091|Folic Acid|folic acid|mesh-list
55812481|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55812482|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
55797189|NCT05697029|Antiviral Agents|antiviral agents|mesh-ancestor
55812495|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812498|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
55812499|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812500|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55812501|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55812502|NCT02309515|Growth Substances|growth substances|mesh-ancestor
55812503|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
55812504|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812506|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55812507|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
55812508|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55812509|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812510|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55812511|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
55812512|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812513|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812514|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
55812515|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812516|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55812517|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55812518|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
55812519|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55812520|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55812522|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55812523|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55812524|NCT02375971|Growth Substances|growth substances|mesh-ancestor
55812525|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812526|NCT02375971|Growth Inhibitors|growth inhibitors|mesh-ancestor
55812528|NCT04886323|Itraconazole|itraconazole|mesh-list
55812530|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812531|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55812532|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55812533|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812534|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812535|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55812544|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812545|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55812546|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812547|NCT02193165|Triclosan|triclosan|mesh-list
55812548|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
55812549|NCT02193165|Fluorides|fluorides|mesh-list
55812550|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
55812551|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
55812552|NCT02193165|Protective Agents|protective agents|mesh-ancestor
55812553|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812554|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55812555|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55812556|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55812557|NCT02193165|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55812558|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
55812559|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812560|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55812561|NCT01617460|Aripiprazole|aripiprazole|mesh-list
55812562|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
55812563|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55812564|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55812565|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55812566|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55812567|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812568|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
55812569|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
55812571|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812572|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55812573|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55812574|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
55812575|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55812576|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55812577|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55812578|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55812579|NCT01889602|Topiramate|topiramate|mesh-list
55812580|NCT01889602|Lorazepam|lorazepam|mesh-list
55812686|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55812687|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55812688|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
55812689|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
55812690|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812691|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812692|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55812693|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
55812694|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
55812695|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55812696|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
55812697|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55812698|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55812699|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55812700|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812701|NCT02210091|Factor VIII|factor viii|mesh-list
55812702|NCT02210091|BAX 855|bax 855|mesh-list
55812703|NCT02210091|Coagulants|coagulants|mesh-ancestor
55812704|NCT02338999|Pioglitazone|pioglitazone|mesh-list
55812705|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55812706|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812707|NCT02169219|Prednisone|prednisone|mesh-list
55812708|NCT02169219|Rituximab|rituximab|mesh-list
55812709|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
55812710|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55812711|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812712|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
55812713|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812715|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55812716|NCT02169219|Hormones|hormones|mesh-ancestor
55812717|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812718|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55812719|NCT04750473|Edetic Acid|edetic acid|mesh-list
55812720|NCT04750473|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55812721|NCT04750473|Chelating Agents|chelating agents|mesh-ancestor
55812722|NCT04750473|Sequestering Agents|sequestering agents|mesh-ancestor
55812723|NCT04750473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812724|NCT04750473|Anticoagulants|anticoagulants|mesh-ancestor
55812725|NCT04750473|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55812726|NCT04750473|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55812727|NCT02191137|Riociguat|riociguat|mesh-list
55812728|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
55812729|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812730|NCT02168439|Midazolam|midazolam|mesh-list
55812731|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
55812732|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55812733|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55812734|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812735|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55812736|NCT02168439|Analgesics|analgesics|mesh-ancestor
55812737|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
55812738|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812739|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55812740|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55812741|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55812742|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
55812743|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812744|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812745|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55812746|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55812747|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55812748|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55812749|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55812755|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55812757|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
55812758|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
55812759|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55812760|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812761|NCT02374099|Azacitidine|azacitidine|mesh-list
55812762|NCT02374099|Fulvestrant|fulvestrant|mesh-list
55812763|NCT02374099|Cc-486|cc-486|mesh-list
55812764|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55812765|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
55812766|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812767|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812840|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55812841|NCT02134353|Mannitol|mannitol|mesh-list
55812842|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55812843|NCT02134353|Diuretics|diuretics|mesh-ancestor
55812844|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
55812845|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812846|NCT01646125|Docetaxel|docetaxel|mesh-list
55812847|NCT01646125|Pemetrexed|pemetrexed|mesh-list
55812848|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812849|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
55812850|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
55812851|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
55812852|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812853|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812854|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55812855|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55812856|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
55812857|NCT01362790|Pentostatin|pentostatin|mesh-list
55812858|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55812859|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55812860|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
55812861|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812862|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55812863|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55812864|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
55812865|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812866|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55812867|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55812868|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
55812869|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55812870|NCT02167893|Leuprolide|leuprolide|mesh-list
55812871|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55812872|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
55812873|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55812874|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812875|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55812877|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
55812878|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55812879|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55812880|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
55812881|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812882|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812883|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812884|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55812885|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55812886|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55812888|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55812890|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55812891|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55812892|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812893|NCT02337907|Donepezil|donepezil|mesh-list
55812894|NCT02337907|BI 409306|bi 409306|mesh-list
55812895|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55812897|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812899|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812900|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812902|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55812904|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55812905|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55812906|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55812907|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55812908|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812909|NCT02166333|Vitamin D|vitamin d|mesh-list
55812910|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
55812911|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
55812912|NCT02166333|Vitamins|vitamins|mesh-list
55812913|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
55812914|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55812915|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55812916|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55812917|NCT02132949|Paclitaxel|paclitaxel|mesh-list
55812918|NCT02132949|Docetaxel|docetaxel|mesh-list
55812919|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
55812983|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55812984|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55812985|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55812986|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55812987|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
55812988|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55812989|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55812990|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55812991|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55812992|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
55812993|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
55812994|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55812995|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55812996|NCT02164929|Analgesics|analgesics|mesh-ancestor
55812997|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
55812998|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55812999|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55813000|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55813001|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55813002|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
55813003|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55813004|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55813005|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55813006|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
55813008|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
55813009|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55813010|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55813011|NCT02164929|Narcotics|narcotics|mesh-ancestor
55813012|NCT01888432|Everolimus|everolimus|mesh-list
55813013|NCT01888432|Tacrolimus|tacrolimus|mesh-list
55813014|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813015|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
55813016|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813017|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55813018|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813019|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813020|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813021|NCT02188719|Acetaminophen|acetaminophen|mesh-list
55813022|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
55813023|NCT02188719|Promethazine|promethazine|mesh-list
55813024|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
55813025|NCT02188719|Valganciclovir|valganciclovir|mesh-list
55813026|NCT02188719|Ganciclovir|ganciclovir|mesh-list
55813027|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
55813028|NCT02188719|Prednisone|prednisone|mesh-list
55813029|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55813030|NCT02188719|Everolimus|everolimus|mesh-list
55813031|NCT02188719|Liver Extracts|liver extracts|mesh-list
55813032|NCT02188719|Tacrolimus|tacrolimus|mesh-list
55813033|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
55813034|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55813035|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813036|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
55813037|NCT02188719|Hormones|hormones|mesh-ancestor
55813038|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813039|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813040|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55813041|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813042|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813043|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
55813044|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55813045|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813046|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813047|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55813048|NCT02188719|Analgesics|analgesics|mesh-ancestor
55813049|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
55813050|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813051|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
55813052|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55813053|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55813054|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
55813055|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55813056|NCT02188719|Hematinics|hematinics|mesh-ancestor
55813057|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55813058|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55813059|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813060|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
55813061|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
55813138|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813139|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
55813140|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55813141|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55813142|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55813143|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
55813144|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813145|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55813146|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55813147|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813148|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813149|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55813150|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55813151|NCT02131155|Afatinib|afatinib|mesh-list
55813152|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813153|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55813154|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813155|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813156|NCT01933594|Romidepsin|romidepsin|mesh-list
55813157|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55813158|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813159|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55813160|NCT02305849|Methotrexate|methotrexate|mesh-list
55813161|NCT02305849|Peficitinib|peficitinib|mesh-list
55813162|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55813163|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
55813164|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55813165|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813166|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55813167|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
55813168|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813170|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
55813171|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813172|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55813173|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813174|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
55813175|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813176|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55813177|NCT02371759|Anesthetics|anesthetics|mesh-list
55813178|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813179|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813180|NCT02531633|Prednisone|prednisone|mesh-list
55813181|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55813182|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813183|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
55813184|NCT02531633|Hormones|hormones|mesh-ancestor
55813185|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813186|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813187|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55813190|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
55813191|NCT02536313|Velpatasvir|velpatasvir|mesh-list
55813192|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
55813193|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813194|NCT05435573|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
55813195|NCT05435573|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55813196|NCT05435573|Plasma Substitutes|plasma substitutes|mesh-ancestor
55813197|NCT05435573|Blood Substitutes|blood substitutes|mesh-ancestor
55813199|NCT05412875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55813200|NCT05412875|Autonomic Agents|autonomic agents|mesh-ancestor
55813201|NCT05412875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813202|NCT05412875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813203|NCT05412875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55813205|NCT05412875|Cholinergic Agents|cholinergic agents|mesh-ancestor
55813206|NCT05412875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813207|NCT05412875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813210|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55813211|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55813212|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813213|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
55813214|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813215|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813216|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55813217|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
55813218|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813219|NCT05379179|Fentanyl|fentanyl|mesh-list
55813220|NCT05379179|Ketamine|ketamine|mesh-list
55813221|NCT05379179|Analgesics|analgesics|mesh-ancestor
55813222|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
55813223|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813224|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813225|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55813226|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55813227|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
55813229|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813230|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55813231|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55813232|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813233|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813234|NCT05379179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55813235|NCT05379179|Narcotics|narcotics|mesh-ancestor
55813236|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55813237|NCT05378945|Varenicline|varenicline|mesh-list
55813238|NCT05378945|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55813239|NCT05378945|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55813240|NCT05378945|Cholinergic Agents|cholinergic agents|mesh-ancestor
55813241|NCT05378945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813242|NCT05378945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813243|NCT05378945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813244|NCT05610527|Etonogestrel|etonogestrel|mesh-list
55813245|NCT05610527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55813246|NCT05610527|Contraceptive Agents|contraceptive agents|mesh-ancestor
55813247|NCT05610527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55813248|NCT05610527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813249|NCT05610527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55813250|NCT05383001|Durvalumab|durvalumab|mesh-list
55813251|NCT05383001|Tremelimumab|tremelimumab|mesh-list
55813252|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55813266|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813267|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
55813268|NCT02527421|Hormones|hormones|mesh-ancestor
55813269|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813270|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813271|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55813272|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
55813273|NCT05610371|Lidocaine|lidocaine|mesh-list
55813274|NCT05610371|Anesthetics, Local|anesthetics, local|mesh-ancestor
55813275|NCT05610371|Anesthetics|anesthetics|mesh-ancestor
55813276|NCT05610371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813277|NCT05610371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813278|NCT05610371|Sensory System Agents|sensory system agents|mesh-ancestor
55813279|NCT05610371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813280|NCT05610371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55813281|NCT05610371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55813282|NCT05610371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55813283|NCT05610371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55813285|NCT02163759|Adalimumab|adalimumab|mesh-list
55813286|NCT02163759|Etrolizumab|etrolizumab|mesh-list
55813287|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813288|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813289|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55813290|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
55813291|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813292|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
55813293|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55813294|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813295|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
55813296|NCT02163447|Piperaquine|piperaquine|mesh-list
55813297|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
55813298|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55813299|NCT02163447|Artenimol|artenimol|mesh-list
55813300|NCT02163447|Artemisinins|artemisinins|mesh-list
55813301|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
55813302|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55813303|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55813304|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813305|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55813306|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813307|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813308|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55813310|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
55813311|NCT01887418|Testosterone|testosterone|mesh-list
55813312|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
55813313|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
55813314|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55813315|NCT01887418|Androgens|androgens|mesh-ancestor
55813317|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813318|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813319|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55813320|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813321|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
55813322|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55813323|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55813324|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55813325|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55813326|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813327|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813328|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813329|NCT01912612|Analgesics|analgesics|mesh-ancestor
55813330|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
55813331|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813332|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
55813333|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55813334|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
55813336|NCT02302807|Docetaxel|docetaxel|mesh-list
55813337|NCT02302807|Atezolizumab|atezolizumab|mesh-list
55813338|NCT02302807|Antibodies|antibodies|mesh-list
55813339|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55813340|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813341|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
55813342|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
55813343|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
55813344|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813345|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
55813346|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813347|NCT05342519|Sirolimus|sirolimus|mesh-list
55813348|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55813349|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813350|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55813351|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813352|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
55813353|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813354|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
55813355|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813356|NCT05379491|Linaclotide|linaclotide|mesh-list
55813357|NCT05379491|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55813358|NCT05379491|Enzyme Activators|enzyme activators|mesh-ancestor
55813359|NCT05379491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813360|NCT05379491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55813361|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
55813362|NCT05308901|Lenvatinib|lenvatinib|mesh-list
55813363|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55813364|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813365|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55813366|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813367|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813368|NCT01931566|Pioglitazone|pioglitazone|mesh-list
55813369|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55813370|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813371|NCT05372939|Adalimumab|adalimumab|mesh-list
55813372|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813373|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813374|NCT01912456|Complement C1s|complement c1s|mesh-list
55813375|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55813376|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
55813377|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
55813378|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813379|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55813380|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813381|NCT04251065|Daratumumab|daratumumab|mesh-list
55813382|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813383|NCT01885936|Albuterol|albuterol|mesh-list
55813384|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55813385|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
55813386|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813387|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813388|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55813389|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
55813390|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
55813393|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55813403|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813404|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813406|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55813407|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55813408|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
55813409|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813410|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813411|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813412|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
55813413|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
55813414|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813415|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55813416|NCT05529173|Povidone-Iodine|povidone-iodine|mesh-list
55813417|NCT05529173|Povidone|povidone|mesh-list
55813418|NCT05529173|Plasma Substitutes|plasma substitutes|mesh-ancestor
55813419|NCT05529173|Blood Substitutes|blood substitutes|mesh-ancestor
55813420|NCT05529173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55813421|NCT05529173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813422|NCT05335109|Xenon|xenon|mesh-list
55813423|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55813424|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
55813425|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
55813426|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813427|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813428|NCT05300087|Albuterol|albuterol|mesh-list
55813429|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55813431|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813432|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813433|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55813434|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
55813436|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55813437|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55813438|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55813439|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55813440|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
55813441|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813442|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813443|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
55813445|NCT05334329|Atezolizumab|atezolizumab|mesh-list
55813446|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
55813447|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55813448|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55813449|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
55813450|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813451|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813452|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55813453|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
55813454|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813455|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55813456|NCT05333549|Istradefylline|istradefylline|mesh-list
55813457|NCT05333549|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
55813458|NCT05333549|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55813459|NCT05333549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55813460|NCT05333549|Purinergic Agents|purinergic agents|mesh-ancestor
55813461|NCT05333549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813462|NCT05333549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813463|NCT05333549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813464|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55813465|NCT01912222|Ixazomib|ixazomib|mesh-list
55813466|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813467|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
55813468|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813469|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813472|NCT05367401|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55813473|NCT05367401|Antimetabolites|antimetabolites|mesh-ancestor
55813474|NCT05367401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813475|NCT05367401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813476|NCT05367401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813477|NCT05367401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55813478|NCT05296577|Vinorelbine|vinorelbine|mesh-list
55813479|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55813480|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813482|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
55813483|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
55813484|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813485|NCT05366933|Folic Acid|folic acid|mesh-list
55813486|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
55813487|NCT05366933|Vitamins|vitamins|mesh-ancestor
55813488|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
55813489|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813490|NCT05366933|Hematinics|hematinics|mesh-ancestor
55813491|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55813492|NCT05500703|Dexmedetomidine|dexmedetomidine|mesh-list
55813493|NCT05500703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55813494|NCT05500703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813495|NCT05500703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813496|NCT05500703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55813497|NCT05500703|Analgesics|analgesics|mesh-ancestor
55813498|NCT05500703|Sensory System Agents|sensory system agents|mesh-ancestor
55813499|NCT05500703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813500|NCT05500703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55813501|NCT05500703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55813502|NCT05500703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55813503|NCT05500703|Adrenergic Agents|adrenergic agents|mesh-ancestor
55813504|NCT05500703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813505|NCT05500703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813506|NCT04246151|Vancomycin|vancomycin|mesh-list
55813507|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55813508|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813509|NCT05331521|Vincristine|vincristine|mesh-list
55813510|NCT05331521|Temozolomide|temozolomide|mesh-list
55813511|NCT05331521|Lomustine|lomustine|mesh-list
55813512|NCT05331521|Procarbazine|procarbazine|mesh-list
55813513|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55813514|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813515|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
55813516|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
55813517|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
55813518|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813519|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55813523|NCT05365451|Furosemide|furosemide|mesh-list
55813524|NCT05365451|Cimetidine|cimetidine|mesh-list
55813525|NCT05365451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55813526|NCT05365451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813527|NCT05365451|Diuretics|diuretics|mesh-ancestor
55813528|NCT05365451|Natriuretic Agents|natriuretic agents|mesh-ancestor
55813529|NCT05365451|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55813530|NCT05365451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55813531|NCT05365451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813532|NCT05365451|Uricosuric Agents|uricosuric agents|mesh-ancestor
55813533|NCT05365451|Gout Suppressants|gout suppressants|mesh-ancestor
55813534|NCT05365451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813536|NCT05365451|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55813537|NCT05365451|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55813538|NCT05365451|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55813539|NCT05365451|Histamine Antagonists|histamine antagonists|mesh-ancestor
55813540|NCT05365451|Histamine Agents|histamine agents|mesh-ancestor
55813541|NCT05365451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813542|NCT05365451|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55813543|NCT05365451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55813544|NCT05365451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813545|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
55813546|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55813547|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813548|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813549|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55813550|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55813551|NCT02524847|Methoxsalen|methoxsalen|mesh-list
55813552|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55813553|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
55813554|NCT05363267|Curcumin|curcumin|mesh-list
55813555|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55813556|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55813557|NCT05363267|Analgesics|analgesics|mesh-ancestor
55813558|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
55813559|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813560|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813561|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813562|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55813563|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813570|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813571|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813572|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55813573|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
55813574|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
55813575|NCT04422275|Hormones|hormones|mesh-ancestor
55813576|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55813577|NCT05361941|Tobramycin|tobramycin|mesh-list
55813578|NCT05361941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55813579|NCT05361941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813580|NCT05290025|Nicotine|nicotine|mesh-list
55813581|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55813582|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
55813583|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813584|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813585|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55813586|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55813587|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
55813588|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813589|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813590|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
55813591|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55813592|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813593|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813594|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55813595|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55813596|NCT05324735|Protective Agents|protective agents|mesh-ancestor
55813597|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813598|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
55813599|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55813601|NCT05359055|Itraconazole|itraconazole|mesh-list
55813602|NCT05359055|Rifampin|rifampin|mesh-list
55813603|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
55813604|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813605|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55813606|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55813607|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813608|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813625|NCT04249583|Botulinum Toxins|botulinum toxins|mesh-list
55813628|NCT04249583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813629|NCT04249583|Cholinergic Agents|cholinergic agents|mesh-ancestor
55813630|NCT04249583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813631|NCT04249583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813632|NCT02524379|Glyburide|glyburide|mesh-list
55813634|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813635|NCT02524145|Isoproterenol|isoproterenol|mesh-list
55813636|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
55813637|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
55813638|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55813639|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813640|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813641|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55813642|NCT02524145|Analgesics|analgesics|mesh-ancestor
55813643|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
55813644|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813645|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55813646|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55813647|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55813648|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
55813649|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813650|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813651|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55813652|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55813653|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55813654|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
55813655|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55813656|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55813657|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
55813768|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813769|NCT02187159|Pregabalin|pregabalin|mesh-list
55813770|NCT02187159|Analgesics|analgesics|mesh-ancestor
55813771|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
55813772|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813773|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813775|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55813778|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55813779|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55813780|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55813781|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813782|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55813785|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813786|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55813787|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55813788|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
55813789|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813790|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55813791|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813792|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55813793|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813794|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813796|NCT02161731|Evacetrapib|evacetrapib|mesh-list
55813797|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
55813798|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55813799|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55813800|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
55813801|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813802|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55813803|NCT02124759|Sevelamer|sevelamer|mesh-list
55813804|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
55813805|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
55813806|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813807|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
55813808|NCT02302339|Nivolumab|nivolumab|mesh-list
55813809|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
55813810|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55813811|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55813812|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813813|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55813814|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813815|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
55813816|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813817|NCT04895917|Daratumumab|daratumumab|mesh-list
55813866|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55813867|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
55813868|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813869|NCT02123511|Protective Agents|protective agents|mesh-ancestor
55813870|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813871|NCT02123511|Antidotes|antidotes|mesh-ancestor
55813872|NCT04746339|Apixaban|apixaban|mesh-list
55813873|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55813874|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
55813875|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55813876|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
55813877|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813878|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813881|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55813882|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
55813883|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813884|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813885|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55813887|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
55813888|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55813889|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813890|NCT02333383|Adalimumab|adalimumab|mesh-list
55813891|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55813893|NCT02369341|Vaccines|vaccines|mesh-list
55813894|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
55813895|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813896|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55813897|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
55813898|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55813899|NCT02158533|Naltrexone|naltrexone|mesh-list
55813900|NCT02158533|Buprenorphine|buprenorphine|mesh-list
55813954|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813955|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
55813956|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55813957|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
55813958|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813959|NCT05319431|Lenvatinib|lenvatinib|mesh-list
55813960|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813961|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55813962|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55813963|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55813964|NCT05276531|Progesterone|progesterone|mesh-list
55813965|NCT05276531|Progestins|progestins|mesh-ancestor
55813966|NCT05276531|Hormones|hormones|mesh-ancestor
55813969|NCT01658579|Insulin|insulin|mesh-list
55813972|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55813973|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813975|NCT05561309|Anesthetics, Local|anesthetics, local|mesh-ancestor
55813976|NCT05561309|Anesthetics|anesthetics|mesh-ancestor
55813977|NCT05561309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813978|NCT05561309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55813979|NCT05561309|Sensory System Agents|sensory system agents|mesh-ancestor
55813980|NCT05561309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55813981|NCT05316467|Megestrol|megestrol|mesh-list
55813982|NCT05316467|Megestrol Acetate|megestrol acetate|mesh-list
55813983|NCT05316467|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55813984|NCT05316467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55813985|NCT05316467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55813986|NCT05316467|Contraceptive Agents|contraceptive agents|mesh-ancestor
55813987|NCT05316467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55813990|NCT05316467|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55813991|NCT05316467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55813992|NCT05316467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55813993|NCT05316467|Appetite Stimulants|appetite stimulants|mesh-ancestor
55813994|NCT05316467|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55813996|NCT05350085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55813997|NCT05350085|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55813998|NCT05350085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55813999|NCT05350085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814001|NCT05350085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55814002|NCT05350085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55814003|NCT05350085|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55814004|NCT05350085|Anesthetics, General|anesthetics, general|mesh-ancestor
55814005|NCT05350085|Anesthetics|anesthetics|mesh-ancestor
55814006|NCT05350085|GABA Modulators|gaba modulators|mesh-ancestor
55814007|NCT05350085|GABA Agents|gaba agents|mesh-ancestor
55814008|NCT05350085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814009|NCT05350085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814010|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
55814012|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55814013|NCT02155647|Avelumab|avelumab|mesh-list
55814014|NCT02155647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55814015|NCT02155647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814016|NCT05266859|Calcium|calcium|mesh-list
55814017|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55814018|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814019|NCT05346731|Dexamethasone|dexamethasone|mesh-list
55814020|NCT05346731|Ondansetron|ondansetron|mesh-list
55814021|NCT05346731|Olanzapine|olanzapine|mesh-list
55814022|NCT05346731|Aprepitant|aprepitant|mesh-list
55814023|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814024|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
55814025|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
55814026|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814027|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814028|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55814029|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
55814030|NCT05346731|Hormones|hormones|mesh-ancestor
55814031|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814032|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55814033|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814034|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
55814035|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
55814036|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55814037|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
55814038|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814039|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814118|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55814119|NCT05254925|Protective Agents|protective agents|mesh-ancestor
55814120|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814129|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814130|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55793035|NCT05538819|Glimepiride|glimepiride|mesh-list
55814131|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55814134|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814135|NCT05253053|Paclitaxel|paclitaxel|mesh-list
55814136|NCT05253053|Atezolizumab|atezolizumab|mesh-list
55814137|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55814138|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814139|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
55814140|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
55814141|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
55814142|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814143|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55814145|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55814146|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814147|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814148|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55814149|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814150|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814151|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
55814152|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814153|NCT05252429|Docetaxel|docetaxel|mesh-list
55814154|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
55814155|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814156|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
55814157|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
55814159|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814160|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55814161|NCT05158517|Vedolizumab|vedolizumab|mesh-list
55814162|NCT05158517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55814163|NCT05157971|Cytarabine|cytarabine|mesh-list
55814164|NCT05157971|Prednisone|prednisone|mesh-list
55814165|NCT05157971|Cortisone|cortisone|mesh-list
55814166|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
55814167|NCT05157971|Methotrexate|methotrexate|mesh-list
55814168|NCT05157971|Vincristine|vincristine|mesh-list
55814169|NCT05157971|Daunorubicin|daunorubicin|mesh-list
55814170|NCT05157971|Asparaginase|asparaginase|mesh-list
55814171|NCT05157971|Venetoclax|venetoclax|mesh-list
55814172|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
55814173|NCT05157971|Pegaspargase|pegaspargase|mesh-list
55814174|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55814175|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
55814176|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814177|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55814178|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55814179|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
55814180|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814181|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814182|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55814213|NCT05250791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55814214|NCT05250791|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55814215|NCT05250791|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55814216|NCT05250791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814217|NCT05250791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814218|NCT02175771|Fluticasone|fluticasone|mesh-list
55814219|NCT02175771|Xhance|xhance|mesh-list
55814220|NCT02175771|Albuterol|albuterol|mesh-list
55814221|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55814222|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55814223|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
55814224|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814225|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55814226|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
55814227|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814228|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814229|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55814230|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
55814231|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
55814232|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55814233|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55814234|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55814235|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
55814236|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814237|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814238|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
55814239|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55814240|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
55814247|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814248|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814250|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55814251|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814252|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55814253|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55814254|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
55814255|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814256|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814257|NCT02115321|Grazoprevir|grazoprevir|mesh-list
55814258|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
55814259|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814261|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55814262|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814263|NCT05248139|Prednisolone|prednisolone|mesh-list
55814264|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55814265|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
55814266|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55814267|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
55814269|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55814270|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55814271|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55814275|NCT05248139|Hormones|hormones|mesh-ancestor
55814295|NCT05247905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814296|NCT05247905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55814297|NCT05247905|Alkylating Agents|alkylating agents|mesh-ancestor
55814305|NCT05154383|Vaccines|vaccines|mesh-list
55814306|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
55814307|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814308|NCT05196815|Dobutamine|dobutamine|mesh-list
55814309|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55814310|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
55814311|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
55814312|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814313|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814314|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55814315|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55814316|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55814317|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
55814318|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814319|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814322|NCT05245877|Dalteparin|dalteparin|mesh-list
55814323|NCT05245877|Tinzaparin|tinzaparin|mesh-list
55814324|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55814325|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
55814326|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55814327|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55814328|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814329|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
55814330|NCT02367781|Paclitaxel|paclitaxel|mesh-list
55814335|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55814336|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55814337|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793086|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
55814338|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
55814339|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
55814340|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
55814341|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814342|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
55814343|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814344|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814345|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55814346|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55814348|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55814349|NCT04242173|Cemiplimab|cemiplimab|mesh-list
55814350|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55814351|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814352|NCT05189015|Olmesartan|olmesartan|mesh-list
55814390|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55814391|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814393|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55814394|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
55814395|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55814396|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
55814397|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814398|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797253|NCT05677373|Trametinib|trametinib|mesh-list
55814437|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814438|NCT05181605|Folfirinox|folfirinox|mesh-list
55814439|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814440|NCT04883281|Paclitaxel|paclitaxel|mesh-list
55814441|NCT04883281|Carboplatin|carboplatin|mesh-list
55814442|NCT04883281|Cetuximab|cetuximab|mesh-list
55814443|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55814444|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814445|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
55814446|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
55814456|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
55814484|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814485|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55814486|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
55814488|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
55814489|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55814490|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814493|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55814494|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814495|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55814496|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55814497|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814498|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814499|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55814500|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
55814501|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814502|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814504|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55814505|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814506|NCT05174039|Miglustat|miglustat|mesh-list
55814507|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814508|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814510|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55814511|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
55814512|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814513|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55814514|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55814515|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814516|NCT05138549|Beta Carotene|beta carotene|mesh-list
55814517|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814518|NCT05138549|Provitamins|provitamins|mesh-ancestor
55814519|NCT05138549|Vitamins|vitamins|mesh-ancestor
55814520|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
55814521|NCT04241549|Azacitidine|azacitidine|mesh-list
55814522|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55814523|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
55814524|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814525|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814526|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814527|NCT02175225|Deferoxamine|deferoxamine|mesh-list
55814528|NCT02175225|Siderophores|siderophores|mesh-ancestor
55814529|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55814530|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
55814531|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
55814532|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814533|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55814534|NCT05170841|Tramadol|tramadol|mesh-list
55814535|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55814536|NCT05170841|Narcotics|narcotics|mesh-ancestor
55814537|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814538|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814539|NCT05170841|Analgesics|analgesics|mesh-ancestor
55814540|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
55814541|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814542|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55814543|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55814544|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814545|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55814547|NCT02152137|Efatutazone|efatutazone|mesh-list
55814548|NCT02152137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55814549|NCT02152137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814550|NCT02152137|Tubulin Modulators|tubulin modulators|mesh-ancestor
55814551|NCT02152137|Antimitotic Agents|antimitotic agents|mesh-ancestor
55814552|NCT02152137|Mitosis Modulators|mitosis modulators|mesh-ancestor
55814553|NCT02152137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814554|NCT05135273|Vaccines|vaccines|mesh-list
55814555|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
55814556|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814557|NCT02299375|Albuterol|albuterol|mesh-list
55814558|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55814559|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
55814560|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814561|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814562|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55814563|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
55814564|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
55814565|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55814566|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55814567|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55814568|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55814569|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
55814570|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814571|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814572|NCT02151591|Varenicline|varenicline|mesh-list
55814573|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55814574|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55814575|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
55814576|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814577|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814578|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814579|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55814580|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55814581|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55814582|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814583|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814584|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55814585|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55814586|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55814587|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55814588|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
55814589|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814590|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814591|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55814592|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55814593|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
55814594|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55814595|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55814605|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
55814606|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
55814607|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814608|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
55814609|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814610|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814611|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55814612|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55814613|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814614|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
55814615|NCT02114385|Vaccines|vaccines|mesh-list
55814616|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
55814617|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814618|NCT05098457|Lidocaine|lidocaine|mesh-list
55814619|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
55814620|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
55814621|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814622|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814623|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
55814624|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814625|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55814626|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55814860|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
55814627|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55814628|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814629|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814630|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
55814631|NCT02114151|Simeprevir|simeprevir|mesh-list
55814632|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
55814633|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814634|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
55814635|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814636|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814637|NCT05220293|Betamethasone|betamethasone|mesh-list
55814638|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
55814645|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814646|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814647|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55814648|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
55814649|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
55814650|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55814651|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
55814652|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55814653|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814654|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814655|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
55814656|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814657|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814658|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55814659|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
55814660|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
55814661|NCT02297503|Protective Agents|protective agents|mesh-ancestor
55814664|NCT05096663|Hydroxocobalamin|hydroxocobalamin|mesh-list
55814665|NCT05096663|Vitamin B 12|vitamin b 12|mesh-list
55814666|NCT05096663|Vitamin B Complex|vitamin b complex|mesh-list
55814667|NCT05096663|Gemcitabine|gemcitabine|mesh-list
55814668|NCT05096663|Dexamethasone|dexamethasone|mesh-list
55814669|NCT05096663|Dexamethasone acetate|dexamethasone acetate|mesh-list
55814670|NCT05096663|Docetaxel|docetaxel|mesh-list
55814671|NCT05096663|Pembrolizumab|pembrolizumab|mesh-list
55814672|NCT05096663|Pemetrexed|pemetrexed|mesh-list
55814673|NCT05096663|Ramucirumab|ramucirumab|mesh-list
55814674|NCT05096663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55814675|NCT05096663|Antibodies|antibodies|mesh-list
55814676|NCT05096663|Immunoglobulins|immunoglobulins|mesh-list
55814677|NCT05096663|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55814678|NCT05096663|Lexatumumab|lexatumumab|mesh-list
55814679|NCT05096663|BB 1101|bb 1101|mesh-list
55814680|NCT05096663|Micronutrients|micronutrients|mesh-ancestor
55814681|NCT05096663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814682|NCT05096663|Immunologic Factors|immunologic factors|mesh-ancestor
55814683|NCT05096663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814685|NCT05096663|Autonomic Agents|autonomic agents|mesh-ancestor
55814686|NCT05096663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814687|NCT05096663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55814688|NCT05096663|Glucocorticoids|glucocorticoids|mesh-ancestor
55814689|NCT05096663|Hormones|hormones|mesh-ancestor
55814690|NCT05096663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814691|NCT05096663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55814692|NCT05096663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814693|NCT05096663|Protease Inhibitors|protease inhibitors|mesh-ancestor
55814694|NCT05096663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814695|NCT05096663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814696|NCT05096663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55814697|NCT05096663|Antimetabolites|antimetabolites|mesh-ancestor
55814700|NCT05096663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55814701|NCT05096663|Tubulin Modulators|tubulin modulators|mesh-ancestor
55814702|NCT05096663|Antimitotic Agents|antimitotic agents|mesh-ancestor
55814703|NCT05096663|Mitosis Modulators|mitosis modulators|mesh-ancestor
55814704|NCT05096663|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55814705|NCT05096663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55814707|NCT02366767|Insulin|insulin|mesh-list
55814708|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55814709|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814710|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
55814711|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
55814712|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55814713|NCT02149875|Protective Agents|protective agents|mesh-ancestor
55814714|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814715|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
55815027|NCT04991597|Lidocaine|lidocaine|mesh-list
55814716|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55814717|NCT05095961|Prednisone|prednisone|mesh-list
55814718|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814719|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
55814720|NCT05095961|Hormones|hormones|mesh-ancestor
55814721|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814722|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814723|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55814724|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814725|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
55814726|NCT05124899|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55814727|NCT05124899|Protective Agents|protective agents|mesh-ancestor
55814729|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
55814742|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814743|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814744|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55814745|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55814746|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
55814747|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814748|NCT02147691|Azelaic acid|azelaic acid|mesh-list
55814749|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55814750|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55814751|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55814752|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55814753|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55814754|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
55814755|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814756|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814757|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814758|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814759|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
55814760|NCT01655693|Doxorubicin|doxorubicin|mesh-list
55814761|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55814762|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55814763|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814764|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55814765|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55814766|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814767|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814768|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
55814787|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55814791|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814793|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55814794|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814795|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55814796|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
55797261|NCT05041907|Ivermectin|ivermectin|mesh-list
55814800|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814802|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814834|NCT05075993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55814835|NCT05075993|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55814836|NCT05075993|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55814837|NCT05075993|Growth Substances|growth substances|mesh-ancestor
55814838|NCT05075993|Growth Inhibitors|growth inhibitors|mesh-ancestor
55814839|NCT04757883|Antibodies|antibodies|mesh-list
55814840|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
55814841|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814842|NCT04751877|Dexamethasone|dexamethasone|mesh-list
55814843|NCT04751877|Lenalidomide|lenalidomide|mesh-list
55814844|NCT04751877|Bortezomib|bortezomib|mesh-list
55814845|NCT04751877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55814846|NCT04751877|Antiemetics|antiemetics|mesh-ancestor
55814848|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814849|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814850|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55814851|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
55814852|NCT04751877|Hormones|hormones|mesh-ancestor
55814853|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814854|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55814855|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814856|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
55814857|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55814858|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55814859|NCT04751877|Growth Substances|growth substances|mesh-ancestor
55814877|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814878|NCT02106975|Protective Agents|protective agents|mesh-ancestor
55814879|NCT05133765|Insulin|insulin|mesh-list
55814880|NCT05133765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55814881|NCT05133765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814882|NCT02520011|Cytarabine|cytarabine|mesh-list
55814883|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
55814884|NCT02520011|Alvocidib|alvocidib|mesh-list
55814885|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55814886|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
55814887|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814888|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814890|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55814891|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55814892|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
55814893|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814894|NCT02520011|Analgesics|analgesics|mesh-ancestor
55814895|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
55814896|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814897|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55814898|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55814899|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814900|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
55814927|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55814928|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814930|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55814931|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55814932|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55814933|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55814934|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814935|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
55814936|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814937|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814938|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55814939|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814941|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55814942|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814943|NCT01364597|Brivaracetam|brivaracetam|mesh-list
55814948|NCT04218539|Hallucinogens|hallucinogens|mesh-ancestor
55814950|NCT04218539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55814978|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55814979|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55814980|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55814982|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55814983|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55814984|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814985|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55814986|NCT05025605|Analgesics|analgesics|mesh-ancestor
55814987|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
55793290|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55814988|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55814989|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55814990|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55814991|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55814992|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
55814993|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55814994|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55814995|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
55814997|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55814998|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55814999|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55815000|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
55815001|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815002|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815003|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55815004|NCT05024747|Nicotine|nicotine|mesh-list
55815005|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55815006|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
55815021|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55815022|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815023|NCT05055323|Pyrvinium|pyrvinium|mesh-list
55815024|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
55815025|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55815026|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815068|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815069|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815070|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55815071|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55815078|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815080|NCT02141997|Adalimumab|adalimumab|mesh-list
55815081|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815082|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815083|NCT04411433|Azithromycin|azithromycin|mesh-list
55815084|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
55815085|NCT04411433|Favipiravir|favipiravir|mesh-list
55815086|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55815087|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815088|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
55815089|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55815090|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55815091|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815092|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815093|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815094|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
55815096|NCT04987463|Vigabatrin|vigabatrin|mesh-list
55815097|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55815107|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815109|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815110|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
55815111|NCT05012735|Provitamins|provitamins|mesh-list
55815112|NCT05012735|Vitamins|vitamins|mesh-ancestor
55815113|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
55815114|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815115|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
55815116|NCT02519777|Maraviroc|maraviroc|mesh-list
55815117|NCT02519777|Dolutegravir|dolutegravir|mesh-list
55815118|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55815119|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55815120|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815121|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55815122|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55815123|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
55815125|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55815126|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55815127|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55815128|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815129|NCT05008913|Adavosertib|adavosertib|mesh-list
55815130|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815131|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815132|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55815133|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55815134|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815135|NCT04982705|Incretins|incretins|mesh-ancestor
55815136|NCT04982705|Hormones|hormones|mesh-ancestor
55815137|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815138|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55815139|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
55815140|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815141|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815142|NCT04944095|Antibodies|antibodies|mesh-list
55815143|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
55815144|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815145|NCT02141295|Leucovorin|leucovorin|mesh-list
55815146|NCT02141295|Folic Acid|folic acid|mesh-list
55815147|NCT02141295|Bevacizumab|bevacizumab|mesh-list
55815148|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
55815149|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
55815150|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55815151|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815152|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55815154|NCT02141295|Growth Substances|growth substances|mesh-ancestor
55815176|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
55815177|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55815178|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55815179|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815180|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55815181|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815182|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815183|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55815184|NCT02514473|Ivacaftor|ivacaftor|mesh-list
55815185|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55815186|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55815187|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815188|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55815189|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55815190|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815191|NCT02513771|Incretins|incretins|mesh-ancestor
55815192|NCT02513771|Hormones|hormones|mesh-ancestor
55815193|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815195|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
55815196|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815197|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815198|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55815199|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
55815200|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815202|NCT04725201|Calcium heparin|calcium heparin|mesh-list
55815203|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
55815204|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55815205|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55815206|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815207|NCT02069379|Metformin|metformin|mesh-list
55815208|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55815209|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815211|NCT02511431|Lonafarnib|lonafarnib|mesh-list
55815212|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55815213|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55815214|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
55815215|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815216|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815217|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55815218|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55815219|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
55815220|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815221|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55815222|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55815224|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55815225|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
55815226|NCT05003453|Palmidrol|palmidrol|mesh-list
55815227|NCT05003453|Analgesics|analgesics|mesh-ancestor
55815228|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
55815229|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815230|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815231|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55815232|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55815233|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815234|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815235|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
55815236|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815237|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55815238|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55815239|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815240|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815241|NCT05003453|Hormones|hormones|mesh-ancestor
55815242|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815243|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
55815244|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55815245|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55815246|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
55815247|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815248|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815249|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815251|NCT01654601|Clozapine|clozapine|mesh-list
55815252|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55815253|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
55815254|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815255|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815256|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815257|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55815258|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55815259|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815260|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55815288|NCT02508935|Sensory System Agents|sensory system agents|mesh-ancestor
55815289|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815367|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
55815290|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55815291|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55815292|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815293|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815294|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55815295|NCT02507375|Pertuzumab|pertuzumab|mesh-list
55815296|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815297|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55815298|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815299|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815300|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55815302|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55815303|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55815304|NCT02507219|Analgesics|analgesics|mesh-ancestor
55815306|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815307|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815308|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815309|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815310|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55815311|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815312|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815313|NCT02483975|Albuterol|albuterol|mesh-list
55815314|NCT02483975|Montelukast|montelukast|mesh-list
55815315|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55815316|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
55815317|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55815318|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
55815319|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815320|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815321|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55815322|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55815323|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815324|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55815325|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
55815326|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815327|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
55815330|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55815331|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55815332|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
55815333|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815334|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55815335|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55815336|NCT02047227|Hormones|hormones|mesh-ancestor
55815337|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815338|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815339|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55815340|NCT02483585|Erenumab|erenumab|mesh-list
55815341|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55815342|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815343|NCT02483585|Analgesics|analgesics|mesh-ancestor
55815344|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
55815345|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815346|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815347|NCT02101983|Cytarabine|cytarabine|mesh-list
55815348|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55815349|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
55815350|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815351|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815352|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
55815353|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815354|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55815355|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
55815356|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815357|NCT04974281|Lenvatinib|lenvatinib|mesh-list
55815358|NCT04974281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815359|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55815360|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815361|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815362|NCT02503865|Orlistat|orlistat|mesh-list
55815363|NCT02503865|Diltiazem|diltiazem|mesh-list
55815364|NCT02503865|Atorvastatin|atorvastatin|mesh-list
55815365|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55815366|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55815368|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815369|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55815370|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55815371|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815372|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55793588|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815373|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55815374|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55815375|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55815376|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815377|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
55815378|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55815382|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55815383|NCT02481947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815384|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55815386|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55815387|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55815388|NCT02503085|Analgesics|analgesics|mesh-ancestor
55815389|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
55815390|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815391|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815392|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815393|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815394|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55815395|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815396|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815397|NCT02502149|Factor VIII|factor viii|mesh-list
55815398|NCT02502149|Coagulants|coagulants|mesh-ancestor
55815399|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55815400|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815404|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815405|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815406|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
55815407|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815408|NCT02046603|Methotrexate|methotrexate|mesh-list
55815409|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55815410|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
55815411|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55815412|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815413|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55815414|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
55815415|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815416|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815417|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
55815418|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815419|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55815420|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55815421|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
55815422|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815423|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55815424|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55815425|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55815426|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55815427|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793679|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55815428|NCT02046369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815429|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55815430|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55815431|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55815432|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55815433|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
55815434|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815435|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815436|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55815437|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55815438|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
55815439|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55815440|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55815441|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
55815443|NCT02101359|Tropicamide|tropicamide|mesh-list
55815445|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
55815532|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815533|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815535|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55815536|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815537|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815538|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
55815539|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815549|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815550|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
55815551|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815552|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815553|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55815554|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815556|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55815557|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
55815558|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55815559|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
55815560|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815561|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815562|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
55815563|NCT02100657|Dexamethasone|dexamethasone|mesh-list
55815591|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
55815592|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55815593|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
55815594|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815595|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815596|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55815598|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55815599|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55815600|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55815602|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
55815603|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55815604|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55815605|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815606|NCT01926886|Trastuzumab|trastuzumab|mesh-list
55815607|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55815608|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815609|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55815610|NCT01925950|Beclomethasone|beclomethasone|mesh-list
55815611|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815612|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
55815613|NCT01925950|Hormones|hormones|mesh-ancestor
55815614|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815615|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815616|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55815617|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
55815618|NCT04415320|Ensartinib|ensartinib|mesh-list
55815619|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815620|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55815621|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815622|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815632|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815633|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55815634|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55815642|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55815643|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
55815644|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815645|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815647|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815648|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815649|NCT04972253|Infigratinib|infigratinib|mesh-list
55815650|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815651|NCT02500979|Insulin|insulin|mesh-list
55815652|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55815653|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
55815654|NCT02500979|Pramlintide|pramlintide|mesh-list
55815655|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
55815683|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815684|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
55815685|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55815686|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815688|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55815690|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815691|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55815692|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55815693|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55815694|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815695|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
55815696|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
55815697|NCT01876732|Vitamins|vitamins|mesh-ancestor
55815698|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
55815699|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815700|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
55815701|NCT01876732|Hematinics|hematinics|mesh-ancestor
55815702|NCT01905592|Niraparib|niraparib|mesh-list
55815703|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55815704|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815705|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815706|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815707|NCT04627870|Paclitaxel|paclitaxel|mesh-list
55815708|NCT04627870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55815709|NCT04627870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815731|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55815732|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55793917|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815733|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55815734|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815735|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
55815736|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815737|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815738|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55815739|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815741|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55815742|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815743|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815744|NCT01903720|Dexamethasone|dexamethasone|mesh-list
55815745|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815746|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
55815748|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815751|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
55815752|NCT01903720|Hormones|hormones|mesh-ancestor
55815753|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55815754|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55815755|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815756|NCT02366689|Triclosan|triclosan|mesh-list
55815765|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55815766|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55815767|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
55815768|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815769|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55815770|NCT01903252|Mesalamine|mesalamine|mesh-list
55815771|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55815772|NCT01903252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55815773|NCT01903252|Analgesics|analgesics|mesh-ancestor
55815774|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
55815775|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815776|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815777|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815778|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815779|NCT01613716|Dexamethasone|dexamethasone|mesh-list
55815780|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815781|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
55815782|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
55815783|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815784|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815785|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55815786|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
55815787|NCT01613716|Hormones|hormones|mesh-ancestor
55815789|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55815809|NCT04415476|Antitubercular Agents|antitubercular agents|mesh-ancestor
55815810|NCT04415476|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55815811|NCT04415476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815812|NCT04415476|Antifungal Agents|antifungal agents|mesh-ancestor
55815814|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55815815|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794231|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815816|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815817|NCT01872910|Celecoxib|celecoxib|mesh-list
55815818|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55815819|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55815820|NCT01872910|Analgesics|analgesics|mesh-ancestor
55815821|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
55815822|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815823|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815824|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815825|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815826|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55815827|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55815828|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815829|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815835|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
55815836|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815837|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55815838|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55815839|NCT01901848|Bupropion|bupropion|mesh-list
55815840|NCT01901848|Nicotine|nicotine|mesh-list
55815841|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55815842|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
55815843|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815844|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815845|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55815846|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55794129|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
55815847|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
55815848|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815849|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815850|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55815851|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
55815852|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55815853|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55815854|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55815855|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55815856|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
55815857|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55815858|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55815859|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815860|NCT01901614|Anesthetics|anesthetics|mesh-list
55815861|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815862|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815863|NCT02499575|Bupivacaine|bupivacaine|mesh-list
55815864|NCT02499575|Ropivacaine|ropivacaine|mesh-list
55815865|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
55815866|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
55815867|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815868|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815869|NCT02499575|Sensory System Agents|sensory system agents|mesh-ancestor
55815870|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55815871|NCT02065791|Canagliflozin|canagliflozin|mesh-list
55815872|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55815873|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815874|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55815875|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815876|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
55815877|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55815878|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
55815881|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
55815882|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55815883|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
55815884|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815885|NCT02499029|Protective Agents|protective agents|mesh-ancestor
55815886|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815887|NCT02499029|Antidotes|antidotes|mesh-ancestor
55815888|NCT04939883|Carvedilol|carvedilol|mesh-list
55815889|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55815890|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55815891|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
55794170|NCT05635357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794171|NCT05635357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55794172|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
55815920|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55815921|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55815922|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815925|NCT02497781|Avibactam|avibactam|mesh-list
55815926|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
55815927|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55797295|NCT05674253|Hydrocortisone|hydrocortisone|mesh-list
55794391|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
55794392|NCT05209425|Vitamins|vitamins|mesh-ancestor
55794393|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
55794394|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794395|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55794396|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55815930|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815931|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815932|NCT02497469|Adalimumab|adalimumab|mesh-list
55815933|NCT02497469|Vedolizumab|vedolizumab|mesh-list
55815934|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55815935|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815936|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55815937|NCT02497391|Evacetrapib|evacetrapib|mesh-list
55815938|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55815939|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55815940|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
55815941|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815942|NCT02497391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55815943|NCT02476175|Mirabegron|mirabegron|mesh-list
55815944|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55815945|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55815946|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55815947|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
55815948|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55815949|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815950|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815951|NCT02476175|Urological Agents|urological agents|mesh-ancestor
55815952|NCT02065557|Adalimumab|adalimumab|mesh-list
55815954|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55815955|NCT02065245|Penicillins|penicillins|mesh-list
55815956|NCT02065245|Streptomycin|streptomycin|mesh-list
55815957|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55815958|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55815959|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55815960|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55815961|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815962|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
55815963|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55815964|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55815965|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
55815966|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
55815967|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55815968|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815969|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55815970|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55815971|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
55815973|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
55815974|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815975|NCT04182555|Protective Agents|protective agents|mesh-ancestor
55815976|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55815977|NCT02366143|Paclitaxel|paclitaxel|mesh-list
55815978|NCT02366143|Bevacizumab|bevacizumab|mesh-list
55815979|NCT02366143|Carboplatin|carboplatin|mesh-list
55815980|NCT02366143|Atezolizumab|atezolizumab|mesh-list
55815981|NCT02366143|Antibodies|antibodies|mesh-list
55815982|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55815983|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55815984|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55815985|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
55815986|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
55815987|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
55815988|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55815989|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55815990|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55815991|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55815992|NCT02366143|Growth Substances|growth substances|mesh-ancestor
55815993|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816105|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55816106|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55816107|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55816108|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55816109|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816110|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816112|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55816113|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816114|NCT04420351|Aspirin|aspirin|mesh-list
55816115|NCT04420351|Clopidogrel|clopidogrel|mesh-list
55816116|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55816117|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55816118|NCT04420351|Analgesics|analgesics|mesh-ancestor
55816119|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
55816120|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816121|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816122|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816123|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816124|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55816125|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55816126|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816127|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55816128|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55816129|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816130|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
55816131|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55816132|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55816133|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55816134|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
55816135|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816136|NCT01864018|Dexamethasone|dexamethasone|mesh-list
55816137|NCT01864018|Dexamethasone acetate|dexamethasone acetate|mesh-list
55816138|NCT01864018|Cyclophosphamide|cyclophosphamide|mesh-list
55816139|NCT01864018|Ixazomib|ixazomib|mesh-list
55816140|NCT01864018|Ichthammol|ichthammol|mesh-list
55816141|NCT01864018|BB 1101|bb 1101|mesh-list
55816142|NCT01864018|Glycine|glycine|mesh-list
55816143|NCT01864018|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55816144|NCT01864018|Immunologic Factors|immunologic factors|mesh-ancestor
55816145|NCT01864018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816146|NCT01864018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816154|NCT01864018|Autonomic Agents|autonomic agents|mesh-ancestor
55816155|NCT01864018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816156|NCT01864018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816157|NCT01864018|Glucocorticoids|glucocorticoids|mesh-ancestor
55816158|NCT01864018|Hormones|hormones|mesh-ancestor
55816159|NCT01864018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816160|NCT01864018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55816161|NCT01864018|Protease Inhibitors|protease inhibitors|mesh-ancestor
55816162|NCT01864018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816163|NCT01864018|Dermatologic Agents|dermatologic agents|mesh-ancestor
55816164|NCT01864018|Glycine Agents|glycine agents|mesh-ancestor
55816165|NCT01864018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816166|NCT01900444|Vaccines|vaccines|mesh-list
55816167|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
55816168|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816169|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
55816170|NCT02496221|Incretins|incretins|mesh-ancestor
55816171|NCT02496221|Hormones|hormones|mesh-ancestor
55816172|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816173|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816174|NCT04967495|Sorafenib|sorafenib|mesh-list
55816175|NCT04967495|Lenvatinib|lenvatinib|mesh-list
55816176|NCT04967495|Chlorotrianisene|chlorotrianisene|mesh-list
55816177|NCT04967495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816179|NCT04967495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816180|NCT04967495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816181|NCT04967495|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55816182|NCT04967495|Estrogens|estrogens|mesh-ancestor
55816183|NCT04967495|Hormones|hormones|mesh-ancestor
55816184|NCT04967495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816186|NCT04967495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55816187|NCT02475629|Ibalizumab|ibalizumab|mesh-list
55816188|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55816189|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55816190|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
55816192|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55816193|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55816195|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816196|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816197|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55816199|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816200|NCT02322775|Benralizumab|benralizumab|mesh-list
55816201|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55816202|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
55816203|NCT01646827|Aripiprazole|aripiprazole|mesh-list
55816204|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
55816205|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55816206|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55816207|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55816208|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816209|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816210|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
55816211|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
55816212|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816213|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816214|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55816215|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55816217|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55816218|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55816219|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55816220|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55816222|NCT02494583|Capecitabine|capecitabine|mesh-list
55816223|NCT02494583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816224|NCT02494583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55816225|NCT02494583|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55816226|NCT02494583|Antimetabolites|antimetabolites|mesh-ancestor
55816227|NCT02494583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816228|NCT02360995|Triclosan|triclosan|mesh-list
55816229|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
55816230|NCT02360995|Fluorides|fluorides|mesh-list
55816231|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
55816232|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
55816233|NCT02360995|Protective Agents|protective agents|mesh-ancestor
55816234|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816235|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55816236|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816237|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55816238|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55816239|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
55816240|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816241|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55816242|NCT02359903|Infliximab|infliximab|mesh-list
55816243|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
55816244|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816245|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816246|NCT02291419|Aspirin|aspirin|mesh-list
55816247|NCT02291419|Ticagrelor|ticagrelor|mesh-list
55816248|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55816249|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55816250|NCT02291419|Analgesics|analgesics|mesh-ancestor
55816251|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
55816252|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816253|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816254|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816255|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816256|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55816257|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55816258|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816259|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55816260|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55816262|NCT02291419|Antipyretics|antipyretics|mesh-ancestor
55816263|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55816264|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55816265|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55816266|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
55816267|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816268|NCT02319031|Ribavirin|ribavirin|mesh-list
55816269|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
55816270|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
55816271|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816421|NCT02318095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816422|NCT02317627|Belumosudil|belumosudil|mesh-list
55816423|NCT02317627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55816425|NCT02317627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816426|NCT02517905|Bupivacaine|bupivacaine|mesh-list
55816427|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
55816428|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
55816429|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816430|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816431|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
55816432|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816434|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
55816435|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816436|NCT02473913|Protective Agents|protective agents|mesh-ancestor
55816437|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816438|NCT02316847|Diazepam|diazepam|mesh-list
55816439|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55816440|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
55816441|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
55816442|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
55816443|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816444|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816445|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816446|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55816447|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816448|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55816449|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55816450|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55816451|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55816452|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55816453|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55816454|NCT02316847|Anesthetics, General|anesthetics, general|mesh-ancestor
55816455|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
55816456|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
55816457|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
55816458|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816459|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816460|NCT02473445|Cysteamine|cysteamine|mesh-list
55816461|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
55816462|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816463|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
55816464|NCT02473367|Antacids|antacids|mesh-list
55816465|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55816466|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55816467|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
55816468|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816470|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55816475|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816476|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55816478|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816479|NCT02316613|Rituximab|rituximab|mesh-list
55816480|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55816481|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816482|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
55816483|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816484|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816485|NCT02492165|Vaccines|vaccines|mesh-list
55816486|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
55816487|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797315|NCT02500641|Febuxostat|febuxostat|mesh-list
55816489|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
55816490|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816491|NCT02286895|Vaccines|vaccines|mesh-list
55816492|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
55816493|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816494|NCT02472977|Nivolumab|nivolumab|mesh-list
55816495|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55816496|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816497|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55816498|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816499|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
55816500|NCT02060487|Citric Acid|citric acid|mesh-list
55816501|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
55816502|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
55816503|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55816504|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
55816586|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816587|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816588|NCT01860040|Gemcitabine|gemcitabine|mesh-list
55816589|NCT01860040|Pemetrexed|pemetrexed|mesh-list
55816590|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816591|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55816592|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
55816593|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816594|NCT01860040|Antiviral Agents|antiviral agents|mesh-ancestor
55816595|NCT01860040|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816597|NCT01860040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55816598|NCT01860040|Immunologic Factors|immunologic factors|mesh-ancestor
55816599|NCT01860040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816600|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55816601|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55816602|NCT04618744|Insulin|insulin|mesh-list
55816603|NCT04618744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55816604|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55816605|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816606|NCT01896934|Sertraline|sertraline|mesh-list
55816607|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
55816608|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55816609|NCT01896934|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55816610|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55816611|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55816612|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816613|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816614|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
55816615|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816617|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816618|NCT02095197|Triamcinolone|triamcinolone|mesh-list
55816619|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816620|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
55816621|NCT02095197|Hormones|hormones|mesh-ancestor
55816622|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816623|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816624|NCT02039427|Dexamethasone|dexamethasone|mesh-list
55816625|NCT02039427|Ketorolac|ketorolac|mesh-list
55816626|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816627|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
55816628|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
55816629|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816630|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816631|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816632|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
55816633|NCT02039427|Hormones|hormones|mesh-ancestor
55816634|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816635|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55816636|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794688|NCT04848857|Colchicine|colchicine|mesh-list
55816637|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55816638|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55816639|NCT02039427|Analgesics|analgesics|mesh-ancestor
55816640|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
55816641|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816642|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55816643|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816644|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816645|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55816646|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
55816647|NCT02094885|Coagulants|coagulants|mesh-ancestor
55816648|NCT01896856|Trifluridine|trifluridine|mesh-list
55816649|NCT01896856|Irinotecan|irinotecan|mesh-list
55816650|NCT01896856|Guadecitabine|guadecitabine|mesh-list
55816651|NCT01896856|Azacitidine|azacitidine|mesh-list
55816652|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55816672|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816673|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
55816674|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
55816675|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816677|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55816678|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816679|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816680|NCT02058537|Bethanechol|bethanechol|mesh-list
55816681|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55816682|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
55816683|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816684|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816685|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55816686|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55816687|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
55816688|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816689|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816690|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
55816691|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
55816692|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
55816693|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816694|NCT02409680|Aspirin|aspirin|mesh-list
55816695|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55816696|NCT02409680|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55816697|NCT02409680|Analgesics|analgesics|mesh-ancestor
55816698|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
55816699|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816700|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816701|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816702|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816703|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55816704|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55816705|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816706|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55816707|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55816708|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816709|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
55816710|NCT01894984|Risperidone|risperidone|mesh-list
55816711|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
55816712|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55816713|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
55816714|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816715|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816716|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816729|NCT02038881|Immunologic Factors|immunologic factors|mesh-ancestor
55816730|NCT02038881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816732|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55816733|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
55816734|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55816735|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
55816736|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816737|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816738|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
55816739|NCT01857310|Folic Acid|folic acid|mesh-list
55816740|NCT01857310|Hematinics|hematinics|mesh-ancestor
55816741|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
55816742|NCT01857310|Vitamins|vitamins|mesh-ancestor
55816743|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
55816744|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816745|NCT02472353|Metformin|metformin|mesh-list
55816746|NCT02472353|Doxorubicin|doxorubicin|mesh-list
55816747|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55816748|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816749|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55816752|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55816753|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816755|NCT02314117|Fluorouracil|fluorouracil|mesh-list
55816756|NCT02314117|Capecitabine|capecitabine|mesh-list
55816757|NCT02314117|Ramucirumab|ramucirumab|mesh-list
55816758|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816759|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
55816760|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816761|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55816762|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55816763|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
55816764|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816765|NCT02058147|Insulin|insulin|mesh-list
55816766|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55816767|NCT02058147|Metformin|metformin|mesh-list
55816768|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
55816769|NCT02058147|Lixisenatide|lixisenatide|mesh-list
55816770|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55816771|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816772|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
55816773|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55816774|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
55816775|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816776|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816777|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55816778|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
55816779|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
55816780|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55816781|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
55816782|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816783|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816784|NCT02471183|Selexipag|selexipag|mesh-list
55816785|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55816786|NCT04964063|Listerine|listerine|mesh-list
55816787|NCT04964063|Fluorides|fluorides|mesh-list
55816788|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
55816789|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
55816790|NCT04964063|Protective Agents|protective agents|mesh-ancestor
55816791|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816792|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55816793|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816794|NCT04204967|Fentanyl|fentanyl|mesh-list
55816795|NCT04204967|Remifentanil|remifentanil|mesh-list
55816796|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55816797|NCT04204967|Narcotics|narcotics|mesh-ancestor
55816798|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816799|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816800|NCT04204967|Analgesics|analgesics|mesh-ancestor
55816801|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
55816802|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816803|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55816804|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55816805|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
55816806|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
55816807|NCT01855828|Paclitaxel|paclitaxel|mesh-list
55816808|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
55816809|NCT01855828|Fluorouracil|fluorouracil|mesh-list
55816810|NCT01855828|Trastuzumab|trastuzumab|mesh-list
55816811|NCT01855828|Epirubicin|epirubicin|mesh-list
55816812|NCT01855828|Pertuzumab|pertuzumab|mesh-list
55816813|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55816814|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816818|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816819|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55816820|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
55816821|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816822|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816823|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55816824|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
55816825|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55816826|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
55816827|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55816828|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55816829|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55816830|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55816831|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55816832|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816833|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
55816834|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55816835|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
55816836|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816837|NCT02351167|Nicotine|nicotine|mesh-list
55816838|NCT02351167|Varenicline|varenicline|mesh-list
55816839|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55816840|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
55816841|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816842|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816843|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55816844|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55816845|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
55816846|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816847|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816848|NCT02350309|Lemborexant|lemborexant|mesh-list
55816849|NCT02350309|Flurazepam|flurazepam|mesh-list
55816850|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55816851|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816852|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816853|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55816854|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55816855|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816856|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816858|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55816859|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55816860|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
55816861|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
55816862|NCT02038647|Paclitaxel|paclitaxel|mesh-list
55816863|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55816865|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
55816866|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
55816867|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
55816868|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816869|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
55816870|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55816871|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816872|NCT02037477|Esomeprazole|esomeprazole|mesh-list
55816873|NCT02037477|Rabeprazole|rabeprazole|mesh-list
55816874|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55816875|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816876|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55816877|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816878|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816879|NCT02057523|Hormones|hormones|mesh-list
55816880|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55816881|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55816882|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
55816883|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55816884|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816885|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55816886|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816887|NCT02037165|Celecoxib|celecoxib|mesh-list
55816888|NCT02037165|Pregabalin|pregabalin|mesh-list
55816889|NCT02037165|Analgesics|analgesics|mesh-ancestor
55816890|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
55797363|NCT03059719|Incretins|incretins|mesh-ancestor
55816891|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55816892|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816893|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
55816894|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55816895|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55816896|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816897|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55816898|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55816899|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55816900|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816901|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55816902|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55816903|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55816904|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55816905|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816906|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55816907|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55816908|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816909|NCT02470403|Licogliflozin|licogliflozin|mesh-list
55816910|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55816911|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816912|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55816913|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816914|NCT01855750|Prednisone|prednisone|mesh-list
55816915|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
55816916|NCT01855750|Rituximab|rituximab|mesh-list
55816918|NCT01855750|Vincristine|vincristine|mesh-list
55816919|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55816920|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
55816921|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816922|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55816923|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55816924|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
55816925|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816926|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55816927|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55816928|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55816929|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55816930|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55816931|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55816980|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55816981|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
55816982|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55816983|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55816984|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55816985|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55816986|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55816987|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55816988|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55816989|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
55816990|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
55816991|NCT01622673|Protective Agents|protective agents|mesh-ancestor
55816993|NCT02469077|Naloxone|naloxone|mesh-list
55816994|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55816995|NCT02469077|Narcotics|narcotics|mesh-ancestor
55816996|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55816997|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55816998|NCT02469077|Analgesics|analgesics|mesh-ancestor
55816999|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
55817000|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817001|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55817002|NCT02486627|Levofloxacin|levofloxacin|mesh-list
55817003|NCT02486627|Ofloxacin|ofloxacin|mesh-list
55817004|NCT02486627|Meropenem|meropenem|mesh-list
55817005|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55817006|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817007|NCT02486627|Renal Agents|renal agents|mesh-ancestor
55817008|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55817009|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55817010|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55817011|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817012|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817013|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817014|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55817015|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55817016|NCT02282293|Piperaquine|piperaquine|mesh-list
55817017|NCT02282293|Trimethoprim|trimethoprim|mesh-list
55817018|NCT02282293|Artenimol|artenimol|mesh-list
55817019|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
55817020|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
55817021|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55817022|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55817023|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817024|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55817025|NCT02282293|Renal Agents|renal agents|mesh-ancestor
55817026|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55817027|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817028|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817031|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55817034|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55817035|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
55817036|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817037|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817038|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55817039|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
55817040|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55817041|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55817042|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55817043|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
55817044|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817045|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817046|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55817047|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55817048|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55817049|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
55817051|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55817052|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
55817053|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
55817054|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817055|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817056|NCT02485691|Prednisone|prednisone|mesh-list
55817057|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
55817073|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
55817074|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817075|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817076|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55817077|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55817078|NCT02517515|Antiviral Agents|antiviral agents|mesh-ancestor
55817079|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817080|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55817081|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55817082|NCT01891864|Etanercept|etanercept|mesh-list
55817083|NCT01891864|GP2015|gp2015|mesh-list
55817084|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55817085|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55817086|NCT01891864|Analgesics|analgesics|mesh-ancestor
55817087|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
55817088|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817089|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817090|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55817091|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817092|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55817093|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817094|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
55817095|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
55817096|NCT02484911|Dexamethasone|dexamethasone|mesh-list
55817097|NCT02484911|Olanzapine|olanzapine|mesh-list
55817098|NCT02484911|Aprepitant|aprepitant|mesh-list
55817099|NCT02484911|Palonosetron|palonosetron|mesh-list
55817100|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55817101|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
55817102|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
55817103|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817104|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817107|NCT02484911|Hormones|hormones|mesh-ancestor
55817116|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55817117|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55817118|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817119|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817120|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
55817121|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55817122|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55817123|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55817124|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
55817125|NCT04306367|Olaparib|olaparib|mesh-list
55817126|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55817127|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817128|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55817129|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817130|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817131|NCT01891396|Hyaluronic Acid|hyaluronic acid|mesh-list
55817132|NCT01891396|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55817133|NCT01891396|Immunologic Factors|immunologic factors|mesh-ancestor
55817135|NCT01891396|Viscosupplements|viscosupplements|mesh-ancestor
55817136|NCT01891396|Protective Agents|protective agents|mesh-ancestor
55817138|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55817139|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817140|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817142|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55817143|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
55817144|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
55817145|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
55817146|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
55817147|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817148|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817150|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55817151|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817152|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
55817153|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55817154|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817155|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817156|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817157|NCT02409368|Nivolumab|nivolumab|mesh-list
55817158|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55817159|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817160|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55817161|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817162|NCT04891484|Ondansetron|ondansetron|mesh-list
55817163|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
55817164|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
55817165|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817753|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55817166|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817167|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55817168|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
55817169|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
55817170|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55817171|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
55817172|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817173|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817174|NCT04891484|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55817175|NCT04891484|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55817176|NCT04891484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55817178|NCT04891484|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55817180|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55817181|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
55817182|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
55817183|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
55817184|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55817185|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817186|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817187|NCT01853254|Ribavirin|ribavirin|mesh-list
55817188|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55817189|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
55817190|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817191|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
55817192|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817193|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55817194|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55817195|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817196|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817197|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
55817198|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817199|NCT01853176|Bupivacaine|bupivacaine|mesh-list
55817200|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
55817201|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
55817202|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55817203|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817204|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
55817205|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817206|NCT02340962|Interferons|interferons|mesh-list
55817207|NCT02340962|Ribavirin|ribavirin|mesh-list
55817208|NCT02340962|Interferon-alpha|interferon-alpha|mesh-list
55817209|NCT02340962|Interferon alpha-2|interferon alpha-2|mesh-list
55817210|NCT02340962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817211|NCT02340962|Antiviral Agents|antiviral agents|mesh-ancestor
55817221|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55817222|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817224|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
55817225|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55817226|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
55817227|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817228|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817229|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
55817230|NCT01835470|Abatacept|abatacept|mesh-list
55817231|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55817232|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817233|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817234|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817235|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
55817236|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817237|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817238|NCT02451137|Insulin|insulin|mesh-list
55817239|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55817240|NCT02451137|Insulin Glargine|insulin glargine|mesh-list
55817241|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
55817242|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817243|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817244|NCT02372006|Afatinib|afatinib|mesh-list
55817245|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817246|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55817247|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817248|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817249|NCT02406248|Ticagrelor|ticagrelor|mesh-list
55817250|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55817251|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55817754|NCT02325518|Maleic acid|maleic acid|mesh-list
55817252|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55817253|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55817254|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
55817255|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817256|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817257|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817258|NCT02450903|Ceritinib|ceritinib|mesh-list
55817259|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817260|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55817261|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817262|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817263|NCT02371616|Listerine|listerine|mesh-list
55817264|NCT02371616|Calcium|calcium|mesh-list
55817265|NCT02371616|Fluorides|fluorides|mesh-list
55817266|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
55817267|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
55817268|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55817269|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817270|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
55817271|NCT02371616|Protective Agents|protective agents|mesh-ancestor
55817272|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55817273|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817275|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817276|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55817277|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55817279|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817280|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
55817281|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55817282|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817283|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817284|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
55817285|NCT01833832|Antidotes|antidotes|mesh-ancestor
55817286|NCT01833832|Protective Agents|protective agents|mesh-ancestor
55817287|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817288|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
55817289|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817290|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
55817291|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55817292|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817294|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
55817296|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
55817297|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
55817298|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817300|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55817301|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817302|NCT02369510|Epinephrine|epinephrine|mesh-list
55817303|NCT02369510|Racepinephrine|racepinephrine|mesh-list
55817304|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
55817305|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55817306|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55817307|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
55817308|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817309|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817310|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817311|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55817312|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55817313|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
55817314|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817315|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55817316|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
55817317|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
55817318|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
55817319|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55817320|NCT01650194|Prednisone|prednisone|mesh-list
55817321|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
55817322|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55817323|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
55817324|NCT01650194|Hormones|hormones|mesh-ancestor
55817331|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817332|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
55817333|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55817334|NCT02404220|Dexamethasone|dexamethasone|mesh-list
55817335|NCT02404220|Vincristine|vincristine|mesh-list
55817336|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55817337|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
55817338|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
55817339|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817340|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817341|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55817342|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
55817343|NCT02404220|Hormones|hormones|mesh-ancestor
55817344|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55817345|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55817346|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817347|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55817348|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
55817349|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
55817350|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
55817420|NCT02349295|Ixekizumab|ixekizumab|mesh-list
55817421|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
55817422|NCT04877587|Gemcitabine|gemcitabine|mesh-list
55817423|NCT04877587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817425|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
55817426|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817427|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817428|NCT04877587|Antiviral Agents|antiviral agents|mesh-ancestor
55817429|NCT04877587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817430|NCT04877587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817431|NCT04877587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817432|NCT04877587|Immunologic Factors|immunologic factors|mesh-ancestor
55817433|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
55817434|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55817435|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55843833|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
55817436|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817437|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55817438|NCT02284243|Analgesics|analgesics|mesh-ancestor
55817439|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
55794821|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794822|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
55817440|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794829|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55794830|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55794831|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
55794832|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55794833|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55794834|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55794835|NCT05168813|Vaccines|vaccines|mesh-list
55794836|NCT05168813|Immunologic Factors|immunologic factors|mesh-ancestor
55794837|NCT05168813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794838|NCT05613491|Insulin|insulin|mesh-list
55794839|NCT05613491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55794840|NCT05613491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55794841|NCT05613491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794842|NCT05597839|Nivolumab|nivolumab|mesh-list
55817441|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55817442|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55817443|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55817444|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
55817445|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817446|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817448|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817449|NCT02284009|Incretins|incretins|mesh-ancestor
55817451|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55817452|NCT02400476|Budesonide|budesonide|mesh-list
55817453|NCT02400476|Loperamide|loperamide|mesh-list
55817454|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
55817455|NCT02400476|Colestipol|colestipol|mesh-list
55817456|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55817457|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55817458|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
55817459|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817460|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817461|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55817462|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
55817463|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
55817464|NCT02400476|Hormones|hormones|mesh-ancestor
55817465|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794843|NCT05597839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55794844|NCT05597839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794845|NCT05597839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55817466|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55817467|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55817468|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
55817469|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817470|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55817471|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
55817472|NCT02363738|Infliximab|infliximab|mesh-list
55817473|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
55817474|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55817475|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817476|NCT02331680|Tolvaptan|tolvaptan|mesh-list
55817477|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55794846|NCT05597839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794847|NCT05592379|Psilocybin|psilocybin|mesh-list
55794848|NCT05592379|Hallucinogens|hallucinogens|mesh-ancestor
55794849|NCT05592379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817478|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817480|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817481|NCT02349061|Ustekinumab|ustekinumab|mesh-list
55817482|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
55817483|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
55817484|NCT02331368|Lenalidomide|lenalidomide|mesh-list
55817485|NCT02331368|Melphalan|melphalan|mesh-list
55817486|NCT02331368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55817487|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817488|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
55817489|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817490|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55817491|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55817492|NCT02331368|Growth Substances|growth substances|mesh-ancestor
55817493|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
55817494|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55817495|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
55817496|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794850|NCT05592379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55794851|NCT05151263|Salicylates|salicylates|mesh-list
55794852|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55817497|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55817498|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817499|NCT02280421|Cyclosporine|cyclosporine|mesh-list
55817500|NCT02280421|Cyclosporins|cyclosporins|mesh-list
55817501|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817502|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817503|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817504|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
55817505|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817506|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
55817507|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817508|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
55794853|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55794854|NCT05151263|Analgesics|analgesics|mesh-ancestor
55817509|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817514|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55817515|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817516|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
55817517|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
55817518|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
55817519|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817520|NCT04892875|Cisplatin|cisplatin|mesh-list
55817521|NCT04892875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817522|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55817523|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
55817524|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55794855|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
55794856|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794857|NCT05151263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794858|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55794859|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55794860|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794861|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55794862|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794863|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
55794864|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55794865|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794866|NCT03066427|Sunitinib|sunitinib|mesh-list
55794867|NCT03066427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794868|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55794869|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55794871|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794872|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
55794873|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55794874|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794875|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794876|NCT05177133|Capecitabine|capecitabine|mesh-list
55794877|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
55794878|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55794879|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
55794880|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794881|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794882|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
55794883|NCT02866643|Etonogestrel|etonogestrel|mesh-list
55794884|NCT02866643|Desogestrel|desogestrel|mesh-list
55794885|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55794886|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794887|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55794888|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55794889|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55794892|NCT02866643|Progestins|progestins|mesh-ancestor
55817525|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55817526|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55817527|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55817528|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817529|NCT02347813|Pioglitazone|pioglitazone|mesh-list
55817530|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817531|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794910|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794911|NCT05176821|Expectorants|expectorants|mesh-ancestor
55794912|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
55794913|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55794914|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55794915|NCT05176821|Renal Agents|renal agents|mesh-ancestor
55794916|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
55794917|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55794918|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55794919|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55794920|NCT05555641|Nafamostat|nafamostat|mesh-list
55794921|NCT05555641|Heparin|heparin|mesh-list
55794922|NCT05555641|Calcium heparin|calcium heparin|mesh-list
55794923|NCT05555641|Anticoagulants|anticoagulants|mesh-ancestor
55794924|NCT05555641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55794925|NCT05555641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55794926|NCT05555641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794927|NCT05555641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55794928|NCT05555641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55794929|NCT05555641|Analgesics|analgesics|mesh-ancestor
55794930|NCT05555641|Sensory System Agents|sensory system agents|mesh-ancestor
55794931|NCT05555641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794932|NCT05555641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794933|NCT05555641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55794934|NCT05555641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55794935|NCT05555641|Protease Inhibitors|protease inhibitors|mesh-ancestor
55794936|NCT05555641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794937|NCT05555641|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55794943|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
55817532|NCT02359994|Hemostatics|hemostatics|mesh-list
55817533|NCT02359994|Coagulants|coagulants|mesh-ancestor
55817534|NCT04905446|Niacinamide|niacinamide|mesh-list
55817535|NCT04905446|Niacin|niacin|mesh-list
55817536|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
55817537|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
55817538|NCT04905446|Vitamins|vitamins|mesh-ancestor
55817539|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
55817540|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817541|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55817542|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
55817543|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817544|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55817545|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
55794948|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
55817546|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
55817547|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817548|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
55794949|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794950|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55794951|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55794952|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794953|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817549|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817550|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817552|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817553|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55817554|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817555|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817611|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55817612|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55794955|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794957|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55817615|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
55817616|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55817617|NCT05565235|Nalbuphine|nalbuphine|mesh-list
55817618|NCT05565235|Bupivacaine|bupivacaine|mesh-list
55817619|NCT05565235|Anesthetics, Local|anesthetics, local|mesh-ancestor
55817620|NCT05565235|Anesthetics|anesthetics|mesh-ancestor
55817621|NCT05565235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55843937|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817623|NCT05565235|Sensory System Agents|sensory system agents|mesh-ancestor
55817624|NCT05565235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817625|NCT05565235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55817626|NCT05565235|Narcotics|narcotics|mesh-ancestor
55817627|NCT05565235|Analgesics|analgesics|mesh-ancestor
55817628|NCT02278003|Propofol|propofol|mesh-list
55817629|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55817630|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55817631|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817632|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55817633|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
55817634|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
55817635|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55817636|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
55817637|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817638|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55817639|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55817640|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55817641|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817642|NCT02395172|Docetaxel|docetaxel|mesh-list
55817643|NCT02395172|Avelumab|avelumab|mesh-list
55794958|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55794959|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55794960|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794961|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55794962|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817644|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817645|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
55817651|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817652|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817654|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
55817655|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55817656|NCT02358044|Grazoprevir|grazoprevir|mesh-list
55817657|NCT02358044|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55817658|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
55817659|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817660|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
55817661|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817662|NCT05536219|Antibodies|antibodies|mesh-list
55817663|NCT05536219|Immunologic Factors|immunologic factors|mesh-ancestor
55817664|NCT05536219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817665|NCT05649241|Nicotine|nicotine|mesh-list
55817666|NCT05649241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55817667|NCT05649241|Autonomic Agents|autonomic agents|mesh-ancestor
55817668|NCT05649241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817669|NCT05649241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817670|NCT05649241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55794963|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
55794964|NCT05613335|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55794965|NCT05613335|Hemostatics|hemostatics|mesh-ancestor
55794966|NCT05613335|Coagulants|coagulants|mesh-ancestor
55794967|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55794968|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
55794969|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
55794970|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
55794971|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55794972|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794973|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
55794974|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794975|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55794976|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55794977|NCT05078463|Antioxidants|antioxidants|mesh-ancestor
55817671|NCT05649241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55817672|NCT05649241|Cholinergic Agents|cholinergic agents|mesh-ancestor
55817673|NCT05649241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817674|NCT05649241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817675|NCT01850524|Dexamethasone|dexamethasone|mesh-list
55817676|NCT01850524|Lenalidomide|lenalidomide|mesh-list
55817678|NCT01850524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55794978|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794980|NCT05170113|Caffeine|caffeine|mesh-list
55794981|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55794982|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794983|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55794984|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794985|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794986|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55794987|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55794988|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
55794989|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794991|NCT05169957|Ipilimumab|ipilimumab|mesh-list
55817679|NCT01850524|Antiemetics|antiemetics|mesh-ancestor
55817680|NCT01850524|Autonomic Agents|autonomic agents|mesh-ancestor
55817681|NCT01850524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817682|NCT01850524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817683|NCT01850524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55817684|NCT01850524|Glucocorticoids|glucocorticoids|mesh-ancestor
55817685|NCT01850524|Hormones|hormones|mesh-ancestor
55817686|NCT01850524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55817687|NCT01850524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55794992|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55794993|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794994|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55817688|NCT01850524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817689|NCT01850524|Immunologic Factors|immunologic factors|mesh-ancestor
55817690|NCT01850524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55817691|NCT01850524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55817692|NCT01850524|Growth Substances|growth substances|mesh-ancestor
55817693|NCT01850524|Growth Inhibitors|growth inhibitors|mesh-ancestor
55817694|NCT01850524|Protease Inhibitors|protease inhibitors|mesh-ancestor
55817695|NCT01850524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817696|NCT01850524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817698|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817699|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55817700|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817701|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817702|NCT02357810|Topotecan|topotecan|mesh-list
55817703|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55817704|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55794995|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794997|NCT05611463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794998|NCT05611463|Tubulin Modulators|tubulin modulators|mesh-ancestor
55794999|NCT05611463|Antimitotic Agents|antimitotic agents|mesh-ancestor
55795000|NCT05611463|Mitosis Modulators|mitosis modulators|mesh-ancestor
55817705|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817706|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817712|NCT01850446|Oseltamivir|oseltamivir|mesh-list
55817724|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817726|NCT01832038|Lacosamide|lacosamide|mesh-list
55817727|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
55817728|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55817729|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55817730|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55817755|NCT02325518|Brinzolamide|brinzolamide|mesh-list
55817731|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817732|NCT01849588|Sorafenib|sorafenib|mesh-list
55795001|NCT05611463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795002|NCT05611385|Amphetamine|amphetamine|mesh-list
55795003|NCT05611385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55795004|NCT05611385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795005|NCT05611385|Sympathomimetics|sympathomimetics|mesh-ancestor
55795007|NCT05611385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795008|NCT05611385|Dopamine Agents|dopamine agents|mesh-ancestor
55795009|NCT05611385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795010|NCT05611385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795011|NCT05611385|Adrenergic Agents|adrenergic agents|mesh-ancestor
55817733|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817734|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55817735|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817736|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817737|NCT02357342|Sirolimus|sirolimus|mesh-list
55817738|NCT02357342|Aflibercept|aflibercept|mesh-list
55817739|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817740|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55795012|NCT05611385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55795013|NCT05611385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55795014|NCT05611385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55795015|NCT05611385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55795017|NCT05475041|Hematinics|hematinics|mesh-ancestor
55795018|NCT05611307|Hormones|hormones|mesh-list
55795019|NCT05611307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795020|NCT05611307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795021|NCT02631577|Lenalidomide|lenalidomide|mesh-list
55795022|NCT02631577|Atezolizumab|atezolizumab|mesh-list
55795023|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
55795024|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
55795025|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795026|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55795027|NCT02631577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55795028|NCT02631577|Growth Substances|growth substances|mesh-ancestor
55795029|NCT02631577|Growth Inhibitors|growth inhibitors|mesh-ancestor
55795030|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795031|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55795032|NCT01667081|Grazoprevir|grazoprevir|mesh-list
55817741|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55817742|NCT02357342|Growth Substances|growth substances|mesh-ancestor
55817743|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817744|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
55817745|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55817746|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817747|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55817748|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
55817749|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817750|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
55817751|NCT02325518|Timolol|timolol|mesh-list
55817752|NCT02325518|Dorzolamide|dorzolamide|mesh-list
55795033|NCT01667081|Antiviral Agents|antiviral agents|mesh-ancestor
55795034|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795035|NCT03067753|Methylprednisolone|methylprednisolone|mesh-list
55795036|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55795037|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55795038|NCT03067753|Prednisolone|prednisolone|mesh-list
55795039|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
55795040|NCT03067753|Hormones|hormones|mesh-list
55795041|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55795042|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
55795043|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795044|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795045|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55795046|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
55795047|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
55795048|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795049|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55795050|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
55795051|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55795052|NCT03067753|Protective Agents|protective agents|mesh-ancestor
55795053|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55795054|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795055|NCT05613179|Ibuprofen|ibuprofen|mesh-list
55817756|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55817757|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817758|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817759|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55795056|NCT05613179|Analgesics|analgesics|mesh-list
55795057|NCT05613179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55795058|NCT05613179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55795059|NCT05613179|Sensory System Agents|sensory system agents|mesh-ancestor
55795060|NCT05613179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795061|NCT05613179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795062|NCT05613179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55795063|NCT05613179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55795064|NCT05613179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55795065|NCT05613179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795066|NCT05613179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795067|NCT04331639|Vitamin D|vitamin d|mesh-list
55795068|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
55795069|NCT04331639|Vitamins|vitamins|mesh-ancestor
55795070|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
55795071|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795072|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55817760|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55817761|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
55817762|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55817763|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817764|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55817765|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55817766|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55817767|NCT02270983|Linaclotide|linaclotide|mesh-list
55817768|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55817769|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
55817770|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817771|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55817772|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55817773|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55817775|NCT02324270|Diclofenac|diclofenac|mesh-list
55795073|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55795074|NCT05611229|Pembrolizumab|pembrolizumab|mesh-list
55795075|NCT05611229|Nivolumab|nivolumab|mesh-list
55795076|NCT05611229|Ipilimumab|ipilimumab|mesh-list
55795077|NCT05611229|Trametinib|trametinib|mesh-list
55795078|NCT05611229|Vemurafenib|vemurafenib|mesh-list
55795079|NCT05611229|Dabrafenib|dabrafenib|mesh-list
55817781|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817784|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817785|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55817786|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817787|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817788|NCT05648071|Pemetrexed|pemetrexed|mesh-list
55817789|NCT05648071|Nedaplatin|nedaplatin|mesh-list
55817790|NCT05648071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817791|NCT05648071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817792|NCT05648071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817793|NCT05648071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55817794|NCT05648071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55817795|NCT03689699|Nivolumab|nivolumab|mesh-list
55817796|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55817797|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817798|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55817799|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817800|NCT01849276|Metformin|metformin|mesh-list
55817801|NCT01849276|Cytarabine|cytarabine|mesh-list
55817802|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817803|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817804|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55817805|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
55817806|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817807|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817808|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
55817809|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817810|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817811|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
55817812|NCT02465489|Deferiprone|deferiprone|mesh-list
55817822|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817823|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817824|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817825|NCT01601821|Sirolimus|sirolimus|mesh-list
55817826|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55817827|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817828|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55817829|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817830|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
55817831|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817832|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
55817833|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817834|NCT01846624|Decitabine|decitabine|mesh-list
55817835|NCT01846624|Azacitidine|azacitidine|mesh-list
55817836|NCT01846624|Midostaurin|midostaurin|mesh-list
55817837|NCT01846624|Staurosporine|staurosporine|mesh-list
55817838|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55817839|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
55817840|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817841|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817842|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817843|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55817844|NCT01844986|Olaparib|olaparib|mesh-list
55817845|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55817846|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817847|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817848|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817849|NCT01827670|Fluorides|fluorides|mesh-list
55817850|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
55817851|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
55817852|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
55817853|NCT01827670|Protective Agents|protective agents|mesh-ancestor
55817854|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817855|NCT01844830|Phenylephrine|phenylephrine|mesh-list
55817856|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
55817857|NCT01844830|Tetracaine|tetracaine|mesh-list
55817858|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
55817882|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55817884|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817885|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55817886|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
55817887|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55817888|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817889|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55817890|NCT02322866|Sarecycline|sarecycline|mesh-list
55817891|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55795143|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
55795144|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795146|NCT04716413|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55795147|NCT04716413|Narcotics|narcotics|mesh-ancestor
55817892|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817893|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
55817895|NCT01844518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55817896|NCT01844518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817897|NCT01844518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817898|NCT01844518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817899|NCT01844518|Immunologic Factors|immunologic factors|mesh-ancestor
55817900|NCT01844518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817901|NCT01844518|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817902|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55817903|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55817904|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55817905|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817907|NCT02356562|Ribavirin|ribavirin|mesh-list
55817908|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
55817909|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55817910|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55817911|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
55817912|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817913|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817915|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55817916|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
55817917|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55817918|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55817919|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55817920|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
55817921|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
55795281|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55817922|NCT02354690|Fludarabine|fludarabine|mesh-list
55817923|NCT02354690|Interleukin-2|interleukin-2|mesh-list
55817924|NCT02354690|Vemurafenib|vemurafenib|mesh-list
55817925|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55817926|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
55817927|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817928|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55817929|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55817930|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
55817931|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817932|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55817933|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55817934|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55817935|NCT02354690|Analgesics|analgesics|mesh-ancestor
55817936|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
55817937|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817938|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55817939|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817940|NCT02354222|Canagliflozin|canagliflozin|mesh-list
55817941|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55817942|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817943|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817944|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817945|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
55817946|NCT02351960|Lansoprazole|lansoprazole|mesh-list
55817947|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55817948|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55817949|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55817950|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817951|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817952|NCT02351180|Beclomethasone|beclomethasone|mesh-list
55817953|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55817954|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
55817955|NCT02351180|Hormones|hormones|mesh-ancestor
55817956|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55817957|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817959|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
55817960|NCT02350478|Linagliptin|linagliptin|mesh-list
55817961|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55817962|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817963|NCT02350478|Incretins|incretins|mesh-ancestor
55817965|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55817966|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55817967|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
55817968|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817969|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817970|NCT02349542|Bupivacaine|bupivacaine|mesh-list
55817971|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
55817972|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
55817973|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55817974|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817975|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
55817976|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817977|NCT02321930|Tofacitinib|tofacitinib|mesh-list
55817978|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55817979|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55817980|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817981|NCT05647057|Polygeline|polygeline|mesh-list
55817982|NCT05647057|Plasma Substitutes|plasma substitutes|mesh-ancestor
55817983|NCT05647057|Blood Substitutes|blood substitutes|mesh-ancestor
55817984|NCT02264821|Morphine|morphine|mesh-list
55817985|NCT02264821|Ropivacaine|ropivacaine|mesh-list
55817986|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
55817987|NCT02264821|Anesthetics|anesthetics|mesh-list
55817988|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55817989|NCT02264821|Narcotics|narcotics|mesh-ancestor
55817990|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55817991|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55817992|NCT02264821|Analgesics|analgesics|mesh-ancestor
55817993|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
55817994|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55817995|NCT04854889|Decitabine|decitabine|mesh-list
55817996|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55817997|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
55817998|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55817999|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818000|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818001|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
55818002|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55818003|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55818004|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55818005|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818006|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818007|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
55818008|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818009|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818010|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55818013|NCT05356741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818014|NCT05356741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818015|NCT05341843|Sertraline|sertraline|mesh-list
55818016|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
55818017|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55818019|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55818020|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818021|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818022|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818023|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
55818024|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818025|NCT05646199|Metformin|metformin|mesh-list
55818026|NCT05646199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55818027|NCT05646199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818028|NCT02258659|Paclitaxel|paclitaxel|mesh-list
55818029|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55818030|NCT02258659|Carboplatin|carboplatin|mesh-list
55818031|NCT02258659|Fluorouracil|fluorouracil|mesh-list
55818032|NCT02258659|Hydroxyurea|hydroxyurea|mesh-list
55818033|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55818034|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818035|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
55818036|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
55818037|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
55818038|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818039|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
55818040|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55818041|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55818042|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
55818043|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818044|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
55818045|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818046|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55818049|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818050|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818051|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55818052|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818053|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
55818054|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55818055|NCT02319668|Listerine|listerine|mesh-list
55818056|NCT02319668|Fluorides|fluorides|mesh-list
55818067|NCT02092467|Tofacitinib|tofacitinib|mesh-list
55818068|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55818069|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55818070|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55818071|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55818073|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
55818074|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818075|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818076|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55818077|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55818078|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
55818079|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55818080|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795455|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55795484|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
55818081|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818083|NCT04951115|Etoposide|etoposide|mesh-list
55818084|NCT04951115|Durvalumab|durvalumab|mesh-list
55818085|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818086|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55818087|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55818088|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55818089|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818090|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818091|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818092|NCT04420871|Capecitabine|capecitabine|mesh-list
55818093|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55818094|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
55818095|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818096|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818097|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55818098|NCT02349386|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55818099|NCT02349386|Estradiol|estradiol|mesh-list
55818100|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55818101|NCT02349386|Estrogens|estrogens|mesh-ancestor
55818102|NCT02349386|Hormones|hormones|mesh-ancestor
55818103|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818104|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818105|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55818106|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
55818107|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55818108|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55818109|NCT04892888|Vaccines|vaccines|mesh-list
55818110|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
55818111|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818112|NCT02036775|Ambroxol|ambroxol|mesh-list
55818113|NCT02036775|Expectorants|expectorants|mesh-ancestor
55818114|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
55818115|NCT02034591|Apixaban|apixaban|mesh-list
55818116|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55818117|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
55818118|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55818119|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
55818120|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818121|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818122|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
55818123|NCT02091921|Ticagrelor|ticagrelor|mesh-list
55818124|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55818125|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55818126|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55818127|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55818128|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
55818129|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818130|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818131|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818132|NCT04716933|Carboplatin|carboplatin|mesh-list
55818133|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
55818134|NCT04716933|Pemetrexed|pemetrexed|mesh-list
55818135|NCT04716933|Lenvatinib|lenvatinib|mesh-list
55818136|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818137|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818138|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818139|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818140|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55818141|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55818142|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55818143|NCT02034513|Insulin|insulin|mesh-list
55818144|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55818145|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
55818146|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
55818147|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55818149|NCT02461745|Ribavirin|ribavirin|mesh-list
55818158|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818159|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55818160|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55818161|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55818162|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55818164|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55818165|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55818166|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818167|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818168|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55818169|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818170|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
55818171|NCT02033889|Insulin|insulin|mesh-list
55818221|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55818222|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818223|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818224|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
55818225|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55818226|NCT01843660|Acetaminophen|acetaminophen|mesh-list
55818227|NCT01843660|Tramadol|tramadol|mesh-list
55818228|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55818230|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
55818231|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818232|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818233|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
55818234|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55818235|NCT01843660|Narcotics|narcotics|mesh-ancestor
55818236|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55818237|NCT02032173|Ranibizumab|ranibizumab|mesh-list
55818238|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55818239|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55818240|NCT02032173|Growth Substances|growth substances|mesh-ancestor
55818241|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818242|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
55818243|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818245|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55818246|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818248|NCT02461589|Hormones|hormones|mesh-ancestor
55818249|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818250|NCT02089737|Panitumumab|panitumumab|mesh-list
55818251|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818252|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818253|NCT02089347|Vaccines|vaccines|mesh-list
55818254|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
55818255|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818256|NCT02419469|Cytarabine|cytarabine|mesh-list
55818257|NCT02419469|Dexamethasone|dexamethasone|mesh-list
55818258|NCT02419469|Prednisone|prednisone|mesh-list
55818259|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
55818260|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
55818261|NCT02419469|Rituximab|rituximab|mesh-list
55818262|NCT02419469|Doxorubicin|doxorubicin|mesh-list
55818263|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55818264|NCT02419469|Methotrexate|methotrexate|mesh-list
55818265|NCT02419469|Vincristine|vincristine|mesh-list
55818266|NCT02419469|Daunorubicin|daunorubicin|mesh-list
55818267|NCT02419469|Asparaginase|asparaginase|mesh-list
55818268|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
55818269|NCT02419469|Ofatumumab|ofatumumab|mesh-list
55818270|NCT02419469|Pegaspargase|pegaspargase|mesh-list
55818271|NCT02419469|Thioguanine|thioguanine|mesh-list
55818272|NCT02419469|BB 1101|bb 1101|mesh-list
55818273|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55818274|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
55818275|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818276|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55818277|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55818278|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
55818279|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818280|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818281|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55818282|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818283|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55818284|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
55818285|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
55818286|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818287|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55818288|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
55818289|NCT02419469|Hormones|hormones|mesh-ancestor
55818290|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818291|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55818292|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55818293|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55818294|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55818295|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818296|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55818297|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
55818298|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55818299|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55818301|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
55818302|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55818303|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55795805|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55818304|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
55818305|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818306|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55818307|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
55818308|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
55818309|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
55818310|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
55818312|NCT04687761|Azacitidine|azacitidine|mesh-list
55818313|NCT04687761|Venetoclax|venetoclax|mesh-list
55818314|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55818315|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
55818316|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818317|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818318|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
55818319|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818320|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55818321|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
55818322|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818323|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818324|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55818325|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55818326|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818327|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818328|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55818329|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818330|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818331|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
55818332|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818333|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
55818334|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55818335|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55818336|NCT04730193|Caffeine|caffeine|mesh-list
55818337|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55818355|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55818356|NCT02088177|Naltrexone|naltrexone|mesh-list
55818357|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55818358|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55818359|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818360|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
55818361|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818362|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
55818363|NCT02030535|Olodaterol|olodaterol|mesh-list
55818364|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55818365|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
55818366|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818367|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818368|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55818369|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
55818370|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
55818371|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55818372|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
55818373|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818374|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818375|NCT02029989|Chrysarobin|chrysarobin|mesh-list
55818376|NCT02029989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55818377|NCT02029989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55818379|NCT02029989|Sensory System Agents|sensory system agents|mesh-ancestor
55818380|NCT02029989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818381|NCT02029989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818382|NCT02029989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55818383|NCT02029989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55818384|NCT02048241|Guanfacine|guanfacine|mesh-list
55818385|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55818386|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55818387|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55818388|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55818389|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
55818390|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818391|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818392|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818394|NCT02087943|Apremilast|apremilast|mesh-list
55818395|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55818396|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55818397|NCT02087943|Analgesics|analgesics|mesh-ancestor
55818398|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
55818399|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818400|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818401|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55818402|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55818403|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55818404|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55818405|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818406|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818407|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55818408|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
55818409|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
55818410|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55818411|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818412|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55818414|NCT02087943|Growth Substances|growth substances|mesh-ancestor
55818428|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818430|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
55818431|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
55818432|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55818433|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795989|NCT05225363|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55818434|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
55818435|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818436|NCT02443883|Ramucirumab|ramucirumab|mesh-list
55818437|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818438|NCT02087241|Carboplatin|carboplatin|mesh-list
55818439|NCT02087241|Pemetrexed|pemetrexed|mesh-list
55818440|NCT02087241|Adavosertib|adavosertib|mesh-list
55818441|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818442|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818443|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818444|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55818445|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55818448|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55818449|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55818450|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55818451|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
55818452|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818453|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818454|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818455|NCT04685577|Nefopam|nefopam|mesh-list
55818456|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55818457|NCT04685577|Analgesics|analgesics|mesh-ancestor
55818458|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
55818459|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818460|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818461|NCT02443337|Necitumumab|necitumumab|mesh-list
55818462|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818463|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818464|NCT02443103|Guanabenz|guanabenz|mesh-list
55818465|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55818466|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55818467|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55818468|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55818469|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
55818470|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818471|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818472|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818473|NCT02022657|Tenofovir|tenofovir|mesh-list
55818474|NCT02022657|Emtricitabine|emtricitabine|mesh-list
55818475|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55818476|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
55818477|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818478|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55818482|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55818485|NCT02021643|Ribavirin|ribavirin|mesh-list
55818486|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
55818487|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818488|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
55818489|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818490|NCT02415959|Pancrelipase|pancrelipase|mesh-list
55818492|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55818493|NCT02021331|Cimetidine|cimetidine|mesh-list
55818494|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55818495|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55818496|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55818497|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
55818498|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
55818499|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818500|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818501|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818502|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55818503|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55818504|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818505|NCT04681833|Vaccines|vaccines|mesh-list
55818506|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
55818507|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818508|NCT02441309|Ifosfamide|ifosfamide|mesh-list
55818509|NCT02441309|Mifamurtide|mifamurtide|mesh-list
55797486|NCT04960657|Glyburide|glyburide|mesh-list
55818552|NCT04920695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818553|NCT04920695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818554|NCT04920695|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55818555|NCT04920695|Respiratory System Agents|respiratory system agents|mesh-ancestor
55818556|NCT04920695|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55818557|NCT04920695|Antioxidants|antioxidants|mesh-ancestor
55797499|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55800420|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800421|NCT04872985|Paclitaxel|paclitaxel|mesh-list
55800422|NCT04872985|Docetaxel|docetaxel|mesh-list
55800423|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
55800424|NCT04872985|Doxorubicin|doxorubicin|mesh-list
55800425|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55800426|NCT04872985|Epirubicin|epirubicin|mesh-list
55800427|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55800428|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800429|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
55797924|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
55797925|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
55800430|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
55800431|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
55800432|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800433|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55797970|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
55800434|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
55800435|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800436|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800437|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55800438|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
55800439|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55800440|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55800441|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55800442|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55800443|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800444|NCT04872907|Fluorides|fluorides|mesh-list
55800445|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
55800446|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
55800447|NCT04872907|Protective Agents|protective agents|mesh-ancestor
55800448|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800449|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
55800450|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
55800451|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55800452|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
55800453|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800454|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800455|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55800456|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
55800465|NCT05512013|Celecoxib|celecoxib|mesh-list
55800466|NCT05512013|Flurbiprofen|flurbiprofen|mesh-list
55800467|NCT05512013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55800468|NCT05512013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55800469|NCT05512013|Analgesics|analgesics|mesh-ancestor
55800470|NCT05512013|Sensory System Agents|sensory system agents|mesh-ancestor
55800471|NCT05512013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55800472|NCT05512013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55800473|NCT05512013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55800474|NCT05512013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55800475|NCT05512013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55800477|NCT05512013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800478|NCT05512013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55800479|NCT04894643|Gemcitabine|gemcitabine|mesh-list
55800480|NCT04894643|Paclitaxel|paclitaxel|mesh-list
55800481|NCT04894643|Capecitabine|capecitabine|mesh-list
55800482|NCT04894643|Pancrelipase|pancrelipase|mesh-list
55800483|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55800484|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55800485|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
55800486|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
55800487|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
55800488|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800489|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55800490|NCT04894643|Antimetabolites|antimetabolites|mesh-ancestor
55800491|NCT04894643|Antiviral Agents|antiviral agents|mesh-ancestor
55800492|NCT04894643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55800493|NCT04894643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55800494|NCT04894643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55800507|NCT05506865|Cholinergic Agents|cholinergic agents|mesh-ancestor
55800508|NCT05506865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55800509|NCT05506865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55800511|NCT05506787|Antidepressive Agents|antidepressive agents|mesh-ancestor
56144958|NCT00826800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56144959|NCT00826800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144960|NCT00826800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56144961|NCT00826800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56144962|NCT00826800|Growth Substances|growth substances|mesh-ancestor
56144963|NCT00826800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144964|NCT00826800|Growth Inhibitors|growth inhibitors|mesh-ancestor
55852333|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56144966|NCT00830076|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
56144967|NCT00830076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56144968|NCT00830076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144969|NCT00830076|Incretins|incretins|mesh-ancestor
56144970|NCT00830076|Hormones|hormones|mesh-ancestor
56144971|NCT00830076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144972|NCT00830076|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
56144973|NCT00830076|Protease Inhibitors|protease inhibitors|mesh-ancestor
56144974|NCT00830076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144975|NCT00830076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144976|NCT00830388|Ketoconazole|ketoconazole|mesh-list
56144977|NCT00830388|Antifungal Agents|antifungal agents|mesh-ancestor
56144978|NCT00830388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144979|NCT00830388|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
56144980|NCT00830388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56144981|NCT00830388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144982|NCT00830388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144983|NCT00830388|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55852515|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144984|NCT00830388|Hormone Antagonists|hormone antagonists|mesh-ancestor
56144985|NCT00830388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144986|NCT00830388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144987|NCT00830388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56144988|NCT00831480|Everolimus|everolimus|mesh-list
56144989|NCT00831480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144990|NCT00831480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144991|NCT00831480|Immunologic Factors|immunologic factors|mesh-ancestor
56144992|NCT00831480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144993|NCT00832338|Dexamethasone|dexamethasone|mesh-list
56144994|NCT00832338|Docetaxel|docetaxel|mesh-list
56144995|NCT00832338|Cyclophosphamide|cyclophosphamide|mesh-list
56144996|NCT00832338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56144997|NCT00832338|Antiemetics|antiemetics|mesh-ancestor
56144998|NCT00832338|Autonomic Agents|autonomic agents|mesh-ancestor
56144999|NCT00832338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145000|NCT00832338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145001|NCT00832338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56145003|NCT00832338|Hormones|hormones|mesh-ancestor
56145004|NCT00832338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145005|NCT00832338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55852584|NCT00231868|Paclitaxel|paclitaxel|mesh-list
56145006|NCT00832338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145007|NCT00832338|Tubulin Modulators|tubulin modulators|mesh-ancestor
56145010|NCT00832338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145011|NCT00832338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145012|NCT00832338|Immunologic Factors|immunologic factors|mesh-ancestor
56145013|NCT00832338|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145014|NCT00832338|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55742398|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
56145015|NCT00832338|Alkylating Agents|alkylating agents|mesh-ancestor
56145016|NCT00832338|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56145017|NCT00834210|Nicotinic Acids|nicotinic acids|mesh-list
56145019|NCT00834210|Tazarotene|tazarotene|mesh-list
56145020|NCT00834210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145022|NCT00834210|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56145023|NCT00834210|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
56145024|NCT00834210|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56145025|NCT00834210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145026|NCT00834210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145027|NCT00834210|Leprostatic Agents|leprostatic agents|mesh-ancestor
56145028|NCT00834210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56145029|NCT00834210|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145030|NCT00834210|Keratolytic Agents|keratolytic agents|mesh-ancestor
56145031|NCT00834210|Vitamin B Complex|vitamin b complex|mesh-ancestor
56145032|NCT00834210|Vitamins|vitamins|mesh-ancestor
56145033|NCT00834210|Micronutrients|micronutrients|mesh-ancestor
55852904|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
55852905|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
56145034|NCT00834210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145035|NCT00834288|Tramadol|tramadol|mesh-list
56145036|NCT00834288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56145037|NCT00834288|Narcotics|narcotics|mesh-ancestor
56145038|NCT00834288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145039|NCT00834288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145040|NCT00834288|Analgesics|analgesics|mesh-ancestor
55853021|NCT00270634|Tacrolimus|tacrolimus|mesh-list
55853022|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55853028|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
56145041|NCT00834288|Sensory System Agents|sensory system agents|mesh-ancestor
56145042|NCT00834288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145043|NCT00834678|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56145044|NCT00834678|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
56145045|NCT00834678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145046|NCT00834678|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56145047|NCT00834678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853113|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56145048|NCT00834678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145049|NCT00834678|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56145050|NCT00834678|Alkylating Agents|alkylating agents|mesh-ancestor
56145052|NCT00835224|Sympathomimetics|sympathomimetics|mesh-ancestor
56145053|NCT00835224|Autonomic Agents|autonomic agents|mesh-ancestor
56145054|NCT00835224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145055|NCT00835224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145056|NCT00835224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56145057|NCT00835224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
56145058|NCT00835224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56145059|NCT00835224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56145060|NCT00835224|Adrenergic Agents|adrenergic agents|mesh-ancestor
55797849|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
56145061|NCT00835224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145062|NCT00835224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145063|NCT00835926|Vaccines|vaccines|mesh-list
56145064|NCT00835926|Immunologic Factors|immunologic factors|mesh-ancestor
56145065|NCT00835926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145066|NCT00837252|Finasteride|finasteride|mesh-list
56145067|NCT00837252|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
56145068|NCT00837252|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56145069|NCT00837252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145070|NCT00837252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145071|NCT00837252|Hormone Antagonists|hormone antagonists|mesh-ancestor
56145072|NCT00837252|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145073|NCT00837252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853114|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145074|NCT00837252|Urological Agents|urological agents|mesh-ancestor
56145075|NCT00839982|Cytarabine|cytarabine|mesh-list
56145076|NCT00839982|Clofarabine|clofarabine|mesh-list
56145077|NCT00839982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56145078|NCT00839982|Antimetabolites|antimetabolites|mesh-ancestor
56145147|NCT00866034|Fertility Agents, Female|fertility agents, female|mesh-ancestor
56145079|NCT00839982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145080|NCT00839982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145081|NCT00839982|Antiviral Agents|antiviral agents|mesh-ancestor
56145082|NCT00839982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145083|NCT00839982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145084|NCT00839982|Immunologic Factors|immunologic factors|mesh-ancestor
56145085|NCT00839982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742399|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
56145086|NCT00845130|Vitamins|vitamins|mesh-list
55853218|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
55772778|NCT03187795|Urological Agents|urological agents|mesh-ancestor
56145088|NCT00845130|Micronutrients|micronutrients|mesh-ancestor
56145089|NCT00845130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145090|NCT00845130|Antioxidants|antioxidants|mesh-ancestor
56145091|NCT00845130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145092|NCT00845130|Protective Agents|protective agents|mesh-ancestor
56145093|NCT00848016|Acetic Acid|acetic acid|mesh-list
56145094|NCT00848016|Retinol acetate|retinol acetate|mesh-list
56145095|NCT00848016|Gossypol acetic acid|gossypol acetic acid|mesh-list
56145096|NCT00848016|Gossypol|gossypol|mesh-list
56145097|NCT00848016|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56145098|NCT00848016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853329|NCT01791400|Sumatriptan|sumatriptan|mesh-list
56145099|NCT00848016|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56145101|NCT00848016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145102|NCT00848016|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
56145103|NCT00848016|Protective Agents|protective agents|mesh-ancestor
56145104|NCT00848016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145105|NCT00848016|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
56145106|NCT00848016|Contraceptive Agents|contraceptive agents|mesh-ancestor
56145107|NCT00848016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56145108|NCT00848016|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56145109|NCT00848016|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56145110|NCT00848016|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
56145111|NCT00848016|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
56145113|NCT00849810|Nebivolol|nebivolol|mesh-list
56145114|NCT00849810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56145115|NCT00849810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56145116|NCT00849810|Sympatholytics|sympatholytics|mesh-ancestor
56145117|NCT00849810|Autonomic Agents|autonomic agents|mesh-ancestor
56145118|NCT00849810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145119|NCT00849810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145120|NCT00849810|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56145121|NCT00849810|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56145122|NCT00849810|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56145123|NCT00849810|Adrenergic Agents|adrenergic agents|mesh-ancestor
56145124|NCT00849810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145125|NCT00849810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145126|NCT00849810|Vasodilator Agents|vasodilator agents|mesh-ancestor
55772821|NCT02433847|Mosapride|mosapride|mesh-list
56145127|NCT00849810|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56145128|NCT00849810|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56145129|NCT00849810|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56145131|NCT00856050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145132|NCT00856050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56145133|NCT00856050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56145134|NCT00856050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145135|NCT00856050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145136|NCT00856050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56145137|NCT00856050|Hormone Antagonists|hormone antagonists|mesh-ancestor
55853623|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
55853624|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853625|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853626|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
55853627|NCT00332644|Bupropion|bupropion|mesh-list
55853628|NCT00332644|Nicotine|nicotine|mesh-list
55853629|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55853630|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
56145138|NCT00856050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145139|NCT00856050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145141|NCT00858468|Immunologic Factors|immunologic factors|mesh-ancestor
56145142|NCT00858468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145143|NCT00858858|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
56145144|NCT00858858|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
56145145|NCT00858858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56145146|NCT00866034|Cetrorelix|cetrorelix|mesh-list
56145149|NCT00866034|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56145150|NCT00866034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145151|NCT00866034|Hormone Antagonists|hormone antagonists|mesh-ancestor
56145152|NCT00866034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145153|NCT00868140|Pioglitazone|pioglitazone|mesh-list
56145154|NCT00868140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56145155|NCT00868140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145156|NCT00868374|Quetiapine Fumarate|quetiapine fumarate|mesh-list
56145157|NCT00868374|Antidepressive Agents|antidepressive agents|mesh-ancestor
56145158|NCT00868374|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56145159|NCT00868374|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56145160|NCT00868374|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56145161|NCT00868374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742400|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55853684|NCT00315328|Atropine|atropine|mesh-list
56145162|NCT00868374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145163|NCT00868452|Valproic Acid|valproic acid|mesh-list
56145164|NCT00868452|Lithium Carbonate|lithium carbonate|mesh-list
56145165|NCT00868452|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
56145166|NCT00868452|Antidepressive Agents|antidepressive agents|mesh-ancestor
56145167|NCT00868452|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56145168|NCT00868452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145169|NCT00868452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145170|NCT00868452|Antimanic Agents|antimanic agents|mesh-ancestor
56145171|NCT00868452|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56145172|NCT00868452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145173|NCT00868452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145174|NCT00868452|Anticonvulsants|anticonvulsants|mesh-ancestor
56145175|NCT00868452|GABA Agents|gaba agents|mesh-ancestor
56145176|NCT00868452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145177|NCT00868452|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
56145178|NCT00868452|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
56145179|NCT00868452|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
56145180|NCT00868452|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56145181|NCT00868452|Adrenergic Agents|adrenergic agents|mesh-ancestor
56145182|NCT00868452|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
56145183|NCT00868452|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
56145184|NCT00868452|Serotonin Agents|serotonin agents|mesh-ancestor
56145185|NCT00868452|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
56145186|NCT00868452|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
56145187|NCT00868452|Dopamine Agents|dopamine agents|mesh-ancestor
55853770|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55853772|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
56145189|NCT00869622|Risedronic Acid|risedronic acid|mesh-list
56145190|NCT00869622|Calcium|calcium|mesh-list
56145191|NCT00869622|Vitamins|vitamins|mesh-ancestor
55853864|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56145192|NCT00869622|Micronutrients|micronutrients|mesh-ancestor
56145193|NCT00869622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145194|NCT00869622|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56145195|NCT00869622|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56145196|NCT00869622|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56145197|NCT00869622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56145198|NCT00869622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145199|NCT00871260|Regadenoson|regadenoson|mesh-list
56145200|NCT00871260|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55853865|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56145201|NCT00871260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
56145203|NCT00871260|Purinergic Agents|purinergic agents|mesh-ancestor
56145204|NCT00871260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145205|NCT00871260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145206|NCT00871260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145207|NCT00874614|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
56145208|NCT00874614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145209|NCT00874614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853922|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
56145210|NCT00874614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145211|NCT00874614|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
56145212|NCT00875550|Fentanyl|fentanyl|mesh-list
56145213|NCT00875550|Midazolam|midazolam|mesh-list
56145214|NCT00875550|Dexmedetomidine|dexmedetomidine|mesh-list
56145215|NCT00875550|Morphine|morphine|mesh-list
56145216|NCT00875550|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56145217|NCT00875550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145218|NCT00875550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145219|NCT00875550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56145220|NCT00875550|Analgesics|analgesics|mesh-ancestor
56145221|NCT00875550|Sensory System Agents|sensory system agents|mesh-ancestor
56145222|NCT00875550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145223|NCT00875550|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
56145224|NCT00875550|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
56145225|NCT00875550|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56145226|NCT00875550|Adrenergic Agents|adrenergic agents|mesh-ancestor
56145227|NCT00875550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145228|NCT00875550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145229|NCT00875550|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56145230|NCT00875550|Narcotics|narcotics|mesh-ancestor
56145231|NCT00875550|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56145232|NCT00875550|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55742401|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55742402|NCT05131893|Tamoxifen|tamoxifen|mesh-list
55742403|NCT05131893|Docetaxel|docetaxel|mesh-list
55854082|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
55742404|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
55854084|NCT00318136|Bevacizumab|bevacizumab|mesh-list
55854085|NCT00318136|Carboplatin|carboplatin|mesh-list
55854086|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55854087|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854088|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
55854089|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
55854090|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854091|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854092|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854100|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
55854116|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
56145233|NCT00875550|Anesthetics, General|anesthetics, general|mesh-ancestor
56145234|NCT00875550|Anesthetics|anesthetics|mesh-ancestor
56145235|NCT00875550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56145236|NCT00875550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56145237|NCT00875550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56145238|NCT00875550|GABA Modulators|gaba modulators|mesh-ancestor
56145239|NCT00875550|GABA Agents|gaba agents|mesh-ancestor
56145240|NCT00878436|Bicalutamide|bicalutamide|mesh-list
56145241|NCT00878436|Panobinostat|panobinostat|mesh-list
56145242|NCT00878436|Androgen Antagonists|androgen antagonists|mesh-ancestor
56145243|NCT00878436|Hormone Antagonists|hormone antagonists|mesh-ancestor
56145244|NCT00878436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145245|NCT00878436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145246|NCT00878436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145247|NCT00878436|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
56145248|NCT00878436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145249|NCT00878436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145250|NCT00878826|Enoxaparin|enoxaparin|mesh-list
56145251|NCT00878826|Anticoagulants|anticoagulants|mesh-ancestor
56145252|NCT00878826|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
56145253|NCT00878826|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55854246|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
56145254|NCT00878826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145255|NCT00879060|Spironolactone|spironolactone|mesh-list
56145256|NCT00879060|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
56145257|NCT00879060|Hormone Antagonists|hormone antagonists|mesh-ancestor
56145258|NCT00879060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145259|NCT00879060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145260|NCT00879060|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
56145261|NCT00879060|Diuretics|diuretics|mesh-ancestor
56145262|NCT00879060|Natriuretic Agents|natriuretic agents|mesh-ancestor
55854334|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
56145263|NCT00882102|Decitabine|decitabine|mesh-list
56145264|NCT00882102|Gemtuzumab|gemtuzumab|mesh-list
56145265|NCT00882102|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56145266|NCT00882102|Antimetabolites|antimetabolites|mesh-ancestor
56145267|NCT00882102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145268|NCT00882102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145269|NCT00882102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145270|NCT00882102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854414|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
55854415|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854416|NCT01437111|Vitamin D|vitamin d|mesh-list
56145271|NCT00884052|Levetiracetam|levetiracetam|mesh-list
56145272|NCT00884052|Anticonvulsants|anticonvulsants|mesh-ancestor
56145273|NCT00884052|Nootropic Agents|nootropic agents|mesh-ancestor
56145307|NCT00887640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145308|NCT00887640|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56145309|NCT00887640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854692|NCT01793350|Benphothiamine|benphothiamine|mesh-list
56145310|NCT00887640|Antifungal Agents|antifungal agents|mesh-ancestor
56145311|NCT00887640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145312|NCT00887640|Immunologic Factors|immunologic factors|mesh-ancestor
56145313|NCT00887640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145314|NCT00887640|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56145315|NCT00887640|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56145316|NCT00887640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145317|NCT00887640|Anesthetics, Local|anesthetics, local|mesh-ancestor
56145318|NCT00887640|Anesthetics|anesthetics|mesh-ancestor
56145319|NCT00887640|Sensory System Agents|sensory system agents|mesh-ancestor
55854696|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
56145320|NCT00887640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145321|NCT00887640|Antiemetics|antiemetics|mesh-ancestor
56145322|NCT00887640|Autonomic Agents|autonomic agents|mesh-ancestor
56145323|NCT00887640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56145324|NCT00887640|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56145325|NCT00887640|Histamine Antagonists|histamine antagonists|mesh-ancestor
56145326|NCT00887640|Histamine Agents|histamine agents|mesh-ancestor
56145327|NCT00887640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145328|NCT00887640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145329|NCT00887640|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56145330|NCT00887640|Antipruritics|antipruritics|mesh-ancestor
56145331|NCT00887640|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145333|NCT00889200|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56145334|NCT00889200|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145335|NCT00889200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145336|NCT00892710|Bevacizumab|bevacizumab|mesh-list
56145337|NCT00892710|Carboplatin|carboplatin|mesh-list
56145339|NCT00892710|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56145340|NCT00892710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145341|NCT00892710|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56145342|NCT00892710|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56145343|NCT00892710|Growth Substances|growth substances|mesh-ancestor
56145344|NCT00892710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145345|NCT00892710|Growth Inhibitors|growth inhibitors|mesh-ancestor
56145346|NCT00892710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854942|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
56145347|NCT00892710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145348|NCT00892710|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56145349|NCT00892710|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56145352|NCT00894504|Panitumumab|panitumumab|mesh-list
56145353|NCT00894504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145354|NCT00894504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56145355|NCT00894504|Antimetabolites|antimetabolites|mesh-ancestor
56145356|NCT00894504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145357|NCT00894504|Antiviral Agents|antiviral agents|mesh-ancestor
56145358|NCT00894504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145359|NCT00894504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145360|NCT00894504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145361|NCT00894504|Immunologic Factors|immunologic factors|mesh-ancestor
56145362|NCT00894504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145363|NCT00894504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56145365|NCT00895752|Anticonvulsants|anticonvulsants|mesh-ancestor
56145366|NCT00895752|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56145367|NCT00895752|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56145368|NCT00895752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145369|NCT00895752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145370|NCT00895752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145371|NCT00895752|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56145372|NCT00895752|Protective Agents|protective agents|mesh-ancestor
56145374|NCT00896064|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
56145375|NCT00896064|Immunologic Factors|immunologic factors|mesh-ancestor
56145376|NCT00896064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145377|NCT00898560|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56145378|NCT00898560|Anticonvulsants|anticonvulsants|mesh-ancestor
56145379|NCT00898560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56145380|NCT00898560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56145381|NCT00898560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55855126|NCT00438880|Rituximab|rituximab|mesh-list
55855128|NCT00438880|Antibodies|antibodies|mesh-list
56145432|NCT00904488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145433|NCT00904488|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
56145434|NCT00904488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56145435|NCT00904488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145436|NCT00904488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55855732|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55855733|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55855814|NCT04149574|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56145437|NCT00904488|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
56145439|NCT00905268|Antioxidants|antioxidants|mesh-ancestor
56145440|NCT00905268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145441|NCT00905268|Protective Agents|protective agents|mesh-ancestor
56145442|NCT00905268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145443|NCT00905580|Pregabalin|pregabalin|mesh-list
56145444|NCT00905580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145445|NCT00905580|Analgesics|analgesics|mesh-ancestor
56145446|NCT00905580|Sensory System Agents|sensory system agents|mesh-ancestor
56145447|NCT00905580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145448|NCT00905580|Anticonvulsants|anticonvulsants|mesh-ancestor
56145449|NCT00905580|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56145450|NCT00905580|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56145451|NCT00905580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145452|NCT00905580|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55742407|NCT05131893|Letrozole|letrozole|mesh-list
55855899|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55855919|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856006|NCT00497770|Pemetrexed|pemetrexed|mesh-list
56145453|NCT00905580|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
56145454|NCT00905580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56145455|NCT00905580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145456|NCT00905580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56145458|NCT00908466|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56145459|NCT00908466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145460|NCT00908466|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56145461|NCT00908466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145462|NCT00908466|Antifungal Agents|antifungal agents|mesh-ancestor
56145463|NCT00908466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145464|NCT00908466|Immunologic Factors|immunologic factors|mesh-ancestor
56145465|NCT00908466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145466|NCT00911586|Methyltestosterone|methyltestosterone|mesh-list
56145467|NCT00911586|Testosterone|testosterone|mesh-list
56145468|NCT00911586|Testosterone undecanoate|testosterone undecanoate|mesh-list
56145469|NCT00911586|Testosterone enanthate|testosterone enanthate|mesh-list
56145470|NCT00911586|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56145471|NCT00911586|Androgens|androgens|mesh-ancestor
56145472|NCT00911586|Hormones|hormones|mesh-ancestor
56145473|NCT00911586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145474|NCT00911586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145475|NCT00911586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56145476|NCT00911586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145477|NCT00911586|Anabolic Agents|anabolic agents|mesh-ancestor
56145478|NCT00911742|Tramadol|tramadol|mesh-list
56145479|NCT00911742|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
56145480|NCT00911742|Narcotics|narcotics|mesh-ancestor
56145481|NCT00911742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145482|NCT00911742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145483|NCT00911742|Analgesics|analgesics|mesh-ancestor
55773109|NCT03191383|Vaccines|vaccines|mesh-list
56145484|NCT00911742|Sensory System Agents|sensory system agents|mesh-ancestor
56145485|NCT00911742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145486|NCT00912990|Cisatracurium|cisatracurium|mesh-list
56145487|NCT00912990|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
56145488|NCT00912990|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
56145489|NCT00912990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145490|NCT00912990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145491|NCT00913068|Lidocaine|lidocaine|mesh-list
56145492|NCT00913068|Ropivacaine|ropivacaine|mesh-list
56145493|NCT00913068|Anesthetics, Local|anesthetics, local|mesh-ancestor
56145494|NCT00913068|Anesthetics|anesthetics|mesh-ancestor
56145495|NCT00913068|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145496|NCT00913068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145497|NCT00913068|Sensory System Agents|sensory system agents|mesh-ancestor
55797938|NCT04947241|Immunologic Factors|immunologic factors|mesh-ancestor
56145498|NCT00913068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145499|NCT00913068|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56145500|NCT00913068|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55797939|NCT04947241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145501|NCT00913068|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56145502|NCT00913068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56145503|NCT00913068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145505|NCT00916032|Coagulants|coagulants|mesh-ancestor
56145506|NCT00922194|Metformin|metformin|mesh-list
56145507|NCT00922194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
56145508|NCT00922194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145509|NCT00923910|Acetaminophen|acetaminophen|mesh-list
56145510|NCT00923910|Diphenhydramine|diphenhydramine|mesh-list
56145511|NCT00923910|Promethazine|promethazine|mesh-list
56145512|NCT00923910|Interleukin-4|interleukin-4|mesh-list
56145513|NCT00923910|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
56145514|NCT00923910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56145515|NCT00923910|Analgesics|analgesics|mesh-ancestor
56145516|NCT00923910|Sensory System Agents|sensory system agents|mesh-ancestor
56145517|NCT00923910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145518|NCT00923910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145519|NCT00923910|Antipyretics|antipyretics|mesh-ancestor
56145520|NCT00923910|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
56145521|NCT00923910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
56145522|NCT00923910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145523|NCT00923910|Anesthetics, Local|anesthetics, local|mesh-ancestor
56145524|NCT00923910|Anesthetics|anesthetics|mesh-ancestor
56145525|NCT00923910|Antiemetics|antiemetics|mesh-ancestor
56145526|NCT00923910|Autonomic Agents|autonomic agents|mesh-ancestor
55742408|NCT05131893|Epirubicin|epirubicin|mesh-list
55742409|NCT05131893|Pertuzumab|pertuzumab|mesh-list
55856210|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856256|NCT01430403|Xhance|xhance|mesh-list
56145527|NCT00923910|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55856269|NCT01408641|Topiramate|topiramate|mesh-list
56145528|NCT00923910|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
56145529|NCT00923910|Histamine Antagonists|histamine antagonists|mesh-ancestor
56145530|NCT00923910|Histamine Agents|histamine agents|mesh-ancestor
56145532|NCT00923910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145533|NCT00923910|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56145534|NCT00923910|Antipruritics|antipruritics|mesh-ancestor
56145535|NCT00923910|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145536|NCT00923910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56145537|NCT00923910|Immunologic Factors|immunologic factors|mesh-ancestor
56145538|NCT00923910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145539|NCT00923910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856334|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55856335|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55856336|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856337|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
55856338|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
56145540|NCT00924066|Epothilones|epothilones|mesh-list
56145541|NCT00924066|Tubulin Modulators|tubulin modulators|mesh-ancestor
56145542|NCT00924066|Antimitotic Agents|antimitotic agents|mesh-ancestor
56145543|NCT00924066|Mitosis Modulators|mitosis modulators|mesh-ancestor
56145544|NCT00924066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145545|NCT00924066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145546|NCT00924612|Methyltestosterone|methyltestosterone|mesh-list
56145547|NCT00924612|Testosterone|testosterone|mesh-list
56145548|NCT00924612|Testosterone undecanoate|testosterone undecanoate|mesh-list
56145549|NCT00924612|Testosterone enanthate|testosterone enanthate|mesh-list
56145550|NCT00924612|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
56145551|NCT00924612|Androgens|androgens|mesh-ancestor
56145552|NCT00924612|Hormones|hormones|mesh-ancestor
56145553|NCT00924612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145554|NCT00924612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145555|NCT00924612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
56145556|NCT00924612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145557|NCT00924612|Anabolic Agents|anabolic agents|mesh-ancestor
56145558|NCT00925782|Melphalan|melphalan|mesh-list
56145559|NCT00925782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56145560|NCT00925782|Alkylating Agents|alkylating agents|mesh-ancestor
56145561|NCT00925782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856409|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55856410|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
55856411|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856412|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
56145694|NCT00943098|Analgesics|analgesics|mesh-ancestor
55856413|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856414|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
55856415|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55856416|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145562|NCT00925782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145563|NCT00925782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56145564|NCT00925782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145565|NCT00925782|Immunologic Factors|immunologic factors|mesh-ancestor
56145566|NCT00925782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145567|NCT00925938|Misoprostol|misoprostol|mesh-list
56145568|NCT00925938|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56145569|NCT00925938|Abortifacient Agents|abortifacient agents|mesh-ancestor
55856433|NCT00520468|Hormones|hormones|mesh-ancestor
56145570|NCT00925938|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55773178|NCT02326727|Fentanyl|fentanyl|mesh-list
56145571|NCT00925938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145572|NCT00925938|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56145573|NCT00925938|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56145574|NCT00925938|Oxytocics|oxytocics|mesh-ancestor
56145575|NCT00926952|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
56145576|NCT00926952|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
56145577|NCT00926952|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145578|NCT00927888|Bupivacaine|bupivacaine|mesh-list
56145579|NCT00927888|Anesthetics, Local|anesthetics, local|mesh-ancestor
56145580|NCT00927888|Anesthetics|anesthetics|mesh-ancestor
56145581|NCT00927888|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145582|NCT00927888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145583|NCT00927888|Sensory System Agents|sensory system agents|mesh-ancestor
56145584|NCT00927888|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856515|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145585|NCT00928200|Cytarabine|cytarabine|mesh-list
56145586|NCT00928200|Dexamethasone|dexamethasone|mesh-list
56145587|NCT00928200|Dexamethasone acetate|dexamethasone acetate|mesh-list
56145588|NCT00928200|Doxorubicin|doxorubicin|mesh-list
56145589|NCT00928200|Methotrexate|methotrexate|mesh-list
56145590|NCT00928200|Vincristine|vincristine|mesh-list
56145591|NCT00928200|Asparaginase|asparaginase|mesh-list
56145592|NCT00928200|Dexrazoxane|dexrazoxane|mesh-list
56145593|NCT00928200|Razoxane|razoxane|mesh-list
56145594|NCT00928200|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
56145595|NCT00928200|BB 1101|bb 1101|mesh-list
56145596|NCT00928200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56145597|NCT00928200|Antiemetics|antiemetics|mesh-ancestor
56145598|NCT00928200|Autonomic Agents|autonomic agents|mesh-ancestor
56145599|NCT00928200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145600|NCT00928200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742410|NCT05131893|Goserelin|goserelin|mesh-list
56145601|NCT00928200|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56145602|NCT00928200|Glucocorticoids|glucocorticoids|mesh-ancestor
56145603|NCT00928200|Hormones|hormones|mesh-ancestor
56145604|NCT00928200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145605|NCT00928200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55773211|NCT03588767|Vitamin D|vitamin d|mesh-list
55742411|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145606|NCT00928200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856706|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856707|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145607|NCT00928200|Protease Inhibitors|protease inhibitors|mesh-ancestor
55856810|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856811|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145609|NCT00928200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145610|NCT00928200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56145611|NCT00928200|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56145612|NCT00928200|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56145613|NCT00928200|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56145614|NCT00928200|Abortifacient Agents|abortifacient agents|mesh-ancestor
56145615|NCT00928200|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56145616|NCT00928200|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56145617|NCT00928200|Antimetabolites|antimetabolites|mesh-ancestor
56145618|NCT00928200|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145619|NCT00928200|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56145620|NCT00928200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145621|NCT00928200|Immunologic Factors|immunologic factors|mesh-ancestor
56145622|NCT00928200|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145623|NCT00928200|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56145624|NCT00928200|Antiviral Agents|antiviral agents|mesh-ancestor
56145625|NCT00928200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145626|NCT00928200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56145627|NCT00928200|Tubulin Modulators|tubulin modulators|mesh-ancestor
56145628|NCT00928200|Antimitotic Agents|antimitotic agents|mesh-ancestor
56145629|NCT00928200|Mitosis Modulators|mitosis modulators|mesh-ancestor
56145630|NCT00928200|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
56145631|NCT00928200|Protective Agents|protective agents|mesh-ancestor
56145632|NCT00931164|Sodium Oxybate|sodium oxybate|mesh-list
56145633|NCT00931164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
56145634|NCT00931164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
56145635|NCT00931164|Anesthetics, General|anesthetics, general|mesh-ancestor
56145636|NCT00931164|Anesthetics|anesthetics|mesh-ancestor
56145637|NCT00931164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145638|NCT00931164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145639|NCT00931242|Thalidomide|thalidomide|mesh-list
56145640|NCT00931242|Apremilast|apremilast|mesh-list
56145641|NCT00931242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56145642|NCT00931242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56145643|NCT00931242|Analgesics|analgesics|mesh-ancestor
56145644|NCT00931242|Sensory System Agents|sensory system agents|mesh-ancestor
56145645|NCT00931242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145646|NCT00931242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145647|NCT00931242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56145648|NCT00931242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145649|NCT00931242|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
56145650|NCT00931242|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56145651|NCT00931242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145652|NCT00931242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145653|NCT00931242|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145654|NCT00931242|Immunologic Factors|immunologic factors|mesh-ancestor
56145655|NCT00931242|Leprostatic Agents|leprostatic agents|mesh-ancestor
56145656|NCT00931242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56145657|NCT00931242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145658|NCT00931242|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
56145659|NCT00931242|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
56145660|NCT00931242|Growth Substances|growth substances|mesh-ancestor
56145661|NCT00931242|Growth Inhibitors|growth inhibitors|mesh-ancestor
56145662|NCT00931242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145663|NCT00932022|Trospium chloride|trospium chloride|mesh-list
56145664|NCT00932022|Parasympatholytics|parasympatholytics|mesh-ancestor
56145665|NCT00932022|Autonomic Agents|autonomic agents|mesh-ancestor
56145666|NCT00932022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145667|NCT00932022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145668|NCT00932022|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56145669|NCT00932022|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
56145670|NCT00932022|Cholinergic Agents|cholinergic agents|mesh-ancestor
56145671|NCT00932022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145672|NCT00932022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145673|NCT00932022|Urological Agents|urological agents|mesh-ancestor
56145674|NCT00939120|Tolterodine Tartrate|tolterodine tartrate|mesh-list
56145675|NCT00939120|Dutasteride|dutasteride|mesh-list
55857003|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55857004|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857005|NCT01400139|Hydrocodone|hydrocodone|mesh-list
56145676|NCT00939120|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55742412|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
56145677|NCT00939120|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55742413|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
56145678|NCT00939120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145679|NCT00939120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145680|NCT00939120|Hormone Antagonists|hormone antagonists|mesh-ancestor
56145681|NCT00939120|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145682|NCT00939120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145683|NCT00939120|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
56145684|NCT00939120|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55857108|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
55857109|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56145685|NCT00939120|Cholinergic Agents|cholinergic agents|mesh-ancestor
56145686|NCT00939120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145687|NCT00939120|Urological Agents|urological agents|mesh-ancestor
56145688|NCT00939900|Zoledronic Acid|zoledronic acid|mesh-list
56145689|NCT00939900|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56145690|NCT00939900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145691|NCT00943098|Diclofenac|diclofenac|mesh-list
56145692|NCT00943098|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
56145693|NCT00943098|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
56145695|NCT00943098|Sensory System Agents|sensory system agents|mesh-ancestor
56145696|NCT00943098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145697|NCT00943098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145698|NCT00943098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56145699|NCT00943098|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145700|NCT00943098|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
56145701|NCT00943098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145702|NCT00943098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145703|NCT00943800|Vidarabine|vidarabine|mesh-list
56145704|NCT00943800|Fludarabine|fludarabine|mesh-list
56145705|NCT00943800|Fludarabine phosphate|fludarabine phosphate|mesh-list
56145706|NCT00943800|Melphalan|melphalan|mesh-list
56145707|NCT00943800|Busulfan|busulfan|mesh-list
56145708|NCT00943800|Thiotepa|thiotepa|mesh-list
56145709|NCT00943800|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56145710|NCT00943800|Thymoglobulin|thymoglobulin|mesh-list
56145711|NCT00943800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145712|NCT00943800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56145713|NCT00943800|Antimetabolites|antimetabolites|mesh-ancestor
56145714|NCT00943800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145715|NCT00943800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145716|NCT00943800|Immunologic Factors|immunologic factors|mesh-ancestor
55857186|NCT01723904|Rotigotine|rotigotine|mesh-list
56145717|NCT00943800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145718|NCT00943800|Antiviral Agents|antiviral agents|mesh-ancestor
56145720|NCT00943800|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56145721|NCT00943800|Alkylating Agents|alkylating agents|mesh-ancestor
56145722|NCT00943800|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56145723|NCT00943878|Vaccines|vaccines|mesh-list
56145724|NCT00943878|Immunologic Factors|immunologic factors|mesh-ancestor
56145725|NCT00943878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145726|NCT00945282|Ritonavir|ritonavir|mesh-list
56145727|NCT00945282|Lopinavir|lopinavir|mesh-list
55857297|NCT01858363|Paclitaxel|paclitaxel|mesh-list
56145728|NCT00945282|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55857349|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
55857350|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145729|NCT00945282|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
56145730|NCT00945282|Protease Inhibitors|protease inhibitors|mesh-ancestor
56145731|NCT00945282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145732|NCT00945282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145733|NCT00945282|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56145734|NCT00945282|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56145735|NCT00945282|Antiviral Agents|antiviral agents|mesh-ancestor
56145736|NCT00945282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145737|NCT00945282|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56145738|NCT00945282|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56145739|NCT00945750|Famotidine|famotidine|mesh-list
56145740|NCT00945750|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56145741|NCT00945750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56145742|NCT00945750|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56145743|NCT00945750|Histamine Antagonists|histamine antagonists|mesh-ancestor
56145744|NCT00945750|Histamine Agents|histamine agents|mesh-ancestor
56145745|NCT00945750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145746|NCT00945750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145747|NCT00945750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145748|NCT00948090|Cyclophosphamide|cyclophosphamide|mesh-list
55742414|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
55742415|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145749|NCT00948090|Busulfan|busulfan|mesh-list
56145750|NCT00948090|Etoposide|etoposide|mesh-list
56145751|NCT00948090|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145752|NCT00948090|Immunologic Factors|immunologic factors|mesh-ancestor
56145753|NCT00948090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145754|NCT00948090|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145755|NCT00948090|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56145756|NCT00948090|Alkylating Agents|alkylating agents|mesh-ancestor
56145757|NCT00948090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145758|NCT00948090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145759|NCT00948090|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56145760|NCT00948090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56145761|NCT00948090|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56145762|NCT00948090|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56145763|NCT00948090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145765|NCT00950352|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
56145766|NCT00950352|Lipotropic Agents|lipotropic agents|mesh-ancestor
56145843|NCT00973752|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56145844|NCT00973752|Tubulin Modulators|tubulin modulators|mesh-ancestor
56145845|NCT00973752|Antimitotic Agents|antimitotic agents|mesh-ancestor
56145846|NCT00973752|Mitosis Modulators|mitosis modulators|mesh-ancestor
56145847|NCT00974142|Cyclosporine|cyclosporine|mesh-list
56145848|NCT00974142|Cyclosporins|cyclosporins|mesh-list
56145849|NCT00974142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145850|NCT00974142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145851|NCT00974142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145852|NCT00974142|Immunologic Factors|immunologic factors|mesh-ancestor
56145853|NCT00974142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145854|NCT00974142|Antifungal Agents|antifungal agents|mesh-ancestor
56145855|NCT00974142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145856|NCT00974142|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145857|NCT00974142|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145858|NCT00974142|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56145859|NCT00974376|Gabapentin|gabapentin|mesh-list
56145860|NCT00974376|Analgesics|analgesics|mesh-ancestor
56145861|NCT00974376|Sensory System Agents|sensory system agents|mesh-ancestor
56145862|NCT00974376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56145863|NCT00974376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145864|NCT00974376|Anticonvulsants|anticonvulsants|mesh-ancestor
55857895|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
56145865|NCT00974376|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55857902|NCT01855789|Methotrexate|methotrexate|mesh-list
56145866|NCT00974376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
56145867|NCT00974376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56145868|NCT00974376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
56145869|NCT00974376|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56145870|NCT00974376|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56145871|NCT00974376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56145872|NCT00974376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145873|NCT00974376|Antimanic Agents|antimanic agents|mesh-ancestor
56145875|NCT00976248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857971|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
56145876|NCT00976248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145877|NCT00976248|Immunologic Factors|immunologic factors|mesh-ancestor
56145878|NCT00976248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145879|NCT00976404|Raltegravir Potassium|raltegravir potassium|mesh-list
56145881|NCT00976404|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56145882|NCT00976404|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56145883|NCT00976404|Antiviral Agents|antiviral agents|mesh-ancestor
56145884|NCT00976404|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145885|NCT00976404|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56145886|NCT00976404|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
56145887|NCT00976404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145888|NCT00976404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145889|NCT00976404|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56145890|NCT00976404|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56145891|NCT00976404|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56145892|NCT00983346|Bortezomib|bortezomib|mesh-list
56145893|NCT00983346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798046|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
55858072|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145894|NCT00986856|Fusidic Acid|fusidic acid|mesh-list
56145895|NCT00986856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56145896|NCT00986856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145897|NCT00986856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
56145898|NCT00986856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742417|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
56145899|NCT00986856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145900|NCT00987480|Cyclosporine|cyclosporine|mesh-list
55858123|NCT04199325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145901|NCT00987480|Cyclophosphamide|cyclophosphamide|mesh-list
56145903|NCT00987480|Fludarabine|fludarabine|mesh-list
56145904|NCT00987480|Cyclosporins|cyclosporins|mesh-list
56145905|NCT00987480|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145906|NCT00987480|Immunologic Factors|immunologic factors|mesh-ancestor
56145907|NCT00987480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145908|NCT00987480|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145909|NCT00987480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55858124|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
55858125|NCT03952299|Oxybutynin|oxybutynin|mesh-list
56145910|NCT00987480|Alkylating Agents|alkylating agents|mesh-ancestor
56145911|NCT00987480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145912|NCT00987480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145913|NCT00987480|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56145914|NCT00987480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145915|NCT00987480|Antifungal Agents|antifungal agents|mesh-ancestor
56145916|NCT00987480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145917|NCT00987480|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145918|NCT00987480|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55858210|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
56145919|NCT00987558|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
56145920|NCT00987558|Simvastatin|simvastatin|mesh-list
56145921|NCT00987558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
56145922|NCT00987558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
56145923|NCT00987558|Antimetabolites|antimetabolites|mesh-ancestor
56145924|NCT00987558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145925|NCT00987558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
56145926|NCT00987558|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
56145927|NCT00987558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145928|NCT00987558|Anticonvulsants|anticonvulsants|mesh-ancestor
56145929|NCT00987558|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
56145930|NCT00987558|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
56145931|NCT00987558|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56145933|NCT00987948|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
56145934|NCT00987948|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
56145935|NCT00987948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145936|NCT00987948|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56145937|NCT00987948|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56145938|NCT00987948|Antiviral Agents|antiviral agents|mesh-ancestor
56145939|NCT00987948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145940|NCT00987948|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
56145941|NCT00989586|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
56145942|NCT00989586|Veltuzumab|veltuzumab|mesh-list
56145943|NCT00989586|Antibodies|antibodies|mesh-list
55858372|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145944|NCT00989586|Immunoglobulins|immunoglobulins|mesh-list
56145945|NCT00989586|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
56145946|NCT00989586|Immunologic Factors|immunologic factors|mesh-ancestor
56145947|NCT00989586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145948|NCT00989586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145949|NCT00990288|Thrombin|thrombin|mesh-list
56145950|NCT00990288|Hemostatics|hemostatics|mesh-list
56145951|NCT00990288|Coagulants|coagulants|mesh-ancestor
56145952|NCT00991458|Cyclosporine|cyclosporine|mesh-list
56145953|NCT00991458|Ophthalmic Solutions|ophthalmic solutions|mesh-list
56145954|NCT00991458|Cyclosporins|cyclosporins|mesh-list
56145955|NCT00991458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56145956|NCT00991458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858437|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56145957|NCT00991458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56145958|NCT00991458|Immunologic Factors|immunologic factors|mesh-ancestor
56145959|NCT00991458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145960|NCT00991458|Antifungal Agents|antifungal agents|mesh-ancestor
56145961|NCT00991458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56145962|NCT00991458|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145963|NCT00991458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145964|NCT00991458|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56145965|NCT00991458|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56145967|NCT00993798|Anesthetics, Local|anesthetics, local|mesh-ancestor
56145969|NCT00993798|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742418|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145970|NCT00993798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145971|NCT00993798|Sensory System Agents|sensory system agents|mesh-ancestor
56145972|NCT00993798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742419|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56145974|NCT00997620|Xhance|xhance|mesh-list
56145975|NCT00997620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56145976|NCT00997620|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
56145977|NCT00997620|Autonomic Agents|autonomic agents|mesh-ancestor
56145978|NCT00997620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858513|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858521|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
56145979|NCT00997620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145980|NCT00997620|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
56145981|NCT00997620|Respiratory System Agents|respiratory system agents|mesh-ancestor
56145982|NCT00997620|Dermatologic Agents|dermatologic agents|mesh-ancestor
56145983|NCT00997620|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
56145984|NCT00997932|Contraceptive Agents|contraceptive agents|mesh-list
56145985|NCT00997932|Levonorgestrel|levonorgestrel|mesh-list
56145986|NCT00997932|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55858606|NCT00527644|Hormones|hormones|mesh-ancestor
56145987|NCT00997932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56145988|NCT00997932|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56145989|NCT00997932|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56145990|NCT00997932|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
56145992|NCT00998010|Temozolomide|temozolomide|mesh-list
56145993|NCT00998010|Bortezomib|bortezomib|mesh-list
56145994|NCT00998010|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55858688|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
56145995|NCT00998010|Alkylating Agents|alkylating agents|mesh-ancestor
56145996|NCT00998010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56145997|NCT00998010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56145998|NCT00999102|Metoprolol|metoprolol|mesh-list
56145999|NCT00999102|Nebivolol|nebivolol|mesh-list
56146000|NCT00999102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56146001|NCT00999102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56146002|NCT00999102|Sympatholytics|sympatholytics|mesh-ancestor
56146003|NCT00999102|Autonomic Agents|autonomic agents|mesh-ancestor
55858828|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
55858829|NCT03519412|Temozolomide|temozolomide|mesh-list
56146004|NCT00999102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146005|NCT00999102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146006|NCT00999102|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
56146007|NCT00999102|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56146008|NCT00999102|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56146009|NCT00999102|Adrenergic Agents|adrenergic agents|mesh-ancestor
56146010|NCT00999102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146011|NCT00999102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146012|NCT00999102|Vasodilator Agents|vasodilator agents|mesh-ancestor
56146013|NCT00999102|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
56146014|NCT00999102|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
56146015|NCT00999102|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
56146016|NCT01000818|Raltegravir Potassium|raltegravir potassium|mesh-list
56146017|NCT01000818|Omeprazole|omeprazole|mesh-list
56146018|NCT01000818|Famotidine|famotidine|mesh-list
55858984|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56146019|NCT01000818|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
56146020|NCT01000818|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56146021|NCT01000818|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55858985|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
56146022|NCT01000818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146023|NCT01000818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146024|NCT01000818|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
56146025|NCT01000818|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
56146026|NCT01000818|Antiviral Agents|antiviral agents|mesh-ancestor
56146027|NCT01000818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56146028|NCT01000818|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
56146030|NCT01000818|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
56146031|NCT01000818|Histamine Antagonists|histamine antagonists|mesh-ancestor
56146032|NCT01000818|Histamine Agents|histamine agents|mesh-ancestor
56146033|NCT01000818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146034|NCT01000818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146036|NCT01001052|Gout Suppressants|gout suppressants|mesh-ancestor
56146037|NCT01001052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146038|NCT01001052|Tubulin Modulators|tubulin modulators|mesh-ancestor
56146039|NCT01001052|Antimitotic Agents|antimitotic agents|mesh-ancestor
55859092|NCT05204368|Meropenem|meropenem|mesh-list
56146040|NCT01001052|Mitosis Modulators|mitosis modulators|mesh-ancestor
55773695|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146041|NCT01001052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146042|NCT01001052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146044|NCT01001442|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56146045|NCT01001442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146046|NCT01001442|Tubulin Modulators|tubulin modulators|mesh-ancestor
56146047|NCT01001442|Antimitotic Agents|antimitotic agents|mesh-ancestor
56146048|NCT01001442|Mitosis Modulators|mitosis modulators|mesh-ancestor
56146049|NCT01001442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859146|NCT03001882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55859147|NCT03001882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859150|NCT02958514|Tobramycin|tobramycin|mesh-list
56146050|NCT01003080|Hemostatics|hemostatics|mesh-list
56146051|NCT01003080|Coagulants|coagulants|mesh-ancestor
56146052|NCT01003938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
56146053|NCT01003938|Topotecan|topotecan|mesh-list
56146054|NCT01003938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146055|NCT01003938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56146056|NCT01003938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146057|NCT01003938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146058|NCT01003938|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
56146059|NCT01003938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56146060|NCT01004718|Deoxyglucose|deoxyglucose|mesh-list
56146061|NCT01004718|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
56146062|NCT01004718|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55859232|NCT04505566|Analgesics|analgesics|mesh-ancestor
56146063|NCT01004718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146064|NCT01004718|Antimetabolites|antimetabolites|mesh-ancestor
56146065|NCT01004718|Antiviral Agents|antiviral agents|mesh-ancestor
56146066|NCT01004718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852893|NCT01898728|Povidone|povidone|mesh-list
56146067|NCT01005576|Fludarabine|fludarabine|mesh-list
56146068|NCT01005576|Melphalan|melphalan|mesh-list
56146069|NCT01005576|Alemtuzumab|alemtuzumab|mesh-list
56146070|NCT01005576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146071|NCT01005576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859307|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146072|NCT01005576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146073|NCT01005576|Immunologic Factors|immunologic factors|mesh-ancestor
56146074|NCT01005576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146075|NCT01005576|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56146076|NCT01005576|Alkylating Agents|alkylating agents|mesh-ancestor
56146077|NCT01005576|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56146078|NCT01005576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56146079|NCT01005810|Acetylcysteine|acetylcysteine|mesh-list
56146080|NCT01005810|N-monoacetylcystine|n-monoacetylcystine|mesh-list
56146081|NCT01005810|Antiviral Agents|antiviral agents|mesh-ancestor
56146082|NCT01005810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56146083|NCT01005810|Expectorants|expectorants|mesh-ancestor
56146084|NCT01005810|Respiratory System Agents|respiratory system agents|mesh-ancestor
56146085|NCT01005810|Free Radical Scavengers|free radical scavengers|mesh-ancestor
56146086|NCT01005810|Antioxidants|antioxidants|mesh-ancestor
56146087|NCT01005810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146088|NCT01005810|Protective Agents|protective agents|mesh-ancestor
56146089|NCT01005810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146090|NCT01005810|Antidotes|antidotes|mesh-ancestor
56146092|NCT01005888|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
56146093|NCT01005888|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
56146094|NCT01005888|Immunologic Factors|immunologic factors|mesh-ancestor
56146095|NCT01005888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146096|NCT01005888|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
56146097|NCT01005888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146098|NCT01007994|Propranolol|propranolol|mesh-list
56146100|NCT01007994|Isradipine|isradipine|mesh-list
56146101|NCT01007994|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
56146102|NCT01007994|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
56146104|NCT01007994|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859464|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146105|NCT01007994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146106|NCT01007994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146107|NCT01007994|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
56146108|NCT01007994|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
56146110|NCT01007994|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
56146111|NCT01007994|Protease Inhibitors|protease inhibitors|mesh-ancestor
56146112|NCT01007994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146113|NCT01007994|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
56146114|NCT01007994|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
56146115|NCT01007994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
56146116|NCT01008462|Cytarabine|cytarabine|mesh-list
56146117|NCT01008462|Mycophenolic Acid|mycophenolic acid|mesh-list
56146118|NCT01008462|Cyclophosphamide|cyclophosphamide|mesh-list
56146119|NCT01008462|Melphalan|melphalan|mesh-list
56146120|NCT01008462|Mechlorethamine|mechlorethamine|mesh-list
56146121|NCT01008462|Carmustine|carmustine|mesh-list
56146122|NCT01008462|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
56146123|NCT01008462|Fludarabine|fludarabine|mesh-list
56146124|NCT01008462|Fludarabine phosphate|fludarabine phosphate|mesh-list
55859585|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146125|NCT01008462|Etoposide|etoposide|mesh-list
56146126|NCT01008462|Etoposide phosphate|etoposide phosphate|mesh-list
56146127|NCT01008462|Podophyllotoxin|podophyllotoxin|mesh-list
56146128|NCT01008462|Tacrolimus|tacrolimus|mesh-list
56146129|NCT01008462|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146190|NCT01015170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146191|NCT01015170|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
56146192|NCT01015170|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56146193|NCT01015170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742420|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55742421|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
56146195|NCT01017042|Gout Suppressants|gout suppressants|mesh-ancestor
56146196|NCT01017042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56146197|NCT01017042|Tubulin Modulators|tubulin modulators|mesh-ancestor
56146198|NCT01017042|Antimitotic Agents|antimitotic agents|mesh-ancestor
55853739|NCT01468233|Adalimumab|adalimumab|mesh-list
56146199|NCT01017042|Mitosis Modulators|mitosis modulators|mesh-ancestor
56146200|NCT01017042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146201|NCT01017042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146203|NCT01018056|Anticonvulsants|anticonvulsants|mesh-ancestor
56146204|NCT01018056|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
56146205|NCT01018056|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
56146206|NCT01018056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
56146207|NCT01018056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146208|NCT01018056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146209|NCT01018056|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
56146210|NCT01018056|Protective Agents|protective agents|mesh-ancestor
56146211|NCT01018134|Desoximetasone|desoximetasone|mesh-list
56146212|NCT01018134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146213|NCT01018134|Glucocorticoids|glucocorticoids|mesh-ancestor
55860109|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
56146214|NCT01018134|Hormones|hormones|mesh-ancestor
56146215|NCT01018134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56146216|NCT01018134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146217|NCT01020006|Gemcitabine|gemcitabine|mesh-list
56146218|NCT01020006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56146219|NCT01020006|Antimetabolites|antimetabolites|mesh-ancestor
56146220|NCT01020006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146221|NCT01020006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146222|NCT01020006|Antiviral Agents|antiviral agents|mesh-ancestor
55853987|NCT01439373|Ribavirin|ribavirin|mesh-list
56146223|NCT01020006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56146224|NCT01020006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146225|NCT01020006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56146226|NCT01020006|Immunologic Factors|immunologic factors|mesh-ancestor
55860233|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55773885|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56146227|NCT01020006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146230|NCT05395962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146231|NCT05395962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
56146232|NCT05394480|Hydrocortisone|hydrocortisone|mesh-list
56146233|NCT05394480|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
56146234|NCT05017584|Bupivacaine|bupivacaine|mesh-list
56146235|NCT05017584|Anesthetics, Local|anesthetics, local|mesh-ancestor
55854077|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
55854078|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55854081|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
56146236|NCT05017584|Anesthetics|anesthetics|mesh-ancestor
56146237|NCT05017584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860300|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
55860302|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56146238|NCT05017584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146239|NCT05017584|Sensory System Agents|sensory system agents|mesh-ancestor
56146240|NCT05017584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146241|NCT04999332|Leucovorin|leucovorin|mesh-list
56146242|NCT04999332|Docetaxel|docetaxel|mesh-list
56146243|NCT04999332|Oxaliplatin|oxaliplatin|mesh-list
56146244|NCT04999332|Levoleucovorin|levoleucovorin|mesh-list
56146245|NCT04999332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56146246|NCT04999332|Tubulin Modulators|tubulin modulators|mesh-ancestor
56146247|NCT04999332|Antimitotic Agents|antimitotic agents|mesh-ancestor
55860458|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
55860459|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56146248|NCT04999332|Mitosis Modulators|mitosis modulators|mesh-ancestor
55860461|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
56146249|NCT04999332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56146250|NCT04999332|Antidotes|antidotes|mesh-ancestor
56146251|NCT04999332|Protective Agents|protective agents|mesh-ancestor
56146252|NCT04999332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56146253|NCT04999332|Vitamin B Complex|vitamin b complex|mesh-ancestor
56146254|NCT04999332|Vitamins|vitamins|mesh-ancestor
55742547|NCT05128617|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55742548|NCT05128617|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55742549|NCT05128617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742550|NCT04495179|Durvalumab|durvalumab|mesh-list
55742551|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55742552|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742553|NCT05118945|Insulin|insulin|mesh-list
55742554|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55742555|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55742556|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742557|NCT05305131|Gemcitabine|gemcitabine|mesh-list
55742558|NCT05305131|Bevacizumab|bevacizumab|mesh-list
55742559|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
55742560|NCT05305131|Cisplatin|cisplatin|mesh-list
55861550|NCT05581875|Hormones|hormones|mesh-ancestor
55742561|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55742562|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742563|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55742564|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55742566|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742567|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
55742568|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55742569|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
55854846|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55742572|NCT05305131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742573|NCT05305131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742574|NCT05305131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55742575|NCT05305131|Immunologic Factors|immunologic factors|mesh-ancestor
55742577|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55742578|NCT03122665|Analgesics|analgesics|mesh-ancestor
55742579|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
55742580|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742581|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742582|NCT05099913|Flupenthixol|flupenthixol|mesh-list
55742583|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55742584|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55742585|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742586|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742587|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55742588|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55742589|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
55742590|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742591|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742592|NCT03346993|Bupivacaine|bupivacaine|mesh-list
55742593|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
55742594|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
55742595|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742596|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742597|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
55742598|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742599|NCT03346837|Itraconazole|itraconazole|mesh-list
55742600|NCT03346837|Rifampin|rifampin|mesh-list
55742601|NCT03346837|Linrodostat|linrodostat|mesh-list
55742602|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
55742603|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742604|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55742605|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55742606|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742607|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861786|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55742608|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55742609|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
55742610|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742611|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742612|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55742613|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55742614|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
55742615|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55742616|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
55742617|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55742618|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55742619|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55742620|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55854909|NCT00427804|Calcitriol|calcitriol|mesh-list
55742623|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55742656|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55742657|NCT05303259|Bevacizumab|bevacizumab|mesh-list
55774235|NCT02018458|Doxorubicin|doxorubicin|mesh-list
55742658|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55742659|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742660|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55742661|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55742662|NCT05303259|Growth Substances|growth substances|mesh-ancestor
55862075|NCT04664933|Neuroprotective Agents|neuroprotective agents|mesh-list
55742663|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742664|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
55742665|NCT03121963|Acetaminophen|acetaminophen|mesh-list
55742667|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55742668|NCT03121963|Oxycodone|oxycodone|mesh-list
55742669|NCT03121963|Gabapentin|gabapentin|mesh-list
55742670|NCT03121963|Hydrocodone|hydrocodone|mesh-list
55742671|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55742672|NCT03121963|Analgesics|analgesics|mesh-ancestor
55742673|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
55742674|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742675|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854980|NCT00434356|Paclitaxel|paclitaxel|mesh-list
55742676|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
55742677|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55742678|NCT03121963|Narcotics|narcotics|mesh-ancestor
55742679|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742680|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55742681|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742683|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55742684|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55742685|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742687|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
55742688|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55742689|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55774277|NCT03178747|Methylene Blue|methylene blue|mesh-list
55742691|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55742692|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55742693|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742694|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
55742695|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
55742696|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
55742697|NCT04502251|Naltrexone|naltrexone|mesh-list
55742698|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55742699|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55742700|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742701|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
55742702|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742704|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55742705|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55742706|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55742707|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55742708|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
55742709|NCT04502017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742710|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742711|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55774314|NCT03196427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55774315|NCT02420665|Acetic Acid|acetic acid|mesh-list
55774316|NCT02420665|Proflavine|proflavine|mesh-list
55774317|NCT02420665|Retinol acetate|retinol acetate|mesh-list
55742712|NCT02648217|Insulin|insulin|mesh-list
55742714|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
55742715|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
55742716|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55742717|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
55742718|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55742719|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742720|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55742721|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55742722|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742723|NCT03122041|Incretins|incretins|mesh-ancestor
55742724|NCT03122041|Hormones|hormones|mesh-ancestor
55742725|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742726|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55742727|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
55774318|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55862478|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862721|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862722|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
55862723|NCT00245050|Vitamins|vitamins|mesh-ancestor
55862724|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
55742759|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742760|NCT04437225|Glycolic acid|glycolic acid|mesh-list
55742761|NCT04437225|Keratolytic Agents|keratolytic agents|mesh-ancestor
55742762|NCT04437225|Dermatologic Agents|dermatologic agents|mesh-ancestor
55742763|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
55742764|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
55742765|NCT05302713|Calcium|calcium|mesh-list
55742766|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55742767|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742768|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55742769|NCT05302713|Antacids|antacids|mesh-ancestor
55742770|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742771|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742772|NCT04921033|Prednisolone|prednisolone|mesh-list
55742773|NCT04921033|Budesonide|budesonide|mesh-list
55742774|NCT04921033|Azathioprine|azathioprine|mesh-list
55742775|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742776|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
55742777|NCT04921033|Hormones|hormones|mesh-ancestor
55742778|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742779|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742781|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742783|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742784|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55742785|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55742786|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
55742788|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742789|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855845|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
55742790|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55742791|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
55742793|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
55742794|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55742795|NCT03346681|Antiviral Agents|antiviral agents|mesh-ancestor
55742796|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742797|NCT03346681|Expectorants|expectorants|mesh-ancestor
55742798|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
55742799|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55742800|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
55742801|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742802|NCT03346681|Protective Agents|protective agents|mesh-ancestor
55742803|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742804|NCT03346681|Antidotes|antidotes|mesh-ancestor
55742805|NCT04488315|Dexamethasone|dexamethasone|mesh-list
55742806|NCT04488315|Ropivacaine|ropivacaine|mesh-list
55742807|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742809|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
55742810|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742811|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742812|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742813|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
55742815|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742816|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55742817|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742818|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
55742819|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
55855941|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
55742820|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742821|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
55742823|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55742825|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
55742826|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742827|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742828|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742829|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55742830|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55742831|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
55742834|NCT04800393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55742835|NCT04800393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742836|NCT04800393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742837|NCT04800393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55742838|NCT04800393|Anesthetics, General|anesthetics, general|mesh-ancestor
55742840|NCT04800393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55742841|NCT04800393|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55742843|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
55742844|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55742845|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
55742846|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742847|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742848|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742849|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55742850|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55742851|NCT04486911|Letrozole|letrozole|mesh-list
55742852|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742853|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55742854|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55742855|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742856|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742857|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55742858|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
55863250|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742859|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742860|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742861|NCT05135013|Drospirenone|drospirenone|mesh-list
55742862|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55742863|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55742864|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55742865|NCT05135013|Norethindrone|norethindrone|mesh-list
55742866|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
55742867|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
55742868|NCT05135013|Estradiol|estradiol|mesh-list
55742869|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55742870|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
55742871|NCT05135013|Estrogens|estrogens|mesh-ancestor
55742873|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742874|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742875|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55742876|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
55742880|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55742881|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55742882|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
55774487|NCT03820817|Rifaximin|rifaximin|mesh-list
55742883|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55742884|NCT05135013|Diuretics|diuretics|mesh-ancestor
55742885|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
55742886|NCT05135013|Progestins|progestins|mesh-ancestor
55742887|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55742888|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55742889|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742890|NCT04505917|Misoprostol|misoprostol|mesh-list
55742891|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55742892|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
55742893|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55863346|NCT05742568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55742894|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742895|NCT04505917|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55742896|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742897|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
55742898|NCT04505683|Ertapenem|ertapenem|mesh-list
55742899|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55742900|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742901|NCT05576155|Compound 21|compound 21|mesh-list
55742902|NCT05576155|Losartan|losartan|mesh-list
55742903|NCT05576155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55742904|NCT05576155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55742914|NCT03351751|PF-06372865|pf-06372865|mesh-list
55742915|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
55742916|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
55742917|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863381|NCT03801226|Calcium|calcium|mesh-list
55863449|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742918|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742919|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742920|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
55742921|NCT03347461|Dexamethasone|dexamethasone|mesh-list
55742922|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742947|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
55742948|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742949|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55742950|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55742951|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55742952|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742953|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
55742954|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742955|NCT03346525|Penicillins|penicillins|mesh-list
55742956|NCT03346525|Penicillin G|penicillin g|mesh-list
55742957|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
55742958|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
55856093|NCT00500656|Analgesics|analgesics|mesh-ancestor
55742963|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55742964|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863525|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863526|NCT00790270|Ibuprofen|ibuprofen|mesh-list
55742969|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742971|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55742972|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55742973|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55742974|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
55742975|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742977|NCT04502641|Fluorouracil|fluorouracil|mesh-list
55742978|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742980|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
55742981|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
55742982|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742984|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55742985|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55742986|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
55742990|NCT05555797|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55742991|NCT05555797|Betamethasone benzoate|betamethasone benzoate|mesh-list
55863598|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742992|NCT05555797|Tazarotene|tazarotene|mesh-list
55863600|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55742993|NCT05555797|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55742994|NCT05555797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742995|NCT05555797|Glucocorticoids|glucocorticoids|mesh-ancestor
55742996|NCT05555797|Hormones|hormones|mesh-ancestor
55856178|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55742997|NCT05555797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742998|NCT05555797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742999|NCT05555797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55743000|NCT05555797|Respiratory System Agents|respiratory system agents|mesh-ancestor
55743001|NCT05555797|Dermatologic Agents|dermatologic agents|mesh-ancestor
55743003|NCT03955575|Liraglutide|liraglutide|mesh-list
55743010|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55743011|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55743012|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
55743013|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743014|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55743015|NCT04163419|Tanezumab|tanezumab|mesh-list
55743017|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
55743018|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743019|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743021|NCT04282629|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55743022|NCT04282629|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55743023|NCT04282629|Vasodilator Agents|vasodilator agents|mesh-ancestor
55743024|NCT04282629|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55743025|NCT04282629|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55743026|NCT04282629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743027|NCT04282629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743028|NCT04282629|Protective Agents|protective agents|mesh-ancestor
55743029|NCT04282629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743030|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55743031|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55743032|NCT03351205|Estradiol|estradiol|mesh-list
55863659|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55743039|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55743040|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
55743041|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55743042|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55743044|NCT04698057|Amoxicillin|amoxicillin|mesh-list
55743045|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
55743046|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
55743047|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
55743048|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55743049|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55743050|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856479|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
55743051|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55743053|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743054|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743055|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743056|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55743057|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55743060|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
55743061|NCT02449005|Coagulants|coagulants|mesh-ancestor
55743062|NCT04132791|Aspirin|aspirin|mesh-list
55743063|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55743067|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743068|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743071|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55743072|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55743074|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55743081|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743082|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743083|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
55743084|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743085|NCT04250493|Insulin|insulin|mesh-list
55743086|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55743087|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743091|NCT01868451|Dacarbazine|dacarbazine|mesh-list
55743092|NCT01868451|Vinblastine|vinblastine|mesh-list
55743093|NCT01868451|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55743094|NCT01868451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743095|NCT01868451|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55743096|NCT01868451|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55743097|NCT01868451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743098|NCT01868451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743099|NCT01868451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55743100|NCT01868451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55743106|NCT04147221|Imipenem|imipenem|mesh-list
55743107|NCT04147221|Relebactam|relebactam|mesh-list
55743108|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55743109|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55743110|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55743111|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743115|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55743117|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55743118|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
55743119|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55743120|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55743121|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
55743122|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55856944|NCT01863667|Glimepiride|glimepiride|mesh-list
55743124|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
55743125|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
55743126|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743137|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55743140|NCT03892395|Vitamins|vitamins|mesh-list
55743141|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
55743149|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743151|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743152|NCT03376659|Bevacizumab|bevacizumab|mesh-list
55743153|NCT03376659|Durvalumab|durvalumab|mesh-list
55743154|NCT03376659|Capecitabine|capecitabine|mesh-list
55743155|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55743156|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743157|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55743158|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55743159|NCT03376659|Growth Substances|growth substances|mesh-ancestor
55743160|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743168|NCT03322215|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55743169|NCT03322215|Antimetabolites|antimetabolites|mesh-ancestor
55743170|NCT03322215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743171|NCT03322215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743172|NCT03322215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55743173|NCT03322215|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55743174|NCT03322215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55743175|NCT03322215|Hormone Antagonists|hormone antagonists|mesh-ancestor
55743176|NCT03322215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55743177|NCT03322215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743178|NCT03322215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55743179|NCT03322215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743180|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
55743181|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55743182|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55743183|NCT04086147|Tenecteplase|tenecteplase|mesh-list
55743186|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743187|NCT03161223|Azacitidine|azacitidine|mesh-list
55743188|NCT03161223|Durvalumab|durvalumab|mesh-list
55743189|NCT03161223|Romidepsin|romidepsin|mesh-list
55743190|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55743194|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743195|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55743196|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55743197|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55743198|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
55743199|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55743200|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
55743201|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55743202|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743203|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55743204|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55743205|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743215|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743217|NCT03083067|Bromides|bromides|mesh-list
55743218|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
55743219|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
55743220|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55743221|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55743223|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743224|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743225|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55743234|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743235|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743236|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
55743237|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55743239|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
55743241|NCT03218137|Verapamil|verapamil|mesh-list
55743244|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743245|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743246|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55743247|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
55743248|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55743249|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
55743250|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
55743254|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743255|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55743256|NCT05638399|Zoledronic Acid|zoledronic acid|mesh-list
55743258|NCT05638399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55743259|NCT05638399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743260|NCT02512471|Ropivacaine|ropivacaine|mesh-list
55743261|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
55743262|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
55743263|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743264|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743278|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743279|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
55743280|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
55743281|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
55743282|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743284|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55743285|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55743286|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55743287|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55743288|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55743289|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
55743290|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743291|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743292|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743293|NCT05431413|Phosphocreatine|phosphocreatine|mesh-list
55743294|NCT05431413|Fluoxetine|fluoxetine|mesh-list
55743296|NCT05431413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55743297|NCT05431413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743298|NCT05431413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743301|NCT05431413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743302|NCT05431413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55743304|NCT05431413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55743305|NCT05431413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55743306|NCT05431413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55743307|NCT05431413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743308|NCT05431413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55743309|NCT05431413|Protective Agents|protective agents|mesh-ancestor
55743310|NCT02507245|Hormones|hormones|mesh-list
55743311|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
55743316|NCT02517307|Glycerol|glycerol|mesh-list
55743317|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
55743318|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55743319|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55743321|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55743322|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55743323|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55743324|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55743325|NCT02517307|Protective Agents|protective agents|mesh-ancestor
55743326|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743327|NCT05431257|Venetoclax|venetoclax|mesh-list
55743328|NCT05431257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743329|NCT05431023|Lactoferrin|lactoferrin|mesh-list
55743330|NCT05431023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857978|NCT01876381|Tolvaptan|tolvaptan|mesh-list
55743336|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55743337|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
55743338|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55743339|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55743342|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743343|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743344|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55743345|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55743346|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55775085|NCT02413021|Cytarabine|cytarabine|mesh-list
55743347|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55743348|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55743349|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55743350|NCT01376167|Chloroquine|chloroquine|mesh-list
55858076|NCT04191135|Carboplatin|carboplatin|mesh-list
55858077|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
55858078|NCT04191135|Olaparib|olaparib|mesh-list
55858079|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858092|NCT04194255|Trace Elements|trace elements|mesh-ancestor
55858093|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
55858095|NCT04171167|Fluticasone|fluticasone|mesh-list
55743355|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55743356|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55743357|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55743360|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55743361|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55743362|NCT01376167|Analgesics|analgesics|mesh-ancestor
55743363|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
55743364|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743368|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
55743369|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
55743370|NCT02511613|Squalamine|squalamine|mesh-list
55743371|NCT02511613|Ranibizumab|ranibizumab|mesh-list
55743372|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55743373|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55743374|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55743375|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55743377|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743378|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
55743379|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743380|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55743384|NCT02506699|Analgesics|analgesics|mesh-list
55743385|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
55743386|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743387|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743388|NCT02506777|Metformin|metformin|mesh-list
55743390|NCT02506777|Doxorubicin|doxorubicin|mesh-list
55743391|NCT02506777|Fluorouracil|fluorouracil|mesh-list
55743392|NCT02506777|Melatonin|melatonin|mesh-list
55743393|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55743395|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743396|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55743397|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55743398|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
55743399|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743400|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743401|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55743402|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55743403|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55743404|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55743405|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55743406|NCT02506777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743407|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
55743408|NCT02506777|Protective Agents|protective agents|mesh-ancestor
55743409|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743415|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55743416|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743417|NCT02511847|Afatinib|afatinib|mesh-list
55743428|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743429|NCT02511223|Olaparib|olaparib|mesh-list
55743430|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55743431|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55775199|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
55743432|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743433|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743436|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55743438|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743439|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743441|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
55743442|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743443|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55743444|NCT02506231|Leucovorin|leucovorin|mesh-list
55743445|NCT02506231|Folic Acid|folic acid|mesh-list
55743446|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
55743447|NCT02506231|Antidotes|antidotes|mesh-ancestor
55743449|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743450|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
55743452|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
55743453|NCT02506231|Hematinics|hematinics|mesh-ancestor
55743454|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55743455|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55743456|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
55743458|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55743459|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55743460|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743461|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858631|NCT05558878|Ambroxol|ambroxol|mesh-list
55743464|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55743465|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55743466|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
55743468|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
55743469|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
55743470|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743471|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743472|NCT02511067|Ranibizumab|ranibizumab|mesh-list
55743473|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55775229|NCT02412085|Golimumab|golimumab|mesh-list
55743474|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55743475|NCT02511067|Growth Substances|growth substances|mesh-ancestor
55743476|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743477|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
55743478|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743479|NCT02505841|Ropivacaine|ropivacaine|mesh-list
55743480|NCT02505841|Succinylcholine|succinylcholine|mesh-list
55743481|NCT02505841|Curare|curare|mesh-list
55743482|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
55743483|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
55743484|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743485|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743486|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
55743487|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743488|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
55743489|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55743490|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55743491|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55743492|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55743493|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55743494|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
55743495|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743496|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743498|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55743499|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55775258|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
55743500|NCT03345667|Growth Substances|growth substances|mesh-ancestor
55743501|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743502|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
55743503|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743505|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
55743506|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55743507|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55743508|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55743509|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55743510|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
55743511|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743513|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
55743514|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
55743515|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743516|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
55743517|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
55743519|NCT02505451|Dobutamine|dobutamine|mesh-list
55743520|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55743521|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
55743525|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55743526|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55743527|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55743528|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
55743529|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743530|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743531|NCT02505451|Protective Agents|protective agents|mesh-ancestor
55743533|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
55775299|NCT03179293|Propofol|propofol|mesh-list
55743534|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743535|NCT02505295|Protective Agents|protective agents|mesh-ancestor
55743536|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743537|NCT02505295|Trace Elements|trace elements|mesh-ancestor
55743538|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
55743539|NCT02510911|Caffeine|caffeine|mesh-list
55743540|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55743541|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743543|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743544|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743545|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55743546|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55743547|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
55743548|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743549|NCT03121807|Leucovorin|leucovorin|mesh-list
55743550|NCT03121807|Fluorouracil|fluorouracil|mesh-list
55743551|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
55743552|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
55743553|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743554|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55743555|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743556|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55743557|NCT03121807|Immunologic Factors|immunologic factors|mesh-ancestor
55743558|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743559|NCT03121807|Antidotes|antidotes|mesh-ancestor
55743563|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
55743564|NCT03343873|Midazolam|midazolam|mesh-list
55743565|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
55743566|NCT03343873|Propofol|propofol|mesh-list
55743567|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55743568|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743569|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743571|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
55743572|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
55859384|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
55743573|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55743574|NCT03343873|Analgesics|analgesics|mesh-ancestor
55743575|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
55743576|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743577|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55743578|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55743579|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55743580|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
55743581|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743582|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743583|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55743584|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55743585|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55743586|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55743587|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
55743589|NCT03343795|Progesterone|progesterone|mesh-list
55743590|NCT03343795|Progestins|progestins|mesh-ancestor
55743591|NCT03343795|Hormones|hormones|mesh-ancestor
55775376|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55743592|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55743593|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743595|NCT02510287|Fentanyl|fentanyl|mesh-list
55743596|NCT02510287|Bupivacaine|bupivacaine|mesh-list
55743597|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
55743598|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
55743599|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743600|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743601|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
55743602|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743603|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55743604|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55743605|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55859511|NCT00612430|Growth Substances|growth substances|mesh-ancestor
55743606|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743607|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743608|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55743611|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55743612|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55743613|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
55743615|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743616|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55743618|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743619|NCT02515201|Taurolidine|taurolidine|mesh-list
55743620|NCT02515201|Heparin|heparin|mesh-list
55743622|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
55743623|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55743624|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55743625|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743627|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55743628|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743629|NCT02504983|Sorafenib|sorafenib|mesh-list
55743630|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743631|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55743632|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743633|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743634|NCT02510053|Caspofungin|caspofungin|mesh-list
55743635|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
55743644|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
55743645|NCT02504359|Carmustine|carmustine|mesh-list
55743646|NCT02504359|Ixazomib|ixazomib|mesh-list
55743647|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
55743648|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55743649|NCT02504359|Tacrolimus|tacrolimus|mesh-list
55743650|NCT02504359|Glycine|glycine|mesh-list
55743651|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55743652|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
55743653|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55743654|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743655|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55743656|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
55743657|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743658|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743659|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
55743660|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743661|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55743662|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55743663|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
55743664|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55743665|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55743666|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55743667|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55743669|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
55743671|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55743672|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55743675|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
55743676|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
55743677|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
55743679|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
55743680|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
55743681|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743682|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
55743684|NCT02729545|Cyproterone|cyproterone|mesh-list
55743685|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55743687|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55743688|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
55743689|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55743690|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743691|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55743693|NCT02729545|Hormones|hormones|mesh-ancestor
55743694|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55743696|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
55743697|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743698|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55743699|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
55743700|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55743701|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55859802|NCT00672100|Ropivacaine|ropivacaine|mesh-list
55743715|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55743716|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55743717|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743718|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743720|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55743721|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55743722|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55743723|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
55743724|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
55743725|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
55743726|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
55743728|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743730|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
55743731|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743733|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
55743734|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
55743735|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55743736|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55743737|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55743738|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
55743739|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
55743740|NCT02514343|Bupivacaine|bupivacaine|mesh-list
55743741|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
55743742|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
55743743|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743744|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743745|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
55743746|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743747|NCT02514343|Analgesics|analgesics|mesh-ancestor
55743748|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55743751|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743752|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743753|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55743754|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
55743755|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55743756|NCT02514421|Gemcitabine|gemcitabine|mesh-list
55743758|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55743759|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743760|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
55743761|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
55743768|NCT02514421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743769|NCT02514421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55743770|NCT02514421|Immunologic Factors|immunologic factors|mesh-ancestor
55743771|NCT02514421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743772|NCT04499209|Naproxen|naproxen|mesh-list
55743773|NCT04499209|Pregabalin|pregabalin|mesh-list
55743774|NCT04499209|Analgesics|analgesics|mesh-ancestor
55743775|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
55743776|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743777|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743778|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
55743779|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55743780|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743781|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743782|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55743783|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55743784|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55743785|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743786|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55743787|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55743789|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55743790|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55743791|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
55743792|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55859840|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
55743809|NCT02509195|Dolutegravir|dolutegravir|mesh-list
55743810|NCT02509195|Triumeq|triumeq|mesh-list
55743811|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55743812|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55743813|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743814|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743816|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55743818|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55743819|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55743820|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55743821|NCT02508805|Diclofenac|diclofenac|mesh-list
55743822|NCT02508805|Tizanidine|tizanidine|mesh-list
55743823|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55743825|NCT02508805|Analgesics|analgesics|mesh-ancestor
55743826|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
55743827|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743828|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743829|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55743830|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55743831|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55743832|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743833|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743835|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55743836|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55743837|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
55743848|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743849|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743850|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743852|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
55743853|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743854|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
55743855|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55743857|NCT03121417|Nivolumab|nivolumab|mesh-list
55743858|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55743859|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743860|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55743861|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743862|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55775724|NCT02677181|Methotrexate|methotrexate|mesh-list
55743863|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55743864|NCT02502643|Picibanil|picibanil|mesh-list
55743865|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743867|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
55743868|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743869|NCT02502565|Protective Agents|protective agents|mesh-ancestor
55743870|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743871|NCT04498897|Acamprosate|acamprosate|mesh-list
55743872|NCT04498897|Vortioxetine|vortioxetine|mesh-list
55743873|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
55743874|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55743875|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55743876|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55743877|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743878|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743879|NCT04498897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55743880|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55743881|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55743882|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743883|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743884|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
55743885|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55743886|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55743887|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55743888|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55743889|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55743890|NCT02502877|Midazolam|midazolam|mesh-list
55743891|NCT02502877|Propofol|propofol|mesh-list
55743895|NCT02502877|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55743896|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
55743897|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
55743898|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55743899|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55743900|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55743901|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55743902|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
55743903|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
55743904|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743905|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743906|NCT03121339|Vaccines|vaccines|mesh-list
55743907|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
55743908|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743910|NCT02502175|Opium|opium|mesh-list
55743911|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55743912|NCT02502175|Narcotics|narcotics|mesh-ancestor
55743913|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743914|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743915|NCT02502175|Analgesics|analgesics|mesh-ancestor
55743916|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
55743917|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743918|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
55743919|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
55743920|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
55743921|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55743925|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743926|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743927|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55743928|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55743929|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
55743931|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743932|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55743933|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55743934|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743935|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743936|NCT02500927|Naquotinib|naquotinib|mesh-list
55743937|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743938|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55743939|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743940|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743941|NCT02501863|Fentanyl|fentanyl|mesh-list
55743942|NCT02501863|Ropivacaine|ropivacaine|mesh-list
55743943|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
55743944|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
55743945|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743946|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743947|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
55743948|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55743949|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55743950|NCT02501863|Narcotics|narcotics|mesh-ancestor
55743951|NCT02501863|Analgesics|analgesics|mesh-ancestor
55743952|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55743953|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55743954|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
55743955|NCT02500459|Topotecan|topotecan|mesh-list
55743956|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55743957|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55743958|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743959|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743960|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55743961|NCT02500225|Sevoflurane|sevoflurane|mesh-list
55743962|NCT02500225|Etomidate|etomidate|mesh-list
55743963|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55743964|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55743966|NCT02500225|Anesthetics|anesthetics|mesh-ancestor
55743967|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55743968|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743969|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55743970|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55743971|NCT02507635|Levocetirizine|levocetirizine|mesh-list
55743972|NCT02507635|Desloratadine|desloratadine|mesh-list
55743973|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55743974|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55743975|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
55743976|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
55743977|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55743978|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743979|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743980|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55743981|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
55743983|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
55743984|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
55743985|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743986|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55743990|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743992|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
55743993|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55743994|NCT03120637|Methylene Blue|methylene blue|mesh-list
55743995|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55743996|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55743998|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55743999|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
55744000|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744001|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744002|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55744003|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55744004|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
55744005|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744006|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744007|NCT00706849|Mipomersen|mipomersen|mesh-list
55744008|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55744009|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55744010|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
55744011|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744012|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55744013|NCT02499445|Sufentanil|sufentanil|mesh-list
55744014|NCT02499445|Remifentanil|remifentanil|mesh-list
55744015|NCT02499445|Propofol|propofol|mesh-list
55744016|NCT02499445|Sevoflurane|sevoflurane|mesh-list
55744017|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55744018|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744019|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744020|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55744021|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
55744022|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
55744023|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55744024|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55744025|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55744026|NCT02499445|Narcotics|narcotics|mesh-ancestor
55744027|NCT02499445|Analgesics|analgesics|mesh-ancestor
55744028|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
55744029|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744030|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55744031|NCT04443049|Mebendazole|mebendazole|mesh-list
55744032|NCT04443049|Piperazine|piperazine|mesh-list
55744033|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
55744034|NCT04443049|Lenvatinib|lenvatinib|mesh-list
55744035|NCT04443049|DMP 777|dmp 777|mesh-list
55744036|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744037|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55744038|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744039|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744040|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
55744041|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
55744042|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55744043|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744062|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55744063|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
55744064|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744065|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55744066|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744067|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744068|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
55744069|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744070|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
55744071|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744072|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55744073|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744074|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55744075|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
55744076|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55744077|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
55744078|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55744079|NCT02494687|Domperidone|domperidone|mesh-list
55744080|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
55744081|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
55744082|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744083|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744084|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55744085|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55744086|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
55744087|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744088|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744091|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
55744092|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55744093|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744094|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55744095|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55744096|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744097|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55744098|NCT03341767|Clofazimine|clofazimine|mesh-list
55744099|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744100|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
55744101|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55744102|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744103|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
55744104|NCT02498509|Levocabastine|levocabastine|mesh-list
55744105|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744106|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
55744107|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55744108|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55744109|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55744110|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
55744111|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
55744112|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744113|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744114|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744115|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
55744116|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55744117|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
55744118|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55744119|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744120|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55744124|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55744125|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55744126|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55744127|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744128|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744129|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
55744130|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55744131|NCT03335527|Dexmedetomidine|dexmedetomidine|mesh-list
55744132|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55744133|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744134|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744135|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744136|NCT03335527|Analgesics|analgesics|mesh-ancestor
55744137|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
55744138|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744139|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55744140|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55744141|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55744142|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
55744143|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744144|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744145|NCT02493049|Domperidone|domperidone|mesh-list
55744146|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744148|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
55744149|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744150|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744151|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55744152|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55744154|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744155|NCT03120715|Heparin|heparin|mesh-list
55744156|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55744158|NCT03120715|Dalteparin|dalteparin|mesh-list
55744159|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55744161|NCT03120715|Estrogens|estrogens|mesh-list
55744162|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
55744163|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55744164|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55744165|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744166|NCT03120715|Progestins|progestins|mesh-ancestor
55744167|NCT03120715|Hormones|hormones|mesh-ancestor
55744168|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744169|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744170|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55744172|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55744173|NCT03120403|Narcotics|narcotics|mesh-ancestor
55744174|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744175|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744176|NCT03120403|Analgesics|analgesics|mesh-ancestor
55744177|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
55744178|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744179|NCT03335293|Epinephrine|epinephrine|mesh-list
55860211|NCT00687544|Ribavirin|ribavirin|mesh-list
55744182|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55744183|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55744184|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
55776034|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744186|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744187|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744188|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55744189|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55744190|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
55744191|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744193|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
55744194|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
55744195|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
55744196|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55744197|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
55744200|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744201|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744202|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55744203|NCT03340753|Diuretics|diuretics|mesh-ancestor
55744204|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
55744205|NCT03340753|Hormones|hormones|mesh-ancestor
55744206|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55744207|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55744208|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744210|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
55744211|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744212|NCT00707161|Cisplatin|cisplatin|mesh-list
55744213|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744215|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55744216|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744217|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744218|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744219|NCT03120247|Analgesics|analgesics|mesh-ancestor
55744220|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
55744221|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744222|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55744223|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55744224|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55744295|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744296|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744297|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55744298|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
55744299|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
55860358|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
55744303|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55744304|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
55744305|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55776190|NCT03115489|Propofol|propofol|mesh-list
55744306|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744308|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55744309|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744310|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
55744311|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744312|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
55744313|NCT03342079|Anesthetics|anesthetics|mesh-list
55744314|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
55744315|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744316|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744317|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
55744318|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744319|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55744320|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
55744321|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744323|NCT04494763|Propranolol|propranolol|mesh-list
55744324|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55744325|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55744326|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
55744327|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744328|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744342|NCT04494529|Betamethasone|betamethasone|mesh-list
55744343|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
55744344|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55744346|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55744347|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744348|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
55744349|NCT04494529|Hormones|hormones|mesh-ancestor
55744350|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744351|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744352|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55744353|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
55744354|NCT02491879|Ketoprofen|ketoprofen|mesh-list
55744355|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55744356|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744357|NCT02491879|Analgesics|analgesics|mesh-ancestor
55744359|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744360|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744361|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744362|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744363|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55744364|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744365|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744367|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55744369|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744370|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744371|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55744372|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55744373|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
55744374|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860509|NCT00662818|Acetaminophen|acetaminophen|mesh-list
55776751|NCT02657369|Lenvatinib|lenvatinib|mesh-list
55786865|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55786867|NCT03079999|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55786868|NCT03079999|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55786869|NCT03079999|Analgesics|analgesics|mesh-ancestor
55786870|NCT03079999|Sensory System Agents|sensory system agents|mesh-ancestor
55786871|NCT03079999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55786872|NCT03079999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55786873|NCT03079999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55786874|NCT03079999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55786875|NCT03079999|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55786876|NCT03079999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55786877|NCT03079999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786878|NCT03079999|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55786879|NCT03079999|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55786880|NCT03079999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786881|NCT03079999|Antipyretics|antipyretics|mesh-ancestor
55786882|NCT04973969|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55786883|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
55786884|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55786886|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55786889|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55786891|NCT02958709|Rifampin|rifampin|mesh-list
55786892|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55786893|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
55786894|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55786895|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55786896|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
55786897|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55786898|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55786899|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786900|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55786901|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55786902|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55786903|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55786904|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55786905|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55786906|NCT04979663|Gemcitabine|gemcitabine|mesh-list
55786907|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
55786908|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55786909|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
55786910|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55786912|NCT04979663|Antiviral Agents|antiviral agents|mesh-ancestor
55786913|NCT04979663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787012|NCT05036473|Levodopa|levodopa|mesh-list
55787013|NCT05036473|Carbidopa|carbidopa|mesh-list
55787014|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55787015|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55787016|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55787017|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
55787018|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787019|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787020|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787021|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55787022|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787023|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55787024|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
55787025|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
55787026|NCT04985851|Durvalumab|durvalumab|mesh-list
55787027|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55787028|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787029|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787033|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
55787034|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55787035|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787036|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55787037|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55787038|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787039|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787040|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
55787041|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787042|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787043|NCT04973579|Anesthetics|anesthetics|mesh-list
55787044|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55787045|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787047|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
55787048|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787049|NCT04834063|Protective Agents|protective agents|mesh-ancestor
55860809|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55787054|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55787055|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55787057|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
55787058|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787059|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787060|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55787061|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787213|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787214|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55787215|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787217|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55787218|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55787221|NCT04271293|Edoxaban|edoxaban|mesh-list
55787222|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55787223|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
55787224|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55787225|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
55787226|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787227|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787228|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
55787230|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55787231|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55787232|NCT04970069|Analgesics|analgesics|mesh-list
55787233|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
55787234|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787235|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787236|NCT04970303|Methylphenidate|methylphenidate|mesh-list
55787237|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55787238|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787239|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55787240|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55787241|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55787242|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787243|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
55787244|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55787246|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55787247|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
55787248|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
55787249|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787250|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787251|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55787252|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
55787253|NCT04432259|Hormones|hormones|mesh-ancestor
55787254|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787255|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55787256|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787257|NCT04964219|Ketamine|ketamine|mesh-list
55787258|NCT04964219|Esketamine|esketamine|mesh-list
55787259|NCT04964219|Analgesics|analgesics|mesh-ancestor
55787260|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
55787261|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55787262|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787534|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55787535|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787536|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55787537|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787538|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
55787540|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
55787541|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55787542|NCT04952051|Hematinics|hematinics|mesh-ancestor
55787543|NCT04952051|Vitamins|vitamins|mesh-ancestor
55787544|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
55787545|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55787546|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
55787547|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55787548|NCT04960943|Trastuzumab|trastuzumab|mesh-list
55787549|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55787550|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55787552|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55787553|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787554|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55787556|NCT04431713|Hormones|hormones|mesh-ancestor
55787557|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55787558|NCT05104333|Vaccines|vaccines|mesh-list
55787559|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
55787560|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55787561|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
55787562|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
55787563|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55787564|NCT04436419|Protective Agents|protective agents|mesh-ancestor
55787565|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788153|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55788154|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55788155|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
55788156|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788157|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788158|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55788159|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55788160|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
55788161|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55788162|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
55788163|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
55788165|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55788166|NCT04400201|Propofol|propofol|mesh-list
55788167|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55788168|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788169|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788170|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55788171|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
55788172|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
55788173|NCT04423107|Acetaminophen|acetaminophen|mesh-list
55788174|NCT04423107|Ibuprofen|ibuprofen|mesh-list
55788183|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788184|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55788185|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55788186|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788187|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788188|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55788189|NCT04423107|Narcotics|narcotics|mesh-ancestor
55788190|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788191|NCT01675531|Oxycodone|oxycodone|mesh-list
55788192|NCT01675531|Naloxone|naloxone|mesh-list
55788193|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55788194|NCT01675531|Narcotics|narcotics|mesh-ancestor
55788195|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788196|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788197|NCT01675531|Analgesics|analgesics|mesh-ancestor
55788198|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
55788355|NCT02144857|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55788356|NCT02144857|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55788357|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
55788358|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55788359|NCT03807817|Ethanol|ethanol|mesh-list
55788360|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55788361|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788362|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788364|NCT05122117|Methylene Blue|methylene blue|mesh-list
55788365|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788366|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788367|NCT05117125|Heparin|heparin|mesh-list
55788368|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
55788369|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55788370|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55788371|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788372|NCT05121883|Edaravone|edaravone|mesh-list
55788373|NCT05121883|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55788374|NCT05121883|Antioxidants|antioxidants|mesh-ancestor
55788375|NCT05121883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788376|NCT05121883|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55788377|NCT05121883|Protective Agents|protective agents|mesh-ancestor
55788378|NCT05121883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788379|NCT05116345|Dexamethasone|dexamethasone|mesh-list
55788380|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
55788381|NCT05116345|BB 1101|bb 1101|mesh-list
55788383|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
55788384|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
55788385|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788386|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788387|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788389|NCT05116345|Hormones|hormones|mesh-ancestor
55788390|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788398|NCT05112211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788399|NCT05112211|Antimalarials|antimalarials|mesh-ancestor
55788400|NCT05112211|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55788401|NCT05112211|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55788402|NCT05076097|Rituximab|rituximab|mesh-list
55788403|NCT05076097|Lenalidomide|lenalidomide|mesh-list
55788404|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55788405|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788406|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
55788407|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788409|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55788410|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55788411|NCT05076097|Growth Substances|growth substances|mesh-ancestor
55788412|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
55788414|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
55788417|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55788418|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788419|NCT04513639|Antiemetics|antiemetics|mesh-ancestor
55788421|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788422|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788423|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788424|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
55788425|NCT04513639|Hormones|hormones|mesh-ancestor
55788426|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788427|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55788428|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788429|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
55788430|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788431|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788432|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
55788435|NCT04675333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788436|NCT04675333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55788437|NCT05229991|Ritonavir|ritonavir|mesh-list
55788438|NCT05229991|Lonafarnib|lonafarnib|mesh-list
55788439|NCT05229991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55788440|NCT05229991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55788441|NCT05229991|Protease Inhibitors|protease inhibitors|mesh-ancestor
55788442|NCT05229991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788443|NCT05229991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788446|NCT05229991|Antiviral Agents|antiviral agents|mesh-ancestor
55788447|NCT05229991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788448|NCT05229991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55788449|NCT05229991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55788450|NCT05229913|Esketamine|esketamine|mesh-list
55788451|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
55788452|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55788454|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55788455|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788456|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788457|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
55788458|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788459|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788460|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55788461|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
55788462|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788463|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
55788464|NCT04418479|Aspirin|aspirin|mesh-list
55788465|NCT04418479|Clopidogrel|clopidogrel|mesh-list
55788470|NCT04418479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788471|NCT04418479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788472|NCT04418479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788474|NCT04418479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55788475|NCT04418479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55788476|NCT04418479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788477|NCT04418479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55788478|NCT04418479|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55788479|NCT04418479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788480|NCT04418479|Antipyretics|antipyretics|mesh-ancestor
55788481|NCT04418479|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55788482|NCT04418479|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55788483|NCT04418479|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55788484|NCT04418479|Purinergic Agents|purinergic agents|mesh-ancestor
55788485|NCT04418479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788486|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55788487|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
55788488|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55788489|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55788490|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55788491|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788492|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788493|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55788494|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55788495|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55788496|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
55788497|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788498|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788499|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55788500|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55788501|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
55788502|NCT05228743|Paclitaxel|paclitaxel|mesh-list
55788503|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55788504|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788505|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
55788506|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
55788507|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
55788508|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788509|NCT03321019|Capsaicin|capsaicin|mesh-list
55788510|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
55788511|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
55788512|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
55788513|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788514|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788516|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55788517|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788518|NCT04507477|Rituximab|rituximab|mesh-list
55860897|NCT02992678|Protective Agents|protective agents|mesh-ancestor
55788528|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55788529|NCT01675141|Growth Substances|growth substances|mesh-ancestor
55788530|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
55788531|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788532|NCT05102149|Vildagliptin|vildagliptin|mesh-list
55788533|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55788534|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788535|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55788536|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
55788537|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788538|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788539|NCT04412395|Lactoferrin|lactoferrin|mesh-list
55788540|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788541|NCT04987099|Choline|choline|mesh-list
55788544|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
55788545|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788546|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55788547|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55788548|NCT04987099|Nootropic Agents|nootropic agents|mesh-ancestor
55788549|NCT03906721|Oxycodone|oxycodone|mesh-list
55788550|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55788551|NCT03906721|Narcotics|narcotics|mesh-ancestor
55788552|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788554|NCT03906721|Analgesics|analgesics|mesh-ancestor
55788555|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
55788556|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788557|NCT04663711|Anesthetics|anesthetics|mesh-list
55788558|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788559|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788561|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55788562|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788563|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788564|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55788565|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
55788566|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788567|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55788568|NCT04772209|Heparin|heparin|mesh-list
55788569|NCT04772209|Anticoagulants|anticoagulants|mesh-ancestor
55788570|NCT04772209|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55788571|NCT04772209|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55788572|NCT04772209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788573|NCT04582591|Cannabidiol|cannabidiol|mesh-list
55788574|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
55788575|NCT04497883|Maribavir|maribavir|mesh-list
55788576|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
55788577|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788578|NCT03688633|Candesartan|candesartan|mesh-list
55788579|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55788580|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55788581|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55788582|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788584|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
55788585|NCT03963895|Coagulants|coagulants|mesh-ancestor
55788586|NCT03662815|Molgramostim|molgramostim|mesh-list
55788588|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
55788589|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788590|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788591|NCT03490903|Fentanyl|fentanyl|mesh-list
55788593|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55788604|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55788605|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55788606|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55788607|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55788609|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
55788610|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788611|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788612|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
55788613|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788614|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
55788615|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55788616|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55788617|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788618|NCT04169191|Urological Agents|urological agents|mesh-ancestor
55788619|NCT03225547|Pembrolizumab|pembrolizumab|mesh-list
55788620|NCT03225547|Mifepristone|mifepristone|mesh-list
55788621|NCT03225547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55788622|NCT03225547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788623|NCT03225547|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55788624|NCT03225547|Abortifacient Agents|abortifacient agents|mesh-ancestor
55788625|NCT03225547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55788626|NCT03225547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788627|NCT03225547|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55788628|NCT03225547|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55788629|NCT03225547|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55788630|NCT03225547|Contraceptive Agents|contraceptive agents|mesh-ancestor
55788631|NCT03225547|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55788632|NCT03225547|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55788633|NCT03225547|Hormone Antagonists|hormone antagonists|mesh-ancestor
55788634|NCT03225547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788635|NCT03225547|Luteolytic Agents|luteolytic agents|mesh-ancestor
55788636|NCT03225547|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55788641|NCT03954613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788642|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788644|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788645|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788646|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
55788647|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55788648|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55788649|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
55788650|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55788651|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55788652|NCT03367819|Cemiplimab|cemiplimab|mesh-list
55788653|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55788654|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788656|NCT04023253|Mirabegron|mirabegron|mesh-list
55788657|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55788658|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55788659|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
55788660|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788661|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788662|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788663|NCT04023253|Urological Agents|urological agents|mesh-ancestor
55788664|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55788665|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55788666|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55788667|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
55788668|NCT03066739|Remifentanil|remifentanil|mesh-list
55788669|NCT03066739|Naloxone|naloxone|mesh-list
55788670|NCT03066739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55788671|NCT03066739|Narcotics|narcotics|mesh-ancestor
55788672|NCT03066739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788673|NCT03066739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788674|NCT03066739|Analgesics|analgesics|mesh-ancestor
55788675|NCT03066739|Sensory System Agents|sensory system agents|mesh-ancestor
55788676|NCT03066739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788677|NCT03066739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55788679|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55788680|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55788681|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788682|NCT04875871|Trace Elements|trace elements|mesh-ancestor
55788683|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
55788684|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788685|NCT04781725|Cisplatin|cisplatin|mesh-list
55788686|NCT04781725|Vinblastine|vinblastine|mesh-list
55788687|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788688|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55788689|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
55788690|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
55788691|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
55788692|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788693|NCT03580525|Nicotine|nicotine|mesh-list
55788694|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55788695|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
55788696|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788697|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788698|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55788699|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55788700|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
55788701|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788716|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788717|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55788720|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55788721|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55788722|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788723|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
55788724|NCT03505723|Coagulants|coagulants|mesh-ancestor
55788725|NCT04264663|Furazolidone|furazolidone|mesh-list
55788727|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55788728|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788729|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55788730|NCT04264663|Renal Agents|renal agents|mesh-ancestor
55788731|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
55788732|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55788733|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55788734|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55788735|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788736|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788737|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
55788738|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55788739|NCT05403307|Vaccines|vaccines|mesh-list
55788740|NCT05403307|Immunologic Factors|immunologic factors|mesh-ancestor
55788741|NCT05403307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788742|NCT04563559|Prednisolone|prednisolone|mesh-list
55788743|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55788744|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
55788745|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55788746|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
55788747|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55788748|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
55788749|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55788752|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788761|NCT04563559|Protective Agents|protective agents|mesh-ancestor
55788763|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55788764|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
55788765|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788766|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788767|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55788768|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55788769|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
55788771|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788772|NCT02002819|Levetiracetam|levetiracetam|mesh-list
55788773|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
55788775|NCT01597193|Fulvestrant|fulvestrant|mesh-list
55788776|NCT01597193|Anastrozole|anastrozole|mesh-list
55788777|NCT01597193|Exemestane|exemestane|mesh-list
55788778|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55788779|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55788780|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55788781|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55788897|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788898|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55788899|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
55788900|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55788901|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788902|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55788904|NCT04929509|Fluorides|fluorides|mesh-list
55788905|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
55788906|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
55788907|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
55788908|NCT04929509|Protective Agents|protective agents|mesh-ancestor
55788909|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788910|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55788911|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788912|NCT03054467|Amlodipine|amlodipine|mesh-list
55788922|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
55788923|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55788924|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788925|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
55788926|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55788927|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
55788928|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55788929|NCT02730325|Antibodies|antibodies|mesh-list
55788930|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
55788931|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788932|NCT04500847|Emtricitabine|emtricitabine|mesh-list
55788933|NCT04500847|Antiviral Agents|antiviral agents|mesh-ancestor
55788934|NCT04500847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55788935|NCT04500847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55788936|NCT04500847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55788937|NCT04500847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788938|NCT04500847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788940|NCT04500847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55788942|NCT04928495|Bromhexine|bromhexine|mesh-list
55788944|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788945|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
55788946|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788961|NCT04922593|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55788963|NCT04922593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55788964|NCT04922593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788965|NCT04922593|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55788966|NCT04922593|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55788967|NCT04922593|Dopamine Agents|dopamine agents|mesh-ancestor
55788968|NCT01573429|Bisphenol A|bisphenol a|mesh-list
55788969|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55788970|NCT01573429|Estrogens|estrogens|mesh-ancestor
55788972|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55777222|NCT02700841|Alkylating Agents|alkylating agents|mesh-ancestor
55788973|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788974|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55788976|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788977|NCT01573429|Protective Agents|protective agents|mesh-ancestor
55788978|NCT04909931|Vitamin D|vitamin d|mesh-list
55788979|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
55788980|NCT04909931|Vitamins|vitamins|mesh-ancestor
55788981|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
55788982|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55788983|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55788984|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55788985|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
55788986|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55788987|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55788988|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788989|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
55788990|NCT04918589|Coagulants|coagulants|mesh-ancestor
55788991|NCT04496401|Tacrolimus|tacrolimus|mesh-list
55788992|NCT04496401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55788993|NCT04496401|Immunologic Factors|immunologic factors|mesh-ancestor
55861194|NCT00733096|Etanercept|etanercept|mesh-list
55788995|NCT04496401|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55788996|NCT04496401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55788997|NCT04496401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55788999|NCT04928651|Analgesics|analgesics|mesh-ancestor
55789000|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
55789001|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789002|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789003|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55789005|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
55789006|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55789007|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55789008|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55789009|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
55789010|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789011|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789013|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55789014|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55789015|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
55789016|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789017|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55789018|NCT02620787|Tedizolid|tedizolid|mesh-list
55789019|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55744433|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744434|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744435|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55744436|NCT03329443|Diuretics|diuretics|mesh-ancestor
55744437|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
55744438|NCT03328975|Dexamethasone|dexamethasone|mesh-list
55744439|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744440|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
55744441|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
55744442|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744443|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744444|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55744445|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
55744446|NCT03328975|Hormones|hormones|mesh-ancestor
55744447|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744448|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55744449|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744450|NCT05430711|Dinoprostone|dinoprostone|mesh-list
55744452|NCT05430711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55744453|NCT05430711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744454|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
55744455|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55744457|NCT03324685|Estrogens|estrogens|mesh-ancestor
55744458|NCT03324685|Hormones|hormones|mesh-ancestor
55744459|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744460|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744461|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55744462|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
55744463|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55744464|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55744465|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55744466|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55744467|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55744468|NCT00977691|Sirolimus|sirolimus|mesh-list
55744469|NCT00977691|Cyclophosphamide|cyclophosphamide|mesh-list
55744470|NCT00977691|Alemtuzumab|alemtuzumab|mesh-list
55744471|NCT00977691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55744472|NCT00977691|Immunologic Factors|immunologic factors|mesh-ancestor
55744473|NCT00977691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744474|NCT00977691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744475|NCT00977691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55744476|NCT00977691|Alkylating Agents|alkylating agents|mesh-ancestor
55744477|NCT00977691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744478|NCT00977691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744487|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55744488|NCT03324139|Tinzaparin|tinzaparin|mesh-list
55744489|NCT03324139|Dalteparin|dalteparin|mesh-list
55744490|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
55744491|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55744492|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55744493|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744494|NCT03324061|Fulvestrant|fulvestrant|mesh-list
55744495|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55744496|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744497|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55744498|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55744499|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
55744500|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789021|NCT04909619|Anesthetics|anesthetics|mesh-list
55744501|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744503|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55744504|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
55744505|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744506|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744507|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55744508|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744509|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55744510|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55744511|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55744512|NCT02579811|Axitinib|axitinib|mesh-list
55744514|NCT02579811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55744515|NCT02579811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744516|NCT02579811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744517|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
55744518|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744519|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55744520|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744521|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744522|NCT05430087|Vitamin D|vitamin d|mesh-list
55744524|NCT05430087|Curcumin|curcumin|mesh-list
55744525|NCT05430087|Piperine|piperine|mesh-list
55744526|NCT05430087|Vitamins|vitamins|mesh-ancestor
55744527|NCT05430087|Micronutrients|micronutrients|mesh-ancestor
55744528|NCT05430087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744529|NCT05430087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55744530|NCT05430087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55744531|NCT05430087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55744532|NCT05430087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744533|NCT05430087|Analgesics|analgesics|mesh-ancestor
55744534|NCT05430087|Sensory System Agents|sensory system agents|mesh-ancestor
55744535|NCT05430087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744536|NCT05430087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744537|NCT05430087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744538|NCT05430087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744539|NCT05430087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861202|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55744546|NCT03327727|VL-2397|vl-2397|mesh-list
55744547|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
55744548|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744549|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55744550|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55744551|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744552|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744553|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55744554|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
55744555|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744556|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744557|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55744558|NCT03327727|Amebicides|amebicides|mesh-ancestor
55744559|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55744560|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55744561|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55744562|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
55744563|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55744564|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744565|NCT03323671|Analgesics|analgesics|mesh-ancestor
55744566|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
55744567|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55777388|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
55744568|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744569|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744570|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744571|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55744572|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744573|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744575|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55744576|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744577|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744578|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744669|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744670|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55744671|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744672|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
55744673|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744674|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744675|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744676|NCT03323047|Analgesics|analgesics|mesh-ancestor
55744677|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
55744678|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
55744679|NCT03322969|Paclitaxel|paclitaxel|mesh-list
55744680|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55744681|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744682|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
55744683|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
55744684|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
55744685|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744711|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55744712|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
55744713|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744714|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744715|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55744716|NCT02487823|Bicalutamide|bicalutamide|mesh-list
55744718|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
55744719|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
55744720|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744721|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744722|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744723|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55744724|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
55744725|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55744726|NCT05463913|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55744727|NCT05463913|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55744728|NCT05463913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744729|NCT02487433|Tofacitinib|tofacitinib|mesh-list
55744730|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55744731|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744732|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744733|NCT04493125|Mosapride|mosapride|mesh-list
55744734|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744738|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55777526|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55744739|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744741|NCT03318835|Prednisone|prednisone|mesh-list
55744742|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
55744743|NCT03318835|Vincristine|vincristine|mesh-list
55744744|NCT03318835|Rituximab|rituximab|mesh-list
55744745|NCT03318835|Doxorubicin|doxorubicin|mesh-list
55744746|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55744747|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
55744748|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744749|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
55744750|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55744751|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744752|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55744753|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55744754|NCT03318835|Growth Substances|growth substances|mesh-ancestor
55744755|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
55744756|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744757|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744758|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55744759|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
55744760|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744761|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55744762|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744763|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
55744764|NCT03318835|Hormones|hormones|mesh-ancestor
55744765|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744766|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55744767|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55744768|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
55744769|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
55744770|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
55744771|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55744772|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55744773|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55744774|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55744775|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744776|NCT03318757|Bupivacaine|bupivacaine|mesh-list
55744777|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
55744778|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
55744779|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744780|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744781|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
55744782|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744783|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
55744784|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
55744786|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
55744787|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
55861240|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
55744791|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744792|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55744793|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744795|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55744796|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55744797|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55744798|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
55744799|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744800|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744801|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55744802|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
55744803|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55777586|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
55744804|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55744805|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55744806|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
55744807|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55744808|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
55744809|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55744810|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744811|NCT01876953|Cytarabine|cytarabine|mesh-list
55744812|NCT01876953|Dasatinib|dasatinib|mesh-list
55744813|NCT01876953|Idarubicin|idarubicin|mesh-list
55744814|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55744815|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
55744816|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744817|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744818|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
55744819|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744820|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55744821|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
55744822|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744823|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55744824|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744826|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55744827|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55744829|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55744830|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55744831|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744832|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55744833|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744834|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55744835|NCT03321955|Protective Agents|protective agents|mesh-ancestor
55744836|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744838|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
55744839|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744840|NCT04493281|Edaravone|edaravone|mesh-list
55744841|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55744842|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
55744843|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744844|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55744845|NCT04493281|Protective Agents|protective agents|mesh-ancestor
55744846|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744847|NCT01764711|Cosyntropin|cosyntropin|mesh-list
55744848|NCT01764711|Hormones|hormones|mesh-ancestor
55744849|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55744850|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744912|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744913|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55744914|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
55744915|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55744917|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55744918|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744919|NCT02483845|Natalizumab|natalizumab|mesh-list
55744920|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
55744921|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744923|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55744924|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744925|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55744926|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
55744927|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55744928|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55744929|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55744930|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744931|NCT02483923|Ropivacaine|ropivacaine|mesh-list
55744933|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
55744934|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744937|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744938|NCT02483689|Bupivacaine|bupivacaine|mesh-list
55744939|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
55744940|NCT02483689|Anesthetics|anesthetics|mesh-list
55744941|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744942|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744943|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
55744944|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744946|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55744948|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744949|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
55744950|NCT03102021|Hematinics|hematinics|mesh-ancestor
55744951|NCT04916691|Ropivacaine|ropivacaine|mesh-list
55744952|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
55744953|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
55744954|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55744955|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744956|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
55744957|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55744959|NCT05105139|Coal Tar|coal tar|mesh-list
55744960|NCT05105139|Allantoin|allantoin|mesh-list
55744961|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55744962|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744963|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55744964|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55744966|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744967|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55744968|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
55744969|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
55744970|NCT05001555|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55744971|NCT05001555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744972|NCT05001555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55744973|NCT05001555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55744978|NCT05001555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744979|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
55744980|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55744981|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744982|NCT03317275|Fluorides|fluorides|mesh-list
55744983|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
55744984|NCT03317275|Protective Agents|protective agents|mesh-ancestor
55777724|NCT01980706|Baclofen|baclofen|mesh-list
55744985|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744987|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
55744988|NCT03317197|Epinephrine|epinephrine|mesh-list
55744989|NCT03317197|Racepinephrine|racepinephrine|mesh-list
55744990|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
55744991|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55744992|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55744993|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
55744994|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744995|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55744996|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55744998|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55745000|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745001|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55745002|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
55745003|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
55745004|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
55745005|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55745006|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
55745007|NCT03317197|Coagulants|coagulants|mesh-ancestor
55745008|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55745009|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
55745010|NCT02483299|Metformin|metformin|mesh-list
55745011|NCT02483299|Liraglutide|liraglutide|mesh-list
55745012|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55745013|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745014|NCT02483299|Incretins|incretins|mesh-ancestor
55745015|NCT02483299|Hormones|hormones|mesh-ancestor
55745016|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745017|NCT01597479|Anesthetics|anesthetics|mesh-list
55745018|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
55745019|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
55745020|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745021|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861441|NCT03904329|Anticoagulants|anticoagulants|mesh-list
55745022|NCT01597479|Sensory System Agents|sensory system agents|mesh-ancestor
55745023|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745025|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55745026|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745027|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745028|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
55745029|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745030|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745031|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55745033|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745034|NCT02489929|Azacitidine|azacitidine|mesh-list
55745035|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55745036|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
55745037|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745038|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745039|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745040|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55745041|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
55745043|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
55745044|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745045|NCT02483143|Expectorants|expectorants|mesh-ancestor
55745046|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
55745047|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55745048|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
55745049|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745050|NCT02483143|Protective Agents|protective agents|mesh-ancestor
55745051|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745052|NCT02483221|Morphine|morphine|mesh-list
55745053|NCT02483221|Hydromorphone|hydromorphone|mesh-list
55745054|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55745055|NCT02483221|Narcotics|narcotics|mesh-ancestor
55745056|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745057|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745058|NCT02483221|Analgesics|analgesics|mesh-ancestor
55745059|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
55745060|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745061|NCT02489461|Efavirenz|efavirenz|mesh-list
55745062|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
55745063|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55745064|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55745065|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55745066|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745067|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745068|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
55745069|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745070|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55745071|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55745072|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55745073|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55745074|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55745075|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55745076|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55745077|NCT05129475|Ritonavir|ritonavir|mesh-list
55745078|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55745079|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55745080|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
55745081|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745082|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745083|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55745084|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55745085|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
55745086|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745087|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55745088|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55745089|NCT05463367|Acetaminophen|acetaminophen|mesh-list
55745090|NCT05463367|Naproxen|naproxen|mesh-list
55745093|NCT05463367|Morphine|morphine|mesh-list
55745094|NCT05463367|Oxycodone|oxycodone|mesh-list
55745095|NCT05463367|Tramadol|tramadol|mesh-list
55745096|NCT05463367|Hydrocodone|hydrocodone|mesh-list
55745097|NCT05463367|Codeine|codeine|mesh-list
55745098|NCT05463367|Levodopa|levodopa|mesh-list
55745099|NCT05463367|Carbidopa|carbidopa|mesh-list
55745100|NCT05463367|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55745101|NCT05463367|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55745102|NCT05463367|Narcotics|narcotics|mesh-ancestor
55745103|NCT05463367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745104|NCT05463367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745105|NCT05463367|Analgesics|analgesics|mesh-ancestor
55745106|NCT05463367|Sensory System Agents|sensory system agents|mesh-ancestor
55745107|NCT05463367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745108|NCT05463367|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55745109|NCT05463367|Antipyretics|antipyretics|mesh-ancestor
55745110|NCT05463367|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55745111|NCT05463367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55745112|NCT05463367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55745113|NCT05463367|Gout Suppressants|gout suppressants|mesh-ancestor
55745114|NCT05463367|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55745115|NCT05463367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745116|NCT05463367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745117|NCT05463367|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55745118|NCT05463367|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55745119|NCT05463367|Dopamine Agents|dopamine agents|mesh-ancestor
55745120|NCT05463367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745121|NCT05463367|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55745122|NCT05463367|Antitussive Agents|antitussive agents|mesh-ancestor
55745123|NCT05463367|Respiratory System Agents|respiratory system agents|mesh-ancestor
55745124|NCT05463367|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55745125|NCT05463367|Immunologic Factors|immunologic factors|mesh-ancestor
55745126|NCT05463367|Dopamine Agonists|dopamine agonists|mesh-ancestor
55745127|NCT05463367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55745129|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
55745130|NCT02485873|Vitamins|vitamins|mesh-ancestor
55745131|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
55745132|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745133|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55745134|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
55745135|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55745136|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
55745137|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861476|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745141|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55745144|NCT04412421|Vitamins|vitamins|mesh-list
55745145|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
55745146|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745147|NCT03315091|Adavosertib|adavosertib|mesh-list
55745148|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745149|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745150|NCT02488993|Rifaximin|rifaximin|mesh-list
55745151|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55745152|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745153|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55745154|NCT02485327|Insulin|insulin|mesh-list
55745155|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55745156|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55745157|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745158|NCT02485249|Dexamethasone|dexamethasone|mesh-list
55745159|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
55745160|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55745161|NCT02485249|BB 1101|bb 1101|mesh-list
55745162|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55745163|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
55745164|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
55745165|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745166|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55777883|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
55745167|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55861528|NCT03020901|Teicoplanin|teicoplanin|mesh-list
55745171|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55745172|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745173|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
55745174|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745175|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745177|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745178|NCT03320629|Apatinib|apatinib|mesh-list
55745179|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745180|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55745181|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745182|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745183|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55745184|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55745185|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55745186|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
55745187|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745189|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55745190|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745192|NCT02476981|Midazolam|midazolam|mesh-list
55745193|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
55745194|NCT02476981|Remifentanil|remifentanil|mesh-list
55745195|NCT02476981|Propofol|propofol|mesh-list
55745196|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55745197|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745198|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745199|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55745200|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
55745201|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
55745202|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55745204|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
55745205|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745206|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55745207|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55745208|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55745209|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
55745210|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745211|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745212|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55745213|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55745214|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55745215|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55745216|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
55745217|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
55745218|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55745219|NCT02476981|Narcotics|narcotics|mesh-ancestor
55745223|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55745224|NCT04248465|Ravulizumab|ravulizumab|mesh-list
55745225|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55745227|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
55745228|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745230|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55745231|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55745232|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745233|NCT05456269|Cytarabine|cytarabine|mesh-list
55745234|NCT05456269|Decitabine|decitabine|mesh-list
55745235|NCT05456269|Bisantrene|bisantrene|mesh-list
55745236|NCT05456269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55745238|NCT05456269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745239|NCT05456269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745240|NCT05456269|Antiviral Agents|antiviral agents|mesh-ancestor
55745241|NCT05456269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745242|NCT05456269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55745243|NCT05456269|Immunologic Factors|immunologic factors|mesh-ancestor
55745244|NCT05456269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745245|NCT05456269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745246|NCT05456269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55745247|NCT02476825|Fluticasone|fluticasone|mesh-list
55745248|NCT02476825|Xhance|xhance|mesh-list
55745249|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55745250|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55745251|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
55745252|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745253|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745254|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55745255|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
55745256|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
55745257|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55745259|NCT05245227|Oxytocin|oxytocin|mesh-list
55745260|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
55745261|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55745262|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745263|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55745264|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
55745265|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55745266|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55745268|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55745269|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745270|NCT04435197|Pembrolizumab|pembrolizumab|mesh-list
55745271|NCT04435197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55745272|NCT04435197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745273|NCT05244837|Paclitaxel|paclitaxel|mesh-list
55745274|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55745275|NCT05244837|Carboplatin|carboplatin|mesh-list
55745276|NCT05244837|Pemetrexed|pemetrexed|mesh-list
55745277|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55745278|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745279|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
55745280|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
55745281|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
55745282|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745283|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745284|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55745285|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55745286|NCT03103893|Sirolimus|sirolimus|mesh-list
55745287|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55745288|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745289|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55745290|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745291|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
55745292|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55745293|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
55745294|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745295|NCT02479789|Lidocaine|lidocaine|mesh-list
55745296|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
55745297|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
55745298|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745299|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745300|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
55745301|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745302|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55745303|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55745304|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55745305|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55745306|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745308|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
55745309|NCT02726113|Vitamins|vitamins|mesh-ancestor
55745310|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
55745311|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745312|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55745313|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55745314|NCT04140903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55745315|NCT04140903|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55745316|NCT04140903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745317|NCT04140903|Antitubercular Agents|antitubercular agents|mesh-ancestor
55745319|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745320|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55745321|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55745322|NCT05243355|Growth Substances|growth substances|mesh-ancestor
55745323|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745325|NCT02479711|Methamphetamine|methamphetamine|mesh-list
55745326|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55745327|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745328|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
55745329|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
55745330|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745331|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
55745332|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745333|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745334|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
55745335|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55745336|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55745337|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55745338|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55745340|NCT05196945|Clarithromycin|clarithromycin|mesh-list
55745341|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
55745342|NCT05196945|Esomeprazole|esomeprazole|mesh-list
55745343|NCT05196945|Bismuth|bismuth|mesh-list
55745344|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745345|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55745346|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745347|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55745348|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55745349|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55745350|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745351|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55745352|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55745353|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55745355|NCT05196945|Diuretics|diuretics|mesh-ancestor
55745356|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
55745357|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745358|NCT05196945|Expectorants|expectorants|mesh-ancestor
55745359|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
55745360|NCT03810105|Durvalumab|durvalumab|mesh-list
55745361|NCT03810105|Olaparib|olaparib|mesh-list
55745362|NCT03810105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55745363|NCT03810105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745364|NCT03810105|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55745365|NCT03810105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745366|NCT03810105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745367|NCT03800979|Tofacitinib|tofacitinib|mesh-list
55745369|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745370|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745371|NCT02476123|Nivolumab|nivolumab|mesh-list
55745372|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
55745373|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55745374|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745375|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55745376|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745378|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55745379|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55745380|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745381|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745382|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
55745383|NCT03101709|Fludarabine|fludarabine|mesh-list
55745384|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55745385|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
55745386|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745387|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55745388|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55745389|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
55745390|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745391|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745392|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55745394|NCT05434663|Antiemetics|antiemetics|mesh-ancestor
55745395|NCT05434663|Autonomic Agents|autonomic agents|mesh-ancestor
55745396|NCT05434663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745397|NCT05434663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745400|NCT05434663|Serotonin Agents|serotonin agents|mesh-ancestor
55745401|NCT05434663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745402|NCT05434663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745404|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
55745405|NCT03101319|Vitamins|vitamins|mesh-ancestor
55745406|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
55745407|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745408|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55745409|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55745410|NCT02479555|Dexamethasone|dexamethasone|mesh-list
55745411|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
55745412|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55745413|NCT02479555|BB 1101|bb 1101|mesh-list
55745414|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55745415|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
55745416|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
55745417|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745418|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745419|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55745420|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
55745421|NCT02479555|Hormones|hormones|mesh-ancestor
55789023|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745422|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745423|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55745424|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745425|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
55745426|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745427|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745428|NCT02476045|Leucovorin|leucovorin|mesh-list
55745429|NCT02476045|Fluorouracil|fluorouracil|mesh-list
55745431|NCT02476045|Panitumumab|panitumumab|mesh-list
55745432|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
55745434|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745435|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55745436|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745437|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55745438|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
55745439|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745440|NCT02476045|Antidotes|antidotes|mesh-ancestor
55745441|NCT02476045|Protective Agents|protective agents|mesh-ancestor
55745442|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
55745443|NCT02476045|Vitamins|vitamins|mesh-ancestor
55745444|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
55745445|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55745446|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
55745447|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55745448|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745449|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55745450|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745451|NCT03885921|Atorvastatin|atorvastatin|mesh-list
55745452|NCT03885921|Simvastatin|simvastatin|mesh-list
55745453|NCT03885921|Ezetimibe|ezetimibe|mesh-list
55745454|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55745455|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55745456|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
55745457|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745458|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55745459|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55745460|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745461|NCT02480881|Fostemsavir|fostemsavir|mesh-list
55745462|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
55745463|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
55745464|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
55745465|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55745466|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745467|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55745468|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55745469|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55745470|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55745471|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
55745472|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55745473|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55745474|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55745475|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
55745476|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745477|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55745478|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55745479|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745480|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
55745481|NCT02480647|Etonogestrel|etonogestrel|mesh-list
55745483|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
55745484|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55745485|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745486|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55745487|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55745488|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55745621|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745623|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55745624|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55745625|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745626|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745627|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55745628|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55745629|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55745630|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55745631|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
55745632|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
55745633|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
55745634|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
55745635|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745638|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55745640|NCT02474953|Analgesics|analgesics|mesh-ancestor
55745641|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
55745642|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745643|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745644|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55745645|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55745646|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745647|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745648|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745649|NCT05714371|Pembrolizumab|pembrolizumab|mesh-list
55745650|NCT05714371|Nivolumab|nivolumab|mesh-list
55745651|NCT05714371|Ipilimumab|ipilimumab|mesh-list
55745652|NCT05714371|Trametinib|trametinib|mesh-list
55745653|NCT05714371|Dabrafenib|dabrafenib|mesh-list
55745654|NCT05714371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55745655|NCT05714371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745656|NCT05714371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55745657|NCT05714371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745658|NCT05714371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55745659|NCT05714371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745661|NCT02472613|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55745662|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55745663|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55745664|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745666|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
55745667|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745668|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55745670|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55745671|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55745672|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55745673|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745674|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
55745675|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55745676|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
55745677|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55745678|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
55745679|NCT02478229|Ledipasvir|ledipasvir|mesh-list
55745680|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
55745681|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745683|NCT01361607|Analgesics|analgesics|mesh-ancestor
55745684|NCT01361607|Sensory System Agents|sensory system agents|mesh-ancestor
55745685|NCT01361607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745686|NCT01361607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745687|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55745688|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55745689|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55745690|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745691|NCT05713045|Vitamin K 1|vitamin k 1|mesh-list
55745692|NCT05713045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55745693|NCT05713045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55745694|NCT05713045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745696|NCT05713045|Coagulants|coagulants|mesh-ancestor
55745697|NCT05713045|Vitamins|vitamins|mesh-ancestor
55745698|NCT05713045|Micronutrients|micronutrients|mesh-ancestor
55745699|NCT05713045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745701|NCT00653835|Ezetimibe|ezetimibe|mesh-list
55745702|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55745703|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55745704|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
55745705|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745706|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55745707|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55745708|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745709|NCT03099759|Vitamin D|vitamin d|mesh-list
55745710|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
55745712|NCT03099759|Vitamins|vitamins|mesh-ancestor
55745713|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
55745714|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745715|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55745716|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55745717|NCT05249569|Avelumab|avelumab|mesh-list
55745718|NCT05249569|Bavituximab|bavituximab|mesh-list
55745720|NCT05249569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55745721|NCT05249569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745722|NCT05249569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55745723|NCT05249569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745724|NCT05249569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745726|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
55745727|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
55745728|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745729|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745730|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55745732|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55745733|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745734|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55745735|NCT05244577|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55745736|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55745738|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745739|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745740|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
55745741|NCT05710237|Risperidone|risperidone|mesh-list
55745743|NCT05710237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55745744|NCT05710237|Serotonin Agents|serotonin agents|mesh-ancestor
55745745|NCT05710237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745746|NCT05710237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745747|NCT05710237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745748|NCT05710237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55745749|NCT05710237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55745750|NCT05710237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745751|NCT05710237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55745752|NCT05710237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55745753|NCT05710237|Dopamine Agents|dopamine agents|mesh-ancestor
55745754|NCT05710237|Hallucinogens|hallucinogens|mesh-ancestor
55745755|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55745756|NCT05067699|Calcifediol|calcifediol|mesh-list
55745758|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
55745759|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745760|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55745762|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55745763|NCT05067153|Tinzaparin|tinzaparin|mesh-list
55745765|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
55745766|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55745767|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55745768|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745769|NCT05067309|Letrozole|letrozole|mesh-list
55745770|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745771|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55745772|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55745773|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745774|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745775|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55745776|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
55745777|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745778|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745781|NCT02474563|Melphalan|melphalan|mesh-list
55745782|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55745783|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
55745784|NCT02474563|Hormones|hormones|mesh-ancestor
55745785|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745786|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745787|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55745788|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745789|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55862011|NCT04405245|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55745791|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745792|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55745793|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55745794|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
55745795|NCT02477995|Vaccines|vaccines|mesh-list
55745796|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
55745797|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745798|NCT03098823|Prednisone|prednisone|mesh-list
55745799|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55745800|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
55745801|NCT03098823|Hormones|hormones|mesh-ancestor
55745802|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745803|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745805|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745806|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
55745807|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55745808|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745809|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745810|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55745811|NCT03108937|Analgesics|analgesics|mesh-ancestor
55745812|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
55745813|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745814|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55745815|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55745816|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55745817|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
55745818|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745819|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745820|NCT03913845|Lidocaine|lidocaine|mesh-list
55745821|NCT03913845|Epinephrine|epinephrine|mesh-list
55745822|NCT03913845|Racepinephrine|racepinephrine|mesh-list
55745823|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
55745824|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
55745825|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
55745826|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55745827|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55778212|NCT04512365|Hormones|hormones|mesh-ancestor
55745828|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
55745829|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745830|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55745831|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55745832|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55745833|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55745834|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745835|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55745836|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55745837|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
55745838|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745839|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55745840|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55745841|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
55745842|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55745843|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
55745845|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
55745846|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55745847|NCT00705523|Varenicline|varenicline|mesh-list
55745848|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55745849|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55745850|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
55745851|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745852|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745853|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745854|NCT03903939|Iloprost|iloprost|mesh-list
55745855|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55745856|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
55745857|NCT05676931|Docetaxel|docetaxel|mesh-list
55745858|NCT05676931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745859|NCT05676931|Tubulin Modulators|tubulin modulators|mesh-ancestor
55745860|NCT05676931|Antimitotic Agents|antimitotic agents|mesh-ancestor
55745861|NCT05676931|Mitosis Modulators|mitosis modulators|mesh-ancestor
55745862|NCT05676931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745863|NCT05065905|Interferons|interferons|mesh-list
55745864|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
55745865|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745866|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
55745867|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745868|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55745869|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55745870|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
55745871|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55745872|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745873|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745874|NCT05010681|Lenvatinib|lenvatinib|mesh-list
55745875|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745876|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55745877|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745878|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745879|NCT03029403|Cyclophosphamide|cyclophosphamide|mesh-list
55745880|NCT03029403|Pembrolizumab|pembrolizumab|mesh-list
55745881|NCT03029403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55745882|NCT03029403|Immunologic Factors|immunologic factors|mesh-ancestor
55745883|NCT03029403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745884|NCT03029403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55745885|NCT03029403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55745886|NCT03029403|Alkylating Agents|alkylating agents|mesh-ancestor
55789025|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
55745887|NCT03029403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745888|NCT03029403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745889|NCT03029403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55745890|NCT03029403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55745892|NCT02725411|Tanezumab|tanezumab|mesh-list
55789026|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789027|NCT03520231|Vitamin D|vitamin d|mesh-list
55745893|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55745894|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55745895|NCT02725411|Analgesics|analgesics|mesh-ancestor
55745896|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
55745897|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55745898|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745899|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55745900|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55745901|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55745902|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55745904|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745905|NCT05058105|Meropenem|meropenem|mesh-list
55745906|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55745907|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745908|NCT05649943|Androgens|androgens|mesh-list
55745909|NCT05649943|Hormones|hormones|mesh-ancestor
55745910|NCT05649943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55745911|NCT05649943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745912|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
55745913|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55745914|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745915|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
55745916|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55745917|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55745918|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745919|NCT04474353|Temozolomide|temozolomide|mesh-list
55745920|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55745922|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745923|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55745925|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55745926|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
55745927|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55745928|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745929|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55745930|NCT05062395|Deoxyglucose|deoxyglucose|mesh-list
55745931|NCT05062395|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55745932|NCT05062395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55745933|NCT05062395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55745934|NCT05062395|Antimetabolites|antimetabolites|mesh-ancestor
55745935|NCT05062395|Antiviral Agents|antiviral agents|mesh-ancestor
55745936|NCT05062395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55745937|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
55745938|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55745940|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55745941|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
55746005|NCT02473627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55746006|NCT03095703|Sirolimus|sirolimus|mesh-list
55746007|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55746008|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746009|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55746010|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746011|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
55746012|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55746013|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
55746014|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746016|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55746017|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
55746018|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746019|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55746020|NCT05035953|Protective Agents|protective agents|mesh-ancestor
55746021|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746022|NCT02471209|Sevoflurane|sevoflurane|mesh-list
55746023|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55746024|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55746025|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
55746026|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
55746027|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746028|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746029|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
55746030|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55746031|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
55746032|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746033|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
55746035|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
55746036|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55746037|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
55746038|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746039|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746040|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55746041|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
55746042|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
55746043|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55746044|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
55746046|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746047|NCT03601507|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
55746048|NCT03601507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746049|NCT03601507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746051|NCT04374877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55789030|NCT03520231|Carboplatin|carboplatin|mesh-list
55789033|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
55789034|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746052|NCT04374877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746054|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
55746055|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746057|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55746058|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55746059|NCT04220125|Midazolam|midazolam|mesh-list
55746060|NCT04220125|Ketamine|ketamine|mesh-list
55746061|NCT04220125|Analgesics|analgesics|mesh-ancestor
55746062|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
55746063|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746064|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746065|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55746066|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55746067|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
55746068|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
55746069|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746071|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55746072|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746073|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746074|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55746075|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55746076|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55746077|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55746078|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55746081|NCT02472691|Lenalidomide|lenalidomide|mesh-list
55746082|NCT02472691|Azacitidine|azacitidine|mesh-list
55746083|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
55746084|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746085|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55746086|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55746087|NCT02472691|Growth Substances|growth substances|mesh-ancestor
55746088|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
55746089|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746090|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55746091|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
55746092|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746093|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746094|NCT03065335|Ketamine|ketamine|mesh-list
55746096|NCT03065335|Sensory System Agents|sensory system agents|mesh-ancestor
55746097|NCT03065335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746098|NCT03065335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746099|NCT03065335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55746100|NCT03065335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55746101|NCT03065335|Anesthetics, General|anesthetics, general|mesh-ancestor
55746102|NCT03065335|Anesthetics|anesthetics|mesh-ancestor
55746103|NCT03065335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746104|NCT03065335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55746105|NCT03065335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55746106|NCT03065335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746107|NCT03065335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746108|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
55746109|NCT02470663|Calcium|calcium|mesh-list
55746110|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55746111|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746112|NCT02470663|Antacids|antacids|mesh-ancestor
55746113|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746114|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746115|NCT00705367|Abatacept|abatacept|mesh-list
55746116|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55746117|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746118|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746119|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55746120|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
55746121|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746122|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55746123|NCT03043729|Leucovorin|leucovorin|mesh-list
55746124|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
55746125|NCT03043729|Aflibercept|aflibercept|mesh-list
55746126|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746127|NCT03043729|Antidotes|antidotes|mesh-ancestor
55746128|NCT03043729|Protective Agents|protective agents|mesh-ancestor
55746129|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746130|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
55746131|NCT03043729|Vitamins|vitamins|mesh-ancestor
55746132|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
55746133|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55746134|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55746135|NCT03043729|Growth Substances|growth substances|mesh-ancestor
55746136|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
55746137|NCT05306431|Biguanides|biguanides|mesh-list
55862147|NCT01279096|Analgesics|analgesics|mesh-ancestor
55746138|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
55746139|NCT05306431|Polihexanide|polihexanide|mesh-list
55746140|NCT05306431|Eusol|eusol|mesh-list
55746141|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
55746142|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746145|NCT03108313|Fluorides|fluorides|mesh-list
55746146|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
55746147|NCT03108313|Protective Agents|protective agents|mesh-ancestor
55746148|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746149|NCT03108625|Vortioxetine|vortioxetine|mesh-list
55746150|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
55746151|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55746152|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55746154|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746155|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746156|NCT03108625|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55746158|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55746159|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746160|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746161|NCT03108625|Serotonin Agents|serotonin agents|mesh-ancestor
55746162|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55746163|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55746164|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55746165|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55746167|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746168|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746169|NCT03900949|Cytarabine|cytarabine|mesh-list
55746171|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
55746172|NCT03900949|Midostaurin|midostaurin|mesh-list
55746173|NCT03900949|Calicheamicins|calicheamicins|mesh-list
55746174|NCT03900949|Staurosporine|staurosporine|mesh-list
55746175|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55746176|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
55746177|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746178|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746179|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
55746180|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746181|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55746182|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
55746183|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746184|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55746185|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55746186|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55746187|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746188|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746189|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55746190|NCT02864251|Carboplatin|carboplatin|mesh-list
55746191|NCT02864251|Nivolumab|nivolumab|mesh-list
55746192|NCT02864251|Pemetrexed|pemetrexed|mesh-list
55746194|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746195|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746196|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55746197|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746198|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746199|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55746200|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55746202|NCT02757859|Pancreatin|pancreatin|mesh-list
55746203|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746204|NCT02468791|Rituximab|rituximab|mesh-list
55746205|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746206|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746207|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
55746208|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746209|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55746210|NCT02693821|Gabapentin|gabapentin|mesh-list
55746211|NCT02693821|Analgesics|analgesics|mesh-ancestor
55746212|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
55746213|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746214|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746215|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
55746216|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55746217|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55746218|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746219|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55746220|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55746221|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55746222|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746223|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746224|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
55746225|NCT02470117|Antacids|antacids|mesh-list
55746226|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746227|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746229|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
55746230|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55746231|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746232|NCT02299999|Gemcitabine|gemcitabine|mesh-list
55746233|NCT02299999|Vincristine|vincristine|mesh-list
55746234|NCT02299999|Vinorelbine|vinorelbine|mesh-list
55746235|NCT02299999|Vinblastine|vinblastine|mesh-list
55746236|NCT02299999|Docetaxel|docetaxel|mesh-list
55746237|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
55746238|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
55746239|NCT02299999|Bevacizumab|bevacizumab|mesh-list
55746240|NCT02299999|Cisplatin|cisplatin|mesh-list
55746241|NCT02299999|Carboplatin|carboplatin|mesh-list
55746242|NCT02299999|Doxorubicin|doxorubicin|mesh-list
55746243|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55746244|NCT02299999|Capecitabine|capecitabine|mesh-list
55746245|NCT02299999|Methotrexate|methotrexate|mesh-list
55746246|NCT02299999|Durvalumab|durvalumab|mesh-list
55746247|NCT02299999|Epirubicin|epirubicin|mesh-list
55746248|NCT02299999|Olaparib|olaparib|mesh-list
55746249|NCT02299999|Mitomycins|mitomycins|mesh-list
55746250|NCT02299999|Mitomycin|mitomycin|mesh-list
55746288|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746289|NCT00705289|Infliximab|infliximab|mesh-list
55746290|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
55746291|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746292|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55746293|NCT02263729|Losartan|losartan|mesh-list
55746294|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55746295|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55746296|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55746298|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746299|NCT03309865|Vedolizumab|vedolizumab|mesh-list
55746300|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746301|NCT02111941|Vaccines|vaccines|mesh-list
55746302|NCT02111941|Immunologic Factors|immunologic factors|mesh-ancestor
55746303|NCT02111941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746306|NCT02038777|Daunorubicin|daunorubicin|mesh-list
55746307|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55746308|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
55746309|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746310|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746311|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
55778465|NCT01976728|Hormones|hormones|mesh-ancestor
55746312|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746313|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55746314|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
55746315|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746316|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746317|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55746318|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55746319|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55746321|NCT03744793|Avelumab|avelumab|mesh-list
55746322|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55746323|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746324|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746325|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746327|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55746328|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746329|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
55862400|NCT01275352|Diuretics|diuretics|mesh-ancestor
55746330|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746332|NCT03713593|Lenvatinib|lenvatinib|mesh-list
55746333|NCT03713593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746334|NCT03713593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746335|NCT03713593|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55746336|NCT03713593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746337|NCT03713593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746338|NCT03309709|Progesterone|progesterone|mesh-list
55746339|NCT03309709|Progestins|progestins|mesh-ancestor
55746340|NCT03309709|Hormones|hormones|mesh-ancestor
55746341|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746342|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746343|NCT01720147|Quercetin|quercetin|mesh-list
55746344|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
55746345|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746346|NCT01720147|Protective Agents|protective agents|mesh-ancestor
55746347|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746348|NCT01141309|Everolimus|everolimus|mesh-list
55746349|NCT01141309|Sorafenib|sorafenib|mesh-list
55746350|NCT01141309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746351|NCT01141309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55746352|NCT01141309|Immunologic Factors|immunologic factors|mesh-ancestor
55746353|NCT01141309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746354|NCT01141309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55746355|NCT01141309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746356|NCT01141309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746357|NCT05285605|Ulipristal acetate|ulipristal acetate|mesh-list
55746358|NCT05285605|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55746359|NCT05285605|Contraceptive Agents|contraceptive agents|mesh-ancestor
55746360|NCT05285605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55746361|NCT05285605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746362|NCT05285605|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55746363|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
55746364|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55746365|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746366|NCT05232409|Pembrolizumab|pembrolizumab|mesh-list
55746367|NCT05232409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746368|NCT05232409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746369|NCT03309163|Tramadol|tramadol|mesh-list
55746370|NCT03309163|Hydromorphone|hydromorphone|mesh-list
55746371|NCT03309163|Ropivacaine|ropivacaine|mesh-list
55746372|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
55746373|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
55746374|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746375|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746376|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
55862420|NCT02662257|Propofol|propofol|mesh-list
55746377|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746380|NCT03309163|Analgesics|analgesics|mesh-ancestor
55746381|NCT03304093|Nivolumab|nivolumab|mesh-list
55746382|NCT03304093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746383|NCT03304093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746384|NCT03304093|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55746385|NCT03304093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746386|NCT03174847|Eplerenone|eplerenone|mesh-list
55746387|NCT03174847|Amiloride|amiloride|mesh-list
55746388|NCT03174847|Spironolactone|spironolactone|mesh-list
55746389|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
55746390|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
55746391|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
55746392|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746393|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746394|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55746395|NCT03174847|Diuretics|diuretics|mesh-ancestor
55746396|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
55746397|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55746398|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
55746399|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55746400|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55746401|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862467|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55746402|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55746404|NCT03313531|Thrombin|thrombin|mesh-list
55746406|NCT03313531|Coagulants|coagulants|mesh-ancestor
55746407|NCT02468167|Polidocanol|polidocanol|mesh-list
55746408|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55746409|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55746410|NCT03308149|Triamcinolone|triamcinolone|mesh-list
55746411|NCT03308149|Bupivacaine|bupivacaine|mesh-list
55746412|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
55746413|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
55746414|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746415|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746416|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
55746417|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746418|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55746419|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
55746420|NCT03308149|Hormones|hormones|mesh-ancestor
55746421|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746422|NCT03303235|Methylergonovine|methylergonovine|mesh-list
55746423|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
55746424|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55746425|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746426|NCT03089983|Isoniazid|isoniazid|mesh-list
55746427|NCT03089983|Rifapentine|rifapentine|mesh-list
55746428|NCT03089983|Buprenorphine|buprenorphine|mesh-list
55746429|NCT03089983|Methadone|methadone|mesh-list
55746430|NCT03089983|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55746431|NCT03089983|Naloxone|naloxone|mesh-list
55746432|NCT03089983|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55746433|NCT03089983|Narcotics|narcotics|mesh-ancestor
55746434|NCT03089983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746435|NCT03089983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746436|NCT03089983|Analgesics|analgesics|mesh-ancestor
55746437|NCT03089983|Sensory System Agents|sensory system agents|mesh-ancestor
55746438|NCT03089983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746439|NCT03089983|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55746440|NCT03089983|Antitussive Agents|antitussive agents|mesh-ancestor
55746441|NCT03089983|Respiratory System Agents|respiratory system agents|mesh-ancestor
55746442|NCT03089983|Antitubercular Agents|antitubercular agents|mesh-ancestor
55746443|NCT03089983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55746444|NCT03089983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746445|NCT03089983|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55746530|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746531|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
55746532|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
55746533|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746535|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55746536|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
55746537|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746538|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746539|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55746540|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
55746541|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
55746542|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55746543|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
55746544|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746545|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746546|NCT03306745|Folic Acid|folic acid|mesh-list
55746547|NCT03306745|Hematinics|hematinics|mesh-ancestor
55746548|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
55746549|NCT03306745|Vitamins|vitamins|mesh-ancestor
55746550|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
55746551|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746552|NCT03306667|Dotinurad|dotinurad|mesh-list
55746553|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
55746554|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
55746555|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55746556|NCT03306667|Renal Agents|renal agents|mesh-ancestor
55746557|NCT03312283|Ranibizumab|ranibizumab|mesh-list
55746558|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55746559|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55746561|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746562|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
55746564|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
55746565|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55746566|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746568|NCT03301207|Bupropion|bupropion|mesh-list
55746569|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
55746570|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55746571|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
55746572|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55746573|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55746574|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746575|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746576|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55746577|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55746578|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55746579|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55746580|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
55746581|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
55746582|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
55746609|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
55746610|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
55746611|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746612|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
55746614|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746615|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
55746616|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55746617|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55746618|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55746619|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55746620|NCT03311737|Anesthetics|anesthetics|mesh-list
55746621|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746622|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746623|NCT02467543|Ethanol|ethanol|mesh-list
55746624|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55746625|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746626|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746627|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746629|NCT03311581|Sevoflurane|sevoflurane|mesh-list
55746631|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746632|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746633|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55746634|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
55746635|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
55746636|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55746637|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55746638|NCT03311425|Dexamethasone|dexamethasone|mesh-list
55746651|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746652|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
55746653|NCT03311425|Hormones|hormones|mesh-ancestor
55746654|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746655|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55746656|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746657|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55746658|NCT03311425|Protective Agents|protective agents|mesh-ancestor
55746659|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
55746660|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
55746661|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55746662|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55746663|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746664|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746665|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746666|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55746667|NCT03300115|Abivertinib|abivertinib|mesh-list
55746668|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55746669|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746670|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746671|NCT02916979|Methotrexate|methotrexate|mesh-list
55746672|NCT02916979|Fludarabine|fludarabine|mesh-list
55746673|NCT02916979|Busulfan|busulfan|mesh-list
55746674|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
55746675|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55746676|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
55746677|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55746678|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746679|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55746681|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746682|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746683|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
55746684|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746685|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55746686|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55746687|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
55746688|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55746689|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55746690|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
55746691|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55746692|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55746693|NCT00702949|Pregabalin|pregabalin|mesh-list
55746695|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
55746696|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746697|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746698|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
55746699|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55778642|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
55746700|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55746701|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746702|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55746703|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55746704|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55746705|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746706|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55746707|NCT04791475|Dexamethasone|dexamethasone|mesh-list
55746708|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
55746709|NCT04791475|Bupivacaine|bupivacaine|mesh-list
55746710|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55746711|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
55746712|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
55746713|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746714|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746715|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746716|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
55746717|NCT04791475|Hormones|hormones|mesh-ancestor
55746718|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746719|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55746720|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746721|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
55746722|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
55746723|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746724|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
55746725|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55746726|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55746737|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746738|NCT02466997|Tacrolimus|tacrolimus|mesh-list
55746739|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55746740|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
55746741|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746742|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55746743|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746744|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746745|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
55746746|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55746747|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55746748|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55746749|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55746750|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746752|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746753|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746754|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55746755|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746757|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55746758|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746759|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746760|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
55746761|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746762|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746763|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
55746766|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
55746767|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746768|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746769|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55746770|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
55746771|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
55746772|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55746773|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55746774|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55746775|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
55746776|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746777|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746778|NCT05727397|Aflibercept|aflibercept|mesh-list
55746779|NCT05727397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55746780|NCT05727397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55746781|NCT05727397|Growth Substances|growth substances|mesh-ancestor
55746782|NCT05727397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746783|NCT05727397|Growth Inhibitors|growth inhibitors|mesh-ancestor
55746784|NCT05727397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746785|NCT05378269|Tamoxifen|tamoxifen|mesh-list
55746786|NCT05378269|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55746787|NCT05378269|Hormone Antagonists|hormone antagonists|mesh-ancestor
55746788|NCT05378269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746789|NCT05378269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746790|NCT05378269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55746791|NCT05378269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746792|NCT05378269|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55746793|NCT05378269|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55746794|NCT05378269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55746796|NCT04804735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746797|NCT04804735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746798|NCT02466919|Amoxicillin|amoxicillin|mesh-list
55746799|NCT02466919|Metronidazole|metronidazole|mesh-list
55746800|NCT02466919|Clarithromycin|clarithromycin|mesh-list
55746801|NCT02466919|Levofloxacin|levofloxacin|mesh-list
55746803|NCT02466919|Pantoprazole|pantoprazole|mesh-list
55746804|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55746805|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746807|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55746808|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55746809|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746810|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746811|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55746812|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55746813|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55746815|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55746816|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55746817|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746818|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55746819|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55746820|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746821|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55746822|NCT05727163|Leucovorin|leucovorin|mesh-list
55746823|NCT05727163|Dexamethasone|dexamethasone|mesh-list
55746824|NCT05727163|Anisodamine|anisodamine|mesh-list
55746825|NCT05727163|Bevacizumab|bevacizumab|mesh-list
55746826|NCT05727163|Fluorouracil|fluorouracil|mesh-list
55746827|NCT05727163|Oxaliplatin|oxaliplatin|mesh-list
55746828|NCT05727163|Irinotecan|irinotecan|mesh-list
55746829|NCT05727163|Levoleucovorin|levoleucovorin|mesh-list
55746830|NCT05727163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746831|NCT05727163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746832|NCT05727163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55746833|NCT05727163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55746834|NCT05727163|Growth Substances|growth substances|mesh-ancestor
55746835|NCT05727163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746836|NCT05727163|Growth Inhibitors|growth inhibitors|mesh-ancestor
55746837|NCT05727163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55746838|NCT05727163|Antiemetics|antiemetics|mesh-ancestor
55746839|NCT05727163|Autonomic Agents|autonomic agents|mesh-ancestor
55746840|NCT05727163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746841|NCT05727163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55746842|NCT05727163|Glucocorticoids|glucocorticoids|mesh-ancestor
55746843|NCT05727163|Hormones|hormones|mesh-ancestor
55746844|NCT05727163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746845|NCT05727163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55746846|NCT05727163|Antimetabolites|antimetabolites|mesh-ancestor
55746847|NCT05727163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862832|NCT03805750|Dronabinol|dronabinol|mesh-list
55746848|NCT05727163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55746849|NCT05727163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55746850|NCT05727163|Immunologic Factors|immunologic factors|mesh-ancestor
55746851|NCT05727163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55746852|NCT05727163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55746853|NCT05727163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746854|NCT05727163|Antidotes|antidotes|mesh-ancestor
55746855|NCT05727163|Protective Agents|protective agents|mesh-ancestor
55746856|NCT05727163|Vitamin B Complex|vitamin b complex|mesh-ancestor
55746857|NCT05727163|Vitamins|vitamins|mesh-ancestor
55746858|NCT05727163|Micronutrients|micronutrients|mesh-ancestor
55746859|NCT05727163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55746860|NCT05727163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55746861|NCT05727163|Adrenergic Agents|adrenergic agents|mesh-ancestor
55746862|NCT05727163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746863|NCT05727163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55746864|NCT05727163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55746865|NCT05727163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55746867|NCT05727163|Sensory System Agents|sensory system agents|mesh-ancestor
55746868|NCT05727163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55746869|NCT05727163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55746870|NCT05727163|Parasympatholytics|parasympatholytics|mesh-ancestor
55746871|NCT05727163|Vasodilator Agents|vasodilator agents|mesh-ancestor
55746872|NCT05727163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55746873|NCT05727163|Antioxidants|antioxidants|mesh-ancestor
55746874|NCT05259709|Cemiplimab|cemiplimab|mesh-list
55746875|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746876|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746878|NCT05302531|Levofloxacin|levofloxacin|mesh-list
55746879|NCT05302531|Ofloxacin|ofloxacin|mesh-list
55746880|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55746881|NCT05302531|Trimethoprim|trimethoprim|mesh-list
55746882|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
55746883|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55746884|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55746885|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55746886|NCT05302531|Renal Agents|renal agents|mesh-ancestor
55746887|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55746888|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55746889|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55746890|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746891|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746892|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55746893|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55746894|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
55746911|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746912|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746913|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55746914|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
55746915|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
55746916|NCT00702325|Hormones|hormones|mesh-ancestor
55746917|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55746918|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55746919|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55746920|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55746921|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
55746922|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55746923|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55778806|NCT00719225|Abatacept|abatacept|mesh-list
55746925|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
55746926|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746927|NCT02464813|Pregabalin|pregabalin|mesh-list
55746928|NCT02464813|Oxycodone|oxycodone|mesh-list
55746929|NCT02464813|Analgesics|analgesics|mesh-ancestor
55746930|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
55746931|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746932|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746933|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
55746934|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55746935|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55746936|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746937|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55746938|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55746939|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55746940|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746941|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55746942|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55746943|NCT02464813|Narcotics|narcotics|mesh-ancestor
55746944|NCT05726929|Capsaicin|capsaicin|mesh-list
55746945|NCT05726929|Antipruritics|antipruritics|mesh-ancestor
55746946|NCT05726929|Dermatologic Agents|dermatologic agents|mesh-ancestor
55746947|NCT05726929|Sensory System Agents|sensory system agents|mesh-ancestor
55746948|NCT05726929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746949|NCT05726929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746951|NCT04682353|Medroxyprogesterone|medroxyprogesterone|mesh-list
55746952|NCT04682353|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55746953|NCT04682353|Contraceptive Agents|contraceptive agents|mesh-ancestor
55746954|NCT04682353|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55746955|NCT04682353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746956|NCT04682353|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55746957|NCT04682353|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55746958|NCT04682353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55746959|NCT04682353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746960|NCT04682353|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55746961|NCT04682353|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55746962|NCT04682353|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55746963|NCT05163223|Pembrolizumab|pembrolizumab|mesh-list
55746964|NCT05163223|Capecitabine|capecitabine|mesh-list
55746965|NCT05163223|Sargramostim|sargramostim|mesh-list
55746966|NCT05163223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55746967|NCT05163223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746968|NCT05163223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55746969|NCT05163223|Antimetabolites|antimetabolites|mesh-ancestor
55746970|NCT05163223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55746971|NCT05163223|Immunologic Factors|immunologic factors|mesh-ancestor
55746972|NCT05163223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746973|NCT05122351|Acetaminophen|acetaminophen|mesh-list
55746974|NCT05122351|Bupivacaine|bupivacaine|mesh-list
55746975|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
55746976|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
55746977|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55746978|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55746979|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
55746980|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746981|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55746982|NCT05122351|Analgesics|analgesics|mesh-ancestor
55746983|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
55746984|NCT02464501|Paclitaxel|paclitaxel|mesh-list
55746985|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55746986|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55746997|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55746998|NCT04368403|Brodalumab|brodalumab|mesh-list
55746999|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
55747000|NCT04298203|Topiramate|topiramate|mesh-list
55747002|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
55747003|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55747004|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747005|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55747006|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
55747007|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55747008|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
55747009|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
55747010|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747011|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
55747012|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747013|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747014|NCT05679661|Chlorhexidine|chlorhexidine|mesh-list
55747015|NCT05679661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55747016|NCT05679661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747017|NCT05679661|Disinfectants|disinfectants|mesh-ancestor
55862862|NCT00765856|Narcotics|narcotics|mesh-ancestor
55747018|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
55747019|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55747020|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
55747021|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747022|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55747023|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55747024|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
55747025|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747026|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747027|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55747029|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
55747030|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747031|NCT00701779|Tamsulosin|tamsulosin|mesh-list
55747032|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55747033|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55747034|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55747035|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
55747036|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747037|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747038|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747039|NCT00701779|Urological Agents|urological agents|mesh-ancestor
55747040|NCT05618587|Lithium Carbonate|lithium carbonate|mesh-list
55747041|NCT05618587|Antidepressive Agents|antidepressive agents|mesh-ancestor
55747042|NCT05618587|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55747043|NCT05618587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747044|NCT05618587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747045|NCT05618587|Antimanic Agents|antimanic agents|mesh-ancestor
55747046|NCT05618587|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55747047|NCT05618587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747048|NCT05618587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747049|NCT02463643|Rabeprazole|rabeprazole|mesh-list
55747050|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55747051|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55747052|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55747053|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747054|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747055|NCT04927975|Upadacitinib|upadacitinib|mesh-list
55747056|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
55747057|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55747058|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747059|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747060|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55747061|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55747062|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55747064|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862910|NCT03805360|Anesthetics|anesthetics|mesh-list
55747066|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
55747067|NCT02465359|Antibodies|antibodies|mesh-list
55747068|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
55747069|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55747070|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55747071|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
55747072|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747073|NCT02463019|Tenofovir|tenofovir|mesh-list
55747116|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747117|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55747118|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747119|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55747120|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
55747121|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
55747122|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747123|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747124|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55747125|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55747126|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
55747128|NCT01612351|Cisplatin|cisplatin|mesh-list
55747129|NCT01612351|Carboplatin|carboplatin|mesh-list
55747130|NCT01612351|Lapatinib|lapatinib|mesh-list
55747131|NCT01612351|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55747132|NCT01612351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747133|NCT01612351|Tubulin Modulators|tubulin modulators|mesh-ancestor
55747134|NCT01612351|Antimitotic Agents|antimitotic agents|mesh-ancestor
55747135|NCT01612351|Mitosis Modulators|mitosis modulators|mesh-ancestor
55747136|NCT01612351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747137|NCT01612351|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55747138|NCT01612351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747139|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55747140|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
55747141|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55747142|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
55747143|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747144|NCT03337087|Calcium, Dietary|calcium, dietary|mesh-list
55747147|NCT03337087|Fluorouracil|fluorouracil|mesh-list
55747149|NCT03337087|Rucaparib|rucaparib|mesh-list
55747150|NCT03337087|Calcium|calcium|mesh-list
55747151|NCT03337087|Levoleucovorin|levoleucovorin|mesh-list
55747152|NCT03337087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55747153|NCT03337087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747154|NCT03337087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55747155|NCT03337087|Antimetabolites|antimetabolites|mesh-ancestor
55747156|NCT03337087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747157|NCT03337087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55747158|NCT03337087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747159|NCT03337087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55747160|NCT03337087|Immunologic Factors|immunologic factors|mesh-ancestor
55747161|NCT03337087|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55747162|NCT03337087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55747163|NCT03337087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747164|NCT03337087|Antidotes|antidotes|mesh-ancestor
55747165|NCT03337087|Protective Agents|protective agents|mesh-ancestor
55747166|NCT03337087|Vitamin B Complex|vitamin b complex|mesh-ancestor
55747167|NCT03337087|Vitamins|vitamins|mesh-ancestor
55747168|NCT03337087|Micronutrients|micronutrients|mesh-ancestor
55747169|NCT03337087|Hematinics|hematinics|mesh-ancestor
55747170|NCT03337087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55747171|NCT03332095|Tenofovir|tenofovir|mesh-list
55747172|NCT03332095|Lamivudine|lamivudine|mesh-list
55747173|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55747174|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
55747175|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747176|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55747177|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55747178|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747179|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747180|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55747181|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
55747182|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55747183|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747184|NCT04489849|Apixaban|apixaban|mesh-list
55747185|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55747186|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
55747187|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55747188|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
55747189|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747190|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747191|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
55747192|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
55747193|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55747194|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55747195|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747196|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
55747258|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55747259|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
55747260|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747261|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
55747262|NCT03290365|Protective Agents|protective agents|mesh-ancestor
55747263|NCT02764489|Thrombin|thrombin|mesh-list
55747264|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
55747265|NCT02764489|Coagulants|coagulants|mesh-list
55747266|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
55747267|NCT02462161|Insulin|insulin|mesh-list
55747268|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55747269|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
55747270|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
55747271|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55747272|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55747273|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747274|NCT03289819|Paclitaxel|paclitaxel|mesh-list
55747275|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55747276|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
55747277|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
55747278|NCT03289819|Epirubicin|epirubicin|mesh-list
55747279|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55747280|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747281|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
55747282|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
55747283|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
55747284|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747285|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55747286|NCT03289819|Immunologic Factors|immunologic factors|mesh-ancestor
55747287|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747288|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55747289|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55747290|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
55747291|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55747292|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55747293|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55747294|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55747295|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55747296|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747297|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
55747298|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55747299|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747300|NCT02713867|Nivolumab|nivolumab|mesh-list
55747301|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55747302|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747303|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55747304|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747305|NCT03372785|Aspirin|aspirin|mesh-list
55747306|NCT03372785|Metoprolol|metoprolol|mesh-list
55747307|NCT03372785|Clopidogrel|clopidogrel|mesh-list
55747308|NCT03372785|Ticagrelor|ticagrelor|mesh-list
55747309|NCT03372785|Atorvastatin|atorvastatin|mesh-list
55747310|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55747311|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55747312|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55747313|NCT03372785|Analgesics|analgesics|mesh-ancestor
55747314|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
55747315|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747316|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747317|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55747318|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55747319|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55747320|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55747321|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747322|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55747323|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55747324|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747325|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
55747326|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55747327|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55747328|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
55747330|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55747331|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55747332|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55747333|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55747334|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
55747335|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747336|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55747337|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55747338|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
55747339|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
55747340|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55747341|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55747342|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55747343|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
55747344|NCT03372473|Loratadine|loratadine|mesh-list
55747345|NCT03372473|Montelukast|montelukast|mesh-list
55747346|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55747347|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
55747348|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55747349|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
55747350|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55747351|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747352|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55747353|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55789037|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
55747354|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747355|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
55747356|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
55747357|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55747358|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55747359|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55747360|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
55747361|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
55747362|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747363|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
55747365|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55747366|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55747367|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
55747368|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747369|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55747370|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55747371|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747372|NCT03289429|Analgesics|analgesics|mesh-ancestor
55747373|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
55747374|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747375|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747376|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
55747377|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747378|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55747379|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
55747380|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55747381|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55747382|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55747384|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55747385|NCT03372239|Tryptophan|tryptophan|mesh-list
55747386|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55747387|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
55747388|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55747390|NCT03294967|Caffeine|caffeine|mesh-list
55747391|NCT03294967|Vitamins|vitamins|mesh-ancestor
55747392|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
55747393|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747394|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55747395|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55747396|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747397|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747398|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55747399|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55747400|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
55747401|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747402|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
55747403|NCT03294967|Protective Agents|protective agents|mesh-ancestor
55747404|NCT03371849|Montelukast|montelukast|mesh-list
55747405|NCT03371849|Levocetirizine|levocetirizine|mesh-list
55747406|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55747407|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
55747408|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55747409|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
55747410|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55747411|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747412|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55747413|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55747414|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747415|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55747416|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55747417|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
55747418|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
55747419|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747420|NCT04307329|Trastuzumab|trastuzumab|mesh-list
55747422|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747423|NCT03371069|Methylphenidate|methylphenidate|mesh-list
55747424|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55747425|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747426|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55747427|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55747428|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55747429|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747430|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
55778968|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
55747431|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747432|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
55747433|NCT03294577|Docetaxel|docetaxel|mesh-list
55747434|NCT03294577|Doxorubicin|doxorubicin|mesh-list
55747435|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55747436|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
55747437|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747438|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55747439|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55747440|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
55747441|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863365|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
55747442|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747443|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55747444|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
55747445|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
55747446|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
55747447|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55747448|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55747449|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55747450|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747452|NCT03370835|Carvedilol|carvedilol|mesh-list
55747453|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55747455|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
55747456|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
55747457|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747458|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747459|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55747460|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55747461|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55747462|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
55747463|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747464|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747465|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
55747466|NCT03370835|Protective Agents|protective agents|mesh-ancestor
55747467|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55747468|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55747469|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55747470|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
55747471|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55747472|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55747473|NCT02460367|Docetaxel|docetaxel|mesh-list
55747474|NCT02460367|Tryptophan|tryptophan|mesh-list
55747475|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747476|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
55747477|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
55747478|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
55747479|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747480|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55747481|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
55747482|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55747484|NCT03370601|Azathioprine|azathioprine|mesh-list
55747485|NCT03370601|Infliximab|infliximab|mesh-list
55747486|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
55747487|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55747488|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55747489|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
55747490|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747491|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55747492|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747493|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55747494|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
55747495|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747496|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55747497|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747498|NCT03370367|Tretinoin|tretinoin|mesh-list
55747499|NCT03370367|Isotretinoin|isotretinoin|mesh-list
55747500|NCT03370367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747501|NCT03370367|Keratolytic Agents|keratolytic agents|mesh-ancestor
55747502|NCT03370367|Dermatologic Agents|dermatologic agents|mesh-ancestor
55747503|NCT03376529|Tazobactam|tazobactam|mesh-list
55747504|NCT03376529|Piperacillin|piperacillin|mesh-list
55747505|NCT03376529|Ceftazidime|ceftazidime|mesh-list
55747506|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55747507|NCT03376529|Aztreonam|aztreonam|mesh-list
55747508|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55747509|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747510|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55747511|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747512|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747513|NCT04132661|Bisacodyl|bisacodyl|mesh-list
55747514|NCT04132661|Cathartics|cathartics|mesh-ancestor
55747515|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55747516|NCT04132661|Laxatives|laxatives|mesh-ancestor
55747517|NCT03700541|Morphine|morphine|mesh-list
55747518|NCT03700541|Pirinitramide|pirinitramide|mesh-list
55747519|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55747520|NCT03700541|Narcotics|narcotics|mesh-ancestor
55747521|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747522|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747524|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
55747525|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747526|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55747527|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55747528|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55747529|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
55747530|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747531|NCT02460211|Vitamin D|vitamin d|mesh-list
55747532|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
55747533|NCT02460211|Vitamins|vitamins|mesh-ancestor
55747534|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
55747535|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747536|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55747537|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55747538|NCT03288259|Anesthetics|anesthetics|mesh-list
55747539|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
55747540|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747541|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747542|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
55747543|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747545|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55747546|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55747547|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747548|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747549|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
55747550|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55747553|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
55747554|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747555|NCT03376139|Zonisamide|zonisamide|mesh-list
55747556|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
55747557|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55747558|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55747559|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747560|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55747561|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747562|NCT03369119|Montelukast|montelukast|mesh-list
55747563|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55747564|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
55747565|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55747566|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
55747567|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55747568|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747569|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55747570|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55747571|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747574|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
55747575|NCT03287011|Protective Agents|protective agents|mesh-ancestor
55747576|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747577|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55747578|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747579|NCT03293641|Folic Acid|folic acid|mesh-list
55747580|NCT03293641|Penicillins|penicillins|mesh-list
55747581|NCT03293641|Penicillin V|penicillin v|mesh-list
55747582|NCT03293641|Proguanil|proguanil|mesh-list
55747583|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
55747584|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
55747585|NCT03293641|Hematinics|hematinics|mesh-ancestor
55747586|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
55747587|NCT03293641|Vitamins|vitamins|mesh-ancestor
55747588|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
55747589|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747590|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747591|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
55747592|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747593|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747594|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55747595|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55747596|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747597|NCT03293641|Astringents|astringents|mesh-ancestor
55747598|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
55747599|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
55747601|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55747602|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
55747603|NCT02519543|Metformin|metformin|mesh-list
55747604|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55747605|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747606|NCT03293407|Iloprost|iloprost|mesh-list
55747607|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55747608|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
55747609|NCT02519699|Norepinephrine|norepinephrine|mesh-list
55747611|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55747612|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
55747613|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747615|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747616|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
55747617|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
55747618|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747619|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55747620|NCT00701311|Apremilast|apremilast|mesh-list
55747621|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55747622|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55747623|NCT00701311|Analgesics|analgesics|mesh-ancestor
55747624|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
55747625|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747626|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747627|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55747628|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55747629|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55747630|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55747631|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747632|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747633|NCT03375671|Midazolam|midazolam|mesh-list
55747634|NCT03375671|Ketamine|ketamine|mesh-list
55747635|NCT03375671|Haloperidol|haloperidol|mesh-list
55747636|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
55747637|NCT03375671|Analgesics|analgesics|mesh-ancestor
55747638|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
55747639|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747640|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747641|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55747642|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55747643|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
55747645|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747646|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55747807|NCT03363425|Analgesics|analgesics|mesh-ancestor
55747647|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55747648|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747649|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747650|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55747651|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55747652|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55747653|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55747654|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55747655|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
55747656|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
55747657|NCT03375671|Antiemetics|antiemetics|mesh-ancestor
55747658|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
55747659|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55747660|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55747661|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55747662|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
55747663|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55747664|NCT03375593|Acetaminophen|acetaminophen|mesh-list
55747665|NCT03375593|Ibuprofen|ibuprofen|mesh-list
55747666|NCT03375593|Oxycodone|oxycodone|mesh-list
55747667|NCT03375593|Hydrocodone|hydrocodone|mesh-list
55747668|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55747669|NCT03375593|Analgesics|analgesics|mesh-ancestor
55747670|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
55747671|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747672|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747674|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55747675|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55779009|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
55747677|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55747678|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747679|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747680|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55747681|NCT03375593|Narcotics|narcotics|mesh-ancestor
55747682|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747683|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
55747684|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
55747685|NCT04525235|Tolbutamide|tolbutamide|mesh-list
55747686|NCT04525235|Rifampin|rifampin|mesh-list
55747687|NCT04525235|Digoxin|digoxin|mesh-list
55747688|NCT04525235|Midazolam|midazolam|mesh-list
55747689|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
55747690|NCT04525235|Caffeine|caffeine|mesh-list
55747691|NCT04525235|Omeprazole|omeprazole|mesh-list
55747692|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55747693|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55747694|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747695|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747696|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55747697|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55747698|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55747699|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55747700|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
55747702|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
55747703|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
55747704|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747705|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747706|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55747707|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55747708|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747709|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55747710|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55747711|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
55747712|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55747713|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55747714|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55747715|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55747716|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
55747717|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55747718|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747719|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
55747720|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55747721|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55747722|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55747723|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55747724|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55747725|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55747726|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55747727|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55747728|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55747729|NCT04525235|Protective Agents|protective agents|mesh-ancestor
55747730|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
55747731|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
55747732|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55747733|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55747737|NCT03363815|Nintedanib|nintedanib|mesh-list
55747738|NCT03363815|Digoxin|digoxin|mesh-list
55747739|NCT03363815|Midazolam|midazolam|mesh-list
55747740|NCT03363815|Omeprazole|omeprazole|mesh-list
55747741|NCT03363815|Warfarin|warfarin|mesh-list
55747742|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55747743|NCT03363815|Vitamins|vitamins|mesh-ancestor
55747744|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
55747745|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747746|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55747747|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55747748|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55747749|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747751|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55747752|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55747753|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55747754|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
55747755|NCT03363815|Anesthetics|anesthetics|mesh-ancestor
55747756|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
55747757|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
55747758|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747759|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747760|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55747761|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55747762|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
55747763|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55747764|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55747765|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747766|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
55747767|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55747768|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55747769|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55747770|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55747771|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55747772|NCT03363815|Protective Agents|protective agents|mesh-ancestor
55747773|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55747774|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55747775|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
55747776|NCT03363815|Coagulants|coagulants|mesh-ancestor
55747777|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747778|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55747779|NCT03363659|Copper|copper|mesh-list
55747780|NCT03363659|Temozolomide|temozolomide|mesh-list
55747781|NCT03363659|Disulfiram|disulfiram|mesh-list
55747782|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55747783|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
55747784|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747785|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747786|NCT03363659|Trace Elements|trace elements|mesh-ancestor
55747787|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
55747788|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747789|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55747790|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
55747791|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747792|NCT03363425|Lidocaine|lidocaine|mesh-list
55747793|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
55747794|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
55747795|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
55747796|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747797|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747798|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
55863537|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55747799|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747801|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55747802|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55747803|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55747804|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747805|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55747806|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55747808|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55747809|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55747810|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55747811|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
55747812|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747814|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55747815|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
55747816|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747817|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
55747818|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
55747819|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55747820|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55747821|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747822|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747823|NCT02519153|Urological Agents|urological agents|mesh-ancestor
55747824|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
55747825|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55747826|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747827|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55747828|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55747829|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747830|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747831|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747832|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55747833|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55747834|NCT03363191|Fluticasone|fluticasone|mesh-list
55747835|NCT03363191|Xhance|xhance|mesh-list
55747836|NCT03363191|Albuterol|albuterol|mesh-list
55747837|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55747838|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55747839|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
55747840|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747841|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747842|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55747843|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
55747844|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
55747845|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55747846|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
55747847|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55747848|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55747849|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55747850|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55747851|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
55747852|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747853|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747854|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
55747855|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55747856|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55863550|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
55747857|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747858|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
55747859|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747860|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747861|NCT03285607|Paclitaxel|paclitaxel|mesh-list
55747862|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
55747863|NCT03285607|Doxorubicin|doxorubicin|mesh-list
55747864|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55747865|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747866|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
55747867|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
55747868|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
55747869|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747870|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55747871|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
55747872|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747873|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55747874|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55747875|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
55747876|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55747877|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55747878|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55747879|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55747880|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747881|NCT03298321|Azacitidine|azacitidine|mesh-list
55747882|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55747884|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747886|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747887|NCT04527055|Metronidazole|metronidazole|mesh-list
55747888|NCT04527055|Tetracycline|tetracycline|mesh-list
55747889|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
55747890|NCT04527055|Esomeprazole|esomeprazole|mesh-list
55747891|NCT04527055|Bismuth|bismuth|mesh-list
55747892|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747893|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55747894|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55747895|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55747896|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55747897|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55747898|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55863579|NCT05521984|Carmustine|carmustine|mesh-list
55747899|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747900|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747901|NCT04527055|Antacids|antacids|mesh-ancestor
55747902|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55747903|NCT02518763|Vitamin D|vitamin d|mesh-list
55747904|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
55747905|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
55747906|NCT02518763|Vitamins|vitamins|mesh-list
55747907|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
55747908|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55779080|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747909|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55747910|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55747911|NCT04019093|Ethanol|ethanol|mesh-list
55747912|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55747914|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747915|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747916|NCT03362411|Linrodostat|linrodostat|mesh-list
55747917|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747918|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747919|NCT02460289|Minoxidil|minoxidil|mesh-list
55747920|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55747921|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
55747922|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
55747923|NCT03291457|Hormones|hormones|mesh-ancestor
55747924|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55747925|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747926|NCT03361709|Dexamethasone|dexamethasone|mesh-list
55747927|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55747928|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
55747929|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
55747930|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747931|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747932|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55747933|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
55747934|NCT03361709|Hormones|hormones|mesh-ancestor
55747935|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55747936|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55747937|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747938|NCT03284749|Copper|copper|mesh-list
55747939|NCT03284749|Trace Elements|trace elements|mesh-ancestor
55747940|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
55747941|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747943|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55747944|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
55747945|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55747946|NCT04523675|Expectorants|expectorants|mesh-ancestor
55747947|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
55747948|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55747949|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
55747950|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747951|NCT04523675|Protective Agents|protective agents|mesh-ancestor
55747952|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747954|NCT03298009|Canagliflozin|canagliflozin|mesh-list
55747955|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55747956|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747957|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55747958|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747959|NCT03291145|Spironolactone|spironolactone|mesh-list
55747960|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55747961|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55747962|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
55747963|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55747964|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747965|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55747966|NCT03291145|Diuretics|diuretics|mesh-ancestor
55747967|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
55747968|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55747969|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
55747970|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55747971|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747972|NCT03297931|Iproplatin|iproplatin|mesh-list
55747973|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747975|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55747976|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
55747977|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747978|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55747979|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55747980|NCT03361397|Lidocaine|lidocaine|mesh-list
55747981|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
55747982|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
55747983|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55747984|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747985|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
55747986|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747987|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55747988|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55747989|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55747990|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55747991|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55747992|NCT03109379|Trospium chloride|trospium chloride|mesh-list
55747993|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
55747994|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
55747995|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55747996|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55747997|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55747998|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55747999|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
55748000|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748001|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748002|NCT03109379|Urological Agents|urological agents|mesh-ancestor
55748003|NCT03361319|Paclitaxel|paclitaxel|mesh-list
55748005|NCT03361319|Nintedanib|nintedanib|mesh-list
55748006|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55748007|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748008|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
55748009|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
55748010|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
55748011|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748012|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55748013|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748014|NCT04489147|Metformin|metformin|mesh-list
55748015|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55748016|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748017|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
55748018|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
55748019|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55748020|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55748021|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748022|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
55748023|NCT03365999|Coagulants|coagulants|mesh-ancestor
55748024|NCT02460055|Dexamethasone|dexamethasone|mesh-list
55748025|NCT02460055|Fentanyl|fentanyl|mesh-list
55748026|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
55748027|NCT02460055|Ondansetron|ondansetron|mesh-list
55748028|NCT02460055|Propofol|propofol|mesh-list
55748029|NCT02460055|Sevoflurane|sevoflurane|mesh-list
55748030|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748031|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
55748032|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
55748033|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748034|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748036|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
55748037|NCT02460055|Hormones|hormones|mesh-ancestor
55748038|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55748039|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55748040|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748041|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55748042|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748043|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55748044|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
55748046|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55748047|NCT02460055|Narcotics|narcotics|mesh-ancestor
55748048|NCT02460055|Analgesics|analgesics|mesh-ancestor
55748049|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
55748050|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55748051|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55748052|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55748053|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
55748054|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
55748055|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55748056|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
55748057|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748058|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748059|NCT02460055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55748060|NCT02460055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55748061|NCT02460055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55748062|NCT02460055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55748063|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748064|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
55748065|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55748066|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55748067|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
55748068|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748069|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748070|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748071|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55748072|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55748073|NCT03365765|Fluorouracil|fluorouracil|mesh-list
55748074|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
55748075|NCT03365765|Apatinib|apatinib|mesh-list
55748076|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
55779135|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748077|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748078|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55748079|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748080|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55863709|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863710|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55863711|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863712|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55863713|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
55863714|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863715|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55863716|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55863717|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
55863718|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
55863719|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55863720|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863721|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55863723|NCT00792142|Growth Substances|growth substances|mesh-ancestor
55748081|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
55748082|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748083|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55748084|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748086|NCT03297463|Interleukin-2|interleukin-2|mesh-list
55748087|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55748088|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748089|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55748090|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748091|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748092|NCT03297463|Analgesics|analgesics|mesh-ancestor
55748093|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
55748094|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748095|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748097|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55748098|NCT03282643|Tinzaparin|tinzaparin|mesh-list
55748099|NCT03282643|Dalteparin|dalteparin|mesh-list
55748100|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
55748155|NCT03107923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748156|NCT03107923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748158|NCT03536455|Acetazolamide|acetazolamide|mesh-list
55748159|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
55748160|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55748161|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748162|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748163|NCT03536455|Diuretics|diuretics|mesh-ancestor
55748164|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
55748165|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748166|NCT03529825|Rifaximin|rifaximin|mesh-list
55748167|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55748168|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748169|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55748170|NCT03281941|Capsaicin|capsaicin|mesh-list
55748171|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
55748172|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
55748173|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
55748174|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748175|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748176|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
55748177|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55748178|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748179|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748180|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748181|NCT02459509|Analgesics|analgesics|mesh-ancestor
55748182|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
55748183|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748184|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55748185|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55748186|NCT02459509|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55748187|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
55748188|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748189|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748190|NCT03264781|CycloProvera|cycloprovera|mesh-list
55748191|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55748192|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55748193|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55748194|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
55748195|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55748196|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748197|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55748198|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55748199|NCT03281863|Antibodies|antibodies|mesh-list
55748200|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
55748201|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
55748202|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748203|NCT03264625|Vitamin D|vitamin d|mesh-list
55748204|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
55748205|NCT03264625|Vitamins|vitamins|mesh-ancestor
55748206|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
55748207|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748208|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55748209|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55748210|NCT03269929|Midazolam|midazolam|mesh-list
55748211|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55748212|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55748213|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748214|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748215|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55748216|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55748217|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55748218|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55748219|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
55748221|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
55748223|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748224|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748225|NCT02730377|Liraglutide|liraglutide|mesh-list
55748226|NCT02730377|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
55748227|NCT02730377|Meglitinide|meglitinide|mesh-list
55748228|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55748229|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55748230|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
55748231|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55748232|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748236|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748237|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
55748241|NCT03264547|Trastuzumab|trastuzumab|mesh-list
55748242|NCT03264547|Pertuzumab|pertuzumab|mesh-list
55748243|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55748244|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748245|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
55748246|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
55748247|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
55748248|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748249|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55748250|NCT03365141|Triamcinolone|triamcinolone|mesh-list
55748251|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55748252|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55748253|NCT03365141|Tacrolimus|tacrolimus|mesh-list
55748254|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55748255|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55748256|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
55748257|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748258|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55748259|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748260|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748261|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748262|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
55748263|NCT03365141|Hormones|hormones|mesh-ancestor
55748264|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55748265|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
55748266|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55748267|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748268|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55748269|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748270|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
55748271|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55748272|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55748273|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55748274|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
55748275|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748276|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748277|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748278|NCT03359837|Insulin|insulin|mesh-list
55748279|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55748280|NCT03359837|Metformin|metformin|mesh-list
55748281|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
55748282|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
55748283|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
55748284|NCT03359837|Acarbose|acarbose|mesh-list
55748285|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
55748286|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
55748287|NCT03359837|Repaglinide|repaglinide|mesh-list
55748288|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55748289|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748290|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55748291|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748292|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748293|NCT03359681|Metformin|metformin|mesh-list
55748294|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55748295|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748296|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
55748297|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55748298|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55748299|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748300|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
55748301|NCT03359525|Coagulants|coagulants|mesh-ancestor
55748302|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
55748303|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55748304|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55748305|NCT03359291|Macitentan|macitentan|mesh-list
55748306|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55748307|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55748308|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
55748309|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748310|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55748311|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55748312|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748395|NCT04521491|Leucovorin|leucovorin|mesh-list
55748313|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55748314|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55748315|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55748317|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748318|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
55748319|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748320|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748321|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55748322|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55748323|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55748324|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55748326|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
55748327|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
55748328|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55748329|NCT03359057|Estradiol|estradiol|mesh-list
55748330|NCT03359057|Estrogens|estrogens|mesh-ancestor
55748331|NCT03359057|Hormones|hormones|mesh-ancestor
55748332|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55748333|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748334|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55748335|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
55748336|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55748337|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55748339|NCT03359057|Vitamins|vitamins|mesh-ancestor
55748340|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
55748341|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55748342|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55748343|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55748345|NCT02714569|Simvastatin|simvastatin|mesh-list
55748346|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55748347|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55748348|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
55748349|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748350|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55748351|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55748352|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748353|NCT04522037|Morphine|morphine|mesh-list
55748354|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55748355|NCT04522037|Narcotics|narcotics|mesh-ancestor
55748356|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748357|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748358|NCT04522037|Analgesics|analgesics|mesh-ancestor
55748359|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
55748360|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748362|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55748363|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55779246|NCT05676463|Hormones|hormones|mesh-list
55748364|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55748366|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748367|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55748368|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748369|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
55748370|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55748371|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
55748372|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748373|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
55748374|NCT03357575|Protective Agents|protective agents|mesh-ancestor
55748375|NCT03280927|Efinaconazole|efinaconazole|mesh-list
55748376|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
55748377|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748378|NCT03269383|Bupivacaine|bupivacaine|mesh-list
55748379|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
55748381|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748382|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748384|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748385|NCT03280849|Chitosan|chitosan|mesh-list
55748386|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55748387|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55748388|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
55748389|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748390|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55748391|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
55748392|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
55748393|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
55748394|NCT03280849|Coagulants|coagulants|mesh-ancestor
55844257|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55844258|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
55844259|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
55844260|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
55844261|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55844262|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55844263|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55844265|NCT01558089|Etanercept|etanercept|mesh-list
55844277|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55844278|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844279|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
55844280|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844281|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55844282|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55844283|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55844284|NCT01558089|Analgesics|analgesics|mesh-ancestor
55844285|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
55844286|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844287|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55844288|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55844289|NCT00084682|Romidepsin|romidepsin|mesh-list
55844337|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55844338|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844339|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
55844340|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
55844341|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
55844342|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844343|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
55844344|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55844345|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55844346|NCT03437746|Prednisolone|prednisolone|mesh-list
55844347|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
55844348|NCT03437746|Anesthetics|anesthetics|mesh-list
55844349|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55844350|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
55844351|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55844352|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
55844353|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
55844354|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748414|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55779271|NCT04886453|Anesthetics|anesthetics|mesh-list
55748415|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
55748416|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748417|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55748418|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748419|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748420|NCT03264079|Itraconazole|itraconazole|mesh-list
55748421|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
55748422|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748423|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55748424|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55748425|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748426|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748427|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55748428|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
55748429|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55748430|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748431|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55748432|NCT04509323|Huperzine A|huperzine a|mesh-list
55748433|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55748434|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748435|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748436|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
55748437|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748438|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748439|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55748440|NCT04509323|Protective Agents|protective agents|mesh-ancestor
55748441|NCT04443647|Oxytocin|oxytocin|mesh-list
55748442|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
55748443|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55748444|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748445|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55748446|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748448|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55748484|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748485|NCT03263689|Analgesics|analgesics|mesh-ancestor
55748486|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
55748487|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748488|NCT03279679|Ropivacaine|ropivacaine|mesh-list
55748489|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
55748490|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
55748491|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748492|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748493|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
55748494|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748495|NCT02518451|Valsartan|valsartan|mesh-list
55748496|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55748497|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55748498|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55748499|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748500|NCT03263299|Aspirin|aspirin|mesh-list
55748501|NCT03263299|Cabergoline|cabergoline|mesh-list
55748502|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55748503|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748504|NCT03263299|Analgesics|analgesics|mesh-ancestor
55748505|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
55748506|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748507|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748508|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748509|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748510|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55748511|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55748512|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748513|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55748514|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55748515|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748516|NCT03263299|Antipyretics|antipyretics|mesh-ancestor
55748517|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55748518|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55748519|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
55748520|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
55748521|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748522|NCT04444349|Ubiquinone|ubiquinone|mesh-list
55748523|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
55748524|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
55748525|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748526|NCT04444349|Vitamins|vitamins|mesh-ancestor
55748527|NCT03263533|Vorinostat|vorinostat|mesh-list
55748528|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748529|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55748530|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748531|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748532|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
55748533|NCT03123107|Vitamins|vitamins|mesh-ancestor
55748535|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748536|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
55748537|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748538|NCT03123107|Protective Agents|protective agents|mesh-ancestor
55748539|NCT04516655|Rituximab|rituximab|mesh-list
55748540|NCT04516655|Methotrexate|methotrexate|mesh-list
55748541|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55748542|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748543|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
55748544|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748545|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748546|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55748547|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
55748548|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55748549|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55748550|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
55748551|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748552|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
55748553|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748554|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55748555|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55748556|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55748557|NCT02458183|Vaccines|vaccines|mesh-list
55748558|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
55748559|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748560|NCT04444193|Durvalumab|durvalumab|mesh-list
55844732|NCT05688202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55844733|NCT05688202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55844734|NCT05688202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844735|NCT05688202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55844736|NCT05688202|Analgesics|analgesics|mesh-ancestor
55844737|NCT05688202|Antipyretics|antipyretics|mesh-ancestor
55844738|NCT05688202|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55844739|NCT05688124|Esomeprazole|esomeprazole|mesh-list
55844740|NCT05688124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55748592|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
55748593|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748594|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748595|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748596|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748597|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
55748598|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55748599|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
55748600|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748602|NCT03353909|Protective Agents|protective agents|mesh-ancestor
55748604|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55748605|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748606|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55748607|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748608|NCT04508231|Hormones|hormones|mesh-list
55748609|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55748610|NCT04508231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748611|NCT03263065|Psyllium|psyllium|mesh-list
55748612|NCT03263065|Cathartics|cathartics|mesh-ancestor
55748613|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55748614|NCT02518373|Omeprazole|omeprazole|mesh-list
55748615|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55748616|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55748617|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55748618|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748619|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748620|NCT03266965|Carbidopa|carbidopa|mesh-list
55748621|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55748622|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55748623|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
55748624|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748625|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748626|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748627|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55748628|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748629|NCT03266731|Aspirin|aspirin|mesh-list
55748630|NCT03266731|Clopidogrel|clopidogrel|mesh-list
55748631|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55748632|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748633|NCT03266731|Analgesics|analgesics|mesh-ancestor
55748634|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
55748635|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748636|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748637|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748638|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748639|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55748640|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55748641|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748642|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55748643|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55748658|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748659|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55748660|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55748661|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748662|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748663|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55748664|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55748665|NCT03353441|Glycine|glycine|mesh-list
55748666|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
55748667|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55748668|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748669|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748670|NCT03353363|Bupivacaine|bupivacaine|mesh-list
55748671|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
55748672|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
55748673|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748674|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748675|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
55748676|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748678|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55748679|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748680|NCT04511195|Analgesics|analgesics|mesh-ancestor
55748681|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
55748682|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748683|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748684|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748685|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748686|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55748687|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748688|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748689|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
55748690|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
55748691|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
55748692|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55748693|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55748694|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748695|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748696|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748697|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748698|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
55748701|NCT04507217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748702|NCT04507217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748703|NCT04507217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748704|NCT04507217|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55748705|NCT04507217|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55748706|NCT03262363|Curcumin|curcumin|mesh-list
55748707|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55748708|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748709|NCT03262363|Analgesics|analgesics|mesh-ancestor
55748710|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
55748711|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748712|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748713|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748714|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748715|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748716|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748717|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748718|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
55748719|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55748720|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
55748721|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748723|NCT04506827|Protective Agents|protective agents|mesh-ancestor
55748724|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
55748725|NCT03352895|Resveratrol|resveratrol|mesh-list
55748726|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
55748727|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748729|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748730|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748731|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55748732|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55748733|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748734|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55748735|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748736|NCT03350633|Azathioprine|azathioprine|mesh-list
55748737|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
55748738|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748739|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55748740|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748741|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55748742|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
55748743|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748744|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748746|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55748747|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
55748749|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748750|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748752|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
55748753|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748762|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748763|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
55748764|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748765|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55748766|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748767|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748768|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55748769|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55748770|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55748771|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
55748772|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748773|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55748774|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55748775|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748776|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55748777|NCT04669561|Lifitegrast|lifitegrast|mesh-list
55748778|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55748779|NCT02729909|Lubiprostone|lubiprostone|mesh-list
55748780|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55748781|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55748782|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748783|NCT03352115|Prednisolone|prednisolone|mesh-list
55748784|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748785|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
55748787|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55748788|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748789|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55748790|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748791|NCT03252457|Dexamethasone|dexamethasone|mesh-list
55748792|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
55748793|NCT03252457|Decitabine|decitabine|mesh-list
55748794|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748795|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
55748796|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
55748797|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748798|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748799|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55748800|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
55748801|NCT03252457|Hormones|hormones|mesh-ancestor
55748802|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55748803|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55748804|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748805|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55748806|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
55779408|NCT04874831|Avelumab|avelumab|mesh-list
55748808|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748810|NCT03258931|Midostaurin|midostaurin|mesh-list
55748811|NCT03258931|Crenolanib|crenolanib|mesh-list
55748812|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55748813|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
55748814|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748815|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748817|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748818|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55748819|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
55748820|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748821|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55748822|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748823|NCT04506125|Chrysarobin|chrysarobin|mesh-list
55748824|NCT04506125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55748825|NCT04506125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748826|NCT04506125|Analgesics|analgesics|mesh-ancestor
55748827|NCT04506125|Sensory System Agents|sensory system agents|mesh-ancestor
55748828|NCT04506125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748829|NCT04506125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748830|NCT04506125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748831|NCT04506125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748832|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
55748833|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55748834|NCT03261349|Ledipasvir|ledipasvir|mesh-list
55748835|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
55748836|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748837|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
55748838|NCT02455609|Ketamine|ketamine|mesh-list
55748839|NCT02455609|Bupivacaine|bupivacaine|mesh-list
55748855|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55748856|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55748857|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
55748858|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55748859|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55748862|NCT05723627|Propofol|propofol|mesh-list
55748863|NCT05723627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55748864|NCT05723627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748865|NCT05723627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748866|NCT05723627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55748867|NCT05723627|Anesthetics, General|anesthetics, general|mesh-ancestor
55748868|NCT05723627|Anesthetics|anesthetics|mesh-ancestor
55748869|NCT03349619|Resveratrol|resveratrol|mesh-list
55748870|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
55748872|NCT03349619|Protective Agents|protective agents|mesh-ancestor
55748873|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748874|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748875|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55748877|NCT04505657|Lidocaine|lidocaine|mesh-list
55748878|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
55748879|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
55748880|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748881|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748882|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
55748883|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748884|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55748885|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55748886|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55748887|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55748888|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748889|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55748890|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55748891|NCT04505657|Analgesics|analgesics|mesh-ancestor
55748892|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55748893|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55748894|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55748895|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55748896|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748897|NCT03259243|Bupivacaine|bupivacaine|mesh-list
55748898|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
55748899|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
55748900|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748901|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748902|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
55748903|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748904|NCT03517969|Carboplatin|carboplatin|mesh-list
55748905|NCT03517969|Docetaxel|docetaxel|mesh-list
55748906|NCT03517969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748907|NCT03517969|Tubulin Modulators|tubulin modulators|mesh-ancestor
55748908|NCT03517969|Antimitotic Agents|antimitotic agents|mesh-ancestor
55748909|NCT03517969|Mitosis Modulators|mitosis modulators|mesh-ancestor
55748910|NCT03517969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748911|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
55748912|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
55748913|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
55748914|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55748915|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748916|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
55748917|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55748919|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55748920|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55748921|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55748922|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55748923|NCT03252067|Azithromycin|azithromycin|mesh-list
55748924|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55748925|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55748926|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748927|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55748928|NCT03252223|Hormones|hormones|mesh-list
55748929|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55748930|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55779474|NCT04520711|Pembrolizumab|pembrolizumab|mesh-list
55748931|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748932|NCT05513807|Niacinamide|niacinamide|mesh-list
55748934|NCT05513807|Nicotinic Acids|nicotinic acids|mesh-list
55748978|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748979|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
55748980|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55748981|NCT03351569|Antibodies|antibodies|mesh-list
55748982|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
55748983|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55748985|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55748987|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
55748988|NCT03348917|Povidone|povidone|mesh-list
55748989|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55748990|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55748991|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
55748992|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
55748993|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
55748995|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
55748996|NCT03251365|Gemcitabine|gemcitabine|mesh-list
55748997|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55748998|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
55748999|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749000|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749001|NCT03251365|Antiviral Agents|antiviral agents|mesh-ancestor
55749002|NCT03251365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749005|NCT03251365|Immunologic Factors|immunologic factors|mesh-ancestor
55749006|NCT03251365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749007|NCT03251443|Apatinib|apatinib|mesh-list
55749008|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749009|NCT03251443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55749010|NCT03251443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749011|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749012|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55749013|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55749014|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749015|NCT05350943|Gemcitabine|gemcitabine|mesh-list
55749016|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
55749017|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55749018|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
55749019|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749020|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749021|NCT05350943|Antiviral Agents|antiviral agents|mesh-ancestor
55749022|NCT05350943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749023|NCT05350943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749024|NCT05350943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55749025|NCT05350943|Immunologic Factors|immunologic factors|mesh-ancestor
55749026|NCT05350943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749027|NCT03261427|Pregabalin|pregabalin|mesh-list
55749028|NCT03261427|Analgesics|analgesics|mesh-ancestor
55749029|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
55749030|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749031|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749032|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
55749033|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55749034|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55749035|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749036|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55749037|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55749038|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55749039|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749040|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55749042|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749043|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749044|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
55749045|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
55749046|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
55749047|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749048|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749049|NCT05320133|Bismuth|bismuth|mesh-list
55749050|NCT05320133|Antacids|antacids|mesh-ancestor
55749051|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749052|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55749053|NCT03122561|Acetaminophen|acetaminophen|mesh-list
55749054|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55749055|NCT03122561|Analgesics|analgesics|mesh-ancestor
55749056|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
55749057|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749058|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749070|NCT03260569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749071|NCT03260569|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55749072|NCT03260569|Vasodilator Agents|vasodilator agents|mesh-ancestor
55749073|NCT03260569|Gasotransmitters|gasotransmitters|mesh-ancestor
55749074|NCT03260569|Protective Agents|protective agents|mesh-ancestor
55749075|NCT04503629|Rabeprazole|rabeprazole|mesh-list
55749076|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55749077|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55749078|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55749079|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749080|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749081|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
55749082|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55749083|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
55749085|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749086|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749087|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
55749088|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55749089|NCT03348371|Ethanol|ethanol|mesh-list
55749090|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55749092|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749093|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749094|NCT05231603|Ivermectin|ivermectin|mesh-list
55749095|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55749096|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749097|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55749098|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55749099|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749100|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
55749101|NCT03467113|Cannabidiol|cannabidiol|mesh-list
55749102|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
55749103|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55749104|NCT03434041|Citalopram|citalopram|mesh-list
55749105|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55749106|NCT03434041|Sertraline|sertraline|mesh-list
55749107|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
55749108|NCT03434041|Esketamine|esketamine|mesh-list
55749109|NCT03434041|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55749110|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55749111|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55749112|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749113|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749114|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
55749115|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749116|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55749117|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55749118|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749119|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55749122|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
55749123|NCT03250741|Rotigotine|rotigotine|mesh-list
55749124|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
55749125|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
55749126|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749127|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749128|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749130|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749131|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55749132|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749133|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749134|NCT02015117|Trametinib|trametinib|mesh-list
55749135|NCT02015117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749136|NCT02015117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55749137|NCT02015117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749138|NCT02015117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749139|NCT01842035|Regadenoson|regadenoson|mesh-list
55749140|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55749141|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55749142|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
55749143|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
55749144|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749145|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749146|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749147|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
55749148|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749150|NCT05585177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749151|NCT05585177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749152|NCT03250039|Abrocitinib|abrocitinib|mesh-list
55749153|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55749154|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749155|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749156|NCT02517827|Paclitaxel|paclitaxel|mesh-list
55749157|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55749158|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749159|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
55749160|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
55749161|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
55749162|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749163|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55749164|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
55749165|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749166|NCT03246451|Metformin|metformin|mesh-list
55749167|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55749168|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749169|NCT05013437|Acetaminophen|acetaminophen|mesh-list
55749170|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
55749171|NCT05013437|Promethazine|promethazine|mesh-list
55749172|NCT05013437|Melphalan|melphalan|mesh-list
55749173|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
55749174|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55749175|NCT05013437|Analgesics|analgesics|mesh-ancestor
55749176|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
55749177|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749179|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
55749180|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55749181|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
55749182|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749183|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749184|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55749185|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55749187|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55749188|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55749189|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749190|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
55749191|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
55749192|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
55749193|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
55749194|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55749195|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55749196|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
55749197|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
55749198|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749199|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55749200|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
55749201|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
55749202|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55749203|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55749204|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55749205|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55749207|NCT03246295|Insulin|insulin|mesh-list
55749208|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55749209|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749210|NCT03346733|Psyllium|psyllium|mesh-list
55749211|NCT03346733|Cathartics|cathartics|mesh-ancestor
55749212|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55749213|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55749214|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55749215|NCT03346187|Atorvastatin|atorvastatin|mesh-list
55749217|NCT03346187|Calcium|calcium|mesh-list
55749218|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55749219|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749220|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55749221|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55749222|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
55749223|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749224|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55749225|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55749226|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749227|NCT04487743|Liraglutide|liraglutide|mesh-list
55749228|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55749229|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749230|NCT04487743|Incretins|incretins|mesh-ancestor
55749232|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749233|NCT05010629|Carboplatin|carboplatin|mesh-list
55749234|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749235|NCT05584631|Immunoglobulins|immunoglobulins|mesh-list
55749236|NCT05584631|Antibodies|antibodies|mesh-list
55749237|NCT05584631|gamma-Globulins|gamma-globulins|mesh-list
55749238|NCT05584631|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55749239|NCT05584631|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55749240|NCT05584631|Immunoglobulin G|immunoglobulin g|mesh-list
55749241|NCT05584631|Immunologic Factors|immunologic factors|mesh-ancestor
55749242|NCT05584631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749243|NCT03249259|Choline|choline|mesh-list
55749244|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
55749245|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55749246|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
55749247|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749248|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55749249|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55749250|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
55749251|NCT04487587|Olaparib|olaparib|mesh-list
55749252|NCT04487587|Cediranib|cediranib|mesh-list
55749253|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55749254|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749255|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749256|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749257|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55749258|NCT04833413|Insulin|insulin|mesh-list
55749259|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55749260|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55749261|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749262|NCT02454751|Fentanyl|fentanyl|mesh-list
55749263|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55749264|NCT02454751|Narcotics|narcotics|mesh-ancestor
55749265|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55779594|NCT04121507|Thiotepa|thiotepa|mesh-list
55749266|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749267|NCT02454751|Analgesics|analgesics|mesh-ancestor
55749268|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
55749269|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749270|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55749271|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55749272|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
55749273|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
55749274|NCT02455921|Atropine|atropine|mesh-list
55749275|NCT02455921|Neostigmine|neostigmine|mesh-list
55749276|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55749277|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55749278|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55749279|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
55749280|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749281|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749282|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55749283|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
55749284|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
55749285|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
55749286|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55749287|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55749288|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
55749289|NCT02455921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749290|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749291|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55749292|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749293|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55749295|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55749296|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
55749298|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
55749299|NCT04786613|Protective Agents|protective agents|mesh-ancestor
55749300|NCT04767191|Lumefantrine|lumefantrine|mesh-list
55749301|NCT04767191|Artemether|artemether|mesh-list
55749303|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55749304|NCT04767191|Artenimol|artenimol|mesh-list
55749305|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
55749306|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55749307|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55749308|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749309|NCT00700999|Paroxetine|paroxetine|mesh-list
55749310|NCT00700999|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55749311|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55749312|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55749313|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749314|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749315|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
55749316|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749317|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55749318|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
55749319|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55749320|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55749321|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55749322|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749323|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
55749324|NCT04502771|Clotrimazole|clotrimazole|mesh-list
55749325|NCT04502771|Miconazole|miconazole|mesh-list
55749326|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749327|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55749328|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55749329|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55749330|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749331|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749332|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55749333|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
55749334|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749335|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749336|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55749338|NCT04502849|Vitamin E|vitamin e|mesh-list
55749339|NCT04502849|Tocopherols|tocopherols|mesh-list
55749340|NCT04502849|alpha-Tocopherol|alpha-tocopherol|mesh-list
55749341|NCT04502849|Vitamins|vitamins|mesh-ancestor
55749342|NCT04502849|Micronutrients|micronutrients|mesh-ancestor
55749343|NCT04502849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749344|NCT04502849|Antioxidants|antioxidants|mesh-ancestor
55749345|NCT04502849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749346|NCT04502849|Protective Agents|protective agents|mesh-ancestor
55749347|NCT04761887|Ropivacaine|ropivacaine|mesh-list
55749348|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
55749349|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
55749350|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749351|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749352|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
55749353|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749354|NCT05584007|Floxacillin|floxacillin|mesh-list
55749355|NCT05584007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55749356|NCT05584007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749358|NCT03249025|Ketamine|ketamine|mesh-list
55749359|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
55749360|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
55749361|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749362|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749363|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
55749364|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749365|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55749366|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55749367|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55749368|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55749369|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749370|NCT03249025|Analgesics|analgesics|mesh-ancestor
55749371|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55749372|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55749373|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
55749374|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55749375|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55749376|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749377|NCT03248713|Mifepristone|mifepristone|mesh-list
55749378|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55749379|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
55749380|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55779628|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
55749381|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749382|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55749383|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55749384|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55749385|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
55749386|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55749387|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55749388|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
55749389|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749390|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
55749391|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55749392|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55749393|NCT03245671|Dexamethasone|dexamethasone|mesh-list
55749394|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
55749395|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55749396|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55749398|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55749399|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
55749400|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
55749401|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749402|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749403|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55749404|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
55749406|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749407|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55749408|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749409|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
55749410|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749411|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749413|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
55749414|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55749415|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55749416|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749420|NCT04663997|Tubulin Modulators|tubulin modulators|mesh-ancestor
55749421|NCT04663997|Antimitotic Agents|antimitotic agents|mesh-ancestor
55749422|NCT04663997|Mitosis Modulators|mitosis modulators|mesh-ancestor
55749423|NCT04663997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749424|NCT04663997|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55749425|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55749426|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55749428|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55749429|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749430|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749431|NCT03363503|Fluticasone|fluticasone|mesh-list
55749432|NCT03363503|Xhance|xhance|mesh-list
55749433|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55749434|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55749435|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55749436|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
55749437|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749438|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749439|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55749440|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
55749441|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
55749442|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55749443|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55749444|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55749445|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55749446|NCT03363503|Adrenergic Agents|adrenergic agents|mesh-ancestor
55749447|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749448|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749450|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
55749451|NCT03248791|Norepinephrine|norepinephrine|mesh-list
55749452|NCT03248791|Bupivacaine|bupivacaine|mesh-list
55749453|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
55749454|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
55749455|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749456|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749457|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
55749458|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749460|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
55749461|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
55749462|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
55749463|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55749464|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
55749465|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
55749466|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55749467|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55749468|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55749484|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749485|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55749486|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55749488|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
55749489|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55749490|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55749492|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55749494|NCT03248401|Cilostazol|cilostazol|mesh-list
55749495|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55749496|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55749497|NCT03248401|Analgesics|analgesics|mesh-ancestor
55749498|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
55749499|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749500|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749501|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55749502|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55749503|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55749504|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55749505|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749506|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55749507|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55749508|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749509|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
55749510|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55749511|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
55749512|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55749513|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
55749514|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
55749515|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55749516|NCT03248401|Protective Agents|protective agents|mesh-ancestor
55749517|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55749518|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55749519|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
55749520|NCT02516423|Dexamethasone|dexamethasone|mesh-list
55749521|NCT02516423|Lenalidomide|lenalidomide|mesh-list
55749522|NCT02516423|Ixazomib|ixazomib|mesh-list
55749523|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55749524|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
55749525|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
55749526|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749527|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749528|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55749529|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
55749530|NCT02516423|Hormones|hormones|mesh-ancestor
55749531|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749532|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55749533|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749535|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55749536|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55749537|NCT02516423|Growth Substances|growth substances|mesh-ancestor
55749538|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
55749539|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55749540|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
55749541|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749542|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749543|NCT03245281|Diuretics|diuretics|mesh-list
55749545|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749546|NCT02515955|Minocycline|minocycline|mesh-list
55749547|NCT02515955|Amphetamine|amphetamine|mesh-list
55749548|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
55749549|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55749551|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55749552|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749553|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
55749554|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
55749555|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749556|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
55749557|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749558|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749559|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
55749560|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55749561|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55749562|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55749563|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55749598|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55749599|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749601|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749602|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
55749603|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55749604|NCT03347591|Protective Agents|protective agents|mesh-ancestor
55749606|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55749607|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55749608|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749609|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749610|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749611|NCT03347513|Glycine|glycine|mesh-list
55749612|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
55749613|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749614|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749615|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749616|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
55749617|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
55749618|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749619|NCT04088591|Protective Agents|protective agents|mesh-ancestor
55749620|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749622|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
55749623|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
55749624|NCT04501289|Analgesics|analgesics|mesh-ancestor
55749625|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
55749626|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749627|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749628|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
55749629|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749630|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55749631|NCT04501289|Anticonvulsants|anticonvulsants|mesh-ancestor
55749632|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55749633|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55749634|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749635|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55749636|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
55749637|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55749638|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
55749639|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55749640|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55749641|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749642|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
55749643|NCT03244423|Coagulants|coagulants|mesh-ancestor
55749644|NCT04501367|Dexamethasone|dexamethasone|mesh-list
55749645|NCT04501367|Dexamethasone acetate|dexamethasone acetate|mesh-list
55749646|NCT04501367|Prednisone|prednisone|mesh-list
55749647|NCT04501367|BB 1101|bb 1101|mesh-list
55749648|NCT04501367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55749649|NCT04501367|Antiemetics|antiemetics|mesh-ancestor
55749650|NCT04501367|Autonomic Agents|autonomic agents|mesh-ancestor
55749651|NCT04501367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749652|NCT04501367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749653|NCT04501367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55749654|NCT04501367|Glucocorticoids|glucocorticoids|mesh-ancestor
55749656|NCT04501367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749657|NCT04501367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55749658|NCT04501367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749659|NCT04501367|Protease Inhibitors|protease inhibitors|mesh-ancestor
55749660|NCT04501367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749661|NCT04501367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749663|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55749664|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
55749665|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749666|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55749667|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749668|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749669|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
55749670|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749671|NCT02515877|Carboplatin|carboplatin|mesh-list
55749672|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749673|NCT03952091|Dexamethasone|dexamethasone|mesh-list
55749674|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
55749675|NCT03952091|Lenalidomide|lenalidomide|mesh-list
55749677|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55749699|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749700|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
55749701|NCT04502537|Hematinics|hematinics|mesh-ancestor
55749702|NCT02453659|Nicotine|nicotine|mesh-list
55749706|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749708|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55749709|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
55749710|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749711|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749712|NCT02513147|Lopinavir|lopinavir|mesh-list
55749713|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55749714|NCT02513147|Darunavir|darunavir|mesh-list
55749716|NCT02513147|Dolutegravir|dolutegravir|mesh-list
55749717|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55749718|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55749719|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
55749720|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749721|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749722|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55749723|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55749724|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
55749725|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749726|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55749727|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55749728|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55749729|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55749730|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
55749731|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55749732|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
55749733|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749734|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55749736|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55749737|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749738|NCT02453893|Risperidone|risperidone|mesh-list
55749739|NCT02453893|Iloperidone|iloperidone|mesh-list
55749740|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55749741|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
55749742|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749743|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749744|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749745|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55749746|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55749747|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749748|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55749749|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55749750|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
55749751|NCT03664895|Goserelin|goserelin|mesh-list
55749752|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55749753|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749754|NCT02513069|Nicotine|nicotine|mesh-list
55749755|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
55749758|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749759|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749760|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55749761|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55749762|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
55749764|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749765|NCT02513069|Antimetabolites|antimetabolites|mesh-ancestor
55749766|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
55749767|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
55749768|NCT02454205|Levofloxacin|levofloxacin|mesh-list
55749770|NCT02454205|Isoniazid|isoniazid|mesh-list
55749771|NCT02454205|Linezolid|linezolid|mesh-list
55749772|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
55749773|NCT02454205|Bedaquiline|bedaquiline|mesh-list
55749774|NCT02454205|Kanamycin|kanamycin|mesh-list
55749775|NCT02454205|Ethionamide|ethionamide|mesh-list
55749776|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55749777|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749778|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55749779|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55749780|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749781|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749782|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749783|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55749785|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55749786|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55749788|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55749789|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55749790|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
55749791|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55749792|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55749793|NCT03235141|Azithromycin|azithromycin|mesh-list
55749794|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55749795|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55749796|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749797|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55749798|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55749799|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
55749800|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749801|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
55749802|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55749803|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55749805|NCT03297593|Ipilimumab|ipilimumab|mesh-list
55749806|NCT03297593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55749807|NCT03297593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749808|NCT03297593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55749809|NCT03297593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749810|NCT03234673|Calcipotriene|calcipotriene|mesh-list
55749811|NCT03234673|Tacrolimus|tacrolimus|mesh-list
55749812|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55749813|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
55749814|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749815|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55749816|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749817|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749819|NCT03148613|Carbon Monoxide|carbon monoxide|mesh-list
55749820|NCT03148613|Antimetabolites|antimetabolites|mesh-ancestor
55749821|NCT03148613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749822|NCT03148613|Gasotransmitters|gasotransmitters|mesh-ancestor
55749823|NCT03148613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749824|NCT03148613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749825|NCT03243643|Apatinib|apatinib|mesh-list
55749826|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749827|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55749828|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789039|NCT03520231|Antiviral Agents|antiviral agents|mesh-ancestor
55749829|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749831|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
55749832|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
55749833|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55749834|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749835|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55749836|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749837|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749838|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
55749839|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55749840|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
55749841|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749842|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
55749843|NCT03238183|Protective Agents|protective agents|mesh-ancestor
55749844|NCT02729051|Albuterol|albuterol|mesh-list
55749845|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55749846|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
55749847|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749848|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749849|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55749850|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
55749851|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
55749852|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55749853|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55749854|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55749855|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55749856|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
55749857|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749858|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749859|NCT03237637|Propranolol|propranolol|mesh-list
55749860|NCT03237637|Atenolol|atenolol|mesh-list
55749861|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55749862|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55749863|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
55749864|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749865|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749866|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749867|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55749868|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55749869|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
55749870|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
55749871|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
55749872|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749873|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55749875|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55749876|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749877|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749878|NCT03345095|Temozolomide|temozolomide|mesh-list
55749879|NCT03345095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55749880|NCT03345095|Alkylating Agents|alkylating agents|mesh-ancestor
55749881|NCT03345095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749882|NCT03345095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749883|NCT03237715|Bilirubin|bilirubin|mesh-list
55749884|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
55749885|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749886|NCT03237715|Protective Agents|protective agents|mesh-ancestor
55749887|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749889|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
55749890|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55749891|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
55749892|NCT02515565|Cephalosporins|cephalosporins|mesh-list
55749893|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55749894|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55749895|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55749896|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55749897|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55749898|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749899|NCT05600075|Insulin|insulin|mesh-list
55749900|NCT05600075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55749901|NCT05600075|Glycolic acid|glycolic acid|mesh-list
55749902|NCT05600075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55749903|NCT05600075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749904|NCT05600075|Keratolytic Agents|keratolytic agents|mesh-ancestor
55749905|NCT05600075|Dermatologic Agents|dermatologic agents|mesh-ancestor
55749906|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
55749907|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
55749908|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55749909|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
55749910|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749911|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55749912|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55749913|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55749914|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55749915|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749916|NCT03233815|Propofol|propofol|mesh-list
55749917|NCT03233815|Sevoflurane|sevoflurane|mesh-list
55749918|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55749919|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749920|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749921|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55749922|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
55749923|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
55749924|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55749925|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55749926|NCT02507609|Rocuronium|rocuronium|mesh-list
55749927|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749928|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55749929|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55749930|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55749931|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749932|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55749933|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55749934|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749936|NCT02512523|Hormones|hormones|mesh-ancestor
55749937|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55749938|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55749939|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
55749940|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750018|NCT02514629|Testosterone|testosterone|mesh-list
55749941|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749943|NCT03233893|Calcium|calcium|mesh-list
55749944|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55749945|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749946|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55749947|NCT05597813|Timolol|timolol|mesh-list
55749948|NCT05597813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55749949|NCT05597813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55749950|NCT05597813|Adrenergic Agents|adrenergic agents|mesh-ancestor
55749951|NCT05597813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749952|NCT05597813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749953|NCT05597813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749954|NCT05597813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55749955|NCT05597813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55779810|NCT03104855|Vitamins|vitamins|mesh-ancestor
55749956|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
55749957|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55749958|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
55749959|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749960|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
55749961|NCT03242707|Protective Agents|protective agents|mesh-ancestor
55749962|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
55749963|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55749964|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749965|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749968|NCT02512055|Analgesics|analgesics|mesh-ancestor
55749969|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
55749970|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55749971|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55749972|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55749973|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55749974|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
55749975|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
55749976|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55749977|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55749978|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55749979|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55749980|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55749981|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55749982|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55749983|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55749984|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
55749985|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55749986|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
55749987|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
55749988|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
55749989|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55749990|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55749991|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
55749992|NCT05211895|Durvalumab|durvalumab|mesh-list
55749993|NCT05211895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55749994|NCT05211895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55749995|NCT02514941|Acetaminophen|acetaminophen|mesh-list
55749996|NCT02514941|Amoxicillin|amoxicillin|mesh-list
55749997|NCT02514941|Talinolol|talinolol|mesh-list
55749998|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55749999|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750000|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750001|NCT02514941|Analgesics|analgesics|mesh-ancestor
55750002|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
55750003|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750004|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750005|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
55750006|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55750007|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55750008|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
55750009|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750010|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750011|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55750012|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55750014|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55779827|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55750015|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750016|NCT02514629|Metformin|metformin|mesh-list
55750017|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
55750019|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
55750020|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
55750021|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55750022|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55750023|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750024|NCT02514629|Androgens|androgens|mesh-ancestor
55750025|NCT02514629|Hormones|hormones|mesh-ancestor
55750026|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750027|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55750028|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750029|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
55750030|NCT02511353|Ivermectin|ivermectin|mesh-list
55750031|NCT02511353|Piperaquine|piperaquine|mesh-list
55750032|NCT02511353|Artenimol|artenimol|mesh-list
55750033|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55750034|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750035|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
55750036|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55750037|NCT03242317|Mitomycins|mitomycins|mesh-list
55750038|NCT03242317|Mitomycin|mitomycin|mesh-list
55750039|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55750040|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750042|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750043|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55750044|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750045|NCT02453503|Triamcinolone|triamcinolone|mesh-list
55750046|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55750047|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55750048|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55750049|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55750050|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
55750052|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750053|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750054|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55750055|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
55750056|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789040|NCT03520231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750057|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750058|NCT04499885|Mineral Oil|mineral oil|mesh-list
55750059|NCT04499885|Emollients|emollients|mesh-ancestor
55750061|NCT02453425|Norepinephrine|norepinephrine|mesh-list
55750062|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55750063|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55750064|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
55750065|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750066|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750067|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750068|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
55750069|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
55750070|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55779842|NCT02102477|Androgens|androgens|mesh-list
55750071|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55750072|NCT03233035|Ketamine|ketamine|mesh-list
55750073|NCT03233035|Analgesics|analgesics|mesh-ancestor
55750074|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
55750075|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750076|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750077|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55750078|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55750079|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
55750080|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
55750081|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750082|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55750083|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55750084|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750085|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750087|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55750088|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750089|NCT03232957|Morphine|morphine|mesh-list
55750090|NCT03232957|Bupivacaine|bupivacaine|mesh-list
55750091|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
55750092|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
55750093|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750094|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750095|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
55789041|NCT03520231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750096|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750097|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55750098|NCT03232957|Narcotics|narcotics|mesh-ancestor
55750099|NCT03232957|Analgesics|analgesics|mesh-ancestor
55750100|NCT02513849|Tamoxifen|tamoxifen|mesh-list
55750101|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55750102|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
55750103|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750104|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750105|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55750106|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750107|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55750108|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55750109|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55750110|NCT02513927|Metoprolol|metoprolol|mesh-list
55750111|NCT02513927|Nifedipine|nifedipine|mesh-list
55750112|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55750113|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55750114|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
55750115|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
55750116|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750117|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750118|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55750119|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55750120|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55750121|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
55750122|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750123|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750124|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55750125|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55750126|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55750127|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
55750128|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
55750129|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55750130|NCT03236623|Menthol|menthol|mesh-list
55750131|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
55750132|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
55750134|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55750135|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
55750136|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750137|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750139|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
55750140|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750141|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750142|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750144|NCT02513693|Neostigmine|neostigmine|mesh-list
55750145|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55750146|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55750147|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55750148|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750149|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750150|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55750151|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750154|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750155|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55750156|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
55750157|NCT03121547|Tramadol|tramadol|mesh-list
55750158|NCT03121547|Tapentadol|tapentadol|mesh-list
55750159|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750160|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55750161|NCT03121547|Narcotics|narcotics|mesh-ancestor
55750162|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750163|NCT03121547|Analgesics|analgesics|mesh-ancestor
55750164|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
55750165|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750166|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55750167|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55750168|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55750169|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750170|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
55750171|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750173|NCT03241381|Vitamins|vitamins|mesh-ancestor
55750174|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
55750175|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750176|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55750177|NCT03241303|Acarbose|acarbose|mesh-list
55750178|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55750179|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750180|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750181|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55750182|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750183|NCT02510963|Tenofovir|tenofovir|mesh-list
55750184|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
55750185|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750186|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55750187|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55750188|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750189|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750190|NCT02510963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55750191|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55750193|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
55750194|NCT02513381|Vitamins|vitamins|mesh-ancestor
55750195|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
55750196|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750197|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55750198|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55750199|NCT03236155|Analgesics, Opioid|analgesics, opioid|mesh-list
55750200|NCT03236155|Narcotics|narcotics|mesh-ancestor
55750201|NCT03236155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750202|NCT03236155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750203|NCT03236155|Analgesics|analgesics|mesh-ancestor
55750204|NCT03236155|Sensory System Agents|sensory system agents|mesh-ancestor
55750205|NCT03236155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750206|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
55750207|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
55750208|NCT03232021|Pregabalin|pregabalin|mesh-list
55750209|NCT03232021|Analgesics|analgesics|mesh-ancestor
55750210|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
55750211|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750212|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750213|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
55750214|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55750215|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55750216|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750217|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55750218|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55750219|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55750220|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750221|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55750222|NCT03235609|Fentanyl|fentanyl|mesh-list
55750223|NCT03235609|Ketamine|ketamine|mesh-list
55750225|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
55750226|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750227|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750228|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55750229|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55750231|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
55750232|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750233|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55750234|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55750235|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750236|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750237|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55750238|NCT03235609|Narcotics|narcotics|mesh-ancestor
55750239|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55750240|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
55750241|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55750242|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750243|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750244|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750245|NCT02509949|Analgesics|analgesics|mesh-ancestor
55750246|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
55750247|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750248|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55750249|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55750250|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55750251|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
55750252|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750253|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750254|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
55750255|NCT03344705|Fludarabine|fludarabine|mesh-list
55750256|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55750257|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
55750258|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750260|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55750261|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
55750262|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750263|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750264|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55750265|NCT02501603|Paclitaxel|paclitaxel|mesh-list
55750266|NCT02501603|Afatinib|afatinib|mesh-list
55750267|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55750268|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750269|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
55750274|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750275|NCT03344627|Meropenem|meropenem|mesh-list
55750276|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55750277|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750278|NCT02501213|Furosemide|furosemide|mesh-list
55750279|NCT02501213|Spironolactone|spironolactone|mesh-list
55750280|NCT02501213|Diuretics|diuretics|mesh-ancestor
55750281|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
55750282|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750283|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55750284|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55750285|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750286|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55750288|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750289|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55750290|NCT02501291|Thalidomide|thalidomide|mesh-list
55750291|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55750292|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
55750293|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750294|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
55750295|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55750296|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750297|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55750298|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55750299|NCT02501291|Growth Substances|growth substances|mesh-ancestor
55750300|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
55750301|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750302|NCT02509559|Propranolol|propranolol|mesh-list
55750303|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55750304|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55750305|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
55750306|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750307|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750308|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750309|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55750310|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55750311|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
55750313|NCT00707993|Glipizide|glipizide|mesh-list
55750314|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55750315|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750316|NCT00707993|Incretins|incretins|mesh-ancestor
55750317|NCT00707993|Hormones|hormones|mesh-ancestor
55750318|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750319|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55750320|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
55750321|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750322|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750323|NCT02509091|Amikacin|amikacin|mesh-list
55750324|NCT02509091|Dimercaprol|dimercaprol|mesh-list
55750326|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750327|NCT02509091|Chelating Agents|chelating agents|mesh-ancestor
55750328|NCT02509091|Sequestering Agents|sequestering agents|mesh-ancestor
55750329|NCT02509091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750331|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
55750332|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55750333|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750334|NCT02508857|Analgesics|analgesics|mesh-ancestor
55750335|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
55750336|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750337|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750338|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55750339|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55750340|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55750341|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750342|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750344|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750345|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55750347|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55750348|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55750349|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55750350|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
55750351|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55750352|NCT02508623|Rifaximin|rifaximin|mesh-list
55750353|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55750354|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750355|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55750356|NCT02500667|Rifampin|rifampin|mesh-list
55750357|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55750358|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
55750359|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55750360|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750361|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
55750362|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55750363|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750364|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750365|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55750366|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55750367|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55750368|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55750369|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55750370|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55750371|NCT02500511|Vaccines|vaccines|mesh-list
55750372|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
55750373|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750374|NCT03344393|Ketamine|ketamine|mesh-list
55750375|NCT03344393|Analgesics|analgesics|mesh-ancestor
55750376|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
55750377|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750378|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750379|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55750380|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55750381|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
55750382|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
55750383|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750384|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55750385|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55750387|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750388|NCT04498793|Paclitaxel|paclitaxel|mesh-list
55750389|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
55750390|NCT04498793|Doxorubicin|doxorubicin|mesh-list
55750391|NCT04498793|Epirubicin|epirubicin|mesh-list
55750392|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55750393|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750394|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
55750395|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
55750396|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
55750397|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750398|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55750399|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
55750400|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750401|NCT04498793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55750402|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55750403|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
55750404|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55750405|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55750406|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55750407|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55750408|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750410|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
55750411|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750413|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
55750428|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750429|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
55750430|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750431|NCT02499965|Anesthetics|anesthetics|mesh-list
55750432|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
55750433|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750434|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750435|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
55750436|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
55750437|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750439|NCT05504057|Histamine Antagonists|histamine antagonists|mesh-list
55750440|NCT05504057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55750441|NCT05504057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55750442|NCT05504057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55750444|NCT05504057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750445|NCT05504057|Dopamine Agents|dopamine agents|mesh-ancestor
55750446|NCT05504057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750447|NCT05504057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750448|NCT05504057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750449|NCT05504057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750450|NCT05504057|Analgesics|analgesics|mesh-ancestor
55750451|NCT05504057|Sensory System Agents|sensory system agents|mesh-ancestor
55750452|NCT05504057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750453|NCT05504057|Histamine Agents|histamine agents|mesh-ancestor
55750454|NCT03344003|Factor VIII|factor viii|mesh-list
55750455|NCT03344003|Coagulants|coagulants|mesh-ancestor
55750456|NCT03235531|Valproic Acid|valproic acid|mesh-list
55750457|NCT03235531|Lorazepam|lorazepam|mesh-list
55750458|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
55750459|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750460|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750461|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
55750462|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750463|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750464|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
55750465|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55750466|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750467|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55750468|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
55750469|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
55750470|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750471|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55750472|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55750473|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55750474|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
55750475|NCT02506829|Nicotine|nicotine|mesh-list
55750476|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55750477|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
55750478|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750479|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750480|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55750481|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55750482|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
55750483|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750484|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750485|NCT02506439|Vitamin D|vitamin d|mesh-list
55750486|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
55750487|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
55750488|NCT02506439|Vitamins|vitamins|mesh-list
55750489|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
55750490|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750491|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55750492|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55750493|NCT02495519|Imatinib Mesylate|imatinib mesylate|mesh-list
55750494|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750495|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55750496|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750497|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750498|NCT02499341|Ketamine|ketamine|mesh-list
55750499|NCT02499341|Tramadol|tramadol|mesh-list
55750500|NCT02499341|Analgesics|analgesics|mesh-ancestor
55750501|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
55750502|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750503|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750504|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55750505|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55750586|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55750587|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750588|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750589|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55750590|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55750591|NCT04494659|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55750592|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55750593|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55750594|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55750596|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
55750597|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750598|NCT03342599|Protective Agents|protective agents|mesh-ancestor
55750599|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750600|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
55750602|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
55750603|NCT03341117|Aspirin|aspirin|mesh-list
55750604|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
55750605|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55750606|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750607|NCT03341117|Analgesics|analgesics|mesh-ancestor
55750608|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
55750609|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750610|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750611|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55750612|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55750613|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55750614|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55750615|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750616|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55750617|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55750618|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750619|NCT03341117|Antipyretics|antipyretics|mesh-ancestor
55750621|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55750622|NCT02498171|Fentanyl|fentanyl|mesh-list
55750623|NCT02498171|Morphine|morphine|mesh-list
55750624|NCT02498171|Bupivacaine|bupivacaine|mesh-list
55750625|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
55750626|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
55750627|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750628|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750629|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
55750630|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750631|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55750632|NCT02498171|Narcotics|narcotics|mesh-ancestor
55750633|NCT02498171|Analgesics|analgesics|mesh-ancestor
55750634|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55750635|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55750637|NCT03120533|Treprostinil|treprostinil|mesh-list
55750638|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55750639|NCT03342443|Memantine|memantine|mesh-list
55750640|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55750641|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55750642|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
55750643|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750644|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750645|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750646|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55750647|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55750648|NCT05035485|Phenylephrine|phenylephrine|mesh-list
55750649|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
55750650|NCT05035485|Norepinephrine|norepinephrine|mesh-list
55750651|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55750652|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55750653|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
55750654|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
55750655|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750656|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750657|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
55750658|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
55750659|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
55750660|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55750661|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55750662|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55750663|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
55750664|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750665|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750666|NCT05035485|Protective Agents|protective agents|mesh-ancestor
55750668|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
55750669|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750670|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
55750671|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750672|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
55750673|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55750674|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750675|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55750676|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
55750677|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55750678|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750679|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750680|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750681|NCT03340493|Tenecteplase|tenecteplase|mesh-list
55750682|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55750683|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55750684|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750685|NCT03098199|Menotropins|menotropins|mesh-list
55750686|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750687|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55750688|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
55750689|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55750690|NCT00707057|Ibuprofen|ibuprofen|mesh-list
55750691|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55750692|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750693|NCT00707057|Analgesics|analgesics|mesh-ancestor
55750694|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
55750695|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750696|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750697|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55750698|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55750699|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55750700|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750701|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750703|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
55750704|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55750705|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55750706|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55750707|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
55750708|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750709|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750710|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750711|NCT02494349|Urological Agents|urological agents|mesh-ancestor
55750712|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55750713|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55750714|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
55750715|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
55750716|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55750717|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750718|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750719|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750721|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
55750722|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750723|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55750724|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55750725|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55750726|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
55750727|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750728|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750729|NCT02497547|Oxytocin|oxytocin|mesh-list
55750730|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
55750731|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55750732|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750733|NCT05043129|Vaccines|vaccines|mesh-list
55750734|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
55750735|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750736|NCT02497313|Metformin|metformin|mesh-list
55750737|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
55750738|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55750739|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750740|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55750741|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55750742|NCT02497157|Leucovorin|leucovorin|mesh-list
55750743|NCT02497157|Bevacizumab|bevacizumab|mesh-list
55750744|NCT02497157|Fluorouracil|fluorouracil|mesh-list
55750745|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
55750746|NCT02497157|Irinotecan|irinotecan|mesh-list
55750747|NCT02497157|Calcium|calcium|mesh-list
55750748|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
55750749|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55750750|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750751|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55750752|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55750753|NCT02497157|Growth Substances|growth substances|mesh-ancestor
55750754|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750755|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
55750756|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55789043|NCT03520231|Immunologic Factors|immunologic factors|mesh-ancestor
55750758|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750759|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55750761|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
55750762|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55750763|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55750764|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750766|NCT02497157|Protective Agents|protective agents|mesh-ancestor
55750767|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
55750768|NCT02497157|Vitamins|vitamins|mesh-ancestor
55750769|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
55750770|NCT03095235|Riboflavin|riboflavin|mesh-list
55750771|NCT03095235|Vitamins|vitamins|mesh-ancestor
55750772|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
55750773|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750774|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
55750775|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55750776|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
55750777|NCT03095079|Endostatins|endostatins|mesh-list
55750778|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55750779|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55750780|NCT03095079|Growth Substances|growth substances|mesh-ancestor
55750781|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750782|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
55750783|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750784|NCT03120923|Triamcinolone|triamcinolone|mesh-list
55750785|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55750786|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55750788|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55750789|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
55750791|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750792|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750793|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
55750794|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750795|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55750796|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55750797|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55750798|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55750799|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750800|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55750801|NCT03120923|Glucocorticoids|glucocorticoids|mesh-ancestor
55750802|NCT03120923|Hormones|hormones|mesh-ancestor
55750803|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750804|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55750805|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
55750806|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750807|NCT02497079|Formaldehyde|formaldehyde|mesh-list
55750808|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
55750809|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750811|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55750812|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
55750813|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55750814|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
55750815|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750816|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750817|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
55750818|NCT02639247|Sofosbuvir|sofosbuvir|mesh-list
55750819|NCT02639247|Velpatasvir|velpatasvir|mesh-list
55750820|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
55750821|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750822|NCT05033535|Olmesartan|olmesartan|mesh-list
55750823|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55750824|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55750825|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55750826|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55750827|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750829|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55750830|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55750831|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55750832|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55750833|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750834|NCT03096327|Montelukast|montelukast|mesh-list
55750835|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55750836|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
55750837|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55750838|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
55750839|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750840|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750841|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55750842|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55750843|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750845|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
55750846|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750847|NCT03095001|Paclitaxel|paclitaxel|mesh-list
55750848|NCT03095001|Bevacizumab|bevacizumab|mesh-list
55750849|NCT03095001|Carboplatin|carboplatin|mesh-list
55750850|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55750851|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750852|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
55750853|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
55750854|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
55750855|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750856|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55750857|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55750858|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55750859|NCT03095001|Growth Substances|growth substances|mesh-ancestor
55750860|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750861|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
55750863|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55750864|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750865|NCT02138955|Curcumin|curcumin|mesh-list
55750866|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55750867|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750868|NCT02138955|Analgesics|analgesics|mesh-ancestor
55750869|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
55750870|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750871|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750872|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55750873|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55750874|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750875|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750876|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750877|NCT03096405|Methicillin|methicillin|mesh-list
55750878|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55750879|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55750881|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55750882|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55750883|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55750884|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
55750885|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750886|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750887|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750888|NCT05032287|Urological Agents|urological agents|mesh-ancestor
55750889|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55750890|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55750891|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750893|NCT02493959|Hormones|hormones|mesh-ancestor
55779931|NCT04701593|Triamcinolone|triamcinolone|mesh-list
55750894|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750895|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55750896|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
55750897|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751062|NCT03094533|Propofol|propofol|mesh-list
55750898|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750899|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
55750900|NCT02496377|Glycine|glycine|mesh-list
55750901|NCT02496377|Hematinics|hematinics|mesh-ancestor
55750902|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
55750903|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55750904|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750905|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750906|NCT02496455|Tramadol|tramadol|mesh-list
55750907|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55750908|NCT02496455|Narcotics|narcotics|mesh-ancestor
55750911|NCT02496455|Analgesics|analgesics|mesh-ancestor
55750912|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
55750913|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750914|NCT02496299|Dexamethasone|dexamethasone|mesh-list
55750915|NCT02496299|Bupivacaine|bupivacaine|mesh-list
55750916|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55750917|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
55750918|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
55750919|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750920|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750921|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55750922|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
55750923|NCT02496299|Hormones|hormones|mesh-ancestor
55750924|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750925|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55750926|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750927|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
55750928|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
55750929|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750930|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
55750931|NCT02493725|Eculizumab|eculizumab|mesh-list
55750932|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55750933|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55750934|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
55750935|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750937|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55750938|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
55750939|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
55750940|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55750941|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750943|NCT05052879|Vasodilator Agents|vasodilator agents|mesh-ancestor
55750944|NCT05052879|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55750945|NCT05052879|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55750946|NCT05052879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750947|NCT05052879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750949|NCT02121405|Capecitabine|capecitabine|mesh-list
55750950|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
55750951|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55750952|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
55750953|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750954|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750955|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
55750956|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55750957|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55750959|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55750960|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55750961|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
55750962|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750963|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750964|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55750965|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
55750966|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
55750967|NCT02493335|Hormones|hormones|mesh-ancestor
55750968|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55750969|NCT03336593|Vaccines|vaccines|mesh-list
55750970|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
55750971|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750972|NCT03337607|Celecoxib|celecoxib|mesh-list
55750973|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55750974|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55750976|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
55750977|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750978|NCT03337607|Analgesics|analgesics|mesh-ancestor
55750979|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
55750980|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55750981|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55750982|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55750983|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55750984|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55750985|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55750986|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55750988|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55750989|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55750990|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55750991|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55750993|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
55750994|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
55750995|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
55750996|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55750997|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55750999|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
55751000|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751001|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751002|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751003|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55751004|NCT03336437|Estradiol|estradiol|mesh-list
55751005|NCT03336437|Estrogens|estrogens|mesh-ancestor
55751006|NCT03336437|Hormones|hormones|mesh-ancestor
55751007|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751008|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751009|NCT03337373|Cisatracurium|cisatracurium|mesh-list
55751010|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55751011|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55751012|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751013|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751014|NCT03336281|Ustekinumab|ustekinumab|mesh-list
55751015|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
55751016|NCT03336125|Vitamin D|vitamin d|mesh-list
55751017|NCT03336125|Vitamins|vitamins|mesh-ancestor
55751018|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
55751019|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751020|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55751022|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
55751023|NCT05051163|Ampicillin|ampicillin|mesh-list
55751024|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55751025|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751026|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55751027|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751028|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751029|NCT03331211|Dasatinib|dasatinib|mesh-list
55751030|NCT03331211|Ponatinib|ponatinib|mesh-list
55751031|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751032|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55751033|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751034|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751035|NCT01929915|Fentanyl|fentanyl|mesh-list
55751036|NCT01929915|Morphine|morphine|mesh-list
55751037|NCT01929915|Bupivacaine|bupivacaine|mesh-list
55751038|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
55751039|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
55751040|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751041|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751042|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
55751043|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751044|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55751045|NCT01929915|Narcotics|narcotics|mesh-ancestor
55751046|NCT01929915|Analgesics|analgesics|mesh-ancestor
55751047|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55751049|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
55751050|NCT05464745|Perindopril|perindopril|mesh-list
55751051|NCT05464745|Indapamide|indapamide|mesh-list
55751052|NCT05464745|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55751053|NCT05464745|Protease Inhibitors|protease inhibitors|mesh-ancestor
55751054|NCT05464745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751055|NCT05464745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751056|NCT05464745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55751057|NCT05464745|Diuretics|diuretics|mesh-ancestor
55751058|NCT05464745|Natriuretic Agents|natriuretic agents|mesh-ancestor
55751059|NCT05464745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751060|NCT05464745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55751061|NCT05464745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55751105|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55751106|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55751107|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55751108|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55751109|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751111|NCT03335423|Codeine|codeine|mesh-list
55751112|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55751113|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751114|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55751115|NCT03335423|Narcotics|narcotics|mesh-ancestor
55751116|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751118|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
55751119|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751120|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
55751121|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
55751122|NCT05038605|Metronidazole|metronidazole|mesh-list
55751123|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751124|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55751125|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55751126|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55751127|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55751128|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55751129|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55751131|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751132|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55751133|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55751134|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751135|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55751136|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55751137|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55751138|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751139|NCT03095547|Cyclosporine|cyclosporine|mesh-list
55751140|NCT03095547|Posaconazole|posaconazole|mesh-list
55751141|NCT03095547|Olorofim|olorofim|mesh-list
55751142|NCT03095547|Pantoprazole|pantoprazole|mesh-list
55751143|NCT03095547|Tacrolimus|tacrolimus|mesh-list
55751144|NCT03095547|Cyclosporins|cyclosporins|mesh-list
55751145|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55751146|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
55751147|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751148|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55751149|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751150|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751151|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
55751152|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751153|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
55751154|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55751155|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55751156|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55751157|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55751158|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55751159|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55751160|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55751161|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55751162|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55751163|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55751164|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
55751165|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751167|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55751168|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751169|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55751170|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55751171|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751173|NCT04968951|Vancomycin|vancomycin|mesh-list
55751174|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751175|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55751176|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55751177|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55751178|NCT05049681|Apatinib|apatinib|mesh-list
55751179|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751180|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55751181|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751182|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751183|NCT03334487|Dexamethasone|dexamethasone|mesh-list
55751184|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751289|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55751290|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
55751291|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751292|NCT05024799|Fentanyl|fentanyl|mesh-list
55751293|NCT05024799|Butorphanol|butorphanol|mesh-list
55751294|NCT05024799|Propofol|propofol|mesh-list
55751295|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55751296|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751297|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751298|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55751299|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
55751300|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
55751301|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55751302|NCT05024799|Narcotics|narcotics|mesh-ancestor
55751303|NCT05024799|Analgesics|analgesics|mesh-ancestor
55751304|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
55751305|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751306|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55751307|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
55751308|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
55751309|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55751310|NCT05018637|Teriparatide|teriparatide|mesh-list
55779969|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
55751311|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55751312|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751313|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55751314|NCT03333395|Heparin|heparin|mesh-list
55751315|NCT03333395|Albuterol|albuterol|mesh-list
55751316|NCT03333395|Anticoagulants|anticoagulants|mesh-ancestor
55751317|NCT03333395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55751318|NCT03333395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55751319|NCT03333395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751320|NCT03333395|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55751321|NCT03333395|Autonomic Agents|autonomic agents|mesh-ancestor
55751323|NCT03333395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751325|NCT03333395|Respiratory System Agents|respiratory system agents|mesh-ancestor
55751326|NCT03333395|Tocolytic Agents|tocolytic agents|mesh-ancestor
55751327|NCT03333395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55751328|NCT03333395|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55751329|NCT03333395|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55751330|NCT03333395|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55751331|NCT03333395|Adrenergic Agents|adrenergic agents|mesh-ancestor
55751332|NCT03333395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751333|NCT03327701|Benralizumab|benralizumab|mesh-list
55751334|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55751335|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
55751336|NCT01991977|Temozolomide|temozolomide|mesh-list
55751337|NCT01991977|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55751338|NCT01991977|Alkylating Agents|alkylating agents|mesh-ancestor
55751339|NCT01991977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751340|NCT01991977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751341|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
55751342|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55751343|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751344|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751345|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55751346|NCT03327389|Analgesics|analgesics|mesh-ancestor
55751347|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
55751348|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751349|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55751350|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55751351|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55751352|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
55751353|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751354|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751356|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
55751357|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55751358|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55751359|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751360|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751362|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751363|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55751364|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55751365|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55751366|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55751450|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55751451|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55751452|NCT03332225|Interferons|interferons|mesh-list
55751453|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
55751454|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55751455|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751456|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
55751457|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751458|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55751459|NCT05023941|Acetazolamide|acetazolamide|mesh-list
55751460|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
55751461|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55751462|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751463|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751464|NCT05023941|Diuretics|diuretics|mesh-ancestor
55751465|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
55751466|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751468|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751469|NCT03090087|Regadenoson|regadenoson|mesh-list
55751470|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55751471|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55751472|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
55751473|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
55751475|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751476|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751477|NCT03326609|Ropivacaine|ropivacaine|mesh-list
55751478|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
55751479|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
55751480|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751481|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751482|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
55751483|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751484|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
55751485|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55751486|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55751487|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55751488|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55751489|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751491|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751492|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751493|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55751494|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751495|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
55751496|NCT03090009|Analgesics|analgesics|mesh-ancestor
55751498|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751499|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751500|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55751501|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55751502|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751503|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55751504|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55751505|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751506|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751507|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
55751508|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55751509|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55751510|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751511|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
55751512|NCT02492087|Coagulants|coagulants|mesh-ancestor
55751514|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
55751515|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55751516|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55751517|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751518|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751520|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
55751521|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55751522|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
55751523|NCT02491697|Capecitabine|capecitabine|mesh-list
55751524|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55751525|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
55751526|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751527|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751528|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
55751529|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55751530|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751531|NCT05464979|Fentanyl|fentanyl|mesh-list
55751532|NCT05464979|Midazolam|midazolam|mesh-list
55751533|NCT05464979|Ketamine|ketamine|mesh-list
55751534|NCT05464979|Esketamine|esketamine|mesh-list
55751535|NCT05464979|Analgesics|analgesics|mesh-ancestor
55751536|NCT05464979|Sensory System Agents|sensory system agents|mesh-ancestor
55751537|NCT05464979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751538|NCT05464979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751539|NCT05464979|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55751540|NCT05464979|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55751541|NCT05464979|Anesthetics, General|anesthetics, general|mesh-ancestor
55751542|NCT05464979|Anesthetics|anesthetics|mesh-ancestor
55751543|NCT05464979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751544|NCT05464979|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55751547|NCT05464979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751548|NCT05464979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55751549|NCT05464979|Narcotics|narcotics|mesh-ancestor
55751550|NCT05464979|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55751551|NCT05464979|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55751552|NCT05464979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55751553|NCT05464979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55751554|NCT05464979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55751555|NCT05464979|GABA Modulators|gaba modulators|mesh-ancestor
55751556|NCT05464979|GABA Agents|gaba agents|mesh-ancestor
55751557|NCT05464979|Antidepressive Agents|antidepressive agents|mesh-ancestor
55751558|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
55751559|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55751560|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55751561|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751562|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
55751563|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751564|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751565|NCT03331523|Betamethasone|betamethasone|mesh-list
55751566|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
55751567|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55751568|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
55751569|NCT03331523|Calcipotriene|calcipotriene|mesh-list
55751570|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55751571|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751572|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
55751573|NCT03331523|Hormones|hormones|mesh-ancestor
55751574|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751575|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751576|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55751577|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
55751578|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
55751579|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
55751580|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
55751581|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751582|NCT05023863|Protective Agents|protective agents|mesh-ancestor
55751583|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751584|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
55751585|NCT05023863|Vitamins|vitamins|mesh-ancestor
55751586|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
55751587|NCT05463809|Oxycodone|oxycodone|mesh-list
55751588|NCT05463809|Analgesics|analgesics|mesh-list
55751589|NCT05463809|Ropivacaine|ropivacaine|mesh-list
55751590|NCT05463809|Anesthetics, Local|anesthetics, local|mesh-ancestor
55751591|NCT05463809|Anesthetics|anesthetics|mesh-ancestor
55751592|NCT05463809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751593|NCT05463809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751594|NCT05463809|Sensory System Agents|sensory system agents|mesh-ancestor
55751595|NCT05463809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751596|NCT05463809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55751597|NCT05463809|Narcotics|narcotics|mesh-ancestor
55751598|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
55751599|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55751600|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
55751601|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751602|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751603|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55751604|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
55751605|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55751606|NCT03331445|Antioxidants|antioxidants|mesh-ancestor
55751607|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751608|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751754|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751755|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
55751756|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
55751757|NCT03230227|Bupivacaine|bupivacaine|mesh-list
55751758|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
55751759|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
55751760|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751761|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751762|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
55751763|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751764|NCT03078465|Clopidogrel|clopidogrel|mesh-list
55751766|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55751767|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55751768|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55751769|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55751770|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
55751771|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751772|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751773|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751775|NCT03324815|Methadone|methadone|mesh-list
55751776|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55751777|NCT03324815|Narcotics|narcotics|mesh-ancestor
55751778|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751779|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751780|NCT03324815|Analgesics|analgesics|mesh-ancestor
55751781|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
55751782|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751783|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
55751784|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
55751785|NCT05006469|Dexamethasone|dexamethasone|mesh-list
55751786|NCT05006469|Doxorubicin|doxorubicin|mesh-list
55751787|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55751788|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55751789|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751790|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
55751791|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
55751792|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751793|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751794|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55751795|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
55751796|NCT05006469|Hormones|hormones|mesh-ancestor
55751797|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751798|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55751799|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751800|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751801|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751802|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55751803|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55751804|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55751805|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55751806|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
55751807|NCT03084783|Dexamethasone|dexamethasone|mesh-list
55751810|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
55751811|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751812|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751813|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55751814|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
55751816|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751817|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55751818|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751819|NCT03228355|Cromakalim|cromakalim|mesh-list
55751820|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55751821|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55751822|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
55751823|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751824|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751825|NCT03228355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55751826|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
55751827|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
55751828|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
55751829|NCT03324503|Prednisone|prednisone|mesh-list
55751830|NCT03324503|Prednisolone|prednisolone|mesh-list
55751831|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55751832|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
55751833|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55751834|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
55751835|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55751836|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
55751837|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
55751838|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751839|NCT03324503|Hormones|hormones|mesh-ancestor
55751840|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751841|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751842|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55751843|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751844|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
55751845|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
55751846|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751847|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55751848|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55751849|NCT03324503|Protective Agents|protective agents|mesh-ancestor
55751850|NCT03324425|Simvastatin|simvastatin|mesh-list
55751851|NCT03324425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55751852|NCT03324425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55751853|NCT03324425|Antimetabolites|antimetabolites|mesh-ancestor
55751854|NCT03324425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751855|NCT03324425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55751856|NCT03324425|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55751857|NCT03324425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751858|NCT05006001|Colchicine|colchicine|mesh-list
55751859|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
55751860|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55751861|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
55751862|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
55751863|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
55751864|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751865|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751866|NCT04493489|Propranolol|propranolol|mesh-list
55751867|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55751868|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55751869|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
55751870|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751871|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751872|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751873|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55751874|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55751875|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
55751877|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751878|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55751879|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751880|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751881|NCT03119857|Docetaxel|docetaxel|mesh-list
55751882|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
55751883|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751884|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
55751885|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
55751886|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
55751887|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751888|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
55751889|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751890|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751891|NCT03320603|Thrombin|thrombin|mesh-list
55751892|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
55751893|NCT03320603|Coagulants|coagulants|mesh-ancestor
55751894|NCT03227653|Ritonavir|ritonavir|mesh-list
55751895|NCT03227653|Lopinavir|lopinavir|mesh-list
55751896|NCT03227653|Nevirapine|nevirapine|mesh-list
55751897|NCT03227653|Efavirenz|efavirenz|mesh-list
55751898|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55751899|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55751900|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
55751901|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751902|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751903|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55751904|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55751905|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
55751906|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55751907|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55751908|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55751909|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55751910|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55751911|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55751912|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55751913|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55751915|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55751917|NCT03320447|Prilocaine|prilocaine|mesh-list
55751918|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55751919|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55751920|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55751921|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
55751922|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
55751923|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751924|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751925|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
55751926|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751927|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55751928|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55751929|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55751930|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55751931|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751932|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55751933|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
55751934|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55751935|NCT04434105|Triamcinolone|triamcinolone|mesh-list
55751936|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55751937|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55751938|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55751939|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751940|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
55751941|NCT04434105|Hormones|hormones|mesh-ancestor
55780091|NCT03491059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751942|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55751943|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751944|NCT04434105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55751945|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
55751946|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55751947|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751949|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55751950|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55751951|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55751952|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
55751953|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
55751954|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55751955|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751956|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751957|NCT03078309|Cannabidiol|cannabidiol|mesh-list
55751958|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
55751960|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55751962|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55751963|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55751964|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
55751965|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751966|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55751968|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55751969|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
55751970|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
55780098|NCT02668393|Docetaxel|docetaxel|mesh-list
55751971|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
55751972|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751973|NCT03323567|Lidocaine|lidocaine|mesh-list
55751974|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55751975|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
55751976|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
55751977|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751978|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751979|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
55751980|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55751981|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55751982|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55751983|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55751984|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55751985|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55751986|NCT04492709|Midazolam|midazolam|mesh-list
55751987|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55751988|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55751989|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55751990|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55751991|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55751992|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55751993|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55751994|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55751995|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
55751997|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
55751998|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
55751999|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752000|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752001|NCT05006235|Epinephrine|epinephrine|mesh-list
55752002|NCT05006235|Albuterol|albuterol|mesh-list
55752003|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55752004|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55752005|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
55752006|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752007|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752008|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752010|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55752012|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752013|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55752014|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
55752015|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
55752016|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
55752017|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55752018|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
55752019|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55752020|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55752021|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
55752022|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55752023|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752025|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
55752026|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752027|NCT02487953|Nicotine|nicotine|mesh-list
55752028|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55752029|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
55752030|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752031|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752032|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55752033|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55752034|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
55752035|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752036|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752037|NCT03091569|Vitamin K|vitamin k|mesh-list
55752038|NCT03091569|Vitamins|vitamins|mesh-ancestor
55752039|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
55752040|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752041|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55752042|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55752043|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752045|NCT03091569|Coagulants|coagulants|mesh-ancestor
55752046|NCT04948749|Sirolimus|sirolimus|mesh-list
55752047|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55752048|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752049|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55752050|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752051|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
55752052|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55752053|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
55752054|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752056|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752057|NCT02487719|Teferrol|teferrol|mesh-list
55752058|NCT02487719|Hematinics|hematinics|mesh-ancestor
55752059|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55752060|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
55752062|NCT04940871|Favipiravir|favipiravir|mesh-list
55752063|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
55752064|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752065|NCT04939935|Metformin|metformin|mesh-list
55752066|NCT04939935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55752067|NCT04939935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752068|NCT03207139|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55752069|NCT03207139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55752070|NCT03207139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752071|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
55752072|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
55752073|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752074|NCT03221881|Docetaxel|docetaxel|mesh-list
55752075|NCT03221881|Doxorubicin|doxorubicin|mesh-list
55752076|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55752077|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752078|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
55752079|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
55752080|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
55752081|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752082|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55752083|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55752084|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55752085|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752086|NCT03091257|Trametinib|trametinib|mesh-list
55752087|NCT03091257|Dabrafenib|dabrafenib|mesh-list
55752088|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752089|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55752090|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752091|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752092|NCT03206671|Cytarabine|cytarabine|mesh-list
55752093|NCT03206671|Dexamethasone|dexamethasone|mesh-list
55752094|NCT03206671|Prednisolone|prednisolone|mesh-list
55752095|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
55752096|NCT03206671|Ifosfamide|ifosfamide|mesh-list
55752097|NCT03206671|Rituximab|rituximab|mesh-list
55752098|NCT03206671|Doxorubicin|doxorubicin|mesh-list
55752099|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55752100|NCT03206671|Methotrexate|methotrexate|mesh-list
55752101|NCT03206671|Etoposide|etoposide|mesh-list
55752102|NCT03206671|Vincristine|vincristine|mesh-list
55752103|NCT03206671|Vindesine|vindesine|mesh-list
55752104|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55752105|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
55752106|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752107|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55752108|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55752109|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
55752110|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752111|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752112|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55752113|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55752114|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752116|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
55752117|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752118|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55752119|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
55752120|NCT03206671|Hormones|hormones|mesh-ancestor
55752121|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55752122|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55752123|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55752124|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55752125|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55752126|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752127|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55752128|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
55752129|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55752130|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55752131|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
55752132|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
55752133|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55752134|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55752135|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55752136|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
55752137|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752138|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
55752139|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
55752140|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
55752142|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
55752143|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752144|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752145|NCT03319121|Theophylline|theophylline|mesh-list
55752148|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55752149|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
55752150|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752151|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752152|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55752153|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
55752154|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55752155|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752156|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752157|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
55752158|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55752159|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55752160|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
55752161|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752162|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55752163|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55752164|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55752166|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55752167|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
55752168|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55752169|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55752170|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752171|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752172|NCT02487407|Protective Agents|protective agents|mesh-ancestor
55752173|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752175|NCT03221569|Ketamine|ketamine|mesh-list
55752176|NCT03221569|Analgesics|analgesics|mesh-ancestor
55752177|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
55752178|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752179|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752180|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55752181|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55752182|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
55752184|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752185|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55752186|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55752187|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752188|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752189|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55752190|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55752191|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752193|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55752195|NCT03319043|Budesonide|budesonide|mesh-list
55752196|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
55752197|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752198|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55752199|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
55752200|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752201|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752202|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55752203|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
55752204|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
55752206|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55752207|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55752208|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55752209|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55752210|NCT03319043|Adrenergic Agents|adrenergic agents|mesh-ancestor
55752211|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752212|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752213|NCT02451475|Amitriptyline|amitriptyline|mesh-list
55752214|NCT02451475|Paroxetine|paroxetine|mesh-list
55752215|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55752216|NCT02451475|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55752217|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55752218|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55752219|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752220|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752221|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
55752222|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752223|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55752224|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
55752226|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55752227|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55752228|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752229|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55752230|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55752231|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55752233|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
55752234|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752235|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55752237|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
55752238|NCT05019417|Glycerol|glycerol|mesh-list
55752239|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55752240|NCT05019417|Protective Agents|protective agents|mesh-ancestor
55752241|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752242|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752243|NCT03225937|Trastuzumab|trastuzumab|mesh-list
55752244|NCT03225937|Pertuzumab|pertuzumab|mesh-list
55752245|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55752246|NCT03225937|Lapatinib|lapatinib|mesh-list
55752247|NCT03225937|Maytansine|maytansine|mesh-list
55752248|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55752249|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752250|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55752251|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752252|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752253|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55752254|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
55752255|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
55752256|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
55752257|NCT03318887|Ribavirin|ribavirin|mesh-list
55752258|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
55752259|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
55752260|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752261|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
55752262|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752263|NCT03119077|Itraconazole|itraconazole|mesh-list
55752264|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
55780179|NCT02382523|Hormones|hormones|mesh-ancestor
55752265|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752266|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55752267|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55752269|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752270|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55752271|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
55752272|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55752273|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752274|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55752275|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
55752276|NCT02487329|Calcium|calcium|mesh-list
55752277|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55752278|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752279|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55752280|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
55752281|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55752282|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752283|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55752284|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752285|NCT04493099|Decitabine|decitabine|mesh-list
55752286|NCT04493099|Venetoclax|venetoclax|mesh-list
55752287|NCT04493099|Alvocidib|alvocidib|mesh-list
55752288|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55752289|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
55752290|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752291|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752292|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752293|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
55752296|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55752298|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752299|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
55752300|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
55752301|NCT03119623|Valsartan|valsartan|mesh-list
55752302|NCT03119623|Enalapril|enalapril|mesh-list
55752303|NCT03119623|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55752304|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55752384|NCT03225781|Bleomycin|bleomycin|mesh-list
55752305|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55752306|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55752307|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752308|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55752309|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
55752310|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752311|NCT03318419|Cytarabine|cytarabine|mesh-list
55752312|NCT03318419|Pegaspargase|pegaspargase|mesh-list
55752313|NCT03318419|Asparaginase|asparaginase|mesh-list
55752314|NCT03318419|Cladribine|cladribine|mesh-list
55752315|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55752316|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
55752317|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752318|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752319|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
55752320|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752321|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55752322|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
55752323|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752324|NCT03321773|Amoxicillin|amoxicillin|mesh-list
55752325|NCT03321773|Metronidazole|metronidazole|mesh-list
55752326|NCT03321773|Clarithromycin|clarithromycin|mesh-list
55752327|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
55752328|NCT03321773|Pantoprazole|pantoprazole|mesh-list
55752330|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55752331|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752332|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55752333|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55752334|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55752335|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752336|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752337|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55752338|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55752339|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55752340|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55752341|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55752343|NCT03077217|Rifaximin|rifaximin|mesh-list
55752344|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55752345|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752346|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55752347|NCT05001243|Bromfenac|bromfenac|mesh-list
55752348|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55752349|NCT05001243|Phenylephrine|phenylephrine|mesh-list
55752350|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
55752351|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
55752352|NCT05001243|Pilocarpine|pilocarpine|mesh-list
55752353|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55752354|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
55752355|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752356|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
55752357|NCT05001243|Protective Agents|protective agents|mesh-ancestor
55752358|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55752359|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55752360|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55752361|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55752362|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
55752363|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752364|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752365|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
55752366|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
55752367|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752368|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
55752369|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55752370|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
55752371|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55752372|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
55752373|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55752374|NCT05001243|Miotics|miotics|mesh-ancestor
55752375|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55752376|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55752377|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
55752378|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55752379|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55752380|NCT05001243|Analgesics|analgesics|mesh-ancestor
55752381|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
55752382|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752383|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55752385|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55752386|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752387|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55752388|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55752389|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752390|NCT03221023|Vancomycin|vancomycin|mesh-list
55752391|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55752392|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752393|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55752394|NCT02490839|Amoxicillin|amoxicillin|mesh-list
55752395|NCT02490839|Metronidazole|metronidazole|mesh-list
55752396|NCT02490839|Tetracycline|tetracycline|mesh-list
55752397|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55752398|NCT02490839|Rabeprazole|rabeprazole|mesh-list
55752399|NCT02490839|Bismuth|bismuth|mesh-list
55752400|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55752401|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752402|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
55752404|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55752405|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55752406|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55752407|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752408|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752409|NCT02490839|Antacids|antacids|mesh-ancestor
55752410|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55752411|NCT02490527|Simvastatin|simvastatin|mesh-list
55752412|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55752413|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55752414|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
55752415|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752416|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55752417|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55752418|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752419|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
55752420|NCT02490449|Lansoprazole|lansoprazole|mesh-list
55752421|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55752423|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55752424|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752426|NCT02452177|Vitamin D|vitamin d|mesh-list
55752427|NCT02452177|Vitamins|vitamins|mesh-ancestor
55752428|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
55752429|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752430|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55752431|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
55752432|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752433|NCT03224923|Aspirin|aspirin|mesh-list
55752434|NCT03224923|Clopidogrel|clopidogrel|mesh-list
55752435|NCT03224923|Ticagrelor|ticagrelor|mesh-list
55752436|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55752437|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55752438|NCT03224923|Analgesics|analgesics|mesh-ancestor
55752439|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
55752441|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752442|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752443|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55752444|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55752445|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55752446|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752447|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55752448|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55752449|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752451|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55752452|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55752453|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55752454|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
55752455|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752456|NCT05004753|Artemisinins|artemisinins|mesh-list
55752457|NCT05004753|Artemisinin|artemisinin|mesh-list
55752458|NCT05004753|Dexamethasone|dexamethasone|mesh-list
55752459|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752460|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
55752461|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
55752462|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752463|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752464|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55752465|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
55752466|NCT05004753|Hormones|hormones|mesh-ancestor
55752467|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55752468|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55752469|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752470|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
55752471|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55752472|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55752473|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752474|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
55752475|NCT05004519|Remifentanil|remifentanil|mesh-list
55752476|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55752477|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752478|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752479|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55752480|NCT05004519|Analgesics|analgesics|mesh-ancestor
55752481|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
55752482|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752483|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55752484|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55752485|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55752486|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
55752487|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752488|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752489|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55752490|NCT05004519|Narcotics|narcotics|mesh-ancestor
55752491|NCT02486549|Bupivacaine|bupivacaine|mesh-list
55752492|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
55752494|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752495|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752496|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
55752497|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752498|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
55752499|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752500|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
55752501|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
55752502|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
55752503|NCT03073317|Mitogens|mitogens|mesh-list
55752504|NCT03073317|Mitosis Modulators|mitosis modulators|mesh-ancestor
55752505|NCT03073317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752506|NCT04485403|Ibuprofen|ibuprofen|mesh-list
55752507|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55780224|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752508|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55752509|NCT04485403|Analgesics|analgesics|mesh-ancestor
55752510|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
55752511|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752512|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752514|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55752515|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55752516|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752517|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752518|NCT03220867|Risperidone|risperidone|mesh-list
55752519|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55752520|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
55752521|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752522|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752523|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752524|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55752525|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55752526|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752527|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55752528|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55752529|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
55752531|NCT03318029|Vitamins|vitamins|mesh-ancestor
55752532|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
55752533|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752534|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55752535|NCT03076281|Metformin|metformin|mesh-list
55752536|NCT03076281|Doxycycline|doxycycline|mesh-list
55752537|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55752538|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752539|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55752540|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752541|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
55752542|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55752543|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55752544|NCT03204955|Plasma-lyte 148|plasma-lyte 148|mesh-list
55752545|NCT03204955|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55752546|NCT03204955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55752547|NCT02452255|Propranolol|propranolol|mesh-list
55752548|NCT02452255|Metoprolol|metoprolol|mesh-list
55752549|NCT02452255|Fenofibrate|fenofibrate|mesh-list
55752550|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55752551|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55752552|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
55752553|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752554|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752555|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752556|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55752557|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55752558|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
55752560|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
55752561|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752562|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55752563|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55752564|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
55752565|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55752566|NCT03205033|Melatonin|melatonin|mesh-list
55752567|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
55780305|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752568|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752569|NCT03205033|Protective Agents|protective agents|mesh-ancestor
55752570|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752571|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752572|NCT03076905|Olorofim|olorofim|mesh-list
55752573|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
55752574|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752575|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
55752576|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55752577|NCT02452099|Protective Agents|protective agents|mesh-ancestor
55752578|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752579|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55752580|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
55752581|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752582|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55752583|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55752584|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752585|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752586|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55752587|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55752588|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752590|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752591|NCT03220789|Methamphetamine|methamphetamine|mesh-list
55752592|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55752593|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752594|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
55752595|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
55752596|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752597|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
55752598|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752599|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752600|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
55752601|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55752602|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55752603|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55752604|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55752605|NCT03220555|Lidocaine|lidocaine|mesh-list
55752606|NCT03220555|Prilocaine|prilocaine|mesh-list
55752607|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
55752608|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
55752609|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752610|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752611|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
55752612|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752613|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55752614|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55752615|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55752616|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55752617|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752620|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752622|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752623|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752625|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55752626|NCT03204799|Ezetimibe|ezetimibe|mesh-list
55752627|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55752628|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752629|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55752630|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55752631|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
55752632|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752633|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55752635|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55752636|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752637|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55752638|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752639|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55752640|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55752641|NCT03204331|Norethindrone|norethindrone|mesh-list
55752642|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
55752643|NCT03204331|Estradiol|estradiol|mesh-list
55752644|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55752645|NCT03204331|Relugolix|relugolix|mesh-list
55752646|NCT03204331|Estrogens|estrogens|mesh-ancestor
55752647|NCT03204331|Hormones|hormones|mesh-ancestor
55752648|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55752649|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752650|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55752651|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
55752652|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55752653|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55752655|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55752656|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55752657|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
55752658|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
55752659|NCT03072849|Fluticasone|fluticasone|mesh-list
55752660|NCT03072849|Azithromycin|azithromycin|mesh-list
55752661|NCT03072849|Montelukast|montelukast|mesh-list
55752662|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752663|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55752664|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
55752665|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752666|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752667|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55752668|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
55752669|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
55752670|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55752671|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55752672|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752673|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55752674|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
55752675|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55752676|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55752677|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55752682|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752683|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752685|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55752686|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752687|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752689|NCT03075657|Risperidone|risperidone|mesh-list
55752690|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
55752691|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55752692|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
55752693|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752694|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752695|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752696|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55752697|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55752698|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752699|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55752700|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55752701|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
55752702|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
55752703|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
55752704|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752705|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55752706|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55752707|NCT02451865|Docetaxel|docetaxel|mesh-list
55752708|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752709|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
55752710|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
55752711|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
55752712|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752713|NCT05004207|Lactulose|lactulose|mesh-list
55752714|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55752715|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
55752716|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
55752717|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55752718|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752719|NCT02489513|Ivosidenib|ivosidenib|mesh-list
55752721|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752722|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752723|NCT03317015|Fluticasone|fluticasone|mesh-list
55752724|NCT03317015|Triamcinolone|triamcinolone|mesh-list
55752725|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752726|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55752727|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
55752728|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752729|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752730|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55752731|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
55752732|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
55752733|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55752734|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
55752735|NCT03317015|Hormones|hormones|mesh-ancestor
55752736|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55752737|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
55752738|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55752739|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
55752740|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752741|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
55752742|NCT03204565|Protective Agents|protective agents|mesh-ancestor
55752743|NCT03224377|Antibodies|antibodies|mesh-list
55752744|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
55752745|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
55752746|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752747|NCT02451787|Vitamin D|vitamin d|mesh-list
55752748|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
55752750|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
55752751|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752752|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55752753|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55752754|NCT03224221|Fluorouracil|fluorouracil|mesh-list
55752755|NCT03224221|Apatinib|apatinib|mesh-list
55752756|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
55752757|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752758|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55752759|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752760|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55752761|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
55752762|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752763|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55752764|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752766|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55752767|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752769|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752770|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55752771|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55752772|NCT03223519|Analgesics|analgesics|mesh-ancestor
55752773|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
55752774|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752775|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752776|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55752779|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752780|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
55752781|NCT03320915|Vitamin D|vitamin d|mesh-list
55752782|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55752783|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752784|NCT03320915|Vitamins|vitamins|mesh-ancestor
55752785|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
55752786|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55752789|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55752790|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752791|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752792|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752793|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55752794|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55752795|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
55752796|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752797|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752798|NCT03220009|Nivolumab|nivolumab|mesh-list
55752799|NCT03220009|Ipilimumab|ipilimumab|mesh-list
55752800|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55752801|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752802|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55752803|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752805|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752806|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
55752807|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
55752808|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752809|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752810|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55752811|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
55752812|NCT02485613|Hormones|hormones|mesh-ancestor
55752813|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55752814|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55752815|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752816|NCT02484833|Cetuximab|cetuximab|mesh-list
55752817|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55752818|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752819|NCT03204019|Thalidomide|thalidomide|mesh-list
55752820|NCT03204019|Temozolomide|temozolomide|mesh-list
55752821|NCT03204019|Tegafur|tegafur|mesh-list
55752822|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55752823|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
55752824|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752825|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752826|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55752827|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
55752828|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55780373|NCT02383771|Analgesics|analgesics|mesh-ancestor
55752829|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
55752830|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55752831|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752832|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55752833|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55752834|NCT03204019|Growth Substances|growth substances|mesh-ancestor
55752835|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
55752836|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55752838|NCT02484677|Docetaxel|docetaxel|mesh-list
55752839|NCT02484677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752840|NCT02484677|Tubulin Modulators|tubulin modulators|mesh-ancestor
55752841|NCT02484677|Antimitotic Agents|antimitotic agents|mesh-ancestor
55752842|NCT02484677|Mitosis Modulators|mitosis modulators|mesh-ancestor
55752843|NCT02484677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752845|NCT02485145|Orphenadrine|orphenadrine|mesh-list
55752846|NCT02485145|Bupivacaine|bupivacaine|mesh-list
55752847|NCT02485145|Baclofen|baclofen|mesh-list
55752848|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
55752849|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
55752850|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752851|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752852|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
55752853|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55752854|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55752855|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55752856|NCT02485145|Analgesics|analgesics|mesh-ancestor
55752857|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55752858|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55752859|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55752860|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752861|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752862|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55752863|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55752864|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55752865|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
55752867|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752868|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55752869|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55752870|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
55752871|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
55752872|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55752873|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55752874|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
55752875|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
55752876|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55752877|NCT02484755|Gefitinib|gefitinib|mesh-list
55752878|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752879|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55752880|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752881|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752885|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55752886|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
55752887|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55752888|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752890|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
55752891|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55752892|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55752893|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55752894|NCT02485067|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55752895|NCT02485067|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55752896|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55752897|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
55752898|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752899|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752900|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752902|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55752903|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55752904|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55752905|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55752906|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55780391|NCT02378623|Apixaban|apixaban|mesh-list
55752907|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
55752908|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752909|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752910|NCT03203317|Insulin|insulin|mesh-list
55752911|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55752912|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752914|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
55752915|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
55752916|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752918|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
55752919|NCT03201601|Vitamins|vitamins|mesh-ancestor
55752920|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
55752921|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752923|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55752925|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
55752926|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752928|NCT04999293|Ticagrelor|ticagrelor|mesh-list
55752929|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55752930|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55752931|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55752932|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55752933|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
55752934|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55752935|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752936|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752937|NCT03315923|Rituximab|rituximab|mesh-list
55752938|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
55752939|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
55752940|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55752941|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752942|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
55752943|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752944|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55752945|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55752946|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55752948|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55752949|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752953|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55752954|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
55752955|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55752956|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752958|NCT04998903|Dimercaprol|dimercaprol|mesh-list
55752959|NCT04998903|Chelating Agents|chelating agents|mesh-ancestor
55752960|NCT04998903|Sequestering Agents|sequestering agents|mesh-ancestor
55752961|NCT04998903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752962|NCT02484287|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55752963|NCT02484287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55752964|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
55752965|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
55752966|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55752967|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
55752968|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752969|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55752970|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55752971|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
55752973|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752974|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55752976|NCT02484209|Glimepiride|glimepiride|mesh-list
55752977|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55752978|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752979|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55752980|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55752981|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
55752982|NCT04999137|Vitamins|vitamins|mesh-list
55752984|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
55752985|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752986|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
55752987|NCT02484053|Rituximab|rituximab|mesh-list
55752988|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55752989|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752990|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
55752991|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55752992|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55752993|NCT03200821|Gemcitabine|gemcitabine|mesh-list
55752994|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55752995|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
55752996|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55752997|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55752999|NCT03200821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55753000|NCT03200821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753001|NCT03200821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55753002|NCT03200821|Immunologic Factors|immunologic factors|mesh-ancestor
55753003|NCT03200821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753004|NCT05353361|Paclitaxel|paclitaxel|mesh-list
55753005|NCT05353361|Pertuzumab|pertuzumab|mesh-list
55753006|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55753007|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753008|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
55753009|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
55753010|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
55753011|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753012|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55753013|NCT02483897|Tetracaine|tetracaine|mesh-list
55753014|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55753015|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
55753016|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
55753017|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753018|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753019|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
55753020|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753021|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55753022|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55753023|NCT01374919|Hematinics|hematinics|mesh-ancestor
55753024|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55753025|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55753027|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55753028|NCT03202459|Pregabalin|pregabalin|mesh-list
55753029|NCT03202459|Gabapentin|gabapentin|mesh-list
55753030|NCT03202459|Analgesics|analgesics|mesh-ancestor
55753032|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753033|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753035|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55753036|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55753037|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753038|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55753040|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55753041|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753042|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55753043|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55753044|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55753045|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753046|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
55753048|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753049|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753050|NCT04492319|Neostigmine|neostigmine|mesh-list
55753051|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55753052|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753053|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753054|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
55753055|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753056|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753057|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55753058|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
55753059|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753060|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
55753061|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55753062|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753063|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55753065|NCT05713721|Dopamine Agonists|dopamine agonists|mesh-list
55753066|NCT05713721|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55753067|NCT05713721|Sympathomimetics|sympathomimetics|mesh-ancestor
55753068|NCT05713721|Autonomic Agents|autonomic agents|mesh-ancestor
55753069|NCT05713721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753070|NCT05713721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753071|NCT05713721|Dopamine Agents|dopamine agents|mesh-ancestor
55753073|NCT05713721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753077|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
55753078|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753079|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753080|NCT05002725|Sensory System Agents|sensory system agents|mesh-ancestor
55753081|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753082|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55753083|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55753084|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55753085|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55753086|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753087|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55753088|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55753089|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55753090|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55780443|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55753091|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753092|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753093|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753094|NCT03315533|Analgesics|analgesics|mesh-ancestor
55753095|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
55753096|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753097|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
55753098|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55753099|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
55753100|NCT05437835|Ropivacaine|ropivacaine|mesh-list
55753101|NCT05437835|Anesthetics, Local|anesthetics, local|mesh-ancestor
55753102|NCT05437835|Anesthetics|anesthetics|mesh-ancestor
55753103|NCT05437835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753104|NCT05437835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753105|NCT05437835|Sensory System Agents|sensory system agents|mesh-ancestor
55753106|NCT05437835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753108|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
55753109|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
55753110|NCT05429489|Morphine|morphine|mesh-list
55753113|NCT05429489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753114|NCT05429489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753116|NCT05429489|Sensory System Agents|sensory system agents|mesh-ancestor
55753117|NCT05429489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753120|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55753121|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753122|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753123|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55753124|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
55753125|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
55753126|NCT04997967|Analgesics|analgesics|mesh-ancestor
55753127|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
55753128|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753129|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55753130|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55753131|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55753132|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753133|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753134|NCT02483195|Minoxidil|minoxidil|mesh-list
55753135|NCT02483195|Spironolactone|spironolactone|mesh-list
55753136|NCT02483195|Finasteride|finasteride|mesh-list
55753137|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55753139|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753140|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753141|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55753142|NCT02483195|Diuretics|diuretics|mesh-ancestor
55753143|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
55753144|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55753145|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
55753146|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55753147|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55753148|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753149|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753150|NCT02483195|Urological Agents|urological agents|mesh-ancestor
55753151|NCT02450773|Furosemide|furosemide|mesh-list
55753152|NCT02450773|Diuretics|diuretics|mesh-ancestor
55753153|NCT02450773|Natriuretic Agents|natriuretic agents|mesh-ancestor
55753154|NCT02450773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753157|NCT02450773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753158|NCT02450149|Sorafenib|sorafenib|mesh-list
55753159|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753160|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55753161|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753162|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753163|NCT02479217|Docetaxel|docetaxel|mesh-list
55753164|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753165|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
55753166|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
55753167|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
55753168|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753169|NCT05002413|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55753170|NCT05002413|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55753171|NCT02479529|Norepinephrine|norepinephrine|mesh-list
55753172|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55753173|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55753174|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
55753175|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753176|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753177|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753178|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
55753180|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753181|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55753182|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
55753183|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
55753184|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
55753185|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753186|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753187|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55753189|NCT03213769|Ubiquinone|ubiquinone|mesh-list
55753190|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
55753191|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
55753192|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753193|NCT03213769|Vitamins|vitamins|mesh-ancestor
55753194|NCT05002101|Zinc|zinc|mesh-list
55753195|NCT05002101|Zinc Sulfate|zinc sulfate|mesh-list
55753196|NCT05002101|Trace Elements|trace elements|mesh-ancestor
55753197|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
55753198|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753199|NCT05002101|Astringents|astringents|mesh-ancestor
55753200|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
55753203|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753204|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753205|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55753206|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
55753207|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55753208|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
55753209|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55753210|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753211|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55753212|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55753213|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753215|NCT03212677|Trace Elements|trace elements|mesh-ancestor
55753216|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
55753217|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753218|NCT03199339|Midazolam|midazolam|mesh-list
55753219|NCT03199339|Bupropion|bupropion|mesh-list
55753220|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55753221|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55753222|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753223|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753224|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55753225|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55753226|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55753227|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55753229|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
55753230|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
55753231|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
55753233|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753234|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55753235|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
55753236|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55753237|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55753238|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55753239|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
55753240|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55753241|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55753242|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753243|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
55753245|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55753246|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
55753247|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753248|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753249|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
55753250|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55753252|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55753253|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753254|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55753255|NCT03199261|Incretins|incretins|mesh-ancestor
55753256|NCT03199261|Hormones|hormones|mesh-ancestor
55753257|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753258|NCT02482961|Colistin|colistin|mesh-list
55753259|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55753260|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55753261|NCT04990713|Ropivacaine|ropivacaine|mesh-list
55753262|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
55753263|NCT04990713|Anesthetics|anesthetics|mesh-list
55753264|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753265|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753266|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
55753267|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753268|NCT04990791|Aspirin|aspirin|mesh-list
55753269|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
55753270|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55753271|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55753272|NCT04990791|Analgesics|analgesics|mesh-ancestor
55753273|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
55753274|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753275|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753276|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753277|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753278|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55753279|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55753280|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753281|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55753282|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55753283|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753284|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
55753285|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55753286|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
55753287|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55753288|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
55753289|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
55753291|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753292|NCT03201835|Analgesics|analgesics|mesh-ancestor
55753293|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
55753294|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753296|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55753297|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55753298|NCT02478515|Growth Substances|growth substances|mesh-ancestor
55753299|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753300|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
55753301|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753302|NCT02448199|Meloxicam|meloxicam|mesh-list
55753303|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
55753304|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55753305|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55753306|NCT02448199|Analgesics|analgesics|mesh-ancestor
55753307|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
55753308|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753309|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753310|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753311|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55753312|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55753313|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753314|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753315|NCT03071289|Cisplatin|cisplatin|mesh-list
55753316|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753317|NCT03199105|Tetracaine|tetracaine|mesh-list
55753318|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
55753319|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
55753320|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753321|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753322|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
55753323|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753324|NCT02482649|Methylphenidate|methylphenidate|mesh-list
55753325|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55753326|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55753327|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753328|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55753329|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55753330|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55753331|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753332|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
55753333|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753334|NCT02482649|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55753335|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
55753337|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55753338|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55753339|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753340|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753341|NCT02478281|Methylene Blue|methylene blue|mesh-list
55753342|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753343|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753344|NCT02478125|Docetaxel|docetaxel|mesh-list
55753345|NCT02478125|Lenograstim|lenograstim|mesh-list
55753346|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753347|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
55753348|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
55753349|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
55753350|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753351|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55753352|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
55753353|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753354|NCT02478047|Dexamethasone|dexamethasone|mesh-list
55753355|NCT02478047|Ramosetron|ramosetron|mesh-list
55753356|NCT02478047|Antiemetics|antiemetics|mesh-list
55753357|NCT02478047|Tropisetron|tropisetron|mesh-list
55753358|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753359|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
55753360|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753361|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753362|NCT02478047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55753363|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
55753364|NCT02478047|Hormones|hormones|mesh-ancestor
55780587|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55753365|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753366|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55753367|NCT02478047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753368|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55753370|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753371|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753372|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55753373|NCT04996485|Ustekinumab|ustekinumab|mesh-list
55753374|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
55753375|NCT02447965|Bupivacaine|bupivacaine|mesh-list
55753376|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
55753377|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
55753378|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753379|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753381|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753382|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55753383|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
55753384|NCT03070275|Coagulants|coagulants|mesh-ancestor
55753385|NCT05713019|Adenosine|adenosine|mesh-list
55753386|NCT05713019|Capsaicin|capsaicin|mesh-list
55753387|NCT05713019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55753388|NCT05713019|Antipruritics|antipruritics|mesh-ancestor
55753389|NCT05713019|Dermatologic Agents|dermatologic agents|mesh-ancestor
55753390|NCT05713019|Sensory System Agents|sensory system agents|mesh-ancestor
55753391|NCT05713019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753392|NCT05713019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753393|NCT05713019|Analgesics|analgesics|mesh-ancestor
55753394|NCT05713019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55753395|NCT05713019|Vasodilator Agents|vasodilator agents|mesh-ancestor
55753396|NCT05713019|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55753397|NCT05713019|Purinergic Agonists|purinergic agonists|mesh-ancestor
55753398|NCT05713019|Purinergic Agents|purinergic agents|mesh-ancestor
55780611|NCT01945216|Alogliptin|alogliptin|mesh-list
55753399|NCT05713019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753400|NCT05713019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753402|NCT03198403|Bupivacaine|bupivacaine|mesh-list
55753403|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
55753404|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
55753405|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753406|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753407|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
55753408|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753409|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55753410|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55753411|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
55753412|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753413|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753414|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55753415|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55753416|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
55753417|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55753419|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
55753420|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
55753421|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55753423|NCT05712941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753425|NCT05712941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55753426|NCT05712941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753427|NCT05712941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753428|NCT05712941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55753429|NCT05712941|Hormone Antagonists|hormone antagonists|mesh-ancestor
55753430|NCT05712941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753431|NCT05712941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753433|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753434|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55753435|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
55753436|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753438|NCT02447809|Clopidogrel|clopidogrel|mesh-list
55753439|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55753440|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55753441|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55753442|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55753443|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
55753444|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753445|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753446|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753447|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55753448|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55753449|NCT02447809|Analgesics|analgesics|mesh-ancestor
55753450|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
55753451|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753452|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753453|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753454|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55753455|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55753458|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
55753459|NCT04915287|Maleic acid|maleic acid|mesh-list
55753460|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753461|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753462|NCT05709353|Methamphetamine|methamphetamine|mesh-list
55753463|NCT05709353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55753464|NCT05709353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753465|NCT05709353|Sympathomimetics|sympathomimetics|mesh-ancestor
55753466|NCT05709353|Autonomic Agents|autonomic agents|mesh-ancestor
55753467|NCT05709353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753468|NCT05709353|Dopamine Agents|dopamine agents|mesh-ancestor
55753469|NCT05709353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753470|NCT05709353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753471|NCT05709353|Adrenergic Agents|adrenergic agents|mesh-ancestor
55753472|NCT05709353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55753473|NCT05709353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55753474|NCT05709353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55753475|NCT05709353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55753476|NCT03195673|Terazosin|terazosin|mesh-list
55753477|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55753478|NCT03195673|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55753479|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55753480|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
55753481|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753482|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753483|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753484|NCT03195673|Urological Agents|urological agents|mesh-ancestor
55753485|NCT02481791|Remifentanil|remifentanil|mesh-list
55753486|NCT02481791|Propofol|propofol|mesh-list
55753487|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55753488|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753489|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753490|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55753491|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
55753492|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
55753493|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55753494|NCT02481791|Narcotics|narcotics|mesh-ancestor
55753495|NCT02481791|Analgesics|analgesics|mesh-ancestor
55753496|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
55753497|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753498|NCT04484467|Menthol|menthol|mesh-list
55753499|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
55753500|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
55753501|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
55753502|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55753503|NCT02726399|Capecitabine|capecitabine|mesh-list
55753504|NCT02726399|Trastuzumab|trastuzumab|mesh-list
55753505|NCT02726399|Ramucirumab|ramucirumab|mesh-list
55753506|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753507|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55753508|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
55753509|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753510|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55753511|NCT02477969|Metformin|metformin|mesh-list
55753512|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55753513|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753515|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
55753516|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753517|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55753519|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55753520|NCT02481323|Cilostazol|cilostazol|mesh-list
55753521|NCT02481323|Isosorbide|isosorbide|mesh-list
55753522|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55753523|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55753524|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55753525|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
55753526|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753527|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753528|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55753529|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
55753530|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55753531|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55753532|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753533|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55753534|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
55753535|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55753538|NCT02481323|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55753539|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753540|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55753541|NCT02481323|Diuretics|diuretics|mesh-ancestor
55753542|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
55753543|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55753544|NCT03197779|Aspirin|aspirin|mesh-list
55753545|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55753546|NCT03197779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55753547|NCT03197779|Analgesics|analgesics|mesh-ancestor
55753548|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
55753549|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753550|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753551|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753552|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753553|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55753554|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55753555|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753556|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55753557|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55753558|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753559|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
55753560|NCT03197623|Alendronate|alendronate|mesh-list
55753561|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55753562|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753563|NCT02449603|Insulin Aspart|insulin aspart|mesh-list
55753564|NCT02449603|Exenatide|exenatide|mesh-list
55753565|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
55789044|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55753566|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
55753567|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55753568|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753569|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55753571|NCT02449603|Hormones|hormones|mesh-ancestor
55753572|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753573|NCT02481479|Saxagliptin|saxagliptin|mesh-list
55753574|NCT02481479|Incretins|incretins|mesh-ancestor
55753575|NCT02481479|Hormones|hormones|mesh-ancestor
55753576|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753577|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753578|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55753579|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
55753580|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753581|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753582|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55753583|NCT03195049|Bilirubin|bilirubin|mesh-list
55753584|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
55753585|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753586|NCT03195049|Protective Agents|protective agents|mesh-ancestor
55753588|NCT03198013|Prednisolone|prednisolone|mesh-list
55753589|NCT03198013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753590|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
55753591|NCT03198013|Hormones|hormones|mesh-ancestor
55753592|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753593|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753594|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55753595|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753597|NCT05651399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55753598|NCT05651399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753599|NCT05651399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753600|NCT05651399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55753601|NCT05651399|Anesthetics, General|anesthetics, general|mesh-ancestor
55753602|NCT05651399|Anesthetics|anesthetics|mesh-ancestor
55753603|NCT02477891|Daratumumab|daratumumab|mesh-list
55753604|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753605|NCT02477813|Temozolomide|temozolomide|mesh-list
55753606|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55753607|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
55753608|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753609|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753610|NCT02480543|Misoprostol|misoprostol|mesh-list
55753611|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55753612|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
55753613|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55753614|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753615|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55753616|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55753617|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
55753618|NCT03197233|Vitamin D|vitamin d|mesh-list
55753619|NCT03197233|Vitamins|vitamins|mesh-list
55753620|NCT03197233|Vitamin A|vitamin a|mesh-list
55753621|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
55753622|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
55753626|NCT03197233|Protective Agents|protective agents|mesh-ancestor
55753627|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55753628|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753629|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55753630|NCT02447185|Triamcinolone|triamcinolone|mesh-list
55753631|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55753632|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55753633|NCT02447185|Ranibizumab|ranibizumab|mesh-list
55753634|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55753635|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55753636|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55753637|NCT02447185|Growth Substances|growth substances|mesh-ancestor
55753638|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753639|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
55753640|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753641|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753642|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
55753644|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753645|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55753646|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
55753647|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753648|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753649|NCT03197077|Contraceptive Agents|contraceptive agents|mesh-list
55753650|NCT03197077|Desogestrel|desogestrel|mesh-list
55753651|NCT03197077|Contraceptives, Oral|contraceptives, oral|mesh-list
55753652|NCT03197077|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55753653|NCT03197077|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55753654|NCT03197077|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55753655|NCT03197077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753657|NCT03197077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753658|NCT03197077|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55753659|NCT03197077|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55753660|NCT03197077|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55753661|NCT03197077|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55753662|NCT03197077|Progestins|progestins|mesh-ancestor
55753663|NCT03196921|Amphotericin B|amphotericin b|mesh-list
55753664|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55753665|NCT03196921|Amebicides|amebicides|mesh-ancestor
55753668|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55753669|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55753670|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
55753671|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55753672|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55753673|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753674|NCT02480465|Incretins|incretins|mesh-ancestor
55753675|NCT02480465|Hormones|hormones|mesh-ancestor
55753676|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753677|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55753678|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
55753680|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753681|NCT05633771|Adalimumab|adalimumab|mesh-list
55753682|NCT05633771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753683|NCT05633771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753684|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55753685|NCT03208465|Empagliflozin|empagliflozin|mesh-list
55753686|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55753687|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753688|NCT03208465|Incretins|incretins|mesh-ancestor
55753689|NCT03208465|Hormones|hormones|mesh-ancestor
55753690|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753691|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55753692|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
55753693|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753694|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753695|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55753696|NCT03197155|Antiviral Agents|antiviral agents|mesh-list
55753697|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55753698|NCT04484779|Insulin|insulin|mesh-list
55753699|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
55753701|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55753702|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753703|NCT02477501|Norepinephrine|norepinephrine|mesh-list
55753704|NCT02477501|Ephedrine|ephedrine|mesh-list
55753705|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55753706|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55753707|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
55753708|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753709|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753710|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753711|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
55753712|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
55753713|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753714|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55753715|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55753716|NCT02446795|Sunitinib|sunitinib|mesh-list
55753717|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753718|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55753719|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55753720|NCT02446795|Growth Substances|growth substances|mesh-ancestor
55753721|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753722|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
55753723|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55753724|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753725|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753726|NCT02477267|Buprenorphine|buprenorphine|mesh-list
55753731|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753732|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753733|NCT02477267|Analgesics|analgesics|mesh-ancestor
55753734|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
55753735|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753736|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55753737|NCT03196843|Raltitrexed|raltitrexed|mesh-list
55753738|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55753739|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
55753740|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753741|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753742|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55753743|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753744|NCT02476955|Paclitaxel|paclitaxel|mesh-list
55753745|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55753746|NCT02476955|Carboplatin|carboplatin|mesh-list
55753747|NCT02476955|Anastrozole|anastrozole|mesh-list
55753748|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55753749|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753750|NCT02476955|Tubulin Modulators|tubulin modulators|mesh-ancestor
55753751|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
55753752|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
55753753|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753754|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55753755|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55753756|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55753757|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753758|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55753759|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
55753760|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753761|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753762|NCT02634801|Methotrexate|methotrexate|mesh-list
55753763|NCT02634801|Ixekizumab|ixekizumab|mesh-list
55753764|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55753765|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
55753766|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55753767|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753768|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55753769|NCT02634801|Antimetabolites|antimetabolites|mesh-ancestor
55753770|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753771|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753772|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
55753773|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753774|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55753775|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55753776|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
55753777|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753778|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55753780|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
55753781|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
55753782|NCT03196531|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55753784|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55753785|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
55753786|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
55753787|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753788|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753789|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753791|NCT02476799|Fentanyl|fentanyl|mesh-list
55753792|NCT02476799|Ropivacaine|ropivacaine|mesh-list
55753793|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
55753794|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
55753795|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753796|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753797|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
55753798|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753799|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55753800|NCT02476799|Narcotics|narcotics|mesh-ancestor
55753801|NCT02476799|Analgesics|analgesics|mesh-ancestor
55753802|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55753803|NCT02476799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55753804|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
55753805|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55753806|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55753807|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753808|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753809|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55753810|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753811|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753812|NCT02449369|Acetaminophen|acetaminophen|mesh-list
55753814|NCT02449369|Hydromorphone|hydromorphone|mesh-list
55753815|NCT02449369|Orphenadrine|orphenadrine|mesh-list
55753816|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55753817|NCT02449369|Analgesics|analgesics|mesh-ancestor
55753818|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
55753819|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753820|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753821|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
55753822|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55753823|NCT02449369|Narcotics|narcotics|mesh-ancestor
55753824|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753825|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55753826|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55780748|NCT00867191|Desloratadine|desloratadine|mesh-list
55753827|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55753828|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55753829|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
55753830|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
55753831|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55753832|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55753833|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
55753834|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753835|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753836|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
55753837|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55753841|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55753842|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753843|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55753844|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753845|NCT03192943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753847|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55753848|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55753849|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753850|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
55753851|NCT04986813|Coagulants|coagulants|mesh-ancestor
55753852|NCT04986735|Empagliflozin|empagliflozin|mesh-list
55753853|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55753854|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753855|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55753856|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753857|NCT02475863|Warfarin|warfarin|mesh-list
55753858|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
55753859|NCT03071055|Ranibizumab|ranibizumab|mesh-list
55753860|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55753861|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55753862|NCT03071055|Growth Substances|growth substances|mesh-ancestor
55753863|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753864|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
55753865|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753866|NCT04433559|Tadalafil|tadalafil|mesh-list
55753867|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
55753868|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55753869|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55753870|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753871|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753872|NCT04433559|Urological Agents|urological agents|mesh-ancestor
55753874|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753875|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55753876|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753877|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753878|NCT03070665|Norepinephrine|norepinephrine|mesh-list
55753879|NCT03070665|Ephedrine|ephedrine|mesh-list
55753880|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55753881|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55753882|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
55753883|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753884|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753885|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753886|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
55753887|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
55780781|NCT02375191|Fentanyl|fentanyl|mesh-list
55753888|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753889|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55753890|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55753892|NCT04891809|Lenalidomide|lenalidomide|mesh-list
55753893|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753894|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
55753895|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
55753896|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753898|NCT04891809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55753899|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
55753900|NCT04891809|Hormones|hormones|mesh-ancestor
55753901|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753902|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55753903|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753904|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
55753905|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55753906|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55753907|NCT04891809|Growth Substances|growth substances|mesh-ancestor
55753908|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
55753909|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55753910|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55753911|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55753912|NCT02475161|Rabeprazole|rabeprazole|mesh-list
55753913|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55753914|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55753915|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55753916|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753917|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753921|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55753922|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753923|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
55753924|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753925|NCT04433481|Dabigatran|dabigatran|mesh-list
55753926|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
55753927|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55753928|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
55753929|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753930|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753931|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
55753932|NCT04860635|Celecoxib|celecoxib|mesh-list
55753933|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55753934|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55753935|NCT04860635|Analgesics|analgesics|mesh-ancestor
55753936|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
55753937|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55753938|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753939|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753940|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753941|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55753942|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55753943|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55780793|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55753944|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753945|NCT04988607|Bevacizumab|bevacizumab|mesh-list
55753946|NCT04988607|Osimertinib|osimertinib|mesh-list
55753947|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55753948|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753949|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55753950|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55753951|NCT04988607|Growth Substances|growth substances|mesh-ancestor
55753952|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753953|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
55753954|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55753955|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753956|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753958|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55753959|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55753960|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55753961|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753962|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55753963|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55753964|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55753965|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753966|NCT03070509|Dopamine Agents|dopamine agents|mesh-ancestor
55753967|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55753968|NCT05322473|Adalimumab|adalimumab|mesh-list
55753969|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55753970|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55753971|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
55753972|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
55753973|NCT02472275|Hormones|hormones|mesh-list
55753974|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55753975|NCT02472275|Androgens|androgens|mesh-list
55753976|NCT02472275|Androgen Antagonists|androgen antagonists|mesh-list
55753977|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55753978|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55753980|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753981|NCT02472275|Protective Agents|protective agents|mesh-ancestor
55753982|NCT02472275|Vitamins|vitamins|mesh-ancestor
55753983|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
55753984|NCT02472275|Estrogens|estrogens|mesh-ancestor
55753985|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55753986|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55753987|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
55753988|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
55753990|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
55753991|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55753992|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55753993|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55753994|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55753995|NCT04491773|Urological Agents|urological agents|mesh-ancestor
55753996|NCT03070353|Dextrans|dextrans|mesh-list
55754001|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55754002|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55754003|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
55754004|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754005|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55754006|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55754007|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754008|NCT02471963|Empagliflozin|empagliflozin|mesh-list
55780810|NCT03100877|Mitogens|mitogens|mesh-list
55754010|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754011|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55754012|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754013|NCT01375751|Evolocumab|evolocumab|mesh-list
55754014|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55754015|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55754016|NCT01375751|Antimetabolites|antimetabolites|mesh-ancestor
55789045|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55754017|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754018|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55754019|NCT05249621|Mannitol|mannitol|mesh-list
55754020|NCT05249621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55754022|NCT05249621|Natriuretic Agents|natriuretic agents|mesh-ancestor
55754023|NCT05249621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754024|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55754025|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55754026|NCT00705575|Diuretics|diuretics|mesh-ancestor
55754027|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
55754028|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754029|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55754030|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55754031|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754032|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55754033|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55754034|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55754035|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55754036|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754037|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754038|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754039|NCT03068247|Analgesics|analgesics|mesh-ancestor
55754040|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
55754041|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754042|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
55754043|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55754044|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
55754045|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55754047|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55754049|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754050|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
55754051|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55754052|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754053|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55754054|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55754055|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754056|NCT04450953|Eplerenone|eplerenone|mesh-list
55754057|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55754058|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
55754059|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55754060|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754061|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55754062|NCT04450953|Diuretics|diuretics|mesh-ancestor
55754063|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
55754064|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55754068|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55754069|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55754070|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55754071|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55754072|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55754073|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754074|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754075|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
55754076|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754077|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55754078|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55754079|NCT02474225|Bevacizumab|bevacizumab|mesh-list
55754080|NCT02474225|Ranibizumab|ranibizumab|mesh-list
55754081|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
55754082|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55754083|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754084|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55754085|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55754086|NCT02474225|Growth Substances|growth substances|mesh-ancestor
55754087|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754088|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
55754089|NCT04521413|Pembrolizumab|pembrolizumab|mesh-list
55754090|NCT04521413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55754092|NCT04448873|Sirolimus|sirolimus|mesh-list
55754093|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55754094|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754095|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55754096|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754097|NCT04448873|Antifungal Agents|antifungal agents|mesh-ancestor
55754098|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55754099|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
55754100|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754101|NCT04430855|Upadacitinib|upadacitinib|mesh-list
55754102|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
55754103|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55754104|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754105|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754106|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55754107|NCT02471105|Bimatoprost|bimatoprost|mesh-list
55754108|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55754109|NCT03108989|Neostigmine|neostigmine|mesh-list
55754110|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55754111|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754112|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754113|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
55754114|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754115|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754116|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55754117|NCT03108989|Autonomic Agents|autonomic agents|mesh-ancestor
55754118|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754120|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55754121|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55754122|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55754130|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
55754131|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754132|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55754133|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55754135|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55754136|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754137|NCT02470559|Aldesleukin|aldesleukin|mesh-list
55754138|NCT02470559|Interleukin-2|interleukin-2|mesh-list
55754139|NCT02470559|Sargramostim|sargramostim|mesh-list
55754140|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55754141|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754142|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55754143|NCT02470559|Analgesics|analgesics|mesh-ancestor
55754144|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
55754145|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754146|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754147|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
55754148|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55754149|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55754150|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
55754151|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754152|NCT05083481|Pembrolizumab|pembrolizumab|mesh-list
55754153|NCT05083481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55754154|NCT05083481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754155|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
55754156|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
55754157|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754158|NCT02470637|Insulin|insulin|mesh-list
55754159|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55754160|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
55754161|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55754162|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754163|NCT04220021|Metformin|metformin|mesh-list
55754164|NCT04220021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55754165|NCT04220021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754166|NCT03994601|Nivolumab|nivolumab|mesh-list
55754168|NCT03994601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754169|NCT03994601|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55754170|NCT03994601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754171|NCT03652961|Abatacept|abatacept|mesh-list
55754172|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55754173|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754174|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754175|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55754176|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
55754177|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754178|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55754179|NCT03948347|Liraglutide|liraglutide|mesh-list
55754180|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55754181|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754183|NCT03948347|Hormones|hormones|mesh-ancestor
55754184|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55754185|NCT03899987|Aspirin|aspirin|mesh-list
55754186|NCT03899987|Interferons|interferons|mesh-list
55754187|NCT03899987|Interferon-alpha|interferon-alpha|mesh-list
55754188|NCT03899987|Interferon alpha-2|interferon alpha-2|mesh-list
55754189|NCT03899987|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
55754190|NCT03899987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754191|NCT03899987|Antiviral Agents|antiviral agents|mesh-ancestor
55754192|NCT03899987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754193|NCT03899987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55754194|NCT03899987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55754195|NCT03899987|Analgesics|analgesics|mesh-ancestor
55754196|NCT03899987|Sensory System Agents|sensory system agents|mesh-ancestor
55780841|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55754197|NCT03899987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754198|NCT03899987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754199|NCT03899987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55754200|NCT03899987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55754201|NCT03899987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55754202|NCT03899987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55754203|NCT03899987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754204|NCT03899987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55754206|NCT03899987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754207|NCT03899987|Antipyretics|antipyretics|mesh-ancestor
55754208|NCT03899987|Immunologic Factors|immunologic factors|mesh-ancestor
55754209|NCT03478865|Vitamin A|vitamin a|mesh-list
55754210|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
55754211|NCT03478865|Vitamins|vitamins|mesh-ancestor
55754212|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
55754213|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754214|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
55754215|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754216|NCT03478865|Protective Agents|protective agents|mesh-ancestor
55754217|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55754218|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754220|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55754222|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754223|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55754224|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754225|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754226|NCT00705341|Fluticasone|fluticasone|mesh-list
55754227|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55754228|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55754229|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
55754230|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754231|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754232|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55754233|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
55754234|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
55754235|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55754236|NCT03847649|Prednisone|prednisone|mesh-list
55754237|NCT03847649|Durvalumab|durvalumab|mesh-list
55754238|NCT03847649|Tremelimumab|tremelimumab|mesh-list
55754239|NCT03847649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55754240|NCT03847649|Glucocorticoids|glucocorticoids|mesh-ancestor
55754241|NCT03847649|Hormones|hormones|mesh-ancestor
55754402|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
55754242|NCT03847649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55754243|NCT03847649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754244|NCT03847649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55754245|NCT03847649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754246|NCT03847649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55754248|NCT03193931|Methotrexate|methotrexate|mesh-list
55754249|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55754251|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55754253|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55754254|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754255|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55754256|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
55754257|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754258|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
55754259|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754260|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55754261|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55754262|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
55754263|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55754264|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55754265|NCT00705263|Ribavirin|ribavirin|mesh-list
55754266|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55754267|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
55754268|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754269|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
55754270|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754271|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
55754272|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55754273|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55754274|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754275|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
55754276|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
55754277|NCT02215265|Cisplatin|cisplatin|mesh-list
55754278|NCT02215265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754279|NCT00704405|Interferons|interferons|mesh-list
55754280|NCT00704405|Ribavirin|ribavirin|mesh-list
55754281|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754282|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
55754283|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754284|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
55754285|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754286|NCT01470755|Albuterol|albuterol|mesh-list
55754287|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55754288|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
55754289|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754290|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754291|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55754292|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
55754293|NCT01470755|Tocolytic Agents|tocolytic agents|mesh-ancestor
55754294|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55754295|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55754296|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55754297|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55754298|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
55754299|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754300|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754303|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754304|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
55754305|NCT03309527|Promethazine|promethazine|mesh-list
55754306|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55754307|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55754308|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754309|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754310|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
55754311|NCT03309527|Anesthetics|anesthetics|mesh-ancestor
55754312|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
55754313|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754314|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
55754315|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
55754316|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55754317|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55754318|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
55754319|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
55754320|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754479|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55754321|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754322|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55754323|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
55754324|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
55754325|NCT03313661|Gliclazide|gliclazide|mesh-list
55754326|NCT03313661|Cabergoline|cabergoline|mesh-list
55754327|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55754328|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55754329|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
55754330|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
55754331|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754332|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754333|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754334|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55754335|NCT00703781|Bromfenac|bromfenac|mesh-list
55754336|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55754337|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55754338|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55754339|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55754340|NCT00703781|Analgesics|analgesics|mesh-ancestor
55754341|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
55754342|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754343|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754344|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55754345|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55754347|NCT03309215|Trace Elements|trace elements|mesh-ancestor
55754348|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
55754349|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754351|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
55754352|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
55754353|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55754354|NCT03309059|Protective Agents|protective agents|mesh-ancestor
55754355|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754356|NCT02469545|Citalopram|citalopram|mesh-list
55754357|NCT02469545|Sertraline|sertraline|mesh-list
55754358|NCT02469545|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55754359|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55754360|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55754361|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754362|NCT02469545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754364|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754365|NCT02469545|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55754366|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
55754367|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55754369|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
55754370|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55754371|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55754373|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55754374|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55754375|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754376|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
55754378|NCT03308201|Fulvestrant|fulvestrant|mesh-list
55754379|NCT03308201|Exemestane|exemestane|mesh-list
55754380|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754381|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55754382|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55754383|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754384|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754385|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55754386|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
55754387|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55754388|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754389|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55754390|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55754392|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55754393|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754394|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754395|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55754397|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
55780879|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55754398|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754399|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55754400|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55754401|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55754403|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754404|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754406|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
55754407|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55754408|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55754409|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55754410|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754411|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754412|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
55754413|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
55754414|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754415|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754416|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55754417|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55754419|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55754420|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55754421|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55754422|NCT02722967|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55754423|NCT04442633|Miconazole|miconazole|mesh-list
55754424|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
55754425|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754426|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55754427|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55754428|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754429|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754430|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55754431|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
55754432|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55754433|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754434|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55754435|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55754436|NCT03312335|Aldesleukin|aldesleukin|mesh-list
55754437|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754438|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55754439|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55754440|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
55754441|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754442|NCT03312179|Incretins|incretins|mesh-list
55754443|NCT03312179|Hormones|hormones|mesh-ancestor
55754444|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55754445|NCT03312179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754446|NCT02468531|Xenon|xenon|mesh-list
55754447|NCT02468531|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55754448|NCT02468531|Anesthetics, General|anesthetics, general|mesh-ancestor
55754449|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
55754450|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754451|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754452|NCT03311945|Lamivudine|lamivudine|mesh-list
55754453|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
55754454|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55754455|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55754456|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754457|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754458|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
55754459|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754460|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55754461|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55754463|NCT03311945|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55754464|NCT03311789|Gemcitabine|gemcitabine|mesh-list
55754465|NCT03311789|Nivolumab|nivolumab|mesh-list
55754466|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55754467|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754468|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55754469|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
55789047|NCT04927481|Analgesics|analgesics|mesh-ancestor
55754470|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754472|NCT03311789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754473|NCT03311789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754474|NCT03311789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55754475|NCT03311789|Immunologic Factors|immunologic factors|mesh-ancestor
55754476|NCT03311789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754477|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55754478|NCT02468999|Insulin|insulin|mesh-list
55754481|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754484|NCT03311321|Vitamin MK 7|vitamin mk 7|mesh-list
55754485|NCT03311321|Vitamins|vitamins|mesh-ancestor
55754486|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
55754487|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754488|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55754489|NCT03311321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55754490|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754491|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
55754492|NCT03311321|Coagulants|coagulants|mesh-ancestor
55754493|NCT02468297|Ibuprofen|ibuprofen|mesh-list
55754494|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55754495|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55754496|NCT02468297|Analgesics|analgesics|mesh-ancestor
55754497|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
55754498|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754499|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754500|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55754501|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55754502|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55754503|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754504|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754505|NCT02468375|Mirabegron|mirabegron|mesh-list
55754506|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55754507|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55754508|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55754509|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
55754510|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754511|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754513|NCT02468375|Urological Agents|urological agents|mesh-ancestor
55754514|NCT03304457|Olanzapine|olanzapine|mesh-list
55754515|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55754516|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
55754517|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
55754518|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754519|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754520|NCT03304457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55754521|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55754522|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55754523|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754524|NCT03304457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55754525|NCT03304457|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55754526|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55754527|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55754528|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754529|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754530|NCT03304457|Serotonin Agents|serotonin agents|mesh-ancestor
55754531|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55754532|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55754533|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55754534|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
55754535|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55754536|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55754537|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55754538|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55754539|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
55754540|NCT04490837|Antibodies|antibodies|mesh-list
55754542|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754544|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
55754545|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
55754546|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754547|NCT03303677|Vancomycin|vancomycin|mesh-list
55754548|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
55754549|NCT03303677|Gentamicins|gentamicins|mesh-list
55754550|NCT03303677|Mupirocin|mupirocin|mesh-list
55754551|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55754552|NCT03303677|Trimethoprim|trimethoprim|mesh-list
55754553|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
55754554|NCT03303677|Budesonide|budesonide|mesh-list
55754555|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55754556|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55754557|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
55754558|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754559|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754560|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55754561|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
55754565|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754566|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55754567|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55754568|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754569|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754570|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754571|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55754572|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55754573|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55754574|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55754575|NCT03303677|Renal Agents|renal agents|mesh-ancestor
55754576|NCT03303677|Antimalarials|antimalarials|mesh-ancestor
55754577|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55754578|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55754579|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55754580|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55754581|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55754582|NCT02468063|Terlipressin|terlipressin|mesh-list
55754583|NCT02468063|Norepinephrine|norepinephrine|mesh-list
55754584|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55754585|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55754586|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55754592|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
55754593|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
55754596|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55754597|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754598|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55754599|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754600|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
55754601|NCT03303209|Narcotics|narcotics|mesh-ancestor
55754617|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55754618|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55754619|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
55754620|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754621|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55754622|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
55754623|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
55754625|NCT02467907|Bevacizumab|bevacizumab|mesh-list
55754626|NCT02467907|Carboplatin|carboplatin|mesh-list
55754627|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55754628|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754629|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
55754630|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
55754631|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
55754632|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754633|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55754635|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55754636|NCT02467907|Growth Substances|growth substances|mesh-ancestor
55754637|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754638|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
55754639|NCT02467127|Vitamin D|vitamin d|mesh-list
55754640|NCT02467127|Vitamins|vitamins|mesh-ancestor
55754641|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
55754642|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754643|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55754644|NCT03302585|Vitamin D|vitamin d|mesh-list
55754645|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
55754646|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
55754647|NCT03302585|Vitamins|vitamins|mesh-list
55754649|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754650|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55754651|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55754653|NCT05727761|Pioglitazone|pioglitazone|mesh-list
55754654|NCT05727761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55754655|NCT05727761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754656|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
55754657|NCT03302351|Ketamine|ketamine|mesh-list
55754658|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55754659|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754660|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754661|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55754662|NCT03302351|Analgesics|analgesics|mesh-ancestor
55754663|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
55754664|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754665|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55754666|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55754667|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55754668|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
55754669|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754670|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754672|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55754673|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
55754674|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
55754675|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55754676|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55754677|NCT05727683|Cyclophosphamide|cyclophosphamide|mesh-list
55754678|NCT05727683|Fludarabine|fludarabine|mesh-list
55754679|NCT05727683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55754680|NCT05727683|Immunologic Factors|immunologic factors|mesh-ancestor
55754681|NCT05727683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754682|NCT05727683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55754683|NCT05727683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55754684|NCT05727683|Alkylating Agents|alkylating agents|mesh-ancestor
55754685|NCT05727683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754686|NCT05727683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754687|NCT05727683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55754689|NCT05727371|Viscosupplements|viscosupplements|mesh-ancestor
55754691|NCT05727371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754693|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
55754694|NCT03302039|Bupivacaine|bupivacaine|mesh-list
55754695|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
55754696|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
55754697|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754698|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754699|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
55754700|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754701|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55754702|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
55754703|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
55754704|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
55754705|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55754706|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
55754707|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
55754708|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55754709|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55754710|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55754711|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
55754718|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754719|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754720|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754721|NCT02466503|Fluticasone|fluticasone|mesh-list
55754723|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55754724|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55754725|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55754726|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
55754727|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754728|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754729|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55780919|NCT02368795|Diuretics|diuretics|mesh-ancestor
55754730|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
55754731|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
55754732|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55754733|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55754734|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55754735|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55754736|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
55754737|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754738|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754741|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
55754742|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
55754743|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754744|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55754745|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55754746|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754747|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754748|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55754749|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
55754750|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55754751|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754752|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55754753|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55754754|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
55754755|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55754756|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
55754757|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55754758|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55754759|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55754760|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55754761|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55754762|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55754763|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55754764|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754765|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55754766|NCT00702221|Vaccines|vaccines|mesh-list
55754767|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
55754768|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754769|NCT03301025|Pregabalin|pregabalin|mesh-list
55754770|NCT03301025|Analgesics|analgesics|mesh-ancestor
55754771|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
55754772|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754773|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754774|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
55754775|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55754776|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55754777|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754778|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55754779|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55754780|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55754781|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754782|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55754783|NCT05726903|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55754784|NCT05726903|Medroxyprogesterone|medroxyprogesterone|mesh-list
55754785|NCT05726903|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55754786|NCT05726903|Contraceptive Agents|contraceptive agents|mesh-ancestor
55754787|NCT05726903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55754788|NCT05726903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754789|NCT05726903|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55754790|NCT05726903|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55754791|NCT05726903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55754792|NCT05726903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754793|NCT05726903|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55754794|NCT05726903|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55754795|NCT05726903|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55754797|NCT02467595|Bromides|bromides|mesh-list
55754798|NCT02467595|Propofol|propofol|mesh-list
55754799|NCT02467595|Sevoflurane|sevoflurane|mesh-list
55754800|NCT02467595|Rocuronium|rocuronium|mesh-list
55754801|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55754802|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754803|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754804|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55754805|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
55754806|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
55754807|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55754808|NCT02467595|Narcotics|narcotics|mesh-ancestor
55754809|NCT02467595|Analgesics|analgesics|mesh-ancestor
55754810|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
55754811|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754812|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55754813|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55754814|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55754816|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55754817|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55754818|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55754820|NCT02467517|Ketamine|ketamine|mesh-list
55754821|NCT02467517|Analgesics|analgesics|mesh-ancestor
55754822|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
55754823|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754824|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754825|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55754826|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55754827|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
55754828|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
55754829|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754830|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55754831|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55754832|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754833|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754834|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55754835|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
55754836|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55754837|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55754838|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55754839|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
55754840|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55754841|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55754842|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55754843|NCT02467673|Estradiol|estradiol|mesh-list
55754844|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55754845|NCT02467673|Progesterone|progesterone|mesh-list
55754846|NCT02467673|Estrogens|estrogens|mesh-ancestor
55754847|NCT02467673|Hormones|hormones|mesh-ancestor
55754848|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55754849|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754850|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55754851|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
55754852|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55754853|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55754855|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55754856|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
55754857|NCT02953145|Coagulants|coagulants|mesh-ancestor
55754858|NCT03300089|Anesthetics|anesthetics|mesh-list
55754859|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754860|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754861|NCT02634333|Aflibercept|aflibercept|mesh-list
55754862|NCT02634333|Endothelial Growth Factors|endothelial growth factors|mesh-list
55754863|NCT02634333|Mitogens|mitogens|mesh-list
55754864|NCT02634333|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55754865|NCT02634333|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55754866|NCT02634333|Growth Substances|growth substances|mesh-ancestor
55754867|NCT02634333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754868|NCT02634333|Growth Inhibitors|growth inhibitors|mesh-ancestor
55754869|NCT02634333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754870|NCT02634333|Mitosis Modulators|mitosis modulators|mesh-ancestor
55754871|NCT02634333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754872|NCT05725031|Ephedrine|ephedrine|mesh-list
55754873|NCT05725031|Rocuronium|rocuronium|mesh-list
55754874|NCT05725031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55754875|NCT05725031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55754876|NCT05725031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55754877|NCT05725031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754878|NCT05725031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754879|NCT05725031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55754880|NCT05725031|Sympathomimetics|sympathomimetics|mesh-ancestor
55754881|NCT05725031|Autonomic Agents|autonomic agents|mesh-ancestor
55754882|NCT05725031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55754883|NCT05725031|Adrenergic Agents|adrenergic agents|mesh-ancestor
55754884|NCT05725031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55754885|NCT05725031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754886|NCT04983615|Fentanyl|fentanyl|mesh-list
55754887|NCT04983615|Midazolam|midazolam|mesh-list
55754888|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55754889|NCT04983615|Narcotics|narcotics|mesh-ancestor
55754890|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55754891|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754892|NCT04983615|Analgesics|analgesics|mesh-ancestor
55754893|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
55754894|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754895|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55754896|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55754897|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
55754898|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
55754899|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55754900|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55754901|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55754903|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
55754904|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
55754905|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755140|NCT05546411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754906|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754907|NCT00702923|Tremelimumab|tremelimumab|mesh-list
55754908|NCT00702923|Bicalutamide|bicalutamide|mesh-list
55754909|NCT00702923|Ipilimumab|ipilimumab|mesh-list
55754910|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55754911|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55780962|NCT05035277|Aspirin|aspirin|mesh-list
55754912|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
55754913|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754914|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
55754915|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
55754916|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55754917|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55754918|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55754919|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754921|NCT05294055|Etoposide|etoposide|mesh-list
55754922|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55754923|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
55754924|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754925|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55754926|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55754927|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
55754928|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754929|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754930|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55754931|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55754932|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55754933|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55754934|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754935|NCT04975919|Decitabine|decitabine|mesh-list
55754936|NCT04975919|Venetoclax|venetoclax|mesh-list
55754937|NCT04975919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55754938|NCT04975919|Antimetabolites|antimetabolites|mesh-ancestor
55754939|NCT04975919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754940|NCT04975919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754941|NCT04975919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754942|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
55754943|NCT03103971|Fludarabine|fludarabine|mesh-list
55754944|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55754945|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
55754946|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754947|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55754948|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55754949|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
55754950|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754951|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754952|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55754955|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55754956|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55754957|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55754958|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754959|NCT03299387|Gentamicins|gentamicins|mesh-list
55754960|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
55754961|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55754962|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754963|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55754964|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754965|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754966|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55754968|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
55754969|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55754970|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754971|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
55754972|NCT02658981|Nivolumab|nivolumab|mesh-list
55754973|NCT02658981|Antibodies|antibodies|mesh-list
55754974|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55754975|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
55754976|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55754977|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55754978|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55754979|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55754980|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754981|NCT04982913|Oseltamivir|oseltamivir|mesh-list
55754982|NCT04982913|Antiviral Agents|antiviral agents|mesh-ancestor
55754983|NCT04982913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55754984|NCT04982913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55754985|NCT04982913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754986|NCT05635929|Betaine|betaine|mesh-list
55754987|NCT05635929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55754988|NCT05635929|Lipotropic Agents|lipotropic agents|mesh-ancestor
55754989|NCT05635929|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55754990|NCT05635929|Antimetabolites|antimetabolites|mesh-ancestor
55754991|NCT05635929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55754992|NCT05635929|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55754993|NCT05635851|Nitroglycerin|nitroglycerin|mesh-list
55754994|NCT05635851|Vasodilator Agents|vasodilator agents|mesh-ancestor
55754995|NCT04794699|Gemcitabine|gemcitabine|mesh-list
55754996|NCT04794699|Paclitaxel|paclitaxel|mesh-list
55754997|NCT04794699|Docetaxel|docetaxel|mesh-list
55754998|NCT04794699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55754999|NCT04794699|Pemetrexed|pemetrexed|mesh-list
55755000|NCT04794699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55755001|NCT04794699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755003|NCT04794699|Antimitotic Agents|antimitotic agents|mesh-ancestor
55755004|NCT04794699|Mitosis Modulators|mitosis modulators|mesh-ancestor
55755005|NCT04794699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755006|NCT04794699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55755007|NCT04794699|Antimetabolites|antimetabolites|mesh-ancestor
55755008|NCT04794699|Antiviral Agents|antiviral agents|mesh-ancestor
55755009|NCT04794699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755010|NCT04794699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755011|NCT04794699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55755012|NCT04794699|Immunologic Factors|immunologic factors|mesh-ancestor
55755013|NCT04794699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755014|NCT04794699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55755015|NCT04794699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55755017|NCT04782687|Lenalidomide|lenalidomide|mesh-list
55755018|NCT04782687|Daratumumab|daratumumab|mesh-list
55755019|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55755020|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
55755021|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
55755022|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755023|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755024|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55755025|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
55755026|NCT04782687|Hormones|hormones|mesh-ancestor
55755027|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55755028|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55755029|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755030|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
55755031|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55755032|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55755033|NCT04782687|Growth Substances|growth substances|mesh-ancestor
55755034|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
55755035|NCT05655689|Moxifloxacin|moxifloxacin|mesh-list
55755037|NCT05655689|Gentamicins|gentamicins|mesh-list
55755038|NCT05655689|Ceftazidime|ceftazidime|mesh-list
55755040|NCT05655689|Voriconazole|voriconazole|mesh-list
55755041|NCT05655689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55755042|NCT05655689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55755043|NCT05655689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55755044|NCT05655689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755045|NCT05655689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55755046|NCT05655689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55755047|NCT05655689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755048|NCT05655689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755049|NCT05655689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755050|NCT05655689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755051|NCT05655689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55755052|NCT05655689|Antifungal Agents|antifungal agents|mesh-ancestor
55755053|NCT05655689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55755054|NCT05655689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55755055|NCT05655689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55755056|NCT05655689|Hormone Antagonists|hormone antagonists|mesh-ancestor
55755057|NCT05655689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55755058|NCT05655689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55755059|NCT05655689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55755060|NCT02466347|Fluticasone|fluticasone|mesh-list
55755061|NCT02466347|Xhance|xhance|mesh-list
55755062|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55755063|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55755064|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55755065|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
55755067|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755068|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55755069|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
55755070|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
55755071|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55755072|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55755073|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55755074|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55755075|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
55755076|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755077|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755078|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
55755079|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755080|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755081|NCT02466191|Gabapentin|gabapentin|mesh-list
55755082|NCT02466191|Memantine|memantine|mesh-list
55755083|NCT02466191|Analgesics|analgesics|mesh-ancestor
55755084|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
55755085|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755086|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755087|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
55755088|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55780998|NCT04095845|Tacrine|tacrine|mesh-list
55755089|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55755090|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755091|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55755092|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55755093|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55755095|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755096|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
55755097|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55755098|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55755099|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
55755100|NCT05555069|Menthol|menthol|mesh-list
55755101|NCT05555069|Antipruritics|antipruritics|mesh-ancestor
55755102|NCT05555069|Dermatologic Agents|dermatologic agents|mesh-ancestor
55755103|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
55755104|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
55755105|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755106|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
55755107|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755108|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755109|NCT03069339|Carvedilol|carvedilol|mesh-list
55755110|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55755111|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55755112|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
55755113|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755114|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755115|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755116|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55755117|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
55755118|NCT03069339|Protective Agents|protective agents|mesh-ancestor
55755119|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55755120|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755121|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55755122|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
55755123|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55755124|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55755125|NCT05546411|Leucovorin|leucovorin|mesh-list
55755126|NCT05546411|Fluorouracil|fluorouracil|mesh-list
55755127|NCT05546411|Oxaliplatin|oxaliplatin|mesh-list
55755128|NCT05546411|Irinotecan|irinotecan|mesh-list
55755129|NCT05546411|Camptothecin|camptothecin|mesh-list
55755130|NCT05546411|Levoleucovorin|levoleucovorin|mesh-list
55755131|NCT05546411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755132|NCT05546411|Antimetabolites|antimetabolites|mesh-ancestor
55755133|NCT05546411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755134|NCT05546411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55755135|NCT05546411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755136|NCT05546411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55755137|NCT05546411|Immunologic Factors|immunologic factors|mesh-ancestor
55755138|NCT05546411|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55755139|NCT05546411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55755146|NCT05546411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55755147|NCT05542589|Phenytoin|phenytoin|mesh-list
55755148|NCT05542589|Anticonvulsants|anticonvulsants|mesh-ancestor
55755149|NCT05542589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55755150|NCT05542589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55755151|NCT05542589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755152|NCT05542589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755153|NCT05542589|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55755154|NCT05542589|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55755156|NCT03069027|Epinephrine|epinephrine|mesh-list
55755158|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
55755159|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
55755161|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755162|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755163|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
55755164|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755165|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55755166|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55755167|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55755168|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755169|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755170|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55755171|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55755172|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
55755173|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755174|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55755175|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55755176|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
55755177|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55755178|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
55755179|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
55755180|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
55755181|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55755182|NCT05635071|Nintedanib|nintedanib|mesh-list
55755183|NCT05635071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755184|NCT05635071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55755185|NCT05635071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755186|NCT05635071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755187|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55755188|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755189|NCT02720081|Albuterol|albuterol|mesh-list
55755190|NCT02720081|Montelukast|montelukast|mesh-list
55755191|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55755192|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
55755193|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55755194|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
55755195|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55755197|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55755198|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55755199|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755200|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55755201|NCT02720081|Autonomic Agents|autonomic agents|mesh-ancestor
55755202|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755203|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
55755204|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55755205|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55755206|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55755207|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55755208|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
55755221|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55755222|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755223|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755224|NCT05634759|Azithromycin|azithromycin|mesh-list
55755225|NCT05634759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55755226|NCT05634759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755227|NCT04809233|Tipifarnib|tipifarnib|mesh-list
55755228|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755229|NCT02310269|Pasireotide|pasireotide|mesh-list
55755230|NCT02310269|Hormones|hormones|mesh-ancestor
55755231|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55755232|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755234|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
55755235|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
55755236|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755237|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755238|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
55755239|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755240|NCT05634525|Adagrasib|adagrasib|mesh-list
55755241|NCT05634525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755242|NCT04489745|Androgens|androgens|mesh-list
55755243|NCT04489745|Hormones|hormones|mesh-ancestor
55755244|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55755245|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755246|NCT04419519|Venetoclax|venetoclax|mesh-list
55755247|NCT04419519|Antibodies|antibodies|mesh-list
55755248|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55755249|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
55755250|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755251|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755252|NCT02464865|Thiamine|thiamine|mesh-list
55755253|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
55755254|NCT02464865|Vitamins|vitamins|mesh-ancestor
55755255|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
55755256|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755257|NCT02466035|Caseins|caseins|mesh-list
55755258|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
55755259|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
55755260|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755261|NCT05173337|Nefopam|nefopam|mesh-list
55755262|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55755263|NCT05173337|Analgesics|analgesics|mesh-ancestor
55755264|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
55755265|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755266|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755267|NCT02464631|Ribavirin|ribavirin|mesh-list
55755268|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
55755269|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
55755270|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755272|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755274|NCT04880577|Rituximab|rituximab|mesh-list
55755275|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
55755276|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755277|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755278|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
55755279|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755280|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55755281|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
55755282|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755283|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55755284|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55755285|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755286|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755287|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55755288|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55755289|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55755290|NCT04490213|Laxatives|laxatives|mesh-ancestor
55755291|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55755293|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55755294|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755295|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
55755296|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755297|NCT04562597|Expectorants|expectorants|mesh-ancestor
55755298|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
55755299|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55755300|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
55755301|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755302|NCT04562597|Protective Agents|protective agents|mesh-ancestor
55755303|NCT04562597|Antidotes|antidotes|mesh-ancestor
55755304|NCT04562129|Aldesleukin|aldesleukin|mesh-list
55755305|NCT04562129|Nivolumab|nivolumab|mesh-list
55755306|NCT04562129|Ipilimumab|ipilimumab|mesh-list
55755307|NCT04562129|Interleukin-2|interleukin-2|mesh-list
55755308|NCT04562129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755309|NCT04562129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755310|NCT04562129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55755311|NCT04562129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755312|NCT04562129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55755313|NCT04562129|Analgesics|analgesics|mesh-ancestor
55755314|NCT04562129|Sensory System Agents|sensory system agents|mesh-ancestor
55755315|NCT04562129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755316|NCT04562129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755317|NCT04562129|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55755318|NCT04562129|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55755319|NCT04562129|Antiviral Agents|antiviral agents|mesh-ancestor
55755320|NCT04562129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755321|NCT04447911|Empagliflozin|empagliflozin|mesh-list
55755322|NCT04447911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55755323|NCT04447911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755324|NCT04447911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55755325|NCT04447911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755328|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
55755329|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755330|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755331|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55755332|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55755333|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
55755335|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755336|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55755337|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55755338|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755339|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755340|NCT05723367|Anesthetics|anesthetics|mesh-list
55755341|NCT05723367|Anesthetics, Local|anesthetics, local|mesh-list
55755342|NCT05723367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755343|NCT05723367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755344|NCT05723367|Sensory System Agents|sensory system agents|mesh-ancestor
55755345|NCT05723367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755346|NCT03853395|Antibodies|antibodies|mesh-list
55755347|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
55755348|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755349|NCT04433169|Tretinoin|tretinoin|mesh-list
55781049|NCT02374567|S 20098|s 20098|mesh-list
55755350|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755351|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
55755352|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
55755353|NCT05709483|Aspirin|aspirin|mesh-list
55789048|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
55755354|NCT05709483|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55755355|NCT05709483|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55755356|NCT05709483|Analgesics|analgesics|mesh-ancestor
55755357|NCT05709483|Sensory System Agents|sensory system agents|mesh-ancestor
55755358|NCT05709483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755359|NCT05709483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755360|NCT05709483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55755361|NCT05709483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55755362|NCT05709483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55755363|NCT05709483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55755364|NCT05709483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755365|NCT05709483|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55755366|NCT05709483|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55755367|NCT05709483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755368|NCT05709483|Antipyretics|antipyretics|mesh-ancestor
55755370|NCT02717195|Risperidone|risperidone|mesh-list
55755371|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55755372|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
55755373|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755374|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755375|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755376|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55755377|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55755378|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755379|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55755380|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55755381|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
55755382|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
55755383|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
55755384|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755385|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55755386|NCT02717195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55755387|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55755388|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755389|NCT04483505|Fulvestrant|fulvestrant|mesh-list
55755391|NCT04483505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55755392|NCT04483505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755393|NCT04483505|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55755394|NCT04483505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55755395|NCT04483505|Hormone Antagonists|hormone antagonists|mesh-ancestor
55755396|NCT04483505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55755397|NCT04483505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755398|NCT04483505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55755399|NCT04483505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755400|NCT04483505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755401|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
55755402|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
55755403|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755404|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755406|NCT05582811|Enzyme Activators|enzyme activators|mesh-ancestor
55755407|NCT05582811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755408|NCT04424225|Niacin|niacin|mesh-list
55755409|NCT04424225|Psilocybin|psilocybin|mesh-list
55755411|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
55755412|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755413|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
55755414|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55755415|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
55755416|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755417|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55755418|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
55755419|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
55755420|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55755421|NCT05581719|Nivolumab|nivolumab|mesh-list
55755422|NCT05581719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755423|NCT05581719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755424|NCT05581719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55755425|NCT05581719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755426|NCT04397003|Durvalumab|durvalumab|mesh-list
55755427|NCT04397003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755428|NCT04397003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755429|NCT05626101|Gemcitabine|gemcitabine|mesh-list
55755430|NCT05626101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55755431|NCT05626101|Antimetabolites|antimetabolites|mesh-ancestor
55755432|NCT05626101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755433|NCT05626101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755434|NCT05626101|Antiviral Agents|antiviral agents|mesh-ancestor
55755435|NCT05626101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755437|NCT05626101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55755438|NCT05626101|Immunologic Factors|immunologic factors|mesh-ancestor
55755439|NCT05626101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755440|NCT05537883|Bupivacaine|bupivacaine|mesh-list
55755441|NCT05537883|Anesthetics, Local|anesthetics, local|mesh-ancestor
55755443|NCT05537883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755444|NCT05537883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755446|NCT05537883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755447|NCT02465801|Lenograstim|lenograstim|mesh-list
55755448|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55755449|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
55755450|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755452|NCT02465645|Simvastatin|simvastatin|mesh-list
55755453|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55755454|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55755455|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
55755456|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755457|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55755458|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55755459|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755460|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55755461|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55755462|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
55755463|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755464|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755465|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55755466|NCT02465645|Antioxidants|antioxidants|mesh-ancestor
55755467|NCT02465645|Protective Agents|protective agents|mesh-ancestor
55755468|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55755469|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755470|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55755471|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
55755472|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55755473|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55755474|NCT05565495|Hydromorphone|hydromorphone|mesh-list
55755475|NCT05565495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55755476|NCT05565495|Narcotics|narcotics|mesh-ancestor
55755477|NCT05565495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755478|NCT05565495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755480|NCT05565495|Sensory System Agents|sensory system agents|mesh-ancestor
55755481|NCT05565495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755483|NCT04872257|Vitamins|vitamins|mesh-ancestor
55755484|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
55755485|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755486|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55755487|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55755488|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55755489|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55755490|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755491|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755492|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755493|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755494|NCT04970121|Analgesics|analgesics|mesh-ancestor
55755495|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
55755496|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755497|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
55755498|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55755499|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
55755500|NCT01918397|Levofloxacin|levofloxacin|mesh-list
55755501|NCT01918397|Ofloxacin|ofloxacin|mesh-list
55755502|NCT01918397|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55755503|NCT01918397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755504|NCT01918397|Renal Agents|renal agents|mesh-ancestor
55755505|NCT01918397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55755506|NCT01918397|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55755507|NCT01918397|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55755508|NCT01918397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755509|NCT01918397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755510|NCT01918397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755511|NCT01918397|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55755512|NCT01918397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55755513|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
55755514|NCT02463929|Promethazine|promethazine|mesh-list
55755516|NCT02463929|Bupivacaine|bupivacaine|mesh-list
55755517|NCT02463929|Sevoflurane|sevoflurane|mesh-list
55781103|NCT02374567|Mianserin|mianserin|mesh-list
55755518|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
55755520|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755521|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755522|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
55755523|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755524|NCT02463929|Analgesics|analgesics|mesh-ancestor
55755525|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55755526|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55755527|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
55755528|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55755529|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55755530|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755531|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755532|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55755533|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55755534|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55755535|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55755537|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
55755538|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55755539|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55755540|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
55755541|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
55755543|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
55755544|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
55755545|NCT02465255|Acetaminophen|acetaminophen|mesh-list
55755546|NCT02465255|Ketorolac|ketorolac|mesh-list
55755547|NCT02465255|Tramadol|tramadol|mesh-list
55755548|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55755549|NCT02465255|Analgesics|analgesics|mesh-ancestor
55755550|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
55755551|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755552|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755554|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55755555|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55755556|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55755557|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55755558|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755559|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755560|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55755561|NCT02465255|Narcotics|narcotics|mesh-ancestor
55755562|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755563|NCT05533125|Rituximab|rituximab|mesh-list
55755564|NCT05533125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755565|NCT05533125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755566|NCT05533125|Immunologic Factors|immunologic factors|mesh-ancestor
55755567|NCT05533125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755568|NCT05533125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55755569|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55755570|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55755572|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
55755574|NCT02462915|Fentanyl|fentanyl|mesh-list
55755575|NCT02462915|Propofol|propofol|mesh-list
55755577|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
55755578|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
55755579|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755580|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755581|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
55755582|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755583|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55755584|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55755585|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55755586|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755587|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755588|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55755589|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55755591|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55755592|NCT02462915|Narcotics|narcotics|mesh-ancestor
55755593|NCT02462915|Analgesics|analgesics|mesh-ancestor
55755594|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55755595|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55755596|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55755598|NCT02462837|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55755599|NCT02462837|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55755600|NCT02462837|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55755602|NCT02462837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755603|NCT02462837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755604|NCT02462837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755605|NCT02462837|Urological Agents|urological agents|mesh-ancestor
55755606|NCT05505123|Propofol|propofol|mesh-list
55755607|NCT05505123|Sevoflurane|sevoflurane|mesh-list
55755608|NCT05505123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55755609|NCT05505123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755610|NCT05505123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755611|NCT05505123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55755612|NCT05505123|Anesthetics, General|anesthetics, general|mesh-ancestor
55755613|NCT05505123|Anesthetics|anesthetics|mesh-ancestor
55755614|NCT05505123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55755615|NCT05505123|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55755616|NCT03732677|Gemcitabine|gemcitabine|mesh-list
55755617|NCT03732677|Durvalumab|durvalumab|mesh-list
55755618|NCT03732677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755619|NCT03732677|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55755620|NCT03732677|Antimetabolites|antimetabolites|mesh-ancestor
55755621|NCT03732677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755622|NCT03732677|Antiviral Agents|antiviral agents|mesh-ancestor
55755623|NCT03732677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755624|NCT03732677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755625|NCT03732677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55755626|NCT03732677|Immunologic Factors|immunologic factors|mesh-ancestor
55755627|NCT03732677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755628|NCT03732677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755629|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
55755630|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755632|NCT02462525|Dexamethasone|dexamethasone|mesh-list
55755633|NCT02462525|Pomalidomide|pomalidomide|mesh-list
55755634|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55755637|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755638|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755639|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55755641|NCT02462525|Hormones|hormones|mesh-ancestor
55755642|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55755643|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55755644|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755645|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
55755646|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55755647|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55755648|NCT02462525|Growth Substances|growth substances|mesh-ancestor
55755649|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
55755650|NCT04111419|Amlodipine|amlodipine|mesh-list
55755651|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
55755653|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55755654|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55755655|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
55755656|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755657|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55755658|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55755659|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755660|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55755661|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55755662|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755663|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55755664|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755665|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
55755666|NCT02462447|Choline|choline|mesh-list
55755667|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
55755668|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55755669|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
55755670|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755671|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55755672|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55755674|NCT02462681|Ketamine|ketamine|mesh-list
55755675|NCT02462681|Analgesics|analgesics|mesh-ancestor
55755676|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
55781170|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
55755678|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755679|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55755680|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55755681|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
55755682|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
55755683|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755684|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55755685|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55755686|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755687|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755689|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755690|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55755691|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755692|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755693|NCT02462369|Glimepiride|glimepiride|mesh-list
55755694|NCT02462369|Saxagliptin|saxagliptin|mesh-list
55755695|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55755696|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55755697|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755698|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55755699|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
55755700|NCT02462369|Incretins|incretins|mesh-ancestor
55755701|NCT02462369|Hormones|hormones|mesh-ancestor
55755702|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55755703|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55755704|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
55755705|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755706|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755708|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55755709|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755710|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755711|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55755712|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755714|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
55755717|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55755718|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755719|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
55755720|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
55755721|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
55755722|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755723|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55755724|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
55755725|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755726|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55755727|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55755728|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
55755729|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55755730|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55755731|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55755732|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55755733|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755735|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55755736|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55755737|NCT02463383|Analgesics|analgesics|mesh-ancestor
55781200|NCT03965741|Apixaban|apixaban|mesh-list
55755738|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
55755739|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755740|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755741|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55755742|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55755743|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55755744|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755745|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755746|NCT03433469|Osimertinib|osimertinib|mesh-list
55755747|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755748|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55755749|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755750|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755751|NCT04008797|Lenvatinib|lenvatinib|mesh-list
55755752|NCT04008797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755753|NCT04008797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55755755|NCT04008797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755757|NCT04006457|Immunologic Factors|immunologic factors|mesh-ancestor
55755758|NCT04006457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755759|NCT03108365|Hemostatics|hemostatics|mesh-list
55755760|NCT03108365|Chitosan|chitosan|mesh-list
55755761|NCT03108365|Coagulants|coagulants|mesh-ancestor
55755762|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55755763|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55755764|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
55755765|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755766|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55755767|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
55755768|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
55755769|NCT02821013|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55755770|NCT02821013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755771|NCT02821013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755772|NCT05345457|Amoxicillin|amoxicillin|mesh-list
55755773|NCT05345457|Azithromycin|azithromycin|mesh-list
55755774|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55755775|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755776|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55755777|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55755778|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55755779|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755780|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755781|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55755782|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755783|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755784|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
55755785|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755786|NCT04729179|Cannabidiol|cannabidiol|mesh-list
55755787|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
55755788|NCT02760329|Nitric Oxide|nitric oxide|mesh-list
55755789|NCT02760329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55755790|NCT02760329|Autonomic Agents|autonomic agents|mesh-ancestor
55755791|NCT02760329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755792|NCT02760329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755793|NCT02760329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55781205|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
55755794|NCT02760329|Respiratory System Agents|respiratory system agents|mesh-ancestor
55755795|NCT02760329|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55755796|NCT02760329|Antioxidants|antioxidants|mesh-ancestor
55755797|NCT02760329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755798|NCT02760329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755799|NCT02760329|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55755800|NCT02760329|Vasodilator Agents|vasodilator agents|mesh-ancestor
55755801|NCT02760329|Gasotransmitters|gasotransmitters|mesh-ancestor
55755802|NCT02760329|Protective Agents|protective agents|mesh-ancestor
55755804|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755805|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755806|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
55755807|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
55755808|NCT03064191|Calcium|calcium|mesh-list
55755809|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55755810|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755811|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55755812|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55755813|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755814|NCT03064191|Disinfectants|disinfectants|mesh-ancestor
55755815|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
55755817|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55755818|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
55755819|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755820|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755821|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55755822|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
55755823|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
55755824|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55755825|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
55755826|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55755827|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755828|NCT03062787|Triamcinolone|triamcinolone|mesh-list
55755829|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55755830|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55755832|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55755833|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55755834|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
55755835|NCT03062787|Hormones|hormones|mesh-ancestor
55755836|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55755837|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755838|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55755839|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
55755840|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755841|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755842|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55755843|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
55755844|NCT03062787|Protective Agents|protective agents|mesh-ancestor
55755845|NCT04601883|Colchicine|colchicine|mesh-list
55755846|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
55755847|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55755848|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
55755849|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
55755850|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
55755851|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755852|NCT04601883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755854|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55755855|NCT05223075|Carticaine|carticaine|mesh-list
55755856|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
55755857|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
55755858|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55781227|NCT05063513|Rituximab|rituximab|mesh-list
55755859|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755860|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
55755861|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755862|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55755863|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55755864|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55755865|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55755866|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755867|NCT03064035|Thrombin|thrombin|mesh-list
55755868|NCT03064035|Hemostatics|hemostatics|mesh-ancestor
55755871|NCT03719313|Ritonavir|ritonavir|mesh-list
55755876|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755877|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
55755878|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755879|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55755880|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55755881|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
55755882|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755883|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755884|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55755885|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55755886|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55755887|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55755888|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
55755889|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755890|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
55755892|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755893|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
55755894|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55755895|NCT03063723|Ledipasvir|ledipasvir|mesh-list
55755896|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
55755897|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755898|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55755899|NCT04338321|Esketamine|esketamine|mesh-list
55755900|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
55755901|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55755902|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55755903|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55755904|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55755905|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755906|NCT00379041|Prednisone|prednisone|mesh-list
55755907|NCT00379041|Doxorubicin|doxorubicin|mesh-list
55755908|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55755909|NCT00379041|Bleomycin|bleomycin|mesh-list
55755910|NCT00379041|Vincristine|vincristine|mesh-list
55755911|NCT00379041|Vinblastine|vinblastine|mesh-list
55755912|NCT00379041|Procarbazine|procarbazine|mesh-list
55755913|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
55755914|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55755915|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755916|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55755917|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55755918|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755919|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755920|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55755921|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
55755922|NCT00379041|Hormones|hormones|mesh-ancestor
55789049|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55755923|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55755925|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55755926|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55755927|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
55755928|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
55755929|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
55755930|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
55755931|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55755932|NCT03502785|Atezolizumab|atezolizumab|mesh-list
55755933|NCT03502785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755934|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55755935|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55755936|NCT03305445|Nivolumab|nivolumab|mesh-list
55755937|NCT03305445|Ipilimumab|ipilimumab|mesh-list
55755938|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755939|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755940|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55755941|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755942|NCT04981899|Carboplatin|carboplatin|mesh-list
55755943|NCT04981899|Nivolumab|nivolumab|mesh-list
55755945|NCT04981899|Ifosfamide|ifosfamide|mesh-list
55755946|NCT04981899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755947|NCT04981899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755948|NCT04981899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55755949|NCT04981899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755950|NCT04981899|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55755951|NCT04981899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55755952|NCT04981899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55755953|NCT04981899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755954|NCT04981899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55755955|NCT04981899|Alkylating Agents|alkylating agents|mesh-ancestor
55755957|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
55755958|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
55755959|NCT04436913|Protective Agents|protective agents|mesh-ancestor
55755960|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755961|NCT02487095|Topotecan|topotecan|mesh-list
55755962|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55755963|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55755964|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755965|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755966|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755967|NCT03837899|Durvalumab|durvalumab|mesh-list
55755969|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55755970|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55755971|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755972|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
55755973|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55755974|NCT03832361|Maytansine|maytansine|mesh-list
55755975|NCT03832361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55755976|NCT03832361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755977|NCT03832361|Tubulin Modulators|tubulin modulators|mesh-ancestor
55755978|NCT03832361|Antimitotic Agents|antimitotic agents|mesh-ancestor
55755979|NCT03832361|Mitosis Modulators|mitosis modulators|mesh-ancestor
55755980|NCT03832361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755981|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55755982|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55755983|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755984|NCT03742193|Apatinib|apatinib|mesh-list
55755985|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55755986|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55755987|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755988|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755989|NCT03108287|Amoxicillin|amoxicillin|mesh-list
55755990|NCT03108287|Clarithromycin|clarithromycin|mesh-list
55755991|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
55755992|NCT03108287|Rabeprazole|rabeprazole|mesh-list
55755994|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55755995|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55755996|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55755997|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55755998|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55755999|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55756000|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55756001|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55756002|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756003|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55756005|NCT02461121|Cyclosporine|cyclosporine|mesh-list
55756006|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
55756008|NCT02461121|Fludarabine|fludarabine|mesh-list
55756009|NCT02461121|Cyclosporins|cyclosporins|mesh-list
55756010|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55756011|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55756013|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756014|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55756015|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55756016|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
55756017|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756019|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55756020|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756021|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
55756022|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756023|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
55756024|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55756025|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55756026|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55756027|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
55756029|NCT00701363|Lanreotide|lanreotide|mesh-list
55756030|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756031|NCT02461043|Paclitaxel|paclitaxel|mesh-list
55756032|NCT02461043|Cisplatin|cisplatin|mesh-list
55756033|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55756034|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756035|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
55756036|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
55756039|NCT03296657|Fluorides|fluorides|mesh-list
55756043|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756044|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
55756045|NCT03296579|Aminophylline|aminophylline|mesh-list
55756046|NCT03296579|Albuterol|albuterol|mesh-list
55756047|NCT03296579|Ipratropium|ipratropium|mesh-list
55756048|NCT03296579|Analgesics|analgesics|mesh-ancestor
55756049|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
55756050|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55781251|NCT02373943|Protective Agents|protective agents|mesh-ancestor
55756051|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756053|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756054|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55756055|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
55756056|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55756057|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55756058|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756059|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55756060|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
55756061|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55756062|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55756063|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
55756064|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55756065|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
55756066|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55756067|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55756068|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55756069|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
55756070|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756071|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55756072|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
55756073|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55756074|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55756075|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756076|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55756077|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55756078|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
55756079|NCT03296579|Protective Agents|protective agents|mesh-ancestor
55756080|NCT02461667|Alendronate|alendronate|mesh-list
55756081|NCT02461667|Metformin|metformin|mesh-list
55756082|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55756083|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756084|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55756085|NCT01670877|Trastuzumab|trastuzumab|mesh-list
55756086|NCT01670877|Fulvestrant|fulvestrant|mesh-list
55756087|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55756088|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756089|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55756090|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55756091|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55756092|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
55756093|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756094|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756096|NCT00701129|Methotrexate|methotrexate|mesh-list
55756097|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55756098|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756099|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
55756100|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756101|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55756102|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55756103|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
55756104|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55756105|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55756106|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
55756107|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756108|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
55756109|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756110|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55756111|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55756112|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55756113|NCT03296189|Dexamethasone|dexamethasone|mesh-list
55756114|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
55756115|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
55756116|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55756117|NCT03296189|BB 1101|bb 1101|mesh-list
55756118|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55756121|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756122|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756123|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756124|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
55756125|NCT03296189|Hormones|hormones|mesh-ancestor
55756126|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756127|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55756129|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
55756130|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
55756131|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756132|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
55756133|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
55756134|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756135|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756136|NCT03295955|Amoxicillin|amoxicillin|mesh-list
55756137|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
55756138|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
55756139|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55756140|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55756141|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756142|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55756143|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756144|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756145|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
55756146|NCT03298373|Nandrolone|nandrolone|mesh-list
55756147|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
55756148|NCT03298373|Androgens|androgens|mesh-ancestor
55756149|NCT03298373|Hormones|hormones|mesh-ancestor
55756150|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756151|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756152|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
55756153|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55756154|NCT01670721|Leucovorin|leucovorin|mesh-list
55756155|NCT01670721|Fluorouracil|fluorouracil|mesh-list
55756157|NCT01670721|Aflibercept|aflibercept|mesh-list
55756158|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
55756159|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756160|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55756161|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756162|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55756163|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
55756164|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756165|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55756166|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55756167|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756169|NCT01670721|Protective Agents|protective agents|mesh-ancestor
55781294|NCT05011487|Pemetrexed|pemetrexed|mesh-list
55756175|NCT01670721|Growth Substances|growth substances|mesh-ancestor
55756176|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
55756177|NCT04491695|Tirofiban|tirofiban|mesh-list
55756178|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55756179|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55756180|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756181|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55756182|NCT04982055|Nadroparin|nadroparin|mesh-list
55756183|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
55756184|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55756185|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55756186|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756187|NCT04981743|Vitamin D|vitamin d|mesh-list
55756188|NCT04981743|Vitamins|vitamins|mesh-ancestor
55756189|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
55756190|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756191|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55756192|NCT04489121|Omalizumab|omalizumab|mesh-list
55756193|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55756194|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55756195|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
55756196|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
55756197|NCT04982211|Propranolol|propranolol|mesh-list
55756198|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55756199|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55756200|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
55756201|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756202|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756203|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756204|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55756205|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55756206|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
55756213|NCT03290963|Analgesics|analgesics|mesh-ancestor
55756214|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
55756217|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55756219|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
55756220|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
55756221|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756222|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55756223|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55756224|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756225|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756227|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
55756228|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
55756229|NCT03062319|Anticoagulants|anticoagulants|mesh-list
55756230|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55756231|NCT03290495|Ketamine|ketamine|mesh-list
55756232|NCT03290495|Analgesics|analgesics|mesh-ancestor
55756233|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
55756234|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756235|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756236|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55756237|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55756238|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
55756239|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
55756240|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756241|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55756242|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55756243|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756244|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756245|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
55756246|NCT04429893|Bupivacaine|bupivacaine|mesh-list
55756247|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
55756248|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
55756249|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756250|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756251|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
55756252|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756253|NCT04429893|Analgesics|analgesics|mesh-ancestor
55756254|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55756255|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
55756256|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55756257|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55756258|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756259|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55756260|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
55756261|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55756263|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
55756264|NCT03290417|Cholecalciferol|cholecalciferol|mesh-list
55756265|NCT03290417|Vitamins|vitamins|mesh-list
55756266|NCT03290417|Curcumin|curcumin|mesh-list
55756268|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
55756269|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756270|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55756271|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55756272|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55756273|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55756275|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
55756276|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756277|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55756278|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55756279|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756280|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756281|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756282|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
55756283|NCT03290417|Protective Agents|protective agents|mesh-ancestor
55756284|NCT04429347|Gabapentin|gabapentin|mesh-list
55756285|NCT04429347|Tizanidine|tizanidine|mesh-list
55756287|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
55756288|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756289|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756290|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
55756293|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756294|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55756296|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55756297|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756298|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756299|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
55756300|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55756301|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55756302|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
55756303|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
55756304|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55756305|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55756306|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55756307|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
55756308|NCT03294551|Vaccines|vaccines|mesh-list
55756309|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
55756310|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756312|NCT04156581|Bupivacaine|bupivacaine|mesh-list
55756313|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55756314|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
55756315|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
55756316|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756317|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756318|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756319|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
55756321|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756322|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55756323|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756324|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
55756326|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756327|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
55756328|NCT02983071|Fulvestrant|fulvestrant|mesh-list
55756329|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55756330|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756331|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55756332|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55756334|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756335|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756336|NCT03294395|Gentamicins|gentamicins|mesh-list
55756337|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
55756338|NCT03294395|Fosfomycin|fosfomycin|mesh-list
55756339|NCT03294395|Ertapenem|ertapenem|mesh-list
55756340|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55756341|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756342|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55756343|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756344|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756345|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
55756346|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55756347|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55756349|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
55756350|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55756351|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
55756352|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
55756353|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55756354|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
55756355|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
55756357|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756358|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756359|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
55756360|NCT04980105|Hormones|hormones|mesh-ancestor
55789050|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756361|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756362|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55756363|NCT04980105|Protective Agents|protective agents|mesh-ancestor
55756364|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55756365|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756366|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55756367|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
55756368|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
55756370|NCT04973319|Pertuzumab|pertuzumab|mesh-list
55756371|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55756372|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756373|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
55756374|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55756376|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756377|NCT03289871|Amorolfine|amorolfine|mesh-list
55756378|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
55756379|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756380|NCT03289637|Vitamin D|vitamin d|mesh-list
55756381|NCT03289637|Vitamins|vitamins|mesh-ancestor
55756382|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
55756383|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756384|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55756386|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
55756387|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756388|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
55756389|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756390|NCT02460497|Minoxidil|minoxidil|mesh-list
55756391|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55756392|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
55756393|NCT03289559|Testosterone|testosterone|mesh-list
55756394|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55756395|NCT03289559|Androgens|androgens|mesh-ancestor
55756396|NCT03289559|Hormones|hormones|mesh-ancestor
55756397|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756398|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756400|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756401|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756402|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55756403|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
55756404|NCT03293927|Fentanyl|fentanyl|mesh-list
55756405|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
55756406|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55756407|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756408|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756409|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55756410|NCT03293927|Analgesics|analgesics|mesh-ancestor
55756411|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
55756412|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756413|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55756414|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55756415|NCT03293927|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55756416|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
55756417|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756418|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756419|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55756421|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55756422|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55756423|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
55756424|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
55756426|NCT02730429|Palbociclib|palbociclib|mesh-list
55756427|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756428|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55756429|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55756430|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756431|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756432|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55756433|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
55756434|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756435|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756436|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55756438|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
55756439|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
55756440|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55756441|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756442|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756443|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55756444|NCT04971759|Analgesics|analgesics|mesh-ancestor
55756448|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55756450|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
55756451|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756452|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756453|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55756454|NCT04971759|Narcotics|narcotics|mesh-ancestor
55756455|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55756456|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55756457|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
55756458|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
55756459|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
55756460|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55756462|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756463|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756464|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55756465|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55756466|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756467|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
55756468|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756469|NCT04979091|Hormones|hormones|mesh-list
55756470|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756471|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756472|NCT04971291|Bupropion|bupropion|mesh-list
55756474|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
55756475|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55756476|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55756477|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55756478|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55756479|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756480|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
55756481|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756482|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756483|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55756484|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55756485|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756486|NCT03107507|Levetiracetam|levetiracetam|mesh-list
55756487|NCT03107507|Phenobarbital|phenobarbital|mesh-list
55756488|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
55756489|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
55756490|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55756491|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756492|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756493|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55756494|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55756495|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756496|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756497|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
55756498|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
55756499|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55756500|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55756501|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55756502|NCT03062631|Amifampridine|amifampridine|mesh-list
55756503|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55756504|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756505|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756506|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55756507|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55756508|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756509|NCT02711137|Gemcitabine|gemcitabine|mesh-list
55756511|NCT02711137|Azacitidine|azacitidine|mesh-list
55756512|NCT02711137|Rucaparib|rucaparib|mesh-list
55756513|NCT02711137|INCB057643|incb057643|mesh-list
55756514|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55756515|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756516|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
55756517|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
55756518|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
55756519|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756520|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55756521|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
55756522|NCT02711137|Antiviral Agents|antiviral agents|mesh-ancestor
55756525|NCT02711137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55756526|NCT02711137|Immunologic Factors|immunologic factors|mesh-ancestor
55756527|NCT02711137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781365|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
55756529|NCT04155411|Dasatinib|dasatinib|mesh-list
55756530|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756531|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55756532|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756533|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756534|NCT04970667|Flupenthixol|flupenthixol|mesh-list
55756535|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
55756536|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55756537|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55756538|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756539|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756540|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55756541|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55756542|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
55756543|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756544|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756545|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
55756546|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
55756547|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756548|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
55756549|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756550|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756551|NCT03288077|Tryptophan|tryptophan|mesh-list
55756552|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55756553|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
55756555|NCT00777127|Diclofenac|diclofenac|mesh-list
55756556|NCT00777127|Imiquimod|imiquimod|mesh-list
55756557|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55756558|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55756559|NCT00777127|Analgesics|analgesics|mesh-ancestor
55756560|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
55756561|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756562|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756563|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55756564|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55756565|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55756566|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756567|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756569|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
55756570|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756571|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
55756573|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55756574|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
55756575|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756576|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756577|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
55756578|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
55756579|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
55756580|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756581|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756582|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55756583|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
55756584|NCT03287609|Evolocumab|evolocumab|mesh-list
55756585|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55756586|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55756587|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
55756588|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756589|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55756591|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756592|NCT03194815|Rituximab|rituximab|mesh-list
55756593|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
55756594|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55756595|NCT03194815|Antibodies|antibodies|mesh-list
55756596|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
55756597|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55756598|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55756599|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756600|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
55756601|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756602|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55756603|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55756604|NCT03291821|Cetrorelix|cetrorelix|mesh-list
55756605|NCT03291821|Menotropins|menotropins|mesh-list
55756606|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55756607|NCT03291821|Ganirelix|ganirelix|mesh-list
55756608|NCT03291821|Hormones|hormones|mesh-ancestor
55756609|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756610|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756611|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
55756612|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55756613|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
55756614|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55756615|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55756616|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55756617|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756618|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55756619|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
55756620|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
55756621|NCT02448901|Edoxaban|edoxaban|mesh-list
55756622|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55756623|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
55756624|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55756625|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
55756626|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756627|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756628|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
55756630|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55756631|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756632|NCT02460341|Ondansetron|ondansetron|mesh-list
55756633|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
55756635|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756636|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756637|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756638|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
55756639|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
55756640|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55756641|NCT02460341|Serotonin Agents|serotonin agents|mesh-ancestor
55756642|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756643|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756644|NCT02460341|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55756645|NCT02460341|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55756646|NCT02460341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756647|NCT02460341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55756648|NCT02460341|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55756650|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55756651|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55756652|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55756653|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55756654|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756655|NCT00189241|Imiquimod|imiquimod|mesh-list
55756656|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55756657|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
55756658|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756659|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756660|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
55756661|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
55756662|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55756663|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55756664|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55756665|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55756666|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756668|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756669|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756671|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756672|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
55756673|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
55756674|NCT03286673|Calcium|calcium|mesh-list
55756675|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55756676|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756677|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55756678|NCT03286673|Antacids|antacids|mesh-ancestor
55756679|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756680|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756681|NCT02151981|Osimertinib|osimertinib|mesh-list
55756682|NCT02151981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756683|NCT02151981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55756684|NCT02151981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756685|NCT02151981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756686|NCT02445703|Vaccines|vaccines|mesh-list
55756687|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
55756688|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756689|NCT03194659|Choline|choline|mesh-list
55756690|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
55756691|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55756692|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
55756693|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756694|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756696|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
55756698|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756699|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756700|NCT03190603|Celecoxib|celecoxib|mesh-list
55756701|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55756702|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55756703|NCT03190603|Analgesics|analgesics|mesh-ancestor
55756704|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
55756705|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756706|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756708|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55756709|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55756710|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55756711|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756712|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756713|NCT05233579|Sulforaphane|sulforaphane|mesh-list
55756714|NCT05233579|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55756716|NCT05233579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756717|NCT05233579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756719|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
55756720|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55756721|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55756722|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55756723|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756724|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756725|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
55756726|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
55756727|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756728|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756729|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55756730|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55756731|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
55756732|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55756733|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55756734|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55756735|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55756737|NCT02439697|Hematinics|hematinics|mesh-ancestor
55756738|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
55756739|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55756740|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756741|NCT03284645|Tenofovir|tenofovir|mesh-list
55756743|NCT03284645|Zidovudine|zidovudine|mesh-list
55756744|NCT03284645|Efavirenz|efavirenz|mesh-list
55756745|NCT03284645|Abacavir|abacavir|mesh-list
55756746|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
55756747|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756748|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55756749|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55756750|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756751|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756752|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55756753|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55756754|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
55756755|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55756756|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55756757|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55756758|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55756759|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55756760|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55756762|NCT03190447|Laxatives|laxatives|mesh-ancestor
55756763|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756765|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55756766|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756768|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
55756769|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55756770|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55756771|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756772|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756773|NCT03192709|Urological Agents|urological agents|mesh-ancestor
55756774|NCT03283943|Durvalumab|durvalumab|mesh-list
55756775|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55756776|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756777|NCT02710045|Vaccines|vaccines|mesh-list
55756778|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
55756779|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756780|NCT02444767|Bimatoprost|bimatoprost|mesh-list
55756781|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55756782|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
55756783|NCT02443285|Cefotaxime|cefotaxime|mesh-list
55756784|NCT02443285|Cefoxitin|cefoxitin|mesh-list
55756785|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55756786|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756788|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55756789|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55756790|NCT03193957|Analgesics|analgesics|mesh-ancestor
55756791|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
55756792|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756793|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756794|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55756795|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55756796|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756797|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55756798|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
55756799|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
55756800|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55756801|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
55756802|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756803|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756804|NCT02444611|Vaccines|vaccines|mesh-list
55756805|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
55756806|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
55756807|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756808|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55756809|NCT02438761|Gedatolisib|gedatolisib|mesh-list
55756810|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55756811|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756812|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756813|NCT03536429|Acetazolamide|acetazolamide|mesh-list
55756814|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
55756815|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55756816|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756817|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756818|NCT03536429|Diuretics|diuretics|mesh-ancestor
55756819|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
55756820|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756821|NCT02438683|BI 409306|bi 409306|mesh-list
55756822|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55756823|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756824|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756825|NCT03270839|Meclizine|meclizine|mesh-list
55756826|NCT03270839|Scopolamine|scopolamine|mesh-list
55756827|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55756828|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
55756829|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
55756830|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756831|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756832|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756833|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
55756834|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55756835|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
55756836|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756837|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756838|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55756839|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55756840|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
55756841|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
55756842|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55756843|NCT02458547|Bupivacaine|bupivacaine|mesh-list
55756844|NCT02458547|Propofol|propofol|mesh-list
55756845|NCT02458547|Desflurane|desflurane|mesh-list
55756846|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
55756847|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
55756848|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756849|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756850|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
55756851|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756852|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55756853|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55756854|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
55756855|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55756856|NCT02458625|Iron|iron|mesh-list
55756857|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55756858|NCT02458625|Trace Elements|trace elements|mesh-ancestor
55756860|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756861|NCT02458625|Hematinics|hematinics|mesh-ancestor
55756862|NCT04978155|Anesthetics|anesthetics|mesh-list
55756868|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756869|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55756870|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55756872|NCT04977843|Chelating Agents|chelating agents|mesh-ancestor
55756873|NCT04977843|Sequestering Agents|sequestering agents|mesh-ancestor
55756874|NCT04977843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756881|NCT04432233|Metronidazole|metronidazole|mesh-list
55756882|NCT04432233|Levofloxacin|levofloxacin|mesh-list
55756883|NCT04432233|Ofloxacin|ofloxacin|mesh-list
55756884|NCT04432233|Esomeprazole|esomeprazole|mesh-list
55756885|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756886|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55756887|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55756888|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55756889|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55756890|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756891|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55756892|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756893|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756894|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55756895|NCT04432233|Renal Agents|renal agents|mesh-ancestor
55756896|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55756897|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55756898|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756899|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55756900|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55756901|NCT03269747|Prednisone|prednisone|mesh-list
55756902|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55756903|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
55756905|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756906|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756907|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55756908|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756909|NCT04369469|Ravulizumab|ravulizumab|mesh-list
55756910|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55756911|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55756913|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756916|NCT03269591|Progestins|progestins|mesh-ancestor
55756917|NCT03269591|Hormones|hormones|mesh-ancestor
55756918|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756919|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756920|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55756921|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55756922|NCT03269591|Analgesics|analgesics|mesh-ancestor
55756923|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
55756924|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756925|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55756926|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55756927|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55756928|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55756929|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756930|NCT03989609|Midazolam|midazolam|mesh-list
55756932|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55756933|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55756934|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756935|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55756936|NCT03989609|Analgesics|analgesics|mesh-ancestor
55756937|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
55756938|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55756939|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55756940|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55756941|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55756942|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
55756943|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55756944|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55756945|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55756946|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55756947|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55756948|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55756949|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55756955|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55756956|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
55781468|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
55756958|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55756959|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
55756960|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756961|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55756962|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
55756963|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756964|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55756965|NCT03280277|Hematinics|hematinics|mesh-ancestor
55756966|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55756967|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55756968|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
55756969|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55756970|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756971|NCT03269279|Misoprostol|misoprostol|mesh-list
55756972|NCT03269279|Mifepristone|mifepristone|mesh-list
55756973|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55756975|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55756976|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55756977|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55756978|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55756979|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
55756980|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55756981|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55756982|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55756983|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55756984|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
55756985|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55756986|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55756987|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
55756988|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55756989|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
55756990|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55756991|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55756994|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55756995|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
55756996|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55756997|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55756998|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
55756999|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55757000|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757001|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757002|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55757003|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55757004|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55757005|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55757006|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55757007|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55757008|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55757009|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55757010|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
55757011|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55757012|NCT03268733|Folic Acid|folic acid|mesh-list
55757013|NCT03268733|Hematinics|hematinics|mesh-ancestor
55757015|NCT03268733|Vitamins|vitamins|mesh-ancestor
55757016|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
55757017|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757021|NCT03277391|Narcotics|narcotics|mesh-ancestor
55757022|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757023|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757024|NCT03277391|Analgesics|analgesics|mesh-ancestor
55757025|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
55757026|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757027|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55757028|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
55757029|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
55757030|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55757031|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55757032|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55757033|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55757034|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55757035|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55757037|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757038|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757039|NCT03277001|Enoxaparin|enoxaparin|mesh-list
55757040|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
55757041|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55757042|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
55757043|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55757044|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
55757045|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757046|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757047|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
55757048|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55757049|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55757050|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55757051|NCT03272711|Vortioxetine|vortioxetine|mesh-list
55757052|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
55757053|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55757054|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55757055|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55757056|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757057|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757058|NCT03272711|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55757059|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55757060|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55757061|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757062|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757063|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
55757064|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55757065|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55757066|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55757067|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55757068|NCT03961919|Fludarabine|fludarabine|mesh-list
55757070|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757071|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757072|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55757073|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
55757074|NCT03267407|Fluconazole|fluconazole|mesh-list
55757075|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
55757076|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757077|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55757078|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55757079|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757080|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757081|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55757082|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
55757083|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55757084|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757085|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55757086|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55757087|NCT03267329|Telmisartan|telmisartan|mesh-list
55757088|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55757089|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55757090|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55757091|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757093|NCT05074589|Fluorouracil|fluorouracil|mesh-list
55757094|NCT05074589|Irinotecan|irinotecan|mesh-list
55757095|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
55757096|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
55757097|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757098|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55757099|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757100|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55757101|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
55757102|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757103|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55757104|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55757105|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757106|NCT05074589|Antidotes|antidotes|mesh-ancestor
55757107|NCT05074589|Protective Agents|protective agents|mesh-ancestor
55757108|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
55757109|NCT05074589|Vitamins|vitamins|mesh-ancestor
55757113|NCT05073965|Vitamin D|vitamin d|mesh-list
55757114|NCT05073965|Vitamins|vitamins|mesh-ancestor
55757116|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757117|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55757119|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55757120|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55757121|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757122|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
55757123|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757124|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757125|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
55757126|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55757127|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757128|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757129|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55757130|NCT05065775|Analgesics|analgesics|mesh-ancestor
55757131|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
55757132|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757133|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55757134|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55757135|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55757136|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
55757137|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757138|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757140|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757141|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55757142|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757143|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757144|NCT02458781|Metronidazole|metronidazole|mesh-list
55757145|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
55757146|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
55757147|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757148|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55757150|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55757151|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55757152|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55757153|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757154|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757155|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757156|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55757157|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55757158|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55757159|NCT04647383|Lemborexant|lemborexant|mesh-list
55757160|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55757161|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757162|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757163|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55757166|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757168|NCT02458157|Diuretics|diuretics|mesh-ancestor
55757169|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
55757170|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757171|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55757172|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55757173|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757174|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
55757175|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55757176|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757177|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757178|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55757179|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55757180|NCT02458079|Protective Agents|protective agents|mesh-ancestor
55757181|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757182|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
55757183|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55757184|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
55757185|NCT03264911|Amoxicillin|amoxicillin|mesh-list
55757186|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55757188|NCT03265223|Ropivacaine|ropivacaine|mesh-list
55757189|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
55757190|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
55757191|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757192|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757193|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
55757194|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757195|NCT03851159|Mannitol|mannitol|mesh-list
55757196|NCT03851159|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55757197|NCT03851159|Diuretics|diuretics|mesh-ancestor
55757198|NCT03851159|Natriuretic Agents|natriuretic agents|mesh-ancestor
55757199|NCT03851159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757200|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
55757201|NCT02456363|Adalimumab|adalimumab|mesh-list
55757202|NCT02456363|Etanercept|etanercept|mesh-list
55757203|NCT02456363|Golimumab|golimumab|mesh-list
55757204|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55757205|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55757206|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55757207|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55757208|NCT02456363|Analgesics|analgesics|mesh-ancestor
55757209|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
55757210|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757211|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757212|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55757213|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55757214|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
55757215|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55757216|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757217|NCT03259607|Nicotine|nicotine|mesh-list
55757218|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55757219|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
55757220|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757221|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757222|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55757223|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55757224|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
55757225|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757226|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757228|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
55757229|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757230|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55757231|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55757232|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757233|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757234|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55757235|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
55757236|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55757237|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757238|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55757239|NCT03263741|Paclitaxel|paclitaxel|mesh-list
55757240|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55757241|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
55757242|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55757243|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757244|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
55757245|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
55757246|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
55757247|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757249|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55757250|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55781543|NCT01951378|Albuterol|albuterol|mesh-list
55757251|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
55757252|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757253|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55757254|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
55757255|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
55757256|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55757257|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
55757258|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757259|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757260|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55757261|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
55757262|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55757263|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55757264|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55757265|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
55757266|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757267|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757268|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
55757269|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55757270|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
55757271|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
55757272|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55757273|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757274|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55757275|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55757276|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757277|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757278|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757279|NCT04976673|Triamcinolone|triamcinolone|mesh-list
55757280|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55757281|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55757282|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55757283|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55757284|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
55757285|NCT04976673|Hormones|hormones|mesh-ancestor
55757286|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55757287|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757288|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55757289|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
55757290|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757291|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757292|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
55757293|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55757294|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55757295|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
55757296|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757297|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757298|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757299|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55757302|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55757303|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757304|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
55757305|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757306|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
55757307|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55757308|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55757309|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757310|NCT03262961|Urological Agents|urological agents|mesh-ancestor
55757311|NCT01670097|Dexamethasone|dexamethasone|mesh-list
55757312|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55757313|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
55757314|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
55757315|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757316|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757317|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55757318|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
55757319|NCT01670097|Hormones|hormones|mesh-ancestor
55757320|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55757321|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55757323|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
55757324|NCT03257423|Metronidazole|metronidazole|mesh-list
55757325|NCT03257423|Levofloxacin|levofloxacin|mesh-list
55757327|NCT03257423|Ertapenem|ertapenem|mesh-list
55757328|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55757329|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757330|NCT03257423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55757331|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55757332|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757333|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757334|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757335|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55757336|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55757337|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55757339|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55757340|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55757341|NCT01670019|Asenapine|asenapine|mesh-list
55757342|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55757343|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55757344|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757345|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757346|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55757348|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55757351|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
55757352|NCT03262727|Estradiol|estradiol|mesh-list
55757353|NCT03262727|Estrogens|estrogens|mesh-ancestor
55757355|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55757356|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757357|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55757358|NCT03262727|Contraceptive Agents|contraceptive agents|mesh-ancestor
55757359|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55757360|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55757361|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55757362|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55757363|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55757365|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55757366|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757367|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757368|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55757370|NCT04975971|Dexamethasone|dexamethasone|mesh-list
55757371|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55757372|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
55757373|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
55757374|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757375|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757376|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55757378|NCT04975971|Hormones|hormones|mesh-ancestor
55757379|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55757380|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55757381|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757382|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
55757383|NCT03062163|Resveratrol|resveratrol|mesh-list
55757384|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
55757385|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757386|NCT03062163|Protective Agents|protective agents|mesh-ancestor
55757387|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757388|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757389|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55757390|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
55757392|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
55757393|NCT02456597|Lidocaine|lidocaine|mesh-list
55757394|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
55757395|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
55757396|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757397|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757398|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
55757399|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757400|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55757401|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55757402|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55757403|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55757404|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757405|NCT03261635|Indomethacin|indomethacin|mesh-list
55757406|NCT03261635|Ranibizumab|ranibizumab|mesh-list
55757407|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55757408|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55757409|NCT03261635|Growth Substances|growth substances|mesh-ancestor
55757410|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757411|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
55757412|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757413|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55757414|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55757415|NCT03261635|Analgesics|analgesics|mesh-ancestor
55757416|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
55757417|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757418|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55757419|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55757420|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
55757421|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
55757422|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55757423|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55757424|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757425|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757426|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
55757427|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55757428|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55757429|NCT03059979|Prednisolone|prednisolone|mesh-list
55757430|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
55757431|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55757432|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
55757433|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55757434|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
55757435|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
55757436|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757437|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757438|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55757439|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
55757441|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55757442|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55757443|NCT03059979|Protective Agents|protective agents|mesh-ancestor
55757444|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55757445|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757447|NCT03256721|Pemetrexed|pemetrexed|mesh-list
55757448|NCT03256721|Apatinib|apatinib|mesh-list
55757449|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757450|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
55757451|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
55757452|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
55757453|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757454|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757455|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55757456|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55757457|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55757458|NCT04967859|Gentamicins|gentamicins|mesh-list
55757459|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55757460|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757461|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55757462|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757463|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757464|NCT03256487|Morphine|morphine|mesh-list
55757465|NCT03256487|Buprenorphine|buprenorphine|mesh-list
55757466|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55757467|NCT03256487|Narcotics|narcotics|mesh-ancestor
55757468|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757469|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757470|NCT03256487|Analgesics|analgesics|mesh-ancestor
55757471|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
55757472|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757473|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55757474|NCT03061227|Glucagon|glucagon|mesh-list
55757475|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55757476|NCT03061227|Hormones|hormones|mesh-ancestor
55757477|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55757478|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757479|NCT03261791|Apatinib|apatinib|mesh-list
55757480|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757481|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55757482|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757483|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757484|NCT03643367|Propofol|propofol|mesh-list
55757485|NCT03643367|Sevoflurane|sevoflurane|mesh-list
55757486|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55757487|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757488|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757489|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55757490|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
55757491|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
55757492|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55757493|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55757495|NCT03060603|Hematinics|hematinics|mesh-ancestor
55757496|NCT04488107|Letrozole|letrozole|mesh-list
55781596|NCT01361009|Pramipexole|pramipexole|mesh-list
55757497|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757498|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55757499|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55757500|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757501|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757503|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
55757504|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55757507|NCT04974723|Abaloparatide|abaloparatide|mesh-list
55757585|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
55757508|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55757509|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757510|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55757511|NCT03060681|Bupivacaine|bupivacaine|mesh-list
55757512|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
55757513|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
55757514|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757515|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757516|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
55757517|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757519|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
55757520|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55757521|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55757522|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757523|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55757524|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55757525|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757526|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55757527|NCT04967469|Vitamins|vitamins|mesh-ancestor
55757528|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
55757529|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55757531|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55757532|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55757533|NCT03254849|Diuretics|diuretics|mesh-ancestor
55757534|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
55757535|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757536|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55757537|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55757538|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757539|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55757540|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55757542|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
55757543|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757544|NCT04432155|Xenon|xenon|mesh-list
55757545|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55757547|NCT04432155|Anesthetics|anesthetics|mesh-ancestor
55757548|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757549|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757550|NCT04487951|Vitamin D|vitamin d|mesh-list
55757551|NCT04487951|Vitamins|vitamins|mesh-ancestor
55757552|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
55757553|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757554|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55757555|NCT04963257|Aripiprazole|aripiprazole|mesh-list
55757556|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
55757557|NCT04963257|Sertraline|sertraline|mesh-list
55757558|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
55757559|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55757560|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55757561|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55757562|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757563|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757564|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
55757565|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
55757566|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781610|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55757567|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757568|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55757569|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55757570|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
55757571|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55757572|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55757573|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55757574|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55757575|NCT04963257|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55757576|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55757577|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55757578|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55757579|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55757581|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55757582|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757583|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55757584|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
55757586|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757587|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
55757588|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757589|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757591|NCT03254927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55757592|NCT03254927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757593|NCT04953741|Fluticasone|fluticasone|mesh-list
55757594|NCT04953741|Xhance|xhance|mesh-list
55757595|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55757596|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55757597|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
55757598|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757599|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757600|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55757601|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
55757602|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
55757603|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55757604|NCT03259919|Metformin|metformin|mesh-list
55757605|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55757606|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757607|NCT04965831|Aflutinib|aflutinib|mesh-list
55757608|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55757609|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757610|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757611|NCT04953117|Paclitaxel|paclitaxel|mesh-list
55757612|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55757613|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757614|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
55757615|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
55757616|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
55757617|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757619|NCT03259529|Rituximab|rituximab|mesh-list
55757620|NCT03259529|Nivolumab|nivolumab|mesh-list
55757621|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55757622|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55757623|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757624|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
55757625|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757626|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55757627|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55757629|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757631|NCT03259529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757632|NCT03259529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757633|NCT03259529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55757634|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55757635|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55757636|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
55757637|NCT03252665|Nicorandil|nicorandil|mesh-list
55757638|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
55757639|NCT03252665|Alprostadil|alprostadil|mesh-list
55757640|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
55757641|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55757642|NCT03252665|Urological Agents|urological agents|mesh-ancestor
55757643|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55757644|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55757645|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
55757646|NCT03252665|Vitamins|vitamins|mesh-ancestor
55757647|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
55757648|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757649|NCT03059667|Carboplatin|carboplatin|mesh-list
55757650|NCT03059667|Etoposide|etoposide|mesh-list
55757651|NCT03059667|Atezolizumab|atezolizumab|mesh-list
55757652|NCT03059667|Topotecan|topotecan|mesh-list
55757653|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757654|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55757655|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55757656|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55757657|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757658|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757659|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55757660|NCT03058419|Midazolam|midazolam|mesh-list
55757661|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
55757662|NCT03058419|Caffeine|caffeine|mesh-list
55757663|NCT03058419|Bupropion|bupropion|mesh-list
55757664|NCT03058419|Omeprazole|omeprazole|mesh-list
55757665|NCT03058419|Warfarin|warfarin|mesh-list
55757666|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55757667|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55757668|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757669|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757671|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55757672|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55757673|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55757674|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
55757675|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
55757676|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
55757677|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
55757678|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757679|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757680|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
55757681|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55757682|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55757683|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757684|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55757685|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55757686|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
55757687|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55757688|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55757689|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55757690|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55757691|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
55757693|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55757694|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55757695|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
55757696|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55757697|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55757698|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
55757699|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
55757700|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55757701|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55757703|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55757704|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
55757705|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55757706|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757707|NCT04952571|Bevacizumab|bevacizumab|mesh-list
55757708|NCT04952571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55757709|NCT04952571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757710|NCT04952571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55757711|NCT04952571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55757712|NCT04952571|Growth Substances|growth substances|mesh-ancestor
55757713|NCT04952571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757714|NCT04952571|Growth Inhibitors|growth inhibitors|mesh-ancestor
55757715|NCT02455271|Eszopiclone|eszopiclone|mesh-list
55757716|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55757717|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757718|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757719|NCT04964583|Azithromycin|azithromycin|mesh-list
55757720|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
55757722|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757723|NCT04964583|Antimalarials|antimalarials|mesh-ancestor
55757724|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55757725|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55757726|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757727|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757728|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55757729|NCT03251417|Irinotecan|irinotecan|mesh-list
55757730|NCT03251417|Apatinib|apatinib|mesh-list
55757731|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55757732|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55757733|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757734|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757735|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757736|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55757737|NCT04961931|Empagliflozin|empagliflozin|mesh-list
55757738|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55757739|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757740|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55757741|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757742|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
55757743|NCT02454881|Oxycodone|oxycodone|mesh-list
55757744|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55757745|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757746|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757747|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55757748|NCT02454881|Analgesics|analgesics|mesh-ancestor
55757749|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
55757750|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757754|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
55757755|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757756|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757757|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55757759|NCT03058341|Propofol|propofol|mesh-list
55757760|NCT03058341|Sevoflurane|sevoflurane|mesh-list
55757761|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55757762|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757763|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757764|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55757765|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
55757766|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
55757767|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55757768|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55757769|NCT04951791|SMOFlipid|smoflipid|mesh-list
55757770|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55757771|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55757772|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55757773|NCT04951713|Clarithromycin|clarithromycin|mesh-list
55757774|NCT04951713|Rifampin|rifampin|mesh-list
55757775|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55757776|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757777|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55757778|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757779|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757780|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55757781|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55757782|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55757784|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
55757785|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55757786|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55757787|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55757788|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55757789|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55757790|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55757791|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55757792|NCT04944069|Bevacizumab|bevacizumab|mesh-list
55757793|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55757794|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757795|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55757796|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55757797|NCT04944069|Growth Substances|growth substances|mesh-ancestor
55757798|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757799|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
55757800|NCT04951167|Norepinephrine|norepinephrine|mesh-list
55757801|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55757802|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55757803|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
55757804|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757805|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757806|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757807|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
55757808|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
55757809|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757810|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55757812|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
55757813|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55757814|NCT04950933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55757815|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55781647|NCT04509115|Sensory System Agents|sensory system agents|mesh-ancestor
55757816|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757817|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757818|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55757819|NCT04950933|Protective Agents|protective agents|mesh-ancestor
55757821|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55757822|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757823|NCT03058263|Neostigmine|neostigmine|mesh-list
55757824|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55757826|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757827|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
55757828|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757829|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757830|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55757831|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
55757832|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757833|NCT04415853|Irinotecan|irinotecan|mesh-list
55757834|NCT04415853|Tegafur|tegafur|mesh-list
55757835|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55757836|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55757837|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757838|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757839|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757840|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55757841|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
55757842|NCT04415151|Tofacitinib|tofacitinib|mesh-list
55757843|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55757844|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757845|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757846|NCT03059277|Aflibercept|aflibercept|mesh-list
55757847|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55757848|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55757849|NCT03059277|Growth Substances|growth substances|mesh-ancestor
55757850|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757851|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
55757852|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757853|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
55757854|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55757855|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
55757856|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757857|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55757858|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55757859|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
55757860|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757861|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757862|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55757864|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55757866|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55757867|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757868|NCT00700817|Incretins|incretins|mesh-ancestor
55757869|NCT00700817|Hormones|hormones|mesh-ancestor
55757870|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55757871|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55757872|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
55757873|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757874|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757875|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55757876|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
55757877|NCT04960293|Coagulants|coagulants|mesh-ancestor
55757878|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55757880|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757881|NCT04948125|Apatinib|apatinib|mesh-list
55757882|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55757883|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55757884|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757885|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757886|NCT02455115|Chromium|chromium|mesh-list
55757887|NCT02455115|Norepinephrine|norepinephrine|mesh-list
55757888|NCT02455115|Edetic Acid|edetic acid|mesh-list
55757889|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
55757890|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55757891|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55757892|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
55757893|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757894|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757895|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757896|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
55757897|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
55757898|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757899|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55757900|NCT02455115|Trace Elements|trace elements|mesh-ancestor
55757901|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
55757902|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
55757903|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55757908|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55757909|NCT03094247|Amoxicillin|amoxicillin|mesh-list
55757910|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55757911|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757912|NCT04947423|Scopolamine|scopolamine|mesh-list
55757913|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55757914|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
55757915|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
55757916|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757917|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757918|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55757919|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
55757920|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55757921|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
55757922|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757930|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55757932|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
55757933|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55757934|NCT03250481|Narcotics|narcotics|mesh-ancestor
55757935|NCT03250481|Analgesics|analgesics|mesh-ancestor
55757936|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
55757937|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757938|NCT04947267|Epinephrine|epinephrine|mesh-list
55757940|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55757941|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55757942|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
55757943|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55757944|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757945|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757946|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55757947|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55757948|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
55757949|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55757950|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55757951|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
55757952|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
55757953|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
55757954|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55757955|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
55757956|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
55757957|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757958|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
55757960|NCT04423731|Gemcitabine|gemcitabine|mesh-list
55757961|NCT04423731|Paclitaxel|paclitaxel|mesh-list
55757962|NCT04423731|Fluorouracil|fluorouracil|mesh-list
55757963|NCT04423731|Folfirinox|folfirinox|mesh-list
55757964|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55757968|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
55757969|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55757970|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55757971|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
55757972|NCT04423731|Antiviral Agents|antiviral agents|mesh-ancestor
55757973|NCT04423731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55757974|NCT04423731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55757975|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55757976|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
55757977|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757979|NCT04423731|Protective Agents|protective agents|mesh-ancestor
55757980|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
55757982|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
55757984|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
55757985|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
55757986|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
55757987|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757988|NCT04947345|Propofol|propofol|mesh-list
55757989|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55757990|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55757991|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55757992|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55757993|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
55757994|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
55757995|NCT04947189|Dexamethasone|dexamethasone|mesh-list
55757996|NCT04947189|Docetaxel|docetaxel|mesh-list
55757997|NCT04947189|Seviteronel|seviteronel|mesh-list
55757998|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55757999|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
55758000|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
55758001|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758002|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758003|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758005|NCT04947189|Hormones|hormones|mesh-ancestor
55758006|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758007|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55781695|NCT02362945|Oxytocin|oxytocin|mesh-list
55758008|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758009|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
55758010|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
55758011|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
55758012|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758013|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55758014|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758015|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55758016|NCT03249311|Milnacipran|milnacipran|mesh-list
55758017|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
55758018|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55758019|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55758020|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55758021|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758022|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758023|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758024|NCT03249311|Analgesics|analgesics|mesh-ancestor
55758025|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
55758026|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758027|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
55758028|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55758029|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
55758030|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55758031|NCT04413123|Nivolumab|nivolumab|mesh-list
55758032|NCT04413123|Ipilimumab|ipilimumab|mesh-list
55758033|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758034|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758035|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55758036|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758037|NCT02454491|Verapamil|verapamil|mesh-list
55758038|NCT02454491|Heparin|heparin|mesh-list
55758039|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
55758040|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55758041|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55758042|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758043|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55758044|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55758045|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55758046|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55758047|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758048|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
55758049|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
55758050|NCT03248765|Narcotics|narcotics|mesh-ancestor
55758051|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55758052|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758053|NCT03248765|Analgesics|analgesics|mesh-ancestor
55758054|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
55758055|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758056|NCT04939857|Trimetazidine|trimetazidine|mesh-list
55758057|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
55758059|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
55758060|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55758061|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758062|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55758063|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781697|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55758064|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758065|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
55758066|NCT03247595|Bisacodyl|bisacodyl|mesh-list
55758067|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55758068|NCT03247595|Cathartics|cathartics|mesh-ancestor
55758069|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758070|NCT03247595|Laxatives|laxatives|mesh-ancestor
55758071|NCT04938453|Nintedanib|nintedanib|mesh-list
55758072|NCT04938453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758073|NCT04938453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55758074|NCT04938453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758075|NCT04938453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758076|NCT03247283|Linrodostat|linrodostat|mesh-list
55758077|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758078|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758079|NCT04938297|Rituximab|rituximab|mesh-list
55758080|NCT04938297|Lenalidomide|lenalidomide|mesh-list
55758081|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
55758082|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758083|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758084|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
55758085|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758086|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55758087|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55758091|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55758092|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758093|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758095|NCT04937907|Benazepril|benazepril|mesh-list
55758096|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
55758097|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55758098|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55758099|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758100|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758101|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758102|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55758103|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55758104|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
55758105|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55758107|NCT02625909|Velpatasvir|velpatasvir|mesh-list
55758108|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
55758109|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758110|NCT03246659|Polygeline|polygeline|mesh-list
55758111|NCT03246659|Gastrins|gastrins|mesh-list
55758112|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
55758113|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
55758114|NCT03246659|Hormones|hormones|mesh-ancestor
55758115|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758116|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758117|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
55758118|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55758120|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758121|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758122|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55758123|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
55758124|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
55758125|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55758126|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
55758127|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758128|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758129|NCT03246113|Temozolomide|temozolomide|mesh-list
55758130|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55758131|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
55758132|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758133|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758134|NCT04937673|Paclitaxel|paclitaxel|mesh-list
55758135|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55758136|NCT04937673|Cisplatin|cisplatin|mesh-list
55758137|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55758138|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758139|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
55758140|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
55758141|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
55758142|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758143|NCT04944381|Vaccines|vaccines|mesh-list
55758144|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
55758145|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758146|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
55758147|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758148|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758149|NCT03245333|Hormones|hormones|mesh-list
55758150|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758151|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758152|NCT04958187|Mitogens|mitogens|mesh-list
55758153|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
55758154|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758156|NCT03244319|Edoxaban|edoxaban|mesh-list
55758157|NCT03244319|Anticoagulants|anticoagulants|mesh-list
55758158|NCT03244319|Coagulants|coagulants|mesh-list
55758159|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55758160|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
55758161|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55758162|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
55758163|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758164|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758165|NCT03244553|Prucalopride|prucalopride|mesh-list
55758166|NCT03244553|Laxatives|laxatives|mesh-ancestor
55758167|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758168|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55758169|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55758170|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
55758171|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758172|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758173|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758174|NCT03244241|Insulin|insulin|mesh-list
55758175|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55758176|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758177|NCT03243851|Metformin|metformin|mesh-list
55758178|NCT03243851|Temozolomide|temozolomide|mesh-list
55758179|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55758180|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55781740|NCT02362711|Estrogens|estrogens|mesh-ancestor
55758181|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55758183|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758184|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758186|NCT02623959|Fentanyl|fentanyl|mesh-list
55758187|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55758188|NCT02623959|Narcotics|narcotics|mesh-ancestor
55758189|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55758190|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758191|NCT02623959|Analgesics|analgesics|mesh-ancestor
55758192|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
55758193|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758194|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55758195|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55758196|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
55758198|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55758199|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758200|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
55758201|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55758202|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55758203|NCT03242993|Folic Acid|folic acid|mesh-list
55758204|NCT03242993|Hematinics|hematinics|mesh-ancestor
55758205|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
55758206|NCT03242993|Vitamins|vitamins|mesh-ancestor
55758207|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
55758208|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758209|NCT04487093|Vaccines|vaccines|mesh-list
55758210|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
55758211|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758212|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
55758213|NCT04936971|Everolimus|everolimus|mesh-list
55758214|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758215|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55758216|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
55758219|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55758220|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
55758221|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55758222|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758223|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758224|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758225|NCT04931433|Lidocaine|lidocaine|mesh-list
55758226|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
55758227|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
55758228|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55758229|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758230|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
55758231|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758232|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55758233|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55758234|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55758235|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55758236|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758237|NCT04931355|Cetrorelix|cetrorelix|mesh-list
55781753|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55758238|NCT04931355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758320|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758239|NCT04931355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758240|NCT04931355|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55758241|NCT04931355|Fertility Agents|fertility agents|mesh-ancestor
55758242|NCT04931355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55758243|NCT04931355|Hormone Antagonists|hormone antagonists|mesh-ancestor
55758244|NCT04931121|Viscosupplements|viscosupplements|mesh-list
55758245|NCT04931121|Protective Agents|protective agents|mesh-ancestor
55758247|NCT03241901|Lumefantrine|lumefantrine|mesh-list
55758248|NCT03241901|Artemether|artemether|mesh-list
55758249|NCT03241901|Primaquine|primaquine|mesh-list
55758250|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55758251|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
55758252|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55758253|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55758254|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758255|NCT03241745|Nivolumab|nivolumab|mesh-list
55758256|NCT03241745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758257|NCT03241745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758258|NCT03241745|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55758259|NCT03241745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758260|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
55758261|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758262|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55758263|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758264|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758266|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55758267|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
55758268|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758269|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55758270|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758271|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758272|NCT02453867|Tacrolimus|tacrolimus|mesh-list
55758273|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55758274|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
55758275|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758277|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758278|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758279|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
55758280|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
55758281|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
55758282|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758283|NCT03239327|Alprostadil|alprostadil|mesh-list
55758284|NCT03239327|Misoprostol|misoprostol|mesh-list
55758285|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55758286|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
55758287|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55758288|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758289|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55758290|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758291|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
55758292|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55758294|NCT03239327|Urological Agents|urological agents|mesh-ancestor
55758295|NCT04930185|Vaccines|vaccines|mesh-list
55758296|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
55758297|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758298|NCT02314559|Propofol|propofol|mesh-list
55758299|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55758300|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55758301|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758302|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55758303|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
55758304|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
55758305|NCT03238703|Tamoxifen|tamoxifen|mesh-list
55758306|NCT03238703|Toremifene|toremifene|mesh-list
55758307|NCT03238703|Letrozole|letrozole|mesh-list
55758308|NCT03238703|Anastrozole|anastrozole|mesh-list
55758309|NCT03238703|Exemestane|exemestane|mesh-list
55758310|NCT03238703|Citric Acid|citric acid|mesh-list
55758311|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
55758313|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55758314|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
55758315|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
55758316|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758317|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758318|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55758319|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55758323|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758324|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758325|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55758326|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55758327|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55758328|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55758330|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
55758331|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
55758332|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55758333|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758335|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758336|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55758337|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55758338|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55758339|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55758340|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758341|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
55758342|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55758343|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
55758344|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758345|NCT05387681|Endostatins|endostatins|mesh-list
55758346|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758347|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55758348|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55781799|NCT04410887|Olaparib|olaparib|mesh-list
55758350|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758351|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
55758352|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
55758353|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55758354|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
55758355|NCT03238157|Hormones|hormones|mesh-ancestor
55758356|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758357|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758358|NCT04485845|Metformin|metformin|mesh-list
55758359|NCT04485845|Vildagliptin|vildagliptin|mesh-list
55758360|NCT04485845|Captopril|captopril|mesh-list
55758361|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55758362|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758363|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55758364|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
55758365|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758366|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758367|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55758368|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55758369|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55758370|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55758371|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55758372|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55758373|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758374|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
55758375|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758376|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758377|NCT03237533|Promethazine|promethazine|mesh-list
55758378|NCT03237533|Doxycycline|doxycycline|mesh-list
55758379|NCT03237533|Nystatin|nystatin|mesh-list
55758380|NCT03237533|Dexamethasone|dexamethasone|mesh-list
55758381|NCT03237533|Triamcinolone|triamcinolone|mesh-list
55758382|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55758384|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
55758385|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758386|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758387|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758388|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
55758389|NCT03237533|Hormones|hormones|mesh-ancestor
55758390|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758391|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55758392|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758393|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758394|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55758395|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758396|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
55758397|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55758401|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55758402|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
55758403|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
55758404|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758405|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55781818|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
55758406|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
55758408|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55758409|NCT03235973|Fludarabine|fludarabine|mesh-list
55758410|NCT03235973|Busulfan|busulfan|mesh-list
55758411|NCT03235973|Cladribine|cladribine|mesh-list
55758412|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758413|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758414|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55758415|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
55758416|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758417|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
55758418|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55758419|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55758420|NCT02453087|Rituximab|rituximab|mesh-list
55758421|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
55758422|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758424|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
55758425|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758426|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55758427|NCT02124772|Trametinib|trametinib|mesh-list
55758428|NCT02124772|Dabrafenib|dabrafenib|mesh-list
55758430|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55758431|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758432|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758433|NCT02159950|Vaccines|vaccines|mesh-list
55758434|NCT02159950|Immunologic Factors|immunologic factors|mesh-ancestor
55758435|NCT02159950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758436|NCT02159482|Interferons|interferons|mesh-list
55758437|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
55758438|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
55758439|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758440|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
55758441|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758442|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
55758443|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758445|NCT05269030|Budesonide|budesonide|mesh-list
55758446|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55758447|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55758448|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
55758449|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758450|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758451|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55758452|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
55758454|NCT05269030|Hormones|hormones|mesh-ancestor
55758455|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758456|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55758457|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758458|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
55758459|NCT02622321|Coagulants|coagulants|mesh-ancestor
55758460|NCT02187172|Ustekinumab|ustekinumab|mesh-list
55758461|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
55758462|NCT03057015|Dexamethasone|dexamethasone|mesh-list
55758463|NCT03057015|Clonidine|clonidine|mesh-list
55758464|NCT03057015|Epinephrine|epinephrine|mesh-list
55758465|NCT03057015|Ropivacaine|ropivacaine|mesh-list
55758466|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55758467|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
55758468|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
55758469|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758470|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758471|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758472|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
55758474|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758475|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55758476|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758477|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
55758478|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
55758479|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55758480|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
55758481|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55758482|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55758483|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
55758484|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758485|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758486|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55758487|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55758488|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55758489|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
55758491|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
55758492|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55758493|NCT03057015|Analgesics|analgesics|mesh-ancestor
55758494|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55758495|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
55758496|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55758497|NCT04934475|Lenalidomide|lenalidomide|mesh-list
55758498|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
55758499|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758500|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55758501|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55758502|NCT04934475|Growth Substances|growth substances|mesh-ancestor
55758503|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
55758504|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758505|NCT03057483|Vaccines|vaccines|mesh-list
55758506|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
55758507|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758508|NCT04922151|Ranibizumab|ranibizumab|mesh-list
55758509|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55758510|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55758512|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758513|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
55758514|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758515|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
55758516|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
55758517|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55758518|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
55758519|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758520|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55758523|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55758524|NCT04920747|Taxane|taxane|mesh-list
55758525|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758526|NCT04927299|Losartan|losartan|mesh-list
55758528|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
55758529|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55758530|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55758531|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55758532|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55758533|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758534|NCT04927299|Diuretics|diuretics|mesh-ancestor
55758535|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
55758536|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758537|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55758538|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55758540|NCT03056625|Vitamins|vitamins|mesh-ancestor
55758541|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
55758542|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758543|NCT04913103|Rituximab|rituximab|mesh-list
55758544|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55758545|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758546|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758547|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
55758548|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758549|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55758550|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55758551|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
55789051|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758552|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758553|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
55758554|NCT04920669|Bupivacaine|bupivacaine|mesh-list
55758555|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
55758556|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
55758557|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55758558|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758559|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
55758560|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758562|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55758563|NCT04920669|Analgesics|analgesics|mesh-ancestor
55758564|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55758565|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55758566|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55758567|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
55758568|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758569|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758571|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758572|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
55758573|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758574|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55758575|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55758576|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
55758577|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758579|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55758580|NCT02621931|Katacalcin|katacalcin|mesh-list
55758581|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55758582|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758583|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55758584|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
55758585|NCT04925973|Tofacitinib|tofacitinib|mesh-list
55758586|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55758587|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758588|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758589|NCT04400175|Silicon|silicon|mesh-list
55758590|NCT04400175|Trace Elements|trace elements|mesh-ancestor
55758591|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
55758592|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758593|NCT04912167|Valsartan|valsartan|mesh-list
55758594|NCT04912167|Enalapril|enalapril|mesh-list
55758595|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55758596|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55758597|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55758598|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55758599|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758600|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55758601|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
55758602|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758603|NCT03056703|Aspirin|aspirin|mesh-list
55758604|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55758605|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55758606|NCT03056703|Analgesics|analgesics|mesh-ancestor
55758607|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
55758608|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758609|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758610|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55758611|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55758614|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758615|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55758616|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55758617|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758618|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
55758619|NCT02158936|Azacitidine|azacitidine|mesh-list
55758620|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55758621|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
55758622|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758623|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758624|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758625|NCT04924647|Dexamethasone|dexamethasone|mesh-list
55758626|NCT04924647|Lenalidomide|lenalidomide|mesh-list
55758627|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55758628|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
55758629|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
55758630|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758631|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758632|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758633|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
55758635|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758636|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55758637|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758638|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
55758639|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55758640|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55758641|NCT04924647|Growth Substances|growth substances|mesh-ancestor
55758642|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
55758644|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55758645|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
55758646|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758647|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758648|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55758649|NCT04912011|Diuretics|diuretics|mesh-ancestor
55758650|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
55758651|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
55758652|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55758653|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
55758654|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758655|NCT04918719|Expectorants|expectorants|mesh-ancestor
55758656|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
55758657|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55758658|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
55758660|NCT04918719|Protective Agents|protective agents|mesh-ancestor
55758661|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758662|NCT04918719|Antidotes|antidotes|mesh-ancestor
55758663|NCT03056391|Acetaminophen|acetaminophen|mesh-list
55758664|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55758665|NCT03056391|Analgesics|analgesics|mesh-ancestor
55758666|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
55758667|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758668|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758669|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
55758670|NCT04150497|Alemtuzumab|alemtuzumab|mesh-list
55758671|NCT04150497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758672|NCT04150497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758673|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
55758674|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758675|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758676|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
55758677|NCT04918563|Acetylcholine|acetylcholine|mesh-list
55758678|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
55758679|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55758680|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
55758682|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758683|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758684|NCT02123446|Cephalexin|cephalexin|mesh-list
55758685|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55758686|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758687|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
55758688|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55758689|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55758690|NCT04918953|Prednisolone|prednisolone|mesh-list
55758691|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
55758692|NCT04918953|Budesonide|budesonide|mesh-list
55758693|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55758694|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
55758695|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55758697|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
55758698|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758699|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758700|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758701|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
55758703|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758704|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55758705|NCT04918953|Protective Agents|protective agents|mesh-ancestor
55758706|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55758707|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758708|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55758709|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55758710|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
55758712|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55758713|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758714|NCT03054207|Clopidogrel|clopidogrel|mesh-list
55758715|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55758716|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55758717|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55758718|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55758719|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55758720|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
55758721|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758722|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758723|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758725|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55758726|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55758727|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55758728|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55758729|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
55758730|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758731|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758732|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758733|NCT03056079|Aflibercept|aflibercept|mesh-list
55758734|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55758735|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55758736|NCT03056079|Growth Substances|growth substances|mesh-ancestor
55758737|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758738|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
55758739|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758740|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55758741|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55758742|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55758743|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758744|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758745|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55758746|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55758747|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758748|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
55758749|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758752|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55758753|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758754|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55758755|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758756|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758757|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55758758|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
55758760|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758761|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758762|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55758763|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55758764|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55758765|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758766|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758768|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55758769|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758770|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55758771|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758772|NCT03054285|Levetiracetam|levetiracetam|mesh-list
55758773|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
55758774|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
55758775|NCT04917627|Vancomycin|vancomycin|mesh-list
55758776|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55758777|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758778|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
55758779|NCT04903743|Bupivacaine|bupivacaine|mesh-list
55758780|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
55758781|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
55758782|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55758783|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758784|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
55758785|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758786|NCT04903743|Analgesics|analgesics|mesh-ancestor
55758787|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55758788|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
55758789|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55758790|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55758791|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758792|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55758793|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
55758794|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55758795|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
55758796|NCT04903275|Fluorides|fluorides|mesh-list
55758797|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
55758798|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
55758799|NCT04903275|Protective Agents|protective agents|mesh-ancestor
55758800|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758804|NCT04902885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758805|NCT04902885|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55758807|NCT04902885|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55758808|NCT04902885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758809|NCT04902885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758810|NCT04902885|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55758811|NCT02121262|Dexamethasone|dexamethasone|mesh-list
55758812|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55758813|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
55758814|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
55758815|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758816|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758817|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55758818|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
55758819|NCT02121262|Hormones|hormones|mesh-ancestor
55758820|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55758821|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55758822|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758823|NCT03053739|Bosentan|bosentan|mesh-list
55758824|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
55758825|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
55758826|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55758827|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55758828|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758829|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758830|NCT03053739|Urological Agents|urological agents|mesh-ancestor
55758831|NCT03053739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55758832|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55758833|NCT04916925|Vitamin D|vitamin d|mesh-list
55758834|NCT04916925|Vitamins|vitamins|mesh-ancestor
55758835|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
55758836|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758837|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55758838|NCT04902261|Gemcitabine|gemcitabine|mesh-list
55758839|NCT04902261|Paclitaxel|paclitaxel|mesh-list
55758840|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55758841|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758843|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
55758844|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
55758845|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758846|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55758847|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
55758848|NCT04902261|Antiviral Agents|antiviral agents|mesh-ancestor
55758849|NCT04902261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758850|NCT04902261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758851|NCT04902261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55758852|NCT04902261|Immunologic Factors|immunologic factors|mesh-ancestor
55758853|NCT04902261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758854|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
55758855|NCT04902027|Analgesics|analgesics|mesh-ancestor
55758856|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
55758857|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758858|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758859|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758860|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55758861|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55758862|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758863|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758865|NCT04902105|Valproic Acid|valproic acid|mesh-list
55758866|NCT04902105|Ecopipam|ecopipam|mesh-list
55758867|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
55758868|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55781943|NCT02357797|Vortioxetine|vortioxetine|mesh-list
55758869|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758870|NCT04902105|GABA Agents|gaba agents|mesh-ancestor
55758871|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758872|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758873|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
55758874|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55758875|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55758876|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55758877|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55758878|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55758879|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
55758880|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55758881|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55758882|NCT04902105|Analgesics|analgesics|mesh-ancestor
55758883|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
55758884|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758885|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55758886|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55758887|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55758888|NCT02120950|Aflibercept|aflibercept|mesh-list
55758889|NCT02120950|Verteporfin|verteporfin|mesh-list
55758890|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55758891|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55758892|NCT02120950|Growth Substances|growth substances|mesh-ancestor
55758893|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758894|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
55758895|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758896|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55758897|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
55758898|NCT02120794|Insulin|insulin|mesh-list
55758899|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55758900|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758901|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
55758904|NCT04900311|Paclitaxel|paclitaxel|mesh-list
55758905|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55758906|NCT04900311|Trastuzumab|trastuzumab|mesh-list
55758907|NCT04900311|Pertuzumab|pertuzumab|mesh-list
55758908|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55758909|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758910|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
55758911|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
55758912|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
55758913|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758914|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758915|NCT04900155|Atorvastatin|atorvastatin|mesh-list
55758916|NCT04900155|Ezetimibe|ezetimibe|mesh-list
55758917|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55758918|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55758919|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
55758920|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758921|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55758922|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55758923|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758924|NCT02155738|Acetaminophen|acetaminophen|mesh-list
55758925|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55758928|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758929|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758930|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
55758931|NCT03053505|Vancomycin|vancomycin|mesh-list
55758932|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
55758933|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55758934|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758935|NCT02181790|Acitretin|acitretin|mesh-list
55758936|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
55758937|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
55758938|NCT03051945|Ketamine|ketamine|mesh-list
55758939|NCT03051945|Analgesics|analgesics|mesh-ancestor
55758940|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
55758941|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55758942|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758943|NCT03051945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55758944|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55758945|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
55758946|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
55758947|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55758948|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55758950|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55758951|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758953|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
55758954|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
55758955|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758957|NCT04899453|Rituximab|rituximab|mesh-list
55758958|NCT04899453|Methotrexate|methotrexate|mesh-list
55758959|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
55758960|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758961|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758962|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
55758963|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55758964|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55758965|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55758966|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
55758967|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55758968|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55758969|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
55758970|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758971|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
55758972|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758973|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55758974|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55758975|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55758976|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55758977|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55758978|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55758979|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758980|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
55758981|NCT04898751|Nivolumab|nivolumab|mesh-list
55758982|NCT04898751|Ipilimumab|ipilimumab|mesh-list
55758983|NCT04898751|Durvalumab|durvalumab|mesh-list
55758984|NCT04898751|Avelumab|avelumab|mesh-list
55758985|NCT04898751|Cemiplimab|cemiplimab|mesh-list
55758986|NCT04898751|Atezolizumab|atezolizumab|mesh-list
55758987|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55758988|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55758989|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55758990|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55758992|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55758995|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55758996|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55758997|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55758998|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55758999|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759000|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759001|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55759002|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
55759003|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55759004|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759005|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55759006|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55759007|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55759008|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
55759010|NCT04908813|Oxaliplatin|oxaliplatin|mesh-list
55759011|NCT04908813|Trastuzumab|trastuzumab|mesh-list
55759012|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55759013|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
55759014|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759015|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759016|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55759017|NCT03051711|Pyrazole|pyrazole|mesh-list
55759018|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759019|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759020|NCT04908345|Fentanyl|fentanyl|mesh-list
55759021|NCT04908345|Methadone|methadone|mesh-list
55759022|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55759023|NCT04908345|Narcotics|narcotics|mesh-ancestor
55759024|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759025|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759026|NCT04908345|Analgesics|analgesics|mesh-ancestor
55759027|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
55759028|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759029|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55759030|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55759031|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
55759032|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
55759033|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
55759034|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
55759036|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
55759037|NCT04893993|Vitamins|vitamins|mesh-ancestor
55759038|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
55759039|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759040|NCT04893525|Buprenorphine|buprenorphine|mesh-list
55759041|NCT04893525|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55759042|NCT04893525|Naloxone|naloxone|mesh-list
55759043|NCT04893525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55759044|NCT04893525|Narcotics|narcotics|mesh-ancestor
55760008|NCT03045471|Protective Agents|protective agents|mesh-ancestor
55759045|NCT04893525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759046|NCT04893525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759047|NCT04893525|Analgesics|analgesics|mesh-ancestor
55759048|NCT04893525|Sensory System Agents|sensory system agents|mesh-ancestor
55759049|NCT04893525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759050|NCT04893525|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55759051|NCT04897971|Antibodies|antibodies|mesh-list
55759052|NCT04897971|Immunologic Factors|immunologic factors|mesh-ancestor
55759053|NCT04897971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759054|NCT03051243|Insulin|insulin|mesh-list
55759056|NCT03051243|Linagliptin|linagliptin|mesh-list
55759057|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55759058|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759059|NCT03051243|Incretins|incretins|mesh-ancestor
55759060|NCT03051243|Hormones|hormones|mesh-ancestor
55759061|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759062|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55759063|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
55759064|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759065|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759066|NCT04897737|Tenofovir|tenofovir|mesh-list
55759067|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
55759068|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759069|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55759070|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55759071|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759072|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759073|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55759074|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55759075|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
55759076|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55759077|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55759078|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759079|NCT04897269|Progesterone|progesterone|mesh-list
55759080|NCT04897269|Progestins|progestins|mesh-ancestor
55759082|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759083|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759084|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55759085|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
55759086|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55759087|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
55759088|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759090|NCT04896177|Paclitaxel|paclitaxel|mesh-list
55759091|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55759092|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759093|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
55759094|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
55759095|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
55782006|NCT02361619|Diclofenac|diclofenac|mesh-list
55759096|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759097|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55759098|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759099|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55759101|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55759102|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
55759103|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759104|NCT03052569|Agerafenib|agerafenib|mesh-list
55759105|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55759106|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759107|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759108|NCT04906317|Midazolam|midazolam|mesh-list
55759109|NCT04906317|Dezocine|dezocine|mesh-list
55759110|NCT04906317|Propofol|propofol|mesh-list
55759111|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55759112|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759113|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759114|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55759115|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
55759116|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
55759117|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55759118|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55759119|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55759120|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55759122|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
55759123|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759124|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759125|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55759126|NCT04906317|Narcotics|narcotics|mesh-ancestor
55759127|NCT04906317|Analgesics|analgesics|mesh-ancestor
55759128|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
55759129|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759131|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
55759132|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759133|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759134|NCT04430361|Dexamethasone|dexamethasone|mesh-list
55759135|NCT04430361|Megestrol|megestrol|mesh-list
55759136|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
55759137|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759138|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
55759139|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
55759140|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759141|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759142|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55759143|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
55759144|NCT04430361|Hormones|hormones|mesh-ancestor
55759145|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759146|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55759147|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759148|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55759149|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55759150|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55759151|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
55759152|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55759154|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55759155|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
55759156|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55759157|NCT04906083|Mitogens|mitogens|mesh-list
55759158|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
55759159|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759160|NCT02616783|Lamivudine|lamivudine|mesh-list
55759161|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55759162|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55759163|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759164|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759166|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759168|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55759169|NCT04895007|Vaccines|vaccines|mesh-list
55759170|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
55759171|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759173|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55759174|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759175|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759176|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55759177|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55759178|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759179|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759180|NCT04894617|Amantadine|amantadine|mesh-list
55759182|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55759183|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
55759184|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759185|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
55759186|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759187|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759188|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759189|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55759190|NCT04894617|Analgesics|analgesics|mesh-ancestor
55759191|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
55759192|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759193|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55759194|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55759196|NCT04398537|Hormones|hormones|mesh-ancestor
55759197|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759199|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759200|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759201|NCT04397991|Furosemide|furosemide|mesh-list
55759202|NCT04397991|Diuretics|diuretics|mesh-ancestor
55759203|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
55759204|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759205|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55759206|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55759207|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759208|NCT04397679|Chloroquine|chloroquine|mesh-list
55759209|NCT04397679|Temozolomide|temozolomide|mesh-list
55782060|NCT02352025|Equol|equol|mesh-list
55759210|NCT04397679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55759211|NCT04397679|Alkylating Agents|alkylating agents|mesh-ancestor
55759212|NCT04397679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759213|NCT04397679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759214|NCT04397679|Amebicides|amebicides|mesh-ancestor
55759215|NCT04397679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55759216|NCT04397679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55759217|NCT04397679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759218|NCT04397679|Antimalarials|antimalarials|mesh-ancestor
55759219|NCT04397679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55759221|NCT04906161|Calcium|calcium|mesh-list
55759222|NCT04906161|Vitamins|vitamins|mesh-ancestor
55759223|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
55759224|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759225|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55759226|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55759227|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55759228|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
55759229|NCT03051009|Coagulants|coagulants|mesh-ancestor
55759230|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55759231|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
55759232|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759233|NCT04889781|Dexamethasone|dexamethasone|mesh-list
55759234|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
55759235|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759236|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
55759237|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
55759238|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759239|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759240|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55759241|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
55759242|NCT04889781|Hormones|hormones|mesh-ancestor
55759243|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759244|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55759245|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759246|NCT02616393|XL647|xl647|mesh-list
55759247|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759248|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55759249|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759250|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759251|NCT04905147|Mosapride|mosapride|mesh-list
55759252|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55759253|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55759254|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
55759255|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759256|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759257|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759259|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55759260|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759261|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55759262|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759263|NCT04882683|Prednisone|prednisone|mesh-list
55759264|NCT04882683|Adalimumab|adalimumab|mesh-list
55759265|NCT04882683|Azathioprine|azathioprine|mesh-list
55759266|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759267|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
55759268|NCT04882683|Hormones|hormones|mesh-ancestor
55759269|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759270|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759271|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55759272|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759273|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55759274|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
55759275|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759276|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55759277|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55759278|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
55759279|NCT02155660|Benralizumab|benralizumab|mesh-list
55759280|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55759281|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
55759282|NCT04753372|Aspirin|aspirin|mesh-list
55759283|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
55759284|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55759285|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
55759286|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55759287|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
55759288|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759289|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759290|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
55759291|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55759292|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55759293|NCT04753372|Analgesics|analgesics|mesh-ancestor
55759294|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
55759295|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759296|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759297|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759298|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55759299|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55759300|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55759301|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55759302|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55759303|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
55759304|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55759305|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55759306|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55759307|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
55759308|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759309|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55759310|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55759311|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759313|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759314|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55759315|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759316|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759318|NCT02181634|Paclitaxel|paclitaxel|mesh-list
55759319|NCT02181634|Antimetabolites|antimetabolites|mesh-list
55759320|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55759321|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759322|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
55759323|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
55759324|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
55759325|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759326|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55759327|NCT02181634|Antiviral Agents|antiviral agents|mesh-ancestor
55759329|NCT02181634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759330|NCT02181634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55759331|NCT02181634|Immunologic Factors|immunologic factors|mesh-ancestor
55759332|NCT02181634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759334|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
55759335|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
55759336|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759337|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759338|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
55759339|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759340|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55759341|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55759342|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55759343|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55759344|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759345|NCT04425291|Vaccines|vaccines|mesh-list
55759346|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
55759347|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759348|NCT04879407|Warfarin|warfarin|mesh-list
55759349|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
55759350|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
55759351|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55759352|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
55759353|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55759354|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
55759355|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759356|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759357|NCT04886193|Leucovorin|leucovorin|mesh-list
55759358|NCT04886193|Docetaxel|docetaxel|mesh-list
55759359|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
55759360|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759361|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
55759362|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
55759363|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
55759364|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759365|NCT04886193|Antidotes|antidotes|mesh-ancestor
55759366|NCT04886193|Protective Agents|protective agents|mesh-ancestor
55759367|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759368|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
55759370|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
55759371|NCT04337073|Propofol|propofol|mesh-list
55759372|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55759373|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759374|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759375|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55759376|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
55759377|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
55759383|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759384|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55759385|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55759386|NCT03049059|Hydroquinone|hydroquinone|mesh-list
55759387|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
55759388|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759389|NCT03049059|Protective Agents|protective agents|mesh-ancestor
55759390|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759391|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55759392|NCT04885413|Niraparib|niraparib|mesh-list
55759393|NCT04885413|Antibodies|antibodies|mesh-list
55759394|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
55759395|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759396|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55759397|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759398|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759399|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759404|NCT03049293|Midazolam|midazolam|mesh-list
55759405|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55759406|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55759407|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759408|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759409|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55759410|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55759411|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55759412|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55759413|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
55759414|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
55759415|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
55759416|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
55759417|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759418|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759419|NCT01595529|Trimethoprim|trimethoprim|mesh-list
55759421|NCT01595529|Cephalexin|cephalexin|mesh-list
55759422|NCT01595529|Cefixime|cefixime|mesh-list
55759423|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55759424|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759425|NCT01595529|Renal Agents|renal agents|mesh-ancestor
55759426|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
55759427|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55759428|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55759429|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55759430|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759431|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759432|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55759433|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55759434|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55759435|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55759436|NCT04368507|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
55759437|NCT04368507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759438|NCT04147533|Imatinib Mesylate|imatinib mesylate|mesh-list
55759439|NCT04147533|Dasatinib|dasatinib|mesh-list
55759440|NCT04147533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55782125|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
55759441|NCT04147533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55759442|NCT04147533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759443|NCT04147533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759444|NCT05257395|Letrozole|letrozole|mesh-list
55759445|NCT05257395|Anastrozole|anastrozole|mesh-list
55759446|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759447|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55759448|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55759449|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759450|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759451|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55759452|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
55759453|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759454|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759455|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55759456|NCT05256693|Vancomycin|vancomycin|mesh-list
55759457|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55759458|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759459|NCT03046953|Avelumab|avelumab|mesh-list
55759460|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55759461|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759462|NCT03047109|Phenylephrine|phenylephrine|mesh-list
55759463|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
55759464|NCT03047109|Ephedrine|ephedrine|mesh-list
55759465|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55759466|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
55759467|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
55759468|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759469|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759470|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
55759471|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55759472|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
55759473|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
55759474|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55759475|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55759476|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55759477|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
55759478|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759479|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759480|NCT03047109|Protective Agents|protective agents|mesh-ancestor
55759481|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55759483|NCT03047265|Cisplatin|cisplatin|mesh-list
55759484|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55759485|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759486|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
55759489|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759491|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55759492|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55759493|NCT05256147|Analgesics|analgesics|mesh-ancestor
55759494|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
55759496|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759497|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759498|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55759499|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55759500|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759501|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759503|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
55759504|NCT05255913|Protective Agents|protective agents|mesh-ancestor
55759505|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759507|NCT05214417|Analgesics|analgesics|mesh-ancestor
55759508|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
55759509|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759510|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759511|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55759512|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55759513|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
55759514|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
55759515|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759516|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55759517|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55759518|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759519|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759520|NCT04870671|Tenofovir|tenofovir|mesh-list
55759521|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
55759522|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759523|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55759524|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55759525|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759526|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759527|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55759528|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55759530|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55759531|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759532|NCT03046719|Bupivacaine|bupivacaine|mesh-list
55759533|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
55759535|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759537|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
55759538|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759539|NCT04146207|Prednisone|prednisone|mesh-list
55759540|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759541|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
55759542|NCT04146207|Hormones|hormones|mesh-ancestor
55759543|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759544|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759545|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55759546|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759547|NCT04876755|TEMPO|tempo|mesh-list
55759548|NCT04876755|TEMPOL-H|tempol-h|mesh-list
55759549|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
55759550|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759551|NCT04876755|Protective Agents|protective agents|mesh-ancestor
55759552|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759553|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55759555|NCT04876521|Amisulpride|amisulpride|mesh-list
55759556|NCT04876521|Fluoxetine|fluoxetine|mesh-list
55759557|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
55759558|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
55759559|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759560|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759561|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55759562|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55759563|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55759564|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759565|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55759566|NCT04876521|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55759567|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55759568|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55759569|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759570|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759571|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
55759572|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55759573|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
55759574|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55759575|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55759576|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759577|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55759578|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
55759580|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55759581|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
55759582|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759583|NCT02181556|Aflibercept|aflibercept|mesh-list
55759584|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55759585|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55759586|NCT02181556|Growth Substances|growth substances|mesh-ancestor
55759587|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759588|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
55759589|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759591|NCT04865991|Sevoflurane|sevoflurane|mesh-list
55759592|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55759593|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759594|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759595|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55759596|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
55759597|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
55759598|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55759599|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55759600|NCT04870203|Adalimumab|adalimumab|mesh-list
55759601|NCT04870203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759602|NCT04870203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55759603|NCT04381143|Aspirin|aspirin|mesh-list
55759604|NCT04381143|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55759605|NCT04381143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55759606|NCT04381143|Analgesics|analgesics|mesh-ancestor
55759607|NCT04381143|Sensory System Agents|sensory system agents|mesh-ancestor
55759608|NCT04381143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759609|NCT04381143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759610|NCT04381143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759611|NCT04381143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55759612|NCT04381143|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55759613|NCT04381143|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55759614|NCT04381143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759615|NCT04381143|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55759616|NCT04381143|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55759617|NCT04381143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759620|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
55759622|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759623|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759624|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
55759625|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759626|NCT04865445|Midazolam|midazolam|mesh-list
55759627|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55759628|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55759629|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759630|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759631|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55759632|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55759633|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55759634|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55759635|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
55759636|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
55759638|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
55759639|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759640|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759642|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55759643|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
55759644|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759645|NCT04864977|Insulin|insulin|mesh-list
55759646|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55759647|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759648|NCT04869501|Atezolizumab|atezolizumab|mesh-list
55759649|NCT04869501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759650|NCT03046173|Mitogens|mitogens|mesh-list
55759651|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
55759652|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759653|NCT04869579|Selenium|selenium|mesh-list
55759654|NCT04869579|Selenious Acid|selenious acid|mesh-list
55759655|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
55759656|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759657|NCT04869579|Protective Agents|protective agents|mesh-ancestor
55759658|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759659|NCT04869579|Trace Elements|trace elements|mesh-ancestor
55759660|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
55759661|NCT03235037|Levodopa|levodopa|mesh-list
55759662|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55759663|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55759664|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
55759665|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759666|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759667|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759669|NCT00700271|Valsartan|valsartan|mesh-list
55759670|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55759671|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55759672|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55759673|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759674|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55759675|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759676|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
55759677|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55759678|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55759680|NCT02613507|Nivolumab|nivolumab|mesh-list
55759681|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759682|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
55759683|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
55759684|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
55759685|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759686|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55759687|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55759688|NCT03228797|Ropivacaine|ropivacaine|mesh-list
55759689|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
55759690|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
55759691|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759692|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759693|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
55759694|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759695|NCT03044379|Dapivirine|dapivirine|mesh-list
55759696|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55759697|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55759698|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
55759699|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759700|NCT04864509|Melatonin|melatonin|mesh-list
55759701|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
55759702|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759703|NCT04864509|Protective Agents|protective agents|mesh-ancestor
55759704|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759705|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759706|NCT04875039|Dexamethasone|dexamethasone|mesh-list
55759707|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
55759708|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
55759709|NCT04875039|BB 1101|bb 1101|mesh-list
55759710|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759711|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
55759712|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
55759713|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759714|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759715|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55759716|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
55759717|NCT04875039|Hormones|hormones|mesh-ancestor
55759718|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759719|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55759723|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759724|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55759725|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759726|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55759727|NCT04875039|Analgesics|analgesics|mesh-ancestor
55759728|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
55759729|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55759730|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55759731|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55759732|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
55759733|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759734|NCT03227705|Progesterone|progesterone|mesh-list
55759735|NCT03227705|Progestins|progestins|mesh-ancestor
55759736|NCT03227705|Hormones|hormones|mesh-ancestor
55759737|NCT03227705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759738|NCT03227705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759739|NCT02452385|Vorolanib|vorolanib|mesh-list
55759740|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55759741|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759742|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759743|NCT03045783|Cefotiam|cefotiam|mesh-list
55759744|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55759745|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759746|NCT01375049|Aztreonam|aztreonam|mesh-list
55759747|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55759748|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759749|NCT04863807|Anesthetics|anesthetics|mesh-list
55759750|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759751|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759752|NCT02452307|Imiquimod|imiquimod|mesh-list
55759753|NCT02452307|Molgramostim|molgramostim|mesh-list
55759754|NCT02452307|Protamines|protamines|mesh-list
55759755|NCT02452307|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55759756|NCT02452307|Sargramostim|sargramostim|mesh-list
55759757|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55759758|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
55759759|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759760|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759761|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
55759762|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
55759763|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759764|NCT02452307|Coagulants|coagulants|mesh-ancestor
55759765|NCT02452151|Infliximab|infliximab|mesh-list
55759766|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
55759767|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55759768|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55759769|NCT04485299|Listerine|listerine|mesh-list
55759770|NCT04485299|Fluorides|fluorides|mesh-list
55759771|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
55759772|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
55759773|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
55759774|NCT04485299|Protective Agents|protective agents|mesh-ancestor
55759775|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759776|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55759777|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759778|NCT01594749|Dexamethasone|dexamethasone|mesh-list
55759779|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
55759780|NCT01594749|Ondansetron|ondansetron|mesh-list
55759781|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
55759782|NCT01594749|Aprepitant|aprepitant|mesh-list
55759783|NCT01594749|BB 1101|bb 1101|mesh-list
55759786|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
55759787|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759788|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759789|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55759790|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
55759791|NCT01594749|Hormones|hormones|mesh-ancestor
55759792|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759793|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55759794|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759795|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
55759796|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759797|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759799|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
55759800|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55759801|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
55759802|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759803|NCT01594749|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55759804|NCT01594749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55759805|NCT01594749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759806|NCT01594749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55759807|NCT01594749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55759808|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55759809|NCT03226145|Scopolamine|scopolamine|mesh-list
55759810|NCT03226145|Bisacodyl|bisacodyl|mesh-list
55759811|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55759812|NCT03226145|Cathartics|cathartics|mesh-ancestor
55782209|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
55759813|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55759814|NCT03226145|Laxatives|laxatives|mesh-ancestor
55759815|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55759816|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
55759817|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
55759818|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759819|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759820|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
55759821|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55759822|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
55759824|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759825|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55759826|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
55759827|NCT04863183|Triamcinolone|triamcinolone|mesh-list
55759828|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55759829|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55759830|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55759831|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759832|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
55759833|NCT04863183|Hormones|hormones|mesh-ancestor
55759834|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759835|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759836|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55759837|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
55759838|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759839|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759840|NCT03234413|Botulinum Toxins|botulinum toxins|mesh-list
55759841|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55759842|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55759843|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55759844|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55759845|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759846|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
55759847|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759848|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759849|NCT03234413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55759850|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759851|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
55759852|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759854|NCT02453009|Docetaxel|docetaxel|mesh-list
55759855|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759856|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
55759858|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
55759859|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759860|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759861|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
55759863|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759864|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759865|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55759866|NCT04868175|Timolol|timolol|mesh-list
55759867|NCT04868175|Travoprost|travoprost|mesh-list
55759868|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55759869|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55759870|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
55759871|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759872|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759873|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759874|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55759875|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55759876|NCT02452775|Poly ICLC|poly iclc|mesh-list
55759877|NCT02452775|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55759878|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
55759879|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
55759880|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759881|NCT02452775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55759882|NCT03045627|Cytarabine|cytarabine|mesh-list
55759883|NCT03045627|Aclarubicin|aclarubicin|mesh-list
55759884|NCT03045627|Lenograstim|lenograstim|mesh-list
55759885|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55759886|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
55759887|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759888|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759889|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
55759890|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55759891|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55759892|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
55759893|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759894|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55759895|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55759896|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55759897|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55759898|NCT03045627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759899|NCT04868019|Fenofibrate|fenofibrate|mesh-list
55759900|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55759901|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
55759902|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759903|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55759904|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
55759905|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759906|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55759907|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759908|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759910|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759911|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759912|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55759914|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55759915|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759916|NCT03233321|Heparin|heparin|mesh-list
55759917|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55759918|NCT03233321|Tinzaparin|tinzaparin|mesh-list
55759919|NCT03233321|Dalteparin|dalteparin|mesh-list
55759920|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
55759921|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55759923|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759924|NCT04868253|Oxazepam|oxazepam|mesh-list
55759925|NCT04868253|Metyrapone|metyrapone|mesh-list
55759926|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
55760007|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55759927|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759928|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759929|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55759930|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759931|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759932|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55759934|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55759935|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
55759936|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
55759937|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759938|NCT02153788|Temazepam|temazepam|mesh-list
55759939|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55759940|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759942|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55759943|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55759944|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55759945|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
55759946|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
55759947|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55759948|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759949|NCT03224039|Sufentanil|sufentanil|mesh-list
55759950|NCT03224039|Morphine|morphine|mesh-list
55759951|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55759952|NCT03224039|Narcotics|narcotics|mesh-ancestor
55759953|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55759954|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759955|NCT03224039|Analgesics|analgesics|mesh-ancestor
55759956|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
55759957|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55759958|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55759959|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55759960|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
55759962|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
55759963|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759964|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55759965|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789052|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55759966|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759967|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
55759968|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55759969|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759970|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55759971|NCT03223961|Epoetin Alfa|epoetin alfa|mesh-list
55759972|NCT03223961|Hematinics|hematinics|mesh-ancestor
55759973|NCT03045471|Prednisolone|prednisolone|mesh-list
55759974|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55759975|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
55759976|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55759977|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
55759978|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
55759979|NCT03045471|Rituximab|rituximab|mesh-list
55759980|NCT03045471|Etoposide|etoposide|mesh-list
55759981|NCT03045471|Vincristine|vincristine|mesh-list
55759982|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55759983|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
55759984|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55759985|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
55759986|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55759987|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55759988|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55759989|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
55759990|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55759991|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55759992|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55759993|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55759994|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55759995|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55759997|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55759998|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55759999|NCT03045471|Glucocorticoids|glucocorticoids|mesh-ancestor
55760001|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760002|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55760004|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
55760005|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760006|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55760013|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55760014|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55760015|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55760016|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55760017|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760018|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
55760019|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760020|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760021|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55760022|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760023|NCT03223025|Hormones|hormones|mesh-list
55760024|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760025|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760026|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
55760027|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760029|NCT04873479|Esketamine|esketamine|mesh-list
55760030|NCT04873479|Analgesics|analgesics|mesh-ancestor
55760031|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
55760032|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760033|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760034|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55760035|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55760036|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
55760037|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
55760038|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760039|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55760040|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55760041|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760042|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760043|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
55760044|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55760045|NCT02451527|Digoxin|digoxin|mesh-list
55760046|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55760047|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55760048|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760049|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760050|NCT02451527|Protective Agents|protective agents|mesh-ancestor
55760051|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760052|NCT04873011|Quinine|quinine|mesh-list
55760053|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
55760054|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55760055|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55760056|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760057|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55760058|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760059|NCT04873011|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55760060|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760061|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55760062|NCT04873011|Analgesics|analgesics|mesh-ancestor
55760064|NCT02451605|Analgesics|analgesics|mesh-list
55760065|NCT02451605|Ropivacaine|ropivacaine|mesh-list
55760066|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
55760067|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
55760068|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760069|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760070|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
55760071|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760072|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
55760073|NCT03222323|Ropivacaine|ropivacaine|mesh-list
55760074|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55760075|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760076|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760078|NCT03222323|Analgesics|analgesics|mesh-ancestor
55760079|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
55760080|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760082|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55760083|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55760084|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
55760085|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760086|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760087|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
55760088|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
55760089|NCT03043677|Adalimumab|adalimumab|mesh-list
55760090|NCT03043677|Golimumab|golimumab|mesh-list
55760091|NCT03043677|Infliximab|infliximab|mesh-list
55760092|NCT03043677|Ustekinumab|ustekinumab|mesh-list
55760094|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760095|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760096|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
55760097|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55760098|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55760099|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760100|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
55760101|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760102|NCT03222089|Leucovorin|leucovorin|mesh-list
55760103|NCT03222089|Fluorouracil|fluorouracil|mesh-list
55760104|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
55760105|NCT03222089|Irinotecan|irinotecan|mesh-list
55760106|NCT03222089|Interleukin-2|interleukin-2|mesh-list
55760107|NCT03222089|Molgramostim|molgramostim|mesh-list
55760108|NCT03222089|Sargramostim|sargramostim|mesh-list
55760109|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
55760110|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
55760111|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760112|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55760113|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760114|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760115|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
55760116|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760117|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55760118|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55760119|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760120|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55760121|NCT03222089|Analgesics|analgesics|mesh-ancestor
55760122|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
55760123|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760124|NCT03222089|Antidotes|antidotes|mesh-ancestor
55760125|NCT03222089|Protective Agents|protective agents|mesh-ancestor
55760126|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
55760128|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
55760129|NCT03043989|Clarithromycin|clarithromycin|mesh-list
55760130|NCT03043989|Docetaxel|docetaxel|mesh-list
55760131|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760133|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
55760134|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
55760135|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760137|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760138|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55760139|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760140|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55760141|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55760143|NCT03222167|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55760144|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
55760145|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760146|NCT03221855|Domperidone|domperidone|mesh-list
55760147|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
55760148|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
55760149|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760150|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760151|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55760152|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55760153|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
55760154|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760155|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760156|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
55760158|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55760159|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55760160|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55760161|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760162|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760163|NCT03047733|Tacrolimus|tacrolimus|mesh-list
55760164|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760165|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
55760166|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760167|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55760168|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760169|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760170|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
55760171|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55760172|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
55760173|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760174|NCT03221231|Expectorants|expectorants|mesh-ancestor
55760175|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
55760176|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55760177|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
55760178|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760179|NCT03221231|Protective Agents|protective agents|mesh-ancestor
55760180|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760181|NCT03221231|Antidotes|antidotes|mesh-ancestor
55760182|NCT03221621|Adalimumab|adalimumab|mesh-list
55760183|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760184|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760185|NCT03220841|Adalimumab|adalimumab|mesh-list
55760186|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760187|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760188|NCT03045393|Maytansine|maytansine|mesh-list
55760189|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55760190|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760191|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
55760192|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
55760193|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
55760194|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760195|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
55760196|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760197|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
55760198|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760199|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760200|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
55760201|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760202|NCT02505971|Propranolol|propranolol|mesh-list
55760203|NCT02505971|Nadolol|nadolol|mesh-list
55760204|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55760205|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55760206|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
55760207|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760208|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760209|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760210|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55760221|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55760223|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55760224|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55760225|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55760226|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760227|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760228|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760229|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55760230|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55760232|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
55760233|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760234|NCT02451293|Protective Agents|protective agents|mesh-ancestor
55760235|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760236|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760237|NCT02505113|Montelukast|montelukast|mesh-list
55760238|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55760239|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
55760240|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55760241|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
55760242|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760243|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760244|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55760245|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55760246|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760247|NCT02504801|Budesonide|budesonide|mesh-list
55760248|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760249|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55760251|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760252|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760253|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55760254|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
55760255|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
55760257|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760258|NCT02504333|Gemcitabine|gemcitabine|mesh-list
55760259|NCT02504333|Paclitaxel|paclitaxel|mesh-list
55760260|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55760261|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55760262|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760266|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760267|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55760268|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
55760269|NCT02504333|Antiviral Agents|antiviral agents|mesh-ancestor
55760270|NCT02504333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760271|NCT02504333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760272|NCT02504333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760273|NCT02504333|Immunologic Factors|immunologic factors|mesh-ancestor
55760274|NCT02504333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760276|NCT02450981|Bevacizumab|bevacizumab|mesh-list
55760277|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55760278|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760279|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55760280|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55760281|NCT02450981|Growth Substances|growth substances|mesh-ancestor
55760282|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760283|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
55760284|NCT02503943|Metformin|metformin|mesh-list
55760285|NCT02503943|Liraglutide|liraglutide|mesh-list
55760286|NCT02503943|Mitiglinide|mitiglinide|mesh-list
55760287|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55760288|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760289|NCT02503943|Incretins|incretins|mesh-ancestor
55760290|NCT02503943|Hormones|hormones|mesh-ancestor
55760291|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760292|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
55760293|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55760294|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760295|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760296|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55760297|NCT03213743|Analgesics|analgesics|mesh-ancestor
55760298|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
55760299|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760300|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55760302|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55760303|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
55760304|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760305|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760306|NCT03212495|Neostigmine|neostigmine|mesh-list
55760307|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760308|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760309|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760310|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760311|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55760312|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760313|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
55760314|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55760315|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
55760316|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
55760317|NCT02503319|Oxytocin|oxytocin|mesh-list
55760318|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
55760319|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55760320|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760321|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55760322|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55760323|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760324|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
55760325|NCT02503319|Coagulants|coagulants|mesh-ancestor
55760326|NCT02610777|Azacitidine|azacitidine|mesh-list
55760327|NCT02610777|Pevonedistat|pevonedistat|mesh-list
55760328|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55760330|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760331|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760332|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760333|NCT01628692|Ribavirin|ribavirin|mesh-list
55760334|NCT01628692|Simeprevir|simeprevir|mesh-list
55760335|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
55760336|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760337|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
55760338|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760339|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
55760340|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760341|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55760342|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55760343|NCT04496921|Vitamins|vitamins|mesh-list
55760344|NCT04496921|Vitamin K|vitamin k|mesh-list
55760346|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760347|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55760348|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55760349|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760350|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
55760351|NCT04496921|Coagulants|coagulants|mesh-ancestor
55760352|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
55760353|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55760354|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55760355|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55760356|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55760357|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760359|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760360|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760361|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55760362|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760364|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
55760365|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760366|NCT03043443|Protective Agents|protective agents|mesh-ancestor
55760367|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760368|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760369|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
55760370|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
55760371|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760372|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760373|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
55760374|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55760375|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55760376|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
55760377|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760378|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
55760379|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
55760380|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
55760381|NCT03209219|Interferons|interferons|mesh-list
55760382|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
55760383|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
55760385|NCT03209219|Cyclosporins|cyclosporins|mesh-list
55760386|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760387|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
55760388|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760389|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760390|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760391|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760392|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
55760393|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760394|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
55760395|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
55760396|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760397|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55760399|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
55760400|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760401|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55760402|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55760403|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760404|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760405|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55760406|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
55760407|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760408|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760409|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55760411|NCT04860531|Lidocaine|lidocaine|mesh-list
55760412|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
55760413|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
55760414|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760415|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760416|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
55760417|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760418|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55760419|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55760420|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55760421|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55760422|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760423|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760424|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
55760425|NCT04860531|Hormones|hormones|mesh-ancestor
55760426|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760427|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55760428|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
55760430|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55760431|NCT01594827|Vancomycin|vancomycin|mesh-list
55760432|NCT01594827|Doxycycline|doxycycline|mesh-list
55760433|NCT01594827|Rifampin|rifampin|mesh-list
55760434|NCT01594827|Trimethoprim|trimethoprim|mesh-list
55760435|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
55760436|NCT01594827|Mupirocin|mupirocin|mesh-list
55760437|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55760438|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760439|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
55760440|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
55760441|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55760443|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55760444|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55760446|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
55760447|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
55760448|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55760449|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760450|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760451|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55760452|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55760453|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55760454|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55760455|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55760456|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55760457|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55760458|NCT01594827|Renal Agents|renal agents|mesh-ancestor
55760459|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55760460|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55760461|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55760462|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55760463|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55760464|NCT04849845|Insulin|insulin|mesh-list
55760465|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55760466|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55760467|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760468|NCT04429191|Antibodies|antibodies|mesh-list
55760469|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55760470|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
55760471|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760472|NCT02610231|Istradefylline|istradefylline|mesh-list
55760473|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
55760474|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55760475|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55760476|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
55760477|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760478|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760479|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760480|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
55760481|NCT04849533|Prednisone|prednisone|mesh-list
55760482|NCT04849533|Everolimus|everolimus|mesh-list
55760485|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55760486|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760487|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
55760488|NCT04849533|Hormones|hormones|mesh-ancestor
55760489|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760490|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760491|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55760493|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760494|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
55760495|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55760496|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55760497|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
55760498|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55760499|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760500|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760501|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760502|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55760503|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760506|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760507|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760508|NCT02178358|Sorafenib|sorafenib|mesh-list
55760509|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760510|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55760511|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760512|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760513|NCT01598896|Clonidine|clonidine|mesh-list
55760514|NCT01598896|Dronabinol|dronabinol|mesh-list
55760515|NCT01598896|Analgesics|analgesics|mesh-ancestor
55760516|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
55760517|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760518|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760519|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55760520|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
55760521|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
55760522|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55760523|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55760524|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55760525|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
55760526|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760527|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760528|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
55760529|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55760530|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55760531|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55760532|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55760533|NCT01598896|Hormones|hormones|mesh-ancestor
55760534|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760535|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
55760536|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55760537|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
55760538|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55760539|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760540|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55760541|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55760542|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55760543|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
55760544|NCT03042429|Ifosfamide|ifosfamide|mesh-list
55760545|NCT03042429|Cisplatin|cisplatin|mesh-list
55760546|NCT03042429|Doxorubicin|doxorubicin|mesh-list
55760547|NCT03042429|Etoposide|etoposide|mesh-list
55760548|NCT03042429|Topotecan|topotecan|mesh-list
55760549|NCT03042429|Vindesine|vindesine|mesh-list
55760550|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760551|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
55760552|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760553|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760554|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55760555|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
55760556|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760557|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760558|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55760559|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55760560|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55760561|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55760562|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760563|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55760564|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55760565|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
55760566|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
55760567|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
55760569|NCT04849299|Cyclosporins|cyclosporins|mesh-list
55760570|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760571|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760572|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760574|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760575|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
55760576|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760577|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
55760578|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760579|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55760580|NCT02117050|Interferons|interferons|mesh-list
55760581|NCT02117050|Interferon-beta|interferon-beta|mesh-list
55760582|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
55760583|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760585|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760586|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
55760587|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760588|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55760589|NCT04860219|Lactoferrin|lactoferrin|mesh-list
55760590|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760591|NCT02728895|Vedolizumab|vedolizumab|mesh-list
55760592|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55760594|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55760595|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55760596|NCT04847895|Growth Substances|growth substances|mesh-ancestor
55760597|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760598|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
55760599|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760600|NCT02450513|Adalimumab|adalimumab|mesh-list
55760601|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760602|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760603|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
55760604|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55782468|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
55760605|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760606|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760607|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55760609|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
55760610|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760611|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55760612|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55760613|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55760614|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
55760615|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760616|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760617|NCT04377087|Olaparib|olaparib|mesh-list
55760618|NCT04377087|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55760619|NCT04377087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760620|NCT04377087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760621|NCT04377087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760622|NCT04857801|Teduglutide|teduglutide|mesh-list
55760623|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55760624|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55760632|NCT02501837|Oxytocin|oxytocin|mesh-list
55760633|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
55760634|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55760635|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760636|NCT04859361|Imiquimod|imiquimod|mesh-list
55760637|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55760638|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
55760639|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760640|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760641|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
55760642|NCT04496141|Antibodies|antibodies|mesh-list
55760643|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
55760644|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760645|NCT03039075|Metformin|metformin|mesh-list
55760646|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55760647|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760649|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55760650|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55760651|NCT04857177|Growth Substances|growth substances|mesh-ancestor
55760652|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760653|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
55760654|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760661|NCT02606877|Pirfenidone|pirfenidone|mesh-list
55760662|NCT02606877|Nintedanib|nintedanib|mesh-list
55760663|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760664|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55760665|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760666|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760667|NCT02606877|Analgesics|analgesics|mesh-ancestor
55760668|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
55760669|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760670|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760671|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55760672|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55760673|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760674|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760675|NCT03206957|Endostatins|endostatins|mesh-list
55760676|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
55760678|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55760679|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55760680|NCT03206957|Growth Substances|growth substances|mesh-ancestor
55760681|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760682|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
55760683|NCT03206723|Hydrocodone|hydrocodone|mesh-list
55760684|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55760685|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55760686|NCT03206723|Narcotics|narcotics|mesh-ancestor
55760687|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760688|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760689|NCT03206723|Analgesics|analgesics|mesh-ancestor
55760690|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
55760691|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760692|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
55760693|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
55760694|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55760695|NCT03201185|Ramipril|ramipril|mesh-list
55760696|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55760698|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760699|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760700|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55760701|NCT04856787|Fluorouracil|fluorouracil|mesh-list
55760702|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
55760703|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760704|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55760705|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760706|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760707|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
55760708|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760709|NCT03206177|Paclitaxel|paclitaxel|mesh-list
55760710|NCT03206177|Carboplatin|carboplatin|mesh-list
55760711|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55760712|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760713|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
55760714|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
55760715|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
55760716|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760717|NCT04839549|Fluorometholone|fluorometholone|mesh-list
55760718|NCT04839549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760719|NCT04839549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760720|NCT04839549|Glucocorticoids|glucocorticoids|mesh-ancestor
55760722|NCT04839549|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760723|NCT04839549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55760724|NCT04839627|Progesterone|progesterone|mesh-list
55760725|NCT04839627|Progestins|progestins|mesh-ancestor
55760726|NCT04839627|Hormones|hormones|mesh-ancestor
55760727|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760728|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760729|NCT04845399|Factor VIII|factor viii|mesh-list
55760730|NCT04845399|Coagulants|coagulants|mesh-ancestor
55760731|NCT04839471|Afatinib|afatinib|mesh-list
55760732|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760733|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55760734|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760735|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760737|NCT04839237|Liraglutide|liraglutide|mesh-list
55760738|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55760739|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760740|NCT04839237|Incretins|incretins|mesh-ancestor
55760741|NCT04839237|Hormones|hormones|mesh-ancestor
55760742|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760743|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
55760744|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55760745|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
55760746|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760748|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55760749|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55760750|NCT03038607|Analgesics|analgesics|mesh-ancestor
55760751|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
55760752|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760753|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760754|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760757|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55760758|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760759|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55760760|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55760761|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760762|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
55760763|NCT03038451|Amlodipine|amlodipine|mesh-list
55760764|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55760765|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55760766|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55760768|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55760769|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760770|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
55760772|NCT03040401|Interleukin-2|interleukin-2|mesh-list
55760773|NCT03040401|Histamine|histamine|mesh-list
55760774|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
55760775|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760776|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55760777|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55760778|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
55760779|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760781|NCT03040401|Analgesics|analgesics|mesh-ancestor
55760782|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
55760783|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760784|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760785|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
55760786|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
55760787|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760788|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760789|NCT03038295|Propranolol|propranolol|mesh-list
55760790|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55760791|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55760792|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
55760793|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760794|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760795|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760796|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55760797|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55760798|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
55760799|NCT03038217|Capecitabine|capecitabine|mesh-list
55760800|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
55760801|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55760802|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
55760803|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760804|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760805|NCT02609607|Bisacodyl|bisacodyl|mesh-list
55760806|NCT02609607|Cathartics|cathartics|mesh-ancestor
55760807|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55760808|NCT02609607|Laxatives|laxatives|mesh-ancestor
55760809|NCT03040167|Epinephrine|epinephrine|mesh-list
55760810|NCT03040167|Bupivacaine|bupivacaine|mesh-list
55760811|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
55760812|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
55760813|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760814|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760815|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
55760816|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760817|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55760818|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55760819|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
55760820|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760821|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760822|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55760823|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55760824|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
55760826|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
55760827|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
55760828|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
55760829|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55760831|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55760832|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55760833|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
55760834|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55760835|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55760836|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55760837|NCT04843839|Analgesics|analgesics|mesh-ancestor
55760838|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
55760839|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760840|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760841|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760842|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760843|NCT04843839|Laxatives|laxatives|mesh-ancestor
55760844|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55760846|NCT04838145|Pleconaril|pleconaril|mesh-list
55760847|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
55760848|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760853|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789053|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55789055|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789056|NCT03056495|Vorinostat|vorinostat|mesh-list
55760854|NCT03041259|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
55760855|NCT03041259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55760856|NCT03041259|Antioxidants|antioxidants|mesh-ancestor
55760857|NCT03041259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760858|NCT03041259|Protective Agents|protective agents|mesh-ancestor
55760859|NCT03041259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760860|NCT04429035|Vitamin K|vitamin k|mesh-list
55760861|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
55760862|NCT04429035|Vitamins|vitamins|mesh-ancestor
55760863|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
55760864|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760865|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55760866|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55760867|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760868|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
55760869|NCT04429035|Coagulants|coagulants|mesh-ancestor
55760870|NCT04843449|Itraconazole|itraconazole|mesh-list
55760872|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
55760873|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760874|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55760875|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55760876|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760877|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760878|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55760879|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
55760880|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760882|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55760883|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55760884|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
55760885|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55760886|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
55760887|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55760888|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55760889|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55760890|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55760891|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55760892|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55760893|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55760894|NCT03037593|Vitamin D|vitamin d|mesh-list
55760895|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
55760896|NCT03037593|Vitamins|vitamins|mesh-ancestor
55760897|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
55760898|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760899|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55760900|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55760901|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
55760902|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55760903|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55760904|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760905|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
55760906|NCT03037515|Coagulants|coagulants|mesh-ancestor
55760907|NCT04842825|Cetrorelix|cetrorelix|mesh-list
55760908|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55760909|NCT04842825|Hormones|hormones|mesh-ancestor
55760910|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55760911|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760912|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55760913|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
55760914|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55760915|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
55760917|NCT04837131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760919|NCT04837131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760920|NCT04837131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760921|NCT02606253|Metolazone|metolazone|mesh-list
55760922|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
55760923|NCT02606253|Tolvaptan|tolvaptan|mesh-list
55782593|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760924|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55760925|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760926|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
55760927|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760928|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55760929|NCT02606253|Diuretics|diuretics|mesh-ancestor
55760930|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55760931|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55760932|NCT04779645|Volagidemab|volagidemab|mesh-list
55760933|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55760934|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760936|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55760937|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55760938|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
55760939|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760940|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
55760941|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55760942|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760943|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760944|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55760945|NCT04854759|Analgesics|analgesics|mesh-ancestor
55760946|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
55760947|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760948|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
55760949|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55760950|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
55760951|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760952|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
55760953|NCT02607735|Velpatasvir|velpatasvir|mesh-list
55760955|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55760956|NCT04772313|Methotrexate|methotrexate|mesh-list
55760957|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55760958|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
55760959|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55760960|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760961|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55760962|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
55760963|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760964|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760965|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
55760966|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760967|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55760968|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55760969|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
55760970|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55760971|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55760972|NCT03040791|Nivolumab|nivolumab|mesh-list
55760973|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55760974|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760975|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55760976|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760977|NCT04854369|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55760978|NCT04854369|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55760979|NCT04854369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760981|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55760982|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55760983|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55760984|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55760985|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55760987|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
55760988|NCT04836819|Ketamine|ketamine|mesh-list
55760990|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
55760991|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55760992|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55760993|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
55760994|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55760995|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55760996|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55760997|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55760998|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55760999|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761000|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55761001|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55761002|NCT04836819|Analgesics|analgesics|mesh-ancestor
55761003|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55761004|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55761005|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55761006|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
55761007|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761008|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55761009|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55761010|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
55761011|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55761012|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55761013|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
55761014|NCT04836507|Fludarabine|fludarabine|mesh-list
55761015|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55761016|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
55761017|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761018|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761019|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55761020|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
55761021|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761022|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761023|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55761025|NCT04835259|Antioxidants|antioxidants|mesh-ancestor
55761026|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761027|NCT04835259|Protective Agents|protective agents|mesh-ancestor
55761028|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761029|NCT04835259|Trace Elements|trace elements|mesh-ancestor
55761030|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
55761031|NCT04853901|Remdesivir|remdesivir|mesh-list
55761032|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789057|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761033|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761034|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
55761035|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
55761036|NCT04834791|Letrozole|letrozole|mesh-list
55761037|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761038|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55761039|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55761040|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761041|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761042|NCT04834791|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55761043|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
55789058|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55761044|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55761045|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761046|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55789059|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761047|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761048|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761050|NCT03038919|Testosterone|testosterone|mesh-list
55761051|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
55761052|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
55761053|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55761055|NCT03038919|Hormones|hormones|mesh-ancestor
55761056|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55761057|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761058|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55761059|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761060|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
55761061|NCT03036891|Naloxegol|naloxegol|mesh-list
55761062|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55761063|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761064|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
55761065|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761066|NCT01668147|Ritonavir|ritonavir|mesh-list
55761067|NCT01668147|Efavirenz|efavirenz|mesh-list
55761068|NCT01668147|Loperamide|loperamide|mesh-list
55761069|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
55761070|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55761071|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55761072|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
55761073|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761074|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761075|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55761076|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55761077|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
55761078|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761079|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55761080|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55761081|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55761082|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55761083|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55761084|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55761085|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55761086|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55761087|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55761088|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55761090|NCT04833777|Bupivacaine|bupivacaine|mesh-list
55761091|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
55761092|NCT04833777|Anesthetics|anesthetics|mesh-list
55761093|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761094|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761095|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
55761096|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761097|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55761098|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55761099|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55761100|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55761101|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761102|NCT04315701|Cemiplimab|cemiplimab|mesh-list
55761103|NCT04315701|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55761104|NCT04315701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761106|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55761107|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761108|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761110|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55761111|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
55761112|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55761113|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761114|NCT04851015|Renal Agents|renal agents|mesh-ancestor
55761115|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
55761116|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55761117|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55761118|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55761119|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761120|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761121|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55761122|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55761123|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55761124|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55761126|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
55761127|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
55761128|NCT04365933|Entecavir|entecavir|mesh-list
55761129|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55761130|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761132|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761133|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
55761134|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761135|NCT04824261|Clotrimazole|clotrimazole|mesh-list
55761136|NCT04824261|Miconazole|miconazole|mesh-list
55761137|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55761138|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761139|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
55761140|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55761141|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55761143|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761144|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55761145|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
55761146|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55761147|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761148|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55761149|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55761150|NCT04850235|Paclitaxel|paclitaxel|mesh-list
55761151|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55761152|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761153|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
55761154|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
55761155|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
55761156|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761157|NCT04850001|Aspirin|aspirin|mesh-list
55761158|NCT04850001|Clopidogrel|clopidogrel|mesh-list
55761159|NCT04850001|Atorvastatin|atorvastatin|mesh-list
55761160|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55761161|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55761162|NCT04850001|Analgesics|analgesics|mesh-ancestor
55761163|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
55761164|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761165|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761166|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761167|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761168|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55761169|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55761170|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761171|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55761172|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55761173|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761175|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55761176|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55761177|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
55761178|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55761179|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55761180|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55761181|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55761182|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55761183|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
55761184|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761185|NCT03036111|Trimebutine|trimebutine|mesh-list
55761186|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55761187|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
55761188|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
55761189|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761190|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761191|NCT04830579|Etoricoxib|etoricoxib|mesh-list
55761192|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55761193|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55761194|NCT04830579|Analgesics|analgesics|mesh-ancestor
55761195|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
55761196|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761197|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761198|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761199|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761200|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55761201|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55761202|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761203|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761204|NCT04816461|Piperaquine|piperaquine|mesh-list
55761205|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
55761206|NCT04816461|Amodiaquine|amodiaquine|mesh-list
55761207|NCT04816461|Artenimol|artenimol|mesh-list
55761208|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
55761209|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55761210|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55761211|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761212|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55761213|NCT04816461|Renal Agents|renal agents|mesh-ancestor
55761214|NCT04427865|Lactoferrin|lactoferrin|mesh-list
55761215|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761216|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
55761217|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55761218|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761219|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55761222|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761223|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761224|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55761225|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55761229|NCT04427787|Lanreotide|lanreotide|mesh-list
55761230|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761231|NCT04821843|Paclitaxel|paclitaxel|mesh-list
55761232|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
55761233|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55761235|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
55761236|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
55761237|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
55761238|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761239|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55761240|NCT04829487|Vitamin D|vitamin d|mesh-list
55761241|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
55761242|NCT04829487|Vitamins|vitamins|mesh-ancestor
55761243|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
55761244|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761245|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55761246|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55761248|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55761249|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55761250|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761251|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
55761252|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761255|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55761256|NCT04821765|Antibodies|antibodies|mesh-list
55761257|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55761258|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761259|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
55761260|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
55761261|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
55761262|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761263|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
55761264|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761266|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55761267|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
55761268|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761269|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761270|NCT04829019|Osimertinib|osimertinib|mesh-list
55761271|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761272|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55761273|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761274|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761275|NCT04821687|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
55761276|NCT04821687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761277|NCT04821687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761278|NCT04821687|Dopamine Agents|dopamine agents|mesh-ancestor
55761279|NCT04821687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761280|NCT04821687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761281|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
55761282|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55761283|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
55761284|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55761285|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761286|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55761287|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55761288|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761290|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761291|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55761292|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
55761293|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55761294|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761295|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55761297|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55761298|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55761300|NCT03976245|Tofacitinib|tofacitinib|mesh-list
55761301|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55761302|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55761304|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
55761305|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761306|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761307|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761308|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761309|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55761310|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55761311|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
55761312|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55761313|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761314|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761315|NCT04820751|Cyproheptadine|cyproheptadine|mesh-list
55761316|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
55761317|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
55761318|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55761319|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55761320|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
55761321|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
55761335|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
55761336|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
55761337|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
55761338|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761339|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55761340|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55761341|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761342|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55761343|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55761344|NCT04820439|Pertuzumab|pertuzumab|mesh-list
55761345|NCT04820439|Antibodies|antibodies|mesh-list
55761346|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55761347|NCT04820439|Mitogens|mitogens|mesh-list
55761349|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761350|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
55761358|NCT05619315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761359|NCT05619315|Antacids|antacids|mesh-ancestor
55761360|NCT05619315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761361|NCT05619315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55761363|NCT05619315|Protective Agents|protective agents|mesh-ancestor
55761364|NCT04819971|Docetaxel|docetaxel|mesh-list
55761365|NCT04819971|Oxaliplatin|oxaliplatin|mesh-list
55761366|NCT04819971|Trastuzumab|trastuzumab|mesh-list
55761367|NCT04819971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761368|NCT04819971|Tubulin Modulators|tubulin modulators|mesh-ancestor
55761369|NCT04819971|Antimitotic Agents|antimitotic agents|mesh-ancestor
55761370|NCT04819971|Mitosis Modulators|mitosis modulators|mesh-ancestor
55761371|NCT04819971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761372|NCT04819971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55761373|NCT04814511|Permethrin|permethrin|mesh-list
55761374|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761375|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761376|NCT04814043|Lenvatinib|lenvatinib|mesh-list
55761377|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55761378|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761379|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55761380|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761381|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761383|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55761384|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55761385|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
55761386|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761387|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55761388|NCT04819503|Anesthetics|anesthetics|mesh-list
55761389|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761390|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761391|NCT04826679|Paclitaxel|paclitaxel|mesh-list
55761393|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55761394|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761395|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
55761396|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
55761397|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
55761398|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761400|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
55761401|NCT02601573|Grazoprevir|grazoprevir|mesh-list
55761402|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
55761488|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55761403|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761404|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
55761405|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761406|NCT04813653|Cyclosporine|cyclosporine|mesh-list
55761408|NCT04813653|Cyclosporins|cyclosporins|mesh-list
55761409|NCT04813653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761410|NCT04813653|Antiemetics|antiemetics|mesh-ancestor
55761411|NCT04813653|Autonomic Agents|autonomic agents|mesh-ancestor
55761412|NCT04813653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761413|NCT04813653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761414|NCT04813653|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55761415|NCT04813653|Glucocorticoids|glucocorticoids|mesh-ancestor
55761416|NCT04813653|Hormones|hormones|mesh-ancestor
55761417|NCT04813653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55761418|NCT04813653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55761419|NCT04813653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761420|NCT04813653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761421|NCT04813653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761422|NCT04813653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55761423|NCT04813653|Immunologic Factors|immunologic factors|mesh-ancestor
55761424|NCT04813653|Antifungal Agents|antifungal agents|mesh-ancestor
55761425|NCT04813653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761426|NCT04813653|Dermatologic Agents|dermatologic agents|mesh-ancestor
55761427|NCT04813653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761428|NCT04813653|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55761429|NCT04818723|Montelukast|montelukast|mesh-list
55761430|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55761431|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
55761432|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55761433|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
55761434|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55761435|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761436|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55761438|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761440|NCT02601027|Oxycodone|oxycodone|mesh-list
55761441|NCT02601027|Hydromorphone|hydromorphone|mesh-list
55761442|NCT02601027|Ondansetron|ondansetron|mesh-list
55761443|NCT02601027|Bupivacaine|bupivacaine|mesh-list
55761445|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
55761446|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761447|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761448|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
55761449|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761450|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55761451|NCT02601027|Narcotics|narcotics|mesh-ancestor
55761452|NCT02601027|Analgesics|analgesics|mesh-ancestor
55761453|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
55761454|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
55761455|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55761456|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
55761457|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
55761458|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55761459|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
55761460|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761461|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761462|NCT02601027|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55761463|NCT02601027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55761464|NCT02601027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55761465|NCT02601027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55761466|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55761469|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55761470|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55761471|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55761474|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761476|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
55761477|NCT02600871|Povidone|povidone|mesh-list
55761478|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
55761479|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
55761480|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55761481|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761482|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55761483|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761484|NCT04818099|Vortioxetine|vortioxetine|mesh-list
55761485|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
55761486|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55761487|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55761489|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761490|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761491|NCT04818099|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55761492|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55761493|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55761494|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761495|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761496|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
55761497|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55761498|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55761499|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55761500|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55761501|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
55761502|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761503|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
55782677|NCT03148717|Misoprostol|misoprostol|mesh-list
55761504|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55761506|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55761507|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55761508|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55761509|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
55761510|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761511|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761512|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761513|NCT04807569|Urological Agents|urological agents|mesh-ancestor
55761514|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
55761515|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55761516|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
55761517|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761518|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761519|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55761520|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
55761521|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55761523|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761524|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761525|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55761526|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
55761527|NCT04807413|Gasotransmitters|gasotransmitters|mesh-ancestor
55761529|NCT04356729|Bevacizumab|bevacizumab|mesh-list
55761530|NCT04356729|Atezolizumab|atezolizumab|mesh-list
55761531|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55761532|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761533|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55761534|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55761535|NCT04356729|Growth Substances|growth substances|mesh-ancestor
55761536|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761537|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
55761538|NCT04807335|Sufentanil|sufentanil|mesh-list
55761539|NCT04807335|Ketamine|ketamine|mesh-list
55761540|NCT04807335|Analgesics|analgesics|mesh-ancestor
55761541|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
55761542|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761543|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761544|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55761545|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55761546|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
55761547|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
55761548|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761549|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55761550|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55761551|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761552|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761553|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55761554|NCT04807335|Narcotics|narcotics|mesh-ancestor
55761555|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55761556|NCT05616507|Fucoidan|fucoidan|mesh-list
55761557|NCT05616507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55761558|NCT05616507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55761559|NCT05616507|Anticoagulants|anticoagulants|mesh-ancestor
55761560|NCT05616507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761561|NCT04806945|Paclitaxel|paclitaxel|mesh-list
55761562|NCT04806945|Carboplatin|carboplatin|mesh-list
55761563|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55761564|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761565|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
55761566|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
55761567|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
55761568|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761569|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
55761570|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55761571|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761572|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55761573|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761574|NCT04805775|Propofol|propofol|mesh-list
55761575|NCT04805775|Desflurane|desflurane|mesh-list
55761576|NCT04805775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55761577|NCT04805775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761578|NCT04805775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761579|NCT04805775|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55761580|NCT04805775|Anesthetics, General|anesthetics, general|mesh-ancestor
55761581|NCT04805775|Anesthetics|anesthetics|mesh-ancestor
55761582|NCT04805775|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55761583|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
55761584|NCT04805229|Narcotics|narcotics|mesh-ancestor
55761585|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761586|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761587|NCT04805229|Analgesics|analgesics|mesh-ancestor
55761588|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
55761589|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761590|NCT04811313|Bupivacaine|bupivacaine|mesh-list
55761591|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
55761592|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
55761593|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
55761594|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761596|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
55761597|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761598|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55761599|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55761600|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761601|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
55761602|NCT04811313|Coagulants|coagulants|mesh-ancestor
55761603|NCT04352439|Aspirin|aspirin|mesh-list
55761604|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55761605|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55761606|NCT04352439|Analgesics|analgesics|mesh-ancestor
55761607|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
55761608|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761609|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761610|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761611|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761612|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55761613|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55761614|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761615|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55761616|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55761617|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761618|NCT04352439|Antipyretics|antipyretics|mesh-ancestor
55761619|NCT04796025|Bevacizumab|bevacizumab|mesh-list
55761620|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55761621|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761622|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55761623|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55761624|NCT04796025|Growth Substances|growth substances|mesh-ancestor
55761625|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761626|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
55761627|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
55761628|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55761629|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761630|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55761631|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55761632|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761633|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761634|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761635|NCT02595723|Megestrol|megestrol|mesh-list
55761636|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
55761637|NCT02595723|Phenytoin|phenytoin|mesh-list
55761638|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55761639|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55761640|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55761641|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
55761642|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55761643|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761644|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55761645|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55761646|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55761647|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761648|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
55761649|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55761650|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
55761651|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55761652|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55761653|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55761654|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761655|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55761656|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55761658|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55761659|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55761660|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55761661|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
55761662|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761663|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761664|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761666|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
55761667|NCT02597049|Empagliflozin|empagliflozin|mesh-list
55761668|NCT02597049|Canagliflozin|canagliflozin|mesh-list
55761669|NCT02597049|Dulaglutide|dulaglutide|mesh-list
55761670|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55761671|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55761672|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761673|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761674|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
55761675|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761676|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
55761677|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
55761678|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
55761679|NCT04802967|Ketoprofen|ketoprofen|mesh-list
55761680|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
55761683|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
55761684|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761685|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761686|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
55761687|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55761688|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55761689|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761690|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55761691|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55761692|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55761693|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761694|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761695|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
55761696|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55761697|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55761698|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761699|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761700|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55761701|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761702|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55761703|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761704|NCT05616117|Vitamin D|vitamin d|mesh-list
55761705|NCT05616117|Vitamins|vitamins|mesh-list
55761706|NCT05616117|Micronutrients|micronutrients|mesh-ancestor
55761707|NCT05616117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761708|NCT05616117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55761709|NCT02594163|Rituximab|rituximab|mesh-list
55761710|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55761711|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55761712|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55761713|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761714|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
55761715|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761716|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761717|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55761718|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
55761719|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761720|NCT04801485|Inositol|inositol|mesh-list
55761721|NCT04801485|Vitamin B Complex|vitamin b complex|mesh-ancestor
55761722|NCT04801485|Vitamins|vitamins|mesh-ancestor
55761723|NCT04801485|Micronutrients|micronutrients|mesh-ancestor
55761724|NCT04801485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761725|NCT03206255|Vaccines|vaccines|mesh-list
55761726|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
55761727|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761729|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55761730|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761731|NCT03206021|Carboplatin|carboplatin|mesh-list
55761732|NCT03206021|Azacitidine|azacitidine|mesh-list
55761733|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761734|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55761736|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761737|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761738|NCT03200561|Prednisolone|prednisolone|mesh-list
55761739|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
55761740|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55761741|NCT03200561|Antibodies|antibodies|mesh-list
55761742|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761743|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
55761744|NCT03200561|Hormones|hormones|mesh-ancestor
55761745|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55761746|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761747|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55761748|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761749|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
55761750|NCT02449811|Amlodipine|amlodipine|mesh-list
55761751|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55761752|NCT02449811|Olmesartan|olmesartan|mesh-list
55761753|NCT02449811|Perindopril|perindopril|mesh-list
55761754|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55761755|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55761756|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55761757|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761758|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55761759|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761760|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
55761761|NCT02449811|Diuretics|diuretics|mesh-ancestor
55761762|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
55761763|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55761764|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55761765|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55761766|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55761767|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
55761768|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761769|NCT03200093|Vancomycin|vancomycin|mesh-list
55761770|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55761771|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761772|NCT03204929|Copper|copper|mesh-list
55761773|NCT03204929|Trace Elements|trace elements|mesh-ancestor
55761774|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
55761775|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761776|NCT02596971|Prednisone|prednisone|mesh-list
55761777|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
55761778|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55761779|NCT02596971|Rituximab|rituximab|mesh-list
55761780|NCT02596971|Doxorubicin|doxorubicin|mesh-list
55761781|NCT02596971|Vincristine|vincristine|mesh-list
55761782|NCT02596971|Atezolizumab|atezolizumab|mesh-list
55761791|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761792|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55761793|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55761794|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55761795|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55761796|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55761797|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761798|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761799|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
55761800|NCT02596971|Hormones|hormones|mesh-ancestor
55761801|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55761802|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55761803|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55761804|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
55761805|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
55761806|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
55761807|NCT04808739|Adalimumab|adalimumab|mesh-list
55761808|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761809|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761810|NCT04808895|Aspirin|aspirin|mesh-list
55761811|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55761812|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55761813|NCT04808895|Analgesics|analgesics|mesh-ancestor
55761814|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
55761815|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761816|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761817|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761818|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761819|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55761820|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55761821|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761822|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55761823|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55761824|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761826|NCT04485689|Capsaicin|capsaicin|mesh-list
55761827|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
55761828|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
55761829|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
55761830|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761831|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761833|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55761834|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761835|NCT04801017|Artemisinins|artemisinins|mesh-list
55761836|NCT04801017|Artemisinin|artemisinin|mesh-list
55761837|NCT04801017|Trabedersen|trabedersen|mesh-list
55761838|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
55761839|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55761840|NCT04801017|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55761841|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761842|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761844|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
55761845|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55761846|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761847|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761848|NCT03107429|Diuretics|diuretics|mesh-ancestor
55761849|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
55761850|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761851|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
55761852|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55761854|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761855|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
55761856|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
55761857|NCT04800081|Valsartan|valsartan|mesh-list
55761858|NCT04800081|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55761859|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55761860|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55761861|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55761862|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761863|NCT03202979|Trazodone|trazodone|mesh-list
55761864|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55761865|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55761866|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761867|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761868|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55761869|NCT03202979|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55761870|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55761871|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55761872|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761873|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761874|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
55761875|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55761876|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
55761877|NCT04799925|Febuxostat|febuxostat|mesh-list
55761878|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
55761879|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761880|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
55761881|NCT04793529|Vitamin D|vitamin d|mesh-list
55761882|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55761883|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761884|NCT04793529|Vitamins|vitamins|mesh-ancestor
55761885|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
55761886|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55761887|NCT03232307|Dexamethasone|dexamethasone|mesh-list
55761888|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
55761889|NCT03232307|Rituximab|rituximab|mesh-list
55761890|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55761891|NCT03232307|Lenalidomide|lenalidomide|mesh-list
55761892|NCT03232307|Antibodies|antibodies|mesh-list
55761893|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
55761894|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55761895|NCT03232307|BB 1101|bb 1101|mesh-list
55761896|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
55761897|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761898|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761899|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55761900|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55761902|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
55761903|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761904|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55761905|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
55761906|NCT03232307|Hormones|hormones|mesh-ancestor
55761907|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55761908|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55761909|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55761910|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55761911|NCT03232307|Growth Substances|growth substances|mesh-ancestor
55761912|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
55761913|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
55761914|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761915|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761916|NCT05615727|Dexmedetomidine|dexmedetomidine|mesh-list
55761917|NCT05615727|Zolpidem|zolpidem|mesh-list
55761918|NCT05615727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55761919|NCT05615727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761920|NCT05615727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761921|NCT05615727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55761922|NCT05615727|Analgesics|analgesics|mesh-ancestor
55761923|NCT05615727|Sensory System Agents|sensory system agents|mesh-ancestor
55761924|NCT05615727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761925|NCT05615727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55761926|NCT05615727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55761927|NCT05615727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55761928|NCT05615727|Adrenergic Agents|adrenergic agents|mesh-ancestor
55761929|NCT05615727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761930|NCT05615727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761931|NCT05615727|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55761932|NCT05615727|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55761933|NCT05615727|GABA Agonists|gaba agonists|mesh-ancestor
55761935|NCT02450279|Edetic Acid|edetic acid|mesh-list
55761936|NCT02450279|Pentetic Acid|pentetic acid|mesh-list
55761937|NCT02450279|Antidotes|antidotes|mesh-ancestor
55761938|NCT02450279|Protective Agents|protective agents|mesh-ancestor
55761939|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761940|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
55761941|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
55761942|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761943|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55761944|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
55761945|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55761946|NCT03231683|Ketamine|ketamine|mesh-list
55761947|NCT03231683|Remifentanil|remifentanil|mesh-list
55761948|NCT03231683|Propofol|propofol|mesh-list
55761949|NCT03231683|Esketamine|esketamine|mesh-list
55761950|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55761951|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761952|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761953|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55761954|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
55761958|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761959|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55761960|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55761961|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55761962|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761963|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761964|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55761966|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
55761968|NCT02593773|Interferons|interferons|mesh-list
55761969|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
55761970|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55761971|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
55761972|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55761973|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
55761974|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55761975|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
55761976|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761977|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
55761978|NCT04798443|Protective Agents|protective agents|mesh-ancestor
55761979|NCT02450045|Bupivacaine|bupivacaine|mesh-list
55761980|NCT02450045|Ropivacaine|ropivacaine|mesh-list
55761981|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
55761982|NCT02450045|Anesthetics|anesthetics|mesh-list
55761983|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55761984|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761986|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761987|NCT02593539|Nemiralisib|nemiralisib|mesh-list
55761988|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55761989|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55761990|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55761991|NCT02593305|Methamphetamine|methamphetamine|mesh-list
55761992|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55761993|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55761994|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
55761995|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
55761996|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55761997|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
55761998|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55761999|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762000|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
55762001|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55782710|NCT04478461|Antibodies|antibodies|mesh-list
55762002|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55762003|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762004|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55762006|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55762007|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
55762008|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55762009|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
55762010|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762011|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762012|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55762013|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55762014|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762015|NCT02448251|Abivertinib|abivertinib|mesh-list
55762016|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55762017|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762018|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762019|NCT03195569|Paclitaxel|paclitaxel|mesh-list
55762021|NCT03195569|Carboplatin|carboplatin|mesh-list
55762022|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55762023|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762024|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
55762025|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
55762026|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
55762027|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762028|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55762029|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55762030|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55762031|NCT03195569|Growth Substances|growth substances|mesh-ancestor
55762032|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762033|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
55762034|NCT02447939|Trametinib|trametinib|mesh-list
55762035|NCT02447939|Dabrafenib|dabrafenib|mesh-list
55762036|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762037|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55762038|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762039|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762040|NCT04785183|Melatonin|melatonin|mesh-list
55762042|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762043|NCT04785183|Protective Agents|protective agents|mesh-ancestor
55762044|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762045|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762047|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55762048|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762049|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55762050|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762051|NCT04792749|Metformin|metformin|mesh-list
55762052|NCT04792749|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55762053|NCT04792749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762054|NCT03195413|Lidocaine|lidocaine|mesh-list
55762055|NCT03195413|Epinephrine|epinephrine|mesh-list
55762056|NCT03195413|Racepinephrine|racepinephrine|mesh-list
55762057|NCT03195413|Bupivacaine|bupivacaine|mesh-list
55762058|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
55762059|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
55762060|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
55762061|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762062|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762063|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
55762064|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762065|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55762066|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55762067|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55762068|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762069|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762070|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55762071|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55762072|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
55762074|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55762075|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55762076|NCT03195413|Autonomic Agents|autonomic agents|mesh-ancestor
55762077|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55762078|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
55762079|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
55762082|NCT04338399|Paclitaxel|paclitaxel|mesh-list
55762083|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55762084|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762085|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
55762086|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
55762087|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
55762088|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762089|NCT02447705|Telbivudine|telbivudine|mesh-list
55762090|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
55762091|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762092|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55762094|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762096|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
55762097|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55762098|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55762099|NCT03195257|Hormones|hormones|mesh-ancestor
55762100|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762101|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762102|NCT03195257|Incretins|incretins|mesh-ancestor
55762105|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55762106|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55762107|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55762108|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
55762109|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
55762110|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762111|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762112|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762113|NCT02447315|Pilocarpine|pilocarpine|mesh-list
55762114|NCT02447315|Miotics|miotics|mesh-ancestor
55762116|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762117|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762118|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55762119|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55762120|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
55762121|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762122|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762124|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762125|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55762126|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762127|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762128|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55762129|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55762130|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762131|NCT03195023|Amlodipine|amlodipine|mesh-list
55762132|NCT03195023|Lisinopril|lisinopril|mesh-list
55762133|NCT03195023|Lercanidipine|lercanidipine|mesh-list
55762134|NCT03195023|Furosemide|furosemide|mesh-list
55762135|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55762136|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55762137|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55762138|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55762139|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762140|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762141|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55762142|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762143|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
55762144|NCT03195023|Diuretics|diuretics|mesh-ancestor
55762145|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
55762146|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55762147|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
55762148|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55762149|NCT03195023|Protective Agents|protective agents|mesh-ancestor
55762150|NCT02446301|Nalbuphine|nalbuphine|mesh-list
55762151|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55762152|NCT02446301|Narcotics|narcotics|mesh-ancestor
55762153|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762154|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762155|NCT02446301|Analgesics|analgesics|mesh-ancestor
55762156|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
55762157|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762158|NCT04791345|Dexamethasone|dexamethasone|mesh-list
55762159|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
55762160|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
55762161|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55762162|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55762163|NCT04791345|Prednisolone|prednisolone|mesh-list
55762166|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55762167|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
55762168|NCT04791345|BB 1101|bb 1101|mesh-list
55762169|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762170|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
55762171|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
55762172|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762173|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762174|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55762175|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
55762176|NCT04791345|Hormones|hormones|mesh-ancestor
55762177|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762178|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55762180|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
55762181|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762182|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762183|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55762184|NCT04791345|Protective Agents|protective agents|mesh-ancestor
55762185|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55762186|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
55762187|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
55762189|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55762190|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762191|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55762192|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
55762193|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55762194|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55762195|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55762196|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
55762197|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762198|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55762200|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762201|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
55762202|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
55762203|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762204|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762205|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55762206|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
55762207|NCT03231215|Hormones|hormones|mesh-ancestor
55762208|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762209|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55762210|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762211|NCT04784481|Ivermectin|ivermectin|mesh-list
55762212|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55762213|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762214|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
55762215|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
55762216|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55762217|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762218|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55762220|NCT03526185|Ipilimumab|ipilimumab|mesh-list
55762221|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55762222|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762223|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55762224|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762225|NCT02445599|Dipyrone|dipyrone|mesh-list
55762226|NCT02445599|Diclofenac|diclofenac|mesh-list
55762227|NCT02445599|Atropine|atropine|mesh-list
55762228|NCT02445599|Fentanyl|fentanyl|mesh-list
55762229|NCT02445599|Midazolam|midazolam|mesh-list
55762230|NCT02445599|Tramadol|tramadol|mesh-list
55762231|NCT02445599|Nalbuphine|nalbuphine|mesh-list
55762232|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55762233|NCT02445599|Narcotics|narcotics|mesh-ancestor
55762234|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762235|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762236|NCT02445599|Analgesics|analgesics|mesh-ancestor
55762237|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
55762238|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762239|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55762240|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55762241|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
55762242|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
55762243|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55762244|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55762245|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55762246|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55762247|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
55762248|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
55762249|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762250|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762251|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55762252|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55762253|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762254|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55762255|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55762256|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762257|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55762258|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55762259|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
55762260|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55762261|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
55762263|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
55762264|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55762265|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55762266|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
55762267|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
55762268|NCT03194633|Nifedipine|nifedipine|mesh-list
55762269|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55762270|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762271|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762272|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55762273|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762274|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
55762275|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
55762276|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55762277|NCT03194555|Acetaminophen|acetaminophen|mesh-list
55762278|NCT03194555|Naltrexone|naltrexone|mesh-list
55762279|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55762280|NCT03194555|Analgesics|analgesics|mesh-ancestor
55762281|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
55762282|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762283|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762290|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55762291|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
55762292|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762293|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762294|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
55762295|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
55762296|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
55762297|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
55762298|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55762299|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
55762300|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
55762301|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762302|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762303|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762304|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55762306|NCT04790331|Diltiazem|diltiazem|mesh-list
55762307|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55762309|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762310|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762311|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55762312|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762313|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
55762314|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55762316|NCT04789941|Cisplatin|cisplatin|mesh-list
55762317|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55762318|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55762319|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762320|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762321|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762322|NCT02445053|Ivacaftor|ivacaftor|mesh-list
55762323|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55762324|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762325|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762326|NCT02444897|Fentanyl|fentanyl|mesh-list
55762327|NCT02444897|Nefopam|nefopam|mesh-list
55762328|NCT02444897|Ramosetron|ramosetron|mesh-list
55762329|NCT02444897|Ropivacaine|ropivacaine|mesh-list
55762330|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
55762331|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
55762332|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762333|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762334|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
55762335|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762336|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55762337|NCT02444897|Narcotics|narcotics|mesh-ancestor
55762338|NCT02444897|Analgesics|analgesics|mesh-ancestor
55762339|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55762340|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55762341|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
55762342|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
55762343|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
55762344|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55762345|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55762346|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
55762347|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762348|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762349|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55762350|NCT03016533|Lamivudine|lamivudine|mesh-list
55762351|NCT03016533|Dolutegravir|dolutegravir|mesh-list
55762352|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55762353|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55782737|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55762355|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762356|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
55762357|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762358|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55762359|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55762360|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55762361|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55762362|NCT03229889|Tadalafil|tadalafil|mesh-list
55762363|NCT03229889|Tamsulosin|tamsulosin|mesh-list
55762364|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
55762365|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55762366|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55762367|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762761|NCT05610969|Anesthetics, General|anesthetics, general|mesh-ancestor
55762368|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762369|NCT03229889|Urological Agents|urological agents|mesh-ancestor
55762370|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55762371|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55762372|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55762373|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
55762374|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762375|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762377|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55762378|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762381|NCT03120221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762382|NCT03120221|Trace Elements|trace elements|mesh-ancestor
55762383|NCT03120221|Micronutrients|micronutrients|mesh-ancestor
55762384|NCT03120221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762385|NCT03193073|Mitogens|mitogens|mesh-list
55762386|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
55762387|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762388|NCT02715609|Copper|copper|mesh-list
55762389|NCT02715609|Temozolomide|temozolomide|mesh-list
55762390|NCT02715609|Disulfiram|disulfiram|mesh-list
55762391|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55762392|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
55762393|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762394|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762395|NCT02715609|Trace Elements|trace elements|mesh-ancestor
55762396|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
55762397|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762398|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55762399|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
55762400|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762401|NCT02444507|Esomeprazole|esomeprazole|mesh-list
55762402|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55762403|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55762404|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55762405|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762406|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762407|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
55762408|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55762409|NCT02572791|Mupirocin|mupirocin|mesh-list
55762410|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55762411|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762412|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
55762413|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
55762414|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55762415|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55762416|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762417|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762418|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55762419|NCT01626352|Ofatumumab|ofatumumab|mesh-list
55762420|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55762421|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
55762422|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762423|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762424|NCT01626118|Indomethacin|indomethacin|mesh-list
55762425|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55762426|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55762427|NCT01626118|Analgesics|analgesics|mesh-ancestor
55762428|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
55762429|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762430|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762431|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762432|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55762433|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
55762434|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
55762436|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55762437|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762438|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762439|NCT04789005|Phenylephrine|phenylephrine|mesh-list
55762440|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
55762441|NCT04789005|Norepinephrine|norepinephrine|mesh-list
55762442|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55762443|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
55762444|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
55762446|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762447|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
55762448|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55762449|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
55762450|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
55762451|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55762452|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55762453|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55762454|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
55762455|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762456|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762457|NCT04789005|Protective Agents|protective agents|mesh-ancestor
55762459|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55762460|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
55762461|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
55762462|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55762463|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762464|NCT05469243|Hallucinogens|hallucinogens|mesh-list
55762465|NCT05469243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762466|NCT05469243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55762467|NCT02177266|Colchicine|colchicine|mesh-list
55762468|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
55762469|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55762470|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
55762471|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
55762472|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
55762473|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762474|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762475|NCT04788381|Bevacizumab|bevacizumab|mesh-list
55762476|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55762477|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762478|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55762479|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55762480|NCT04788381|Growth Substances|growth substances|mesh-ancestor
55762481|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762482|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
55762484|NCT05474937|Ketamine|ketamine|mesh-list
55762485|NCT05474937|Propofol|propofol|mesh-list
55762486|NCT05474937|Sevoflurane|sevoflurane|mesh-list
55762487|NCT05474937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55762488|NCT05474937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762489|NCT05474937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762490|NCT05474937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55762491|NCT05474937|Anesthetics, General|anesthetics, general|mesh-ancestor
55762492|NCT05474937|Anesthetics|anesthetics|mesh-ancestor
55762493|NCT05474937|Analgesics|analgesics|mesh-ancestor
55762494|NCT05474937|Sensory System Agents|sensory system agents|mesh-ancestor
55762495|NCT05474937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762496|NCT05474937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55762497|NCT05474937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55762498|NCT05474937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55762499|NCT05474937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762500|NCT05474937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762501|NCT05474937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55762502|NCT05474937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55762503|NCT05474937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55762504|NCT05474937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55762506|NCT05474937|GABA Agents|gaba agents|mesh-ancestor
55762507|NCT05474937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55762508|NCT05474937|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55762510|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55762511|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762512|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55762513|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55762514|NCT04787289|Growth Substances|growth substances|mesh-ancestor
55762515|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762516|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
55762517|NCT05474781|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55762518|NCT05474781|Antiviral Agents|antiviral agents|mesh-ancestor
55762519|NCT05474781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762520|NCT02177032|Vaccines|vaccines|mesh-list
55762521|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
55762522|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55762523|NCT02177032|Antibodies|antibodies|mesh-list
55762525|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762527|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762528|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
55762762|NCT05610969|Anesthetics|anesthetics|mesh-ancestor
55762530|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762531|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762532|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55762533|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
55762534|NCT05474001|Fentanyl|fentanyl|mesh-list
55762535|NCT05474001|Bupivacaine|bupivacaine|mesh-list
55762536|NCT05474001|Anesthetics, Local|anesthetics, local|mesh-ancestor
55762537|NCT05474001|Anesthetics|anesthetics|mesh-ancestor
55762538|NCT05474001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762539|NCT05474001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762540|NCT05474001|Sensory System Agents|sensory system agents|mesh-ancestor
55762541|NCT05474001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762542|NCT05474001|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55762543|NCT05474001|Narcotics|narcotics|mesh-ancestor
55762544|NCT05474001|Analgesics|analgesics|mesh-ancestor
55762545|NCT05474001|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55762546|NCT05474001|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55762547|NCT05474001|Anesthetics, General|anesthetics, general|mesh-ancestor
55762548|NCT02176642|Oxybutynin|oxybutynin|mesh-list
55762549|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
55762550|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
55762551|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762552|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762554|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55762555|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
55762556|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762557|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762558|NCT02176642|Urological Agents|urological agents|mesh-ancestor
55762559|NCT02116660|Ritonavir|ritonavir|mesh-list
55762560|NCT02116660|Lopinavir|lopinavir|mesh-list
55762561|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55762562|NCT02116660|Darunavir|darunavir|mesh-list
55762563|NCT02116660|Tenofovir|tenofovir|mesh-list
55762564|NCT02116660|Lamivudine|lamivudine|mesh-list
55762565|NCT02116660|Emtricitabine|emtricitabine|mesh-list
55762566|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
55762567|NCT02116660|Nevirapine|nevirapine|mesh-list
55762568|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55762569|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55762570|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
55762571|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762572|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762573|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55762574|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55762575|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
55762576|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762577|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55762578|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55762579|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55762580|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55762581|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55762582|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55762583|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55762584|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55762585|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55762586|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
55762588|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
55762589|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
55762590|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
55762591|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55762592|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55762593|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762594|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762595|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762596|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55762597|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55762598|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
55762599|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55762600|NCT02176018|Antimalarials|antimalarials|mesh-ancestor
55762601|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55762602|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55762603|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762604|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762605|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55762606|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55762607|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
55762608|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55762609|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55762610|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762611|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55762612|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55762615|NCT05611827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762616|NCT05611827|Protective Agents|protective agents|mesh-ancestor
55762617|NCT05611827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762618|NCT05612607|Immunoglobulins|immunoglobulins|mesh-list
55762619|NCT05612607|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55762620|NCT05612607|Antibodies|antibodies|mesh-list
55762621|NCT05612607|Immunologic Factors|immunologic factors|mesh-ancestor
55762622|NCT05612607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762623|NCT04870359|Prednisolone|prednisolone|mesh-list
55762624|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55762625|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762626|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
55762627|NCT04870359|Hormones|hormones|mesh-ancestor
55762628|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762629|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762630|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55762631|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762632|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
55762633|NCT02589639|Empagliflozin|empagliflozin|mesh-list
55762634|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55762635|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762636|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55762637|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762638|NCT05611749|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55762639|NCT05611749|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55762640|NCT05611749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55762641|NCT05611749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762642|NCT05611749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762643|NCT05611749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762644|NCT05611749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762645|NCT05611749|Analgesics|analgesics|mesh-ancestor
55762646|NCT05611749|Sensory System Agents|sensory system agents|mesh-ancestor
55762647|NCT05611749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762648|NCT05611749|Antidepressive Agents|antidepressive agents|mesh-ancestor
55762649|NCT05611749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55762650|NCT05611749|Dopamine Agents|dopamine agents|mesh-ancestor
55762651|NCT00555555|Factor VIII|factor viii|mesh-list
55762652|NCT00555555|Coagulants|coagulants|mesh-ancestor
55762653|NCT05611593|Finasteride|finasteride|mesh-list
55762654|NCT05611593|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55762656|NCT05611593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762657|NCT05611593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762658|NCT05611593|Hormone Antagonists|hormone antagonists|mesh-ancestor
55762659|NCT05611593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762660|NCT05611593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762661|NCT05611593|Urological Agents|urological agents|mesh-ancestor
55762662|NCT05612451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55762664|NCT05612451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55762665|NCT05612451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762666|NCT05612451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762669|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55762670|NCT02151682|Narcotics|narcotics|mesh-ancestor
55762671|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762672|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762673|NCT02151682|Analgesics|analgesics|mesh-ancestor
55762674|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
55762675|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762676|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55762678|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762679|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762680|NCT02151682|Adrenergic Agents|adrenergic agents|mesh-ancestor
55762681|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762682|NCT05350215|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55762683|NCT05350215|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55762684|NCT05350215|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55762763|NCT05610969|GABA Modulators|gaba modulators|mesh-ancestor
55762685|NCT05350215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762686|NCT05350215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762687|NCT05350215|Adrenergic Agents|adrenergic agents|mesh-ancestor
55782781|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
55762688|NCT05350215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762689|NCT05350215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762690|NCT04331691|Amiloride|amiloride|mesh-list
55762691|NCT04331691|Spironolactone|spironolactone|mesh-list
55762692|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55762693|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
55762694|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762695|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762696|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55762697|NCT04331691|Diuretics|diuretics|mesh-ancestor
55762698|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
55762699|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
55762700|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55762701|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762702|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762703|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55762704|NCT05304273|Letrozole|letrozole|mesh-list
55762705|NCT05304273|Misoprostol|misoprostol|mesh-list
55762706|NCT05304273|Mifepristone|mifepristone|mesh-list
55762707|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762708|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55762709|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55762710|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762711|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762712|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55762713|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
55762714|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762715|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762716|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55762718|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55762719|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55762720|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55762722|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55762723|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55762724|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55762725|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55762727|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55762728|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55762729|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
55762730|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55762731|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55762732|NCT02174848|Deferiprone|deferiprone|mesh-list
55762733|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55762734|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
55762735|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
55762736|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762737|NCT02151058|Listerine|listerine|mesh-list
55762738|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
55762739|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
55762740|NCT02151058|Protective Agents|protective agents|mesh-ancestor
55762741|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762742|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55762743|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762744|NCT05205759|Bamlanivimab|bamlanivimab|mesh-list
55762745|NCT05205759|Antiviral Agents|antiviral agents|mesh-ancestor
55762746|NCT05205759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762747|NCT02149264|Testosterone|testosterone|mesh-list
55762748|NCT02149264|Androgens|androgens|mesh-ancestor
55762750|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762751|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762752|NCT05610969|Midazolam|midazolam|mesh-list
55762753|NCT05610969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55762754|NCT05610969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55762755|NCT05610969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762756|NCT05610969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762757|NCT05610969|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55762758|NCT05610969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55762759|NCT05610969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55762760|NCT05610969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55762765|NCT05610969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762766|NCT05610969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762767|NCT05557149|Cocaine|cocaine|mesh-list
55762768|NCT05557149|Anesthetics, Local|anesthetics, local|mesh-ancestor
55762769|NCT05557149|Anesthetics|anesthetics|mesh-ancestor
55762770|NCT05557149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762771|NCT05557149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762772|NCT05557149|Sensory System Agents|sensory system agents|mesh-ancestor
55762773|NCT05557149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762774|NCT05557149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55762775|NCT05557149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55762776|NCT05557149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55762777|NCT05557149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762778|NCT05557149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762779|NCT05557149|Dopamine Agents|dopamine agents|mesh-ancestor
55762780|NCT05557149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762781|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
55762782|NCT02115256|Terbutaline|terbutaline|mesh-list
55762783|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
55762784|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55762785|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
55762786|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762787|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762788|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55762789|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
55762790|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
55762791|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
55762792|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55762793|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55762794|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55762795|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55762796|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
55762797|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762798|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762799|NCT02173054|Adapalene|adapalene|mesh-list
55762800|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55762801|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55762802|NCT02173054|Analgesics|analgesics|mesh-ancestor
55762803|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
55762804|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762805|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762806|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762807|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55762808|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
55762810|NCT04225221|Estradiol|estradiol|mesh-list
55762811|NCT04225221|Progesterone|progesterone|mesh-list
55762817|NCT04225221|Progestins|progestins|mesh-ancestor
55762818|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55762819|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
55762820|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55762821|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762822|NCT05555667|Propofol|propofol|mesh-list
55762823|NCT05555667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55762824|NCT05555667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762825|NCT05555667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762826|NCT05555667|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55762827|NCT05555667|Anesthetics, General|anesthetics, general|mesh-ancestor
55762828|NCT05555667|Anesthetics|anesthetics|mesh-ancestor
55762830|NCT04425993|Isosorbide|isosorbide|mesh-list
55762831|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55762832|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55762833|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55762834|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55762835|NCT04425993|Analgesics|analgesics|mesh-ancestor
55762836|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
55762837|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762838|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762839|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762840|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55762841|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
55762842|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
55762843|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55762844|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55762845|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762846|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762853|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55762854|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55762855|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
55762856|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762857|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55762858|NCT04745559|Immunologic Factors|immunologic factors|mesh-ancestor
55762859|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762866|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762867|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55762868|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762869|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762870|NCT03708315|Dexmedetomidine|dexmedetomidine|mesh-list
55762871|NCT03708315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55762872|NCT03708315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55762873|NCT03708315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762874|NCT03708315|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55762875|NCT03708315|Analgesics|analgesics|mesh-ancestor
55762876|NCT03708315|Sensory System Agents|sensory system agents|mesh-ancestor
55762877|NCT03708315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762878|NCT03708315|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55762879|NCT03708315|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55762880|NCT03708315|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55762881|NCT03708315|Adrenergic Agents|adrenergic agents|mesh-ancestor
55762882|NCT03708315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55762883|NCT03708315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762885|NCT05700669|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55762886|NCT05700669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762887|NCT05700669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762888|NCT05700669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762889|NCT02148718|Adalimumab|adalimumab|mesh-list
55762890|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762891|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55762892|NCT03397953|Vinorelbine|vinorelbine|mesh-list
55762893|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55762894|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762895|NCT03397953|Tubulin Modulators|tubulin modulators|mesh-ancestor
55762896|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
55762897|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
55762898|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762899|NCT05549973|Dexamethasone|dexamethasone|mesh-list
55762900|NCT05549973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762901|NCT05549973|Antiemetics|antiemetics|mesh-ancestor
55762902|NCT05549973|Autonomic Agents|autonomic agents|mesh-ancestor
55762903|NCT05549973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762904|NCT05549973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762905|NCT05549973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55762906|NCT05549973|Glucocorticoids|glucocorticoids|mesh-ancestor
55762907|NCT05549973|Hormones|hormones|mesh-ancestor
55762908|NCT05549973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762909|NCT05549973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55762910|NCT05549973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762911|NCT02148250|Insulin|insulin|mesh-list
55762912|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55762913|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55762914|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762915|NCT02705859|Trastuzumab|trastuzumab|mesh-list
55762916|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55762917|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762919|NCT05549583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55762920|NCT05549583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55762921|NCT05549583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762922|NCT05549583|Incretins|incretins|mesh-ancestor
55762923|NCT05549583|Hormones|hormones|mesh-ancestor
55762924|NCT05549583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762925|NCT05549583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55762926|NCT05549583|Protease Inhibitors|protease inhibitors|mesh-ancestor
55762927|NCT05549583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762928|NCT05549583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762929|NCT05549505|Anastrozole|anastrozole|mesh-list
55762930|NCT05549505|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55762931|NCT05549505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762932|NCT05549505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55762933|NCT05549505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55762935|NCT05549505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762936|NCT05549505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55762937|NCT05549505|Hormone Antagonists|hormone antagonists|mesh-ancestor
55762938|NCT05549505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762939|NCT05549505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762940|NCT05554731|Hemostatics|hemostatics|mesh-list
55762941|NCT05554731|Coagulants|coagulants|mesh-ancestor
55762942|NCT02172040|Celecoxib|celecoxib|mesh-list
55762943|NCT02172040|Amlodipine|amlodipine|mesh-list
55762944|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55762945|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55762946|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55762947|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55762948|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55762949|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762950|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
55762951|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55762952|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55762953|NCT02172040|Analgesics|analgesics|mesh-ancestor
55762954|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
55762955|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55762956|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55762957|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55762958|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55762959|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55762960|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55762961|NCT02367105|Testosterone|testosterone|mesh-list
55762962|NCT02367105|Androgens|androgens|mesh-ancestor
55762963|NCT02367105|Hormones|hormones|mesh-ancestor
55762964|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762965|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762966|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
55762967|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762968|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
55762969|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55762970|NCT01318317|Plerixafor|plerixafor|mesh-list
55762972|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55762973|NCT01318317|Antibodies|antibodies|mesh-list
55762974|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
55762975|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55762977|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
55762978|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762979|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55762980|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55762981|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55762982|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55762983|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55762984|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
55762985|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55762986|NCT05700903|Leuprolide|leuprolide|mesh-list
55762987|NCT05700903|Goserelin|goserelin|mesh-list
55762988|NCT05700903|Flutamide|flutamide|mesh-list
55762989|NCT05700903|Bicalutamide|bicalutamide|mesh-list
55762990|NCT05700903|Hormones|hormones|mesh-list
55762991|NCT05700903|Androgens|androgens|mesh-list
55762992|NCT05700903|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
55762993|NCT05700903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55762994|NCT05700903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55762995|NCT05700903|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55762996|NCT05700903|Fertility Agents|fertility agents|mesh-ancestor
55762997|NCT05700903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55762998|NCT05700903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55762999|NCT05700903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763000|NCT05700903|Androgen Antagonists|androgen antagonists|mesh-ancestor
55763001|NCT05700903|Hormone Antagonists|hormone antagonists|mesh-ancestor
55763002|NCT05554185|Aspirin|aspirin|mesh-list
55763003|NCT05554185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55763004|NCT05554185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55763005|NCT05554185|Analgesics|analgesics|mesh-ancestor
55763006|NCT05554185|Sensory System Agents|sensory system agents|mesh-ancestor
55763007|NCT05554185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763008|NCT05554185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763009|NCT05554185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763010|NCT05554185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55763011|NCT05554185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55763012|NCT05554185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55763013|NCT05554185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763014|NCT05554185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55763015|NCT05554185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55763016|NCT05554185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763017|NCT05554185|Antipyretics|antipyretics|mesh-ancestor
55763018|NCT05558397|Morphine|morphine|mesh-list
55763019|NCT05558397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55763020|NCT05558397|Narcotics|narcotics|mesh-ancestor
55763021|NCT05558397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763022|NCT05558397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763023|NCT05558397|Analgesics|analgesics|mesh-ancestor
55763024|NCT05558397|Sensory System Agents|sensory system agents|mesh-ancestor
55763025|NCT05558397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763026|NCT05558319|Dexamethasone|dexamethasone|mesh-list
55763027|NCT05558319|Lenalidomide|lenalidomide|mesh-list
55763028|NCT05558319|Bortezomib|bortezomib|mesh-list
55763029|NCT05558319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763030|NCT05558319|Antiemetics|antiemetics|mesh-ancestor
55763031|NCT05558319|Autonomic Agents|autonomic agents|mesh-ancestor
55763032|NCT05558319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763033|NCT05558319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763034|NCT05558319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55763036|NCT05558319|Hormones|hormones|mesh-ancestor
55763037|NCT05558319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763038|NCT05558319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55763040|NCT05558319|Immunologic Factors|immunologic factors|mesh-ancestor
55763041|NCT05558319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55763042|NCT05558319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55763043|NCT05558319|Growth Substances|growth substances|mesh-ancestor
55763044|NCT05558319|Growth Inhibitors|growth inhibitors|mesh-ancestor
55763045|NCT05553717|Carvedilol|carvedilol|mesh-list
55763046|NCT05553717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55763047|NCT05553717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55763048|NCT05553717|Adrenergic Agents|adrenergic agents|mesh-ancestor
55763049|NCT05553717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763050|NCT05553717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763051|NCT05553717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763052|NCT05553717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55763053|NCT05553717|Antioxidants|antioxidants|mesh-ancestor
55763054|NCT05553717|Protective Agents|protective agents|mesh-ancestor
55763055|NCT05553717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55763056|NCT05553717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55763057|NCT05553717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55763058|NCT05553717|Vasodilator Agents|vasodilator agents|mesh-ancestor
55763059|NCT05553717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55763060|NCT05553717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55763061|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
55763062|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55763063|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
55763064|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55763065|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763066|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55763067|NCT05553093|Insulin|insulin|mesh-list
55763068|NCT05553093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55763069|NCT05553093|Insulin Glargine|insulin glargine|mesh-list
55763070|NCT05553093|Tirzepatide|tirzepatide|mesh-list
55763071|NCT05553093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55763072|NCT05553093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763073|NCT05553093|Incretins|incretins|mesh-ancestor
55763074|NCT05553093|Hormones|hormones|mesh-ancestor
55763075|NCT05553093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763077|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55763078|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55763080|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
55763081|NCT04757740|Lidocaine|lidocaine|mesh-list
55763082|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55763083|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
55763084|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
55763085|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
55763086|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763087|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763088|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
55763089|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763090|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55763091|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55763092|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55763093|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55763094|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763095|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763096|NCT04757740|Antiemetics|antiemetics|mesh-ancestor
55763097|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
55763098|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55763099|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
55763100|NCT04757740|Hormones|hormones|mesh-ancestor
55763101|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763102|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55763103|NCT04757740|Protective Agents|protective agents|mesh-ancestor
55763104|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55763105|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763106|NCT05552937|Lenalidomide|lenalidomide|mesh-list
55763107|NCT05552937|Immunologic Factors|immunologic factors|mesh-ancestor
55763108|NCT05552937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763109|NCT05552937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55763110|NCT05552937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55763111|NCT05552937|Growth Substances|growth substances|mesh-ancestor
55763112|NCT05552937|Growth Inhibitors|growth inhibitors|mesh-ancestor
55763113|NCT05552937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763115|NCT02112448|Ketorolac|ketorolac|mesh-list
55763116|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55763117|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55763118|NCT02112448|Analgesics|analgesics|mesh-ancestor
55763119|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
55763120|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763121|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763122|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
55763123|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55763124|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763125|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55763126|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55763127|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763128|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763131|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
55763132|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763133|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763134|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763135|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55763136|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55763137|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763138|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55763139|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55763140|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
55763141|NCT02109484|Vaccines|vaccines|mesh-list
55763142|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
55763143|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763144|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
55763145|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55763146|NCT05134792|Antibodies|antibodies|mesh-list
55763147|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
55763148|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55763149|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
55763150|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763151|NCT04738318|Dexamethasone|dexamethasone|mesh-list
55763152|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
55763153|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
55763154|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763156|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
55763157|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763158|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763159|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55763160|NCT04738318|Hormones|hormones|mesh-ancestor
55763161|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763162|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55763163|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763164|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55763165|NCT04738318|Protective Agents|protective agents|mesh-ancestor
55763166|NCT02105974|Fluticasone|fluticasone|mesh-list
55763168|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763169|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55763170|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
55763171|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763753|NCT04062201|Isoniazid|isoniazid|mesh-list
55763172|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763173|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55763174|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
55763175|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
55763176|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55763177|NCT02105662|Grazoprevir|grazoprevir|mesh-list
55763178|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
55763179|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763180|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
55763181|NCT02142712|Promethazine|promethazine|mesh-list
55763183|NCT02142712|Pantoprazole|pantoprazole|mesh-list
55763184|NCT02142712|Famotidine|famotidine|mesh-list
55763185|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55763186|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55763187|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55763188|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763189|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763190|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55763191|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55763192|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763193|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763194|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
55763195|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
55763196|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
55763197|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763198|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
55763199|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
55763200|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55763201|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
55763202|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
55763203|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763204|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55763205|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
55763206|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
55763207|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
55763208|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
55763209|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55763210|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55763211|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55763212|NCT02105272|Carteolol|carteolol|mesh-list
55763215|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55763216|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55763217|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55763218|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
55763219|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763220|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763221|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763222|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55763223|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55763224|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
55763225|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
55763226|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763227|NCT02141854|Fluticasone|fluticasone|mesh-list
55763228|NCT02141854|Xhance|xhance|mesh-list
55763229|NCT02141854|Albuterol|albuterol|mesh-list
55763230|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55763231|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
55763232|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763233|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55763234|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
55763235|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763236|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763237|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55763238|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
55763239|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
55763240|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55763241|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55763242|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55763244|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763245|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763246|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
55763247|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55763248|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
55763249|NCT02141620|Cocaine|cocaine|mesh-list
55763250|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55763251|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
55763252|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763253|NCT02141620|Expectorants|expectorants|mesh-ancestor
55763254|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
55763255|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55763256|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
55763257|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763258|NCT02141620|Protective Agents|protective agents|mesh-ancestor
55763259|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763260|NCT02141620|Antidotes|antidotes|mesh-ancestor
55763261|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
55763262|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
55763263|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763264|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
55763265|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763266|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55763267|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55763269|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55763270|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
55763271|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763272|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55763273|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55763274|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
55763275|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55763276|NCT01664949|Laxatives|laxatives|mesh-ancestor
55763277|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55763278|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
55763280|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
55763281|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763282|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763283|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
55763284|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763285|NCT02587065|Interferons|interferons|mesh-list
55763286|NCT02587065|Interferon-beta|interferon-beta|mesh-list
55763287|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
55763288|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763289|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
55763290|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763291|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
55763292|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763293|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55763294|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
55763295|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55763296|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763297|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55763298|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55763299|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763300|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763301|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763302|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55763303|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55763304|NCT05552391|Dexmedetomidine|dexmedetomidine|mesh-list
55763305|NCT05552391|Ketamine|ketamine|mesh-list
55763306|NCT05552391|Bupivacaine|bupivacaine|mesh-list
55763307|NCT05552391|Anesthetics, Local|anesthetics, local|mesh-ancestor
55763308|NCT05552391|Anesthetics|anesthetics|mesh-ancestor
55763309|NCT05552391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763310|NCT05552391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763311|NCT05552391|Sensory System Agents|sensory system agents|mesh-ancestor
55763312|NCT05552391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763313|NCT05552391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55763314|NCT05552391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55763315|NCT05552391|Analgesics|analgesics|mesh-ancestor
55763316|NCT05552391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55763317|NCT05552391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55763318|NCT05552391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55763319|NCT05552391|Adrenergic Agents|adrenergic agents|mesh-ancestor
55763320|NCT05552391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763321|NCT05552391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763322|NCT05552391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55763323|NCT05552391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55763324|NCT05552391|Anesthetics, General|anesthetics, general|mesh-ancestor
55763325|NCT05552391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55763326|NCT05552391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55763327|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
55763328|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55763329|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55763509|NCT05539521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763330|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763331|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55763332|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763333|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55763334|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
55763335|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55763336|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
55763337|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763338|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55763340|NCT02105116|Fludarabine|fludarabine|mesh-list
55763341|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
55763342|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763343|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55763344|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
55763345|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763346|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55763347|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
55763348|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763349|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
55763350|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763351|NCT05551767|Cisplatin|cisplatin|mesh-list
55763352|NCT05551767|Pembrolizumab|pembrolizumab|mesh-list
55763353|NCT05551767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763354|NCT05551767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55763355|NCT05551689|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55763356|NCT05551689|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55763357|NCT05551689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763358|NCT05551689|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55763359|NCT05551689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55763360|NCT05551689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55763361|NCT05551689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763362|NCT05551689|Dopamine Agents|dopamine agents|mesh-ancestor
55763363|NCT05551689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763364|NCT05547789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55763365|NCT05547789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55763366|NCT05547789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55763368|NCT05547789|Sensory System Agents|sensory system agents|mesh-ancestor
55763369|NCT05547789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763370|NCT05547789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763371|NCT05547789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55763373|NCT05542095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55763374|NCT05542095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55763375|NCT05542095|Antimetabolites|antimetabolites|mesh-ancestor
55763376|NCT05542095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763377|NCT05542095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55763378|NCT05542095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55763379|NCT05542095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763380|NCT05551221|Tamsulosin|tamsulosin|mesh-list
55763381|NCT05551221|Silodosin|silodosin|mesh-list
55763382|NCT05551221|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55763383|NCT05551221|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55763384|NCT05551221|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55763385|NCT05551221|Adrenergic Agents|adrenergic agents|mesh-ancestor
55763386|NCT05551221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763387|NCT05551221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763388|NCT05551221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763389|NCT05551221|Urological Agents|urological agents|mesh-ancestor
55763390|NCT02104804|Insulin|insulin|mesh-list
55763391|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55763392|NCT02104804|Metformin|metformin|mesh-list
55763393|NCT02104804|Saxagliptin|saxagliptin|mesh-list
55763394|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
55763395|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55763396|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763398|NCT02104804|Hormones|hormones|mesh-ancestor
55763399|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763400|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55763401|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
55763402|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763403|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763419|NCT05550441|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55763510|NCT05539521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763420|NCT05550441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763421|NCT05550441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55763422|NCT05550441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763423|NCT05550207|Meloxicam|meloxicam|mesh-list
55763424|NCT05550207|Rizatriptan|rizatriptan|mesh-list
55763425|NCT05550207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55763426|NCT05550207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55763427|NCT05550207|Analgesics|analgesics|mesh-ancestor
55763429|NCT05550207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763430|NCT05550207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763431|NCT05550207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763432|NCT05550207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55763433|NCT05550207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55763434|NCT05550207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55763435|NCT05550207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763436|NCT05550207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763437|NCT05550207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55763439|NCT05550207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763440|NCT05546853|Leucovorin|leucovorin|mesh-list
55763441|NCT05546853|Oxaliplatin|oxaliplatin|mesh-list
55763442|NCT05546853|Irinotecan|irinotecan|mesh-list
55763443|NCT05546853|Calcium|calcium|mesh-list
55763444|NCT05546853|Levoleucovorin|levoleucovorin|mesh-list
55763445|NCT05546853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55763446|NCT05546853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763447|NCT05546853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763448|NCT05546853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55763449|NCT05546853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55763450|NCT05546853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763451|NCT05546853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763452|NCT05546853|Antidotes|antidotes|mesh-ancestor
55763453|NCT05546853|Protective Agents|protective agents|mesh-ancestor
55763454|NCT05546853|Vitamin B Complex|vitamin b complex|mesh-ancestor
55763455|NCT05546853|Vitamins|vitamins|mesh-ancestor
55763456|NCT05546853|Micronutrients|micronutrients|mesh-ancestor
55763457|NCT05698095|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
55763458|NCT05698095|Hallucinogens|hallucinogens|mesh-ancestor
55763459|NCT05698095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763460|NCT05698095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55763461|NCT05698095|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55763462|NCT05698095|Serotonin Agents|serotonin agents|mesh-ancestor
55763463|NCT05698095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763464|NCT05698095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763465|NCT05698095|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55763466|NCT05540145|Paclitaxel|paclitaxel|mesh-list
55763467|NCT05540145|Antibodies|antibodies|mesh-list
55763468|NCT05540145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55763469|NCT05540145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763470|NCT05540145|Tubulin Modulators|tubulin modulators|mesh-ancestor
55763471|NCT05540145|Antimitotic Agents|antimitotic agents|mesh-ancestor
55763473|NCT05540145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763474|NCT05540145|Immunologic Factors|immunologic factors|mesh-ancestor
55763475|NCT05540145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763486|NCT05699655|Oxaliplatin|oxaliplatin|mesh-list
55763487|NCT05699655|Apatinib|apatinib|mesh-list
55763488|NCT05699655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763489|NCT05699655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55763490|NCT05699655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763491|NCT05699655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763492|NCT05592327|Citric Acid|citric acid|mesh-list
55763493|NCT05592327|Sodium Citrate|sodium citrate|mesh-list
55763494|NCT05592327|Anticoagulants|anticoagulants|mesh-ancestor
55763495|NCT05592327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55763496|NCT05592327|Chelating Agents|chelating agents|mesh-ancestor
55763497|NCT05592327|Sequestering Agents|sequestering agents|mesh-ancestor
55763498|NCT05592327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763499|NCT05592171|Chlorotrianisene|chlorotrianisene|mesh-list
55763500|NCT05592171|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55763501|NCT05592171|Estrogens|estrogens|mesh-ancestor
55763502|NCT05592171|Hormones|hormones|mesh-ancestor
55763503|NCT05592171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763504|NCT05592171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763505|NCT05592171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55763506|NCT05592171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763507|NCT05539521|Propofol|propofol|mesh-list
55763508|NCT05539521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55763511|NCT05539521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55763512|NCT05539521|Anesthetics, General|anesthetics, general|mesh-ancestor
55763514|NCT05592015|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
55763515|NCT05592015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55763516|NCT05592015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763517|NCT05592015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763533|NCT05538507|Memantine|memantine|mesh-list
55763534|NCT05538507|Donepezil|donepezil|mesh-list
55763535|NCT05538507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55763536|NCT05538507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763537|NCT05538507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763538|NCT05538507|Cholinergic Agents|cholinergic agents|mesh-ancestor
55763539|NCT05538507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763540|NCT05538507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763541|NCT05538507|Nootropic Agents|nootropic agents|mesh-ancestor
55763542|NCT05538507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55763544|NCT05538507|Dopamine Agents|dopamine agents|mesh-ancestor
55763545|NCT05538507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55763546|NCT05538507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55763547|NCT05591235|Metformin|metformin|mesh-list
55763548|NCT05591235|Pioglitazone|pioglitazone|mesh-list
55763549|NCT05591235|Dapagliflozin|dapagliflozin|mesh-list
55763550|NCT05591235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55763551|NCT05591235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763552|NCT05591235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55763553|NCT05591235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763554|NCT05545527|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55763556|NCT05545527|Hematinics|hematinics|mesh-ancestor
55763557|NCT01666119|Buprenorphine|buprenorphine|mesh-list
55763558|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55763559|NCT01666119|Narcotics|narcotics|mesh-ancestor
55763560|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763561|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763562|NCT01666119|Analgesics|analgesics|mesh-ancestor
55763563|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
55763564|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763565|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55763566|NCT05361993|Aripiprazole|aripiprazole|mesh-list
55763567|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
55763568|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55763569|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55763570|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55763571|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763572|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763573|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
55763574|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
55763575|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763576|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763577|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55763578|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55763579|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
55763580|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55763581|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55763582|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55763583|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55763584|NCT04425681|Bevacizumab|bevacizumab|mesh-list
55763585|NCT04425681|Osimertinib|osimertinib|mesh-list
55763586|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55763587|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763588|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55763589|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55763590|NCT04425681|Growth Substances|growth substances|mesh-ancestor
55763591|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763592|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
55763593|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55763594|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763595|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763596|NCT05545059|Amlodipine|amlodipine|mesh-list
55763597|NCT05545059|Valsartan|valsartan|mesh-list
55763598|NCT05545059|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55763599|NCT05545059|Spironolactone|spironolactone|mesh-list
55763600|NCT05545059|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55763601|NCT05545059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55763602|NCT05545059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55763603|NCT05545059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55763604|NCT05545059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763605|NCT05545059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55763606|NCT05545059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763607|NCT05545059|Vasodilator Agents|vasodilator agents|mesh-ancestor
55763608|NCT05545059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55782825|NCT05255575|Ertapenem|ertapenem|mesh-list
55763609|NCT05545059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55763610|NCT05545059|Diuretics|diuretics|mesh-ancestor
55763611|NCT05545059|Natriuretic Agents|natriuretic agents|mesh-ancestor
55763612|NCT05545059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55763613|NCT05545059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55763614|NCT05545059|Hormone Antagonists|hormone antagonists|mesh-ancestor
55763615|NCT05545059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763616|NCT05545059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55763617|NCT02586207|Cisplatin|cisplatin|mesh-list
55763618|NCT02586207|Pembrolizumab|pembrolizumab|mesh-list
55763619|NCT02586207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763620|NCT02586207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55763621|NCT05128773|Tamoxifen|tamoxifen|mesh-list
55763622|NCT05128773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55763623|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
55763624|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763625|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763626|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55763627|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763628|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55763629|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55763630|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55763631|NCT04991025|Gemcitabine|gemcitabine|mesh-list
55763632|NCT04991025|Carboplatin|carboplatin|mesh-list
55763634|NCT04991025|Pemetrexed|pemetrexed|mesh-list
55763635|NCT04991025|Certolizumab Pegol|certolizumab pegol|mesh-list
55763636|NCT04991025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763637|NCT04991025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55763638|NCT04991025|Antimetabolites|antimetabolites|mesh-ancestor
55763639|NCT04991025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763640|NCT04991025|Antiviral Agents|antiviral agents|mesh-ancestor
55763641|NCT04991025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763642|NCT04991025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763643|NCT04991025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55763644|NCT04991025|Immunologic Factors|immunologic factors|mesh-ancestor
55763645|NCT04991025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763646|NCT04991025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55763647|NCT04991025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55763648|NCT04991025|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55763649|NCT04991025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55763650|NCT04991025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55763651|NCT05536011|Sodium Oxybate|sodium oxybate|mesh-list
55763652|NCT05536011|Methylphenidate|methylphenidate|mesh-list
55763653|NCT05536011|Modafinil|modafinil|mesh-list
55763654|NCT05536011|Amphetamine|amphetamine|mesh-list
55763655|NCT05536011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55763656|NCT05536011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763657|NCT05536011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55763658|NCT05536011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55763659|NCT05536011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55763660|NCT05536011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763661|NCT05536011|Dopamine Agents|dopamine agents|mesh-ancestor
55763662|NCT05536011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763663|NCT05536011|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55763664|NCT05536011|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55763665|NCT05536011|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55763666|NCT05536011|Sympathomimetics|sympathomimetics|mesh-ancestor
55763667|NCT05536011|Autonomic Agents|autonomic agents|mesh-ancestor
55763668|NCT05536011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763669|NCT05536011|Adrenergic Agents|adrenergic agents|mesh-ancestor
55763670|NCT05536011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55763671|NCT05536011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55782830|NCT05026229|Methotrexate|methotrexate|mesh-list
55763672|NCT05536011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55763673|NCT05536011|Anesthetics, General|anesthetics, general|mesh-ancestor
55763675|NCT05536011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763676|NCT04809051|Metronidazole|metronidazole|mesh-list
55763677|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763678|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55763679|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55763680|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55763681|NCT04015869|Pregnanolone|pregnanolone|mesh-list
55763682|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
55763683|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763684|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763686|NCT04677855|Dutasteride|dutasteride|mesh-list
55763687|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763688|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
55763689|NCT04677855|Hormones|hormones|mesh-ancestor
55763690|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763691|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763692|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55763693|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763694|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55763695|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55763696|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763697|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763698|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
55763699|NCT03784677|SOR-C13|sor-c13|mesh-list
55763700|NCT03784677|Calcium|calcium|mesh-list
55763701|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55763702|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763703|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763704|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55763705|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55763706|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763707|NCT05696613|Rituximab|rituximab|mesh-list
55763708|NCT05696613|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55763709|NCT05696613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55763710|NCT05696613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763711|NCT05696613|Immunologic Factors|immunologic factors|mesh-ancestor
55763712|NCT05696613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763713|NCT05696613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55763714|NCT05696613|Hormones|hormones|mesh-ancestor
55763715|NCT05696613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55763716|NCT02584959|Complement C1s|complement c1s|mesh-list
55763717|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55763718|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
55763719|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
55763720|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763721|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55763722|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55763723|NCT05544045|Calcium Carbonate|calcium carbonate|mesh-list
55763724|NCT05544045|Antacids|antacids|mesh-ancestor
55763725|NCT05544045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763726|NCT05544045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55763727|NCT02584257|Albuterol|albuterol|mesh-list
55763728|NCT02584257|Procaterol|procaterol|mesh-list
55763729|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
55763730|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55763731|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
55763732|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763733|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763734|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55763735|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
55763736|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
55763737|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55763738|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55763739|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55763740|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55763741|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
55763742|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55782841|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
55763743|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763744|NCT02584257|Miotics|miotics|mesh-ancestor
55763745|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55763746|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
55763747|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55763749|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
55763750|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
55763751|NCT04062201|Levofloxacin|levofloxacin|mesh-list
55763752|NCT04062201|Ofloxacin|ofloxacin|mesh-list
55763762|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55763763|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55763764|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55763765|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763766|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763767|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763768|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55763769|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55763770|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
55763771|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55763772|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55763773|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
55763774|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55763775|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55763776|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763777|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
55763779|NCT02583477|Paclitaxel|paclitaxel|mesh-list
55763780|NCT02583477|Durvalumab|durvalumab|mesh-list
55763781|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55763782|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55763783|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763784|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
55763785|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
55763786|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
55763787|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763788|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55763790|NCT02583477|Antiviral Agents|antiviral agents|mesh-ancestor
55763791|NCT02583477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763792|NCT02583477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763793|NCT02583477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55763794|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
55763795|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763796|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55763797|NCT01582269|Lomustine|lomustine|mesh-list
55763798|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55763799|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
55763800|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763801|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763802|NCT02583399|Ibuprofen|ibuprofen|mesh-list
55763803|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55763804|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55763805|NCT02583399|Analgesics|analgesics|mesh-ancestor
55763806|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
55763807|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763808|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763809|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55763810|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55763811|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55763812|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763813|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763814|NCT02580591|Empagliflozin|empagliflozin|mesh-list
55763815|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55763816|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763817|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55763818|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763819|NCT04159155|Paclitaxel|paclitaxel|mesh-list
55763820|NCT04159155|Carboplatin|carboplatin|mesh-list
55763821|NCT04159155|Niraparib|niraparib|mesh-list
55763822|NCT04159155|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55763823|NCT04159155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763824|NCT04159155|Tubulin Modulators|tubulin modulators|mesh-ancestor
55763825|NCT04159155|Antimitotic Agents|antimitotic agents|mesh-ancestor
55763826|NCT04159155|Mitosis Modulators|mitosis modulators|mesh-ancestor
55763827|NCT04159155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763828|NCT04159155|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55763829|NCT04159155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763830|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
55763832|NCT05390307|Glucagon|glucagon|mesh-list
55763833|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55763834|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55763835|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763836|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55763837|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763862|NCT03569085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55763863|NCT03569085|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55763864|NCT03569085|Anesthetics, General|anesthetics, general|mesh-ancestor
55763865|NCT03569085|Anesthetics|anesthetics|mesh-ancestor
55763866|NCT03569085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763867|NCT03569085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763868|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
55763869|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55763870|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763871|NCT03496779|Gemcitabine|gemcitabine|mesh-list
55763872|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55763873|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55763874|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55763875|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
55763876|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763877|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763878|NCT03496779|Antiviral Agents|antiviral agents|mesh-ancestor
55763879|NCT03496779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55763881|NCT03496779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55763882|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
55763883|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763884|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55763885|NCT03398655|Paclitaxel|paclitaxel|mesh-list
55763886|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55763887|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55763888|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763889|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
55763890|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
55763891|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
55763892|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763893|NCT03391479|Avelumab|avelumab|mesh-list
55763894|NCT03391479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55763895|NCT03391479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763896|NCT05695287|Propofol|propofol|mesh-list
55763897|NCT05695287|Sevoflurane|sevoflurane|mesh-list
55763898|NCT05695287|Isoflurane|isoflurane|mesh-list
55763899|NCT05695287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55763900|NCT05695287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763901|NCT05695287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763902|NCT05695287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55763903|NCT05695287|Anesthetics, General|anesthetics, general|mesh-ancestor
55763904|NCT05695287|Anesthetics|anesthetics|mesh-ancestor
55763905|NCT05695287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55763906|NCT05695287|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55763907|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
55763908|NCT03808025|Narcotics|narcotics|mesh-ancestor
55763909|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763910|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763911|NCT03808025|Analgesics|analgesics|mesh-ancestor
55763912|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
55763913|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763914|NCT03009201|Doxorubicin|doxorubicin|mesh-list
55763915|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55763916|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55763917|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763918|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55763919|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55763920|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763921|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763922|NCT00591227|Insulin|insulin|mesh-list
55763923|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55763924|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
55763925|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
55763926|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55763927|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763928|NCT05494437|Gabapentin|gabapentin|mesh-list
55763929|NCT05494437|Nabilone|nabilone|mesh-list
55763930|NCT05494437|Analgesics|analgesics|mesh-ancestor
55763931|NCT05494437|Sensory System Agents|sensory system agents|mesh-ancestor
55763932|NCT05494437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55763933|NCT05494437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763934|NCT05494437|Anticonvulsants|anticonvulsants|mesh-ancestor
55763935|NCT05494437|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55763936|NCT05494437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55763937|NCT05494437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55763938|NCT05494437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55763939|NCT05494437|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55763940|NCT05494437|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55763941|NCT05494437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55763942|NCT05494437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763943|NCT05494437|Antimanic Agents|antimanic agents|mesh-ancestor
55763944|NCT05494437|Antiemetics|antiemetics|mesh-ancestor
55763945|NCT05494437|Autonomic Agents|autonomic agents|mesh-ancestor
55763946|NCT05494437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55763947|NCT00408473|Flecainide|flecainide|mesh-list
55763948|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55763949|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55763950|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55763951|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55763952|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763954|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
55763955|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763956|NCT00328601|Protective Agents|protective agents|mesh-ancestor
55763957|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763958|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
55763959|NCT00328601|Vitamins|vitamins|mesh-ancestor
55763960|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
55763961|NCT00189293|Imiquimod|imiquimod|mesh-list
55763962|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55763963|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
55763964|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763965|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763966|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
55763967|NCT03194009|Metformin|metformin|mesh-list
55763968|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55763969|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763970|NCT02581995|Aflibercept|aflibercept|mesh-list
55763971|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55763973|NCT02581995|Growth Substances|growth substances|mesh-ancestor
55763974|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763975|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
55763976|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55763977|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
55763978|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
55763979|NCT03193307|BI 409306|bi 409306|mesh-list
55763980|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55763981|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55763982|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763983|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55763984|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
55763985|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55763986|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55763987|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55763988|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55763989|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55763990|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55763991|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55763992|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
55763993|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55763994|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55763995|NCT02910843|Capecitabine|capecitabine|mesh-list
55763996|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55763997|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
55763998|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55763999|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764000|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55764001|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
55764002|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55764003|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
55764004|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55764005|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764006|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55764007|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55764008|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764010|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55764011|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55764012|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55764013|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55764014|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764015|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
55764016|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764017|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764019|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764020|NCT03193463|Topotecan|topotecan|mesh-list
55764021|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55764022|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55764023|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764024|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764025|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764026|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55764028|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55764029|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764030|NCT02577003|Incretins|incretins|mesh-ancestor
55764031|NCT02577003|Hormones|hormones|mesh-ancestor
55764032|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764033|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55764034|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
55764035|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764036|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764037|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55764038|NCT05487417|Minocycline|minocycline|mesh-list
55764039|NCT05487417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55764040|NCT05487417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764041|NCT03471611|Lenograstim|lenograstim|mesh-list
55764042|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55764043|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
55764044|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764045|NCT05694819|Goserelin|goserelin|mesh-list
55764046|NCT05694819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55764047|NCT05694819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764048|NCT02443727|Oxytocin|oxytocin|mesh-list
55764050|NCT02443727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55764051|NCT02443727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764052|NCT05676411|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55764053|NCT05676411|Dermatologic Agents|dermatologic agents|mesh-ancestor
55764054|NCT02600897|Rituximab|rituximab|mesh-list
55764055|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
55764056|NCT02600897|Lenalidomide|lenalidomide|mesh-list
55764057|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55764058|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764060|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764061|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764062|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55764063|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55764064|NCT02600897|Growth Substances|growth substances|mesh-ancestor
55764065|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
55764066|NCT02232191|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55764067|NCT02232191|Immunologic Factors|immunologic factors|mesh-ancestor
55764068|NCT02232191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764070|NCT05674305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764072|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
55764073|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55764074|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764075|NCT03192449|Anticestodal Agents|anticestodal agents|mesh-ancestor
55764076|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55764077|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55764078|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
55764079|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
55764080|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
55764081|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764085|NCT05691933|Narcotics|narcotics|mesh-ancestor
55764086|NCT05691933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764087|NCT05691933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764088|NCT05691933|Analgesics|analgesics|mesh-ancestor
55764089|NCT05691933|Sensory System Agents|sensory system agents|mesh-ancestor
55764090|NCT05691933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764091|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
55764092|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
55764093|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764094|NCT00977483|Protective Agents|protective agents|mesh-ancestor
55764095|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764096|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
55764150|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764151|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764154|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55764155|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764156|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764158|NCT02442713|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55764159|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55764160|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55764161|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764162|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764163|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
55764164|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55764165|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
55764166|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55764167|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55764168|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764169|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55764170|NCT03189953|Exenatide|exenatide|mesh-list
55764171|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55764172|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764173|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55764174|NCT03189953|Incretins|incretins|mesh-ancestor
55764175|NCT03189953|Hormones|hormones|mesh-ancestor
55764176|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764177|NCT02204085|Decitabine|decitabine|mesh-list
55764178|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55764179|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
55764180|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764181|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764182|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764183|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
55764184|NCT04314843|Fludarabine|fludarabine|mesh-list
55764185|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764186|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
55764187|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764188|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764189|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55764190|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
55764191|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764192|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764193|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55764194|NCT03192293|Metformin|metformin|mesh-list
55764195|NCT03192293|Fulvestrant|fulvestrant|mesh-list
55764196|NCT03192293|Simvastatin|simvastatin|mesh-list
55764197|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55764198|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764199|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55764200|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55764201|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
55764202|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764204|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55764205|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764206|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55764207|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764208|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55764209|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55764210|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
55764211|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764213|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55764214|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
55764215|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764216|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764217|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764218|NCT02441933|Carboplatin|carboplatin|mesh-list
55764220|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764221|NCT01604265|Nabiximols|nabiximols|mesh-list
55764222|NCT01604265|Analgesics|analgesics|mesh-ancestor
55764223|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
55764224|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764225|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764226|NCT04483427|Ketorolac|ketorolac|mesh-list
55764227|NCT04483427|Nalbuphine|nalbuphine|mesh-list
55764228|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55764229|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55764230|NCT04483427|Analgesics|analgesics|mesh-ancestor
55764231|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
55764232|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764233|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764234|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55764235|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764236|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55764237|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764238|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764239|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55764240|NCT04483427|Narcotics|narcotics|mesh-ancestor
55764241|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764242|NCT01664247|Liraglutide|liraglutide|mesh-list
55764243|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55764244|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764245|NCT01664247|Incretins|incretins|mesh-ancestor
55764246|NCT01664247|Hormones|hormones|mesh-ancestor
55764247|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764248|NCT02441465|Vemurafenib|vemurafenib|mesh-list
55764249|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764250|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55764251|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764252|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764253|NCT02438657|Lidocaine|lidocaine|mesh-list
55764255|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
55764257|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764258|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764259|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
55764260|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764261|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55764262|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55764263|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55764264|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55764265|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764266|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55764267|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55764268|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
55764269|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764270|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55764271|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55764272|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
55764273|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55764274|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
55764275|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
55764276|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
55764277|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55764278|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
55764279|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55764280|NCT01441947|Fulvestrant|fulvestrant|mesh-list
55764281|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55764282|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764283|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55764284|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55764285|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
55764286|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764287|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764288|NCT03192059|Aspirin|aspirin|mesh-list
55764290|NCT03192059|Curcumin|curcumin|mesh-list
55764291|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
55764292|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
55764293|NCT03192059|Lansoprazole|lansoprazole|mesh-list
55764294|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
55764295|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764296|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
55764297|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764298|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764299|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55764300|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
55764301|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764302|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764303|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55764304|NCT03192059|Vitamins|vitamins|mesh-ancestor
55764340|NCT05562999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764341|NCT02438345|Leronlimab|leronlimab|mesh-list
55764342|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55764343|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55764344|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764345|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55764348|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764349|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
55764350|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
55764351|NCT03191981|Lenalidomide|lenalidomide|mesh-list
55764352|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764353|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
55764354|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764355|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764356|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55764357|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
55764358|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764359|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764360|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55764361|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55764362|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55764363|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55764364|NCT03191981|Growth Substances|growth substances|mesh-ancestor
55764365|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
55764366|NCT05535075|Vancomycin|vancomycin|mesh-list
55764367|NCT05535075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55764368|NCT05535075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764369|NCT05530785|Bevacizumab|bevacizumab|mesh-list
55764370|NCT05530785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55764371|NCT05530785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764372|NCT05530785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55764373|NCT05530785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55764374|NCT05530785|Growth Substances|growth substances|mesh-ancestor
55764375|NCT05530785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764376|NCT05530785|Growth Inhibitors|growth inhibitors|mesh-ancestor
55764377|NCT05530395|Testosterone|testosterone|mesh-list
55764378|NCT05530395|Androgens|androgens|mesh-ancestor
55764379|NCT05530395|Hormones|hormones|mesh-ancestor
55764380|NCT05530395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764381|NCT05530395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764383|NCT05389995|Methamphetamine|methamphetamine|mesh-list
55764384|NCT05389995|Citric Acid|citric acid|mesh-list
55764385|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
55764386|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
55764387|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55764388|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
55764389|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
55764390|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764391|NCT05389995|Diuretics|diuretics|mesh-ancestor
55764392|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
55764393|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764394|NCT05389995|Expectorants|expectorants|mesh-ancestor
55764395|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
55764396|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55764397|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
55764399|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764400|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
55764401|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764402|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
55764403|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55764404|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55764405|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55764406|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55764407|NCT04529265|Methylene Blue|methylene blue|mesh-list
55764408|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764409|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764410|NCT03191903|Triamcinolone|triamcinolone|mesh-list
55764411|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55764412|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55764413|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55764414|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55764415|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
55764416|NCT03191903|Hormones|hormones|mesh-ancestor
55764417|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764418|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764419|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764420|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
55764421|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764422|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764424|NCT05534685|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55764425|NCT05534685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55764426|NCT05534685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55764427|NCT05534685|Autonomic Agents|autonomic agents|mesh-ancestor
55764428|NCT05534685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764429|NCT05534685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764430|NCT05534685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55764431|NCT05534685|Respiratory System Agents|respiratory system agents|mesh-ancestor
55764432|NCT05534685|Glucocorticoids|glucocorticoids|mesh-ancestor
55764433|NCT05534685|Hormones|hormones|mesh-ancestor
55764434|NCT05534685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764435|NCT04303689|Colchicine|colchicine|mesh-list
55764436|NCT04303689|Gout Suppressants|gout suppressants|mesh-ancestor
55764437|NCT04303689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764438|NCT04303689|Tubulin Modulators|tubulin modulators|mesh-ancestor
55764439|NCT04303689|Antimitotic Agents|antimitotic agents|mesh-ancestor
55764440|NCT04303689|Mitosis Modulators|mitosis modulators|mesh-ancestor
55764441|NCT04303689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764442|NCT04303689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764443|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
55764445|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
55764446|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764447|NCT05534529|Rezafungin|rezafungin|mesh-list
55764448|NCT05534529|Antifungal Agents|antifungal agents|mesh-ancestor
55764449|NCT05534529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764450|NCT05529927|Dextroamphetamine|dextroamphetamine|mesh-list
55764451|NCT05529927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55764452|NCT05529927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764453|NCT05529927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55764454|NCT05529927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55764455|NCT05529927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55764456|NCT05529927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764458|NCT05529927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764459|NCT02437721|Folic Acid|folic acid|mesh-list
55764460|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
55764461|NCT02437721|Hematinics|hematinics|mesh-ancestor
55764462|NCT02437721|Vitamins|vitamins|mesh-ancestor
55764463|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
55764464|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764465|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
55764466|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764467|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
55764468|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
55764469|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
55764470|NCT05533983|Nivolumab|nivolumab|mesh-list
55764471|NCT05533983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55764472|NCT05533983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764479|NCT05627271|Immunologic Factors|immunologic factors|mesh-ancestor
55764480|NCT05627271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764489|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
55764490|NCT02436395|Povidone|povidone|mesh-list
55764491|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
55764492|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
55764493|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55764494|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764495|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55764496|NCT02436083|Cefuroxime|cefuroxime|mesh-list
55764497|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
55764498|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764499|NCT03117335|Endostatins|endostatins|mesh-list
55764500|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764501|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55764502|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55764503|NCT03117335|Growth Substances|growth substances|mesh-ancestor
55764504|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764505|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
55764506|NCT02435927|Leucovorin|leucovorin|mesh-list
55764507|NCT02435927|Fluorouracil|fluorouracil|mesh-list
55764508|NCT02435927|Capecitabine|capecitabine|mesh-list
55764509|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
55764510|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
55764511|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764512|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55764513|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764514|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764515|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
55764516|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764517|NCT02435927|Antidotes|antidotes|mesh-ancestor
55764518|NCT02435927|Protective Agents|protective agents|mesh-ancestor
55764519|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
55764520|NCT02435927|Vitamins|vitamins|mesh-ancestor
55764521|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
55764522|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
55764523|NCT02435771|Vitamin D|vitamin d|mesh-list
55764524|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55764525|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764526|NCT02435771|Vitamins|vitamins|mesh-ancestor
55764527|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
55764531|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
55764532|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764533|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55764534|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55764535|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764536|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764537|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55764538|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
55764539|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764540|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764541|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55764542|NCT02440841|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55764543|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
55764544|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55764545|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
55764546|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55764547|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55764548|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55764549|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55764550|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55764551|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55764552|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55764554|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764555|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
55764556|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764557|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
55764559|NCT02435537|Bupivacaine|bupivacaine|mesh-list
55764560|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
55764561|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
55764562|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764563|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764564|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
55764565|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764566|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55764567|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55764568|NCT02435537|Analgesics|analgesics|mesh-ancestor
55764569|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55764570|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55764571|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55764572|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
55764573|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764574|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764575|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55764577|NCT02576067|Methotrexate|methotrexate|mesh-list
55764578|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55764579|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
55764580|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55764581|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764582|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55764584|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764585|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764586|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
55764587|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764588|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55764589|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764590|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
55764591|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764592|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55764634|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764635|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55764636|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764637|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764638|NCT02709005|Monolaurin|monolaurin|mesh-list
55764639|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
55764643|NCT03188471|Aspirin|aspirin|mesh-list
55764644|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764645|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55764646|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55764647|NCT03188471|Analgesics|analgesics|mesh-ancestor
55764648|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
55764649|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764650|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55764651|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764652|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55764653|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55764654|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764655|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55764656|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55764657|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764658|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
55764659|NCT04650087|Apixaban|apixaban|mesh-list
55764660|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55764661|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
55764662|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55764663|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
55764664|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764665|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764666|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
55764667|NCT03188159|Vinorelbine|vinorelbine|mesh-list
55764668|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55764669|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764670|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
55764671|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
55764672|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
55764673|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764676|NCT05532501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55764677|NCT05532501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764678|NCT05524857|Decitabine|decitabine|mesh-list
55764679|NCT05524857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55764680|NCT05524857|Antimetabolites|antimetabolites|mesh-ancestor
55764681|NCT05524857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764682|NCT05524857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764683|NCT05524857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764684|NCT05192889|Leucovorin|leucovorin|mesh-list
55764685|NCT05192889|Cytarabine|cytarabine|mesh-list
55764686|NCT05192889|Dexamethasone|dexamethasone|mesh-list
55764687|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
55764688|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
55764689|NCT05192889|Methotrexate|methotrexate|mesh-list
55764691|NCT05192889|Vincristine|vincristine|mesh-list
55764692|NCT05192889|Asparaginase|asparaginase|mesh-list
55764693|NCT05192889|Venetoclax|venetoclax|mesh-list
55764694|NCT05192889|Dasatinib|dasatinib|mesh-list
55764695|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
55764696|NCT05192889|Pegaspargase|pegaspargase|mesh-list
55764697|NCT05192889|Blinatumomab|blinatumomab|mesh-list
55764698|NCT05192889|Navitoclax|navitoclax|mesh-list
55764699|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764700|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
55764701|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764702|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764703|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55764704|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
55764705|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764706|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764707|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55764708|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55764709|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
55764710|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
55764711|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764712|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55764713|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
55764714|NCT05192889|Hormones|hormones|mesh-ancestor
55764715|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764716|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55764717|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55764718|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
55764719|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55764720|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55764722|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
55764723|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764724|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55764725|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55764726|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55764727|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55764728|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55764729|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
55764730|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764731|NCT05192889|Antidotes|antidotes|mesh-ancestor
55764732|NCT05192889|Protective Agents|protective agents|mesh-ancestor
55764733|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
55764734|NCT05192889|Vitamins|vitamins|mesh-ancestor
55764735|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
55764736|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
55764737|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
55764738|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
55764739|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55764740|NCT05327439|Nicotine|nicotine|mesh-list
55764741|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55764742|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
55764743|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764744|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764745|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55764746|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55764747|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
55764748|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764749|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764751|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55764752|NCT03187691|Amebicides|amebicides|mesh-ancestor
55764753|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55764754|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55764755|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764756|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55764757|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
55764758|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
55764759|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55764760|NCT02433899|Dexamethasone|dexamethasone|mesh-list
55764761|NCT02433899|Epinephrine|epinephrine|mesh-list
55764762|NCT02433899|Mepivacaine|mepivacaine|mesh-list
55764763|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55764764|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
55764765|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
55764766|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764767|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764768|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55764770|NCT02433899|Hormones|hormones|mesh-ancestor
55764771|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764772|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55764773|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764774|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55764775|NCT02433899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764776|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
55764777|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
55764778|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55764779|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55764780|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
55764781|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764782|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764783|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55764784|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55764785|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55764786|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
55764787|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
55764788|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
55764789|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55764790|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
55764791|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
55764792|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764793|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
55764794|NCT05532267|Ciprofloxacin|ciprofloxacin|mesh-list
55764795|NCT05532267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55764796|NCT05532267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764797|NCT05532267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55764798|NCT05532267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55764799|NCT05532267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764800|NCT05532267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764801|NCT05532267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764802|NCT05532267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55764803|NCT05532267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55764805|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764806|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55764807|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55764808|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55764809|NCT03187223|Melphalan|melphalan|mesh-list
55764810|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55764811|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55764813|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764814|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764815|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55764816|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764817|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
55764818|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764819|NCT05532111|Cyclophosphamide|cyclophosphamide|mesh-list
55764820|NCT05532111|Rituximab|rituximab|mesh-list
55764821|NCT05532111|Tacrolimus|tacrolimus|mesh-list
55764822|NCT05532111|Glucocorticoids|glucocorticoids|mesh-list
55764823|NCT05532111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764824|NCT05532111|Immunologic Factors|immunologic factors|mesh-ancestor
55764825|NCT05532111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764826|NCT05532111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764827|NCT05532111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55764828|NCT05532111|Alkylating Agents|alkylating agents|mesh-ancestor
55764829|NCT05532111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764830|NCT05532111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764831|NCT05532111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55764832|NCT05532111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55764833|NCT05532111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55764834|NCT05532111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764835|NCT05532111|Hormones|hormones|mesh-ancestor
55764836|NCT05532111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764837|NCT05524077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55764839|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764840|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55764841|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55764842|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55764843|NCT02433587|Aspirin|aspirin|mesh-list
55764844|NCT02433587|Clopidogrel|clopidogrel|mesh-list
55764845|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55764846|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55764847|NCT02433587|Analgesics|analgesics|mesh-ancestor
55764848|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
55764849|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764850|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764851|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55764852|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55764853|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55764854|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55764855|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764856|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55764857|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55764858|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764859|NCT02433587|Antipyretics|antipyretics|mesh-ancestor
55764860|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55764861|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55764862|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55764863|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
55764864|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764865|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55764866|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55764867|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55764868|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55764869|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764870|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764871|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764872|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55764873|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
55764874|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55764876|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55764877|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55764878|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764879|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
55764880|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764881|NCT03190733|Fludarabine|fludarabine|mesh-list
55764883|NCT04425135|Carboplatin|carboplatin|mesh-list
55764884|NCT04425135|Apatinib|apatinib|mesh-list
55764885|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764886|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55764887|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764888|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764889|NCT02573883|Clobetasol|clobetasol|mesh-list
55764890|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55764891|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
55764892|NCT02573883|Hormones|hormones|mesh-ancestor
55764893|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55764894|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764895|NCT02432885|Enalapril|enalapril|mesh-list
55764896|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55764897|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
55764898|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764899|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764900|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55764901|NCT02433041|Ketamine|ketamine|mesh-list
55764902|NCT02433041|Haloperidol|haloperidol|mesh-list
55764903|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
55764904|NCT02433041|Analgesics|analgesics|mesh-ancestor
55764905|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
55764906|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764907|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764908|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55764909|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55764910|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
55764911|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
55764912|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55764913|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55764914|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55764915|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764916|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764918|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
55764919|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55764920|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55764921|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55764922|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55764923|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55764924|NCT02433041|Dopamine Agents|dopamine agents|mesh-ancestor
55764925|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55764926|NCT02429921|Selenium|selenium|mesh-list
55764927|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
55764928|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764929|NCT02429921|Protective Agents|protective agents|mesh-ancestor
55764930|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764931|NCT02429921|Trace Elements|trace elements|mesh-ancestor
55764932|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
55764933|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55764934|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55764935|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55764936|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764937|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764938|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
55764939|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764940|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55764941|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55764942|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55764943|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55764944|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764945|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55764946|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
55764947|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765027|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764949|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55764950|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55764951|NCT05527275|Mitoxantrone|mitoxantrone|mesh-list
55764952|NCT05527275|Analgesics|analgesics|mesh-ancestor
55764953|NCT05527275|Sensory System Agents|sensory system agents|mesh-ancestor
55764954|NCT05527275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764955|NCT05527275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55782884|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
55764956|NCT05527275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764957|NCT05527275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55764958|NCT05527275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55764959|NCT05527275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764961|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
55764962|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55764963|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
55764964|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55764965|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55764966|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55764967|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
55764968|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55764969|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55764970|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55764971|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
55764972|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55764973|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764975|NCT02429687|Etoposide|etoposide|mesh-list
55764976|NCT02429687|Carboplatin|carboplatin|mesh-list
55764977|NCT02429687|Bleomycin|bleomycin|mesh-list
55764978|NCT02429687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55764979|NCT02429687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55764980|NCT02429687|Tubulin Modulators|tubulin modulators|mesh-ancestor
55764981|NCT02429687|Antimitotic Agents|antimitotic agents|mesh-ancestor
55764982|NCT02429687|Mitosis Modulators|mitosis modulators|mesh-ancestor
55764983|NCT02429687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764984|NCT02429687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55764985|NCT02429687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55764986|NCT02429687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764987|NCT02429687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55764988|NCT05164653|Valsartan|valsartan|mesh-list
55764989|NCT05164653|Angiotensin II|angiotensin ii|mesh-list
55764990|NCT05164653|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55764991|NCT05164653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55764992|NCT05164653|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55764993|NCT05164653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55764994|NCT05164653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55764995|NCT05164653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55764996|NCT05164653|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55764997|NCT05164653|Protease Inhibitors|protease inhibitors|mesh-ancestor
55764998|NCT05164653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55764999|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
55765000|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55765001|NCT03186053|Protective Agents|protective agents|mesh-ancestor
55765002|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765004|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55765005|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765006|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765007|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765008|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55765009|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
55765010|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765012|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
55765013|NCT02429453|Coagulants|coagulants|mesh-ancestor
55765015|NCT02428751|Rituximab|rituximab|mesh-list
55765016|NCT02428751|Doxorubicin|doxorubicin|mesh-list
55765017|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55765018|NCT02428751|Vincristine|vincristine|mesh-list
55765019|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55765020|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765021|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
55765022|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765023|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765024|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55765025|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55765026|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55765028|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765029|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765030|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
55765032|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765033|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55765034|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55765035|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
55765036|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
55765037|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
55765038|NCT05526807|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55765039|NCT05526807|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55765040|NCT05526807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55765041|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55765043|NCT05155293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55765044|NCT05155293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55765045|NCT05155293|Growth Substances|growth substances|mesh-ancestor
55765046|NCT05155293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765047|NCT05155293|Growth Inhibitors|growth inhibitors|mesh-ancestor
55765048|NCT05155293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765049|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55765050|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
55765051|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765053|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765054|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55765055|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55765056|NCT02432651|Growth Substances|growth substances|mesh-ancestor
55765057|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765058|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
55765059|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55765060|NCT02707757|Hematinics|hematinics|mesh-ancestor
55765061|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
55765062|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55765063|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765064|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55765065|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
55765066|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55765067|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765068|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765069|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765070|NCT03184805|Aspirin|aspirin|mesh-list
55765071|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55765072|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55765073|NCT03184805|Analgesics|analgesics|mesh-ancestor
55765074|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
55765075|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765076|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765077|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765078|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765079|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55765080|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55765081|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765082|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55765083|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55765084|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765085|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
55765086|NCT05518383|Cytarabine|cytarabine|mesh-list
55765087|NCT05518383|Dexamethasone|dexamethasone|mesh-list
55765088|NCT05518383|Dexamethasone acetate|dexamethasone acetate|mesh-list
55765089|NCT05518383|Cyclophosphamide|cyclophosphamide|mesh-list
55765090|NCT05518383|Melphalan|melphalan|mesh-list
55765091|NCT05518383|Ifosfamide|ifosfamide|mesh-list
55765092|NCT05518383|Isophosphamide mustard|isophosphamide mustard|mesh-list
55765093|NCT05518383|Doxorubicin|doxorubicin|mesh-list
55765094|NCT05518383|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55765095|NCT05518383|Methotrexate|methotrexate|mesh-list
55765096|NCT05518383|Etoposide|etoposide|mesh-list
55765097|NCT05518383|Etoposide phosphate|etoposide phosphate|mesh-list
55765098|NCT05518383|Vincristine|vincristine|mesh-list
55765100|NCT05518383|Carboplatin|carboplatin|mesh-list
55765101|NCT05518383|BB 1101|bb 1101|mesh-list
55765102|NCT05518383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55765103|NCT05518383|Immunologic Factors|immunologic factors|mesh-ancestor
55765104|NCT05518383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765105|NCT05518383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765106|NCT05518383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55765107|NCT05518383|Alkylating Agents|alkylating agents|mesh-ancestor
55765108|NCT05518383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765109|NCT05518383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765110|NCT05518383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55765111|NCT05518383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765112|NCT05518383|Antiemetics|antiemetics|mesh-ancestor
55765113|NCT05518383|Autonomic Agents|autonomic agents|mesh-ancestor
55765114|NCT05518383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765115|NCT05518383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55765116|NCT05518383|Glucocorticoids|glucocorticoids|mesh-ancestor
55765118|NCT05518383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765119|NCT05518383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55765120|NCT05518383|Protease Inhibitors|protease inhibitors|mesh-ancestor
55765121|NCT05518383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765122|NCT05518383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55765123|NCT05518383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55765124|NCT05518383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55765125|NCT05518383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55765126|NCT05518383|Abortifacient Agents|abortifacient agents|mesh-ancestor
55765127|NCT05518383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55765128|NCT05518383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55765129|NCT05518383|Antimetabolites|antimetabolites|mesh-ancestor
55765130|NCT05518383|Dermatologic Agents|dermatologic agents|mesh-ancestor
55765131|NCT05518383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55765132|NCT05518383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55765133|NCT05518383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55765134|NCT05518383|Antiviral Agents|antiviral agents|mesh-ancestor
55765135|NCT05518383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765136|NCT05518383|Tubulin Modulators|tubulin modulators|mesh-ancestor
55765137|NCT05518383|Antimitotic Agents|antimitotic agents|mesh-ancestor
55765138|NCT05518383|Mitosis Modulators|mitosis modulators|mesh-ancestor
55765139|NCT02432027|Betamethasone|betamethasone|mesh-list
55765140|NCT02432027|Calcipotriene|calcipotriene|mesh-list
55765141|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765142|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
55765144|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765145|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765146|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55765147|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
55765148|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
55765149|NCT02428439|Lamotrigine|lamotrigine|mesh-list
55765150|NCT02428439|Bupropion|bupropion|mesh-list
55765151|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55765152|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
55765153|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55765154|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55765155|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55765156|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55765157|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765158|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
55765159|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765160|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765161|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55765162|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55765163|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765164|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
55765165|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55765166|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55765167|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55765168|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55765169|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765170|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55765171|NCT03186443|Pregabalin|pregabalin|mesh-list
55765172|NCT03186443|Gabapentin|gabapentin|mesh-list
55765173|NCT03186443|Analgesics|analgesics|mesh-ancestor
55765174|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
55765175|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765176|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765177|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
55765178|NCT03186443|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55765179|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55765180|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765181|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55765182|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55765373|NCT02425865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765375|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
55765376|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
55765377|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55765378|NCT03183557|Vitamins|vitamins|mesh-ancestor
55765379|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
55765380|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765381|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55765382|NCT02426723|Dexamethasone|dexamethasone|mesh-list
55765383|NCT02426723|Lenalidomide|lenalidomide|mesh-list
55765384|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765385|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
55765386|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
55765387|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765388|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765389|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55765390|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
55765391|NCT02426723|Hormones|hormones|mesh-ancestor
55765392|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765393|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55765394|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765395|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
55765396|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55765397|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55765398|NCT02426723|Growth Substances|growth substances|mesh-ancestor
55765399|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
55765400|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
55765401|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
55765402|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55765403|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55765404|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
55765405|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765406|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765407|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765408|NCT02425241|Vaccines|vaccines|mesh-list
55765409|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
55765410|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765411|NCT03182855|Ticagrelor|ticagrelor|mesh-list
55765413|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55765414|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55765415|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55765416|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55765417|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
55765418|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765419|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765420|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765421|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
55765422|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765423|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55765424|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765425|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765426|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
55765427|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765428|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765429|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55765431|NCT02426177|Nifedipine|nifedipine|mesh-list
55765432|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55765433|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55765434|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765435|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55765436|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765437|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
55765438|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
55765439|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55765440|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55765441|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55765442|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
55765443|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765444|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55765446|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
55765447|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765448|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55765449|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55765450|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
55765451|NCT02426099|Spironolactone|spironolactone|mesh-list
55765452|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55765453|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
55782901|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
55765454|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765458|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
55765459|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55765460|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
55765461|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765462|NCT02425709|Diclofenac|diclofenac|mesh-list
55765463|NCT02425709|Tramadol|tramadol|mesh-list
55765464|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55765465|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55765466|NCT02425709|Analgesics|analgesics|mesh-ancestor
55765467|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
55765468|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765469|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765470|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765472|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55765473|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765474|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765475|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55765476|NCT02425709|Narcotics|narcotics|mesh-ancestor
55765477|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765478|NCT02073682|Heparin|heparin|mesh-list
55765479|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55765480|NCT02073682|Tinzaparin|tinzaparin|mesh-list
55765481|NCT02073682|Dalteparin|dalteparin|mesh-list
55765482|NCT02073682|Edoxaban|edoxaban|mesh-list
55765483|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
55765484|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55765485|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55765486|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765487|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55765488|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
55765489|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55765490|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
55765491|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765492|NCT03181919|Letrozole|letrozole|mesh-list
55765493|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765494|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55765495|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55765496|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765497|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765499|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
55765500|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765501|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765502|NCT02706899|Azacitidine|azacitidine|mesh-list
55765503|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55765504|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
55765505|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765506|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765507|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765508|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
55765509|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
55765510|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55765512|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765513|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765514|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765515|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765516|NCT02424695|Gabapentin|gabapentin|mesh-list
55765517|NCT02424695|Analgesics|analgesics|mesh-ancestor
55765518|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
55765519|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765520|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765521|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
55765524|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765525|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55765526|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55765527|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55765528|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55765529|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765530|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
55765619|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765620|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765621|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765622|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55765623|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55765624|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
55765626|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55765627|NCT01598506|Narcotics|narcotics|mesh-ancestor
55765628|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765629|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765630|NCT01598506|Analgesics|analgesics|mesh-ancestor
55765631|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
55765632|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765633|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
55765634|NCT02423915|Sirolimus|sirolimus|mesh-list
55765635|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
55765636|NCT02423915|Rituximab|rituximab|mesh-list
55765637|NCT02423915|Fludarabine|fludarabine|mesh-list
55765638|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
55765639|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55765640|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
55765641|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765642|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765643|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55765644|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
55765645|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765646|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765647|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55765648|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55765649|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55765650|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
55765651|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765652|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55765653|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55765654|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
55765655|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55765656|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765657|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
55765659|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55765660|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55765661|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765662|NCT02423837|Immunologic Factors|immunologic factors|mesh-ancestor
55765663|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765664|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765665|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55765666|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
55765667|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765669|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55765670|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55765671|NCT02140060|Brinzolamide|brinzolamide|mesh-list
55765672|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55765673|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55765674|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765675|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765676|NCT03178721|Calcium|calcium|mesh-list
55765677|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55765678|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765679|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
55765681|NCT02421029|Calcium|calcium|mesh-list
55765682|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
55765683|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55765684|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765685|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55765686|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
55765687|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55765688|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
55765689|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
55765690|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765691|NCT02421029|Antidotes|antidotes|mesh-ancestor
55765692|NCT02421029|Protective Agents|protective agents|mesh-ancestor
55765693|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55765694|NCT02139982|Ropivacaine|ropivacaine|mesh-list
55765696|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
55765697|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55765698|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765699|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
55765700|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765701|NCT03178643|Piperaquine|piperaquine|mesh-list
55765702|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
55765703|NCT03178643|Amodiaquine|amodiaquine|mesh-list
55765704|NCT03178643|Artenimol|artenimol|mesh-list
55765705|NCT03178643|Proguanil|proguanil|mesh-list
55765706|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
55765707|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55765708|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55765709|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55765710|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55765711|NCT03178643|Renal Agents|renal agents|mesh-ancestor
55765712|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
55765713|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765714|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55765715|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55765716|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765717|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
55765718|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55765719|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
55765720|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765721|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765722|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55765723|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
55765724|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765725|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765726|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55765727|NCT02072434|Enoxaparin|enoxaparin|mesh-list
55765728|NCT02072434|Warfarin|warfarin|mesh-list
55765729|NCT02072434|Edoxaban|edoxaban|mesh-list
55765730|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
55765733|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765734|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55765735|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
55765736|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55765737|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
55765738|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765739|NCT04725994|Irinotecan|irinotecan|mesh-list
55765740|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55765741|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55765742|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765743|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765744|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765746|NCT02139046|Colchicine|colchicine|mesh-list
55765747|NCT02139046|Febuxostat|febuxostat|mesh-list
55765748|NCT02139046|Lansoprazole|lansoprazole|mesh-list
55765749|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
55765750|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55765751|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55765752|NCT02139046|Analgesics|analgesics|mesh-ancestor
55765753|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
55765754|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765755|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765756|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765757|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765758|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
55765759|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55765760|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765761|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765762|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
55765763|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
55765764|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
55765765|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765766|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55765773|NCT04735354|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55765774|NCT04735354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765775|NCT04734262|Paclitaxel|paclitaxel|mesh-list
55765776|NCT04734262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55765777|NCT04734262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55765778|NCT04734262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55765779|NCT04734262|Tubulin Modulators|tubulin modulators|mesh-ancestor
55765780|NCT04734262|Antimitotic Agents|antimitotic agents|mesh-ancestor
55765781|NCT04734262|Mitosis Modulators|mitosis modulators|mesh-ancestor
55765782|NCT04734262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55765784|NCT02100670|Menthol|menthol|mesh-list
55866712|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765785|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55765786|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55765787|NCT02100670|Analgesics|analgesics|mesh-ancestor
55765788|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
55765789|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765790|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55765791|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55765792|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55765793|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55765794|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863732|NCT05640778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55863733|NCT05640778|Alkylating Agents|alkylating agents|mesh-ancestor
55863734|NCT05640778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863735|NCT05640778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863736|NCT05640778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55863737|NCT05640778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55863738|NCT05640778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863739|NCT05640778|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55863740|NCT05640778|Hormone Antagonists|hormone antagonists|mesh-ancestor
55863741|NCT05640778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863745|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55863746|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
55863747|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863748|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55863749|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55863750|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863751|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863752|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55863753|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
55863754|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863755|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
55863758|NCT00792922|Azithromycin|azithromycin|mesh-list
55863759|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55863760|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863761|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
55863762|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55863763|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55863764|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
55863765|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863766|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55863767|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55863769|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863770|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
55863771|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55863772|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55863773|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863774|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55863775|NCT04382170|Analgesics|analgesics|mesh-ancestor
55863776|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
55863777|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863778|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55863779|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55863780|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55863781|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
55863782|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863783|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863784|NCT04718350|Simendan|simendan|mesh-list
55863785|NCT04718350|Milrinone|milrinone|mesh-list
55863786|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55863787|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
55863788|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55863789|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55863790|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863791|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863792|NCT04718350|Protective Agents|protective agents|mesh-ancestor
55863793|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863794|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55863803|NCT01729819|Urological Agents|urological agents|mesh-ancestor
55863804|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
55863805|NCT01729819|Coagulants|coagulants|mesh-ancestor
55863806|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55863807|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
55863808|NCT05440708|Bevacizumab|bevacizumab|mesh-list
55863810|NCT05440708|Atezolizumab|atezolizumab|mesh-list
55863811|NCT05440708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55863812|NCT05440708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863813|NCT05440708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55863815|NCT05440708|Growth Substances|growth substances|mesh-ancestor
55863816|NCT05440708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863831|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863832|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863833|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55863834|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55863835|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55863836|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55863837|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55863838|NCT05394298|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55863839|NCT05394298|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55863856|NCT01709084|Emtricitabine|emtricitabine|mesh-list
55863857|NCT01709084|Efavirenz|efavirenz|mesh-list
55863859|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
55863860|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863861|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55863862|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55863863|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863864|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863865|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55863866|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55863867|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55863898|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55863900|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55863901|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55863902|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55863903|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55863904|NCT04658927|Dexamethasone|dexamethasone|mesh-list
55863905|NCT04658927|Prednisone|prednisone|mesh-list
55863906|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55863908|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
55863910|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863911|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55863912|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
55863913|NCT04658927|Hormones|hormones|mesh-ancestor
55866663|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866664|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866666|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
55866667|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866668|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866669|NCT03217474|Ganciclovir|ganciclovir|mesh-list
55866670|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
55866671|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
55866672|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866673|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55866674|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866675|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866677|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
55866678|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
55866679|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866681|NCT03213886|Calcifediol|calcifediol|mesh-list
55866682|NCT03213886|Vitamins|vitamins|mesh-ancestor
55866683|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
55866684|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866685|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55866686|NCT03217084|Fluorides|fluorides|mesh-list
55866687|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
55866688|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
55866689|NCT03217084|Protective Agents|protective agents|mesh-ancestor
55866690|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866691|NCT00899470|Metformin|metformin|mesh-list
55866692|NCT00899470|Saxagliptin|saxagliptin|mesh-list
55866693|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55866694|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866695|NCT00899470|Incretins|incretins|mesh-ancestor
55866696|NCT00899470|Hormones|hormones|mesh-ancestor
55866697|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866698|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55866699|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
55866709|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866710|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
55866711|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55866713|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866714|NCT00904618|Lidocaine|lidocaine|mesh-list
55866715|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
55866716|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
55866717|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55866719|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
55866720|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866721|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55866722|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55866723|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55866724|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55866725|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866726|NCT01839370|Pramlintide|pramlintide|mesh-list
55866727|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55866728|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866729|NCT00907426|Bimatoprost|bimatoprost|mesh-list
55866730|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55866731|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55866732|NCT01832662|Caffeine|caffeine|mesh-list
55866733|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55866734|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866735|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55866736|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866737|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866738|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55866739|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55789091|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789092|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55789093|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55866740|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
55866741|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866743|NCT00909064|Fondaparinux|fondaparinux|mesh-list
55866744|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55866745|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
55866746|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55866747|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
55866748|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866749|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866750|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
55866751|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55866752|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55866753|NCT01832896|Ecallantide|ecallantide|mesh-list
55866754|NCT01832896|Analgesics|analgesics|mesh-ancestor
55866755|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
55866756|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866757|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866758|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55866759|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866760|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866761|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866762|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55866763|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
55866773|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866774|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866775|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55866776|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55866777|NCT01830478|Growth Substances|growth substances|mesh-ancestor
55866778|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
55866782|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55866783|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866784|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55866785|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866786|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
55866787|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55866788|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866789|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55866790|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55866791|NCT01838200|Antimetabolites|antimetabolites|mesh-ancestor
55866792|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55866793|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55866794|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
55866795|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866797|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55866844|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55866846|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866847|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
55866848|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
55866849|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
55866850|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866854|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
55866855|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55866856|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55866857|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
55866858|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55866859|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
55866860|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55866861|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
55866862|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
55866863|NCT03830398|Acetaminophen|acetaminophen|mesh-list
55866864|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866865|NCT03830398|Analgesics|analgesics|mesh-ancestor
55866866|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
55866867|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866868|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866869|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
55866870|NCT04405323|Itraconazole|itraconazole|mesh-list
55866871|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
55866872|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866873|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55866874|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55866875|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866876|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866877|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55866879|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866880|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866881|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55866882|NCT01720498|Remifentanil|remifentanil|mesh-list
55866883|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55866884|NCT01720498|Narcotics|narcotics|mesh-ancestor
55866885|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55866886|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866887|NCT01720498|Analgesics|analgesics|mesh-ancestor
55866888|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
55866900|NCT04170543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55866901|NCT04170543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866902|NCT00911326|Dextrans|dextrans|mesh-list
55866903|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
55866904|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
55866905|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
55866906|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
55866907|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
55866908|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
55866909|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866911|NCT01833676|Sevoflurane|sevoflurane|mesh-list
55789096|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789097|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866912|NCT01833676|Desflurane|desflurane|mesh-list
55866913|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55866914|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55866915|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
55866916|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
55866917|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55866918|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866919|NCT04380376|Melphalan|melphalan|mesh-list
55866920|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55866921|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
55866922|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866923|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866924|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55866925|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866926|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
55866927|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866928|NCT04380298|Ketorolac|ketorolac|mesh-list
55866929|NCT04380298|Epinephrine|epinephrine|mesh-list
55866930|NCT04380298|Ropivacaine|ropivacaine|mesh-list
55866931|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
55866932|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
55867955|NCT01592864|Protective Agents|protective agents|mesh-ancestor
55866933|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55866934|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866935|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
55866936|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866937|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55866938|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55866939|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
55866940|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866941|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866942|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55866943|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55866944|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
55866945|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55866946|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
55866947|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
55866948|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
55866949|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55866951|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866952|NCT04380298|Analgesics|analgesics|mesh-ancestor
55866975|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866976|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866977|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55866978|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55866979|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
55866980|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
55866981|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55866982|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55866983|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55866984|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866985|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866986|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
55866987|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
55866988|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55866989|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
55866990|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
55866991|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55866992|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
55866993|NCT03152955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55866994|NCT03152955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55866995|NCT03152955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55866996|NCT03152955|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55866997|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55866998|NCT03152955|Narcotics|narcotics|mesh-ancestor
55866999|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55867000|NCT01676493|Codeine|codeine|mesh-list
55867001|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55867002|NCT01676493|Narcotics|narcotics|mesh-ancestor
55867003|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789099|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55867004|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867005|NCT01676493|Analgesics|analgesics|mesh-ancestor
55867006|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
55867007|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867008|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
55867040|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867041|NCT03210064|Fluorouracil|fluorouracil|mesh-list
55867042|NCT03210064|Apatinib|apatinib|mesh-list
55867043|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
55867044|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867045|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55867046|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867084|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
55867085|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55867086|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867087|NCT05372991|Atropine|atropine|mesh-list
55867088|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55867089|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55867090|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55867091|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
55867092|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867093|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867094|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55867104|NCT04764825|Methadone|methadone|mesh-list
55867105|NCT04764825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55867106|NCT04764825|Narcotics|narcotics|mesh-ancestor
55867107|NCT04764825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55867108|NCT04764825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867109|NCT04764825|Analgesics|analgesics|mesh-ancestor
55867110|NCT04764825|Sensory System Agents|sensory system agents|mesh-ancestor
55867111|NCT04764825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867112|NCT04764825|Antitussive Agents|antitussive agents|mesh-ancestor
55867113|NCT04764825|Respiratory System Agents|respiratory system agents|mesh-ancestor
55867116|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55867117|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867118|NCT03594435|Ibudilast|ibudilast|mesh-list
55867119|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55867120|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
55867121|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867122|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867123|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55867124|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
55867125|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55867126|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867127|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867128|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55867129|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
55867130|NCT01722448|Choline|choline|mesh-list
55867131|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
55867132|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55867133|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
55867134|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867135|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55867136|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55867137|NCT01722448|Nootropic Agents|nootropic agents|mesh-ancestor
55867138|NCT01834768|Eplerenone|eplerenone|mesh-list
55867139|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55867140|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
55867141|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55867142|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867143|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55867144|NCT01834768|Diuretics|diuretics|mesh-ancestor
55867145|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
55789100|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789101|NCT05301517|Epoetin Alfa|epoetin alfa|mesh-list
55867146|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55867147|NCT01672671|Paclitaxel|paclitaxel|mesh-list
55867148|NCT01672671|Doxorubicin|doxorubicin|mesh-list
55867149|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55867150|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867151|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
55867152|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
55867153|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
55867154|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867155|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55867156|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55867157|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55867158|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867159|NCT02459457|Paclitaxel|paclitaxel|mesh-list
55867177|NCT01835236|Trastuzumab|trastuzumab|mesh-list
55867178|NCT01835236|Pertuzumab|pertuzumab|mesh-list
55867179|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55867180|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867181|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
55867182|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
55867183|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
55867184|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867185|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55867186|NCT03152409|Aspirin|aspirin|mesh-list
55867187|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
55867188|NCT03152409|Salicylates|salicylates|mesh-list
55867189|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55867190|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55867191|NCT03152409|Analgesics|analgesics|mesh-ancestor
55867192|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
55867193|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867194|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867195|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55867196|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867197|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55867198|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55867199|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867200|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55867201|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55867202|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867203|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
55867204|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867205|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
55867206|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
55867207|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
55867208|NCT01830322|Gemcitabine|gemcitabine|mesh-list
55867209|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55867210|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
55867211|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867212|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867213|NCT01830322|Antiviral Agents|antiviral agents|mesh-ancestor
55867214|NCT01830322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867215|NCT01830322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867216|NCT01830322|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55867217|NCT01830322|Immunologic Factors|immunologic factors|mesh-ancestor
55867218|NCT01830322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867233|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55867234|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55867235|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
55867236|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867237|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867238|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55867239|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
55867240|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
55867241|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55867243|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
55867244|NCT04378972|Curcumin|curcumin|mesh-list
55867245|NCT04378972|Tramiprosate|tramiprosate|mesh-list
55867246|NCT04378972|Vitamins|vitamins|mesh-ancestor
55867247|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
55867248|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867249|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55867250|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55867251|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55867252|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55867253|NCT04378972|Analgesics|analgesics|mesh-ancestor
55867254|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
55867255|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867256|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55867257|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867258|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867259|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867260|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867261|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
55867262|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
55867263|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
55867264|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867265|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
55867266|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
55867267|NCT01723150|Ertapenem|ertapenem|mesh-list
55867268|NCT01723150|Trimethoprim|trimethoprim|mesh-list
55867269|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
55867270|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55867271|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867272|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55867273|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55867274|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867275|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867276|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867277|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55867278|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55867279|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55867280|NCT01723150|Renal Agents|renal agents|mesh-ancestor
55867281|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
55867282|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55867296|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55867297|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55867298|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55867299|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55867300|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
55867301|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867302|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867303|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55867304|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
55867305|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
55867306|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55867307|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55867308|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55867309|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55867310|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
55867311|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867312|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867313|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
55867314|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55867315|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
55867316|NCT01836016|Hormones|hormones|mesh-ancestor
55867317|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55867318|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
55867319|NCT01836094|Methylene Blue|methylene blue|mesh-list
55867320|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867321|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867322|NCT01726192|Ropivacaine|ropivacaine|mesh-list
55867323|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
55867324|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
55867325|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55867326|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867327|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
55867328|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867329|NCT01836328|Methadone|methadone|mesh-list
55867330|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55867331|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55867332|NCT01836328|Narcotics|narcotics|mesh-ancestor
55867333|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55867334|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867335|NCT01836328|Analgesics|analgesics|mesh-ancestor
55789103|NCT04909775|Gemcitabine|gemcitabine|mesh-list
55789104|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789105|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55867336|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
55867337|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867338|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
55867342|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55867343|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55867344|NCT01836406|Analgesics|analgesics|mesh-ancestor
55867366|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55867368|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55867369|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
55867370|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867371|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867372|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55867373|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
55867374|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
55867375|NCT00915538|Hormones|hormones|mesh-ancestor
55867376|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55867378|NCT01724086|Ritonavir|ritonavir|mesh-list
55867379|NCT01724086|Ribavirin|ribavirin|mesh-list
55867380|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
55867381|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
55867382|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55867383|NCT01724086|Simeprevir|simeprevir|mesh-list
55867384|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867385|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
55867386|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867387|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55867388|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55867389|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
55867390|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867391|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867392|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55867393|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55867394|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55867395|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55867412|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867413|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867415|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55867416|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
55867417|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55867418|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867419|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55867420|NCT01837108|Diuretics|diuretics|mesh-ancestor
55867421|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
55867422|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55867423|NCT01724554|Aflibercept|aflibercept|mesh-list
55867424|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55867425|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55867426|NCT01724554|Growth Substances|growth substances|mesh-ancestor
55867427|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867428|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
55867429|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867430|NCT01724788|Furosemide|furosemide|mesh-list
55867431|NCT01724788|Diuretics|diuretics|mesh-ancestor
55867432|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
55867433|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867434|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55867435|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55867436|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867438|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55867439|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867440|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867441|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
55789106|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
55867442|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867443|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867444|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55867445|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
55867446|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867447|NCT01705574|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55867448|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
55867449|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867450|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55867463|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867464|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55867465|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867466|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55867467|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867468|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867470|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
55867471|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867472|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55867473|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867474|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867475|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55867476|NCT01725100|Protective Agents|protective agents|mesh-ancestor
55867477|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867478|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55867481|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
55867482|NCT01725412|Vitamins|vitamins|mesh-ancestor
55867483|NCT01725412|Micronutrients|micronutrients|mesh-ancestor
55867484|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867485|NCT01725490|Metformin|metformin|mesh-list
55867486|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55867487|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867488|NCT04553666|Vitamins|vitamins|mesh-list
55867489|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
55867490|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
55867491|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
55867492|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867493|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
55867494|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867495|NCT04553666|Protective Agents|protective agents|mesh-ancestor
55867496|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55867497|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55867498|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867499|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55867500|NCT03834766|Amphetamine|amphetamine|mesh-list
55867501|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55867502|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867503|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
55867504|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
55867505|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867506|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
55867507|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867508|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867509|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
55867510|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55867511|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55867512|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55867513|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55867514|NCT01838434|Lenalidomide|lenalidomide|mesh-list
55867534|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55867535|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867536|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867537|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867538|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867539|NCT04377646|Trace Elements|trace elements|mesh-ancestor
55867540|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
55867541|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867542|NCT01728922|Vitamin D|vitamin d|mesh-list
55867544|NCT01728922|Cholecalciferol|cholecalciferol|mesh-list
55867545|NCT01728922|Vitamins|vitamins|mesh-list
55789107|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789109|NCT04909775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789110|NCT04909775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789111|NCT04909775|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55789112|NCT04909775|Immunologic Factors|immunologic factors|mesh-ancestor
55789113|NCT04909775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789114|NCT04925141|Dasatinib|dasatinib|mesh-list
55867546|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
55867547|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867548|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55867549|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55867550|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
55867551|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
55867552|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867553|NCT01838902|Primaquine|primaquine|mesh-list
55867554|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
55867555|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55867556|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55867557|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867558|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
55867559|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
55867560|NCT01714544|Hormones|hormones|mesh-ancestor
55867561|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55867562|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867563|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55867564|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55867565|NCT03409432|Lenalidomide|lenalidomide|mesh-list
55867566|NCT03409432|Antibodies|antibodies|mesh-list
55867567|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
55867568|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55867569|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
55867570|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
55867571|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867572|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867573|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55867585|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55867586|NCT01729468|Analgesics|analgesics|mesh-ancestor
55867587|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
55867588|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867589|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867591|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867592|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55867593|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55867594|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867595|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55867596|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55867597|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867599|NCT04376788|Methylene Blue|methylene blue|mesh-list
55867600|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867601|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867602|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55867603|NCT01714310|Fluoxetine|fluoxetine|mesh-list
55867604|NCT01714310|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55867605|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55867606|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55867607|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867608|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867610|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867611|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55867612|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
55867613|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55867614|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55789115|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789116|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55867615|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55867616|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867617|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55867618|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55867619|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
55867621|NCT03408574|Nicotine|nicotine|mesh-list
55867622|NCT03408574|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55867623|NCT03408574|Autonomic Agents|autonomic agents|mesh-ancestor
55867624|NCT03408574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867625|NCT03408574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867626|NCT03408574|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55867627|NCT03408574|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55867628|NCT03408574|Cholinergic Agents|cholinergic agents|mesh-ancestor
55867629|NCT03408574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867630|NCT03408574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867631|NCT03408574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55867632|NCT03408574|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
55867633|NCT03408574|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55867634|NCT03408574|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55867652|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867653|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
55867654|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
55867655|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55867656|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55867657|NCT03407872|Esketamine|esketamine|mesh-list
55867658|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
55867659|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55867660|NCT03834610|Tadalafil|tadalafil|mesh-list
55867661|NCT03834610|Testosterone|testosterone|mesh-list
55867662|NCT03834610|Androgens|androgens|mesh-ancestor
55867664|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55867665|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867666|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
55867667|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55867668|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55867669|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867670|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867671|NCT03834610|Urological Agents|urological agents|mesh-ancestor
55867672|NCT01681472|Leucovorin|leucovorin|mesh-list
55867673|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
55867674|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
55867675|NCT01681472|Antidotes|antidotes|mesh-ancestor
55867676|NCT01681472|Protective Agents|protective agents|mesh-ancestor
55867677|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867678|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
55867679|NCT01681472|Vitamins|vitamins|mesh-ancestor
55867680|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
55867681|NCT00915928|Perindopril|perindopril|mesh-list
55867682|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55867683|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
55867684|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867685|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867686|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55867687|NCT03407404|Midazolam|midazolam|mesh-list
55867688|NCT03407404|Ketamine|ketamine|mesh-list
55867689|NCT03407404|Morphine|morphine|mesh-list
55867690|NCT03407404|Analgesics|analgesics|mesh-ancestor
55867691|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
55867692|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867693|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867694|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55867695|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55867696|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
55867697|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
55867698|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55867733|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867734|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868302|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
55867735|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55867736|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55789117|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789118|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789120|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55789121|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55867738|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55867739|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55867740|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55867741|NCT03830086|Narcotics|narcotics|mesh-ancestor
55867742|NCT03830086|Analgesics|analgesics|mesh-ancestor
55867743|NCT02240212|Paclitaxel|paclitaxel|mesh-list
55867744|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55867777|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867779|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55867780|NCT02240602|Narcotics|narcotics|mesh-ancestor
55867781|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55867782|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867783|NCT02240602|Analgesics|analgesics|mesh-ancestor
55867784|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
55867785|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867786|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
55867787|NCT03406546|Remifentanil|remifentanil|mesh-list
55867788|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55867800|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867801|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55867802|NCT03406546|Narcotics|narcotics|mesh-ancestor
55867803|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55867804|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55867805|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867806|NCT01046110|Incretins|incretins|mesh-ancestor
55867808|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55867809|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55867810|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
55867811|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867812|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867813|NCT01713530|Insulin|insulin|mesh-list
55867814|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55867815|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
55867816|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
55867817|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55867818|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55867819|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867821|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
55867822|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867823|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867824|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867825|NCT02982694|Bevacizumab|bevacizumab|mesh-list
55867826|NCT02982694|Atezolizumab|atezolizumab|mesh-list
55867827|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55867828|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867829|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55867830|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55867831|NCT02982694|Growth Substances|growth substances|mesh-ancestor
55867832|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867833|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
55867834|NCT01712984|Fluconazole|fluconazole|mesh-list
55867835|NCT01712984|Vaccines|vaccines|mesh-list
55867836|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
55867837|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867838|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
55867839|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867840|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55867841|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55867842|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789122|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789123|NCT04925063|Metformin|metformin|mesh-list
55789124|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55867843|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867844|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55867845|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
55867846|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55867847|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55867848|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55867849|NCT00921310|Sirolimus|sirolimus|mesh-list
55867863|NCT02241148|Acetaminophen|acetaminophen|mesh-list
55867864|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55867865|NCT02241148|Analgesics|analgesics|mesh-ancestor
55867866|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
55867867|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867868|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867869|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
55867870|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
55867871|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55867872|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55867873|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55867874|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
55867875|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867876|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867878|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
55867879|NCT01040728|Olodaterol|olodaterol|mesh-list
55867880|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55867881|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
55867882|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867883|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867884|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55867885|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
55867887|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55867889|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867890|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867891|NCT01593020|Paclitaxel|paclitaxel|mesh-list
55867892|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
55867893|NCT01593020|Doxorubicin|doxorubicin|mesh-list
55867894|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55867895|NCT01593020|Fluorouracil|fluorouracil|mesh-list
55867896|NCT01593020|Epirubicin|epirubicin|mesh-list
55867897|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55867898|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867899|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
55867900|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
55867901|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
55867902|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867903|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55867904|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
55867905|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867906|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867907|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55867908|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
55867909|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55867910|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55867922|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55867924|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867925|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867927|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55867928|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867929|NCT03405376|Aflibercept|aflibercept|mesh-list
55867930|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55867931|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55867932|NCT03405376|Growth Substances|growth substances|mesh-ancestor
55867933|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867934|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
55867935|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867937|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
55867938|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
55867939|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55867940|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867941|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
55867942|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867943|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55867944|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55867945|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55867947|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867948|NCT01712204|Febuxostat|febuxostat|mesh-list
55867949|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
55867950|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867951|NCT01592864|Fluorides|fluorides|mesh-list
55867952|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
55867953|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
55867954|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
55867956|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867957|NCT01592786|Memantine|memantine|mesh-list
55867958|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55867959|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55867960|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
55867961|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867962|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867963|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867964|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55867965|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55867966|NCT01592708|Erythromycin|erythromycin|mesh-list
55867967|NCT01592708|Ibuprofen|ibuprofen|mesh-list
55867968|NCT01592708|Ketorolac|ketorolac|mesh-list
55867969|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55867970|NCT01592708|Fentanyl|fentanyl|mesh-list
55867971|NCT01592708|Scopolamine|scopolamine|mesh-list
55867972|NCT01592708|Droperidol|droperidol|mesh-list
55867973|NCT01592708|Remifentanil|remifentanil|mesh-list
55867974|NCT01592708|Hydrocodone|hydrocodone|mesh-list
55867975|NCT01592708|Ondansetron|ondansetron|mesh-list
55867976|NCT01592708|Antiemetics|antiemetics|mesh-list
55867996|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867998|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55867999|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
55868000|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
55868001|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55868002|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
55868004|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55868005|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55868006|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55868007|NCT01592708|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55868008|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
55868009|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
55868010|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55868011|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868012|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55868014|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55868015|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
55868016|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55868017|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
55868018|NCT01592708|Hormones|hormones|mesh-ancestor
55868019|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55868020|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55868021|NCT01592708|Protective Agents|protective agents|mesh-ancestor
55868022|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55868023|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868024|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55868025|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55868026|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
55868027|NCT01042522|Paclitaxel|paclitaxel|mesh-list
55789125|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789126|NCT04909151|Methamphetamine|methamphetamine|mesh-list
55868028|NCT01042522|Etoposide|etoposide|mesh-list
55868029|NCT01042522|Cisplatin|cisplatin|mesh-list
55868030|NCT01042522|Carboplatin|carboplatin|mesh-list
55868031|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55868032|NCT01042522|Bleomycin|bleomycin|mesh-list
55868033|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
55868046|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868047|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
55868048|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
55868049|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
55868050|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868052|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55868053|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
55868054|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868055|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868056|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55868057|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55868058|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
55868059|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868060|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868061|NCT02241616|Entecavir|entecavir|mesh-list
55868062|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
55868063|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868064|NCT03400306|Paclitaxel|paclitaxel|mesh-list
55868065|NCT03400306|Carboplatin|carboplatin|mesh-list
55868066|NCT03400306|Veliparib|veliparib|mesh-list
55868067|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55868068|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868081|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868083|NCT03404908|Dipyrone|dipyrone|mesh-list
55868084|NCT03404908|Ketoprofen|ketoprofen|mesh-list
55868085|NCT03404908|Morphine|morphine|mesh-list
55868086|NCT03404908|Ropivacaine|ropivacaine|mesh-list
55868087|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55868088|NCT03404908|Narcotics|narcotics|mesh-ancestor
55868089|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868090|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868091|NCT03404908|Analgesics|analgesics|mesh-ancestor
55868092|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
55868094|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
55868095|NCT03404908|Anesthetics|anesthetics|mesh-ancestor
55868096|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55868097|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
55868104|NCT01702298|Metformin|metformin|mesh-list
55868105|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55868106|NCT01702298|Simvastatin|simvastatin|mesh-list
55868107|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55868108|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868109|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55868110|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55868111|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
55868112|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868113|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55868114|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55868115|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868116|NCT01702298|Incretins|incretins|mesh-ancestor
55868117|NCT01702298|Hormones|hormones|mesh-ancestor
55868118|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55868119|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55789127|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55789128|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868120|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
55868121|NCT03404752|Lenograstim|lenograstim|mesh-list
55868122|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55868123|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
55868124|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868125|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
55868126|NCT03401710|Hematinics|hematinics|mesh-ancestor
55868127|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55868128|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55868129|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55868130|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868131|NCT01701674|Aldesleukin|aldesleukin|mesh-list
55868132|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
55868133|NCT01701674|Fludarabine|fludarabine|mesh-list
55868134|NCT01701674|Ipilimumab|ipilimumab|mesh-list
55868135|NCT01701674|Interleukin-2|interleukin-2|mesh-list
55868138|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868139|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55868140|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55868141|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
55868142|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868143|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868144|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55868145|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55868146|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55868147|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55868148|NCT01701674|Analgesics|analgesics|mesh-ancestor
55868149|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
55868150|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868151|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55868152|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55868153|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
55868154|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868155|NCT02993523|Azacitidine|azacitidine|mesh-list
55868156|NCT02993523|Venetoclax|venetoclax|mesh-list
55868157|NCT02993523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55868158|NCT02993523|Antimetabolites|antimetabolites|mesh-ancestor
55868159|NCT02993523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868160|NCT02993523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868161|NCT02993523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868162|NCT01701362|Pregabalin|pregabalin|mesh-list
55868163|NCT01701362|Analgesics|analgesics|mesh-ancestor
55868164|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
55868165|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868178|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
55868179|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
55868180|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868181|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868182|NCT01710800|Esomeprazole|esomeprazole|mesh-list
55868184|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55868185|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55868186|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868187|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868189|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55868190|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868191|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868193|NCT02982850|Warfarin|warfarin|mesh-list
55868194|NCT02982850|Dabigatran|dabigatran|mesh-list
55868195|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55868196|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55868197|NCT02982850|Analgesics|analgesics|mesh-ancestor
55868198|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
55868199|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868200|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868201|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55789130|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
55789131|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868202|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55868203|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55868204|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55868205|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868206|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55868207|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55868208|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868209|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
55868210|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
55868211|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
55868212|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55868213|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
55868214|NCT04413890|Dinoprostone|dinoprostone|mesh-list
55868215|NCT04413890|Oxytocics|oxytocics|mesh-ancestor
55868216|NCT04413890|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55868217|NCT04413890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868218|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
55868219|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
55868220|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55868221|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
55868222|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868223|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868224|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55868225|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
55868226|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55868227|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55868228|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55868256|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55868257|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55868258|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55868259|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
55868260|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868261|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868262|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868263|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55868264|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55868265|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
55868266|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868267|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55868268|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
55868269|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
55868270|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
55868271|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55868272|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55868273|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
55868274|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55868275|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
55868276|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55868298|NCT02242474|Adalimumab|adalimumab|mesh-list
55868299|NCT02242474|Etanercept|etanercept|mesh-list
55868300|NCT02242474|Golimumab|golimumab|mesh-list
55868301|NCT02242474|Infliximab|infliximab|mesh-list
55868340|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
55868341|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55868342|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55868343|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55868344|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868345|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55868346|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55868347|NCT02242864|Diuretics|diuretics|mesh-ancestor
55868348|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
55868349|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868350|NCT01709708|Bupivacaine|bupivacaine|mesh-list
55868351|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
55868352|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
55868353|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868354|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868355|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
55868356|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868357|NCT02243098|Digoxin|digoxin|mesh-list
55868358|NCT02243098|Atorvastatin|atorvastatin|mesh-list
55868359|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55868360|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55868361|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
55868362|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868363|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55868364|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55868365|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868366|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55868367|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55868368|NCT02243098|Protective Agents|protective agents|mesh-ancestor
55868369|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868370|NCT02845323|Nivolumab|nivolumab|mesh-list
55868371|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55868372|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868373|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55868374|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868375|NCT05289063|Atorvastatin|atorvastatin|mesh-list
55868376|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55868377|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55868378|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
55868379|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868380|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55868381|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55868382|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868383|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55789141|NCT05132413|Cisplatin|cisplatin|mesh-list
55789142|NCT05132413|Carboplatin|carboplatin|mesh-list
55789143|NCT05132413|Pemetrexed|pemetrexed|mesh-list
55868384|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55868385|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55868387|NCT01709318|Estradiol|estradiol|mesh-list
55868388|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55868389|NCT01709318|Estrogens|estrogens|mesh-ancestor
55868390|NCT01709318|Hormones|hormones|mesh-ancestor
55868418|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55868420|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
55868421|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868423|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55868424|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55868425|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
55868426|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
55868427|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868428|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868429|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55868430|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55868431|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55868432|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
55868433|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868434|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868435|NCT04373824|Ivermectin|ivermectin|mesh-list
55868436|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55868462|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55868463|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868464|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55868465|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868467|NCT02077959|Lenalidomide|lenalidomide|mesh-list
55868468|NCT02077959|Pidilizumab|pidilizumab|mesh-list
55868469|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
55868470|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868471|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55868472|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55868473|NCT02077959|Growth Substances|growth substances|mesh-ancestor
55868474|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
55868475|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868476|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55868477|NCT04548518|Vaccines|vaccines|mesh-list
55868478|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
55868479|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868480|NCT01699022|CycloProvera|cycloprovera|mesh-list
55868481|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55868482|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55868526|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55868527|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
55868528|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
55868529|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
55868530|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868531|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868533|NCT01988883|Modafinil|modafinil|mesh-list
55868534|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55868535|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55868536|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
55868537|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868538|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868539|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868540|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55868541|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55868542|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
55868543|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55868544|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55868545|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55868546|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55868547|NCT01935921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55789144|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55789145|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789146|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55868549|NCT01935921|Ipilimumab|ipilimumab|mesh-list
55868550|NCT01935921|Antibodies|antibodies|mesh-list
55868551|NCT01935921|Immunoglobulins|immunoglobulins|mesh-list
55868552|NCT01935921|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55868553|NCT01935921|Immunologic Factors|immunologic factors|mesh-ancestor
55868554|NCT01935921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868555|NCT01935921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868556|NCT01935921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55868557|NCT01935921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868558|NCT04373356|Listerine|listerine|mesh-list
55868559|NCT04373356|Fluorides|fluorides|mesh-list
55868560|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
55868561|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
55868562|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
55868563|NCT04373356|Protective Agents|protective agents|mesh-ancestor
55868564|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868565|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55868566|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868567|NCT01745757|Paclitaxel|paclitaxel|mesh-list
55868568|NCT01745757|Bevacizumab|bevacizumab|mesh-list
55868569|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55868570|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868571|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
55868572|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
55868573|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
55868574|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868575|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55868576|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55868577|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55868578|NCT01745757|Growth Substances|growth substances|mesh-ancestor
55868579|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868580|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
55868581|NCT01709162|Ipilimumab|ipilimumab|mesh-list
55868590|NCT02243800|Vitamins|vitamins|mesh-ancestor
55868591|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
55868592|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55868593|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55868594|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55868595|NCT04764045|Ropivacaine|ropivacaine|mesh-list
55868596|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
55868597|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
55868598|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868599|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868600|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
55868601|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868602|NCT01698554|Bimatoprost|bimatoprost|mesh-list
55868603|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55868604|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55868605|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55868606|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868607|NCT00895791|Umirolimus|umirolimus|mesh-list
55868608|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55868609|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55868611|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868612|NCT01698320|Albuterol|albuterol|mesh-list
55868613|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55868614|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
55868615|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868616|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868617|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55868618|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
55868619|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
55868620|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55868621|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55868622|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55868623|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55868624|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
55868625|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868626|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868628|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55868629|NCT03401476|Narcotics|narcotics|mesh-ancestor
55868630|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868631|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868635|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
55868636|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55868637|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868638|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55868639|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868640|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
55868641|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55868642|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55868643|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
55868644|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868645|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55868661|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868663|NCT01674933|Fluorides|fluorides|mesh-list
55868664|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
55868665|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
55868666|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
55868667|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
55868668|NCT01674933|Protective Agents|protective agents|mesh-ancestor
55868669|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868670|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55868671|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868673|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
55868674|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55868675|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55868676|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868677|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868678|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868679|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55868683|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
55868684|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55868685|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868686|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
55868687|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55868688|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55868689|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55868690|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
55868691|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868692|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868693|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868694|NCT01569152|Methotrexate|methotrexate|mesh-list
55868695|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55868696|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
55868697|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55868701|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868703|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
55868723|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868725|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868726|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55868727|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55868728|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55868729|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55868731|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55868732|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868733|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55868734|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868735|NCT01675947|Antifungal Agents|antifungal agents|mesh-ancestor
55868736|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55868737|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
55868740|NCT03840915|Docetaxel|docetaxel|mesh-list
55868741|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55868742|NCT03840915|Carboplatin|carboplatin|mesh-list
55868743|NCT03840915|Pemetrexed|pemetrexed|mesh-list
55868744|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55868745|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868746|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
55868747|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
55868748|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
55868749|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868750|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55868751|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
55868752|NCT03840915|Antiviral Agents|antiviral agents|mesh-ancestor
55868753|NCT03840915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868754|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868755|NCT03840915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55868756|NCT03840915|Immunologic Factors|immunologic factors|mesh-ancestor
55868757|NCT03840915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868758|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55868759|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55868770|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
55868771|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868772|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55868773|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55868774|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868775|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55868776|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55868777|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868778|NCT03743025|Dulaglutide|dulaglutide|mesh-list
55868779|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55868780|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868782|NCT03653247|Busulfan|busulfan|mesh-list
55868783|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
55868784|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868787|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868789|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868790|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55868791|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55868792|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55868793|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
55868794|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868795|NCT04124432|Nicotine|nicotine|mesh-list
55868796|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55868797|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
55868798|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868799|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868800|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55868801|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55868802|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
55868803|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869065|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
55868804|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868805|NCT03742245|Olaparib|olaparib|mesh-list
55868806|NCT03742245|Vorinostat|vorinostat|mesh-list
55868807|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55868808|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868809|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868810|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868811|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55868817|NCT03643107|Prednisolone|prednisolone|mesh-list
55868818|NCT03643107|Irofulven|irofulven|mesh-list
55868819|NCT03643107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55868821|NCT03643107|Hormones|hormones|mesh-ancestor
55868822|NCT03643107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55868823|NCT03643107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868824|NCT03643107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55868837|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55868838|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55868839|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868841|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55868842|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55868843|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868844|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55868845|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55868846|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
55868847|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868848|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55868850|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
55868851|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868852|NCT02245126|Lidocaine|lidocaine|mesh-list
55868853|NCT02245126|Bupivacaine|bupivacaine|mesh-list
55868854|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
55868855|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
55868856|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868857|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868858|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
55868859|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868860|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55868861|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55868862|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55868863|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55868864|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868865|NCT03728673|Dexetimide|dexetimide|mesh-list
55868866|NCT03728673|Citalopram|citalopram|mesh-list
55868867|NCT03728673|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55868868|NCT03728673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55868869|NCT03728673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55868870|NCT03728673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868871|NCT03728673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868872|NCT03728673|Serotonin Agents|serotonin agents|mesh-ancestor
55868873|NCT03728673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868874|NCT03728673|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55868875|NCT03728673|Antidepressive Agents|antidepressive agents|mesh-ancestor
55868876|NCT03728673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55868877|NCT03728673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55868878|NCT03728673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55868879|NCT03728673|Parasympatholytics|parasympatholytics|mesh-ancestor
55868880|NCT03728673|Autonomic Agents|autonomic agents|mesh-ancestor
55868881|NCT03728673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868882|NCT03728673|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55868883|NCT03728673|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55868884|NCT03728673|Cholinergic Agents|cholinergic agents|mesh-ancestor
55868885|NCT04372342|Remifentanil|remifentanil|mesh-list
55868886|NCT04372342|Nalbuphine|nalbuphine|mesh-list
55868920|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55868921|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55868922|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
55868924|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
55868925|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
55868926|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868927|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868928|NCT03721653|Leucovorin|leucovorin|mesh-list
55868929|NCT03721653|Bevacizumab|bevacizumab|mesh-list
55868930|NCT03721653|Fluorouracil|fluorouracil|mesh-list
55868944|NCT03721653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55868945|NCT03721653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55868946|NCT03721653|Immunologic Factors|immunologic factors|mesh-ancestor
55789147|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55789148|NCT05132413|Growth Substances|growth substances|mesh-ancestor
55868947|NCT03721653|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55868948|NCT03721653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55868949|NCT03721653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868951|NCT03721653|Protective Agents|protective agents|mesh-ancestor
55868952|NCT03721653|Vitamin B Complex|vitamin b complex|mesh-ancestor
55868954|NCT03721653|Micronutrients|micronutrients|mesh-ancestor
55868955|NCT02244190|Ritonavir|ritonavir|mesh-list
55868956|NCT02244190|Tipranavir|tipranavir|mesh-list
55868957|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55868958|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55868959|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
55868960|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868961|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868962|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55868963|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55868964|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
55868965|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868966|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55868967|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55868968|NCT00926380|Denosumab|denosumab|mesh-list
55868969|NCT00926380|Teriparatide|teriparatide|mesh-list
55868970|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55868971|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868972|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55868973|NCT02244268|Tamsulosin|tamsulosin|mesh-list
55868974|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55868975|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55868976|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55868979|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868980|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868981|NCT02244268|Urological Agents|urological agents|mesh-ancestor
55868982|NCT03823131|Pembrolizumab|pembrolizumab|mesh-list
55868983|NCT03823131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55868984|NCT03823131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868986|NCT03630315|Ranibizumab|ranibizumab|mesh-list
55868987|NCT03630315|Aflibercept|aflibercept|mesh-list
55868988|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55868989|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868990|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55868991|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55868992|NCT03630315|Growth Substances|growth substances|mesh-ancestor
55868993|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869016|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55869017|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869018|NCT04371874|Aspirin|aspirin|mesh-list
55869019|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55869020|NCT04371874|Captopril|captopril|mesh-list
55869021|NCT04371874|Nitrendipine|nitrendipine|mesh-list
55869022|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55869023|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55869025|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
55869026|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869027|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869028|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55869029|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869030|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55869031|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55869032|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869033|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55869034|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55869035|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869036|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
55869037|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55869038|NCT04371874|Diuretics|diuretics|mesh-ancestor
55869039|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
55869040|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55869041|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869061|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869062|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869063|NCT04376554|Amoxicillin|amoxicillin|mesh-list
55869064|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
55869066|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55869067|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55869068|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869069|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55869070|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869071|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869072|NCT03627741|Triamcinolone|triamcinolone|mesh-list
55869073|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55869074|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55869075|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55869076|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55869077|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
55869078|NCT03627741|Hormones|hormones|mesh-ancestor
55869079|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55869081|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55869082|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
55869083|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869084|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869085|NCT03626337|Thiamine|thiamine|mesh-list
55869086|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
55869087|NCT03626337|Vitamins|vitamins|mesh-ancestor
55869088|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
55869089|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869090|NCT00929578|Fluphenazine|fluphenazine|mesh-list
55869091|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
55869092|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
55869093|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55869094|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55869095|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869096|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869097|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55869098|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55869099|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
55869100|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869101|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869102|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
55869103|NCT03615105|Melphalan|melphalan|mesh-list
55869104|NCT03615105|Busulfan|busulfan|mesh-list
55869105|NCT03615105|Thiotepa|thiotepa|mesh-list
55869106|NCT03615105|Rituximab|rituximab|mesh-list
55869107|NCT03615105|Fludarabine|fludarabine|mesh-list
55869108|NCT03615105|Clofarabine|clofarabine|mesh-list
55869119|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55869120|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55869121|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55869122|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
55869123|NCT04371406|Azithromycin|azithromycin|mesh-list
55869124|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
55869125|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55869126|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869127|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
55869128|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55869129|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55869130|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869131|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869132|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869133|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
55869134|NCT03716739|Testosterone|testosterone|mesh-list
55869135|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
55869139|NCT03716739|Hormones|hormones|mesh-ancestor
55869140|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55869141|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869142|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55869144|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
55869145|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
55869146|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55869147|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55869148|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55869149|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869150|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869151|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
55869152|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869153|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869156|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
55869157|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55869158|NCT00004143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869213|NCT03703167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869214|NCT03703167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869215|NCT03703167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55869216|NCT03703167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55869217|NCT03703167|Growth Substances|growth substances|mesh-ancestor
55869218|NCT03703167|Growth Inhibitors|growth inhibitors|mesh-ancestor
55869220|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
55869221|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869222|NCT04364464|Riociguat|riociguat|mesh-list
55869223|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
55869224|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869225|NCT03600441|Abexinostat|abexinostat|mesh-list
55869226|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55869228|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869229|NCT01592240|Bococizumab|bococizumab|mesh-list
55869230|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55869231|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55869232|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
55869233|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869234|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55869235|NCT03594747|Paclitaxel|paclitaxel|mesh-list
55869236|NCT03594747|Carboplatin|carboplatin|mesh-list
55869237|NCT03594747|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55869238|NCT03594747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869239|NCT03594747|Tubulin Modulators|tubulin modulators|mesh-ancestor
55869274|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869275|NCT04369534|Clopidogrel|clopidogrel|mesh-list
55869276|NCT04369534|Ticagrelor|ticagrelor|mesh-list
55869277|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55869278|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55869297|NCT03685773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55869299|NCT03685773|Vitamin B Complex|vitamin b complex|mesh-ancestor
55869300|NCT03685773|Vitamins|vitamins|mesh-ancestor
55869301|NCT03685773|Micronutrients|micronutrients|mesh-ancestor
55869302|NCT03685773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869303|NCT03685773|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55869304|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
55869305|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
55869306|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55869307|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55869308|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869309|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869310|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869311|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869312|NCT03685149|Flecainide|flecainide|mesh-list
55869313|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55869314|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55869315|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55869316|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869317|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869318|NCT04370080|Fluorides|fluorides|mesh-list
55869319|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
55869320|NCT04370080|Protective Agents|protective agents|mesh-ancestor
55869321|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869322|NCT01591616|Lidocaine|lidocaine|mesh-list
55869323|NCT01591616|Prilocaine|prilocaine|mesh-list
55869325|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
55869326|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869327|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869328|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
55869329|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869330|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55869331|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55869332|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55869333|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869334|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869335|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
55869336|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55869337|NCT00938314|Hematinics|hematinics|mesh-ancestor
55869355|NCT04369222|Salicylates|salicylates|mesh-list
55869356|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55869357|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55869358|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55869359|NCT04369222|Analgesics|analgesics|mesh-ancestor
55869360|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
55789149|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789150|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
55869361|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869362|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869363|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
55869364|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869365|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
55869366|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
55869367|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
55869368|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869369|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55869370|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869371|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869372|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55869373|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55869374|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55869375|NCT03584373|Acetaminophen|acetaminophen|mesh-list
55869376|NCT03584373|Ketorolac|ketorolac|mesh-list
55869377|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55869378|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55869379|NCT03584373|Oxycodone|oxycodone|mesh-list
55869380|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55869381|NCT03584373|Analgesics|analgesics|mesh-ancestor
55869382|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
55869383|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869384|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869385|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
55869387|NCT03584373|Narcotics|narcotics|mesh-ancestor
55869388|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869389|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55869390|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55869391|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869392|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55869393|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869394|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869395|NCT01591460|Ribavirin|ribavirin|mesh-list
55869396|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55869397|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
55869398|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
55869424|NCT04363060|Azithromycin|azithromycin|mesh-list
55869425|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
55869426|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
55869427|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55869428|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55869429|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869430|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55869431|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869432|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869433|NCT01591382|Ketamine|ketamine|mesh-list
55869434|NCT01591382|Hydromorphone|hydromorphone|mesh-list
55869435|NCT01591382|Analgesics|analgesics|mesh-ancestor
55869436|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
55869437|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869438|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869439|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55869440|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55869441|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
55869442|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
55869443|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869444|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55869445|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55869446|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869455|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
55869456|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869457|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55869458|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55869459|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55869460|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869461|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869462|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
55869463|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55869464|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869465|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869466|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55869468|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55869469|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55869470|NCT00928174|Fluorides|fluorides|mesh-list
55869471|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
55869472|NCT00928174|Protective Agents|protective agents|mesh-ancestor
55869473|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869474|NCT01696214|Fluticasone|fluticasone|mesh-list
55869475|NCT01696214|Xhance|xhance|mesh-list
55869476|NCT01696214|Theophylline|theophylline|mesh-list
55869477|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55869478|NCT01696214|Ipratropium|ipratropium|mesh-list
55869479|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55869480|NCT01696214|Montelukast|montelukast|mesh-list
55869481|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55869482|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55869483|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
55869484|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869485|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869486|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55869487|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
55869488|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
55869489|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55869490|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55869491|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55869492|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55869493|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
55869494|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869495|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869496|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55869497|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
55869498|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55869499|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55869500|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55869501|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55869502|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
55869503|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55869504|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869505|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
55869506|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55869507|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55869508|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
55869509|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
55869511|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
55869512|NCT03794037|Montelukast|montelukast|mesh-list
55869513|NCT03794037|Progesterone|progesterone|mesh-list
55869514|NCT03794037|Progestins|progestins|mesh-ancestor
55869542|NCT04368598|Hormones|hormones|mesh-ancestor
55869543|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55869544|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55869545|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869546|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
55869547|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869548|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869549|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
55869550|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869551|NCT04368598|Expectorants|expectorants|mesh-ancestor
55869552|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
55869553|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55869554|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
55869556|NCT04368598|Antidotes|antidotes|mesh-ancestor
55869558|NCT05347641|Methotrexate|methotrexate|mesh-list
55869559|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869560|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
55869573|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55869574|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
55869575|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789152|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869576|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
55869577|NCT01696058|Olodaterol|olodaterol|mesh-list
55869578|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55869579|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
55869580|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869581|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869582|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55869583|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
55869584|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
55869585|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55869586|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
55869587|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869588|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869589|NCT04368520|Vitamin D|vitamin d|mesh-list
55869590|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
55869591|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
55869592|NCT04368520|Vitamins|vitamins|mesh-list
55869593|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
55869594|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869595|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55869596|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55869597|NCT03790137|Fenfluramine|fenfluramine|mesh-list
55869598|NCT03790137|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55869599|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55869600|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869601|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869602|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869603|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
55869604|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869605|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55869606|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55869607|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55869608|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
55869609|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869611|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
55869612|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
55869613|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55869614|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869615|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869616|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55869617|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55869618|NCT03580317|Analgesics|analgesics|mesh-ancestor
55869619|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
55869620|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869621|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55869674|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55869675|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
55869676|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869677|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869678|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869679|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55869680|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55869681|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
55869682|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
55869684|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869685|NCT00938548|Analgesics|analgesics|mesh-ancestor
55869686|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
55869687|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869688|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
55869689|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55869690|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869691|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869692|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55869693|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55869694|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55869696|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55869697|NCT00932620|Simvastatin|simvastatin|mesh-list
55869698|NCT00932620|Ezetimibe|ezetimibe|mesh-list
55869699|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55869700|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55869701|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
55869702|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869703|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55869726|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869727|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869728|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869729|NCT01677351|Clonidine|clonidine|mesh-list
55869730|NCT01677351|Analgesics|analgesics|mesh-ancestor
55869731|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
55869732|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869733|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869736|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
55869737|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55869738|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55869739|NCT01677351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55869740|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
55869741|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869742|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869743|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55869744|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
55869745|NCT00938704|Glycerol|glycerol|mesh-list
55869746|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55869747|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
55869748|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869749|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
55869750|NCT00938704|Protective Agents|protective agents|mesh-ancestor
55869751|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55869752|NCT00938704|Laxatives|laxatives|mesh-ancestor
55869753|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55869754|NCT03666351|Losartan|losartan|mesh-list
55869755|NCT03666351|Amlodipine|amlodipine|mesh-list
55869756|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
55869791|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
55869792|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55869793|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869794|NCT03575403|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55869810|NCT03553875|Memantine|memantine|mesh-list
55869811|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55869812|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55869814|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869815|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869817|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55869818|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55869820|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55869821|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55869822|NCT04355416|Analgesics|analgesics|mesh-ancestor
55869823|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
55869824|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869825|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869826|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55869827|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869828|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869829|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869830|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869831|NCT03777813|Leucovorin|leucovorin|mesh-list
55869832|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
55869833|NCT03777813|Durvalumab|durvalumab|mesh-list
55869834|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
55869835|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869836|NCT03777813|Antidotes|antidotes|mesh-ancestor
55869837|NCT03777813|Protective Agents|protective agents|mesh-ancestor
55869838|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869839|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
55869840|NCT03777813|Vitamins|vitamins|mesh-ancestor
55789153|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55789154|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55869841|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
55869842|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55869843|NCT04355494|Eculizumab|eculizumab|mesh-list
55869844|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55869845|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55869846|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
55869847|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869848|NCT00934024|Varenicline|varenicline|mesh-list
55869849|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55869850|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55869851|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
55869864|NCT03552471|Mitosis Modulators|mitosis modulators|mesh-ancestor
55869865|NCT04361032|Deferoxamine|deferoxamine|mesh-list
55869866|NCT04361032|Siderophores|siderophores|mesh-ancestor
55869867|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55869868|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
55869869|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
55869870|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869872|NCT00928954|Memantine|memantine|mesh-list
55869873|NCT00928954|Analgesics|analgesics|mesh-ancestor
55869874|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
55869875|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869876|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869877|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
55870182|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55789174|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789175|NCT04917497|Protective Agents|protective agents|mesh-ancestor
55870183|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55870184|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870185|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870186|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55870187|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55870188|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
55870189|NCT03420963|Etoposide|etoposide|mesh-list
55870190|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
55870191|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
55870192|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870193|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
55870194|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870195|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870196|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55870197|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
55870198|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870199|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870200|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55870201|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55870202|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55870203|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55870204|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870205|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
55870206|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
55870226|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55870228|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55870229|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870230|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55870231|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55870233|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870234|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870235|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55870236|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870237|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55870238|NCT03032458|Narcotics|narcotics|mesh-ancestor
55870239|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55870240|NCT02401035|Pantoprazole|pantoprazole|mesh-list
55870241|NCT02401035|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55870242|NCT02401035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55870243|NCT02401035|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55870244|NCT02401035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870245|NCT02401035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870246|NCT02245438|Ritonavir|ritonavir|mesh-list
55870247|NCT02245438|Tipranavir|tipranavir|mesh-list
55870248|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55870249|NCT02245438|Norethindrone|norethindrone|mesh-list
55870250|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
55870251|NCT02245438|Norinyl|norinyl|mesh-list
55870252|NCT02245438|Estradiol|estradiol|mesh-list
55870253|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55870254|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55870255|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
55870256|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870257|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870258|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55870259|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55870260|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
55870261|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870262|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55870263|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55870264|NCT02245438|Estrogens|estrogens|mesh-ancestor
55870266|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870267|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870268|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55870280|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789176|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870281|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870282|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870283|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
55870284|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
55870285|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870286|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55870287|NCT00939952|Ertapenem|ertapenem|mesh-list
55870288|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55870289|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870290|NCT02401815|Sunitinib|sunitinib|mesh-list
55870291|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870292|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55870293|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55870294|NCT02401815|Growth Substances|growth substances|mesh-ancestor
55870295|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870296|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
55870297|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55870298|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870299|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870300|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
55870301|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
55870302|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55870303|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
55870304|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870305|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870306|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870313|NCT03456687|Incretins|incretins|mesh-ancestor
55870314|NCT03456687|Hormones|hormones|mesh-ancestor
55870315|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870316|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55870317|NCT00948298|Vitamin D|vitamin d|mesh-list
55870318|NCT00948298|Vitamins|vitamins|mesh-ancestor
55870319|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
55870320|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870321|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55870322|NCT00948610|Infliximab|infliximab|mesh-list
55870323|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
55870324|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55870325|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870326|NCT03031834|Quinapril|quinapril|mesh-list
55870327|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55870328|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
55870329|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870330|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870331|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55870332|NCT00944554|Varenicline|varenicline|mesh-list
55870342|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870345|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55870346|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55870347|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55870348|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
55870349|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870350|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870351|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55870352|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
55870353|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
55870354|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
55870355|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55870356|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55870359|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870361|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55870362|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55870363|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
55870364|NCT00945256|Nitroprusside|nitroprusside|mesh-list
55789178|NCT03933007|Colchicine|colchicine|mesh-list
55789179|NCT03933007|Midazolam|midazolam|mesh-list
55870365|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55870366|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
55870367|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55870368|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870369|NCT03854032|Nivolumab|nivolumab|mesh-list
55870370|NCT03854032|Linrodostat|linrodostat|mesh-list
55870371|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870372|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870373|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55870374|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870375|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870376|NCT03031444|Leucovorin|leucovorin|mesh-list
55870377|NCT03031444|Cetuximab|cetuximab|mesh-list
55870378|NCT03031444|Fluorouracil|fluorouracil|mesh-list
55870379|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
55870380|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870381|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870382|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
55870383|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870384|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55870385|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870386|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
55870387|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870388|NCT03031444|Antidotes|antidotes|mesh-ancestor
55870389|NCT03031444|Protective Agents|protective agents|mesh-ancestor
55870390|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
55870391|NCT03031444|Vitamins|vitamins|mesh-ancestor
55870392|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
55870393|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
55870394|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55870395|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
55870396|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870397|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
55870398|NCT03031054|Protective Agents|protective agents|mesh-ancestor
55870399|NCT00945334|Rifaximin|rifaximin|mesh-list
55870400|NCT00945334|Neomycin|neomycin|mesh-list
55870411|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870412|NCT03656536|Antiviral Agents|antiviral agents|mesh-ancestor
55870413|NCT03656536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870414|NCT03656536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870415|NCT03656536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870416|NCT03656536|Immunologic Factors|immunologic factors|mesh-ancestor
55870417|NCT03656536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870418|NCT03559114|Dalteparin|dalteparin|mesh-list
55870419|NCT03559114|Tinzaparin|tinzaparin|mesh-list
55870420|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55870421|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
55870422|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55870423|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55870424|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870425|NCT05153590|Liraglutide|liraglutide|mesh-list
55870426|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55870427|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870428|NCT05153590|Incretins|incretins|mesh-ancestor
55870429|NCT05153590|Hormones|hormones|mesh-ancestor
55870430|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870443|NCT05100862|Zanubrutinib|zanubrutinib|mesh-list
55870444|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870445|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870446|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
55870447|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789180|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55789181|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55789182|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789183|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789185|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55789186|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55789187|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55789188|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
55789190|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
55789191|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
55789192|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789193|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789195|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55789196|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
55789197|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
55789198|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
55789199|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870448|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870449|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55870450|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55870451|NCT05100862|Growth Substances|growth substances|mesh-ancestor
55870459|NCT03455829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870460|NCT03455829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870461|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
55870462|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870463|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
55870464|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870491|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
55870492|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55870493|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55870494|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870495|NCT05099848|Leucovorin|leucovorin|mesh-list
55870496|NCT05099848|Fluorouracil|fluorouracil|mesh-list
55870497|NCT05099848|Oxaliplatin|oxaliplatin|mesh-list
55870498|NCT05099848|Apatinib|apatinib|mesh-list
55870499|NCT05099848|Antimetabolites|antimetabolites|mesh-ancestor
55870500|NCT05099848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870501|NCT05099848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55870502|NCT05099848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870503|NCT05099848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870504|NCT05099848|Immunologic Factors|immunologic factors|mesh-ancestor
55870505|NCT05099848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870506|NCT05099848|Antidotes|antidotes|mesh-ancestor
55870507|NCT05099848|Protective Agents|protective agents|mesh-ancestor
55870508|NCT05099848|Vitamin B Complex|vitamin b complex|mesh-ancestor
55789200|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55789201|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55789202|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55789203|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
55870509|NCT05099848|Vitamins|vitamins|mesh-ancestor
55870510|NCT05099848|Micronutrients|micronutrients|mesh-ancestor
55870511|NCT05099848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55870512|NCT05099848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870513|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
55870544|NCT00941668|Triclosan|triclosan|mesh-list
55870545|NCT00941668|Fluorides|fluorides|mesh-list
55870546|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
55870547|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
55870548|NCT00941668|Protective Agents|protective agents|mesh-ancestor
55870549|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870550|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55870551|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870552|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55870553|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55870554|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
55870555|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870556|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55870557|NCT01597414|Trastuzumab|trastuzumab|mesh-list
55870558|NCT01597414|Pertuzumab|pertuzumab|mesh-list
55870559|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870572|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870574|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55870575|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870576|NCT00265798|Sorafenib|sorafenib|mesh-list
55870577|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870578|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55870592|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870594|NCT00089583|Ritonavir|ritonavir|mesh-list
55870595|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
55870596|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55870597|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55870598|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
55870599|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870600|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870601|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55870605|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55870606|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55870607|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
55870608|NCT03029494|Vitamins|vitamins|mesh-ancestor
55870609|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
55870610|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870611|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
55870612|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870613|NCT03029494|Protective Agents|protective agents|mesh-ancestor
55870614|NCT04402047|Diclofenac|diclofenac|mesh-list
55789204|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
55789205|NCT04907747|Amoxicillin|amoxicillin|mesh-list
55870616|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55870617|NCT04402047|Analgesics|analgesics|mesh-ancestor
55870618|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
55870619|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870620|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870621|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870622|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870623|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55870635|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
55870636|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
55870637|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55870638|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55870639|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55870641|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870642|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55870644|NCT00088881|Prednisone|prednisone|mesh-list
55870645|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
55870646|NCT00088881|Rituximab|rituximab|mesh-list
55870647|NCT00088881|Doxorubicin|doxorubicin|mesh-list
55870648|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55870649|NCT00088881|Vincristine|vincristine|mesh-list
55870650|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870651|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
55870652|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870653|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870654|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55870655|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
55870656|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870657|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870658|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55870659|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870660|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55870661|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55870662|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55870663|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870664|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870665|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
55870666|NCT00088881|Hormones|hormones|mesh-ancestor
55870667|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870668|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55870669|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55870670|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
55870671|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
55870673|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
55870674|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870675|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870676|NCT03025750|Vaccines|vaccines|mesh-list
55870677|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
55870678|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870679|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
55870680|NCT03017404|Docetaxel|docetaxel|mesh-list
55870681|NCT03017404|Doxorubicin|doxorubicin|mesh-list
55870682|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55870683|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870684|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
55870685|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870686|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870721|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55870722|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55870723|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55870758|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55870759|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870761|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
55870762|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55870763|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55789206|NCT04907747|Furazolidone|furazolidone|mesh-list
55789207|NCT04907747|Esomeprazole|esomeprazole|mesh-list
55789208|NCT04907747|Bismuth|bismuth|mesh-list
55870784|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55870785|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870786|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55870787|NCT03483363|Bacitracin|bacitracin|mesh-list
55870788|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55870789|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870790|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
55870791|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55870792|NCT03086733|Metformin|metformin|mesh-list
55870793|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55870794|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870795|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
55870796|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870797|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55870798|NCT00085917|Interferons|interferons|mesh-list
55870799|NCT00085917|Ribavirin|ribavirin|mesh-list
55870800|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
55870801|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55789473|NCT04901117|Bismuth|bismuth|mesh-list
55870802|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870803|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
55870804|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870805|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
55870806|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870807|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
55870808|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870810|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870811|NCT04402671|Glutaral|glutaral|mesh-list
55870812|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
55870813|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870814|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
55870815|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55870816|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870817|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55870818|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870819|NCT01678365|Metronidazole|metronidazole|mesh-list
55870820|NCT01678365|Gentamicins|gentamicins|mesh-list
55870821|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
55870822|NCT01678365|Ampicillin|ampicillin|mesh-list
55870823|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870824|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55870825|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55870826|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55870827|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55870828|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870829|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870830|NCT00946270|Thalidomide|thalidomide|mesh-list
55870831|NCT00946270|Prednisone|prednisone|mesh-list
55870832|NCT00946270|Pomalidomide|pomalidomide|mesh-list
55870833|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870834|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
55870850|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55870851|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870852|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55870853|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55870854|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870855|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870856|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870857|NCT03021694|Caseins|caseins|mesh-list
55789212|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789213|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55789214|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789215|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789217|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55789218|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55789219|NCT04907747|Renal Agents|renal agents|mesh-ancestor
55789220|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
55789221|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55789222|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55789223|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55789224|NCT03052673|Fentanyl|fentanyl|mesh-list
55789225|NCT03052673|Ketamine|ketamine|mesh-list
55789226|NCT03052673|Analgesics|analgesics|mesh-ancestor
55789227|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
55870858|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
55870859|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
55870860|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870864|NCT00956254|Fentanyl|fentanyl|mesh-list
55870865|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55870866|NCT00956254|Narcotics|narcotics|mesh-ancestor
55870867|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55870868|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870869|NCT00956254|Analgesics|analgesics|mesh-ancestor
55870870|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
55870871|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870872|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55870873|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55870874|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
55870875|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
55870876|NCT03020680|Ubiquinone|ubiquinone|mesh-list
55870877|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
55870878|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
55870879|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870880|NCT03020680|Vitamins|vitamins|mesh-ancestor
55870881|NCT01678599|Benzonidazole|benzonidazole|mesh-list
55870882|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870883|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
55870884|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870885|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55870910|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55870911|NCT01678677|Vaccines|vaccines|mesh-list
55870912|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
55870913|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870914|NCT00946348|Dronabinol|dronabinol|mesh-list
55870915|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
55870916|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870917|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55870918|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55870919|NCT00946348|Analgesics|analgesics|mesh-ancestor
55789228|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870920|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
55870921|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870922|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55870923|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55870924|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870925|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870927|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870928|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
55870929|NCT00081159|Doxorubicin|doxorubicin|mesh-list
55870930|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55870931|NCT00081159|Leuprolide|leuprolide|mesh-list
55870932|NCT00081159|Goserelin|goserelin|mesh-list
55870933|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55870934|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870935|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55870961|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870962|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870965|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870966|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55870967|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55870968|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55870969|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870970|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
55870971|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870973|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870975|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
55870976|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870977|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870978|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55870979|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
55870980|NCT03033316|Hormones|hormones|mesh-ancestor
55870981|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870982|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55870983|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870984|NCT03032848|Estrogens|estrogens|mesh-list
55871011|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55871012|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871013|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55871014|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
55871015|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
55871016|NCT01005706|Sirolimus|sirolimus|mesh-list
55871017|NCT01005706|Tacrolimus|tacrolimus|mesh-list
55871018|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55871019|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
55871020|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871021|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55871022|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871023|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871024|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55871025|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871026|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55871027|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
55871028|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55871029|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871030|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
55871031|NCT03085485|Ivacaftor|ivacaftor|mesh-list
55871061|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
55871062|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
55871063|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871064|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871065|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
55871067|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55871068|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789229|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789230|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55871069|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
55871070|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55871071|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871072|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
55871073|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871074|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55871075|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55871097|NCT03080805|Lapatinib|lapatinib|mesh-list
55871098|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55871099|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
55871100|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871101|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871102|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55871103|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871104|NCT03019120|Vitamin D|vitamin d|mesh-list
55871105|NCT03019120|Vitamins|vitamins|mesh-ancestor
55871106|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
55871107|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871108|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55871109|NCT00960622|Tenofovir|tenofovir|mesh-list
55871110|NCT00960622|Lamivudine|lamivudine|mesh-list
55871111|NCT00960622|Zidovudine|zidovudine|mesh-list
55871112|NCT00960622|Emtricitabine|emtricitabine|mesh-list
55871113|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55871114|NCT00960622|Abacavir|abacavir|mesh-list
55871115|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
55871116|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
55871117|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
55871118|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871119|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55871120|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55871121|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871122|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871123|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55871124|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55871125|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
55871126|NCT03430947|Vemurafenib|vemurafenib|mesh-list
55871127|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871145|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
55871147|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55871148|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
55871149|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871150|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871151|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55871152|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
55871153|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871154|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871155|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55871156|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
55871157|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55871158|NCT01008280|Baclofen|baclofen|mesh-list
55871159|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55871160|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871167|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871168|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55871169|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
55871170|NCT03089073|Coagulants|coagulants|mesh-ancestor
55871171|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55871172|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
55871173|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871174|NCT05689047|Artesunate|artesunate|mesh-list
55871176|NCT05689047|Antimalarials|antimalarials|mesh-ancestor
55871177|NCT05689047|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55871178|NCT05689047|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55871179|NCT05689047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871180|NCT05689047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871236|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871237|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871238|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55871239|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
55790094|NCT04876859|Anesthetics|anesthetics|mesh-list
55871240|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55871241|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
55871242|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
55871243|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871244|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871245|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
55871246|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55871247|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55871248|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871249|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
55871250|NCT03019198|Coagulants|coagulants|mesh-ancestor
55871251|NCT03083613|Paclitaxel|paclitaxel|mesh-list
55871252|NCT03083613|Raltitrexed|raltitrexed|mesh-list
55871253|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55871254|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871255|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
55871256|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
55871257|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
55871258|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871259|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55871260|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
55871261|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55871262|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871295|NCT05685537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871296|NCT05685537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871297|NCT05685537|Protective Agents|protective agents|mesh-ancestor
55871298|NCT05685537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871299|NCT04400721|Ropivacaine|ropivacaine|mesh-list
55871300|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
55871301|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
55871302|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871303|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871337|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871338|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871339|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55871340|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
55871342|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
55871360|NCT05688345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55871361|NCT05688345|Analgesics|analgesics|mesh-ancestor
55871362|NCT05688345|Sensory System Agents|sensory system agents|mesh-ancestor
55871363|NCT05688345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871364|NCT05688345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55871365|NCT05688345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55871366|NCT05688345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55871367|NCT05688345|Adrenergic Agents|adrenergic agents|mesh-ancestor
55871368|NCT05688345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871369|NCT05688345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871371|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
55871372|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871373|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871374|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
55871375|NCT04401345|Bromides|bromides|mesh-list
55871376|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
55871377|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55871378|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55871379|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55871380|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
55871381|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871382|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871383|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871384|NCT01015534|Temozolomide|temozolomide|mesh-list
55789232|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
55789234|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871385|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55871386|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
55871387|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871388|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871389|NCT05684055|Antihypertensive Agents|antihypertensive agents|mesh-list
55871390|NCT00968890|Vaccines|vaccines|mesh-list
55871391|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
55871392|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871393|NCT00970216|Telbivudine|telbivudine|mesh-list
55871394|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
55871395|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871396|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55871397|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871411|NCT03384537|Listerine|listerine|mesh-list
55871412|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55871426|NCT05687409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871427|NCT05687409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55871428|NCT02162680|Lidocaine|lidocaine|mesh-list
55871430|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
55871431|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871432|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871433|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
55871434|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871435|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55871436|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55871437|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55871438|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55871439|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871440|NCT05678673|Nivolumab|nivolumab|mesh-list
55871441|NCT05678673|Sunitinib|sunitinib|mesh-list
55871442|NCT05678673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55871443|NCT05678673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871444|NCT05678673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55871445|NCT05678673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871446|NCT05678673|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55871447|NCT05678673|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55789321|NCT05125627|Progestins|progestins|mesh-ancestor
55789322|NCT05125627|Hormones|hormones|mesh-ancestor
55789323|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789324|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789325|NCT05125549|Clopidogrel|clopidogrel|mesh-list
55789326|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55789327|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55789328|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55789329|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55789330|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
55789331|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789332|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789334|NCT04398719|Capsaicin|capsaicin|mesh-list
55789335|NCT04398719|Antipruritics|antipruritics|mesh-ancestor
55789336|NCT04398719|Dermatologic Agents|dermatologic agents|mesh-ancestor
55789337|NCT04398719|Sensory System Agents|sensory system agents|mesh-ancestor
55789338|NCT04398719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789339|NCT04398719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789340|NCT04903847|Tenofovir|tenofovir|mesh-list
55789342|NCT04903847|Dolutegravir|dolutegravir|mesh-list
55789343|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
55789344|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789345|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55789346|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55789348|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789350|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55789351|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55789353|NCT04905953|Neostigmine|neostigmine|mesh-list
55789354|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55789355|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789356|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789357|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
55789358|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789359|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789360|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55789361|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
55789362|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789364|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55789365|NCT04916093|Vildagliptin|vildagliptin|mesh-list
55789366|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55789367|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789369|NCT04916093|Hormones|hormones|mesh-ancestor
55789370|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55789371|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55789372|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
55789373|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789374|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789376|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55789377|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789378|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789379|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789380|NCT03512119|Ivacaftor|ivacaftor|mesh-list
55789381|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55789382|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55789383|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789384|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
55789385|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55789387|NCT03052361|Ondansetron|ondansetron|mesh-list
55789388|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
55789390|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55789391|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789392|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789393|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
55789395|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55789396|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
55789397|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789398|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789399|NCT03052361|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55789400|NCT03052361|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55789401|NCT03052361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55789402|NCT03052361|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55789403|NCT03052361|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55789405|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
55789406|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789407|NCT01752049|Timolol|timolol|mesh-list
55789408|NCT01752049|Maleic acid|maleic acid|mesh-list
55789409|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789410|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789411|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55789412|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55789413|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
55789414|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55789415|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789416|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55789417|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55789418|NCT04966507|Listerine|listerine|mesh-list
55789419|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
55789420|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789421|NCT04949113|Nivolumab|nivolumab|mesh-list
55789422|NCT04949113|Ipilimumab|ipilimumab|mesh-list
55789424|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789425|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55789426|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789428|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789429|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55789430|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789431|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789432|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
55789433|NCT05109949|Empagliflozin|empagliflozin|mesh-list
55789434|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55789435|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789436|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55789437|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789438|NCT04901663|Amoxicillin|amoxicillin|mesh-list
55789440|NCT04901663|Omeprazole|omeprazole|mesh-list
55789441|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55789442|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789443|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55789444|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789445|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55789446|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789447|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789449|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55789452|NCT05134519|Antibodies|antibodies|mesh-list
55789456|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55789466|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789467|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
55789468|NCT04901117|Amoxicillin|amoxicillin|mesh-list
55789469|NCT04901117|Metronidazole|metronidazole|mesh-list
55789470|NCT04901117|Clarithromycin|clarithromycin|mesh-list
55789471|NCT04901117|Tetracycline|tetracycline|mesh-list
55789472|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
55789474|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789475|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55789476|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55789477|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55789478|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55789479|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55789480|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789481|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55789482|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55789483|NCT04901117|Antacids|antacids|mesh-ancestor
55789484|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55789485|NCT04901117|Diuretics|diuretics|mesh-ancestor
55789486|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
55789487|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789488|NCT04901117|Expectorants|expectorants|mesh-ancestor
55789489|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
55789490|NCT05121571|Sorafenib|sorafenib|mesh-list
55789491|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55789492|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55789493|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55789494|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55789495|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
55789496|NCT03051269|Calcium|calcium|mesh-list
55789497|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55789498|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55789499|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55789500|NCT04576663|Phenylephrine|phenylephrine|mesh-list
55789501|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
55789502|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55789505|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790036|NCT04870541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790037|NCT04870541|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55790038|NCT04870541|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55790039|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55790041|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
55790045|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
55790046|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790047|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55790048|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55790049|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55790050|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
55790051|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790053|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
55790055|NCT04878497|Apixaban|apixaban|mesh-list
55790057|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
55790058|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55790059|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
55790060|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55790061|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
55790062|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790063|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790065|NCT03257033|Paclitaxel|paclitaxel|mesh-list
55790066|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55790067|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790068|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
55790070|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
55790071|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790072|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790074|NCT03257033|Antiviral Agents|antiviral agents|mesh-ancestor
55790075|NCT03257033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790076|NCT03257033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790077|NCT03257033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55790078|NCT03257033|Immunologic Factors|immunologic factors|mesh-ancestor
55790079|NCT03257033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790081|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790082|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790085|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55790086|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790088|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
55790089|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790090|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790091|NCT01495637|Sargramostim|sargramostim|mesh-list
55790092|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
55790093|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790095|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790096|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790098|NCT04876313|Nivolumab|nivolumab|mesh-list
55790099|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55790100|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790101|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
55790102|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
55790103|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
55790104|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790105|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790107|NCT03049085|Aspirin|aspirin|mesh-list
55790108|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790109|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55790110|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55790111|NCT03049085|Analgesics|analgesics|mesh-ancestor
55790112|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
55790113|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790114|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55790115|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790116|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55790117|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55790118|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790119|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55790120|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55790121|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790122|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
55790123|NCT04875611|Nivolumab|nivolumab|mesh-list
55790124|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790125|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790126|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55790127|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790128|NCT04386317|Terazosin|terazosin|mesh-list
55790129|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55790130|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55790131|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55790132|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
55790133|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55790134|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790135|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790136|NCT04386317|Urological Agents|urological agents|mesh-ancestor
55790137|NCT05256953|Anesthetics|anesthetics|mesh-list
55790138|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790139|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790141|NCT05256719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55790142|NCT05256719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790143|NCT05256719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790144|NCT05256719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55790145|NCT05256719|Immunologic Factors|immunologic factors|mesh-ancestor
55790149|NCT04868903|Cholecalciferol|cholecalciferol|mesh-list
55790150|NCT04868903|Vitamins|vitamins|mesh-ancestor
55790152|NCT04868903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790154|NCT04868903|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55790156|NCT04874675|Ibuprofen|ibuprofen|mesh-list
55790158|NCT04874675|Codeine|codeine|mesh-list
55790159|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55790161|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
55790162|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790164|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
55790165|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55790166|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55790167|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55790168|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55790169|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790170|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790171|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55790172|NCT04874675|Narcotics|narcotics|mesh-ancestor
55790173|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790174|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
55790175|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
55790176|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
55790179|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
55790180|NCT04868513|Protective Agents|protective agents|mesh-ancestor
55790181|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790182|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55790183|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790185|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
55790186|NCT03047837|Aspirin|aspirin|mesh-list
55790187|NCT03047837|Metformin|metformin|mesh-list
55790188|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55790189|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790190|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55790191|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55790192|NCT03047837|Analgesics|analgesics|mesh-ancestor
55790193|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
55790199|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790200|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55790201|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55790202|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790205|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
55790206|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790207|NCT05256173|Protective Agents|protective agents|mesh-ancestor
55790208|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790209|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55790211|NCT02648347|Hematinics|hematinics|mesh-ancestor
55790212|NCT02614703|Acetic Acid|acetic acid|mesh-list
55790213|NCT02614703|Retinol acetate|retinol acetate|mesh-list
55790214|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55790215|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790216|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55790217|NCT02614703|Immunologic Factors|immunologic factors|mesh-ancestor
55790218|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790219|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55790220|NCT02614703|Protective Agents|protective agents|mesh-ancestor
55790221|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790223|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790224|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55790225|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55790226|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790227|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790228|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55790229|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
55790230|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55790231|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790232|NCT04874597|Ocrelizumab|ocrelizumab|mesh-list
55790234|NCT04874597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790235|NCT04722601|Azacitidine|azacitidine|mesh-list
55790237|NCT04722601|Obinutuzumab|obinutuzumab|mesh-list
55790239|NCT04722601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55790240|NCT04722601|Antimetabolites|antimetabolites|mesh-ancestor
55790241|NCT04722601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790242|NCT04722601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55790243|NCT04722601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790244|NCT04722601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55790247|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55790248|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
55790249|NCT04383743|Methotrexate|methotrexate|mesh-list
55790250|NCT04383743|Daunorubicin|daunorubicin|mesh-list
55790534|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55790536|NCT04682743|Ondansetron|ondansetron|mesh-list
55790537|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55790538|NCT04682743|Analgesics|analgesics|mesh-ancestor
55790539|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
55790540|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55790541|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55790542|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
55790543|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
55790760|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55790761|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790762|NCT03998839|Pyrimethamine|pyrimethamine|mesh-list
55790763|NCT03998839|Sulfadoxine|sulfadoxine|mesh-list
55790764|NCT03998839|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55790765|NCT03998839|Antimalarials|antimalarials|mesh-ancestor
55790766|NCT03998839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55790767|NCT03998839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55790768|NCT03998839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55790769|NCT03998839|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55790770|NCT03998839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55790788|NCT04108039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55715068|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55715069|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
55715070|NCT02203253|Hormones|hormones|mesh-ancestor
55715071|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55715072|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55715073|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715074|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55715075|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
55715076|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
55715077|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715078|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715079|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55715080|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55715081|NCT02203253|Growth Substances|growth substances|mesh-ancestor
55715082|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
55715083|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55715084|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55715085|NCT02203253|Serotonin Agents|serotonin agents|mesh-ancestor
55715086|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715087|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715089|NCT02207699|Benzonatate|benzonatate|mesh-list
55715090|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715091|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715092|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55715093|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55715094|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715095|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715096|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715097|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
55715098|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
55715099|NCT01838187|Vorinostat|vorinostat|mesh-list
55715100|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
55715101|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715102|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55715103|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715104|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715105|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55715106|NCT02296138|Tiotropium Bromide|tiotropium bromide|mesh-list
55715107|NCT02296138|Olodaterol|olodaterol|mesh-list
55715108|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55715109|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
55715110|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715111|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715112|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55715113|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
55715114|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
55715115|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55715116|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
55715117|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715118|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715119|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
55715120|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
55715121|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
55715122|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715123|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715124|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
55715125|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715126|NCT01345851|Paclitaxel|paclitaxel|mesh-list
55715127|NCT01345851|Carboplatin|carboplatin|mesh-list
55715128|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55715129|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715130|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
55824064|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824065|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824066|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824067|NCT04420247|Amebicides|amebicides|mesh-ancestor
55824068|NCT01644890|Paclitaxel|paclitaxel|mesh-list
55824069|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55715131|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
55715132|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
55715133|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715134|NCT03532841|Tramadol|tramadol|mesh-list
55715135|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55715136|NCT03532841|Narcotics|narcotics|mesh-ancestor
55715137|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715138|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715139|NCT03532841|Analgesics|analgesics|mesh-ancestor
55715140|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
55715141|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715142|NCT04334941|Atezolizumab|atezolizumab|mesh-list
55715143|NCT04334941|Talazoparib|talazoparib|mesh-list
55715144|NCT04334941|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55715145|NCT04334941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715146|NCT04334941|Immunologic Factors|immunologic factors|mesh-ancestor
55715147|NCT04334941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715148|NCT04334941|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55715149|NCT04334941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715150|NCT04334941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715151|NCT02199431|Itraconazole|itraconazole|mesh-list
55715152|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
55715153|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715154|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55715155|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55715156|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715157|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715158|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55715159|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
55715160|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55715161|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715162|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55715163|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
55715164|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715167|NCT03532763|Tocopherols|tocopherols|mesh-list
55715168|NCT03532763|Tocovid|tocovid|mesh-list
55715169|NCT03532763|Antioxidants|antioxidants|mesh-ancestor
55715170|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715171|NCT03532763|Protective Agents|protective agents|mesh-ancestor
55715172|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715173|NCT03532763|Vitamins|vitamins|mesh-ancestor
55824080|NCT01628965|Rotigotine|rotigotine|mesh-list
55715175|NCT02208245|Ropivacaine|ropivacaine|mesh-list
55715176|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
55715177|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
55715178|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715179|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715180|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
55715181|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715183|NCT03514901|Nivolumab|nivolumab|mesh-list
55715184|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55715185|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715186|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55715187|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715188|NCT04441021|Penicillins|penicillins|mesh-list
55715189|NCT04441021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715190|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715191|NCT03533387|Ibudilast|ibudilast|mesh-list
55715192|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55715193|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
55715194|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715195|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715196|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55715197|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
55715198|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55715199|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715200|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715201|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55715202|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
55715203|NCT02324842|Liraglutide|liraglutide|mesh-list
55715204|NCT02324842|Canagliflozin|canagliflozin|mesh-list
55715205|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55715206|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715208|NCT02324842|Hormones|hormones|mesh-ancestor
55715209|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55715210|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55715211|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715212|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
55715213|NCT02295280|Promethazine|promethazine|mesh-list
55715214|NCT02295280|Codeine|codeine|mesh-list
55715215|NCT02295280|Metoclopramide|metoclopramide|mesh-list
55715216|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55715217|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55715218|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715219|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715222|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
55715223|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715224|NCT02295280|Antiemetics|antiemetics|mesh-ancestor
55715225|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
55715226|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55715227|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55715228|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
55715229|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
55715230|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715231|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715232|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55715233|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
55715234|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
55715235|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55715236|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55715237|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
55715238|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55715239|NCT02295280|Narcotics|narcotics|mesh-ancestor
55715240|NCT02295280|Analgesics|analgesics|mesh-ancestor
55715241|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
55715242|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
55715243|NCT05263505|Methotrexate|methotrexate|mesh-list
55715244|NCT05263505|Azathioprine|azathioprine|mesh-list
55715245|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55715246|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
55715247|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55715248|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715249|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55715250|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
55715251|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715252|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715253|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
55715254|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715255|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55715256|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55715257|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
55715258|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55715259|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55715261|NCT05488405|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55715262|NCT05488405|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55715263|NCT05488405|Analgesics|analgesics|mesh-ancestor
55715264|NCT05488405|Sensory System Agents|sensory system agents|mesh-ancestor
55715265|NCT05488405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715266|NCT05488405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715267|NCT05488405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55715268|NCT05488405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55715269|NCT02204501|Midazolam|midazolam|mesh-list
55715270|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55715271|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55715272|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715273|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715274|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55715275|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55715276|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55715277|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55715278|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
55715280|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
55715281|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
55715282|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715288|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55715289|NCT03533231|Metronidazole|metronidazole|mesh-list
55715290|NCT03533231|Ciprofloxacin|ciprofloxacin|mesh-list
55715292|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715293|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55715294|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55715295|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55715296|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55715297|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715298|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715299|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715300|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55715494|NCT03172975|Immunologic Factors|immunologic factors|mesh-ancestor
55715301|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55715309|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55715310|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55715311|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715312|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715313|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715314|NCT05374057|Ibuprofen|ibuprofen|mesh-list
55715315|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55715316|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55715317|NCT05374057|Analgesics|analgesics|mesh-ancestor
55715318|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
55715319|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715320|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715321|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55715322|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55715323|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55715324|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715325|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715327|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715328|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715330|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824220|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824221|NCT01631227|Eprosartan|eprosartan|mesh-list
55824222|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55824223|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
55715332|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55715333|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
55715334|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715335|NCT05223101|Telmisartan|telmisartan|mesh-list
55715336|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55715337|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55715338|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55715339|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715341|NCT02852057|Dorzolamide|dorzolamide|mesh-list
55715342|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715343|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715344|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55715345|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55715346|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
55715347|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715348|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715349|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55715350|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55715351|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55715352|NCT04020445|Insulin|insulin|mesh-list
55715353|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55715354|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715355|NCT03524833|Amoxicillin|amoxicillin|mesh-list
55715356|NCT03524833|Metronidazole|metronidazole|mesh-list
55715357|NCT03524833|Lansoprazole|lansoprazole|mesh-list
55715358|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
55715359|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715360|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715361|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55715362|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55715363|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55715364|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55715365|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55715366|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715367|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715368|NCT02220647|Metformin|metformin|mesh-list
55715369|NCT02220647|Linagliptin|linagliptin|mesh-list
55715370|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55715371|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715372|NCT02220647|Incretins|incretins|mesh-ancestor
55715374|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55715375|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55715376|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
55715377|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715378|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715379|NCT05426395|Vitamins|vitamins|mesh-list
55715380|NCT05426395|Hydroxocobalamin|hydroxocobalamin|mesh-list
55715381|NCT05426395|Vitamin B 12|vitamin b 12|mesh-list
55715382|NCT05426395|Vitamin B Complex|vitamin b complex|mesh-list
55715388|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715389|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
55715390|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
55715391|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
55715392|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715393|NCT02209025|Theobromine|theobromine|mesh-list
55715394|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55715395|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
55715396|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715397|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715398|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55715399|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
55715400|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
55715402|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
55715403|NCT02220803|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55715404|NCT02220803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715405|NCT02220803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715407|NCT02220803|Natriuretic Agents|natriuretic agents|mesh-ancestor
55715408|NCT02220803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715410|NCT04972123|Oxymetazoline|oxymetazoline|mesh-list
55715411|NCT04972123|Caffeine|caffeine|mesh-list
55715412|NCT04972123|Capsaicin|capsaicin|mesh-list
55715413|NCT04972123|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55715414|NCT04972123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715415|NCT04972123|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55715416|NCT04972123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715417|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715418|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55715419|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55715420|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
55715421|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715422|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55715423|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
55715424|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
55715425|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715426|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
55715427|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55715428|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
55715429|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
55715430|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55715431|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55715432|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55715434|NCT04972123|Protective Agents|protective agents|mesh-ancestor
55715435|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
55715436|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
55715437|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
55715438|NCT02322892|Thiamine|thiamine|mesh-list
55715439|NCT02322892|Vitamins|vitamins|mesh-ancestor
55715440|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
55715441|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715442|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
55715443|NCT03274375|Rituximab|rituximab|mesh-list
55715444|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55715445|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715446|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
55715447|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715448|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55715449|NCT03250117|Ropinirole|ropinirole|mesh-list
55715450|NCT03250117|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55715451|NCT03250117|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55715452|NCT03250117|Dopamine Agonists|dopamine agonists|mesh-ancestor
55715453|NCT03250117|Dopamine Agents|dopamine agents|mesh-ancestor
55715454|NCT03250117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715455|NCT03250117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715456|NCT03250117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715457|NCT04141501|Psilocybin|psilocybin|mesh-list
55715458|NCT04141501|Hallucinogens|hallucinogens|mesh-ancestor
55715459|NCT04141501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715460|NCT04141501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55715487|NCT03172975|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55715488|NCT03172975|Tubulin Modulators|tubulin modulators|mesh-ancestor
55715489|NCT03172975|Antimitotic Agents|antimitotic agents|mesh-ancestor
55715490|NCT03172975|Mitosis Modulators|mitosis modulators|mesh-ancestor
55715491|NCT03172975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715492|NCT03172975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715493|NCT03172975|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55715495|NCT03172975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715496|NCT03172975|Antacids|antacids|mesh-ancestor
55824490|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55824491|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55824492|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824493|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55824494|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
55824495|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
55824497|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55715497|NCT03172975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55715498|NCT03088813|Irinotecan|irinotecan|mesh-list
55715499|NCT03088813|Topotecan|topotecan|mesh-list
55715500|NCT03088813|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55715501|NCT03088813|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55715502|NCT03088813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715503|NCT03088813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715504|NCT03088813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715505|NCT02739997|Metronidazole|metronidazole|mesh-list
55715506|NCT02739997|Tazobactam|tazobactam|mesh-list
55715507|NCT02739997|Ceftolozane|ceftolozane|mesh-list
55715508|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715509|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715510|NCT02739997|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55715511|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55715512|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55715513|NCT02739997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715514|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715515|NCT04467931|Losartan|losartan|mesh-list
55715516|NCT04467931|Timolol|timolol|mesh-list
55715517|NCT04467931|Propranolol|propranolol|mesh-list
55715518|NCT04467931|Metoprolol|metoprolol|mesh-list
55715519|NCT04467931|Atenolol|atenolol|mesh-list
55715520|NCT04467931|Verapamil|verapamil|mesh-list
55715521|NCT04467931|Felodipine|felodipine|mesh-list
55715522|NCT04467931|Nadolol|nadolol|mesh-list
55715523|NCT04467931|Acebutolol|acebutolol|mesh-list
55715524|NCT04467931|Amlodipine|amlodipine|mesh-list
55715525|NCT04467931|Valsartan|valsartan|mesh-list
55715526|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55715527|NCT04467931|Telmisartan|telmisartan|mesh-list
55715528|NCT04467931|Clonidine|clonidine|mesh-list
55715529|NCT04467931|Carvedilol|carvedilol|mesh-list
55715530|NCT04467931|Candesartan|candesartan|mesh-list
55715531|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
55715532|NCT04467931|Ramipril|ramipril|mesh-list
55715533|NCT04467931|Olmesartan|olmesartan|mesh-list
55715534|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55715535|NCT04467931|Enalapril|enalapril|mesh-list
55715536|NCT04467931|Enalaprilat|enalaprilat|mesh-list
55715537|NCT04467931|Lisinopril|lisinopril|mesh-list
55715538|NCT04467931|Irbesartan|irbesartan|mesh-list
55715539|NCT04467931|Eplerenone|eplerenone|mesh-list
55715540|NCT04467931|Nebivolol|nebivolol|mesh-list
55715541|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
55715542|NCT04467931|Bisoprolol|bisoprolol|mesh-list
55715543|NCT04467931|Perindopril|perindopril|mesh-list
55715544|NCT04467931|Diltiazem|diltiazem|mesh-list
55715545|NCT04467931|Guanfacine|guanfacine|mesh-list
55715546|NCT04467931|Minoxidil|minoxidil|mesh-list
55715547|NCT04467931|Prazosin|prazosin|mesh-list
55715548|NCT04467931|Doxazosin|doxazosin|mesh-list
55715549|NCT04467931|Benazepril|benazepril|mesh-list
55715550|NCT04467931|Labetalol|labetalol|mesh-list
55715551|NCT04467931|Hydralazine|hydralazine|mesh-list
55715552|NCT04467931|Captopril|captopril|mesh-list
55715553|NCT04467931|Indapamide|indapamide|mesh-list
55715554|NCT04467931|Nicardipine|nicardipine|mesh-list
55715555|NCT04467931|Quinapril|quinapril|mesh-list
55715556|NCT04467931|Metolazone|metolazone|mesh-list
55715557|NCT04467931|Trandolapril|trandolapril|mesh-list
55715558|NCT04467931|Torsemide|torsemide|mesh-list
55715559|NCT04467931|Methyldopa|methyldopa|mesh-list
55715560|NCT04467931|Fosinopril|fosinopril|mesh-list
55715561|NCT04467931|Isradipine|isradipine|mesh-list
55715562|NCT04467931|Eprosartan|eprosartan|mesh-list
55715563|NCT04467931|Pindolol|pindolol|mesh-list
55715564|NCT04467931|Betaxolol|betaxolol|mesh-list
55715565|NCT04467931|Moexipril|moexipril|mesh-list
55715566|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
55715568|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
55715569|NCT04467931|Guanabenz|guanabenz|mesh-list
55715570|NCT04467931|Nisoldipine|nisoldipine|mesh-list
55715571|NCT04467931|Penbutolol|penbutolol|mesh-list
55715572|NCT04467931|Nifedipine|nifedipine|mesh-list
55715573|NCT04467931|Amiloride|amiloride|mesh-list
55715575|NCT04467931|Furosemide|furosemide|mesh-list
55715576|NCT04467931|Spironolactone|spironolactone|mesh-list
55715577|NCT04467931|Bumetanide|bumetanide|mesh-list
55715578|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
55715580|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55715581|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55715582|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55715583|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55715584|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55715585|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715586|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55715587|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715588|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
55715589|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55715590|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55715591|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55715592|NCT04467931|Diuretics|diuretics|mesh-ancestor
55715593|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
55715594|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55715595|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55715596|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55715597|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
55715598|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715599|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55715600|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
55715601|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
55715602|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715603|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55715604|NCT04467931|Analgesics|analgesics|mesh-ancestor
55715605|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
55715606|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55715607|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55715608|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55715609|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55715610|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
55715611|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55715612|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55715614|NCT04467931|Protective Agents|protective agents|mesh-ancestor
55715615|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55715616|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55715617|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
55715618|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715619|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
55715620|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55715621|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55715622|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55715623|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55715624|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
55715625|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55715626|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55715627|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
55715628|NCT04467931|Urological Agents|urological agents|mesh-ancestor
55715629|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
55824574|NCT05642780|Pembrolizumab|pembrolizumab|mesh-list
55715630|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55715632|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55715633|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55715634|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715635|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55715636|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55715637|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55715638|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
55715639|NCT03705559|Narcotics|narcotics|mesh-ancestor
55715640|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715641|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715643|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
55715644|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715646|NCT03522649|Fluorouracil|fluorouracil|mesh-list
55715647|NCT03522649|Irinotecan|irinotecan|mesh-list
55715648|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
55715649|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715650|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55715651|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715652|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55715653|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
55715654|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715655|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55715656|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55715713|NCT04466917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715714|NCT04466917|Tubulin Modulators|tubulin modulators|mesh-ancestor
55715715|NCT04466917|Antimitotic Agents|antimitotic agents|mesh-ancestor
55715716|NCT04466917|Mitosis Modulators|mitosis modulators|mesh-ancestor
55715717|NCT04466917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824607|NCT05544734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715718|NCT04466917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55715719|NCT04466917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55715720|NCT04466917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55715721|NCT04466917|Growth Substances|growth substances|mesh-ancestor
55715722|NCT04466917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715723|NCT04466917|Growth Inhibitors|growth inhibitors|mesh-ancestor
55715725|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55715726|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55715727|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
55715728|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715729|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715730|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55715731|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55715732|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
55715733|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715734|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55715735|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55824608|NCT05544734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55824609|NCT05544734|Narcotics|narcotics|mesh-ancestor
55824610|NCT05544734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55824611|NCT05544734|Antitussive Agents|antitussive agents|mesh-ancestor
55824612|NCT05544734|Respiratory System Agents|respiratory system agents|mesh-ancestor
55715739|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55715740|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715741|NCT03526159|Gentamicins|gentamicins|mesh-list
55715742|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715743|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715744|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55715745|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715746|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715747|NCT03523741|Clozapine|clozapine|mesh-list
55715748|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55715749|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
55715750|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715751|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715752|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715753|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55715754|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55715755|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715756|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55715757|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
55715758|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
55715759|NCT02362581|Factor VIII|factor viii|mesh-list
55715760|NCT02362581|Coagulants|coagulants|mesh-ancestor
55715761|NCT03525925|Nivolumab|nivolumab|mesh-list
55715762|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55715763|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715764|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55715765|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715766|NCT02373579|Methotrexate|methotrexate|mesh-list
55715767|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55715768|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
55824651|NCT05493566|Analgesics|analgesics|mesh-ancestor
55715769|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55715770|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715771|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55715772|NCT02373579|Antimetabolites|antimetabolites|mesh-ancestor
55715773|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715774|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715775|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
55715776|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715777|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55715778|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55715779|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
55715780|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55715781|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55715782|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
55715814|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55715815|NCT03112707|Analgesics|analgesics|mesh-ancestor
55715816|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
55715817|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715818|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715819|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55715820|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55715821|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55715822|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55715823|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715824|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55824765|NCT04652960|Nivolumab|nivolumab|mesh-list
55715825|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55715826|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715827|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
55715829|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715830|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55715831|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715832|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715833|NCT02209649|Telmisartan|telmisartan|mesh-list
55715834|NCT02209649|Lacidipine|lacidipine|mesh-list
55715835|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55715836|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55715837|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55715838|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715839|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55715840|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55715841|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55715842|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715843|NCT02361567|Acetaminophen|acetaminophen|mesh-list
55715844|NCT02361567|Oxycodone|oxycodone|mesh-list
55715845|NCT02361567|Tramadol|tramadol|mesh-list
55715846|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55715847|NCT02361567|Narcotics|narcotics|mesh-ancestor
55715848|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55715849|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715850|NCT02361567|Analgesics|analgesics|mesh-ancestor
55715851|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
55715852|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55715853|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55715854|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
55715855|NCT03112785|Cimetidine|cimetidine|mesh-list
55715856|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55715857|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55715858|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55715859|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
55715860|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
55715861|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715862|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715863|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715864|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55715865|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55715866|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824816|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55715868|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
55824817|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824818|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
55824819|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824821|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
55824822|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55715869|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55715870|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
55715871|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55715872|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715873|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55715874|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715875|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55715876|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
55715877|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55715879|NCT05262335|Docetaxel|docetaxel|mesh-list
55715880|NCT05262335|Capecitabine|capecitabine|mesh-list
55715881|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
55715882|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55715883|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715884|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
55715919|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715920|NCT05186129|Clopidogrel|clopidogrel|mesh-list
55715921|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55715922|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55715923|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55715924|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55715925|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
55715926|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55715927|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715928|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715929|NCT03596281|Bevacizumab|bevacizumab|mesh-list
55715930|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
55715931|NCT03596281|Doxorubicin|doxorubicin|mesh-list
55715932|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55715933|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55715934|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715935|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55715936|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55715937|NCT03596281|Growth Substances|growth substances|mesh-ancestor
55715938|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715939|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
55715940|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55715941|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55715942|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55715943|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715944|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715946|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
55715947|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715948|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
55715949|NCT02359149|Growth Substances|growth substances|mesh-ancestor
55715950|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715952|NCT02221583|Tacrolimus|tacrolimus|mesh-list
55824876|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55824877|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824878|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
55824879|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824880|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55824881|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824882|NCT05369468|Analgesics|analgesics|mesh-ancestor
55824883|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55715953|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55715954|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
55715955|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715956|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55715957|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715958|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715959|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55715960|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715961|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55715962|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
55715963|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55715964|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55715966|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55715967|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
55715968|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715969|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715971|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
55715972|NCT03500731|Fludarabine|fludarabine|mesh-list
55715973|NCT03500731|Thiotepa|thiotepa|mesh-list
55715974|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
55715975|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55715976|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55715977|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
55715978|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55715979|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55715980|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55715981|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55715982|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55715983|NCT03500731|Alkylating Agents|alkylating agents|mesh-ancestor
55715984|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55715985|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
55715986|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55715988|NCT02751359|Cannabidiol|cannabidiol|mesh-list
55716007|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55716008|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716009|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55716010|NCT03395197|Talazoparib|talazoparib|mesh-list
55716011|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55716012|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716013|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716014|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716015|NCT05092841|Naltrexone|naltrexone|mesh-list
55716016|NCT05092841|Baclofen|baclofen|mesh-list
55716017|NCT05092841|Sorbitol|sorbitol|mesh-list
55716018|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55716019|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55716020|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716021|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
55716022|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716023|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55716024|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55716025|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55716026|NCT05092841|GABA Agonists|gaba agonists|mesh-ancestor
55716027|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
55716028|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716029|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716030|NCT05092841|Cathartics|cathartics|mesh-ancestor
55716031|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55716032|NCT02224937|Melatonin|melatonin|mesh-list
55716033|NCT02224937|Antioxidants|antioxidants|mesh-ancestor
55716034|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716035|NCT02224937|Protective Agents|protective agents|mesh-ancestor
55716036|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716037|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716038|NCT02290327|Pantoprazole|pantoprazole|mesh-list
55716039|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55716040|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55716041|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55716042|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716043|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716044|NCT03333343|Gefitinib|gefitinib|mesh-list
55716046|NCT03333343|Nazartinib|nazartinib|mesh-list
55716047|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716048|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55716049|NCT03333343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55765216|NCT02432261|Testosterone|testosterone|mesh-list
55716050|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716051|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
55716052|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55716053|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716054|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55716055|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716056|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
55716057|NCT02358057|Alfentanil|alfentanil|mesh-list
55716058|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55716059|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716061|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55716062|NCT02358057|Analgesics|analgesics|mesh-ancestor
55716063|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
55716064|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716065|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55716066|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55716067|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55716068|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
55716069|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716070|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716071|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55716072|NCT02358057|Narcotics|narcotics|mesh-ancestor
55716073|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55716074|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
55716075|NCT02358057|Anesthetics|anesthetics|mesh-ancestor
55716076|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
55716077|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55716078|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716079|NCT02225093|Dextromethorphan|dextromethorphan|mesh-list
55716080|NCT02225093|Caffeine|caffeine|mesh-list
55716081|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55716082|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716083|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55716084|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716085|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716086|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55716087|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55824933|NCT05341154|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55824934|NCT05341154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824935|NCT05341154|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824936|NCT05341154|Analgesics|analgesics|mesh-ancestor
55824937|NCT05341154|Sensory System Agents|sensory system agents|mesh-ancestor
55824938|NCT05341154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824939|NCT05341154|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55824940|NCT05341154|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55824941|NCT05341154|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55824942|NCT05341154|Adrenergic Agents|adrenergic agents|mesh-ancestor
55824943|NCT05341154|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716088|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
55716100|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716102|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55716103|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55716104|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716105|NCT02372487|Urological Agents|urological agents|mesh-ancestor
55716118|NCT02361177|Oxytocin|oxytocin|mesh-list
55716119|NCT02361177|Oxytocics|oxytocics|mesh-ancestor
55716120|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55716121|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716122|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55716123|NCT05055713|Somatostatin|somatostatin|mesh-list
55716124|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55716125|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
55716126|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716127|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716128|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716130|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716132|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55716133|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716134|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55716135|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716136|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
55716137|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55824945|NCT05341154|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55824946|NCT05341154|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55824947|NCT05341154|Anesthetics, General|anesthetics, general|mesh-ancestor
55824948|NCT05341154|Anesthetics|anesthetics|mesh-ancestor
55824949|NCT05341154|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55824950|NCT05341154|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55824951|NCT04513184|Dexamethasone|dexamethasone|mesh-list
55824952|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
55824953|NCT04513184|BB 1101|bb 1101|mesh-list
55824954|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824955|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
55716138|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
55716139|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716141|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55716142|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716143|NCT05030519|Trastuzumab|trastuzumab|mesh-list
55716144|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55716145|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716146|NCT02357277|Budesonide|budesonide|mesh-list
55716147|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55716148|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55716149|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
55716150|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716151|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716152|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55716153|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
55716154|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
55716155|NCT02357277|Hormones|hormones|mesh-ancestor
55716156|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716157|NCT02222441|Pioglitazone|pioglitazone|mesh-list
55716158|NCT02222441|Palbociclib|palbociclib|mesh-list
55716159|NCT02222441|Modafinil|modafinil|mesh-list
55716160|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55716161|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716162|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716163|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55716164|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716165|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716166|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55716167|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55716168|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55716169|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55716171|NCT02290717|Xhance|xhance|mesh-list
55716172|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55716173|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55716174|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
55716175|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55765251|NCT03184493|Metformin|metformin|mesh-list
55716176|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716177|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55716178|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
55716179|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
55716180|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55716181|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
55716182|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55716183|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
55824967|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824968|NCT05409872|Vitamin D|vitamin d|mesh-list
55824969|NCT05409872|Vitamins|vitamins|mesh-list
55824970|NCT05409872|Inositol|inositol|mesh-list
55824971|NCT05409872|Vitamin B 6|vitamin b 6|mesh-list
55716184|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55716185|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
55716186|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716187|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55716188|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55716189|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
55716190|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716191|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716192|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55716193|NCT02360007|Buprenorphine|buprenorphine|mesh-list
55716194|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55716195|NCT02360007|Narcotics|narcotics|mesh-ancestor
55716196|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716197|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716198|NCT02360007|Analgesics|analgesics|mesh-ancestor
55716199|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
55716200|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716201|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55716202|NCT02294305|Vortioxetine|vortioxetine|mesh-list
55716203|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
55716204|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55716205|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55716206|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55716207|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716208|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716209|NCT02294305|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55716210|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55716211|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55716212|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716213|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716215|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55716216|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55716217|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55716218|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55716219|NCT01672255|Fluoxetine|fluoxetine|mesh-list
55716220|NCT01672255|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55716221|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55716222|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55716223|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716224|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716225|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
55716226|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716227|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55716228|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
55716230|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55824994|NCT04464512|Sufentanil|sufentanil|mesh-list
55716231|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55716234|NCT02222519|Rocuronium|rocuronium|mesh-list
55716235|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
55716236|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55716237|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55716238|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55716239|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716240|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716241|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
55716242|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55716243|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
55716244|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716245|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716246|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55716247|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
55716248|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55716249|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
55716250|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716251|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716252|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55716253|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
55716254|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
55716255|NCT02220023|Protective Agents|protective agents|mesh-ancestor
55716256|NCT02356965|Ketamine|ketamine|mesh-list
55716257|NCT02356965|Analgesics|analgesics|mesh-ancestor
55716258|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
55716259|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716260|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716261|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55716262|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55716263|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
55716264|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
55716265|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716266|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55716267|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55716268|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716269|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716270|NCT02907359|Guadecitabine|guadecitabine|mesh-list
55716271|NCT02907359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716272|NCT02359695|Hormones|hormones|mesh-list
55716273|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716274|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716275|NCT02294539|Losartan|losartan|mesh-list
55716276|NCT02294539|Amlodipine|amlodipine|mesh-list
55716277|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55716278|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55716279|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55716280|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55716281|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716282|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55716283|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716284|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
55716285|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55716286|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55716287|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55716288|NCT02294539|Diuretics|diuretics|mesh-ancestor
55716289|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
55716290|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55716292|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55716293|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716294|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55716295|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
55716296|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55716297|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55716298|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55716299|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
55716300|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55716301|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716302|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55716303|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55716304|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55716305|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55716306|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716308|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55716309|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
55716310|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716311|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716312|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55716313|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55716314|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
55716315|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716316|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716317|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55716318|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55716319|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55716320|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55716321|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716322|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716323|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716324|NCT02291341|Analgesics|analgesics|mesh-ancestor
55716325|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
55716326|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716327|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
55716328|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55716329|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
55716330|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
55716331|NCT02352987|Salicylates|salicylates|mesh-list
55716334|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
55716335|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
55716336|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55716337|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55716338|NCT02352987|Analgesics|analgesics|mesh-ancestor
55716339|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
55716340|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716341|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716342|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55716343|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55716344|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55765286|NCT02431013|Cilostazol|cilostazol|mesh-list
55716345|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716346|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716347|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
55716348|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55716349|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55716350|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716351|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55716352|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
55716353|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55716354|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716355|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716356|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825063|NCT05324462|Hormones|hormones|mesh-ancestor
55716358|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716359|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716361|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55716362|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55716363|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55716364|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55716365|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
55716366|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716367|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716368|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716370|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55716371|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716372|NCT02481245|Bezafibrate|bezafibrate|mesh-list
55716373|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55716374|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
55716375|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716376|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55716377|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55716378|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55716379|NCT02352597|Clomiphene|clomiphene|mesh-list
55716380|NCT02352597|Enclomiphene|enclomiphene|mesh-list
55716381|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
55716382|NCT02352597|Estradiol|estradiol|mesh-list
55716383|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55716384|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
55716385|NCT02352597|Estrogens|estrogens|mesh-ancestor
55716386|NCT02352597|Hormones|hormones|mesh-ancestor
55716387|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716388|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716389|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55716390|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
55716391|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55765303|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55716392|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55716394|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
55716395|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55716396|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
55825080|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
55825081|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
55825082|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825083|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825084|NCT04824794|Daratumumab|daratumumab|mesh-list
55825085|NCT04824794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825086|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
55825087|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55825088|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825089|NCT04178642|Idarubicin|idarubicin|mesh-list
55825090|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
55716397|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55716398|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55716399|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55716400|NCT03521167|Acetaminophen|acetaminophen|mesh-list
55716401|NCT03521167|Lidocaine|lidocaine|mesh-list
55716402|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
55716403|NCT03521167|Ketamine|ketamine|mesh-list
55716404|NCT03521167|Gabapentin|gabapentin|mesh-list
55716405|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
55716406|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
55716407|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716408|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716409|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
55716410|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716411|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55716412|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55716413|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55716414|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55716415|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716416|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55716417|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55716418|NCT03521167|Analgesics|analgesics|mesh-ancestor
55716419|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55716420|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55716421|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55716422|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
55716423|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716424|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55716425|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55716426|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
55716427|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55716429|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
55716430|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55716431|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55716432|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55716433|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
55716435|NCT02352519|Anesthetics|anesthetics|mesh-list
55716436|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
55716437|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55825120|NCT04327934|Androgens|androgens|mesh-ancestor
55716438|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716439|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
55716440|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716441|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
55716442|NCT02356419|Hematinics|hematinics|mesh-ancestor
55716443|NCT02220335|Digoxin|digoxin|mesh-list
55716444|NCT02220335|Diuretics|diuretics|mesh-list
55716445|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55716446|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
55716447|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55716448|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55825160|NCT04307576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55825161|NCT04307576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55716484|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55716485|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716486|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
55716487|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716488|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
55716489|NCT03521713|Hematinics|hematinics|mesh-ancestor
55716490|NCT02223533|Morphine|morphine|mesh-list
55716491|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55716492|NCT02223533|Narcotics|narcotics|mesh-ancestor
55716493|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716494|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716495|NCT02223533|Analgesics|analgesics|mesh-ancestor
55716496|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
55716497|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716498|NCT02231021|Pioglitazone|pioglitazone|mesh-list
55716499|NCT02231021|Alogliptin|alogliptin|mesh-list
55716500|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55716501|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716502|NCT02231021|Incretins|incretins|mesh-ancestor
55716503|NCT02231021|Hormones|hormones|mesh-ancestor
55716504|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716505|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55716508|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716509|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55716510|NCT04465123|Spironolactone|spironolactone|mesh-list
55716511|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55716512|NCT04465123|Diuretics|diuretics|mesh-ancestor
55716513|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
55716514|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716515|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55716516|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55716517|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716518|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55716520|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716521|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55716522|NCT02401347|Talazoparib|talazoparib|mesh-list
55716523|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55716524|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716525|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825220|NCT04818944|Tirofiban|tirofiban|mesh-list
55825221|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55825222|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55825223|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825224|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55825225|NCT04818866|Fibrin fragment D|fibrin fragment d|mesh-list
55825226|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55825227|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55825228|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825229|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
55716526|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716528|NCT02231255|Antioxidants|antioxidants|mesh-ancestor
55716529|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716530|NCT02231255|Protective Agents|protective agents|mesh-ancestor
55716531|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716532|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55716533|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55716534|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
55716535|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
55716536|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716537|NCT02352051|Methylphenidate|methylphenidate|mesh-list
55716538|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55716539|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55716540|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716541|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55825250|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
55825251|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55825252|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825253|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
55825254|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55825255|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55716581|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716582|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
55716583|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55716584|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
55716585|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55716586|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55716587|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716588|NCT02351973|Amiloride|amiloride|mesh-list
55716589|NCT02351973|Diuretics|diuretics|mesh-ancestor
55716590|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
55716591|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716592|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
55716593|NCT02351973|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55716594|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55716595|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716596|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55716597|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55716598|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
55716599|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55716600|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55716601|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716602|NCT04831619|Antimetabolites|antimetabolites|mesh-ancestor
55716603|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
55716604|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716606|NCT03520543|Yohimbine|yohimbine|mesh-list
55716607|NCT03520543|Analgesics|analgesics|mesh-ancestor
55716608|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
55716609|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716610|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716611|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55716612|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
55716613|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
55716614|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55716615|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55716616|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55716617|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
55716618|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825362|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
55716619|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716621|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55716622|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55716623|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55716624|NCT03520543|Urological Agents|urological agents|mesh-ancestor
55716625|NCT02355639|Betamethasone|betamethasone|mesh-list
55716626|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
55716627|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55716628|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
55716629|NCT02355639|Clobetasol|clobetasol|mesh-list
55716630|NCT02355639|Petrolatum|petrolatum|mesh-list
55716631|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55716632|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55716633|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
55716635|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716636|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716637|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55716638|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
55716639|NCT02355639|Emollients|emollients|mesh-ancestor
55716640|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
55716641|NCT02351895|Copper|copper|mesh-list
55716642|NCT02351895|Trace Elements|trace elements|mesh-ancestor
55716643|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
55716644|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716645|NCT00503035|Celecoxib|celecoxib|mesh-list
55716646|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55716647|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55716648|NCT00503035|Analgesics|analgesics|mesh-ancestor
55716649|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
55716650|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716651|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716653|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55716654|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55716655|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55716656|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716657|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716658|NCT02227745|Dorzolamide|dorzolamide|mesh-list
55716692|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
55716693|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716694|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55716695|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
55716696|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55716697|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55716698|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55716699|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55716700|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716701|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
55716702|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825400|NCT05651750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55825412|NCT03740204|Estradiol|estradiol|mesh-list
55716703|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55716704|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55716705|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716706|NCT02355093|Ropivacaine|ropivacaine|mesh-list
55716707|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
55716708|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
55716709|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716710|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716711|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
55716712|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716714|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
55716715|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
55716716|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55716717|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716718|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716719|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
55716720|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716721|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716722|NCT02295475|Warfarin|warfarin|mesh-list
55716723|NCT02295475|Apixaban|apixaban|mesh-list
55716724|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
55716725|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55716726|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
55716727|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55716728|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
55716729|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716730|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716732|NCT02227901|Tipifarnib|tipifarnib|mesh-list
55716733|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55716734|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
55716735|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716736|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716737|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
55716740|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716741|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
55716742|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716743|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
55716744|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55716745|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716746|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
55716747|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
55716748|NCT03133195|Vitamin D|vitamin d|mesh-list
55716749|NCT03133195|Teriparatide|teriparatide|mesh-list
55716750|NCT03133195|Calcium|calcium|mesh-list
55716751|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
55716752|NCT03133195|Vitamins|vitamins|mesh-ancestor
55716753|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
55716754|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716755|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55716756|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55716757|NCT03159741|Glucagon|glucagon|mesh-list
55716758|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55716759|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55716761|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716762|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716763|NCT03159741|Incretins|incretins|mesh-ancestor
55716764|NCT02292277|Ticagrelor|ticagrelor|mesh-list
55716765|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55716766|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55716767|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55716768|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55716789|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716790|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
55716791|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716792|NCT02295709|Dexamethasone|dexamethasone|mesh-list
55716793|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
55716794|NCT02295709|BB 1101|bb 1101|mesh-list
55716795|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55716796|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
55716797|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
55716798|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716799|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716801|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
55716802|NCT02295709|Hormones|hormones|mesh-ancestor
55716803|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716804|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55716805|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716806|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
55716807|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716808|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716809|NCT02354937|Cabotegravir|cabotegravir|mesh-list
55716810|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55716811|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55716812|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716813|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716814|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55716815|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55716816|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
55716817|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716818|NCT02231879|Plerixafor|plerixafor|mesh-list
55716819|NCT02231879|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55716820|NCT02231879|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55716821|NCT02231879|Antiviral Agents|antiviral agents|mesh-ancestor
55716822|NCT02231879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716823|NCT02295787|Ketamine|ketamine|mesh-list
55716824|NCT02295787|Analgesics|analgesics|mesh-ancestor
55716825|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
55716826|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716827|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716828|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55716829|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55716830|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
55716831|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
55716832|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716833|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55716834|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55716835|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716836|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716838|NCT04530383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55716839|NCT04530383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716840|NCT04464967|Trastuzumab|trastuzumab|mesh-list
55716841|NCT04464967|Cetuximab|cetuximab|mesh-list
55716842|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55716843|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716844|NCT02228369|Osimertinib|osimertinib|mesh-list
55716845|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716846|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55716847|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716848|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716849|NCT03146871|Azacitidine|azacitidine|mesh-list
55716850|NCT03146871|Decitabine|decitabine|mesh-list
55716851|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55716852|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
55716853|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716854|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716855|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716856|NCT02231957|Vaccines|vaccines|mesh-list
55716857|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
55716858|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716859|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
55716860|NCT02354547|Topotecan|topotecan|mesh-list
55716861|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55716862|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
55716863|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716864|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55716865|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55716866|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
55716867|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825506|NCT01681186|Lansoprazole|lansoprazole|mesh-list
55716868|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716869|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55716870|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55716871|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55716872|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716874|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55716876|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
55716877|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
55716878|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716879|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716881|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55716882|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716883|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55716884|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55716885|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55716886|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55716887|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55716888|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55716889|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
55716890|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
55716891|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
55716892|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
55716893|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716894|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716895|NCT02296021|Amoxicillin|amoxicillin|mesh-list
55716896|NCT02296021|Clarithromycin|clarithromycin|mesh-list
55716897|NCT02296021|Esomeprazole|esomeprazole|mesh-list
55716898|NCT02296021|Bismuth|bismuth|mesh-list
55716899|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55716900|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716901|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55716902|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55716903|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55716904|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716905|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716906|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55716907|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55716908|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55716909|NCT02296021|Antacids|antacids|mesh-ancestor
55716910|NCT02289391|Anesthetics|anesthetics|mesh-list
55825549|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55716911|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716912|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716913|NCT02354313|Lenalidomide|lenalidomide|mesh-list
55716914|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
55716915|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716916|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55765471|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55716917|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55716918|NCT02354313|Growth Substances|growth substances|mesh-ancestor
55716919|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
55716920|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716921|NCT02292667|Acetaminophen|acetaminophen|mesh-list
55716922|NCT02292667|Morphine|morphine|mesh-list
55716923|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55716924|NCT02292667|Narcotics|narcotics|mesh-ancestor
55716925|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55716926|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716927|NCT02292667|Analgesics|analgesics|mesh-ancestor
55716928|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
55716929|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716930|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55716931|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
55716932|NCT02232269|Felodipine|felodipine|mesh-list
55716933|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55716934|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55716935|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55716936|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55716937|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716938|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55716939|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716940|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
55716941|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
55716942|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55716943|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716944|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55825595|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55825596|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55825597|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55825598|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55825599|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
55825600|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825640|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825641|NCT04802408|Listerine|listerine|mesh-list
55825642|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
55825643|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55825644|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55716945|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55716946|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
55716947|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716948|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716949|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55716950|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55716951|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55716953|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716954|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55716955|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55716956|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716957|NCT02289547|Capecitabine|capecitabine|mesh-list
55716958|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55716959|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
55716960|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716961|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716962|NCT02351427|Bortezomib|bortezomib|mesh-list
55716963|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55716964|NCT02232971|Glucagon|glucagon|mesh-list
55716965|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55716966|NCT02232971|Hormones|hormones|mesh-ancestor
55716967|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55716968|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716969|NCT02296333|Ondansetron|ondansetron|mesh-list
55716970|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
55716971|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
55716972|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55716973|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55716974|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55716975|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
55716976|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
55716977|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55716978|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
55716979|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55716980|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716981|NCT02296333|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55716982|NCT02296333|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55716983|NCT02296333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55825661|NCT03498716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825662|NCT03498716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55825663|NCT03498716|Immunologic Factors|immunologic factors|mesh-ancestor
55825664|NCT03498716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825665|NCT03498716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55825666|NCT03498716|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55825667|NCT03498716|Alkylating Agents|alkylating agents|mesh-ancestor
55825668|NCT03498716|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55716984|NCT02296333|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55716985|NCT02296333|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55716987|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55716989|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
55716990|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
55716991|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
55716992|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55716993|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
55716994|NCT02289703|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55716995|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
55716996|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55716997|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
55716998|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717072|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
55716999|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717000|NCT02289703|Anticoagulants|anticoagulants|mesh-ancestor
55717003|NCT02232347|Analgesics|analgesics|mesh-ancestor
55717004|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
55717005|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717006|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717007|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55717008|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55717009|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
55717010|NCT02232347|Anesthetics|anesthetics|mesh-ancestor
55717011|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717012|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55717013|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55717014|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717015|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717016|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55717017|NCT02232347|Narcotics|narcotics|mesh-ancestor
55717018|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55717019|NCT03542669|Doxorubicin|doxorubicin|mesh-list
55717020|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55717021|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717022|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55717023|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55717024|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717025|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717027|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55717028|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55717029|NCT03146481|Analgesics|analgesics|mesh-ancestor
55717030|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
55717031|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717032|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717033|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717035|NCT03541655|Celecoxib|celecoxib|mesh-list
55717036|NCT03541655|Bupivacaine|bupivacaine|mesh-list
55717037|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
55717038|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
55717039|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717040|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717041|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
55717042|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717043|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55717044|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55717045|NCT03541655|Analgesics|analgesics|mesh-ancestor
55717046|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717047|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717048|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55717049|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55717050|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825804|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717051|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717052|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
55717054|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
55717055|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55717056|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55825805|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
55825806|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
55825807|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825808|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55825809|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
55825818|NCT04786964|Hematinics|hematinics|mesh-ancestor
55717057|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55717058|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
55717059|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717060|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717061|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717062|NCT04581473|Paclitaxel|paclitaxel|mesh-list
55717063|NCT04581473|Irinotecan|irinotecan|mesh-list
55717064|NCT04581473|Apatinib|apatinib|mesh-list
55717065|NCT04581473|Antibodies|antibodies|mesh-list
55717066|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55717067|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717068|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
55717069|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
55717070|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
55717071|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717073|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717074|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55717075|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55717076|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717077|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55717078|NCT04249401|Warfarin|warfarin|mesh-list
55717079|NCT04249401|Rivaroxaban|rivaroxaban|mesh-list
55717080|NCT04249401|Dabigatran|dabigatran|mesh-list
55717081|NCT04249401|Apixaban|apixaban|mesh-list
55717082|NCT04249401|Anticoagulants|anticoagulants|mesh-ancestor
55717083|NCT04249401|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55717084|NCT04249401|Antithrombins|antithrombins|mesh-ancestor
55717085|NCT04249401|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55717086|NCT04249401|Protease Inhibitors|protease inhibitors|mesh-ancestor
55717087|NCT04249401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717088|NCT04249401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717089|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
55717090|NCT02229617|Testosterone|testosterone|mesh-list
55717091|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
55717092|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
55717093|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55717094|NCT02229617|Androgens|androgens|mesh-ancestor
55825841|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55825842|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
55825843|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55825844|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55825845|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
55825847|NCT04216784|Diuretics|diuretics|mesh-ancestor
55825848|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
55825849|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825850|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55825851|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55825852|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825853|NCT05173298|Bevacizumab|bevacizumab|mesh-list
55717096|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55717097|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717098|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55717099|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717100|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
55717101|NCT02347059|Dopamine|dopamine|mesh-list
55717102|NCT02347059|Levodopa|levodopa|mesh-list
55717103|NCT02347059|Pramipexole|pramipexole|mesh-list
55717104|NCT02347059|Dopamine Agonists|dopamine agonists|mesh-list
55717105|NCT02347059|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55717106|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55717107|NCT02347059|Dopamine Agents|dopamine agents|mesh-ancestor
55717108|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717109|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717110|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717111|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
55717112|NCT02347059|Protective Agents|protective agents|mesh-ancestor
55717113|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55717114|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
55717115|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
55717116|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717117|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55717118|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55717119|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717120|NCT02296567|Bevacizumab|bevacizumab|mesh-list
55717121|NCT02296567|Ranibizumab|ranibizumab|mesh-list
55717123|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55717124|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717125|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55717126|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55717127|NCT02296567|Growth Substances|growth substances|mesh-ancestor
55717128|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717129|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
55717130|NCT02296723|Valganciclovir|valganciclovir|mesh-list
55717131|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
55717132|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717134|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
55717135|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
55717136|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717137|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717138|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
55717139|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717140|NCT03446807|Droxidopa|droxidopa|mesh-list
55717197|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825893|NCT02209597|Bupropion|bupropion|mesh-list
55825901|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
55717199|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
55717200|NCT02346201|Methylphenidate|methylphenidate|mesh-list
55717201|NCT02346201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55717202|NCT02346201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717203|NCT02346201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55717204|NCT02346201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55717205|NCT02346201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55717206|NCT02346201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717207|NCT02346201|Dopamine Agents|dopamine agents|mesh-ancestor
55717208|NCT02346201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717209|NCT03514771|Valacyclovir|valacyclovir|mesh-list
55717210|NCT03514771|Isotretinoin|isotretinoin|mesh-list
55717211|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
55717212|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717213|NCT03514771|Dermatologic Agents|dermatologic agents|mesh-ancestor
55717214|NCT02298283|Prednisone|prednisone|mesh-list
55717215|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
55717216|NCT02298283|Doxorubicin|doxorubicin|mesh-list
55717217|NCT02298283|Etoposide|etoposide|mesh-list
55717218|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55717219|NCT02298283|Vincristine|vincristine|mesh-list
55717220|NCT02298283|Bleomycin|bleomycin|mesh-list
55717221|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55717222|NCT02298283|Procarbazine|procarbazine|mesh-list
55717223|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717224|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
55717225|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717227|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55717228|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
55717230|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717231|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55717232|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55717233|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55717234|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55717235|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717236|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717237|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
55717238|NCT02298283|Hormones|hormones|mesh-ancestor
55717239|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55717240|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55717241|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55717242|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
55717243|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
55717244|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
55717245|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55717246|NCT02346357|Ropivacaine|ropivacaine|mesh-list
55717247|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
55717248|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
55717249|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717250|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717251|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
55717252|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717253|NCT03146247|Apremilast|apremilast|mesh-list
55717254|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55825963|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717255|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55717257|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
55717258|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717259|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717260|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717261|NCT03146247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717262|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55717263|NCT03146247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55717264|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717265|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717266|NCT03263273|Minocycline|minocycline|mesh-list
55717267|NCT03263273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55717268|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717269|NCT03146325|Metronidazole|metronidazole|mesh-list
55717270|NCT03146325|Tetracycline|tetracycline|mesh-list
55717271|NCT03146325|Omeprazole|omeprazole|mesh-list
55717272|NCT03146325|Bismuth|bismuth|mesh-list
55717273|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717274|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55717275|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55717276|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55717277|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55717278|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55717279|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55717280|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717281|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717282|NCT03146325|Antacids|antacids|mesh-ancestor
55717283|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55717284|NCT04189133|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55717285|NCT04189133|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55717286|NCT04189133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717288|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55717289|NCT02233049|Dasatinib|dasatinib|mesh-list
55717290|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717291|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717292|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
55717293|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717294|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55717295|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717296|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717297|NCT02350725|Furosemide|furosemide|mesh-list
55717298|NCT02350725|Diuretics|diuretics|mesh-ancestor
55717299|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
55717300|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717301|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55826002|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
55826004|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55826005|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55826006|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
55826007|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717302|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55717303|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717304|NCT02350959|Atorvastatin|atorvastatin|mesh-list
55717305|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55717306|NCT02350959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55717307|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
55717308|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717309|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55717310|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55717311|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717312|NCT02350335|Nicotine|nicotine|mesh-list
55717313|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55717314|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
55717315|NCT02350335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717316|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717317|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55717318|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55717319|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
55717320|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717321|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717323|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
55717324|NCT02293447|Anesthetics|anesthetics|mesh-list
55717325|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55717326|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717327|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
55717328|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717329|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55717330|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55717331|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55717332|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55717333|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717334|NCT04464811|Furosemide|furosemide|mesh-list
55717335|NCT04464811|Diuretics|diuretics|mesh-ancestor
55717336|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
55717337|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717338|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55717339|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55717340|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717342|NCT02293525|Oxycodone|oxycodone|mesh-list
55717343|NCT02293525|Ropivacaine|ropivacaine|mesh-list
55717344|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55717535|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55717536|NCT02294071|Analgesics|analgesics|mesh-ancestor
55717537|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
55717538|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717539|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717541|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55717542|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717543|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717544|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55717545|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717546|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717547|NCT02233439|Galactogogues|galactogogues|mesh-list
55717549|NCT02350023|Betamethasone|betamethasone|mesh-list
55717550|NCT02350023|Latanoprost|latanoprost|mesh-list
55717551|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55717552|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55717553|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717554|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
55717555|NCT02350023|Hormones|hormones|mesh-ancestor
55717556|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55717557|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717558|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55717559|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
55717560|NCT02342925|Metformin|metformin|mesh-list
55717561|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55717562|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717563|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55717564|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55717565|NCT02344641|Exenatide|exenatide|mesh-list
55717566|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55717567|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717568|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55717569|NCT02344641|Incretins|incretins|mesh-ancestor
55717570|NCT02344641|Hormones|hormones|mesh-ancestor
55717571|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55717573|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717574|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
55717575|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
55717576|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
55717577|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717578|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
55717579|NCT04083183|Sirolimus|sirolimus|mesh-list
55717580|NCT04083183|Vidarabine|vidarabine|mesh-list
55717581|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
55717582|NCT04083183|Fludarabine|fludarabine|mesh-list
55717583|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
55717584|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55717585|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
55717586|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55717587|NCT04083183|Antibodies|antibodies|mesh-list
55717588|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
55717589|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55717590|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
55717591|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55717592|NCT04083183|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55717593|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717594|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
55717595|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717596|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717597|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55717598|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
55717599|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717600|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717601|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55717602|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55717604|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55717605|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55717606|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
55717607|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55717608|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717609|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717610|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
55717611|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
55717613|NCT02342769|Abacavir|abacavir|mesh-list
55717614|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55717615|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55717616|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717654|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717655|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
55717656|NCT02302495|Hormones|hormones|mesh-ancestor
55717657|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55826367|NCT01599806|Trimethoprim|trimethoprim|mesh-list
55826368|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
55826369|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55826370|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717658|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717659|NCT02302495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55717660|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717661|NCT02302495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55717662|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
55717663|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717664|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55717665|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717666|NCT02302495|Immunologic Factors|immunologic factors|mesh-ancestor
55717667|NCT03747575|Astegolimab|astegolimab|mesh-list
55717668|NCT03747575|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55717669|NCT03747575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717670|NCT03747575|Antiviral Agents|antiviral agents|mesh-ancestor
55717671|NCT03747575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717672|NCT02813447|Sertraline|sertraline|mesh-list
55717673|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
55717674|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55717675|NCT02813447|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55717676|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55717677|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55717678|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717679|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717680|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
55717681|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717682|NCT02342145|Cyclosporine|cyclosporine|mesh-list
55717683|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
55717684|NCT02342145|Methotrexate|methotrexate|mesh-list
55717685|NCT02342145|Cyclosporins|cyclosporins|mesh-list
55717686|NCT02342145|Basiliximab|basiliximab|mesh-list
55717687|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55717688|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
55717689|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55717690|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717691|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55717692|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
55717693|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717694|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717695|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
55717696|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717697|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55717698|NCT02342145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717699|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
55717700|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717701|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55717702|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
55717703|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717704|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55717705|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55717706|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55717707|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
55717708|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55717709|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
55717710|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55717712|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
55717713|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55717714|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55717715|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55717716|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
55717717|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55717718|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717719|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55717721|NCT02349399|Hormones|hormones|mesh-ancestor
55717722|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55717723|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
55717724|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
55717725|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717726|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55717727|NCT02306473|Mannitol|mannitol|mesh-list
55717728|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55717729|NCT02306473|Diuretics|diuretics|mesh-ancestor
55717730|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
55717731|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717732|NCT03737123|Gemcitabine|gemcitabine|mesh-list
55717733|NCT03737123|Carboplatin|carboplatin|mesh-list
55717734|NCT03737123|Docetaxel|docetaxel|mesh-list
55717735|NCT03737123|Atezolizumab|atezolizumab|mesh-list
55717736|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717737|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55717738|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
55717739|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717740|NCT03737123|Antiviral Agents|antiviral agents|mesh-ancestor
55717741|NCT03737123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717742|NCT03737123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717743|NCT03737123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717744|NCT03737123|Immunologic Factors|immunologic factors|mesh-ancestor
55717745|NCT03737123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717746|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
55717747|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
55717748|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
55717749|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55717750|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55717753|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55717754|NCT02344095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717755|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
55717756|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
55717757|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
55717758|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717759|NCT00157339|Insulin|insulin|mesh-list
55717760|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55717761|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55717762|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717764|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
55717765|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55717766|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717767|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55717768|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717769|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55717770|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55717771|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
55717772|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717773|NCT02344017|Prednisone|prednisone|mesh-list
55717774|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717775|NCT02344017|Glucocorticoids|glucocorticoids|mesh-ancestor
55717776|NCT02344017|Hormones|hormones|mesh-ancestor
55717777|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55717778|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717779|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55717780|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717781|NCT02343861|Emollients|emollients|mesh-list
55717782|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
55717783|NCT03676751|Azithromycin|azithromycin|mesh-list
55717785|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717786|NCT02302729|Micronutrients|micronutrients|mesh-list
55717787|NCT02302729|Trace Elements|trace elements|mesh-list
55717788|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717789|NCT03513601|Rituximab|rituximab|mesh-list
55717790|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55717791|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717792|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
55717793|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717794|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717795|NCT03647111|Crizotinib|crizotinib|mesh-list
55717796|NCT03647111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717797|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55717798|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717799|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717800|NCT03507829|Insulin|insulin|mesh-list
55717801|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55717802|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
55717803|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
55717804|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
55717805|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
55717806|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55717807|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717837|NCT05039177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55717838|NCT05039177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717839|NCT05039177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55717840|NCT05039177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717841|NCT05039177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717843|NCT05230797|Propolis|propolis|mesh-list
55717844|NCT05230797|Eugenol|eugenol|mesh-list
55717845|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
55717846|NCT05230797|Trace Elements|trace elements|mesh-ancestor
55717847|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
55717848|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717849|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717850|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
55717851|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
55717852|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55717853|NCT05230797|Protective Agents|protective agents|mesh-ancestor
55717854|NCT02341365|Vitamin D|vitamin d|mesh-list
55717855|NCT02341365|Vitamins|vitamins|mesh-ancestor
55717856|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
55717857|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717858|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55717859|NCT02299687|Omeprazole|omeprazole|mesh-list
55717860|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55717861|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55717862|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55717863|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717864|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717865|NCT02349243|Entacapone|entacapone|mesh-list
55717866|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55717867|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55717868|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55717869|NCT02349243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717870|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717871|NCT02341209|Doxycycline|doxycycline|mesh-list
55717872|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55717873|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717874|NCT02341209|Antimalarials|antimalarials|mesh-ancestor
55717875|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55717876|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55717877|NCT02349165|Riboflavin|riboflavin|mesh-list
55717878|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
55717879|NCT02349165|Vitamins|vitamins|mesh-ancestor
55717880|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
55717881|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717882|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55717883|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
55717884|NCT03112005|Mydriatics|mydriatics|mesh-list
55826562|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
55717885|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
55717886|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826563|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826564|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55717887|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717889|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55717890|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55717891|NCT02306785|Analgesics|analgesics|mesh-ancestor
55717892|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
55717893|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717894|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717895|NCT02306785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717896|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717897|NCT02299765|Gemcitabine|gemcitabine|mesh-list
55717898|NCT02299765|Carboplatin|carboplatin|mesh-list
55717899|NCT02299765|Gefitinib|gefitinib|mesh-list
55717900|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717901|NCT02299765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55717902|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
55717903|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717905|NCT02299765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717906|NCT02299765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717907|NCT02299765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717908|NCT02299765|Immunologic Factors|immunologic factors|mesh-ancestor
55717909|NCT02299765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717910|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55717911|NCT04771923|Epinephrine|epinephrine|mesh-list
55826634|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55826635|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55717945|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717946|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
55717947|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717948|NCT04598321|Talazoparib|talazoparib|mesh-list
55717949|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55717950|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717951|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717952|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717954|NCT04718025|Ticagrelor|ticagrelor|mesh-list
55717955|NCT04718025|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55717956|NCT04718025|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55717957|NCT04718025|Analgesics|analgesics|mesh-ancestor
55717958|NCT04718025|Sensory System Agents|sensory system agents|mesh-ancestor
55717959|NCT04718025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55717960|NCT04718025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717961|NCT04718025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55717962|NCT04718025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55717964|NCT04718025|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55717965|NCT04718025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717966|NCT04718025|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55717967|NCT04718025|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55717968|NCT04718025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717969|NCT04718025|Antipyretics|antipyretics|mesh-ancestor
55717970|NCT04718025|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55717971|NCT04718025|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55717972|NCT04718025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55717973|NCT04718025|Purinergic Agents|purinergic agents|mesh-ancestor
55717974|NCT04718025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717975|NCT05254899|Gemcitabine|gemcitabine|mesh-list
55717976|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
55717977|NCT05254899|Pegaspargase|pegaspargase|mesh-list
55717978|NCT05254899|Antibodies|antibodies|mesh-list
55717979|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55717980|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
55717981|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717982|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55717983|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
55717984|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717985|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55717986|NCT05254899|Antiviral Agents|antiviral agents|mesh-ancestor
55717987|NCT05254899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55717988|NCT05254899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55717989|NCT05254899|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55717990|NCT03148509|Risperidone|risperidone|mesh-list
55717991|NCT03148509|Aripiprazole|aripiprazole|mesh-list
55717993|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55717994|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
55717995|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55717996|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55717997|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55717998|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55717999|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55718000|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718001|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55718002|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55718003|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
55718004|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55718005|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
55718006|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55718007|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55718008|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55718010|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55718011|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718012|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
55718013|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55718014|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55718015|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55718016|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55718017|NCT05254665|Docetaxel|docetaxel|mesh-list
55718018|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718019|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
55718020|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
55718021|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
55826878|NCT02236988|Apremilast|apremilast|mesh-list
55718022|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718023|NCT03513055|Insulin|insulin|mesh-list
55718024|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55718025|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718026|NCT03510325|Olanzapine|olanzapine|mesh-list
55718027|NCT03510325|Risperidone|risperidone|mesh-list
55718028|NCT03510325|Aripiprazole|aripiprazole|mesh-list
55718029|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55718030|NCT03510325|Amisulpride|amisulpride|mesh-list
55718031|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55718032|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
55718033|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826779|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
55826780|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
55826781|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826782|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55826783|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55826784|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826785|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826786|NCT04115878|Oxybutynin|oxybutynin|mesh-list
55826787|NCT04115878|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55826797|NCT04115878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718034|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718045|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718046|NCT03510325|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55718047|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55718048|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55718049|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
55718051|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55718052|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55718053|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55718054|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55718055|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55718056|NCT03507127|Varenicline|varenicline|mesh-list
55718058|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55718059|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
55718060|NCT03507127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718061|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718063|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55718064|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55718065|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718066|NCT02336529|Bupivacaine|bupivacaine|mesh-list
55718067|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
55718068|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
55718069|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718070|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718071|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
55718072|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718073|NCT04636437|Tenofovir|tenofovir|mesh-list
55718074|NCT04636437|Lamivudine|lamivudine|mesh-list
55718076|NCT04636437|Integrase Inhibitors|integrase inhibitors|mesh-list
55718077|NCT04636437|Antiviral Agents|antiviral agents|mesh-ancestor
55718078|NCT04636437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718079|NCT04636437|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55718080|NCT04636437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55718081|NCT04636437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718082|NCT04636437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718083|NCT04636437|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55718084|NCT04636437|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55718085|NCT02307487|Mitomycins|mitomycins|mesh-list
55718086|NCT02307487|Mitomycin|mitomycin|mesh-list
55718087|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55718088|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718089|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
55718090|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718091|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55718092|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718093|NCT02307565|Midodrine|midodrine|mesh-list
55718094|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
55718095|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
55718096|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718097|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718098|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55718099|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55718100|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55718101|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55718102|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
55718103|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718104|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718105|NCT03510013|Anesthetics|anesthetics|mesh-list
55718106|NCT03510013|Sevoflurane|sevoflurane|mesh-list
55718107|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
55718108|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718109|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718110|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55718111|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
55718112|NCT02307721|Remifentanil|remifentanil|mesh-list
55718113|NCT02307721|Naloxone|naloxone|mesh-list
55718114|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55718115|NCT02307721|Narcotics|narcotics|mesh-ancestor
55718116|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718117|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718118|NCT02307721|Analgesics|analgesics|mesh-ancestor
55718119|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
55718120|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718121|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55718122|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
55718123|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55718124|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
55718125|NCT03506815|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55718126|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
55718127|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718128|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718129|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
55718130|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55718131|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718132|NCT02348463|Clindamycin|clindamycin|mesh-list
55718133|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
55718134|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
55718135|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55718136|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718137|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55718138|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718139|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718140|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
55718141|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55718142|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55718143|NCT02340273|Adrenergic Agents|adrenergic agents|mesh-ancestor
55718144|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718145|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718146|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718147|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
55718148|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
55765608|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
55718149|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718150|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
55718151|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55718152|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
55718154|NCT02300623|Stavudine|stavudine|mesh-list
55718155|NCT02300623|Indinavir|indinavir|mesh-list
55718156|NCT02300623|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55718157|NCT02300623|Interleukin-2|interleukin-2|mesh-list
55718158|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55718159|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55718160|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718161|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826904|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
55718162|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
55718163|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718164|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55718165|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718166|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55718167|NCT02300623|Analgesics|analgesics|mesh-ancestor
55718168|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
55718169|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718170|NCT02300623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718171|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
55718172|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55718173|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55718174|NCT02300623|Protease Inhibitors|protease inhibitors|mesh-ancestor
55826925|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826926|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
55826927|NCT01922271|Albuterol|albuterol|mesh-list
55826928|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
55826929|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55826930|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
55826931|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826932|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826933|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55718206|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55718207|NCT02348307|Renal Agents|renal agents|mesh-ancestor
55718208|NCT02340117|Gemcitabine|gemcitabine|mesh-list
55718209|NCT02340117|Paclitaxel|paclitaxel|mesh-list
55718210|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55718211|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55718212|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718213|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
55718214|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
55718215|NCT02340117|Mitosis Modulators|mitosis modulators|mesh-ancestor
55718216|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718217|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55718218|NCT02340117|Antimetabolites|antimetabolites|mesh-ancestor
55718219|NCT02340117|Antiviral Agents|antiviral agents|mesh-ancestor
55718220|NCT02340117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718221|NCT02340117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718222|NCT02340117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55718223|NCT02340117|Immunologic Factors|immunologic factors|mesh-ancestor
55718224|NCT02340117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718225|NCT02300701|Omalizumab|omalizumab|mesh-list
55718226|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55718227|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55718228|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
55718229|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
55718230|NCT02336139|Velpatasvir|velpatasvir|mesh-list
55718232|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718234|NCT02300935|Trametinib|trametinib|mesh-list
55718235|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55718236|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718237|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
55718238|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
55718239|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
55718240|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718241|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55718242|NCT02300935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718243|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55718244|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55718245|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718246|NCT02301091|Mitomycins|mitomycins|mesh-list
55718247|NCT02301091|Mitomycin|mitomycin|mesh-list
55718248|NCT02301091|Pirarubicin|pirarubicin|mesh-list
55718249|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55718250|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718251|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
55718252|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718253|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55718254|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718255|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
55718256|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
55718257|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55718258|NCT02335593|Hematinics|hematinics|mesh-ancestor
55718259|NCT02335593|Astringents|astringents|mesh-ancestor
55718260|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718261|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
55718262|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55718263|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
55718265|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718266|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55827009|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55827010|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55827011|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827012|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55827013|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55827014|NCT01632566|Analgesics|analgesics|mesh-ancestor
55827015|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
55827016|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827017|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827018|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55718290|NCT02309281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718292|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55718293|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55718294|NCT02335281|Analgesics|analgesics|mesh-ancestor
55718295|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
55718296|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718297|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718298|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55718299|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55718300|NCT02309437|Oxycodone|oxycodone|mesh-list
55718301|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55718302|NCT02309437|Narcotics|narcotics|mesh-ancestor
55718303|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718304|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718305|NCT02309437|Analgesics|analgesics|mesh-ancestor
55718306|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
55718307|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718308|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
55718309|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55718310|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55718311|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718312|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
55718313|NCT02335359|Coagulants|coagulants|mesh-ancestor
55718314|NCT03511261|Curcumin|curcumin|mesh-list
55718315|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55718316|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55718317|NCT03511261|Analgesics|analgesics|mesh-ancestor
55718318|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
55718319|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718320|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718321|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55718322|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55718323|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718324|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718325|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718326|NCT03509701|Antibodies|antibodies|mesh-list
55718327|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
55718328|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718329|NCT03511183|Bevacizumab|bevacizumab|mesh-list
55718330|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55718331|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718332|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55718333|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55718334|NCT03511183|Growth Substances|growth substances|mesh-ancestor
55718335|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718336|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
55718337|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
55718338|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55718339|NCT02303587|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55718340|NCT02303587|Prednisolone|prednisolone|mesh-list
55718341|NCT02303587|Prednisolone acetate|prednisolone acetate|mesh-list
55718342|NCT02303587|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55718343|NCT02303587|Prednisolone phosphate|prednisolone phosphate|mesh-list
55718344|NCT02303587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55718345|NCT02303587|Antiemetics|antiemetics|mesh-ancestor
55718346|NCT02303587|Autonomic Agents|autonomic agents|mesh-ancestor
55718347|NCT02303587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718348|NCT02303587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718349|NCT02303587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718352|NCT02303587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55718353|NCT02303587|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55718354|NCT02303587|Protective Agents|protective agents|mesh-ancestor
55718355|NCT02303587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55718356|NCT02303587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718357|NCT03916419|Paclitaxel|paclitaxel|mesh-list
55718358|NCT03916419|Carboplatin|carboplatin|mesh-list
55718359|NCT03916419|Durvalumab|durvalumab|mesh-list
55718360|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55718361|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718362|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
55718363|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
55718364|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
55765695|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
55718365|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718366|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55718464|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55718465|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718466|NCT02334501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718467|NCT02331927|Aflibercept|aflibercept|mesh-list
55718468|NCT02331927|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55718469|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55718470|NCT02331927|Growth Substances|growth substances|mesh-ancestor
55718471|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718472|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
55718473|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718474|NCT02322190|Methoxsalen|methoxsalen|mesh-list
55718475|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55718476|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
55718478|NCT02304055|Carbetocin|carbetocin|mesh-list
55718480|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55718481|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718482|NCT02310295|Triamcinolone|triamcinolone|mesh-list
55718483|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55718484|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55718485|NCT02310295|Bevacizumab|bevacizumab|mesh-list
55718486|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55827199|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55718487|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55718488|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718489|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55718490|NCT02310295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55718491|NCT02310295|Growth Substances|growth substances|mesh-ancestor
55718492|NCT02310295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718493|NCT02310295|Growth Inhibitors|growth inhibitors|mesh-ancestor
55718494|NCT02310295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55718495|NCT02310295|Glucocorticoids|glucocorticoids|mesh-ancestor
55718496|NCT02310295|Hormones|hormones|mesh-ancestor
55718497|NCT02310295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55718498|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55718499|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
55718500|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718501|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718502|NCT05012865|Avelumab|avelumab|mesh-list
55718503|NCT05012865|Axitinib|axitinib|mesh-list
55718504|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55718505|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718506|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55718507|NCT05012865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718508|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718509|NCT03505489|Mannitol|mannitol|mesh-list
55718510|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
55718511|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55718512|NCT03505489|Diuretics|diuretics|mesh-ancestor
55718513|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
55718514|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718515|NCT03505489|Miotics|miotics|mesh-ancestor
55718516|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
55718517|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718518|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55718519|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
55718520|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
55718522|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55718523|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
55718524|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718525|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718526|NCT02310373|Nicotine|nicotine|mesh-list
55718527|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55718528|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
55718529|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718530|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718531|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55718532|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55718533|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
55718534|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718535|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718536|NCT02338323|Febuxostat|febuxostat|mesh-list
55718537|NCT02338323|Benzbromarone|benzbromarone|mesh-list
55718538|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
55718539|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55718540|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
55718541|NCT02338323|Renal Agents|renal agents|mesh-ancestor
55718596|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55718597|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55718598|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55718599|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55718600|NCT03504865|Bupivacaine|bupivacaine|mesh-list
55718601|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
55718602|NCT03504865|Anesthetics|anesthetics|mesh-ancestor
55718603|NCT03504865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718604|NCT03504865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718605|NCT03504865|Sensory System Agents|sensory system agents|mesh-ancestor
55718606|NCT03504865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718608|NCT02304289|Antimalarials|antimalarials|mesh-ancestor
55718609|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55718610|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55827249|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
55827250|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
55827251|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55827252|NCT02199314|Desflurane|desflurane|mesh-list
55827253|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55827254|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
55718611|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718612|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718613|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
55718614|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
55718615|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55718616|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
55718617|NCT02292784|Atosiban|atosiban|mesh-list
55718618|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
55718619|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55718620|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718621|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
55718622|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55718623|NCT02338011|Gefitinib|gefitinib|mesh-list
55718624|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718625|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55718626|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718627|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718628|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55718629|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55718630|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
55718631|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718633|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718634|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718635|NCT02320396|Desloratadine|desloratadine|mesh-list
55718636|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55718637|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
55718638|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718639|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718640|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718641|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55718642|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55718643|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
55718644|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
55718645|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55718646|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
55718647|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55718648|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
55718649|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55718650|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718651|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55718652|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55718653|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718654|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
55718656|NCT02310997|Busulfan|busulfan|mesh-list
55718657|NCT02310997|Fludarabine|fludarabine|mesh-list
55718658|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55718659|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
55718660|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718661|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55718662|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55718663|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
55718664|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718665|NCT02310997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718666|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55718667|NCT03505411|Melatonin|melatonin|mesh-list
55718730|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718731|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
55718732|NCT02311231|Heparin|heparin|mesh-list
55718733|NCT02311231|Calcium heparin|calcium heparin|mesh-list
55718734|NCT02311231|Bivalirudin|bivalirudin|mesh-list
55718735|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
55718736|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55718737|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55718738|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718739|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
55718740|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55718741|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
55718742|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718744|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718745|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55718746|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55718747|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55718748|NCT02333565|Everolimus|everolimus|mesh-list
55718749|NCT02333565|Octreotide|octreotide|mesh-list
55718750|NCT02333565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718751|NCT02333565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55718752|NCT02333565|Immunologic Factors|immunologic factors|mesh-ancestor
55718753|NCT02333565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718754|NCT02333565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718755|NCT02333565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55718756|NCT03105375|Omeprazole|omeprazole|mesh-list
55718757|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55718758|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718759|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55718760|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718761|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718762|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
55718765|NCT02304445|Hormones|hormones|mesh-ancestor
55718766|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55718767|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718768|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55718769|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718771|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55718772|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
55718773|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55718774|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718775|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55718776|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55718777|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
55718778|NCT02327091|Alfacalcidol|alfacalcidol|mesh-list
55718779|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55718780|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55718781|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718782|NCT02327091|Vitamins|vitamins|mesh-ancestor
55718783|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
55718784|NCT03801525|Venetoclax|venetoclax|mesh-list
55718785|NCT03801525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718786|NCT02316535|Capecitabine|capecitabine|mesh-list
55718787|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55718788|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
55718789|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718790|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718791|NCT02333253|Cetrorelix|cetrorelix|mesh-list
55718792|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55718793|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
55718794|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55718795|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718796|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
55718797|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55718798|NCT02039661|Lidocaine|lidocaine|mesh-list
55718799|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
55718800|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
55718801|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55718802|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718803|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
55718804|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718805|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55718806|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55718807|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55718808|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55718809|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718810|NCT02326779|Aspirin|aspirin|mesh-list
55718811|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55827333|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55827351|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
55827352|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827353|NCT03602261|Calcifediol|calcifediol|mesh-list
55827354|NCT03602261|Vitamins|vitamins|mesh-ancestor
55718812|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55718813|NCT02326779|Analgesics|analgesics|mesh-ancestor
55718814|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
55718815|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718816|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718818|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55718819|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55718820|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55718821|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718822|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55718823|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55718824|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718825|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
55718826|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55718827|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718828|NCT02312635|Cycloserine|cycloserine|mesh-list
55718829|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55718830|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55718831|NCT02312635|Renal Agents|renal agents|mesh-ancestor
55718832|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55718833|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
55718834|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55718835|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
55718836|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718837|NCT03144453|Atropine|atropine|mesh-list
55718838|NCT03144453|Neostigmine|neostigmine|mesh-list
55718839|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55718841|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55718842|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
55718843|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718844|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718845|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55718846|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
55718847|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
55718848|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
55718849|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55718850|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55718851|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
55718852|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55718853|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718854|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55718855|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718856|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55718857|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
55718858|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718859|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55718860|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55718861|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55718862|NCT02332941|Rituximab|rituximab|mesh-list
55718863|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55718864|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718865|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
55718866|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718867|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55718868|NCT03503227|Aspirin|aspirin|mesh-list
55718869|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
55718870|NCT03503227|Prednisolone|prednisolone|mesh-list
55718871|NCT03503227|Salicylates|salicylates|mesh-list
55718872|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55718873|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
55718874|NCT03503227|Hormones|hormones|mesh-ancestor
55718875|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55718876|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55718877|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55718878|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55718879|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55718880|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719017|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55719018|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55719019|NCT02330757|Clomiphene|clomiphene|mesh-list
55719020|NCT02330757|Enclomiphene|enclomiphene|mesh-list
55719021|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
55719022|NCT02330757|Estradiol|estradiol|mesh-list
55719023|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55719024|NCT02330757|Estrogens|estrogens|mesh-ancestor
55719025|NCT02330757|Hormones|hormones|mesh-ancestor
55719026|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55719027|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719028|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55719029|NCT02330757|Contraceptive Agents|contraceptive agents|mesh-ancestor
55719030|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55719031|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55719032|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55719033|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
55719034|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55719035|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
55719036|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55719037|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55719038|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55719039|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719040|NCT03332797|Palbociclib|palbociclib|mesh-list
55719041|NCT03332797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719042|NCT03332797|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55719043|NCT03332797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719044|NCT03332797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719045|NCT02305615|Bevacizumab|bevacizumab|mesh-list
55719046|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55719047|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719048|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55827508|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
55719049|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55719051|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719052|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
55719054|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719055|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55719056|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55719057|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719058|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719059|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55719060|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
55719061|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55719062|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719063|NCT02317861|Febuxostat|febuxostat|mesh-list
55719064|NCT02317861|Verinurad|verinurad|mesh-list
55719065|NCT02317861|Benzbromarone|benzbromarone|mesh-list
55719066|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
55719067|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719068|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
55719069|NCT02317861|Renal Agents|renal agents|mesh-ancestor
55719070|NCT02318017|Methylphenidate|methylphenidate|mesh-list
55719071|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55719072|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719073|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55719074|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55719075|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55719076|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719077|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
55719078|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719079|NCT02313727|Pamidronate|pamidronate|mesh-list
55719080|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55719081|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719082|NCT02313805|Insulin|insulin|mesh-list
55719083|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55719084|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719085|NCT03132493|Nivolumab|nivolumab|mesh-list
55719086|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55719087|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719088|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55719089|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719090|NCT02313883|Taurolidine|taurolidine|mesh-list
55719091|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719092|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55719093|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719094|NCT03500653|Curcumin|curcumin|mesh-list
55719095|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55719096|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55765783|NCT02100670|Diclofenac|diclofenac|mesh-list
55719097|NCT03500653|Analgesics|analgesics|mesh-ancestor
55719098|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
55719099|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827594|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719100|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719101|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55719102|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719103|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719104|NCT03500653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719105|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719106|NCT02305927|Vitamin D|vitamin d|mesh-list
55719107|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
55719108|NCT02305927|Vitamins|vitamins|mesh-ancestor
55719109|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
55719110|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719111|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55744395|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55719112|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55719113|NCT02440009|Itraconazole|itraconazole|mesh-list
55719114|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
55719115|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
55719116|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719117|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55719118|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55719119|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719120|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719121|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55719122|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
55719123|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55719124|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719125|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55719127|NCT02318563|Cannabidiol|cannabidiol|mesh-list
55719128|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55719129|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
55719130|NCT02314195|Serotonin|serotonin|mesh-list
55719131|NCT02314195|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55719132|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55719133|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
55719134|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719135|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719136|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719137|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55719138|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55719139|NCT02314273|Oprelvekin|oprelvekin|mesh-list
55719140|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719141|NCT02314351|Fentanyl|fentanyl|mesh-list
55719142|NCT02314351|Metoclopramide|metoclopramide|mesh-list
55719143|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55719144|NCT02314351|Narcotics|narcotics|mesh-ancestor
55827646|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
55827647|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55827648|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55827649|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55827650|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
55827651|NCT01584232|Dulaglutide|dulaglutide|mesh-list
55827652|NCT01584232|Biguanides|biguanides|mesh-list
55827653|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55827654|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827655|NCT02119663|Capecitabine|capecitabine|mesh-list
55827656|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55827657|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
55827658|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827660|NCT04481009|Gemcitabine|gemcitabine|mesh-list
55719145|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719146|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719147|NCT02314351|Analgesics|analgesics|mesh-ancestor
55719148|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
55719149|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719150|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55719230|NCT02319343|Protective Agents|protective agents|mesh-ancestor
55719151|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55719152|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
55719153|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
55719154|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
55719155|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
55719156|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55719157|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55719158|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55719159|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
55719160|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719161|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719162|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
55719164|NCT04463875|Ubiquinone|ubiquinone|mesh-list
55719165|NCT04463875|Andrographolide|andrographolide|mesh-list
55719166|NCT04463875|Vitamins|vitamins|mesh-ancestor
55719167|NCT04463875|Micronutrients|micronutrients|mesh-ancestor
55719168|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719169|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
55719170|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55719171|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
55719172|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55719173|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55719174|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719176|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
55719177|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719178|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719179|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55719180|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55719181|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719182|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
55719183|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55719184|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
55719185|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55719187|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719188|NCT02306239|Terlipressin|terlipressin|mesh-list
55719189|NCT02306239|Norepinephrine|norepinephrine|mesh-list
55719190|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55719191|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55719192|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
55719193|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719194|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719195|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719196|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
55719197|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
55719198|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719199|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55719200|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55719201|NCT02319187|Irinotecan|irinotecan|mesh-list
55719202|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55719203|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55719204|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719205|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719206|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719207|NCT02319265|Melatonin|melatonin|mesh-list
55719208|NCT02319265|Antioxidants|antioxidants|mesh-ancestor
55719209|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719210|NCT02319265|Protective Agents|protective agents|mesh-ancestor
55719211|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719212|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719213|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
55719214|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55719215|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55719216|NCT02319343|Prednisolone|prednisolone|mesh-list
55719217|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
55719218|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55719219|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
55719220|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55719221|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
55719222|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
55719223|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719224|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719225|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55719226|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
55719227|NCT02319343|Hormones|hormones|mesh-ancestor
55719228|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55719229|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55719231|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55719232|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719233|NCT02319499|Vitamin A|vitamin a|mesh-list
55719235|NCT02319499|Zinc|zinc|mesh-list
55719236|NCT02319499|Vitamins|vitamins|mesh-ancestor
55719237|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
55719238|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719239|NCT02319499|Trace Elements|trace elements|mesh-ancestor
55719240|NCT03499639|Ritonavir|ritonavir|mesh-list
55719241|NCT03499639|Ribavirin|ribavirin|mesh-list
55719242|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55719243|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55719244|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
55719245|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719246|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719247|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55719248|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55719249|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
55719250|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719251|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55719252|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55719253|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
55719254|NCT03502135|Phenylephrine|phenylephrine|mesh-list
55719255|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
55719256|NCT03502135|Tetracaine|tetracaine|mesh-list
55719257|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
55719258|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
55719259|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719260|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719261|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
55719262|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719263|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55719264|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55719265|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
55719266|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719267|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719268|NCT03502135|Sympathomimetics|sympathomimetics|mesh-ancestor
55719269|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
55719270|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
55719271|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55719272|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
55719273|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55765804|NCT02069392|Nicotine|nicotine|mesh-list
55719287|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719288|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55719289|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719290|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55719291|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719292|NCT03132259|Dexmedetomidine|dexmedetomidine|mesh-list
55719293|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55719294|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719295|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719296|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719297|NCT03132259|Analgesics|analgesics|mesh-ancestor
55719298|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
55719299|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719300|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55719301|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55827689|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827690|NCT01583530|Belimumab|belimumab|mesh-list
55827691|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55827692|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
55827693|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827694|NCT01639001|Carboplatin|carboplatin|mesh-list
55827695|NCT01639001|Pemetrexed|pemetrexed|mesh-list
55827696|NCT01639001|Crizotinib|crizotinib|mesh-list
55827697|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827698|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827699|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719302|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55719303|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
55719304|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719305|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719306|NCT03499171|Citalopram|citalopram|mesh-list
55719307|NCT03499171|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55719308|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55719531|NCT03491371|Apatinib|apatinib|mesh-list
55719310|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719311|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719312|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
55719313|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719314|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55719315|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
55719316|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55719317|NCT02447419|Gefitinib|gefitinib|mesh-list
55719318|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719319|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55719320|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719321|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719322|NCT02319889|Paclitaxel|paclitaxel|mesh-list
55719323|NCT02319889|Carboplatin|carboplatin|mesh-list
55719324|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55719325|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55719326|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719327|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
55719328|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
55719329|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
55719330|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719332|NCT02324413|Analgesics|analgesics|mesh-ancestor
55719333|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
55719334|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719335|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719336|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55719337|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
55719338|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
55719339|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55719340|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55719341|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55719342|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
55719343|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719344|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719345|NCT03498703|Azathioprine|azathioprine|mesh-list
55719346|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
55719347|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719348|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55719349|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719350|NCT03498703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55719351|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
55719352|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719353|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719355|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55719356|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55719357|NCT02324491|Growth Substances|growth substances|mesh-ancestor
55719358|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719359|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
55719360|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719361|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55719362|NCT03494257|Brinzolamide|brinzolamide|mesh-list
55719363|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55719364|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55719365|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55719366|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55719367|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
55719368|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719369|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719370|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719371|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55719372|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719373|NCT03132181|Empagliflozin|empagliflozin|mesh-list
55719374|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55719375|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719376|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55719377|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719380|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719381|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55719382|NCT02320045|Incretins|incretins|mesh-ancestor
55719383|NCT02320045|Hormones|hormones|mesh-ancestor
55719384|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55719385|NCT02320357|Clopidogrel|clopidogrel|mesh-list
55719683|NCT02750345|Nitisinone|nitisinone|mesh-list
55719386|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55719387|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55719388|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55719389|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55719390|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
55719391|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719392|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719393|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719394|NCT03498235|Propofol|propofol|mesh-list
55719395|NCT03498235|Sevoflurane|sevoflurane|mesh-list
55719396|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55719397|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719398|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719399|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55719400|NCT03498235|Anesthetics, General|anesthetics, general|mesh-ancestor
55719401|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
55719402|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55719403|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55719404|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
55719405|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55719406|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
55719407|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719408|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
55719409|NCT03491761|Protective Agents|protective agents|mesh-ancestor
55719410|NCT05043805|Dextromethorphan|dextromethorphan|mesh-list
55719412|NCT05043805|Respiratory System Agents|respiratory system agents|mesh-ancestor
55719413|NCT05043805|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55719414|NCT05043805|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55719415|NCT05043805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719416|NCT05043805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719417|NCT05043805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719418|NCT03497923|Magnesium Sulfate|magnesium sulfate|mesh-list
55719420|NCT03497923|Sensory System Agents|sensory system agents|mesh-ancestor
55719421|NCT03497923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719422|NCT03497923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719423|NCT03497923|Anesthetics|anesthetics|mesh-ancestor
55719424|NCT03497923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719425|NCT03497923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55719426|NCT03497923|Anticonvulsants|anticonvulsants|mesh-ancestor
55719427|NCT03497923|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55719428|NCT03497923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55719429|NCT03497923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719430|NCT03497923|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55719431|NCT03497923|Tocolytic Agents|tocolytic agents|mesh-ancestor
55719432|NCT03497923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55719434|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
55719435|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
55719436|NCT03132103|Vitamins|vitamins|mesh-list
55719437|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
55719438|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719439|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55719440|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55719442|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55719443|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719444|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55719445|NCT04461925|Azithromycin|azithromycin|mesh-list
55719446|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
55719447|NCT04461925|Dexamethasone|dexamethasone|mesh-list
55719448|NCT04461925|Enoxaparin|enoxaparin|mesh-list
55719449|NCT04461925|Anticoagulants|anticoagulants|mesh-list
55719450|NCT04461925|Hormones|hormones|mesh-list
55719451|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55719452|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
55719453|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
55827817|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
55827818|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827819|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55827820|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55827821|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55719455|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719456|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55719457|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
55719458|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55719459|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55719460|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719461|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719462|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719463|NCT04461925|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55719464|NCT04461925|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55719465|NCT02325583|Midazolam|midazolam|mesh-list
55719466|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55719467|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55719468|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719469|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719470|NCT02325583|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55719471|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55719472|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55719473|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55719474|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
55719475|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
55719476|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
55719477|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
55719478|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719479|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719481|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55719482|NCT02321293|Gefitinib|gefitinib|mesh-list
55719483|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719484|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55719485|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719486|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719487|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55719488|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719489|NCT02321293|Analgesics|analgesics|mesh-ancestor
55719490|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
55719491|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719492|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719493|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55719494|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719495|NCT03491527|Salicylic Acid|salicylic acid|mesh-list
55827887|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55827888|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55827889|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827890|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827891|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55827904|NCT05387759|Aticaprant|aticaprant|mesh-list
55827924|NCT04721015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827925|NCT02222714|Protein C|protein c|mesh-list
55827926|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
55827927|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55827928|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55827929|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827930|NCT04809311|Insulin|insulin|mesh-list
55827931|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55719497|NCT03491527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719498|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719499|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719500|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55719501|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55719502|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719503|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
55719504|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
55719505|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827936|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55827937|NCT04809311|Hormones|hormones|mesh-ancestor
55827939|NCT04809311|Incretins|incretins|mesh-ancestor
55719516|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55719517|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
55719518|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
55719519|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719520|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719522|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
55719523|NCT04002037|Hormones|hormones|mesh-ancestor
55719524|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55719525|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55719526|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719527|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55719528|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
55719529|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719530|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719532|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719533|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55719534|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719535|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719536|NCT03546829|Vancomycin|vancomycin|mesh-list
55719537|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55719538|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719539|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
55719541|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55719542|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55719543|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55719544|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719545|NCT03284047|Cholinergic Agents|cholinergic agents|mesh-ancestor
55719547|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719548|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55719549|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719551|NCT05118685|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55719552|NCT05118685|Hormones|hormones|mesh-ancestor
55719553|NCT05118685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55719554|NCT05118685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719555|NCT03493087|Vitamin K|vitamin k|mesh-list
55719556|NCT03493087|Vitamins|vitamins|mesh-ancestor
55719557|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
55719558|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719559|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55827989|NCT04794569|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55827990|NCT04794569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55827991|NCT05651789|Propranolol|propranolol|mesh-list
55827992|NCT05651789|Carvedilol|carvedilol|mesh-list
55827993|NCT05651789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55719560|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55719561|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719562|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
55719564|NCT03136627|Nivolumab|nivolumab|mesh-list
55719565|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55719566|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719567|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55719568|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719569|NCT02922985|Acetaminophen|acetaminophen|mesh-list
55719570|NCT02922985|Ketorolac|ketorolac|mesh-list
55719571|NCT02922985|Bupivacaine|bupivacaine|mesh-list
55719572|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
55719573|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
55719574|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719575|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719576|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
55719577|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719578|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55719579|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719580|NCT02922985|Analgesics|analgesics|mesh-ancestor
55719581|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55719582|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719583|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55719584|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719585|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719586|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
55719587|NCT04881955|Ecopipam|ecopipam|mesh-list
55719588|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55719589|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55719590|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719591|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719592|NCT04881955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55719593|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55719594|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
55719595|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719596|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719597|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
55719598|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55719599|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
55719600|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55719601|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
55719602|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719603|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719604|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
55719605|NCT03492931|Ticagrelor|ticagrelor|mesh-list
55719606|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55719607|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55719608|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55828002|NCT05651789|Antioxidants|antioxidants|mesh-ancestor
55828003|NCT05651789|Protective Agents|protective agents|mesh-ancestor
55828004|NCT05651789|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55828005|NCT05651789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55719609|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55719611|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719612|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719613|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719614|NCT04715191|Cyclophosphamide|cyclophosphamide|mesh-list
55719615|NCT04715191|Fludarabine|fludarabine|mesh-list
55719616|NCT04715191|Fludarabine phosphate|fludarabine phosphate|mesh-list
55719617|NCT04715191|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55719618|NCT04715191|Immunologic Factors|immunologic factors|mesh-ancestor
55719619|NCT04715191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719620|NCT04715191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719621|NCT04715191|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55719622|NCT04715191|Alkylating Agents|alkylating agents|mesh-ancestor
55719623|NCT04715191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719624|NCT04715191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719625|NCT04715191|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55719626|NCT04715191|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55719627|NCT04715191|Antimetabolites|antimetabolites|mesh-ancestor
55719628|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
55719631|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
55719632|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719633|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55719634|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719635|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55719636|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
55719637|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719638|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719639|NCT02234921|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55719640|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55719641|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
55719642|NCT02321761|Amantadine|amantadine|mesh-list
55719645|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
55719646|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719647|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
55719648|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719649|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719650|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719651|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719653|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
55719654|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719655|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
55719656|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55719657|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719658|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719659|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719660|NCT04674241|Analgesics|analgesics|mesh-ancestor
55719661|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
55719662|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719663|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55719664|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55719665|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55719666|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
55719667|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719668|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719669|NCT02259647|Sorafenib|sorafenib|mesh-list
55719670|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719671|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55719672|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719673|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719674|NCT02321839|Ranibizumab|ranibizumab|mesh-list
55719676|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55719678|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719679|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
55719680|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719681|NCT03490279|Lactoferrin|lactoferrin|mesh-list
55719682|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719746|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55719747|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
55719748|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55719749|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55719750|NCT02749799|Glucocorticoids|glucocorticoids|mesh-ancestor
55719751|NCT02749799|Hormones|hormones|mesh-ancestor
55719752|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55765878|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55719753|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719754|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55719755|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
55719758|NCT03492775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55719759|NCT03492775|Alkylating Agents|alkylating agents|mesh-ancestor
55719760|NCT03492775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719761|NCT03492775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719762|NCT03492775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55719763|NCT03492541|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55719764|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55719765|NCT03492385|Ticagrelor|ticagrelor|mesh-list
55719766|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55719767|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55719768|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55719769|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55719770|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
55719771|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719772|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719773|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719774|NCT03736265|Carvedilol|carvedilol|mesh-list
55719775|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55719776|NCT03736265|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55719777|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
55719778|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719779|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719780|NCT03736265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719788|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55719789|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55719790|NCT04939363|Venetoclax|venetoclax|mesh-list
55719791|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
55719792|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719793|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55719794|NCT02236403|Metronidazole|metronidazole|mesh-list
55719795|NCT02236403|Ivermectin|ivermectin|mesh-list
55719796|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719797|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55719798|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55719799|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55719800|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55719801|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719803|NCT02934529|Folic Acid|folic acid|mesh-list
55719804|NCT02934529|Bevacizumab|bevacizumab|mesh-list
55719805|NCT02934529|Cetuximab|cetuximab|mesh-list
55719806|NCT02934529|Fluorouracil|fluorouracil|mesh-list
55719807|NCT02934529|Capecitabine|capecitabine|mesh-list
55719808|NCT02934529|Irinotecan|irinotecan|mesh-list
55719809|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
55719810|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55719811|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719812|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55719813|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55719814|NCT02934529|Growth Substances|growth substances|mesh-ancestor
55719815|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719816|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
55719817|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
55719818|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719819|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55719820|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55719821|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
55719822|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55719823|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55719824|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719825|NCT02934529|Antidotes|antidotes|mesh-ancestor
55719826|NCT02934529|Protective Agents|protective agents|mesh-ancestor
55719827|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
55719828|NCT02934529|Vitamins|vitamins|mesh-ancestor
55719829|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
55719874|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719875|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55719876|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719877|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55719878|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55719879|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719880|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55719881|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55719882|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719884|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55719885|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55719886|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55828116|NCT05647889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828117|NCT05647889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719888|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719889|NCT02262299|Pirfenidone|pirfenidone|mesh-list
55719890|NCT02262299|Analgesics|analgesics|mesh-ancestor
55719891|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
55719892|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719893|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719894|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55719895|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55719896|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55719897|NCT02262299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55719898|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719899|NCT02608697|Atorvastatin|atorvastatin|mesh-list
55719900|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55719901|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55719902|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
55719903|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719904|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55719905|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55719906|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719907|NCT02262455|Doxorubicin|doxorubicin|mesh-list
55719908|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55719909|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55719910|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719911|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55719912|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55719913|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719914|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719916|NCT02262533|Apixaban|apixaban|mesh-list
55719917|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55719918|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
55719919|NCT02262533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55719920|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
55719921|NCT02262533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719922|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719923|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
55719924|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55719925|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55719926|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
55719927|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
55719928|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719929|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719930|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55719931|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55719932|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55719933|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
55719934|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719935|NCT02262611|Telmisartan|telmisartan|mesh-list
55719936|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
55719937|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55719938|NCT02262611|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55719940|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719941|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55719942|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55719943|NCT02262611|Diuretics|diuretics|mesh-ancestor
55719944|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
55719945|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719947|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
55719948|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
55719949|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719950|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719951|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55719952|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
55719953|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55719954|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
55719955|NCT02589275|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55719957|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719958|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55719959|NCT02589275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55719960|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55719961|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55719962|NCT02580305|Memantine|memantine|mesh-list
55719963|NCT02580305|Donepezil|donepezil|mesh-list
55719964|NCT02580305|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1H-indole dimesylate monohydrate|1-((2-bromophenyl)sulfonyl)-5-methoxy-3-((4-methyl-1-piperazinyl)methyl)-1h-indole dimesylate monohydrate|mesh-list
55719965|NCT02580305|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55719966|NCT02580305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55719967|NCT02580305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55719968|NCT02580305|Cholinergic Agents|cholinergic agents|mesh-ancestor
55719969|NCT02580305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55719970|NCT02580305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719971|NCT02580305|Nootropic Agents|nootropic agents|mesh-ancestor
55719972|NCT02580305|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55719973|NCT02580305|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55719974|NCT02580305|Dopamine Agents|dopamine agents|mesh-ancestor
55719975|NCT02580305|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55719976|NCT02580305|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55719977|NCT02580305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55719979|NCT02515175|Vaccines|vaccines|mesh-list
55719980|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
55719981|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719982|NCT02513303|Sirolimus|sirolimus|mesh-list
55719983|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55719984|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55719985|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55719986|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719987|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
55719988|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55719989|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
55719990|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55719991|NCT01616303|Paclitaxel|paclitaxel|mesh-list
55719992|NCT01616303|Carboplatin|carboplatin|mesh-list
55719993|NCT01616303|Oregovomab|oregovomab|mesh-list
55719994|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55719995|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55719996|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
55719997|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
55719998|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
55720000|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55720002|NCT01590719|Folic Acid|folic acid|mesh-list
55720003|NCT01590719|Fluorouracil|fluorouracil|mesh-list
55720004|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
55720005|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
55720006|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
55720007|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720009|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720010|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720011|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
55720014|NCT01590719|Protective Agents|protective agents|mesh-ancestor
55720015|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
55720017|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
55720018|NCT01590719|Hematinics|hematinics|mesh-ancestor
55720019|NCT01536041|Montelukast|montelukast|mesh-list
55720020|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55720021|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
55720022|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55720023|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
55720024|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720026|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55720027|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55720028|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720029|NCT01534403|Epratuzumab|epratuzumab|mesh-list
55720030|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55720031|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720032|NCT01522469|Crenolanib|crenolanib|mesh-list
55720033|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720034|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
55720035|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55720036|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720037|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55720038|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55720040|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720041|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720042|NCT02264093|Propranolol|propranolol|mesh-list
55720043|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55720044|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55720045|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
55720046|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720047|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720048|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720049|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55720050|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55720051|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
55720052|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
55828119|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
55828120|NCT03943901|Rituximab|rituximab|mesh-list
55828121|NCT03943901|Doxorubicin|doxorubicin|mesh-list
55828122|NCT03943901|Vincristine|vincristine|mesh-list
55828123|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828124|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
55828125|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828126|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720053|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55720054|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55720055|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
55720056|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720057|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55720058|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
55720059|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720060|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
55720061|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720062|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720063|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55720064|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
55720065|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720066|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720067|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55720068|NCT01516073|Fluticasone|fluticasone|mesh-list
55720070|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720071|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55720072|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
55720073|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720074|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720076|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
55720077|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
55720078|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55720079|NCT01495247|Paclitaxel|paclitaxel|mesh-list
55720080|NCT01495247|Dactolisib|dactolisib|mesh-list
55720081|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55720082|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720083|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
55720084|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
55720085|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
55720086|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720087|NCT01495013|Glimepiride|glimepiride|mesh-list
55720088|NCT01495013|Atorvastatin|atorvastatin|mesh-list
55720089|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55720090|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55720091|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
55720092|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720093|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55828130|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828131|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55828132|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55828133|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55828134|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55828135|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55828136|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828137|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55828138|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
55720094|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55720095|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720096|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55720097|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55720098|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720099|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720100|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
55720103|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55720104|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55720106|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
55720107|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720108|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720109|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720110|NCT02264171|Urological Agents|urological agents|mesh-ancestor
55720111|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
55720112|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720113|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55720114|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55720115|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720116|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55720117|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
55720118|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720119|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55720120|NCT01481051|Latanoprost|latanoprost|mesh-list
55720122|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55720123|NCT01480583|Alovudine|alovudine|mesh-list
55720124|NCT01480583|Trastuzumab|trastuzumab|mesh-list
55720125|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55720127|NCT01480583|Antiviral Agents|antiviral agents|mesh-ancestor
55720128|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720129|NCT01470131|Dexamethasone|dexamethasone|mesh-list
55720130|NCT01470131|Bortezomib|bortezomib|mesh-list
55720131|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720132|NCT01470131|Antiemetics|antiemetics|mesh-ancestor
55720133|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
55720134|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720135|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720136|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55720137|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
55720138|NCT01470131|Hormones|hormones|mesh-ancestor
55765918|NCT02099110|Incretins|incretins|mesh-ancestor
55720139|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720141|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720144|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720145|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55720146|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720147|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720148|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55720150|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
55720151|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720152|NCT01464437|Metformin|metformin|mesh-list
55720153|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55720154|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720155|NCT01461317|Etrolizumab|etrolizumab|mesh-list
55720156|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55720157|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
55720158|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720160|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55720161|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720162|NCT01445795|Ribavirin|ribavirin|mesh-list
55720163|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
55720164|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720165|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
55720166|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720167|NCT02264795|Lidocaine|lidocaine|mesh-list
55720168|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
55720169|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
55720170|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720171|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720172|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
55720173|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720174|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55720175|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55720176|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55720177|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55720178|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720179|NCT02264873|Decitabine|decitabine|mesh-list
55720180|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55720181|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
55720182|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720183|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720184|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720185|NCT00156533|Zolpidem|zolpidem|mesh-list
55720186|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55720187|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55720188|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720189|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720190|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55720191|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
55720192|NCT00156533|GABA Agents|gaba agents|mesh-ancestor
55720193|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720194|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720195|NCT01410695|Methotrexate|methotrexate|mesh-list
55720196|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55720197|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
55720198|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55720199|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720200|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55720201|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
55720202|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720203|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720204|NCT01410695|Dermatologic Agents|dermatologic agents|mesh-ancestor
55720205|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720206|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55720207|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720208|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
55720209|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720210|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55720211|NCT01660022|Piperaquine|piperaquine|mesh-list
55720212|NCT01660022|Artefenomel|artefenomel|mesh-list
55720213|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
55720214|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55720215|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55720216|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720217|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
55720218|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55720219|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
55720220|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720221|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
55720222|NCT02265575|Protective Agents|protective agents|mesh-ancestor
55720224|NCT02265731|Venetoclax|venetoclax|mesh-list
55720225|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55720226|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720227|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
55720228|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720229|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720230|NCT02265809|Aldesleukin|aldesleukin|mesh-list
55720231|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720232|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55720234|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
55720235|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720236|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
55720237|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55720238|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
55720239|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720241|NCT01372475|Protective Agents|protective agents|mesh-ancestor
55720242|NCT00156065|Haloperidol|haloperidol|mesh-list
55720243|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
55720244|NCT00156065|Asenapine|asenapine|mesh-list
55720245|NCT00156065|Antiemetics|antiemetics|mesh-ancestor
55720246|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
55720247|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720248|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720249|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55720250|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55720251|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55720252|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720253|NCT00156065|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55720254|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55720255|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
55720256|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720257|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720258|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55720259|NCT04476173|Morphine|morphine|mesh-list
55720260|NCT04476173|Methoxyflurane|methoxyflurane|mesh-list
55720261|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55720262|NCT04476173|Narcotics|narcotics|mesh-ancestor
55720263|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720264|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720265|NCT04476173|Analgesics|analgesics|mesh-ancestor
55720266|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
55720267|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720268|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55720269|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
55720270|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
55720271|NCT01554956|Plasminogen|plasminogen|mesh-list
55720272|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55720273|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55720274|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720275|NCT01360853|Gemcitabine|gemcitabine|mesh-list
55720276|NCT01360853|ON 01910|on 01910|mesh-list
55720277|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55720278|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
55720279|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720280|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720281|NCT01360853|Antiviral Agents|antiviral agents|mesh-ancestor
55720282|NCT01360853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720283|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720284|NCT01360853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720285|NCT01360853|Immunologic Factors|immunologic factors|mesh-ancestor
55720286|NCT01360853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720287|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55720288|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
55720290|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
55720291|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720292|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
55720293|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720294|NCT02266355|Omalizumab|omalizumab|mesh-list
55720295|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55720296|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55720297|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
55720298|NCT01348919|Dexamethasone|dexamethasone|mesh-list
55720299|NCT01348919|Lenalidomide|lenalidomide|mesh-list
55720300|NCT01348919|Delanzomib|delanzomib|mesh-list
55720301|NCT01348919|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720302|NCT01348919|Antiemetics|antiemetics|mesh-ancestor
55720303|NCT01348919|Autonomic Agents|autonomic agents|mesh-ancestor
55720304|NCT01348919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720305|NCT01348919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720306|NCT01348919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55720309|NCT01348919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720310|NCT01348919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55720311|NCT01348919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720312|NCT01348919|Immunologic Factors|immunologic factors|mesh-ancestor
55720313|NCT01348919|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55720314|NCT01348919|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55720315|NCT01348919|Growth Substances|growth substances|mesh-ancestor
55720316|NCT01348919|Growth Inhibitors|growth inhibitors|mesh-ancestor
55720317|NCT01348919|Proteasome Inhibitors|proteasome inhibitors|mesh-ancestor
55720318|NCT01348919|Protease Inhibitors|protease inhibitors|mesh-ancestor
55720319|NCT01348919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720320|NCT01348919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720322|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55720323|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55720324|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55720325|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
55720326|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720327|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720328|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720329|NCT02266511|Urological Agents|urological agents|mesh-ancestor
55720330|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
55720331|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720332|NCT01330979|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55720333|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55720334|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55720404|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720405|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55720406|NCT05177939|Protective Agents|protective agents|mesh-ancestor
55720407|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55720408|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720409|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
55720410|NCT05174507|Empagliflozin|empagliflozin|mesh-list
55720411|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55720412|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55720413|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720414|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55720415|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720416|NCT05174507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720417|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
55720418|NCT01480154|Antimalarials|antimalarials|mesh-ancestor
55720419|NCT01480154|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55720420|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55720421|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720422|NCT01480154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720423|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720424|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720425|NCT02267915|Rituximab|rituximab|mesh-list
55720426|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55720427|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720428|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
55720429|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720430|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720431|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
55720432|NCT02268149|Prednisone|prednisone|mesh-list
55720433|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720434|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
55720435|NCT02268149|Hormones|hormones|mesh-ancestor
55720436|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720437|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720438|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55720439|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720440|NCT01258907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55720442|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720445|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
55720446|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55720447|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55720448|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
55720450|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720451|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720452|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55720453|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55720454|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
55720455|NCT01255709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720456|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55720457|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
55720458|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
55720459|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
55720460|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55720461|NCT02233907|Oxitropium|oxitropium|mesh-list
55720462|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
55720463|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
55720464|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720465|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720466|NCT01253603|Fluticasone|fluticasone|mesh-list
55720468|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
55720469|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720470|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55720471|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
55720472|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720473|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720474|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55720475|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
55720476|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
55720477|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55720478|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
55720479|NCT01253603|Growth Substances|growth substances|mesh-ancestor
55720480|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
55720481|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720483|NCT02268383|Hematinics|hematinics|mesh-ancestor
55720484|NCT01329419|Adefovir|adefovir|mesh-list
55720520|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720521|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720522|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55828180|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55828181|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55720523|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720524|NCT01207115|Gout Suppressants|gout suppressants|mesh-ancestor
55720525|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55720526|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828182|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
55828183|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828184|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828185|NCT03877289|Urological Agents|urological agents|mesh-ancestor
55828186|NCT02530463|Nivolumab|nivolumab|mesh-list
55828187|NCT02530463|Ipilimumab|ipilimumab|mesh-list
55828188|NCT02530463|Azacitidine|azacitidine|mesh-list
55828189|NCT02530463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55720527|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720528|NCT01186991|Paclitaxel|paclitaxel|mesh-list
55720529|NCT01186991|Bevacizumab|bevacizumab|mesh-list
55720530|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55720531|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55720532|NCT01186991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720533|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
55720534|NCT01186991|Antimitotic Agents|antimitotic agents|mesh-ancestor
55720535|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
55720536|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720537|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55720538|NCT01186991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55720539|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55720540|NCT01186991|Growth Substances|growth substances|mesh-ancestor
55720541|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720542|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
55720543|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
55720544|NCT02268773|Aspirin|aspirin|mesh-list
55720545|NCT02268773|Dipyridamole|dipyridamole|mesh-list
55720546|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
55720547|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55720548|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55720549|NCT02268773|Analgesics|analgesics|mesh-ancestor
55720550|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
55720551|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720552|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720553|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720554|NCT02268773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720555|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55720556|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55720557|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720558|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55720559|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55720560|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720561|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
55720562|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55720563|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
55720564|NCT01183949|Bortezomib|bortezomib|mesh-list
55720565|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720566|NCT01092065|Levodopa|levodopa|mesh-list
55720567|NCT01092065|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55720568|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55720569|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
55720570|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720571|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720572|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720573|NCT05626829|Tranilast|tranilast|mesh-list
55720574|NCT05626829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55720575|NCT05626829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55720576|NCT05626829|Analgesics|analgesics|mesh-ancestor
55720577|NCT05626829|Sensory System Agents|sensory system agents|mesh-ancestor
55720578|NCT05626829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720579|NCT05626829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720580|NCT05626829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720581|NCT05626829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720582|NCT05626829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55720583|NCT05626829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55720661|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
55720584|NCT05626829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720585|NCT05626829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55720587|NCT05626829|Histamine Antagonists|histamine antagonists|mesh-ancestor
55828220|NCT01634555|Irinotecan|irinotecan|mesh-list
55828221|NCT01634555|Ramucirumab|ramucirumab|mesh-list
55720588|NCT05626829|Histamine Agents|histamine agents|mesh-ancestor
55720589|NCT05626829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720590|NCT05626829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55720591|NCT05626829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55720592|NCT01173497|Irinotecan|irinotecan|mesh-list
55720593|NCT01173497|Iniparib|iniparib|mesh-list
55720594|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55720595|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55720596|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720597|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720598|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720599|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55720600|NCT01171313|Carbidopa|carbidopa|mesh-list
55720601|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55720602|NCT01171313|Levodopa|levodopa|mesh-list
55720603|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55720604|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55720605|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
55720606|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720607|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720608|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720609|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55720610|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720611|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55720612|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
55720613|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
55720614|NCT02269319|Linezolid|linezolid|mesh-list
55720615|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55720616|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720617|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55720618|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720619|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720620|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
55720621|NCT01071239|Busulfan|busulfan|mesh-list
55720622|NCT01071239|Fludarabine|fludarabine|mesh-list
55720623|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720624|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
55720625|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720626|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720627|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55720628|NCT01071239|Alkylating Agents|alkylating agents|mesh-ancestor
55720629|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720630|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720631|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55720632|NCT01156415|S 20098|s 20098|mesh-list
55720633|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55720634|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720635|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720637|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55720638|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
55720639|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720640|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
55720641|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720642|NCT01027013|Rebamipide|rebamipide|mesh-list
55720643|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55720644|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55720645|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55720646|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55720647|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
55720648|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720649|NCT01027013|Protective Agents|protective agents|mesh-ancestor
55720650|NCT01027013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720651|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720652|NCT01138163|Docetaxel|docetaxel|mesh-list
55720653|NCT01138163|Bavituximab|bavituximab|mesh-list
55720654|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720656|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
55720658|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720659|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55720660|NCT01022801|Entecavir|entecavir|mesh-list
55720662|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720663|NCT05628467|Antidepressive Agents|antidepressive agents|mesh-list
55720664|NCT05628467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55720665|NCT05628389|Nicotine|nicotine|mesh-list
55720666|NCT05628389|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55720667|NCT05628389|Autonomic Agents|autonomic agents|mesh-ancestor
55720668|NCT05628389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720669|NCT05628389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720670|NCT05628389|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55720671|NCT05628389|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55720672|NCT05628389|Cholinergic Agents|cholinergic agents|mesh-ancestor
55720674|NCT05628389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720675|NCT01128335|Tacrolimus|tacrolimus|mesh-list
55720676|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720677|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
55720678|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720679|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55720680|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720681|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720682|NCT01012895|Interferons|interferons|mesh-list
55720683|NCT01012895|Ribavirin|ribavirin|mesh-list
55720684|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
55720685|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
55720686|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55720687|NCT01012895|Asunaprevir|asunaprevir|mesh-list
55720688|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720689|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
55720690|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720691|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
55720692|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720693|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
55720694|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720695|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
55720696|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720697|NCT01009775|Docetaxel|docetaxel|mesh-list
55720698|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720699|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
55720700|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
55720701|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
55720702|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720703|NCT02319148|Itraconazole|itraconazole|mesh-list
55720704|NCT02319148|Verapamil|verapamil|mesh-list
55720705|NCT02319148|Diltiazem|diltiazem|mesh-list
55720706|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
55720707|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720708|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55720709|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55720710|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720711|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720712|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55720713|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
55720714|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720715|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720717|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55720718|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55720719|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55720720|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55720721|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
55720722|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55720723|NCT02526212|Buprenorphine|buprenorphine|mesh-list
55720724|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55720725|NCT02526212|Narcotics|narcotics|mesh-ancestor
55720726|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720727|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720728|NCT02526212|Analgesics|analgesics|mesh-ancestor
55720729|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
55720730|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720731|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55720732|NCT05627843|Curcumin|curcumin|mesh-list
55720733|NCT05627843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55720734|NCT05627843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55720735|NCT05627843|Analgesics|analgesics|mesh-ancestor
55720736|NCT05627843|Sensory System Agents|sensory system agents|mesh-ancestor
55720737|NCT05627843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720738|NCT05627843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720816|NCT01745588|Dexamethasone|dexamethasone|mesh-list
55720739|NCT05627843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720740|NCT05627843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720741|NCT05627843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720742|NCT05627843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720743|NCT05627843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720744|NCT01004081|Exemestane|exemestane|mesh-list
55720745|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720746|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55720747|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55720748|NCT01004081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720749|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720750|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55720751|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
55720752|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720753|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720755|NCT05401916|Ibuprofen|ibuprofen|mesh-list
55720756|NCT05401916|Tramadol|tramadol|mesh-list
55720757|NCT05401916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55720758|NCT05401916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55720759|NCT05401916|Analgesics|analgesics|mesh-ancestor
55720760|NCT05401916|Sensory System Agents|sensory system agents|mesh-ancestor
55720761|NCT05401916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720762|NCT05401916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720763|NCT05401916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720764|NCT05401916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720765|NCT05401916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55720766|NCT05401916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720767|NCT05401916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720769|NCT05401916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55720770|NCT05401916|Narcotics|narcotics|mesh-ancestor
55720771|NCT05401916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720772|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
55720773|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55720774|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
55720775|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720776|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720778|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
55720779|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55720780|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55720781|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55720782|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
55720783|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720784|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720785|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55720786|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
55720787|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720788|NCT05401214|Prednisone|prednisone|mesh-list
55720789|NCT05401214|Prednisolone|prednisolone|mesh-list
55720790|NCT05401214|Abiraterone Acetate|abiraterone acetate|mesh-list
55720791|NCT05401214|Niraparib|niraparib|mesh-list
55720792|NCT05401214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55766036|NCT03180125|Lidocaine|lidocaine|mesh-list
55720793|NCT05401214|Glucocorticoids|glucocorticoids|mesh-ancestor
55720795|NCT05401214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55720796|NCT05401214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720797|NCT05401214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55720798|NCT05401214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720799|NCT05401214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55720800|NCT05401214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720801|NCT05401214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720802|NCT05401214|Hormone Antagonists|hormone antagonists|mesh-ancestor
55720803|NCT05401214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55720804|NCT05401214|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55720806|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55720807|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
55720808|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720809|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720810|NCT02532374|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55720811|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55720812|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
55720813|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720814|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720815|NCT01745588|Clarithromycin|clarithromycin|mesh-list
55720833|NCT01745588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720834|NCT01745588|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55720835|NCT01745588|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55720836|NCT01745588|Immunologic Factors|immunologic factors|mesh-ancestor
55720837|NCT01745588|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55720838|NCT01745588|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55720839|NCT01745588|Growth Substances|growth substances|mesh-ancestor
55720840|NCT01745588|Growth Inhibitors|growth inhibitors|mesh-ancestor
55720841|NCT05398874|Acetaminophen|acetaminophen|mesh-list
55720842|NCT05398874|Diclofenac|diclofenac|mesh-list
55720843|NCT05398874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55720845|NCT05398874|Sensory System Agents|sensory system agents|mesh-ancestor
55720846|NCT05398874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720847|NCT05398874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720848|NCT05398874|Antipyretics|antipyretics|mesh-ancestor
55720849|NCT05398874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55720850|NCT05398874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720851|NCT05398874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720852|NCT05398874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55720853|NCT05398874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720854|NCT05398874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720855|NCT01281176|Paclitaxel|paclitaxel|mesh-list
55720856|NCT01281176|Carboplatin|carboplatin|mesh-list
55720857|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55720858|NCT01281176|Vorinostat|vorinostat|mesh-list
55720859|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55720860|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720861|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
55720862|NCT01281176|Antimitotic Agents|antimitotic agents|mesh-ancestor
55720863|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
55720864|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720865|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55720866|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720867|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
55720868|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55720869|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720870|NCT05360732|Folfirinox|folfirinox|mesh-list
55828274|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
55828275|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720871|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720872|NCT00152477|Paclitaxel|paclitaxel|mesh-list
55720873|NCT00152477|Carboplatin|carboplatin|mesh-list
55720874|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55720875|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720876|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
55720877|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
55720878|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
55720879|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720880|NCT01111955|Metformin|metformin|mesh-list
55720881|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55720882|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720883|NCT01106807|Adapalene|adapalene|mesh-list
55720884|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
55720885|NCT01106807|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55720886|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
55720887|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55720888|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55720890|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
55720891|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720892|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720893|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55720894|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55720895|NCT05533229|Fentanyl|fentanyl|mesh-list
55720896|NCT05533229|Morphine|morphine|mesh-list
55720897|NCT05533229|Bupivacaine|bupivacaine|mesh-list
55720898|NCT05533229|Anesthetics, Local|anesthetics, local|mesh-ancestor
55720899|NCT05533229|Anesthetics|anesthetics|mesh-ancestor
55720900|NCT05533229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55720901|NCT05533229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720902|NCT05533229|Sensory System Agents|sensory system agents|mesh-ancestor
55720903|NCT05533229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720904|NCT05533229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55720905|NCT05533229|Narcotics|narcotics|mesh-ancestor
55720906|NCT05533229|Analgesics|analgesics|mesh-ancestor
55720907|NCT05533229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55720908|NCT05533229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55720945|NCT02289898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720946|NCT05355974|Norepinephrine|norepinephrine|mesh-list
55720947|NCT05355974|Plasma-lyte 148|plasma-lyte 148|mesh-list
55720948|NCT05355974|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55720950|NCT05355974|Adrenergic Agents|adrenergic agents|mesh-ancestor
55720951|NCT05355974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55720952|NCT05355974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720953|NCT05355974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720954|NCT05355974|Sympathomimetics|sympathomimetics|mesh-ancestor
55720955|NCT05355974|Autonomic Agents|autonomic agents|mesh-ancestor
55720956|NCT05355974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55720957|NCT05355974|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55720958|NCT05355974|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55720959|NCT05355974|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55720960|NCT01659554|Cisplatin|cisplatin|mesh-list
55720961|NCT01659554|Doxorubicin|doxorubicin|mesh-list
55720962|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55720963|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720964|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55720965|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55720966|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55720967|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720968|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720969|NCT05355350|Meropenem|meropenem|mesh-list
55720970|NCT05355350|Tazobactam|tazobactam|mesh-list
55720971|NCT05355350|Piperacillin|piperacillin|mesh-list
55720972|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55720973|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55720974|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720975|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55720976|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55720977|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720978|NCT01054196|Lenalidomide|lenalidomide|mesh-list
55720979|NCT01054196|Melphalan|melphalan|mesh-list
55720980|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
55720981|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55720982|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55720983|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55720985|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
55720986|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55720987|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55720988|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
55720989|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55720990|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55720991|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55720992|NCT01659320|Minocycline|minocycline|mesh-list
55720993|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55720994|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55720995|NCT05354102|Nivolumab|nivolumab|mesh-list
55720996|NCT05354102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55720998|NCT05354102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55828289|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828290|NCT03800693|Antidotes|antidotes|mesh-ancestor
55828291|NCT03800693|Protective Agents|protective agents|mesh-ancestor
55828292|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
55720999|NCT05354102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721000|NCT05414084|Phenol|phenol|mesh-list
55721001|NCT05414084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55721002|NCT05414084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721003|NCT05414084|Disinfectants|disinfectants|mesh-ancestor
55721004|NCT05414084|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55721005|NCT05414084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55828293|NCT03800693|Vitamins|vitamins|mesh-ancestor
55828294|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
55828295|NCT04814537|Bupivacaine|bupivacaine|mesh-list
55828296|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
55828297|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
55721019|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721021|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
55721022|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721023|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721024|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55721025|NCT01660256|Rebamipide|rebamipide|mesh-list
55721026|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55721027|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721028|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
55721029|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721030|NCT01660256|Protective Agents|protective agents|mesh-ancestor
55721031|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721032|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721033|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55721034|NCT04968938|Hallucinogens|hallucinogens|mesh-ancestor
55721035|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721036|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55721037|NCT04968938|Serotonin Agents|serotonin agents|mesh-ancestor
55721038|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721039|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721040|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55721041|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55721042|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55721043|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
55721044|NCT05412758|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
55721045|NCT05412758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721046|NCT02330367|Abivertinib|abivertinib|mesh-list
55721047|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55721048|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766067|NCT03180281|Hormones|hormones|mesh-ancestor
55721049|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721051|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
55721052|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
55721053|NCT05077215|Lenvatinib|lenvatinib|mesh-list
55721054|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55721055|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721056|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55721057|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721058|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721059|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55721060|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55721061|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55721062|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55721063|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721065|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721066|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
55721067|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55721068|NCT05559008|Azacitidine|azacitidine|mesh-list
55721069|NCT05559008|Apatinib|apatinib|mesh-list
55721070|NCT05559008|Dasatinib|dasatinib|mesh-list
55721071|NCT05559008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55721072|NCT05559008|Antimetabolites|antimetabolites|mesh-ancestor
55721073|NCT05559008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721074|NCT05559008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721075|NCT05559008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721076|NCT05559008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55721077|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55721078|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721079|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55721080|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721081|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721082|NCT05053425|Cytarabine|cytarabine|mesh-list
55721083|NCT05053425|Azacitidine|azacitidine|mesh-list
55721084|NCT05053425|Venetoclax|venetoclax|mesh-list
55721085|NCT05053425|Idarubicin|idarubicin|mesh-list
55721086|NCT05053425|Cladribine|cladribine|mesh-list
55721087|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55721088|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
55721089|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721090|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721091|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
55721092|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721093|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55721094|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
55721095|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721096|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721097|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55721098|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55721099|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55721101|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55721102|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721103|NCT05350124|Vitamins|vitamins|mesh-list
55721216|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721217|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
55721218|NCT04662723|Hormones|hormones|mesh-ancestor
55721219|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721220|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55828362|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
55721221|NCT04662723|Protective Agents|protective agents|mesh-ancestor
55721222|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55721223|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721224|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721225|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55721226|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55721227|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55721228|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55721229|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55721230|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55721231|NCT04662723|Protease Inhibitors|protease inhibitors|mesh-ancestor
55721232|NCT04662723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721233|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55721235|NCT05340764|Dermatologic Agents|dermatologic agents|mesh-ancestor
55721236|NCT05340764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721237|NCT05340764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55721238|NCT05307926|Lenvatinib|lenvatinib|mesh-list
55721239|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55721240|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721241|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55721242|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721243|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721244|NCT05610800|Exenatide|exenatide|mesh-list
55721245|NCT05610800|Nicotine|nicotine|mesh-list
55721246|NCT05610800|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55721247|NCT05610800|Autonomic Agents|autonomic agents|mesh-ancestor
55721248|NCT05610800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721249|NCT05610800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721250|NCT05610800|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55721251|NCT05610800|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55721252|NCT05610800|Cholinergic Agents|cholinergic agents|mesh-ancestor
55721253|NCT05610800|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721254|NCT05610800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721255|NCT05610800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55721256|NCT05610800|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55721257|NCT05610800|Incretins|incretins|mesh-ancestor
55721258|NCT05610800|Hormones|hormones|mesh-ancestor
55721259|NCT05610800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721260|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
55721261|NCT04248452|Leucovorin|leucovorin|mesh-list
55721262|NCT04248452|Folic Acid|folic acid|mesh-list
55721263|NCT04248452|Fluorouracil|fluorouracil|mesh-list
55721264|NCT04248452|Capecitabine|capecitabine|mesh-list
55721265|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
55721266|NCT04248452|Calcium|calcium|mesh-list
55721267|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
55721268|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55721269|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721270|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55721271|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
55721272|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721273|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55721274|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721275|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55721276|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
55721277|NCT04248452|Antidotes|antidotes|mesh-ancestor
55721278|NCT04248452|Protective Agents|protective agents|mesh-ancestor
55721279|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
55721281|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
55721282|NCT04248452|Hematinics|hematinics|mesh-ancestor
55721283|NCT04026945|Lidocaine|lidocaine|mesh-list
55721284|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
55721286|NCT04026945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55721287|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721288|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
55721289|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721290|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55721291|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55721293|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55721518|NCT02328183|Polymyxin B|polymyxin b|mesh-list
55721294|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721295|NCT02328729|Epinephrine|epinephrine|mesh-list
55721296|NCT02328729|Racepinephrine|racepinephrine|mesh-list
55721297|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
55721298|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55721299|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55721300|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
55721301|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721302|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721303|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721304|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55721305|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55721306|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
55721307|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721308|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55721309|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
55721310|NCT02328729|Mydriatics|mydriatics|mesh-ancestor
55721311|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
55721312|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55721313|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
55721315|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721316|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55721317|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
55721318|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721319|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55721320|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55721321|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
55721322|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55721323|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55766099|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
55721324|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721325|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721326|NCT03520647|Cyclophosphamide|cyclophosphamide|mesh-list
55721327|NCT03520647|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55721328|NCT03520647|Immunologic Factors|immunologic factors|mesh-ancestor
55721329|NCT03520647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721330|NCT03520647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55721331|NCT03520647|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55721332|NCT03520647|Alkylating Agents|alkylating agents|mesh-ancestor
55721333|NCT03520647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721334|NCT03520647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721335|NCT03520647|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55721336|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
55721337|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55828395|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828396|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828398|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
55721339|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721341|NCT03353259|Coagulants|coagulants|mesh-ancestor
55721342|NCT04478721|Meropenem|meropenem|mesh-list
55721343|NCT04478721|Temocillin|temocillin|mesh-list
55721344|NCT04478721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55721345|NCT04478721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721346|NCT02328651|Ribavirin|ribavirin|mesh-list
55721347|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
55721348|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721349|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
55721350|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721351|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55721352|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55721353|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55721354|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55721355|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55721356|NCT02289352|Adrenergic Agents|adrenergic agents|mesh-ancestor
55721357|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721358|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721359|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721360|NCT05337566|Azithromycin|azithromycin|mesh-list
55721361|NCT05337566|Cefuroxime|cefuroxime|mesh-list
55721362|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
55721363|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55721364|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721365|NCT02328495|Misoprostol|misoprostol|mesh-list
55721366|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55721367|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
55721368|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55721369|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721370|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55721371|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721372|NCT02328495|Oxytocics|oxytocics|mesh-ancestor
55721373|NCT04886986|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55721374|NCT04886986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55721375|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721376|NCT02287402|Voglibose|voglibose|mesh-list
55721377|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55721378|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721379|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55721380|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721381|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721382|NCT05384756|Sirolimus|sirolimus|mesh-list
55721383|NCT05384756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55721384|NCT05384756|Alemtuzumab|alemtuzumab|mesh-list
55721385|NCT05384756|Antibodies|antibodies|mesh-list
55721386|NCT05384756|Immunoglobulins|immunoglobulins|mesh-list
55721387|NCT05384756|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55721388|NCT05384756|Immunologic Factors|immunologic factors|mesh-ancestor
55721389|NCT05384756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721390|NCT05384756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721391|NCT05384756|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55721392|NCT05384756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721393|NCT05384756|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55721394|NCT05384756|Antifungal Agents|antifungal agents|mesh-ancestor
55721395|NCT05384756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828427|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828428|NCT03624101|Ivacaftor|ivacaftor|mesh-list
55828429|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55828432|NCT02218736|Aticaprant|aticaprant|mesh-list
55721396|NCT02913495|Progesterone|progesterone|mesh-list
55721397|NCT02913495|Progestins|progestins|mesh-ancestor
55721398|NCT02913495|Hormones|hormones|mesh-ancestor
55721399|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721400|NCT02913495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721401|NCT03111069|Doxorubicin|doxorubicin|mesh-list
55721402|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55721403|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55721404|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721405|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55721406|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55721407|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721408|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721409|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55721410|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55721411|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
55721412|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721413|NCT03110757|Antacids|antacids|mesh-ancestor
55721414|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721415|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721416|NCT05303792|Cytarabine|cytarabine|mesh-list
55721417|NCT05303792|Dexamethasone|dexamethasone|mesh-list
55721418|NCT05303792|Prednisone|prednisone|mesh-list
55721419|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
55721420|NCT05303792|Cyclophosphamide|cyclophosphamide|mesh-list
55721421|NCT05303792|Rituximab|rituximab|mesh-list
55721422|NCT05303792|Doxorubicin|doxorubicin|mesh-list
55721423|NCT05303792|Methotrexate|methotrexate|mesh-list
55721424|NCT05303792|Vincristine|vincristine|mesh-list
55721425|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
55721426|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
55721427|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55721428|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
55721429|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721430|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55721431|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55721432|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
55721433|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721434|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721435|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55721436|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55721437|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55721438|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
55721439|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
55721440|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721441|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721442|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
55721444|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721445|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55721446|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55721447|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55721448|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55721449|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721450|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55721451|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
55721452|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55721453|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55828443|NCT04801589|Midazolam|midazolam|mesh-list
55721454|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
55721455|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
55721456|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55721457|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55721458|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
55721459|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721460|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55721461|NCT05303792|Tubulin Modulators|tubulin modulators|mesh-ancestor
55721462|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
55721463|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
55721464|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55721465|NCT05303792|Protective Agents|protective agents|mesh-ancestor
55721466|NCT05080569|Progesterone|progesterone|mesh-list
55721467|NCT05080569|Progestins|progestins|mesh-ancestor
55721468|NCT05080569|Hormones|hormones|mesh-ancestor
55721469|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721471|NCT03145467|Acetaminophen|acetaminophen|mesh-list
55721472|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
55721473|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55721474|NCT03145467|Analgesics|analgesics|mesh-ancestor
55721475|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
55721476|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721477|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721478|NCT03145467|Antipyretics|antipyretics|mesh-ancestor
55721479|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55721480|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55721481|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
55721482|NCT03145467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721483|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721484|NCT05302856|Antibodies|antibodies|mesh-list
55721485|NCT05302856|Testosterone|testosterone|mesh-list
55721486|NCT05302856|Immunologic Factors|immunologic factors|mesh-ancestor
55721487|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721488|NCT05302856|Androgens|androgens|mesh-ancestor
55721489|NCT05302856|Hormones|hormones|mesh-ancestor
55721490|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721491|NCT04022967|Ritonavir|ritonavir|mesh-list
55721492|NCT04022967|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55721493|NCT04022967|Tenofovir|tenofovir|mesh-list
55721494|NCT04022967|Lamivudine|lamivudine|mesh-list
55721495|NCT04022967|Dolutegravir|dolutegravir|mesh-list
55721496|NCT04022967|Efavirenz|efavirenz|mesh-list
55721497|NCT04022967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55721498|NCT04022967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55721499|NCT04022967|Protease Inhibitors|protease inhibitors|mesh-ancestor
55721500|NCT04022967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721501|NCT04022967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721502|NCT04022967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55721503|NCT04022967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55721504|NCT04022967|Antiviral Agents|antiviral agents|mesh-ancestor
55721505|NCT04022967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721506|NCT04022967|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55721507|NCT04022967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55721508|NCT04022967|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55721509|NCT04022967|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55721510|NCT04022967|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55721511|NCT04022967|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55721512|NCT04022967|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55721513|NCT04022967|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55721514|NCT04022967|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55721515|NCT04022967|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55721516|NCT04022967|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55721519|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55721520|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721522|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55721524|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721525|NCT05382104|Maribavir|maribavir|mesh-list
55721526|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
55721527|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55721528|NCT01646320|Metformin|metformin|mesh-list
55828455|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
55721529|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
55721530|NCT01646320|Saxagliptin|saxagliptin|mesh-list
55721531|NCT01646320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55721532|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721533|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55721534|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721536|NCT01646320|Hormones|hormones|mesh-ancestor
55721537|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721538|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55721539|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
55828456|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828457|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828458|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55828459|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55721546|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721547|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
55721548|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
55721549|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55721550|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
55721551|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721552|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721553|NCT03141645|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55721554|NCT03141645|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55721555|NCT03141645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55721556|NCT03141645|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55721557|NCT03141645|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55721558|NCT05330858|Rabeprazole|rabeprazole|mesh-list
55721559|NCT05330858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55721560|NCT05330858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721561|NCT05330858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55721562|NCT05330858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721563|NCT05330858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721570|NCT05327426|Vaccines|vaccines|mesh-list
55721571|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
55721572|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721573|NCT05327270|Nivolumab|nivolumab|mesh-list
55721574|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55721575|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721576|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55721577|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721578|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
55721579|NCT05297396|Narcotics|narcotics|mesh-ancestor
55721580|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55721581|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721582|NCT05297396|Analgesics|analgesics|mesh-ancestor
55721583|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
55721584|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721585|NCT05296304|Bexarotene|bexarotene|mesh-list
55721586|NCT05296304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721587|NCT01658150|Isradipine|isradipine|mesh-list
55721588|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55721589|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55721590|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55721591|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721592|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55721593|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721594|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
55721595|NCT02285998|Vaccines|vaccines|mesh-list
55721596|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
55721597|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721598|NCT02285920|Spironolactone|spironolactone|mesh-list
55721599|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55721600|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
55721601|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721602|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721603|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55721604|NCT02285920|Diuretics|diuretics|mesh-ancestor
55721605|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
55721606|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
55721607|NCT05292872|Cathartics|cathartics|mesh-ancestor
55721608|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721609|NCT05265728|Natalizumab|natalizumab|mesh-list
55721610|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
55721611|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721613|NCT02035137|Vincristine|vincristine|mesh-list
55721614|NCT02035137|Vorinostat|vorinostat|mesh-list
55721615|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
55721616|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55721617|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55721618|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721619|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721620|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721621|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55721622|NCT02035137|Tubulin Modulators|tubulin modulators|mesh-ancestor
55721623|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
55721624|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
55721625|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55721626|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55721627|NCT05321810|Warfarin|warfarin|mesh-list
55721628|NCT05321810|Apixaban|apixaban|mesh-list
55721629|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
55721630|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55721631|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
55721632|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55721633|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
55721635|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721636|NCT05264870|Norepinephrine|norepinephrine|mesh-list
55721637|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55721638|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55721639|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
55721640|NCT05264870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721641|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721642|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721643|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
55721644|NCT05264870|Autonomic Agents|autonomic agents|mesh-ancestor
55721645|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721646|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55721647|NCT04249232|Abaloparatide|abaloparatide|mesh-list
55721648|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55721649|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721650|NCT05079087|Midazolam|midazolam|mesh-list
55721651|NCT05079087|Ketamine|ketamine|mesh-list
55721652|NCT05079087|Analgesics|analgesics|mesh-ancestor
55721653|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
55721654|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721655|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721656|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55721657|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55721658|NCT05079087|Anesthetics, General|anesthetics, general|mesh-ancestor
55721659|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
55721660|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55721661|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55721662|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55721663|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721664|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721665|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55721666|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55721667|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55721668|NCT05079087|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55721669|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55721670|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
55721671|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
55721673|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55721674|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55721675|NCT02522780|Analgesics|analgesics|mesh-ancestor
55721676|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
55721677|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721678|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721680|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55721681|NCT03618225|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55721682|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55721683|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55721684|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55721685|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721686|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721687|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721688|NCT03618225|Analgesics|analgesics|mesh-ancestor
55721689|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
55721690|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721691|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
55721692|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55721693|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
55721694|NCT03566199|Panobinostat|panobinostat|mesh-list
55721695|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721696|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55721697|NCT03566199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721698|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721699|NCT03561831|Propofol|propofol|mesh-list
55721700|NCT03561831|Sevoflurane|sevoflurane|mesh-list
55721701|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55721702|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55721703|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721704|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55721705|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
55721706|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
55721707|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55721708|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55721709|NCT05289830|Citalopram|citalopram|mesh-list
55721710|NCT05289830|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55721711|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55721712|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55721713|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721714|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55721715|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
55721716|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721717|NCT05289830|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55721718|NCT05289830|Antidepressive Agents|antidepressive agents|mesh-ancestor
55721719|NCT05289830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55721720|NCT03144843|Apatinib|apatinib|mesh-list
55721721|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721722|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55721723|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721724|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721725|NCT05288348|Sufentanil|sufentanil|mesh-list
55721726|NCT05288348|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55721727|NCT05288348|Narcotics|narcotics|mesh-ancestor
55721728|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55721729|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721730|NCT05288348|Analgesics|analgesics|mesh-ancestor
55721731|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
55721732|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721733|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55721734|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55721735|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
55721736|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
55721737|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55721738|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55721739|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721740|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721742|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
55721743|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721744|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721745|NCT05259800|Peppermint oil|peppermint oil|mesh-list
55721746|NCT05259800|Mineral Oil|mineral oil|mesh-list
55721747|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
55721748|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
55721749|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55721750|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721751|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721752|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
55721753|NCT05259800|Emollients|emollients|mesh-ancestor
55721754|NCT05259800|Dermatologic Agents|dermatologic agents|mesh-ancestor
55721755|NCT05387187|Pentoxifylline|pentoxifylline|mesh-list
55721756|NCT05387187|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55721814|NCT02951013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721815|NCT02951013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55721816|NCT02951013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55721817|NCT05080803|Bevacizumab|bevacizumab|mesh-list
55721818|NCT05080803|Ranibizumab|ranibizumab|mesh-list
55721819|NCT05080803|Aflibercept|aflibercept|mesh-list
55721820|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55721821|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721822|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55721823|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55721824|NCT05080803|Growth Substances|growth substances|mesh-ancestor
55721825|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721826|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
55721827|NCT02285062|Prednisone|prednisone|mesh-list
55721828|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
55721829|NCT02285062|Rituximab|rituximab|mesh-list
55721830|NCT02285062|Doxorubicin|doxorubicin|mesh-list
55721831|NCT02285062|Vincristine|vincristine|mesh-list
55721832|NCT02285062|Lenalidomide|lenalidomide|mesh-list
55721833|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55721834|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
55721835|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721836|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55721837|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55721838|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
55721839|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721840|NCT02285062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721841|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55721842|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55721843|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55721844|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55721845|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55721846|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721847|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55721848|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
55828481|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55828482|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
55828483|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
55828484|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828485|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721849|NCT02285062|Hormones|hormones|mesh-ancestor
55721850|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55721851|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55721852|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55766163|NCT02416739|Niacinamide|niacinamide|mesh-list
55721853|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
55721854|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
55721855|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
55721856|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55721857|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55721858|NCT02285062|Growth Substances|growth substances|mesh-ancestor
55721859|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
55721860|NCT02431767|Interleukin-12|interleukin-12|mesh-list
55721861|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55721862|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
55721863|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721864|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55721865|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55721866|NCT02431767|Growth Substances|growth substances|mesh-ancestor
55721867|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
55721868|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55721869|NCT05313620|Adalimumab|adalimumab|mesh-list
55721870|NCT05313620|Golimumab|golimumab|mesh-list
55721871|NCT05313620|Infliximab|infliximab|mesh-list
55721872|NCT05313620|Tofacitinib|tofacitinib|mesh-list
55721873|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55721874|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55721876|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55721877|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55721878|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55721879|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55721880|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55721881|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55721882|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
55721883|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55721884|NCT04571697|Methotrexate|methotrexate|mesh-list
55721885|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55722001|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55722002|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722003|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55722004|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
55722005|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55722006|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722007|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722008|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722009|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
55722010|NCT03140553|Carboplatin|carboplatin|mesh-list
55722011|NCT03140553|Docetaxel|docetaxel|mesh-list
55722012|NCT03140553|Trastuzumab|trastuzumab|mesh-list
55722013|NCT03140553|Epirubicin|epirubicin|mesh-list
55722014|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55722015|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
55722016|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722017|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722018|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55722019|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
55722020|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722021|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722022|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55722023|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
55722024|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
55722025|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
55722026|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55722027|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55722028|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55722029|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55722030|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722031|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
55722032|NCT05279456|Paraproteins|paraproteins|mesh-list
55722033|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
55722034|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722035|NCT00905567|Topiramate|topiramate|mesh-list
55828488|NCT01580020|Hormones|hormones|mesh-ancestor
55722036|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
55722037|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722038|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722039|NCT05277896|Ketamine|ketamine|mesh-list
55722040|NCT05277896|Etomidate|etomidate|mesh-list
55722041|NCT05277896|Analgesics|analgesics|mesh-ancestor
55722042|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
55722043|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722044|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722045|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55722046|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55722047|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
55722049|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722050|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55722051|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55722052|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722053|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722054|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55722055|NCT02282020|Olaparib|olaparib|mesh-list
55722056|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55722057|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722058|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722059|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722060|NCT05249972|Calcitriol|calcitriol|mesh-list
55722061|NCT05249972|Betamethasone|betamethasone|mesh-list
55722062|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
55722063|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55722064|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
55722065|NCT05249972|Calcipotriene|calcipotriene|mesh-list
55722066|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55722067|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55722068|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
55722069|NCT05249972|Hormones|hormones|mesh-ancestor
55722070|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55722071|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722072|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55722073|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
55722074|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
55722075|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55722076|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55722077|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722078|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722079|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55722080|NCT05249972|Vitamins|vitamins|mesh-ancestor
55722081|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
55722082|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55722083|NCT00904943|Topiramate|topiramate|mesh-list
55722084|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
55722085|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722086|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722087|NCT00902291|Gemcitabine|gemcitabine|mesh-list
55722088|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55722089|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
55722090|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722091|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722092|NCT00902291|Antiviral Agents|antiviral agents|mesh-ancestor
55722093|NCT00902291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722094|NCT00902291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722095|NCT00902291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55722096|NCT00902291|Immunologic Factors|immunologic factors|mesh-ancestor
55722097|NCT00902291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722099|NCT05217680|Ranibizumab|ranibizumab|mesh-list
55722100|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55722101|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722102|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55722103|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55722104|NCT05217680|Growth Substances|growth substances|mesh-ancestor
55722105|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722106|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
55722107|NCT02281552|Tofacitinib|tofacitinib|mesh-list
55722108|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55722109|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722110|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722111|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
55722112|NCT03832647|Salicylates|salicylates|mesh-list
55722113|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722114|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
55722115|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
55722116|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
55722117|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55766215|NCT02415881|Panitumumab|panitumumab|mesh-list
55722118|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55722119|NCT03832647|Analgesics|analgesics|mesh-ancestor
55722120|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
55722121|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722122|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722123|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55722124|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722125|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55722126|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722127|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722128|NCT00901979|Metformin|metformin|mesh-list
55722129|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55722130|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722131|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722132|NCT00901979|Incretins|incretins|mesh-ancestor
55722133|NCT00901979|Hormones|hormones|mesh-ancestor
55722134|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55722135|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55722136|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
55722137|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722138|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722139|NCT03778671|Fentanyl|fentanyl|mesh-list
55722140|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
55722141|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
55722142|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55722143|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722144|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722145|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55828512|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
55828513|NCT01539538|Sufentanil|sufentanil|mesh-list
55828514|NCT01539538|Morphine|morphine|mesh-list
55828515|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55722146|NCT03778671|Analgesics|analgesics|mesh-ancestor
55722147|NCT03778671|Sensory System Agents|sensory system agents|mesh-ancestor
55722148|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722149|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55722150|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55722151|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55722152|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
55722153|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722154|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722155|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55722156|NCT03778671|Narcotics|narcotics|mesh-ancestor
55722157|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55722158|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55722159|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
55722160|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
55722161|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
55722163|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
55722164|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722165|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
55722166|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722167|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
55722168|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55722169|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722170|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55722171|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55722172|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722173|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722174|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722175|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55722176|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55722177|NCT03558789|Lactoferrin|lactoferrin|mesh-list
55722178|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722179|NCT03495921|Irinotecan|irinotecan|mesh-list
55722180|NCT03495921|Camptothecin|camptothecin|mesh-list
55722181|NCT03495921|Temozolomide|temozolomide|mesh-list
55722182|NCT03495921|Immunologic Factors|immunologic factors|mesh-list
55722183|NCT03495921|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55722184|NCT03495921|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55722185|NCT03495921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722186|NCT03495921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722187|NCT03495921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722188|NCT03495921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55722189|NCT03495921|Alkylating Agents|alkylating agents|mesh-ancestor
55722190|NCT03495921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722191|NCT03495921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55722192|NCT00890591|Amlodipine|amlodipine|mesh-list
55722193|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55722195|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55722196|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55722197|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55722198|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722199|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722200|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55722201|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722202|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
55722203|NCT00890591|Diuretics|diuretics|mesh-ancestor
55722204|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
55722205|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55722206|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55722207|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55722208|NCT05248334|Ranibizumab|ranibizumab|mesh-list
55722209|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55722210|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55722211|NCT05248334|Growth Substances|growth substances|mesh-ancestor
55722212|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722213|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
55722214|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722215|NCT03140787|Lidocaine|lidocaine|mesh-list
55722216|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
55722217|NCT03140787|Anesthetics|anesthetics|mesh-ancestor
55722218|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722219|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722220|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
55722221|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722222|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55722528|NCT05162222|Itraconazole|itraconazole|mesh-list
55722223|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55722224|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55722225|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722226|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722227|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
55722228|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55722229|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722230|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55722231|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55722232|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722233|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722234|NCT00889967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722235|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55722236|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55722237|NCT03317223|Amoxicillin|amoxicillin|mesh-list
55722238|NCT03317223|Clarithromycin|clarithromycin|mesh-list
55722239|NCT03317223|Lansoprazole|lansoprazole|mesh-list
55722240|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55722241|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722242|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55722243|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722244|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722245|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55722246|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55722247|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55722248|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55722249|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55722250|NCT02284906|Pioglitazone|pioglitazone|mesh-list
55722251|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722252|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722253|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
55722254|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55766218|NCT02415803|Clopidogrel|clopidogrel|mesh-list
55722255|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722256|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722257|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55722258|NCT02566863|Analgesics|analgesics|mesh-ancestor
55722259|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
55722260|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722261|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55722262|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55722263|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55722264|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
55722265|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722266|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722267|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
55722268|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722269|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
55722270|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55722271|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55722272|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55722273|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722274|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722275|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
55722276|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722277|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722278|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55722279|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722280|NCT04474457|Favipiravir|favipiravir|mesh-list
55722281|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
55722282|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722283|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55722284|NCT05084235|Empagliflozin|empagliflozin|mesh-list
55722285|NCT05084235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55722286|NCT05084235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722287|NCT05084235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722288|NCT05084235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722289|NCT00880217|Methylphenidate|methylphenidate|mesh-list
55722290|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55722291|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55722292|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722293|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55722294|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55722295|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722296|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722297|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
55722298|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722299|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55722300|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
55722302|NCT01657760|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55722303|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55722304|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722305|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722306|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722307|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
55722308|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722309|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55722310|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
55722311|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55722312|NCT00966953|Honokiol|honokiol|mesh-list
55722313|NCT00966953|Triclosan|triclosan|mesh-list
55722314|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55722315|NCT00966953|Fluorides|fluorides|mesh-list
55722316|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
55722317|NCT00966953|Protective Agents|protective agents|mesh-ancestor
55722318|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722319|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55722320|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722321|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55722322|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55722323|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
55766228|NCT04482881|Isosorbide|isosorbide|mesh-list
55722324|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722325|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55722326|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55722327|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55722328|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722329|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722330|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722331|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55722332|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55722333|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55722334|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55722335|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55722336|NCT05247320|Sotalol|sotalol|mesh-list
55722337|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55722338|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55722339|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
55722340|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722341|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722342|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722343|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55722344|NCT05247320|Sympatholytics|sympatholytics|mesh-ancestor
55722345|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
55722346|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722347|NCT05084079|Insulin|insulin|mesh-list
55722348|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55722349|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722350|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722351|NCT05084001|Listerine|listerine|mesh-list
55722352|NCT05084001|Fluorides|fluorides|mesh-list
55722353|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
55722354|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
55722355|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
55722356|NCT05084001|Protective Agents|protective agents|mesh-ancestor
55722357|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722358|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55722359|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722360|NCT05245916|Rituximab|rituximab|mesh-list
55722361|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55722362|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722363|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
55722364|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722365|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722366|NCT00875459|Insulin|insulin|mesh-list
55722367|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55722368|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722529|NCT05162222|Diltiazem|diltiazem|mesh-list
55722369|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722370|NCT03837353|Docetaxel|docetaxel|mesh-list
55722371|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722372|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
55722373|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
55722374|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
55722375|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722376|NCT03140709|Oxytocin|oxytocin|mesh-list
55722377|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
55722378|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55722379|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722380|NCT02283658|Everolimus|everolimus|mesh-list
55722382|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722383|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55722384|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
55722385|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722386|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55722387|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55722388|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722389|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722390|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55722391|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
55722392|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55722393|NCT00872885|Morphine|morphine|mesh-list
55722394|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55722395|NCT00872885|Narcotics|narcotics|mesh-ancestor
55722396|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722397|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722398|NCT00872885|Analgesics|analgesics|mesh-ancestor
55722399|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
55722400|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722401|NCT00871481|Aldesleukin|aldesleukin|mesh-list
55722403|NCT00871481|Ipilimumab|ipilimumab|mesh-list
55722404|NCT00871481|Interleukin-2|interleukin-2|mesh-list
55722405|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55722406|NCT00871481|Antibodies|antibodies|mesh-list
55722407|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
55722408|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55722409|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55722410|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
55722411|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722412|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722413|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55722414|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
55722415|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722416|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722417|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55722418|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55722419|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55722420|NCT00871481|Analgesics|analgesics|mesh-ancestor
55722421|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
55722422|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722424|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55722425|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
55722426|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722427|NCT05456165|Ipilimumab|ipilimumab|mesh-list
55722428|NCT05456165|Atezolizumab|atezolizumab|mesh-list
55722429|NCT05456165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55722430|NCT05456165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722431|NCT05456165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55722432|NCT05456165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722433|NCT05083689|Bevacizumab|bevacizumab|mesh-list
55722434|NCT05083689|Timolol|timolol|mesh-list
55722435|NCT05083689|Dorzolamide|dorzolamide|mesh-list
55722436|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
55722437|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55722438|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722439|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55722440|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55722441|NCT05083689|Growth Substances|growth substances|mesh-ancestor
55722442|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722443|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
55722444|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55722445|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55722446|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
55722447|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722448|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722449|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55722450|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55722451|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55722452|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55722453|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55722454|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722455|NCT05165966|Vaccines|vaccines|mesh-list
55722456|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
55722457|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722458|NCT05165732|Vaccines|vaccines|mesh-list
55722459|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
55722460|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722462|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
55722463|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55722464|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55722465|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722466|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722467|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722468|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722469|NCT03138759|Probenecid|probenecid|mesh-list
55722470|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
55722471|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
55722472|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722473|NCT03138759|Renal Agents|renal agents|mesh-ancestor
55722474|NCT03079921|Propranolol|propranolol|mesh-list
55722475|NCT03079921|Phentolamine|phentolamine|mesh-list
55722476|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55722477|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55722478|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
55722479|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722480|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722481|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722482|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55722483|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55722484|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
55722485|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55722486|NCT04473989|Teriparatide|teriparatide|mesh-list
55722487|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55722488|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722489|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55766256|NCT02415569|Bisacodyl|bisacodyl|mesh-list
55722491|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55722492|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722493|NCT05209490|Trace Elements|trace elements|mesh-ancestor
55722494|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
55722495|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722497|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
55722498|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55722499|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
55722500|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55722501|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
55722502|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722503|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722504|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
55722505|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55722506|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55722507|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
55722508|NCT04473911|Sirolimus|sirolimus|mesh-list
55722509|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
55722510|NCT04473911|Melphalan|melphalan|mesh-list
55722511|NCT04473911|Fludarabine|fludarabine|mesh-list
55722512|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55722513|NCT04473911|Immunologic Factors|immunologic factors|mesh-ancestor
55722514|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722515|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722517|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
55722518|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722519|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722520|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55722521|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55722522|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55722523|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
55722524|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55722525|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722526|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722527|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
55722576|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55722577|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55722578|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55722579|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55722580|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722581|NCT04461379|Vaccines|vaccines|mesh-list
55722582|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
55722583|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
55722584|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722585|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55722586|NCT00854945|ON 01910|on 01910|mesh-list
55722587|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722588|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55722589|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722590|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722592|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55722593|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55722594|NCT04876534|Prednisolone|prednisolone|mesh-list
55722595|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
55722596|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55722597|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55722598|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
55828567|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828568|NCT01537120|Vildagliptin|vildagliptin|mesh-list
55722599|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55722600|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
55722601|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
55722602|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722603|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722604|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55722605|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
55722606|NCT04876534|Hormones|hormones|mesh-ancestor
55722607|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55722608|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55722609|NCT04876534|Protective Agents|protective agents|mesh-ancestor
55722610|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55722611|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722612|NCT05082753|Ivermectin|ivermectin|mesh-list
55722613|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55722614|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722615|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
55722616|NCT02443831|Fludarabine|fludarabine|mesh-list
55722617|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55722618|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
55722619|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722620|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722621|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55722622|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
55722623|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722625|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55722626|NCT00851045|Leucovorin|leucovorin|mesh-list
55722627|NCT00851045|Bevacizumab|bevacizumab|mesh-list
55722628|NCT00851045|Fluorouracil|fluorouracil|mesh-list
55722629|NCT00851045|Irinotecan|irinotecan|mesh-list
55722630|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55722631|NCT00851045|Calcium|calcium|mesh-list
55722632|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
55722633|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55722634|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722635|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55722636|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55722637|NCT00851045|Growth Substances|growth substances|mesh-ancestor
55722638|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722639|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
55722640|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55722641|NCT00851045|Antimetabolites|antimetabolites|mesh-ancestor
55722642|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722643|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55722644|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55722645|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
55722646|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55722647|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55722648|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722649|NCT00851045|Antidotes|antidotes|mesh-ancestor
55722651|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
55722652|NCT00851045|Vitamins|vitamins|mesh-ancestor
55722692|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55722693|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55722694|NCT05082441|Bupivacaine|bupivacaine|mesh-list
55722695|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
55722696|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
55722697|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722698|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722699|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
55722700|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722701|NCT00950885|Melatonin|melatonin|mesh-list
55722702|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
55722703|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722704|NCT00950885|Protective Agents|protective agents|mesh-ancestor
55722705|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722706|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722708|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
55722709|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
55722710|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
55722711|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
55722712|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55722713|NCT03140397|Estrogens|estrogens|mesh-ancestor
55722715|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55722716|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722717|NCT05047445|Vaccines|vaccines|mesh-list
55722718|NCT05047445|Immunologic Factors|immunologic factors|mesh-ancestor
55722719|NCT05047445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722720|NCT05235542|Paclitaxel|paclitaxel|mesh-list
55722721|NCT05235542|Docetaxel|docetaxel|mesh-list
55722722|NCT05235542|Capecitabine|capecitabine|mesh-list
55722723|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
55722724|NCT05235542|Irinotecan|irinotecan|mesh-list
55722725|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55722726|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722727|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
55722728|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
55722729|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
55722730|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722731|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55722732|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
55722733|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55722734|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55722735|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722736|NCT00840281|Cefprozil|cefprozil|mesh-list
55722737|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55722738|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722739|NCT00840203|Mesalamine|mesalamine|mesh-list
55722740|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55722741|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55722742|NCT00840203|Analgesics|analgesics|mesh-ancestor
55722743|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
55722744|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722745|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722746|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55722747|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722748|NCT00838799|Pregabalin|pregabalin|mesh-list
55722749|NCT00838799|Analgesics|analgesics|mesh-ancestor
55722750|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
55722751|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722752|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722753|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
55722754|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55722755|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722756|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722757|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55722758|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55722759|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55722760|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722761|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55722763|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55722764|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722765|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722766|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722767|NCT00836069|Paroxetine|paroxetine|mesh-list
55722768|NCT00836069|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55722769|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55722770|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722771|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722772|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55722774|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722775|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55722776|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
55722777|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55722778|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55722779|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55722780|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722781|NCT03134729|Ropivacaine|ropivacaine|mesh-list
55722782|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
55722783|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
55722784|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722785|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722786|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
55722787|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722788|NCT03134651|Propofol|propofol|mesh-list
55722789|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55722790|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722791|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722792|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55722793|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
55722794|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
55722795|NCT05202860|Vaccines|vaccines|mesh-list
55722796|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
55722797|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722798|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
55722799|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722800|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55722801|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722802|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722803|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
55722804|NCT05202080|Narcotics|narcotics|mesh-ancestor
55722805|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55722806|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722807|NCT05202080|Analgesics|analgesics|mesh-ancestor
55722808|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
55722809|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722810|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
55722811|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55722812|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722813|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722814|NCT05155124|Cetuximab|cetuximab|mesh-list
55722815|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55722816|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722817|NCT00927641|Ketoprofen|ketoprofen|mesh-list
55828589|NCT04410094|Itraconazole|itraconazole|mesh-list
55828590|NCT04410094|Rifampin|rifampin|mesh-list
55828591|NCT04410094|Lazertinib|lazertinib|mesh-list
55828592|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
55828593|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828596|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722818|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55722819|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55722820|NCT00927641|Analgesics|analgesics|mesh-ancestor
55722821|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
55722822|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55722823|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722824|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55722825|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55722826|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55722827|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722828|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722829|NCT05200364|Bevacizumab|bevacizumab|mesh-list
55722830|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55722831|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722832|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55722833|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55722834|NCT05200364|Growth Substances|growth substances|mesh-ancestor
55722835|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722836|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
55722837|NCT05200208|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55722922|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55722923|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
55722924|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55722925|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55722926|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55722927|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55722928|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55722929|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
55722931|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
55722932|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55722933|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55722934|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722935|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722936|NCT05142254|Urological Agents|urological agents|mesh-ancestor
55722937|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722938|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
55722939|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55722940|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55722941|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
55722942|NCT00835211|Coagulants|coagulants|mesh-ancestor
55722943|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55722944|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
55722945|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722947|NCT00834977|Benazepril|benazepril|mesh-list
55722948|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55722949|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55722950|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55722951|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722952|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55722953|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722954|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
55722955|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55722956|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
55722957|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722958|NCT05141708|Talazoparib|talazoparib|mesh-list
55722959|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55722960|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722961|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722962|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722963|NCT05227664|Paclitaxel|paclitaxel|mesh-list
55722964|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55722965|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55722966|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55722967|NCT05227664|Tubulin Modulators|tubulin modulators|mesh-ancestor
55722968|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
55722969|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
55722970|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722971|NCT02275780|Ritonavir|ritonavir|mesh-list
55722972|NCT02275780|Darunavir|darunavir|mesh-list
55722973|NCT02275780|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55722974|NCT02275780|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55722975|NCT02275780|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55722976|NCT02275780|Protease Inhibitors|protease inhibitors|mesh-ancestor
55722977|NCT02275780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55722978|NCT02275780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55722979|NCT02275780|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55722980|NCT02275780|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55722981|NCT02275780|Antiviral Agents|antiviral agents|mesh-ancestor
55722982|NCT02275780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722983|NCT02275780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55722984|NCT02275780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55722985|NCT02275780|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55722986|NCT02275780|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55722987|NCT00834743|Metformin|metformin|mesh-list
55722988|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722989|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722990|NCT00834587|Metformin|metformin|mesh-list
55722991|NCT00834587|Glipizide|glipizide|mesh-list
55722992|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55722993|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55722994|NCT05225558|Vancomycin|vancomycin|mesh-list
55722995|NCT05225558|Delpazolid|delpazolid|mesh-list
55722996|NCT05225558|Oxazolidinones|oxazolidinones|mesh-list
55722997|NCT05225558|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55722998|NCT05225558|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55722999|NCT05225558|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55723000|NCT05225558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723001|NCT05225558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723002|NCT00834431|Famciclovir|famciclovir|mesh-list
55723003|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
55723004|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723005|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55723006|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723007|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723008|NCT04875767|Coal Tar|coal tar|mesh-list
55723009|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
55723010|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
55723011|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55723012|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55723013|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723014|NCT00834275|Cefadroxil|cefadroxil|mesh-list
55723015|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55723016|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723017|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
55723018|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723019|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723020|NCT05191004|Fulvestrant|fulvestrant|mesh-list
55723021|NCT05191004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55723022|NCT05191004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723023|NCT05191004|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55723024|NCT05191004|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55723025|NCT05191004|Hormone Antagonists|hormone antagonists|mesh-ancestor
55828601|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828602|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55723026|NCT05191004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723027|NCT05191004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723028|NCT00834197|Mirtazapine|mirtazapine|mesh-list
55828603|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55828604|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
55828605|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55828606|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
55828607|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55723035|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723036|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723037|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55723038|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55723039|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55723040|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55723041|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55723042|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55723043|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
55723044|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55723045|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55723046|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
55723047|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55723048|NCT00833495|Prednisolone|prednisolone|mesh-list
55723049|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55723050|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
55723051|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55723052|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
55723053|NCT00833495|Prednisone|prednisone|mesh-list
55723054|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55723055|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
55723056|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723057|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
55723058|NCT00833495|Hormones|hormones|mesh-ancestor
55723059|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723060|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723061|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55723062|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723063|NCT00833495|Antiemetics|antiemetics|mesh-ancestor
55723064|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
55723065|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723066|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55723067|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55723068|NCT00833495|Protective Agents|protective agents|mesh-ancestor
55723069|NCT00830219|Ropinirole|ropinirole|mesh-list
55723070|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55723071|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55723072|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
55723073|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
55723074|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723075|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723076|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723086|NCT05386979|Anesthetics|anesthetics|mesh-list
55723087|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55723088|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723089|NCT05386979|Narcotics|narcotics|mesh-ancestor
55723090|NCT05386979|Analgesics|analgesics|mesh-ancestor
55723091|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
55723092|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723093|NCT02274766|Amantadine|amantadine|mesh-list
55723094|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55723095|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55723096|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
55723097|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723098|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
55723099|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723100|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723101|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723102|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55723103|NCT02274766|Analgesics|analgesics|mesh-ancestor
55723104|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
55723105|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723106|NCT05134922|Gedatolisib|gedatolisib|mesh-list
55723107|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55723108|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723109|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723110|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
55723111|NCT04757363|Nivolumab|nivolumab|mesh-list
55723112|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723113|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723114|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55723115|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723116|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
55723117|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55723118|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723119|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55723120|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55723121|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55723122|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723123|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
55723124|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723125|NCT05221658|Cisplatin|cisplatin|mesh-list
55723126|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723127|NCT05132114|Lugol's solution|lugol's solution|mesh-list
55723128|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
55723129|NCT05132114|Coagulants|coagulants|mesh-ancestor
55723130|NCT05187182|Leucovorin|leucovorin|mesh-list
55723131|NCT05187182|Pembrolizumab|pembrolizumab|mesh-list
55723132|NCT05187182|Nivolumab|nivolumab|mesh-list
55723133|NCT05187182|Trastuzumab|trastuzumab|mesh-list
55723134|NCT05187182|Oxaliplatin|oxaliplatin|mesh-list
55723135|NCT05187182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723136|NCT05187182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723137|NCT05187182|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55723138|NCT05187182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723139|NCT05187182|Antidotes|antidotes|mesh-ancestor
55723140|NCT05187182|Protective Agents|protective agents|mesh-ancestor
55723141|NCT05187182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723142|NCT05187182|Vitamin B Complex|vitamin b complex|mesh-ancestor
55723143|NCT05187182|Vitamins|vitamins|mesh-ancestor
55723144|NCT05187182|Micronutrients|micronutrients|mesh-ancestor
55723145|NCT02370238|Paclitaxel|paclitaxel|mesh-list
55723146|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55723147|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723148|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
55723149|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
55723150|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
55723151|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723152|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
55723153|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55723154|NCT05109104|Protective Agents|protective agents|mesh-ancestor
55724936|NCT05151679|Iron|iron|mesh-list
55723155|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723156|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
55723157|NCT05108870|Paclitaxel|paclitaxel|mesh-list
55723158|NCT05108870|Carboplatin|carboplatin|mesh-list
55723159|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55723160|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723161|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
55723162|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
55723163|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
55723164|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723165|NCT05126342|Niraparib|niraparib|mesh-list
55723166|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55723167|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723168|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723169|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723170|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
55723171|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55723172|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723174|NCT05473910|Antioxidants|antioxidants|mesh-ancestor
55723175|NCT05473910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723176|NCT05473910|Protective Agents|protective agents|mesh-ancestor
55723177|NCT05473910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723178|NCT05473910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55723179|NCT05473910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723181|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55723182|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723183|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55723184|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723185|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
55723186|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55723187|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
55723188|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723190|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723191|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55723192|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
55828614|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55828616|NCT01576042|Sotalol|sotalol|mesh-list
55828617|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55828618|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
55828619|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55723193|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723194|NCT05180474|Antibodies|antibodies|mesh-list
55723195|NCT05180474|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55723196|NCT05180474|Immunologic Factors|immunologic factors|mesh-ancestor
55723197|NCT05180474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723198|NCT05102552|Huperzine A|huperzine a|mesh-list
55723199|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55723201|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723202|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
55723203|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723204|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723205|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55723206|NCT05102552|Protective Agents|protective agents|mesh-ancestor
55723207|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
55723208|NCT05096390|Axitinib|axitinib|mesh-list
55723209|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723210|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723211|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55723212|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723213|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723214|NCT05114096|Betamethasone|betamethasone|mesh-list
55723215|NCT05114096|Betamethasone Valerate|betamethasone valerate|mesh-list
55723216|NCT05114096|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55723217|NCT05114096|Betamethasone benzoate|betamethasone benzoate|mesh-list
55723218|NCT05114096|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55723219|NCT05114096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723220|NCT05114096|Glucocorticoids|glucocorticoids|mesh-ancestor
55723221|NCT05114096|Hormones|hormones|mesh-ancestor
55723222|NCT05114096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723223|NCT05114096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723224|NCT05114096|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55723225|NCT05114096|Respiratory System Agents|respiratory system agents|mesh-ancestor
55723227|NCT02273050|Saxagliptin|saxagliptin|mesh-list
55723228|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55723229|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723230|NCT02273050|Incretins|incretins|mesh-ancestor
55723231|NCT02273050|Hormones|hormones|mesh-ancestor
55723232|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723233|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55723234|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
55723235|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723236|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723237|NCT05177822|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55723238|NCT05177822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55723239|NCT02272816|Carboplatin|carboplatin|mesh-list
55723240|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723241|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55723242|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
55723243|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723244|NCT05170256|Trastuzumab|trastuzumab|mesh-list
55723245|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723246|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723247|NCT02367352|Paclitaxel|paclitaxel|mesh-list
55723248|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55723249|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723251|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
55723252|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
55723253|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723254|NCT05169008|Vaccines|vaccines|mesh-list
55723255|NCT05169008|Immunologic Factors|immunologic factors|mesh-ancestor
55723256|NCT05169008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723257|NCT02270944|Vaccines|vaccines|mesh-list
55723258|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
55723259|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723260|NCT05648734|Pirfenidone|pirfenidone|mesh-list
55723261|NCT05648734|Colchicine|colchicine|mesh-list
55723263|NCT05648734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55723264|NCT05648734|Tubulin Modulators|tubulin modulators|mesh-ancestor
55723265|NCT05648734|Antimitotic Agents|antimitotic agents|mesh-ancestor
55723266|NCT05648734|Mitosis Modulators|mitosis modulators|mesh-ancestor
55723267|NCT05648734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723268|NCT05648734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723269|NCT05648734|Analgesics|analgesics|mesh-ancestor
55723270|NCT05648734|Sensory System Agents|sensory system agents|mesh-ancestor
55723271|NCT05648734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723272|NCT05648734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723273|NCT05648734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55723274|NCT05648734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55723275|NCT05648734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723276|NCT02365558|Omeprazole|omeprazole|mesh-list
55723277|NCT02365558|Evacetrapib|evacetrapib|mesh-list
55723278|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55828627|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55828628|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55828629|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55828630|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55828631|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
55828632|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828633|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828634|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
55828635|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
55723279|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55723280|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55723281|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723282|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723283|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55723284|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55723286|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55723287|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
55723288|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723289|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723290|NCT02270242|Aspirin|aspirin|mesh-list
55723291|NCT02270242|Ticagrelor|ticagrelor|mesh-list
55723292|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55723293|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55723294|NCT02270242|Analgesics|analgesics|mesh-ancestor
55723295|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
55723296|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828639|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55723297|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723298|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723299|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55723300|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55723301|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55723302|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723303|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55723304|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55723305|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723307|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55723308|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55723309|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55723310|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
55723311|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723313|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55723314|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55723315|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723316|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
55723317|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55723318|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723319|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55723320|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723321|NCT05648266|Analgesics|analgesics|mesh-list
55723322|NCT05648266|Sensory System Agents|sensory system agents|mesh-ancestor
55723323|NCT05648266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723324|NCT05648266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723325|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
55723326|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723327|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723329|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55723330|NCT04993352|Mitogens|mitogens|mesh-list
55723331|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
55723332|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
55723333|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723334|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
55723335|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723336|NCT04993352|Growth Substances|growth substances|mesh-ancestor
55828640|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
55828641|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828642|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828643|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55828644|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
55723338|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
55723339|NCT04992026|Hormones|hormones|mesh-list
55723340|NCT04992026|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55723341|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723342|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
55723343|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723344|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723345|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55723346|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723347|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55723348|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723349|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723350|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
55723351|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55723352|NCT04991402|Dolutegravir|dolutegravir|mesh-list
55723353|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55723354|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55723355|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55723356|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723357|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723358|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55723359|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
55723360|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723361|NCT05042102|Donepezil|donepezil|mesh-list
55723362|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55723363|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723364|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723365|NCT05042102|Cholinergic Agents|cholinergic agents|mesh-ancestor
55723366|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723367|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723463|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723464|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55723465|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55723466|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723467|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723468|NCT05025800|Rituximab|rituximab|mesh-list
55723469|NCT05025800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55723470|NCT05025800|Lenalidomide|lenalidomide|mesh-list
55723471|NCT05025800|Antibodies|antibodies|mesh-list
55723472|NCT05025800|Immunoglobulins|immunoglobulins|mesh-list
55723473|NCT05025800|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55723474|NCT05025800|Immunologic Factors|immunologic factors|mesh-ancestor
55723475|NCT05025800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723476|NCT05025800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723477|NCT05025800|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55723478|NCT05025800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55723479|NCT05025800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55723480|NCT05025800|Growth Substances|growth substances|mesh-ancestor
55723481|NCT05025800|Growth Inhibitors|growth inhibitors|mesh-ancestor
55723482|NCT05022524|Acetic Acid|acetic acid|mesh-list
55723483|NCT05022524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55723484|NCT05022524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723485|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
55723486|NCT02267746|Tazarotene|tazarotene|mesh-list
55723487|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
55723488|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
55723489|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
55723490|NCT02267746|Vitamins|vitamins|mesh-ancestor
55723491|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
55723492|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723493|NCT04970108|Empagliflozin|empagliflozin|mesh-list
55723494|NCT04970108|Telmisartan|telmisartan|mesh-list
55723495|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55723496|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723497|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55723498|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723499|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55723500|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55723502|NCT04421534|Lactoferrin|lactoferrin|mesh-list
55723503|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723504|NCT05060744|Antacids|antacids|mesh-list
55723505|NCT05060744|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
55723506|NCT05060744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723507|NCT05060744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55723508|NCT05059028|Oxytocin|oxytocin|mesh-list
55723509|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
55723510|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55723511|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723512|NCT04205552|Nivolumab|nivolumab|mesh-list
55723513|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55723514|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723515|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723516|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55723517|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723518|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55723519|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55723520|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55723521|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723523|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
55723524|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723526|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
55723527|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723528|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723529|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55723530|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
55723531|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
55723532|NCT04215848|Hormones|hormones|mesh-ancestor
55723533|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723534|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55723535|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55723536|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55723537|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
55723538|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723539|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723540|NCT04215146|Paclitaxel|paclitaxel|mesh-list
55828654|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723575|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
55723576|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723577|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723578|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55723579|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55723580|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
55723581|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55723582|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
55723583|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55723584|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55723585|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55723586|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55723587|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55723588|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55723589|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55723591|NCT05008484|Vitamins|vitamins|mesh-ancestor
55723592|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
55723593|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723594|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55723595|NCT04212416|Leflunomide|leflunomide|mesh-list
55723596|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723597|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723598|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55723599|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
55723600|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723601|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
55723602|NCT04947254|Prednisone|prednisone|mesh-list
55723603|NCT04947254|Cortisone|cortisone|mesh-list
55723604|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
55723605|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
55723606|NCT04947254|Niraparib|niraparib|mesh-list
55723607|NCT04947254|Hormones|hormones|mesh-list
55723608|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55723609|NCT04947254|Androgens|androgens|mesh-list
55723610|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
55723611|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723612|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
55723613|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723614|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723615|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55723616|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723617|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55723618|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723619|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723620|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
55723621|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55723622|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55723623|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
55723624|NCT04947254|Protective Agents|protective agents|mesh-ancestor
55723625|NCT04947254|Vitamins|vitamins|mesh-ancestor
55723627|NCT04947254|Estrogens|estrogens|mesh-ancestor
55723628|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
55723629|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
55723630|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
55723631|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
55723632|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723633|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723634|NCT04954664|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55723635|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55723636|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
55723637|NCT04954664|Histamine Agents|histamine agents|mesh-ancestor
55723638|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723639|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723640|NCT04946864|Palbociclib|palbociclib|mesh-list
55723641|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723642|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55723643|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723644|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723645|NCT04945148|Metformin|metformin|mesh-list
55723646|NCT04945148|Temozolomide|temozolomide|mesh-list
55723647|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55723648|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723649|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55723698|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55723699|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723700|NCT02392429|Cytarabine|cytarabine|mesh-list
55723701|NCT02392429|Alovudine|alovudine|mesh-list
55723702|NCT02392429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55723703|NCT02392429|Antimetabolites|antimetabolites|mesh-ancestor
55723704|NCT02392429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723705|NCT02392429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723706|NCT02392429|Antiviral Agents|antiviral agents|mesh-ancestor
55723707|NCT02392429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723708|NCT02392429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55723709|NCT02392429|Immunologic Factors|immunologic factors|mesh-ancestor
55723710|NCT02392429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723711|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
55723712|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55723713|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
55723714|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723715|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723716|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55723717|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
55723718|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
55723719|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55723720|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
55723721|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723722|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723723|NCT04461535|Hormones|hormones|mesh-list
55723724|NCT04461535|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55723725|NCT04461535|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55723726|NCT04461535|beta-Endorphin|beta-endorphin|mesh-list
55723727|NCT04461535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723728|NCT04461535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723729|NCT04461535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723730|NCT04461535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723732|NCT04462003|Apixaban|apixaban|mesh-list
55723733|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
55723734|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55723735|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55723736|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723737|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55723738|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
55723739|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55723740|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
55723741|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723742|NCT03489265|Eluxadoline|eluxadoline|mesh-list
55723743|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55723744|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
55723746|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55723747|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723748|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55723749|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723750|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55723751|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723752|NCT03260881|Liraglutide|liraglutide|mesh-list
55723753|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55723754|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723755|NCT03260881|Incretins|incretins|mesh-ancestor
55723757|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723758|NCT03238495|Metformin|metformin|mesh-list
55723759|NCT03238495|Carboplatin|carboplatin|mesh-list
55723760|NCT03238495|Docetaxel|docetaxel|mesh-list
55723761|NCT03238495|Trastuzumab|trastuzumab|mesh-list
55723762|NCT03238495|Pertuzumab|pertuzumab|mesh-list
55723763|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723764|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55723765|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723766|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
55723767|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
55723768|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
55723769|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723770|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723771|NCT02536339|Trastuzumab|trastuzumab|mesh-list
55723772|NCT02536339|Pertuzumab|pertuzumab|mesh-list
55723773|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723774|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723775|NCT01869361|Indomethacin|indomethacin|mesh-list
55723776|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55723777|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55723778|NCT01869361|Analgesics|analgesics|mesh-ancestor
55723779|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
55723780|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723781|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723782|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723783|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55723784|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
55723785|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
55723786|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55723787|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55723788|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723789|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723790|NCT02322619|Moxifloxacin|moxifloxacin|mesh-list
55723791|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55723792|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723793|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55723794|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55723795|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723796|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723797|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723798|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55723799|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723800|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723801|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
55723802|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55723803|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723805|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55723806|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
55723807|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723808|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723809|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55723810|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723811|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55723812|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55723813|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55723814|NCT03488719|Metoprolol|metoprolol|mesh-list
55723815|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55723816|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55723817|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
55723818|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
55723819|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723820|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723821|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55723822|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55723823|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55723824|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
55723825|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723826|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723827|NCT03496831|Adalimumab|adalimumab|mesh-list
55723828|NCT03496831|Etanercept|etanercept|mesh-list
55723829|NCT03496831|Golimumab|golimumab|mesh-list
55723830|NCT03496831|Abatacept|abatacept|mesh-list
55723831|NCT03496831|Infliximab|infliximab|mesh-list
55723832|NCT03496831|Ustekinumab|ustekinumab|mesh-list
55723833|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723834|NCT03496831|Immunologic Factors|immunologic factors|mesh-ancestor
55723835|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723836|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55723837|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723838|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
55723839|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55723840|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55723841|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55723842|NCT03496831|Analgesics|analgesics|mesh-ancestor
55723843|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
55723844|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723845|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55723846|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55723847|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723848|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55723849|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
55723850|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
55723902|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55723903|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
55723904|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723905|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723906|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723907|NCT03675815|Ritonavir|ritonavir|mesh-list
55723908|NCT03675815|Darunavir|darunavir|mesh-list
55723909|NCT03675815|Tenofovir|tenofovir|mesh-list
55723910|NCT03675815|Lamivudine|lamivudine|mesh-list
55723911|NCT03675815|Emtricitabine|emtricitabine|mesh-list
55723912|NCT03675815|Dolutegravir|dolutegravir|mesh-list
55723913|NCT03675815|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
55723914|NCT03675815|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55723915|NCT03675815|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55723916|NCT03675815|Protease Inhibitors|protease inhibitors|mesh-ancestor
55723917|NCT03675815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723918|NCT03675815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723919|NCT03675815|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55723920|NCT03675815|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55723921|NCT03675815|Antiviral Agents|antiviral agents|mesh-ancestor
55723922|NCT03675815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723923|NCT03675815|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55723924|NCT03675815|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55723925|NCT03675815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55723926|NCT03675815|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55723927|NCT03675815|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55723928|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
55723929|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55723930|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55723931|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55723932|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55723933|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723934|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
55723935|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55723936|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723937|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55723938|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723939|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
55723940|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
55723941|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
55723942|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723943|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723944|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55723945|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55723946|NCT00805805|Growth Substances|growth substances|mesh-ancestor
55723947|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723948|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
55723949|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723950|NCT03488173|Lansoprazole|lansoprazole|mesh-list
55723951|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
55723952|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55723953|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55723954|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55723955|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723956|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723957|NCT03420521|Nivolumab|nivolumab|mesh-list
55723958|NCT03420521|Ipilimumab|ipilimumab|mesh-list
55723959|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55723960|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55723961|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55723962|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723964|NCT04750759|Camostat|camostat|mesh-list
55723965|NCT04750759|Protease Inhibitors|protease inhibitors|mesh-ancestor
55723966|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723967|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723968|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55723969|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55723970|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
55723971|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55723972|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
55723973|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55723974|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55723975|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
55723976|NCT03382925|Triamcinolone|triamcinolone|mesh-list
55723977|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55723978|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55723980|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55723981|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
55723982|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
55723983|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55723984|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55723985|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
55723986|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55723987|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55723988|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55723989|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55723990|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55723991|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55723992|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55723993|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
55723994|NCT03382925|Hormones|hormones|mesh-ancestor
55723995|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55723996|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55723997|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
55723998|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55723999|NCT03487939|Fluorouracil|fluorouracil|mesh-list
55724000|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
55724001|NCT03487939|Irinotecan|irinotecan|mesh-list
55724002|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
55724003|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724004|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55724005|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724006|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55724007|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
55724008|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724009|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55724010|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55724011|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724012|NCT00796289|Citric Acid|citric acid|mesh-list
55724013|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
55724014|NCT00796289|Clomiphene|clomiphene|mesh-list
55724015|NCT00796289|Enclomiphene|enclomiphene|mesh-list
55724016|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
55724017|NCT00796289|Hormones|hormones|mesh-list
55766449|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
55724018|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55724019|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
55724020|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55724021|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
55724022|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
55724023|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724024|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724025|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724026|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55724027|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
55724028|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55724029|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
55724030|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55724031|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55724032|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55724034|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
55724035|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724037|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55724038|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
55724039|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724041|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
55724042|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55724043|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
55724044|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724045|NCT04460521|Protective Agents|protective agents|mesh-ancestor
55828712|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55828713|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
55724046|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724047|NCT04460521|Antidotes|antidotes|mesh-ancestor
55724048|NCT00698789|Metformin|metformin|mesh-list
55724049|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55724050|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724051|NCT03487783|Aripiprazole|aripiprazole|mesh-list
55724052|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55724053|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
55724112|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724113|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724114|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55724115|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724116|NCT02799095|Pembrolizumab|pembrolizumab|mesh-list
55724117|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724118|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724119|NCT02011321|Clevidipine|clevidipine|mesh-list
55724120|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55724121|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55724122|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724123|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55724124|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724125|NCT03916627|Cemiplimab|cemiplimab|mesh-list
55724126|NCT03916627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724127|NCT03916627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724128|NCT01352585|Anagrelide|anagrelide|mesh-list
55724129|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55724130|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55724131|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724132|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55724133|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
55724134|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
55724135|NCT03484507|Prednisolone|prednisolone|mesh-list
55724136|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55724137|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
55724138|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55724139|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
55724140|NCT03484507|Povidone|povidone|mesh-list
55724141|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55724142|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
55724143|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724144|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
55724145|NCT03484507|Hormones|hormones|mesh-ancestor
55724146|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724147|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724148|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55724149|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724150|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
55724151|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
55724152|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724153|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55724154|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55724155|NCT03484507|Protective Agents|protective agents|mesh-ancestor
55724156|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55724157|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724158|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
55724159|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
55724160|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
55724161|NCT02773355|Liraglutide|liraglutide|mesh-list
55724162|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55724163|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724164|NCT02773355|Incretins|incretins|mesh-ancestor
55724166|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724167|NCT02744183|Benzocaine|benzocaine|mesh-list
55724168|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
55724169|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
55724170|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724171|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724172|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
55724173|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724174|NCT03484195|Fluorouracil|fluorouracil|mesh-list
55724175|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
55724176|NCT03484195|Irinotecan|irinotecan|mesh-list
55724177|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
55724178|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724179|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55724180|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724181|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55724182|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
55724183|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724184|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55724185|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55724186|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724187|NCT02713607|Doxycycline|doxycycline|mesh-list
55724188|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55724189|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724190|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
55724191|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55724192|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55724193|NCT04526821|Lactoferrin|lactoferrin|mesh-list
55724194|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724195|NCT02681549|Bevacizumab|bevacizumab|mesh-list
55724196|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
55724197|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724198|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724199|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55724200|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55724201|NCT02681549|Growth Substances|growth substances|mesh-ancestor
55724202|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724203|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
55724204|NCT02323399|Phenylephrine|phenylephrine|mesh-list
55724205|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
55724206|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55724207|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
55724208|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
55724209|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724210|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724211|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
55724212|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55724213|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
55724214|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
55724215|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55724216|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55724217|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55724218|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
55724219|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724220|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724221|NCT02323399|Protective Agents|protective agents|mesh-ancestor
55724222|NCT02617277|Durvalumab|durvalumab|mesh-list
55724223|NCT02617277|Adavosertib|adavosertib|mesh-list
55724224|NCT02617277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724225|NCT02617277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724226|NCT02617277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724227|NCT02617277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724228|NCT02032823|Olaparib|olaparib|mesh-list
55724229|NCT02032823|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55724230|NCT02032823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724236|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55724237|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55724238|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724239|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724240|NCT01352507|Urological Agents|urological agents|mesh-ancestor
55724241|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
55724242|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55724243|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55724244|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
55724245|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724246|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724247|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55724248|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
55724249|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55724250|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
55724251|NCT04460963|Protective Agents|protective agents|mesh-ancestor
55724252|NCT00873275|Leucovorin|leucovorin|mesh-list
55724253|NCT00873275|Bevacizumab|bevacizumab|mesh-list
55724254|NCT00873275|Fluorouracil|fluorouracil|mesh-list
55724255|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
55724256|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55724257|NCT00873275|Calcium|calcium|mesh-list
55724258|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
55724259|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724260|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724261|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55724262|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55724263|NCT00873275|Growth Substances|growth substances|mesh-ancestor
55724264|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724265|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
55724266|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55724267|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
55724268|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724269|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55724270|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55724271|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
55724272|NCT00873275|Antidotes|antidotes|mesh-ancestor
55724274|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
55724275|NCT00873275|Vitamins|vitamins|mesh-ancestor
55724276|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
55724277|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55724278|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55724279|NCT04403243|Colchicine|colchicine|mesh-list
55724280|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
55724281|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724282|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
55724283|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
55724284|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
55724285|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766483|NCT02413853|Vitamins|vitamins|mesh-ancestor
55724286|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724288|NCT05648032|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55724289|NCT05648032|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55724290|NCT05648032|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55724291|NCT05648032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724292|NCT05648032|Glucocorticoids|glucocorticoids|mesh-ancestor
55724293|NCT05648032|Hormones|hormones|mesh-ancestor
55724294|NCT05648032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724295|NCT05648032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724296|NCT05648032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55724297|NCT05648032|Immunologic Factors|immunologic factors|mesh-ancestor
55724298|NCT05648032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724299|NCT05648032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724300|NCT00774761|Fluticasone|fluticasone|mesh-list
55724302|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
55724303|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724304|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55724305|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
55724306|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724307|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724308|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55724309|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
55724310|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
55724311|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55724312|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55724313|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55724314|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55724315|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
55724316|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724317|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724318|NCT00772343|Vaccines|vaccines|mesh-list
55724319|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
55724320|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724321|NCT05647954|Pembrolizumab|pembrolizumab|mesh-list
55724322|NCT05647954|Temozolomide|temozolomide|mesh-list
55724323|NCT05647954|Chlorotrianisene|chlorotrianisene|mesh-list
55724324|NCT05647954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724325|NCT05647954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724326|NCT05647954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55724327|NCT05647954|Alkylating Agents|alkylating agents|mesh-ancestor
55724328|NCT05647954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724329|NCT05647954|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55724330|NCT05647954|Estrogens|estrogens|mesh-ancestor
55724331|NCT05647954|Hormones|hormones|mesh-ancestor
55766490|NCT00704483|Hematinics|hematinics|mesh-ancestor
55724332|NCT05647954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724333|NCT05647954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724334|NCT05647954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55724335|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55724336|NCT00770081|Vildagliptin|vildagliptin|mesh-list
55724337|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55724338|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724339|NCT00770081|Incretins|incretins|mesh-ancestor
55724340|NCT00770081|Hormones|hormones|mesh-ancestor
55724341|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724342|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55724343|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
55724344|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724345|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724346|NCT02360098|Anesthetics|anesthetics|mesh-list
55724347|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724348|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724349|NCT02273609|Vitamin K|vitamin k|mesh-list
55724350|NCT02273609|Warfarin|warfarin|mesh-list
55724351|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
55724352|NCT02273609|Vitamins|vitamins|mesh-ancestor
55724353|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
55724354|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724355|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
55724356|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55724357|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55724358|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724359|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
55724360|NCT02273609|Coagulants|coagulants|mesh-ancestor
55724362|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
55724364|NCT02273843|Vitamins|vitamins|mesh-list
55724365|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
55724366|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724367|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55724368|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55724369|NCT00666497|Azacitidine|azacitidine|mesh-list
55724370|NCT00666497|Mocetinostat|mocetinostat|mesh-list
55724371|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55724372|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
55724373|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724374|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724375|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724376|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55724377|NCT02274077|Bupivacaine|bupivacaine|mesh-list
55724378|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
55724379|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
55724380|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724381|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724382|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
55724383|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724384|NCT00765323|Octreotide|octreotide|mesh-list
55724385|NCT00765323|Somatostatin|somatostatin|mesh-list
55724386|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55724387|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55724388|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724389|NCT00765323|Hormones|hormones|mesh-ancestor
55724390|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724391|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724392|NCT02276495|Ketorolac|ketorolac|mesh-list
55724393|NCT02276495|Clonidine|clonidine|mesh-list
55724394|NCT02276495|Epinephrine|epinephrine|mesh-list
55724395|NCT02276495|Ropivacaine|ropivacaine|mesh-list
55724396|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
55724397|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
55724398|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724399|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724400|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
55724401|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724402|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55724403|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55724404|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
55724405|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724406|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724407|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55724408|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55724409|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
55724410|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55724411|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
55724412|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
55724413|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
55724414|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55724415|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55724416|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55724417|NCT02276495|Analgesics|analgesics|mesh-ancestor
55724418|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724419|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724420|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55724421|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724422|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55724423|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
55724424|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55724425|NCT02277587|Hydrocortisone|hydrocortisone|mesh-list
55724426|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55724427|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55724428|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55724429|NCT02277587|Cortisone|cortisone|mesh-list
55724430|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
55724431|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724432|NCT02277587|Hormones|hormones|mesh-ancestor
55724433|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724434|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724435|NCT00663767|Celecoxib|celecoxib|mesh-list
55724436|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
55724437|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55724438|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55724439|NCT00663767|Analgesics|analgesics|mesh-ancestor
55724440|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
55724441|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724442|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724443|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724444|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724445|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55724446|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724447|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724448|NCT00662597|Paclitaxel|paclitaxel|mesh-list
55724449|NCT00662597|Carboplatin|carboplatin|mesh-list
55724451|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55724452|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724453|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
55724454|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
55724455|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
55724456|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724458|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724459|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724460|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
55724461|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724462|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724463|NCT01641952|Rituximab|rituximab|mesh-list
55724464|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724465|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724466|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
55724467|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724468|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724469|NCT00660881|Epratuzumab|epratuzumab|mesh-list
55724470|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724471|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724472|NCT02359552|Rasagiline|rasagiline|mesh-list
55724473|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55724474|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724475|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724476|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55724477|NCT02359552|Protective Agents|protective agents|mesh-ancestor
55724478|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724479|NCT02279537|Aflibercept|aflibercept|mesh-list
55724480|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55724481|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55724482|NCT02279537|Growth Substances|growth substances|mesh-ancestor
55724483|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724484|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
55724485|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724486|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
55724487|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55724488|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55724489|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55724490|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55724491|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724492|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
55724493|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724494|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724495|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55724496|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724497|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
55724498|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55724499|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55724500|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55724501|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55724502|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724503|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
55724504|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724505|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724506|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55724507|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724509|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
55724510|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
55724511|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724512|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724513|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
55724514|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724515|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55724516|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55724517|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55724518|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55724519|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724520|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
55724521|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724523|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55724524|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55724525|NCT02280629|Analgesics|analgesics|mesh-ancestor
55724526|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
55724527|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724528|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724529|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724530|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724531|NCT03134573|Interferons|interferons|mesh-list
55724532|NCT03134573|Interferon-beta|interferon-beta|mesh-list
55724533|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
55724534|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724535|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
55724536|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724537|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
55724538|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724539|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55724540|NCT00743795|Ribavirin|ribavirin|mesh-list
55724541|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55724542|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
55724543|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724544|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
55724545|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724546|NCT04232033|Mitogens|mitogens|mesh-list
55724547|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
55724548|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724549|NCT03134417|Vitamin D|vitamin d|mesh-list
55724550|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
55724551|NCT03134417|Cholecalciferol|cholecalciferol|mesh-list
55724552|NCT03134417|Vitamins|vitamins|mesh-list
55724553|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
55724554|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724555|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55724556|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55724557|NCT00649025|Fluticasone|fluticasone|mesh-list
55724559|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724560|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55724561|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
55724562|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724563|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724564|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55724565|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
55724566|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
55724567|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55724568|NCT00647231|Ketoprofen|ketoprofen|mesh-list
55724569|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55724570|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55724571|NCT00647231|Analgesics|analgesics|mesh-ancestor
55724572|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
55724573|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724574|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724575|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724576|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724577|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55724578|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724579|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724580|NCT00739349|Cyclosporine|cyclosporine|mesh-list
55724581|NCT00739349|Cyclosporins|cyclosporins|mesh-list
55724582|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724583|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724584|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55724585|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
55724586|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724587|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
55724588|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724589|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
55724590|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724591|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55724593|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55724594|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55724595|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55724596|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55724597|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
55724598|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724599|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724600|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724601|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55724602|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724603|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724605|NCT04158635|Paclitaxel|paclitaxel|mesh-list
55724606|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55724607|NCT04158635|Bosentan|bosentan|mesh-list
55724608|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55724609|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828722|NCT04626791|Cortisone|cortisone|mesh-list
55828723|NCT04626791|Cyclophosphamide|cyclophosphamide|mesh-list
55828724|NCT04626791|Rituximab|rituximab|mesh-list
55828725|NCT04626791|Doxorubicin|doxorubicin|mesh-list
55828726|NCT04626791|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55828727|NCT04626791|Bortezomib|bortezomib|mesh-list
55828728|NCT04626791|Acalabrutinib|acalabrutinib|mesh-list
55724610|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
55724611|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
55724612|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
55724613|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724614|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55724615|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
55724616|NCT04158635|Antiviral Agents|antiviral agents|mesh-ancestor
55724617|NCT04158635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724618|NCT04158635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724619|NCT04158635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55724620|NCT04158635|Immunologic Factors|immunologic factors|mesh-ancestor
55724621|NCT04158635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724622|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55724623|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55724624|NCT00734435|Zonisamide|zonisamide|mesh-list
55724625|NCT00734435|Olanzapine|olanzapine|mesh-list
55724626|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
55724627|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
55724628|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724629|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724630|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55724631|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55724632|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55724633|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724634|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55724635|NCT00734435|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55724636|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55724637|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55724638|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724639|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724640|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
55724641|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
55724642|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55724643|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55724644|NCT04040231|Nivolumab|nivolumab|mesh-list
55724645|NCT04040231|Sargramostim|sargramostim|mesh-list
55724646|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724647|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724648|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55724649|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724650|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
55724651|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724652|NCT00728351|Metformin|metformin|mesh-list
55724653|NCT00728351|Vildagliptin|vildagliptin|mesh-list
55724654|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55724655|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724656|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55724657|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
55724658|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724659|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724660|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55724661|NCT00616811|Vildagliptin|vildagliptin|mesh-list
55724662|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55724663|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724664|NCT00616811|Incretins|incretins|mesh-ancestor
55724665|NCT00616811|Hormones|hormones|mesh-ancestor
55724666|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724667|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55724668|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
55724669|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724670|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724671|NCT00615251|Progesterone|progesterone|mesh-list
55724672|NCT00615251|Progestins|progestins|mesh-ancestor
55724673|NCT00615251|Hormones|hormones|mesh-ancestor
55724674|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724675|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724676|NCT02265796|Ranolazine|ranolazine|mesh-list
55724677|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55724678|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55724679|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724680|NCT05647642|Midazolam|midazolam|mesh-list
55724681|NCT05647642|Dexmedetomidine|dexmedetomidine|mesh-list
55724682|NCT05647642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55724683|NCT05647642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724684|NCT05647642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724685|NCT05647642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55724686|NCT05647642|Analgesics|analgesics|mesh-ancestor
55724687|NCT05647642|Sensory System Agents|sensory system agents|mesh-ancestor
55724688|NCT05647642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724689|NCT05647642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55724690|NCT05647642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55724691|NCT05647642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55724692|NCT05647642|Adrenergic Agents|adrenergic agents|mesh-ancestor
55724693|NCT05647642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724694|NCT05647642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724695|NCT05647642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55724696|NCT05647642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55724697|NCT05647642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55724698|NCT05647642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55724699|NCT05647642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55724700|NCT05647642|Anesthetics, General|anesthetics, general|mesh-ancestor
55724701|NCT05647642|Anesthetics|anesthetics|mesh-ancestor
55724702|NCT05647642|GABA Modulators|gaba modulators|mesh-ancestor
55724703|NCT05647642|GABA Agents|gaba agents|mesh-ancestor
55724704|NCT02357368|Copper|copper|mesh-list
55724705|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55724706|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
55724707|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
55724708|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
55724709|NCT02357368|Etonogestrel|etonogestrel|mesh-list
55724710|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55724711|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724712|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55724713|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55724714|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55724715|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55724716|NCT02357368|Trace Elements|trace elements|mesh-ancestor
55724717|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
55724718|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55724719|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55724720|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55724721|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724723|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55724724|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55724725|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55724726|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55724727|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724728|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724729|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724731|NCT05647408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724732|NCT05647408|Antiemetics|antiemetics|mesh-ancestor
55724733|NCT05647408|Autonomic Agents|autonomic agents|mesh-ancestor
55724734|NCT05647408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724735|NCT05647408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724736|NCT05647408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55724737|NCT05647408|Glucocorticoids|glucocorticoids|mesh-ancestor
55724738|NCT05647408|Hormones|hormones|mesh-ancestor
55724739|NCT05647408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724740|NCT05647408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55724741|NCT05647408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724742|NCT03483415|Morphine|morphine|mesh-list
55724743|NCT03483415|Bupivacaine|bupivacaine|mesh-list
55724744|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
55724745|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
55724746|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724747|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724748|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
55724749|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724750|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55724752|NCT03483415|Analgesics|analgesics|mesh-ancestor
55724753|NCT03487003|Bromides|bromides|mesh-list
55724754|NCT03487003|Rocuronium|rocuronium|mesh-list
55724755|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
55724756|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55724757|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55724758|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55724759|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724760|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724761|NCT03486925|Oxytocin|oxytocin|mesh-list
55724762|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
55724763|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55724764|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724765|NCT02262754|Naproxen|naproxen|mesh-list
55724766|NCT02262754|PF-06372865|pf-06372865|mesh-list
55724767|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55724768|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55724769|NCT02262754|Analgesics|analgesics|mesh-ancestor
55724771|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724772|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724774|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724775|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
55724776|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55724777|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724778|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724779|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
55724780|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
55724781|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724782|NCT03483181|Enoxaparin|enoxaparin|mesh-list
55724783|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
55724784|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55724785|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
55724786|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55724787|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
55724788|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724789|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724790|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
55724791|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55724792|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55724793|NCT03069937|Docetaxel|docetaxel|mesh-list
55724794|NCT03069937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724795|NCT03069937|Tubulin Modulators|tubulin modulators|mesh-ancestor
55724796|NCT03069937|Antimitotic Agents|antimitotic agents|mesh-ancestor
55724797|NCT03069937|Mitosis Modulators|mitosis modulators|mesh-ancestor
55724798|NCT03069937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724799|NCT00309985|Docetaxel|docetaxel|mesh-list
55724800|NCT00309985|Androgens|androgens|mesh-list
55724801|NCT00309985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724802|NCT00309985|Tubulin Modulators|tubulin modulators|mesh-ancestor
55724804|NCT00309985|Mitosis Modulators|mitosis modulators|mesh-ancestor
55724805|NCT00309985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724867|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55724869|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724870|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
55724871|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
55724872|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724873|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724874|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55724875|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
55724876|NCT02260804|Rituximab|rituximab|mesh-list
55724877|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724878|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724879|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
55724880|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724881|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55724882|NCT03486457|Tofacitinib|tofacitinib|mesh-list
55724883|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55724884|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724885|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724886|NCT02260648|Atorvastatin|atorvastatin|mesh-list
55724887|NCT02260648|Ezetimibe|ezetimibe|mesh-list
55724888|NCT02260648|Evacetrapib|evacetrapib|mesh-list
55724889|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55724890|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55724891|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
55724892|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724893|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55724894|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55724895|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724896|NCT04179019|Amlodipine|amlodipine|mesh-list
55724897|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55724898|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55724899|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55724900|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724901|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55724902|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724903|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
55724906|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55724907|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55724908|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724909|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55724910|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
55724911|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724912|NCT02260492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828767|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828769|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828770|NCT01574716|Gemcitabine|gemcitabine|mesh-list
55828771|NCT01574716|Docetaxel|docetaxel|mesh-list
55828772|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55828773|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
55828774|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828775|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724913|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55724914|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
55724915|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
55724916|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55724917|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55724918|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55724919|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55724920|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
55724921|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724922|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724923|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
55724924|NCT02260492|Hormones|hormones|mesh-ancestor
55724925|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724926|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
55724927|NCT03966625|Autoantibodies|autoantibodies|mesh-list
55724928|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
55724929|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724930|NCT02260258|Rocuronium|rocuronium|mesh-list
55724931|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55724932|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55724933|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55724935|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724937|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
55724938|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
55724939|NCT05151679|Trace Elements|trace elements|mesh-ancestor
55724940|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
55724941|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724942|NCT05151679|Hematinics|hematinics|mesh-ancestor
55724943|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
55724944|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
55724947|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55724948|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724950|NCT02353468|Lenalidomide|lenalidomide|mesh-list
55724951|NCT02353468|Bortezomib|bortezomib|mesh-list
55724952|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55724953|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
55724954|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
55724955|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55724956|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724957|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55724958|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
55724959|NCT02353468|Hormones|hormones|mesh-ancestor
55724960|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55724961|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55724962|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724963|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
55724964|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55724965|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55724966|NCT02353468|Growth Substances|growth substances|mesh-ancestor
55724967|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
55724968|NCT02523859|Propofol|propofol|mesh-list
55724969|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55724970|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55724971|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724972|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55724973|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
55724974|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
55724975|NCT04459663|Axitinib|axitinib|mesh-list
55724976|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724977|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55724978|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55724979|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724980|NCT05150899|Fexofenadine|fexofenadine|mesh-list
55724982|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55724983|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55724985|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
55724986|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55724987|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55724988|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55724989|NCT05150899|Urological Agents|urological agents|mesh-ancestor
55724990|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55724991|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55724992|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55724993|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
55724994|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
55724995|NCT01530997|Cisplatin|cisplatin|mesh-list
55724996|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55724997|NCT00593905|Bosentan|bosentan|mesh-list
55724998|NCT00593905|Ambrisentan|ambrisentan|mesh-list
55724999|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
55725000|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55725001|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55725002|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725003|NCT02259088|Ranibizumab|ranibizumab|mesh-list
55725004|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55725005|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55725006|NCT02259088|Growth Substances|growth substances|mesh-ancestor
55725007|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725008|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
55725009|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725011|NCT02830477|Coagulants|coagulants|mesh-ancestor
55725012|NCT02259010|Itraconazole|itraconazole|mesh-list
55725013|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
55725014|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725015|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55725016|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55725017|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725018|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725019|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55725020|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
55725021|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55725022|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725023|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55725024|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55725025|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
55725026|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725028|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
55725029|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
55725030|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725031|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725032|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
55725033|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725034|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55725035|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55725036|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55725037|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55725039|NCT00151775|Olmesartan|olmesartan|mesh-list
55725040|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
55725041|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55725042|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55725043|NCT00151775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55725044|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725045|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55725046|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725047|NCT03476941|Clindamycin|clindamycin|mesh-list
55725048|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
55725049|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
55725050|NCT03476941|Gentamicins|gentamicins|mesh-list
55725051|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55725052|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725053|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55725054|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725055|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725056|NCT00609323|Lidocaine|lidocaine|mesh-list
55725057|NCT00609323|Tetracaine|tetracaine|mesh-list
55725058|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
55725059|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
55725060|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725061|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725062|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
55725063|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725064|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55725065|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55725066|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55725067|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55766573|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55725068|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725069|NCT02682901|Bromocriptine|bromocriptine|mesh-list
55725070|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55725071|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55725072|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
55725073|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55725074|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725075|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
55725076|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
55725077|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725078|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725079|NCT02258074|Niacinamide|niacinamide|mesh-list
55725081|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
55725082|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
55725083|NCT02258074|Vitamins|vitamins|mesh-ancestor
55725084|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
55725085|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725086|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55725087|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
55725088|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725089|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55725090|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
55725091|NCT04473053|Nafamostat|nafamostat|mesh-list
55725092|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55725165|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
55725093|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55725094|NCT04473053|Analgesics|analgesics|mesh-ancestor
55725095|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
55725096|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725097|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725098|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55725099|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55725100|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
55725101|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
55725102|NCT04473053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725103|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725104|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55725105|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55725106|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55725107|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725108|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
55725109|NCT02281643|Doxycycline|doxycycline|mesh-list
55725110|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55725111|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725112|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
55725113|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55725114|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55725115|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
55725116|NCT02281721|Antacids|antacids|mesh-ancestor
55828816|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55828817|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55828818|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55828823|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
55725117|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725118|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55725120|NCT01642732|Leuprolide|leuprolide|mesh-list
55725121|NCT01642732|Bicalutamide|bicalutamide|mesh-list
55725122|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725123|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725124|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
55725125|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725126|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55725127|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
55725128|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55725129|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55725130|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
55725131|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
55725132|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55725133|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
55725134|NCT02281799|Azathioprine|azathioprine|mesh-list
55725135|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
55725136|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725137|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55725138|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725139|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725140|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
55725141|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725142|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55725143|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725144|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55725145|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55725146|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55725147|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55864060|NCT02152696|Methotrexate|methotrexate|mesh-list
55725148|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
55725149|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725150|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55725151|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55725152|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725153|NCT00589823|Fentanyl|fentanyl|mesh-list
55725154|NCT00589823|Morphine|morphine|mesh-list
55725155|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55725156|NCT00589823|Narcotics|narcotics|mesh-ancestor
55725157|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725158|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725159|NCT00589823|Analgesics|analgesics|mesh-ancestor
55725160|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
55725161|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725162|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55725163|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55725164|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
55725219|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55725220|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55725221|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
55725222|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725223|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725224|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55725225|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
55725226|NCT04660747|Anticoagulants|anticoagulants|mesh-list
55725227|NCT02348008|Bevacizumab|bevacizumab|mesh-list
55725228|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
55725229|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55725230|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725231|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55725232|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55725234|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725235|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
55725237|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
55725238|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725239|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55725240|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55725241|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55725242|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
55725243|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725244|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725245|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55725246|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55725247|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
55725248|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725249|NCT00495131|Interferons|interferons|mesh-list
55725250|NCT00495131|Ribavirin|ribavirin|mesh-list
55725251|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
55725252|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
55725253|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55725254|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725255|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
55725256|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725257|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
55725258|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725259|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
55725260|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725262|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55725263|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
55725264|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725265|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725266|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55725267|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
55725268|NCT02257372|Tocolytic Agents|tocolytic agents|mesh-ancestor
55725269|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55725270|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55725271|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55725272|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55725273|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
55725274|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725275|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725276|NCT02256982|Gemcitabine|gemcitabine|mesh-list
55725278|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725279|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55725280|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
55725281|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725282|NCT02256982|Antiviral Agents|antiviral agents|mesh-ancestor
55725283|NCT02256982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725284|NCT02256982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725285|NCT02256982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725286|NCT02256982|Immunologic Factors|immunologic factors|mesh-ancestor
55725287|NCT02256982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725288|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
55725289|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55725290|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
55725291|NCT03480607|Dexamethasone|dexamethasone|mesh-list
55725292|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
55725293|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55725294|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
55725295|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
55725296|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725297|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725298|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55725355|NCT05646394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725356|NCT05646394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55725357|NCT05646394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725359|NCT05646394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55725360|NCT05646394|Hemostatics|hemostatics|mesh-ancestor
55725361|NCT05646394|Coagulants|coagulants|mesh-ancestor
55725362|NCT00563459|Topiramate|topiramate|mesh-list
55725363|NCT00563459|Levetiracetam|levetiracetam|mesh-list
55725364|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
55725365|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55725366|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725367|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
55725368|NCT04947631|Tadalafil|tadalafil|mesh-list
55725369|NCT04947631|Dutasteride|dutasteride|mesh-list
55725370|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
55725371|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55725372|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55725373|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725374|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725375|NCT04947631|Urological Agents|urological agents|mesh-ancestor
55725376|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55725377|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55725378|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
55725379|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55828844|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828845|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55828846|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55828847|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828848|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828849|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55725380|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725382|NCT00561743|Doxorubicin|doxorubicin|mesh-list
55725383|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55725384|NCT00561743|Bortezomib|bortezomib|mesh-list
55725385|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55725386|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
55725387|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
55725388|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725389|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725390|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55864768|NCT01698775|Glipizide|glipizide|mesh-list
55725391|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
55725393|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55725394|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55725395|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725396|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55725397|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55725398|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55725399|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725400|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725401|NCT00488267|Ketoprofen|ketoprofen|mesh-list
55725402|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55725403|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55725404|NCT00488267|Analgesics|analgesics|mesh-ancestor
55725405|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
55725406|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725407|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725408|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55725409|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55725410|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55725411|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725412|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725413|NCT00560183|Morphine|morphine|mesh-list
55725414|NCT00560183|Oxycodone|oxycodone|mesh-list
55725415|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55725416|NCT00560183|Narcotics|narcotics|mesh-ancestor
55864963|NCT03856216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55725417|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725418|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725419|NCT00560183|Analgesics|analgesics|mesh-ancestor
55725420|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
55725421|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725422|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55725423|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
55725424|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725476|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55725477|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55725478|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55725479|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
55725480|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725481|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725482|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55725483|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55725484|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
55725485|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725486|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
55725487|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55725488|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725489|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725490|NCT00465959|Trospium chloride|trospium chloride|mesh-list
55725491|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
55725492|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
55725493|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725494|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725495|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55725496|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55725497|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
55725498|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725499|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725500|NCT00465959|Urological Agents|urological agents|mesh-ancestor
55725501|NCT00465803|Timolol|timolol|mesh-list
55725502|NCT00465803|Travoprost|travoprost|mesh-list
55725503|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55725504|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55725505|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725506|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55725507|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55725508|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
55725509|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725510|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725511|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55725512|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55725513|NCT02282891|Ketamine|ketamine|mesh-list
55725514|NCT02282891|Propofol|propofol|mesh-list
55725515|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55725516|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725517|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725518|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55725519|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
55725520|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
55725521|NCT02282891|Analgesics|analgesics|mesh-ancestor
55725522|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
55725523|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865453|NCT02986321|Budesonide|budesonide|mesh-list
55725524|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55725525|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55725526|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55725527|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725528|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725529|NCT00464633|Alvocidib|alvocidib|mesh-list
55725530|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725531|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
55725532|NCT00464633|Growth Substances|growth substances|mesh-ancestor
55725533|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725534|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55725535|NCT00464633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725536|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725537|NCT00464555|Sirolimus|sirolimus|mesh-list
55725538|NCT00464555|Lisofylline|lisofylline|mesh-list
55725539|NCT00464555|Tacrolimus|tacrolimus|mesh-list
55725540|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55725541|NCT00464555|Basiliximab|basiliximab|mesh-list
55725542|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725543|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
55725544|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725545|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55725546|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725547|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725548|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55725549|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725550|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55725551|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725552|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
55725553|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55725554|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55725555|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55725556|NCT00464555|Analgesics|analgesics|mesh-ancestor
55725557|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
55725558|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725560|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55725561|NCT00464243|Volinanserin|volinanserin|mesh-list
55725562|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55725563|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
55725564|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725565|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725566|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725568|NCT03336541|Analgesics|analgesics|mesh-ancestor
55725569|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
55725570|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725571|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725572|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55725573|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55725574|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
55725575|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
55725576|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725577|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55725578|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55725579|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725580|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725581|NCT00525941|Indiplon|indiplon|mesh-list
55725582|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55725583|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725584|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725585|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
55725586|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
55725587|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725588|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725589|NCT03476083|Tenofovir|tenofovir|mesh-list
55725590|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
55725591|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725592|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55725593|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55725594|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725595|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725596|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55725597|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55725598|NCT02738203|Lidocaine|lidocaine|mesh-list
55725599|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
55725600|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
55725601|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725602|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725603|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
55725604|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725605|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55725606|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55725607|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55725608|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55725609|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725611|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55725612|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55725613|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55725614|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
55725615|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725616|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725617|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725618|NCT00457457|Urological Agents|urological agents|mesh-ancestor
55725619|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55725620|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
55725621|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
55725622|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725623|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
55725699|NCT00508625|Growth Substances|growth substances|mesh-ancestor
55725624|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725625|NCT03472651|Flupenthixol|flupenthixol|mesh-list
55725626|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
55725627|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55725628|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55725629|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725630|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725632|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55725633|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
55725634|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725635|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725636|NCT00517049|Rituximab|rituximab|mesh-list
55725637|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55725638|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725639|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
55725640|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725641|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55725642|NCT02283203|Acetaminophen|acetaminophen|mesh-list
55725643|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55725644|NCT02283203|Analgesics|analgesics|mesh-ancestor
55725645|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
55725646|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725647|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725649|NCT02536183|Doxorubicin|doxorubicin|mesh-list
55725650|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55725651|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55725652|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725653|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55725654|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55725655|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725656|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725657|NCT02523313|Nivolumab|nivolumab|mesh-list
55725658|NCT02523313|Ipilimumab|ipilimumab|mesh-list
55725659|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55865788|NCT01685983|Hormones|hormones|mesh-ancestor
55725660|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725661|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55725662|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725663|NCT02452034|Posaconazole|posaconazole|mesh-list
55725664|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
55725665|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725666|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55725667|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55725668|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55725669|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55725670|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55725671|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725672|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725673|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55725674|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
55725675|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55725676|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725677|NCT02283359|Irinotecan|irinotecan|mesh-list
55725678|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55725679|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55725680|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725681|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725682|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725683|NCT00511043|Vatalanib|vatalanib|mesh-list
55725684|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55725685|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725686|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725687|NCT00508625|Paclitaxel|paclitaxel|mesh-list
55725688|NCT00508625|Bevacizumab|bevacizumab|mesh-list
55725689|NCT00508625|Carboplatin|carboplatin|mesh-list
55725690|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55725691|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725692|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
55725693|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
55725694|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
55725695|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725696|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55725697|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55725698|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55725700|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725701|NCT00508625|Growth Inhibitors|growth inhibitors|mesh-ancestor
55725702|NCT02284529|Leucovorin|leucovorin|mesh-list
55725703|NCT02284529|Fluorouracil|fluorouracil|mesh-list
55725704|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
55725705|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725706|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55725707|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725708|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725709|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
55725710|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725711|NCT02284529|Antidotes|antidotes|mesh-ancestor
55725712|NCT02284529|Protective Agents|protective agents|mesh-ancestor
55725713|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
55725714|NCT02284529|Vitamins|vitamins|mesh-ancestor
55725715|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
55725716|NCT02482298|Ticagrelor|ticagrelor|mesh-list
55725717|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55725718|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55725719|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55725720|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55725721|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
55725722|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725723|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725724|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725725|NCT04470479|Pilocarpine|pilocarpine|mesh-list
55725727|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
55725728|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725729|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725730|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55725731|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55725732|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
55725733|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725734|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725735|NCT00383513|Epratuzumab|epratuzumab|mesh-list
55725736|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55725737|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725738|NCT00382811|Carboplatin|carboplatin|mesh-list
55725739|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725740|NCT02286635|Clarithromycin|clarithromycin|mesh-list
55725741|NCT02286635|Rifampin|rifampin|mesh-list
55725742|NCT02286635|Deflazacort|deflazacort|mesh-list
55725743|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55725744|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725745|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55725747|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725748|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55725749|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55725750|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55725751|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
55725752|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
55725753|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55725754|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55725755|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55725756|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55725757|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55725758|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55725759|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55725760|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55725761|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725762|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
55725763|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725764|NCT00440531|Vaccines|vaccines|mesh-list
55725765|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
55725766|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725767|NCT00380159|Lamivudine|lamivudine|mesh-list
55725768|NCT00380159|Emtricitabine|emtricitabine|mesh-list
55725769|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
55725770|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55725771|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55725772|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725773|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725774|NCT00380159|Antiviral Agents|antiviral agents|mesh-ancestor
55725775|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725827|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55725828|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725829|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55725830|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
55725831|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55725832|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55725833|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725834|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
55867232|NCT01706198|Xhance|xhance|mesh-list
55725835|NCT04470557|Coagulants|coagulants|mesh-ancestor
55725836|NCT00372437|Gemcitabine|gemcitabine|mesh-list
55725837|NCT00372437|Mocetinostat|mocetinostat|mesh-list
55725838|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55725839|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
55725840|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725841|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725842|NCT00372437|Antiviral Agents|antiviral agents|mesh-ancestor
55725843|NCT00372437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725844|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725845|NCT00372437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725846|NCT00372437|Immunologic Factors|immunologic factors|mesh-ancestor
55725847|NCT00372437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725848|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55725849|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55725850|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
55725851|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725852|NCT04470791|Antivenins|antivenins|mesh-list
55725853|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
55725854|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725855|NCT00364247|Tapentadol|tapentadol|mesh-list
55725856|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55725857|NCT00364247|Narcotics|narcotics|mesh-ancestor
55725858|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725859|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725860|NCT00364247|Analgesics|analgesics|mesh-ancestor
55725861|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
55725862|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725863|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55867642|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
55725864|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55725865|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55725866|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725867|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
55725868|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725869|NCT00424697|Lorazepam|lorazepam|mesh-list
55725870|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
55725871|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
55725872|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
55828885|NCT03918850|Buprenorphine|buprenorphine|mesh-list
55725873|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725874|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725875|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55867773|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
55725876|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55725877|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55725878|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55725879|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55725880|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55725881|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
55725882|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
55725883|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725884|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725886|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725887|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725888|NCT00356681|Niacinamide|niacinamide|mesh-list
55725889|NCT00356681|Paclitaxel|paclitaxel|mesh-list
55725890|NCT00356681|Bevacizumab|bevacizumab|mesh-list
55725891|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
55725892|NCT00356681|Imetelstat|imetelstat|mesh-list
55725893|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55725894|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725895|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
55725896|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
55725897|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
55725898|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725900|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55725901|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55725902|NCT00356681|Growth Substances|growth substances|mesh-ancestor
55725903|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725904|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
55725905|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55725906|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725907|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
55725908|NCT00356681|Vitamins|vitamins|mesh-ancestor
55725909|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
55725910|NCT00417209|Fluorouracil|fluorouracil|mesh-list
55725911|NCT00417209|Capecitabine|capecitabine|mesh-list
55725912|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
55725913|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725914|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55725915|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725916|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725917|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
55725918|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725919|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55725920|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55725921|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55725922|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55725923|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725925|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55725926|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725927|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55725928|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725930|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725931|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55725932|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
55725934|NCT00407303|Obatoclax|obatoclax|mesh-list
55725936|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725937|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725938|NCT00344045|Acetaminophen|acetaminophen|mesh-list
55725939|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55725940|NCT00344045|Analgesics|analgesics|mesh-ancestor
55725941|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
55725942|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55725943|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725944|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
55725945|NCT02256436|Paclitaxel|paclitaxel|mesh-list
55725946|NCT02256436|Docetaxel|docetaxel|mesh-list
55725947|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
55725948|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55725949|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725950|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
55725951|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
55725952|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
55725953|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725954|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55725955|NCT00343109|Sargramostim|sargramostim|mesh-list
55725956|NCT00343109|Vaccines|vaccines|mesh-list
55725957|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
55725958|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725959|NCT02481830|Nivolumab|nivolumab|mesh-list
55725960|NCT02481830|Topotecan|topotecan|mesh-list
55725961|NCT02481830|Amrubicin|amrubicin|mesh-list
55725962|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55725963|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725964|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55725965|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725966|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55725967|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55725968|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55725969|NCT00405743|Cytarabine|cytarabine|mesh-list
55725970|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55725971|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
55725972|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55725973|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725974|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
55725975|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55725976|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55725977|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
55725978|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725979|NCT00403169|Lenalidomide|lenalidomide|mesh-list
55725980|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
55725981|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725982|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55725983|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55725984|NCT00403169|Growth Substances|growth substances|mesh-ancestor
55725985|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
55725986|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725987|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
55725988|NCT00332657|Anecortave|anecortave|mesh-list
55725989|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55725990|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55725991|NCT00332657|Growth Substances|growth substances|mesh-ancestor
55725992|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55725993|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
55725994|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55725995|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55725996|NCT00330473|Insulin|insulin|mesh-list
55725997|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55725998|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55725999|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726000|NCT00327743|Capecitabine|capecitabine|mesh-list
55726001|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55726002|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
55726003|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726004|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726005|NCT02285075|Temocillin|temocillin|mesh-list
55726006|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55726007|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726008|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55726009|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726010|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55726011|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726012|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726013|NCT00398879|Capecitabine|capecitabine|mesh-list
55726014|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55726015|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
55726016|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726017|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726018|NCT00309179|Cetuximab|cetuximab|mesh-list
55726019|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55726020|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726021|NCT00394199|Fluticasone|fluticasone|mesh-list
55726022|NCT00394199|Xhance|xhance|mesh-list
55726023|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
55726024|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726025|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55726026|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
55726027|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726028|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726029|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55726030|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
55726031|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
55726032|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55726033|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55726034|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55726035|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55726036|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
55726037|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726038|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726039|NCT00394121|Fluticasone|fluticasone|mesh-list
55726040|NCT00394121|Xhance|xhance|mesh-list
55726041|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
55726042|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726043|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55726044|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
55726045|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726046|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726047|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55726048|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
55726049|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
55726050|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55726051|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55726052|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55726053|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55726054|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
55726055|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726130|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55726056|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726057|NCT02480114|Acetaminophen|acetaminophen|mesh-list
55726058|NCT02480114|Ibuprofen|ibuprofen|mesh-list
55726059|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55726060|NCT02480114|Fentanyl|fentanyl|mesh-list
55726061|NCT02480114|Oxycodone|oxycodone|mesh-list
55726062|NCT02480114|Hydrocodone|hydrocodone|mesh-list
55726063|NCT02480114|Gabapentin|gabapentin|mesh-list
55726064|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55726065|NCT02480114|Narcotics|narcotics|mesh-ancestor
55726066|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726067|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726068|NCT02480114|Analgesics|analgesics|mesh-ancestor
55726069|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
55726070|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726071|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55726072|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55726073|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
55726074|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
55726075|NCT02480114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55726076|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
55726077|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55726078|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726079|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726080|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55726081|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726082|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869651|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
55726084|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55726085|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55726086|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55726087|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55726088|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55726089|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726090|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
55726091|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
55726092|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
55726093|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
55726094|NCT00299507|Anecortave|anecortave|mesh-list
55726095|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55726096|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55726097|NCT00299507|Growth Substances|growth substances|mesh-ancestor
55726098|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726099|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
55726100|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726101|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726102|NCT02285309|Enoximone|enoximone|mesh-list
55726103|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55726104|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
55726105|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55726106|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55726107|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55766729|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55766733|NCT05514405|Propofol|propofol|mesh-list
55726108|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726109|NCT02285309|Protective Agents|protective agents|mesh-ancestor
55726110|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726112|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
55726113|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726114|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55726115|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55726116|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726117|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726118|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55726119|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55726120|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
55726121|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870473|NCT00949234|Tenofovir|tenofovir|mesh-list
55726122|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726123|NCT00297089|Pemetrexed|pemetrexed|mesh-list
55726124|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726125|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726126|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726127|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55726128|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55726129|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
55726131|NCT00286793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726132|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55726133|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
55726134|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55726135|NCT00286793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726136|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
55726137|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
55726138|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55726139|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
55726140|NCT02285699|Citalopram|citalopram|mesh-list
55726141|NCT02285699|Fluoxetine|fluoxetine|mesh-list
55726142|NCT02285699|Paroxetine|paroxetine|mesh-list
55726143|NCT02285699|Sertraline|sertraline|mesh-list
55726144|NCT02285699|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55726145|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55726146|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55726147|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726148|NCT02285699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726149|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
55726150|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726151|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55828923|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
55828924|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828925|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55828926|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55828927|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55726152|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
55726153|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55726154|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55726155|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55726156|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726157|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55726158|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55726159|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726160|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55726161|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55726162|NCT02288429|Colistin|colistin|mesh-list
55726163|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55726164|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726165|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
55726166|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55726167|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726168|NCT00265655|Satraplatin|satraplatin|mesh-list
55726169|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726170|NCT00254891|Paclitaxel|paclitaxel|mesh-list
55726171|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55726172|NCT00254891|Carboplatin|carboplatin|mesh-list
55726173|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55726174|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726175|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
55726176|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
55726177|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
55726178|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726180|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55726181|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
55726182|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726183|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726184|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55726185|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
55726186|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
55726187|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55726188|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55726189|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55870890|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
55870891|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55726190|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55726191|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
55726192|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726193|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726194|NCT00254579|Tremelimumab|tremelimumab|mesh-list
55726195|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726196|NCT00252005|Apixaban|apixaban|mesh-list
55726197|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55726198|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
55726199|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55726200|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
55726201|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726202|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726203|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
55726204|NCT02288507|Sorafenib|sorafenib|mesh-list
55726205|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726206|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55726207|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726208|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726209|NCT00231257|Sirolimus|sirolimus|mesh-list
55726210|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55726211|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726212|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55726213|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726214|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
55726215|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55726216|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
55726217|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726218|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
55726219|NCT00224003|Hematinics|hematinics|mesh-ancestor
55726220|NCT00216593|Galantamine|galantamine|mesh-list
55726221|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55726222|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726223|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726224|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
55726225|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726226|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726228|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
55766755|NCT04987775|Expectorants|expectorants|mesh-ancestor
55726229|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726230|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
55726231|NCT00389675|Guanfacine|guanfacine|mesh-list
55726232|NCT00389675|Darusentan|darusentan|mesh-list
55726233|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55726234|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55726235|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55726236|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55726237|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
55726238|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726239|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726240|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726241|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55726242|NCT02288741|Dexamethasone|dexamethasone|mesh-list
55726243|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
55726245|NCT02288741|BB 1101|bb 1101|mesh-list
55726246|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726247|NCT02288741|Antiemetics|antiemetics|mesh-ancestor
55726248|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
55726249|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726250|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726252|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
55726253|NCT02288741|Hormones|hormones|mesh-ancestor
55726254|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55726255|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55726256|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726257|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
55726258|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726259|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726260|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55726261|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
55726262|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55726263|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55726264|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
55726265|NCT02450552|Ezogabine|ezogabine|mesh-list
55726266|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
55726267|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55726268|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726269|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
55726270|NCT02508428|Diuretics|diuretics|mesh-ancestor
55726271|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
55726272|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726273|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55726274|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55726353|NCT03472339|Diclofenac|diclofenac|mesh-list
55726275|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726276|NCT02448446|Ranibizumab|ranibizumab|mesh-list
55726277|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55726278|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55726279|NCT02448446|Growth Substances|growth substances|mesh-ancestor
55726280|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726281|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
55726282|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726283|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
55726284|NCT02478398|Loratadine|loratadine|mesh-list
55726285|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55726286|NCT02478398|Epinephrine|epinephrine|mesh-list
55726287|NCT02478398|Albuterol|albuterol|mesh-list
55726288|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55726289|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55726290|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
55726291|NCT02478398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726292|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726293|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726294|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55726295|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55726297|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726298|NCT02478398|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55726299|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
55726300|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
55726301|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
55726302|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55726303|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
55726304|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55726305|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55726306|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726307|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
55726308|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55726309|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
55726310|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55726311|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55726312|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
55726313|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
55726314|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55726315|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55726316|NCT02478398|Analgesics|analgesics|mesh-ancestor
55726317|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
55726318|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726319|NCT02478164|Ponatinib|ponatinib|mesh-list
55726320|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726321|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55726322|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726323|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726324|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55726325|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55726326|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55726327|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55726328|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
55726329|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55726330|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726331|NCT05259319|Atezolizumab|atezolizumab|mesh-list
55726332|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726333|NCT05259007|Amoxicillin|amoxicillin|mesh-list
55726334|NCT05259007|Clarithromycin|clarithromycin|mesh-list
55726335|NCT05259007|Propolis|propolis|mesh-list
55726336|NCT05259007|Lansoprazole|lansoprazole|mesh-list
55726337|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
55726338|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55726339|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726340|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55726341|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726342|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726343|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55726344|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55726346|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55726347|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55726348|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
55726349|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55726350|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726351|NCT00380653|Sapacitabine|sapacitabine|mesh-list
55726352|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726354|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55726355|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55726356|NCT03472339|Analgesics|analgesics|mesh-ancestor
55726357|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
55726358|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726359|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726360|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726361|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726362|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55726363|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726364|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726365|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
55726366|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55726367|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55726368|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55726369|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55726370|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726371|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
55726372|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726373|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726374|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55726375|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726377|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
55726378|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726379|NCT03951025|Protective Agents|protective agents|mesh-ancestor
55726380|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726381|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726382|NCT02255500|Bupivacaine|bupivacaine|mesh-list
55726383|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
55726384|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
55726385|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726386|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726387|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
55726388|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726389|NCT03475693|Acetaminophen|acetaminophen|mesh-list
55726390|NCT03475693|Ondansetron|ondansetron|mesh-list
55726391|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
55726392|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55726393|NCT03475693|Analgesics|analgesics|mesh-ancestor
55726394|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
55726395|NCT03475693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726396|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726398|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
55726399|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
55726400|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55726401|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
55726402|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
55726403|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55726404|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
55726405|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726406|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726407|NCT03475693|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55726408|NCT03475693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55726409|NCT03475693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726410|NCT03475693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55726411|NCT03475693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55726412|NCT03475693|Antacids|antacids|mesh-ancestor
55726413|NCT05646082|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
55726414|NCT05646082|Antiviral Agents|antiviral agents|mesh-ancestor
55726415|NCT05646082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726417|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55726418|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
55726419|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726420|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726421|NCT03475615|Paclitaxel|paclitaxel|mesh-list
55726423|NCT03475615|Tegafur|tegafur|mesh-list
55726424|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55726425|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726426|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
55726427|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
55726428|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
55726429|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726430|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55726431|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
55726432|NCT03478423|Oxycodone|oxycodone|mesh-list
55726438|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726439|NCT03478423|Analgesics|analgesics|mesh-ancestor
55726440|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
55726441|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726442|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
55726443|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
55726444|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
55726445|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726446|NCT03130933|Amoxicillin|amoxicillin|mesh-list
55726447|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55726448|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726449|NCT05155969|Ketamine|ketamine|mesh-list
55726450|NCT05155969|Esketamine|esketamine|mesh-list
55726451|NCT05155969|Analgesics|analgesics|mesh-ancestor
55726452|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
55726453|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726454|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726455|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55726456|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55726457|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
55726459|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726460|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55726461|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55726462|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726463|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726464|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
55726465|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55726466|NCT05112913|Vaccines|vaccines|mesh-list
55726467|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
55726468|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726470|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
55726471|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726472|NCT03475459|Protective Agents|protective agents|mesh-ancestor
55726473|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726474|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726475|NCT03478111|Methotrexate|methotrexate|mesh-list
55726476|NCT03478111|Infliximab|infliximab|mesh-list
55726477|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55726478|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
55726479|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55726480|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726481|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55726482|NCT03478111|Antimetabolites|antimetabolites|mesh-ancestor
55726483|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726484|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726485|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
55726487|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55726488|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55726489|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
55726490|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726491|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55726492|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55726494|NCT03478033|Rifabutin|rifabutin|mesh-list
55726495|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55726496|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
55726497|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55726498|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726500|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55726501|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726502|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726503|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55726504|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55726505|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55726506|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55726507|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55726508|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55726509|NCT03477955|Silicon|silicon|mesh-list
55726510|NCT03477955|Trace Elements|trace elements|mesh-ancestor
55726511|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
55726512|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726513|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
55726514|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726515|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55726516|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726517|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726518|NCT05084599|Metaraminol|metaraminol|mesh-list
55726519|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
55726520|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
55726521|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726522|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726523|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55726524|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55726525|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55726526|NCT05084599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55726527|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
55726528|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726529|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726530|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
55726531|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55726532|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
55726533|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726534|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726536|NCT00701623|Calcium heparin|calcium heparin|mesh-list
55726537|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
55726538|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55726539|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55726540|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726541|NCT04456153|Atovaquone|atovaquone|mesh-list
55726542|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726544|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55726545|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55726546|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726547|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726548|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
55726549|NCT04403971|Listerine|listerine|mesh-list
55726550|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55726551|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726552|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
55726553|NCT02447432|Vaccines|vaccines|mesh-list
55726554|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55726555|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
55726556|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726557|NCT02446886|Hormones|hormones|mesh-list
55726558|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55726559|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55726560|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
55726561|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55726562|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726563|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726564|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55766807|NCT02410031|Estrogens|estrogens|mesh-ancestor
55726566|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726567|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
55726568|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726569|NCT05008003|Vitamin D|vitamin d|mesh-list
55726570|NCT05008003|Cholecalciferol|cholecalciferol|mesh-list
55726571|NCT05008003|Vitamins|vitamins|mesh-ancestor
55726572|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
55726573|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726574|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55726575|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55726576|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
55726577|NCT03475225|Vitamin D|vitamin d|mesh-list
55726578|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55726579|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726580|NCT03475225|Vitamins|vitamins|mesh-ancestor
55726581|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
55726582|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55726583|NCT03448939|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55726584|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
55726585|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
55726586|NCT02504294|Hematinics|hematinics|mesh-ancestor
55726587|NCT02446418|Fluticasone|fluticasone|mesh-list
55726589|NCT02446418|Budesonide|budesonide|mesh-list
55726590|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
55726591|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55726592|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726593|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55726594|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
55726595|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726596|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726597|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55726598|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
55726599|NCT02446418|Dermatologic Agents|dermatologic agents|mesh-ancestor
55726600|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55726601|NCT02446418|Glucocorticoids|glucocorticoids|mesh-ancestor
55726602|NCT02446418|Hormones|hormones|mesh-ancestor
55726603|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55726604|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55726605|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55828962|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
55726619|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55726620|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55726621|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726622|NCT04864210|Bupivacaine|bupivacaine|mesh-list
55726623|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
55726624|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
55726625|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726626|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726627|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
55726628|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726629|NCT01641640|Sofosbuvir|sofosbuvir|mesh-list
55726630|NCT01641640|Ribavirin|ribavirin|mesh-list
55726631|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
55726632|NCT01641640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726633|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
55726634|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726635|NCT05650216|Paclitaxel|paclitaxel|mesh-list
55726636|NCT05650216|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55726637|NCT05650216|Carboplatin|carboplatin|mesh-list
55726638|NCT05650216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55766808|NCT02410031|Hormones|hormones|mesh-ancestor
55726639|NCT05650216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726640|NCT05650216|Tubulin Modulators|tubulin modulators|mesh-ancestor
55726641|NCT05650216|Antimitotic Agents|antimitotic agents|mesh-ancestor
55726642|NCT05650216|Mitosis Modulators|mitosis modulators|mesh-ancestor
55726643|NCT05650216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726657|NCT04848688|Ivermectin|ivermectin|mesh-list
55726658|NCT04848688|Moxidectin|moxidectin|mesh-list
55726659|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55726660|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726661|NCT04848688|Anthelmintics|anthelmintics|mesh-ancestor
55726662|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
55726663|NCT05369650|Lidocaine|lidocaine|mesh-list
55726664|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
55726665|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
55726666|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726667|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726668|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
55726669|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726670|NCT05369650|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55726671|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55726672|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55726673|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55726674|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726675|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55726676|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55726677|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55726678|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55726679|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726680|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
55726681|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726682|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726683|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
55726684|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55726685|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55726686|NCT05069740|Analgesics|analgesics|mesh-ancestor
55726687|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
55726688|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726689|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726690|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726691|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726692|NCT01601626|Pyridoxine|pyridoxine|mesh-list
55726693|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
55726694|NCT01601626|Ritonavir|ritonavir|mesh-list
55726704|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726705|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55726706|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55726707|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
55726708|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726709|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726710|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55726711|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55726712|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
55726713|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726714|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55726715|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55726716|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
55726717|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55726718|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55726719|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55726720|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
55726721|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55726722|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
55726723|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55726724|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55726725|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55726726|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55726727|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55726728|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55726729|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55726730|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55726733|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55726734|NCT05428150|Pirfenidone|pirfenidone|mesh-list
55726735|NCT05428150|Analgesics|analgesics|mesh-ancestor
55726736|NCT05428150|Sensory System Agents|sensory system agents|mesh-ancestor
55726737|NCT05428150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726738|NCT05428150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726739|NCT05428150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55726740|NCT05428150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55726741|NCT05428150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726742|NCT05428150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726743|NCT05428150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726744|NCT02737501|Crizotinib|crizotinib|mesh-list
55726745|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726746|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55726747|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726748|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726750|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55726751|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55726752|NCT04848220|Serotonin Agents|serotonin agents|mesh-ancestor
55726753|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726754|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726755|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726756|NCT05642182|Vitamin D|vitamin d|mesh-list
55726757|NCT05642182|Ergocalciferols|ergocalciferols|mesh-list
55726758|NCT05642182|Cholecalciferol|cholecalciferol|mesh-list
55726759|NCT05642182|Vitamins|vitamins|mesh-list
55726760|NCT05642182|Micronutrients|micronutrients|mesh-ancestor
55726761|NCT05642182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726762|NCT05642182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55726763|NCT05642182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55726764|NCT03471559|Cannabidiol|cannabidiol|mesh-list
55726765|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
55726766|NCT05641480|Donepezil|donepezil|mesh-list
55726767|NCT05641480|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55726768|NCT05641480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726769|NCT05641480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726770|NCT05641480|Cholinergic Agents|cholinergic agents|mesh-ancestor
55726771|NCT05641480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726772|NCT05641480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726773|NCT05641480|Nootropic Agents|nootropic agents|mesh-ancestor
55726774|NCT05640934|Melatonin|melatonin|mesh-list
55726775|NCT05640934|Antioxidants|antioxidants|mesh-ancestor
55726776|NCT05640934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726777|NCT05640934|Protective Agents|protective agents|mesh-ancestor
55726778|NCT05640934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726779|NCT05640934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726780|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55726781|NCT03377803|Cantharidin|cantharidin|mesh-list
55726782|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726783|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726784|NCT03471325|Methamphetamine|methamphetamine|mesh-list
55726785|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55726786|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726787|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
55726788|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
55726789|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55726790|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
55726791|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55726792|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726793|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
55726794|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55726795|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55726796|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55726797|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55726798|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
55726799|NCT04844164|Vitamin D|vitamin d|mesh-list
55726800|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55726801|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726802|NCT04844164|Vitamins|vitamins|mesh-ancestor
55726803|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
55726804|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55726805|NCT05392972|Anesthetics|anesthetics|mesh-list
55726806|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55726807|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726808|NCT03474601|Hormones|hormones|mesh-list
55726809|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55726810|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828975|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55828976|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
55828977|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55828978|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726811|NCT04988308|Adalimumab|adalimumab|mesh-list
55726812|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726813|NCT04988308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726814|NCT04984798|Vitamin E|vitamin e|mesh-list
55726815|NCT04984798|Tocopherols|tocopherols|mesh-list
55726816|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
55726817|NCT04984798|Vitamins|vitamins|mesh-ancestor
55726818|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
55726819|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726820|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
55726821|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726823|NCT05576662|Ritonavir|ritonavir|mesh-list
55726824|NCT05576662|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55726825|NCT05576662|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55726826|NCT05576662|Protease Inhibitors|protease inhibitors|mesh-ancestor
55726827|NCT05576662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726828|NCT05576662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726829|NCT05576662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55726830|NCT05576662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55726831|NCT05576662|Antiviral Agents|antiviral agents|mesh-ancestor
55726832|NCT05576662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726833|NCT05576662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55726834|NCT05576662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55726835|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
55726836|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55726837|NCT02230163|Antibodies|antibodies|mesh-list
55726838|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
55726839|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726840|NCT02230319|Paclitaxel|paclitaxel|mesh-list
55726841|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55726842|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726843|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
55726844|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
55726845|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
55726846|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726847|NCT00135395|Ritonavir|ritonavir|mesh-list
55726848|NCT00135395|Lopinavir|lopinavir|mesh-list
55726849|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55726850|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55726851|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55726854|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726855|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55726856|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55726857|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
55766814|NCT04939701|Pembrolizumab|pembrolizumab|mesh-list
55726858|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726859|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55726860|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55726861|NCT02230553|Lapatinib|lapatinib|mesh-list
55726862|NCT02230553|Trametinib|trametinib|mesh-list
55726863|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726864|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55726865|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726866|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726867|NCT04261049|Triamcinolone|triamcinolone|mesh-list
55726868|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55726869|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55726870|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55726871|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55726872|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
55726873|NCT04261049|Hormones|hormones|mesh-ancestor
55726874|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55726875|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726876|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55726877|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
55726878|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726879|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726883|NCT00057473|Carboplatin|carboplatin|mesh-list
55726884|NCT00057473|Irinotecan|irinotecan|mesh-list
55726885|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726886|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55726887|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55726888|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726889|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726890|NCT00035789|Entecavir|entecavir|mesh-list
55726891|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
55726892|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726894|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
55726895|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726896|NCT00028301|Ritonavir|ritonavir|mesh-list
55726897|NCT00028301|Lopinavir|lopinavir|mesh-list
55726898|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55726899|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55726900|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55726901|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
55726902|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726903|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726904|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55726905|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55726906|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
55726907|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726908|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55726909|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55726910|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55726911|NCT00028067|Nelfinavir|nelfinavir|mesh-list
55726912|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55726913|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55726914|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
55726915|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726916|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726917|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55726918|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55726919|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
55726920|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55726921|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
55726922|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726924|NCT00004907|Busulfan|busulfan|mesh-list
55726925|NCT00004907|Etoposide|etoposide|mesh-list
55726926|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55726927|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
55726928|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726929|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726930|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55726931|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
55726932|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726933|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726934|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55726935|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55726936|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55726937|NCT00004907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55726938|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726939|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
55726940|NCT04469777|Hematinics|hematinics|mesh-ancestor
55726941|NCT00004895|Octreotide|octreotide|mesh-list
55726942|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55726943|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55726944|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726945|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
55726947|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55726948|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
55726949|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726950|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726951|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55726952|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
55726953|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726954|NCT00004181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726955|NCT00004181|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55726956|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
55726957|NCT00004175|Docetaxel|docetaxel|mesh-list
55726958|NCT00004175|Doxorubicin|doxorubicin|mesh-list
55726959|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55726960|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55726961|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
55726962|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726963|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726964|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55726965|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
55726966|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726967|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726968|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55726969|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
55726970|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
55726971|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
55726972|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55726973|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55726974|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55726975|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726976|NCT05708573|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55726977|NCT05708573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55726978|NCT05708573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55726980|NCT05708573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726981|NCT05708573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55726982|NCT05708573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55726983|NCT05708573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55726984|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
55726985|NCT00004169|Carboplatin|carboplatin|mesh-list
55726986|NCT00004169|Etoposide|etoposide|mesh-list
55726987|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55726988|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
55726989|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55726990|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55726991|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55726992|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
55726993|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55726994|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55726995|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55726996|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55726997|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55726998|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55726999|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727000|NCT00002429|Lamivudine|lamivudine|mesh-list
55727001|NCT00002429|Zidovudine|zidovudine|mesh-list
55727002|NCT00002429|Didanosine|didanosine|mesh-list
55727003|NCT00002429|Stavudine|stavudine|mesh-list
55727004|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
55727005|NCT00002429|Nelfinavir|nelfinavir|mesh-list
55727006|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55727007|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55727008|NCT00002429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727009|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727010|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
55727011|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727012|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55727013|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55727014|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
55727015|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55727016|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55727017|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
55727018|NCT00002411|Lamivudine|lamivudine|mesh-list
55727019|NCT00002411|Zidovudine|zidovudine|mesh-list
55727020|NCT00002411|Didanosine|didanosine|mesh-list
55727021|NCT00002411|Stavudine|stavudine|mesh-list
55727022|NCT00002411|Nelfinavir|nelfinavir|mesh-list
55727023|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55727024|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55727025|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727026|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727027|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
55727028|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727029|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55727030|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55727031|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
55727032|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55727033|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55727034|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
55727035|NCT03530033|Lidocaine|lidocaine|mesh-list
55727036|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
55727038|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727039|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727040|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
55727041|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727042|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55727043|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55727044|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55727045|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55727046|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727047|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
55727048|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55727049|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727050|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727051|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55727052|NCT03529643|Analgesics|analgesics|mesh-ancestor
55727053|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
55727054|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727055|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55727056|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55727057|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55727058|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
55727059|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727060|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727061|NCT03529331|Acetaminophen|acetaminophen|mesh-list
55727062|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55727063|NCT03529331|Morphine|morphine|mesh-list
55727064|NCT03529331|Oxycodone|oxycodone|mesh-list
55727065|NCT03529331|Hydrocodone|hydrocodone|mesh-list
55727066|NCT03529331|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55727067|NCT03529331|Narcotics|narcotics|mesh-ancestor
55727068|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727069|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727070|NCT03529331|Analgesics|analgesics|mesh-ancestor
55727071|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
55727072|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727073|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55727074|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
55727075|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
55727076|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
55727077|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55727078|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55727079|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55727080|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55727081|NCT03529253|Calcium|calcium|mesh-list
55727082|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55727083|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727084|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55727085|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55727086|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
55727471|NCT03525821|Ketamine|ketamine|mesh-list
55727087|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727088|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55727089|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55727090|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727091|NCT00002207|Didanosine|didanosine|mesh-list
55727092|NCT00002207|Stavudine|stavudine|mesh-list
55727093|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
55727094|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727095|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55727096|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55727097|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727099|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727101|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55727102|NCT05725499|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
55727103|NCT05725499|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55727104|NCT05725499|Immunologic Factors|immunologic factors|mesh-ancestor
55727105|NCT05725499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727106|NCT03529175|Gemcitabine|gemcitabine|mesh-list
55727107|NCT03529175|Paclitaxel|paclitaxel|mesh-list
55727108|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55727109|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55727110|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727111|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
55727112|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
55727113|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
55727114|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727115|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55727116|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
55727117|NCT03529175|Antiviral Agents|antiviral agents|mesh-ancestor
55727118|NCT03529175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727119|NCT03529175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727120|NCT03529175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55727121|NCT03529175|Immunologic Factors|immunologic factors|mesh-ancestor
55727122|NCT03529175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727123|NCT03529097|Dipyrone|dipyrone|mesh-list
55727124|NCT03529097|Diclofenac|diclofenac|mesh-list
55727125|NCT03529097|Morphine|morphine|mesh-list
55727126|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55727127|NCT03529097|Narcotics|narcotics|mesh-ancestor
55727128|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727129|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727130|NCT03529097|Analgesics|analgesics|mesh-ancestor
55727131|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
55727132|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727133|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55829014|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727134|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55727135|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55727136|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55727137|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55727138|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727139|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727140|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
55727141|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
55727142|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
55727143|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727144|NCT03531749|Protective Agents|protective agents|mesh-ancestor
55727145|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727146|NCT03531749|Vitamins|vitamins|mesh-ancestor
55727147|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
55727148|NCT05258747|Olaparib|olaparib|mesh-list
55727149|NCT05258747|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55727150|NCT05258747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727151|NCT05258747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727152|NCT05258747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727153|NCT03528785|Leucovorin|leucovorin|mesh-list
55727154|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
55727155|NCT03528785|Irinotecan|irinotecan|mesh-list
55727156|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
55727157|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727158|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55727159|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55727160|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727161|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727162|NCT03528785|Antidotes|antidotes|mesh-ancestor
55727163|NCT03528785|Protective Agents|protective agents|mesh-ancestor
55727164|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727165|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
55727166|NCT03528785|Vitamins|vitamins|mesh-ancestor
55727167|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
55727168|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55727169|NCT03531437|Gestodene|gestodene|mesh-list
55727170|NCT03531437|Estradiol|estradiol|mesh-list
55727171|NCT03531437|Estrogens|estrogens|mesh-ancestor
55727172|NCT03531437|Hormones|hormones|mesh-ancestor
55727173|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55727174|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727175|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55727176|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
55727177|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55727178|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55727179|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55727180|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55727181|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55727183|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
55727184|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55727185|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
55727186|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727187|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727188|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55727189|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
55727190|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55727192|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727193|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727194|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55727195|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
55727196|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
55727197|NCT03527381|Protective Agents|protective agents|mesh-ancestor
55727198|NCT04441385|Maraviroc|maraviroc|mesh-list
55727199|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55727200|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55727201|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727202|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55727203|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55727204|NCT04441385|Antiviral Agents|antiviral agents|mesh-ancestor
55727205|NCT04441385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727206|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55727207|NCT03531359|Midazolam|midazolam|mesh-list
55727208|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55727209|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55727210|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727211|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727212|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55727213|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55727214|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55727215|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55727216|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
55727217|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
55727218|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
55727219|NCT03531359|GABA Agents|gaba agents|mesh-ancestor
55727220|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727221|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727222|NCT03531281|Sirolimus|sirolimus|mesh-list
55727223|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
55727224|NCT03531281|Etoposide|etoposide|mesh-list
55727225|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
55727226|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
55727227|NCT03531281|Tacrolimus|tacrolimus|mesh-list
55727228|NCT03531281|Mitogens|mitogens|mesh-list
55727229|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55727230|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
55727231|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727232|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55727233|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55727234|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
55727235|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727236|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727237|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55727238|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55727239|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55727240|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55727241|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727242|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55727243|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55727244|NCT03531281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727245|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55727246|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
55727247|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
55727248|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
55727249|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727250|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
55727251|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
55727252|NCT05724329|Dasatinib|dasatinib|mesh-list
55727253|NCT05724329|Quercetin|quercetin|mesh-list
55727254|NCT05724329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727255|NCT05724329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55727256|NCT05724329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727257|NCT05724329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727258|NCT05724329|Antioxidants|antioxidants|mesh-ancestor
55727259|NCT05724329|Protective Agents|protective agents|mesh-ancestor
55727260|NCT05724329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727261|NCT05179499|Norepinephrine|norepinephrine|mesh-list
55727262|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55727263|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55727264|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
55727265|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727266|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727267|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727268|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
55727269|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
55727270|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727271|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55727272|NCT04468685|Ondansetron|ondansetron|mesh-list
55727273|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
55727274|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
55727275|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727276|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727277|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55727278|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
55727279|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727280|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55727281|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
55727282|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727283|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727284|NCT04468685|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55727285|NCT04468685|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55727286|NCT04468685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727287|NCT04468685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55727288|NCT04468685|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55727289|NCT03531047|Riboflavin|riboflavin|mesh-list
55727290|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
55727291|NCT03531047|Vitamins|vitamins|mesh-ancestor
55727292|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
55727293|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727294|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55727295|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727296|NCT04440917|Apatinib|apatinib|mesh-list
55727297|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55727298|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727299|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55727300|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727301|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727302|NCT04192019|Glucagon|glucagon|mesh-list
55727303|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55727304|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55727305|NCT04192019|Hormones|hormones|mesh-ancestor
55727306|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55727307|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727308|NCT04192019|Incretins|incretins|mesh-ancestor
55727309|NCT05459129|Paclitaxel|paclitaxel|mesh-list
55727310|NCT05459129|Carboplatin|carboplatin|mesh-list
55727311|NCT05459129|Atezolizumab|atezolizumab|mesh-list
55727312|NCT05459129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55727313|NCT05459129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727314|NCT05459129|Tubulin Modulators|tubulin modulators|mesh-ancestor
55727315|NCT05459129|Antimitotic Agents|antimitotic agents|mesh-ancestor
55727316|NCT05459129|Mitosis Modulators|mitosis modulators|mesh-ancestor
55727317|NCT05459129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727318|NCT05455931|Mogamulizumab|mogamulizumab|mesh-list
55727319|NCT05455931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727320|NCT05062031|Atropine|atropine|mesh-list
55727321|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55727322|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55727323|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55727324|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55727325|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
55727326|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727327|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727328|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55727329|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
55727330|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
55727331|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
55727332|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55727333|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55727334|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
55727335|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727336|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727337|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55727338|NCT05446571|Valacyclovir|valacyclovir|mesh-list
55727339|NCT05446571|Letermovir|letermovir|mesh-list
55727340|NCT05446571|Antiviral Agents|antiviral agents|mesh-ancestor
55727341|NCT05446571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727342|NCT05446571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55727344|NCT05446571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727345|NCT05446571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727346|NCT05439005|Dexmedetomidine|dexmedetomidine|mesh-list
55727347|NCT05439005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55727348|NCT05439005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727349|NCT05439005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727350|NCT05439005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55727351|NCT05439005|Analgesics|analgesics|mesh-ancestor
55727352|NCT05439005|Sensory System Agents|sensory system agents|mesh-ancestor
55727353|NCT05439005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727354|NCT05439005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55727355|NCT05439005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55727356|NCT05439005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55727357|NCT05439005|Adrenergic Agents|adrenergic agents|mesh-ancestor
55727358|NCT05439005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727359|NCT05439005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727361|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727362|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
55727363|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727364|NCT04468139|Protective Agents|protective agents|mesh-ancestor
55727365|NCT03526445|Glucagon|glucagon|mesh-list
55727366|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55727367|NCT03526445|Hormones|hormones|mesh-ancestor
55727368|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55727369|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727370|NCT04939649|Midazolam|midazolam|mesh-list
55727371|NCT04939649|Ketamine|ketamine|mesh-list
55727372|NCT04939649|Analgesics|analgesics|mesh-ancestor
55727373|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
55727374|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727375|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727376|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55727377|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55727378|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
55727379|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
55727380|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727381|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55727382|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55727383|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727384|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727385|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55727386|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55727387|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55727388|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55727389|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55727390|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
55727391|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
55727393|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55727394|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55727395|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55727396|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55727397|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
55727398|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727399|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727400|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727401|NCT04589819|Teriparatide|teriparatide|mesh-list
55727402|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55727403|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727404|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55727405|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55727406|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55727407|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55727408|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
55727409|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727410|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55727411|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55727412|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727413|NCT04845035|Cytarabine|cytarabine|mesh-list
55727414|NCT04845035|Methotrexate|methotrexate|mesh-list
55727415|NCT04845035|Dasatinib|dasatinib|mesh-list
55727416|NCT04845035|Ponatinib|ponatinib|mesh-list
55727417|NCT04845035|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55727418|NCT04845035|Abortifacient Agents|abortifacient agents|mesh-ancestor
55727419|NCT04845035|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55727420|NCT04845035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727421|NCT04845035|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55727422|NCT04845035|Antimetabolites|antimetabolites|mesh-ancestor
55727423|NCT04845035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727424|NCT04845035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727425|NCT04845035|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727426|NCT04845035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727427|NCT04845035|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55727428|NCT04845035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55727429|NCT04845035|Immunologic Factors|immunologic factors|mesh-ancestor
55727430|NCT04845035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55727431|NCT04845035|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55727432|NCT04845035|Antiviral Agents|antiviral agents|mesh-ancestor
55727433|NCT04845035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727434|NCT04845035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55727435|NCT04467983|Denosumab|denosumab|mesh-list
55727436|NCT04467983|Abaloparatide|abaloparatide|mesh-list
55727437|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55727438|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727439|NCT04839731|Fluorouracil|fluorouracil|mesh-list
55727440|NCT04839731|Calcipotriene|calcipotriene|mesh-list
55727441|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
55727442|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727443|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55727444|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727445|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55727446|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
55727447|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727448|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727449|NCT03525509|Morphine|morphine|mesh-list
55727450|NCT03525509|Methadone|methadone|mesh-list
55727451|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55727452|NCT03525509|Narcotics|narcotics|mesh-ancestor
55727453|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727454|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727455|NCT03525509|Analgesics|analgesics|mesh-ancestor
55727456|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
55727457|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727458|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
55727459|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
55727460|NCT04699721|Paclitaxel|paclitaxel|mesh-list
55727461|NCT04699721|Carboplatin|carboplatin|mesh-list
55727462|NCT04699721|Nivolumab|nivolumab|mesh-list
55727463|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55727464|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727465|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
55727466|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
55727467|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
55727468|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727469|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55727470|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55727473|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
55727474|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727475|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727476|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55727477|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55727478|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
55727480|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727481|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55727482|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55727483|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727484|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727485|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55727486|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
55727487|NCT04221035|Temozolomide|temozolomide|mesh-list
55727488|NCT04221035|Melphalan|melphalan|mesh-list
55727489|NCT04221035|Busulfan|busulfan|mesh-list
55727490|NCT04221035|Ifosfamide|ifosfamide|mesh-list
55727491|NCT04221035|Thiotepa|thiotepa|mesh-list
55727492|NCT04221035|Dacarbazine|dacarbazine|mesh-list
55727493|NCT04221035|Carboplatin|carboplatin|mesh-list
55727494|NCT04221035|Doxorubicin|doxorubicin|mesh-list
55727495|NCT04221035|Irinotecan|irinotecan|mesh-list
55727496|NCT04221035|Etoposide|etoposide|mesh-list
55727497|NCT04221035|Vincristine|vincristine|mesh-list
55727499|NCT04221035|Dinutuximab|dinutuximab|mesh-list
55727500|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55727501|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
55727502|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727503|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55727504|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55727505|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
55727506|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727507|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727508|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55727509|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55727510|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55727511|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55727512|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727513|NCT04221035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55727514|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55727515|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
55727516|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
55727517|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
55727518|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
55727519|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55727521|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55727522|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
55727523|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
55727524|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
55727525|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727526|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727527|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55727528|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55727529|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727530|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55727531|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55727532|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55727533|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55727534|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55727535|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55727536|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
55727537|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
55727538|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
55727539|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
55727540|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727541|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727543|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
55727544|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727545|NCT04969198|Nicotine|nicotine|mesh-list
55727546|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55727547|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
55727548|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727549|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727550|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55727551|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55727552|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
55727553|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727554|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727555|NCT04666636|Mirabegron|mirabegron|mesh-list
55727556|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55727557|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55727558|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55727559|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
55727560|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727561|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727562|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727563|NCT04666636|Urological Agents|urological agents|mesh-ancestor
55727564|NCT04925284|Bevacizumab|bevacizumab|mesh-list
55727565|NCT04925284|Nivolumab|nivolumab|mesh-list
55727566|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55727567|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727568|NCT04925284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55727569|NCT04925284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55727570|NCT04925284|Growth Substances|growth substances|mesh-ancestor
55727571|NCT04925284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727572|NCT04925284|Growth Inhibitors|growth inhibitors|mesh-ancestor
55727573|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55727574|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727575|NCT04890106|Bimatoprost|bimatoprost|mesh-list
55727576|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55727577|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55727578|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55727579|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55727580|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55727581|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55727582|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727583|NCT05214664|Anesthetics|anesthetics|mesh-list
55727584|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727585|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727587|NCT05206084|Everolimus|everolimus|mesh-list
55727588|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727589|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55727590|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
55727591|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727592|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55727593|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727594|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55727595|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
55727596|NCT05198362|Metoprolol|metoprolol|mesh-list
55727597|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55727598|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55727599|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
55727600|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
55727601|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727602|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727603|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55727604|NCT05198362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55727606|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
55727607|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727608|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727609|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55727610|NCT05184712|Carboplatin|carboplatin|mesh-list
55727611|NCT05184712|Pemetrexed|pemetrexed|mesh-list
55727612|NCT05184712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727613|NCT05184712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727614|NCT05184712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727615|NCT05184712|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55727616|NCT05184712|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55727617|NCT04810156|Mycophenolic Acid|mycophenolic acid|mesh-list
55727618|NCT04810156|Prednisone|prednisone|mesh-list
55727619|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
55727620|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55727621|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55727622|NCT04810156|Prednisolone|prednisolone|mesh-list
55727623|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
55727624|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55727625|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55727626|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
55727627|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55727628|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
55727629|NCT04810156|Hormones|hormones|mesh-ancestor
55727707|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55727630|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55727631|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727632|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55727633|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727634|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55727635|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55727636|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
55727637|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55727638|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727639|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727640|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727642|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
55727643|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727644|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55727645|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55727646|NCT04810156|Protective Agents|protective agents|mesh-ancestor
55727647|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55727648|NCT04837924|Acetaminophen|acetaminophen|mesh-list
55727649|NCT04837924|Tramadol|tramadol|mesh-list
55727650|NCT04837924|Analgesics|analgesics|mesh-list
55727651|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
55727652|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55727653|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
55727654|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727655|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727656|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
55727657|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55727658|NCT04837924|Narcotics|narcotics|mesh-ancestor
55727659|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55727660|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
55727661|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
55727662|NCT05406466|Lenvatinib|lenvatinib|mesh-list
55727663|NCT05406466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727664|NCT05406466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55727665|NCT05406466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727666|NCT05406466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727667|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
55727668|NCT05152420|Apixaban|apixaban|mesh-list
55727669|NCT05152420|Edoxaban|edoxaban|mesh-list
55727670|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55727671|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
55727672|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55727673|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
55727674|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727675|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727676|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
55727677|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
55727678|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55727679|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
55727680|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55727681|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55727682|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727683|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727684|NCT01601470|Urological Agents|urological agents|mesh-ancestor
55727685|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55727686|NCT04418908|Cetrorelix|cetrorelix|mesh-list
55727687|NCT04418908|Estradiol|estradiol|mesh-list
55727688|NCT04418908|Estrogens|estrogens|mesh-ancestor
55727689|NCT04418908|Hormones|hormones|mesh-ancestor
55727690|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55727691|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727692|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55727693|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55727694|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
55727695|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
55727696|NCT04546126|Dexamethasone|dexamethasone|mesh-list
55727697|NCT04546126|Cosyntropin|cosyntropin|mesh-list
55727698|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55727699|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
55727700|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
55727701|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727702|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727703|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55727704|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
55727705|NCT04546126|Hormones|hormones|mesh-ancestor
55727706|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55727708|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727709|NCT04762498|Methotrexate|methotrexate|mesh-list
55727710|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55727711|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
55727712|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55727713|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727714|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55727715|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
55727716|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727717|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727718|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727719|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727720|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55727721|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55727722|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
55727723|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55727724|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55727725|NCT03275285|Dexamethasone|dexamethasone|mesh-list
55727726|NCT03275285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55727727|NCT03275285|Antiemetics|antiemetics|mesh-ancestor
55727729|NCT03275285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727730|NCT03275285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727731|NCT03275285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55727732|NCT03275285|Glucocorticoids|glucocorticoids|mesh-ancestor
55727733|NCT03275285|Hormones|hormones|mesh-ancestor
55727734|NCT03275285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55727735|NCT03275285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55727736|NCT03275285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727737|NCT04821778|Paclitaxel|paclitaxel|mesh-list
55727738|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
55727739|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55829045|NCT01920555|Ketamine|ketamine|mesh-list
55727740|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727741|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
55727742|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
55727743|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
55727744|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727745|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55727746|NCT04831450|Cemiplimab|cemiplimab|mesh-list
55727747|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55727748|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727749|NCT04830982|Diazoxide|diazoxide|mesh-list
55727750|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55727751|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
55727752|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
55727753|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727754|NCT05302804|Menthol|menthol|mesh-list
55727755|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
55727756|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727757|NCT04145440|Felzartamab|felzartamab|mesh-list
55727758|NCT04145440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727759|NCT04145440|Immunologic Factors|immunologic factors|mesh-ancestor
55727760|NCT04145440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727761|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
55727762|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55727763|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727764|NCT04820452|Aflibercept|aflibercept|mesh-list
55727765|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55727766|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55727767|NCT04820452|Growth Substances|growth substances|mesh-ancestor
55727768|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727769|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
55727770|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727771|NCT05298202|Capsaicin|capsaicin|mesh-list
55727772|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
55727773|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727774|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
55727775|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727776|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727777|NCT01637272|Pasireotide|pasireotide|mesh-list
55727778|NCT01637272|Hormones|hormones|mesh-ancestor
55727779|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55727780|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727781|NCT04458922|Atezolizumab|atezolizumab|mesh-list
55727782|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55727783|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727785|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727786|NCT03178864|Heparin|heparin|mesh-list
55727787|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
55727788|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
55727789|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55727790|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55727791|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727792|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55727793|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
55727794|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55727795|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
55727796|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727797|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55727798|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
55727799|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727800|NCT05323552|Curare|curare|mesh-list
55727801|NCT05323552|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55727802|NCT05323552|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55727803|NCT05323552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55727804|NCT05323552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727805|NCT05323552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727806|NCT05323552|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55727807|NCT05323552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55727808|NCT05323552|Cholinergic Agents|cholinergic agents|mesh-ancestor
55727809|NCT05323552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727810|NCT05323552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727811|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
55727812|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727813|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
55727814|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55727815|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727816|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55727817|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55727818|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727819|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727820|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727821|NCT02987686|Infliximab|infliximab|mesh-list
55727822|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727823|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55727824|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55727825|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
55727826|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55727827|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
55727828|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55727829|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
55727830|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727831|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727832|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
55727833|NCT05277922|Nitroprusside|nitroprusside|mesh-list
55727834|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55727835|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
55727836|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55727837|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727838|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
55727839|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
55727840|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55727841|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55727842|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727843|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727844|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727845|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55727846|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
55766991|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
55727847|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55727848|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727849|NCT02917096|Vidarabine|vidarabine|mesh-list
55727850|NCT02917096|Sirolimus|sirolimus|mesh-list
55727851|NCT02917096|Fludarabine|fludarabine|mesh-list
55727852|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
55727853|NCT02917096|Melphalan|melphalan|mesh-list
55727854|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
55727855|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55727856|NCT02917096|Tacrolimus|tacrolimus|mesh-list
55727857|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727858|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55727859|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
55727860|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727861|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55727862|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
55727863|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727864|NCT02917096|Antiviral Agents|antiviral agents|mesh-ancestor
55727865|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727866|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55727867|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727868|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55727869|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55727870|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
55727871|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55727872|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
55727873|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55727874|NCT03934684|Dexamethasone|dexamethasone|mesh-list
55727875|NCT03934684|Dexamethasone acetate|dexamethasone acetate|mesh-list
55727876|NCT03934684|Lenalidomide|lenalidomide|mesh-list
55727877|NCT03934684|BB 1101|bb 1101|mesh-list
55727878|NCT03934684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55727879|NCT03934684|Antiemetics|antiemetics|mesh-ancestor
55727880|NCT03934684|Autonomic Agents|autonomic agents|mesh-ancestor
55727881|NCT03934684|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727882|NCT03934684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727883|NCT03934684|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55727884|NCT03934684|Glucocorticoids|glucocorticoids|mesh-ancestor
55727885|NCT03934684|Hormones|hormones|mesh-ancestor
55727886|NCT03934684|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55727887|NCT03934684|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55727888|NCT03934684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727889|NCT03934684|Protease Inhibitors|protease inhibitors|mesh-ancestor
55727890|NCT03934684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727891|NCT03934684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727892|NCT03934684|Immunologic Factors|immunologic factors|mesh-ancestor
55727893|NCT03934684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55727894|NCT03934684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55727895|NCT03934684|Growth Substances|growth substances|mesh-ancestor
55727896|NCT03934684|Growth Inhibitors|growth inhibitors|mesh-ancestor
55727897|NCT04194424|Metformin|metformin|mesh-list
55727898|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55727899|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727900|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
55727901|NCT02473640|Esomeprazole|esomeprazole|mesh-list
55727902|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55727903|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55727904|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55727905|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727906|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727907|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55727908|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727909|NCT04311502|Pyridoxine|pyridoxine|mesh-list
55727910|NCT04311502|Pyridoxal|pyridoxal|mesh-list
55727911|NCT04311502|Vitamin B 6|vitamin b 6|mesh-list
55727912|NCT04311502|Rifampin|rifampin|mesh-list
55727913|NCT04311502|Rifapentine|rifapentine|mesh-list
55727914|NCT04311502|Clofazimine|clofazimine|mesh-list
55727915|NCT04311502|Isoniazid|isoniazid|mesh-list
55727916|NCT04311502|Pyrazinamide|pyrazinamide|mesh-list
55727917|NCT04311502|Ethambutol|ethambutol|mesh-list
55727918|NCT04311502|Vitamins|vitamins|mesh-ancestor
55727920|NCT04311502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727921|NCT04311502|Vitamin B Complex|vitamin b complex|mesh-ancestor
55727922|NCT04311502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55727923|NCT04311502|Antitubercular Agents|antitubercular agents|mesh-ancestor
55727924|NCT04311502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55727925|NCT04311502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55727926|NCT04311502|Leprostatic Agents|leprostatic agents|mesh-ancestor
55727927|NCT04311502|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55727928|NCT04311502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55727929|NCT04311502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727930|NCT04311502|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55727931|NCT04311502|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55727932|NCT04311502|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55727933|NCT04311502|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55727934|NCT04311502|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55727935|NCT04311502|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55727936|NCT04311502|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55727937|NCT04311502|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55727938|NCT04311502|Antimetabolites|antimetabolites|mesh-ancestor
55727939|NCT04311502|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55727940|NCT04311502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55727941|NCT01637584|Prazosin|prazosin|mesh-list
55727942|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55727943|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55727944|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55727945|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55727946|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
55727947|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727948|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727949|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727950|NCT03875092|Paclitaxel|paclitaxel|mesh-list
55727951|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55727952|NCT03875092|Carboplatin|carboplatin|mesh-list
55727953|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
55727954|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55727955|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727956|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
55727957|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
55727958|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
55727959|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727960|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55727961|NCT02728102|Lenalidomide|lenalidomide|mesh-list
55727962|NCT02728102|Melphalan|melphalan|mesh-list
55727963|NCT02728102|Molgramostim|molgramostim|mesh-list
55727964|NCT02728102|Vaccines|vaccines|mesh-list
55727965|NCT02728102|Sargramostim|sargramostim|mesh-list
55727966|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
55727967|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727968|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55727969|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55727970|NCT02728102|Growth Substances|growth substances|mesh-ancestor
55727971|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
55727972|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55727973|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55727974|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
55727975|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727976|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55727977|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55727978|NCT02502734|Fluticasone|fluticasone|mesh-list
55727979|NCT02502734|Xhance|xhance|mesh-list
55727980|NCT02502734|Albuterol|albuterol|mesh-list
55727981|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55727982|NCT02502734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55727983|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
55727984|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55727985|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55727986|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55727987|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
55727988|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
55727989|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55727990|NCT02502734|Tocolytic Agents|tocolytic agents|mesh-ancestor
55727991|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55727992|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55727993|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55727994|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55727995|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
55727996|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55727997|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55727998|NCT04193878|Budesonide|budesonide|mesh-list
55727999|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
55728000|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55728001|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55728002|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
55728003|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728004|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728005|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55767064|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728006|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
55728008|NCT04193878|Hormones|hormones|mesh-ancestor
55728009|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728010|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55728011|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55728012|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55728013|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
55728089|NCT03775486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728014|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728015|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728016|NCT02473250|Fluoxetine|fluoxetine|mesh-list
55728017|NCT02473250|Citalopram|citalopram|mesh-list
55728018|NCT02473250|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55728019|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55728020|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55728021|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728022|NCT02473250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728023|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
55728024|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728025|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55728026|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
55728027|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55728028|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55728029|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55728030|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728031|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55728032|NCT04253626|Hematinics|hematinics|mesh-ancestor
55728033|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55728034|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55728035|NCT03840148|Meropenem|meropenem|mesh-list
55728036|NCT03840148|Cefepime|cefepime|mesh-list
55728037|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55728038|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728039|NCT02667418|Vancomycin|vancomycin|mesh-list
55728040|NCT02667418|Fidaxomicin|fidaxomicin|mesh-list
55728041|NCT02667418|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55728042|NCT02667418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728043|NCT02611024|Irinotecan|irinotecan|mesh-list
55728044|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55728045|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55728046|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728047|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728048|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728049|NCT04222504|Tenofovir|tenofovir|mesh-list
55728050|NCT04222504|Emtricitabine|emtricitabine|mesh-list
55728051|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
55728052|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728053|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55728054|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55728055|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728056|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728057|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55728058|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55728059|NCT02500706|Insulin|insulin|mesh-list
55728060|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55728061|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
55728062|NCT02500706|Insulin, Long-Acting|insulin, long-acting|mesh-list
55728063|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55728064|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55728065|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728066|NCT04201496|Empagliflozin|empagliflozin|mesh-list
55728067|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55767098|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728068|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728069|NCT04201496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55728070|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728071|NCT03775486|Gemcitabine|gemcitabine|mesh-list
55728072|NCT03775486|Paclitaxel|paclitaxel|mesh-list
55728073|NCT03775486|Cisplatin|cisplatin|mesh-list
55728074|NCT03775486|Carboplatin|carboplatin|mesh-list
55728075|NCT03775486|Pemetrexed|pemetrexed|mesh-list
55728076|NCT03775486|Durvalumab|durvalumab|mesh-list
55728077|NCT03775486|Olaparib|olaparib|mesh-list
55728078|NCT03775486|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55728079|NCT03775486|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55728080|NCT03775486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728081|NCT03775486|Tubulin Modulators|tubulin modulators|mesh-ancestor
55728082|NCT03775486|Antimitotic Agents|antimitotic agents|mesh-ancestor
55728083|NCT03775486|Mitosis Modulators|mitosis modulators|mesh-ancestor
55728084|NCT03775486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728085|NCT03775486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55728086|NCT03775486|Antimetabolites|antimetabolites|mesh-ancestor
55728087|NCT03775486|Antiviral Agents|antiviral agents|mesh-ancestor
55728088|NCT03775486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728090|NCT03775486|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55728091|NCT03775486|Immunologic Factors|immunologic factors|mesh-ancestor
55728092|NCT03775486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728093|NCT03775486|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55728094|NCT03775486|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55728095|NCT03775486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55728096|NCT03775486|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55728097|NCT03774472|Hydroxychloroquine|hydroxychloroquine|mesh-list
55728098|NCT03774472|Letrozole|letrozole|mesh-list
55728099|NCT03774472|Palbociclib|palbociclib|mesh-list
55728100|NCT03774472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728101|NCT03774472|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55728102|NCT03774472|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55728103|NCT03774472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728104|NCT03774472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728105|NCT03774472|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55728106|NCT03774472|Hormone Antagonists|hormone antagonists|mesh-ancestor
55728107|NCT03774472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728108|NCT03774472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728109|NCT03774472|Antimalarials|antimalarials|mesh-ancestor
55728110|NCT03774472|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55728111|NCT03774472|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55728112|NCT03774472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728113|NCT03774472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728114|NCT03774472|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55728115|NCT02456974|Amoxicillin|amoxicillin|mesh-list
55728116|NCT02456974|Vancomycin|vancomycin|mesh-list
55728117|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
55728118|NCT02456974|Meropenem|meropenem|mesh-list
55728119|NCT02456974|Tazobactam|tazobactam|mesh-list
55728120|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
55728121|NCT02456974|Amikacin|amikacin|mesh-list
55728122|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55728123|NCT02456974|Teicoplanin|teicoplanin|mesh-list
55728124|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55728125|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728126|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55728127|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55728128|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728129|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728130|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728131|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55728132|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55728133|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55728134|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
55728135|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
55728136|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55728137|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55728138|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728139|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55767246|NCT01662999|Hormones|hormones|mesh-ancestor
55728140|NCT04797286|Urological Agents|urological agents|mesh-ancestor
55728141|NCT03682276|Nivolumab|nivolumab|mesh-list
55728142|NCT03682276|Ipilimumab|ipilimumab|mesh-list
55728143|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55728144|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728145|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55728146|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728147|NCT05653024|Albuterol|albuterol|mesh-list
55728148|NCT05653024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55728149|NCT05653024|Autonomic Agents|autonomic agents|mesh-ancestor
55728150|NCT05653024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728151|NCT05653024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728152|NCT05653024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55728153|NCT05653024|Respiratory System Agents|respiratory system agents|mesh-ancestor
55728154|NCT05653024|Tocolytic Agents|tocolytic agents|mesh-ancestor
55728155|NCT05653024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55728156|NCT05653024|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55728157|NCT05653024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55728158|NCT05653024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55728159|NCT05653024|Adrenergic Agents|adrenergic agents|mesh-ancestor
55728160|NCT05653024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728161|NCT05653024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728163|NCT04796584|Immunologic Factors|immunologic factors|mesh-ancestor
55728596|NCT02532257|Antibodies|antibodies|mesh-list
55728164|NCT04796584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728165|NCT02499770|Carboplatin|carboplatin|mesh-list
55728166|NCT02499770|Etoposide|etoposide|mesh-list
55728167|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728168|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55728169|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55728170|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55728171|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728172|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728173|NCT04418674|Fentanyl|fentanyl|mesh-list
55728174|NCT04418674|Ketamine|ketamine|mesh-list
55728175|NCT04418674|Analgesics|analgesics|mesh-ancestor
55728176|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
55728177|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728178|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728179|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55728180|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55728181|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
55728182|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
55728183|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55728184|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55728185|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55728186|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728187|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728188|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55728189|NCT04418674|Narcotics|narcotics|mesh-ancestor
55728190|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55728191|NCT02442284|Ritonavir|ritonavir|mesh-list
55728192|NCT02442284|Ribavirin|ribavirin|mesh-list
55728193|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55728194|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55728195|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
55728196|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728197|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728198|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55728199|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55728200|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
55728201|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728202|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55728203|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55728204|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
55728205|NCT03781960|Nivolumab|nivolumab|mesh-list
55728206|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55728207|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728208|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55728209|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728210|NCT05178550|Heparin|heparin|mesh-list
55728211|NCT05178550|Anticoagulants|anticoagulants|mesh-ancestor
55728212|NCT05178550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55728213|NCT05178550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55728214|NCT05178550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728215|NCT02499146|Letrozole|letrozole|mesh-list
55728216|NCT02499146|Palbociclib|palbociclib|mesh-list
55728217|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728218|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55728219|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55728220|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728221|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728222|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55728223|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
55728224|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728225|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728226|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55728227|NCT04199468|Ketamine|ketamine|mesh-list
55728228|NCT04199468|Dronabinol|dronabinol|mesh-list
55728229|NCT04199468|Analgesics|analgesics|mesh-ancestor
55728230|NCT04199468|Sensory System Agents|sensory system agents|mesh-ancestor
55728231|NCT04199468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728232|NCT04199468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728233|NCT04199468|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55728234|NCT04199468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55728235|NCT04199468|Anesthetics, General|anesthetics, general|mesh-ancestor
55728236|NCT04199468|Anesthetics|anesthetics|mesh-ancestor
55728237|NCT04199468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55728238|NCT04199468|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55728239|NCT04199468|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55728240|NCT04199468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728241|NCT04199468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728242|NCT04199468|Hallucinogens|hallucinogens|mesh-ancestor
55728243|NCT04199468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55728244|NCT04199468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55728245|NCT04199468|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55728246|NCT04199468|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55728247|NCT04199468|Hormones|hormones|mesh-ancestor
55728248|NCT04199468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728249|NCT01634854|Misoprostol|misoprostol|mesh-list
55728250|NCT01634854|Oxytocin|oxytocin|mesh-list
55728251|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
55728252|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55728253|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728254|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55728255|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
55728256|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55728257|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55728259|NCT05651464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55728260|NCT05651464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728261|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55728262|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728263|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55728264|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728265|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728266|NCT02441114|Fluticasone|fluticasone|mesh-list
55728267|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
55728268|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55728269|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55728270|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55728271|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55728272|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
55728273|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767306|NCT04582305|Bleomycin|bleomycin|mesh-list
55728274|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728275|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55728276|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
55728277|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
55728278|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55728279|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
55728280|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55728281|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
55728282|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728283|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728284|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55728285|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55728286|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55728287|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
55728288|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
55728289|NCT02441114|Hormones|hormones|mesh-ancestor
55728290|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728291|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
55728292|NCT03424018|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
55728293|NCT03424018|Natriuretic Agents|natriuretic agents|mesh-ancestor
55728294|NCT03424018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728295|NCT02498444|Treprostinil|treprostinil|mesh-list
55728296|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55728297|NCT05235256|Dexamethasone|dexamethasone|mesh-list
55728299|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55728300|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
55728301|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
55728302|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728303|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728304|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55728305|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
55728306|NCT05235256|Hormones|hormones|mesh-ancestor
55728307|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728308|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55728309|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728310|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
55728311|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
55728312|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55728313|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
55728314|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55728315|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55728316|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55728317|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55728318|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728319|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
55728320|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55728321|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
55728322|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728323|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728324|NCT04791514|Treprostinil|treprostinil|mesh-list
55728325|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55728326|NCT04810546|Lactoferrin|lactoferrin|mesh-list
55728327|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728328|NCT04596826|Dronabinol|dronabinol|mesh-list
55728329|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
55728330|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728331|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55728332|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55728334|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
55728335|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728336|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55728337|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55728338|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728339|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728340|NCT04596826|Hormones|hormones|mesh-ancestor
55728341|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728342|NCT02440568|Cytarabine|cytarabine|mesh-list
55728343|NCT02440568|Idarubicin|idarubicin|mesh-list
55728344|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
55728345|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55728346|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
55728347|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728348|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728349|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
55728350|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728351|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55728352|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
55728353|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728354|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55728355|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55728356|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55728357|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728358|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55728359|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55728360|NCT01038778|Aldesleukin|aldesleukin|mesh-list
55728361|NCT01038778|Deoxyglucose|deoxyglucose|mesh-list
55728362|NCT01038778|Interleukin-2|interleukin-2|mesh-list
55728363|NCT01038778|Entinostat|entinostat|mesh-list
55728364|NCT01038778|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55728365|NCT01038778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
55728366|NCT01038778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728367|NCT01038778|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55728369|NCT01038778|Sensory System Agents|sensory system agents|mesh-ancestor
55728370|NCT01038778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728371|NCT01038778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728372|NCT01038778|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55728373|NCT01038778|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55728374|NCT01038778|Antiviral Agents|antiviral agents|mesh-ancestor
55728375|NCT01038778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728376|NCT01038778|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55728377|NCT01038778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728378|NCT01038778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728379|NCT01038778|Antimetabolites|antimetabolites|mesh-ancestor
55728380|NCT00679120|Cimetidine|cimetidine|mesh-list
55728381|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55728382|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55728383|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55728384|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
55728385|NCT00679120|Histamine Agents|histamine agents|mesh-ancestor
55728386|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728387|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728388|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728389|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55728597|NCT02532257|Immunoglobulins|immunoglobulins|mesh-list
55728390|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55728391|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728392|NCT04420624|Colchicine|colchicine|mesh-list
55728393|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
55767363|NCT04664361|Niacinamide|niacinamide|mesh-list
55728394|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728395|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
55728396|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
55728397|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
55728398|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728399|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728400|NCT04782778|Bupivacaine|bupivacaine|mesh-list
55728401|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
55728402|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
55728403|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55728404|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728405|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
55728406|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728408|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55728409|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55728420|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
55728422|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728423|NCT04047797|Rituximab|rituximab|mesh-list
55728424|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55728425|NCT04047797|Ixazomib|ixazomib|mesh-list
55728426|NCT04047797|Antibodies|antibodies|mesh-list
55728427|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
55728428|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55728429|NCT04047797|Glycine|glycine|mesh-list
55728430|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
55728431|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728432|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728434|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728435|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
55728436|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728437|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
55728438|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728439|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
55728440|NCT04002401|Rituximab|rituximab|mesh-list
55728441|NCT04002401|Fludarabine|fludarabine|mesh-list
55728442|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55728443|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
55728444|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728445|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728446|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55728447|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
55728448|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728449|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728450|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55728451|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55728452|NCT03046511|Cefazolin|cefazolin|mesh-list
55728453|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55728454|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728455|NCT02439320|Lasmiditan|lasmiditan|mesh-list
55728456|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55728457|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
55728458|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728459|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728460|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728461|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
55728462|NCT02468648|Velpatasvir|velpatasvir|mesh-list
55728463|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
55728464|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728465|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55728466|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55728467|NCT02466386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728468|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55728469|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55728470|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55728471|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728472|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
55728473|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767400|NCT05504577|Coagulants|coagulants|mesh-ancestor
55728518|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55728520|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
55728521|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728522|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55728523|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55728524|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55728525|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
55728526|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728527|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728528|NCT01632904|Hydroxyurea|hydroxyurea|mesh-list
55728529|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728530|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
55728531|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728532|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728533|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55728534|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
55728535|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55728536|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728537|NCT04240756|Amphetamine|amphetamine|mesh-list
55728538|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55728539|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728540|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
55728541|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
55728542|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728543|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
55728544|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728545|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728546|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
55728547|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55728548|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55728549|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55728550|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55728551|NCT04467125|Lidocaine|lidocaine|mesh-list
55728552|NCT04467125|Prilocaine|prilocaine|mesh-list
55728553|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55728554|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
55728555|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
55728556|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55728557|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728558|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
55728559|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728560|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55728561|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55728562|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55728563|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55728564|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728565|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55728566|NCT02692313|Epinephrine|epinephrine|mesh-list
55728567|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55728568|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55728569|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
55728570|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728571|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728572|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728573|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55728574|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55728575|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
55728576|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728577|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55728578|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
55728580|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
55728581|NCT02692313|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55728582|NCT02595905|Cisplatin|cisplatin|mesh-list
55728583|NCT02595905|Veliparib|veliparib|mesh-list
55728584|NCT02595905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728585|NCT02595905|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55728586|NCT02595905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728587|NCT02595905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728588|NCT02465528|Ceritinib|ceritinib|mesh-list
55728589|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728590|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55728591|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728592|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728593|NCT02532257|Rituximab|rituximab|mesh-list
55728594|NCT02532257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55728595|NCT02532257|Lenalidomide|lenalidomide|mesh-list
55728600|NCT02532257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728601|NCT02532257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728602|NCT02532257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728603|NCT02532257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55728604|NCT02532257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55728605|NCT02532257|Growth Substances|growth substances|mesh-ancestor
55728606|NCT02532257|Growth Inhibitors|growth inhibitors|mesh-ancestor
55728607|NCT03524261|Antibodies|antibodies|mesh-list
55728608|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55728609|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
55728610|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728611|NCT03386721|Gemcitabine|gemcitabine|mesh-list
55728612|NCT03386721|Atezolizumab|atezolizumab|mesh-list
55728613|NCT03386721|Vinorelbine|vinorelbine|mesh-list
55728614|NCT03386721|Antibodies|antibodies|mesh-list
55728615|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
55728616|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728617|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55728618|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
55728619|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728620|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728621|NCT03386721|Antiviral Agents|antiviral agents|mesh-ancestor
55728622|NCT03386721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728623|NCT03386721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728624|NCT03386721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55728625|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55728626|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
55728627|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
55728628|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
55728629|NCT02462720|Polidocanol|polidocanol|mesh-list
55728630|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55728631|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55728632|NCT02246218|Glycerol|glycerol|mesh-list
55728633|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55728634|NCT02246218|Protective Agents|protective agents|mesh-ancestor
55728635|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728636|NCT05073939|Oxytocin|oxytocin|mesh-list
55728637|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
55728638|NCT05073939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55728639|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728640|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
55728641|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55728642|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
55728643|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728644|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
55728645|NCT04192630|Protective Agents|protective agents|mesh-ancestor
55728647|NCT00159783|Asenapine|asenapine|mesh-list
55728648|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
55728649|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
55728650|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728651|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728652|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55728653|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55728654|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55728655|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55728657|NCT00159783|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55728658|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55728659|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55728660|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728661|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728662|NCT00159783|Serotonin Agents|serotonin agents|mesh-ancestor
55728663|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
55728664|NCT01023737|Vorinostat|vorinostat|mesh-list
55728665|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
55728666|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55728667|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55728668|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728669|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728670|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728671|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728672|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728673|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55728674|NCT04105270|Carboplatin|carboplatin|mesh-list
55728675|NCT04105270|Pemetrexed|pemetrexed|mesh-list
55728676|NCT04105270|Durvalumab|durvalumab|mesh-list
55728677|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728678|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728755|NCT03522935|Elafin|elafin|mesh-list
55728679|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728680|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55728681|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55728682|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55728683|NCT05634785|Cyclophosphamide|cyclophosphamide|mesh-list
55728684|NCT05634785|Fludarabine|fludarabine|mesh-list
55728685|NCT05634785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55728686|NCT05634785|Immunologic Factors|immunologic factors|mesh-ancestor
55728687|NCT05634785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728688|NCT05634785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728689|NCT05634785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55728690|NCT05634785|Alkylating Agents|alkylating agents|mesh-ancestor
55728691|NCT05634785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728692|NCT05634785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728693|NCT05634785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55728694|NCT02243176|Saxagliptin|saxagliptin|mesh-list
55728695|NCT02243176|Acarbose|acarbose|mesh-list
55728696|NCT02243176|Incretins|incretins|mesh-ancestor
55728697|NCT02243176|Hormones|hormones|mesh-ancestor
55728698|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728699|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728700|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55728701|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
55728702|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728703|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728704|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55728705|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55728707|NCT00692939|Melphalan|melphalan|mesh-list
55728708|NCT00692939|Thiotepa|thiotepa|mesh-list
55728709|NCT00692939|Rituximab|rituximab|mesh-list
55728710|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
55728711|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
55728712|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55728713|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55728714|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
55728715|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728716|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728717|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55728718|NCT00692939|Alkylating Agents|alkylating agents|mesh-ancestor
55728719|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728720|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728721|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55728722|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55728724|NCT04551261|Tenofovir|tenofovir|mesh-list
55728725|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55728726|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55728727|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
55728728|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728729|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728730|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55728731|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55728732|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
55728733|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728734|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55728735|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55728736|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55728737|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55728738|NCT04534257|Sirolimus|sirolimus|mesh-list
55728739|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55728740|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728741|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55728742|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728743|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
55728744|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55728745|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
55728746|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728747|NCT03416153|Paclitaxel|paclitaxel|mesh-list
55728748|NCT03416153|Carboplatin|carboplatin|mesh-list
55728749|NCT03416153|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55728750|NCT03416153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728751|NCT03416153|Tubulin Modulators|tubulin modulators|mesh-ancestor
55728752|NCT03416153|Antimitotic Agents|antimitotic agents|mesh-ancestor
55728753|NCT03416153|Mitosis Modulators|mitosis modulators|mesh-ancestor
55728754|NCT03416153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728758|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728759|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
55728760|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55728761|NCT03138681|Protective Agents|protective agents|mesh-ancestor
55728762|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728763|NCT05392257|Rituximab|rituximab|mesh-list
55728764|NCT05392257|Lenalidomide|lenalidomide|mesh-list
55728765|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
55728766|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55728767|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728768|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
55728769|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728770|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728771|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55728772|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55728773|NCT05392257|Growth Substances|growth substances|mesh-ancestor
55728774|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
55728775|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55728776|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728777|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728778|NCT02240680|Linagliptin|linagliptin|mesh-list
55728779|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55728780|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728781|NCT02240680|Incretins|incretins|mesh-ancestor
55728782|NCT02240680|Hormones|hormones|mesh-ancestor
55767567|NCT04697602|Febuxostat|febuxostat|mesh-list
55728783|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728784|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55728785|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
55728786|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728787|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728788|NCT05391867|Sorafenib|sorafenib|mesh-list
55728789|NCT05391867|Lenvatinib|lenvatinib|mesh-list
55728790|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728791|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55728792|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728793|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728794|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
55728795|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55728796|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
55728797|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728798|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
55728799|NCT03110679|Protective Agents|protective agents|mesh-ancestor
55728800|NCT05391789|Urinastatin|urinastatin|mesh-list
55728801|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55728802|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55728803|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
55728804|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728805|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728806|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
55728807|NCT04699071|Lenvatinib|lenvatinib|mesh-list
55728808|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55728809|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728810|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55728811|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728812|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728813|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
55728814|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
55728815|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55728816|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
55728817|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728818|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728819|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55728820|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
55728821|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728822|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728823|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55728824|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55728825|NCT03967288|Bupivacaine|bupivacaine|mesh-list
55728826|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
55728828|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
55728829|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
55728830|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55728831|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728832|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
55728833|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728835|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
55728836|NCT04167111|Vitamins|vitamins|mesh-ancestor
55728837|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
55728838|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728839|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55728840|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55728841|NCT03962062|Moxidectin|moxidectin|mesh-list
55728842|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
55728843|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55728844|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728845|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
55728846|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55728847|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728848|NCT02239510|Linaclotide|linaclotide|mesh-list
55728849|NCT02239510|Sennosides|sennosides|mesh-list
55728850|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55728851|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
55728852|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728853|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55728854|NCT02239510|Laxatives|laxatives|mesh-ancestor
55728855|NCT04507581|Anesthetics|anesthetics|mesh-list
55728856|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55728857|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728858|NCT02291471|T0001|t0001|mesh-list
55728859|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
55728860|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55728861|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
55728862|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728864|NCT03899961|Carbetocin|carbetocin|mesh-list
55728865|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
55728866|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55728867|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728868|NCT02462486|Ranibizumab|ranibizumab|mesh-list
55728869|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55728870|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55728871|NCT02462486|Growth Substances|growth substances|mesh-ancestor
55728872|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728873|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
55728874|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728875|NCT03521219|Apatinib|apatinib|mesh-list
55728876|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728877|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55728878|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55767602|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
55728879|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728880|NCT05318157|Emedastine|emedastine|mesh-list
55728881|NCT05318157|Budesonide|budesonide|mesh-list
55728882|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55728883|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55728884|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55728885|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55728886|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
55728887|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728888|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728889|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55728890|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
55728891|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
55728892|NCT05318157|Hormones|hormones|mesh-ancestor
55728893|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728894|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55728895|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
55728896|NCT05318157|Histamine Agents|histamine agents|mesh-ancestor
55728897|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55728898|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728899|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55728901|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55728902|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
55728903|NCT02294279|Hormones|hormones|mesh-ancestor
55728904|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728905|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728906|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55728907|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
55728908|NCT02294357|Dexamethasone|dexamethasone|mesh-list
55728909|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
55728910|NCT02294357|Prednisone|prednisone|mesh-list
55728911|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
55728912|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55728913|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55728914|NCT02294357|Prednisolone|prednisolone|mesh-list
55728915|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
55728916|NCT02294357|Lenalidomide|lenalidomide|mesh-list
55728917|NCT02294357|Pomalidomide|pomalidomide|mesh-list
55728918|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55728919|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
55728920|NCT02294357|BB 1101|bb 1101|mesh-list
55728921|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55728922|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
55728923|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
55728924|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728925|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728926|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55728927|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
55728929|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728930|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55728931|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55728932|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
55728933|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55728934|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728935|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
55728936|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55728937|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55728938|NCT02294357|Growth Substances|growth substances|mesh-ancestor
55728939|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
55728940|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55728941|NCT02294357|Protective Agents|protective agents|mesh-ancestor
55728942|NCT03880539|Vancomycin|vancomycin|mesh-list
55728943|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55728944|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728945|NCT02291705|Tramadol|tramadol|mesh-list
55728946|NCT02291705|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55728947|NCT02291705|Narcotics|narcotics|mesh-ancestor
55728948|NCT02291705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55728949|NCT02291705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728950|NCT02291705|Analgesics|analgesics|mesh-ancestor
55728951|NCT02291705|Sensory System Agents|sensory system agents|mesh-ancestor
55728952|NCT02291705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728953|NCT03518021|Naloxone|naloxone|mesh-list
55728954|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55728955|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728956|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
55728957|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728958|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55728959|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55728960|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55728961|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728962|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
55728963|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55728964|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
55728965|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55728966|NCT02294591|Expectorants|expectorants|mesh-ancestor
55728967|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
55728968|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55728969|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
55728970|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55728971|NCT02294591|Protective Agents|protective agents|mesh-ancestor
55728972|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728973|NCT02294591|Antidotes|antidotes|mesh-ancestor
55728975|NCT03521063|Poractant alfa|poractant alfa|mesh-list
55728976|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55728977|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55728978|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
55728979|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728980|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728981|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55728982|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
55728983|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
55728985|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55728986|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
55728987|NCT03520985|Dexamethasone|dexamethasone|mesh-list
55728988|NCT03520985|Pomalidomide|pomalidomide|mesh-list
55728989|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55728990|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
55728991|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
55728992|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55728993|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55728994|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55728995|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
55728996|NCT03520985|Hormones|hormones|mesh-ancestor
55728997|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55767649|NCT02058628|Clindamycin|clindamycin|mesh-list
55728998|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55728999|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729000|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
55729001|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55729002|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55729003|NCT03520985|Growth Substances|growth substances|mesh-ancestor
55729004|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
55729005|NCT03517943|Loratadine|loratadine|mesh-list
55729006|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
55729007|NCT03517943|Ephedrine|ephedrine|mesh-list
55729008|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
55729009|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
55729010|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55729011|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55729012|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55729013|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
55729014|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
55729015|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729016|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729017|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729018|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55729019|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
55729020|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729021|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55729022|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
55729023|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
55729024|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55729025|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55729026|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
55729027|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
55729028|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
55729029|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55729030|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55729031|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55729032|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55729033|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55729034|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729035|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
55729036|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729037|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729038|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55729039|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729040|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
55729041|NCT04465175|Analgesics|analgesics|mesh-ancestor
55729043|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729044|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729045|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
55729046|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729047|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55729048|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
55729049|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55729050|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55729051|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729052|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729053|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
55729054|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55729056|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55729057|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729058|NCT03138447|Insulin|insulin|mesh-list
55729059|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55829097|NCT04753970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829099|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829100|NCT04641195|Vitamin D|vitamin d|mesh-list
55829101|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
55829102|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
55829103|NCT04641195|Vitamins|vitamins|mesh-list
55829104|NCT04641195|Zinc|zinc|mesh-list
55829105|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
55829110|NCT02213042|Trastuzumab|trastuzumab|mesh-list
55729060|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729062|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
55729063|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729064|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55729065|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
55729066|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729067|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55729068|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729069|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55729070|NCT03109977|Pertuzumab|pertuzumab|mesh-list
55729071|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55729072|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729073|NCT03520595|Diclofenac|diclofenac|mesh-list
55729074|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55729075|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55729076|NCT03520595|Analgesics|analgesics|mesh-ancestor
55729077|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
55729078|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729079|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729080|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729081|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729082|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55729083|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729084|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729085|NCT03520439|Mifepristone|mifepristone|mesh-list
55729086|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55729087|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
55729088|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55729089|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729090|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55729091|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55729092|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55729093|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
55845504|NCT03621904|Progestins|progestins|mesh-ancestor
55729094|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55729095|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55729096|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
55729097|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729098|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
55729099|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55729100|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55729101|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
55729102|NCT04543227|Narcotics|narcotics|mesh-ancestor
55729103|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729104|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729105|NCT04543227|Analgesics|analgesics|mesh-ancestor
55729106|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
55729107|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729109|NCT04542993|Resveratrol|resveratrol|mesh-list
55729110|NCT04542993|Picolinic acid|picolinic acid|mesh-list
55729111|NCT04542993|Trace Elements|trace elements|mesh-ancestor
55729112|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
55729113|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729114|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
55729115|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729117|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729118|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55729119|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55729120|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
55729121|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
55729122|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55729123|NCT02292173|Sorafenib|sorafenib|mesh-list
55729124|NCT02292173|Trametinib|trametinib|mesh-list
55729125|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729126|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55729127|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729128|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729129|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
55729130|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55729131|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55729132|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55729133|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55729134|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729136|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729137|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729138|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55729139|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729140|NCT03520049|Oseltamivir|oseltamivir|mesh-list
55729141|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
55729142|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729143|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729144|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729145|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
55729146|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729147|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729148|NCT02461160|Midazolam|midazolam|mesh-list
55729149|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55729150|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55729151|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729152|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729153|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55729154|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55729155|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55729156|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55729157|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
55729158|NCT02461160|Anesthetics|anesthetics|mesh-ancestor
55729159|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
55729160|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
55729161|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729162|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729163|NCT02296073|Fentanyl|fentanyl|mesh-list
55729164|NCT02296073|Midazolam|midazolam|mesh-list
55729165|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
55729166|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55729167|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729168|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729169|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55729170|NCT02296073|Analgesics|analgesics|mesh-ancestor
55729171|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
55729172|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729173|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55729174|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55729175|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55729176|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
55729177|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729178|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729179|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55729181|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55729182|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55729183|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
55729184|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
55729185|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55729186|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55729187|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55729188|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
55729189|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
55729190|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55729191|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55767683|NCT02087176|Adavosertib|adavosertib|mesh-list
55729192|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55729193|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55729194|NCT02293187|Vitamin D|vitamin d|mesh-list
55729195|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
55729196|NCT02293187|Vitamins|vitamins|mesh-ancestor
55729197|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
55729198|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729199|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55729200|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729201|NCT02296463|Vaccines|vaccines|mesh-list
55729202|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
55729203|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729204|NCT02495168|Budesonide|budesonide|mesh-list
55729205|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
55729206|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55729207|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729208|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55729209|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
55729210|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729211|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729212|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55729213|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
55729214|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
55729215|NCT02495168|Hormones|hormones|mesh-ancestor
55729216|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729217|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55729218|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55729219|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55729220|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
55729221|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729222|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729223|NCT04934072|Denosumab|denosumab|mesh-list
55729224|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55729225|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729226|NCT03518489|Lappaconitine|lappaconitine|mesh-list
55729227|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55729228|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55729229|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55729230|NCT03518489|Analgesics|analgesics|mesh-ancestor
55729231|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
55729232|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55767694|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
55729233|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729234|NCT04933526|Dasatinib|dasatinib|mesh-list
55729235|NCT04933526|HH-GV-678|hh-gv-678|mesh-list
55729236|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729237|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55729238|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729239|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729240|NCT02293889|Vitamin D|vitamin d|mesh-list
55729241|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
55729242|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
55729243|NCT02293889|Vitamins|vitamins|mesh-list
55729244|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
55729245|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729246|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55729247|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729249|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729250|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
55729251|NCT02298335|Hormones|hormones|mesh-ancestor
55729252|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729253|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729254|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55729255|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729257|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55729258|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55729259|NCT03514667|Analgesics|analgesics|mesh-ancestor
55729260|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
55729261|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729262|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729263|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729264|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729265|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729266|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729267|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729268|NCT04465097|Exemestane|exemestane|mesh-list
55729269|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729270|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55729271|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55729272|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729273|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729274|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55729275|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
55829112|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55729276|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729277|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729278|NCT02493764|Tazobactam|tazobactam|mesh-list
55729279|NCT02493764|Linezolid|linezolid|mesh-list
55729280|NCT02493764|Piperacillin|piperacillin|mesh-list
55729281|NCT02493764|Imipenem|imipenem|mesh-list
55729282|NCT02493764|Relebactam|relebactam|mesh-list
55729283|NCT02493764|Cilastatin|cilastatin|mesh-list
55729284|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55729285|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729286|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55729288|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729289|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55729290|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
55729291|NCT02297477|Artesunate|artesunate|mesh-list
55729292|NCT02297477|Atovaquone|atovaquone|mesh-list
55729293|NCT02297477|Proguanil|proguanil|mesh-list
55729294|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
55729295|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
55729296|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55729297|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55729298|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729299|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729300|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
55729301|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
55729302|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55729303|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
55729304|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729305|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729306|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
55729307|NCT02460380|Vitamin D|vitamin d|mesh-list
55729308|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
55729309|NCT02460380|Vitamins|vitamins|mesh-ancestor
55729310|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
55729311|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729312|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55729313|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729314|NCT02299115|Prednisolone|prednisolone|mesh-list
55729315|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55729316|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
55729317|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55729318|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
55729319|NCT02299115|Vigabatrin|vigabatrin|mesh-list
55729320|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55729321|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
55729322|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729323|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
55729324|NCT02299115|Hormones|hormones|mesh-ancestor
55729325|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729326|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729327|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55729328|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729329|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
55729330|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
55729331|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729332|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55729333|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55729334|NCT02299115|Protective Agents|protective agents|mesh-ancestor
55729335|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
55729336|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729337|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729338|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
55729339|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729340|NCT03515369|Liver Extracts|liver extracts|mesh-list
55729341|NCT03515369|Hematinics|hematinics|mesh-ancestor
55729342|NCT03515213|Fenofibrate|fenofibrate|mesh-list
55729343|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55729344|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
55729345|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729346|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55729347|NCT02297945|Metyrapone|metyrapone|mesh-list
55729348|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
55729349|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729350|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729351|NCT02492984|Factor VIII|factor viii|mesh-list
55729352|NCT02492984|Coagulants|coagulants|mesh-ancestor
55729353|NCT03132623|Andrographolide|andrographolide|mesh-list
55729354|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729355|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55729356|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55729357|NCT03132623|Analgesics|analgesics|mesh-ancestor
55729358|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
55729359|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729360|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729361|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729362|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55729363|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55729364|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729365|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
55729366|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55729367|NCT03514979|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55729368|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
55729369|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729370|NCT02298101|Edetic Acid|edetic acid|mesh-list
55729371|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
55729372|NCT02298101|Antidotes|antidotes|mesh-ancestor
55729373|NCT02298101|Protective Agents|protective agents|mesh-ancestor
55729374|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729375|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
55729376|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
55729377|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729378|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55729379|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
55729380|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55729381|NCT02491892|Pertuzumab|pertuzumab|mesh-list
55729382|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55729383|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729384|NCT03476811|Analgesics|analgesics|mesh-list
55729385|NCT03476811|Bupivacaine|bupivacaine|mesh-list
55729386|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
55729387|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
55729388|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729389|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729390|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
55729391|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729392|NCT02834403|Aspirin|aspirin|mesh-list
55729393|NCT02834403|Docetaxel|docetaxel|mesh-list
55729394|NCT02834403|Amlodipine|amlodipine|mesh-list
55729395|NCT02834403|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
55729396|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729397|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
55729398|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
55729399|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
55729400|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729401|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55729402|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55729403|NCT02834403|Analgesics|analgesics|mesh-ancestor
55729404|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
55729405|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729406|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729407|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729408|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729409|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55767827|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
55729410|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55729411|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55729412|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55729413|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729415|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55729416|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55729417|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55729418|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729419|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
55729420|NCT02299271|Ropivacaine|ropivacaine|mesh-list
55729421|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
55729422|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
55729423|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729424|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729425|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
55729426|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729427|NCT02302469|Lenalidomide|lenalidomide|mesh-list
55729428|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
55729429|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729430|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55729431|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55729432|NCT02302469|Growth Substances|growth substances|mesh-ancestor
55729433|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
55729434|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729435|NCT02302547|Ritonavir|ritonavir|mesh-list
55729436|NCT02302547|Lopinavir|lopinavir|mesh-list
55729437|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55729438|NCT02302547|Darunavir|darunavir|mesh-list
55729439|NCT02302547|Indinavir|indinavir|mesh-list
55729440|NCT02302547|Saquinavir|saquinavir|mesh-list
55729441|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
55729442|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
55729443|NCT02302547|Tenofovir|tenofovir|mesh-list
55829121|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829122|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729446|NCT02302547|Nevirapine|nevirapine|mesh-list
55729447|NCT02302547|Maraviroc|maraviroc|mesh-list
55729448|NCT02302547|Dolutegravir|dolutegravir|mesh-list
55729449|NCT02302547|Cobicistat|cobicistat|mesh-list
55729450|NCT02302547|Rilpivirine|rilpivirine|mesh-list
55729451|NCT02302547|Tipranavir|tipranavir|mesh-list
55729452|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
55729453|NCT02302547|Elvitegravir|elvitegravir|mesh-list
55729454|NCT02302547|Efavirenz|efavirenz|mesh-list
55729455|NCT02302547|Etravirine|etravirine|mesh-list
55729456|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
55729457|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
55729458|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
55729459|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55729460|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729461|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729462|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55729463|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55729464|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
55729465|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729466|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55729467|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55729468|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55729469|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55729470|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55729471|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55729472|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55729473|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55729474|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55729475|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55729476|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55729477|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55729478|NCT01190787|Prednisone|prednisone|mesh-list
55729479|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
55729480|NCT01190787|Melphalan|melphalan|mesh-list
55729481|NCT01190787|Bortezomib|bortezomib|mesh-list
55729482|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55729483|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
55729484|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729485|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729486|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55729487|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
55767852|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55729488|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729489|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729490|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55729491|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729492|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
55729493|NCT01190787|Hormones|hormones|mesh-ancestor
55729494|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729495|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55729496|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55729497|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55729498|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729499|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
55729500|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
55729501|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55729502|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729503|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
55729504|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
55729505|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729506|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
55729507|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55729508|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
55729509|NCT03510611|Ensartinib|ensartinib|mesh-list
55729510|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729511|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55729512|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729513|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729514|NCT02299817|Denosumab|denosumab|mesh-list
55729515|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55729516|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729517|NCT01679613|Ketoconazole|ketoconazole|mesh-list
55729518|NCT01679613|Nintedanib|nintedanib|mesh-list
55729520|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729521|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55729522|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55729523|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729524|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729525|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55729526|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
55729527|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729528|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729529|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55729530|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729531|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55729532|NCT02489630|Ketamine|ketamine|mesh-list
55729533|NCT02489630|Analgesics|analgesics|mesh-list
55729534|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
55729535|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729536|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729537|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55729538|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55729539|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
55729540|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
55729541|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729542|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55729543|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55729544|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729545|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729546|NCT02303171|Enoxaparin|enoxaparin|mesh-list
55729547|NCT02303171|Warfarin|warfarin|mesh-list
55729548|NCT02303171|Anticoagulants|anticoagulants|mesh-ancestor
55729549|NCT02303171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55729550|NCT02303171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55729551|NCT02303171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729552|NCT05089539|Valsartan|valsartan|mesh-list
55729553|NCT05089539|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55729554|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55729555|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55729556|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55729557|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729559|NCT05089383|Progestins|progestins|mesh-ancestor
55729560|NCT05089383|Hormones|hormones|mesh-ancestor
55729561|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729562|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729563|NCT03510533|Autoantibodies|autoantibodies|mesh-list
55729564|NCT03510533|alpha-MSH|alpha-msh|mesh-list
55729565|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
55729566|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729568|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729569|NCT03512873|Tranilast|tranilast|mesh-list
55729570|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55729571|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55729572|NCT03512873|Analgesics|analgesics|mesh-ancestor
55729573|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
55729574|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729575|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729576|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729577|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729578|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55729579|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55729580|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729581|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729582|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55729583|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
55729584|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
55729585|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55767872|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55729586|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55729587|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55729588|NCT01678911|Gabapentin|gabapentin|mesh-list
55729589|NCT01678911|Analgesics|analgesics|mesh-ancestor
55729590|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
55729591|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729592|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729593|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
55729594|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55729595|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55729596|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729597|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55729598|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55729599|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55729600|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729601|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729602|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
55729603|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
55729604|NCT03132701|Analgesics|analgesics|mesh-ancestor
55729605|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
55729606|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729607|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729608|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
55729609|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729610|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55729611|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
55729612|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55729613|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55729614|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729615|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729616|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
55729617|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55729618|NCT02322099|Alendronate|alendronate|mesh-list
55729619|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
55729620|NCT02322099|Vitamin D|vitamin d|mesh-list
55729621|NCT02322099|Tenofovir|tenofovir|mesh-list
55729622|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
55729623|NCT02322099|Calcium|calcium|mesh-list
55729624|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729625|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729626|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
55729627|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729628|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55729629|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55729630|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729631|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729632|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55729633|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55729634|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55729635|NCT02322099|Antacids|antacids|mesh-ancestor
55729636|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55729637|NCT02322099|Vitamins|vitamins|mesh-ancestor
55729638|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
55729639|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
55729640|NCT02487446|Bromides|bromides|mesh-list
55729641|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
55729642|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729643|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55729644|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55729645|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55729646|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
55729647|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729648|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729649|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
55729650|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729651|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
55729652|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729653|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729654|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55729655|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
55729656|NCT04464005|Analgesics|analgesics|mesh-ancestor
55729657|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
55729658|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729659|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729660|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
55729661|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729662|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55729663|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
55729664|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55729665|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55729666|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729667|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729668|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
55729669|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55729670|NCT02303327|Androgens|androgens|mesh-list
55729671|NCT02303327|Hormones|hormones|mesh-ancestor
55729672|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729673|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729675|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729676|NCT03510221|Protective Agents|protective agents|mesh-ancestor
55729677|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729678|NCT03509831|Irsogladine|irsogladine|mesh-list
55729679|NCT03509831|Nizatidine|nizatidine|mesh-list
55729680|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729681|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55729682|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55729683|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55729684|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
55729685|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
55729686|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729687|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729688|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729689|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55729690|NCT03509831|Protective Agents|protective agents|mesh-ancestor
55729691|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55729692|NCT02303483|Niacinamide|niacinamide|mesh-list
55729693|NCT02303483|Niacin|niacin|mesh-list
55729694|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
55729695|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
55729696|NCT02303483|Vitamins|vitamins|mesh-ancestor
55729697|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
55729698|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729699|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55729700|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
55729701|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829201|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55829202|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55829203|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55829204|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829205|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
55829206|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
55829207|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
55829208|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829209|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
55829210|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
55829211|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55729702|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55729703|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
55729704|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
55729705|NCT05378061|Growth Substances|growth substances|mesh-ancestor
55729706|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729707|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
55729708|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729709|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729710|NCT02303639|Amiodarone|amiodarone|mesh-list
55729711|NCT02303639|Sotalol|sotalol|mesh-list
55729712|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55729713|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
55729714|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55729715|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55729716|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729717|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55729718|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55729719|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55729720|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729721|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55729722|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55729723|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55729724|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55729725|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55729726|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
55729727|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729728|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729729|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
55729730|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
55729731|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729733|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55729734|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729735|NCT04757493|Prucalopride|prucalopride|mesh-list
55729736|NCT04757493|Laxatives|laxatives|mesh-ancestor
55729737|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55729738|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55729739|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55729740|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
55729741|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729742|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729743|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729744|NCT02303951|Atezolizumab|atezolizumab|mesh-list
55729745|NCT02303951|Vemurafenib|vemurafenib|mesh-list
55729746|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729747|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55729748|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729749|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729750|NCT04406415|Nafamostat|nafamostat|mesh-list
55729751|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55729752|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55729753|NCT04406415|Analgesics|analgesics|mesh-ancestor
55729754|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
55729755|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729756|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729757|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729758|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729759|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
55729760|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
55729761|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729762|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729763|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55729764|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55729765|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55729766|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55729767|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
55729768|NCT02304107|Letrozole|letrozole|mesh-list
55729769|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729770|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55729771|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55729772|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729773|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729774|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55729775|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
55729776|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729777|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729778|NCT03509285|Cenobamate|cenobamate|mesh-list
55729779|NCT03509285|Alprazolam|alprazolam|mesh-list
55729780|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55729781|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729782|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729783|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55729784|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55729785|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55729786|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
55729787|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
55729788|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729789|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729790|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
55729791|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
55729792|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55729793|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55729794|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55729795|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
55729796|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729797|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55729798|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55729799|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729800|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55729801|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55729802|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729804|NCT03135795|Sufentanil|sufentanil|mesh-list
55729814|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55729815|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55729816|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729817|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55729818|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
55729819|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
55729820|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55729821|NCT03135795|Analgesics|analgesics|mesh-ancestor
55729822|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
55729823|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729824|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55729825|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55729826|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55729827|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
55729828|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729829|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729830|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
55729831|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55729832|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
55729833|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
55729834|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55729835|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55729836|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55729838|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
55729839|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55729840|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55729841|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55729842|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55729843|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55729844|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55729845|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729846|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55729847|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729848|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729849|NCT03469531|Cisplatin|cisplatin|mesh-list
55729850|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
55729851|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729852|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55729854|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
55729855|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55729856|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729857|NCT03309007|Antacids|antacids|mesh-ancestor
55729858|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729859|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55729860|NCT03508817|Atropine|atropine|mesh-list
55729861|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55729862|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55729863|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55729864|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55729865|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55729866|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
55729867|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729868|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729869|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55729870|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
55729872|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
55729873|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55729874|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55729875|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
55729876|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729877|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729878|NCT05158777|Vaccines|vaccines|mesh-list
55729879|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
55729880|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729881|NCT01678209|Methylphenidate|methylphenidate|mesh-list
55729882|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55729883|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55829214|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
55729884|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729885|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55729886|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55729887|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55729888|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729889|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
55729890|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729891|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55729892|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
55729893|NCT02239120|Dabigatran|dabigatran|mesh-list
55729894|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
55729895|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55729896|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
55729897|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729898|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729899|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
55729900|NCT04464863|Metronidazole|metronidazole|mesh-list
55729901|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55729902|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55729903|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55729904|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55729905|NCT05158699|Dexamethasone|dexamethasone|mesh-list
55729906|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
55729907|NCT05158699|Triamcinolone|triamcinolone|mesh-list
55729908|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55729909|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55729910|NCT05158699|Ketorolac|ketorolac|mesh-list
55729911|NCT05158699|Bromfenac|bromfenac|mesh-list
55729912|NCT05158699|Phenylephrine|phenylephrine|mesh-list
55729913|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55729914|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55729915|NCT05158699|BB 1101|bb 1101|mesh-list
55729916|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55729917|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729918|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
55729919|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
55729920|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729921|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729922|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55729923|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
55729924|NCT05158699|Hormones|hormones|mesh-ancestor
55729925|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729926|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55729927|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729929|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55729930|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729931|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55729932|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
55729933|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55729934|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55729935|NCT05158699|Analgesics|analgesics|mesh-ancestor
55729936|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
55729937|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55729938|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55729939|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55729940|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
55729941|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
55729942|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55729943|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
55729944|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
55729945|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55729946|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55729947|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55729948|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
55729949|NCT05158699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729950|NCT05158699|Protective Agents|protective agents|mesh-ancestor
55729951|NCT04464629|Prednisolone|prednisolone|mesh-list
55729952|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55729953|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
55729954|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55729955|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
55729956|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55729957|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
55729958|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55729959|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
55729960|NCT04464629|Hormones|hormones|mesh-ancestor
55729961|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55729962|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729963|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55729964|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729965|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
55729966|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
55729967|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729968|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55729969|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55729970|NCT04464629|Protective Agents|protective agents|mesh-ancestor
55729971|NCT02304887|Denosumab|denosumab|mesh-list
55729972|NCT02304887|Teriparatide|teriparatide|mesh-list
55729973|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55729974|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729975|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55729976|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55729977|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55729978|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55729979|NCT03512171|Amphetamine|amphetamine|mesh-list
55729980|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
55729981|NCT03512171|Fallypride|fallypride|mesh-list
55729982|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55729983|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55729984|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
55729985|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
55729986|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55729987|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
55729988|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55729989|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55729990|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
55729991|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55729992|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55729993|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55729994|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55729995|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55729996|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55729997|NCT03739099|Pancrelipase|pancrelipase|mesh-list
55729998|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55729999|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55730000|NCT03469375|Folfirinox|folfirinox|mesh-list
55730001|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730002|NCT01603407|Prednisone|prednisone|mesh-list
55730003|NCT01603407|Deflazacort|deflazacort|mesh-list
55730004|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55730005|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
55730006|NCT01603407|Hormones|hormones|mesh-ancestor
55730007|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730008|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730009|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55730010|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730011|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55730012|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
55730013|NCT02305355|Atorvastatin|atorvastatin|mesh-list
55730014|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55730015|NCT02305355|Simvastatin|simvastatin|mesh-list
55730016|NCT02305355|Pravastatin|pravastatin|mesh-list
55730017|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55730018|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55730019|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
55730020|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730021|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55730022|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55730023|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730025|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730026|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55730027|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730028|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730029|NCT03777436|Apremilast|apremilast|mesh-list
55730030|NCT03777436|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55730031|NCT03777436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55730032|NCT03777436|Analgesics|analgesics|mesh-ancestor
55730033|NCT03777436|Sensory System Agents|sensory system agents|mesh-ancestor
55730034|NCT03777436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730035|NCT03777436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730036|NCT03777436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55730037|NCT03777436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55730038|NCT03777436|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55730039|NCT03777436|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55730040|NCT03777436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730041|NCT03777436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730042|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55730043|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55730045|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730046|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730047|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55730048|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55730049|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730050|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
55730051|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730052|NCT02301221|Vancomycin|vancomycin|mesh-list
55730053|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730054|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730055|NCT02518555|Vaccines|vaccines|mesh-list
55730056|NCT02518555|Immunologic Factors|immunologic factors|mesh-ancestor
55730057|NCT02518555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730058|NCT03770416|Nivolumab|nivolumab|mesh-list
55730059|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55730060|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730061|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55730062|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730063|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
55730064|NCT03122431|Thalidomide|thalidomide|mesh-list
55730065|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
55730066|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55730067|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55730068|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730069|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730070|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730071|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55730072|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55730073|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
55730074|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730075|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
55730076|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730077|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55730078|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55730079|NCT03122431|Growth Substances|growth substances|mesh-ancestor
55730080|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
55730081|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730082|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55730083|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55730084|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730086|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55730087|NCT02305823|Ziprasidone|ziprasidone|mesh-list
55730088|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
55730089|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55730090|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55730091|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55730092|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730093|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730095|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
55730096|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730097|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730098|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55730099|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55730100|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
55730101|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55730102|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55730103|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55730104|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55730105|NCT05376189|Vitamin D|vitamin d|mesh-list
55730106|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
55730107|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
55730108|NCT05376189|Vitamins|vitamins|mesh-list
55730109|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
55730110|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730111|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55730112|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55730113|NCT02235298|Metformin|metformin|mesh-list
55730114|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
55730115|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55768036|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
55730116|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730117|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55730118|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730119|NCT02305901|Repaglinide|repaglinide|mesh-list
55730338|NCT04778176|Levodopa|levodopa|mesh-list
55730121|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55730122|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
55730123|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55730124|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55730125|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55730126|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55730127|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730128|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
55730129|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730130|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730131|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55730132|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55730133|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730134|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55730135|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
55730136|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55730137|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55730138|NCT03942887|Prednisolone|prednisolone|mesh-list
55730139|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
55730140|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
55730142|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55730143|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
55730144|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55730145|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
55730146|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730147|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55730148|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55730149|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
55730150|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730151|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730152|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55730153|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55730154|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55730155|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
55730156|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
55730157|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730158|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55730159|NCT03942887|Glucocorticoids|glucocorticoids|mesh-ancestor
55730160|NCT03942887|Hormones|hormones|mesh-ancestor
55730161|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730162|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55730163|NCT03942887|Protective Agents|protective agents|mesh-ancestor
55730164|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55730165|NCT02234596|Nintedanib|nintedanib|mesh-list
55730166|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730167|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55730168|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730169|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730170|NCT02305979|Loratadine|loratadine|mesh-list
55730171|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
55730172|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
55730173|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55730174|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55730175|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55730176|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
55730177|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
55730178|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730179|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730180|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730181|NCT04539951|Memantine|memantine|mesh-list
55730182|NCT04539951|Aripiprazole|aripiprazole|mesh-list
55730183|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
55730184|NCT04539951|Sertraline|sertraline|mesh-list
55730185|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55730186|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
55730187|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55730188|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55730189|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55730190|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730191|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730193|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
55730194|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730195|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730196|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55730197|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55730198|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
55730199|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55730200|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55730201|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55730202|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55730203|NCT04539951|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55730204|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55730205|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55730206|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55730207|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55730208|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55730209|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55730210|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55730211|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55730212|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55730213|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55730214|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55730215|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730216|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55730218|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55730219|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730220|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730221|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730222|NCT02234362|Vortioxetine|vortioxetine|mesh-list
55730223|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
55730224|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55730225|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55730226|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55730227|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730228|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730229|NCT02234362|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55730230|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55730231|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55730232|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730233|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730234|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
55730235|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55730236|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55730237|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55730238|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55730239|NCT05091177|Acetylcholine|acetylcholine|mesh-list
55730240|NCT05091177|Antibodies|antibodies|mesh-list
55730241|NCT05091177|Neostigmine|neostigmine|mesh-list
55730242|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
55730243|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730244|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55730245|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730246|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730247|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
55730248|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730249|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55730250|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
55730251|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730252|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
55730253|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55730254|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
55730255|NCT05091099|Alendronate|alendronate|mesh-list
55730256|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55730257|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730258|NCT05197426|Azacitidine|azacitidine|mesh-list
55730259|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55730260|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
55730261|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730262|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730263|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730265|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55730266|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730267|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730268|NCT02232880|Abatacept|abatacept|mesh-list
55730269|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55730270|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730271|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730272|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55730273|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
55730274|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730275|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55730276|NCT02896855|Docetaxel|docetaxel|mesh-list
55730277|NCT02896855|Trastuzumab|trastuzumab|mesh-list
55730278|NCT02896855|Pertuzumab|pertuzumab|mesh-list
55768092|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
55730279|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730280|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
55730281|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
55730282|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
55730283|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730284|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55730285|NCT02311439|Folfirinox|folfirinox|mesh-list
55730286|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730287|NCT02311517|Ropivacaine|ropivacaine|mesh-list
55730288|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
55730289|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
55730290|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730291|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730292|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
55730293|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730294|NCT02232802|Enoxaparin|enoxaparin|mesh-list
55730295|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
55730296|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
55730297|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55730298|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55730299|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730300|NCT04463459|Vitamins|vitamins|mesh-list
55730301|NCT04463459|Vitamin E|vitamin e|mesh-list
55730302|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
55730303|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730304|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
55730305|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730306|NCT04463459|Protective Agents|protective agents|mesh-ancestor
55730307|NCT00821587|Cyclosporine|cyclosporine|mesh-list
55730308|NCT00821587|Tacrolimus|tacrolimus|mesh-list
55730309|NCT00821587|Cyclosporins|cyclosporins|mesh-list
55730310|NCT00821587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829237|NCT02985658|Vinorelbine|vinorelbine|mesh-list
55829238|NCT02985658|Veliparib|veliparib|mesh-list
55829239|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829240|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55829241|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
55829242|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
55829243|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
55829244|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730311|NCT00821587|Immunologic Factors|immunologic factors|mesh-ancestor
55730312|NCT00821587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730313|NCT00821587|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55730314|NCT00821587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730315|NCT00821587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730316|NCT00821587|Antifungal Agents|antifungal agents|mesh-ancestor
55730317|NCT00821587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730318|NCT00821587|Dermatologic Agents|dermatologic agents|mesh-ancestor
55730319|NCT00821587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55730320|NCT02434328|Aflibercept|aflibercept|mesh-list
55730321|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55730322|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55730323|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55730324|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55730325|NCT02434328|Growth Substances|growth substances|mesh-ancestor
55730326|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730327|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
55730328|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730329|NCT04785274|Chrysarobin|chrysarobin|mesh-list
55730330|NCT04785274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55730331|NCT04785274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55730332|NCT04785274|Analgesics|analgesics|mesh-ancestor
55730333|NCT04785274|Sensory System Agents|sensory system agents|mesh-ancestor
55730334|NCT04785274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730335|NCT04785274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730336|NCT04785274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55730337|NCT04785274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55730341|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55730342|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
55730343|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730344|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730345|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730346|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55730347|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730348|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
55730349|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55730350|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55730351|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730352|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
55730353|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
55730354|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730355|NCT05076253|Ivermectin|ivermectin|mesh-list
55730356|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55730357|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730358|NCT05077839|Trifluridine|trifluridine|mesh-list
55730359|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
55730360|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730361|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
55730362|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730363|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
55730364|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55730365|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
55730366|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55730367|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
55730368|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730369|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730370|NCT05077683|Anticoagulants|anticoagulants|mesh-ancestor
55730371|NCT03132233|Calcium|calcium|mesh-list
55730372|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55730373|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730374|NCT02307227|Paclitaxel|paclitaxel|mesh-list
55730375|NCT02307227|Docetaxel|docetaxel|mesh-list
55730376|NCT02307227|Trastuzumab|trastuzumab|mesh-list
55730377|NCT02307227|Epirubicin|epirubicin|mesh-list
55730378|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55730379|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730380|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
55730381|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
55730382|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
55730383|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730384|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55730385|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55730386|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55730387|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55730388|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730390|NCT02307305|Celecoxib|celecoxib|mesh-list
55730391|NCT02307305|Naproxen|naproxen|mesh-list
55730392|NCT02307305|Oxycodone|oxycodone|mesh-list
55730393|NCT02307305|Tramadol|tramadol|mesh-list
55730394|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55730395|NCT02307305|Naloxone|naloxone|mesh-list
55730396|NCT02307305|Esomeprazole|esomeprazole|mesh-list
55730397|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55730398|NCT02307305|Analgesics|analgesics|mesh-ancestor
55730399|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
55730400|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730401|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730402|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
55730403|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55730404|NCT02307305|Narcotics|narcotics|mesh-ancestor
55730405|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730406|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55730407|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55730408|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55730409|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55730410|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55730411|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730412|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730413|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55730414|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55730415|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55730416|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55730417|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55730418|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55730419|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730420|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
55730421|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55730422|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
55730423|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
55730424|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55730425|NCT02660229|Morphine|morphine|mesh-list
55730426|NCT02660229|Oxycodone|oxycodone|mesh-list
55730427|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55730429|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730430|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730431|NCT02660229|Analgesics|analgesics|mesh-ancestor
55730432|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
55730433|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730434|NCT02307383|Lactitol|lactitol|mesh-list
55730435|NCT02307383|Cathartics|cathartics|mesh-ancestor
55730436|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55730437|NCT02232178|Bupivacaine|bupivacaine|mesh-list
55730438|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
55730439|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
55730440|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730441|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730442|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
55730443|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730445|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55730446|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55730447|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
55730448|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
55730449|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730450|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730451|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55730452|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55730453|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55730454|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
55730455|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730456|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730457|NCT05718297|Durvalumab|durvalumab|mesh-list
55730458|NCT05718297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55730459|NCT05718297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730460|NCT04448431|Vortioxetine|vortioxetine|mesh-list
55768123|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
55730461|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55730462|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
55730463|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55730464|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55730465|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55730466|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730467|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730468|NCT04448431|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55730469|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55730470|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55730471|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730472|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730473|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
55730474|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55730475|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55730476|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55730477|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55730478|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55730479|NCT05713149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55730480|NCT05713149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730481|NCT02307695|Saxagliptin|saxagliptin|mesh-list
55730482|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55730483|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55730484|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730485|NCT02307695|Incretins|incretins|mesh-ancestor
55730486|NCT02307695|Hormones|hormones|mesh-ancestor
55730487|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730488|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
55730489|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730490|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730491|NCT05161975|Vitamin K|vitamin k|mesh-list
55730492|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
55730493|NCT05161975|Vitamins|vitamins|mesh-ancestor
55730495|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730496|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55730497|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55730498|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730500|NCT05161975|Coagulants|coagulants|mesh-ancestor
55730501|NCT05707377|Zanubrutinib|zanubrutinib|mesh-list
55730502|NCT05707377|Tacrolimus|tacrolimus|mesh-list
55730503|NCT05707377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55730504|NCT05707377|Immunologic Factors|immunologic factors|mesh-ancestor
55730505|NCT05707377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730506|NCT05707377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55730507|NCT05707377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730508|NCT05707377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730509|NCT05707377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730510|NCT05707377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55730511|NCT03504527|Budesonide|budesonide|mesh-list
55730512|NCT03504527|Bromides|bromides|mesh-list
55730513|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
55730514|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55730517|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730518|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730519|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55730520|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
55730521|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
55730522|NCT03504527|Hormones|hormones|mesh-ancestor
55730523|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730524|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
55730525|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55730526|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
55730527|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730528|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730529|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
55730530|NCT04608955|Bedaquiline|bedaquiline|mesh-list
55730531|NCT04608955|Antitubercular Agents|antitubercular agents|mesh-ancestor
55730532|NCT04608955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730533|NCT04608955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730534|NCT01678131|Ribavirin|ribavirin|mesh-list
55730535|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55730536|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
55730537|NCT01678131|Liver Extracts|liver extracts|mesh-list
55730538|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
55730539|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730540|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
55730541|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730542|NCT01678131|Hematinics|hematinics|mesh-ancestor
55730543|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730544|NCT04579783|Triamcinolone|triamcinolone|mesh-list
55730545|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55730546|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55730547|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55730548|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55730549|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
55730550|NCT04579783|Hormones|hormones|mesh-ancestor
55730551|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730552|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730553|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55730554|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
55730555|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730556|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730557|NCT02231164|Docetaxel|docetaxel|mesh-list
55730558|NCT02231164|Nintedanib|nintedanib|mesh-list
55730559|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730560|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
55730561|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
55730562|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
55730563|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730564|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55730565|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730566|NCT03506789|Dexamethasone|dexamethasone|mesh-list
55730567|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55730568|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
55730569|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
55730570|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730571|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730572|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55730573|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
55730574|NCT03506789|Hormones|hormones|mesh-ancestor
55730575|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730576|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55730577|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730584|NCT02312297|Minocycline|minocycline|mesh-list
55730585|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730586|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730587|NCT05108974|Choline|choline|mesh-list
55730588|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
55730589|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55730590|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
55829261|NCT01571362|Naltrexone|naltrexone|mesh-list
55730591|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829262|NCT01571362|Oxycodone|oxycodone|mesh-list
55829263|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55829264|NCT01571362|Narcotics|narcotics|mesh-ancestor
55829265|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845505|NCT03621904|Hormones|hormones|mesh-ancestor
55829266|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730592|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55730593|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55730594|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
55730595|NCT03473431|Ketamine|ketamine|mesh-list
55730596|NCT03473431|Analgesics|analgesics|mesh-ancestor
55730597|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
55730598|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730599|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730600|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55730601|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55730602|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
55730603|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
55730604|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730605|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55730606|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55730607|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730608|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730609|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55730610|NCT02378805|Ramipril|ramipril|mesh-list
55730611|NCT02378805|Spironolactone|spironolactone|mesh-list
55730612|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55730613|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55730614|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
55730615|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730616|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730617|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55730618|NCT02378805|Diuretics|diuretics|mesh-ancestor
55730619|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
55730620|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
55730621|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730622|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730623|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55730624|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55730625|NCT05094375|Misoprostol|misoprostol|mesh-list
55730626|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55730627|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
55730628|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55730629|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730630|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55730631|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55730632|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
55730633|NCT04345861|Azithromycin|azithromycin|mesh-list
55730634|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
55730635|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730636|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730637|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
55730638|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55730639|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55730640|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730641|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730642|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55730643|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
55730644|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730645|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
55730646|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
55730647|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
55730648|NCT02230306|Vemurafenib|vemurafenib|mesh-list
55730649|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730650|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55730651|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730652|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730654|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55730655|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55730656|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730657|NCT02308319|Tenofovir|tenofovir|mesh-list
55730658|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
55730659|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730660|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55730661|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55730662|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730663|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730664|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55730665|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55730667|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55730668|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55730669|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55730670|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730671|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55730672|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730673|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
55730674|NCT05062174|Mifepristone|mifepristone|mesh-list
55730675|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55829280|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55829281|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829282|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829283|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829284|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
55829288|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
55730676|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
55730677|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55730678|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730679|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55730681|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55730682|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
55730683|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55730684|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55730685|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
55730686|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730687|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
55730688|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55730689|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55730691|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55730693|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55730694|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730695|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
55730696|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
55730697|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
55730698|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730699|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55730700|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
55730701|NCT05095077|Tadalafil|tadalafil|mesh-list
55730702|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
55730703|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55730704|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55730705|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730706|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730707|NCT05095077|Urological Agents|urological agents|mesh-ancestor
55730708|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
55730709|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55730710|NCT02312531|Antibodies|antibodies|mesh-list
55730711|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
55730712|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730713|NCT04234477|Metoprolol|metoprolol|mesh-list
55730714|NCT04234477|Verapamil|verapamil|mesh-list
55730715|NCT04234477|Diltiazem|diltiazem|mesh-list
55730716|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
55730717|NCT04234477|Calcium|calcium|mesh-list
55730718|NCT04234477|Esmolol|esmolol|mesh-list
55730719|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55730720|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55730721|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730722|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55730723|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55730724|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
55730725|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
55730726|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730727|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55730728|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55730729|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
55730730|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730731|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730732|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55730733|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
55730734|NCT02449031|Tobramycin|tobramycin|mesh-list
55730735|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730736|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730737|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
55730738|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
55730740|NCT01680861|Tacrolimus|tacrolimus|mesh-list
55730741|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55730742|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
55730743|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730744|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55730745|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730746|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730747|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730748|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55730749|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55730750|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
55730751|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730752|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730753|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55730754|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
55730755|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
55730756|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730758|NCT01680861|Glucocorticoids|glucocorticoids|mesh-ancestor
55730759|NCT01680861|Hormones|hormones|mesh-ancestor
55730760|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730761|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55730762|NCT01680861|Protective Agents|protective agents|mesh-ancestor
55730763|NCT02229214|Topiramate|topiramate|mesh-list
55730764|NCT02229214|Phentermine|phentermine|mesh-list
55730765|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
55730766|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55730767|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730768|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55730769|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
55730770|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55730771|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
55730772|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
55730773|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730774|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
55730775|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730776|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730777|NCT02308553|Paclitaxel|paclitaxel|mesh-list
55730778|NCT02308553|Nintedanib|nintedanib|mesh-list
55730779|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55730780|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730781|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
55730782|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
55730783|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
55768251|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
55730784|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730785|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55730786|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730787|NCT05093907|Capecitabine|capecitabine|mesh-list
55730788|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55730789|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
55730790|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730791|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730792|NCT02228980|Vaccines|vaccines|mesh-list
55730793|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
55730794|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730795|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
55730796|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
55730797|NCT03783091|Hematinics|hematinics|mesh-ancestor
55730801|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730802|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
55730803|NCT05057481|Rituximab|rituximab|mesh-list
55730804|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55730805|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730806|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
55730807|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730808|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55730809|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55730810|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55730811|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
55730812|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730813|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730814|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730815|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730817|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730818|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730819|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
55730820|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55730821|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
55730822|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
55730823|NCT03506399|Estradiol|estradiol|mesh-list
55730824|NCT03506399|Estrogens|estrogens|mesh-ancestor
55730825|NCT03506399|Hormones|hormones|mesh-ancestor
55730826|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730827|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730828|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55730829|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55730830|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55730831|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55730832|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55730833|NCT02228590|Apomorphine|apomorphine|mesh-list
55730834|NCT02228590|Emetics|emetics|mesh-ancestor
55730835|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730836|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
55730837|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730838|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55730839|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
55730840|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
55730841|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730842|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730843|NCT03503201|Chromium|chromium|mesh-list
55730844|NCT03503201|Trace Elements|trace elements|mesh-ancestor
55730845|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
55730846|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829319|NCT02136914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55730847|NCT02309177|Gemcitabine|gemcitabine|mesh-list
55730848|NCT02309177|Paclitaxel|paclitaxel|mesh-list
55730849|NCT02309177|Carboplatin|carboplatin|mesh-list
55730850|NCT02309177|Nivolumab|nivolumab|mesh-list
55768266|NCT02396225|Voriconazole|voriconazole|mesh-list
55730851|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55730852|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730853|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
55730854|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
55730855|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
55730856|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730857|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55730858|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
55730859|NCT02309177|Antiviral Agents|antiviral agents|mesh-ancestor
55730860|NCT02309177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730861|NCT02309177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730862|NCT02309177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55730863|NCT02309177|Immunologic Factors|immunologic factors|mesh-ancestor
55730864|NCT02309177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730865|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55730866|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55730867|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
55730868|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730869|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55730870|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
55730871|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
55730872|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55730873|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55730874|NCT04863261|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
55730875|NCT04863261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55730952|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
55730876|NCT04863261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55730877|NCT04863261|Antiviral Agents|antiviral agents|mesh-ancestor
55730878|NCT04863261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730880|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55730881|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55730882|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730883|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55730884|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730885|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55730886|NCT03423355|Diuretics|diuretics|mesh-ancestor
55730887|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
55730888|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55730889|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55730890|NCT02226562|Listerine|listerine|mesh-list
55730891|NCT02226562|Fluorides|fluorides|mesh-list
55730892|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
55730893|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
55730894|NCT02226562|Protective Agents|protective agents|mesh-ancestor
55730895|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730896|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55730897|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730898|NCT04430985|Leucovorin|leucovorin|mesh-list
55730899|NCT04430985|Fluorouracil|fluorouracil|mesh-list
55730900|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
55730901|NCT04430985|Nivolumab|nivolumab|mesh-list
55730902|NCT04430985|Ipilimumab|ipilimumab|mesh-list
55730903|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
55730904|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730905|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55730906|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730907|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55730908|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
55730909|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730910|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55730911|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55730912|NCT04430985|Antidotes|antidotes|mesh-ancestor
55730913|NCT04430985|Protective Agents|protective agents|mesh-ancestor
55730914|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
55730915|NCT04430985|Vitamins|vitamins|mesh-ancestor
55730916|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
55730917|NCT03365635|Ribavirin|ribavirin|mesh-list
55730918|NCT03365635|Grazoprevir|grazoprevir|mesh-list
55730919|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55730920|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
55730921|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730922|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
55730923|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730924|NCT02901184|Spironolactone|spironolactone|mesh-list
55730925|NCT02901184|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55730926|NCT02901184|Hormone Antagonists|hormone antagonists|mesh-ancestor
55730927|NCT02901184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55730928|NCT02901184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730929|NCT02901184|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55730930|NCT02901184|Diuretics|diuretics|mesh-ancestor
55730931|NCT02901184|Natriuretic Agents|natriuretic agents|mesh-ancestor
55730932|NCT04658277|Clarithromycin|clarithromycin|mesh-list
55730933|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730934|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730935|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55730936|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730937|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730938|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55730939|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55730940|NCT04456777|Vortioxetine|vortioxetine|mesh-list
55730941|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
55730942|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55730943|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55730944|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55730945|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730946|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730947|NCT04456777|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55730948|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55730949|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55730950|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730951|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55730953|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55730954|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55730955|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55730956|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55730958|NCT02874430|Doxycycline|doxycycline|mesh-list
55730959|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55730960|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730961|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55730962|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55730964|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55730965|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55730967|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55730968|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55730969|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730970|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730971|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55730972|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55730973|NCT03506009|Argatroban|argatroban|mesh-list
55730974|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55730975|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55730976|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730977|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
55730978|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55730979|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
55730980|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730981|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
55730982|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55730984|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
55730985|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
55730986|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55730987|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55768278|NCT04272801|Tamoxifen|tamoxifen|mesh-list
55730988|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
55730989|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55730990|NCT02309801|Daidzin|daidzin|mesh-list
55730991|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55730992|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55730993|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55730994|NCT04456387|Factor VIII|factor viii|mesh-list
55730995|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
55730996|NCT04456387|Coagulants|coagulants|mesh-ancestor
55730997|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
55730998|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55730999|NCT02309879|Lidocaine|lidocaine|mesh-list
55731000|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
55731001|NCT02309879|Remifentanil|remifentanil|mesh-list
55731002|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
55731003|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
55731004|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731005|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731006|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
55731007|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731008|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55731009|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55731010|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55731011|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731012|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731013|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55731014|NCT02309879|Narcotics|narcotics|mesh-ancestor
55731015|NCT02309879|Analgesics|analgesics|mesh-ancestor
55731016|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
55731017|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55731018|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55731019|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
55829370|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
55731020|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55731021|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
55731022|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
55731023|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55731024|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55731025|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731026|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731027|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731028|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55731029|NCT03197467|Pembrolizumab|pembrolizumab|mesh-list
55731183|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
55731030|NCT03197467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55731031|NCT03197467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731033|NCT02476786|Fulvestrant|fulvestrant|mesh-list
55731034|NCT02476786|Anastrozole|anastrozole|mesh-list
55731035|NCT02476786|Goserelin|goserelin|mesh-list
55731036|NCT02476786|Exemestane|exemestane|mesh-list
55731037|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55731038|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
55731039|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731040|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731041|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55731042|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731043|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55731044|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55731045|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55731046|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55731047|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55731048|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55731049|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731050|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731052|NCT02820961|Entinostat|entinostat|mesh-list
55731053|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731054|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55731055|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55731056|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731057|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731058|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55731059|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
55731060|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731061|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731062|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55731064|NCT04658173|Propofol|propofol|mesh-list
55731065|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55731066|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731067|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731068|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55731069|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
55731070|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
55731071|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55731072|NCT04658173|Narcotics|narcotics|mesh-ancestor
55731073|NCT04658173|Analgesics|analgesics|mesh-ancestor
55731074|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
55731075|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731076|NCT02399410|Bevacizumab|bevacizumab|mesh-list
55731077|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
55731078|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55731079|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731080|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55731081|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55731082|NCT02399410|Growth Substances|growth substances|mesh-ancestor
55731083|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731084|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
55731085|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
55731086|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55731087|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55731088|NCT03636165|Prednisolone|prednisolone|mesh-list
55731089|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
55731090|NCT03636165|Ropivacaine|ropivacaine|mesh-list
55731091|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55731092|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
55731093|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
55731094|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
55731095|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731096|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731097|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
55731098|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731099|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55731100|NCT03636165|Antiemetics|antiemetics|mesh-ancestor
55731101|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
55731102|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55731103|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
55731104|NCT03636165|Hormones|hormones|mesh-ancestor
55731105|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731106|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55731107|NCT03636165|Protective Agents|protective agents|mesh-ancestor
55731108|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55731109|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731110|NCT03521037|Rucaparib|rucaparib|mesh-list
55731111|NCT03521037|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55731112|NCT03521037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731113|NCT03521037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731114|NCT03521037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731115|NCT02310347|Dronabinol|dronabinol|mesh-list
55731116|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
55731117|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731118|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55731119|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55731121|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
55731122|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731123|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55731124|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55731125|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731126|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731127|NCT02310347|Hormones|hormones|mesh-ancestor
55731128|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731129|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
55731130|NCT02758431|Anastrozole|anastrozole|mesh-list
55731131|NCT02758431|Testosterone|testosterone|mesh-list
55731132|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
55731133|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
55731134|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55731135|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55731136|NCT02758431|Acyline|acyline|mesh-list
55731137|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
55731138|NCT02758431|Hormones|hormones|mesh-ancestor
55731139|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731140|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731141|NCT02758431|Androgens|androgens|mesh-ancestor
55731142|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55731143|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731144|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
55731145|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55731146|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731147|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731148|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55731149|NCT04429425|Anesthetics|anesthetics|mesh-list
55731150|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731151|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731152|NCT03502889|Ropivacaine|ropivacaine|mesh-list
55731153|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
55731154|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
55731155|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731156|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731157|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
55731158|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731159|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55731160|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
55731161|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55731162|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55731163|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55731164|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55768321|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55731165|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731166|NCT05098119|Paclitaxel|paclitaxel|mesh-list
55731167|NCT05098119|Carboplatin|carboplatin|mesh-list
55731168|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55731169|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731170|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
55731171|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
55731172|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
55731173|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731175|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
55731176|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55731177|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55731178|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731179|NCT02738879|Incretins|incretins|mesh-ancestor
55731180|NCT02738879|Hormones|hormones|mesh-ancestor
55731181|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731182|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55731185|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731186|NCT04373707|Enoxaparin|enoxaparin|mesh-list
55731187|NCT04373707|Dalteparin|dalteparin|mesh-list
55731188|NCT04373707|Tinzaparin|tinzaparin|mesh-list
55731189|NCT04373707|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55731190|NCT04373707|Nadroparin|nadroparin|mesh-list
55731191|NCT04373707|Enoxaparin sodium|enoxaparin sodium|mesh-list
55731192|NCT04373707|Anticoagulants|anticoagulants|mesh-ancestor
55829396|NCT04099888|Antiviral Agents|antiviral agents|mesh-ancestor
55829397|NCT04099888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829398|NCT04099888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829399|NCT04099888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829400|NCT04099888|Immunologic Factors|immunologic factors|mesh-ancestor
55829401|NCT04099888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731193|NCT04373707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55731194|NCT04373707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55731195|NCT04373707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731196|NCT03253913|Sirolimus|sirolimus|mesh-list
55731197|NCT03253913|Resveratrol|resveratrol|mesh-list
55731198|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55731199|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731200|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55731202|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
55731203|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55731204|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
55731205|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731206|NCT03253913|Antioxidants|antioxidants|mesh-ancestor
55731207|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731208|NCT03253913|Protective Agents|protective agents|mesh-ancestor
55731209|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731210|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55731211|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
55731212|NCT03237819|Analgesics|analgesics|mesh-ancestor
55731213|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
55768326|NCT03168035|NC-4016|nc-4016|mesh-list
55731214|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731215|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731216|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
55731217|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731218|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55731219|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
55731220|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55731221|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731222|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731223|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55731224|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
55731225|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55731226|NCT03468907|Tenofovir|tenofovir|mesh-list
55731227|NCT03468907|Telbivudine|telbivudine|mesh-list
55731228|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
55731229|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731230|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55731231|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55731232|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731233|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731234|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55731235|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55731236|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
55731237|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
55731238|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55731239|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55731240|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55731241|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731242|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731243|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
55731244|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731245|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731246|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55731247|NCT05089851|Protective Agents|protective agents|mesh-ancestor
55731248|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
55731249|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55731250|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731251|NCT04657809|Insulin|insulin|mesh-list
55731252|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55731253|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731254|NCT05350917|Maleic acid|maleic acid|mesh-list
55731256|NCT05350917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731257|NCT05390905|Tramadol|tramadol|mesh-list
55731258|NCT05390905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55731259|NCT05390905|Narcotics|narcotics|mesh-ancestor
55845508|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55731260|NCT05390905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731261|NCT05390905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731262|NCT05390905|Analgesics|analgesics|mesh-ancestor
55731263|NCT05390905|Sensory System Agents|sensory system agents|mesh-ancestor
55731264|NCT05390905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731266|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731267|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55731268|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731269|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731271|NCT05390749|Methotrexate|methotrexate|mesh-list
55731272|NCT05390749|Pomalidomide|pomalidomide|mesh-list
55731273|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55731274|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731275|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
55731276|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731277|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55731278|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55731279|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
55731280|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55731281|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55731282|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
55731283|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731284|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
55731285|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731286|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55731287|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55731288|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55731289|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55731290|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55731291|NCT05390749|Growth Substances|growth substances|mesh-ancestor
55731292|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
55731293|NCT02813655|Cosyntropin|cosyntropin|mesh-list
55731295|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731296|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731298|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
55731299|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731300|NCT04912791|Anesthetics|anesthetics|mesh-list
55731301|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731302|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731303|NCT02316197|Peposertib|peposertib|mesh-list
55731304|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55731305|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731306|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731307|NCT02314013|Metronidazole|metronidazole|mesh-list
55731308|NCT02314013|Cephalosporins|cephalosporins|mesh-list
55731309|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731310|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55731311|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55731312|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55731313|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
55731314|NCT01677195|Antacids|antacids|mesh-ancestor
55731315|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731316|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55731317|NCT05331807|Vitamin D|vitamin d|mesh-list
55731318|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
55731319|NCT05331807|Cholecalciferol|cholecalciferol|mesh-list
55731320|NCT05331807|Vitamins|vitamins|mesh-list
55731321|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
55731322|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731323|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55731324|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55731325|NCT02314325|Factor VIII|factor viii|mesh-list
55731326|NCT02314325|Coagulants|coagulants|mesh-ancestor
55731327|NCT02630641|Hormones|hormones|mesh-list
55731328|NCT02630641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731329|NCT02630641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731330|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
55731331|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55731332|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731334|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731335|NCT02513329|Bupivacaine|bupivacaine|mesh-list
55731336|NCT02513329|Anesthetics, Local|anesthetics, local|mesh-ancestor
55731337|NCT02513329|Anesthetics|anesthetics|mesh-ancestor
55731338|NCT02513329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731339|NCT02513329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731340|NCT02513329|Sensory System Agents|sensory system agents|mesh-ancestor
55731341|NCT02513329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731342|NCT02314481|Trastuzumab|trastuzumab|mesh-list
55731343|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55731344|NCT02314481|Atezolizumab|atezolizumab|mesh-list
55731345|NCT02314481|Vemurafenib|vemurafenib|mesh-list
55731346|NCT02314481|Maytansine|maytansine|mesh-list
55731347|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55731348|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731349|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55731350|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731351|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731352|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55731353|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
55731354|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
55731355|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
55731356|NCT03502421|Ketamine|ketamine|mesh-list
55731357|NCT03502421|Analgesics|analgesics|mesh-ancestor
55731358|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
55731359|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731360|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829409|NCT04098718|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55829413|NCT02174276|Tenofovir|tenofovir|mesh-list
55731361|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55731362|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55731363|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
55731364|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
55731365|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731366|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55731367|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55731368|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731369|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731371|NCT03502343|Paclitaxel|paclitaxel|mesh-list
55731372|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55731373|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731374|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
55731375|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
55731376|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
55731377|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731378|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55731379|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
55731380|NCT03502343|Antiviral Agents|antiviral agents|mesh-ancestor
55731381|NCT03502343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731382|NCT03502343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731383|NCT03502343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55731384|NCT03502343|Immunologic Factors|immunologic factors|mesh-ancestor
55731385|NCT03502343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731386|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55731387|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
55731388|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731389|NCT04345887|Spironolactone|spironolactone|mesh-list
55731390|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55731391|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
55731392|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731393|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731394|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55731396|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
55731397|NCT02316899|Linaclotide|linaclotide|mesh-list
55731398|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55731399|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
55731400|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731401|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55731402|NCT02314871|Morphine|morphine|mesh-list
55731403|NCT02314871|Pirinitramide|pirinitramide|mesh-list
55731404|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55731405|NCT02314871|Narcotics|narcotics|mesh-ancestor
55731406|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731407|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731408|NCT02314871|Analgesics|analgesics|mesh-ancestor
55731409|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
55731410|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731411|NCT02224846|Tadalafil|tadalafil|mesh-list
55731412|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
55731413|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55731414|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55731415|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731416|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731417|NCT02224846|Urological Agents|urological agents|mesh-ancestor
55731418|NCT03470077|Nalbuphine|nalbuphine|mesh-list
55731419|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731420|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731421|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55731422|NCT03470077|Narcotics|narcotics|mesh-ancestor
55731423|NCT03470077|Analgesics|analgesics|mesh-ancestor
55731424|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
55731425|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731426|NCT03519295|Atezolizumab|atezolizumab|mesh-list
55731427|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731428|NCT02224690|Cannabidiol|cannabidiol|mesh-list
55731429|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
55731430|NCT05150431|Parecoxib|parecoxib|mesh-list
55731431|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55731432|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55829449|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
55731433|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731434|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731435|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55731436|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55731438|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
55731439|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731440|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731441|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55731442|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55731443|NCT03501251|Albendazole|albendazole|mesh-list
55731444|NCT03501251|Moxidectin|moxidectin|mesh-list
55731445|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
55731446|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55731447|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731448|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
55731449|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55731450|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55731451|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
55731452|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
55731453|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
55731454|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731455|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731456|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
55731457|NCT01169259|Vitamin D|vitamin d|mesh-list
55731458|NCT01169259|Ergocalciferols|ergocalciferols|mesh-list
55731459|NCT01169259|Cholecalciferol|cholecalciferol|mesh-list
55731460|NCT01169259|Vitamins|vitamins|mesh-list
55731461|NCT01169259|Micronutrients|micronutrients|mesh-ancestor
55731462|NCT01169259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731463|NCT01169259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55731464|NCT01169259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55731465|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
55731466|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
55731467|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731468|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55731469|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55731470|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
55731471|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731472|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731473|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55731474|NCT05390203|Testosterone|testosterone|mesh-list
55731475|NCT05390203|Androgens|androgens|mesh-ancestor
55731476|NCT05390203|Hormones|hormones|mesh-ancestor
55731477|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731478|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731479|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
55731480|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55731481|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
55731482|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731483|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731484|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55731485|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
55731486|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
55731487|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55731488|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
55731489|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731490|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731491|NCT02315495|Saxagliptin|saxagliptin|mesh-list
55731493|NCT02315495|Incretins|incretins|mesh-ancestor
55731495|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731496|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731497|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55731498|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
55731499|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731500|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731501|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55731502|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55731503|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
55731504|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55829465|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55829466|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829467|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
55829468|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
55829470|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55731505|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55731506|NCT02317601|Prednisolone|prednisolone|mesh-list
55731507|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
55731508|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55731509|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
55731510|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55731511|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
55731512|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
55731513|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731514|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731515|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55731516|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
55731517|NCT02317601|Hormones|hormones|mesh-ancestor
55731518|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731520|NCT02317601|Protective Agents|protective agents|mesh-ancestor
55731521|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55731522|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731523|NCT05101785|Lidocaine|lidocaine|mesh-list
55731524|NCT05101785|Epinephrine|epinephrine|mesh-list
55731525|NCT05101785|Racepinephrine|racepinephrine|mesh-list
55731526|NCT05101785|Carticaine|carticaine|mesh-list
55731527|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
55731528|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
55731529|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
55731530|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731531|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731532|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
55731533|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731534|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55731535|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55731536|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55731537|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731538|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731539|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55731540|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55731541|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
55731542|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731543|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55731544|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55731545|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
55731546|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55731547|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
55731549|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
55731550|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55731551|NCT02315573|Lidocaine|lidocaine|mesh-list
55731552|NCT02315573|Epinephrine|epinephrine|mesh-list
55731553|NCT02315573|Racepinephrine|racepinephrine|mesh-list
55731554|NCT02315573|Bupivacaine|bupivacaine|mesh-list
55731555|NCT02315573|Epinephryl borate|epinephryl borate|mesh-list
55731556|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
55731557|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
55731558|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731559|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731560|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
55829482|NCT01514422|Minocycline|minocycline|mesh-list
55731562|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55731563|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55731564|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55731565|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731566|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731567|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55731568|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55731569|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
55731570|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731571|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55731572|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55731573|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
55731574|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55731575|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
55731576|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
55731577|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
55731578|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55731579|NCT02724241|Nicotine|nicotine|mesh-list
55731580|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55731581|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
55731582|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731583|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731584|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55731585|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55731586|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
55731587|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731588|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731589|NCT02315651|Ubiquinone|ubiquinone|mesh-list
55731590|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
55731591|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
55731592|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731593|NCT02315651|Vitamins|vitamins|mesh-ancestor
55731594|NCT05366725|Avelumab|avelumab|mesh-list
55731595|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55731596|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731597|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
55731598|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
55731599|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55731600|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55731601|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731602|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731603|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731604|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55731606|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55731607|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55731608|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731609|NCT03475381|Ivacaftor|ivacaftor|mesh-list
55731610|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55731611|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731612|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731613|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55731614|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55731615|NCT04535505|Erythromycin|erythromycin|mesh-list
55731616|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
55731617|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55731618|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
55731619|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55731620|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731621|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55731622|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55731623|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731624|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731625|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
55731626|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55731627|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
55731628|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731629|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731630|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55731631|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
55731632|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55731633|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
55731634|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731635|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731636|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55731637|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
55731638|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
55731639|NCT03500783|Protective Agents|protective agents|mesh-ancestor
55731641|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
55731642|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
55731643|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731644|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731645|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
55731646|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731647|NCT02320877|Methaqualone|methaqualone|mesh-list
55731648|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55731649|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731650|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731652|NCT05256745|Docetaxel|docetaxel|mesh-list
55731653|NCT05256745|Cyclophosphamide|cyclophosphamide|mesh-list
55731654|NCT05256745|Carboplatin|carboplatin|mesh-list
55731655|NCT05256745|Doxorubicin|doxorubicin|mesh-list
55731656|NCT05256745|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55731657|NCT05256745|Trastuzumab|trastuzumab|mesh-list
55731658|NCT05256745|Pertuzumab|pertuzumab|mesh-list
55731659|NCT05256745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55731660|NCT05256745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731661|NCT05256745|Tubulin Modulators|tubulin modulators|mesh-ancestor
55731662|NCT05256745|Antimitotic Agents|antimitotic agents|mesh-ancestor
55731663|NCT05256745|Mitosis Modulators|mitosis modulators|mesh-ancestor
55731664|NCT05256745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731666|NCT05256745|Immunologic Factors|immunologic factors|mesh-ancestor
55731667|NCT05256745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731668|NCT05256745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55731669|NCT05256745|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55731670|NCT05256745|Alkylating Agents|alkylating agents|mesh-ancestor
55731671|NCT05256745|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55731672|NCT05256745|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55731673|NCT05256745|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55731674|NCT05256745|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55731675|NCT05256745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731676|NCT05256745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55731677|NCT01322971|Metronidazole|metronidazole|mesh-list
55731678|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731679|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55829497|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55829498|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55829499|NCT01547728|Antithrombins|antithrombins|mesh-list
55829500|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
55731680|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55731681|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55731682|NCT04454281|Naloxone|naloxone|mesh-list
55731683|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55731684|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731685|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
55731686|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731687|NCT02318225|Misoprostol|misoprostol|mesh-list
55731688|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55731689|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
55731690|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55731691|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731693|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55731694|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
55731695|NCT00424099|Methylphenidate|methylphenidate|mesh-list
55731696|NCT00424099|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55731697|NCT00424099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731698|NCT00424099|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55731699|NCT00424099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55731700|NCT00424099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731701|NCT00424099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731702|NCT00424099|Dopamine Agents|dopamine agents|mesh-ancestor
55731703|NCT00424099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731704|NCT01378429|Ciclesonide|ciclesonide|mesh-list
55731705|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
55731706|NCT01378429|Hormones|hormones|mesh-ancestor
55731707|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731708|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731710|NCT01599754|Axitinib|axitinib|mesh-list
55731711|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731712|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55731713|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731714|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731715|NCT02321267|Ranibizumab|ranibizumab|mesh-list
55731716|NCT02321267|Aflibercept|aflibercept|mesh-list
55731717|NCT02321267|Verteporfin|verteporfin|mesh-list
55731718|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55731719|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55731720|NCT02321267|Growth Substances|growth substances|mesh-ancestor
55731721|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731722|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
55731723|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731724|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55731725|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
55731726|NCT02318537|Cannabidiol|cannabidiol|mesh-list
55731727|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55731728|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
55731729|NCT04462523|Prednisolone|prednisolone|mesh-list
55731730|NCT04462523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55731731|NCT04462523|Glucocorticoids|glucocorticoids|mesh-ancestor
55731733|NCT04462523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731734|NCT04462523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731735|NCT04462523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55731736|NCT04462523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731737|NCT04642261|Empagliflozin|empagliflozin|mesh-list
55731738|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55731739|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731740|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55731741|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731742|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
55731743|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55731744|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731745|NCT04936399|Nivolumab|nivolumab|mesh-list
55731746|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55731747|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731748|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55731749|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731750|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
55731751|NCT02319161|Calcium|calcium|mesh-list
55731752|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55731753|NCT02319161|Esmolol|esmolol|mesh-list
55731754|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55731755|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731756|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55731757|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
55731758|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731759|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731760|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731761|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55731763|NCT02321579|Pyridoxal|pyridoxal|mesh-list
55731764|NCT02321579|Pyridoxine|pyridoxine|mesh-list
55731765|NCT02321579|Vitamins|vitamins|mesh-ancestor
55731766|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
55731767|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731768|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
55731769|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
55731770|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55731771|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55731772|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
55731773|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
55731774|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731775|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731776|NCT03109691|Dexamethasone|dexamethasone|mesh-list
55731777|NCT03109691|Bupivacaine|bupivacaine|mesh-list
55731778|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55731779|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
55731780|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
55731781|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731782|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731783|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55731784|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
55731785|NCT03109691|Hormones|hormones|mesh-ancestor
55731786|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731787|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55731788|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731789|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
55731790|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
55731791|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731792|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
55731793|NCT04814368|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55731794|NCT04814368|Immunologic Factors|immunologic factors|mesh-ancestor
55731795|NCT04814368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731796|NCT03497351|Nicardipine|nicardipine|mesh-list
55731797|NCT03497351|Urapidil|urapidil|mesh-list
55731798|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55731799|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55731800|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731801|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731802|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55731803|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731804|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
55731805|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55731806|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
55731807|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731808|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55731809|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55768482|NCT05492487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55731810|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55731811|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
55731813|NCT02223364|Ropivacaine|ropivacaine|mesh-list
55731814|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
55731815|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
55731816|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731817|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731818|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
55731819|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55731820|NCT01378975|Vemurafenib|vemurafenib|mesh-list
55731821|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731822|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55731823|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731824|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731825|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
55731826|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55731827|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55731828|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731829|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
55731830|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
55731831|NCT03499457|Amoxicillin|amoxicillin|mesh-list
55731832|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55731833|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731834|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
55731835|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55731836|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
55731837|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55731838|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731839|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55731840|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55731841|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55731843|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
55731844|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731845|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55731846|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55731847|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731848|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731849|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55731850|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55731851|NCT02322203|Niacin|niacin|mesh-list
55731852|NCT02322203|Niacinamide|niacinamide|mesh-list
55731853|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
55731854|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55731855|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
55731856|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731857|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55731858|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
55731859|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
55731860|NCT02322203|Vitamins|vitamins|mesh-ancestor
55731861|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
55731876|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55731877|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731881|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55731882|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55731883|NCT03499223|Growth Substances|growth substances|mesh-ancestor
55731884|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731885|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
55731886|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731887|NCT02319707|Oxytocin|oxytocin|mesh-list
55731888|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
55731889|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55731890|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731891|NCT05398861|Bevacizumab|bevacizumab|mesh-list
55731892|NCT05398861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55731893|NCT05398861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731894|NCT05398861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55731895|NCT05398861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55731896|NCT05398861|Growth Substances|growth substances|mesh-ancestor
55731897|NCT05398861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731898|NCT05398861|Growth Inhibitors|growth inhibitors|mesh-ancestor
55731899|NCT02448329|Paclitaxel|paclitaxel|mesh-list
55731900|NCT02448329|Adavosertib|adavosertib|mesh-list
55731901|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55731902|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731903|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
55731904|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
55731905|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
55731906|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731907|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731908|NCT05398393|Tenofovir|tenofovir|mesh-list
55731909|NCT05398393|Amlodipine|amlodipine|mesh-list
55731910|NCT05398393|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
55731911|NCT05398393|Atorvastatin|atorvastatin|mesh-list
55731912|NCT05398393|Hypolipidemic Agents|hypolipidemic agents|mesh-list
55731913|NCT05398393|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55731914|NCT05398393|Antimetabolites|antimetabolites|mesh-ancestor
55731915|NCT05398393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731916|NCT05398393|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55731917|NCT05398393|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55731918|NCT05398393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731919|NCT05398393|Antiviral Agents|antiviral agents|mesh-ancestor
55731920|NCT05398393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731921|NCT05398393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55731922|NCT05398393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55731923|NCT05398393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55731924|NCT05398393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55731925|NCT05398393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55731926|NCT05398393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55731927|NCT05398393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731928|NCT05398393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55731929|NCT05398393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731930|NCT05398393|Vasodilator Agents|vasodilator agents|mesh-ancestor
55731931|NCT01356628|Palbociclib|palbociclib|mesh-list
55731932|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55731933|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55731934|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55731935|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731936|NCT02319941|Clopidogrel|clopidogrel|mesh-list
55731938|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55731939|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55731940|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55731941|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55731942|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
55731943|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731944|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731945|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731946|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
55731947|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
55731948|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55731949|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55731950|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731951|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55731952|NCT05164627|Analgesics|analgesics|mesh-ancestor
55731953|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
55731954|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732098|NCT02323451|Chitosan|chitosan|mesh-list
55731955|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55731956|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55731957|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55731958|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
55731959|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55731960|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731961|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
55731962|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55731963|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
55731964|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55731965|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55731966|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55731967|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
55731968|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55731969|NCT02322671|Montelukast|montelukast|mesh-list
55731970|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55731971|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
55731972|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55731973|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
55731974|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55731975|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731976|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55731977|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55731978|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731980|NCT05096143|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55731981|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55731982|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55731983|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55731984|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731986|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
55731987|NCT03494387|Antioxidants|antioxidants|mesh-list
55731988|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
55731989|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55731990|NCT03494387|Expectorants|expectorants|mesh-ancestor
55731991|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
55731992|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55731993|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55731994|NCT03494387|Protective Agents|protective agents|mesh-ancestor
55731995|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55731997|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
55731998|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55731999|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55732000|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55732001|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732002|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
55732003|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732004|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732005|NCT05398081|Ceftriaxone|ceftriaxone|mesh-list
55732006|NCT05398081|Cefuroxime|cefuroxime|mesh-list
55732007|NCT05398081|Cefuroxime axetil|cefuroxime axetil|mesh-list
55732008|NCT05398081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55732009|NCT05398081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732010|NCT02324621|TIC10 compound|tic10 compound|mesh-list
55732011|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732012|NCT03821545|Lidocaine|lidocaine|mesh-list
55732013|NCT03821545|Ketamine|ketamine|mesh-list
55732014|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
55732015|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
55732016|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732017|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732018|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
55732019|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732020|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55732021|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55732022|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55732023|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55829534|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829535|NCT01950273|Rituximab|rituximab|mesh-list
55732024|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732026|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55732027|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55732028|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
55732029|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55732030|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55732031|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732032|NCT02324933|Fentanyl|fentanyl|mesh-list
55732033|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55732034|NCT02324933|Narcotics|narcotics|mesh-ancestor
55732035|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732036|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732037|NCT02324933|Analgesics|analgesics|mesh-ancestor
55732038|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
55732039|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732040|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55732041|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55732042|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
55732043|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
55732044|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
55732045|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55732046|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
55732047|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55732048|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732049|NCT01378117|Incretins|incretins|mesh-ancestor
55732050|NCT01378117|Hormones|hormones|mesh-ancestor
55732051|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55732052|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55732053|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
55732054|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732055|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732056|NCT02323139|Azacitidine|azacitidine|mesh-list
55732057|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55732058|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
55732059|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732060|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732061|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732063|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55732064|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732065|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
55732066|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55732067|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55732068|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732069|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
55732070|NCT02323373|Coagulants|coagulants|mesh-ancestor
55732071|NCT02325479|Enoxaparin|enoxaparin|mesh-list
55732072|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
55732073|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55732074|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55732075|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829542|NCT01919229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829543|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55829544|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55829545|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829546|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829547|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55829548|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
55732076|NCT05236231|Tadalafil|tadalafil|mesh-list
55732077|NCT05236231|Macitentan|macitentan|mesh-list
55732078|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
55732079|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55732080|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55732081|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732082|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732083|NCT05236231|Urological Agents|urological agents|mesh-ancestor
55732084|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55732085|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55732086|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55732087|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
55732088|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55732089|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732090|NCT05615311|Vitamin D|vitamin d|mesh-list
55732091|NCT05615311|Ergocalciferols|ergocalciferols|mesh-list
55732092|NCT05615311|Cholecalciferol|cholecalciferol|mesh-list
55732093|NCT05615311|Vitamins|vitamins|mesh-list
55732094|NCT05615311|Micronutrients|micronutrients|mesh-ancestor
55732095|NCT05615311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732096|NCT05615311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55732097|NCT05615311|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55732100|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55732101|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
55732102|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732103|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
55732104|NCT02323451|Protective Agents|protective agents|mesh-ancestor
55732105|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55732106|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55732107|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
55732108|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732109|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55732110|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
55732111|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
55732112|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
55732113|NCT02323451|Coagulants|coagulants|mesh-ancestor
55732114|NCT02323529|Nitisinone|nitisinone|mesh-list
55732115|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732116|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732117|NCT02323607|Cytarabine|cytarabine|mesh-list
55732118|NCT02323607|Decitabine|decitabine|mesh-list
55732119|NCT02323607|Daunorubicin|daunorubicin|mesh-list
55732120|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55732121|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
55732122|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732123|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732124|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
55732125|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55768606|NCT04543071|Paclitaxel|paclitaxel|mesh-list
55732126|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55732127|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
55732128|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732129|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55732130|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55732131|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55732132|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732133|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
55732134|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
55732135|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732136|NCT03493841|Protective Agents|protective agents|mesh-ancestor
55732137|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732138|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
55732139|NCT03493841|Vitamins|vitamins|mesh-ancestor
55732140|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
55732141|NCT05118737|Colchicine|colchicine|mesh-list
55732142|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
55732143|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55732144|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
55732145|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
55732146|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
55732147|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732148|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732149|NCT04987931|Talazoparib|talazoparib|mesh-list
55732150|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55732151|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732152|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732153|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732154|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
55732155|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55732156|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55732157|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732159|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
55732160|NCT03491579|Cytarabine|cytarabine|mesh-list
55732161|NCT03491579|Cladribine|cladribine|mesh-list
55732162|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55732163|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
55732164|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732165|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732166|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
55732167|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732168|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55732169|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
55732170|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732171|NCT04600895|Favipiravir|favipiravir|mesh-list
55732172|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
55732173|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732174|NCT03492593|Beta Carotene|beta carotene|mesh-list
55732175|NCT03492593|Lycopene|lycopene|mesh-list
55732176|NCT03492593|Carotenoids|carotenoids|mesh-list
55732177|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55732179|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732180|NCT03492593|Protective Agents|protective agents|mesh-ancestor
55732181|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732182|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55732183|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55732184|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732185|NCT03492593|Provitamins|provitamins|mesh-ancestor
55732186|NCT03492593|Vitamins|vitamins|mesh-ancestor
55732187|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
55732188|NCT02717611|Acalabrutinib|acalabrutinib|mesh-list
55732189|NCT02717611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732190|NCT05479045|Nivolumab|nivolumab|mesh-list
55732191|NCT05479045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55732192|NCT05479045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732193|NCT05479045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55732194|NCT05479045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732195|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
55732196|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
55732197|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55732198|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55732199|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732200|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732201|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732202|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55732203|NCT04034459|Leucovorin|leucovorin|mesh-list
55732204|NCT04034459|Folic Acid|folic acid|mesh-list
55732205|NCT04034459|Bevacizumab|bevacizumab|mesh-list
55732206|NCT04034459|Cetuximab|cetuximab|mesh-list
55732207|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
55732208|NCT04034459|Irinotecan|irinotecan|mesh-list
55732209|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
55732210|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55732211|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732212|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55732213|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55732214|NCT04034459|Growth Substances|growth substances|mesh-ancestor
55732215|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732216|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
55732217|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55732218|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55732219|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732220|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732221|NCT04034459|Antidotes|antidotes|mesh-ancestor
55732222|NCT04034459|Protective Agents|protective agents|mesh-ancestor
55732223|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
55732225|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
55732226|NCT04034459|Hematinics|hematinics|mesh-ancestor
55732227|NCT03914885|Fludarabine|fludarabine|mesh-list
55732228|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55732229|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732230|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732231|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55732232|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
55732233|NCT03779243|Melatonin|melatonin|mesh-list
55732234|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
55732235|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732236|NCT03779243|Protective Agents|protective agents|mesh-ancestor
55732237|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732238|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732239|NCT03757013|Apremilast|apremilast|mesh-list
55732240|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55732241|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55732242|NCT03757013|Analgesics|analgesics|mesh-ancestor
55732243|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
55732244|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732245|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732246|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55732247|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55732248|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55732249|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55732250|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732251|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732252|NCT02736409|Budesonide|budesonide|mesh-list
55732253|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55732254|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55732255|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
55732256|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732257|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732258|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55732259|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
55732260|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
55732261|NCT02736409|Hormones|hormones|mesh-ancestor
55732262|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55732263|NCT05396677|Acetaminophen|acetaminophen|mesh-list
55732265|NCT05396677|Analgesics|analgesics|mesh-ancestor
55732266|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
55732267|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732268|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732269|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
55732270|NCT05131867|Nimodipine|nimodipine|mesh-list
55732271|NCT05131867|Milrinone|milrinone|mesh-list
55732272|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55732273|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55732274|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
55732275|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55732276|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55732277|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732278|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732279|NCT05131867|Protective Agents|protective agents|mesh-ancestor
55732280|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732281|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55732282|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55732283|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55732284|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55732285|NCT02837783|Linaclotide|linaclotide|mesh-list
55732286|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
55732287|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
55732288|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732289|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55732290|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55732291|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55732292|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55732293|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55732294|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732295|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
55732296|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732297|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732298|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55732299|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732300|NCT05007145|Paclitaxel|paclitaxel|mesh-list
55732301|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55732302|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55732303|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55732304|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732305|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
55732306|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
55732307|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
55732308|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732309|NCT04952857|Vitamin D|vitamin d|mesh-list
55732310|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
55732311|NCT04952857|Vitamins|vitamins|mesh-ancestor
55732312|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
55732313|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732314|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55732315|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55732316|NCT02220712|Aripiprazole|aripiprazole|mesh-list
55732317|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
55829550|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829552|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
55829553|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829554|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
55829555|NCT01511536|Hormones|hormones|mesh-ancestor
55829556|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55732318|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55732319|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55732320|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55732321|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732322|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732323|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
55732324|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
55732326|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732327|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55732328|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55732329|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
55732330|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55732331|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55732332|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55732333|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55732334|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
55732335|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55732336|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732337|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55732338|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732339|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
55732340|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
55732341|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
55732342|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732343|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732344|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55732345|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55732346|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
55732347|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
55732348|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732349|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732350|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
55732351|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55732352|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55732353|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732354|NCT00846430|Interferons|interferons|mesh-list
55732355|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
55732356|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
55732357|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55732359|NCT00846430|Vincristine|vincristine|mesh-list
55732360|NCT00846430|Temozolomide|temozolomide|mesh-list
55732361|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732362|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
55732363|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732364|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55732365|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
55732366|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
55732367|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
55732368|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732369|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55732370|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
55732371|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
55732372|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732373|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55732374|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55732375|NCT00846430|Analgesics|analgesics|mesh-ancestor
55732376|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
55732377|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732378|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55732379|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55732380|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55732381|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55732382|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732384|NCT04527289|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55732385|NCT04527289|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55732386|NCT04527289|Antiviral Agents|antiviral agents|mesh-ancestor
55732387|NCT04527289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732388|NCT04527289|Dopamine Agents|dopamine agents|mesh-ancestor
55732389|NCT04527289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732390|NCT04527289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732391|NCT04527289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732392|NCT04527289|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55732393|NCT04527289|Analgesics|analgesics|mesh-ancestor
55732394|NCT04527289|Sensory System Agents|sensory system agents|mesh-ancestor
55732395|NCT04527289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732396|NCT05439577|Heparinoids|heparinoids|mesh-list
55732397|NCT05439577|Glucocorticoids|glucocorticoids|mesh-list
55732398|NCT05439577|Hormones|hormones|mesh-ancestor
55732399|NCT05439577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55732400|NCT05439577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732401|NCT05439577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55732402|NCT05439577|Anticoagulants|anticoagulants|mesh-ancestor
55732403|NCT05385523|Dexamethasone|dexamethasone|mesh-list
55732404|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55732405|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
55732406|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
55732407|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732408|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732410|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
55732411|NCT05385523|Hormones|hormones|mesh-ancestor
55732412|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55732413|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55732414|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732415|NCT03910621|Miglustat|miglustat|mesh-list
55732416|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732417|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732418|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55732419|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55732420|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
55732421|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732422|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55732423|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55732424|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732425|NCT02218372|Vancomycin|vancomycin|mesh-list
55732426|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
55732427|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55732428|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732429|NCT02217982|Simethicone|simethicone|mesh-list
55732430|NCT02217982|Loperamide|loperamide|mesh-list
55732431|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
55732432|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55732433|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
55732434|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732436|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
55732437|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
55732438|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55732439|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
55732440|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732441|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
55732442|NCT02207608|Protective Agents|protective agents|mesh-ancestor
55732443|NCT03530995|Itraconazole|itraconazole|mesh-list
55732444|NCT03530995|Rifampin|rifampin|mesh-list
55732445|NCT03530995|Omeprazole|omeprazole|mesh-list
55732446|NCT03530995|Rabeprazole|rabeprazole|mesh-list
55732447|NCT03530995|Belumosudil|belumosudil|mesh-list
55732448|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55732449|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55732450|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55732451|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732452|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732453|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
55732454|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732455|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55732456|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55732457|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55732458|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
55732459|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55732460|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732461|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55732462|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55732463|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
55732464|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55732466|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55732467|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55732468|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55732469|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55732470|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55732471|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55732472|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55732473|NCT03530995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55732475|NCT05438875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732476|NCT05438875|Keratolytic Agents|keratolytic agents|mesh-ancestor
55732477|NCT05438875|Dermatologic Agents|dermatologic agents|mesh-ancestor
55732478|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
55732479|NCT04740307|Lenvatinib|lenvatinib|mesh-list
55732559|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
55732480|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55732481|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732482|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55732483|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732484|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732485|NCT02207530|Durvalumab|durvalumab|mesh-list
55732486|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55732487|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732488|NCT05359315|Interferons|interferons|mesh-list
55732489|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
55732490|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732491|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
55732492|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732494|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732495|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55732496|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732497|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732498|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55732499|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
55732500|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732501|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732502|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55732503|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732504|NCT02786537|Ritonavir|ritonavir|mesh-list
55732505|NCT02786537|Ribavirin|ribavirin|mesh-list
55732506|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
55732507|NCT02786537|Grazoprevir|grazoprevir|mesh-list
55732508|NCT02786537|Ledipasvir|ledipasvir|mesh-list
55732509|NCT02786537|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55732511|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55732512|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
55732513|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732514|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732515|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55732516|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55732517|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
55732518|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732519|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55732520|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55732521|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
55732522|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
55732523|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55732524|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732525|NCT03466645|Vancomycin|vancomycin|mesh-list
55732526|NCT03466645|Cefazolin|cefazolin|mesh-list
55732527|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55732528|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732529|NCT04461665|Vitamin D|vitamin d|mesh-list
55732530|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
55732531|NCT04461665|Cholecalciferol|cholecalciferol|mesh-list
55732532|NCT04461665|Vitamins|vitamins|mesh-list
55732533|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
55732534|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732535|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55846183|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55732536|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55732538|NCT02252536|Analgesics|analgesics|mesh-ancestor
55732539|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
55732540|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732541|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732542|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
55732543|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55732544|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55732545|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732546|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55732547|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55732548|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55732549|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732550|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732551|NCT02252536|Antimanic Agents|antimanic agents|mesh-ancestor
55732552|NCT03490487|Prednisolone|prednisolone|mesh-list
55732553|NCT03490487|Carbamazepine|carbamazepine|mesh-list
55732554|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
55732555|NCT03490487|Levetiracetam|levetiracetam|mesh-list
55732556|NCT03490487|Valproic Acid|valproic acid|mesh-list
55732557|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
55732558|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55732561|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55732562|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732563|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55732564|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732565|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732566|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
55732567|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732568|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732570|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732571|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
55732572|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55732573|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732574|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55732575|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55732576|NCT03490487|Analgesics|analgesics|mesh-ancestor
55732577|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
55732578|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55732579|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55732580|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55732581|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55732582|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55732583|NCT05271331|Anesthetics|anesthetics|mesh-list
55732584|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
55732585|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732586|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732587|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
55732588|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732590|NCT03466567|Probenecid|probenecid|mesh-list
55732591|NCT03466567|Cyclosporins|cyclosporins|mesh-list
55732592|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732593|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732594|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829617|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732595|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
55732596|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732597|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
55732598|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732599|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
55732600|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55732601|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55732602|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
55732603|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
55732604|NCT03466567|Renal Agents|renal agents|mesh-ancestor
55732605|NCT03130153|Aspirin|aspirin|mesh-list
55732606|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
55732607|NCT03130153|Salicylates|salicylates|mesh-list
55732608|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55732609|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55732610|NCT03130153|Analgesics|analgesics|mesh-ancestor
55732611|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
55732612|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732613|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732614|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55732615|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55732616|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55732617|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55732618|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732619|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55732620|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55732621|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732622|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
55732623|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732624|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
55732625|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
55732626|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
55732627|NCT03466333|Enalapril|enalapril|mesh-list
55732628|NCT03466333|Enalaprilat|enalaprilat|mesh-list
55732629|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732630|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732631|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55732632|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
55732633|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55732634|NCT05382715|Ozanimod|ozanimod|mesh-list
55732635|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55732636|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829618|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
55829619|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829620|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55829621|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
55829622|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
55829623|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829624|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
55829625|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829626|NCT01543204|Etanercept|etanercept|mesh-list
55732637|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55732638|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
55732639|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732640|NCT03492047|Acetylcysteine|acetylcysteine|mesh-list
55732641|NCT03492047|Paclitaxel|paclitaxel|mesh-list
55732642|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55768686|NCT05476731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732643|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55732644|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732645|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
55732646|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
55732647|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
55732648|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732649|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
55732650|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732651|NCT03492047|Expectorants|expectorants|mesh-ancestor
55732652|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
55732653|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55732654|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
55732655|NCT03492047|Protective Agents|protective agents|mesh-ancestor
55732656|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732657|NCT03492047|Antidotes|antidotes|mesh-ancestor
55732658|NCT02251990|Grazoprevir|grazoprevir|mesh-list
55732659|NCT02251990|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55732660|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
55732661|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732662|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
55732663|NCT03490097|Simvastatin|simvastatin|mesh-list
55829627|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55829628|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55829629|NCT01543204|Analgesics|analgesics|mesh-ancestor
55829630|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
55829631|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829632|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829633|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829634|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829635|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55829637|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
55829638|NCT01518946|Midodrine|midodrine|mesh-list
55829639|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
55829640|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
55829641|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846299|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
55732664|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55732665|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55732666|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
55732667|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732668|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55732669|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55732670|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732671|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
55732672|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732673|NCT04453735|Atorvastatin|atorvastatin|mesh-list
55732674|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55732675|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55732676|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
55732677|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732678|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55732679|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55732680|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732681|NCT03490019|Metformin|metformin|mesh-list
55732682|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55732683|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732684|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
55732685|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
55732686|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732688|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732689|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
55732690|NCT03491969|Vitamins|vitamins|mesh-ancestor
55732691|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
55732692|NCT02251912|Oxytocin|oxytocin|mesh-list
55732693|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
55732694|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55732695|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732696|NCT01976273|Glycolic acid|glycolic acid|mesh-list
55732697|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
55732698|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
55732699|NCT02206048|Proflavine|proflavine|mesh-list
55732700|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55732701|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732702|NCT03466021|Liraglutide|liraglutide|mesh-list
55732703|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55732704|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732705|NCT03466021|Incretins|incretins|mesh-ancestor
55732706|NCT03466021|Hormones|hormones|mesh-ancestor
55768706|NCT05481957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732707|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55732708|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55732709|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
55732710|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
55732711|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55732712|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
55732713|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732714|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55732715|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55732716|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
55732717|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732718|NCT04108897|Doxycycline|doxycycline|mesh-list
55732720|NCT04108897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55732721|NCT04108897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732722|NCT04108897|Antimalarials|antimalarials|mesh-ancestor
55732723|NCT04108897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55732724|NCT04108897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55732725|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55732726|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
55732727|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732728|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55732729|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55732730|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732731|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
55732732|NCT03489005|Zamicastat|zamicastat|mesh-list
55732733|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55732734|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732735|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55732736|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55732737|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732738|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732739|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732740|NCT02215252|Pregabalin|pregabalin|mesh-list
55732741|NCT02215252|Analgesics|analgesics|mesh-ancestor
55732742|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
55732743|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732744|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732745|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
55732746|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55732747|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55732748|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732749|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55732750|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55732751|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55732752|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732753|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55732754|NCT04894721|Ivermectin|ivermectin|mesh-list
55732755|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55732756|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732757|NCT02204410|Methylphenidate|methylphenidate|mesh-list
55732758|NCT02204410|Amphetamine|amphetamine|mesh-list
55732759|NCT02204410|Adderall|adderall|mesh-list
55732760|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
55732761|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55732762|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732763|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55732764|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55732765|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55732766|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732767|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
55732768|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732769|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
55732770|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
55732771|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732772|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
55732773|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55732774|NCT05154370|Immunoglobulins|immunoglobulins|mesh-list
55732775|NCT05154370|Immunologic Factors|immunologic factors|mesh-ancestor
55732776|NCT05154370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732777|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55732778|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
55732779|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732780|NCT03461575|Cyclosporine|cyclosporine|mesh-list
55732781|NCT03461575|Cyclosporins|cyclosporins|mesh-list
55732782|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732783|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732784|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55732785|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
55732786|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732787|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
55732788|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732789|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
55732790|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55732791|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55732792|NCT03131843|Ethanol|ethanol|mesh-list
55732793|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55732794|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732795|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732796|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732797|NCT02213380|Anesthetics|anesthetics|mesh-list
55732798|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732799|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732800|NCT03488147|Esomeprazole|esomeprazole|mesh-list
55732801|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55732802|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55732803|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55732804|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732805|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732806|NCT03797261|Venetoclax|venetoclax|mesh-list
55732807|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732808|NCT02202850|Etanercept|etanercept|mesh-list
55732809|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55732810|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55732811|NCT02202850|Analgesics|analgesics|mesh-ancestor
55732812|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
55732813|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732814|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732815|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55732816|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55732817|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55732818|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55732819|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
55732820|NCT03489395|Edoxaban|edoxaban|mesh-list
55732821|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55732822|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
55732823|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55732824|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
55732825|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732826|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732827|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
55732828|NCT03489317|Metformin|metformin|mesh-list
55732829|NCT03489317|Amlodipine|amlodipine|mesh-list
55732830|NCT03489317|Simvastatin|simvastatin|mesh-list
55732831|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55732832|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732833|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55732834|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55732835|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55732836|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732837|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55732838|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
55732839|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55732840|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55732841|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
55732842|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55732843|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55732844|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732846|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55732847|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
55732848|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732849|NCT02212678|Expectorants|expectorants|mesh-ancestor
55768718|NCT05475561|Bupivacaine|bupivacaine|mesh-list
55732850|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
55732851|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55732852|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
55732853|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732854|NCT02212678|Protective Agents|protective agents|mesh-ancestor
55732855|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732856|NCT02212678|Antidotes|antidotes|mesh-ancestor
55732858|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
55732859|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732860|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55732861|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55732862|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732863|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732864|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55732865|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55732866|NCT03489161|Buprenorphine|buprenorphine|mesh-list
55732867|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55732868|NCT03489161|Narcotics|narcotics|mesh-ancestor
55732869|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732870|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732871|NCT03489161|Analgesics|analgesics|mesh-ancestor
55732872|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
55732873|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732874|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55732875|NCT04804709|Panobinostat|panobinostat|mesh-list
55732876|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732877|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55732878|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732879|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732880|NCT04690673|Acetaminophen|acetaminophen|mesh-list
55732881|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55732882|NCT04690673|Analgesics|analgesics|mesh-ancestor
55732883|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
55732884|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732885|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732886|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
55732887|NCT03104075|Vaccines|vaccines|mesh-list
55732888|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55732889|NCT03104075|Immunologic Factors|immunologic factors|mesh-ancestor
55732890|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732891|NCT02907983|Bupivacaine|bupivacaine|mesh-list
55732892|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
55732893|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
55732894|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732895|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732896|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
55732897|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732898|NCT02841215|Ivermectin|ivermectin|mesh-list
55732899|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55732900|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732901|NCT02799641|Lidocaine|lidocaine|mesh-list
55732902|NCT02799641|Diazepam|diazepam|mesh-list
55732903|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
55732904|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
55732905|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55732906|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732907|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
55732908|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732909|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55732910|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55732911|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55732912|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55733212|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732913|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732914|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55732915|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
55732916|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
55732917|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
55732918|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55732919|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55732920|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55732921|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55732922|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55732923|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55732924|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55732925|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55732926|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
55732927|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
55732928|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
55732929|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732930|NCT04388501|Atorvastatin|atorvastatin|mesh-list
55732931|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55732932|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55829693|NCT01505608|Temozolomide|temozolomide|mesh-list
55732933|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
55732934|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732935|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55732936|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55732937|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732940|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55732941|NCT02249182|Ledipasvir|ledipasvir|mesh-list
55732942|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
55732943|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732944|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
55732945|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55732946|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
55732947|NCT04006769|Entacapone|entacapone|mesh-list
55732948|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732949|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55732950|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55732951|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732952|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55732953|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55732954|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55732955|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55732956|NCT03487211|Citalopram|citalopram|mesh-list
55732957|NCT03487211|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55732958|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55732959|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55732960|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732961|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732962|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
55732963|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732964|NCT03487211|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55732966|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55732967|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732968|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55732969|NCT03487211|Analgesics|analgesics|mesh-ancestor
55732970|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
55732971|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
55732972|NCT03487133|Dexamethasone|dexamethasone|mesh-list
55732973|NCT03487133|Bortezomib|bortezomib|mesh-list
55732974|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55732975|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
55732976|NCT03487133|Autonomic Agents|autonomic agents|mesh-ancestor
55732977|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732978|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732979|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55732980|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
55732981|NCT03487133|Hormones|hormones|mesh-ancestor
55732982|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55732983|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55732984|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55732985|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55732986|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55732987|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55732988|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55732989|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55732990|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55732991|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55732992|NCT02248480|Analgesics|analgesics|mesh-ancestor
55732993|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
55732994|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55732995|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
55732996|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55732997|NCT02248480|Dopamine Agents|dopamine agents|mesh-ancestor
55732998|NCT01653158|Docetaxel|docetaxel|mesh-list
55732999|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733000|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
55733001|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
55733002|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
55733003|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733004|NCT00701207|Nicotine|nicotine|mesh-list
55733005|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55733006|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
55733007|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733008|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733009|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55733010|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55733011|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
55733012|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733013|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733014|NCT02247466|Rocuronium|rocuronium|mesh-list
55733015|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55733016|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55733017|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55733018|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733019|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733020|NCT03417479|Gabapentin|gabapentin|mesh-list
55733021|NCT03417479|Analgesics|analgesics|mesh-ancestor
55733022|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
55733023|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733024|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733026|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55733027|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55733028|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55733029|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55733030|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55733031|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55733032|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733033|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733034|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
55733035|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
55733036|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
55733037|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55733038|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55733039|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733041|NCT03317795|Coagulants|coagulants|mesh-ancestor
55733042|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55733043|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
55733044|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55733045|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733046|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55733047|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55733048|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55733049|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
55733050|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733051|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55733052|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55733053|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55733054|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
55733055|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733056|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733057|NCT04943198|Vemurafenib|vemurafenib|mesh-list
55733058|NCT04943198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733059|NCT04943198|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55733060|NCT04943198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733061|NCT04943198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733062|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55733063|NCT03876119|Plasminogen|plasminogen|mesh-list
55733064|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55733065|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55733066|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733067|NCT02455076|Exenatide|exenatide|mesh-list
55733068|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
55733069|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55733070|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733071|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55733072|NCT02455076|Incretins|incretins|mesh-ancestor
55733073|NCT02455076|Hormones|hormones|mesh-ancestor
55733074|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733075|NCT02432846|Sunitinib|sunitinib|mesh-list
55733076|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733077|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55733078|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55733079|NCT02432846|Growth Substances|growth substances|mesh-ancestor
55733080|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733081|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
55733082|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55733083|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733084|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733085|NCT03486509|Afatinib|afatinib|mesh-list
55733086|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733087|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55733088|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733089|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733090|NCT04460807|Exemestane|exemestane|mesh-list
55768768|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
55733091|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733092|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55733093|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55733094|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733095|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733096|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55733097|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
55733098|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733099|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733100|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55733101|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
55733102|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733103|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55733104|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55733105|NCT04928222|Doxorubicin|doxorubicin|mesh-list
55733106|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55733107|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733108|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55733109|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55733111|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733112|NCT00805961|Bevacizumab|bevacizumab|mesh-list
55733113|NCT00805961|Everolimus|everolimus|mesh-list
55733114|NCT00805961|Temozolomide|temozolomide|mesh-list
55733115|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55733116|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733117|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55733118|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55733119|NCT00805961|Growth Substances|growth substances|mesh-ancestor
55733120|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733121|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
55733122|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55733123|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
55733124|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55733125|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
55733126|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733127|NCT02454608|Verapamil|verapamil|mesh-list
55733128|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55733129|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55733130|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55733131|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733132|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55733133|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733134|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
55733136|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55733137|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55733139|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733140|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733141|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55733142|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
55733143|NCT05152355|Glucocorticoids|glucocorticoids|mesh-ancestor
55733144|NCT05152355|Hormones|hormones|mesh-ancestor
55733145|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733146|NCT02246764|Timolol|timolol|mesh-list
55733147|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55733148|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55733149|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733150|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55733151|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55768772|NCT03426891|Pembrolizumab|pembrolizumab|mesh-list
55733152|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
55733153|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733154|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733155|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55733156|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55733157|NCT03484091|Hylan|hylan|mesh-list
55733158|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
55733159|NCT03484091|Protective Agents|protective agents|mesh-ancestor
55733160|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733161|NCT03486353|Azacitidine|azacitidine|mesh-list
55733162|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55733163|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
55733164|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733165|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733166|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733167|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
55733168|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55733169|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55733170|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55733171|NCT02431676|Metformin|metformin|mesh-list
55733172|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55733173|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733174|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55733175|NCT03483545|Hormones|hormones|mesh-ancestor
55733176|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733177|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733178|NCT03483389|Ethanol|ethanol|mesh-list
55733179|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55733180|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733181|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55733182|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733183|NCT03486119|Nivolumab|nivolumab|mesh-list
55733184|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55733185|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733186|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55733187|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733188|NCT02523833|Albuterol|albuterol|mesh-list
55733189|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55733190|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
55733191|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733192|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733193|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55733194|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
55733195|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
55733196|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55733197|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55733198|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55733199|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55733200|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
55733201|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733202|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733203|NCT04349579|Rifamycins|rifamycins|mesh-list
55733204|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
55733205|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55733206|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733207|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55733208|NCT04234529|Caffeine|caffeine|mesh-list
55733209|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55733210|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733211|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55733213|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733214|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55733215|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55733216|NCT04234529|Purinergic Agents|purinergic agents|mesh-ancestor
55733217|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733218|NCT01652690|Denosumab|denosumab|mesh-list
55733219|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55733220|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733221|NCT03481517|Bupivacaine|bupivacaine|mesh-list
55733222|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
55733223|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
55733224|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55733225|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733226|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
55733227|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733229|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
55733230|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55733231|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733232|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55733233|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733234|NCT02201524|Abrocitinib|abrocitinib|mesh-list
55733235|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55733236|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733237|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733238|NCT05153603|Olaparib|olaparib|mesh-list
55733239|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55733240|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733241|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733242|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733243|NCT05152901|Epinephrine|epinephrine|mesh-list
55733244|NCT05152901|Racepinephrine|racepinephrine|mesh-list
55733245|NCT05152901|Epinephryl borate|epinephryl borate|mesh-list
55733246|NCT05152901|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55733247|NCT05152901|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55733248|NCT05152901|Adrenergic Agents|adrenergic agents|mesh-ancestor
55733249|NCT05152901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733250|NCT05152901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733251|NCT05152901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733252|NCT05152901|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55733253|NCT05152901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55733254|NCT05152901|Autonomic Agents|autonomic agents|mesh-ancestor
55733255|NCT05152901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733257|NCT05152901|Respiratory System Agents|respiratory system agents|mesh-ancestor
55733258|NCT05152901|Mydriatics|mydriatics|mesh-ancestor
55733259|NCT05152901|Sympathomimetics|sympathomimetics|mesh-ancestor
55733260|NCT05152901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55733261|NCT02137252|Naltrexone|naltrexone|mesh-list
55733262|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55733263|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55733264|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733265|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
55733266|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733267|NCT05152667|Dienogest|dienogest|mesh-list
55733268|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
55733269|NCT05152667|Progestins|progestins|mesh-list
55733270|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55733271|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
55733272|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55733273|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733274|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55733275|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55733276|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55733277|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55733278|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55733279|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
55733280|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733281|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55733282|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733283|NCT05152667|Hormones|hormones|mesh-ancestor
55733284|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
55733285|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55733286|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733287|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733438|NCT02553161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55733288|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55733289|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55733290|NCT05152511|Protective Agents|protective agents|mesh-ancestor
55733291|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733292|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
55733293|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55733294|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
55733295|NCT02568449|Nintedanib|nintedanib|mesh-list
55733296|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733297|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55733298|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733299|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733300|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
55733301|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
55733302|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733303|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
55733304|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55733305|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
55733306|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
55733307|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55733308|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733309|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55733310|NCT04884893|Analgesics|analgesics|mesh-ancestor
55733311|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
55733312|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733313|NCT03479879|Misoprostol|misoprostol|mesh-list
55733314|NCT03479879|Estradiol|estradiol|mesh-list
55733315|NCT03479879|Estrogens|estrogens|mesh-ancestor
55733316|NCT03479879|Hormones|hormones|mesh-ancestor
55733317|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733318|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733319|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55733320|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55733321|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
55733322|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55733323|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55733324|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
55733325|NCT03479411|Itraconazole|itraconazole|mesh-list
55733326|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
55733327|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
55733328|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733329|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55733330|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55733331|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733332|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733333|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55733334|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
55733335|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733336|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733337|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55733338|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
55733339|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55733340|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55733341|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733342|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55733344|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
55733345|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733346|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55733347|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55733348|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55733349|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
55733350|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733351|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733352|NCT03475589|Apatinib|apatinib|mesh-list
55733353|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733354|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55733355|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733356|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733357|NCT03478709|Norepinephrine|norepinephrine|mesh-list
55733358|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55733359|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55733360|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
55733361|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733439|NCT03473093|Pregabalin|pregabalin|mesh-list
55733362|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733363|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733364|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
55733365|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
55733366|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733367|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55733368|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
55733369|NCT03478475|Vitamin D|vitamin d|mesh-list
55733370|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55733371|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733372|NCT03478475|Vitamins|vitamins|mesh-ancestor
55733374|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55733375|NCT03475121|Topotecan|topotecan|mesh-list
55733376|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55733377|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55733378|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733379|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733380|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733381|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55733382|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733383|NCT02523755|Ropivacaine|ropivacaine|mesh-list
55733384|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
55733385|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
55733386|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55733387|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733388|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
55733389|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733390|NCT02168842|Isradipine|isradipine|mesh-list
55733391|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55733392|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55733393|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55733394|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733395|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55733396|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733397|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
55733398|NCT03347123|Nivolumab|nivolumab|mesh-list
55733399|NCT03347123|Ipilimumab|ipilimumab|mesh-list
55733400|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55733401|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733402|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55733403|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733404|NCT03131141|Lefamulin|lefamulin|mesh-list
55733405|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55733406|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733407|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55733408|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55733409|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733412|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
55733413|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733414|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733415|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55733416|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
55733417|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55733418|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55733419|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55733420|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733421|NCT03474263|Antibodies|antibodies|mesh-list
55733422|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55733423|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
55733424|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733425|NCT03477461|Terlipressin|terlipressin|mesh-list
55733426|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55733427|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55733428|NCT02553161|Citalopram|citalopram|mesh-list
55733429|NCT02553161|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55733430|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55733431|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55733432|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733433|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733434|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
55733435|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733436|NCT02553161|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55733437|NCT02553161|Antidepressive Agents|antidepressive agents|mesh-ancestor
55733443|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55733444|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733445|NCT03473093|Analgesics|analgesics|mesh-ancestor
55733446|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
55733447|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733449|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55733450|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55733451|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733452|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55733453|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55733454|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55733455|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55733456|NCT02523131|Insulin|insulin|mesh-list
55733457|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55733458|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733459|NCT04339049|Lidocaine|lidocaine|mesh-list
55733460|NCT04339049|Misoprostol|misoprostol|mesh-list
55733461|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
55733462|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
55733463|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55733464|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733465|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
55733466|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733467|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55733468|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55733469|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55733470|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55733471|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733472|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55733474|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55733475|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55733476|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55733477|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
55733478|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
55733479|NCT02133742|Axitinib|axitinib|mesh-list
55733480|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55733481|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733482|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55733483|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733484|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733486|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
55733487|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733488|NCT02133664|Protective Agents|protective agents|mesh-ancestor
55733489|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733490|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
55733491|NCT02133664|Vitamins|vitamins|mesh-ancestor
55733492|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
55733493|NCT02133352|Ranolazine|ranolazine|mesh-list
55733494|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55733495|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55733496|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733497|NCT04418128|Nafamostat|nafamostat|mesh-list
55768863|NCT02393573|Metformin|metformin|mesh-list
55733498|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55733499|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55733501|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
55733502|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733503|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733504|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55733505|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55733506|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
55733507|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
55733508|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733509|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733510|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55733511|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55733512|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55733513|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55733514|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
55733515|NCT02555657|Gemcitabine|gemcitabine|mesh-list
55733516|NCT02555657|Capecitabine|capecitabine|mesh-list
55733517|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
55733518|NCT02555657|Vinorelbine|vinorelbine|mesh-list
55733519|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55733521|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733522|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733523|NCT02555657|Antiviral Agents|antiviral agents|mesh-ancestor
55733524|NCT02555657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733525|NCT02555657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733526|NCT02555657|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55733527|NCT02555657|Immunologic Factors|immunologic factors|mesh-ancestor
55733528|NCT02555657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733529|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55733530|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55733531|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
55733532|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
55733533|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
55733534|NCT02195518|Tenofovir|tenofovir|mesh-list
55733535|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
55733536|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733537|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55733538|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55733539|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733540|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733541|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55733542|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55733544|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733545|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
55733546|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
55733547|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
55733548|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733550|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
55733551|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
55733552|NCT03380507|Thiamine|thiamine|mesh-list
55733553|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
55733554|NCT03380507|Vitamins|vitamins|mesh-ancestor
55733556|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733557|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55733558|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
55733559|NCT03471455|Itraconazole|itraconazole|mesh-list
55733560|NCT03471455|Terbinafine|terbinafine|mesh-list
55733561|NCT03471455|Isotretinoin|isotretinoin|mesh-list
55733562|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
55733563|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733564|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55733565|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55733566|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733567|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733568|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55733569|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
55733570|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733571|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733572|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55733573|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
55733575|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55733576|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55733577|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
55733578|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
55733579|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733580|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733581|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55733582|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
55733583|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55733584|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
55733585|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733586|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733587|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55733588|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
55733589|NCT03202667|Empagliflozin|empagliflozin|mesh-list
55733590|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55733591|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733592|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55733593|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733594|NCT05157893|Analgesics|analgesics|mesh-list
55733595|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
55733596|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733597|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733598|NCT02523053|Fluorouracil|fluorouracil|mesh-list
55733600|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733601|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55733602|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733603|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55733604|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
55733605|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733606|NCT04457609|Azithromycin|azithromycin|mesh-list
55733607|NCT04457609|Oseltamivir|oseltamivir|mesh-list
55733608|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55733609|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733610|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
55733611|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733612|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733613|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
55733614|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55733615|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733616|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
55733617|NCT04457765|Povidone|povidone|mesh-list
55733618|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
55733619|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
55733620|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55733637|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55733638|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
55733639|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55733641|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733642|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733643|NCT03470597|Iodine|iodine|mesh-list
55733644|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55733645|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733646|NCT03470597|Trace Elements|trace elements|mesh-ancestor
55733647|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
55733648|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733649|NCT02522897|Ranibizumab|ranibizumab|mesh-list
55733650|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55733651|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55733652|NCT02522897|Growth Substances|growth substances|mesh-ancestor
55733653|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733654|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
55733655|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733656|NCT04351061|Acetazolamide|acetazolamide|mesh-list
55733657|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
55733658|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55733659|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733660|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733661|NCT04351061|Diuretics|diuretics|mesh-ancestor
55733662|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
55733663|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733664|NCT03130829|Fucoidan|fucoidan|mesh-list
55733665|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55733666|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55733667|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
55733668|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733669|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55733670|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
55733671|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
55733672|NCT04206761|Bromides|bromides|mesh-list
55733674|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55733675|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
55733676|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55733677|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55733678|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55733679|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55733680|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
55733681|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733682|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733683|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733684|NCT03181529|Psilocybin|psilocybin|mesh-list
55733685|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
55733686|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733687|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55733688|NCT03668639|Dexamethasone|dexamethasone|mesh-list
55733689|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55733690|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
55733691|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
55733692|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733693|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733694|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55733697|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733698|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55733699|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733700|NCT03470363|Sufentanil|sufentanil|mesh-list
55733701|NCT03470363|Bupivacaine|bupivacaine|mesh-list
55733702|NCT03470363|Sevoflurane|sevoflurane|mesh-list
55733703|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
55733704|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
55733705|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55733706|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733707|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
55733708|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733709|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55733710|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55733711|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
55733712|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55733713|NCT03470363|Narcotics|narcotics|mesh-ancestor
55733714|NCT03470363|Analgesics|analgesics|mesh-ancestor
55733715|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55733716|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55733717|NCT03469895|Idelalisib|idelalisib|mesh-list
55733718|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733719|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733720|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733721|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
55733722|NCT05160623|Povidone|povidone|mesh-list
55733723|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
55733724|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
55733725|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55733726|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733727|NCT04713137|Erythritol|erythritol|mesh-list
55733728|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
55733729|NCT04456985|Folic Acid|folic acid|mesh-list
55733731|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
55733732|NCT04456985|Vitamins|vitamins|mesh-ancestor
55733733|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
55733734|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733735|NCT04456985|Hematinics|hematinics|mesh-ancestor
55733736|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
55733737|NCT03469583|Entecavir|entecavir|mesh-list
55733738|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
55733739|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733740|NCT05159531|Tenofovir|tenofovir|mesh-list
55733741|NCT05159531|Emtricitabine|emtricitabine|mesh-list
55733742|NCT05159531|Antiviral Agents|antiviral agents|mesh-ancestor
55733743|NCT05159531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733744|NCT05159531|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55733745|NCT05159531|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55733747|NCT05159531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733748|NCT05159531|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55733749|NCT05159531|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55733750|NCT05096039|Valsartan|valsartan|mesh-list
55733751|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55733752|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55733753|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55733754|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55733755|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733757|NCT05604131|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55733758|NCT05604131|Chelating Agents|chelating agents|mesh-ancestor
55733759|NCT05604131|Sequestering Agents|sequestering agents|mesh-ancestor
55733760|NCT05604131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733761|NCT03469271|Calcitriol|calcitriol|mesh-list
55733762|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
55733763|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55733764|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733765|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55733766|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55733767|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733768|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55733769|NCT03469271|Vitamins|vitamins|mesh-ancestor
55733770|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
55733771|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55733772|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
55733773|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55733774|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733775|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55733778|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733779|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733780|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55733781|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55733782|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55733783|NCT04363697|Dapagliflozin|dapagliflozin|mesh-list
55733784|NCT04363697|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55733785|NCT04363697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733786|NCT04363697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55733787|NCT04363697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733788|NCT02421341|Fentanyl|fentanyl|mesh-list
55829733|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55733789|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
55733790|NCT02421341|Analgesics|analgesics|mesh-list
55733791|NCT02421341|Narcotics|narcotics|mesh-ancestor
55733792|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55733793|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733794|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
55733795|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733796|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55733797|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55733798|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
55733799|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
55733800|NCT02149121|Rituximab|rituximab|mesh-list
55733801|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55733802|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733803|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
55733804|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733805|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55733806|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
55733807|NCT05162417|Methylene Blue|methylene blue|mesh-list
55733808|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733809|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733813|NCT05162183|Liraglutide|liraglutide|mesh-list
55733814|NCT05162183|Glimepiride|glimepiride|mesh-list
55733815|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55733816|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733817|NCT05162183|Incretins|incretins|mesh-ancestor
55733818|NCT05162183|Hormones|hormones|mesh-ancestor
55733819|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733820|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55733821|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55733822|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
55733823|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
55733824|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55733825|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
55733826|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733827|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
55733828|NCT05161403|Protective Agents|protective agents|mesh-ancestor
55733829|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
55733830|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55733831|NCT03166085|Paclitaxel|paclitaxel|mesh-list
55733832|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
55733833|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55733834|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733835|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
55733836|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
55733837|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
55733838|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733839|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
55733840|NCT05390255|Omalizumab|omalizumab|mesh-list
55733841|NCT05390255|Hormones|hormones|mesh-list
55733842|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733843|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733844|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55733845|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
55733846|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55733847|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55733848|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
55733849|NCT04456829|Resveratrol|resveratrol|mesh-list
55733850|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
55733851|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733852|NCT04456829|Protective Agents|protective agents|mesh-ancestor
55733930|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
55733853|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733854|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733855|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55733856|NCT02492867|Paclitaxel|paclitaxel|mesh-list
55733857|NCT02492867|Carboplatin|carboplatin|mesh-list
55733858|NCT02492867|Durvalumab|durvalumab|mesh-list
55733859|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55733860|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733861|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
55733862|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
55733863|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
55733864|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733865|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55733866|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
55733867|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55733868|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55733869|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
55733870|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733871|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733872|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733873|NCT02522221|Warfarin|warfarin|mesh-list
55733874|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
55733875|NCT05389943|Vitamin D|vitamin d|mesh-list
55733876|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
55733877|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
55733878|NCT05389943|Vitamins|vitamins|mesh-list
55733879|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
55733880|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733881|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55733882|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55733883|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
55733884|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55733885|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733886|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
55733887|NCT02522975|Hematinics|hematinics|mesh-ancestor
55733888|NCT04508803|Trastuzumab|trastuzumab|mesh-list
55733890|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55733891|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733892|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55733893|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733894|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733895|NCT02375555|Dexamethasone|dexamethasone|mesh-list
55733896|NCT02375555|Lenalidomide|lenalidomide|mesh-list
55733897|NCT02375555|Bortezomib|bortezomib|mesh-list
55733898|NCT02375555|Elotuzumab|elotuzumab|mesh-list
55733899|NCT02375555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55733900|NCT02375555|Antiemetics|antiemetics|mesh-ancestor
55733901|NCT02375555|Autonomic Agents|autonomic agents|mesh-ancestor
55733902|NCT02375555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55733903|NCT02375555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733904|NCT02375555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55733905|NCT02375555|Glucocorticoids|glucocorticoids|mesh-ancestor
55733906|NCT02375555|Hormones|hormones|mesh-ancestor
55733907|NCT02375555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733908|NCT02375555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55733909|NCT02375555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733910|NCT02375555|Immunologic Factors|immunologic factors|mesh-ancestor
55733911|NCT02375555|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55733912|NCT02375555|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55733913|NCT02375555|Growth Substances|growth substances|mesh-ancestor
55733914|NCT02375555|Growth Inhibitors|growth inhibitors|mesh-ancestor
55733915|NCT04492033|Paclitaxel|paclitaxel|mesh-list
55733916|NCT04492033|Irinotecan|irinotecan|mesh-list
55733917|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55733918|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733919|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
55733920|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
55733921|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
55733922|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733923|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55733924|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55733925|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733926|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
55733927|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55733928|NCT03461185|Growth Substances|growth substances|mesh-ancestor
55733929|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733931|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733932|NCT04453423|Carboplatin|carboplatin|mesh-list
55733933|NCT04453423|Pemetrexed|pemetrexed|mesh-list
55733934|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733935|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733936|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733937|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55733938|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55733939|NCT04453189|Lansoprazole|lansoprazole|mesh-list
55733940|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
55733941|NCT04453189|Famotidine|famotidine|mesh-list
55733942|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55733943|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55733944|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55733945|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55733946|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733947|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55733948|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
55733949|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
55733950|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55733951|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733952|NCT03465085|Heparin|heparin|mesh-list
55733953|NCT03465085|Calcium heparin|calcium heparin|mesh-list
55733954|NCT03465085|Streptokinase|streptokinase|mesh-list
55733955|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
55733956|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55733957|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55733958|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733959|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
55733960|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55733961|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
55733962|NCT05030155|Azathioprine|azathioprine|mesh-list
55829757|NCT01948791|Protective Agents|protective agents|mesh-ancestor
55733963|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55733964|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
55733965|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733966|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55733967|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55733968|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
55733969|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733970|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733971|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55733972|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
55733973|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55733974|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
55733975|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55733977|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733978|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
55733979|NCT04453111|Protective Agents|protective agents|mesh-ancestor
55733980|NCT03468595|Listerine|listerine|mesh-list
55733981|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55733982|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55733983|NCT04453345|Thalidomide|thalidomide|mesh-list
55733984|NCT04453345|Prednisone|prednisone|mesh-list
55733985|NCT04453345|Methotrexate|methotrexate|mesh-list
55733986|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55733987|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
55733988|NCT04453345|Hormones|hormones|mesh-ancestor
55733989|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55733990|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55733991|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55733992|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55733993|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55733994|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
55733995|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55733996|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55733997|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
55733998|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55733999|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
55734000|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734001|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55734002|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55734003|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
55734004|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55734005|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55734006|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
55734007|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55734008|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734009|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55734010|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55734011|NCT04453345|Growth Substances|growth substances|mesh-ancestor
55734012|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
55734013|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
55734014|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734015|NCT03464539|Chitosan|chitosan|mesh-list
55734016|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55734017|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55734018|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
55734019|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734020|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55734021|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
55734022|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
55734023|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
55734024|NCT03464539|Coagulants|coagulants|mesh-ancestor
55734025|NCT01633541|Carboplatin|carboplatin|mesh-list
55734026|NCT01633541|Docetaxel|docetaxel|mesh-list
55734027|NCT01633541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734028|NCT01633541|Tubulin Modulators|tubulin modulators|mesh-ancestor
55734029|NCT01633541|Antimitotic Agents|antimitotic agents|mesh-ancestor
55734030|NCT01633541|Mitosis Modulators|mitosis modulators|mesh-ancestor
55734031|NCT01633541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734032|NCT03896269|Cytarabine|cytarabine|mesh-list
55734033|NCT03896269|Daunorubicin|daunorubicin|mesh-list
55734034|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55734035|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
55734036|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734037|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734038|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
55734039|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734040|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55734041|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
55734042|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734043|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55734044|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55734045|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55734046|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734047|NCT03460405|Vaccines|vaccines|mesh-list
55734048|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
55734049|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734050|NCT05166005|Vitamin D|vitamin d|mesh-list
55734051|NCT05166005|Vitamins|vitamins|mesh-ancestor
55734052|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
55734053|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734054|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55734056|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55734057|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55734058|NCT03464305|Analgesics|analgesics|mesh-ancestor
55734059|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
55734060|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734061|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734062|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734063|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55734064|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55734065|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55734066|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734067|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55734068|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55734069|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734070|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
55734072|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55734073|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734074|NCT03468439|Phenol|phenol|mesh-list
55734075|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55734076|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734077|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
55734078|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55734080|NCT05165303|Lidocaine|lidocaine|mesh-list
55734081|NCT05165303|Propofol|propofol|mesh-list
55734082|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
55734083|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
55734084|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734085|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734086|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
55734235|NCT05322265|Epinephrine|epinephrine|mesh-list
55734087|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734088|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55734089|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55734090|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55734091|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55734092|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829759|NCT01898091|Glycerol|glycerol|mesh-list
55734093|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55734094|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55734095|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
55734096|NCT03376763|Aripiprazole|aripiprazole|mesh-list
55734097|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
55734098|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55734099|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55734100|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55734101|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734102|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734103|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
55734104|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
55734105|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734106|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734107|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55734108|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55734109|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
55734110|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55734111|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55734112|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55734113|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55734114|NCT05153135|Palbociclib|palbociclib|mesh-list
55734115|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734116|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55734117|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734118|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734119|NCT02616185|Tremelimumab|tremelimumab|mesh-list
55734120|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734121|NCT04857307|Alprazolam|alprazolam|mesh-list
55734122|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55734123|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734124|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734125|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55734126|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55734127|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55734128|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
55734129|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
55734130|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734131|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734132|NCT03467893|Antacids|antacids|mesh-list
55734133|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829789|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
55734134|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55734135|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
55734136|NCT05170711|Anesthetics|anesthetics|mesh-list
55734137|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734138|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734139|NCT03454945|Doxycycline|doxycycline|mesh-list
55734140|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55734141|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734142|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
55734143|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55734144|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55734145|NCT01857115|Dexamethasone|dexamethasone|mesh-list
55734146|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
55734147|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55734148|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
55734149|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734150|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55734151|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55734152|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
55734153|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734154|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734155|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55734156|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734158|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
55734159|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734160|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55734161|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
55734162|NCT01857115|Hormones|hormones|mesh-ancestor
55734163|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55734164|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55734165|NCT03453541|Ketorolac|ketorolac|mesh-list
55734166|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55734167|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55734168|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55734169|NCT03453541|Analgesics|analgesics|mesh-ancestor
55734170|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
55734171|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734172|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734173|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734174|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55734175|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55734176|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734177|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734178|NCT00893789|Modafinil|modafinil|mesh-list
55734179|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55734180|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734181|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55734182|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55734183|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55734184|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734185|NCT03449251|Verapamil|verapamil|mesh-list
55734186|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
55734187|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55734188|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55734189|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55734190|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734191|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55734192|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734193|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
55734194|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734195|NCT05322499|Paclitaxel|paclitaxel|mesh-list
55734196|NCT05322499|Docetaxel|docetaxel|mesh-list
55734197|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55734198|NCT05322499|Irinotecan|irinotecan|mesh-list
55734199|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55734201|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
55734202|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
55734203|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
55734204|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734205|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55734206|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55734207|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734208|NCT03449173|Sunitinib|sunitinib|mesh-list
55734209|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734210|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55734211|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55734212|NCT03449173|Growth Substances|growth substances|mesh-ancestor
55734213|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734214|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
55734215|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55734216|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734217|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734218|NCT04760041|Midazolam|midazolam|mesh-list
55734219|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55734220|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55734221|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734222|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734223|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55734224|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55734225|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55734226|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55734227|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
55734228|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
55734229|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
55734230|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
55734231|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734232|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734233|NCT04754035|Venetoclax|venetoclax|mesh-list
55734234|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734238|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55734239|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55734240|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
55734241|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734242|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734243|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734244|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55734245|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55734246|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
55734247|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734248|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55734249|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
55734250|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
55734251|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
55734252|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55734253|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
55734254|NCT05322187|Lenvatinib|lenvatinib|mesh-list
55734255|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55734256|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55734257|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734258|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55734259|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734260|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734261|NCT02164864|Aspirin|aspirin|mesh-list
55734262|NCT02164864|Warfarin|warfarin|mesh-list
55734263|NCT02164864|Dabigatran|dabigatran|mesh-list
55734264|NCT02164864|Clopidogrel|clopidogrel|mesh-list
55734265|NCT02164864|Ticagrelor|ticagrelor|mesh-list
55734266|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55846307|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
55734267|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55734268|NCT02164864|Analgesics|analgesics|mesh-ancestor
55734269|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
55734270|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734271|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734272|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734273|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55734274|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55734275|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55734276|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734277|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55734278|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55734279|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734281|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55734282|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55734283|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55734284|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
55734285|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734286|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
55734287|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
55734288|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55734289|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
55734290|NCT05579249|Liraglutide|liraglutide|mesh-list
55734291|NCT05579249|Topiramate|topiramate|mesh-list
55829895|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829913|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
55734292|NCT05579249|Orlistat|orlistat|mesh-list
55734293|NCT05579249|Phentermine|phentermine|mesh-list
55734294|NCT05579249|Naltrexone|naltrexone|mesh-list
55734295|NCT05579249|Bupropion|bupropion|mesh-list
55734296|NCT05579249|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55734297|NCT05579249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55734298|NCT05579249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734299|NCT05579249|Sensory System Agents|sensory system agents|mesh-ancestor
55734300|NCT05579249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734301|NCT05579249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55734303|NCT05579249|Hormones|hormones|mesh-ancestor
55734304|NCT05579249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55734305|NCT05579249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55734306|NCT05579249|Antidepressive Agents|antidepressive agents|mesh-ancestor
55734307|NCT05579249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55734308|NCT05579249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55734309|NCT05579249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55734310|NCT05579249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55734311|NCT05579249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734312|NCT05579249|Dopamine Agents|dopamine agents|mesh-ancestor
55734313|NCT05579249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734314|NCT05579249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55734315|NCT05579249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55734316|NCT05579249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734317|NCT05579249|Anticonvulsants|anticonvulsants|mesh-ancestor
55734318|NCT05579249|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55734319|NCT05579249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55734320|NCT05579249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55734321|NCT05579249|Appetite Depressants|appetite depressants|mesh-ancestor
55734322|NCT05579249|Sympathomimetics|sympathomimetics|mesh-ancestor
55734323|NCT05579249|Autonomic Agents|autonomic agents|mesh-ancestor
55734324|NCT05579249|Adrenergic Agents|adrenergic agents|mesh-ancestor
55734325|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55734326|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
55734327|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55734328|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734329|NCT01998529|Cisplatin|cisplatin|mesh-list
55734330|NCT01998529|Amifostine|amifostine|mesh-list
55734331|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734332|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55734333|NCT01998529|Protective Agents|protective agents|mesh-ancestor
55734334|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734336|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
55734337|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734338|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
55734339|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55734340|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
55734341|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734342|NCT03448549|Capecitabine|capecitabine|mesh-list
55734343|NCT03448549|Tegafur|tegafur|mesh-list
55734344|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
55734345|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55734346|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
55734347|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734348|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734349|NCT03679091|Clopidogrel|clopidogrel|mesh-list
55734350|NCT03679091|Ticagrelor|ticagrelor|mesh-list
55734351|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55734352|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55734353|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55734354|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55734355|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
55734356|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734357|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734358|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829938|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55829939|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734359|NCT01628926|Ropinirole|ropinirole|mesh-list
55734360|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55734361|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55734362|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
55734363|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
55734364|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734365|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734366|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734367|NCT05313659|Ketamine|ketamine|mesh-list
55734368|NCT05313659|Analgesics|analgesics|mesh-ancestor
55734369|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
55734370|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734371|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734372|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55734373|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55734374|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
55734376|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734377|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55734378|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55734379|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734380|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734381|NCT04609579|Pembrolizumab|pembrolizumab|mesh-list
55734382|NCT04609579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55734383|NCT04609579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734384|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
55734385|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
55734386|NCT03436199|Amantadine|amantadine|mesh-list
55829973|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829974|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55829975|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55829976|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829977|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
55829978|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829979|NCT01502644|Morphine|morphine|mesh-list
55829980|NCT01502644|Oxycodone|oxycodone|mesh-list
55829981|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55829982|NCT01502644|Narcotics|narcotics|mesh-ancestor
55734388|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55734389|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
55734390|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734391|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
55734392|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734393|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734394|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734395|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55734396|NCT03436199|Analgesics|analgesics|mesh-ancestor
55734397|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
55734398|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734399|NCT02131324|Clobetasol|clobetasol|mesh-list
55734400|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734401|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
55734402|NCT02131324|Hormones|hormones|mesh-ancestor
55734403|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55734404|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734405|NCT04749394|Apatinib|apatinib|mesh-list
55734406|NCT04749394|Antibodies|antibodies|mesh-list
55734407|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
55734408|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55734409|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
55734410|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734411|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734412|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55734413|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734414|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734415|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
55734416|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55734417|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
55734418|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734419|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55734420|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55734421|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
55734422|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734423|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734424|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55734425|NCT03846427|Zanubrutinib|zanubrutinib|mesh-list
55734426|NCT03846427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734427|NCT03846427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55734428|NCT03846427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734429|NCT03846427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734430|NCT05159219|Colchicine|colchicine|mesh-list
55734431|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
55830000|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830001|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55830002|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55734432|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55734433|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
55734434|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
55734435|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
55734436|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734437|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734438|NCT05321329|Capecitabine|capecitabine|mesh-list
55830003|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55830004|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55830005|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
55734439|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55734440|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
55734441|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734442|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734443|NCT02521831|Bupivacaine|bupivacaine|mesh-list
55734444|NCT02521831|Anesthetics|anesthetics|mesh-list
55734445|NCT02521831|Isoflurane|isoflurane|mesh-list
55734446|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
55734528|NCT04923659|Nimodipine|nimodipine|mesh-list
55734447|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734448|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734450|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734451|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55734453|NCT01425541|Progesterone|progesterone|mesh-list
55734454|NCT01425541|Estradiol|estradiol|mesh-list
55734455|NCT01425541|Estrogens|estrogens|mesh-list
55734456|NCT01425541|Progestins|progestins|mesh-ancestor
55734457|NCT01425541|Hormones|hormones|mesh-ancestor
55734458|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55734459|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734460|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
55734461|NCT03447925|Salicylates|salicylates|mesh-list
55734462|NCT03447925|Petrolatum|petrolatum|mesh-list
55734463|NCT03447925|Emollients|emollients|mesh-ancestor
55734464|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
55830007|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
55734465|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55734466|NCT03447925|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55734467|NCT03447925|Analgesics|analgesics|mesh-ancestor
55734468|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
55734469|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734470|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734471|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734472|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55734473|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55734474|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734475|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734476|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734477|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
55734478|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
55734479|NCT04928183|Nitroprusside|nitroprusside|mesh-list
55734480|NCT04928183|Phenylephrine|phenylephrine|mesh-list
55734481|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
55734482|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
55734483|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55734484|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
55734485|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
55734486|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734487|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734488|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
55734489|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55830009|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734490|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
55734491|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
55734492|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55734493|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55734494|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55734495|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
55734496|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734497|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734499|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
55734500|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
55734501|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55734502|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
55734503|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55734504|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
55734505|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55734506|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55734507|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734508|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
55734509|NCT04311073|Coagulants|coagulants|mesh-ancestor
55734510|NCT03447691|Remifentanil|remifentanil|mesh-list
55734511|NCT03447691|Anesthetics|anesthetics|mesh-list
55734513|NCT03447691|Desflurane|desflurane|mesh-list
55734514|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734515|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734516|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55734517|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55734518|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
55734519|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55734520|NCT03447691|Narcotics|narcotics|mesh-ancestor
55734521|NCT03447691|Analgesics|analgesics|mesh-ancestor
55734522|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
55734523|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734524|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55734526|NCT04602533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55734527|NCT04602533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734533|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
55734534|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55734535|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55734536|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734537|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734538|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734539|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
55734540|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
55734541|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
55734542|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734543|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55734544|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55734545|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734546|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55734547|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55734548|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55734549|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
55734550|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
55734551|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
55734552|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55734553|NCT04923659|Analgesics|analgesics|mesh-ancestor
55734554|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
55734555|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55734556|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55734557|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55734558|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55734559|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55734560|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55734561|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55734562|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
55734564|NCT05398679|Moxifloxacin|moxifloxacin|mesh-list
55734565|NCT05398679|Ciprofloxacin|ciprofloxacin|mesh-list
55734566|NCT05398679|Levofloxacin|levofloxacin|mesh-list
55734567|NCT05398679|Ofloxacin|ofloxacin|mesh-list
55734568|NCT05398679|Clindamycin|clindamycin|mesh-list
55734569|NCT05398679|Clindamycin palmitate|clindamycin palmitate|mesh-list
55734570|NCT05398679|Clindamycin phosphate|clindamycin phosphate|mesh-list
55734571|NCT05398679|Rifampin|rifampin|mesh-list
55734572|NCT05398679|Linezolid|linezolid|mesh-list
55734573|NCT05398679|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55734574|NCT05398679|Tedizolid|tedizolid|mesh-list
55734575|NCT05398679|Fusidic Acid|fusidic acid|mesh-list
55734576|NCT05398679|Dicloxacillin|dicloxacillin|mesh-list
55734577|NCT05398679|Cefaclor|cefaclor|mesh-list
55734578|NCT05398679|Trimethoprim|trimethoprim|mesh-list
55734579|NCT05398679|Sulfamethoxazole|sulfamethoxazole|mesh-list
55734580|NCT05398679|Oxazolidinones|oxazolidinones|mesh-list
55734581|NCT05398679|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
55734582|NCT05398679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55734583|NCT05398679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734584|NCT05398679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55734585|NCT05398679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55734587|NCT05398679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734588|NCT05398679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734589|NCT05398679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55734590|NCT05398679|Contraceptive Agents|contraceptive agents|mesh-ancestor
55734591|NCT05398679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55734592|NCT05398679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734593|NCT05398679|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55734594|NCT05398679|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55734595|NCT05398679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55734596|NCT05398679|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55734597|NCT05398679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55734598|NCT05398679|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55734599|NCT05398679|Renal Agents|renal agents|mesh-ancestor
55734600|NCT05398679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55734601|NCT05398679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55734602|NCT05398679|Antitubercular Agents|antitubercular agents|mesh-ancestor
55734603|NCT05398679|Leprostatic Agents|leprostatic agents|mesh-ancestor
55734604|NCT05398679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55734605|NCT05398679|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55734606|NCT05398679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55734607|NCT05398679|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55734608|NCT05398679|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55734609|NCT05398679|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55734610|NCT05398679|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55734611|NCT05398679|Antimalarials|antimalarials|mesh-ancestor
55734612|NCT05398679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55734613|NCT05398679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55734614|NCT05398679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55734615|NCT05398679|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55734616|NCT05398679|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55734617|NCT04818749|Dexamethasone|dexamethasone|mesh-list
55734618|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
55734619|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
55734621|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734622|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
55734623|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
55734624|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734625|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734626|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55734627|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
55734628|NCT04818749|Hormones|hormones|mesh-ancestor
55734629|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55734630|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55734631|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734632|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
55734633|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734634|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734635|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55734636|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734637|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55734638|NCT04818749|Analgesics|analgesics|mesh-ancestor
55734639|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
55734640|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55734641|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55734642|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55734643|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
55734644|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734645|NCT04817501|Edetic Acid|edetic acid|mesh-list
55734646|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
55734647|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55734648|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
55734649|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
55734650|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734651|NCT05398367|Galactogogues|galactogogues|mesh-list
55734652|NCT05398367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734653|NCT05398055|Azithromycin|azithromycin|mesh-list
55734654|NCT05398055|Doxycycline|doxycycline|mesh-list
55734655|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55734656|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734658|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55734659|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55734660|NCT04421339|Melatonin|melatonin|mesh-list
55734661|NCT04421339|Antioxidants|antioxidants|mesh-ancestor
55769085|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734662|NCT04421339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734663|NCT04421339|Protective Agents|protective agents|mesh-ancestor
55734664|NCT04421339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734665|NCT04421339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734666|NCT04301843|Eflornithine|eflornithine|mesh-list
55734667|NCT04301843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734668|NCT04301843|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55734669|NCT04301843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55734670|NCT04301843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55734671|NCT04301843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734672|NCT04301843|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
55734673|NCT04301843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734674|NCT04301843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734675|NCT01378325|Phenylephrine|phenylephrine|mesh-list
55734676|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
55734678|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
55734679|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
55734680|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734681|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734682|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
55734683|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55734684|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
55734685|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
55734686|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55734687|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55734690|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734691|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734692|NCT01378325|Protective Agents|protective agents|mesh-ancestor
55734693|NCT03854903|Fulvestrant|fulvestrant|mesh-list
55734694|NCT03854903|Palbociclib|palbociclib|mesh-list
55734695|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55734696|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734697|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55734698|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55734699|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
55734700|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55734701|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734702|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55734703|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734704|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734705|NCT01093573|Azacitidine|azacitidine|mesh-list
55734706|NCT01093573|Midostaurin|midostaurin|mesh-list
55734707|NCT01093573|Staurosporine|staurosporine|mesh-list
55734708|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55734709|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
55734710|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734711|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734712|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734713|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55734714|NCT03367741|Nivolumab|nivolumab|mesh-list
55734715|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55734716|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734717|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55734718|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734719|NCT03402503|Montelukast|montelukast|mesh-list
55734720|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55734721|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
55734722|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55734723|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
55734724|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55734725|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55769091|NCT03290079|Lenvatinib|lenvatinib|mesh-list
55734726|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55734727|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55734728|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734729|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
55734730|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
55734731|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734732|NCT05174845|Protective Agents|protective agents|mesh-ancestor
55734733|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734734|NCT05174845|Vitamins|vitamins|mesh-ancestor
55734735|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
55734736|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
55734737|NCT04155203|Mupirocin|mupirocin|mesh-list
55734738|NCT04155203|Calcium|calcium|mesh-list
55734739|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55734740|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734741|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55734742|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55734743|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734744|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55734745|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734746|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734747|NCT04238143|Complement Factor H|complement factor h|mesh-list
55734748|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55734749|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55734750|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
55734751|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734753|NCT04073615|Apatinib|apatinib|mesh-list
55734754|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734755|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55734756|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734757|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734758|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
55734759|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
55734760|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734761|NCT03344965|Olaparib|olaparib|mesh-list
55734762|NCT03344965|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55734764|NCT03344965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734765|NCT03344965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734766|NCT05303311|Dexamethasone|dexamethasone|mesh-list
55734768|NCT05303311|Bupivacaine|bupivacaine|mesh-list
55734769|NCT05303311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734770|NCT05303311|Antiemetics|antiemetics|mesh-ancestor
55734771|NCT05303311|Autonomic Agents|autonomic agents|mesh-ancestor
55734772|NCT05303311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734773|NCT05303311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734774|NCT05303311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55734775|NCT05303311|Glucocorticoids|glucocorticoids|mesh-ancestor
55734776|NCT05303311|Hormones|hormones|mesh-ancestor
55734777|NCT05303311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830261|NCT02144012|Maytansine|maytansine|mesh-list
55734778|NCT05303311|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55734779|NCT05303311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734780|NCT05303311|Anesthetics, Local|anesthetics, local|mesh-ancestor
55734781|NCT05303311|Anesthetics|anesthetics|mesh-ancestor
55734782|NCT05303311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734783|NCT05303311|Sensory System Agents|sensory system agents|mesh-ancestor
55734784|NCT05303311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55734785|NCT05303311|Narcotics|narcotics|mesh-ancestor
55734786|NCT05303311|Analgesics|analgesics|mesh-ancestor
55734787|NCT05303311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55734788|NCT03728881|Vaccines|vaccines|mesh-list
55734789|NCT03728881|Immunologic Factors|immunologic factors|mesh-ancestor
55734790|NCT03728881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734791|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
55734792|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55734793|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734794|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
55734795|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55734796|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734797|NCT02974621|Bevacizumab|bevacizumab|mesh-list
55734798|NCT02974621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55734799|NCT02974621|Olaparib|olaparib|mesh-list
55734800|NCT02974621|Cediranib|cediranib|mesh-list
55734801|NCT02974621|Endothelial Growth Factors|endothelial growth factors|mesh-list
55734802|NCT02974621|Antibodies|antibodies|mesh-list
55734803|NCT02974621|Immunoglobulins|immunoglobulins|mesh-list
55734804|NCT02974621|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55734805|NCT02974621|Immunoglobulin G|immunoglobulin g|mesh-list
55734806|NCT02974621|Maleic acid|maleic acid|mesh-list
55734807|NCT02974621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734808|NCT02974621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55734809|NCT02974621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55734810|NCT02974621|Growth Substances|growth substances|mesh-ancestor
55734811|NCT02974621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734812|NCT02974621|Growth Inhibitors|growth inhibitors|mesh-ancestor
55734813|NCT02974621|Immunologic Factors|immunologic factors|mesh-ancestor
55734814|NCT02974621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734815|NCT02974621|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55734816|NCT02974621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734817|NCT02974621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55734818|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
55734819|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
55734820|NCT03446599|Methylene Blue|methylene blue|mesh-list
55734821|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734822|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734823|NCT03446599|Hematinics|hematinics|mesh-ancestor
55734824|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
55734826|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
55734827|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734828|NCT05202145|Cyclosporine|cyclosporine|mesh-list
55734829|NCT05202145|Tacrolimus|tacrolimus|mesh-list
55734830|NCT05202145|Cyclosporins|cyclosporins|mesh-list
55734831|NCT05202145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55734832|NCT05202145|Immunologic Factors|immunologic factors|mesh-ancestor
55734833|NCT05202145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734834|NCT05202145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55734835|NCT05202145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734836|NCT05202145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734837|NCT05202145|Antifungal Agents|antifungal agents|mesh-ancestor
55734838|NCT05202145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734839|NCT05202145|Dermatologic Agents|dermatologic agents|mesh-ancestor
55734840|NCT05202145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55734841|NCT02856451|Nivolumab|nivolumab|mesh-list
55734842|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55734843|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734844|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55734845|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734846|NCT03446443|Metronidazole|metronidazole|mesh-list
55734847|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734848|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55734849|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55734850|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55734851|NCT02087423|Durvalumab|durvalumab|mesh-list
55734852|NCT02087423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55734853|NCT02087423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734854|NCT05102071|Metformin|metformin|mesh-list
55734855|NCT05102071|Empagliflozin|empagliflozin|mesh-list
55734856|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55734857|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734858|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55734859|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734860|NCT01351103|Spartalizumab|spartalizumab|mesh-list
55734861|NCT01351103|LGK974|lgk974|mesh-list
55734862|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55734872|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734873|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734874|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734875|NCT05006599|Insulin|insulin|mesh-list
55734876|NCT05006599|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55734877|NCT05006599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55734878|NCT05006599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734879|NCT04742777|Sirolimus|sirolimus|mesh-list
55734880|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55734881|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734882|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55734883|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734884|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
55734885|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55734886|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
55734887|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734888|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
55734889|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55734891|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
55734892|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55734893|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
55734894|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734895|NCT03445897|Miltefosine|miltefosine|mesh-list
55734896|NCT03445897|Pentamidine|pentamidine|mesh-list
55734897|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
55734898|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734899|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734900|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55734901|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55734902|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55734911|NCT03237611|Dexamethasone|dexamethasone|mesh-list
55734912|NCT03237611|Ondansetron|ondansetron|mesh-list
55734913|NCT03237611|Aprepitant|aprepitant|mesh-list
55734914|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
55830609|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55734915|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734916|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
55734917|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
55734918|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734919|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734920|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55734921|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
55734922|NCT03237611|Hormones|hormones|mesh-ancestor
55734923|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55734924|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55734925|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734926|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
55734927|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
55734928|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55734929|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
55734930|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55734931|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734932|NCT03237611|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55734933|NCT03237611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55830705|NCT03631043|Lenalidomide|lenalidomide|mesh-list
55734934|NCT03237611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734935|NCT03237611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55734937|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55734938|NCT03234491|Insulin|insulin|mesh-list
55734939|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55734940|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55734941|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734942|NCT01961063|Busulfan|busulfan|mesh-list
55734943|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
55734944|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734945|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55734946|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
55734947|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734948|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55734949|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734950|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55734951|NCT02951377|Dexamethasone|dexamethasone|mesh-list
55734952|NCT02951377|Lidocaine|lidocaine|mesh-list
55769166|NCT05431725|Vaccines|vaccines|mesh-list
55734953|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734954|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
55734955|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
55734956|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55734957|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734958|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55734959|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
55734961|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55734962|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55734963|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734964|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
55734965|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
55734966|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55734967|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
55734968|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55734969|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55734970|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55734971|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55734972|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734973|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
55734974|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55734975|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734976|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
55734977|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55734978|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734979|NCT03042143|Plasma-lyte 148|plasma-lyte 148|mesh-list
55734980|NCT03042143|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55734981|NCT03042143|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55734982|NCT03442621|Cortisone|cortisone|mesh-list
55734983|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55734984|NCT03444649|Cytarabine|cytarabine|mesh-list
55734985|NCT03444649|Daunorubicin|daunorubicin|mesh-list
55734986|NCT03444649|Idarubicin|idarubicin|mesh-list
55734987|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55734988|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
55734989|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55734990|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55734991|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
55734992|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55734993|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55734994|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
55734995|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55734996|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55734997|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55734998|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55734999|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735000|NCT02811523|Doxorubicin|doxorubicin|mesh-list
55735001|NCT02811523|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55735002|NCT02811523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735003|NCT02811523|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55735004|NCT02811523|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55735005|NCT02811523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735006|NCT02811523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735007|NCT02743741|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55735008|NCT02743741|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55735009|NCT02743741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735010|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55735011|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735012|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55735013|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735014|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735015|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
55735016|NCT03466775|Giapreza|giapreza|mesh-list
55735017|NCT03466775|Antibodies|antibodies|mesh-list
55735018|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
55735019|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
55735020|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735021|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55735022|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55735023|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
55735024|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735025|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735026|NCT02611817|Vedolizumab|vedolizumab|mesh-list
55735027|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55735028|NCT05430893|Botulinum Toxins|botulinum toxins|mesh-list
55735029|NCT05430893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55735030|NCT05430893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55735031|NCT05430893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55735032|NCT05430893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55735033|NCT05430893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735034|NCT05430893|Cholinergic Agents|cholinergic agents|mesh-ancestor
55735035|NCT05430893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735036|NCT05430893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735037|NCT05430893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55735038|NCT05430893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735039|NCT05391971|Bupivacaine|bupivacaine|mesh-list
55735040|NCT05391971|Anesthetics, Local|anesthetics, local|mesh-ancestor
55735041|NCT05391971|Anesthetics|anesthetics|mesh-ancestor
55735042|NCT05391971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735043|NCT05391971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735044|NCT05391971|Sensory System Agents|sensory system agents|mesh-ancestor
55735045|NCT05391971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735046|NCT02557139|Belumosudil|belumosudil|mesh-list
55735047|NCT02557139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55735048|NCT02557139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735049|NCT02557139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830947|NCT04775381|Vitamin D|vitamin d|mesh-list
55735050|NCT02546921|Immunoglobulin E|immunoglobulin e|mesh-list
55735051|NCT02546921|Immunologic Factors|immunologic factors|mesh-ancestor
55735052|NCT02546921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735054|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735055|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55735056|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735057|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735059|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
55735060|NCT02457221|Tacrolimus|tacrolimus|mesh-list
55735061|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55735062|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
55735063|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735065|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55735066|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
55735067|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735068|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735069|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55735070|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55735071|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
55735072|NCT02457221|Hormones|hormones|mesh-ancestor
55735073|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55735074|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55735075|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55735076|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735077|NCT05263895|Ritonavir|ritonavir|mesh-list
55735078|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55735079|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55735080|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
55735081|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735082|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735083|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55735084|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55735085|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
55735086|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735087|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55735088|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55735090|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
55735091|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55735092|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
55735093|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
55735094|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
55735095|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735096|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735098|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
55735099|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735100|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
55735101|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735102|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55735103|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735104|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735105|NCT03170817|Regadenoson|regadenoson|mesh-list
55735106|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55735107|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55735108|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
55735109|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
55735110|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735111|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735112|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735113|NCT05101005|Sirolimus|sirolimus|mesh-list
55735114|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55735115|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735116|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55735117|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735118|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
55735119|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55735120|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
55735121|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735122|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55735123|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55735124|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735125|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
55735126|NCT05015387|Procyanidin|procyanidin|mesh-list
55735127|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
55735128|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735129|NCT05015387|Protective Agents|protective agents|mesh-ancestor
55735130|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735131|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55735132|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55735133|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735135|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55735136|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
55735137|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55735138|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735139|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55735140|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735141|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55735142|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55735143|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55735144|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55735145|NCT03464435|Tobramycin|tobramycin|mesh-list
55735146|NCT03464435|Tacrolimus|tacrolimus|mesh-list
55735147|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55735148|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
55735149|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735150|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55735151|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735152|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735153|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55735154|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735155|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55735156|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55735157|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735159|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55735160|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
55735161|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735162|NCT03463967|Protective Agents|protective agents|mesh-ancestor
55735163|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735164|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55735165|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55735166|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735168|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
55735169|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55831306|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55735170|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
55735171|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735172|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735173|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
55735174|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735175|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55735177|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
55735178|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735179|NCT03468023|Calpastatin|calpastatin|mesh-list
55735180|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55735181|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
55735182|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735183|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735184|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
55735185|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55735186|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735187|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
55735188|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
55735189|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735190|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735191|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735193|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
55735194|NCT02659059|Paclitaxel|paclitaxel|mesh-list
55735195|NCT02659059|Cisplatin|cisplatin|mesh-list
55735196|NCT02659059|Carboplatin|carboplatin|mesh-list
55735197|NCT02659059|Nivolumab|nivolumab|mesh-list
55735198|NCT02659059|Pemetrexed|pemetrexed|mesh-list
55735199|NCT02659059|Ipilimumab|ipilimumab|mesh-list
55735200|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55735201|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735202|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
55735203|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
55735204|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
55735205|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735206|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55735207|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55735208|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735209|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55735210|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55735211|NCT05100303|Cytarabine|cytarabine|mesh-list
55735212|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
55735213|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55735214|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
55735215|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735216|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735217|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
55831407|NCT01458106|Factor VIII|factor viii|mesh-list
55735218|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735219|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55735220|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
55735221|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735222|NCT05100303|Analgesics|analgesics|mesh-ancestor
55735223|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
55735224|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735225|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55735226|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55735227|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735228|NCT03462173|Yimitasvir|yimitasvir|mesh-list
55735229|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
55735230|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735231|NCT05096715|Bevacizumab|bevacizumab|mesh-list
55735233|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55735234|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735235|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55735236|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55735237|NCT05096715|Growth Substances|growth substances|mesh-ancestor
55735238|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735239|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
55735240|NCT04984889|Protein C|protein c|mesh-list
55735241|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
55735243|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55735244|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735245|NCT04966481|Cetuximab|cetuximab|mesh-list
55735246|NCT04966481|Palbociclib|palbociclib|mesh-list
55735247|NCT04966481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55735248|NCT04966481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735249|NCT04966481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55735250|NCT04966481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735251|NCT04966481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735252|NCT05099601|Silymarin|silymarin|mesh-list
55735253|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
55735254|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735255|NCT05099601|Protective Agents|protective agents|mesh-ancestor
55735256|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735257|NCT03736629|Azithromycin|azithromycin|mesh-list
55831443|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735258|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55735259|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735260|NCT03461783|Charcoal|charcoal|mesh-list
55735261|NCT03461783|Antidotes|antidotes|mesh-ancestor
55735262|NCT03461783|Protective Agents|protective agents|mesh-ancestor
55735263|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735264|NCT01677507|Timolol|timolol|mesh-list
55735265|NCT01677507|Latanoprost|latanoprost|mesh-list
55735266|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55735267|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55735268|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
55735269|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735270|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735271|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735272|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55735273|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55735274|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55735275|NCT01677507|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55735276|NCT04796363|Anesthetics|anesthetics|mesh-list
55735277|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735278|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735279|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55735280|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55735281|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
55735282|NCT03522753|Hormones|hormones|mesh-ancestor
55735283|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55735284|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735285|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735286|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735287|NCT05103813|Beraprost|beraprost|mesh-list
55735288|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55735289|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
55735290|NCT03461627|Fluticasone|fluticasone|mesh-list
55735291|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55735292|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55735293|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55735294|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55735295|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
55735296|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735297|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735298|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55735299|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
55735300|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
55735301|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55769282|NCT03190941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55735302|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55735303|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55735304|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55735305|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
55735306|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735307|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735308|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
55735309|NCT03461627|Hormones|hormones|mesh-ancestor
55735310|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55735311|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
55735312|NCT03435939|Losartan|losartan|mesh-list
55735313|NCT03435939|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55735314|NCT03435939|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55735315|NCT03435939|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55735316|NCT03435939|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55735317|NCT03435939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735318|NCT04452929|Calcitonin|calcitonin|mesh-list
55735319|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
55735320|NCT04452929|Cilostazol|cilostazol|mesh-list
55735321|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55735323|NCT04452929|Katacalcin|katacalcin|mesh-list
55735324|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55735325|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
55735326|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735327|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735328|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55735329|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
55735330|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55735331|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55735332|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735333|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55735335|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55735336|NCT04452929|Protective Agents|protective agents|mesh-ancestor
55735337|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55735338|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55735339|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735340|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55735341|NCT04452929|Analgesics|analgesics|mesh-ancestor
55735342|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
55735343|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55735344|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55735346|NCT05103501|Fluorouracil|fluorouracil|mesh-list
55735348|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55735349|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55735350|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735351|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
55735352|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735353|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55735354|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55735355|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
55735356|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735357|NCT02522117|Atorvastatin|atorvastatin|mesh-list
55735358|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55735359|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55735360|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
55735361|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735362|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55735363|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55735364|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735365|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
55735366|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55735367|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55735368|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735369|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
55735370|NCT05087199|Coagulants|coagulants|mesh-ancestor
55735371|NCT04628429|Erenumab|erenumab|mesh-list
55735372|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55735373|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735374|NCT04628429|Analgesics|analgesics|mesh-ancestor
55735375|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
55735376|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735377|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735378|NCT03461081|Amlodipine|amlodipine|mesh-list
55735379|NCT03461081|Telmisartan|telmisartan|mesh-list
55735380|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
55735381|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
55735382|NCT03461081|Atorvastatin|atorvastatin|mesh-list
55735383|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55735384|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55735385|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
55735386|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735387|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55735388|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55735389|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735390|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55735391|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55735392|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55735393|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55735394|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735395|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
55735396|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55735397|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55735398|NCT04557527|Hyaluronic Acid|hyaluronic acid|mesh-list
55735399|NCT04557527|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55735400|NCT04557527|Immunologic Factors|immunologic factors|mesh-ancestor
55735401|NCT04557527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735402|NCT04557527|Viscosupplements|viscosupplements|mesh-ancestor
55735403|NCT04557527|Protective Agents|protective agents|mesh-ancestor
55735404|NCT02522039|Timolol|timolol|mesh-list
55735405|NCT02522039|Dorzolamide|dorzolamide|mesh-list
55735406|NCT02522039|Latanoprost|latanoprost|mesh-list
55735407|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55735408|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55735409|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
55735410|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735411|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735412|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735413|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55735414|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55735415|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55735416|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55735417|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55735418|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735419|NCT04669197|Gemcitabine|gemcitabine|mesh-list
55735420|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
55735421|NCT04669197|Paclitaxel|paclitaxel|mesh-list
55735422|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55735423|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55735424|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735425|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
55735426|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
55735427|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
55735428|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735429|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55735430|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
55735431|NCT04669197|Antiviral Agents|antiviral agents|mesh-ancestor
55735432|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735433|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735434|NCT04669197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55735435|NCT04669197|Immunologic Factors|immunologic factors|mesh-ancestor
55735436|NCT04669197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735437|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
55735438|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55735439|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55735440|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55735441|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55735442|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55735443|NCT04430699|Cisplatin|cisplatin|mesh-list
55735444|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
55735445|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735446|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55735447|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55735448|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
55735449|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735450|NCT04358003|Coal Tar|coal tar|mesh-list
55735451|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
55735452|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
55735453|NCT04519905|Paclitaxel|paclitaxel|mesh-list
55735454|NCT04519905|Carboplatin|carboplatin|mesh-list
55735455|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55735456|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735457|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
55735458|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
55735459|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
55735460|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735461|NCT04423341|Cannabidiol|cannabidiol|mesh-list
55735462|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
55735463|NCT03378479|Posaconazole|posaconazole|mesh-list
55735464|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
55735465|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735466|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55735467|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55735469|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55735470|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55735471|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735472|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735473|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55735474|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
55735475|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55735476|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735477|NCT03460145|Propofol|propofol|mesh-list
55735478|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55735479|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735480|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735481|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55735482|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
55735483|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
55735484|NCT04125771|Diclofenac|diclofenac|mesh-list
55735485|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55735487|NCT04125771|Analgesics|analgesics|mesh-ancestor
55735488|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
55735489|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735490|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735491|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55735492|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55735493|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55735494|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735495|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735496|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55735497|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55735498|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55735499|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55735500|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735501|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735502|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735503|NCT05115123|Analgesics|analgesics|mesh-ancestor
55735504|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
55735505|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735506|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
55735515|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
55735516|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55735517|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55735518|NCT04636671|Prednisolone|prednisolone|mesh-list
55735519|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
55735520|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55735521|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
55735522|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55735523|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
55735524|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
55735525|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735526|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735527|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55735528|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
55735529|NCT04636671|Hormones|hormones|mesh-ancestor
55735530|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55769321|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
55735531|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55735532|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735533|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55735534|NCT04636671|Protective Agents|protective agents|mesh-ancestor
55735535|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55735536|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55735537|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735538|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55735539|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735540|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735542|NCT03126539|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55735543|NCT03126539|Protective Agents|protective agents|mesh-ancestor
55735544|NCT03126539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735545|NCT03126539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735547|NCT02935205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55735548|NCT02935205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55735549|NCT02935205|Analgesics|analgesics|mesh-ancestor
55735550|NCT02935205|Sensory System Agents|sensory system agents|mesh-ancestor
55735551|NCT02935205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735552|NCT02935205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735553|NCT02935205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55735554|NCT02935205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55735555|NCT02935205|Gout Suppressants|gout suppressants|mesh-ancestor
55735556|NCT02935205|Tocolytic Agents|tocolytic agents|mesh-ancestor
55735557|NCT02935205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55735558|NCT02935205|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55735559|NCT02935205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735560|NCT02935205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735561|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
55735562|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55735563|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735564|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735565|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55735567|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
55735568|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735569|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55831976|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
55735570|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55735571|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55735572|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
55735573|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735574|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735576|NCT04019873|Rilpivirine|rilpivirine|mesh-list
55735577|NCT04019873|Dolutegravir|dolutegravir|mesh-list
55735578|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55735579|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55735580|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735581|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735582|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
55735583|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735584|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55735585|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55735586|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55735587|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55735588|NCT04771689|Buprenorphine|buprenorphine|mesh-list
55832062|NCT02100475|Liraglutide|liraglutide|mesh-list
55735589|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55735591|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55735592|NCT04771689|Narcotics|narcotics|mesh-ancestor
55735593|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735594|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735595|NCT04771689|Analgesics|analgesics|mesh-ancestor
55735596|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
55735597|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735598|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55735599|NCT04674345|Sorafenib|sorafenib|mesh-list
55735600|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735601|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55735602|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735603|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735604|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
55735605|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
55735606|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735607|NCT04165239|Protective Agents|protective agents|mesh-ancestor
55735608|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735609|NCT03756311|Paclitaxel|paclitaxel|mesh-list
55735610|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55735611|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55735612|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735613|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
55735614|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
55735615|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
55735616|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735617|NCT04576767|Anesthetics|anesthetics|mesh-list
55735618|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735619|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735620|NCT03248531|Adalimumab|adalimumab|mesh-list
55769378|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735621|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55735622|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55735623|NCT03866525|Irinotecan|irinotecan|mesh-list
55735624|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55735625|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55735627|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735628|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735629|NCT03129347|Nalmefene|nalmefene|mesh-list
55735630|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55832242|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55832243|NCT02097823|Olanzapine|olanzapine|mesh-list
55735631|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735632|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
55735633|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735634|NCT02262923|Metoclopramide|metoclopramide|mesh-list
55735635|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
55735636|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
55735637|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735638|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735639|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55735640|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55735641|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55735642|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
55735643|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735644|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735645|NCT02194595|Insulin|insulin|mesh-list
55735646|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55735647|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
55735648|NCT02194595|Exenatide|exenatide|mesh-list
55735649|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
55735650|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55735651|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735652|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55735653|NCT02194595|Incretins|incretins|mesh-ancestor
55735654|NCT02194595|Hormones|hormones|mesh-ancestor
55832356|NCT02162771|Prednisone|prednisone|mesh-list
55791781|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55735655|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55735656|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
55735657|NCT02656329|Lugol's solution|lugol's solution|mesh-list
55735658|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735659|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735660|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735661|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55735662|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
55735663|NCT02656329|Coagulants|coagulants|mesh-ancestor
55735664|NCT02712905|Nivolumab|nivolumab|mesh-list
55735665|NCT02712905|Azacitidine|azacitidine|mesh-list
55735666|NCT02712905|Tretinoin|tretinoin|mesh-list
55735667|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55735668|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735669|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55735670|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735671|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55735672|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
55735673|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735674|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
55735675|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
55735676|NCT01166633|Atorvastatin|atorvastatin|mesh-list
55735677|NCT01166633|Pitavastatin|pitavastatin|mesh-list
55735678|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55735679|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55735680|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
55735681|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735682|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55735683|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55735684|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735685|NCT04315311|Pancrelipase|pancrelipase|mesh-list
55735686|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55832600|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55735687|NCT03596073|Calcipotriene|calcipotriene|mesh-list
55735688|NCT03596073|Petrolatum|petrolatum|mesh-list
55735689|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
55735690|NCT03596073|Emollients|emollients|mesh-ancestor
55735691|NCT05320757|Olaparib|olaparib|mesh-list
55735692|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55735693|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735694|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735695|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735696|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
55735697|NCT03449693|Antacids|antacids|mesh-ancestor
55735785|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
55735698|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735699|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55735700|NCT03449537|Caseins|caseins|mesh-list
55735701|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
55735702|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
55769423|NCT03162185|Antidepressive Agents|antidepressive agents|mesh-ancestor
55735703|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735704|NCT03730649|Sulforaphane|sulforaphane|mesh-list
55735705|NCT03730649|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55735706|NCT03730649|Protective Agents|protective agents|mesh-ancestor
55735707|NCT03730649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735708|NCT03730649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735709|NCT02237183|Iloprost|iloprost|mesh-list
55735710|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55735711|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
55735712|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
55735723|NCT03179943|Atezolizumab|atezolizumab|mesh-list
55735724|NCT03179943|Guadecitabine|guadecitabine|mesh-list
55735725|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735726|NCT04528173|Ketorolac|ketorolac|mesh-list
55735727|NCT04528173|Fentanyl|fentanyl|mesh-list
55735728|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
55735729|NCT04528173|Morphine|morphine|mesh-list
55735730|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55735731|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735732|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735733|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55735734|NCT04528173|Analgesics|analgesics|mesh-ancestor
55735735|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
55735736|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735737|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55735738|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55735739|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55735741|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735742|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735743|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55735744|NCT04528173|Narcotics|narcotics|mesh-ancestor
55735745|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55735746|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55735747|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
55735748|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
55735749|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55735750|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832770|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55735751|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55735752|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55735753|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735755|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55735756|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735757|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735758|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
55735759|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735760|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735761|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
55735762|NCT02181413|Ixazomib|ixazomib|mesh-list
55735763|NCT02181413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735764|NCT02181413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735765|NCT02181413|Protease Inhibitors|protease inhibitors|mesh-ancestor
55735766|NCT02181413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735767|NCT05109585|Antibodies|antibodies|mesh-list
55735768|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
55735769|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
55735770|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
55735771|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735772|NCT02142803|Bevacizumab|bevacizumab|mesh-list
55735773|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55735774|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
55735775|NCT02142803|Antibodies|antibodies|mesh-list
55735776|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
55735777|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55735778|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
55735779|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735780|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55735781|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55735782|NCT02142803|Growth Substances|growth substances|mesh-ancestor
55735783|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735784|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
55735790|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735791|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55735792|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55735793|NCT05283161|Analgesics|analgesics|mesh-ancestor
55735794|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
55735795|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735796|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55735797|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55735798|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735799|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735801|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55735803|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55735804|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735805|NCT03448835|Docetaxel|docetaxel|mesh-list
55735806|NCT03448835|Capecitabine|capecitabine|mesh-list
55735807|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
55735808|NCT03448835|Atezolizumab|atezolizumab|mesh-list
55735809|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735810|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
55735811|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
55735812|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
55735813|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735814|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55735815|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
55735816|NCT03690453|Ivermectin|ivermectin|mesh-list
55735817|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55735818|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735819|NCT04527393|Morphine|morphine|mesh-list
55735820|NCT04527393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55735821|NCT04527393|Narcotics|narcotics|mesh-ancestor
55735822|NCT04527393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735823|NCT04527393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735824|NCT04527393|Analgesics|analgesics|mesh-ancestor
55735825|NCT04527393|Sensory System Agents|sensory system agents|mesh-ancestor
55735826|NCT04527393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735827|NCT05211635|Vitamin D|vitamin d|mesh-list
55735828|NCT05211635|Vitamins|vitamins|mesh-ancestor
55735829|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
55735830|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735831|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55735832|NCT05184335|RP5063|rp5063|mesh-list
55735833|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55735834|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55735835|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735836|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735837|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55735838|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
55735839|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735840|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735841|NCT04756791|Anesthetics|anesthetics|mesh-list
55735842|NCT04756791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735843|NCT04756791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735844|NCT03443609|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55735845|NCT03443609|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55735846|NCT03443609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735847|NCT01709123|Chromium|chromium|mesh-list
55735848|NCT01709123|Trace Elements|trace elements|mesh-ancestor
55735849|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
55735850|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735851|NCT01301807|Panobinostat|panobinostat|mesh-list
55833079|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55735852|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735853|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55735854|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735855|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735857|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
55735858|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735861|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
55735862|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735864|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735865|NCT03443141|Protective Agents|protective agents|mesh-ancestor
55735866|NCT04937543|Beclomethasone|beclomethasone|mesh-list
55735867|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
55735868|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
55735869|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55735871|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735872|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735873|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55735874|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
55735875|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55735876|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55735877|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55735878|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
55735879|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735880|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735881|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55735883|NCT04937543|Hormones|hormones|mesh-ancestor
55735884|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55735885|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55735886|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55735887|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55735888|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
55735889|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
55735890|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
55735891|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55735892|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55735893|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735894|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55735895|NCT04923737|Analgesics|analgesics|mesh-ancestor
55735896|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
55735897|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735898|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55735900|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55735901|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
55735902|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735903|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735904|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
55769530|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
55735905|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55735906|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735907|NCT04921943|Azithromycin|azithromycin|mesh-list
55735908|NCT04921943|Rifampin|rifampin|mesh-list
55735909|NCT04921943|Ethambutol|ethambutol|mesh-list
55735910|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55735911|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735912|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55735913|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
55735914|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
55735915|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55735916|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735917|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735918|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55735919|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55735920|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55735921|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55735922|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55735923|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55735925|NCT02419508|Bimatoprost|bimatoprost|mesh-list
55735926|NCT02419508|Travoprost|travoprost|mesh-list
55735927|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55735928|NCT02419508|Latanoprost|latanoprost|mesh-list
55735929|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55735930|NCT02419508|Brinzolamide|brinzolamide|mesh-list
55735931|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55735932|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55735933|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55735934|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55735935|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
55735936|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735937|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735938|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735939|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55735940|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735942|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
55735943|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735945|NCT03441815|Glutarimide|glutarimide|mesh-list
55735946|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
55735947|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
55736113|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55735948|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55735949|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735950|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735951|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55735952|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735953|NCT02426918|Vancomycin|vancomycin|mesh-list
55735954|NCT02426918|Linezolid|linezolid|mesh-list
55735955|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55735956|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735957|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55735958|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735959|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735960|NCT02387762|Methotrexate|methotrexate|mesh-list
55735961|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
55735962|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55735963|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
55735964|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55735965|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735966|NCT02387762|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55735967|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
55735968|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735969|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55735970|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
55735971|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55735972|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55735973|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55735974|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
55735975|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55735976|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55735978|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55735979|NCT02418182|Analgesics|analgesics|mesh-ancestor
55735980|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
55735981|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55735982|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55735983|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
55735984|NCT02387372|Tazobactam|tazobactam|mesh-list
55735985|NCT02387372|Ceftolozane|ceftolozane|mesh-list
55735986|NCT02387372|Cephalosporins|cephalosporins|mesh-list
55735987|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
55735988|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
55735989|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55735990|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55735991|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55735992|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833525|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55735993|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55735994|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55735996|NCT03446495|Trabectedin|trabectedin|mesh-list
55735997|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55735998|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
55735999|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736000|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736001|NCT02657343|Trastuzumab|trastuzumab|mesh-list
55736002|NCT02657343|Fulvestrant|fulvestrant|mesh-list
55736003|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55736004|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736005|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55736006|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55736011|NCT03441035|Anesthetics|anesthetics|mesh-list
55736012|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736013|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736014|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55736015|NCT05105633|Tenecteplase|tenecteplase|mesh-list
55736016|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55736017|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55736018|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736019|NCT04807673|Paclitaxel|paclitaxel|mesh-list
55736020|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
55736021|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55833636|NCT02057198|Amebicides|amebicides|mesh-list
55736022|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736023|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
55736024|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
55736025|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
55736114|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
55736026|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736027|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55736033|NCT04581447|Metformin|metformin|mesh-list
55736034|NCT04581447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55736035|NCT04581447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736036|NCT02425826|Thalidomide|thalidomide|mesh-list
55736038|NCT02425826|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55736039|NCT02425826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736040|NCT02425826|Analgesics|analgesics|mesh-ancestor
55736041|NCT02425826|Sensory System Agents|sensory system agents|mesh-ancestor
55736042|NCT02425826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736043|NCT02425826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736044|NCT02425826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736045|NCT02425826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736048|NCT02425826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736049|NCT02425826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736050|NCT02425826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55736051|NCT02425826|Immunologic Factors|immunologic factors|mesh-ancestor
55736052|NCT02425826|Leprostatic Agents|leprostatic agents|mesh-ancestor
55736053|NCT02425826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55736054|NCT02425826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736055|NCT02425826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55736056|NCT02425826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55736057|NCT02425826|Growth Substances|growth substances|mesh-ancestor
55736058|NCT02425826|Growth Inhibitors|growth inhibitors|mesh-ancestor
55736059|NCT02425826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736061|NCT02656173|Mirabegron|mirabegron|mesh-list
55736062|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55736063|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55736064|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55736065|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
55736066|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736067|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736068|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736069|NCT02656173|Urological Agents|urological agents|mesh-ancestor
55736070|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55736071|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55736072|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55736073|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55736074|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
55736078|NCT04418895|Leucovorin|leucovorin|mesh-list
55736079|NCT04418895|Fluorouracil|fluorouracil|mesh-list
55736080|NCT04418895|Capecitabine|capecitabine|mesh-list
55736081|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
55736082|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
55736083|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736084|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
55736085|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736086|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55736087|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736088|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55736089|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
55736090|NCT04418895|Antidotes|antidotes|mesh-ancestor
55736091|NCT04418895|Protective Agents|protective agents|mesh-ancestor
55736092|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
55833869|NCT04720105|Tazarotene|tazarotene|mesh-list
55736094|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
55736095|NCT04715633|Apatinib|apatinib|mesh-list
55736096|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55736097|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736098|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55736099|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736100|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736101|NCT03439943|Lixisenatide|lixisenatide|mesh-list
55736102|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55736103|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736104|NCT03439787|Epinephrine|epinephrine|mesh-list
55736105|NCT03439787|Bupivacaine|bupivacaine|mesh-list
55736106|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736107|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
55736108|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736109|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736110|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
55736111|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736112|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55833974|NCT04417543|Memantine|memantine|mesh-list
55736115|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736116|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736117|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55736118|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55736119|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
55736120|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55736121|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
55736122|NCT03439787|Mydriatics|mydriatics|mesh-ancestor
55736123|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
55736124|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55736125|NCT05082155|Bupivacaine|bupivacaine|mesh-list
55736126|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736127|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
55736128|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736129|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736130|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
55736131|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736132|NCT02656017|Metformin|metformin|mesh-list
55736133|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55736134|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736135|NCT03439709|Lanreotide|lanreotide|mesh-list
55736136|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736137|NCT04451447|SMOFlipid|smoflipid|mesh-list
55736138|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55736139|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55736140|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55736141|NCT04516941|Colchicine|colchicine|mesh-list
55736142|NCT04516941|Edoxaban|edoxaban|mesh-list
55736143|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
55736144|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736145|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
55736146|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
55736147|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
55736148|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736149|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736150|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55736151|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
55736152|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55736153|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
55736154|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736155|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
55736156|NCT03444467|Glucagon|glucagon|mesh-list
55736157|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55736158|NCT03444467|Hormones|hormones|mesh-ancestor
55736159|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736160|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736161|NCT04542837|Lenvatinib|lenvatinib|mesh-list
55736162|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736163|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55736164|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736165|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736166|NCT02655237|Leuprolide|leuprolide|mesh-list
55736167|NCT02655237|Relugolix|relugolix|mesh-list
55736168|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55736169|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
55736170|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55736171|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736172|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55736173|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736174|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
55736175|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
55736176|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736177|NCT03443999|Sirolimus|sirolimus|mesh-list
55834120|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55834121|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834152|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736178|NCT03443999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55736179|NCT03443999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736180|NCT03443999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55736181|NCT03443999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736183|NCT03443999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55736184|NCT03443999|Immunologic Factors|immunologic factors|mesh-ancestor
55736185|NCT03443999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736187|NCT03890133|Analgesics|analgesics|mesh-ancestor
55736188|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
55736189|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736190|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736191|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
55736192|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55736193|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55736194|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736195|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55736196|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55736197|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55736198|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736199|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55736200|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55736201|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55736202|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
55736203|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736204|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736205|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736206|NCT03443921|Paclitaxel|paclitaxel|mesh-list
55736207|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55736208|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736209|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
55736210|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
55736211|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
55736212|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736213|NCT03443843|Fluticasone|fluticasone|mesh-list
55736214|NCT03443843|Xhance|xhance|mesh-list
55736215|NCT03443843|Loratadine|loratadine|mesh-list
55736216|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
55834313|NCT02141633|Fluticasone|fluticasone|mesh-list
55736217|NCT03443843|Ephedrine|ephedrine|mesh-list
55736218|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736219|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55736220|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
55736221|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736222|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736223|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55736224|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
55736225|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
55736226|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55736227|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
55736228|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55736229|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55834461|NCT02116205|Vaccines|vaccines|mesh-list
55736230|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
55736231|NCT03443843|Histamine Agents|histamine agents|mesh-ancestor
55736232|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55769738|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55736233|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736234|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
55736235|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55736236|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55736237|NCT03443843|Sympathomimetics|sympathomimetics|mesh-ancestor
55736238|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
55834545|NCT02030041|Vitamin D|vitamin d|mesh-list
55736239|NCT03438227|Dextrans|dextrans|mesh-list
55736240|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
55834546|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
55736241|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
55736242|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
55736243|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
55736245|NCT03433235|Edoxaban|edoxaban|mesh-list
55736246|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55736247|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
55736248|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55736249|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
55736250|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736251|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736253|NCT03783351|Clopidogrel|clopidogrel|mesh-list
55736254|NCT03783351|Ticagrelor|ticagrelor|mesh-list
55736255|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55736256|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55736257|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55736258|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55736259|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
55736260|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736261|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736262|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736265|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55834748|NCT02038790|Naloxone|naloxone|mesh-list
55736266|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736267|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55736268|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736269|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55736270|NCT03234309|Hematinics|hematinics|mesh-ancestor
55736271|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55736272|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55736273|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
55736274|NCT02657031|Promethazine|promethazine|mesh-list
55736276|NCT02657031|Ondansetron|ondansetron|mesh-list
55736277|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
55736278|NCT02657031|Analgesics|analgesics|mesh-ancestor
55736279|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
55736280|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736281|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736282|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55736283|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55736284|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
55736286|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736287|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55736288|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55736289|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736290|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736291|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
55736292|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
55736293|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55736294|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
55736295|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
55736296|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55736297|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
55736298|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55736299|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55736300|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55736301|NCT02657031|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55736302|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55736304|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736305|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55736306|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
55736307|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
55736308|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55736309|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55736310|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
55736311|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
55736312|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55736313|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55736314|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55736315|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55736316|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736317|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
55736318|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736319|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736320|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55736321|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736323|NCT03433001|Lenalidomide|lenalidomide|mesh-list
55736324|NCT03433001|Ixazomib|ixazomib|mesh-list
55736325|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736326|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
55834916|NCT03272139|Bupivacaine|bupivacaine|mesh-list
55736327|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
55769774|NCT02084134|Glucocorticoids|glucocorticoids|mesh-ancestor
55736328|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736329|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736331|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
55736332|NCT03433001|Hormones|hormones|mesh-ancestor
55736333|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736334|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55736335|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736336|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
55736338|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55736339|NCT03433001|Growth Substances|growth substances|mesh-ancestor
55736340|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
55736341|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
55834948|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736342|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834978|NCT01967173|Xhance|xhance|mesh-list
55736343|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736344|NCT03797469|Niacinamide|niacinamide|mesh-list
55736345|NCT03797469|Niacin|niacin|mesh-list
55736346|NCT03797469|Nicotinic Acids|nicotinic acids|mesh-list
55736347|NCT03797469|Vitamins|vitamins|mesh-ancestor
55736348|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
55736349|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736350|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
55736351|NCT03797469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55736352|NCT03797469|Antimetabolites|antimetabolites|mesh-ancestor
55736353|NCT03797469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736354|NCT03797469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55736355|NCT03797469|Vasodilator Agents|vasodilator agents|mesh-ancestor
55736357|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736358|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
55736359|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736360|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736361|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
55736362|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736363|NCT02384577|Budesonide|budesonide|mesh-list
55736364|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
55736365|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736366|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55736367|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
55736368|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736369|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736370|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55736371|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
55736372|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
55736374|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736375|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55736376|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55736377|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55736378|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
55736379|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736380|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736382|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736383|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736384|NCT02030457|Beclomethasone|beclomethasone|mesh-list
55736385|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736387|NCT02030457|Hormones|hormones|mesh-ancestor
55736388|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736389|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736390|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55736391|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
55736392|NCT04489433|Trametinib|trametinib|mesh-list
55736393|NCT04489433|Dabrafenib|dabrafenib|mesh-list
55736394|NCT04489433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835194|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736395|NCT04489433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55736396|NCT04489433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736397|NCT04489433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736399|NCT03432767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55736400|NCT03432767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736401|NCT03432767|Analgesics|analgesics|mesh-ancestor
55736402|NCT03432767|Sensory System Agents|sensory system agents|mesh-ancestor
55736403|NCT03432767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736404|NCT03432767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736405|NCT03432767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736406|NCT03432767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736407|NCT03437057|Aspirin|aspirin|mesh-list
55736408|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55736409|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736410|NCT03437057|Analgesics|analgesics|mesh-ancestor
55736411|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
55736412|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736413|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736414|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736415|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736416|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55736417|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55736418|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736419|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55736420|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55736421|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736422|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
55736423|NCT03579693|Niacinamide|niacinamide|mesh-list
55736425|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
55736426|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
55736427|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
55736428|NCT03579693|Vitamins|vitamins|mesh-ancestor
55736429|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
55736430|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736431|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55736432|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
55736433|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736434|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55736435|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
55736436|NCT03432689|Cycloserine|cycloserine|mesh-list
55736437|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55736438|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736439|NCT03432689|Renal Agents|renal agents|mesh-ancestor
55736440|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55736441|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
55835371|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736442|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55736443|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
55736444|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736446|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736447|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55736448|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
55736449|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736450|NCT04380311|Tacrolimus|tacrolimus|mesh-list
55736451|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55736452|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
55736453|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736454|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55736455|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736456|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736457|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55736458|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55736459|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55736460|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55736461|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736462|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736463|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736464|NCT05018013|Analgesics|analgesics|mesh-ancestor
55736465|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
55736466|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736467|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
55736468|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55769923|NCT03158129|Cisplatin|cisplatin|mesh-list
55736469|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
55736470|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55736471|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55736472|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55835431|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
55736473|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55736474|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736475|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736476|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736477|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
55736478|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55736480|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
55736481|NCT04360421|Bupivacaine|bupivacaine|mesh-list
55736482|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736483|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
55736484|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736485|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846308|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55736486|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
55736487|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736488|NCT02387216|Docetaxel|docetaxel|mesh-list
55736489|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736490|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
55736491|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
55736492|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
55736567|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736493|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736494|NCT03431909|Aspirin|aspirin|mesh-list
55736495|NCT03431909|Kallikreins|kallikreins|mesh-list
55736496|NCT03431909|Clopidogrel|clopidogrel|mesh-list
55736497|NCT03431909|Atorvastatin|atorvastatin|mesh-list
55736498|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55736499|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736500|NCT03431909|Analgesics|analgesics|mesh-ancestor
55736501|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
55736502|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736503|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736504|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736505|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736506|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55736507|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55736508|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736509|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55736510|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55835475|NCT01805037|Antibodies|antibodies|mesh-list
55736511|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736512|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
55736513|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55736514|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55736515|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
55835530|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736516|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55736517|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55736518|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55736519|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55736520|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55736521|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
55736522|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835699|NCT01962103|Paclitaxel|paclitaxel|mesh-list
55736524|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
55736525|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
55736526|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55736528|NCT03436121|Ketamine|ketamine|mesh-list
55736529|NCT03436121|Analgesics|analgesics|mesh-ancestor
55736530|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
55736531|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736532|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736533|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55736534|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55736535|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
55736536|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
55736537|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736538|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55736539|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55736540|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736541|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736542|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55736543|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55736544|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55736545|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55736546|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55736547|NCT03436121|GABA Modulators|gaba modulators|mesh-ancestor
55736548|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
55736549|NCT02417246|Metoprolol|metoprolol|mesh-list
55736550|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55736551|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55736552|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
55736553|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
55736554|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736555|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736556|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55736557|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55736558|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55736559|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
55736560|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736561|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736563|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55736564|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736565|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55736566|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55736568|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736569|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736570|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55736571|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55835736|NCT02007434|Loratadine|loratadine|mesh-list
55736573|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55736574|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55736575|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736576|NCT03431597|Micronutrients|micronutrients|mesh-list
55736577|NCT03431597|Trace Elements|trace elements|mesh-list
55736578|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736579|NCT02424578|Diclofenac|diclofenac|mesh-list
55736580|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55736581|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736582|NCT02424578|Analgesics|analgesics|mesh-ancestor
55736583|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
55736584|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736585|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736586|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736587|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835746|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736588|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55736589|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736590|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736591|NCT03431285|Ketamine|ketamine|mesh-list
55736592|NCT03431285|Morphine|morphine|mesh-list
55736593|NCT03431285|Analgesics|analgesics|mesh-ancestor
55736594|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
55736595|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736596|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736597|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55736598|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55736599|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
55736600|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
55736601|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736602|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55736603|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55736604|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736605|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736606|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55736608|NCT02416934|Dexamethasone|dexamethasone|mesh-list
55736609|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736610|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
55736611|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
55736612|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736613|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736614|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55736616|NCT02416934|Hormones|hormones|mesh-ancestor
55736617|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736618|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55736620|NCT02819635|Upadacitinib|upadacitinib|mesh-list
55736621|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
55736622|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55736623|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736624|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736625|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736626|NCT03874325|Durvalumab|durvalumab|mesh-list
55736627|NCT03874325|Letrozole|letrozole|mesh-list
55736628|NCT03874325|Anastrozole|anastrozole|mesh-list
55736629|NCT03874325|Exemestane|exemestane|mesh-list
55736630|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55736631|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736632|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55736633|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55736634|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736635|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736636|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55736637|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
55736638|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736639|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736640|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55736641|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
55736642|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55736643|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
55736644|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736645|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736646|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55736647|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
55736648|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55736649|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55736650|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55736651|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
55736652|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736653|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736656|NCT03861611|Diclofenac|diclofenac|mesh-list
55736657|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55736658|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736659|NCT03861611|Analgesics|analgesics|mesh-ancestor
55736660|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
55736661|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736662|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736663|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736664|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736665|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55736666|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736667|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736668|NCT03430817|Amantadine|amantadine|mesh-list
55736669|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55736670|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55736672|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
55736673|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736674|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
55736675|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736676|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736677|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736678|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736679|NCT03430817|Analgesics|analgesics|mesh-ancestor
55736680|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
55736681|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736682|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
55736683|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
55736684|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55736685|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736686|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55736687|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736688|NCT03799835|Atezolizumab|atezolizumab|mesh-list
55736689|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
55736690|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736692|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
55736693|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736694|NCT03735095|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
55736695|NCT03735095|Trioxsalen|trioxsalen|mesh-list
55736696|NCT03735095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736697|NCT03735095|Dermatologic Agents|dermatologic agents|mesh-ancestor
55736698|NCT03735095|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55736699|NCT03430505|Albuterol|albuterol|mesh-list
55736700|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55736701|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
55736702|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736703|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736704|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55736705|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
55736706|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
55736707|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55736708|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55736709|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55736710|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55736711|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
55736712|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835974|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835975|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736713|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736714|NCT03434951|Morphine|morphine|mesh-list
55736716|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736717|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
55736718|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736719|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736720|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
55736721|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736722|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55736723|NCT03434951|Narcotics|narcotics|mesh-ancestor
55736724|NCT03434951|Analgesics|analgesics|mesh-ancestor
55736725|NCT02234323|Factor VIII|factor viii|mesh-list
55736726|NCT02234323|Coagulants|coagulants|mesh-ancestor
55736727|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
55736728|NCT02413346|Sarecycline|sarecycline|mesh-list
55736729|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55736730|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736731|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
55736732|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55736733|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55736734|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55736735|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736736|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736737|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55736738|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55736739|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736740|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
55736743|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55736744|NCT03429179|Narcotics|narcotics|mesh-ancestor
55736745|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736746|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736747|NCT03429179|Analgesics|analgesics|mesh-ancestor
55736748|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
55736749|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736750|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
55736751|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
55736752|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55736753|NCT03429101|Trastuzumab|trastuzumab|mesh-list
55736754|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55736755|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55736756|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736757|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
55836018|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736758|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
55736759|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
55736760|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736761|NCT04116203|Metformin|metformin|mesh-list
55736762|NCT04116203|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55736763|NCT04116203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736764|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55736765|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
55736766|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736767|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
55736768|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55736769|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55736770|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55736771|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
55736772|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55736773|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736774|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55736775|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55736776|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
55736777|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55736779|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736780|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
55736781|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736782|NCT03428633|Morphine|morphine|mesh-list
55736783|NCT03428633|Ropivacaine|ropivacaine|mesh-list
55736784|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55736785|NCT03428633|Narcotics|narcotics|mesh-ancestor
55736786|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736787|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736788|NCT03428633|Analgesics|analgesics|mesh-ancestor
55736789|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
55736790|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736791|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736792|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
55736793|NCT02412878|Dexamethasone|dexamethasone|mesh-list
55736794|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736795|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
55736797|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736798|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736799|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55736800|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
55736801|NCT02412878|Hormones|hormones|mesh-ancestor
55736802|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736803|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55736804|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736805|NCT03423329|Ibuprofen|ibuprofen|mesh-list
55736806|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55736807|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736808|NCT03423329|Analgesics|analgesics|mesh-ancestor
55736809|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
55736810|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736811|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736812|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736813|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736814|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55836082|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55736815|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736816|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736817|NCT02380742|Lidocaine|lidocaine|mesh-list
55736818|NCT02380742|Prilocaine|prilocaine|mesh-list
55736819|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55736820|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736821|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
55736822|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736823|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736824|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
55736825|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736826|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55736827|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55736828|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55736829|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55736830|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736831|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55736832|NCT02944019|Edoxaban|edoxaban|mesh-list
55736833|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55736834|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
55836113|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736835|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55736837|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736838|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736839|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
55736840|NCT02022059|Lidocaine|lidocaine|mesh-list
55736841|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736842|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
55736843|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736844|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736845|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
55736846|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736847|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55736848|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55736849|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55736850|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55736851|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736852|NCT03422393|Venetoclax|venetoclax|mesh-list
55736853|NCT03422393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736854|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
55736855|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55736856|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
55736857|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55736858|NCT03422315|Propofol|propofol|mesh-list
55736859|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55736860|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736861|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736862|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55736863|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
55736864|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
55736865|NCT03427385|Ropivacaine|ropivacaine|mesh-list
55736866|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736867|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
55736868|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736869|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736870|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
55736871|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736872|NCT03427229|Vancomycin|vancomycin|mesh-list
55736873|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55736874|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736875|NCT04449185|Amoxicillin|amoxicillin|mesh-list
55736876|NCT04449185|Clarithromycin|clarithromycin|mesh-list
55736877|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55736878|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736879|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55736880|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736881|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736882|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55736883|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55736885|NCT03426761|Cefazolin|cefazolin|mesh-list
55736886|NCT03426761|Daptomycin|daptomycin|mesh-list
55736887|NCT03426761|Dalbavancin|dalbavancin|mesh-list
55736888|NCT03426761|Nafcillin|nafcillin|mesh-list
55836235|NCT02059187|Insulin|insulin|mesh-list
55736889|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55736890|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736891|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
55736892|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
55736893|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
55736894|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736895|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736896|NCT03426527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55736897|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736898|NCT03426527|Analgesics|analgesics|mesh-ancestor
55736899|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
55736900|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736901|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55736902|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55736903|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55736904|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
55736905|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736906|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736907|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736908|NCT02805257|Mitomycins|mitomycins|mesh-list
55736909|NCT02805257|Mitomycin|mitomycin|mesh-list
55736910|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55736911|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736912|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
55736913|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736914|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55736915|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55736916|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55736917|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
55736918|NCT02636387|Coagulants|coagulants|mesh-ancestor
55736919|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55736920|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
55736921|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736922|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
55736923|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
55736924|NCT03425747|Calcium|calcium|mesh-list
55736925|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55836353|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
55736926|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736927|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55736928|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736930|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55736931|NCT03425669|Methylphenidate|methylphenidate|mesh-list
55736932|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55736933|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736934|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55736935|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55736936|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55736937|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736939|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55736941|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
55736942|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55736943|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
55736944|NCT03424733|Acetaminophen|acetaminophen|mesh-list
55736945|NCT03424733|Interferons|interferons|mesh-list
55736949|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736950|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
55736951|NCT03424733|Hormones|hormones|mesh-ancestor
55736952|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736953|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736954|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55736955|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736956|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
55736957|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55736958|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55736959|NCT03424733|Analgesics|analgesics|mesh-ancestor
55736960|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
55736961|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736962|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
55736963|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
55736964|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55736965|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55736966|NCT03441841|Lidocaine|lidocaine|mesh-list
55736967|NCT03441841|Prilocaine|prilocaine|mesh-list
55736968|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55736969|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
55736970|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
55736971|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55736972|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736973|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
55836453|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55836454|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
55736974|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736975|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55736976|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55736977|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55836524|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55736979|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55736980|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55736981|NCT02692339|Dexamethasone|dexamethasone|mesh-list
55736982|NCT02692339|Lenalidomide|lenalidomide|mesh-list
55736983|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55736984|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
55736985|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
55836528|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736986|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55736987|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55736988|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55736989|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
55736990|NCT02692339|Hormones|hormones|mesh-ancestor
55736991|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55736992|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55736993|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55736995|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55736996|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55736997|NCT02692339|Growth Substances|growth substances|mesh-ancestor
55836551|NCT01443130|Amebicides|amebicides|mesh-ancestor
55736998|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
55737000|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55737001|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737002|NCT03438253|Anesthetics|anesthetics|mesh-list
55737003|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737004|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737005|NCT02535325|Cisplatin|cisplatin|mesh-list
55737006|NCT02535325|Pemetrexed|pemetrexed|mesh-list
55737007|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737008|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737009|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737010|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55737011|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55737012|NCT03441529|Tazobactam|tazobactam|mesh-list
55737013|NCT03441529|Piperacillin|piperacillin|mesh-list
55737014|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55737015|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55737016|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737017|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55737018|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737019|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737020|NCT03441373|Histamine|histamine|mesh-list
55737021|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
55737025|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737026|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737027|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737028|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55737029|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737030|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
55737031|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55737032|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55737033|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55737034|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737035|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
55737036|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737037|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55737038|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737039|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737040|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
55737041|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737042|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737043|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55737045|NCT03437785|Rebamipide|rebamipide|mesh-list
55737046|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55737047|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737048|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737049|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737050|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55737051|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55737052|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
55737053|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737054|NCT03437785|Protective Agents|protective agents|mesh-ancestor
55737056|NCT03437707|Acetaminophen|acetaminophen|mesh-list
55737057|NCT03437707|Ibuprofen|ibuprofen|mesh-list
55737058|NCT03437707|Morphine|morphine|mesh-list
55737059|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55737060|NCT03437707|Narcotics|narcotics|mesh-ancestor
55737061|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737062|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737063|NCT03437707|Analgesics|analgesics|mesh-ancestor
55737064|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
55737065|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737066|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55737067|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55836602|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
55737069|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737070|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55737071|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737072|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737073|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
55737074|NCT03437629|Calcium|calcium|mesh-list
55737075|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55737076|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737077|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55737078|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
55737079|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737080|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737081|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737082|NCT03441217|Scopolamine|scopolamine|mesh-list
55737083|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55737084|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55737085|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
55737086|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
55737087|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737088|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737089|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55737091|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55737092|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
55737093|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737094|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737095|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55737096|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
55737097|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
55737098|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737099|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
55737100|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737101|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737102|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55737103|NCT02521441|Lenograstim|lenograstim|mesh-list
55737104|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55737105|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
55737106|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737107|NCT03432871|Niacinamide|niacinamide|mesh-list
55737108|NCT03432871|Niacin|niacin|mesh-list
55737109|NCT03432871|Nicotinic Acids|nicotinic acids|mesh-list
55737110|NCT03432871|Vitamin B Complex|vitamin b complex|mesh-ancestor
55737111|NCT03432871|Vitamins|vitamins|mesh-ancestor
55737112|NCT03432871|Micronutrients|micronutrients|mesh-ancestor
55737113|NCT03432871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737114|NCT03432871|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55737115|NCT03432871|Antimetabolites|antimetabolites|mesh-ancestor
55737116|NCT03432871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737117|NCT03432871|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55737118|NCT03432871|Vasodilator Agents|vasodilator agents|mesh-ancestor
55737119|NCT04420585|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55737120|NCT04420585|Hemostatics|hemostatics|mesh-ancestor
55737121|NCT04420585|Coagulants|coagulants|mesh-ancestor
55737122|NCT04420585|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55737123|NCT04420585|Natriuretic Agents|natriuretic agents|mesh-ancestor
55737124|NCT04420585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737125|NCT04451239|Cyclosporine|cyclosporine|mesh-list
55737126|NCT04451239|Cyclosporins|cyclosporins|mesh-list
55737127|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737128|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737129|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55737130|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
55737132|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
55737133|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737134|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
55737135|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737136|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55737137|NCT03440515|Prednisone|prednisone|mesh-list
55737138|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737139|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
55737140|NCT03440515|Hormones|hormones|mesh-ancestor
55737141|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737142|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737143|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55737144|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737145|NCT03432793|Itraconazole|itraconazole|mesh-list
55737146|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
55737147|NCT03432793|Caffeine|caffeine|mesh-list
55737148|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55737149|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737150|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55737151|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737152|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737153|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55737154|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55737155|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
55737156|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737157|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
55737158|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737159|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55737160|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55737161|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55737162|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
55846309|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55737163|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737164|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55737165|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55737166|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55737167|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737168|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55737169|NCT03432793|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55737170|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55737171|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55737173|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55737174|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
55737175|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55737176|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55737177|NCT03436693|Canagliflozin|canagliflozin|mesh-list
55737178|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55737179|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737180|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55737181|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737182|NCT03432637|Anesthetics|anesthetics|mesh-list
55737183|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737184|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737185|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
55737186|NCT03436303|Progestins|progestins|mesh-ancestor
55737188|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737189|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737190|NCT03436225|Dexamethasone|dexamethasone|mesh-list
55737191|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
55737192|NCT03436225|Budesonide|budesonide|mesh-list
55737193|NCT03436225|Albuterol|albuterol|mesh-list
55737194|NCT03436225|BB 1101|bb 1101|mesh-list
55737195|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737196|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
55737197|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
55737198|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737199|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737200|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55737201|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
55737202|NCT03436225|Hormones|hormones|mesh-ancestor
55737203|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737204|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55737205|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737206|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
55737207|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737208|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737209|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55737210|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55737211|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
55737213|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55737214|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55737215|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55737216|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55737217|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
55737218|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737219|NCT03440359|Letrozole|letrozole|mesh-list
55737220|NCT03440359|Progesterone|progesterone|mesh-list
55737221|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737222|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55737223|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55737224|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737225|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737226|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55737227|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
55770022|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
55737228|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737229|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737230|NCT03440359|Progestins|progestins|mesh-ancestor
55737231|NCT03440359|Hormones|hormones|mesh-ancestor
55737232|NCT04294225|Letrozole|letrozole|mesh-list
55737233|NCT04294225|Anastrozole|anastrozole|mesh-list
55737234|NCT04294225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737235|NCT04294225|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55737236|NCT04294225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55737240|NCT04294225|Hormone Antagonists|hormone antagonists|mesh-ancestor
55737241|NCT04294225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737242|NCT04294225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737243|NCT04294225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55737244|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55737245|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
55737246|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737247|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55737248|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
55737249|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
55737250|NCT03431623|Hematinics|hematinics|mesh-ancestor
55737251|NCT04451395|Micronutrients|micronutrients|mesh-list
55737252|NCT04451395|Trace Elements|trace elements|mesh-list
55737253|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737254|NCT04451083|Camostat|camostat|mesh-list
55737255|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
55737257|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737258|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55737259|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55737260|NCT03435289|Gemcitabine|gemcitabine|mesh-list
55737261|NCT03435289|Paclitaxel|paclitaxel|mesh-list
55737262|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55737263|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55737264|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737265|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
55737266|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
55737267|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
55836749|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55737268|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737269|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55737270|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
55737271|NCT03435289|Antiviral Agents|antiviral agents|mesh-ancestor
55737272|NCT03435289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737273|NCT03435289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737274|NCT03435289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55737275|NCT03435289|Immunologic Factors|immunologic factors|mesh-ancestor
55737276|NCT03435289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737277|NCT03435133|Ticagrelor|ticagrelor|mesh-list
55737278|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55737279|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55737280|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55737281|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55737282|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55737284|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737285|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737286|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737287|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
55737288|NCT03431077|Giapreza|giapreza|mesh-list
55737289|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
55737290|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55737291|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55737293|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737294|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737298|NCT03439501|Avelumab|avelumab|mesh-list
55770026|NCT01515527|Cladribine|cladribine|mesh-list
55737299|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55737300|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737301|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
55737302|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55737303|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737304|NCT04255381|Pancrelipase|pancrelipase|mesh-list
55737305|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55737306|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
55737307|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55737308|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737309|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737310|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55737311|NCT03757897|Analgesics|analgesics|mesh-ancestor
55737312|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
55737313|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737314|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55737315|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55737316|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55737317|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
55737318|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737319|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737320|NCT03434275|Meloxicam|meloxicam|mesh-list
55737321|NCT03434275|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55737322|NCT03434275|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55737323|NCT03434275|Analgesics|analgesics|mesh-ancestor
55737324|NCT03434275|Sensory System Agents|sensory system agents|mesh-ancestor
55737325|NCT03434275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737326|NCT03434275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737327|NCT03434275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737328|NCT03434275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737329|NCT03434275|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55737330|NCT03434275|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55737331|NCT03434275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737332|NCT03434275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737333|NCT03434197|Diclofenac|diclofenac|mesh-list
55737334|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55737335|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55737336|NCT03434197|Analgesics|analgesics|mesh-ancestor
55737337|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
55737338|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737339|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737340|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737341|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737342|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55737343|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737344|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737345|NCT03430609|Hormones|hormones|mesh-list
55737346|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737347|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737349|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55737350|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55737351|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55737352|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737354|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55737355|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
55737356|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737357|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737359|NCT03433807|Antioxidants|antioxidants|mesh-ancestor
55737360|NCT03433807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737361|NCT03433807|Protective Agents|protective agents|mesh-ancestor
55737364|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55737365|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737366|NCT03344419|Ketamine|ketamine|mesh-list
55737367|NCT03344419|Analgesics|analgesics|mesh-ancestor
55737368|NCT03344419|Sensory System Agents|sensory system agents|mesh-ancestor
55737369|NCT03344419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737370|NCT03344419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737371|NCT03344419|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55737372|NCT03344419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55737373|NCT03344419|Anesthetics, General|anesthetics, general|mesh-ancestor
55737374|NCT03344419|Anesthetics|anesthetics|mesh-ancestor
55737375|NCT03344419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737376|NCT03344419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55737377|NCT03344419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55737378|NCT03344419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737379|NCT03344419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737380|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55737381|NCT03621553|Vitamin D|vitamin d|mesh-list
55737382|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
55737383|NCT03621553|Cholecalciferol|cholecalciferol|mesh-list
55737384|NCT03621553|Vitamins|vitamins|mesh-list
55737385|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
55737386|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737387|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55846462|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
55737388|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55737389|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
55737390|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55737391|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
55737392|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737393|NCT03423667|Expectorants|expectorants|mesh-ancestor
55737394|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
55737395|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55737396|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
55737397|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737398|NCT03423667|Protective Agents|protective agents|mesh-ancestor
55737399|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737401|NCT01559363|XL647|xl647|mesh-list
55737402|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737403|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55737404|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737405|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737406|NCT03605719|Dexamethasone|dexamethasone|mesh-list
55737407|NCT03605719|Nivolumab|nivolumab|mesh-list
55737408|NCT03605719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737409|NCT03605719|Antiemetics|antiemetics|mesh-ancestor
55737410|NCT03605719|Autonomic Agents|autonomic agents|mesh-ancestor
55737411|NCT03605719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737412|NCT03605719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737413|NCT03605719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55737414|NCT03605719|Glucocorticoids|glucocorticoids|mesh-ancestor
55737415|NCT03605719|Hormones|hormones|mesh-ancestor
55737416|NCT03605719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737417|NCT03605719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55737418|NCT03605719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737419|NCT03605719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55737420|NCT03605719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55737421|NCT03605719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737423|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55737424|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737425|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737426|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55737427|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
55737428|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
55737429|NCT01504919|Nicotine|nicotine|mesh-list
55737430|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55737431|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
55737432|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737433|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737434|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55737435|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55737436|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
55737437|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737438|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737439|NCT02732327|Vancomycin|vancomycin|mesh-list
55737440|NCT02732327|Meropenem|meropenem|mesh-list
55737441|NCT02732327|Tazobactam|tazobactam|mesh-list
55737442|NCT02732327|Linezolid|linezolid|mesh-list
55737443|NCT02732327|Piperacillin|piperacillin|mesh-list
55737444|NCT02732327|Cefepime|cefepime|mesh-list
55737445|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55737446|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55737447|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737448|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55737449|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737450|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737451|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55737452|NCT03428503|Acetaminophen|acetaminophen|mesh-list
55737453|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55737454|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55737455|NCT03428503|Analgesics|analgesics|mesh-ancestor
55737456|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
55737457|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737458|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737459|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
55737460|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55737461|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737462|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737463|NCT03428425|Paclitaxel|paclitaxel|mesh-list
55737464|NCT03428425|Apatinib|apatinib|mesh-list
55737465|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55737466|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737467|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
55737468|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
55737469|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
55737470|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737471|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55737472|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737473|NCT03416777|Tocopherols|tocopherols|mesh-list
55737474|NCT03416777|Vitamin E|vitamin e|mesh-list
55737475|NCT03416777|Tocotrienols|tocotrienols|mesh-list
55737476|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
55737477|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
55737478|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737479|NCT03416777|Protective Agents|protective agents|mesh-ancestor
55737480|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737481|NCT03416777|Vitamins|vitamins|mesh-ancestor
55737482|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
55737483|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
55737484|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737486|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
55737487|NCT03422887|Nalbuphine|nalbuphine|mesh-list
55737488|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55737489|NCT03422887|Narcotics|narcotics|mesh-ancestor
55737490|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737491|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737492|NCT03422887|Analgesics|analgesics|mesh-ancestor
55737493|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
55737494|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737495|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55737496|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55737497|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737498|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737499|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55737500|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737501|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737502|NCT02521207|Ibuprofen|ibuprofen|mesh-list
55737503|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55737504|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55737505|NCT02521207|Analgesics|analgesics|mesh-ancestor
55737506|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
55737507|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737508|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737509|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737510|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737511|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55737512|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737513|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737515|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737516|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
55737517|NCT03179605|Hormones|hormones|mesh-ancestor
55737518|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737519|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737520|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
55737521|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
55737522|NCT03173053|Clarithromycin|clarithromycin|mesh-list
55737523|NCT03173053|Doxycycline|doxycycline|mesh-list
55737524|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
55737525|NCT03173053|Rifampin|rifampin|mesh-list
55737526|NCT03173053|Clindamycin|clindamycin|mesh-list
55737527|NCT03173053|Trimethoprim|trimethoprim|mesh-list
55737528|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
55737529|NCT03173053|Mupirocin|mupirocin|mesh-list
55737530|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
55737531|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55737532|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55737533|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737534|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
55737535|NCT03173053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55737536|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55737537|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737538|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737539|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55737540|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55737541|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
55737542|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55737543|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55846568|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
55737544|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55737545|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55737546|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737547|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55737548|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55737549|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
55737550|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
55737551|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55737552|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55737553|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55737554|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55737555|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55737556|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55737557|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55737558|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55737559|NCT03173053|Renal Agents|renal agents|mesh-ancestor
55737560|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55737561|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55737562|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55737563|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55837229|NCT02015195|Lidocaine|lidocaine|mesh-list
55737565|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55737566|NCT03109795|Diuretics|diuretics|mesh-ancestor
55737567|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
55737568|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737569|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55737570|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55737571|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737572|NCT03109795|Analgesics|analgesics|mesh-ancestor
55737573|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
55737574|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737575|NCT03109795|Sympatholytics|sympatholytics|mesh-ancestor
55737576|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
55737577|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55737578|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55737579|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55737580|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
55737581|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737582|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
55737583|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55737584|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55737585|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
55737586|NCT03428191|Remifentanil|remifentanil|mesh-list
55737587|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55737589|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737590|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55737591|NCT03428191|Analgesics|analgesics|mesh-ancestor
55737592|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
55737593|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737594|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55737595|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55737596|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55737597|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
55737598|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737599|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737600|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55737601|NCT03428191|Narcotics|narcotics|mesh-ancestor
55737602|NCT03422575|Etoricoxib|etoricoxib|mesh-list
55737603|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55737604|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55737605|NCT03422575|Analgesics|analgesics|mesh-ancestor
55737606|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
55737607|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737608|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737609|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737610|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737611|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55737612|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55737613|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737614|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737615|NCT02412722|Paclitaxel|paclitaxel|mesh-list
55737616|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55737617|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737618|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
55737619|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
55737620|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
55737621|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737623|NCT01912651|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55737624|NCT01912651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737625|NCT03422419|Heparin|heparin|mesh-list
55737626|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
55737627|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55737628|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55737629|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737630|NCT04449289|Lidocaine|lidocaine|mesh-list
55737631|NCT04449289|Ropivacaine|ropivacaine|mesh-list
55737632|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
55737633|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
55737634|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737635|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737636|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
55737637|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737638|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55737639|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55737640|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55737641|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55737642|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737643|NCT03128203|Oxytocin|oxytocin|mesh-list
55737644|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
55737645|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55737646|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737647|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
55737648|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55737649|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55737650|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55737651|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55737652|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737653|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
55737654|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737655|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737656|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55737657|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737658|NCT02935309|Capecitabine|capecitabine|mesh-list
55737659|NCT02935309|Lenvatinib|lenvatinib|mesh-list
55737660|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55737661|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
55737662|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737663|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737664|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55737665|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737666|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
55737667|NCT03463993|Oxytocin|oxytocin|mesh-list
55737668|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
55737669|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55737670|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737671|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55737672|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55737673|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737674|NCT03463993|Hemostatics|hemostatics|mesh-ancestor
55737675|NCT03463993|Coagulants|coagulants|mesh-ancestor
55837318|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55737676|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55737677|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55737678|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737679|NCT03417037|Nivolumab|nivolumab|mesh-list
55737680|NCT03417037|Linrodostat|linrodostat|mesh-list
55737681|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55737682|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737683|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55737684|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737685|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737686|NCT02378480|Linezolid|linezolid|mesh-list
55737687|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55737688|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737689|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55737690|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737692|NCT02345330|Interleukin-12|interleukin-12|mesh-list
55737693|NCT02345330|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55737694|NCT02345330|Immunologic Factors|immunologic factors|mesh-ancestor
55737695|NCT02345330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737696|NCT02345330|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55737697|NCT02345330|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55737698|NCT02345330|Growth Substances|growth substances|mesh-ancestor
55737699|NCT02345330|Growth Inhibitors|growth inhibitors|mesh-ancestor
55737700|NCT02345330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737702|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55737703|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55737704|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
55737705|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737706|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55737707|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
55737708|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
55737709|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
55737710|NCT03421717|Coagulants|coagulants|mesh-ancestor
55737711|NCT03427801|Hematinics|hematinics|mesh-list
55737712|NCT03416569|Prazosin|prazosin|mesh-list
55737713|NCT03416569|Nicotine|nicotine|mesh-list
55737714|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55737715|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
55737716|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737942|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55737717|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737718|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55737719|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55737720|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
55737721|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737722|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737723|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55737724|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55737725|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55737726|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55737727|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
55737728|NCT01025089|Cyclophosphamide|cyclophosphamide|mesh-list
55737729|NCT01025089|Doxorubicin|doxorubicin|mesh-list
55737730|NCT01025089|Cetuximab|cetuximab|mesh-list
55737731|NCT01025089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55737732|NCT01025089|Immunologic Factors|immunologic factors|mesh-ancestor
55737733|NCT01025089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737734|NCT01025089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737735|NCT01025089|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55737736|NCT01025089|Alkylating Agents|alkylating agents|mesh-ancestor
55737737|NCT01025089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737738|NCT01025089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737739|NCT01025089|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55737740|NCT01025089|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55737741|NCT01025089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55737742|NCT01025089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55737743|NCT01025089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737744|NCT01025089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55737745|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
55737746|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
55737747|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55737748|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
55737749|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737750|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737753|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
55737754|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
55737755|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737756|NCT03420937|Atropine|atropine|mesh-list
55737757|NCT03420937|Neostigmine|neostigmine|mesh-list
55737758|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55737759|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55737760|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55737761|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
55737762|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737763|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737764|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55737765|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
55737767|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
55737768|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55737769|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55737770|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
55737771|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737772|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837459|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
55737773|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55737774|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737775|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55737776|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
55737777|NCT02900443|Azathioprine|azathioprine|mesh-list
55737778|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55737779|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737780|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55737781|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
55737782|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55737783|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737784|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737785|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737786|NCT02900443|Antimetabolites|antimetabolites|mesh-ancestor
55737787|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55737788|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55737789|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
55737790|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737791|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737792|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
55737793|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55737794|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55737795|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55737796|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55737797|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55737798|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737799|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
55737800|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737801|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737802|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55737803|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737805|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55737806|NCT03420703|Narcotics|narcotics|mesh-ancestor
55770109|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55737807|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737808|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737809|NCT03420703|Analgesics|analgesics|mesh-ancestor
55737810|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
55737811|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737813|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55737814|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
55737815|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55737816|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55737817|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55737818|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55737819|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737820|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
55737821|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737822|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737823|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55737824|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55737825|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737826|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
55737827|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737828|NCT03415711|Mesalamine|mesalamine|mesh-list
55737829|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55737830|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55737831|NCT03415711|Analgesics|analgesics|mesh-ancestor
55737832|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
55737833|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737834|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737835|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737836|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55737837|NCT03420313|Buprenorphine|buprenorphine|mesh-list
55737838|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55737839|NCT03420313|Naloxone|naloxone|mesh-list
55737840|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55737841|NCT03420313|Narcotics|narcotics|mesh-ancestor
55846976|NCT05601700|Letrozole|letrozole|mesh-list
55737842|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737843|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737844|NCT03420313|Analgesics|analgesics|mesh-ancestor
55737845|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
55737846|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737847|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55737848|NCT03415555|Acetaminophen|acetaminophen|mesh-list
55737849|NCT03415555|Oxycodone|oxycodone|mesh-list
55737850|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737851|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737852|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55737853|NCT03415555|Analgesics|analgesics|mesh-ancestor
55737854|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
55737855|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737856|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
55737857|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55737858|NCT03415555|Narcotics|narcotics|mesh-ancestor
55737859|NCT03415477|Denosumab|denosumab|mesh-list
55737860|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55737861|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737862|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
55737863|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
55737864|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737865|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55770125|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55737866|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55737867|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737868|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737870|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55737871|NCT03419923|Citric Acid|citric acid|mesh-list
55737872|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
55737873|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
55737874|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55737875|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
55737876|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
55737877|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737878|NCT03426553|Riboflavin|riboflavin|mesh-list
55737879|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
55737880|NCT03426553|Vitamins|vitamins|mesh-ancestor
55737881|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
55737882|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737883|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55737884|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
55737885|NCT03415087|Fentanyl|fentanyl|mesh-list
55737886|NCT03415087|Bupivacaine|bupivacaine|mesh-list
55837620|NCT01933334|Pirfenidone|pirfenidone|mesh-list
55737887|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
55737888|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
55737889|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737890|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737891|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
55737892|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737893|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55737894|NCT03415087|Narcotics|narcotics|mesh-ancestor
55837631|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
55737895|NCT03415087|Analgesics|analgesics|mesh-ancestor
55737896|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55737897|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55737898|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
55737899|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
55737900|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737902|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
55737903|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737904|NCT03419767|Protective Agents|protective agents|mesh-ancestor
55737905|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737906|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737907|NCT03414931|Sertraline|sertraline|mesh-list
55837699|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
55737908|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
55737909|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55737910|NCT03414931|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55737911|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55737912|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55737913|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737914|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737915|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
55847084|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55737917|NCT04699591|Domperidone|domperidone|mesh-list
55737918|NCT04699591|Antiemetics|antiemetics|mesh-ancestor
55737919|NCT04699591|Autonomic Agents|autonomic agents|mesh-ancestor
55737920|NCT04699591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737921|NCT04699591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737922|NCT04699591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55737923|NCT04699591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55737924|NCT04699591|Dopamine Agents|dopamine agents|mesh-ancestor
55737925|NCT04699591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55737926|NCT04699591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737927|NCT04448821|Metformin|metformin|mesh-list
55737928|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55737929|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737930|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55737931|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
55737932|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
55737933|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737934|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
55737935|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55737937|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737938|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737939|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55737940|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55737941|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55737944|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737945|NCT04448587|Incretins|incretins|mesh-ancestor
55737946|NCT04448587|Hormones|hormones|mesh-ancestor
55737947|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737948|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55737949|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
55737950|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737951|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737952|NCT03426085|Liraglutide|liraglutide|mesh-list
55737953|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55737954|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737955|NCT03426085|Incretins|incretins|mesh-ancestor
55737956|NCT03426085|Hormones|hormones|mesh-ancestor
55737957|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737958|NCT03418597|Anesthetics|anesthetics|mesh-list
55737959|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55737960|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737962|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
55737963|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55737964|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737965|NCT03127189|Rilpivirine|rilpivirine|mesh-list
55737966|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55737967|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55737968|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55737969|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55737970|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
55737971|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55737973|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55737974|NCT02521051|Bevacizumab|bevacizumab|mesh-list
55737975|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55737976|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737977|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55737978|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55737979|NCT02521051|Growth Substances|growth substances|mesh-ancestor
55737980|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737981|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
55737982|NCT01239797|Dexamethasone|dexamethasone|mesh-list
55837782|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
55837783|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
55737983|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
55737984|NCT01239797|Lenalidomide|lenalidomide|mesh-list
55737985|NCT01239797|Elotuzumab|elotuzumab|mesh-list
55737986|NCT01239797|BB 1101|bb 1101|mesh-list
55737987|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55737988|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
55737989|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
55847173|NCT03036904|Prednisone|prednisone|mesh-list
55737990|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55737991|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55737994|NCT01239797|Hormones|hormones|mesh-ancestor
55737995|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55737996|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55737997|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55737998|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
55737999|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738000|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738001|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
55738002|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55738003|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55738004|NCT01239797|Growth Substances|growth substances|mesh-ancestor
55738005|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
55738007|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55738008|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738009|NCT02735707|Aspirin|aspirin|mesh-list
55738010|NCT02735707|Vitamins|vitamins|mesh-list
55738011|NCT02735707|Ascorbic Acid|ascorbic acid|mesh-list
55738012|NCT02735707|Interferons|interferons|mesh-list
55738013|NCT02735707|Ritonavir|ritonavir|mesh-list
55738014|NCT02735707|Lopinavir|lopinavir|mesh-list
55738015|NCT02735707|Interferon-beta|interferon-beta|mesh-list
55738016|NCT02735707|Oseltamivir|oseltamivir|mesh-list
55738017|NCT02735707|Interferon beta-1a|interferon beta-1a|mesh-list
55738018|NCT02735707|Antiviral Agents|antiviral agents|mesh-list
55738019|NCT02735707|Amoxicillin|amoxicillin|mesh-list
55738020|NCT02735707|Moxifloxacin|moxifloxacin|mesh-list
55738021|NCT02735707|Hydroxychloroquine|hydroxychloroquine|mesh-list
55738022|NCT02735707|Levofloxacin|levofloxacin|mesh-list
55738023|NCT02735707|Ivermectin|ivermectin|mesh-list
55738026|NCT02735707|Piperacillin|piperacillin|mesh-list
55738027|NCT02735707|Clavulanic Acid|clavulanic acid|mesh-list
55738028|NCT02735707|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55738029|NCT02735707|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
55738030|NCT02735707|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55738032|NCT02735707|Hydrocortisone|hydrocortisone|mesh-list
55738033|NCT02735707|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55738034|NCT02735707|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55738035|NCT02735707|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55738036|NCT02735707|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55738037|NCT02735707|Losartan|losartan|mesh-list
55738038|NCT02735707|Valsartan|valsartan|mesh-list
55738039|NCT02735707|Telmisartan|telmisartan|mesh-list
55738040|NCT02735707|Candesartan|candesartan|mesh-list
55738041|NCT02735707|Ramipril|ramipril|mesh-list
55738042|NCT02735707|Olmesartan|olmesartan|mesh-list
55738043|NCT02735707|Enalapril|enalapril|mesh-list
55738044|NCT02735707|Lisinopril|lisinopril|mesh-list
55738045|NCT02735707|Irbesartan|irbesartan|mesh-list
55738046|NCT02735707|Perindopril|perindopril|mesh-list
55738047|NCT02735707|Captopril|captopril|mesh-list
55738048|NCT02735707|Trandolapril|trandolapril|mesh-list
55738049|NCT02735707|Clopidogrel|clopidogrel|mesh-list
55738050|NCT02735707|Ticagrelor|ticagrelor|mesh-list
55738051|NCT02735707|Simvastatin|simvastatin|mesh-list
55738052|NCT02735707|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55738053|NCT02735707|Immunoglobulins|immunoglobulins|mesh-list
55738054|NCT02735707|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
55770165|NCT03806309|Antidotes|antidotes|mesh-ancestor
55738055|NCT02735707|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55837893|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55738057|NCT02735707|Micronutrients|micronutrients|mesh-ancestor
55738058|NCT02735707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738059|NCT02735707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738060|NCT02735707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738061|NCT02735707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55738062|NCT02735707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55738064|NCT02735707|Sensory System Agents|sensory system agents|mesh-ancestor
55738065|NCT02735707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738066|NCT02735707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55738067|NCT02735707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55738068|NCT02735707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55738069|NCT02735707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55738070|NCT02735707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738071|NCT02735707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55738072|NCT02735707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55738074|NCT02735707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55738075|NCT02735707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55738076|NCT02735707|Protease Inhibitors|protease inhibitors|mesh-ancestor
55738077|NCT02735707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55738078|NCT02735707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55738079|NCT02735707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55738080|NCT02735707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55738081|NCT02735707|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55738082|NCT02735707|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55738083|NCT02735707|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55738084|NCT02735707|Purinergic Agents|purinergic agents|mesh-ancestor
55738085|NCT02735707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738086|NCT02735707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55738087|NCT02735707|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55738089|NCT02735707|Antimetabolites|antimetabolites|mesh-ancestor
55738090|NCT02735707|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55738091|NCT02735707|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55738092|NCT02735707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55738093|NCT02735707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55738094|NCT02735707|Immunologic Factors|immunologic factors|mesh-ancestor
55738095|NCT02735707|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55738096|NCT02735707|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55738097|NCT02735707|Antimalarials|antimalarials|mesh-ancestor
55738098|NCT02735707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55738099|NCT02735707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55738100|NCT02735707|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55738101|NCT02735707|Antioxidants|antioxidants|mesh-ancestor
55738102|NCT02735707|Protective Agents|protective agents|mesh-ancestor
55738103|NCT02735707|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55738104|NCT02735707|Renal Agents|renal agents|mesh-ancestor
55738105|NCT02735707|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55738106|NCT02735707|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55738107|NCT02735707|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55738108|NCT02735707|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55738109|NCT02735707|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55738110|NCT02735707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55738111|NCT02735707|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
55738113|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
55738114|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738115|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738117|NCT01092143|Xhance|xhance|mesh-list
55738118|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55738119|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55738120|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
55738121|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738122|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738123|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55738124|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
55738125|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
55738126|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55738127|NCT00950989|Folic Acid|folic acid|mesh-list
55738128|NCT00950989|Methotrexate|methotrexate|mesh-list
55738129|NCT00950989|Brodalumab|brodalumab|mesh-list
55738130|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55738131|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
55738132|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55838038|NCT01432600|Growth Substances|growth substances|mesh-ancestor
55838039|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
55738133|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738134|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55738135|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
55738136|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738137|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738138|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
55738139|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738140|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55738141|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55738142|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
55738143|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55738144|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55738145|NCT00950989|Hematinics|hematinics|mesh-ancestor
55738146|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
55738147|NCT00950989|Vitamins|vitamins|mesh-ancestor
55738148|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
55738150|NCT03420911|Midazolam|midazolam|mesh-list
55738151|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55738152|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55738153|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738154|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738155|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55738156|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55738157|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55738158|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55738159|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
55738160|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
55738161|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
55738162|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
55738163|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738164|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738165|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55738166|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55738167|NCT03420911|Analgesics|analgesics|mesh-ancestor
55838229|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55738168|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
55738169|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738170|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55738171|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55738172|NCT03416231|Docetaxel|docetaxel|mesh-list
55738173|NCT03416231|Apatinib|apatinib|mesh-list
55738174|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738175|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
55738176|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
55738177|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
55738178|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738179|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55738180|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738181|NCT04537715|Itraconazole|itraconazole|mesh-list
55738182|NCT04537715|Rifampin|rifampin|mesh-list
55770197|NCT02389751|Paclitaxel|paclitaxel|mesh-list
55738183|NCT04537715|Antifungal Agents|antifungal agents|mesh-ancestor
55738184|NCT04537715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738185|NCT04537715|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55738186|NCT04537715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55738187|NCT04537715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738188|NCT04537715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738189|NCT04537715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55738190|NCT04537715|Hormone Antagonists|hormone antagonists|mesh-ancestor
55738191|NCT04537715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55738192|NCT04537715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738193|NCT04537715|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55738194|NCT04537715|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55738195|NCT04537715|Antitubercular Agents|antitubercular agents|mesh-ancestor
55738196|NCT04537715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55738197|NCT04537715|Leprostatic Agents|leprostatic agents|mesh-ancestor
55738198|NCT04537715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55738199|NCT04537715|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55738200|NCT04537715|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55738201|NCT04537715|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55738202|NCT04537715|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55738203|NCT04537715|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55738204|NCT04537715|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55738206|NCT03415763|Capecitabine|capecitabine|mesh-list
55738207|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
55738208|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55738209|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
55738210|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738211|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738212|NCT03415763|Antidotes|antidotes|mesh-ancestor
55738213|NCT03415763|Protective Agents|protective agents|mesh-ancestor
55738214|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738215|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
55738216|NCT03415763|Vitamins|vitamins|mesh-ancestor
55738217|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
55738218|NCT00593567|Levofloxacin|levofloxacin|mesh-list
55738219|NCT00593567|Ofloxacin|ofloxacin|mesh-list
55738220|NCT00593567|Gentamicins|gentamicins|mesh-list
55738221|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55738222|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738223|NCT00593567|Renal Agents|renal agents|mesh-ancestor
55738224|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55738225|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55738226|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55738227|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738228|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738229|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738230|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55738231|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55738232|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55738233|NCT03419975|Latanoprost|latanoprost|mesh-list
55738234|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55738235|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55738236|NCT00006455|Leucovorin|leucovorin|mesh-list
55738237|NCT00006455|Cytarabine|cytarabine|mesh-list
55738238|NCT00006455|Dexamethasone|dexamethasone|mesh-list
55738239|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
55738240|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55738241|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55738242|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55738243|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
55738244|NCT00006455|Ifosfamide|ifosfamide|mesh-list
55738245|NCT00006455|Doxorubicin|doxorubicin|mesh-list
55738246|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55738247|NCT00006455|Methotrexate|methotrexate|mesh-list
55738248|NCT00006455|Etoposide|etoposide|mesh-list
55738249|NCT00006455|Vinblastine|vinblastine|mesh-list
55738250|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
55738251|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55738252|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
55738253|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738254|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838702|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738255|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55738256|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
55738631|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738257|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738258|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738259|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55738260|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55738262|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
55738263|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738264|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55738265|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
55738266|NCT00006455|Hormones|hormones|mesh-ancestor
55738267|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838779|NCT01759407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55738268|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55738269|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55738270|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55738271|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55738272|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738273|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55738274|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
55838888|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
55738275|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55738276|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55738277|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
55738278|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
55738279|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55738280|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55738281|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55738282|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
55738283|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738284|NCT00006455|Antidotes|antidotes|mesh-ancestor
55738285|NCT00006455|Protective Agents|protective agents|mesh-ancestor
55738286|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
55738287|NCT00006455|Vitamins|vitamins|mesh-ancestor
55738288|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
55738289|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
55738290|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
55738291|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
55738292|NCT01602315|Cetuximab|cetuximab|mesh-list
55738293|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55738294|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738295|NCT02537197|Naltrexone|naltrexone|mesh-list
55738296|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55738297|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55738298|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738299|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
55738300|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738301|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55738302|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55738303|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55738304|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55738306|NCT03413371|Lidocaine|lidocaine|mesh-list
55738307|NCT03413371|Bupivacaine|bupivacaine|mesh-list
55738308|NCT03413371|Ropivacaine|ropivacaine|mesh-list
55738309|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
55738310|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
55738311|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738312|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738313|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
55738314|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738315|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55738316|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55738317|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55738318|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55738319|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738320|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55738322|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
55738323|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
55738324|NCT05116995|Ticagrelor|ticagrelor|mesh-list
55738325|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55738326|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55738327|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55738328|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55738329|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
55738330|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839264|NCT01402492|Analgesics|analgesics|mesh-ancestor
55839869|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55738331|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738332|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738333|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55738334|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
55738335|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55738336|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
55738337|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839466|NCT01385098|Vitamin D|vitamin d|mesh-list
55738338|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
55738340|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55738341|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738342|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
55738343|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55738344|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738346|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55738348|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
55738349|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738350|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55738351|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55738352|NCT03677115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55738353|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
55738354|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738355|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738356|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
55738357|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55738358|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
55738359|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
55738360|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55738361|NCT05116371|Estradiol|estradiol|mesh-list
55738362|NCT05116371|Estrogens|estrogens|mesh-ancestor
55738363|NCT05116371|Hormones|hormones|mesh-ancestor
55738364|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55738365|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738366|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55738367|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55738368|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55738369|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55738370|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55738372|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
55738373|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55738374|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55738375|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55738376|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738377|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738378|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
55738379|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
55738380|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738381|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738382|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55738383|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55738384|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
55738385|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55738386|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55738387|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55738388|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55738389|NCT03417427|Cytarabine|cytarabine|mesh-list
55738390|NCT03417427|Decitabine|decitabine|mesh-list
55738391|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55738392|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
55738393|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738394|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738395|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
55738396|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738397|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55738398|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
55738399|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738400|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738401|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
55738402|NCT03425617|Olodaterol|olodaterol|mesh-list
55738403|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55738404|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
55738405|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738406|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738407|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55738408|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
55738409|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
55738410|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55738411|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
55738412|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738413|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738414|NCT03419429|Simvastatin|simvastatin|mesh-list
55738415|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55738416|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55738417|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
55738418|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738419|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55738420|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55738421|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738423|NCT02654145|Albuterol|albuterol|mesh-list
55738424|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55738425|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
55738426|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738427|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738428|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55738429|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
55738430|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
55840014|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
55738431|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55738432|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55738433|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55738435|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
55738436|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738437|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738438|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55738439|NCT05122455|Edoxaban|edoxaban|mesh-list
55738440|NCT05122455|Clopidogrel|clopidogrel|mesh-list
55738441|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55738442|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55738443|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55738444|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55738445|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
55738446|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738447|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847174|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
55738448|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738449|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55738450|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
55738451|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55738452|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
55738453|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738454|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
55738455|NCT03413059|Triamcinolone|triamcinolone|mesh-list
55738456|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55738457|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55738458|NCT03413059|Morphine|morphine|mesh-list
55738459|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55738460|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55738461|NCT03413059|Narcotics|narcotics|mesh-ancestor
55738462|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738463|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738464|NCT03413059|Analgesics|analgesics|mesh-ancestor
55738465|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
55738466|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738467|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55738468|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
55738469|NCT03413059|Hormones|hormones|mesh-ancestor
55738470|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55738471|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55738472|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
55738473|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738474|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738475|NCT05122377|Goserelin|goserelin|mesh-list
55738476|NCT05122377|Leuprolide|leuprolide|mesh-list
55738477|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55738478|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738479|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55738480|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
55738481|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55738482|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738483|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55738484|NCT03425461|Nivolumab|nivolumab|mesh-list
55738485|NCT03425461|Ipilimumab|ipilimumab|mesh-list
55738486|NCT03425461|Antibodies|antibodies|mesh-list
55738487|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
55738488|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55738489|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
55738490|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738491|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738492|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55738493|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738494|NCT04753437|Amoxicillin|amoxicillin|mesh-list
55738495|NCT04753437|Clarithromycin|clarithromycin|mesh-list
55738496|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
55738497|NCT04753437|Esomeprazole|esomeprazole|mesh-list
55738498|NCT04753437|Bismuth|bismuth|mesh-list
55738499|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738500|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55738501|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738502|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55738503|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55738504|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55738505|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738506|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55738507|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55738508|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55738509|NCT04753437|Antacids|antacids|mesh-ancestor
55738510|NCT04753437|Diuretics|diuretics|mesh-ancestor
55738511|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
55738512|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738513|NCT04753437|Expectorants|expectorants|mesh-ancestor
55738514|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
55738515|NCT03411109|Hydromorphone|hydromorphone|mesh-list
55738516|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55738517|NCT03411109|Narcotics|narcotics|mesh-ancestor
55738518|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738519|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738520|NCT03411109|Analgesics|analgesics|mesh-ancestor
55738521|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
55738522|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738524|NCT01111565|Citalopram|citalopram|mesh-list
55738525|NCT01111565|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55847175|NCT03036904|Rituximab|rituximab|mesh-list
55738526|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55738527|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55738528|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738530|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
55738531|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738532|NCT01111565|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55738533|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
55738534|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55738535|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55738536|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55738537|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738538|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
55738539|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
55840590|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55738540|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55738541|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55738542|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55738543|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55738544|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55738545|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55738546|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55738547|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55738548|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
55738549|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738550|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738551|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738552|NCT03412513|Mirabegron|mirabegron|mesh-list
55738553|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55738554|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55738555|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55738556|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
55738557|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738558|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738559|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738560|NCT03412513|Urological Agents|urological agents|mesh-ancestor
55738561|NCT04370379|Aflibercept|aflibercept|mesh-list
55738562|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55738563|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55738564|NCT04370379|Growth Substances|growth substances|mesh-ancestor
55738565|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738567|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738568|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
55738569|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55738570|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55738571|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738572|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
55738573|NCT03413891|Coagulants|coagulants|mesh-ancestor
55738574|NCT03317613|Capsaicin|capsaicin|mesh-list
55738575|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
55738576|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
55738577|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
55840905|NCT01850030|Progesterone|progesterone|mesh-list
55738578|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738579|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738580|NCT03126877|Mitomycins|mitomycins|mesh-list
55738581|NCT03126877|Mitomycin|mitomycin|mesh-list
55738582|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55738583|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738584|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
55770252|NCT02388581|Amoxicillin|amoxicillin|mesh-list
55738585|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738586|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55738587|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738588|NCT04260477|Rifampin|rifampin|mesh-list
55738589|NCT04260477|Isoniazid|isoniazid|mesh-list
55738590|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
55738591|NCT04260477|Ethambutol|ethambutol|mesh-list
55738592|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55738593|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
55738594|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55738595|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738596|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
55738597|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55738598|NCT04260477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847184|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55738599|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738600|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55738601|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55738602|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55738603|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55738604|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55738605|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55738606|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55738607|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55738608|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
55738609|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55738610|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
55738611|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
55738612|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55738613|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
55738614|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738615|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738616|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55738617|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
55738618|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55738619|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55738620|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55738621|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
55738622|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738623|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738624|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55738625|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55738626|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55738627|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
55738628|NCT03424759|Osimertinib|osimertinib|mesh-list
55738629|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738630|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55738632|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738633|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
55738634|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55738635|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738637|NCT04814745|Tramadol|tramadol|mesh-list
55738638|NCT04814745|Ropivacaine|ropivacaine|mesh-list
55738639|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55738640|NCT04814745|Narcotics|narcotics|mesh-ancestor
55738641|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738642|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738644|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
55738645|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738646|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
55738647|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
55738648|NCT04640571|Metformin|metformin|mesh-list
55738649|NCT04640571|Valacyclovir|valacyclovir|mesh-list
55738650|NCT04640571|Enalaprilat|enalaprilat|mesh-list
55738651|NCT04640571|Enalapril|enalapril|mesh-list
55738652|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
55738653|NCT04640571|Pravastatin|pravastatin|mesh-list
55738654|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55738655|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738656|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55738657|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55738658|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
55738659|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738660|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55738661|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55738662|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738663|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
55738664|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738665|NCT04640571|Cathartics|cathartics|mesh-ancestor
55738666|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55738667|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55738668|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
55738669|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55738670|NCT04431141|Empagliflozin|empagliflozin|mesh-list
55738671|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55738672|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738673|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55738674|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738675|NCT05229627|Methylphenidate|methylphenidate|mesh-list
55738676|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55738677|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55738678|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738679|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55738680|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55738681|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55738682|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738683|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
55738684|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738685|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55841594|NCT04149964|Acetaminophen|acetaminophen|mesh-list
55738686|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
55738687|NCT01976169|Palbociclib|palbociclib|mesh-list
55738688|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55738689|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738690|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55738691|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738692|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738693|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55738694|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
55738695|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
55738696|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
55738697|NCT00148629|Mebendazole|mebendazole|mesh-list
55738698|NCT00148629|Piperazine|piperazine|mesh-list
55738699|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
55738700|NCT00148629|DMP 777|dmp 777|mesh-list
55738701|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
55738702|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
55738703|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55738704|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738705|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
55738706|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
55738707|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
55738708|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738709|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738710|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738711|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
55738713|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738714|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738716|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
55738717|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738718|NCT01328041|Dolutegravir|dolutegravir|mesh-list
55738719|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55738720|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55738721|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738722|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738723|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55738724|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55738725|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
55738726|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738728|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
55738729|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738730|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738731|NCT03418337|Lansoprazole|lansoprazole|mesh-list
55738732|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
55738733|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55738734|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55738735|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55738736|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738737|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738738|NCT03411967|Docetaxel|docetaxel|mesh-list
55738739|NCT03411967|Apatinib|apatinib|mesh-list
55738740|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738741|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
55738742|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
55738743|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
55738744|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738745|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55738746|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841948|NCT05580328|Hematoporphyrins|hematoporphyrins|mesh-list
55738748|NCT05228925|Vitamins|vitamins|mesh-ancestor
55738749|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
55738750|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847580|NCT02542696|Emetics|emetics|mesh-ancestor
55738751|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55738752|NCT03412409|Cytarabine|cytarabine|mesh-list
55738753|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
55738754|NCT03412409|Busulfan|busulfan|mesh-list
55738755|NCT03412409|Semustine|semustine|mesh-list
55738756|NCT03412409|Fludarabine|fludarabine|mesh-list
55738757|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55738758|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55738759|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
55738760|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738761|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55738762|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55738763|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
55738764|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738765|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738766|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55738767|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55738768|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
55842048|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738769|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
55738770|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738771|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
55738772|NCT02410772|Rifapentine|rifapentine|mesh-list
55738773|NCT02410772|Rifampin|rifampin|mesh-list
55738774|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55738775|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738776|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55738777|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55738778|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738779|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738780|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738781|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55738782|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
55738783|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
55738784|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55738785|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55738865|NCT03424135|Analgesics|analgesics|mesh-ancestor
55738786|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55738787|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55738788|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55738789|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55738790|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55738794|NCT03127319|Apatinib|apatinib|mesh-list
55738795|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738796|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
55738797|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
55738798|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
55738799|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738800|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55738801|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738803|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
55738804|NCT03417947|Vitamins|vitamins|mesh-ancestor
55738805|NCT03417947|Micronutrients|micronutrients|mesh-ancestor
55738806|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738807|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55842292|NCT03020602|Ubiquinone|ubiquinone|mesh-list
55842293|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
55738808|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55738809|NCT03905811|Terazosin|terazosin|mesh-list
55738810|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55738811|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55738812|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55738813|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
55738814|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738815|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738816|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738817|NCT03905811|Urological Agents|urological agents|mesh-ancestor
55738818|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55738819|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55738820|NCT05171309|Apatinib|apatinib|mesh-list
55738821|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738822|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55738823|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738824|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738825|NCT03409237|Mannitol|mannitol|mesh-list
55738826|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55842489|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738827|NCT03409237|Diuretics|diuretics|mesh-ancestor
55738828|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
55738829|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738830|NCT03408847|Beclomethasone|beclomethasone|mesh-list
55738831|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55738832|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
55738834|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55738835|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738836|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55738837|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
55738838|NCT03424291|Apatinib|apatinib|mesh-list
55738839|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738840|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55738841|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738842|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738844|NCT03407521|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55738845|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55738846|NCT03407521|Misoprostol|misoprostol|mesh-list
55738847|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55738848|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
55738849|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55842619|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
55738851|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55738852|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55738853|NCT03407521|Oxytocics|oxytocics|mesh-ancestor
55738854|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55738855|NCT03407521|Diuretics|diuretics|mesh-ancestor
55738856|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
55738858|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55738859|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738860|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
55738861|NCT03424135|Promethazine|promethazine|mesh-list
55738862|NCT03424135|Naproxen|naproxen|mesh-list
55738863|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55738864|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55738866|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
55738867|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738868|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738869|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55738870|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55738871|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
55738872|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55738874|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738875|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55738876|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55738877|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738878|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
55738879|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
55738880|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
55738881|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
55738882|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55738883|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55738884|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
55738885|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
55738886|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738887|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55738888|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
55738889|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
55738890|NCT03411941|Aflibercept|aflibercept|mesh-list
55842993|NCT02081950|Enoxaparin|enoxaparin|mesh-list
55738891|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55738892|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55738894|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738895|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
55738896|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738897|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55738898|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
55738899|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55738900|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738901|NCT03406819|Nitroprusside|nitroprusside|mesh-list
55738902|NCT03406819|Tirofiban|tirofiban|mesh-list
55738903|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55738904|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
55738905|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55847732|NCT01892332|Lidocaine|lidocaine|mesh-list
55738906|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738907|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55738908|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55738909|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55738910|NCT05170217|Cannabidiol|cannabidiol|mesh-list
55738911|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
55738912|NCT03411551|Anesthetics|anesthetics|mesh-list
55843268|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55738913|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738914|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738916|NCT05170061|Nebivolol|nebivolol|mesh-list
55738917|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55738918|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55738919|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55738920|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738921|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
55738922|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55738923|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55738925|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
55738926|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738927|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738928|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
55738929|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55738930|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55738931|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
55738932|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738933|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55738934|NCT02520635|Temozolomide|temozolomide|mesh-list
55738935|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55738937|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738938|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738939|NCT03404947|Ethanol|ethanol|mesh-list
55738940|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55738941|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738942|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738943|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738945|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55738946|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738947|NCT03423823|Ranibizumab|ranibizumab|mesh-list
55843693|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55738948|NCT03423823|Aflibercept|aflibercept|mesh-list
55738949|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738950|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55738951|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55738953|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738954|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
55738955|NCT03411161|Paclitaxel|paclitaxel|mesh-list
55738956|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55738957|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55738958|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738959|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
55738960|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
55738961|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
55738962|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738963|NCT04737603|Buprenorphine|buprenorphine|mesh-list
55738964|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55738965|NCT04737603|Naloxone|naloxone|mesh-list
55738966|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55738967|NCT04737603|Narcotics|narcotics|mesh-ancestor
55738968|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55738969|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738970|NCT04737603|Analgesics|analgesics|mesh-ancestor
55738971|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
55738972|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55738973|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55738974|NCT05168137|Colchicine|colchicine|mesh-list
55738975|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
55738976|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55738977|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
55738978|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
55738979|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
55738980|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738981|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55738982|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55738983|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738984|NCT05168059|Clevidipine|clevidipine|mesh-list
55738985|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55738986|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55738987|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55738988|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55738989|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55738991|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55738992|NCT02375295|Nitrofurantoin|nitrofurantoin|mesh-list
55738993|NCT02375295|Trimethoprim|trimethoprim|mesh-list
55738994|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55738995|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55738996|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55738997|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55738998|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55738999|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739000|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739001|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55739002|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55739003|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55739004|NCT02375295|Renal Agents|renal agents|mesh-ancestor
55739005|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
55739008|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55739009|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55739010|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55739012|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739013|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
55739014|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
55739015|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
55739016|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739017|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
55739018|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55739019|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55739020|NCT03393949|Prednisolone|prednisolone|mesh-list
55739021|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
55739022|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55739023|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
55739024|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55739025|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
55739026|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
55739027|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739028|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739029|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55739030|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
55739031|NCT03393949|Hormones|hormones|mesh-ancestor
55739032|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739033|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55739034|NCT03393949|Protective Agents|protective agents|mesh-ancestor
55739035|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55739036|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739037|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
55739038|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55739039|NCT03818061|Bevacizumab|bevacizumab|mesh-list
55739040|NCT03818061|Atezolizumab|atezolizumab|mesh-list
55739041|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739042|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739043|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55739044|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55739045|NCT03818061|Growth Substances|growth substances|mesh-ancestor
55739046|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739047|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
55739048|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
55739049|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55739050|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739051|NCT04435743|Lenalidomide|lenalidomide|mesh-list
55739052|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
55739053|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739054|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55739055|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55739056|NCT04435743|Growth Substances|growth substances|mesh-ancestor
55739057|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
55739058|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739059|NCT03393715|Perindopril|perindopril|mesh-list
55739060|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55844292|NCT01556997|Amlodipine|amlodipine|mesh-list
55739064|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55739065|NCT03397537|Letrozole|letrozole|mesh-list
55739066|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739067|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55739068|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55739069|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739070|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739071|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55739072|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
55739073|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739074|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739078|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
55739079|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739080|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
55739081|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739082|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739083|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739084|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55739086|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
55739087|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739089|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
55739090|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55739091|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55739092|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739094|NCT01936857|Methadone|methadone|mesh-list
55739095|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55739096|NCT01936857|Naloxone|naloxone|mesh-list
55739097|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55739098|NCT01936857|Narcotics|narcotics|mesh-ancestor
55739099|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844550|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55739100|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844560|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
55739102|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
55739103|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739104|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55739105|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
55739106|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739108|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55739109|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739110|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739111|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55739112|NCT03393403|Analgesics|analgesics|mesh-ancestor
55739113|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
55739114|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739115|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55739116|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55739118|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
55739119|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739120|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739122|NCT03399955|Paromomycin|paromomycin|mesh-list
55739123|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55739124|NCT03399955|Miltefosine|miltefosine|mesh-list
55739125|NCT03399955|Amebicides|amebicides|mesh-ancestor
55739126|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55739127|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55739128|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739129|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55739130|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
55739131|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739133|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739134|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55844745|NCT05665270|Prednisolone|prednisolone|mesh-list
55739136|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739137|NCT05188053|Ketorolac|ketorolac|mesh-list
55739138|NCT05188053|Epinephrine|epinephrine|mesh-list
55739139|NCT05188053|Ropivacaine|ropivacaine|mesh-list
55739146|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55739148|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
55739149|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739150|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739151|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55739152|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55845071|NCT03330028|Anesthetics|anesthetics|mesh-ancestor
55739155|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739156|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
55739157|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
55739158|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55739159|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55739161|NCT05188053|Analgesics|analgesics|mesh-ancestor
55739162|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55739163|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55739164|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55739165|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739166|NCT03393325|Tadalafil|tadalafil|mesh-list
55739167|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
55739168|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55739169|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55739170|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845202|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739171|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739172|NCT03393325|Urological Agents|urological agents|mesh-ancestor
55739173|NCT03399643|Atezolizumab|atezolizumab|mesh-list
55739174|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739175|NCT03393247|Azathioprine|azathioprine|mesh-list
55739176|NCT03393247|Infliximab|infliximab|mesh-list
55739177|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
55739178|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55739179|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55739180|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
55739181|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739182|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55739184|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55770312|NCT02084056|Linagliptin|linagliptin|mesh-list
55739185|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
55739186|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739187|NCT03407027|Triamcinolone|triamcinolone|mesh-list
55739188|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55739189|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55739190|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55739191|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55739194|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739195|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739196|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55739197|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
55739198|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739199|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739202|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739203|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739204|NCT01602224|Dexamethasone|dexamethasone|mesh-list
55739205|NCT01602224|Bortezomib|bortezomib|mesh-list
55739206|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55739207|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
55739208|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
55739209|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847733|NCT01892332|Fentanyl|fentanyl|mesh-list
55744396|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55739214|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739216|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739217|NCT03399487|Ceritinib|ceritinib|mesh-list
55739218|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739219|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55739221|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739223|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55739224|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739226|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
55739227|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
55739228|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
55739229|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739230|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739231|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
55739232|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739233|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55739234|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55739236|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55744397|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55739237|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739239|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
55739240|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845740|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739241|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55739242|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55739243|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55739244|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55739245|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
55739246|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739247|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
55739248|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55739249|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55739250|NCT05060991|Antimetabolites|antimetabolites|mesh-list
55739251|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739254|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55739255|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55739256|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739257|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739258|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55739259|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55739260|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55739261|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55739262|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
55739263|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
55739264|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
55739265|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
55739266|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739267|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739268|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
55739269|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739270|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739271|NCT03399019|Midazolam|midazolam|mesh-list
55739272|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
55739273|NCT03399019|Propofol|propofol|mesh-list
55739274|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55739275|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739276|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739277|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55739278|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
55739279|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
55739280|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55739281|NCT03399019|Analgesics|analgesics|mesh-ancestor
55739288|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744399|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
55739289|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739290|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55739291|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55739292|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55739293|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55739294|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
55739295|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
55739297|NCT04452383|Propofol|propofol|mesh-list
55739298|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55739299|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739300|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739301|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55739302|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
55739303|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
55739304|NCT04452383|Analgesics|analgesics|mesh-ancestor
55739305|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
55739306|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739307|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55739308|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55739309|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55739310|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739311|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739313|NCT02520479|Asparaginase|asparaginase|mesh-list
55739314|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739315|NCT02520947|Desflurane|desflurane|mesh-list
55739316|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55739317|NCT02520947|Anesthetics, General|anesthetics, general|mesh-ancestor
55739318|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
55739319|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739320|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739321|NCT03398941|Octreotide|octreotide|mesh-list
55739322|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55739323|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55739324|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739325|NCT03396601|Ketamine|ketamine|mesh-list
55739326|NCT03396601|Analgesics|analgesics|mesh-ancestor
55739327|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
55739328|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739329|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739330|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55739331|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55739332|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
55739333|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
55739334|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846727|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739335|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55739336|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55739338|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739340|NCT03392623|Niacin|niacin|mesh-list
55739341|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
55739342|NCT03392623|Tretinoin|tretinoin|mesh-list
55739343|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
55739344|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739345|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
55739346|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
55739347|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55739348|NCT03392623|Protective Agents|protective agents|mesh-ancestor
55739349|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739350|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
55739351|NCT03392623|Vitamins|vitamins|mesh-ancestor
55739352|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
55739353|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55739354|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
55739359|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55739360|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
55739361|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
55739362|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739363|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739366|NCT03396107|Hormones|hormones|mesh-ancestor
55847577|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
55739367|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739368|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55739369|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739370|NCT03398785|Epinephrine|epinephrine|mesh-list
55739371|NCT03398785|Racepinephrine|racepinephrine|mesh-list
55739372|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
55739373|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55739374|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55739375|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
55739376|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739377|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739378|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739379|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55739380|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55739381|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
55739382|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739384|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739385|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
55739386|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
55739387|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55739388|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
55739389|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
55739390|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739392|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55739393|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55739394|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55739395|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55739396|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
55739397|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739398|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739399|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739400|NCT04300595|Anesthetics|anesthetics|mesh-list
55739401|NCT04300595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739402|NCT04300595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739403|NCT04608019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55847270|NCT03827278|Amebicides|amebicides|mesh-ancestor
55739404|NCT04608019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739406|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55739407|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739408|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
55739409|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
55739410|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
55739411|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739412|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
55739413|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55739414|NCT04167761|Glipizide|glipizide|mesh-list
55739415|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739416|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55739417|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739418|NCT03401177|Naproxen|naproxen|mesh-list
55739419|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55739420|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55739421|NCT03401177|Analgesics|analgesics|mesh-ancestor
55739422|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
55739423|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739424|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739425|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55739426|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847478|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55847484|NCT02926222|Lomustine|lomustine|mesh-list
55739430|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739432|NCT04446715|Meperidine|meperidine|mesh-list
55739433|NCT04446715|Bupivacaine|bupivacaine|mesh-list
55739434|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
55739435|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
55739436|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739437|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739438|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
55739439|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739440|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55739441|NCT04446715|Narcotics|narcotics|mesh-ancestor
55739442|NCT04446715|Analgesics|analgesics|mesh-ancestor
55847575|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55847576|NCT01456312|Entecavir|entecavir|mesh-list
55847578|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847579|NCT02542696|Apomorphine|apomorphine|mesh-list
55739443|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55739444|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55739445|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
55739446|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
55739448|NCT03991403|Paclitaxel|paclitaxel|mesh-list
55739449|NCT03991403|Bevacizumab|bevacizumab|mesh-list
55739450|NCT03991403|Carboplatin|carboplatin|mesh-list
55847720|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
55739451|NCT03991403|Pemetrexed|pemetrexed|mesh-list
55739452|NCT03991403|Atezolizumab|atezolizumab|mesh-list
55739453|NCT03991403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55739455|NCT03991403|Tubulin Modulators|tubulin modulators|mesh-ancestor
55739456|NCT03991403|Antimitotic Agents|antimitotic agents|mesh-ancestor
55739457|NCT03991403|Mitosis Modulators|mitosis modulators|mesh-ancestor
55739458|NCT03991403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739459|NCT03991403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739460|NCT03991403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55739461|NCT03991403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55739462|NCT03991403|Growth Substances|growth substances|mesh-ancestor
55739463|NCT03991403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739464|NCT03991403|Growth Inhibitors|growth inhibitors|mesh-ancestor
55739465|NCT03991403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739466|NCT03991403|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55739467|NCT03991403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55739468|NCT03395951|Diuretics|diuretics|mesh-list
55739469|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
55739470|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739471|NCT04535791|Vitamin D|vitamin d|mesh-list
55739472|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
55739473|NCT04535791|Vitamins|vitamins|mesh-ancestor
55739474|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
55739475|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739476|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55739477|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55739478|NCT03395873|Decitabine|decitabine|mesh-list
55739479|NCT03395873|Avelumab|avelumab|mesh-list
55739480|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55739481|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
55739482|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739483|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739484|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739485|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739486|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55739487|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55739488|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739489|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
55848031|NCT05600296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848032|NCT05604586|Acetylcysteine|acetylcysteine|mesh-list
55739498|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
55739499|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55739500|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55739501|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55739502|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
55739503|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55848134|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55848137|NCT04127500|Analgesics|analgesics|mesh-ancestor
55739504|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739505|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55739506|NCT03126097|Estrogens|estrogens|mesh-ancestor
55739507|NCT03126097|Hormones|hormones|mesh-ancestor
55739508|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739509|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55739510|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
55848222|NCT04126252|Urological Agents|urological agents|mesh-ancestor
55848230|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
55739511|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55739512|NCT03126097|Diuretics|diuretics|mesh-ancestor
55739513|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
55739516|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739517|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739518|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55739519|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55739520|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55739521|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
55739522|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
55739523|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848300|NCT04411069|Droperidol|droperidol|mesh-list
55739524|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739525|NCT03392311|Calcipotriene|calcipotriene|mesh-list
55739526|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
55739528|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55739529|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55739530|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739531|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739532|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55739533|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55739534|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55739535|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55739536|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
55739537|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
55739538|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
55739539|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
55848419|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55739540|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848420|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744401|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55744402|NCT03332719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55739541|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739542|NCT04928521|Bupivacaine|bupivacaine|mesh-list
55739543|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
55739544|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
55739545|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739546|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739547|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
55739548|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739549|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
55739550|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
55739551|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739552|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
55739553|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739554|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739555|NCT03391843|Cetuximab|cetuximab|mesh-list
55739556|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
55739557|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739559|NCT03389659|Vitamin D|vitamin d|mesh-list
55739560|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
55739561|NCT03389659|Vitamins|vitamins|mesh-ancestor
55739562|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
55739563|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848628|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55739564|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55739566|NCT04446637|Albuterol|albuterol|mesh-list
55739567|NCT04446637|Ipratropium|ipratropium|mesh-list
55739568|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55739569|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
55739570|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739571|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739572|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55739573|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739575|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55739576|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55739577|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55739578|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55739579|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
55739580|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739581|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739582|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55739583|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
55739584|NCT03395171|Vitamin D|vitamin d|mesh-list
55739585|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
55739586|NCT03395171|Vitamins|vitamins|mesh-ancestor
55848707|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739587|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
55739588|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739589|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55739590|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55739591|NCT03395977|Febuxostat|febuxostat|mesh-list
55739592|NCT03395977|Rasburicase|rasburicase|mesh-list
55739593|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
55739594|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55739595|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
55739596|NCT02678143|Sirolimus|sirolimus|mesh-list
55739597|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
55739598|NCT02678143|Fludarabine|fludarabine|mesh-list
55739599|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
55739600|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55739601|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
55739602|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739603|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55739604|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55739605|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
55739606|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739607|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739608|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55739609|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55739610|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55739611|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
55739612|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55739613|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739614|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739615|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
55739616|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739617|NCT03395093|Fentanyl|fentanyl|mesh-list
55739618|NCT03395093|Midazolam|midazolam|mesh-list
55739619|NCT03395093|Propofol|propofol|mesh-list
55739620|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55739621|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739622|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739623|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55739624|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
55739625|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
55739626|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55739628|NCT03395093|Analgesics|analgesics|mesh-ancestor
55739629|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
55739630|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739631|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55739632|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55739633|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55739634|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55739635|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
55739636|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
55739637|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739638|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739639|NCT03389191|Acyclovir|acyclovir|mesh-list
55739640|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
55739641|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849034|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739642|NCT04330183|Ketamine|ketamine|mesh-list
55739643|NCT04330183|Analgesics|analgesics|mesh-ancestor
55739644|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
55739645|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739646|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739647|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55739648|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55739649|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
55739650|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
55739651|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739652|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55739653|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55739654|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739655|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739656|NCT03398993|Clomiphene|clomiphene|mesh-list
55739657|NCT03398993|Enclomiphene|enclomiphene|mesh-list
55739658|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
55739659|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55739660|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55739661|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
55739662|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739663|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739664|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55739665|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
55739666|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55849307|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739667|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55739668|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55739670|NCT04295863|Nivolumab|nivolumab|mesh-list
55739671|NCT04295863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739672|NCT04295863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739673|NCT04295863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55739674|NCT04295863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739675|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
55739676|NCT04249297|Progestins|progestins|mesh-ancestor
55739677|NCT04249297|Hormones|hormones|mesh-ancestor
55739678|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739679|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739680|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
55739681|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55739682|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55849555|NCT05585866|Anesthetics|anesthetics|mesh-list
55739683|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849558|NCT01992952|Fulvestrant|fulvestrant|mesh-list
55739684|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55739686|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
55739687|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739688|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55739689|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55739690|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55739691|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
55739692|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739693|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739696|NCT03398837|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55739697|NCT03398837|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55739698|NCT03398837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739699|NCT03398837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739707|NCT03398837|Sensory System Agents|sensory system agents|mesh-ancestor
55739708|NCT03398837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739709|NCT03398759|Butorphanol|butorphanol|mesh-list
55739710|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55739711|NCT03398759|Narcotics|narcotics|mesh-ancestor
55739712|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739713|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739714|NCT03398759|Analgesics|analgesics|mesh-ancestor
55739715|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
55849847|NCT01865110|Hormones|hormones|mesh-ancestor
55739716|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739717|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
55739718|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739719|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55739720|NCT03391219|Bevacizumab|bevacizumab|mesh-list
55739721|NCT03391219|Fasudil|fasudil|mesh-list
55739722|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739724|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55739725|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55739726|NCT03391219|Growth Substances|growth substances|mesh-ancestor
55739727|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739728|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
55739729|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55739730|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55739731|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739732|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55739733|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
55739734|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55739735|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739737|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55739738|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55739739|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
55739740|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739741|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739742|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739743|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55739744|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55739746|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
55739747|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55744405|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739748|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739749|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739750|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
55850027|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55739752|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55740524|NCT03378323|Anesthetics|anesthetics|mesh-list
55739753|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739755|NCT04447105|Propofol|propofol|mesh-list
55739756|NCT04447105|Desflurane|desflurane|mesh-list
55739757|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739758|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739759|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55739760|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55739762|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55739764|NCT03126461|Ipilimumab|ipilimumab|mesh-list
55739765|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55739766|NCT03126461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739767|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55739776|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739777|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
55739778|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739779|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55739780|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55739781|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55739782|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55739783|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739784|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55739785|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55739786|NCT03394001|Analgesics|analgesics|mesh-ancestor
55739787|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55739788|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55739789|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55739790|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739791|NCT03393767|Ranibizumab|ranibizumab|mesh-list
55739792|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55739793|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55739795|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739797|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739798|NCT03389321|Macitentan|macitentan|mesh-list
55739800|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55739801|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55739802|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739803|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55739804|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
55739806|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55739807|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55739808|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55739809|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739810|NCT05181527|Dextromethorphan|dextromethorphan|mesh-list
55739811|NCT05181527|Serotonin|serotonin|mesh-list
55739812|NCT05181527|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55739813|NCT05181527|Antitussive Agents|antitussive agents|mesh-ancestor
55739814|NCT05181527|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739815|NCT05181527|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55739816|NCT05181527|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55739817|NCT05181527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55770469|NCT02384915|Prilocaine|prilocaine|mesh-list
55739818|NCT05181527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739819|NCT05181527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739820|NCT05181527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55739821|NCT05181527|Serotonin Agents|serotonin agents|mesh-ancestor
55739822|NCT05181527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55739823|NCT05181527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55739825|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
55739826|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739827|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55739829|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739830|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
55739831|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
55739833|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739834|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55739835|NCT00783263|Ezetimibe|ezetimibe|mesh-list
55739840|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55744407|NCT03332329|Entecavir|entecavir|mesh-list
55744408|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55739841|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55739842|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739843|NCT00664937|Montelukast|montelukast|mesh-list
55739844|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55739845|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739846|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55739847|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
55744409|NCT03332329|Molgramostim|molgramostim|mesh-list
55739848|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739849|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739850|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55739851|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55744411|NCT03332329|Sargramostim|sargramostim|mesh-list
55739852|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739853|NCT00540839|Fluticasone|fluticasone|mesh-list
55739854|NCT00540839|Xhance|xhance|mesh-list
55739855|NCT00540839|Montelukast|montelukast|mesh-list
55739856|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55739857|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55739858|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
55739859|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739860|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739861|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55744412|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
55739862|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739863|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
55739864|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55739865|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55739866|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
55739867|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739868|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55739869|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55739870|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739871|NCT03389087|Etoposide|etoposide|mesh-list
55739872|NCT03389087|Apatinib|apatinib|mesh-list
55770474|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
55739873|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55739874|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739875|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55739876|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55739877|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739878|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739879|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55739880|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
55739881|NCT03388853|Doxofylline|doxofylline|mesh-list
55739882|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55739883|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
55739884|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55739885|NCT03388853|Expectorants|expectorants|mesh-ancestor
55739886|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739887|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55739888|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
55739889|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739890|NCT03388853|Protective Agents|protective agents|mesh-ancestor
55739891|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739892|NCT03388853|Antidotes|antidotes|mesh-ancestor
55739893|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
55739894|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55739895|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
55850397|NCT00410956|Hormones|hormones|mesh-ancestor
55739896|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739904|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
55744413|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739905|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739906|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739907|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55739908|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55739909|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739910|NCT03388697|Insulin|insulin|mesh-list
55739911|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55739912|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739913|NCT03987919|Tirzepatide|tirzepatide|mesh-list
55739914|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55739915|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739916|NCT03987919|Incretins|incretins|mesh-ancestor
55739917|NCT03987919|Hormones|hormones|mesh-ancestor
55740006|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
55739918|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739919|NCT03388957|Propranolol|propranolol|mesh-list
55739920|NCT03388957|Midazolam|midazolam|mesh-list
55739921|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55739922|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55739923|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739924|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739925|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55739926|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55739927|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55739928|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55739929|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
55739930|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
55739931|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
55739932|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
55739933|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55739934|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739936|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55739937|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
55739938|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55739939|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55739940|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
55739941|NCT03395665|Estradiol|estradiol|mesh-list
55739942|NCT03395665|Progesterone|progesterone|mesh-list
55739943|NCT03395665|Estrogens|estrogens|mesh-ancestor
55739944|NCT03395665|Hormones|hormones|mesh-ancestor
55739945|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55739946|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739948|NCT00535405|Atorvastatin|atorvastatin|mesh-list
55739949|NCT00535405|Simvastatin|simvastatin|mesh-list
55739950|NCT00535405|Ezetimibe|ezetimibe|mesh-list
55739951|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55739952|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55739953|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
55739954|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739955|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55739956|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55739957|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739959|NCT03390595|Carboplatin|carboplatin|mesh-list
55739960|NCT03390595|Avelumab|avelumab|mesh-list
55739961|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55739962|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55739963|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
55739964|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739975|NCT00271817|Simvastatin|simvastatin|mesh-list
55739976|NCT00271817|Ezetimibe|ezetimibe|mesh-list
55739977|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
55739978|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55739979|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55739980|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
55739981|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55739982|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55739983|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55739984|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55739985|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
55739986|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
55739987|NCT00271817|Vitamins|vitamins|mesh-ancestor
55739988|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
55739989|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739990|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
55739991|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55739992|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55739993|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55739994|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55739995|NCT03388541|Analgesics|analgesics|mesh-ancestor
55739996|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
55739997|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55739998|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55739999|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55740000|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55740001|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
55740002|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740003|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740004|NCT00092989|Montelukast|montelukast|mesh-list
55740005|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55740007|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55850463|NCT01506609|Paclitaxel|paclitaxel|mesh-list
55740008|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
55740009|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55740010|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740011|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55740012|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55740013|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740015|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55740016|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55740017|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55740018|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744415|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740019|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740020|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
55740021|NCT03858049|Progestins|progestins|mesh-ancestor
55740022|NCT03858049|Hormones|hormones|mesh-ancestor
55744416|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55744417|NCT03330223|Clopidogrel|clopidogrel|mesh-list
55740023|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55740024|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740025|NCT03388151|Midazolam|midazolam|mesh-list
55740026|NCT03388151|Propofol|propofol|mesh-list
55740027|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55740028|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740029|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740039|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740040|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740041|NCT03392909|Gentamicins|gentamicins|mesh-list
55740042|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55740043|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740044|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55740045|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740046|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740047|NCT04501211|Granisetron|granisetron|mesh-list
55740048|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
55740049|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
55740050|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740051|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740052|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55740053|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55740054|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
55740055|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744419|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55740056|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740058|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
55740059|NCT03126071|Irinotecan|irinotecan|mesh-list
55740060|NCT03126071|Raltitrexed|raltitrexed|mesh-list
55740061|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55740062|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740063|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55740064|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55740065|NCT03126071|Growth Substances|growth substances|mesh-ancestor
55740066|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740067|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
55740068|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55740069|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55740070|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744420|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55740071|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740072|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55740073|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
55740074|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55740075|NCT03392051|Clopidogrel|clopidogrel|mesh-list
55740076|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55740077|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55740078|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55740079|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55740080|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
55740081|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740082|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740083|NCT03392051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740085|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55740087|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
55740088|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55740096|NCT04446533|Protective Agents|protective agents|mesh-ancestor
55740097|NCT03386591|Naloxone|naloxone|mesh-list
55740098|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55740099|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740100|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
55740101|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740102|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
55740103|NCT03386279|Abrocitinib|abrocitinib|mesh-list
55740104|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55740105|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740106|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55740107|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55740108|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740109|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740110|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740111|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55740112|NCT03386201|Methylene Blue|methylene blue|mesh-list
55740113|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740114|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740116|NCT03391427|Ketamine|ketamine|mesh-list
55740117|NCT03391427|Anesthetics, Local|anesthetics, local|mesh-ancestor
55740118|NCT03391427|Anesthetics|anesthetics|mesh-ancestor
55740119|NCT03391427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740120|NCT03391427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740121|NCT03391427|Sensory System Agents|sensory system agents|mesh-ancestor
55740122|NCT03391427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740123|NCT03391427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55740124|NCT03391427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55740125|NCT03391427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55740126|NCT03391427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55744421|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55740127|NCT03391427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740128|NCT03391427|Analgesics|analgesics|mesh-ancestor
55740130|NCT03391427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55740131|NCT03391427|Anesthetics, General|anesthetics, general|mesh-ancestor
55740132|NCT03391427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55740133|NCT03391427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55740134|NCT03391427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740135|NCT03268811|Teduglutide|teduglutide|mesh-list
55740136|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55740137|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55740138|NCT03268811|Protective Agents|protective agents|mesh-ancestor
55740139|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740140|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
55740141|NCT03385967|Ropivacaine|ropivacaine|mesh-list
55740142|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55740143|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740144|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740145|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55740146|NCT03385967|Analgesics|analgesics|mesh-ancestor
55740147|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
55770533|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
55740149|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55740150|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55740151|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55740152|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
55740153|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740154|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740164|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
55740166|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
55740167|NCT02732015|Aprepitant|aprepitant|mesh-list
55740168|NCT02732015|BB 1101|bb 1101|mesh-list
55740169|NCT02732015|Rolapitant|rolapitant|mesh-list
55740171|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55740172|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
55740174|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740175|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740176|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55740177|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
55740178|NCT02732015|Hormones|hormones|mesh-ancestor
55744422|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55740179|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55740180|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55740181|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740182|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
55740183|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740184|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740185|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55744423|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
55740186|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55740187|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55740188|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55740189|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
55740190|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
55740191|NCT02732015|Mitosis Modulators|mitosis modulators|mesh-ancestor
55740192|NCT02732015|Antipruritics|antipruritics|mesh-ancestor
55740193|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
55740194|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55740195|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
55740196|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740197|NCT02732015|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55740198|NCT02732015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55740199|NCT02732015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740200|NCT02732015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55740201|NCT02732015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55740202|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55740203|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
55740204|NCT02732015|Protective Agents|protective agents|mesh-ancestor
55740205|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55740206|NCT02520245|Cemiplimab|cemiplimab|mesh-list
55740207|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55740208|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740209|NCT03537833|Pemetrexed|pemetrexed|mesh-list
55740210|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740211|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740212|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740213|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55740214|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55740216|NCT03439085|Interleukin-12|interleukin-12|mesh-list
55740217|NCT03439085|Vaccines|vaccines|mesh-list
55740218|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
55740219|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55740220|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
55740221|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
55740222|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740223|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55740224|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55770551|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
55740233|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740234|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740235|NCT01964807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55740236|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55740237|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
55740239|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740241|NCT01164995|Adavosertib|adavosertib|mesh-list
55740242|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740243|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740244|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740245|NCT00999401|Roscovitine|roscovitine|mesh-list
55740246|NCT00999401|Sapacitabine|sapacitabine|mesh-list
55740247|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740248|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
55740249|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740250|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55740251|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740252|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740253|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
55740254|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
55744424|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740255|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740256|NCT04446065|Protective Agents|protective agents|mesh-ancestor
55740257|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740258|NCT04446065|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55740259|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55740260|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740261|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55740262|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
55740263|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55740264|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
55740265|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740266|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
55740267|NCT00225095|Protective Agents|protective agents|mesh-ancestor
55740268|NCT02732119|Everolimus|everolimus|mesh-list
55740269|NCT02732119|Exemestane|exemestane|mesh-list
55850644|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
55740270|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740271|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55740273|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740274|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55740275|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55740276|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740277|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740278|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55740279|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
55740280|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55740282|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
55740283|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740291|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740292|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55740293|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55740295|NCT05174195|Hormones|hormones|mesh-ancestor
55740296|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55740297|NCT05238727|Mepivacaine|mepivacaine|mesh-list
55740298|NCT05238727|Carticaine|carticaine|mesh-list
55740299|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
55740300|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
55740301|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740302|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740303|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
55740304|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740305|NCT03754153|Atropine|atropine|mesh-list
55740306|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55740307|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55740308|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55740309|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
55740310|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740311|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740312|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55740313|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
55740314|NCT03754153|Mydriatics|mydriatics|mesh-ancestor
55740315|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
55740317|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55740318|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
55740319|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740320|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740322|NCT03731923|Hematinics|hematinics|mesh-ancestor
55740323|NCT03727633|Idarubicin|idarubicin|mesh-list
55740324|NCT03727633|Ethiodized Oil|ethiodized oil|mesh-list
55740325|NCT03727633|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55850726|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55740326|NCT03727633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740327|NCT03727633|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55740328|NCT03727633|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55740329|NCT03727633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740330|NCT03727633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740332|NCT03380039|Fludarabine|fludarabine|mesh-list
55740333|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55740334|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
55740335|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740336|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55740337|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55740338|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
55740339|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740340|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740341|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55740342|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55740343|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
55740344|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740352|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740353|NCT02520817|Protective Agents|protective agents|mesh-ancestor
55740354|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55740356|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740357|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
55740358|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55740360|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740361|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
55740362|NCT03384095|Protective Agents|protective agents|mesh-ancestor
55740363|NCT03379181|Propranolol|propranolol|mesh-list
55740364|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55740365|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55740366|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
55740367|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740368|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740369|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740370|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55740371|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55740372|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
55740373|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55740374|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55740375|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55740376|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
55740377|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740378|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740379|NCT03379103|Propofol|propofol|mesh-list
55740380|NCT03379103|Sevoflurane|sevoflurane|mesh-list
55740381|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55740382|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740383|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740384|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55740385|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
55740386|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
55740387|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55740388|NCT03379103|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55740389|NCT03387631|Lumefantrine|lumefantrine|mesh-list
55740391|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
55740392|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
55740393|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55740394|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55740395|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740396|NCT03636451|Lidocaine|lidocaine|mesh-list
55740397|NCT03636451|Anesthetics, Local|anesthetics, local|mesh-ancestor
55740398|NCT03636451|Anesthetics|anesthetics|mesh-ancestor
55740399|NCT03636451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740400|NCT03636451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740401|NCT03636451|Sensory System Agents|sensory system agents|mesh-ancestor
55740402|NCT03636451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740403|NCT03636451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55740404|NCT03636451|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55740405|NCT03636451|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55740406|NCT03636451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55740407|NCT03636451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740409|NCT03383393|Eptifibatide|eptifibatide|mesh-list
55740410|NCT03383393|Analgesics|analgesics|mesh-ancestor
55740411|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
55740412|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740414|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55740415|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
55740416|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55740417|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
55740418|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
55740421|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55740422|NCT03394807|Levobupivacaine|levobupivacaine|mesh-list
55740423|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
55740424|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
55740425|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740426|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740427|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
55740428|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740430|NCT03383315|Metoclopramide|metoclopramide|mesh-list
55740431|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55740432|NCT03383315|Narcotics|narcotics|mesh-ancestor
55740433|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740436|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
55740437|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740439|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
55740440|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55740441|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55740442|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55740443|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
55740444|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740445|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740446|NCT03394729|Propolis|propolis|mesh-list
55740447|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740448|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
55850795|NCT04782388|Alprazolam|alprazolam|mesh-list
55740449|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55740450|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
55740451|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740452|NCT03252925|Expectorants|expectorants|mesh-ancestor
55740453|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
55740454|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55740455|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
55740456|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740457|NCT03252925|Protective Agents|protective agents|mesh-ancestor
55740458|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740459|NCT03252925|Antidotes|antidotes|mesh-ancestor
55740460|NCT03383237|Apatinib|apatinib|mesh-list
55740461|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740462|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55740463|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740464|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740465|NCT03387241|Fluticasone|fluticasone|mesh-list
55740466|NCT03387241|Xhance|xhance|mesh-list
55740467|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
55740468|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55740469|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55740470|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55740471|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55740472|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
55740473|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55770662|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
55740474|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740475|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55740476|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
55740477|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
55740478|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55740479|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55740480|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55740481|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55740482|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
55740483|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740484|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740485|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
55740487|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55740488|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
55740489|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
55740490|NCT03378791|Trace Elements|trace elements|mesh-ancestor
55740491|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
55740492|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740493|NCT03383003|Amoxicillin|amoxicillin|mesh-list
55740494|NCT03383003|Metronidazole|metronidazole|mesh-list
55740495|NCT03383003|Clarithromycin|clarithromycin|mesh-list
55740504|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740505|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740506|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55740507|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55740508|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55740511|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
55740512|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
55850804|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740513|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55740514|NCT03378713|Androgens|androgens|mesh-ancestor
55740515|NCT03378713|Hormones|hormones|mesh-ancestor
55740516|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55770693|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
55740517|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740518|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55740519|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740520|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
55740521|NCT03378401|Octenidine|octenidine|mesh-list
55740522|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740523|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55740526|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740527|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740528|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
55740529|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740530|NCT01327885|Dacarbazine|dacarbazine|mesh-list
55740531|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55740532|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
55740533|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740534|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740536|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740538|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55740539|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740540|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
55740541|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740542|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55740543|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
55740544|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
55740545|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740546|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740547|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740548|NCT03381755|Ticagrelor|ticagrelor|mesh-list
55740549|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55740550|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55740551|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55740552|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55740553|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
55740554|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740555|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740556|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740557|NCT03387163|Valsartan|valsartan|mesh-list
55740558|NCT03387163|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55740559|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55740560|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55740561|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55740570|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740572|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740573|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55740574|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
55740575|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55740576|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55740577|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740578|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55740579|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
55740580|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55740582|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55740584|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740585|NCT03394573|Aflibercept|aflibercept|mesh-list
55740586|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55740587|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55740588|NCT03394573|Growth Substances|growth substances|mesh-ancestor
55740589|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740590|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
55740591|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740592|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
55740593|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740594|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55740595|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740596|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740597|NCT03380975|Montelukast|montelukast|mesh-list
55740598|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55740599|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
55740600|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55740601|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
55740602|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55740603|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740604|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55740605|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55740606|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740609|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55740695|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
55740610|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740611|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740612|NCT03460015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55740613|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
55740614|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
55740615|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55740616|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55740618|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55740619|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740620|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55740621|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55740622|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
55740623|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740624|NCT03375515|Hydromorphone|hydromorphone|mesh-list
55740626|NCT03375515|Narcotics|narcotics|mesh-ancestor
55740627|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740628|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740629|NCT03375515|Analgesics|analgesics|mesh-ancestor
55740630|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
55740631|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740632|NCT03436433|Lacosamide|lacosamide|mesh-list
55850836|NCT04781998|Incretins|incretins|mesh-ancestor
55740639|NCT03436433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740640|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
55740642|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740643|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55740644|NCT03374501|PAZ320|paz320|mesh-list
55740645|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55740646|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740647|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
55740648|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740649|NCT03374345|Mitogens|mitogens|mesh-ancestor
55740650|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
55740651|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740652|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
55740653|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55740654|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740656|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
55740657|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740658|NCT02814695|Protective Agents|protective agents|mesh-ancestor
55740659|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740660|NCT02814695|Vitamins|vitamins|mesh-ancestor
55740661|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
55740662|NCT03386305|Tacrolimus|tacrolimus|mesh-list
55740663|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55740664|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
55740665|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740666|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55740667|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740668|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740669|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55740670|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740671|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
55740672|NCT05237323|Azathioprine|azathioprine|mesh-list
55740673|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55740674|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740675|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55740676|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
55740677|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55740678|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740679|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740680|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740681|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
55740682|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55740683|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55740684|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
55740685|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740686|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55740687|NCT02520505|Citric Acid|citric acid|mesh-list
55740688|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
55740689|NCT02520505|Clomiphene|clomiphene|mesh-list
55740690|NCT02520505|Enclomiphene|enclomiphene|mesh-list
55740691|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
55740692|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
55740693|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55740694|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
55740696|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740697|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55740698|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
55850851|NCT03300544|Antidotes|antidotes|mesh-ancestor
55740699|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55740700|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740707|NCT03380689|Irinotecan|irinotecan|mesh-list
55740708|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55740709|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740710|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55740711|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55740712|NCT03380689|Growth Substances|growth substances|mesh-ancestor
55740713|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740714|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
55740715|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55740716|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55740717|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740718|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740719|NCT03380533|Buprenorphine|buprenorphine|mesh-list
55740720|NCT03380533|Tramadol|tramadol|mesh-list
55770906|NCT02373215|Nalbuphine|nalbuphine|mesh-list
55740721|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55740722|NCT03380533|Narcotics|narcotics|mesh-ancestor
55740723|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740724|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740725|NCT03380533|Analgesics|analgesics|mesh-ancestor
55740726|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
55740727|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740728|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55740729|NCT03386149|Loxoprofen|loxoprofen|mesh-list
55740730|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55740731|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55740732|NCT03386149|Analgesics|analgesics|mesh-ancestor
55740733|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
55740734|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740735|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740736|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55740737|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55740738|NCT03386071|Trametinib|trametinib|mesh-list
55740739|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740740|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55740741|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740742|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740744|NCT03231085|Trace Elements|trace elements|mesh-ancestor
55740745|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
55740746|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740747|NCT03385135|Allopurinol|allopurinol|mesh-list
55740748|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
55740749|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740750|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850879|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
55740751|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
55740753|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55740754|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
55740755|NCT03385135|Protective Agents|protective agents|mesh-ancestor
55740756|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740758|NCT02766335|Durvalumab|durvalumab|mesh-list
55740759|NCT02766335|Immunoglobulins|immunoglobulins|mesh-list
55740760|NCT02766335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55740761|NCT02766335|Immunoglobulin G|immunoglobulin g|mesh-list
55740762|NCT02766335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740763|NCT02766335|Tubulin Modulators|tubulin modulators|mesh-ancestor
55740764|NCT02766335|Antimitotic Agents|antimitotic agents|mesh-ancestor
55740765|NCT02766335|Mitosis Modulators|mitosis modulators|mesh-ancestor
55740766|NCT02766335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740767|NCT02766335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55740768|NCT02766335|Immunologic Factors|immunologic factors|mesh-ancestor
55740769|NCT02766335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740770|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
55740771|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55740772|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740777|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740779|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55740780|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
55740781|NCT04409041|Naltrexone|naltrexone|mesh-list
55740782|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55740783|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55740784|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55770975|NCT02369939|Mitomycins|mitomycins|mesh-list
55740785|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
55740786|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740787|NCT03090997|Vitamins|vitamins|mesh-list
55740788|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
55740789|NCT03090997|Resveratrol|resveratrol|mesh-list
55740790|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
55740791|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740792|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
55740793|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740794|NCT03090997|Protective Agents|protective agents|mesh-ancestor
55740795|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740796|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55740797|NCT04446091|Irinotecan|irinotecan|mesh-list
55740798|NCT04446091|Apatinib|apatinib|mesh-list
55740799|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
55740800|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55740801|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55740802|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740803|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740804|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851068|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
55740805|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55740806|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55740807|NCT04446091|Growth Substances|growth substances|mesh-ancestor
55740808|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740809|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
55740810|NCT04445935|Bivalirudin|bivalirudin|mesh-list
55740811|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
55740812|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55740813|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
55740814|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740815|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740816|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
55740817|NCT03385057|Acetaminophen|acetaminophen|mesh-list
55740818|NCT03385057|Ibuprofen|ibuprofen|mesh-list
55740819|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55740821|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
55740822|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740823|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740824|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
55740825|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55740826|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55740827|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55740828|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55740829|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740830|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740832|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55740833|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55740834|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55740835|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55740836|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
55740837|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740838|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740839|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740840|NCT00372073|Roscovitine|roscovitine|mesh-list
55740841|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740842|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
55740843|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740844|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55740845|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740846|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740847|NCT03373409|Albuterol|albuterol|mesh-list
55740848|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55740849|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
55740850|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740851|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740852|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55740853|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
55740854|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
55740855|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55740856|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55740857|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55740858|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55740859|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
55740860|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740861|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740862|NCT03379987|Morphine|morphine|mesh-list
55740863|NCT03379987|Bupivacaine|bupivacaine|mesh-list
55740864|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
55740865|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
55740866|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740867|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740868|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
55740869|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740870|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55740872|NCT03379987|Analgesics|analgesics|mesh-ancestor
55740873|NCT02730793|Aztreonam|aztreonam|mesh-list
55740874|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55740875|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740876|NCT03379909|Metformin|metformin|mesh-list
55740877|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55740878|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740879|NCT02678533|Plerixafor|plerixafor|mesh-list
55740880|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55740881|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55740882|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
55740883|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740884|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
55740885|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55740886|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740887|NCT03384511|Apatinib|apatinib|mesh-list
55740888|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740889|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55740890|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740891|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740892|NCT03385525|Valproic Acid|valproic acid|mesh-list
55740893|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
55740894|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740895|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740896|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
55740897|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55740898|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740899|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
55740900|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55740901|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740902|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55740903|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
55740904|NCT05172739|Anesthetics|anesthetics|mesh-list
55851157|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55740905|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55740906|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740907|NCT05172739|Narcotics|narcotics|mesh-ancestor
55740908|NCT05172739|Analgesics|analgesics|mesh-ancestor
55740909|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
55740910|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55740911|NCT03375463|Tirzepatide|tirzepatide|mesh-list
55740912|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55740913|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740914|NCT03375463|Incretins|incretins|mesh-ancestor
55740915|NCT03375463|Hormones|hormones|mesh-ancestor
55740916|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55740918|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55740919|NCT04445311|Ivermectin|ivermectin|mesh-list
55740920|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55740922|NCT03384121|Rifampin|rifampin|mesh-list
55740923|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55740924|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
55740925|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55740926|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740927|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
55740928|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55740929|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740930|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740931|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55740932|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55740933|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55740934|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55740935|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55740936|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55740937|NCT03378661|Benzonidazole|benzonidazole|mesh-list
55740938|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55740939|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
55740940|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55740941|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55740943|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55740944|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740945|NCT03378427|Doxycycline|doxycycline|mesh-list
55740946|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
55740947|NCT03378427|Levofloxacin|levofloxacin|mesh-list
55740948|NCT03378427|Ofloxacin|ofloxacin|mesh-list
55740949|NCT03378427|Minocycline|minocycline|mesh-list
55740950|NCT03378427|Rifampin|rifampin|mesh-list
55740951|NCT03378427|Clindamycin|clindamycin|mesh-list
55740952|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55740953|NCT03378427|Tedizolid|tedizolid|mesh-list
55740954|NCT03378427|Teicoplanin|teicoplanin|mesh-list
55740955|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
55740956|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
55740957|NCT03378427|Trimethoprim|trimethoprim|mesh-list
55740958|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
55740959|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55740960|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55740961|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
55740962|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55740963|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55740964|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55740965|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55740966|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55740967|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740968|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55740969|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55740970|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55740971|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55740972|NCT03378427|Renal Agents|renal agents|mesh-ancestor
55740973|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55740974|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
55740975|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
55740976|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55740977|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55740978|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55740979|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55740980|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55740981|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55740982|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55740983|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55740984|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55740985|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55740986|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55740987|NCT05172115|Heparin|heparin|mesh-list
55740988|NCT05172115|Enoxaparin|enoxaparin|mesh-list
55740989|NCT05172115|Plasminogen|plasminogen|mesh-list
55740990|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55740991|NCT05172115|Tinzaparin|tinzaparin|mesh-list
55740992|NCT05172115|Dalteparin|dalteparin|mesh-list
55740996|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55740997|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55740998|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
55740999|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
55741000|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
55741001|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
55741002|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55741003|NCT03383185|Progestins|progestins|mesh-list
55741004|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55741005|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741006|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55741007|NCT03383185|Hormones|hormones|mesh-ancestor
55741008|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741009|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55741010|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55741011|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55741012|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55741013|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55741014|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741016|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
55741017|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55741018|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
55741019|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741021|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741022|NCT03374293|Antibodies|antibodies|mesh-list
55741023|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
55741024|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741025|NCT02730871|Timolol|timolol|mesh-list
55741026|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55741027|NCT02730871|Travoprost|travoprost|mesh-list
55741028|NCT02730871|Brinzolamide|brinzolamide|mesh-list
55741029|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55741030|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55741031|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
55741032|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741033|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741034|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741035|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55741036|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55741037|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55741038|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55851444|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
55851445|NCT01473381|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55741040|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55741041|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741042|NCT03377335|Metformin|metformin|mesh-list
55741043|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
55741044|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741045|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741046|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55741047|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741048|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
55741049|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
55741050|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55741051|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55741052|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
55741053|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741054|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741055|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741056|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741057|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55741058|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741060|NCT03373903|Dactolisib|dactolisib|mesh-list
55741061|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741071|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55741072|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
55741073|NCT03373825|Fentanyl|fentanyl|mesh-list
55741074|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55741075|NCT03373825|Narcotics|narcotics|mesh-ancestor
55741076|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741077|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741078|NCT03373825|Analgesics|analgesics|mesh-ancestor
55741079|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
55741080|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741081|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55741082|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55741083|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
55741084|NCT03373825|Anesthetics|anesthetics|mesh-ancestor
55741085|NCT04445779|Ubiquinone|ubiquinone|mesh-list
55741086|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
55741087|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
55771249|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55741088|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741089|NCT04445779|Vitamins|vitamins|mesh-ancestor
55741090|NCT03377101|Fulvestrant|fulvestrant|mesh-list
55741091|NCT03377101|Palbociclib|palbociclib|mesh-list
55741092|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55741093|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741094|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55741095|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55741096|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
55744425|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741097|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741098|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741099|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55741100|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741101|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741102|NCT04445467|Favipiravir|favipiravir|mesh-list
55741103|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
55741104|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741105|NCT03373669|Vaccines|vaccines|mesh-list
55741106|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
55741107|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741109|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
55741110|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741113|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741114|NCT03376789|MYL-1501D|myl-1501d|mesh-list
55741115|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741116|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741117|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
55741118|NCT03376555|Acetylcholine|acetylcholine|mesh-list
55741119|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
55741120|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55741121|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
55741122|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741123|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741124|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741126|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
55741127|NCT03700411|Morphine|morphine|mesh-list
55741128|NCT03700411|Pirinitramide|pirinitramide|mesh-list
55741129|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55741130|NCT03700411|Narcotics|narcotics|mesh-ancestor
55741131|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851531|NCT02119468|Hormones|hormones|mesh-ancestor
55741135|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741137|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55741138|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
55741139|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741140|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741141|NCT03381859|Grazoprevir|grazoprevir|mesh-list
55741142|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55741143|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
55741144|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741145|NCT03381781|Cytarabine|cytarabine|mesh-list
55741146|NCT03381781|Decitabine|decitabine|mesh-list
55741147|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
55741148|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55741149|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
55771336|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741150|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741151|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741152|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
55741153|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741154|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55741155|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
55741156|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741157|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741158|NCT03381703|YH12852|yh12852|mesh-list
55741159|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55741160|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55741161|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
55741162|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741163|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741164|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741165|NCT03372265|Ropivacaine|ropivacaine|mesh-list
55741166|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
55741167|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
55741168|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741169|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741170|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
55741171|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741173|NCT03372109|Turmeric extract|turmeric extract|mesh-list
55741174|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55741175|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741176|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
55741177|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741178|NCT03372109|Protective Agents|protective agents|mesh-ancestor
55741179|NCT03371953|Atracurium|atracurium|mesh-list
55851556|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741180|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
55741181|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55741182|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55741185|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741187|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55741188|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
55741189|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741190|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741191|NCT03371797|Amlodipine|amlodipine|mesh-list
55741192|NCT03371797|Valsartan|valsartan|mesh-list
55741193|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55741194|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55741195|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55741196|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741197|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55741199|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
55741200|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55741201|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55741203|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
55741212|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55741213|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
55741214|NCT02520115|Hormones|hormones|mesh-ancestor
55741215|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741216|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55741217|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741218|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
55741219|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741220|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741221|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
55741222|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
55741223|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741224|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
55741225|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55741226|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741227|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55741228|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
55741229|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
55741230|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741231|NCT04527133|Aprotinin|aprotinin|mesh-list
55741232|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
55741233|NCT04527133|Coagulants|coagulants|mesh-ancestor
55741234|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55741235|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55741236|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
55741237|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741238|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741239|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55741240|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741241|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55741242|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
55741243|NCT03369847|Budesonide|budesonide|mesh-list
55741244|NCT03369847|Beclomethasone|beclomethasone|mesh-list
55741245|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55741247|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
55741248|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741249|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741250|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55741251|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
55741252|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
55741254|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741255|NCT04526353|Oxybutynin|oxybutynin|mesh-list
55741256|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
55741257|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
55741258|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741259|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741260|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55741261|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55741262|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
55741263|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741264|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741265|NCT04526353|Urological Agents|urological agents|mesh-ancestor
55741266|NCT03371173|Ferric maltol|ferric maltol|mesh-list
55741267|NCT03371173|Hematinics|hematinics|mesh-ancestor
55741268|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
55741269|NCT03371095|Infliximab|infliximab|mesh-list
55741270|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55741271|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
55741272|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741273|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55741274|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55741275|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
55741280|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55741281|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55741282|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741283|NCT03363295|Moxifloxacin|moxifloxacin|mesh-list
55741284|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55741285|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741286|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55741287|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55741288|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741289|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741290|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741291|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
55741292|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
55741294|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55741295|NCT03370705|Atorvastatin|atorvastatin|mesh-list
55741296|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55741297|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55741298|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55741299|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
55741300|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741301|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55741302|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55741303|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741304|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
55741305|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55741306|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
55741307|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55741308|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55741309|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741310|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741311|NCT03370705|Analgesics|analgesics|mesh-ancestor
55741312|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
55741313|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741314|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55741315|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55741316|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55741317|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55741318|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55741320|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
55741321|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741322|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
55741323|NCT03369379|Vitamins|vitamins|mesh-ancestor
55741324|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
55741325|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741326|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55741327|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55741328|NCT03362905|Lidocaine|lidocaine|mesh-list
55741329|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
55741330|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
55741331|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741332|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741333|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
55741334|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741336|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55741337|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55741338|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55741339|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741341|NCT03370159|Docetaxel|docetaxel|mesh-list
55741342|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741343|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
55741344|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
55741346|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741347|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
55741357|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55741359|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
55741360|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741361|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741528|NCT01675167|Analgesics|analgesics|mesh-ancestor
55741362|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741363|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55741364|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55741365|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
55741366|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741367|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55741368|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
55741370|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
55741371|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55741372|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55741373|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55741375|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55741376|NCT03369067|Insulin|insulin|mesh-list
55741377|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55741378|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741379|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741380|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55741381|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741382|NCT04525729|Rituximab|rituximab|mesh-list
55741383|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55741384|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741385|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
55741386|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741387|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55741388|NCT04525495|Dopamine|dopamine|mesh-list
55741389|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55741390|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
55741391|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
55741392|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741393|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741394|NCT04525495|Dopamine Agents|dopamine agents|mesh-ancestor
55741395|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744426|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55771599|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55741396|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741397|NCT04525495|Protective Agents|protective agents|mesh-ancestor
55741399|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741400|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55741401|NCT03362281|Amoxicillin|amoxicillin|mesh-list
55741402|NCT03362281|Clarithromycin|clarithromycin|mesh-list
55741403|NCT03362281|Omeprazole|omeprazole|mesh-list
55741404|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55741405|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741406|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55741407|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55741408|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55741409|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744427|NCT03331861|Metformin|metformin|mesh-list
55741410|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741412|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55741413|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55744428|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741415|NCT03362047|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55741416|NCT03362047|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55741417|NCT03362047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847735|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
55741424|NCT02518789|Etomidate|etomidate|mesh-list
55741425|NCT02518789|Atracurium|atracurium|mesh-list
55741426|NCT02518789|Rocuronium|rocuronium|mesh-list
55741427|NCT02518789|Cisatracurium|cisatracurium|mesh-list
55741428|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55741429|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741430|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741431|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55741432|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
55741433|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
55741434|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55741435|NCT02518789|Analgesics|analgesics|mesh-ancestor
55741436|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
55741437|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741438|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55741439|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55741440|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55741441|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
55741442|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741443|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741444|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55741445|NCT02518789|Narcotics|narcotics|mesh-ancestor
55741446|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55741447|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55741448|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55741449|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55741450|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
55741451|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
55741452|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55741453|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55741454|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55741455|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
55741456|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55741457|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
55741459|NCT03357757|Valproic Acid|valproic acid|mesh-list
55741460|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55741461|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741462|NCT03357757|Anticonvulsants|anticonvulsants|mesh-ancestor
55741463|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55744429|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741464|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741466|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741467|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741468|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
55741469|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55741470|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741471|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55741472|NCT02929485|Bromocriptine|bromocriptine|mesh-list
55741473|NCT02929485|Tolcapone|tolcapone|mesh-list
55741474|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55741475|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55741476|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
55741477|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741478|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741479|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
55741480|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
55741481|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55744430|NCT03329443|Spironolactone|spironolactone|mesh-list
55741482|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741483|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55741484|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741485|NCT04523623|Ibuprofen|ibuprofen|mesh-list
55741486|NCT04523623|Oxycodone|oxycodone|mesh-list
55741487|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55741488|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55741489|NCT04523623|Analgesics|analgesics|mesh-ancestor
55741490|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
55847876|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
55741498|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55741499|NCT04523623|Narcotics|narcotics|mesh-ancestor
55741500|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741501|NCT03368131|Capecitabine|capecitabine|mesh-list
55741502|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
55741503|NCT03368131|Trastuzumab|trastuzumab|mesh-list
55741504|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55741505|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
55741506|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741507|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741508|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55741510|NCT04521751|Orlistat|orlistat|mesh-list
55741511|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55741512|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741513|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741515|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741516|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55741517|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55741519|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
55741520|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741521|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741522|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741524|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55741525|NCT01675167|Narcotics|narcotics|mesh-ancestor
55741526|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741527|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741529|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
55741530|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741531|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55741532|NCT03367663|Prednisone|prednisone|mesh-list
55741533|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55741534|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
55741535|NCT03367663|Hormones|hormones|mesh-ancestor
55741536|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741537|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741538|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55741539|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741540|NCT03123289|Gallium citrate|gallium citrate|mesh-list
55741541|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741542|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55741543|NCT04521049|Saxagliptin|saxagliptin|mesh-list
55741544|NCT04521049|Incretins|incretins|mesh-ancestor
55741545|NCT04521049|Hormones|hormones|mesh-ancestor
55741546|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741547|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851751|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
55741548|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55741549|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
55741550|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741551|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741556|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55741557|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741559|NCT03123445|Endostar protein|endostar protein|mesh-list
55741561|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741562|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55741563|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
55741564|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741565|NCT03123445|Antiviral Agents|antiviral agents|mesh-ancestor
55741566|NCT03123445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741567|NCT03123445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741568|NCT03123445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55741569|NCT03123445|Immunologic Factors|immunologic factors|mesh-ancestor
55741570|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741571|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55741572|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55741573|NCT03123445|Growth Substances|growth substances|mesh-ancestor
55741574|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
55741575|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55741577|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55741578|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55741579|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741580|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55741581|NCT03357055|Ketamine|ketamine|mesh-list
55741582|NCT03357055|Analgesics|analgesics|mesh-ancestor
55741583|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
55741585|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741586|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55741589|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
55741591|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55741592|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55741593|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741594|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741595|NCT03367585|Vitamin D|vitamin d|mesh-list
55741597|NCT03367585|Vitamins|vitamins|mesh-ancestor
55741598|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
55741599|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741600|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55741601|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55741603|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741604|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741605|NCT00584025|Levetiracetam|levetiracetam|mesh-list
55741606|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
55741607|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
55741608|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
55741609|NCT01735461|Calcium|calcium|mesh-list
55741610|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55741611|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741612|NCT01735461|Antacids|antacids|mesh-ancestor
55741613|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741614|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55741615|NCT01595841|Sirolimus|sirolimus|mesh-list
55741616|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55741617|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741618|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55741619|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741621|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55741622|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
55741623|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741624|NCT05405049|Lidocaine|lidocaine|mesh-list
55741625|NCT05405049|Fentanyl|fentanyl|mesh-list
55741626|NCT05405049|Morphine|morphine|mesh-list
55741627|NCT05405049|Bupivacaine|bupivacaine|mesh-list
55741628|NCT05405049|Anesthetics, Local|anesthetics, local|mesh-ancestor
55741629|NCT05405049|Anesthetics|anesthetics|mesh-ancestor
55741630|NCT05405049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741631|NCT05405049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741639|NCT05405049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55741640|NCT05405049|Narcotics|narcotics|mesh-ancestor
55741641|NCT05405049|Analgesics|analgesics|mesh-ancestor
55741642|NCT05405049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55741643|NCT05405049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55741644|NCT05405049|Anesthetics, General|anesthetics, general|mesh-ancestor
55741645|NCT04520503|Propofol|propofol|mesh-list
55741646|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55741647|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741648|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741649|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55741650|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
55741651|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
55741652|NCT02871843|Temozolomide|temozolomide|mesh-list
55741653|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55741654|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
55741655|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741656|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741657|NCT03356899|Bupivacaine|bupivacaine|mesh-list
55741658|NCT03356899|Anesthetics|anesthetics|mesh-list
55741659|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
55741660|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741661|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741662|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
55741663|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741665|NCT02848131|Quercetin|quercetin|mesh-list
55741666|NCT02848131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741667|NCT02848131|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55741668|NCT02848131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741669|NCT02848131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741670|NCT02848131|Antioxidants|antioxidants|mesh-ancestor
55741671|NCT02848131|Protective Agents|protective agents|mesh-ancestor
55741672|NCT02848131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741673|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
55741674|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
55741675|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55741676|NCT04523467|Growth Substances|growth substances|mesh-ancestor
55741677|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741678|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
55741679|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55771866|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55741680|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55741682|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55741683|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55741684|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741685|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741686|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741687|NCT03367195|Omeprazole|omeprazole|mesh-list
55851813|NCT01471197|Pemetrexed|pemetrexed|mesh-list
55741688|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55741689|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55741690|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55741691|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741692|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741693|NCT02672475|Paclitaxel|paclitaxel|mesh-list
55741694|NCT02672475|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55741703|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741705|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
55741706|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741707|NCT05127369|Fluoxetine|fluoxetine|mesh-list
55741708|NCT05127369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55741709|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55741710|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55741711|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741712|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741714|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741715|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55741716|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
55741717|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55741718|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55741719|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55741720|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741722|NCT05126901|Hematinics|hematinics|mesh-ancestor
55741724|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741725|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
55741727|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55741729|NCT03356353|Urological Agents|urological agents|mesh-ancestor
55741730|NCT04520035|Paclitaxel|paclitaxel|mesh-list
55741731|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55741732|NCT04520035|Cisplatin|cisplatin|mesh-list
55741733|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55741734|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741735|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
55741736|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
55741738|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741739|NCT04208997|Amiodarone|amiodarone|mesh-list
55741740|NCT04208997|Sotalol|sotalol|mesh-list
55741741|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
55741742|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
55741743|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55741744|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55741745|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741746|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55741747|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55741748|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55741750|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55741751|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55741752|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55741753|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55771950|NCT03155477|Vitamin D|vitamin d|mesh-list
55741754|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55741755|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
55741756|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741757|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741758|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
55741759|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
55741760|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741761|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
55741762|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55741763|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55741771|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741772|NCT04518475|Rituximab|rituximab|mesh-list
55741773|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55741774|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741775|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
55741776|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741777|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55741778|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55741779|NCT04278651|Hematinics|hematinics|mesh-ancestor
55741780|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55741781|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55741782|NCT05125575|Metformin|metformin|mesh-list
55741783|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741784|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741786|NCT03366883|Cisplatin|cisplatin|mesh-list
55741787|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55741788|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741789|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
55741790|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
55741791|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
55741792|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741793|NCT03366571|Entecavir|entecavir|mesh-list
55741794|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
55741795|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741796|NCT05052099|Bevacizumab|bevacizumab|mesh-list
55741797|NCT05052099|Atezolizumab|atezolizumab|mesh-list
55741798|NCT05052099|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55741800|NCT05052099|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55741801|NCT05052099|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55741802|NCT05052099|Growth Substances|growth substances|mesh-ancestor
55741803|NCT05052099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741804|NCT05052099|Growth Inhibitors|growth inhibitors|mesh-ancestor
55741807|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
55741808|NCT05124951|Ifosfamide|ifosfamide|mesh-list
55741809|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741810|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55741811|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55741812|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55741813|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741814|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741815|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55741816|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
55741818|NCT04523077|Hormones|hormones|mesh-list
55741819|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
55741820|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741821|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741822|NCT05124717|Metformin|metformin|mesh-list
55741823|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741824|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741826|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
55741827|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55741828|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
55741829|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
55741830|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
55741831|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741832|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741833|NCT03366259|Misoprostol|misoprostol|mesh-list
55741834|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55741835|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
55741839|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55741840|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
55741841|NCT03366025|Progesterone|progesterone|mesh-list
55741842|NCT03366025|Progestins|progestins|mesh-ancestor
55741843|NCT03366025|Hormones|hormones|mesh-ancestor
55741844|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741845|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741846|NCT05115591|Anesthetics|anesthetics|mesh-list
55741847|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55741848|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741849|NCT05403099|Hyaluronic Acid|hyaluronic acid|mesh-list
55741850|NCT05403099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55741851|NCT05403099|Immunologic Factors|immunologic factors|mesh-ancestor
55772052|NCT02348333|Dotinurad|dotinurad|mesh-list
55741852|NCT05403099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741854|NCT05403099|Protective Agents|protective agents|mesh-ancestor
55741855|NCT03365869|Sirolimus|sirolimus|mesh-list
55741856|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55741857|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55741858|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55741859|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741860|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
55741861|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55741862|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
55741863|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741864|NCT04932213|Tropicamide|tropicamide|mesh-list
55741865|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
55741866|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
55741867|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741868|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741869|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55741870|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55741871|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
55741872|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741873|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741874|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
55741875|NCT03684213|Norepinephrine|norepinephrine|mesh-list
55741876|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
55741877|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
55741878|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741879|NCT03684213|Protective Agents|protective agents|mesh-ancestor
55741880|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741881|NCT03684213|Vitamins|vitamins|mesh-ancestor
55741882|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
55741883|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55741884|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55741885|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
55741886|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55741887|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
55741888|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
55741889|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741890|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55741891|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741892|NCT03365479|Iloprost|iloprost|mesh-list
55741893|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55741894|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
55741895|NCT03355027|Atorvastatin|atorvastatin|mesh-list
55741896|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55741897|NCT03355027|Simvastatin|simvastatin|mesh-list
55741898|NCT03355027|Ezetimibe|ezetimibe|mesh-list
55741899|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55741900|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55741901|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
55741902|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741903|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55741904|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55741906|NCT03828045|Apremilast|apremilast|mesh-list
55741907|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55741908|NCT03828045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55741909|NCT03828045|Analgesics|analgesics|mesh-ancestor
55741910|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
55741918|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741919|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
55741920|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55741921|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741922|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55741923|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
55741924|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55741926|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741927|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
55741928|NCT02519335|Razoxane|razoxane|mesh-list
55741929|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55741930|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55741931|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55741932|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55741933|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55741934|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741935|NCT02519335|Protective Agents|protective agents|mesh-ancestor
55741936|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741937|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
55741938|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
55741939|NCT04509583|Vitamin E|vitamin e|mesh-list
55741940|NCT04509583|Vitamins|vitamins|mesh-ancestor
55741941|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
55741942|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741943|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
55741944|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741945|NCT04509583|Protective Agents|protective agents|mesh-ancestor
55741946|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
55741947|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
55741948|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741949|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741950|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55741951|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
55741952|NCT03350737|Heparin|heparin|mesh-list
55741953|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
55741954|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55741956|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741957|NCT03350659|Midodrine|midodrine|mesh-list
55741958|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55741959|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55741960|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55741961|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55741962|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55741963|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
55741964|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792295|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
55741965|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741966|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
55741967|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
55741968|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741969|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55741970|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55741981|NCT03350347|Hematinics|hematinics|mesh-ancestor
55741982|NCT03350191|Exenatide|exenatide|mesh-list
55741983|NCT03350191|Glucagon|glucagon|mesh-list
55741984|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55741985|NCT03350191|Hormones|hormones|mesh-ancestor
55741986|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55741987|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741988|NCT03350191|Incretins|incretins|mesh-ancestor
55741989|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55741990|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55741991|NCT02649231|Ketamine|ketamine|mesh-list
55741993|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
55741994|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55741995|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55741996|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55741997|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55741998|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
55741999|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
55742000|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742001|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55742002|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55742003|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742004|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742005|NCT03364075|Propranolol|propranolol|mesh-list
55742006|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55742008|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55742009|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55742010|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55742011|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742012|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55772173|NCT02345837|Clomiphene|clomiphene|mesh-list
55742013|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742015|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
55742016|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742017|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
55742018|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55742019|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
55742020|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55742021|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55742022|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
55742023|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55742024|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55742025|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
55742026|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55742027|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
55742028|NCT03349957|Idarubicin|idarubicin|mesh-list
55742029|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55742030|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742031|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55742032|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55742033|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742034|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742035|NCT04524169|Thymalfasin|thymalfasin|mesh-list
55742037|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
55742046|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55742047|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742051|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
55742053|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
55742054|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742055|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55742056|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
55742057|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742058|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55742060|NCT04773405|Lidocaine|lidocaine|mesh-list
55742061|NCT04773405|Epinephrine|epinephrine|mesh-list
55742063|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
55742064|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
55742065|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742066|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742067|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
55742068|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742069|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55742070|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55742071|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55742072|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55742073|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742074|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55851959|NCT00194116|Valproic Acid|valproic acid|mesh-list
55742075|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55742076|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
55742077|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742078|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55742079|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55742080|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
55742081|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55742082|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
55742084|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
55742085|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55742086|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
55742087|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55742088|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742089|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55742090|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742091|NCT01376245|Fluticasone|fluticasone|mesh-list
55742092|NCT01376245|Xhance|xhance|mesh-list
55742093|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742095|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
55742096|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742097|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742098|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55742099|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
55742100|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
55742102|NCT04754061|Psilocybin|psilocybin|mesh-list
55742103|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
55742104|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742105|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55742106|NCT03349489|Insulin|insulin|mesh-list
55742107|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55742108|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55742109|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742110|NCT04584567|Doxycycline|doxycycline|mesh-list
55742111|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55851995|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742121|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
55742122|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742123|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851996|NCT00108550|Gabapentin|gabapentin|mesh-list
55742124|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55742125|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
55742126|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742127|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742128|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55742129|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
55742130|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
55742131|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
55742132|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
55742133|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55742134|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55742135|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55742138|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
55742139|NCT04691505|Methotrexate|methotrexate|mesh-list
55742140|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55742141|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
55742142|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55742143|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742144|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55742145|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
55742146|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742147|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742148|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
55742149|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742150|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55742151|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55742152|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
55742153|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55742154|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55742155|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
55742156|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55742157|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55742158|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742159|NCT05400265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55742160|NCT05400265|Antibodies|antibodies|mesh-list
55742161|NCT05400265|Immunoglobulins|immunoglobulins|mesh-list
55742162|NCT05400265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55742163|NCT05400265|Immunologic Factors|immunologic factors|mesh-ancestor
55742164|NCT05400265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742165|NCT05400265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742166|NCT05364619|Bismuth|bismuth|mesh-list
55742167|NCT05364619|Antacids|antacids|mesh-ancestor
55742169|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742170|NCT03353857|Rifampin|rifampin|mesh-list
55742171|NCT03353857|Dienogest|dienogest|mesh-list
55742172|NCT03353857|Drospirenone|drospirenone|mesh-list
55742173|NCT03353857|Midazolam|midazolam|mesh-list
55742174|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
55742175|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55742176|NCT03353857|Norethindrone|norethindrone|mesh-list
55742186|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55742187|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
55742188|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
55742189|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
55742190|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
55742191|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55742192|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55772331|NCT04850495|Doxorubicin|doxorubicin|mesh-list
55742193|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55742194|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
55742195|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55742196|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55742197|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55742198|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55742199|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55742200|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
55742201|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55742202|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742203|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
55742204|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55742205|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742206|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55742207|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55742208|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55742209|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55742210|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55742211|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55742212|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55742213|NCT03353857|Estrogens|estrogens|mesh-ancestor
55742215|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742216|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55742218|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55742219|NCT03353857|Diuretics|diuretics|mesh-ancestor
55742220|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
55742221|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55742222|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55742223|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742224|NCT03353857|Progestins|progestins|mesh-ancestor
55742225|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55742226|NCT04499859|Ezetimibe|ezetimibe|mesh-list
55742227|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55742228|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55742229|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
55742230|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742231|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55742232|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55742234|NCT05306899|Ketamine|ketamine|mesh-list
55742235|NCT05306899|Analgesics|analgesics|mesh-ancestor
55742236|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
55742237|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742238|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852035|NCT00201448|Vaccines|vaccines|mesh-list
55742239|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55742240|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55742241|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
55742243|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742244|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55742254|NCT00700791|Tocopherols|tocopherols|mesh-list
55742255|NCT00700791|Tocotrienols|tocotrienols|mesh-list
55742256|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
55742257|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
55742258|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742259|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
55742260|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742261|NCT00700791|Protective Agents|protective agents|mesh-ancestor
55742262|NCT05344365|Iloperidone|iloperidone|mesh-list
55742263|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55742264|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55742265|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55742266|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742267|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55742268|NCT05129085|Dexamethasone|dexamethasone|mesh-list
55742269|NCT05129085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742270|NCT05129085|Antiemetics|antiemetics|mesh-ancestor
55742271|NCT05129085|Autonomic Agents|autonomic agents|mesh-ancestor
55742272|NCT05129085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742273|NCT05129085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742274|NCT05129085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742275|NCT05129085|Glucocorticoids|glucocorticoids|mesh-ancestor
55742276|NCT05129085|Hormones|hormones|mesh-ancestor
55742277|NCT05129085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742278|NCT05129085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55742279|NCT05129085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742280|NCT04373733|Favipiravir|favipiravir|mesh-list
55742281|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
55742282|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742283|NCT05403489|Dimercaprol|dimercaprol|mesh-list
55742284|NCT05403489|Chelating Agents|chelating agents|mesh-ancestor
55742285|NCT05403489|Sequestering Agents|sequestering agents|mesh-ancestor
55852154|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55742286|NCT05403489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742287|NCT04969731|Gemcitabine|gemcitabine|mesh-list
55742288|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55742289|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
55742290|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742291|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742292|NCT04969731|Antiviral Agents|antiviral agents|mesh-ancestor
55742293|NCT04969731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55742294|NCT04969731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742295|NCT04969731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55742296|NCT04969731|Immunologic Factors|immunologic factors|mesh-ancestor
55742297|NCT04969731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742298|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
55742299|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
55742300|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
55742301|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742302|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742303|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742304|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55742305|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
55742306|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
55742308|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742310|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
55742311|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55742312|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742320|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
55742321|NCT04038489|Aspirin|aspirin|mesh-list
55742322|NCT04038489|Tamoxifen|tamoxifen|mesh-list
55742323|NCT04038489|Paclitaxel|paclitaxel|mesh-list
55742324|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
55742325|NCT04038489|Doxorubicin|doxorubicin|mesh-list
55742326|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55742327|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742328|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
55742329|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
55742330|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
55742331|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742332|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55742334|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742335|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55742336|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55742337|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
55742338|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55742339|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55742340|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55742341|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55742342|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742343|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55742344|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55742346|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
55742348|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742350|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55742351|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55742353|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
55742354|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55742355|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
55742356|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742357|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55742358|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55742359|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55742360|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55742362|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742363|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55742364|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742365|NCT04287855|Dexamethasone|dexamethasone|mesh-list
55742366|NCT04287855|Pomalidomide|pomalidomide|mesh-list
55742367|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55742368|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
55742369|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
55742370|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55742371|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55742372|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55742374|NCT04287855|Hormones|hormones|mesh-ancestor
55744431|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55742375|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55742376|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55742377|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55742378|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
55742379|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55742380|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55742381|NCT04287855|Growth Substances|growth substances|mesh-ancestor
55742382|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
55742384|NCT04435587|Darunavir|darunavir|mesh-list
55742385|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
55852216|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55742386|NCT04435587|Ivermectin|ivermectin|mesh-list
55742387|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55852217|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
55852219|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55742389|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
55742390|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55742391|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55742392|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55742393|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55742394|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
55742395|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55744432|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
56144794|NCT05131152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144795|NCT05131152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
56144796|NCT05131152|Immunologic Factors|immunologic factors|mesh-ancestor
56144797|NCT05131152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144798|NCT05131152|Antifungal Agents|antifungal agents|mesh-ancestor
56144799|NCT05131152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144800|NCT05131152|Dermatologic Agents|dermatologic agents|mesh-ancestor
56144801|NCT05131152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
56144802|NCT05131152|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
56144803|NCT04900116|Bupivacaine|bupivacaine|mesh-list
56144804|NCT04900116|Anesthetics, Local|anesthetics, local|mesh-ancestor
56144805|NCT04900116|Anesthetics|anesthetics|mesh-ancestor
56144806|NCT04900116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144807|NCT04900116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144808|NCT04900116|Sensory System Agents|sensory system agents|mesh-ancestor
56144809|NCT04900116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144810|NCT04694976|Vitamin D|vitamin d|mesh-list
56144811|NCT04694976|Vitamins|vitamins|mesh-ancestor
56144812|NCT04694976|Micronutrients|micronutrients|mesh-ancestor
56144813|NCT04694976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144814|NCT04694976|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
56144815|NCT04603248|Nivolumab|nivolumab|mesh-list
56144816|NCT04603248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56144817|NCT04603248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144818|NCT04603248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
56144819|NCT04603248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144820|NCT03936270|Letrozole|letrozole|mesh-list
56144821|NCT03936270|Palbociclib|palbociclib|mesh-list
56144822|NCT03936270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144823|NCT03936270|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
56144824|NCT03936270|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
56144825|NCT03936270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144826|NCT03936270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144827|NCT03936270|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
56144828|NCT03936270|Hormone Antagonists|hormone antagonists|mesh-ancestor
56144829|NCT03936270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
56144830|NCT03936270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144831|NCT03936270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56144832|NCT03781986|Carboplatin|carboplatin|mesh-list
56144833|NCT03781986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144834|NCT03763656|Hydroxyurea|hydroxyurea|mesh-list
56144835|NCT03763656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144836|NCT03763656|Antisickling Agents|antisickling agents|mesh-ancestor
56144837|NCT03763656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144838|NCT03763656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144839|NCT03763656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56144840|NCT02845596|Cyclosporine|cyclosporine|mesh-list
56144841|NCT02845596|Cyclophosphamide|cyclophosphamide|mesh-list
56144842|NCT02845596|Methotrexate|methotrexate|mesh-list
56144843|NCT02845596|Fludarabine|fludarabine|mesh-list
56144844|NCT02845596|Cyclosporins|cyclosporins|mesh-list
56144845|NCT02845596|Thymoglobulin|thymoglobulin|mesh-list
56144846|NCT02845596|Antilymphocyte Serum|antilymphocyte serum|mesh-list
56144847|NCT02845596|Immunosuppressive Agents|immunosuppressive agents|mesh-list
56144848|NCT02845596|Immunologic Factors|immunologic factors|mesh-ancestor
56144849|NCT02845596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144851|NCT02845596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
56144852|NCT02845596|Alkylating Agents|alkylating agents|mesh-ancestor
56144853|NCT02845596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144854|NCT02845596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144855|NCT02845596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
56144856|NCT02845596|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
56144857|NCT02845596|Abortifacient Agents|abortifacient agents|mesh-ancestor
56144858|NCT02845596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56144859|NCT02845596|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
56144861|NCT02845596|Dermatologic Agents|dermatologic agents|mesh-ancestor
56144862|NCT02845596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144863|NCT02845596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
56144864|NCT02845596|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
56144865|NCT02845596|Antifungal Agents|antifungal agents|mesh-ancestor
56144866|NCT02845596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144867|NCT02845596|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55742396|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
56144868|NCT02682888|Oxytocin|oxytocin|mesh-list
56144869|NCT02682888|Oxytocics|oxytocics|mesh-ancestor
56144870|NCT02682888|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56144871|NCT02682888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144872|NCT02641236|Vancomycin|vancomycin|mesh-list
56144873|NCT02641236|Polymyxins|polymyxins|mesh-list
56144874|NCT02641236|Polymyxin B|polymyxin b|mesh-list
56144875|NCT02641236|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56144876|NCT02641236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144877|NCT00142272|Ciprofloxacin|ciprofloxacin|mesh-list
56144878|NCT00142272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56144879|NCT00142272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144880|NCT00142272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55772536|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
56144881|NCT00142272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56144882|NCT00142272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144883|NCT00142272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144884|NCT00142272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144885|NCT00142272|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
56144886|NCT00142272|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
56144887|NCT00821886|Carboplatin|carboplatin|mesh-list
56144888|NCT00821886|Trastuzumab|trastuzumab|mesh-list
56144889|NCT00821886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144890|NCT00821886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
56144891|NCT00821964|Paclitaxel|paclitaxel|mesh-list
56144892|NCT00821964|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
56144893|NCT00821964|Imiquimod|imiquimod|mesh-list
56144894|NCT00821964|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
56144895|NCT00821964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
56144896|NCT00821964|Tubulin Modulators|tubulin modulators|mesh-ancestor
56144897|NCT00821964|Antimitotic Agents|antimitotic agents|mesh-ancestor
56144898|NCT00821964|Mitosis Modulators|mitosis modulators|mesh-ancestor
56144899|NCT00821964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144900|NCT00821964|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
56144901|NCT00821964|Immunologic Factors|immunologic factors|mesh-ancestor
56144902|NCT00821964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144903|NCT00821964|Interferon Inducers|interferon inducers|mesh-ancestor
56144904|NCT00822354|Tadalafil|tadalafil|mesh-list
56144905|NCT00822354|Vasodilator Agents|vasodilator agents|mesh-ancestor
56144906|NCT00822354|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
56144907|NCT00822354|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
56144908|NCT00822354|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144909|NCT00822354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144910|NCT00822354|Urological Agents|urological agents|mesh-ancestor
56144911|NCT00824070|Moxifloxacin|moxifloxacin|mesh-list
56144912|NCT00824070|Gatifloxacin|gatifloxacin|mesh-list
56144913|NCT00824070|Besifloxacin|besifloxacin|mesh-list
56144914|NCT00824070|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
56144915|NCT00824070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
56144916|NCT00824070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
56144917|NCT00824070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
56144918|NCT00824070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
56144919|NCT00824070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
56144920|NCT00824070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144921|NCT00824070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55772579|NCT02331563|Bupivacaine|bupivacaine|mesh-list
56144922|NCT00824070|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
56144923|NCT00824070|Contraceptive Agents|contraceptive agents|mesh-ancestor
56144924|NCT00824070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
56144925|NCT00824070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144926|NCT00824070|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
56144927|NCT00824070|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
56144928|NCT00824070|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
56144929|NCT00824070|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
56144930|NCT00824070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
56144946|NCT00824538|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
56144948|NCT00824538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
56144951|NCT00825786|Anesthetics, Local|anesthetics, local|mesh-ancestor
56144952|NCT00825786|Anesthetics|anesthetics|mesh-ancestor
56144953|NCT00825786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
56144954|NCT00825786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
56144955|NCT00825786|Sensory System Agents|sensory system agents|mesh-ancestor
56144956|NCT00825786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
56144957|NCT00826800|Bevacizumab|bevacizumab|mesh-list
55791782|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55791783|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791784|NCT02643355|Clonidine|clonidine|mesh-list
55791785|NCT02643355|Olanzapine|olanzapine|mesh-list
55791786|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
55791787|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
55791788|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791789|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791790|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791791|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55791792|NCT02643355|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55791793|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791794|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55791795|NCT02643355|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55791796|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55791797|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55792296|NCT05035381|Vitamins|vitamins|mesh-ancestor
55791798|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791799|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791800|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
55791801|NCT02643355|Analgesics|analgesics|mesh-ancestor
55791802|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
55791803|NCT02643355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55791804|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
55791814|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
55791815|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
55791816|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791817|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791818|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791819|NCT03036605|Glucocorticoids|glucocorticoids|mesh-ancestor
55791821|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791822|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55791823|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791824|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
55791825|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791826|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791827|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
55791828|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
55791829|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55791830|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
55791831|NCT03098875|Remifentanil|remifentanil|mesh-list
55791832|NCT03098875|Propofol|propofol|mesh-list
55791833|NCT03098875|Sevoflurane|sevoflurane|mesh-list
55791862|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55791863|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791865|NCT03101137|Bupivacaine|bupivacaine|mesh-list
55791866|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55791867|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
55791868|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
55791869|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791870|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791871|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791873|NCT03101137|Hormones|hormones|mesh-ancestor
55791874|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55791875|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55791876|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791877|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
55791889|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55791891|NCT00794599|Histamine Antagonists|histamine antagonists|mesh-ancestor
55791892|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
55791893|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791894|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791895|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791896|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55791897|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
55791899|NCT00783133|Desloratadine|desloratadine|mesh-list
55791900|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55791901|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
55791902|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55791903|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791904|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848211|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
55791949|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55791950|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
55791951|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791952|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55791953|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55791954|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791955|NCT00650689|Atorvastatin|atorvastatin|mesh-list
55791956|NCT00650689|Ezetimibe|ezetimibe|mesh-list
55791957|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55791958|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55791960|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791961|NCT00650689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55791962|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55791963|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791964|NCT05067517|Nintedanib|nintedanib|mesh-list
55791965|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55791966|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55791967|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791968|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791969|NCT03100513|Lactulose|lactulose|mesh-list
55791970|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55791971|NCT00552097|Simvastatin|simvastatin|mesh-list
55791972|NCT00552097|Ezetimibe|ezetimibe|mesh-list
55791980|NCT00396175|Finasteride|finasteride|mesh-list
55791981|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55791982|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791983|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55791984|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55791985|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55791986|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
55791995|NCT02603393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55791996|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55791997|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55791998|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
55792000|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55792001|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
55792002|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55792003|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
55792004|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792005|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792006|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55848487|NCT02980510|Fluorouracil|fluorouracil|mesh-list
55792017|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55792019|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792020|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55792021|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55792022|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792024|NCT01659567|Ribavirin|ribavirin|mesh-list
55792025|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
55792026|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
55792027|NCT01659567|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55792028|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792029|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
55792046|NCT05363631|Trace Elements|trace elements|mesh-ancestor
55792047|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
55792048|NCT04832399|Natalizumab|natalizumab|mesh-list
55792049|NCT04832399|Immunologic Factors|immunologic factors|mesh-ancestor
55792050|NCT04832399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792051|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
55792052|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55792053|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792055|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55792066|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792068|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55792069|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792070|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792071|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
55792072|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792073|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792074|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55792075|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
55792076|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792105|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
55792106|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792107|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55792108|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55792109|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55792110|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55792111|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792112|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792113|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792115|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
55792116|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792117|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
55792118|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55792130|NCT05046457|Vitamins|vitamins|mesh-ancestor
55792131|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
55792132|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792133|NCT05063071|Tenofovir|tenofovir|mesh-list
55792134|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
55792135|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792136|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55792137|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55792138|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792139|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792140|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55792141|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55792142|NCT05062681|Dexamethasone|dexamethasone|mesh-list
55792143|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
55792144|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55792145|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55792157|NCT05062681|Hormones|hormones|mesh-ancestor
55792158|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792159|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55792160|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792161|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55792162|NCT05062681|Protective Agents|protective agents|mesh-ancestor
55792164|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
55792176|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792177|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792178|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55792179|NCT05045053|Lifitegrast|lifitegrast|mesh-list
55792180|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55792181|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
55792182|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
55792183|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792184|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792185|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792186|NCT05060809|Vitamin K|vitamin k|mesh-list
55792187|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
55792188|NCT05060809|Vitamins|vitamins|mesh-ancestor
55792189|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
55792190|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792191|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55792192|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55792193|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792194|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
55792195|NCT05060809|Coagulants|coagulants|mesh-ancestor
55792196|NCT05060419|Meropenem|meropenem|mesh-list
55792197|NCT05060419|Tazobactam|tazobactam|mesh-list
55792198|NCT05060419|Piperacillin|piperacillin|mesh-list
55792199|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55792200|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55792201|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792202|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55792203|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792204|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792215|NCT03097003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55792216|NCT03097003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792217|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792218|NCT02605967|Spartalizumab|spartalizumab|mesh-list
55792219|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55792220|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792221|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792223|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55792224|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792225|NCT03036059|Ivermectin|ivermectin|mesh-list
55792226|NCT03036059|Albendazole|albendazole|mesh-list
55792227|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55792228|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792229|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
55792230|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
55792231|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55792232|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55792233|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
55792234|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
55792235|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
55792236|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792237|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792238|NCT04834427|Ketamine|ketamine|mesh-list
55792239|NCT04834427|Esketamine|esketamine|mesh-list
55792240|NCT04834427|Analgesics|analgesics|mesh-ancestor
55792290|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55792291|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55792292|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792293|NCT05035381|Antidotes|antidotes|mesh-ancestor
55792294|NCT05035381|Protective Agents|protective agents|mesh-ancestor
55792297|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
55792298|NCT04821323|Indomethacin|indomethacin|mesh-list
55792299|NCT04821323|Mannitol|mannitol|mesh-list
55792300|NCT04821323|Lactulose|lactulose|mesh-list
55792301|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55792302|NCT04821323|Diuretics|diuretics|mesh-ancestor
55792303|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
55792304|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792305|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55792306|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55792307|NCT04821323|Analgesics|analgesics|mesh-ancestor
55792309|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792310|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792311|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55792312|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
55792313|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
55792314|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55792315|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55792316|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792332|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
55792333|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
55792363|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
55792364|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
55792365|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
55792366|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55792367|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55792381|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792382|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55792383|NCT04816253|Protective Agents|protective agents|mesh-ancestor
55792384|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55792385|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792386|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55792387|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
55792388|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
55792389|NCT04816097|Dexamethasone|dexamethasone|mesh-list
55792390|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55792391|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792392|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
55792393|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
55792394|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792395|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792396|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792397|NCT04816097|Glucocorticoids|glucocorticoids|mesh-ancestor
55792398|NCT04816097|Hormones|hormones|mesh-ancestor
55792399|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55792400|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55792401|NCT04816097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792402|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
55792403|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55792404|NCT02600351|Ledipasvir|ledipasvir|mesh-list
55792405|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
55792406|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792407|NCT04829435|Rasburicase|rasburicase|mesh-list
55792454|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55792455|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55792456|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
55792472|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
55792473|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792474|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792475|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792476|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55792477|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55792493|NCT03094663|Bupivacaine|bupivacaine|mesh-list
55792495|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792496|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
55848488|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
55792530|NCT04814381|Analgesics|analgesics|mesh-ancestor
55792531|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
55792532|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792533|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792534|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55792535|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55792536|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
55792537|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
55848705|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
55792546|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55792547|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55792548|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
55792549|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55792551|NCT04819217|Antidotes|antidotes|mesh-ancestor
55792552|NCT04819217|Protective Agents|protective agents|mesh-ancestor
55792553|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792554|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55792555|NCT05052619|Cefmetazole|cefmetazole|mesh-list
55792556|NCT05052619|Sulperazone|sulperazone|mesh-list
55792557|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792558|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55792559|NCT05052619|Renal Agents|renal agents|mesh-ancestor
55792560|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
55792561|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55792562|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792563|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
55792564|NCT04813523|Cisplatin|cisplatin|mesh-list
55792565|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
55792566|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792567|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55792568|NCT05032261|Norepinephrine|norepinephrine|mesh-list
55792569|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55792570|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55792571|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
55792572|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792578|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55792579|NCT05619341|Psyllium|psyllium|mesh-list
55792580|NCT05619341|Cathartics|cathartics|mesh-ancestor
55792581|NCT05619341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792582|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
55792583|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
55792584|NCT05051137|Infliximab|infliximab|mesh-list
55792585|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
55792587|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55792588|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792589|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792590|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792591|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55792592|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
55792593|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792594|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55792595|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55792596|NCT05051137|Analgesics|analgesics|mesh-ancestor
55792597|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
55792598|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792599|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792600|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792601|NCT05038969|Esomeprazole|esomeprazole|mesh-list
55792602|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55792603|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55792604|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55792605|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792606|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792608|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792609|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
55792610|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55792611|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55792612|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792613|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55792614|NCT05038111|Analgesics|analgesics|mesh-ancestor
55792615|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
55792616|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792617|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55792619|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55792620|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
55792621|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55792622|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792623|NCT05030077|Gemcitabine|gemcitabine|mesh-list
55792624|NCT05030077|Carboplatin|carboplatin|mesh-list
55792625|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792626|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55792627|NCT05030077|Antimetabolites|antimetabolites|mesh-ancestor
55792628|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792629|NCT05030077|Antiviral Agents|antiviral agents|mesh-ancestor
55792630|NCT05030077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792631|NCT05030077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792632|NCT05030077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55792633|NCT05030077|Immunologic Factors|immunologic factors|mesh-ancestor
55792634|NCT05030077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792636|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792637|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55792638|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55792639|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792640|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
55792641|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
55792642|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55792643|NCT05037253|Vitamin D|vitamin d|mesh-list
55792644|NCT05037253|Vitamins|vitamins|mesh-ancestor
55792645|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
55792646|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792674|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55792675|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55792676|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
55792677|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
55792678|NCT05028907|Protective Agents|protective agents|mesh-ancestor
55792689|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55792701|NCT05050357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55848838|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
55792721|NCT05023915|Dexamethasone|dexamethasone|mesh-list
55792722|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
55792723|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792724|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
55792725|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
55792726|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849145|NCT02559778|Sorafenib|sorafenib|mesh-list
55792769|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792770|NCT02528253|Analgesics|analgesics|mesh-ancestor
55792771|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
55792772|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792773|NCT03093103|Empagliflozin|empagliflozin|mesh-list
55792774|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55792775|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792776|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55792777|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792778|NCT03093805|Calcipotriene|calcipotriene|mesh-list
55792779|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827549|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792787|NCT05023759|Cannabidiol|cannabidiol|mesh-list
55792788|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
55792789|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
55792790|NCT01672957|Immunosuppressive Agents|immunosuppressive agents|mesh-list
55792807|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55792808|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55792809|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55792810|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55792813|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55792814|NCT05021887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55792815|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
55792816|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55792817|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55792818|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55792819|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
55793142|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55793143|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793144|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55793145|NCT03079141|Diuretics|diuretics|mesh-ancestor
55793146|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
55793147|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55793148|NCT03085849|Durvalumab|durvalumab|mesh-list
55793149|NCT03085849|Tremelimumab|tremelimumab|mesh-list
55793150|NCT03085849|Guadecitabine|guadecitabine|mesh-list
55793151|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55793152|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793153|NCT05001529|Antibodies|antibodies|mesh-list
55793154|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
55793155|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793156|NCT05001061|Misoprostol|misoprostol|mesh-list
55793157|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55793158|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
55793159|NCT05001061|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55793160|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793170|NCT05531955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55793171|NCT05531955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793172|NCT05531955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55793175|NCT05339529|Thymalfasin|thymalfasin|mesh-list
55793264|NCT05305989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55793265|NCT05305989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793266|NCT05305989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793269|NCT05013697|Cisplatin|cisplatin|mesh-list
55793270|NCT05013697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55793271|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793272|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
55793273|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
55793274|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
55793275|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793276|NCT05509647|Heparin|heparin|mesh-list
55793277|NCT05509647|Calcium heparin|calcium heparin|mesh-list
55793430|NCT05262777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793431|NCT05262777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793432|NCT05262777|Sensory System Agents|sensory system agents|mesh-ancestor
55793433|NCT05262777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793442|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55793443|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793444|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793445|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793446|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55793447|NCT05260359|Protective Agents|protective agents|mesh-ancestor
55793448|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
55793449|NCT05260359|Emollients|emollients|mesh-ancestor
55793450|NCT05331027|Sevoflurane|sevoflurane|mesh-list
55793451|NCT05331027|Desflurane|desflurane|mesh-list
55793452|NCT05331027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55793453|NCT05331027|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55793454|NCT05331027|Anesthetics, General|anesthetics, general|mesh-ancestor
55793455|NCT05331027|Anesthetics|anesthetics|mesh-ancestor
55793456|NCT05331027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793457|NCT05331027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793458|NCT05329155|Heparin|heparin|mesh-list
55793459|NCT05329155|Calcium heparin|calcium heparin|mesh-list
55793460|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
55793461|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55793480|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
55793481|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
55793482|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55793483|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793484|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
55793485|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793486|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55793487|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55793500|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
55793501|NCT01659021|Ofatumumab|ofatumumab|mesh-list
55793502|NCT01659021|Idelalisib|idelalisib|mesh-list
55793503|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793504|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793505|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793582|NCT05616923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793583|NCT05616923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793586|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55793587|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55793589|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
55793590|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793591|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55793592|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
55793593|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55793594|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55793595|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55793596|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55793597|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793598|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
55793658|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793659|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55793660|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55793712|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
55793713|NCT05246085|Hydrocortisone|hydrocortisone|mesh-list
55793714|NCT05246085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793715|NCT05518695|Antibodies, Blocking|antibodies, blocking|mesh-list
55793716|NCT05518695|Immunologic Factors|immunologic factors|mesh-ancestor
55793717|NCT05518695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793718|NCT04136067|Insulin Glargine|insulin glargine|mesh-list
55793719|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55793720|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793721|NCT05282901|Pembrolizumab|pembrolizumab|mesh-list
55793722|NCT05282901|Lenvatinib|lenvatinib|mesh-list
55793723|NCT05282901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55793724|NCT05282901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793725|NCT05282901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55793726|NCT05282901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793727|NCT05282901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793744|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55793745|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
55793746|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793747|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793749|NCT03073057|Protective Agents|protective agents|mesh-ancestor
55793750|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
55793751|NCT03073369|Vitamin D|vitamin d|mesh-list
55793752|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55793753|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793754|NCT03073369|Vitamins|vitamins|mesh-ancestor
55793776|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55793777|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793778|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793779|NCT04911127|Cannabidiol|cannabidiol|mesh-list
55793780|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
55793781|NCT04995133|Colistin|colistin|mesh-list
55793782|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55793783|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55793784|NCT04362839|Nivolumab|nivolumab|mesh-list
55793785|NCT04362839|Ipilimumab|ipilimumab|mesh-list
55793786|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55793787|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793788|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55793789|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793790|NCT04360889|Tocopherols|tocopherols|mesh-list
55793791|NCT04360889|Vitamin E|vitamin e|mesh-list
55793792|NCT04360889|Tocotrienols|tocotrienols|mesh-list
55793793|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
55793794|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
55793814|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793815|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793832|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55793852|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
55793853|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55793854|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793903|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
55793913|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793914|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
55793915|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793916|NCT04987567|Antioxidants|antioxidants|mesh-list
55793918|NCT04987567|Protective Agents|protective agents|mesh-ancestor
55793919|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793920|NCT03072199|Rituximab|rituximab|mesh-list
55793921|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55793922|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793923|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
55793924|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793925|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55793926|NCT04806737|Teriflunomide|teriflunomide|mesh-list
55793927|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55793928|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55793929|NCT04806737|Analgesics|analgesics|mesh-ancestor
55793930|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
55793931|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793932|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793933|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793934|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55793935|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55793936|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
55793937|NCT04991155|Zamicastat|zamicastat|mesh-list
55793938|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55793939|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55793941|NCT04462315|Chromium|chromium|mesh-list
55793942|NCT04462315|Everolimus|everolimus|mesh-list
55793943|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55793944|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55793945|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
55793946|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793947|NCT04462315|Trace Elements|trace elements|mesh-ancestor
55793948|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
55793949|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55793950|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55793979|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55793980|NCT03069781|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55793981|NCT03069781|Estradiol|estradiol|mesh-list
55793982|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55793983|NCT03069781|Estrogens|estrogens|mesh-ancestor
55793984|NCT03069781|Hormones|hormones|mesh-ancestor
55793985|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55793986|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793987|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55793988|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
55793989|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55793990|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55793991|NCT03071575|Vaccines|vaccines|mesh-list
55793992|NCT03071575|Immunologic Factors|immunologic factors|mesh-ancestor
55793993|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55793994|NCT04798391|Dexamethasone|dexamethasone|mesh-list
55793995|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55793996|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
55793997|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
55793998|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55793999|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794000|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794022|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
55794023|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
55794024|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794025|NCT04805957|Sulforaphane|sulforaphane|mesh-list
55794026|NCT04805957|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55794027|NCT04805957|Protective Agents|protective agents|mesh-ancestor
55794028|NCT04805957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794065|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55794094|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794095|NCT05281341|Hormones|hormones|mesh-list
55794127|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55794182|NCT05226429|Immunologic Factors|immunologic factors|mesh-ancestor
55794183|NCT05226429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794219|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794220|NCT04785911|Autonomic Agents|autonomic agents|mesh-ancestor
55794228|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55794229|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
55794230|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55794232|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794233|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
55794251|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55794252|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794253|NCT05221749|Fluorides|fluorides|mesh-list
55794254|NCT05221749|Cariostatic Agents|cariostatic agents|mesh-ancestor
55794255|NCT05221749|Protective Agents|protective agents|mesh-ancestor
55794256|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794257|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
55794258|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55794259|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
55794260|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794261|NCT04426721|Viscosupplements|viscosupplements|mesh-ancestor
55794262|NCT04426721|Protective Agents|protective agents|mesh-ancestor
55794263|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
55794264|NCT05221359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55794265|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794266|NCT04794413|Pimavanserin|pimavanserin|mesh-list
55794267|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55794268|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55794269|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55794270|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55794271|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55794272|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794273|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55794274|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55794275|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55794276|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
55794277|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794639|NCT05097261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55794278|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794279|NCT05359861|Bevacizumab|bevacizumab|mesh-list
55794280|NCT05359861|Atezolizumab|atezolizumab|mesh-list
55794281|NCT05359861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55794282|NCT05359861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794283|NCT05359861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55794284|NCT05359861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55794285|NCT05359861|Growth Substances|growth substances|mesh-ancestor
55794294|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794295|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794297|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
55794298|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794299|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794300|NCT05214573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55794301|NCT04988191|Bevacizumab|bevacizumab|mesh-list
55794308|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794309|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
55794355|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
55794357|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794373|NCT05615987|Cholinergic Agents|cholinergic agents|mesh-ancestor
55794374|NCT05615987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794382|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794383|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794384|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55794385|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
55794386|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794387|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55794459|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55794461|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55794462|NCT05104983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794463|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55794464|NCT05104983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794465|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
55794466|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55794467|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
55794483|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55794484|NCT04230759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794485|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55794486|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
55794487|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794488|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55794489|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55794490|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
55794491|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55794492|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794493|NCT05471687|Adenosine|adenosine|mesh-list
55794494|NCT05471687|Analgesics|analgesics|mesh-ancestor
55794495|NCT05471687|Sensory System Agents|sensory system agents|mesh-ancestor
55794504|NCT05471687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794506|NCT05471609|Carbidopa|carbidopa|mesh-list
55794507|NCT05471609|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55794508|NCT05471609|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55794509|NCT05471609|Dopamine Agents|dopamine agents|mesh-ancestor
55794510|NCT05471609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794520|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
55794521|NCT05370729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55794522|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
55794523|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794524|NCT05370729|Protective Agents|protective agents|mesh-ancestor
55794598|NCT04799873|Protease Inhibitors|protease inhibitors|mesh-ancestor
55794599|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794625|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794627|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
55794628|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
55794629|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794630|NCT05097261|Ketamine|ketamine|mesh-list
55794631|NCT05097261|Analgesics|analgesics|mesh-ancestor
55794632|NCT05097261|Sensory System Agents|sensory system agents|mesh-ancestor
55794633|NCT05097261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794634|NCT05097261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794635|NCT05097261|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55794636|NCT05097261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55794637|NCT05097261|Anesthetics, General|anesthetics, general|mesh-ancestor
55794640|NCT05097261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55794641|NCT05097261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55794642|NCT05097261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794659|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794661|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
55794662|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
55794663|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55794664|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794703|NCT03901001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794704|NCT03901001|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55794705|NCT03901001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794706|NCT03901001|Antifungal Agents|antifungal agents|mesh-ancestor
55794707|NCT03901001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55794708|NCT03901001|Immunologic Factors|immunologic factors|mesh-ancestor
55794709|NCT03901001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794710|NCT03901001|Antiviral Agents|antiviral agents|mesh-ancestor
55794711|NCT03901001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794712|NCT03901001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794714|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
55794715|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55794716|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55794736|NCT02633059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55794737|NCT02633059|Antiemetics|antiemetics|mesh-ancestor
55794738|NCT02633059|Autonomic Agents|autonomic agents|mesh-ancestor
55794779|NCT04583969|Antimetabolites|antimetabolites|mesh-ancestor
55794780|NCT04583969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794781|NCT04583969|Antiviral Agents|antiviral agents|mesh-ancestor
55794782|NCT04583969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794792|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794794|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
55794795|NCT05195177|Histamine|histamine|mesh-list
55794796|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
55794797|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55794798|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55794799|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794800|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
55794801|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794802|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
55794803|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
55794804|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55794805|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794806|NCT05170919|Olanzapine|olanzapine|mesh-list
55794807|NCT05170919|Mirtazapine|mirtazapine|mesh-list
55794808|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
55794809|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
55794810|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55794827|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55794828|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55794890|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55794891|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55794893|NCT02866643|Hormones|hormones|mesh-ancestor
55794894|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55794895|NCT05176821|Amoxicillin|amoxicillin|mesh-list
55794896|NCT05176821|Furazolidone|furazolidone|mesh-list
55794897|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
55794898|NCT05176821|Esomeprazole|esomeprazole|mesh-list
55794899|NCT05176821|Bismuth|bismuth|mesh-list
55794900|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55794901|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55794902|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55794903|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55794904|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55794905|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55794906|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55794907|NCT05176821|Antacids|antacids|mesh-ancestor
55794908|NCT05176821|Diuretics|diuretics|mesh-ancestor
55794909|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
55794938|NCT05555641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55794939|NCT05555641|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55794940|NCT05555641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55794941|NCT05555641|Immunologic Factors|immunologic factors|mesh-ancestor
55794944|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55794945|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55794946|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55794947|NCT05115513|Analgesics|analgesics|mesh-ancestor
55795270|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
55795080|NCT05611229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55795081|NCT05611229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795082|NCT05611229|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55795083|NCT05611229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795084|NCT05611229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55795085|NCT05611229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795087|NCT03067597|Oxytocics|oxytocics|mesh-ancestor
55795089|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795104|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55795105|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795106|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55795107|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55795108|NCT04733963|Growth Substances|growth substances|mesh-ancestor
55795109|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795110|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
55795111|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55795112|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
55795113|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795114|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
55795115|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55795116|NCT04222023|Antibodies|antibodies|mesh-list
55795117|NCT04222023|gamma-Globulins|gamma-globulins|mesh-list
55795118|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55795119|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
55795120|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795121|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
55795123|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55795124|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55795125|NCT03066115|Analgesics|analgesics|mesh-ancestor
55795126|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
55795127|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795128|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795129|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55795130|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55795131|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55795132|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795133|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795134|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
55795135|NCT03066115|Protective Agents|protective agents|mesh-ancestor
55795136|NCT03066115|Vitamins|vitamins|mesh-ancestor
55795137|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
55795138|NCT04212039|Bupivacaine|bupivacaine|mesh-list
55795139|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
55795140|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
55795141|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795142|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795148|NCT04716413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795149|NCT04716413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795150|NCT04716413|Analgesics|analgesics|mesh-ancestor
55795151|NCT04716413|Sensory System Agents|sensory system agents|mesh-ancestor
55795152|NCT04716413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795153|NCT05048589|Vaccines|vaccines|mesh-list
55795154|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
55795155|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795156|NCT05728333|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55795157|NCT05728333|Tirofiban|tirofiban|mesh-list
55795158|NCT05728333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55795159|NCT05728333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55795166|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
55795167|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
55795168|NCT04990869|Vitamins|vitamins|mesh-ancestor
55795169|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
55795170|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795171|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55795172|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
55795173|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795174|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55795175|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
55795176|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55795178|NCT04401553|Cephalosporins|cephalosporins|mesh-list
55795179|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795180|NCT01364649|Vortioxetine|vortioxetine|mesh-list
55795181|NCT01364649|Citalopram|citalopram|mesh-list
55795182|NCT01364649|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55795183|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55795184|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55795185|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795186|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795188|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795189|NCT01364649|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55795191|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55795192|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55795193|NCT01364649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55795194|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795195|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55795196|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55795197|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55795198|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55795199|NCT03065569|Bupivacaine|bupivacaine|mesh-list
55795200|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
55795201|NCT03065569|Anesthetics|anesthetics|mesh-ancestor
55795202|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795203|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795204|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
55795205|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795206|NCT05723419|Anesthetics|anesthetics|mesh-list
55795207|NCT05723419|Anesthetics, Local|anesthetics, local|mesh-list
55795208|NCT05723419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795209|NCT05723419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795210|NCT05723419|Sensory System Agents|sensory system agents|mesh-ancestor
55795211|NCT05723419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795212|NCT05042973|Empagliflozin|empagliflozin|mesh-list
55795213|NCT05042973|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55795214|NCT05042973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795215|NCT05042973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55795216|NCT05042973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795217|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55795218|NCT02588261|Gefitinib|gefitinib|mesh-list
55795219|NCT02588261|Naquotinib|naquotinib|mesh-list
55795220|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795221|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55795222|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795223|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795224|NCT04989699|Aflibercept|aflibercept|mesh-list
55795225|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55795226|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55795227|NCT04989699|Growth Substances|growth substances|mesh-ancestor
55795228|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795229|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
55795230|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795231|NCT05067933|Vaccines|vaccines|mesh-list
55795240|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795241|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795243|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
55795244|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
55795245|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795246|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
55795247|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795248|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
55795249|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795250|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55795251|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795252|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795253|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795255|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55795256|NCT01672723|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55795257|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795258|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
55795259|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795260|NCT04443673|Glycine|glycine|mesh-list
55795261|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
55795262|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795263|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795264|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795265|NCT05036577|Dexamethasone|dexamethasone|mesh-list
55795266|NCT05036577|Rituximab|rituximab|mesh-list
55795267|NCT05036577|Methotrexate|methotrexate|mesh-list
55795268|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55795269|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795271|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795272|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55795273|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55795274|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
55795275|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
55795276|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795277|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55795278|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
55795279|NCT05036577|Hormones|hormones|mesh-ancestor
55795280|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795282|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55795283|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
55795284|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55795285|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55795286|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
55795287|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795288|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
55795289|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795290|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55795291|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795292|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55795294|NCT04982367|Paclitaxel|paclitaxel|mesh-list
55795296|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55795297|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795298|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
55795299|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
55795300|NCT04982367|Mitosis Modulators|mitosis modulators|mesh-ancestor
55795301|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795311|NCT05031975|Irinotecan|irinotecan|mesh-list
55795312|NCT05031975|Temozolomide|temozolomide|mesh-list
55795313|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55795314|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55795316|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795317|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795318|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55795319|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
55795320|NCT02632747|Empagliflozin|empagliflozin|mesh-list
55795322|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55795323|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795324|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55795325|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795326|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55795328|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795329|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55795330|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
55795331|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
55795332|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795333|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55795334|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795335|NCT04216797|Diazepam|diazepam|mesh-list
55795336|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55795337|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
55795338|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
55795339|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
55795340|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795341|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795342|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55795343|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55795344|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795345|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55795346|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55795347|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55795348|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55795349|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55795350|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55795351|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
55795352|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
55795386|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795387|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795389|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795390|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55795391|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55795392|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795393|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795394|NCT04421547|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55795395|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
55795396|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795397|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795399|NCT03066817|Vitamin D|vitamin d|mesh-list
55795400|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55795401|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795402|NCT03066817|Vitamins|vitamins|mesh-ancestor
55795403|NCT03066817|Micronutrients|micronutrients|mesh-ancestor
55795404|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55795405|NCT05060913|Lidocaine|lidocaine|mesh-list
55795406|NCT05060913|Prilocaine|prilocaine|mesh-list
55795407|NCT05060913|Benzocaine|benzocaine|mesh-list
55795408|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55795418|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55795419|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795420|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55795421|NCT03870763|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55795422|NCT03870763|Dermatologic Agents|dermatologic agents|mesh-ancestor
55795423|NCT03870763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795424|NCT03870763|Immunologic Factors|immunologic factors|mesh-ancestor
55795425|NCT03870763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795427|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
55795428|NCT05165251|Atorvastatin|atorvastatin|mesh-list
55795429|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55795430|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55795431|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
55795432|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795433|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55795434|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55795435|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795436|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55795437|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55795438|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55795439|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55795440|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795441|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
55795442|NCT04209075|Metformin|metformin|mesh-list
55795443|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55795444|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795445|NCT04980495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55795446|NCT05023473|Morphine|morphine|mesh-list
55795447|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55795448|NCT05023473|Narcotics|narcotics|mesh-ancestor
55795449|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795450|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795451|NCT05023473|Analgesics|analgesics|mesh-ancestor
55795452|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
55795453|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795454|NCT03066661|Entrectinib|entrectinib|mesh-list
55795456|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795457|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795458|NCT05022147|Dopamine|dopamine|mesh-list
55795459|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
55795460|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55795461|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
55795462|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
55795463|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795464|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795466|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795467|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795468|NCT05022147|Protective Agents|protective agents|mesh-ancestor
55795469|NCT05104567|Pembrolizumab|pembrolizumab|mesh-list
55795470|NCT05104567|Cetuximab|cetuximab|mesh-list
55795471|NCT05104567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55795472|NCT05104567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795473|NCT03775629|Tramadol|tramadol|mesh-list
55795474|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55795480|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795481|NCT01671319|Cyclophosphamide|cyclophosphamide|mesh-list
55795482|NCT01671319|Docetaxel|docetaxel|mesh-list
55795483|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795485|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795486|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55795487|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55795488|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
55795489|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795490|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795491|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55795492|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
55795493|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
55795494|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
55795495|NCT04940065|Ofatumumab|ofatumumab|mesh-list
55795496|NCT04940065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795497|NCT05019885|Ketamine|ketamine|mesh-list
55795498|NCT05019885|Analgesics|analgesics|mesh-ancestor
55795499|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
55795504|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
55795512|NCT05016609|Velpatasvir|velpatasvir|mesh-list
55795513|NCT05016609|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55795514|NCT05016609|Antibodies|antibodies|mesh-list
55795515|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
55795516|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
55795517|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795518|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
55795519|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795520|NCT03763305|Fentanyl|fentanyl|mesh-list
55795521|NCT03763305|Remifentanil|remifentanil|mesh-list
55795522|NCT03763305|Propofol|propofol|mesh-list
55795523|NCT03763305|Sevoflurane|sevoflurane|mesh-list
55795524|NCT03763305|Desflurane|desflurane|mesh-list
55795525|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55795526|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55795527|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795528|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795529|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55795530|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
55795531|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
55795532|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55795533|NCT03763305|Narcotics|narcotics|mesh-ancestor
55795535|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
55795536|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795537|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55795538|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55795539|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55795541|NCT05054361|Lactulose|lactulose|mesh-list
55795542|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55795543|NCT05054361|Diuretics|diuretics|mesh-ancestor
55795544|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
55795545|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795546|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55795547|NCT04970355|Erenumab|erenumab|mesh-list
55795548|NCT04970355|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55827585|NCT04524689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55795549|NCT04970355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795550|NCT04970355|Analgesics|analgesics|mesh-ancestor
55795551|NCT04970355|Sensory System Agents|sensory system agents|mesh-ancestor
55795552|NCT04970355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795553|NCT04970355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795554|NCT04906213|Empagliflozin|empagliflozin|mesh-list
55795555|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55795556|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795557|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55795558|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795559|NCT01670539|Triamcinolone|triamcinolone|mesh-list
55795569|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
55795570|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795571|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795572|NCT02252887|Antiviral Agents|antiviral agents|mesh-ancestor
55795573|NCT02252887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795574|NCT02252887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795575|NCT02252887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795576|NCT02252887|Immunologic Factors|immunologic factors|mesh-ancestor
55795577|NCT02252887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795578|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55795579|NCT04431895|Tofacitinib|tofacitinib|mesh-list
55795580|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55795581|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795582|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795584|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
55795586|NCT03064633|Bupivacaine|bupivacaine|mesh-list
55795588|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55795589|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
55795590|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
55795591|NCT03064633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795592|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795593|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55795594|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
55795595|NCT03064633|Hormones|hormones|mesh-ancestor
55795596|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795597|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55795598|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795599|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
55795600|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795601|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795602|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
55795603|NCT03064633|Anesthetics|anesthetics|mesh-ancestor
55795604|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795605|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
55795606|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55795607|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55795608|NCT03064633|Analgesics|analgesics|mesh-ancestor
55795609|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55795610|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55795611|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55795612|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
55795613|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795614|NCT04950465|Fluorides|fluorides|mesh-list
55795615|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
55795636|NCT04877821|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55795637|NCT04877821|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55795638|NCT04877821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795639|NCT02589665|Mirikizumab|mirikizumab|mesh-list
55795640|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55795641|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55795642|NCT02589665|Analgesics|analgesics|mesh-ancestor
55795643|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
55795644|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795646|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55795647|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55795648|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55795649|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55795650|NCT04840615|Ipilimumab|ipilimumab|mesh-list
55795651|NCT04840615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55795652|NCT04840615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795653|NCT04840615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55795654|NCT04840615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795655|NCT05011383|Testosterone|testosterone|mesh-list
55795656|NCT05011383|Androgens|androgens|mesh-list
55795657|NCT05011383|Hormones|hormones|mesh-ancestor
55795658|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795659|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795661|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
55795662|NCT01697527|Fludarabine|fludarabine|mesh-list
55795663|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
55795664|NCT01697527|Interleukin-2|interleukin-2|mesh-list
55795666|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55795667|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795668|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
55795669|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795670|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55795671|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55795672|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
55795673|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795683|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55795684|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
55795685|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795687|NCT04426409|Ofloxacin|ofloxacin|mesh-list
55795688|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55795689|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795690|NCT04426409|Renal Agents|renal agents|mesh-ancestor
55795691|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55795692|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55795693|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55795694|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795798|NCT04062695|Tofacitinib|tofacitinib|mesh-list
55795695|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795696|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795697|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55795698|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55795700|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55795701|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795703|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
55795704|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795705|NCT05556083|Sildenafil Citrate|sildenafil citrate|mesh-list
55795706|NCT05556083|Vasodilator Agents|vasodilator agents|mesh-ancestor
55795707|NCT05556083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55795708|NCT05556083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55795709|NCT05556083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795710|NCT05556083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795711|NCT05556083|Urological Agents|urological agents|mesh-ancestor
55795713|NCT05556005|Vasodilator Agents|vasodilator agents|mesh-ancestor
55795714|NCT05008809|Leucovorin|leucovorin|mesh-list
55795715|NCT05008809|Fluorouracil|fluorouracil|mesh-list
55795716|NCT05008809|Oxaliplatin|oxaliplatin|mesh-list
55795727|NCT05008809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55795728|NCT05008809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795729|NCT05008809|Antidotes|antidotes|mesh-ancestor
55795730|NCT05008809|Protective Agents|protective agents|mesh-ancestor
55795731|NCT05008809|Vitamin B Complex|vitamin b complex|mesh-ancestor
55795732|NCT05008809|Vitamins|vitamins|mesh-ancestor
55795733|NCT05008809|Micronutrients|micronutrients|mesh-ancestor
55795734|NCT04374461|Acetylcysteine|acetylcysteine|mesh-list
55795735|NCT04374461|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55795736|NCT04374461|Antiviral Agents|antiviral agents|mesh-ancestor
55795737|NCT04374461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795738|NCT04374461|Expectorants|expectorants|mesh-ancestor
55795739|NCT04374461|Respiratory System Agents|respiratory system agents|mesh-ancestor
55795740|NCT04374461|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55795741|NCT04374461|Antioxidants|antioxidants|mesh-ancestor
55795742|NCT04374461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795743|NCT04374461|Protective Agents|protective agents|mesh-ancestor
55795744|NCT04374461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795745|NCT04374461|Antidotes|antidotes|mesh-ancestor
55795746|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
55795747|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
55795748|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55795749|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55795750|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795751|NCT04373603|Hemostatics|hemostatics|mesh-ancestor
55795752|NCT04373603|Coagulants|coagulants|mesh-ancestor
55795753|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55795754|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
55795755|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795756|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
55795757|NCT04373603|Protective Agents|protective agents|mesh-ancestor
55795758|NCT02519595|Ketamine|ketamine|mesh-list
55795771|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795772|NCT04278755|Drospirenone|drospirenone|mesh-list
55795773|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55795774|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
55795776|NCT04278755|Estrogens|estrogens|mesh-ancestor
55795777|NCT04278755|Hormones|hormones|mesh-ancestor
55795778|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795779|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795780|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55795781|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
55795782|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55795783|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55795784|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55795785|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55795786|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55795787|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
55795788|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55795789|NCT04278755|Diuretics|diuretics|mesh-ancestor
55795790|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
55795791|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
55795792|NCT04277975|Narcotics|narcotics|mesh-ancestor
55795793|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795794|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795796|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
55795797|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795799|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55795800|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795801|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795802|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
55795811|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55795812|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
55795813|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795814|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795815|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795816|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55795817|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795818|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55795819|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
55795820|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
55795821|NCT05612711|Dronabinol|dronabinol|mesh-list
55795822|NCT05612711|Hallucinogens|hallucinogens|mesh-ancestor
55827586|NCT04524689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55795823|NCT05612711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795824|NCT05612711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55795825|NCT05612711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55795827|NCT05612711|Sensory System Agents|sensory system agents|mesh-ancestor
55795828|NCT05612711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795829|NCT05612711|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55795830|NCT05612711|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55795831|NCT05612711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795832|NCT05612711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795833|NCT05612711|Hormones|hormones|mesh-ancestor
55795834|NCT05612711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795835|NCT04807309|Danazol|danazol|mesh-list
55795836|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55795837|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
55795838|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55795839|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795840|NCT04744649|Fluorouracil|fluorouracil|mesh-list
55795841|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
55795842|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795843|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55795844|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795845|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795846|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
55795847|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795849|NCT05701007|Goserelin|goserelin|mesh-list
55795850|NCT05701007|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55795851|NCT05701007|Leuprolide|leuprolide|mesh-list
55795852|NCT05701007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795853|NCT05701007|Tubulin Modulators|tubulin modulators|mesh-ancestor
55795854|NCT05701007|Antimitotic Agents|antimitotic agents|mesh-ancestor
55795855|NCT05701007|Mitosis Modulators|mitosis modulators|mesh-ancestor
55795856|NCT05701007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795857|NCT05701007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55795858|NCT05701007|Luteolytic Agents|luteolytic agents|mesh-ancestor
55795859|NCT05701007|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55795860|NCT05701007|Contraceptive Agents|contraceptive agents|mesh-ancestor
55795861|NCT05701007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55795862|NCT05701007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795873|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795875|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
55795876|NCT02630563|Cyclosporins|cyclosporins|mesh-list
55795877|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827587|NCT04524689|Tubulin Modulators|tubulin modulators|mesh-ancestor
55795878|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795879|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795880|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
55795881|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795882|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
55795883|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795884|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
55795885|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55795886|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55795887|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55795888|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795889|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55795995|NCT05554055|Anticoagulants|anticoagulants|mesh-ancestor
55795890|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
55795891|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55795898|NCT05555147|Anesthetics, Local|anesthetics, local|mesh-ancestor
55795900|NCT05555147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795901|NCT05555147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795902|NCT05555147|Sensory System Agents|sensory system agents|mesh-ancestor
55795903|NCT05555147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795904|NCT02587247|Antibodies|antibodies|mesh-list
55795905|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
55795906|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795907|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
55795908|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55795909|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
55795910|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55795920|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
55795921|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55795922|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795923|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55795924|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55795925|NCT02521415|Anesthetics, General|anesthetics, general|mesh-ancestor
55795927|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55795928|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55795929|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55795930|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55795931|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795932|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55795934|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55795935|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55795936|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
55795937|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55795938|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55795939|NCT02521415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55795940|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55795941|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795942|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
55795943|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
55795944|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795945|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
55795946|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795947|NCT02588339|Sirolimus|sirolimus|mesh-list
55795948|NCT02588339|Panobinostat|panobinostat|mesh-list
55795949|NCT02588339|Tacrolimus|tacrolimus|mesh-list
55795950|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795951|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
55795952|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795953|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55795954|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55795955|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795956|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55795957|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55795958|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55795959|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795960|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
55795961|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55795962|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
55795963|NCT01752491|Temozolomide|temozolomide|mesh-list
55795964|NCT01752491|Vitamins|vitamins|mesh-ancestor
55795965|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
55795966|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795967|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55795968|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
55795969|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795970|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55795971|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
55795973|NCT05554211|Tranexamic Acid|tranexamic acid|mesh-list
55795974|NCT05554211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55795975|NCT05554211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55795976|NCT05554211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795977|NCT05554211|Hemostatics|hemostatics|mesh-ancestor
55795978|NCT05554211|Coagulants|coagulants|mesh-ancestor
55795979|NCT05225363|Cyclophosphamide|cyclophosphamide|mesh-list
55795980|NCT05225363|Fludarabine|fludarabine|mesh-list
55795981|NCT05225363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55795982|NCT05225363|Immunologic Factors|immunologic factors|mesh-ancestor
55795983|NCT05225363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55795996|NCT05554055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55795997|NCT05554055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55795998|NCT05554055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55795999|NCT05700617|Dobutamine|dobutamine|mesh-list
55796000|NCT05700617|Milrinone|milrinone|mesh-list
55796001|NCT05700617|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55796002|NCT05700617|Sympathomimetics|sympathomimetics|mesh-ancestor
55796003|NCT05700617|Autonomic Agents|autonomic agents|mesh-ancestor
55796004|NCT05700617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796005|NCT05700617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796006|NCT05700617|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55796007|NCT05700617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55796009|NCT05700617|Adrenergic Agents|adrenergic agents|mesh-ancestor
55796011|NCT05700617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796012|NCT05700617|Protective Agents|protective agents|mesh-ancestor
55796013|NCT05700617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55796014|NCT05700617|Vasodilator Agents|vasodilator agents|mesh-ancestor
55796015|NCT05700617|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55796016|NCT05700617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55796017|NCT05700617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796019|NCT05553743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796020|NCT05553665|Lidocaine|lidocaine|mesh-list
55796021|NCT05553665|Fentanyl|fentanyl|mesh-list
55796022|NCT05553665|Midazolam|midazolam|mesh-list
55796023|NCT05553665|Complement System Proteins|complement system proteins|mesh-list
55796024|NCT05553665|Complement C4|complement c4|mesh-list
55796025|NCT05553665|Anesthetics, Local|anesthetics, local|mesh-ancestor
55796026|NCT05553665|Anesthetics|anesthetics|mesh-ancestor
55796027|NCT05553665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796028|NCT05553665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796029|NCT05553665|Sensory System Agents|sensory system agents|mesh-ancestor
55796030|NCT05553665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796031|NCT05553665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55796032|NCT05553665|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55796033|NCT05553665|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55796034|NCT05553665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55796035|NCT05553665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796036|NCT05553665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55796037|NCT05553665|Narcotics|narcotics|mesh-ancestor
55796038|NCT05553665|Analgesics|analgesics|mesh-ancestor
55827589|NCT04524689|Mitosis Modulators|mitosis modulators|mesh-ancestor
55796039|NCT05553665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55796040|NCT05553665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55796041|NCT05553665|Anesthetics, General|anesthetics, general|mesh-ancestor
55796042|NCT05553665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55796043|NCT05553665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55796060|NCT05548985|Antiemetics|antiemetics|mesh-ancestor
55796061|NCT05548985|Autonomic Agents|autonomic agents|mesh-ancestor
55796062|NCT05548985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796063|NCT05548985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796064|NCT05548985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796065|NCT05548985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55796066|NCT05548985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55796067|NCT05548985|Dopamine Agents|dopamine agents|mesh-ancestor
55796068|NCT05548985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796069|NCT05548985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796070|NCT05548985|Sympathomimetics|sympathomimetics|mesh-ancestor
55796071|NCT05548985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55796072|NCT05548985|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55796073|NCT05548985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55796074|NCT05548985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55796075|NCT05548985|Adrenergic Agents|adrenergic agents|mesh-ancestor
55796076|NCT05698979|Botulinum Toxins|botulinum toxins|mesh-list
55796077|NCT05698979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55796078|NCT05698979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55796079|NCT05698979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796080|NCT05698979|Cholinergic Agents|cholinergic agents|mesh-ancestor
55796081|NCT05698979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796082|NCT05698979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796083|NCT04981951|Dexmedetomidine|dexmedetomidine|mesh-list
55796084|NCT04981951|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55796085|NCT04981951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796086|NCT04981951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796087|NCT04981951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55796088|NCT04981951|Analgesics|analgesics|mesh-ancestor
55796089|NCT04981951|Sensory System Agents|sensory system agents|mesh-ancestor
55796090|NCT04981951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796091|NCT04981951|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55796092|NCT04981951|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55796093|NCT04981951|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55796094|NCT04981951|Adrenergic Agents|adrenergic agents|mesh-ancestor
55796095|NCT04981951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796096|NCT04981951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796097|NCT05548361|Chlorhexidine|chlorhexidine|mesh-list
55796098|NCT05548361|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55796099|NCT05548361|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55796100|NCT05548361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796101|NCT05548361|Disinfectants|disinfectants|mesh-ancestor
55796102|NCT05548361|Dermatologic Agents|dermatologic agents|mesh-ancestor
55796113|NCT05552807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796114|NCT05552807|Tubulin Modulators|tubulin modulators|mesh-ancestor
55796115|NCT05552807|Antimitotic Agents|antimitotic agents|mesh-ancestor
55796116|NCT05552807|Mitosis Modulators|mitosis modulators|mesh-ancestor
55796117|NCT05552807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796118|NCT05552729|Vitamin D|vitamin d|mesh-list
55796119|NCT05552729|Ergocalciferols|ergocalciferols|mesh-list
55796120|NCT05552729|Cholecalciferol|cholecalciferol|mesh-list
55796121|NCT05552729|Vitamins|vitamins|mesh-list
55796122|NCT05552729|Micronutrients|micronutrients|mesh-ancestor
55796123|NCT05552729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796124|NCT05552729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55796125|NCT05552729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55796126|NCT04436107|Lenalidomide|lenalidomide|mesh-list
55796127|NCT04436107|Zanubrutinib|zanubrutinib|mesh-list
55796128|NCT04436107|Immunologic Factors|immunologic factors|mesh-ancestor
55796129|NCT04436107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796130|NCT04436107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55796131|NCT04436107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55796132|NCT04436107|Growth Substances|growth substances|mesh-ancestor
55796133|NCT04436107|Growth Inhibitors|growth inhibitors|mesh-ancestor
55796134|NCT04436107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796135|NCT04436107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55796136|NCT04436107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796137|NCT04436107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796138|NCT05699993|Itraconazole|itraconazole|mesh-list
55796139|NCT05699993|Dextromethorphan|dextromethorphan|mesh-list
55796140|NCT05699993|Antifungal Agents|antifungal agents|mesh-ancestor
55796141|NCT05699993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796142|NCT05699993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55796143|NCT05699993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55796144|NCT05699993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796145|NCT05699993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796146|NCT05699993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55796147|NCT05699993|Hormone Antagonists|hormone antagonists|mesh-ancestor
55796148|NCT05699993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796149|NCT05699993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796150|NCT05699993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55796151|NCT05699993|Antitussive Agents|antitussive agents|mesh-ancestor
55796152|NCT05699993|Respiratory System Agents|respiratory system agents|mesh-ancestor
55796153|NCT05699993|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55796154|NCT05699993|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55796155|NCT05699993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796157|NCT05552651|Carboplatin|carboplatin|mesh-list
55796158|NCT05552651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55796159|NCT05552651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55796160|NCT05552651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796161|NCT05552651|Tubulin Modulators|tubulin modulators|mesh-ancestor
55796184|NCT05547659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55796185|NCT05547659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796186|NCT05547659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55796187|NCT05547659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55796188|NCT05547659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55796189|NCT05547659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796190|NCT05547659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55796191|NCT05547659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55796192|NCT05547659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796193|NCT05547659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55796194|NCT05547659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55796195|NCT05547659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55796196|NCT05547659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796198|NCT05541419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796199|NCT05541419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55796200|NCT05541419|Autonomic Agents|autonomic agents|mesh-ancestor
55796201|NCT05541419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796202|NCT05541419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796203|NCT05541419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55796204|NCT05541419|Respiratory System Agents|respiratory system agents|mesh-ancestor
55796205|NCT05541419|Glucocorticoids|glucocorticoids|mesh-ancestor
55796206|NCT05541419|Hormones|hormones|mesh-ancestor
55796207|NCT05541419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796208|NCT05546879|Bevacizumab|bevacizumab|mesh-list
55796209|NCT05546879|Atezolizumab|atezolizumab|mesh-list
55796210|NCT05546879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55796211|NCT05546879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796212|NCT05546879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55796213|NCT05546879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55796214|NCT05546879|Growth Substances|growth substances|mesh-ancestor
55796215|NCT05546879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796216|NCT05546879|Growth Inhibitors|growth inhibitors|mesh-ancestor
55796217|NCT05541185|Naproxen|naproxen|mesh-list
55796218|NCT05541185|Lidocaine|lidocaine|mesh-list
55796228|NCT05541185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55796229|NCT05541185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796230|NCT05541185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55796231|NCT05541185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55796232|NCT05541185|Analgesics|analgesics|mesh-ancestor
55796233|NCT05541185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796234|NCT05541185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55796235|NCT05541185|Gout Suppressants|gout suppressants|mesh-ancestor
55796236|NCT05541185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55796237|NCT05541185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796238|NCT02518113|Dexamethasone|dexamethasone|mesh-list
55796239|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796240|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
55796241|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
55796242|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796243|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796244|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796245|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
55796247|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796248|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55796249|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796250|NCT05541107|Amphotericin B|amphotericin b|mesh-list
55796251|NCT05541107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55796253|NCT05541107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55796254|NCT05541107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55796255|NCT05541107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796256|NCT05541107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55796257|NCT05541107|Antifungal Agents|antifungal agents|mesh-ancestor
55796258|NCT03062839|Melatonin|melatonin|mesh-list
55796259|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
55796260|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796261|NCT03062839|Protective Agents|protective agents|mesh-ancestor
55796262|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796263|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796264|NCT05540951|Bevacizumab|bevacizumab|mesh-list
55796265|NCT05540951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55827590|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55796289|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796290|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55796291|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796293|NCT05551247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796294|NCT05551247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55796295|NCT05551247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55796297|NCT05551247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796298|NCT05551247|Growth Inhibitors|growth inhibitors|mesh-ancestor
55796299|NCT05698511|Psilocybin|psilocybin|mesh-list
55796300|NCT05698511|Hallucinogens|hallucinogens|mesh-ancestor
55796301|NCT05698511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796302|NCT05698511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55796304|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55796305|NCT02629861|Katacalcin|katacalcin|mesh-list
55796324|NCT05545475|Anticoagulants|anticoagulants|mesh-ancestor
55796325|NCT05545475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55796326|NCT05545475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55796327|NCT05545475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796335|NCT05545397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55796336|NCT05545397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796337|NCT05545397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796338|NCT05545397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55796339|NCT05545397|Anesthetics, General|anesthetics, general|mesh-ancestor
55796340|NCT05545397|Anesthetics|anesthetics|mesh-ancestor
55796341|NCT04952727|Vaccines|vaccines|mesh-list
55796342|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
55796343|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796344|NCT04433143|Minocycline|minocycline|mesh-list
55796345|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55796346|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796348|NCT01665911|Fluorides|fluorides|mesh-list
55796349|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
55796350|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
55796351|NCT01665911|Protective Agents|protective agents|mesh-ancestor
55796352|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796353|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55796354|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796355|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
55827591|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796356|NCT03063073|Bupivacaine|bupivacaine|mesh-list
55796357|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
55796358|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
55796359|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796360|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796361|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
55796362|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796363|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55796364|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55796366|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55796367|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55796368|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55796392|NCT04428307|Artemisinin|artemisinin|mesh-list
55796393|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
55796394|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55796395|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55796396|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796398|NCT05535725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55796399|NCT05535725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796400|NCT05544695|Hyaluronic Acid|hyaluronic acid|mesh-list
55796401|NCT05544695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55796402|NCT05544695|Immunologic Factors|immunologic factors|mesh-ancestor
55796403|NCT05544695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796404|NCT05544695|Viscosupplements|viscosupplements|mesh-ancestor
55796405|NCT05544695|Protective Agents|protective agents|mesh-ancestor
55796406|NCT05535569|Paclitaxel|paclitaxel|mesh-list
55796407|NCT05535569|Nivolumab|nivolumab|mesh-list
55796408|NCT05535569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55796409|NCT05535569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796410|NCT05535569|Tubulin Modulators|tubulin modulators|mesh-ancestor
55796411|NCT05535569|Antimitotic Agents|antimitotic agents|mesh-ancestor
55796412|NCT05535569|Mitosis Modulators|mitosis modulators|mesh-ancestor
55796413|NCT05535569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796414|NCT05535569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55796415|NCT05535569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55796416|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55796417|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55796418|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796419|NCT03064165|Epinephrine|epinephrine|mesh-list
55796420|NCT03064165|Bupivacaine|bupivacaine|mesh-list
55796421|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
55796422|NCT03064165|Anesthetics|anesthetics|mesh-ancestor
55796441|NCT05535413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55796443|NCT05535413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796444|NCT05535413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796445|NCT03813199|Methotrexate|methotrexate|mesh-list
55796446|NCT03813199|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55796447|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
55796448|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55796449|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796450|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55796451|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
55796452|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796453|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796454|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
55796455|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796456|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55796457|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55796458|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
55796459|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55796460|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55796462|NCT05699135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55796463|NCT05699135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796464|NCT03791593|Evolocumab|evolocumab|mesh-list
55796465|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55796466|NCT03791593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55796467|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
55796468|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796469|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55796470|NCT03064243|Apatinib|apatinib|mesh-list
55796471|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796472|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55796473|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796487|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55796488|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55796504|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796505|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
55796506|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796507|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55796508|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55796509|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55796510|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55796511|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796512|NCT03706885|Efavirenz|efavirenz|mesh-list
55796513|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55796514|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55796515|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796517|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
55796518|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796519|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55796520|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55796521|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55796522|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55796523|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55796524|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55796525|NCT01665599|Testosterone|testosterone|mesh-list
55796527|NCT01665599|Hormones|hormones|mesh-ancestor
55796528|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796529|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796530|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
55796531|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
55796532|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
55796533|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796552|NCT05697809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796553|NCT05697809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55796554|NCT05697809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796555|NCT03980483|Methotrexate|methotrexate|mesh-list
55796556|NCT03980483|Tofacitinib|tofacitinib|mesh-list
55796557|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55796558|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
55796559|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55796560|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796561|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55796562|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
55796563|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796564|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796565|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827593|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796581|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796582|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796583|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
55796584|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
55796585|NCT03063775|Coagulants|coagulants|mesh-ancestor
55796586|NCT03063541|Aspirin|aspirin|mesh-list
55796587|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55796589|NCT03063541|Analgesics|analgesics|mesh-ancestor
55796590|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
55796591|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796592|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796593|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796594|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55796595|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55796596|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55796597|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796611|NCT03491683|Alkylating Agents|alkylating agents|mesh-ancestor
55796612|NCT03491683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796613|NCT03491683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796615|NCT03490513|Anastrozole|anastrozole|mesh-list
55796616|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55796617|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796618|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55796619|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55796620|NCT03490513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796621|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796622|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55796623|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
55796624|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796625|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796626|NCT03439345|Fenofibrate|fenofibrate|mesh-list
55796627|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55796628|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
55796629|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796630|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55796632|NCT04977661|Tocopherols|tocopherols|mesh-list
55796633|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
55796634|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
55796635|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55796636|NCT04977661|Vitamins|vitamins|mesh-ancestor
55796638|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796639|NCT04977661|Antioxidants|antioxidants|mesh-ancestor
55796640|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796641|NCT04977661|Protective Agents|protective agents|mesh-ancestor
55796642|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55796643|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796644|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55796645|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55796647|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55796648|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55796649|NCT04977661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796650|NCT04977427|Prednisolone|prednisolone|mesh-list
55796651|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55796652|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
55796653|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55796654|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
55796655|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55796676|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55796678|NCT04261855|Avelumab|avelumab|mesh-list
55796679|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55796680|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55796681|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796682|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55796683|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796685|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55796686|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55796687|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796688|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796689|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796691|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55796712|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796713|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796714|NCT02475369|Pancrelipase|pancrelipase|mesh-list
55796715|NCT02475369|Pancreatin|pancreatin|mesh-list
55796716|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796717|NCT03862157|Azacitidine|azacitidine|mesh-list
55796718|NCT03862157|Venetoclax|venetoclax|mesh-list
55796719|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55796720|NCT03862157|Pevonedistat|pevonedistat|mesh-list
55796721|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55796722|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
55796723|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796724|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796726|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796760|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796761|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796762|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796763|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55796764|NCT02450487|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55796765|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796766|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796767|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
55796768|NCT02506881|Hematinics|hematinics|mesh-ancestor
55796769|NCT02506257|Biguanides|biguanides|mesh-list
55796770|NCT02506257|Polihexanide|polihexanide|mesh-list
55796772|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796774|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796775|NCT02505945|Omeprazole|omeprazole|mesh-list
55796776|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55796777|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796778|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55796800|NCT03117751|Cytarabine|cytarabine|mesh-list
55796801|NCT03117751|Dexamethasone|dexamethasone|mesh-list
55796802|NCT03117751|Prednisone|prednisone|mesh-list
55796803|NCT03117751|Prednisolone|prednisolone|mesh-list
55796805|NCT03117751|Doxorubicin|doxorubicin|mesh-list
55796806|NCT03117751|Methotrexate|methotrexate|mesh-list
55796807|NCT03117751|Etoposide|etoposide|mesh-list
55796808|NCT03117751|Etoposide phosphate|etoposide phosphate|mesh-list
55796809|NCT03117751|Vincristine|vincristine|mesh-list
55796810|NCT03117751|Bortezomib|bortezomib|mesh-list
55796811|NCT03117751|Daunorubicin|daunorubicin|mesh-list
55796812|NCT03117751|Asparaginase|asparaginase|mesh-list
55796813|NCT03117751|Dasatinib|dasatinib|mesh-list
55796814|NCT03117751|Mercaptopurine|mercaptopurine|mesh-list
55796815|NCT03117751|Vorinostat|vorinostat|mesh-list
55796816|NCT03117751|Idarubicin|idarubicin|mesh-list
55796817|NCT03117751|Clofarabine|clofarabine|mesh-list
55796818|NCT03117751|Pegaspargase|pegaspargase|mesh-list
55796821|NCT03117751|Asparaginase erwinia chrysanthemi, recombinant-rywn|asparaginase erwinia chrysanthemi, recombinant-rywn|mesh-list
55796822|NCT03117751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55796823|NCT03117751|Immunologic Factors|immunologic factors|mesh-ancestor
55796824|NCT03117751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796825|NCT03117751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55796826|NCT03117751|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55796827|NCT03117751|Alkylating Agents|alkylating agents|mesh-ancestor
55796828|NCT03117751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796829|NCT03117751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796830|NCT03117751|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55796831|NCT03117751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55796832|NCT03117751|Antiemetics|antiemetics|mesh-ancestor
55796833|NCT03117751|Autonomic Agents|autonomic agents|mesh-ancestor
55796834|NCT03117751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796847|NCT03117751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55796848|NCT03117751|Antimetabolites|antimetabolites|mesh-ancestor
55796849|NCT03117751|Dermatologic Agents|dermatologic agents|mesh-ancestor
55796850|NCT03117751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55796851|NCT03117751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55796852|NCT03117751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55796854|NCT03117751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796867|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796869|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55796870|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796871|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
55796872|NCT04924257|Esketamine|esketamine|mesh-list
55796873|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
55796874|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55796875|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
55796876|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55796877|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796878|NCT03063307|Fluorides|fluorides|mesh-list
55796879|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
55796880|NCT03063307|Protective Agents|protective agents|mesh-ancestor
55796882|NCT04874935|Lansoprazole|lansoprazole|mesh-list
55796883|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
55796884|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55796885|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55796886|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55796887|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796888|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796889|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
55796890|NCT02961361|Ropivacaine|ropivacaine|mesh-list
55796891|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55796892|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55796893|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796894|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55796895|NCT02961361|Analgesics|analgesics|mesh-ancestor
55796896|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
55796897|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55796898|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55796899|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55796900|NCT02961361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55796901|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
55796902|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796903|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796904|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
55796905|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
55796906|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
55796907|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
55796908|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796909|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55796911|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796912|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796928|NCT02426281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796929|NCT02448537|Gemcitabine|gemcitabine|mesh-list
55796930|NCT02448537|Doxorubicin|doxorubicin|mesh-list
55796931|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55796932|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55796933|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
55796934|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796935|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55796936|NCT02448537|Antiviral Agents|antiviral agents|mesh-ancestor
55796937|NCT02448537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796938|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796939|NCT02448537|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55796940|NCT02448537|Immunologic Factors|immunologic factors|mesh-ancestor
55796941|NCT02448537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796942|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55827595|NCT02119819|Metformin|metformin|mesh-list
55827596|NCT02119819|Exenatide|exenatide|mesh-list
55796945|NCT04838743|Xultophy|xultophy|mesh-list
55796946|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55796947|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796948|NCT04838743|Incretins|incretins|mesh-ancestor
55796949|NCT04838743|Hormones|hormones|mesh-ancestor
55796950|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55796951|NCT03060265|Acetaminophen|acetaminophen|mesh-list
55796952|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55796953|NCT03060265|Analgesics|analgesics|mesh-ancestor
55796954|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
55796969|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
55796970|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796971|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
55796972|NCT02448225|Fluorides|fluorides|mesh-list
55796973|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55796974|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
55796975|NCT02448225|Protective Agents|protective agents|mesh-ancestor
55796976|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796977|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55796978|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796979|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
55796980|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
55796981|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55796983|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55796984|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
55796985|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55796986|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796987|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55796988|NCT02586155|Atorvastatin|atorvastatin|mesh-list
55796989|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55796990|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55796991|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55796992|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
55796993|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55796994|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55796995|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55796996|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55796997|NCT05696093|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55796998|NCT05696093|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55796999|NCT05696093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797000|NCT05696093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55797001|NCT05696093|Renal Agents|renal agents|mesh-ancestor
55797002|NCT05696093|Antimalarials|antimalarials|mesh-ancestor
55797003|NCT05696093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55797004|NCT05696093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55797005|NCT05536661|Lubricant Eye Drops|lubricant eye drops|mesh-list
55797006|NCT05536661|Hyaluronic Acid|hyaluronic acid|mesh-list
55797007|NCT05536661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55797008|NCT05536661|Immunologic Factors|immunologic factors|mesh-ancestor
55797009|NCT05536661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797010|NCT05536661|Viscosupplements|viscosupplements|mesh-ancestor
55797011|NCT05536661|Protective Agents|protective agents|mesh-ancestor
55797026|NCT05536193|Metformin|metformin|mesh-list
55797027|NCT05536193|Salicylic Acid|salicylic acid|mesh-list
55797028|NCT05536193|Salicylates|salicylates|mesh-list
55797030|NCT05536193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55797031|NCT05536193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797032|NCT05536193|Mitosis Modulators|mitosis modulators|mesh-ancestor
55797033|NCT05536193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797034|NCT05536193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797035|NCT05536193|Antifungal Agents|antifungal agents|mesh-ancestor
55797036|NCT05536193|Keratolytic Agents|keratolytic agents|mesh-ancestor
55797037|NCT05536193|Dermatologic Agents|dermatologic agents|mesh-ancestor
55797038|NCT05536193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55797046|NCT05536193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797047|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
55797052|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797053|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797054|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797055|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797056|NCT05697185|Evolocumab|evolocumab|mesh-list
55797057|NCT05697185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55797058|NCT05697185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55797059|NCT05697185|Antimetabolites|antimetabolites|mesh-ancestor
55797060|NCT05697185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797062|NCT05695781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55797063|NCT05695781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55797064|NCT04725149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55797066|NCT02581163|Ribavirin|ribavirin|mesh-list
55797067|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55797068|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55797069|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
55797070|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797071|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797072|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55797073|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55797084|NCT05591417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797086|NCT05591417|Autonomic Agents|autonomic agents|mesh-ancestor
55797087|NCT05591417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797088|NCT05591417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797089|NCT05591417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55797090|NCT05591417|Glucocorticoids|glucocorticoids|mesh-ancestor
55797091|NCT05591417|Hormones|hormones|mesh-ancestor
55797092|NCT05591417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797093|NCT05591417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55797094|NCT05591417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797095|NCT05591417|Protease Inhibitors|protease inhibitors|mesh-ancestor
55797096|NCT05591417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797097|NCT05591417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797098|NCT05591417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55797099|NCT05591417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797100|NCT05591417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55797102|NCT05591417|Sensory System Agents|sensory system agents|mesh-ancestor
55797103|NCT05591417|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55797104|NCT05591417|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55797105|NCT05591417|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55797106|NCT05591417|Adrenergic Agents|adrenergic agents|mesh-ancestor
55797107|NCT05591417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797108|NCT05591417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55797109|NCT05591417|Narcotics|narcotics|mesh-ancestor
55797110|NCT01938547|Clevidipine|clevidipine|mesh-list
55797111|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55797112|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55797113|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797114|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55797115|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797117|NCT05695625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797118|NCT05695625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797119|NCT05586737|Rituximab|rituximab|mesh-list
55797120|NCT05586737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55797121|NCT05586737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797123|NCT05586737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797124|NCT05586737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797126|NCT05678933|Cyclophosphamide|cyclophosphamide|mesh-list
55797127|NCT05678933|Vincristine|vincristine|mesh-list
55797128|NCT05678933|Azacitidine|azacitidine|mesh-list
55797129|NCT05678933|Epirubicin|epirubicin|mesh-list
55797130|NCT05678933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55797131|NCT05678933|Immunologic Factors|immunologic factors|mesh-ancestor
55797139|NCT05678933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797142|NCT05678933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797143|NCT05678933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55827597|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55797144|NCT05678933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55797145|NCT05678933|Tubulin Modulators|tubulin modulators|mesh-ancestor
55797146|NCT05678933|Antimitotic Agents|antimitotic agents|mesh-ancestor
55797147|NCT05678933|Mitosis Modulators|mitosis modulators|mesh-ancestor
55797148|NCT05678933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55797149|NCT05678933|Antimetabolites|antimetabolites|mesh-ancestor
55797150|NCT05678933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797151|NCT05678933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55797152|NCT05678933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55797153|NCT05678933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55797154|NCT05678621|Amoxicillin|amoxicillin|mesh-list
55797155|NCT05678621|Ciprofloxacin|ciprofloxacin|mesh-list
55797156|NCT05678621|Clavulanic Acids|clavulanic acids|mesh-list
55797157|NCT05678621|Clavulanic Acid|clavulanic acid|mesh-list
55797158|NCT05678621|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55797159|NCT05678621|Trimethoprim|trimethoprim|mesh-list
55797160|NCT05678621|Sulfamethoxazole|sulfamethoxazole|mesh-list
55797161|NCT05678621|Immunoglobulins|immunoglobulins|mesh-list
55797162|NCT05678621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55797163|NCT05678621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797164|NCT05678621|Immunologic Factors|immunologic factors|mesh-ancestor
55797165|NCT05678621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797166|NCT05678621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55797167|NCT05678621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55797168|NCT05678621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797169|NCT05678621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797170|NCT05678621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797171|NCT05678621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55797172|NCT05678621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55797173|NCT05678621|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55797174|NCT05678621|Renal Agents|renal agents|mesh-ancestor
55797175|NCT05678621|Antimalarials|antimalarials|mesh-ancestor
55797176|NCT05678621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55797177|NCT05678621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55827598|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797179|NCT05678621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55797180|NCT05678621|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55797182|NCT05697029|Tetrandrine|tetrandrine|mesh-list
55797183|NCT05697029|Antimalarials|antimalarials|mesh-ancestor
55797184|NCT05697029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55797185|NCT05697029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55797186|NCT05697029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797187|NCT05697029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55797197|NCT04708613|Corticosterone|corticosterone|mesh-list
55797198|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797199|NCT02627677|Ponatinib|ponatinib|mesh-list
55797200|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797201|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55797202|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797203|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797204|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
55797205|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55797206|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797207|NCT05110001|Chlorhexidine|chlorhexidine|mesh-list
55797208|NCT05110001|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55797209|NCT05110001|Natamycin|natamycin|mesh-list
55797210|NCT05110001|Moxifloxacin|moxifloxacin|mesh-list
55797211|NCT05110001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55797213|NCT05110001|Disinfectants|disinfectants|mesh-ancestor
55797214|NCT05110001|Dermatologic Agents|dermatologic agents|mesh-ancestor
55797215|NCT05110001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55797216|NCT05110001|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55797217|NCT05110001|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55797218|NCT05110001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797219|NCT05110001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797220|NCT05110001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797221|NCT05110001|Antifungal Agents|antifungal agents|mesh-ancestor
55797222|NCT05182073|Cyclophosphamide|cyclophosphamide|mesh-list
55797223|NCT05182073|Fludarabine|fludarabine|mesh-list
55797224|NCT05182073|Daratumumab|daratumumab|mesh-list
55797225|NCT05182073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55827599|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55797226|NCT05182073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55797227|NCT05182073|Immunologic Factors|immunologic factors|mesh-ancestor
55797229|NCT05182073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797230|NCT05182073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55797231|NCT05182073|Alkylating Agents|alkylating agents|mesh-ancestor
55797232|NCT05182073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797233|NCT05182073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797234|NCT05182073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55797236|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55797238|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
55797239|NCT02585999|Ortho Evra|ortho evra|mesh-list
55797240|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55797241|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797242|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55797243|NCT05696951|Tranylcypromine|tranylcypromine|mesh-list
55797244|NCT05696951|Antidepressive Agents|antidepressive agents|mesh-ancestor
55797245|NCT05696951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55797246|NCT05696951|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55797247|NCT05696951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797248|NCT05696951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797257|NCT05677373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797258|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
55797259|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827634|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55797262|NCT05041907|Nitazoxanide|nitazoxanide|mesh-list
55797263|NCT05041907|Remdesivir|remdesivir|mesh-list
55797264|NCT05041907|Favipiravir|favipiravir|mesh-list
55827635|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797265|NCT05041907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55797266|NCT05041907|Fluoxetine|fluoxetine|mesh-list
55797267|NCT05041907|Antibodies|antibodies|mesh-list
55797268|NCT05041907|Immunoglobulins|immunoglobulins|mesh-list
55797269|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55797270|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
55797271|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797272|NCT05041907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797273|NCT05041907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55797274|NCT05041907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55797275|NCT05041907|Protease Inhibitors|protease inhibitors|mesh-ancestor
55797276|NCT05041907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797277|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797279|NCT05041907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55797280|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
55797281|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797282|NCT05041907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55797283|NCT05041907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55797284|NCT05041907|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55797285|NCT05041907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55797286|NCT05041907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55797287|NCT05041907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797288|NCT05041907|Serotonin Agents|serotonin agents|mesh-ancestor
55797289|NCT05041907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55797290|NCT05041907|Antidepressive Agents|antidepressive agents|mesh-ancestor
55797291|NCT05041907|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55797292|NCT05041907|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55797293|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55797294|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
55797296|NCT05674253|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55797297|NCT05674253|Dexmedetomidine|dexmedetomidine|mesh-list
55797298|NCT05674253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55797299|NCT05674253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797300|NCT05674253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797301|NCT05674253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55797302|NCT05674253|Analgesics|analgesics|mesh-ancestor
55797303|NCT05674253|Sensory System Agents|sensory system agents|mesh-ancestor
55797304|NCT05674253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797305|NCT05674253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55797306|NCT05674253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55797307|NCT05674253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55797308|NCT05674253|Adrenergic Agents|adrenergic agents|mesh-ancestor
55797309|NCT05674253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797310|NCT05674253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797311|NCT05674253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797313|NCT02500641|Colchicine|colchicine|mesh-list
55797324|NCT02500641|Analgesics|analgesics|mesh-ancestor
55797325|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
55797326|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797327|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797328|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797329|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797330|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
55797331|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55797332|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
55797333|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
55797334|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
55797335|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797336|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
55797337|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55797338|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
55797339|NCT02500641|Protective Agents|protective agents|mesh-ancestor
55797340|NCT04973293|Bevacizumab|bevacizumab|mesh-list
55797341|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55797342|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797343|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55797344|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55797345|NCT04973293|Growth Substances|growth substances|mesh-ancestor
55797346|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797347|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
55797349|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55797350|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55797351|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55797353|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
55797354|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797355|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797356|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797357|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
55797358|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797359|NCT03059719|Exenatide|exenatide|mesh-list
55797360|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55797361|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797362|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55797365|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797366|NCT05653271|Cyclophosphamide|cyclophosphamide|mesh-list
55797367|NCT05653271|Fludarabine|fludarabine|mesh-list
55797375|NCT05653271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797376|NCT05653271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797377|NCT05653271|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55797378|NCT05653271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55797379|NCT03060031|Oxytocin|oxytocin|mesh-list
55797380|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
55797381|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55797382|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797383|NCT02499783|Adalimumab|adalimumab|mesh-list
55797384|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797385|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797386|NCT04972045|Curcumin|curcumin|mesh-list
55797387|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55797388|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55797389|NCT04972045|Analgesics|analgesics|mesh-ancestor
55797390|NCT04972045|Sensory System Agents|sensory system agents|mesh-ancestor
55797391|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797392|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797393|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797394|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797395|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797396|NCT04972045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797397|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797398|NCT05614115|Empagliflozin|empagliflozin|mesh-list
55797399|NCT05614115|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55797400|NCT05614115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797401|NCT05614115|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55797402|NCT05614115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797403|NCT03059017|Albuterol|albuterol|mesh-list
55797404|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55797406|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797407|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797408|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55797409|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
55797410|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
55797411|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55797412|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55797413|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55797415|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
55797416|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797417|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797419|NCT04971577|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55797420|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55797421|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
55797422|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797423|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55797424|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55797426|NCT04425655|Fludarabine|fludarabine|mesh-list
55797427|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797428|NCT04970719|Remdesivir|remdesivir|mesh-list
55797429|NCT04970719|Dexamethasone|dexamethasone|mesh-list
55797430|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
55797431|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797432|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
55797433|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
55797434|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797435|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797436|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55797437|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
55797438|NCT04970719|Hormones|hormones|mesh-ancestor
55797441|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797442|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
55797443|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797444|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
55797445|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797446|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55797447|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797448|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55797449|NCT02466399|Latanoprost|latanoprost|mesh-list
55797450|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55797451|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
55797452|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55797453|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797455|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55797456|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55797457|NCT04970251|Growth Substances|growth substances|mesh-ancestor
55797458|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797460|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797462|NCT04201197|Hallucinogens|hallucinogens|mesh-ancestor
55797463|NCT04201197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797464|NCT04201197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55797465|NCT04201197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55797466|NCT04201197|Analgesics|analgesics|mesh-ancestor
55797467|NCT04201197|Sensory System Agents|sensory system agents|mesh-ancestor
55797468|NCT04201197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797469|NCT04201197|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55797470|NCT04201197|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55797471|NCT04201197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797472|NCT04201197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797473|NCT04201197|Hormones|hormones|mesh-ancestor
55797475|NCT03059563|Varenicline|varenicline|mesh-list
55797476|NCT03059563|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55797477|NCT03059563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55797478|NCT03059563|Cholinergic Agents|cholinergic agents|mesh-ancestor
55797479|NCT03059563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797480|NCT03059563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797481|NCT03059563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797484|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
55797485|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
55797487|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
55797488|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55797489|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797490|NCT04960657|Growth Substances|growth substances|mesh-ancestor
55797491|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
55797492|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797493|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797494|NCT02464059|Vitamin D|vitamin d|mesh-list
55797495|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
55797496|NCT02464059|Vitamins|vitamins|mesh-ancestor
55797497|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
55797498|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797500|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55797502|NCT02463357|Nifedipine|nifedipine|mesh-list
55797503|NCT02463357|Methazolamide|methazolamide|mesh-list
55797504|NCT02463357|Quercetin|quercetin|mesh-list
55797505|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55797506|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797507|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55797508|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55797509|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797510|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55797511|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
55797512|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
55797513|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55797514|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
55797515|NCT02463357|Protective Agents|protective agents|mesh-ancestor
55797516|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55797517|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797519|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
55797522|NCT05595083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797523|NCT05595083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797524|NCT05595083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55797526|NCT05595083|Sensory System Agents|sensory system agents|mesh-ancestor
55797527|NCT05595083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797528|NCT05595083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55797529|NCT05595083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55797531|NCT05595083|Adrenergic Agents|adrenergic agents|mesh-ancestor
55797532|NCT05595083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797533|NCT05595083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797535|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55797536|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55797538|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55797539|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
55797540|NCT04959721|Anesthetics|anesthetics|mesh-ancestor
55797541|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797542|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797543|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
55797544|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797545|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797546|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
55797548|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797549|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55797550|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
55797551|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797552|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797553|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
55797554|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797555|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797556|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
55797557|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797558|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797561|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797562|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
55797563|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797564|NCT05575427|Levofloxacin|levofloxacin|mesh-list
55797565|NCT05575427|Ofloxacin|ofloxacin|mesh-list
55797566|NCT05575427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55797567|NCT05575427|Minocycline|minocycline|mesh-list
55797568|NCT05575427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55797569|NCT05575427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797570|NCT05575427|Renal Agents|renal agents|mesh-ancestor
55797571|NCT05575427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55797572|NCT05575427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55797574|NCT05575427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797575|NCT05575427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797576|NCT05575427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797577|NCT05575427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55797578|NCT05575427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55797579|NCT05575427|Antimalarials|antimalarials|mesh-ancestor
55797580|NCT05575427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55797581|NCT05575427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55797582|NCT04959253|Psilocybin|psilocybin|mesh-list
55797583|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
55797584|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797585|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55797586|NCT02499159|Bupivacaine|bupivacaine|mesh-list
55797587|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
55797588|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
55797589|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797590|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797591|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
55797592|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797593|NCT01664039|Bimatoprost|bimatoprost|mesh-list
55797594|NCT01664039|Travoprost|travoprost|mesh-list
55797595|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55797596|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55797597|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55797598|NCT05645705|Listerine|listerine|mesh-list
55797599|NCT05645705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
55797607|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55797608|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797609|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
55797610|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797611|NCT04959409|Tetracaine|tetracaine|mesh-list
55797613|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
55797614|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797615|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797616|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
55797617|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797618|NCT05571059|Ifetroban|ifetroban|mesh-list
55797619|NCT05571059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55797620|NCT03058939|Tamoxifen|tamoxifen|mesh-list
55797621|NCT03058939|Paclitaxel|paclitaxel|mesh-list
55797622|NCT03058939|Carboplatin|carboplatin|mesh-list
55797624|NCT03058939|Letrozole|letrozole|mesh-list
55797625|NCT03058939|Pertuzumab|pertuzumab|mesh-list
55797626|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55797627|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797628|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
55797629|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
55797630|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
55797631|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797632|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55797633|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55797634|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55797635|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797636|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55797637|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
55797638|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797639|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797640|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55797641|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55797642|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55797643|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55797645|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55797646|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
55797647|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55797648|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797649|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55797651|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797652|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797653|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
55797654|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797655|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55797656|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55797657|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
55797658|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797659|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55797661|NCT02579603|Nintedanib|nintedanib|mesh-list
55797662|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797663|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55797664|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797665|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797666|NCT02579603|Analgesics|analgesics|mesh-ancestor
55797667|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
55797668|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797669|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797670|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55797671|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55797683|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797684|NCT03060889|Hemostatics|hemostatics|mesh-ancestor
55797685|NCT03060889|Coagulants|coagulants|mesh-ancestor
55797686|NCT04177433|Methylprednisolone|methylprednisolone|mesh-list
55797688|NCT04177433|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55797689|NCT04177433|Prednisolone|prednisolone|mesh-list
55797690|NCT04177433|Prednisolone acetate|prednisolone acetate|mesh-list
55797691|NCT04177433|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55797692|NCT04177433|Prednisolone phosphate|prednisolone phosphate|mesh-list
55797693|NCT04177433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797694|NCT04177433|Antiemetics|antiemetics|mesh-ancestor
55797695|NCT04177433|Autonomic Agents|autonomic agents|mesh-ancestor
55797696|NCT04177433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797697|NCT04177433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797698|NCT04177433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55797699|NCT04177433|Glucocorticoids|glucocorticoids|mesh-ancestor
55797700|NCT04177433|Hormones|hormones|mesh-ancestor
55797701|NCT04177433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797702|NCT04177433|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55797703|NCT04177433|Protective Agents|protective agents|mesh-ancestor
55797704|NCT04177433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55797705|NCT04177433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797706|NCT04692077|Tenofovir|tenofovir|mesh-list
55797707|NCT04692077|Emtricitabine|emtricitabine|mesh-list
55797708|NCT04692077|Cabotegravir|cabotegravir|mesh-list
55797709|NCT04692077|Antiviral Agents|antiviral agents|mesh-ancestor
55797710|NCT04692077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797711|NCT04692077|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55797712|NCT04692077|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55797713|NCT04692077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797714|NCT04692077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797715|NCT04692077|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55797716|NCT04692077|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55797719|NCT05546957|Aspirin|aspirin|mesh-list
55797720|NCT05546957|Rivaroxaban|rivaroxaban|mesh-list
55797721|NCT05546957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55797722|NCT05546957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55797723|NCT05546957|Analgesics|analgesics|mesh-ancestor
55797724|NCT05546957|Sensory System Agents|sensory system agents|mesh-ancestor
55797725|NCT05546957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797726|NCT05546957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797727|NCT05546957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797728|NCT05546957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797729|NCT05546957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55797732|NCT05546957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55797733|NCT05546957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55797734|NCT05546957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797736|NCT05546957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55797737|NCT05546957|Antithrombins|antithrombins|mesh-ancestor
55797738|NCT05546957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55797739|NCT05546957|Protease Inhibitors|protease inhibitors|mesh-ancestor
55797740|NCT05546957|Anticoagulants|anticoagulants|mesh-ancestor
55797741|NCT04950205|Sevoflurane|sevoflurane|mesh-list
55797742|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55797743|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55797744|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
55797745|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
55797746|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797747|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797748|NCT02625259|Lansoprazole|lansoprazole|mesh-list
55797749|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
55797750|NCT02625259|Serabelisib|serabelisib|mesh-list
55797751|NCT02625259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55797752|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55797753|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55797754|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797755|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797760|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797761|NCT02577107|Growth Inhibitors|growth inhibitors|mesh-ancestor
55797762|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797764|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797765|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55797766|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797767|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797768|NCT04957927|Fluticasone|fluticasone|mesh-list
55797769|NCT04957927|Xhance|xhance|mesh-list
55797770|NCT04957927|Montelukast|montelukast|mesh-list
55797771|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797772|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55797773|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
55797774|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797775|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797776|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55797777|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
55797778|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
55797779|NCT04957927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55797780|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55797781|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
55797782|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797783|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55797784|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55797785|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797787|NCT04950049|Dexamethasone|dexamethasone|mesh-list
55797788|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
55797789|NCT04950049|BB 1101|bb 1101|mesh-list
55797790|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797791|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
55797792|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
55797793|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797794|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797795|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55797796|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
55797797|NCT04950049|Hormones|hormones|mesh-ancestor
55797798|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797799|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55797800|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797801|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
55797802|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797803|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797804|NCT05587673|Methylprednisolone|methylprednisolone|mesh-list
55797805|NCT05587673|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55797806|NCT05587673|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55797807|NCT05587673|Prednisolone|prednisolone|mesh-list
55797812|NCT05587673|Antiemetics|antiemetics|mesh-ancestor
55797813|NCT05587673|Autonomic Agents|autonomic agents|mesh-ancestor
55797814|NCT05587673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797815|NCT05587673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797816|NCT05587673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55797819|NCT05587673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55797820|NCT05587673|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55797821|NCT05587673|Protective Agents|protective agents|mesh-ancestor
55797999|NCT04943653|Capecitabine|capecitabine|mesh-list
55797822|NCT05587673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55797823|NCT05587673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797824|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
55797825|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797827|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55797828|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55797829|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797830|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55797831|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55797832|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
55797833|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797834|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55797836|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55797837|NCT04949347|Protective Agents|protective agents|mesh-ancestor
55797838|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797839|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
55797841|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
55797842|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55797843|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55797844|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55797845|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
55797846|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797847|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797848|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797850|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55797851|NCT04948801|Velpatasvir|velpatasvir|mesh-list
55797852|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
55797853|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797854|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
55797855|NCT04948567|Analgesics|analgesics|mesh-ancestor
55797856|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
55797857|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797858|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797859|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
55797860|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55797861|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55797862|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
55797863|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55797864|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55797865|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797866|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55797867|NCT04948567|Tocolytic Agents|tocolytic agents|mesh-ancestor
55797868|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55797869|NCT04419181|Carboplatin|carboplatin|mesh-list
55797870|NCT04419181|Docetaxel|docetaxel|mesh-list
55797871|NCT04419181|Trastuzumab|trastuzumab|mesh-list
55797872|NCT04419181|Pertuzumab|pertuzumab|mesh-list
55797873|NCT04419181|Maytansine|maytansine|mesh-list
55797874|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55797875|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797876|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
55797877|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
55797878|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
55797879|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797880|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55797881|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55797883|NCT04964869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55797887|NCT04964869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797889|NCT04964869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55797890|NCT04964869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55797891|NCT04964869|Autonomic Agents|autonomic agents|mesh-ancestor
55797894|NCT04964869|Respiratory System Agents|respiratory system agents|mesh-ancestor
55797895|NCT04964869|Mydriatics|mydriatics|mesh-ancestor
55797896|NCT04964869|Sympathomimetics|sympathomimetics|mesh-ancestor
55797897|NCT04964869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55797898|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55797899|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
55797900|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797901|NCT04946929|Heparin|heparin|mesh-list
55797902|NCT04946929|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55797903|NCT04946929|Tinzaparin|tinzaparin|mesh-list
55797904|NCT04946929|Dalteparin|dalteparin|mesh-list
55797905|NCT04946929|Ticagrelor|ticagrelor|mesh-list
55797906|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
55797907|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55797908|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55797909|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797910|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55797911|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55797912|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55797913|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55797914|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
55797915|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797916|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797917|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
55797919|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55797920|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797921|NCT03058237|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55797922|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797923|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55797926|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797927|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797928|NCT04947241|Gemcitabine|gemcitabine|mesh-list
55797929|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55797930|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797931|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55797932|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
55797933|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797934|NCT04947241|Antiviral Agents|antiviral agents|mesh-ancestor
55797935|NCT04947241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797936|NCT04947241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797937|NCT04947241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55797940|NCT04410991|Teriflunomide|teriflunomide|mesh-list
55797941|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55797942|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55797943|NCT04410991|Analgesics|analgesics|mesh-ancestor
55797944|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
55797945|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55797946|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797947|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55797948|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55797949|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55797950|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
55797951|NCT04933279|Iodine|iodine|mesh-list
55797952|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
55797953|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55797954|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797955|NCT04933279|Trace Elements|trace elements|mesh-ancestor
55797956|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
55797957|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797958|NCT04946461|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55797959|NCT04946461|Dextroamphetamine|dextroamphetamine|mesh-list
55797960|NCT04946461|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55797961|NCT04946461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797971|NCT02577029|Interferon alpha-2|interferon alpha-2|mesh-list
55797972|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55797973|NCT02577029|Entecavir|entecavir|mesh-list
55797974|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
55797975|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55797976|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797977|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
55797978|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55797979|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55797980|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55797981|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797982|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797983|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55797984|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55797985|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
55797987|NCT02577029|Histamine Agents|histamine agents|mesh-ancestor
55797988|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55797989|NCT04946383|Dasatinib|dasatinib|mesh-list
55797990|NCT04946383|Quercetin|quercetin|mesh-list
55797991|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55797992|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55797993|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55797994|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55797995|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
55797996|NCT04946383|Protective Agents|protective agents|mesh-ancestor
55797997|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55797998|NCT04943653|Paclitaxel|paclitaxel|mesh-list
55798000|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
55798001|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55798002|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798003|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
55798004|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
55798005|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
55798006|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798007|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55798009|NCT04943029|Paclitaxel|paclitaxel|mesh-list
55798010|NCT04943029|Carboplatin|carboplatin|mesh-list
55798011|NCT04943029|Pemetrexed|pemetrexed|mesh-list
55798012|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55798013|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798014|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
55798015|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
55798016|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
55798017|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798018|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798019|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55798020|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55798021|NCT05535023|Cemiplimab|cemiplimab|mesh-list
55798022|NCT05535023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798023|NCT05535023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798024|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
55798025|NCT03660059|Peficitinib|peficitinib|mesh-list
55798026|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55798027|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798028|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55798029|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
55798030|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798031|NCT04946227|Paclitaxel|paclitaxel|mesh-list
55798032|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
55798033|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55798034|NCT04946227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798035|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
55798036|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
55798037|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
55798038|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798039|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55798040|NCT04932187|Capecitabine|capecitabine|mesh-list
55798041|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55798043|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55798044|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798045|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55798047|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798048|NCT03597347|Molgramostim|molgramostim|mesh-list
55798049|NCT03597347|Sargramostim|sargramostim|mesh-list
55798050|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55798051|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
55798052|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55798053|NCT04930627|Empagliflozin|empagliflozin|mesh-list
55798054|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55852334|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55852335|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
55852336|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852337|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852338|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55852339|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
55852340|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
55852341|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55852342|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55852343|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55852344|NCT00119158|Analgesics|analgesics|mesh-ancestor
55852345|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
55852346|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852347|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852348|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
55852349|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55852350|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852351|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852352|NCT00119392|Cyclosporine|cyclosporine|mesh-list
55852353|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
55852354|NCT00119392|Rituximab|rituximab|mesh-list
55852355|NCT00119392|Fludarabine|fludarabine|mesh-list
55852356|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
55852383|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55852384|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55852385|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852387|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
55852388|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852389|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
55852390|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852391|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
55852392|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55852393|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55852394|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55852395|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55852396|NCT00121186|Methotrexate|methotrexate|mesh-list
55852397|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
55852442|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
55852443|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852444|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852445|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
55852446|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852447|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
55852448|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852449|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55852450|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55852451|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55852452|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
55852453|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55852454|NCT00123604|Metoprolol|metoprolol|mesh-list
55852455|NCT00123604|Carvedilol|carvedilol|mesh-list
55852456|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55852501|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
55852502|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852505|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852506|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852507|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55852508|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55852509|NCT00130780|Growth Substances|growth substances|mesh-ancestor
55852510|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852511|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
55852512|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
55852513|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
55852514|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
55852516|NCT00225784|Gemcitabine|gemcitabine|mesh-list
55852517|NCT00225784|Cetuximab|cetuximab|mesh-list
55852518|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852519|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
55852520|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852521|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852522|NCT00225784|Antiviral Agents|antiviral agents|mesh-ancestor
55852523|NCT00225784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852524|NCT00225784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852525|NCT00225784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852551|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852552|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852553|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55852554|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
55852555|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852556|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852557|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55852558|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852559|NCT00254410|Analgesics|analgesics|mesh-ancestor
55852560|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
55852561|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852562|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55852563|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55852564|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852565|NCT00254488|Valproic Acid|valproic acid|mesh-list
55852566|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852567|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852568|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852569|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
55852570|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55852571|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55852572|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852573|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
55852574|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
55852575|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852576|NCT01899118|Capecitabine|capecitabine|mesh-list
55852577|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
55852578|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
55852579|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852580|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
55852581|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852583|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852585|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55852586|NCT00231868|Carboplatin|carboplatin|mesh-list
55852587|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55852588|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852589|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
55852590|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
55852591|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
55852592|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852593|NCT00257686|Pravastatin|pravastatin|mesh-list
55852594|NCT00257686|Pitavastatin|pitavastatin|mesh-list
55852595|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55852596|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55852597|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
55852598|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852599|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55852600|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55852601|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852602|NCT01469013|Methotrexate|methotrexate|mesh-list
55852603|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55852604|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
55852605|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55852629|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55852630|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852631|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
55852632|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
55852633|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
55852634|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852636|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
55852698|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852699|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852700|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
55852701|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852702|NCT01606748|Antiviral Agents|antiviral agents|mesh-ancestor
55852703|NCT01606748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852704|NCT01606748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852705|NCT01606748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852706|NCT01606748|Immunologic Factors|immunologic factors|mesh-ancestor
55852707|NCT01606748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852708|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852709|NCT01597622|Belimumab|belimumab|mesh-list
55852710|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852711|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
55852712|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852713|NCT01761266|Sorafenib|sorafenib|mesh-list
55852714|NCT01761266|Lenvatinib|lenvatinib|mesh-list
55852715|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852716|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55852717|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852718|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852719|NCT01759862|Aminophylline|aminophylline|mesh-list
55852720|NCT01759862|Theophylline|theophylline|mesh-list
55852721|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55852722|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
55852723|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852749|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852750|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852751|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55852752|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852753|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55852754|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
55852755|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55852756|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852757|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55852758|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
55852759|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
55852760|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852761|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55852762|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
55852763|NCT01790594|Hormones|hormones|mesh-ancestor
55852764|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55852765|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55852766|NCT01790594|Protective Agents|protective agents|mesh-ancestor
55852767|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55852768|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852769|NCT01790516|Cetuximab|cetuximab|mesh-list
55852770|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852771|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852772|NCT01790438|Insulin|insulin|mesh-list
55852773|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55852797|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55852798|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
55852872|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
55852873|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55852874|NCT00259090|Fulvestrant|fulvestrant|mesh-list
55852875|NCT00259090|Anastrozole|anastrozole|mesh-list
55852876|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55852877|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852878|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55852879|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55852880|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
55852881|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55852882|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852883|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55852884|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55852885|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852886|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852889|NCT00236938|Hematinics|hematinics|mesh-ancestor
55852891|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
55852892|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
55852894|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55852895|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55852896|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55852897|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55852898|NCT01898728|Trace Elements|trace elements|mesh-ancestor
55852899|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
55852900|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852901|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
55852902|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
55852903|NCT00260962|Olanzapine|olanzapine|mesh-list
55852916|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852917|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852918|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
55852920|NCT00237718|Tocopherols|tocopherols|mesh-list
55852921|NCT00237718|Tocotrienols|tocotrienols|mesh-list
55852922|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
55852923|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
55852924|NCT00237718|Vitamins|vitamins|mesh-ancestor
55852925|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
55852926|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852927|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
55852928|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852929|NCT00237718|Protective Agents|protective agents|mesh-ancestor
55852930|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
55852931|NCT00238108|Melatonin|melatonin|mesh-list
55852932|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
55852933|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852934|NCT00238108|Protective Agents|protective agents|mesh-ancestor
55852935|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852936|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55852937|NCT00266110|Trastuzumab|trastuzumab|mesh-list
55852938|NCT00266110|Vinorelbine|vinorelbine|mesh-list
55852939|NCT00266110|Sargramostim|sargramostim|mesh-list
55852940|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852941|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852942|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55852943|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
55852962|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55852963|NCT01899430|Metformin|metformin|mesh-list
55852964|NCT01899430|Liraglutide|liraglutide|mesh-list
55852965|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55852966|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852967|NCT01899430|Incretins|incretins|mesh-ancestor
55852968|NCT01899430|Hormones|hormones|mesh-ancestor
55853106|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55852969|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55852970|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
55852971|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55852972|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852973|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852974|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55852975|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55852976|NCT00267670|Protective Agents|protective agents|mesh-ancestor
55852977|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852978|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
55852979|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55852980|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
55852981|NCT00247624|Eszopiclone|eszopiclone|mesh-list
55852982|NCT00247624|Fluoxetine|fluoxetine|mesh-list
55852983|NCT00247624|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55852987|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853014|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
55853015|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55853016|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
55853017|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853018|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853019|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
55853020|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55853023|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
55853024|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853025|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55853026|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853027|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853029|NCT04110340|Gentamicins|gentamicins|mesh-list
55853030|NCT04110340|Streptomycin|streptomycin|mesh-list
55853031|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55853032|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853033|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55853034|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55853035|NCT04110340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853036|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853037|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853038|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55853039|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55853040|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55853060|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
55853061|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55853062|NCT05237596|Analgesics|analgesics|mesh-ancestor
55853063|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
55853064|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853065|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853066|NCT05237596|Antipyretics|antipyretics|mesh-ancestor
55853067|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853069|NCT02102932|Empagliflozin|empagliflozin|mesh-list
55853070|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55853071|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853072|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55853073|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853074|NCT00273754|Caffeine|caffeine|mesh-list
55853075|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55853076|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853077|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55853078|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853079|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853080|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55853081|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55853082|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
55853083|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853084|NCT04751344|Bupivacaine|bupivacaine|mesh-list
55853085|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
55853086|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
55853087|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55853088|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853089|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
55853102|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853103|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
55853104|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
55853105|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55853107|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55853108|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55853109|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853110|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
55853111|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853112|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853115|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55853117|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
55853118|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
55853119|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55853120|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853157|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55853158|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55853159|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
55853160|NCT00283816|Metformin|metformin|mesh-list
55853161|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
55853162|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
55853163|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55853164|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55853165|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853166|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55853167|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55853168|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
55853169|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55853170|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55853172|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55853173|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853174|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
55853175|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853176|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853177|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55853178|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853179|NCT04339426|Azithromycin|azithromycin|mesh-list
55853181|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55853200|NCT00287872|Bortezomib|bortezomib|mesh-list
55853206|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55853207|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853208|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55853209|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55853210|NCT00287872|Growth Substances|growth substances|mesh-ancestor
55853211|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
55853212|NCT00288574|Fluoxetine|fluoxetine|mesh-list
55853213|NCT00288574|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55853214|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55853215|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55853216|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853217|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853219|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853220|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55853221|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
55853222|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55853223|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55853224|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55853225|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853226|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55853227|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55853228|NCT04079218|Estradiol|estradiol|mesh-list
55853229|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55853230|NCT04079218|Estrogens|estrogens|mesh-ancestor
55853231|NCT04079218|Hormones|hormones|mesh-ancestor
55853232|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853233|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853238|NCT04061590|Cisplatin|cisplatin|mesh-list
55853248|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55853249|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853250|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55853251|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853252|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
55853253|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55853254|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
55853255|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853256|NCT00291226|Glycine|glycine|mesh-list
55853257|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
55853258|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853259|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853260|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853261|NCT01791166|Antibodies|antibodies|mesh-list
55853262|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
55853263|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853264|NCT00291694|Celecoxib|celecoxib|mesh-list
55853265|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55853305|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
55853306|NCT00292162|Protective Agents|protective agents|mesh-ancestor
55853307|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55853308|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55853309|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55853310|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
55853311|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55853312|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55853313|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
55853314|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853315|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55853317|NCT00296296|Tacrolimus|tacrolimus|mesh-list
55853318|NCT00296296|Cyclosporins|cyclosporins|mesh-list
55853319|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55853320|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
55853321|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853322|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55853323|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853324|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853325|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
55853326|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853327|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
55853328|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853330|NCT01791400|Metoclopramide|metoclopramide|mesh-list
55853355|NCT00300430|Fenofibrate|fenofibrate|mesh-list
55853356|NCT00300430|Calcium|calcium|mesh-list
55853357|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55853358|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853359|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55853360|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55853361|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55853362|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
55853363|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853364|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55853365|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55853366|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853367|NCT02104414|Epinephrine|epinephrine|mesh-list
55853368|NCT02104414|Bupivacaine|bupivacaine|mesh-list
55853369|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
55853370|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
55853371|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55853372|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853373|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
55853374|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853375|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55853376|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55853377|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
55853378|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853379|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853380|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55853381|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55853382|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
55853383|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55853384|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
55853385|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
55853386|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
55853397|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
55853398|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55853399|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
55853400|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853401|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55853402|NCT02101918|Aflibercept|aflibercept|mesh-list
55853403|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
55853404|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55853405|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55853406|NCT02101918|Growth Substances|growth substances|mesh-ancestor
55853407|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853408|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
55853409|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853410|NCT00300742|Topiramate|topiramate|mesh-list
55853411|NCT00300742|Anticonvulsants|anticonvulsants|mesh-ancestor
55853412|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55853413|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853414|NCT00301756|Belinostat|belinostat|mesh-list
55853415|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853416|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55853417|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853418|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853419|NCT00302068|Sertraline|sertraline|mesh-list
55853420|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
55853421|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55853422|NCT00302068|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55853423|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55853424|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55853442|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55853443|NCT00302848|Diuretics|diuretics|mesh-ancestor
55853444|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
55853445|NCT00302848|Hormones|hormones|mesh-ancestor
55853446|NCT00303862|Cediranib|cediranib|mesh-list
55853447|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841599|NCT04149964|Analgesics|analgesics|mesh-ancestor
55853448|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853449|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853450|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55853451|NCT00304096|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55853452|NCT00304096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55853453|NCT00304096|Immunologic Factors|immunologic factors|mesh-ancestor
55853454|NCT00304096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853455|NCT05267392|Durvalumab|durvalumab|mesh-list
55853456|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55853457|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853458|NCT00142168|Rituximab|rituximab|mesh-list
55853459|NCT00142168|Lenalidomide|lenalidomide|mesh-list
55853460|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55853461|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853462|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
55853463|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853464|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853465|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55853466|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55853467|NCT00142168|Growth Substances|growth substances|mesh-ancestor
55853468|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
55853469|NCT02578732|Leucovorin|leucovorin|mesh-list
55853470|NCT02578732|Oxaliplatin|oxaliplatin|mesh-list
55853471|NCT02578732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853490|NCT00148798|Vinorelbine|vinorelbine|mesh-list
55853491|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853492|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55853493|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55853494|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
55853495|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
55853496|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
55853497|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853498|NCT00149734|Ondansetron|ondansetron|mesh-list
55853499|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
55853500|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
55853501|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853502|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853503|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55853504|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
55853505|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
55853506|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55853507|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
55853508|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853509|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853511|NCT00149734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55853512|NCT00149734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55853513|NCT00149734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55853514|NCT00149734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55853515|NCT00198328|Bleomycin|bleomycin|mesh-list
55853516|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55853517|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853518|NCT00305578|Memantine|memantine|mesh-list
55853533|NCT01468311|Daclizumab|daclizumab|mesh-list
55853535|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
55853536|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853537|NCT00306202|Dasatinib|dasatinib|mesh-list
55853538|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853539|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55853540|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853541|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853542|NCT00325078|Infliximab|infliximab|mesh-list
55853543|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
55853544|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55853545|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853546|NCT00325780|Pitavastatin|pitavastatin|mesh-list
55853547|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55853548|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55853549|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55853550|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
55853551|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853552|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853553|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55853554|NCT00326170|Azacitidine|azacitidine|mesh-list
55853555|NCT00326170|Tretinoin|tretinoin|mesh-list
55853556|NCT00326170|Valproic Acid|valproic acid|mesh-list
55853557|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55853558|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
55853559|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853560|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853561|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853562|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
55853563|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
55853564|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
55853565|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
55853566|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853567|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853568|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
55853569|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55853570|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55853571|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55853572|NCT00326872|Cediranib|cediranib|mesh-list
55853573|NCT00326872|Maleic acid|maleic acid|mesh-list
55853574|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853575|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853576|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853577|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55853578|NCT05266690|Dextrans|dextrans|mesh-list
55853579|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
55853580|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
55853581|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
55853582|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
55853583|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55853584|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853585|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55853586|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853587|NCT05266534|Terlipressin|terlipressin|mesh-list
55853588|NCT05266534|Carbetocin|carbetocin|mesh-list
55853589|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55853590|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55853591|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
55853592|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55853593|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853594|NCT01730378|Vaccines|vaccines|mesh-list
55853595|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
55853596|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853597|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
55853604|NCT01790308|Liraglutide|liraglutide|mesh-list
55853621|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55853631|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853632|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853633|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55853634|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55853635|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
55853636|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853637|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853638|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55853639|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
55853640|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55853641|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55853642|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55853643|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55853644|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
55853645|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55853646|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55853647|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853648|NCT01755416|Insulin|insulin|mesh-list
55853668|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
55853669|NCT00333814|Hormones|hormones|mesh-ancestor
55853670|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853671|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55853672|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853673|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
55853674|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853675|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853676|NCT01728584|Bromides|bromides|mesh-list
55853677|NCT01728584|Rocuronium|rocuronium|mesh-list
55853678|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
55853679|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55853680|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55853681|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55853682|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853683|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853685|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55853686|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55853687|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55853688|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
55853689|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853690|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853719|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
55853720|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853721|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55853722|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55853723|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853724|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
55853725|NCT00336232|Coagulants|coagulants|mesh-ancestor
55853726|NCT00336700|Gemcitabine|gemcitabine|mesh-list
55853727|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55853728|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55853729|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
55853730|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853731|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853732|NCT00336700|Antiviral Agents|antiviral agents|mesh-ancestor
55853733|NCT00336700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853734|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853735|NCT00336700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55853736|NCT00336700|Immunologic Factors|immunologic factors|mesh-ancestor
55853737|NCT00336700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853738|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55853740|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55853741|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853742|NCT01754402|Dexamethasone|dexamethasone|mesh-list
55853743|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55853744|NCT01754402|Pomalidomide|pomalidomide|mesh-list
55853745|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55853746|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
55853747|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
55853748|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853749|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853750|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55853751|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
55853761|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55853762|NCT01754402|Growth Substances|growth substances|mesh-ancestor
55853763|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
55853764|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55853765|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
55853766|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853768|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
55853769|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
55853771|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853773|NCT01782872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853774|NCT01490697|Cycloserine|cycloserine|mesh-list
55853775|NCT01490697|Mifepristone|mifepristone|mesh-list
55853776|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55853777|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
55853778|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55853779|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853780|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55853781|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55853782|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55853783|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
55853784|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55853785|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55853786|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
55853787|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853788|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
55853804|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853805|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
55853806|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853807|NCT01728194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55853808|NCT01728194|Antidepressive Agents|antidepressive agents|mesh-ancestor
55853809|NCT01728194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55853810|NCT04408911|Midazolam|midazolam|mesh-list
55853811|NCT04408911|Lormetazepam|lormetazepam|mesh-list
55853812|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55853813|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55853814|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841808|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
55853816|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55853817|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55853818|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55853819|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55853820|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
55853821|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
55853822|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
55853823|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
55853824|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853860|NCT01753856|Calcium|calcium|mesh-list
55853861|NCT01753856|Vitamins|vitamins|mesh-ancestor
55853862|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
55853863|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853866|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55853867|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853868|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55853869|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853870|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853871|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
55853872|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55853873|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55853874|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55853875|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55853876|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853877|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
55853878|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853879|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853880|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55853881|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853882|NCT01521117|Donepezil|donepezil|mesh-list
55853883|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55853884|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853885|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853886|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
55853887|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853888|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853889|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
55853890|NCT01466595|Rifaximin|rifaximin|mesh-list
55853891|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55853892|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853893|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55853894|NCT02073747|Albuterol|albuterol|mesh-list
55853896|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
55853897|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853898|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853899|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55853900|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
55853901|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
55853902|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55853903|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55853904|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55853905|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55853906|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
55853907|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853908|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853909|NCT01465659|Temozolomide|temozolomide|mesh-list
55853910|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55853911|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
55853912|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853913|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853914|NCT01462929|Bromides|bromides|mesh-list
55853915|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
55853916|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55853917|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
55853918|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853919|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853920|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55853921|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
55853923|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55853924|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
55853925|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55853926|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853927|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
55853929|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853932|NCT01462695|Growth Substances|growth substances|mesh-ancestor
55853933|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853934|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
55853935|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55853936|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853937|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853938|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
55853939|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
55853940|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853941|NCT01465347|Protective Agents|protective agents|mesh-ancestor
55853942|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853943|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55853944|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853945|NCT01465191|Morphine|morphine|mesh-list
55853946|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55853947|NCT01465191|Narcotics|narcotics|mesh-ancestor
55853948|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55853949|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853950|NCT01465191|Analgesics|analgesics|mesh-ancestor
55853951|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
55853952|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853953|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
55853954|NCT01519947|Hematinics|hematinics|mesh-ancestor
55853955|NCT01462227|Naltrexone|naltrexone|mesh-list
55853956|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55853957|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55853958|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853959|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
55853960|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55853961|NCT01464879|Testosterone|testosterone|mesh-list
55853962|NCT01464879|Androgens|androgens|mesh-ancestor
55853963|NCT01464879|Hormones|hormones|mesh-ancestor
55853964|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55853965|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853966|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
55853972|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
55853973|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55853974|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853975|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55853976|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
55853977|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853978|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853979|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
55853980|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55853981|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55853982|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55853983|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
55853984|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55853985|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55853986|NCT01439373|Interferons|interferons|mesh-list
55853988|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
55853989|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
55853990|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55853991|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55853992|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
55853993|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55853994|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
55853995|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55853996|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
55853997|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55853998|NCT01461369|Diclofenac|diclofenac|mesh-list
55853999|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55854017|NCT01752842|Fenofibrate|fenofibrate|mesh-list
55854018|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55854019|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
55854020|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854021|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55854022|NCT01461057|Capecitabine|capecitabine|mesh-list
55854023|NCT01461057|Trastuzumab|trastuzumab|mesh-list
55854024|NCT01461057|Pertuzumab|pertuzumab|mesh-list
55854025|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854026|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55854027|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
55841809|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
55854028|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854029|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854030|NCT04567407|Ropivacaine|ropivacaine|mesh-list
55854031|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
55854032|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
55854033|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55854034|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854035|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
55854036|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854037|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55854038|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55854039|NCT01519635|Diuretics|diuretics|mesh-ancestor
55854040|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
55854041|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854042|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55854043|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55854044|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854045|NCT01519323|Vemurafenib|vemurafenib|mesh-list
55854046|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854047|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55854048|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854050|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
55854058|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
55854059|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55854060|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55854061|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854062|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55854064|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
55854065|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854066|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55854067|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55854068|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55854069|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
55854070|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854071|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854072|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55854073|NCT01519167|Narcotics|narcotics|mesh-ancestor
55854074|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55854075|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55854076|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
55854079|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55854080|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55854102|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55854103|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854104|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
55854105|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854106|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55854107|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55854108|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
55854109|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854110|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854111|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55854112|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55854113|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
55854114|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55854115|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
55854117|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
55854118|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55854119|NCT01791868|Valproic Acid|valproic acid|mesh-list
55854120|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
55854121|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854122|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854123|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
55854124|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854125|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854126|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
55854127|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55854128|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55854129|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55854142|NCT03793114|Cosyntropin|cosyntropin|mesh-list
55854143|NCT03793114|Hormones|hormones|mesh-ancestor
55854144|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55854145|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854146|NCT00348946|Androgens|androgens|mesh-list
55854147|NCT00348946|Oxandrolone|oxandrolone|mesh-list
55854148|NCT00348946|Hormones|hormones|mesh-ancestor
55854149|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55854150|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854151|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
55854152|NCT00349336|Bevacizumab|bevacizumab|mesh-list
55854153|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854154|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854155|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55854156|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854157|NCT00349336|Growth Substances|growth substances|mesh-ancestor
55854158|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854159|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
55854160|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
55854161|NCT04751188|Bezafibrate|bezafibrate|mesh-list
55854162|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55854163|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55854164|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55854165|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
55854166|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854167|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55854168|NCT00352612|Clindamycin|clindamycin|mesh-list
55854169|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
55854170|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
55854171|NCT00352612|Cephalexin|cephalexin|mesh-list
55854172|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55854173|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854174|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55854175|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854177|NCT00323362|Gemcitabine|gemcitabine|mesh-list
55854181|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854182|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854183|NCT00323362|Antiviral Agents|antiviral agents|mesh-ancestor
55854184|NCT00323362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854185|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854186|NCT00323362|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55854187|NCT00323362|Immunologic Factors|immunologic factors|mesh-ancestor
55854188|NCT00323362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854189|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55854190|NCT00390364|Everolimus|everolimus|mesh-list
55854191|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854192|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55854193|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
55854194|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854195|NCT00354640|Anastrozole|anastrozole|mesh-list
55854196|NCT00354640|Simvastatin|simvastatin|mesh-list
55854197|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55854198|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55854199|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
55854200|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854201|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55854202|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55854203|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854231|NCT00392704|Paclitaxel|paclitaxel|mesh-list
55854232|NCT00392704|Bevacizumab|bevacizumab|mesh-list
55854233|NCT00392704|Fluorouracil|fluorouracil|mesh-list
55854234|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55854235|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55854236|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854237|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
55854238|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
55854239|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854240|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854241|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854242|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55854243|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854244|NCT00392704|Growth Substances|growth substances|mesh-ancestor
55854245|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854247|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
55854248|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55854249|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55854250|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
55854251|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55854252|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854253|NCT00392782|Fludarabine|fludarabine|mesh-list
55854254|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
55854255|NCT00392782|Thiotepa|thiotepa|mesh-list
55854256|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55854257|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854258|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55854259|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
55854260|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854261|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55854262|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
55854263|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854264|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55854265|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
55854270|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854271|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55854272|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55854273|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854274|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854275|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854276|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55854277|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
55854278|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55854279|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854280|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55854281|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55854282|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55854283|NCT01518309|Pimavanserin|pimavanserin|mesh-list
55854284|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55854285|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55854286|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55854287|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55854288|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55854289|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854290|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55854291|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55854292|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55854293|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
55854296|NCT01419717|Denosumab|denosumab|mesh-list
55854318|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854320|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55854321|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55854322|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55854323|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55854324|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
55854325|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854326|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854327|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854328|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
55854329|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
55854330|NCT01458171|Antibodies|antibodies|mesh-list
55854331|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
55854332|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55854333|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55854335|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854336|NCT00395044|Gabapentin|gabapentin|mesh-list
55854337|NCT00395044|Analgesics|analgesics|mesh-ancestor
55854338|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
55854339|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854340|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854341|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
55854342|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55854343|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55854344|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55854345|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55854346|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55854347|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55854348|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854360|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
55854361|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55854362|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854363|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55854364|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
55854365|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55854366|NCT01457703|Hormones|hormones|mesh-ancestor
55854367|NCT02076321|Acetaminophen|acetaminophen|mesh-list
55854368|NCT02076321|Ibuprofen|ibuprofen|mesh-list
55854369|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55854370|NCT02076321|Analgesics|analgesics|mesh-ancestor
55854371|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
55854372|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854373|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854374|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
55854375|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55854376|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55854377|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55854378|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55854379|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854380|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854381|NCT00358462|Azithromycin|azithromycin|mesh-list
55854382|NCT00358462|Doxycycline|doxycycline|mesh-list
55854383|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55854384|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854385|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
55854386|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55854387|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55854388|NCT03652870|Dexetimide|dexetimide|mesh-list
55854389|NCT03652870|Citalopram|citalopram|mesh-list
55854390|NCT03652870|Nortriptyline|nortriptyline|mesh-list
55854391|NCT03652870|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55854392|NCT03652870|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55854393|NCT03652870|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55854398|NCT03652870|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55854399|NCT03652870|Antidepressive Agents|antidepressive agents|mesh-ancestor
55854400|NCT03652870|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55854401|NCT03652870|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55854402|NCT03652870|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55854403|NCT03652870|Parasympatholytics|parasympatholytics|mesh-ancestor
55854404|NCT03652870|Autonomic Agents|autonomic agents|mesh-ancestor
55854405|NCT03652870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854406|NCT03652870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55854407|NCT03652870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55854408|NCT03652870|Cholinergic Agents|cholinergic agents|mesh-ancestor
55854409|NCT03652870|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55854410|NCT03652870|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55854411|NCT03652870|Adrenergic Agents|adrenergic agents|mesh-ancestor
55854412|NCT01437267|Vaccines|vaccines|mesh-list
55854413|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55854417|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
55854418|NCT01437111|Alendronate|alendronate|mesh-list
55854419|NCT01437111|Vitamins|vitamins|mesh-ancestor
55854420|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
55854421|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854422|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55854423|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55854424|NCT04065555|Cetuximab|cetuximab|mesh-list
55854425|NCT04065555|Avelumab|avelumab|mesh-list
55854426|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55854443|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
55854444|NCT00398398|Capecitabine|capecitabine|mesh-list
55854445|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
55854446|NCT00398398|Cetuximab|cetuximab|mesh-list
55854447|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55854448|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
55854449|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854450|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854451|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854452|NCT00398476|Fluticasone|fluticasone|mesh-list
55854453|NCT00398476|Xhance|xhance|mesh-list
55854454|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55854455|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55854456|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
55854457|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854458|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854459|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55854460|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
55854461|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
55854462|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55854463|NCT01436643|Fluoxetine|fluoxetine|mesh-list
55854464|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55854465|NCT01436643|Citalopram|citalopram|mesh-list
55854466|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55854467|NCT01436643|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55854468|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55854469|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55854470|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854471|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854472|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
55854473|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854475|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
55854485|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
55854486|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55854487|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55854488|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854489|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854490|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854491|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55854492|NCT00361972|Lansoprazole|lansoprazole|mesh-list
55854493|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
55854494|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55854495|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55854496|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55854497|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854498|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854499|NCT00362440|Metformin|metformin|mesh-list
55854500|NCT00362440|Pioglitazone|pioglitazone|mesh-list
55854501|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55854502|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854503|NCT02109640|Oxycodone|oxycodone|mesh-list
55854504|NCT02109640|Naloxone|naloxone|mesh-list
55854505|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55854506|NCT02109640|Narcotics|narcotics|mesh-ancestor
55854546|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55854547|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55854548|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854549|NCT00369226|Methotrexate|methotrexate|mesh-list
55854550|NCT00369226|Bortezomib|bortezomib|mesh-list
55854551|NCT00369226|Tacrolimus|tacrolimus|mesh-list
55854552|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55854553|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
55854554|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55854555|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854556|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55854557|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
55854558|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854559|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854560|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
55854561|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854562|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55854563|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55854564|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
55854565|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55854566|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55854567|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55854568|NCT01416441|Aripiprazole|aripiprazole|mesh-list
55854569|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
55854570|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55854571|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55854579|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55854580|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55854582|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55854583|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55854584|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55854585|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55854586|NCT00406276|Docetaxel|docetaxel|mesh-list
55854587|NCT00406276|Everolimus|everolimus|mesh-list
55854588|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854589|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
55854590|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
55854591|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854592|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854593|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55854594|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
55854595|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854596|NCT00408070|Paclitaxel|paclitaxel|mesh-list
55854597|NCT00408070|Bevacizumab|bevacizumab|mesh-list
55854598|NCT00408070|Carboplatin|carboplatin|mesh-list
55854599|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55854600|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854601|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
55854603|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854604|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854605|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854626|NCT03675412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854627|NCT03675412|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55854628|NCT03675412|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55854629|NCT03675412|Purinergic Agents|purinergic agents|mesh-ancestor
55854630|NCT03675412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854631|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
55854632|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
55854633|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854634|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
55854635|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854636|NCT02111746|Bupivacaine|bupivacaine|mesh-list
55854637|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
55854638|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
55854639|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55854640|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854641|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
55854642|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854643|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
55854644|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55854645|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854646|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854647|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55854648|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55854649|NCT01793272|Protective Agents|protective agents|mesh-ancestor
55854650|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854651|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
55854652|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55854653|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
55854654|NCT00410488|Dexamethasone|dexamethasone|mesh-list
55854655|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
55854656|NCT00410488|Doxorubicin|doxorubicin|mesh-list
55854657|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55854658|NCT00410488|Vincristine|vincristine|mesh-list
55854659|NCT00410488|Ifosfamide|ifosfamide|mesh-list
55854660|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
55854661|NCT00410488|Palonosetron|palonosetron|mesh-list
55854666|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854667|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854668|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55854669|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
55854670|NCT00410488|Hormones|hormones|mesh-ancestor
55854671|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55854672|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55854673|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854674|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
55854675|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854676|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854677|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55854678|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55854679|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55854680|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55854681|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
55854682|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
55854683|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854684|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55854685|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
55854686|NCT00410488|Protective Agents|protective agents|mesh-ancestor
55854687|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55854688|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55854689|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
55854690|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854691|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55854693|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55854694|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
55854695|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854697|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
55854698|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854699|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
55854700|NCT03127774|Antidotes|antidotes|mesh-ancestor
55854701|NCT03127774|Protective Agents|protective agents|mesh-ancestor
55854703|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
55854704|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854705|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
55854706|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55854707|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854708|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
55854709|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
55854710|NCT00416494|Bevacizumab|bevacizumab|mesh-list
55854711|NCT00416494|Capecitabine|capecitabine|mesh-list
55854712|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
55854713|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854714|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854715|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55854716|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854717|NCT00416494|Growth Substances|growth substances|mesh-ancestor
55854718|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854719|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
55854720|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55854721|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
55854722|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854723|NCT02845882|Cytarabine|cytarabine|mesh-list
55854724|NCT02845882|Dexamethasone|dexamethasone|mesh-list
55854725|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
55854726|NCT02845882|Prednisone|prednisone|mesh-list
55854727|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
55854728|NCT02845882|Ifosfamide|ifosfamide|mesh-list
55854729|NCT02845882|Doxorubicin|doxorubicin|mesh-list
55854730|NCT02845882|Methotrexate|methotrexate|mesh-list
55854731|NCT02845882|Etoposide|etoposide|mesh-list
55854745|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854746|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854747|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55854748|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55854749|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
55854750|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
55854751|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854752|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55854753|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
55854754|NCT02845882|Hormones|hormones|mesh-ancestor
55854755|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55854756|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55854757|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
55854758|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854759|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55854760|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55854761|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55854762|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55854763|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
55854764|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55854765|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55854766|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
55854767|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
55854768|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55854769|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55854771|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
55854792|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854793|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854794|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55854795|NCT04749940|Laxatives|laxatives|mesh-ancestor
55854796|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55854797|NCT05286346|Tenofovir|tenofovir|mesh-list
55854798|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
55854799|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854800|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55854801|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55854802|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854803|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854804|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55854805|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55854806|NCT05286268|Plasminogen|plasminogen|mesh-list
55854807|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55854808|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55854809|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854810|NCT00422032|Clofarabine|clofarabine|mesh-list
55854811|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55854812|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
55854813|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854814|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854815|NCT01388920|Tesamorelin|tesamorelin|mesh-list
55854816|NCT01388920|Growth Substances|growth substances|mesh-ancestor
55854817|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854818|NCT00423358|Vitamin D|vitamin d|mesh-list
55854819|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
55854820|NCT00423358|Vitamins|vitamins|mesh-ancestor
55854821|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
55854822|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854823|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55854824|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55854832|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854833|NCT00424840|Growth Substances|growth substances|mesh-ancestor
55854834|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854835|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
55854836|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
55854837|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
55854838|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854839|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854840|NCT00425386|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55854841|NCT00425386|Sunitinib|sunitinib|mesh-list
55854842|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854843|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55854844|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854845|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854847|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854848|NCT00425386|Growth Substances|growth substances|mesh-ancestor
55854849|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854887|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
55854888|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55854889|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55854890|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
55854891|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854892|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55854893|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55854894|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
55854895|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854896|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854897|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55854898|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55854899|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
55854900|NCT00371176|Cycloserine|cycloserine|mesh-list
55854901|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55854902|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55854903|NCT00371176|Renal Agents|renal agents|mesh-ancestor
55854904|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55854905|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
55854906|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55854907|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
55854908|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854910|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55854911|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854912|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55854913|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55854914|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854915|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55854916|NCT00427804|Vitamins|vitamins|mesh-ancestor
55854917|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
55854918|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55854919|NCT00428584|Interferons|interferons|mesh-list
55854920|NCT00428584|Interferon-beta|interferon-beta|mesh-list
55854926|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854927|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55854928|NCT05187286|Apixaban|apixaban|mesh-list
55854929|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55854930|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
55854931|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55854932|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
55854933|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854934|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854935|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
55854936|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
55854937|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55854938|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55854939|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55854940|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55854941|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854943|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854944|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854945|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55854946|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55854947|NCT00373360|Treprostinil|treprostinil|mesh-list
55854948|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55854949|NCT00455650|Mecamylamine|mecamylamine|mesh-list
55854950|NCT00455650|Varenicline|varenicline|mesh-list
55854951|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55854952|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55854953|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
55854954|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55854955|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854956|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854957|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55854967|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854968|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
55854969|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55854970|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854971|NCT04388176|Compound 21|compound 21|mesh-list
55854972|NCT04388176|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55854974|NCT00455962|Progesterone|progesterone|mesh-list
55854975|NCT00455962|Estrogens|estrogens|mesh-ancestor
55854977|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55854978|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854979|NCT00455962|Progestins|progestins|mesh-ancestor
55854981|NCT00434356|Bevacizumab|bevacizumab|mesh-list
55854982|NCT00434356|Sunitinib|sunitinib|mesh-list
55854983|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55854984|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55854985|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
55854986|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
55854987|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
55854988|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55854989|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55854990|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55854991|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55854992|NCT00434356|Growth Substances|growth substances|mesh-ancestor
55854993|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55854994|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
55854995|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55854996|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55854997|NCT00376948|Gemcitabine|gemcitabine|mesh-list
55854998|NCT00376948|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55854999|NCT00376948|Genistein|genistein|mesh-list
55855000|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855008|NCT00376948|Immunologic Factors|immunologic factors|mesh-ancestor
55855009|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855010|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55855011|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55855012|NCT00376948|Protective Agents|protective agents|mesh-ancestor
55855013|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
55855014|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
55855015|NCT00376948|Estrogens|estrogens|mesh-ancestor
55855016|NCT00376948|Hormones|hormones|mesh-ancestor
55855017|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855018|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55855019|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55855020|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855021|NCT00438100|Capecitabine|capecitabine|mesh-list
55855022|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855023|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
55855024|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855025|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855026|NCT00456508|Ecallantide|ecallantide|mesh-list
55855027|NCT00456508|Analgesics|analgesics|mesh-ancestor
55855028|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
55855029|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855031|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55855032|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55855033|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855034|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855035|NCT00457366|Lorazepam|lorazepam|mesh-list
55855036|NCT00457366|Haloperidol|haloperidol|mesh-list
55855037|NCT00457366|Benztropine|benztropine|mesh-list
55855053|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855054|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55855055|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
55855056|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55855057|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55855058|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
55855059|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
55855060|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55855061|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
55855062|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55855063|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55855064|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
55855065|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55855066|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55855067|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55855068|NCT00458848|Prednisone|prednisone|mesh-list
55855069|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
55855070|NCT00458848|Methotrexate|methotrexate|mesh-list
55855071|NCT00458848|Etoposide|etoposide|mesh-list
55855072|NCT00458848|Vincristine|vincristine|mesh-list
55855073|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
55855074|NCT00458848|Daunorubicin|daunorubicin|mesh-list
55855075|NCT00458848|Asparaginase|asparaginase|mesh-list
55855076|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
55855077|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
55855104|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
55855106|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
55855107|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855108|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55855109|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55855110|NCT00458848|Protective Agents|protective agents|mesh-ancestor
55855111|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55855112|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55855113|NCT00458848|Analgesics|analgesics|mesh-ancestor
55855114|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
55855115|NCT00438802|Alefacept|alefacept|mesh-list
55855116|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
55855117|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
55855118|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855119|NCT00377572|Omalizumab|omalizumab|mesh-list
55855120|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55855121|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55855122|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55855123|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
55855124|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
55855125|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855127|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55855129|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
55855130|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55855131|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
55855133|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855153|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
55855154|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855155|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855156|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55855157|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
55855158|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855159|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855222|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55855223|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55855224|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55855225|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55855226|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855227|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855228|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855229|NCT00464698|Analgesics|analgesics|mesh-ancestor
55855230|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
55855231|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855232|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
55855233|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55855234|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
55855235|NCT00465088|Niacin|niacin|mesh-list
55855236|NCT00465088|Niacinamide|niacinamide|mesh-list
55855237|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
55855238|NCT00465088|Atorvastatin|atorvastatin|mesh-list
55855239|NCT00465088|Simvastatin|simvastatin|mesh-list
55855240|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55855241|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55855242|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
55855243|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855244|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55855246|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855270|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855271|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855272|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855273|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55855274|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55855275|NCT00384670|Vaccines|vaccines|mesh-list
55855276|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
55855277|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855278|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55855279|NCT00467350|Laxatives|laxatives|mesh-ancestor
55855280|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55855281|NCT00444028|Loxapine|loxapine|mesh-list
55855282|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55855283|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55855284|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855285|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855287|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55855288|NCT00444028|Dopamine Agents|dopamine agents|mesh-ancestor
55855289|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855290|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855291|NCT00444964|Hormones|hormones|mesh-list
55855292|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855293|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855294|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55855295|NCT00445588|Sorafenib|sorafenib|mesh-list
55855296|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855297|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55855298|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818580|NCT01843348|Cyclosporine|cyclosporine|mesh-list
55855299|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855300|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
55855301|NCT00445744|Busulfan|busulfan|mesh-list
55855302|NCT00445744|Methotrexate|methotrexate|mesh-list
55855303|NCT00445744|Tacrolimus|tacrolimus|mesh-list
55855309|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
55855310|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855311|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855312|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55855313|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55855314|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
55855315|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55855316|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855317|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
55855318|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
55855319|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855320|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55855321|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55855322|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55855323|NCT00468208|Abatacept|abatacept|mesh-list
55855324|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55855325|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855326|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855327|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855328|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
55855329|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855330|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855331|NCT00385138|Clopidogrel|clopidogrel|mesh-list
55855332|NCT00385138|Cangrelor|cangrelor|mesh-list
55855333|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55855336|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55855357|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55855358|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
55855359|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855360|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855361|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55855362|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855363|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55855364|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855365|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855366|NCT00470392|Clobetasol|clobetasol|mesh-list
55855367|NCT00470392|Imiquimod|imiquimod|mesh-list
55855368|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55855369|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
55855370|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855371|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855372|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
55855373|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855374|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
55855375|NCT00470392|Hormones|hormones|mesh-ancestor
55855376|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855377|NCT00470548|Paclitaxel|paclitaxel|mesh-list
55855378|NCT00470548|Pemetrexed|pemetrexed|mesh-list
55855379|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55855380|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55855381|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855382|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
55855383|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
55855384|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
55855385|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855386|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855387|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55855388|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55855389|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55855396|NCT00388414|Analgesics|analgesics|mesh-ancestor
55855397|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
55855398|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855399|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
55855400|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55855401|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
55855402|NCT00475150|Cediranib|cediranib|mesh-list
55855403|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855404|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855405|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855406|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55855407|NCT00451048|Sunitinib|sunitinib|mesh-list
55855408|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855409|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55855410|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55855411|NCT00451048|Growth Substances|growth substances|mesh-ancestor
55855412|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855413|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
55855414|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55855415|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855416|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855417|NCT00388804|Leuprolide|leuprolide|mesh-list
55855418|NCT00388804|Goserelin|goserelin|mesh-list
55855419|NCT00388804|Flutamide|flutamide|mesh-list
55855420|NCT00388804|Bicalutamide|bicalutamide|mesh-list
55855421|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55855422|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
55855423|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55855424|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855425|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55855426|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855427|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
55855432|NCT00389818|Rituximab|rituximab|mesh-list
55855441|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55855442|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
55855443|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855444|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855445|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55855446|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55855447|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55855448|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55855449|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55855450|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855451|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855452|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
55855453|NCT00389818|Hormones|hormones|mesh-ancestor
55855454|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855455|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55855456|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55855457|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
55855458|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
55855462|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
55855463|NCT00452374|Fludarabine|fludarabine|mesh-list
55855464|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
55855465|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55855466|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855467|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
55855468|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855469|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855470|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855471|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
55855472|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855473|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855481|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55855482|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55855484|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855485|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855486|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855487|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55855488|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55855489|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55855490|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55855491|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
55855492|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855493|NCT00476788|Insulin|insulin|mesh-list
55855494|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55855495|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55855496|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855497|NCT01795144|Glucagon|glucagon|mesh-list
55855498|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55855499|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55855500|NCT01795144|Hormones|hormones|mesh-ancestor
55855501|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855502|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855503|NCT01795144|Incretins|incretins|mesh-ancestor
55855504|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55855505|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
55855506|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55855507|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55855508|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855509|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55855525|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55855526|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
55855527|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855528|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855529|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55855530|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55855531|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
55855532|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855533|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
55855534|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55855536|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55855537|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55855538|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55855539|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
55855540|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55855541|NCT04062123|Fentanyl|fentanyl|mesh-list
55855542|NCT04062123|Dexmedetomidine|dexmedetomidine|mesh-list
55855543|NCT04062123|Propofol|propofol|mesh-list
55855544|NCT04062123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55855545|NCT04062123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855546|NCT04062123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855547|NCT04062123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55855548|NCT04062123|Anesthetics, General|anesthetics, general|mesh-ancestor
55855549|NCT04062123|Anesthetics|anesthetics|mesh-ancestor
55855550|NCT04062123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55855551|NCT04062123|Analgesics|analgesics|mesh-ancestor
55855552|NCT04062123|Sensory System Agents|sensory system agents|mesh-ancestor
55855561|NCT04062123|Narcotics|narcotics|mesh-ancestor
55855571|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855572|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855573|NCT01453725|Golimumab|golimumab|mesh-list
55855574|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55855575|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855576|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855577|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
55855578|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855579|NCT00454324|Paclitaxel|paclitaxel|mesh-list
55855580|NCT00454324|Carboplatin|carboplatin|mesh-list
55855581|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55855582|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55855583|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855584|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
55855585|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
55855586|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
55855587|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855588|NCT02110264|Naltrexone|naltrexone|mesh-list
55855589|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55855590|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55855591|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855592|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
55855593|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855594|NCT01795222|Midazolam|midazolam|mesh-list
55855595|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55855596|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55855597|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855598|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855599|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55855600|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55855601|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55855602|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55855614|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855615|NCT00528190|Itraconazole|itraconazole|mesh-list
55855616|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
55855617|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55855618|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55855619|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55855620|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855621|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855622|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55855623|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
55855624|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855625|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855626|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55855628|NCT02334813|Prednisone|prednisone|mesh-list
55855629|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855630|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
55855631|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
55855632|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855633|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855634|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55855635|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
55855636|NCT02334813|Hormones|hormones|mesh-ancestor
55855637|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855638|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55855639|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855640|NCT00478036|Prednisolone|prednisolone|mesh-list
55855641|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
55855642|NCT00478036|Ketorolac|ketorolac|mesh-list
55855647|NCT00478036|Hormones|hormones|mesh-ancestor
55855876|NCT04075149|Diuretics|diuretics|mesh-ancestor
55855655|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55855657|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
55855658|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855659|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55855660|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855661|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855662|NCT00478036|Laxatives|laxatives|mesh-ancestor
55855663|NCT04048863|Imidacloprid|imidacloprid|mesh-list
55855664|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
55855665|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855666|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855667|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855668|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
55855669|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855670|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
55855671|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55855672|NCT01453023|Fluticasone|fluticasone|mesh-list
55855673|NCT01453023|Xhance|xhance|mesh-list
55855674|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855675|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55855676|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
55855677|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855679|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55855708|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855709|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55855710|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55855711|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
55855712|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55855713|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55855714|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
55855715|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855716|NCT00528580|Simvastatin|simvastatin|mesh-list
55855717|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55855718|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55855719|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
55855720|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855721|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55855722|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55855723|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855724|NCT00529126|Epinephrine|epinephrine|mesh-list
55855725|NCT00529126|Bupivacaine|bupivacaine|mesh-list
55855726|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
55855727|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
55855728|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855729|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855730|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
55855731|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855734|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
55855735|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855736|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855737|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55855738|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55855745|NCT00529204|Exenatide|exenatide|mesh-list
55855751|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855752|NCT01451541|Ciclesonide|ciclesonide|mesh-list
55855753|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
55855754|NCT01451541|Hormones|hormones|mesh-ancestor
55855755|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855756|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855757|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55855758|NCT00530764|Nabiximols|nabiximols|mesh-list
55855759|NCT00530764|Dronabinol|dronabinol|mesh-list
55855760|NCT00530764|Cannabidiol|cannabidiol|mesh-list
55855761|NCT00530764|Analgesics|analgesics|mesh-ancestor
55855762|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
55855763|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855764|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855765|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
55855766|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
55855767|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55855768|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55855769|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55855770|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55855771|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855772|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855773|NCT00530764|Hormones|hormones|mesh-ancestor
55855774|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855775|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55855776|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55855777|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55855778|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55855779|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855780|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855781|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855782|NCT00532480|Analgesics|analgesics|mesh-ancestor
55855789|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855790|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
55855791|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
55855792|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55855793|NCT00483496|Protective Agents|protective agents|mesh-ancestor
55855794|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855795|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
55855796|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55855797|NCT00485836|Ranibizumab|ranibizumab|mesh-list
55855798|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55855799|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55855800|NCT00485836|Growth Substances|growth substances|mesh-ancestor
55855801|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855802|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
55855803|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855804|NCT00488488|Tigecycline|tigecycline|mesh-list
55855805|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55855806|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55855807|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55855808|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855809|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855811|NCT04149574|BCG Vaccine|bcg vaccine|mesh-list
55855812|NCT04149574|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55855813|NCT04149574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855815|NCT04149574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855816|NCT04149574|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55855817|NCT04149574|Immunologic Factors|immunologic factors|mesh-ancestor
55855818|NCT04149574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855819|NCT01450761|Carboplatin|carboplatin|mesh-list
55855820|NCT01450761|Etoposide|etoposide|mesh-list
55855821|NCT01450761|Ipilimumab|ipilimumab|mesh-list
55855822|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855831|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55855832|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
55855833|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55855834|NCT00538642|Ziprasidone|ziprasidone|mesh-list
55855835|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55855836|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
55855837|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55855838|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855839|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855840|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55855841|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55855842|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855843|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55855844|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55855846|NCT01433991|Lenvatinib|lenvatinib|mesh-list
55855847|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855848|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55855849|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855850|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855851|NCT01450683|Itraconazole|itraconazole|mesh-list
55855852|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
55855853|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55855854|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55855855|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55855856|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855857|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855858|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55855859|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
55855873|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55855874|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855875|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55855877|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
55855878|NCT01412229|Paclitaxel|paclitaxel|mesh-list
55855879|NCT01412229|Carboplatin|carboplatin|mesh-list
55855880|NCT01412229|Cetuximab|cetuximab|mesh-list
55855881|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55855882|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855883|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
55855884|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
55855885|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
55855886|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855887|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55855888|NCT01432275|Insulin|insulin|mesh-list
55855889|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55855890|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855891|NCT01411995|Lidocaine|lidocaine|mesh-list
55855892|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
55855893|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
55855894|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855895|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855896|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
55855897|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855898|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55855921|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
55855922|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55855923|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55855924|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855925|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55855926|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855927|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55855928|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55855929|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855930|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55855931|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55855932|NCT01447407|Vaccines|vaccines|mesh-list
55855933|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
55855934|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
55855935|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855936|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55855937|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55855938|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
55855939|NCT00540982|Vinorelbine|vinorelbine|mesh-list
55855940|NCT00540982|Lidocaine|lidocaine|mesh-list
55855942|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
55855943|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55855944|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855945|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
55855946|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55855947|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55855948|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55855949|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55855950|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55855959|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55855960|NCT00542620|Insulin|insulin|mesh-list
55855961|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55855962|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
55855963|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
55855964|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55855965|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
55855966|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55855967|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855968|NCT00543400|Heparin|heparin|mesh-list
55855969|NCT00543400|Calcium heparin|calcium heparin|mesh-list
55855970|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
55855971|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55855972|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55855973|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855974|NCT01796938|Lacosamide|lacosamide|mesh-list
55855975|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
55855976|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55855977|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55855978|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55855979|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855980|NCT00492544|Vaccines|vaccines|mesh-list
55855981|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
55855982|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55855983|NCT00492622|Omeprazole|omeprazole|mesh-list
55855984|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55855985|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55855986|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55855987|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55855988|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55855989|NCT00494494|Nepafenac|nepafenac|mesh-list
55855990|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55855991|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55856001|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818789|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
55856002|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55856003|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55856004|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856005|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856007|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856008|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856009|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856010|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55856011|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55856012|NCT00498550|Clozapine|clozapine|mesh-list
55856013|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55856014|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
55856015|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856016|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856017|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856018|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55856019|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55856020|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856021|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55856022|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
55856023|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
55856024|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55856025|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
55856026|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55856027|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55856028|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55856029|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856030|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856031|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55856032|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55856033|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856034|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856035|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55856036|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
55856037|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856038|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856040|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
55856041|NCT00499408|Vitamins|vitamins|mesh-ancestor
55856042|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
55856043|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856044|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55856045|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55856046|NCT03019666|Niacinamide|niacinamide|mesh-list
55856047|NCT03019666|Niacin|niacin|mesh-list
55856048|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
55856049|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
55856050|NCT03019666|Vitamins|vitamins|mesh-ancestor
55856051|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
55856052|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856053|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55856054|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
55856055|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856056|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55856057|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
55856058|NCT03495388|Oxycodone|oxycodone|mesh-list
55856059|NCT03495388|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55856060|NCT03495388|Narcotics|narcotics|mesh-ancestor
55856061|NCT03495388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856062|NCT03495388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856063|NCT03495388|Analgesics|analgesics|mesh-ancestor
55856087|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55856088|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856089|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
55856090|NCT00500656|Coagulants|coagulants|mesh-ancestor
55856561|NCT04415983|Metronidazole|metronidazole|mesh-list
55856091|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55856092|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55856094|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
55856095|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856096|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856097|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856098|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856099|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55856100|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
55856101|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55856102|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856103|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
55856104|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
55856105|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55856106|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856107|NCT01445847|Lidocaine|lidocaine|mesh-list
55856108|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
55856109|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
55856110|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856111|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856112|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
55856113|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856130|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856132|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55856133|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
55856134|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55856135|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
55856136|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856137|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55856138|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55856139|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
55856140|NCT00545974|Memantine|memantine|mesh-list
55856141|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55856142|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55856143|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
55856144|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856145|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856146|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856147|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55856148|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55856149|NCT00548470|Varenicline|varenicline|mesh-list
55856150|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55856151|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55856152|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
55856153|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856154|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856155|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856156|NCT02675452|Itraconazole|itraconazole|mesh-list
55856157|NCT02675452|Azacitidine|azacitidine|mesh-list
55856158|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55856159|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
55856160|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856170|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856171|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55856172|NCT00509002|Gefitinib|gefitinib|mesh-list
55856173|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856174|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55856175|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856176|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856177|NCT00887380|Anastrozole|anastrozole|mesh-list
55856179|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856180|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55856181|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55856182|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856183|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856184|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55856185|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
55856186|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856187|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856188|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
55856189|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856190|NCT00557284|Montelukast|montelukast|mesh-list
55856191|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55856192|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
55856193|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55856194|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
55856195|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856196|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856197|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55856198|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55856199|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856200|NCT00557362|Voriconazole|voriconazole|mesh-list
55856202|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
55856203|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856204|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55856205|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55856206|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856207|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856208|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55856209|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
55856270|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
55856271|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55856272|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856273|NCT01429077|Levodopa|levodopa|mesh-list
55856274|NCT01429077|Carbidopa|carbidopa|mesh-list
55856275|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55856276|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55856277|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
55856278|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856279|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856280|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856281|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55856282|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856283|NCT01408563|Fludarabine|fludarabine|mesh-list
55856284|NCT01408563|Melphalan|melphalan|mesh-list
55856285|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856286|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856287|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856288|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
55856289|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856290|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55856291|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
55856292|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55856293|NCT01442493|Methadone|methadone|mesh-list
55856294|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55856295|NCT01442493|Narcotics|narcotics|mesh-ancestor
55856296|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856297|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856298|NCT01442493|Analgesics|analgesics|mesh-ancestor
55856299|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
55856311|NCT01428063|Interferons|interferons|mesh-list
55856312|NCT01428063|Ribavirin|ribavirin|mesh-list
55856313|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
55856314|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
55856315|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55856316|NCT01428063|Asunaprevir|asunaprevir|mesh-list
55856317|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856318|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
55856319|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856320|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
55856321|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856322|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
55856323|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856324|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
55856325|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856326|NCT00513292|Paclitaxel|paclitaxel|mesh-list
55856327|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
55856328|NCT00513292|Trastuzumab|trastuzumab|mesh-list
55856329|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55856330|NCT00513292|Epirubicin|epirubicin|mesh-list
55856331|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55856332|NCT00513292|Antibodies|antibodies|mesh-list
55856333|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
55856339|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
55856340|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856341|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856342|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
55856562|NCT04415983|Clarithromycin|clarithromycin|mesh-list
55856343|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856344|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856345|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55856346|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
55856347|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55856348|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55856349|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55856350|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55856351|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856352|NCT00513370|Adalimumab|adalimumab|mesh-list
55856353|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856354|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856355|NCT00559468|Bromides|bromides|mesh-list
55856356|NCT00559468|Propofol|propofol|mesh-list
55856357|NCT00559468|Sevoflurane|sevoflurane|mesh-list
55856358|NCT00559468|Rocuronium|rocuronium|mesh-list
55856359|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55856360|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856361|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856362|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55856363|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
55856364|NCT00559468|Anesthetics|anesthetics|mesh-ancestor
55856365|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55856366|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55856367|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
55856368|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55856369|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55856370|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55856371|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856372|NCT00513526|Vaccines|vaccines|mesh-list
55856373|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
55856374|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856396|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55856397|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55856398|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55856399|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
55856400|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856401|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856402|NCT00563290|Dasatinib|dasatinib|mesh-list
55856403|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856404|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55856405|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856406|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856407|NCT00556504|Ribavirin|ribavirin|mesh-list
55856408|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55856417|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55856418|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55856419|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
55856420|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856421|NCT00520234|Caspofungin|caspofungin|mesh-list
55856422|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
55856423|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856424|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856425|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856427|NCT00520468|Prednisone|prednisone|mesh-list
55856428|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
55856429|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
55856430|NCT00520468|Cyclosporins|cyclosporins|mesh-list
55856431|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856432|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
55856434|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856435|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856436|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55856437|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856438|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856439|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856440|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856441|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
55856442|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
55856443|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856444|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
55856445|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856446|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55856447|NCT00520468|Hematinics|hematinics|mesh-ancestor
55856448|NCT05560516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55856450|NCT05560516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55856468|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856469|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856470|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
55856471|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856472|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856473|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
55856474|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856475|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856476|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55856477|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55856480|NCT01441635|Estradiol|estradiol|mesh-list
55856481|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55856482|NCT01441635|Progesterone|progesterone|mesh-list
55856483|NCT01441635|Estrogens|estrogens|mesh-ancestor
55856484|NCT01441635|Hormones|hormones|mesh-ancestor
55856485|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856486|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856487|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55856488|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
55856489|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55856490|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55856491|NCT01441635|Progestins|progestins|mesh-ancestor
55856492|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55856493|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55856494|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55856495|NCT01427907|Calcium|calcium|mesh-list
55856496|NCT01427907|Sevelamer|sevelamer|mesh-list
55856497|NCT01427907|Calcium acetate|calcium acetate|mesh-list
55856498|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55856499|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856500|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
55856501|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
55856502|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856503|NCT02985333|Dexamethasone|dexamethasone|mesh-list
55856504|NCT02985333|Paclitaxel|paclitaxel|mesh-list
55856508|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
55856509|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
55856510|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
55856511|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856512|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856513|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
55856514|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856516|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55856517|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
55856518|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55856519|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856520|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
55856521|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
55856522|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856523|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55856524|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
55856525|NCT02985333|Hormones|hormones|mesh-ancestor
55856526|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856527|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55856528|NCT01427751|Dexamethasone|dexamethasone|mesh-list
55856529|NCT01427751|Ranibizumab|ranibizumab|mesh-list
55856530|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856531|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
55856532|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
55856533|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856534|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856535|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55856536|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
55856537|NCT01427751|Hormones|hormones|mesh-ancestor
55856538|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856540|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856551|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856552|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55856553|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856555|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
55856556|NCT01426347|Vitamins|vitamins|mesh-ancestor
55856557|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
55856558|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856559|NCT01426347|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55856560|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55856563|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
55856564|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
55856565|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856566|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55856567|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55856568|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55856569|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55856570|NCT04415983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856571|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856572|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55856573|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55856574|NCT01426269|Metronidazole|metronidazole|mesh-list
55856575|NCT01426269|Doxycycline|doxycycline|mesh-list
55856576|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856577|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55856578|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55856579|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55856580|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
55856581|NCT01426113|Timolol|timolol|mesh-list
55856582|NCT01426113|Bimatoprost|bimatoprost|mesh-list
55856583|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55856584|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55856585|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55856592|NCT01426113|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55856593|NCT01393899|Tofacitinib|tofacitinib|mesh-list
55856594|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55856595|NCT01393899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856596|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856597|NCT02078193|Abatacept|abatacept|mesh-list
55856598|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55856599|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856600|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856601|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856602|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
55856603|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856604|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856605|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55856606|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55856608|NCT01405911|Incretins|incretins|mesh-ancestor
55856650|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55856651|NCT01392573|Liraglutide|liraglutide|mesh-list
55856652|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
55856653|NCT01392573|Xultophy|xultophy|mesh-list
55856654|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55856655|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856656|NCT01392573|Incretins|incretins|mesh-ancestor
55856657|NCT01392573|Hormones|hormones|mesh-ancestor
55856658|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856659|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
55856660|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856661|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55856662|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856663|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856664|NCT01405053|Rufinamide|rufinamide|mesh-list
55856665|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
55856666|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55856667|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55856668|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55856669|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856670|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55856671|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
55856672|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856673|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
55856674|NCT01392183|Sirolimus|sirolimus|mesh-list
55856675|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55856676|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856677|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55856678|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856679|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
55856680|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856693|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55856694|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
55856696|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856697|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856698|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55856699|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
55856701|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55856702|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856703|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55856704|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55856705|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856708|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55856709|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55856710|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55856711|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55856712|NCT01402947|Analgesics|analgesics|mesh-ancestor
55856713|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
55856714|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856715|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856716|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856717|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856718|NCT03025893|Sunitinib|sunitinib|mesh-list
55856719|NCT03025893|Lomustine|lomustine|mesh-list
55856720|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856721|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55856722|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55856723|NCT03025893|Growth Substances|growth substances|mesh-ancestor
55856724|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856732|NCT01402869|Epinephrine|epinephrine|mesh-list
55856733|NCT01402869|Prilocaine|prilocaine|mesh-list
55856734|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
55856735|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
55856736|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856737|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856738|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
55856739|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856740|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55856741|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55856742|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55856743|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55856744|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856745|NCT01402869|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55856746|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55856747|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
55856748|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856749|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55856750|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55856751|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
55856786|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856787|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
55856788|NCT04558736|Fludarabine|fludarabine|mesh-list
55856789|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
55856790|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55856791|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856792|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
55856793|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856794|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856795|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55856796|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
55856797|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856798|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856799|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55856800|NCT01422213|Vortioxetine|vortioxetine|mesh-list
55856801|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
55856802|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55856803|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55856804|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55856805|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856806|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856807|NCT01422213|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55856808|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55856809|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55856812|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
55856813|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55856814|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55856815|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55856827|NCT04036305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856828|NCT04036305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55856829|NCT04036305|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55856830|NCT04036305|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55856831|NCT04036305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55856832|NCT04036305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856833|NCT01725386|Capecitabine|capecitabine|mesh-list
55856834|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55856835|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
55856836|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856837|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856839|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
55856840|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
55856841|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856842|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856843|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
55856844|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856845|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55856846|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55856847|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55856848|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55856849|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856851|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55856852|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55856853|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856854|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
55856855|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856856|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856857|NCT01891669|PF-06263507|pf-06263507|mesh-list
55856858|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55856859|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856863|NCT01421511|Linezolid|linezolid|mesh-list
55856865|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856866|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55856867|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856868|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856870|NCT01891357|Trastuzumab|trastuzumab|mesh-list
55856871|NCT01891357|Lapatinib|lapatinib|mesh-list
55856872|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55856873|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856874|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
55856875|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
55856876|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
55856877|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818969|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
55856878|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55856879|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55856880|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856881|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
55856882|NCT01420965|Antibodies|antibodies|mesh-list
55856883|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
55856884|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856885|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
55856886|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856887|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55856888|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55856889|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
55856890|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856891|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856892|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55856893|NCT04033575|Listerine|listerine|mesh-list
55856894|NCT04033575|Fluorides|fluorides|mesh-list
55856911|NCT01390389|Vitamins|vitamins|mesh-ancestor
55856912|NCT03835533|Nivolumab|nivolumab|mesh-list
55856913|NCT03835533|Poly ICLC|poly iclc|mesh-list
55856914|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55856915|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856916|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55856917|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856918|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
55856919|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
55856920|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856921|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
55856922|NCT01401465|Ciclesonide|ciclesonide|mesh-list
55856923|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55856924|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
55856925|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55856926|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
55856927|NCT01401465|Hormones|hormones|mesh-ancestor
55856928|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55856929|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856930|NCT01890967|Atorvastatin|atorvastatin|mesh-list
55856931|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55856932|NCT01890967|Simvastatin|simvastatin|mesh-list
55856933|NCT01890967|Ezetimibe|ezetimibe|mesh-list
55856934|NCT01890967|Pravastatin|pravastatin|mesh-list
55856935|NCT01890967|Pitavastatin|pitavastatin|mesh-list
55856936|NCT01890967|Lovastatin|lovastatin|mesh-list
55856937|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55856938|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55856939|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
55856940|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856941|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55856942|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55856943|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856945|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55856946|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55856947|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856948|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856949|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
55856950|NCT01614769|Glimepiride|glimepiride|mesh-list
55856951|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55856952|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55856953|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856954|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55856955|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
55856956|NCT01614457|Ivacaftor|ivacaftor|mesh-list
55856957|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55856958|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55856959|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856960|NCT04590781|Pembrolizumab|pembrolizumab|mesh-list
55856961|NCT04590781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55856962|NCT04590781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55856963|NCT01835431|Insulin|insulin|mesh-list
55856964|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55856965|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
55856966|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
55856967|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55856968|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
55856969|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55856970|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856972|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
55856973|NCT01880593|Analgesics|analgesics|mesh-ancestor
55856974|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
55856975|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55856976|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55856980|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
55856981|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55856982|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55856983|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55856984|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55856985|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856986|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
55856987|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55856988|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856989|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
55856990|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55856991|NCT01880515|Tetracycline|tetracycline|mesh-list
55856992|NCT01880515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55856993|NCT01880515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55856994|NCT01880515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55856995|NCT01880515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55856996|NCT01880515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55856998|NCT01400451|Vemurafenib|vemurafenib|mesh-list
55856999|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55857000|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857001|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55857002|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857006|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55857007|NCT01400139|Narcotics|narcotics|mesh-ancestor
55857008|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857025|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
55857026|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55857027|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55857028|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55857029|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857030|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857031|NCT01724528|Allopurinol|allopurinol|mesh-list
55857033|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
55857034|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857035|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857036|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
55857037|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857038|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55857039|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
55857040|NCT01724528|Protective Agents|protective agents|mesh-ancestor
55857086|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857087|NCT01388361|Insulin|insulin|mesh-list
55857088|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55857089|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
55857090|NCT01388361|Liraglutide|liraglutide|mesh-list
55857091|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55857092|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857093|NCT01388361|Incretins|incretins|mesh-ancestor
55857094|NCT01388361|Hormones|hormones|mesh-ancestor
55857095|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857096|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
55857097|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55857098|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857099|NCT01399125|Rivastigmine|rivastigmine|mesh-list
55857100|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55857101|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857102|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857103|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
55857104|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857105|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857106|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55857107|NCT01399125|Protective Agents|protective agents|mesh-ancestor
55857110|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857111|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55857112|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
55857113|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55857114|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857115|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857116|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857117|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55857118|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55857119|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
55857120|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55857121|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857122|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857123|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55857124|NCT04040439|Analgesics|analgesics|mesh-ancestor
55857125|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
55857126|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857127|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55857128|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55857129|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55857130|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
55857131|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857132|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857133|NCT04012827|Doxorubicin|doxorubicin|mesh-list
55857134|NCT04012827|Apatinib|apatinib|mesh-list
55857135|NCT04012827|Ifosfamide|ifosfamide|mesh-list
55857136|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55857137|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857138|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55857139|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55857140|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857141|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857142|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55857143|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55857144|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
55857145|NCT01879579|Insulin|insulin|mesh-list
55857146|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55857147|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857149|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55857150|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
55857151|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857152|NCT01386645|Expectorants|expectorants|mesh-ancestor
55857153|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
55857154|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55857155|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
55857156|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857157|NCT01386645|Protective Agents|protective agents|mesh-ancestor
55857159|NCT01386645|Antidotes|antidotes|mesh-ancestor
55857164|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55857165|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
55857166|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55857167|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857168|NCT01830595|Lactoferrin|lactoferrin|mesh-list
55857169|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857170|NCT01748162|Fluticasone|fluticasone|mesh-list
55857171|NCT01748162|Prednisolone|prednisolone|mesh-list
55857172|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857173|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55857174|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
55857175|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857176|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857177|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55857178|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
55857179|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
55857180|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55857181|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
55857183|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857184|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55857185|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857187|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
55857188|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
55857189|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857190|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857191|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857192|NCT01830127|Ribavirin|ribavirin|mesh-list
55857193|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
55857194|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857195|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
55857196|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857197|NCT01614067|Ganirelix|ganirelix|mesh-list
55857198|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
55857199|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857200|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857201|NCT01397409|Ranibizumab|ranibizumab|mesh-list
55857202|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55857203|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55857204|NCT01397409|Growth Substances|growth substances|mesh-ancestor
55857205|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857206|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
55857207|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857208|NCT04766775|Fluorides|fluorides|mesh-list
55857209|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
55857222|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857223|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857224|NCT03024879|Erythromycin|erythromycin|mesh-list
55857225|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
55857226|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55857227|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
55857228|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55857229|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857230|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55857231|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55857232|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857233|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857234|NCT01383993|Voriconazole|voriconazole|mesh-list
55857235|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
55857236|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857237|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55857238|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55819026|NCT01816048|Fluorides|fluorides|mesh-list
55857239|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857240|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857241|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55857242|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
55857246|NCT05365035|Cytarabine|cytarabine|mesh-list
55857274|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857275|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55857277|NCT01396083|Hormones|hormones|mesh-ancestor
55857278|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857279|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55857280|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857281|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55857282|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55857283|NCT01396083|Growth Substances|growth substances|mesh-ancestor
55857284|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
55857285|NCT01776008|Anastrozole|anastrozole|mesh-list
55857286|NCT01776008|Goserelin|goserelin|mesh-list
55857287|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55857288|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857289|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55857290|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55857291|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857292|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857293|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55857294|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
55857295|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857296|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857298|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55857299|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857300|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
55857301|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
55857302|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
55857303|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857304|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
55857305|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
55857306|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857307|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55857312|NCT01396005|Naloxone|naloxone|mesh-list
55857313|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55857314|NCT01396005|Narcotics|narcotics|mesh-ancestor
55857315|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857316|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857317|NCT01396005|Analgesics|analgesics|mesh-ancestor
55857318|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
55857319|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857320|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55857321|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
55857322|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
55857323|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
55857324|NCT03024957|Morphine|morphine|mesh-list
55857325|NCT03024957|Bupivacaine|bupivacaine|mesh-list
55857326|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
55857327|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
55857328|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857329|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857330|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
55857331|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857332|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55857333|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55857334|NCT03024957|Analgesics|analgesics|mesh-ancestor
55857335|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55857336|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55857337|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55857338|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
55857339|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857340|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857341|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55857342|NCT03024957|Narcotics|narcotics|mesh-ancestor
55857343|NCT03025113|Ketoprofen|ketoprofen|mesh-list
55857344|NCT03025113|Amitriptyline|amitriptyline|mesh-list
55857345|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
55857346|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55857348|NCT03025113|Analgesics|analgesics|mesh-ancestor
55857351|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857352|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857353|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857354|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55857355|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857356|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857357|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55857358|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
55857359|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55857360|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55857361|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55857362|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55857363|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857364|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55857365|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55857366|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55857367|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
55857368|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857369|NCT01877083|Lenvatinib|lenvatinib|mesh-list
55857370|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857371|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55857372|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857373|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857374|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
55857375|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857390|NCT05368623|Mydriatics|mydriatics|mesh-list
55857391|NCT05368623|Autonomic Agents|autonomic agents|mesh-ancestor
55857392|NCT05368623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857393|NCT05368623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857394|NCT01394523|Bupivacaine|bupivacaine|mesh-list
55857395|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
55857396|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
55857397|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857398|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857399|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
55857400|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857401|NCT05363553|Caseins|caseins|mesh-list
55857402|NCT05363553|Chelating Agents|chelating agents|mesh-ancestor
55857403|NCT05363553|Sequestering Agents|sequestering agents|mesh-ancestor
55857404|NCT05363553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857406|NCT01857583|Edoxaban|edoxaban|mesh-list
55857449|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857453|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857454|NCT05631795|Fulvestrant|fulvestrant|mesh-list
55857455|NCT05631795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55857456|NCT05631795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857457|NCT05631795|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55857458|NCT05631795|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55857459|NCT05631795|Hormone Antagonists|hormone antagonists|mesh-ancestor
55857460|NCT05631795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857461|NCT05631795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857462|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55857463|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857464|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55857465|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857466|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857467|NCT01721486|Acetaminophen|acetaminophen|mesh-list
55857468|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55857469|NCT01721486|Analgesics|analgesics|mesh-ancestor
55857470|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
55857500|NCT05631405|Autonomic Agents|autonomic agents|mesh-ancestor
55857501|NCT05631405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857502|NCT05631405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857503|NCT05631405|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55857504|NCT05631405|Glucocorticoids|glucocorticoids|mesh-ancestor
55857505|NCT05631405|Hormones|hormones|mesh-ancestor
55857506|NCT05631405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857507|NCT05631405|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55857508|NCT05631405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857509|NCT04007055|Ticagrelor|ticagrelor|mesh-list
55857510|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55857511|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55857512|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55857513|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55857514|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
55857515|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857516|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857517|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857518|NCT01721330|Naltrexone|naltrexone|mesh-list
55857519|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55857520|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55857521|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857522|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
55857523|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857524|NCT03595683|Pembrolizumab|pembrolizumab|mesh-list
55857525|NCT03595683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55857526|NCT03595683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857527|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
55857528|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55857529|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857532|NCT05634057|Anisodamine|anisodamine|mesh-list
55857539|NCT05634057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55857540|NCT05634057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55857541|NCT05634057|Adrenergic Agents|adrenergic agents|mesh-ancestor
55857542|NCT05634057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857543|NCT05634057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857544|NCT05634057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55857545|NCT05634057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55857546|NCT05634057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55857547|NCT05634057|Analgesics|analgesics|mesh-ancestor
55857548|NCT05634057|Sensory System Agents|sensory system agents|mesh-ancestor
55857549|NCT05634057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857550|NCT05634057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857551|NCT05634057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857552|NCT05634057|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55857553|NCT05634057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55857554|NCT05634057|Parasympatholytics|parasympatholytics|mesh-ancestor
55857555|NCT05634057|Autonomic Agents|autonomic agents|mesh-ancestor
55857556|NCT05634057|Vasodilator Agents|vasodilator agents|mesh-ancestor
55857557|NCT05634057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55857558|NCT05634057|Antioxidants|antioxidants|mesh-ancestor
55857559|NCT05634057|Protective Agents|protective agents|mesh-ancestor
55857560|NCT03596385|Metoprolol|metoprolol|mesh-list
55857561|NCT03596385|Atenolol|atenolol|mesh-list
55857562|NCT03596385|Carvedilol|carvedilol|mesh-list
55857563|NCT03596385|Bisoprolol|bisoprolol|mesh-list
55857564|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55857565|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55857566|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55857588|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857589|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857590|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55857591|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55857592|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55857593|NCT03758781|Nivolumab|nivolumab|mesh-list
55857594|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55857595|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857596|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55857597|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857598|NCT05633667|Paclitaxel|paclitaxel|mesh-list
55857599|NCT05633667|Docetaxel|docetaxel|mesh-list
55857600|NCT05633667|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55857601|NCT05633667|Carboplatin|carboplatin|mesh-list
55857602|NCT05633667|Pemetrexed|pemetrexed|mesh-list
55857603|NCT05633667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55857604|NCT05633667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857605|NCT05633667|Tubulin Modulators|tubulin modulators|mesh-ancestor
55857606|NCT05633667|Antimitotic Agents|antimitotic agents|mesh-ancestor
55857607|NCT05633667|Mitosis Modulators|mitosis modulators|mesh-ancestor
55857608|NCT05633667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857609|NCT05633667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857610|NCT05633667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55857611|NCT05633667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55857612|NCT01828021|Margetuximab|margetuximab|mesh-list
55857613|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857614|NCT03784599|Trastuzumab|trastuzumab|mesh-list
55857615|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55857616|NCT03784599|Osimertinib|osimertinib|mesh-list
55857617|NCT03784599|Maytansine|maytansine|mesh-list
55857618|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55857619|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857620|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55857621|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857622|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857623|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55857624|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
55857625|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
55857626|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
55857627|NCT01827943|Sirolimus|sirolimus|mesh-list
55857628|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55857629|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857630|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55857631|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857632|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
55857633|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857634|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
55857635|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857636|NCT02985255|Docetaxel|docetaxel|mesh-list
55857637|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857638|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
55857639|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
55857640|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
55857641|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857642|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55857643|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857644|NCT00217971|Dronabinol|dronabinol|mesh-list
55857645|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
55857646|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857647|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55857648|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55857650|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
55857651|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857652|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55857653|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55857654|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857655|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857656|NCT00217971|Hormones|hormones|mesh-ancestor
55857657|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857658|NCT03976323|Cisplatin|cisplatin|mesh-list
55857659|NCT03976323|Carboplatin|carboplatin|mesh-list
55857660|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
55857661|NCT03976323|Pemetrexed|pemetrexed|mesh-list
55857662|NCT03976323|Olaparib|olaparib|mesh-list
55857663|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857664|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55857665|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857666|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857667|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55857668|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55857669|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55857670|NCT00217581|Bevacizumab|bevacizumab|mesh-list
55857671|NCT00217581|Docetaxel|docetaxel|mesh-list
55857692|NCT00217425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857693|NCT00217425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857694|NCT00217425|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55857695|NCT00217425|Alkylating Agents|alkylating agents|mesh-ancestor
55857696|NCT00217425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857697|NCT00217425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857698|NCT00217425|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55857699|NCT00217425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55857700|NCT00217425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55857701|NCT00217425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55857702|NCT00217425|Growth Substances|growth substances|mesh-ancestor
55857703|NCT00217425|Growth Inhibitors|growth inhibitors|mesh-ancestor
55857704|NCT00217425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55857705|NCT00217425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55857706|NCT00217425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55857707|NCT00217425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857708|NCT00217425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857709|NCT00217425|Glucocorticoids|glucocorticoids|mesh-ancestor
55857710|NCT00217425|Hormones|hormones|mesh-ancestor
55857711|NCT00217425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857712|NCT00217425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55857713|NCT00217425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55857714|NCT00217425|Tubulin Modulators|tubulin modulators|mesh-ancestor
55857715|NCT00217425|Antimitotic Agents|antimitotic agents|mesh-ancestor
55857716|NCT00217425|Mitosis Modulators|mitosis modulators|mesh-ancestor
55857717|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
55857718|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
55857719|NCT01856257|Abatacept|abatacept|mesh-list
55857720|NCT01856257|Tacrolimus|tacrolimus|mesh-list
55857722|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55857723|NCT01856257|Basiliximab|basiliximab|mesh-list
55857724|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857725|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
55857726|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857727|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55857730|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55857731|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857732|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55857733|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
55857734|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55857735|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857736|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857738|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
55857739|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857740|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55857741|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
55857742|NCT01856257|Hormones|hormones|mesh-ancestor
55857743|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857744|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55857745|NCT01856257|Protective Agents|protective agents|mesh-ancestor
55857746|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55857747|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857748|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
55857749|NCT00215943|Thalidomide|thalidomide|mesh-list
55857750|NCT00215943|Dexamethasone|dexamethasone|mesh-list
55857751|NCT00215943|Doxorubicin|doxorubicin|mesh-list
55857752|NCT00215943|Vincristine|vincristine|mesh-list
55857753|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55857754|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857755|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
55857756|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
55857757|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857758|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857759|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55857775|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
55857776|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
55857777|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55857778|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857779|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55857780|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55857781|NCT00215943|Growth Substances|growth substances|mesh-ancestor
55857782|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
55857783|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55857784|NCT03593811|Cyproheptadine|cyproheptadine|mesh-list
55857785|NCT03593811|Ondansetron|ondansetron|mesh-list
55857786|NCT03593811|Antiemetics|antiemetics|mesh-ancestor
55857787|NCT03593811|Autonomic Agents|autonomic agents|mesh-ancestor
55857788|NCT03593811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857789|NCT03593811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857790|NCT03593811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55857791|NCT03593811|Antipruritics|antipruritics|mesh-ancestor
55857792|NCT03593811|Dermatologic Agents|dermatologic agents|mesh-ancestor
55857793|NCT03593811|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55857794|NCT03593811|Serotonin Agents|serotonin agents|mesh-ancestor
55857795|NCT03593811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857796|NCT03593811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857797|NCT03593811|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55857798|NCT03593811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55857799|NCT03593811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857800|NCT03593811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55857801|NCT03593811|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55857802|NCT03593811|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55857803|NCT03593811|Histamine Antagonists|histamine antagonists|mesh-ancestor
55857822|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857824|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55857825|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55857826|NCT00211887|Interferons|interferons|mesh-list
55857827|NCT00211887|Interferon-beta|interferon-beta|mesh-list
55857828|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
55857829|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
55857830|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
55857831|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857832|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
55857833|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857834|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
55857835|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857836|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55857837|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857838|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857839|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55857840|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55857841|NCT04002297|Rituximab|rituximab|mesh-list
55857842|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55857843|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
55857844|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55857845|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857855|NCT03592485|Oxycodone|oxycodone|mesh-list
55857873|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55857874|NCT04199013|Narcotics|narcotics|mesh-ancestor
55857875|NCT04199013|Analgesics|analgesics|mesh-ancestor
55857876|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55857877|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55857878|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
55857879|NCT03989115|Osimertinib|osimertinib|mesh-list
55857880|NCT03989115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857881|NCT03989115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55857882|NCT03989115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857883|NCT03989115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857884|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
55857885|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55857886|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
55857887|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857888|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
55857889|NCT04198467|Protective Agents|protective agents|mesh-ancestor
55857890|NCT03599427|Lidocaine|lidocaine|mesh-list
55857891|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
55857892|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
55857893|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857894|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857896|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857897|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55857898|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55857899|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55857900|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55857901|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857903|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55857904|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
55857914|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55857915|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
55857916|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55857917|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55857918|NCT04198233|Diazepam|diazepam|mesh-list
55857919|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55857920|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
55857921|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
55857922|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
55857923|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55857924|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857925|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55857926|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55857927|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55857928|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55857929|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55857930|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55857931|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55857932|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55857933|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55857934|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
55857935|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
55857936|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
55857937|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
55857938|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55857939|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857940|NCT03987711|Warfarin|warfarin|mesh-list
55857941|NCT03987711|Apixaban|apixaban|mesh-list
55857942|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
55857943|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55857944|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
55857945|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55857946|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
55857947|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857948|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857949|NCT03591471|Prednisone|prednisone|mesh-list
55857957|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857958|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55857959|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
55857960|NCT03591471|Hormones|hormones|mesh-ancestor
55857961|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55857962|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55857963|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55857964|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
55857965|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55857966|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55857967|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857968|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55857969|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55857970|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55857972|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55857973|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
55857974|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55857975|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
55857976|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
55857977|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55857979|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55857980|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55857981|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
55857983|NCT03591003|Antibodies|antibodies|mesh-list
55858001|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858002|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55858003|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858004|NCT01855243|Insulin|insulin|mesh-list
55858005|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55858006|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55858007|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858008|NCT04196829|Fluorides|fluorides|mesh-list
55858009|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
55858010|NCT04196829|Protective Agents|protective agents|mesh-ancestor
55858011|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858012|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55858013|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
55858014|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55858015|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55858016|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55858017|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858018|NCT01854697|Interferons|interferons|mesh-list
55858019|NCT01854697|Ribavirin|ribavirin|mesh-list
55858020|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
55858021|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
55858022|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55858023|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858024|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
55858025|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858026|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
55858027|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858048|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858049|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858050|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55858051|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
55858053|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858054|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55858055|NCT03598725|Coagulants|coagulants|mesh-ancestor
55858056|NCT04766307|Interleukin-2|interleukin-2|mesh-list
55858057|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858058|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55858059|NCT04766307|Analgesics|analgesics|mesh-ancestor
55858060|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
55858061|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858062|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858063|NCT01875367|Trastuzumab|trastuzumab|mesh-list
55858064|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55858065|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858066|NCT04194957|Fluorouracil|fluorouracil|mesh-list
55858067|NCT04194957|Capecitabine|capecitabine|mesh-list
55858068|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
55858069|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858070|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55858071|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858073|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
55858074|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858075|NCT04191135|Gemcitabine|gemcitabine|mesh-list
55858094|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858096|NCT04171167|Xhance|xhance|mesh-list
55858097|NCT04171167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55858098|NCT04171167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55858099|NCT04171167|Autonomic Agents|autonomic agents|mesh-ancestor
55858100|NCT04171167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858101|NCT04171167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858102|NCT04171167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55858103|NCT04171167|Respiratory System Agents|respiratory system agents|mesh-ancestor
55858104|NCT04171167|Dermatologic Agents|dermatologic agents|mesh-ancestor
55858105|NCT04171167|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55858106|NCT04406883|Simvastatin|simvastatin|mesh-list
55858107|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55858108|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55858109|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
55858110|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858111|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55858112|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55858113|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858119|NCT04199325|Uric Acid|uric acid|mesh-list
55858120|NCT04199325|Antioxidants|antioxidants|mesh-ancestor
55858121|NCT04199325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858122|NCT04199325|Protective Agents|protective agents|mesh-ancestor
55858126|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
55858127|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
55858128|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858129|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858130|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55858131|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55858132|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
55858133|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858134|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858135|NCT03952299|Urological Agents|urological agents|mesh-ancestor
55858136|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55858137|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858138|NCT03952299|Renal Agents|renal agents|mesh-ancestor
55858139|NCT03597867|Diclofenac|diclofenac|mesh-list
55858140|NCT03597867|Indomethacin|indomethacin|mesh-list
55858141|NCT03597867|Nepafenac|nepafenac|mesh-list
55858142|NCT03597867|Bromfenac|bromfenac|mesh-list
55858143|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55858144|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55858146|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55858169|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858170|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55858171|NCT03597477|Analgesics|analgesics|mesh-ancestor
55858172|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
55858173|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858174|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55858175|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55858176|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55858177|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
55858178|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858179|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858180|NCT04193319|Fluconazole|fluconazole|mesh-list
55858181|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
55858182|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858183|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55858184|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55858185|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858186|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858187|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55858188|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
55858189|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858190|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858191|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55858192|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55858193|NCT04192617|Methotrexate|methotrexate|mesh-list
55858194|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55858195|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
55858196|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55858209|NCT04026009|Vaccines|vaccines|mesh-list
55858211|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858212|NCT01874665|Ponatinib|ponatinib|mesh-list
55858213|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858214|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55858215|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858216|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858217|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
55858218|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
55858219|NCT04028739|Curcumin|curcumin|mesh-list
55858220|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55858221|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55858222|NCT04028739|Analgesics|analgesics|mesh-ancestor
55858223|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
55858224|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858225|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858226|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55858227|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858228|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858229|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858230|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858231|NCT04028505|Terlipressin|terlipressin|mesh-list
55858232|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55858233|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55858234|NCT04190745|Paclitaxel|paclitaxel|mesh-list
55858235|NCT04190745|Apatinib|apatinib|mesh-list
55858236|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55858237|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858238|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
55858239|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
55858240|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
55858242|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55858250|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858251|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55858252|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55858253|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858255|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55858256|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55858257|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858258|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
55858259|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858260|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
55841917|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55858261|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55858262|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858263|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55858264|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858265|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858266|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
55858267|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
55858268|NCT04027959|Vitamins|vitamins|mesh-ancestor
55858269|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
55858270|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858271|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
55858272|NCT04027959|Hematinics|hematinics|mesh-ancestor
55858273|NCT04344951|Chloroquine|chloroquine|mesh-list
55858274|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
55858275|NCT04344951|Amebicides|amebicides|mesh-ancestor
55858276|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55858277|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55858278|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858279|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
55858283|NCT04344951|Analgesics|analgesics|mesh-ancestor
55858294|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858295|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858296|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55858297|NCT01822561|Diuretics|diuretics|mesh-ancestor
55858298|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
55858299|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55858300|NCT02080455|Atorvastatin|atorvastatin|mesh-list
55858301|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55858302|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55858303|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
55858304|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858305|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55858306|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55858307|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858308|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55858309|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
55858310|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858311|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
55858312|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55858313|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55858314|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858315|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
55858316|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55858317|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55858318|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55858319|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55858320|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858321|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
55858322|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858323|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858324|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55858325|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858326|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55858330|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858331|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
55858332|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858333|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858334|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55858335|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858336|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
55858337|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55858338|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55858339|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858340|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
55858341|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
55858342|NCT04199169|Vaccines|vaccines|mesh-list
55858343|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
55858344|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858345|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
55858346|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55858347|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55858348|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55858349|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
55858350|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
55858351|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55858352|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55858353|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
55858354|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55858355|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
55858356|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55858357|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
55858358|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858360|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55858361|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
55858362|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55858363|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55858364|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55858370|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55858371|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55858373|NCT01872715|Doxycycline|doxycycline|mesh-list
55858374|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55858375|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858376|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
55858377|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55858378|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55858379|NCT03932643|TIC10 compound|tic10 compound|mesh-list
55858380|NCT03932643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858381|NCT01613599|Rituximab|rituximab|mesh-list
55858382|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55858383|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858384|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
55858385|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858386|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858387|NCT03930771|Capecitabine|capecitabine|mesh-list
55858388|NCT03930771|Temozolomide|temozolomide|mesh-list
55858389|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55858390|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
55858391|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858392|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858393|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55858394|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
55858395|NCT04024683|Ropivacaine|ropivacaine|mesh-list
55858396|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
55858397|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
55858398|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55858399|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858400|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
55858402|NCT04024527|Amoxicillin|amoxicillin|mesh-list
55858412|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858413|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858414|NCT01819129|Insulin|insulin|mesh-list
55858415|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55858416|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
55858417|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
55858418|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
55858419|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55858420|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55858421|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858422|NCT04025775|Insulin|insulin|mesh-list
55858423|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55858424|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858425|NCT04022811|Tobramycin|tobramycin|mesh-list
55858426|NCT04022811|Dexamethasone|dexamethasone|mesh-list
55858427|NCT04022811|Bromfenac|bromfenac|mesh-list
55858428|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
55858429|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55858430|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
55858431|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
55858432|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858433|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858434|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55858435|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
55858436|NCT04022811|Hormones|hormones|mesh-ancestor
55858438|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55858439|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858440|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55858441|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858442|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55858443|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
55858444|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
55858445|NCT04022811|Protective Agents|protective agents|mesh-ancestor
55858446|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55858447|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55858448|NCT04022811|Analgesics|analgesics|mesh-ancestor
55858449|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
55858450|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858451|NCT04145583|Voriconazole|voriconazole|mesh-list
55858452|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
55858453|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858454|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55858455|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55858456|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858457|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858458|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55858459|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
55858460|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858461|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858462|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55858463|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
55858464|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
55858465|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55858466|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55858467|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858468|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858469|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858470|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858471|NCT04145193|Leucovorin|leucovorin|mesh-list
55858472|NCT04145193|Fluorouracil|fluorouracil|mesh-list
55858473|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
55858474|NCT04145193|Durvalumab|durvalumab|mesh-list
55858475|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55858476|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
55858478|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55858493|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55858494|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
55858495|NCT04147845|Hormones|hormones|mesh-ancestor
55858496|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858497|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858498|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55858499|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
55858500|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858501|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858502|NCT01849783|Thalidomide|thalidomide|mesh-list
55858503|NCT01849783|Dexamethasone|dexamethasone|mesh-list
55858504|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
55858505|NCT01849783|Melphalan|melphalan|mesh-list
55858506|NCT01849783|Doxorubicin|doxorubicin|mesh-list
55858507|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55858508|NCT01849783|Etoposide|etoposide|mesh-list
55858509|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
55858510|NCT01849783|Bortezomib|bortezomib|mesh-list
55858511|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55858512|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
55858514|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858515|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55858516|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
55858517|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858518|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858519|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55858541|NCT01611883|Ezetimibe|ezetimibe|mesh-list
55858542|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55858543|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55858544|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
55858545|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858546|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55858547|NCT04170517|Progesterone|progesterone|mesh-list
55858548|NCT04170517|Progestins|progestins|mesh-ancestor
55858549|NCT04170517|Hormones|hormones|mesh-ancestor
55858550|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858551|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858552|NCT01848457|Methotrexate|methotrexate|mesh-list
55858553|NCT01848457|Pantoprazole|pantoprazole|mesh-list
55858554|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55858555|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
55858556|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55858557|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858558|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55858559|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
55858560|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858561|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858562|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
55858563|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858564|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55858565|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55858589|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55858590|NCT01870921|Ticagrelor|ticagrelor|mesh-list
55858591|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55858592|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55858593|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55858594|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55858595|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
55858596|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858597|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858598|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858599|NCT00526474|Vorapaxar|vorapaxar|mesh-list
55858600|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55858601|NCT01848145|Ofatumumab|ofatumumab|mesh-list
55858602|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858603|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55858604|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55858605|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
55858607|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55858608|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858609|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858610|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858611|NCT01847443|Nicotine|nicotine|mesh-list
55858612|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55858613|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
55858614|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858615|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858616|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55858617|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55858618|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
55858619|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858620|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858621|NCT00527878|Ranitidine|ranitidine|mesh-list
55858622|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
55858623|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55858625|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55858626|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
55858627|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
55858628|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858629|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858630|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858632|NCT05558878|Expectorants|expectorants|mesh-ancestor
55858633|NCT05558878|Respiratory System Agents|respiratory system agents|mesh-ancestor
55858634|NCT05621668|Cyclophosphamide|cyclophosphamide|mesh-list
55858635|NCT05621668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55858636|NCT05621668|Immunologic Factors|immunologic factors|mesh-ancestor
55858637|NCT05621668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858638|NCT05621668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55858639|NCT05621668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55858640|NCT05621668|Alkylating Agents|alkylating agents|mesh-ancestor
55858641|NCT05621668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858642|NCT05621668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858643|NCT05621668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55858644|NCT05621434|Maleic acid|maleic acid|mesh-list
55858645|NCT05621434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858646|NCT05621434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858647|NCT04741204|Metformin|metformin|mesh-list
55858648|NCT04741204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55858649|NCT04741204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858650|NCT01870843|Citalopram|citalopram|mesh-list
55858651|NCT01870843|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55858652|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55858653|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55858666|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
55858667|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858668|NCT05618002|Clonidine|clonidine|mesh-list
55858669|NCT05618002|Lemborexant|lemborexant|mesh-list
55858670|NCT05618002|Zopiclone|zopiclone|mesh-list
55858671|NCT05618002|Analgesics|analgesics|mesh-ancestor
55858672|NCT05618002|Sensory System Agents|sensory system agents|mesh-ancestor
55858673|NCT05618002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858674|NCT05618002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858675|NCT05618002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55858676|NCT05618002|Sympatholytics|sympatholytics|mesh-ancestor
55858677|NCT05618002|Autonomic Agents|autonomic agents|mesh-ancestor
55858678|NCT05618002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55858679|NCT05618002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55858680|NCT05618002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55858681|NCT05618002|Adrenergic Agents|adrenergic agents|mesh-ancestor
55858682|NCT05618002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858683|NCT05618002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858684|NCT05618002|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55858685|NCT05618002|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55858686|NCT05618002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55858687|NCT05618002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55858689|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55858690|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55858713|NCT04699240|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55858714|NCT04699240|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55858715|NCT01610167|Listerine|listerine|mesh-list
55858716|NCT01610167|Fluorides|fluorides|mesh-list
55858717|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
55858718|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
55858719|NCT01610167|Protective Agents|protective agents|mesh-ancestor
55858720|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858721|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55858722|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858723|NCT04478500|Minocycline|minocycline|mesh-list
55858724|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55858725|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858726|NCT01816243|Fentanyl|fentanyl|mesh-list
55858727|NCT01816243|Morphine|morphine|mesh-list
55858728|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55858729|NCT01816243|Narcotics|narcotics|mesh-ancestor
55858730|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55858731|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858732|NCT01816243|Analgesics|analgesics|mesh-ancestor
55858733|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
55858768|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858769|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858770|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55858771|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
55858772|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
55858773|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55858774|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55858775|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55858776|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55858777|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
55858778|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55858779|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858780|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55858781|NCT04148872|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55858782|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858783|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858784|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55858785|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55858786|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858787|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
55858788|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819327|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55858818|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55858819|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55858820|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858821|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858822|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55858823|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55858824|NCT03667846|Topiramate|topiramate|mesh-list
55858825|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
55858826|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55858827|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858830|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55858831|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858832|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55858880|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55858881|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858882|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
55858883|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
55858884|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858886|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55858887|NCT03232138|Protective Agents|protective agents|mesh-ancestor
55858888|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858889|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858890|NCT01814137|Insulin|insulin|mesh-list
55858891|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55858892|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
55858893|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
55858894|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55858895|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55858896|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858897|NCT01813435|Aspirin|aspirin|mesh-list
55858898|NCT01813435|Clopidogrel|clopidogrel|mesh-list
55858899|NCT01813435|Ticagrelor|ticagrelor|mesh-list
55858900|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55858901|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55858902|NCT01813435|Analgesics|analgesics|mesh-ancestor
55858933|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55858934|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
55858935|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858936|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55858937|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55858938|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858939|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55858940|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858941|NCT03944902|Niraparib|niraparib|mesh-list
55858942|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55858943|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858944|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858945|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858946|NCT01811953|Metformin|metformin|mesh-list
55858947|NCT01811953|Empagliflozin|empagliflozin|mesh-list
55858948|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55858949|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858950|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55858951|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858952|NCT03895762|Fentanyl|fentanyl|mesh-list
55858953|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55858954|NCT03895762|Narcotics|narcotics|mesh-ancestor
55858955|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55858956|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55858957|NCT03895762|Analgesics|analgesics|mesh-ancestor
55858958|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
55858959|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55858960|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55858978|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55858979|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55858980|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
55858981|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55858982|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
55858983|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55858986|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
55858987|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55858988|NCT00997906|Gemcitabine|gemcitabine|mesh-list
55858989|NCT00997906|Paclitaxel|paclitaxel|mesh-list
55858990|NCT00997906|Carboplatin|carboplatin|mesh-list
55858991|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55858992|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55858993|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
55858994|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
55858995|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
55858996|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55858997|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55858998|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
55858999|NCT00997906|Antiviral Agents|antiviral agents|mesh-ancestor
55859000|NCT00997906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859001|NCT00997906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859031|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55859032|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55859033|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55859034|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859035|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859036|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
55859037|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
55859038|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859039|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859040|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859041|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
55859042|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
55859043|NCT04170283|Zanubrutinib|zanubrutinib|mesh-list
55859044|NCT04170283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859045|NCT04170283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55859046|NCT04170283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859047|NCT04170283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859048|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55859049|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55859050|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859051|NCT01613131|Estradiol|estradiol|mesh-list
55859052|NCT01613131|Estrogens|estrogens|mesh-ancestor
55859053|NCT01613131|Hormones|hormones|mesh-ancestor
55859054|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859055|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859056|NCT05362942|Cytarabine|cytarabine|mesh-list
55859079|NCT03481972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55859080|NCT03481972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859081|NCT03481972|Antimalarials|antimalarials|mesh-ancestor
55859083|NCT03481972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55859084|NCT03481972|Antiviral Agents|antiviral agents|mesh-ancestor
55859085|NCT03481972|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55859086|NCT03481972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55859087|NCT01868503|Lapatinib|lapatinib|mesh-list
55859088|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859089|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55859090|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859091|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859093|NCT05204368|Imipenem|imipenem|mesh-list
55859094|NCT05204368|Cilastatin|cilastatin|mesh-list
55859095|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55859096|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859097|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
55859098|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859099|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859100|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
55859101|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859102|NCT04414969|Asparaginase|asparaginase|mesh-list
55859103|NCT04414969|Pegaspargase|pegaspargase|mesh-list
55859104|NCT04414969|Antibodies|antibodies|mesh-list
55859105|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
55859106|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
55859107|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859108|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859109|NCT03293680|Pembrolizumab|pembrolizumab|mesh-list
55859110|NCT03293680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55859111|NCT03293680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859112|NCT01609933|Interferons|interferons|mesh-list
55859113|NCT01609933|Ritonavir|ritonavir|mesh-list
55859114|NCT01609933|Ribavirin|ribavirin|mesh-list
55859115|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
55859117|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55859118|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859119|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
55859120|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859121|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55859122|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55859123|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
55859124|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859125|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859126|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55859127|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55859128|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55859129|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55859130|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
55859131|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
55859132|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859133|NCT05361772|Colchicine|colchicine|mesh-list
55859134|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
55859135|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55859136|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
55859137|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
55859138|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
55859139|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859140|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859142|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55859143|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859144|NCT03001882|Nivolumab|nivolumab|mesh-list
55859145|NCT03001882|Ipilimumab|ipilimumab|mesh-list
55859158|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
55859160|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859161|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55859162|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859163|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55859164|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859165|NCT01867021|Vaccines|vaccines|mesh-list
55859166|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
55859167|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859168|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
55859169|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
55859170|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
55859171|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859172|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
55859173|NCT01841593|Amlodipine|amlodipine|mesh-list
55859174|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55859175|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55859176|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55859177|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859178|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55859179|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859180|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
55859182|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55859183|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
55859184|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859185|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55859202|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55859203|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55859204|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859205|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
55859206|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859207|NCT05183854|Vaccines|vaccines|mesh-list
55859208|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55859209|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
55859210|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859211|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
55859213|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
55859214|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859215|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859216|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
55859217|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859218|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55859219|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
55859220|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55859221|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55859222|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859223|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55859224|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
55859225|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55859226|NCT04505566|Ketorolac|ketorolac|mesh-list
55859227|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55859228|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
55859229|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55859230|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55859231|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55859243|NCT05076292|Hormones|hormones|mesh-ancestor
55859244|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859245|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859246|NCT04789330|Phenylephrine|phenylephrine|mesh-list
55859247|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
55859248|NCT04789330|Norepinephrine|norepinephrine|mesh-list
55859249|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55859250|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
55859251|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
55859252|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859253|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859254|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
55859255|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55859256|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
55859257|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
55859258|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55859259|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55859260|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55859261|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
55859262|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859263|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859264|NCT04789330|Protective Agents|protective agents|mesh-ancestor
55859265|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
55859266|NCT02339038|Ledipasvir|ledipasvir|mesh-list
55859267|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
55859268|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859288|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859290|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
55859291|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
55859292|NCT04509622|Cytarabine|cytarabine|mesh-list
55859293|NCT04509622|Venetoclax|venetoclax|mesh-list
55859294|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55859295|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
55859296|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859297|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859298|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
55859299|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859300|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859301|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
55859302|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859303|NCT00570700|Dasatinib|dasatinib|mesh-list
55859304|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859305|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55859306|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859308|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
55859309|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55859310|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55859311|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
55859312|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859313|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859315|NCT00573508|Urological Agents|urological agents|mesh-ancestor
55859334|NCT03934840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859335|NCT03934840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859336|NCT03934840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55859337|NCT04259398|Propofol|propofol|mesh-list
55859338|NCT04259398|Sevoflurane|sevoflurane|mesh-list
55859339|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55859340|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859341|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859342|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55859343|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
55859344|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
55859345|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55859346|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55859347|NCT01592110|Risperidone|risperidone|mesh-list
55859348|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55859349|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
55859350|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859351|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859352|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859353|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55859354|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55859355|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859356|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55859357|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55859358|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
55859359|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
55859360|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
55859361|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
55859362|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55819856|NCT02014467|Vitamins|vitamins|mesh-ancestor
55859363|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
55859364|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859376|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55859377|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55859378|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55859379|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859380|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859381|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
55859382|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859383|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859385|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859386|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
55859387|NCT00580294|Oxymorphone|oxymorphone|mesh-list
55859388|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55859389|NCT00580294|Narcotics|narcotics|mesh-ancestor
55859390|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859391|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859392|NCT00580294|Analgesics|analgesics|mesh-ancestor
55859393|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
55859394|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859395|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55859396|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
55859397|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859398|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
55859399|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859400|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55859401|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55859402|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
55859403|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859404|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859405|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55859407|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55859408|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55859409|NCT02134210|Analgesics|analgesics|mesh-ancestor
55859410|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
55859411|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859412|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859413|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55859414|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55859415|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55859416|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859417|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
55859418|NCT00607594|Saracatinib|saracatinib|mesh-list
55859419|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859420|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859421|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859422|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
55859424|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55859425|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819917|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
55859426|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55859427|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859428|NCT00607672|Candesartan|candesartan|mesh-list
55859429|NCT00607672|Ramipril|ramipril|mesh-list
55859430|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55859431|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55859432|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55859433|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859434|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55859435|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
55859436|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859437|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55859438|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55859453|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55859454|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
55859455|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55859456|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55859457|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55859458|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859459|NCT00608062|Estradiol|estradiol|mesh-list
55859460|NCT00608062|Ganirelix|ganirelix|mesh-list
55859461|NCT00608062|Estrogens|estrogens|mesh-ancestor
55859462|NCT00608062|Hormones|hormones|mesh-ancestor
55859463|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859465|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
55859466|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
55859467|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55859468|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55859469|NCT02829268|Dantrolene|dantrolene|mesh-list
55859470|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55859471|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859472|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55859473|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859474|NCT02202772|Gemcitabine|gemcitabine|mesh-list
55859475|NCT02202772|Cisplatin|cisplatin|mesh-list
55859476|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859477|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55859478|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
55859479|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859480|NCT02202772|Antiviral Agents|antiviral agents|mesh-ancestor
55859481|NCT02202772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859482|NCT02202772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859483|NCT02202772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859484|NCT02202772|Immunologic Factors|immunologic factors|mesh-ancestor
55859485|NCT02202772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859486|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
55859487|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859488|NCT01801735|Meloxicam|meloxicam|mesh-list
55859492|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
55859493|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859494|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859495|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55859496|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819949|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
55859497|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55859498|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55859499|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859500|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859501|NCT01841359|Pramlintide|pramlintide|mesh-list
55859502|NCT01841359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55859582|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
55859503|NCT01841359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859504|NCT00612430|Bevacizumab|bevacizumab|mesh-list
55859505|NCT00612430|Etoposide|etoposide|mesh-list
55859506|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
55859507|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55859508|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859509|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55859510|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55859512|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859513|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
55859514|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55859515|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55859516|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55859517|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859518|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859519|NCT01571128|Tenofovir|tenofovir|mesh-list
55859520|NCT01571128|Emtricitabine|emtricitabine|mesh-list
55859521|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
55859522|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859523|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55859524|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55859525|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859526|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859527|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55859528|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55859529|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
55859530|NCT00614458|Valproic Acid|valproic acid|mesh-list
55859531|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55859532|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55859533|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
55859534|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859535|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55859536|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55859537|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859538|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859539|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
55859540|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
55859541|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859542|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859543|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
55859544|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55859545|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859546|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55859547|NCT01429168|Etoricoxib|etoricoxib|mesh-list
55859548|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55859549|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55859550|NCT01429168|Analgesics|analgesics|mesh-ancestor
55859551|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
55859552|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859553|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859554|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55859555|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55859556|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55859557|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55859558|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859559|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859560|NCT00771160|Montelukast|montelukast|mesh-list
55859566|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859567|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55859568|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55859569|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859570|NCT00756418|Theophylline|theophylline|mesh-list
55859571|NCT00756418|Montelukast|montelukast|mesh-list
55859572|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55859573|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
55859574|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55859575|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
55859576|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859577|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859578|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55859579|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55859580|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859581|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55859583|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859584|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55859586|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
55859587|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55859588|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55859589|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
55859590|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859591|NCT00615472|Remifentanil|remifentanil|mesh-list
55859592|NCT00615472|Propofol|propofol|mesh-list
55859593|NCT00615472|Isoflurane|isoflurane|mesh-list
55859594|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55859595|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859596|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859607|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859608|NCT00755794|Montelukast|montelukast|mesh-list
55819991|NCT01787188|Meloxicam|meloxicam|mesh-list
55859609|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55859610|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
55859611|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55859612|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
55859613|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859614|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859615|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55859616|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55859617|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859619|NCT00652444|Ezetimibe|ezetimibe|mesh-list
55859620|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55859621|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55859622|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
55859623|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859624|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55859625|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55859626|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859627|NCT00585910|Methylphenidate|methylphenidate|mesh-list
55859628|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55859629|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55859630|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859652|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55859653|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
55859654|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859655|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55859656|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55859658|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55859659|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859660|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55859661|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55859662|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
55859663|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859664|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859665|NCT00618436|Phenytoin|phenytoin|mesh-list
55859666|NCT00618436|Levetiracetam|levetiracetam|mesh-list
55859667|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
55859668|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
55820033|NCT01768858|Adalimumab|adalimumab|mesh-list
55859669|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55859670|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55859675|NCT00619060|Niacin|niacin|mesh-list
55859705|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55859706|NCT00619684|Growth Substances|growth substances|mesh-ancestor
55859707|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
55859708|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859709|NCT00588406|Prednisone|prednisone|mesh-list
55859710|NCT00588406|Budesonide|budesonide|mesh-list
55859711|NCT00588406|Bromides|bromides|mesh-list
55859712|NCT00588406|Albuterol|albuterol|mesh-list
55859713|NCT00588406|Ipratropium|ipratropium|mesh-list
55859714|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55859717|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55859718|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859719|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55859720|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859721|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55859722|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
55859723|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859724|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55859725|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
55859726|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
55859727|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
55859728|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55859757|NCT00621946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55859758|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55859759|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55859760|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859761|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55859762|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
55859763|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859764|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55859765|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
55859766|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55859767|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55859768|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55859769|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
55859770|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
55859771|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859772|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55859773|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55859774|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
55859775|NCT02139358|Gemcitabine|gemcitabine|mesh-list
55859776|NCT02139358|Trastuzumab|trastuzumab|mesh-list
55859777|NCT02139358|Pertuzumab|pertuzumab|mesh-list
55859778|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55859779|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
55859780|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859781|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859782|NCT02139358|Antiviral Agents|antiviral agents|mesh-ancestor
55859783|NCT02139358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859784|NCT02139358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859785|NCT02139358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859786|NCT02139358|Immunologic Factors|immunologic factors|mesh-ancestor
55859789|NCT02140372|Colchicine|colchicine|mesh-list
55859799|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859800|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
55859801|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859803|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
55859804|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
55859805|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859806|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859807|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
55859808|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859809|NCT00593866|Gemcitabine|gemcitabine|mesh-list
55859810|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55859811|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
55859812|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859813|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859814|NCT00593866|Antiviral Agents|antiviral agents|mesh-ancestor
55859815|NCT00593866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859816|NCT00593866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859817|NCT00593866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859818|NCT00593866|Immunologic Factors|immunologic factors|mesh-ancestor
55859819|NCT00593866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859820|NCT00624910|Bupivacaine|bupivacaine|mesh-list
55859821|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
55859822|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
55859823|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859824|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859825|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
55859826|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55859827|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
55859828|NCT00626626|Clofarabine|clofarabine|mesh-list
55859829|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
55859830|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55859831|NCT00626626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859832|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55859839|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55859841|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55859842|NCT00626782|Ranibizumab|ranibizumab|mesh-list
55859843|NCT00626782|Mitomycins|mitomycins|mesh-list
55859844|NCT00626782|Mitomycin|mitomycin|mesh-list
55859845|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55859846|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55859847|NCT00626782|Growth Substances|growth substances|mesh-ancestor
55859848|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859849|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
55859850|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859851|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55859852|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
55859853|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859854|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55859855|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859857|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55859858|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55859859|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
55859860|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
55859861|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55859862|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859863|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55859864|NCT00627406|Buserelin|buserelin|mesh-list
55859865|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55859866|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859867|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55859868|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
55859869|NCT00673738|Docetaxel|docetaxel|mesh-list
55859870|NCT00673738|Cetuximab|cetuximab|mesh-list
55859871|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859872|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
55859873|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
55859874|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
55859875|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859877|NCT00674206|Gemcitabine|gemcitabine|mesh-list
55859878|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
55859879|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55859880|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
55859881|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859883|NCT00674206|Antiviral Agents|antiviral agents|mesh-ancestor
55859884|NCT00674206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859885|NCT00674206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55859886|NCT00674206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859887|NCT00674206|Immunologic Factors|immunologic factors|mesh-ancestor
55859888|NCT00674206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859889|NCT00595270|Vaccines|vaccines|mesh-list
55859890|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
55859891|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859892|NCT00628498|Defibrotide|defibrotide|mesh-list
55859936|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55859937|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
55859938|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859939|NCT00633256|Isoniazid|isoniazid|mesh-list
55859940|NCT00633256|Cycloserine|cycloserine|mesh-list
55859941|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
55859942|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55859943|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859944|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55859945|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55859946|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
55859947|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859948|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55859949|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55859950|NCT00633256|Renal Agents|renal agents|mesh-ancestor
55859951|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55859952|NCT00634270|Sirolimus|sirolimus|mesh-list
55859953|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55859954|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859955|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55859956|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55859957|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
55859958|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55859959|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
55859960|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859961|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
55859962|NCT00675922|Mafenide|mafenide|mesh-list
55859963|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55859964|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859983|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55859984|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55859985|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55860267|NCT00651040|Methotrexate|methotrexate|mesh-list
55859986|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55859988|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55859989|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
55859990|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55859991|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
55859992|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55859993|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
55859997|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55859998|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
55859999|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55860000|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55860002|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860003|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860004|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55860005|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55860032|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860033|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55860034|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860035|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55860036|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
55860037|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55860038|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55860039|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
55860040|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860041|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860042|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860043|NCT01799902|Urological Agents|urological agents|mesh-ancestor
55860044|NCT01478542|Rituximab|rituximab|mesh-list
55860045|NCT01478542|Vincristine|vincristine|mesh-list
55860046|NCT01478542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55860047|NCT01478542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860049|NCT01478542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860050|NCT01478542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860051|NCT01478542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55860052|NCT01478542|Tubulin Modulators|tubulin modulators|mesh-ancestor
55860053|NCT01478542|Antimitotic Agents|antimitotic agents|mesh-ancestor
55860054|NCT01478542|Mitosis Modulators|mitosis modulators|mesh-ancestor
55860055|NCT01478542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860057|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55860058|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
55860059|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
55860060|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860061|NCT00681538|Nabiximols|nabiximols|mesh-list
55860062|NCT00681538|Analgesics|analgesics|mesh-ancestor
55860063|NCT00681538|Sensory System Agents|sensory system agents|mesh-ancestor
55860064|NCT00681538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860065|NCT00681538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860066|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
55860067|NCT00602836|Rituximab|rituximab|mesh-list
55860068|NCT00602836|Lenalidomide|lenalidomide|mesh-list
55860069|NCT00602836|Pentostatin|pentostatin|mesh-list
55860070|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860071|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
55860072|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860073|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860074|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55860075|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
55860091|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860092|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55860093|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
55860094|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860095|NCT00640822|Calcitriol|calcitriol|mesh-list
55860096|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
55860097|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55860098|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55860099|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55860100|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
55860101|NCT00640822|Calcipotriene|calcipotriene|mesh-list
55860102|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55860103|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
55860104|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55860105|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860106|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55860107|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860108|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860110|NCT00640822|Vitamins|vitamins|mesh-ancestor
55860111|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
55860112|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55860113|NCT00640978|Everolimus|everolimus|mesh-list
55860114|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55860115|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860136|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
55860137|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
55860138|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860139|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55860140|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55860141|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
55860142|NCT00705874|Leucovorin|leucovorin|mesh-list
55860143|NCT00705874|Gemcitabine|gemcitabine|mesh-list
55860144|NCT00705874|Bevacizumab|bevacizumab|mesh-list
55860145|NCT00705874|Sunitinib|sunitinib|mesh-list
55860146|NCT00705874|Docetaxel|docetaxel|mesh-list
55860156|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
55860200|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55860201|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
55860202|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860203|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55860204|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55860205|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
55860206|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55860207|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
55860208|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
55860209|NCT00687076|Vitamins|vitamins|mesh-ancestor
55860210|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
55860212|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55860213|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
55860214|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860215|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
55860216|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860217|NCT02143648|Nalbuphine|nalbuphine|mesh-list
55860218|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55860219|NCT02143648|Narcotics|narcotics|mesh-ancestor
55860220|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860221|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860222|NCT02143648|Analgesics|analgesics|mesh-ancestor
55860223|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
55860224|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860225|NCT02997982|Valacyclovir|valacyclovir|mesh-list
55860226|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
55860227|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860228|NCT00689572|Ondansetron|ondansetron|mesh-list
55860229|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
55860230|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
55860231|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860232|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860234|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
55860235|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
55860236|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55860240|NCT00689572|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55860241|NCT00689572|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55860242|NCT00689572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860243|NCT00689572|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55860244|NCT00689572|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55860245|NCT01840579|Paclitaxel|paclitaxel|mesh-list
55860246|NCT01840579|Etoposide|etoposide|mesh-list
55860247|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55860248|NCT01840579|Carboplatin|carboplatin|mesh-list
55860249|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
55860250|NCT01840579|Pemetrexed|pemetrexed|mesh-list
55860252|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55860253|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860254|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
55860255|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
55860256|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
55860257|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860258|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55860259|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55860260|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55860261|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860262|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55860263|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55860264|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55860265|NCT00651040|Prednisone|prednisone|mesh-list
55860266|NCT00651040|Prednisolone|prednisolone|mesh-list
55860268|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55860269|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
55860270|NCT00651040|Hormones|hormones|mesh-ancestor
55860271|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55860283|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55860284|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860285|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
55860286|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860287|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55860288|NCT00654784|Idebenone|idebenone|mesh-list
55860289|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
55860290|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860291|NCT00654784|Protective Agents|protective agents|mesh-ancestor
55860292|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860293|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55860294|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55860295|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860296|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55860297|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860298|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860301|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55860303|NCT00691600|Renal Agents|renal agents|mesh-ancestor
55860338|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
55860339|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55860340|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55860341|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55860342|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
55860343|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
55860344|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
55860345|NCT00656656|Dexamethasone|dexamethasone|mesh-list
55860346|NCT00656656|Rituximab|rituximab|mesh-list
55860347|NCT00656656|Azathioprine|azathioprine|mesh-list
55860348|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55860349|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860350|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
55860351|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860352|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860353|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55860354|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
55860355|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
55860356|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860357|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55860359|NCT00656656|Hormones|hormones|mesh-ancestor
55860360|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55860361|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55860362|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
55860363|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860364|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55860386|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860388|NCT00693160|Remifentanil|remifentanil|mesh-list
55860389|NCT00693160|Capsaicin|capsaicin|mesh-list
55860390|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55860391|NCT00693160|Narcotics|narcotics|mesh-ancestor
55860392|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860393|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860394|NCT00693160|Analgesics|analgesics|mesh-ancestor
55860395|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
55860396|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860397|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55860398|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55860399|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55860400|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860401|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55860402|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860403|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860404|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
55860442|NCT01154920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860443|NCT01154920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55860445|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55860446|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55860447|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
55860448|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860449|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860450|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860452|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55860453|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860454|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55860455|NCT01792102|Dexamethasone|dexamethasone|mesh-list
55860456|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55860457|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
55860460|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860462|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
55860463|NCT01792102|Hormones|hormones|mesh-ancestor
55860464|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55860465|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55860493|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55860494|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55860496|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860497|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
55860498|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860499|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55860500|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55860501|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55860502|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55860503|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55860504|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55860505|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55860506|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55860507|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55860508|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55860510|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55860511|NCT00662818|Analgesics|analgesics|mesh-ancestor
55860512|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
55860513|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860544|NCT01839487|Gemcitabine|gemcitabine|mesh-list
55860545|NCT01839487|Dexamethasone|dexamethasone|mesh-list
55860546|NCT01839487|Paclitaxel|paclitaxel|mesh-list
55860547|NCT01839487|Enoxaparin|enoxaparin|mesh-list
55860548|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55860549|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860550|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
55860551|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
55860552|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
55860553|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860554|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55860555|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
55860556|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
55860557|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860558|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860559|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55860560|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
55860561|NCT01839487|Hormones|hormones|mesh-ancestor
55860562|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55860563|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55860564|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55860565|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
55860566|NCT01839487|Antiviral Agents|antiviral agents|mesh-ancestor
55860567|NCT01839487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860568|NCT01839487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860569|NCT01839487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860570|NCT01839487|Immunologic Factors|immunologic factors|mesh-ancestor
55860571|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
55860572|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55860573|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55860574|NCT00665470|Aldesleukin|aldesleukin|mesh-list
55860575|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860576|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55860577|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55860587|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860588|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55860589|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860591|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55860592|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
55860593|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860595|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
55860596|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
55860597|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
55860598|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55860599|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55860600|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860601|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820531|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
55860602|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860603|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55860605|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
55860606|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55860607|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
55860608|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55860609|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55860610|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860611|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860612|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55860613|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55860614|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
55860615|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55860616|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55860617|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860618|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55860619|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55860620|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55860621|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55860622|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55860623|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860624|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860625|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
55860626|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860627|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860628|NCT00713284|Sirolimus|sirolimus|mesh-list
55860629|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55860630|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860631|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55860632|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860633|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
55860634|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860635|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
55860636|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860637|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
55860638|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
55860639|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55860640|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55860641|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55860642|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860643|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860665|NCT02999230|Listerine|listerine|mesh-list
55860666|NCT02999230|Fluorides|fluorides|mesh-list
55860667|NCT02999230|Sodium Fluoride|sodium fluoride|mesh-list
55860668|NCT02999230|Cariostatic Agents|cariostatic agents|mesh-ancestor
55860669|NCT02999230|Protective Agents|protective agents|mesh-ancestor
55860670|NCT02999230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860671|NCT02999230|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55860672|NCT02999230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860673|NCT02990728|Metformin|metformin|mesh-list
55860674|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55860675|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860676|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
55860677|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
55860678|NCT02995330|Testosterone|testosterone|mesh-list
55860679|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
55860680|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
55860681|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55860682|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860683|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
55860685|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860686|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55860687|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
55860688|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860689|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860690|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55860691|NCT02995330|Androgens|androgens|mesh-ancestor
55860693|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55860699|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860841|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
55860700|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860701|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55860702|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55860703|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
55860704|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
55860708|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860740|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
55860741|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860742|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860743|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55860744|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
55860745|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860746|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860747|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55860749|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55860750|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55860751|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860752|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55860753|NCT04270708|Analgesics|analgesics|mesh-ancestor
55860754|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
55860755|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55860756|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55860757|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55860758|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55860759|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
55860790|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
55860791|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860792|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860793|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55860794|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
55860795|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55860796|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55860797|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55860798|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860799|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
55860800|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55860801|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55860802|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860804|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55860805|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860806|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55860807|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860808|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
55860810|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
55860811|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860812|NCT01275976|Complement C1s|complement c1s|mesh-list
55860813|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55860814|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
55860815|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
55860816|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860817|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55860818|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860820|NCT01270438|Bevacizumab|bevacizumab|mesh-list
55860821|NCT01270438|Fluorouracil|fluorouracil|mesh-list
55860822|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
55860823|NCT01270438|Calcium|calcium|mesh-list
55860824|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
55860825|NCT01270438|R04929097|r04929097|mesh-list
55860826|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55860827|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860828|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55860829|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55860830|NCT01270438|Growth Substances|growth substances|mesh-ancestor
55860831|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860832|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
55860833|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55860834|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
55860835|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860836|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55860837|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860838|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
55860839|NCT01270438|Antidotes|antidotes|mesh-ancestor
55860840|NCT01270438|Protective Agents|protective agents|mesh-ancestor
55860842|NCT01270438|Vitamins|vitamins|mesh-ancestor
55860843|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
55860844|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860845|NCT01270672|Carvedilol|carvedilol|mesh-list
55860846|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55860847|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55860848|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55860849|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
55860850|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860851|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860852|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860853|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55860854|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
55860855|NCT01270672|Protective Agents|protective agents|mesh-ancestor
55860856|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55860857|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860858|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55860859|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
55860860|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55860861|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55860862|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
55860863|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55860864|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
55860865|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55860866|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55860867|NCT01276210|Sorafenib|sorafenib|mesh-list
55860868|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860869|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55860870|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860871|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860872|NCT00727636|Vaccines|vaccines|mesh-list
55860873|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
55860874|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860875|NCT01270750|Bosentan|bosentan|mesh-list
55860876|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55860877|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55860878|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860879|NCT00709696|Varenicline|varenicline|mesh-list
55860880|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55860881|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55860882|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
55860883|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55860884|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860885|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860886|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
55860887|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860888|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55860889|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860890|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860891|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
55860892|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55860893|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860894|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860895|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55860896|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55860898|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860899|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
55860900|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55860901|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
55860902|NCT02992912|Atezolizumab|atezolizumab|mesh-list
55860907|NCT01271140|Insulin|insulin|mesh-list
55860908|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55860909|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860910|NCT01271374|Losartan|losartan|mesh-list
55860911|NCT01271374|Amlodipine|amlodipine|mesh-list
55860912|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55860913|NCT01271374|Olmesartan|olmesartan|mesh-list
55860914|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
55860915|NCT01271374|Spironolactone|spironolactone|mesh-list
55860916|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55860917|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55860918|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55860919|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860920|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55860921|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860922|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
55860923|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55860924|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55860925|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55860926|NCT01271374|Diuretics|diuretics|mesh-ancestor
55860927|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
55860928|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55860929|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55860930|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
55860931|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55860933|NCT01276834|Everolimus|everolimus|mesh-list
55860934|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860935|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860936|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
55860937|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860938|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
55860939|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55860940|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860941|NCT00711490|Sirolimus|sirolimus|mesh-list
55860942|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55820696|NCT02312219|Folic Acid|folic acid|mesh-list
55860943|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860944|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55860945|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55860946|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
55860947|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860948|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
55860949|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860950|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
55860951|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55860952|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860953|NCT00717418|Cyclosporine|cyclosporine|mesh-list
55860954|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
55860955|NCT00717418|Cyclosporins|cyclosporins|mesh-list
55860956|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55860957|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55860958|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55860959|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
55860960|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55860961|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
55860962|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55860963|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
55860964|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55860965|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55860966|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55860967|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55860969|NCT00717574|Propofol|propofol|mesh-list
55861007|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861008|NCT00721162|Ramucirumab|ramucirumab|mesh-list
55861009|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861010|NCT01838941|Betaine|betaine|mesh-list
55861011|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55861012|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
55861013|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55861014|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
55861015|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861016|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55861017|NCT01773109|Irinotecan|irinotecan|mesh-list
55861018|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
55861019|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
55861020|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55861021|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861022|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861023|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861065|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861066|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861069|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
55861070|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
55861071|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55861072|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55861073|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55861074|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
55861075|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861076|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861077|NCT01278238|Protective Agents|protective agents|mesh-ancestor
55861078|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55861079|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55861124|NCT05586477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55861125|NCT05586477|Antipruritics|antipruritics|mesh-ancestor
55861126|NCT05586477|Dermatologic Agents|dermatologic agents|mesh-ancestor
55861127|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55861129|NCT04386850|Vitamins|vitamins|mesh-ancestor
55861130|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
55861131|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861133|NCT01272778|Lorazepam|lorazepam|mesh-list
55861134|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
55861135|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
55861136|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
55861137|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861138|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861139|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55861140|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55861141|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861142|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55861143|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55861144|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55861145|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
55861146|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
55861147|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861148|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861149|NCT01272856|Abatacept|abatacept|mesh-list
55861150|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55861151|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861152|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861153|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861154|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
55861156|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861168|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861169|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
55861170|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861171|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861173|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55861174|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55861175|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
55861176|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861177|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861178|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55861179|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55861180|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
55861181|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861182|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55861183|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55861184|NCT01273558|Canagliflozin|canagliflozin|mesh-list
55861185|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55861187|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55861188|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861189|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
55861190|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55861191|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55861192|NCT00733096|Prednisolone|prednisolone|mesh-list
55861193|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
55861195|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55861196|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
55861197|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55861198|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
55861199|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
55861200|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861201|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861203|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
55861204|NCT00733096|Hormones|hormones|mesh-ancestor
55861205|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55861206|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55861207|NCT00733096|Protective Agents|protective agents|mesh-ancestor
55861208|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55861209|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861210|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55861211|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55861212|NCT00733096|Analgesics|analgesics|mesh-ancestor
55861213|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
55861214|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861215|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861216|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
55861217|NCT02991196|Nivolumab|nivolumab|mesh-list
55861218|NCT02991196|DS-8273a|ds-8273a|mesh-list
55861219|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861220|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861221|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55861222|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861223|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
55861224|NCT01278784|Chitosan|chitosan|mesh-list
55861225|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55861226|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55861227|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55861228|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
55861229|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861231|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
55861232|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55861233|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
55861234|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861235|NCT01278784|Protective Agents|protective agents|mesh-ancestor
55861236|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861237|NCT01278784|Antidotes|antidotes|mesh-ancestor
55861238|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55861239|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55861241|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55861242|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
55861243|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
55861244|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
55861245|NCT01278784|Coagulants|coagulants|mesh-ancestor
55861246|NCT01276288|Empagliflozin|empagliflozin|mesh-list
55861247|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55861248|NCT01276288|Torsemide|torsemide|mesh-list
55861249|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55861250|NCT01276288|Diuretics|diuretics|mesh-ancestor
55861251|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
55861252|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861253|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55861254|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55861255|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861256|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55861257|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55861258|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55861259|NCT00722566|Bortezomib|bortezomib|mesh-list
55861260|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861261|NCT00722722|Bortezomib|bortezomib|mesh-list
55861262|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861263|NCT00723580|Risperidone|risperidone|mesh-list
55861264|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55820773|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
55861270|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55861271|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861272|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55861273|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55861274|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
55861275|NCT01273948|Interferons|interferons|mesh-list
55861276|NCT01273948|Bavituximab|bavituximab|mesh-list
55861277|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861278|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
55861279|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861280|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861281|NCT03945903|Golimumab|golimumab|mesh-list
55861282|NCT03945903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55861283|NCT03945903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55861284|NCT03945903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861285|NCT03945903|Immunologic Factors|immunologic factors|mesh-ancestor
55861286|NCT03945903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861287|NCT00734344|Tenofovir|tenofovir|mesh-list
55861288|NCT00734344|Efavirenz|efavirenz|mesh-list
55861289|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
55861290|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
55861291|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861292|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55861293|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55861294|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861295|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861296|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55861297|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55861415|NCT04142151|Analgesics|analgesics|mesh-ancestor
55861298|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55861299|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55861300|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55861313|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
55861314|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861315|NCT04143321|Empagliflozin|empagliflozin|mesh-list
55861316|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55861317|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861318|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55861319|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861320|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
55861321|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55861322|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861323|NCT00734968|Renal Agents|renal agents|mesh-ancestor
55861324|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55861325|NCT00735436|Bevacizumab|bevacizumab|mesh-list
55861326|NCT00735436|Irinotecan|irinotecan|mesh-list
55861327|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861328|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861329|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55861330|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55861331|NCT00735436|Growth Substances|growth substances|mesh-ancestor
55861332|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861333|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
55861334|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55861335|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55861336|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861337|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861338|NCT04143165|Lidocaine|lidocaine|mesh-list
55861339|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
55861340|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
55861341|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861342|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861343|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
55861344|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861345|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55861346|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55861347|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55861348|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55861349|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861350|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
55861351|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55861352|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55861353|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55861354|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861355|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861356|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861357|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55861358|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
55861393|NCT04142931|Nivolumab|nivolumab|mesh-list
55861394|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861395|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861396|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55861397|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861398|NCT04143477|Peficitinib|peficitinib|mesh-list
55861399|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861400|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861401|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861402|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
55861403|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861404|NCT05586009|Cisplatin|cisplatin|mesh-list
55861405|NCT05586009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861406|NCT03020979|Apatinib|apatinib|mesh-list
55861407|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861408|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55861409|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861410|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861411|NCT04142151|Aspirin|aspirin|mesh-list
55861412|NCT04142151|Clopidogrel|clopidogrel|mesh-list
55861413|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55861414|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55861416|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
55861417|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861418|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861427|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
55861437|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861438|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55861439|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55861440|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861443|NCT04141995|Fluorouracil|fluorouracil|mesh-list
55861444|NCT04141995|Oxaliplatin|oxaliplatin|mesh-list
55861445|NCT04141995|Irinotecan|irinotecan|mesh-list
55861446|NCT04141995|Camptothecin|camptothecin|mesh-list
55861447|NCT04141995|Digoxin|digoxin|mesh-list
55861448|NCT04141995|Calcium|calcium|mesh-list
55861449|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
55861450|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55861451|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861452|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
55861453|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861454|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55861455|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861456|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861457|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
55861458|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55861459|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55861460|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861461|NCT04141995|Antidotes|antidotes|mesh-ancestor
55861463|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
55861465|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
55861466|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55861467|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55861468|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55861469|NCT04149483|Atorvastatin|atorvastatin|mesh-list
55861470|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55861471|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55861472|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
55861473|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861474|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55861475|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55861477|NCT04149327|Amoxicillin|amoxicillin|mesh-list
55861478|NCT04149327|Metronidazole|metronidazole|mesh-list
55861479|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55861480|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861481|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55861482|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55861483|NCT05582577|Bevacizumab|bevacizumab|mesh-list
55861484|NCT05582577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861485|NCT05582577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861486|NCT05582577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55861487|NCT05582577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55861488|NCT05582577|Growth Substances|growth substances|mesh-ancestor
55861489|NCT05582577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861490|NCT05582577|Growth Inhibitors|growth inhibitors|mesh-ancestor
55861491|NCT04149015|Paclitaxel|paclitaxel|mesh-list
55861492|NCT04149015|Fluorouracil|fluorouracil|mesh-list
55861493|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
55861494|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55861495|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861496|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
55861497|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
55861498|NCT04149015|Mitosis Modulators|mitosis modulators|mesh-ancestor
55861499|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861500|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
55861516|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861517|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861518|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861519|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55861520|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55861521|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
55861522|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861524|NCT05582109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861525|NCT05582109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55861526|NCT05582109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861527|NCT05582109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861529|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55861530|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861531|NCT04140201|Simvastatin|simvastatin|mesh-list
55861532|NCT04140201|Fenofibrate|fenofibrate|mesh-list
55861533|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55861534|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55861535|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
55861536|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861537|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55861538|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55861539|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861540|NCT05581875|Dexamethasone|dexamethasone|mesh-list
55861541|NCT05581875|Daratumumab|daratumumab|mesh-list
55861542|NCT05581875|Pomalidomide|pomalidomide|mesh-list
55861543|NCT05581875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55861544|NCT05581875|Antiemetics|antiemetics|mesh-ancestor
55861545|NCT05581875|Autonomic Agents|autonomic agents|mesh-ancestor
55861546|NCT05581875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861547|NCT05581875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861548|NCT05581875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55861549|NCT05581875|Glucocorticoids|glucocorticoids|mesh-ancestor
55861551|NCT05581875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55861552|NCT05581875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55861553|NCT05581875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861554|NCT05581875|Immunologic Factors|immunologic factors|mesh-ancestor
55861555|NCT05581875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55861556|NCT05581875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55861557|NCT05581875|Growth Substances|growth substances|mesh-ancestor
55861558|NCT05581875|Growth Inhibitors|growth inhibitors|mesh-ancestor
55861559|NCT03945513|Dienogest|dienogest|mesh-list
55861560|NCT03945513|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55861561|NCT03945513|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55861562|NCT03945513|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55861563|NCT03945513|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55861564|NCT03945513|Contraceptive Agents|contraceptive agents|mesh-ancestor
55861565|NCT03945513|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55861566|NCT03945513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861567|NCT03945513|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55861610|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55861611|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55861612|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861613|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861614|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861615|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55861616|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861617|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55861618|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55861619|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55861620|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
55861621|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55861622|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55861623|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55861624|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55861667|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
55861668|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
55861669|NCT03588351|Coagulants|coagulants|mesh-ancestor
55861670|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
55861671|NCT03585465|Capecitabine|capecitabine|mesh-list
55861672|NCT03585465|Nivolumab|nivolumab|mesh-list
55861673|NCT03585465|Vinblastine|vinblastine|mesh-list
55861674|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861675|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
55861677|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861678|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55861679|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
55861680|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861681|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861682|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55861683|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55861684|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
55861685|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861686|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55861687|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55861688|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
55861689|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
55861690|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
55861692|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55861693|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861694|NCT03588039|Paclitaxel|paclitaxel|mesh-list
55861695|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
55861696|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55861697|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861698|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
55861699|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
55861700|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
55861701|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861702|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861703|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
55861704|NCT02984865|Sufentanil|sufentanil|mesh-list
55861705|NCT02984865|Nalbuphine|nalbuphine|mesh-list
55861706|NCT02984865|Dsuvia|dsuvia|mesh-list
55861707|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55861708|NCT02984865|Narcotics|narcotics|mesh-ancestor
55861709|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861710|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861711|NCT02984865|Analgesics|analgesics|mesh-ancestor
55861712|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
55861713|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861714|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55861715|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55861718|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55861719|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55861720|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55861721|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861723|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861748|NCT01611259|Rituximab|rituximab|mesh-list
55861749|NCT01611259|Lenalidomide|lenalidomide|mesh-list
55861750|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861751|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861752|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
55861753|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861754|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861755|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55861756|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55861757|NCT01611259|Growth Substances|growth substances|mesh-ancestor
55861758|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
55861759|NCT03586869|Leucovorin|leucovorin|mesh-list
55861760|NCT03586869|Paclitaxel|paclitaxel|mesh-list
55861761|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
55861762|NCT03586869|Bevacizumab|bevacizumab|mesh-list
55861763|NCT03586869|Fluorouracil|fluorouracil|mesh-list
55861764|NCT03586869|Capecitabine|capecitabine|mesh-list
55861765|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
55861766|NCT03586869|Avelumab|avelumab|mesh-list
55861767|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55861768|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861769|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
55861770|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
55861771|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
55861772|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861773|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861774|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
55861775|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861776|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55861777|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55861778|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
55861779|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55861780|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861781|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55861782|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55861783|NCT03586869|Growth Substances|growth substances|mesh-ancestor
55861784|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
55861785|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
55861787|NCT03586869|Antidotes|antidotes|mesh-ancestor
55861788|NCT03586869|Protective Agents|protective agents|mesh-ancestor
55861789|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
55861790|NCT03586869|Vitamins|vitamins|mesh-ancestor
55861791|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
55861792|NCT01796197|Paclitaxel|paclitaxel|mesh-list
55861793|NCT01796197|Cyclophosphamide|cyclophosphamide|mesh-list
55861794|NCT01796197|Doxorubicin|doxorubicin|mesh-list
55861795|NCT01796197|Trastuzumab|trastuzumab|mesh-list
55861796|NCT01796197|Pertuzumab|pertuzumab|mesh-list
55861797|NCT01796197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55861937|NCT03156153|Diuretics|diuretics|mesh-ancestor
55861798|NCT01796197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861799|NCT01796197|Tubulin Modulators|tubulin modulators|mesh-ancestor
55861800|NCT01796197|Antimitotic Agents|antimitotic agents|mesh-ancestor
55861801|NCT01796197|Mitosis Modulators|mitosis modulators|mesh-ancestor
55861802|NCT01796197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861803|NCT01796197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861804|NCT01796197|Immunologic Factors|immunologic factors|mesh-ancestor
55861805|NCT01796197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861838|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
55861840|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
55861841|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861842|NCT04765527|Protective Agents|protective agents|mesh-ancestor
55861843|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861844|NCT02947503|Metformin|metformin|mesh-list
55861845|NCT02947503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55861846|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861847|NCT03586323|Lidocaine|lidocaine|mesh-list
55861848|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
55861849|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
55861850|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55861851|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861852|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
55861853|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861854|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55861855|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55861856|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55861857|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55861858|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861859|NCT03586089|Diazepam|diazepam|mesh-list
55861860|NCT03586089|Phenobarbital|phenobarbital|mesh-list
55861861|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55861888|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55861889|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861890|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55861891|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861892|NCT04592653|Pembrolizumab|pembrolizumab|mesh-list
55861893|NCT04592653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55861894|NCT04592653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861895|NCT03580395|Paclitaxel|paclitaxel|mesh-list
55861896|NCT03580395|Apatinib|apatinib|mesh-list
55861897|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55861898|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861899|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
55861900|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
55861901|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
55861902|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861903|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55861904|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861905|NCT01770145|Levodopa|levodopa|mesh-list
55861906|NCT01770145|Carbidopa|carbidopa|mesh-list
55861907|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55861908|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
55861909|NCT01770145|Apomorphine|apomorphine|mesh-list
55861910|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55861911|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55861912|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
55861913|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861914|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861915|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861916|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55861917|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861918|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55861919|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
55861920|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
55861927|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861928|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55861929|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55861930|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861931|NCT03580239|Everolimus|everolimus|mesh-list
55861932|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55861933|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55861934|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
55861935|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861936|NCT03156153|Bumetanide|bumetanide|mesh-list
55861938|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
55861939|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861940|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55861941|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55861942|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861943|NCT03156231|Acetazolamide|acetazolamide|mesh-list
55861944|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
55861945|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55861947|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861948|NCT03156231|Diuretics|diuretics|mesh-ancestor
55861949|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
55861950|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861951|NCT05702151|Morphine|morphine|mesh-list
55861978|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55861979|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55861980|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
55861981|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55861982|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55861983|NCT03584841|Pilocarpine|pilocarpine|mesh-list
55861984|NCT03584841|Miotics|miotics|mesh-ancestor
55861985|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
55861986|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861987|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861988|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55861989|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55861990|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
55861991|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55861992|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55861993|NCT02000921|Nicotine|nicotine|mesh-list
55861994|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55861995|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
55861996|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55861997|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55861998|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55861999|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55862000|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
55862001|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862002|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862004|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
55862005|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
55862006|NCT03586947|Vitamins|vitamins|mesh-list
55862007|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
55862008|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862009|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55862010|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55862012|NCT04405245|Latanoprost|latanoprost|mesh-list
55862013|NCT04405245|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55862014|NCT03584529|Vitamin D|vitamin d|mesh-list
55862015|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
55862016|NCT03584529|Vitamins|vitamins|mesh-ancestor
55862017|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
55862018|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862019|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55862020|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55862022|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55862023|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862024|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862025|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
55862026|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55862027|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55862028|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862029|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
55862030|NCT03113253|Coagulants|coagulants|mesh-ancestor
55862031|NCT01836523|Liraglutide|liraglutide|mesh-list
55862032|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55862033|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862034|NCT01836523|Incretins|incretins|mesh-ancestor
55862035|NCT01836523|Hormones|hormones|mesh-ancestor
55862036|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862037|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
55862038|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862039|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55862040|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862041|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862042|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55862043|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55862044|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862045|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
55862046|NCT03020589|Tacrolimus|tacrolimus|mesh-list
55862047|NCT03020589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55862048|NCT03020589|Immunologic Factors|immunologic factors|mesh-ancestor
55862049|NCT03020589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862050|NCT03020589|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55862051|NCT03020589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862052|NCT03020589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862053|NCT02000531|Gemcitabine|gemcitabine|mesh-list
55862054|NCT02000531|Cisplatin|cisplatin|mesh-list
55862055|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55862056|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862057|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55862058|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
55862059|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862060|NCT02000531|Antiviral Agents|antiviral agents|mesh-ancestor
55862061|NCT02000531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862062|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862063|NCT02000531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55862064|NCT02000531|Immunologic Factors|immunologic factors|mesh-ancestor
55862065|NCT02000531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862066|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55862067|NCT01609231|Irinotecan|irinotecan|mesh-list
55862068|NCT01609231|Cetuximab|cetuximab|mesh-list
55862069|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55862070|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55862071|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862072|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862073|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862074|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55862076|NCT04664933|Protective Agents|protective agents|mesh-ancestor
55862077|NCT04664933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862078|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
55862079|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55862080|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55862081|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55862082|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55862083|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862084|NCT04405011|Entecavir|entecavir|mesh-list
55862085|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
55862086|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862087|NCT01769443|Bortezomib|bortezomib|mesh-list
55862088|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862089|NCT03154827|Atezolizumab|atezolizumab|mesh-list
55862090|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862091|NCT01274182|Rituximab|rituximab|mesh-list
55862093|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862117|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862119|NCT01274104|Vitamin D|vitamin d|mesh-list
55862120|NCT01274104|Cholecalciferol|cholecalciferol|mesh-list
55862121|NCT01274104|Vitamins|vitamins|mesh-ancestor
55862122|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
55862123|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862124|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55862125|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55862126|NCT01279096|Dexamethasone|dexamethasone|mesh-list
55862127|NCT01279096|Etoposide|etoposide|mesh-list
55862128|NCT01279096|Asparaginase|asparaginase|mesh-list
55862129|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
55862130|NCT01279096|Clofarabine|clofarabine|mesh-list
55862131|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862132|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
55862133|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
55862134|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862135|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862136|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862137|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
55862138|NCT01279096|Hormones|hormones|mesh-ancestor
55862139|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862140|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55862141|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862142|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862143|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862144|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55862145|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55862146|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55862148|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
55862149|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55862150|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
55862152|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55862153|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55862154|NCT01272934|Analgesics|analgesics|mesh-ancestor
55862155|NCT01272934|Sensory System Agents|sensory system agents|mesh-ancestor
55862156|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862157|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862158|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862159|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862160|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55862161|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862162|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862163|NCT01279252|Metronidazole|metronidazole|mesh-list
55862164|NCT01279252|Clarithromycin|clarithromycin|mesh-list
55862165|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
55862166|NCT01279252|Lansoprazole|lansoprazole|mesh-list
55862167|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
55862168|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862169|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55862170|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55862172|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55862173|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862202|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
55862203|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862204|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862205|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862206|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
55862207|NCT01274260|Hormones|hormones|mesh-ancestor
55862208|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862209|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55862210|NCT01274260|Protective Agents|protective agents|mesh-ancestor
55862251|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
55862252|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862253|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862254|NCT01791985|Letrozole|letrozole|mesh-list
55862255|NCT01791985|Anastrozole|anastrozole|mesh-list
55862256|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862257|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55862258|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55862259|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862260|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862261|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55862262|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
55862263|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862264|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862266|NCT04176497|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55862318|NCT03157479|Anesthetics|anesthetics|mesh-list
55862319|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
55862320|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55862321|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862322|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
55862323|NCT03013491|Ipilimumab|ipilimumab|mesh-list
55862324|NCT03013491|Vemurafenib|vemurafenib|mesh-list
55862325|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55862326|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862327|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55862328|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862329|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55862330|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862331|NCT01272232|Liraglutide|liraglutide|mesh-list
55862332|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55862333|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862334|NCT01272232|Incretins|incretins|mesh-ancestor
55862335|NCT01272232|Hormones|hormones|mesh-ancestor
55862336|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862337|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
55862338|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55862339|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55862340|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862341|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
55862342|NCT03157401|Coagulants|coagulants|mesh-ancestor
55862344|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
55862345|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
55862346|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
55862347|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862348|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862349|NCT03156855|Bismuth|bismuth|mesh-list
55862350|NCT03156855|Antacids|antacids|mesh-ancestor
55862351|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862352|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862353|NCT00739960|Abatacept|abatacept|mesh-list
55862354|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55862355|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862356|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862357|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55862358|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
55862359|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862360|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862361|NCT03153657|Piroxicam|piroxicam|mesh-list
55862362|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
55862363|NCT03153657|Betadex|betadex|mesh-list
55862366|NCT03153657|Analgesics|analgesics|mesh-ancestor
55862392|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55862393|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862395|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
55862396|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
55862397|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862398|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862399|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55862401|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
55862402|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55862403|NCT01676259|Gemcitabine|gemcitabine|mesh-list
55862404|NCT01676259|Paclitaxel|paclitaxel|mesh-list
55862405|NCT01676259|Folfirinox|folfirinox|mesh-list
55862406|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55862407|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862408|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
55862409|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
55862410|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
55862411|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862412|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55862413|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
55862414|NCT01676259|Antiviral Agents|antiviral agents|mesh-ancestor
55862415|NCT01676259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862416|NCT01676259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862417|NCT01676259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55862418|NCT01676259|Immunologic Factors|immunologic factors|mesh-ancestor
55862419|NCT01676259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862421|NCT02662257|Sevoflurane|sevoflurane|mesh-list
55862422|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55862423|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55862424|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862425|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55862426|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
55862427|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
55862428|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55862429|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55862430|NCT03153267|Doxycycline|doxycycline|mesh-list
55862431|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55862432|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862433|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
55862436|NCT00746512|Prednisone|prednisone|mesh-list
55862463|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862464|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862465|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55862466|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862468|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862469|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862470|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55862471|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
55862472|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55862473|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55862474|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55862475|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55862476|NCT01279876|Melatonin|melatonin|mesh-list
55862477|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
55862479|NCT01279876|Protective Agents|protective agents|mesh-ancestor
55862480|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862482|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55862516|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862517|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55862518|NCT01278394|Tavaborole|tavaborole|mesh-list
55862519|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
55862520|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862521|NCT00240916|Vaccines|vaccines|mesh-list
55862522|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
55862523|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862524|NCT01278160|Insulin|insulin|mesh-list
55862525|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55862526|NCT01278160|Metformin|metformin|mesh-list
55862527|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
55862528|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
55862529|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55862530|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
55862531|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
55862532|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
55862533|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55862534|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862535|NCT00748072|Vasopressins|vasopressins|mesh-list
55862536|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
55862537|NCT00748072|Coagulants|coagulants|mesh-ancestor
55862538|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55862539|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55862540|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
55862541|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862542|NCT01835587|Cc-486|cc-486|mesh-list
55862543|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862562|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55862563|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55862564|NCT01277302|Growth Substances|growth substances|mesh-ancestor
55862565|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862566|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
55862567|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862568|NCT04414579|Insulin|insulin|mesh-list
55862569|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55862570|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
55862571|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
55862572|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55862573|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55862574|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862575|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
55862576|NCT01980875|Idelalisib|idelalisib|mesh-list
55862577|NCT01980875|Chlorambucil|chlorambucil|mesh-list
55862578|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55862579|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862580|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862581|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862582|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55862583|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
55862584|NCT01967225|Linezolid|linezolid|mesh-list
55862585|NCT01967225|Tedizolid|tedizolid|mesh-list
55862586|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
55862587|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55862588|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862589|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55862590|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862591|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862592|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55862593|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55862595|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55862596|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
55862597|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862598|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862599|NCT01765543|Rifampin|rifampin|mesh-list
55862600|NCT01765543|Vemurafenib|vemurafenib|mesh-list
55862601|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55862602|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
55862603|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55862604|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862605|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
55862606|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55862607|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862915|NCT00756964|Rasburicase|rasburicase|mesh-list
55862608|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862609|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55862610|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55862611|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55862612|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55862613|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55862643|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55862644|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
55862645|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862646|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55862647|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862648|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55862649|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55862650|NCT01764997|Analgesics|analgesics|mesh-ancestor
55862651|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
55862652|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862653|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862654|NCT01276756|Interferons|interferons|mesh-list
55862656|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
55862657|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
55862658|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55862659|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
55862660|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862661|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
55862662|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862663|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
55862664|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862665|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
55862666|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862667|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55862668|NCT00246376|Niacin|niacin|mesh-list
55862669|NCT00246376|Fenofibrate|fenofibrate|mesh-list
55862670|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55862671|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
55862672|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862673|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55862674|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
55862675|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
55862676|NCT00246376|Vitamins|vitamins|mesh-ancestor
55862677|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
55862678|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862683|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862684|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862685|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55862686|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
55862687|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862688|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862689|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
55862690|NCT00754546|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55862691|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
55862692|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862693|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862694|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55862695|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
55862696|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55862697|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55862698|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55862699|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
55862700|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862701|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862702|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
55862703|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55862704|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862705|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55862706|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55862707|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862708|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862709|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862710|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55862711|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55862712|NCT00245050|Pyridoxine|pyridoxine|mesh-list
55862713|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
55862714|NCT00245050|Doxorubicin|doxorubicin|mesh-list
55862715|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55862716|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55862717|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862718|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55862719|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55862720|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862725|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862726|NCT04345588|Dexamethasone|dexamethasone|mesh-list
55862727|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
55862728|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862729|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
55862730|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
55862731|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862732|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862733|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862734|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
55862735|NCT04345588|Hormones|hormones|mesh-ancestor
55862737|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55862767|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55862768|NCT00763360|Hyaluronic Acid|hyaluronic acid|mesh-list
55862769|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55862770|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
55862771|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862772|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
55862773|NCT00763360|Protective Agents|protective agents|mesh-ancestor
55862775|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55862776|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
55862777|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862778|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862779|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
55862781|NCT00243412|Methotrexate|methotrexate|mesh-list
55862782|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55862783|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862784|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
55862785|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862786|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862787|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55862788|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
55862789|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55862790|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55862791|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
55862792|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862793|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
55862794|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862795|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55862796|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55862797|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55862798|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862799|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
55862800|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
55862801|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862802|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55862803|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
55862804|NCT00243412|Hormones|hormones|mesh-ancestor
55862805|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862807|NCT00243412|Protective Agents|protective agents|mesh-ancestor
55862808|NCT00765232|Ketorolac|ketorolac|mesh-list
55862809|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55862810|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55862811|NCT00765232|Analgesics|analgesics|mesh-ancestor
55862812|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
55862813|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862814|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862815|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862816|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862817|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55862818|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862819|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862820|NCT03805282|Lidocaine|lidocaine|mesh-list
55862821|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
55862822|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
55862823|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55862824|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862825|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
55862826|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862827|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55862828|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55862829|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55862830|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55862831|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862833|NCT03805750|Cannabidiol|cannabidiol|mesh-list
55862834|NCT03805750|Anticonvulsants|anticonvulsants|mesh-ancestor
55862835|NCT03805750|Hallucinogens|hallucinogens|mesh-ancestor
55862836|NCT03805750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862837|NCT03805750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55862838|NCT03805750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55862839|NCT03805750|Analgesics|analgesics|mesh-ancestor
55862840|NCT03805750|Sensory System Agents|sensory system agents|mesh-ancestor
55862841|NCT03805750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862842|NCT03805750|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55862843|NCT03805750|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55862844|NCT03805750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862845|NCT03805750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862846|NCT03805750|Hormones|hormones|mesh-ancestor
55862847|NCT03805750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55862848|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55862849|NCT03804268|Pilocarpine|pilocarpine|mesh-list
55862850|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55862851|NCT03804268|Miotics|miotics|mesh-ancestor
55862852|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
55862853|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862854|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862855|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
55862856|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55862857|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
55862858|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862859|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862861|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55862863|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55862864|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862865|NCT00765856|Analgesics|analgesics|mesh-ancestor
55862866|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
55862867|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862868|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55862869|NCT00780208|Methylphenidate|methylphenidate|mesh-list
55862870|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55862871|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862872|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55862873|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55862874|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55862875|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862876|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
55862877|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862878|NCT03830164|Vitamins|vitamins|mesh-list
55862879|NCT03830164|Vitamin E|vitamin e|mesh-list
55862880|NCT03830164|Tocopherols|tocopherols|mesh-list
55862881|NCT03830164|Tocotrienols|tocotrienols|mesh-list
55862882|NCT03830164|alpha-Tocopherol|alpha-tocopherol|mesh-list
55862883|NCT03830164|Pentoxifylline|pentoxifylline|mesh-list
55862884|NCT03830164|Atorvastatin|atorvastatin|mesh-list
55862885|NCT03830164|Micronutrients|micronutrients|mesh-ancestor
55862886|NCT03830164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862887|NCT03830164|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55862888|NCT03830164|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55862889|NCT03830164|Antimetabolites|antimetabolites|mesh-ancestor
55862890|NCT03830164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862891|NCT03830164|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55862900|NCT03830164|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55862901|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
55862902|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
55862903|NCT00243022|Vitamins|vitamins|mesh-ancestor
55862904|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
55862905|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862906|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
55862907|NCT00243022|Hematinics|hematinics|mesh-ancestor
55862908|NCT03805360|Ropivacaine|ropivacaine|mesh-list
55862909|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
55862911|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55862912|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862913|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
55862914|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862916|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
55862917|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862918|NCT00780442|Cycloserine|cycloserine|mesh-list
55862919|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55862920|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55862921|NCT00780442|Renal Agents|renal agents|mesh-ancestor
55862922|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55862923|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
55862924|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55862925|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
55862926|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862927|NCT04384666|Rotigotine|rotigotine|mesh-list
55862928|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
55862929|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
55862930|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862931|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862932|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862933|NCT00767572|Atorvastatin|atorvastatin|mesh-list
55862934|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55862935|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55862936|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
55862937|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862938|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55862939|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55862940|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862941|NCT00780676|Dasatinib|dasatinib|mesh-list
55862942|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862943|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55862944|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862945|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862946|NCT00768118|Curcumin|curcumin|mesh-list
55862947|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55862948|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55862949|NCT00768118|Analgesics|analgesics|mesh-ancestor
55862950|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
55862951|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862952|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862953|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55862954|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55862955|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55862956|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55862957|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862958|NCT04345432|Gabapentin|gabapentin|mesh-list
55862959|NCT04345432|Analgesics|analgesics|mesh-ancestor
55862960|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
55862961|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55862962|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862963|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
55862964|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55862965|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55862966|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55862967|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55862968|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55862969|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55862970|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55862971|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55862972|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
55862973|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
55862975|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
55862976|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55862977|NCT03809884|Expectorants|expectorants|mesh-ancestor
55862978|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
55862979|NCT00757822|Dronabinol|dronabinol|mesh-list
55862980|NCT00757822|Ondansetron|ondansetron|mesh-list
55862981|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
55862982|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
55862983|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863010|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
55863011|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863013|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55863014|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55863015|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55863016|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863017|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863018|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
55863019|NCT00769600|Itraconazole|itraconazole|mesh-list
55863020|NCT00769600|Pemetrexed|pemetrexed|mesh-list
55863021|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863022|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863023|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863024|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55863025|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55863026|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
55863027|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863028|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55863029|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55863030|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55863031|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
55863033|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863059|NCT05743504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55863060|NCT05743504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863061|NCT05743504|Tubulin Modulators|tubulin modulators|mesh-ancestor
55863062|NCT05743504|Antimitotic Agents|antimitotic agents|mesh-ancestor
55863063|NCT05743504|Mitosis Modulators|mitosis modulators|mesh-ancestor
55863064|NCT05743504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863065|NCT03803254|Lenvatinib|lenvatinib|mesh-list
55863066|NCT03803254|Antibodies|antibodies|mesh-list
55863067|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
55863068|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863069|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863070|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55863071|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863072|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863073|NCT04730999|Bevacizumab|bevacizumab|mesh-list
55863074|NCT04730999|Carboplatin|carboplatin|mesh-list
55863075|NCT04730999|Etoposide|etoposide|mesh-list
55863076|NCT04730999|Atezolizumab|atezolizumab|mesh-list
55863077|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55863078|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863079|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55821726|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
55863080|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55863081|NCT04730999|Growth Substances|growth substances|mesh-ancestor
55863082|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863107|NCT05743270|Carboplatin|carboplatin|mesh-list
55863109|NCT05743270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55863110|NCT05743270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863111|NCT05743270|Tubulin Modulators|tubulin modulators|mesh-ancestor
55863112|NCT05743270|Antimitotic Agents|antimitotic agents|mesh-ancestor
55863113|NCT05743270|Mitosis Modulators|mitosis modulators|mesh-ancestor
55863114|NCT05743270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863115|NCT05743270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55863116|NCT05743270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55863117|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
55863118|NCT01736215|Hematinics|hematinics|mesh-ancestor
55863119|NCT05743192|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55863120|NCT05743192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863121|NCT01786603|Rasagiline|rasagiline|mesh-list
55863122|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55863123|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863124|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863125|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55863126|NCT01786603|Protective Agents|protective agents|mesh-ancestor
55863127|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863128|NCT00786916|Lidocaine|lidocaine|mesh-list
55863129|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
55863130|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
55863131|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55863132|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863133|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
55863134|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863135|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55863136|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55863137|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55863138|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55863139|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863140|NCT04414267|Vaccines|vaccines|mesh-list
55863142|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
55863143|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863144|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55863145|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
55863146|NCT01619423|Edetic Acid|edetic acid|mesh-list
55863147|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
55863148|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
55863149|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
55863150|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
55863151|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863152|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
55863153|NCT01619423|Vitamins|vitamins|mesh-ancestor
55863154|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
55863155|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863156|NCT03802552|Cephalexin|cephalexin|mesh-list
55863157|NCT03802552|Cefadroxil|cefadroxil|mesh-list
55863158|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55863159|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863160|NCT01735279|Mineral Oil|mineral oil|mesh-list
55863161|NCT01735279|Emollients|emollients|mesh-ancestor
55863162|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
55863163|NCT03802318|Amoxicillin|amoxicillin|mesh-list
55863164|NCT03802318|Rabeprazole|rabeprazole|mesh-list
55863165|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55863166|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863167|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55863168|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55863169|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55863170|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863171|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863172|NCT01758523|Dutasteride|dutasteride|mesh-list
55863173|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55863174|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55863175|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863176|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863177|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
55863179|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863180|NCT00773422|Naltrexone|naltrexone|mesh-list
55863181|NCT00773422|Varenicline|varenicline|mesh-list
55863182|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55863183|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55863184|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863185|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
55863186|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863187|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55863188|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55863189|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
55863190|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863191|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863192|NCT00786994|Petrolatum|petrolatum|mesh-list
55863193|NCT00786994|Emollients|emollients|mesh-ancestor
55863194|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
55863195|NCT00774202|Prednisone|prednisone|mesh-list
55863196|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
55863197|NCT00774202|Rituximab|rituximab|mesh-list
55863198|NCT00774202|Vincristine|vincristine|mesh-list
55863199|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55863200|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
55863201|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863202|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55863203|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55863204|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
55863205|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863206|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863207|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55863208|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55863209|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55863224|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55863225|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55863226|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
55863227|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863228|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863229|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863230|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55863231|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55863232|NCT01757275|Esomeprazole|esomeprazole|mesh-list
55863233|NCT01757275|Cimetidine|cimetidine|mesh-list
55863234|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55863235|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55864403|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
55863236|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55863237|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863238|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863239|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55863240|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
55863241|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
55863242|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863243|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863244|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55863245|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55863246|NCT00787852|Paclitaxel|paclitaxel|mesh-list
55863247|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55863248|NCT00787852|Dasatinib|dasatinib|mesh-list
55863249|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55863251|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
55863252|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
55863253|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
55863254|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863255|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55863256|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863257|NCT00788008|Propofol|propofol|mesh-list
55863258|NCT00788008|Isoflurane|isoflurane|mesh-list
55863259|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
55863260|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55863261|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863262|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55863263|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55863264|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
55863265|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55863266|NCT00760006|Ampicillin|ampicillin|mesh-list
55863267|NCT00760006|Sulbactam|sulbactam|mesh-list
55863268|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55863269|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55863270|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863271|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55863272|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863273|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863274|NCT01784965|Liraglutide|liraglutide|mesh-list
55863313|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863314|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55863315|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55863316|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
55863317|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863319|NCT01733329|Misoprostol|misoprostol|mesh-list
55863320|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55863321|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
55863322|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55863323|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863324|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55863325|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55863326|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
55863327|NCT01733329|Hematinics|hematinics|mesh-ancestor
55863328|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
55863329|NCT01733329|Vitamins|vitamins|mesh-ancestor
55863330|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
55863331|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
55863332|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55863333|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55863334|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55821848|NCT04499677|Lopinavir|lopinavir|mesh-list
55863335|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55863336|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863338|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863339|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863340|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55863341|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863342|NCT05742568|Amoxicillin|amoxicillin|mesh-list
55863343|NCT05742568|Clarithromycin|clarithromycin|mesh-list
55863344|NCT05742568|Esomeprazole|esomeprazole|mesh-list
55863345|NCT05742568|Bismuth|bismuth|mesh-list
55863347|NCT05742568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863353|NCT05742568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55863354|NCT05742568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55863355|NCT05742568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55863356|NCT05742568|Antacids|antacids|mesh-ancestor
55863357|NCT01607593|Sertraline|sertraline|mesh-list
55863358|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
55863359|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55863360|NCT01607593|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55863361|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55863362|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55863363|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863364|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863366|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863367|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55863368|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55863369|NCT01755637|Albendazole|albendazole|mesh-list
55863370|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
55863371|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55863372|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863373|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
55863374|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55863375|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55863376|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
55863377|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
55863378|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
55863379|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863380|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863382|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55863383|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863385|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863386|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55863387|NCT02148874|Vaccines|vaccines|mesh-list
55863388|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
55863389|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863390|NCT01755091|Dronabinol|dronabinol|mesh-list
55863391|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
55863392|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863393|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55863394|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55863395|NCT01755091|Analgesics|analgesics|mesh-ancestor
55863444|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55863445|NCT01783015|Analgesics|analgesics|mesh-ancestor
55863446|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
55863447|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863448|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863451|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55863452|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55863453|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
55863455|NCT05567770|Hormones|hormones|mesh-ancestor
55863456|NCT05567770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863457|NCT05567770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863458|NCT01782859|Prednisone|prednisone|mesh-list
55863459|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
55863460|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55863461|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55863462|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55863463|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55863464|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
55863465|NCT01782859|Hormones|hormones|mesh-ancestor
55863466|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863467|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863468|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55863469|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863470|NCT04574947|Lidocaine|lidocaine|mesh-list
55863471|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
55863472|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
55863473|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55863474|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863475|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
55863476|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863477|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55863483|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55863484|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
55863485|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55863486|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55863487|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55863488|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55863489|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864508|NCT03879538|Nitrous Oxide|nitrous oxide|mesh-list
55863490|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55863491|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55863492|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55863493|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
55863494|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863495|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863496|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55863497|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55863498|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
55863499|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55863500|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55863501|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
55863502|NCT01781611|Aspirin|aspirin|mesh-list
55822000|NCT01945593|BAX 855|bax 855|mesh-list
55863503|NCT01781611|Dipyridamole|dipyridamole|mesh-list
55863504|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55863505|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55863506|NCT01781611|Analgesics|analgesics|mesh-ancestor
55863507|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
55863508|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863509|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863510|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55863511|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55863512|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55863513|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55863514|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863515|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55863516|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55863518|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
55863519|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55863520|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
55863521|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
55863522|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863523|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55863524|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863527|NCT00790270|Amitriptyline|amitriptyline|mesh-list
55863528|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
55863530|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55863531|NCT00790270|Analgesics|analgesics|mesh-ancestor
55863532|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
55863533|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863534|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863535|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55822111|NCT01774786|Pertuzumab|pertuzumab|mesh-list
55863536|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55863538|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863539|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863540|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55863541|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
55863542|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55863543|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55863544|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55863545|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55863546|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55863547|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55863548|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55863549|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55863551|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863552|NCT01780987|Heparin|heparin|mesh-list
55863553|NCT01780987|Calcium heparin|calcium heparin|mesh-list
55863554|NCT01780987|Warfarin|warfarin|mesh-list
55863555|NCT01780987|Apixaban|apixaban|mesh-list
55863556|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
55863557|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55863558|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55863559|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863560|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55863561|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
55863562|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55863563|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
55863564|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863565|NCT03800290|Clenbuterol|clenbuterol|mesh-list
55863566|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55863567|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55863568|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
55863569|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863570|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863571|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863572|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55863573|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
55863574|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863575|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55863576|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
55863577|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
55863578|NCT05521984|Dapagliflozin|dapagliflozin|mesh-list
55863580|NCT05521984|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55863581|NCT05521984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863593|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
55863594|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55863595|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863596|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55863597|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55863601|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
55863602|NCT05688904|Imipramine|imipramine|mesh-list
55863603|NCT05688904|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55863604|NCT05688904|Antidepressive Agents|antidepressive agents|mesh-ancestor
55863605|NCT05688904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55863606|NCT05688904|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55863607|NCT05688904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55863608|NCT05688904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55863609|NCT05688904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863610|NCT05688904|Adrenergic Agents|adrenergic agents|mesh-ancestor
55863611|NCT05688904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863612|NCT05688904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863613|NCT04795336|Melatonin|melatonin|mesh-list
55863614|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
55863615|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863616|NCT04795336|Protective Agents|protective agents|mesh-ancestor
55863617|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863618|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55863619|NCT00809848|Bimatoprost|bimatoprost|mesh-list
55863620|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55863621|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55863622|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55863623|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55863624|NCT01730053|Ezetimibe|ezetimibe|mesh-list
55863625|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55863626|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55863627|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
55863629|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55863631|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863632|NCT01751113|Fluticasone|fluticasone|mesh-list
55863633|NCT01751113|Xhance|xhance|mesh-list
55863634|NCT01751113|Bromides|bromides|mesh-list
55863635|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
55863636|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55863637|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55863638|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55863639|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55863640|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
55863641|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863642|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863643|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55863644|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
55863645|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
55863646|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55863647|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
55863648|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55863649|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
55863650|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55863651|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863652|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55863653|NCT01751113|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55863654|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55863655|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
55863656|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
55863657|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
55863658|NCT01751113|Hormones|hormones|mesh-ancestor
55863660|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
55863661|NCT00795340|Paclitaxel|paclitaxel|mesh-list
55863662|NCT00795340|Carboplatin|carboplatin|mesh-list
55863663|NCT00795340|Cediranib|cediranib|mesh-list
55863664|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55863665|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863693|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863695|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55863696|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863697|NCT00792142|Thalidomide|thalidomide|mesh-list
55863698|NCT00792142|Dexamethasone|dexamethasone|mesh-list
55863699|NCT00792142|Bortezomib|bortezomib|mesh-list
55863700|NCT00792142|Melphalan|melphalan|mesh-list
55863701|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55863702|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
55863703|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
55863704|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55863705|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863706|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55863707|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
55863708|NCT00792142|Hormones|hormones|mesh-ancestor
55847197|NCT03036904|Hormones|hormones|mesh-ancestor
55863920|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55863921|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55863922|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863923|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863924|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863926|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
55863927|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55863928|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
55863929|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863930|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863931|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
55863932|NCT01964963|Alogliptin|alogliptin|mesh-list
55863933|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55863934|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863935|NCT01964963|Incretins|incretins|mesh-ancestor
55863936|NCT01964963|Hormones|hormones|mesh-ancestor
55863937|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863938|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55863939|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
55863940|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863941|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863942|NCT01974323|Dapsone|dapsone|mesh-list
55863943|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55863944|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
55863945|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55863946|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55863947|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55863948|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863949|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863950|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
55863951|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55863952|NCT01973387|Rituximab|rituximab|mesh-list
55863953|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55863954|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863955|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
55863956|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863957|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55863958|NCT01973231|Liraglutide|liraglutide|mesh-list
55863959|NCT01973231|Lixisenatide|lixisenatide|mesh-list
55863960|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55863961|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55863962|NCT01973231|Incretins|incretins|mesh-ancestor
55863963|NCT01973231|Hormones|hormones|mesh-ancestor
55863964|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55863966|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55863967|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55863968|NCT04382950|Tretinoin|tretinoin|mesh-list
55863969|NCT04382950|Isotretinoin|isotretinoin|mesh-list
55863970|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55863971|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
55863972|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
55863973|NCT04537156|Vaccines|vaccines|mesh-list
55863974|NCT04537156|Immunologic Factors|immunologic factors|mesh-ancestor
55863976|NCT04267978|Irinotecan|irinotecan|mesh-list
55863999|NCT03839446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864000|NCT03839446|Analgesics|analgesics|mesh-ancestor
55864001|NCT03839446|Sensory System Agents|sensory system agents|mesh-ancestor
55864002|NCT03839446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864669|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
55864003|NCT03839446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864004|NCT03839446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55864005|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
55864006|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55864009|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55864010|NCT04383418|Analgesics|analgesics|mesh-ancestor
55864011|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
55864012|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864013|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55864014|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55864015|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55864016|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
55864017|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864018|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864019|NCT03414112|Oxytocin|oxytocin|mesh-list
55864020|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
55864023|NCT03839134|Lidocaine|lidocaine|mesh-list
55864048|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
55864049|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55864050|NCT03906526|Nivolumab|nivolumab|mesh-list
55864051|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55864052|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864053|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55864054|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864055|NCT03088930|Crizotinib|crizotinib|mesh-list
55864056|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864057|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55864058|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864059|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864061|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55864062|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
55864063|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55864064|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864065|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55864066|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
55864067|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864069|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
55864100|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
55864101|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55864102|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55864103|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55864104|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
55864105|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864106|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864107|NCT01149850|Bevacizumab|bevacizumab|mesh-list
55864108|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55864109|NCT01149850|Temozolomide|temozolomide|mesh-list
55864110|NCT01149850|Antibodies|antibodies|mesh-list
55864111|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
55864112|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55864113|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864114|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55864115|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55864116|NCT01149850|Growth Substances|growth substances|mesh-ancestor
55864117|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864118|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
55864119|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
55864151|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864152|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
55864153|NCT01708915|Capsaicin|capsaicin|mesh-list
55864154|NCT01708915|Nonivamide|nonivamide|mesh-list
55864155|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
55864156|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864157|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864158|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
55864159|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
55864160|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
55864161|NCT01708915|Vitamins|vitamins|mesh-ancestor
55864162|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
55864163|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
55864164|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55864165|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
55864166|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864167|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864168|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55864169|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
55864170|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
55864171|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55864172|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
55864173|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864174|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864175|NCT01747915|Pregabalin|pregabalin|mesh-list
55864176|NCT01747915|Analgesics|analgesics|mesh-ancestor
55864189|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
55864200|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
55864201|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
55864202|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
55864203|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864204|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55864205|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
55864206|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55864207|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55864208|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55864209|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864210|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864211|NCT01970501|Metoprolol|metoprolol|mesh-list
55864212|NCT01970501|Bucindolol|bucindolol|mesh-list
55864213|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55864214|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55864215|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
55864216|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
55864217|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864218|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864219|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55864220|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55864221|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55864222|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
55864223|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864224|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864225|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
55864226|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
55864227|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55864228|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55864229|NCT01969799|Amikacin|amikacin|mesh-list
55864230|NCT01969799|Fosfomycin|fosfomycin|mesh-list
55864244|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
55864245|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
55864246|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55864247|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
55864248|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55864249|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
55864250|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864251|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864252|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55864253|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55864254|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55864255|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
55864256|NCT01969565|Dexamethasone|dexamethasone|mesh-list
55864257|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55864258|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
55864259|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
55864260|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864261|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864262|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55864263|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
55864264|NCT01969565|Hormones|hormones|mesh-ancestor
55864265|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864266|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55864267|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864268|NCT01968707|Ethanol|ethanol|mesh-list
55864269|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
55864270|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55864271|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55864272|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864273|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864274|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864275|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
55864286|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55864287|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55864404|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55864405|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
55864288|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55864289|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55864290|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55864292|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864294|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
55864295|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55864296|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
55864297|NCT01946165|Hormones|hormones|mesh-ancestor
55864298|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864299|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864300|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55864301|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864302|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55864303|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864304|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864305|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
55864306|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55864307|NCT01707667|Prucalopride|prucalopride|mesh-list
55864308|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
55864309|NCT01707667|Laxatives|laxatives|mesh-ancestor
55864310|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55864311|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55864312|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55864313|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
55864314|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864315|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864316|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864317|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55864318|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
55864319|NCT01959503|Coagulants|coagulants|mesh-ancestor
55864320|NCT01706575|Interferons|interferons|mesh-list
55864329|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864330|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
55864331|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864333|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55864334|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864335|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
55864336|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55864337|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55864338|NCT01725451|Testosterone|testosterone|mesh-list
55864339|NCT01725451|Androgens|androgens|mesh-ancestor
55864340|NCT01725451|Hormones|hormones|mesh-ancestor
55864341|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864342|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864343|NCT01707290|Ivacaftor|ivacaftor|mesh-list
55864344|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55864345|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55864346|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864347|NCT01717040|Pioglitazone|pioglitazone|mesh-list
55864348|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55864349|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864350|NCT00803062|Paclitaxel|paclitaxel|mesh-list
55864351|NCT00803062|Bevacizumab|bevacizumab|mesh-list
55864352|NCT00803062|Cisplatin|cisplatin|mesh-list
55864353|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55864354|NCT00803062|Topotecan|topotecan|mesh-list
55864355|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55864356|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
55864357|NCT00803062|Antibodies|antibodies|mesh-list
55864358|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
55864359|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55864360|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
55864361|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55864362|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864363|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
55864364|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
55864365|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
55864366|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864367|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55864368|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55864369|NCT00803062|Growth Substances|growth substances|mesh-ancestor
55864370|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864371|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
55864376|NCT01743001|Macitentan|macitentan|mesh-list
55864402|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
55864406|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864407|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864408|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55864409|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55864410|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55864411|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864412|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864413|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55864414|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55864415|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55864417|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864418|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864419|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55864420|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55864421|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
55864422|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55864423|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55864425|NCT01703221|Incretins|incretins|mesh-ancestor
55864453|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864454|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55864455|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55864456|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864457|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
55864458|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864460|NCT00824044|Citalopram|citalopram|mesh-list
55864461|NCT00824044|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55864462|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55864463|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55864464|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864465|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864466|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
55864467|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864468|NCT00824044|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55864469|NCT00824044|Antidepressive Agents|antidepressive agents|mesh-ancestor
55864470|NCT00824044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55864471|NCT01702519|Nicotine|nicotine|mesh-list
55864472|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55864473|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
55864474|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864475|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864476|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55864477|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55864478|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
55864479|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864480|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864481|NCT01739335|Mifepristone|mifepristone|mesh-list
55864482|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55864483|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
55864484|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55864485|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864486|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55864487|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55864488|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55864489|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
55864490|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55864491|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55864492|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
55864493|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864494|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
55864495|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55864496|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55864498|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864499|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55864500|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864501|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864502|NCT01722097|Rocuronium|rocuronium|mesh-list
55864503|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55864504|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55864505|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55864506|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864507|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864509|NCT03879538|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55864510|NCT03879538|Anesthetics, General|anesthetics, general|mesh-ancestor
55864535|NCT05039632|Ipilimumab|ipilimumab|mesh-list
55864536|NCT05039632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55864537|NCT05039632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864538|NCT05039632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55864539|NCT05039632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864540|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55864541|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55864542|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864543|NCT01701973|Incretins|incretins|mesh-ancestor
55864544|NCT01701973|Hormones|hormones|mesh-ancestor
55864545|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864546|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55864547|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
55864548|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864549|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864550|NCT00825370|Hydromorphone|hydromorphone|mesh-list
55864551|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55864552|NCT00825370|Narcotics|narcotics|mesh-ancestor
55864553|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864554|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864555|NCT00825370|Analgesics|analgesics|mesh-ancestor
55864584|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55864585|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55864587|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
55864588|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864589|NCT01700959|Protective Agents|protective agents|mesh-ancestor
55864590|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864591|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864592|NCT00829738|Pantoprazole|pantoprazole|mesh-list
55864593|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55864594|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55864595|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55864596|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864597|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864598|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
55864599|NCT01737931|Promethazine|promethazine|mesh-list
55864600|NCT01737931|Dexamethasone|dexamethasone|mesh-list
55864601|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55864602|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
55864603|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55864604|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
55864605|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
55864606|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864607|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864642|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55864643|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
55864644|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864645|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864646|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864647|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55864648|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55864649|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
55864650|NCT01944839|Ranibizumab|ranibizumab|mesh-list
55864651|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55864652|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55864653|NCT01944839|Growth Substances|growth substances|mesh-ancestor
55864654|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864655|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
55864656|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864657|NCT04645589|Mycophenolic Acid|mycophenolic acid|mesh-list
55864658|NCT04645589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55864659|NCT04645589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864660|NCT04645589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55864661|NCT04645589|Antitubercular Agents|antitubercular agents|mesh-ancestor
55864662|NCT04645589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55864663|NCT04645589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864664|NCT04645589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864665|NCT04645589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864666|NCT01720225|Azacitidine|azacitidine|mesh-list
55864667|NCT01720225|Decitabine|decitabine|mesh-list
55864823|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864668|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55864670|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864671|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864672|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864673|NCT04548661|Povidone-Iodine|povidone-iodine|mesh-list
55864674|NCT04548661|Povidone|povidone|mesh-list
55864675|NCT04548661|Plasma Substitutes|plasma substitutes|mesh-ancestor
55864676|NCT04548661|Blood Substitutes|blood substitutes|mesh-ancestor
55864677|NCT04548661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55864678|NCT04548661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864679|NCT01943435|Acetaminophen|acetaminophen|mesh-list
55864680|NCT01943435|Ibuprofen|ibuprofen|mesh-list
55864681|NCT01943435|Celecoxib|celecoxib|mesh-list
55864682|NCT01943435|Diclofenac|diclofenac|mesh-list
55864683|NCT01943435|Gabapentin|gabapentin|mesh-list
55864684|NCT01943435|Tramadol|tramadol|mesh-list
55864685|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55864705|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55864706|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
55864707|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55864708|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55864709|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55864710|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
55864711|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
55864712|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55864713|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55864714|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864715|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55864716|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55864717|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55864718|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864719|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
55864720|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55864721|NCT01943435|Narcotics|narcotics|mesh-ancestor
55864722|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55864723|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55864724|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55864765|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
55864766|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864767|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55864769|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55864770|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864771|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
55864772|NCT01941095|Chloroquine|chloroquine|mesh-list
55864773|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
55864774|NCT01941095|Methotrexate|methotrexate|mesh-list
55864775|NCT01941095|Azathioprine|azathioprine|mesh-list
55864776|NCT01941095|Leflunomide|leflunomide|mesh-list
55864777|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55864778|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
55864779|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55864780|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864781|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55864782|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
55864783|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864784|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864785|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
55864786|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864787|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55864788|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55864789|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
55864790|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55864791|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55864792|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
55864793|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55864794|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55864795|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864796|NCT01941095|Amebicides|amebicides|mesh-ancestor
55864815|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864816|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55864817|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55864818|NCT00831766|Growth Substances|growth substances|mesh-ancestor
55864819|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
55864820|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55864821|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55864822|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55864826|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864827|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
55864828|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864829|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55864830|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55864834|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55864835|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55864837|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864838|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864839|NCT04644029|Tenofovir|tenofovir|mesh-list
55864840|NCT04644029|Emtricitabine|emtricitabine|mesh-list
55864862|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864863|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
55864864|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864865|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55864866|NCT00834652|Metformin|metformin|mesh-list
55864867|NCT00834652|Sertraline|sertraline|mesh-list
55864868|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55864869|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864870|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
55864871|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55864872|NCT00834652|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55864873|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55864874|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55864875|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864876|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55864877|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
55864878|NCT00834808|Tramadol|tramadol|mesh-list
55864879|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55864880|NCT00834808|Narcotics|narcotics|mesh-ancestor
55864894|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864895|NCT00835198|Dapsone|dapsone|mesh-list
55864896|NCT00835198|Tretinoin|tretinoin|mesh-list
55864897|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55864898|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
55864899|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
55864900|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864901|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
55864902|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55864903|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55864904|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55864905|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864906|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864907|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
55864908|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55864909|NCT00835510|Butenafine|butenafine|mesh-list
55864910|NCT00835510|Clotrimazole|clotrimazole|mesh-list
55864911|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
55864912|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55864953|NCT03856216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864954|NCT03856216|Dermatologic Agents|dermatologic agents|mesh-ancestor
55864955|NCT03856216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864956|NCT03856216|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55864957|NCT03856216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55864958|NCT03856216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55864959|NCT03856216|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55864960|NCT03856216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55864961|NCT03856216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55864962|NCT03856216|Alkylating Agents|alkylating agents|mesh-ancestor
55864964|NCT03856216|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55864965|NCT01954121|Carbamazepine|carbamazepine|mesh-list
55864966|NCT01954121|Levetiracetam|levetiracetam|mesh-list
55864967|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
55864968|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
55864969|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
55864970|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55864971|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55864972|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55864973|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55864974|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55864975|NCT01954121|Analgesics|analgesics|mesh-ancestor
55864976|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
55864977|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55864978|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55864979|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55864980|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864981|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55865095|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
55864982|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55864983|NCT03643744|Celecoxib|celecoxib|mesh-list
55864984|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55864986|NCT03643744|Analgesics|analgesics|mesh-ancestor
55864991|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55864992|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55864993|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55864994|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55864995|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55864996|NCT03770260|Ixazomib|ixazomib|mesh-list
55864997|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55864998|NCT03770260|Pevonedistat|pevonedistat|mesh-list
55864999|NCT03770260|Glycine|glycine|mesh-list
55865000|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865001|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865002|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
55865003|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
55865004|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865005|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865006|NCT00838162|Ritonavir|ritonavir|mesh-list
55865007|NCT00838162|TMC-310911|tmc-310911|mesh-list
55865008|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55865009|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55865010|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
55865011|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865012|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865013|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55865014|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55865015|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
55865016|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865017|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55865038|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55865039|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
55865040|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865041|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55865042|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
55865043|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55865044|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55865045|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865046|NCT00853840|Urological Agents|urological agents|mesh-ancestor
55865047|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
55865049|NCT00841828|Trastuzumab|trastuzumab|mesh-list
55865050|NCT00841828|Epirubicin|epirubicin|mesh-list
55865051|NCT00841828|Lapatinib|lapatinib|mesh-list
55865052|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865053|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
55865054|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865055|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865056|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55865057|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
55865058|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865059|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865060|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55865061|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
55865062|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
55865063|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
55865064|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55865065|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55865066|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55865067|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55865068|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865069|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55865070|NCT00855010|Pioglitazone|pioglitazone|mesh-list
55865071|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55865080|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55865081|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55865082|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55865083|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55865084|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865085|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55865086|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
55865087|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865088|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865089|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55865090|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
55865094|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865096|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865097|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
55865098|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55865099|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55865100|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55865134|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865135|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865136|NCT02453620|Nivolumab|nivolumab|mesh-list
55865137|NCT02453620|Ipilimumab|ipilimumab|mesh-list
55865138|NCT02453620|Entinostat|entinostat|mesh-list
55865139|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
55865140|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55865141|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865142|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55865143|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865144|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865198|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865199|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
55865200|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
55865201|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865203|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
55865204|NCT00890656|Hormones|hormones|mesh-ancestor
55865205|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55865206|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55865207|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865208|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55865209|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55865210|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55865211|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55865212|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
55865213|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55865214|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55865215|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
55865216|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
55865217|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55865218|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55865219|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55865220|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
55865221|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
55865222|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
55865240|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865241|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55865242|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
55865243|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865244|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865245|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55865246|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
55865247|NCT00860938|Glucocorticoids|glucocorticoids|mesh-ancestor
55865248|NCT00860938|Hormones|hormones|mesh-ancestor
55865249|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55865250|NCT04266730|Pembrolizumab|pembrolizumab|mesh-list
55865251|NCT04266730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55865252|NCT04266730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865253|NCT01719757|Oxycodone|oxycodone|mesh-list
55865254|NCT01719757|Naloxone|naloxone|mesh-list
55865255|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55865256|NCT01719757|Narcotics|narcotics|mesh-ancestor
55865257|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55865258|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865259|NCT01719757|Analgesics|analgesics|mesh-ancestor
55865260|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
55865261|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865262|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55865263|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55865293|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865294|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55865295|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
55865296|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865297|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865298|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55865299|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55865300|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55865301|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55865302|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865303|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55865304|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
55865305|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
55865306|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
55865307|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55865308|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55865309|NCT01857934|Analgesics|analgesics|mesh-ancestor
55865310|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
55865311|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865312|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55865313|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55865314|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
55865315|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865316|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55865317|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
55865319|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
55865320|NCT00862810|Vaccines|vaccines|mesh-list
55865321|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
55865322|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865323|NCT00863122|Lapatinib|lapatinib|mesh-list
55865328|NCT01604785|Dopamine|dopamine|mesh-list
55865333|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865334|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55865335|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
55865336|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
55865337|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55865338|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
55865339|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
55865340|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865341|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
55865342|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865343|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865344|NCT01604785|Protective Agents|protective agents|mesh-ancestor
55865345|NCT01681849|Paroxetine|paroxetine|mesh-list
55865346|NCT01681849|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55865347|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55865348|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55865349|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865350|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865351|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
55865352|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865353|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55865354|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
55865355|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865356|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55865357|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55865358|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865359|NCT00863356|Hemostatics|hemostatics|mesh-list
55865360|NCT00863356|Chitosan|chitosan|mesh-list
55865361|NCT00863356|Coagulants|coagulants|mesh-ancestor
55865362|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55865363|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55865377|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865378|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
55865379|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865380|NCT04228042|Infigratinib|infigratinib|mesh-list
55865381|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865382|NCT04209790|Temozolomide|temozolomide|mesh-list
55865383|NCT04209790|Benzolamide|benzolamide|mesh-list
55865384|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55865385|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
55865386|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865387|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865388|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55865389|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865390|NCT01718353|Prednisone|prednisone|mesh-list
55865391|NCT01718353|Docetaxel|docetaxel|mesh-list
55865392|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865393|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
55865394|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
55865395|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
55865396|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865397|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865398|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
55865399|NCT01718353|Hormones|hormones|mesh-ancestor
55865400|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55865428|NCT01935947|Azacitidine|azacitidine|mesh-list
55865429|NCT01935947|Docetaxel|docetaxel|mesh-list
55865430|NCT01935947|Irinotecan|irinotecan|mesh-list
55865431|NCT01935947|Pemetrexed|pemetrexed|mesh-list
55865432|NCT01935947|Camptothecin|camptothecin|mesh-list
55865433|NCT01935947|Entinostat|entinostat|mesh-list
55865434|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
55865435|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55865436|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
55865437|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865438|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865439|NCT01935947|Antiviral Agents|antiviral agents|mesh-ancestor
55865440|NCT01935947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865441|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865442|NCT01935947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865443|NCT01935947|Immunologic Factors|immunologic factors|mesh-ancestor
55865444|NCT01935947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865445|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
55865446|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
55865447|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
55865448|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55865449|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55865450|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55865477|NCT01951157|Immunologic Factors|immunologic factors|mesh-ancestor
55865478|NCT01951157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865479|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
55865480|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
55865481|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
55865482|NCT01363349|Risperidone|risperidone|mesh-list
55865483|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55865484|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
55865485|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865486|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865487|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865488|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55865489|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55865490|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55865491|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865492|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55865493|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
55865494|NCT00818272|Infliximab|infliximab|mesh-list
55865495|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
55865496|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55865497|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865498|NCT00868348|Ketorolac|ketorolac|mesh-list
55865499|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55865500|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55865501|NCT00868348|Analgesics|analgesics|mesh-ancestor
55865502|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
55865503|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865504|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865505|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865522|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
55865523|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55865524|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
55865525|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55865526|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55865527|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55865528|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
55865529|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55865530|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865531|NCT01933217|Methylphenidate|methylphenidate|mesh-list
55865532|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55865533|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865534|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55865535|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55865536|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55865537|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865538|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
55865540|NCT01949051|Levocabastine|levocabastine|mesh-list
55865541|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55865542|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55865544|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
55865545|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865546|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865677|NCT01929083|Ibutilide|ibutilide|mesh-list
55865547|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865548|NCT01692301|Amlodipine|amlodipine|mesh-list
55865549|NCT01692301|Valsartan|valsartan|mesh-list
55865564|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
55865565|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55865567|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55865568|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55865569|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
55865570|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865571|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865572|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865573|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55865574|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55865575|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
55865576|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865577|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
55865578|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865579|NCT01592695|Ethanol|ethanol|mesh-list
55865580|NCT01592695|Bupropion|bupropion|mesh-list
55865581|NCT01592695|Nicotine|nicotine|mesh-list
55865582|NCT01592695|Varenicline|varenicline|mesh-list
55865583|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55865584|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
55865585|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865586|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865587|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55865588|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55865589|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
55865590|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865591|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865592|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55865593|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865594|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55865595|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55865596|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
55865597|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865598|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55865599|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55865600|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55865601|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
55865602|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55865603|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55865604|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865605|NCT01929863|Metformin|metformin|mesh-list
55865606|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55865607|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865608|NCT01714609|Sorafenib|sorafenib|mesh-list
55865609|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865610|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55865614|NCT04553263|Naltrexone|naltrexone|mesh-list
55865651|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865652|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55865653|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865654|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865655|NCT01929317|Ropinirole|ropinirole|mesh-list
55865656|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55865657|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55865658|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
55865659|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
55865660|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865661|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865662|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865663|NCT01711879|Aflibercept|aflibercept|mesh-list
55865664|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55865665|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55865666|NCT01711879|Growth Substances|growth substances|mesh-ancestor
55865667|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865668|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
55865669|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865670|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
55865671|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55865672|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865674|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
55865675|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55865676|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865678|NCT01929083|Progesterone|progesterone|mesh-list
55865679|NCT01929083|Progestins|progestins|mesh-ancestor
55865680|NCT01929083|Hormones|hormones|mesh-ancestor
55865682|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865698|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
55865699|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55865700|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
55865701|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865702|NCT01711645|Antacids|antacids|mesh-ancestor
55865703|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865704|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55865705|NCT00820534|Penciclovir|penciclovir|mesh-list
55865706|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
55865707|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865708|NCT01590433|Exenatide|exenatide|mesh-list
55865709|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55865710|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865711|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55865712|NCT01590433|Incretins|incretins|mesh-ancestor
55865713|NCT01590433|Hormones|hormones|mesh-ancestor
55865714|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55865715|NCT00820612|Indomethacin|indomethacin|mesh-list
55865716|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55865717|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55865718|NCT00820612|Analgesics|analgesics|mesh-ancestor
55865719|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
55865720|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865721|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865722|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865723|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55865724|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
55865725|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
55865726|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55865727|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55865728|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865729|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865730|NCT01928927|Telmisartan|telmisartan|mesh-list
55865732|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55865733|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55865734|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865735|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
55865736|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55865737|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55865738|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865739|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55865740|NCT00871624|Analgesics|analgesics|mesh-ancestor
55865741|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
55865742|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55865743|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55865744|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55865745|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55865746|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
55865747|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865748|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865749|NCT01710709|Aripiprazole|aripiprazole|mesh-list
55865750|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
55865751|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865752|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55865780|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865781|NCT05236504|Protective Agents|protective agents|mesh-ancestor
55865782|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865783|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55865784|NCT01685983|Prednisolone|prednisolone|mesh-list
55865785|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
55865786|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55865787|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
55865789|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55865790|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865791|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55865792|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865793|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55865795|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865796|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
55865797|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55865798|NCT02151448|Interferons|interferons|mesh-list
55865799|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
55865800|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
55865801|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
55865802|NCT02151448|Celecoxib|celecoxib|mesh-list
55865803|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865804|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
55865805|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865810|NCT02151448|Analgesics|analgesics|mesh-ancestor
55865829|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55865830|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865831|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55865832|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55865833|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
55865834|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55865863|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55865865|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55865866|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55865867|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865868|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
55865869|NCT01589497|Rifampin|rifampin|mesh-list
55865870|NCT01589497|Isoniazid|isoniazid|mesh-list
55865871|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
55865872|NCT01589497|Ethambutol|ethambutol|mesh-list
55865873|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55865874|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55865875|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55865876|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55865877|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865878|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865879|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865880|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55865881|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
55865919|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55865920|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55865921|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
55865922|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55865923|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55865924|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55865930|NCT01927757|Analgesics|analgesics|mesh-ancestor
55865988|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55865989|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55865990|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55865991|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55865992|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55865993|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55865994|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55865995|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55865996|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55865997|NCT01911845|Ribavirin|ribavirin|mesh-list
55865998|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
55865999|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866000|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
55866001|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866002|NCT01925183|Interferons|interferons|mesh-list
55866003|NCT01925183|Ribavirin|ribavirin|mesh-list
55866004|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
55866046|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866047|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866048|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55866050|NCT01908803|Hormones|hormones|mesh-ancestor
55866051|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866052|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55866053|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866054|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55866055|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55866056|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55866057|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55866058|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866059|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866060|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55866061|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55866101|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55866102|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55866103|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55866104|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55866105|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866106|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
55866107|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866108|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866109|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55866168|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866169|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
55866170|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55866171|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866172|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
55866173|NCT00879034|Pravastatin|pravastatin|mesh-list
55866175|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55866176|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866177|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55866178|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55866179|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
55866180|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866181|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55866182|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55866183|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866184|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
55866185|NCT04088890|Fludarabine|fludarabine|mesh-list
55866186|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866187|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
55866188|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866219|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866220|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
55866221|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
55866222|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866223|NCT01709149|Riluzole|riluzole|mesh-list
55866224|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
55866225|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55866226|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55866286|NCT01903031|Tenofovir|tenofovir|mesh-list
55866287|NCT01903031|Efavirenz|efavirenz|mesh-list
55866288|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
55866289|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
55866290|NCT01903031|Etonogestrel|etonogestrel|mesh-list
55866291|NCT01903031|NuvaRing|nuvaring|mesh-list
55866292|NCT01903031|Estradiol|estradiol|mesh-list
55866293|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55866294|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55866295|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
55866296|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866306|NCT01903031|Hormones|hormones|mesh-ancestor
55866352|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
55866353|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866354|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55866355|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55866356|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866357|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866358|NCT00893074|Hormones|hormones|mesh-ancestor
55866359|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55866364|NCT00887458|Itraconazole|itraconazole|mesh-list
55866414|NCT03218722|Coagulants|coagulants|mesh-ancestor
55866415|NCT00888628|Etanercept|etanercept|mesh-list
55866416|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55866417|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866418|NCT00888628|Analgesics|analgesics|mesh-ancestor
55866419|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
55866420|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866421|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866422|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866423|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866424|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55866425|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866426|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
55866428|NCT03837886|Calcium|calcium|mesh-list
55866429|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55866430|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866431|NCT03837886|Antacids|antacids|mesh-ancestor
55866432|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866433|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55866434|NCT03219970|Osimertinib|osimertinib|mesh-list
55866435|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866436|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55866437|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866438|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866439|NCT03175432|Bevacizumab|bevacizumab|mesh-list
55866440|NCT03175432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55866441|NCT03175432|Atezolizumab|atezolizumab|mesh-list
55866442|NCT03175432|Endothelial Growth Factors|endothelial growth factors|mesh-list
55866443|NCT03175432|Antibodies|antibodies|mesh-list
55866444|NCT03175432|Immunoglobulins|immunoglobulins|mesh-list
55866445|NCT03175432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55866446|NCT03175432|Immunoglobulin G|immunoglobulin g|mesh-list
55866447|NCT03175432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866448|NCT03175432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55866453|NCT03175432|Immunologic Factors|immunologic factors|mesh-ancestor
55866454|NCT00889330|Alcaftadine|alcaftadine|mesh-list
55866455|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55866456|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
55866457|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
55866458|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866459|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866460|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866461|NCT03219580|Fluorouracil|fluorouracil|mesh-list
55866462|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
55866469|NCT03215446|Anesthetics|anesthetics|mesh-list
55866516|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55866517|NCT01919801|Icatibant|icatibant|mesh-list
55866518|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55866519|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55866520|NCT01919801|Analgesics|analgesics|mesh-ancestor
55866521|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
55866522|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866523|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866524|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866525|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866526|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
55866527|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
55866576|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55866577|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866578|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866579|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866580|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
55866581|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866582|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866584|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
55866585|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55866586|NCT01889069|Rituximab|rituximab|mesh-list
55866587|NCT01889069|Doxorubicin|doxorubicin|mesh-list
55866588|NCT01889069|Vincristine|vincristine|mesh-list
55866589|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866590|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
55866591|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866592|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866635|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55866636|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866637|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
55866638|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55866639|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
55866640|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866641|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55866642|NCT03217942|Mitogens|mitogens|mesh-list
55866643|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
55867728|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55866644|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866645|NCT00903448|Omeprazole|omeprazole|mesh-list
55866700|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866701|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866702|NCT01738646|Bevacizumab|bevacizumab|mesh-list
55866703|NCT01738646|Vorinostat|vorinostat|mesh-list
55866704|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55866705|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866706|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55866707|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55866708|NCT01738646|Growth Substances|growth substances|mesh-ancestor
55866764|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55866765|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55866766|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55866767|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866769|NCT01830478|Lenalidomide|lenalidomide|mesh-list
55866770|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55866771|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866772|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
55866779|NCT01838200|Isoniazid|isoniazid|mesh-list
55866830|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55866831|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866832|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
55866833|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866834|NCT01671891|Capecitabine|capecitabine|mesh-list
55866835|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
55866836|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55866837|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
55866838|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866839|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866840|NCT05189457|Docetaxel|docetaxel|mesh-list
55866841|NCT05189457|Leuprolide|leuprolide|mesh-list
55866842|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55866843|NCT05189457|Hormones|hormones|mesh-list
55866845|NCT05189457|Relugolix|relugolix|mesh-list
55866889|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55866890|NCT01672047|Vitamin D|vitamin d|mesh-list
55866891|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
55866892|NCT01672047|Vitamins|vitamins|mesh-ancestor
55866893|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
55866894|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55866895|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55866896|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55866897|NCT04170543|Dapagliflozin|dapagliflozin|mesh-list
55866898|NCT04170543|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55866899|NCT04170543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866953|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55866954|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866955|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55866956|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55866957|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55866958|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55866959|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
55866961|NCT05384691|Hematinics|hematinics|mesh-ancestor
55866962|NCT03210610|Colchicine|colchicine|mesh-list
55866963|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
55866964|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55866965|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
55866966|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
55866967|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
55866968|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55866969|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55866970|NCT03152955|Sufentanil|sufentanil|mesh-list
55866971|NCT03152955|Ketamine|ketamine|mesh-list
55866972|NCT03152955|Ondansetron|ondansetron|mesh-list
55866973|NCT03152955|Analgesics|analgesics|mesh-ancestor
55866974|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
55867009|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
55867010|NCT01721434|Simendan|simendan|mesh-list
55867011|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55867012|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
55867013|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55867014|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55867015|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867016|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867017|NCT01721434|Protective Agents|protective agents|mesh-ancestor
55867729|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55867020|NCT03210532|Telmisartan|telmisartan|mesh-list
55867021|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
55867022|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55867023|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55867024|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55867025|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55867026|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867027|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55867028|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867029|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
55867030|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55867031|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55867033|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55867034|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55867035|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867036|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55867037|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55867038|NCT03152565|Avelumab|avelumab|mesh-list
55867039|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55867049|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867050|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55867051|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867052|NCT03215524|Thalidomide|thalidomide|mesh-list
55867053|NCT03215524|Dexamethasone|dexamethasone|mesh-list
55867054|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
55867055|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
55867056|NCT03215524|Daratumumab|daratumumab|mesh-list
55867057|NCT03215524|Pomalidomide|pomalidomide|mesh-list
55867058|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55867059|NCT03215524|BB 1101|bb 1101|mesh-list
55867060|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55867061|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
55867062|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867063|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867064|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55867065|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
55867066|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867067|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867068|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55867069|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55867070|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
55867071|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
55867072|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867073|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55867074|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
55867075|NCT03215524|Hormones|hormones|mesh-ancestor
55867076|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55867077|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55867078|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
55867095|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
55867096|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
55867097|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
55867098|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55867099|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55867100|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
55867101|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867102|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867103|NCT04764825|Morphine|morphine|mesh-list
55867160|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55867161|NCT02459457|Carboplatin|carboplatin|mesh-list
55867162|NCT02459457|Fluorouracil|fluorouracil|mesh-list
55867163|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55867164|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867165|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
55867166|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
55867167|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
55867168|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867169|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
55867170|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55867171|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55867172|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
55867173|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867174|NCT01835236|Paclitaxel|paclitaxel|mesh-list
55867175|NCT01835236|Vinorelbine|vinorelbine|mesh-list
55867176|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55867219|NCT01835314|Stiripentol|stiripentol|mesh-list
55867220|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
55867221|NCT01725802|Levodopa|levodopa|mesh-list
55867222|NCT01725802|Carbidopa|carbidopa|mesh-list
55867223|NCT01725802|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55867224|NCT01725802|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55867225|NCT01725802|Dopamine Agents|dopamine agents|mesh-ancestor
55867226|NCT01725802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867227|NCT01725802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867228|NCT01725802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868037|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
55867229|NCT01725802|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55867230|NCT01725802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867231|NCT01706198|Fluticasone|fluticasone|mesh-list
55867283|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55867284|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55867285|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55867286|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55867287|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55867288|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867289|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55867290|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867291|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867292|NCT01836016|Fluticasone|fluticasone|mesh-list
55867293|NCT01836016|Xhance|xhance|mesh-list
55867294|NCT01836016|Albuterol|albuterol|mesh-list
55867295|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
55867345|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
55867346|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867347|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867348|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55867349|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867350|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55867351|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867352|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867353|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55867354|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55867355|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867356|NCT01726816|Probucol|probucol|mesh-list
55867357|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55867358|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55867359|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
55867360|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867361|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55867362|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
55867363|NCT01726816|Protective Agents|protective agents|mesh-ancestor
55867364|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867365|NCT00915538|Budesonide|budesonide|mesh-list
55867367|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55867396|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
55867397|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
55867398|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867399|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
55867400|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
55867401|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867402|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867403|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867404|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55867405|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
55867406|NCT01727050|Coagulants|coagulants|mesh-ancestor
55867407|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
55867408|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55867409|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55867410|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867411|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
55867414|NCT01837108|Eplerenone|eplerenone|mesh-list
55867451|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55867452|NCT01837576|Calcipotriene|calcipotriene|mesh-list
55867453|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
55867454|NCT01737710|Vaccines|vaccines|mesh-list
55867455|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
55867456|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867457|NCT01837810|Ibuprofen|ibuprofen|mesh-list
55867730|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55867458|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55867459|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55867460|NCT01837810|Analgesics|analgesics|mesh-ancestor
55867461|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
55867462|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867469|NCT01725100|Trametinib|trametinib|mesh-list
55867515|NCT01838434|Idelalisib|idelalisib|mesh-list
55867516|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
55867517|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867518|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55867519|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55867520|NCT01838434|Growth Substances|growth substances|mesh-ancestor
55867521|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
55867522|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867523|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867524|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867525|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55867526|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
55867527|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55867528|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
55867529|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867530|NCT04377646|Zinc|zinc|mesh-list
55867531|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
55867532|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
55867533|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55867574|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55867575|NCT03409432|Growth Substances|growth substances|mesh-ancestor
55867576|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
55867577|NCT01703858|Pantoprazole|pantoprazole|mesh-list
55867578|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55867579|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55867580|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55867581|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867582|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867583|NCT01729468|Aspirin|aspirin|mesh-list
55867584|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55867636|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
55867637|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867638|NCT03405142|Panitumumab|panitumumab|mesh-list
55867639|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
55867640|NCT03405142|Dextrans|dextrans|mesh-list
55867641|NCT03405142|Edetic Acid|edetic acid|mesh-list
55867643|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55867644|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867645|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
55867646|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
55867647|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
55867648|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55867649|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867650|NCT03405142|Antidotes|antidotes|mesh-ancestor
55867651|NCT03405142|Protective Agents|protective agents|mesh-ancestor
55867699|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55867700|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55867702|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867703|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55867704|NCT03407404|Narcotics|narcotics|mesh-ancestor
55867705|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55867706|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55867707|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55867708|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55867709|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55867710|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
55867711|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
55867713|NCT03830086|Sufentanil|sufentanil|mesh-list
55867714|NCT03830086|Bupivacaine|bupivacaine|mesh-list
55867715|NCT03830086|Propofol|propofol|mesh-list
55867716|NCT03830086|Sevoflurane|sevoflurane|mesh-list
55867717|NCT03830086|Rocuronium|rocuronium|mesh-list
55867718|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
55867719|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
55867720|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55867721|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867722|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
55867723|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867724|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55867725|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55867726|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
55867727|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55867745|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867746|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
55867747|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
55867748|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
55867749|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867751|NCT01047436|Quinine|quinine|mesh-list
55867752|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
55867753|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55867754|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55867755|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867756|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55867757|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867758|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55867759|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867760|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55867761|NCT01047436|Analgesics|analgesics|mesh-ancestor
55867762|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
55867763|NCT03406936|Midazolam|midazolam|mesh-list
55867764|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55867765|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55867766|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55867767|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867768|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55867769|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55867770|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55867771|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55867772|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
55867774|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
55867775|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
55867776|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867778|NCT02240602|Oxycodone|oxycodone|mesh-list
55867789|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55867790|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867792|NCT03406546|Analgesics|analgesics|mesh-ancestor
55867793|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
55867794|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867795|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55867796|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55867797|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55867798|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
55867799|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55867850|NCT00921310|Pemetrexed|pemetrexed|mesh-list
55867851|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55867852|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867853|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55867854|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55867855|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55867856|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55867857|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55867858|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55867859|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
55867860|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55867861|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
55867862|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867911|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55867912|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55867913|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867914|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
55867915|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55867916|NCT01040260|Nicotine|nicotine|mesh-list
55867917|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55867918|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
55867919|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867920|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867921|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55867926|NCT01046422|Metformin|metformin|mesh-list
55867977|NCT01592708|Propofol|propofol|mesh-list
55867978|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
55867979|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55867980|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55867981|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55867982|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55867983|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
55867984|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55867985|NCT01592708|Narcotics|narcotics|mesh-ancestor
55867986|NCT01592708|Analgesics|analgesics|mesh-ancestor
55867987|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
55867988|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55867989|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55867990|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55867991|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55867992|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55867993|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55867994|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55867995|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55867997|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
55868034|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55868035|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868036|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
55868038|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
55868039|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868040|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55868041|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55868042|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868043|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55868044|NCT01702844|Paclitaxel|paclitaxel|mesh-list
55868045|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55868098|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55868099|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55868100|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55868101|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55868102|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868103|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868166|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868167|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
55868168|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55868169|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55868170|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868171|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55868172|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55868173|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55868174|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868175|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55868177|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55868192|NCT02982850|Aspirin|aspirin|mesh-list
55868229|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
55868230|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868231|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868232|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
55868233|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55868234|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
55868235|NCT03403972|Vancomycin|vancomycin|mesh-list
55868236|NCT03403972|Simvastatin|simvastatin|mesh-list
55868237|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55868238|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55868239|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
55868240|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868241|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55868242|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55868243|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868244|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55868245|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868246|NCT02242318|Valsartan|valsartan|mesh-list
55868247|NCT02242318|Telmisartan|telmisartan|mesh-list
55868248|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55868249|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55868250|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55868251|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868252|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
55868253|NCT01700192|Loratadine|loratadine|mesh-list
55868254|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55868277|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55868278|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
55868279|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
55868280|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55868281|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55868282|NCT01700192|Analgesics|analgesics|mesh-ancestor
55868283|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
55868284|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55868286|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55868287|NCT02242396|Telmisartan|telmisartan|mesh-list
55868288|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
55868289|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55868290|NCT02242396|Diuretics|diuretics|mesh-ancestor
55868291|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
55868292|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868293|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55868294|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55868295|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868296|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55868297|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55868328|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868329|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868331|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55868332|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
55868333|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868334|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868335|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55868336|NCT04374604|Mitogens|mitogens|mesh-list
55868391|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55868392|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868393|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55868394|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
55868395|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55868396|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55868397|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55868398|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55868399|NCT02243254|Ibuprofen|ibuprofen|mesh-list
55868400|NCT02243254|Remifentanil|remifentanil|mesh-list
55868401|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55868402|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55868403|NCT02243254|Analgesics|analgesics|mesh-ancestor
55868404|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
55868405|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868406|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868407|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55868408|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55868409|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55868410|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868411|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868412|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55868413|NCT02243254|Narcotics|narcotics|mesh-ancestor
55868414|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868415|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
55868422|NCT01673997|Metoprolol|metoprolol|mesh-list
55868437|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868439|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
55868440|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55868441|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55868442|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55868443|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868444|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868445|NCT01676571|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55868446|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55868447|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55868448|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868449|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55868450|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
55868451|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55868452|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55868453|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55868454|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55868455|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
55868456|NCT01699178|Testosterone|testosterone|mesh-list
55868457|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
55868458|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
55868459|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55868460|NCT01699178|Androgens|androgens|mesh-ancestor
55868461|NCT01699178|Hormones|hormones|mesh-ancestor
55868485|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55868486|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868487|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55868488|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55868489|NCT01670175|Sirolimus|sirolimus|mesh-list
55868490|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
55868491|NCT01670175|Topotecan|topotecan|mesh-list
55868492|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55868493|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
55868494|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868495|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55868496|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55868497|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
55868498|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868499|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868500|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55868501|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55868502|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868503|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55868504|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
55868505|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55868506|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55868507|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868508|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55868509|NCT02243566|Telmisartan|telmisartan|mesh-list
55868510|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
55868512|NCT02243566|Diuretics|diuretics|mesh-ancestor
55868513|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
55868514|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868515|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55868516|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55868517|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868518|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55868519|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55868520|NCT02243644|Albendazole|albendazole|mesh-list
55868521|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
55868522|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55868523|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55868524|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
55868525|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55868532|NCT01988883|Propranolol|propranolol|mesh-list
55868582|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55868583|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868584|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55868585|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868586|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
55868587|NCT02243800|Vitamin D|vitamin d|mesh-list
55868588|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55868589|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868647|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55868648|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
55868649|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868650|NCT03854799|Capecitabine|capecitabine|mesh-list
55868651|NCT03854799|Avelumab|avelumab|mesh-list
55868652|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55868653|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
55868654|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868655|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868656|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55868657|NCT00924352|Dasatinib|dasatinib|mesh-list
55868658|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868659|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55868660|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868662|NCT01674933|Listerine|listerine|mesh-list
55868704|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868705|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55868706|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55868707|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
55868708|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55868709|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55868710|NCT01675557|Vitamin D|vitamin d|mesh-list
55868711|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
55868712|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
55868713|NCT01675557|Vitamins|vitamins|mesh-list
55868714|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
55868715|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868716|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55868717|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55868718|NCT01675947|Sirolimus|sirolimus|mesh-list
55868719|NCT01675947|Lidocaine|lidocaine|mesh-list
55868720|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
55868721|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
55868722|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868724|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
55868761|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868762|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
55868763|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868764|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868765|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55868766|NCT01567826|Atorvastatin|atorvastatin|mesh-list
55868767|NCT01567826|Simvastatin|simvastatin|mesh-list
55868768|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55868769|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55868781|NCT03653247|Plerixafor|plerixafor|mesh-list
55868825|NCT03643107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868826|NCT03643107|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55868827|NCT03643107|Alkylating Agents|alkylating agents|mesh-ancestor
55868828|NCT03643107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868830|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55868831|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
55868832|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55868833|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868834|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55868835|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55868836|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
55868849|NCT04372732|Autoantibodies|autoantibodies|mesh-list
55868887|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55868888|NCT04372342|Narcotics|narcotics|mesh-ancestor
55868889|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868890|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868891|NCT04372342|Analgesics|analgesics|mesh-ancestor
55868892|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
55868893|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868894|NCT04372264|Acetaminophen|acetaminophen|mesh-list
55868895|NCT04372264|Ibuprofen|ibuprofen|mesh-list
55868896|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55868897|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55868898|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55868899|NCT04372264|Analgesics|analgesics|mesh-ancestor
55868900|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
55868901|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55868902|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868903|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55868904|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55868905|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55868906|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55868907|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868909|NCT02083809|Oxytocin|oxytocin|mesh-list
55868910|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
55868911|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55868912|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868913|NCT02244112|Midazolam|midazolam|mesh-list
55868914|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55868915|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55868916|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55868917|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868918|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55868919|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55868923|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
55868931|NCT03721653|Oxaliplatin|oxaliplatin|mesh-list
55868932|NCT03721653|Irinotecan|irinotecan|mesh-list
55868933|NCT03721653|Atezolizumab|atezolizumab|mesh-list
55868934|NCT03721653|Levoleucovorin|levoleucovorin|mesh-list
55868935|NCT03721653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55868936|NCT03721653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55868937|NCT03721653|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55868938|NCT03721653|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55868939|NCT03721653|Growth Substances|growth substances|mesh-ancestor
55868940|NCT03721653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55868941|NCT03721653|Growth Inhibitors|growth inhibitors|mesh-ancestor
55868942|NCT03721653|Antimetabolites|antimetabolites|mesh-ancestor
55869658|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
55868943|NCT03721653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55868996|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55868997|NCT00929344|Analgesics|analgesics|mesh-ancestor
55868998|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
55868999|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869000|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869001|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
55869002|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55869003|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869004|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869005|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55869006|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55869007|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55869008|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869009|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55869010|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55869011|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55869012|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869013|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
55869014|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
55869045|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55869046|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
55869048|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869049|NCT03629613|Protective Agents|protective agents|mesh-ancestor
55869050|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869051|NCT03629223|Tepotinib|tepotinib|mesh-list
55869052|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869053|NCT03720717|Baclofen|baclofen|mesh-list
55869054|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55869055|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869109|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55869110|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
55869111|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55869112|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
55869113|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869114|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869115|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55869116|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
55869117|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869118|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869173|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869174|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55869175|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
55869176|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55869177|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55869178|NCT04370782|Azithromycin|azithromycin|mesh-list
55869179|NCT04370782|Doxycycline|doxycycline|mesh-list
55869180|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
55869181|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
55869182|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55869240|NCT03594747|Antimitotic Agents|antimitotic agents|mesh-ancestor
55869241|NCT03594747|Mitosis Modulators|mitosis modulators|mesh-ancestor
55869242|NCT03594747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869243|NCT05620654|Paclitaxel|paclitaxel|mesh-list
55869244|NCT05620654|Cisplatin|cisplatin|mesh-list
55869245|NCT05620654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55869246|NCT05620654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869247|NCT05620654|Tubulin Modulators|tubulin modulators|mesh-ancestor
55869248|NCT05620654|Antimitotic Agents|antimitotic agents|mesh-ancestor
55869249|NCT05620654|Mitosis Modulators|mitosis modulators|mesh-ancestor
55869250|NCT05620654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869251|NCT03692325|Nivolumab|nivolumab|mesh-list
55869252|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55869253|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869254|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55869255|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869256|NCT04357522|Vaccines|vaccines|mesh-list
55869257|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55869258|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
55869259|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869260|NCT03801369|Durvalumab|durvalumab|mesh-list
55869261|NCT03801369|Olaparib|olaparib|mesh-list
55869262|NCT03801369|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
55869263|NCT03801369|Immunoglobulins|immunoglobulins|mesh-list
55869264|NCT03801369|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55869265|NCT03801369|Immunoglobulin G|immunoglobulin g|mesh-list
55869266|NCT03801369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55869267|NCT03801369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869268|NCT03801369|Immunologic Factors|immunologic factors|mesh-ancestor
55869269|NCT03801369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869270|NCT03801369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869271|NCT03801369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869272|NCT00005901|Pamidronate|pamidronate|mesh-list
55869273|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55869279|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55869280|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55869281|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
55869282|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869283|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869284|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869286|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869287|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
55869288|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
55869289|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
55869291|NCT03685773|Nicotinic Acids|nicotinic acids|mesh-list
55869292|NCT03685773|Niacinamide|niacinamide|mesh-list
55869293|NCT03685773|Diazoxide|diazoxide|mesh-list
55869294|NCT03685773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55869295|NCT03685773|Antimetabolites|antimetabolites|mesh-ancestor
55869296|NCT03685773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869298|NCT03685773|Vasodilator Agents|vasodilator agents|mesh-ancestor
55869338|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55869339|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869340|NCT03587961|Ivacaftor|ivacaftor|mesh-list
55869341|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55869342|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869343|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869344|NCT04370392|Anesthetics|anesthetics|mesh-list
55869345|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
55869346|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869347|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869348|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
55869349|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869350|NCT03797001|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55869399|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869400|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
55869401|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869402|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
55869403|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869404|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
55869405|NCT04363216|Vitamins|vitamins|mesh-ancestor
55869406|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
55869407|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869408|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
55869409|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869410|NCT04363216|Protective Agents|protective agents|mesh-ancestor
55869411|NCT03678675|Ketorolac|ketorolac|mesh-list
55869412|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55869413|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55869414|NCT03678675|Analgesics|analgesics|mesh-ancestor
55869415|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
55869416|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869417|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869418|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55869419|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869420|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55869421|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869422|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869423|NCT04363060|Amoxicillin|amoxicillin|mesh-list
55869447|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869448|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55869449|NCT01591382|Narcotics|narcotics|mesh-ancestor
55869450|NCT03677817|Lidocaine|lidocaine|mesh-list
55869451|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
55869452|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
55869453|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869454|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869515|NCT03794037|Hormones|hormones|mesh-ancestor
55869516|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55869517|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869518|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55869519|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
55869520|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55869521|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
55869522|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55869523|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55869524|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869525|NCT04356508|Nivolumab|nivolumab|mesh-list
55869526|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55869527|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869528|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55869529|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869530|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
55869531|NCT04368598|Dexamethasone|dexamethasone|mesh-list
55869532|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
55869533|NCT04368598|BB 1101|bb 1101|mesh-list
55869534|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55869535|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55869536|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
55869537|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
55869538|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869539|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869540|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55869541|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
55869561|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869562|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869563|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55869564|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
55869565|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55869566|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55869567|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
55869568|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869569|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
55869570|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869571|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55869623|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869624|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55869625|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55869627|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55869628|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
55869629|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869630|NCT04356118|Methotrexate|methotrexate|mesh-list
55869631|NCT04356118|Endostatins|endostatins|mesh-list
55869632|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55869633|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
55869634|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55869635|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869636|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55869637|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
55869638|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869639|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869640|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
55869641|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869642|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55869643|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55869644|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
55869645|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55869646|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55869647|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55869648|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55869649|NCT04356118|Growth Substances|growth substances|mesh-ancestor
55869650|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
55869652|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
55869653|NCT04361812|Omalizumab|omalizumab|mesh-list
55869654|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55869655|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55869656|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55869657|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
55869659|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869660|NCT04355962|Sevoflurane|sevoflurane|mesh-list
55869661|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55869662|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55869663|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
55869664|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
55869665|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869666|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869667|NCT00705081|Ezetimibe|ezetimibe|mesh-list
55869668|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55869669|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55869670|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
55869671|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869672|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55869673|NCT00704769|Desloratadine|desloratadine|mesh-list
55869704|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55869705|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869707|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869708|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869709|NCT04367818|Anesthetics|anesthetics|mesh-list
55869710|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
55869711|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869712|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869713|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
55869714|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869715|NCT01677273|Caseins|caseins|mesh-list
55869716|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
55869717|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
55869718|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869719|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55869720|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55869721|NCT04355806|Vaccines|vaccines|mesh-list
55869722|NCT04355806|Antibodies|antibodies|mesh-list
55869723|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
55869724|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55869725|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
55869757|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55869758|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55869759|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869760|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869761|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55869762|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869763|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
55869764|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55869765|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55869766|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55869767|NCT03666351|Diuretics|diuretics|mesh-ancestor
55869768|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
55869769|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55869770|NCT00928642|Gemcitabine|gemcitabine|mesh-list
55869771|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
55869772|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55869773|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
55869774|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869775|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869776|NCT00928642|Antiviral Agents|antiviral agents|mesh-ancestor
55869777|NCT00928642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55869778|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869779|NCT00928642|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55869780|NCT00928642|Immunologic Factors|immunologic factors|mesh-ancestor
55869781|NCT00928642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869782|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55869784|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55869785|NCT03663543|Hormones|hormones|mesh-ancestor
55869786|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55869787|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869788|NCT04361422|Isotretinoin|isotretinoin|mesh-list
55869789|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
55869790|NCT03579615|Insulin|insulin|mesh-list
55869795|NCT03575403|Methylphenidate|methylphenidate|mesh-list
55869796|NCT03575403|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55869797|NCT03575403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869798|NCT03575403|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55870106|NCT05618470|Cholinergic Agents|cholinergic agents|mesh-ancestor
55869799|NCT03575403|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55869800|NCT03575403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55869801|NCT03575403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869803|NCT03575403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869804|NCT03575403|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55869805|NCT03575403|Analgesics|analgesics|mesh-ancestor
55869806|NCT03575403|Sensory System Agents|sensory system agents|mesh-ancestor
55869807|NCT03575403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869808|NCT03575403|Antidepressive Agents|antidepressive agents|mesh-ancestor
55869809|NCT03575403|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55869852|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55869853|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869854|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869855|NCT03552471|Rucaparib|rucaparib|mesh-list
55869856|NCT03552471|Maytansine|maytansine|mesh-list
55870516|NCT05097976|Prednisolone|prednisolone|mesh-list
55869857|NCT03552471|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55869858|NCT03552471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869859|NCT03552471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869860|NCT03552471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869861|NCT03552471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55869862|NCT03552471|Tubulin Modulators|tubulin modulators|mesh-ancestor
55869863|NCT03552471|Antimitotic Agents|antimitotic agents|mesh-ancestor
55869913|NCT03542175|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55869914|NCT03542175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55869915|NCT03542175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869916|NCT03542175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55869917|NCT04359862|Propofol|propofol|mesh-list
55869918|NCT04359862|Sevoflurane|sevoflurane|mesh-list
55869919|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55869920|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55869921|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869922|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55869923|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
55869924|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
55869925|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55869974|NCT03537495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55869975|NCT04359550|Antibodies|antibodies|mesh-list
55869976|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55869977|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
55869978|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55869979|NCT02084511|Celecoxib|celecoxib|mesh-list
55869980|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55869981|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55869982|NCT02084511|Analgesics|analgesics|mesh-ancestor
55869983|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
55869984|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55869992|NCT00942448|Diclofenac|diclofenac|mesh-list
55870037|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55870038|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
55870039|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
55870040|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870041|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870042|NCT04601350|Midazolam|midazolam|mesh-list
55870043|NCT04601350|Anesthetics|anesthetics|mesh-list
55870044|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55870045|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870046|NCT04601350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55870047|NCT04601350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55870048|NCT04601350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55870049|NCT04601350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55870050|NCT04601350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55870051|NCT04601350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55870060|NCT04358614|Ritonavir|ritonavir|mesh-list
55870097|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55870099|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870100|NCT05618470|Botulinum Toxins|botulinum toxins|mesh-list
55870101|NCT05618470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55870102|NCT05618470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55870103|NCT05618470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55870104|NCT05618470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55870105|NCT05618470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870107|NCT05618470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870108|NCT05618470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870109|NCT05618470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55870110|NCT05618470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870111|NCT04358146|Locust bean gum|locust bean gum|mesh-list
55870112|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
55870113|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55870114|NCT05620498|Lenvatinib|lenvatinib|mesh-list
55870115|NCT05620498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870116|NCT05620498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55870149|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
55870150|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55870151|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55870152|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870153|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55870154|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55870155|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870156|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870157|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
55870158|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
55870159|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55870211|NCT03032614|Veliparib|veliparib|mesh-list
55870212|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870213|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55870214|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870215|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870216|NCT03032458|Ketorolac|ketorolac|mesh-list
55870217|NCT03032458|Lidocaine|lidocaine|mesh-list
55870218|NCT03032458|Meperidine|meperidine|mesh-list
55870219|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
55870220|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
55870221|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55870222|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870223|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
55870224|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870225|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55870227|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55870269|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
55870270|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55870271|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55870272|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55870273|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55870274|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55870275|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55870276|NCT03087669|Norepinephrine|norepinephrine|mesh-list
55870277|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55870278|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55870279|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
55870333|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55870334|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55870335|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
55870336|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870337|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870338|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870341|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870343|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870401|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55870402|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870403|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55870404|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55870405|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870406|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870407|NCT03656536|Gemcitabine|gemcitabine|mesh-list
55870408|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870409|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55870410|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
55870465|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870466|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55870467|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
55870468|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870469|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870470|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55870471|NCT00949234|Ritonavir|ritonavir|mesh-list
55870472|NCT00949234|Lopinavir|lopinavir|mesh-list
55870475|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55870476|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55870477|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
55870478|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870479|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870480|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55870481|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55870482|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
55870483|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870484|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55870485|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55870486|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55870487|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55870488|NCT03090880|Tinzaparin|tinzaparin|mesh-list
55870489|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55870490|NCT03090880|Dalteparin|dalteparin|mesh-list
55870515|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55870517|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
55870518|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55870519|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
55870520|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870521|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
55870522|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
55870523|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870524|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870525|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55870526|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
55870527|NCT05097976|Hormones|hormones|mesh-ancestor
55870528|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870529|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55870530|NCT05097976|Protective Agents|protective agents|mesh-ancestor
55870531|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55870532|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870533|NCT03030430|Bevacizumab|bevacizumab|mesh-list
55870534|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55870535|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870536|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55870537|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55870538|NCT03030430|Growth Substances|growth substances|mesh-ancestor
55870539|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870540|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
55870541|NCT00089661|Denosumab|denosumab|mesh-list
55870560|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870561|NCT04984330|Dexamethasone|dexamethasone|mesh-list
55870562|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870563|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
55870564|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
55870565|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870566|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870567|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55870568|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
55870570|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870571|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55870573|NCT03030196|Denosumab|denosumab|mesh-list
55870624|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870625|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870627|NCT03017248|Morphine|morphine|mesh-list
55870628|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55870629|NCT03017248|Analgesics|analgesics|mesh-ancestor
55870630|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
55870631|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870632|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870633|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55870634|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55870688|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
55870689|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870690|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55870691|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55870692|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
55870693|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
55870694|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
55870695|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55870696|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55871195|NCT03425643|Antiviral Agents|antiviral agents|mesh-ancestor
55870698|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870699|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
55870700|NCT00953212|Amiodarone|amiodarone|mesh-list
55870701|NCT00953212|Metoprolol|metoprolol|mesh-list
55870702|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
55870703|NCT00953212|Vitamins|vitamins|mesh-ancestor
55870704|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
55870705|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870706|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
55870707|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870708|NCT00953212|Protective Agents|protective agents|mesh-ancestor
55870709|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55870710|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
55870711|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870712|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55870713|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
55870714|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55870715|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55870716|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55870717|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55870718|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55870719|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870720|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55870724|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
55870725|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
55870726|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870727|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55870728|NCT03034408|Mannitol|mannitol|mesh-list
55870729|NCT03034408|Baclofen|baclofen|mesh-list
55870730|NCT03034408|Nalmefene|nalmefene|mesh-list
55870731|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55870732|NCT03034408|Diuretics|diuretics|mesh-ancestor
55870733|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
55870734|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870735|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55870736|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55870737|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870738|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
55870739|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
55870740|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
55870741|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870742|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870743|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55870744|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
55870745|NCT03023020|Aspirin|aspirin|mesh-list
55870746|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
55870747|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55870748|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55870749|NCT03023020|Analgesics|analgesics|mesh-ancestor
55870750|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
55870751|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870752|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870753|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870754|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870755|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55870756|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55870760|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
55870766|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
55870767|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55870768|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870769|NCT03022318|Levodopa|levodopa|mesh-list
55870770|NCT03022318|Carbidopa|carbidopa|mesh-list
55870771|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55870772|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55870773|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55870783|NCT01677897|Metformin|metformin|mesh-list
55870838|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55870840|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
55870841|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55870842|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55870843|NCT00946270|Growth Substances|growth substances|mesh-ancestor
55870844|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
55870845|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55870846|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
55870847|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55870848|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870849|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
55870886|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55870887|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55870888|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870889|NCT03019822|Amphetamine|amphetamine|mesh-list
55870892|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
55870893|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55870894|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870895|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
55870896|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
55870897|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870898|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
55870899|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55870900|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870901|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
55870902|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55870903|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55870904|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55870905|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55870906|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
55870907|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55870908|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
55870909|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55870936|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55870937|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870938|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870939|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55870940|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870941|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55870942|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
55870943|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55870944|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55870946|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
55870947|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
55870948|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55870949|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55870950|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55870951|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55870952|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55870953|NCT02981836|Vaccines|vaccines|mesh-list
55870954|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
55870955|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870958|NCT03033160|Estradiol|estradiol|mesh-list
55870959|NCT03033160|Estrogens|estrogens|mesh-ancestor
55870960|NCT03033160|Hormones|hormones|mesh-ancestor
55870985|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55870986|NCT03032848|Hormones|hormones|mesh-ancestor
55870987|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55870988|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870989|NCT00080223|Pirfenidone|pirfenidone|mesh-list
55870990|NCT00080223|Analgesics|analgesics|mesh-ancestor
55870991|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
55870992|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55870993|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55870994|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55870995|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55870996|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55870997|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55870998|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871000|NCT04402359|Ceftazidime|ceftazidime|mesh-list
55871001|NCT04402359|Avibactam|avibactam|mesh-list
55871002|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55871003|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871004|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55871005|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871006|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871007|NCT00959764|Calcitonin|calcitonin|mesh-list
55871008|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
55871009|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
55871010|NCT00959764|Katacalcin|katacalcin|mesh-list
55871032|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55871033|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55871034|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871035|NCT01679691|Anesthetics|anesthetics|mesh-list
55871036|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871037|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871038|NCT03470805|Olaparib|olaparib|mesh-list
55871039|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55871040|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871041|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871042|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871043|NCT04278573|Vitamin D|vitamin d|mesh-list
55871044|NCT04278573|Cholecalciferol|cholecalciferol|mesh-list
55871045|NCT04278573|Vitamins|vitamins|mesh-ancestor
55871046|NCT04278573|Micronutrients|micronutrients|mesh-ancestor
55871047|NCT04278573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871048|NCT04278573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55871049|NCT04278573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55871050|NCT03088059|Durvalumab|durvalumab|mesh-list
55871051|NCT03088059|Palbociclib|palbociclib|mesh-list
55871052|NCT03088059|Niraparib|niraparib|mesh-list
55871053|NCT03088059|Afatinib|afatinib|mesh-list
55871054|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55871055|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871056|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55871057|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871058|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871059|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55871060|NCT03084549|Ropivacaine|ropivacaine|mesh-list
55871077|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55871078|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871079|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
55871080|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
55871081|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
55871082|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871083|NCT03701763|Apremilast|apremilast|mesh-list
55871084|NCT03701763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55871085|NCT03701763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55871086|NCT03701763|Analgesics|analgesics|mesh-ancestor
55871087|NCT03701763|Sensory System Agents|sensory system agents|mesh-ancestor
55871088|NCT03701763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871089|NCT03701763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871090|NCT03701763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55871091|NCT03701763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871092|NCT03701763|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55871093|NCT03701763|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55871094|NCT03701763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871095|NCT03701763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871096|NCT03080805|Capecitabine|capecitabine|mesh-list
55871129|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871130|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871132|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55871133|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
55871134|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871135|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871136|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55871137|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55871138|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
55871139|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871140|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871141|NCT03080181|Pasireotide|pasireotide|mesh-list
55871142|NCT03080181|Hormones|hormones|mesh-ancestor
55871143|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55871144|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871146|NCT03088293|Infliximab|infliximab|mesh-list
55871182|NCT05689047|Schistosomicides|schistosomicides|mesh-ancestor
55871183|NCT05689047|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55871184|NCT05689047|Anthelmintics|anthelmintics|mesh-ancestor
55871185|NCT05688813|Anesthetics|anesthetics|mesh-list
55871186|NCT05688813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871187|NCT05688813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871188|NCT03425643|Gemcitabine|gemcitabine|mesh-list
55871189|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
55871190|NCT03425643|Pemetrexed|pemetrexed|mesh-list
55871191|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871192|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55871193|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
55871194|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871196|NCT03425643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55871197|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871198|NCT03425643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55871199|NCT03425643|Immunologic Factors|immunologic factors|mesh-ancestor
55871200|NCT03425643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871201|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55871202|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55871203|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55871204|NCT01009918|Carvedilol|carvedilol|mesh-list
55871205|NCT01009918|Lisinopril|lisinopril|mesh-list
55871206|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55871207|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55871208|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
55871209|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871210|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871211|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871212|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55871214|NCT01009918|Protective Agents|protective agents|mesh-ancestor
55871215|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55871216|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55871217|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55871218|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
55871219|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55871220|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55871222|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
55871223|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871224|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55871225|NCT05688579|Spironolactone|spironolactone|mesh-list
55871226|NCT05688579|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55871227|NCT05688579|Hormone Antagonists|hormone antagonists|mesh-ancestor
55871228|NCT05688579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55871229|NCT05688579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871230|NCT05688579|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55871231|NCT05688579|Diuretics|diuretics|mesh-ancestor
55871232|NCT05688579|Natriuretic Agents|natriuretic agents|mesh-ancestor
55871233|NCT04401657|Adenosine|adenosine|mesh-list
55871234|NCT04401657|Analgesics|analgesics|mesh-ancestor
55871235|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
55871263|NCT00963508|Permethrin|permethrin|mesh-list
55871264|NCT00963508|Malathion|malathion|mesh-list
55871265|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55871266|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871267|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55871268|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
55871269|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871270|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871271|NCT03088371|Lidocaine|lidocaine|mesh-list
55871272|NCT03088371|Bupivacaine|bupivacaine|mesh-list
55871273|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
55871274|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
55871275|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871276|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871277|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
55871278|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871279|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55871280|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55871281|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55871282|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55871283|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871284|NCT03083691|Nivolumab|nivolumab|mesh-list
55871285|NCT03083691|Ipilimumab|ipilimumab|mesh-list
55871286|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55871287|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871288|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55871289|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871290|NCT05685537|Simendan|simendan|mesh-list
55871291|NCT05685537|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55871292|NCT05685537|Vasodilator Agents|vasodilator agents|mesh-ancestor
55871293|NCT05685537|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55871294|NCT05685537|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55871304|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
55871305|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871306|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
55871317|NCT03387579|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55871318|NCT03387579|SMOFlipid|smoflipid|mesh-list
55871319|NCT03387579|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55871320|NCT03387579|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55871321|NCT03387579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55871322|NCT01012336|Dexamethasone|dexamethasone|mesh-list
55871323|NCT01012336|Aprepitant|aprepitant|mesh-list
55871324|NCT01012336|Ramosetron|ramosetron|mesh-list
55871325|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55871326|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
55871327|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
55871328|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871329|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871330|NCT01012336|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55871331|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
55871332|NCT01012336|Hormones|hormones|mesh-ancestor
55871333|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55871334|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55871335|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871336|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
55871341|NCT03387501|Mitogens|mitogens|mesh-list
55871344|NCT01012492|Abatacept|abatacept|mesh-list
55871345|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55871346|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871347|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55871348|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55871349|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
55871350|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871351|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55871352|NCT05688345|Dexmedetomidine|dexmedetomidine|mesh-list
55871353|NCT05688345|Propofol|propofol|mesh-list
55871354|NCT05688345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55871355|NCT05688345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55871356|NCT05688345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871357|NCT05688345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55871358|NCT05688345|Anesthetics, General|anesthetics, general|mesh-ancestor
55871359|NCT05688345|Anesthetics|anesthetics|mesh-ancestor
55871403|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55871404|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55871405|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
55871406|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55871407|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871408|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55871409|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55871410|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
55871448|NCT05678673|Growth Substances|growth substances|mesh-ancestor
55871449|NCT05678673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55871450|NCT05678673|Growth Inhibitors|growth inhibitors|mesh-ancestor
55871451|NCT05678673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55871452|NCT05678673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818563|NCT04920695|Protective Agents|protective agents|mesh-ancestor
55818565|NCT02458469|Trazodone|trazodone|mesh-list
55818566|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55818567|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55818568|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55818569|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818570|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55818571|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55818572|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
55818573|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818574|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818575|NCT02458469|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55818576|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55818577|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818578|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55818579|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
55818581|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
55818582|NCT01843348|Everolimus|everolimus|mesh-list
55818583|NCT01843348|Tacrolimus|tacrolimus|mesh-list
55818591|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818592|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
55818593|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818594|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
55818595|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55818596|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818597|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55818598|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55818599|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
55818600|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55818601|NCT01825876|Warfarin|warfarin|mesh-list
55818602|NCT01825876|Evacetrapib|evacetrapib|mesh-list
55818603|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
55818604|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55818605|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55818606|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
55818607|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818608|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55818609|NCT01825798|Metformin|metformin|mesh-list
55818610|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55818621|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
55818622|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55818623|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55818624|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55818625|NCT05370599|Diuretics|diuretics|mesh-ancestor
55818626|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
55818627|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55818628|NCT02412761|Amlodipine|amlodipine|mesh-list
55818629|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55818630|NCT02412761|Lisinopril|lisinopril|mesh-list
55818631|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
55818632|NCT02412761|Diuretics|diuretics|mesh-list
55818633|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
55818634|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55818635|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
55818636|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55818643|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
55818644|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55818645|NCT02412761|Protective Agents|protective agents|mesh-ancestor
55818646|NCT01842334|Nicotine|nicotine|mesh-list
55818647|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55818648|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
55818649|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818650|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818651|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55818652|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55818654|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818656|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
55818658|NCT02457611|Ledipasvir|ledipasvir|mesh-list
55818662|NCT02083653|Capecitabine|capecitabine|mesh-list
55818663|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55818664|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
55818665|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818679|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
55818732|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
55818733|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818734|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818735|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
55818736|NCT01840228|Progesterone|progesterone|mesh-list
55818737|NCT01840228|Progestins|progestins|mesh-ancestor
55818739|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818740|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818741|NCT01823146|Oxytocin|oxytocin|mesh-list
55818742|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
55818743|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55818744|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818745|NCT02083185|Leuprolide|leuprolide|mesh-list
55818746|NCT02083185|Relugolix|relugolix|mesh-list
55818747|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55818748|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
55818749|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55818750|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818751|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55818752|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818753|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
55818755|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818757|NCT02412371|Carboplatin|carboplatin|mesh-list
55818758|NCT02412371|Veliparib|veliparib|mesh-list
55818759|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55818760|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818761|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
55818762|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
55818763|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
55818764|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818765|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55818766|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818767|NCT01822756|Gemcitabine|gemcitabine|mesh-list
55818768|NCT01822756|Paclitaxel|paclitaxel|mesh-list
55818769|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55818770|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818771|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
55818772|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
55818773|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
55818774|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818775|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55818776|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
55818777|NCT01822756|Antiviral Agents|antiviral agents|mesh-ancestor
55818778|NCT01822756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818779|NCT01822756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818780|NCT01822756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55818781|NCT01822756|Immunologic Factors|immunologic factors|mesh-ancestor
55818782|NCT01822756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818783|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55818784|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
55818785|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55818786|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55818787|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818788|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818790|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
55818791|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818792|NCT01611298|Vaccines|vaccines|mesh-list
55818793|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
55818794|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818795|NCT01822132|Naltrexone|naltrexone|mesh-list
55818796|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55818797|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55818798|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818799|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
55818800|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818801|NCT01821898|Budesonide|budesonide|mesh-list
55818802|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55818803|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55818806|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818807|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55818808|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
55818809|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
55818810|NCT01821898|Hormones|hormones|mesh-ancestor
55818811|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818812|NCT02411591|Necitumumab|necitumumab|mesh-list
55818813|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818815|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
55818816|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
55818817|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
55818818|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818819|NCT01838044|Celecoxib|celecoxib|mesh-list
55818820|NCT01838044|Pregabalin|pregabalin|mesh-list
55818821|NCT01838044|Analgesics|analgesics|mesh-ancestor
55818822|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
55818823|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818824|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818825|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
55818826|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55818827|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55818828|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818829|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55818830|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55818831|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55818832|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55818833|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55818834|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55818835|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55818860|NCT01820572|Cyclosporine|cyclosporine|mesh-list
55818861|NCT01820572|Abatacept|abatacept|mesh-list
55818862|NCT01820572|Tacrolimus|tacrolimus|mesh-list
55818863|NCT01820572|Cyclosporins|cyclosporins|mesh-list
55818864|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55818865|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
55818866|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818867|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55818868|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818869|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818870|NCT01820572|Antifungal Agents|antifungal agents|mesh-ancestor
55818871|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55818872|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
55818873|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55818874|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55818875|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818876|NCT03232918|Oxytocin|oxytocin|mesh-list
55818877|NCT03232918|Oxytocics|oxytocics|mesh-ancestor
55818878|NCT03232918|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55818879|NCT03232918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818880|NCT01610596|Halobetasol|halobetasol|mesh-list
55818881|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55818882|NCT01818700|Buprenorphine|buprenorphine|mesh-list
55818883|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55818884|NCT01818700|Narcotics|narcotics|mesh-ancestor
55818885|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55818886|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818887|NCT01818700|Analgesics|analgesics|mesh-ancestor
55818888|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
55818889|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818890|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55818891|NCT01817764|Fluticasone|fluticasone|mesh-list
55818892|NCT01817764|Xhance|xhance|mesh-list
55818893|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55818894|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55818895|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55818896|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
55818897|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818898|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818899|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55818900|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
55818901|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
55818902|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55818903|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55818904|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55818905|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55818906|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
55818907|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55818908|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818910|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55818939|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818941|NCT01816594|Trastuzumab|trastuzumab|mesh-list
55818942|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55818943|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818944|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
55818945|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
55818946|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
55818947|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818948|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818949|NCT02453711|Liraglutide|liraglutide|mesh-list
55818950|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55818951|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818952|NCT02453711|Incretins|incretins|mesh-ancestor
55818954|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818955|NCT02453555|Empagliflozin|empagliflozin|mesh-list
55818956|NCT02453555|Linagliptin|linagliptin|mesh-list
55818957|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55818958|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818959|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55818960|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818961|NCT02453555|Incretins|incretins|mesh-ancestor
55818962|NCT02453555|Hormones|hormones|mesh-ancestor
55818963|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818964|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55818965|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
55818966|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55818967|NCT02453321|Bupivacaine|bupivacaine|mesh-list
55818968|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
55818970|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55818971|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818972|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
55818973|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55818974|NCT01610284|Fulvestrant|fulvestrant|mesh-list
55818975|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55818976|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818977|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55818978|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55818979|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
55818980|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55818981|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818982|NCT02452463|Durvalumab|durvalumab|mesh-list
55818983|NCT02452463|Nintedanib|nintedanib|mesh-list
55818984|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
55818985|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55818986|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
55818987|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55818988|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55818989|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
55818990|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818991|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55818992|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819123|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55818993|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818994|NCT04916327|Antioxidants|antioxidants|mesh-list
55818995|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55818996|NCT04916327|Protective Agents|protective agents|mesh-ancestor
55818997|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55818998|NCT03628391|Haloperidol|haloperidol|mesh-list
55818999|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
55819000|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
55819001|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
55819002|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819003|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819004|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819005|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55819006|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55819007|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55819011|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819012|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819027|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
55819028|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
55819029|NCT01816048|Protective Agents|protective agents|mesh-ancestor
55819030|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819031|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55819032|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819033|NCT01612858|Metformin|metformin|mesh-list
55819034|NCT01612858|Pioglitazone|pioglitazone|mesh-list
55819035|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55819036|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819037|NCT01612702|Dexamethasone|dexamethasone|mesh-list
55819038|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819039|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
55819057|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819058|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55819060|NCT04926545|Fluorouracil|fluorouracil|mesh-list
55819061|NCT04926545|Irinotecan|irinotecan|mesh-list
55819062|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
55819063|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819064|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55819065|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819066|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55819067|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
55819068|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819069|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55819070|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55819071|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819072|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55819073|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
55819074|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819075|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55819076|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55819077|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55819078|NCT01652573|Calcitonin|calcitonin|mesh-list
55819079|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
55819103|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55819104|NCT02387957|Bevacizumab|bevacizumab|mesh-list
55819105|NCT02387957|Ranibizumab|ranibizumab|mesh-list
55819106|NCT02387957|Aflibercept|aflibercept|mesh-list
55819107|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55819108|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819109|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55819110|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55819111|NCT02387957|Growth Substances|growth substances|mesh-ancestor
55819112|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819113|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
55819114|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55819115|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55819116|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55819117|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55819118|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819119|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819120|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
55819121|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819122|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55819124|NCT01651403|Tenofovir|tenofovir|mesh-list
55819125|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
55819126|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819127|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55819128|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55819146|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819147|NCT02431247|Tenofovir|tenofovir|mesh-list
55819148|NCT02431247|Emtricitabine|emtricitabine|mesh-list
55819149|NCT02431247|Darunavir|darunavir|mesh-list
55819150|NCT02431247|Cobicistat|cobicistat|mesh-list
55819151|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
55819152|NCT02431247|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
55819153|NCT02431247|Antiviral Agents|antiviral agents|mesh-ancestor
55819154|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819155|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55819156|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55819157|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819158|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819159|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55819160|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55819161|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55819162|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55819163|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
55819164|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55819165|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55819166|NCT01814878|Acetaminophen|acetaminophen|mesh-list
55819167|NCT01814878|Tramadol|tramadol|mesh-list
55819168|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55819169|NCT01814878|Analgesics|analgesics|mesh-ancestor
55819170|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
55819171|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819185|NCT04602754|Calcium|calcium|mesh-list
55819187|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819188|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55819189|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55819190|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55819191|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
55819192|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819193|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55819194|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55819195|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819196|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55819197|NCT04602754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55819198|NCT01813474|Olaparib|olaparib|mesh-list
55819199|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55819210|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55819236|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55819238|NCT04908449|Anesthetics, Local|anesthetics, local|mesh-ancestor
55819239|NCT04908449|Anesthetics|anesthetics|mesh-ancestor
55819240|NCT04908449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55819241|NCT04908449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819242|NCT04908449|Sensory System Agents|sensory system agents|mesh-ancestor
55819243|NCT04908449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819244|NCT02404805|Dolutegravir|dolutegravir|mesh-list
55819245|NCT02404805|Simeprevir|simeprevir|mesh-list
55819246|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55819247|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55819248|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819249|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819250|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55819251|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55819252|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
55819253|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819254|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
55819255|NCT02430311|Paclitaxel|paclitaxel|mesh-list
55819256|NCT02430311|Olaparib|olaparib|mesh-list
55819257|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55819258|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819259|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
55819260|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
55819261|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
55819263|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55819275|NCT02383433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819276|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
55819277|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55819278|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55819279|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
55819280|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819281|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55819282|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55819283|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819297|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55819298|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55819299|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55819305|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819306|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55819307|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55819309|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55819310|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
55819311|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
55819313|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55819314|NCT02404103|Flunisolide|flunisolide|mesh-list
55819315|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819316|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55819317|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
55819318|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
55819319|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
55819320|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819321|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55819322|NCT02403635|Midazolam|midazolam|mesh-list
55819323|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55819324|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55819325|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55819326|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819328|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55819329|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55819330|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55819345|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819346|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819347|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819348|NCT04414852|Apatinib|apatinib|mesh-list
55819349|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819350|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55819351|NCT04414852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819352|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819353|NCT04415008|Cytarabine|cytarabine|mesh-list
55819354|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55819355|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
55819356|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819357|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819358|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
55819359|NCT04415008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819360|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55819361|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
55819362|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819364|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55819365|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55819366|NCT01810042|Growth Substances|growth substances|mesh-ancestor
55819367|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819400|NCT02401529|Dexamethasone|dexamethasone|mesh-list
55819401|NCT02401529|Prednisolone|prednisolone|mesh-list
55819402|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819403|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
55819404|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
55819405|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819406|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819407|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819408|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
55819409|NCT02401529|Hormones|hormones|mesh-ancestor
55819410|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819411|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55819412|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819413|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55819414|NCT02401529|Analgesics|analgesics|mesh-ancestor
55819415|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
55819416|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
55819417|NCT01866826|Rifaximin|rifaximin|mesh-list
55819418|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55819421|NCT04600336|Oxybutynin|oxybutynin|mesh-list
55819446|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55819447|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55819448|NCT01807234|Analgesics|analgesics|mesh-ancestor
55819449|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
55819450|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819451|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819452|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819453|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819454|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55819455|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819456|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819457|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55819458|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55819503|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55819504|NCT01772368|Fluticasone|fluticasone|mesh-list
55819505|NCT01772368|Xhance|xhance|mesh-list
55819506|NCT01772368|Albuterol|albuterol|mesh-list
55819508|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55819509|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
55819571|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
55819572|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55819573|NCT02016183|Diuretics|diuretics|mesh-ancestor
55819574|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
55819575|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819576|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55819577|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55819578|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819579|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55819580|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55819581|NCT02421419|Dexamethasone|dexamethasone|mesh-list
55819582|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
55819583|NCT02421419|Lidocaine|lidocaine|mesh-list
55819626|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55819627|NCT02420717|BB 1101|bb 1101|mesh-list
55819628|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55819629|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
55819630|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819631|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819632|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55819633|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
55819634|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819635|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819636|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55819637|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819638|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
55819639|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
55819640|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819641|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819684|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55819685|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819686|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819687|NCT02420327|Galantamine|galantamine|mesh-list
55819689|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55819690|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
55819691|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819692|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819693|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55819694|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55819695|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
55819696|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819697|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819698|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55819699|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819700|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55819701|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
55819702|NCT02374853|Vancomycin|vancomycin|mesh-list
55819703|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55819704|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819705|NCT02015793|Adalimumab|adalimumab|mesh-list
55819706|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819707|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819708|NCT02347631|Dipivefrin|dipivefrin|mesh-list
55819714|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
55819734|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
55819735|NCT04898075|Nicotine|nicotine|mesh-list
55819736|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55819737|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
55819738|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819739|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819740|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55819741|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55819742|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
55819743|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819799|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
55819800|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819801|NCT01624467|Necitumumab|necitumumab|mesh-list
55819802|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55819803|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819804|NCT01624233|Ixekizumab|ixekizumab|mesh-list
55819805|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
55819806|NCT01993017|Bupropion|bupropion|mesh-list
55819807|NCT01993017|Sertraline|sertraline|mesh-list
55819808|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
55819809|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55819811|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55819812|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55819813|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55819814|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819816|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55819817|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819818|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55819819|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55819857|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
55819858|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819859|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55819860|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55819861|NCT02013765|Trastuzumab|trastuzumab|mesh-list
55819862|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55819878|NCT01988103|Thalidomide|thalidomide|mesh-list
55819906|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
55819907|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819908|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819909|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55819910|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
55819911|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819912|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819913|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55819914|NCT02013375|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55819915|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55819916|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55819918|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55819920|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55819925|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819926|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
55819927|NCT02078817|Ketamine|ketamine|mesh-list
55819928|NCT02078817|Analgesics|analgesics|mesh-ancestor
55819929|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
55819930|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819931|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819932|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55819933|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55819934|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
55819935|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
55819936|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55819937|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55819938|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55819945|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
55819946|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819947|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819948|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55819950|NCT02011113|Hormones|hormones|mesh-ancestor
55819951|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819952|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55819953|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819954|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
55819955|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55819956|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55819957|NCT02011113|Growth Substances|growth substances|mesh-ancestor
55819958|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
55819959|NCT01987479|Methotrexate|methotrexate|mesh-list
55819960|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55819961|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
55819962|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55819963|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819964|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55819965|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
55819966|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819967|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819968|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
55819969|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819970|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55819971|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55819972|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
55819973|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55819974|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55819977|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819979|NCT01620489|Hormones|hormones|mesh-ancestor
55819980|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55819981|NCT02010567|Capecitabine|capecitabine|mesh-list
55819982|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55819983|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
55819987|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55819988|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55819989|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55819990|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55819992|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55819993|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55819994|NCT01787188|Analgesics|analgesics|mesh-ancestor
55819995|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
55819996|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55819997|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55819998|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55819999|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820000|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55820001|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55820002|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820003|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820004|NCT01787032|Ketoconazole|ketoconazole|mesh-list
55820005|NCT01787032|Voriconazole|voriconazole|mesh-list
55820006|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
55820007|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820008|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55820009|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55820010|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820024|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
55820025|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55820026|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820027|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55820028|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55820029|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820030|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820031|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
55820032|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820034|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55820035|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820036|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
55820037|NCT01736254|Evacetrapib|evacetrapib|mesh-list
55820038|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55820039|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
55820040|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820079|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
55820080|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820082|NCT04575922|Ipilimumab|ipilimumab|mesh-list
55820083|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820084|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820085|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55820086|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820087|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
55820088|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820089|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55820090|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820091|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820092|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
55820093|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820101|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820128|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55820129|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55820130|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55820131|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820132|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55820133|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55820134|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
55820135|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55820136|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55820137|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55820139|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
55820140|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55820141|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55820188|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820189|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820190|NCT02394665|Temozolomide|temozolomide|mesh-list
55820191|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55820192|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
55820193|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820194|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820195|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
55820196|NCT02367833|NuvaRing|nuvaring|mesh-list
55820197|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
55820198|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
55820199|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55820200|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820201|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55820202|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55820203|NCT02338193|Metformin|metformin|mesh-list
55820204|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
55820205|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55820206|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820207|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55820208|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820209|NCT01783444|Capecitabine|capecitabine|mesh-list
55820210|NCT01783444|Everolimus|everolimus|mesh-list
55820211|NCT01783444|Exemestane|exemestane|mesh-list
55820236|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
55820237|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820238|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820239|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55820240|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
55820241|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820242|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820243|NCT04905251|Misoprostol|misoprostol|mesh-list
55820244|NCT04905251|Mifepristone|mifepristone|mesh-list
55820245|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55820292|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
55820293|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
55820303|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
55820304|NCT01765582|Vitamins|vitamins|mesh-ancestor
55820305|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
55820306|NCT01765582|Hematinics|hematinics|mesh-ancestor
55820307|NCT04413838|Nivolumab|nivolumab|mesh-list
55820308|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820309|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820310|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55820311|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820312|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55820313|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
55820314|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820315|NCT01648283|Methadone|methadone|mesh-list
55820336|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820337|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820338|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
55820339|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820340|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820341|NCT02362451|Vaccines|vaccines|mesh-list
55820342|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
55820343|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820344|NCT01765270|Saxagliptin|saxagliptin|mesh-list
55820345|NCT01765270|Incretins|incretins|mesh-ancestor
55820346|NCT01765270|Hormones|hormones|mesh-ancestor
55820347|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820348|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820349|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55820350|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
55820351|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820352|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820353|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55820354|NCT01733758|Liraglutide|liraglutide|mesh-list
55820355|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
55820356|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55820357|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55820358|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820361|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820362|NCT01607554|Irinotecan|irinotecan|mesh-list
55820382|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820383|NCT01733680|Amiloride|amiloride|mesh-list
55820384|NCT01733680|Diuretics|diuretics|mesh-ancestor
55820385|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
55820386|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820387|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
55820388|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55820389|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55820390|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820391|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
55820392|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55820393|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
55820394|NCT02348216|Fludarabine|fludarabine|mesh-list
55820395|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820396|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
55820397|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820398|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820399|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55820400|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
55820401|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820402|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820403|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55820404|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55820405|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820406|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820408|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
55820427|NCT02336165|Growth Substances|growth substances|mesh-ancestor
55820428|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820429|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
55820430|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
55820431|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820432|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
55820433|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820434|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820435|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55820436|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
55820437|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820438|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820439|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55820440|NCT02319044|Durvalumab|durvalumab|mesh-list
55820441|NCT02319044|Tremelimumab|tremelimumab|mesh-list
55820442|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55820443|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820444|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820445|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
55820446|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820447|NCT01649765|Belimumab|belimumab|mesh-list
55820448|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820449|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
55820450|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820451|NCT02317016|Osimertinib|osimertinib|mesh-list
55820452|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55820453|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55820454|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55820455|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
55820456|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820457|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55820471|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820472|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55820473|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820474|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820475|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55820476|NCT02281760|Protective Agents|protective agents|mesh-ancestor
55820477|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820478|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55820479|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
55820480|NCT02390531|Bevacizumab|bevacizumab|mesh-list
55820481|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820482|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820483|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55820484|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55820486|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820487|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
55820489|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55820490|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55820491|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820492|NCT02334215|Methadone|methadone|mesh-list
55820493|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55820494|NCT02334215|Narcotics|narcotics|mesh-ancestor
55820495|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820496|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820520|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
55820521|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820522|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55820523|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55820524|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
55820526|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
55820527|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
55820528|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55820529|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55820530|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
55820532|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820533|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820534|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55820535|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
55820536|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
55820537|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55820538|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55820539|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55820540|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55820541|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
55820542|NCT02358863|Leucovorin|leucovorin|mesh-list
55820543|NCT02358863|Cisplatin|cisplatin|mesh-list
55820544|NCT02358863|Docetaxel|docetaxel|mesh-list
55820545|NCT02358863|Capecitabine|capecitabine|mesh-list
55820546|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
55820547|NCT02358863|Irinotecan|irinotecan|mesh-list
55820548|NCT02358863|Epirubicin|epirubicin|mesh-list
55820549|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820550|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
55820551|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
55820552|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
55820568|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
55820569|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820570|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
55820571|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
55820572|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
55820573|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820574|NCT02357459|Triamcinolone|triamcinolone|mesh-list
55820575|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55820576|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55820578|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55820579|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55820580|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
55820581|NCT02357459|Hormones|hormones|mesh-ancestor
55820582|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820583|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820584|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820622|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820623|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
55820624|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55820625|NCT02010255|Ledipasvir|ledipasvir|mesh-list
55820626|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
55820627|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820628|NCT04666701|Ketorolac|ketorolac|mesh-list
55820629|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55820630|NCT04666701|Scopolamine|scopolamine|mesh-list
55820631|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55820632|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55820633|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55820634|NCT04666701|Analgesics|analgesics|mesh-ancestor
55820635|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
55820636|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820637|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820638|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55820669|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820670|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
55820671|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55820672|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55820673|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55820674|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55820675|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820676|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
55820691|NCT02009397|Ipilimumab|ipilimumab|mesh-list
55820692|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820693|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820694|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55820695|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820697|NCT02312219|Methotrexate|methotrexate|mesh-list
55820698|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55820699|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
55820700|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55820709|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820710|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
55820711|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820712|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55820713|NCT02312219|Hematinics|hematinics|mesh-ancestor
55820714|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
55820715|NCT02312219|Vitamins|vitamins|mesh-ancestor
55820716|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
55820717|NCT01986231|Glucagon|glucagon|mesh-list
55820718|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55820719|NCT01986231|Hormones|hormones|mesh-ancestor
55820720|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55820721|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820722|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55820723|NCT02312063|Glimepiride|glimepiride|mesh-list
55820724|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55820725|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820726|NCT02312063|Incretins|incretins|mesh-ancestor
55820757|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
55820758|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55820759|NCT01983969|Pyridoxine|pyridoxine|mesh-list
55820760|NCT01983969|Gemcitabine|gemcitabine|mesh-list
55820761|NCT01983969|Dexamethasone|dexamethasone|mesh-list
55820762|NCT01983969|Rituximab|rituximab|mesh-list
55820763|NCT01983969|Azacitidine|azacitidine|mesh-list
55820764|NCT01983969|Melphalan|melphalan|mesh-list
55820765|NCT01983969|Busulfan|busulfan|mesh-list
55820766|NCT01983969|Vorinostat|vorinostat|mesh-list
55820767|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820768|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820769|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
55820770|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820771|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820772|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55820774|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
55820806|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820807|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55820808|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55820809|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
55820818|NCT03571945|Anesthetics|anesthetics|mesh-list
55820819|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820820|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820821|NCT02311361|Durvalumab|durvalumab|mesh-list
55820822|NCT02311361|Tremelimumab|tremelimumab|mesh-list
55820823|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820824|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820825|NCT02329223|Omalizumab|omalizumab|mesh-list
55820826|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55820827|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55820828|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
55820829|NCT05644873|Magnesium Sulfate|magnesium sulfate|mesh-list
55820830|NCT05644873|Analgesics|analgesics|mesh-ancestor
55820831|NCT05644873|Sensory System Agents|sensory system agents|mesh-ancestor
55820832|NCT05644873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820833|NCT05644873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820834|NCT05644873|Anesthetics|anesthetics|mesh-ancestor
55820835|NCT05644873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820836|NCT05644873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55820837|NCT05644873|Anticonvulsants|anticonvulsants|mesh-ancestor
55820838|NCT05644873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55820839|NCT05644873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55820842|NCT05644873|Tocolytic Agents|tocolytic agents|mesh-ancestor
55820845|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820846|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820847|NCT02310581|Buprenorphine|buprenorphine|mesh-list
55820850|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820851|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820853|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
55820854|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820855|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55820856|NCT04892693|Talazoparib|talazoparib|mesh-list
55820857|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55820858|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820859|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820860|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820861|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
55820862|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55820863|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
55820864|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55820865|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
55820866|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820867|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820868|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
55820869|NCT02008227|Docetaxel|docetaxel|mesh-list
55820870|NCT02008227|Atezolizumab|atezolizumab|mesh-list
55820871|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820872|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
55820873|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
55820874|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
55820875|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820889|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820890|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55820891|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
55820892|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820893|NCT02006667|Antiviral Agents|antiviral agents|mesh-ancestor
55820894|NCT02006667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55820895|NCT02006667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820896|NCT02006667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55820897|NCT02006667|Immunologic Factors|immunologic factors|mesh-ancestor
55820898|NCT02006667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820899|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55820900|NCT01983111|Acetaminophen|acetaminophen|mesh-list
55820901|NCT01983111|Buprenorphine|buprenorphine|mesh-list
55820902|NCT01983111|Tramadol|tramadol|mesh-list
55820903|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55820904|NCT01983111|Analgesics|analgesics|mesh-ancestor
55820905|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
55820906|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820907|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820908|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
55820909|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55820910|NCT01983111|Narcotics|narcotics|mesh-ancestor
55820911|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55820912|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55820913|NCT04672941|Bromides|bromides|mesh-list
55820914|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
55820915|NCT04672941|Olodaterol|olodaterol|mesh-list
55820916|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55820917|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
55820918|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55820919|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820920|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55820933|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
55820934|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820935|NCT02326025|Doxorubicin|doxorubicin|mesh-list
55820936|NCT02326025|Olaratumab|olaratumab|mesh-list
55820937|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55820938|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820939|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55820940|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55820941|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55820942|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820943|NCT01619865|Edotreotide|edotreotide|mesh-list
55820944|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55820945|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55820946|NCT02006121|Apomorphine|apomorphine|mesh-list
55820947|NCT02006121|Emetics|emetics|mesh-ancestor
55820948|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55820949|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
55820988|NCT04672005|Gemcitabine|gemcitabine|mesh-list
55820991|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
55820992|NCT04672005|Irinotecan|irinotecan|mesh-list
55820993|NCT04672005|Folfirinox|folfirinox|mesh-list
55820994|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55820995|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55820996|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
55820997|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
55820998|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
55820999|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821000|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55821001|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
55821002|NCT04672005|Antiviral Agents|antiviral agents|mesh-ancestor
55821003|NCT04672005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821004|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821005|NCT04672005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821006|NCT04672005|Immunologic Factors|immunologic factors|mesh-ancestor
55821007|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821008|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55821009|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55821010|NCT04672005|Antidotes|antidotes|mesh-ancestor
55821011|NCT04672005|Protective Agents|protective agents|mesh-ancestor
55821012|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
55821013|NCT04672005|Vitamins|vitamins|mesh-ancestor
55821014|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
55821030|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821031|NCT01732822|Clopidogrel|clopidogrel|mesh-list
55821032|NCT01732822|Ticagrelor|ticagrelor|mesh-list
55821033|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55821034|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55821035|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55821036|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55821037|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
55821038|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821039|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821040|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821041|NCT02004093|Gemcitabine|gemcitabine|mesh-list
55821042|NCT02004093|Paclitaxel|paclitaxel|mesh-list
55821043|NCT02004093|Carboplatin|carboplatin|mesh-list
55821044|NCT02004093|Pertuzumab|pertuzumab|mesh-list
55821045|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55821046|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821047|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
55821048|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
55821060|NCT01641367|Tenofovir|tenofovir|mesh-list
55821086|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821087|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55821088|NCT04877639|Analgesics|analgesics|mesh-ancestor
55821089|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
55821090|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821147|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821150|NCT02254681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821151|NCT02254681|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821152|NCT02254681|Immunologic Factors|immunologic factors|mesh-ancestor
55821153|NCT02254681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821155|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
55821156|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821157|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
55821158|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821159|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
55821160|NCT04872595|Melphalan|melphalan|mesh-list
55821161|NCT04872595|Busulfan|busulfan|mesh-list
55821162|NCT04872595|Thiotepa|thiotepa|mesh-list
55821163|NCT04872595|Fludarabine|fludarabine|mesh-list
55821164|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821165|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
55821166|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821167|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821168|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55821169|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
55821170|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821174|NCT01639729|Dsuvia|dsuvia|mesh-list
55821194|NCT05650723|Venetoclax|venetoclax|mesh-list
55821195|NCT05650723|Obinutuzumab|obinutuzumab|mesh-list
55821196|NCT05650723|Zanubrutinib|zanubrutinib|mesh-list
55821197|NCT05650723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821198|NCT05650723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55821491|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
55821199|NCT05650723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55821200|NCT05650723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821201|NCT05650723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821202|NCT05247697|Mirtazapine|mirtazapine|mesh-list
55821203|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
55821204|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55821205|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55821206|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
55821207|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
55821220|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
55821253|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
55821254|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821255|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55821256|NCT05596747|Insulin Glargine|insulin glargine|mesh-list
55821257|NCT05596747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55821258|NCT05596747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821259|NCT05429593|Dapagliflozin|dapagliflozin|mesh-list
55821260|NCT05429593|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55821261|NCT05429593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821262|NCT05429593|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55821263|NCT05429593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821264|NCT01763164|Dacarbazine|dacarbazine|mesh-list
55821265|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55821266|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
55821267|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821268|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821270|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821271|NCT04561180|Dexamethasone|dexamethasone|mesh-list
55821272|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55821273|NCT04561180|Antiemetics|antiemetics|mesh-ancestor
55821274|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
55821275|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821276|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821277|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821278|NCT04561180|Glucocorticoids|glucocorticoids|mesh-ancestor
55821279|NCT04561180|Hormones|hormones|mesh-ancestor
55821293|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
55821294|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821295|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
55821296|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
55821298|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55821299|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821300|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55821301|NCT04836637|Antacids|antacids|mesh-ancestor
55821302|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821303|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821304|NCT04419259|Erenumab|erenumab|mesh-list
55821305|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55821306|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821307|NCT04419259|Analgesics|analgesics|mesh-ancestor
55821308|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
55821309|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821310|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821311|NCT02000427|Blinatumomab|blinatumomab|mesh-list
55821312|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821313|NCT04846231|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55821314|NCT04846231|Red yeast rice|red yeast rice|mesh-list
55821315|NCT04846231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55821316|NCT04846231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55821317|NCT04846231|Antimetabolites|antimetabolites|mesh-ancestor
55821318|NCT04846231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821319|NCT04846231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55821322|NCT04845217|Peppermint oil|peppermint oil|mesh-list
55821336|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55821337|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55821338|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55821339|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55821340|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
55821341|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821342|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821343|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821344|NCT04625257|Antibodies|antibodies|mesh-list
55821345|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
55821346|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821347|NCT05011513|Ritonavir|ritonavir|mesh-list
55821348|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55821349|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55821350|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
55821351|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821360|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821361|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55821362|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821363|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821364|NCT04832269|Methylprednisolone|methylprednisolone|mesh-list
55821365|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55821366|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55821367|NCT04832269|Prednisolone|prednisolone|mesh-list
55821368|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
55821376|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821377|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
55821378|NCT04832269|Hormones|hormones|mesh-ancestor
55821379|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821380|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55821381|NCT04832269|Protective Agents|protective agents|mesh-ancestor
55821382|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55821383|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821384|NCT04623931|Temozolomide|temozolomide|mesh-list
55821385|NCT04623931|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55821386|NCT04623931|Alkylating Agents|alkylating agents|mesh-ancestor
55821387|NCT04623931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821388|NCT04623931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821389|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
55821390|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55821391|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821392|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821393|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55821395|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
55821396|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821397|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55821398|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55821399|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55821400|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
55821424|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821425|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55821426|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821427|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821428|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821435|NCT04419493|Anticoagulants|anticoagulants|mesh-ancestor
55821436|NCT04419493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55821437|NCT04419493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55821438|NCT04419493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821439|NCT05411575|Plerixafor|plerixafor|mesh-list
55821440|NCT05411575|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55821441|NCT05411575|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55821442|NCT05411575|Antiviral Agents|antiviral agents|mesh-ancestor
55821443|NCT05411575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821444|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
55821445|NCT04001647|Nitroprusside|nitroprusside|mesh-list
55821446|NCT04001647|Acetylcholine|acetylcholine|mesh-list
55821447|NCT04001647|Vitamins|vitamins|mesh-ancestor
55821448|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
55821449|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821450|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
55821452|NCT04001647|Protective Agents|protective agents|mesh-ancestor
55821475|NCT04428385|Artemisinins|artemisinins|mesh-list
55821476|NCT04428385|Artemisinin|artemisinin|mesh-list
55821477|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
55821478|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55821479|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55821480|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821481|NCT04880707|Anesthetics|anesthetics|mesh-list
55821482|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
55821483|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821484|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821485|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
55821486|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821487|NCT01999335|Dexamethasone|dexamethasone|mesh-list
55821488|NCT01999335|Pomalidomide|pomalidomide|mesh-list
55821489|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55821490|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
55821492|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821493|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821494|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55821495|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
55821496|NCT01999335|Hormones|hormones|mesh-ancestor
55821497|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55821498|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55821499|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821500|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
55821501|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55821502|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55821503|NCT01999335|Growth Substances|growth substances|mesh-ancestor
55821504|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
55821523|NCT01977729|Sertraline|sertraline|mesh-list
55821524|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
55821525|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55821526|NCT01977729|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55821527|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55821528|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55821529|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821530|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821531|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
55821582|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55821583|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
55821584|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821585|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821586|NCT01759420|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55821587|NCT01759420|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55821588|NCT01759420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821589|NCT01759420|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55821590|NCT01759420|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55821592|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821593|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55821594|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821595|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821596|NCT01729156|Metformin|metformin|mesh-list
55821597|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55821598|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821599|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55821600|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55821601|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821602|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821603|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
55821604|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821605|NCT04572256|Montelukast|montelukast|mesh-list
55821606|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55821607|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
55821608|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55821609|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
55821624|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55821625|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55821626|NCT01962987|Analgesics|analgesics|mesh-ancestor
55821627|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
55821628|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821629|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821630|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55821631|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821632|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55821633|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821634|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821635|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
55821636|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
55821637|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821638|NCT01638013|Peficitinib|peficitinib|mesh-list
55821639|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821640|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821641|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821660|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
55821661|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55821662|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55821663|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821664|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55821665|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821666|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55821667|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55821668|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821669|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55821670|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55821672|NCT05309629|Etoposide|etoposide|mesh-list
55821673|NCT05309629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821685|NCT05406583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821687|NCT05406583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55821688|NCT05406583|Antiviral Agents|antiviral agents|mesh-ancestor
55821689|NCT05406583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821691|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55821704|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821705|NCT04419025|Protective Agents|protective agents|mesh-ancestor
55821706|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821707|NCT04419025|Antidotes|antidotes|mesh-ancestor
55821708|NCT04781647|Interferons|interferons|mesh-list
55821709|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
55821710|NCT04781647|Entecavir|entecavir|mesh-list
55821711|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821712|NCT04781647|Antiviral Agents|antiviral agents|mesh-ancestor
55821713|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821714|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
55821715|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821716|NCT03593473|Oxytocin|oxytocin|mesh-list
55821717|NCT03593473|Oxytocics|oxytocics|mesh-ancestor
55821718|NCT03593473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55821719|NCT03593473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821720|NCT05259787|Propofol|propofol|mesh-list
55821721|NCT05259787|Etomidate|etomidate|mesh-list
55821722|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55821723|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821724|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821725|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55821727|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
55821728|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
55821745|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821747|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55821748|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821749|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821750|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55821751|NCT05226325|Analgesics|analgesics|mesh-ancestor
55821752|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
55821753|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821754|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55821755|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55821756|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55821757|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
55821763|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55821764|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821765|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821795|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821796|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
55821797|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821798|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55821799|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55821800|NCT05218915|Dulaglutide|dulaglutide|mesh-list
55821801|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55821802|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821803|NCT01995201|Methotrexate|methotrexate|mesh-list
55821804|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55821805|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
55822193|NCT01708954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821806|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55821807|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821808|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55821809|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
55821812|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
55821829|NCT02996773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821830|NCT02996773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55821831|NCT02996773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55821832|NCT02996773|Alkylating Agents|alkylating agents|mesh-ancestor
55821833|NCT02996773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821834|NCT02996773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821835|NCT02996773|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55821836|NCT05165641|Anesthetics|anesthetics|mesh-list
55821837|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55821838|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821839|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55821846|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821847|NCT04499677|Ritonavir|ritonavir|mesh-list
55821849|NCT04499677|Favipiravir|favipiravir|mesh-list
55821850|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55821851|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55821852|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
55821853|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55821854|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821855|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55821856|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55821875|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55821876|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
55821947|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821948|NCT01753570|Interferon-beta|interferon-beta|mesh-list
55821949|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55821950|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
55821951|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55821952|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
55821953|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821954|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
55821955|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55821956|NCT01753336|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55821957|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55821958|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55821959|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55821960|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
55821961|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55821962|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55821963|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55821964|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55821966|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
55821967|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
55822001|NCT01945593|Coagulants|coagulants|mesh-ancestor
55822002|NCT01945281|Amphotericin B|amphotericin b|mesh-list
55822003|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
55822004|NCT01945281|Caspofungin|caspofungin|mesh-list
55822005|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
55822006|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
55822007|NCT01945281|Amebicides|amebicides|mesh-ancestor
55822008|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55822009|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55822010|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822011|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55822012|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
55822013|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822014|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822015|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55822016|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55822017|NCT01961349|Propofol|propofol|mesh-list
55822018|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55822019|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55822055|NCT01973439|Abacavir|abacavir|mesh-list
55822061|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
55822063|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55822064|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55822065|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
55822066|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55822067|NCT01973283|Citalopram|citalopram|mesh-list
55822068|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
55822069|NCT01973283|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55822070|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55822071|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55822072|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822073|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822074|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
55822075|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822076|NCT01973283|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55822077|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55822078|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822079|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55822081|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
55822082|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
55822083|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
55822084|NCT01972659|Analgesics|analgesics|mesh-ancestor
55822088|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
55822099|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
55822100|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822101|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822102|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822103|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
55822104|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
55822105|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55822106|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55822107|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822108|NCT01774786|Fluorouracil|fluorouracil|mesh-list
55822109|NCT01774786|Capecitabine|capecitabine|mesh-list
55822110|NCT01774786|Trastuzumab|trastuzumab|mesh-list
55822112|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822113|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
55822114|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822115|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55822116|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822117|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
55822118|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822119|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822120|NCT01942161|Aripiprazole|aripiprazole|mesh-list
55822121|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
55822122|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55822123|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55822124|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55822125|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822126|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822127|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
55822128|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
55822129|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822130|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822131|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55822132|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55822133|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
55822136|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55822137|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55822139|NCT01971645|Ropivacaine|ropivacaine|mesh-list
55822140|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55822141|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
55822142|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
55822143|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822144|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822145|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55822146|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
55822147|NCT01971645|Hormones|hormones|mesh-ancestor
55822148|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55822149|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55822150|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822151|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
55822152|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
55822153|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822154|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
55822155|NCT01941537|Fezakinumab|fezakinumab|mesh-list
55822156|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
55822157|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
55822158|NCT01960413|Montelukast|montelukast|mesh-list
55822159|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55822191|NCT01708954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822192|NCT01708954|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55822194|NCT01708954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822195|NCT01939899|Ixazomib|ixazomib|mesh-list
55822196|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822197|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
55822198|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822199|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822200|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
55822203|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822205|NCT01970397|Protective Agents|protective agents|mesh-ancestor
55822206|NCT01970241|Insulin|insulin|mesh-list
55822207|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55822209|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822210|NCT01728376|Daptomycin|daptomycin|mesh-list
55822211|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55822212|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822213|NCT02488759|Nivolumab|nivolumab|mesh-list
55822214|NCT02488759|Ipilimumab|ipilimumab|mesh-list
55822218|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55822219|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822221|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
55822222|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55822223|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55822224|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822225|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822226|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
55822227|NCT02161783|Fludarabine|fludarabine|mesh-list
55822228|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822229|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
55822230|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822231|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822232|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55822233|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
55822234|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822236|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55822237|NCT02158507|Lapatinib|lapatinib|mesh-list
55822238|NCT02158507|Veliparib|veliparib|mesh-list
55822239|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822240|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55822241|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822242|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822243|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55822244|NCT04791553|Cenobamate|cenobamate|mesh-list
55822245|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
55822246|NCT05651347|Melatonin|melatonin|mesh-list
55822247|NCT05651347|Antioxidants|antioxidants|mesh-ancestor
55822248|NCT05651347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822260|NCT05651269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822261|NCT05651269|Immunologic Factors|immunologic factors|mesh-ancestor
55822262|NCT05651269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822264|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
55822265|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
55822266|NCT01707004|Busulfan|busulfan|mesh-list
55822267|NCT01707004|Fludarabine|fludarabine|mesh-list
55822268|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
55822269|NCT01707004|Azacitidine|azacitidine|mesh-list
55822270|NCT01707004|Decitabine|decitabine|mesh-list
55822271|NCT01707004|Tacrolimus|tacrolimus|mesh-list
55822272|NCT01707004|Lenograstim|lenograstim|mesh-list
55822282|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55822284|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
55822285|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822286|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55822287|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822288|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55822289|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55822290|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55822291|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
55822305|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55822307|NCT03734029|Gemcitabine|gemcitabine|mesh-list
55822308|NCT03734029|Paclitaxel|paclitaxel|mesh-list
55822309|NCT03734029|Camptothecin|camptothecin|mesh-list
55822310|NCT03734029|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55822311|NCT03734029|Capecitabine|capecitabine|mesh-list
55822312|NCT03734029|Trastuzumab|trastuzumab|mesh-list
55822313|NCT03734029|Immunoconjugates|immunoconjugates|mesh-list
55822314|NCT03734029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55822315|NCT03734029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822316|NCT03734029|Tubulin Modulators|tubulin modulators|mesh-ancestor
55822317|NCT03734029|Antimitotic Agents|antimitotic agents|mesh-ancestor
55822318|NCT03734029|Mitosis Modulators|mitosis modulators|mesh-ancestor
55822319|NCT03734029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822320|NCT03734029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55822321|NCT03734029|Antimetabolites|antimetabolites|mesh-ancestor
55822322|NCT03734029|Antiviral Agents|antiviral agents|mesh-ancestor
55822323|NCT03734029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822324|NCT03734029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822325|NCT03734029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822326|NCT03734029|Immunologic Factors|immunologic factors|mesh-ancestor
55822327|NCT03734029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822351|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55822353|NCT05546515|Suvorexant|suvorexant|mesh-list
55822354|NCT05546515|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-list
55822355|NCT05546515|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55822356|NCT05546515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55822357|NCT05546515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822358|NCT05546515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822359|NCT05546515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822360|NCT05546515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822361|NCT03542695|Alendronate|alendronate|mesh-list
55822362|NCT03542695|Copper|copper|mesh-list
55822363|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55822364|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822365|NCT03542695|Trace Elements|trace elements|mesh-ancestor
55822366|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
55822367|NCT04789837|Cilostazol|cilostazol|mesh-list
55822368|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55822369|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
55822370|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822371|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822372|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55822373|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
55822374|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55822375|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55822376|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822377|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55822378|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
55822379|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55822380|NCT04789837|Protective Agents|protective agents|mesh-ancestor
55822381|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55822382|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55822383|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822384|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
55822385|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55822386|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
55822387|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55822388|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
55822389|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822390|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822391|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
55822392|NCT02000089|Secretin|secretin|mesh-list
55822393|NCT02000089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55822394|NCT02000089|Hormones|hormones|mesh-ancestor
55822395|NCT02000089|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55822396|NCT02000089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822397|NCT01937871|Tadalafil|tadalafil|mesh-list
55822398|NCT01937871|Tamsulosin|tamsulosin|mesh-list
55822399|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
55822400|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55822401|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55822402|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822403|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822404|NCT01937871|Urological Agents|urological agents|mesh-ancestor
55822405|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55822406|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55822407|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55822408|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
55822409|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822410|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822411|NCT01942135|Fulvestrant|fulvestrant|mesh-list
55822412|NCT01942135|Palbociclib|palbociclib|mesh-list
55822413|NCT01942135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55822414|NCT01942135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822563|NCT01726270|Urological Agents|urological agents|mesh-ancestor
55822415|NCT01942135|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55822416|NCT01942135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55822417|NCT01942135|Hormone Antagonists|hormone antagonists|mesh-ancestor
55822418|NCT01942135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55822421|NCT01942135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822422|NCT01942135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822423|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
55822424|NCT03220477|Guadecitabine|guadecitabine|mesh-list
55822425|NCT03220477|Mocetinostat|mocetinostat|mesh-list
55822426|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822427|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822429|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822430|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822432|NCT01747447|Ergocalciferols|ergocalciferols|mesh-list
55822433|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
55822434|NCT01747447|Vitamins|vitamins|mesh-list
55822435|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
55822436|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822437|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55822438|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55822440|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55822441|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55822442|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55822443|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
55822444|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822470|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
55822471|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55822481|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55822482|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
55822483|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
55822484|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55822485|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
55822486|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822487|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822488|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
55822489|NCT01937715|Bevacizumab|bevacizumab|mesh-list
55822490|NCT01937715|Gedatolisib|gedatolisib|mesh-list
55822491|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822492|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822494|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55822495|NCT01937715|Growth Substances|growth substances|mesh-ancestor
55822496|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822497|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
55822498|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55822499|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822500|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822501|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
55822502|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55822503|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55822504|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822505|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
55822506|NCT01937559|Coagulants|coagulants|mesh-ancestor
55822507|NCT01918371|Ranibizumab|ranibizumab|mesh-list
55822508|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55822509|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55822510|NCT01918371|Growth Substances|growth substances|mesh-ancestor
55822511|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822512|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
55822546|NCT01916109|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822547|NCT01916109|Immunologic Factors|immunologic factors|mesh-ancestor
55822548|NCT01916109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822549|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822550|NCT01958619|Artefenomel|artefenomel|mesh-list
55822551|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
55822552|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55822553|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55822554|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822555|NCT01726270|Tamsulosin|tamsulosin|mesh-list
55822556|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55822557|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55822559|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
55822560|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822561|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822562|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822564|NCT00942331|Gemcitabine|gemcitabine|mesh-list
55822565|NCT00942331|Bevacizumab|bevacizumab|mesh-list
55822566|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55822567|NCT00942331|Cisplatin|cisplatin|mesh-list
55822568|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
55822569|NCT00942331|Antibodies|antibodies|mesh-list
55822570|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
55822571|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55822573|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822574|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55822575|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55822594|NCT00630565|Sargramostim|sargramostim|mesh-list
55822595|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822596|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
55822597|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822598|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822599|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55822600|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
55822601|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822610|NCT00630565|Hormones|hormones|mesh-ancestor
55822611|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55822612|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55822613|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55822614|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55822615|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55822616|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822617|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55822618|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55822639|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822640|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822641|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55822642|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55822643|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822644|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822645|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55822646|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55822647|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822648|NCT01931865|Cholinergic Agents|cholinergic agents|mesh-ancestor
55822649|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822650|NCT01617447|Aripiprazole|aripiprazole|mesh-list
55822651|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
55822652|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55822653|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55822654|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55822655|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822656|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822657|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
55822658|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
55822659|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822660|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822661|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55822662|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55822663|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
55822664|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55822665|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55822666|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55822667|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55822668|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
55822669|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55822670|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822671|NCT04798027|Vaccines|vaccines|mesh-list
55822672|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
55822673|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822674|NCT04797325|Prednisolone|prednisolone|mesh-list
55822675|NCT04797325|Infliximab|infliximab|mesh-list
55822676|NCT04797325|Vedolizumab|vedolizumab|mesh-list
55822677|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55822678|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
55822679|NCT04797325|Hormones|hormones|mesh-ancestor
55822680|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55822681|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822682|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55822683|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822684|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55822685|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
55822686|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822687|NCT02246647|Mannitol|mannitol|mesh-list
55822688|NCT02246647|Lactulose|lactulose|mesh-list
55822689|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55822690|NCT02246647|Diuretics|diuretics|mesh-ancestor
55822691|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
55822692|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822693|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55822694|NCT02244619|Acetaminophen|acetaminophen|mesh-list
55822702|NCT02243371|Nivolumab|nivolumab|mesh-list
55822732|NCT01646177|Ixekizumab|ixekizumab|mesh-list
55822733|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55822734|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55822736|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
55822737|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822738|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822739|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55822740|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55822741|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55822742|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822743|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
55822744|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
55822759|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55822760|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55822761|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55822762|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
55822775|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822776|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55822777|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
55822778|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55822779|NCT02280473|Laxatives|laxatives|mesh-ancestor
55822780|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55822781|NCT02308007|Metronidazole|metronidazole|mesh-list
55822782|NCT02308007|Terconazole|terconazole|mesh-list
55822783|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822784|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55822785|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55822792|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822794|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
55822795|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822796|NCT01957215|Indomethacin|indomethacin|mesh-list
55822797|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55822798|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55822799|NCT01957215|Analgesics|analgesics|mesh-ancestor
55822806|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
55822823|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55822824|NCT01928433|Renal Agents|renal agents|mesh-ancestor
55822825|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55822827|NCT02322281|Paclitaxel|paclitaxel|mesh-list
55822828|NCT02322281|Docetaxel|docetaxel|mesh-list
55822829|NCT02322281|Pemetrexed|pemetrexed|mesh-list
55822830|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55822831|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822832|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
55822833|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
55822834|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
55822835|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822836|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55822837|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
55822838|NCT02322281|Antiviral Agents|antiviral agents|mesh-ancestor
55822839|NCT02322281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822840|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822841|NCT02322281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822842|NCT02322281|Immunologic Factors|immunologic factors|mesh-ancestor
55822843|NCT02322281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822844|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55822845|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55822846|NCT02243293|Ribavirin|ribavirin|mesh-list
55822847|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
55822848|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822849|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
55822850|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822851|NCT02322047|Prazosin|prazosin|mesh-list
55822852|NCT02322047|Naltrexone|naltrexone|mesh-list
55822853|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55822854|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55822855|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822856|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
55822857|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822858|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55822863|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822864|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822867|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822869|NCT02254291|Hormones|hormones|mesh-ancestor
55822870|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55822871|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55822872|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
55822873|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822874|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822875|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55822876|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
55822877|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822878|NCT02320721|Insulin|insulin|mesh-list
55822879|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55822880|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
55822881|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55822882|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822883|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55822885|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55822886|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
55822887|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822888|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822889|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822891|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
55822892|NCT04197089|Vitamins|vitamins|mesh-ancestor
55822893|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
55822894|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822906|NCT02242201|Epinephrine|epinephrine|mesh-list
55822907|NCT02242201|Bupivacaine|bupivacaine|mesh-list
55822908|NCT02242201|Ropivacaine|ropivacaine|mesh-list
55822909|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
55822910|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
55822911|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55822912|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822913|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
55822914|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55822915|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55822916|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55822917|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
55822918|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55822919|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822920|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55822959|NCT04892953|Durvalumab|durvalumab|mesh-list
55822960|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
55822961|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55822962|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
55822963|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55822964|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55822965|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
55822966|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
55822967|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
55822968|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822969|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55822970|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
55822971|NCT04892953|Antiviral Agents|antiviral agents|mesh-ancestor
55822972|NCT04892953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55822973|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55822974|NCT04892953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55822977|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55822978|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55822979|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55822981|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
55822982|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55822983|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55822984|NCT02207491|Timolol|timolol|mesh-list
55822985|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55822986|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55822987|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55822988|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55822989|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55822990|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
55822991|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823001|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823002|NCT02276027|Ceritinib|ceritinib|mesh-list
55823003|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823005|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823006|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823007|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
55823008|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55823009|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55823010|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55823011|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
55823012|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823013|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823014|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823015|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
55823016|NCT04761133|Povidone|povidone|mesh-list
55823017|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
55823018|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
55823019|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55823020|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823021|NCT02233309|Anesthetics|anesthetics|mesh-list
55823022|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823023|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823024|NCT02280044|Rifaximin|rifaximin|mesh-list
55823025|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55823026|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823027|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55823028|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
55823029|NCT02308748|Lidocaine|lidocaine|mesh-list
55823046|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55823047|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55823049|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823050|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55823051|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55823052|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55823053|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
55823054|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55823055|NCT04745689|Carboplatin|carboplatin|mesh-list
55823056|NCT04745689|Etoposide|etoposide|mesh-list
55823057|NCT04745689|Durvalumab|durvalumab|mesh-list
55823058|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823059|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55823060|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55823061|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55823062|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823063|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823064|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55823065|NCT02308124|Midodrine|midodrine|mesh-list
55823066|NCT02308124|Bromides|bromides|mesh-list
55823069|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
55823070|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
55823071|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823072|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823073|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55823092|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
55823093|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823094|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823095|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55823096|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
55823097|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
55823098|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55823099|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
55823100|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823101|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823102|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55823103|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55823104|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55823105|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
55823106|NCT02308046|Terconazole|terconazole|mesh-list
55823107|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
55823108|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823109|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55823110|NCT02318693|Glyburide|glyburide|mesh-list
55823111|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55823112|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823113|NCT02318693|Incretins|incretins|mesh-ancestor
55823114|NCT02318693|Hormones|hormones|mesh-ancestor
55823141|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55823142|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55823143|NCT02302859|Nicotine|nicotine|mesh-list
55823144|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55823145|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
55823146|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823152|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823153|NCT02274311|Clomiphene|clomiphene|mesh-list
55823154|NCT02274311|Enclomiphene|enclomiphene|mesh-list
55823155|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
55823156|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55823157|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
55823158|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823159|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823160|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55823161|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
55823162|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55823163|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55823164|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55823165|NCT02316353|Complement C1s|complement c1s|mesh-list
55823166|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
55823167|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
55823168|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
55823169|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823170|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55823171|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823182|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55823183|NCT05649956|Letrozole|letrozole|mesh-list
55823184|NCT05649956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823185|NCT05649956|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55823186|NCT05649956|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55823187|NCT05649956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823188|NCT05649956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823189|NCT05649956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55823190|NCT05649956|Hormone Antagonists|hormone antagonists|mesh-ancestor
55823191|NCT05649956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823192|NCT05649956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823193|NCT04876430|Meropenem|meropenem|mesh-list
55823194|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55823195|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823196|NCT02305238|Aflibercept|aflibercept|mesh-list
55823197|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55823198|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55823199|NCT02305238|Growth Substances|growth substances|mesh-ancestor
55823200|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823201|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
55823202|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823203|NCT02304926|Simvastatin|simvastatin|mesh-list
55823204|NCT02304926|Ezetimibe|ezetimibe|mesh-list
55823205|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
55823206|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55823207|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55823208|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
55823209|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823210|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55823211|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55823212|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823213|NCT01646255|Levodopa|levodopa|mesh-list
55823214|NCT01646255|Rotigotine|rotigotine|mesh-list
55823215|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55823216|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55823217|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
55823218|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823219|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823220|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823232|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55823233|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55823234|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
55823235|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823236|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823237|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823238|NCT01642277|Urological Agents|urological agents|mesh-ancestor
55823239|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
55823240|NCT02230189|Miotics|miotics|mesh-ancestor
55823241|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
55823242|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823243|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823244|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55823265|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823267|NCT02301143|Paclitaxel|paclitaxel|mesh-list
55823268|NCT02301143|Capecitabine|capecitabine|mesh-list
55823269|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55823270|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823271|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
55823272|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
55823273|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
55823274|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823275|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55823276|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
55823277|NCT02301143|Antiviral Agents|antiviral agents|mesh-ancestor
55823278|NCT02301143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823279|NCT02301143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823280|NCT02301143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823281|NCT02301143|Immunologic Factors|immunologic factors|mesh-ancestor
55823282|NCT02301143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823283|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
55823284|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
55823285|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55823286|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
55823287|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823288|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823289|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55823290|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
55823291|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
55823292|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55823293|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
55823294|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823295|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823296|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55823297|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55823307|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55823308|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55823309|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55823310|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
55823311|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823312|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823314|NCT05649020|Anesthetics, Local|anesthetics, local|mesh-ancestor
55823315|NCT05649020|Anesthetics|anesthetics|mesh-ancestor
55823316|NCT05649020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823317|NCT05649020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823318|NCT05649020|Sensory System Agents|sensory system agents|mesh-ancestor
55823319|NCT05649020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823320|NCT04869488|Prednisone|prednisone|mesh-list
55823321|NCT04869488|Apatinib|apatinib|mesh-list
55823322|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
55823323|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55823324|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
55823325|NCT04869488|Hormones|hormones|mesh-ancestor
55823326|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823327|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823336|NCT04883528|Valsartan|valsartan|mesh-list
55823358|NCT01750918|Panitumumab|panitumumab|mesh-list
55823359|NCT01750918|Trametinib|trametinib|mesh-list
55823360|NCT01750918|Dabrafenib|dabrafenib|mesh-list
55823361|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
55823362|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823363|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55823364|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823365|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823366|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
55823367|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823368|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55823369|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55823370|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823371|NCT01750840|Cimetidine|cimetidine|mesh-list
55823372|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55823373|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55823374|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
55823375|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
55823376|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
55823377|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823378|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823379|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823380|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55823381|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55823382|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823383|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55823384|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55823385|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55823386|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823387|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823388|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55823398|NCT02269943|Cc-486|cc-486|mesh-list
55823400|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
55823401|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823402|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823403|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823408|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
55823409|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
55823410|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823411|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823412|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55823413|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55823414|NCT01605370|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55823415|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
55823416|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823417|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823418|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
55823456|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55823457|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55823458|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
55823459|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
55823461|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
55823462|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55823463|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55823464|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
55823465|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
55823513|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55823514|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55823515|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823516|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823517|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
55823518|NCT02273726|Hematinics|hematinics|mesh-ancestor
55823519|NCT01723228|Rasagiline|rasagiline|mesh-list
55823520|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
55823521|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823522|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823523|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55823524|NCT01723228|Protective Agents|protective agents|mesh-ancestor
55823525|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823526|NCT02273180|Insulin|insulin|mesh-list
55823527|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55823528|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
55823529|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
55823530|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55823531|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823532|NCT01745380|Phenylephrine|phenylephrine|mesh-list
55823533|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
55823534|NCT01745380|Tetracaine|tetracaine|mesh-list
55823535|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
55823536|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
55823537|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823539|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
55823563|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55823564|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823565|NCT02299388|Liraglutide|liraglutide|mesh-list
55823566|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55823567|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823568|NCT02299388|Incretins|incretins|mesh-ancestor
55823570|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823571|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
55823572|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
55823573|NCT02202577|Povidone|povidone|mesh-list
55823574|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55823575|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55823576|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
55823577|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
55823621|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55823622|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823623|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
55823624|NCT01644188|Ezetimibe|ezetimibe|mesh-list
55823625|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55823626|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55823627|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55823628|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
55823629|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823630|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55823631|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
55823632|NCT01644188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823633|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
55823634|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
55823636|NCT02271854|Diclofenac|diclofenac|mesh-list
55823637|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55823638|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55823639|NCT02271854|Analgesics|analgesics|mesh-ancestor
55823640|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
55823641|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823642|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823643|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55823644|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55823645|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55823646|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823647|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823648|NCT02296892|Midazolam|midazolam|mesh-list
55823658|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
55823668|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55823670|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55823671|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
55823672|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823673|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823674|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823675|NCT01927419|Nivolumab|nivolumab|mesh-list
55823676|NCT01927419|Ipilimumab|ipilimumab|mesh-list
55823677|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55823678|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823679|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55823680|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823681|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
55823682|NCT02168491|Lixisenatide|lixisenatide|mesh-list
55823683|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55823684|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823685|NCT01721746|Paclitaxel|paclitaxel|mesh-list
55823686|NCT01721746|Carboplatin|carboplatin|mesh-list
55823687|NCT01721746|Nivolumab|nivolumab|mesh-list
55823688|NCT01721746|Dacarbazine|dacarbazine|mesh-list
55823689|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55823690|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823691|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
55823692|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
55823693|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
55823694|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823695|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55823696|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55823697|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55823698|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
55823699|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
55823700|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823701|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
55823707|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823708|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55823709|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55823710|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
55823711|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823712|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55823713|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
55823714|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823716|NCT02201251|Levetiracetam|levetiracetam|mesh-list
55823717|NCT02201251|Anticonvulsants|anticonvulsants|mesh-ancestor
55823718|NCT02201251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55823719|NCT02201251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823720|NCT02201251|Nootropic Agents|nootropic agents|mesh-ancestor
55823721|NCT02296190|Etripamil|etripamil|mesh-list
55823722|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55825214|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
55823723|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55823724|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823725|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55823726|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823727|NCT04875026|Fluorouracil|fluorouracil|mesh-list
55823728|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
55823729|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823730|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55823731|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823732|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55823733|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
55823734|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823754|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823755|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55823756|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
55823757|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823758|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55823759|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55823760|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55823761|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55823762|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55823763|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55823764|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55823765|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55823766|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
55823767|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55823768|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55823769|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55823770|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
55823771|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55823772|NCT02225353|Progesterone|progesterone|mesh-list
55823773|NCT02225353|Progestins|progestins|mesh-ancestor
55823774|NCT02225353|Hormones|hormones|mesh-ancestor
55823775|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823810|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823811|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
55823812|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55823813|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823814|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55823815|NCT01956123|Hormones|hormones|mesh-ancestor
55823816|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823817|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823818|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
55823819|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
55823824|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823825|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55823826|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55823827|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
55823828|NCT02298023|Coagulants|coagulants|mesh-ancestor
55823829|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
55823830|NCT02296931|Analgesics|analgesics|mesh-ancestor
55823831|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
55823832|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823833|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823834|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
55823835|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823843|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55823844|NCT02166697|Candesartan|candesartan|mesh-list
55823845|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
55823846|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55823847|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55823848|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55823849|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823850|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55823851|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55823852|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823853|NCT02197897|Tamoxifen|tamoxifen|mesh-list
55823854|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55823855|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
55824033|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55823856|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55823857|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823858|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55823859|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823860|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55823861|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55823894|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55823895|NCT02164981|Nitroprusside|nitroprusside|mesh-list
55823896|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55823897|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
55823898|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
55823899|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823900|NCT01908699|Beraprost|beraprost|mesh-list
55823901|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55823902|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
55823903|NCT01363011|Darunavir|darunavir|mesh-list
55823904|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55823915|NCT05648591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55823916|NCT05648591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55823917|NCT05648591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55823918|NCT05648591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55823919|NCT05648591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55823941|NCT04620759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55823942|NCT04620759|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55823943|NCT04620759|Serotonin Agents|serotonin agents|mesh-ancestor
55823944|NCT04620759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55823950|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55823951|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55823952|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55823953|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55823954|NCT02263079|Interferons|interferons|mesh-list
55823955|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
55823956|NCT02263079|Lamivudine|lamivudine|mesh-list
55823957|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
55823958|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55823959|NCT02263079|Entecavir|entecavir|mesh-list
55823960|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55823971|NCT02260817|Choline|choline|mesh-list
55823998|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
55823999|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55824000|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
55824001|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824002|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824003|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
55824004|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55824005|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55824006|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55824007|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55824008|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
55824009|NCT05647265|Nivolumab|nivolumab|mesh-list
55824010|NCT05647265|Ipilimumab|ipilimumab|mesh-list
55824011|NCT05647265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824012|NCT05647265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824013|NCT05647265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55824014|NCT05647265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824015|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55824016|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
55824017|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824018|NCT01645280|Methotrexate|methotrexate|mesh-list
55824019|NCT01645280|Ustekinumab|ustekinumab|mesh-list
55824020|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55824021|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
55824022|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55824023|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824024|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55824025|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
55824026|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824027|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824028|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
55824029|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824030|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55824031|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55824032|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
55824034|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55824036|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
55824037|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824038|NCT04188223|Vaccines|vaccines|mesh-list
55824039|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
55824040|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824041|NCT02220907|Canagliflozin|canagliflozin|mesh-list
55824046|NCT01601873|Heparin|heparin|mesh-list
55824059|NCT04420247|Chloroquine|chloroquine|mesh-list
55824060|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
55824061|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55824062|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55824063|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55824070|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824071|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
55824072|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
55824073|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
55824074|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824075|NCT04865237|Remdesivir|remdesivir|mesh-list
55824076|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
55824077|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824078|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
55824079|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55824081|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
55824082|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
55824083|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824084|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824085|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824086|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
55824087|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55824088|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
55824089|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824090|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824093|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
55824102|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824103|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55824104|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55824106|NCT02266706|Ceftolozane|ceftolozane|mesh-list
55824107|NCT02266706|Cephalosporins|cephalosporins|mesh-list
55824108|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
55824109|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
55824110|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55824111|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55824112|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55824113|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824114|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824115|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55824117|NCT02292719|Ritonavir|ritonavir|mesh-list
55824118|NCT02292719|Ribavirin|ribavirin|mesh-list
55824119|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
55824120|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55824121|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55824122|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
55824123|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824124|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824125|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55824126|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55824127|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
55824128|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55824151|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55824153|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824154|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824155|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55824156|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
55824157|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
55824158|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
55824159|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824160|NCT01702558|Capecitabine|capecitabine|mesh-list
55824161|NCT01702558|Trastuzumab|trastuzumab|mesh-list
55824162|NCT01702558|Maytansine|maytansine|mesh-list
55824163|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55824164|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55824165|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
55824166|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824167|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824206|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55824207|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
55824208|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824209|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824211|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55824212|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824213|NCT01702246|Simvastatin|simvastatin|mesh-list
55824214|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55824215|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55824216|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
55824217|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824218|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55824219|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55824224|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55824225|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824226|NCT05645861|Benzocaine|benzocaine|mesh-list
55824227|NCT05645861|Anesthetics, Local|anesthetics, local|mesh-ancestor
55824228|NCT05645861|Anesthetics|anesthetics|mesh-ancestor
55824229|NCT05645861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55824230|NCT05645861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824231|NCT05645861|Sensory System Agents|sensory system agents|mesh-ancestor
55824232|NCT05645861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824251|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55824252|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55824253|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824254|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
55824256|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55824257|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
55824258|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824259|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
55824260|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
55824261|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824262|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824263|NCT01741792|Blinatumomab|blinatumomab|mesh-list
55824264|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824266|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824267|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55824268|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
55824269|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55824270|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55824271|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55824272|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824305|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824306|NCT01717768|Testosterone|testosterone|mesh-list
55824307|NCT01717768|Androgens|androgens|mesh-ancestor
55824308|NCT01717768|Hormones|hormones|mesh-ancestor
55824309|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824310|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824311|NCT02260934|Acetaminophen|acetaminophen|mesh-list
55824373|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824374|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55824376|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55824377|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55824378|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55824379|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55824380|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55824381|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824382|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
55824383|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
55824384|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55824434|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55824435|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55824436|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55824437|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824438|NCT01698814|Analgesics|analgesics|mesh-ancestor
55824439|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
55824440|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824441|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824442|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824443|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824444|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55824445|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55824446|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55824447|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
55824448|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
55824449|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824450|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824451|NCT01738594|Romidepsin|romidepsin|mesh-list
55824452|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55824453|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824454|NCT01697956|Beclomethasone|beclomethasone|mesh-list
55824455|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824456|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
55824457|NCT01697956|Hormones|hormones|mesh-ancestor
55824458|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824459|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824460|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55824461|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
55824462|NCT01697800|Tadalafil|tadalafil|mesh-list
55824463|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
55824464|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55824465|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55824466|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824467|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824468|NCT01697800|Urological Agents|urological agents|mesh-ancestor
55824469|NCT04553770|Trastuzumab|trastuzumab|mesh-list
55824471|NCT04553770|Camptothecin|camptothecin|mesh-list
55824472|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
55824473|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824474|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824475|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55824476|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55824477|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55824478|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824479|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824480|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55824481|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
55824482|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824483|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824484|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55824485|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55824486|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55824487|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
55824488|NCT01644500|Glimepiride|glimepiride|mesh-list
55824498|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55824499|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55824500|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824501|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824502|NCT04872608|Letrozole|letrozole|mesh-list
55824503|NCT04872608|Palbociclib|palbociclib|mesh-list
55824504|NCT04872608|Onapristone|onapristone|mesh-list
55824505|NCT04872608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824506|NCT04872608|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55824507|NCT04872608|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55824508|NCT04872608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824509|NCT04872608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824510|NCT04872608|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55824511|NCT04872608|Hormone Antagonists|hormone antagonists|mesh-ancestor
55824512|NCT04872608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55824513|NCT04872608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824514|NCT04872608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55824515|NCT04872608|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55824516|NCT04872608|Fertility Agents|fertility agents|mesh-ancestor
55824517|NCT04872608|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55824518|NCT01716052|Ibuprofen|ibuprofen|mesh-list
55824519|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55824557|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
55824558|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824559|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55824560|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55824561|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
55824563|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
55824564|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824565|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824566|NCT01715896|Golimumab|golimumab|mesh-list
55824567|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
55824568|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55824569|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824570|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55824571|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
55824572|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824573|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824575|NCT05642780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824576|NCT05642780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824577|NCT05642702|Vitamins|vitamins|mesh-list
55824578|NCT05642702|Ascorbic Acid|ascorbic acid|mesh-list
55824579|NCT05642702|Niacinamide|niacinamide|mesh-list
55824580|NCT05642702|Niacin|niacin|mesh-list
55824581|NCT05642702|Nicotinic Acids|nicotinic acids|mesh-list
55824582|NCT05642702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55824583|NCT05642702|Micronutrients|micronutrients|mesh-ancestor
55824584|NCT05642702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824586|NCT05642702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824587|NCT05642702|Protective Agents|protective agents|mesh-ancestor
55824588|NCT05642702|Vitamin B Complex|vitamin b complex|mesh-ancestor
55824589|NCT05642702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55824590|NCT05642702|Antimetabolites|antimetabolites|mesh-ancestor
55824591|NCT05642702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55824592|NCT05642702|Vasodilator Agents|vasodilator agents|mesh-ancestor
55824593|NCT05544734|Acetaminophen|acetaminophen|mesh-list
55824599|NCT05544734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824600|NCT05544734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824602|NCT05544734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55824603|NCT05544734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824604|NCT05544734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824605|NCT05544734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55824606|NCT05544734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824613|NCT02254772|Ipilimumab|ipilimumab|mesh-list
55824614|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824615|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824616|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55824617|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824618|NCT01682044|Rituximab|rituximab|mesh-list
55824619|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824620|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824621|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
55824622|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824648|NCT05493566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824649|NCT05493566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824650|NCT05493566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55824652|NCT05493566|Sensory System Agents|sensory system agents|mesh-ancestor
55824653|NCT05493566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824654|NCT05493566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824655|NCT05493566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55824656|NCT05493566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55824657|NCT05493566|Antiviral Agents|antiviral agents|mesh-ancestor
55824658|NCT05493566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55824659|NCT04871594|Nivolumab|nivolumab|mesh-list
55824660|NCT04871594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824661|NCT04871594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824662|NCT04871594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55824663|NCT04871594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824664|NCT04871204|Octreotide|octreotide|mesh-list
55824668|NCT05625776|Capsaicin|capsaicin|mesh-list
55824703|NCT05438264|Nootropic Agents|nootropic agents|mesh-ancestor
55824704|NCT04835870|Prednisone|prednisone|mesh-list
55824705|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
55824706|NCT04835870|Rituximab|rituximab|mesh-list
55824707|NCT04835870|Doxorubicin|doxorubicin|mesh-list
55824708|NCT04835870|Vincristine|vincristine|mesh-list
55824709|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
55824710|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55824711|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
55824712|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824713|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55824714|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55824715|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
55824716|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824717|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824718|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55824719|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824720|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55824721|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55824726|NCT04835870|Hormones|hormones|mesh-ancestor
55824758|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
55824759|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824760|NCT04654208|Palbociclib|palbociclib|mesh-list
55824761|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824762|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55824763|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824764|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824766|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55824768|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55824769|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824770|NCT05357846|Paclitaxel|paclitaxel|mesh-list
55824771|NCT05357846|Cisplatin|cisplatin|mesh-list
55824772|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55824773|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824774|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
55824823|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
55824824|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
55824825|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824826|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824827|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
55824828|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55824829|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
55824830|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
55824831|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55824832|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55824833|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55824834|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
55824835|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824836|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824837|NCT04419662|Protective Agents|protective agents|mesh-ancestor
55824838|NCT04621526|Dexmedetomidine|dexmedetomidine|mesh-list
55824839|NCT04621526|Ketamine|ketamine|mesh-list
55824840|NCT04621526|Propofol|propofol|mesh-list
55824841|NCT04621526|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55824864|NCT04589546|Vitamins|vitamins|mesh-ancestor
55824865|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
55824866|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824867|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55824868|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
55824869|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824870|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55824871|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
55824872|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
55824873|NCT05369468|Bupivacaine|bupivacaine|mesh-list
55824874|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
55824875|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
55824884|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55824885|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55824886|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
55824887|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824888|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824889|NCT02164513|Fluticasone|fluticasone|mesh-list
55824891|NCT02164513|Bromides|bromides|mesh-list
55824892|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55824893|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55824894|NCT02164513|Autonomic Agents|autonomic agents|mesh-ancestor
55824895|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824896|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824897|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55824898|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
55824899|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
55824900|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55824902|NCT04562246|Antibodies|antibodies|mesh-list
55824903|NCT04562246|Immunologic Factors|immunologic factors|mesh-ancestor
55824904|NCT04562246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824905|NCT05252390|Olaparib|olaparib|mesh-list
55824906|NCT05252390|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55824907|NCT05252390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824908|NCT05252390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824909|NCT05252390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824910|NCT04532372|Leflunomide|leflunomide|mesh-list
55824911|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824912|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824913|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55824914|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
55824915|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824918|NCT04831736|Sensory System Agents|sensory system agents|mesh-ancestor
55824919|NCT04831736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824920|NCT04831736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824921|NCT04831736|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55824922|NCT04831736|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55824923|NCT04831736|Anesthetics, General|anesthetics, general|mesh-ancestor
55824924|NCT04831736|Anesthetics|anesthetics|mesh-ancestor
55824925|NCT04831736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55824926|NCT04831736|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55824927|NCT04831736|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55824928|NCT04831736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55824929|NCT04831736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824930|NCT05341154|Dexmedetomidine|dexmedetomidine|mesh-list
55824931|NCT05341154|Ketamine|ketamine|mesh-list
55824932|NCT05341154|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55824944|NCT05341154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824956|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
55824957|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55824958|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824960|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
55824965|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
55824966|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55824972|NCT05409872|Pyridoxal|pyridoxal|mesh-list
55824973|NCT05409872|Pyridoxine|pyridoxine|mesh-list
55824974|NCT05409872|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
55824975|NCT05409872|Micronutrients|micronutrients|mesh-ancestor
55824976|NCT05409872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824977|NCT05409872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55824978|NCT05409872|Vitamin B Complex|vitamin b complex|mesh-ancestor
55824979|NCT05409872|Antioxidants|antioxidants|mesh-ancestor
55824980|NCT05409872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55824981|NCT05409872|Protective Agents|protective agents|mesh-ancestor
55824982|NCT05409872|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
55824983|NCT05409872|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55824984|NCT05409872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824985|NCT05409872|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55824986|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55824987|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55824989|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
55824990|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55824991|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55824992|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
55824993|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55824995|NCT04464512|Buprenorphine|buprenorphine|mesh-list
55824996|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55824997|NCT04464512|Narcotics|narcotics|mesh-ancestor
55824998|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55825000|NCT04464512|Analgesics|analgesics|mesh-ancestor
55825010|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55825011|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
55825012|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55825013|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
55825014|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825015|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
55825016|NCT04839692|Protective Agents|protective agents|mesh-ancestor
55825017|NCT04421378|Bevacizumab|bevacizumab|mesh-list
55825018|NCT04421378|Temozolomide|temozolomide|mesh-list
55825019|NCT04421378|Carmustine|carmustine|mesh-list
55825020|NCT04421378|Lomustine|lomustine|mesh-list
55825021|NCT04421378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55825022|NCT04421378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825023|NCT04421378|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55825024|NCT04421378|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55825025|NCT04421378|Growth Substances|growth substances|mesh-ancestor
55825026|NCT04421378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825027|NCT04421378|Growth Inhibitors|growth inhibitors|mesh-ancestor
55825028|NCT04421378|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55825029|NCT04421378|Alkylating Agents|alkylating agents|mesh-ancestor
55825030|NCT04421378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825064|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825065|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
55825066|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55825067|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55825069|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55825070|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55825071|NCT01363700|Analgesics|analgesics|mesh-ancestor
55825072|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
55825073|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825074|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825075|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825076|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55825077|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55825078|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55825079|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55825091|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55825092|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825093|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55825105|NCT04838288|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55825106|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825107|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825109|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55825110|NCT04327934|Testosterone|testosterone|mesh-list
55825111|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
55825112|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
55825113|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55825115|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825116|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825117|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825118|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825119|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
55825121|NCT04791566|Dexamethasone|dexamethasone|mesh-list
55825122|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825123|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
55825124|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
55825125|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825126|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825127|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55825128|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
55825129|NCT04791566|Hormones|hormones|mesh-ancestor
55825130|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825131|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825132|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825133|NCT04307576|Dexamethasone|dexamethasone|mesh-list
55825134|NCT04307576|Doxorubicin|doxorubicin|mesh-list
55825135|NCT04307576|Vincristine|vincristine|mesh-list
55825149|NCT04307576|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825150|NCT04307576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825151|NCT04307576|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55825152|NCT04307576|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55825153|NCT04307576|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55825154|NCT04307576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825155|NCT04307576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825156|NCT04307576|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55825157|NCT04307576|Tubulin Modulators|tubulin modulators|mesh-ancestor
55825158|NCT04307576|Antimitotic Agents|antimitotic agents|mesh-ancestor
55825162|NCT04307576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55825163|NCT04307576|Antimetabolites|antimetabolites|mesh-ancestor
55825164|NCT04129736|Teriflunomide|teriflunomide|mesh-list
55825165|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55825166|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55825167|NCT04129736|Analgesics|analgesics|mesh-ancestor
55825168|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
55825202|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
55825203|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825204|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55825205|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825206|NCT04824638|Vaccines|vaccines|mesh-list
55825207|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
55825208|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825209|NCT02217475|Cenicriviroc|cenicriviroc|mesh-list
55825210|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55825211|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825213|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55825215|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55825217|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55825218|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825230|NCT04818866|Coagulants|coagulants|mesh-ancestor
55825231|NCT02189941|Deferiprone|deferiprone|mesh-list
55825232|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55825233|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
55825246|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
55825247|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825248|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825249|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55825261|NCT04207190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55825263|NCT04207190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825264|NCT04207190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825265|NCT04207190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55825266|NCT04207190|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55825299|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825300|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825301|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
55825302|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55825303|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55825304|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
55825305|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55825306|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55825307|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825308|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55825309|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
55825310|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55825311|NCT05221190|Lidocaine|lidocaine|mesh-list
55825312|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
55825313|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
55825314|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55825315|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825316|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
55825317|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825318|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55825319|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55825320|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55825321|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55825322|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825324|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
55825325|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825326|NCT04816682|Protective Agents|protective agents|mesh-ancestor
55825327|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825328|NCT02162719|Paclitaxel|paclitaxel|mesh-list
55825329|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55825330|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825331|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
55825332|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
55825333|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
55825335|NCT04808882|Tinzaparin|tinzaparin|mesh-list
55825336|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55825337|NCT04808882|Dalteparin|dalteparin|mesh-list
55825338|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
55825339|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55825340|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55825341|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825342|NCT05652374|Nitrofurantoin|nitrofurantoin|mesh-list
55825343|NCT05652374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55825344|NCT05652374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55825345|NCT05652374|Renal Agents|renal agents|mesh-ancestor
55825346|NCT05652374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55825347|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55825348|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55825349|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
55825350|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825351|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825352|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55825353|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
55825354|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55825355|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55825356|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55825358|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825359|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825361|NCT04794842|Tetracaine|tetracaine|mesh-list
55825363|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
55825364|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55825365|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825366|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
55825367|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825376|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825377|NCT03783182|Betamethasone|betamethasone|mesh-list
55825378|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
55825379|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
55825380|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
55825381|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
55825382|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
55825383|NCT03783182|Hormones|hormones|mesh-ancestor
55825384|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825385|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825386|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825387|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55825388|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
55825389|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
55825390|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55825391|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55825393|NCT05651750|Xhance|xhance|mesh-list
55825394|NCT05651750|Montelukast|montelukast|mesh-list
55825395|NCT05651750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825396|NCT05651750|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55825397|NCT05651750|Autonomic Agents|autonomic agents|mesh-ancestor
55825398|NCT05651750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825399|NCT05651750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825401|NCT05651750|Respiratory System Agents|respiratory system agents|mesh-ancestor
55825402|NCT05651750|Dermatologic Agents|dermatologic agents|mesh-ancestor
55825403|NCT05651750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55825404|NCT05651750|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55825405|NCT05651750|Hormone Antagonists|hormone antagonists|mesh-ancestor
55825406|NCT05651750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825407|NCT05651750|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55825408|NCT05651750|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55825409|NCT05651750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825410|NCT03740204|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55825411|NCT03740204|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55825413|NCT03740204|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55825414|NCT03740204|Progesterone|progesterone|mesh-list
55825415|NCT03740204|Estrogens|estrogens|mesh-ancestor
55825417|NCT03740204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825418|NCT03740204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825419|NCT03740204|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55825420|NCT03740204|Contraceptive Agents|contraceptive agents|mesh-ancestor
55825421|NCT03740204|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55825422|NCT03740204|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55825423|NCT03740204|Progestins|progestins|mesh-ancestor
55825424|NCT02160145|Tolvaptan|tolvaptan|mesh-list
55825425|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
55825426|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825427|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
55825428|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825429|NCT04793906|Iron|iron|mesh-list
55825430|NCT04793906|Trace Elements|trace elements|mesh-ancestor
55825431|NCT04793906|Micronutrients|micronutrients|mesh-ancestor
55825432|NCT04793906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825433|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
55825434|NCT02216071|Dexamethasone|dexamethasone|mesh-list
55825435|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
55825436|NCT02216071|BB 1101|bb 1101|mesh-list
55825437|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825438|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
55825439|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
55825440|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825441|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825442|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55825443|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
55825444|NCT02216071|Hormones|hormones|mesh-ancestor
55825896|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55825445|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825447|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825455|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55825456|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55825457|NCT01681576|Valsartan|valsartan|mesh-list
55825458|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55825459|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55825460|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55825461|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55825462|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825463|NCT02188459|Bupropion|bupropion|mesh-list
55825464|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55825465|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
55825466|NCT02188459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55825467|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55825468|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55825469|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55825470|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825471|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
55825472|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825473|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825474|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55825475|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55825476|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825477|NCT02743364|Simvastatin|simvastatin|mesh-list
55825478|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55825479|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55825480|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
55825481|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825482|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55825496|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
55825497|NCT02214121|Ticagrelor|ticagrelor|mesh-list
55825498|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55825499|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55825500|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55825501|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55825502|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
55825503|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825504|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825505|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825507|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
55825508|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55825509|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55825510|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55825511|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825512|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825513|NCT01695772|Bevacizumab|bevacizumab|mesh-list
55825514|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55825515|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825516|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55825517|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55825518|NCT01695772|Growth Substances|growth substances|mesh-ancestor
55825519|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825520|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
55825521|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55825522|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55825523|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55825524|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825528|NCT01712854|Budesonide|budesonide|mesh-list
55825536|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
55825537|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
55825538|NCT01712854|Hormones|hormones|mesh-ancestor
55825539|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825540|NCT02986594|Aspirin|aspirin|mesh-list
55825541|NCT02986594|Heparin|heparin|mesh-list
55825542|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55825543|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55825544|NCT02986594|Analgesics|analgesics|mesh-ancestor
55825545|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
55825546|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825547|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825548|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825550|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55825551|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55825552|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825553|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55825554|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55825555|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825556|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
55825557|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
55825558|NCT02159365|Dexamethasone|dexamethasone|mesh-list
55825559|NCT02159365|Lenalidomide|lenalidomide|mesh-list
55825560|NCT02159365|Elotuzumab|elotuzumab|mesh-list
55825561|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825562|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
55825563|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
55825584|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825586|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55825587|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55825588|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55825589|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
55825590|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825591|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825592|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55825593|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55825594|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
55825645|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
55825646|NCT04802408|Protective Agents|protective agents|mesh-ancestor
55825647|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825648|NCT01635764|Adalimumab|adalimumab|mesh-list
55825649|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825650|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55825651|NCT03498716|Paclitaxel|paclitaxel|mesh-list
55825652|NCT03498716|Cyclophosphamide|cyclophosphamide|mesh-list
55825653|NCT03498716|Doxorubicin|doxorubicin|mesh-list
55825654|NCT03498716|Atezolizumab|atezolizumab|mesh-list
55825655|NCT03498716|Epirubicin|epirubicin|mesh-list
55825656|NCT03498716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55825657|NCT03498716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825658|NCT03498716|Tubulin Modulators|tubulin modulators|mesh-ancestor
55825659|NCT03498716|Antimitotic Agents|antimitotic agents|mesh-ancestor
55825660|NCT03498716|Mitosis Modulators|mitosis modulators|mesh-ancestor
55825669|NCT03498716|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55825670|NCT03498716|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55825671|NCT03498716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55825672|NCT03498716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825673|NCT03341078|Ibudilast|ibudilast|mesh-list
55825674|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55825675|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
55825676|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825678|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55825679|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
55825680|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55825681|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825682|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825683|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55825684|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
55825685|NCT04810598|Venetoclax|venetoclax|mesh-list
55825686|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825687|NCT05195918|Pirfenidone|pirfenidone|mesh-list
55825688|NCT05195918|Nintedanib|nintedanib|mesh-list
55825689|NCT05195918|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
55825690|NCT05195918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825691|NCT05195918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55825692|NCT05195918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825693|NCT05195918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825694|NCT05195918|Analgesics|analgesics|mesh-ancestor
55825695|NCT05195918|Sensory System Agents|sensory system agents|mesh-ancestor
55825702|NCT05195918|Antioxidants|antioxidants|mesh-ancestor
55825733|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55825735|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825736|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825738|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55825739|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
55825740|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55825741|NCT02049866|Denosumab|denosumab|mesh-list
55825742|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55825743|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825744|NCT04787744|Prednisone|prednisone|mesh-list
55825745|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
55825746|NCT04787744|Docetaxel|docetaxel|mesh-list
55825747|NCT04787744|Leuprolide|leuprolide|mesh-list
55825748|NCT04787744|Goserelin|goserelin|mesh-list
55825749|NCT04787744|Bicalutamide|bicalutamide|mesh-list
55825750|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
55825751|NCT04787744|Flutamide|flutamide|mesh-list
55825752|NCT04787744|Nilutamide|nilutamide|mesh-list
55825753|NCT04787744|Relugolix|relugolix|mesh-list
55825754|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825761|NCT04787744|Hormones|hormones|mesh-ancestor
55825789|NCT05180942|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55825790|NCT05180942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825792|NCT04274894|Androgens|androgens|mesh-ancestor
55825793|NCT04274894|Hormones|hormones|mesh-ancestor
55825794|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825795|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825796|NCT04786964|Folic Acid|folic acid|mesh-list
55825797|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
55825798|NCT04786964|Dexamethasone|dexamethasone|mesh-list
55825799|NCT04786964|Carboplatin|carboplatin|mesh-list
55825800|NCT04786964|Pemetrexed|pemetrexed|mesh-list
55825801|NCT04786964|Vitamins|vitamins|mesh-ancestor
55825802|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
55825803|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825811|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825812|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825813|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825814|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825815|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825816|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55825817|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55825835|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825837|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55825838|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825839|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
55825840|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825854|NCT05173298|Atezolizumab|atezolizumab|mesh-list
55825855|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55825856|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825857|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55825858|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55825859|NCT05173298|Growth Substances|growth substances|mesh-ancestor
55825860|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825861|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
55825862|NCT05168930|Venetoclax|venetoclax|mesh-list
55825863|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
55825864|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825865|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55825866|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825867|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825868|NCT01975064|Propofol|propofol|mesh-list
55825869|NCT01975064|Sevoflurane|sevoflurane|mesh-list
55825870|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55825873|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55825874|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
55825875|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
55825876|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55825877|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55825878|NCT04062266|Azacitidine|azacitidine|mesh-list
55825879|NCT04062266|Venetoclax|venetoclax|mesh-list
55825880|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55825881|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
55825882|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825883|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825884|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825885|NCT02210689|Clindamycin|clindamycin|mesh-list
55825886|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
55825887|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
55825888|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55825889|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55825890|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55825891|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825892|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825894|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55825895|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
55825897|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55825898|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55825899|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55825900|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825902|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55825903|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825904|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55825905|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55825906|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825911|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55825912|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825913|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
55825914|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
55825915|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
55825916|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825917|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55825919|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55825920|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55825921|NCT01469156|Growth Substances|growth substances|mesh-ancestor
55825922|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825923|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
55825924|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825925|NCT04799054|Pembrolizumab|pembrolizumab|mesh-list
55825926|NCT04799054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55825927|NCT04799054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825928|NCT04191434|Budesonide|budesonide|mesh-list
55825929|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
55825930|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55825931|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825932|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55825933|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
55825934|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825935|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825936|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55825937|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
55825938|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
55825939|NCT04191434|Hormones|hormones|mesh-ancestor
55825940|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825941|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55825942|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55825943|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55825944|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
55825947|NCT03835676|Treprostinil|treprostinil|mesh-list
55825948|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55825949|NCT03752684|Calcium|calcium|mesh-list
55825950|NCT03752684|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55825951|NCT03752684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825952|NCT03651128|Dexamethasone|dexamethasone|mesh-list
55825953|NCT03651128|Lenalidomide|lenalidomide|mesh-list
55825954|NCT03651128|Bortezomib|bortezomib|mesh-list
55825955|NCT03651128|Daratumumab|daratumumab|mesh-list
55825956|NCT03651128|Pomalidomide|pomalidomide|mesh-list
55825957|NCT03651128|Ixazomib|ixazomib|mesh-list
55825958|NCT03651128|Elotuzumab|elotuzumab|mesh-list
55825959|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55825960|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
55825961|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
55825962|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55825964|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55825967|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55825968|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55825969|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825970|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
55825971|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55825972|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55825973|NCT03651128|Growth Substances|growth substances|mesh-ancestor
55825974|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
55825975|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
55825976|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55825977|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55825978|NCT00664898|Bortezomib|bortezomib|mesh-list
55825979|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55825980|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
55825981|NCT04827992|Narcotics|narcotics|mesh-ancestor
55825982|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55825983|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825984|NCT04827992|Analgesics|analgesics|mesh-ancestor
55825985|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
55825989|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55825990|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55825991|NCT02187055|Adalimumab|adalimumab|mesh-list
55825992|NCT02187055|Methotrexate|methotrexate|mesh-list
55825993|NCT02187055|Tofacitinib|tofacitinib|mesh-list
55825994|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55825995|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
55825996|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55825997|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55825998|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55825999|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
55826000|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826001|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826008|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55826009|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826010|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55826011|NCT00119366|Iodine|iodine|mesh-list
55826012|NCT00119366|Cyclosporine|cyclosporine|mesh-list
55826013|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
55826014|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55826039|NCT00119366|Trace Elements|trace elements|mesh-ancestor
55826040|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
55826041|NCT02246660|Resveratrol|resveratrol|mesh-list
55826042|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
55826043|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826044|NCT02246660|Protective Agents|protective agents|mesh-ancestor
55826045|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826046|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826047|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55826048|NCT03471260|Azacitidine|azacitidine|mesh-list
55826049|NCT03471260|Venetoclax|venetoclax|mesh-list
55826050|NCT03471260|Ivosidenib|ivosidenib|mesh-list
55826051|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55826052|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
55826053|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826054|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826055|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826056|NCT02246582|Insulin|insulin|mesh-list
55826057|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55826058|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826059|NCT02137369|Dexetimide|dexetimide|mesh-list
55826060|NCT02137369|Citalopram|citalopram|mesh-list
55826061|NCT02137369|Sertraline|sertraline|mesh-list
55826062|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
55826063|NCT02137369|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-list
55826064|NCT02137369|Serotonin|serotonin|mesh-list
55826065|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55826066|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55826087|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826088|NCT02155309|Scopolamine|scopolamine|mesh-list
55826089|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55826090|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55826091|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
55826092|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
55826093|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826094|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826095|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55826096|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
55826097|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55826098|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
55826099|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826100|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826101|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55826102|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
55826103|NCT02186821|Ceritinib|ceritinib|mesh-list
55826104|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826105|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55826106|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826107|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826108|NCT01710358|Adalimumab|adalimumab|mesh-list
55826109|NCT01710358|Methotrexate|methotrexate|mesh-list
55826137|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826138|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55826140|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826141|NCT01691482|Albuterol|albuterol|mesh-list
55826142|NCT01691482|Ipratropium|ipratropium|mesh-list
55826143|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55826144|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
55826145|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826146|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826147|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55826148|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
55826149|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
55826150|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55826151|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55826153|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55826154|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
55826155|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826156|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826157|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55826158|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
55826159|NCT01710046|Tofacitinib|tofacitinib|mesh-list
55826160|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55826161|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826162|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826163|NCT03148418|Atezolizumab|atezolizumab|mesh-list
55826164|NCT03148418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826165|NCT02154529|Trastuzumab|trastuzumab|mesh-list
55826167|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55826168|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826169|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55826170|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826171|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826172|NCT02154139|Leuprolide|leuprolide|mesh-list
55826175|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55826176|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826177|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55826178|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826179|NCT02154061|Metronidazole|metronidazole|mesh-list
55826180|NCT02154061|Vancomycin|vancomycin|mesh-list
55826181|NCT02154061|Neomycin|neomycin|mesh-list
55826182|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826183|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55826184|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55826185|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55826186|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55826187|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826188|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826189|NCT01907217|Methohexital|methohexital|mesh-list
55826190|NCT01907217|Succinylcholine|succinylcholine|mesh-list
55826191|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
55826192|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55826193|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55826194|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826195|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826196|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55826197|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
55826198|NCT01907217|Anesthetics|anesthetics|mesh-ancestor
55826199|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826200|NCT01953783|Ixazomib|ixazomib|mesh-list
55826201|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826202|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
55826203|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826204|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826205|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55826206|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826207|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55826208|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826212|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826214|NCT01630135|Xhance|xhance|mesh-list
55826215|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826225|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55826227|NCT01924767|Empagliflozin|empagliflozin|mesh-list
55826228|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55826229|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826230|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55826231|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826234|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
55826235|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826236|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826237|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55826238|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55826239|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
55826240|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
55826241|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826242|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55826257|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55826258|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
55826259|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826260|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826261|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
55826262|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826263|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55826264|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55826265|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
55826266|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55826267|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55826268|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
55826269|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55826270|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55826271|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826272|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55826273|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55826313|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
55826314|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826315|NCT02153905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55826316|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55826317|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
55826318|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826319|NCT04752631|Tenecteplase|tenecteplase|mesh-list
55826320|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55826321|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55826322|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826323|NCT04546672|Neostigmine|neostigmine|mesh-list
55826324|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55826325|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826326|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826327|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
55826328|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826329|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826330|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55826331|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
55826332|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826342|NCT01591096|Plasminogen|plasminogen|mesh-list
55826343|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55826344|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55826345|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55826346|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826347|NCT01953003|Capecitabine|capecitabine|mesh-list
55826348|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55826349|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
55826350|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826351|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826352|NCT01709500|Atorvastatin|atorvastatin|mesh-list
55826353|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55826354|NCT01709500|Simvastatin|simvastatin|mesh-list
55826355|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55826356|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55826357|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
55826358|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826359|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55826360|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55826361|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826362|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
55826366|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55826371|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55826372|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55826373|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826374|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826375|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826376|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55826377|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55826378|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55826379|NCT01599806|Renal Agents|renal agents|mesh-ancestor
55826380|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
55826381|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55826382|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55826383|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55826384|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55826385|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55826386|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55826387|NCT01599325|Azacitidine|azacitidine|mesh-list
55826388|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55826389|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
55826390|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826391|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826392|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826393|NCT01924299|Fluconazole|fluconazole|mesh-list
55826394|NCT01924299|Ketoconazole|ketoconazole|mesh-list
55826408|NCT02182999|Ropivacaine|ropivacaine|mesh-list
55826409|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
55826410|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
55826411|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826412|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826413|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
55826414|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826416|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55826417|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826418|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
55826419|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55826420|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55826421|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826422|NCT02978222|Molgramostim|molgramostim|mesh-list
55826423|NCT02978222|Sargramostim|sargramostim|mesh-list
55826424|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
55826425|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826426|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826428|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55826429|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826430|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55826431|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
55826460|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826461|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826462|NCT02180659|Analgesics|analgesics|mesh-ancestor
55826463|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
55826464|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826465|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55826467|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
55826468|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826469|NCT05156606|Testosterone|testosterone|mesh-list
55826470|NCT05156606|Androgens|androgens|mesh-ancestor
55826471|NCT05156606|Hormones|hormones|mesh-ancestor
55826472|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55826473|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826474|NCT02241512|Ibuprofen|ibuprofen|mesh-list
55826475|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55826476|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55826478|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
55826479|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826480|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826481|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826482|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55826483|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55826484|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826485|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826486|NCT01709110|Vitamin D|vitamin d|mesh-list
55826487|NCT01709110|Teriparatide|teriparatide|mesh-list
55826488|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
55826489|NCT01709110|Calcium|calcium|mesh-list
55826490|NCT01709110|Vitamins|vitamins|mesh-ancestor
55826491|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
55826492|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826493|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55826494|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55826495|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55826497|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826499|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55826500|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826501|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55826502|NCT01590082|Doxycycline|doxycycline|mesh-list
55826503|NCT01590082|Temozolomide|temozolomide|mesh-list
55826505|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55826506|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
55826507|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826508|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826509|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55826510|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55826511|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55826512|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826513|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
55826514|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55826515|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55826516|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55826517|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55826518|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55826519|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826520|NCT02179177|Apixaban|apixaban|mesh-list
55826521|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55826522|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
55826523|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55826524|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
55826525|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826526|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826527|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
55826528|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55826537|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
55826538|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826539|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826540|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55826541|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55826542|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
55826543|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55826544|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55826545|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
55826547|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826548|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55826549|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826550|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826551|NCT02238626|Ibudilast|ibudilast|mesh-list
55826552|NCT02238626|Riluzole|riluzole|mesh-list
55826553|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
55826554|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55826555|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55826556|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826557|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826558|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826559|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55826560|NCT02238626|Protective Agents|protective agents|mesh-ancestor
55826561|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55826565|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
55826566|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55826567|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826568|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55826569|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
55826570|NCT02151643|Iron|iron|mesh-list
55826571|NCT02151643|Trace Elements|trace elements|mesh-ancestor
55826576|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
55826577|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826578|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826579|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826580|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55826581|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55826582|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826583|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55826584|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55826585|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
55826586|NCT02178709|Leucovorin|leucovorin|mesh-list
55826587|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
55826588|NCT02178709|Irinotecan|irinotecan|mesh-list
55826591|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55826592|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55826593|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826594|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826595|NCT02178709|Antidotes|antidotes|mesh-ancestor
55826596|NCT02178709|Protective Agents|protective agents|mesh-ancestor
55826597|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826632|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55826633|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826638|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
55826639|NCT01688830|Dabigatran|dabigatran|mesh-list
55826640|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
55826641|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55826642|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
55826643|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826644|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826645|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
55826646|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
55826647|NCT01604278|Bromides|bromides|mesh-list
55826648|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
55826649|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55826650|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55826651|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55826652|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
55826653|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826654|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826655|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826656|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
55826657|NCT01687270|Ribavirin|ribavirin|mesh-list
55826658|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
55826659|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826660|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
55826661|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826662|NCT01588990|Leucovorin|leucovorin|mesh-list
55826663|NCT01588990|Bevacizumab|bevacizumab|mesh-list
55826664|NCT01588990|Capecitabine|capecitabine|mesh-list
55826665|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
55826672|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826673|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
55826674|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55826675|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
55826676|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826677|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55826678|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55826679|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826680|NCT01588990|Antidotes|antidotes|mesh-ancestor
55826681|NCT01588990|Protective Agents|protective agents|mesh-ancestor
55826682|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
55826683|NCT01588990|Vitamins|vitamins|mesh-ancestor
55826684|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
55826685|NCT02126839|Albuterol|albuterol|mesh-list
55826686|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55826688|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826689|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826690|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55826691|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
55826692|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
55826693|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55826694|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55826695|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55826696|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55826697|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
55826698|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826699|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826700|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
55826701|NCT04747795|Vitamins|vitamins|mesh-ancestor
55826702|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
55826703|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826704|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
55826706|NCT04747795|Protective Agents|protective agents|mesh-ancestor
55826712|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826713|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55826714|NCT02125279|Vitamins|vitamins|mesh-ancestor
55826715|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
55826716|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55826718|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55826719|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826721|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55826723|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826724|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826725|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55826726|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55826727|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
55826728|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55826729|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826730|NCT02147587|Tofacitinib|tofacitinib|mesh-list
55826731|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55826732|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826733|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826734|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
55826735|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55826736|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
55826737|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55826738|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826739|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55826740|NCT04751929|Atezolizumab|atezolizumab|mesh-list
55826741|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826756|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
55826758|NCT01568866|Dexamethasone|dexamethasone|mesh-list
55826759|NCT01568866|Bortezomib|bortezomib|mesh-list
55826760|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826761|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
55826762|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
55826763|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826764|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826765|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55826766|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
55826767|NCT01568866|Hormones|hormones|mesh-ancestor
55826768|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55826769|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55826770|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826771|NCT01567852|Ketamine|ketamine|mesh-list
55826772|NCT01567852|Methohexital|methohexital|mesh-list
55826773|NCT01567852|Analgesics|analgesics|mesh-ancestor
55826774|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
55826775|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826776|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826777|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55826778|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55826798|NCT04115878|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55826799|NCT04115878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55826800|NCT04115878|Cholinergic Agents|cholinergic agents|mesh-ancestor
55826801|NCT04115878|Urological Agents|urological agents|mesh-ancestor
55826804|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55826805|NCT01587274|Oxycodone|oxycodone|mesh-list
55826806|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
55826807|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55826808|NCT01587274|Analgesics|analgesics|mesh-ancestor
55826809|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
55826810|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826811|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826812|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
55826813|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55826814|NCT01587274|Narcotics|narcotics|mesh-ancestor
55826815|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826816|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55826817|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826818|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55826819|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
55826820|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55826821|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826822|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826825|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55826845|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826846|NCT01952145|Insulin|insulin|mesh-list
55826847|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55826848|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
55826849|NCT01952145|Liraglutide|liraglutide|mesh-list
55826850|NCT01952145|Xultophy|xultophy|mesh-list
55826851|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55826854|NCT01952145|Hormones|hormones|mesh-ancestor
55826855|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55826856|NCT01923363|Tazobactam|tazobactam|mesh-list
55826857|NCT01923363|Piperacillin|piperacillin|mesh-list
55826858|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55826859|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55826860|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826861|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55826862|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826863|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826864|NCT01904721|Bimatoprost|bimatoprost|mesh-list
55826865|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55826866|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55826867|NCT01922739|Hydrocodone|hydrocodone|mesh-list
55826868|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55826869|NCT01922739|Narcotics|narcotics|mesh-ancestor
55826870|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55826871|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826872|NCT01922739|Analgesics|analgesics|mesh-ancestor
55826873|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
55826874|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826875|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
55826876|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
55826877|NCT02236988|Thalidomide|thalidomide|mesh-list
55826879|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55826880|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55826882|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
55826883|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55826884|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826885|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55826886|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55826887|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55826888|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55826889|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55826890|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55826891|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55826892|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
55826893|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
55826894|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55826895|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826896|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55826897|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55826898|NCT02236988|Growth Substances|growth substances|mesh-ancestor
55826899|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
55826900|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826901|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
55826902|NCT02236520|Spironolactone|spironolactone|mesh-list
55826903|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55826905|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55826906|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826907|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55826908|NCT02236520|Diuretics|diuretics|mesh-ancestor
55826909|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
55826910|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55826911|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55826919|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55826934|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
55826935|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
55826936|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55826944|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55826945|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
55826946|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55826947|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55826949|NCT02236130|Morphine|morphine|mesh-list
55826951|NCT02236130|Analgesics|analgesics|mesh-list
55826964|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
55826965|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
55826966|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
55826967|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55826968|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
55826970|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55826971|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
55826972|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55826973|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55826974|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55826975|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55826976|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
55826977|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55826978|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55826979|NCT01641809|Tenofovir|tenofovir|mesh-list
55826980|NCT01641809|Lamivudine|lamivudine|mesh-list
55826981|NCT01641809|Emtricitabine|emtricitabine|mesh-list
55826982|NCT01641809|Efavirenz|efavirenz|mesh-list
55826983|NCT01641809|Abacavir|abacavir|mesh-list
55826984|NCT01641809|Rilpivirine|rilpivirine|mesh-list
55826985|NCT01641809|Cabotegravir|cabotegravir|mesh-list
55826986|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
55826987|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55826988|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55826989|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55826990|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827008|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827026|NCT02254304|Interferon-beta|interferon-beta|mesh-list
55827027|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
55827028|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827029|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
55827030|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827031|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
55827032|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827055|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
55827056|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55827057|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
55827058|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
55827059|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827060|NCT05638529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55827061|NCT05638529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55827062|NCT05638529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827064|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55827065|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55827066|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55827067|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827068|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55827069|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55827070|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827071|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827072|NCT02121847|Cyclosporine|cyclosporine|mesh-list
55827073|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55827074|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55827075|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
55827077|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827078|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827079|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55827080|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
55827081|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827082|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
55827083|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827084|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827100|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
55827101|NCT01586806|Hormones|hormones|mesh-ancestor
55827102|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827103|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55827104|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827113|NCT05631041|Antioxidants|antioxidants|mesh-ancestor
55827114|NCT05631041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827115|NCT05631041|Protective Agents|protective agents|mesh-ancestor
55827116|NCT05631041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827117|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55827118|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
55827119|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55827120|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827121|NCT05544071|Sertraline|sertraline|mesh-list
55827122|NCT05544071|Antidepressive Agents|antidepressive agents|mesh-ancestor
55827123|NCT05544071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55827146|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55827147|NCT05598905|Pregabalin|pregabalin|mesh-list
55827148|NCT05598905|Lacosamide|lacosamide|mesh-list
55827149|NCT05598905|Oxycodone|oxycodone|mesh-list
55827150|NCT05598905|Analgesics|analgesics|mesh-ancestor
55827151|NCT05598905|Sensory System Agents|sensory system agents|mesh-ancestor
55827152|NCT05598905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827153|NCT05598905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827154|NCT05598905|Anticonvulsants|anticonvulsants|mesh-ancestor
55827155|NCT05598905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55827156|NCT05598905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55827157|NCT05598905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827158|NCT05598905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55827159|NCT05598905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55827160|NCT05598905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55827161|NCT05598905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827162|NCT05598905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55827163|NCT05598905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55827165|NCT05598905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55827166|NCT05598905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55827168|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
55827169|NCT01586338|Protective Agents|protective agents|mesh-ancestor
55827170|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827171|NCT02143141|Morphine|morphine|mesh-list
55827172|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55827173|NCT02143141|Narcotics|narcotics|mesh-ancestor
55827174|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827175|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827176|NCT02143141|Analgesics|analgesics|mesh-ancestor
55827177|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
55827178|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827179|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
55827180|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55827181|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55827187|NCT05497583|Factor VIII|factor viii|mesh-list
55827188|NCT05497583|Coagulants|coagulants|mesh-ancestor
55827189|NCT02253992|Nivolumab|nivolumab|mesh-list
55827190|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55827191|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827192|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55827193|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827194|NCT02252588|Chlorhexidine|chlorhexidine|mesh-list
55827195|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55827196|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827197|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
55827198|NCT01585558|Tamoxifen|tamoxifen|mesh-list
55827200|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
55827201|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827202|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827203|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55827204|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827205|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55827206|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55827207|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55827208|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
55827209|NCT01585246|Urological Agents|urological agents|mesh-ancestor
55827210|NCT01585168|Memantine|memantine|mesh-list
55827211|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55827212|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55827213|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
55827214|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55827215|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827216|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827217|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55827218|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55827228|NCT02252042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55827229|NCT02252042|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55827230|NCT02252042|Abortifacient Agents|abortifacient agents|mesh-ancestor
55827231|NCT02252042|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55827232|NCT02252042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827233|NCT02252042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55827235|NCT02252042|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827237|NCT02252042|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55827238|NCT02252042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55827239|NCT02252042|Immunologic Factors|immunologic factors|mesh-ancestor
55827240|NCT02252042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55827241|NCT02252042|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55827242|NCT02231918|Pramipexole|pramipexole|mesh-list
55827243|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
55827244|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827245|NCT02231918|Protective Agents|protective agents|mesh-ancestor
55827246|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827247|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55827248|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55827255|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
55827256|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827257|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827258|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
55827259|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55827260|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55827261|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827267|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
55827268|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55827269|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827271|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
55827272|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
55827273|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55827274|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827275|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827276|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
55827277|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
55827278|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55827279|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827280|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827281|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
55827282|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
55827283|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
55827284|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55827285|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827286|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55827287|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55827288|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
55827289|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827290|NCT01683994|Prednisone|prednisone|mesh-list
55827291|NCT01683994|Docetaxel|docetaxel|mesh-list
55827292|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827293|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
55827294|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
55827295|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
55827296|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827298|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
55827299|NCT01683994|Hormones|hormones|mesh-ancestor
55827300|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827301|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827302|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55827303|NCT02247440|Interferons|interferons|mesh-list
55827304|NCT02247440|Ribavirin|ribavirin|mesh-list
55827305|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827306|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
55827307|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827308|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
55827309|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827310|NCT04844099|Piperaquine|piperaquine|mesh-list
55827311|NCT04844099|Artenimol|artenimol|mesh-list
55827312|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
55827313|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55827314|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55827315|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827317|NCT04857203|Vitamins|vitamins|mesh-ancestor
55827318|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
55827319|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827320|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55827321|NCT05381597|Fluorouracil|fluorouracil|mesh-list
55827322|NCT05381597|Calcipotriene|calcipotriene|mesh-list
55827323|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
55827324|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827325|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55827326|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827327|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55827328|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
55827329|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827330|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827331|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
55827332|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55827355|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
55827356|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827357|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55827359|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
55827360|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
55827361|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827362|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827363|NCT04638881|Magnesium Sulfate|magnesium sulfate|mesh-list
55827364|NCT04638881|Analgesics|analgesics|mesh-ancestor
55827365|NCT04638881|Sensory System Agents|sensory system agents|mesh-ancestor
55827366|NCT04638881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827367|NCT04638881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827368|NCT04638881|Anesthetics|anesthetics|mesh-ancestor
55827369|NCT04638881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827370|NCT04638881|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55827371|NCT04638881|Anticonvulsants|anticonvulsants|mesh-ancestor
55827372|NCT04638881|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55827373|NCT04638881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55827374|NCT04638881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827375|NCT04638881|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55827376|NCT04638881|Tocolytic Agents|tocolytic agents|mesh-ancestor
55827377|NCT04638881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55827378|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55827379|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55827380|NCT05422703|Analgesics|analgesics|mesh-list
55827381|NCT05422703|Sensory System Agents|sensory system agents|mesh-ancestor
55827382|NCT05422703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827383|NCT05422703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827384|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
55827385|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55827389|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827391|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
55827392|NCT02170207|Lansoprazole|lansoprazole|mesh-list
55827393|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
55827394|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55827395|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55827396|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55827397|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827398|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827399|NCT05382299|Gemcitabine|gemcitabine|mesh-list
55827400|NCT05382299|Paclitaxel|paclitaxel|mesh-list
55827401|NCT05382299|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55827402|NCT05382299|Carboplatin|carboplatin|mesh-list
55827403|NCT05382299|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55827404|NCT05382299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827405|NCT05382299|Tubulin Modulators|tubulin modulators|mesh-ancestor
55827406|NCT05382299|Antimitotic Agents|antimitotic agents|mesh-ancestor
55827407|NCT05382299|Mitosis Modulators|mitosis modulators|mesh-ancestor
55827408|NCT05382299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827409|NCT05382299|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55827411|NCT05382299|Antiviral Agents|antiviral agents|mesh-ancestor
55827412|NCT05382299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827413|NCT05382299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827414|NCT05382299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55827415|NCT05382299|Immunologic Factors|immunologic factors|mesh-ancestor
55827416|NCT05382299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827417|NCT02227784|Atorvastatin|atorvastatin|mesh-list
55827418|NCT02227784|Ezetimibe|ezetimibe|mesh-list
55827419|NCT02227784|Evacetrapib|evacetrapib|mesh-list
55827420|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55827421|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55827422|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
55827423|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827429|NCT04577417|Adderall|adderall|mesh-list
55827431|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
55827432|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55827433|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827435|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55827436|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55827437|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827440|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
55827441|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
55827442|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827443|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
55827444|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55827445|NCT01683058|Aripiprazole|aripiprazole|mesh-list
55827446|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
55827447|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55827448|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55827485|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55827486|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
55827487|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55827488|NCT02193776|Antimetabolites|antimetabolites|mesh-ancestor
55827489|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55827490|NCT04740697|Tamoxifen|tamoxifen|mesh-list
55827491|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55827492|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
55827493|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827494|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827495|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55827496|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827497|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55827498|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55827499|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55827500|NCT05358587|Anesthetics|anesthetics|mesh-list
55827501|NCT05358587|Anesthetics, Local|anesthetics, local|mesh-list
55827502|NCT05358587|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55827503|NCT05358587|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827504|NCT05358587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827505|NCT05358587|Sensory System Agents|sensory system agents|mesh-ancestor
55827506|NCT05358587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827507|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55827509|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55827510|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55827529|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827530|NCT02169830|Topiramate|topiramate|mesh-list
55827531|NCT02169830|Nortriptyline|nortriptyline|mesh-list
55827532|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
55827533|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55827534|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827535|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55827536|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
55827537|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55827538|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55827539|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55827540|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55827541|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827542|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
55827667|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827673|NCT04481009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55827674|NCT04481009|Immunologic Factors|immunologic factors|mesh-ancestor
55827675|NCT04481009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827676|NCT05327231|Docetaxel|docetaxel|mesh-list
55827677|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827678|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
55827679|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
55827680|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
55827681|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827682|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
55827683|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827684|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827685|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
55827686|NCT01628107|Hematinics|hematinics|mesh-ancestor
55827687|NCT04745377|Antibodies|antibodies|mesh-list
55827688|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
55827700|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55827702|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55827720|NCT05323955|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55827721|NCT05323955|Maytansine|maytansine|mesh-list
55827722|NCT05323955|Tucatinib|tucatinib|mesh-list
55827723|NCT05323955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55827724|NCT05323955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827725|NCT05323955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55827726|NCT05323955|Tubulin Modulators|tubulin modulators|mesh-ancestor
55827727|NCT05323955|Antimitotic Agents|antimitotic agents|mesh-ancestor
55827728|NCT05323955|Mitosis Modulators|mitosis modulators|mesh-ancestor
55827729|NCT05323955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827730|NCT05323955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55827731|NCT05323955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827732|NCT04839185|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55827733|NCT04839185|Hematinics|hematinics|mesh-ancestor
55827734|NCT04839185|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55827735|NCT04839185|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55827736|NCT04824131|Tenofovir|tenofovir|mesh-list
55827737|NCT04824131|Emtricitabine|emtricitabine|mesh-list
55827738|NCT04824131|Cabotegravir|cabotegravir|mesh-list
55827739|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
55827740|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827741|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55827742|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55827743|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827744|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827746|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55827747|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55827748|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55827767|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55827769|NCT02224274|Ticagrelor|ticagrelor|mesh-list
55827770|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55827771|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55827772|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55827773|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55827774|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
55827775|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55827776|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827777|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827778|NCT05219669|Nalmefene|nalmefene|mesh-list
55827779|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55827780|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827781|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
55827782|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827783|NCT04763252|Coal Tar|coal tar|mesh-list
55827784|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
55827785|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
55827786|NCT05369039|Prednisolone|prednisolone|mesh-list
55827787|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55827788|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
55827789|NCT05369039|Hormones|hormones|mesh-ancestor
55827790|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827791|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827792|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55827793|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827794|NCT04373369|Atezolizumab|atezolizumab|mesh-list
55827795|NCT04373369|Vorolanib|vorolanib|mesh-list
55827796|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827798|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827813|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55827814|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827815|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55827816|NCT04791059|Analgesics|analgesics|mesh-ancestor
55827822|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
55827823|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55827824|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827825|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55827872|NCT05398913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827873|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55827874|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55827875|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55827876|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827877|NCT01583374|Thalidomide|thalidomide|mesh-list
55827878|NCT01583374|Apremilast|apremilast|mesh-list
55828244|NCT05355155|Growth Substances|growth substances|mesh-ancestor
55827879|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55827880|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55827881|NCT01583374|Analgesics|analgesics|mesh-ancestor
55827882|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
55827883|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55827884|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827885|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55827886|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55827932|NCT04809311|Glucagon|glucagon|mesh-list
55827933|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55827938|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55827940|NCT03184571|Pembrolizumab|pembrolizumab|mesh-list
55827941|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55827942|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827943|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55827944|NCT02164916|Cetuximab|cetuximab|mesh-list
55827945|NCT02164916|Irinotecan|irinotecan|mesh-list
55827946|NCT02164916|Camptothecin|camptothecin|mesh-list
55827947|NCT02164916|Vemurafenib|vemurafenib|mesh-list
55827948|NCT02164916|Antibodies|antibodies|mesh-list
55827949|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
55827950|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55827951|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
55827952|NCT02164916|Mitogens|mitogens|mesh-list
55827953|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
55827954|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827963|NCT04091867|Cetuximab|cetuximab|mesh-list
55827971|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55827972|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55827973|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55827974|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827975|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827976|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55827977|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
55827978|NCT04794569|Tinzaparin|tinzaparin|mesh-list
55827979|NCT04794569|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
55827980|NCT04794569|Dalteparin|dalteparin|mesh-list
55827981|NCT04794569|Rivaroxaban|rivaroxaban|mesh-list
55827982|NCT04794569|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55827983|NCT04794569|Antithrombins|antithrombins|mesh-ancestor
55827984|NCT04794569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55827985|NCT04794569|Protease Inhibitors|protease inhibitors|mesh-ancestor
55827986|NCT04794569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55827987|NCT04794569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827988|NCT04794569|Anticoagulants|anticoagulants|mesh-ancestor
55827994|NCT05651789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55827995|NCT05651789|Adrenergic Agents|adrenergic agents|mesh-ancestor
55827996|NCT05651789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55827997|NCT05651789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55827998|NCT05651789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55827999|NCT05651789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55828000|NCT05651789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55828001|NCT05651789|Vasodilator Agents|vasodilator agents|mesh-ancestor
55828006|NCT05651789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55828007|NCT05651789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55828008|NCT05651789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55828010|NCT05651633|Anesthetics, Local|anesthetics, local|mesh-ancestor
55828011|NCT05651633|Anesthetics|anesthetics|mesh-ancestor
55828012|NCT05651633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828013|NCT05651633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828014|NCT05651633|Sensory System Agents|sensory system agents|mesh-ancestor
55828015|NCT05651633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828016|NCT05651633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55828017|NCT05651633|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55828018|NCT05651633|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55828019|NCT05651633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828020|NCT05651633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828021|NCT02999477|Paclitaxel|paclitaxel|mesh-list
55828022|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
55828023|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55828024|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828025|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
55828026|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
55828027|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
55828028|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828030|NCT02222558|Testosterone|testosterone|mesh-list
55828031|NCT02222558|Androgens|androgens|mesh-ancestor
55828032|NCT02222558|Hormones|hormones|mesh-ancestor
55828033|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55828034|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828035|NCT02975999|Vasopressins|vasopressins|mesh-list
55828036|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
55828040|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55828041|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
55828042|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828043|NCT04807517|Buspirone|buspirone|mesh-list
55828044|NCT04807517|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55828045|NCT04807517|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55828046|NCT04807517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828047|NCT04807517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828048|NCT04807517|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55828049|NCT04807517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55828050|NCT04807517|Serotonin Agents|serotonin agents|mesh-ancestor
55828051|NCT04807517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828052|NCT04807517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828053|NCT02188784|Iron|iron|mesh-list
55828055|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
55828056|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828057|NCT02222246|Morphine|morphine|mesh-list
55828058|NCT02222246|Hydromorphone|hydromorphone|mesh-list
55828059|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55828060|NCT02222246|Narcotics|narcotics|mesh-ancestor
55828061|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828062|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828063|NCT02222246|Analgesics|analgesics|mesh-ancestor
55828064|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
55828065|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828066|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55828067|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55828068|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
55828079|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828080|NCT04013555|Antidotes|antidotes|mesh-ancestor
55828081|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55828082|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
55828083|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55828084|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
55828085|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
55828099|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55828100|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828101|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55828102|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55828103|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
55828104|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828105|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828106|NCT05647889|Lidocaine|lidocaine|mesh-list
55828107|NCT05647889|Anesthetics, Local|anesthetics, local|mesh-ancestor
55828108|NCT05647889|Anesthetics|anesthetics|mesh-ancestor
55828109|NCT05647889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828110|NCT05647889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828111|NCT05647889|Sensory System Agents|sensory system agents|mesh-ancestor
55828112|NCT05647889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828113|NCT05647889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55828114|NCT05647889|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55828115|NCT05647889|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55828127|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55828128|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
55828129|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828139|NCT03943901|Hormones|hormones|mesh-ancestor
55828140|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55828141|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55828142|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55828143|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
55828144|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
55828145|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
55828146|NCT02696993|Nivolumab|nivolumab|mesh-list
55828147|NCT02696993|Ipilimumab|ipilimumab|mesh-list
55828148|NCT02696993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55828149|NCT02696993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828151|NCT02696993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828152|NCT04790279|Amlodipine|amlodipine|mesh-list
55828153|NCT04790279|Nifedipine|nifedipine|mesh-list
55828154|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55828155|NCT04790279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55828156|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828157|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828158|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55828159|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828160|NCT04790279|Vasodilator Agents|vasodilator agents|mesh-ancestor
55828161|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
55828162|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55828164|NCT05577845|Antiemetics|antiemetics|mesh-ancestor
55828165|NCT05577845|Autonomic Agents|autonomic agents|mesh-ancestor
55828166|NCT05577845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828167|NCT05577845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828168|NCT05577845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55828169|NCT05577845|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55828170|NCT05577845|Serotonin Agents|serotonin agents|mesh-ancestor
55828171|NCT05577845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828172|NCT05577845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828173|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55828174|NCT03877289|Oxybutynin|oxybutynin|mesh-list
55828175|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828176|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
55828177|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
55828178|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828179|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828190|NCT02530463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828191|NCT02530463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55828192|NCT02530463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828193|NCT02530463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55828195|NCT02530463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828196|NCT05554679|Metformin|metformin|mesh-list
55828197|NCT05554679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55828198|NCT05554679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828199|NCT05494619|Immunoglobulins|immunoglobulins|mesh-list
55828200|NCT05494619|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55828201|NCT05494619|Antibodies|antibodies|mesh-list
55828202|NCT05494619|gamma-Globulins|gamma-globulins|mesh-list
55828203|NCT05494619|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55828204|NCT05494619|Immunologic Factors|immunologic factors|mesh-ancestor
55828205|NCT05494619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828206|NCT01583218|Enoxaparin|enoxaparin|mesh-list
55828207|NCT01583218|Betrixaban|betrixaban|mesh-list
55828208|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
55828209|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55828210|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55828211|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828212|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55828213|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
55828214|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55828215|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
55828216|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828217|NCT01634555|Leucovorin|leucovorin|mesh-list
55828218|NCT01634555|Folic Acid|folic acid|mesh-list
55828219|NCT01634555|Fluorouracil|fluorouracil|mesh-list
55828222|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
55828223|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
55828224|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828225|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55828230|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55828231|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55828232|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828233|NCT01634555|Antidotes|antidotes|mesh-ancestor
55828234|NCT01634555|Protective Agents|protective agents|mesh-ancestor
55828235|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
55828236|NCT01634555|Vitamins|vitamins|mesh-ancestor
55828237|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
55828238|NCT01634555|Hematinics|hematinics|mesh-ancestor
55828239|NCT05355155|Bevacizumab|bevacizumab|mesh-list
55828240|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55828241|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828242|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55828243|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55828245|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828246|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
55828247|NCT01634243|Rotigotine|rotigotine|mesh-list
55828248|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
55828249|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
55828250|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828251|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828252|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828253|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
55828254|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
55828255|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55828257|NCT02321501|Ceritinib|ceritinib|mesh-list
55828258|NCT02321501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828259|NCT02321501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828260|NCT02321501|Immunologic Factors|immunologic factors|mesh-ancestor
55828261|NCT02321501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828262|NCT02321501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55828263|NCT02321501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828264|NCT02321501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828265|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55828266|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55828267|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
55828269|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55828270|NCT04104646|Narcotics|narcotics|mesh-ancestor
55828271|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828272|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828273|NCT04104646|Analgesics|analgesics|mesh-ancestor
55828277|NCT05418647|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55828278|NCT04814615|Daratumumab|daratumumab|mesh-list
55828279|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828280|NCT03800693|Leucovorin|leucovorin|mesh-list
55828281|NCT03800693|Fluorouracil|fluorouracil|mesh-list
55828282|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
55828283|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
55828284|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828285|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55828286|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828287|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828288|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
55828298|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828299|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828300|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
55828301|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828302|NCT01582282|Psyllium|psyllium|mesh-list
55828303|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
55828304|NCT01582282|Cathartics|cathartics|mesh-ancestor
55828305|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55828306|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
55828307|NCT01599650|Ranibizumab|ranibizumab|mesh-list
55828308|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55828309|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55828310|NCT01599650|Growth Substances|growth substances|mesh-ancestor
55828311|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828312|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
55828313|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828314|NCT03774875|Apremilast|apremilast|mesh-list
55828316|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55828317|NCT03774875|Analgesics|analgesics|mesh-ancestor
55828318|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
55828319|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828320|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828321|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55828322|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55828323|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55828324|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55828325|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828326|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828327|NCT01563172|Listerine|listerine|mesh-list
55828328|NCT01563172|Fluorides|fluorides|mesh-list
55828329|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
55828330|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
55828331|NCT01563172|Protective Agents|protective agents|mesh-ancestor
55828332|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828333|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55828334|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828335|NCT04755764|Atenolol|atenolol|mesh-list
55828336|NCT04755764|Labetalol|labetalol|mesh-list
55828338|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55828339|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828341|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55828342|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828344|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
55828345|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55828346|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55828347|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55828348|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
55828349|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
55828350|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828351|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55828352|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55828353|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55828354|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
55828355|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828356|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
55828357|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55828358|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55828359|NCT04113616|Cytarabine|cytarabine|mesh-list
55828360|NCT04113616|Decitabine|decitabine|mesh-list
55828361|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55828376|NCT03774641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55828377|NCT03774641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828378|NCT03774641|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55828379|NCT03774641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55828380|NCT03774641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828381|NCT03774641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55828382|NCT03774641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55828383|NCT02161718|Olanzapine|olanzapine|mesh-list
55828384|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
55828385|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
55828386|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828387|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828388|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55828389|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55828390|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55828391|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828392|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55828393|NCT02161718|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55828397|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828399|NCT03734237|Vaccines|vaccines|mesh-list
55828400|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
55828402|NCT02074631|Vitamin D|vitamin d|mesh-list
55828424|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828425|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55828426|NCT04813991|Narcotics|narcotics|mesh-ancestor
55828430|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828431|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828433|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
55828434|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828435|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
55828436|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828437|NCT03623243|Siponimod|siponimod|mesh-list
55828438|NCT03623243|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55828439|NCT03623243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828440|NCT03623243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828441|NCT03623243|Immunologic Factors|immunologic factors|mesh-ancestor
55828442|NCT03623243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828444|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
55828445|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55828446|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828447|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828448|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55828449|NCT04801589|Analgesics|analgesics|mesh-ancestor
55828450|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
55828451|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828452|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55828453|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55828454|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55828460|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55828461|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55828462|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55828463|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
55828464|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
55828465|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
55828466|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
55828467|NCT01580488|Calcitriol|calcitriol|mesh-list
55828468|NCT01580488|Calcipotriene|calcipotriene|mesh-list
55828469|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55828470|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
55828471|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55828472|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828473|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55828474|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828475|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828476|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55828478|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
55828479|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55828480|NCT01580020|Dexamethasone|dexamethasone|mesh-list
55828486|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55828487|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
55828489|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55828490|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55828491|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828492|NCT01579318|Interleukin-12|interleukin-12|mesh-list
55828493|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55828494|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
55828495|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828496|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55828497|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55828498|NCT01579318|Growth Substances|growth substances|mesh-ancestor
55828499|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
55828500|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828502|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55828503|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55828504|NCT01578850|Analgesics|analgesics|mesh-ancestor
55828505|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
55828506|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828507|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828508|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55828509|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55828510|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55828511|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828516|NCT01539538|Narcotics|narcotics|mesh-ancestor
55828517|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828518|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828519|NCT01539538|Analgesics|analgesics|mesh-ancestor
55828520|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
55828521|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828528|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
55828529|NCT01562548|Expectorants|expectorants|mesh-ancestor
55828530|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
55828531|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55828532|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55828533|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
55828534|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828535|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828536|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828537|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
55828538|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55828539|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
55828540|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
55828541|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828542|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
55828543|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55828544|NCT03027934|Ticagrelor|ticagrelor|mesh-list
55828545|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55828546|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55828547|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55828548|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55828549|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55828550|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
55828551|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828552|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828839|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55828554|NCT01562314|Cannabidiol|cannabidiol|mesh-list
55828555|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
55828556|NCT04112368|Estradiol|estradiol|mesh-list
55828557|NCT04112368|Progesterone|progesterone|mesh-list
55828558|NCT04112368|Estrogens|estrogens|mesh-ancestor
55828559|NCT04112368|Hormones|hormones|mesh-ancestor
55828560|NCT04112368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55828561|NCT04112368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828562|NCT04112368|Progestins|progestins|mesh-ancestor
55828563|NCT01539226|Dapivirine|dapivirine|mesh-list
55828564|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55828565|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55828569|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55828570|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828572|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
55828573|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828574|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828575|NCT01537042|Rotigotine|rotigotine|mesh-list
55828576|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
55828577|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
55828578|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828579|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828580|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828581|NCT01536574|Ropinirole|ropinirole|mesh-list
55828582|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55828583|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55828584|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
55828585|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
55828586|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828587|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828588|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828594|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55828595|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55828597|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828598|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55828600|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55828608|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55828609|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55828610|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55828611|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55828612|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55828620|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828621|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828622|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55828623|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55828624|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55828625|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828626|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55828636|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828637|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
55828638|NCT01536262|Olodaterol|olodaterol|mesh-list
55828645|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
55828646|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55828647|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
55828648|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828649|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828650|NCT04102618|Trastuzumab|trastuzumab|mesh-list
55828655|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55828656|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55828657|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828658|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828659|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55828660|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
55828661|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55828662|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828663|NCT01575028|Bupivacaine|bupivacaine|mesh-list
55828664|NCT01575028|Ropivacaine|ropivacaine|mesh-list
55828665|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
55828666|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
55828667|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828668|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828669|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
55828670|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828672|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55828673|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828674|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55828675|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828677|NCT05168657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55828678|NCT04443569|Lidocaine|lidocaine|mesh-list
55828679|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
55828680|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
55828681|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828682|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828683|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
55828684|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828685|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55828686|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55828687|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55828688|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828689|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828690|NCT01792583|Modafinil|modafinil|mesh-list
55828691|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55828692|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828693|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55828694|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55828695|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55828696|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828697|NCT04691375|Pembrolizumab|pembrolizumab|mesh-list
55828698|NCT04691375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55828699|NCT04691375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828700|NCT03508895|Caseins|caseins|mesh-list
55828701|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
55828702|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
55828703|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828705|NCT03507491|Paclitaxel|paclitaxel|mesh-list
55828706|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55828707|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828708|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
55828709|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
55828710|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
55828711|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828714|NCT03507491|Antiviral Agents|antiviral agents|mesh-ancestor
55828715|NCT03507491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828716|NCT03507491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828717|NCT03507491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828718|NCT03507491|Immunologic Factors|immunologic factors|mesh-ancestor
55828719|NCT03507491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828721|NCT04626791|Prednisone|prednisone|mesh-list
55828729|NCT04626791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55828730|NCT04626791|Antibodies|antibodies|mesh-list
55828731|NCT04626791|Immunoglobulins|immunoglobulins|mesh-list
55828732|NCT04626791|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55828733|NCT04626791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828734|NCT04626791|Immunologic Factors|immunologic factors|mesh-ancestor
55828735|NCT04626791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828736|NCT04626791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55828737|NCT04626791|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55828738|NCT04626791|Alkylating Agents|alkylating agents|mesh-ancestor
55828739|NCT04626791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828740|NCT04626791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828741|NCT04626791|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55828742|NCT04626791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55828743|NCT04626791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55828744|NCT04626791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55828745|NCT04626791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828746|NCT04626791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55828747|NCT04626791|Glucocorticoids|glucocorticoids|mesh-ancestor
55828748|NCT04626791|Hormones|hormones|mesh-ancestor
55828749|NCT04626791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55828750|NCT04626791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55828840|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55828752|NCT04626791|Antimetabolites|antimetabolites|mesh-ancestor
55828753|NCT04626791|Antiviral Agents|antiviral agents|mesh-ancestor
55828754|NCT04626791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828755|NCT04566653|Calcium|calcium|mesh-list
55828756|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
55828757|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55828758|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828759|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
55828760|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
55828761|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828762|NCT04521569|Regadenoson|regadenoson|mesh-list
55828763|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55828764|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55828765|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
55828766|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
55828776|NCT01574716|Antiviral Agents|antiviral agents|mesh-ancestor
55828777|NCT01574716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828778|NCT01574716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828779|NCT01574716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828781|NCT01574716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828782|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
55828783|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
55828784|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
55828785|NCT02161562|Omalizumab|omalizumab|mesh-list
55828786|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55828787|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55828788|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55828789|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
55828790|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
55828791|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828792|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
55828793|NCT01559116|Olodaterol|olodaterol|mesh-list
55828794|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55828795|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
55828796|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828797|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828798|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55828799|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
55828800|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
55828801|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55828802|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
55828803|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828804|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828806|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
55828807|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
55828808|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828809|NCT01574248|Icatibant|icatibant|mesh-list
55828810|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55828811|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55828812|NCT01574248|Analgesics|analgesics|mesh-ancestor
55828813|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
55828814|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828815|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828819|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
55828820|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828821|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55828822|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828824|NCT04761094|Insulin|insulin|mesh-list
55828825|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55828826|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828827|NCT01557946|Citalopram|citalopram|mesh-list
55828828|NCT01557946|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55828829|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55828830|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55828831|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828832|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828833|NCT01557946|Serotonin Agents|serotonin agents|mesh-ancestor
55828834|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828835|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55828836|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
55828837|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55828838|NCT01534078|Doxorubicin|doxorubicin|mesh-list
55828850|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55828851|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
55828852|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55828853|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
55828854|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
55828855|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
55828857|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55828858|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828862|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828863|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828864|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828865|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
55828866|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828867|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55828868|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
55828870|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
55828871|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
55828872|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828879|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828880|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
55828881|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55828882|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828883|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
55828884|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
55828886|NCT03918850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55828887|NCT03918850|Narcotics|narcotics|mesh-ancestor
55828888|NCT03918850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828889|NCT03918850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828891|NCT03918850|Sensory System Agents|sensory system agents|mesh-ancestor
55828892|NCT03918850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828893|NCT03918850|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55828894|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
55828895|NCT01533922|Olodaterol|olodaterol|mesh-list
55828896|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55828897|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
55828898|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828899|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828900|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55828901|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
55828902|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
55828903|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55828904|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
55828905|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828906|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828907|NCT01533688|Bisacodyl|bisacodyl|mesh-list
55828908|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55828910|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55828912|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
55828913|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
55828914|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828915|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55828916|NCT02217878|Morphine|morphine|mesh-list
55828917|NCT02217878|Ticagrelor|ticagrelor|mesh-list
55828918|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55828919|NCT02217878|Narcotics|narcotics|mesh-ancestor
55828920|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828921|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828922|NCT02217878|Analgesics|analgesics|mesh-ancestor
55828928|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55828929|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
55828930|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828931|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828933|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
55828934|NCT02217566|Androgens|androgens|mesh-list
55828935|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55828936|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
55828937|NCT02217566|Hormones|hormones|mesh-ancestor
55828938|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55828940|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55828941|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828942|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55828943|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828944|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828945|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
55828946|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55828947|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
55828948|NCT02217410|Tacrolimus|tacrolimus|mesh-list
55828949|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55828950|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
55828951|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828952|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55828953|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55828954|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828955|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55828956|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55828957|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55828958|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
55828959|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55828960|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55828963|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55828964|NCT02217332|Protective Agents|protective agents|mesh-ancestor
55828965|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828966|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55828967|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55828968|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
55828970|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55828971|NCT02184572|Vaccines|vaccines|mesh-list
55828972|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
55828973|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828974|NCT04755218|Misoprostol|misoprostol|mesh-list
55828979|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55828980|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55828981|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
55828982|NCT02181842|Pioglitazone|pioglitazone|mesh-list
55828983|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55828984|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828985|NCT01632020|Metformin|metformin|mesh-list
55828986|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55828987|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828988|NCT02181296|Ropivacaine|ropivacaine|mesh-list
55828989|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
55828990|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
55828991|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55828992|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55828993|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
55828994|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55828995|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
55828996|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
55828997|NCT02158442|Ticarcillin|ticarcillin|mesh-list
55828998|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55828999|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829000|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829001|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55829002|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829003|NCT02158364|Vaccines|vaccines|mesh-list
55829004|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
55829005|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829006|NCT02180672|Fluticasone|fluticasone|mesh-list
55829007|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829008|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55829009|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
55829012|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55829013|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
55829015|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55829016|NCT01920711|Valsartan|valsartan|mesh-list
55829017|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55829018|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55829019|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55829020|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55829021|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829023|NCT02180438|Emtricitabine|emtricitabine|mesh-list
55829024|NCT02180438|Cobicistat|cobicistat|mesh-list
55829025|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55829027|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
55829028|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829029|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55829030|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55829031|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829032|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829033|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55829034|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55829035|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55829036|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55829037|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55829038|NCT02157116|Docetaxel|docetaxel|mesh-list
55829039|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829041|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
55829042|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
55829043|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829046|NCT01920555|Analgesics|analgesics|mesh-ancestor
55829047|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
55829048|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829049|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829050|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55829051|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55829052|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
55829053|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
55829054|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55829055|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55829056|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55829057|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829058|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829059|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55829060|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55829061|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55829062|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55829063|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55829064|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
55829065|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
55829066|NCT02156804|Nivolumab|nivolumab|mesh-list
55829067|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55829068|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829069|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55829070|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829071|NCT02156492|Atorvastatin|atorvastatin|mesh-list
55829073|NCT02156492|Evacetrapib|evacetrapib|mesh-list
55829074|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55829075|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55829076|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
55829077|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829078|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55829079|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55829080|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829081|NCT04753970|Cilostazol|cilostazol|mesh-list
55829082|NCT04753970|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55829083|NCT04753970|Autonomic Agents|autonomic agents|mesh-ancestor
55829084|NCT04753970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829085|NCT04753970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829086|NCT04753970|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55829087|NCT04753970|Respiratory System Agents|respiratory system agents|mesh-ancestor
55829088|NCT04753970|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55829089|NCT04753970|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55829090|NCT04753970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829091|NCT04753970|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55829092|NCT04753970|Vasodilator Agents|vasodilator agents|mesh-ancestor
55829093|NCT04753970|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55829094|NCT04753970|Protective Agents|protective agents|mesh-ancestor
55829095|NCT04753970|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
55829096|NCT04753970|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55829106|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829107|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55829108|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55829109|NCT04641195|Trace Elements|trace elements|mesh-ancestor
55829113|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55829114|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829115|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55829116|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829117|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829118|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55829119|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55829126|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829127|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55829128|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
55829129|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55829130|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829132|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55829133|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829134|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
55829135|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
55829136|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
55829137|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829138|NCT02211638|Candesartan|candesartan|mesh-list
55829139|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
55829140|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55829141|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55829142|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55829143|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829144|NCT02178566|Treprostinil|treprostinil|mesh-list
55829145|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55829146|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
55829147|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829148|NCT01631864|Amlodipine|amlodipine|mesh-list
55829149|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55829150|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55829151|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55829152|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55829153|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829154|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55829155|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829157|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55829158|NCT01557244|Fesoterodine|fesoterodine|mesh-list
55829159|NCT01557244|Oxybutynin|oxybutynin|mesh-list
55829160|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55829161|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55829162|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
55829163|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829164|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829165|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829166|NCT01557244|Urological Agents|urological agents|mesh-ancestor
55829167|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
55829168|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
55829169|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829170|NCT02177942|Micronutrients|micronutrients|mesh-list
55829171|NCT02177942|Trace Elements|trace elements|mesh-list
55829172|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829173|NCT02155322|Interferons|interferons|mesh-list
55829174|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
55829175|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
55829176|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55829177|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829178|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
55829179|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829180|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
55829197|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
55829198|NCT01556932|Promethazine|promethazine|mesh-list
55829199|NCT01556932|Lorazepam|lorazepam|mesh-list
55829200|NCT01556932|Haloperidol|haloperidol|mesh-list
55829212|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55829213|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
55829215|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829216|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829217|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55829219|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
55829220|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55829221|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55829222|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55829223|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55829224|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
55829225|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55829226|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
55829227|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55829228|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
55829229|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
55829230|NCT02985736|Desoximetasone|desoximetasone|mesh-list
55829231|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829232|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
55829234|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829235|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829245|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55829246|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829248|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55829249|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829250|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829251|NCT02153918|Metronidazole|metronidazole|mesh-list
55829252|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829253|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55829254|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55829255|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55829256|NCT04752566|Eculizumab|eculizumab|mesh-list
55829257|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55829258|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829259|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
55829260|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829268|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
55829269|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829271|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55829272|NCT01571284|Aflibercept|aflibercept|mesh-list
55829273|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55829274|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55829275|NCT01571284|Growth Substances|growth substances|mesh-ancestor
55829276|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829277|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
55829278|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829279|NCT02137772|Letermovir|letermovir|mesh-list
55829285|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829286|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55829287|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55829289|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829290|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829291|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55829292|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
55829293|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55829294|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55829295|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55829296|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
55829297|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829298|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829299|NCT02137226|Adalimumab|adalimumab|mesh-list
55829300|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829301|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829302|NCT01530334|Gefitinib|gefitinib|mesh-list
55829303|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829304|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55829305|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829306|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829307|NCT01570192|Vancomycin|vancomycin|mesh-list
55829308|NCT01570192|Gentamicins|gentamicins|mesh-list
55829309|NCT01570192|Meropenem|meropenem|mesh-list
55829310|NCT01570192|Linezolid|linezolid|mesh-list
55829311|NCT01570192|Tobramycin|tobramycin|mesh-list
55829312|NCT01570192|Amikacin|amikacin|mesh-list
55829313|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55829314|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829315|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55829316|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829317|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829318|NCT02136914|Amantadine|amantadine|mesh-list
55829320|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55829321|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
55829322|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829323|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
55829324|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829325|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829326|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829327|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55829328|NCT02136914|Analgesics|analgesics|mesh-ancestor
55829329|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
55829330|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829331|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
55829332|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55829333|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55829793|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
55829335|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
55829336|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829337|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829338|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829340|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55829341|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829342|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
55829343|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829344|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829346|NCT01553188|Trebananib|trebananib|mesh-list
55829347|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829348|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
55829349|NCT01553188|Hormones|hormones|mesh-ancestor
55829350|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829351|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829352|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55829353|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829354|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55829355|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55829356|NCT01553188|Growth Substances|growth substances|mesh-ancestor
55829357|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
55829358|NCT02175758|Ribavirin|ribavirin|mesh-list
55829359|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
55829360|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
55829361|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829362|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
55829363|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829364|NCT01599104|Olmesartan|olmesartan|mesh-list
55829365|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55829366|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55829367|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55829368|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55829369|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829371|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55829372|NCT01518244|Timolol|timolol|mesh-list
55829373|NCT01518244|Brinzolamide|brinzolamide|mesh-list
55829374|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829375|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829376|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55829377|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55829378|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
55829379|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829380|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829381|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55829382|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55829383|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55829384|NCT01552408|Ranibizumab|ranibizumab|mesh-list
55829385|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55829386|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55829387|NCT01552408|Growth Substances|growth substances|mesh-ancestor
55829388|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829389|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
55829390|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829391|NCT04099888|Gemcitabine|gemcitabine|mesh-list
55829392|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829393|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55829394|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
55829395|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829402|NCT04098718|Prednisolone|prednisolone|mesh-list
55829403|NCT04098718|Benralizumab|benralizumab|mesh-list
55829404|NCT04098718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829406|NCT04098718|Hormones|hormones|mesh-ancestor
55829407|NCT04098718|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829408|NCT04098718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829410|NCT04098718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829411|NCT04098718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55829412|NCT04098718|Respiratory System Agents|respiratory system agents|mesh-ancestor
55829414|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
55829415|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829416|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55829417|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55829419|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829420|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55829421|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55829422|NCT01527682|Dorzolamide|dorzolamide|mesh-list
55829423|NCT01527682|Latanoprost|latanoprost|mesh-list
55829424|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55829425|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55829427|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55829428|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829429|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829430|NCT01516216|Vitamin D|vitamin d|mesh-list
55829431|NCT01516216|Leucovorin|leucovorin|mesh-list
55829432|NCT01516216|Bevacizumab|bevacizumab|mesh-list
55829433|NCT01516216|Fluorouracil|fluorouracil|mesh-list
55829434|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
55829435|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55829436|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829437|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55829438|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55829439|NCT01516216|Growth Substances|growth substances|mesh-ancestor
55829440|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829441|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
55829442|NCT01516216|Vitamins|vitamins|mesh-ancestor
55829443|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
55829444|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55829446|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829447|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55829448|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829450|NCT01516216|Antidotes|antidotes|mesh-ancestor
55829451|NCT01516216|Protective Agents|protective agents|mesh-ancestor
55829452|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
55829453|NCT01950819|Cyclosporine|cyclosporine|mesh-list
55829454|NCT01950819|Prednisone|prednisone|mesh-list
55829455|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
55829457|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
55829458|NCT01950819|Cyclosporins|cyclosporins|mesh-list
55829459|NCT01950819|Basiliximab|basiliximab|mesh-list
55829460|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829461|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
55829462|NCT01950819|Hormones|hormones|mesh-ancestor
55829463|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829469|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829471|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55829472|NCT01950819|Protective Agents|protective agents|mesh-ancestor
55829473|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829474|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
55829475|NCT01950819|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55829476|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829477|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829478|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829479|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
55829480|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
55829481|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829483|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55829484|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829485|NCT01524796|Pregabalin|pregabalin|mesh-list
55829486|NCT01524796|Analgesics|analgesics|mesh-ancestor
55829487|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
55829488|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829489|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829490|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
55829491|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55829492|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55829493|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829494|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55829496|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55829501|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55829503|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829504|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829505|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
55829506|NCT01523392|Clopidogrel|clopidogrel|mesh-list
55829507|NCT01523392|Ticagrelor|ticagrelor|mesh-list
55829508|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55829509|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55829510|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55829511|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55829512|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
55829513|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829514|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829515|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829517|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55829518|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55829519|NCT01512160|Analgesics|analgesics|mesh-ancestor
55829521|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829522|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829523|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829524|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829525|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55829526|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829527|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829528|NCT01950741|Aflibercept|aflibercept|mesh-list
55829529|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55829530|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55829531|NCT01950741|Growth Substances|growth substances|mesh-ancestor
55829532|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829533|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
55829536|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55829537|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829538|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
55829539|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829540|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829549|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829557|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829558|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55829559|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829560|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55829561|NCT01511536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829562|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829563|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
55829564|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55829566|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55829567|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55829568|NCT01510912|Analgesics|analgesics|mesh-ancestor
55829569|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
55829570|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829571|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829572|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829573|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829574|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55829575|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829576|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829577|NCT01510756|Sorafenib|sorafenib|mesh-list
55829578|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829579|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55829580|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829581|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829582|NCT01522456|Tretinoin|tretinoin|mesh-list
55829583|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
55829584|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829585|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
55829586|NCT01521364|Clarithromycin|clarithromycin|mesh-list
55829587|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55829588|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829589|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55829590|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829591|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829592|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55829593|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55829594|NCT01545388|Metformin|metformin|mesh-list
55829595|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55829596|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55829597|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829600|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829601|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55829603|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829794|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
55829604|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829605|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
55829606|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
55829607|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829608|NCT01544920|Interferons|interferons|mesh-list
55829609|NCT01544920|Ribavirin|ribavirin|mesh-list
55829610|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
55829611|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
55829612|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55829613|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829614|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
55829615|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829616|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
55829642|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829643|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55829644|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55829645|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55829646|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55829647|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
55829648|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829649|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829650|NCT01507246|Morphine|morphine|mesh-list
55829651|NCT01507246|Bupivacaine|bupivacaine|mesh-list
55829652|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
55829653|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
55829654|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55829655|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829656|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
55829657|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829658|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55829659|NCT01507246|Narcotics|narcotics|mesh-ancestor
55829660|NCT01507246|Analgesics|analgesics|mesh-ancestor
55829661|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
55829662|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
55829663|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829664|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
55829665|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829666|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829667|NCT02073448|Adapalene|adapalene|mesh-list
55829668|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55829669|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
55829670|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55829671|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55829672|NCT02073448|Analgesics|analgesics|mesh-ancestor
55829673|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
55829674|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829675|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829676|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829677|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829678|NCT01487200|Triamcinolone|triamcinolone|mesh-list
55829679|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55829680|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55829682|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55829683|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829685|NCT01487200|Hormones|hormones|mesh-ancestor
55829686|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829687|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829688|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829689|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
55829690|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829691|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829692|NCT01505608|Irinotecan|irinotecan|mesh-list
55829694|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55829695|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55829696|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829697|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829698|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829700|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
55829701|NCT01486966|Insulin|insulin|mesh-list
55829702|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55829703|NCT01486966|Metformin|metformin|mesh-list
55829704|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
55829705|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
55829706|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
55829707|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
55829708|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
55829709|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55829712|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829714|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829715|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55829716|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829717|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829718|NCT01900431|Leucovorin|leucovorin|mesh-list
55829719|NCT01900431|Folic Acid|folic acid|mesh-list
55829720|NCT01900431|Prednisone|prednisone|mesh-list
55829721|NCT01900431|Methotrexate|methotrexate|mesh-list
55829722|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
55829723|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829724|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
55829725|NCT01900431|Hormones|hormones|mesh-ancestor
55829726|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829727|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829728|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55829729|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829730|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55829731|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
55829732|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55829734|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
55829735|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829736|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
55829737|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829738|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55829739|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829740|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
55829741|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829742|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55829743|NCT01900431|Antidotes|antidotes|mesh-ancestor
55829744|NCT01900431|Protective Agents|protective agents|mesh-ancestor
55829745|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
55829746|NCT01900431|Vitamins|vitamins|mesh-ancestor
55829747|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
55829748|NCT01900431|Hematinics|hematinics|mesh-ancestor
55829749|NCT01948791|Rivastigmine|rivastigmine|mesh-list
55829750|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55829751|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829752|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829753|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
55829754|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829755|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829756|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55829760|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
55829761|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829762|NCT01898091|Protective Agents|protective agents|mesh-ancestor
55829763|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829764|NCT01898091|Vitamins|vitamins|mesh-ancestor
55829765|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
55829766|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55829767|NCT01947855|Empagliflozin|empagliflozin|mesh-list
55829768|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55829769|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829770|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55829771|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829772|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
55829773|NCT01888497|Promethazine|promethazine|mesh-list
55829774|NCT01888497|Triazolam|triazolam|mesh-list
55829776|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829778|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
55829779|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829780|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829781|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
55829782|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55829783|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55829784|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55829785|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55829786|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55829787|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55829788|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829790|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55829791|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55829792|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
55829796|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55829797|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55829798|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
55829799|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
55829800|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55829801|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
55829802|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
55829803|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55829804|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
55829805|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
55829806|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
55829807|NCT01485796|Antibodies|antibodies|mesh-list
55829808|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
55829809|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55829810|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55829811|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
55829812|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829814|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55829815|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55829816|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829818|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829819|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55829820|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829821|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829822|NCT01946529|Sirolimus|sirolimus|mesh-list
55829823|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
55829824|NCT01946529|Temozolomide|temozolomide|mesh-list
55829825|NCT01946529|Ifosfamide|ifosfamide|mesh-list
55829826|NCT01946529|Bevacizumab|bevacizumab|mesh-list
55829827|NCT01946529|Doxorubicin|doxorubicin|mesh-list
55829828|NCT01946529|Etoposide|etoposide|mesh-list
55829829|NCT01946529|Vincristine|vincristine|mesh-list
55829830|NCT01946529|Sorafenib|sorafenib|mesh-list
55829831|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55829832|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
55829833|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829834|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829835|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55829836|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
55829837|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829838|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829839|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55829840|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55829841|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55829842|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55829843|NCT01946529|Growth Substances|growth substances|mesh-ancestor
55829844|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
55829845|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55829846|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55829847|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55829848|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829849|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55829850|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
55829851|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
55829852|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
55829853|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55829854|NCT01946529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55829855|NCT01946529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829856|NCT01946529|Antifungal Agents|antifungal agents|mesh-ancestor
55829857|NCT01463098|Zolpidem|zolpidem|mesh-list
55829858|NCT01463098|Lemborexant|lemborexant|mesh-list
55829859|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55829860|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55829861|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55829863|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55829864|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
55829865|NCT01463098|GABA Agents|gaba agents|mesh-ancestor
55829866|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829867|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829868|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55829869|NCT01462942|Bromides|bromides|mesh-list
55829870|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
55829871|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55829872|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
55829873|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829874|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829875|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55829876|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
55829877|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55829879|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55829880|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
55829881|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829882|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829883|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
55829884|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55829885|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55829886|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829887|NCT01504204|Adapalene|adapalene|mesh-list
55829888|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
55829889|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55829890|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
55829891|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55829892|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55829893|NCT01504204|Analgesics|analgesics|mesh-ancestor
55829896|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829897|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55829898|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55829899|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55829900|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55829901|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55829902|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55829903|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829904|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55829905|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55829906|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55829907|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55829908|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
55829909|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829910|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829911|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55829912|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55829914|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55829915|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55829916|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
55829917|NCT02118961|Vaccines|vaccines|mesh-list
55829918|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
55829919|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829920|NCT02140645|Linagliptin|linagliptin|mesh-list
55829921|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55829922|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829923|NCT02140645|Incretins|incretins|mesh-ancestor
55829924|NCT02140645|Hormones|hormones|mesh-ancestor
55829925|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55829926|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55829927|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
55829928|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829929|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829930|NCT02140411|Ranibizumab|ranibizumab|mesh-list
55829931|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55829932|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55829933|NCT02140411|Growth Substances|growth substances|mesh-ancestor
55829934|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829935|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
55829936|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55829937|NCT02139943|Canagliflozin|canagliflozin|mesh-list
55829940|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55829941|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829942|NCT01485172|Ropinirole|ropinirole|mesh-list
55829943|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55829944|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55829945|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
55829946|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
55829947|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55829948|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829949|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829950|NCT02105701|Ribavirin|ribavirin|mesh-list
55829951|NCT02105701|Grazoprevir|grazoprevir|mesh-list
55829952|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
55829953|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829956|NCT04411225|Cannabidiol|cannabidiol|mesh-list
55829957|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
55829958|NCT04742491|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55829959|NCT04742491|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
55829960|NCT04742491|Emtricitabine|emtricitabine|mesh-list
55829961|NCT04742491|Tenofovir|tenofovir|mesh-list
55829962|NCT04742491|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55829963|NCT04742491|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55829964|NCT04742491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55829965|NCT04742491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55829966|NCT04742491|Antiviral Agents|antiviral agents|mesh-ancestor
55829967|NCT04742491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55829968|NCT04742491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55829969|NCT04742491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55829970|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55829971|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55829983|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55829984|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829986|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
55829987|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55829989|NCT01462318|Midazolam|midazolam|mesh-list
55829990|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
55829991|NCT01462318|Caffeine|caffeine|mesh-list
55829992|NCT01462318|Omeprazole|omeprazole|mesh-list
55829993|NCT01462318|Warfarin|warfarin|mesh-list
55829994|NCT01462318|Daclizumab|daclizumab|mesh-list
55829995|NCT01462318|Vitamins|vitamins|mesh-ancestor
55829996|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
55829997|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55829998|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55829999|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55830006|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
55830008|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
55830010|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830011|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
55830012|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55830013|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55830014|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830015|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55830017|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
55830018|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55830019|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55830020|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55830021|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55830022|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55830024|NCT01462318|Coagulants|coagulants|mesh-ancestor
55830025|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
55830026|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
55830027|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55830028|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55830029|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830030|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
55830031|NCT01485094|Pregabalin|pregabalin|mesh-list
55830032|NCT01485094|Analgesics|analgesics|mesh-ancestor
55830033|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
55830034|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830035|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830036|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
55830037|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55830038|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55830039|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830040|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55830041|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55830042|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55830043|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830044|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55830045|NCT04079686|Cefazolin|cefazolin|mesh-list
55830046|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55830047|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830049|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55830050|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55830051|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830052|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
55830053|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830055|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830056|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55830057|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830058|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830060|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55830061|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55830062|NCT04757636|Growth Substances|growth substances|mesh-ancestor
55830063|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830064|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
55830065|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830084|NCT02150954|Oxytocin|oxytocin|mesh-list
55830100|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830101|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55830102|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55830103|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830104|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55830105|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55830106|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55830107|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830108|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
55830109|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830111|NCT02131064|Docetaxel|docetaxel|mesh-list
55830112|NCT02131064|Trastuzumab|trastuzumab|mesh-list
55830113|NCT02131064|Pertuzumab|pertuzumab|mesh-list
55830114|NCT02131064|Maytansine|maytansine|mesh-list
55830115|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55830116|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830117|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
55830118|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
55830154|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830155|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830156|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
55830157|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55830158|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55830159|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830160|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55830161|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55830162|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55830163|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830164|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55830166|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55830167|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55830168|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55830169|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830170|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55830171|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830172|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
55830174|NCT02128490|Colchicine|colchicine|mesh-list
55830175|NCT02128490|Febuxostat|febuxostat|mesh-list
55830176|NCT02128490|Lansoprazole|lansoprazole|mesh-list
55830177|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
55830178|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55830179|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55830180|NCT02128490|Analgesics|analgesics|mesh-ancestor
55830181|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
55830182|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830183|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830184|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55830185|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55830186|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
55830187|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55830188|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830189|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830190|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
55830191|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
55830192|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
55830193|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830194|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55830195|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55830196|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55830198|NCT02105636|Methotrexate|methotrexate|mesh-list
55830199|NCT02105636|Nivolumab|nivolumab|mesh-list
55830200|NCT02105636|Cetuximab|cetuximab|mesh-list
55830201|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830205|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830206|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55830208|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55830209|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830210|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55830211|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
55830212|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
55830213|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830214|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55830215|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830216|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
55830217|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55830218|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55830219|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55830220|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55830221|NCT04748042|Prednisone|prednisone|mesh-list
55830222|NCT04748042|Olaparib|olaparib|mesh-list
55830223|NCT04748042|Androgens|androgens|mesh-list
55830224|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55830225|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
55830226|NCT04748042|Hormones|hormones|mesh-ancestor
55830227|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830228|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830229|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55830230|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830231|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55830232|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830233|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830234|NCT01626872|Risperidone|risperidone|mesh-list
55830235|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55830236|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
55830237|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830238|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830239|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830240|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55830241|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55830242|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830243|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55830244|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55830245|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
55830246|NCT01598090|Ribavirin|ribavirin|mesh-list
55830247|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55830248|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
55830249|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830250|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
55830251|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830252|NCT02145182|Eculizumab|eculizumab|mesh-list
55830253|NCT02145182|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55830254|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830255|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
55830256|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830257|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
55830258|NCT02145026|Hematinics|hematinics|mesh-ancestor
55830260|NCT02144012|Trastuzumab|trastuzumab|mesh-list
55830262|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55830263|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830264|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
55830265|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
55830266|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
55830267|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830268|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55830269|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55830270|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55830271|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830272|NCT02141672|Cyclosporine|cyclosporine|mesh-list
55830273|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
55830274|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830275|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
55830276|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830277|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830278|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830279|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
55830657|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
55830280|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830281|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55830282|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55830283|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
55830284|NCT01628120|Hematinics|hematinics|mesh-ancestor
55830285|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55830286|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
55830287|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830288|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
55830289|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830290|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
55830291|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55830292|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830293|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830294|NCT02123966|Sirolimus|sirolimus|mesh-list
55830295|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55830296|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830297|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55830298|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830299|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
55830300|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830301|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
55830302|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830303|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
55830304|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55830305|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830306|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830307|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55830308|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55830309|NCT02123576|Protective Agents|protective agents|mesh-ancestor
55830310|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830311|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
55830312|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55830313|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
55830314|NCT03368729|Trastuzumab|trastuzumab|mesh-list
55830316|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55830317|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830318|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55830320|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830321|NCT02140970|Ibuprofen|ibuprofen|mesh-list
55830322|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55830323|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55830324|NCT02140970|Analgesics|analgesics|mesh-ancestor
55830325|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
55830326|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830327|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830328|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55830329|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55830330|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55830331|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830332|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830333|NCT02101112|Apixaban|apixaban|mesh-list
55830334|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55830335|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
55830336|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55830337|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
55830338|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830339|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830340|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
55830341|NCT02139644|Fluticasone|fluticasone|mesh-list
55830342|NCT02139644|Xhance|xhance|mesh-list
55830343|NCT02139644|Beclomethasone|beclomethasone|mesh-list
55830344|NCT02139644|Albuterol|albuterol|mesh-list
55830345|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55830346|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
55830347|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55830348|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55830349|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
55830350|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830351|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830352|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55830353|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
55830354|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
55830355|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55830658|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
55830356|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55830357|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55830358|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
55830359|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830360|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830361|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
55830362|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55830363|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
55830364|NCT02139644|Hormones|hormones|mesh-ancestor
55830365|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830366|NCT02100644|Lamotrigine|lamotrigine|mesh-list
55830367|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
55830368|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55830369|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55830371|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55830372|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830374|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55830375|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830376|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55830377|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55830378|NCT02246621|Letrozole|letrozole|mesh-list
55830379|NCT02246621|Anastrozole|anastrozole|mesh-list
55830380|NCT02246621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830381|NCT02246621|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55830382|NCT02246621|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55830383|NCT02246621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830384|NCT02246621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830385|NCT02246621|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55830386|NCT02246621|Hormone Antagonists|hormone antagonists|mesh-ancestor
55830387|NCT02246621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830388|NCT02246621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830389|NCT02246621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55830390|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
55830392|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
55830393|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
55830394|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55830395|NCT04798469|Androgens|androgens|mesh-ancestor
55830396|NCT04798469|Hormones|hormones|mesh-ancestor
55830397|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830398|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830399|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55830400|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830401|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
55830402|NCT02074982|Ustekinumab|ustekinumab|mesh-list
55830403|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55830404|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
55830405|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830406|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
55830407|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55830408|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55830409|NCT04798001|Vaccines|vaccines|mesh-list
55830410|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
55830411|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830412|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
55830413|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
55830414|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830415|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
55830416|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55830417|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55830418|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55830423|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830424|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55830425|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830426|NCT04070573|Aspirin|aspirin|mesh-list
55830427|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55830428|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55830430|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
55830431|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830432|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830433|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55830434|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55830435|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55830436|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55830437|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830438|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55830439|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55830441|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
55830442|NCT02099708|Lansoprazole|lansoprazole|mesh-list
55830443|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
55830444|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55830445|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55830446|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55830447|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830448|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830449|NCT02073656|Sofosbuvir|sofosbuvir|mesh-list
55830450|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55830451|NCT02073656|Ledipasvir|ledipasvir|mesh-list
55830452|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
55830453|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830454|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
55830455|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55830456|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830457|NCT04020341|Nitrofurantoin|nitrofurantoin|mesh-list
55830458|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55830459|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830460|NCT04020341|Renal Agents|renal agents|mesh-ancestor
55830461|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55830462|NCT02209181|Acetaminophen|acetaminophen|mesh-list
55830463|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55830464|NCT02209181|Analgesics|analgesics|mesh-ancestor
55830465|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
55830466|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830467|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830468|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
55830469|NCT02242487|Levodopa|levodopa|mesh-list
55830470|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55830471|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55830472|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
55830473|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830474|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830475|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830476|NCT03978611|Ipilimumab|ipilimumab|mesh-list
55830477|NCT03978611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55830478|NCT03978611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830481|NCT02241785|Natalizumab|natalizumab|mesh-list
55830517|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55830518|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830519|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830520|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55830521|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55830522|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
55830523|NCT02072096|Metformin|metformin|mesh-list
55830524|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
55830525|NCT02072096|Pioglitazone|pioglitazone|mesh-list
55830526|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55830527|NCT02072096|Liraglutide|liraglutide|mesh-list
55830528|NCT02072096|Exenatide|exenatide|mesh-list
55830529|NCT02072096|Glimepiride|glimepiride|mesh-list
55830530|NCT02072096|Linagliptin|linagliptin|mesh-list
55830532|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55830533|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830534|NCT02072096|Incretins|incretins|mesh-ancestor
55830535|NCT02072096|Hormones|hormones|mesh-ancestor
55830536|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830537|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55830538|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
55830539|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830540|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830541|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55830542|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55830543|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830546|NCT01631825|Rotigotine|rotigotine|mesh-list
55830574|NCT02123108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830575|NCT02097134|Melphalan|melphalan|mesh-list
55830576|NCT02097134|Mechlorethamine|mechlorethamine|mesh-list
55830577|NCT02097134|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55830578|NCT02097134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55830579|NCT02097134|Alkylating Agents|alkylating agents|mesh-ancestor
55830580|NCT02097134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830581|NCT02097134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830582|NCT02097134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55830583|NCT02097134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830584|NCT02097134|Immunologic Factors|immunologic factors|mesh-ancestor
55830585|NCT02097134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830586|NCT02121392|Bupivacaine|bupivacaine|mesh-list
55830587|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
55830588|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
55830589|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830590|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830591|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
55830592|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830593|NCT02097056|Donepezil|donepezil|mesh-list
55830594|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55830595|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830596|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830597|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
55830598|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830599|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830600|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
55830601|NCT02121002|Diclofenac|diclofenac|mesh-list
55830602|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55830603|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55830604|NCT02121002|Analgesics|analgesics|mesh-ancestor
55830605|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
55830606|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830607|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830608|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55830610|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55830611|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830612|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830613|NCT02096900|Midazolam|midazolam|mesh-list
55830614|NCT02096900|Zolpidem|zolpidem|mesh-list
55830615|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55830616|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55830617|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830618|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830619|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55830620|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55830621|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55830622|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55830623|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
55830624|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
55830625|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
55830626|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
55830627|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830707|NCT03631043|Immunologic Factors|immunologic factors|mesh-ancestor
55830628|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830629|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55830630|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55830631|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
55830632|NCT02120924|Azelaic acid|azelaic acid|mesh-list
55830633|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830634|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
55830635|NCT02096744|Clonidine|clonidine|mesh-list
55830636|NCT02096744|Analgesics|analgesics|mesh-ancestor
55830637|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
55830638|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830639|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830640|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55830641|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
55830642|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
55830643|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55830644|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55830645|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55830646|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
55830647|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830648|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830649|NCT02096042|Azacitidine|azacitidine|mesh-list
55830650|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55830651|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55830652|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
55830653|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830654|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830655|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830656|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55830659|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830660|NCT02069366|Dronabinol|dronabinol|mesh-list
55830661|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
55830662|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830663|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55830664|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55830665|NCT02069366|Analgesics|analgesics|mesh-ancestor
55830666|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
55830667|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830668|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55830669|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55830670|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830671|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830672|NCT02069366|Hormones|hormones|mesh-ancestor
55830673|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830674|NCT04732208|Mydriatics|mydriatics|mesh-list
55830675|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
55830676|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830677|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830678|NCT02068508|Pioglitazone|pioglitazone|mesh-list
55830679|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55830680|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830681|NCT02207231|Adalimumab|adalimumab|mesh-list
55830682|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55830683|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55830684|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55830685|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
55830686|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830687|NCT02206685|Methadone|methadone|mesh-list
55830688|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55830689|NCT02206685|Narcotics|narcotics|mesh-ancestor
55830690|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55830691|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830692|NCT02206685|Analgesics|analgesics|mesh-ancestor
55830693|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
55830695|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
55830696|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
55830697|NCT02095106|Calpastatin|calpastatin|mesh-list
55830698|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
55830699|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
55830700|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830701|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830702|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
55830703|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55830704|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830706|NCT03631043|Vaccines|vaccines|mesh-list
55830708|NCT03631043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830709|NCT03631043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55830710|NCT03631043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55830711|NCT03631043|Growth Substances|growth substances|mesh-ancestor
55830712|NCT03631043|Growth Inhibitors|growth inhibitors|mesh-ancestor
55830713|NCT03631043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830714|NCT02235311|Pantoprazole|pantoprazole|mesh-list
55830715|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55830716|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55830717|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55830718|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830719|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830721|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55830722|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
55830723|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830724|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830725|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55830726|NCT02235077|Diuretics|diuretics|mesh-ancestor
55830727|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
55830728|NCT02234141|Selonsertib|selonsertib|mesh-list
55830729|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55830730|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830731|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830733|NCT01896531|Fluorouracil|fluorouracil|mesh-list
55830734|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
55830735|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
55830736|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830737|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55830738|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830739|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830740|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
55830741|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830742|NCT01896531|Antidotes|antidotes|mesh-ancestor
55830743|NCT01896531|Protective Agents|protective agents|mesh-ancestor
55830744|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
55830746|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
55830747|NCT01618305|Lamivudine|lamivudine|mesh-list
55830748|NCT01618305|Zidovudine|zidovudine|mesh-list
55830749|NCT01618305|Efavirenz|efavirenz|mesh-list
55830750|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
55830751|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
55830752|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55830753|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55830754|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830755|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830756|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
55830757|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830758|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55830759|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55830760|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
55830761|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55830762|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55830763|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55830764|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55830765|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55830766|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55830767|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55830768|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55830769|NCT01896297|Dabigatran|dabigatran|mesh-list
55830770|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
55830771|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55830772|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
55830773|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830774|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830775|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
55830776|NCT01884675|Ambrisentan|ambrisentan|mesh-list
55830777|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55830778|NCT01884597|Ranibizumab|ranibizumab|mesh-list
55830779|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55830780|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55830781|NCT01884597|Growth Substances|growth substances|mesh-ancestor
55830782|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830783|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
55830784|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830785|NCT01864005|Clopidogrel|clopidogrel|mesh-list
55830786|NCT01864005|Ticagrelor|ticagrelor|mesh-list
55830787|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55830788|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55830789|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55830790|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55830791|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
55830792|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830793|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830794|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830795|NCT01863771|Golimumab|golimumab|mesh-list
55830796|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55830797|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55830798|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830799|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
55830800|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830801|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55830802|NCT01894581|Hormones|hormones|mesh-ancestor
55830803|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830804|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830805|NCT02203331|Anastrozole|anastrozole|mesh-list
55830806|NCT02203331|Leuprolide|leuprolide|mesh-list
55830807|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
55830808|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55830809|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830810|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55830811|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55830812|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830813|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830814|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55830815|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
55830816|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830817|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830818|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55830819|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
55830820|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55830821|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55830822|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
55830823|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55830824|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55830825|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55830827|NCT03355469|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55830828|NCT03355469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830829|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
55830830|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55830831|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55830832|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55830833|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55830834|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55830835|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830836|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
55830837|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830838|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830839|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55830840|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830841|NCT01862991|Digoxin|digoxin|mesh-list
55830842|NCT01862991|Misoprostol|misoprostol|mesh-list
55830843|NCT01862991|Mifepristone|mifepristone|mesh-list
55830844|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55830845|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
55830846|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55830847|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830848|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55830849|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55830850|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
55830851|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55830852|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55830853|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830854|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830855|NCT01862991|Protective Agents|protective agents|mesh-ancestor
55830856|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55830857|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55830858|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55830859|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55830860|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
55830861|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55830862|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55830863|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
55830875|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830876|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830877|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55830879|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
55830880|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55830881|NCT02118337|Nivolumab|nivolumab|mesh-list
55830882|NCT02118337|Durvalumab|durvalumab|mesh-list
55830883|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55830884|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830885|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55830886|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830887|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55830888|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
55830889|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830890|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
55830891|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
55830892|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830893|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830894|NCT02105467|Grazoprevir|grazoprevir|mesh-list
55830895|NCT02105467|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55830897|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830950|NCT04775381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830951|NCT04775381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55830953|NCT02623205|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55830954|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55830955|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55830956|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830957|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830958|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
55830959|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830960|NCT02623205|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55830961|NCT02623205|Antidepressive Agents|antidepressive agents|mesh-ancestor
55830962|NCT02623205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55830963|NCT01500694|Guanfacine|guanfacine|mesh-list
55830964|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55830965|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55830966|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55830967|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55830968|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
55830969|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830970|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830971|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830972|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55830973|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55830974|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55830975|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55830976|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55830977|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
55830978|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55830979|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55830980|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830981|NCT01500382|Urological Agents|urological agents|mesh-ancestor
55830982|NCT02137837|Everolimus|everolimus|mesh-list
55830983|NCT02137837|Fulvestrant|fulvestrant|mesh-list
55830984|NCT02137837|Anastrozole|anastrozole|mesh-list
55830985|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55830986|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55830987|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
55830988|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55830989|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55830990|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55830991|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55830992|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
55830993|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55830994|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55830995|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55830996|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55830997|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831000|NCT01483690|Methotrexate|methotrexate|mesh-list
55831001|NCT01483690|Vincristine|vincristine|mesh-list
55831003|NCT01483690|Asparaginase|asparaginase|mesh-list
55831004|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
55831005|NCT01483690|Vorinostat|vorinostat|mesh-list
55831006|NCT01483690|Pegaspargase|pegaspargase|mesh-list
55831007|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
55831008|NCT01483690|BB 1101|bb 1101|mesh-list
55831009|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831010|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
55831011|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
55831012|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831013|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831014|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55831015|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
55831016|NCT01483690|Hormones|hormones|mesh-ancestor
55831017|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831018|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55831019|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831020|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
55831021|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831022|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831023|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55831024|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
55831025|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55831026|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55831027|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
55831028|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
55831029|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55831030|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831031|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
55831032|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831033|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55831034|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55831035|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
55831036|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
55831037|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
55831039|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
55831040|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55831041|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55831042|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55831044|NCT01483144|Sulindac|sulindac|mesh-list
55831045|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831046|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55831047|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55831048|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55831049|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831050|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
55831051|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831052|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831053|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55831054|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55831055|NCT01483144|Analgesics|analgesics|mesh-ancestor
55831056|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
55831057|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831451|NCT03026842|Analgesics|analgesics|mesh-ancestor
55831058|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831076|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
55831077|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831078|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55831079|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
55831080|NCT01881789|Hormones|hormones|mesh-ancestor
55831081|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831082|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55831083|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55831084|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55831085|NCT01881789|Growth Substances|growth substances|mesh-ancestor
55831086|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
55831087|NCT02075203|BCG Vaccine|bcg vaccine|mesh-list
55831088|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55831089|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
55831090|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831091|NCT01892163|Dexamethasone|dexamethasone|mesh-list
55831092|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831093|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
55831094|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
55831095|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831096|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831097|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55831098|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
55831099|NCT01892163|Hormones|hormones|mesh-ancestor
55831100|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831101|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55831125|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831126|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831127|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831128|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55831129|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55831130|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55831131|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55831132|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55831133|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
55831134|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55831135|NCT01859793|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55831136|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831137|NCT01859793|Incretins|incretins|mesh-ancestor
55831138|NCT01859793|Hormones|hormones|mesh-ancestor
55831139|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831140|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55831141|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
55831142|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831143|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831144|NCT01859715|Oxycodone|oxycodone|mesh-list
55831145|NCT01859715|Hydrocodone|hydrocodone|mesh-list
55831146|NCT01859715|Ondansetron|ondansetron|mesh-list
55831147|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55831148|NCT01859715|Narcotics|narcotics|mesh-ancestor
55831149|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55831150|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831151|NCT01859715|Analgesics|analgesics|mesh-ancestor
55831152|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
55831153|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831154|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
55831155|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
55831156|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55831157|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
55831158|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
55831159|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55831160|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
55831161|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831162|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831163|NCT01859715|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55831164|NCT01859715|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55831165|NCT01859715|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55831166|NCT01859715|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55831167|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
55831168|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
55831169|NCT04599465|Ivacaftor|ivacaftor|mesh-list
55831170|NCT04599465|Elexacaftor|elexacaftor|mesh-list
55831171|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55831172|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831173|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831174|NCT04590495|Cannabidiol|cannabidiol|mesh-list
55831175|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
55831176|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55831177|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55831178|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55831179|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831180|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
55831181|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831182|NCT02117479|Capecitabine|capecitabine|mesh-list
55831183|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55831184|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
55831185|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831186|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831187|NCT01482910|Aflibercept|aflibercept|mesh-list
55831188|NCT01482910|Verteporfin|verteporfin|mesh-list
55831189|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55831544|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55831190|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55831191|NCT01482910|Growth Substances|growth substances|mesh-ancestor
55831192|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831193|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
55831194|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831195|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55831196|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
55831197|NCT04077190|Cortisone|cortisone|mesh-list
55831198|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831199|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55831200|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
55831201|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831202|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
55831203|NCT02229539|Promethazine|promethazine|mesh-list
55831204|NCT02229539|Lidocaine|lidocaine|mesh-list
55831205|NCT02229539|Doxepin|doxepin|mesh-list
55831206|NCT02229539|Antacids|antacids|mesh-list
55831207|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
55831208|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
55831209|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55831210|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831211|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
55831212|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831213|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55831214|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55831215|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55831216|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831217|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831218|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55831219|NCT02229539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55831221|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
55831222|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55831263|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
55831264|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
55831265|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55831266|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831267|NCT02229227|Incretins|incretins|mesh-ancestor
55831268|NCT02229227|Hormones|hormones|mesh-ancestor
55831269|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831270|NCT01499290|Metronidazole|metronidazole|mesh-list
55831271|NCT01499290|Meropenem|meropenem|mesh-list
55831272|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831273|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55831274|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55831275|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55831276|NCT01833897|Cycloserine|cycloserine|mesh-list
55831277|NCT01833897|Ketamine|ketamine|mesh-list
55831278|NCT01833897|Olanzapine|olanzapine|mesh-list
55831279|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
55831280|NCT01833897|Fluoxetine|fluoxetine|mesh-list
55831281|NCT01833897|Analgesics|analgesics|mesh-ancestor
55831282|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
55831283|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831284|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831285|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55831286|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55831287|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
55831288|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
55831289|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55831290|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55831291|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55831292|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831293|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831295|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
55831296|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55831297|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55831298|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55831299|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55831300|NCT01833897|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55831301|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55831302|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831303|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
55831304|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
55831305|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55831307|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55831308|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831309|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55831310|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831311|NCT01833897|Renal Agents|renal agents|mesh-ancestor
55831312|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55831313|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
55831314|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55831315|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
55831316|NCT02226653|Evacetrapib|evacetrapib|mesh-list
55831317|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55831318|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55831319|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
55831320|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831321|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55831322|NCT02201771|Aspirin|aspirin|mesh-list
55831323|NCT02201771|Ticagrelor|ticagrelor|mesh-list
55831324|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55831325|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55831326|NCT02201771|Analgesics|analgesics|mesh-ancestor
55831327|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
55831328|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831329|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831330|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831331|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831332|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55831333|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55831334|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831335|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55831336|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55831337|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831338|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
55831339|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55831340|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55831341|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55831342|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
55831343|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831344|NCT02200445|Aldesleukin|aldesleukin|mesh-list
55831345|NCT02200445|Interleukin-2|interleukin-2|mesh-list
55831346|NCT02200445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831347|NCT02200445|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55831348|NCT02200445|Analgesics|analgesics|mesh-ancestor
55831349|NCT02200445|Sensory System Agents|sensory system agents|mesh-ancestor
55831350|NCT02200445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831351|NCT02200445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831352|NCT02200445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55831353|NCT02200445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55831354|NCT02200445|Antiviral Agents|antiviral agents|mesh-ancestor
55831355|NCT02200445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831356|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
55831357|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55831358|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831359|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55831360|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55831361|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831362|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831363|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831364|NCT01460290|Asenapine|asenapine|mesh-list
55831365|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55831366|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55831367|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55831368|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831371|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55831373|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55831374|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831375|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831376|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
55831377|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831378|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831379|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55831380|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831381|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
55831382|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
55831383|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
55831384|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
55831385|NCT01645475|Coagulants|coagulants|mesh-ancestor
55831386|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
55831387|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
55831679|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
55831388|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831390|NCT04767113|Calcium heparin|calcium heparin|mesh-list
55831391|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
55831392|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55831393|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55831394|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831395|NCT04774991|Azithromycin|azithromycin|mesh-list
55831396|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55831397|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831399|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
55831400|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
55831401|NCT01458574|Tofacitinib|tofacitinib|mesh-list
55831402|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55831403|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831404|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831405|NCT02224703|Cannabidiol|cannabidiol|mesh-list
55831406|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
55831408|NCT01458106|Coagulants|coagulants|mesh-ancestor
55831409|NCT01457950|Denosumab|denosumab|mesh-list
55831410|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55831411|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831412|NCT01499134|Metoprolol|metoprolol|mesh-list
55831413|NCT01499134|Nebivolol|nebivolol|mesh-list
55831414|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55831415|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55831416|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
55831417|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
55831418|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831419|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831420|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55831421|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55831422|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55831423|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
55831424|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831425|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831426|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
55831427|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55831428|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55831429|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55831430|NCT02198651|Adalimumab|adalimumab|mesh-list
55831431|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831432|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831434|NCT03026842|Decitabine|decitabine|mesh-list
55831435|NCT03026842|Daunorubicin|daunorubicin|mesh-list
55831436|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
55831437|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
55831438|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55831439|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
55831440|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831441|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831442|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
55831444|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831445|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
55831446|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831447|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55831448|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55831449|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55831450|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831452|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
55831453|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831454|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55831455|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
55831456|NCT01498822|Levetiracetam|levetiracetam|mesh-list
55831457|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
55831458|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
55831459|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55831460|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55831461|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831462|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831463|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55831464|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55831465|NCT01498120|Rotigotine|rotigotine|mesh-list
55831466|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
55831467|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
55831468|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831469|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831470|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831471|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55831472|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55831473|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831474|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831475|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
55831476|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831477|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
55831478|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55831479|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55831480|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831481|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
55831482|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
55831483|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55831484|NCT02197247|Rifampin|rifampin|mesh-list
55831485|NCT02197247|Osimertinib|osimertinib|mesh-list
55831486|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55831487|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
55831488|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55831489|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831490|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
55831491|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55831492|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831493|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831494|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55831495|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55831496|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55831497|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55831498|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55831499|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55831500|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831501|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55831502|NCT02224157|Budesonide|budesonide|mesh-list
55831503|NCT02224157|Terbutaline|terbutaline|mesh-list
55831504|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
55831505|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831506|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55831507|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
55831508|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831509|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831510|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55831511|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
55831512|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
55831513|NCT02224157|Hormones|hormones|mesh-ancestor
55831514|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831515|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55831516|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55831517|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55831518|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
55831519|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831520|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831521|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
55831522|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
55831523|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55831524|NCT02196701|Adalimumab|adalimumab|mesh-list
55831526|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55831527|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
55831528|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55831529|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831530|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55831531|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
55831532|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831533|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831534|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
55831535|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831536|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55831537|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831538|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
55831539|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831540|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55831541|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831542|NCT01481116|Glimepiride|glimepiride|mesh-list
55831543|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55831545|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831546|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831547|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
55831549|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55831550|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55831551|NCT02222207|Growth Substances|growth substances|mesh-ancestor
55831552|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831553|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
55831554|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831555|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
55831556|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55831558|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55831559|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831560|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831561|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
55831562|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831563|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831564|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55831565|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831567|NCT04189757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831569|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55831570|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831571|NCT01623752|Etanercept|etanercept|mesh-list
55831572|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55831574|NCT01623752|Analgesics|analgesics|mesh-ancestor
55831616|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55831617|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55831619|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831620|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831621|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55831622|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55831623|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
55831624|NCT02219087|Bupivacaine|bupivacaine|mesh-list
55831625|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
55831626|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
55831627|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55831628|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831629|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
55831630|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831631|NCT02248961|Losartan|losartan|mesh-list
55831632|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55831633|NCT02248961|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55831634|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55831635|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55831636|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831637|NCT02219009|Aripiprazole|aripiprazole|mesh-list
55831638|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
55831639|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55831640|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55831641|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55831642|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55831643|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831659|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
55831660|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831661|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831662|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55831663|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55831664|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
55831665|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831666|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831667|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55831668|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
55831669|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55831670|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55831671|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55831672|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831674|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55831675|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55831676|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831677|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55831678|NCT01456780|Tobramycin|tobramycin|mesh-list
55831680|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55831681|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831682|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55831683|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55831684|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55831685|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55831686|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
55831687|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831688|NCT01479868|Interferons|interferons|mesh-list
55831689|NCT01479868|Ribavirin|ribavirin|mesh-list
55831690|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
55831691|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
55831692|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55831693|NCT01479868|Simeprevir|simeprevir|mesh-list
55831694|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831695|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
55831696|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831697|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
55831698|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831699|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
55831700|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831701|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
55831702|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831703|NCT01455220|Natalizumab|natalizumab|mesh-list
55831704|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
55831705|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831706|NCT01454596|Aldesleukin|aldesleukin|mesh-list
55831707|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
55831708|NCT01454596|Fludarabine|fludarabine|mesh-list
55831709|NCT01454596|Mitogens|mitogens|mesh-list
55831710|NCT01454596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831711|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
55831712|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831713|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831714|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55831715|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
55831716|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831717|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831718|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55831719|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
55831720|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55831721|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55831722|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
55831724|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
55831725|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55831726|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831727|NCT04541290|Tacrolimus|tacrolimus|mesh-list
55831728|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831729|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
55831730|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831731|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55831732|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831733|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831822|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55831734|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55831735|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
55831736|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831737|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55831738|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55831739|NCT01495000|Denosumab|denosumab|mesh-list
55831740|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55831741|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831742|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55831743|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55831744|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
55831745|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831746|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831747|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55831748|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
55831749|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
55831750|NCT01494610|Hormones|hormones|mesh-ancestor
55831751|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831752|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
55831753|NCT02116777|Temozolomide|temozolomide|mesh-list
55831754|NCT02116777|Talazoparib|talazoparib|mesh-list
55831848|NCT02189837|Evolocumab|evolocumab|mesh-list
55831755|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55831756|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
55831757|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831758|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831759|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55831760|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831761|NCT01494532|Ropinirole|ropinirole|mesh-list
55831762|NCT01494532|Levodopa|levodopa|mesh-list
55831763|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
55831764|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
55831765|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831766|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831767|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831768|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55831769|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55831770|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
55831771|NCT02191397|Dexetimide|dexetimide|mesh-list
55831772|NCT02191397|Citalopram|citalopram|mesh-list
55831773|NCT02191397|Bupropion|bupropion|mesh-list
55831774|NCT02191397|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55831775|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55831776|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831777|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831778|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831779|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
55831780|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831781|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55831782|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
55831783|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55831784|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55831785|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55831786|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
55831787|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
55831788|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831789|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55831790|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55831791|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
55831792|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55831793|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
55831794|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55831795|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55831796|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831798|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
55831799|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
55831800|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
55831801|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55831802|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55831803|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831804|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831820|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55831821|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55831823|NCT02170025|Riociguat|riociguat|mesh-list
55831825|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831827|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831828|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
55831829|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831830|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831831|NCT02216357|Ifetroban|ifetroban|mesh-list
55831832|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55831833|NCT01492426|Ribavirin|ribavirin|mesh-list
55831834|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55831835|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
55831836|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831837|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
55831838|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831839|NCT01453348|Vaccines|vaccines|mesh-list
55831840|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
55831841|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831842|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
55831843|NCT01475734|Incretins|incretins|mesh-ancestor
55831844|NCT01475734|Hormones|hormones|mesh-ancestor
55831845|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55831846|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831847|NCT02189837|Atorvastatin|atorvastatin|mesh-list
55831849|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55831850|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55831851|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55831853|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831855|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55831856|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831857|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
55831858|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831859|NCT02216123|Chloroquine|chloroquine|mesh-list
55831860|NCT02216123|Primaquine|primaquine|mesh-list
55831861|NCT02216123|Tafenoquine|tafenoquine|mesh-list
55831862|NCT02216123|Amebicides|amebicides|mesh-ancestor
55831863|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55831864|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55831865|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831866|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
55831867|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831868|NCT01490866|Leucovorin|leucovorin|mesh-list
55831869|NCT01490866|Bevacizumab|bevacizumab|mesh-list
55831870|NCT01490866|Fluorouracil|fluorouracil|mesh-list
55831871|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
55831872|NCT01490866|Axitinib|axitinib|mesh-list
55831873|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55831874|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831875|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55831876|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55831877|NCT01490866|Growth Substances|growth substances|mesh-ancestor
55831878|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831879|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
55831880|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
55831881|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831882|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55831883|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831884|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
55831885|NCT01490866|Antidotes|antidotes|mesh-ancestor
55831886|NCT01490866|Protective Agents|protective agents|mesh-ancestor
55831887|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
55831888|NCT01490866|Vitamins|vitamins|mesh-ancestor
55831889|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
55831890|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55831892|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
55831893|NCT02215967|Fludarabine|fludarabine|mesh-list
55831894|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831895|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
55831896|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831897|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831898|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55831899|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
55831900|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831901|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831902|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55831903|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
55831904|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55831905|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
55831906|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831908|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
55831909|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55831910|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
55831911|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831912|NCT02168387|Protective Agents|protective agents|mesh-ancestor
55831913|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831914|NCT02168387|Antidotes|antidotes|mesh-ancestor
55831915|NCT04418219|Interferons|interferons|mesh-list
55831916|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
55831917|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
55831918|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
55831920|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831921|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
55831922|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831923|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831924|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55831925|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
55831926|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831927|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831929|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55831931|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831933|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55831934|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55831935|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831936|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55831937|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55831938|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
55831939|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831940|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
55831942|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831943|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831944|NCT02101021|Gemcitabine|gemcitabine|mesh-list
55831945|NCT02101021|Paclitaxel|paclitaxel|mesh-list
55831946|NCT02101021|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
55831947|NCT02101021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55831948|NCT02101021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55831949|NCT02101021|Tubulin Modulators|tubulin modulators|mesh-ancestor
55831950|NCT02101021|Antimitotic Agents|antimitotic agents|mesh-ancestor
55831951|NCT02101021|Mitosis Modulators|mitosis modulators|mesh-ancestor
55831952|NCT02101021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831953|NCT02101021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55831954|NCT02101021|Antimetabolites|antimetabolites|mesh-ancestor
55831955|NCT02101021|Antiviral Agents|antiviral agents|mesh-ancestor
55831956|NCT02101021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55831957|NCT02101021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831958|NCT02101021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55831959|NCT02101021|Immunologic Factors|immunologic factors|mesh-ancestor
55831960|NCT02101021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831961|NCT02101021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55831962|NCT02116309|Indomethacin|indomethacin|mesh-list
55831963|NCT02116309|Epinephrine|epinephrine|mesh-list
55831964|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55831965|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55831966|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
55831967|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55831968|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55831969|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831970|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55831971|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55831972|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
55831973|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55831974|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55831975|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
55831977|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
55831978|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55831979|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55831980|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55831981|NCT02116309|Analgesics|analgesics|mesh-ancestor
55831982|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
55831983|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55831984|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55831985|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
55831986|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
55831987|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55831988|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55831989|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55831990|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
55831991|NCT01474486|Thiamine|thiamine|mesh-list
55831992|NCT01474486|Micronutrients|micronutrients|mesh-list
55831993|NCT01474486|Trace Elements|trace elements|mesh-list
55831994|NCT01474486|Vitamins|vitamins|mesh-ancestor
55831995|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55831996|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
55831997|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55831998|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55832000|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55832001|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832002|NCT02073565|Everolimus|everolimus|mesh-list
55832003|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832004|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832005|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
55832006|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832007|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55832008|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
55832009|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55832010|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
55832011|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832012|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832013|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55832014|NCT01450696|Capecitabine|capecitabine|mesh-list
55832015|NCT01450696|Trastuzumab|trastuzumab|mesh-list
55832016|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832017|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55832018|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
55832045|NCT02113579|Fluorides|fluorides|mesh-list
55832046|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
55832047|NCT02113579|Protective Agents|protective agents|mesh-ancestor
55832048|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832049|NCT01474018|Bromocriptine|bromocriptine|mesh-list
55832050|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55832051|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55832052|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
55832053|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832054|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832055|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
55832056|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
55832057|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832058|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832059|NCT02100475|Insulin|insulin|mesh-list
55832060|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55832061|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
55832063|NCT02100475|Xultophy|xultophy|mesh-list
55832064|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55832065|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832066|NCT02100475|Incretins|incretins|mesh-ancestor
55832067|NCT02100475|Hormones|hormones|mesh-ancestor
55832068|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832069|NCT04075240|Aspirin|aspirin|mesh-list
55832070|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
55832071|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55832072|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55832073|NCT04075240|Analgesics|analgesics|mesh-ancestor
55832078|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832092|NCT02070757|Tazobactam|tazobactam|mesh-list
55832093|NCT02070757|Ceftolozane|ceftolozane|mesh-list
55832094|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
55832095|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55832096|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832097|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55832098|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832099|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832100|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55832101|NCT02070757|Renal Agents|renal agents|mesh-ancestor
55832102|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
55832103|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55832104|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55832105|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832106|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
55832107|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55832109|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832110|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55832111|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55832113|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832114|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
55832115|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55832116|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
55832117|NCT01473940|Gemcitabine|gemcitabine|mesh-list
55832139|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832140|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55832141|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
55832142|NCT01832727|Hormones|hormones|mesh-ancestor
55832143|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832144|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55832145|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832146|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
55832147|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
55832148|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55832149|NCT01473394|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55832150|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55832151|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55832152|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832153|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832154|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
55832155|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832156|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55832157|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55832158|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
55832159|NCT04408144|Progestins|progestins|mesh-ancestor
55832160|NCT04408144|Hormones|hormones|mesh-ancestor
55832161|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832162|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832163|NCT01449682|Dexamethasone|dexamethasone|mesh-list
55832185|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
55832186|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832187|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832188|NCT01857531|Nicotine|nicotine|mesh-list
55832189|NCT01857531|Ganaxolone|ganaxolone|mesh-list
55832190|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55832192|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832193|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832194|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55832195|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55832196|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
55832197|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832198|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832199|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
55832200|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
55832201|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
55832202|NCT02166047|Vesatolimod|vesatolimod|mesh-list
55832203|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
55832204|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832205|NCT01831089|Paclitaxel|paclitaxel|mesh-list
55832206|NCT01831089|Bevacizumab|bevacizumab|mesh-list
55832207|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55832208|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832209|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
55832210|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
55832211|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
55832212|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832213|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55832214|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55832215|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55832216|NCT01831089|Growth Substances|growth substances|mesh-ancestor
55832217|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832218|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
55832226|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
55832227|NCT02111785|Hormones|hormones|mesh-ancestor
55832228|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832229|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55832230|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832231|NCT02068495|Amlodipine|amlodipine|mesh-list
55832234|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55832235|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55832236|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55832237|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832238|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55832239|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832240|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
55832241|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55832244|NCT02097823|Aprepitant|aprepitant|mesh-list
55832245|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
55832246|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
55832247|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832248|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832249|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55832250|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55832251|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55832252|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55832253|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55832254|NCT02097823|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55832255|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55832256|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55832257|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832261|NCT01857063|Montelukast|montelukast|mesh-list
55833060|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55832266|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832267|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832268|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55832269|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55832270|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832272|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55832273|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55832274|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832275|NCT01856907|Incretins|incretins|mesh-ancestor
55832276|NCT01856907|Hormones|hormones|mesh-ancestor
55832277|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832278|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55832279|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
55832280|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832281|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832282|NCT02097745|Rituximab|rituximab|mesh-list
55832283|NCT02097745|Methotrexate|methotrexate|mesh-list
55832284|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55832285|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832286|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
55832287|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832288|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832289|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55832290|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
55832291|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55832292|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55832293|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
55832294|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832295|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
55832296|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832298|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832299|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55832300|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
55832301|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55832302|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832304|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55832305|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
55832306|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55832307|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832308|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55832309|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
55832310|NCT02212379|Etravirine|etravirine|mesh-list
55832311|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55832312|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55832313|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
55832314|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832315|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55832316|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55832317|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832318|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832319|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55832320|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55832321|NCT02187809|Clobazam|clobazam|mesh-list
55832322|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
55832323|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55832324|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55832325|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55832326|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832327|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55832328|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
55832329|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
55832330|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
55832331|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832332|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832334|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55832335|NCT02110225|Mitogens|mitogens|mesh-list
55832336|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
55832337|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832338|NCT04756505|Interleukin-12|interleukin-12|mesh-list
55832339|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
55832340|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55832341|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
55832342|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832343|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55832344|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55832345|NCT04756505|Growth Substances|growth substances|mesh-ancestor
55832346|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
55832347|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832348|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
55832349|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55832350|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832351|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55832352|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55832353|NCT04750655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832354|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832355|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832357|NCT02162771|Prednisolone|prednisolone|mesh-list
55832358|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
55832359|NCT02162771|Rituximab|rituximab|mesh-list
55832360|NCT02162771|Vincristine|vincristine|mesh-list
55832361|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832362|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
55832363|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832364|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832365|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55832366|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
55832367|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832368|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832369|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55832370|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55832371|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832373|NCT02162771|Hormones|hormones|mesh-ancestor
55832374|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832375|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55832376|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55832377|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
55832378|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
55832379|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
55832380|NCT02160041|Infigratinib|infigratinib|mesh-list
55832381|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832382|NCT02186873|Golimumab|golimumab|mesh-list
55832383|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55832384|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832385|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832386|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
55832387|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832388|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55832389|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
55832420|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
55832421|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55832422|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
55832423|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
55832424|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55832425|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
55832429|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55832430|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55832431|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832432|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
55832433|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
55832434|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
55832435|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832436|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55832437|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
55832438|NCT02109445|Antiviral Agents|antiviral agents|mesh-ancestor
55832439|NCT02109445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832440|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832441|NCT02109445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832442|NCT02109445|Immunologic Factors|immunologic factors|mesh-ancestor
55832443|NCT02109445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832444|NCT02109133|Rocuronium|rocuronium|mesh-list
55832445|NCT02109133|Atracurium|atracurium|mesh-list
55832446|NCT02109133|Neostigmine|neostigmine|mesh-list
55832447|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55832448|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55832449|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55832450|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832451|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832452|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55832463|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
55832464|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832465|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832466|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
55832467|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55832468|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55832469|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55832470|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55832471|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55832472|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55832473|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832474|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832475|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
55832476|NCT02095951|Ethanol|ethanol|mesh-list
55832477|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55832478|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832522|NCT02066389|Upadacitinib|upadacitinib|mesh-list
55832523|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
55832524|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55832525|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832526|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832527|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832528|NCT02106403|Disinfectants|disinfectants|mesh-list
55832529|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832530|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
55832531|NCT02133131|Grazoprevir|grazoprevir|mesh-list
55832532|NCT02133131|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
55832533|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
55832534|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832535|NCT02106325|Diphenhydramine|diphenhydramine|mesh-list
55832536|NCT02106325|Promethazine|promethazine|mesh-list
55832537|NCT02106325|Ketamine|ketamine|mesh-list
55832538|NCT02106325|Analgesics|analgesics|mesh-ancestor
55832544|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
55832587|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
55832588|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832589|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55832591|NCT02159807|Analgesics|analgesics|mesh-ancestor
55832592|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55832593|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55832594|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
55832595|NCT02183675|Amlodipine|amlodipine|mesh-list
55832596|NCT02183675|Telmisartan|telmisartan|mesh-list
55832597|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
55832598|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
55832599|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55832601|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55832602|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832603|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55832604|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832605|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
55832682|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832606|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55832607|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55832608|NCT02183675|Diuretics|diuretics|mesh-ancestor
55832609|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
55832610|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55832611|NCT02183519|Capsaicin|capsaicin|mesh-list
55832612|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
55832613|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
55832614|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
55832615|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832616|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832617|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55832618|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
55832619|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
55832620|NCT02132195|Hormones|hormones|mesh-ancestor
55832621|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832622|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832623|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832624|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832625|NCT02182895|Saxagliptin|saxagliptin|mesh-list
55832626|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55832627|NCT02182895|Incretins|incretins|mesh-ancestor
55832628|NCT02182895|Hormones|hormones|mesh-ancestor
55833061|NCT01598753|Narcotics|narcotics|mesh-ancestor
55832629|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832630|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832631|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
55832632|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832633|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832634|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55832635|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
55832636|NCT01625377|Everolimus|everolimus|mesh-list
55832637|NCT01625377|Tacrolimus|tacrolimus|mesh-list
55832638|NCT01625377|Basiliximab|basiliximab|mesh-list
55832639|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832640|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
55832641|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832642|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55832643|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832645|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832646|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55832647|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55832648|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
55832649|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55832650|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832651|NCT02132117|Phenylephrine|phenylephrine|mesh-list
55832652|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
55832653|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55832654|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55832655|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
55832656|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832657|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832658|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832659|NCT02132117|Sympathomimetics|sympathomimetics|mesh-ancestor
55832660|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
55832661|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832662|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
55832663|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55832664|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
55832665|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55832666|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
55832667|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55832668|NCT02132117|Protective Agents|protective agents|mesh-ancestor
55832669|NCT02047045|Prucalopride|prucalopride|mesh-list
55832670|NCT02047045|Serotonin|serotonin|mesh-list
55832671|NCT02047045|Laxatives|laxatives|mesh-ancestor
55832672|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55832673|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55832674|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55832675|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
55832676|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832677|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832678|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832679|NCT02131259|Afatinib|afatinib|mesh-list
55832680|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832681|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55832683|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832684|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
55832685|NCT01829295|Prednisone|prednisone|mesh-list
55832686|NCT01829295|Methotrexate|methotrexate|mesh-list
55832687|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832688|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
55832689|NCT01829295|Hormones|hormones|mesh-ancestor
55832690|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832691|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832692|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55832693|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832702|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55832703|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832704|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
55832705|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832706|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55832707|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55832708|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55832709|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
55832710|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55832711|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832712|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
55832713|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55832714|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55832715|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
55832716|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832717|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832718|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55832719|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
55832720|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55832721|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55832722|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55832723|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
55832724|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832725|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832727|NCT04754399|Anticonvulsants|anticonvulsants|mesh-ancestor
55832728|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
55832729|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
55832730|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
55832731|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832732|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832733|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55832734|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55832735|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55832736|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
55832737|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832738|NCT02092285|Golimumab|golimumab|mesh-list
55832739|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55832740|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832741|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832742|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
55832743|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832744|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
55832745|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55832746|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55832747|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
55832748|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55832749|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55832750|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832751|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
55832752|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832753|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832754|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55832755|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832756|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
55832757|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
55832758|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55832759|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
55832760|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832761|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832762|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55832763|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
55832764|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55832765|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55832766|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55832767|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
55832768|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832769|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832771|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
55832772|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55832773|NCT04731103|Lamivudine|lamivudine|mesh-list
55832774|NCT04731103|Zidovudine|zidovudine|mesh-list
55832775|NCT04731103|Abacavir|abacavir|mesh-list
55832776|NCT04731103|Dideoxynucleosides|dideoxynucleosides|mesh-list
55832777|NCT04731103|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55832778|NCT04731103|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55832779|NCT04731103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832780|NCT04731103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832781|NCT04731103|Antiviral Agents|antiviral agents|mesh-ancestor
55832782|NCT04731103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832783|NCT04731103|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55832784|NCT04731103|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55832785|NCT04731103|Antimetabolites|antimetabolites|mesh-ancestor
55832786|NCT01827267|Sirolimus|sirolimus|mesh-list
55832787|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55832788|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832789|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55832791|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
55832792|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832793|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
55832794|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832795|NCT01827111|Paclitaxel|paclitaxel|mesh-list
55832796|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55832797|NCT01827111|Ipilimumab|ipilimumab|mesh-list
55832798|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55832809|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55832810|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
55832811|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832812|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832813|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
55832814|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
55832815|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832816|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55832817|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832818|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832819|NCT01854645|Bromides|bromides|mesh-list
55832820|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
55832821|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55832822|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
55832823|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832824|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832825|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55832826|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
55832827|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
55832828|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55832829|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
55832830|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832831|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832832|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
55832834|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55832835|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55832836|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
55832837|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832838|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55832839|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55832840|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832841|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
55832842|NCT01825941|Promethazine|promethazine|mesh-list
55832843|NCT01825941|Metoclopramide|metoclopramide|mesh-list
55832844|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55832845|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55832846|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55832847|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832848|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
55832849|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
55832850|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
55832851|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832852|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
55832853|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
55832855|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55832856|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
55832858|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832859|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832860|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55832861|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
55832862|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
55832863|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55832864|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55832865|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
55832866|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
55832867|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55832868|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832869|NCT02180165|Voriconazole|voriconazole|mesh-list
55832870|NCT02180165|Posaconazole|posaconazole|mesh-list
55832871|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
55832872|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832873|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55832874|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55832875|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832876|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832877|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55832879|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832880|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832881|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55832882|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55832883|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55832884|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55832885|NCT02155985|Aspirin|aspirin|mesh-list
55832886|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55832887|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55832888|NCT02155985|Analgesics|analgesics|mesh-ancestor
55832889|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
55832890|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832891|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832892|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55832893|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832894|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55832896|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832897|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55832898|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55832899|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832900|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
55832901|NCT02155829|Riluzole|riluzole|mesh-list
55832902|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
55832903|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55832904|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55832905|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832906|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832907|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832908|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55832909|NCT02155829|Protective Agents|protective agents|mesh-ancestor
55832910|NCT02178995|Methylphenidate|methylphenidate|mesh-list
55832911|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55832912|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832913|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55832914|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55832915|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55832916|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832917|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
55832918|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832919|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
55832920|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832921|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
55832922|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832923|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55832924|NCT02154347|Mitiglinide|mitiglinide|mesh-list
55832926|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832927|NCT01627067|Metformin|metformin|mesh-list
55832928|NCT01627067|Everolimus|everolimus|mesh-list
55832929|NCT01627067|Exemestane|exemestane|mesh-list
55832930|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55832931|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832932|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55832933|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55832934|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
55832935|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55832936|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55832937|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55832938|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832939|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55832940|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
55832941|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55832943|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55832944|NCT02178059|Autonomic Agents|autonomic agents|mesh-ancestor
55832945|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832946|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55832947|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55832948|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
55832949|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
55832950|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
55832951|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55832952|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55832953|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55832954|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55832955|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
55832956|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55832957|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832959|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
55832960|NCT02128217|Ledipasvir|ledipasvir|mesh-list
55832961|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55832962|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
55832963|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832964|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
55832965|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832966|NCT01628549|Sarecycline|sarecycline|mesh-list
55832967|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55832968|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55832969|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
55832970|NCT02127125|Sevelamer|sevelamer|mesh-list
55832971|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
55832972|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
55832973|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55832974|NCT02090413|Aspirin|aspirin|mesh-list
55832975|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55832976|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55832977|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55832978|NCT02090413|Analgesics|analgesics|mesh-ancestor
55832979|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
55832980|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55832981|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833006|NCT01598987|Cyclosporins|cyclosporins|mesh-list
55833007|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55833008|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
55833009|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833010|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55833011|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833012|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833013|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
55833014|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833015|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
55833016|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55833017|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833019|NCT02062879|Hydromorphone|hydromorphone|mesh-list
55833020|NCT02062879|Analgesics|analgesics|mesh-ancestor
55833021|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
55833022|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833023|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833024|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55833025|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55833026|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
55833027|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
55833028|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833029|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55833030|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55833031|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833032|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833033|NCT02062879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55833034|NCT02062879|Narcotics|narcotics|mesh-ancestor
55833035|NCT02062645|Amlodipine|amlodipine|mesh-list
55833037|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
55833038|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55833039|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55833040|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55833041|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833042|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55833043|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833044|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
55833046|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55833048|NCT04700839|Canagliflozin|canagliflozin|mesh-list
55833049|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
55833050|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55833051|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833052|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833053|NCT02043301|Bococizumab|bococizumab|mesh-list
55833054|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55833055|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55833056|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
55833057|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833058|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55833059|NCT01598753|Tramadol|tramadol|mesh-list
55833062|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833063|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833064|NCT01598753|Analgesics|analgesics|mesh-ancestor
55833065|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
55833066|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833067|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
55833069|NCT01824693|Melphalan|melphalan|mesh-list
55833070|NCT01824693|Busulfan|busulfan|mesh-list
55833071|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
55833072|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55833073|NCT01824693|Fludarabine|fludarabine|mesh-list
55833074|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
55833075|NCT01824693|Tacrolimus|tacrolimus|mesh-list
55833076|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55833077|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
55833078|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833080|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55833081|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
55833082|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833083|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833084|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55833085|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55833086|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
55833087|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55833088|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833089|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55833090|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55833091|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
55833092|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55833093|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833094|NCT02176655|Aspirin|aspirin|mesh-list
55833095|NCT02176655|Sumatriptan|sumatriptan|mesh-list
55833096|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55833097|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55833098|NCT02176655|Analgesics|analgesics|mesh-ancestor
55833099|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
55833100|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833101|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833102|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833103|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55833104|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55833105|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55833106|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833107|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55833108|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55833109|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833111|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55833112|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55833113|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55833114|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
55833115|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833116|NCT01853475|Artefenomel|artefenomel|mesh-list
55833117|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
55833118|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55833119|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55833120|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833121|NCT01622569|Fluticasone|fluticasone|mesh-list
55833123|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833124|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55833125|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
55833126|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833127|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833128|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55833129|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
55833130|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
55833131|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55833132|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55833133|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833134|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55833135|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833136|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833137|NCT04747301|Dinoprostone|dinoprostone|mesh-list
55833138|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
55833139|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55833140|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833273|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
55833142|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55833143|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55833144|NCT02152163|Analgesics|analgesics|mesh-ancestor
55833145|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
55833146|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833147|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833148|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833149|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55833150|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55833151|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833152|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833153|NCT02152007|Sirolimus|sirolimus|mesh-list
55833154|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55833155|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833156|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55833157|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833158|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
55833159|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55833160|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
55833161|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833162|NCT02151851|Methotrexate|methotrexate|mesh-list
55833163|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
55833164|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55833165|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
55833166|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55833167|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833168|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55833169|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
55833170|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833171|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833172|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
55833173|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833174|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55833212|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
55833213|NCT02042443|Hematinics|hematinics|mesh-ancestor
55833214|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55833215|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833216|NCT04747145|Temozolomide|temozolomide|mesh-list
55833217|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55833218|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
55833219|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833220|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833221|NCT02118896|Tacrolimus|tacrolimus|mesh-list
55833222|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55833223|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
55833224|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833225|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55833227|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833228|NCT02124707|Paclitaxel|paclitaxel|mesh-list
55833229|NCT02124707|Carboplatin|carboplatin|mesh-list
55833230|NCT02124707|Cetuximab|cetuximab|mesh-list
55833231|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55833232|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833233|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
55833234|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
55833235|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
55833236|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833237|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55833248|NCT02066402|Linezolid|linezolid|mesh-list
55833257|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55833258|NCT02060383|Liraglutide|liraglutide|mesh-list
55833259|NCT02060383|Pasireotide|pasireotide|mesh-list
55833260|NCT02060383|Somatostatin|somatostatin|mesh-list
55833261|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55833262|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833263|NCT02060383|Incretins|incretins|mesh-ancestor
55833264|NCT02060383|Hormones|hormones|mesh-ancestor
55833265|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833266|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55833267|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
55833268|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833269|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833270|NCT02086591|Doxycycline|doxycycline|mesh-list
55833271|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55833272|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833274|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55833275|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55833276|NCT02065622|Adalimumab|adalimumab|mesh-list
55833277|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833278|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55833279|NCT02117648|Clarithromycin|clarithromycin|mesh-list
55833280|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55833281|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833282|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55833283|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833284|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833285|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55833286|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55833287|NCT02124161|Vaccines|vaccines|mesh-list
55833288|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55833289|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
55833290|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833291|NCT02117570|Vaccines|vaccines|mesh-list
55833292|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
55833293|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833294|NCT02123459|Cephalexin|cephalexin|mesh-list
55833295|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55833296|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833297|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
55833298|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833299|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
55833300|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833301|NCT04411160|Protective Agents|protective agents|mesh-ancestor
55833302|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55833303|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
55833304|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833305|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55833306|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
55833307|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55833308|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833309|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
55833310|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
55833311|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
55833312|NCT02151773|Vaccines|vaccines|mesh-list
55833313|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
55833314|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833315|NCT02151461|Metformin|metformin|mesh-list
55833316|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55833317|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833318|NCT02091986|Budesonide|budesonide|mesh-list
55833319|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55833320|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833321|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55833322|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
55833323|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833324|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833325|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55833326|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
55833327|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
55833329|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833330|NCT02117024|Gemcitabine|gemcitabine|mesh-list
55833331|NCT02117024|Paclitaxel|paclitaxel|mesh-list
55833332|NCT02117024|Vinorelbine|vinorelbine|mesh-list
55833333|NCT02117024|Docetaxel|docetaxel|mesh-list
55833334|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
55833335|NCT02117024|Pemetrexed|pemetrexed|mesh-list
55833336|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55833337|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55833338|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833339|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
55833340|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
55833341|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
55833342|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833343|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55833344|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
55833345|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833346|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55833347|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55833348|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
55833349|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55833350|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55833351|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
55833352|NCT02117024|Antiviral Agents|antiviral agents|mesh-ancestor
55833353|NCT02117024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833354|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833355|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55833356|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55833357|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55833358|NCT02064920|Donepezil|donepezil|mesh-list
55833359|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55833360|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833361|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833362|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
55833363|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833364|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833365|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
55833366|NCT02151149|Paclitaxel|paclitaxel|mesh-list
55833367|NCT02151149|Carboplatin|carboplatin|mesh-list
55833368|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55833369|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833370|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
55833371|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
55833372|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
55833373|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833374|NCT02150213|Dexamethasone|dexamethasone|mesh-list
55833401|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55833402|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55833403|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833404|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833405|NCT02115308|Regadenoson|regadenoson|mesh-list
55833406|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55833407|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55833408|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
55833409|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
55833410|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833411|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833412|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833413|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
55833414|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55833415|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833416|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55833417|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55833418|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833420|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833421|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
55833422|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
55833423|NCT02090114|Testosterone|testosterone|mesh-list
55833424|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
55833425|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
55833426|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55833427|NCT02090114|Androgens|androgens|mesh-ancestor
55833428|NCT02090114|Hormones|hormones|mesh-ancestor
55833429|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833430|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833431|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55833432|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833433|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
55833434|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55833435|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833436|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833437|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
55833438|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55833439|NCT04742036|Paclitaxel|paclitaxel|mesh-list
55833440|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55833441|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833442|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
55833443|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
55833444|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
55833445|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833446|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
55833447|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55833448|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
55833449|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55833450|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
55833451|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833452|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833454|NCT02111096|Metformin|metformin|mesh-list
55833455|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55833456|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55833457|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833458|NCT02111096|Incretins|incretins|mesh-ancestor
55833459|NCT02111096|Hormones|hormones|mesh-ancestor
55833460|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833461|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55833462|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
55833463|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833466|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55833506|NCT02121509|Metformin|metformin|mesh-list
55833507|NCT02121509|Linagliptin|linagliptin|mesh-list
55833508|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55833509|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833510|NCT02121509|Incretins|incretins|mesh-ancestor
55833511|NCT02121509|Hormones|hormones|mesh-ancestor
55833512|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833513|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55833514|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
55833515|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833516|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833517|NCT02149199|Budesonide|budesonide|mesh-list
55833518|NCT02149199|Terbutaline|terbutaline|mesh-list
55833519|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
55833520|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833521|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55833522|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
55833523|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833524|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833526|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
55833527|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
55833528|NCT02149199|Hormones|hormones|mesh-ancestor
55833529|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833530|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55833531|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55833532|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55833533|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
55833534|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833535|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833537|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
55833538|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55833539|NCT02120417|Capecitabine|capecitabine|mesh-list
55833546|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55833547|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55833548|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55833549|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833550|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
55833551|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833552|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833553|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55833554|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833556|NCT02058368|Dutasteride|dutasteride|mesh-list
55833557|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55833558|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55833559|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55833560|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
55833561|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833562|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833563|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833564|NCT02058368|Urological Agents|urological agents|mesh-ancestor
55833565|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55833566|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55833567|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833568|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
55833569|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833570|NCT02058290|Morphine|morphine|mesh-list
55833571|NCT02058290|Bupivacaine|bupivacaine|mesh-list
55833572|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
55833573|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
55833574|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833575|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833576|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
55833577|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833578|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55833579|NCT02058290|Narcotics|narcotics|mesh-ancestor
55833580|NCT02058290|Analgesics|analgesics|mesh-ancestor
55833581|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
55833582|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55833583|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55833584|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833585|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833586|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55833587|NCT04718480|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55833588|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55833589|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55833590|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833591|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833592|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
55833593|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55833594|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
55833595|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55833596|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55833597|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833598|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55833599|NCT02106884|Gemcitabine|gemcitabine|mesh-list
55833601|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55833602|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833603|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
55833604|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
55833605|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
55833606|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833607|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55833608|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
55833609|NCT02106884|Antiviral Agents|antiviral agents|mesh-ancestor
55833610|NCT02106884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833611|NCT02106884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833612|NCT02106884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55833613|NCT02106884|Immunologic Factors|immunologic factors|mesh-ancestor
55833614|NCT02106884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833616|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55833617|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55833618|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833619|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
55833620|NCT01625000|Risperidone|risperidone|mesh-list
55833621|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55833622|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
55833623|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833624|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833625|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833626|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55833627|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55833628|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833629|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55833630|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55833631|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
55833632|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55833633|NCT02057198|Metronidazole|metronidazole|mesh-list
55833634|NCT02057198|Vancomycin|vancomycin|mesh-list
55833635|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
55833637|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833638|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55833639|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55833640|NCT02056340|Atorvastatin|atorvastatin|mesh-list
55833641|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55833642|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55833643|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
55833644|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833645|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55833646|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55833653|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833654|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833655|NCT04726592|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55833656|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55833657|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55833658|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
55833659|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833660|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833661|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55833662|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55833663|NCT04726592|Analgesics|analgesics|mesh-ancestor
55833664|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
55833665|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833666|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55833667|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55833668|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833669|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
55833670|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55833671|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55833672|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833673|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55833674|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
55833675|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
55833676|NCT02046122|Cytarabine|cytarabine|mesh-list
55833677|NCT02046122|Idarubicin|idarubicin|mesh-list
55833702|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55833703|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55833704|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55833705|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
55833706|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
55833707|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833708|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55833709|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55833710|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
55833711|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
55833712|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55833713|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833714|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55833715|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833716|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833717|NCT02078102|Meloxicam|meloxicam|mesh-list
55833718|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833719|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55833720|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55833721|NCT02078102|Analgesics|analgesics|mesh-ancestor
55833722|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
55833723|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833724|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833725|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55833726|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55833727|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55833728|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833729|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833730|NCT02054702|Aripiprazole|aripiprazole|mesh-list
55833731|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
55833732|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
55833733|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55833734|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55833735|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55833736|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833737|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833738|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
55833776|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833777|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833778|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55833779|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55833780|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
55833782|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833783|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55833784|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55833785|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833786|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833787|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
55833788|NCT04700696|Narcotics|narcotics|mesh-ancestor
55833789|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55833790|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833791|NCT04700696|Analgesics|analgesics|mesh-ancestor
55833792|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
55833793|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833794|NCT02052440|Baclofen|baclofen|mesh-list
55833795|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55833796|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833829|NCT01621568|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55833831|NCT01621568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833832|NCT01621568|Growth Inhibitors|growth inhibitors|mesh-ancestor
55833833|NCT01621568|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55833834|NCT01621568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833835|NCT01621568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833836|NCT02041429|Paclitaxel|paclitaxel|mesh-list
55833837|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55833838|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833839|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
55833840|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
55833841|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
55833842|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833843|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55833844|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
55833845|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833846|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
55833847|NCT02083783|Amphetamine|amphetamine|mesh-list
55833848|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55833849|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833850|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
55833851|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
55833852|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833853|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
55833854|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833855|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833856|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
55833857|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55833858|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55833859|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55833860|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55833861|NCT02059135|Antithrombins|antithrombins|mesh-list
55833862|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
55833863|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55833864|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
55833865|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833866|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833868|NCT04720105|Halobetasol|halobetasol|mesh-list
55833870|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
55833871|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
55833872|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55833873|NCT04695769|Ribavirin|ribavirin|mesh-list
55833874|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
55833875|NCT04695769|Velpatasvir|velpatasvir|mesh-list
55833876|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55833877|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
55833878|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833879|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
55833880|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55833881|NCT02038933|Nivolumab|nivolumab|mesh-list
55833882|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55833883|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833884|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55833885|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833886|NCT02081599|Insulin|insulin|mesh-list
55833887|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55833888|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833889|NCT02038153|Lenalidomide|lenalidomide|mesh-list
55833890|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
55833891|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833892|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55833894|NCT02038153|Growth Substances|growth substances|mesh-ancestor
55833908|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55833909|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55833910|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
55833911|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
55833912|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55833913|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833914|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55833915|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
55833916|NCT02079649|Hormones|hormones|mesh-ancestor
55833917|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833918|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55833919|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833920|NCT02036515|Metformin|metformin|mesh-list
55833921|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55833922|NCT02036515|Glimepiride|glimepiride|mesh-list
55833923|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
55833924|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55833925|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833926|NCT02036515|Incretins|incretins|mesh-ancestor
55833927|NCT02036515|Hormones|hormones|mesh-ancestor
55833928|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55833955|NCT02034565|Apixaban|apixaban|mesh-list
55833962|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
55833963|NCT02075515|Vaccines|vaccines|mesh-list
55833964|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
55833965|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833966|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
55833967|NCT04682587|Avelumab|avelumab|mesh-list
55833968|NCT04682587|Axitinib|axitinib|mesh-list
55833969|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55833970|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55833971|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55833972|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55833973|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833975|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55833976|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55833977|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
55833978|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55833979|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55833980|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55833981|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55833982|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55834014|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834015|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
55834016|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834017|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834018|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55834019|NCT02040428|Hemostatics|hemostatics|mesh-ancestor
55834020|NCT02040428|Coagulants|coagulants|mesh-ancestor
55834021|NCT02018822|Urethane|urethane|mesh-list
55834022|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834023|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55834024|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
55834025|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
55834026|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834027|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834028|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
55834029|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
55834030|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834031|NCT02022007|Metformin|metformin|mesh-list
55834032|NCT02022007|Saxagliptin|saxagliptin|mesh-list
55834033|NCT02022007|Biguanides|biguanides|mesh-list
55834034|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
55834035|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834036|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834037|NCT02022007|Incretins|incretins|mesh-ancestor
55834038|NCT02022007|Hormones|hormones|mesh-ancestor
55834039|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55834040|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
55834041|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834042|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834043|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
55834044|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55834045|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
55834046|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55834047|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
55834048|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834049|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834050|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
55834051|NCT04681729|Histamine Antagonists|histamine antagonists|mesh-list
55834052|NCT04681729|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
55834053|NCT04681729|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-list
55834054|NCT04681729|Histamine Agents|histamine agents|mesh-ancestor
55834059|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834073|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834074|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
55834075|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
55834076|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55834077|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55834078|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834079|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
55834080|NCT02030821|Coagulants|coagulants|mesh-ancestor
55834081|NCT02052739|Brexanolone|brexanolone|mesh-list
55834082|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
55834083|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834084|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834085|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834086|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
55834087|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
55834088|NCT02019277|Paclitaxel|paclitaxel|mesh-list
55834089|NCT02019277|Docetaxel|docetaxel|mesh-list
55834090|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55834091|NCT02019277|Trastuzumab|trastuzumab|mesh-list
55834092|NCT02019277|Pertuzumab|pertuzumab|mesh-list
55834093|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55834094|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834095|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
55834096|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
55834097|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
55834098|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834099|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55834100|NCT04712539|Oseltamivir|oseltamivir|mesh-list
55834101|NCT04712539|Baloxavir|baloxavir|mesh-list
55834102|NCT04712539|Antiviral Agents|antiviral agents|mesh-ancestor
55834103|NCT04712539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834104|NCT04712539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834105|NCT04712539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834106|NCT01823835|Palbociclib|palbociclib|mesh-list
55834107|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834108|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55834109|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834110|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834111|NCT01823679|Capecitabine|capecitabine|mesh-list
55834112|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55834113|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
55834114|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834115|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834118|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834119|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55834122|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834153|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834154|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
55834155|NCT01822665|Acetaminophen|acetaminophen|mesh-list
55834156|NCT01822665|Ibuprofen|ibuprofen|mesh-list
55834157|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55834158|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55834159|NCT01822665|Analgesics|analgesics|mesh-ancestor
55834160|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
55834161|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834162|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834163|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834164|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834165|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55834166|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834167|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834168|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
55834169|NCT01822587|Propranolol|propranolol|mesh-list
55834170|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55834171|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55834208|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834209|NCT01821729|Antidotes|antidotes|mesh-ancestor
55834210|NCT01821729|Protective Agents|protective agents|mesh-ancestor
55834211|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
55834212|NCT01821729|Vitamins|vitamins|mesh-ancestor
55834213|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
55834214|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55834215|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55834216|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55834217|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55834218|NCT01820637|Paclitaxel|paclitaxel|mesh-list
55834219|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55834220|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834221|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
55834222|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
55834223|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
55834224|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834225|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
55834226|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834227|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
55834228|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55834229|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55834230|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
55834231|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55834232|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55834233|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55834234|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834235|NCT02171429|Adalimumab|adalimumab|mesh-list
55834236|NCT02171429|Etrolizumab|etrolizumab|mesh-list
55834237|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834238|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834239|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55834240|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
55834251|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834252|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55834253|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
55834254|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834255|NCT04170465|Metformin|metformin|mesh-list
55834256|NCT04170465|Paclitaxel|paclitaxel|mesh-list
55834257|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
55834258|NCT04170465|Doxorubicin|doxorubicin|mesh-list
55834259|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55834260|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834261|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
55834262|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
55834263|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
55834264|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834265|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834266|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
55834267|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834268|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834269|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55834270|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
55834271|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55834272|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834273|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55834274|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55834275|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55834276|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834277|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55834278|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834279|NCT01847313|Liraglutide|liraglutide|mesh-list
55834280|NCT01847313|Glucagon|glucagon|mesh-list
55834281|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55834282|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834283|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834295|NCT02117687|Protective Agents|protective agents|mesh-ancestor
55834296|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55834297|NCT02117687|Laxatives|laxatives|mesh-ancestor
55834298|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55834299|NCT04740593|Methamphetamine|methamphetamine|mesh-list
55834300|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55834301|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834302|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
55834303|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
55834304|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834305|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
55834306|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834307|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834308|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
55834309|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55834310|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55834311|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55834312|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55834314|NCT02141633|Xhance|xhance|mesh-list
55834315|NCT02141633|Albuterol|albuterol|mesh-list
55834316|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834317|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55834318|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
55834958|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
55834319|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834320|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834321|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55834322|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
55834323|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
55834324|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55834325|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
55834326|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55834327|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55834328|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55834329|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55834330|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
55834331|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834332|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834334|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55834335|NCT01846611|Doxorubicin|doxorubicin|mesh-list
55834336|NCT01846611|Trabectedin|trabectedin|mesh-list
55834337|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834338|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
55834339|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
55834340|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834341|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834393|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834394|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834395|NCT01845831|Incretins|incretins|mesh-ancestor
55834396|NCT01845831|Hormones|hormones|mesh-ancestor
55834397|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55834398|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55834399|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
55834400|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834401|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834402|NCT01844895|Abatacept|abatacept|mesh-list
55834403|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55834404|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834405|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834421|NCT04594239|Lidocaine|lidocaine|mesh-list
55834452|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55834453|NCT01814553|Afatinib|afatinib|mesh-list
55834454|NCT01814553|Loperamide|loperamide|mesh-list
55834455|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
55834456|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834457|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55834458|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834459|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834460|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55834462|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
55834463|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834464|NCT01844583|Rifampin|rifampin|mesh-list
55834465|NCT01844583|Esomeprazole|esomeprazole|mesh-list
55834466|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55834467|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55834468|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55834469|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834470|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834471|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55834472|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
55834473|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55834474|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834483|NCT04742075|Durvalumab|durvalumab|mesh-list
55834504|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
55834505|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834506|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
55834507|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834508|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834509|NCT02138825|Riociguat|riociguat|mesh-list
55834510|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
55834511|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834512|NCT02138747|Mirabegron|mirabegron|mesh-list
55834513|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
55834514|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55834515|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55834516|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55834517|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
55834518|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834519|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834520|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834521|NCT02138747|Urological Agents|urological agents|mesh-ancestor
55834522|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55834523|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55834524|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
55834525|NCT02105285|Carteolol|carteolol|mesh-list
55834526|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55834527|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55834528|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55834529|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55834530|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
55834531|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834532|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834533|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834534|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55834535|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55834536|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
55834537|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
55834538|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834539|NCT01621490|Nivolumab|nivolumab|mesh-list
55834540|NCT01621490|Ipilimumab|ipilimumab|mesh-list
55834541|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55834542|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834543|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55834544|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834547|NCT02030041|Simvastatin|simvastatin|mesh-list
55834548|NCT02030041|Vitamins|vitamins|mesh-ancestor
55834549|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
55834550|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834551|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55834552|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55834553|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55834554|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55834555|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
55834556|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834557|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55834558|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55834594|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834595|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834598|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55834599|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834600|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55834601|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
55834602|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
55834603|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55834604|NCT01844115|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55834605|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55834606|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55834607|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834608|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834609|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
55834610|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834611|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55834612|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55834613|NCT02018042|Abatacept|abatacept|mesh-list
55834614|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55834615|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834616|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834617|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834618|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
55834619|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834620|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834621|NCT02017171|Allopurinol|allopurinol|mesh-list
55834622|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
55834623|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834624|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834625|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
55834626|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834627|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55834628|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
55834629|NCT02017171|Protective Agents|protective agents|mesh-ancestor
55834630|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834668|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55834669|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55834670|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
55834671|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55834672|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55834673|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834674|NCT02050321|Vemurafenib|vemurafenib|mesh-list
55834676|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834677|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55834678|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834679|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834680|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
55834681|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
55834682|NCT02017015|Gemcitabine|gemcitabine|mesh-list
55834683|NCT02017015|Paclitaxel|paclitaxel|mesh-list
55834684|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55834685|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834725|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55834726|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55834727|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55834728|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55834729|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55834730|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
55834731|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834732|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834733|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834734|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
55834735|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
55834736|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55834737|NCT02015546|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55834738|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55834739|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55834740|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834741|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834742|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
55834743|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834744|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55834745|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55834747|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55834749|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55834750|NCT02038790|Narcotics|narcotics|mesh-ancestor
55834751|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834752|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834753|NCT02038790|Analgesics|analgesics|mesh-ancestor
55834754|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
55834755|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834756|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55834757|NCT02027311|Midazolam|midazolam|mesh-list
55834758|NCT02027311|Meperidine|meperidine|mesh-list
55834759|NCT02027311|Etomidate|etomidate|mesh-list
55834760|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55834761|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55834762|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834763|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834764|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55834765|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55834766|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55834767|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55834768|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
55834769|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
55834770|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
55834771|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
55834772|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834773|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834774|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55834775|NCT02027311|Narcotics|narcotics|mesh-ancestor
55834776|NCT02027311|Analgesics|analgesics|mesh-ancestor
55834777|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
55834778|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834779|NCT02047903|Afatinib|afatinib|mesh-list
55834780|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834781|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55834782|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834783|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834803|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834804|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834805|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55834806|NCT02026141|Analgesics|analgesics|mesh-ancestor
55834807|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
55834808|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834809|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55834810|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55834812|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
55834813|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834814|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834815|NCT02025907|Canagliflozin|canagliflozin|mesh-list
55834816|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55834817|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834818|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834819|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834820|NCT02025751|Metoclopramide|metoclopramide|mesh-list
55834821|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
55834822|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
55834823|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834824|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834825|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55834826|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55834827|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55834828|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
55834829|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834830|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834831|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55834832|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55834833|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
55834834|NCT02024971|Metformin|metformin|mesh-list
55834835|NCT02024971|Pioglitazone|pioglitazone|mesh-list
55834836|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834837|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834838|NCT01843023|Naltrexone|naltrexone|mesh-list
55834839|NCT01843023|Buprenorphine|buprenorphine|mesh-list
55834840|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55834841|NCT01843023|Narcotics|narcotics|mesh-ancestor
55834842|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834843|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834845|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
55834846|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834847|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55834848|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55834849|NCT01812759|Fentanyl|fentanyl|mesh-list
55834850|NCT01812759|Hydromorphone|hydromorphone|mesh-list
55834851|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55834852|NCT01812759|Narcotics|narcotics|mesh-ancestor
55834853|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834854|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834855|NCT01812759|Analgesics|analgesics|mesh-ancestor
55834856|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
55834857|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834858|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55834859|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55834860|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
55834861|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
55834862|NCT01812057|Dexamethasone|dexamethasone|mesh-list
55834863|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834864|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
55834865|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
55834866|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834867|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834868|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55834869|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
55834870|NCT01812057|Hormones|hormones|mesh-ancestor
55834871|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55834872|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55834873|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834874|NCT01842633|Acetaminophen|acetaminophen|mesh-list
55834875|NCT01842633|Ibuprofen|ibuprofen|mesh-list
55834876|NCT01842633|Caffeine|caffeine|mesh-list
55834877|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55834878|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55834879|NCT01842633|Analgesics|analgesics|mesh-ancestor
55834880|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
55834881|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834882|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834883|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834884|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55834885|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55834886|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834887|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834888|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
55834889|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55834890|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55834891|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55834892|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55834893|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
55834894|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834896|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55834897|NCT01841697|Glimepiride|glimepiride|mesh-list
55834898|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834899|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834900|NCT01841697|Incretins|incretins|mesh-ancestor
55834901|NCT01841697|Hormones|hormones|mesh-ancestor
55834902|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55834903|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55834904|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
55834905|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834906|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834907|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55834908|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834909|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
55834910|NCT01809327|Metformin|metformin|mesh-list
55834911|NCT01809327|Canagliflozin|canagliflozin|mesh-list
55834912|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55834913|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834914|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55834915|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834917|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
55834918|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
55834919|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55834920|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834921|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
55834922|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834923|NCT01808313|Ambrisentan|ambrisentan|mesh-list
55834924|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55834925|NCT01840605|Ketotifen|ketotifen|mesh-list
55834926|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
55834927|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
55834928|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
55834929|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55834930|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
55834931|NCT01840605|Histamine Agents|histamine agents|mesh-ancestor
55834932|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55834933|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834934|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834935|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55834936|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55834937|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
55834938|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834939|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
55834940|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55834941|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834942|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
55834944|NCT02013817|Fludarabine|fludarabine|mesh-list
55834945|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834946|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
55834947|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834949|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55834950|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
55834951|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834952|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55834953|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55834954|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55834955|NCT02023099|Ritonavir|ritonavir|mesh-list
55834956|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55834957|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55834959|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55834960|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55834961|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55834962|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55834963|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
55834964|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55834965|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55834966|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55834967|NCT02013037|Eculizumab|eculizumab|mesh-list
55834968|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55834969|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55834970|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
55834971|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834972|NCT04416607|Menotropins|menotropins|mesh-list
55834973|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55834974|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
55834975|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55834976|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834977|NCT01967173|Fluticasone|fluticasone|mesh-list
55834979|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
55834980|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55834981|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
55834982|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55834983|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55834984|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55834985|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
55834986|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
55834987|NCT01967173|Hormones|hormones|mesh-ancestor
55834988|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55834989|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
55834990|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55834991|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
55834992|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55835005|NCT02012491|Mifepristone|mifepristone|mesh-list
55835006|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55835007|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
55835008|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55835009|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835010|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55835232|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835011|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55835012|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
55835013|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55835014|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55835015|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55835016|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55835017|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
55835018|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55835019|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55835020|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
55835021|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55835022|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
55835023|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55835024|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55835025|NCT02038010|Trastuzumab|trastuzumab|mesh-list
55835026|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55835027|NCT02038010|Maytansine|maytansine|mesh-list
55835028|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
55835029|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
55835030|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55835040|NCT04678154|Vancomycin|vancomycin|mesh-list
55835051|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835052|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835053|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
55835054|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835055|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55835056|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
55835057|NCT01988402|Protective Agents|protective agents|mesh-ancestor
55835058|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835059|NCT01988090|Vitamin D|vitamin d|mesh-list
55835060|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
55835061|NCT01988090|Cholecalciferol|cholecalciferol|mesh-list
55835062|NCT01988090|Vitamins|vitamins|mesh-list
55835063|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
55835064|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835065|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55835066|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55835067|NCT02011945|Nivolumab|nivolumab|mesh-list
55835068|NCT02011945|Dasatinib|dasatinib|mesh-list
55835069|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55835070|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835071|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55835072|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835073|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55835074|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835075|NCT02013830|Bevacizumab|bevacizumab|mesh-list
55835076|NCT02013830|Capecitabine|capecitabine|mesh-list
55835077|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55835097|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835098|NCT01619059|Metformin|metformin|mesh-list
55835099|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
55835100|NCT01619059|Saxagliptin|saxagliptin|mesh-list
55835101|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55835102|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835103|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55835104|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835105|NCT01619059|Incretins|incretins|mesh-ancestor
55835106|NCT01619059|Hormones|hormones|mesh-ancestor
55835107|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55835108|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55835109|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
55835110|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835112|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
55835113|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55835114|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
55835115|NCT04691804|Hormones|hormones|mesh-ancestor
55835116|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55835117|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835118|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55835130|NCT01807923|Ivacaftor|ivacaftor|mesh-list
55835149|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
55835150|NCT01839279|Tizanidine|tizanidine|mesh-list
55835151|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55835152|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835153|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55835154|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55835155|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835156|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835157|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835158|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835159|NCT01839279|Analgesics|analgesics|mesh-ancestor
55835160|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
55835161|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835162|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
55835163|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55835164|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55835165|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
55835166|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
55835167|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55835168|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55835169|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55835170|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
55835171|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835173|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55835174|NCT01965535|Ledipasvir|ledipasvir|mesh-list
55835175|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
55835176|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835177|NCT01964755|Leucovorin|leucovorin|mesh-list
55835178|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
55835179|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
55835180|NCT01964755|Zidovudine|zidovudine|mesh-list
55835181|NCT01964755|Rituximab|rituximab|mesh-list
55835182|NCT01964755|Doxorubicin|doxorubicin|mesh-list
55835183|NCT01964755|Methotrexate|methotrexate|mesh-list
55835184|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
55835185|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
55835186|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55835187|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835188|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
55835189|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835190|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835191|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55835192|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55835193|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55835195|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835196|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55835197|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
55835198|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55835199|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55835200|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
55835201|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
55835202|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55835203|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55835204|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55835205|NCT01964755|Antidotes|antidotes|mesh-ancestor
55835206|NCT01964755|Protective Agents|protective agents|mesh-ancestor
55835207|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
55835208|NCT01964755|Vitamins|vitamins|mesh-ancestor
55835209|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
55835210|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55835211|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
55835212|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835213|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55835214|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55835215|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
55835216|NCT01991743|Bupivacaine|bupivacaine|mesh-list
55835217|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
55835218|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
55835219|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55835220|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835221|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
55835222|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835223|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55835224|NCT01991197|Gliclazide|gliclazide|mesh-list
55835225|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55835226|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835227|NCT01991197|Incretins|incretins|mesh-ancestor
55835228|NCT01991197|Hormones|hormones|mesh-ancestor
55835229|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55835230|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55835231|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
55835233|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835234|NCT01990573|Methadone|methadone|mesh-list
55835277|NCT01989169|Midazolam|midazolam|mesh-list
55835278|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55835279|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55835280|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55835281|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835282|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55835283|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55835284|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55835285|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55835286|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
55835287|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
55835288|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
55835289|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
55835290|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835291|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835292|NCT01988779|Levofloxacin|levofloxacin|mesh-list
55835293|NCT01988779|Ofloxacin|ofloxacin|mesh-list
55835294|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55835295|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835296|NCT01988779|Renal Agents|renal agents|mesh-ancestor
55835297|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55835298|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55835299|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55835300|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835328|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55835329|NCT04676204|Analgesics|analgesics|mesh-ancestor
55835330|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
55835331|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835332|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55835333|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835334|NCT02010632|Clopidogrel|clopidogrel|mesh-list
55835335|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55835336|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55835337|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55835338|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55835339|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
55835340|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835341|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835342|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835344|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55835345|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835346|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
55835347|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
55835348|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835349|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
55835350|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835351|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835352|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
55835353|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55835354|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55835355|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835356|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55835357|NCT02031536|Everolimus|everolimus|mesh-list
55835358|NCT02031536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835359|NCT02031536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55835360|NCT02031536|Immunologic Factors|immunologic factors|mesh-ancestor
55835361|NCT02031536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835362|NCT01985126|Acetaminophen|acetaminophen|mesh-list
55835363|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
55835364|NCT01985126|Promethazine|promethazine|mesh-list
55835365|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
55835366|NCT01985126|Daratumumab|daratumumab|mesh-list
55835367|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55835368|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55835369|NCT01985126|Analgesics|analgesics|mesh-ancestor
55835370|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
55835372|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835373|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
55835374|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55835376|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
55835377|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55835378|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
55835379|NCT01985126|Hormones|hormones|mesh-ancestor
55835380|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55835381|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55835382|NCT01985126|Protective Agents|protective agents|mesh-ancestor
55835383|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835384|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
55835385|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55835386|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55835387|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55835388|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
55835389|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
55835390|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55835391|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
55835392|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
55835393|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835394|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835395|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55835396|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
55835397|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
55835398|NCT01984892|Poly ICLC|poly iclc|mesh-list
55835399|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
55835400|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
55835401|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835402|NCT01807221|Eplerenone|eplerenone|mesh-list
55835403|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55835419|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835420|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835421|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55835422|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
55835423|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
55835424|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55835425|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
55835426|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835427|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835428|NCT04687514|Dulaglutide|dulaglutide|mesh-list
55835429|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55835430|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835432|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
55835433|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835434|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835435|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835436|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
55835437|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
55835438|NCT01984424|Atorvastatin|atorvastatin|mesh-list
55835440|NCT01984424|Evolocumab|evolocumab|mesh-list
55835441|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55835442|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55835443|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55835444|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
55835445|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835446|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55835447|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55835448|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835449|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
55835450|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835451|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55835453|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55835454|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55835455|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
55835456|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835457|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835458|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55835459|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55835460|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
55835461|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835462|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55835463|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55835464|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
55835465|NCT01984268|Hormones|hormones|mesh-ancestor
55835466|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55835467|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835468|NCT02009384|Ipilimumab|ipilimumab|mesh-list
55835469|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55835470|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835471|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55835653|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55835472|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835473|NCT01805037|Rituximab|rituximab|mesh-list
55835474|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55835476|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
55835477|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55835478|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
55835479|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
55835480|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835481|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55835482|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835483|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835484|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
55835485|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55835486|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55835487|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835488|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835489|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835490|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835491|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
55835492|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55835493|NCT01836549|Imetelstat|imetelstat|mesh-list
55835494|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
55835495|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835496|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835497|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55835498|NCT01836471|Fluticasone|fluticasone|mesh-list
55835499|NCT01836471|Xhance|xhance|mesh-list
55835500|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
55835501|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55835502|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55835503|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
55835504|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835505|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835506|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55835507|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
55835508|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
55835509|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55835510|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
55835511|NCT01836471|Growth Substances|growth substances|mesh-ancestor
55835512|NCT02030600|Insulin|insulin|mesh-list
55835513|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55835514|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
55835515|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55835516|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835517|NCT01802775|Aspirin|aspirin|mesh-list
55835518|NCT01802775|Edoxaban|edoxaban|mesh-list
55835519|NCT01802775|Clopidogrel|clopidogrel|mesh-list
55835520|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55835521|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55835522|NCT01802775|Analgesics|analgesics|mesh-ancestor
55835523|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
55835524|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835525|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835526|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55835527|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835528|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55835529|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55835532|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55835533|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835534|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
55835535|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55835536|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55835537|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55835538|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
55835539|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835540|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55835541|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
55835542|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55835543|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
55835544|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
55835546|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
55835547|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55835548|NCT01802385|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55835549|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55835550|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835880|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55835551|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835552|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835553|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
55835554|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835557|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
55835558|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835559|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835560|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
55835561|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55835562|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835563|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835564|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55835565|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55835566|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55835567|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55835568|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55835569|NCT01802073|Vancomycin|vancomycin|mesh-list
55835570|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55835596|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835597|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55835598|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55835599|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835600|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835601|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55835602|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55835603|NCT04177082|Riboflavin|riboflavin|mesh-list
55835604|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
55835605|NCT04177082|Vitamins|vitamins|mesh-ancestor
55835606|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
55835607|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835608|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55835609|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
55835610|NCT04177004|Sirolimus|sirolimus|mesh-list
55835611|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
55835612|NCT04177004|Etoposide|etoposide|mesh-list
55835613|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
55835614|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
55835615|NCT04177004|Tacrolimus|tacrolimus|mesh-list
55835616|NCT04177004|Mitogens|mitogens|mesh-list
55835617|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55835618|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
55835619|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835620|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835621|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55835622|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
55835623|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835624|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835625|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55835626|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55835627|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55835628|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55835629|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835630|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55835631|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55835632|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835635|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
55835636|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
55835637|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
55835638|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
55835639|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
55835640|NCT01982942|Ibudilast|ibudilast|mesh-list
55835641|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55835642|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
55835643|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835644|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835645|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55835646|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
55835647|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55835648|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835649|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835650|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55835651|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
55835652|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55835654|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55835655|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835656|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835657|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
55835658|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835659|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55835660|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55835661|NCT01769391|Paclitaxel|paclitaxel|mesh-list
55835662|NCT01769391|Carboplatin|carboplatin|mesh-list
55835663|NCT01769391|Necitumumab|necitumumab|mesh-list
55835664|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55835665|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835666|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
55835667|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
55835668|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
55835669|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835670|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55835671|NCT01767987|Ranolazine|ranolazine|mesh-list
55835672|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55835673|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835674|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835675|NCT01767909|Insulin|insulin|mesh-list
55835676|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55835677|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55835678|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835679|NCT02029274|Siponimod|siponimod|mesh-list
55835680|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55835681|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835682|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55835683|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
55835684|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835685|NCT02008370|Bupivacaine|bupivacaine|mesh-list
55835686|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
55835687|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
55835688|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55835689|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835690|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
55835691|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835692|NCT01981616|Vedolizumab|vedolizumab|mesh-list
55835693|NCT01981616|Vaccines|vaccines|mesh-list
55835694|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
55835695|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835696|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55835697|NCT04896866|Anti-Infective Agents|anti-infective agents|mesh-list
55835698|NCT04896866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55835700|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55835701|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55835702|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835703|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
55835704|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
55835705|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
55835706|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835707|NCT01961323|Nebivolol|nebivolol|mesh-list
55835708|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55835709|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
55835710|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
55835711|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55835712|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55835713|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
55835714|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835715|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835716|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835717|NCT04656145|Chlorhexidine|chlorhexidine|mesh-list
55835718|NCT04656145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55835719|NCT04656145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55835722|NCT04656145|Dermatologic Agents|dermatologic agents|mesh-ancestor
55835723|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
55835724|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
55835725|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835726|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835727|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835728|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
55835729|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
55835730|NCT01960855|Upadacitinib|upadacitinib|mesh-list
55835731|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
55835732|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55835733|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835734|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835735|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835737|NCT02007434|Ibuprofen|ibuprofen|mesh-list
55835738|NCT02007434|Lidocaine|lidocaine|mesh-list
55835739|NCT02007434|Epinephrine|epinephrine|mesh-list
55835740|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
55835741|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
55835742|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
55835743|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55835744|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835745|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
55835747|NCT02007434|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55835748|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55835749|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55835750|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835751|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835752|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55835753|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55835754|NCT02007434|Analgesics|analgesics|mesh-ancestor
55835755|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55835756|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835757|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55835758|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835759|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55835760|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55835761|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
55835762|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835763|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55835764|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55835765|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
55835768|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
55835803|NCT02073929|Hormones|hormones|mesh-ancestor
55835804|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55835805|NCT02113007|Rituximab|rituximab|mesh-list
55835806|NCT02113007|Temozolomide|temozolomide|mesh-list
55835807|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55835808|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835809|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
55835810|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835811|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835812|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55835813|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
55835814|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835815|NCT02005471|Rituximab|rituximab|mesh-list
55835816|NCT02005471|Venetoclax|venetoclax|mesh-list
55835817|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55835818|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55835819|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835820|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
55835821|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835822|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55835823|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55835824|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
55835825|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835826|NCT02104505|Tocopherols|tocopherols|mesh-list
55835827|NCT02104505|Vitamin E|vitamin e|mesh-list
55835835|NCT02104505|Vitamins|vitamins|mesh-ancestor
55835864|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835865|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55835866|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
55835867|NCT02069093|Hormones|hormones|mesh-ancestor
55835868|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55835869|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55835870|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835871|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55835872|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
55835873|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55835874|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55835875|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835876|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835877|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55835878|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
55835879|NCT02109029|Insulin|insulin|mesh-list
55835882|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835884|NCT02107703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55835885|NCT02107703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55835886|NCT02107703|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55835887|NCT02107703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55835888|NCT02107703|Hormone Antagonists|hormone antagonists|mesh-ancestor
55835889|NCT02107703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55835890|NCT02107703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835891|NCT02007278|Metformin|metformin|mesh-list
55835892|NCT02007278|Glimepiride|glimepiride|mesh-list
55835893|NCT02007278|Vildagliptin|vildagliptin|mesh-list
55835894|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55835895|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835896|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55835897|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55835898|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
55835899|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55835900|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
55835901|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835902|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835904|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55835905|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55835906|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
55835907|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835909|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55835910|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
55835911|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835912|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835913|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835914|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55835915|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55835916|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55835917|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55835918|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55835919|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
55835920|NCT02106923|Metformin|metformin|mesh-list
55835921|NCT02106923|Empagliflozin|empagliflozin|mesh-list
55835922|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55835923|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835924|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55835925|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835927|NCT02006732|Olodaterol|olodaterol|mesh-list
55835928|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55835929|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
55835930|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55835931|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835932|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55835933|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
55835934|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
55835935|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55835936|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
55835937|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835938|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835940|NCT02098733|Glimepiride|glimepiride|mesh-list
55835941|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55835943|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55835944|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55835945|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
55835946|NCT02098109|Plerixafor|plerixafor|mesh-list
55835947|NCT02098109|Lenograstim|lenograstim|mesh-list
55835948|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55835949|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
55835950|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835951|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55835952|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55835953|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
55835954|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55835955|NCT02097719|Timolol|timolol|mesh-list
55835956|NCT02097719|Bimatoprost|bimatoprost|mesh-list
55835957|NCT02097719|Travoprost|travoprost|mesh-list
55835958|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835959|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55835960|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55835961|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
55835962|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55835963|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835964|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55835965|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55835966|NCT01449370|Serabelisib|serabelisib|mesh-list
55835967|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55835968|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835969|NCT02066129|Fluticasone|fluticasone|mesh-list
55835970|NCT02066129|Xhance|xhance|mesh-list
55835971|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55835972|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55835973|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
55835976|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55835977|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
55835978|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
55835979|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55835980|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55835981|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55835982|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835983|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
55835984|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55835985|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55835986|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55835987|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55835988|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835989|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55835993|NCT04684238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55835994|NCT04684238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55835995|NCT04684238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55835996|NCT04684238|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55835997|NCT04684238|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55835998|NCT04684238|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55835999|NCT04684238|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55836005|NCT04684238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836006|NCT04684238|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55836008|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55836009|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55836010|NCT02006576|Analgesics|analgesics|mesh-ancestor
55836011|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
55836015|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55836016|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55836017|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836020|NCT01448824|Evacetrapib|evacetrapib|mesh-list
55836021|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
55836022|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836023|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55836024|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55836025|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836026|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836027|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55836028|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
55836029|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836030|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836031|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55836032|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55836033|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55836034|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
55836035|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55836037|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
55836038|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
55836039|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55836040|NCT02005562|Cyclosporins|cyclosporins|mesh-list
55836041|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836042|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836043|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836044|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
55836045|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836046|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
55836047|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836048|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
55836049|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55836050|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55836051|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55836052|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836053|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55836054|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
55836055|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55836056|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836057|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
55836058|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
55836059|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836060|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55836061|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
55836062|NCT02005562|Hormones|hormones|mesh-ancestor
55836063|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836064|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55836065|NCT02005562|Protective Agents|protective agents|mesh-ancestor
55836066|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55836067|NCT01448044|Interferons|interferons|mesh-list
55836068|NCT01448044|Ribavirin|ribavirin|mesh-list
55836069|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
55836070|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
55836071|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55836072|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836073|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
55836074|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836075|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
55836076|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836077|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
55836078|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836079|NCT01472380|Efavirenz|efavirenz|mesh-list
55836080|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
55836081|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55836083|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836084|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836085|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
55836086|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836087|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55836088|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55836089|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55836090|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55836092|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55836093|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55836095|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
55836096|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55836097|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
55836098|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55836099|NCT01447420|Ribavirin|ribavirin|mesh-list
55836100|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55836101|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
55836102|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836103|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
55836104|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836105|NCT04083898|Prednisone|prednisone|mesh-list
55836106|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55836107|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836108|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
55836109|NCT04083898|Hormones|hormones|mesh-ancestor
55836110|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836111|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836112|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55836114|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55836115|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
55836116|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836117|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
55836118|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55836119|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836120|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
55836121|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
55836122|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
55836123|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55836124|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836125|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55836126|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55836127|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
55836128|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55836129|NCT01438840|Maleic acid|maleic acid|mesh-list
55836130|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836242|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
55836131|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836133|NCT01471054|Bevacizumab|bevacizumab|mesh-list
55836134|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55836135|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836136|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55836137|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55836138|NCT01471054|Growth Substances|growth substances|mesh-ancestor
55836139|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836140|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
55836141|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836142|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
55836143|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
55836144|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836145|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55836146|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
55836147|NCT01471054|Hormones|hormones|mesh-ancestor
55836148|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836149|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55836150|NCT01978184|Gemcitabine|gemcitabine|mesh-list
55836151|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
55836152|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55836153|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55836154|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
55836155|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836156|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836157|NCT01978184|Antiviral Agents|antiviral agents|mesh-ancestor
55836158|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836159|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836160|NCT01978184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836161|NCT01978184|Immunologic Factors|immunologic factors|mesh-ancestor
55836162|NCT01978184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836163|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
55836164|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55836165|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55836166|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55836465|NCT02033369|Protective Agents|protective agents|mesh-ancestor
55836168|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55836169|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836170|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55836171|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836172|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
55836173|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836174|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
55836175|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836177|NCT01977794|Bisoprolol|bisoprolol|mesh-list
55836178|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55836179|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55836180|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55836181|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836183|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836215|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
55836216|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55836217|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836218|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836219|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836220|NCT02096003|Morphine|morphine|mesh-list
55836221|NCT02096003|Hydromorphone|hydromorphone|mesh-list
55836222|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55836223|NCT02096003|Narcotics|narcotics|mesh-ancestor
55836224|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55836225|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836226|NCT02096003|Analgesics|analgesics|mesh-ancestor
55836227|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
55836228|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836229|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
55836230|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55836231|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55836232|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836233|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
55836234|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
55836236|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55836237|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
55836238|NCT02059187|MK-1293|mk-1293|mesh-list
55836240|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836241|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55836243|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836244|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55836245|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
55836246|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836247|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836248|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836249|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55836250|NCT01622231|Fluticasone|fluticasone|mesh-list
55836251|NCT01622231|Xhance|xhance|mesh-list
55836256|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836257|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55836258|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
55836260|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55836261|NCT02042183|Lubiprostone|lubiprostone|mesh-list
55836262|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55836263|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55836264|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836265|NCT02058095|Tadalafil|tadalafil|mesh-list
55836266|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
55836267|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55836268|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55836269|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836270|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836271|NCT02058095|Urological Agents|urological agents|mesh-ancestor
55836278|NCT02023112|Ritonavir|ritonavir|mesh-list
55836279|NCT02023112|Ribavirin|ribavirin|mesh-list
55836280|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55836281|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55836282|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
55836283|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836284|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836285|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55836286|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55836287|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
55836288|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836289|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55836290|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55836291|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
55836293|NCT04670666|Empagliflozin|empagliflozin|mesh-list
55836294|NCT04670666|Linagliptin|linagliptin|mesh-list
55836295|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836296|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836297|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55836298|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836299|NCT04670666|Incretins|incretins|mesh-ancestor
55836301|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836302|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55836303|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
55836304|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836305|NCT01976624|Timolol|timolol|mesh-list
55836306|NCT01976624|Bimatoprost|bimatoprost|mesh-list
55836307|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55836308|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55836309|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
55836310|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836311|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836312|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836314|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55836315|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55836316|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
55836317|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836318|NCT04717973|Vitamin D|vitamin d|mesh-list
55836320|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
55836321|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
55836322|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
55836323|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836324|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55836325|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
55836326|NCT04717973|Hematinics|hematinics|mesh-ancestor
55836327|NCT02057549|Haloperidol|haloperidol|mesh-list
55836328|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
55836329|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
55836330|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
55836331|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836332|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836333|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55836334|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55836335|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55836336|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55836337|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55836338|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55836339|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
55836340|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836341|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836342|NCT02057549|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55836343|NCT02057393|Methylene Blue|methylene blue|mesh-list
55836344|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836345|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836346|NCT02040779|Beclomethasone|beclomethasone|mesh-list
55836347|NCT02040779|Albuterol|albuterol|mesh-list
55836348|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
55836349|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
55836350|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836351|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836352|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55836354|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
55836355|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55836356|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55836357|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55836358|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55836359|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
55836360|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836361|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836362|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836363|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
55836364|NCT02040779|Hormones|hormones|mesh-ancestor
55836365|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836366|NCT02056301|Morphine|morphine|mesh-list
55836367|NCT02056301|Hydromorphone|hydromorphone|mesh-list
55836375|NCT01967576|Axitinib|axitinib|mesh-list
55836385|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
55836386|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836387|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836388|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836389|NCT01976312|Ranibizumab|ranibizumab|mesh-list
55836390|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55836391|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55836392|NCT01976312|Growth Substances|growth substances|mesh-ancestor
55836393|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836394|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
55836395|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836396|NCT02053493|Isosorbide|isosorbide|mesh-list
55836397|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
55836398|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
55836399|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55836400|NCT02053493|Diuretics|diuretics|mesh-ancestor
55836401|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
55836402|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836403|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
55836405|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836406|NCT02003144|Eculizumab|eculizumab|mesh-list
55836407|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55836408|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836409|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
55836410|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836411|NCT02038907|Vaccines|vaccines|mesh-list
55836412|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
55836413|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836414|NCT02052011|Ranolazine|ranolazine|mesh-list
55836415|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55836416|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55836417|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836418|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
55836419|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55836420|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55836421|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55836422|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55836423|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836424|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
55836425|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836426|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836427|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55836428|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836430|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55836431|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55836432|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55836433|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55836434|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55836435|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836436|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55836437|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55836438|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55836439|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
55836440|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836441|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836442|NCT01445080|Sorafenib|sorafenib|mesh-list
55836443|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836444|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55836445|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836446|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836447|NCT04709471|Nicotine|nicotine|mesh-list
55836448|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55836449|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
55836450|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836451|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836452|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55836455|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836456|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836457|NCT01959529|Insulin|insulin|mesh-list
55836458|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55836459|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
55836460|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836461|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836462|NCT02033369|Pramipexole|pramipexole|mesh-list
55836463|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
55836464|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836466|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836467|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55836468|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55836469|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
55836470|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
55836471|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836472|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
55836473|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
55836474|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836475|NCT04681469|Niraparib|niraparib|mesh-list
55836476|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55836477|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836478|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836479|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836480|NCT01986751|Clonidine|clonidine|mesh-list
55836481|NCT01986751|Ropivacaine|ropivacaine|mesh-list
55836482|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
55836483|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
55836484|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55836485|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836486|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
55836487|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836489|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55836490|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
55836491|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
55836492|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55836493|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55836494|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55836495|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
55836496|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836497|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836512|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55836513|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55836514|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55836515|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55836516|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
55836517|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55836771|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
55836518|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55836519|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836520|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
55836521|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836522|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
55836523|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836525|NCT02020577|Cetuximab|cetuximab|mesh-list
55836526|NCT02020577|Afatinib|afatinib|mesh-list
55836527|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55836529|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55836530|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836531|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836533|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55836534|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836535|NCT02030405|Ixazomib|ixazomib|mesh-list
55836536|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
55836537|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836539|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836540|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836541|NCT01975376|Bococizumab|bococizumab|mesh-list
55836542|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55836544|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
55836545|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836546|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55836547|NCT01443130|Chloroquine|chloroquine|mesh-list
55836548|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
55836549|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
55836550|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
55836552|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55836553|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55836554|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836555|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
55836556|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55836557|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55836558|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836559|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836560|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55836563|NCT04066192|Serotonin Agents|serotonin agents|mesh-ancestor
55836564|NCT04066192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836565|NCT04066192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836566|NCT04066192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836567|NCT04066192|Dopamine Agonists|dopamine agonists|mesh-ancestor
55836568|NCT04066192|Dopamine Agents|dopamine agents|mesh-ancestor
55836580|NCT01959139|Immunologic Factors|immunologic factors|mesh-ancestor
55836581|NCT01959139|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55836582|NCT01959139|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55836583|NCT01959139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836585|NCT01959139|Protective Agents|protective agents|mesh-ancestor
55836586|NCT01959139|Vitamin B Complex|vitamin b complex|mesh-ancestor
55836587|NCT01959139|Vitamins|vitamins|mesh-ancestor
55836588|NCT01959139|Micronutrients|micronutrients|mesh-ancestor
55836589|NCT01436500|Ifetroban|ifetroban|mesh-list
55836590|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55836591|NCT01958827|Adalimumab|adalimumab|mesh-list
55836592|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836593|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55836594|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
55836595|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836596|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
55836597|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55836598|NCT01436110|Fluticasone|fluticasone|mesh-list
55836599|NCT01436110|Xhance|xhance|mesh-list
55836600|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836601|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55836603|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836604|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836605|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55836606|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
55836607|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
55836608|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55836610|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
55836611|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
55836612|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55836613|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836614|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
55836615|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836616|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55836617|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55836618|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55836619|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55836620|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836622|NCT04069936|Tadalafil|tadalafil|mesh-list
55836623|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55836624|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836625|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55836626|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836627|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
55836628|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55836629|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55836630|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836631|NCT04069936|Urological Agents|urological agents|mesh-ancestor
55836632|NCT02000882|Capecitabine|capecitabine|mesh-list
55836633|NCT02000882|Trastuzumab|trastuzumab|mesh-list
55836634|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55836635|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
55836636|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836637|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836638|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55836639|NCT01958671|Metformin|metformin|mesh-list
55836640|NCT01958671|Glimepiride|glimepiride|mesh-list
55836641|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
55836642|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836643|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836644|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55836645|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836646|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
55836647|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55836648|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836649|NCT04666129|Prednisone|prednisone|mesh-list
55836650|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
55836651|NCT04666129|Docetaxel|docetaxel|mesh-list
55836652|NCT04666129|Relugolix|relugolix|mesh-list
55836653|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836654|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
55836655|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
55836656|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
55836657|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836658|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836659|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
55836661|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836662|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836663|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55836665|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
55836666|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836667|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55836668|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55836669|NCT04666129|Protective Agents|protective agents|mesh-ancestor
55836670|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
55836671|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
55836672|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55836673|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
55836674|NCT04666051|Coagulants|coagulants|mesh-ancestor
55836675|NCT01965704|Ondansetron|ondansetron|mesh-list
55836676|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
55836677|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
55836678|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836679|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836680|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55836681|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
55836682|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
55836683|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55836684|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
55836685|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836686|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836687|NCT01965704|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55836688|NCT01965704|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55836689|NCT01965704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55836690|NCT01965704|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55836691|NCT01965704|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55836692|NCT02003365|Triamcinolone|triamcinolone|mesh-list
55836693|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55836694|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55836696|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55836697|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836698|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
55836699|NCT02003365|Hormones|hormones|mesh-ancestor
55836700|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836701|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836702|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836703|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
55836704|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836705|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836706|NCT01975220|Metformin|metformin|mesh-list
55836707|NCT01975220|Empagliflozin|empagliflozin|mesh-list
55836708|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836709|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836710|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55836711|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836712|NCT01974752|Dacarbazine|dacarbazine|mesh-list
55836713|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55836714|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
55836715|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836716|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836717|NCT01999946|Naltrexone|naltrexone|mesh-list
55836718|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55836719|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55836720|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836721|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
55836722|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836724|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55836725|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
55836726|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836727|NCT02002975|Pioglitazone|pioglitazone|mesh-list
55836728|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836729|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836730|NCT02001181|Tofacitinib|tofacitinib|mesh-list
55836731|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55836732|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836733|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836734|NCT04176055|Haloperidol|haloperidol|mesh-list
55836735|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
55836736|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
55836737|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
55836738|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836739|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836740|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55836741|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55836742|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55836743|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55836744|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55836745|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55836746|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
55836747|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836748|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836750|NCT04659278|Peppermint oil|peppermint oil|mesh-list
55836751|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
55836752|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
55836753|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836754|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836755|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55836756|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
55836757|NCT04659044|Rituximab|rituximab|mesh-list
55836758|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55836759|NCT04659044|Venetoclax|venetoclax|mesh-list
55836760|NCT04659044|Antibodies|antibodies|mesh-list
55836761|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
55836762|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55836763|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
55836764|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
55836765|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836766|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836767|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55836768|NCT01999868|Abatacept|abatacept|mesh-list
55836769|NCT01999868|Ustekinumab|ustekinumab|mesh-list
55836770|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
55836772|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836773|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55836774|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836775|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836776|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836777|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55836778|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
55836779|NCT03511963|Bevacizumab|bevacizumab|mesh-list
55836780|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55836781|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836782|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55836783|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55836784|NCT03511963|Growth Substances|growth substances|mesh-ancestor
55836785|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836786|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
55836788|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55836789|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
55836790|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
55836791|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
55836792|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836793|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836794|NCT05126966|Ranibizumab|ranibizumab|mesh-list
55836795|NCT05126966|Aflibercept|aflibercept|mesh-list
55836796|NCT05126966|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55836797|NCT05126966|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55836798|NCT05126966|Growth Substances|growth substances|mesh-ancestor
55836799|NCT05126966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836800|NCT05126966|Growth Inhibitors|growth inhibitors|mesh-ancestor
55836801|NCT05126966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836802|NCT01964924|Trametinib|trametinib|mesh-list
55836803|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836804|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55836805|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836807|NCT01964378|Morphine|morphine|mesh-list
55836826|NCT01998919|Antiviral Agents|antiviral agents|mesh-ancestor
55836827|NCT01998919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836828|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836829|NCT01998919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836830|NCT01998919|Immunologic Factors|immunologic factors|mesh-ancestor
55836831|NCT01998919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836832|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55836833|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55836834|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
55836835|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836836|NCT01972724|Metformin|metformin|mesh-list
55836837|NCT01972724|Pioglitazone|pioglitazone|mesh-list
55836838|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836839|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836840|NCT01441960|Rocuronium|rocuronium|mesh-list
55836841|NCT01441960|Succinylcholine|succinylcholine|mesh-list
55836842|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
55836843|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
55836844|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55836845|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836846|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836847|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
55836849|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
55836850|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836851|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
55836852|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
55836853|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
55836854|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55836855|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55836866|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
55836867|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55836868|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836869|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
55836870|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55836871|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55836872|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55836873|NCT01954927|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55836874|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55836875|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55836876|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836877|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836878|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
55836880|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836881|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55836882|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836883|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836884|NCT01970540|Doxorubicin|doxorubicin|mesh-list
55836885|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55836886|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836887|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55836888|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55836889|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836890|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836891|NCT01996826|Bevacizumab|bevacizumab|mesh-list
55836892|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55836893|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55836894|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836895|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55836896|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55836897|NCT01996826|Growth Substances|growth substances|mesh-ancestor
55836898|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836899|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
55836900|NCT01996826|Laxatives|laxatives|mesh-ancestor
55836901|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55836902|NCT01621178|Insulin|insulin|mesh-list
55836903|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55836904|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
55836905|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
55836906|NCT01621178|Dulaglutide|dulaglutide|mesh-list
55836907|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836908|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836909|NCT01962974|Golimumab|golimumab|mesh-list
55836910|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
55836911|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55836912|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836913|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
55836914|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836915|NCT01962896|Sirolimus|sirolimus|mesh-list
55836916|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55836917|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55836918|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55836919|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836920|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836921|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55836922|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836923|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55836924|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
55836925|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55836926|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
55836927|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836928|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55836929|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55836930|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836933|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55836934|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55836935|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
55836936|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836937|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836938|NCT01995266|Asunaprevir|asunaprevir|mesh-list
55836939|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
55836940|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836941|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836942|NCT01969058|Isotretinoin|isotretinoin|mesh-list
55836943|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
55836944|NCT01968980|Bococizumab|bococizumab|mesh-list
55836945|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55836946|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55836947|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
55836948|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836949|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55836950|NCT01968434|Carbocysteine|carbocysteine|mesh-list
55836952|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55836977|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836979|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55836980|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55836981|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55836982|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55836983|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836984|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55836985|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
55836986|NCT02017535|Fluoxetine|fluoxetine|mesh-list
55836987|NCT02017535|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55836988|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55836989|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55836990|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55836991|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55836992|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
55836993|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55836994|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55836995|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
55836996|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55836997|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55836998|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55836999|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837000|NCT01944098|Lidocaine|lidocaine|mesh-list
55837001|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
55837002|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
55837003|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837004|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837005|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
55837006|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837007|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55837008|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55837009|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55837010|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55837011|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837012|NCT04624178|Nivolumab|nivolumab|mesh-list
55837013|NCT04624178|Rucaparib|rucaparib|mesh-list
55837014|NCT04624178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55837015|NCT04624178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837016|NCT04624178|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55837017|NCT04624178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837018|NCT04624178|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55837019|NCT04624178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837020|NCT01943552|Bromides|bromides|mesh-list
55837021|NCT01943552|Ipratropium|ipratropium|mesh-list
55837022|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
55837023|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55837024|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
55837025|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837026|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837027|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55837028|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
55837029|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55837030|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
55837031|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837042|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837043|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55837044|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55837045|NCT01914926|Metoprolol|metoprolol|mesh-list
55837046|NCT01914926|Diltiazem|diltiazem|mesh-list
55837047|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55837048|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55837049|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
55837050|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
55837051|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837052|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837053|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55837054|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55837055|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55837056|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
55837057|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837058|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837059|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55837060|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55837061|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55837062|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
55837063|NCT05119166|Niacinamide|niacinamide|mesh-list
55837065|NCT05119166|Nicotinic Acids|nicotinic acids|mesh-list
55837066|NCT05119166|Azithromycin|azithromycin|mesh-list
55837068|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
55837069|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837070|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55837071|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837072|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
55837073|NCT05119166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55837074|NCT05119166|Antimetabolites|antimetabolites|mesh-ancestor
55837075|NCT05119166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837077|NCT05119166|Vasodilator Agents|vasodilator agents|mesh-ancestor
55837078|NCT01942148|Aripiprazole|aripiprazole|mesh-list
55837079|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
55837080|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55837081|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55837082|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55837083|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837084|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837085|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
55837086|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
55837087|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837088|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837089|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55837090|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55837091|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
55837092|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55837093|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55837094|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55837095|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55837096|NCT02030015|Miglustat|miglustat|mesh-list
55837097|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837098|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837099|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55837100|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55837101|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
55837102|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837103|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
55837104|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55837105|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837106|NCT02029235|Acetaminophen|acetaminophen|mesh-list
55837107|NCT02029235|Ibuprofen|ibuprofen|mesh-list
55837109|NCT02029235|Hydrocodone|hydrocodone|mesh-list
55837118|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837119|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55837120|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837121|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837122|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55837123|NCT02029235|Narcotics|narcotics|mesh-ancestor
55837124|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837125|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
55837126|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
55837127|NCT01617434|Liraglutide|liraglutide|mesh-list
55837128|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55837129|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837130|NCT01617434|Incretins|incretins|mesh-ancestor
55837131|NCT01617434|Hormones|hormones|mesh-ancestor
55837132|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55837133|NCT04623398|Lithium Carbonate|lithium carbonate|mesh-list
55837134|NCT04623398|Antidepressive Agents|antidepressive agents|mesh-ancestor
55837135|NCT04623398|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55837136|NCT04623398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837137|NCT04623398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837138|NCT04623398|Antimanic Agents|antimanic agents|mesh-ancestor
55837139|NCT04623398|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55837140|NCT04623398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837141|NCT04623398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837142|NCT01940900|Ranibizumab|ranibizumab|mesh-list
55837143|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55837144|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55837145|NCT01940900|Growth Substances|growth substances|mesh-ancestor
55837146|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837147|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
55837148|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837149|NCT01911260|Chelating Agents|chelating agents|mesh-list
55837150|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
55837151|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837155|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
55837156|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55837157|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837158|NCT02015819|Antidotes|antidotes|mesh-ancestor
55837159|NCT02015819|Protective Agents|protective agents|mesh-ancestor
55837160|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
55837161|NCT02015819|Vitamins|vitamins|mesh-ancestor
55837162|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
55837163|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
55837164|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837165|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
55837166|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837167|NCT01939496|Canagliflozin|canagliflozin|mesh-list
55837168|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55837169|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837170|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55837171|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837172|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55837173|NCT01938716|Gemcitabine|gemcitabine|mesh-list
55837174|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55837175|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
55837176|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837177|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837178|NCT01938716|Antiviral Agents|antiviral agents|mesh-ancestor
55837179|NCT01938716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837180|NCT01938716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837181|NCT01938716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55837182|NCT01938716|Immunologic Factors|immunologic factors|mesh-ancestor
55837183|NCT01938716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837184|NCT01937390|Bromides|bromides|mesh-list
55837185|NCT01937390|Tiotropium Bromide|tiotropium bromide|mesh-list
55837186|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55837187|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
55837188|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837189|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837190|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55837191|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
55837192|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
55837193|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55837194|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
55837195|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837196|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837197|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
55837198|NCT02015663|Tobramycin|tobramycin|mesh-list
55837199|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55837200|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837201|NCT02028767|Metformin|metformin|mesh-list
55837202|NCT02028767|Empagliflozin|empagliflozin|mesh-list
55837203|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55837204|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837205|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55837206|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837208|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55837209|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55837210|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837211|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
55837212|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837213|NCT04683965|Bevacizumab|bevacizumab|mesh-list
55837214|NCT04683965|Pemetrexed|pemetrexed|mesh-list
55837215|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55837216|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837217|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55837218|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55837219|NCT04683965|Growth Substances|growth substances|mesh-ancestor
55837220|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837221|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
55837222|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837223|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837224|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55837225|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55837236|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55837237|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55837238|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55837239|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55837240|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837241|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55837242|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837243|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55837244|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55837245|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
55837246|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
55837247|NCT02015195|Protective Agents|protective agents|mesh-ancestor
55837248|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837249|NCT02025725|Metoclopramide|metoclopramide|mesh-list
55837250|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
55837251|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
55837252|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837253|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837254|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55837255|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55837256|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55837257|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
55837258|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837259|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837260|NCT02025179|Teriparatide|teriparatide|mesh-list
55837261|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55837262|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837263|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55837264|NCT02013791|Cyclosporine|cyclosporine|mesh-list
55837266|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837267|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837268|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55837269|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
55837270|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837271|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
55837272|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837273|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
55837274|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837275|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55837276|NCT02024867|Trimethoprim|trimethoprim|mesh-list
55837277|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
55837279|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55837280|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837281|NCT02024867|Renal Agents|renal agents|mesh-ancestor
55837282|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
55837283|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55837284|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55837285|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55837286|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837287|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837288|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55837289|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
55837290|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55837291|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55837292|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
55837293|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837294|NCT01951417|Adapalene|adapalene|mesh-list
55837295|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55837296|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
55837297|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55837298|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55837300|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
55837301|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837302|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837303|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837304|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837306|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55837307|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55837308|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
55837309|NCT04667585|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55837310|NCT04667585|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55837311|NCT04667585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837312|NCT01979185|Simvastatin|simvastatin|mesh-list
55837313|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55837314|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55837315|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
55837316|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837317|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55837319|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837320|NCT01946425|Vaccines|vaccines|mesh-list
55837321|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
55837322|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837323|NCT01959698|Rituximab|rituximab|mesh-list
55837324|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55837325|NCT01959698|Carboplatin|carboplatin|mesh-list
55837326|NCT01959698|Etoposide|etoposide|mesh-list
55837327|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
55837328|NCT01959698|Ifosfamide|ifosfamide|mesh-list
55837329|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
55837330|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
55837331|NCT01959698|Antibodies|antibodies|mesh-list
55837332|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
55837333|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55837334|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
55837335|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837336|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837337|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837338|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55837339|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55837340|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55837341|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837342|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837343|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55837344|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
55837345|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
55837346|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
55837347|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
55837348|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
55837349|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
55837350|NCT04650698|Tranexamic Acid|tranexamic acid|mesh-list
55837351|NCT04650698|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55837352|NCT04650698|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55837353|NCT04650698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837354|NCT04650698|Hemostatics|hemostatics|mesh-ancestor
55837355|NCT04650698|Coagulants|coagulants|mesh-ancestor
55837357|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
55837358|NCT01910402|Tenofovir|tenofovir|mesh-list
55837359|NCT01910402|Lamivudine|lamivudine|mesh-list
55837360|NCT01910402|Emtricitabine|emtricitabine|mesh-list
55837361|NCT01910402|Dolutegravir|dolutegravir|mesh-list
55837362|NCT01910402|Abacavir|abacavir|mesh-list
55837363|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55837364|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55837365|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
55837366|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837367|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837368|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55837369|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55837370|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
55837371|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837372|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55837373|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55837374|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55837375|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55837376|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55837377|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55837378|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55837379|NCT01937312|Travoprost|travoprost|mesh-list
55837380|NCT01937312|Brinzolamide|brinzolamide|mesh-list
55837381|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55837382|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55837383|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55837384|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55837385|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
55837386|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837387|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837388|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837389|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55837390|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837391|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55837392|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55837393|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837394|NCT01935128|Everolimus|everolimus|mesh-list
55837395|NCT01935128|Tacrolimus|tacrolimus|mesh-list
55837396|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55837397|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
55837398|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837400|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837401|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837402|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837404|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55837405|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837406|NCT01934972|Renal Agents|renal agents|mesh-ancestor
55837407|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55837408|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
55837409|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55837410|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
55837411|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837412|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55837413|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55837414|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55837415|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55837416|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55837417|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55837418|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55837419|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
55837420|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837421|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837422|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837423|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55837424|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
55837425|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837426|NCT01977937|Gabapentin|gabapentin|mesh-list
55837427|NCT01977937|Analgesics|analgesics|mesh-ancestor
55837428|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
55837429|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837430|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837431|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
55837432|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55837433|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55837434|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837435|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55837436|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55837437|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55837438|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837440|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
55837441|NCT01951105|Naproxen|naproxen|mesh-list
55837442|NCT01951105|Levodopa|levodopa|mesh-list
55837443|NCT01951105|Carbidopa|carbidopa|mesh-list
55837444|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
55837445|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55837446|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55837448|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
55837449|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837450|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837451|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837452|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837453|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
55837454|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55837455|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837456|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837457|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55837458|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55837460|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837461|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
55837462|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55837463|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
55837464|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
55837465|NCT01958918|Ranibizumab|ranibizumab|mesh-list
55837466|NCT01958918|Aflibercept|aflibercept|mesh-list
55837467|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55837468|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55837469|NCT01958918|Growth Substances|growth substances|mesh-ancestor
55837470|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837474|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55837475|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55837476|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55837477|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55837478|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837479|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
55837480|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837481|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837482|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55837483|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837484|NCT01934894|Lapatinib|lapatinib|mesh-list
55837485|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837486|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55837487|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837488|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837489|NCT01950169|Vitamin D|vitamin d|mesh-list
55837490|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
55837491|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
55837492|NCT01950169|Diphosphonates|diphosphonates|mesh-list
55837493|NCT01950169|Calcium|calcium|mesh-list
55837494|NCT01950169|Vitamins|vitamins|mesh-ancestor
55837495|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
55837496|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837497|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55837498|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55837499|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55837500|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55837501|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837502|NCT01909466|Aripiprazole|aripiprazole|mesh-list
55837503|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
55837504|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55837505|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55837506|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55837507|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837508|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837509|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
55837510|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
55837511|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837512|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837513|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55837514|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55837515|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
55837516|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55837517|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55837518|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55837519|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55837520|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55837521|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55837522|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837523|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55837524|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55837525|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55837526|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837527|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
55837528|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837529|NCT01995071|Ribavirin|ribavirin|mesh-list
55837530|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
55837531|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837532|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
55837533|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837534|NCT01994837|Venetoclax|venetoclax|mesh-list
55837535|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837536|NCT02010593|Dapivirine|dapivirine|mesh-list
55837537|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55837538|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55837539|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
55837540|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837541|NCT01994291|Ranibizumab|ranibizumab|mesh-list
55837542|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55837543|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55837544|NCT01994291|Growth Substances|growth substances|mesh-ancestor
55837545|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837546|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
55837564|NCT04667039|Growth Substances|growth substances|mesh-ancestor
55837565|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837566|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
55837567|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837568|NCT01993823|Clotrimazole|clotrimazole|mesh-list
55837569|NCT01993823|Miconazole|miconazole|mesh-list
55837570|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55837571|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837572|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
55837573|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55837574|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55837575|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837576|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837577|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55837578|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
55837579|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55837580|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837581|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55837582|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55837583|NCT01993667|Acetazolamide|acetazolamide|mesh-list
55837584|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
55837585|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55837586|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837587|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837588|NCT01993667|Diuretics|diuretics|mesh-ancestor
55837589|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
55837590|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837591|NCT01934192|Metoclopramide|metoclopramide|mesh-list
55837592|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
55837593|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
55837594|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837595|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837596|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55837597|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55837598|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55837599|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
55837600|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837601|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837602|NCT01933880|Methylphenidate|methylphenidate|mesh-list
55837603|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55837604|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837605|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55837606|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55837607|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55837608|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837609|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
55837610|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837612|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55837613|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837614|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55837615|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837616|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
55837617|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55837618|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
55837619|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837622|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
55837623|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837624|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837625|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55837626|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55837627|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837628|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837629|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837630|NCT01932788|Vitamin D|vitamin d|mesh-list
55837632|NCT01932788|Vitamins|vitamins|mesh-list
55837633|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
55837634|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837635|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55837636|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55837637|NCT01908140|Fluticasone|fluticasone|mesh-list
55837638|NCT01908140|Bromides|bromides|mesh-list
55837639|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
55837640|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
55837641|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837642|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55837643|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
55837644|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837645|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837646|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55837647|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
55837648|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
55837649|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55837650|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55837651|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55837652|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55837653|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
55837654|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837655|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837656|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
55837657|NCT02008565|Loperamide|loperamide|mesh-list
55837658|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
55837659|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55837670|NCT01906346|Cocaine|cocaine|mesh-list
55837671|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
55837672|NCT01906346|Anesthetics|anesthetics|mesh-ancestor
55837673|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837674|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837675|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
55837676|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837677|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55837678|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55837679|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55837680|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55837681|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837682|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
55837683|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837684|NCT04645004|Aspirin|aspirin|mesh-list
55837685|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55837686|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55837687|NCT04645004|Analgesics|analgesics|mesh-ancestor
55837688|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
55837689|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837690|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837691|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837692|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837693|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55837694|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55837695|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837696|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55837697|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55837698|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837700|NCT01929980|Bortezomib|bortezomib|mesh-list
55837701|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837703|NCT04630808|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55837704|NCT04630808|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55837705|NCT01363076|Ketorolac|ketorolac|mesh-list
55837706|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
55837707|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55837708|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55837709|NCT01363076|Analgesics|analgesics|mesh-ancestor
55837710|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
55837711|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837712|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837713|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837714|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837715|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55837716|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837717|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837718|NCT01929044|Anisodamine|anisodamine|mesh-list
55837719|NCT01929044|Scopolamine|scopolamine|mesh-list
55837720|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55837721|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55837722|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
55837723|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
55837724|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837725|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837726|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55837727|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
55837728|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55837730|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837731|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837732|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55837733|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
55837734|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55837735|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55837736|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
55837737|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55837738|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55837739|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55837741|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
55837742|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837743|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837744|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55837745|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
55837746|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55837747|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
55837748|NCT01929044|Protective Agents|protective agents|mesh-ancestor
55837749|NCT01957202|Levocabastine|levocabastine|mesh-list
55837750|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55837751|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55837752|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
55837753|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
55837754|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837755|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837756|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837757|NCT01616654|Tazarotene|tazarotene|mesh-list
55837758|NCT01616654|Trifarotene|trifarotene|mesh-list
55837759|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
55837760|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
55837761|NCT01902290|Brodalumab|brodalumab|mesh-list
55837762|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
55837763|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
55837764|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55837765|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
55837766|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837767|NCT01467466|Expectorants|expectorants|mesh-ancestor
55837768|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
55837769|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55837770|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
55837771|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837772|NCT01467466|Protective Agents|protective agents|mesh-ancestor
55837773|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837774|NCT01467466|Antidotes|antidotes|mesh-ancestor
55837775|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
55837776|NCT01441180|Ribavirin|ribavirin|mesh-list
55837777|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
55837778|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837780|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837781|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
55837784|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55837785|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55837786|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837787|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837788|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837790|NCT04069156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55837791|NCT04069156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55837792|NCT04069156|Analgesics|analgesics|mesh-ancestor
55837793|NCT04069156|Sensory System Agents|sensory system agents|mesh-ancestor
55837794|NCT04069156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837795|NCT04069156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837796|NCT04069156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837797|NCT04069156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837798|NCT04069156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55837799|NCT04069156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55837800|NCT04069156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837801|NCT04069156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55837802|NCT04069156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55837803|NCT04069156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837804|NCT04069156|Antipyretics|antipyretics|mesh-ancestor
55837805|NCT04061980|Nivolumab|nivolumab|mesh-list
55837806|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55837807|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837808|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55837809|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837810|NCT01467076|Alprostadil|alprostadil|mesh-list
55837811|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55837812|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
55837813|NCT01467076|Urological Agents|urological agents|mesh-ancestor
55837815|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
55837816|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837818|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55837819|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55837820|NCT04504864|Analgesics|analgesics|mesh-ancestor
55837821|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
55837822|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837823|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837824|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837825|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837826|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55837827|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55837828|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837829|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55837830|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55837831|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837832|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
55837833|NCT04060342|Gemcitabine|gemcitabine|mesh-list
55837834|NCT04060342|Paclitaxel|paclitaxel|mesh-list
55837835|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
55837836|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55837837|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837838|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
55837839|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
55837840|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
55837841|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837842|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55837843|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
55837844|NCT04060342|Antiviral Agents|antiviral agents|mesh-ancestor
55837845|NCT04060342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837846|NCT04060342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837847|NCT04060342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55837849|NCT04060342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837850|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55837851|NCT04060030|Calcium, Dietary|calcium, dietary|mesh-list
55837852|NCT04060030|Leucovorin|leucovorin|mesh-list
55837853|NCT04060030|Calcium|calcium|mesh-list
55837854|NCT04060030|Levoleucovorin|levoleucovorin|mesh-list
55837933|NCT01902134|Narcotics|narcotics|mesh-ancestor
55837855|NCT04060030|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55837856|NCT04060030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837857|NCT04060030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55837858|NCT04060030|Antidotes|antidotes|mesh-ancestor
55837859|NCT04060030|Protective Agents|protective agents|mesh-ancestor
55837860|NCT04060030|Vitamin B Complex|vitamin b complex|mesh-ancestor
55837861|NCT04060030|Vitamins|vitamins|mesh-ancestor
55837862|NCT04060030|Micronutrients|micronutrients|mesh-ancestor
55837863|NCT01435018|Tenofovir|tenofovir|mesh-list
55837864|NCT01435018|Emtricitabine|emtricitabine|mesh-list
55837865|NCT01435018|Efavirenz|efavirenz|mesh-list
55837866|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55837867|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55837868|NCT01435018|Paclitaxel|paclitaxel|mesh-list
55837869|NCT01435018|Etoposide|etoposide|mesh-list
55837870|NCT01435018|Vincristine|vincristine|mesh-list
55837871|NCT01435018|Bleomycin|bleomycin|mesh-list
55837872|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55837873|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837874|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
55837875|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
55837876|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
55837877|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837878|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55837879|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55837880|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837881|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
55837882|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837883|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55837884|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55837885|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55837886|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55837967|NCT01415518|Ipratropium|ipratropium|mesh-list
55837887|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55837888|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55837889|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55837890|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55837891|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55837892|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55837894|NCT01419184|Vancomycin|vancomycin|mesh-list
55837895|NCT01419184|Daptomycin|daptomycin|mesh-list
55837896|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55837897|NCT01419184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55837899|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837900|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55837901|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837902|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837903|NCT01417078|Diazepam|diazepam|mesh-list
55837904|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55837905|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
55837906|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
55837907|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
55837908|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837909|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837910|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55837911|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55837912|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837913|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55837914|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55837915|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55837916|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55837917|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55837918|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55837919|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
55837920|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
55837921|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
55837922|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
55837923|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837924|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837926|NCT01464424|Travoprost|travoprost|mesh-list
55837927|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55837928|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55837929|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55837930|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
55837931|NCT01902134|Tramadol|tramadol|mesh-list
55837932|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55837934|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55837935|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837936|NCT01902134|Analgesics|analgesics|mesh-ancestor
55837937|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
55837938|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837939|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55837940|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55837941|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837942|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837943|NCT01954082|Inositol|inositol|mesh-list
55837944|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
55837945|NCT01954082|Vitamins|vitamins|mesh-ancestor
55837946|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
55837947|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837948|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
55837949|NCT01417000|Pancrelipase|pancrelipase|mesh-list
55837950|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55837951|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
55837952|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837953|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55837954|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55837955|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
55837956|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837957|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837958|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55837959|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55837960|NCT01415986|Temoporfin|temoporfin|mesh-list
55837961|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55837962|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55837963|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
55837964|NCT01415518|Budesonide|budesonide|mesh-list
55837965|NCT01415518|Theophylline|theophylline|mesh-list
55837966|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
55837968|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55837969|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55837970|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55837971|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
55837972|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55837973|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55837974|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55837975|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
55837976|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
55837977|NCT01415518|Hormones|hormones|mesh-ancestor
55837978|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55837979|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55837980|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55837981|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55837982|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
55837983|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55837984|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55837985|NCT01415518|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55837986|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
55837987|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55837988|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55837989|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
55837990|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55838003|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55838004|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55838005|NCT04767178|Analgesics|analgesics|mesh-ancestor
55838006|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
55838007|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838008|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838009|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55838010|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838011|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55838012|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838013|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838014|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
55838015|NCT01432600|Dexamethasone|dexamethasone|mesh-list
55838016|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
55838017|NCT01432600|Pomalidomide|pomalidomide|mesh-list
55838018|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55838019|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
55838020|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838021|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838022|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55838023|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
55838025|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838026|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55838027|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55838029|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
55838030|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838031|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55838032|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
55838033|NCT01432600|Hormones|hormones|mesh-ancestor
55838034|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838035|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55838036|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55838037|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55838040|NCT01432444|Aripiprazole|aripiprazole|mesh-list
55838041|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
55838042|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55838043|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55838044|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55838045|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55838046|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838047|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
55838048|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
55838049|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838050|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838051|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55838052|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55838053|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
55838054|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55838055|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55838056|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55838058|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55838059|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55838060|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838061|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55838062|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55838063|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55838064|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838066|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838067|NCT01431976|Lamotrigine|lamotrigine|mesh-list
55838068|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
55838069|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55838070|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55838071|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838072|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55838073|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838074|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55838075|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55838076|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55838077|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55838078|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55838079|NCT01413958|Loratadine|loratadine|mesh-list
55838080|NCT01413958|Phenylephrine|phenylephrine|mesh-list
55838081|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
55838082|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55838083|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
55838084|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
55838085|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838086|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838087|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
55838088|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55838089|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
55838107|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55838108|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
55838109|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838110|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838111|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55838112|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55838113|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
55838114|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838115|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55838116|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
55838453|NCT01925612|Rituximab|rituximab|mesh-list
55838117|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838118|NCT03025906|Valproic Acid|valproic acid|mesh-list
55838119|NCT03025906|Phenobarbital|phenobarbital|mesh-list
55838120|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
55838121|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838122|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838123|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
55838124|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838125|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838126|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
55838127|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55838128|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55838129|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55838130|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55838131|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55838132|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55838133|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
55838134|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55838135|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55838136|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55838138|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55838139|NCT04053712|Hormones|hormones|mesh-ancestor
55838141|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838144|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
55838145|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
55838146|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
55838147|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838148|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
55838150|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55838151|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55838152|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55838153|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55838154|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838155|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
55838156|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838157|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838158|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55838159|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838160|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55838161|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55838162|NCT01767519|Urological Agents|urological agents|mesh-ancestor
55838163|NCT04581603|Topiramate|topiramate|mesh-list
55838164|NCT04581603|Anticonvulsants|anticonvulsants|mesh-ancestor
55838165|NCT04581603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55838166|NCT04581603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838167|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
55838168|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55838169|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55838170|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55838171|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55838172|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838173|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
55838186|NCT01765569|Protective Agents|protective agents|mesh-ancestor
55838187|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838188|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838189|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55838190|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55838191|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
55838192|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838194|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838195|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838196|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
55838197|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838198|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838199|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
55838200|NCT01765179|Testosterone|testosterone|mesh-list
55838201|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
55838202|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
55838203|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55838204|NCT01765179|Androgens|androgens|mesh-ancestor
55838205|NCT01765179|Hormones|hormones|mesh-ancestor
55838206|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838207|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838208|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55838209|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838210|NCT01765179|Anabolic Agents|anabolic agents|mesh-ancestor
55838211|NCT01793883|Laninamivir|laninamivir|mesh-list
55838212|NCT01793883|Zanamivir|zanamivir|mesh-list
55838213|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
55838214|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838215|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838216|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838217|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
55838218|NCT01953692|Lenalidomide|lenalidomide|mesh-list
55838219|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838220|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838221|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
55838222|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838225|NCT01953692|Growth Substances|growth substances|mesh-ancestor
55838226|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
55838228|NCT01791153|Methotrexate|methotrexate|mesh-list
55838230|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
55838231|NCT01791153|Hormones|hormones|mesh-ancestor
55838232|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838233|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838234|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55838235|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838236|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55838237|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
55838238|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55838239|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55838240|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
55838241|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838242|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
55838243|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838244|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55838245|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55838246|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
55838247|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838248|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55838249|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55838250|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
55838251|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838252|NCT01926626|Moclobemide|moclobemide|mesh-list
55838253|NCT01926626|Nicotine|nicotine|mesh-list
55838254|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55838270|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838271|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
55838272|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838273|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838274|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
55838275|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55838276|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55838277|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55838278|NCT01952834|Vancomycin|vancomycin|mesh-list
55838279|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55838280|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838281|NCT01952054|Denosumab|denosumab|mesh-list
55838282|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55838283|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838284|NCT01925768|Apremilast|apremilast|mesh-list
55838285|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55838286|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55838287|NCT01925768|Analgesics|analgesics|mesh-ancestor
55838288|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
55838289|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838290|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838291|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55838292|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838293|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55838294|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55838295|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838296|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838297|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
55838298|NCT01431274|Olodaterol|olodaterol|mesh-list
55838299|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55838300|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
55838301|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838302|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838303|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55838304|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
55838305|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
55838306|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55838307|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
55838308|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838309|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838310|NCT01991795|Ticagrelor|ticagrelor|mesh-list
55838311|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55838312|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55838313|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55838314|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55838315|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
55838316|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838317|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838318|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838319|NCT02076100|Ruzasvir|ruzasvir|mesh-list
55838320|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
55838321|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838323|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55838324|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838325|NCT01411774|Renal Agents|renal agents|mesh-ancestor
55838326|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55838327|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
55838328|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55838329|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
55838330|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838331|NCT01410604|Metformin|metformin|mesh-list
55838332|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55838333|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838334|NCT01410448|Cyclosporine|cyclosporine|mesh-list
55838391|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55838392|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838393|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55838394|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55838395|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
55838397|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838398|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55838399|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838400|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838401|NCT01989455|Deferiprone|deferiprone|mesh-list
55838402|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55838403|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
55838404|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
55838405|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838406|NCT01987895|Vancomycin|vancomycin|mesh-list
55838407|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
55838408|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55838409|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838410|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55838411|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838412|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838413|NCT01618669|Regadenoson|regadenoson|mesh-list
55838414|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
55838415|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
55838416|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
55838434|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55838435|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
55838436|NCT01429792|Ribavirin|ribavirin|mesh-list
55838437|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
55838438|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
55838439|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838440|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
55838441|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838442|NCT01940887|Bevacizumab|bevacizumab|mesh-list
55838443|NCT01940887|Aflibercept|aflibercept|mesh-list
55838444|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838445|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838446|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55838447|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55838448|NCT01940887|Growth Substances|growth substances|mesh-ancestor
55838449|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838450|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
55838451|NCT01925612|Prednisone|prednisone|mesh-list
55838452|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
55838454|NCT01925612|Doxorubicin|doxorubicin|mesh-list
55838455|NCT01925612|Vincristine|vincristine|mesh-list
55838456|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55838457|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55838458|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55838459|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
55838460|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838461|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838462|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55838463|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
55838464|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838465|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838466|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55838476|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55838477|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55838478|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
55838479|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
55838480|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
55838481|NCT02093663|Mesalamine|mesalamine|mesh-list
55838482|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55838483|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55838484|NCT02093663|Analgesics|analgesics|mesh-ancestor
55838485|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
55838486|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838487|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838488|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55838489|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838490|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
55838492|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55838494|NCT01408888|Incretins|incretins|mesh-ancestor
55838495|NCT01408888|Hormones|hormones|mesh-ancestor
55838496|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838497|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55838498|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
55838499|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838500|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838501|NCT01918033|Desloratadine|desloratadine|mesh-list
55838502|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55838518|NCT01390402|Busulfan|busulfan|mesh-list
55838525|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55838526|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838527|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55838528|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
55838529|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838530|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838531|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
55838532|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838533|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55838534|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55838535|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
55838536|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838537|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55838538|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
55838539|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838540|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55838541|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
55838542|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55838543|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55838544|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55838545|NCT01390402|Analgesics|analgesics|mesh-ancestor
55838546|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
55838547|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838548|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55838549|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55838550|NCT04661683|Charcoal|charcoal|mesh-list
55838551|NCT04661683|Antidotes|antidotes|mesh-ancestor
55838552|NCT04661683|Protective Agents|protective agents|mesh-ancestor
55838553|NCT04661683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838554|NCT01428076|Polidocanol|polidocanol|mesh-list
55838555|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55838556|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55838557|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55838558|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838559|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55838560|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838893|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
55838561|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838562|NCT02093351|Tamoxifen|tamoxifen|mesh-list
55838563|NCT02093351|Letrozole|letrozole|mesh-list
55838564|NCT02093351|Olaparib|olaparib|mesh-list
55838565|NCT02093351|Anastrozole|anastrozole|mesh-list
55838566|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838567|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55838568|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55838569|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838570|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838571|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55838572|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
55838573|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838574|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838575|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55838576|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55838577|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55838578|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55838579|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55838580|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
55838581|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
55838582|NCT02078284|Protective Agents|protective agents|mesh-ancestor
55838583|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838584|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55838585|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
55838586|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838588|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55838589|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838590|NCT01940497|Paclitaxel|paclitaxel|mesh-list
55838591|NCT01940497|Docetaxel|docetaxel|mesh-list
55838592|NCT01940497|Doxorubicin|doxorubicin|mesh-list
55838593|NCT01940497|Trastuzumab|trastuzumab|mesh-list
55838594|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55838599|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838600|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55838601|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55838602|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55838603|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838604|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838605|NCT01987505|Rituximab|rituximab|mesh-list
55838606|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838607|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838608|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
55838609|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838610|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838611|NCT01923896|Cycloserine|cycloserine|mesh-list
55838612|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55838613|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838614|NCT01923896|Renal Agents|renal agents|mesh-ancestor
55838615|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55838616|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
55838617|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55838618|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
55838619|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838620|NCT01938625|Cyclosporine|cyclosporine|mesh-list
55838621|NCT01938625|Ribavirin|ribavirin|mesh-list
55838622|NCT01938625|Simeprevir|simeprevir|mesh-list
55838623|NCT01938625|Tacrolimus|tacrolimus|mesh-list
55838624|NCT01938625|Cyclosporins|cyclosporins|mesh-list
55838625|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55838626|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
55838627|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838638|NCT01975675|Sofosbuvir|sofosbuvir|mesh-list
55838646|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838647|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55838648|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
55838650|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838651|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55838652|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838653|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55838654|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
55838655|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838656|NCT04624399|Atezolizumab|atezolizumab|mesh-list
55838657|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838658|NCT01915849|Licogliflozin|licogliflozin|mesh-list
55838659|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55838660|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838661|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55838662|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838663|NCT01915303|Cabergoline|cabergoline|mesh-list
55838664|NCT01915303|Pasireotide|pasireotide|mesh-list
55838665|NCT01915303|Hormones|hormones|mesh-ancestor
55838666|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55838667|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838668|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55838669|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55838670|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
55838671|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
55838672|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838673|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838675|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55838676|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838677|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
55838678|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55838679|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
55838680|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
55838681|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838683|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838684|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838685|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
55838686|NCT01937299|Travoprost|travoprost|mesh-list
55838691|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55838692|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55838693|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55838694|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
55838695|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838696|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838697|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838698|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
55838699|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838700|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55838701|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
55838703|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
55838704|NCT01597557|Analgesics|analgesics|mesh-ancestor
55838705|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
55838706|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838707|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838708|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
55838709|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55838710|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55838711|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
55838712|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55838713|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55838714|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838719|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55838720|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
55838721|NCT02003573|Decitabine|decitabine|mesh-list
55838722|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55838723|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
55838724|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838725|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838726|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838727|NCT01789281|Everolimus|everolimus|mesh-list
55838728|NCT01789281|Octreotide|octreotide|mesh-list
55838729|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838730|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55838731|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
55838732|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838733|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55838734|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55838735|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
55838736|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55838737|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838738|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55838739|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55838740|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838741|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838742|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838743|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55838769|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55838770|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55838771|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55838772|NCT01617187|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55838773|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55838774|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55838775|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838776|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838777|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
55838778|NCT01759407|Epinephrine|epinephrine|mesh-list
55838780|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55838781|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
55838782|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55838783|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838784|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838785|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55838786|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55838787|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
55838788|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838789|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55838790|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
55838793|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55838794|NCT01787331|Itraconazole|itraconazole|mesh-list
55838795|NCT01787331|Antifungal Agents|antifungal agents|mesh-ancestor
55838796|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838797|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55838798|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55838799|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838801|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55838804|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838805|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55838806|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
55838807|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
55838808|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55838809|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
55838810|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838811|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838812|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55838813|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
55838814|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55838815|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55838826|NCT01786707|Metformin|metformin|mesh-list
55838863|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
55838864|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838865|NCT01785615|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55838866|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55838867|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838868|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55838869|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838870|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55838871|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838872|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838873|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
55838874|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
55838875|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55838876|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55838877|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55838878|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838879|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838880|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55838881|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
55838882|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55838883|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838884|NCT01783821|Budesonide|budesonide|mesh-list
55838885|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
55838886|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55838887|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55838889|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838890|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838891|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55838892|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
55838904|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838905|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55838906|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55838907|NCT01608087|Growth Substances|growth substances|mesh-ancestor
55838908|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838909|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
55838910|NCT01912963|Trastuzumab|trastuzumab|mesh-list
55838912|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838913|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838914|NCT01912807|Ondansetron|ondansetron|mesh-list
55838915|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
55838916|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
55838917|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838918|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838919|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55838920|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
55838921|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
55838922|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55838923|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
55838959|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
55838960|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55838961|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55838962|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55838963|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838964|NCT01910389|Urological Agents|urological agents|mesh-ancestor
55838966|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
55838967|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
55838968|NCT01932697|Docetaxel|docetaxel|mesh-list
55838969|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838970|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
55838971|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
55838972|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
55838973|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838974|NCT01970527|Ipilimumab|ipilimumab|mesh-list
55838975|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838976|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838977|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55838978|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55838979|NCT01408576|Epratuzumab|epratuzumab|mesh-list
55838980|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55838981|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55838982|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
55838983|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
55838984|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
55838985|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55838986|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838987|NCT01427608|Olanzapine|olanzapine|mesh-list
55838988|NCT01427608|Sertraline|sertraline|mesh-list
55838989|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
55838990|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
55838991|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55838992|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55838993|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55838994|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55838995|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55838996|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55838997|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55838998|NCT01427608|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55838999|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55839000|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55839001|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839002|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839003|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
55839004|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
55839005|NCT01408030|Bevacizumab|bevacizumab|mesh-list
55839006|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
55839007|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
55839009|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55839010|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839011|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55839012|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55839013|NCT01408030|Growth Substances|growth substances|mesh-ancestor
55839014|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839015|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
55839048|NCT01896128|Modafinil|modafinil|mesh-list
55839049|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55839050|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839051|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55839052|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55839053|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55839054|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839055|NCT01949870|Gemcitabine|gemcitabine|mesh-list
55839056|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839057|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55839058|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
55839059|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839060|NCT01949870|Antiviral Agents|antiviral agents|mesh-ancestor
55839061|NCT01949870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839062|NCT01949870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839063|NCT01949870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55839064|NCT01949870|Immunologic Factors|immunologic factors|mesh-ancestor
55839065|NCT01949870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839103|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55839104|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55839105|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55839106|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839107|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55839108|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55839109|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839110|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
55839111|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55839112|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
55839113|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55839114|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
55839115|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
55839116|NCT01426438|Vitamins|vitamins|mesh-ancestor
55839117|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
55839118|NCT01782495|Ritonavir|ritonavir|mesh-list
55839119|NCT01782495|Ribavirin|ribavirin|mesh-list
55839120|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55839121|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55839122|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
55839123|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839124|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839125|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55839126|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55839127|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
55839128|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839129|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55839152|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55839153|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839154|NCT01754259|Ranolazine|ranolazine|mesh-list
55839155|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55839156|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55839157|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839158|NCT01405456|Eplerenone|eplerenone|mesh-list
55839159|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55839160|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
55839161|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839162|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839163|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55839164|NCT01405456|Diuretics|diuretics|mesh-ancestor
55839165|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
55839166|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55839167|NCT01404208|Cycloserine|cycloserine|mesh-list
55839168|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55839169|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839170|NCT01404208|Renal Agents|renal agents|mesh-ancestor
55839171|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55839172|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
55839173|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55839174|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
55839175|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839176|NCT01617668|Paclitaxel|paclitaxel|mesh-list
55839177|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55839178|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839179|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
55839183|NCT01896050|Tamoxifen|tamoxifen|mesh-list
55839195|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839196|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55839197|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55839198|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55839199|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55839201|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55839202|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55839203|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55839204|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839205|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55839206|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839207|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
55839208|NCT01424644|Vaccines|vaccines|mesh-list
55839209|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
55839211|NCT01424566|Nabiximols|nabiximols|mesh-list
55839254|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839255|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55839256|NCT01402492|Naltrexone|naltrexone|mesh-list
55839257|NCT01402492|Buprenorphine|buprenorphine|mesh-list
55839258|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55839259|NCT01402492|Naloxone|naloxone|mesh-list
55839260|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55839261|NCT01402492|Narcotics|narcotics|mesh-ancestor
55839262|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839263|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839265|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
55839266|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839267|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55839268|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55839269|NCT01894256|Olaparib|olaparib|mesh-list
55839270|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55839271|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839272|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839273|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839274|NCT01780935|Ranibizumab|ranibizumab|mesh-list
55839275|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55839276|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55839277|NCT01780935|Growth Substances|growth substances|mesh-ancestor
55839278|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839279|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
55839280|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839281|NCT01422538|Mannitol|mannitol|mesh-list
55839282|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
55839283|NCT01422538|Diuretics|diuretics|mesh-ancestor
55839284|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
55839285|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839286|NCT04026256|Denosumab|denosumab|mesh-list
55839287|NCT04026256|Teriparatide|teriparatide|mesh-list
55839296|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839297|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55839298|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839299|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
55839300|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55839301|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55839302|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55839303|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
55839304|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839305|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55839306|NCT01401322|Lenalidomide|lenalidomide|mesh-list
55839307|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
55839308|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839309|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55839310|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55839311|NCT01401322|Growth Substances|growth substances|mesh-ancestor
55839354|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55839355|NCT01387516|Nicotine|nicotine|mesh-list
55839356|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55839357|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
55839358|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839359|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839360|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55839361|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55839362|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
55839363|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839364|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839365|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
55839366|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55839367|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55839368|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839369|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839370|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55839371|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
55839372|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55839373|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55839374|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
55839375|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839376|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839404|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839405|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839407|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839408|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
55839409|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
55839410|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
55839411|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839412|NCT01780389|Milnacipran|milnacipran|mesh-list
55839413|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
55839568|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55839414|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55839415|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55839416|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55839417|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839418|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839420|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55839461|NCT01399372|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55839462|NCT01399372|Tubulin Modulators|tubulin modulators|mesh-ancestor
55839463|NCT01399372|Antimitotic Agents|antimitotic agents|mesh-ancestor
55839464|NCT01399372|Mitosis Modulators|mitosis modulators|mesh-ancestor
55839465|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
55839467|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
55839468|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
55839469|NCT01385098|Vitamins|vitamins|mesh-list
55839470|NCT01385098|Calcium|calcium|mesh-list
55839471|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
55839472|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839473|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55839474|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55839475|NCT01398514|Citalopram|citalopram|mesh-list
55839476|NCT01398514|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55839477|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55839478|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55839479|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839480|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839481|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
55839482|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839483|NCT01398514|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55839484|NCT01398514|Antidepressive Agents|antidepressive agents|mesh-ancestor
55839485|NCT01398514|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55839486|NCT03025282|Betamethasone|betamethasone|mesh-list
55839487|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
55839488|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55839507|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839508|NCT01777581|Milnacipran|milnacipran|mesh-list
55839509|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
55839510|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55839511|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55839512|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55839513|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839514|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839515|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839516|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55839517|NCT01777581|Analgesics|analgesics|mesh-ancestor
55839518|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
55839519|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839520|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
55839521|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55839522|NCT01864148|Interferons|interferons|mesh-list
55839523|NCT01864148|Interferon-beta|interferon-beta|mesh-list
55839524|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
55839525|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839526|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
55839527|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839528|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
55839529|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839530|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55839531|NCT01890122|Metformin|metformin|mesh-list
55839532|NCT01890122|Alogliptin|alogliptin|mesh-list
55839533|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55839534|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839555|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839556|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55839557|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55839558|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55839559|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
55839560|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839561|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839562|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
55839563|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55839564|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
55839565|NCT01777269|Tamsulosin|tamsulosin|mesh-list
55839566|NCT01777269|Dutasteride|dutasteride|mesh-list
55839567|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
55839570|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
55839571|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839572|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839573|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839574|NCT01777269|Urological Agents|urological agents|mesh-ancestor
55839575|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55839576|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55839577|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839578|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
55839579|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839580|NCT04024696|Abexinostat|abexinostat|mesh-list
55839581|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55839582|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839583|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839584|NCT01777191|Ixekizumab|ixekizumab|mesh-list
55839585|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
55839593|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55839594|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
55839595|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839596|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839597|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
55839598|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
55839599|NCT01775475|Prednisone|prednisone|mesh-list
55839600|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
55839601|NCT01775475|Lomustine|lomustine|mesh-list
55839602|NCT01775475|Doxorubicin|doxorubicin|mesh-list
55839603|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55839604|NCT01775475|Etoposide|etoposide|mesh-list
55839605|NCT01775475|Vincristine|vincristine|mesh-list
55839606|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
55839607|NCT01775475|Procarbazine|procarbazine|mesh-list
55839608|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55839609|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
55839610|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839611|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55839612|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55839613|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
55839614|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839615|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839616|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55839617|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55839618|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55839619|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55839641|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
55839642|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
55839643|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55839644|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839645|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839646|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55839647|NCT01774305|Analgesics|analgesics|mesh-ancestor
55839648|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
55839649|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839650|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55839651|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55839652|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55839653|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
55839654|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839655|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839656|NCT01397422|Amantadine|amantadine|mesh-list
55839657|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55839658|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55839659|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
55839660|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839661|NCT01397422|Dopamine Agents|dopamine agents|mesh-ancestor
55839662|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839663|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839664|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839665|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55839666|NCT01397422|Analgesics|analgesics|mesh-ancestor
55839667|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
55839668|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839669|NCT01736475|Factor VIII|factor viii|mesh-list
55839670|NCT01736475|BAX 855|bax 855|mesh-list
55839671|NCT01736475|Coagulants|coagulants|mesh-ancestor
55839674|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
55839681|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839682|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839683|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55839684|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
55839685|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
55839686|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55839687|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55839688|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55839689|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55839690|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
55839691|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839692|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839693|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55839694|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
55839695|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55839696|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55839697|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55839698|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55839699|NCT01886690|Laxatives|laxatives|mesh-ancestor
55839700|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55839701|NCT04590404|Nicotine|nicotine|mesh-list
55839702|NCT04590404|Varenicline|varenicline|mesh-list
55839703|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55839704|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
55839705|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839706|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839707|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55839708|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55839709|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
55839710|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839712|NCT01885208|Exenatide|exenatide|mesh-list
55839725|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839726|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839727|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55839728|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
55839730|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839731|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55839732|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839733|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55839734|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55839735|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839736|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55839737|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55839738|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839739|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839740|NCT01747551|Leucovorin|leucovorin|mesh-list
55839741|NCT01747551|Fluorouracil|fluorouracil|mesh-list
55839742|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
55839743|NCT01747551|Aflibercept|aflibercept|mesh-list
55839744|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
55839745|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839746|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55839747|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839748|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55839749|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
55839750|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839751|NCT01747551|Antidotes|antidotes|mesh-ancestor
55839752|NCT01747551|Protective Agents|protective agents|mesh-ancestor
55839753|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
55839754|NCT01747551|Vitamins|vitamins|mesh-ancestor
55839760|NCT01859390|Antioxidants|antioxidants|mesh-list
55839769|NCT01746225|Mitosis Modulators|mitosis modulators|mesh-ancestor
55839770|NCT01746225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839771|NCT01858766|Ribavirin|ribavirin|mesh-list
55839772|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
55839773|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839774|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
55839775|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839776|NCT01745367|Paclitaxel|paclitaxel|mesh-list
55839777|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55839778|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839779|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
55839780|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
55839781|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
55840045|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55839782|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839783|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
55839784|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55839785|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55839786|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55839787|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839788|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
55839789|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55839790|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839791|NCT01383928|Dexamethasone|dexamethasone|mesh-list
55839792|NCT01383928|Lenalidomide|lenalidomide|mesh-list
55839819|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
55839820|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839821|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839822|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55839823|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
55839824|NCT05368012|Hormones|hormones|mesh-ancestor
55839825|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839826|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55839827|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839828|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
55839829|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
55839830|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839831|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
55839832|NCT01606137|Nabiximols|nabiximols|mesh-list
55839833|NCT01606137|Analgesics|analgesics|mesh-ancestor
55839834|NCT01606137|Sensory System Agents|sensory system agents|mesh-ancestor
55839835|NCT01606137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839836|NCT01606137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839837|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
55839838|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55839839|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55839840|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839841|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
55839842|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
55839843|NCT01381900|Metformin|metformin|mesh-list
55839844|NCT01381900|Canagliflozin|canagliflozin|mesh-list
55839845|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55839846|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839847|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55839848|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839849|NCT01744197|Lidocaine|lidocaine|mesh-list
55839850|NCT01744197|Tetracaine|tetracaine|mesh-list
55839851|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
55839852|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
55839853|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839854|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839855|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
55839856|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839857|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55839858|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55839859|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55839860|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55839861|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839863|NCT04565301|Neostigmine|neostigmine|mesh-list
55839864|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55839865|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
55839866|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
55839867|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55839868|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839870|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
55839871|NCT04565301|Hormones|hormones|mesh-ancestor
55839872|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55839873|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55839874|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839875|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55839876|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839877|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839898|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839899|NCT01380730|Evolocumab|evolocumab|mesh-list
55839900|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55839901|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55839902|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55839903|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
55839904|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839905|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55839906|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
55839907|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839908|NCT04010968|Venetoclax|venetoclax|mesh-list
55839909|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839910|NCT01395784|Pioglitazone|pioglitazone|mesh-list
55839911|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55839912|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839913|NCT01380184|Sirolimus|sirolimus|mesh-list
55839914|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55839915|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839916|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55839917|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839918|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
55839919|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55839920|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
55839921|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839922|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
55839924|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839948|NCT01614795|Sirolimus|sirolimus|mesh-list
55839949|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55839950|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55839951|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55839952|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55839953|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839954|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
55839955|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55839956|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
55839957|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839958|NCT01834586|Anesthetics|anesthetics|mesh-list
55839959|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55839960|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839961|NCT01614093|Oxytocin|oxytocin|mesh-list
55839962|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
55839963|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55839964|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55839965|NCT04559607|Apatinib|apatinib|mesh-list
55839966|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55839967|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55839968|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55839969|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55839970|NCT01834274|Metformin|metformin|mesh-list
55840000|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840001|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840002|NCT01738503|Analgesics|analgesics|mesh-ancestor
55840003|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
55840004|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840005|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55840006|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
55840007|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55840008|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55840009|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55840162|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
55840010|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840011|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
55840012|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840013|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840015|NCT01737879|Hematinics|hematinics|mesh-ancestor
55840016|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
55840017|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
55840018|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55840019|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840020|NCT01726335|Risperidone|risperidone|mesh-list
55840021|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55840022|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
55840023|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840024|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840025|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840026|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55840027|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55840028|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840031|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
55840042|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840043|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55840044|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55840046|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55840047|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840048|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840049|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
55840050|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840051|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
55840052|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55840053|NCT04609761|Antibodies|antibodies|mesh-list
55840054|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
55840055|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55840056|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
55840057|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840058|NCT01858532|Atrasentan|atrasentan|mesh-list
55840059|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840060|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55840061|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55840062|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840063|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
55840064|NCT04613960|Analgesics|analgesics|mesh-ancestor
55840065|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
55840066|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840067|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840068|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
55840069|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840070|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55840071|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
55840072|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55840073|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55840074|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840075|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55840076|NCT04613960|Tocolytic Agents|tocolytic agents|mesh-ancestor
55840080|NCT03361436|Antimitotic Agents|antimitotic agents|mesh-ancestor
55840081|NCT03361436|Mitosis Modulators|mitosis modulators|mesh-ancestor
55840082|NCT03361436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840083|NCT03361436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840084|NCT04599140|Nivolumab|nivolumab|mesh-list
55840085|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55840086|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840148|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840149|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
55840150|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840151|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55840152|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55840153|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
55840154|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55840155|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55840156|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55840157|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55840158|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
55840159|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
55840160|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840161|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55840163|NCT01875237|Hormones|hormones|mesh-ancestor
55840164|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840165|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55840166|NCT01875237|Protective Agents|protective agents|mesh-ancestor
55840167|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55840168|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55840169|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
55840200|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840201|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840202|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
55840203|NCT01720797|Anesthetics|anesthetics|mesh-list
55840204|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
55840205|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840206|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840207|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55840208|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840209|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
55840210|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
55840211|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840212|NCT01831466|Tofacitinib|tofacitinib|mesh-list
55840213|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55840265|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840266|NCT01880528|Lisinopril|lisinopril|mesh-list
55840267|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55840268|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
55840269|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840270|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840271|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55840272|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55840273|NCT01880528|Protective Agents|protective agents|mesh-ancestor
55840274|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840275|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
55840276|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
55840277|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840278|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840279|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840280|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
55840281|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
55840282|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
55840283|NCT01854710|Loxapine|loxapine|mesh-list
55840284|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55840288|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840293|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55840294|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840295|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55840296|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55840297|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
55840298|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840299|NCT01828034|Gemcitabine|gemcitabine|mesh-list
55840300|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840301|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55840302|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
55840303|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840304|NCT01828034|Antiviral Agents|antiviral agents|mesh-ancestor
55840305|NCT01828034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840306|NCT01828034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840307|NCT01828034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55840308|NCT01828034|Immunologic Factors|immunologic factors|mesh-ancestor
55840309|NCT01828034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840310|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
55840311|NCT01853696|Prednisolone|prednisolone|mesh-list
55840312|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55840313|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
55840314|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55840315|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
55840316|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55840317|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
55840318|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55840319|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
55840341|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
55840342|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840343|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840344|NCT01853618|Tremelimumab|tremelimumab|mesh-list
55840345|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840346|NCT01719783|Vaccines|vaccines|mesh-list
55840347|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
55840348|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840349|NCT01719237|Ropivacaine|ropivacaine|mesh-list
55840353|NCT01719237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840354|NCT01719237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840355|NCT01719237|Sensory System Agents|sensory system agents|mesh-ancestor
55840356|NCT01719237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840357|NCT01878890|Efavirenz|efavirenz|mesh-list
55840358|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55840359|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55840360|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840361|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840362|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
55840363|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840364|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
55840365|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55840366|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
55840367|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55840388|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55840389|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
55840390|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840391|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840392|NCT01705587|Teriparatide|teriparatide|mesh-list
55840393|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55840394|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840395|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55840396|NCT01705509|Ranolazine|ranolazine|mesh-list
55840397|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55840398|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55840399|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840400|NCT01853072|Prednisolone|prednisolone|mesh-list
55840401|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55840402|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
55840447|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840448|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840449|NCT04605393|Hormones|hormones|mesh-ancestor
55840450|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840451|NCT01827254|Sunitinib|sunitinib|mesh-list
55840452|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840453|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55840454|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55840455|NCT01827254|Growth Substances|growth substances|mesh-ancestor
55840456|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840457|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
55840458|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55840459|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840460|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840461|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
55840462|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
55840463|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55840464|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55840465|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55840466|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840467|NCT01704651|Alvimopan|alvimopan|mesh-list
55840468|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55840469|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
55840470|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840471|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55840472|NCT01876082|Methotrexate|methotrexate|mesh-list
55840491|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
55840492|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
55840493|NCT01716585|Ribavirin|ribavirin|mesh-list
55840494|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
55840495|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840496|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
55840497|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840498|NCT01852292|Paclitaxel|paclitaxel|mesh-list
55840499|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55840500|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840501|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
55840502|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
55840503|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
55840504|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840505|NCT01715805|Cariprazine|cariprazine|mesh-list
55840506|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
55840510|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840511|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840512|NCT01852214|Ticagrelor|ticagrelor|mesh-list
55840513|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
55840514|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55840515|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55840516|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55840517|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55840518|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
55840519|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840520|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840521|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840522|NCT04594772|Gemcitabine|gemcitabine|mesh-list
55840523|NCT04594772|Paclitaxel|paclitaxel|mesh-list
55840533|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840534|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55840535|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
55840536|NCT04594772|Antiviral Agents|antiviral agents|mesh-ancestor
55840537|NCT04594772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840538|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840539|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55840540|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
55840541|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840542|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55840543|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55840544|NCT01393990|Tamoxifen|tamoxifen|mesh-list
55840545|NCT01393990|Midazolam|midazolam|mesh-list
55840546|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55840547|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55840548|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840549|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840550|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55840551|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55840552|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55840553|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55840554|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
55840555|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
55840556|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
55840557|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
55840558|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840559|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840560|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55840561|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
55840562|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840563|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55840564|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840565|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55840566|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55840567|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55840568|NCT00210184|Leucovorin|leucovorin|mesh-list
55840570|NCT00210184|Irinotecan|irinotecan|mesh-list
55840571|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
55840572|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840573|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55840574|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840575|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55840576|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
55840577|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840578|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55840579|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55840580|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840581|NCT00210184|Antidotes|antidotes|mesh-ancestor
55840582|NCT00210184|Protective Agents|protective agents|mesh-ancestor
55840583|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
55840584|NCT00210184|Vitamins|vitamins|mesh-ancestor
55840585|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
55840586|NCT05364190|Empagliflozin|empagliflozin|mesh-list
55840587|NCT05364190|Canagliflozin|canagliflozin|mesh-list
55840588|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55840589|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840591|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840592|NCT00210964|Linezolid|linezolid|mesh-list
55840593|NCT00210964|Ceftazidime|ceftazidime|mesh-list
55840594|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
55840595|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
55840596|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55840597|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840616|NCT05630638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55840617|NCT05630638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840618|NCT05630638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840619|NCT05630638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55840620|NCT05630638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55840621|NCT05630638|Antiviral Agents|antiviral agents|mesh-ancestor
55840622|NCT05630638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840624|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
55840625|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
55840626|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
55840627|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840628|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840629|NCT03792958|Vorolanib|vorolanib|mesh-list
55840630|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55840631|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840632|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840633|NCT03789604|Antibodies|antibodies|mesh-list
55840634|NCT03789604|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55840635|NCT03789604|Immunologic Factors|immunologic factors|mesh-ancestor
55840636|NCT03789604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840637|NCT03598426|Dexamethasone|dexamethasone|mesh-list
55840638|NCT03598426|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55840639|NCT03598426|Antiemetics|antiemetics|mesh-ancestor
55840640|NCT03598426|Autonomic Agents|autonomic agents|mesh-ancestor
55840641|NCT03598426|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840642|NCT03598426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840643|NCT03598426|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55840644|NCT03598426|Glucocorticoids|glucocorticoids|mesh-ancestor
55840645|NCT03598426|Hormones|hormones|mesh-ancestor
55840646|NCT03598426|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840647|NCT03598426|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55840648|NCT03598426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840658|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55840659|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55840660|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840661|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55840662|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840663|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840664|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
55840665|NCT03599596|Renal Agents|renal agents|mesh-ancestor
55840666|NCT04407130|Doxycycline|doxycycline|mesh-list
55840667|NCT04407130|Ivermectin|ivermectin|mesh-list
55840668|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55840669|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840670|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
55840671|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55840672|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55840673|NCT03599284|Clopidogrel|clopidogrel|mesh-list
55840674|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55840675|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55840676|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55840677|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55840678|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
55840679|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840680|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840681|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840682|NCT05630872|Lamivudine|lamivudine|mesh-list
55840683|NCT05630872|Dolutegravir|dolutegravir|mesh-list
55840686|NCT05630872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55840706|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55840707|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55840708|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840709|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
55840710|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55840711|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840773|NCT05633758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840774|NCT05633758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55840775|NCT05633758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55840776|NCT05633758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840778|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55840779|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
55840780|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55840781|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55840782|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55840783|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55840784|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840835|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840836|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55840837|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55840838|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
55840839|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
55840840|NCT03598192|Sufentanil|sufentanil|mesh-list
55840841|NCT03598192|Dsuvia|dsuvia|mesh-list
55840842|NCT03598192|Ropivacaine|ropivacaine|mesh-list
55840843|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
55840844|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
55840845|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55840846|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840847|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
55840848|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840849|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55840850|NCT03598192|Narcotics|narcotics|mesh-ancestor
55840851|NCT03598192|Analgesics|analgesics|mesh-ancestor
55840854|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
55840894|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55840895|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
55840896|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
55840897|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55840898|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840899|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55840900|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
55840901|NCT00216736|Hormones|hormones|mesh-ancestor
55840902|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840903|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55840904|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840906|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
55840907|NCT01850030|Progestins|progestins|mesh-ancestor
55840908|NCT01850030|Hormones|hormones|mesh-ancestor
55840909|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840910|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840911|NCT00215644|Capecitabine|capecitabine|mesh-list
55840912|NCT00215644|Epirubicin|epirubicin|mesh-list
55840913|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55840950|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55840951|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55840952|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
55840953|NCT00212758|Hormones|hormones|mesh-list
55840954|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840955|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840956|NCT03592342|Clobetasol|clobetasol|mesh-list
55840957|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55840958|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
55840959|NCT03592342|Hormones|hormones|mesh-ancestor
55840960|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55840961|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840962|NCT01715415|Ribavirin|ribavirin|mesh-list
55840963|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
55840964|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55840965|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
55840966|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55840967|NCT00211510|Insulin|insulin|mesh-list
55840968|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55840969|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55840970|NCT04549311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55840971|NCT04549311|Amoxicillin|amoxicillin|mesh-list
55840972|NCT04549311|Metronidazole|metronidazole|mesh-list
55840973|NCT04549311|Ciprofloxacin|ciprofloxacin|mesh-list
55840974|NCT04549311|Clavulanic Acids|clavulanic acids|mesh-list
55840990|NCT04198636|Denosumab|denosumab|mesh-list
55841000|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841001|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55841002|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55841003|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55841004|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841005|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841007|NCT01869699|Acetaminophen|acetaminophen|mesh-list
55841008|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55841009|NCT01869699|Analgesics|analgesics|mesh-ancestor
55841010|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
55841011|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841012|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841014|NCT03981796|Paclitaxel|paclitaxel|mesh-list
55841015|NCT03981796|Carboplatin|carboplatin|mesh-list
55841016|NCT03981796|Niraparib|niraparib|mesh-list
55841017|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55841018|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841019|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
55841020|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
55841021|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
55841022|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841023|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55841051|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841052|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841053|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55841054|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
55841055|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
55841056|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55841057|NCT03595852|Cefazolin|cefazolin|mesh-list
55841058|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55841059|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841060|NCT04191382|Letrozole|letrozole|mesh-list
55841061|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841062|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55841063|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55841064|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841065|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841066|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55841067|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
55841068|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841069|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841070|NCT01703091|Docetaxel|docetaxel|mesh-list
55841071|NCT01703091|Ramucirumab|ramucirumab|mesh-list
55841072|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841073|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
55841074|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
55841075|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
55841076|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841077|NCT04196998|Tenofovir|tenofovir|mesh-list
55841078|NCT04196998|Entecavir|entecavir|mesh-list
55841079|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
55841097|NCT03956056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841098|NCT03956056|Laxatives|laxatives|mesh-ancestor
55841099|NCT03956056|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841100|NCT03956056|Antiviral Agents|antiviral agents|mesh-ancestor
55841101|NCT03956056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841102|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
55841103|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841104|NCT03967054|Ivermectin|ivermectin|mesh-list
55841105|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55841106|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841107|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
55841108|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55841110|NCT04196608|Tazobactam|tazobactam|mesh-list
55841160|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841161|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841163|NCT04021108|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55841164|NCT04021108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841165|NCT04021108|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55841166|NCT04021108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841167|NCT03594058|Solabegron|solabegron|mesh-list
55841168|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55841169|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55841170|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55841171|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
55841172|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841173|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841174|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841175|NCT03970954|Interleukin-2|interleukin-2|mesh-list
55841176|NCT03970954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841177|NCT03970954|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55841178|NCT03970954|Analgesics|analgesics|mesh-ancestor
55841179|NCT03970954|Sensory System Agents|sensory system agents|mesh-ancestor
55841180|NCT03970954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841182|NCT03970720|Metoclopramide|metoclopramide|mesh-list
55841183|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
55841206|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841207|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55841209|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55841210|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55841211|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841212|NCT04194034|Flucytosine|flucytosine|mesh-list
55841213|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
55841214|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841215|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
55841216|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841218|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55841219|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841220|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
55841221|NCT04027972|Neostigmine|neostigmine|mesh-list
55841222|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55841223|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841224|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841225|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
55841226|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841227|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841228|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
55841229|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
55841230|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841231|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55841232|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55841233|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55841234|NCT04191928|Apixaban|apixaban|mesh-list
55841235|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55841236|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
55841237|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55841238|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
55841248|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841249|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55841250|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55841251|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55841252|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55841253|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
55841255|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
55841256|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
55841257|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841258|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841259|NCT04406506|Erythromycin|erythromycin|mesh-list
55841260|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
55841261|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
55841262|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
55841263|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55841264|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841265|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841266|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55841267|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841268|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841270|NCT03828292|Bortezomib|bortezomib|mesh-list
55841271|NCT03828292|Pomalidomide|pomalidomide|mesh-list
55841272|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55841273|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
55841274|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
55841275|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841276|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841277|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841278|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
55841279|NCT03828292|Hormones|hormones|mesh-ancestor
55841282|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841292|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841293|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841294|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
55841295|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
55841296|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55841297|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
55841298|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841299|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841300|NCT04191694|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55841301|NCT04191694|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55841302|NCT04191694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841303|NCT04191694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55841304|NCT04191694|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55841306|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55841307|NCT04026022|Narcotics|narcotics|mesh-ancestor
55841308|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841309|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841310|NCT04026022|Analgesics|analgesics|mesh-ancestor
55841311|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
55841312|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841313|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55841314|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55841315|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
55841316|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
55841317|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55841318|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841319|NCT04020328|Prednisone|prednisone|mesh-list
55841320|NCT04020328|Leflunomide|leflunomide|mesh-list
55841321|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55841322|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
55841323|NCT04020328|Hormones|hormones|mesh-ancestor
55841324|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841327|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841334|NCT02080468|Norgestimate|norgestimate|mesh-list
55841335|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55841336|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
55841337|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55841338|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841339|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55841340|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55841341|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55841342|NCT04020016|Nalbuphine|nalbuphine|mesh-list
55841343|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55841344|NCT04020016|Narcotics|narcotics|mesh-ancestor
55841345|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841346|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841347|NCT04020016|Analgesics|analgesics|mesh-ancestor
55841348|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
55841349|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841350|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55841351|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55841352|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55841353|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
55841354|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841386|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
55841387|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
55841388|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
55841389|NCT04026880|Androgens|androgens|mesh-ancestor
55841395|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
55841454|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841455|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
55841456|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55841458|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841523|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55841524|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841525|NCT02708680|Atezolizumab|atezolizumab|mesh-list
55841526|NCT02708680|Entinostat|entinostat|mesh-list
55841527|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841528|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55841529|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841530|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841531|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
55841532|NCT03931642|Blinatumomab|blinatumomab|mesh-list
55841533|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841534|NCT04021420|Nivolumab|nivolumab|mesh-list
55841585|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55841586|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55841588|NCT01711359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55841589|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55841590|NCT01711359|Hematinics|hematinics|mesh-ancestor
55841591|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
55841592|NCT01711359|Vitamins|vitamins|mesh-ancestor
55841593|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
55841595|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55841596|NCT04149964|Oxycodone|oxycodone|mesh-list
55841597|NCT04149964|Hydrocodone|hydrocodone|mesh-list
55841598|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55841600|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
55841601|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841602|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841646|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841647|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841648|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841649|NCT04146610|Antibodies|antibodies|mesh-list
55841650|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
55841651|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
55841652|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841653|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
55841654|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55841655|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55841656|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841657|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
55841658|NCT04146376|Coagulants|coagulants|mesh-ancestor
55841659|NCT01710657|Lacosamide|lacosamide|mesh-list
55841660|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
55841661|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55841662|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55841663|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55841664|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841665|NCT04145518|Naproxen|naproxen|mesh-list
55841668|NCT04145518|Analgesics|analgesics|mesh-ancestor
55841699|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841700|NCT05581420|Ferrous fumarate|ferrous fumarate|mesh-list
55841701|NCT05581420|Trace Elements|trace elements|mesh-ancestor
55841702|NCT05581420|Micronutrients|micronutrients|mesh-ancestor
55841703|NCT05581420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841704|NCT03904498|Tolcapone|tolcapone|mesh-list
55841705|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55841706|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55841707|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
55841708|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841709|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841710|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
55841711|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
55841712|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55841760|NCT05580094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841761|NCT05580094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841762|NCT05589766|Niacinamide|niacinamide|mesh-list
55841763|NCT05589766|Niacin|niacin|mesh-list
55841764|NCT05589766|Nicotinic Acids|nicotinic acids|mesh-list
55841765|NCT05589766|Vitamin B Complex|vitamin b complex|mesh-ancestor
55841766|NCT05589766|Vitamins|vitamins|mesh-ancestor
55841767|NCT05589766|Micronutrients|micronutrients|mesh-ancestor
55841768|NCT05589766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841769|NCT05589766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55841770|NCT05589766|Antimetabolites|antimetabolites|mesh-ancestor
55841771|NCT05589766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841772|NCT05589766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55841773|NCT05589766|Vasodilator Agents|vasodilator agents|mesh-ancestor
55841774|NCT05586100|Cetuximab|cetuximab|mesh-list
55841775|NCT05586100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55841776|NCT05586100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841777|NCT05585086|Peppermint oil|peppermint oil|mesh-list
55841778|NCT05585086|Antiemetics|antiemetics|mesh-ancestor
55841779|NCT05585086|Autonomic Agents|autonomic agents|mesh-ancestor
55841780|NCT05585086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841781|NCT05585086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841782|NCT05585086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55841783|NCT05585086|Parasympatholytics|parasympatholytics|mesh-ancestor
55841784|NCT01710501|Interferons|interferons|mesh-list
55841785|NCT01710501|Ribavirin|ribavirin|mesh-list
55841786|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
55841787|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
55841788|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55841789|NCT01710501|Grazoprevir|grazoprevir|mesh-list
55841790|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841791|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
55841792|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55841793|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
55841795|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
55841804|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841805|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841806|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55841807|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55841810|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841811|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55841812|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55841813|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841814|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841815|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55841816|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55841817|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55841818|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55841819|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55841820|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
55841821|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
55841822|NCT04143880|Progesterone|progesterone|mesh-list
55841823|NCT04143880|Progestins|progestins|mesh-ancestor
55841824|NCT04143880|Hormones|hormones|mesh-ancestor
55841825|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841856|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
55841857|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
55841858|NCT04143412|Ramipril|ramipril|mesh-list
55841859|NCT04143412|Eplerenone|eplerenone|mesh-list
55841860|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55841861|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
55841862|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841863|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841864|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55841865|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55841866|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
55841867|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55841868|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841869|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55841870|NCT04143412|Diuretics|diuretics|mesh-ancestor
55841871|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
55841872|NCT05582278|Lenvatinib|lenvatinib|mesh-list
55841873|NCT05582278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55841874|NCT05582278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55841875|NCT05582278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55841876|NCT05582278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841877|NCT05582278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841878|NCT01710033|Tofacitinib|tofacitinib|mesh-list
55841879|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55841880|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841881|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841882|NCT01822496|Paclitaxel|paclitaxel|mesh-list
55841883|NCT01822496|Etoposide|etoposide|mesh-list
55841884|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
55841885|NCT01822496|Cisplatin|cisplatin|mesh-list
55841886|NCT01822496|Carboplatin|carboplatin|mesh-list
55841887|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55841888|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
55841889|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55841890|NCT01822496|Crizotinib|crizotinib|mesh-list
55841891|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55841894|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
55841895|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
55841896|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841897|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55841898|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55841899|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841900|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55841901|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
55841902|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
55841903|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
55841904|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
55841905|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55841906|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841907|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
55841908|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55841909|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841910|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841911|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55841913|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
55841914|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55841915|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55841916|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55841939|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55841940|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55841941|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
55841943|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841944|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55841945|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55841946|NCT03896230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841947|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841949|NCT05580328|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55841950|NCT05580328|Dermatologic Agents|dermatologic agents|mesh-ancestor
55841951|NCT03588676|Melatonin|melatonin|mesh-list
55841952|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
55841953|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841954|NCT03588676|Protective Agents|protective agents|mesh-ancestor
55841955|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55841956|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55841957|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
55841958|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55841959|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
55841961|NCT01709721|Hydromorphone|hydromorphone|mesh-list
55841992|NCT01866657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55841993|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
55841994|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55841995|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55841996|NCT01866657|Protective Agents|protective agents|mesh-ancestor
55841997|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55841998|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
55841999|NCT03584152|Acetaminophen|acetaminophen|mesh-list
55842000|NCT03584152|Ibuprofen|ibuprofen|mesh-list
55842001|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842002|NCT03584152|Analgesics|analgesics|mesh-ancestor
55842003|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
55842004|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842005|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842006|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
55842007|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55842008|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842009|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842010|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55842011|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842012|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842013|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
55842014|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
55842015|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842016|NCT03589690|Protective Agents|protective agents|mesh-ancestor
55842017|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842018|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
55842019|NCT03589690|Vitamins|vitamins|mesh-ancestor
55842020|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
55842021|NCT03587194|Apremilast|apremilast|mesh-list
55842024|NCT03587194|Analgesics|analgesics|mesh-ancestor
55842036|NCT01699815|Analgesics|analgesics|mesh-ancestor
55842037|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
55842038|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842039|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842040|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
55842041|NCT03589222|Dexamethasone|dexamethasone|mesh-list
55842042|NCT03589222|Bortezomib|bortezomib|mesh-list
55842043|NCT03589222|Daratumumab|daratumumab|mesh-list
55842044|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842045|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
55842046|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
55842047|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842049|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842050|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
55842051|NCT03589222|Hormones|hormones|mesh-ancestor
55842052|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842053|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55842054|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842055|NCT03589066|Rotigotine|rotigotine|mesh-list
55842056|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
55842057|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
55842058|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842059|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842060|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842061|NCT03020368|Diclofenac|diclofenac|mesh-list
55842062|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55842063|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842064|NCT03020368|Analgesics|analgesics|mesh-ancestor
55842065|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
55842066|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842080|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
55842081|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55842082|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842083|NCT05702944|Phenoxybenzamine|phenoxybenzamine|mesh-list
55842084|NCT05702944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55842085|NCT05702944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55842086|NCT05702944|Adrenergic Agents|adrenergic agents|mesh-ancestor
55842087|NCT05702944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842088|NCT05702944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842089|NCT05702944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842146|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842147|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842149|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
55842150|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842151|NCT01698801|Dexamethasone|dexamethasone|mesh-list
55842152|NCT01698801|Lenalidomide|lenalidomide|mesh-list
55842153|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842154|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
55842155|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
55842156|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842157|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842158|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842159|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
55842160|NCT01698801|Hormones|hormones|mesh-ancestor
55842161|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842162|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55842169|NCT03735628|Nivolumab|nivolumab|mesh-list
55842204|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
55842205|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842206|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842207|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842208|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55842209|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
55842210|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842211|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55842212|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
55842213|NCT03587038|Temozolomide|temozolomide|mesh-list
55842214|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55842215|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
55842216|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842217|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842218|NCT03582124|Panitumumab|panitumumab|mesh-list
55842219|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842220|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842221|NCT01682031|Selenium|selenium|mesh-list
55842222|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
55842223|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842224|NCT01682031|Protective Agents|protective agents|mesh-ancestor
55842225|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842226|NCT01682031|Trace Elements|trace elements|mesh-ancestor
55842227|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
55842228|NCT03020134|Ritonavir|ritonavir|mesh-list
55842229|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55842230|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55842231|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
55842232|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842246|NCT03026062|Durvalumab|durvalumab|mesh-list
55842249|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
55842250|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55842251|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
55842252|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842253|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842254|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
55842255|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842256|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55842257|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842259|NCT03584074|Pregabalin|pregabalin|mesh-list
55842260|NCT03584074|Analgesics|analgesics|mesh-ancestor
55842261|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
55842262|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842263|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842264|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
55842265|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55842266|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55842267|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842268|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55842269|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55842270|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55842271|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842272|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55842273|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55842274|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842275|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842276|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842277|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55842278|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55842279|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842280|NCT03583138|Buprenorphine|buprenorphine|mesh-list
55842281|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55842289|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
55842290|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842291|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842294|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
55842295|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842297|NCT01567527|Aripiprazole|aripiprazole|mesh-list
55842298|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
55842299|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55842300|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55842301|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55842302|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842303|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842304|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
55842305|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
55842306|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842307|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842308|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55842324|NCT03159598|Urethane|urethane|mesh-list
55842344|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55842345|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55842346|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
55842347|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
55842348|NCT03582280|Calcium|calcium|mesh-list
55842349|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55842350|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842351|NCT03582280|Antacids|antacids|mesh-ancestor
55842352|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842353|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842354|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55842355|NCT03159754|Metronidazole|metronidazole|mesh-list
55842356|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
55842357|NCT03159754|Tazobactam|tazobactam|mesh-list
55842358|NCT03159754|Piperacillin|piperacillin|mesh-list
55842359|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55842360|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842361|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55842362|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55842363|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55842364|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55842365|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842366|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842367|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842368|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55842369|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55842392|NCT03158584|Narcotics|narcotics|mesh-ancestor
55842393|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842394|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842396|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
55842397|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842398|NCT04765228|Doxorubicin|doxorubicin|mesh-list
55842399|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55842400|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55842401|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842402|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55842403|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55842404|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842405|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842406|NCT05696626|Fulvestrant|fulvestrant|mesh-list
55842407|NCT05696626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55842408|NCT05696626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842409|NCT05696626|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55842410|NCT05696626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55842411|NCT05696626|Hormone Antagonists|hormone antagonists|mesh-ancestor
55842412|NCT05696626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842413|NCT05696626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842414|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55842415|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55842416|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55842417|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
55842418|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842419|NCT04140448|Ranibizumab|ranibizumab|mesh-list
55842420|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55842435|NCT03156322|Narcotics|narcotics|mesh-ancestor
55842436|NCT03156322|Analgesics|analgesics|mesh-ancestor
55842437|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55842438|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55842439|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
55842440|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
55842441|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842442|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842444|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
55842445|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
55842446|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842447|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842448|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842449|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
55842450|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
55842451|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55842452|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
55842453|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842454|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842455|NCT04140058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55842456|NCT04140058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55842457|NCT04140058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842458|NCT04140058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55842459|NCT04140058|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55842460|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
55842461|NCT04146298|Fludarabine|fludarabine|mesh-list
55842462|NCT04146298|Antibodies|antibodies|mesh-list
55842463|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55842464|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55842465|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
55842466|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842473|NCT02899078|Nivolumab|nivolumab|mesh-list
55842477|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842479|NCT01670890|Temozolomide|temozolomide|mesh-list
55842480|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842481|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55842482|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
55842483|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842484|NCT04551196|Acetaminophen|acetaminophen|mesh-list
55842485|NCT04551196|Ibuprofen|ibuprofen|mesh-list
55842486|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842487|NCT04551196|Analgesics|analgesics|mesh-ancestor
55842488|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
55842490|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842491|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
55842492|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55842536|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842537|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
55842539|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55842540|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55842541|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842542|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842543|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842544|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55842545|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
55842547|NCT03154918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842548|NCT03154918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55842549|NCT03154918|Immunologic Factors|immunologic factors|mesh-ancestor
55842846|NCT03152890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55842550|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55842551|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55842552|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55842553|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55842554|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
55842555|NCT01671904|Rituximab|rituximab|mesh-list
55842556|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
55842557|NCT01671904|Venetoclax|venetoclax|mesh-list
55842558|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55842559|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842560|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842561|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
55842583|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55842584|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842585|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55842586|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842587|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842589|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
55842590|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55842591|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842592|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842593|NCT02564068|Oxytocin|oxytocin|mesh-list
55842594|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
55842595|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55842596|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842597|NCT03154528|Vitamin D|vitamin d|mesh-list
55842598|NCT03154528|Vitamins|vitamins|mesh-ancestor
55842599|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
55842600|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842601|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55842602|NCT03154372|Metronidazole|metronidazole|mesh-list
55842603|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842604|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55842605|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55842606|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55842607|NCT01676506|Ranibizumab|ranibizumab|mesh-list
55842608|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55842609|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55842610|NCT01676506|Growth Substances|growth substances|mesh-ancestor
55842611|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842612|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
55842613|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842614|NCT03154294|Paclitaxel|paclitaxel|mesh-list
55842615|NCT03154294|Serabelisib|serabelisib|mesh-list
55842616|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55842617|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842618|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
55842620|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
55842621|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842622|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842623|NCT03154606|Calcium|calcium|mesh-list
55842624|NCT03154606|Caseins|caseins|mesh-list
55842625|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55842626|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842627|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
55842628|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
55842629|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842630|NCT03806452|Hydroxyurea|hydroxyurea|mesh-list
55842631|NCT03806452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842632|NCT03806452|Antisickling Agents|antisickling agents|mesh-ancestor
55842633|NCT03806452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842634|NCT03806452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842635|NCT03806452|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55842636|NCT01672450|Ipilimumab|ipilimumab|mesh-list
55842637|NCT01672450|Interleukin-2|interleukin-2|mesh-list
55842638|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55842639|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842640|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55842641|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842642|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55842643|NCT01672450|Analgesics|analgesics|mesh-ancestor
55842644|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
55842645|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842668|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842669|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842670|NCT01594281|Ranibizumab|ranibizumab|mesh-list
55842671|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55842672|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55842673|NCT01594281|Growth Substances|growth substances|mesh-ancestor
55842674|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842675|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
55842676|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55842677|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
55842678|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55842679|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
55842680|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842681|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842682|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55842683|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55842684|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55842685|NCT04964050|Diuretics|diuretics|mesh-ancestor
55842686|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
55842687|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842688|NCT02386774|Benoxinate|benoxinate|mesh-list
55842689|NCT02386774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55842690|NCT02386774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55842691|NCT02386774|Anesthetics, Local|anesthetics, local|mesh-ancestor
55842692|NCT02386774|Anesthetics|anesthetics|mesh-ancestor
55842693|NCT02386774|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842694|NCT02386774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842695|NCT02386774|Sensory System Agents|sensory system agents|mesh-ancestor
55842713|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842714|NCT01818284|Plerixafor|plerixafor|mesh-list
55842715|NCT01818284|Lenograstim|lenograstim|mesh-list
55842716|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55842717|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
55842718|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842719|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55842720|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55842721|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
55842722|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842723|NCT02081014|Glucagon|glucagon|mesh-list
55842724|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
55842725|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842726|NCT02081014|Hormones|hormones|mesh-ancestor
55842729|NCT02081014|Incretins|incretins|mesh-ancestor
55842777|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
55842778|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842779|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842780|NCT04404946|Protective Agents|protective agents|mesh-ancestor
55842781|NCT01673542|Lidocaine|lidocaine|mesh-list
55842782|NCT01673542|Prilocaine|prilocaine|mesh-list
55842783|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
55842784|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
55842785|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
55842786|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842787|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842788|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
55842789|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842790|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55842791|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55842792|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55842793|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55842794|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842795|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55842796|NCT04804540|Vedolizumab|vedolizumab|mesh-list
55842829|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842830|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55842831|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
55842832|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842833|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
55842834|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55842835|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
55842836|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55842837|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55842838|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55842839|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55842842|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55842843|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842844|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842847|NCT03152890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842883|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55842884|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
55842885|NCT04603508|Empagliflozin|empagliflozin|mesh-list
55842886|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55842887|NCT04603508|Calcium|calcium|mesh-list
55842888|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55842889|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842890|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55842891|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55842892|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55842893|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
55842894|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842895|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55842896|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55842897|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55842898|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55842899|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55842900|NCT01674166|Prucalopride|prucalopride|mesh-list
55842901|NCT01674166|Laxatives|laxatives|mesh-ancestor
55842902|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842903|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
55842904|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55842905|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
55842934|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
55842935|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
55842936|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
55842937|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842938|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55842939|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
55842940|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842941|NCT04685980|Morphine|morphine|mesh-list
55842942|NCT04685980|Anesthetics|anesthetics|mesh-list
55842943|NCT04685980|Anesthetics, Local|anesthetics, local|mesh-list
55842944|NCT04685980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842945|NCT04685980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842946|NCT04685980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55842947|NCT04685980|Narcotics|narcotics|mesh-ancestor
55842948|NCT04685980|Analgesics|analgesics|mesh-ancestor
55842949|NCT04685980|Sensory System Agents|sensory system agents|mesh-ancestor
55842950|NCT04685980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842951|NCT04764916|Bupivacaine|bupivacaine|mesh-list
55842952|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
55842953|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
55842954|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55842955|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842956|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
55842957|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55842958|NCT01674868|Fluoxetine|fluoxetine|mesh-list
55842959|NCT01674868|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55842960|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55842961|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55842962|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842963|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842964|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
55842965|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842975|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55842976|NCT01675024|Rotigotine|rotigotine|mesh-list
55842977|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
55842978|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
55842979|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55842980|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55842981|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55842982|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
55842983|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55842984|NCT03883828|Mupirocin|mupirocin|mesh-list
55842985|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55842986|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843042|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843043|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
55843044|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
55843045|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
55843046|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843047|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
55843048|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843049|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
55843050|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55843051|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843052|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843053|NCT01675804|Methylphenidate|methylphenidate|mesh-list
55843054|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55843090|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843091|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843092|NCT03755440|Antibodies|antibodies|mesh-list
55843093|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
55843094|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843095|NCT04764214|Osimertinib|osimertinib|mesh-list
55843096|NCT04764214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843097|NCT04764214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55843098|NCT04764214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843099|NCT04764214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843100|NCT03749902|Misoprostol|misoprostol|mesh-list
55843101|NCT03749902|Oxytocin|oxytocin|mesh-list
55843102|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
55843103|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55843104|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843105|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55843106|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
55843107|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55843108|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55843109|NCT01565889|Ritonavir|ritonavir|mesh-list
55843110|NCT01565889|Ribavirin|ribavirin|mesh-list
55843111|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55843112|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55843113|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
55843114|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843115|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843116|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55843137|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843138|NCT01591785|Retapamulin|retapamulin|mesh-list
55843139|NCT01591785|Petrolatum|petrolatum|mesh-list
55843140|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55843141|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843142|NCT01591785|Emollients|emollients|mesh-ancestor
55843143|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
55843145|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
55843146|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
55843147|NCT03660046|Etonogestrel|etonogestrel|mesh-list
55843148|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55843149|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
55843150|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55843151|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843152|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55843153|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55843154|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55843155|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55843156|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55843157|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55843158|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843166|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
55843168|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843225|NCT01590771|Gliclazide|gliclazide|mesh-list
55843226|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55843227|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843228|NCT01590771|Incretins|incretins|mesh-ancestor
55843229|NCT01590771|Hormones|hormones|mesh-ancestor
55843230|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55843231|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55843232|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
55843233|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843234|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843235|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55843236|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843237|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
55843238|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
55843239|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55843240|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843241|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
55843242|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843243|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843244|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
55843245|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
55843246|NCT03735316|Vitamins|vitamins|mesh-ancestor
55843247|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
55843248|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843249|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
55843250|NCT03735316|Hematinics|hematinics|mesh-ancestor
55843251|NCT01694433|Vitamin D|vitamin d|mesh-list
55843252|NCT01694433|Calcitriol|calcitriol|mesh-list
55843253|NCT01694433|Calcipotriene|calcipotriene|mesh-list
55843254|NCT01694433|Vitamins|vitamins|mesh-ancestor
55843255|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
55843256|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843257|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55843258|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
55843259|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55843260|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
55843262|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843263|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55843264|NCT01693185|Midazolam|midazolam|mesh-list
55843265|NCT01693185|Meperidine|meperidine|mesh-list
55843266|NCT01693185|Remifentanil|remifentanil|mesh-list
55843267|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55843269|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55843270|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843271|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55843272|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55843273|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55843274|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55843275|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
55843276|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
55843277|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
55843278|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
55843279|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843280|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843281|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55843282|NCT01693185|Narcotics|narcotics|mesh-ancestor
55843283|NCT01693185|Analgesics|analgesics|mesh-ancestor
55843284|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
55843285|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843286|NCT03825796|Cytarabine|cytarabine|mesh-list
55843287|NCT03825796|Daunorubicin|daunorubicin|mesh-list
55843288|NCT03825796|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55843289|NCT03825796|Antimetabolites|antimetabolites|mesh-ancestor
55843290|NCT03825796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843291|NCT03825796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843308|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843309|NCT03824938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55843310|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55843311|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55843312|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55843313|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843314|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55843315|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55843316|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843317|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
55843318|NCT03630640|Nivolumab|nivolumab|mesh-list
55843319|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843320|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843321|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55843322|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843323|NCT03820726|Nintedanib|nintedanib|mesh-list
55843324|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843325|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55843326|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843327|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843328|NCT03625726|Thrombin|thrombin|mesh-list
55843329|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
55843330|NCT03625726|Coagulants|coagulants|mesh-ancestor
55843331|NCT03814954|Epinephrine|epinephrine|mesh-list
55843332|NCT03814954|Albuterol|albuterol|mesh-list
55843345|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
55843375|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55843376|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55843377|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
55843378|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843617|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
55843408|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843409|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843410|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
55843411|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843412|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55843413|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
55843414|NCT01693029|Hematinics|hematinics|mesh-ancestor
55843415|NCT01589445|Metformin|metformin|mesh-list
55843416|NCT01589445|Pioglitazone|pioglitazone|mesh-list
55843417|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55843418|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843419|NCT00003910|Prednisone|prednisone|mesh-list
55843420|NCT00003910|Cyclophosphamide|cyclophosphamide|mesh-list
55843421|NCT00003910|Methotrexate|methotrexate|mesh-list
55843422|NCT00003910|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843423|NCT00003910|Immunologic Factors|immunologic factors|mesh-ancestor
55843424|NCT00003910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843425|NCT00003910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55843426|NCT00003910|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55843427|NCT00003910|Alkylating Agents|alkylating agents|mesh-ancestor
55843428|NCT00003910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843429|NCT00003910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843430|NCT00003910|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55843431|NCT00003910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55843433|NCT00003910|Hormones|hormones|mesh-ancestor
55843462|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55843464|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
55843465|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
55843466|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
55843467|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843468|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55843469|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55843470|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843471|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55843472|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843473|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
55843474|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
55843475|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
55843476|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55843477|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55843478|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
55843479|NCT01587885|Omeprazole|omeprazole|mesh-list
55843480|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55843481|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55843482|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55843483|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843484|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843485|NCT03802240|Pemetrexed|pemetrexed|mesh-list
55843486|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843487|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843488|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843489|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55843490|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55843491|NCT03710122|Vancomycin|vancomycin|mesh-list
55843492|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55843493|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843494|NCT03706690|Durvalumab|durvalumab|mesh-list
55843501|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55843502|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55843503|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
55843504|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843505|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843506|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843507|NCT04763434|Dexamethasone|dexamethasone|mesh-list
55843508|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
55843509|NCT04763434|Ropivacaine|ropivacaine|mesh-list
55843510|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55843511|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
55843512|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
55843513|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843514|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843515|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55843516|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
55843517|NCT04763434|Hormones|hormones|mesh-ancestor
55843518|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55843519|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55843520|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843521|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55843522|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55843523|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55843525|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
55843526|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55843527|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55843528|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55843529|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
55843530|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843532|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
55843544|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
55843545|NCT04762966|Metformin|metformin|mesh-list
55843546|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55843547|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843548|NCT03602560|Seladelpar|seladelpar|mesh-list
55843549|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55843550|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
55843551|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843552|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55843553|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
55843554|NCT03797326|Lenvatinib|lenvatinib|mesh-list
55843555|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843556|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843557|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55843558|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843559|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843560|NCT00779116|Cetirizine|cetirizine|mesh-list
55843561|NCT00779116|Desloratadine|desloratadine|mesh-list
55843562|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55843563|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55843564|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55843565|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
55843566|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
55843567|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843568|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843569|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843570|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55843571|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
55843572|NCT01691781|Lisinopril|lisinopril|mesh-list
55843573|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55843574|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
55843575|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843576|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843586|NCT04112043|Micronutrients|micronutrients|mesh-ancestor
55843587|NCT04112043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843588|NCT04112043|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55843589|NCT04112043|Antimetabolites|antimetabolites|mesh-ancestor
55843590|NCT04112043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843591|NCT04112043|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55843592|NCT04112043|Vasodilator Agents|vasodilator agents|mesh-ancestor
55843593|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
55843594|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
55843595|NCT01561755|Antibodies|antibodies|mesh-list
55843596|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
55843597|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
55843599|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843600|NCT03789214|Suvorexant|suvorexant|mesh-list
55843601|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55843602|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55843603|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55843604|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843605|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
55843606|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843607|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843608|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
55843609|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55843610|NCT04124367|Protective Agents|protective agents|mesh-ancestor
55843611|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843612|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
55843613|NCT01560507|Bupropion|bupropion|mesh-list
55843614|NCT01560507|Nicotine|nicotine|mesh-list
55843615|NCT01560507|Varenicline|varenicline|mesh-list
55843616|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55843618|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843619|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843620|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55843626|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
55843627|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55843628|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55843629|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55843630|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55843632|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55843633|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55843634|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843636|NCT03593590|Immunologic Factors|immunologic factors|mesh-ancestor
55843637|NCT03593590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843638|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
55843639|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843640|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843641|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
55843642|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843643|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843644|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
55843645|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
55843646|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
55843647|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843648|NCT03586414|Ubiquinone|ubiquinone|mesh-list
55843649|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
55843650|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843651|NCT03684538|Zinc|zinc|mesh-list
55843674|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55843675|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55843676|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55843677|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55843678|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843679|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
55843680|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843681|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843682|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55843683|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843684|NCT03580408|Nivolumab|nivolumab|mesh-list
55843685|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843686|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843687|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55843688|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843689|NCT03775096|Carvedilol|carvedilol|mesh-list
55843690|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55843691|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55843692|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
55843724|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
55843725|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843726|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
55843727|NCT03766750|Linagliptin|linagliptin|mesh-list
55843728|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55843729|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843730|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55843731|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843732|NCT03766750|Incretins|incretins|mesh-ancestor
55843734|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55843735|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
55843736|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
55843737|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843738|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
55843739|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
55843740|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843741|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
55843742|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843743|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55843744|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55843745|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
55843746|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843747|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843748|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55843750|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55843751|NCT03674242|Gemcitabine|gemcitabine|mesh-list
55843752|NCT03674242|Carboplatin|carboplatin|mesh-list
55843753|NCT03674242|Asparaginase|asparaginase|mesh-list
55843768|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55843769|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
55843770|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843771|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55843772|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843773|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843774|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
55843775|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843776|NCT03673072|Gemcitabine|gemcitabine|mesh-list
55843777|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843778|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55843779|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
55843780|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843781|NCT03673072|Antiviral Agents|antiviral agents|mesh-ancestor
55843782|NCT03673072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843783|NCT03673072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843784|NCT03673072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843785|NCT03673072|Immunologic Factors|immunologic factors|mesh-ancestor
55843786|NCT03673072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843787|NCT03557008|Metronidazole|metronidazole|mesh-list
55843788|NCT03557008|Vancomycin|vancomycin|mesh-list
55843789|NCT03557008|Neomycin|neomycin|mesh-list
55843790|NCT03557008|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843791|NCT03557008|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55843792|NCT03557008|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55843793|NCT03557008|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55843794|NCT03557008|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55843795|NCT03557008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843796|NCT03557008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843797|NCT03572530|Azacitidine|azacitidine|mesh-list
55843798|NCT03572530|Decitabine|decitabine|mesh-list
55843799|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55843800|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
55843808|NCT01690299|Analgesics|analgesics|mesh-ancestor
55843809|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
55843810|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843811|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843812|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55843813|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55843814|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55843815|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843816|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
55843817|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
55843818|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55843819|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843820|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843821|NCT03570814|Azithromycin|azithromycin|mesh-list
55843823|NCT03570814|Albendazole|albendazole|mesh-list
55843824|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55843825|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843826|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55843827|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
55843828|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
55843829|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55843830|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55843834|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843835|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843836|NCT00723736|Desloratadine|desloratadine|mesh-list
55843837|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55843838|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
55843839|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843840|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843849|NCT01690143|Melphalan|melphalan|mesh-list
55843850|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55843851|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
55843852|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843853|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843854|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55843855|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843856|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
55843857|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843858|NCT05347498|Febuxostat|febuxostat|mesh-list
55843859|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
55843860|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55843861|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
55843862|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55843863|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55843864|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843865|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
55843866|NCT03553186|Coagulants|coagulants|mesh-ancestor
55843867|NCT01677364|Oxytocin|oxytocin|mesh-list
55843868|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
55843869|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55843870|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843871|NCT03563248|Nivolumab|nivolumab|mesh-list
55843872|NCT03563248|Folfirinox|folfirinox|mesh-list
55843873|NCT03563248|Losartan|losartan|mesh-list
55843874|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843875|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843876|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55843877|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843878|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55843879|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55843880|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55843881|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55843890|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843891|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843892|NCT03662074|Antiviral Agents|antiviral agents|mesh-ancestor
55843893|NCT03662074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843894|NCT03662074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843895|NCT03662074|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843896|NCT03662074|Immunologic Factors|immunologic factors|mesh-ancestor
55843897|NCT03662074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843898|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55843899|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55843900|NCT03559348|Leucovorin|leucovorin|mesh-list
55843901|NCT03559348|Gemcitabine|gemcitabine|mesh-list
55843902|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55843903|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
55843904|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843905|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55843906|NCT03559348|Antiviral Agents|antiviral agents|mesh-ancestor
55843907|NCT03559348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55843908|NCT03559348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843909|NCT03559348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55843910|NCT03559348|Immunologic Factors|immunologic factors|mesh-ancestor
55843911|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843912|NCT03559348|Antidotes|antidotes|mesh-ancestor
55843913|NCT03559348|Protective Agents|protective agents|mesh-ancestor
55843914|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
55843915|NCT03559348|Vitamins|vitamins|mesh-ancestor
55843923|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
55843924|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
55843927|NCT01559259|Acetaminophen|acetaminophen|mesh-list
55843931|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
55843932|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843933|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843934|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
55843935|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55843936|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55843938|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55843939|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55843940|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843941|NCT03088306|Acetaminophen|acetaminophen|mesh-list
55843942|NCT03088306|Fentanyl|fentanyl|mesh-list
55843943|NCT03088306|Ketamine|ketamine|mesh-list
55843944|NCT03088306|Gabapentin|gabapentin|mesh-list
55843945|NCT03088306|Hydromorphone|hydromorphone|mesh-list
55843946|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
55843947|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55843948|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843949|NCT03088306|Analgesics|analgesics|mesh-ancestor
55843950|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
55843951|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843952|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55843953|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55843954|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
55843955|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55843956|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55843957|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843958|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843959|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55843960|NCT03088306|Narcotics|narcotics|mesh-ancestor
55843961|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55843962|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55843963|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
55843964|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
55843972|NCT01672762|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55843973|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843975|NCT03088384|Analgesics|analgesics|mesh-ancestor
55843976|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
55843977|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55843978|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55843979|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
55843980|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55843981|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
55843982|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
55843983|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55843984|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55843985|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55843986|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55843987|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55843988|NCT01677598|Ustekinumab|ustekinumab|mesh-list
55843989|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
55844020|NCT01670500|Cisplatin|cisplatin|mesh-list
55844021|NCT01670500|Doxorubicin|doxorubicin|mesh-list
55844022|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844023|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
55844024|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844025|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844026|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55844027|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
55844028|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844029|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844030|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55844031|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55844032|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55844033|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55844034|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844035|NCT01678612|Copper|copper|mesh-list
55844036|NCT01678612|Trace Elements|trace elements|mesh-ancestor
55844037|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
55844038|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844039|NCT03525574|Ivacaftor|ivacaftor|mesh-list
55844040|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55844041|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55844042|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844043|NCT02402920|Cisplatin|cisplatin|mesh-list
55844044|NCT02402920|Carboplatin|carboplatin|mesh-list
55844045|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
55844070|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844072|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844073|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844074|NCT02984722|Metformin|metformin|mesh-list
55844075|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55844252|NCT00084838|Antidotes|antidotes|mesh-ancestor
55844076|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844077|NCT02401750|Naltrexone|naltrexone|mesh-list
55844078|NCT02401750|Oxycodone|oxycodone|mesh-list
55844079|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55844080|NCT02401750|Narcotics|narcotics|mesh-ancestor
55844081|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844082|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844083|NCT02401750|Analgesics|analgesics|mesh-ancestor
55844084|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
55844085|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844086|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55844087|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55844088|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
55844089|NCT03087136|Antibodies|antibodies|mesh-list
55844090|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
55844091|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844092|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55844093|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55844094|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844095|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
55844096|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844097|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
55844098|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55844099|NCT03087136|Protective Agents|protective agents|mesh-ancestor
55844192|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844194|NCT03447808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844195|NCT00085540|Romidepsin|romidepsin|mesh-list
55844196|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55844197|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844199|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55844200|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844201|NCT01688739|Analgesics|analgesics|mesh-ancestor
55844202|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
55844203|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844204|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844205|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
55844206|NCT00084838|Leucovorin|leucovorin|mesh-list
55844207|NCT00084838|Cytarabine|cytarabine|mesh-list
55844208|NCT00084838|Dactinomycin|dactinomycin|mesh-list
55844209|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
55844210|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55844211|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55844212|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55844213|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
55844214|NCT00084838|Temozolomide|temozolomide|mesh-list
55844215|NCT00084838|Cisplatin|cisplatin|mesh-list
55844216|NCT00084838|Doxorubicin|doxorubicin|mesh-list
55844217|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55844218|NCT00084838|Methotrexate|methotrexate|mesh-list
55844219|NCT00084838|Etoposide|etoposide|mesh-list
55844220|NCT00084838|Vincristine|vincristine|mesh-list
55844221|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
55844222|NCT00084838|Razoxane|razoxane|mesh-list
55844223|NCT00084838|Lenograstim|lenograstim|mesh-list
55844224|NCT00084838|Calcium|calcium|mesh-list
55844225|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
55844226|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844227|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
55844228|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844229|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844234|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55844235|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55844236|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55844237|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55844238|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844239|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55844240|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55844241|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55844242|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
55844243|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55844244|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55844245|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
55844246|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
55844247|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55844248|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55844249|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55844250|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
55844251|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844355|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844356|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55844357|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
55844358|NCT03437746|Hormones|hormones|mesh-ancestor
55844365|NCT03479476|Metformin|metformin|mesh-list
55844388|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55844389|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844390|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
55844391|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844392|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844394|NCT03084328|Vitamins|vitamins|mesh-ancestor
55844395|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
55844396|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844397|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55844398|NCT03475342|Tranexamic Acid|tranexamic acid|mesh-list
55844399|NCT03475342|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55844400|NCT03475342|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55844401|NCT03475342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844402|NCT03475342|Hemostatics|hemostatics|mesh-ancestor
55844403|NCT03475342|Coagulants|coagulants|mesh-ancestor
55844404|NCT03435718|Albendazole|albendazole|mesh-list
55844405|NCT03435718|Oxfendazole|oxfendazole|mesh-list
55844406|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
55844407|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55844408|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844409|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
55844410|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
55844411|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55844412|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
55844413|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
55844414|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
55844415|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844416|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844417|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
55844418|NCT01678690|Gemcitabine|gemcitabine|mesh-list
55844431|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55844432|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844433|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55844434|NCT03083782|Cyclosporine|cyclosporine|mesh-list
55844435|NCT03083782|Apixaban|apixaban|mesh-list
55844436|NCT03083782|Tacrolimus|tacrolimus|mesh-list
55844437|NCT03083782|Cyclosporins|cyclosporins|mesh-list
55844438|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844439|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
55844440|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844441|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55844442|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844443|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844444|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
55844445|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844446|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
55844447|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844448|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55844449|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
55844450|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55844451|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
55844452|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
55844453|NCT03083704|Enoxaparin|enoxaparin|mesh-list
55844454|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
55844455|NCT03083704|Apixaban|apixaban|mesh-list
55844456|NCT03083704|Edoxaban|edoxaban|mesh-list
55844457|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
55844458|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55844459|NCT03083704|Antithrombins|antithrombins|mesh-ancestor
55844460|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55844461|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
55844462|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844463|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844464|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
55844465|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55844466|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55844467|NCT03471442|Bupivacaine|bupivacaine|mesh-list
55844468|NCT03471442|Ropivacaine|ropivacaine|mesh-list
55844469|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
55844470|NCT03471442|Anesthetics|anesthetics|mesh-list
55844471|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
55844472|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844473|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844474|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
55844475|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844476|NCT01679392|Ropivacaine|ropivacaine|mesh-list
55844477|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
55844478|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
55844479|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844480|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844481|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
55844482|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844483|NCT03082534|Pembrolizumab|pembrolizumab|mesh-list
55844484|NCT03082534|Cetuximab|cetuximab|mesh-list
55844485|NCT03082534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55844486|NCT03082534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844487|NCT03083080|Epinephrine|epinephrine|mesh-list
55844488|NCT03083080|Ropivacaine|ropivacaine|mesh-list
55844489|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
55844490|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
55844491|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844492|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844493|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
55844494|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844495|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55844496|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55844497|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
55844498|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844499|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844500|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55844501|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55844502|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
55844509|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55844510|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844511|NCT03466294|Azacitidine|azacitidine|mesh-list
55844512|NCT03466294|Venetoclax|venetoclax|mesh-list
55844513|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55844514|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
55844515|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844516|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844517|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844518|NCT03082300|Naquotinib|naquotinib|mesh-list
55844519|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844520|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55844521|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844522|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844523|NCT03435250|Gemcitabine|gemcitabine|mesh-list
55844524|NCT03435250|Paclitaxel|paclitaxel|mesh-list
55844525|NCT03435250|Docetaxel|docetaxel|mesh-list
55844526|NCT03435250|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55844527|NCT03435250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844528|NCT03435250|Tubulin Modulators|tubulin modulators|mesh-ancestor
55844529|NCT03435250|Antimitotic Agents|antimitotic agents|mesh-ancestor
55844530|NCT03435250|Mitosis Modulators|mitosis modulators|mesh-ancestor
55844531|NCT03435250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844532|NCT03435250|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55844533|NCT03435250|Antimetabolites|antimetabolites|mesh-ancestor
55844534|NCT03435250|Antiviral Agents|antiviral agents|mesh-ancestor
55844535|NCT03435250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844536|NCT03435250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844537|NCT03435250|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844538|NCT03435250|Immunologic Factors|immunologic factors|mesh-ancestor
55844539|NCT03435250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844540|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
55844541|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
55844542|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844543|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55844544|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844545|NCT05346952|Carboplatin|carboplatin|mesh-list
55844547|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844548|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844549|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844551|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55844553|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
55844554|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55844555|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
55844556|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55844557|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844558|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55844559|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55844561|NCT03431194|Midodrine|midodrine|mesh-list
55844562|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
55844563|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
55844564|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844565|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844566|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55844567|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
55844568|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55844569|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55844570|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
55844596|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844597|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844598|NCT03080350|Fentanyl|fentanyl|mesh-list
55844599|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55844600|NCT03080350|Narcotics|narcotics|mesh-ancestor
55844601|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844602|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844603|NCT03080350|Analgesics|analgesics|mesh-ancestor
55844604|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
55844605|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844606|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55844607|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55844608|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
55844609|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
55844610|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
55844611|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55844612|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55844613|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844614|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844615|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55844616|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
55844617|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55844618|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
55844619|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844620|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844621|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55844622|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55844623|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
55844625|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844626|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55844627|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844637|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
55844638|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
55844639|NCT03323866|Hormones|hormones|mesh-ancestor
55844640|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55844641|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
55844642|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55844643|NCT05688670|Anesthetics|anesthetics|mesh-list
55844644|NCT05688670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844645|NCT05688670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844646|NCT05684848|Resveratrol|resveratrol|mesh-list
55844647|NCT05684848|Antioxidants|antioxidants|mesh-ancestor
55844648|NCT05684848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844649|NCT05684848|Protective Agents|protective agents|mesh-ancestor
55844650|NCT05684848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844651|NCT05684848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844652|NCT05684848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55844654|NCT03366766|Cisplatin|cisplatin|mesh-list
55844655|NCT03366766|Nivolumab|nivolumab|mesh-list
55844656|NCT03366766|Pemetrexed|pemetrexed|mesh-list
55844657|NCT03366766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844658|NCT03366766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55844659|NCT03366766|Antimetabolites|antimetabolites|mesh-ancestor
55844660|NCT03366766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844661|NCT03366766|Antiviral Agents|antiviral agents|mesh-ancestor
55844662|NCT03366766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844671|NCT03366298|Epinephrine|epinephrine|mesh-list
55844687|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
55844688|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55844689|NCT05688436|Interferons|interferons|mesh-list
55844690|NCT05688436|Interferon-beta|interferon-beta|mesh-list
55844691|NCT05688436|Alemtuzumab|alemtuzumab|mesh-list
55844692|NCT05688436|Glatiramer Acetate|glatiramer acetate|mesh-list
55844693|NCT05688436|Ocrelizumab|ocrelizumab|mesh-list
55844694|NCT05688436|Natalizumab|natalizumab|mesh-list
55844695|NCT05688436|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55844741|NCT05688124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55844742|NCT05688124|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55844743|NCT05688124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844744|NCT05688124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844746|NCT05665270|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55844747|NCT05665270|Methylprednisolone|methylprednisolone|mesh-list
55844748|NCT05665270|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55844749|NCT05665270|Prednisolone acetate|prednisolone acetate|mesh-list
55844750|NCT05665270|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55844751|NCT05665270|Prednisolone phosphate|prednisolone phosphate|mesh-list
55844752|NCT05665270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55844753|NCT05665270|Glucocorticoids|glucocorticoids|mesh-ancestor
55844754|NCT05665270|Hormones|hormones|mesh-ancestor
55844755|NCT05665270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55844756|NCT05665270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844757|NCT05665270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55844758|NCT05665270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844759|NCT05665270|Antiemetics|antiemetics|mesh-ancestor
55844765|NCT01842620|Metformin|metformin|mesh-list
55844773|NCT05687344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55844774|NCT05687344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844775|NCT05687344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55844776|NCT05687344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844777|NCT05687344|Vasodilator Agents|vasodilator agents|mesh-ancestor
55844778|NCT05687344|Tocolytic Agents|tocolytic agents|mesh-ancestor
55844779|NCT05687344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55844780|NCT04760704|Antibodies|antibodies|mesh-list
55844781|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
55844782|NCT04760704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844783|NCT03356860|Paclitaxel|paclitaxel|mesh-list
55844784|NCT03356860|Cyclophosphamide|cyclophosphamide|mesh-list
55844785|NCT03356860|Durvalumab|durvalumab|mesh-list
55844786|NCT03356860|Epirubicin|epirubicin|mesh-list
55844787|NCT03356860|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55844788|NCT03356860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844789|NCT03356860|Tubulin Modulators|tubulin modulators|mesh-ancestor
55844790|NCT03356860|Antimitotic Agents|antimitotic agents|mesh-ancestor
55844791|NCT03356860|Mitosis Modulators|mitosis modulators|mesh-ancestor
55844792|NCT03356860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844793|NCT03356860|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844794|NCT03356860|Immunologic Factors|immunologic factors|mesh-ancestor
55844795|NCT03356860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844796|NCT03356860|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844797|NCT03356860|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55844798|NCT03356860|Alkylating Agents|alkylating agents|mesh-ancestor
55844799|NCT03356860|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55844800|NCT03356860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55844801|NCT03356860|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55844802|NCT03356860|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55844803|NCT03356860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55844804|NCT03356860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844805|NCT01931839|Ivacaftor|ivacaftor|mesh-list
55844806|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
55844807|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55844811|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55844812|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55844813|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
55844814|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844815|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844816|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55844817|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844818|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
55844819|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844821|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55844822|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
55844823|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844824|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844825|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844826|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55844827|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55844828|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844829|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55844830|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55844831|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
55844833|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
55844834|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
55844835|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844858|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844859|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844860|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844861|NCT05640232|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
55844862|NCT05640232|Parasympatholytics|parasympatholytics|mesh-ancestor
55844863|NCT05640232|Autonomic Agents|autonomic agents|mesh-ancestor
55844864|NCT05640232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844865|NCT05640232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844866|NCT05640232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55844867|NCT05640232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55844868|NCT05640232|Cholinergic Agents|cholinergic agents|mesh-ancestor
55844869|NCT05640232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55844870|NCT05640232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844871|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55844874|NCT01970371|Tigecycline|tigecycline|mesh-list
55844875|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55844876|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55844877|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844879|NCT04348006|Dexamethasone|dexamethasone|mesh-list
55844910|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55844911|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844912|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844913|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844914|NCT05604742|Belimumab|belimumab|mesh-list
55844915|NCT05604742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55844916|NCT05604742|Immunologic Factors|immunologic factors|mesh-ancestor
55844917|NCT05604742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844918|NCT05600062|Racecadotril|racecadotril|mesh-list
55844919|NCT05600062|Antidiarrheals|antidiarrheals|mesh-ancestor
55844920|NCT05600062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55844921|NCT05600062|Protease Inhibitors|protease inhibitors|mesh-ancestor
55844922|NCT05600062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844923|NCT05600062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844924|NCT03350386|Oxaprozin|oxaprozin|mesh-list
55844925|NCT03350386|Dotinurad|dotinurad|mesh-list
55844926|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
55844927|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
55844928|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844929|NCT03350386|Renal Agents|renal agents|mesh-ancestor
55844930|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55844931|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55844932|NCT03350386|Analgesics|analgesics|mesh-ancestor
55844933|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
55844934|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55844961|NCT05548582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844962|NCT05548582|Antipyretics|antipyretics|mesh-ancestor
55844963|NCT05548582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55844964|NCT05548582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55844965|NCT05548582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55844966|NCT05548582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55844967|NCT05548582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55844968|NCT05548582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844969|NCT05548582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55844970|NCT05548582|Narcotics|narcotics|mesh-ancestor
55844971|NCT05548582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55844972|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
55844973|NCT05259046|Vitamin K|vitamin k|mesh-list
55844974|NCT05259046|Vitamin MK 7|vitamin mk 7|mesh-list
55844975|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55844976|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55844977|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844978|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
55844979|NCT05259046|Coagulants|coagulants|mesh-ancestor
55844980|NCT05259046|Vitamins|vitamins|mesh-ancestor
55844981|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
55844982|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55844983|NCT03274258|Nivolumab|nivolumab|mesh-list
55844984|NCT03274258|Ipilimumab|ipilimumab|mesh-list
55844985|NCT03274258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55844986|NCT03274258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844987|NCT03274258|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55844988|NCT03274258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55844989|NCT05084638|Ofatumumab|ofatumumab|mesh-list
55844990|NCT05084638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55844991|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55844995|NCT05223088|Apatinib|apatinib|mesh-list
55845005|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55845006|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55845007|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55845008|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845009|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845010|NCT03279250|Prednisone|prednisone|mesh-list
55845011|NCT03279250|Cortisone|cortisone|mesh-list
55845012|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
55845013|NCT03279250|Hormones|hormones|mesh-list
55845014|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
55845015|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55845016|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
55845017|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845018|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845019|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55845020|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845021|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55845022|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845023|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845024|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
55845025|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55845026|NCT01838642|Ponatinib|ponatinib|mesh-list
55845027|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845028|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55845029|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845030|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845042|NCT03330028|Paclitaxel|paclitaxel|mesh-list
55845053|NCT03330028|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55845054|NCT03330028|Antiemetics|antiemetics|mesh-ancestor
55845055|NCT03330028|Autonomic Agents|autonomic agents|mesh-ancestor
55845056|NCT03330028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845057|NCT03330028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845058|NCT03330028|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845059|NCT03330028|Glucocorticoids|glucocorticoids|mesh-ancestor
55845060|NCT03330028|Hormones|hormones|mesh-ancestor
55845061|NCT03330028|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845062|NCT03330028|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55845063|NCT03330028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55845064|NCT03330028|Alkylating Agents|alkylating agents|mesh-ancestor
55845065|NCT03330028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55845066|NCT03330028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845067|NCT03330028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55845068|NCT03330028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55845069|NCT03330028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845070|NCT03330028|Anesthetics, Local|anesthetics, local|mesh-ancestor
55845072|NCT03330028|Sensory System Agents|sensory system agents|mesh-ancestor
55845073|NCT03330028|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55845074|NCT03330028|Histamine Antagonists|histamine antagonists|mesh-ancestor
55845075|NCT03330028|Histamine Agents|histamine agents|mesh-ancestor
55845082|NCT04415060|Sevoflurane|sevoflurane|mesh-list
55845104|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845105|NCT01811732|Vancomycin|vancomycin|mesh-list
55845106|NCT01811732|Aztreonam|aztreonam|mesh-list
55845107|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55845108|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845109|NCT05139004|Fludarabine|fludarabine|mesh-list
55845110|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
55845111|NCT05139004|Melphalan|melphalan|mesh-list
55845112|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
55845113|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
55845114|NCT05139004|Basiliximab|basiliximab|mesh-list
55845115|NCT05139004|Mitogens|mitogens|mesh-list
55845116|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
55845117|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845118|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55845119|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
55845120|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845121|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55845122|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
55845123|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845124|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55845125|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
55845126|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55845127|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
55845128|NCT05139004|Chelating Agents|chelating agents|mesh-ancestor
55845129|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
55845130|NCT01811186|Oxycodone|oxycodone|mesh-list
55845131|NCT01811186|Naloxone|naloxone|mesh-list
55845132|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55845133|NCT01811186|Narcotics|narcotics|mesh-ancestor
55845134|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845135|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845136|NCT01811186|Analgesics|analgesics|mesh-ancestor
55845137|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
55845148|NCT04885972|Triamcinolone|triamcinolone|mesh-list
55845149|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
55845150|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
55845151|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
55845152|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55845153|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
55845154|NCT04885972|Hormones|hormones|mesh-ancestor
55845155|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845156|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845157|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55845158|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
55845159|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845160|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845161|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55845162|NCT04039750|Clindamycin|clindamycin|mesh-list
55845163|NCT04039750|Gentamicins|gentamicins|mesh-list
55845164|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845165|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55845166|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845168|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
55845203|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
55845205|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55845206|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55845207|NCT01865552|Analgesics|analgesics|mesh-ancestor
55845208|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
55845209|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845210|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845211|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55845212|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55845213|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845214|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55845215|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
55845216|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
55845217|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55845218|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845219|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
55845227|NCT05185024|Iron|iron|mesh-list
55845260|NCT03229798|Sumatriptan|sumatriptan|mesh-list
55845261|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55845262|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
55845263|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
55845264|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
55845265|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845266|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845267|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845268|NCT04805944|Dolutegravir|dolutegravir|mesh-list
55845269|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55845270|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55845271|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845272|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845273|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55845274|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55845275|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
55845276|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845277|NCT03906292|Niacinamide|niacinamide|mesh-list
55845278|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
55845279|NCT03906292|Dasatinib|dasatinib|mesh-list
55845280|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845281|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55845282|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845283|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845284|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
55845285|NCT03906292|Vitamins|vitamins|mesh-ancestor
55845287|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845307|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55845308|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55845309|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
55845310|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845311|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
55845312|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55845313|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845314|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55845315|NCT04756804|Ethanol|ethanol|mesh-list
55845316|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
55845317|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55845318|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55845319|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845320|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845321|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845322|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
55845323|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
55845324|NCT03829462|Irinotecan|irinotecan|mesh-list
55845546|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
55845325|NCT03829462|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55845326|NCT03829462|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55845327|NCT03829462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845328|NCT03829462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845329|NCT03829462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845330|NCT03199924|Diclofenac|diclofenac|mesh-list
55845331|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
55845332|NCT03199924|Lidocaine|lidocaine|mesh-list
55845333|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
55845334|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
55845335|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
55845336|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845337|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845338|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
55845339|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845340|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55845346|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55845347|NCT03199924|Analgesics|analgesics|mesh-ancestor
55845348|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55845349|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55845350|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845351|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
55845352|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55845353|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55845354|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
55845355|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55845356|NCT03199300|Trastuzumab|trastuzumab|mesh-list
55845357|NCT03199300|Bleomycin|bleomycin|mesh-list
55845358|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845359|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55845360|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55845361|NCT04746430|Dexamethasone|dexamethasone|mesh-list
55845362|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55845363|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
55845364|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
55845365|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845366|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845367|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845368|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
55845369|NCT04746430|Hormones|hormones|mesh-ancestor
55845370|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845371|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55845372|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845373|NCT03781414|Tacrolimus|tacrolimus|mesh-list
55845374|NCT03781414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55845375|NCT03781414|Immunologic Factors|immunologic factors|mesh-ancestor
55845376|NCT03781414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845377|NCT03781414|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55845378|NCT03781414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845379|NCT03781414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845386|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845387|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845388|NCT04691986|Niacinamide|niacinamide|mesh-list
55845390|NCT04691986|Nicotinic Acids|nicotinic acids|mesh-list
55845391|NCT04691986|Vitamin B Complex|vitamin b complex|mesh-ancestor
55845392|NCT04691986|Vitamins|vitamins|mesh-ancestor
55845394|NCT04691986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845396|NCT04691986|Antimetabolites|antimetabolites|mesh-ancestor
55845397|NCT04691986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845398|NCT04691986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55845399|NCT04691986|Vasodilator Agents|vasodilator agents|mesh-ancestor
55845400|NCT04407442|Dexamethasone|dexamethasone|mesh-list
55845401|NCT04407442|Dexamethasone acetate|dexamethasone acetate|mesh-list
55845402|NCT04407442|Azacitidine|azacitidine|mesh-list
55845403|NCT04407442|Daratumumab|daratumumab|mesh-list
55845404|NCT04407442|Ichthammol|ichthammol|mesh-list
55845405|NCT04407442|BB 1101|bb 1101|mesh-list
55845406|NCT04407442|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55845407|NCT04407442|Antiemetics|antiemetics|mesh-ancestor
55845408|NCT04407442|Autonomic Agents|autonomic agents|mesh-ancestor
55845409|NCT04407442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845442|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55845443|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845444|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845446|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845447|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55845448|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
55845449|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55845450|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
55845451|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55845452|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845453|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
55845454|NCT01908829|Mirabegron|mirabegron|mesh-list
55845455|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
55845456|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55845457|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
55845458|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845459|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845460|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845461|NCT01908829|Urological Agents|urological agents|mesh-ancestor
55845462|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
55845463|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55845464|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55845465|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
55845466|NCT03764098|Guanfacine|guanfacine|mesh-list
55845467|NCT03764098|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55845468|NCT03764098|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55845469|NCT03764098|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55845470|NCT03764098|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55845471|NCT03764098|Adrenergic Agents|adrenergic agents|mesh-ancestor
55845472|NCT03764098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845473|NCT03764098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845474|NCT03764098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845475|NCT01773122|Dapsone|dapsone|mesh-list
55845476|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845478|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55845479|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55845480|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55845481|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845482|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845483|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
55845484|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55845485|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
55845486|NCT01808534|Ifosfamide|ifosfamide|mesh-list
55845487|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55845488|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
55845489|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845490|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845491|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
55845492|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55845493|NCT03218800|Ertapenem|ertapenem|mesh-list
55845494|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55845495|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845496|NCT01802216|Minocycline|minocycline|mesh-list
55845497|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55845498|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845499|NCT03621904|Tamoxifen|tamoxifen|mesh-list
55845500|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
55845501|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
55845502|NCT03621904|Progesterone|progesterone|mesh-list
55845522|NCT03588754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845523|NCT03588754|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55845524|NCT03588754|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55845525|NCT03588754|Vasodilator Agents|vasodilator agents|mesh-ancestor
55845527|NCT01808144|Lesinurad|lesinurad|mesh-list
55845528|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
55845529|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55845530|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
55845531|NCT01808144|Renal Agents|renal agents|mesh-ancestor
55845532|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
55845533|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55845534|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845535|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55845536|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
55845537|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845538|NCT01801436|Bortezomib|bortezomib|mesh-list
55845539|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845540|NCT01771250|Insulin|insulin|mesh-list
55845541|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55845542|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
55845543|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55845544|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845545|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
55845547|NCT03568708|Estradiol|estradiol|mesh-list
55845548|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
55845549|NCT03568708|Estrogens|estrogens|mesh-list
55845550|NCT03568708|Hormones|hormones|mesh-ancestor
55845551|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845552|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845553|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55845554|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
55845555|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55845567|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55845568|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845569|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55845570|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55845571|NCT04305106|Growth Substances|growth substances|mesh-ancestor
55845572|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845573|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
55845574|NCT04305106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55845575|NCT04305106|Antiemetics|antiemetics|mesh-ancestor
55845576|NCT04305106|Autonomic Agents|autonomic agents|mesh-ancestor
55845577|NCT04305106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845578|NCT04305106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845579|NCT04305106|Glucocorticoids|glucocorticoids|mesh-ancestor
55845581|NCT04305106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845582|NCT04305106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55845583|NCT04305106|Protease Inhibitors|protease inhibitors|mesh-ancestor
55845584|NCT04305106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845585|NCT04305106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845586|NCT04305106|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55845587|NCT04305106|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55845588|NCT01770392|Rifampin|rifampin|mesh-list
55845590|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55845591|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
55845592|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55845593|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845611|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845612|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
55845613|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845614|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845615|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55845616|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845617|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
55845618|NCT03492112|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
55845619|NCT03492112|Velpatasvir|velpatasvir|mesh-list
55845620|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
55845621|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845622|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
55845623|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55845624|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845625|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845626|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55845627|NCT04397458|Dexamethasone|dexamethasone|mesh-list
55845628|NCT04397458|Bupivacaine|bupivacaine|mesh-list
55845629|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55845630|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
55845631|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
55845632|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845633|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845634|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845635|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
55845637|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845638|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55845639|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845640|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
55845641|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
55845642|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845643|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
55845644|NCT04398316|Lidocaine|lidocaine|mesh-list
55845645|NCT04398316|Hydromorphone|hydromorphone|mesh-list
55845647|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
55845649|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845650|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
55845651|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845652|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55845653|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55845654|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55845655|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55845656|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845657|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55845658|NCT04398316|Narcotics|narcotics|mesh-ancestor
55845659|NCT04398316|Analgesics|analgesics|mesh-ancestor
55845660|NCT01576575|Rifampin|rifampin|mesh-list
55845661|NCT01576575|Ketoconazole|ketoconazole|mesh-list
55845662|NCT01576575|Buprenorphine|buprenorphine|mesh-list
55845663|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55845664|NCT01576575|Narcotics|narcotics|mesh-ancestor
55845665|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845666|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845667|NCT01576575|Analgesics|analgesics|mesh-ancestor
55845668|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
55845669|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845670|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55845671|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55845672|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
55845673|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55845674|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845675|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
55845676|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55845677|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845678|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845679|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55845680|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55845681|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55845687|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55845688|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55845689|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
55845690|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845691|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55845692|NCT05051566|Esomeprazole|esomeprazole|mesh-list
55845693|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55845694|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845695|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55845696|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845697|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845698|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
55845699|NCT01576341|Hematinics|hematinics|mesh-ancestor
55845700|NCT04276090|Dexamethasone|dexamethasone|mesh-list
55845701|NCT04276090|Floxuridine|floxuridine|mesh-list
55845702|NCT04276090|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55845703|NCT04276090|Antiemetics|antiemetics|mesh-ancestor
55845704|NCT04276090|Autonomic Agents|autonomic agents|mesh-ancestor
55845705|NCT04276090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845706|NCT04276090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845707|NCT04276090|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845708|NCT04276090|Glucocorticoids|glucocorticoids|mesh-ancestor
55845709|NCT04276090|Hormones|hormones|mesh-ancestor
55845807|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
55845710|NCT04276090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845711|NCT04276090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55845712|NCT04276090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845713|NCT04276090|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55845714|NCT04276090|Antimetabolites|antimetabolites|mesh-ancestor
55845715|NCT04276090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845716|NCT04226248|Rivastigmine|rivastigmine|mesh-list
55845717|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55845718|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845719|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845726|NCT01892722|Interferon-beta|interferon-beta|mesh-list
55845727|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
55845728|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55845729|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845730|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
55845731|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845732|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
55845733|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845734|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55845735|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55845736|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845962|NCT05249920|Protective Agents|protective agents|mesh-ancestor
55845737|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55845739|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55845741|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55845742|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845743|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845744|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55845745|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55845746|NCT01687413|Cisplatin|cisplatin|mesh-list
55845747|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845748|NCT01555671|Meperidine|meperidine|mesh-list
55845749|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55845750|NCT01555671|Narcotics|narcotics|mesh-ancestor
55845751|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845752|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845753|NCT01555671|Analgesics|analgesics|mesh-ancestor
55845757|NCT03226756|Nivolumab|nivolumab|mesh-list
55845770|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55845771|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845772|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55845773|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
55845774|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55845775|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845776|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845777|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845778|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55845779|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845780|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55845781|NCT01769456|Tenofovir|tenofovir|mesh-list
55845783|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55845784|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
55845785|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845786|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55845787|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55845788|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845789|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845790|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55845791|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55845792|NCT01769378|Glimepiride|glimepiride|mesh-list
55845793|NCT01769378|Dulaglutide|dulaglutide|mesh-list
55845794|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55845795|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55845796|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845797|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55845798|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
55845799|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55845800|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
55845801|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845802|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55845803|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
55845804|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845805|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
55845806|NCT01768286|Ledipasvir|ledipasvir|mesh-list
55845808|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845809|NCT01800968|Liraglutide|liraglutide|mesh-list
55845810|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55845811|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845812|NCT01800968|Incretins|incretins|mesh-ancestor
55845813|NCT01800968|Hormones|hormones|mesh-ancestor
55845814|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845815|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
55845816|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
55845817|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55845818|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
55845819|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
55845820|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
55845821|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845822|NCT01687101|Menthol|menthol|mesh-list
55845823|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
55845824|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
55845825|NCT01968967|Bococizumab|bococizumab|mesh-list
55845826|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55845827|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55845828|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
55845829|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846489|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
55845830|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55845831|NCT01806662|Ustekinumab|ustekinumab|mesh-list
55845832|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
55845833|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
55845834|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
55845856|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
55845857|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845858|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55845859|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55845860|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55845861|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55845862|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845863|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
55845864|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
55845865|NCT01806584|Coagulants|coagulants|mesh-ancestor
55845869|NCT01798706|Lixisenatide|lixisenatide|mesh-list
55845870|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
55845871|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845872|NCT01767194|Sirolimus|sirolimus|mesh-list
55845873|NCT01767194|Irinotecan|irinotecan|mesh-list
55845874|NCT01767194|Camptothecin|camptothecin|mesh-list
55845875|NCT01767194|Temozolomide|temozolomide|mesh-list
55845876|NCT01767194|Dinutuximab|dinutuximab|mesh-list
55845877|NCT01767194|Sargramostim|sargramostim|mesh-list
55845878|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55845879|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55845880|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845881|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845882|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845883|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55845896|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55845898|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845899|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
55845900|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55845901|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845902|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845903|NCT01575873|Denosumab|denosumab|mesh-list
55845904|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55845905|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845906|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
55845907|NCT04276636|Antacids|antacids|mesh-ancestor
55845908|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845909|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55845910|NCT00002644|Tamoxifen|tamoxifen|mesh-list
55845911|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55845912|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
55845913|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55845914|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845915|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55845916|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845917|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55845918|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55845919|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55845942|NCT04397770|Apatinib|apatinib|mesh-list
55845943|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55845944|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
55845945|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845946|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845947|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55845948|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55845949|NCT03082846|Temozolomide|temozolomide|mesh-list
55845950|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55845951|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
55845952|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845953|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845954|NCT02397226|Anesthetics|anesthetics|mesh-list
55845955|NCT02397226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55845956|NCT02397226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845957|NCT05249920|Edaravone|edaravone|mesh-list
55845958|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55845959|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
55845960|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845961|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55845963|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845964|NCT01609790|Bevacizumab|bevacizumab|mesh-list
55845965|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55845966|NCT01609790|Trebananib|trebananib|mesh-list
55845967|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
55845968|NCT01609790|Antibodies|antibodies|mesh-list
55845969|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
55845970|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55845971|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
55845972|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55845984|NCT01574703|Bupropion|bupropion|mesh-list
55845985|NCT01574703|Nicotine|nicotine|mesh-list
55845986|NCT01574703|Varenicline|varenicline|mesh-list
55845987|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
55845988|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
55845989|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55845990|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55845991|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55845992|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55845993|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
55845994|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55845995|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55845996|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55845997|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
55845998|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55845999|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55846007|NCT01686633|Xhance|xhance|mesh-list
55846044|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55846045|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
55846046|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55846047|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846048|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55846049|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55846050|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55846051|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55846052|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55846053|NCT03614494|Analgesics|analgesics|mesh-ancestor
55846054|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
55846055|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846056|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846057|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846058|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55846059|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846060|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846061|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
55846062|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846063|NCT04276480|Tazobactam|tazobactam|mesh-list
55846064|NCT04276480|Piperacillin|piperacillin|mesh-list
55846065|NCT04276480|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
55846066|NCT04276480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55846067|NCT04276480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846068|NCT04276480|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55846069|NCT04276480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846070|NCT04276480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846072|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
55846075|NCT01922596|Ropivacaine|ropivacaine|mesh-list
55846088|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846089|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55846090|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
55846091|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
55846092|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55846093|NCT04396990|Prednisolone|prednisolone|mesh-list
55846094|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846095|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
55846096|NCT04396990|Hormones|hormones|mesh-ancestor
55846097|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846098|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846099|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55846100|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846101|NCT03133546|Bevacizumab|bevacizumab|mesh-list
55846102|NCT03133546|Osimertinib|osimertinib|mesh-list
55846103|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55846104|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846105|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55846106|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55846107|NCT03133546|Growth Substances|growth substances|mesh-ancestor
55846108|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846109|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
55846110|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55846111|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846112|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846113|NCT01551303|Oxytocin|oxytocin|mesh-list
55846114|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
55846115|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55846116|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846117|NCT01685073|Zolpidem|zolpidem|mesh-list
55846118|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
55846124|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
55846130|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846131|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846132|NCT01572675|Celecoxib|celecoxib|mesh-list
55846133|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55846134|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55846135|NCT01572675|Analgesics|analgesics|mesh-ancestor
55846136|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
55846137|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846138|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846139|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846140|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846141|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55846142|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55846143|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846144|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846145|NCT01550289|Vaccines|vaccines|mesh-list
55846146|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
55846147|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846148|NCT01968031|Istradefylline|istradefylline|mesh-list
55846149|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
55846150|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55846151|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55846152|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
55846153|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846154|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846155|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846156|NCT01684215|Letrozole|letrozole|mesh-list
55846157|NCT01684215|Palbociclib|palbociclib|mesh-list
55846172|NCT03911739|Buprenorphine|buprenorphine|mesh-list
55846173|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55846174|NCT03911739|Narcotics|narcotics|mesh-ancestor
55846175|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846176|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846177|NCT03911739|Analgesics|analgesics|mesh-ancestor
55846178|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
55846179|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846180|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55846181|NCT01549041|Asenapine|asenapine|mesh-list
55846182|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55846184|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846185|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846186|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55846188|NCT04106115|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
55846189|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55846190|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846191|NCT04106115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55846192|NCT04106115|Immunologic Factors|immunologic factors|mesh-ancestor
55846193|NCT04106115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846194|NCT01907815|Trametinib|trametinib|mesh-list
55846226|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55846227|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55846228|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55846229|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846230|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55846231|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
55846232|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55846233|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846234|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55846235|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55846236|NCT01548573|Growth Substances|growth substances|mesh-ancestor
55846237|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
55846238|NCT01570491|Anesthetics|anesthetics|mesh-list
55846239|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846240|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846241|NCT01518153|Methotrexate|methotrexate|mesh-list
55846242|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
55846243|NCT01518153|Fludarabine|fludarabine|mesh-list
55846244|NCT01518153|Melphalan|melphalan|mesh-list
55846245|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
55846246|NCT01518153|Tacrolimus|tacrolimus|mesh-list
55846247|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55846248|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
55846249|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55846250|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846251|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55846252|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
55846253|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846254|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846255|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
55846256|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846257|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55846258|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55846267|NCT04620343|Anesthetics|anesthetics|mesh-list
55846268|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846269|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846270|NCT01517373|Glimepiride|glimepiride|mesh-list
55846271|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55846272|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55846273|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846274|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55846275|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
55846276|NCT01517295|Hydrocodone|hydrocodone|mesh-list
55846277|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55846278|NCT01517295|Narcotics|narcotics|mesh-ancestor
55846279|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846280|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846281|NCT01517295|Analgesics|analgesics|mesh-ancestor
55846282|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
55846283|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846284|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
55846285|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
55846286|NCT01548417|Mifepristone|mifepristone|mesh-list
55846287|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55846288|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
55846289|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55846290|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846291|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55846292|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55846293|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55846294|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
55846295|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55846296|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55846297|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
55846310|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846311|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55846312|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55846313|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55846314|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846315|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846316|NCT01546857|Antimanic Agents|antimanic agents|mesh-ancestor
55846317|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
55846318|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846319|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
55846320|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
55846321|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55846322|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55846323|NCT00637000|Buprenorphine|buprenorphine|mesh-list
55846324|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
55846325|NCT00637000|Naloxone|naloxone|mesh-list
55846326|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55846327|NCT00637000|Narcotics|narcotics|mesh-ancestor
55846328|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846329|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846330|NCT00637000|Analgesics|analgesics|mesh-ancestor
55846331|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
55846355|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
55846356|NCT00635050|Bevacizumab|bevacizumab|mesh-list
55846357|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55846358|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846359|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
55846360|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
55846361|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
55846362|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846363|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55846364|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
55846365|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846366|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846367|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55846368|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
55846369|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55846370|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55846371|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55846375|NCT01923376|Lactulose|lactulose|mesh-list
55846414|NCT00634114|Esomeprazole|esomeprazole|mesh-list
55846415|NCT00634114|Omeprazole|omeprazole|mesh-list
55846416|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
55846417|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55846418|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55846419|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846420|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846421|NCT00634036|Pioglitazone|pioglitazone|mesh-list
55846422|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55846423|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846424|NCT05241496|Lidocaine|lidocaine|mesh-list
55846425|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
55846426|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
55846427|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846428|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846429|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
55846430|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846431|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55846432|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55846433|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55846434|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55846435|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846436|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55846437|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
55846438|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846439|NCT01539837|Deferiprone|deferiprone|mesh-list
55846440|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55846441|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
55846442|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
55846444|NCT03156790|Asparaginase|asparaginase|mesh-list
55846458|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
55846459|NCT01924078|Capecitabine|capecitabine|mesh-list
55846460|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
55846461|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55846463|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846464|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846465|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55846466|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846467|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55846468|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
55846469|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846470|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846471|NCT00630994|Decitabine|decitabine|mesh-list
55846472|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55846473|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
55846474|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846475|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846476|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846477|NCT03126214|Warfarin|warfarin|mesh-list
55846478|NCT03126214|Anticoagulants|anticoagulants|mesh-list
55846479|NCT01924234|Morphine|morphine|mesh-list
55846480|NCT01924234|Remifentanil|remifentanil|mesh-list
55846481|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55846482|NCT01924234|Narcotics|narcotics|mesh-ancestor
55846483|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846484|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846485|NCT01924234|Analgesics|analgesics|mesh-ancestor
55846486|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
55846487|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846488|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
55846490|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
55846491|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
55846500|NCT01924468|Haloperidol|haloperidol|mesh-list
55846501|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
55846502|NCT01924468|Methylphenidate|methylphenidate|mesh-list
55846503|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55846504|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846505|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55846506|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55846507|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55846508|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846509|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
55846510|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846511|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
55846512|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
55846513|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846514|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55846515|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55846516|NCT01924468|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55846517|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55846518|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55846519|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55846520|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55846521|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
55846522|NCT01923064|Polidocanol|polidocanol|mesh-list
55846523|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846524|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
55846525|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55846549|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846550|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
55846551|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846552|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
55846553|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55846554|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846555|NCT01925092|Mifepristone|mifepristone|mesh-list
55846556|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
55846557|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
55846558|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55846559|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846560|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55846561|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55846562|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55846563|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
55846564|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
55846565|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
55846566|NCT01925092|Hormone Antagonists|hormone antagonists|mesh-ancestor
55846567|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846569|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55846570|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55846571|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
55846572|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55846573|NCT01905943|Chlorambucil|chlorambucil|mesh-list
55846574|NCT01905943|Fludarabine|fludarabine|mesh-list
55846575|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
55846576|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55846577|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
55846578|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846579|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846580|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55846587|NCT01929031|Caffeine|caffeine|mesh-list
55846588|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55846589|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55846590|NCT01929031|Analgesics|analgesics|mesh-ancestor
55846591|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
55846592|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846593|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846594|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846595|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846596|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55846597|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846598|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846599|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55846600|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55846822|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846601|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
55846602|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55846603|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
55846604|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846606|NCT00989092|Hematinics|hematinics|mesh-ancestor
55846607|NCT00988858|Pemetrexed|pemetrexed|mesh-list
55846608|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846609|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846610|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846636|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
55846637|NCT00986986|Vitamins|vitamins|mesh-ancestor
55846713|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846714|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55846715|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55846716|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846717|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846718|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55846719|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
55846720|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846721|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846722|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55846723|NCT00985738|Dutasteride|dutasteride|mesh-list
55846724|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
55846725|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55846726|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846728|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
55846729|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846730|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846731|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
55846733|NCT00985504|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55846734|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55846735|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55846736|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846737|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55846738|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
55846742|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55846752|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
55846753|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846754|NCT04275388|Interferons|interferons|mesh-list
55846755|NCT04275388|Ritonavir|ritonavir|mesh-list
55846756|NCT04275388|Lopinavir|lopinavir|mesh-list
55846757|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
55846758|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
55846759|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846760|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
55846761|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846762|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55846975|NCT05601700|Carboplatin|carboplatin|mesh-list
55846763|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55846764|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
55846765|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846766|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846767|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55846768|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55846769|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55846770|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55846771|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
55846772|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846774|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
55846806|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
55846807|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
55846808|NCT00984568|Prednisolone|prednisolone|mesh-list
55846810|NCT00984568|Azathioprine|azathioprine|mesh-list
55846811|NCT00984568|Infliximab|infliximab|mesh-list
55846812|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846813|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
55846814|NCT00984568|Hormones|hormones|mesh-ancestor
55846815|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846816|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846817|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55846818|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846819|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846820|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55846821|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
55846823|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
55846824|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846825|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55846826|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55846827|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
55846859|NCT01890265|Nintedanib|nintedanib|mesh-list
55846860|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
55846861|NCT01890265|Antibodies|antibodies|mesh-list
55846862|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
55846863|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55846864|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
55846865|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846866|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846867|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55846868|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846869|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846870|NCT01890265|Analgesics|analgesics|mesh-ancestor
55846871|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
55846872|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846873|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55846874|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55846875|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846876|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55846877|NCT01926652|Amlodipine|amlodipine|mesh-list
55846878|NCT01926652|Candesartan|candesartan|mesh-list
55846879|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
55846880|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55846881|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55846882|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55846883|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846910|NCT01928329|Hormones|hormones|mesh-ancestor
55846911|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846912|NCT01890109|Erenumab|erenumab|mesh-list
55846913|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
55846914|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846915|NCT01890109|Analgesics|analgesics|mesh-ancestor
55846916|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
55846917|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55846918|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846919|NCT03069976|Metronidazole|metronidazole|mesh-list
55846920|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55846921|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55846924|NCT00982930|Tobramycin|tobramycin|mesh-list
55846971|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55846972|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55846973|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
55846974|NCT05601700|Paclitaxel|paclitaxel|mesh-list
55846977|NCT05601700|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55846978|NCT05601700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55846979|NCT05601700|Tubulin Modulators|tubulin modulators|mesh-ancestor
55846980|NCT05601700|Antimitotic Agents|antimitotic agents|mesh-ancestor
55846981|NCT05601700|Mitosis Modulators|mitosis modulators|mesh-ancestor
55846982|NCT05601700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55846983|NCT05601700|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55846984|NCT05601700|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55846985|NCT05601700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55846986|NCT05601700|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55846987|NCT05601700|Hormone Antagonists|hormone antagonists|mesh-ancestor
55846988|NCT05601700|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846989|NCT05601700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846990|NCT01927588|Prednisone|prednisone|mesh-list
55846991|NCT01927588|Everolimus|everolimus|mesh-list
55846992|NCT01927588|Tacrolimus|tacrolimus|mesh-list
55846993|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55846994|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
55846995|NCT01927588|Hormones|hormones|mesh-ancestor
55846996|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55846997|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55846998|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55846999|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847017|NCT05601466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55847018|NCT05601466|Antimetabolites|antimetabolites|mesh-ancestor
55847019|NCT05601466|Antiviral Agents|antiviral agents|mesh-ancestor
55847020|NCT05601466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847021|NCT01903837|Naltrexone|naltrexone|mesh-list
55847022|NCT01903837|Olanzapine|olanzapine|mesh-list
55847024|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
55847025|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
55847026|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847027|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847028|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55847029|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55847030|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55847031|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847032|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55847033|NCT01903837|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55847034|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55847035|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55847036|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847037|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847038|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
55847039|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55847040|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55847041|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
55847042|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
55847043|NCT00982696|Mitogens|mitogens|mesh-list
55847044|NCT00982696|Enkephalins|enkephalins|mesh-list
55847045|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
55847046|NCT00982696|Narcotics|narcotics|mesh-ancestor
55847047|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847048|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847063|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55847064|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55847065|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847066|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55847067|NCT00981526|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55847068|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55847069|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55847070|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847071|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847072|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
55847073|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55847074|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55847075|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55847076|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
55847077|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
55847078|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
55847079|NCT04274920|Calcium|calcium|mesh-list
55847080|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55847081|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847082|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
55847083|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55847085|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55847086|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55847087|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847088|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
55847089|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847090|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847091|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55847092|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847093|NCT05607940|Chrysarobin|chrysarobin|mesh-list
55847103|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55847104|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
55847105|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847106|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847107|NCT05600608|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
55847108|NCT05600608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847109|NCT01616173|Dexamethasone|dexamethasone|mesh-list
55847110|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
55847111|NCT01616173|BB 1101|bb 1101|mesh-list
55847112|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847113|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
55847114|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
55847115|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847116|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847117|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55847118|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
55847119|NCT01616173|Hormones|hormones|mesh-ancestor
55847120|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847121|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55847122|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847123|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
55847124|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847125|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847126|NCT05609500|Warfarin|warfarin|mesh-list
55847127|NCT05609500|Anticoagulants|anticoagulants|mesh-ancestor
55847128|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
55847129|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55847130|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
55847131|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847132|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847133|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55847134|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
55847135|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55847136|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
55847142|NCT03044314|Protective Agents|protective agents|mesh-ancestor
55847143|NCT05608642|Prednisolone|prednisolone|mesh-list
55847144|NCT05608642|Lidocaine|lidocaine|mesh-list
55847145|NCT05608642|Anesthetics, Local|anesthetics, local|mesh-ancestor
55847146|NCT05608642|Anesthetics|anesthetics|mesh-ancestor
55847147|NCT05608642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847148|NCT05608642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847149|NCT05608642|Sensory System Agents|sensory system agents|mesh-ancestor
55847150|NCT05608642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847151|NCT05608642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55847152|NCT05608642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55847153|NCT05608642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55847154|NCT05608642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55847155|NCT05608642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847156|NCT05608642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847157|NCT05608642|Glucocorticoids|glucocorticoids|mesh-ancestor
55847158|NCT05608642|Hormones|hormones|mesh-ancestor
55847159|NCT05608642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847160|NCT05608642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55847161|NCT05608642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847162|NCT05608564|Amoxicillin|amoxicillin|mesh-list
55847163|NCT05608564|Metronidazole|metronidazole|mesh-list
55847164|NCT05608564|Tazobactam|tazobactam|mesh-list
55847165|NCT05608564|Piperacillin|piperacillin|mesh-list
55847166|NCT05608564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55847167|NCT05608564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847168|NCT05608564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55847169|NCT05608564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55847170|NCT05608564|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
55847171|NCT05608564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847172|NCT05608564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847185|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55847186|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
55847187|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847188|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847189|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55847190|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55847191|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55847192|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55847193|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55847194|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847195|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847196|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
55847198|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847199|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55847200|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55847201|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
55847202|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
55847203|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
55847237|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847238|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
55847240|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847241|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55847242|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55847243|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55847244|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847245|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847246|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55847247|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55847248|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847249|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
55847250|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847251|NCT03827200|Ambrisentan|ambrisentan|mesh-list
55847252|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55847253|NCT02983630|Penicillins|penicillins|mesh-list
55847254|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55847255|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847256|NCT03827278|Itraconazole|itraconazole|mesh-list
55847257|NCT03827278|Voriconazole|voriconazole|mesh-list
55847258|NCT03827278|Amphotericin B|amphotericin b|mesh-list
55847259|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
55847260|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847261|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
55847262|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55847263|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847264|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847265|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55847266|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
55847267|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847268|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847275|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55847276|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
55847277|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
55847278|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55847279|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847280|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
55847281|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55847282|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847283|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847284|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847285|NCT03109990|Analgesics|analgesics|mesh-ancestor
55847286|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
55847287|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847288|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55847289|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55847290|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55847291|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
55847292|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847293|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847294|NCT03071536|Furosemide|furosemide|mesh-list
55847295|NCT03071536|Diuretics|diuretics|mesh-ancestor
55847296|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
55847297|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847299|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55847300|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847301|NCT01513317|Siltuximab|siltuximab|mesh-list
55847302|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847303|NCT03825250|Valproic Acid|valproic acid|mesh-list
55847304|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
55847305|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847306|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847307|NCT03825250|GABA Agents|gaba agents|mesh-ancestor
55847308|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847309|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847312|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847313|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55847315|NCT03825328|Paclitaxel|paclitaxel|mesh-list
55847316|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
55847317|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55847318|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55847319|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847320|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
55847321|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
55847322|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
55847323|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847324|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55847325|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
55847326|NCT03825328|Antiviral Agents|antiviral agents|mesh-ancestor
55847327|NCT03825328|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847328|NCT03825328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847329|NCT03825328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55847330|NCT03825328|Immunologic Factors|immunologic factors|mesh-ancestor
55847331|NCT03825328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847332|NCT03825016|Diclofenac|diclofenac|mesh-list
55847333|NCT03825016|Lidocaine|lidocaine|mesh-list
55847366|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55847367|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55847368|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
55847369|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
55847370|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
55847371|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
55847372|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
55847373|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847374|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
55847375|NCT03824314|Fentanyl|fentanyl|mesh-list
55847376|NCT03824314|Midazolam|midazolam|mesh-list
55847377|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55847378|NCT03824314|Narcotics|narcotics|mesh-ancestor
55847379|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847380|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847381|NCT03824314|Analgesics|analgesics|mesh-ancestor
55847382|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
55847383|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847384|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55847385|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55847386|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
55847387|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
55847388|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55847389|NCT03824314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55847390|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55847419|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55847420|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847421|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847422|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55847423|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55847424|NCT03823846|Narcotics|narcotics|mesh-ancestor
55847425|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847426|NCT02908750|Fexofenadine|fexofenadine|mesh-list
55847427|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847428|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55847429|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
55847430|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
55847431|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
55847433|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847434|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847435|NCT03823612|Calcium|calcium|mesh-list
55847436|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55847437|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847438|NCT02810704|Aspirin|aspirin|mesh-list
55847439|NCT02810704|Warfarin|warfarin|mesh-list
55847440|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
55847441|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55847442|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847443|NCT02810704|Analgesics|analgesics|mesh-ancestor
55847444|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
55847448|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847465|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
55847466|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847467|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55847468|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847470|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
55847471|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847472|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847473|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847474|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55847475|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55847479|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847480|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
55847481|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
55847482|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
55847483|NCT02735902|Coagulants|coagulants|mesh-ancestor
55847485|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55847486|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
55847487|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847489|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
55847516|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847523|NCT01454440|Eptifibatide|eptifibatide|mesh-list
55847524|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55847525|NCT01454518|Anesthetics|anesthetics|mesh-list
55847526|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
55847527|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847528|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847529|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
55847530|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847532|NCT02983084|Nickel|nickel|mesh-list
55847533|NCT02983084|Trace Elements|trace elements|mesh-ancestor
55847534|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
55847535|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847537|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
55847538|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55847539|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847540|NCT01455532|Gemcitabine|gemcitabine|mesh-list
55847541|NCT01455532|Carboplatin|carboplatin|mesh-list
55847542|NCT01455532|Doxorubicin|doxorubicin|mesh-list
55847543|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55847544|NCT01455532|Iniparib|iniparib|mesh-list
55847545|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847546|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55847547|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
55847548|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847549|NCT01455532|Antiviral Agents|antiviral agents|mesh-ancestor
55847550|NCT01455532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847551|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847552|NCT01455532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55847557|NCT01455532|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55847558|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55847559|NCT01455922|Glimepiride|glimepiride|mesh-list
55847560|NCT01455922|Exenatide|exenatide|mesh-list
55847561|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55847562|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55847563|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847564|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55847565|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
55847566|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
55847567|NCT01455922|Incretins|incretins|mesh-ancestor
55847568|NCT01455922|Hormones|hormones|mesh-ancestor
55847569|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847570|NCT01456234|Oseltamivir|oseltamivir|mesh-list
55847571|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
55847572|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847573|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847574|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847581|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847582|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
55847583|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847584|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55847585|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
55847586|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
55847587|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847588|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847590|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847591|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
55847600|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847601|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847602|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847603|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
55847604|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55847605|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55847606|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847607|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
55847608|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
55847609|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55847610|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847611|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
55847612|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55847613|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847614|NCT01457716|Budesonide|budesonide|mesh-list
55847615|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
55847616|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847617|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55847618|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
55847619|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847624|NCT01457716|Hormones|hormones|mesh-ancestor
55847808|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
55847653|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847654|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55847655|NCT02490904|Diuretics|diuretics|mesh-ancestor
55847656|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
55847657|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55847660|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847661|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55847662|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847663|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847669|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847670|NCT02873806|Tobramycin|tobramycin|mesh-list
55847671|NCT02873806|Dexamethasone|dexamethasone|mesh-list
55847672|NCT02873806|Travoprost|travoprost|mesh-list
55847673|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847674|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
55847675|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
55847676|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847677|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847678|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55847679|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
55847680|NCT02873806|Hormones|hormones|mesh-ancestor
55847706|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55847707|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847708|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847709|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55847710|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847711|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847713|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55847714|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847715|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55847716|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55847717|NCT01891708|Growth Substances|growth substances|mesh-ancestor
55847718|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847719|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
55847721|NCT01892098|Astringents|astringents|mesh-ancestor
55847722|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847723|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
55847724|NCT01892176|Ubiquinone|ubiquinone|mesh-list
55847725|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
55847726|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
55847727|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847728|NCT01892176|Vitamins|vitamins|mesh-ancestor
55847729|NCT01892254|Metformin|metformin|mesh-list
55847730|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55847731|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847754|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847755|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847756|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847757|NCT02809690|Clevudine|clevudine|mesh-list
55847758|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
55847759|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847760|NCT01892644|Deferasirox|deferasirox|mesh-list
55847761|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
55847762|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
55847763|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
55847764|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847765|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
55847766|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55847767|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847768|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
55847769|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
55847770|NCT02798536|Paclitaxel|paclitaxel|mesh-list
55847771|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55847772|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847773|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
55847774|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
55847775|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
55847776|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847777|NCT04758286|Anesthetics|anesthetics|mesh-list
55847778|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847779|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847803|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847804|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847805|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847806|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55847807|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55847809|NCT01893424|Dronabinol|dronabinol|mesh-list
55847810|NCT01893424|Nabiximols|nabiximols|mesh-list
55847811|NCT01893424|Cannabidiol|cannabidiol|mesh-list
55847812|NCT01893424|Piperine|piperine|mesh-list
55847813|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
55847814|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
55847815|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847816|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55847817|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847818|NCT01893424|Analgesics|analgesics|mesh-ancestor
55847819|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
55847820|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847821|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
55847822|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
55847823|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847824|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847825|NCT01893424|Hormones|hormones|mesh-ancestor
55847826|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847827|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55847828|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847852|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
55847853|NCT02773732|Etoposide|etoposide|mesh-list
55847854|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55847855|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847856|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55847857|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55847858|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847859|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847860|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55847861|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847862|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55847863|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55847864|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
55847865|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55847866|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847867|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
55847868|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847869|NCT02735122|Acetaminophen|acetaminophen|mesh-list
55847870|NCT02735122|Ibuprofen|ibuprofen|mesh-list
55847871|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847872|NCT02735122|Analgesics|analgesics|mesh-ancestor
55847873|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
55847874|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847875|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847877|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55847878|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847879|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847880|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55847881|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847882|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847896|NCT02720068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847897|NCT02720068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55847898|NCT02720068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55847899|NCT02720068|Immunologic Factors|immunologic factors|mesh-ancestor
55847900|NCT02720068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55847901|NCT02720068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55847902|NCT02720068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847904|NCT02720068|Protective Agents|protective agents|mesh-ancestor
55847905|NCT02720068|Vitamin B Complex|vitamin b complex|mesh-ancestor
55847907|NCT02720068|Micronutrients|micronutrients|mesh-ancestor
55847908|NCT02720068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55847909|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55847910|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55847911|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55847912|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55847913|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847914|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
55847915|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55847916|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847917|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55847918|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847919|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
55847920|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55847921|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
55847922|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847923|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847924|NCT01893658|Omalizumab|omalizumab|mesh-list
55847925|NCT01893658|Prednisone|prednisone|mesh-list
55847926|NCT01893658|Prednisolone|prednisolone|mesh-list
55847927|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847928|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
55847929|NCT01893658|Hormones|hormones|mesh-ancestor
55847930|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55847931|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847932|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55847933|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847934|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55847935|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55847936|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
55847937|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
55847938|NCT02707588|Cetuximab|cetuximab|mesh-list
55847939|NCT02707588|Antibodies|antibodies|mesh-list
55847940|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
55847941|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
55847942|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847943|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55847944|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847945|NCT02703610|Acetaminophen|acetaminophen|mesh-list
55847946|NCT02703610|Ibuprofen|ibuprofen|mesh-list
55847947|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
55847948|NCT02703610|Oxycodone|oxycodone|mesh-list
55847949|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55847950|NCT02703610|Analgesics|analgesics|mesh-ancestor
55847951|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
55847952|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55847953|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847954|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
55847955|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55847956|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55847957|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847958|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55847959|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847960|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847961|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55847962|NCT02703610|Narcotics|narcotics|mesh-ancestor
55847963|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55847965|NCT02688556|Cyclosporins|cyclosporins|mesh-list
55847967|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847968|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55847969|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
55847970|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847971|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
55847972|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55847973|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
55847974|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55847975|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55847976|NCT02684578|Metformin|metformin|mesh-list
55847977|NCT02684578|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55847978|NCT02684578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55847980|NCT02684032|Fulvestrant|fulvestrant|mesh-list
55847981|NCT02684032|Palbociclib|palbociclib|mesh-list
55847982|NCT02684032|Gedatolisib|gedatolisib|mesh-list
55847983|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55847984|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55847985|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55847986|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55847987|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55847988|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55847989|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
55847995|NCT02388178|Fluorides|fluorides|mesh-list
55848003|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848004|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55848005|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55848006|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
55848007|NCT01898923|Laxatives|laxatives|mesh-ancestor
55848008|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55848009|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
55848010|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55848011|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848012|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55848013|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55848014|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55848015|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848016|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
55848017|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848018|NCT01886287|Octreotide|octreotide|mesh-list
55848019|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55848020|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55848021|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848022|NCT05602480|Vaccines|vaccines|mesh-list
55848023|NCT05602480|Immunologic Factors|immunologic factors|mesh-ancestor
55848024|NCT05602480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848025|NCT05600296|Levobupivacaine|levobupivacaine|mesh-list
55848026|NCT05600296|Anesthetics, Local|anesthetics, local|mesh-ancestor
55848027|NCT05600296|Anesthetics|anesthetics|mesh-ancestor
55848028|NCT05600296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55848029|NCT05600296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848030|NCT05600296|Sensory System Agents|sensory system agents|mesh-ancestor
55848033|NCT05604586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55848034|NCT05604586|Antiviral Agents|antiviral agents|mesh-ancestor
55848043|NCT05604586|Antidotes|antidotes|mesh-ancestor
55848044|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
55848045|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
55848046|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848047|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
55848048|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848049|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55848050|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55848051|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
55848052|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848053|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848054|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55848055|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55848057|NCT05604118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55848058|NCT05604118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55848060|NCT05604118|Sensory System Agents|sensory system agents|mesh-ancestor
55848061|NCT05604118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848062|NCT05604118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848063|NCT05604118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848064|NCT05604118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55848065|NCT05604118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55848066|NCT05604118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55848067|NCT05604118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848068|NCT05604118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55848069|NCT05604118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55848070|NCT05604118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848071|NCT05604118|Antipyretics|antipyretics|mesh-ancestor
55848072|NCT05603884|Cytarabine|cytarabine|mesh-list
55848073|NCT05603884|Azacitidine|azacitidine|mesh-list
55848074|NCT05603884|Venetoclax|venetoclax|mesh-list
55848075|NCT05603884|Mitoxantrone|mitoxantrone|mesh-list
55848076|NCT05603884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55848085|NCT05603884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848086|NCT05603884|Analgesics|analgesics|mesh-ancestor
55848087|NCT05603884|Sensory System Agents|sensory system agents|mesh-ancestor
55848088|NCT05603884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848089|NCT05603884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55848090|NCT05603884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55848091|NCT05603650|Listerine|listerine|mesh-list
55848092|NCT05603650|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55848093|NCT05603650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848094|NCT04129060|Cholinergic Agents|cholinergic agents|mesh-list
55848095|NCT04129060|Cholinergic Antagonists|cholinergic antagonists|mesh-list
55848096|NCT04129060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848097|NCT04129060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848098|NCT04129060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848099|NCT04126096|Lactams|lactams|mesh-list
55848100|NCT04126096|beta-Lactams|beta-lactams|mesh-list
55848101|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55848102|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848103|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
55848104|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
55848105|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
55848106|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848107|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
55848109|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848133|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55848135|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848136|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55848138|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
55848139|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848140|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
55848141|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55848142|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55848143|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
55848144|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848145|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848146|NCT03017326|Gemcitabine|gemcitabine|mesh-list
55848147|NCT03017326|Carboplatin|carboplatin|mesh-list
55848148|NCT03017326|Doxorubicin|doxorubicin|mesh-list
55848149|NCT03017326|Fluorouracil|fluorouracil|mesh-list
55848150|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
55848151|NCT03017326|Irinotecan|irinotecan|mesh-list
55848152|NCT03017326|Etoposide|etoposide|mesh-list
55848153|NCT03017326|Vincristine|vincristine|mesh-list
55848154|NCT03017326|Sorafenib|sorafenib|mesh-list
55848155|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848189|NCT03012880|Hormones|hormones|mesh-ancestor
55848190|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848191|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55848192|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848193|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
55848194|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55848195|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55848196|NCT03012880|Growth Substances|growth substances|mesh-ancestor
55848197|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
55848198|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848199|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
55848200|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848201|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
55848202|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
55848203|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848205|NCT04126330|Vitamins|vitamins|mesh-ancestor
55848206|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
55848207|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848208|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55848209|NCT04126720|Vitamin E|vitamin e|mesh-list
55848210|NCT04126720|Vitamins|vitamins|mesh-ancestor
55848212|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848213|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
55848214|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848215|NCT04126720|Protective Agents|protective agents|mesh-ancestor
55848216|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
55848217|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848218|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
55848219|NCT04126252|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
55848220|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
55848221|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848231|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
55848232|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
55848233|NCT03007732|Androgens|androgens|mesh-list
55848234|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55848235|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848236|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848237|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
55848238|NCT03007732|Hormones|hormones|mesh-ancestor
55848239|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848240|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848241|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55848242|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55848243|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
55848244|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55848245|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55848246|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848247|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848248|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
55848249|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55848250|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
55848251|NCT03007732|Protective Agents|protective agents|mesh-ancestor
55848252|NCT03007732|Vitamins|vitamins|mesh-ancestor
55848253|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
55848254|NCT03007732|Estrogens|estrogens|mesh-ancestor
55848255|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
55848256|NCT03007420|Lidocaine|lidocaine|mesh-list
55848257|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
55848258|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
55848259|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55848260|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848261|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
55848262|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848263|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55848264|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55848265|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55848267|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848268|NCT04125706|Metronidazole|metronidazole|mesh-list
55848269|NCT04125706|Minocycline|minocycline|mesh-list
55848270|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848271|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55848272|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55848273|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55848274|NCT03005782|Cemiplimab|cemiplimab|mesh-list
55848275|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55848276|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848277|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55848278|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
55848279|NCT04125082|Insulin|insulin|mesh-list
55848280|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55848281|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55848282|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848283|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
55848284|NCT04393246|Ambrisentan|ambrisentan|mesh-list
55848285|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55848286|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848287|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55848288|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848289|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55848290|NCT04124302|Insulin|insulin|mesh-list
55848291|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55848292|NCT04124302|Insulin Aspart|insulin aspart|mesh-list
55848293|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
55848294|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
55848295|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55848296|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848297|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
55848298|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55848299|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848310|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55848311|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
55848312|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55848313|NCT04411069|Dopamine Agents|dopamine agents|mesh-ancestor
55848314|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848315|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848316|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
55848317|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55848318|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
55848319|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848320|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
55848321|NCT03003130|Protective Agents|protective agents|mesh-ancestor
55848322|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
55848323|NCT01884571|Prednisone|prednisone|mesh-list
55848324|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
55848325|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55848326|NCT01884571|Tacrolimus|tacrolimus|mesh-list
55848327|NCT01884571|Basiliximab|basiliximab|mesh-list
55848328|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848329|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
55848330|NCT01884571|Hormones|hormones|mesh-ancestor
55848331|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848332|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848333|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55848334|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848335|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848336|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
55848337|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55848338|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848339|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848340|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55848341|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55848342|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
55848344|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848352|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55848354|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55848355|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
55848356|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848357|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848358|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
55848360|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55848361|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55848362|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848363|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55848364|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848365|NCT04123210|Vitamin A|vitamin a|mesh-list
55848366|NCT04123210|Vitamins|vitamins|mesh-ancestor
55848367|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
55848414|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
55848415|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848416|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55848417|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848418|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55848421|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848422|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55848423|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
55848424|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
55848425|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848426|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848428|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
55848473|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55848474|NCT01895335|Analgesics|analgesics|mesh-ancestor
55848475|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
55848476|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848477|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848478|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848479|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55848480|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848481|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
55848482|NCT02980510|Leucovorin|leucovorin|mesh-list
55848483|NCT02980510|Folic Acid|folic acid|mesh-list
55848484|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
55848485|NCT02980510|Irinotecan|irinotecan|mesh-list
55848486|NCT02980510|Panitumumab|panitumumab|mesh-list
55848489|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848490|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55848491|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55848492|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848493|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848494|NCT02980510|Antidotes|antidotes|mesh-ancestor
55848495|NCT02980510|Protective Agents|protective agents|mesh-ancestor
55848496|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848497|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
55848498|NCT02980510|Vitamins|vitamins|mesh-ancestor
55848499|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
55848500|NCT02980510|Hematinics|hematinics|mesh-ancestor
55848524|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848525|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
55848526|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55848527|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
55848528|NCT03829774|Acetaminophen|acetaminophen|mesh-list
55848529|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55848530|NCT03829774|Analgesics|analgesics|mesh-ancestor
55848531|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
55848532|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848533|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848534|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
55848535|NCT02977780|Temozolomide|temozolomide|mesh-list
55848536|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55848537|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
55848538|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848539|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848540|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
55848541|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
55848542|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
55848543|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848544|NCT02972398|Expectorants|expectorants|mesh-ancestor
55848545|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
55848546|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
55848547|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
55848548|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848549|NCT02972398|Protective Agents|protective agents|mesh-ancestor
55848550|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848551|NCT02972398|Antidotes|antidotes|mesh-ancestor
55848552|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55848553|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
55848568|NCT03828682|Prednisone|prednisone|mesh-list
55848569|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
55848570|NCT03828682|Tacrolimus|tacrolimus|mesh-list
55848571|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
55848572|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55848573|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848574|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
55848575|NCT03828682|Hormones|hormones|mesh-ancestor
55848576|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848577|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848578|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55848579|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848580|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848581|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
55848582|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55848583|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848584|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848585|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55848586|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55848587|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
55848588|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55848589|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848590|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
55848591|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
55848592|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848593|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55848594|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55848595|NCT03828682|Protective Agents|protective agents|mesh-ancestor
55848596|NCT03483649|Bevacizumab|bevacizumab|mesh-list
55848597|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55848598|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848599|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55848600|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55848610|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848611|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848612|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848613|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848614|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55848615|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55848617|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
55848618|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848619|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848620|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55848621|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
55848622|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55848623|NCT01894477|Fludarabine|fludarabine|mesh-list
55848624|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
55848625|NCT01894477|Treosulfan|treosulfan|mesh-list
55848626|NCT01894477|Busulfan|busulfan|mesh-list
55848627|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848629|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
55848630|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848631|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848632|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
55848633|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848634|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55848635|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
55848636|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55848637|NCT04391998|Metronidazole|metronidazole|mesh-list
55848638|NCT04391998|Albendazole|albendazole|mesh-list
55848655|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848656|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55848657|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
55848658|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848659|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848660|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55848661|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
55848662|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
55848663|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55848664|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55848665|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55848666|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55848667|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
55848668|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848669|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848670|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
55848671|NCT03820180|Hormones|hormones|mesh-ancestor
55848672|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848673|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
55848674|NCT01894243|Olaparib|olaparib|mesh-list
55848675|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55848676|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848677|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848678|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848679|NCT01450384|Pemetrexed|pemetrexed|mesh-list
55848680|NCT01450384|Sorafenib|sorafenib|mesh-list
55848681|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848682|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848683|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848684|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55848685|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55848686|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55848687|NCT01450462|Vitamin D|vitamin d|mesh-list
55848688|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
55848689|NCT01450462|Vitamins|vitamins|mesh-ancestor
55848693|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55848694|NCT01450774|Beclomethasone|beclomethasone|mesh-list
55848695|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
55848696|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55848697|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
55848698|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848699|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848700|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55848701|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
55848702|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55848703|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55848704|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55848708|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848709|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
55848710|NCT01450774|Hormones|hormones|mesh-ancestor
55848711|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848712|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
55848713|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55848714|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55848715|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55848716|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848717|NCT02913196|Prednisone|prednisone|mesh-list
55848718|NCT02913196|Docetaxel|docetaxel|mesh-list
55848719|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
55848738|NCT01451710|Prednisone|prednisone|mesh-list
55848739|NCT01451710|Prednisolone|prednisolone|mesh-list
55848740|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55848741|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
55848742|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55848743|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
55848744|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55848745|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
55848746|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848747|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
55848748|NCT01451710|Hormones|hormones|mesh-ancestor
55848749|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55848750|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848751|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55848752|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848753|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
55848754|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
55848755|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848756|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55848757|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55848758|NCT01451710|Protective Agents|protective agents|mesh-ancestor
55848759|NCT01451788|Thrombin|thrombin|mesh-list
55848760|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
55848761|NCT01451788|Coagulants|coagulants|mesh-ancestor
55848762|NCT03553810|Valsartan|valsartan|mesh-list
55848763|NCT03553810|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
55848764|NCT03553810|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55848765|NCT03553810|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55848766|NCT03553810|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55848767|NCT03553810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848768|NCT01452100|Prednisone|prednisone|mesh-list
55848769|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848770|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
55848771|NCT01452100|Hormones|hormones|mesh-ancestor
55848779|NCT02638090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848780|NCT02638090|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55848781|NCT02638090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848782|NCT02638090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848784|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55848785|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848786|NCT01452568|Aspirin|aspirin|mesh-list
55848787|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
55848788|NCT01452568|Salicylates|salicylates|mesh-list
55848789|NCT01452568|Warfarin|warfarin|mesh-list
55848790|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55848791|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55848792|NCT01452568|Analgesics|analgesics|mesh-ancestor
55848793|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
55848794|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848795|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848796|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848797|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55848798|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55848799|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55848800|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848831|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
55848832|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848833|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55848834|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55848835|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848836|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848837|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
55848839|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848840|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
55848841|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848842|NCT01453504|Everolimus|everolimus|mesh-list
55848843|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848844|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848845|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
55848846|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848847|NCT01453582|Propolis|propolis|mesh-list
55848848|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848849|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
55848850|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
55848851|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55848852|NCT04847752|Aspirin|aspirin|mesh-list
55848853|NCT04847752|Warfarin|warfarin|mesh-list
55848854|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
55848855|NCT04847752|Dabigatran|dabigatran|mesh-list
55848856|NCT04847752|Anticoagulants|anticoagulants|mesh-list
55848857|NCT04847752|Clopidogrel|clopidogrel|mesh-list
55848858|NCT04847752|Atorvastatin|atorvastatin|mesh-list
55848859|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
55848860|NCT04847752|Evolocumab|evolocumab|mesh-list
55848861|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
55848862|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55848863|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55848864|NCT04847752|Analgesics|analgesics|mesh-ancestor
55848865|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
55848866|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848869|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55848872|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848873|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55848874|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55848875|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848876|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
55848877|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55848878|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55848879|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
55848880|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55848881|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
55848882|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
55848883|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
55848884|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
55848885|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848886|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
55848887|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
55848888|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55848889|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
55848890|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
55848891|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
55848892|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
55848893|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848894|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55848895|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
55848896|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55848897|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848898|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55848899|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55848900|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55848901|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
55848914|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
55848915|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
55848916|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
55848917|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848918|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
55848919|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55848920|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848921|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
55848922|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848924|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55848925|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
55848926|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55848927|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848928|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55848929|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
55848930|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848931|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848932|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
55848933|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848934|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55848935|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848936|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
55848937|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55848938|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55848940|NCT04840342|Eplerenone|eplerenone|mesh-list
55848941|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55848942|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
55848956|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55848957|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
55848958|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848959|NCT05021926|Lidocaine|lidocaine|mesh-list
55848960|NCT05021926|Hyaluronic Acid|hyaluronic acid|mesh-list
55848961|NCT05021926|Anesthetics, Local|anesthetics, local|mesh-ancestor
55848962|NCT05021926|Anesthetics|anesthetics|mesh-ancestor
55848963|NCT05021926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55848964|NCT05021926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848965|NCT05021926|Sensory System Agents|sensory system agents|mesh-ancestor
55848966|NCT05021926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848967|NCT05021926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55848968|NCT05021926|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55848969|NCT05021926|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55848970|NCT05021926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55848971|NCT05021926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848972|NCT05021926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55848973|NCT05021926|Immunologic Factors|immunologic factors|mesh-ancestor
55848974|NCT05021926|Viscosupplements|viscosupplements|mesh-ancestor
55848975|NCT05021926|Protective Agents|protective agents|mesh-ancestor
55848976|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
55848977|NCT05024188|Metronidazole|metronidazole|mesh-list
55848978|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
55848979|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55848980|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55848981|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55848982|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55848983|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55848984|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55848985|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55848986|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55848987|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
55848988|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55848989|NCT05029960|Brivaracetam|brivaracetam|mesh-list
55848990|NCT05029960|Anticonvulsants|anticonvulsants|mesh-ancestor
55848991|NCT04390594|Nafamostat|nafamostat|mesh-list
55848995|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
55848996|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55848997|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55848998|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55848999|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849000|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
55849001|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
55849002|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849003|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849004|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
55849005|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
55849006|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
55849007|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849008|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
55849009|NCT02839642|Rivastigmine|rivastigmine|mesh-list
55849010|NCT02839642|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
55849011|NCT02839642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849012|NCT02839642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849013|NCT02839642|Cholinergic Agents|cholinergic agents|mesh-ancestor
55849014|NCT02839642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849015|NCT02839642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849016|NCT02839642|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
55849017|NCT02839642|Protective Agents|protective agents|mesh-ancestor
55849018|NCT05024422|Pyridoxine|pyridoxine|mesh-list
55849019|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
55849020|NCT05024422|Cabergoline|cabergoline|mesh-list
55849021|NCT05024422|Vitamins|vitamins|mesh-ancestor
55849022|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
55849023|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849024|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
55849025|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55849026|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55849027|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
55849028|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
55849029|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849033|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849035|NCT02818894|Lidocaine|lidocaine|mesh-list
55849036|NCT02818894|Bupivacaine|bupivacaine|mesh-list
55849037|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
55849038|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
55849039|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55849040|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849041|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
55849042|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849043|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55849044|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55849045|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55849046|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55849047|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849048|NCT02668666|Tamoxifen|tamoxifen|mesh-list
55849049|NCT02668666|Palbociclib|palbociclib|mesh-list
55849050|NCT02668666|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55849051|NCT02668666|Hormone Antagonists|hormone antagonists|mesh-ancestor
55849052|NCT02668666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849053|NCT02668666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849054|NCT02668666|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55849055|NCT02668666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849056|NCT02668666|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
55849057|NCT02668666|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
55849058|NCT02668666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55849077|NCT05586568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849078|NCT05586568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55849079|NCT05586568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55849080|NCT05586568|Antitubercular Agents|antitubercular agents|mesh-ancestor
55849081|NCT05586568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55849082|NCT05586568|Leprostatic Agents|leprostatic agents|mesh-ancestor
55849083|NCT05586568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55849084|NCT05586568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
55849085|NCT05586568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55849086|NCT05586568|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
55849087|NCT05586568|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
55849088|NCT05586568|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
55849089|NCT05586568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55849091|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849092|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849093|NCT02632708|Cytarabine|cytarabine|mesh-list
55849094|NCT02632708|Etoposide|etoposide|mesh-list
55849095|NCT02632708|Daunorubicin|daunorubicin|mesh-list
55849096|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
55849097|NCT02632708|Idarubicin|idarubicin|mesh-list
55849098|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849099|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849126|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55849127|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849128|NCT02608216|Paclitaxel|paclitaxel|mesh-list
55849129|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849130|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849131|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
55849132|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
55849133|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
55849134|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849135|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
55849136|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
55849137|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
55849138|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55849139|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849140|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
55849141|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
55849142|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55849143|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849144|NCT02559778|Eflornithine|eflornithine|mesh-list
55849149|NCT02559778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849150|NCT02559778|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55849151|NCT02559778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849152|NCT02559778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849153|NCT02559778|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
55849154|NCT02559778|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55849155|NCT02559778|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55849156|NCT02559778|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55849246|NCT02523976|Etoposide|etoposide|mesh-list
55849247|NCT02523976|Vincristine|vincristine|mesh-list
55849248|NCT02523976|Daunorubicin|daunorubicin|mesh-list
55849249|NCT02523976|Dasatinib|dasatinib|mesh-list
55849250|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
55849251|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
55849252|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849253|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
55849254|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849255|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849256|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55849257|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
55849258|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849259|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849260|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55849261|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849262|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
55849263|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
55849264|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849265|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55849266|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
55849267|NCT02523976|Hormones|hormones|mesh-ancestor
55849268|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849269|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55849270|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55849271|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
55849272|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55849273|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55849274|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
55849275|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
55849276|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849289|NCT02523976|Analgesics|analgesics|mesh-ancestor
55849290|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
55849291|NCT02523040|Lenalidomide|lenalidomide|mesh-list
55849292|NCT02523040|Immunologic Factors|immunologic factors|mesh-ancestor
55849293|NCT02523040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849294|NCT02523040|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55849295|NCT02523040|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55849296|NCT02523040|Growth Substances|growth substances|mesh-ancestor
55849297|NCT02523040|Growth Inhibitors|growth inhibitors|mesh-ancestor
55849298|NCT02523040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849299|NCT02514382|Dexamethasone|dexamethasone|mesh-list
55849300|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
55849302|NCT02514382|Ichthammol|ichthammol|mesh-list
55849303|NCT02514382|BB 1101|bb 1101|mesh-list
55849304|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849305|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
55849306|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
55849308|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849309|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55849310|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
55849311|NCT02514382|Hormones|hormones|mesh-ancestor
55849312|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849313|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55849314|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849341|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
55849342|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55849343|NCT02493322|Diuretics|diuretics|mesh-ancestor
55849344|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
55849345|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849346|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
55849347|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55849348|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849349|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
55849350|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
55849351|NCT04757974|Fostemsavir|fostemsavir|mesh-list
55849352|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55849353|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55849354|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
55849355|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849356|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
55849357|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
55849358|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849359|NCT04757506|Naltrexone|naltrexone|mesh-list
55849360|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55849361|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55849362|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849363|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
55849364|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849365|NCT02477644|Olaparib|olaparib|mesh-list
55849366|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
55849367|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849368|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849369|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849384|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849385|NCT01894048|Beclomethasone|beclomethasone|mesh-list
55849386|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849387|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
55849388|NCT01894048|Hormones|hormones|mesh-ancestor
55849389|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849390|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849391|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55849392|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
55849393|NCT02420860|Lenalidomide|lenalidomide|mesh-list
55849394|NCT02420860|Elotuzumab|elotuzumab|mesh-list
55849395|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
55849396|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849398|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55849399|NCT02420860|Growth Substances|growth substances|mesh-ancestor
55849400|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
55849401|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849402|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
55849403|NCT02420314|Paclitaxel|paclitaxel|mesh-list
55849404|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55849405|NCT02420314|Carboplatin|carboplatin|mesh-list
55849406|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849407|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849439|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
55849440|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
55849441|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55849442|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55849443|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55849444|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55849445|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
55849446|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849447|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849448|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
55849449|NCT04746040|Hormones|hormones|mesh-ancestor
55849450|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849451|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
55849452|NCT02400814|Atezolizumab|atezolizumab|mesh-list
55849453|NCT02400814|Antibodies|antibodies|mesh-list
55849454|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55849455|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
55849456|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849457|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849458|NCT02398240|Rituximab|rituximab|mesh-list
55849459|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55849460|NCT02398240|Doxorubicin|doxorubicin|mesh-list
55849461|NCT02398240|Vincristine|vincristine|mesh-list
55849462|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849463|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849464|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
55849466|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849489|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849490|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55849491|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849492|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849493|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
55849494|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849496|NCT02363374|Protective Agents|protective agents|mesh-ancestor
55849497|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
55849498|NCT02363374|Vitamins|vitamins|mesh-ancestor
55849504|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849505|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
55849506|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849507|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849508|NCT02344186|Liraglutide|liraglutide|mesh-list
55849509|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55849510|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849511|NCT02344186|Incretins|incretins|mesh-ancestor
55849512|NCT02344186|Hormones|hormones|mesh-ancestor
55849513|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849514|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
55849515|NCT01537887|Evacetrapib|evacetrapib|mesh-list
55849516|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55849538|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849539|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55849540|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
55849541|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55849542|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849543|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849544|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849545|NCT01928056|Montelukast|montelukast|mesh-list
55849546|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55849547|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
55849548|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
55849549|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
55849550|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849551|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849552|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
55849553|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55849554|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849556|NCT05585866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55849557|NCT05585866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849559|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55849560|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849561|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55849562|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55849563|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
55849564|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849565|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849566|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
55849567|NCT01928134|Calcium|calcium|mesh-list
55849568|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55849569|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849570|NCT01928134|Antacids|antacids|mesh-ancestor
55849574|NCT02285140|Cefazolin|cefazolin|mesh-list
55849575|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55849576|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849577|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55849578|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55849579|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55849580|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55849581|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849582|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
55849583|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849584|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849585|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55849586|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849587|NCT04756492|Cyclosporine|cyclosporine|mesh-list
55849588|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
55849589|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849590|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
55849591|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849592|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849593|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849594|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
55849595|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849625|NCT02257138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849626|NCT02257138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849628|NCT01928914|Tafenoquine|tafenoquine|mesh-list
55849629|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55849630|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849631|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55849632|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55849634|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849635|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849636|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
55849637|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55849638|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55849639|NCT02249104|Adapalene|adapalene|mesh-list
55849640|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
55849641|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
55849642|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
55849643|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55849644|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55849645|NCT02249104|Analgesics|analgesics|mesh-ancestor
55849646|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
55849647|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849648|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849649|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849650|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849651|NCT01927744|Docetaxel|docetaxel|mesh-list
55849652|NCT01927744|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55849653|NCT01927744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849654|NCT01927744|Tubulin Modulators|tubulin modulators|mesh-ancestor
55849670|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55849671|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
55849672|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
55849673|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849674|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849675|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
55849676|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55849677|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55849678|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55849679|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55849680|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849681|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
55849682|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849683|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849684|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55849685|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849686|NCT01916278|Lidocaine|lidocaine|mesh-list
55849687|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
55849688|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
55849689|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55849690|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849691|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
55849692|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849693|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55849694|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
55849695|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55849696|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55849697|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849698|NCT01905046|Metformin|metformin|mesh-list
55849699|NCT01905046|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55849700|NCT01905046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849710|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849711|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
55849712|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849714|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
55849715|NCT02223208|Doxorubicin|doxorubicin|mesh-list
55849716|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55849717|NCT02223208|Etoposide|etoposide|mesh-list
55849718|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
55849719|NCT02223208|Romidepsin|romidepsin|mesh-list
55849720|NCT02223208|Vincristine|vincristine|mesh-list
55849721|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849722|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
55849723|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849724|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849725|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55849726|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
55849727|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849728|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849729|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55849730|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849731|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55849732|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55849734|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849737|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849738|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55849739|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849741|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
55849742|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
55849743|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
55849744|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55849751|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849752|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55849753|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849754|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849755|NCT01516606|Clarithromycin|clarithromycin|mesh-list
55849756|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55849757|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849758|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
55849759|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849760|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849761|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55849762|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55849763|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
55849764|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
55849765|NCT02209636|Vitamins|vitamins|mesh-ancestor
55849766|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
55849767|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849768|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
55849769|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849771|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
55849772|NCT01508325|Metoprolol|metoprolol|mesh-list
55849773|NCT01508325|Bisoprolol|bisoprolol|mesh-list
55849774|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55849775|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55849776|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
55849777|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
55849778|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849779|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849780|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
55849781|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
55849782|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55849783|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
55849784|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849793|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55849794|NCT01506856|Carboplatin|carboplatin|mesh-list
55849795|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849796|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849797|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
55849798|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
55849799|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
55849800|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849801|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
55849802|NCT02191930|Doxorubicin|doxorubicin|mesh-list
55849803|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
55849804|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55849805|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849806|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
55849807|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849808|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849809|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55849810|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
55849811|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849812|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849813|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55849814|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849815|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55849816|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55849839|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
55849840|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849841|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55849842|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
55849843|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849844|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55849845|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849846|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
55849848|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55849849|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55849850|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55849851|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
55849852|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
55849853|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
55849854|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849855|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55849856|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55849857|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849859|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849860|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55849861|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
55849862|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849863|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849864|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55849865|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
55849866|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
55849867|NCT01484691|Hormones|hormones|mesh-ancestor
55849883|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55849884|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55849885|NCT01464034|Growth Substances|growth substances|mesh-ancestor
55849886|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
55849887|NCT01535235|Lisinopril|lisinopril|mesh-list
55849888|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
55849889|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
55849890|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849891|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849892|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
55849893|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
55849894|NCT01535235|Protective Agents|protective agents|mesh-ancestor
55849895|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849896|NCT02317744|Naltrexone|naltrexone|mesh-list
55849897|NCT02317744|Bupropion|bupropion|mesh-list
55849898|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
55849899|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
55849900|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849901|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
55849902|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55849903|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55849904|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
55849905|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55849906|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55849907|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55849908|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55849909|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849910|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
55849911|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849914|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849927|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849928|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55849929|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
55849930|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849931|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849932|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55849933|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55849934|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55849935|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55849936|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
55849937|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
55849938|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55849939|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55849940|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
55849941|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55849942|NCT02144584|Memantine|memantine|mesh-list
55849943|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55849944|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55849945|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
55849946|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55849947|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55849948|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849949|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55849951|NCT05577442|Trastuzumab|trastuzumab|mesh-list
55849952|NCT05577442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849953|NCT05577442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849955|NCT01895764|Methotrexate|methotrexate|mesh-list
55849956|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55849957|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
55849958|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55849959|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849966|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55849967|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55849968|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
55849969|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849970|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55849971|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55849972|NCT01415752|Rituximab|rituximab|mesh-list
55849973|NCT01415752|Lenalidomide|lenalidomide|mesh-list
55849974|NCT01415752|Bortezomib|bortezomib|mesh-list
55849975|NCT01415752|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
55849976|NCT01415752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55849977|NCT01415752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55849978|NCT01415752|Immunologic Factors|immunologic factors|mesh-ancestor
55849979|NCT01415752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55849980|NCT01415752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55849981|NCT01415752|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55849982|NCT01415752|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55849983|NCT01415752|Growth Substances|growth substances|mesh-ancestor
55849984|NCT01415752|Growth Inhibitors|growth inhibitors|mesh-ancestor
55850022|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
55850023|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850024|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850025|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850026|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
55850028|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850029|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55850030|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
55850031|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
55850032|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55850033|NCT01787500|Cetuximab|cetuximab|mesh-list
55850034|NCT01787500|Irinotecan|irinotecan|mesh-list
55850035|NCT01787500|Camptothecin|camptothecin|mesh-list
55850036|NCT01787500|Vemurafenib|vemurafenib|mesh-list
55850037|NCT01787500|Antibodies|antibodies|mesh-list
55850038|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
55850039|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55850040|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
55850041|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850042|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850043|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55850044|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55850045|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850046|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850047|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55850048|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55850049|NCT01782352|Vitamin D|vitamin d|mesh-list
55850050|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
55850051|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
55850052|NCT01782352|Vitamins|vitamins|mesh-list
55850053|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
55850054|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850057|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
55850064|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850065|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850066|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55850067|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850068|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
55850069|NCT01895218|Hematinics|hematinics|mesh-ancestor
55850071|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55850072|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
55850073|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850074|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850075|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55850076|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
55850085|NCT02073994|Ivosidenib|ivosidenib|mesh-list
55850124|NCT01659658|Lenalidomide|lenalidomide|mesh-list
55850127|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
55850128|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850129|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55850130|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55850131|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
55850132|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850133|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850134|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55850135|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55850136|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
55850137|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
55850138|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850139|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850140|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
55850141|NCT01659658|Hormones|hormones|mesh-ancestor
55850142|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850143|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55850144|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55850145|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55850146|NCT01659658|Growth Substances|growth substances|mesh-ancestor
55850147|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
55850148|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
55850149|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55850150|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850151|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
55850152|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850154|NCT01639690|Alkylating Agents|alkylating agents|mesh-ancestor
55850155|NCT01639690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850156|NCT01639690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850157|NCT01639690|Immunologic Factors|immunologic factors|mesh-ancestor
55850164|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850166|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55850167|NCT01615510|Narcotics|narcotics|mesh-ancestor
55850168|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850169|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850170|NCT01615510|Analgesics|analgesics|mesh-ancestor
55850171|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
55850172|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850173|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55850174|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55850175|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55850176|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850177|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
55850178|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850179|NCT00530062|Albuterol|albuterol|mesh-list
55850180|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55850181|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
55850182|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850183|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850184|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55850185|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
55850186|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
55850187|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55850188|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55850189|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55850190|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55850191|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
55850192|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850193|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850194|NCT04283656|Tenofovir|tenofovir|mesh-list
55850195|NCT04283656|Lamivudine|lamivudine|mesh-list
55850196|NCT04283656|Spironolactone|spironolactone|mesh-list
55850197|NCT04283656|Estradiol|estradiol|mesh-list
55850198|NCT04283656|Antiviral Agents|antiviral agents|mesh-ancestor
55850199|NCT04283656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850201|NCT04283656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55850202|NCT04283656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850203|NCT04283656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850204|NCT04283656|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55850205|NCT04283656|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55850206|NCT04283656|Estrogens|estrogens|mesh-ancestor
55850207|NCT04283656|Hormones|hormones|mesh-ancestor
55850315|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
55850208|NCT04283656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850209|NCT04283656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850210|NCT04283656|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
55850211|NCT04283656|Hormone Antagonists|hormone antagonists|mesh-ancestor
55850212|NCT04283656|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
55850213|NCT04283656|Diuretics|diuretics|mesh-ancestor
55850214|NCT04283656|Natriuretic Agents|natriuretic agents|mesh-ancestor
55850215|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
55850216|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55850217|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55850218|NCT01209364|Prednisolone|prednisolone|mesh-list
55850219|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
55850220|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55850221|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
55850222|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55850223|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
55850224|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
55850228|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
55850252|NCT00479128|Immunologic Factors|immunologic factors|mesh-ancestor
55850253|NCT00479128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850254|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55850255|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55850256|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55850257|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
55850259|NCT00472966|Glycolic acid|glycolic acid|mesh-list
55850260|NCT00472966|Hydroquinone|hydroquinone|mesh-list
55850261|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850262|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
55850263|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
55850264|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55850265|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
55850266|NCT00472966|Hormones|hormones|mesh-ancestor
55850267|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850268|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850269|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
55850270|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850271|NCT00472966|Protective Agents|protective agents|mesh-ancestor
55850272|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55850273|NCT01573780|Gemcitabine|gemcitabine|mesh-list
55850274|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850275|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
55850276|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850277|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850278|NCT01573780|Antiviral Agents|antiviral agents|mesh-ancestor
55850279|NCT01573780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850280|NCT01573780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850281|NCT01573780|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850282|NCT01573780|Immunologic Factors|immunologic factors|mesh-ancestor
55850283|NCT01573780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850284|NCT01547260|Gemcitabine|gemcitabine|mesh-list
55850285|NCT01547260|Lenalidomide|lenalidomide|mesh-list
55850287|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
55850290|NCT01547260|Antiviral Agents|antiviral agents|mesh-ancestor
55850291|NCT01547260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850292|NCT01547260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850293|NCT01547260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850294|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
55850295|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850296|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55850297|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55850299|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
55850300|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
55850301|NCT04205266|Hematinics|hematinics|mesh-ancestor
55850302|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
55850303|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
55850304|NCT01896388|Ifenprodil|ifenprodil|mesh-list
55850305|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
55850306|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
55850307|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
55850308|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850309|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850310|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850311|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
55850312|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55850313|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55850314|NCT01125436|Vitamin D|vitamin d|mesh-list
55850318|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850319|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55850320|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55850322|NCT04755322|Folic Acid|folic acid|mesh-list
55850323|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
55850324|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
55850325|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55850326|NCT04755322|Analgesics|analgesics|mesh-ancestor
55850329|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850330|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55850332|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55850333|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
55850334|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850335|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55850336|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
55850337|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850338|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
55850339|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
55850340|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55850341|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55850342|NCT04755322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850343|NCT04755322|Hematinics|hematinics|mesh-ancestor
55850344|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
55850345|NCT04755322|Vitamins|vitamins|mesh-ancestor
55850346|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
55850347|NCT00436540|Clobetasol|clobetasol|mesh-list
55850348|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55850349|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
55850350|NCT00436540|Hormones|hormones|mesh-ancestor
55850366|NCT00412594|Rituximab|rituximab|mesh-list
55850382|NCT00410956|Bevacizumab|bevacizumab|mesh-list
55850383|NCT00410956|Floxuridine|floxuridine|mesh-list
55850384|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55850385|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850386|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55850387|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55850388|NCT00410956|Growth Substances|growth substances|mesh-ancestor
55850389|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850390|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
55850391|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55850392|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
55850393|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
55850394|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850395|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850396|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
55850398|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850399|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55850400|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850401|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
55850402|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850403|NCT03800524|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
55850404|NCT03800524|Antiviral Agents|antiviral agents|mesh-ancestor
55850405|NCT03800524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850431|NCT04564612|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
55850432|NCT01066858|Tenofovir|tenofovir|mesh-list
55850433|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
55850434|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850435|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55850436|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55850437|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850438|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850439|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55850440|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55850441|NCT04777552|Diazepam|diazepam|mesh-list
55850442|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
55850444|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
55850445|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
55850446|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850447|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850448|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55850449|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55850450|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850451|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
55850452|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55850453|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55850456|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
55850457|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
55850458|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
55850459|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
55850460|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
55850477|NCT03027219|Alprostadil|alprostadil|mesh-list
55850478|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55850479|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
55850480|NCT03027219|Urological Agents|urological agents|mesh-ancestor
55850481|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
55850482|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
55850483|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850484|NCT01506453|Gabapentin|gabapentin|mesh-list
55850485|NCT01506453|Analgesics|analgesics|mesh-ancestor
55850486|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
55850487|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850488|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850489|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
55850490|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55850491|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55850492|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850493|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55850494|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55850495|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55850496|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850497|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850498|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
55850499|NCT04389580|Tamoxifen|tamoxifen|mesh-list
55850519|NCT00199108|Hormones|hormones|mesh-ancestor
55850528|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850529|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
55850530|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850531|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55850532|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850533|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850535|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
55850536|NCT04753918|Trioxsalen|trioxsalen|mesh-list
55850537|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850538|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
55850539|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55850540|NCT04161664|Paclitaxel|paclitaxel|mesh-list
55850541|NCT04161664|Carboplatin|carboplatin|mesh-list
55850542|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55850543|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850544|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
55850545|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
55850546|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
55850547|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850548|NCT00936832|Leucovorin|leucovorin|mesh-list
55850549|NCT00936832|Fluorouracil|fluorouracil|mesh-list
55850550|NCT00936832|Irinotecan|irinotecan|mesh-list
55850551|NCT00936832|Sunitinib|sunitinib|mesh-list
55850552|NCT00936832|Calcium|calcium|mesh-list
55850553|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
55850554|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55850555|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850578|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
55850579|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55850580|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55850581|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
55850582|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850583|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850584|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55850585|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
55850586|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
55850587|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
55850588|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
55850589|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55850590|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
55850591|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55850592|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
55850593|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850594|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850596|NCT04776226|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55850597|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55850598|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55850599|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850600|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850602|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850604|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
55850625|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
55850626|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
55850627|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
55850628|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
55850629|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850630|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850631|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55850632|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55850633|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
55850634|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850635|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
55850636|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
55850637|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
55850638|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55850639|NCT04784104|Epinephrine|epinephrine|mesh-list
55850640|NCT04784104|Racepinephrine|racepinephrine|mesh-list
55850641|NCT04784104|Bupivacaine|bupivacaine|mesh-list
55850642|NCT04784104|Prilocaine|prilocaine|mesh-list
55850643|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
55850645|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
55850646|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
55850647|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850648|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850649|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
55850650|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850651|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
55850652|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
55850653|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
55850654|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850655|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850656|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
55850657|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
55850658|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
55850661|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
55850663|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
55850664|NCT00880594|Desipramine|desipramine|mesh-list
55850665|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
55850666|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
55850667|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55850668|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850958|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
55850669|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850670|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
55850671|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55850672|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55850673|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
55850674|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850675|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850676|NCT04783870|Dapagliflozin|dapagliflozin|mesh-list
55850677|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55850678|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850679|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55850719|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
55850720|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
55850721|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
55850722|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
55850723|NCT04783636|Leuprolide|leuprolide|mesh-list
55850724|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
55850725|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
55850727|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850728|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55850729|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850730|NCT03510208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
55850731|NCT03510208|Panitumumab|panitumumab|mesh-list
55850732|NCT03510208|Antibodies|antibodies|mesh-list
55850733|NCT03510208|Immunoglobulins|immunoglobulins|mesh-list
55850734|NCT03510208|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
55850735|NCT03510208|Immunologic Factors|immunologic factors|mesh-ancestor
55850781|NCT04306900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850782|NCT04306900|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850783|NCT04306900|Antimetabolites|antimetabolites|mesh-ancestor
55850784|NCT04306900|Antiviral Agents|antiviral agents|mesh-ancestor
55850785|NCT04306900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55850786|NCT04306900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55850787|NCT04306900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850788|NCT04306900|Immunologic Factors|immunologic factors|mesh-ancestor
55850789|NCT04306900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850790|NCT04306900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55850791|NCT04774822|Mydriatics|mydriatics|mesh-list
55850792|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
55850793|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850794|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850796|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
55850797|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850798|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850799|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55850800|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55850801|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55850802|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
55850803|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
55850805|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850828|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55850829|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55850830|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850831|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
55850832|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
55850833|NCT04781998|Liraglutide|liraglutide|mesh-list
55850834|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55850835|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850837|NCT04781998|Hormones|hormones|mesh-ancestor
55850838|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55850839|NCT03300544|Leucovorin|leucovorin|mesh-list
55850840|NCT03300544|Fluorouracil|fluorouracil|mesh-list
55850841|NCT03300544|Capecitabine|capecitabine|mesh-list
55850842|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
55850843|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
55850844|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
55850845|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850846|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55850847|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55850848|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55850849|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
55850850|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850852|NCT03300544|Protective Agents|protective agents|mesh-ancestor
55850957|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55850959|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
55850960|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
55850961|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
55850962|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55850963|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55850964|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
55850965|NCT02090374|Vitamin D|vitamin d|mesh-list
55850966|NCT02090374|Poly ICLC|poly iclc|mesh-list
55850967|NCT02090374|Vitamins|vitamins|mesh-ancestor
55850968|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
55850969|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850970|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
55850971|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
55850972|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
55850973|NCT02222740|Hydrocodone|hydrocodone|mesh-list
55850974|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55850975|NCT02222740|Narcotics|narcotics|mesh-ancestor
55850976|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55850977|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55850978|NCT02222740|Analgesics|analgesics|mesh-ancestor
55850979|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
55850980|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55850981|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
55850982|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
55850983|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
55850984|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55851005|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55851006|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851513|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851007|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851009|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851010|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851011|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
55851012|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
55851013|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
55851014|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851015|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
55851016|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
55851017|NCT05411380|Capecitabine|capecitabine|mesh-list
55851018|NCT05411380|Letrozole|letrozole|mesh-list
55851019|NCT05411380|Fulvestrant|fulvestrant|mesh-list
55851020|NCT05411380|Anastrozole|anastrozole|mesh-list
55851021|NCT05411380|Exemestane|exemestane|mesh-list
55851022|NCT05411380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851023|NCT05411380|Antimetabolites|antimetabolites|mesh-ancestor
55851024|NCT05411380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851025|NCT05411380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851026|NCT05411380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
55851027|NCT05411380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
55851028|NCT05411380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851029|NCT05411380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
55851030|NCT05411380|Hormone Antagonists|hormone antagonists|mesh-ancestor
55851031|NCT05411380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851032|NCT05411380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851033|NCT05411380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55851034|NCT05411380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
55851035|NCT04779580|Anesthetics|anesthetics|mesh-list
55851036|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
55851037|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851038|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851039|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
55851041|NCT03925480|Azithromycin|azithromycin|mesh-list
55851043|NCT03925480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851044|NCT04770688|Osimertinib|osimertinib|mesh-list
55851045|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851046|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851047|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851048|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851049|NCT05390476|Capecitabine|capecitabine|mesh-list
55851050|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851051|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
55851052|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851053|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851054|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
55851055|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55851483|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
55851056|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851058|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851059|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851060|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851061|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851062|NCT00054028|Suramin|suramin|mesh-list
55851063|NCT00054028|Paclitaxel|paclitaxel|mesh-list
55851064|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55851065|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851066|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
55851067|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
55851069|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851070|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
55851071|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
55851072|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55851073|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851074|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
55851087|NCT00060346|Doxorubicin|doxorubicin|mesh-list
55851088|NCT00060346|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55851089|NCT00060346|Vincristine|vincristine|mesh-list
55851090|NCT00060346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851091|NCT00060346|Immunologic Factors|immunologic factors|mesh-ancestor
55851092|NCT00060346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851093|NCT00060346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851094|NCT00060346|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55851095|NCT00060346|Alkylating Agents|alkylating agents|mesh-ancestor
55851096|NCT00060346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851098|NCT00060346|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55851099|NCT00060346|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55851100|NCT00060346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55851103|NCT00060346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851145|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55851146|NCT00062764|Pioglitazone|pioglitazone|mesh-list
55851147|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55851148|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851149|NCT00063232|Metformin|metformin|mesh-list
55851150|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55851151|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851152|NCT00063622|Vitamin E|vitamin e|mesh-list
55851153|NCT00063622|Pioglitazone|pioglitazone|mesh-list
55851154|NCT00063622|Vitamins|vitamins|mesh-ancestor
55851155|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
55851156|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851158|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
55851159|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851160|NCT00063622|Protective Agents|protective agents|mesh-ancestor
55851161|NCT05605756|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
55851162|NCT05605756|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
55851163|NCT05605756|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55851164|NCT05605756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851165|NCT05605756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851166|NCT05605756|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
55851167|NCT05605756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55851197|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
55851198|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851199|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851200|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
55851201|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
55851266|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851267|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
55851268|NCT00071890|Aldesleukin|aldesleukin|mesh-list
55851269|NCT00071890|Interleukin-2|interleukin-2|mesh-list
55851270|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851271|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55851272|NCT00071890|Analgesics|analgesics|mesh-ancestor
55851273|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
55851274|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851275|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851276|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55851277|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55851278|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
55851279|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851280|NCT01475253|Lidocaine|lidocaine|mesh-list
55851325|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55851326|NCT00074308|Growth Substances|growth substances|mesh-ancestor
55851327|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851328|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
55851329|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
55851330|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851331|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851332|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851333|NCT00166036|Atorvastatin|atorvastatin|mesh-list
55851334|NCT00166036|Pravastatin|pravastatin|mesh-list
55851335|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55851336|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55851337|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
55851338|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851339|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55851340|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55851341|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851342|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
55851343|NCT00167206|Fludarabine|fludarabine|mesh-list
55851344|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851345|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
55851346|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851347|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851348|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55851349|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
55851350|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851371|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851374|NCT00168298|Hormones|hormones|mesh-ancestor
55851375|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851376|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55851377|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851378|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
55851379|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851380|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851381|NCT00078286|Sertraline|sertraline|mesh-list
55851382|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
55851384|NCT00078286|Serotonin Uptake Inhibitors|serotonin uptake inhibitors|mesh-ancestor
55851385|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55851386|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55851427|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
55851428|NCT00083122|Growth Substances|growth substances|mesh-ancestor
55851429|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851430|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851431|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851432|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851434|NCT01474239|Fotemustine|fotemustine|mesh-list
55851435|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55851436|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851437|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55851438|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55851439|NCT01474239|Growth Substances|growth substances|mesh-ancestor
55851440|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851441|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
55851442|NCT01473381|Dexetimide|dexetimide|mesh-list
55851443|NCT01473381|Citalopram|citalopram|mesh-list
55851446|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55851447|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55851448|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851449|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851450|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
55851451|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851452|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55851453|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
55851454|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55851471|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
55851472|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851473|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851474|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
55851475|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851476|NCT01499277|Vancomycin|vancomycin|mesh-list
55851477|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55851478|NCT01499277|Aztreonam|aztreonam|mesh-list
55851479|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55851480|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851482|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
55851484|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851485|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851486|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55851487|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55851488|NCT00176800|Growth Substances|growth substances|mesh-ancestor
55851489|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851490|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
55851491|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851492|NCT00176878|Fludarabine|fludarabine|mesh-list
55851493|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
55851494|NCT00176878|Busulfan|busulfan|mesh-list
55851495|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55851496|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851497|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851499|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851500|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851501|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
55851502|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851503|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
55851504|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55851506|NCT01898182|Kinetin|kinetin|mesh-list
55851511|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
55851512|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
55851514|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851516|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55851517|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
55851518|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851519|NCT02119468|Dexamethasone|dexamethasone|mesh-list
55851520|NCT02119468|Pomalidomide|pomalidomide|mesh-list
55851521|NCT02119468|Ixazomib|ixazomib|mesh-list
55851522|NCT02119468|Glycine|glycine|mesh-list
55851523|NCT02119468|Proteasome Inhibitors|proteasome inhibitors|mesh-list
55851524|NCT02119468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55851525|NCT02119468|Antiemetics|antiemetics|mesh-ancestor
55851526|NCT02119468|Autonomic Agents|autonomic agents|mesh-ancestor
55851527|NCT02119468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851528|NCT02119468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851529|NCT02119468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55851530|NCT02119468|Glucocorticoids|glucocorticoids|mesh-ancestor
55851532|NCT02119468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851533|NCT02119468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
55851535|NCT02119468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851536|NCT02119468|Immunologic Factors|immunologic factors|mesh-ancestor
55851537|NCT02119468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55851538|NCT02119468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55851539|NCT02119468|Growth Substances|growth substances|mesh-ancestor
55851540|NCT02119468|Growth Inhibitors|growth inhibitors|mesh-ancestor
55851543|NCT02119468|Glycine Agents|glycine agents|mesh-ancestor
55851557|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55851558|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851559|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
55851560|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
55851561|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851562|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851563|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
55851564|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851565|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
55851566|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
55851567|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851568|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55851569|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851570|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
55851571|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
55851572|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
55851573|NCT01527357|Coagulants|coagulants|mesh-ancestor
55851574|NCT00181714|Methylphenidate|methylphenidate|mesh-list
55851575|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55851576|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851577|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
55851578|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
55851583|NCT01472835|Fentanyl|fentanyl|mesh-list
55851606|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
55851608|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
55851609|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
55851610|NCT00185692|Prednisolone|prednisolone|mesh-list
55851611|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
55851612|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
55851613|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
55851614|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
55851615|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
55851616|NCT00185692|Cyclosporins|cyclosporins|mesh-list
55851617|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
55851618|NCT00185692|Lenograstim|lenograstim|mesh-list
55851619|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
55851620|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
55851621|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851622|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851623|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851624|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
55851625|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851626|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
55851627|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851628|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
55851629|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851630|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55851631|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55851632|NCT00185692|Analgesics|analgesics|mesh-ancestor
55851633|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
55851634|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851651|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
55851653|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
55851654|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
55851655|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
55851656|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55851657|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851658|NCT00094900|Rilonacept|rilonacept|mesh-list
55851659|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55851660|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
55851661|NCT00096460|Carmustine|carmustine|mesh-list
55851662|NCT00096460|Rituximab|rituximab|mesh-list
55851663|NCT00096460|Methotrexate|methotrexate|mesh-list
55851664|NCT00096460|Fludarabine|fludarabine|mesh-list
55851665|NCT00096460|Etoposide|etoposide|mesh-list
55851666|NCT00096460|Tacrolimus|tacrolimus|mesh-list
55851667|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851668|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
55851669|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851670|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851671|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55851672|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
55851673|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851674|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851675|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55851676|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55851677|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
55851678|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
55851679|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
55851680|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851681|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
55851682|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
55851698|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
55851699|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851700|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
55851701|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55851702|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851703|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851704|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55851705|NCT00098956|Topotecan|topotecan|mesh-list
55851706|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
55851707|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55851708|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55851709|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851710|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851711|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851712|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851713|NCT02197156|Acetaminophen|acetaminophen|mesh-list
55851714|NCT02197156|Hydrocodone|hydrocodone|mesh-list
55851715|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
55851716|NCT02197156|Analgesics|analgesics|mesh-ancestor
55851717|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
55851718|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851719|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851720|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
55851721|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
55851722|NCT02197156|Narcotics|narcotics|mesh-ancestor
55851723|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55851747|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
55851748|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55851749|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
55851750|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
55851752|NCT01525875|Antacids|antacids|mesh-ancestor
55851753|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851754|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
55851755|NCT01525641|Pramipexole|pramipexole|mesh-list
55851756|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
55851757|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851758|NCT01525641|Protective Agents|protective agents|mesh-ancestor
55851759|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851760|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
55851761|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
55851762|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
55851763|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
55851764|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851804|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55851896|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
55851805|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851806|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
55851807|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
55851808|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
55851809|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851810|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
55851811|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
55851812|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851814|NCT01471197|Ipilimumab|ipilimumab|mesh-list
55851815|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851816|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851817|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851818|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55851819|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55851820|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55851821|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
55851822|NCT04408989|Bevacizumab|bevacizumab|mesh-list
55851823|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55851824|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851825|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55851826|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55851827|NCT04408989|Growth Substances|growth substances|mesh-ancestor
55851828|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851829|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
55851830|NCT00011986|Gemcitabine|gemcitabine|mesh-list
55851831|NCT00011986|Paclitaxel|paclitaxel|mesh-list
55851832|NCT00011986|Carboplatin|carboplatin|mesh-list
55851833|NCT00011986|Doxorubicin|doxorubicin|mesh-list
55851847|NCT00011986|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851848|NCT00011986|Immunologic Factors|immunologic factors|mesh-ancestor
55851849|NCT00011986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851850|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55851851|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55851852|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55851853|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
55851854|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
55851855|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
55851856|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
55851858|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851859|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851860|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
55851861|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851862|NCT01494987|Glimepiride|glimepiride|mesh-list
55851863|NCT01494987|Ranolazine|ranolazine|mesh-list
55851864|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
55851865|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
55851866|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851867|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851868|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
55851869|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
55851870|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
55851871|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851872|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
55851873|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
55851874|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
55851875|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
55851876|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851877|NCT01470417|Gemcitabine|gemcitabine|mesh-list
55851878|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
55851879|NCT01470417|Paclitaxel|paclitaxel|mesh-list
55851880|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55851881|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
55851882|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851883|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851884|NCT01470417|Antiviral Agents|antiviral agents|mesh-ancestor
55851885|NCT01470417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851886|NCT01470417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851887|NCT01470417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55851888|NCT01470417|Immunologic Factors|immunologic factors|mesh-ancestor
55851889|NCT01470417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851890|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
55851891|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
55851892|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
55851893|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
55851895|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
55851898|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851899|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851900|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851937|NCT00193258|Growth Substances|growth substances|mesh-ancestor
55851938|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851939|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
55851940|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851941|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851942|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851945|NCT00029536|Hormones|hormones|mesh-ancestor
55851946|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
55851947|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851948|NCT00193492|Bevacizumab|bevacizumab|mesh-list
55851950|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55851951|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851952|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55851953|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55851954|NCT00193492|Growth Substances|growth substances|mesh-ancestor
55851955|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851956|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
55851957|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
55851958|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851960|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
55851961|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851962|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851963|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
55851964|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55851965|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55851984|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
55851985|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
55851986|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
55851987|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
55851988|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851989|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55851990|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55851992|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55851993|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
55851994|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55851997|NCT00108550|Analgesics|analgesics|mesh-ancestor
55851998|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
55851999|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852000|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852001|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
55852002|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
55852003|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
55852004|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
55852005|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852006|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
55852007|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
55852008|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852009|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852010|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
55852011|NCT02093962|Pemetrexed|pemetrexed|mesh-list
55852012|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852013|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852014|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852015|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
55852016|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
55852018|NCT00200902|Citalopram|citalopram|mesh-list
55852023|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852024|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
55852025|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
55852026|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852027|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
55852028|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
55852029|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
55852030|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
55852031|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
55852032|NCT00200902|Analgesics|analgesics|mesh-ancestor
55852033|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
55852034|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
55852037|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852038|NCT00201760|Gemcitabine|gemcitabine|mesh-list
55852039|NCT00201760|Trastuzumab|trastuzumab|mesh-list
55852040|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852041|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852042|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
55852051|NCT00201838|Gemcitabine|gemcitabine|mesh-list
55852075|NCT00040846|Fludarabine|fludarabine|mesh-list
55852151|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
55852152|NCT00112918|Calcium|calcium|mesh-list
55852153|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
55852155|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852156|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55852157|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55852158|NCT00112918|Growth Substances|growth substances|mesh-ancestor
55852159|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852160|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
55852161|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
55852162|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
55852163|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852164|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852165|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852166|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
55852167|NCT00112918|Antidotes|antidotes|mesh-ancestor
55852168|NCT00112918|Protective Agents|protective agents|mesh-ancestor
55852169|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
55852170|NCT00112918|Vitamins|vitamins|mesh-ancestor
55852171|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
55852172|NCT00046228|Reteplase|reteplase|mesh-list
55852173|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
55852174|NCT00046228|Abciximab|abciximab|mesh-list
55852175|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
55852176|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
55852177|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
55852200|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
55852201|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
55852202|NCT00113230|Growth Substances|growth substances|mesh-ancestor
55852203|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852204|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
55852205|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852206|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
55852207|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852208|NCT00049036|Prednisone|prednisone|mesh-list
55852209|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
55852210|NCT00049036|Rituximab|rituximab|mesh-list
55852211|NCT00049036|Doxorubicin|doxorubicin|mesh-list
55852212|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
55852213|NCT00049036|Etoposide|etoposide|mesh-list
55852214|NCT00049036|Vincristine|vincristine|mesh-list
55852215|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
55852218|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852220|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55852221|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
55852222|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852223|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852224|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55852225|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852226|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
55852227|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
55852228|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
55852229|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852230|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
55852231|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
55852243|NCT00049504|Tacrolimus|tacrolimus|mesh-list
55852244|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852245|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
55852246|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852247|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852248|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55852249|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
55852250|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852251|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852252|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55852253|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
55852254|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
55852255|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
55852256|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
55852266|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852267|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852290|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852292|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
55852293|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852294|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
55852295|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
55852296|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
55852297|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852298|NCT00217438|Melphalan|melphalan|mesh-list
55852299|NCT00217438|Amifostine|amifostine|mesh-list
55852300|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
55852301|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
55852302|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
55852303|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852304|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
55852305|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
55852306|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
55852307|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852308|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
55852309|NCT00217438|Protective Agents|protective agents|mesh-ancestor
55852310|NCT04480450|Rituximab|rituximab|mesh-list
55852311|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852312|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852313|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
55852314|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
55852315|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
55852316|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
55852317|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
55852318|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
55852319|NCT00052078|Sertraline|sertraline|mesh-list
55852320|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
55852332|NCT00119158|Tacrolimus|tacrolimus|mesh-list
